data_2k3m_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 2k3m _Structure_validation_residue.Date_analyzed 2016-10-07 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 N--CA 1.488 1.468 0 N-CA-C 108.866 -0.79 . . . . 1.0 108.866 . . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 85.5 p -106.87 10.47 30.62 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.297 -0.41 . . . . 1.0 110.405 -179.575 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 1.7 t70 166.07 94.37 0.0 OUTLIER 'General case' 0 N--CA 1.465 0.322 0 CA-C-N 115.965 -0.561 . . . . 1.0 110.003 179.646 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 54.7 t80 -149.04 144.77 26.92 Favored 'General case' 0 C--N 1.33 -0.262 0 N-CA-C 110.293 -0.262 . . . . 1.0 110.293 179.369 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 5' ' ' ASP . . . . . 0.516 ' N ' ' OD1' ' A' ' 5' ' ' ASP . 0.6 OUTLIER -154.95 151.48 28.57 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.799 0.333 . . . . 1.0 110.554 -179.285 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 6' ' ' THR . . . . . 0.672 ' O ' ' N ' ' A' ' 10' ' ' SER . 0.2 OUTLIER -67.99 176.18 2.75 Favored 'General case' 0 C--O 1.206 -1.223 0 CA-C-N 116.352 -0.385 . . . . 1.0 110.526 -179.617 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . 0.528 ' O ' ' N ' ' A' ' 11' ' ' ARG . 82.2 tt0 -58.49 -58.76 7.12 Favored 'General case' 0 C--N 1.318 -0.769 0 CA-C-O 121.466 0.651 . . . . 1.0 110.254 -177.558 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 8' ' ' ARG . . . . . 0.494 ' O ' ' CB ' ' A' ' 12' ' ' ALA . 26.9 mtp180 -47.86 -55.06 10.64 Favored 'General case' 0 C--O 1.213 -0.82 0 N-CA-C 107.06 -1.459 . . . . 1.0 107.06 -178.874 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . 0.585 ' O ' ' CG2' ' A' ' 13' ' ' VAL . 63.1 t -64.89 -49.17 81.15 Favored 'Isoleucine or valine' 0 C--O 1.199 -1.589 0 CA-C-N 114.356 -1.293 . . . . 1.0 110.702 177.971 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 10' ' ' SER . . . . . 0.672 ' N ' ' O ' ' A' ' 6' ' ' THR . 75.2 m -67.82 -65.54 0.68 Allowed 'General case' 0 C--N 1.316 -0.882 0 C-N-CA 119.764 -0.774 . . . . 1.0 112.098 -178.302 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 11' ' ' ARG . . . . . 0.528 ' N ' ' O ' ' A' ' 7' ' ' GLU . 11.2 ttm180 -64.35 -58.48 6.38 Favored 'General case' 0 C--N 1.324 -0.519 0 C-N-CA 119.839 -0.744 . . . . 1.0 111.764 -176.066 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . 0.494 ' CB ' ' O ' ' A' ' 8' ' ' ARG . . . -47.9 -48.64 31.42 Favored 'General case' 0 CA--C 1.539 0.547 0 N-CA-C 106.71 -1.589 . . . . 1.0 106.71 -177.907 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . 0.659 ' O ' ' N ' ' A' ' 17' ' ' LEU . 97.6 t -62.07 -50.9 78.2 Favored 'Isoleucine or valine' 0 C--O 1.194 -1.846 0 C-N-CA 118.839 -1.145 . . . . 1.0 109.28 177.281 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -56.85 -62.21 1.9 Allowed 'General case' 0 C--O 1.207 -1.151 0 O-C-N 120.871 -1.143 . . . . 1.0 109.572 -179.938 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . 0.558 ' O ' ' N ' ' A' ' 19' ' ' GLY . . . -51.36 -54.3 27.78 Favored 'General case' 0 C--N 1.319 -0.754 0 CA-C-O 121.79 0.805 . . . . 1.0 109.248 -178.521 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . 0.466 ' CB ' ' O ' ' A' ' 12' ' ' ALA . . . -61.52 -54.63 40.73 Favored 'General case' 0 C--N 1.308 -1.218 0 CA-C-N 114.62 -1.173 . . . . 1.0 108.508 -179.207 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . 0.659 ' N ' ' O ' ' A' ' 13' ' ' VAL . 42.4 tp -55.46 -54.29 45.72 Favored 'General case' 0 N--CA 1.478 0.961 0 CA-C-N 113.574 -1.648 . . . . 1.0 109.053 -177.16 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . 0.603 HG21 ' H ' ' A' ' 19' ' ' GLY . 3.6 m -68.65 -57.0 10.24 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.235 0 N-CA-C 108.992 -0.744 . . . . 1.0 108.992 178.912 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . 0.603 ' H ' HG21 ' A' ' 18' ' ' VAL . . . -63.04 -170.72 1.37 Allowed Glycine 0 CA--C 1.525 0.66 0 N-CA-C 110.829 -0.908 . . . . 1.0 110.829 -179.992 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 20' ' ' PRO . . . . . 0.648 ' O ' ' N ' ' A' ' 24' ' ' ALA . 93.0 Cg_endo -79.25 -27.02 4.65 Favored 'Trans proline' 0 C--N 1.308 -1.591 0 C-N-CA 122.797 2.331 . . . . 1.0 114.129 -178.33 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -57.16 -56.21 26.23 Favored Glycine 0 N--CA 1.477 1.375 0 C-N-CA 119.822 -1.18 . . . . 1.0 111.064 -177.624 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . 0.453 ' N ' ' O ' ' A' ' 16' ' ' ALA . . . -60.38 -55.83 27.85 Favored Glycine 0 N--CA 1.468 0.803 0 N-CA-C 108.587 -1.805 . . . . 1.0 108.587 -178.39 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -59.77 -35.15 58.41 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.204 0 CA-C-N 114.561 -0.82 . . . . 1.0 109.417 -179.94 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . 0.648 ' N ' ' O ' ' A' ' 20' ' ' PRO . . . -57.89 -61.92 2.19 Favored 'General case' 0 N--CA 1.452 -0.36 0 C-N-CA 118.99 -1.084 . . . . 1.0 109.739 -178.704 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 16.2 tp -65.38 -42.11 93.04 Favored 'General case' 0 N--CA 1.451 -0.411 0 C-N-CA 119.853 -0.739 . . . . 1.0 111.904 -178.326 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 89.6 t -61.57 -60.39 2.78 Favored 'Isoleucine or valine' 0 CA--C 1.522 -0.104 0 C-N-CA 118.834 -1.147 . . . . 1.0 110.307 -177.931 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . 0.411 ' O ' ' CB ' ' A' ' 31' ' ' ALA . 93.4 t -62.57 -38.26 81.03 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 N-CA-C 112.814 0.672 . . . . 1.0 112.814 -178.316 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 3.3 ttmp? -64.34 -55.02 24.05 Favored 'General case' 0 C--N 1.314 -0.95 0 CA-C-O 121.929 0.871 . . . . 1.0 108.775 -178.213 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 55.6 t -64.58 -45.15 96.35 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.008 0 CA-C-N 113.632 -1.622 . . . . 1.0 109.801 -178.533 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 30' ' ' CYS . . . . . . . . . . . . . 43.1 t -65.85 -61.16 2.22 Favored 'General case' 0 N--CA 1.445 -0.715 0 C-N-CA 118.666 -1.213 . . . . 1.0 108.743 179.729 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . 0.411 ' CB ' ' O ' ' A' ' 27' ' ' VAL . . . -63.73 -57.09 11.06 Favored 'General case' 0 CA--C 1.512 -0.514 0 N-CA-C 113.486 0.921 . . . . 1.0 113.486 -176.358 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . 0.475 ' O ' ' CB ' ' A' ' 33' ' ' LEU . . . 89.92 74.02 1.28 Allowed Glycine 0 CA--C 1.526 0.737 0 N-CA-C 110.862 -0.895 . . . . 1.0 110.862 -178.92 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . 0.475 ' CB ' ' O ' ' A' ' 32' ' ' GLY . 4.7 tp 87.43 84.08 0.04 OUTLIER Pre-proline 0 CA--C 1.544 0.746 0 CA-C-O 120.999 0.428 . . . . 1.0 111.204 179.578 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 52.1 Cg_exo -55.48 -33.3 85.69 Favored 'Trans proline' 0 N--CA 1.503 2.037 0 C-N-CA 123.798 2.998 . . . . 1.0 115.298 -179.528 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -55.39 -58.65 12.88 Favored Glycine 0 N--CA 1.469 0.871 0 C-N-CA 118.462 -1.827 . . . . 1.0 108.616 -178.804 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . 0.558 ' O ' ' CB ' ' A' ' 37' ' ' ILE . 23.2 m -86.77 160.05 3.06 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.649 0 N-CA-C 107.081 -1.451 . . . . 1.0 107.081 177.616 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . 0.558 ' CB ' ' O ' ' A' ' 36' ' ' VAL . 14.3 tt 126.97 115.35 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.477 0.886 0 O-C-N 124.195 0.934 . . . . 1.0 110.503 -179.741 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 38' ' ' HIS . . . . . 0.438 ' ND1' ' O ' ' A' ' 37' ' ' ILE . 0.1 OUTLIER -141.04 133.14 27.88 Favored 'General case' 0 C--N 1.325 -0.494 0 N-CA-C 108.154 -1.054 . . . . 1.0 108.154 177.518 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 38.8 p -115.03 143.55 30.38 Favored Pre-proline 0 C--N 1.33 -0.265 0 N-CA-C 108.771 -0.826 . . . . 1.0 108.771 179.501 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 40' ' ' PRO . . . . . 0.427 ' HG2' ' H ' ' A' ' 41' ' ' ALA . 57.1 Cg_endo -72.22 -82.73 0.01 OUTLIER 'Trans proline' 0 C--N 1.306 -1.699 0 C-N-CA 121.708 1.605 . . . . 1.0 112.551 -179.363 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . 0.427 ' H ' ' HG2' ' A' ' 40' ' ' PRO . . . -78.34 124.11 27.74 Favored 'General case' 0 C--N 1.311 -1.074 0 CA-C-N 114.436 -1.256 . . . . 1.0 111.686 -176.7 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . 0.723 ' C ' ' H ' ' A' ' 44' ' ' GLY . 13.6 ptt180 -170.9 169.71 6.66 Favored 'General case' 0 C--N 1.313 -0.981 0 CA-C-N 114.634 -1.167 . . . . 1.0 109.696 178.786 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 7.2 tpt180 -61.65 18.04 0.01 OUTLIER 'General case' 0 C--N 1.322 -0.608 0 C-N-CA 120.568 -0.453 . . . . 1.0 109.957 178.321 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . 0.723 ' H ' ' C ' ' A' ' 42' ' ' ARG . . . 82.98 -24.83 5.04 Favored Glycine 0 N--CA 1.446 -0.634 0 N-CA-C 110.506 -1.038 . . . . 1.0 110.506 -179.658 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . 0.759 ' O ' ' CG ' ' A' ' 46' ' ' PHE . 0.2 OUTLIER -164.5 172.82 12.81 Favored 'General case' 0 C--O 1.221 -0.403 0 C-N-CA 121.101 -0.24 . . . . 1.0 110.656 -179.553 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 46' ' ' PHE . . . . . 0.759 ' CG ' ' O ' ' A' ' 45' ' ' PHE . 22.0 m-30 127.1 90.41 0.0 OUTLIER 'General case' 0 N--CA 1.484 1.256 0 O-C-N 125.534 1.771 . . . . 1.0 111.688 179.391 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 47' ' ' ARG . . . . . 0.721 ' O ' ' SG ' ' A' ' 48' ' ' CYS . 2.2 ptm180 121.09 156.49 0.0 OUTLIER 'General case' 0 N--CA 1.477 0.895 0 O-C-N 125.449 1.718 . . . . 1.0 109.187 179.355 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 48' ' ' CYS . . . . . 0.721 ' SG ' ' O ' ' A' ' 47' ' ' ARG . 2.0 p 67.74 68.85 0.36 Allowed 'General case' 0 CA--C 1.532 0.284 0 CA-C-O 121.897 0.856 . . . . 1.0 109.523 -179.156 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -142.91 151.84 57.31 Favored Pre-proline 0 CA--C 1.534 0.361 0 N-CA-C 108.297 -1.001 . . . . 1.0 108.297 179.864 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 89.3 Cg_endo -77.31 69.9 6.98 Favored 'Trans proline' 0 C--N 1.308 -1.58 0 C-N-CA 122.015 1.81 . . . . 1.0 112.608 -179.728 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 5.4 tp10 64.68 26.93 13.19 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 120.697 0.284 . . . . 1.0 111.462 179.198 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -102.28 138.92 38.57 Favored 'General case' 0 N--CA 1.466 0.373 0 CA-C-N 116.474 -0.33 . . . . 1.0 110.262 179.066 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . 0.445 ' O ' ' N ' ' A' ' 55' ' ' ILE . 19.6 tt -66.61 139.64 20.8 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.251 0 CA-C-O 121.423 0.63 . . . . 1.0 110.718 179.553 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 4.2 pt20 -63.41 80.41 0.02 OUTLIER 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 114.781 -1.1 . . . . 1.0 109.586 -178.458 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . 0.445 ' N ' ' O ' ' A' ' 53' ' ' ILE . 1.8 tt -148.03 156.89 8.9 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.415 0 N-CA-C 109.902 -0.407 . . . . 1.0 109.902 178.242 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 113.57 -4.67 24.69 Favored Glycine 0 N--CA 1.467 0.705 0 N-CA-C 110.606 -0.998 . . . . 1.0 110.606 -179.765 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 14.8 p-10 -79.36 96.48 6.01 Favored 'General case' 0 C--N 1.325 -0.464 0 N-CA-C 109.318 -0.623 . . . . 1.0 109.318 177.625 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 58' ' ' TRP . . . . . 0.519 ' CE3' ' NH1' ' A' ' 59' ' ' ARG . 0.8 OUTLIER -86.54 176.36 7.86 Favored 'General case' 0 N--CA 1.467 0.421 0 CA-C-O 122.229 1.014 . . . . 1.0 112.647 -178.37 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 59' ' ' ARG . . . . . 0.519 ' NH1' ' CE3' ' A' ' 58' ' ' TRP . 0.0 OUTLIER -87.29 -56.28 3.43 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 113.326 -1.761 . . . . 1.0 112.388 -179.394 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 73.6 t80 -93.81 -16.86 23.7 Favored 'General case' 0 C--O 1.249 1.044 0 CA-C-O 121.813 0.816 . . . . 1.0 113.153 -179.112 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . 0.459 ' O ' ' N ' ' A' ' 65' ' ' ASP . 6.5 tt0 -78.79 -13.23 59.92 Favored 'General case' 0 N--CA 1.444 -0.766 0 O-C-N 121.418 -0.801 . . . . 1.0 111.516 -178.24 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 62' ' ' VAL . . . . . 0.596 ' O ' ' N ' ' A' ' 66' ' ' GLY . 0.0 OUTLIER -47.8 -55.63 2.38 Favored 'Isoleucine or valine' 0 C--O 1.208 -1.11 0 C-N-CA 119.244 -0.983 . . . . 1.0 109.589 -175.559 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -65.01 -52.42 56.19 Favored 'General case' 0 C--N 1.31 -1.136 0 C-N-CA 119.335 -0.946 . . . . 1.0 109.192 -179.984 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 64' ' ' HIS . . . . . 0.475 ' O ' ' HB2' ' A' ' 67' ' ' ARG . 6.0 t-80 -50.78 -57.78 7.54 Favored 'General case' 0 CA--C 1.536 0.43 0 C-N-CA 119.463 -0.895 . . . . 1.0 109.894 -179.534 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 65' ' ' ASP . . . . . 0.577 ' O ' ' ND2' ' A' ' 75' ' ' ASN . 3.3 t0 -70.1 -47.05 63.46 Favored 'General case' 0 C--N 1.314 -0.963 0 CA-C-O 122.065 0.935 . . . . 1.0 110.303 179.188 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . 0.596 ' N ' ' O ' ' A' ' 62' ' ' VAL . . . -70.13 28.25 0.43 Allowed Glycine 0 C--N 1.316 -0.572 0 O-C-N 121.47 -0.769 . . . . 1.0 111.642 179.725 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 67' ' ' ARG . . . . . 0.565 ' H ' ' C ' ' A' ' 65' ' ' ASP . 0.0 OUTLIER -81.25 -3.01 51.08 Favored 'General case' 0 C--N 1.319 -0.755 0 N-CA-C 107.964 -1.124 . . . . 1.0 107.964 176.559 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . 0.4 ' O ' ' HB3' ' A' ' 72' ' ' HIS . 8.7 tp -42.25 -31.67 0.42 Allowed 'General case' 0 C--O 1.216 -0.679 0 CA-C-N 115.567 -0.742 . . . . 1.0 109.495 -179.904 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 3.8 tt -67.83 -68.66 0.37 Allowed 'General case' 0 CA--C 1.54 0.581 0 C-N-CA 118.434 -1.306 . . . . 1.0 112.877 -177.347 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . 0.601 ' C ' ' H ' ' A' ' 72' ' ' HIS . . . -74.58 -84.36 0.05 OUTLIER 'General case' 0 N--CA 1.47 0.563 0 C-N-CA 116.757 -1.977 . . . . 1.0 109.03 -176.426 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 71' ' ' ALA . . . . . 0.884 ' O ' ' N ' ' A' ' 73' ' ' MET . . . -56.37 16.28 0.0 OUTLIER 'General case' 0 C--N 1.308 -1.233 0 C-N-CA 124.993 1.317 . . . . 1.0 113.588 -179.738 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 72' ' ' HIS . . . . . 0.601 ' H ' ' C ' ' A' ' 70' ' ' ALA . 0.0 OUTLIER -17.92 -29.32 0.0 OUTLIER 'General case' 0 N--CA 1.473 0.676 0 N-CA-C 112.758 0.651 . . . . 1.0 112.758 -175.048 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 73' ' ' MET . . . . . 0.884 ' N ' ' O ' ' A' ' 71' ' ' ALA . 19.0 mmt -64.81 -56.59 12.59 Favored 'General case' 0 N--CA 1.446 -0.646 0 C-N-CA 119.667 -0.813 . . . . 1.0 108.84 176.4 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . 0.665 ' O ' ' N ' ' A' ' 76' ' ' GLY . 34.8 m -43.96 -50.97 1.62 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.821 0 CA-C-O 117.814 -1.089 . . . . 1.0 111.565 -174.815 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 75' ' ' ASN . . . . . 0.577 ' ND2' ' O ' ' A' ' 65' ' ' ASP . 2.0 t-20 -36.42 -18.24 0.0 OUTLIER 'General case' 0 N--CA 1.47 0.533 0 CA-C-N 121.042 1.746 . . . . 1.0 112.299 -179.831 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 76' ' ' GLY . . . . . 0.665 ' N ' ' O ' ' A' ' 74' ' ' VAL . . . -47.72 -28.19 5.1 Favored Glycine 0 CA--C 1.537 1.437 0 N-CA-C 109.16 -1.576 . . . . 1.0 109.16 177.681 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 77' ' ' ILE . . . . . 0.621 ' CG1' ' H ' ' A' ' 78' ' ' VAL . 6.9 pt -69.29 -51.77 39.7 Favored 'Isoleucine or valine' 0 C--O 1.21 -1.009 0 CA-C-O 122.114 0.959 . . . . 1.0 108.828 -179.967 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . 0.621 ' H ' ' CG1' ' A' ' 77' ' ' ILE . 77.0 t -36.25 -33.12 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.313 -0.979 0 CA-C-N 113.003 -1.908 . . . . 1.0 107.292 -176.701 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . 0.502 ' N ' ' O ' ' A' ' 77' ' ' ILE . 0.7 OUTLIER -96.77 -31.68 4.02 Favored 'Isoleucine or valine' 0 C--O 1.213 -0.842 0 CA-C-N 115.606 -0.724 . . . . 1.0 110.938 176.653 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 80' ' ' ALA . . . . . 0.604 ' N ' ' O ' ' A' ' 77' ' ' ILE . . . -82.45 -8.78 59.61 Favored 'General case' 0 N--CA 1.473 0.68 0 N-CA-C 112.521 0.563 . . . . 1.0 112.521 179.367 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 81' ' ' GLU . . . . . 0.553 ' N ' ' O ' ' A' ' 77' ' ' ILE . 7.6 mm-40 -91.15 -72.69 0.57 Allowed 'General case' 0 N--CA 1.439 -0.982 0 O-C-N 122.036 -0.415 . . . . 1.0 112.018 -178.258 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 8.3 t70 -92.68 -14.4 28.12 Favored 'General case' 0 C--N 1.346 0.423 0 N-CA-C 115.024 1.49 . . . . 1.0 115.024 -178.89 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . 0.583 ' O ' ' N ' ' A' ' 85' ' ' ILE . . . -54.26 -44.8 72.14 Favored 'General case' 0 CA--C 1.54 0.595 0 C-N-CA 118.464 -1.294 . . . . 1.0 112.894 -177.505 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . 0.747 ' H ' ' CD1' ' A' ' 84' ' ' LEU . 0.0 OUTLIER -42.75 -14.74 0.01 OUTLIER 'General case' 0 N--CA 1.474 0.752 0 CA-C-N 119.018 0.826 . . . . 1.0 111.079 -177.682 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 85' ' ' ILE . . . . . 0.583 ' N ' ' O ' ' A' ' 83' ' ' ALA . 3.5 mm -94.04 -29.81 4.27 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.25 0 C-N-CA 120.674 -0.41 . . . . 1.0 110.223 179.056 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 86' ' ' ALA . . . . . 0.695 ' C ' ' H ' ' A' ' 88' ' ' ALA . . . -93.02 -24.24 18.4 Favored 'General case' 0 CA--C 1.522 -0.125 0 CA-C-O 121.513 0.673 . . . . 1.0 109.732 179.26 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 20.3 tt0 -63.82 25.85 0.01 OUTLIER 'General case' 0 C--N 1.32 -0.714 0 CA-C-O 121.491 0.662 . . . . 1.0 110.474 -179.036 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 88' ' ' ALA . . . . . 0.695 ' H ' ' C ' ' A' ' 86' ' ' ALA . . . -123.31 -7.31 8.19 Favored 'General case' 0 N--CA 1.474 0.766 0 CA-C-O 122.207 1.004 . . . . 1.0 108.519 178.836 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 2.4 t -84.31 36.9 0.05 OUTLIER 'Isoleucine or valine' 0 C--O 1.216 -0.659 0 CA-C-N 112.77 -2.014 . . . . 1.0 109.172 178.383 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 90' ' ' GLY . . . . . 0.513 ' N ' ' CD ' ' A' ' 91' ' ' PRO . . . -74.26 -40.52 40.98 Favored Glycine 0 C--N 1.345 1.052 0 C-N-CA 120.504 -0.855 . . . . 1.0 111.382 179.57 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 91' ' ' PRO . . . . . 0.513 ' CD ' ' N ' ' A' ' 90' ' ' GLY . 98.3 Cg_exo -43.51 -21.64 0.31 Allowed 'Trans proline' 0 N--CA 1.497 1.698 0 CA-C-N 119.572 1.686 . . . . 1.0 109.788 -179.701 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 92' ' ' HIS . . . . . 0.799 ' O ' ' N ' ' A' ' 96' ' ' ALA . 0.3 OUTLIER -55.34 -18.4 6.49 Favored 'General case' 0 C--O 1.194 -1.832 0 N-CA-C 107.167 -1.42 . . . . 1.0 107.167 179.897 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 93' ' ' LEU . . . . . 0.457 ' HG ' ' H ' ' A' ' 94' ' ' ALA . 2.8 pp -51.01 -53.66 31.45 Favored 'General case' 0 CA--C 1.541 0.612 0 N-CA-C 108.669 -0.863 . . . . 1.0 108.669 178.556 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 94' ' ' ALA . . . . . 0.457 ' H ' ' HG ' ' A' ' 93' ' ' LEU . . . -52.23 -44.87 65.06 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-N 114.521 -1.218 . . . . 1.0 108.972 -179.279 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 95' ' ' ARG . . . . . 0.529 ' C ' ' H ' ' A' ' 97' ' ' LEU . 0.0 OUTLIER -78.18 -49.87 13.01 Favored 'General case' 0 CA--C 1.553 1.077 0 CA-C-O 125.921 2.772 . . . . 1.0 109.142 178.619 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 96' ' ' ALA . . . . . 0.799 ' N ' ' O ' ' A' ' 92' ' ' HIS . . . -68.49 28.0 0.03 OUTLIER 'General case' 0 C--N 1.259 -3.335 0 CA-C-N 112.901 -1.954 . . . . 1.0 107.264 173.028 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 97' ' ' LEU . . . . . 0.744 ' O ' ' N ' ' A' ' 100' ' ' ILE . 0.0 OUTLIER -43.71 -46.34 7.45 Favored 'General case' 0 C--O 1.202 -1.444 0 N-CA-C 108.861 -0.792 . . . . 1.0 108.861 178.64 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 98' ' ' GLY . . . . . 0.628 ' H ' HD11 ' A' ' 97' ' ' LEU . . . -49.22 -28.2 8.32 Favored Glycine 0 CA--C 1.5 -0.891 0 N-CA-C 107.867 -2.093 . . . . 1.0 107.867 -179.862 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 99' ' ' GLN . . . . . 0.62 ' N ' ' O ' ' A' ' 96' ' ' ALA . 0.0 OUTLIER -59.41 -22.19 61.05 Favored 'General case' 0 C--O 1.216 -0.7 0 N-CA-C 106.693 -1.595 . . . . 1.0 106.693 176.811 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 100' ' ' ILE . . . . . 0.744 ' N ' ' O ' ' A' ' 97' ' ' LEU . 6.1 mm -67.68 -51.55 49.73 Favored 'Isoleucine or valine' 0 C--O 1.207 -1.155 0 CA-C-N 115.387 -0.824 . . . . 1.0 110.045 178.704 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 101' ' ' VAL . . . . . 0.698 ' O ' ' N ' ' A' ' 105' ' ' GLY . 0.4 OUTLIER -52.87 -61.06 0.89 Allowed 'Isoleucine or valine' 0 C--O 1.213 -0.835 0 C-N-CA 119.085 -1.046 . . . . 1.0 110.412 -178.296 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 102' ' ' CYS . . . . . 0.572 ' N ' ' CG1' ' A' ' 101' ' ' VAL . 1.4 p -56.06 -21.77 23.74 Favored 'General case' 0 C--N 1.316 -0.881 0 C-N-CA 118.942 -1.103 . . . . 1.0 110.062 -176.98 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -84.51 -53.89 5.12 Favored 'General case' 0 N--CA 1.481 1.082 0 O-C-N 124.339 1.025 . . . . 1.0 112.399 178.888 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 104' ' ' TYR . . . . . . . . . . . . . 17.9 t80 -96.37 21.18 9.41 Favored 'General case' 0 C--N 1.309 -1.19 0 C-N-CA 126.44 1.896 . . . . 1.0 108.753 178.636 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 105' ' ' GLY . . . . . 0.698 ' N ' ' O ' ' A' ' 101' ' ' VAL . . . -153.62 -96.49 0.13 Allowed Glycine 0 C--N 1.335 0.492 0 N-CA-C 107.893 -2.083 . . . . 1.0 107.893 178.926 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . 67.2 109.37 0.04 OUTLIER 'General case' 0 CA--C 1.541 0.622 0 O-C-N 122.988 -0.125 . . . . 1.0 111.297 -178.976 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 107' ' ' THR . . . . . 0.649 ' C ' ' H ' ' A' ' 109' ' ' ILE . 0.3 OUTLIER -134.66 -63.69 0.7 Allowed 'General case' 0 C--N 1.353 0.731 0 N-CA-C 105.932 -1.877 . . . . 1.0 105.932 176.926 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 26.9 m -67.16 23.61 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.324 -0.519 0 O-C-N 121.657 -0.652 . . . . 1.0 109.453 179.686 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 109' ' ' ILE . . . . . 0.649 ' H ' ' C ' ' A' ' 107' ' ' THR . 0.1 OUTLIER -115.5 -57.09 0.04 OUTLIER Pre-proline 0 CA--C 1.552 1.032 0 N-CA-C 108.278 -1.008 . . . . 1.0 108.278 175.79 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 110' ' ' PRO . . . . . 0.603 ' HD2' ' H ' ' A' ' 109' ' ' ILE . 18.6 Cg_endo -53.82 -39.46 84.05 Favored 'Trans proline' 0 N--CA 1.506 2.237 0 C-N-CA 122.673 2.249 . . . . 1.0 112.046 177.584 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 111' ' ' ASN . . . . . 0.447 ' C ' ' N ' ' A' ' 113' ' ' ASN . 39.3 t30 -67.68 -67.62 0.45 Allowed 'General case' 0 C--O 1.238 0.45 0 C-N-CA 119.91 -0.716 . . . . 1.0 110.463 -178.342 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 112' ' ' ILE . . . . . 0.417 ' CD1' ' C ' ' A' ' 112' ' ' ILE . 1.4 pp -52.88 -21.45 3.11 Favored 'Isoleucine or valine' 0 C--O 1.212 -0.87 0 CA-C-O 121.998 0.904 . . . . 1.0 108.647 -179.924 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 113' ' ' ASN . . . . . 0.447 ' N ' ' C ' ' A' ' 111' ' ' ASN . 0.0 OUTLIER -60.58 -52.82 63.52 Favored 'General case' 0 C--N 1.311 -1.093 0 CA-C-N 112.698 -2.046 . . . . 1.0 108.813 -179.894 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -58.18 -28.83 65.13 Favored 'General case' 0 N--CA 1.455 -0.194 0 CA-C-N 119.01 0.823 . . . . 1.0 111.48 179.226 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 115' ' ' ALA . . . . . 0.555 ' O ' ' N ' ' A' ' 118' ' ' VAL . . . -81.1 -52.06 7.8 Favored 'General case' 0 C--O 1.219 -0.53 0 N-CA-C 109.108 -0.701 . . . . 1.0 109.108 177.552 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 116' ' ' ILE . . . . . 0.425 ' O ' ' N ' ' A' ' 120' ' ' GLY . 1.2 tp -42.13 -49.7 0.96 Allowed 'Isoleucine or valine' 0 N--CA 1.478 0.943 0 N-CA-C 105.611 -1.996 . . . . 1.0 105.611 179.766 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 117' ' ' GLU . . . . . 0.417 ' O ' ' CA ' ' A' ' 121' ' ' THR . 62.7 mt-10 -45.1 -57.53 3.82 Favored 'General case' 0 C--N 1.312 -1.036 0 CA-C-N 110.493 -3.049 . . . . 1.0 105.857 178.341 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 118' ' ' VAL . . . . . 0.555 ' N ' ' O ' ' A' ' 115' ' ' ALA . 54.9 t -68.15 -57.13 10.22 Favored 'Isoleucine or valine' 0 CA--C 1.551 1.004 0 C-N-CA 120.684 -0.406 . . . . 1.0 111.046 178.042 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 119' ' ' LEU . . . . . 0.506 ' N ' ' O ' ' A' ' 115' ' ' ALA . 59.2 tp -52.77 -19.85 2.77 Favored 'General case' 0 CA--C 1.538 0.492 0 N-CA-C 113.78 1.03 . . . . 1.0 113.78 -178.666 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 120' ' ' GLY . . . . . 0.607 ' O ' ' OG1' ' A' ' 121' ' ' THR . . . -127.3 -73.81 0.19 Allowed Glycine 0 CA--C 1.547 2.076 0 N-CA-C 106.535 -2.626 . . . . 1.0 106.535 172.719 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 121' ' ' THR . . . . . 0.607 ' OG1' ' O ' ' A' ' 120' ' ' GLY . 17.6 m 161.9 -44.62 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.772 0 CA-C-N 112.686 -1.757 . . . . 1.0 112.796 179.444 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 122' ' ' GLY . . . . . 0.68 ' O ' ' N ' ' A' ' 124' ' ' ASP . . . 104.76 -15.22 49.07 Favored Glycine 0 N--CA 1.471 0.985 0 N-CA-C 108.282 -1.927 . . . . 1.0 108.282 -175.98 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 123' ' ' THR . . . . . 0.453 ' O ' ' CG ' ' A' ' 124' ' ' ASP . 8.4 t -56.95 81.11 0.01 OUTLIER 'General case' 0 N--CA 1.469 0.511 0 N-CA-C 104.615 -2.365 . . . . 1.0 104.615 178.438 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 124' ' ' ASP . . . . . 0.68 ' N ' ' O ' ' A' ' 122' ' ' GLY . 28.6 m-20 -166.93 178.37 5.83 Favored 'General case' 0 N--CA 1.465 0.307 0 CA-C-N 113.464 -1.698 . . . . 1.0 111.552 179.815 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 125' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -142.06 143.07 32.93 Favored 'General case' 0 CA--C 1.54 0.564 0 N-CA-C 108.086 -1.079 . . . . 1.0 108.086 175.766 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 3.0 tpm_? -147.43 146.02 29.42 Favored 'General case' 0 C--N 1.332 -0.185 0 N-CA-C 110.049 -0.352 . . . . 1.0 110.049 179.43 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 127' ' ' PHE . . . . . . . . . . . . . 1.5 t80 . . . . . 0 C--O 1.221 -0.411 0 CA-C-O 117.94 -1.028 . . . . 1.0 109.528 179.498 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 11.8 mtt . . . . . 0 N--CA 1.49 1.55 0 N-CA-C 108.918 -0.771 . . . . 1.0 108.918 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 93.1 p -90.12 3.64 52.76 Favored 'General case' 0 N--CA 1.464 0.238 0 CA-C-N 116.564 -0.289 . . . . 1.0 110.933 -179.555 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 2.1 t70 163.14 114.96 0.0 OUTLIER 'General case' 0 N--CA 1.465 0.296 0 O-C-N 123.675 0.609 . . . . 1.0 110.04 179.162 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 92.8 t80 -147.57 143.99 28.16 Favored 'General case' 0 CA--C 1.513 -0.446 0 N-CA-C 109.133 -0.691 . . . . 1.0 109.133 178.861 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 5' ' ' ASP . . . . . 0.424 ' HB2' ' N ' ' A' ' 10' ' ' SER . 1.0 OUTLIER -153.32 148.64 27.01 Favored 'General case' 0 C--N 1.326 -0.444 0 C-N-CA 120.557 -0.457 . . . . 1.0 110.512 -179.39 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 6' ' ' THR . . . . . 0.696 ' O ' ' N ' ' A' ' 10' ' ' SER . 0.2 OUTLIER -116.72 -152.7 0.51 Allowed 'General case' 0 C--O 1.209 -1.031 0 CA-C-O 121.425 0.631 . . . . 1.0 110.313 179.896 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . 0.579 ' OE1' ' N ' ' A' ' 8' ' ' ARG . 0.0 OUTLIER -59.34 -49.64 77.05 Favored 'General case' 0 C--N 1.309 -1.196 0 CA-C-O 121.872 0.844 . . . . 1.0 110.603 -177.895 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 8' ' ' ARG . . . . . 0.579 ' N ' ' OE1' ' A' ' 7' ' ' GLU . 5.0 ptt180 -67.35 -57.79 5.98 Favored 'General case' 0 C--N 1.302 -1.487 0 C-N-CA 118.725 -1.19 . . . . 1.0 108.759 178.43 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . 0.528 ' H ' ' HG3' ' A' ' 8' ' ' ARG . 6.7 t -66.08 -53.45 37.27 Favored 'Isoleucine or valine' 0 C--O 1.197 -1.665 0 C-N-CA 119.219 -0.992 . . . . 1.0 111.427 -178.322 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 10' ' ' SER . . . . . 0.696 ' N ' ' O ' ' A' ' 6' ' ' THR . 1.4 t -69.23 -62.46 1.37 Allowed 'General case' 0 C--N 1.309 -1.188 0 C-N-CA 119.363 -0.935 . . . . 1.0 111.974 -178.972 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 11' ' ' ARG . . . . . 0.511 ' HB2' ' O ' ' A' ' 7' ' ' GLU . 1.7 mmt180 -65.3 -45.55 83.96 Favored 'General case' 0 N--CA 1.474 0.74 0 N-CA-C 112.53 0.567 . . . . 1.0 112.53 -176.229 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . 0.471 ' CB ' ' O ' ' A' ' 8' ' ' ARG . . . -68.57 -55.59 11.12 Favored 'General case' 0 C--N 1.326 -0.45 0 C-N-CA 118.068 -1.453 . . . . 1.0 108.412 178.463 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . 0.642 ' O ' ' CB ' ' A' ' 17' ' ' LEU . 0.4 OUTLIER -62.44 -52.59 58.14 Favored 'Isoleucine or valine' 0 C--O 1.201 -1.471 0 C-N-CA 118.225 -1.39 . . . . 1.0 109.145 -179.264 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . 0.533 ' N ' ' O ' ' A' ' 10' ' ' SER . . . -61.05 -61.35 2.64 Favored 'General case' 0 C--N 1.314 -0.978 0 C-N-CA 117.177 -1.809 . . . . 1.0 110.429 179.929 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . 0.53 ' O ' ' N ' ' A' ' 19' ' ' GLY . . . -54.17 -56.12 21.25 Favored 'General case' 0 N--CA 1.475 0.815 0 C-N-CA 119.268 -0.973 . . . . 1.0 110.141 -178.058 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . 0.575 ' CA ' ' H ' ' A' ' 22' ' ' GLY . . . -65.43 -55.71 16.49 Favored 'General case' 0 C--N 1.315 -0.909 0 C-N-CA 118.793 -1.163 . . . . 1.0 110.364 -179.271 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . 0.642 ' CB ' ' O ' ' A' ' 13' ' ' VAL . 10.8 tp -57.16 -56.14 25.58 Favored 'General case' 0 N--CA 1.485 1.293 0 C-N-CA 119.341 -0.944 . . . . 1.0 108.665 -178.184 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . 0.602 HG22 ' H ' ' A' ' 19' ' ' GLY . 1.3 m -71.68 -57.75 6.7 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.571 0 C-N-CA 119.519 -0.872 . . . . 1.0 110.557 -179.711 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . 0.602 ' H ' HG22 ' A' ' 18' ' ' VAL . . . -62.9 -163.33 0.38 Allowed Glycine 0 CA--C 1.522 0.503 0 N-CA-C 111.748 -0.541 . . . . 1.0 111.748 -178.041 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 20' ' ' PRO . . . . . 0.601 ' O ' ' N ' ' A' ' 24' ' ' ALA . 69.3 Cg_endo -80.51 -21.91 7.09 Favored 'Trans proline' 0 C--N 1.304 -1.797 0 C-N-CA 122.419 2.079 . . . . 1.0 114.472 -178.044 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -60.66 -61.04 7.48 Favored Glycine 0 N--CA 1.476 1.326 0 C-N-CA 118.945 -1.598 . . . . 1.0 111.489 -177.165 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . 0.575 ' H ' ' CA ' ' A' ' 16' ' ' ALA . . . -59.63 -54.65 35.9 Favored Glycine 0 N--CA 1.466 0.66 0 N-CA-C 107.903 -2.079 . . . . 1.0 107.903 179.674 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . 0.411 ' O ' ' CG1' ' A' ' 27' ' ' VAL . 85.0 t -56.57 -34.15 41.27 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 C-N-CA 119.46 -0.896 . . . . 1.0 109.411 -179.273 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . 0.601 ' N ' ' O ' ' A' ' 20' ' ' PRO . . . -64.65 -61.35 2.25 Favored 'General case' 0 N--CA 1.47 0.533 0 C-N-CA 118.879 -1.129 . . . . 1.0 110.341 179.314 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 13.4 tp -61.05 -49.45 77.33 Favored 'General case' 0 CA--C 1.519 -0.219 0 C-N-CA 120.049 -0.66 . . . . 1.0 112.119 -177.015 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 70.0 t -59.18 -60.05 2.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 C-N-CA 119.095 -1.042 . . . . 1.0 110.476 -177.521 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . 0.411 ' CG1' ' O ' ' A' ' 23' ' ' VAL . 1.4 p -59.54 -38.46 75.48 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 C-N-CA 120.406 -0.517 . . . . 1.0 111.709 -177.163 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 88.5 tttt -69.28 -55.81 9.4 Favored 'General case' 0 C--N 1.317 -0.847 0 C-N-CA 120.161 -0.616 . . . . 1.0 110.113 -179.174 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 53.8 t -66.25 -52.09 51.55 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.619 0 CA-C-N 115.318 -0.855 . . . . 1.0 111.633 -176.499 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 30' ' ' CYS . . . . . . . . . . . . . 49.4 t -66.55 -60.79 2.4 Favored 'General case' 0 N--CA 1.445 -0.723 0 C-N-CA 118.761 -1.175 . . . . 1.0 110.589 -178.086 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -64.5 -49.97 69.24 Favored 'General case' 0 CA--C 1.513 -0.463 0 C-N-CA 120.691 -0.404 . . . . 1.0 111.78 -175.627 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . 0.512 ' O ' ' CB ' ' A' ' 33' ' ' LEU . . . 77.78 62.57 2.35 Favored Glycine 0 N--CA 1.447 -0.622 0 N-CA-C 107.923 -2.071 . . . . 1.0 107.923 -177.492 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . 0.512 ' CB ' ' O ' ' A' ' 32' ' ' GLY . 9.8 tp 90.32 94.43 0.03 OUTLIER Pre-proline 0 CA--C 1.541 0.625 0 CA-C-N 115.093 -0.553 . . . . 1.0 110.076 -179.064 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 59.4 Cg_endo -74.15 -11.27 23.13 Favored 'Trans proline' 0 N--CA 1.495 1.61 0 C-N-CA 122.012 1.808 . . . . 1.0 112.56 -179.212 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -58.04 -60.81 8.27 Favored Glycine 0 CA--C 1.534 1.235 0 C-N-CA 118.834 -1.65 . . . . 1.0 109.401 -178.847 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . 0.523 ' O ' ' CB ' ' A' ' 37' ' ' ILE . 1.6 m -90.19 176.4 0.66 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.47 0 N-CA-C 106.496 -1.668 . . . . 1.0 106.496 176.676 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . 0.523 ' CB ' ' O ' ' A' ' 36' ' ' VAL . 9.5 tt 107.72 115.49 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.481 1.089 0 O-C-N 124.787 1.304 . . . . 1.0 110.234 179.564 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 76.6 m80 -143.62 136.91 27.91 Favored 'General case' 0 C--O 1.231 0.093 0 CA-C-O 120.862 0.363 . . . . 1.0 110.024 179.995 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 39' ' ' THR . . . . . 0.426 ' OG1' ' O ' ' A' ' 41' ' ' ALA . 0.0 OUTLIER -106.93 118.62 53.67 Favored Pre-proline 0 CA--C 1.535 0.399 0 N-CA-C 109.17 -0.678 . . . . 1.0 109.17 179.167 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 65.8 Cg_exo -47.13 -24.22 3.37 Favored 'Trans proline' 0 N--CA 1.493 1.483 0 C-N-CA 121.629 1.553 . . . . 1.0 113.549 -179.403 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . 0.426 ' O ' ' OG1' ' A' ' 39' ' ' THR . . . -127.94 135.95 50.66 Favored 'General case' 0 N--CA 1.467 0.377 0 CA-C-O 119.911 -0.09 . . . . 1.0 110.824 179.013 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . 0.729 ' C ' ' H ' ' A' ' 44' ' ' GLY . 14.0 ptm180 -167.16 166.42 14.97 Favored 'General case' 0 C--N 1.319 -0.726 0 C-N-CA 120.015 -0.674 . . . . 1.0 110.485 178.226 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 43' ' ' ARG . . . . . 0.673 ' C ' ' H ' ' A' ' 45' ' ' PHE . 25.6 tpt180 -62.13 22.54 0.01 OUTLIER 'General case' 0 CA--C 1.545 0.769 0 CA-C-O 121.63 0.728 . . . . 1.0 109.826 -179.92 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . 0.729 ' H ' ' C ' ' A' ' 42' ' ' ARG . . . 66.85 -30.28 0.18 Allowed Glycine 0 C--N 1.337 0.599 0 N-CA-C 110.663 -0.975 . . . . 1.0 110.663 179.125 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . 0.673 ' H ' ' C ' ' A' ' 43' ' ' ARG . 0.7 OUTLIER -166.43 173.12 10.22 Favored 'General case' 0 N--CA 1.446 -0.649 0 N-CA-C 108.939 -0.763 . . . . 1.0 108.939 -179.194 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 46' ' ' PHE . . . . . 0.547 ' CB ' ' O ' ' A' ' 45' ' ' PHE . 6.8 t80 110.4 106.67 0.0 OUTLIER 'General case' 0 N--CA 1.48 1.053 0 O-C-N 125.278 1.611 . . . . 1.0 109.495 179.555 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 47' ' ' ARG . . . . . 0.42 ' CB ' ' O ' ' A' ' 46' ' ' PHE . 2.5 ptm180 102.67 150.61 0.01 OUTLIER 'General case' 0 N--CA 1.48 1.03 0 O-C-N 125.012 1.445 . . . . 1.0 110.695 -179.452 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 37.5 t 60.84 67.49 0.81 Allowed 'General case' 0 CA--C 1.509 -0.619 0 N-CA-C 108.256 -1.016 . . . . 1.0 108.256 179.453 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 49' ' ' ASN . . . . . 0.426 ' O ' ' N ' ' A' ' 51' ' ' GLU . 0.5 OUTLIER -130.73 160.97 63.94 Favored Pre-proline 0 C--N 1.327 -0.395 0 CA-C-N 115.892 -0.595 . . . . 1.0 109.912 -178.842 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 50' ' ' PRO . . . . . 0.539 ' CG ' HH21 ' A' ' 52' ' ' ARG . 17.9 Cg_endo -62.12 52.59 0.11 Allowed 'Trans proline' 0 N--CA 1.494 1.557 0 C-N-CA 123.049 2.5 . . . . 1.0 112.061 179.394 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . 0.426 ' N ' ' O ' ' A' ' 49' ' ' ASN . 1.4 pm0 29.72 44.38 0.02 OUTLIER 'General case' 0 N--CA 1.471 0.599 0 CA-C-N 115.991 -0.549 . . . . 1.0 112.355 179.64 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . 0.539 HH21 ' CG ' ' A' ' 50' ' ' PRO . 75.5 mtm180 -122.85 141.56 51.74 Favored 'General case' 0 N--CA 1.476 0.846 0 N-CA-C 109.86 -0.422 . . . . 1.0 109.86 178.808 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 8.8 tp -37.66 135.68 0.24 Allowed 'Isoleucine or valine' 0 CA--C 1.53 0.179 0 CA-C-O 122.666 1.222 . . . . 1.0 112.745 -174.923 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -92.03 77.29 5.38 Favored 'General case' 0 C--N 1.339 0.121 0 CA-C-N 112.589 -2.096 . . . . 1.0 113.076 -177.899 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 3.8 tp -144.26 150.33 16.78 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.365 0 N-CA-C 108.471 -0.937 . . . . 1.0 108.471 176.82 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 104.27 2.29 44.6 Favored Glycine 0 CA--C 1.527 0.806 0 N-CA-C 109.495 -1.442 . . . . 1.0 109.495 -179.056 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . 0.443 ' CG ' ' CE2' ' A' ' 45' ' ' PHE . 22.6 m-20 -86.13 107.07 17.68 Favored 'General case' 0 CA--C 1.538 0.516 0 N-CA-C 113.032 0.753 . . . . 1.0 113.032 -178.69 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 58' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -80.56 178.74 8.13 Favored 'General case' 0 N--CA 1.469 0.515 0 CA-C-N 114.387 -1.279 . . . . 1.0 108.324 177.997 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 59' ' ' ARG . . . . . 0.815 ' H ' ' HE ' ' A' ' 59' ' ' ARG . 0.0 OUTLIER -101.23 -54.2 2.84 Favored 'General case' 0 CA--C 1.545 0.755 0 CA-C-N 119.246 0.93 . . . . 1.0 110.576 178.295 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -79.19 -13.26 59.81 Favored 'General case' 0 N--CA 1.482 1.151 0 CA-C-N 114.52 -1.218 . . . . 1.0 111.3 -178.914 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 42.5 tt0 -69.25 -13.92 62.67 Favored 'General case' 0 C--N 1.303 -1.44 0 CA-C-N 115.124 -0.943 . . . . 1.0 108.459 179.11 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 62' ' ' VAL . . . . . 0.498 ' O ' ' N ' ' A' ' 66' ' ' GLY . 11.6 m -44.59 -51.64 1.81 Allowed 'Isoleucine or valine' 0 C--N 1.317 -0.844 0 CA-C-N 115.787 -0.642 . . . . 1.0 110.516 -175.757 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 63' ' ' ALA . . . . . 0.597 ' O ' ' HG2' ' A' ' 67' ' ' ARG . . . -67.38 -47.28 70.81 Favored 'General case' 0 N--CA 1.423 -1.798 0 C-N-CA 119.608 -0.837 . . . . 1.0 109.028 179.871 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 64' ' ' HIS . . . . . 0.437 ' O ' ' CG ' ' A' ' 67' ' ' ARG . 0.2 OUTLIER -54.04 -59.59 4.45 Favored 'General case' 0 CA--C 1.542 0.649 0 CA-C-N 115.756 -0.657 . . . . 1.0 110.301 179.612 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 65' ' ' ASP . . . . . 0.629 ' C ' ' H ' ' A' ' 67' ' ' ARG . 1.1 t70 -65.99 -52.24 51.21 Favored 'General case' 0 C--O 1.242 0.666 0 CA-C-O 121.658 0.742 . . . . 1.0 109.21 177.864 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . 0.498 ' N ' ' O ' ' A' ' 62' ' ' VAL . . . -64.27 29.18 0.1 OUTLIER Glycine 0 CA--C 1.53 1.031 0 N-CA-C 110.979 -0.849 . . . . 1.0 110.979 178.002 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 67' ' ' ARG . . . . . 0.629 ' H ' ' C ' ' A' ' 65' ' ' ASP . 5.5 mmm180 -78.9 -4.18 48.43 Favored 'General case' 0 C--N 1.323 -0.566 0 N-CA-C 108.056 -1.09 . . . . 1.0 108.056 175.836 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . 0.456 ' C ' ' O ' ' A' ' 67' ' ' ARG . 0.6 OUTLIER -35.45 -29.16 0.01 OUTLIER 'General case' 0 N--CA 1.48 1.075 0 N-CA-C 108.033 -1.099 . . . . 1.0 108.033 -177.298 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . 0.576 ' N ' ' O ' ' A' ' 67' ' ' ARG . 8.4 tt -62.83 -64.86 0.79 Allowed 'General case' 0 C--N 1.313 -1.02 0 N-CA-C 106.914 -1.513 . . . . 1.0 106.914 177.224 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . 0.646 ' C ' ' H ' ' A' ' 72' ' ' HIS . . . -76.96 -71.43 0.4 Allowed 'General case' 0 N--CA 1.467 0.388 0 N-CA-C 106.642 -1.614 . . . . 1.0 106.642 177.187 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 71' ' ' ALA . . . . . 0.531 ' O ' ' C ' ' A' ' 72' ' ' HIS . . . -45.07 0.39 0.0 OUTLIER 'General case' 0 N--CA 1.475 0.775 0 C-N-CA 124.188 0.995 . . . . 1.0 113.404 178.384 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 72' ' ' HIS . . . . . 0.646 ' H ' ' C ' ' A' ' 70' ' ' ALA . 0.0 OUTLIER -22.09 -62.67 0.03 OUTLIER 'General case' 0 C--O 1.231 0.13 0 CA-C-N 117.951 0.342 . . . . 1.0 111.311 -176.142 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 73' ' ' MET . . . . . 0.638 ' N ' ' CG ' ' A' ' 72' ' ' HIS . 31.6 ttm -75.54 -50.07 16.75 Favored 'General case' 0 C--N 1.319 -0.752 0 C-N-CA 118.881 -1.127 . . . . 1.0 109.667 177.823 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . 0.643 ' O ' ' N ' ' A' ' 76' ' ' GLY . 97.2 t -43.75 -46.18 1.89 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.375 0 CA-C-O 118.472 -0.775 . . . . 1.0 110.378 -175.434 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 75' ' ' ASN . . . . . 0.499 ' O ' ' N ' ' A' ' 77' ' ' ILE . 0.5 OUTLIER -36.81 -19.37 0.01 OUTLIER 'General case' 0 N--CA 1.487 1.414 0 CA-C-N 119.779 1.172 . . . . 1.0 111.356 179.232 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 76' ' ' GLY . . . . . 0.643 ' N ' ' O ' ' A' ' 74' ' ' VAL . . . -44.03 -19.58 0.13 Allowed Glycine 0 CA--C 1.544 1.855 0 N-CA-C 108.967 -1.653 . . . . 1.0 108.967 177.237 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 77' ' ' ILE . . . . . 0.666 ' O ' ' N ' ' A' ' 80' ' ' ALA . 12.2 pt -90.13 -51.45 11.95 Favored 'Isoleucine or valine' 0 C--N 1.346 0.433 0 N-CA-C 108.621 -0.881 . . . . 1.0 108.621 179.371 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . 0.465 ' C ' ' O ' ' A' ' 77' ' ' ILE . 42.3 t -34.86 -36.86 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.446 -0.642 0 N-CA-C 109.003 -0.74 . . . . 1.0 109.003 -177.796 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . 0.414 ' N ' ' O ' ' A' ' 77' ' ' ILE . 33.0 pt -90.44 -21.06 6.75 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.575 0 CA-C-N 116.159 -0.473 . . . . 1.0 111.934 179.788 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 80' ' ' ALA . . . . . 0.666 ' N ' ' O ' ' A' ' 77' ' ' ILE . . . -82.99 -7.31 59.68 Favored 'General case' 0 CA--C 1.536 0.404 0 C-N-CA 123.771 0.828 . . . . 1.0 111.244 177.102 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 3.7 mm-40 -74.0 -68.72 0.49 Allowed 'General case' 0 N--CA 1.452 -0.356 0 N-CA-C 108.771 -0.826 . . . . 1.0 108.771 178.444 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 82' ' ' ASP . . . . . 0.594 ' O ' ' N ' ' A' ' 84' ' ' LEU . 18.8 p-10 -59.23 -59.19 5.85 Favored 'General case' 0 CA--C 1.512 -0.511 0 C-N-CA 119.489 -0.884 . . . . 1.0 108.941 179.578 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . 0.535 ' C ' ' O ' ' A' ' 82' ' ' ASP . . . 3.35 -70.47 0.0 OUTLIER 'General case' 0 N--CA 1.486 1.365 0 O-C-N 124.469 1.105 . . . . 1.0 111.069 -179.913 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . 0.594 ' N ' ' O ' ' A' ' 82' ' ' ASP . 58.8 mt -26.78 -44.68 0.02 OUTLIER 'General case' 0 N--CA 1.474 0.746 0 CA-C-N 115.435 -0.802 . . . . 1.0 111.044 -176.64 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 85' ' ' ILE . . . . . 0.436 ' N ' ' O ' ' A' ' 83' ' ' ALA . 1.3 pp -97.65 -49.5 11.84 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.293 0 N-CA-C 108.299 -1.0 . . . . 1.0 108.299 177.636 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 86' ' ' ALA . . . . . 0.708 ' C ' ' H ' ' A' ' 88' ' ' ALA . . . -44.45 -41.94 6.66 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 114.453 -1.249 . . . . 1.0 110.333 179.938 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 10.6 pt-20 -60.54 24.84 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.361 -0.381 . . . . 1.0 111.061 179.922 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 88' ' ' ALA . . . . . 0.708 ' H ' ' C ' ' A' ' 86' ' ' ALA . . . -122.76 -9.15 8.39 Favored 'General case' 0 N--CA 1.456 -0.173 0 CA-C-N 116.229 -0.441 . . . . 1.0 109.854 179.592 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 4.0 m -107.66 34.69 0.59 Allowed 'Isoleucine or valine' 0 C--O 1.224 -0.267 0 N-CA-C 109.093 -0.706 . . . . 1.0 109.093 179.377 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 90' ' ' GLY . . . . . 0.558 ' O ' ' N ' ' A' ' 92' ' ' HIS . . . -67.49 -40.42 91.09 Favored Glycine 0 CA--C 1.532 1.118 0 CA-C-O 119.616 -0.547 . . . . 1.0 111.957 179.16 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 91' ' ' PRO . . . . . 0.508 ' CD ' ' N ' ' A' ' 90' ' ' GLY . 80.4 Cg_exo -44.06 -13.19 0.05 OUTLIER 'Trans proline' 0 N--CA 1.494 1.549 0 C-N-CA 122.066 1.844 . . . . 1.0 111.483 179.294 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 92' ' ' HIS . . . . . 0.558 ' N ' ' O ' ' A' ' 90' ' ' GLY . 2.8 p80 -58.15 -17.13 16.39 Favored 'General case' 0 N--CA 1.44 -0.928 0 CA-C-N 115.676 -0.693 . . . . 1.0 109.201 179.396 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 93' ' ' LEU . . . . . 0.444 ' HG ' ' H ' ' A' ' 94' ' ' ALA . 1.5 pp -69.71 -59.18 3.11 Favored 'General case' 0 C--O 1.234 0.276 0 N-CA-C 109.759 -0.46 . . . . 1.0 109.759 178.993 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 94' ' ' ALA . . . . . 0.444 ' H ' ' HG ' ' A' ' 93' ' ' LEU . . . -55.87 -51.42 67.6 Favored 'General case' 0 CA--C 1.512 -0.508 0 N-CA-C 108.854 -0.795 . . . . 1.0 108.854 179.509 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 95' ' ' ARG . . . . . 0.657 ' O ' ' N ' ' A' ' 97' ' ' LEU . 7.1 mmm-85 -54.09 -59.02 5.2 Favored 'General case' 0 C--O 1.246 0.882 0 CA-C-O 122.985 1.374 . . . . 1.0 107.642 178.572 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 96' ' ' ALA . . . . . 0.77 ' O ' ' N ' ' A' ' 98' ' ' GLY . . . -46.33 -12.14 0.02 OUTLIER 'General case' 0 C--N 1.304 -1.375 0 O-C-N 119.524 -1.985 . . . . 1.0 111.556 -177.262 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 97' ' ' LEU . . . . . 0.657 ' N ' ' O ' ' A' ' 95' ' ' ARG . 0.3 OUTLIER 1.17 -53.76 0.0 OUTLIER 'General case' 0 N--CA 1.482 1.147 0 C-N-CA 124.246 1.018 . . . . 1.0 112.011 -169.101 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 98' ' ' GLY . . . . . 0.77 ' N ' ' O ' ' A' ' 96' ' ' ALA . . . -50.71 -23.27 6.58 Favored Glycine 0 C--N 1.3 -1.427 0 CA-C-N 121.905 2.138 . . . . 1.0 108.918 175.642 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 99' ' ' GLN . . . . . 0.607 ' N ' ' O ' ' A' ' 96' ' ' ALA . 9.4 tt0 -69.25 -24.07 63.94 Favored 'General case' 0 C--N 1.353 0.742 0 N-CA-C 107.872 -1.158 . . . . 1.0 107.872 178.011 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 100' ' ' ILE . . . . . 0.588 ' N ' ' O ' ' A' ' 97' ' ' LEU . 0.9 OUTLIER -63.6 -38.61 82.7 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.676 0 CA-C-N 114.471 -1.241 . . . . 1.0 108.895 178.442 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 101' ' ' VAL . . . . . 0.542 ' O ' ' N ' ' A' ' 105' ' ' GLY . 86.9 t -61.72 -60.01 3.39 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.199 0 N-CA-C 109.156 -0.683 . . . . 1.0 109.156 179.987 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 102' ' ' CYS . . . . . 0.402 ' O ' ' CB ' ' A' ' 106' ' ' ALA . 0.0 OUTLIER -44.41 -20.53 0.03 OUTLIER 'General case' 0 C--O 1.22 -0.478 0 CA-C-O 119.641 -0.218 . . . . 1.0 111.2 -178.574 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 103' ' ' ARG . . . . . 0.449 ' H ' ' C ' ' A' ' 101' ' ' VAL . 17.1 ttm180 -88.82 -37.36 15.45 Favored 'General case' 0 N--CA 1.484 1.239 0 CA-C-O 122.766 1.27 . . . . 1.0 110.664 178.316 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 104' ' ' TYR . . . . . 0.588 ' CG ' ' O ' ' A' ' 104' ' ' TYR . 50.9 t80 -99.79 20.99 13.16 Favored 'General case' 0 C--N 1.31 -1.116 0 CA-C-N 112.117 -2.31 . . . . 1.0 110.342 177.184 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 105' ' ' GLY . . . . . 0.542 ' N ' ' O ' ' A' ' 101' ' ' VAL . . . -163.5 -88.81 0.07 OUTLIER Glycine 0 N--CA 1.445 -0.719 0 N-CA-C 108.023 -2.031 . . . . 1.0 108.023 178.073 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 106' ' ' ALA . . . . . 0.584 ' O ' ' CD ' ' A' ' 110' ' ' PRO . . . 66.46 66.62 0.46 Allowed 'General case' 0 N--CA 1.441 -0.892 0 CA-C-N 115.654 -0.273 . . . . 1.0 111.545 -179.857 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 14.0 m -77.47 -60.97 2.14 Favored 'General case' 0 N--CA 1.473 0.718 0 O-C-N 121.325 -0.859 . . . . 1.0 109.388 179.711 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 32.3 m -66.51 -43.92 90.56 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.171 0 CA-C-O 121.293 0.568 . . . . 1.0 109.511 -179.158 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 109' ' ' ILE . . . . . 0.46 ' O ' ' CB ' ' A' ' 113' ' ' ASN . 1.8 mm -36.5 -61.23 0.64 Allowed Pre-proline 0 CA--C 1.549 0.932 0 CA-C-O 118.171 -0.919 . . . . 1.0 111.095 -178.269 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 110' ' ' PRO . . . . . 0.584 ' CD ' ' O ' ' A' ' 106' ' ' ALA . 55.5 Cg_endo -63.85 -21.33 69.17 Favored 'Trans proline' 0 N--CA 1.505 2.149 0 C-N-CA 124.013 3.142 . . . . 1.0 113.11 179.875 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 14.7 t-20 -63.31 -69.9 0.24 Allowed 'General case' 0 N--CA 1.467 0.392 0 C-N-CA 120.387 -0.525 . . . . 1.0 111.175 -178.191 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -73.07 -25.33 21.65 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.567 0 CA-C-O 121.969 0.89 . . . . 1.0 109.499 -179.643 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 113' ' ' ASN . . . . . 0.566 ' ND2' ' OE1' ' A' ' 117' ' ' GLU . 0.4 OUTLIER -52.02 -59.2 4.63 Favored 'General case' 0 C--N 1.3 -1.552 0 CA-C-N 114.002 -1.453 . . . . 1.0 108.908 -177.45 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -66.26 -20.46 66.12 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 115.891 -0.595 . . . . 1.0 110.954 179.107 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -76.41 -60.81 2.18 Favored 'General case' 0 N--CA 1.443 -0.804 0 C-N-CA 120.282 -0.567 . . . . 1.0 111.171 178.001 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 116' ' ' ILE . . . . . 0.526 ' O ' ' N ' ' A' ' 119' ' ' LEU . 7.6 tt -72.39 -41.54 64.97 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.213 0 O-C-N 121.213 -0.93 . . . . 1.0 111.981 -178.236 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 117' ' ' GLU . . . . . 0.566 ' OE1' ' ND2' ' A' ' 113' ' ' ASN . 1.0 OUTLIER -48.81 -58.61 4.53 Favored 'General case' 0 CA--C 1.508 -0.671 0 N-CA-C 108.288 -1.005 . . . . 1.0 108.288 -178.476 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 86.9 t -54.71 -14.26 0.96 Allowed 'Isoleucine or valine' 0 N--CA 1.436 -1.131 0 C-N-CA 120.253 -0.579 . . . . 1.0 109.442 179.52 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 119' ' ' LEU . . . . . 0.526 ' N ' ' O ' ' A' ' 116' ' ' ILE . 0.2 OUTLIER -76.33 -60.18 2.45 Favored 'General case' 0 C--N 1.347 0.477 0 N-CA-C 107.77 -1.196 . . . . 1.0 107.77 175.796 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -68.25 -83.08 0.15 Allowed Glycine 0 C--N 1.364 2.114 0 C-N-CA 117.57 -2.253 . . . . 1.0 111.23 179.449 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 18.8 m -161.36 -17.97 0.05 OUTLIER 'General case' 0 C--N 1.326 -0.427 0 N-CA-C 108.564 -0.902 . . . . 1.0 108.564 -179.639 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 122' ' ' GLY . . . . . 0.416 ' O ' ' C ' ' A' ' 123' ' ' THR . . . 111.26 -35.91 4.49 Favored Glycine 0 CA--C 1.523 0.577 0 CA-C-N 113.959 -1.473 . . . . 1.0 112.1 179.569 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 123' ' ' THR . . . . . 0.416 ' C ' ' O ' ' A' ' 122' ' ' GLY . 0.1 OUTLIER -33.43 95.4 0.01 OUTLIER 'General case' 0 N--CA 1.471 0.614 0 CA-C-N 118.342 1.071 . . . . 1.0 112.489 -178.618 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 124' ' ' ASP . . . . . 0.414 ' N ' ' O ' ' A' ' 122' ' ' GLY . 55.6 m-20 -148.59 147.88 29.51 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 115.484 -0.78 . . . . 1.0 109.548 179.26 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 125' ' ' TYR . . . . . 0.418 ' CD1' ' C ' ' A' ' 125' ' ' TYR . 0.0 OUTLIER -151.85 150.25 29.89 Favored 'General case' 0 CA--C 1.532 0.279 0 CA-C-O 120.863 0.363 . . . . 1.0 110.124 179.946 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -149.67 150.55 32.32 Favored 'General case' 0 CA--C 1.537 0.45 0 CA-C-N 116.07 -0.513 . . . . 1.0 110.019 177.719 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 127' ' ' PHE . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 C--O 1.22 -0.467 0 CA-C-O 118.172 -0.918 . . . . 1.0 109.249 179.44 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 N--CA 1.493 1.715 0 N-CA-C 109.259 -0.645 . . . . 1.0 109.259 . . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 2' ' ' SER . . . . . 0.487 ' O ' ' CG ' ' A' ' 3' ' ' ASP . 55.1 p -83.28 5.63 22.48 Favored 'General case' 0 CA--C 1.531 0.246 0 CA-C-N 116.489 -0.323 . . . . 1.0 111.478 -179.062 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 3' ' ' ASP . . . . . 0.487 ' CG ' ' O ' ' A' ' 2' ' ' SER . 24.0 m-20 153.69 127.41 0.0 OUTLIER 'General case' 0 N--CA 1.477 0.876 0 O-C-N 123.904 0.753 . . . . 1.0 111.2 178.94 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 60.9 t80 -155.92 151.19 26.73 Favored 'General case' 0 N--CA 1.462 0.145 0 CA-C-N 116.089 -0.505 . . . . 1.0 110.953 179.235 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 4.2 p30 -153.7 148.63 26.63 Favored 'General case' 0 CA--C 1.536 0.419 0 CA-C-N 116.308 -0.406 . . . . 1.0 110.158 -179.692 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 6' ' ' THR . . . . . 0.816 ' O ' ' N ' ' A' ' 10' ' ' SER . 0.1 OUTLIER -80.76 170.4 16.35 Favored 'General case' 0 C--O 1.188 -2.165 0 C-N-CA 120.856 -0.338 . . . . 1.0 110.305 -179.39 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . 0.542 ' O ' ' N ' ' A' ' 11' ' ' ARG . 39.2 tt0 -56.87 -57.05 14.16 Favored 'General case' 0 C--N 1.313 -0.984 0 CA-C-O 121.775 0.797 . . . . 1.0 110.54 -177.974 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 8' ' ' ARG . . . . . 0.431 ' O ' ' CB ' ' A' ' 12' ' ' ALA . 0.0 OUTLIER -54.02 -55.51 26.66 Favored 'General case' 0 C--N 1.313 -1.01 0 N-CA-C 106.96 -1.496 . . . . 1.0 106.96 -178.079 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . 0.646 ' O ' ' HB ' ' A' ' 13' ' ' VAL . 0.2 OUTLIER -66.41 -51.89 52.97 Favored 'Isoleucine or valine' 0 C--O 1.189 -2.124 0 CA-C-N 114.35 -1.296 . . . . 1.0 109.659 179.651 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 10' ' ' SER . . . . . 0.816 ' N ' ' O ' ' A' ' 6' ' ' THR . 22.5 t -65.78 -64.89 0.76 Allowed 'General case' 0 N--CA 1.482 1.139 0 C-N-CA 120.256 -0.578 . . . . 1.0 111.649 -178.924 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 11' ' ' ARG . . . . . 0.542 ' N ' ' O ' ' A' ' 7' ' ' GLU . 0.3 OUTLIER -65.52 -57.82 7.3 Favored 'General case' 0 C--O 1.218 -0.589 0 N-CA-C 112.313 0.486 . . . . 1.0 112.313 -176.81 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . 0.431 ' CB ' ' O ' ' A' ' 8' ' ' ARG . . . -54.12 -49.69 68.59 Favored 'General case' 0 N--CA 1.476 0.856 0 C-N-CA 117.874 -1.53 . . . . 1.0 107.41 -176.497 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . 0.646 ' HB ' ' O ' ' A' ' 9' ' ' VAL . 91.2 t -62.34 -50.05 81.49 Favored 'Isoleucine or valine' 0 C--O 1.197 -1.679 0 N-CA-C 107.585 -1.265 . . . . 1.0 107.585 178.476 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . 0.503 ' O ' ' N ' ' A' ' 18' ' ' VAL . . . -56.41 -60.24 3.8 Favored 'General case' 0 C--O 1.207 -1.143 0 C-N-CA 117.57 -1.652 . . . . 1.0 108.508 -178.806 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . 0.573 ' O ' ' N ' ' A' ' 19' ' ' GLY . . . -53.63 -53.65 48.91 Favored 'General case' 0 C--N 1.322 -0.618 0 O-C-N 123.718 0.636 . . . . 1.0 109.726 -178.855 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . 0.437 ' O ' ' N ' ' A' ' 22' ' ' GLY . . . -63.72 -57.98 8.31 Favored 'General case' 0 N--CA 1.474 0.745 0 CA-C-O 121.693 0.759 . . . . 1.0 109.707 -179.547 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . 0.628 ' N ' ' O ' ' A' ' 13' ' ' VAL . 7.5 tt -55.42 -54.46 43.47 Favored 'General case' 0 N--CA 1.477 0.903 0 CA-C-N 114.422 -1.263 . . . . 1.0 108.652 -178.578 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . 0.7 HG23 ' H ' ' A' ' 19' ' ' GLY . 2.3 m -69.16 -57.45 8.56 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.568 0 C-N-CA 119.335 -0.946 . . . . 1.0 109.166 179.857 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . 0.7 ' H ' HG23 ' A' ' 18' ' ' VAL . . . -56.78 -162.95 0.03 OUTLIER Glycine 0 C--O 1.22 -0.77 0 N-CA-C 111.225 -0.75 . . . . 1.0 111.225 -178.317 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 20' ' ' PRO . . . . . 0.441 ' O ' ' N ' ' A' ' 24' ' ' ALA . 83.0 Cg_endo -82.76 -30.34 1.05 Allowed 'Trans proline' 0 C--N 1.303 -1.836 0 C-N-CA 122.508 2.139 . . . . 1.0 113.988 -178.619 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . 0.401 ' O ' ' N ' ' A' ' 24' ' ' ALA . . . -62.87 -61.52 6.38 Favored Glycine 0 N--CA 1.48 1.57 0 C-N-CA 119.897 -1.144 . . . . 1.0 113.364 -176.508 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . 0.437 ' N ' ' O ' ' A' ' 16' ' ' ALA . . . -54.16 -52.81 41.27 Favored Glycine 0 N--CA 1.471 0.997 0 N-CA-C 106.6 -2.6 . . . . 1.0 106.6 -177.11 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 12.3 t -57.06 -29.17 30.92 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.853 0 C-N-CA 119.569 -0.852 . . . . 1.0 109.096 177.696 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . 0.441 ' N ' ' O ' ' A' ' 20' ' ' PRO . . . -61.89 -63.63 1.2 Allowed 'General case' 0 C--N 1.349 0.568 0 C-N-CA 118.106 -1.437 . . . . 1.0 111.138 179.922 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . 0.423 ' N ' ' CD1' ' A' ' 25' ' ' LEU . 9.6 mp -63.6 -47.72 80.28 Favored 'General case' 0 N--CA 1.472 0.649 0 CA-C-N 119.008 0.822 . . . . 1.0 112.651 -177.486 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 94.9 t -58.01 -58.84 4.67 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.575 0 C-N-CA 119.169 -1.013 . . . . 1.0 110.061 -177.416 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . 0.483 ' O ' ' CB ' ' A' ' 31' ' ' ALA . 0.5 OUTLIER -61.41 -36.33 72.35 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.601 0 CA-C-O 121.224 0.535 . . . . 1.0 110.322 -178.505 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . 0.405 ' CB ' ' O ' ' A' ' 24' ' ' ALA . 33.0 tttm -67.52 -58.52 4.57 Favored 'General case' 0 C--N 1.316 -0.891 0 C-N-CA 119.461 -0.896 . . . . 1.0 110.424 -178.918 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 95.8 t -65.32 -49.85 76.43 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.116 0 C-N-CA 119.821 -0.752 . . . . 1.0 111.221 -177.283 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 30' ' ' CYS . . . . . . . . . . . . . 4.9 t -65.65 -61.64 1.97 Allowed 'General case' 0 N--CA 1.44 -0.969 0 C-N-CA 119.197 -1.001 . . . . 1.0 109.826 -179.344 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . 0.483 ' CB ' ' O ' ' A' ' 27' ' ' VAL . . . -63.07 -49.47 74.4 Favored 'General case' 0 C--N 1.322 -0.621 0 C-N-CA 119.968 -0.693 . . . . 1.0 110.714 -177.244 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . 0.487 ' O ' ' HB2' ' A' ' 33' ' ' LEU . . . 58.44 60.02 9.71 Favored Glycine 0 C--O 1.222 -0.62 0 CA-C-O 118.165 -1.353 . . . . 1.0 111.003 179.644 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . 0.487 ' HB2' ' O ' ' A' ' 32' ' ' GLY . 6.3 mp 100.21 140.62 0.02 OUTLIER Pre-proline 0 N--CA 1.484 1.26 0 C-N-CA 125.478 1.511 . . . . 1.0 111.65 179.761 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 31.3 Cg_exo -51.76 -57.76 1.98 Allowed 'Trans proline' 0 N--CA 1.501 1.936 0 C-N-CA 122.17 1.913 . . . . 1.0 113.763 -178.505 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . 0.464 ' O ' ' C ' ' A' ' 36' ' ' VAL . . . -65.85 -59.65 7.34 Favored Glycine 0 C--N 1.338 0.678 0 C-N-CA 117.944 -2.074 . . . . 1.0 109.223 -178.404 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . 0.583 ' O ' ' CG2' ' A' ' 37' ' ' ILE . 70.4 t -38.94 139.36 0.23 Allowed 'Isoleucine or valine' 0 C--O 1.215 -0.73 0 N-CA-C 107.398 -1.334 . . . . 1.0 107.398 178.658 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . 0.692 HG22 ' O ' ' A' ' 37' ' ' ILE . 2.3 tp 71.96 73.3 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.476 0.831 0 CA-C-O 122.266 1.031 . . . . 1.0 110.15 -177.201 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 7.2 p80 -139.42 136.04 34.25 Favored 'General case' 0 C--N 1.322 -0.592 0 O-C-N 120.514 -1.366 . . . . 1.0 109.489 179.988 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -113.77 140.0 24.16 Favored Pre-proline 0 CA--C 1.533 0.32 0 N-CA-C 109.251 -0.648 . . . . 1.0 109.251 179.528 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 59.8 Cg_endo -71.28 -7.36 21.17 Favored 'Trans proline' 0 C--N 1.311 -1.41 0 C-N-CA 122.058 1.838 . . . . 1.0 112.187 -179.38 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -112.78 91.91 3.82 Favored 'General case' 0 CA--C 1.507 -0.691 0 C-N-CA 120.591 -0.444 . . . . 1.0 111.13 -178.078 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . 0.658 ' C ' ' H ' ' A' ' 44' ' ' GLY . 0.6 OUTLIER -123.58 140.3 53.14 Favored 'General case' 0 CA--C 1.537 0.453 0 CA-C-O 121.744 0.783 . . . . 1.0 111.576 -178.361 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 43' ' ' ARG . . . . . 0.675 ' C ' ' H ' ' A' ' 45' ' ' PHE . 1.5 tpp180 -59.31 37.74 0.01 OUTLIER 'General case' 0 CA--C 1.562 1.415 0 CA-C-N 112.976 -1.92 . . . . 1.0 108.303 -179.714 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . 0.658 ' H ' ' C ' ' A' ' 42' ' ' ARG . . . 67.8 -30.13 0.23 Allowed Glycine 0 C--N 1.338 0.656 0 N-CA-C 109.605 -1.398 . . . . 1.0 109.605 -179.11 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . 0.675 ' H ' ' C ' ' A' ' 43' ' ' ARG . 0.2 OUTLIER -170.39 175.28 4.87 Favored 'General case' 0 N--CA 1.443 -0.821 0 CA-C-N 114.749 -0.725 . . . . 1.0 109.126 179.379 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 46' ' ' PHE . . . . . 0.516 ' HB2' ' O ' ' A' ' 45' ' ' PHE . 8.6 m-85 114.84 110.56 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.668 0 C-N-CA 126.868 2.067 . . . . 1.0 108.432 -179.272 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 47' ' ' ARG . . . . . 0.496 ' HB2' ' O ' ' A' ' 46' ' ' PHE . 3.6 mmp_? 100.11 153.36 0.01 OUTLIER 'General case' 0 N--CA 1.469 0.516 0 O-C-N 124.94 1.4 . . . . 1.0 111.266 179.62 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER 66.44 70.51 0.41 Allowed 'General case' 0 N--CA 1.449 -0.48 0 CA-C-N 114.778 -1.101 . . . . 1.0 109.315 179.825 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 49' ' ' ASN . . . . . 0.5 ' O ' ' N ' ' A' ' 51' ' ' GLU . 0.7 OUTLIER -136.45 160.73 65.66 Favored Pre-proline 0 N--CA 1.466 0.367 0 CA-C-N 116.455 -0.339 . . . . 1.0 110.473 -179.175 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 25.1 Cg_endo -60.54 58.74 0.09 OUTLIER 'Trans proline' 0 N--CA 1.499 1.798 0 C-N-CA 123.265 2.643 . . . . 1.0 111.886 179.054 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . 0.5 ' N ' ' O ' ' A' ' 49' ' ' ASN . 2.9 tt0 45.33 29.85 0.62 Allowed 'General case' 0 CA--C 1.536 0.407 0 CA-C-O 121.121 0.486 . . . . 1.0 110.442 179.13 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . 0.632 ' NH2' ' CE1' ' A' ' 92' ' ' HIS . 49.5 mtt180 -124.59 151.84 44.3 Favored 'General case' 0 N--CA 1.472 0.637 0 CA-C-O 121.541 0.686 . . . . 1.0 110.978 179.527 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 7.2 tp -55.87 139.99 14.46 Favored 'Isoleucine or valine' 0 CA--C 1.555 1.141 0 CA-C-O 123.935 1.826 . . . . 1.0 115.217 -177.407 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -86.53 86.11 7.33 Favored 'General case' 0 C--N 1.316 -0.864 0 CA-C-N 110.229 -3.168 . . . . 1.0 112.258 179.833 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 19.6 tt -143.92 151.0 16.55 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.032 0 N-CA-C 109.522 -0.548 . . . . 1.0 109.522 177.578 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 102.13 1.3 51.37 Favored Glycine 0 C--N 1.343 0.964 0 N-CA-C 110.753 -0.939 . . . . 1.0 110.753 179.837 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 1.3 p30 -89.71 113.28 24.76 Favored 'General case' 0 CA--C 1.54 0.566 0 CA-C-O 122.294 1.045 . . . . 1.0 113.226 -177.881 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 58' ' ' TRP . . . . . . . . . . . . . 36.4 m0 -81.74 -177.27 6.49 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 113.952 -1.476 . . . . 1.0 108.287 177.696 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 59' ' ' ARG . . . . . 0.58 ' HD2' ' H ' ' A' ' 59' ' ' ARG . 0.0 OUTLIER -97.3 -53.58 3.43 Favored 'General case' 0 CA--C 1.556 1.196 0 CA-C-N 119.18 0.9 . . . . 1.0 110.642 179.717 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 60' ' ' TYR . . . . . 0.485 ' CG ' ' O ' ' A' ' 60' ' ' TYR . 77.0 t80 -77.47 -6.0 51.92 Favored 'General case' 0 N--CA 1.483 1.207 0 C-N-CA 125.778 1.631 . . . . 1.0 111.833 -179.367 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -70.1 -16.7 63.16 Favored 'General case' 0 C--N 1.307 -1.244 0 CA-C-O 121.575 0.703 . . . . 1.0 109.453 179.181 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 62' ' ' VAL . . . . . 0.489 ' O ' ' N ' ' A' ' 66' ' ' GLY . 6.1 m -45.81 -52.37 2.8 Favored 'Isoleucine or valine' 0 CA--C 1.5 -0.961 0 C-N-CA 120.067 -0.653 . . . . 1.0 110.512 -174.774 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 63' ' ' ALA . . . . . 0.414 ' O ' ' HG2' ' A' ' 67' ' ' ARG . . . -65.2 -47.75 75.82 Favored 'General case' 0 N--CA 1.424 -1.768 0 N-CA-C 109.447 -0.575 . . . . 1.0 109.447 179.414 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 64' ' ' HIS . . . . . 0.407 ' O ' ' CG ' ' A' ' 67' ' ' ARG . 0.1 OUTLIER -54.71 -59.46 4.68 Favored 'General case' 0 CA--C 1.549 0.907 0 CA-C-N 115.474 -0.785 . . . . 1.0 110.54 179.837 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 65' ' ' ASP . . . . . 0.622 ' C ' ' H ' ' A' ' 67' ' ' ARG . 13.4 m-20 -67.72 -50.0 59.7 Favored 'General case' 0 C--O 1.243 0.751 0 N-CA-C 108.322 -0.992 . . . . 1.0 108.322 178.36 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . 0.489 ' N ' ' O ' ' A' ' 62' ' ' VAL . . . -63.23 30.24 0.08 OUTLIER Glycine 0 C--N 1.336 0.533 0 O-C-N 121.873 -0.517 . . . . 1.0 112.097 179.013 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 67' ' ' ARG . . . . . 0.622 ' H ' ' C ' ' A' ' 65' ' ' ASP . 14.9 mmt180 -78.96 -3.0 42.76 Favored 'General case' 0 C--N 1.308 -1.219 0 N-CA-C 108.322 -0.992 . . . . 1.0 108.322 175.927 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . 0.473 HD22 ' H ' ' A' ' 69' ' ' LEU . 1.8 pt? -36.11 -29.95 0.02 OUTLIER 'General case' 0 N--CA 1.477 0.921 0 N-CA-C 108.57 -0.9 . . . . 1.0 108.57 -176.948 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . 0.558 ' N ' ' O ' ' A' ' 67' ' ' ARG . 0.5 OUTLIER -71.91 -69.52 0.39 Allowed 'General case' 0 CA--C 1.538 0.5 0 CA-C-N 115.15 -0.932 . . . . 1.0 111.206 -178.583 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . 0.629 ' C ' ' H ' ' A' ' 72' ' ' HIS . . . -76.53 -78.16 0.13 Allowed 'General case' 0 N--CA 1.463 0.221 0 C-N-CA 119.201 -1.0 . . . . 1.0 109.2 -179.458 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 71' ' ' ALA . . . . . 0.462 ' O ' ' C ' ' A' ' 72' ' ' HIS . . . -58.84 13.05 0.01 OUTLIER 'General case' 0 C--N 1.321 -0.643 0 C-N-CA 124.444 1.098 . . . . 1.0 113.159 -179.019 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 72' ' ' HIS . . . . . 0.68 ' CD2' ' OG1' ' A' ' 123' ' ' THR . 0.0 OUTLIER -18.1 -60.05 0.02 OUTLIER 'General case' 0 CA--C 1.534 0.353 0 N-CA-C 113.32 0.859 . . . . 1.0 113.32 -177.429 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 73' ' ' MET . . . . . 0.649 ' N ' ' CG ' ' A' ' 72' ' ' HIS . 0.0 OUTLIER -64.82 -53.96 38.59 Favored 'General case' 0 C--N 1.317 -0.81 0 C-N-CA 119.831 -0.748 . . . . 1.0 111.341 -177.842 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . 0.635 ' O ' ' N ' ' A' ' 76' ' ' GLY . 0.8 OUTLIER -44.31 -46.31 2.36 Favored 'Isoleucine or valine' 0 C--O 1.215 -0.75 0 CA-C-O 117.989 -1.005 . . . . 1.0 111.219 -174.566 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 75' ' ' ASN . . . . . 0.48 ' C ' ' N ' ' A' ' 77' ' ' ILE . 2.3 t30 -37.66 -21.47 0.01 OUTLIER 'General case' 0 N--CA 1.482 1.16 0 CA-C-O 122.972 1.368 . . . . 1.0 110.026 178.3 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 76' ' ' GLY . . . . . 0.635 ' N ' ' O ' ' A' ' 74' ' ' VAL . . . -49.49 -20.41 2.51 Favored Glycine 0 C--O 1.21 -1.361 0 N-CA-C 107.666 -2.174 . . . . 1.0 107.666 175.235 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 77' ' ' ILE . . . . . 0.496 ' O ' ' N ' ' A' ' 79' ' ' ILE . 7.9 pt -56.84 -46.93 83.65 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.454 0 CA-C-N 115.301 -0.45 . . . . 1.0 111.75 -177.556 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 57.9 t -44.14 -17.99 0.06 OUTLIER 'Isoleucine or valine' 0 CA--C 1.51 -0.562 0 CA-C-N 118.775 0.716 . . . . 1.0 112.39 179.805 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . 0.496 ' N ' ' O ' ' A' ' 77' ' ' ILE . 0.6 OUTLIER -91.33 -40.17 12.28 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.759 0 C-N-CA 119.593 -0.843 . . . . 1.0 112.506 179.555 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 80' ' ' ALA . . . . . 0.416 ' N ' ' CG1' ' A' ' 79' ' ' ILE . . . -82.01 -24.41 35.41 Favored 'General case' 0 C--N 1.328 -0.344 0 N-CA-C 114.279 1.215 . . . . 1.0 114.279 -178.241 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 81' ' ' GLU . . . . . 0.472 ' CG ' ' O ' ' A' ' 77' ' ' ILE . 0.0 OUTLIER -92.24 -74.45 0.51 Allowed 'General case' 0 N--CA 1.469 0.515 0 N-CA-C 113.998 1.11 . . . . 1.0 113.998 -177.591 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 9.3 m-20 -92.17 -22.2 19.97 Favored 'General case' 0 C--O 1.217 -0.627 0 N-CA-C 115.291 1.589 . . . . 1.0 115.291 -177.993 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . 0.582 ' O ' ' N ' ' A' ' 85' ' ' ILE . . . -58.68 -40.77 84.53 Favored 'General case' 0 N--CA 1.461 0.108 0 C-N-CA 118.405 -1.318 . . . . 1.0 112.101 -176.005 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . 0.455 ' C ' ' CD2' ' A' ' 84' ' ' LEU . 0.0 OUTLIER -41.45 -14.81 0.01 OUTLIER 'General case' 0 CA--C 1.536 0.406 0 N-CA-C 112.742 0.645 . . . . 1.0 112.742 -178.488 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 85' ' ' ILE . . . . . 0.582 ' N ' ' O ' ' A' ' 83' ' ' ALA . 3.5 tt -90.07 -43.95 14.79 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.408 0 N-CA-C 112.029 0.381 . . . . 1.0 112.029 179.87 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 86' ' ' ALA . . . . . 0.492 ' H ' HG21 ' A' ' 85' ' ' ILE . . . -94.2 -23.48 17.88 Favored 'General case' 0 CA--C 1.527 0.082 0 CA-C-O 120.681 0.277 . . . . 1.0 111.337 -178.826 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 87' ' ' GLU . . . . . 0.581 ' OE1' ' N ' ' A' ' 88' ' ' ALA . 0.0 OUTLIER -83.72 -26.97 29.29 Favored 'General case' 0 C--N 1.332 -0.187 0 N-CA-C 109.277 -0.638 . . . . 1.0 109.277 179.813 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 88' ' ' ALA . . . . . 0.581 ' N ' ' OE1' ' A' ' 87' ' ' GLU . . . -62.95 13.44 0.02 OUTLIER 'General case' 0 N--CA 1.445 -0.717 0 CA-C-N 115.669 -0.696 . . . . 1.0 110.717 -179.689 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 89' ' ' VAL . . . . . 0.588 ' O ' ' N ' ' A' ' 92' ' ' HIS . 33.5 t -84.89 45.2 0.06 OUTLIER 'Isoleucine or valine' 0 C--O 1.218 -0.558 0 CA-C-N 118.385 0.539 . . . . 1.0 110.996 -179.942 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 90' ' ' GLY . . . . . 0.724 ' O ' ' N ' ' A' ' 92' ' ' HIS . . . -30.08 -42.22 0.05 OUTLIER Glycine 0 CA--C 1.539 1.553 0 CA-C-O 117.575 -1.68 . . . . 1.0 111.149 -174.782 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 91' ' ' PRO . . . . . 0.502 ' C ' ' N ' ' A' ' 93' ' ' LEU . 95.3 Cg_exo -43.11 -4.0 0.01 OUTLIER 'Trans proline' 0 N--CA 1.499 1.842 0 CA-C-N 121.807 2.804 . . . . 1.0 111.602 170.475 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 92' ' ' HIS . . . . . 0.724 ' N ' ' O ' ' A' ' 90' ' ' GLY . 0.4 OUTLIER -48.47 -15.83 0.09 Allowed 'General case' 0 C--N 1.343 0.308 0 N-CA-C 107.873 -1.158 . . . . 1.0 107.873 -177.308 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 93' ' ' LEU . . . . . 0.625 ' O ' ' N ' ' A' ' 96' ' ' ALA . 7.1 tp -58.49 -50.27 74.36 Favored 'General case' 0 N--CA 1.447 -0.592 0 N-CA-C 106.62 -1.622 . . . . 1.0 106.62 176.183 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 94' ' ' ALA . . . . . 0.447 ' N ' ' O ' ' A' ' 91' ' ' PRO . . . -46.91 -50.43 18.79 Favored 'General case' 0 CA--C 1.518 -0.267 0 N-CA-C 107.685 -1.228 . . . . 1.0 107.685 -178.089 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 95' ' ' ARG . . . . . 0.466 ' HE ' ' HA ' ' A' ' 92' ' ' HIS . 4.5 mtm-85 -61.33 -28.48 69.24 Favored 'General case' 0 N--CA 1.443 -0.78 0 N-CA-C 109.057 -0.72 . . . . 1.0 109.057 176.122 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 96' ' ' ALA . . . . . 0.675 ' O ' ' N ' ' A' ' 100' ' ' ILE . . . -54.34 -52.06 62.76 Favored 'General case' 0 N--CA 1.475 0.822 0 N-CA-C 107.104 -1.443 . . . . 1.0 107.104 -179.946 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 97' ' ' LEU . . . . . 0.497 ' O ' ' CG2' ' A' ' 100' ' ' ILE . 0.7 OUTLIER -36.57 -26.18 0.01 OUTLIER 'General case' 0 CA--C 1.577 1.992 0 CA-C-N 114.274 -1.33 . . . . 1.0 108.485 -178.04 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 98' ' ' GLY . . . . . 0.572 ' N ' ' O ' ' A' ' 96' ' ' ALA . . . -84.68 -51.09 3.96 Favored Glycine 0 CA--C 1.55 2.279 0 CA-C-O 123.814 1.786 . . . . 1.0 110.749 173.939 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 99' ' ' GLN . . . . . 0.558 ' N ' ' O ' ' A' ' 96' ' ' ALA . 30.2 mm100 -75.84 9.71 2.22 Favored 'General case' 0 N--CA 1.428 -1.543 0 CA-C-N 113.514 -1.343 . . . . 1.0 107.649 177.037 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 100' ' ' ILE . . . . . 0.675 ' N ' ' O ' ' A' ' 96' ' ' ALA . 9.7 tt -61.62 -55.8 22.01 Favored 'Isoleucine or valine' 0 CA--C 1.482 -1.651 0 N-CA-C 109.307 -0.627 . . . . 1.0 109.307 179.063 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 101' ' ' VAL . . . . . 0.612 ' N ' ' CG2' ' A' ' 100' ' ' ILE . 5.8 p -56.68 -59.48 2.96 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.739 0 C-N-CA 117.485 -1.686 . . . . 1.0 107.739 179.789 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 102' ' ' CYS . . . . . 0.536 ' H ' ' CG1' ' A' ' 101' ' ' VAL . 0.5 OUTLIER -44.24 -18.13 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.438 0 C-N-CA 120.5 -0.48 . . . . 1.0 111.448 -177.001 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 103' ' ' ARG . . . . . 0.496 ' H ' ' C ' ' A' ' 101' ' ' VAL . 6.1 ttp180 -98.07 -37.42 9.75 Favored 'General case' 0 N--CA 1.474 0.739 0 CA-C-O 121.944 0.878 . . . . 1.0 112.859 178.127 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 104' ' ' TYR . . . . . 0.637 ' CG ' ' O ' ' A' ' 104' ' ' TYR . 51.5 t80 -101.84 21.69 14.17 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-N 113.785 -1.552 . . . . 1.0 110.552 179.206 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 105' ' ' GLY . . . . . 0.769 ' O ' ' N ' ' A' ' 107' ' ' THR . . . -171.36 -12.26 0.02 OUTLIER Glycine 0 C--O 1.22 -0.741 0 C-N-CA 119.145 -1.503 . . . . 1.0 112.286 179.516 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 106' ' ' ALA . . . . . 0.473 ' C ' ' O ' ' A' ' 105' ' ' GLY . . . -16.53 67.38 0.0 OUTLIER 'General case' 0 N--CA 1.476 0.874 0 O-C-N 124.432 0.725 . . . . 1.0 111.989 -179.8 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 107' ' ' THR . . . . . 0.769 ' N ' ' O ' ' A' ' 105' ' ' GLY . 9.9 t -117.78 -7.01 11.03 Favored 'General case' 0 CA--C 1.516 -0.33 0 N-CA-C 109.448 -0.575 . . . . 1.0 109.448 -179.621 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 11.5 m -87.14 17.7 0.57 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.452 0 N-CA-C 109.546 -0.538 . . . . 1.0 109.546 179.76 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 109' ' ' ILE . . . . . 0.671 ' N ' ' CD ' ' A' ' 110' ' ' PRO . 48.5 pt -113.71 -19.02 0.11 Allowed Pre-proline 0 CA--C 1.576 1.953 0 N-CA-C 113.773 1.027 . . . . 1.0 113.773 177.58 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 110' ' ' PRO . . . . . 0.671 ' CD ' ' N ' ' A' ' 109' ' ' ILE . 14.2 Cg_endo -53.73 -38.64 85.03 Favored 'Trans proline' 0 N--CA 1.497 1.703 0 C-N-CA 123.736 2.957 . . . . 1.0 113.991 -172.684 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 23.7 t30 -63.24 -67.95 0.38 Allowed 'General case' 0 N--CA 1.441 -0.881 0 C-N-CA 118.526 -1.27 . . . . 1.0 109.278 -179.268 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -63.35 -29.54 47.5 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.387 0 CA-C-O 121.416 0.627 . . . . 1.0 110.016 -178.261 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 113' ' ' ASN . . . . . 0.503 ' OD1' ' OE2' ' A' ' 117' ' ' GLU . 0.7 OUTLIER -58.76 -64.02 1.08 Allowed 'General case' 0 C--N 1.309 -1.169 0 C-N-CA 118.874 -1.13 . . . . 1.0 110.044 -175.882 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 114' ' ' ALA . . . . . 0.5 ' N ' HD21 ' A' ' 113' ' ' ASN . . . -62.65 -25.74 68.28 Favored 'General case' 0 C--N 1.319 -0.73 0 C-N-CA 119.936 -0.706 . . . . 1.0 111.986 -179.708 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -77.39 -59.33 2.82 Favored 'General case' 0 C--O 1.232 0.173 0 C-N-CA 119.463 -0.895 . . . . 1.0 110.459 179.176 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 116' ' ' ILE . . . . . 0.417 ' O ' ' N ' ' A' ' 119' ' ' LEU . 50.4 mt -63.58 -48.34 87.29 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.398 0 C-N-CA 119.954 -0.698 . . . . 1.0 109.604 -179.379 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 117' ' ' GLU . . . . . 0.503 ' OE2' ' OD1' ' A' ' 113' ' ' ASN . 93.4 mt-10 -46.94 -67.0 0.32 Allowed 'General case' 0 CA--C 1.503 -0.865 0 C-N-CA 119.835 -0.746 . . . . 1.0 109.195 -178.245 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 39.5 t -48.48 -22.53 0.68 Allowed 'Isoleucine or valine' 0 N--CA 1.44 -0.936 0 C-N-CA 120.114 -0.634 . . . . 1.0 109.971 179.744 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 119' ' ' LEU . . . . . 0.417 ' N ' ' O ' ' A' ' 116' ' ' ILE . 0.4 OUTLIER -78.45 -60.03 2.54 Favored 'General case' 0 C--N 1.346 0.431 0 N-CA-C 107.736 -1.209 . . . . 1.0 107.736 178.721 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 120' ' ' GLY . . . . . 0.436 ' O ' ' CB ' ' A' ' 121' ' ' THR . . . -62.28 -81.43 0.09 OUTLIER Glycine 0 C--N 1.354 1.537 0 C-N-CA 117.907 -2.092 . . . . 1.0 108.292 176.51 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 121' ' ' THR . . . . . 0.436 ' CB ' ' O ' ' A' ' 120' ' ' GLY . 1.4 t 151.08 -16.12 0.0 OUTLIER 'General case' 0 N--CA 1.486 1.37 0 O-C-N 125.322 1.248 . . . . 1.0 113.505 178.28 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 122' ' ' GLY . . . . . 0.657 ' O ' ' N ' ' A' ' 124' ' ' ASP . . . 109.74 -13.18 32.44 Favored Glycine 0 N--CA 1.47 0.919 0 N-CA-C 108.521 -1.831 . . . . 1.0 108.521 -176.195 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 123' ' ' THR . . . . . 0.68 ' OG1' ' CD2' ' A' ' 72' ' ' HIS . 15.1 t -58.58 80.0 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.202 0 N-CA-C 106.755 -1.572 . . . . 1.0 106.755 178.735 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 124' ' ' ASP . . . . . 0.657 ' N ' ' O ' ' A' ' 122' ' ' GLY . 14.9 t70 -164.62 169.09 17.43 Favored 'General case' 0 N--CA 1.444 -0.76 0 CA-C-N 113.719 -1.582 . . . . 1.0 112.107 -179.631 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 125' ' ' TYR . . . . . 0.551 ' CD1' ' C ' ' A' ' 125' ' ' TYR . 0.0 OUTLIER -146.68 145.47 30.02 Favored 'General case' 0 CA--C 1.54 0.584 0 N-CA-C 108.889 -0.782 . . . . 1.0 108.889 177.393 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -148.84 149.06 30.65 Favored 'General case' 0 CA--C 1.536 0.418 0 N-CA-C 110.166 -0.309 . . . . 1.0 110.166 178.266 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 127' ' ' PHE . . . . . . . . . . . . . 27.2 p90 . . . . . 0 N--CA 1.471 0.595 0 CA-C-O 117.864 -1.065 . . . . 1.0 110.249 179.08 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 39.0 mtt . . . . . 0 N--CA 1.489 1.475 0 N-CA-C 108.704 -0.851 . . . . 1.0 108.704 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 78.3 p -109.16 -3.79 17.03 Favored 'General case' 0 N--CA 1.466 0.334 0 CA-C-N 116.336 -0.393 . . . . 1.0 110.575 178.912 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 3' ' ' ASP . . . . . 0.44 ' OD1' ' N ' ' A' ' 3' ' ' ASP . 7.8 p-10 -174.66 91.96 0.07 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.28 -0.418 . . . . 1.0 111.785 -179.72 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 52.2 t80 -150.2 144.31 25.56 Favored 'General case' 0 C--N 1.328 -0.335 0 N-CA-C 109.367 -0.605 . . . . 1.0 109.367 179.162 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 5' ' ' ASP . . . . . 0.834 ' OD1' ' N ' ' A' ' 10' ' ' SER . 31.8 t0 -150.66 146.82 26.73 Favored 'General case' 0 C--N 1.328 -0.337 0 N-CA-C 110.082 -0.34 . . . . 1.0 110.082 -179.29 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 6' ' ' THR . . . . . 0.681 ' O ' ' N ' ' A' ' 10' ' ' SER . 0.2 OUTLIER -100.79 -178.1 3.67 Favored 'General case' 0 C--O 1.199 -1.599 0 CA-C-O 121.103 0.478 . . . . 1.0 110.782 179.904 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . 0.509 ' O ' ' HB3' ' A' ' 11' ' ' ARG . 29.0 tt0 -55.04 -41.23 71.15 Favored 'General case' 0 C--N 1.303 -1.442 0 CA-C-N 116.477 -0.329 . . . . 1.0 111.488 179.181 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 8' ' ' ARG . . . . . 0.578 ' O ' ' CB ' ' A' ' 12' ' ' ALA . 31.3 mtp180 -69.02 -63.98 0.96 Allowed 'General case' 0 C--N 1.313 -0.996 0 CA-C-O 123.086 1.422 . . . . 1.0 110.249 178.886 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . 0.617 ' O ' ' HB ' ' A' ' 13' ' ' VAL . 12.2 t -57.63 -43.67 83.91 Favored 'Isoleucine or valine' 0 C--N 1.282 -2.358 0 CA-C-N 114.464 -1.244 . . . . 1.0 109.188 178.304 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 10' ' ' SER . . . . . 0.834 ' N ' ' OD1' ' A' ' 5' ' ' ASP . 14.9 t -68.6 -65.92 0.64 Allowed 'General case' 0 C--N 1.305 -1.337 0 O-C-N 121.256 -0.902 . . . . 1.0 111.282 -179.02 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 11' ' ' ARG . . . . . 0.509 ' HB3' ' O ' ' A' ' 7' ' ' GLU . 23.1 tpp180 -60.94 -42.41 98.13 Favored 'General case' 0 C--N 1.314 -0.973 0 CA-C-N 116.278 -0.419 . . . . 1.0 110.566 -177.562 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . 0.578 ' CB ' ' O ' ' A' ' 8' ' ' ARG . . . -69.56 -61.04 1.95 Allowed 'General case' 0 C--N 1.319 -0.752 0 C-N-CA 119.106 -1.038 . . . . 1.0 111.169 -179.602 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . 0.798 ' O ' ' CB ' ' A' ' 17' ' ' LEU . 0.3 OUTLIER -56.8 -45.9 83.21 Favored 'Isoleucine or valine' 0 C--O 1.187 -2.228 0 N-CA-C 106.602 -1.629 . . . . 1.0 106.602 179.921 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . 0.728 ' O ' HG22 ' A' ' 18' ' ' VAL . . . -66.47 -65.51 0.67 Allowed 'General case' 0 C--N 1.307 -1.263 0 C-N-CA 117.094 -1.842 . . . . 1.0 112.731 -178.745 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . 0.524 ' O ' ' N ' ' A' ' 19' ' ' GLY . . . -50.16 -53.45 27.6 Favored 'General case' 0 C--N 1.32 -0.708 0 N-CA-C 108.088 -1.079 . . . . 1.0 108.088 179.897 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . 0.484 ' CB ' ' O ' ' A' ' 12' ' ' ALA . . . -66.34 -59.95 3.23 Favored 'General case' 0 C--N 1.298 -1.667 0 C-N-CA 118.27 -1.372 . . . . 1.0 111.41 179.512 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . 0.798 ' CB ' ' O ' ' A' ' 13' ' ' VAL . 7.7 tt -55.01 -55.55 29.66 Favored 'General case' 0 N--CA 1.481 1.114 0 CA-C-N 114.777 -1.101 . . . . 1.0 108.625 -176.884 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . 0.829 HG22 ' H ' ' A' ' 19' ' ' GLY . 2.0 m -71.12 -59.36 3.52 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.658 0 CA-C-N 116.146 -0.479 . . . . 1.0 110.692 179.603 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . 0.829 ' H ' HG22 ' A' ' 18' ' ' VAL . . . -55.48 -171.69 0.1 OUTLIER Glycine 0 CA--C 1.486 -1.741 0 N-CA-C 109.593 -1.403 . . . . 1.0 109.593 -176.986 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 20' ' ' PRO . . . . . 0.632 ' O ' ' HB2' ' A' ' 24' ' ' ALA . 81.1 Cg_endo -81.69 -26.88 2.89 Favored 'Trans proline' 0 C--N 1.286 -2.758 0 C-N-CA 122.025 1.817 . . . . 1.0 113.894 -177.555 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . 0.413 ' O ' ' HB1' ' A' ' 24' ' ' ALA . . . -59.81 -59.05 11.2 Favored Glycine 0 N--CA 1.473 1.159 0 O-C-N 124.156 0.91 . . . . 1.0 111.357 -178.903 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . 0.423 ' H ' ' HA ' ' A' ' 16' ' ' ALA . . . -55.79 -56.99 21.03 Favored Glycine 0 CA--C 1.5 -0.848 0 C-N-CA 117.083 -2.484 . . . . 1.0 107.577 -177.823 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 93.2 t -53.94 -29.59 18.57 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.145 0 CA-C-N 113.97 -1.115 . . . . 1.0 108.201 178.573 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . 0.632 ' HB2' ' O ' ' A' ' 20' ' ' PRO . . . -63.63 -65.53 0.67 Allowed 'General case' 0 C--O 1.213 -0.825 0 C-N-CA 119.503 -0.879 . . . . 1.0 111.291 -178.939 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -58.35 -48.68 79.81 Favored 'General case' 0 C--N 1.311 -1.092 0 C-N-CA 119.632 -0.827 . . . . 1.0 111.131 -179.139 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 81.5 t -58.26 -61.42 1.37 Allowed 'Isoleucine or valine' 0 CA--C 1.503 -0.849 0 C-N-CA 119.517 -0.873 . . . . 1.0 110.471 -174.404 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . 0.437 ' O ' ' CB ' ' A' ' 31' ' ' ALA . 2.0 p -56.35 -36.59 47.25 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.97 0 C-N-CA 120.081 -0.648 . . . . 1.0 109.632 -178.969 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 20.1 mtpp -68.13 -59.3 3.34 Favored 'General case' 0 C--N 1.318 -0.775 0 C-N-CA 119.452 -0.899 . . . . 1.0 111.932 -176.84 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 2.9 t -62.24 -50.22 80.85 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.379 0 CA-C-N 114.504 -1.225 . . . . 1.0 110.191 -177.688 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 30' ' ' CYS . . . . . . . . . . . . . 21.2 t -64.32 -62.36 1.65 Allowed 'General case' 0 N--CA 1.442 -0.857 0 C-N-CA 119.214 -0.994 . . . . 1.0 110.484 -177.598 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . 0.437 ' CB ' ' O ' ' A' ' 27' ' ' VAL . . . -56.46 -48.19 77.59 Favored 'General case' 0 CA--C 1.502 -0.878 0 CA-C-O 121.536 0.684 . . . . 1.0 110.076 -176.879 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . 0.609 ' O ' ' HB2' ' A' ' 33' ' ' LEU . . . 76.78 68.37 1.54 Allowed Glycine 0 CA--C 1.496 -1.114 0 N-CA-C 109.915 -1.274 . . . . 1.0 109.915 -179.657 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . 0.609 ' HB2' ' O ' ' A' ' 32' ' ' GLY . 5.2 mt 86.04 123.29 0.03 OUTLIER Pre-proline 0 CA--C 1.544 0.742 0 O-C-N 124.965 1.038 . . . . 1.0 110.402 -179.159 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 49.2 Cg_endo -69.22 -17.94 39.78 Favored 'Trans proline' 0 N--CA 1.493 1.456 0 C-N-CA 122.131 1.887 . . . . 1.0 112.903 -178.324 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -62.95 -63.62 4.45 Favored Glycine 0 CA--C 1.527 0.806 0 C-N-CA 118.497 -1.811 . . . . 1.0 111.187 -178.093 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . 0.688 ' O ' HG23 ' A' ' 37' ' ' ILE . 5.1 p -77.5 -152.73 0.02 OUTLIER 'Isoleucine or valine' 0 CA--C 1.491 -1.304 0 N-CA-C 107.334 -1.358 . . . . 1.0 107.334 -179.641 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . 0.688 HG23 ' O ' ' A' ' 36' ' ' VAL . 0.3 OUTLIER 75.62 76.69 0.04 OUTLIER 'Isoleucine or valine' 0 C--O 1.218 -0.574 0 O-C-N 125.132 1.52 . . . . 1.0 111.534 178.069 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 38' ' ' HIS . . . . . 0.564 ' ND1' ' O ' ' A' ' 37' ' ' ILE . 1.8 m80 -137.64 133.93 34.9 Favored 'General case' 0 CA--C 1.487 -1.453 0 O-C-N 119.304 -2.122 . . . . 1.0 107.594 179.781 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 39' ' ' THR . . . . . 0.563 ' OG1' ' O ' ' A' ' 41' ' ' ALA . 0.5 OUTLIER -107.99 122.78 39.67 Favored Pre-proline 0 CA--C 1.54 0.568 0 O-C-N 123.74 0.65 . . . . 1.0 110.549 -178.963 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 32.6 Cg_exo -61.83 -23.57 76.22 Favored 'Trans proline' 0 N--CA 1.495 1.57 0 C-N-CA 122.483 2.122 . . . . 1.0 112.378 178.046 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . 0.563 ' O ' ' OG1' ' A' ' 39' ' ' THR . . . -128.14 132.62 48.92 Favored 'General case' 0 N--CA 1.475 0.783 0 C-N-CA 122.394 0.278 . . . . 1.0 110.421 178.301 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . 0.435 ' CD ' ' O ' ' A' ' 39' ' ' THR . 0.0 OUTLIER -177.56 -177.59 0.68 Allowed 'General case' 0 N--CA 1.465 0.278 0 CA-C-N 117.962 0.346 . . . . 1.0 110.893 179.721 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 77.1 ttt180 -57.16 -46.1 83.04 Favored 'General case' 0 CA--C 1.536 0.427 0 N-CA-C 107.911 -1.144 . . . . 1.0 107.911 177.873 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . 0.516 ' C ' ' CG ' ' A' ' 45' ' ' PHE . . . 118.09 -25.57 8.27 Favored Glycine 0 N--CA 1.474 1.184 0 CA-C-O 120.067 -0.296 . . . . 1.0 112.642 178.912 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . 0.677 ' O ' ' HB2' ' A' ' 46' ' ' PHE . 0.1 OUTLIER -159.19 166.42 31.47 Favored 'General case' 0 CA--C 1.486 -1.496 0 N-CA-C 106.966 -1.494 . . . . 1.0 106.966 -179.258 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 46' ' ' PHE . . . . . 0.677 ' HB2' ' O ' ' A' ' 45' ' ' PHE . 31.2 m-85 104.1 116.95 0.01 OUTLIER 'General case' 0 N--CA 1.487 1.379 0 O-C-N 126.134 2.147 . . . . 1.0 110.589 179.815 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 47' ' ' ARG . . . . . 0.564 ' CG ' ' O ' ' A' ' 46' ' ' PHE . 0.0 OUTLIER 87.29 161.36 0.08 Allowed 'General case' 0 C--N 1.348 0.531 0 O-C-N 124.487 1.117 . . . . 1.0 110.499 179.366 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 48' ' ' CYS . . . . . 0.452 ' N ' ' HD3' ' A' ' 47' ' ' ARG . 41.2 t 61.67 67.19 0.78 Allowed 'General case' 0 CA--C 1.506 -0.723 0 N-CA-C 109.629 -0.508 . . . . 1.0 109.629 178.379 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 49' ' ' ASN . . . . . 0.769 ' O ' ' N ' ' A' ' 51' ' ' GLU . 10.5 m-80 -150.76 157.66 35.79 Favored Pre-proline 0 C--N 1.319 -0.721 0 CA-C-O 118.333 -0.842 . . . . 1.0 109.323 179.053 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 50' ' ' PRO . . . . . 0.561 ' HB2' ' HE ' ' A' ' 52' ' ' ARG . 50.1 Cg_exo -45.52 54.5 0.01 OUTLIER 'Trans proline' 0 N--CA 1.506 2.259 0 C-N-CA 123.768 2.979 . . . . 1.0 112.724 178.173 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . 0.769 ' N ' ' O ' ' A' ' 49' ' ' ASN . 1.6 mt-10 47.48 54.67 9.33 Favored 'General case' 0 C--N 1.33 -0.263 0 C-N-CA 123.357 0.663 . . . . 1.0 111.616 179.332 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . 0.561 ' HE ' ' HB2' ' A' ' 50' ' ' PRO . 34.3 mtm105 -152.24 167.2 29.38 Favored 'General case' 0 N--CA 1.469 0.507 0 CA-C-N 116.429 -0.35 . . . . 1.0 110.732 -179.125 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . 0.505 ' C ' ' NE2' ' A' ' 54' ' ' GLN . 2.2 tp -83.5 169.45 1.55 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.342 0 N-CA-C 108.531 -0.915 . . . . 1.0 108.531 178.536 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 54' ' ' GLN . . . . . 0.505 ' NE2' ' C ' ' A' ' 53' ' ' ILE . 0.0 OUTLIER -135.35 132.18 37.31 Favored 'General case' 0 N--CA 1.466 0.333 0 N-CA-C 109.294 -0.632 . . . . 1.0 109.294 -179.395 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . 0.482 ' N ' HD13 ' A' ' 55' ' ' ILE . 0.2 OUTLIER -145.4 154.63 13.62 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 N-CA-C 110.243 -0.28 . . . . 1.0 110.243 179.695 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 100.63 4.62 54.61 Favored Glycine 0 C--N 1.335 0.501 0 N-CA-C 109.975 -1.25 . . . . 1.0 109.975 179.47 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 73.1 m-20 -95.1 116.77 29.15 Favored 'General case' 0 CA--C 1.541 0.627 0 CA-C-O 122.842 1.306 . . . . 1.0 113.095 -179.68 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 58' ' ' TRP . . . . . 0.439 ' CD1' ' N ' ' A' ' 58' ' ' TRP . 17.8 m0 -79.19 179.46 7.37 Favored 'General case' 0 N--CA 1.483 1.206 0 CA-C-N 112.731 -2.031 . . . . 1.0 110.185 178.191 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 59' ' ' ARG . . . . . 0.513 ' HG2' ' H ' ' A' ' 60' ' ' TYR . 0.0 OUTLIER -93.22 -55.9 3.15 Favored 'General case' 0 CA--C 1.544 0.715 0 CA-C-N 118.434 0.561 . . . . 1.0 111.111 178.65 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 60' ' ' TYR . . . . . 0.513 ' H ' ' HG2' ' A' ' 59' ' ' ARG . 34.4 p90 -69.99 0.67 5.58 Favored 'General case' 0 C--O 1.239 0.53 0 C-N-CA 124.171 0.988 . . . . 1.0 108.866 178.676 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . 0.548 ' O ' ' N ' ' A' ' 65' ' ' ASP . 1.3 tt0 -61.63 -17.92 57.29 Favored 'General case' 0 C--O 1.21 -1.0 0 CA-C-N 115.348 -0.842 . . . . 1.0 112.447 -178.76 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 62' ' ' VAL . . . . . 0.521 ' CG2' ' H ' ' A' ' 63' ' ' ALA . 17.4 m -46.61 -56.29 1.36 Allowed 'Isoleucine or valine' 0 C--N 1.304 -1.394 0 N-CA-C 109.299 -0.63 . . . . 1.0 109.299 -174.724 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 63' ' ' ALA . . . . . 0.522 ' O ' ' HG3' ' A' ' 67' ' ' ARG . . . -60.9 -51.22 70.22 Favored 'General case' 0 N--CA 1.423 -1.796 0 N-CA-C 108.493 -0.928 . . . . 1.0 108.493 178.786 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 64' ' ' HIS . . . . . 0.522 ' HA ' ' HE ' ' A' ' 67' ' ' ARG . 19.1 t-80 -57.61 -60.62 3.4 Favored 'General case' 0 CA--C 1.548 0.903 0 CA-C-O 121.809 0.814 . . . . 1.0 112.356 -179.643 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 65' ' ' ASP . . . . . 0.586 ' C ' ' H ' ' A' ' 67' ' ' ARG . 29.7 t70 -66.83 -53.47 32.33 Favored 'General case' 0 C--N 1.312 -1.051 0 O-C-N 121.264 -0.897 . . . . 1.0 110.246 -179.267 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . 0.447 ' N ' ' O ' ' A' ' 62' ' ' VAL . . . -60.96 30.4 0.05 OUTLIER Glycine 0 CA--C 1.527 0.841 0 CA-C-N 115.734 -0.666 . . . . 1.0 112.593 -179.212 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 67' ' ' ARG . . . . . 0.611 ' O ' ' N ' ' A' ' 70' ' ' ALA . 94.8 mtt-85 -82.83 -5.09 58.8 Favored 'General case' 0 C--N 1.321 -0.672 0 O-C-N 122.746 -0.267 . . . . 1.0 111.647 175.697 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . 0.69 ' O ' ' HA ' ' A' ' 72' ' ' HIS . 0.2 OUTLIER -38.11 -28.74 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.524 0 CA-C-O 123.33 1.538 . . . . 1.0 107.084 178.907 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . 0.623 ' CG ' ' H ' ' A' ' 70' ' ' ALA . 0.9 OUTLIER -65.89 -64.01 0.96 Allowed 'General case' 0 CA--C 1.552 1.024 0 N-CA-C 105.847 -1.909 . . . . 1.0 105.847 175.716 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . 0.751 ' C ' ' H ' ' A' ' 72' ' ' HIS . . . -77.57 -73.36 0.31 Allowed 'General case' 0 C--N 1.364 1.232 0 N-CA-C 107.458 -1.312 . . . . 1.0 107.458 178.712 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 71' ' ' ALA . . . . . 0.708 ' HB1' ' HB ' ' A' ' 74' ' ' VAL . . . -50.17 7.4 0.0 OUTLIER 'General case' 0 C--N 1.351 0.671 0 C-N-CA 124.746 1.218 . . . . 1.0 110.744 177.834 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 72' ' ' HIS . . . . . 0.751 ' H ' ' C ' ' A' ' 70' ' ' ALA . 0.0 OUTLIER -17.56 -65.11 0.02 OUTLIER 'General case' 0 CA--C 1.492 -1.271 0 C-N-CA 123.565 0.746 . . . . 1.0 111.208 -175.852 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 73' ' ' MET . . . . . 0.465 ' H ' ' CG ' ' A' ' 72' ' ' HIS . 0.0 OUTLIER -77.24 -48.57 17.18 Favored 'General case' 0 C--N 1.292 -1.914 0 C-N-CA 120.275 -0.57 . . . . 1.0 110.452 178.264 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . 0.708 ' HB ' ' HB1' ' A' ' 71' ' ' ALA . 69.3 t -42.08 -44.45 0.98 Allowed 'Isoleucine or valine' 0 C--O 1.221 -0.405 0 CA-C-O 117.64 -1.172 . . . . 1.0 109.388 -174.7 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 75' ' ' ASN . . . . . 0.406 ' C ' ' N ' ' A' ' 77' ' ' ILE . 27.7 t-20 -36.75 -19.26 0.01 OUTLIER 'General case' 0 CA--C 1.553 1.094 0 CA-C-O 123.327 1.537 . . . . 1.0 110.639 179.342 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 76' ' ' GLY . . . . . 0.669 ' O ' HG12 ' A' ' 79' ' ' ILE . . . -49.05 -20.97 2.22 Favored Glycine 0 CA--C 1.543 1.827 0 N-CA-C 108.657 -1.777 . . . . 1.0 108.657 174.864 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 77' ' ' ILE . . . . . 0.457 HG13 ' H ' ' A' ' 78' ' ' VAL . 4.7 pt -47.4 -50.31 7.99 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.64 0 O-C-N 120.972 -1.31 . . . . 1.0 113.059 -179.02 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . 0.457 ' H ' HG13 ' A' ' 77' ' ' ILE . 12.0 p -55.1 -22.1 10.0 Favored 'Isoleucine or valine' 0 CA--C 1.504 -0.791 0 CA-C-O 120.832 0.348 . . . . 1.0 111.11 -178.024 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . 0.669 HG12 ' O ' ' A' ' 76' ' ' GLY . 0.5 OUTLIER -83.44 -46.01 18.56 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.867 0 C-N-CA 119.871 -0.731 . . . . 1.0 110.873 179.885 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 80' ' ' ALA . . . . . 0.507 ' N ' ' CG1' ' A' ' 79' ' ' ILE . . . -76.99 -21.84 54.08 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 115.633 -0.712 . . . . 1.0 111.007 -178.74 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 81' ' ' GLU . . . . . 0.547 ' OE1' ' N ' ' A' ' 81' ' ' GLU . 0.7 OUTLIER -83.07 -69.24 0.64 Allowed 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.011 -0.54 . . . . 1.0 111.093 -179.569 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 82' ' ' ASP . . . . . 0.636 ' O ' ' N ' ' A' ' 84' ' ' LEU . 88.9 m-20 -60.54 -60.86 3.13 Favored 'General case' 0 CA--C 1.496 -1.104 0 CA-C-O 118.048 -0.977 . . . . 1.0 110.376 -177.622 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . 0.568 ' O ' ' N ' ' A' ' 87' ' ' GLU . . . 0.94 -66.22 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.773 0 O-C-N 125.475 1.735 . . . . 1.0 110.312 -179.793 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . 0.636 ' N ' ' O ' ' A' ' 82' ' ' ASP . 4.4 mm? -25.15 -49.87 0.03 OUTLIER 'General case' 0 N--CA 1.473 0.687 0 CA-C-N 115.521 -0.763 . . . . 1.0 109.802 -176.713 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 85' ' ' ILE . . . . . 0.468 ' CG2' ' N ' ' A' ' 86' ' ' ALA . 13.7 tt -98.29 -51.0 10.76 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.699 0 N-CA-C 109.438 -0.579 . . . . 1.0 109.438 177.014 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 86' ' ' ALA . . . . . 0.468 ' N ' ' CG2' ' A' ' 85' ' ' ILE . . . -50.39 -46.95 56.47 Favored 'General case' 0 C--O 1.224 -0.267 0 CA-C-N 116.026 -0.533 . . . . 1.0 110.747 -179.184 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 87' ' ' GLU . . . . . 0.568 ' N ' ' O ' ' A' ' 83' ' ' ALA . 22.6 tp10 -47.7 -18.32 0.14 Allowed 'General case' 0 C--N 1.323 -0.577 0 CA-C-O 120.987 0.422 . . . . 1.0 110.328 179.601 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 88' ' ' ALA . . . . . 0.816 ' C ' ' H ' ' A' ' 90' ' ' GLY . . . -74.45 6.11 4.04 Favored 'General case' 0 CA--C 1.491 -1.309 0 CA-C-N 115.745 -0.661 . . . . 1.0 110.818 -179.718 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 89' ' ' VAL . . . . . 0.715 ' O ' ' N ' ' A' ' 92' ' ' HIS . 19.3 m -48.63 15.88 0.0 OUTLIER 'Isoleucine or valine' 0 C--O 1.216 -0.685 0 O-C-N 124.529 1.143 . . . . 1.0 111.616 -179.746 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 90' ' ' GLY . . . . . 0.816 ' H ' ' C ' ' A' ' 88' ' ' ALA . . . -33.58 -50.65 0.57 Allowed Glycine 0 C--N 1.351 1.386 0 N-CA-C 108.05 -2.02 . . . . 1.0 108.05 -177.08 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 91' ' ' PRO . . . . . 0.466 ' O ' ' N ' ' A' ' 94' ' ' ALA . 73.0 Cg_exo -48.11 0.35 0.02 OUTLIER 'Trans proline' 0 N--CA 1.495 1.565 0 C-N-CA 122.463 2.109 . . . . 1.0 112.216 173.163 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 92' ' ' HIS . . . . . 0.715 ' N ' ' O ' ' A' ' 89' ' ' VAL . 0.0 OUTLIER -47.57 -37.05 11.55 Favored 'General case' 0 N--CA 1.445 -0.707 0 N-CA-C 107.794 -1.187 . . . . 1.0 107.794 -176.053 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 1.5 pp -61.78 -37.8 85.67 Favored 'General case' 0 N--CA 1.436 -1.145 0 CA-C-O 121.702 0.763 . . . . 1.0 111.107 178.59 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 94' ' ' ALA . . . . . 0.466 ' N ' ' O ' ' A' ' 91' ' ' PRO . . . -62.57 -62.4 1.77 Allowed 'General case' 0 C--N 1.33 -0.26 0 N-CA-C 107.795 -1.187 . . . . 1.0 107.795 179.279 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 63.4 mmt-85 -59.52 -28.84 67.43 Favored 'General case' 0 N--CA 1.438 -1.059 0 N-CA-C 109.237 -0.653 . . . . 1.0 109.237 179.71 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 96' ' ' ALA . . . . . 0.797 ' O ' ' N ' ' A' ' 100' ' ' ILE . . . -59.49 -53.87 53.09 Favored 'General case' 0 CA--C 1.496 -1.13 0 N-CA-C 107.114 -1.439 . . . . 1.0 107.114 179.915 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 97' ' ' LEU . . . . . 0.567 ' O ' ' CG2' ' A' ' 100' ' ' ILE . 0.9 OUTLIER -37.78 -32.17 0.05 Allowed 'General case' 0 CA--C 1.556 1.175 0 N-CA-C 108.217 -1.031 . . . . 1.0 108.217 -179.191 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 98' ' ' GLY . . . . . 0.485 ' N ' ' O ' ' A' ' 96' ' ' ALA . . . -82.17 -52.72 3.92 Favored Glycine 0 CA--C 1.564 3.152 0 CA-C-O 123.692 1.718 . . . . 1.0 112.131 173.875 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 99' ' ' GLN . . . . . 0.442 ' N ' ' O ' ' A' ' 96' ' ' ALA . 60.9 mm-40 -77.71 9.59 3.34 Favored 'General case' 0 N--CA 1.44 -0.932 0 N-CA-C 107.978 -1.119 . . . . 1.0 107.978 178.895 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 100' ' ' ILE . . . . . 0.797 ' N ' ' O ' ' A' ' 96' ' ' ALA . 18.9 tt -59.74 -55.1 26.13 Favored 'Isoleucine or valine' 0 CA--C 1.493 -1.215 0 N-CA-C 109.578 -0.527 . . . . 1.0 109.578 -178.51 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 101' ' ' VAL . . . . . 0.63 ' CG1' ' H ' ' A' ' 102' ' ' CYS . 4.2 p -58.58 -58.85 4.88 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.535 0 C-N-CA 118.862 -1.135 . . . . 1.0 108.26 178.636 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 102' ' ' CYS . . . . . 0.63 ' H ' ' CG1' ' A' ' 101' ' ' VAL . 13.1 t -45.61 -26.57 0.63 Allowed 'General case' 0 C--O 1.215 -0.75 0 C-N-CA 120.212 -0.595 . . . . 1.0 109.525 -177.835 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 103' ' ' ARG . . . . . 0.431 ' N ' ' C ' ' A' ' 101' ' ' VAL . 0.0 OUTLIER -88.63 -41.96 12.32 Favored 'General case' 0 CA--C 1.549 0.911 0 CA-C-O 122.347 1.07 . . . . 1.0 113.846 179.598 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 104' ' ' TYR . . . . . 0.748 ' CG ' ' O ' ' A' ' 104' ' ' TYR . 4.0 t80 -95.25 23.0 6.16 Favored 'General case' 0 C--N 1.303 -1.445 0 C-N-CA 127.05 2.14 . . . . 1.0 108.722 178.128 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 105' ' ' GLY . . . . . 0.522 ' N ' ' O ' ' A' ' 101' ' ' VAL . . . -163.15 -86.29 0.06 OUTLIER Glycine 0 N--CA 1.442 -0.93 0 N-CA-C 108.058 -2.017 . . . . 1.0 108.058 178.102 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 106' ' ' ALA . . . . . 0.458 ' HB2' ' O ' ' A' ' 102' ' ' CYS . . . 64.08 66.66 0.63 Allowed 'General case' 0 C--N 1.32 -0.681 0 N-CA-C 112.42 0.526 . . . . 1.0 112.42 179.854 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 107' ' ' THR . . . . . 0.483 ' C ' ' HD2' ' A' ' 110' ' ' PRO . 0.5 OUTLIER -109.61 -9.93 14.86 Favored 'General case' 0 CA--C 1.536 0.431 0 O-C-N 122.136 -0.352 . . . . 1.0 110.438 179.086 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 108' ' ' VAL . . . . . 0.553 ' C ' ' HD2' ' A' ' 110' ' ' PRO . 0.0 OUTLIER -82.6 -62.81 1.34 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.694 0 N-CA-C 113.595 0.961 . . . . 1.0 113.595 -176.359 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 109' ' ' ILE . . . . . 0.594 ' N ' ' CD ' ' A' ' 110' ' ' PRO . 0.6 OUTLIER -54.61 -35.99 38.56 Favored Pre-proline 0 C--N 1.321 -0.673 0 N-CA-C 112.161 0.43 . . . . 1.0 112.161 179.933 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 110' ' ' PRO . . . . . 0.594 ' CD ' ' N ' ' A' ' 109' ' ' ILE . 81.4 Cg_exo -45.81 -32.48 9.19 Favored 'Trans proline' 0 C--N 1.323 -0.779 0 C-N-CA 122.258 1.972 . . . . 1.0 112.565 -174.697 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 111' ' ' ASN . . . . . 0.755 ' CG ' ' H ' ' A' ' 112' ' ' ILE . 12.5 p-10 -61.66 -68.62 0.3 Allowed 'General case' 0 CA--C 1.545 0.753 0 C-N-CA 119.699 -0.801 . . . . 1.0 110.355 -179.674 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 112' ' ' ILE . . . . . 0.755 ' H ' ' CG ' ' A' ' 111' ' ' ASN . 2.9 mm -74.7 -24.8 18.54 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.746 0 CA-C-O 121.851 0.834 . . . . 1.0 110.026 -178.122 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 18.9 t30 -51.72 -58.89 5.11 Favored 'General case' 0 C--N 1.298 -1.651 0 CA-C-N 114.159 -1.382 . . . . 1.0 109.933 -178.416 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -66.09 -19.5 65.86 Favored 'General case' 0 N--CA 1.447 -0.584 0 CA-C-N 116.22 -0.445 . . . . 1.0 110.359 179.197 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -75.13 -61.03 2.03 Favored 'General case' 0 CA--C 1.544 0.72 0 C-N-CA 120.312 -0.555 . . . . 1.0 111.242 178.388 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 116' ' ' ILE . . . . . 0.477 ' O ' ' CB ' ' A' ' 119' ' ' LEU . 15.1 tt -67.57 -38.94 81.41 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.334 0 O-C-N 121.052 -1.03 . . . . 1.0 110.918 -178.851 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 117' ' ' GLU . . . . . 0.494 ' C ' ' H ' ' A' ' 119' ' ' LEU . 1.0 OUTLIER -46.67 -68.06 0.23 Allowed 'General case' 0 C--N 1.3 -1.583 0 CA-C-N 115.334 -0.848 . . . . 1.0 110.493 -178.249 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 89.8 t -47.31 -14.03 0.08 OUTLIER 'Isoleucine or valine' 0 CA--C 1.505 -0.757 0 CA-C-N 114.838 -1.073 . . . . 1.0 109.515 -178.396 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 119' ' ' LEU . . . . . 0.494 ' H ' ' C ' ' A' ' 117' ' ' GLU . 3.2 tp -77.19 -61.6 1.93 Allowed 'General case' 0 N--CA 1.45 -0.447 0 C-N-CA 119.464 -0.894 . . . . 1.0 110.43 179.101 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -73.36 -81.13 0.41 Allowed Glycine 0 C--N 1.362 2.013 0 C-N-CA 117.891 -2.1 . . . . 1.0 111.339 -178.348 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 1.2 t -158.53 -18.63 0.07 Allowed 'General case' 0 C--N 1.322 -0.601 0 CA-C-O 121.237 0.542 . . . . 1.0 110.601 -179.033 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 122' ' ' GLY . . . . . 0.453 ' O ' ' C ' ' A' ' 123' ' ' THR . . . 107.7 -38.45 3.32 Favored Glycine 0 N--CA 1.472 1.076 0 C-N-CA 125.026 1.298 . . . . 1.0 112.758 178.889 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 123' ' ' THR . . . . . 0.453 ' C ' ' O ' ' A' ' 122' ' ' GLY . 8.5 m -30.62 102.73 0.02 OUTLIER 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 118.49 1.145 . . . . 1.0 112.427 -177.128 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 38.0 p-10 -143.72 139.72 29.62 Favored 'General case' 0 C--N 1.332 -0.158 0 N-CA-C 106.985 -1.487 . . . . 1.0 106.985 178.744 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 125' ' ' TYR . . . . . 0.538 ' OH ' ' CE1' ' A' ' 127' ' ' PHE . 0.0 OUTLIER -153.95 150.72 28.61 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 116.185 -0.461 . . . . 1.0 110.165 -177.848 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 126' ' ' ARG . . . . . 0.487 ' HG2' ' O ' ' A' ' 125' ' ' TYR . 2.0 mmp_? -152.07 156.97 40.97 Favored 'General case' 0 CA--C 1.538 0.483 0 O-C-N 124.497 1.123 . . . . 1.0 111.962 176.829 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 127' ' ' PHE . . . . . 0.538 ' CE1' ' OH ' ' A' ' 125' ' ' TYR . 1.1 p90 . . . . . 0 C--O 1.222 -0.377 0 CA-C-O 118.007 -0.997 . . . . 1.0 110.465 178.886 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 1' ' ' MET . . . . . 0.458 ' N ' ' SD ' ' A' ' 1' ' ' MET . 0.0 OUTLIER . . . . . 0 N--CA 1.493 1.696 0 N-CA-C 109.236 -0.654 . . . . 1.0 109.236 . . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 2' ' ' SER . . . . . 0.517 ' O ' ' CB ' ' A' ' 3' ' ' ASP . 87.6 p -86.47 9.09 19.31 Favored 'General case' 0 N--CA 1.463 0.209 0 CA-C-N 116.554 -0.294 . . . . 1.0 111.204 -179.818 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 3' ' ' ASP . . . . . 0.517 ' CB ' ' O ' ' A' ' 2' ' ' SER . 3.5 t70 149.99 123.81 0.0 OUTLIER 'General case' 0 N--CA 1.479 0.995 0 O-C-N 124.16 0.912 . . . . 1.0 111.189 178.551 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . 0.412 ' O ' ' OD1' ' A' ' 5' ' ' ASP . 83.9 t80 -155.25 150.92 27.48 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.408 -0.814 . . . . 1.0 110.403 178.812 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 5' ' ' ASP . . . . . 0.412 ' OD1' ' O ' ' A' ' 4' ' ' PHE . 74.9 m-20 -150.8 148.12 28.12 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.065 -0.516 . . . . 1.0 109.703 179.513 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 6' ' ' THR . . . . . 0.71 ' O ' ' N ' ' A' ' 10' ' ' SER . 0.2 OUTLIER -70.19 167.85 16.98 Favored 'General case' 0 C--O 1.195 -1.802 0 CA-C-O 121.156 0.503 . . . . 1.0 110.274 -179.461 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . 0.633 ' CG ' ' H ' ' A' ' 8' ' ' ARG . 5.4 pt-20 -57.62 -57.78 11.21 Favored 'General case' 0 C--N 1.299 -1.587 0 CA-C-O 121.271 0.558 . . . . 1.0 110.369 -179.26 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 8' ' ' ARG . . . . . 0.633 ' H ' ' CG ' ' A' ' 7' ' ' GLU . 7.9 ttm180 -52.64 -56.07 18.01 Favored 'General case' 0 C--N 1.316 -0.87 0 N-CA-C 107.805 -1.183 . . . . 1.0 107.805 -178.187 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . 0.543 ' O ' ' CG2' ' A' ' 13' ' ' VAL . 0.0 OUTLIER -64.46 -50.42 76.2 Favored 'Isoleucine or valine' 0 C--O 1.203 -1.355 0 C-N-CA 119.488 -0.885 . . . . 1.0 109.816 178.718 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 10' ' ' SER . . . . . 0.71 ' N ' ' O ' ' A' ' 6' ' ' THR . 20.9 t -65.41 -63.92 0.98 Allowed 'General case' 0 C--N 1.316 -0.884 0 C-N-CA 119.42 -0.912 . . . . 1.0 111.257 -178.565 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 11' ' ' ARG . . . . . 0.593 ' N ' ' O ' ' A' ' 7' ' ' GLU . 4.1 tpp180 -63.9 -59.03 5.02 Favored 'General case' 0 N--CA 1.471 0.624 0 CA-C-O 121.103 0.477 . . . . 1.0 111.888 -176.804 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . 0.487 ' CB ' ' O ' ' A' ' 8' ' ' ARG . . . -50.18 -49.38 52.58 Favored 'General case' 0 C--N 1.317 -0.82 0 N-CA-C 107.458 -1.312 . . . . 1.0 107.458 -177.232 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . 0.6 ' O ' ' N ' ' A' ' 17' ' ' LEU . 93.4 t -60.92 -49.47 84.52 Favored 'Isoleucine or valine' 0 C--O 1.198 -1.607 0 C-N-CA 118.733 -1.187 . . . . 1.0 107.946 177.347 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . 0.411 ' O ' ' N ' ' A' ' 18' ' ' VAL . . . -57.53 -62.11 2.02 Favored 'General case' 0 C--O 1.212 -0.889 0 C-N-CA 118.519 -1.273 . . . . 1.0 109.913 -179.8 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . 0.57 ' O ' ' N ' ' A' ' 19' ' ' GLY . . . -51.28 -53.57 34.36 Favored 'General case' 0 N--CA 1.472 0.648 0 CA-C-O 121.706 0.765 . . . . 1.0 109.287 -178.245 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -62.94 -55.08 29.01 Favored 'General case' 0 C--N 1.309 -1.186 0 CA-C-N 114.603 -1.18 . . . . 1.0 109.037 -178.988 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . 0.6 ' N ' ' O ' ' A' ' 13' ' ' VAL . 4.8 tt -55.91 -54.16 48.11 Favored 'General case' 0 N--CA 1.478 0.966 0 CA-C-N 113.921 -1.49 . . . . 1.0 109.063 -177.413 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . 0.554 HG21 ' H ' ' A' ' 19' ' ' GLY . 2.3 m -69.29 -57.4 8.62 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.359 0 N-CA-C 108.939 -0.763 . . . . 1.0 108.939 178.426 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . 0.57 ' N ' ' O ' ' A' ' 15' ' ' ALA . . . -58.03 -169.45 0.18 Allowed Glycine 0 C--O 1.216 -1.027 0 N-CA-C 110.67 -0.972 . . . . 1.0 110.67 179.722 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 20' ' ' PRO . . . . . 0.499 ' O ' ' N ' ' A' ' 24' ' ' ALA . 3.5 Cg_endo -79.62 -31.07 2.13 Favored 'Trans proline' 0 N--CA 1.499 1.798 0 C-N-CA 123.052 2.501 . . . . 1.0 115.154 -178.06 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -59.88 -57.43 19.39 Favored Glycine 0 N--CA 1.475 1.298 0 C-N-CA 120.699 -0.763 . . . . 1.0 112.665 -176.8 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -55.99 -54.16 37.28 Favored Glycine 0 N--CA 1.469 0.844 0 N-CA-C 107.74 -2.144 . . . . 1.0 107.74 -175.534 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . 0.554 ' CG2' ' O ' ' A' ' 19' ' ' GLY . 0.0 OUTLIER -60.84 -32.23 51.61 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.391 0 CA-C-N 114.617 -0.792 . . . . 1.0 109.607 178.923 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . 0.499 ' N ' ' O ' ' A' ' 20' ' ' PRO . . . -56.01 -62.12 1.92 Allowed 'General case' 0 CA--C 1.532 0.28 0 C-N-CA 117.993 -1.483 . . . . 1.0 109.408 179.791 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -65.56 -45.16 84.39 Favored 'General case' 0 C--N 1.341 0.23 0 N-CA-C 112.82 0.674 . . . . 1.0 112.82 -178.464 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 98.5 t -60.22 -59.11 4.57 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.192 0 C-N-CA 118.849 -1.14 . . . . 1.0 110.21 -177.375 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 1.2 p -59.74 -35.16 58.33 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.286 0 CA-C-O 120.982 0.42 . . . . 1.0 111.95 -178.341 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 32.2 ttpt -66.54 -53.92 29.44 Favored 'General case' 0 C--N 1.315 -0.921 0 CA-C-O 121.906 0.86 . . . . 1.0 109.069 -178.376 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 91.1 t -64.37 -48.59 84.62 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.1 0 CA-C-N 113.668 -1.605 . . . . 1.0 111.557 -177.413 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 30' ' ' CYS . . . . . 0.572 ' SG ' ' N ' ' A' ' 31' ' ' ALA . 0.0 OUTLIER -63.82 -58.58 6.37 Favored 'General case' 0 N--CA 1.452 -0.336 0 C-N-CA 118.86 -1.136 . . . . 1.0 108.518 -179.299 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . 0.572 ' N ' ' SG ' ' A' ' 30' ' ' CYS . . . -61.7 -53.52 55.02 Favored 'General case' 0 C--N 1.326 -0.415 0 N-CA-C 112.422 0.527 . . . . 1.0 112.422 -177.515 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . 0.473 ' O ' ' CB ' ' A' ' 33' ' ' LEU . . . 86.86 74.42 1.27 Allowed Glycine 0 CA--C 1.522 0.481 0 N-CA-C 110.656 -0.978 . . . . 1.0 110.656 -178.87 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . 0.473 ' CB ' ' O ' ' A' ' 32' ' ' GLY . 1.0 OUTLIER 86.06 101.84 0.03 OUTLIER Pre-proline 0 CA--C 1.547 0.841 0 N-CA-C 109.813 -0.44 . . . . 1.0 109.813 -179.876 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 55.9 Cg_endo -71.48 -26.02 20.64 Favored 'Trans proline' 0 N--CA 1.501 1.96 0 C-N-CA 122.087 1.858 . . . . 1.0 114.055 -177.955 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -59.84 -59.45 10.47 Favored Glycine 0 CA--C 1.523 0.554 0 C-N-CA 118.081 -2.009 . . . . 1.0 108.884 -178.539 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . 0.525 ' O ' ' CB ' ' A' ' 37' ' ' ILE . 10.8 p -90.53 161.92 2.54 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.541 0 N-CA-C 107.277 -1.379 . . . . 1.0 107.277 177.565 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . 0.525 ' CB ' ' O ' ' A' ' 36' ' ' VAL . 14.8 tt 120.0 113.17 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.472 0.626 0 O-C-N 124.85 1.344 . . . . 1.0 110.061 179.615 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 22.7 m-70 -140.61 135.46 31.76 Favored 'General case' 0 C--N 1.322 -0.625 0 N-CA-C 108.874 -0.787 . . . . 1.0 108.874 178.87 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 42.5 p -112.54 139.8 23.1 Favored Pre-proline 0 C--N 1.331 -0.23 0 N-CA-C 109.146 -0.687 . . . . 1.0 109.146 179.716 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 40' ' ' PRO . . . . . 0.404 ' HG2' ' H ' ' A' ' 41' ' ' ALA . 57.6 Cg_endo -70.88 -87.15 0.0 OUTLIER 'Trans proline' 0 C--N 1.312 -1.367 0 C-N-CA 121.747 1.631 . . . . 1.0 112.015 -179.433 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . 0.404 ' H ' ' HG2' ' A' ' 40' ' ' PRO . . . -66.6 125.07 24.62 Favored 'General case' 0 C--N 1.315 -0.93 0 CA-C-N 114.786 -1.097 . . . . 1.0 110.623 -178.902 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . 0.676 ' C ' ' H ' ' A' ' 44' ' ' GLY . 4.2 ptt180 -170.7 168.42 7.44 Favored 'General case' 0 N--CA 1.445 -0.711 0 CA-C-N 115.556 -0.747 . . . . 1.0 109.779 179.893 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -63.31 24.86 0.01 OUTLIER 'General case' 0 C--N 1.317 -0.826 0 CA-C-N 115.88 -0.6 . . . . 1.0 110.369 179.83 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . 0.676 ' H ' ' C ' ' A' ' 42' ' ' ARG . . . 87.14 -26.2 7.1 Favored Glycine 0 C--N 1.333 0.402 0 N-CA-C 110.605 -0.998 . . . . 1.0 110.605 179.4 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . 0.646 ' CG ' ' O ' ' A' ' 44' ' ' GLY . 74.0 m-85 -167.37 175.15 7.45 Favored 'General case' 0 C--O 1.216 -0.675 0 O-C-N 124.759 0.917 . . . . 1.0 110.696 178.551 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 46' ' ' PHE . . . . . 0.524 ' HB2' ' O ' ' A' ' 45' ' ' PHE . 2.0 m-85 132.58 89.02 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.611 0 C-N-CA 125.625 1.57 . . . . 1.0 109.432 179.01 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 47' ' ' ARG . . . . . 0.508 ' CB ' ' O ' ' A' ' 46' ' ' PHE . 48.6 mmt-85 124.53 142.06 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.509 0 C-N-CA 124.33 1.052 . . . . 1.0 110.781 178.666 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 2.6 t 69.45 70.62 0.25 Allowed 'General case' 0 C--N 1.331 -0.226 0 N-CA-C 108.355 -0.98 . . . . 1.0 108.355 -178.916 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 49' ' ' ASN . . . . . 0.559 ' CG ' HE22 ' A' ' 54' ' ' GLN . 1.7 p30 -125.17 152.79 71.34 Favored Pre-proline 0 C--O 1.233 0.232 0 CA-C-N 116.448 -0.342 . . . . 1.0 110.551 -178.969 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 50' ' ' PRO . . . . . 0.469 ' HG2' HH11 ' A' ' 52' ' ' ARG . 78.7 Cg_endo -73.17 55.84 3.03 Favored 'Trans proline' 0 C--N 1.311 -1.427 0 C-N-CA 122.022 1.815 . . . . 1.0 110.812 178.889 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 46.8 mm-40 68.18 -2.5 1.5 Allowed 'General case' 0 CA--C 1.528 0.127 0 CA-C-N 116.149 -0.478 . . . . 1.0 111.08 -179.635 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . 0.469 HH11 ' HG2' ' A' ' 50' ' ' PRO . 80.0 mtt85 -77.85 159.71 28.78 Favored 'General case' 0 N--CA 1.466 0.329 0 CA-C-O 120.999 0.428 . . . . 1.0 110.581 179.095 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . 0.429 ' O ' ' N ' ' A' ' 55' ' ' ILE . 19.4 tt -78.13 138.71 19.77 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.187 0 CA-C-N 115.906 -0.588 . . . . 1.0 111.218 -179.324 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 54' ' ' GLN . . . . . 0.559 HE22 ' CG ' ' A' ' 49' ' ' ASN . 29.2 mm-40 -63.16 81.4 0.02 OUTLIER 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 115.273 -0.876 . . . . 1.0 110.468 -177.973 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . 0.429 ' N ' ' O ' ' A' ' 53' ' ' ILE . 15.4 tt -147.01 156.02 11.01 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.152 0 CA-C-N 115.264 -0.88 . . . . 1.0 109.613 177.63 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 109.97 -2.13 30.12 Favored Glycine 0 N--CA 1.466 0.634 0 N-CA-C 110.683 -0.967 . . . . 1.0 110.683 -179.748 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . 0.418 ' O ' ' CG ' ' A' ' 57' ' ' ASP . 18.9 p-10 -79.43 99.56 7.25 Favored 'General case' 0 C--N 1.325 -0.468 0 N-CA-C 109.33 -0.619 . . . . 1.0 109.33 178.891 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 58' ' ' TRP . . . . . . . . . . . . . 3.9 m0 -89.99 170.58 10.23 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 123.753 1.739 . . . . 1.0 113.337 -177.052 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 59' ' ' ARG . . . . . 0.42 ' HG3' ' N ' ' A' ' 60' ' ' TYR . 48.3 ptt85 -82.29 -57.89 3.18 Favored 'General case' 0 C--N 1.312 -1.062 0 CA-C-N 110.393 -3.094 . . . . 1.0 112.779 -178.865 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 60' ' ' TYR . . . . . 0.42 ' N ' ' HG3' ' A' ' 59' ' ' ARG . 79.9 t80 -92.67 -15.68 26.46 Favored 'General case' 0 N--CA 1.485 1.285 0 N-CA-C 113.406 0.891 . . . . 1.0 113.406 -179.979 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 6.3 tt0 -77.49 -14.03 59.78 Favored 'General case' 0 C--N 1.313 -1.005 0 CA-C-N 116.065 -0.516 . . . . 1.0 111.073 -178.852 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 62' ' ' VAL . . . . . 0.638 ' O ' ' N ' ' A' ' 66' ' ' GLY . 27.5 m -48.22 -54.65 3.86 Favored 'Isoleucine or valine' 0 C--O 1.198 -1.616 0 C-N-CA 119.485 -0.886 . . . . 1.0 109.84 -175.346 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -68.01 -50.65 54.23 Favored 'General case' 0 C--N 1.306 -1.297 0 O-C-N 121.32 -0.862 . . . . 1.0 109.022 -179.968 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -48.5 -58.59 4.44 Favored 'General case' 0 N--CA 1.465 0.307 0 C-N-CA 119.594 -0.842 . . . . 1.0 109.274 -179.893 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 65' ' ' ASP . . . . . 0.581 ' C ' ' H ' ' A' ' 67' ' ' ARG . 18.5 t0 -71.63 -49.97 35.14 Favored 'General case' 0 C--N 1.314 -0.968 0 CA-C-N 115.147 -0.933 . . . . 1.0 110.159 178.832 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . 0.638 ' N ' ' O ' ' A' ' 62' ' ' VAL . . . -71.69 25.83 0.62 Allowed Glycine 0 CA--C 1.52 0.393 0 N-CA-C 110.915 -0.874 . . . . 1.0 110.915 178.241 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 67' ' ' ARG . . . . . 0.628 ' O ' ' N ' ' A' ' 69' ' ' LEU . 0.2 OUTLIER -75.89 2.49 12.31 Favored 'General case' 0 C--N 1.323 -0.564 0 N-CA-C 105.706 -1.961 . . . . 1.0 105.706 175.607 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . 0.51 ' H ' ' C ' ' A' ' 66' ' ' GLY . 0.0 OUTLIER -35.23 -27.32 0.01 OUTLIER 'General case' 0 N--CA 1.482 1.169 0 N-CA-C 107.991 -1.114 . . . . 1.0 107.991 -176.559 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . 0.628 ' N ' ' O ' ' A' ' 67' ' ' ARG . 2.9 tm? -62.68 -64.49 0.9 Allowed 'General case' 0 C--N 1.323 -0.56 0 C-N-CA 117.679 -1.608 . . . . 1.0 107.732 177.772 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . 0.706 ' C ' ' H ' ' A' ' 72' ' ' HIS . . . -79.01 -74.52 0.28 Allowed 'General case' 0 N--CA 1.479 0.995 0 N-CA-C 107.385 -1.339 . . . . 1.0 107.385 178.509 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 71' ' ' ALA . . . . . 0.435 ' O ' ' C ' ' A' ' 72' ' ' HIS . . . -45.15 4.16 0.0 OUTLIER 'General case' 0 C--O 1.224 -0.239 0 C-N-CA 124.849 1.26 . . . . 1.0 112.479 178.754 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 72' ' ' HIS . . . . . 0.706 ' H ' ' C ' ' A' ' 70' ' ' ALA . 1.9 t60 -29.83 -73.85 0.03 OUTLIER 'General case' 0 C--N 1.333 -0.123 0 N-CA-C 112.261 0.467 . . . . 1.0 112.261 -179.373 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 73' ' ' MET . . . . . 0.598 ' N ' ' SD ' ' A' ' 73' ' ' MET . 0.0 OUTLIER -58.34 -54.51 46.24 Favored 'General case' 0 C--N 1.329 -0.32 0 N-CA-C 106.521 -1.659 . . . . 1.0 106.521 178.655 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . 0.765 ' O ' ' N ' ' A' ' 76' ' ' GLY . 61.4 t -42.38 -39.83 0.87 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-O 117.271 -1.347 . . . . 1.0 111.681 -176.13 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 75' ' ' ASN . . . . . 0.492 ' C ' ' N ' ' A' ' 77' ' ' ILE . 33.4 p-10 -35.15 -15.18 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.607 0 CA-C-N 120.824 1.647 . . . . 1.0 110.806 179.558 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 76' ' ' GLY . . . . . 0.765 ' N ' ' O ' ' A' ' 74' ' ' VAL . . . -49.6 -19.93 2.38 Favored Glycine 0 N--CA 1.436 -1.328 0 N-CA-C 107.244 -2.343 . . . . 1.0 107.244 173.394 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 77' ' ' ILE . . . . . 0.492 ' N ' ' C ' ' A' ' 75' ' ' ASN . 14.1 pt -56.49 -50.59 72.17 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.032 0 CA-C-O 117.747 -1.12 . . . . 1.0 110.384 -179.334 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 24.4 t -54.71 -20.69 5.82 Favored 'Isoleucine or valine' 0 C--N 1.352 0.699 0 CA-C-N 121.095 1.77 . . . . 1.0 113.427 179.701 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . 0.567 ' CG2' HH22 ' A' ' 126' ' ' ARG . 44.8 pt -91.68 -40.27 12.25 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.34 0 C-N-CA 118.888 -1.125 . . . . 1.0 109.677 178.012 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -79.56 -19.85 48.46 Favored 'General case' 0 CA--C 1.538 0.494 0 N-CA-C 113.604 0.964 . . . . 1.0 113.604 179.495 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 81' ' ' GLU . . . . . 0.542 ' CG ' ' H ' ' A' ' 82' ' ' ASP . 1.1 pp20? -94.15 -71.52 0.66 Allowed 'General case' 0 C--N 1.345 0.4 0 N-CA-C 114.47 1.285 . . . . 1.0 114.47 -177.474 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 82' ' ' ASP . . . . . 0.542 ' H ' ' CG ' ' A' ' 81' ' ' GLU . 27.4 t70 -88.93 -15.04 35.31 Favored 'General case' 0 CA--C 1.538 0.493 0 N-CA-C 114.447 1.277 . . . . 1.0 114.447 -178.237 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . 0.523 ' O ' ' N ' ' A' ' 87' ' ' GLU . . . -49.75 -46.21 50.27 Favored 'General case' 0 C--O 1.214 -0.813 0 C-N-CA 118.116 -1.434 . . . . 1.0 112.352 -177.816 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 2.7 tm? -39.77 -45.47 1.75 Allowed 'General case' 0 N--CA 1.471 0.586 0 CA-C-N 118.207 0.458 . . . . 1.0 111.602 -178.026 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 6.4 tt -66.36 -34.64 71.5 Favored 'Isoleucine or valine' 0 C--O 1.235 0.296 0 C-N-CA 119.698 -0.801 . . . . 1.0 111.022 -179.583 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 86' ' ' ALA . . . . . 0.552 ' O ' ' N ' ' A' ' 89' ' ' VAL . . . -93.64 -23.88 18.1 Favored 'General case' 0 C--O 1.211 -0.967 0 N-CA-C 111.728 0.27 . . . . 1.0 111.728 179.904 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 87' ' ' GLU . . . . . 0.523 ' N ' ' O ' ' A' ' 83' ' ' ALA . 38.9 tp10 -54.51 -18.81 4.76 Favored 'General case' 0 C--N 1.324 -0.509 0 O-C-N 121.447 -0.783 . . . . 1.0 109.946 -178.818 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -75.49 -5.83 47.12 Favored 'General case' 0 N--CA 1.473 0.687 0 CA-C-O 122.762 1.268 . . . . 1.0 108.097 178.329 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 89' ' ' VAL . . . . . 0.552 ' N ' ' O ' ' A' ' 86' ' ' ALA . 3.2 m -86.05 36.31 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.318 -0.785 0 CA-C-N 112.173 -2.285 . . . . 1.0 107.962 177.085 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 90' ' ' GLY . . . . . 0.882 ' O ' ' N ' ' A' ' 92' ' ' HIS . . . -56.26 -19.66 25.72 Favored Glycine 0 C--N 1.373 2.601 0 CA-C-O 117.049 -1.973 . . . . 1.0 113.465 178.362 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 91' ' ' PRO . . . . . 0.632 ' HD2' ' N ' ' A' ' 90' ' ' GLY . 3.0 Cg_exo -34.38 3.42 0.0 OUTLIER 'Trans proline' 0 N--CA 1.499 1.817 0 CA-C-N 121.618 2.709 . . . . 1.0 113.693 172.409 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 92' ' ' HIS . . . . . 0.882 ' N ' ' O ' ' A' ' 90' ' ' GLY . 1.4 t-160 -47.2 -35.15 7.12 Favored 'General case' 0 N--CA 1.443 -0.816 0 N-CA-C 106.04 -1.837 . . . . 1.0 106.04 179.484 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 93' ' ' LEU . . . . . 0.409 ' O ' ' HB1' ' A' ' 96' ' ' ALA . 5.6 tp -62.57 -45.86 91.0 Favored 'General case' 0 C--N 1.35 0.609 0 N-CA-C 108.652 -0.869 . . . . 1.0 108.652 176.058 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 94' ' ' ALA . . . . . 0.545 ' N ' ' O ' ' A' ' 91' ' ' PRO . . . -53.69 -58.17 8.18 Favored 'General case' 0 C--N 1.333 -0.15 0 N-CA-C 106.344 -1.724 . . . . 1.0 106.344 178.685 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -58.32 -29.73 66.14 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-N 114.65 -1.159 . . . . 1.0 109.314 177.981 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 96' ' ' ALA . . . . . 0.855 ' O ' ' N ' ' A' ' 100' ' ' ILE . . . -54.35 -51.21 65.47 Favored 'General case' 0 C--O 1.199 -1.57 0 N-CA-C 107.84 -1.17 . . . . 1.0 107.84 -176.145 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 97' ' ' LEU . . . . . 0.508 ' C ' ' O ' ' A' ' 96' ' ' ALA . 2.7 tm? -34.02 -28.37 0.01 OUTLIER 'General case' 0 CA--C 1.567 1.622 0 CA-C-N 113.788 -1.551 . . . . 1.0 108.052 -178.03 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 98' ' ' GLY . . . . . 0.648 ' N ' ' O ' ' A' ' 96' ' ' ALA . . . -89.37 -53.32 2.49 Favored Glycine 0 CA--C 1.56 2.866 0 CA-C-O 123.279 1.488 . . . . 1.0 111.956 170.46 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 99' ' ' GLN . . . . . 0.541 ' N ' ' O ' ' A' ' 96' ' ' ALA . 5.4 mm100 -75.93 6.48 5.09 Favored 'General case' 0 N--CA 1.439 -0.986 0 N-CA-C 107.64 -1.244 . . . . 1.0 107.64 179.156 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 100' ' ' ILE . . . . . 0.855 ' N ' ' O ' ' A' ' 96' ' ' ALA . 19.2 tt -63.46 -50.6 77.86 Favored 'Isoleucine or valine' 0 CA--C 1.471 -2.069 0 N-CA-C 107.784 -1.191 . . . . 1.0 107.784 -179.956 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 101' ' ' VAL . . . . . 0.673 ' O ' ' N ' ' A' ' 105' ' ' GLY . 76.1 t -51.84 -60.16 1.14 Allowed 'Isoleucine or valine' 0 C--O 1.212 -0.893 0 C-N-CA 118.292 -1.363 . . . . 1.0 107.389 178.691 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 102' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -53.63 -25.39 17.55 Favored 'General case' 0 C--N 1.306 -1.299 0 CA-C-N 115.428 -0.806 . . . . 1.0 111.434 -176.78 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 51.1 ttm-85 -84.36 -52.05 6.49 Favored 'General case' 0 N--CA 1.488 1.471 0 CA-C-O 122.415 1.102 . . . . 1.0 113.337 -179.407 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 104' ' ' TYR . . . . . 0.671 ' CG ' ' O ' ' A' ' 104' ' ' TYR . 0.0 OUTLIER -96.33 21.79 8.61 Favored 'General case' 0 C--N 1.302 -1.488 0 C-N-CA 127.378 2.271 . . . . 1.0 106.819 177.874 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 105' ' ' GLY . . . . . 0.673 ' N ' ' O ' ' A' ' 101' ' ' VAL . . . -159.08 -97.88 0.13 Allowed Glycine 0 CA--C 1.53 0.99 0 N-CA-C 109.442 -1.463 . . . . 1.0 109.442 179.028 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . 60.64 114.38 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.253 0 N-CA-C 108.985 -0.746 . . . . 1.0 108.985 -176.254 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 107' ' ' THR . . . . . 0.745 ' O ' ' HD2' ' A' ' 110' ' ' PRO . 22.0 m -133.28 -61.61 0.82 Allowed 'General case' 0 C--O 1.194 -1.819 0 N-CA-C 106.789 -1.56 . . . . 1.0 106.789 177.78 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 32.7 m -71.5 30.66 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.318 -0.795 0 O-C-N 121.22 -0.925 . . . . 1.0 109.251 -178.239 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 109' ' ' ILE . . . . . 0.529 ' H ' ' CD ' ' A' ' 110' ' ' PRO . 0.1 OUTLIER -111.8 -40.46 0.1 Allowed Pre-proline 0 CA--C 1.56 1.346 0 CA-C-N 118.573 0.624 . . . . 1.0 110.882 177.969 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 110' ' ' PRO . . . . . 0.745 ' HD2' ' O ' ' A' ' 107' ' ' THR . 31.2 Cg_exo -65.33 -23.83 58.49 Favored 'Trans proline' 0 N--CA 1.496 1.62 0 C-N-CA 122.609 2.206 . . . . 1.0 111.82 179.72 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 111' ' ' ASN . . . . . 0.549 ' CG ' ' N ' ' A' ' 112' ' ' ILE . 0.0 OUTLIER -66.43 -66.77 0.51 Allowed 'General case' 0 CA--C 1.535 0.384 0 C-N-CA 119.51 -0.876 . . . . 1.0 109.132 -179.353 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 112' ' ' ILE . . . . . 0.549 ' N ' ' CG ' ' A' ' 111' ' ' ASN . 0.0 OUTLIER -52.43 -32.47 16.49 Favored 'Isoleucine or valine' 0 C--O 1.213 -0.821 0 CA-C-O 122.253 1.025 . . . . 1.0 109.139 178.783 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 8.4 m-20 -55.39 -55.29 33.28 Favored 'General case' 0 C--N 1.296 -1.722 0 CA-C-N 113.345 -1.752 . . . . 1.0 107.581 -179.105 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -60.51 -29.31 69.01 Favored 'General case' 0 N--CA 1.44 -0.958 0 C-N-CA 119.383 -0.927 . . . . 1.0 110.995 178.934 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -77.93 -59.56 2.73 Favored 'General case' 0 N--CA 1.451 -0.413 0 C-N-CA 119.558 -0.857 . . . . 1.0 110.031 178.949 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 116' ' ' ILE . . . . . 0.64 ' O ' ' N ' ' A' ' 120' ' ' GLY . 1.4 tp -50.8 -48.21 28.34 Favored 'Isoleucine or valine' 0 CA--C 1.498 -1.055 0 N-CA-C 108.859 -0.793 . . . . 1.0 108.859 -179.096 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 117' ' ' GLU . . . . . 0.53 ' N ' ' CG2' ' A' ' 116' ' ' ILE . 51.6 mt-10 -38.9 -58.53 1.08 Allowed 'General case' 0 C--N 1.317 -0.838 0 N-CA-C 104.707 -2.331 . . . . 1.0 104.707 179.424 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 99.4 t -58.62 -52.02 64.81 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.716 0 C-N-CA 119.608 -0.837 . . . . 1.0 109.076 176.951 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 119' ' ' LEU . . . . . 0.474 ' N ' ' O ' ' A' ' 116' ' ' ILE . 0.3 OUTLIER -56.34 -69.64 0.14 Allowed 'General case' 0 N--CA 1.47 0.561 0 C-N-CA 118.362 -1.335 . . . . 1.0 107.641 -178.594 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 120' ' ' GLY . . . . . 0.64 ' N ' ' O ' ' A' ' 116' ' ' ILE . . . -72.0 -85.11 0.2 Allowed Glycine 0 CA--C 1.55 2.223 0 C-N-CA 119.172 -1.489 . . . . 1.0 111.25 178.229 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 121' ' ' THR . . . . . 0.402 ' HA ' ' O ' ' A' ' 117' ' ' GLU . 1.5 t 160.96 -27.66 0.0 OUTLIER 'General case' 0 N--CA 1.486 1.375 0 CA-C-N 113.797 -1.202 . . . . 1.0 113.362 -178.715 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 122' ' ' GLY . . . . . 0.632 ' O ' ' N ' ' A' ' 124' ' ' ASP . . . 97.38 -21.74 44.54 Favored Glycine 0 N--CA 1.476 1.36 0 N-CA-C 107.884 -2.086 . . . . 1.0 107.884 -177.511 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 123' ' ' THR . . . . . 0.542 ' O ' ' NE2' ' A' ' 72' ' ' HIS . 7.6 m -47.7 89.41 0.0 OUTLIER 'General case' 0 N--CA 1.467 0.413 0 N-CA-C 105.21 -2.144 . . . . 1.0 105.21 177.603 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 124' ' ' ASP . . . . . 0.632 ' N ' ' O ' ' A' ' 122' ' ' GLY . 29.8 t70 -166.32 175.57 8.14 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 114.856 -1.065 . . . . 1.0 112.361 -179.505 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 125' ' ' TYR . . . . . 0.521 ' H ' ' CG ' ' A' ' 124' ' ' ASP . 56.2 t80 -146.71 145.32 29.95 Favored 'General case' 0 CA--C 1.533 0.298 0 CA-C-N 115.102 -0.954 . . . . 1.0 109.106 176.7 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 126' ' ' ARG . . . . . 0.567 HH22 ' CG2' ' A' ' 79' ' ' ILE . 0.8 OUTLIER -147.18 146.46 29.86 Favored 'General case' 0 C--N 1.327 -0.387 0 N-CA-C 108.701 -0.851 . . . . 1.0 108.701 178.91 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 127' ' ' PHE . . . . . . . . . . . . . 29.2 p90 . . . . . 0 N--CA 1.47 0.573 0 CA-C-O 117.899 -1.048 . . . . 1.0 110.297 179.737 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 1' ' ' MET . . . . . 0.622 ' N ' ' SD ' ' A' ' 1' ' ' MET . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.619 0 N-CA-C 108.998 -0.742 . . . . 1.0 108.998 . . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 2' ' ' SER . . . . . 0.466 ' O ' ' CB ' ' A' ' 3' ' ' ASP . 78.2 p -81.07 5.92 15.15 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.854 -0.612 . . . . 1.0 110.771 -179.805 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 3' ' ' ASP . . . . . 0.478 ' N ' ' OD1' ' A' ' 3' ' ' ASP . 5.1 p30 154.17 127.72 0.0 OUTLIER 'General case' 0 N--CA 1.472 0.629 0 O-C-N 123.669 0.606 . . . . 1.0 110.556 178.965 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 71.9 t80 -154.1 149.7 27.41 Favored 'General case' 0 N--CA 1.466 0.338 0 CA-C-O 120.789 0.328 . . . . 1.0 110.762 179.33 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 68.4 m-20 -152.92 147.96 26.58 Favored 'General case' 0 CA--C 1.535 0.389 0 N-CA-C 109.555 -0.535 . . . . 1.0 109.555 179.747 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 6' ' ' THR . . . . . 0.809 ' O ' ' N ' ' A' ' 10' ' ' SER . 0.2 OUTLIER -93.64 -177.61 4.44 Favored 'General case' 0 C--O 1.187 -2.225 0 CA-C-N 116.68 -0.236 . . . . 1.0 110.972 -179.485 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . 0.532 ' O ' ' N ' ' A' ' 11' ' ' ARG . 66.5 tt0 -59.93 -55.44 34.1 Favored 'General case' 0 N--CA 1.476 0.849 0 CA-C-O 121.518 0.675 . . . . 1.0 110.933 -179.274 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 8' ' ' ARG . . . . . 0.531 ' O ' ' CB ' ' A' ' 12' ' ' ALA . 0.6 OUTLIER -53.58 -58.98 5.22 Favored 'General case' 0 C--N 1.304 -1.409 0 N-CA-C 107.749 -1.204 . . . . 1.0 107.749 179.865 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . 0.552 ' O ' ' N ' ' A' ' 13' ' ' VAL . 0.0 OUTLIER -65.47 -49.32 78.96 Favored 'Isoleucine or valine' 0 CA--C 1.559 1.308 0 CA-C-N 114.575 -1.193 . . . . 1.0 110.978 179.816 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 10' ' ' SER . . . . . 0.809 ' N ' ' O ' ' A' ' 6' ' ' THR . 32.2 t -61.11 -57.94 10.42 Favored 'General case' 0 N--CA 1.492 1.668 0 CA-C-O 122.23 1.014 . . . . 1.0 108.315 179.057 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 11' ' ' ARG . . . . . 0.532 ' N ' ' O ' ' A' ' 7' ' ' GLU . 7.6 tpt180 -61.97 -40.79 96.8 Favored 'General case' 0 C--N 1.315 -0.92 0 CA-C-N 115.412 -0.813 . . . . 1.0 109.167 -177.578 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . 0.531 ' CB ' ' O ' ' A' ' 8' ' ' ARG . . . -68.05 -55.44 12.55 Favored 'General case' 0 N--CA 1.475 0.825 0 C-N-CA 119.193 -1.003 . . . . 1.0 108.557 176.164 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . 0.625 ' O ' ' CB ' ' A' ' 17' ' ' LEU . 4.5 m -63.28 -53.03 51.09 Favored 'Isoleucine or valine' 0 C--O 1.205 -1.246 0 C-N-CA 118.241 -1.384 . . . . 1.0 108.894 -178.957 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . 0.587 ' N ' ' O ' ' A' ' 10' ' ' SER . . . -60.8 -64.35 0.98 Allowed 'General case' 0 C--N 1.305 -1.347 0 C-N-CA 117.953 -1.499 . . . . 1.0 110.464 179.668 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . 0.515 ' O ' ' N ' ' A' ' 19' ' ' GLY . . . -56.52 -56.45 21.05 Favored 'General case' 0 N--CA 1.479 0.992 0 C-N-CA 119.522 -0.871 . . . . 1.0 111.375 -177.883 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . 0.509 ' CB ' ' O ' ' A' ' 12' ' ' ALA . . . -65.6 -56.42 12.31 Favored 'General case' 0 C--N 1.318 -0.791 0 C-N-CA 119.068 -1.053 . . . . 1.0 110.298 -178.596 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . 0.625 ' CB ' ' O ' ' A' ' 13' ' ' VAL . 5.2 tt -58.36 -54.94 41.39 Favored 'General case' 0 N--CA 1.485 1.293 0 C-N-CA 118.869 -1.132 . . . . 1.0 108.853 -178.289 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . 0.594 HG22 ' H ' ' A' ' 19' ' ' GLY . 1.3 m -71.88 -57.75 6.65 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.858 0 C-N-CA 119.112 -1.035 . . . . 1.0 110.851 -179.823 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . 0.594 ' H ' HG22 ' A' ' 18' ' ' VAL . . . -57.33 -175.22 0.34 Allowed Glycine 0 N--CA 1.444 -0.808 0 C-N-CA 121.23 -0.509 . . . . 1.0 112.076 -177.036 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 20' ' ' PRO . . . . . 0.641 ' O ' ' N ' ' A' ' 24' ' ' ALA . 4.1 Cg_endo -81.06 -27.03 3.16 Favored 'Trans proline' 0 C--N 1.307 -1.647 0 C-N-CA 122.749 2.3 . . . . 1.0 113.172 -178.433 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -63.05 -61.26 6.57 Favored Glycine 0 N--CA 1.474 1.17 0 C-N-CA 119.279 -1.439 . . . . 1.0 112.432 -176.33 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . 0.415 ' H ' ' HA ' ' A' ' 16' ' ' ALA . . . -53.08 -51.87 43.55 Favored Glycine 0 N--CA 1.472 1.087 0 N-CA-C 106.14 -2.784 . . . . 1.0 106.14 -177.697 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 40.5 t -61.61 -31.5 50.91 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.089 0 C-N-CA 119.42 -0.912 . . . . 1.0 109.811 178.517 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . 0.641 ' N ' ' O ' ' A' ' 20' ' ' PRO . . . -57.68 -62.49 1.76 Allowed 'General case' 0 C--N 1.353 0.756 0 C-N-CA 118.551 -1.26 . . . . 1.0 109.703 -179.501 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . 0.444 ' HG ' ' N ' ' A' ' 26' ' ' VAL . 0.5 OUTLIER -61.42 -44.72 96.64 Favored 'General case' 0 N--CA 1.464 0.251 0 C-N-CA 119.902 -0.719 . . . . 1.0 111.93 -178.237 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . 0.444 ' N ' ' HG ' ' A' ' 25' ' ' LEU . 31.6 t -58.98 -58.35 7.27 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.819 0 C-N-CA 119.455 -0.898 . . . . 1.0 110.278 -177.843 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . 0.402 ' O ' ' CB ' ' A' ' 31' ' ' ALA . 1.4 p -63.01 -36.67 76.78 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.716 0 C-N-CA 120.393 -0.523 . . . . 1.0 110.971 -177.999 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 2.0 tppp? -65.47 -57.81 7.37 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-O 121.756 0.788 . . . . 1.0 109.199 -179.237 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 79.3 t -63.56 -47.78 89.9 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.023 0 CA-C-N 114.622 -1.172 . . . . 1.0 110.208 -177.351 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 30' ' ' CYS . . . . . . . . . . . . . 51.4 t -65.56 -61.02 2.34 Favored 'General case' 0 N--CA 1.446 -0.64 0 C-N-CA 119.355 -0.938 . . . . 1.0 110.358 -179.397 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . 0.402 ' CB ' ' O ' ' A' ' 27' ' ' VAL . . . -59.71 -47.8 84.21 Favored 'General case' 0 CA--C 1.515 -0.378 0 O-C-N 122.083 -0.385 . . . . 1.0 111.158 -176.954 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . 0.483 ' O ' ' HB2' ' A' ' 33' ' ' LEU . . . 72.89 64.62 2.51 Favored Glycine 0 N--CA 1.449 -0.492 0 N-CA-C 108.788 -1.725 . . . . 1.0 108.788 -178.144 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . 0.483 ' HB2' ' O ' ' A' ' 32' ' ' GLY . 27.2 mt 83.77 129.88 0.03 OUTLIER Pre-proline 0 CA--C 1.544 0.739 0 O-C-N 125.295 1.233 . . . . 1.0 111.12 -178.465 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 58.7 Cg_endo -72.13 -5.26 16.76 Favored 'Trans proline' 0 N--CA 1.495 1.594 0 C-N-CA 122.788 2.325 . . . . 1.0 112.599 179.028 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -62.12 -62.16 5.94 Favored Glycine 0 C--N 1.336 0.568 0 C-N-CA 118.405 -1.855 . . . . 1.0 111.095 -178.565 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . 0.636 ' CG2' ' H ' ' A' ' 37' ' ' ILE . 8.7 p -87.26 -142.71 0.01 OUTLIER 'Isoleucine or valine' 0 C--O 1.216 -0.683 0 N-CA-C 107.552 -1.277 . . . . 1.0 107.552 178.793 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . 0.636 ' H ' ' CG2' ' A' ' 36' ' ' VAL . 0.3 OUTLIER 70.54 76.46 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.473 0.716 0 CA-C-O 122.344 1.069 . . . . 1.0 111.42 179.842 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 95.4 m-70 -139.75 133.2 30.12 Favored 'General case' 0 C--N 1.33 -0.269 0 O-C-N 120.989 -1.069 . . . . 1.0 109.18 179.311 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -108.57 124.79 33.39 Favored Pre-proline 0 CA--C 1.541 0.615 0 N-CA-C 109.67 -0.493 . . . . 1.0 109.67 179.789 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 52.0 Cg_exo -49.94 -23.08 8.39 Favored 'Trans proline' 0 N--CA 1.5 1.866 0 C-N-CA 121.796 1.664 . . . . 1.0 113.827 179.985 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -126.17 134.86 51.15 Favored 'General case' 0 N--CA 1.469 0.506 0 N-CA-C 111.311 0.115 . . . . 1.0 111.311 178.54 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . 0.704 ' C ' ' H ' ' A' ' 44' ' ' GLY . 19.3 ttp-105 -164.68 164.46 21.37 Favored 'General case' 0 C--N 1.328 -0.353 0 C-N-CA 120.197 -0.601 . . . . 1.0 109.787 177.172 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 43' ' ' ARG . . . . . 0.658 ' C ' ' H ' ' A' ' 45' ' ' PHE . 4.7 tpt180 -60.92 24.59 0.01 OUTLIER 'General case' 0 CA--C 1.545 0.75 0 CA-C-N 115.789 -0.642 . . . . 1.0 110.623 -178.864 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . 0.704 ' H ' ' C ' ' A' ' 42' ' ' ARG . . . 66.27 -32.12 0.16 Allowed Glycine 0 C--N 1.34 0.769 0 N-CA-C 110.65 -0.98 . . . . 1.0 110.65 179.456 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . 0.658 ' H ' ' C ' ' A' ' 43' ' ' ARG . 11.8 t80 -169.34 170.81 8.24 Favored 'General case' 0 N--CA 1.446 -0.642 0 N-CA-C 108.378 -0.971 . . . . 1.0 108.378 179.141 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 46' ' ' PHE . . . . . 0.587 ' HB2' ' O ' ' A' ' 45' ' ' PHE . 1.0 OUTLIER 120.8 106.64 0.0 OUTLIER 'General case' 0 N--CA 1.497 1.921 0 C-N-CA 127.333 2.253 . . . . 1.0 106.34 -179.346 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 47' ' ' ARG . . . . . 0.511 ' C ' ' SG ' ' A' ' 48' ' ' CYS . 0.1 OUTLIER 103.24 149.84 0.01 OUTLIER 'General case' 0 N--CA 1.479 1.0 0 C-N-CA 124.827 1.251 . . . . 1.0 109.86 -178.602 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 48' ' ' CYS . . . . . 0.511 ' SG ' ' C ' ' A' ' 47' ' ' ARG . 0.0 OUTLIER 64.3 71.92 0.46 Allowed 'General case' 0 CA--C 1.534 0.361 0 CA-C-N 114.984 -1.007 . . . . 1.0 110.396 -178.892 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 49' ' ' ASN . . . . . 0.413 ' C ' ' H ' ' A' ' 51' ' ' GLU . 0.0 OUTLIER -140.85 163.53 42.13 Favored Pre-proline 0 C--N 1.33 -0.269 0 O-C-N 121.92 -0.487 . . . . 1.0 110.747 -179.22 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 38.4 Cg_endo -66.18 47.08 0.22 Allowed 'Trans proline' 0 N--CA 1.498 1.773 0 C-N-CA 123.107 2.538 . . . . 1.0 111.78 178.738 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . 0.531 ' OE1' ' NH2' ' A' ' 95' ' ' ARG . 7.6 mt-10 57.02 12.4 1.22 Allowed 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 115.37 -0.832 . . . . 1.0 111.393 179.593 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 24.9 ptt85 -85.87 147.31 26.33 Favored 'General case' 0 C--N 1.333 -0.119 0 N-CA-C 107.296 -1.372 . . . . 1.0 107.296 177.846 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 8.8 tp -49.46 138.4 4.89 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.496 0 CA-C-O 122.012 0.91 . . . . 1.0 113.033 -177.893 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 54' ' ' GLN . . . . . 0.478 ' CD ' ' H ' ' A' ' 54' ' ' GLN . 0.0 OUTLIER -76.17 79.51 2.98 Favored 'General case' 0 CA--C 1.534 0.351 0 CA-C-N 114.074 -1.421 . . . . 1.0 109.222 179.613 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 1.8 mt -147.38 157.12 9.88 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.75 0 CA-C-N 115.244 -0.889 . . . . 1.0 110.211 178.094 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 108.5 -0.24 32.67 Favored Glycine 0 C--N 1.338 0.691 0 N-CA-C 110.553 -1.019 . . . . 1.0 110.553 179.766 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . 0.424 ' OD1' ' O ' ' A' ' 57' ' ' ASP . 31.1 p-10 -80.27 101.74 9.08 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 121.584 0.707 . . . . 1.0 112.393 -178.816 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 58' ' ' TRP . . . . . . . . . . . . . 10.0 m0 -78.61 179.12 7.3 Favored 'General case' 0 C--N 1.323 -0.548 0 N-CA-C 108.028 -1.101 . . . . 1.0 108.028 178.34 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 59' ' ' ARG . . . . . 0.577 ' O ' ' CG2' ' A' ' 62' ' ' VAL . 1.0 OUTLIER -100.28 -49.12 4.36 Favored 'General case' 0 CA--C 1.546 0.81 0 CA-C-N 121.522 1.965 . . . . 1.0 111.613 178.535 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 60' ' ' TYR . . . . . 0.411 ' CD1' ' C ' ' A' ' 60' ' ' TYR . 3.7 p90 -85.98 -9.6 56.55 Favored 'General case' 0 N--CA 1.488 1.43 0 C-N-CA 124.997 1.319 . . . . 1.0 113.281 -177.98 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . 0.402 ' O ' ' N ' ' A' ' 65' ' ' ASP . 27.1 tt0 -75.32 -14.07 60.46 Favored 'General case' 0 C--N 1.308 -1.219 0 O-C-N 121.554 -0.716 . . . . 1.0 110.622 -178.952 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 62' ' ' VAL . . . . . 0.577 ' CG2' ' O ' ' A' ' 59' ' ' ARG . 0.0 OUTLIER -44.28 -50.34 1.92 Allowed 'Isoleucine or valine' 0 C--N 1.315 -0.901 0 N-CA-C 109.715 -0.476 . . . . 1.0 109.715 -175.69 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 63' ' ' ALA . . . . . 0.485 ' O ' ' HG2' ' A' ' 67' ' ' ARG . . . -67.6 -47.15 70.52 Favored 'General case' 0 N--CA 1.425 -1.683 0 N-CA-C 108.587 -0.894 . . . . 1.0 108.587 -179.878 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 64' ' ' HIS . . . . . 0.449 ' O ' ' CG ' ' A' ' 67' ' ' ARG . 0.5 OUTLIER -55.21 -59.22 5.07 Favored 'General case' 0 CA--C 1.547 0.841 0 CA-C-N 115.292 -0.867 . . . . 1.0 109.871 179.683 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 65' ' ' ASP . . . . . 0.639 ' C ' ' H ' ' A' ' 67' ' ' ARG . 29.6 t70 -67.08 -53.39 31.38 Favored 'General case' 0 C--O 1.243 0.739 0 CA-C-O 121.667 0.746 . . . . 1.0 109.27 178.438 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . 0.551 ' N ' ' O ' ' A' ' 62' ' ' VAL . . . -63.3 31.14 0.08 OUTLIER Glycine 0 CA--C 1.523 0.573 0 N-CA-C 111.477 -0.649 . . . . 1.0 111.477 178.263 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 67' ' ' ARG . . . . . 0.639 ' H ' ' C ' ' A' ' 65' ' ' ASP . 6.3 mmt180 -76.34 -2.59 32.47 Favored 'General case' 0 C--N 1.315 -0.901 0 N-CA-C 108.07 -1.085 . . . . 1.0 108.07 174.876 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . 0.483 ' C ' ' O ' ' A' ' 67' ' ' ARG . 5.8 tt -35.16 -30.35 0.01 OUTLIER 'General case' 0 N--CA 1.475 0.82 0 N-CA-C 108.63 -0.878 . . . . 1.0 108.63 -176.403 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . 0.57 ' N ' ' O ' ' A' ' 67' ' ' ARG . 9.9 mp -69.24 -68.57 0.39 Allowed 'General case' 0 CA--C 1.549 0.921 0 CA-C-N 115.09 -0.959 . . . . 1.0 111.063 179.686 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . 0.632 ' C ' ' H ' ' A' ' 72' ' ' HIS . . . -77.16 -76.85 0.16 Allowed 'General case' 0 N--CA 1.473 0.723 0 C-N-CA 119.016 -1.074 . . . . 1.0 109.457 -178.373 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 71' ' ' ALA . . . . . 0.549 ' O ' ' N ' ' A' ' 74' ' ' VAL . . . -57.31 10.48 0.01 OUTLIER 'General case' 0 C--N 1.324 -0.502 0 C-N-CA 124.652 1.181 . . . . 1.0 112.574 179.784 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 72' ' ' HIS . . . . . 0.861 ' CD2' ' H ' ' A' ' 73' ' ' MET . 1.3 p80 -19.84 -48.23 0.01 OUTLIER 'General case' 0 N--CA 1.465 0.323 0 N-CA-C 114.669 1.359 . . . . 1.0 114.669 -177.197 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 73' ' ' MET . . . . . 0.861 ' H ' ' CD2' ' A' ' 72' ' ' HIS . 15.4 ptp -74.87 -47.91 27.67 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 119.275 0.943 . . . . 1.0 109.353 179.058 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . 0.661 ' O ' ' N ' ' A' ' 76' ' ' GLY . 59.3 t -43.23 -48.46 1.41 Allowed 'Isoleucine or valine' 0 C--O 1.214 -0.79 0 CA-C-O 117.736 -1.126 . . . . 1.0 110.972 -175.389 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 75' ' ' ASN . . . . . 0.402 ' C ' ' O ' ' A' ' 74' ' ' VAL . 3.9 m120 -37.52 -19.66 0.01 OUTLIER 'General case' 0 N--CA 1.48 1.075 0 CA-C-O 122.714 1.245 . . . . 1.0 109.987 178.507 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 76' ' ' GLY . . . . . 0.661 ' N ' ' O ' ' A' ' 74' ' ' VAL . . . -50.99 -24.3 8.3 Favored Glycine 0 C--O 1.213 -1.177 0 N-CA-C 108.143 -1.983 . . . . 1.0 108.143 176.207 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 9.5 pt -45.64 -43.78 4.1 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.323 0 O-C-N 122.289 -0.536 . . . . 1.0 110.9 179.523 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 57.5 t -55.65 -22.04 11.5 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.343 0 CA-C-N 118.649 0.659 . . . . 1.0 111.05 -179.67 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . 0.41 HG12 ' O ' ' A' ' 76' ' ' GLY . 0.3 OUTLIER -88.03 -42.49 15.0 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.715 0 C-N-CA 119.32 -0.952 . . . . 1.0 110.058 178.556 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -78.93 -23.03 44.95 Favored 'General case' 0 CA--C 1.537 0.444 0 N-CA-C 112.262 0.467 . . . . 1.0 112.262 -178.892 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 94.8 mt-10 -91.11 -68.25 0.8 Allowed 'General case' 0 CA--C 1.533 0.289 0 N-CA-C 112.475 0.546 . . . . 1.0 112.475 178.718 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 82' ' ' ASP . . . . . 0.46 ' O ' ' C ' ' A' ' 83' ' ' ALA . 1.2 m-20 -74.76 -21.49 59.31 Favored 'General case' 0 C--N 1.349 0.555 0 N-CA-C 114.991 1.478 . . . . 1.0 114.991 -176.35 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . 0.505 ' O ' ' N ' ' A' ' 85' ' ' ILE . . . -37.38 -50.08 1.03 Allowed 'General case' 0 N--CA 1.483 1.187 0 CA-C-N 120.253 1.388 . . . . 1.0 111.355 178.743 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . 0.49 ' C ' ' O ' ' A' ' 83' ' ' ALA . 0.1 OUTLIER -26.88 -41.74 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.609 0 CA-C-O 120.62 0.248 . . . . 1.0 110.645 -175.327 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 85' ' ' ILE . . . . . 0.505 ' N ' ' O ' ' A' ' 83' ' ' ALA . 2.9 pt -98.63 -46.65 12.39 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 N-CA-C 109.468 -0.568 . . . . 1.0 109.468 177.605 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 86' ' ' ALA . . . . . 0.437 ' H ' HG13 ' A' ' 85' ' ' ILE . . . -49.54 -44.27 46.44 Favored 'General case' 0 N--CA 1.461 0.102 0 CA-C-N 115.931 -0.577 . . . . 1.0 110.14 -177.913 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 21.6 pt-20 -53.73 -21.9 8.1 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.929 0.395 . . . . 1.0 110.54 179.62 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -82.36 -13.84 56.23 Favored 'General case' 0 CA--C 1.517 -0.316 0 CA-C-O 121.289 0.566 . . . . 1.0 109.889 -179.476 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 89' ' ' VAL . . . . . 0.465 ' O ' ' ND1' ' A' ' 92' ' ' HIS . 18.5 t -93.06 34.74 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.553 0 CA-C-N 114.964 -1.016 . . . . 1.0 109.419 178.972 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 90' ' ' GLY . . . . . 0.534 ' O ' ' N ' ' A' ' 92' ' ' HIS . . . -74.66 -41.44 35.17 Favored Glycine 0 CA--C 1.539 1.555 0 N-CA-C 111.501 -0.64 . . . . 1.0 111.501 179.09 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 91' ' ' PRO . . . . . 0.48 ' CD ' ' N ' ' A' ' 90' ' ' GLY . 91.0 Cg_exo -41.35 -20.89 0.11 Allowed 'Trans proline' 0 N--CA 1.492 1.391 0 CA-C-N 119.354 1.577 . . . . 1.0 111.177 -179.795 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 92' ' ' HIS . . . . . 0.692 ' O ' ' N ' ' A' ' 96' ' ' ALA . 27.6 p-80 -53.73 -38.7 64.6 Favored 'General case' 0 C--O 1.196 -1.733 0 N-CA-C 106.489 -1.671 . . . . 1.0 106.489 -179.162 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 93' ' ' LEU . . . . . 0.508 ' CD1' ' N ' ' A' ' 94' ' ' ALA . 2.6 pp -46.17 -58.98 3.18 Favored 'General case' 0 C--N 1.319 -0.745 0 C-N-CA 120.183 -0.607 . . . . 1.0 110.428 -179.757 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 94' ' ' ALA . . . . . 0.508 ' N ' ' CD1' ' A' ' 93' ' ' LEU . . . -59.5 -56.79 17.59 Favored 'General case' 0 N--CA 1.465 0.275 0 CA-C-N 118.514 0.597 . . . . 1.0 109.692 -179.953 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 95' ' ' ARG . . . . . 0.668 ' O ' ' N ' ' A' ' 97' ' ' LEU . 5.8 mtp-105 -54.53 -58.61 6.82 Favored 'General case' 0 C--O 1.238 0.494 0 N-CA-C 107.789 -1.189 . . . . 1.0 107.789 178.347 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 96' ' ' ALA . . . . . 0.745 ' O ' ' N ' ' A' ' 98' ' ' GLY . . . -45.15 -12.99 0.02 OUTLIER 'General case' 0 C--N 1.294 -1.821 0 O-C-N 119.383 -2.073 . . . . 1.0 110.627 179.558 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 97' ' ' LEU . . . . . 0.668 ' N ' ' O ' ' A' ' 95' ' ' ARG . 0.8 OUTLIER 1.91 -54.71 0.0 OUTLIER 'General case' 0 N--CA 1.48 1.026 0 C-N-CA 124.407 1.083 . . . . 1.0 111.987 -169.958 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 98' ' ' GLY . . . . . 0.745 ' N ' ' O ' ' A' ' 96' ' ' ALA . . . -48.85 -23.05 3.25 Favored Glycine 0 CA--C 1.539 1.554 0 CA-C-N 122.233 2.288 . . . . 1.0 108.62 175.173 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 99' ' ' GLN . . . . . 0.627 ' N ' ' O ' ' A' ' 96' ' ' ALA . 1.2 mp0 -69.68 -24.14 63.55 Favored 'General case' 0 C--N 1.364 1.204 0 C-N-CA 118.338 -1.345 . . . . 1.0 107.776 178.47 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 100' ' ' ILE . . . . . 0.584 ' N ' ' O ' ' A' ' 97' ' ' LEU . 4.7 mm -65.23 -40.03 87.36 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.755 0 CA-C-N 115.026 -0.988 . . . . 1.0 108.762 177.945 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 101' ' ' VAL . . . . . 0.565 ' O ' ' N ' ' A' ' 105' ' ' GLY . 0.5 OUTLIER -58.52 -57.28 11.67 Favored 'Isoleucine or valine' 0 C--N 1.343 0.289 0 N-CA-C 107.407 -1.331 . . . . 1.0 107.407 179.669 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 102' ' ' CYS . . . . . 0.453 ' O ' ' CB ' ' A' ' 106' ' ' ALA . 0.7 OUTLIER -41.6 -17.61 0.01 OUTLIER 'General case' 0 CA--C 1.536 0.417 0 CA-C-O 120.763 0.316 . . . . 1.0 111.107 -179.537 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 103' ' ' ARG . . . . . 0.528 ' N ' ' O ' ' A' ' 101' ' ' VAL . 4.3 ttm180 -93.29 -35.01 13.3 Favored 'General case' 0 N--CA 1.478 0.954 0 CA-C-O 122.327 1.061 . . . . 1.0 111.523 177.71 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 104' ' ' TYR . . . . . 0.75 ' CG ' ' O ' ' A' ' 104' ' ' TYR . 1.2 t80 -106.44 19.08 21.04 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 112.722 -2.035 . . . . 1.0 109.746 177.817 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 105' ' ' GLY . . . . . 0.735 ' O ' ' N ' ' A' ' 107' ' ' THR . . . -165.76 -18.88 0.02 OUTLIER Glycine 0 C--O 1.223 -0.538 0 C-N-CA 117.461 -2.304 . . . . 1.0 113.035 179.263 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 106' ' ' ALA . . . . . 0.48 ' C ' ' O ' ' A' ' 105' ' ' GLY . . . -11.39 65.0 0.0 OUTLIER 'General case' 0 N--CA 1.477 0.915 0 O-C-N 124.778 0.928 . . . . 1.0 111.93 -179.55 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 107' ' ' THR . . . . . 0.735 ' N ' ' O ' ' A' ' 105' ' ' GLY . 99.4 m -98.42 -4.41 34.7 Favored 'General case' 0 CA--C 1.511 -0.55 0 O-C-N 121.678 -0.639 . . . . 1.0 109.347 -178.999 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 108' ' ' VAL . . . . . 0.462 ' C ' ' HD2' ' A' ' 110' ' ' PRO . 41.2 t -81.86 -54.05 10.67 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.494 0 CA-C-N 116.288 -0.414 . . . . 1.0 110.105 178.466 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 109' ' ' ILE . . . . . 0.507 ' O ' ' CB ' ' A' ' 113' ' ' ASN . 0.2 OUTLIER -47.49 -38.86 17.82 Favored Pre-proline 0 N--CA 1.473 0.699 0 N-CA-C 114.822 1.415 . . . . 1.0 114.822 -179.095 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 110' ' ' PRO . . . . . 0.482 ' CD ' ' N ' ' A' ' 109' ' ' ILE . 83.7 Cg_exo -47.02 -41.49 26.19 Favored 'Trans proline' 0 C--N 1.31 -1.48 0 C-N-CA 121.929 1.753 . . . . 1.0 112.623 -174.818 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 1.2 t-20 -63.49 -69.39 0.27 Allowed 'General case' 0 CA--C 1.536 0.421 0 C-N-CA 118.877 -1.129 . . . . 1.0 110.29 179.88 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 112' ' ' ILE . . . . . 0.465 ' O ' ' N ' ' A' ' 116' ' ' ILE . 0.1 OUTLIER -61.84 -44.74 99.28 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.539 0 CA-C-O 121.325 0.583 . . . . 1.0 110.543 -178.1 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 113' ' ' ASN . . . . . 0.507 ' CB ' ' O ' ' A' ' 109' ' ' ILE . 20.9 t30 -45.79 -62.17 1.42 Allowed 'General case' 0 C--N 1.309 -1.168 0 CA-C-N 115.3 -0.864 . . . . 1.0 111.511 -174.733 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -61.67 -24.59 66.85 Favored 'General case' 0 N--CA 1.433 -1.294 0 C-N-CA 118.873 -1.131 . . . . 1.0 110.703 179.586 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -82.32 -61.43 1.9 Allowed 'General case' 0 C--O 1.239 0.504 0 N-CA-C 113.95 1.093 . . . . 1.0 113.95 178.323 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 116' ' ' ILE . . . . . 0.589 ' O ' ' N ' ' A' ' 119' ' ' LEU . 47.0 mt -69.82 -49.03 60.71 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.678 0 O-C-N 120.501 -1.374 . . . . 1.0 111.596 -177.985 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 117' ' ' GLU . . . . . 0.479 ' OE1' ' OD1' ' A' ' 113' ' ' ASN . 18.5 tt0 -46.2 -61.58 1.71 Allowed 'General case' 0 C--N 1.312 -1.05 0 N-CA-C 108.393 -0.966 . . . . 1.0 108.393 -177.106 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 97.5 t -54.28 -16.02 1.31 Allowed 'Isoleucine or valine' 0 N--CA 1.44 -0.96 0 O-C-N 124.408 1.068 . . . . 1.0 109.317 178.453 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 119' ' ' LEU . . . . . 0.589 ' N ' ' O ' ' A' ' 116' ' ' ILE . 0.2 OUTLIER -80.01 -61.31 2.03 Favored 'General case' 0 C--N 1.349 0.551 0 C-N-CA 119.793 -0.763 . . . . 1.0 110.453 178.342 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 120' ' ' GLY . . . . . 0.458 ' C ' ' HG1' ' A' ' 121' ' ' THR . . . -66.62 -85.52 0.08 OUTLIER Glycine 0 C--N 1.361 1.96 0 C-N-CA 117.519 -2.277 . . . . 1.0 112.103 179.916 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 121' ' ' THR . . . . . 0.458 ' HG1' ' C ' ' A' ' 120' ' ' GLY . 0.2 OUTLIER -163.73 -27.18 0.04 OUTLIER 'General case' 0 N--CA 1.473 0.713 0 N-CA-C 107.422 -1.325 . . . . 1.0 107.422 -178.604 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 122' ' ' GLY . . . . . 0.554 ' O ' ' N ' ' A' ' 124' ' ' ASP . . . 116.76 -36.2 3.86 Favored Glycine 0 CA--C 1.531 1.033 0 CA-C-N 113.933 -1.485 . . . . 1.0 113.432 179.699 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 123' ' ' THR . . . . . 0.454 ' C ' ' O ' ' A' ' 122' ' ' GLY . 0.1 OUTLIER -32.78 89.64 0.0 OUTLIER 'General case' 0 N--CA 1.476 0.839 0 CA-C-N 120.578 2.189 . . . . 1.0 112.774 -178.652 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 124' ' ' ASP . . . . . 0.554 ' N ' ' O ' ' A' ' 122' ' ' GLY . 11.6 t0 -147.45 143.86 28.21 Favored 'General case' 0 CA--C 1.521 -0.162 0 N-CA-C 108.454 -0.943 . . . . 1.0 108.454 179.94 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 125' ' ' TYR . . . . . 0.471 ' O ' ' CD1' ' A' ' 125' ' ' TYR . 0.1 OUTLIER -150.79 148.43 28.5 Favored 'General case' 0 C--N 1.324 -0.526 0 N-CA-C 109.596 -0.52 . . . . 1.0 109.596 179.891 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 126' ' ' ARG . . . . . 0.423 ' CZ ' ' O ' ' A' ' 125' ' ' TYR . 10.8 mmp_? -145.74 148.4 32.95 Favored 'General case' 0 N--CA 1.471 0.623 0 N-CA-C 109.592 -0.521 . . . . 1.0 109.592 177.264 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 127' ' ' PHE . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 C--O 1.218 -0.575 0 CA-C-O 118.049 -0.977 . . . . 1.0 110.008 -179.9 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 60.1 mtt . . . . . 0 N--CA 1.491 1.584 0 N-CA-C 109.013 -0.736 . . . . 1.0 109.013 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 48.7 m -107.78 -0.97 21.33 Favored 'General case' 0 N--CA 1.466 0.351 0 CA-C-N 116.404 -0.362 . . . . 1.0 110.692 179.553 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 3' ' ' ASP . . . . . 0.526 ' N ' ' OD1' ' A' ' 3' ' ' ASP . 8.1 p-10 -178.83 92.66 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.478 -0.328 . . . . 1.0 110.854 -179.747 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 37.2 t80 -151.59 147.75 27.16 Favored 'General case' 0 CA--C 1.513 -0.444 0 CA-C-O 120.899 0.38 . . . . 1.0 110.112 179.358 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 5' ' ' ASP . . . . . 0.498 ' C ' ' OG ' ' A' ' 10' ' ' SER . 32.1 p30 -156.58 153.05 28.02 Favored 'General case' 0 N--CA 1.448 -0.538 0 CA-C-N 116.058 -0.519 . . . . 1.0 110.748 179.472 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 6' ' ' THR . . . . . 0.725 ' H ' ' CG2' ' A' ' 9' ' ' VAL . 0.2 OUTLIER -102.69 -170.2 1.77 Allowed 'General case' 0 C--O 1.199 -1.605 0 CA-C-O 121.661 0.743 . . . . 1.0 110.467 178.131 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . 0.433 ' O ' ' HB2' ' A' ' 11' ' ' ARG . 33.4 tt0 -56.25 -40.97 75.0 Favored 'General case' 0 C--N 1.304 -1.391 0 CA-C-O 121.653 0.74 . . . . 1.0 110.586 -179.555 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 8' ' ' ARG . . . . . 0.713 ' CG ' ' H ' ' A' ' 9' ' ' VAL . 0.9 OUTLIER -70.01 -62.78 1.25 Allowed 'General case' 0 C--N 1.31 -1.122 0 C-N-CA 118.654 -1.218 . . . . 1.0 111.252 179.548 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . 0.725 ' CG2' ' H ' ' A' ' 6' ' ' THR . 0.0 OUTLIER -62.7 -48.45 88.08 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.712 0 CA-C-N 114.113 -1.403 . . . . 1.0 108.229 179.144 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 10' ' ' SER . . . . . 0.669 ' N ' ' O ' ' A' ' 6' ' ' THR . 1.6 m -67.8 -68.35 0.39 Allowed 'General case' 0 C--O 1.189 -2.128 0 C-N-CA 118.3 -1.36 . . . . 1.0 112.915 179.857 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 11' ' ' ARG . . . . . 0.57 ' O ' ' N ' ' A' ' 15' ' ' ALA . 2.3 mmt85 -67.83 -49.93 59.46 Favored 'General case' 0 N--CA 1.48 1.072 0 N-CA-C 113.965 1.098 . . . . 1.0 113.965 -176.551 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . 0.464 ' O ' ' CB ' ' A' ' 16' ' ' ALA . . . -60.69 -58.74 7.16 Favored 'General case' 0 C--N 1.314 -0.956 0 C-N-CA 117.866 -1.534 . . . . 1.0 107.526 -178.873 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . 0.696 ' O ' ' N ' ' A' ' 17' ' ' LEU . 0.5 OUTLIER -60.0 -50.36 80.46 Favored 'Isoleucine or valine' 0 C--O 1.184 -2.393 0 N-CA-C 106.561 -1.644 . . . . 1.0 106.561 179.215 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . 0.632 ' CB ' ' O ' ' A' ' 10' ' ' SER . . . -58.76 -64.05 1.07 Allowed 'General case' 0 C--O 1.199 -1.599 0 C-N-CA 116.493 -2.083 . . . . 1.0 111.497 -179.101 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . 0.575 ' O ' ' N ' ' A' ' 19' ' ' GLY . . . -52.21 -55.04 23.69 Favored 'General case' 0 C--N 1.314 -0.949 0 N-CA-C 108.46 -0.941 . . . . 1.0 108.46 -178.622 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . 0.464 ' CB ' ' O ' ' A' ' 12' ' ' ALA . . . -64.36 -57.86 8.13 Favored 'General case' 0 C--N 1.304 -1.395 0 C-N-CA 118.886 -1.126 . . . . 1.0 111.042 -179.95 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . 0.696 ' N ' ' O ' ' A' ' 13' ' ' VAL . 19.1 tp -55.78 -55.27 34.4 Favored 'General case' 0 N--CA 1.49 1.569 0 N-CA-C 107.909 -1.145 . . . . 1.0 107.909 -177.768 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . 0.709 HG23 ' H ' ' A' ' 19' ' ' GLY . 1.5 m -71.29 -59.13 3.75 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.411 0 CA-C-N 116.045 -0.525 . . . . 1.0 110.471 179.925 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . 0.709 ' H ' HG23 ' A' ' 18' ' ' VAL . . . -56.67 -169.27 0.1 OUTLIER Glycine 0 N--CA 1.438 -1.187 0 N-CA-C 111.225 -0.75 . . . . 1.0 111.225 -177.655 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 20' ' ' PRO . . . . . 0.642 ' O ' ' N ' ' A' ' 24' ' ' ALA . 58.6 Cg_endo -85.32 -29.24 0.66 Allowed 'Trans proline' 0 C--N 1.29 -2.5 0 C-N-CA 122.456 2.104 . . . . 1.0 113.455 -177.564 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -60.42 -59.73 9.79 Favored Glycine 0 N--CA 1.471 0.993 0 C-N-CA 120.143 -1.027 . . . . 1.0 112.26 -177.747 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . 0.461 ' H ' ' HA ' ' A' ' 16' ' ' ALA . . . -56.51 -53.33 44.24 Favored Glycine 0 CA--C 1.497 -1.072 0 N-CA-C 106.53 -2.628 . . . . 1.0 106.53 -176.374 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 22.4 t -56.74 -31.22 34.62 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.242 0 N-CA-C 108.216 -1.031 . . . . 1.0 108.216 178.043 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . 0.642 ' N ' ' O ' ' A' ' 20' ' ' PRO . . . -59.18 -63.21 1.38 Allowed 'General case' 0 C--N 1.354 0.791 0 C-N-CA 118.712 -1.195 . . . . 1.0 110.331 -178.823 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 1.2 mt -62.27 -46.04 90.59 Favored 'General case' 0 C--N 1.325 -0.458 0 C-N-CA 120.335 -0.546 . . . . 1.0 111.333 -177.063 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 88.0 t -59.64 -58.94 4.87 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.669 0 C-N-CA 119.898 -0.721 . . . . 1.0 109.604 -177.78 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . 0.453 ' O ' ' CB ' ' A' ' 31' ' ' ALA . 1.5 p -60.62 -37.45 75.53 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.508 0 C-N-CA 120.076 -0.65 . . . . 1.0 110.245 -177.99 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 27.2 ttpp -65.29 -56.96 9.75 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 115.89 -0.595 . . . . 1.0 110.462 -179.018 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 84.1 t -63.27 -47.88 90.05 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.784 0 CA-C-N 114.936 -1.029 . . . . 1.0 109.692 -177.715 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 30' ' ' CYS . . . . . . . . . . . . . 36.8 t -65.01 -60.82 2.62 Favored 'General case' 0 N--CA 1.441 -0.884 0 C-N-CA 119.787 -0.765 . . . . 1.0 109.588 -178.82 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . 0.453 ' CB ' ' O ' ' A' ' 27' ' ' VAL . . . -57.8 -47.62 82.07 Favored 'General case' 0 CA--C 1.497 -1.091 0 CA-C-O 121.29 0.567 . . . . 1.0 109.769 -176.427 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . 0.454 ' O ' ' HB2' ' A' ' 33' ' ' LEU . . . 74.2 67.92 1.67 Allowed Glycine 0 N--CA 1.439 -1.131 0 N-CA-C 108.982 -1.647 . . . . 1.0 108.982 -178.525 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . 0.478 ' O ' ' O ' ' A' ' 36' ' ' VAL . 17.7 mt 97.41 78.52 0.02 OUTLIER Pre-proline 0 N--CA 1.47 0.54 0 C-N-CA 124.542 1.137 . . . . 1.0 110.645 -179.452 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 76.5 Cg_exo -45.93 -29.45 5.99 Favored 'Trans proline' 0 C--N 1.312 -1.386 0 C-N-CA 121.973 1.782 . . . . 1.0 112.672 179.793 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -60.38 -60.61 8.26 Favored Glycine 0 CA--C 1.536 1.37 0 C-N-CA 118.756 -1.687 . . . . 1.0 109.894 -178.375 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . 0.624 ' CG2' ' H ' ' A' ' 37' ' ' ILE . 8.5 p -98.81 177.87 0.66 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.68 0 N-CA-C 107.36 -1.348 . . . . 1.0 107.36 177.793 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . 0.624 ' H ' ' CG2' ' A' ' 36' ' ' VAL . 2.9 mm 101.15 120.34 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.479 1.01 0 O-C-N 124.818 1.323 . . . . 1.0 110.952 179.609 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 79.8 m80 -142.75 136.97 29.44 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 115.572 -0.74 . . . . 1.0 109.508 178.456 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 11.1 m -91.95 127.48 49.52 Favored Pre-proline 0 CA--C 1.537 0.474 0 N-CA-C 108.966 -0.753 . . . . 1.0 108.966 179.678 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 29.7 Cg_endo -62.94 -30.55 76.97 Favored 'Trans proline' 0 N--CA 1.498 1.745 0 C-N-CA 121.752 1.635 . . . . 1.0 113.368 -178.192 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -110.36 90.93 3.46 Favored 'General case' 0 CA--C 1.507 -0.696 0 CA-C-O 121.599 0.714 . . . . 1.0 112.664 -176.498 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 16.3 ptm180 -139.82 143.0 36.61 Favored 'General case' 0 C--N 1.318 -0.768 0 CA-C-N 114.552 -1.204 . . . . 1.0 108.479 178.927 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 76.5 ttt180 -50.91 -15.61 0.32 Allowed 'General case' 0 N--CA 1.451 -0.41 0 O-C-N 121.958 -0.464 . . . . 1.0 111.299 -176.003 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 119.11 -25.34 7.89 Favored Glycine 0 N--CA 1.468 0.792 0 N-CA-C 111.148 -0.781 . . . . 1.0 111.148 178.885 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . 0.565 ' O ' ' CD1' ' A' ' 46' ' ' PHE . 0.6 OUTLIER -156.84 161.53 39.72 Favored 'General case' 0 C--N 1.323 -0.557 0 N-CA-C 108.171 -1.048 . . . . 1.0 108.171 178.446 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 46' ' ' PHE . . . . . 0.834 ' O ' ' CD1' ' A' ' 46' ' ' PHE . 0.0 OUTLIER 115.66 120.46 0.0 OUTLIER 'General case' 0 N--CA 1.479 1.024 0 O-C-N 125.288 1.618 . . . . 1.0 112.433 179.342 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 47' ' ' ARG . . . . . 0.556 ' HB2' ' O ' ' A' ' 46' ' ' PHE . 5.9 mtm180 76.75 163.32 0.24 Allowed 'General case' 0 N--CA 1.479 1.023 0 O-C-N 119.266 -2.146 . . . . 1.0 110.727 -178.67 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 4.1 t 61.35 70.03 0.63 Allowed 'General case' 0 C--O 1.232 0.147 0 N-CA-C 108.786 -0.82 . . . . 1.0 108.786 -178.196 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 49' ' ' ASN . . . . . 0.605 ' O ' ' N ' ' A' ' 51' ' ' GLU . 0.0 OUTLIER -146.1 163.95 27.75 Favored Pre-proline 0 CA--C 1.538 0.511 0 N-CA-C 109.519 -0.549 . . . . 1.0 109.519 -178.726 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 50' ' ' PRO . . . . . 0.512 ' O ' ' NE ' ' A' ' 52' ' ' ARG . 11.2 Cg_endo -54.41 58.48 0.03 OUTLIER 'Trans proline' 0 N--CA 1.514 2.68 0 C-N-CA 123.32 2.68 . . . . 1.0 112.057 179.611 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . 0.605 ' N ' ' O ' ' A' ' 49' ' ' ASN . 40.5 mt-10 55.02 37.39 28.84 Favored 'General case' 0 N--CA 1.475 0.797 0 O-C-N 121.192 -0.943 . . . . 1.0 112.678 176.956 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . 0.551 ' O ' ' ND2' ' A' ' 49' ' ' ASN . 0.0 OUTLIER -151.69 179.9 8.0 Favored 'General case' 0 N--CA 1.476 0.829 0 CA-C-O 121.71 0.767 . . . . 1.0 110.439 179.069 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . 0.419 HG13 ' H ' ' A' ' 54' ' ' GLN . 4.6 tp -82.25 168.72 1.74 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 114.869 -1.059 . . . . 1.0 108.993 177.78 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 54' ' ' GLN . . . . . 0.419 ' H ' HG13 ' A' ' 53' ' ' ILE . 1.1 tp60 -132.44 131.98 42.29 Favored 'General case' 0 CA--C 1.533 0.318 0 N-CA-C 108.793 -0.817 . . . . 1.0 108.793 178.624 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 20.4 tt -144.91 155.08 14.13 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.661 0 N-CA-C 110.334 -0.247 . . . . 1.0 110.334 178.563 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 101.38 1.57 53.74 Favored Glycine 0 C--N 1.341 0.842 0 N-CA-C 110.157 -1.177 . . . . 1.0 110.157 -179.827 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 9.4 t70 -93.2 115.55 28.16 Favored 'General case' 0 CA--C 1.539 0.521 0 CA-C-O 122.229 1.014 . . . . 1.0 113.035 -178.214 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 58' ' ' TRP . . . . . 0.502 ' HB2' ' HB2' ' A' ' 61' ' ' GLU . 37.7 m0 -82.92 -178.4 7.1 Favored 'General case' 0 C--N 1.318 -0.799 0 CA-C-N 112.673 -2.058 . . . . 1.0 109.411 177.682 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 59' ' ' ARG . . . . . 0.408 ' HG3' ' H ' ' A' ' 60' ' ' TYR . 13.7 ptt-85 -94.61 -55.39 3.16 Favored 'General case' 0 CA--C 1.543 0.701 0 CA-C-O 121.24 0.543 . . . . 1.0 111.333 179.412 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 60' ' ' TYR . . . . . 0.573 ' CG ' ' O ' ' A' ' 60' ' ' TYR . 17.3 t80 -76.68 -4.03 41.04 Favored 'General case' 0 N--CA 1.476 0.836 0 C-N-CA 124.327 1.051 . . . . 1.0 111.255 179.231 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . 0.502 ' HB2' ' HB2' ' A' ' 58' ' ' TRP . 31.8 tt0 -77.36 -17.33 58.33 Favored 'General case' 0 C--N 1.309 -1.16 0 O-C-N 121.447 -0.783 . . . . 1.0 111.089 -179.994 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 62' ' ' VAL . . . . . 0.439 ' O ' ' N ' ' A' ' 66' ' ' GLY . 91.0 t -46.08 -49.33 5.2 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.03 0 N-CA-C 109.043 -0.725 . . . . 1.0 109.043 -175.639 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 63' ' ' ALA . . . . . 0.505 ' O ' ' HG3' ' A' ' 67' ' ' ARG . . . -64.91 -49.33 70.86 Favored 'General case' 0 N--CA 1.419 -1.993 0 N-CA-C 108.624 -0.88 . . . . 1.0 108.624 177.358 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 4.3 t-80 -56.0 -61.65 2.24 Favored 'General case' 0 CA--C 1.547 0.85 0 CA-C-N 115.977 -0.556 . . . . 1.0 111.904 179.52 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 65' ' ' ASP . . . . . 0.628 ' C ' ' H ' ' A' ' 67' ' ' ARG . 13.7 t70 -66.79 -54.34 23.67 Favored 'General case' 0 C--O 1.246 0.918 0 O-C-N 121.226 -0.921 . . . . 1.0 110.31 178.507 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . 0.439 ' N ' ' O ' ' A' ' 62' ' ' VAL . . . -62.91 32.9 0.07 OUTLIER Glycine 0 CA--C 1.523 0.587 0 N-CA-C 111.52 -0.632 . . . . 1.0 111.52 178.825 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 67' ' ' ARG . . . . . 0.635 ' HB3' ' H ' ' A' ' 71' ' ' ALA . 50.5 mtt180 -77.03 4.16 10.71 Favored 'General case' 0 C--N 1.313 -0.986 0 C-N-CA 123.739 0.816 . . . . 1.0 110.352 175.641 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . 0.609 ' O ' ' HA ' ' A' ' 72' ' ' HIS . 0.8 OUTLIER -33.95 -31.1 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.651 0 N-CA-C 107.335 -1.357 . . . . 1.0 107.335 -179.267 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . 0.611 ' N ' ' O ' ' A' ' 67' ' ' ARG . 0.3 OUTLIER -63.48 -65.14 0.73 Allowed 'General case' 0 C--N 1.312 -1.064 0 C-N-CA 118.037 -1.465 . . . . 1.0 107.213 175.838 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . 0.692 ' C ' ' H ' ' A' ' 72' ' ' HIS . . . -76.64 -73.67 0.27 Allowed 'General case' 0 N--CA 1.474 0.749 0 N-CA-C 107.537 -1.283 . . . . 1.0 107.537 178.627 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 71' ' ' ALA . . . . . 0.635 ' H ' ' HB3' ' A' ' 67' ' ' ARG . . . -49.7 4.63 0.01 OUTLIER 'General case' 0 N--CA 1.476 0.835 0 C-N-CA 125.907 1.683 . . . . 1.0 112.07 178.475 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 72' ' ' HIS . . . . . 0.962 ' CD2' ' H ' ' A' ' 73' ' ' MET . 1.4 p80 -17.74 -62.56 0.02 OUTLIER 'General case' 0 CA--C 1.519 -0.225 0 O-C-N 123.755 0.66 . . . . 1.0 112.519 -175.899 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 73' ' ' MET . . . . . 0.962 ' H ' ' CD2' ' A' ' 72' ' ' HIS . 16.6 ptm -80.89 -45.63 16.5 Favored 'General case' 0 C--N 1.298 -1.644 0 CA-C-N 117.968 0.349 . . . . 1.0 110.56 177.41 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . 0.672 ' O ' ' N ' ' A' ' 76' ' ' GLY . 97.3 t -40.7 -43.41 0.63 Allowed 'Isoleucine or valine' 0 C--N 1.35 0.592 0 CA-C-O 118.687 -0.673 . . . . 1.0 110.076 -174.164 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 19.4 t-20 -36.75 -19.64 0.01 OUTLIER 'General case' 0 N--CA 1.477 0.882 0 CA-C-O 122.491 1.139 . . . . 1.0 110.533 179.107 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 76' ' ' GLY . . . . . 0.672 ' N ' ' O ' ' A' ' 74' ' ' VAL . . . -50.38 -21.02 4.06 Favored Glycine 0 C--O 1.205 -1.709 0 N-CA-C 108.991 -1.644 . . . . 1.0 108.991 174.321 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 77' ' ' ILE . . . . . 0.437 ' N ' ' O ' ' A' ' 74' ' ' VAL . 6.1 pt -54.49 -46.82 71.39 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.555 0 O-C-N 121.637 -0.92 . . . . 1.0 112.446 -176.934 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 3.7 t -59.29 -19.24 15.73 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.716 0 O-C-N 121.925 -0.484 . . . . 1.0 111.93 -178.406 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . 0.576 HG12 ' O ' ' A' ' 76' ' ' GLY . 0.3 OUTLIER -81.39 -46.06 20.46 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.702 0 C-N-CA 119.941 -0.704 . . . . 1.0 111.493 -179.748 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 80' ' ' ALA . . . . . 0.466 ' N ' ' CG1' ' A' ' 79' ' ' ILE . . . -84.17 -18.66 35.94 Favored 'General case' 0 N--CA 1.467 0.384 0 N-CA-C 112.791 0.663 . . . . 1.0 112.791 179.41 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 64.5 mt-10 -84.7 -71.85 0.5 Allowed 'General case' 0 C--O 1.231 0.124 0 N-CA-C 112.964 0.727 . . . . 1.0 112.964 -178.813 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 82' ' ' ASP . . . . . 0.432 ' O ' ' C ' ' A' ' 83' ' ' ALA . 93.4 m-20 -71.05 -18.08 62.58 Favored 'General case' 0 CA--C 1.515 -0.403 0 N-CA-C 111.612 0.227 . . . . 1.0 111.612 -177.669 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . 0.442 ' O ' ' C ' ' A' ' 84' ' ' LEU . . . -36.14 -50.81 0.73 Allowed 'General case' 0 N--CA 1.47 0.575 0 C-N-CA 120.612 -0.435 . . . . 1.0 110.907 177.898 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . 0.442 ' C ' ' O ' ' A' ' 83' ' ' ALA . 0.2 OUTLIER -28.79 -46.88 0.05 OUTLIER 'General case' 0 N--CA 1.48 1.054 0 CA-C-N 116.175 -0.466 . . . . 1.0 111.257 -173.825 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 73.8 mt -95.11 -54.67 6.89 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.704 0 N-CA-C 109.831 -0.433 . . . . 1.0 109.831 178.061 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -43.38 -39.98 3.45 Favored 'General case' 0 N--CA 1.465 0.298 0 CA-C-N 115.759 -0.655 . . . . 1.0 110.317 -178.83 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 79.7 tt0 -54.74 -29.74 54.41 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.785 -0.643 . . . . 1.0 110.65 -179.879 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -77.77 -12.46 59.98 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.632 -0.713 . . . . 1.0 109.377 -179.909 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 89' ' ' VAL . . . . . 0.4 ' C ' ' HD2' ' A' ' 91' ' ' PRO . 3.5 t -86.92 39.12 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.448 -0.553 0 N-CA-C 108.172 -1.047 . . . . 1.0 108.172 178.556 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 90' ' ' GLY . . . . . 0.859 ' O ' ' N ' ' A' ' 92' ' ' HIS . . . -55.69 -24.63 40.96 Favored Glycine 0 C--N 1.362 1.997 0 CA-C-O 117.294 -1.837 . . . . 1.0 111.156 176.934 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 91' ' ' PRO . . . . . 0.633 ' HD2' ' N ' ' A' ' 90' ' ' GLY . 26.0 Cg_exo -32.27 -3.74 0.0 OUTLIER 'Trans proline' 0 N--CA 1.507 2.299 0 C-N-CA 123.828 3.018 . . . . 1.0 113.495 173.365 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 92' ' ' HIS . . . . . 0.859 ' N ' ' O ' ' A' ' 90' ' ' GLY . 20.6 t60 -50.95 -30.83 15.98 Favored 'General case' 0 N--CA 1.443 -0.791 0 N-CA-C 107.098 -1.445 . . . . 1.0 107.098 177.34 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 93' ' ' LEU . . . . . 0.634 ' O ' ' N ' ' A' ' 96' ' ' ALA . 0.4 OUTLIER -59.42 -58.37 8.91 Favored 'General case' 0 C--O 1.214 -0.809 0 CA-C-N 119.064 0.847 . . . . 1.0 109.27 176.808 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 94' ' ' ALA . . . . . 0.533 ' H ' ' HG ' ' A' ' 93' ' ' LEU . . . -48.28 -53.3 17.7 Favored 'General case' 0 C--O 1.221 -0.406 0 N-CA-C 106.56 -1.644 . . . . 1.0 106.56 -178.712 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 95' ' ' ARG . . . . . 0.503 HH21 ' HB3' ' A' ' 91' ' ' PRO . 0.0 OUTLIER -59.5 -26.5 65.34 Favored 'General case' 0 C--N 1.305 -1.339 0 N-CA-C 108.699 -0.852 . . . . 1.0 108.699 176.328 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 96' ' ' ALA . . . . . 0.84 ' O ' ' N ' ' A' ' 100' ' ' ILE . . . -59.31 -52.55 65.16 Favored 'General case' 0 C--O 1.202 -1.43 0 N-CA-C 106.735 -1.58 . . . . 1.0 106.735 179.624 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 97' ' ' LEU . . . . . 0.51 ' C ' ' O ' ' A' ' 96' ' ' ALA . 1.5 mt -38.3 -32.11 0.06 Allowed 'General case' 0 CA--C 1.576 1.976 0 N-CA-C 107.401 -1.333 . . . . 1.0 107.401 -179.439 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 98' ' ' GLY . . . . . 0.479 ' N ' ' O ' ' A' ' 96' ' ' ALA . . . -82.09 -52.14 4.17 Favored Glycine 0 CA--C 1.551 2.332 0 CA-C-O 123.422 1.568 . . . . 1.0 111.356 173.897 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 99' ' ' GLN . . . . . 0.435 ' N ' ' O ' ' A' ' 96' ' ' ALA . 76.1 mm-40 -78.39 9.63 3.76 Favored 'General case' 0 N--CA 1.434 -1.235 0 N-CA-C 108.185 -1.042 . . . . 1.0 108.185 178.794 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 100' ' ' ILE . . . . . 0.84 ' N ' ' O ' ' A' ' 96' ' ' ALA . 1.1 tt -59.49 -51.46 72.39 Favored 'Isoleucine or valine' 0 CA--C 1.477 -1.85 0 N-CA-C 108.015 -1.106 . . . . 1.0 108.015 179.917 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 101' ' ' VAL . . . . . 0.602 ' O ' ' N ' ' A' ' 105' ' ' GLY . 70.6 t -57.2 -57.23 10.84 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.768 0 C-N-CA 116.666 -2.014 . . . . 1.0 106.627 178.307 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 102' ' ' CYS . . . . . 0.467 ' O ' ' CB ' ' A' ' 106' ' ' ALA . 1.9 t -45.13 -23.09 0.13 Allowed 'General case' 0 C--O 1.218 -0.584 0 C-N-CA 119.559 -0.857 . . . . 1.0 110.809 -177.573 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 103' ' ' ARG . . . . . 0.409 ' HG3' HH11 ' A' ' 103' ' ' ARG . 0.0 OUTLIER -91.29 -43.19 9.95 Favored 'General case' 0 CA--C 1.541 0.627 0 CA-C-O 122.095 0.95 . . . . 1.0 113.147 179.302 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 104' ' ' TYR . . . . . 0.746 ' CG ' ' O ' ' A' ' 104' ' ' TYR . 0.2 OUTLIER -102.88 21.55 15.41 Favored 'General case' 0 C--N 1.31 -1.146 0 CA-C-N 113.292 -1.776 . . . . 1.0 109.886 179.813 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 105' ' ' GLY . . . . . 0.766 ' O ' ' N ' ' A' ' 107' ' ' THR . . . -166.01 -14.52 0.02 OUTLIER Glycine 0 C--O 1.215 -1.093 0 C-N-CA 118.381 -1.866 . . . . 1.0 111.39 178.193 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 106' ' ' ALA . . . . . 0.482 ' C ' ' O ' ' A' ' 105' ' ' GLY . . . -13.87 65.86 0.0 OUTLIER 'General case' 0 N--CA 1.478 0.933 0 O-C-N 124.742 0.907 . . . . 1.0 112.002 -179.876 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 107' ' ' THR . . . . . 0.766 ' N ' ' O ' ' A' ' 105' ' ' GLY . 99.5 m -101.25 -4.37 27.25 Favored 'General case' 0 N--CA 1.452 -0.348 0 CA-C-N 115.869 -0.605 . . . . 1.0 110.048 -179.419 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 108' ' ' VAL . . . . . 0.496 ' CG2' ' N ' ' A' ' 109' ' ' ILE . 33.3 m -85.19 -58.22 3.68 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.466 0 N-CA-C 111.647 0.24 . . . . 1.0 111.647 -178.579 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 109' ' ' ILE . . . . . 0.564 ' N ' ' HD2' ' A' ' 110' ' ' PRO . 0.3 OUTLIER -47.79 -43.37 52.08 Favored Pre-proline 0 C--N 1.353 0.754 0 N-CA-C 112.709 0.633 . . . . 1.0 112.709 179.244 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 110' ' ' PRO . . . . . 0.564 ' HD2' ' N ' ' A' ' 109' ' ' ILE . 7.9 Cg_endo -40.51 -38.32 2.43 Favored 'Trans proline' 0 N--CA 1.482 0.81 0 C-N-CA 121.154 1.236 . . . . 1.0 113.126 -175.4 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 16.8 t-20 -64.56 -68.26 0.37 Allowed 'General case' 0 C--N 1.315 -0.906 0 C-N-CA 118.601 -1.24 . . . . 1.0 110.726 -178.344 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 112' ' ' ILE . . . . . 0.404 ' H ' HG23 ' A' ' 112' ' ' ILE . 2.0 pt -67.59 -27.8 39.63 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.54 0 CA-C-O 121.841 0.829 . . . . 1.0 111.547 -178.004 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 113' ' ' ASN . . . . . 0.59 HD21 ' N ' ' A' ' 114' ' ' ALA . 0.3 OUTLIER -54.98 -61.51 2.26 Favored 'General case' 0 C--N 1.306 -1.304 0 CA-C-N 114.075 -1.42 . . . . 1.0 109.837 -175.281 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 114' ' ' ALA . . . . . 0.59 ' N ' HD21 ' A' ' 113' ' ' ASN . . . -61.81 -22.55 65.56 Favored 'General case' 0 C--N 1.306 -1.301 0 CA-C-N 116.063 -0.517 . . . . 1.0 110.709 -179.979 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -78.48 -60.74 2.25 Favored 'General case' 0 N--CA 1.448 -0.532 0 N-CA-C 112.715 0.635 . . . . 1.0 112.715 178.278 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 116' ' ' ILE . . . . . 0.476 ' O ' ' CB ' ' A' ' 119' ' ' LEU . 95.3 mt -69.4 -46.21 77.03 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.323 0 O-C-N 120.477 -1.39 . . . . 1.0 112.359 -177.094 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 117' ' ' GLU . . . . . 0.462 ' OE1' ' ND2' ' A' ' 113' ' ' ASN . 94.9 mt-10 -47.59 -64.37 0.8 Allowed 'General case' 0 C--N 1.316 -0.856 0 CA-C-N 115.538 -0.755 . . . . 1.0 110.109 -176.994 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 4.1 p -51.71 -15.14 0.48 Allowed 'Isoleucine or valine' 0 N--CA 1.437 -1.107 0 CA-C-N 115.4 -0.818 . . . . 1.0 109.251 -179.662 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 119' ' ' LEU . . . . . 0.476 ' CB ' ' O ' ' A' ' 116' ' ' ILE . 1.6 tt -77.13 -61.07 2.11 Favored 'General case' 0 C--N 1.348 0.508 0 C-N-CA 119.116 -1.033 . . . . 1.0 109.328 177.949 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -70.39 -81.21 0.26 Allowed Glycine 0 C--N 1.355 1.618 0 C-N-CA 117.259 -2.4 . . . . 1.0 111.076 179.55 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 45.2 m -160.41 -17.82 0.06 Allowed 'General case' 0 CA--C 1.54 0.592 0 CA-C-O 121.414 0.626 . . . . 1.0 109.97 -179.595 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 122' ' ' GLY . . . . . 0.441 ' O ' ' C ' ' A' ' 123' ' ' THR . . . 109.88 -36.8 4.09 Favored Glycine 0 N--CA 1.476 1.327 0 C-N-CA 125.215 1.388 . . . . 1.0 111.888 179.96 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 123' ' ' THR . . . . . 0.441 ' C ' ' O ' ' A' ' 122' ' ' GLY . 4.2 t -31.17 94.98 0.01 OUTLIER 'General case' 0 N--CA 1.473 0.676 0 CA-C-N 118.47 1.135 . . . . 1.0 112.675 -178.708 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 124' ' ' ASP . . . . . 0.407 ' N ' ' O ' ' A' ' 122' ' ' GLY . 73.1 m-20 -143.67 144.58 31.93 Favored 'General case' 0 C--N 1.33 -0.275 0 N-CA-C 108.56 -0.904 . . . . 1.0 108.56 178.571 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 125' ' ' TYR . . . . . 0.433 ' O ' ' NE ' ' A' ' 126' ' ' ARG . 0.0 OUTLIER -151.74 148.96 28.52 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.763 0.316 . . . . 1.0 110.305 -178.525 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 126' ' ' ARG . . . . . 0.433 ' NE ' ' O ' ' A' ' 125' ' ' TYR . 0.0 OUTLIER -149.85 151.78 34.05 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.167 -0.47 . . . . 1.0 110.006 177.928 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 127' ' ' PHE . . . . . 0.548 ' O ' ' CD2' ' A' ' 92' ' ' HIS . 0.1 OUTLIER . . . . . 0 C--O 1.22 -0.481 0 CA-C-O 117.873 -1.06 . . . . 1.0 110.398 -178.57 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 2.2 mpt? . . . . . 0 N--CA 1.491 1.612 0 N-CA-C 109.139 -0.689 . . . . 1.0 109.139 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 51.9 m -95.64 1.72 53.75 Favored 'General case' 0 N--CA 1.463 0.187 0 CA-C-N 116.449 -0.341 . . . . 1.0 110.913 -179.825 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER 169.56 106.68 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.361 -0.381 . . . . 1.0 110.274 -179.94 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 18.2 t80 -149.21 145.53 27.17 Favored 'General case' 0 C--N 1.33 -0.254 0 N-CA-C 109.723 -0.473 . . . . 1.0 109.723 178.896 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 14.4 m-20 -152.82 147.71 26.34 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.359 -0.382 . . . . 1.0 110.117 -179.025 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 6' ' ' THR . . . . . 0.657 ' O ' ' N ' ' A' ' 10' ' ' SER . 0.2 OUTLIER -103.88 -165.97 1.21 Allowed 'General case' 0 C--O 1.206 -1.191 0 CA-C-O 121.51 0.671 . . . . 1.0 109.386 178.931 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . 0.679 ' O ' ' HB2' ' A' ' 11' ' ' ARG . 27.5 tt0 -58.92 -45.31 90.67 Favored 'General case' 0 C--N 1.304 -1.371 0 CA-C-O 121.891 0.853 . . . . 1.0 110.548 -179.801 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 8' ' ' ARG . . . . . 0.531 ' O ' ' CB ' ' A' ' 12' ' ' ALA . 0.1 OUTLIER -67.9 -60.13 2.75 Favored 'General case' 0 C--N 1.306 -1.301 0 C-N-CA 118.953 -1.099 . . . . 1.0 109.482 179.065 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . 0.6 HG22 ' H ' ' A' ' 6' ' ' THR . 0.0 OUTLIER -66.32 -50.69 65.9 Favored 'Isoleucine or valine' 0 C--O 1.201 -1.449 0 CA-C-N 115.107 -0.951 . . . . 1.0 110.686 -178.777 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 10' ' ' SER . . . . . 0.657 ' N ' ' O ' ' A' ' 6' ' ' THR . 2.5 t -65.69 -62.23 1.63 Allowed 'General case' 0 N--CA 1.488 1.447 0 C-N-CA 120.025 -0.67 . . . . 1.0 111.176 179.185 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 11' ' ' ARG . . . . . 0.679 ' HB2' ' O ' ' A' ' 7' ' ' GLU . 4.6 mmt85 -64.87 -41.18 95.88 Favored 'General case' 0 CA--C 1.547 0.861 0 CA-C-O 119.302 -0.38 . . . . 1.0 111.792 -177.213 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . 0.531 ' CB ' ' O ' ' A' ' 8' ' ' ARG . . . -69.61 -54.17 15.28 Favored 'General case' 0 N--CA 1.483 1.19 0 C-N-CA 118.165 -1.414 . . . . 1.0 108.125 175.84 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . 0.643 ' O ' ' CB ' ' A' ' 17' ' ' LEU . 60.3 t -61.67 -55.02 27.07 Favored 'Isoleucine or valine' 0 C--O 1.198 -1.647 0 C-N-CA 117.423 -1.711 . . . . 1.0 108.438 -179.033 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . 0.6 ' O ' HG22 ' A' ' 18' ' ' VAL . . . -57.1 -62.27 1.87 Allowed 'General case' 0 C--O 1.211 -0.925 0 C-N-CA 118.542 -1.263 . . . . 1.0 109.95 179.653 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . 0.489 ' O ' ' N ' ' A' ' 19' ' ' GLY . . . -55.34 -55.66 28.94 Favored 'General case' 0 N--CA 1.475 0.805 0 C-N-CA 118.807 -1.157 . . . . 1.0 110.517 -176.952 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . 0.549 ' HA ' ' H ' ' A' ' 22' ' ' GLY . . . -65.66 -55.98 14.58 Favored 'General case' 0 CA--C 1.547 0.847 0 C-N-CA 119.761 -0.776 . . . . 1.0 110.033 -178.889 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . 0.643 ' CB ' ' O ' ' A' ' 13' ' ' VAL . 7.3 tp -56.8 -57.58 11.83 Favored 'General case' 0 N--CA 1.483 1.186 0 CA-C-N 115.397 -0.819 . . . . 1.0 108.827 -178.965 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . 0.6 HG22 ' O ' ' A' ' 14' ' ' ALA . 1.3 m -71.82 -58.22 5.61 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.423 0 C-N-CA 119.282 -0.967 . . . . 1.0 110.772 -179.536 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . 0.556 ' H ' HG22 ' A' ' 18' ' ' VAL . . . -56.34 -172.94 0.16 Allowed Glycine 0 CA--C 1.519 0.341 0 C-N-CA 120.924 -0.655 . . . . 1.0 112.109 -177.768 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 20' ' ' PRO . . . . . 0.605 ' O ' ' N ' ' A' ' 24' ' ' ALA . 1.7 Cg_endo -81.05 -21.96 6.36 Favored 'Trans proline' 0 C--N 1.308 -1.581 0 C-N-CA 123.122 2.548 . . . . 1.0 112.501 -178.841 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -63.35 -62.03 5.76 Favored Glycine 0 N--CA 1.478 1.437 0 C-N-CA 119.687 -1.245 . . . . 1.0 112.906 -176.492 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . 0.549 ' H ' ' HA ' ' A' ' 16' ' ' ALA . . . -55.44 -52.03 50.56 Favored Glycine 0 N--CA 1.472 1.048 0 N-CA-C 106.277 -2.729 . . . . 1.0 106.277 -179.255 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 26.7 t -58.23 -31.81 43.12 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.731 0 C-N-CA 119.455 -0.898 . . . . 1.0 108.966 178.326 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . 0.605 ' N ' ' O ' ' A' ' 20' ' ' PRO . . . -60.2 -61.97 2.21 Favored 'General case' 0 N--CA 1.481 1.09 0 C-N-CA 118.616 -1.233 . . . . 1.0 109.677 178.614 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -60.33 -50.35 73.98 Favored 'General case' 0 N--CA 1.478 0.938 0 N-CA-C 112.633 0.605 . . . . 1.0 112.633 -178.482 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 86.0 t -57.89 -59.44 3.42 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.021 0 C-N-CA 118.986 -1.086 . . . . 1.0 110.612 -177.204 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . 0.415 ' O ' ' CB ' ' A' ' 31' ' ' ALA . 1.2 p -58.41 -36.54 59.18 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.687 0 C-N-CA 120.672 -0.411 . . . . 1.0 111.16 -178.089 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 20.9 tttt -65.84 -56.57 11.2 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-O 121.463 0.649 . . . . 1.0 109.884 -179.706 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 25.1 t -63.51 -49.27 83.3 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.54 0 CA-C-N 115.292 -0.867 . . . . 1.0 111.088 -177.776 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 30' ' ' CYS . . . . . . . . . . . . . 14.0 t -63.54 -61.61 2.21 Favored 'General case' 0 C--N 1.316 -0.849 0 C-N-CA 118.901 -1.12 . . . . 1.0 109.43 -179.396 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . 0.415 ' CB ' ' O ' ' A' ' 27' ' ' VAL . . . -58.44 -50.89 72.07 Favored 'General case' 0 C--N 1.319 -0.718 0 C-N-CA 120.553 -0.459 . . . . 1.0 110.847 -178.416 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . 0.527 ' O ' ' CB ' ' A' ' 33' ' ' LEU . . . 74.51 67.85 1.67 Allowed Glycine 0 CA--C 1.518 0.238 0 N-CA-C 108.158 -1.977 . . . . 1.0 108.158 -178.383 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . 0.527 ' CB ' ' O ' ' A' ' 32' ' ' GLY . 13.5 tp 94.34 81.31 0.03 OUTLIER Pre-proline 0 CA--C 1.54 0.588 0 CA-C-N 114.457 -0.871 . . . . 1.0 109.663 -177.719 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 13.0 Cg_endo -54.53 -23.08 30.35 Favored 'Trans proline' 0 N--CA 1.502 2.027 0 C-N-CA 121.637 1.558 . . . . 1.0 113.952 -179.276 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . 0.452 ' O ' ' CD1' ' A' ' 112' ' ' ILE . . . -62.56 -61.61 6.37 Favored Glycine 0 CA--C 1.536 1.356 0 C-N-CA 117.873 -2.108 . . . . 1.0 109.863 -178.403 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . 0.5 ' O ' ' CB ' ' A' ' 37' ' ' ILE . 2.6 m -95.57 178.39 0.59 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.519 0 N-CA-C 107.965 -1.124 . . . . 1.0 107.965 176.579 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . 0.5 ' CB ' ' O ' ' A' ' 36' ' ' VAL . 0.1 OUTLIER 102.56 121.94 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.479 0.989 0 O-C-N 124.297 0.998 . . . . 1.0 112.036 179.601 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 81.3 m-70 -143.2 135.29 26.98 Favored 'General case' 0 N--CA 1.463 0.198 0 N-CA-C 109.073 -0.714 . . . . 1.0 109.073 178.445 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 39' ' ' THR . . . . . 0.403 ' O ' ' CG ' ' A' ' 42' ' ' ARG . 0.0 OUTLIER -90.62 115.83 65.05 Favored Pre-proline 0 CA--C 1.546 0.804 0 N-CA-C 109.329 -0.619 . . . . 1.0 109.329 179.774 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 50.2 Cg_exo -49.01 -32.63 23.97 Favored 'Trans proline' 0 N--CA 1.496 1.619 0 C-N-CA 121.678 1.585 . . . . 1.0 113.569 -179.053 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -111.34 93.67 4.59 Favored 'General case' 0 CA--C 1.513 -0.459 0 N-CA-C 114.051 1.13 . . . . 1.0 114.051 -175.12 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . 0.42 ' C ' ' N ' ' A' ' 44' ' ' GLY . 0.2 OUTLIER -141.6 143.06 33.49 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 114.589 -1.187 . . . . 1.0 108.271 178.806 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 43' ' ' ARG . . . . . 0.417 HH22 ' HB3' ' A' ' 59' ' ' ARG . 14.9 tpt85 -50.49 -13.35 0.12 Allowed 'General case' 0 C--N 1.322 -0.6 0 C-N-CA 120.447 -0.501 . . . . 1.0 110.806 -177.164 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . 0.42 ' N ' ' C ' ' A' ' 42' ' ' ARG . . . 121.08 -23.52 7.68 Favored Glycine 0 N--CA 1.472 1.095 0 N-CA-C 110.346 -1.102 . . . . 1.0 110.346 179.823 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . 0.541 ' O ' ' CB ' ' A' ' 46' ' ' PHE . 36.0 p90 -152.25 159.6 43.51 Favored 'General case' 0 C--N 1.327 -0.391 0 N-CA-C 108.601 -0.889 . . . . 1.0 108.601 177.618 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 46' ' ' PHE . . . . . 0.541 ' CB ' ' O ' ' A' ' 45' ' ' PHE . 4.7 t80 117.24 103.11 0.0 OUTLIER 'General case' 0 N--CA 1.487 1.41 0 O-C-N 124.61 1.194 . . . . 1.0 110.274 -179.954 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 47' ' ' ARG . . . . . 0.491 ' CB ' ' O ' ' A' ' 46' ' ' PHE . 6.5 ptp180 120.5 135.68 0.0 OUTLIER 'General case' 0 N--CA 1.488 1.453 0 C-N-CA 124.886 1.274 . . . . 1.0 110.557 179.609 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 2.6 t 67.61 73.68 0.32 Allowed 'General case' 0 C--O 1.218 -0.588 0 C-N-CA 119.718 -0.793 . . . . 1.0 110.229 177.939 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 49' ' ' ASN . . . . . 0.659 ' H ' HD21 ' A' ' 49' ' ' ASN . 0.0 OUTLIER -135.82 153.56 77.29 Favored Pre-proline 0 N--CA 1.47 0.542 0 CA-C-O 119.427 -0.321 . . . . 1.0 110.173 -178.634 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 50' ' ' PRO . . . . . 0.462 ' C ' ' H ' ' A' ' 52' ' ' ARG . 33.7 Cg_endo -60.31 47.84 0.07 OUTLIER 'Trans proline' 0 N--CA 1.509 2.431 0 C-N-CA 122.763 2.308 . . . . 1.0 113.278 179.503 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . 0.491 ' N ' ' O ' ' A' ' 49' ' ' ASN . 15.8 mp0 70.77 -18.5 0.25 Allowed 'General case' 0 N--CA 1.47 0.561 0 C-N-CA 123.571 0.748 . . . . 1.0 111.486 179.697 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . 0.462 ' H ' ' C ' ' A' ' 50' ' ' PRO . 1.6 mpp_? -56.92 138.78 53.44 Favored 'General case' 0 CA--C 1.531 0.242 0 N-CA-C 109.436 -0.579 . . . . 1.0 109.436 179.445 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . 0.6 ' O ' ' N ' ' A' ' 55' ' ' ILE . 2.6 tp -58.91 129.83 21.54 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-N 115.551 -0.75 . . . . 1.0 110.917 -179.188 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 54' ' ' GLN . . . . . 0.511 ' NE2' ' OD1' ' A' ' 49' ' ' ASN . 0.0 OUTLIER -59.34 79.26 0.01 OUTLIER 'General case' 0 CA--C 1.537 0.474 0 N-CA-C 108.28 -1.007 . . . . 1.0 108.28 -178.014 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . 0.6 ' N ' ' O ' ' A' ' 53' ' ' ILE . 13.9 tt -154.49 162.97 1.79 Allowed 'Isoleucine or valine' 0 CA--C 1.523 -0.066 0 CA-C-N 114.802 -1.09 . . . . 1.0 111.325 178.438 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 100.81 -28.07 17.67 Favored Glycine 0 N--CA 1.452 -0.25 0 N-CA-C 111.943 -0.463 . . . . 1.0 111.943 176.849 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 12.9 m-20 -67.81 135.53 52.74 Favored 'General case' 0 N--CA 1.446 -0.646 0 CA-C-O 122.807 1.289 . . . . 1.0 113.661 -177.42 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 58' ' ' TRP . . . . . . . . . . . . . 32.4 m0 -78.13 -179.06 5.93 Favored 'General case' 0 N--CA 1.44 -0.964 0 CA-C-N 112.484 -2.143 . . . . 1.0 107.235 177.293 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 59' ' ' ARG . . . . . 0.563 ' CD ' ' H ' ' A' ' 59' ' ' ARG . 0.0 OUTLIER -99.05 -56.12 2.51 Favored 'General case' 0 CA--C 1.557 1.232 0 CA-C-N 119.646 1.112 . . . . 1.0 111.896 -179.734 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 24.8 t80 -78.66 -7.24 57.47 Favored 'General case' 0 N--CA 1.481 1.119 0 C-N-CA 125.429 1.492 . . . . 1.0 111.688 -178.418 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 69.4 tt0 -71.36 -13.89 62.01 Favored 'General case' 0 C--N 1.296 -1.749 0 CA-C-N 114.944 -1.025 . . . . 1.0 109.358 179.814 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 62' ' ' VAL . . . . . 0.513 ' O ' ' N ' ' A' ' 66' ' ' GLY . 10.4 m -44.51 -51.83 1.73 Allowed 'Isoleucine or valine' 0 CA--C 1.496 -1.133 0 C-N-CA 120.449 -0.501 . . . . 1.0 110.36 -175.448 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 63' ' ' ALA . . . . . 0.637 ' O ' ' HG2' ' A' ' 67' ' ' ARG . . . -65.51 -48.15 73.51 Favored 'General case' 0 N--CA 1.421 -1.919 0 N-CA-C 109.223 -0.658 . . . . 1.0 109.223 179.517 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 64' ' ' HIS . . . . . 0.408 ' O ' ' CG ' ' A' ' 67' ' ' ARG . 1.2 m-70 -54.57 -58.47 7.35 Favored 'General case' 0 CA--C 1.548 0.89 0 O-C-N 123.913 0.758 . . . . 1.0 110.368 179.829 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 65' ' ' ASP . . . . . 0.636 ' C ' ' H ' ' A' ' 67' ' ' ARG . 23.8 t70 -67.45 -53.38 29.43 Favored 'General case' 0 C--O 1.24 0.604 0 CA-C-O 121.15 0.5 . . . . 1.0 109.751 178.264 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . 0.513 ' N ' ' O ' ' A' ' 62' ' ' VAL . . . -63.72 30.94 0.09 OUTLIER Glycine 0 CA--C 1.527 0.826 0 N-CA-C 110.866 -0.894 . . . . 1.0 110.866 177.65 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 67' ' ' ARG . . . . . 0.637 ' HG2' ' O ' ' A' ' 63' ' ' ALA . 24.1 mmm-85 -80.25 -3.73 50.39 Favored 'General case' 0 N--CA 1.448 -0.567 0 N-CA-C 107.704 -1.221 . . . . 1.0 107.704 175.855 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . 0.489 ' O ' ' HA ' ' A' ' 72' ' ' HIS . 4.9 tt -35.1 -29.86 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.792 0 N-CA-C 107.705 -1.22 . . . . 1.0 107.705 -178.741 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . 0.691 ' CD2' ' H ' ' A' ' 70' ' ' ALA . 1.2 pt? -62.92 -62.34 1.78 Allowed 'General case' 0 N--CA 1.48 1.048 0 C-N-CA 117.121 -1.832 . . . . 1.0 106.914 177.689 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . 0.697 ' C ' ' H ' ' A' ' 72' ' ' HIS . . . -77.56 -72.55 0.35 Allowed 'General case' 0 C--O 1.214 -0.777 0 N-CA-C 106.663 -1.606 . . . . 1.0 106.663 178.057 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 71' ' ' ALA . . . . . 0.511 ' O ' ' C ' ' A' ' 72' ' ' HIS . . . -45.06 3.72 0.0 OUTLIER 'General case' 0 CA--C 1.516 -0.355 0 C-N-CA 124.402 1.081 . . . . 1.0 112.847 177.633 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 72' ' ' HIS . . . . . 0.697 ' H ' ' C ' ' A' ' 70' ' ' ALA . 0.0 OUTLIER -21.57 -68.29 0.03 OUTLIER 'General case' 0 CA--C 1.518 -0.275 0 C-N-CA 122.872 0.469 . . . . 1.0 111.437 -176.8 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 73' ' ' MET . . . . . 0.563 ' N ' ' ND1' ' A' ' 72' ' ' HIS . 32.6 mtt -73.51 -48.02 36.51 Favored 'General case' 0 C--N 1.31 -1.148 0 C-N-CA 119.069 -1.052 . . . . 1.0 109.151 177.355 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . 0.677 ' O ' ' N ' ' A' ' 76' ' ' GLY . 65.5 t -43.79 -49.21 1.78 Allowed 'Isoleucine or valine' 0 C--O 1.22 -0.497 0 CA-C-O 118.141 -0.933 . . . . 1.0 111.04 -176.146 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 75' ' ' ASN . . . . . 0.47 ' C ' ' N ' ' A' ' 77' ' ' ILE . 21.8 t30 -36.52 -20.34 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.746 0 CA-C-N 120.238 1.381 . . . . 1.0 110.312 177.755 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 76' ' ' GLY . . . . . 0.677 ' N ' ' O ' ' A' ' 74' ' ' VAL . . . -49.3 -20.87 2.51 Favored Glycine 0 C--O 1.216 -1.019 0 N-CA-C 107.948 -2.061 . . . . 1.0 107.948 174.885 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 77' ' ' ILE . . . . . 0.477 ' N ' ' O ' ' A' ' 74' ' ' VAL . 82.2 mt -53.27 -43.77 51.49 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.133 0 O-C-N 122.635 -0.333 . . . . 1.0 111.019 -178.044 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 42.5 t -50.44 -19.78 0.79 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.424 0 CA-C-N 118.667 0.667 . . . . 1.0 111.978 -179.445 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . 0.424 HG12 ' O ' ' A' ' 76' ' ' GLY . 0.3 OUTLIER -90.15 -38.67 11.27 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.077 0 C-N-CA 120.007 -0.677 . . . . 1.0 111.543 179.466 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -82.37 -27.36 32.17 Favored 'General case' 0 CA--C 1.541 0.633 0 N-CA-C 113.116 0.784 . . . . 1.0 113.116 -179.255 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 81' ' ' GLU . . . . . 0.648 ' CG ' ' H ' ' A' ' 82' ' ' ASP . 12.6 pt-20 -84.3 -67.63 0.78 Allowed 'General case' 0 CA--C 1.544 0.72 0 N-CA-C 110.152 -0.314 . . . . 1.0 110.152 178.171 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 82' ' ' ASP . . . . . 0.648 ' H ' ' CG ' ' A' ' 81' ' ' GLU . 67.1 m-20 -66.25 -20.05 66.0 Favored 'General case' 0 CA--C 1.495 -1.164 0 O-C-N 121.269 -0.894 . . . . 1.0 112.384 -177.664 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . 0.555 ' C ' ' O ' ' A' ' 82' ' ' ASP . . . -18.65 -55.03 0.01 OUTLIER 'General case' 0 N--CA 1.468 0.465 0 CA-C-O 118.946 -0.549 . . . . 1.0 111.846 176.642 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . 0.449 ' N ' ' O ' ' A' ' 82' ' ' ASP . 3.8 mm? -28.0 -53.78 0.09 Allowed 'General case' 0 N--CA 1.484 1.227 0 CA-C-N 119.657 1.117 . . . . 1.0 113.43 -177.896 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 15.6 pt -91.05 -35.43 7.15 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 C-N-CA 120.587 -0.445 . . . . 1.0 109.811 -179.404 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 86' ' ' ALA . . . . . 0.481 ' O ' ' CG1' ' A' ' 89' ' ' VAL . . . -52.92 -54.92 27.79 Favored 'General case' 0 C--N 1.33 -0.244 0 C-N-CA 120.376 -0.529 . . . . 1.0 109.685 -179.514 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 87' ' ' GLU . . . . . 0.405 ' OE1' ' C ' ' A' ' 87' ' ' GLU . 9.0 tm-20 -57.4 -21.04 33.67 Favored 'General case' 0 C--N 1.33 -0.277 0 C-N-CA 120.062 -0.655 . . . . 1.0 109.508 179.304 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 88' ' ' ALA . . . . . 0.733 ' C ' ' H ' ' A' ' 90' ' ' GLY . . . -73.36 -13.51 61.11 Favored 'General case' 0 C--O 1.225 -0.192 0 C-N-CA 120.352 -0.539 . . . . 1.0 109.923 179.457 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 89' ' ' VAL . . . . . 0.549 ' O ' ' N ' ' A' ' 92' ' ' HIS . 27.8 m -49.09 11.4 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.48 1.037 0 N-CA-C 113.27 0.841 . . . . 1.0 113.27 -178.979 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 90' ' ' GLY . . . . . 0.733 ' H ' ' C ' ' A' ' 88' ' ' ALA . . . -34.37 -42.12 0.27 Allowed Glycine 0 CA--C 1.543 1.83 0 CA-C-O 117.871 -1.516 . . . . 1.0 110.561 -177.26 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 91' ' ' PRO . . . . . 0.462 ' HD2' ' N ' ' A' ' 90' ' ' GLY . 1.1 Cg_endo -44.64 0.76 0.01 OUTLIER 'Trans proline' 0 N--CA 1.5 1.911 0 CA-C-N 121.292 2.546 . . . . 1.0 110.925 170.724 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 92' ' ' HIS . . . . . 0.73 ' N ' ' O ' ' A' ' 90' ' ' GLY . 16.4 t-80 -51.17 -41.7 60.33 Favored 'General case' 0 CA--C 1.51 -0.589 0 N-CA-C 109.21 -0.663 . . . . 1.0 109.21 -177.454 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 39.0 tp -63.03 -39.86 96.0 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 119.17 0.895 . . . . 1.0 110.349 177.718 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -61.8 -60.21 4.0 Favored 'General case' 0 CA--C 1.496 -1.116 0 N-CA-C 106.085 -1.82 . . . . 1.0 106.085 -179.398 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 3.7 mmp_? -57.8 -29.92 65.27 Favored 'General case' 0 N--CA 1.432 -1.34 0 CA-C-N 115.29 -0.868 . . . . 1.0 108.738 177.825 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 96' ' ' ALA . . . . . 0.813 ' O ' ' N ' ' A' ' 100' ' ' ILE . . . -59.04 -53.81 54.21 Favored 'General case' 0 C--O 1.198 -1.617 0 C-N-CA 118.127 -1.429 . . . . 1.0 108.558 -176.73 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 97' ' ' LEU . . . . . 0.487 ' C ' ' O ' ' A' ' 96' ' ' ALA . 1.2 tt -34.46 -28.82 0.01 OUTLIER 'General case' 0 CA--C 1.565 1.521 0 O-C-N 124.341 1.026 . . . . 1.0 108.59 -177.929 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 98' ' ' GLY . . . . . 0.616 ' N ' ' O ' ' A' ' 96' ' ' ALA . . . -88.62 -53.08 2.67 Favored Glycine 0 CA--C 1.543 1.829 0 CA-C-O 123.589 1.66 . . . . 1.0 111.401 174.144 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 99' ' ' GLN . . . . . 0.487 ' N ' ' O ' ' A' ' 96' ' ' ALA . 6.1 tt0 -78.73 6.18 9.52 Favored 'General case' 0 N--CA 1.433 -1.309 0 CA-C-N 114.473 -0.864 . . . . 1.0 108.991 178.693 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 100' ' ' ILE . . . . . 0.813 ' N ' ' O ' ' A' ' 96' ' ' ALA . 0.2 OUTLIER -63.8 -47.09 92.46 Favored 'Isoleucine or valine' 0 CA--C 1.495 -1.159 0 N-CA-C 108.022 -1.103 . . . . 1.0 108.022 179.948 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 101' ' ' VAL . . . . . 0.521 ' CG2' ' H ' ' A' ' 102' ' ' CYS . 17.6 m -55.54 -60.01 2.08 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.477 0 C-N-CA 117.035 -1.866 . . . . 1.0 108.958 179.65 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 102' ' ' CYS . . . . . 0.521 ' H ' ' CG2' ' A' ' 101' ' ' VAL . 42.3 t -41.11 -19.71 0.01 OUTLIER 'General case' 0 C--N 1.311 -1.075 0 N-CA-C 113.217 0.821 . . . . 1.0 113.217 -176.231 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 103' ' ' ARG . . . . . 0.517 ' N ' ' O ' ' A' ' 101' ' ' VAL . 7.6 ttp180 -89.98 -35.27 15.64 Favored 'General case' 0 N--CA 1.497 1.922 0 N-CA-C 114.534 1.309 . . . . 1.0 114.534 178.956 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 104' ' ' TYR . . . . . 0.649 ' CG ' ' O ' ' A' ' 104' ' ' TYR . 0.0 OUTLIER -100.18 22.97 10.63 Favored 'General case' 0 C--N 1.303 -1.45 0 CA-C-N 113.188 -1.824 . . . . 1.0 110.076 -179.816 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -161.5 -88.15 0.07 OUTLIER Glycine 0 N--CA 1.451 -0.33 0 N-CA-C 107.413 -2.275 . . . . 1.0 107.413 179.64 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 106' ' ' ALA . . . . . 0.561 ' O ' ' CD ' ' A' ' 110' ' ' PRO . . . 69.53 58.17 0.32 Allowed 'General case' 0 CA--C 1.548 0.895 0 N-CA-C 112.704 0.631 . . . . 1.0 112.704 179.334 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 107' ' ' THR . . . . . 0.473 ' O ' ' HD2' ' A' ' 110' ' ' PRO . 20.0 m -76.41 -57.84 3.63 Favored 'General case' 0 N--CA 1.48 1.037 0 O-C-N 121.257 -0.902 . . . . 1.0 109.384 179.555 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 108' ' ' VAL . . . . . 0.521 ' O ' ' N ' ' A' ' 111' ' ' ASN . 16.5 m -68.61 -45.45 81.53 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.747 0 N-CA-C 110.405 -0.22 . . . . 1.0 110.405 -179.371 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -36.83 -54.01 1.79 Allowed Pre-proline 0 CA--C 1.568 1.659 0 CA-C-N 116.159 -0.473 . . . . 1.0 110.199 -178.694 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 110' ' ' PRO . . . . . 0.561 ' CD ' ' O ' ' A' ' 106' ' ' ALA . 31.4 Cg_exo -57.14 -24.52 59.1 Favored 'Trans proline' 0 N--CA 1.504 2.141 0 C-N-CA 123.296 2.664 . . . . 1.0 113.087 176.284 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 111' ' ' ASN . . . . . 0.567 ' CG ' ' N ' ' A' ' 112' ' ' ILE . 0.1 OUTLIER -63.04 -66.19 0.58 Allowed 'General case' 0 CA--C 1.54 0.587 0 C-N-CA 120.114 -0.634 . . . . 1.0 109.8 -178.531 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 112' ' ' ILE . . . . . 0.567 ' N ' ' CG ' ' A' ' 111' ' ' ASN . 1.9 tt -61.56 -27.84 42.86 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.493 0 CA-C-O 121.308 0.575 . . . . 1.0 110.804 178.707 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 113' ' ' ASN . . . . . 0.434 ' O ' ' CG ' ' A' ' 117' ' ' GLU . 1.6 m120 -57.54 -64.88 0.75 Allowed 'General case' 0 C--N 1.305 -1.341 0 CA-C-N 115.066 -0.97 . . . . 1.0 111.275 -175.203 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -67.63 -23.86 65.39 Favored 'General case' 0 C--N 1.318 -0.796 0 N-CA-C 112.124 0.416 . . . . 1.0 112.124 -178.926 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -78.97 -62.91 1.55 Allowed 'General case' 0 CA--C 1.536 0.422 0 N-CA-C 112.828 0.677 . . . . 1.0 112.828 178.988 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 116' ' ' ILE . . . . . 0.583 ' O ' ' N ' ' A' ' 119' ' ' LEU . 19.7 mt -69.68 -47.09 72.86 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.651 0 O-C-N 121.414 -0.804 . . . . 1.0 112.532 -178.329 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 117' ' ' GLU . . . . . 0.434 ' CG ' ' O ' ' A' ' 113' ' ' ASN . 73.9 mt-10 -46.84 -59.73 2.88 Favored 'General case' 0 CA--C 1.498 -1.04 0 N-CA-C 108.681 -0.859 . . . . 1.0 108.681 -177.001 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 88.9 t -55.59 -16.19 2.3 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.314 0 CA-C-N 115.407 -0.815 . . . . 1.0 109.191 179.052 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 119' ' ' LEU . . . . . 0.583 ' N ' ' O ' ' A' ' 116' ' ' ILE . 0.2 OUTLIER -79.87 -61.11 2.09 Favored 'General case' 0 C--N 1.351 0.633 0 C-N-CA 119.691 -0.803 . . . . 1.0 109.362 176.964 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -67.15 -84.39 0.1 Allowed Glycine 0 C--N 1.361 1.97 0 C-N-CA 117.154 -2.451 . . . . 1.0 110.874 178.705 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 9.3 p -159.27 -23.71 0.07 Allowed 'General case' 0 C--N 1.32 -0.688 0 N-CA-C 108.274 -1.01 . . . . 1.0 108.274 -179.564 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 122' ' ' GLY . . . . . 0.462 ' O ' ' C ' ' A' ' 123' ' ' THR . . . 112.54 -37.09 3.8 Favored Glycine 0 CA--C 1.525 0.681 0 CA-C-N 113.895 -1.502 . . . . 1.0 111.913 179.368 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 123' ' ' THR . . . . . 0.462 ' C ' ' O ' ' A' ' 122' ' ' GLY . 4.2 t -30.46 93.22 0.01 OUTLIER 'General case' 0 N--CA 1.472 0.675 0 CA-C-N 118.781 1.291 . . . . 1.0 112.33 -178.932 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 124' ' ' ASP . . . . . 0.46 ' N ' ' O ' ' A' ' 122' ' ' GLY . 40.9 m-20 -146.35 143.43 29.09 Favored 'General case' 0 C--N 1.332 -0.159 0 N-CA-C 108.946 -0.761 . . . . 1.0 108.946 179.238 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 125' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -148.01 147.16 29.32 Favored 'General case' 0 CA--C 1.535 0.385 0 N-CA-C 109.695 -0.483 . . . . 1.0 109.695 179.725 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 8.3 mmm180 -146.15 146.24 30.78 Favored 'General case' 0 CA--C 1.536 0.414 0 N-CA-C 109.018 -0.734 . . . . 1.0 109.018 178.622 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 127' ' ' PHE . . . . . 0.534 ' CD2' ' OXT' ' A' ' 127' ' ' PHE . 87.4 t80 . . . . . 0 N--CA 1.473 0.713 0 CA-C-O 118.069 -0.967 . . . . 1.0 110.865 179.557 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 1' ' ' MET . . . . . 0.494 ' C ' ' H ' ' A' ' 3' ' ' ASP . 0.4 OUTLIER . . . . . 0 N--CA 1.489 1.495 0 N-CA-C 108.19 -1.041 . . . . 1.0 108.19 . . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 2' ' ' SER . . . . . 0.55 ' O ' ' CB ' ' A' ' 3' ' ' ASP . 75.0 m -75.61 13.48 0.79 Allowed 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 116.25 -0.432 . . . . 1.0 110.852 179.709 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 3' ' ' ASP . . . . . 0.55 ' CB ' ' O ' ' A' ' 2' ' ' SER . 21.4 t0 135.69 134.15 0.0 OUTLIER 'General case' 0 N--CA 1.478 0.954 0 O-C-N 124.68 1.238 . . . . 1.0 110.346 179.066 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . 0.521 ' N ' ' OD1' ' A' ' 3' ' ' ASP . 71.1 t80 -167.36 91.8 0.38 Allowed 'General case' 0 C--N 1.329 -0.3 0 N-CA-C 114.833 1.42 . . . . 1.0 114.833 175.164 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 65.6 m-20 -73.61 146.78 44.4 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 114.684 -1.144 . . . . 1.0 109.212 178.898 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 6' ' ' THR . . . . . 0.577 ' O ' ' N ' ' A' ' 10' ' ' SER . 58.6 m -56.59 160.48 3.23 Favored 'General case' 0 C--O 1.217 -0.649 0 C-N-CA 120.076 -0.649 . . . . 1.0 109.505 179.519 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . 0.559 ' O ' ' N ' ' A' ' 11' ' ' ARG . 30.6 tt0 -57.07 -60.43 3.6 Favored 'General case' 0 C--N 1.316 -0.855 0 CA-C-O 121.565 0.697 . . . . 1.0 109.372 -178.072 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 8' ' ' ARG . . . . . 0.545 ' CG ' ' H ' ' A' ' 9' ' ' VAL . 48.0 ptt85 -49.36 -52.31 29.08 Favored 'General case' 0 C--N 1.313 -0.987 0 N-CA-C 108.082 -1.081 . . . . 1.0 108.082 -177.472 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . 0.545 ' H ' ' CG ' ' A' ' 8' ' ' ARG . 57.0 t -62.74 -48.02 90.09 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.36 0 CA-C-N 114.837 -1.074 . . . . 1.0 109.262 179.814 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 10' ' ' SER . . . . . 0.577 ' N ' ' O ' ' A' ' 6' ' ' THR . 48.3 t -63.41 -62.31 1.76 Allowed 'General case' 0 N--CA 1.476 0.836 0 CA-C-N 115.835 -0.621 . . . . 1.0 109.979 -179.214 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 11' ' ' ARG . . . . . 0.559 ' N ' ' O ' ' A' ' 7' ' ' GLU . 0.0 OUTLIER -57.42 -57.56 12.13 Favored 'General case' 0 N--CA 1.47 0.55 0 N-CA-C 109.062 -0.718 . . . . 1.0 109.062 -178.671 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . 0.513 ' CB ' ' O ' ' A' ' 8' ' ' ARG . . . -47.99 -48.09 32.74 Favored 'General case' 0 N--CA 1.478 0.954 0 N-CA-C 106.193 -1.78 . . . . 1.0 106.193 -178.198 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . 0.583 ' O ' ' CB ' ' A' ' 17' ' ' LEU . 45.1 t -60.5 -47.89 90.78 Favored 'Isoleucine or valine' 0 C--O 1.203 -1.392 0 C-N-CA 119.078 -1.049 . . . . 1.0 108.886 176.817 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -60.96 -61.91 2.23 Favored 'General case' 0 C--O 1.212 -0.903 0 C-N-CA 119.017 -1.073 . . . . 1.0 110.018 179.145 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . 0.536 ' N ' ' O ' ' A' ' 11' ' ' ARG . . . -51.84 -55.06 22.27 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-O 121.932 0.872 . . . . 1.0 109.228 -177.902 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . 0.479 ' CA ' ' H ' ' A' ' 22' ' ' GLY . . . -61.57 -54.4 43.51 Favored 'General case' 0 C--N 1.311 -1.07 0 CA-C-N 114.135 -1.393 . . . . 1.0 109.113 -179.43 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . 0.583 ' CB ' ' O ' ' A' ' 13' ' ' VAL . 6.8 tt -57.19 -54.16 49.91 Favored 'General case' 0 N--CA 1.484 1.257 0 CA-C-N 114.411 -1.268 . . . . 1.0 109.312 -177.711 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . 0.539 HG23 ' H ' ' A' ' 19' ' ' GLY . 2.6 m -68.45 -56.46 12.4 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.501 0 C-N-CA 119.384 -0.926 . . . . 1.0 109.324 178.893 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . 0.539 ' H ' HG23 ' A' ' 18' ' ' VAL . . . -64.17 -170.7 2.06 Favored Glycine 0 CA--C 1.526 0.731 0 N-CA-C 111.352 -0.699 . . . . 1.0 111.352 -179.568 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 20' ' ' PRO . . . . . 0.522 ' O ' ' N ' ' A' ' 24' ' ' ALA . 1.8 Cg_endo -77.41 -25.12 8.58 Favored 'Trans proline' 0 N--CA 1.494 1.53 0 C-N-CA 123.011 2.474 . . . . 1.0 114.522 -178.561 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -59.33 -58.48 14.19 Favored Glycine 0 N--CA 1.476 1.322 0 C-N-CA 119.894 -1.146 . . . . 1.0 111.358 -177.22 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . 0.479 ' H ' ' CA ' ' A' ' 16' ' ' ALA . . . -57.64 -54.16 39.42 Favored Glycine 0 N--CA 1.471 0.975 0 N-CA-C 106.813 -2.515 . . . . 1.0 106.813 -178.136 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 53.9 t -53.96 -33.03 23.28 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.059 0 CA-C-N 114.543 -0.828 . . . . 1.0 109.069 179.313 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . 0.522 ' N ' ' O ' ' A' ' 20' ' ' PRO . . . -60.73 -61.02 2.89 Favored 'General case' 0 CA--C 1.53 0.204 0 C-N-CA 118.554 -1.258 . . . . 1.0 109.486 179.559 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 3.7 tp -64.34 -47.43 79.4 Favored 'General case' 0 C--N 1.344 0.346 0 N-CA-C 113.497 0.925 . . . . 1.0 113.497 -177.985 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 98.6 t -60.23 -60.58 2.34 Favored 'Isoleucine or valine' 0 C--N 1.339 0.137 0 C-N-CA 118.366 -1.334 . . . . 1.0 110.231 -176.976 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 1.4 p -55.14 -35.23 34.75 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.244 0 CA-C-O 120.869 0.366 . . . . 1.0 111.798 -178.209 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 8.2 tttm -67.56 -54.02 23.41 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-O 121.51 0.671 . . . . 1.0 109.436 -179.016 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 44.2 t -61.75 -49.67 83.34 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.887 0 CA-C-N 114.68 -1.146 . . . . 1.0 111.246 -178.527 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 30' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -64.96 -61.18 2.32 Favored 'General case' 0 CA--C 1.534 0.346 0 C-N-CA 118.542 -1.263 . . . . 1.0 109.905 -179.218 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -60.84 -51.65 68.42 Favored 'General case' 0 CA--C 1.515 -0.396 0 N-CA-C 112.535 0.569 . . . . 1.0 112.535 -176.702 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . 0.489 ' O ' ' CB ' ' A' ' 33' ' ' LEU . . . 81.57 77.19 1.04 Allowed Glycine 0 CA--C 1.523 0.534 0 N-CA-C 108.856 -1.698 . . . . 1.0 108.856 -178.069 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . 0.491 ' O ' ' O ' ' A' ' 36' ' ' VAL . 1.3 tt 84.74 85.41 0.05 OUTLIER Pre-proline 0 CA--C 1.543 0.676 0 N-CA-C 109.523 -0.547 . . . . 1.0 109.523 -178.961 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 77.8 Cg_exo -52.35 -33.05 54.38 Favored 'Trans proline' 0 N--CA 1.51 2.496 0 C-N-CA 123.564 2.842 . . . . 1.0 114.556 -178.504 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -58.98 -58.79 12.69 Favored Glycine 0 CA--C 1.527 0.84 0 C-N-CA 118.974 -1.584 . . . . 1.0 109.843 -178.083 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . 0.547 ' O ' ' CB ' ' A' ' 37' ' ' ILE . 0.4 OUTLIER -94.38 160.62 2.69 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.453 0 N-CA-C 107.083 -1.451 . . . . 1.0 107.083 178.641 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . 0.547 ' CB ' ' O ' ' A' ' 36' ' ' VAL . 5.9 tp 124.63 111.27 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.484 1.272 0 O-C-N 124.141 0.901 . . . . 1.0 109.069 -178.944 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 57.0 m80 -138.39 130.72 28.82 Favored 'General case' 0 C--N 1.329 -0.304 0 N-CA-C 108.044 -1.095 . . . . 1.0 108.044 178.865 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 11.2 t -91.79 153.19 43.69 Favored Pre-proline 0 N--CA 1.467 0.418 0 CA-C-O 119.391 -0.338 . . . . 1.0 110.363 -179.023 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 6.1 Cg_endo -86.11 -38.74 0.09 OUTLIER 'Trans proline' 0 N--CA 1.483 0.881 0 C-N-CA 121.213 1.275 . . . . 1.0 112.828 -179.786 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -125.53 129.88 50.62 Favored 'General case' 0 N--CA 1.47 0.561 0 CA-C-N 116.203 -0.453 . . . . 1.0 109.918 179.361 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . 0.688 HH12 ' CD ' ' A' ' 47' ' ' ARG . 42.0 ttp180 -176.18 168.95 2.84 Favored 'General case' 0 C--N 1.323 -0.584 0 N-CA-C 107.12 -1.437 . . . . 1.0 107.12 177.294 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 43' ' ' ARG . . . . . 0.434 ' N ' ' CG ' ' A' ' 42' ' ' ARG . 0.0 OUTLIER -52.51 -37.34 57.27 Favored 'General case' 0 N--CA 1.449 -0.478 0 CA-C-N 120.114 1.325 . . . . 1.0 109.132 -179.642 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 125.16 -19.62 6.79 Favored Glycine 0 C--N 1.34 0.773 0 N-CA-C 111.079 -0.809 . . . . 1.0 111.079 -179.106 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . 0.499 ' O ' ' CB ' ' A' ' 46' ' ' PHE . 4.5 t80 -149.7 149.94 31.35 Favored 'General case' 0 CA--C 1.538 0.509 0 CA-C-N 117.815 0.808 . . . . 1.0 109.019 179.76 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 46' ' ' PHE . . . . . 0.499 ' CB ' ' O ' ' A' ' 45' ' ' PHE . 3.8 m-30 132.31 86.17 0.0 OUTLIER 'General case' 0 N--CA 1.484 1.239 0 N-CA-C 107.384 -1.339 . . . . 1.0 107.384 -179.559 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 47' ' ' ARG . . . . . 0.688 ' CD ' HH12 ' A' ' 42' ' ' ARG . 5.7 ptp180 132.87 141.91 0.0 OUTLIER 'General case' 0 N--CA 1.485 1.279 0 O-C-N 124.434 1.084 . . . . 1.0 110.932 178.188 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 3.3 m 71.03 71.5 0.18 Allowed 'General case' 0 N--CA 1.455 -0.179 0 N-CA-C 110.286 -0.264 . . . . 1.0 110.286 -179.992 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 69.4 m-80 -132.44 140.32 37.52 Favored Pre-proline 0 C--N 1.33 -0.263 0 N-CA-C 108.007 -1.108 . . . . 1.0 108.007 179.226 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 44.1 Cg_endo -67.86 65.55 0.91 Allowed 'Trans proline' 0 C--N 1.312 -1.394 0 C-N-CA 121.54 1.493 . . . . 1.0 111.374 -179.339 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . 0.525 ' N ' ' OE1' ' A' ' 51' ' ' GLU . 0.0 OUTLIER 64.11 7.48 3.45 Favored 'General case' 0 N--CA 1.463 0.196 0 CA-C-N 114.92 -1.036 . . . . 1.0 111.061 -179.638 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . 0.411 ' HG2' HH11 ' A' ' 52' ' ' ARG . 33.1 mtt-85 -87.97 159.85 18.14 Favored 'General case' 0 C--N 1.331 -0.233 0 N-CA-C 109.572 -0.529 . . . . 1.0 109.572 179.278 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . 0.468 ' O ' ' N ' ' A' ' 55' ' ' ILE . 10.7 tt -79.85 135.54 25.29 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-O 121.87 0.843 . . . . 1.0 111.605 -179.245 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 54' ' ' GLN . . . . . 0.453 ' OE1' ' CE2' ' A' ' 46' ' ' PHE . 5.0 pt20 -61.04 83.24 0.01 OUTLIER 'General case' 0 C--N 1.32 -0.68 0 CA-C-N 114.267 -1.333 . . . . 1.0 109.013 -178.487 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . 0.468 ' N ' ' O ' ' A' ' 53' ' ' ILE . 13.1 tt -149.65 158.64 5.81 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.472 0 CA-C-N 115.717 -0.674 . . . . 1.0 110.547 178.164 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 107.13 -5.33 36.06 Favored Glycine 0 N--CA 1.473 1.15 0 N-CA-C 110.991 -0.844 . . . . 1.0 110.991 179.187 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 3.7 p-10 -81.2 105.58 12.51 Favored 'General case' 0 C--N 1.316 -0.877 0 CA-C-N 114.912 -0.644 . . . . 1.0 110.256 179.769 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 58' ' ' TRP . . . . . . . . . . . . . 1.4 m95 -91.09 173.9 7.7 Favored 'General case' 0 CA--C 1.541 0.6 0 CA-C-O 124.289 1.995 . . . . 1.0 114.836 -177.011 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 31.2 mtm180 -78.54 -62.64 1.62 Allowed 'General case' 0 C--N 1.312 -1.053 0 CA-C-N 109.266 -3.606 . . . . 1.0 111.654 -179.096 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 60' ' ' TYR . . . . . 0.499 ' CG ' ' O ' ' A' ' 60' ' ' TYR . 47.1 t80 -91.95 -11.87 34.98 Favored 'General case' 0 C--O 1.249 1.078 0 N-CA-C 113.621 0.971 . . . . 1.0 113.621 179.612 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 6.7 tt0 -81.63 -15.78 53.55 Favored 'General case' 0 N--CA 1.443 -0.82 0 O-C-N 120.686 -1.259 . . . . 1.0 111.804 -178.689 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 62' ' ' VAL . . . . . 0.568 ' O ' ' N ' ' A' ' 66' ' ' GLY . 0.0 OUTLIER -46.57 -52.65 3.47 Favored 'Isoleucine or valine' 0 C--O 1.208 -1.095 0 C-N-CA 120.231 -0.588 . . . . 1.0 111.719 -174.524 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -69.1 -46.4 67.82 Favored 'General case' 0 C--N 1.311 -1.098 0 C-N-CA 119.376 -0.93 . . . . 1.0 109.616 -179.218 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 3.0 m-70 -50.57 -55.4 16.41 Favored 'General case' 0 N--CA 1.469 0.483 0 C-N-CA 119.08 -1.048 . . . . 1.0 108.823 179.222 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 65' ' ' ASP . . . . . 0.74 ' C ' ' H ' ' A' ' 67' ' ' ARG . 34.3 m-20 -73.58 -48.99 28.53 Favored 'General case' 0 C--O 1.244 0.765 0 CA-C-O 121.214 0.53 . . . . 1.0 109.886 178.714 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . 0.568 ' N ' ' O ' ' A' ' 62' ' ' VAL . . . -65.77 27.92 0.14 Allowed Glycine 0 N--CA 1.451 -0.351 0 N-CA-C 110.152 -1.179 . . . . 1.0 110.152 177.396 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 67' ' ' ARG . . . . . 0.74 ' H ' ' C ' ' A' ' 65' ' ' ASP . 0.0 OUTLIER -73.4 0.34 12.51 Favored 'General case' 0 N--CA 1.433 -1.321 0 N-CA-C 105.869 -1.901 . . . . 1.0 105.869 174.058 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . 0.466 ' H ' ' C ' ' A' ' 66' ' ' GLY . 1.0 OUTLIER -39.05 -39.3 0.54 Allowed 'General case' 0 C--N 1.346 0.434 0 CA-C-N 116.162 -0.472 . . . . 1.0 110.478 -177.978 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -64.5 -69.08 0.31 Allowed 'General case' 0 N--CA 1.48 1.044 0 C-N-CA 119.258 -0.977 . . . . 1.0 113.34 -175.662 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . 0.536 ' C ' ' H ' ' A' ' 72' ' ' HIS . . . -77.07 -79.07 0.11 Allowed 'General case' 0 CA--C 1.512 -0.483 0 C-N-CA 117.957 -1.497 . . . . 1.0 110.107 -176.037 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 71' ' ' ALA . . . . . 0.778 ' O ' ' N ' ' A' ' 73' ' ' MET . . . -65.24 14.95 0.03 OUTLIER 'General case' 0 C--N 1.312 -1.035 0 C-N-CA 124.784 1.234 . . . . 1.0 112.85 -178.365 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 72' ' ' HIS . . . . . 0.536 ' H ' ' C ' ' A' ' 70' ' ' ALA . 0.8 OUTLIER -18.55 -32.97 0.0 OUTLIER 'General case' 0 N--CA 1.467 0.404 0 O-C-N 124.315 1.01 . . . . 1.0 113.197 -175.036 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 73' ' ' MET . . . . . 0.778 ' N ' ' O ' ' A' ' 71' ' ' ALA . 8.6 ptp -61.15 -53.13 60.8 Favored 'General case' 0 C--N 1.319 -0.76 0 C-N-CA 118.755 -1.178 . . . . 1.0 108.465 176.49 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . 0.713 ' O ' ' N ' ' A' ' 76' ' ' GLY . 34.2 m -44.65 -51.64 1.84 Allowed 'Isoleucine or valine' 0 C--O 1.206 -1.219 0 CA-C-O 116.363 -1.78 . . . . 1.0 112.426 -175.112 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 75' ' ' ASN . . . . . 0.413 ' C ' ' O ' ' A' ' 74' ' ' VAL . 5.9 t30 -36.68 -17.21 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.49 0 CA-C-N 122.472 2.396 . . . . 1.0 111.604 -179.231 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 76' ' ' GLY . . . . . 0.713 ' N ' ' O ' ' A' ' 74' ' ' VAL . . . -54.39 -23.66 27.54 Favored Glycine 0 CA--C 1.532 1.115 0 N-CA-C 107.178 -2.369 . . . . 1.0 107.178 174.252 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 77' ' ' ILE . . . . . 0.484 ' N ' ' O ' ' A' ' 74' ' ' VAL . 18.2 pt -51.06 -48.98 29.55 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.033 0 CA-C-O 118.457 -0.782 . . . . 1.0 109.874 -179.793 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 19.3 t -55.97 -19.73 7.65 Favored 'Isoleucine or valine' 0 C--N 1.345 0.409 0 CA-C-N 120.94 1.7 . . . . 1.0 112.833 178.775 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . 0.459 HG13 ' N ' ' A' ' 80' ' ' ALA . 0.6 OUTLIER -90.6 -44.71 14.79 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.402 0 C-N-CA 119.683 -0.807 . . . . 1.0 109.855 179.077 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 80' ' ' ALA . . . . . 0.459 ' N ' HG13 ' A' ' 79' ' ' ILE . . . -80.04 -17.59 52.37 Favored 'General case' 0 C--N 1.323 -0.546 0 N-CA-C 113.267 0.84 . . . . 1.0 113.267 -179.587 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 81' ' ' GLU . . . . . 0.587 ' CG ' ' H ' ' A' ' 82' ' ' ASP . 10.2 pt-20 -94.18 -70.66 0.7 Allowed 'General case' 0 CA--C 1.537 0.463 0 C-N-CA 119.624 -0.83 . . . . 1.0 113.206 -177.987 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 82' ' ' ASP . . . . . 0.587 ' H ' ' CG ' ' A' ' 81' ' ' GLU . 13.4 t70 -90.62 -14.27 32.71 Favored 'General case' 0 CA--C 1.537 0.472 0 N-CA-C 114.821 1.415 . . . . 1.0 114.821 -178.49 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . 0.515 ' O ' ' N ' ' A' ' 86' ' ' ALA . . . -52.16 -46.32 65.41 Favored 'General case' 0 C--O 1.22 -0.498 0 C-N-CA 117.644 -1.622 . . . . 1.0 111.203 -178.924 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . 0.404 ' C ' ' O ' ' A' ' 83' ' ' ALA . 0.1 OUTLIER -39.34 -25.79 0.02 OUTLIER 'General case' 0 N--CA 1.469 0.499 0 O-C-N 121.427 -0.795 . . . . 1.0 111.533 -179.605 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 85' ' ' ILE . . . . . 0.499 ' N ' ' O ' ' A' ' 83' ' ' ALA . 3.2 tt -91.18 -34.41 6.34 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.327 0 C-N-CA 120.851 -0.339 . . . . 1.0 110.236 179.119 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 86' ' ' ALA . . . . . 0.515 ' N ' ' O ' ' A' ' 83' ' ' ALA . . . -95.52 -29.0 14.6 Favored 'General case' 0 C--O 1.207 -1.16 0 O-C-N 122.038 -0.414 . . . . 1.0 111.572 178.994 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 87' ' ' GLU . . . . . 0.557 ' C ' ' H ' ' A' ' 89' ' ' VAL . 0.3 OUTLIER -61.59 -17.34 54.72 Favored 'General case' 0 C--N 1.321 -0.673 0 O-C-N 121.237 -0.914 . . . . 1.0 110.077 -179.262 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 88' ' ' ALA . . . . . 0.422 ' N ' ' OE1' ' A' ' 87' ' ' GLU . . . -73.89 -4.59 35.94 Favored 'General case' 0 N--CA 1.477 0.888 0 CA-C-O 123.549 1.643 . . . . 1.0 106.759 177.163 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 89' ' ' VAL . . . . . 0.557 ' H ' ' C ' ' A' ' 87' ' ' GLU . 26.0 t -80.96 39.51 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.44 -0.964 0 CA-C-N 110.91 -2.859 . . . . 1.0 108.178 175.866 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 90' ' ' GLY . . . . . 0.844 ' O ' ' N ' ' A' ' 92' ' ' HIS . . . -56.91 -29.02 58.46 Favored Glycine 0 C--N 1.37 2.461 0 CA-C-O 117.423 -1.765 . . . . 1.0 111.844 177.337 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 91' ' ' PRO . . . . . 0.547 ' HD2' ' N ' ' A' ' 90' ' ' GLY . 52.2 Cg_exo -38.36 -2.19 0.0 OUTLIER 'Trans proline' 0 N--CA 1.498 1.75 0 CA-C-N 121.672 2.736 . . . . 1.0 111.728 173.945 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 92' ' ' HIS . . . . . 0.844 ' N ' ' O ' ' A' ' 90' ' ' GLY . 18.1 p-80 -50.19 -31.3 13.44 Favored 'General case' 0 N--CA 1.432 -1.365 0 N-CA-C 106.966 -1.494 . . . . 1.0 106.966 179.243 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 93' ' ' LEU . . . . . 0.403 ' O ' ' HB2' ' A' ' 96' ' ' ALA . 1.5 tt -61.02 -50.13 74.6 Favored 'General case' 0 C--O 1.222 -0.36 0 N-CA-C 106.995 -1.483 . . . . 1.0 106.995 176.367 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 94' ' ' ALA . . . . . 0.479 ' N ' ' O ' ' A' ' 91' ' ' PRO . . . -52.04 -54.91 24.41 Favored 'General case' 0 C--N 1.322 -0.628 0 N-CA-C 107.586 -1.264 . . . . 1.0 107.586 179.644 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -63.63 -29.72 70.93 Favored 'General case' 0 CA--C 1.543 0.685 0 CA-C-O 121.537 0.684 . . . . 1.0 109.574 178.405 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 96' ' ' ALA . . . . . 0.783 ' O ' ' N ' ' A' ' 100' ' ' ILE . . . -50.9 -42.94 59.65 Favored 'General case' 0 C--O 1.197 -1.691 0 N-CA-C 106.799 -1.556 . . . . 1.0 106.799 -177.754 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 97' ' ' LEU . . . . . 0.517 ' O ' ' CG2' ' A' ' 100' ' ' ILE . 0.3 OUTLIER -35.61 -23.05 0.01 OUTLIER 'General case' 0 CA--C 1.594 2.641 0 CA-C-N 114.18 -1.373 . . . . 1.0 108.005 -177.156 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 98' ' ' GLY . . . . . 0.674 ' N ' ' O ' ' A' ' 96' ' ' ALA . . . -86.06 -50.23 3.97 Favored Glycine 0 CA--C 1.562 3.011 0 CA-C-O 123.057 1.365 . . . . 1.0 111.286 169.713 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 99' ' ' GLN . . . . . 0.692 ' N ' ' O ' ' A' ' 96' ' ' ALA . 0.0 OUTLIER -76.59 7.16 4.82 Favored 'General case' 0 N--CA 1.441 -0.878 0 N-CA-C 106.391 -1.707 . . . . 1.0 106.391 177.142 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 100' ' ' ILE . . . . . 0.783 ' N ' ' O ' ' A' ' 96' ' ' ALA . 17.7 tt -58.12 -55.4 22.31 Favored 'Isoleucine or valine' 0 CA--C 1.481 -1.69 0 N-CA-C 106.232 -1.766 . . . . 1.0 106.232 177.438 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 101' ' ' VAL . . . . . 0.684 ' O ' ' N ' ' A' ' 105' ' ' GLY . 7.0 p -57.49 -60.04 2.58 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.579 0 C-N-CA 118.368 -1.333 . . . . 1.0 107.871 178.668 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 102' ' ' CYS . . . . . 0.552 ' H ' ' CG1' ' A' ' 101' ' ' VAL . 18.2 t -52.48 -26.26 12.45 Favored 'General case' 0 C--N 1.32 -0.707 0 N-CA-C 112.712 0.634 . . . . 1.0 112.712 -177.324 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 103' ' ' ARG . . . . . 0.536 ' N ' ' O ' ' A' ' 99' ' ' GLN . 45.6 ttt180 -86.23 -49.31 7.8 Favored 'General case' 0 N--CA 1.49 1.568 0 CA-C-O 122.763 1.268 . . . . 1.0 112.686 179.019 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 104' ' ' TYR . . . . . 0.686 ' CG ' ' O ' ' A' ' 104' ' ' TYR . 0.0 OUTLIER -97.04 24.13 6.59 Favored 'General case' 0 C--N 1.295 -1.8 0 CA-C-N 112.258 -2.246 . . . . 1.0 107.571 178.618 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 105' ' ' GLY . . . . . 0.684 ' N ' ' O ' ' A' ' 101' ' ' VAL . . . -164.92 -96.84 0.11 Allowed Glycine 0 CA--C 1.533 1.206 0 N-CA-C 108.166 -1.974 . . . . 1.0 108.166 179.081 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 106' ' ' ALA . . . . . 0.422 ' C ' ' H ' ' A' ' 108' ' ' VAL . . . 68.4 55.68 0.5 Allowed 'General case' 0 CA--C 1.534 0.351 0 C-N-CA 122.989 0.515 . . . . 1.0 111.747 -178.886 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 91.8 m -80.32 6.1 12.96 Favored 'General case' 0 CA--C 1.514 -0.407 0 N-CA-C 107.222 -1.399 . . . . 1.0 107.222 177.033 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 108' ' ' VAL . . . . . 0.422 ' H ' ' C ' ' A' ' 106' ' ' ALA . 18.0 m -84.4 -54.03 9.68 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.242 0 CA-C-N 115.575 -0.739 . . . . 1.0 110.472 178.721 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 109' ' ' ILE . . . . . 0.477 ' O ' ' N ' ' A' ' 113' ' ' ASN . 85.4 mt -41.99 -51.89 9.69 Favored Pre-proline 0 C--N 1.347 0.46 0 N-CA-C 114.805 1.409 . . . . 1.0 114.805 -179.446 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 110' ' ' PRO . . . . . 0.445 ' HD2' ' N ' ' A' ' 109' ' ' ILE . 2.3 Cg_endo -40.68 -52.02 3.34 Favored 'Trans proline' 0 C--N 1.314 -1.286 0 CA-C-N 120.618 1.257 . . . . 1.0 113.293 -176.407 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 111' ' ' ASN . . . . . 0.439 ' ND2' ' H ' ' A' ' 112' ' ' ILE . 0.8 OUTLIER -69.51 -69.12 0.36 Allowed 'General case' 0 C--O 1.233 0.222 0 C-N-CA 118.229 -1.389 . . . . 1.0 110.444 -178.403 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 112' ' ' ILE . . . . . 0.439 ' H ' ' ND2' ' A' ' 111' ' ' ASN . 0.0 OUTLIER -46.97 -27.62 0.91 Allowed 'Isoleucine or valine' 0 C--O 1.216 -0.672 0 N-CA-C 109.174 -0.676 . . . . 1.0 109.174 -179.947 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 113' ' ' ASN . . . . . 0.477 ' N ' ' O ' ' A' ' 109' ' ' ILE . 16.4 t-20 -58.19 -54.55 45.76 Favored 'General case' 0 C--N 1.308 -1.198 0 C-N-CA 118.131 -1.428 . . . . 1.0 108.096 -177.928 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 114' ' ' ALA . . . . . 0.438 ' O ' ' HG2' ' A' ' 117' ' ' GLU . . . -58.69 -33.9 70.67 Favored 'General case' 0 N--CA 1.447 -0.611 0 N-CA-C 113.116 0.784 . . . . 1.0 113.116 -178.633 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -82.99 -49.44 9.58 Favored 'General case' 0 C--O 1.215 -0.761 0 O-C-N 120.426 -1.421 . . . . 1.0 110.8 179.173 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 116' ' ' ILE . . . . . 0.461 ' O ' ' N ' ' A' ' 120' ' ' GLY . 0.6 OUTLIER -50.91 -54.92 8.51 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.184 0 N-CA-C 107.345 -1.354 . . . . 1.0 107.345 -179.415 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 117' ' ' GLU . . . . . 0.466 ' CG ' ' N ' ' A' ' 118' ' ' VAL . 17.5 pt-20 -45.96 -58.11 3.83 Favored 'General case' 0 C--O 1.212 -0.898 0 CA-C-N 113.175 -1.83 . . . . 1.0 106.136 -179.052 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 118' ' ' VAL . . . . . 0.466 ' N ' ' CG ' ' A' ' 117' ' ' GLU . 57.7 t -58.36 -53.35 47.51 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.133 0 C-N-CA 119.89 -0.724 . . . . 1.0 110.207 179.068 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 13.2 tp -53.76 -73.04 0.05 OUTLIER 'General case' 0 CA--C 1.54 0.581 0 N-CA-C 108.129 -1.063 . . . . 1.0 108.129 -178.66 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 120' ' ' GLY . . . . . 0.512 ' O ' ' CB ' ' A' ' 121' ' ' THR . . . -67.82 -76.11 0.43 Allowed Glycine 0 CA--C 1.54 1.603 0 C-N-CA 118.948 -1.596 . . . . 1.0 111.026 179.165 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 121' ' ' THR . . . . . 0.512 ' CB ' ' O ' ' A' ' 120' ' ' GLY . 2.3 m 144.92 -27.4 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.434 0 CA-C-N 112.536 -1.832 . . . . 1.0 111.026 -178.381 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 122' ' ' GLY . . . . . 0.659 ' O ' ' N ' ' A' ' 124' ' ' ASP . . . 104.72 -17.94 44.87 Favored Glycine 0 C--O 1.223 -0.577 0 N-CA-C 107.944 -2.062 . . . . 1.0 107.944 -177.0 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 123' ' ' THR . . . . . 0.438 ' O ' ' CG2' ' A' ' 123' ' ' THR . 11.0 t -54.41 83.52 0.0 OUTLIER 'General case' 0 CA--C 1.532 0.275 0 N-CA-C 106.351 -1.722 . . . . 1.0 106.351 178.617 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 124' ' ' ASP . . . . . 0.659 ' N ' ' O ' ' A' ' 122' ' ' GLY . 48.5 p-10 -166.93 176.77 6.77 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 113.539 -1.664 . . . . 1.0 111.375 179.285 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 125' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -146.76 144.63 29.53 Favored 'General case' 0 CA--C 1.541 0.605 0 N-CA-C 108.364 -0.976 . . . . 1.0 108.364 176.904 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 38.0 ttm180 -149.84 151.74 34.0 Favored 'General case' 0 N--CA 1.471 0.588 0 CA-C-O 120.534 0.207 . . . . 1.0 110.935 178.844 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 127' ' ' PHE . . . . . . . . . . . . . 13.9 p90 . . . . . 0 C--O 1.219 -0.506 0 CA-C-O 117.958 -1.02 . . . . 1.0 110.646 -179.985 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 1' ' ' MET . . . . . 0.513 ' N ' ' SD ' ' A' ' 1' ' ' MET . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.558 0 N-CA-C 108.862 -0.792 . . . . 1.0 108.862 . . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 2' ' ' SER . . . . . 0.508 ' O ' ' CG ' ' A' ' 3' ' ' ASP . 70.8 m -72.4 7.71 1.68 Allowed 'General case' 0 C--O 1.223 -0.31 0 CA-C-O 119.43 -0.319 . . . . 1.0 110.844 179.474 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 3' ' ' ASP . . . . . 0.508 ' CG ' ' O ' ' A' ' 2' ' ' SER . 62.1 m-20 144.16 137.39 0.0 OUTLIER 'General case' 0 N--CA 1.482 1.141 0 O-C-N 124.189 0.93 . . . . 1.0 110.097 179.239 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 91.4 t80 -154.92 150.46 27.44 Favored 'General case' 0 N--CA 1.465 0.296 0 CA-C-N 116.073 -0.512 . . . . 1.0 110.88 179.214 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -150.13 145.23 26.19 Favored 'General case' 0 CA--C 1.543 0.686 0 N-CA-C 109.553 -0.536 . . . . 1.0 109.553 179.465 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 6' ' ' THR . . . . . 0.843 ' O ' ' N ' ' A' ' 10' ' ' SER . 0.2 OUTLIER -87.14 176.71 7.46 Favored 'General case' 0 C--O 1.179 -2.627 0 CA-C-O 120.43 0.157 . . . . 1.0 111.236 -179.27 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . 0.598 ' O ' ' N ' ' A' ' 11' ' ' ARG . 10.9 mt-10 -60.65 -50.68 72.53 Favored 'General case' 0 C--N 1.312 -1.056 0 CA-C-O 121.194 0.521 . . . . 1.0 109.713 -179.405 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 8' ' ' ARG . . . . . 0.496 ' O ' ' CB ' ' A' ' 12' ' ' ALA . 18.6 mtp-105 -57.95 -58.93 6.23 Favored 'General case' 0 C--N 1.315 -0.916 0 C-N-CA 118.416 -1.313 . . . . 1.0 107.536 -179.011 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . 0.639 ' O ' ' HB ' ' A' ' 13' ' ' VAL . 0.0 OUTLIER -66.82 -50.83 61.82 Favored 'Isoleucine or valine' 0 C--O 1.183 -2.418 0 CA-C-N 114.267 -1.333 . . . . 1.0 109.287 179.686 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 10' ' ' SER . . . . . 0.843 ' N ' ' O ' ' A' ' 6' ' ' THR . 19.3 t -63.84 -61.16 2.47 Favored 'General case' 0 N--CA 1.492 1.669 0 C-N-CA 119.437 -0.905 . . . . 1.0 110.268 179.171 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 11' ' ' ARG . . . . . 0.598 ' N ' ' O ' ' A' ' 7' ' ' GLU . 5.3 tpt180 -67.39 -54.32 21.5 Favored 'General case' 0 C--O 1.214 -0.797 0 N-CA-C 112.546 0.573 . . . . 1.0 112.546 -176.674 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . 0.496 ' CB ' ' O ' ' A' ' 8' ' ' ARG . . . -56.06 -50.7 70.22 Favored 'General case' 0 N--CA 1.476 0.862 0 C-N-CA 117.023 -1.871 . . . . 1.0 106.565 -178.09 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . 0.676 ' O ' ' N ' ' A' ' 17' ' ' LEU . 65.7 t -61.25 -48.49 88.7 Favored 'Isoleucine or valine' 0 C--O 1.18 -2.593 0 N-CA-C 107.033 -1.469 . . . . 1.0 107.033 178.659 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . 0.556 ' N ' ' O ' ' A' ' 10' ' ' SER . . . -59.32 -61.56 2.53 Favored 'General case' 0 C--O 1.201 -1.467 0 C-N-CA 118.132 -1.427 . . . . 1.0 109.696 179.253 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . 0.597 ' N ' ' O ' ' A' ' 11' ' ' ARG . . . -52.57 -53.38 47.29 Favored 'General case' 0 C--O 1.216 -0.685 0 N-CA-C 108.576 -0.898 . . . . 1.0 108.576 -178.456 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . 0.636 ' CA ' ' H ' ' A' ' 22' ' ' GLY . . . -65.42 -57.15 9.02 Favored 'General case' 0 CA--C 1.546 0.792 0 CA-C-O 121.663 0.744 . . . . 1.0 109.951 -179.747 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . 0.676 ' N ' ' O ' ' A' ' 13' ' ' VAL . 18.7 tp -55.74 -55.98 25.93 Favored 'General case' 0 N--CA 1.491 1.582 0 N-CA-C 107.953 -1.128 . . . . 1.0 107.953 -178.929 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . 0.619 HG22 ' H ' ' A' ' 19' ' ' GLY . 1.2 m -70.89 -59.02 3.87 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.397 0 C-N-CA 119.854 -0.738 . . . . 1.0 110.136 -179.896 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . 0.619 ' H ' HG22 ' A' ' 18' ' ' VAL . . . -60.75 -161.93 0.13 Allowed Glycine 0 C--N 1.338 0.651 0 N-CA-C 111.819 -0.512 . . . . 1.0 111.819 -178.399 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 20' ' ' PRO . . . . . 0.509 ' O ' ' CB ' ' A' ' 24' ' ' ALA . 86.3 Cg_endo -81.23 -23.1 5.43 Favored 'Trans proline' 0 C--N 1.318 -1.04 0 C-N-CA 123.165 2.577 . . . . 1.0 113.682 -177.979 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -63.35 -62.29 5.52 Favored Glycine 0 N--CA 1.484 1.847 0 C-N-CA 120.178 -1.01 . . . . 1.0 112.996 -176.406 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . 0.636 ' H ' ' CA ' ' A' ' 16' ' ' ALA . . . -57.61 -57.61 18.87 Favored Glycine 0 C--N 1.312 -0.784 0 N-CA-C 107.349 -2.301 . . . . 1.0 107.349 -177.845 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 34.3 m -56.63 -32.28 36.94 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.744 0 C-N-CA 118.773 -1.171 . . . . 1.0 109.294 -179.977 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . 0.509 ' CB ' ' O ' ' A' ' 20' ' ' PRO . . . -60.5 -62.13 2.09 Favored 'General case' 0 N--CA 1.471 0.6 0 C-N-CA 118.142 -1.423 . . . . 1.0 110.117 179.745 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 18.4 mt -61.38 -47.8 84.17 Favored 'General case' 0 CA--C 1.514 -0.43 0 CA-C-N 118.616 0.644 . . . . 1.0 112.137 -177.28 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 90.5 t -58.55 -59.14 4.04 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.535 0 C-N-CA 119.29 -0.964 . . . . 1.0 109.61 -177.846 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . 0.452 ' O ' ' CB ' ' A' ' 31' ' ' ALA . 84.8 t -57.28 -38.65 63.12 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.462 0 CA-C-O 120.866 0.365 . . . . 1.0 110.482 -178.236 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 9.2 ttmt -66.37 -55.33 16.38 Favored 'General case' 0 C--N 1.316 -0.876 0 C-N-CA 119.686 -0.806 . . . . 1.0 109.956 -178.873 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 92.3 t -63.73 -51.39 70.53 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.777 0 CA-C-N 114.903 -1.044 . . . . 1.0 110.917 -176.541 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 30' ' ' CYS . . . . . . . . . . . . . 50.1 t -64.54 -61.55 2.14 Favored 'General case' 0 N--CA 1.443 -0.779 0 C-N-CA 119.407 -0.917 . . . . 1.0 109.889 -179.084 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . 0.452 ' CB ' ' O ' ' A' ' 27' ' ' VAL . . . -59.3 -53.54 57.12 Favored 'General case' 0 C--N 1.318 -0.773 0 CA-C-O 120.874 0.369 . . . . 1.0 111.354 -177.295 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . 0.519 ' O ' ' CB ' ' A' ' 33' ' ' LEU . . . 80.29 69.68 1.38 Allowed Glycine 0 CA--C 1.521 0.418 0 N-CA-C 109.898 -1.281 . . . . 1.0 109.898 -179.77 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . 0.568 ' CD2' ' H ' ' A' ' 35' ' ' GLY . 2.0 tt 88.96 101.6 0.03 OUTLIER Pre-proline 0 CA--C 1.545 0.781 0 CA-C-N 115.442 -0.379 . . . . 1.0 110.553 -179.821 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 51.7 Cg_exo -51.86 -21.97 12.94 Favored 'Trans proline' 0 N--CA 1.503 2.05 0 C-N-CA 122.328 2.018 . . . . 1.0 113.939 179.745 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . 0.568 ' H ' ' CD2' ' A' ' 33' ' ' LEU . . . -62.12 -62.3 5.8 Favored Glycine 0 C--N 1.34 0.796 0 C-N-CA 119.263 -1.446 . . . . 1.0 109.952 -178.389 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . 0.609 ' CG2' ' H ' ' A' ' 37' ' ' ILE . 8.4 p -73.37 -152.88 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.325 -0.488 0 N-CA-C 107.96 -1.126 . . . . 1.0 107.96 178.333 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . 0.609 ' H ' ' CG2' ' A' ' 36' ' ' VAL . 2.1 mm 70.96 79.33 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.475 0.804 0 CA-C-O 122.069 0.938 . . . . 1.0 112.79 179.598 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 88.0 m-70 -135.32 129.56 33.68 Favored 'General case' 0 C--N 1.318 -0.763 0 N-CA-C 106.826 -1.546 . . . . 1.0 106.826 176.971 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 25.1 m -120.44 132.2 24.21 Favored Pre-proline 0 N--CA 1.465 0.297 0 N-CA-C 110.073 -0.343 . . . . 1.0 110.073 -178.883 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 27.7 Cg_endo -62.98 -78.17 0.01 OUTLIER 'Trans proline' 0 N--CA 1.49 1.311 0 CA-C-N 119.654 0.912 . . . . 1.0 111.898 -179.457 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -67.72 125.65 26.9 Favored 'General case' 0 C--N 1.317 -0.844 0 CA-C-N 114.859 -1.064 . . . . 1.0 110.613 -178.805 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . 0.526 ' HG2' ' H ' ' A' ' 43' ' ' ARG . 31.0 ttp180 -173.28 174.52 3.33 Favored 'General case' 0 C--N 1.32 -0.674 0 CA-C-N 115.832 -0.622 . . . . 1.0 109.982 179.516 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 43' ' ' ARG . . . . . 0.56 ' NH1' ' OD2' ' A' ' 57' ' ' ASP . 1.1 tmt_? -58.08 -45.19 87.55 Favored 'General case' 0 CA--C 1.541 0.598 0 N-CA-C 107.1 -1.444 . . . . 1.0 107.1 179.528 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . 0.476 ' O ' ' CD1' ' A' ' 45' ' ' PHE . . . 123.58 -25.12 6.31 Favored Glycine 0 CA--C 1.533 1.173 0 CA-C-O 119.852 -0.416 . . . . 1.0 112.147 179.138 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . 0.593 ' O ' ' HB2' ' A' ' 46' ' ' PHE . 7.5 m-85 -156.52 162.92 39.91 Favored 'General case' 0 N--CA 1.474 0.749 0 N-CA-C 109.111 -0.7 . . . . 1.0 109.111 177.726 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 46' ' ' PHE . . . . . 0.65 ' O ' ' CG ' ' A' ' 47' ' ' ARG . 6.9 m-85 118.41 104.08 0.0 OUTLIER 'General case' 0 N--CA 1.499 2.001 0 O-C-N 125.375 1.672 . . . . 1.0 110.592 -179.743 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 47' ' ' ARG . . . . . 0.756 ' O ' ' SG ' ' A' ' 48' ' ' CYS . 0.0 OUTLIER 98.42 162.78 0.01 OUTLIER 'General case' 0 N--CA 1.472 0.64 0 O-C-N 125.08 1.488 . . . . 1.0 111.434 178.232 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 48' ' ' CYS . . . . . 0.756 ' SG ' ' O ' ' A' ' 47' ' ' ARG . 7.0 p 56.66 72.08 0.53 Allowed 'General case' 0 C--O 1.202 -1.416 0 O-C-N 125.081 1.488 . . . . 1.0 110.567 -177.591 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 49' ' ' ASN . . . . . 0.697 ' O ' ' N ' ' A' ' 51' ' ' GLU . 0.5 OUTLIER -144.66 155.45 56.53 Favored Pre-proline 0 N--CA 1.474 0.728 0 CA-C-O 118.753 -0.642 . . . . 1.0 110.438 179.752 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 50' ' ' PRO . . . . . 0.501 ' C ' ' H ' ' A' ' 52' ' ' ARG . 53.9 Cg_exo -51.8 57.75 0.02 OUTLIER 'Trans proline' 0 N--CA 1.509 2.419 0 C-N-CA 122.688 2.259 . . . . 1.0 112.138 177.775 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . 0.697 ' N ' ' O ' ' A' ' 49' ' ' ASN . 59.2 mm-40 47.93 13.56 0.04 OUTLIER 'General case' 0 C--N 1.321 -0.658 0 N-CA-C 110.029 -0.36 . . . . 1.0 110.029 -179.129 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . 0.634 HH11 ' CE1' ' A' ' 92' ' ' HIS . 23.5 mtm-85 -100.08 142.86 30.99 Favored 'General case' 0 N--CA 1.475 0.806 0 CA-C-O 121.204 0.526 . . . . 1.0 112.052 -179.857 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 9.6 tp -53.29 135.89 14.92 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.648 0 CA-C-O 124.426 2.06 . . . . 1.0 114.579 -178.661 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -88.62 88.02 7.47 Favored 'General case' 0 C--N 1.312 -1.022 0 CA-C-N 110.063 -3.244 . . . . 1.0 113.643 179.567 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 18.6 tt -144.47 153.34 15.06 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.67 0 CA-C-N 115.478 -0.783 . . . . 1.0 109.678 177.273 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 107.76 3.1 34.61 Favored Glycine 0 C--N 1.348 1.226 0 N-CA-C 110.878 -0.889 . . . . 1.0 110.878 -179.891 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . 0.56 ' OD2' ' NH1' ' A' ' 43' ' ' ARG . 5.6 p-10 -86.88 103.38 15.22 Favored 'General case' 0 CA--C 1.533 0.292 0 CA-C-O 122.185 0.993 . . . . 1.0 112.651 -178.834 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 58' ' ' TRP . . . . . . . . . . . . . 38.4 m0 -81.39 -177.97 6.73 Favored 'General case' 0 N--CA 1.47 0.563 0 CA-C-N 114.023 -1.444 . . . . 1.0 108.154 178.205 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 59' ' ' ARG . . . . . 0.673 ' HD2' ' H ' ' A' ' 59' ' ' ARG . 0.0 OUTLIER -101.85 -54.86 2.63 Favored 'General case' 0 CA--C 1.56 1.359 0 CA-C-N 121.91 2.141 . . . . 1.0 110.74 179.676 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 60' ' ' TYR . . . . . 0.461 ' H ' ' HD2' ' A' ' 59' ' ' ARG . 93.2 t80 -79.45 -14.34 58.98 Favored 'General case' 0 N--CA 1.485 1.305 0 C-N-CA 125.723 1.609 . . . . 1.0 112.225 -178.283 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 31.9 tt0 -70.77 -14.11 62.31 Favored 'General case' 0 C--N 1.304 -1.387 0 N-CA-C 108.635 -0.876 . . . . 1.0 108.635 -179.874 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 62' ' ' VAL . . . . . 0.416 ' O ' ' N ' ' A' ' 66' ' ' GLY . 13.4 m -45.7 -53.07 2.29 Favored 'Isoleucine or valine' 0 CA--C 1.493 -1.244 0 CA-C-N 115.811 -0.632 . . . . 1.0 109.972 -174.495 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 63' ' ' ALA . . . . . 0.789 ' O ' ' HD2' ' A' ' 67' ' ' ARG . . . -65.2 -50.39 66.06 Favored 'General case' 0 N--CA 1.415 -2.189 0 N-CA-C 108.943 -0.762 . . . . 1.0 108.943 179.364 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -51.03 -59.39 4.21 Favored 'General case' 0 CA--C 1.548 0.904 0 C-N-CA 119.795 -0.762 . . . . 1.0 110.715 -179.996 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 65' ' ' ASP . . . . . 0.59 ' C ' ' H ' ' A' ' 67' ' ' ARG . 28.9 t70 -64.79 -50.34 67.16 Favored 'General case' 0 C--O 1.241 0.632 0 CA-C-O 121.694 0.759 . . . . 1.0 109.704 178.371 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . 0.416 ' N ' ' O ' ' A' ' 62' ' ' VAL . . . -61.34 29.53 0.05 OUTLIER Glycine 0 CA--C 1.535 1.325 0 O-C-N 121.801 -0.562 . . . . 1.0 112.016 178.106 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 67' ' ' ARG . . . . . 0.789 ' HD2' ' O ' ' A' ' 63' ' ' ALA . 0.0 OUTLIER -79.58 -2.84 44.29 Favored 'General case' 0 CA--C 1.5 -0.946 0 CA-C-O 118.632 -0.699 . . . . 1.0 109.371 175.206 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . 0.555 ' O ' ' CG ' ' A' ' 72' ' ' HIS . 11.1 mp -33.94 -28.06 0.01 OUTLIER 'General case' 0 N--CA 1.486 1.327 0 N-CA-C 107.023 -1.473 . . . . 1.0 107.023 -179.012 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . 0.674 ' N ' ' O ' ' A' ' 67' ' ' ARG . 3.4 tt -64.83 -64.23 0.92 Allowed 'General case' 0 CA--C 1.548 0.898 0 N-CA-C 106.572 -1.64 . . . . 1.0 106.572 175.573 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . 0.704 ' C ' ' H ' ' A' ' 72' ' ' HIS . . . -78.76 -73.53 0.32 Allowed 'General case' 0 N--CA 1.478 0.948 0 N-CA-C 107.828 -1.175 . . . . 1.0 107.828 177.865 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 71' ' ' ALA . . . . . 0.628 ' H ' ' HB3' ' A' ' 67' ' ' ARG . . . -46.23 2.34 0.0 OUTLIER 'General case' 0 N--CA 1.469 0.499 0 C-N-CA 124.435 1.094 . . . . 1.0 112.747 178.402 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 72' ' ' HIS . . . . . 0.704 ' H ' ' C ' ' A' ' 70' ' ' ALA . 0.2 OUTLIER -20.02 -70.53 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.227 0 C-N-CA 123.179 0.592 . . . . 1.0 111.139 -177.993 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 73' ' ' MET . . . . . . . . . . . . . 16.4 mtm -73.9 -47.63 36.55 Favored 'General case' 0 C--N 1.31 -1.131 0 C-N-CA 118.967 -1.093 . . . . 1.0 109.611 177.149 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . 0.577 ' O ' ' N ' ' A' ' 76' ' ' GLY . 24.4 t -46.68 -48.98 6.94 Favored 'Isoleucine or valine' 0 C--N 1.344 0.354 0 CA-C-O 118.456 -0.783 . . . . 1.0 110.958 -176.599 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 75' ' ' ASN . . . . . 0.53 ' O ' ' N ' ' A' ' 77' ' ' ILE . 26.9 t-20 -39.18 -21.56 0.01 OUTLIER 'General case' 0 C--N 1.352 0.705 0 CA-C-O 122.895 1.331 . . . . 1.0 110.435 177.401 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 76' ' ' GLY . . . . . 0.577 ' N ' ' O ' ' A' ' 74' ' ' VAL . . . -42.31 -19.89 0.06 OUTLIER Glycine 0 CA--C 1.539 1.533 0 CA-C-N 113.55 -1.659 . . . . 1.0 109.248 178.864 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 77' ' ' ILE . . . . . 0.689 ' O ' ' N ' ' A' ' 80' ' ' ALA . 7.7 pt -71.24 -45.41 70.71 Favored 'Isoleucine or valine' 0 C--O 1.207 -1.174 0 CA-C-O 122.01 0.91 . . . . 1.0 109.458 -179.341 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . 0.485 ' C ' ' O ' ' A' ' 77' ' ' ILE . 26.8 m -35.21 -32.43 0.04 OUTLIER 'Isoleucine or valine' 0 CA--C 1.556 1.178 0 CA-C-N 113.058 -1.883 . . . . 1.0 107.359 -176.483 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . 0.529 ' N ' ' O ' ' A' ' 77' ' ' ILE . 1.1 pp -92.94 -26.97 4.66 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 CA-C-O 121.511 0.672 . . . . 1.0 111.571 177.525 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 80' ' ' ALA . . . . . 0.689 ' N ' ' O ' ' A' ' 77' ' ' ILE . . . -87.24 -18.78 29.46 Favored 'General case' 0 CA--C 1.55 0.949 0 N-CA-C 113.35 0.87 . . . . 1.0 113.35 178.976 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 81' ' ' GLU . . . . . 0.424 ' N ' ' O ' ' A' ' 77' ' ' ILE . 9.3 mm-40 -82.46 -71.87 0.47 Allowed 'General case' 0 N--CA 1.45 -0.426 0 C-N-CA 122.667 0.387 . . . . 1.0 110.169 -179.908 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 82' ' ' ASP . . . . . 0.549 ' O ' ' N ' ' A' ' 84' ' ' LEU . 92.9 m-20 -66.42 -16.81 64.39 Favored 'General case' 0 N--CA 1.444 -0.761 0 CA-C-O 119.09 -0.481 . . . . 1.0 110.261 -179.382 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . 0.501 ' O ' ' N ' ' A' ' 86' ' ' ALA . . . -15.19 -50.09 0.0 OUTLIER 'General case' 0 C--N 1.355 0.811 0 N-CA-C 113.04 0.755 . . . . 1.0 113.04 178.05 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . 0.549 ' N ' ' O ' ' A' ' 82' ' ' ASP . 0.2 OUTLIER -27.58 -50.78 0.06 Allowed 'General case' 0 C--N 1.355 0.827 0 N-CA-C 113.046 0.758 . . . . 1.0 113.046 -177.057 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 19.9 pt -85.57 -37.78 12.32 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.664 0 N-CA-C 109.584 -0.524 . . . . 1.0 109.584 179.235 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 86' ' ' ALA . . . . . 0.682 ' O ' ' N ' ' A' ' 88' ' ' ALA . . . -47.46 -54.86 10.31 Favored 'General case' 0 CA--C 1.518 -0.287 0 C-N-CA 120.329 -0.548 . . . . 1.0 110.333 -179.341 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 87' ' ' GLU . . . . . 0.558 ' C ' ' H ' ' A' ' 89' ' ' VAL . 0.5 OUTLIER -38.21 -14.81 0.01 OUTLIER 'General case' 0 CA--C 1.539 0.525 0 CA-C-N 117.768 0.258 . . . . 1.0 111.214 -179.686 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 88' ' ' ALA . . . . . 0.682 ' N ' ' O ' ' A' ' 86' ' ' ALA . . . -54.8 -5.26 0.08 Allowed 'General case' 0 C--O 1.218 -0.577 0 N-CA-C 108.811 -0.811 . . . . 1.0 108.811 177.213 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 89' ' ' VAL . . . . . 0.558 ' H ' ' C ' ' A' ' 87' ' ' GLU . 4.4 m -33.13 -31.53 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.551 0.991 0 CA-C-O 121.099 0.476 . . . . 1.0 110.787 -177.591 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 90' ' ' GLY . . . . . 0.523 ' N ' ' O ' ' A' ' 88' ' ' ALA . . . -49.33 -75.2 0.21 Allowed Glycine 0 CA--C 1.549 2.2 0 C-N-CA 119.889 -1.148 . . . . 1.0 111.21 -178.734 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 91' ' ' PRO . . . . . 0.466 ' HD2' ' O ' ' A' ' 88' ' ' ALA . 9.9 Cg_endo -52.05 -28.88 34.14 Favored 'Trans proline' 0 N--CA 1.504 2.114 0 C-N-CA 122.955 2.437 . . . . 1.0 111.229 176.663 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 92' ' ' HIS . . . . . 0.634 ' CE1' HH11 ' A' ' 52' ' ' ARG . 26.9 m80 -54.14 -19.37 4.91 Favored 'General case' 0 CA--C 1.514 -0.424 0 N-CA-C 107.4 -1.333 . . . . 1.0 107.4 -176.473 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 93' ' ' LEU . . . . . 0.549 ' O ' ' N ' ' A' ' 96' ' ' ALA . 20.7 tp -57.03 -49.98 74.13 Favored 'General case' 0 N--CA 1.45 -0.425 0 N-CA-C 106.59 -1.633 . . . . 1.0 106.59 176.797 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -49.13 -51.9 29.36 Favored 'General case' 0 CA--C 1.517 -0.301 0 N-CA-C 106.662 -1.607 . . . . 1.0 106.662 -179.352 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 3.0 mmt180 -61.03 -32.13 71.75 Favored 'General case' 0 C--N 1.316 -0.849 0 N-CA-C 108.622 -0.881 . . . . 1.0 108.622 177.191 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 96' ' ' ALA . . . . . 0.777 ' O ' ' N ' ' A' ' 100' ' ' ILE . . . -55.82 -51.44 67.47 Favored 'General case' 0 C--O 1.199 -1.556 0 C-N-CA 118.817 -1.153 . . . . 1.0 107.918 -178.947 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 97' ' ' LEU . . . . . 0.466 ' C ' ' O ' ' A' ' 96' ' ' ALA . 0.2 OUTLIER -34.15 -26.15 0.01 OUTLIER 'General case' 0 CA--C 1.587 2.399 0 N-CA-C 107.58 -1.267 . . . . 1.0 107.58 -178.325 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 98' ' ' GLY . . . . . 0.659 ' N ' ' O ' ' A' ' 96' ' ' ALA . . . -86.48 -52.77 3.1 Favored Glycine 0 CA--C 1.546 1.981 0 CA-C-O 123.967 1.871 . . . . 1.0 110.617 173.963 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 99' ' ' GLN . . . . . 0.612 ' N ' ' O ' ' A' ' 96' ' ' ALA . 24.6 tt0 -76.97 7.56 4.74 Favored 'General case' 0 N--CA 1.418 -2.047 0 N-CA-C 107.837 -1.171 . . . . 1.0 107.837 177.177 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 100' ' ' ILE . . . . . 0.777 ' N ' ' O ' ' A' ' 96' ' ' ALA . 6.8 tp -62.48 -47.91 90.77 Favored 'Isoleucine or valine' 0 CA--C 1.481 -1.678 0 N-CA-C 108.66 -0.867 . . . . 1.0 108.66 179.82 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 101' ' ' VAL . . . . . 0.57 ' N ' ' CG2' ' A' ' 100' ' ' ILE . 46.3 t -53.57 -59.92 1.61 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.622 0 C-N-CA 117.352 -1.739 . . . . 1.0 108.341 179.095 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 102' ' ' CYS . . . . . 0.489 ' SG ' ' CG ' ' A' ' 99' ' ' GLN . 0.0 OUTLIER -52.41 -31.7 35.52 Favored 'General case' 0 CA--C 1.545 0.767 0 C-N-CA 119.831 -0.748 . . . . 1.0 111.215 -176.743 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 103' ' ' ARG . . . . . 0.431 ' NH2' ' CB ' ' A' ' 96' ' ' ALA . 11.8 ttp180 -82.15 -47.89 11.98 Favored 'General case' 0 N--CA 1.494 1.759 0 CA-C-O 122.287 1.041 . . . . 1.0 113.014 178.666 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 104' ' ' TYR . . . . . 0.439 ' O ' ' CD2' ' A' ' 104' ' ' TYR . 50.6 t80 -92.08 22.73 4.17 Favored 'General case' 0 C--N 1.29 -1.98 0 CA-C-N 113.653 -1.612 . . . . 1.0 108.502 178.802 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 105' ' ' GLY . . . . . 0.527 ' N ' ' O ' ' A' ' 101' ' ' VAL . . . -159.81 -86.98 0.06 OUTLIER Glycine 0 CA--C 1.526 0.779 0 N-CA-C 110.337 -1.105 . . . . 1.0 110.337 178.618 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 106' ' ' ALA . . . . . 0.404 ' O ' ' O ' ' A' ' 105' ' ' GLY . . . 57.13 106.65 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.17 0 N-CA-C 109.22 -0.659 . . . . 1.0 109.22 -177.117 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 107' ' ' THR . . . . . 0.633 ' O ' ' CD ' ' A' ' 110' ' ' PRO . 26.0 m -134.24 -60.59 0.8 Allowed 'General case' 0 C--O 1.205 -1.276 0 CA-C-O 118.606 -0.711 . . . . 1.0 110.076 179.086 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 12.3 p -82.83 34.97 0.04 OUTLIER 'Isoleucine or valine' 0 C--O 1.235 0.29 0 C-N-CA 123.659 0.784 . . . . 1.0 111.265 -175.812 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 109' ' ' ILE . . . . . 0.665 ' N ' ' CD ' ' A' ' 110' ' ' PRO . 31.5 pt -104.7 -22.87 0.19 Allowed Pre-proline 0 CA--C 1.568 1.641 0 CA-C-N 115.876 -0.602 . . . . 1.0 111.363 177.55 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 110' ' ' PRO . . . . . 0.665 ' CD ' ' N ' ' A' ' 109' ' ' ILE . 71.6 Cg_endo -73.14 -15.66 25.6 Favored 'Trans proline' 0 N--CA 1.483 0.883 0 C-N-CA 123.292 2.661 . . . . 1.0 113.674 -177.402 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 6.3 t30 -61.72 -69.2 0.26 Allowed 'General case' 0 C--O 1.237 0.401 0 C-N-CA 120.357 -0.537 . . . . 1.0 110.472 -177.941 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -65.53 -28.68 44.92 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.413 0 CA-C-O 122.015 0.912 . . . . 1.0 109.996 179.614 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 113' ' ' ASN . . . . . 0.487 ' O ' ' OE1' ' A' ' 117' ' ' GLU . 42.1 t30 -55.16 -63.86 1.02 Allowed 'General case' 0 C--N 1.306 -1.32 0 CA-C-N 115.062 -0.972 . . . . 1.0 110.519 -176.738 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -61.49 -23.06 65.63 Favored 'General case' 0 C--N 1.31 -1.132 0 C-N-CA 120.788 -0.365 . . . . 1.0 111.383 179.832 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -79.34 -60.01 2.54 Favored 'General case' 0 CA--C 1.536 0.433 0 N-CA-C 112.485 0.55 . . . . 1.0 112.485 178.733 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 116' ' ' ILE . . . . . 0.54 ' O ' ' N ' ' A' ' 119' ' ' LEU . 3.3 mm -70.3 -49.11 56.74 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.365 0 O-C-N 121.102 -0.999 . . . . 1.0 112.187 -177.982 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 117' ' ' GLU . . . . . 0.612 ' OE1' ' N ' ' A' ' 117' ' ' GLU . 10.3 mp0 -46.96 -61.55 1.82 Allowed 'General case' 0 C--N 1.317 -0.846 0 N-CA-C 108.728 -0.841 . . . . 1.0 108.728 -176.815 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 2.0 p -51.9 -16.35 0.64 Allowed 'Isoleucine or valine' 0 N--CA 1.443 -0.797 0 C-N-CA 119.896 -0.721 . . . . 1.0 109.078 179.157 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 119' ' ' LEU . . . . . 0.54 ' N ' ' O ' ' A' ' 116' ' ' ILE . 0.3 OUTLIER -78.39 -60.45 2.37 Favored 'General case' 0 C--N 1.356 0.87 0 N-CA-C 108.808 -0.812 . . . . 1.0 108.808 176.802 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -68.29 -83.07 0.15 Allowed Glycine 0 C--N 1.367 2.251 0 C-N-CA 116.759 -2.639 . . . . 1.0 110.747 178.671 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 121' ' ' THR . . . . . 0.628 ' HG1' ' HE2' ' A' ' 72' ' ' HIS . 13.3 m -159.75 -18.83 0.06 Allowed 'General case' 0 N--CA 1.475 0.801 0 CA-C-O 122.107 0.956 . . . . 1.0 109.307 -179.645 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 122' ' ' GLY . . . . . 0.45 ' O ' ' C ' ' A' ' 123' ' ' THR . . . 111.48 -36.73 4.04 Favored Glycine 0 CA--C 1.523 0.588 0 CA-C-N 113.365 -1.743 . . . . 1.0 112.098 179.733 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 123' ' ' THR . . . . . 0.45 ' C ' ' O ' ' A' ' 122' ' ' GLY . 91.1 m -31.4 95.15 0.01 OUTLIER 'General case' 0 N--CA 1.477 0.904 0 CA-C-N 118.913 1.356 . . . . 1.0 112.369 -178.267 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 124' ' ' ASP . . . . . 0.406 ' N ' ' O ' ' A' ' 122' ' ' GLY . 0.0 OUTLIER -146.02 144.6 30.19 Favored 'General case' 0 C--N 1.347 0.494 0 N-CA-C 108.259 -1.015 . . . . 1.0 108.259 178.596 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 125' ' ' TYR . . . . . 0.451 ' O ' ' NE ' ' A' ' 126' ' ' ARG . 1.1 p90 -149.57 148.79 29.76 Favored 'General case' 0 C--N 1.325 -0.498 0 N-CA-C 109.951 -0.389 . . . . 1.0 109.951 179.817 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 126' ' ' ARG . . . . . 0.495 ' HA ' ' HE ' ' A' ' 126' ' ' ARG . 0.0 OUTLIER -146.73 149.48 33.49 Favored 'General case' 0 N--CA 1.465 0.302 0 N-CA-C 109.2 -0.667 . . . . 1.0 109.2 177.081 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 127' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.222 -0.389 0 CA-C-O 117.998 -1.001 . . . . 1.0 111.057 -178.507 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.492 1.633 0 N-CA-C 109.219 -0.66 . . . . 1.0 109.219 . . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 2' ' ' SER . . . . . 0.462 ' O ' ' CG ' ' A' ' 3' ' ' ASP . 86.7 p -89.19 4.48 48.47 Favored 'General case' 0 N--CA 1.463 0.212 0 CA-C-N 115.97 -0.559 . . . . 1.0 111.338 -179.56 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 3' ' ' ASP . . . . . 0.462 ' CG ' ' O ' ' A' ' 2' ' ' SER . 11.4 m-20 160.39 118.46 0.0 OUTLIER 'General case' 0 N--CA 1.465 0.316 0 O-C-N 123.578 0.549 . . . . 1.0 110.833 179.44 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . 0.443 ' O ' ' OD1' ' A' ' 5' ' ' ASP . 72.9 t80 -149.79 145.57 26.69 Favored 'General case' 0 CA--C 1.518 -0.261 0 N-CA-C 109.073 -0.714 . . . . 1.0 109.073 178.027 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 5' ' ' ASP . . . . . 0.443 ' OD1' ' O ' ' A' ' 4' ' ' PHE . 72.0 m-20 -149.92 146.5 27.1 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.963 -0.562 . . . . 1.0 110.472 -179.054 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 6' ' ' THR . . . . . 0.696 ' O ' ' N ' ' A' ' 10' ' ' SER . 0.2 OUTLIER -114.31 -156.23 0.59 Allowed 'General case' 0 C--O 1.206 -1.219 0 CA-C-O 121.699 0.762 . . . . 1.0 110.245 179.291 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . 0.503 ' O ' ' CB ' ' A' ' 11' ' ' ARG . 10.5 tm-20 -57.04 -48.37 78.68 Favored 'General case' 0 C--N 1.306 -1.323 0 O-C-N 121.67 -0.643 . . . . 1.0 110.361 -178.443 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 8' ' ' ARG . . . . . 0.498 ' O ' ' CB ' ' A' ' 12' ' ' ALA . 39.1 ttm180 -67.28 -58.23 5.21 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-O 122.046 0.927 . . . . 1.0 109.781 178.506 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . 0.589 ' O ' ' HB ' ' A' ' 13' ' ' VAL . 0.2 OUTLIER -65.2 -51.16 68.76 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.847 0 CA-C-N 114.64 -1.163 . . . . 1.0 109.456 -178.243 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 10' ' ' SER . . . . . 0.696 ' N ' ' O ' ' A' ' 6' ' ' THR . 1.1 m -69.43 -64.07 0.95 Allowed 'General case' 0 C--N 1.302 -1.462 0 O-C-N 120.78 -1.2 . . . . 1.0 111.325 178.801 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 11' ' ' ARG . . . . . 0.503 ' CB ' ' O ' ' A' ' 7' ' ' GLU . 30.5 ttm-85 -63.97 -48.65 75.63 Favored 'General case' 0 N--CA 1.472 0.633 0 O-C-N 121.396 -0.815 . . . . 1.0 112.735 -176.206 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . 0.498 ' CB ' ' O ' ' A' ' 8' ' ' ARG . . . -70.03 -58.61 3.63 Favored 'General case' 0 N--CA 1.472 0.663 0 C-N-CA 118.96 -1.096 . . . . 1.0 109.284 178.286 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . 0.705 ' O ' ' CB ' ' A' ' 17' ' ' LEU . 1.0 OUTLIER -63.18 -54.08 37.78 Favored 'Isoleucine or valine' 0 C--O 1.195 -1.788 0 C-N-CA 117.773 -1.571 . . . . 1.0 108.921 -179.662 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . 0.607 ' O ' HG23 ' A' ' 18' ' ' VAL . . . -63.48 -62.87 1.39 Allowed 'General case' 0 N--CA 1.48 1.073 0 C-N-CA 117.123 -1.831 . . . . 1.0 111.353 179.888 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . 0.543 ' O ' ' N ' ' A' ' 19' ' ' GLY . . . -54.93 -55.98 24.61 Favored 'General case' 0 N--CA 1.485 1.286 0 C-N-CA 118.877 -1.129 . . . . 1.0 111.311 -177.327 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . 0.462 ' CB ' ' O ' ' A' ' 12' ' ' ALA . . . -66.06 -57.16 8.34 Favored 'General case' 0 CA--C 1.548 0.874 0 C-N-CA 119.589 -0.844 . . . . 1.0 109.935 -178.425 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . 0.705 ' CB ' ' O ' ' A' ' 13' ' ' VAL . 7.0 tt -56.29 -54.07 49.77 Favored 'General case' 0 N--CA 1.483 1.206 0 CA-C-N 115.065 -0.97 . . . . 1.0 108.421 -178.224 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . 0.7 HG23 ' H ' ' A' ' 19' ' ' GLY . 1.8 m -71.14 -57.81 6.71 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.602 0 C-N-CA 119.307 -0.957 . . . . 1.0 110.169 179.868 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . 0.7 ' H ' HG23 ' A' ' 18' ' ' VAL . . . -57.88 -171.54 0.25 Allowed Glycine 0 N--CA 1.448 -0.526 0 N-CA-C 111.17 -0.772 . . . . 1.0 111.17 -177.911 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 20' ' ' PRO . . . . . 0.585 ' O ' ' N ' ' A' ' 24' ' ' ALA . 89.8 Cg_endo -81.76 -24.51 4.12 Favored 'Trans proline' 0 C--N 1.298 -2.1 0 C-N-CA 122.691 2.261 . . . . 1.0 113.276 -178.583 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . 0.441 ' O ' ' N ' ' A' ' 24' ' ' ALA . . . -63.96 -61.89 5.71 Favored Glycine 0 N--CA 1.484 1.856 0 C-N-CA 119.237 -1.458 . . . . 1.0 111.981 -176.992 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . 0.442 ' H ' ' HA ' ' A' ' 16' ' ' ALA . . . -53.01 -51.83 43.55 Favored Glycine 0 N--CA 1.47 0.927 0 N-CA-C 106.212 -2.755 . . . . 1.0 106.212 179.69 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 34.3 t -56.88 -30.74 34.12 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.733 0 N-CA-C 108.832 -0.803 . . . . 1.0 108.832 178.332 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . 0.585 ' N ' ' O ' ' A' ' 20' ' ' PRO . . . -58.22 -61.37 2.62 Favored 'General case' 0 C--N 1.352 0.706 0 C-N-CA 118.354 -1.339 . . . . 1.0 109.499 179.638 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 9.0 mp -57.59 -44.27 85.24 Favored 'General case' 0 C--O 1.223 -0.315 0 C-N-CA 119.629 -0.829 . . . . 1.0 110.341 -177.893 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 65.5 t -58.6 -60.33 2.46 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.861 0 C-N-CA 119.087 -1.045 . . . . 1.0 111.053 -178.61 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 18.1 t -58.51 -41.83 82.88 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.231 0 N-CA-C 112.843 0.683 . . . . 1.0 112.843 -177.64 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . 0.528 ' HZ3' ' CG2' ' A' ' 29' ' ' VAL . 3.9 pptp? -68.33 -54.41 17.56 Favored 'General case' 0 C--N 1.325 -0.459 0 C-N-CA 119.078 -1.049 . . . . 1.0 109.966 -178.027 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . 0.528 ' CG2' ' HZ3' ' A' ' 28' ' ' LYS . 1.3 t -60.58 -50.71 79.32 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.6 0 C-N-CA 119.748 -0.781 . . . . 1.0 110.576 179.862 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 30' ' ' CYS . . . . . . . . . . . . . 8.6 t -65.14 -63.1 1.19 Allowed 'General case' 0 N--CA 1.447 -0.6 0 C-N-CA 119.425 -0.91 . . . . 1.0 110.51 -179.184 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -56.19 -50.38 71.39 Favored 'General case' 0 CA--C 1.517 -0.323 0 C-N-CA 120.3 -0.56 . . . . 1.0 111.168 -177.53 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . 0.419 ' O ' ' HB2' ' A' ' 33' ' ' LEU . . . 74.3 70.44 1.25 Allowed Glycine 0 N--CA 1.45 -0.43 0 N-CA-C 108.621 -1.791 . . . . 1.0 108.621 -178.182 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . 0.433 ' O ' ' N ' ' A' ' 35' ' ' GLY . 0.1 OUTLIER 84.75 93.8 0.04 OUTLIER Pre-proline 0 CA--C 1.55 0.968 0 O-C-N 124.477 0.751 . . . . 1.0 109.657 -178.286 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 74.7 Cg_exo -45.69 -13.55 0.08 OUTLIER 'Trans proline' 0 N--CA 1.491 1.378 0 C-N-CA 121.919 1.746 . . . . 1.0 113.634 -179.56 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . 0.433 ' N ' ' O ' ' A' ' 33' ' ' LEU . . . -62.81 -61.85 6.07 Favored Glycine 0 N--CA 1.471 0.989 0 C-N-CA 118.885 -1.626 . . . . 1.0 110.422 -178.263 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . 0.609 ' O ' HG23 ' A' ' 37' ' ' ILE . 34.3 m -76.94 -147.01 0.01 OUTLIER 'Isoleucine or valine' 0 C--O 1.213 -0.858 0 N-CA-C 107.58 -1.267 . . . . 1.0 107.58 178.431 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . 0.609 HG23 ' O ' ' A' ' 36' ' ' VAL . 0.3 OUTLIER 71.93 75.4 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.474 0.741 0 CA-C-O 122.993 1.378 . . . . 1.0 111.675 179.934 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 38' ' ' HIS . . . . . 0.433 ' CD2' ' O ' ' A' ' 37' ' ' ILE . 35.1 m170 -137.75 131.97 32.06 Favored 'General case' 0 C--N 1.327 -0.376 0 O-C-N 120.707 -1.246 . . . . 1.0 109.103 178.997 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 1.7 t -128.65 112.99 19.19 Favored Pre-proline 0 CA--C 1.542 0.642 0 N-CA-C 109.015 -0.735 . . . . 1.0 109.015 179.745 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 40' ' ' PRO . . . . . 0.547 ' O ' ' NE ' ' A' ' 42' ' ' ARG . 83.8 Cg_exo -42.63 -68.05 0.11 Allowed 'Trans proline' 0 N--CA 1.49 1.293 0 C-N-CA 121.542 1.495 . . . . 1.0 112.569 -178.673 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -74.7 128.02 34.54 Favored 'General case' 0 C--N 1.316 -0.889 0 CA-C-N 115.173 -0.921 . . . . 1.0 111.244 -177.694 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . 0.657 ' C ' ' H ' ' A' ' 44' ' ' GLY . 0.1 OUTLIER -173.78 175.44 2.89 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 114.859 -1.064 . . . . 1.0 110.726 179.631 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 43' ' ' ARG . . . . . 0.601 ' C ' ' H ' ' A' ' 45' ' ' PHE . 25.3 tpt180 -63.51 19.11 0.01 OUTLIER 'General case' 0 CA--C 1.549 0.905 0 CA-C-O 121.254 0.549 . . . . 1.0 109.927 178.532 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . 0.657 ' H ' ' C ' ' A' ' 42' ' ' ARG . . . 69.93 -27.94 0.41 Allowed Glycine 0 C--N 1.342 0.906 0 N-CA-C 110.66 -0.976 . . . . 1.0 110.66 -179.715 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . 0.63 ' O ' ' HB2' ' A' ' 46' ' ' PHE . 1.1 p90 -159.79 161.01 34.52 Favored 'General case' 0 C--N 1.326 -0.415 0 N-CA-C 109.022 -0.733 . . . . 1.0 109.022 179.77 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 46' ' ' PHE . . . . . 0.63 ' HB2' ' O ' ' A' ' 45' ' ' PHE . 0.7 OUTLIER 131.87 94.35 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.506 0 O-C-N 125.414 1.696 . . . . 1.0 109.604 179.153 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 47' ' ' ARG . . . . . 0.581 ' CB ' ' O ' ' A' ' 46' ' ' PHE . 0.0 OUTLIER 112.58 143.14 0.0 OUTLIER 'General case' 0 N--CA 1.48 1.072 0 O-C-N 124.415 1.072 . . . . 1.0 111.709 178.229 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 35.8 t 66.96 73.18 0.35 Allowed 'General case' 0 C--O 1.22 -0.463 0 O-C-N 124.317 1.011 . . . . 1.0 110.579 179.257 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 49' ' ' ASN . . . . . 0.516 ' O ' ' N ' ' A' ' 51' ' ' GLU . 0.4 OUTLIER -136.44 153.89 76.54 Favored Pre-proline 0 CA--C 1.536 0.435 0 N-CA-C 109.863 -0.421 . . . . 1.0 109.863 -179.19 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 50' ' ' PRO . . . . . 0.569 ' C ' ' H ' ' A' ' 52' ' ' ARG . 27.9 Cg_endo -58.64 56.67 0.06 OUTLIER 'Trans proline' 0 N--CA 1.51 2.455 0 C-N-CA 123.219 2.612 . . . . 1.0 113.516 179.931 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . 0.558 ' OE1' ' ND1' ' A' ' 92' ' ' HIS . 49.1 mt-10 63.85 -34.44 0.14 Allowed 'General case' 0 N--CA 1.47 0.541 0 CA-C-N 116.129 -0.487 . . . . 1.0 111.984 179.855 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . 0.569 ' H ' ' C ' ' A' ' 50' ' ' PRO . 75.7 mtt85 -45.9 136.3 6.5 Favored 'General case' 0 C--N 1.325 -0.468 0 N-CA-C 109.588 -0.523 . . . . 1.0 109.588 179.696 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . 0.607 ' O ' ' N ' ' A' ' 55' ' ' ILE . 3.0 tp -49.73 125.56 3.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 N-CA-C 109.615 -0.513 . . . . 1.0 109.615 -178.713 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -57.17 80.37 0.01 OUTLIER 'General case' 0 C--N 1.322 -0.588 0 CA-C-O 121.931 0.872 . . . . 1.0 109.054 -177.393 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . 0.607 ' N ' ' O ' ' A' ' 53' ' ' ILE . 3.3 tt -155.12 165.01 1.26 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.249 0 CA-C-N 114.687 -1.142 . . . . 1.0 111.449 178.501 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 105.55 -28.83 12.77 Favored Glycine 0 C--O 1.226 -0.405 0 CA-C-N 115.916 -0.584 . . . . 1.0 112.134 176.737 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -52.56 117.61 3.01 Favored 'General case' 0 CA--C 1.537 0.478 0 CA-C-N 118.013 0.906 . . . . 1.0 112.627 -178.783 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 58' ' ' TRP . . . . . . . . . . . . . 36.1 m95 -79.83 168.26 19.51 Favored 'General case' 0 CA--C 1.556 1.182 0 CA-C-O 124.214 1.959 . . . . 1.0 111.045 178.649 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -86.17 -64.14 1.2 Allowed 'General case' 0 N--CA 1.509 2.518 0 CA-C-N 110.745 -2.934 . . . . 1.0 112.902 -176.989 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 60' ' ' TYR . . . . . 0.415 ' O ' ' CG ' ' A' ' 60' ' ' TYR . 17.5 t80 -88.07 -16.44 33.56 Favored 'General case' 0 N--CA 1.483 1.205 0 N-CA-C 113.171 0.804 . . . . 1.0 113.171 179.728 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . 0.49 ' O ' ' N ' ' A' ' 65' ' ' ASP . 11.3 tt0 -79.42 -12.88 59.89 Favored 'General case' 0 C--N 1.313 -1.002 0 O-C-N 121.704 -0.622 . . . . 1.0 109.64 179.941 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 62' ' ' VAL . . . . . 0.557 ' O ' ' N ' ' A' ' 66' ' ' GLY . 12.2 m -45.42 -51.4 2.74 Favored 'Isoleucine or valine' 0 CA--C 1.5 -0.974 0 C-N-CA 120.04 -0.664 . . . . 1.0 110.354 -176.126 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 63' ' ' ALA . . . . . 0.435 ' O ' ' HG3' ' A' ' 67' ' ' ARG . . . -68.29 -48.35 65.19 Favored 'General case' 0 N--CA 1.426 -1.66 0 C-N-CA 119.752 -0.779 . . . . 1.0 109.325 179.763 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 1.8 t-80 -56.49 -59.65 4.68 Favored 'General case' 0 CA--C 1.545 0.755 0 CA-C-N 115.358 -0.837 . . . . 1.0 110.37 -179.645 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 65' ' ' ASP . . . . . 0.593 ' C ' ' H ' ' A' ' 67' ' ' ARG . 1.0 OUTLIER -69.42 -55.46 10.25 Favored 'General case' 0 CA--C 1.549 0.917 0 CA-C-O 121.976 0.893 . . . . 1.0 109.756 177.767 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . 0.557 ' N ' ' O ' ' A' ' 62' ' ' VAL . . . -67.34 33.3 0.2 Allowed Glycine 0 CA--C 1.529 0.939 0 O-C-N 120.726 -1.234 . . . . 1.0 111.227 178.957 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 67' ' ' ARG . . . . . 0.644 ' O ' ' N ' ' A' ' 69' ' ' LEU . 0.8 OUTLIER -77.98 5.93 8.82 Favored 'General case' 0 C--N 1.32 -0.678 0 N-CA-C 108.85 -0.796 . . . . 1.0 108.85 177.045 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . 0.537 ' O ' ' HA ' ' A' ' 72' ' ' HIS . 0.3 OUTLIER -32.86 -28.36 0.01 OUTLIER 'General case' 0 N--CA 1.487 1.396 0 N-CA-C 108.226 -1.027 . . . . 1.0 108.226 -177.879 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . 0.644 ' N ' ' O ' ' A' ' 67' ' ' ARG . 2.4 mp -64.4 -65.2 0.71 Allowed 'General case' 0 N--CA 1.469 0.488 0 C-N-CA 117.922 -1.511 . . . . 1.0 107.301 177.16 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . 0.681 ' C ' ' H ' ' A' ' 72' ' ' HIS . . . -76.09 -72.22 0.34 Allowed 'General case' 0 CA--C 1.51 -0.573 0 N-CA-C 106.157 -1.794 . . . . 1.0 106.157 178.249 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 71' ' ' ALA . . . . . 0.523 ' H ' ' HB3' ' A' ' 67' ' ' ARG . . . -43.87 3.22 0.0 OUTLIER 'General case' 0 N--CA 1.472 0.634 0 C-N-CA 125.135 1.374 . . . . 1.0 113.798 176.897 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 72' ' ' HIS . . . . . 1.004 ' CD2' ' H ' ' A' ' 73' ' ' MET . 0.4 OUTLIER -19.41 -65.92 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.314 0 N-CA-C 112.728 0.64 . . . . 1.0 112.728 -176.372 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 73' ' ' MET . . . . . 1.004 ' H ' ' CD2' ' A' ' 72' ' ' HIS . 28.1 mtt -76.64 -45.78 28.56 Favored 'General case' 0 N--CA 1.438 -1.059 0 CA-C-N 119.023 0.828 . . . . 1.0 109.22 177.557 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . 0.591 ' O ' ' N ' ' A' ' 76' ' ' GLY . 94.5 t -45.27 -50.37 2.9 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.306 0 CA-C-O 118.082 -0.961 . . . . 1.0 109.894 -177.099 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 75' ' ' ASN . . . . . 0.512 ' C ' ' N ' ' A' ' 77' ' ' ILE . 19.0 t-20 -39.44 -21.18 0.01 OUTLIER 'General case' 0 C--N 1.357 0.925 0 CA-C-N 120.312 1.415 . . . . 1.0 110.715 177.346 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 76' ' ' GLY . . . . . 0.591 ' N ' ' O ' ' A' ' 74' ' ' VAL . . . -43.48 -20.95 0.14 Allowed Glycine 0 CA--C 1.534 1.237 0 N-CA-C 108.675 -1.77 . . . . 1.0 108.675 178.934 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 77' ' ' ILE . . . . . 0.763 ' O ' ' N ' ' A' ' 80' ' ' ALA . 96.7 mt -82.43 -50.04 16.49 Favored 'Isoleucine or valine' 0 C--O 1.213 -0.855 0 N-CA-C 108.766 -0.827 . . . . 1.0 108.766 179.421 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . 0.467 ' C ' ' O ' ' A' ' 77' ' ' ILE . 43.8 t -35.4 -34.49 0.06 OUTLIER 'Isoleucine or valine' 0 CA--C 1.541 0.603 0 N-CA-C 108.481 -0.933 . . . . 1.0 108.481 -178.254 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . 0.46 ' N ' ' O ' ' A' ' 77' ' ' ILE . 0.1 OUTLIER -88.16 -24.7 6.1 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.602 0 CA-C-O 121.007 0.432 . . . . 1.0 110.104 178.789 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 80' ' ' ALA . . . . . 0.763 ' N ' ' O ' ' A' ' 77' ' ' ILE . . . -89.78 -9.25 49.96 Favored 'General case' 0 CA--C 1.539 0.522 0 C-N-CA 123.843 0.857 . . . . 1.0 111.653 177.061 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 81' ' ' GLU . . . . . 0.544 ' N ' ' O ' ' A' ' 77' ' ' ILE . 51.2 tp10 -77.86 -71.77 0.4 Allowed 'General case' 0 N--CA 1.444 -0.765 0 CA-C-O 118.477 -0.773 . . . . 1.0 111.516 -179.288 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 82' ' ' ASP . . . . . 0.549 ' O ' HG13 ' A' ' 85' ' ' ILE . 1.7 m-20 -81.67 -18.72 43.53 Favored 'General case' 0 C--O 1.21 -0.983 0 O-C-N 123.517 0.51 . . . . 1.0 112.226 -178.095 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . 0.596 ' O ' ' N ' ' A' ' 85' ' ' ILE . . . -45.05 -52.41 9.0 Favored 'General case' 0 N--CA 1.469 0.491 0 N-CA-C 115.093 1.516 . . . . 1.0 115.093 -179.813 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . 0.822 ' H ' ' CD1' ' A' ' 84' ' ' LEU . 0.0 OUTLIER -31.78 -28.67 0.01 OUTLIER 'General case' 0 N--CA 1.48 1.048 0 CA-C-O 118.962 -0.542 . . . . 1.0 112.408 -174.304 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 85' ' ' ILE . . . . . 0.596 ' N ' ' O ' ' A' ' 83' ' ' ALA . 1.4 pp -100.02 -58.9 3.58 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.878 0 CA-C-N 118.631 0.65 . . . . 1.0 109.262 177.565 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 86' ' ' ALA . . . . . 0.578 ' H ' HG13 ' A' ' 85' ' ' ILE . . . -53.22 -37.53 62.11 Favored 'General case' 0 C--O 1.222 -0.347 0 CA-C-N 115.6 -0.727 . . . . 1.0 110.745 179.869 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 9.8 tt0 -47.5 -11.86 0.03 OUTLIER 'General case' 0 N--CA 1.465 0.295 0 CA-C-O 121.07 0.462 . . . . 1.0 110.046 179.649 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 88' ' ' ALA . . . . . 0.565 ' H ' ' C ' ' A' ' 86' ' ' ALA . . . -84.16 -2.33 56.65 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.754 -0.657 . . . . 1.0 110.103 179.657 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 89' ' ' VAL . . . . . 0.484 ' N ' ' O ' ' A' ' 86' ' ' ALA . 54.2 t -93.25 33.03 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.62 0 CA-C-N 115.414 -0.812 . . . . 1.0 109.231 179.079 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 90' ' ' GLY . . . . . 0.607 ' N ' ' HD2' ' A' ' 91' ' ' PRO . . . -67.22 -44.81 85.27 Favored Glycine 0 CA--C 1.535 1.342 0 CA-C-O 119.163 -0.798 . . . . 1.0 112.005 178.134 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 91' ' ' PRO . . . . . 0.607 ' HD2' ' N ' ' A' ' 90' ' ' GLY . 7.7 Cg_exo -39.3 -18.55 0.04 OUTLIER 'Trans proline' 0 N--CA 1.493 1.445 0 C-N-CA 122.236 1.957 . . . . 1.0 111.336 179.263 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 92' ' ' HIS . . . . . 0.713 ' O ' ' N ' ' A' ' 96' ' ' ALA . 3.3 p80 -53.95 -44.83 71.04 Favored 'General case' 0 N--CA 1.441 -0.923 0 N-CA-C 106.357 -1.72 . . . . 1.0 106.357 -179.568 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 93' ' ' LEU . . . . . 0.573 ' N ' ' CG ' ' A' ' 92' ' ' HIS . 2.3 pp -41.51 -61.38 1.07 Allowed 'General case' 0 CA--C 1.566 1.572 0 C-N-CA 119.578 -0.849 . . . . 1.0 111.762 177.682 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 94' ' ' ALA . . . . . 0.534 ' H ' ' HG ' ' A' ' 93' ' ' LEU . . . -58.29 -58.76 7.07 Favored 'General case' 0 C--O 1.219 -0.547 0 CA-C-N 119.229 0.922 . . . . 1.0 108.763 179.67 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 95' ' ' ARG . . . . . 0.578 ' O ' ' N ' ' A' ' 97' ' ' LEU . 44.7 mtp85 -51.56 -61.38 2.28 Favored 'General case' 0 C--O 1.246 0.885 0 CA-C-O 123.359 1.552 . . . . 1.0 108.658 178.177 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 96' ' ' ALA . . . . . 0.845 ' O ' ' N ' ' A' ' 98' ' ' GLY . . . -47.82 -14.37 0.05 OUTLIER 'General case' 0 N--CA 1.43 -1.429 0 O-C-N 118.186 -2.821 . . . . 1.0 111.206 -178.446 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 97' ' ' LEU . . . . . 0.628 ' O ' ' N ' ' A' ' 100' ' ' ILE 0.258 6.1 tt 3.68 -51.28 0.0 OUTLIER 'General case' 0 C--N 1.368 1.393 0 C-N-CA 124.109 0.964 . . . . 1.0 112.736 -170.72 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 98' ' ' GLY . . . . . 0.845 ' N ' ' O ' ' A' ' 96' ' ' ALA . . . -49.56 -23.05 4.36 Favored Glycine 0 N--CA 1.434 -1.479 0 CA-C-N 122.187 2.267 . . . . 1.0 108.152 174.589 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 99' ' ' GLN . . . . . 0.518 ' O ' ' SG ' ' A' ' 102' ' ' CYS . 25.2 mm100 -68.88 -19.81 64.24 Favored 'General case' 0 C--N 1.363 1.162 0 C-N-CA 117.308 -1.757 . . . . 1.0 108.58 177.765 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 100' ' ' ILE . . . . . 0.628 ' N ' ' O ' ' A' ' 97' ' ' LEU . 10.3 mt -65.41 -32.72 59.45 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.813 0 C-N-CA 119.749 -0.781 . . . . 1.0 110.214 177.179 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 101' ' ' VAL . . . . . 0.648 HG13 ' H ' ' A' ' 102' ' ' CYS . 3.8 p -60.13 -62.09 1.22 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.509 0 C-N-CA 119.355 -0.938 . . . . 1.0 110.622 -178.847 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 102' ' ' CYS . . . . . 0.648 ' H ' HG13 ' A' ' 101' ' ' VAL . 1.2 p -48.72 -19.29 0.34 Allowed 'General case' 0 C--O 1.217 -0.627 0 O-C-N 122.122 -0.361 . . . . 1.0 111.655 -178.364 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 103' ' ' ARG . . . . . 0.601 ' CG ' HH11 ' A' ' 103' ' ' ARG . 0.0 OUTLIER -85.9 -42.61 13.93 Favored 'General case' 0 N--CA 1.498 1.943 0 CA-C-O 124.419 2.057 . . . . 1.0 111.235 -179.98 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 104' ' ' TYR . . . . . 0.803 ' O ' ' CD1' ' A' ' 104' ' ' TYR . 0.0 OUTLIER -97.62 22.48 8.93 Favored 'General case' 0 C--N 1.267 -2.995 0 CA-C-N 110.561 -3.018 . . . . 1.0 107.332 176.949 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 105' ' ' GLY . . . . . 0.512 ' N ' ' O ' ' A' ' 101' ' ' VAL . . . -165.5 -88.3 0.07 OUTLIER Glycine 0 CA--C 1.529 0.913 0 O-C-N 119.634 -1.916 . . . . 1.0 109.081 179.13 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . 65.52 58.58 0.82 Allowed 'General case' 0 CA--C 1.533 0.308 0 CA-C-O 120.885 0.374 . . . . 1.0 110.688 -178.713 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 13.1 t -89.49 -5.34 57.4 Favored 'General case' 0 CA--C 1.514 -0.412 0 N-CA-C 108.614 -0.884 . . . . 1.0 108.614 178.593 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 108' ' ' VAL . . . . . 0.442 ' CG2' ' N ' ' A' ' 109' ' ' ILE . 14.7 m -87.53 -53.54 9.76 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.626 0 C-N-CA 120.842 -0.343 . . . . 1.0 110.608 178.537 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 109' ' ' ILE . . . . . 0.507 ' N ' ' CD ' ' A' ' 110' ' ' PRO . 0.2 OUTLIER -50.34 -34.34 10.65 Favored Pre-proline 0 C--N 1.351 0.658 0 N-CA-C 115.086 1.513 . . . . 1.0 115.086 -178.921 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 110' ' ' PRO . . . . . 0.507 ' CD ' ' N ' ' A' ' 109' ' ' ILE . 76.8 Cg_exo -53.07 -37.89 79.78 Favored 'Trans proline' 0 C--N 1.307 -1.612 0 CA-C-N 120.458 1.199 . . . . 1.0 111.276 -175.212 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -64.76 -67.48 0.43 Allowed 'General case' 0 C--N 1.325 -0.471 0 C-N-CA 119.639 -0.824 . . . . 1.0 109.326 179.647 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 112' ' ' ILE . . . . . 0.485 ' CG1' ' N ' ' A' ' 113' ' ' ASN . 0.3 OUTLIER -60.28 -44.91 96.7 Favored 'Isoleucine or valine' 0 C--O 1.213 -0.817 0 C-N-CA 120.245 -0.582 . . . . 1.0 110.527 -178.819 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 113' ' ' ASN . . . . . 0.498 ' CB ' ' O ' ' A' ' 109' ' ' ILE . 18.0 t30 -44.14 -63.07 0.94 Allowed 'General case' 0 C--N 1.31 -1.118 0 CA-C-N 115.181 -0.918 . . . . 1.0 112.113 -174.659 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -57.18 -23.8 50.05 Favored 'General case' 0 C--N 1.312 -1.061 0 C-N-CA 119.743 -0.783 . . . . 1.0 111.555 -179.664 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -84.21 -58.46 2.75 Favored 'General case' 0 CA--C 1.555 1.162 0 CA-C-O 122.503 1.144 . . . . 1.0 113.846 178.191 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 116' ' ' ILE . . . . . 0.497 ' O ' ' N ' ' A' ' 119' ' ' LEU . 76.0 mt -65.88 -59.8 3.52 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.863 0 CA-C-N 113.814 -1.539 . . . . 1.0 110.825 -177.254 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 117' ' ' GLU . . . . . 0.418 ' HB3' ' O ' ' A' ' 113' ' ' ASN . 11.3 tt0 -45.1 -62.49 1.22 Allowed 'General case' 0 C--N 1.307 -1.257 0 CA-C-N 116.058 -0.519 . . . . 1.0 109.743 -178.285 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 48.7 t -53.49 -14.88 0.76 Allowed 'Isoleucine or valine' 0 N--CA 1.437 -1.119 0 C-N-CA 119.922 -0.711 . . . . 1.0 109.628 -179.782 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 119' ' ' LEU . . . . . 0.497 ' N ' ' O ' ' A' ' 116' ' ' ILE . 3.7 tp -79.79 -60.79 2.21 Favored 'General case' 0 C--N 1.348 0.527 0 C-N-CA 119.776 -0.77 . . . . 1.0 109.966 178.261 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -70.3 -85.1 0.16 Allowed Glycine 0 C--N 1.357 1.735 0 C-N-CA 118.626 -1.75 . . . . 1.0 111.285 179.925 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 7.7 m -164.57 -22.79 0.03 OUTLIER 'General case' 0 C--N 1.325 -0.478 0 N-CA-C 108.121 -1.066 . . . . 1.0 108.121 -179.035 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 122' ' ' GLY . . . . . 0.53 ' O ' ' N ' ' A' ' 124' ' ' ASP . . . 114.37 -36.42 3.98 Favored Glycine 0 CA--C 1.523 0.562 0 CA-C-O 118.125 -1.375 . . . . 1.0 113.028 179.308 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 123' ' ' THR . . . . . 0.461 ' C ' ' O ' ' A' ' 122' ' ' GLY . 0.0 OUTLIER -32.54 91.32 0.0 OUTLIER 'General case' 0 N--CA 1.47 0.573 0 CA-C-N 119.609 1.705 . . . . 1.0 112.065 -179.565 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 124' ' ' ASP . . . . . 0.53 ' N ' ' O ' ' A' ' 122' ' ' GLY . 11.6 p-10 -146.43 144.39 29.67 Favored 'General case' 0 N--CA 1.463 0.222 0 N-CA-C 108.986 -0.746 . . . . 1.0 108.986 179.051 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 125' ' ' TYR . . . . . 0.419 ' CD1' ' C ' ' A' ' 125' ' ' TYR . 0.2 OUTLIER -151.07 148.99 28.99 Favored 'General case' 0 CA--C 1.536 0.442 0 CA-C-O 121.367 0.603 . . . . 1.0 110.247 -179.962 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 74.8 mtt85 -149.57 150.88 32.92 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.59 -0.732 . . . . 1.0 110.245 178.077 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 127' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--O 1.22 -0.476 0 CA-C-O 118.042 -0.98 . . . . 1.0 109.291 178.83 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.7 mpt? . . . . . 0 N--CA 1.492 1.633 0 N-CA-C 109.061 -0.718 . . . . 1.0 109.061 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 33.4 m -107.69 7.68 28.6 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.322 -0.399 . . . . 1.0 110.402 179.872 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 3' ' ' ASP . . . . . 0.408 ' N ' ' OD1' ' A' ' 3' ' ' ASP . 1.2 p30 170.72 93.12 0.0 OUTLIER 'General case' 0 N--CA 1.463 0.213 0 CA-C-N 116.288 -0.415 . . . . 1.0 110.414 179.77 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 72.8 t80 -150.84 145.59 25.78 Favored 'General case' 0 N--CA 1.462 0.15 0 CA-C-O 120.684 0.278 . . . . 1.0 110.51 -179.998 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 5' ' ' ASP . . . . . 0.479 ' N ' ' OD1' ' A' ' 5' ' ' ASP . 3.4 p30 -155.53 151.68 27.94 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.434 -0.348 . . . . 1.0 110.444 179.901 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 6' ' ' THR . . . . . 0.617 ' O ' ' N ' ' A' ' 10' ' ' SER . 0.2 OUTLIER -64.7 169.16 5.26 Favored 'General case' 0 C--O 1.208 -1.119 0 N-CA-C 109.556 -0.535 . . . . 1.0 109.556 179.979 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . 0.527 ' O ' ' N ' ' A' ' 11' ' ' ARG . 0.0 OUTLIER -59.33 -58.05 10.33 Favored 'General case' 0 C--N 1.315 -0.93 0 CA-C-O 121.359 0.6 . . . . 1.0 110.213 -178.44 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 8' ' ' ARG . . . . . 0.509 ' O ' ' CB ' ' A' ' 12' ' ' ALA . 1.8 ptm180 -50.83 -56.31 12.8 Favored 'General case' 0 C--O 1.212 -0.899 0 N-CA-C 107.994 -1.113 . . . . 1.0 107.994 -177.825 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . 0.508 ' H ' ' HG3' ' A' ' 8' ' ' ARG . 0.0 OUTLIER -64.12 -47.46 90.06 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.966 0 CA-C-N 115.037 -0.983 . . . . 1.0 110.364 179.502 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 10' ' ' SER . . . . . 0.617 ' N ' ' O ' ' A' ' 6' ' ' THR . 47.9 t -63.81 -63.06 1.27 Allowed 'General case' 0 N--CA 1.48 1.037 0 O-C-N 123.454 0.471 . . . . 1.0 110.905 -178.968 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 11' ' ' ARG . . . . . 0.527 ' N ' ' O ' ' A' ' 7' ' ' GLU . 12.1 ttt180 -58.68 -54.82 42.8 Favored 'General case' 0 N--CA 1.469 0.489 0 N-CA-C 109.404 -0.591 . . . . 1.0 109.404 -177.069 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . 0.509 ' CB ' ' O ' ' A' ' 8' ' ' ARG . . . -46.48 -46.82 19.24 Favored 'General case' 0 N--CA 1.477 0.923 0 N-CA-C 105.762 -1.94 . . . . 1.0 105.762 -178.13 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . 0.604 ' O ' ' CB ' ' A' ' 17' ' ' LEU . 1.5 t -61.32 -52.02 66.21 Favored 'Isoleucine or valine' 0 C--O 1.206 -1.196 0 CA-C-N 114.495 -1.23 . . . . 1.0 108.147 176.004 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . 0.44 ' O ' ' CG1' ' A' ' 18' ' ' VAL . . . -57.21 -63.65 1.15 Allowed 'General case' 0 C--O 1.213 -0.86 0 C-N-CA 117.763 -1.575 . . . . 1.0 110.232 -179.876 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . 0.557 ' O ' ' N ' ' A' ' 19' ' ' GLY . . . -53.8 -56.26 19.07 Favored 'General case' 0 N--CA 1.473 0.71 0 CA-C-O 121.559 0.695 . . . . 1.0 110.916 -177.956 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . 0.459 ' CB ' ' O ' ' A' ' 12' ' ' ALA . . . -64.63 -55.57 19.4 Favored 'General case' 0 C--N 1.31 -1.112 0 CA-C-N 115.135 -0.938 . . . . 1.0 109.611 -178.419 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . 0.604 ' CB ' ' O ' ' A' ' 13' ' ' VAL . 0.3 OUTLIER -57.85 -52.14 66.73 Favored 'General case' 0 N--CA 1.474 0.766 0 CA-C-N 114.506 -1.224 . . . . 1.0 108.004 -177.516 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . 0.602 HG22 ' H ' ' A' ' 19' ' ' GLY . 2.3 m -68.37 -57.28 9.59 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.605 0 C-N-CA 118.86 -1.136 . . . . 1.0 109.706 178.685 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . 0.602 ' H ' HG22 ' A' ' 18' ' ' VAL . . . -61.95 -171.84 1.21 Allowed Glycine 0 C--N 1.332 0.319 0 N-CA-C 110.941 -0.863 . . . . 1.0 110.941 -179.059 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 20' ' ' PRO . . . . . 0.609 ' O ' ' N ' ' A' ' 24' ' ' ALA . 2.1 Cg_endo -78.24 -26.3 6.38 Favored 'Trans proline' 0 C--N 1.309 -1.514 0 C-N-CA 122.636 2.224 . . . . 1.0 113.993 -178.752 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -59.62 -58.06 16.26 Favored Glycine 0 N--CA 1.48 1.591 0 C-N-CA 120.256 -0.973 . . . . 1.0 111.808 -177.031 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -57.91 -52.12 54.13 Favored Glycine 0 N--CA 1.469 0.859 0 N-CA-C 107.112 -2.395 . . . . 1.0 107.112 -177.901 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 9.6 t -58.91 -32.66 47.79 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.078 0 CA-C-N 114.487 -0.856 . . . . 1.0 109.513 179.115 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . 0.609 ' N ' ' O ' ' A' ' 20' ' ' PRO . . . -58.51 -61.27 2.72 Favored 'General case' 0 CA--C 1.533 0.307 0 C-N-CA 118.503 -1.279 . . . . 1.0 109.579 -179.947 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -65.04 -43.85 91.03 Favored 'General case' 0 CA--C 1.535 0.387 0 N-CA-C 112.763 0.653 . . . . 1.0 112.763 -177.939 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 53.4 t -61.46 -59.83 3.66 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.171 0 C-N-CA 118.77 -1.172 . . . . 1.0 110.011 -177.626 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 2.3 p -58.39 -35.6 54.79 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.217 0 N-CA-C 112.016 0.376 . . . . 1.0 112.016 -178.071 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 6.7 ttmm -67.29 -55.09 15.33 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-O 121.727 0.775 . . . . 1.0 109.477 -179.017 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 94.9 t -64.39 -48.22 86.18 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.673 0 CA-C-N 114.281 -1.327 . . . . 1.0 111.131 -177.689 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 30' ' ' CYS . . . . . . . . . . . . . 2.2 t -65.05 -61.23 2.28 Favored 'General case' 0 N--CA 1.447 -0.601 0 C-N-CA 118.807 -1.157 . . . . 1.0 109.189 -179.255 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -62.46 -51.87 65.77 Favored 'General case' 0 CA--C 1.51 -0.56 0 N-CA-C 112.29 0.478 . . . . 1.0 112.29 -177.06 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . 0.43 ' O ' ' CB ' ' A' ' 33' ' ' LEU . . . 81.46 71.62 1.28 Allowed Glycine 0 CA--C 1.523 0.581 0 N-CA-C 108.432 -1.867 . . . . 1.0 108.432 -177.967 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . 0.44 ' O ' ' O ' ' A' ' 36' ' ' VAL . 5.2 mt 89.06 73.42 0.05 OUTLIER Pre-proline 0 N--CA 1.476 0.835 0 C-N-CA 123.293 0.637 . . . . 1.0 109.809 -179.502 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 76.6 Cg_exo -50.74 -32.14 35.45 Favored 'Trans proline' 0 N--CA 1.507 2.31 0 C-N-CA 123.728 2.952 . . . . 1.0 114.954 -179.076 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -58.43 -57.44 19.86 Favored Glycine 0 CA--C 1.533 1.161 0 C-N-CA 118.492 -1.813 . . . . 1.0 108.9 -178.828 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . 0.508 ' O ' ' HB ' ' A' ' 37' ' ' ILE . 13.9 p -92.48 167.45 1.64 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.579 0 N-CA-C 106.917 -1.512 . . . . 1.0 106.917 177.447 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . 0.508 ' HB ' ' O ' ' A' ' 36' ' ' VAL . 91.4 mt 111.22 127.09 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.478 0.971 0 C-N-CA 123.827 0.851 . . . . 1.0 109.581 -179.529 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -141.59 132.38 25.78 Favored 'General case' 0 C--N 1.331 -0.236 0 N-CA-C 108.085 -1.08 . . . . 1.0 108.085 179.792 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 7.3 p -93.31 124.43 57.69 Favored Pre-proline 0 CA--C 1.534 0.35 0 N-CA-C 109.656 -0.498 . . . . 1.0 109.656 -179.792 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 52.5 Cg_exo -50.27 -37.62 50.06 Favored 'Trans proline' 0 N--CA 1.488 1.192 0 C-N-CA 121.399 1.399 . . . . 1.0 113.21 -179.702 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -121.47 101.43 7.61 Favored 'General case' 0 N--CA 1.47 0.535 0 N-CA-C 112.614 0.598 . . . . 1.0 112.614 -177.659 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . 0.727 ' C ' ' H ' ' A' ' 44' ' ' GLY . 14.4 ptm180 -135.84 152.86 51.49 Favored 'General case' 0 C--N 1.316 -0.868 0 CA-C-O 121.735 0.779 . . . . 1.0 112.834 179.773 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 43' ' ' ARG . . . . . 0.53 ' C ' ' H ' ' A' ' 45' ' ' PHE . 61.0 ttt180 -61.18 28.97 0.01 OUTLIER 'General case' 0 CA--C 1.539 0.552 0 CA-C-N 113.531 -1.668 . . . . 1.0 109.225 -179.84 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . 0.727 ' H ' ' C ' ' A' ' 42' ' ' ARG . . . 75.65 -26.46 1.36 Allowed Glycine 0 N--CA 1.448 -0.527 0 N-CA-C 110.396 -1.081 . . . . 1.0 110.396 179.899 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . 0.699 ' CD1' ' N ' ' A' ' 45' ' ' PHE . 0.0 OUTLIER -172.79 172.61 4.07 Favored 'General case' 0 CA--C 1.536 0.423 0 CA-C-O 119.293 -0.384 . . . . 1.0 110.125 -177.867 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 46' ' ' PHE . . . . . 0.623 ' HB2' ' O ' ' A' ' 45' ' ' PHE . 0.4 OUTLIER 126.17 102.31 0.0 OUTLIER 'General case' 0 N--CA 1.505 2.296 0 O-C-N 125.675 1.859 . . . . 1.0 109.724 179.583 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 47' ' ' ARG . . . . . 0.567 ' NE ' ' O ' ' A' ' 46' ' ' PHE . 1.6 ptp180 108.1 162.37 0.0 OUTLIER 'General case' 0 N--CA 1.487 1.395 0 O-C-N 124.302 1.002 . . . . 1.0 110.669 178.942 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER 69.2 70.46 0.26 Allowed 'General case' 0 N--CA 1.453 -0.293 0 N-CA-C 108.343 -0.984 . . . . 1.0 108.343 -179.366 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 49' ' ' ASN . . . . . 0.581 ' O ' ' N ' ' A' ' 51' ' ' GLU . 2.7 p30 -147.13 138.87 13.54 Favored Pre-proline 0 CA--C 1.542 0.645 0 N-CA-C 108.252 -1.018 . . . . 1.0 108.252 179.82 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 50' ' ' PRO . . . . . 0.49 ' C ' ' H ' ' A' ' 52' ' ' ARG . 34.8 Cg_exo -54.61 72.05 0.03 OUTLIER 'Trans proline' 0 N--CA 1.502 1.987 0 C-N-CA 121.495 1.463 . . . . 1.0 112.299 179.456 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . 0.581 ' N ' ' O ' ' A' ' 49' ' ' ASN . 1.2 mp0 57.24 4.5 0.21 Allowed 'General case' 0 C--N 1.324 -0.514 0 O-C-N 121.736 -0.603 . . . . 1.0 111.091 179.304 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . 0.49 ' H ' ' C ' ' A' ' 50' ' ' PRO . 92.5 mtt180 -84.89 141.16 30.61 Favored 'General case' 0 CA--C 1.513 -0.452 0 N-CA-C 109.325 -0.62 . . . . 1.0 109.325 178.774 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 14.2 tt -66.48 146.91 12.9 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.704 0 CA-C-O 123.146 1.451 . . . . 1.0 113.355 -177.544 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -74.95 81.01 2.17 Favored 'General case' 0 C--N 1.311 -1.104 0 CA-C-N 111.309 -2.678 . . . . 1.0 111.071 -178.952 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 2.4 pp -148.49 156.89 8.13 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.888 0 N-CA-C 109.78 -0.452 . . . . 1.0 109.78 176.708 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 106.51 -3.84 37.11 Favored Glycine 0 N--CA 1.474 1.176 0 N-CA-C 110.266 -1.134 . . . . 1.0 110.266 179.575 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . 0.403 ' HB3' ' CD1' ' A' ' 45' ' ' PHE . 18.9 m-20 -80.94 103.98 11.14 Favored 'General case' 0 C--N 1.317 -0.831 0 CA-C-N 114.279 -0.96 . . . . 1.0 110.06 178.963 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 58' ' ' TRP . . . . . . . . . . . . . 5.9 m0 -90.09 172.24 8.97 Favored 'General case' 0 CA--C 1.542 0.659 0 CA-C-O 123.678 1.704 . . . . 1.0 114.288 -177.283 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 59' ' ' ARG . . . . . 0.478 ' CG ' ' N ' ' A' ' 60' ' ' TYR . 28.5 ptt-85 -78.6 -60.18 2.48 Favored 'General case' 0 CA--C 1.55 0.946 0 CA-C-N 110.451 -3.068 . . . . 1.0 113.865 -177.661 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 60' ' ' TYR . . . . . 0.478 ' N ' ' CG ' ' A' ' 59' ' ' ARG . 0.3 OUTLIER -92.21 -9.94 40.45 Favored 'General case' 0 N--CA 1.483 1.191 0 C-N-CA 124.122 0.969 . . . . 1.0 113.151 -179.728 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 22.3 tt0 -77.26 -14.73 59.7 Favored 'General case' 0 C--N 1.31 -1.133 0 CA-C-N 115.886 -0.597 . . . . 1.0 111.688 -178.3 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 62' ' ' VAL . . . . . 0.605 ' O ' ' N ' ' A' ' 66' ' ' GLY . 0.6 OUTLIER -48.05 -55.85 2.43 Favored 'Isoleucine or valine' 0 C--O 1.207 -1.14 0 C-N-CA 119.825 -0.75 . . . . 1.0 110.265 -175.156 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 63' ' ' ALA . . . . . 0.508 ' O ' ' HG3' ' A' ' 67' ' ' ARG . . . -65.98 -52.73 46.93 Favored 'General case' 0 C--N 1.307 -1.269 0 C-N-CA 119.722 -0.791 . . . . 1.0 109.75 -178.966 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 85.4 m-70 -48.9 -57.37 6.55 Favored 'General case' 0 N--CA 1.472 0.626 0 O-C-N 124.093 0.871 . . . . 1.0 109.964 -179.72 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 65' ' ' ASP . . . . . 0.644 ' C ' ' H ' ' A' ' 67' ' ' ARG . 5.8 t0 -72.45 -47.83 45.78 Favored 'General case' 0 C--N 1.313 -1.001 0 CA-C-O 121.582 0.706 . . . . 1.0 110.362 178.8 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . 0.605 ' N ' ' O ' ' A' ' 62' ' ' VAL . . . -70.71 26.47 0.5 Allowed Glycine 0 C--N 1.32 -0.322 0 O-C-N 120.868 -1.145 . . . . 1.0 110.636 177.985 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 67' ' ' ARG . . . . . 0.644 ' H ' ' C ' ' A' ' 65' ' ' ASP . 6.0 mtp85 -73.11 3.89 5.02 Favored 'General case' 0 N--CA 1.445 -0.688 0 N-CA-C 106.514 -1.661 . . . . 1.0 106.514 175.418 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . 0.529 ' H ' ' C ' ' A' ' 66' ' ' GLY . 0.0 OUTLIER -33.21 -29.65 0.01 OUTLIER 'General case' 0 N--CA 1.486 1.367 0 N-CA-C 108.489 -0.93 . . . . 1.0 108.489 -176.794 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . 0.606 ' N ' ' O ' ' A' ' 67' ' ' ARG . 22.2 mt -61.87 -63.39 1.27 Allowed 'General case' 0 C--N 1.315 -0.933 0 C-N-CA 118.542 -1.263 . . . . 1.0 107.814 178.289 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . 0.648 ' C ' ' H ' ' A' ' 72' ' ' HIS . . . -79.18 -75.28 0.25 Allowed 'General case' 0 N--CA 1.465 0.303 0 N-CA-C 106.271 -1.752 . . . . 1.0 106.271 176.635 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 71' ' ' ALA . . . . . 0.459 ' O ' ' C ' ' A' ' 72' ' ' HIS . . . -44.1 3.71 0.0 OUTLIER 'General case' 0 CA--C 1.519 -0.223 0 C-N-CA 124.826 1.25 . . . . 1.0 113.831 178.947 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 72' ' ' HIS . . . . . 0.648 ' H ' ' C ' ' A' ' 70' ' ' ALA . 0.2 OUTLIER -28.4 -67.85 0.07 Allowed 'General case' 0 N--CA 1.463 0.19 0 CA-C-N 118.36 0.527 . . . . 1.0 111.589 -178.658 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 73' ' ' MET . . . . . . . . . . . . . 13.8 ptp -69.57 -48.57 59.82 Favored 'General case' 0 C--N 1.325 -0.469 0 C-N-CA 118.983 -1.087 . . . . 1.0 108.968 178.525 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . 0.767 ' C ' ' H ' ' A' ' 76' ' ' GLY . 68.8 t -43.76 -40.54 1.48 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.265 0 CA-C-O 117.351 -1.309 . . . . 1.0 111.539 -176.35 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 75' ' ' ASN . . . . . 0.47 ' C ' ' N ' ' A' ' 77' ' ' ILE . 3.0 m120 -35.14 -12.62 0.0 OUTLIER 'General case' 0 N--CA 1.501 2.078 0 CA-C-N 121.244 1.838 . . . . 1.0 112.257 179.277 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 76' ' ' GLY . . . . . 0.767 ' H ' ' C ' ' A' ' 74' ' ' VAL . . . -45.72 -21.44 0.55 Allowed Glycine 0 CA--C 1.542 1.739 0 N-CA-C 107.844 -2.102 . . . . 1.0 107.844 175.173 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 77' ' ' ILE . . . . . 0.639 HG13 ' H ' ' A' ' 78' ' ' VAL . 1.2 pt -72.11 -55.9 11.86 Favored 'Isoleucine or valine' 0 C--O 1.216 -0.692 0 N-CA-C 107.696 -1.224 . . . . 1.0 107.696 178.021 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . 0.639 ' H ' HG13 ' A' ' 77' ' ' ILE . 95.8 t -33.79 -34.99 0.04 OUTLIER 'Isoleucine or valine' 0 CA--C 1.546 0.794 0 CA-C-N 113.2 -1.818 . . . . 1.0 106.849 -177.565 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . 0.538 ' N ' ' O ' ' A' ' 77' ' ' ILE . 0.0 OUTLIER -98.31 -33.24 4.12 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.878 0 CA-C-N 115.605 -0.725 . . . . 1.0 112.416 176.556 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 80' ' ' ALA . . . . . 0.537 ' N ' ' O ' ' A' ' 77' ' ' ILE . . . -84.2 -10.71 57.5 Favored 'General case' 0 N--CA 1.478 0.974 0 O-C-N 121.257 -0.902 . . . . 1.0 113.184 179.662 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 81' ' ' GLU . . . . . 0.445 ' N ' ' O ' ' A' ' 77' ' ' ILE . 0.0 OUTLIER -89.27 -73.89 0.49 Allowed 'General case' 0 N--CA 1.451 -0.424 0 N-CA-C 112.115 0.413 . . . . 1.0 112.115 -177.629 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 24.3 m-20 -91.75 -16.8 26.35 Favored 'General case' 0 C--N 1.346 0.437 0 N-CA-C 114.532 1.308 . . . . 1.0 114.532 -179.096 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . 0.569 ' O ' ' N ' ' A' ' 86' ' ' ALA . . . -49.67 -42.12 44.68 Favored 'General case' 0 C--O 1.211 -0.965 0 C-N-CA 118.304 -1.358 . . . . 1.0 110.792 -177.391 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -40.33 -35.13 0.39 Allowed 'General case' 0 CA--C 1.543 0.7 0 CA-C-O 120.819 0.342 . . . . 1.0 111.131 -179.789 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 1.2 pp -74.4 -33.69 34.21 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.433 0 C-N-CA 119.999 -0.68 . . . . 1.0 110.125 178.477 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 86' ' ' ALA . . . . . 0.569 ' N ' ' O ' ' A' ' 83' ' ' ALA . . . -96.23 -26.36 15.46 Favored 'General case' 0 CA--C 1.54 0.573 0 CA-C-O 120.798 0.333 . . . . 1.0 111.698 179.175 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 87' ' ' GLU . . . . . 0.567 ' C ' ' H ' ' A' ' 89' ' ' VAL . 44.8 tt0 -57.9 -20.25 35.75 Favored 'General case' 0 C--N 1.329 -0.318 0 O-C-N 121.667 -0.646 . . . . 1.0 110.103 -178.833 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -71.98 -1.6 15.13 Favored 'General case' 0 N--CA 1.47 0.533 0 N-CA-C 107.494 -1.299 . . . . 1.0 107.494 178.095 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 89' ' ' VAL . . . . . 0.567 ' H ' ' C ' ' A' ' 87' ' ' GLU . 3.5 t -98.54 36.02 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.447 -0.616 0 CA-C-N 111.922 -2.399 . . . . 1.0 107.831 177.029 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 90' ' ' GLY . . . . . 0.844 ' O ' ' N ' ' A' ' 92' ' ' HIS . . . -55.95 -26.91 49.56 Favored Glycine 0 C--N 1.367 2.26 0 CA-C-O 117.609 -1.662 . . . . 1.0 111.519 176.672 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 91' ' ' PRO . . . . . 0.664 ' HD2' ' N ' ' A' ' 90' ' ' GLY . 11.5 Cg_exo -36.48 3.09 0.0 OUTLIER 'Trans proline' 0 N--CA 1.499 1.803 0 C-N-CA 123.084 2.523 . . . . 1.0 113.68 173.913 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 92' ' ' HIS . . . . . 0.844 ' N ' ' O ' ' A' ' 90' ' ' GLY . 0.0 OUTLIER -47.48 -27.91 1.95 Allowed 'General case' 0 N--CA 1.436 -1.141 0 N-CA-C 106.942 -1.503 . . . . 1.0 106.942 -179.887 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 93' ' ' LEU . . . . . 0.608 ' HG ' ' H ' ' A' ' 94' ' ' ALA . 2.0 pp -58.49 -52.46 65.55 Favored 'General case' 0 N--CA 1.448 -0.545 0 N-CA-C 106.931 -1.507 . . . . 1.0 106.931 176.417 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 94' ' ' ALA . . . . . 0.608 ' H ' ' HG ' ' A' ' 93' ' ' LEU . . . -49.8 -52.05 35.05 Favored 'General case' 0 C--O 1.221 -0.447 0 N-CA-C 107.457 -1.312 . . . . 1.0 107.457 -179.84 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 1.3 mpt_? -64.37 -31.44 72.64 Favored 'General case' 0 C--N 1.321 -0.666 0 N-CA-C 109.386 -0.598 . . . . 1.0 109.386 178.146 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 96' ' ' ALA . . . . . 0.842 ' O ' ' N ' ' A' ' 100' ' ' ILE . . . -50.87 -44.17 59.63 Favored 'General case' 0 C--O 1.197 -1.673 0 N-CA-C 106.368 -1.716 . . . . 1.0 106.368 -176.448 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 97' ' ' LEU . . . . . 0.488 ' O ' ' CG2' ' A' ' 100' ' ' ILE . 2.1 tt -35.05 -24.84 0.01 OUTLIER 'General case' 0 CA--C 1.588 2.423 0 CA-C-N 112.585 -2.098 . . . . 1.0 107.625 -178.937 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 98' ' ' GLY . . . . . 0.674 ' N ' ' O ' ' A' ' 96' ' ' ALA . . . -89.32 -51.84 2.85 Favored Glycine 0 CA--C 1.563 3.043 0 CA-C-O 123.312 1.507 . . . . 1.0 111.686 170.763 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 99' ' ' GLN . . . . . 0.562 ' N ' ' O ' ' A' ' 96' ' ' ALA . 6.3 mt-30 -76.72 8.43 3.66 Favored 'General case' 0 N--CA 1.437 -1.111 0 N-CA-C 106.607 -1.627 . . . . 1.0 106.607 177.676 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 100' ' ' ILE . . . . . 0.842 ' N ' ' O ' ' A' ' 96' ' ' ALA . 20.3 tt -59.36 -52.98 54.47 Favored 'Isoleucine or valine' 0 CA--C 1.474 -1.971 0 N-CA-C 106.276 -1.75 . . . . 1.0 106.276 178.296 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 101' ' ' VAL . . . . . 0.584 ' O ' ' N ' ' A' ' 105' ' ' GLY . 0.2 OUTLIER -57.05 -61.03 1.4 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.658 0 C-N-CA 118.273 -1.371 . . . . 1.0 108.299 179.415 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 102' ' ' CYS . . . . . 0.512 ' H ' HG11 ' A' ' 101' ' ' VAL . 0.1 OUTLIER -50.63 -25.03 3.73 Favored 'General case' 0 C--N 1.317 -0.845 0 C-N-CA 120.588 -0.445 . . . . 1.0 111.179 -177.15 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 68.8 ttp85 -85.74 -49.0 8.29 Favored 'General case' 0 N--CA 1.482 1.158 0 O-C-N 124.731 1.269 . . . . 1.0 112.566 179.238 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 104' ' ' TYR . . . . . 0.735 ' CG ' ' O ' ' A' ' 104' ' ' TYR . 0.1 OUTLIER -96.38 23.63 6.55 Favored 'General case' 0 C--N 1.302 -1.457 0 C-N-CA 126.918 2.087 . . . . 1.0 108.788 179.401 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 105' ' ' GLY . . . . . 0.584 ' N ' ' O ' ' A' ' 101' ' ' VAL . . . -162.56 -93.4 0.09 OUTLIER Glycine 0 N--CA 1.45 -0.402 0 N-CA-C 106.608 -2.597 . . . . 1.0 106.608 178.313 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 106' ' ' ALA . . . . . 0.638 ' O ' ' CD ' ' A' ' 110' ' ' PRO . . . 69.06 64.14 0.29 Allowed 'General case' 0 C--O 1.219 -0.548 0 N-CA-C 113.146 0.795 . . . . 1.0 113.146 179.267 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 96.2 m -78.21 -58.73 3.1 Favored 'General case' 0 CA--C 1.547 0.829 0 O-C-N 121.152 -0.967 . . . . 1.0 109.353 179.529 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 3.8 p -58.64 -44.38 89.52 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-O 121.856 0.836 . . . . 1.0 109.662 -177.376 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 3.3 mm -41.41 -61.41 1.4 Allowed Pre-proline 0 CA--C 1.569 1.689 0 CA-C-N 114.134 -1.394 . . . . 1.0 109.217 179.769 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 110' ' ' PRO . . . . . 0.638 ' CD ' ' O ' ' A' ' 106' ' ' ALA . 21.5 Cg_exo -47.64 -36.92 26.23 Favored 'Trans proline' 0 N--CA 1.502 1.998 0 C-N-CA 123.511 2.807 . . . . 1.0 113.401 174.802 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 111' ' ' ASN . . . . . 0.431 ' C ' ' N ' ' A' ' 113' ' ' ASN . 5.4 t30 -67.7 -67.78 0.43 Allowed 'General case' 0 C--O 1.236 0.381 0 O-C-N 121.082 -1.011 . . . . 1.0 109.946 -177.999 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 2.1 pt -49.02 -24.37 1.11 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-O 122.481 1.134 . . . . 1.0 109.154 -179.531 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 113' ' ' ASN . . . . . 0.436 ' HB3' ' O ' ' A' ' 110' ' ' PRO . 40.1 t30 -59.72 -53.71 54.77 Favored 'General case' 0 C--N 1.307 -1.264 0 CA-C-N 112.649 -2.069 . . . . 1.0 107.778 -177.695 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -56.92 -32.42 65.92 Favored 'General case' 0 N--CA 1.445 -0.687 0 CA-C-O 119.04 -0.505 . . . . 1.0 112.262 -179.652 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -78.83 -47.25 16.99 Favored 'General case' 0 C--O 1.211 -0.925 0 CA-C-O 122.314 1.054 . . . . 1.0 110.109 178.487 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 116' ' ' ILE . . . . . 0.468 ' O ' ' N ' ' A' ' 120' ' ' GLY . 32.2 mt -53.67 -53.09 28.27 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.101 0 CA-C-N 113.507 -1.679 . . . . 1.0 107.452 -179.148 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 10.6 tt0 -44.36 -64.68 0.63 Allowed 'General case' 0 C--N 1.317 -0.816 0 CA-C-N 112.915 -1.948 . . . . 1.0 108.385 -179.249 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 29.2 m -59.6 -50.7 79.0 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.663 0 C-N-CA 119.652 -0.819 . . . . 1.0 109.723 179.885 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -52.54 -71.29 0.07 Allowed 'General case' 0 CA--C 1.539 0.534 0 N-CA-C 106.845 -1.539 . . . . 1.0 106.845 -178.083 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 120' ' ' GLY . . . . . 0.706 ' O ' ' OG1' ' A' ' 121' ' ' THR . . . -69.28 -79.2 0.3 Allowed Glycine 0 CA--C 1.539 1.537 0 C-N-CA 119.133 -1.508 . . . . 1.0 111.023 179.964 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 121' ' ' THR . . . . . 0.706 ' OG1' ' O ' ' A' ' 120' ' ' GLY . 51.8 m 157.3 -32.01 0.0 OUTLIER 'General case' 0 N--CA 1.487 1.417 0 CA-C-N 112.422 -1.889 . . . . 1.0 111.818 179.859 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 122' ' ' GLY . . . . . 0.621 ' O ' ' N ' ' A' ' 124' ' ' ASP . . . 98.0 -21.81 44.12 Favored Glycine 0 N--CA 1.465 0.613 0 N-CA-C 108.027 -2.029 . . . . 1.0 108.027 -177.291 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 123' ' ' THR . . . . . 0.547 ' O ' ' CE1' ' A' ' 72' ' ' HIS . 58.3 m -46.22 90.61 0.0 OUTLIER 'General case' 0 N--CA 1.476 0.839 0 N-CA-C 105.928 -1.878 . . . . 1.0 105.928 177.832 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 124' ' ' ASP . . . . . 0.621 ' N ' ' O ' ' A' ' 122' ' ' GLY . 51.4 p-10 -162.86 171.1 17.19 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 115.596 -0.729 . . . . 1.0 112.177 -179.343 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 125' ' ' TYR . . . . . . . . . . . . . 86.0 t80 -142.55 141.91 32.11 Favored 'General case' 0 C--N 1.329 -0.315 0 N-CA-C 108.758 -0.831 . . . . 1.0 108.758 176.593 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 126' ' ' ARG . . . . . 0.423 HH12 ' CG2' ' A' ' 79' ' ' ILE . 14.3 mmm180 -147.75 147.87 30.35 Favored 'General case' 0 CA--C 1.533 0.306 0 N-CA-C 109.876 -0.416 . . . . 1.0 109.876 179.218 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 127' ' ' PHE . . . . . . . . . . . . . 23.2 t80 . . . . . 0 N--CA 1.471 0.607 0 CA-C-O 117.995 -1.003 . . . . 1.0 110.824 179.775 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 2.7 mmt . . . . . 0 N--CA 1.489 1.479 0 N-CA-C 108.838 -0.801 . . . . 1.0 108.838 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 2' ' ' SER . . . . . 0.503 ' O ' ' CB ' ' A' ' 3' ' ' ASP . 47.1 t -73.36 4.94 4.07 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.218 -0.446 . . . . 1.0 110.732 179.777 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 3' ' ' ASP . . . . . 0.503 ' CB ' ' O ' ' A' ' 2' ' ' SER . 12.0 p30 149.22 135.57 0.0 OUTLIER 'General case' 0 N--CA 1.478 0.928 0 O-C-N 123.725 0.64 . . . . 1.0 110.81 179.759 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 87.3 t80 -154.15 149.43 27.07 Favored 'General case' 0 CA--C 1.518 -0.268 0 CA-C-O 121.014 0.435 . . . . 1.0 110.365 178.982 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -150.78 147.33 27.16 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.133 -0.485 . . . . 1.0 110.055 179.935 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 6' ' ' THR . . . . . 0.731 ' O ' ' N ' ' A' ' 10' ' ' SER . 0.2 OUTLIER -112.21 -162.74 0.81 Allowed 'General case' 0 C--O 1.207 -1.172 0 CA-C-O 121.629 0.728 . . . . 1.0 110.749 -178.639 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . 0.489 ' O ' ' HB2' ' A' ' 11' ' ' ARG . 73.2 mm-40 -54.41 -43.45 71.52 Favored 'General case' 0 C--N 1.304 -1.399 0 CA-C-O 121.984 0.897 . . . . 1.0 108.733 -179.233 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 8' ' ' ARG . . . . . 0.541 ' O ' ' CB ' ' A' ' 12' ' ' ALA . 60.0 mtp180 -72.73 -60.68 2.12 Favored 'General case' 0 C--N 1.313 -0.987 0 C-N-CA 118.095 -1.442 . . . . 1.0 110.487 177.713 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . 0.956 ' O ' ' HB ' ' A' ' 13' ' ' VAL . 10.7 t -60.51 -51.11 76.91 Favored 'Isoleucine or valine' 0 C--O 1.196 -1.761 0 C-N-CA 117.921 -1.512 . . . . 1.0 110.639 179.963 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 10' ' ' SER . . . . . 0.731 ' N ' ' O ' ' A' ' 6' ' ' THR . 2.6 t -70.09 -66.25 0.62 Allowed 'General case' 0 C--N 1.303 -1.445 0 O-C-N 121.271 -0.893 . . . . 1.0 113.03 -178.775 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 11' ' ' ARG . . . . . 0.489 ' HB2' ' O ' ' A' ' 7' ' ' GLU . 1.7 mmt85 -62.11 -43.87 97.89 Favored 'General case' 0 C--N 1.318 -0.787 0 CA-C-O 120.455 0.169 . . . . 1.0 111.4 -176.496 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . 0.541 ' CB ' ' O ' ' A' ' 8' ' ' ARG . . . -70.74 -59.7 2.66 Favored 'General case' 0 C--N 1.32 -0.68 0 C-N-CA 118.4 -1.32 . . . . 1.0 110.241 -179.993 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . 0.956 ' HB ' ' O ' ' A' ' 9' ' ' VAL . 4.6 t -57.35 -51.3 71.28 Favored 'Isoleucine or valine' 0 C--O 1.199 -1.605 0 N-CA-C 107.029 -1.471 . . . . 1.0 107.029 179.503 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . 0.675 ' O ' HG23 ' A' ' 18' ' ' VAL . . . -62.06 -66.5 0.53 Allowed 'General case' 0 C--N 1.306 -1.284 0 C-N-CA 115.549 -2.461 . . . . 1.0 113.061 -178.765 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . 0.543 ' O ' ' N ' ' A' ' 19' ' ' GLY . . . -51.18 -55.27 18.82 Favored 'General case' 0 C--N 1.319 -0.737 0 C-N-CA 119.706 -0.797 . . . . 1.0 109.257 -178.728 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . 0.644 ' O ' ' N ' ' A' ' 22' ' ' GLY . . . -64.35 -59.17 4.69 Favored 'General case' 0 C--N 1.299 -1.605 0 C-N-CA 118.101 -1.44 . . . . 1.0 111.346 -179.924 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . 0.701 ' CB ' ' O ' ' A' ' 13' ' ' VAL . 6.8 tt -55.09 -55.23 33.36 Favored 'General case' 0 N--CA 1.477 0.876 0 N-CA-C 108.832 -0.803 . . . . 1.0 108.832 -177.051 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . 0.781 HG23 ' H ' ' A' ' 19' ' ' GLY . 2.3 m -71.26 -58.86 4.22 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 CA-C-N 115.895 -0.593 . . . . 1.0 110.212 -179.817 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . 0.781 ' H ' HG23 ' A' ' 18' ' ' VAL . . . -58.16 -166.44 0.12 Allowed Glycine 0 CA--C 1.491 -1.454 0 N-CA-C 110.815 -0.914 . . . . 1.0 110.815 -177.322 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 20' ' ' PRO . . . . . 0.607 ' O ' ' N ' ' A' ' 24' ' ' ALA . 1.0 OUTLIER -79.85 -26.18 4.72 Favored 'Trans proline' 0 C--N 1.292 -2.421 0 C-N-CA 122.032 1.822 . . . . 1.0 113.59 -177.657 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . 0.432 ' O ' ' HB2' ' A' ' 24' ' ' ALA . . . -62.68 -58.49 11.97 Favored Glycine 0 N--CA 1.473 1.156 0 C-N-CA 119.496 -1.335 . . . . 1.0 111.877 -178.217 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . 0.644 ' N ' ' O ' ' A' ' 16' ' ' ALA . . . -57.61 -54.15 39.53 Favored Glycine 0 C--N 1.307 -1.068 0 C-N-CA 116.447 -2.787 . . . . 1.0 107.073 -178.778 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 54.0 t -52.63 -31.26 15.8 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.042 0 N-CA-C 107.859 -1.163 . . . . 1.0 107.859 178.564 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . 0.607 ' N ' ' O ' ' A' ' 20' ' ' PRO . . . -63.72 -63.9 1.04 Allowed 'General case' 0 C--O 1.218 -0.593 0 C-N-CA 119.416 -0.914 . . . . 1.0 110.969 -179.467 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 61.6 mt -61.64 -46.47 89.63 Favored 'General case' 0 C--N 1.321 -0.64 0 C-N-CA 119.666 -0.814 . . . . 1.0 111.881 -176.571 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 92.1 t -60.35 -60.75 2.1 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.531 0 C-N-CA 119.708 -0.797 . . . . 1.0 110.041 -177.004 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . 0.479 ' O ' ' CB ' ' A' ' 31' ' ' ALA . 2.2 p -54.81 -36.68 38.05 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.736 0 C-N-CA 119.622 -0.831 . . . . 1.0 109.203 -177.819 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . 0.401 ' HB2' ' O ' ' A' ' 24' ' ' ALA . 3.7 tmmm? -66.2 -55.52 15.85 Favored 'General case' 0 C--N 1.315 -0.892 0 C-N-CA 119.254 -0.979 . . . . 1.0 110.713 -177.532 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 82.3 t -62.95 -49.9 81.76 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.973 0 CA-C-N 114.641 -1.163 . . . . 1.0 110.135 -177.517 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 30' ' ' CYS . . . . . . . . . . . . . 4.1 t -65.27 -62.11 1.73 Allowed 'General case' 0 N--CA 1.443 -0.822 0 C-N-CA 119.675 -0.81 . . . . 1.0 109.458 -178.544 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . 0.479 ' CB ' ' O ' ' A' ' 27' ' ' VAL . . . -51.71 -46.44 63.93 Favored 'General case' 0 CA--C 1.5 -0.97 0 CA-C-O 121.282 0.563 . . . . 1.0 110.568 -176.23 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . 0.462 ' O ' ' CB ' ' A' ' 33' ' ' LEU . . . 66.56 67.05 2.13 Favored Glycine 0 N--CA 1.443 -0.896 0 N-CA-C 109.627 -1.389 . . . . 1.0 109.627 -179.998 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . 0.462 ' CB ' ' O ' ' A' ' 32' ' ' GLY . 0.3 OUTLIER 82.88 104.26 0.03 OUTLIER Pre-proline 0 CA--C 1.542 0.644 0 CA-C-N 113.048 -1.576 . . . . 1.0 108.343 -178.622 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 52.2 Cg_exo -48.64 -20.34 2.64 Favored 'Trans proline' 0 N--CA 1.499 1.825 0 C-N-CA 122.504 2.136 . . . . 1.0 114.293 -178.259 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -67.54 -62.72 4.16 Favored Glycine 0 N--CA 1.467 0.74 0 C-N-CA 118.357 -1.877 . . . . 1.0 112.27 -176.73 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . 0.622 ' O ' HG21 ' A' ' 37' ' ' ILE . 18.3 m -78.83 -153.88 0.03 OUTLIER 'Isoleucine or valine' 0 C--O 1.216 -0.696 0 N-CA-C 108.121 -1.066 . . . . 1.0 108.121 -179.119 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . 0.64 ' O ' ' CG2' ' A' ' 37' ' ' ILE . 0.3 OUTLIER 73.63 77.06 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.32 -0.688 0 O-C-N 124.2 0.938 . . . . 1.0 111.553 178.97 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 1.3 t60 -139.32 135.73 34.08 Favored 'General case' 0 CA--C 1.492 -1.278 0 O-C-N 120.906 -1.121 . . . . 1.0 109.329 179.4 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 3.3 m -115.32 132.19 23.2 Favored Pre-proline 0 N--CA 1.451 -0.409 0 C-N-CA 120.413 -0.515 . . . . 1.0 109.984 -178.913 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 23.6 Cg_endo -62.14 -15.21 42.56 Favored 'Trans proline' 0 N--CA 1.494 1.52 0 C-N-CA 122.039 1.826 . . . . 1.0 112.179 179.356 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -128.79 135.11 48.7 Favored 'General case' 0 N--CA 1.468 0.438 0 CA-C-N 116.729 -0.214 . . . . 1.0 110.504 178.399 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . 0.566 ' CG ' ' H ' ' A' ' 43' ' ' ARG . 39.1 ttp180 -173.16 174.25 3.45 Favored 'General case' 0 C--N 1.328 -0.339 0 C-N-CA 120.558 -0.457 . . . . 1.0 111.14 178.718 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 43' ' ' ARG . . . . . 0.566 ' H ' ' CG ' ' A' ' 42' ' ' ARG . 67.1 ttt-85 -57.61 -45.97 84.68 Favored 'General case' 0 CA--C 1.538 0.517 0 N-CA-C 107.697 -1.224 . . . . 1.0 107.697 178.53 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . 0.436 ' O ' ' CD1' ' A' ' 45' ' ' PHE . . . 121.58 -25.03 7.04 Favored Glycine 0 N--CA 1.481 1.675 0 CA-C-N 116.925 -0.125 . . . . 1.0 112.829 179.653 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . 0.75 ' O ' ' HB2' ' A' ' 46' ' ' PHE . 1.5 m-85 -158.58 167.52 29.38 Favored 'General case' 0 C--N 1.306 -1.314 0 N-CA-C 108.23 -1.026 . . . . 1.0 108.23 179.564 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 46' ' ' PHE . . . . . 0.75 ' HB2' ' O ' ' A' ' 45' ' ' PHE . 0.2 OUTLIER 107.45 116.7 0.01 OUTLIER 'General case' 0 N--CA 1.472 0.66 0 O-C-N 125.094 1.496 . . . . 1.0 111.367 179.408 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 47' ' ' ARG . . . . . 0.459 ' CB ' ' O ' ' A' ' 46' ' ' PHE . 9.5 ptt85 90.36 156.5 0.04 OUTLIER 'General case' 0 N--CA 1.479 1.01 0 O-C-N 123.64 0.587 . . . . 1.0 111.405 179.325 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 37.3 t 61.15 68.08 0.76 Allowed 'General case' 0 CA--C 1.509 -0.609 0 CA-C-N 116.151 -0.477 . . . . 1.0 109.851 179.145 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 49' ' ' ASN . . . . . 0.667 ' O ' ' N ' ' A' ' 51' ' ' GLU . 0.2 OUTLIER -149.56 159.14 36.97 Favored Pre-proline 0 C--N 1.315 -0.898 0 CA-C-N 115.869 -0.605 . . . . 1.0 109.381 179.203 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 4.1 Cg_endo -48.87 53.34 0.02 OUTLIER 'Trans proline' 0 N--CA 1.511 2.527 0 C-N-CA 123.981 3.121 . . . . 1.0 113.919 177.544 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . 0.667 ' N ' ' O ' ' A' ' 49' ' ' ASN . 2.7 mm-40 42.56 57.71 3.37 Favored 'General case' 0 CA--C 1.536 0.414 0 CA-C-O 121.246 0.546 . . . . 1.0 111.756 178.038 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . 0.647 HH21 ' CD1' ' A' ' 85' ' ' ILE . 2.5 ptm180 -156.36 168.83 26.12 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.308 -0.406 . . . . 1.0 111.501 179.225 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . 0.42 HG13 ' N ' ' A' ' 54' ' ' GLN . 7.4 tp -83.44 166.94 2.06 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 N-CA-C 108.612 -0.884 . . . . 1.0 108.612 176.65 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 54' ' ' GLN . . . . . 0.42 ' N ' HG13 ' A' ' 53' ' ' ILE . 35.8 mt-30 -134.72 134.31 40.88 Favored 'General case' 0 N--CA 1.467 0.415 0 O-C-N 121.775 -0.578 . . . . 1.0 109.551 179.419 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 19.9 tt -144.36 154.06 15.12 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.637 0 N-CA-C 110.139 -0.319 . . . . 1.0 110.139 178.948 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 103.23 4.51 47.29 Favored Glycine 0 N--CA 1.469 0.866 0 N-CA-C 110.178 -1.169 . . . . 1.0 110.178 -179.059 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 29.3 t70 -95.49 114.16 25.89 Favored 'General case' 0 CA--C 1.54 0.589 0 N-CA-C 113.632 0.975 . . . . 1.0 113.632 -178.886 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 58' ' ' TRP . . . . . 0.442 ' HB2' ' HB2' ' A' ' 61' ' ' GLU . 35.4 m95 -83.07 -176.69 6.46 Favored 'General case' 0 C--O 1.236 0.375 0 CA-C-N 112.527 -2.124 . . . . 1.0 109.677 176.15 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 59' ' ' ARG . . . . . 0.572 ' HD2' ' H ' ' A' ' 59' ' ' ARG . 0.0 OUTLIER -94.45 -55.61 3.1 Favored 'General case' 0 CA--C 1.547 0.844 0 CA-C-O 121.545 0.688 . . . . 1.0 110.471 179.566 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 60' ' ' TYR . . . . . 0.544 ' CG ' ' O ' ' A' ' 60' ' ' TYR . 4.7 t80 -73.96 -5.69 42.78 Favored 'General case' 0 N--CA 1.469 0.481 0 C-N-CA 124.338 1.055 . . . . 1.0 110.146 178.317 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . 0.529 ' O ' ' N ' ' A' ' 64' ' ' HIS . 4.7 tt0 -68.57 -17.91 64.23 Favored 'General case' 0 C--N 1.312 -1.058 0 O-C-N 121.07 -1.019 . . . . 1.0 111.444 -179.56 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 62' ' ' VAL . . . . . 0.443 ' C ' ' O ' ' A' ' 61' ' ' GLU . 16.1 m -42.01 -49.63 0.93 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.504 0 CA-C-O 121.118 0.485 . . . . 1.0 109.706 -174.42 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -64.23 -45.25 89.0 Favored 'General case' 0 N--CA 1.42 -1.958 0 N-CA-C 108.316 -0.994 . . . . 1.0 108.316 177.039 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 64' ' ' HIS . . . . . 0.529 ' N ' ' O ' ' A' ' 61' ' ' GLU . 0.1 OUTLIER -56.68 -61.3 2.52 Favored 'General case' 0 CA--C 1.537 0.455 0 C-N-CA 118.927 -1.109 . . . . 1.0 111.108 179.803 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 65' ' ' ASP . . . . . 0.693 ' C ' ' H ' ' A' ' 67' ' ' ARG . 4.6 m-20 -63.19 -48.44 78.32 Favored 'General case' 0 C--O 1.24 0.594 0 CA-C-O 121.526 0.679 . . . . 1.0 109.808 179.139 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -62.2 28.76 0.06 OUTLIER Glycine 0 C--N 1.317 -0.499 0 N-CA-C 110.87 -0.892 . . . . 1.0 110.87 -179.09 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 67' ' ' ARG . . . . . 0.693 ' H ' ' C ' ' A' ' 65' ' ' ASP . 0.0 OUTLIER -82.92 -13.82 55.33 Favored 'General case' 0 N--CA 1.436 -1.153 0 C-N-CA 122.766 0.426 . . . . 1.0 111.558 176.394 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . 0.671 ' O ' ' HA ' ' A' ' 72' ' ' HIS . 0.8 OUTLIER -40.24 -30.11 0.09 Allowed 'General case' 0 C--O 1.22 -0.451 0 N-CA-C 107.009 -1.478 . . . . 1.0 107.009 179.05 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . 0.488 ' N ' ' C ' ' A' ' 67' ' ' ARG . 3.4 tt -65.67 -66.12 0.59 Allowed 'General case' 0 C--N 1.311 -1.071 0 C-N-CA 117.39 -1.724 . . . . 1.0 108.267 177.877 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . 0.706 ' C ' ' H ' ' A' ' 72' ' ' HIS . . . -76.32 -74.45 0.23 Allowed 'General case' 0 N--CA 1.466 0.346 0 N-CA-C 108.895 -0.78 . . . . 1.0 108.895 -179.753 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 71' ' ' ALA . . . . . 0.589 ' O ' ' N ' ' A' ' 74' ' ' VAL . . . -58.0 13.51 0.01 OUTLIER 'General case' 0 C--N 1.321 -0.65 0 C-N-CA 124.25 1.02 . . . . 1.0 110.851 -178.163 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 72' ' ' HIS . . . . . 0.706 ' H ' ' C ' ' A' ' 70' ' ' ALA . 0.3 OUTLIER -12.07 -74.53 0.01 OUTLIER 'General case' 0 N--CA 1.478 0.959 0 C-N-CA 124.295 1.038 . . . . 1.0 113.113 -174.654 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 73' ' ' MET . . . . . . . . . . . . . 1.4 mpt? -62.63 -41.91 99.29 Favored 'General case' 0 C--N 1.285 -2.216 0 C-N-CA 119.164 -1.014 . . . . 1.0 111.565 -178.431 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . 0.589 ' N ' ' O ' ' A' ' 71' ' ' ALA . 41.4 t -44.27 -49.3 2.12 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.346 0 C-N-CA 119.864 -0.734 . . . . 1.0 110.103 -175.515 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 75' ' ' ASN . . . . . 0.499 ' C ' ' H ' ' A' ' 77' ' ' ILE . 14.0 t-20 -39.52 -21.57 0.01 OUTLIER 'General case' 0 N--CA 1.472 0.664 0 CA-C-O 122.787 1.279 . . . . 1.0 111.441 -179.815 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 76' ' ' GLY . . . . . 0.569 ' N ' ' O ' ' A' ' 74' ' ' VAL . . . -43.87 -19.5 0.11 Allowed Glycine 0 CA--C 1.539 1.585 0 CA-C-N 113.662 -1.608 . . . . 1.0 109.827 178.674 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 77' ' ' ILE . . . . . 0.65 ' O ' ' N ' ' A' ' 80' ' ' ALA . 10.3 pt -88.17 -47.0 15.72 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.45 0 N-CA-C 108.386 -0.968 . . . . 1.0 108.386 -178.674 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . 0.506 ' O ' ' HB3' ' A' ' 82' ' ' ASP . 21.6 t -37.74 -35.7 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.433 -1.3 0 N-CA-C 108.14 -1.059 . . . . 1.0 108.14 -177.165 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . 0.484 ' O ' ' HB2' ' A' ' 83' ' ' ALA . 0.3 OUTLIER -87.07 -24.48 6.39 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.34 0 CA-C-O 121.03 0.443 . . . . 1.0 111.083 179.577 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 80' ' ' ALA . . . . . 0.65 ' N ' ' O ' ' A' ' 77' ' ' ILE . . . -73.29 -10.48 59.8 Favored 'General case' 0 C--N 1.319 -0.737 0 O-C-N 122.21 -0.306 . . . . 1.0 111.809 179.119 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 71.8 mt-10 -120.99 -62.79 1.41 Allowed 'General case' 0 CA--C 1.531 0.247 0 CA-C-O 121.705 0.764 . . . . 1.0 111.133 176.953 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 82' ' ' ASP . . . . . 0.797 ' O ' HG13 ' A' ' 85' ' ' ILE . 0.0 OUTLIER -58.73 -62.83 1.58 Allowed 'General case' 0 C--O 1.202 -1.401 0 CA-C-N 114.939 -1.028 . . . . 1.0 109.561 -179.54 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . 0.484 ' HB2' ' O ' ' A' ' 79' ' ' ILE . . . -56.63 -38.08 71.63 Favored 'General case' 0 CA--C 1.506 -0.718 0 C-N-CA 119.803 -0.759 . . . . 1.0 110.14 -176.087 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . 0.542 ' O ' ' N ' ' A' ' 86' ' ' ALA . 3.4 tm? -32.01 -35.32 0.02 OUTLIER 'General case' 0 CA--C 1.51 -0.564 0 CA-C-N 115.525 -0.762 . . . . 1.0 111.839 -174.647 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 85' ' ' ILE . . . . . 0.797 HG13 ' O ' ' A' ' 82' ' ' ASP . 4.7 mt -43.96 -17.83 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.323 -0.544 0 C-N-CA 120.492 -0.483 . . . . 1.0 110.205 179.622 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 86' ' ' ALA . . . . . 0.674 ' O ' ' N ' ' A' ' 90' ' ' GLY . . . -60.61 -58.46 8.37 Favored 'General case' 0 C--O 1.221 -0.446 0 C-N-CA 119.898 -0.721 . . . . 1.0 109.768 179.852 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 87' ' ' GLU . . . . . 0.444 ' OE1' ' N ' ' A' ' 87' ' ' GLU . 0.2 OUTLIER -35.64 -24.15 0.01 OUTLIER 'General case' 0 N--CA 1.468 0.468 0 CA-C-O 121.023 0.44 . . . . 1.0 110.663 -177.981 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 88' ' ' ALA . . . . . 0.621 ' N ' ' O ' ' A' ' 86' ' ' ALA . . . -101.31 -43.46 5.95 Favored 'General case' 0 C--O 1.237 0.444 0 N-CA-C 109.099 -0.704 . . . . 1.0 109.099 177.324 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 89' ' ' VAL . . . . . 0.544 ' C ' ' HD2' ' A' ' 91' ' ' PRO . 3.0 t -100.19 38.26 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.34 0.186 0 N-CA-C 108.775 -0.824 . . . . 1.0 108.775 178.01 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 90' ' ' GLY . . . . . 0.889 ' O ' ' N ' ' A' ' 92' ' ' HIS . . . -62.08 -17.59 55.78 Favored Glycine 0 C--N 1.358 1.801 0 CA-C-O 117.553 -1.693 . . . . 1.0 111.92 177.83 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 91' ' ' PRO . . . . . 0.72 ' HD2' ' N ' ' A' ' 90' ' ' GLY . 75.3 Cg_exo -32.62 1.01 0.0 OUTLIER 'Trans proline' 0 N--CA 1.513 2.659 0 C-N-CA 124.382 3.388 . . . . 1.0 113.694 171.811 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 92' ' ' HIS . . . . . 0.889 ' N ' ' O ' ' A' ' 90' ' ' GLY . 42.1 t-80 -49.88 -30.11 9.43 Favored 'General case' 0 N--CA 1.427 -1.591 0 N-CA-C 108.357 -0.979 . . . . 1.0 108.357 176.479 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 93' ' ' LEU . . . . . 0.672 ' O ' ' N ' ' A' ' 96' ' ' ALA . 0.8 OUTLIER -61.17 -60.64 3.45 Favored 'General case' 0 C--O 1.222 -0.367 0 N-CA-C 107.358 -1.349 . . . . 1.0 107.358 177.684 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 94' ' ' ALA . . . . . 0.569 ' CB ' HH21 ' A' ' 95' ' ' ARG . . . -45.75 -51.18 13.01 Favored 'General case' 0 N--CA 1.437 -1.104 0 N-CA-C 108.064 -1.087 . . . . 1.0 108.064 -179.193 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 95' ' ' ARG . . . . . 0.569 HH21 ' CB ' ' A' ' 94' ' ' ALA . 0.0 OUTLIER -60.21 -25.27 65.48 Favored 'General case' 0 N--CA 1.434 -1.226 0 C-N-CA 120.013 -0.675 . . . . 1.0 109.334 176.494 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 96' ' ' ALA . . . . . 0.759 ' O ' ' N ' ' A' ' 100' ' ' ILE . . . -57.05 -52.1 66.61 Favored 'General case' 0 C--O 1.207 -1.135 0 N-CA-C 107.227 -1.397 . . . . 1.0 107.227 179.511 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 97' ' ' LEU . . . . . 0.565 ' O ' ' CG2' ' A' ' 100' ' ' ILE . 0.1 OUTLIER -35.55 -29.16 0.01 OUTLIER 'General case' 0 CA--C 1.567 1.63 0 N-CA-C 107.238 -1.393 . . . . 1.0 107.238 -179.716 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 98' ' ' GLY . . . . . 0.611 ' N ' ' O ' ' A' ' 96' ' ' ALA . . . -81.51 -52.9 4.01 Favored Glycine 0 CA--C 1.551 2.309 0 CA-C-O 123.083 1.379 . . . . 1.0 110.831 174.422 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 99' ' ' GLN . . . . . 0.612 ' N ' ' O ' ' A' ' 96' ' ' ALA . 27.0 mt-30 -79.19 7.66 7.24 Favored 'General case' 0 N--CA 1.438 -1.028 0 N-CA-C 108.548 -0.908 . . . . 1.0 108.548 178.366 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 100' ' ' ILE . . . . . 0.759 ' N ' ' O ' ' A' ' 96' ' ' ALA . 16.7 tt -60.39 -51.25 75.2 Favored 'Isoleucine or valine' 0 CA--C 1.493 -1.233 0 N-CA-C 108.71 -0.848 . . . . 1.0 108.71 179.826 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 101' ' ' VAL . . . . . 0.566 ' O ' ' N ' ' A' ' 105' ' ' GLY . 24.1 t -55.05 -57.12 7.87 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.977 0 C-N-CA 117.083 -1.847 . . . . 1.0 107.058 178.058 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 102' ' ' CYS . . . . . . . . . . . . . 4.9 t -44.47 -25.63 0.28 Allowed 'General case' 0 C--O 1.214 -0.791 0 C-N-CA 120.085 -0.646 . . . . 1.0 109.854 -178.944 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 103' ' ' ARG . . . . . 0.426 ' N ' ' C ' ' A' ' 101' ' ' VAL . 1.7 tpp85 -87.19 -45.06 11.0 Favored 'General case' 0 N--CA 1.476 0.862 0 N-CA-C 113.444 0.905 . . . . 1.0 113.444 179.459 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 104' ' ' TYR . . . . . 0.747 ' CG ' ' O ' ' A' ' 104' ' ' TYR . 3.0 t80 -99.19 19.63 14.98 Favored 'General case' 0 C--N 1.31 -1.121 0 C-N-CA 127.066 2.146 . . . . 1.0 110.137 -179.623 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 105' ' ' GLY . . . . . 0.823 ' O ' ' N ' ' A' ' 107' ' ' THR . . . -164.27 -7.79 0.03 OUTLIER Glycine 0 N--CA 1.441 -0.975 0 C-N-CA 117.891 -2.1 . . . . 1.0 111.588 177.337 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 106' ' ' ALA . . . . . 0.454 ' C ' ' O ' ' A' ' 105' ' ' GLY . . . -15.53 62.7 0.0 OUTLIER 'General case' 0 N--CA 1.471 0.6 0 O-C-N 125.147 1.145 . . . . 1.0 111.997 -179.034 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 107' ' ' THR . . . . . 0.823 ' N ' ' O ' ' A' ' 105' ' ' GLY . 11.4 p -100.38 -2.81 32.47 Favored 'General case' 0 CA--C 1.534 0.339 0 CA-C-N 116.265 -0.425 . . . . 1.0 110.119 -179.425 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 108' ' ' VAL . . . . . 0.524 ' CG1' ' N ' ' A' ' 109' ' ' ILE . 8.1 p -84.72 -57.84 4.03 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.427 0 CA-C-N 116.389 -0.369 . . . . 1.0 111.057 -178.194 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 109' ' ' ILE . . . . . 0.574 ' N ' ' HD2' ' A' ' 110' ' ' PRO . 0.2 OUTLIER -47.22 -47.76 56.03 Favored Pre-proline 0 CA--C 1.503 -0.842 0 C-N-CA 122.756 0.422 . . . . 1.0 111.852 179.458 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 110' ' ' PRO . . . . . 0.574 ' HD2' ' N ' ' A' ' 109' ' ' ILE . 6.0 Cg_endo -40.65 -39.84 3.15 Favored 'Trans proline' 0 CA--C 1.507 -0.85 0 C-N-CA 121.025 1.15 . . . . 1.0 114.081 -172.414 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 19.6 m-20 -65.09 -68.0 0.39 Allowed 'General case' 0 C--N 1.305 -1.33 0 C-N-CA 119.047 -1.061 . . . . 1.0 110.475 -176.967 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -69.21 -25.48 29.65 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.788 0 CA-C-N 115.498 -0.773 . . . . 1.0 110.594 -178.012 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 113' ' ' ASN . . . . . 0.499 ' N ' ' O ' ' A' ' 109' ' ' ILE . 7.0 t30 -54.65 -61.83 2.05 Favored 'General case' 0 CA--C 1.488 -1.438 0 CA-C-N 114.268 -1.333 . . . . 1.0 110.854 -174.882 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -65.12 -20.46 66.47 Favored 'General case' 0 N--CA 1.432 -1.35 0 O-C-N 124.233 0.958 . . . . 1.0 110.255 -179.723 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -75.33 -61.78 1.79 Allowed 'General case' 0 C--O 1.241 0.624 0 C-N-CA 120.255 -0.578 . . . . 1.0 112.078 178.86 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 116' ' ' ILE . . . . . 0.484 ' O ' ' CB ' ' A' ' 119' ' ' LEU . 26.5 pt -68.52 -40.92 82.72 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.498 0 O-C-N 121.079 -1.013 . . . . 1.0 111.589 -177.895 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 117' ' ' GLU . . . . . 0.471 ' C ' ' N ' ' A' ' 119' ' ' LEU . 2.6 tt0 -47.21 -66.2 0.44 Allowed 'General case' 0 C--N 1.317 -0.823 0 CA-C-N 115.42 -0.809 . . . . 1.0 110.432 -177.18 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 72.0 t -50.11 -14.58 0.26 Allowed 'Isoleucine or valine' 0 N--CA 1.437 -1.121 0 O-C-N 124.572 1.17 . . . . 1.0 109.332 -178.822 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 119' ' ' LEU . . . . . 0.484 ' CB ' ' O ' ' A' ' 116' ' ' ILE . 0.2 OUTLIER -79.04 -62.6 1.64 Allowed 'General case' 0 N--CA 1.451 -0.413 0 C-N-CA 119.316 -0.954 . . . . 1.0 109.514 176.345 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -70.18 -84.98 0.16 Allowed Glycine 0 N--CA 1.481 1.689 0 C-N-CA 117.53 -2.271 . . . . 1.0 112.052 -179.139 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 34.0 m -161.8 -19.73 0.05 OUTLIER 'General case' 0 CA--C 1.542 0.651 0 CA-C-O 120.769 0.319 . . . . 1.0 110.231 -179.139 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 122' ' ' GLY . . . . . 0.481 ' O ' ' N ' ' A' ' 124' ' ' ASP . . . 111.59 -36.13 4.35 Favored Glycine 0 N--CA 1.477 1.387 0 C-N-CA 125.202 1.382 . . . . 1.0 112.138 179.752 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 123' ' ' THR . . . . . 0.464 ' C ' ' O ' ' A' ' 122' ' ' GLY . 0.0 OUTLIER -32.09 93.21 0.01 OUTLIER 'General case' 0 N--CA 1.469 0.523 0 CA-C-N 118.867 1.333 . . . . 1.0 112.461 -177.888 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 124' ' ' ASP . . . . . 0.481 ' N ' ' O ' ' A' ' 122' ' ' GLY . 8.7 t70 -141.49 141.6 33.62 Favored 'General case' 0 C--N 1.328 -0.352 0 N-CA-C 107.425 -1.324 . . . . 1.0 107.425 177.452 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 125' ' ' TYR . . . . . . . . . . . . . 9.7 t80 -153.58 147.24 25.16 Favored 'General case' 0 C--N 1.324 -0.532 0 N-CA-C 109.692 -0.484 . . . . 1.0 109.692 -177.569 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 9.0 mmp_? -147.5 152.08 37.43 Favored 'General case' 0 CA--C 1.542 0.646 0 CA-C-N 115.532 -0.758 . . . . 1.0 110.777 177.281 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 127' ' ' PHE . . . . . . . . . . . . . 22.6 p90 . . . . . 0 N--CA 1.47 0.574 0 CA-C-O 118.275 -0.869 . . . . 1.0 110.253 179.608 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 64.6 mtt . . . . . 0 N--CA 1.491 1.577 0 N-CA-C 109.332 -0.618 . . . . 1.0 109.332 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 88.9 p -103.63 7.7 37.51 Favored 'General case' 0 N--CA 1.467 0.398 0 CA-C-N 116.097 -0.501 . . . . 1.0 110.751 -179.723 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 3' ' ' ASP . . . . . 0.459 ' N ' ' OD1' ' A' ' 3' ' ' ASP . 1.6 p30 167.42 99.87 0.0 OUTLIER 'General case' 0 N--CA 1.466 0.342 0 CA-C-N 116.109 -0.496 . . . . 1.0 110.42 179.096 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 16.6 t80 -150.21 145.82 26.47 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.219 -0.446 . . . . 1.0 110.059 179.329 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 5' ' ' ASP . . . . . 0.615 ' OD1' ' N ' ' A' ' 10' ' ' SER . 0.3 OUTLIER -157.21 153.42 27.58 Favored 'General case' 0 C--N 1.327 -0.377 0 N-CA-C 109.887 -0.412 . . . . 1.0 109.887 179.674 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 6' ' ' THR . . . . . 0.676 ' O ' ' N ' ' A' ' 10' ' ' SER . 0.2 OUTLIER -75.01 175.74 7.87 Favored 'General case' 0 C--O 1.212 -0.872 0 CA-C-N 116.112 -0.495 . . . . 1.0 111.802 -178.123 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . 0.504 ' O ' ' N ' ' A' ' 11' ' ' ARG . 0.5 OUTLIER -58.7 -56.21 25.19 Favored 'General case' 0 N--CA 1.478 0.974 0 CA-C-N 115.72 -0.673 . . . . 1.0 109.863 -178.781 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 8' ' ' ARG . . . . . 0.462 ' O ' ' CB ' ' A' ' 12' ' ' ALA . 0.0 OUTLIER -49.39 -54.77 15.67 Favored 'General case' 0 C--N 1.318 -0.794 0 N-CA-C 106.349 -1.723 . . . . 1.0 106.349 -178.034 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . 0.778 ' O ' ' HB ' ' A' ' 13' ' ' VAL . 1.3 t -63.74 -46.46 94.49 Favored 'Isoleucine or valine' 0 C--O 1.193 -1.914 0 CA-C-N 111.834 -2.439 . . . . 1.0 109.165 -179.705 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 10' ' ' SER . . . . . 0.676 ' N ' ' O ' ' A' ' 6' ' ' THR . 6.6 t -69.67 -63.32 1.1 Allowed 'General case' 0 N--CA 1.487 1.405 0 N-CA-C 112.648 0.61 . . . . 1.0 112.648 -178.279 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 11' ' ' ARG . . . . . 0.537 ' O ' ' N ' ' A' ' 15' ' ' ALA . 3.6 mmt85 -64.07 -55.39 22.42 Favored 'General case' 0 N--CA 1.478 0.963 0 CA-C-O 121.119 0.485 . . . . 1.0 110.866 -176.402 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . 0.47 ' O ' ' CB ' ' A' ' 16' ' ' ALA . . . -51.24 -50.73 58.61 Favored 'General case' 0 C--N 1.314 -0.953 0 N-CA-C 106.363 -1.717 . . . . 1.0 106.363 -178.756 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . 0.778 ' HB ' ' O ' ' A' ' 9' ' ' VAL . 8.1 t -60.62 -52.26 63.54 Favored 'Isoleucine or valine' 0 C--O 1.197 -1.662 0 C-N-CA 119.419 -0.912 . . . . 1.0 109.184 176.823 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . 0.461 ' O ' ' N ' ' A' ' 18' ' ' VAL . . . -58.24 -62.13 2.06 Favored 'General case' 0 C--O 1.21 -1.019 0 C-N-CA 118.682 -1.207 . . . . 1.0 110.185 -179.352 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . 0.563 ' O ' ' N ' ' A' ' 19' ' ' GLY . . . -52.25 -55.64 19.98 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-O 121.918 0.866 . . . . 1.0 109.943 -178.245 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . 0.524 ' CA ' ' H ' ' A' ' 22' ' ' GLY . . . -61.27 -54.76 39.94 Favored 'General case' 0 C--N 1.311 -1.101 0 CA-C-N 114.413 -1.267 . . . . 1.0 109.097 -179.269 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . 0.581 ' N ' ' O ' ' A' ' 13' ' ' VAL . 7.0 tt -57.79 -53.7 55.24 Favored 'General case' 0 N--CA 1.482 1.153 0 CA-C-N 114.001 -1.454 . . . . 1.0 109.294 -177.693 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . 0.594 HG23 ' H ' ' A' ' 19' ' ' GLY . 2.6 m -68.98 -56.67 11.17 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.501 0 C-N-CA 119.268 -0.973 . . . . 1.0 109.274 178.978 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . 0.594 ' H ' HG23 ' A' ' 18' ' ' VAL . . . -66.74 -160.59 1.0 Allowed Glycine 0 CA--C 1.534 1.248 0 CA-C-N 116.771 -0.195 . . . . 1.0 113.162 -178.037 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 20' ' ' PRO . . . . . 0.498 ' O ' ' CB ' ' A' ' 24' ' ' ALA . 90.8 Cg_endo -79.87 -30.02 2.49 Favored 'Trans proline' 0 N--CA 1.502 2.026 0 C-N-CA 123.476 2.784 . . . . 1.0 115.117 -177.42 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -60.15 -58.21 15.21 Favored Glycine 0 N--CA 1.478 1.437 0 C-N-CA 119.864 -1.16 . . . . 1.0 112.458 -176.296 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . 0.524 ' H ' ' CA ' ' A' ' 16' ' ' ALA . . . -59.16 -56.26 26.21 Favored Glycine 0 C--N 1.312 -0.757 0 N-CA-C 108.403 -1.879 . . . . 1.0 108.403 -177.243 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 34.6 m -59.77 -34.39 55.46 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.84 0 C-N-CA 120.109 -0.636 . . . . 1.0 109.713 -179.489 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . 0.498 ' CB ' ' O ' ' A' ' 20' ' ' PRO . . . -57.38 -61.52 2.43 Favored 'General case' 0 CA--C 1.534 0.337 0 C-N-CA 118.078 -1.449 . . . . 1.0 109.011 179.884 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 5.2 mp -63.85 -44.18 93.91 Favored 'General case' 0 C--N 1.347 0.465 0 C-N-CA 120.24 -0.584 . . . . 1.0 112.19 -178.598 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 73.8 t -60.87 -59.59 3.99 Favored 'Isoleucine or valine' 0 CA--C 1.527 0.083 0 C-N-CA 118.776 -1.169 . . . . 1.0 109.793 -177.991 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 83.9 t -59.97 -39.16 79.43 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.212 0 N-CA-C 112.19 0.441 . . . . 1.0 112.19 -178.429 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 27.5 tttm -65.94 -54.42 26.59 Favored 'General case' 0 C--N 1.319 -0.739 0 N-CA-C 108.941 -0.763 . . . . 1.0 108.941 -179.223 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 59.5 t -63.98 -48.44 86.05 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.825 0 CA-C-N 114.599 -1.182 . . . . 1.0 110.587 -177.892 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 30' ' ' CYS . . . . . . . . . . . . . 20.0 t -65.16 -61.23 2.26 Favored 'General case' 0 N--CA 1.446 -0.664 0 C-N-CA 119.245 -0.982 . . . . 1.0 109.566 -179.51 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -65.18 -53.2 48.49 Favored 'General case' 0 N--CA 1.453 -0.309 0 N-CA-C 113.487 0.921 . . . . 1.0 113.487 -176.24 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 84.6 77.89 1.15 Allowed Glycine 0 CA--C 1.527 0.822 0 C-N-CA 120.338 -0.934 . . . . 1.0 111.474 -179.76 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . 0.445 ' O ' ' N ' ' A' ' 35' ' ' GLY . 10.0 mp 69.89 101.37 0.04 OUTLIER Pre-proline 0 CA--C 1.548 0.88 0 C-N-CA 123.207 0.603 . . . . 1.0 110.25 -179.131 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 1.1 Cg_endo -45.26 -10.13 0.04 OUTLIER 'Trans proline' 0 N--CA 1.501 1.944 0 C-N-CA 122.109 1.872 . . . . 1.0 114.818 -179.247 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . 0.445 ' N ' ' O ' ' A' ' 33' ' ' LEU . . . -60.82 -59.76 9.62 Favored Glycine 0 N--CA 1.468 0.823 0 C-N-CA 118.223 -1.941 . . . . 1.0 110.088 -178.037 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . 0.604 ' CG2' ' H ' ' A' ' 37' ' ' ILE . 9.4 p -83.87 -146.58 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.465 0.324 0 N-CA-C 109.303 -0.629 . . . . 1.0 109.303 -179.945 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . 0.604 ' H ' ' CG2' ' A' ' 36' ' ' VAL . 2.2 mp 73.71 76.8 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.474 0.727 0 CA-C-N 117.949 0.341 . . . . 1.0 111.578 -179.551 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 98.9 m-70 -134.94 127.2 30.15 Favored 'General case' 0 N--CA 1.451 -0.385 0 N-CA-C 106.902 -1.518 . . . . 1.0 106.902 177.777 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 27.7 p -109.1 146.55 34.09 Favored Pre-proline 0 C--N 1.328 -0.349 0 N-CA-C 109.631 -0.507 . . . . 1.0 109.631 -179.037 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 51.0 Cg_endo -66.0 -24.94 52.23 Favored 'Trans proline' 0 C--N 1.306 -1.659 0 C-N-CA 121.502 1.468 . . . . 1.0 112.819 -178.854 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -126.81 130.15 49.69 Favored 'General case' 0 CA--C 1.516 -0.349 0 N-CA-C 109.567 -0.531 . . . . 1.0 109.567 178.921 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . 0.695 ' C ' ' H ' ' A' ' 44' ' ' GLY . 4.0 tmm_? -159.27 156.05 28.04 Favored 'General case' 0 C--N 1.318 -0.781 0 C-N-CA 119.908 -0.717 . . . . 1.0 109.175 178.05 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 43' ' ' ARG . . . . . 0.425 ' C ' ' H ' ' A' ' 45' ' ' PHE . 0.2 OUTLIER -62.97 17.95 0.01 OUTLIER 'General case' 0 C--N 1.32 -0.7 0 CA-C-N 115.963 -0.562 . . . . 1.0 110.147 179.204 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . 0.695 ' H ' ' C ' ' A' ' 42' ' ' ARG . . . 76.59 -27.19 1.58 Allowed Glycine 0 C--N 1.337 0.617 0 N-CA-C 111.306 -0.718 . . . . 1.0 111.306 179.389 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . 0.564 ' CD1' ' N ' ' A' ' 45' ' ' PHE . 0.1 OUTLIER -155.59 156.58 35.33 Favored 'General case' 0 CA--C 1.548 0.868 0 N-CA-C 109.795 -0.446 . . . . 1.0 109.795 -179.684 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 46' ' ' PHE . . . . . 0.576 ' O ' ' HB2' ' A' ' 47' ' ' ARG . 0.5 OUTLIER 139.66 85.36 0.0 OUTLIER 'General case' 0 N--CA 1.5 2.068 0 C-N-CA 126.23 1.812 . . . . 1.0 109.05 179.251 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 47' ' ' ARG . . . . . 0.576 ' HB2' ' O ' ' A' ' 46' ' ' PHE . 2.5 mtm-85 131.89 138.24 0.0 OUTLIER 'General case' 0 N--CA 1.505 2.294 0 C-N-CA 125.189 1.396 . . . . 1.0 109.989 178.528 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 48' ' ' CYS . . . . . 0.546 ' SG ' ' C ' ' A' ' 47' ' ' ARG . 0.0 OUTLIER 75.5 70.66 0.08 Allowed 'General case' 0 C--O 1.219 -0.531 0 N-CA-C 108.988 -0.745 . . . . 1.0 108.988 179.662 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 49' ' ' ASN . . . . . 0.649 ' O ' ' N ' ' A' ' 51' ' ' GLU . 1.2 p-10 -143.32 116.09 5.95 Favored Pre-proline 0 C--N 1.327 -0.407 0 N-CA-C 107.988 -1.116 . . . . 1.0 107.988 -179.733 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 74.7 Cg_exo -47.42 63.52 0.01 OUTLIER 'Trans proline' 0 N--CA 1.509 2.399 0 C-N-CA 122.688 2.258 . . . . 1.0 114.788 -178.801 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . 0.649 ' N ' ' O ' ' A' ' 49' ' ' ASN . 17.1 mp0 62.02 28.49 17.26 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.463 -0.335 . . . . 1.0 111.064 -179.644 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -102.71 134.34 46.25 Favored 'General case' 0 CA--C 1.516 -0.329 0 N-CA-C 109.206 -0.664 . . . . 1.0 109.206 178.55 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . 0.419 ' O ' ' N ' ' A' ' 55' ' ' ILE . 13.0 tt -57.92 138.58 18.68 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.374 0 CA-C-O 122.273 1.035 . . . . 1.0 112.066 -178.056 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 54' ' ' GLN . . . . . 0.544 ' OE1' ' CE2' ' A' ' 46' ' ' PHE . 0.0 OUTLIER -65.98 80.62 0.08 Allowed 'General case' 0 C--N 1.318 -0.794 0 CA-C-N 113.75 -1.568 . . . . 1.0 108.067 -179.761 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . 0.427 ' CG2' ' N ' ' A' ' 56' ' ' GLY . 11.7 mt -149.12 158.06 6.54 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.657 0 CA-C-N 115.864 -0.607 . . . . 1.0 109.835 178.694 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . 0.427 ' N ' ' CG2' ' A' ' 55' ' ' ILE . . . 111.62 -2.14 27.65 Favored Glycine 0 N--CA 1.468 0.817 0 N-CA-C 110.205 -1.158 . . . . 1.0 110.205 -179.865 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . 0.464 ' OD1' ' CG ' ' A' ' 45' ' ' PHE . 36.3 m-20 -79.19 97.95 6.41 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 115.234 -0.483 . . . . 1.0 110.533 179.533 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 58' ' ' TRP . . . . . . . . . . . . . 6.5 m0 -87.99 172.27 9.69 Favored 'General case' 0 CA--C 1.539 0.525 0 CA-C-O 123.0 1.381 . . . . 1.0 112.58 -177.956 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 59' ' ' ARG . . . . . 0.52 ' CD ' ' H ' ' A' ' 59' ' ' ARG . 0.0 OUTLIER -82.49 -60.43 2.2 Favored 'General case' 0 C--N 1.311 -1.097 0 CA-C-N 111.622 -2.535 . . . . 1.0 112.839 -179.31 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 44.8 t80 -91.69 -14.04 30.71 Favored 'General case' 0 C--N 1.317 -0.824 0 N-CA-C 113.777 1.028 . . . . 1.0 113.777 -179.118 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . 0.442 ' O ' ' N ' ' A' ' 65' ' ' ASP . 4.6 tt0 -80.18 -14.61 58.32 Favored 'General case' 0 C--O 1.214 -0.804 0 O-C-N 121.709 -0.619 . . . . 1.0 110.592 -179.493 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 62' ' ' VAL . . . . . 0.637 ' O ' ' N ' ' A' ' 66' ' ' GLY . 28.9 m -46.46 -54.25 2.24 Favored 'Isoleucine or valine' 0 C--O 1.212 -0.92 0 C-N-CA 119.268 -0.973 . . . . 1.0 110.46 -175.715 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 63' ' ' ALA . . . . . 0.498 ' O ' ' CG ' ' A' ' 67' ' ' ARG . . . -67.42 -48.39 67.44 Favored 'General case' 0 C--N 1.303 -1.428 0 O-C-N 121.402 -0.811 . . . . 1.0 108.962 179.824 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 11.0 t-80 -51.56 -58.09 7.28 Favored 'General case' 0 CA--C 1.541 0.627 0 C-N-CA 119.463 -0.895 . . . . 1.0 109.419 -179.649 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 65' ' ' ASP . . . . . 0.62 ' C ' ' H ' ' A' ' 67' ' ' ARG . 22.8 m-20 -75.38 -52.03 11.74 Favored 'General case' 0 C--O 1.245 0.826 0 CA-C-N 115.733 -0.667 . . . . 1.0 111.24 178.837 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . 0.637 ' N ' ' O ' ' A' ' 62' ' ' VAL . . . -71.76 25.97 0.63 Allowed Glycine 0 CA--C 1.522 0.483 0 O-C-N 120.345 -1.472 . . . . 1.0 110.337 177.423 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 67' ' ' ARG . . . . . 0.671 ' O ' ' N ' ' A' ' 69' ' ' LEU . 0.6 OUTLIER -71.71 7.2 1.58 Allowed 'General case' 0 CA--C 1.507 -0.687 0 N-CA-C 106.197 -1.779 . . . . 1.0 106.197 174.47 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . 0.628 ' H ' ' C ' ' A' ' 66' ' ' GLY . 3.1 mt -30.48 -30.11 0.01 OUTLIER 'General case' 0 N--CA 1.472 0.669 0 O-C-N 124.045 0.84 . . . . 1.0 108.767 -177.653 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . 0.671 ' N ' ' O ' ' A' ' 67' ' ' ARG . 10.9 mp -62.35 -66.15 0.58 Allowed 'General case' 0 N--CA 1.476 0.842 0 C-N-CA 119.296 -0.961 . . . . 1.0 109.016 178.401 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . 0.645 ' C ' ' H ' ' A' ' 72' ' ' HIS . . . -79.49 -75.63 0.24 Allowed 'General case' 0 N--CA 1.476 0.835 0 N-CA-C 107.36 -1.348 . . . . 1.0 107.36 178.051 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 71' ' ' ALA . . . . . 0.44 ' O ' ' C ' ' A' ' 72' ' ' HIS . . . -46.44 5.87 0.0 OUTLIER 'General case' 0 CA--C 1.536 0.409 0 C-N-CA 124.837 1.255 . . . . 1.0 113.539 177.671 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 72' ' ' HIS . . . . . 0.645 ' H ' ' C ' ' A' ' 70' ' ' ALA . 1.1 t-80 -28.69 -68.17 0.07 Allowed 'General case' 0 N--CA 1.467 0.414 0 C-N-CA 122.827 0.451 . . . . 1.0 111.788 -179.449 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 73' ' ' MET . . . . . 0.549 ' N ' ' SD ' ' A' ' 73' ' ' MET . 0.0 OUTLIER -66.83 -47.58 71.58 Favored 'General case' 0 C--N 1.329 -0.325 0 C-N-CA 118.263 -1.375 . . . . 1.0 109.133 178.966 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . 0.793 ' O ' ' N ' ' A' ' 76' ' ' GLY . 72.9 t -42.2 -41.17 0.91 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.26 0 CA-C-O 117.621 -1.18 . . . . 1.0 111.524 -176.089 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 3.0 t-20 -33.63 -12.22 0.0 OUTLIER 'General case' 0 N--CA 1.498 1.947 0 CA-C-N 120.175 1.352 . . . . 1.0 112.315 179.25 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 76' ' ' GLY . . . . . 0.793 ' N ' ' O ' ' A' ' 74' ' ' VAL . . . -48.86 -22.67 3.04 Favored Glycine 0 CA--C 1.542 1.736 0 N-CA-C 108.455 -1.858 . . . . 1.0 108.455 174.629 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 77' ' ' ILE . . . . . 0.667 ' O ' ' N ' ' A' ' 80' ' ' ALA . 0.9 OUTLIER -75.54 -59.86 2.88 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.588 0 N-CA-C 108.068 -1.086 . . . . 1.0 108.068 178.36 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . 0.547 ' H ' HG13 ' A' ' 77' ' ' ILE . 75.6 t -34.39 -31.18 0.02 OUTLIER 'Isoleucine or valine' 0 CA--C 1.547 0.828 0 CA-C-N 113.532 -1.667 . . . . 1.0 107.947 -176.207 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . 0.553 ' N ' ' O ' ' A' ' 77' ' ' ILE . 40.3 pt -95.45 -29.9 4.03 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.843 0 CA-C-N 115.989 -0.55 . . . . 1.0 111.595 178.392 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 80' ' ' ALA . . . . . 0.667 ' N ' ' O ' ' A' ' 77' ' ' ILE . . . -86.14 -10.79 54.17 Favored 'General case' 0 CA--C 1.548 0.882 0 N-CA-C 113.284 0.846 . . . . 1.0 113.284 178.387 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 81' ' ' GLU . . . . . 0.442 ' N ' ' O ' ' A' ' 77' ' ' ILE . 8.5 mt-10 -83.1 -68.56 0.7 Allowed 'General case' 0 C--N 1.355 0.805 0 CA-C-N 118.855 0.752 . . . . 1.0 109.067 178.254 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 82' ' ' ASP . . . . . 0.512 ' O ' ' C ' ' A' ' 83' ' ' ALA . 49.7 p-10 -74.95 -14.2 60.61 Favored 'General case' 0 N--CA 1.443 -0.796 0 CA-C-O 118.846 -0.597 . . . . 1.0 112.136 -179.48 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . 0.533 ' O ' ' N ' ' A' ' 87' ' ' GLU . . . -23.08 -47.35 0.01 OUTLIER 'General case' 0 N--CA 1.473 0.698 0 CA-C-N 118.436 0.562 . . . . 1.0 112.013 177.746 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . 0.48 ' N ' ' O ' ' A' ' 82' ' ' ASP . 2.9 tt -37.7 -36.2 0.17 Allowed 'General case' 0 N--CA 1.465 0.324 0 N-CA-C 112.85 0.685 . . . . 1.0 112.85 -177.617 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 11.2 pt -98.68 -43.1 11.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 N-CA-C 108.436 -0.95 . . . . 1.0 108.436 177.526 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 86' ' ' ALA . . . . . 0.478 ' O ' HG21 ' A' ' 89' ' ' VAL . . . -56.36 -57.45 12.2 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 114.142 -1.39 . . . . 1.0 109.503 179.45 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 87' ' ' GLU . . . . . 0.533 ' N ' ' O ' ' A' ' 83' ' ' ALA . 19.8 tt0 -79.3 26.41 0.28 Allowed 'General case' 0 CA--C 1.544 0.723 0 O-C-N 120.851 -1.156 . . . . 1.0 112.202 -178.149 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -116.49 -15.75 10.86 Favored 'General case' 0 N--CA 1.489 1.504 0 CA-C-O 123.415 1.579 . . . . 1.0 107.896 177.68 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 89' ' ' VAL . . . . . 0.478 HG21 ' O ' ' A' ' 86' ' ' ALA . 5.3 m -100.44 39.23 0.15 Allowed 'Isoleucine or valine' 0 C--O 1.205 -1.238 0 CA-C-N 110.83 -2.896 . . . . 1.0 109.987 178.573 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 90' ' ' GLY . . . . . 0.541 ' C ' ' H ' ' A' ' 92' ' ' HIS . . . -71.59 -39.15 61.13 Favored Glycine 0 C--N 1.351 1.381 0 N-CA-C 111.023 -0.831 . . . . 1.0 111.023 178.329 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 91' ' ' PRO . . . . . 0.528 ' CD ' ' N ' ' A' ' 90' ' ' GLY . 89.6 Cg_exo -46.45 -12.82 0.09 OUTLIER 'Trans proline' 0 N--CA 1.497 1.712 0 C-N-CA 121.572 1.515 . . . . 1.0 110.346 178.406 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 92' ' ' HIS . . . . . 0.541 ' H ' ' C ' ' A' ' 90' ' ' GLY . 3.5 p80 -57.54 -17.15 12.35 Favored 'General case' 0 C--O 1.208 -1.108 0 N-CA-C 107.56 -1.274 . . . . 1.0 107.56 179.675 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 93' ' ' LEU . . . . . 0.44 ' CD1' ' N ' ' A' ' 94' ' ' ALA . 2.1 pp -67.84 -59.37 3.35 Favored 'General case' 0 N--CA 1.455 -0.215 0 N-CA-C 108.817 -0.809 . . . . 1.0 108.817 178.884 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 94' ' ' ALA . . . . . 0.44 ' N ' ' CD1' ' A' ' 93' ' ' LEU . . . -56.45 -53.36 58.31 Favored 'General case' 0 N--CA 1.454 -0.265 0 N-CA-C 108.914 -0.773 . . . . 1.0 108.914 178.701 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 95' ' ' ARG . . . . . 0.643 ' O ' ' N ' ' A' ' 97' ' ' LEU . 42.8 mtm105 -57.54 -57.44 12.69 Favored 'General case' 0 C--O 1.241 0.653 0 N-CA-C 107.822 -1.177 . . . . 1.0 107.822 178.846 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 96' ' ' ALA . . . . . 0.885 ' O ' ' N ' ' A' ' 98' ' ' GLY . . . -47.47 -12.35 0.03 OUTLIER 'General case' 0 N--CA 1.436 -1.128 0 O-C-N 118.905 -2.372 . . . . 1.0 110.375 -179.195 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 97' ' ' LEU . . . . . 0.692 ' O ' ' N ' ' A' ' 100' ' ' ILE . 16.2 tp 5.96 -53.25 0.0 OUTLIER 'General case' 0 C--N 1.377 1.801 0 CA-C-O 117.481 -1.247 . . . . 1.0 110.275 -167.843 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 98' ' ' GLY . . . . . 0.885 ' N ' ' O ' ' A' ' 96' ' ' ALA . . . -49.06 -23.75 4.06 Favored Glycine 0 CA--C 1.543 1.784 0 CA-C-N 122.572 2.442 . . . . 1.0 107.902 175.331 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 99' ' ' GLN . . . . . 0.552 ' N ' ' O ' ' A' ' 96' ' ' ALA . 0.0 OUTLIER -63.88 -17.45 63.2 Favored 'General case' 0 C--N 1.36 1.026 0 N-CA-C 107.046 -1.465 . . . . 1.0 107.046 176.706 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 100' ' ' ILE . . . . . 0.692 ' N ' ' O ' ' A' ' 97' ' ' LEU . 1.9 tp -66.42 -43.33 91.18 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.518 0 N-CA-C 108.746 -0.835 . . . . 1.0 108.746 178.98 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 101' ' ' VAL . . . . . 0.672 ' O ' ' N ' ' A' ' 105' ' ' GLY . 0.5 OUTLIER -54.48 -58.28 4.25 Favored 'Isoleucine or valine' 0 C--O 1.219 -0.546 0 N-CA-C 106.844 -1.539 . . . . 1.0 106.844 178.69 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 102' ' ' CYS . . . . . 0.548 ' N ' ' CG1' ' A' ' 101' ' ' VAL . 17.1 t -44.74 -20.6 0.04 OUTLIER 'General case' 0 C--N 1.314 -0.974 0 CA-C-N 115.961 -0.563 . . . . 1.0 111.977 -179.932 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 103' ' ' ARG . . . . . 0.507 ' CG ' HH11 ' A' ' 103' ' ' ARG . 0.0 OUTLIER -92.76 -44.69 8.4 Favored 'General case' 0 N--CA 1.472 0.646 0 CA-C-O 122.328 1.061 . . . . 1.0 111.521 178.299 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 104' ' ' TYR . . . . . 0.581 ' O ' ' CD2' ' A' ' 104' ' ' TYR . 0.0 OUTLIER -105.72 22.39 15.64 Favored 'General case' 0 C--N 1.312 -1.027 0 CA-C-N 113.625 -1.625 . . . . 1.0 111.325 179.294 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 105' ' ' GLY . . . . . 0.776 ' O ' ' N ' ' A' ' 107' ' ' THR . . . -171.67 -9.29 0.02 OUTLIER Glycine 0 C--N 1.345 1.028 0 C-N-CA 118.437 -1.84 . . . . 1.0 113.125 178.987 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 106' ' ' ALA . . . . . 0.547 ' O ' ' CD ' ' A' ' 110' ' ' PRO . . . -27.71 68.68 0.0 OUTLIER 'General case' 0 N--CA 1.475 0.793 0 N-CA-C 113.521 0.934 . . . . 1.0 113.521 -178.707 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 107' ' ' THR . . . . . 0.776 ' N ' ' O ' ' A' ' 105' ' ' GLY . 8.8 t -91.9 2.66 56.39 Favored 'General case' 0 CA--C 1.51 -0.595 0 N-CA-C 106.902 -1.518 . . . . 1.0 106.902 177.601 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 60.2 t -85.37 -57.73 4.09 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.76 0 CA-C-N 115.475 -0.784 . . . . 1.0 110.514 178.547 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 109' ' ' ILE . . . . . 0.491 ' N ' ' HD2' ' A' ' 110' ' ' PRO . 0.1 OUTLIER -65.98 -39.8 32.76 Favored Pre-proline 0 CA--C 1.555 1.158 0 N-CA-C 114.552 1.316 . . . . 1.0 114.552 -177.971 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 110' ' ' PRO . . . . . 0.547 ' CD ' ' O ' ' A' ' 106' ' ' ALA . 6.8 Cg_endo -48.13 -47.7 18.71 Favored 'Trans proline' 0 N--CA 1.504 2.096 0 CA-C-N 122.397 1.892 . . . . 1.0 113.065 -178.283 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 23.4 t30 -64.79 -67.03 0.47 Allowed 'General case' 0 N--CA 1.464 0.248 0 C-N-CA 119.47 -0.892 . . . . 1.0 109.434 -178.267 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 112' ' ' ILE . . . . . 0.458 ' O ' ' N ' ' A' ' 115' ' ' ALA . 28.3 mm -49.25 -39.92 13.3 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.575 0 CA-C-O 122.813 1.292 . . . . 1.0 108.459 179.737 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 113' ' ' ASN . . . . . 0.484 ' N ' ' O ' ' A' ' 109' ' ' ILE . 6.4 t-20 -47.14 -51.14 18.9 Favored 'General case' 0 C--N 1.31 -1.121 0 CA-C-N 112.273 -2.24 . . . . 1.0 108.03 -176.892 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -62.21 -29.81 70.64 Favored 'General case' 0 N--CA 1.441 -0.894 0 C-N-CA 119.611 -0.835 . . . . 1.0 110.343 178.772 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 115' ' ' ALA . . . . . 0.458 ' N ' ' O ' ' A' ' 112' ' ' ILE . . . -77.34 -60.44 2.36 Favored 'General case' 0 C--N 1.347 0.477 0 C-N-CA 119.659 -0.817 . . . . 1.0 110.031 179.077 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 116' ' ' ILE . . . . . 0.506 ' O ' ' N ' ' A' ' 120' ' ' GLY . 1.0 OUTLIER -49.95 -50.07 19.93 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.707 0 CA-C-O 122.013 0.911 . . . . 1.0 109.562 -179.41 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 117' ' ' GLU . . . . . 0.449 ' C ' ' O ' ' A' ' 116' ' ' ILE . 17.8 mt-10 -42.53 -55.73 3.37 Favored 'General case' 0 C--N 1.316 -0.887 0 N-CA-C 106.106 -1.812 . . . . 1.0 106.106 -179.394 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 98.8 t -58.82 -53.11 51.95 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.677 0 C-N-CA 119.428 -0.909 . . . . 1.0 108.787 176.875 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -51.74 -72.62 0.05 OUTLIER 'General case' 0 CA--C 1.543 0.707 0 N-CA-C 108.083 -1.081 . . . . 1.0 108.083 -178.699 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 120' ' ' GLY . . . . . 0.552 ' O ' ' OG1' ' A' ' 121' ' ' THR . . . -64.9 -79.03 0.19 Allowed Glycine 0 CA--C 1.541 1.698 0 C-N-CA 119.055 -1.545 . . . . 1.0 110.3 179.308 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 121' ' ' THR . . . . . 0.552 ' OG1' ' O ' ' A' ' 120' ' ' GLY . 2.8 m 154.27 -31.57 0.01 OUTLIER 'General case' 0 N--CA 1.481 1.098 0 CA-C-N 112.371 -1.914 . . . . 1.0 111.463 179.974 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 122' ' ' GLY . . . . . 0.669 ' O ' ' N ' ' A' ' 124' ' ' ASP . . . 104.25 -17.5 47.54 Favored Glycine 0 N--CA 1.462 0.373 0 N-CA-C 107.319 -2.312 . . . . 1.0 107.319 -176.46 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 123' ' ' THR . . . . . 0.45 ' O ' ' CG2' ' A' ' 123' ' ' THR . 12.7 t -56.37 82.3 0.01 OUTLIER 'General case' 0 N--CA 1.469 0.509 0 N-CA-C 106.031 -1.84 . . . . 1.0 106.031 178.647 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 124' ' ' ASP . . . . . 0.669 ' N ' ' O ' ' A' ' 122' ' ' GLY . 34.6 m-20 -167.26 178.05 5.79 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 112.826 -1.988 . . . . 1.0 111.516 179.01 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 125' ' ' TYR . . . . . . . . . . . . . 21.3 t80 -141.96 140.22 32.67 Favored 'General case' 0 CA--C 1.536 0.417 0 N-CA-C 107.328 -1.36 . . . . 1.0 107.328 174.932 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 24.0 mmm-85 -146.18 148.1 32.18 Favored 'General case' 0 N--CA 1.471 0.598 0 N-CA-C 109.879 -0.415 . . . . 1.0 109.879 178.594 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 127' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 C--N 1.327 -0.409 0 CA-C-O 117.982 -1.009 . . . . 1.0 110.079 179.3 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 1' ' ' MET . . . . . 0.455 ' C ' ' H ' ' A' ' 3' ' ' ASP . 0.0 OUTLIER . . . . . 0 N--CA 1.494 1.75 0 N-CA-C 108.103 -1.073 . . . . 1.0 108.103 . . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 2' ' ' SER . . . . . 0.46 ' O ' ' CB ' ' A' ' 3' ' ' ASP . 93.9 p -70.66 7.1 1.19 Allowed 'General case' 0 C--O 1.223 -0.316 0 CA-C-O 119.449 -0.31 . . . . 1.0 111.352 179.615 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 3' ' ' ASP . . . . . 0.46 ' CB ' ' O ' ' A' ' 2' ' ' SER . 12.7 p-10 142.55 142.19 0.0 OUTLIER 'General case' 0 N--CA 1.481 1.079 0 O-C-N 124.126 0.891 . . . . 1.0 110.349 179.07 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 42.1 t80 -155.59 151.33 27.41 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 121.134 0.492 . . . . 1.0 110.532 178.701 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 5' ' ' ASP . . . . . 0.482 ' C ' ' OG ' ' A' ' 10' ' ' SER . 51.3 m-20 -148.46 144.6 27.5 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.562 -0.745 . . . . 1.0 109.53 179.84 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 6' ' ' THR . . . . . 0.674 ' O ' ' N ' ' A' ' 10' ' ' SER . 5.6 m -109.46 -161.57 0.77 Allowed 'General case' 0 C--O 1.206 -1.188 0 CA-C-O 121.656 0.741 . . . . 1.0 110.48 -179.776 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . 0.656 ' H ' ' CG2' ' A' ' 6' ' ' THR . 28.5 tt0 -58.26 -44.37 88.31 Favored 'General case' 0 C--N 1.302 -1.497 0 CA-C-O 121.872 0.844 . . . . 1.0 109.447 -178.5 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 8' ' ' ARG . . . . . 0.55 ' O ' ' CB ' ' A' ' 12' ' ' ALA . 21.8 ttp-105 -69.87 -60.64 2.18 Favored 'General case' 0 C--N 1.307 -1.241 0 C-N-CA 117.916 -1.514 . . . . 1.0 110.089 178.242 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . 0.623 HG23 ' H ' ' A' ' 6' ' ' THR . 0.1 OUTLIER -61.38 -52.61 59.27 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.412 0 CA-C-N 115.11 -0.95 . . . . 1.0 110.129 -179.6 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 10' ' ' SER . . . . . 0.674 ' N ' ' O ' ' A' ' 6' ' ' THR . 1.2 m -68.21 -65.21 0.72 Allowed 'General case' 0 N--CA 1.487 1.409 0 C-N-CA 120.166 -0.614 . . . . 1.0 112.525 179.66 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 11' ' ' ARG . . . . . 0.543 ' HB2' ' O ' ' A' ' 7' ' ' GLU . 5.0 mtt-85 -61.9 -43.41 98.89 Favored 'General case' 0 C--N 1.317 -0.841 0 C-N-CA 120.419 -0.512 . . . . 1.0 111.382 -176.955 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . 0.55 ' CB ' ' O ' ' A' ' 8' ' ' ARG . . . -69.87 -57.58 4.88 Favored 'General case' 0 N--CA 1.468 0.443 0 C-N-CA 118.334 -1.346 . . . . 1.0 108.998 178.719 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . 0.673 ' O ' ' CB ' ' A' ' 17' ' ' LEU . 41.7 t -61.84 -55.44 24.24 Favored 'Isoleucine or valine' 0 C--O 1.198 -1.623 0 C-N-CA 117.51 -1.676 . . . . 1.0 107.879 -179.266 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . 0.623 ' O ' HG22 ' A' ' 18' ' ' VAL . . . -57.96 -64.92 0.74 Allowed 'General case' 0 C--N 1.313 -1.009 0 C-N-CA 116.53 -2.068 . . . . 1.0 111.457 -179.94 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . 0.559 ' O ' ' N ' ' A' ' 19' ' ' GLY . . . -54.59 -54.71 37.74 Favored 'General case' 0 C--O 1.218 -0.601 0 C-N-CA 118.596 -1.242 . . . . 1.0 110.334 -177.187 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . 0.57 ' HA ' ' H ' ' A' ' 22' ' ' GLY . . . -65.69 -55.64 16.34 Favored 'General case' 0 C--N 1.309 -1.176 0 C-N-CA 118.676 -1.21 . . . . 1.0 110.569 -179.109 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . 0.673 ' CB ' ' O ' ' A' ' 13' ' ' VAL . 2.2 tp -56.51 -54.56 44.4 Favored 'General case' 0 N--CA 1.491 1.591 0 N-CA-C 108.087 -1.079 . . . . 1.0 108.087 -177.728 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . 0.708 HG22 ' H ' ' A' ' 19' ' ' GLY . 1.8 m -71.88 -58.59 4.77 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.405 0 C-N-CA 120.371 -0.531 . . . . 1.0 110.446 -179.953 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . 0.708 ' H ' HG22 ' A' ' 18' ' ' VAL . . . -60.67 -168.39 0.43 Allowed Glycine 0 N--CA 1.439 -1.131 0 N-CA-C 111.969 -0.452 . . . . 1.0 111.969 -177.288 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 20' ' ' PRO . . . . . 0.677 ' O ' ' N ' ' A' ' 24' ' ' ALA . 4.2 Cg_endo -81.73 -25.96 3.34 Favored 'Trans proline' 0 C--N 1.294 -2.339 0 C-N-CA 121.847 1.698 . . . . 1.0 113.72 -178.041 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -63.51 -60.01 8.03 Favored Glycine 0 N--CA 1.473 1.134 0 C-N-CA 118.984 -1.579 . . . . 1.0 112.679 -176.004 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . 0.57 ' H ' ' HA ' ' A' ' 16' ' ' ALA . . . -57.31 -53.01 48.15 Favored Glycine 0 C--N 1.31 -0.874 0 N-CA-C 106.259 -2.736 . . . . 1.0 106.259 -178.848 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 21.3 t -56.37 -32.29 35.31 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.849 0 N-CA-C 108.177 -1.045 . . . . 1.0 108.177 178.428 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . 0.677 ' N ' ' O ' ' A' ' 20' ' ' PRO . . . -60.4 -62.88 1.54 Allowed 'General case' 0 C--N 1.352 0.716 0 C-N-CA 118.573 -1.251 . . . . 1.0 110.087 -179.47 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 86.5 mt -61.91 -46.32 89.89 Favored 'General case' 0 CA--C 1.516 -0.336 0 C-N-CA 120.202 -0.599 . . . . 1.0 111.612 -177.223 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 97.9 t -59.85 -59.85 3.39 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.582 0 C-N-CA 119.332 -0.947 . . . . 1.0 110.393 -177.617 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . 0.436 ' O ' ' CB ' ' A' ' 31' ' ' ALA . 1.4 p -58.65 -36.93 62.49 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.442 0 C-N-CA 120.571 -0.452 . . . . 1.0 110.345 -177.353 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 8.7 tttm -65.69 -56.19 13.41 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 115.646 -0.706 . . . . 1.0 109.869 -179.882 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 97.6 t -62.29 -48.73 86.99 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.699 0 CA-C-N 115.314 -0.857 . . . . 1.0 110.002 -177.699 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 30' ' ' CYS . . . . . . . . . . . . . 49.2 t -65.45 -62.1 1.72 Allowed 'General case' 0 N--CA 1.443 -0.796 0 C-N-CA 119.849 -0.74 . . . . 1.0 110.206 -178.815 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . 0.436 ' CB ' ' O ' ' A' ' 27' ' ' VAL . . . -57.15 -50.21 73.52 Favored 'General case' 0 CA--C 1.507 -0.697 0 CA-C-O 120.879 0.371 . . . . 1.0 110.26 -176.668 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . 0.403 ' O ' ' CB ' ' A' ' 33' ' ' LEU . . . 74.82 70.66 1.22 Allowed Glycine 0 N--CA 1.443 -0.859 0 N-CA-C 109.001 -1.64 . . . . 1.0 109.001 -178.106 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . 0.403 ' CB ' ' O ' ' A' ' 32' ' ' GLY . 5.2 mt 91.79 82.81 0.04 OUTLIER Pre-proline 0 C--N 1.332 -0.192 0 O-C-N 124.963 1.037 . . . . 1.0 109.453 -178.281 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 50.8 Cg_exo -50.39 -28.85 22.11 Favored 'Trans proline' 0 C--N 1.312 -1.37 0 C-N-CA 122.481 2.121 . . . . 1.0 113.555 -179.333 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -62.36 -61.02 7.01 Favored Glycine 0 N--CA 1.47 0.932 0 C-N-CA 118.353 -1.88 . . . . 1.0 109.909 -178.027 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . 0.534 ' O ' ' CB ' ' A' ' 37' ' ' ILE . 11.4 p -86.47 167.11 1.84 Allowed 'Isoleucine or valine' 0 CA--C 1.507 -0.698 0 N-CA-C 107.719 -1.215 . . . . 1.0 107.719 178.41 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . 0.534 ' CB ' ' O ' ' A' ' 36' ' ' VAL . 8.2 tt 115.91 107.37 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.484 1.257 0 O-C-N 125.403 1.689 . . . . 1.0 110.6 179.752 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 60.8 m80 -140.39 135.67 32.32 Favored 'General case' 0 C--N 1.328 -0.337 0 O-C-N 121.95 -0.469 . . . . 1.0 109.782 179.153 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 6.1 m -106.42 130.93 22.18 Favored Pre-proline 0 CA--C 1.534 0.342 0 N-CA-C 110.278 -0.268 . . . . 1.0 110.278 -179.582 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 37.0 Cg_endo -65.69 -24.07 55.56 Favored 'Trans proline' 0 N--CA 1.493 1.465 0 C-N-CA 121.141 1.227 . . . . 1.0 112.702 -179.684 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -128.47 135.99 50.22 Favored 'General case' 0 N--CA 1.466 0.361 0 N-CA-C 110.376 -0.231 . . . . 1.0 110.376 177.839 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . 0.712 ' C ' ' H ' ' A' ' 44' ' ' GLY . 11.8 ptm180 -171.23 172.09 5.42 Favored 'General case' 0 C--N 1.322 -0.608 0 C-N-CA 120.2 -0.6 . . . . 1.0 110.941 178.342 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 43' ' ' ARG . . . . . 0.553 ' C ' ' H ' ' A' ' 45' ' ' PHE . 37.2 tpt85 -63.33 24.13 0.01 OUTLIER 'General case' 0 CA--C 1.55 0.953 0 CA-C-O 121.518 0.675 . . . . 1.0 109.816 179.296 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . 0.712 ' H ' ' C ' ' A' ' 42' ' ' ARG . . . 76.98 -26.78 1.72 Allowed Glycine 0 C--N 1.338 0.686 0 N-CA-C 110.533 -1.027 . . . . 1.0 110.533 179.394 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . 0.553 ' H ' ' C ' ' A' ' 43' ' ' ARG . 11.8 p90 -175.32 -174.15 0.71 Allowed 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 114.352 -0.924 . . . . 1.0 109.451 179.87 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 46' ' ' PHE . . . . . 0.534 ' HB2' ' O ' ' A' ' 45' ' ' PHE . 0.7 OUTLIER 110.81 107.38 0.0 OUTLIER 'General case' 0 N--CA 1.479 1.015 0 O-C-N 125.398 1.686 . . . . 1.0 109.851 -179.78 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 47' ' ' ARG . . . . . 0.515 ' CB ' ' O ' ' A' ' 46' ' ' PHE . 34.3 ttm-85 97.69 154.21 0.02 OUTLIER 'General case' 0 N--CA 1.472 0.655 0 O-C-N 123.966 0.791 . . . . 1.0 110.964 179.7 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 4.4 t 67.2 86.5 0.13 Allowed 'General case' 0 C--N 1.328 -0.335 0 N-CA-C 108.161 -1.051 . . . . 1.0 108.161 -177.685 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 49' ' ' ASN . . . . . 0.501 ' O ' ' N ' ' A' ' 51' ' ' GLU . 0.0 OUTLIER -153.0 160.71 30.6 Favored Pre-proline 0 N--CA 1.466 0.364 0 CA-C-N 115.675 -0.693 . . . . 1.0 111.33 -179.352 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 30.8 Cg_endo -63.13 60.94 0.17 Allowed 'Trans proline' 0 C--N 1.311 -1.409 0 C-N-CA 122.545 2.163 . . . . 1.0 111.403 177.976 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . 0.501 ' N ' ' O ' ' A' ' 49' ' ' ASN . 40.9 mt-10 41.91 37.72 0.87 Allowed 'General case' 0 C--O 1.233 0.227 0 CA-C-O 120.68 0.276 . . . . 1.0 111.501 178.31 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . 0.675 ' HE ' ' HB ' ' A' ' 89' ' ' VAL . 73.9 mtt85 -146.62 167.78 22.9 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 121.025 0.44 . . . . 1.0 111.702 -179.119 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 21.0 tt -76.22 164.13 3.67 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.324 0 N-CA-C 108.061 -1.088 . . . . 1.0 108.061 176.891 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 56.1 tt0 -132.82 131.2 40.78 Favored 'General case' 0 CA--C 1.535 0.399 0 N-CA-C 108.857 -0.794 . . . . 1.0 108.857 179.057 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 10.5 tt -143.48 153.82 16.37 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.728 0 N-CA-C 110.169 -0.308 . . . . 1.0 110.169 178.852 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 104.14 2.35 45.03 Favored Glycine 0 C--N 1.341 0.848 0 N-CA-C 109.851 -1.3 . . . . 1.0 109.851 -179.108 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 18.2 m-20 -90.57 109.8 20.95 Favored 'General case' 0 CA--C 1.542 0.642 0 CA-C-O 122.138 0.971 . . . . 1.0 113.09 -178.152 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 58' ' ' TRP . . . . . 0.56 ' CD1' ' OE1' ' A' ' 61' ' ' GLU . 9.2 m95 -82.8 -176.92 6.54 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 113.43 -1.714 . . . . 1.0 108.678 176.599 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 59' ' ' ARG . . . . . 0.457 ' CG ' ' H ' ' A' ' 60' ' ' TYR . 8.0 ptm180 -98.64 -54.28 3.07 Favored 'General case' 0 CA--C 1.552 1.042 0 CA-C-N 118.955 0.798 . . . . 1.0 111.188 178.21 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 60' ' ' TYR . . . . . 0.457 ' H ' ' CG ' ' A' ' 59' ' ' ARG . 0.2 OUTLIER -80.29 -11.24 59.74 Favored 'General case' 0 N--CA 1.479 1.007 0 C-N-CA 124.561 1.145 . . . . 1.0 112.397 -178.511 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . 0.56 ' OE1' ' CD1' ' A' ' 58' ' ' TRP . 86.6 mt-10 -80.08 -16.47 54.94 Favored 'General case' 0 CA--C 1.496 -1.127 0 O-C-N 121.58 -0.7 . . . . 1.0 110.413 179.302 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 62' ' ' VAL . . . . . 0.478 ' O ' ' N ' ' A' ' 66' ' ' GLY . 28.7 m -44.24 -46.52 2.3 Favored 'Isoleucine or valine' 0 CA--C 1.499 -1.01 0 N-CA-C 109.215 -0.661 . . . . 1.0 109.215 -175.798 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 63' ' ' ALA . . . . . 0.422 ' O ' ' CG ' ' A' ' 67' ' ' ARG . . . -66.19 -46.29 77.84 Favored 'General case' 0 N--CA 1.415 -2.206 0 N-CA-C 108.109 -1.071 . . . . 1.0 108.109 177.147 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 64' ' ' HIS . . . . . 0.485 ' N ' ' O ' ' A' ' 61' ' ' GLU . 4.2 t-80 -57.96 -60.65 3.4 Favored 'General case' 0 CA--C 1.547 0.83 0 CA-C-N 115.572 -0.74 . . . . 1.0 111.269 179.322 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 65' ' ' ASP . . . . . 0.596 ' C ' ' H ' ' A' ' 67' ' ' ARG . 0.7 OUTLIER -69.96 -55.63 9.11 Favored 'General case' 0 CA--C 1.554 1.116 0 O-C-N 121.128 -0.983 . . . . 1.0 110.24 178.632 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . 0.478 ' N ' ' O ' ' A' ' 62' ' ' VAL . . . -64.84 32.59 0.1 Allowed Glycine 0 N--CA 1.471 1.008 0 O-C-N 121.475 -0.765 . . . . 1.0 111.421 178.461 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 67' ' ' ARG . . . . . 0.63 ' O ' ' N ' ' A' ' 69' ' ' LEU . 0.0 OUTLIER -77.45 6.4 7.07 Favored 'General case' 0 C--N 1.316 -0.863 0 C-N-CA 123.605 0.762 . . . . 1.0 110.08 176.173 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . 0.63 ' O ' ' HA ' ' A' ' 72' ' ' HIS . 0.8 OUTLIER -33.15 -30.16 0.01 OUTLIER 'General case' 0 N--CA 1.486 1.366 0 N-CA-C 107.481 -1.303 . . . . 1.0 107.481 -179.072 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . 0.63 ' N ' ' O ' ' A' ' 67' ' ' ARG . 2.3 mt -63.25 -64.68 0.84 Allowed 'General case' 0 C--N 1.317 -0.847 0 C-N-CA 117.509 -1.676 . . . . 1.0 107.558 176.754 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . 0.695 ' C ' ' H ' ' A' ' 72' ' ' HIS . . . -77.17 -72.25 0.36 Allowed 'General case' 0 N--CA 1.478 0.932 0 N-CA-C 106.671 -1.603 . . . . 1.0 106.671 177.615 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 71' ' ' ALA . . . . . 0.601 ' H ' ' HB3' ' A' ' 67' ' ' ARG . . . -49.16 4.19 0.01 OUTLIER 'General case' 0 N--CA 1.467 0.418 0 C-N-CA 125.203 1.401 . . . . 1.0 112.31 178.536 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 72' ' ' HIS . . . . . 0.729 ' CG ' ' H ' ' A' ' 73' ' ' MET . 0.0 OUTLIER -18.11 -72.87 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.396 0 C-N-CA 123.155 0.582 . . . . 1.0 112.527 -176.592 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 73' ' ' MET . . . . . 0.729 ' H ' ' CG ' ' A' ' 72' ' ' HIS . 45.4 mtt -71.28 -43.04 67.93 Favored 'General case' 0 C--N 1.298 -1.658 0 C-N-CA 119.309 -0.957 . . . . 1.0 110.239 178.082 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . 0.618 ' O ' ' N ' ' A' ' 76' ' ' GLY . 42.3 t -43.08 -45.99 1.32 Allowed 'Isoleucine or valine' 0 N--CA 1.463 0.21 0 CA-C-O 118.822 -0.609 . . . . 1.0 110.248 -175.4 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 75' ' ' ASN . . . . . 0.508 ' O ' ' N ' ' A' ' 77' ' ' ILE . 5.2 t30 -38.45 -18.96 0.01 OUTLIER 'General case' 0 N--CA 1.473 0.693 0 CA-C-O 122.025 0.917 . . . . 1.0 111.815 179.192 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 76' ' ' GLY . . . . . 0.618 ' N ' ' O ' ' A' ' 74' ' ' VAL . . . -43.35 -19.05 0.07 OUTLIER Glycine 0 CA--C 1.54 1.641 0 N-CA-C 109.344 -1.503 . . . . 1.0 109.344 177.89 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 77' ' ' ILE . . . . . 0.767 ' O ' ' N ' ' A' ' 80' ' ' ALA . 9.7 pt -89.9 -49.7 13.61 Favored 'Isoleucine or valine' 0 C--O 1.211 -0.952 0 N-CA-C 107.982 -1.118 . . . . 1.0 107.982 179.963 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . 0.484 ' C ' ' O ' ' A' ' 77' ' ' ILE . 6.0 t -35.15 -35.04 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.447 -0.583 0 N-CA-C 108.532 -0.914 . . . . 1.0 108.532 -177.268 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . 0.583 ' O ' ' CB ' ' A' ' 83' ' ' ALA . 1.3 pp -91.56 -21.92 6.28 Favored 'Isoleucine or valine' 0 C--O 1.198 -1.638 0 CA-C-N 115.824 -0.626 . . . . 1.0 110.26 178.511 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 80' ' ' ALA . . . . . 0.767 ' N ' ' O ' ' A' ' 77' ' ' ILE . . . -92.65 -9.64 40.21 Favored 'General case' 0 CA--C 1.554 1.111 0 O-C-N 121.368 -0.832 . . . . 1.0 112.682 176.258 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 81' ' ' GLU . . . . . 0.531 ' N ' ' O ' ' A' ' 77' ' ' ILE . 4.9 mm-40 -79.15 -76.76 0.19 Allowed 'General case' 0 C--N 1.344 0.328 0 N-CA-C 112.583 0.586 . . . . 1.0 112.583 -176.121 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 82' ' ' ASP . . . . . 0.721 ' O ' HG12 ' A' ' 85' ' ' ILE . 5.9 m-20 -86.42 -17.34 34.58 Favored 'General case' 0 C--O 1.206 -1.205 0 CA-C-N 116.455 -0.339 . . . . 1.0 111.201 -179.795 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . 0.583 ' CB ' ' O ' ' A' ' 79' ' ' ILE . . . -58.47 -40.09 81.74 Favored 'General case' 0 C--N 1.316 -0.854 0 C-N-CA 118.188 -1.405 . . . . 1.0 111.944 -175.888 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . 0.422 ' CD1' ' C ' ' A' ' 84' ' ' LEU . 3.4 tm? -37.72 -37.07 0.21 Allowed 'General case' 0 N--CA 1.467 0.399 0 N-CA-C 112.719 0.637 . . . . 1.0 112.719 -175.65 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 85' ' ' ILE . . . . . 0.721 HG12 ' O ' ' A' ' 82' ' ' ASP . 22.4 pt -69.49 -26.49 31.28 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.568 0 C-N-CA 120.341 -0.544 . . . . 1.0 111.547 -179.804 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 86' ' ' ALA . . . . . 0.532 ' C ' ' H ' ' A' ' 88' ' ' ALA . . . -86.34 -15.16 41.4 Favored 'General case' 0 C--N 1.33 -0.249 0 N-CA-C 111.935 0.346 . . . . 1.0 111.935 -179.328 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 3.4 tt0 -53.04 -8.88 0.11 Allowed 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 120.868 0.366 . . . . 1.0 110.034 -179.467 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 88' ' ' ALA . . . . . 0.532 ' H ' ' C ' ' A' ' 86' ' ' ALA . . . -93.26 -8.1 43.16 Favored 'General case' 0 N--CA 1.47 0.573 0 CA-C-O 121.529 0.681 . . . . 1.0 109.421 -179.914 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 89' ' ' VAL . . . . . 0.675 ' HB ' ' HE ' ' A' ' 52' ' ' ARG . 4.5 t -92.61 36.22 0.1 OUTLIER 'Isoleucine or valine' 0 N--CA 1.438 -1.058 0 N-CA-C 108.103 -1.073 . . . . 1.0 108.103 178.602 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 90' ' ' GLY . . . . . 0.866 ' O ' ' N ' ' A' ' 92' ' ' HIS . . . -50.88 -28.15 15.79 Favored Glycine 0 C--N 1.355 1.585 0 CA-C-O 117.303 -1.832 . . . . 1.0 111.247 176.309 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 91' ' ' PRO . . . . . 0.601 ' HD2' ' N ' ' A' ' 90' ' ' GLY . 27.9 Cg_exo -32.73 -1.76 0.0 OUTLIER 'Trans proline' 0 N--CA 1.506 2.232 0 C-N-CA 123.388 2.725 . . . . 1.0 114.112 173.644 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 92' ' ' HIS . . . . . 0.866 ' N ' ' O ' ' A' ' 90' ' ' GLY . 1.5 t-80 -50.4 -29.73 10.81 Favored 'General case' 0 N--CA 1.443 -0.817 0 N-CA-C 107.094 -1.447 . . . . 1.0 107.094 178.897 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 93' ' ' LEU . . . . . 0.58 ' HG ' ' H ' ' A' ' 94' ' ' ALA . 2.0 pp -60.04 -52.29 66.01 Favored 'General case' 0 N--CA 1.448 -0.565 0 N-CA-C 108.404 -0.962 . . . . 1.0 108.404 177.185 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 94' ' ' ALA . . . . . 0.58 ' H ' ' HG ' ' A' ' 93' ' ' LEU . . . -50.61 -56.02 13.69 Favored 'General case' 0 CA--C 1.515 -0.394 0 N-CA-C 107.236 -1.394 . . . . 1.0 107.236 -179.433 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 95' ' ' ARG . . . . . 0.403 HH11 ' HG3' ' A' ' 20' ' ' PRO . 89.8 mtt-85 -59.41 -32.18 69.93 Favored 'General case' 0 C--N 1.313 -0.999 0 N-CA-C 108.325 -0.991 . . . . 1.0 108.325 177.538 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 96' ' ' ALA . . . . . 0.768 ' O ' ' N ' ' A' ' 100' ' ' ILE . . . -55.75 -49.77 72.21 Favored 'General case' 0 C--O 1.207 -1.156 0 N-CA-C 106.824 -1.547 . . . . 1.0 106.824 -178.741 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 97' ' ' LEU . . . . . 0.47 ' C ' ' O ' ' A' ' 96' ' ' ALA . 0.6 OUTLIER -36.88 -26.58 0.01 OUTLIER 'General case' 0 CA--C 1.568 1.669 0 N-CA-C 107.216 -1.401 . . . . 1.0 107.216 -179.912 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 98' ' ' GLY . . . . . 0.606 ' N ' ' O ' ' A' ' 96' ' ' ALA . . . -84.95 -52.87 3.32 Favored Glycine 0 CA--C 1.55 2.261 0 CA-C-O 123.119 1.399 . . . . 1.0 111.19 173.816 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 99' ' ' GLN . . . . . 0.563 ' N ' ' O ' ' A' ' 96' ' ' ALA . 24.9 mt-30 -79.07 7.97 6.52 Favored 'General case' 0 N--CA 1.438 -1.073 0 CA-C-N 114.742 -0.729 . . . . 1.0 109.521 177.989 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 100' ' ' ILE . . . . . 0.768 ' N ' ' O ' ' A' ' 96' ' ' ALA . 14.7 tt -60.3 -49.77 82.9 Favored 'Isoleucine or valine' 0 CA--C 1.484 -1.561 0 N-CA-C 107.936 -1.135 . . . . 1.0 107.936 179.694 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 101' ' ' VAL . . . . . 0.551 ' N ' ' CG2' ' A' ' 100' ' ' ILE . 22.7 t -60.12 -56.7 15.78 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.636 0 C-N-CA 116.495 -2.082 . . . . 1.0 107.763 178.135 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 102' ' ' CYS . . . . . 0.531 ' O ' ' O ' ' A' ' 105' ' ' GLY . 0.5 OUTLIER -46.53 -38.17 8.98 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 114.971 -1.013 . . . . 1.0 110.663 -175.869 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 7.3 ttp180 -65.05 -54.62 27.32 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 125.595 1.809 . . . . 1.0 113.302 176.844 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 104' ' ' TYR . . . . . 0.656 ' CG ' ' O ' ' A' ' 104' ' ' TYR . 50.8 t80 -93.28 32.0 1.4 Allowed 'General case' 0 C--N 1.311 -1.096 0 C-N-CA 126.082 1.753 . . . . 1.0 107.441 178.969 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 105' ' ' GLY . . . . . 0.539 ' O ' ' CB ' ' A' ' 106' ' ' ALA . . . 172.56 -141.78 6.43 Favored Glycine 0 N--CA 1.431 -1.649 0 N-CA-C 107.199 -2.36 . . . . 1.0 107.199 178.665 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 106' ' ' ALA . . . . . 0.539 ' CB ' ' O ' ' A' ' 105' ' ' GLY . . . 109.67 107.63 0.0 OUTLIER 'General case' 0 C--N 1.315 -0.896 0 C-N-CA 126.736 2.014 . . . . 1.0 116.237 178.712 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 107' ' ' THR . . . . . 0.494 ' O ' ' HG2' ' A' ' 110' ' ' PRO . 27.7 m -72.44 -52.06 17.54 Favored 'General case' 0 N--CA 1.476 0.842 0 CA-C-N 115.614 -0.721 . . . . 1.0 110.12 175.252 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 108' ' ' VAL . . . . . 0.422 ' O ' ' C ' ' A' ' 109' ' ' ILE . 8.7 p -61.46 -46.12 97.22 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.035 0 O-C-N 121.639 -0.663 . . . . 1.0 112.019 -178.452 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 109' ' ' ILE . . . . . 0.422 ' C ' ' O ' ' A' ' 108' ' ' VAL . 2.6 mt -38.0 -59.6 1.15 Allowed Pre-proline 0 N--CA 1.484 1.253 0 CA-C-N 116.399 -0.364 . . . . 1.0 110.778 -178.401 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 110' ' ' PRO . . . . . 0.494 ' HG2' ' O ' ' A' ' 107' ' ' THR . 31.9 Cg_endo -56.18 -21.82 37.35 Favored 'Trans proline' 0 C--N 1.314 -1.25 0 C-N-CA 120.895 1.064 . . . . 1.0 112.177 -177.888 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 4.0 m-80 -64.37 -65.7 0.64 Allowed 'General case' 0 N--CA 1.469 0.522 0 C-N-CA 119.631 -0.827 . . . . 1.0 109.808 178.77 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 112' ' ' ILE . . . . . 0.627 ' O ' ' HB ' ' A' ' 116' ' ' ILE . 2.0 tt -45.72 -27.45 0.64 Allowed 'Isoleucine or valine' 0 C--O 1.22 -0.474 0 CA-C-O 122.383 1.087 . . . . 1.0 109.121 -179.166 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 113' ' ' ASN . . . . . 0.709 ' O ' ' HB3' ' A' ' 117' ' ' GLU . 25.4 t-20 -84.05 -53.03 5.83 Favored 'General case' 0 C--N 1.308 -1.199 0 CA-C-O 122.953 1.359 . . . . 1.0 110.018 178.949 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -56.07 -58.04 9.58 Favored 'General case' 0 C--N 1.295 -1.793 0 C-N-CA 119.257 -0.977 . . . . 1.0 110.261 -178.688 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -79.89 -59.59 2.67 Favored 'General case' 0 C--O 1.246 0.893 0 N-CA-C 114.465 1.283 . . . . 1.0 114.465 179.921 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 116' ' ' ILE . . . . . 0.627 ' HB ' ' O ' ' A' ' 112' ' ' ILE . 11.2 mt -68.23 -55.36 16.67 Favored 'Isoleucine or valine' 0 C--O 1.217 -0.638 0 C-N-CA 117.919 -1.512 . . . . 1.0 113.055 -175.183 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 117' ' ' GLU . . . . . 0.709 ' HB3' ' O ' ' A' ' 113' ' ' ASN . 0.0 OUTLIER -39.56 -65.6 0.37 Allowed 'General case' 0 C--O 1.251 1.166 0 C-N-CA 121.079 -0.248 . . . . 1.0 110.453 -174.271 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 2.5 t -45.36 -18.63 0.1 Allowed 'Isoleucine or valine' 0 N--CA 1.446 -0.643 0 C-N-CA 119.124 -1.031 . . . . 1.0 109.81 -178.963 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 119' ' ' LEU . . . . . 0.603 ' N ' ' O ' ' A' ' 116' ' ' ILE . 4.7 tt -88.57 -54.92 3.94 Favored 'General case' 0 CA--C 1.538 0.504 0 N-CA-C 112.566 0.58 . . . . 1.0 112.566 176.899 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 120' ' ' GLY . . . . . 0.564 ' C ' ' H ' ' A' ' 122' ' ' GLY . . . -93.3 44.87 2.44 Favored Glycine 0 C--N 1.367 2.251 0 C-N-CA 119.821 -1.18 . . . . 1.0 113.937 -175.968 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 41.5 m 73.66 -27.85 0.19 Allowed 'General case' 0 N--CA 1.476 0.848 0 C-N-CA 123.432 0.693 . . . . 1.0 109.92 177.742 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 122' ' ' GLY . . . . . 0.564 ' H ' ' C ' ' A' ' 120' ' ' GLY . . . 106.81 -36.07 4.64 Favored Glycine 0 C--N 1.319 -0.405 0 C-N-CA 124.777 1.179 . . . . 1.0 110.634 179.811 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 123' ' ' THR . . . . . 0.434 ' C ' ' O ' ' A' ' 122' ' ' GLY . 81.4 m -31.42 98.96 0.01 OUTLIER 'General case' 0 N--CA 1.465 0.281 0 CA-C-N 117.643 0.722 . . . . 1.0 112.421 -178.07 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 12.1 p-10 -142.83 143.25 32.05 Favored 'General case' 0 N--CA 1.45 -0.439 0 N-CA-C 108.058 -1.09 . . . . 1.0 108.058 177.352 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 125' ' ' TYR . . . . . 0.519 ' OH ' ' CD1' ' A' ' 127' ' ' PHE . 0.0 OUTLIER -153.03 149.1 27.81 Favored 'General case' 0 CA--C 1.542 0.646 0 C-N-CA 122.95 0.5 . . . . 1.0 109.682 -178.498 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 126' ' ' ARG . . . . . 0.465 ' NE ' ' O ' ' A' ' 125' ' ' TYR . 9.6 mmp_? -149.58 152.85 36.17 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.857 -0.61 . . . . 1.0 109.92 177.24 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 127' ' ' PHE . . . . . 0.519 ' CD1' ' OH ' ' A' ' 125' ' ' TYR . 10.6 p90 . . . . . 0 C--O 1.221 -0.436 0 CA-C-O 118.041 -0.981 . . . . 1.0 110.152 179.262 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.586 0 N-CA-C 109.083 -0.71 . . . . 1.0 109.083 . . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 2' ' ' SER . . . . . 0.414 ' O ' ' CG ' ' A' ' 3' ' ' ASP . 87.3 p -104.18 8.92 36.34 Favored 'General case' 0 N--CA 1.465 0.31 0 CA-C-N 115.672 -0.694 . . . . 1.0 110.187 -179.708 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 3' ' ' ASP . . . . . 0.414 ' CG ' ' O ' ' A' ' 2' ' ' SER . 1.6 m-20 166.44 98.32 0.0 OUTLIER 'General case' 0 CA--C 1.532 0.258 0 CA-C-N 116.163 -0.471 . . . . 1.0 109.963 178.974 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 3.4 t80 -149.68 145.84 26.93 Favored 'General case' 0 C--N 1.33 -0.251 0 N-CA-C 109.612 -0.514 . . . . 1.0 109.612 179.122 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 5' ' ' ASP . . . . . 0.631 ' O ' ' O ' ' A' ' 6' ' ' THR . 0.1 OUTLIER -155.06 154.31 32.25 Favored 'General case' 0 C--N 1.327 -0.413 0 N-CA-C 109.229 -0.656 . . . . 1.0 109.229 -179.95 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 6' ' ' THR . . . . . 0.631 ' O ' ' O ' ' A' ' 5' ' ' ASP . 3.1 m -37.1 177.51 0.0 OUTLIER 'General case' 0 N--CA 1.469 0.501 0 CA-C-O 121.656 0.741 . . . . 1.0 111.646 -178.23 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . 0.433 ' H ' ' CG2' ' A' ' 6' ' ' THR . 50.9 mt-10 -66.29 -58.44 5.34 Favored 'General case' 0 C--N 1.319 -0.759 0 CA-C-N 116.231 -0.44 . . . . 1.0 110.758 -178.808 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -68.55 -31.49 70.74 Favored 'General case' 0 N--CA 1.451 -0.41 0 CA-C-N 119.01 0.823 . . . . 1.0 111.029 179.477 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . 0.518 ' O ' ' CG2' ' A' ' 13' ' ' VAL . 60.0 t -66.69 -55.07 19.7 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.705 0 N-CA-C 108.228 -1.027 . . . . 1.0 108.228 179.651 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 22.9 t -68.49 -38.46 81.0 Favored 'General case' 0 C--N 1.321 -0.658 0 O-C-N 121.912 -0.493 . . . . 1.0 111.626 178.251 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 14.3 ttt-85 -74.12 -64.09 1.09 Allowed 'General case' 0 N--CA 1.453 -0.314 0 CA-C-O 118.488 -0.768 . . . . 1.0 111.361 -179.505 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . 0.528 ' O ' ' N ' ' A' ' 16' ' ' ALA . . . -52.29 -30.77 29.72 Favored 'General case' 0 CA--C 1.501 -0.914 0 CA-C-N 120.319 1.418 . . . . 1.0 110.09 -179.48 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . 0.607 ' O ' ' CB ' ' A' ' 17' ' ' LEU . 3.6 t -56.27 -52.0 56.76 Favored 'Isoleucine or valine' 0 C--O 1.202 -1.43 0 N-CA-C 106.15 -1.796 . . . . 1.0 106.15 176.922 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -59.16 -63.54 1.26 Allowed 'General case' 0 CA--C 1.544 0.743 0 C-N-CA 117.395 -1.722 . . . . 1.0 110.983 177.72 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . 0.528 ' O ' ' N ' ' A' ' 19' ' ' GLY . . . -53.13 -54.73 31.38 Favored 'General case' 0 N--CA 1.484 1.225 0 CA-C-O 122.16 0.981 . . . . 1.0 110.844 -177.139 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . 0.528 ' N ' ' O ' ' A' ' 12' ' ' ALA . . . -63.07 -53.75 48.71 Favored 'General case' 0 C--N 1.303 -1.439 0 CA-C-N 113.915 -1.493 . . . . 1.0 108.984 -178.47 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . 0.607 ' CB ' ' O ' ' A' ' 13' ' ' VAL . 10.0 tp -57.47 -52.46 65.3 Favored 'General case' 0 N--CA 1.484 1.267 0 CA-C-N 114.48 -1.236 . . . . 1.0 108.576 -176.759 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . 0.577 HG23 ' H ' ' A' ' 19' ' ' GLY . 3.5 m -67.46 -56.56 12.9 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.245 0 C-N-CA 119.043 -1.063 . . . . 1.0 108.763 179.153 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . 0.577 ' H ' HG23 ' A' ' 18' ' ' VAL . . . -61.61 -167.1 0.47 Allowed Glycine 0 CA--C 1.522 0.499 0 N-CA-C 111.58 -0.608 . . . . 1.0 111.58 -179.704 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 20' ' ' PRO . . . . . 0.627 ' O ' ' N ' ' A' ' 24' ' ' ALA . 56.1 Cg_endo -81.86 -32.71 0.75 Allowed 'Trans proline' 0 C--N 1.304 -1.773 0 C-N-CA 122.72 2.28 . . . . 1.0 114.467 -178.2 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -58.17 -57.41 19.98 Favored Glycine 0 N--CA 1.479 1.525 0 C-N-CA 120.481 -0.866 . . . . 1.0 112.318 -177.328 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -58.65 -49.7 74.67 Favored Glycine 0 N--CA 1.472 1.034 0 N-CA-C 105.849 -2.9 . . . . 1.0 105.849 -176.123 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 2.5 t -58.7 -33.76 49.85 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.079 0 CA-C-N 114.035 -1.082 . . . . 1.0 108.355 178.334 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . 0.627 ' N ' ' O ' ' A' ' 20' ' ' PRO . . . -58.2 -61.9 2.22 Favored 'General case' 0 CA--C 1.536 0.413 0 C-N-CA 118.276 -1.37 . . . . 1.0 110.309 -179.511 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 56.5 mt -64.73 -42.67 95.04 Favored 'General case' 0 CA--C 1.52 -0.211 0 CA-C-N 118.982 0.81 . . . . 1.0 112.374 -177.49 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 75.1 t -60.68 -58.69 6.29 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.358 0 C-N-CA 119.096 -1.042 . . . . 1.0 109.327 -177.313 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 1.9 p -60.35 -34.66 58.44 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.518 0 N-CA-C 112.286 0.476 . . . . 1.0 112.286 -177.86 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 7.6 tppt? -65.55 -53.6 39.76 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-O 122.246 1.022 . . . . 1.0 109.094 -178.494 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 88.1 t -63.11 -46.58 95.68 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.125 0 CA-C-N 113.216 -1.811 . . . . 1.0 109.863 -177.231 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 30' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -65.35 -59.83 3.62 Favored 'General case' 0 N--CA 1.447 -0.602 0 C-N-CA 118.455 -1.298 . . . . 1.0 109.054 -179.419 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -60.27 -52.36 65.63 Favored 'General case' 0 CA--C 1.509 -0.619 0 N-CA-C 112.118 0.414 . . . . 1.0 112.118 -176.708 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . 0.471 ' O ' ' CB ' ' A' ' 33' ' ' LEU . . . 83.57 77.58 1.11 Allowed Glycine 0 CA--C 1.524 0.642 0 N-CA-C 109.918 -1.273 . . . . 1.0 109.918 -178.55 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . 0.471 ' CB ' ' O ' ' A' ' 32' ' ' GLY . 4.0 tp 85.02 107.84 0.03 OUTLIER Pre-proline 0 CA--C 1.548 0.884 0 O-C-N 123.885 0.403 . . . . 1.0 110.685 -179.927 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 37.6 Cg_endo -67.83 -27.51 37.32 Favored 'Trans proline' 0 N--CA 1.499 1.837 0 C-N-CA 121.632 1.555 . . . . 1.0 113.711 -179.001 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -60.83 -59.72 9.68 Favored Glycine 0 CA--C 1.525 0.694 0 C-N-CA 118.516 -1.802 . . . . 1.0 109.551 -177.564 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . 0.585 ' O ' ' CG2' ' A' ' 37' ' ' ILE . 1.7 p -84.01 142.71 13.04 Favored 'Isoleucine or valine' 0 C--O 1.211 -0.924 0 N-CA-C 106.822 -1.547 . . . . 1.0 106.822 178.011 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . 0.585 ' CG2' ' O ' ' A' ' 36' ' ' VAL . 0.6 OUTLIER 150.54 88.87 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.475 0.809 0 O-C-N 123.556 0.535 . . . . 1.0 109.75 179.694 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 26.2 m-70 -134.64 128.0 32.25 Favored 'General case' 0 C--O 1.233 0.195 0 N-CA-C 107.277 -1.379 . . . . 1.0 107.277 176.91 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 39' ' ' THR . . . . . 0.553 ' O ' ' NH2' ' A' ' 42' ' ' ARG . 1.0 OUTLIER -121.6 158.5 53.85 Favored Pre-proline 0 N--CA 1.468 0.463 0 N-CA-C 109.43 -0.581 . . . . 1.0 109.43 -179.189 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 40' ' ' PRO . . . . . 0.486 ' HG2' ' H ' ' A' ' 41' ' ' ALA . 97.4 Cg_endo -85.41 -78.76 0.0 OUTLIER 'Trans proline' 0 C--N 1.31 -1.456 0 C-N-CA 121.36 1.374 . . . . 1.0 113.306 179.99 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . 0.486 ' H ' ' HG2' ' A' ' 40' ' ' PRO . . . -76.11 123.3 25.59 Favored 'General case' 0 C--N 1.319 -0.737 0 CA-C-N 114.955 -1.021 . . . . 1.0 111.875 -176.802 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . 0.679 ' C ' ' H ' ' A' ' 44' ' ' GLY . 0.0 OUTLIER -171.14 171.06 5.89 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 114.493 -1.23 . . . . 1.0 109.502 179.071 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 43' ' ' ARG . . . . . 0.414 ' C ' ' H ' ' A' ' 45' ' ' PHE . 8.6 tpt180 -63.53 18.07 0.01 OUTLIER 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.512 -0.767 . . . . 1.0 109.761 178.989 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . 0.679 ' H ' ' C ' ' A' ' 42' ' ' ARG . . . 81.38 -25.48 3.77 Favored Glycine 0 C--N 1.336 0.542 0 N-CA-C 110.731 -0.948 . . . . 1.0 110.731 179.343 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . 0.538 ' O ' ' CD1' ' A' ' 46' ' ' PHE . 84.9 t80 -161.72 163.23 29.81 Favored 'General case' 0 CA--C 1.535 0.388 0 N-CA-C 110.5 -0.185 . . . . 1.0 110.5 -179.328 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 46' ' ' PHE . . . . . 0.538 ' CD1' ' O ' ' A' ' 45' ' ' PHE . 3.9 m-30 136.61 86.49 0.0 OUTLIER 'General case' 0 N--CA 1.487 1.405 0 O-C-N 124.782 1.301 . . . . 1.0 110.308 179.369 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 47' ' ' ARG . . . . . 0.509 ' CB ' ' O ' ' A' ' 46' ' ' PHE . 5.2 mmp_? 132.57 140.77 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.512 0 C-N-CA 124.392 1.077 . . . . 1.0 109.642 178.568 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 1.9 t 72.74 72.02 0.14 Allowed 'General case' 0 N--CA 1.451 -0.386 0 C-N-CA 120.277 -0.569 . . . . 1.0 109.672 -179.631 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 49' ' ' ASN . . . . . 0.655 ' O ' ' N ' ' A' ' 51' ' ' GLU . 0.0 OUTLIER -136.37 121.9 13.38 Favored Pre-proline 0 C--O 1.221 -0.439 0 N-CA-C 107.923 -1.14 . . . . 1.0 107.923 -179.464 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 52.4 Cg_exo -52.21 63.96 0.02 OUTLIER 'Trans proline' 0 N--CA 1.503 2.03 0 C-N-CA 121.94 1.76 . . . . 1.0 113.311 178.786 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . 0.655 ' N ' ' O ' ' A' ' 49' ' ' ASN . 2.5 mp0 65.05 36.79 7.15 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 120.523 0.202 . . . . 1.0 110.81 -179.978 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 4.7 mtp85 -111.21 138.58 47.48 Favored 'General case' 0 N--CA 1.466 0.367 0 CA-C-N 116.515 -0.311 . . . . 1.0 110.176 179.634 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 4.7 tp -66.54 141.38 18.07 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-O 121.836 0.826 . . . . 1.0 110.611 179.97 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 54' ' ' GLN . . . . . 0.521 ' CG ' ' O ' ' A' ' 54' ' ' GLN . 0.0 OUTLIER -63.03 80.78 0.02 OUTLIER 'General case' 0 CA--C 1.55 0.977 0 CA-C-N 113.739 -1.573 . . . . 1.0 109.915 -176.433 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -150.05 158.38 5.65 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.875 0 O-C-N 121.038 -1.039 . . . . 1.0 110.224 178.091 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 110.43 -7.26 30.29 Favored Glycine 0 N--CA 1.474 1.17 0 N-CA-C 111.05 -0.82 . . . . 1.0 111.05 -179.522 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . 0.452 ' OD1' ' O ' ' A' ' 57' ' ' ASP . 42.3 p-10 -77.22 97.88 4.95 Favored 'General case' 0 C--N 1.318 -0.769 0 N-CA-C 108.079 -1.082 . . . . 1.0 108.079 177.59 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 58' ' ' TRP . . . . . . . . . . . . . 0.6 OUTLIER -88.88 175.19 7.55 Favored 'General case' 0 CA--C 1.538 0.506 0 CA-C-O 122.757 1.265 . . . . 1.0 112.321 -177.753 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -88.52 -57.69 2.83 Favored 'General case' 0 C--N 1.318 -0.79 0 CA-C-N 112.479 -2.146 . . . . 1.0 112.985 179.963 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 79.0 t80 -90.73 -17.73 26.2 Favored 'General case' 0 C--O 1.245 0.866 0 CA-C-N 115.115 -0.948 . . . . 1.0 113.012 -178.553 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . 0.485 ' O ' ' N ' ' A' ' 65' ' ' ASP . 17.6 tt0 -77.19 -12.9 60.0 Favored 'General case' 0 N--CA 1.435 -1.214 0 O-C-N 121.844 -0.535 . . . . 1.0 110.275 -178.605 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 62' ' ' VAL . . . . . 0.521 ' O ' ' N ' ' A' ' 66' ' ' GLY . 16.1 m -45.45 -55.73 1.18 Allowed 'Isoleucine or valine' 0 C--O 1.21 -1.01 0 C-N-CA 119.602 -0.839 . . . . 1.0 109.126 -175.385 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -65.43 -48.86 71.29 Favored 'General case' 0 C--N 1.306 -1.315 0 N-CA-C 109.306 -0.627 . . . . 1.0 109.306 178.721 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER -53.15 -58.85 5.61 Favored 'General case' 0 CA--C 1.539 0.533 0 C-N-CA 119.28 -0.968 . . . . 1.0 109.429 -179.084 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 65' ' ' ASP . . . . . 0.558 ' C ' ' H ' ' A' ' 67' ' ' ARG . 19.0 m-20 -65.28 -45.67 83.52 Favored 'General case' 0 C--N 1.324 -0.524 0 N-CA-C 108.849 -0.797 . . . . 1.0 108.849 178.085 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . 0.521 ' N ' ' O ' ' A' ' 62' ' ' VAL . . . -67.49 24.44 0.22 Allowed Glycine 0 C--N 1.338 0.655 0 N-CA-C 111.629 -0.588 . . . . 1.0 111.629 -179.976 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 67' ' ' ARG . . . . . 0.558 ' H ' ' C ' ' A' ' 65' ' ' ASP . 0.0 OUTLIER -86.36 -9.89 55.47 Favored 'General case' 0 C--N 1.315 -0.893 0 N-CA-C 108.587 -0.894 . . . . 1.0 108.587 175.602 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . 0.513 ' O ' ' CA ' ' A' ' 72' ' ' HIS . 1.4 pt? -63.35 -34.92 78.77 Favored 'General case' 0 N--CA 1.472 0.632 0 N-CA-C 112.97 0.73 . . . . 1.0 112.97 -177.868 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -52.29 -65.51 0.55 Allowed 'General case' 0 C--N 1.317 -0.828 0 C-N-CA 117.433 -1.707 . . . . 1.0 109.25 -177.622 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -64.7 -75.76 0.08 Allowed 'General case' 0 C--N 1.312 -1.029 0 N-CA-C 106.511 -1.662 . . . . 1.0 106.511 -179.811 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 71' ' ' ALA . . . . . 0.745 ' O ' ' N ' ' A' ' 73' ' ' MET . . . -59.56 15.74 0.01 OUTLIER 'General case' 0 C--N 1.321 -0.636 0 C-N-CA 127.172 2.189 . . . . 1.0 116.084 179.94 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 72' ' ' HIS . . . . . 0.513 ' CA ' ' O ' ' A' ' 68' ' ' LEU . 0.0 OUTLIER -21.94 -28.48 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.588 0 CA-C-N 119.638 1.108 . . . . 1.0 113.756 -176.11 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 73' ' ' MET . . . . . 0.745 ' N ' ' O ' ' A' ' 71' ' ' ALA . 4.0 mmt -63.72 -56.65 14.03 Favored 'General case' 0 C--N 1.317 -0.816 0 C-N-CA 117.64 -1.624 . . . . 1.0 106.875 174.789 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . 0.783 ' O ' ' N ' ' A' ' 76' ' ' GLY . 27.9 t -36.92 -51.08 0.3 Allowed 'Isoleucine or valine' 0 N--CA 1.48 1.037 0 CA-C-O 118.483 -0.77 . . . . 1.0 111.155 -175.86 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 75' ' ' ASN . . . . . 0.465 ' ND2' HH12 ' A' ' 126' ' ' ARG . 26.0 t30 -30.71 -16.64 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.492 0 CA-C-N 119.302 0.956 . . . . 1.0 113.382 -178.2 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 76' ' ' GLY . . . . . 0.783 ' N ' ' O ' ' A' ' 74' ' ' VAL . . . -48.2 -25.05 3.85 Favored Glycine 0 CA--C 1.543 1.822 0 N-CA-C 109.991 -1.243 . . . . 1.0 109.991 176.404 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 77' ' ' ILE . . . . . 0.664 HG13 ' H ' ' A' ' 78' ' ' VAL . 3.0 pt -73.29 -55.55 12.3 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.679 0 CA-C-O 122.366 1.079 . . . . 1.0 109.078 178.552 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . 0.664 ' H ' HG13 ' A' ' 77' ' ' ILE . 1.4 p -38.59 -34.85 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.311 -1.083 0 CA-C-N 112.395 -2.184 . . . . 1.0 105.405 -175.666 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . 0.484 ' N ' ' C ' ' A' ' 77' ' ' ILE . 16.2 pt -100.06 -37.58 5.92 Favored 'Isoleucine or valine' 0 CA--C 1.554 1.126 0 N-CA-C 113.924 1.083 . . . . 1.0 113.924 176.712 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 80' ' ' ALA . . . . . 0.575 ' N ' ' O ' ' A' ' 76' ' ' GLY . . . -82.39 -12.78 57.7 Favored 'General case' 0 N--CA 1.478 0.969 0 N-CA-C 113.645 0.98 . . . . 1.0 113.645 -178.86 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 45.5 tt0 -92.17 -73.14 0.56 Allowed 'General case' 0 N--CA 1.439 -0.995 0 CA-C-O 118.918 -0.563 . . . . 1.0 112.507 -178.636 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 28.3 m-20 -93.82 -16.84 23.72 Favored 'General case' 0 C--N 1.352 0.69 0 N-CA-C 114.843 1.423 . . . . 1.0 114.843 -178.551 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . 0.62 ' O ' ' N ' ' A' ' 85' ' ' ILE . . . -52.94 -41.46 64.51 Favored 'General case' 0 N--CA 1.468 0.44 0 C-N-CA 118.713 -1.195 . . . . 1.0 111.205 -177.588 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 49.5 mt -39.37 -15.71 0.01 OUTLIER 'General case' 0 CA--C 1.538 0.505 0 N-CA-C 111.869 0.322 . . . . 1.0 111.869 -179.577 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 85' ' ' ILE . . . . . 0.62 ' N ' ' O ' ' A' ' 83' ' ' ALA . 0.8 OUTLIER -96.68 -31.55 4.01 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.618 0 C-N-CA 120.973 -0.291 . . . . 1.0 111.246 178.285 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 86' ' ' ALA . . . . . 0.533 ' C ' ' H ' ' A' ' 88' ' ' ALA . . . -94.64 -28.66 15.25 Favored 'General case' 0 N--CA 1.466 0.375 0 CA-C-O 120.811 0.339 . . . . 1.0 111.842 -179.408 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -54.54 -7.7 0.18 Allowed 'General case' 0 C--N 1.32 -0.703 0 C-N-CA 119.308 -0.957 . . . . 1.0 110.196 -178.781 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 88' ' ' ALA . . . . . 0.533 ' H ' ' C ' ' A' ' 86' ' ' ALA . . . -79.73 -0.85 35.93 Favored 'General case' 0 N--CA 1.472 0.655 0 CA-C-O 122.209 1.004 . . . . 1.0 109.245 179.324 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 3.2 m -102.01 34.53 0.36 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.54 0 CA-C-N 113.025 -1.898 . . . . 1.0 109.744 178.548 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 90' ' ' GLY . . . . . 0.619 ' C ' ' H ' ' A' ' 92' ' ' HIS . . . -67.06 -38.27 92.38 Favored Glycine 0 C--N 1.345 1.052 0 N-CA-C 111.146 -0.782 . . . . 1.0 111.146 178.575 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 91' ' ' PRO . . . . . 0.539 ' CD ' ' N ' ' A' ' 90' ' ' GLY . 80.6 Cg_exo -46.96 -8.0 0.04 OUTLIER 'Trans proline' 0 N--CA 1.488 1.199 0 C-N-CA 121.75 1.633 . . . . 1.0 110.712 177.995 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 92' ' ' HIS . . . . . 0.619 ' H ' ' C ' ' A' ' 90' ' ' GLY . 2.6 p80 -57.42 -21.05 33.95 Favored 'General case' 0 N--CA 1.439 -1.0 0 N-CA-C 108.051 -1.092 . . . . 1.0 108.051 179.949 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 93' ' ' LEU . . . . . 0.55 ' N ' ' ND1' ' A' ' 92' ' ' HIS . 2.3 pp -61.64 -58.52 7.76 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.764 -0.653 . . . . 1.0 109.345 178.307 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 94' ' ' ALA . . . . . 0.528 ' H ' ' HG ' ' A' ' 93' ' ' LEU . . . -56.01 -52.39 64.38 Favored 'General case' 0 CA--C 1.515 -0.374 0 N-CA-C 108.983 -0.747 . . . . 1.0 108.983 179.532 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 95' ' ' ARG . . . . . 0.627 ' O ' ' N ' ' A' ' 97' ' ' LEU . 33.5 ttp180 -58.95 -60.25 4.16 Favored 'General case' 0 N--CA 1.442 -0.86 0 N-CA-C 107.565 -1.272 . . . . 1.0 107.565 178.39 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 96' ' ' ALA . . . . . 0.978 ' O ' ' N ' ' A' ' 98' ' ' GLY . . . -47.18 -13.71 0.03 OUTLIER 'General case' 0 C--N 1.301 -1.533 0 O-C-N 119.104 -2.247 . . . . 1.0 111.153 -178.689 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 97' ' ' LEU . . . . . 0.688 ' O ' ' N ' ' A' ' 100' ' ' ILE . 1.3 tm? 6.91 -52.53 0.0 OUTLIER 'General case' 0 C--N 1.365 1.242 0 CA-C-O 118.13 -0.938 . . . . 1.0 108.881 -166.886 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 98' ' ' GLY . . . . . 0.978 ' N ' ' O ' ' A' ' 96' ' ' ALA . . . -49.93 -24.29 6.19 Favored Glycine 0 CA--C 1.545 1.934 0 N-CA-C 107.898 -2.081 . . . . 1.0 107.898 174.218 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 99' ' ' GLN . . . . . 0.645 ' N ' ' O ' ' A' ' 96' ' ' ALA . 19.0 mt-30 -67.68 -19.32 65.16 Favored 'General case' 0 C--N 1.364 1.222 0 C-N-CA 116.073 -2.251 . . . . 1.0 107.263 176.375 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 100' ' ' ILE . . . . . 0.688 ' N ' ' O ' ' A' ' 97' ' ' LEU . 3.4 mm -66.67 -43.6 90.16 Favored 'Isoleucine or valine' 0 C--O 1.212 -0.872 0 C-N-CA 119.171 -1.012 . . . . 1.0 109.519 177.594 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 101' ' ' VAL . . . . . 0.48 ' CG1' ' N ' ' A' ' 102' ' ' CYS . 4.6 p -60.27 -56.8 15.19 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.32 0 C-N-CA 116.684 -2.006 . . . . 1.0 107.483 -179.924 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 102' ' ' CYS . . . . . 0.509 ' O ' ' CB ' ' A' ' 106' ' ' ALA . 0.5 OUTLIER -51.09 -31.67 19.78 Favored 'General case' 0 C--O 1.214 -0.812 0 CA-C-O 121.223 0.535 . . . . 1.0 112.019 179.845 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 103' ' ' ARG . . . . . 0.437 HH22 ' HB3' ' A' ' 93' ' ' LEU . 3.2 ttp180 -85.34 -47.46 10.0 Favored 'General case' 0 N--CA 1.477 0.904 0 CA-C-N 115.254 -0.884 . . . . 1.0 111.745 179.545 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 104' ' ' TYR . . . . . 0.436 ' N ' ' O ' ' A' ' 100' ' ' ILE . 8.7 t80 -49.73 -19.36 0.62 Allowed 'General case' 0 C--N 1.3 -1.571 0 CA-C-N 114.086 -1.416 . . . . 1.0 108.937 179.28 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -173.64 -46.52 0.05 OUTLIER Glycine 0 N--CA 1.448 -0.526 0 C-N-CA 117.967 -2.063 . . . . 1.0 110.828 179.379 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 106' ' ' ALA . . . . . 0.509 ' CB ' ' O ' ' A' ' 102' ' ' CYS . . . 69.7 82.63 0.16 Allowed 'General case' 0 N--CA 1.44 -0.963 0 N-CA-C 111.628 0.232 . . . . 1.0 111.628 -179.081 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 107' ' ' THR . . . . . 0.426 ' O ' ' CD ' ' A' ' 110' ' ' PRO . 9.4 t -92.26 3.49 55.27 Favored 'General case' 0 CA--C 1.514 -0.44 0 N-CA-C 107.304 -1.369 . . . . 1.0 107.304 177.164 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 108' ' ' VAL . . . . . 0.516 ' CG1' ' O ' ' A' ' 108' ' ' VAL . 62.2 t -90.65 20.11 0.64 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.526 0 CA-C-N 114.883 -1.053 . . . . 1.0 111.352 178.593 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 109' ' ' ILE . . . . . 0.688 ' N ' ' CD ' ' A' ' 110' ' ' PRO . 0.1 OUTLIER -106.07 -18.26 0.17 Allowed Pre-proline 0 CA--C 1.548 0.869 0 O-C-N 120.162 -1.586 . . . . 1.0 110.954 177.994 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 110' ' ' PRO . . . . . 0.688 ' CD ' ' N ' ' A' ' 109' ' ' ILE . 19.5 Cg_endo -59.5 -49.56 10.2 Favored 'Trans proline' 0 N--CA 1.482 0.851 0 CA-C-N 120.5 1.214 . . . . 1.0 113.095 -174.533 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 111' ' ' ASN . . . . . 0.427 HD21 ' C ' ' A' ' 111' ' ' ASN . 0.2 OUTLIER -68.66 -66.78 0.53 Allowed 'General case' 0 C--O 1.217 -0.617 0 C-N-CA 118.542 -1.263 . . . . 1.0 109.55 -178.526 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 112' ' ' ILE . . . . . 0.537 ' O ' ' HB ' ' A' ' 116' ' ' ILE . 0.9 OUTLIER -48.41 -38.64 9.08 Favored 'Isoleucine or valine' 0 C--O 1.213 -0.862 0 CA-C-O 121.127 0.489 . . . . 1.0 111.659 -177.854 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 113' ' ' ASN . . . . . 0.477 ' N ' ' CG2' ' A' ' 112' ' ' ILE . 1.6 t-20 -67.59 -40.61 84.8 Favored 'General case' 0 C--N 1.313 -1.019 0 N-CA-C 106.502 -1.666 . . . . 1.0 106.502 178.585 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 114' ' ' ALA . . . . . 0.407 ' N ' ' O ' ' A' ' 111' ' ' ASN . . . -61.16 -51.4 69.21 Favored 'General case' 0 C--N 1.306 -1.307 0 CA-C-N 112.956 -1.929 . . . . 1.0 108.249 179.198 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -80.09 -59.7 2.62 Favored 'General case' 0 CA--C 1.544 0.725 0 N-CA-C 114.782 1.401 . . . . 1.0 114.782 179.582 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 116' ' ' ILE . . . . . 0.537 ' HB ' ' O ' ' A' ' 112' ' ' ILE . 0.7 OUTLIER -47.34 -50.53 7.52 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.884 0 CA-C-N 119.483 1.038 . . . . 1.0 111.52 -178.202 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 117' ' ' GLU . . . . . 0.498 ' CG ' ' N ' ' A' ' 118' ' ' VAL . 13.3 pt-20 -43.3 -58.57 2.47 Favored 'General case' 0 C--N 1.322 -0.623 0 N-CA-C 105.701 -1.962 . . . . 1.0 105.701 -179.365 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 118' ' ' VAL . . . . . 0.498 ' N ' ' CG ' ' A' ' 117' ' ' GLU . 88.1 t -58.43 -53.37 47.5 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.069 0 C-N-CA 119.24 -0.984 . . . . 1.0 110.043 177.757 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -52.31 -71.75 0.06 Allowed 'General case' 0 CA--C 1.545 0.765 0 N-CA-C 107.805 -1.183 . . . . 1.0 107.805 -177.922 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 120' ' ' GLY . . . . . 0.531 ' N ' ' O ' ' A' ' 116' ' ' ILE . . . -70.18 -76.05 0.55 Allowed Glycine 0 CA--C 1.546 2.002 0 C-N-CA 119.737 -1.221 . . . . 1.0 111.267 -179.87 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 121' ' ' THR . . . . . 0.498 ' OG1' ' O ' ' A' ' 120' ' ' GLY . 1.9 m 148.33 -28.68 0.01 OUTLIER 'General case' 0 N--CA 1.487 1.404 0 CA-C-N 112.294 -1.953 . . . . 1.0 110.914 -178.414 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 122' ' ' GLY . . . . . 0.643 ' O ' ' N ' ' A' ' 124' ' ' ASP . . . 102.59 -17.25 53.67 Favored Glycine 0 C--O 1.224 -0.497 0 N-CA-C 107.629 -2.188 . . . . 1.0 107.629 -176.856 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 123' ' ' THR . . . . . 0.407 ' O ' ' CG ' ' A' ' 124' ' ' ASP . 8.1 t -53.99 85.34 0.0 OUTLIER 'General case' 0 N--CA 1.466 0.34 0 N-CA-C 106.043 -1.836 . . . . 1.0 106.043 178.379 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 124' ' ' ASP . . . . . 0.643 ' N ' ' O ' ' A' ' 122' ' ' GLY . 45.3 m-20 -163.41 169.45 18.91 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 113.344 -1.753 . . . . 1.0 111.972 -179.537 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 125' ' ' TYR . . . . . . . . . . . . . 2.0 t80 -146.47 144.52 29.72 Favored 'General case' 0 CA--C 1.542 0.662 0 N-CA-C 108.461 -0.94 . . . . 1.0 108.461 176.258 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 126' ' ' ARG . . . . . 0.465 HH12 ' ND2' ' A' ' 75' ' ' ASN . 1.9 mtp85 -146.44 149.33 33.5 Favored 'General case' 0 N--CA 1.466 0.326 0 N-CA-C 109.446 -0.576 . . . . 1.0 109.446 177.611 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 127' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.219 -0.506 0 CA-C-O 117.869 -1.062 . . . . 1.0 109.112 179.252 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 1' ' ' MET . . . . . 0.587 ' N ' ' SD ' ' A' ' 1' ' ' MET . 0.0 OUTLIER . . . . . 0 N--CA 1.493 1.682 0 N-CA-C 108.561 -0.903 . . . . 1.0 108.561 . . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 35.9 t -106.18 7.96 31.83 Favored 'General case' 0 N--CA 1.466 0.337 0 CA-C-N 116.317 -0.401 . . . . 1.0 110.361 -179.867 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 3.9 t0 167.5 96.86 0.0 OUTLIER 'General case' 0 N--CA 1.47 0.551 0 O-C-N 123.728 0.642 . . . . 1.0 110.242 179.244 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 82.7 t80 -150.34 146.29 26.65 Favored 'General case' 0 N--CA 1.463 0.191 0 CA-C-N 116.161 -0.472 . . . . 1.0 110.568 179.7 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 5' ' ' ASP . . . . . 0.51 ' N ' ' OD1' ' A' ' 5' ' ' ASP . 1.5 p30 -158.55 153.95 25.86 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 121.129 0.49 . . . . 1.0 110.407 179.984 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 6' ' ' THR . . . . . 0.614 ' O ' ' N ' ' A' ' 10' ' ' SER . 0.2 OUTLIER -69.72 170.55 10.7 Favored 'General case' 0 C--O 1.205 -1.251 0 CA-C-N 115.777 -0.647 . . . . 1.0 110.359 -179.453 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 1.6 tm-20 -55.31 -58.36 8.03 Favored 'General case' 0 C--N 1.31 -1.144 0 CA-C-N 115.367 -0.833 . . . . 1.0 109.72 -178.719 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 8' ' ' ARG . . . . . 0.486 ' O ' ' CB ' ' A' ' 12' ' ' ALA . 5.5 tmm_? -51.52 -54.7 24.58 Favored 'General case' 0 C--N 1.311 -1.072 0 C-N-CA 119.17 -1.012 . . . . 1.0 108.599 -177.553 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . 0.408 HG13 HH11 ' A' ' 8' ' ' ARG . 0.0 OUTLIER -65.51 -48.76 81.69 Favored 'Isoleucine or valine' 0 CA--C 1.551 0.991 0 CA-C-N 115.673 -0.694 . . . . 1.0 110.718 178.896 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 10' ' ' SER . . . . . 0.614 ' N ' ' O ' ' A' ' 6' ' ' THR . 35.5 t -63.41 -41.11 98.71 Favored 'General case' 0 C--N 1.318 -0.778 0 N-CA-C 115.007 1.484 . . . . 1.0 115.007 -178.18 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 11' ' ' ARG . . . . . 0.597 ' O ' ' N ' ' A' ' 15' ' ' ALA . 56.9 ttm-85 -79.99 -55.11 5.19 Favored 'General case' 0 C--O 1.216 -0.704 0 CA-C-O 122.478 1.133 . . . . 1.0 108.988 176.808 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . 0.486 ' CB ' ' O ' ' A' ' 8' ' ' ARG . . . -45.85 -50.31 14.4 Favored 'General case' 0 N--CA 1.469 0.489 0 N-CA-C 106.361 -1.718 . . . . 1.0 106.361 -177.605 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . 0.602 ' O ' ' CB ' ' A' ' 17' ' ' LEU . 75.0 t -60.24 -49.8 82.75 Favored 'Isoleucine or valine' 0 C--O 1.202 -1.433 0 C-N-CA 118.265 -1.374 . . . . 1.0 107.686 177.568 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . 0.432 ' N ' ' O ' ' A' ' 11' ' ' ARG . . . -59.01 -62.84 1.58 Allowed 'General case' 0 N--CA 1.48 1.072 0 C-N-CA 119.356 -0.938 . . . . 1.0 111.443 178.821 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . 0.597 ' N ' ' O ' ' A' ' 11' ' ' ARG . . . -53.43 -55.38 25.66 Favored 'General case' 0 N--CA 1.473 0.71 0 CA-C-O 121.586 0.707 . . . . 1.0 109.902 -177.77 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . 0.44 ' CB ' ' O ' ' A' ' 12' ' ' ALA . . . -63.91 -53.99 41.77 Favored 'General case' 0 C--N 1.314 -0.935 0 CA-C-N 114.39 -1.277 . . . . 1.0 108.879 -179.272 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . 0.602 ' CB ' ' O ' ' A' ' 13' ' ' VAL . 8.2 tt -56.57 -53.71 54.41 Favored 'General case' 0 N--CA 1.477 0.907 0 C-N-CA 118.698 -1.201 . . . . 1.0 109.026 -177.477 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . 0.523 HG21 ' H ' ' A' ' 19' ' ' GLY . 2.4 m -68.4 -55.78 14.94 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.798 0 C-N-CA 119.436 -0.906 . . . . 1.0 109.84 179.599 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . 0.532 ' N ' ' O ' ' A' ' 15' ' ' ALA . . . -65.88 -174.46 5.28 Favored Glycine 0 CA--C 1.531 1.071 0 N-CA-C 111.825 -0.51 . . . . 1.0 111.825 -178.617 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 20' ' ' PRO . . . . . 0.597 ' O ' ' N ' ' A' ' 24' ' ' ALA . 1.3 Cg_endo -77.22 -23.15 10.55 Favored 'Trans proline' 0 N--CA 1.492 1.394 0 C-N-CA 123.065 2.51 . . . . 1.0 114.501 -179.123 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -59.73 -58.56 13.6 Favored Glycine 0 N--CA 1.474 1.185 0 C-N-CA 119.517 -1.325 . . . . 1.0 110.893 -177.205 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -56.63 -53.37 44.23 Favored Glycine 0 C--N 1.314 -0.659 0 N-CA-C 107.231 -2.348 . . . . 1.0 107.231 -178.743 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 60.9 t -58.01 -31.74 42.01 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.883 0 CA-C-N 114.789 -0.705 . . . . 1.0 110.245 179.598 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . 0.597 ' N ' ' O ' ' A' ' 20' ' ' PRO . . . -61.54 -59.96 4.42 Favored 'General case' 0 CA--C 1.533 0.307 0 C-N-CA 118.884 -1.126 . . . . 1.0 108.61 179.888 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 19.1 tp -61.94 -47.6 84.16 Favored 'General case' 0 C--N 1.342 0.282 0 N-CA-C 112.852 0.686 . . . . 1.0 112.852 -179.099 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 89.9 t -60.03 -60.19 2.91 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.189 0 C-N-CA 119.055 -1.058 . . . . 1.0 110.105 -177.669 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 1.8 p -58.91 -35.33 55.92 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.352 0 N-CA-C 112.456 0.539 . . . . 1.0 112.456 -178.52 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 1.1 mmmm -66.08 -54.48 25.24 Favored 'General case' 0 CA--C 1.517 -0.298 0 C-N-CA 119.499 -0.881 . . . . 1.0 108.874 -178.745 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 4.0 t -65.89 -48.78 80.78 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.842 0 CA-C-N 114.016 -1.447 . . . . 1.0 111.017 -177.242 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 30' ' ' CYS . . . . . . . . . . . . . 4.8 t -64.45 -60.51 3.07 Favored 'General case' 0 N--CA 1.445 -0.721 0 C-N-CA 117.685 -1.606 . . . . 1.0 109.61 -179.837 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -68.2 -55.59 11.76 Favored 'General case' 0 C--N 1.331 -0.235 0 N-CA-C 114.846 1.425 . . . . 1.0 114.846 -175.163 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . 0.41 ' O ' ' CB ' ' A' ' 33' ' ' LEU . . . 85.69 72.9 1.28 Allowed Glycine 0 CA--C 1.534 1.223 0 C-N-CA 120.673 -0.775 . . . . 1.0 111.56 -178.76 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . 0.436 ' O ' ' N ' ' A' ' 35' ' ' GLY . 0.9 OUTLIER 73.0 99.36 0.04 OUTLIER Pre-proline 0 CA--C 1.554 1.101 0 C-N-CA 120.985 -0.286 . . . . 1.0 111.304 178.107 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_exo -43.45 -9.98 0.03 OUTLIER 'Trans proline' 0 N--CA 1.511 2.525 0 C-N-CA 123.92 3.08 . . . . 1.0 115.57 -179.218 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . 0.436 ' N ' ' O ' ' A' ' 33' ' ' LEU . . . -59.54 -59.04 11.3 Favored Glycine 0 CA--C 1.529 0.952 0 C-N-CA 118.562 -1.78 . . . . 1.0 109.189 -179.047 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 6.1 m -85.96 -148.1 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.332 -0.177 0 N-CA-C 109.199 -0.667 . . . . 1.0 109.199 179.422 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 2.1 mp 74.71 80.03 0.04 OUTLIER 'Isoleucine or valine' 0 CA--C 1.514 -0.436 0 N-CA-C 112.819 0.674 . . . . 1.0 112.819 179.415 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 55.6 m80 -135.71 126.74 27.85 Favored 'General case' 0 C--N 1.329 -0.29 0 N-CA-C 106.514 -1.661 . . . . 1.0 106.514 176.979 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 39' ' ' THR . . . . . 0.576 ' OG1' ' NE ' ' A' ' 42' ' ' ARG . 0.0 OUTLIER -103.36 136.63 19.19 Favored Pre-proline 0 N--CA 1.469 0.492 0 N-CA-C 109.835 -0.431 . . . . 1.0 109.835 -178.968 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 32.3 Cg_exo -53.92 -32.53 68.11 Favored 'Trans proline' 0 N--CA 1.486 1.088 0 C-N-CA 121.076 1.184 . . . . 1.0 113.529 -179.68 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -128.21 132.06 48.82 Favored 'General case' 0 N--CA 1.463 0.192 0 O-C-N 122.191 -0.318 . . . . 1.0 111.226 -179.864 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . 0.71 ' C ' ' H ' ' A' ' 44' ' ' GLY . 12.1 mtm180 -160.39 158.57 29.78 Favored 'General case' 0 C--N 1.321 -0.665 0 N-CA-C 109.151 -0.685 . . . . 1.0 109.151 176.131 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 43' ' ' ARG . . . . . 0.47 ' C ' ' H ' ' A' ' 45' ' ' PHE . 41.9 ttt85 -60.28 23.46 0.01 OUTLIER 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 115.487 -0.779 . . . . 1.0 110.142 179.933 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . 0.71 ' H ' ' C ' ' A' ' 42' ' ' ARG . . . 80.68 -26.38 3.17 Favored Glycine 0 N--CA 1.445 -0.72 0 N-CA-C 110.126 -1.19 . . . . 1.0 110.126 -179.645 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . 0.588 ' CG ' ' C ' ' A' ' 44' ' ' GLY . 0.1 OUTLIER -179.33 -174.13 0.3 Allowed 'General case' 0 CA--C 1.537 0.464 0 C-N-CA 120.91 -0.316 . . . . 1.0 111.083 -178.801 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 46' ' ' PHE . . . . . 0.549 ' CB ' ' O ' ' A' ' 45' ' ' PHE . 15.2 t80 117.64 107.05 0.0 OUTLIER 'General case' 0 N--CA 1.488 1.428 0 O-C-N 125.044 1.465 . . . . 1.0 109.359 -179.454 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 47' ' ' ARG . . . . . 0.496 ' CB ' ' O ' ' A' ' 46' ' ' PHE . 3.9 tmm_? 100.09 167.3 0.01 OUTLIER 'General case' 0 N--CA 1.467 0.395 0 CA-C-N 115.141 -0.936 . . . . 1.0 108.632 -178.244 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 7.7 t 75.6 -18.03 0.48 Allowed 'General case' 0 N--CA 1.472 0.643 0 CA-C-O 120.646 0.26 . . . . 1.0 111.332 -179.158 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 49' ' ' ASN . . . . . 0.693 ' ND2' ' H ' ' A' ' 52' ' ' ARG . 0.2 OUTLIER -62.2 146.27 92.69 Favored Pre-proline 0 CA--C 1.547 0.838 0 CA-C-N 116.317 -0.402 . . . . 1.0 111.909 -179.17 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 50' ' ' PRO . . . . . 0.417 ' N ' ' ND2' ' A' ' 49' ' ' ASN . 25.2 Cg_exo -60.68 66.65 0.08 OUTLIER 'Trans proline' 0 N--CA 1.501 1.94 0 C-N-CA 121.918 1.746 . . . . 1.0 111.703 177.289 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . 0.522 ' N ' ' O ' ' A' ' 49' ' ' ASN . 23.1 mm-40 46.76 55.73 7.44 Favored 'General case' 0 CA--C 1.554 1.096 0 N-CA-C 113.074 0.768 . . . . 1.0 113.074 177.979 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . 0.697 ' NH2' ' NE2' ' A' ' 92' ' ' HIS . 7.7 mtt-85 -143.57 155.72 44.38 Favored 'General case' 0 N--CA 1.498 1.928 0 CA-C-O 119.494 -0.289 . . . . 1.0 110.555 178.225 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 10.4 tp -75.75 127.94 37.24 Favored 'Isoleucine or valine' 0 CA--C 1.56 1.358 0 N-CA-C 116.258 1.947 . . . . 1.0 116.258 -174.361 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 47.3 tp60 -65.2 86.0 0.06 Allowed 'General case' 0 N--CA 1.476 0.848 0 CA-C-N 109.728 -3.396 . . . . 1.0 109.457 -177.716 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -147.27 155.58 10.86 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.845 0 N-CA-C 109.692 -0.484 . . . . 1.0 109.692 178.151 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 107.51 -5.38 35.29 Favored Glycine 0 N--CA 1.48 1.621 0 N-CA-C 111.262 -0.735 . . . . 1.0 111.262 179.452 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -112.7 129.61 56.34 Favored 'General case' 0 C--N 1.317 -0.808 0 N-CA-C 108.206 -1.035 . . . . 1.0 108.206 178.071 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 58' ' ' TRP . . . . . 0.54 ' H ' ' HB2' ' A' ' 61' ' ' GLU . 11.5 m0 -134.25 152.36 51.78 Favored 'General case' 0 C--N 1.348 0.536 0 CA-C-O 122.333 1.063 . . . . 1.0 109.834 -179.829 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -37.73 -39.79 0.37 Allowed 'General case' 0 CA--C 1.558 1.252 0 CA-C-N 113.047 -1.888 . . . . 1.0 110.767 -177.015 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 7.3 t80 -86.29 -27.4 24.4 Favored 'General case' 0 N--CA 1.481 1.099 0 CA-C-O 121.953 0.882 . . . . 1.0 112.626 -179.434 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . 0.54 ' HB2' ' H ' ' A' ' 58' ' ' TRP . 39.9 mt-10 -78.64 -13.0 60.04 Favored 'General case' 0 CA--C 1.509 -0.613 0 CA-C-N 115.639 -0.709 . . . . 1.0 110.377 179.015 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 62' ' ' VAL . . . . . 0.654 ' O ' ' N ' ' A' ' 66' ' ' GLY . 49.5 t -50.01 -57.06 2.51 Favored 'Isoleucine or valine' 0 C--O 1.202 -1.401 0 C-N-CA 119.328 -0.949 . . . . 1.0 109.8 -176.806 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 63' ' ' ALA . . . . . 0.441 ' O ' ' HG3' ' A' ' 67' ' ' ARG . . . -65.27 -57.36 8.64 Favored 'General case' 0 C--N 1.307 -1.278 0 O-C-N 121.33 -0.856 . . . . 1.0 110.21 -178.669 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 40.3 t-80 -47.44 -56.92 6.01 Favored 'General case' 0 N--CA 1.472 0.67 0 O-C-N 124.171 0.919 . . . . 1.0 109.573 179.976 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 65' ' ' ASP . . . . . 0.629 ' C ' ' H ' ' A' ' 67' ' ' ARG . 30.0 t0 -74.56 -48.99 23.58 Favored 'General case' 0 C--N 1.316 -0.853 0 CA-C-N 115.476 -0.784 . . . . 1.0 111.167 179.511 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . 0.654 ' N ' ' O ' ' A' ' 62' ' ' VAL . . . -74.3 26.42 1.04 Allowed Glycine 0 CA--C 1.521 0.427 0 N-CA-C 109.905 -1.278 . . . . 1.0 109.905 177.35 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 67' ' ' ARG . . . . . 0.647 ' O ' ' N ' ' A' ' 69' ' ' LEU . 33.4 mtm180 -71.97 5.51 2.62 Favored 'General case' 0 CA--C 1.512 -0.516 0 N-CA-C 104.996 -2.224 . . . . 1.0 104.996 174.032 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . 0.643 ' H ' ' C ' ' A' ' 66' ' ' GLY . 7.9 tt -31.76 -29.13 0.01 OUTLIER 'General case' 0 N--CA 1.473 0.686 0 O-C-N 124.11 0.881 . . . . 1.0 108.948 -177.417 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . 0.647 ' N ' ' O ' ' A' ' 67' ' ' ARG . 1.3 mt -64.35 -65.66 0.65 Allowed 'General case' 0 C--N 1.322 -0.628 0 C-N-CA 119.341 -0.943 . . . . 1.0 108.825 178.895 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . 0.622 ' O ' ' N ' ' A' ' 72' ' ' HIS . . . -78.62 -76.68 0.19 Allowed 'General case' 0 N--CA 1.47 0.554 0 N-CA-C 106.376 -1.712 . . . . 1.0 106.376 177.793 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 71' ' ' ALA . . . . . 0.482 ' O ' ' C ' ' A' ' 72' ' ' HIS . . . -43.06 4.13 0.0 OUTLIER 'General case' 0 C--N 1.326 -0.437 0 N-CA-C 114.336 1.235 . . . . 1.0 114.336 177.906 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 72' ' ' HIS . . . . . 0.682 ' CD2' ' H ' ' A' ' 73' ' ' MET . 1.4 p80 -32.21 -53.8 0.3 Allowed 'General case' 0 N--CA 1.467 0.407 0 CA-C-N 120.126 1.33 . . . . 1.0 112.11 -177.851 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 73' ' ' MET . . . . . 0.682 ' H ' ' CD2' ' A' ' 72' ' ' HIS . 4.9 tpp -73.57 -56.85 4.5 Favored 'General case' 0 C--N 1.331 -0.219 0 N-CA-C 108.017 -1.105 . . . . 1.0 108.017 177.926 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . 0.758 ' C ' ' H ' ' A' ' 76' ' ' GLY . 62.1 t -45.47 -42.72 3.44 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.319 0 CA-C-O 116.964 -1.493 . . . . 1.0 111.316 -176.515 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 75' ' ' ASN . . . . . 0.485 ' C ' ' N ' ' A' ' 77' ' ' ILE . 1.2 m-20 -36.55 -13.84 0.0 OUTLIER 'General case' 0 N--CA 1.501 2.078 0 CA-C-N 121.77 2.077 . . . . 1.0 111.318 177.907 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 76' ' ' GLY . . . . . 0.758 ' H ' ' C ' ' A' ' 74' ' ' VAL . . . -49.12 -20.7 2.19 Favored Glycine 0 CA--C 1.535 1.321 0 N-CA-C 106.624 -2.591 . . . . 1.0 106.624 173.035 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 77' ' ' ILE . . . . . 0.512 ' O ' ' N ' ' A' ' 81' ' ' GLU . 25.4 pt -61.21 -48.81 87.29 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.925 0 CA-C-O 117.043 -1.456 . . . . 1.0 112.159 -179.114 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 9.9 p -57.5 -18.49 9.22 Favored 'Isoleucine or valine' 0 C--N 1.363 1.162 0 CA-C-N 122.925 2.602 . . . . 1.0 113.069 179.444 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -89.67 -38.63 11.38 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 N-CA-C 107.042 -1.466 . . . . 1.0 107.042 177.904 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -80.9 -16.67 52.96 Favored 'General case' 0 CA--C 1.538 0.483 0 CA-C-N 114.822 -1.081 . . . . 1.0 113.496 178.589 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 81' ' ' GLU . . . . . 0.512 ' N ' ' O ' ' A' ' 77' ' ' ILE . 48.2 tt0 -93.68 -71.94 0.63 Allowed 'General case' 0 N--CA 1.448 -0.543 0 CA-C-N 118.882 0.764 . . . . 1.0 112.47 -178.385 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 25.2 m-20 -89.29 -15.82 32.61 Favored 'General case' 0 CA--C 1.549 0.907 0 N-CA-C 115.717 1.747 . . . . 1.0 115.717 -178.137 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . 0.497 ' O ' ' N ' ' A' ' 86' ' ' ALA . . . -54.51 -44.94 73.17 Favored 'General case' 0 N--CA 1.475 0.802 0 C-N-CA 118.747 -1.181 . . . . 1.0 111.897 -177.821 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -40.0 -28.74 0.06 Allowed 'General case' 0 CA--C 1.54 0.588 0 CA-C-N 119.141 0.882 . . . . 1.0 111.119 179.686 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 85' ' ' ILE . . . . . 0.421 ' N ' ' O ' ' A' ' 83' ' ' ALA . 68.1 mt -83.75 -37.13 12.99 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.509 0 CA-C-N 116.543 -0.298 . . . . 1.0 110.884 178.419 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 86' ' ' ALA . . . . . 0.497 ' N ' ' O ' ' A' ' 83' ' ' ALA . . . -93.41 -26.83 17.06 Favored 'General case' 0 N--CA 1.471 0.623 0 CA-C-O 120.863 0.363 . . . . 1.0 111.324 179.855 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 87' ' ' GLU . . . . . 0.567 ' C ' ' H ' ' A' ' 89' ' ' VAL . 40.6 tp10 -54.26 -11.31 0.48 Allowed 'General case' 0 C--N 1.324 -0.514 0 CA-C-O 121.134 0.492 . . . . 1.0 110.081 -179.456 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 88' ' ' ALA . . . . . 0.459 ' H ' ' C ' ' A' ' 86' ' ' ALA . . . -74.8 2.25 10.57 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-O 122.439 1.114 . . . . 1.0 108.342 178.382 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 89' ' ' VAL . . . . . 0.567 ' H ' ' C ' ' A' ' 87' ' ' GLU . 2.1 m -114.5 36.21 0.84 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.516 0 CA-C-N 112.766 -2.015 . . . . 1.0 110.334 178.914 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 90' ' ' GLY . . . . . 0.593 ' N ' ' CD ' ' A' ' 91' ' ' PRO . . . -77.59 -37.66 30.15 Favored Glycine 0 CA--C 1.534 1.26 0 N-CA-C 110.548 -1.021 . . . . 1.0 110.548 179.032 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 91' ' ' PRO . . . . . 0.593 ' CD ' ' N ' ' A' ' 90' ' ' GLY . 77.1 Cg_exo -50.63 -7.87 0.13 Allowed 'Trans proline' 0 N--CA 1.499 1.823 0 C-N-CA 122.459 2.106 . . . . 1.0 110.552 178.513 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 92' ' ' HIS . . . . . 0.697 ' NE2' ' NH2' ' A' ' 52' ' ' ARG . 0.2 OUTLIER -56.38 -12.22 1.57 Allowed 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 114.211 -1.359 . . . . 1.0 107.847 178.805 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 93' ' ' LEU . . . . . 0.519 ' H ' ' C ' ' A' ' 91' ' ' PRO . 1.7 pp -68.34 -59.57 3.09 Favored 'General case' 0 CA--C 1.528 0.107 0 CA-C-N 115.493 -0.776 . . . . 1.0 109.172 178.158 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 94' ' ' ALA . . . . . 0.412 ' H ' ' HG ' ' A' ' 93' ' ' LEU . . . -58.22 -50.06 74.89 Favored 'General case' 0 CA--C 1.52 -0.208 0 C-N-CA 120.017 -0.673 . . . . 1.0 109.363 179.761 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 95' ' ' ARG . . . . . 0.594 ' O ' ' N ' ' A' ' 97' ' ' LEU . 17.2 tpt180 -56.72 -57.62 11.64 Favored 'General case' 0 CA--C 1.534 0.335 0 CA-C-O 123.034 1.397 . . . . 1.0 107.609 179.314 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 96' ' ' ALA . . . . . 1.046 ' O ' ' N ' ' A' ' 98' ' ' GLY . . . -49.21 -9.62 0.03 OUTLIER 'General case' 0 C--N 1.304 -1.403 0 O-C-N 118.643 -2.536 . . . . 1.0 111.126 179.395 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 97' ' ' LEU . . . . . 0.72 ' O ' ' N ' ' A' ' 100' ' ' ILE . 0.0 OUTLIER 8.23 -47.81 0.0 OUTLIER 'General case' 0 N--CA 1.498 1.969 0 CA-C-O 117.361 -1.304 . . . . 1.0 109.105 -166.703 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 98' ' ' GLY . . . . . 1.046 ' N ' ' O ' ' A' ' 96' ' ' ALA . . . -48.03 -24.13 3.08 Favored Glycine 0 CA--C 1.551 2.313 0 CA-C-N 122.975 2.625 . . . . 1.0 107.071 171.998 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 99' ' ' GLN . . . . . 0.485 ' N ' ' O ' ' A' ' 96' ' ' ALA . 5.7 mm100 -69.82 -24.32 63.45 Favored 'General case' 0 C--N 1.386 2.17 0 C-N-CA 117.863 -1.535 . . . . 1.0 107.759 175.701 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 100' ' ' ILE . . . . . 0.72 ' N ' ' O ' ' A' ' 97' ' ' LEU . 10.2 mt -65.48 -45.61 92.32 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.837 0 C-N-CA 119.829 -0.748 . . . . 1.0 109.107 177.209 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 101' ' ' VAL . . . . . 0.699 ' O ' ' N ' ' A' ' 105' ' ' GLY . 21.7 t -55.23 -60.73 1.41 Allowed 'Isoleucine or valine' 0 C--O 1.214 -0.806 0 N-CA-C 108.065 -1.087 . . . . 1.0 108.065 178.723 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 102' ' ' CYS . . . . . 0.475 ' O ' ' HB1' ' A' ' 106' ' ' ALA . 0.5 OUTLIER -49.91 -22.16 1.42 Allowed 'General case' 0 C--O 1.204 -1.325 0 N-CA-C 112.768 0.655 . . . . 1.0 112.768 -179.163 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 58.8 ttt-85 -89.09 -48.13 7.62 Favored 'General case' 0 N--CA 1.485 1.292 0 CA-C-O 123.229 1.49 . . . . 1.0 112.194 179.418 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 104' ' ' TYR . . . . . 0.664 ' CG ' ' O ' ' A' ' 104' ' ' TYR . 0.0 OUTLIER -98.52 25.31 6.49 Favored 'General case' 0 C--N 1.297 -1.684 0 CA-C-N 111.663 -2.517 . . . . 1.0 107.157 177.849 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 105' ' ' GLY . . . . . 0.699 ' N ' ' O ' ' A' ' 101' ' ' VAL . . . -167.59 -100.61 0.14 Allowed Glycine 0 N--CA 1.441 -0.972 0 N-CA-C 108.725 -1.75 . . . . 1.0 108.725 179.363 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 106' ' ' ALA . . . . . 0.475 ' HB1' ' O ' ' A' ' 102' ' ' CYS . . . 73.6 59.14 0.09 Allowed 'General case' 0 N--CA 1.442 -0.827 0 CA-C-O 119.262 -0.399 . . . . 1.0 111.22 -178.6 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -80.11 5.37 14.49 Favored 'General case' 0 CA--C 1.51 -0.594 0 O-C-N 119.764 -1.835 . . . . 1.0 106.319 176.341 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 108' ' ' VAL . . . . . 0.416 ' H ' ' C ' ' A' ' 106' ' ' ALA . 17.4 m -83.77 -53.52 11.03 Favored 'Isoleucine or valine' 0 C--N 1.347 0.472 0 C-N-CA 120.338 -0.545 . . . . 1.0 110.591 178.138 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 109' ' ' ILE . . . . . 0.484 ' O ' ' CB ' ' A' ' 113' ' ' ASN . 0.1 OUTLIER -49.02 -37.7 21.01 Favored Pre-proline 0 N--CA 1.472 0.666 0 N-CA-C 115.308 1.596 . . . . 1.0 115.308 -176.894 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_exo -51.52 -49.36 17.43 Favored 'Trans proline' 0 C--N 1.311 -1.433 0 CA-C-N 122.386 1.888 . . . . 1.0 113.126 -176.475 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 87.2 m-20 -70.7 -69.05 0.39 Allowed 'General case' 0 CA--C 1.53 0.199 0 C-N-CA 118.829 -1.148 . . . . 1.0 110.915 -178.833 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 6.4 pt -46.22 -28.37 0.86 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.467 0 CA-C-O 121.826 0.822 . . . . 1.0 109.736 -179.477 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 113' ' ' ASN . . . . . 0.484 ' CB ' ' O ' ' A' ' 109' ' ' ILE . 34.2 t30 -61.92 -55.15 32.57 Favored 'General case' 0 CA--C 1.506 -0.733 0 CA-C-N 114.301 -1.318 . . . . 1.0 107.811 -178.976 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -61.98 -36.5 81.64 Favored 'General case' 0 N--CA 1.439 -0.976 0 CA-C-N 118.86 0.755 . . . . 1.0 112.387 -179.036 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -75.48 -58.92 2.99 Favored 'General case' 0 C--N 1.349 0.557 0 CA-C-N 120.402 1.455 . . . . 1.0 110.114 179.572 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 116' ' ' ILE . . . . . 0.537 ' O ' ' N ' ' A' ' 120' ' ' GLY . 5.0 mm -49.37 -48.87 18.63 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.663 0 CA-C-O 121.619 0.723 . . . . 1.0 109.182 -178.173 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 117' ' ' GLU . . . . . 0.485 ' C ' ' O ' ' A' ' 116' ' ' ILE . 37.7 tt0 -39.96 -60.74 0.97 Allowed 'General case' 0 C--O 1.215 -0.735 0 N-CA-C 106.213 -1.773 . . . . 1.0 106.213 179.279 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 94.2 t -59.14 -53.96 40.85 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.873 0 CA-C-N 114.973 -1.012 . . . . 1.0 109.824 178.559 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -53.09 -71.44 0.07 Allowed 'General case' 0 CA--C 1.552 1.021 0 N-CA-C 108.087 -1.079 . . . . 1.0 108.087 -178.395 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 120' ' ' GLY . . . . . 0.537 ' N ' ' O ' ' A' ' 116' ' ' ILE . . . -66.68 -76.85 0.33 Allowed Glycine 0 CA--C 1.538 1.502 0 C-N-CA 119.54 -1.314 . . . . 1.0 110.635 179.713 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 121' ' ' THR . . . . . 0.522 ' CB ' ' O ' ' A' ' 120' ' ' GLY . 2.2 m 145.43 -29.16 0.01 OUTLIER 'General case' 0 N--CA 1.486 1.359 0 CA-C-N 111.516 -2.342 . . . . 1.0 111.015 -178.451 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 122' ' ' GLY . . . . . 0.625 ' O ' ' N ' ' A' ' 124' ' ' ASP . . . 106.6 -16.12 41.0 Favored Glycine 0 C--O 1.226 -0.372 0 N-CA-C 107.763 -2.135 . . . . 1.0 107.763 -176.541 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 12.6 t -59.65 82.23 0.01 OUTLIER 'General case' 0 CA--C 1.537 0.471 0 N-CA-C 107.02 -1.474 . . . . 1.0 107.02 178.94 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 124' ' ' ASP . . . . . 0.625 ' N ' ' O ' ' A' ' 122' ' ' GLY . 27.8 m-20 -163.5 172.27 14.69 Favored 'General case' 0 N--CA 1.453 -0.302 0 CA-C-N 112.074 -2.33 . . . . 1.0 110.745 178.859 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 125' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -143.9 142.04 30.58 Favored 'General case' 0 C--N 1.32 -0.691 0 N-CA-C 107.298 -1.371 . . . . 1.0 107.298 175.846 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 1.3 tpm_? -149.67 152.0 34.63 Favored 'General case' 0 C--N 1.33 -0.244 0 N-CA-C 110.111 -0.329 . . . . 1.0 110.111 178.772 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 127' ' ' PHE . . . . . . . . . . . . . 2.4 p90 . . . . . 0 N--CA 1.471 0.585 0 CA-C-O 117.874 -1.06 . . . . 1.0 111.12 -179.86 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 1' ' ' MET . . . . . 0.404 ' N ' ' SD ' ' A' ' 1' ' ' MET . 4.7 mmt . . . . . 0 N--CA 1.491 1.613 0 N-CA-C 109.686 -0.487 . . . . 1.0 109.686 . . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 34.6 t -107.45 5.06 26.88 Favored 'General case' 0 N--CA 1.467 0.422 0 CA-C-N 116.11 -0.495 . . . . 1.0 110.273 179.33 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 1.3 p30 173.96 94.59 0.01 OUTLIER 'General case' 0 CA--C 1.53 0.182 0 CA-C-N 116.032 -0.531 . . . . 1.0 111.823 -179.893 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . 0.429 ' O ' ' OD1' ' A' ' 5' ' ' ASP . 1.4 t80 -151.27 146.75 26.26 Favored 'General case' 0 N--CA 1.464 0.255 0 CA-C-N 116.341 -0.39 . . . . 1.0 110.25 178.937 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 5' ' ' ASP . . . . . 0.429 ' OD1' ' O ' ' A' ' 4' ' ' PHE . 0.0 OUTLIER -155.95 151.95 27.61 Favored 'General case' 0 CA--C 1.538 0.51 0 N-CA-C 109.453 -0.573 . . . . 1.0 109.453 179.523 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 6' ' ' THR . . . . . 0.71 ' O ' ' N ' ' A' ' 10' ' ' SER . 0.3 OUTLIER -69.24 168.5 14.04 Favored 'General case' 0 C--O 1.204 -1.339 0 CA-C-N 116.206 -0.452 . . . . 1.0 110.143 -179.234 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . 0.563 ' O ' ' N ' ' A' ' 11' ' ' ARG . 0.9 OUTLIER -58.14 -60.11 4.26 Favored 'General case' 0 C--N 1.317 -0.82 0 CA-C-O 121.352 0.596 . . . . 1.0 109.567 -177.646 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 8' ' ' ARG . . . . . 0.49 ' HG2' ' N ' ' A' ' 9' ' ' VAL . 0.0 OUTLIER -49.23 -53.78 19.84 Favored 'General case' 0 CA--C 1.545 0.751 0 N-CA-C 107.637 -1.245 . . . . 1.0 107.637 -178.304 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . 0.574 ' O ' ' CG2' ' A' ' 13' ' ' VAL . 0.0 OUTLIER -66.97 -50.64 62.68 Favored 'Isoleucine or valine' 0 C--O 1.196 -1.734 0 CA-C-N 115.155 -0.93 . . . . 1.0 109.794 179.294 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 10' ' ' SER . . . . . 0.71 ' N ' ' O ' ' A' ' 6' ' ' THR . 25.6 t -62.83 -63.79 1.11 Allowed 'General case' 0 C--N 1.313 -0.985 0 C-N-CA 119.595 -0.842 . . . . 1.0 111.055 -179.582 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 11' ' ' ARG . . . . . 0.563 ' N ' ' O ' ' A' ' 7' ' ' GLU . 38.2 ttm-85 -65.9 -61.35 2.11 Favored 'General case' 0 N--CA 1.466 0.366 0 C-N-CA 120.463 -0.495 . . . . 1.0 111.88 -175.945 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . 0.446 ' CB ' ' O ' ' A' ' 8' ' ' ARG . . . -48.66 -47.49 40.54 Favored 'General case' 0 N--CA 1.474 0.739 0 N-CA-C 107.257 -1.386 . . . . 1.0 107.257 -177.868 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . 0.615 ' O ' ' N ' ' A' ' 17' ' ' LEU . 84.2 t -62.24 -51.04 77.21 Favored 'Isoleucine or valine' 0 C--O 1.205 -1.241 0 C-N-CA 118.548 -1.261 . . . . 1.0 108.187 177.098 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . 0.476 ' O ' ' N ' ' A' ' 18' ' ' VAL . . . -55.94 -61.29 2.47 Favored 'General case' 0 C--O 1.21 -1.023 0 C-N-CA 117.933 -1.507 . . . . 1.0 108.775 -179.712 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . 0.579 ' O ' ' N ' ' A' ' 19' ' ' GLY . . . -52.17 -54.56 29.2 Favored 'General case' 0 N--CA 1.47 0.564 0 CA-C-O 121.467 0.651 . . . . 1.0 109.855 -178.849 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . 0.432 ' CB ' ' O ' ' A' ' 12' ' ' ALA . . . -63.73 -57.23 10.61 Favored 'General case' 0 C--N 1.316 -0.877 0 CA-C-N 114.994 -1.003 . . . . 1.0 109.943 -179.011 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . 0.615 ' N ' ' O ' ' A' ' 13' ' ' VAL . 1.2 tt -57.0 -53.29 59.71 Favored 'General case' 0 C--N 1.315 -0.916 0 CA-C-N 114.51 -1.223 . . . . 1.0 108.017 -177.85 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . 0.661 HG21 ' H ' ' A' ' 19' ' ' GLY . 2.4 m -68.57 -58.44 5.86 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.526 0 C-N-CA 119.446 -0.902 . . . . 1.0 109.592 178.923 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . 0.661 ' H ' HG21 ' A' ' 18' ' ' VAL . . . -55.7 -169.31 0.07 OUTLIER Glycine 0 C--O 1.213 -1.179 0 N-CA-C 110.287 -1.125 . . . . 1.0 110.287 -179.515 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 20' ' ' PRO . . . . . 0.465 ' O ' ' N ' ' A' ' 24' ' ' ALA . 1.9 Cg_endo -78.96 -32.55 1.84 Allowed 'Trans proline' 0 C--N 1.305 -1.721 0 C-N-CA 123.114 2.543 . . . . 1.0 114.625 -178.524 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -60.19 -57.88 16.89 Favored Glycine 0 N--CA 1.478 1.48 0 C-N-CA 120.164 -1.017 . . . . 1.0 113.348 -176.192 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . 0.408 ' N ' ' O ' ' A' ' 16' ' ' ALA . . . -55.37 -51.76 52.24 Favored Glycine 0 N--CA 1.469 0.867 0 N-CA-C 107.401 -2.28 . . . . 1.0 107.401 -176.851 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . 0.598 ' CG2' ' O ' ' A' ' 19' ' ' GLY . 0.1 OUTLIER -60.81 -31.45 49.52 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.999 0 N-CA-C 108.692 -0.855 . . . . 1.0 108.692 178.277 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . 0.465 ' N ' ' O ' ' A' ' 20' ' ' PRO . . . -58.11 -62.07 2.09 Favored 'General case' 0 C--N 1.34 0.17 0 C-N-CA 117.766 -1.573 . . . . 1.0 109.487 -179.655 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . 0.438 ' CD2' ' H ' ' A' ' 25' ' ' LEU . 0.0 OUTLIER -62.95 -46.35 88.15 Favored 'General case' 0 CA--C 1.53 0.209 0 O-C-N 121.377 -0.827 . . . . 1.0 111.599 -178.168 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 79.5 t -57.49 -57.99 7.95 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 C-N-CA 119.562 -0.855 . . . . 1.0 109.338 -178.033 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . 0.451 ' O ' ' CB ' ' A' ' 31' ' ' ALA . 49.0 t -60.64 -37.27 75.09 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.65 0 CA-C-O 120.663 0.268 . . . . 1.0 110.743 -178.977 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . 0.434 ' CG ' ' O ' ' A' ' 24' ' ' ALA . 32.5 mmtt -65.91 -56.6 10.94 Favored 'General case' 0 CA--C 1.513 -0.453 0 C-N-CA 119.693 -0.803 . . . . 1.0 109.662 -178.573 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 94.7 t -63.37 -48.21 88.31 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.011 0 CA-C-N 114.365 -1.289 . . . . 1.0 109.942 -177.624 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 30' ' ' CYS . . . . . . . . . . . . . 20.2 t -66.33 -61.1 2.19 Favored 'General case' 0 N--CA 1.443 -0.814 0 C-N-CA 118.936 -1.106 . . . . 1.0 110.372 -179.417 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . 0.451 ' CB ' ' O ' ' A' ' 27' ' ' VAL . . . -63.1 -52.0 64.37 Favored 'General case' 0 CA--C 1.514 -0.434 0 N-CA-C 112.057 0.392 . . . . 1.0 112.057 -176.583 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . 0.423 ' O ' ' HB2' ' A' ' 33' ' ' LEU . . . 82.31 69.26 1.4 Allowed Glycine 0 CA--C 1.521 0.447 0 N-CA-C 109.696 -1.362 . . . . 1.0 109.696 -178.978 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . 0.491 ' O ' ' O ' ' A' ' 36' ' ' VAL . 3.9 mt 90.38 82.97 0.04 OUTLIER Pre-proline 0 N--CA 1.475 0.795 0 C-N-CA 123.565 0.746 . . . . 1.0 111.858 179.583 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 53.0 Cg_exo -54.89 -25.85 45.7 Favored 'Trans proline' 0 N--CA 1.499 1.796 0 C-N-CA 123.008 2.472 . . . . 1.0 112.73 178.562 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -57.15 -58.96 11.88 Favored Glycine 0 CA--C 1.531 1.06 0 N-CA-C 108.86 -1.696 . . . . 1.0 108.86 -179.349 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . 0.555 ' O ' ' CB ' ' A' ' 37' ' ' ILE . 14.1 p -98.09 169.44 1.51 Allowed 'Isoleucine or valine' 0 C--O 1.219 -0.516 0 N-CA-C 106.602 -1.629 . . . . 1.0 106.602 176.71 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . 0.555 ' CB ' ' O ' ' A' ' 36' ' ' VAL . 8.9 tt 117.14 116.52 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.486 1.337 0 O-C-N 124.532 1.145 . . . . 1.0 110.366 -179.725 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 38' ' ' HIS . . . . . 0.496 ' CD2' ' N ' ' A' ' 38' ' ' HIS . 0.4 OUTLIER -138.03 129.13 27.34 Favored 'General case' 0 N--CA 1.463 0.193 0 N-CA-C 108.215 -1.031 . . . . 1.0 108.215 178.983 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 12.8 m -99.53 133.22 22.05 Favored Pre-proline 0 C--N 1.328 -0.367 0 N-CA-C 109.049 -0.722 . . . . 1.0 109.049 179.251 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 42.1 Cg_endo -66.33 -96.3 0.0 OUTLIER 'Trans proline' 0 N--CA 1.492 1.423 0 C-N-CA 120.926 1.084 . . . . 1.0 111.827 -179.451 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -62.48 123.78 19.22 Favored 'General case' 0 C--N 1.319 -0.748 0 CA-C-N 115.895 -0.593 . . . . 1.0 110.092 -179.06 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . 0.622 ' C ' ' H ' ' A' ' 44' ' ' GLY . 2.8 mmm-85 -169.75 167.32 9.46 Favored 'General case' 0 C--N 1.32 -0.713 0 N-CA-C 108.798 -0.816 . . . . 1.0 108.798 179.332 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 43' ' ' ARG . . . . . 0.575 ' HG3' ' O ' ' A' ' 45' ' ' PHE . 0.3 OUTLIER -66.48 26.71 0.02 OUTLIER 'General case' 0 C--N 1.316 -0.857 0 CA-C-N 115.157 -0.929 . . . . 1.0 110.721 179.696 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . 0.622 ' H ' ' C ' ' A' ' 42' ' ' ARG . . . 80.68 -26.19 3.21 Favored Glycine 0 CA--C 1.528 0.883 0 N-CA-C 111.677 -0.569 . . . . 1.0 111.677 179.758 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . 0.741 ' CG ' ' N ' ' A' ' 46' ' ' PHE . 0.5 OUTLIER -174.88 175.36 2.38 Favored 'General case' 0 C--O 1.2 -1.531 0 C-N-CA 120.888 -0.325 . . . . 1.0 110.95 -179.157 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 46' ' ' PHE . . . . . 0.741 ' N ' ' CG ' ' A' ' 45' ' ' PHE . 13.8 t80 161.13 13.86 0.0 OUTLIER 'General case' 0 N--CA 1.478 0.964 0 CA-C-N 116.296 -0.411 . . . . 1.0 110.997 176.429 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 47' ' ' ARG . . . . . 0.48 ' C ' ' SG ' ' A' ' 48' ' ' CYS . 3.9 mtp180 -175.64 169.24 3.08 Favored 'General case' 0 C--N 1.325 -0.462 0 C-N-CA 119.831 -0.748 . . . . 1.0 110.692 -178.61 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 48' ' ' CYS . . . . . 0.48 ' SG ' ' C ' ' A' ' 47' ' ' ARG . 1.2 m 72.62 69.32 0.13 Allowed 'General case' 0 N--CA 1.452 -0.373 0 N-CA-C 108.246 -1.02 . . . . 1.0 108.246 -178.437 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 49' ' ' ASN . . . . . 0.687 ' N ' ' OD1' ' A' ' 49' ' ' ASN . 0.0 OUTLIER -132.21 123.76 18.97 Favored Pre-proline 0 N--CA 1.468 0.472 0 CA-C-O 118.628 -0.701 . . . . 1.0 109.465 -179.215 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 50' ' ' PRO . . . . . 0.589 ' O ' ' CD ' ' A' ' 51' ' ' GLU . 75.0 Cg_exo -45.82 68.82 0.01 OUTLIER 'Trans proline' 0 N--CA 1.495 1.597 0 C-N-CA 121.928 1.752 . . . . 1.0 114.992 179.98 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . 0.668 ' N ' ' O ' ' A' ' 49' ' ' ASN . 10.3 pm0 62.98 23.39 13.99 Favored 'General case' 0 N--CA 1.472 0.653 0 C-N-CA 123.251 0.62 . . . . 1.0 112.365 -179.305 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 25.4 mtp85 -103.65 159.39 15.65 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 120.934 0.397 . . . . 1.0 111.71 -178.926 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . 0.479 ' O ' ' N ' ' A' ' 55' ' ' ILE . 6.8 tp -75.15 137.51 22.83 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.167 0 CA-C-O 120.95 0.405 . . . . 1.0 110.916 -179.657 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 54' ' ' GLN . . . . . 0.439 ' OE1' ' O ' ' A' ' 46' ' ' PHE . 28.0 mt-30 -60.85 81.78 0.01 OUTLIER 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.763 -0.653 . . . . 1.0 110.935 -176.507 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . 0.479 ' N ' ' O ' ' A' ' 53' ' ' ILE . 11.1 tt -148.58 158.8 6.98 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.358 0 CA-C-N 115.684 -0.689 . . . . 1.0 110.453 177.69 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 111.98 -2.3 27.13 Favored Glycine 0 N--CA 1.468 0.826 0 N-CA-C 111.277 -0.729 . . . . 1.0 111.277 -179.566 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . 0.503 ' OD2' ' NH1' ' A' ' 43' ' ' ARG . 1.6 p-10 -80.91 97.6 7.49 Favored 'General case' 0 CA--C 1.516 -0.338 0 C-N-CA 119.968 -0.693 . . . . 1.0 109.307 178.281 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 58' ' ' TRP . . . . . . . . . . . . . 6.2 m0 -88.62 173.09 8.82 Favored 'General case' 0 C--N 1.319 -0.741 0 CA-C-O 122.8 1.286 . . . . 1.0 112.526 -178.146 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -85.26 -60.31 2.07 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 111.896 -2.411 . . . . 1.0 113.306 -178.433 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 75.2 t80 -90.83 -16.95 27.4 Favored 'General case' 0 N--CA 1.479 1.025 0 N-CA-C 113.74 1.015 . . . . 1.0 113.74 -178.883 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . 0.516 ' O ' ' N ' ' A' ' 65' ' ' ASP . 0.0 OUTLIER -77.91 -13.16 59.98 Favored 'General case' 0 C--N 1.318 -0.8 0 O-C-N 121.92 -0.487 . . . . 1.0 110.304 -179.149 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 62' ' ' VAL . . . . . 0.604 ' O ' ' N ' ' A' ' 66' ' ' GLY . 2.5 m -47.17 -55.45 1.96 Allowed 'Isoleucine or valine' 0 C--O 1.209 -1.074 0 C-N-CA 119.442 -0.903 . . . . 1.0 110.12 -176.431 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -67.2 -50.97 58.91 Favored 'General case' 0 C--N 1.307 -1.271 0 O-C-N 121.325 -0.859 . . . . 1.0 110.443 179.959 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 64' ' ' HIS . . . . . 0.479 ' O ' ' HB2' ' A' ' 67' ' ' ARG . 0.5 OUTLIER -56.3 -56.94 14.88 Favored 'General case' 0 CA--C 1.54 0.594 0 C-N-CA 119.192 -1.003 . . . . 1.0 109.359 -179.953 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 65' ' ' ASP . . . . . 0.604 ' C ' ' H ' ' A' ' 67' ' ' ARG . 25.7 t70 -72.34 -53.04 13.49 Favored 'General case' 0 C--N 1.316 -0.887 0 O-C-N 121.486 -0.759 . . . . 1.0 110.601 178.556 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . 0.604 ' N ' ' O ' ' A' ' 62' ' ' VAL . . . -65.25 30.35 0.12 Allowed Glycine 0 CA--C 1.526 0.753 0 O-C-N 121.151 -0.968 . . . . 1.0 111.457 179.051 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 67' ' ' ARG . . . . . 0.604 ' H ' ' C ' ' A' ' 65' ' ' ASP . 7.6 ttt85 -81.19 1.27 32.79 Favored 'General case' 0 C--N 1.32 -0.71 0 N-CA-C 107.34 -1.356 . . . . 1.0 107.34 175.662 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . 0.537 ' N ' ' OD1' ' A' ' 75' ' ' ASN . 2.1 pt? -39.52 -31.14 0.08 Allowed 'General case' 0 C--N 1.35 0.617 0 CA-C-O 121.275 0.56 . . . . 1.0 109.837 -178.459 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . 0.414 ' H ' HD22 ' A' ' 68' ' ' LEU . 4.3 tt -67.91 -68.58 0.38 Allowed 'General case' 0 CA--C 1.545 0.753 0 C-N-CA 119.32 -0.952 . . . . 1.0 112.65 -175.782 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . 0.554 ' C ' ' H ' ' A' ' 72' ' ' HIS . . . -73.6 -78.42 0.09 Allowed 'General case' 0 N--CA 1.474 0.76 0 C-N-CA 118.653 -1.219 . . . . 1.0 109.878 -176.981 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 71' ' ' ALA . . . . . 0.809 ' O ' ' N ' ' A' ' 73' ' ' MET . . . -62.43 14.82 0.01 OUTLIER 'General case' 0 C--N 1.318 -0.779 0 C-N-CA 125.964 1.705 . . . . 1.0 112.55 179.221 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 72' ' ' HIS . . . . . 0.554 ' H ' ' C ' ' A' ' 70' ' ' ALA . 52.8 p-80 -19.02 -29.68 0.0 OUTLIER 'General case' 0 N--CA 1.468 0.452 0 N-CA-C 114.056 1.132 . . . . 1.0 114.056 -174.744 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 73' ' ' MET . . . . . 0.809 ' N ' ' O ' ' A' ' 71' ' ' ALA . 20.9 mtt -66.25 -54.91 19.38 Favored 'General case' 0 C--N 1.318 -0.789 0 C-N-CA 119.118 -1.033 . . . . 1.0 109.336 176.123 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . 0.634 ' O ' ' N ' ' A' ' 76' ' ' GLY . 34.6 m -43.57 -52.95 1.13 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.579 0 CA-C-O 117.298 -1.334 . . . . 1.0 111.614 -174.74 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 75' ' ' ASN . . . . . 0.537 ' OD1' ' N ' ' A' ' 68' ' ' LEU . 3.4 m120 -38.53 -19.79 0.01 OUTLIER 'General case' 0 N--CA 1.482 1.138 0 CA-C-N 120.603 1.547 . . . . 1.0 110.992 -179.666 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 76' ' ' GLY . . . . . 0.634 ' N ' ' O ' ' A' ' 74' ' ' VAL . . . -48.22 -24.45 3.51 Favored Glycine 0 CA--C 1.532 1.141 0 N-CA-C 107.214 -2.354 . . . . 1.0 107.214 176.664 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 77' ' ' ILE . . . . . 0.54 ' O ' ' N ' ' A' ' 81' ' ' GLU . 24.1 pt -59.02 -43.21 88.44 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.056 0 C-N-CA 119.722 -0.791 . . . . 1.0 110.941 -179.309 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . 0.419 ' CG2' ' OD1' ' A' ' 65' ' ' ASP . 60.6 t -56.64 -25.25 20.94 Favored 'Isoleucine or valine' 0 C--O 1.24 0.601 0 CA-C-N 121.708 2.049 . . . . 1.0 114.147 -178.887 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . 0.413 HG13 ' N ' ' A' ' 80' ' ' ALA . 0.8 OUTLIER -91.08 -37.09 8.78 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.452 0 N-CA-C 108.005 -1.109 . . . . 1.0 108.005 178.804 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 80' ' ' ALA . . . . . 0.413 ' N ' HG13 ' A' ' 79' ' ' ILE . . . -79.8 -17.54 53.13 Favored 'General case' 0 CA--C 1.545 0.772 0 CA-C-N 115.469 -0.787 . . . . 1.0 112.033 178.927 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 81' ' ' GLU . . . . . 0.54 ' N ' ' O ' ' A' ' 77' ' ' ILE . 62.5 mm-40 -91.91 -67.36 0.86 Allowed 'General case' 0 N--CA 1.447 -0.582 0 O-C-N 121.748 -0.595 . . . . 1.0 110.581 178.492 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 82' ' ' ASP . . . . . 0.519 ' O ' ' C ' ' A' ' 83' ' ' ALA . 1.5 m-20 -72.2 -18.06 61.88 Favored 'General case' 0 N--CA 1.45 -0.464 0 O-C-N 121.11 -0.994 . . . . 1.0 112.794 -178.272 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . 0.519 ' C ' ' O ' ' A' ' 82' ' ' ASP . . . -21.08 -51.31 0.01 OUTLIER 'General case' 0 N--CA 1.479 0.998 0 CA-C-N 119.048 0.84 . . . . 1.0 112.464 178.656 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . 0.46 ' N ' ' O ' ' A' ' 82' ' ' ASP . 3.6 mm? -31.94 -39.64 0.03 OUTLIER 'General case' 0 N--CA 1.479 0.988 0 N-CA-C 111.805 0.298 . . . . 1.0 111.805 -176.627 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 67.9 mt -94.95 -40.36 11.09 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.452 0 CA-C-O 120.896 0.379 . . . . 1.0 110.764 178.407 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -53.64 -59.33 4.74 Favored 'General case' 0 CA--C 1.533 0.309 0 CA-C-N 115.951 -0.568 . . . . 1.0 111.537 -178.159 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 15.1 pt-20 -62.32 -14.21 36.97 Favored 'General case' 0 CA--C 1.518 -0.276 0 C-N-CA 120.96 -0.296 . . . . 1.0 110.681 -178.996 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -77.18 -18.92 57.41 Favored 'General case' 0 C--N 1.325 -0.497 0 N-CA-C 108.586 -0.894 . . . . 1.0 108.586 179.109 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 89' ' ' VAL . . . . . 0.431 ' O ' ' OE2' ' A' ' 51' ' ' GLU . 35.6 m -113.97 35.19 0.91 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.22 0 CA-C-N 113.61 -1.632 . . . . 1.0 110.781 178.705 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 90' ' ' GLY . . . . . 0.623 ' C ' ' H ' ' A' ' 92' ' ' HIS . . . -69.61 -33.44 71.78 Favored Glycine 0 C--N 1.351 1.407 0 CA-C-O 119.205 -0.775 . . . . 1.0 111.99 178.243 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 91' ' ' PRO . . . . . 0.552 ' CD ' ' N ' ' A' ' 90' ' ' GLY . 78.6 Cg_exo -45.57 -4.0 0.02 OUTLIER 'Trans proline' 0 N--CA 1.501 1.941 0 C-N-CA 122.379 2.053 . . . . 1.0 112.659 177.703 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 92' ' ' HIS . . . . . 0.639 ' ND1' ' N ' ' A' ' 93' ' ' LEU . 0.0 OUTLIER -49.31 -15.52 0.14 Allowed 'General case' 0 N--CA 1.448 -0.531 0 O-C-N 123.794 0.684 . . . . 1.0 110.047 -178.718 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 93' ' ' LEU . . . . . 0.639 ' N ' ' ND1' ' A' ' 92' ' ' HIS . 1.7 pp -66.28 -58.06 6.17 Favored 'General case' 0 N--CA 1.445 -0.692 0 N-CA-C 108.892 -0.781 . . . . 1.0 108.892 177.095 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 94' ' ' ALA . . . . . 0.563 ' H ' ' HG ' ' A' ' 93' ' ' LEU . . . -59.77 -58.19 9.64 Favored 'General case' 0 N--CA 1.449 -0.489 0 N-CA-C 109.959 -0.386 . . . . 1.0 109.959 179.725 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 95' ' ' ARG . . . . . 0.613 ' O ' ' N ' ' A' ' 97' ' ' LEU . 0.0 OUTLIER -61.47 -63.53 1.24 Allowed 'General case' 0 N--CA 1.449 -0.492 0 CA-C-O 121.428 0.632 . . . . 1.0 109.572 -178.592 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 96' ' ' ALA . . . . . 0.957 ' O ' ' N ' ' A' ' 98' ' ' GLY . . . -49.44 -11.08 0.04 OUTLIER 'General case' 0 N--CA 1.438 -1.064 0 O-C-N 118.791 -2.443 . . . . 1.0 111.266 -178.911 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 97' ' ' LEU . . . . . 0.745 ' O ' ' N ' ' A' ' 100' ' ' ILE . 0.3 OUTLIER 5.89 -48.0 0.0 OUTLIER 'General case' 0 N--CA 1.487 1.419 0 C-N-CA 124.426 1.09 . . . . 1.0 110.38 -167.96 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 98' ' ' GLY . . . . . 0.957 ' N ' ' O ' ' A' ' 96' ' ' ALA . . . -51.35 -24.28 10.28 Favored Glycine 0 C--N 1.286 -2.214 0 N-CA-C 106.488 -2.645 . . . . 1.0 106.488 173.273 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 99' ' ' GLN . . . . . 0.625 ' N ' ' O ' ' A' ' 96' ' ' ALA . 35.1 mt-30 -65.57 -23.16 66.79 Favored 'General case' 0 C--N 1.377 1.766 0 N-CA-C 105.94 -1.874 . . . . 1.0 105.94 175.983 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 100' ' ' ILE . . . . . 0.745 ' N ' ' O ' ' A' ' 97' ' ' LEU . 1.4 tp -64.59 -37.06 79.11 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.21 0 C-N-CA 118.87 -1.132 . . . . 1.0 108.118 178.884 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 101' ' ' VAL . . . . . 0.711 ' O ' ' N ' ' A' ' 105' ' ' GLY . 88.1 t -57.62 -63.13 0.71 Allowed 'Isoleucine or valine' 0 C--O 1.216 -0.704 0 C-N-CA 119.923 -0.711 . . . . 1.0 109.687 178.713 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 102' ' ' CYS . . . . . 0.448 ' SG ' ' HA ' ' A' ' 99' ' ' GLN . 0.9 OUTLIER -49.22 -17.34 0.23 Allowed 'General case' 0 CA--C 1.545 0.754 0 C-N-CA 118.36 -1.336 . . . . 1.0 111.579 -178.446 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 24.0 ttm180 -89.64 -46.71 8.44 Favored 'General case' 0 N--CA 1.479 0.998 0 CA-C-O 122.573 1.178 . . . . 1.0 111.851 178.275 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 104' ' ' TYR . . . . . 0.622 ' CG ' ' O ' ' A' ' 104' ' ' TYR . 0.0 OUTLIER -104.47 21.83 16.01 Favored 'General case' 0 CA--C 1.549 0.931 0 CA-C-N 112.684 -2.053 . . . . 1.0 110.208 178.262 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 105' ' ' GLY . . . . . 0.756 ' O ' ' N ' ' A' ' 107' ' ' THR . . . -168.26 -12.5 0.02 OUTLIER Glycine 0 C--N 1.345 1.03 0 C-N-CA 118.523 -1.798 . . . . 1.0 113.969 178.769 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 106' ' ' ALA . . . . . 0.447 ' CB ' ' O ' ' A' ' 102' ' ' CYS . . . -20.08 64.8 0.0 OUTLIER 'General case' 0 N--CA 1.479 0.98 0 N-CA-C 114.671 1.36 . . . . 1.0 114.671 -179.601 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 107' ' ' THR . . . . . 0.756 ' N ' ' O ' ' A' ' 105' ' ' GLY . 96.4 m -102.28 -4.96 24.84 Favored 'General case' 0 N--CA 1.447 -0.585 0 N-CA-C 107.532 -1.285 . . . . 1.0 107.532 177.008 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 16.9 m -95.59 11.69 4.36 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.511 0 CA-C-N 116.084 -0.507 . . . . 1.0 110.053 176.325 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 109' ' ' ILE . . . . . 0.717 ' H ' ' CD ' ' A' ' 110' ' ' PRO . 0.1 OUTLIER -112.81 -27.94 0.12 Allowed Pre-proline 0 CA--C 1.555 1.161 0 CA-C-N 119.187 0.903 . . . . 1.0 111.64 177.523 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 110' ' ' PRO . . . . . 0.717 ' CD ' ' H ' ' A' ' 109' ' ' ILE . 48.7 Cg_endo -65.86 -37.41 27.36 Favored 'Trans proline' 0 N--CA 1.496 1.643 0 C-N-CA 122.827 2.351 . . . . 1.0 113.579 -173.19 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 34.3 t30 -64.57 -67.95 0.39 Allowed 'General case' 0 CA--C 1.507 -0.686 0 C-N-CA 119.061 -1.056 . . . . 1.0 109.078 -178.186 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 112' ' ' ILE . . . . . 0.575 ' O ' ' N ' ' A' ' 116' ' ' ILE . 6.3 pt -52.01 -42.54 34.64 Favored 'Isoleucine or valine' 0 C--O 1.209 -1.038 0 CA-C-O 122.065 0.936 . . . . 1.0 108.857 179.907 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 113' ' ' ASN . . . . . 0.544 ' N ' ' CG1' ' A' ' 112' ' ' ILE . 2.8 m120 -50.19 -53.57 26.98 Favored 'General case' 0 C--N 1.315 -0.922 0 CA-C-N 113.929 -1.487 . . . . 1.0 108.745 -176.738 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 114' ' ' ALA . . . . . 0.444 ' O ' ' CG2' ' A' ' 118' ' ' VAL . . . -62.97 -34.36 77.35 Favored 'General case' 0 C--N 1.311 -1.083 0 O-C-N 121.035 -1.04 . . . . 1.0 112.501 179.551 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -84.63 -60.02 2.19 Favored 'General case' 0 N--CA 1.471 0.605 0 CA-C-N 118.672 0.669 . . . . 1.0 112.684 179.095 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 116' ' ' ILE . . . . . 0.693 HG22 ' H ' ' A' ' 117' ' ' GLU . 9.9 tt -54.57 -61.87 0.89 Allowed 'Isoleucine or valine' 0 C--O 1.223 -0.313 0 CA-C-N 115.336 -0.847 . . . . 1.0 108.795 -176.998 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 117' ' ' GLU . . . . . 0.693 ' H ' HG22 ' A' ' 116' ' ' ILE . 98.2 mt-10 -45.46 -49.3 13.58 Favored 'General case' 0 C--N 1.314 -0.935 0 N-CA-C 106.501 -1.666 . . . . 1.0 106.501 -178.236 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 118' ' ' VAL . . . . . 0.444 ' CG2' ' O ' ' A' ' 114' ' ' ALA . 23.8 t -62.77 -30.18 48.8 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.689 0 CA-C-O 118.88 -0.581 . . . . 1.0 109.913 178.164 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 119' ' ' LEU . . . . . 0.562 ' N ' ' O ' ' A' ' 116' ' ' ILE . 14.3 tp -80.66 -63.01 1.5 Allowed 'General case' 0 C--N 1.351 0.653 0 CA-C-N 120.028 1.285 . . . . 1.0 108.032 178.548 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 120' ' ' GLY . . . . . 0.465 ' N ' ' O ' ' A' ' 116' ' ' ILE . . . -61.65 -86.81 0.04 OUTLIER Glycine 0 N--CA 1.434 -1.462 0 C-N-CA 117.991 -2.052 . . . . 1.0 108.415 177.839 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 121' ' ' THR . . . . . 0.405 ' HG1' ' HB ' ' A' ' 123' ' ' THR . 0.0 OUTLIER 171.96 -41.4 0.01 OUTLIER 'General case' 0 C--N 1.316 -0.849 0 CA-C-N 113.947 -1.127 . . . . 1.0 113.755 179.737 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 122' ' ' GLY . . . . . 0.651 ' O ' ' N ' ' A' ' 124' ' ' ASP . . . 102.17 -16.78 55.18 Favored Glycine 0 N--CA 1.472 1.069 0 N-CA-C 108.015 -2.034 . . . . 1.0 108.015 -176.959 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 123' ' ' THR . . . . . 0.536 ' O ' ' CG2' ' A' ' 123' ' ' THR . 1.7 t -52.62 86.84 0.0 OUTLIER 'General case' 0 CA--C 1.538 0.505 0 N-CA-C 105.479 -2.045 . . . . 1.0 105.479 179.063 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 124' ' ' ASP . . . . . 0.651 ' N ' ' O ' ' A' ' 122' ' ' GLY . 37.5 m-20 -164.48 171.65 14.35 Favored 'General case' 0 CA--C 1.522 -0.107 0 CA-C-N 114.107 -1.406 . . . . 1.0 112.018 -178.462 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 125' ' ' TYR . . . . . . . . . . . . . 26.1 t80 -148.38 145.42 28.06 Favored 'General case' 0 CA--C 1.536 0.415 0 CA-C-N 114.785 -1.098 . . . . 1.0 108.633 175.678 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 126' ' ' ARG . . . . . 0.404 HH21 ' CG2' ' A' ' 79' ' ' ILE . 2.6 mmp_? -145.5 149.4 34.56 Favored 'General case' 0 N--CA 1.474 0.765 0 N-CA-C 109.5 -0.556 . . . . 1.0 109.5 178.16 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 127' ' ' PHE . . . . . . . . . . . . . 40.4 p90 . . . . . 0 C--O 1.22 -0.454 0 CA-C-O 118.086 -0.959 . . . . 1.0 110.709 179.713 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 1' ' ' MET . . . . . 0.511 ' C ' ' H ' ' A' ' 3' ' ' ASP . 57.9 mtt . . . . . 0 N--CA 1.493 1.68 0 N-CA-C 108.902 -0.777 . . . . 1.0 108.902 . . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 2' ' ' SER . . . . . 0.531 ' O ' ' CG ' ' A' ' 3' ' ' ASP . 6.9 t -69.44 10.01 0.4 Allowed 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.309 -0.405 . . . . 1.0 111.013 178.915 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 3' ' ' ASP . . . . . 0.531 ' CG ' ' O ' ' A' ' 2' ' ' SER . 80.9 m-20 138.3 142.82 0.0 OUTLIER 'General case' 0 N--CA 1.486 1.326 0 O-C-N 124.564 1.165 . . . . 1.0 109.954 179.075 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 60.9 t80 -156.4 152.5 27.6 Favored 'General case' 0 N--CA 1.463 0.225 0 CA-C-N 115.932 -0.576 . . . . 1.0 110.642 179.341 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 69.9 m-20 -150.07 146.19 26.8 Favored 'General case' 0 CA--C 1.534 0.334 0 N-CA-C 109.09 -0.707 . . . . 1.0 109.09 179.435 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 6' ' ' THR . . . . . 0.802 ' O ' ' N ' ' A' ' 10' ' ' SER . 0.2 OUTLIER -87.74 177.67 6.95 Favored 'General case' 0 C--O 1.194 -1.859 0 CA-C-O 121.094 0.473 . . . . 1.0 111.314 -178.702 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . 0.413 ' O ' ' N ' ' A' ' 11' ' ' ARG . 7.7 tm-20 -56.54 -58.18 9.15 Favored 'General case' 0 C--N 1.312 -1.052 0 CA-C-O 121.687 0.755 . . . . 1.0 110.932 -177.894 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 8' ' ' ARG . . . . . 0.426 ' O ' ' CB ' ' A' ' 12' ' ' ALA . 48.6 ttp85 -55.01 -57.28 12.32 Favored 'General case' 0 C--N 1.318 -0.777 0 CA-C-N 114.089 -1.414 . . . . 1.0 107.8 -178.02 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . 0.645 ' O ' ' HB ' ' A' ' 13' ' ' VAL . 0.0 OUTLIER -66.31 -54.06 30.14 Favored 'Isoleucine or valine' 0 C--O 1.188 -2.164 0 CA-C-N 114.499 -1.228 . . . . 1.0 110.655 178.883 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 10' ' ' SER . . . . . 0.802 ' N ' ' O ' ' A' ' 6' ' ' THR . 11.0 t -67.03 -64.58 0.82 Allowed 'General case' 0 N--CA 1.486 1.369 0 CA-C-N 118.769 0.713 . . . . 1.0 112.406 -178.132 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 11' ' ' ARG . . . . . 0.511 ' O ' ' N ' ' A' ' 15' ' ' ALA . 6.7 tpt180 -63.57 -59.07 5.1 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-O 121.083 0.468 . . . . 1.0 111.371 -175.104 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . 0.488 ' O ' ' CB ' ' A' ' 16' ' ' ALA . . . -51.58 -46.76 63.61 Favored 'General case' 0 C--N 1.322 -0.619 0 N-CA-C 106.512 -1.662 . . . . 1.0 106.512 -176.022 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . 0.659 ' O ' ' N ' ' A' ' 17' ' ' LEU . 67.6 t -62.3 -50.99 77.72 Favored 'Isoleucine or valine' 0 C--O 1.2 -1.532 0 CA-C-N 114.664 -1.153 . . . . 1.0 107.931 177.499 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . 0.547 ' O ' HG23 ' A' ' 18' ' ' VAL . . . -57.17 -62.39 1.79 Allowed 'General case' 0 C--O 1.207 -1.138 0 C-N-CA 117.335 -1.746 . . . . 1.0 109.097 -178.723 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . 0.589 ' O ' ' N ' ' A' ' 19' ' ' GLY . . . -53.73 -53.91 45.57 Favored 'General case' 0 C--O 1.215 -0.753 0 O-C-N 123.843 0.714 . . . . 1.0 109.703 -178.684 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . 0.488 ' CB ' ' O ' ' A' ' 12' ' ' ALA . . . -63.8 -57.8 8.8 Favored 'General case' 0 N--CA 1.474 0.738 0 C-N-CA 120.022 -0.671 . . . . 1.0 110.215 -179.737 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . 0.659 ' N ' ' O ' ' A' ' 13' ' ' VAL . 6.1 tt -55.91 -54.53 43.61 Favored 'General case' 0 N--CA 1.48 1.072 0 CA-C-N 114.752 -1.113 . . . . 1.0 108.012 -178.013 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . 0.735 HG23 ' H ' ' A' ' 19' ' ' GLY . 2.2 m -69.39 -58.34 5.91 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 C-N-CA 119.374 -0.93 . . . . 1.0 109.104 179.913 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . 0.735 ' H ' HG23 ' A' ' 18' ' ' VAL . . . -54.97 -167.11 0.03 OUTLIER Glycine 0 C--O 1.225 -0.44 0 N-CA-C 111.298 -0.721 . . . . 1.0 111.298 -178.276 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 20' ' ' PRO . . . . . 0.673 ' O ' ' N ' ' A' ' 24' ' ' ALA . 74.0 Cg_endo -83.6 -28.97 1.19 Allowed 'Trans proline' 0 C--N 1.296 -2.184 0 C-N-CA 122.73 2.287 . . . . 1.0 112.556 -178.582 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -62.11 -59.63 9.24 Favored Glycine 0 N--CA 1.475 1.24 0 C-N-CA 119.508 -1.33 . . . . 1.0 111.902 -176.671 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . 0.459 ' N ' ' O ' ' A' ' 16' ' ' ALA . . . -55.72 -51.17 56.83 Favored Glycine 0 N--CA 1.47 0.909 0 N-CA-C 106.503 -2.639 . . . . 1.0 106.503 -178.608 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 38.3 t -60.41 -32.58 51.47 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.607 0 C-N-CA 119.493 -0.883 . . . . 1.0 109.19 178.415 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . 0.673 ' N ' ' O ' ' A' ' 20' ' ' PRO . . . -59.37 -63.85 1.15 Allowed 'General case' 0 C--N 1.349 0.552 0 C-N-CA 118.761 -1.176 . . . . 1.0 110.425 -178.709 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 19.5 mt -62.18 -44.19 97.15 Favored 'General case' 0 CA--C 1.509 -0.63 0 C-N-CA 119.581 -0.848 . . . . 1.0 110.845 -177.878 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 71.1 t -57.88 -60.4 2.23 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.695 0 C-N-CA 119.004 -1.078 . . . . 1.0 110.012 -178.186 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . 0.421 ' O ' ' CB ' ' A' ' 31' ' ' ALA . 1.4 p -60.46 -36.07 67.18 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-O 120.81 0.338 . . . . 1.0 111.645 -178.31 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 21.6 ttpp -65.72 -56.27 12.93 Favored 'General case' 0 C--N 1.321 -0.673 0 N-CA-C 109.004 -0.739 . . . . 1.0 109.004 -179.645 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 94.6 t -61.06 -47.7 92.38 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.614 0 CA-C-N 115.001 -1.0 . . . . 1.0 109.743 -178.328 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 30' ' ' CYS . . . . . 0.659 ' SG ' ' N ' ' A' ' 31' ' ' ALA . 0.0 OUTLIER -66.1 -60.38 2.87 Favored 'General case' 0 C--N 1.326 -0.446 0 C-N-CA 118.79 -1.164 . . . . 1.0 110.132 -179.511 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . 0.659 ' N ' ' SG ' ' A' ' 30' ' ' CYS . . . -60.43 -50.98 71.42 Favored 'General case' 0 CA--C 1.507 -0.697 0 C-N-CA 120.986 -0.286 . . . . 1.0 111.093 -176.003 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . 0.53 ' O ' ' CB ' ' A' ' 33' ' ' LEU . . . 78.23 69.58 1.38 Allowed Glycine 0 N--CA 1.448 -0.541 0 N-CA-C 109.516 -1.434 . . . . 1.0 109.516 -178.616 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . 0.53 ' CB ' ' O ' ' A' ' 32' ' ' GLY . 1.2 tt 90.31 77.21 0.04 OUTLIER Pre-proline 0 CA--C 1.534 0.359 0 CA-C-N 115.176 -0.512 . . . . 1.0 110.388 -179.58 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 58.8 Cg_exo -50.47 -23.09 9.95 Favored 'Trans proline' 0 N--CA 1.492 1.415 0 C-N-CA 122.839 2.359 . . . . 1.0 112.491 179.578 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -58.03 -61.08 7.84 Favored Glycine 0 CA--C 1.538 1.53 0 C-N-CA 119.102 -1.523 . . . . 1.0 109.538 -178.616 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . 0.545 ' O ' ' CB ' ' A' ' 37' ' ' ILE . 13.5 p -94.93 171.73 1.1 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.651 0 N-CA-C 107.108 -1.441 . . . . 1.0 107.108 176.901 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . 0.545 ' CB ' ' O ' ' A' ' 36' ' ' VAL . 4.1 mm 112.79 113.54 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.484 1.249 0 O-C-N 124.614 1.196 . . . . 1.0 110.009 -179.73 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 16.9 m-70 -139.98 133.58 30.27 Favored 'General case' 0 C--N 1.332 -0.17 0 N-CA-C 108.651 -0.87 . . . . 1.0 108.651 179.2 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 11.4 m -107.84 109.79 62.27 Favored Pre-proline 0 N--CA 1.469 0.492 0 N-CA-C 109.975 -0.38 . . . . 1.0 109.975 179.99 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 40' ' ' PRO . . . . . 0.449 ' HB2' ' H ' ' A' ' 41' ' ' ALA . 79.0 Cg_exo -42.6 -90.9 0.0 OUTLIER 'Trans proline' 0 N--CA 1.493 1.444 0 C-N-CA 121.471 1.447 . . . . 1.0 112.252 -179.127 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . 0.449 ' H ' ' HB2' ' A' ' 40' ' ' PRO . . . -65.56 125.02 23.89 Favored 'General case' 0 C--N 1.324 -0.541 0 N-CA-C 109.447 -0.575 . . . . 1.0 109.447 -179.389 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 34.5 ptt180 -174.2 177.05 2.37 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.205 -0.452 . . . . 1.0 110.617 179.394 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 4.3 tpp180 -58.58 -45.55 88.83 Favored 'General case' 0 C--N 1.324 -0.53 0 N-CA-C 107.965 -1.124 . . . . 1.0 107.965 178.711 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 122.24 -25.11 6.77 Favored Glycine 0 N--CA 1.471 1.016 0 N-CA-C 111.134 -0.786 . . . . 1.0 111.134 -179.788 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . 0.5 ' O ' ' HB2' ' A' ' 46' ' ' PHE . 64.7 t80 -149.98 153.66 36.93 Favored 'General case' 0 N--CA 1.466 0.368 0 N-CA-C 107.726 -1.213 . . . . 1.0 107.726 176.812 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 46' ' ' PHE . . . . . 0.732 ' O ' ' HB2' ' A' ' 47' ' ' ARG . 2.1 m-85 128.59 95.99 0.0 OUTLIER 'General case' 0 N--CA 1.481 1.109 0 C-N-CA 126.054 1.742 . . . . 1.0 108.317 -178.735 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 47' ' ' ARG . . . . . 0.732 ' HB2' ' O ' ' A' ' 46' ' ' PHE . 0.1 OUTLIER 118.16 137.79 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.825 0 C-N-CA 124.766 1.227 . . . . 1.0 110.151 179.308 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 5.4 t 71.07 78.64 0.17 Allowed 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 116.074 -0.512 . . . . 1.0 110.413 179.287 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 49' ' ' ASN . . . . . 0.523 ' O ' ' N ' ' A' ' 51' ' ' GLU . 9.4 p30 -144.66 145.43 28.23 Favored Pre-proline 0 C--N 1.324 -0.515 0 CA-C-N 115.632 -0.713 . . . . 1.0 110.838 179.753 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 50' ' ' PRO . . . . . 0.502 ' HD2' HH12 ' A' ' 52' ' ' ARG . 20.5 Cg_endo -61.27 55.48 0.1 Allowed 'Trans proline' 0 N--CA 1.494 1.524 0 C-N-CA 121.979 1.786 . . . . 1.0 113.239 179.901 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . 0.523 ' N ' ' O ' ' A' ' 49' ' ' ASN . 2.3 mp0 65.9 68.34 0.46 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.679 -0.691 . . . . 1.0 111.497 177.967 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . 0.502 HH12 ' HD2' ' A' ' 50' ' ' PRO . 7.8 mtm-85 -145.95 153.57 40.95 Favored 'General case' 0 N--CA 1.467 0.379 0 CA-C-N 115.685 -0.689 . . . . 1.0 110.468 179.157 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . 0.519 ' O ' ' N ' ' A' ' 55' ' ' ILE . 12.3 pt -65.65 127.99 27.72 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 CA-C-N 115.829 -0.623 . . . . 1.0 111.073 179.799 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 54' ' ' GLN . . . . . 0.769 HE21 ' H ' ' A' ' 54' ' ' GLN . 0.0 OUTLIER -57.74 85.49 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 121.426 0.632 . . . . 1.0 109.714 -177.367 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . 0.519 ' N ' ' O ' ' A' ' 53' ' ' ILE . 0.5 OUTLIER -146.83 159.17 9.96 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.157 0 CA-C-N 115.066 -0.97 . . . . 1.0 110.043 178.269 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 114.23 0.61 23.75 Favored Glycine 0 C--N 1.332 0.36 0 N-CA-C 110.178 -1.169 . . . . 1.0 110.178 -178.183 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . 0.432 ' O ' ' CG ' ' A' ' 57' ' ' ASP . 13.2 p-10 -80.82 93.57 6.27 Favored 'General case' 0 N--CA 1.455 -0.197 0 C-N-CA 119.379 -0.929 . . . . 1.0 109.845 178.791 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 58' ' ' TRP . . . . . . . . . . . . . 10.8 m0 -88.7 169.21 11.86 Favored 'General case' 0 CA--C 1.547 0.856 0 CA-C-O 122.618 1.199 . . . . 1.0 111.63 -178.103 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 59' ' ' ARG . . . . . 0.472 ' CG ' ' H ' ' A' ' 60' ' ' TYR . 6.8 ptt85 -83.86 -60.91 1.96 Allowed 'General case' 0 C--N 1.31 -1.129 0 CA-C-N 112.119 -2.309 . . . . 1.0 113.5 -178.495 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 60' ' ' TYR . . . . . 0.472 ' H ' ' CG ' ' A' ' 59' ' ' ARG . 0.0 OUTLIER -89.19 -18.26 27.48 Favored 'General case' 0 C--O 1.248 0.998 0 N-CA-C 113.167 0.803 . . . . 1.0 113.167 -179.005 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . 0.519 ' O ' ' N ' ' A' ' 65' ' ' ASP . 25.0 tt0 -71.14 -12.95 61.77 Favored 'General case' 0 C--N 1.31 -1.149 0 O-C-N 121.973 -0.454 . . . . 1.0 110.662 -177.86 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 62' ' ' VAL . . . . . 0.566 ' O ' ' N ' ' A' ' 66' ' ' GLY . 17.0 m -45.13 -56.26 0.96 Allowed 'Isoleucine or valine' 0 C--N 1.309 -1.188 0 C-N-CA 120.121 -0.632 . . . . 1.0 110.025 -175.124 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 63' ' ' ALA . . . . . 0.434 ' H ' ' CG2' ' A' ' 62' ' ' VAL . . . -65.91 -49.84 66.59 Favored 'General case' 0 N--CA 1.428 -1.53 0 CA-C-O 121.349 0.595 . . . . 1.0 109.435 179.728 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 1.8 t60 -54.04 -59.95 3.98 Favored 'General case' 0 CA--C 1.547 0.849 0 C-N-CA 119.474 -0.891 . . . . 1.0 109.934 -179.747 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 65' ' ' ASP . . . . . 0.576 ' C ' ' H ' ' A' ' 67' ' ' ARG . 2.6 t70 -66.94 -54.72 19.2 Favored 'General case' 0 C--O 1.244 0.808 0 CA-C-O 121.848 0.832 . . . . 1.0 110.729 177.851 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . 0.566 ' N ' ' O ' ' A' ' 62' ' ' VAL . . . -65.72 27.74 0.14 Allowed Glycine 0 CA--C 1.524 0.617 0 O-C-N 121.163 -0.961 . . . . 1.0 112.489 179.078 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 67' ' ' ARG . . . . . 0.718 ' O ' ' N ' ' A' ' 69' ' ' LEU . 1.1 mtt-85 -76.43 -1.11 25.44 Favored 'General case' 0 C--N 1.322 -0.619 0 N-CA-C 108.72 -0.844 . . . . 1.0 108.72 175.775 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . 0.48 ' C ' ' O ' ' A' ' 67' ' ' ARG . 0.8 OUTLIER -32.39 -26.01 0.0 OUTLIER 'General case' 0 N--CA 1.488 1.44 0 N-CA-C 107.732 -1.21 . . . . 1.0 107.732 -177.486 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . 0.718 ' N ' ' O ' ' A' ' 67' ' ' ARG . 20.0 tp -66.91 -67.67 0.43 Allowed 'General case' 0 CA--C 1.548 0.875 0 C-N-CA 119.342 -0.943 . . . . 1.0 108.853 177.029 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . 0.702 ' C ' ' H ' ' A' ' 72' ' ' HIS . . . -78.1 -73.45 0.31 Allowed 'General case' 0 N--CA 1.472 0.653 0 N-CA-C 107.577 -1.268 . . . . 1.0 107.577 179.084 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 71' ' ' ALA . . . . . 0.476 ' O ' ' C ' ' A' ' 72' ' ' HIS . . . -48.02 5.51 0.0 OUTLIER 'General case' 0 N--CA 1.469 0.522 0 C-N-CA 124.273 1.029 . . . . 1.0 112.261 177.81 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 72' ' ' HIS . . . . . 0.702 ' H ' ' C ' ' A' ' 70' ' ' ALA . 0.0 OUTLIER -21.87 -75.92 0.01 OUTLIER 'General case' 0 CA--C 1.516 -0.351 0 C-N-CA 123.332 0.653 . . . . 1.0 112.328 -177.956 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 73' ' ' MET . . . . . 0.657 ' H ' ' CG ' ' A' ' 72' ' ' HIS . 57.9 mtm -69.29 -45.31 69.94 Favored 'General case' 0 C--N 1.311 -1.097 0 C-N-CA 118.692 -1.203 . . . . 1.0 109.463 178.065 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . 0.729 ' O ' ' N ' ' A' ' 76' ' ' GLY . 85.3 t -41.1 -42.27 0.67 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.384 0 CA-C-O 118.604 -0.712 . . . . 1.0 110.167 -176.553 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 75' ' ' ASN . . . . . 0.479 ' C ' ' N ' ' A' ' 77' ' ' ILE . 1.0 OUTLIER -36.66 -15.58 0.0 OUTLIER 'General case' 0 N--CA 1.48 1.067 0 CA-C-O 121.497 0.665 . . . . 1.0 110.721 178.363 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 76' ' ' GLY . . . . . 0.729 ' N ' ' O ' ' A' ' 74' ' ' VAL . . . -43.92 -20.14 0.14 Allowed Glycine 0 CA--C 1.539 1.549 0 N-CA-C 108.734 -1.747 . . . . 1.0 108.734 176.971 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 77' ' ' ILE . . . . . 0.627 ' O ' ' N ' ' A' ' 80' ' ' ALA . 0.2 OUTLIER -73.45 -50.33 31.28 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.14 0 CA-C-O 122.274 1.035 . . . . 1.0 108.524 178.85 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . 0.472 ' N ' ' O ' ' A' ' 75' ' ' ASN . 93.5 t -35.54 -36.3 0.08 OUTLIER 'Isoleucine or valine' 0 CA--C 1.553 1.083 0 CA-C-N 112.092 -2.322 . . . . 1.0 107.956 -176.254 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . 0.53 HG13 ' O ' ' A' ' 76' ' ' GLY . 1.4 pp -95.37 -24.97 4.59 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.852 0 CA-C-N 116.195 -0.457 . . . . 1.0 111.355 177.614 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 80' ' ' ALA . . . . . 0.627 ' N ' ' O ' ' A' ' 77' ' ' ILE . . . -80.67 -14.96 57.69 Favored 'General case' 0 N--CA 1.475 0.779 0 O-C-N 122.261 -0.274 . . . . 1.0 111.564 179.278 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 33.1 tt0 -81.17 -67.88 0.74 Allowed 'General case' 0 N--CA 1.444 -0.74 0 N-CA-C 109.448 -0.575 . . . . 1.0 109.448 177.668 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 82' ' ' ASP . . . . . 0.815 ' O ' ' N ' ' A' ' 84' ' ' LEU . 89.1 m-20 -59.35 -60.52 3.73 Favored 'General case' 0 CA--C 1.504 -0.801 0 C-N-CA 119.075 -1.05 . . . . 1.0 109.039 -179.454 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . 0.527 ' O ' ' N ' ' A' ' 86' ' ' ALA . . . 22.83 -68.21 0.0 OUTLIER 'General case' 0 N--CA 1.484 1.235 0 O-C-N 124.852 1.345 . . . . 1.0 111.386 -179.957 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . 0.815 ' N ' ' O ' ' A' ' 82' ' ' ASP . 4.8 tt -29.31 -45.3 0.04 OUTLIER 'General case' 0 N--CA 1.478 0.95 0 C-N-CA 123.512 0.725 . . . . 1.0 112.666 -178.288 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 3.3 pt -91.12 -36.55 8.21 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.87 0 N-CA-C 109.384 -0.598 . . . . 1.0 109.384 178.081 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 86' ' ' ALA . . . . . 0.604 ' C ' ' H ' ' A' ' 88' ' ' ALA . . . -51.16 -55.78 16.13 Favored 'General case' 0 CA--C 1.534 0.34 0 C-N-CA 120.42 -0.512 . . . . 1.0 110.086 -178.749 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 27.3 mt-10 -61.55 5.66 0.07 Allowed 'General case' 0 C--N 1.326 -0.419 0 C-N-CA 120.656 -0.417 . . . . 1.0 110.664 -179.433 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 88' ' ' ALA . . . . . 0.604 ' H ' ' C ' ' A' ' 86' ' ' ALA . . . -105.76 -23.98 12.6 Favored 'General case' 0 C--O 1.237 0.4 0 CA-C-N 116.402 -0.363 . . . . 1.0 110.506 179.55 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 9.3 m -88.63 -8.79 10.9 Favored 'Isoleucine or valine' 0 C--O 1.236 0.367 0 CA-C-N 115.98 -0.555 . . . . 1.0 109.716 179.307 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -40.92 -49.67 4.21 Favored Glycine 0 CA--C 1.535 1.301 0 CA-C-O 119.466 -0.63 . . . . 1.0 111.633 -177.999 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 85.7 Cg_exo -45.38 -27.83 3.48 Favored 'Trans proline' 0 N--CA 1.495 1.608 0 CA-C-N 120.072 1.936 . . . . 1.0 112.052 177.726 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 92' ' ' HIS . . . . . 0.492 ' ND1' ' HG2' ' A' ' 51' ' ' GLU . 25.9 t-80 -56.36 -33.91 66.13 Favored 'General case' 0 C--O 1.22 -0.476 0 N-CA-C 107.849 -1.167 . . . . 1.0 107.849 -177.607 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 93' ' ' LEU . . . . . 0.636 ' CD2' ' H ' ' A' ' 94' ' ' ALA . 0.5 OUTLIER -42.45 -51.85 4.85 Favored 'General case' 0 N--CA 1.473 0.697 0 C-N-CA 120.375 -0.53 . . . . 1.0 109.592 -179.833 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 94' ' ' ALA . . . . . 0.636 ' H ' ' CD2' ' A' ' 93' ' ' LEU . . . -56.1 -53.9 51.51 Favored 'General case' 0 N--CA 1.449 -0.513 0 N-CA-C 107.998 -1.112 . . . . 1.0 107.998 178.877 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 95' ' ' ARG . . . . . 0.592 ' O ' ' N ' ' A' ' 97' ' ' LEU . 0.2 OUTLIER -51.3 -58.57 5.83 Favored 'General case' 0 C--O 1.241 0.649 0 CA-C-O 123.358 1.551 . . . . 1.0 107.075 177.614 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 96' ' ' ALA . . . . . 0.85 ' O ' ' N ' ' A' ' 98' ' ' GLY . . . -49.24 -11.88 0.05 OUTLIER 'General case' 0 N--CA 1.427 -1.622 0 O-C-N 118.731 -2.481 . . . . 1.0 110.895 -179.842 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 97' ' ' LEU . . . . . 0.66 ' O ' ' N ' ' A' ' 100' ' ' ILE . 0.4 OUTLIER 4.79 -49.52 0.0 OUTLIER 'General case' 0 CA--C 1.511 -0.549 0 C-N-CA 124.9 1.28 . . . . 1.0 112.865 -170.101 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 98' ' ' GLY . . . . . 0.85 ' N ' ' O ' ' A' ' 96' ' ' ALA . . . -53.24 -22.41 14.43 Favored Glycine 0 N--CA 1.426 -2.008 0 N-CA-C 107.817 -2.113 . . . . 1.0 107.817 174.806 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 99' ' ' GLN . . . . . 0.596 ' O ' ' HG3' ' A' ' 103' ' ' ARG . 15.2 mm100 -71.54 -22.95 61.69 Favored 'General case' 0 CA--C 1.5 -0.975 0 C-N-CA 116.551 -2.06 . . . . 1.0 107.127 177.576 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 100' ' ' ILE . . . . . 0.66 ' N ' ' O ' ' A' ' 97' ' ' LEU . 2.8 tt -66.05 -34.78 72.54 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.135 0 O-C-N 124.797 1.311 . . . . 1.0 109.453 178.779 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 101' ' ' VAL . . . . . 0.557 ' CG1' ' N ' ' A' ' 102' ' ' CYS . 0.4 OUTLIER -57.96 -57.97 8.32 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 N-CA-C 106.852 -1.536 . . . . 1.0 106.852 -178.757 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 102' ' ' CYS . . . . . 0.557 ' N ' ' CG1' ' A' ' 101' ' ' VAL . 0.1 OUTLIER -48.99 -28.89 4.23 Favored 'General case' 0 N--CA 1.441 -0.883 0 CA-C-N 115.224 -0.898 . . . . 1.0 110.078 178.954 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 103' ' ' ARG . . . . . 0.596 ' HG3' ' O ' ' A' ' 99' ' ' GLN . 74.7 mtt-85 -72.58 -56.61 5.09 Favored 'General case' 0 N--CA 1.478 0.972 0 O-C-N 123.984 0.803 . . . . 1.0 110.085 179.063 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 104' ' ' TYR . . . . . 0.712 ' HD1' ' O ' ' A' ' 104' ' ' TYR . 0.5 OUTLIER -90.34 25.77 2.13 Favored 'General case' 0 CA--C 1.494 -1.187 0 C-N-CA 125.435 1.494 . . . . 1.0 108.44 177.291 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 105' ' ' GLY . . . . . 0.529 ' N ' ' O ' ' A' ' 101' ' ' VAL . . . -155.43 -91.02 0.08 OUTLIER Glycine 0 N--CA 1.443 -0.841 0 C-N-CA 118.793 -1.67 . . . . 1.0 109.86 176.932 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 106' ' ' ALA . . . . . 0.472 ' O ' ' O ' ' A' ' 105' ' ' GLY . . . 58.18 114.36 0.01 OUTLIER 'General case' 0 CA--C 1.551 0.993 0 N-CA-C 108.92 -0.77 . . . . 1.0 108.92 -179.309 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 107' ' ' THR . . . . . 0.76 ' O ' ' HD2' ' A' ' 110' ' ' PRO . 5.2 m -134.7 -54.4 0.82 Allowed 'General case' 0 N--CA 1.481 1.115 0 N-CA-C 108.548 -0.908 . . . . 1.0 108.548 178.751 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 108' ' ' VAL . . . . . 0.525 ' O ' ' N ' ' A' ' 111' ' ' ASN . 16.7 m -70.85 -43.82 76.63 Favored 'Isoleucine or valine' 0 C--N 1.348 0.53 0 CA-C-O 121.993 0.901 . . . . 1.0 108.873 -179.574 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 109' ' ' ILE . . . . . 0.488 ' N ' ' CD ' ' A' ' 110' ' ' PRO . 0.0 OUTLIER -39.06 -46.72 3.62 Favored Pre-proline 0 CA--C 1.553 1.065 0 CA-C-N 114.2 -1.364 . . . . 1.0 109.919 -178.179 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 110' ' ' PRO . . . . . 0.76 ' HD2' ' O ' ' A' ' 107' ' ' THR . 28.1 Cg_exo -64.43 -24.27 64.27 Favored 'Trans proline' 0 N--CA 1.504 2.108 0 C-N-CA 124.44 3.427 . . . . 1.0 111.871 177.675 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 111' ' ' ASN . . . . . 0.525 ' N ' ' O ' ' A' ' 108' ' ' VAL . 2.9 t-20 -62.3 -69.04 0.28 Allowed 'General case' 0 C--O 1.236 0.374 0 CA-C-N 115.996 -0.547 . . . . 1.0 109.74 -179.007 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 112' ' ' ILE . . . . . 0.505 ' O ' ' N ' ' A' ' 115' ' ' ALA . 0.0 OUTLIER -67.43 -36.55 76.78 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.538 0 CA-C-O 121.924 0.869 . . . . 1.0 110.13 178.777 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 113' ' ' ASN . . . . . 0.419 ' O ' ' HB3' ' A' ' 117' ' ' GLU . 10.3 t30 -48.27 -52.42 21.32 Favored 'General case' 0 C--N 1.309 -1.165 0 N-CA-C 107.266 -1.383 . . . . 1.0 107.266 -178.264 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -62.2 -24.72 67.38 Favored 'General case' 0 N--CA 1.451 -0.419 0 CA-C-N 116.378 -0.374 . . . . 1.0 110.432 177.307 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 115' ' ' ALA . . . . . 0.505 ' N ' ' O ' ' A' ' 112' ' ' ILE . . . -77.07 -59.1 2.92 Favored 'General case' 0 C--O 1.235 0.292 0 C-N-CA 119.957 -0.697 . . . . 1.0 110.799 178.419 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 116' ' ' ILE . . . . . 0.623 ' O ' ' N ' ' A' ' 119' ' ' LEU . 11.5 tt -67.31 -50.54 61.79 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.571 0 CA-C-O 120.983 0.42 . . . . 1.0 110.906 -178.378 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 117' ' ' GLU . . . . . 0.486 ' N ' ' CG2' ' A' ' 116' ' ' ILE . 23.6 tt0 -42.63 -60.47 1.54 Allowed 'General case' 0 C--O 1.244 0.794 0 N-CA-C 108.074 -1.084 . . . . 1.0 108.074 -177.471 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 18.7 t -51.71 -23.48 3.38 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.086 0 CA-C-N 114.261 -1.336 . . . . 1.0 109.357 177.662 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 119' ' ' LEU . . . . . 0.623 ' N ' ' O ' ' A' ' 116' ' ' ILE . 2.5 tp -81.68 -62.67 1.58 Allowed 'General case' 0 C--N 1.344 0.328 0 C-N-CA 120.304 -0.558 . . . . 1.0 111.468 179.108 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -67.6 -86.77 0.08 OUTLIER Glycine 0 C--N 1.355 1.622 0 C-N-CA 117.421 -2.323 . . . . 1.0 110.417 179.756 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 38.3 m -162.61 -25.45 0.04 OUTLIER 'General case' 0 C--N 1.32 -0.682 0 N-CA-C 107.364 -1.347 . . . . 1.0 107.364 -179.962 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 122' ' ' GLY . . . . . 0.479 ' O ' ' N ' ' A' ' 124' ' ' ASP . . . 114.32 -35.79 4.28 Favored Glycine 0 C--N 1.347 1.152 0 C-N-CA 125.32 1.438 . . . . 1.0 113.539 178.907 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 123' ' ' THR . . . . . 0.436 ' C ' ' O ' ' A' ' 122' ' ' GLY . 1.8 t -33.21 92.12 0.01 OUTLIER 'General case' 0 N--CA 1.473 0.705 0 CA-C-N 120.124 1.962 . . . . 1.0 113.344 -179.124 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 124' ' ' ASP . . . . . 0.479 ' N ' ' O ' ' A' ' 122' ' ' GLY . 22.6 m-20 -142.65 143.22 32.27 Favored 'General case' 0 C--N 1.328 -0.344 0 N-CA-C 108.49 -0.93 . . . . 1.0 108.49 177.655 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 125' ' ' TYR . . . . . . . . . . . . . 11.2 t80 -148.64 143.19 26.37 Favored 'General case' 0 CA--C 1.536 0.412 0 N-CA-C 109.247 -0.649 . . . . 1.0 109.247 -179.591 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 4.0 mmp_? -151.76 155.15 37.67 Favored 'General case' 0 CA--C 1.535 0.372 0 CA-C-N 116.259 -0.428 . . . . 1.0 110.59 178.54 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 127' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--O 1.218 -0.576 0 CA-C-O 118.193 -0.908 . . . . 1.0 109.726 178.476 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 24.5 mmt . . . . . 0 N--CA 1.495 1.802 0 N-CA-C 109.081 -0.711 . . . . 1.0 109.081 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 2' ' ' SER . . . . . 0.438 ' O ' ' OD1' ' A' ' 3' ' ' ASP . 58.3 p -108.84 11.23 26.29 Favored 'General case' 0 N--CA 1.469 0.495 0 C-N-CA 122.957 0.503 . . . . 1.0 110.247 179.489 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 3' ' ' ASP . . . . . 0.438 ' OD1' ' O ' ' A' ' 2' ' ' SER . 2.2 m-20 166.67 91.54 0.0 OUTLIER 'General case' 0 N--CA 1.468 0.429 0 CA-C-N 116.321 -0.4 . . . . 1.0 110.044 179.615 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 76.2 t80 -147.98 143.68 27.46 Favored 'General case' 0 C--N 1.332 -0.156 0 N-CA-C 109.993 -0.373 . . . . 1.0 109.993 179.364 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 5' ' ' ASP . . . . . 0.451 ' N ' ' OD1' ' A' ' 5' ' ' ASP . 0.3 OUTLIER -153.38 149.0 27.36 Favored 'General case' 0 CA--C 1.534 0.359 0 CA-C-N 116.657 -0.247 . . . . 1.0 110.361 -178.916 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 6' ' ' THR . . . . . 0.733 ' O ' ' N ' ' A' ' 10' ' ' SER . 62.6 p -70.39 -178.56 1.77 Allowed 'General case' 0 C--O 1.202 -1.439 0 C-N-CA 121.155 -0.218 . . . . 1.0 110.838 179.888 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . 0.483 ' O ' ' N ' ' A' ' 11' ' ' ARG . 0.0 OUTLIER -58.71 -56.14 25.99 Favored 'General case' 0 N--CA 1.48 1.025 0 CA-C-O 121.645 0.736 . . . . 1.0 110.785 -177.631 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 8' ' ' ARG . . . . . 0.441 ' O ' ' CB ' ' A' ' 12' ' ' ALA . 65.1 ttt180 -50.95 -56.49 12.15 Favored 'General case' 0 C--N 1.32 -0.716 0 N-CA-C 106.723 -1.584 . . . . 1.0 106.723 -178.562 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . 0.577 ' O ' ' CG2' ' A' ' 13' ' ' VAL . 48.7 t -65.91 -49.72 75.0 Favored 'Isoleucine or valine' 0 C--O 1.2 -1.514 0 CA-C-N 113.641 -1.618 . . . . 1.0 110.761 179.136 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 10' ' ' SER . . . . . 0.733 ' N ' ' O ' ' A' ' 6' ' ' THR . 38.9 t -67.68 -65.41 0.69 Allowed 'General case' 0 N--CA 1.478 0.97 0 O-C-N 121.585 -0.697 . . . . 1.0 112.436 -178.391 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 11' ' ' ARG . . . . . 0.52 ' O ' ' N ' ' A' ' 15' ' ' ALA . 21.6 ttt180 -65.38 -58.61 5.44 Favored 'General case' 0 N--CA 1.467 0.399 0 C-N-CA 120.749 -0.381 . . . . 1.0 111.491 -175.966 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . 0.441 ' CB ' ' O ' ' A' ' 8' ' ' ARG . . . -49.82 -49.2 49.8 Favored 'General case' 0 N--CA 1.473 0.703 0 N-CA-C 106.449 -1.686 . . . . 1.0 106.449 -176.937 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . 0.602 ' O ' ' N ' ' A' ' 17' ' ' LEU . 93.9 t -60.71 -48.55 88.26 Favored 'Isoleucine or valine' 0 C--O 1.202 -1.412 0 C-N-CA 118.061 -1.456 . . . . 1.0 108.149 176.745 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -57.25 -61.96 2.1 Favored 'General case' 0 C--O 1.211 -0.934 0 C-N-CA 118.088 -1.445 . . . . 1.0 109.636 -179.849 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . 0.549 ' O ' ' N ' ' A' ' 19' ' ' GLY . . . -52.42 -54.64 29.43 Favored 'General case' 0 N--CA 1.473 0.721 0 CA-C-O 121.702 0.763 . . . . 1.0 109.857 -178.342 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . 0.491 ' CA ' ' H ' ' A' ' 22' ' ' GLY . . . -61.88 -55.11 33.16 Favored 'General case' 0 C--N 1.309 -1.154 0 CA-C-N 114.57 -1.196 . . . . 1.0 109.051 -179.023 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . 0.602 ' N ' ' O ' ' A' ' 13' ' ' VAL . 6.7 tp -56.41 -53.22 59.94 Favored 'General case' 0 N--CA 1.478 0.96 0 CA-C-N 113.726 -1.579 . . . . 1.0 108.638 -177.504 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . 0.609 HG23 ' H ' ' A' ' 19' ' ' GLY . 3.5 m -68.02 -56.43 12.89 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.258 0 N-CA-C 108.63 -0.878 . . . . 1.0 108.63 179.262 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . 0.609 ' H ' HG23 ' A' ' 18' ' ' VAL . . . -64.77 -171.69 2.81 Favored Glycine 0 CA--C 1.521 0.423 0 N-CA-C 110.28 -1.128 . . . . 1.0 110.28 179.571 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 20' ' ' PRO . . . . . 0.657 ' O ' ' N ' ' A' ' 24' ' ' ALA . 43.7 Cg_endo -80.63 -21.37 7.31 Favored 'Trans proline' 0 C--N 1.301 -1.942 0 C-N-CA 122.115 1.876 . . . . 1.0 113.097 -179.316 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -56.73 -58.13 16.03 Favored Glycine 0 CA--C 1.535 1.33 0 C-N-CA 119.488 -1.339 . . . . 1.0 110.355 -177.725 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . 0.491 ' H ' ' CA ' ' A' ' 16' ' ' ALA . . . -62.68 -53.1 43.79 Favored Glycine 0 N--CA 1.471 0.976 0 N-CA-C 108.13 -1.988 . . . . 1.0 108.13 -179.845 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -56.44 -38.38 55.76 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.737 0 N-CA-C 108.316 -0.994 . . . . 1.0 108.316 -179.411 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . 0.657 ' N ' ' O ' ' A' ' 20' ' ' PRO . . . -58.14 -59.99 4.44 Favored 'General case' 0 N--CA 1.468 0.436 0 C-N-CA 119.484 -0.886 . . . . 1.0 109.652 -179.301 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -62.74 -42.57 99.73 Favored 'General case' 0 CA--C 1.519 -0.217 0 C-N-CA 119.685 -0.806 . . . . 1.0 111.041 -178.642 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 69.9 t -61.93 -61.11 1.76 Allowed 'Isoleucine or valine' 0 N--CA 1.448 -0.536 0 C-N-CA 118.606 -1.238 . . . . 1.0 110.711 -178.33 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 9.8 p -60.21 -37.6 74.1 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.333 0 N-CA-C 112.749 0.648 . . . . 1.0 112.749 -176.706 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 59.8 tttm -69.0 -54.11 16.95 Favored 'General case' 0 C--N 1.315 -0.895 0 CA-C-O 121.815 0.816 . . . . 1.0 109.378 -178.916 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 95.0 t -64.17 -49.26 82.1 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.83 0 CA-C-N 114.216 -1.357 . . . . 1.0 110.29 -177.7 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 30' ' ' CYS . . . . . . . . . . . . . 44.5 t -67.03 -61.44 1.93 Allowed 'General case' 0 N--CA 1.444 -0.767 0 C-N-CA 119.07 -1.052 . . . . 1.0 110.416 -179.247 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -64.94 -53.79 40.81 Favored 'General case' 0 CA--C 1.514 -0.441 0 N-CA-C 112.726 0.639 . . . . 1.0 112.726 -175.427 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . 0.413 ' O ' ' CB ' ' A' ' 33' ' ' LEU . . . 89.05 72.02 1.27 Allowed Glycine 0 CA--C 1.522 0.506 0 N-CA-C 108.403 -1.879 . . . . 1.0 108.403 -177.446 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . 0.413 ' CB ' ' O ' ' A' ' 32' ' ' GLY . 6.1 tp 81.65 122.28 0.03 OUTLIER Pre-proline 0 CA--C 1.54 0.587 0 C-N-CA 122.858 0.463 . . . . 1.0 111.268 -179.547 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 39.8 Cg_endo -68.45 -18.36 43.69 Favored 'Trans proline' 0 N--CA 1.495 1.574 0 C-N-CA 121.433 1.422 . . . . 1.0 113.56 179.668 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -57.22 -61.03 7.97 Favored Glycine 0 C--N 1.338 0.677 0 C-N-CA 118.126 -1.987 . . . . 1.0 108.802 -179.022 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . 0.599 ' CG2' ' H ' ' A' ' 37' ' ' ILE . 9.0 p -69.25 -150.78 0.0 OUTLIER 'Isoleucine or valine' 0 C--O 1.215 -0.721 0 N-CA-C 106.057 -1.831 . . . . 1.0 106.057 177.869 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . 0.599 ' H ' ' CG2' ' A' ' 36' ' ' VAL . 6.8 tp 79.15 75.25 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.483 1.186 0 O-C-N 124.281 0.988 . . . . 1.0 112.597 179.444 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 10.3 m80 -136.23 130.46 33.14 Favored 'General case' 0 C--N 1.334 -0.08 0 O-C-N 120.858 -1.151 . . . . 1.0 108.653 177.619 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 39' ' ' THR . . . . . 0.67 ' HG1' ' NE ' ' A' ' 42' ' ' ARG . 20.0 p -110.19 144.54 30.28 Favored Pre-proline 0 N--CA 1.464 0.228 0 N-CA-C 109.65 -0.5 . . . . 1.0 109.65 -179.859 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 90.7 Cg_endo -73.27 -29.22 11.66 Favored 'Trans proline' 0 N--CA 1.493 1.497 0 C-N-CA 122.144 1.896 . . . . 1.0 113.425 -178.818 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -127.59 133.39 49.73 Favored 'General case' 0 N--CA 1.468 0.457 0 CA-C-N 116.767 -0.197 . . . . 1.0 110.786 179.123 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . 0.67 ' NE ' ' HG1' ' A' ' 39' ' ' THR . 4.4 mtm180 -171.67 171.64 5.23 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-O 121.461 0.648 . . . . 1.0 109.529 176.391 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -69.51 15.92 0.07 Allowed 'General case' 0 C--N 1.315 -0.898 0 CA-C-N 114.805 -1.089 . . . . 1.0 108.981 179.422 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . 0.62 ' H ' ' C ' ' A' ' 42' ' ' ARG . . . 93.9 -19.91 50.31 Favored Glycine 0 C--N 1.336 0.558 0 N-CA-C 110.035 -1.226 . . . . 1.0 110.035 179.232 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . 0.689 ' O ' ' HB2' ' A' ' 46' ' ' PHE . 1.1 p90 -167.23 169.08 12.88 Favored 'General case' 0 CA--C 1.538 0.485 0 N-CA-C 109.884 -0.414 . . . . 1.0 109.884 179.868 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 46' ' ' PHE . . . . . 0.689 ' HB2' ' O ' ' A' ' 45' ' ' PHE . 0.2 OUTLIER 148.12 71.24 0.0 OUTLIER 'General case' 0 N--CA 1.504 2.257 0 O-C-N 125.772 1.92 . . . . 1.0 110.176 178.555 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 47' ' ' ARG . . . . . 0.503 ' CB ' ' O ' ' A' ' 46' ' ' PHE . 4.2 mmt-85 142.94 142.87 0.0 OUTLIER 'General case' 0 N--CA 1.483 1.202 0 N-CA-C 108.831 -0.803 . . . . 1.0 108.831 179.082 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 1.8 t 70.75 68.6 0.19 Allowed 'General case' 0 N--CA 1.446 -0.661 0 N-CA-C 108.7 -0.852 . . . . 1.0 108.7 -179.594 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 49' ' ' ASN . . . . . 0.605 ' ND2' ' O ' ' A' ' 49' ' ' ASN . 3.2 p-10 -140.71 105.7 6.36 Favored Pre-proline 0 CA--C 1.54 0.579 0 N-CA-C 107.929 -1.137 . . . . 1.0 107.929 -179.89 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 50' ' ' PRO . . . . . 0.538 ' C ' ' H ' ' A' ' 52' ' ' ARG . 62.8 Cg_exo -49.72 68.64 0.02 OUTLIER 'Trans proline' 0 N--CA 1.505 2.174 0 C-N-CA 122.733 2.289 . . . . 1.0 114.533 -178.749 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . 0.6 ' N ' ' O ' ' A' ' 49' ' ' ASN . 42.6 mm-40 71.52 -23.13 0.19 Allowed 'General case' 0 N--CA 1.468 0.451 0 C-N-CA 122.636 0.375 . . . . 1.0 110.711 -179.695 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . 0.572 ' NH2' HH22 ' A' ' 126' ' ' ARG . 17.0 mmt180 -48.05 114.14 0.87 Allowed 'General case' 0 C--N 1.329 -0.319 0 N-CA-C 109.302 -0.629 . . . . 1.0 109.302 179.98 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . 0.466 ' O ' ' N ' ' A' ' 55' ' ' ILE . 21.5 tt -54.71 143.58 6.92 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-O 121.385 0.612 . . . . 1.0 110.482 -179.292 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 11.4 mm100 -64.65 77.64 0.04 OUTLIER 'General case' 0 C--N 1.318 -0.788 0 C-N-CA 119.123 -1.031 . . . . 1.0 109.683 -177.917 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . 0.466 ' N ' ' O ' ' A' ' 53' ' ' ILE . 3.2 tp -150.11 158.05 5.79 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.299 0 N-CA-C 110.406 -0.22 . . . . 1.0 110.406 178.179 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 113.44 -27.42 9.41 Favored Glycine 0 CA--C 1.519 0.296 0 N-CA-C 110.305 -1.118 . . . . 1.0 110.305 179.3 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . 0.453 ' N ' ' OD1' ' A' ' 57' ' ' ASP . 11.4 p-10 -57.43 101.95 0.08 Allowed 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 117.638 0.719 . . . . 1.0 110.254 179.529 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 58' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -86.25 176.06 8.14 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-O 122.526 1.155 . . . . 1.0 111.843 -179.169 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 59' ' ' ARG . . . . . 0.503 ' CG ' ' N ' ' A' ' 60' ' ' TYR . 22.2 ptt-85 -90.82 -56.38 3.2 Favored 'General case' 0 C--N 1.316 -0.884 0 CA-C-N 112.756 -2.02 . . . . 1.0 112.224 179.841 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 60' ' ' TYR . . . . . 0.503 ' N ' ' CG ' ' A' ' 59' ' ' ARG . 0.4 OUTLIER -91.22 -20.64 21.72 Favored 'General case' 0 C--O 1.247 0.967 0 CA-C-O 121.948 0.88 . . . . 1.0 113.046 -179.107 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . 0.4 ' O ' ' N ' ' A' ' 65' ' ' ASP . 3.5 tt0 -79.21 -12.77 59.97 Favored 'General case' 0 N--CA 1.436 -1.157 0 N-CA-C 109.425 -0.583 . . . . 1.0 109.425 -179.893 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 62' ' ' VAL . . . . . 0.568 ' O ' ' N ' ' A' ' 66' ' ' GLY . 6.1 p -46.84 -55.85 1.59 Allowed 'Isoleucine or valine' 0 C--O 1.212 -0.899 0 C-N-CA 119.656 -0.817 . . . . 1.0 109.811 -175.69 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 63' ' ' ALA . . . . . 0.463 ' O ' ' HG2' ' A' ' 67' ' ' ARG . . . -64.87 -54.63 27.96 Favored 'General case' 0 N--CA 1.435 -1.199 0 C-N-CA 120.177 -0.609 . . . . 1.0 109.509 -179.68 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 64' ' ' HIS . . . . . 0.424 ' O ' ' CG ' ' A' ' 67' ' ' ARG . 0.2 OUTLIER -48.45 -57.95 5.35 Favored 'General case' 0 CA--C 1.538 0.495 0 CA-C-N 115.484 -0.78 . . . . 1.0 110.153 -179.567 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 65' ' ' ASP . . . . . 0.662 ' C ' ' H ' ' A' ' 67' ' ' ARG . 0.8 OUTLIER -69.78 -46.49 65.65 Favored 'General case' 0 C--N 1.316 -0.858 0 CA-C-O 122.309 1.052 . . . . 1.0 110.222 179.19 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . 0.568 ' N ' ' O ' ' A' ' 62' ' ' VAL . . . -71.08 27.38 0.54 Allowed Glycine 0 N--CA 1.447 -0.621 0 N-CA-C 109.585 -1.406 . . . . 1.0 109.585 177.755 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 67' ' ' ARG . . . . . 0.697 ' O ' ' N ' ' A' ' 69' ' ' LEU . 14.5 mmt85 -74.9 1.26 13.16 Favored 'General case' 0 N--CA 1.441 -0.909 0 N-CA-C 107.87 -1.159 . . . . 1.0 107.87 176.23 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . 0.453 ' C ' ' O ' ' A' ' 67' ' ' ARG . 0.8 OUTLIER -33.05 -24.46 0.0 OUTLIER 'General case' 0 N--CA 1.475 0.79 0 O-C-N 123.745 0.653 . . . . 1.0 109.5 -175.99 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . 0.697 ' N ' ' O ' ' A' ' 67' ' ' ARG . 4.8 mp -67.31 -64.64 0.81 Allowed 'General case' 0 CA--C 1.54 0.571 0 C-N-CA 119.326 -0.95 . . . . 1.0 109.681 177.999 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . 0.676 ' C ' ' H ' ' A' ' 72' ' ' HIS . . . -80.53 -76.93 0.21 Allowed 'General case' 0 N--CA 1.473 0.685 0 N-CA-C 106.035 -1.839 . . . . 1.0 106.035 177.173 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 71' ' ' ALA . . . . . 0.471 ' O ' ' C ' ' A' ' 72' ' ' HIS . . . -42.6 0.59 0.0 OUTLIER 'General case' 0 N--CA 1.469 0.499 0 C-N-CA 124.631 1.173 . . . . 1.0 113.089 179.723 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 72' ' ' HIS . . . . . 0.676 ' H ' ' C ' ' A' ' 70' ' ' ALA . 1.2 p-80 -26.27 -58.71 0.08 Allowed 'General case' 0 C--N 1.342 0.251 0 C-N-CA 122.747 0.419 . . . . 1.0 111.541 -178.738 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 73' ' ' MET . . . . . 0.618 ' H ' ' CG ' ' A' ' 72' ' ' HIS . 49.5 mtt -75.37 -49.79 17.93 Favored 'General case' 0 C--N 1.321 -0.65 0 C-N-CA 120.545 -0.462 . . . . 1.0 109.878 177.408 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . 0.63 ' O ' ' N ' ' A' ' 76' ' ' GLY . 57.5 t -44.63 -42.07 2.19 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.167 0 CA-C-O 117.883 -1.056 . . . . 1.0 111.954 -175.409 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 75' ' ' ASN . . . . . 0.462 ' C ' ' N ' ' A' ' 77' ' ' ILE . 40.7 t30 -40.13 -14.72 0.01 OUTLIER 'General case' 0 N--CA 1.478 0.938 0 CA-C-N 121.071 1.759 . . . . 1.0 112.195 176.796 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 76' ' ' GLY . . . . . 0.63 ' N ' ' O ' ' A' ' 74' ' ' VAL . . . -45.43 -24.04 0.95 Allowed Glycine 0 CA--C 1.539 1.566 0 N-CA-C 108.734 -1.746 . . . . 1.0 108.734 178.866 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 77' ' ' ILE . . . . . 0.535 ' O ' ' N ' ' A' ' 80' ' ' ALA . 2.2 pt -89.87 -61.62 1.86 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.719 0 CA-C-N 114.261 -0.97 . . . . 1.0 110.672 -178.837 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . 0.501 ' H ' ' CG1' ' A' ' 77' ' ' ILE . 56.0 t -36.89 -29.91 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.448 -0.53 0 N-CA-C 109.267 -0.642 . . . . 1.0 109.267 -177.27 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . 0.566 ' O ' ' CB ' ' A' ' 83' ' ' ALA . 2.5 pt -64.75 -52.75 50.51 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.03 0 C-N-CA 119.151 -1.02 . . . . 1.0 109.626 178.786 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 80' ' ' ALA . . . . . 0.544 ' N ' ' CG1' ' A' ' 79' ' ' ILE . . . -55.86 -63.42 1.18 Allowed 'General case' 0 C--O 1.214 -0.768 0 C-N-CA 118.245 -1.382 . . . . 1.0 111.156 -178.489 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 47.5 mt-10 -50.1 -71.18 0.07 Allowed 'General case' 0 CA--C 1.531 0.216 0 C-N-CA 119.587 -0.845 . . . . 1.0 110.335 -179.151 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 21.2 t70 -62.88 -63.88 1.08 Allowed 'General case' 0 C--N 1.323 -0.582 0 C-N-CA 118.529 -1.268 . . . . 1.0 109.953 -177.997 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . 0.58 ' O ' ' N ' ' A' ' 85' ' ' ILE . . . -53.04 -13.97 0.54 Allowed 'General case' 0 CA--C 1.536 0.409 0 C-N-CA 118.672 -1.211 . . . . 1.0 111.043 -177.801 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . 0.485 ' N ' ' O ' ' A' ' 80' ' ' ALA . 1.0 OUTLIER -40.73 -16.54 0.01 OUTLIER 'General case' 0 C--N 1.37 1.495 0 CA-C-N 120.463 1.483 . . . . 1.0 112.047 -179.756 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 85' ' ' ILE . . . . . 0.58 ' N ' ' O ' ' A' ' 83' ' ' ALA . 19.8 pt -62.25 -41.65 92.29 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.245 0 N-CA-C 109.123 -0.695 . . . . 1.0 109.123 179.806 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 86' ' ' ALA . . . . . 0.438 ' CB ' ' CZ ' ' A' ' 52' ' ' ARG . . . -97.07 -2.7 42.74 Favored 'General case' 0 CA--C 1.539 0.523 0 C-N-CA 123.286 0.634 . . . . 1.0 112.506 179.896 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 34.1 tp10 -51.25 -20.89 1.79 Allowed 'General case' 0 C--N 1.32 -0.709 0 CA-C-N 115.307 -0.86 . . . . 1.0 109.842 -179.927 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -123.18 14.63 9.77 Favored 'General case' 0 N--CA 1.475 0.816 0 CA-C-O 121.459 0.647 . . . . 1.0 109.792 178.765 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 24.1 t -109.01 29.24 1.48 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.453 0 CA-C-N 114.579 -1.191 . . . . 1.0 109.655 177.861 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 90' ' ' GLY . . . . . 0.534 ' N ' ' CD ' ' A' ' 91' ' ' PRO . . . -68.78 -43.2 76.07 Favored Glycine 0 CA--C 1.525 0.694 0 N-CA-C 109.632 -1.387 . . . . 1.0 109.632 177.156 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 91' ' ' PRO . . . . . 0.534 ' CD ' ' N ' ' A' ' 90' ' ' GLY . 81.7 Cg_exo -45.71 -14.09 0.1 OUTLIER 'Trans proline' 0 N--CA 1.489 1.217 0 C-N-CA 121.686 1.591 . . . . 1.0 110.686 178.733 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 92' ' ' HIS . . . . . 0.654 ' CD2' HH21 ' A' ' 95' ' ' ARG . 40.9 t-80 -57.1 -17.38 10.32 Favored 'General case' 0 C--O 1.204 -1.32 0 N-CA-C 107.941 -1.133 . . . . 1.0 107.941 -179.886 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 93' ' ' LEU . . . . . 0.517 ' HG ' ' H ' ' A' ' 94' ' ' ALA . 2.9 pp -62.41 -55.7 25.33 Favored 'General case' 0 C--N 1.325 -0.468 0 N-CA-C 109.081 -0.711 . . . . 1.0 109.081 178.083 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 94' ' ' ALA . . . . . 0.517 ' H ' ' HG ' ' A' ' 93' ' ' LEU . . . -57.92 -52.52 65.14 Favored 'General case' 0 CA--C 1.513 -0.46 0 N-CA-C 108.64 -0.874 . . . . 1.0 108.64 179.476 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 95' ' ' ARG . . . . . 0.654 HH21 ' CD2' ' A' ' 92' ' ' HIS . 18.3 ttp180 -57.82 -58.37 8.65 Favored 'General case' 0 N--CA 1.446 -0.633 0 N-CA-C 106.692 -1.596 . . . . 1.0 106.692 178.482 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 96' ' ' ALA . . . . . 1.005 ' O ' ' N ' ' A' ' 98' ' ' GLY . . . -47.36 -10.95 0.02 OUTLIER 'General case' 0 C--N 1.299 -1.625 0 O-C-N 118.887 -2.383 . . . . 1.0 111.504 178.236 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 97' ' ' LEU . . . . . 0.661 ' O ' ' N ' ' A' ' 100' ' ' ILE . 3.5 pp 9.49 -45.32 0.0 OUTLIER 'General case' 0 N--CA 1.475 0.796 0 C-N-CA 124.202 1.001 . . . . 1.0 112.177 -164.879 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 98' ' ' GLY . . . . . 1.005 ' N ' ' O ' ' A' ' 96' ' ' ALA . . . -53.33 -23.71 19.64 Favored Glycine 0 C--N 1.295 -1.736 0 N-CA-C 106.423 -2.671 . . . . 1.0 106.423 173.269 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 99' ' ' GLN . . . . . 0.513 ' O ' ' SG ' ' A' ' 102' ' ' CYS . 1.1 tp-100 -58.27 -21.17 47.64 Favored 'General case' 0 C--N 1.367 1.346 0 N-CA-C 106.523 -1.658 . . . . 1.0 106.523 177.167 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 100' ' ' ILE . . . . . 0.661 ' N ' ' O ' ' A' ' 97' ' ' LEU . 84.3 mt -65.72 -42.49 92.64 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.925 0 CA-C-N 113.51 -1.677 . . . . 1.0 109.532 178.0 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 101' ' ' VAL . . . . . 0.611 HG11 ' H ' ' A' ' 102' ' ' CYS . 2.8 p -52.74 -62.84 0.55 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.383 0 C-N-CA 119.03 -1.068 . . . . 1.0 111.647 -177.055 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 102' ' ' CYS . . . . . 0.611 ' H ' HG11 ' A' ' 101' ' ' VAL . 0.8 OUTLIER -49.77 -22.5 1.44 Allowed 'General case' 0 C--N 1.316 -0.849 0 N-CA-C 112.421 0.526 . . . . 1.0 112.421 -177.572 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 60.1 ttt-85 -85.2 -46.89 10.64 Favored 'General case' 0 N--CA 1.482 1.146 0 CA-C-O 122.303 1.049 . . . . 1.0 112.344 179.584 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 104' ' ' TYR . . . . . 0.714 ' CG ' ' O ' ' A' ' 104' ' ' TYR . 0.0 OUTLIER -96.53 19.67 11.88 Favored 'General case' 0 C--N 1.308 -1.234 0 CA-C-N 113.341 -1.754 . . . . 1.0 109.539 178.591 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 105' ' ' GLY . . . . . 0.473 ' N ' ' O ' ' A' ' 101' ' ' VAL . . . -153.06 -85.28 0.05 OUTLIER Glycine 0 C--N 1.342 0.888 1 N-CA-C 102.268 -4.333 . . . . 1.0 102.268 175.955 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 106' ' ' ALA . . . . . 0.709 ' O ' ' CD ' ' A' ' 110' ' ' PRO . . . 73.99 60.41 0.08 Allowed 'General case' 0 C--O 1.206 -1.232 0 N-CA-C 115.046 1.499 . . . . 1.0 115.046 176.568 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 75.6 m -82.53 -57.38 3.37 Favored 'General case' 0 CA--C 1.548 0.887 0 O-C-N 120.859 -1.151 . . . . 1.0 109.649 179.866 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 27.2 m -66.44 -7.17 5.1 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.056 0 CA-C-O 121.565 0.698 . . . . 1.0 111.525 -179.59 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 1.5 mp -83.16 -64.18 0.25 Allowed Pre-proline 0 CA--C 1.55 0.975 0 CA-C-N 114.607 -1.179 . . . . 1.0 111.401 -179.831 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 110' ' ' PRO . . . . . 0.709 ' CD ' ' O ' ' A' ' 106' ' ' ALA . 58.6 Cg_endo -66.35 -33.95 36.7 Favored 'Trans proline' 0 N--CA 1.504 2.115 0 C-N-CA 124.407 3.405 . . . . 1.0 113.131 179.753 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 111' ' ' ASN . . . . . 0.436 ' C ' ' N ' ' A' ' 113' ' ' ASN . 39.8 t30 -66.48 -67.73 0.43 Allowed 'General case' 0 C--O 1.237 0.417 0 C-N-CA 120.61 -0.436 . . . . 1.0 110.029 -178.012 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 7.4 mm -51.93 -22.2 2.69 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.639 0 CA-C-O 122.135 0.969 . . . . 1.0 108.511 178.651 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 113' ' ' ASN . . . . . 0.456 ' O ' HG22 ' A' ' 116' ' ' ILE . 0.9 OUTLIER -61.25 -53.3 58.62 Favored 'General case' 0 C--N 1.305 -1.34 0 CA-C-N 113.358 -1.746 . . . . 1.0 108.174 -178.188 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -55.52 -29.23 58.51 Favored 'General case' 0 C--N 1.313 -1.011 0 O-C-N 120.668 -1.27 . . . . 1.0 111.775 -179.617 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -83.29 -50.09 8.74 Favored 'General case' 0 C--O 1.212 -0.89 0 CA-C-O 121.777 0.798 . . . . 1.0 111.584 177.527 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 116' ' ' ILE . . . . . 0.556 ' CG2' ' N ' ' A' ' 117' ' ' GLU . 1.5 tp -46.21 -53.93 2.27 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.704 0 CA-C-N 114.194 -1.367 . . . . 1.0 107.676 -179.005 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 117' ' ' GLU . . . . . 0.556 ' N ' ' CG2' ' A' ' 116' ' ' ILE . 44.2 tt0 -40.05 -50.95 2.6 Favored 'General case' 0 N--CA 1.478 0.928 0 N-CA-C 105.034 -2.21 . . . . 1.0 105.034 -178.812 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 43.3 t -70.26 -53.16 24.39 Favored 'Isoleucine or valine' 0 CA--C 1.558 1.286 0 CA-C-N 113.3 -1.773 . . . . 1.0 111.08 178.192 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -59.65 -24.87 64.22 Favored 'General case' 0 N--CA 1.482 1.138 0 N-CA-C 115.145 1.535 . . . . 1.0 115.145 -177.268 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -135.71 -48.43 0.08 OUTLIER Glycine 0 CA--C 1.542 1.759 0 CA-C-N 120.418 1.463 . . . . 1.0 113.035 177.234 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 1.2 m 160.56 -39.38 0.0 OUTLIER 'General case' 0 N--CA 1.468 0.472 0 N-CA-C 101.414 -3.55 . . . . 1.0 101.414 -177.268 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 122' ' ' GLY . . . . . 0.441 ' O ' ' N ' ' A' ' 124' ' ' ASP . . . 115.06 -32.89 5.57 Favored Glycine 0 CA--C 1.526 0.748 0 CA-C-N 111.114 -2.766 . . . . 1.0 116.869 175.638 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 123' ' ' THR . . . . . 0.44 ' C ' ' O ' ' A' ' 122' ' ' GLY . 43.8 m -40.63 98.35 0.01 OUTLIER 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 121.225 2.513 . . . . 1.0 112.967 -178.661 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 124' ' ' ASP . . . . . 0.441 ' N ' ' O ' ' A' ' 122' ' ' GLY . 31.8 m-20 -137.21 138.4 40.13 Favored 'General case' 0 N--CA 1.465 0.284 0 N-CA-C 107.207 -1.405 . . . . 1.0 107.207 177.112 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 125' ' ' TYR . . . . . 0.47 ' O ' ' CD1' ' A' ' 125' ' ' TYR . 0.1 OUTLIER -155.34 153.74 30.96 Favored 'General case' 0 CA--C 1.537 0.481 0 CA-C-O 121.18 0.514 . . . . 1.0 110.719 -179.581 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 126' ' ' ARG . . . . . 0.572 HH22 ' NH2' ' A' ' 52' ' ' ARG . 4.4 mtp85 -150.42 153.89 36.75 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.324 -0.853 . . . . 1.0 111.506 177.467 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 127' ' ' PHE . . . . . . . . . . . . . 47.3 p90 . . . . . 0 C--O 1.22 -0.451 0 CA-C-O 117.931 -1.033 . . . . 1.0 110.489 -179.474 . . . . . . . . 0 0 . 1 . 021 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 20.1 mmt . . . . . 0 N--CA 1.493 1.679 0 N-CA-C 108.779 -0.822 . . . . 1.0 108.779 . . . . . . . . . 0 0 . 1 . 021 nuclear orig core ' A' A ' 2' ' ' SER . . . . . 0.431 ' O ' ' OD2' ' A' ' 3' ' ' ASP . 50.6 m -107.77 8.78 29.0 Favored 'General case' 0 N--CA 1.466 0.329 0 C-N-CA 122.322 0.249 . . . . 1.0 110.544 179.943 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 3' ' ' ASP . . . . . 0.431 ' OD2' ' O ' ' A' ' 2' ' ' SER . 0.4 OUTLIER 169.59 93.99 0.0 OUTLIER 'General case' 0 CA--C 1.534 0.338 0 N-CA-C 110.284 -0.265 . . . . 1.0 110.284 179.966 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 70.4 t80 -150.15 144.53 25.74 Favored 'General case' 0 N--CA 1.466 0.353 0 N-CA-C 110.228 -0.286 . . . . 1.0 110.228 179.587 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 47.9 m-20 -153.07 149.26 27.94 Favored 'General case' 0 N--CA 1.465 0.309 0 N-CA-C 110.233 -0.284 . . . . 1.0 110.233 179.888 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 6' ' ' THR . . . . . 0.649 ' O ' ' N ' ' A' ' 10' ' ' SER . 11.2 m -69.07 174.48 4.52 Favored 'General case' 0 C--O 1.205 -1.267 0 N-CA-C 109.793 -0.447 . . . . 1.0 109.793 179.774 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . 0.576 ' O ' ' N ' ' A' ' 11' ' ' ARG . 39.6 tt0 -61.55 -55.59 29.28 Favored 'General case' 0 C--N 1.317 -0.847 0 CA-C-O 121.475 0.655 . . . . 1.0 110.349 -177.822 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 8' ' ' ARG . . . . . 0.544 ' O ' ' CB ' ' A' ' 12' ' ' ALA . 7.4 ttp-105 -51.27 -57.81 7.86 Favored 'General case' 0 C--O 1.209 -1.072 0 N-CA-C 107.788 -1.19 . . . . 1.0 107.788 -178.188 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . 0.47 ' O ' ' CG1' ' A' ' 13' ' ' VAL . 0.0 OUTLIER -66.14 -47.0 86.19 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.071 0 CA-C-N 114.435 -1.257 . . . . 1.0 110.99 179.554 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 10' ' ' SER . . . . . 0.649 ' N ' ' O ' ' A' ' 6' ' ' THR . 35.4 t -62.93 -59.06 5.35 Favored 'General case' 0 N--CA 1.482 1.155 0 N-CA-C 108.582 -0.895 . . . . 1.0 108.582 179.636 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 11' ' ' ARG . . . . . 0.576 ' N ' ' O ' ' A' ' 7' ' ' GLU . 20.9 ttm180 -66.09 -55.06 18.4 Favored 'General case' 0 C--N 1.314 -0.944 0 O-C-N 121.732 -0.605 . . . . 1.0 110.815 -178.06 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . 0.544 ' CB ' ' O ' ' A' ' 8' ' ' ARG . . . -49.64 -53.31 24.93 Favored 'General case' 0 N--CA 1.485 1.276 0 C-N-CA 118.467 -1.293 . . . . 1.0 108.043 -176.566 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . 0.62 ' O ' ' N ' ' A' ' 17' ' ' LEU . 4.5 m -60.58 -47.34 93.25 Favored 'Isoleucine or valine' 0 C--O 1.203 -1.377 0 C-N-CA 118.067 -1.453 . . . . 1.0 107.342 178.204 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . 0.475 ' O ' HG22 ' A' ' 18' ' ' VAL . . . -56.31 -62.11 1.94 Allowed 'General case' 0 C--O 1.206 -1.201 0 C-N-CA 117.062 -1.855 . . . . 1.0 109.706 179.645 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . 0.595 ' O ' ' N ' ' A' ' 19' ' ' GLY . . . -54.14 -56.26 19.91 Favored 'General case' 0 N--CA 1.472 0.659 0 CA-C-O 121.474 0.654 . . . . 1.0 110.097 -178.246 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . 0.427 ' N ' ' O ' ' A' ' 12' ' ' ALA . . . -62.28 -56.01 22.68 Favored 'General case' 0 CA--C 1.552 1.037 0 CA-C-N 115.25 -0.886 . . . . 1.0 109.281 -179.419 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . 0.62 ' N ' ' O ' ' A' ' 13' ' ' VAL . 4.3 tt -57.17 -52.43 65.36 Favored 'General case' 0 N--CA 1.484 1.244 0 CA-C-N 114.675 -1.148 . . . . 1.0 108.275 -177.965 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . 0.684 HG22 ' H ' ' A' ' 19' ' ' GLY . 2.8 m -69.26 -57.87 7.29 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.349 0 C-N-CA 119.737 -0.785 . . . . 1.0 109.806 179.095 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . 0.684 ' H ' HG22 ' A' ' 18' ' ' VAL . . . -59.86 -175.84 1.08 Allowed Glycine 0 N--CA 1.447 -0.585 0 N-CA-C 111.106 -0.798 . . . . 1.0 111.106 -179.261 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 20' ' ' PRO . . . . . 0.576 ' O ' ' N ' ' A' ' 24' ' ' ALA . 36.8 Cg_endo -83.47 -26.79 2.01 Favored 'Trans proline' 0 C--N 1.299 -2.044 0 C-N-CA 122.658 2.239 . . . . 1.0 112.988 -178.507 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -59.02 -58.65 13.41 Favored Glycine 0 N--CA 1.475 1.25 0 C-N-CA 120.066 -1.064 . . . . 1.0 111.536 -176.995 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -55.96 -51.59 54.46 Favored Glycine 0 N--CA 1.474 1.23 0 N-CA-C 106.981 -2.448 . . . . 1.0 106.981 -178.158 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 47.9 t -59.56 -31.54 47.04 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.427 0 N-CA-C 108.735 -0.839 . . . . 1.0 108.735 178.792 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . 0.576 ' N ' ' O ' ' A' ' 20' ' ' PRO . . . -58.17 -63.09 1.38 Allowed 'General case' 0 C--N 1.348 0.502 0 C-N-CA 118.858 -1.137 . . . . 1.0 110.659 -178.742 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -64.52 -43.37 94.28 Favored 'General case' 0 CA--C 1.517 -0.309 0 C-N-CA 119.858 -0.737 . . . . 1.0 111.814 -178.1 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 93.0 t -59.59 -59.63 3.64 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.544 0 C-N-CA 118.818 -1.153 . . . . 1.0 110.102 -177.927 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER -58.87 -34.76 53.33 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 O-C-N 122.235 -0.291 . . . . 1.0 111.1 -178.283 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 37.5 ttpt -67.16 -55.85 12.41 Favored 'General case' 0 C--N 1.325 -0.482 0 N-CA-C 109.391 -0.596 . . . . 1.0 109.391 -179.297 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 42.2 t -62.24 -47.82 91.32 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.605 0 CA-C-N 115.162 -0.926 . . . . 1.0 109.989 -179.07 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 30' ' ' CYS . . . . . . . . . . . . . 0.7 OUTLIER -67.47 -62.53 1.38 Allowed 'General case' 0 N--CA 1.446 -0.628 0 C-N-CA 119.052 -1.059 . . . . 1.0 110.841 -179.098 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -60.3 -51.61 68.82 Favored 'General case' 0 CA--C 1.506 -0.737 0 O-C-N 122.055 -0.403 . . . . 1.0 111.091 -176.697 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . 0.452 ' O ' ' HB2' ' A' ' 33' ' ' LEU . . . 84.66 75.04 1.23 Allowed Glycine 0 N--CA 1.442 -0.941 0 N-CA-C 109.828 -1.309 . . . . 1.0 109.828 -178.662 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . 0.452 ' HB2' ' O ' ' A' ' 32' ' ' GLY . 0.9 OUTLIER 87.21 100.39 0.03 OUTLIER Pre-proline 0 CA--C 1.549 0.917 0 C-N-CA 124.015 0.926 . . . . 1.0 110.654 -179.238 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 58.6 Cg_endo -71.4 -31.51 13.87 Favored 'Trans proline' 0 N--CA 1.502 1.997 0 C-N-CA 121.925 1.75 . . . . 1.0 114.807 -178.652 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -58.02 -58.96 11.85 Favored Glycine 0 N--CA 1.472 1.077 0 C-N-CA 118.466 -1.826 . . . . 1.0 108.957 -178.4 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . 0.542 ' O ' ' CB ' ' A' ' 37' ' ' ILE . 7.9 p -93.43 165.89 1.86 Allowed 'Isoleucine or valine' 0 CA--C 1.514 -0.415 0 N-CA-C 106.75 -1.574 . . . . 1.0 106.75 177.318 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . 0.542 ' CB ' ' O ' ' A' ' 36' ' ' VAL . 8.8 tp 115.81 121.57 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.476 0.842 0 O-C-N 124.523 1.139 . . . . 1.0 110.244 -179.841 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 0.9 OUTLIER -143.33 135.8 27.29 Favored 'General case' 0 CA--C 1.533 0.293 0 N-CA-C 109.146 -0.687 . . . . 1.0 109.146 179.461 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 10.4 m -111.47 111.2 55.11 Favored Pre-proline 0 N--CA 1.468 0.444 0 N-CA-C 109.55 -0.537 . . . . 1.0 109.55 179.266 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 40' ' ' PRO . . . . . 0.413 ' HB2' ' H ' ' A' ' 41' ' ' ALA . 72.1 Cg_exo -43.09 -85.83 0.01 OUTLIER 'Trans proline' 0 N--CA 1.491 1.366 0 C-N-CA 121.662 1.575 . . . . 1.0 112.834 -178.637 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . 0.413 ' H ' ' HB2' ' A' ' 40' ' ' PRO . . . -67.28 120.15 13.34 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 116.108 -0.496 . . . . 1.0 111.313 -177.784 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 3.6 ptm180 -174.04 175.39 2.77 Favored 'General case' 0 N--CA 1.448 -0.563 0 CA-C-N 116.101 -0.499 . . . . 1.0 110.01 178.46 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 5.3 tpt85 -57.53 -43.35 84.27 Favored 'General case' 0 C--N 1.32 -0.691 0 N-CA-C 107.452 -1.314 . . . . 1.0 107.452 179.919 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . 0.43 ' O ' ' CD1' ' A' ' 45' ' ' PHE . . . 121.5 -21.55 8.05 Favored Glycine 0 N--CA 1.465 0.613 0 N-CA-C 110.715 -0.954 . . . . 1.0 110.715 -179.127 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . 0.528 ' O ' ' HB2' ' A' ' 46' ' ' PHE . 42.6 m-85 -150.34 153.82 36.74 Favored 'General case' 0 C--O 1.216 -0.707 0 N-CA-C 109.006 -0.739 . . . . 1.0 109.006 177.795 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 46' ' ' PHE . . . . . 0.609 ' O ' ' NE ' ' A' ' 47' ' ' ARG . 8.6 m-85 128.59 96.33 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.582 0 O-C-N 124.939 1.399 . . . . 1.0 110.287 -179.933 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 47' ' ' ARG . . . . . 0.609 ' NE ' ' O ' ' A' ' 46' ' ' PHE . 0.7 OUTLIER 110.1 160.85 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.503 0 C-N-CA 125.464 1.506 . . . . 1.0 109.884 -179.809 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 0.9 OUTLIER 67.8 70.64 0.34 Allowed 'General case' 0 C--O 1.224 -0.246 0 N-CA-C 108.811 -0.811 . . . . 1.0 108.811 -178.455 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 49' ' ' ASN . . . . . 0.606 ' O ' ' N ' ' A' ' 51' ' ' GLU . 39.4 m-80 -136.13 129.37 17.93 Favored Pre-proline 0 CA--C 1.534 0.364 0 O-C-N 121.787 -0.571 . . . . 1.0 109.509 -178.979 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 50' ' ' PRO . . . . . 0.453 ' C ' ' H ' ' A' ' 52' ' ' ARG . 68.8 Cg_exo -46.75 74.57 0.01 OUTLIER 'Trans proline' 0 N--CA 1.498 1.78 0 C-N-CA 121.964 1.776 . . . . 1.0 113.476 179.927 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . 0.606 ' N ' ' O ' ' A' ' 49' ' ' ASN . 7.4 mm-40 48.84 14.09 0.07 Allowed 'General case' 0 C--N 1.331 -0.209 0 O-C-N 121.867 -0.521 . . . . 1.0 110.999 179.408 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . 0.453 ' H ' ' C ' ' A' ' 50' ' ' PRO . 1.4 ptp180 -116.45 162.23 17.88 Favored 'General case' 0 N--CA 1.472 0.65 0 CA-C-N 116.554 -0.294 . . . . 1.0 110.874 -179.573 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 19.4 tt -71.25 136.54 25.63 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.779 0 CA-C-O 123.508 1.623 . . . . 1.0 115.325 -177.146 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 54' ' ' GLN . . . . . 0.601 ' CG ' HD22 ' A' ' 49' ' ' ASN . 0.5 OUTLIER -74.93 87.6 2.31 Favored 'General case' 0 C--N 1.314 -0.973 0 CA-C-N 110.233 -3.167 . . . . 1.0 110.247 -178.985 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . 0.425 ' CG2' ' N ' ' A' ' 56' ' ' GLY . 5.9 mm -146.05 156.9 12.19 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.789 0 CA-C-N 115.703 -0.681 . . . . 1.0 109.883 177.495 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . 0.425 ' N ' ' CG2' ' A' ' 55' ' ' ILE . . . 110.52 -2.29 29.28 Favored Glycine 0 N--CA 1.475 1.243 0 N-CA-C 111.379 -0.688 . . . . 1.0 111.379 -179.897 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 13.9 p-10 -87.44 104.95 16.94 Favored 'General case' 0 N--CA 1.466 0.357 0 CA-C-O 121.396 0.617 . . . . 1.0 111.435 -179.815 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 58' ' ' TRP . . . . . . . . . . . . . 9.0 m0 -89.14 171.56 9.73 Favored 'General case' 0 CA--C 1.567 1.603 0 CA-C-O 122.941 1.353 . . . . 1.0 112.354 -178.634 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -76.83 -61.71 1.88 Allowed 'General case' 0 N--CA 1.49 1.556 0 CA-C-N 111.12 -2.764 . . . . 1.0 113.902 -176.941 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 4.0 t80 -90.56 -9.03 48.64 Favored 'General case' 0 N--CA 1.484 1.23 0 CA-C-O 122.348 1.07 . . . . 1.0 112.753 -179.295 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . 0.477 ' O ' ' N ' ' A' ' 65' ' ' ASP . 2.7 tt0 -78.45 -14.48 59.35 Favored 'General case' 0 C--N 1.306 -1.3 0 CA-C-N 114.895 -1.048 . . . . 1.0 110.291 -179.637 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 62' ' ' VAL . . . . . 0.627 ' O ' ' N ' ' A' ' 66' ' ' GLY . 11.1 m -48.26 -55.79 2.63 Favored 'Isoleucine or valine' 0 C--O 1.204 -1.295 0 C-N-CA 119.566 -0.854 . . . . 1.0 109.241 -176.723 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 63' ' ' ALA . . . . . 0.427 ' O ' ' CG ' ' A' ' 67' ' ' ARG . . . -63.26 -54.65 34.01 Favored 'General case' 0 C--N 1.297 -1.677 0 O-C-N 121.588 -0.695 . . . . 1.0 109.359 179.438 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -50.56 -59.5 3.97 Favored 'General case' 0 CA--C 1.545 0.786 0 CA-C-N 115.342 -0.845 . . . . 1.0 110.234 -179.342 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 65' ' ' ASP . . . . . 0.579 ' C ' ' H ' ' A' ' 67' ' ' ARG . 26.8 t70 -72.42 -50.82 23.61 Favored 'General case' 0 C--N 1.312 -1.049 0 CA-C-O 121.91 0.862 . . . . 1.0 111.504 178.77 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . 0.627 ' N ' ' O ' ' A' ' 62' ' ' VAL . . . -69.96 29.5 0.41 Allowed Glycine 0 C--O 1.227 -0.329 0 O-C-N 120.986 -1.071 . . . . 1.0 111.046 177.661 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 67' ' ' ARG . . . . . 0.608 ' O ' ' N ' ' A' ' 69' ' ' LEU . 0.0 OUTLIER -77.96 8.41 4.73 Favored 'General case' 0 C--N 1.316 -0.856 0 N-CA-C 107.984 -1.117 . . . . 1.0 107.984 176.877 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . 0.492 ' CD2' ' O ' ' A' ' 66' ' ' GLY . 1.5 pt? -34.19 -27.96 0.01 OUTLIER 'General case' 0 N--CA 1.483 1.218 0 CA-C-O 121.757 0.789 . . . . 1.0 108.88 -178.158 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . 0.608 ' N ' ' O ' ' A' ' 67' ' ' ARG . 1.3 mt -64.57 -65.15 0.71 Allowed 'General case' 0 N--CA 1.473 0.715 0 C-N-CA 118.833 -1.147 . . . . 1.0 107.918 178.761 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . 0.667 ' C ' ' H ' ' A' ' 72' ' ' HIS . . . -78.22 -75.09 0.24 Allowed 'General case' 0 N--CA 1.469 0.494 0 N-CA-C 105.108 -2.182 . . . . 1.0 105.108 176.919 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 71' ' ' ALA . . . . . 0.46 ' O ' ' C ' ' A' ' 72' ' ' HIS . . . -44.87 4.1 0.0 OUTLIER 'General case' 0 CA--C 1.52 -0.209 0 C-N-CA 124.694 1.197 . . . . 1.0 113.425 178.57 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 72' ' ' HIS . . . . . 0.763 ' CD2' ' H ' ' A' ' 73' ' ' MET . 1.5 p80 -28.22 -55.05 0.11 Allowed 'General case' 0 C--N 1.335 -0.065 0 CA-C-N 118.067 0.394 . . . . 1.0 111.967 -179.408 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 73' ' ' MET . . . . . 0.763 ' H ' ' CD2' ' A' ' 72' ' ' HIS . 3.8 ppp? -76.84 -53.5 7.82 Favored 'General case' 0 C--N 1.316 -0.858 0 N-CA-C 108.483 -0.932 . . . . 1.0 108.483 177.278 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . 0.725 ' O ' ' N ' ' A' ' 76' ' ' GLY . 65.8 t -44.51 -41.87 2.1 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.424 0 CA-C-O 117.748 -1.12 . . . . 1.0 110.775 -176.122 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 75' ' ' ASN . . . . . 0.533 ' C ' ' N ' ' A' ' 77' ' ' ILE . 1.8 t-20 -35.09 -14.58 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.7 0 CA-C-N 120.857 1.662 . . . . 1.0 112.836 178.403 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 76' ' ' GLY . . . . . 0.725 ' N ' ' O ' ' A' ' 74' ' ' VAL . . . -44.04 -19.21 0.11 Allowed Glycine 0 CA--C 1.543 1.82 0 N-CA-C 107.846 -2.102 . . . . 1.0 107.846 175.917 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 77' ' ' ILE . . . . . 0.548 HG13 ' H ' ' A' ' 78' ' ' VAL . 0.8 OUTLIER -72.11 -54.98 14.85 Favored 'Isoleucine or valine' 0 C--O 1.207 -1.138 0 N-CA-C 107.683 -1.228 . . . . 1.0 107.683 178.267 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . 0.548 ' H ' HG13 ' A' ' 77' ' ' ILE . 55.5 t -33.52 -37.51 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.314 -0.973 0 CA-C-N 113.252 -1.795 . . . . 1.0 106.849 -178.391 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . 0.527 ' N ' ' O ' ' A' ' 77' ' ' ILE . 23.7 pt -97.77 -34.49 4.76 Favored 'Isoleucine or valine' 0 C--O 1.207 -1.146 0 CA-C-N 115.287 -0.869 . . . . 1.0 112.005 176.846 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 80' ' ' ALA . . . . . 0.501 ' N ' ' O ' ' A' ' 77' ' ' ILE . . . -84.78 -9.35 58.27 Favored 'General case' 0 N--CA 1.482 1.151 0 O-C-N 120.955 -1.091 . . . . 1.0 113.588 179.674 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 81' ' ' GLU . . . . . 0.495 ' N ' ' O ' ' A' ' 77' ' ' ILE . 82.3 tt0 -90.63 -75.77 0.45 Allowed 'General case' 0 N--CA 1.453 -0.314 0 N-CA-C 113.572 0.953 . . . . 1.0 113.572 -176.769 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 6.7 m-20 -91.04 -16.71 27.46 Favored 'General case' 0 C--O 1.22 -0.45 0 N-CA-C 113.463 0.912 . . . . 1.0 113.463 -179.141 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . 0.527 ' O ' ' N ' ' A' ' 86' ' ' ALA . . . -46.7 -42.21 16.24 Favored 'General case' 0 C--O 1.22 -0.479 0 C-N-CA 119.369 -0.933 . . . . 1.0 111.348 -177.681 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 14.3 tp -37.46 -46.02 0.77 Allowed 'General case' 0 N--CA 1.47 0.55 0 CA-C-O 121.48 0.657 . . . . 1.0 110.613 -178.349 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -65.46 -37.1 79.24 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.855 0 CA-C-N 114.75 -1.114 . . . . 1.0 110.564 -179.127 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 86' ' ' ALA . . . . . 0.542 ' O ' ' N ' ' A' ' 89' ' ' VAL . . . -90.61 -26.03 19.86 Favored 'General case' 0 C--O 1.222 -0.372 0 CA-C-O 120.641 0.258 . . . . 1.0 111.668 -179.762 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 87' ' ' GLU . . . . . 0.426 ' N ' ' O ' ' A' ' 83' ' ' ALA . 30.6 tp10 -54.71 -24.94 24.33 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 121.423 0.63 . . . . 1.0 109.659 -179.068 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -72.25 -8.56 55.48 Favored 'General case' 0 C--N 1.324 -0.503 0 N-CA-C 107.823 -1.177 . . . . 1.0 107.823 178.89 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 89' ' ' VAL . . . . . 0.542 ' N ' ' O ' ' A' ' 86' ' ' ALA . 3.2 t -92.49 36.03 0.1 OUTLIER 'Isoleucine or valine' 0 C--N 1.315 -0.909 0 CA-C-N 112.759 -2.019 . . . . 1.0 107.414 177.478 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 90' ' ' GLY . . . . . 0.902 ' O ' ' N ' ' A' ' 92' ' ' HIS . . . -55.82 -25.27 44.09 Favored Glycine 0 C--N 1.366 2.237 0 CA-C-O 117.346 -1.808 . . . . 1.0 112.082 176.955 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 91' ' ' PRO . . . . . 0.667 ' HD2' ' N ' ' A' ' 90' ' ' GLY . 20.8 Cg_exo -32.99 1.28 0.0 OUTLIER 'Trans proline' 0 N--CA 1.496 1.641 0 C-N-CA 123.41 2.74 . . . . 1.0 113.526 173.295 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 92' ' ' HIS . . . . . 0.902 ' N ' ' O ' ' A' ' 90' ' ' GLY . 0.0 OUTLIER -49.82 -33.27 16.2 Favored 'General case' 0 N--CA 1.431 -1.412 0 N-CA-C 106.91 -1.515 . . . . 1.0 106.91 178.346 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 24.8 tp -59.8 -57.1 14.35 Favored 'General case' 0 N--CA 1.453 -0.284 0 N-CA-C 107.537 -1.283 . . . . 1.0 107.537 177.396 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -51.72 -53.9 34.2 Favored 'General case' 0 C--N 1.323 -0.561 0 N-CA-C 107.953 -1.128 . . . . 1.0 107.953 -178.955 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 6.2 mmp_? -64.81 -32.93 74.85 Favored 'General case' 0 N--CA 1.47 0.562 0 CA-C-O 121.894 0.854 . . . . 1.0 110.911 178.225 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 96' ' ' ALA . . . . . 0.811 ' O ' ' N ' ' A' ' 100' ' ' ILE . . . -48.16 -39.2 20.02 Favored 'General case' 0 N--CA 1.493 1.711 0 N-CA-C 105.489 -2.041 . . . . 1.0 105.489 -177.31 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 97' ' ' LEU . . . . . 0.451 ' C ' ' O ' ' A' ' 96' ' ' ALA . 1.6 tm? -33.14 -24.34 0.0 OUTLIER 'General case' 0 CA--C 1.576 1.957 0 CA-C-N 112.693 -2.049 . . . . 1.0 107.219 -179.798 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 98' ' ' GLY . . . . . 0.722 ' N ' ' O ' ' A' ' 96' ' ' ALA . . . -90.04 -53.69 2.31 Favored Glycine 0 CA--C 1.557 2.665 0 CA-C-O 123.033 1.352 . . . . 1.0 111.796 171.226 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 99' ' ' GLN . . . . . 0.6 ' N ' ' O ' ' A' ' 96' ' ' ALA . 0.1 OUTLIER -77.97 8.02 5.27 Favored 'General case' 0 N--CA 1.443 -0.803 0 N-CA-C 107.458 -1.312 . . . . 1.0 107.458 177.691 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 100' ' ' ILE . . . . . 0.811 ' N ' ' O ' ' A' ' 96' ' ' ALA . 3.8 tp -61.73 -52.03 65.71 Favored 'Isoleucine or valine' 0 CA--C 1.48 -1.744 0 N-CA-C 107.076 -1.453 . . . . 1.0 107.076 179.416 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 101' ' ' VAL . . . . . 0.596 ' O ' ' N ' ' A' ' 105' ' ' GLY . 62.7 t -52.93 -57.09 5.07 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 N-CA-C 106.464 -1.68 . . . . 1.0 106.464 177.654 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 102' ' ' CYS . . . . . 0.417 ' O ' ' CB ' ' A' ' 106' ' ' ALA . 0.0 OUTLIER -46.43 -19.8 0.09 Allowed 'General case' 0 CA--C 1.541 0.606 0 C-N-CA 120.038 -0.665 . . . . 1.0 109.423 -179.226 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 103' ' ' ARG . . . . . 0.563 HH21 ' CB ' ' A' ' 96' ' ' ALA . 11.4 mtm-85 -94.13 -48.28 6.28 Favored 'General case' 0 N--CA 1.474 0.763 0 N-CA-C 113.793 1.035 . . . . 1.0 113.793 178.228 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 104' ' ' TYR . . . . . 0.57 ' CG ' ' O ' ' A' ' 104' ' ' TYR . 60.8 t80 -103.92 21.44 16.33 Favored 'General case' 0 C--N 1.32 -0.706 0 C-N-CA 125.724 1.61 . . . . 1.0 110.895 -179.73 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 105' ' ' GLY . . . . . 0.596 ' N ' ' O ' ' A' ' 101' ' ' VAL . . . -165.08 -8.03 0.03 OUTLIER Glycine 0 N--CA 1.453 -0.169 0 C-N-CA 119.606 -1.283 . . . . 1.0 111.072 -179.8 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 106' ' ' ALA . . . . . 0.464 ' C ' ' O ' ' A' ' 105' ' ' GLY . . . -28.72 117.65 0.11 Allowed 'General case' 0 CA--C 1.534 0.362 0 C-N-CA 122.117 0.167 . . . . 1.0 111.06 178.671 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 107' ' ' THR . . . . . 0.883 ' O ' ' HD2' ' A' ' 110' ' ' PRO . 6.6 m -135.7 -58.35 0.77 Allowed 'General case' 0 C--O 1.195 -1.777 0 N-CA-C 107.787 -1.19 . . . . 1.0 107.787 178.616 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 26.9 m -70.28 28.66 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.312 -1.061 0 O-C-N 120.735 -1.228 . . . . 1.0 108.847 -178.39 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 109' ' ' ILE . . . . . 0.578 ' H ' ' CD ' ' A' ' 110' ' ' PRO . 0.0 OUTLIER -111.01 -45.18 0.08 OUTLIER Pre-proline 0 CA--C 1.55 0.969 0 O-C-N 121.834 -0.542 . . . . 1.0 110.277 178.86 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 110' ' ' PRO . . . . . 0.883 ' HD2' ' O ' ' A' ' 107' ' ' THR . 24.6 Cg_exo -66.72 -29.12 43.26 Favored 'Trans proline' 0 N--CA 1.496 1.675 0 C-N-CA 123.453 2.769 . . . . 1.0 111.262 -178.7 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 4.9 t30 -68.35 -68.47 0.39 Allowed 'General case' 0 N--CA 1.455 -0.211 0 C-N-CA 120.405 -0.518 . . . . 1.0 109.847 -178.763 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 21.3 pt -51.39 -28.57 8.15 Favored 'Isoleucine or valine' 0 C--O 1.217 -0.61 0 CA-C-O 122.623 1.202 . . . . 1.0 109.367 179.09 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 1.6 t30 -59.25 -51.89 68.01 Favored 'General case' 0 C--N 1.294 -1.814 0 CA-C-N 112.62 -2.082 . . . . 1.0 107.752 -177.855 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -59.59 -32.69 70.62 Favored 'General case' 0 N--CA 1.45 -0.464 0 N-CA-C 112.368 0.507 . . . . 1.0 112.368 -179.646 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -80.81 -53.47 6.46 Favored 'General case' 0 C--O 1.21 -0.977 0 CA-C-O 121.7 0.762 . . . . 1.0 110.398 178.141 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 116' ' ' ILE . . . . . 0.524 ' O ' ' N ' ' A' ' 120' ' ' GLY . 28.5 mt -50.32 -61.26 0.65 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.707 0 CA-C-N 114.143 -1.39 . . . . 1.0 108.6 -178.823 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 117' ' ' GLU . . . . . 0.422 ' C ' ' O ' ' A' ' 116' ' ' ILE . 49.2 mt-10 -42.16 -52.83 4.24 Favored 'General case' 0 C--N 1.307 -1.274 0 CA-C-N 112.239 -2.255 . . . . 1.0 106.791 -177.969 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 94.6 t -60.63 -53.05 54.3 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.492 0 N-CA-C 108.355 -0.98 . . . . 1.0 108.355 177.187 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 2.9 tp -51.29 -69.38 0.11 Allowed 'General case' 0 CA--C 1.536 0.414 0 N-CA-C 106.687 -1.597 . . . . 1.0 106.687 -178.775 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 120' ' ' GLY . . . . . 0.658 ' O ' ' OG1' ' A' ' 121' ' ' THR . . . -73.05 -84.59 0.25 Allowed Glycine 0 CA--C 1.537 1.419 0 C-N-CA 119.356 -1.402 . . . . 1.0 111.102 -179.555 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 121' ' ' THR . . . . . 0.658 ' OG1' ' O ' ' A' ' 120' ' ' GLY . 41.6 m 170.37 -39.72 0.0 OUTLIER 'General case' 0 N--CA 1.476 0.862 0 CA-C-N 113.649 -1.276 . . . . 1.0 112.67 179.156 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 122' ' ' GLY . . . . . 0.695 ' O ' ' N ' ' A' ' 124' ' ' ASP . . . 100.6 -18.78 54.64 Favored Glycine 0 N--CA 1.469 0.836 0 N-CA-C 106.815 -2.514 . . . . 1.0 106.815 -176.242 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 123' ' ' THR . . . . . 0.475 ' O ' ' CG2' ' A' ' 123' ' ' THR . 8.9 t -52.52 83.74 0.0 OUTLIER 'General case' 0 N--CA 1.477 0.875 0 N-CA-C 104.733 -2.321 . . . . 1.0 104.733 178.414 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 124' ' ' ASP . . . . . 0.695 ' N ' ' O ' ' A' ' 122' ' ' GLY . 4.9 m-20 -171.49 -175.43 1.61 Allowed 'General case' 0 CA--C 1.53 0.181 0 CA-C-N 113.976 -1.465 . . . . 1.0 111.434 179.523 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 125' ' ' TYR . . . . . . . . . . . . . 78.4 t80 -145.98 144.71 30.28 Favored 'General case' 0 CA--C 1.538 0.483 0 CA-C-N 114.749 -1.114 . . . . 1.0 109.011 175.813 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 36.4 mmt-85 -146.34 147.02 30.9 Favored 'General case' 0 N--CA 1.474 0.727 0 N-CA-C 109.794 -0.447 . . . . 1.0 109.794 179.848 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 127' ' ' PHE . . . . . 0.412 ' CD1' ' C ' ' A' ' 127' ' ' PHE . 0.1 OUTLIER . . . . . 0 C--O 1.221 -0.412 0 CA-C-O 117.937 -1.03 . . . . 1.0 110.558 179.328 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 13.8 mmt . . . . . 0 N--CA 1.496 1.837 0 N-CA-C 109.691 -0.485 . . . . 1.0 109.691 . . . . . . . . . 0 0 . 1 . 022 nuclear orig core ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 98.1 p -106.35 9.44 31.86 Favored 'General case' 0 N--CA 1.469 0.482 0 CA-C-N 115.945 -0.57 . . . . 1.0 110.455 -179.946 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER 166.29 97.1 0.0 OUTLIER 'General case' 0 N--CA 1.466 0.362 0 CA-C-N 116.019 -0.537 . . . . 1.0 110.451 179.382 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 85.2 t80 -149.26 144.98 26.85 Favored 'General case' 0 N--CA 1.466 0.343 0 CA-C-N 116.053 -0.522 . . . . 1.0 110.104 179.441 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 5' ' ' ASP . . . . . 0.445 ' N ' ' OD1' ' A' ' 5' ' ' ASP . 5.1 p30 -153.54 148.65 26.8 Favored 'General case' 0 C--N 1.33 -0.274 0 N-CA-C 109.997 -0.372 . . . . 1.0 109.997 -179.761 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 6' ' ' THR . . . . . 0.63 ' O ' ' N ' ' A' ' 10' ' ' SER . 0.2 OUTLIER -70.87 177.15 3.79 Favored 'General case' 0 C--O 1.211 -0.95 0 C-N-CA 120.337 -0.545 . . . . 1.0 110.038 -179.979 . . . . . . . . 3 3 . 1 . 022 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . 0.549 ' O ' ' N ' ' A' ' 11' ' ' ARG . 0.6 OUTLIER -59.62 -55.46 34.18 Favored 'General case' 0 C--N 1.317 -0.845 0 CA-C-O 121.566 0.698 . . . . 1.0 109.804 -178.436 . . . . . . . . 3 3 . 1 . 022 nuclear orig core ' A' A ' 8' ' ' ARG . . . . . 0.462 ' O ' ' CB ' ' A' ' 12' ' ' ALA . 0.2 OUTLIER -51.61 -57.11 10.06 Favored 'General case' 0 C--N 1.318 -0.761 0 N-CA-C 107.613 -1.255 . . . . 1.0 107.613 -178.182 . . . . . . . . 3 3 . 1 . 022 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . 0.533 ' O ' ' CG1' ' A' ' 13' ' ' VAL . 0.0 OUTLIER -66.26 -47.9 82.87 Favored 'Isoleucine or valine' 0 CA--C 1.556 1.18 0 CA-C-N 114.036 -1.438 . . . . 1.0 110.127 -178.857 . . . . . . . . 3 3 . 1 . 022 nuclear orig core ' A' A ' 10' ' ' SER . . . . . 0.63 ' N ' ' O ' ' A' ' 6' ' ' THR . 32.6 t -62.45 -59.48 4.9 Favored 'General case' 0 N--CA 1.491 1.604 0 CA-C-O 121.022 0.439 . . . . 1.0 109.998 179.148 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 11' ' ' ARG . . . . . 0.577 ' O ' ' N ' ' A' ' 15' ' ' ALA . 20.2 tpp180 -66.08 -55.16 17.9 Favored 'General case' 0 CA--C 1.547 0.835 0 O-C-N 121.539 -0.726 . . . . 1.0 110.404 -177.397 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . 0.462 ' CB ' ' O ' ' A' ' 8' ' ' ARG . . . -50.97 -52.24 44.58 Favored 'General case' 0 N--CA 1.481 1.103 0 C-N-CA 118.228 -1.389 . . . . 1.0 107.307 -178.893 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . 0.604 ' O ' ' N ' ' A' ' 17' ' ' LEU . 3.2 m -63.21 -48.91 85.36 Favored 'Isoleucine or valine' 0 C--O 1.199 -1.593 0 C-N-CA 117.796 -1.562 . . . . 1.0 108.791 177.576 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . 0.423 ' O ' ' N ' ' A' ' 18' ' ' VAL . . . -57.12 -61.88 2.15 Favored 'General case' 0 C--O 1.211 -0.964 0 C-N-CA 117.621 -1.632 . . . . 1.0 109.638 179.039 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . 0.577 ' N ' ' O ' ' A' ' 11' ' ' ARG . . . -53.07 -55.78 21.21 Favored 'General case' 0 N--CA 1.475 0.82 0 CA-C-O 121.552 0.691 . . . . 1.0 110.263 -177.702 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . 0.509 ' CA ' ' H ' ' A' ' 22' ' ' GLY . . . -62.85 -54.55 37.11 Favored 'General case' 0 C--N 1.312 -1.055 0 CA-C-N 114.598 -1.183 . . . . 1.0 108.999 -179.346 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . 0.604 ' N ' ' O ' ' A' ' 13' ' ' VAL . 24.2 tp -56.75 -53.96 51.75 Favored 'General case' 0 N--CA 1.477 0.922 0 CA-C-N 114.606 -1.179 . . . . 1.0 108.752 -177.284 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . 0.6 HG23 ' H ' ' A' ' 19' ' ' GLY . 2.5 m -68.58 -55.98 14.02 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.355 0 C-N-CA 119.511 -0.876 . . . . 1.0 109.139 179.637 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . 0.6 ' H ' HG23 ' A' ' 18' ' ' VAL . . . -64.9 -165.28 1.07 Allowed Glycine 0 CA--C 1.525 0.693 0 CA-C-N 116.292 -0.413 . . . . 1.0 112.81 -178.596 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 20' ' ' PRO . . . . . 0.594 ' O ' ' N ' ' A' ' 24' ' ' ALA . 3.2 Cg_endo -81.17 -25.65 3.86 Favored 'Trans proline' 0 C--N 1.312 -1.374 0 C-N-CA 123.134 2.556 . . . . 1.0 112.486 -178.716 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -57.65 -58.75 12.93 Favored Glycine 0 CA--C 1.532 1.125 0 C-N-CA 119.522 -1.323 . . . . 1.0 110.924 -176.663 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . 0.509 ' H ' ' CA ' ' A' ' 16' ' ' ALA . . . -61.94 -54.36 35.78 Favored Glycine 0 N--CA 1.47 0.936 0 N-CA-C 108.152 -1.979 . . . . 1.0 108.152 -178.94 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 24.2 t -56.17 -38.66 55.1 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.636 0 N-CA-C 109.166 -0.679 . . . . 1.0 109.166 -179.794 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . 0.594 ' N ' ' O ' ' A' ' 20' ' ' PRO . . . -60.28 -61.06 2.88 Favored 'General case' 0 CA--C 1.536 0.414 0 C-N-CA 119.272 -0.971 . . . . 1.0 111.011 -179.488 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 16.3 mt -64.1 -46.88 82.27 Favored 'General case' 0 N--CA 1.468 0.447 0 N-CA-C 113.446 0.906 . . . . 1.0 113.446 -177.009 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . 0.493 ' CG2' ' H ' ' A' ' 27' ' ' VAL . 18.9 m -61.51 -58.26 8.38 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 C-N-CA 118.845 -1.142 . . . . 1.0 110.297 -177.688 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . 0.493 ' H ' ' CG2' ' A' ' 26' ' ' VAL . 1.1 p -63.07 -37.73 80.16 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 N-CA-C 112.518 0.562 . . . . 1.0 112.518 -177.377 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 7.9 tmtm? -67.52 -54.69 17.92 Favored 'General case' 0 C--N 1.319 -0.737 0 N-CA-C 108.556 -0.905 . . . . 1.0 108.556 -178.764 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 93.2 t -63.64 -48.48 86.52 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.972 0 CA-C-N 114.394 -1.275 . . . . 1.0 110.331 -178.294 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 30' ' ' CYS . . . . . . . . . . . . . 34.9 t -64.77 -60.8 2.68 Favored 'General case' 0 C--N 1.326 -0.445 0 C-N-CA 119.231 -0.988 . . . . 1.0 109.944 -179.106 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -64.11 -51.88 61.86 Favored 'General case' 0 C--N 1.325 -0.493 0 N-CA-C 111.992 0.367 . . . . 1.0 111.992 -176.074 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 88.48 74.09 1.28 Allowed Glycine 0 CA--C 1.527 0.805 0 N-CA-C 109.994 -1.242 . . . . 1.0 109.994 -179.196 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 38.6 mt 75.29 126.15 0.03 OUTLIER Pre-proline 0 N--CA 1.476 0.846 0 C-N-CA 122.815 0.446 . . . . 1.0 110.562 -179.422 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 56.6 Cg_endo -72.26 -13.01 28.13 Favored 'Trans proline' 0 N--CA 1.505 2.15 0 C-N-CA 122.227 1.952 . . . . 1.0 114.762 -179.316 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -60.19 -59.57 10.13 Favored Glycine 0 N--CA 1.468 0.804 0 C-N-CA 118.156 -1.973 . . . . 1.0 109.584 -178.787 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . 0.437 HG12 ' H ' ' A' ' 37' ' ' ILE . 1.5 t -78.64 -145.56 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.323 -0.572 0 N-CA-C 107.089 -1.449 . . . . 1.0 107.089 178.095 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . 0.437 ' H ' HG12 ' A' ' 36' ' ' VAL . 5.4 mm 76.71 78.36 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 N-CA-C 112.762 0.653 . . . . 1.0 112.762 177.756 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 38' ' ' HIS . . . . . 0.409 ' HE2' ' HA ' ' A' ' 36' ' ' VAL . 0.0 OUTLIER -135.99 126.99 27.77 Favored 'General case' 0 CA--C 1.538 0.484 0 N-CA-C 106.809 -1.552 . . . . 1.0 106.809 177.904 . . . . . . . . 3 3 . 1 . 022 nuclear orig core ' A' A ' 39' ' ' THR . . . . . 0.528 ' OG1' ' NH2' ' A' ' 47' ' ' ARG . 23.9 p -104.54 149.68 37.68 Favored Pre-proline 0 N--CA 1.47 0.57 0 N-CA-C 110.103 -0.332 . . . . 1.0 110.103 -178.972 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 89.6 Cg_endo -75.79 -34.31 3.28 Favored 'Trans proline' 0 C--N 1.311 -1.402 0 C-N-CA 121.675 1.583 . . . . 1.0 114.211 -178.685 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -128.82 134.64 48.41 Favored 'General case' 0 N--CA 1.477 0.88 0 CA-C-N 118.089 0.404 . . . . 1.0 111.548 179.035 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . 0.669 HH21 ' N ' ' A' ' 46' ' ' PHE . 16.6 ptm180 -169.37 167.89 9.83 Favored 'General case' 0 C--N 1.325 -0.491 0 C-N-CA 119.789 -0.765 . . . . 1.0 111.266 177.071 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -67.48 18.9 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.051 -0.522 . . . . 1.0 109.988 179.377 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . 0.651 ' H ' ' C ' ' A' ' 42' ' ' ARG . . . 79.45 -24.62 3.03 Favored Glycine 0 CA--C 1.522 0.502 0 N-CA-C 111.278 -0.729 . . . . 1.0 111.278 179.803 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . 0.532 ' O ' ' CD1' ' A' ' 46' ' ' PHE . 0.2 OUTLIER -150.54 149.14 29.54 Favored 'General case' 0 CA--C 1.542 0.65 0 N-CA-C 109.061 -0.718 . . . . 1.0 109.061 -178.886 . . . . . . . . 3 3 . 1 . 022 nuclear orig core ' A' A ' 46' ' ' PHE . . . . . 0.669 ' N ' HH21 ' A' ' 42' ' ' ARG . 1.9 m-30 144.53 73.45 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.826 0 O-C-N 124.408 1.067 . . . . 1.0 111.664 179.006 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 47' ' ' ARG . . . . . 0.559 ' O ' ' SG ' ' A' ' 48' ' ' CYS . 2.2 ptt-85 135.2 151.09 0.0 OUTLIER 'General case' 0 N--CA 1.5 2.03 0 CA-C-O 116.905 -1.521 . . . . 1.0 108.643 -179.758 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 48' ' ' CYS . . . . . 0.559 ' SG ' ' O ' ' A' ' 47' ' ' ARG . 6.2 p 51.1 62.31 2.78 Favored 'General case' 0 N--CA 1.482 1.161 0 CA-C-N 120.717 1.599 . . . . 1.0 111.982 -179.258 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -110.79 147.21 36.01 Favored Pre-proline 0 N--CA 1.473 0.702 0 N-CA-C 110.144 -0.317 . . . . 1.0 110.144 177.921 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 50' ' ' PRO . . . . . 0.414 ' C ' ' H ' ' A' ' 52' ' ' ARG . 72.4 Cg_endo -71.99 55.08 2.26 Favored 'Trans proline' 0 N--CA 1.494 1.516 0 C-N-CA 122.369 2.046 . . . . 1.0 111.762 179.959 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER 67.43 -3.42 1.07 Allowed 'General case' 0 N--CA 1.468 0.427 0 CA-C-N 115.071 -0.968 . . . . 1.0 111.474 179.189 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . 0.414 ' H ' ' C ' ' A' ' 50' ' ' PRO . 16.3 mtm-85 -85.92 154.03 21.78 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 121.377 0.608 . . . . 1.0 111.839 -179.557 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . 0.51 ' O ' ' N ' ' A' ' 55' ' ' ILE . 8.5 tp -68.22 137.0 25.39 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.306 0 CA-C-N 115.208 -0.905 . . . . 1.0 110.177 179.705 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -59.76 80.44 0.01 OUTLIER 'General case' 0 C--N 1.316 -0.858 0 CA-C-N 114.52 -1.218 . . . . 1.0 109.289 -177.548 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . 0.51 ' N ' ' O ' ' A' ' 53' ' ' ILE . 18.2 tt -149.17 157.91 6.58 Favored 'Isoleucine or valine' 0 C--N 1.348 0.538 0 N-CA-C 110.109 -0.33 . . . . 1.0 110.109 177.991 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 110.48 -6.38 29.99 Favored Glycine 0 N--CA 1.472 1.047 0 N-CA-C 110.698 -0.961 . . . . 1.0 110.698 -179.722 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 16.1 p-10 -76.46 98.31 4.56 Favored 'General case' 0 C--N 1.323 -0.58 0 N-CA-C 108.855 -0.794 . . . . 1.0 108.855 177.788 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 58' ' ' TRP . . . . . . . . . . . . . 24.1 m0 -87.84 174.54 8.3 Favored 'General case' 0 CA--C 1.533 0.324 0 CA-C-O 122.531 1.157 . . . . 1.0 112.513 -177.636 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 12.9 mtm180 -84.5 -62.03 1.65 Allowed 'General case' 0 C--N 1.317 -0.837 0 CA-C-N 112.523 -2.126 . . . . 1.0 112.628 -178.958 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 9.3 p90 -90.53 -15.25 31.04 Favored 'General case' 0 C--O 1.247 0.924 0 N-CA-C 113.615 0.969 . . . . 1.0 113.615 -178.861 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 4.8 tt0 -78.72 -14.44 59.28 Favored 'General case' 0 C--N 1.323 -0.554 0 O-C-N 121.569 -0.707 . . . . 1.0 110.53 -179.318 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 62' ' ' VAL . . . . . 0.566 ' O ' ' N ' ' A' ' 66' ' ' GLY . 27.8 m -46.26 -55.13 1.64 Allowed 'Isoleucine or valine' 0 C--O 1.209 -1.053 0 C-N-CA 119.931 -0.707 . . . . 1.0 110.099 -175.281 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 63' ' ' ALA . . . . . 0.404 ' H ' ' CG2' ' A' ' 62' ' ' VAL . . . -67.44 -52.17 42.78 Favored 'General case' 0 C--N 1.307 -1.273 0 CA-C-N 117.968 0.349 . . . . 1.0 110.25 -179.728 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 64' ' ' HIS . . . . . 0.498 ' O ' ' CG ' ' A' ' 67' ' ' ARG . 0.1 OUTLIER -50.3 -56.25 12.03 Favored 'General case' 0 CA--C 1.544 0.714 0 N-CA-C 108.595 -0.891 . . . . 1.0 108.595 -179.713 . . . . . . . . 3 3 . 1 . 022 nuclear orig core ' A' A ' 65' ' ' ASP . . . . . 0.705 ' C ' ' H ' ' A' ' 67' ' ' ARG . 21.0 t0 -69.8 -48.45 59.05 Favored 'General case' 0 C--N 1.318 -0.762 0 CA-C-O 121.813 0.816 . . . . 1.0 110.011 178.386 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . 0.566 ' N ' ' O ' ' A' ' 62' ' ' VAL . . . -68.74 27.2 0.29 Allowed Glycine 0 CA--C 1.516 0.153 0 N-CA-C 109.68 -1.368 . . . . 1.0 109.68 177.468 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 67' ' ' ARG . . . . . 0.705 ' H ' ' C ' ' A' ' 65' ' ' ASP . 29.0 mmt-85 -70.83 -0.74 9.71 Favored 'General case' 0 N--CA 1.438 -1.06 0 N-CA-C 106.486 -1.672 . . . . 1.0 106.486 174.771 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . 0.496 ' H ' ' C ' ' A' ' 66' ' ' GLY . 4.8 tt -32.95 -29.86 0.01 OUTLIER 'General case' 0 C--N 1.354 0.786 0 O-C-N 123.757 0.661 . . . . 1.0 109.327 -175.221 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . 0.617 ' N ' ' O ' ' A' ' 67' ' ' ARG . 4.3 tp -68.4 -66.94 0.51 Allowed 'General case' 0 CA--C 1.548 0.876 0 CA-C-N 114.554 -1.203 . . . . 1.0 111.224 179.748 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . 0.67 ' C ' ' H ' ' A' ' 72' ' ' HIS . . . -80.29 -78.56 0.17 Allowed 'General case' 0 N--CA 1.478 0.938 0 C-N-CA 118.145 -1.422 . . . . 1.0 108.862 179.814 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 71' ' ' ALA . . . . . 0.538 ' O ' ' N ' ' A' ' 74' ' ' VAL . . . -52.14 7.98 0.0 OUTLIER 'General case' 0 C--N 1.324 -0.522 0 C-N-CA 123.985 0.914 . . . . 1.0 112.468 -179.808 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 72' ' ' HIS . . . . . 0.76 ' CD2' ' H ' ' A' ' 73' ' ' MET . 1.3 p80 -24.93 -51.91 0.03 OUTLIER 'General case' 0 N--CA 1.469 0.481 0 N-CA-C 113.034 0.753 . . . . 1.0 113.034 -178.907 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 73' ' ' MET . . . . . 0.76 ' H ' ' CD2' ' A' ' 72' ' ' HIS . 2.2 tpp -73.53 -49.32 27.09 Favored 'General case' 0 C--N 1.322 -0.606 0 C-N-CA 119.309 -0.956 . . . . 1.0 108.901 178.936 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . 0.667 ' O ' ' N ' ' A' ' 76' ' ' GLY . 61.8 t -43.46 -42.53 1.49 Allowed 'Isoleucine or valine' 0 CA--C 1.517 -0.3 0 CA-C-O 118.43 -0.795 . . . . 1.0 111.804 -175.706 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 75' ' ' ASN . . . . . 0.633 ' O ' ' N ' ' A' ' 78' ' ' VAL . 0.7 OUTLIER -39.37 -13.86 0.01 OUTLIER 'General case' 0 N--CA 1.478 0.926 0 CA-C-N 120.01 1.277 . . . . 1.0 111.68 178.582 . . . . . . . . 3 3 . 1 . 022 nuclear orig core ' A' A ' 76' ' ' GLY . . . . . 0.667 ' N ' ' O ' ' A' ' 74' ' ' VAL . . . -43.31 -23.98 0.31 Allowed Glycine 0 CA--C 1.546 1.979 0 N-CA-C 108.068 -2.013 . . . . 1.0 108.068 178.412 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 77' ' ' ILE . . . . . 0.587 ' O ' ' N ' ' A' ' 80' ' ' ALA . 9.8 pt -69.75 -48.81 62.62 Favored 'Isoleucine or valine' 0 C--O 1.214 -0.799 0 N-CA-C 107.385 -1.339 . . . . 1.0 107.385 177.274 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . 0.633 ' N ' ' O ' ' A' ' 75' ' ' ASN . 3.7 p -34.26 -36.68 0.06 OUTLIER 'Isoleucine or valine' 0 CA--C 1.542 0.643 0 N-CA-C 107.399 -1.334 . . . . 1.0 107.399 -177.076 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . 0.464 ' N ' ' O ' ' A' ' 77' ' ' ILE . 43.9 pt -97.65 -26.49 3.93 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.862 0 N-CA-C 111.924 0.342 . . . . 1.0 111.924 178.077 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 80' ' ' ALA . . . . . 0.587 ' N ' ' O ' ' A' ' 77' ' ' ILE . . . -86.6 -10.72 53.29 Favored 'General case' 0 N--CA 1.48 1.039 0 N-CA-C 113.475 0.917 . . . . 1.0 113.475 178.681 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 81' ' ' GLU . . . . . 0.489 ' N ' ' O ' ' A' ' 77' ' ' ILE . 2.6 mt-10 -78.56 -68.96 0.6 Allowed 'General case' 0 N--CA 1.436 -1.126 0 N-CA-C 107.405 -1.331 . . . . 1.0 107.405 178.041 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 82' ' ' ASP . . . . . 0.9 ' O ' ' N ' ' A' ' 84' ' ' LEU . 0.5 OUTLIER -59.58 -60.87 3.16 Favored 'General case' 0 N--CA 1.437 -1.101 0 N-CA-C 107.928 -1.138 . . . . 1.0 107.928 178.705 . . . . . . . . 3 3 . 1 . 022 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . 0.424 ' O ' ' N ' ' A' ' 86' ' ' ALA . . . 31.8 -64.52 0.0 OUTLIER 'General case' 0 N--CA 1.478 0.946 0 O-C-N 124.501 1.126 . . . . 1.0 111.812 179.32 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . 0.9 ' N ' ' O ' ' A' ' 82' ' ' ASP . 19.9 mt -33.78 -37.48 0.04 OUTLIER 'General case' 0 N--CA 1.475 0.788 0 N-CA-C 112.8 0.667 . . . . 1.0 112.8 -177.68 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 85' ' ' ILE . . . . . 0.548 ' CD1' ' N ' ' A' ' 86' ' ' ALA . 0.0 OUTLIER -100.43 -34.44 4.09 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.473 0 N-CA-C 108.584 -0.895 . . . . 1.0 108.584 177.857 . . . . . . . . 3 3 . 1 . 022 nuclear orig core ' A' A ' 86' ' ' ALA . . . . . 0.626 ' C ' ' H ' ' A' ' 88' ' ' ALA . . . -62.78 -61.25 2.54 Favored 'General case' 0 CA--C 1.539 0.55 0 CA-C-N 115.104 -0.953 . . . . 1.0 109.849 -179.413 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -64.66 16.35 0.02 OUTLIER 'General case' 0 CA--C 1.537 0.457 0 O-C-N 121.836 -0.54 . . . . 1.0 110.84 -179.206 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 88' ' ' ALA . . . . . 0.626 ' H ' ' C ' ' A' ' 86' ' ' ALA . . . -115.97 -14.94 11.23 Favored 'General case' 0 N--CA 1.466 0.353 0 N-CA-C 108.626 -0.879 . . . . 1.0 108.626 178.116 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 21.5 m -109.79 31.54 1.11 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.238 0 CA-C-N 115.11 -0.95 . . . . 1.0 109.775 177.734 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 90' ' ' GLY . . . . . 0.577 ' C ' ' H ' ' A' ' 92' ' ' HIS . . . -69.29 -39.76 81.5 Favored Glycine 0 CA--C 1.529 0.907 0 N-CA-C 111.059 -0.817 . . . . 1.0 111.059 178.216 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 91' ' ' PRO . . . . . 0.55 ' CD ' ' N ' ' A' ' 90' ' ' GLY . 81.0 Cg_exo -48.24 -8.53 0.06 OUTLIER 'Trans proline' 0 N--CA 1.493 1.466 0 C-N-CA 121.836 1.691 . . . . 1.0 111.048 179.266 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 92' ' ' HIS . . . . . 0.577 ' H ' ' C ' ' A' ' 90' ' ' GLY . 28.9 t60 -58.05 -14.37 6.49 Favored 'General case' 0 C--O 1.214 -0.804 0 N-CA-C 108.245 -1.02 . . . . 1.0 108.245 179.893 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 93' ' ' LEU . . . . . 0.464 ' HG ' ' H ' ' A' ' 94' ' ' ALA . 1.2 pp -63.44 -55.97 19.92 Favored 'General case' 0 CA--C 1.531 0.24 0 N-CA-C 108.128 -1.064 . . . . 1.0 108.128 177.464 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 94' ' ' ALA . . . . . 0.464 ' H ' ' HG ' ' A' ' 93' ' ' LEU . . . -56.45 -50.57 71.32 Favored 'General case' 0 CA--C 1.515 -0.376 0 N-CA-C 108.804 -0.813 . . . . 1.0 108.804 178.861 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 95' ' ' ARG . . . . . 0.611 ' O ' ' N ' ' A' ' 97' ' ' LEU . 7.8 ttt180 -59.65 -59.61 5.17 Favored 'General case' 0 CA--C 1.507 -0.68 0 N-CA-C 106.994 -1.484 . . . . 1.0 106.994 178.472 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 96' ' ' ALA . . . . . 0.924 ' O ' ' N ' ' A' ' 98' ' ' GLY . . . -47.21 -14.2 0.03 OUTLIER 'General case' 0 N--CA 1.418 -2.035 0 O-C-N 119.026 -2.296 . . . . 1.0 111.23 -179.976 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 97' ' ' LEU . . . . . 0.671 ' O ' ' N ' ' A' ' 100' ' ' ILE . 16.4 tp 7.1 -51.94 0.0 OUTLIER 'General case' 0 N--CA 1.487 1.394 0 CA-C-O 118.133 -0.937 . . . . 1.0 110.407 -168.103 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 98' ' ' GLY . . . . . 0.924 ' N ' ' O ' ' A' ' 96' ' ' ALA . . . -50.74 -23.55 6.95 Favored Glycine 0 CA--C 1.548 2.122 0 CA-C-N 122.221 2.282 . . . . 1.0 107.618 173.753 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 99' ' ' GLN . . . . . 0.577 ' N ' ' O ' ' A' ' 96' ' ' ALA . 1.4 tp-100 -67.02 -20.48 65.87 Favored 'General case' 0 C--N 1.377 1.788 0 N-CA-C 106.665 -1.605 . . . . 1.0 106.665 176.805 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 100' ' ' ILE . . . . . 0.671 ' N ' ' O ' ' A' ' 97' ' ' LEU . 2.7 tp -63.57 -39.59 85.93 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.867 0 N-CA-C 107.245 -1.391 . . . . 1.0 107.245 177.664 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 101' ' ' VAL . . . . . 0.662 ' O ' ' N ' ' A' ' 105' ' ' GLY . 97.6 t -59.26 -61.71 1.33 Allowed 'Isoleucine or valine' 0 C--O 1.215 -0.731 0 N-CA-C 108.894 -0.78 . . . . 1.0 108.894 178.954 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 102' ' ' CYS . . . . . . . . . . . . . 3.5 t -45.46 -26.99 0.64 Allowed 'General case' 0 C--N 1.315 -0.928 0 N-CA-C 112.368 0.507 . . . . 1.0 112.368 -179.089 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 53.8 ttt-85 -86.78 -47.39 9.12 Favored 'General case' 0 N--CA 1.494 1.752 0 CA-C-O 122.632 1.206 . . . . 1.0 112.891 179.639 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 104' ' ' TYR . . . . . 0.668 ' CG ' ' O ' ' A' ' 104' ' ' TYR . 0.0 OUTLIER -98.62 24.19 7.77 Favored 'General case' 0 C--N 1.299 -1.596 0 CA-C-N 112.203 -2.271 . . . . 1.0 107.88 178.09 . . . . . . . . 3 3 . 1 . 022 nuclear orig core ' A' A ' 105' ' ' GLY . . . . . 0.662 ' N ' ' O ' ' A' ' 101' ' ' VAL . . . -162.62 -94.82 0.1 Allowed Glycine 0 CA--C 1.533 1.206 0 N-CA-C 106.589 -2.604 . . . . 1.0 106.589 177.987 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . 70.69 63.18 0.19 Allowed 'General case' 0 CA--C 1.543 0.679 0 N-CA-C 114.021 1.119 . . . . 1.0 114.021 -179.362 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 107' ' ' THR . . . . . 0.643 ' O ' ' HD2' ' A' ' 110' ' ' PRO . 97.9 m -79.96 -57.76 3.49 Favored 'General case' 0 C--O 1.212 -0.881 0 O-C-N 120.349 -1.469 . . . . 1.0 109.435 177.845 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 108' ' ' VAL . . . . . 0.415 ' CG1' ' O ' ' A' ' 108' ' ' VAL . 21.4 t -80.22 25.04 0.08 OUTLIER 'Isoleucine or valine' 0 CA--C 1.538 0.486 0 O-C-N 121.254 -0.903 . . . . 1.0 113.079 -175.997 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 109' ' ' ILE . . . . . 0.553 ' H ' ' CD ' ' A' ' 110' ' ' PRO . 0.5 OUTLIER -109.38 -38.25 0.13 Allowed Pre-proline 0 CA--C 1.561 1.381 0 CA-C-N 118.909 0.777 . . . . 1.0 110.71 176.683 . . . . . . . . 3 3 . 1 . 022 nuclear orig core ' A' A ' 110' ' ' PRO . . . . . 0.643 ' HD2' ' O ' ' A' ' 107' ' ' THR . 23.0 Cg_exo -67.88 -23.15 41.53 Favored 'Trans proline' 0 N--CA 1.507 2.296 0 C-N-CA 123.642 2.894 . . . . 1.0 110.794 178.291 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 21.3 t-20 -69.17 -67.84 0.45 Allowed 'General case' 0 C--O 1.237 0.423 0 N-CA-C 109.169 -0.678 . . . . 1.0 109.169 -179.624 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -49.03 -30.39 3.55 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.596 0 CA-C-O 121.911 0.863 . . . . 1.0 108.701 177.861 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 113' ' ' ASN . . . . . 0.438 ' HB3' ' O ' ' A' ' 110' ' ' PRO . 20.4 t30 -55.25 -55.56 30.0 Favored 'General case' 0 C--N 1.309 -1.153 0 CA-C-N 113.833 -1.53 . . . . 1.0 108.31 -178.111 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -56.75 -31.78 64.92 Favored 'General case' 0 CA--C 1.537 0.458 0 N-CA-C 113.116 0.784 . . . . 1.0 113.116 -179.469 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -81.04 -50.4 9.72 Favored 'General case' 0 N--CA 1.472 0.664 0 CA-C-O 121.988 0.899 . . . . 1.0 110.951 178.237 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 116' ' ' ILE . . . . . 0.497 ' O ' ' N ' ' A' ' 119' ' ' LEU . 0.4 OUTLIER -49.07 -57.84 1.52 Allowed 'Isoleucine or valine' 0 C--N 1.314 -0.95 0 CA-C-N 113.969 -1.468 . . . . 1.0 107.562 -179.961 . . . . . . . . 3 3 . 1 . 022 nuclear orig core ' A' A ' 117' ' ' GLU . . . . . 0.461 ' C ' ' O ' ' A' ' 116' ' ' ILE . 2.4 tt0 -37.89 -55.99 1.16 Allowed 'General case' 0 N--CA 1.475 0.808 0 CA-C-N 113.187 -1.824 . . . . 1.0 106.526 -178.711 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 84.6 t -58.58 -50.58 78.5 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.723 0 CA-C-N 113.314 -1.767 . . . . 1.0 108.386 178.818 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 119' ' ' LEU . . . . . 0.497 ' N ' ' O ' ' A' ' 116' ' ' ILE . 1.2 tp -57.38 -73.98 0.06 Allowed 'General case' 0 CA--C 1.547 0.861 0 C-N-CA 119.823 -0.751 . . . . 1.0 109.666 -178.239 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -77.62 -82.21 0.6 Allowed Glycine 0 CA--C 1.543 1.837 0 C-N-CA 118.55 -1.786 . . . . 1.0 113.209 -178.904 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 121' ' ' THR . . . . . 0.411 ' H ' ' H ' ' A' ' 122' ' ' GLY . 27.3 m -168.5 -22.92 0.02 OUTLIER 'General case' 0 C--N 1.303 -1.425 0 N-CA-C 105.2 -2.148 . . . . 1.0 105.2 -176.621 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 122' ' ' GLY . . . . . 0.411 ' H ' ' H ' ' A' ' 121' ' ' THR . . . 109.1 -33.61 6.04 Favored Glycine 0 N--CA 1.449 -0.472 0 CA-C-N 112.472 -2.149 . . . . 1.0 114.686 177.37 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 123' ' ' THR . . . . . 0.408 ' C ' ' O ' ' A' ' 122' ' ' GLY . 0.2 OUTLIER -41.75 106.89 0.07 Allowed 'General case' 0 CA--C 1.538 0.49 0 CA-C-N 120.351 2.075 . . . . 1.0 113.05 -177.515 . . . . . . . . 3 3 . 1 . 022 nuclear orig core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 28.8 m-20 -142.6 145.03 33.12 Favored 'General case' 0 N--CA 1.465 0.298 0 CA-C-N 114.276 -1.329 . . . . 1.0 108.768 178.082 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 125' ' ' TYR . . . . . 0.421 ' CD1' ' C ' ' A' ' 125' ' ' TYR . 0.0 OUTLIER -151.5 146.64 26.05 Favored 'General case' 0 CA--C 1.546 0.801 0 N-CA-C 109.061 -0.718 . . . . 1.0 109.061 179.191 . . . . . . . . 3 3 . 1 . 022 nuclear orig core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 11.9 mmp_? -146.92 151.68 37.43 Favored 'General case' 0 N--CA 1.472 0.645 0 CA-C-N 115.112 -0.949 . . . . 1.0 109.341 177.534 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 127' ' ' PHE . . . . . . . . . . . . . 7.9 p90 . . . . . 0 C--O 1.219 -0.539 0 CA-C-O 118.173 -0.918 . . . . 1.0 110.533 178.726 . . . . . . . . 0 0 . 1 . 023 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.494 1.73 0 CA-C-O 121.226 0.536 . . . . 1.0 109.963 . . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 2' ' ' SER . . . . . 0.49 ' O ' ' CB ' ' A' ' 3' ' ' ASP . 6.7 m -83.92 9.14 12.93 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.448 -0.796 . . . . 1.0 110.892 179.825 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 3' ' ' ASP . . . . . 0.49 ' CB ' ' O ' ' A' ' 2' ' ' SER . 1.4 m-20 150.35 126.96 0.0 OUTLIER 'General case' 0 N--CA 1.478 0.956 0 O-C-N 124.088 0.867 . . . . 1.0 111.208 178.713 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 27.4 t80 -157.26 152.58 26.27 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.829 -0.623 . . . . 1.0 110.506 178.428 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 8.4 p30 -151.75 147.5 26.75 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.726 -0.67 . . . . 1.0 109.201 179.806 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 6' ' ' THR . . . . . 0.527 ' O ' ' N ' ' A' ' 10' ' ' SER . 0.2 OUTLIER -71.5 171.29 11.62 Favored 'General case' 0 C--O 1.211 -0.968 0 C-N-CA 120.917 -0.313 . . . . 1.0 110.179 -179.325 . . . . . . . . 3 3 . 1 . 023 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . 0.527 ' O ' ' CG ' ' A' ' 11' ' ' ARG . 90.7 mt-10 -53.83 -69.58 0.12 Allowed 'General case' 0 C--N 1.31 -1.137 0 C-N-CA 120.645 -0.422 . . . . 1.0 110.2 -176.697 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 8' ' ' ARG . . . . . 0.493 ' O ' ' CB ' ' A' ' 12' ' ' ALA . 0.0 OUTLIER -42.22 -51.18 4.8 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-N 115.397 -0.819 . . . . 1.0 109.298 -176.299 . . . . . . . . 3 3 . 1 . 023 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -66.83 -50.1 68.25 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.462 0 CA-C-N 115.151 -0.931 . . . . 1.0 111.055 177.657 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 10' ' ' SER . . . . . 0.527 ' N ' ' O ' ' A' ' 6' ' ' THR . 28.2 t -56.79 -40.24 75.54 Favored 'General case' 0 C--N 1.323 -0.564 0 N-CA-C 113.467 0.914 . . . . 1.0 113.467 -178.566 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 11' ' ' ARG . . . . . 0.677 ' O ' ' N ' ' A' ' 15' ' ' ALA . 2.3 ptp180 -85.76 -54.28 4.62 Favored 'General case' 0 C--O 1.213 -0.849 0 CA-C-O 121.743 0.783 . . . . 1.0 110.313 175.334 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . 0.521 ' H ' ' HG3' ' A' ' 11' ' ' ARG . . . -47.9 -52.83 17.85 Favored 'General case' 0 CA--C 1.496 -1.104 0 N-CA-C 106.896 -1.52 . . . . 1.0 106.896 -175.343 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . 0.626 ' O ' ' CB ' ' A' ' 17' ' ' LEU . 93.1 t -61.68 -54.86 29.09 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.466 0 C-N-CA 117.01 -1.876 . . . . 1.0 108.76 178.085 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . 0.534 ' O ' HG22 ' A' ' 18' ' ' VAL . . . -58.03 -64.64 0.84 Allowed 'General case' 0 C--O 1.207 -1.136 0 C-N-CA 117.81 -1.556 . . . . 1.0 110.755 -179.127 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . 0.677 ' N ' ' O ' ' A' ' 11' ' ' ARG . . . -52.78 -56.08 18.28 Favored 'General case' 0 N--CA 1.473 0.683 0 CA-C-O 121.053 0.454 . . . . 1.0 110.924 -179.23 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . 0.507 ' CB ' ' O ' ' A' ' 12' ' ' ALA . . . -63.96 -56.19 16.95 Favored 'General case' 0 C--N 1.312 -1.035 0 C-N-CA 119.172 -1.011 . . . . 1.0 109.199 -179.219 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . 0.626 ' CB ' ' O ' ' A' ' 13' ' ' VAL . 28.5 tp -55.85 -53.68 53.76 Favored 'General case' 0 N--CA 1.484 1.258 0 CA-C-N 114.95 -1.023 . . . . 1.0 108.705 -177.326 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . 0.731 HG22 ' H ' ' A' ' 19' ' ' GLY . 2.6 m -68.83 -58.2 6.49 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.365 0 N-CA-C 109.22 -0.659 . . . . 1.0 109.22 179.603 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . 0.731 ' H ' HG22 ' A' ' 18' ' ' VAL . . . -58.83 -165.04 0.1 Allowed Glycine 0 N--CA 1.442 -0.915 0 N-CA-C 110.607 -0.997 . . . . 1.0 110.607 -178.844 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 20' ' ' PRO . . . . . 0.579 ' O ' ' N ' ' A' ' 24' ' ' ALA . 65.4 Cg_endo -82.86 -31.4 0.74 Allowed 'Trans proline' 0 C--N 1.296 -2.235 0 C-N-CA 122.632 2.222 . . . . 1.0 113.847 -177.788 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -61.56 -59.6 9.56 Favored Glycine 0 CA--C 1.539 1.573 0 C-N-CA 119.881 -1.152 . . . . 1.0 112.987 -176.683 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . 0.483 ' H ' ' CA ' ' A' ' 16' ' ' ALA . . . -56.36 -53.63 41.72 Favored Glycine 0 N--CA 1.47 0.939 0 N-CA-C 107.304 -2.318 . . . . 1.0 107.304 -176.564 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 1.1 p -62.64 -30.63 49.73 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.184 0 C-N-CA 119.211 -0.995 . . . . 1.0 109.394 179.116 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . 0.579 ' N ' ' O ' ' A' ' 20' ' ' PRO . . . -56.63 -63.75 1.1 Allowed 'General case' 0 C--N 1.357 0.906 0 C-N-CA 118.86 -1.136 . . . . 1.0 110.867 -178.376 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 10.4 mt -63.93 -42.84 97.25 Favored 'General case' 0 CA--C 1.517 -0.303 0 C-N-CA 120.404 -0.518 . . . . 1.0 111.54 -177.92 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 78.8 t -58.41 -59.98 2.88 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.519 0 C-N-CA 119.25 -0.98 . . . . 1.0 110.211 -178.13 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . 0.418 ' O ' ' CB ' ' A' ' 31' ' ' ALA . 1.9 p -63.42 -36.52 76.53 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 C-N-CA 120.643 -0.423 . . . . 1.0 111.627 -178.433 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 59.2 tttm -66.26 -57.2 8.05 Favored 'General case' 0 C--N 1.318 -0.774 0 C-N-CA 119.749 -0.78 . . . . 1.0 109.28 -178.742 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 96.2 t -64.51 -47.23 90.07 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.127 0 CA-C-N 114.716 -1.129 . . . . 1.0 110.046 -178.345 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 30' ' ' CYS . . . . . . . . . . . . . 54.1 t -66.81 -61.92 1.71 Allowed 'General case' 0 N--CA 1.448 -0.548 0 C-N-CA 119.475 -0.89 . . . . 1.0 110.613 -179.71 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . 0.418 ' CB ' ' O ' ' A' ' 27' ' ' VAL . . . -62.08 -46.02 90.93 Favored 'General case' 0 CA--C 1.506 -0.733 0 CA-C-O 121.061 0.458 . . . . 1.0 111.18 -176.45 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . 0.504 ' O ' ' HB2' ' A' ' 33' ' ' LEU . . . 77.77 69.13 1.43 Allowed Glycine 0 N--CA 1.444 -0.813 0 N-CA-C 110.122 -1.191 . . . . 1.0 110.122 -179.357 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . 0.504 ' HB2' ' O ' ' A' ' 32' ' ' GLY . 3.8 mp 84.61 86.99 0.05 OUTLIER Pre-proline 0 N--CA 1.477 0.907 0 O-C-N 124.769 0.923 . . . . 1.0 111.617 -179.21 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 29.4 Cg_endo -64.2 -15.88 51.94 Favored 'Trans proline' 0 N--CA 1.497 1.716 0 C-N-CA 121.525 1.484 . . . . 1.0 111.824 178.519 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -55.95 -59.63 10.3 Favored Glycine 0 CA--C 1.522 0.524 0 C-N-CA 119.02 -1.562 . . . . 1.0 109.435 -179.092 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . 0.549 ' O ' ' CB ' ' A' ' 37' ' ' ILE . 1.3 p -97.81 172.87 1.04 Allowed 'Isoleucine or valine' 0 CA--C 1.51 -0.587 0 N-CA-C 105.215 -2.143 . . . . 1.0 105.215 177.131 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . 0.549 ' CB ' ' O ' ' A' ' 36' ' ' VAL . 6.8 tp 113.07 120.02 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.477 0.907 0 O-C-N 124.689 1.243 . . . . 1.0 110.38 179.411 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 59.5 m80 -141.12 131.42 25.04 Favored 'General case' 0 C--N 1.328 -0.337 0 N-CA-C 108.484 -0.932 . . . . 1.0 108.484 179.395 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -94.64 132.75 27.99 Favored Pre-proline 0 CA--C 1.543 0.679 0 C-N-CA 121.047 -0.261 . . . . 1.0 110.775 -178.849 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 44.8 Cg_exo -54.36 -42.86 63.94 Favored 'Trans proline' 0 N--CA 1.495 1.567 0 C-N-CA 121.902 1.735 . . . . 1.0 113.726 179.363 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -126.38 132.79 51.47 Favored 'General case' 0 N--CA 1.468 0.44 0 CA-C-N 116.602 -0.272 . . . . 1.0 110.861 179.805 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . 0.675 ' C ' ' H ' ' A' ' 44' ' ' GLY . 17.6 ptm180 -166.32 163.73 17.56 Favored 'General case' 0 C--N 1.323 -0.548 0 C-N-CA 120.115 -0.634 . . . . 1.0 109.931 178.1 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 43' ' ' ARG . . . . . 0.554 ' C ' ' H ' ' A' ' 45' ' ' PHE . 0.1 OUTLIER -62.76 24.47 0.01 OUTLIER 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 115.872 -0.604 . . . . 1.0 110.348 -179.973 . . . . . . . . 3 3 . 1 . 023 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . 0.675 ' H ' ' C ' ' A' ' 42' ' ' ARG . . . 70.32 -28.56 0.45 Allowed Glycine 0 C--N 1.339 0.723 0 N-CA-C 111.376 -0.69 . . . . 1.0 111.376 179.982 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . 0.554 ' H ' ' C ' ' A' ' 43' ' ' ARG . 27.6 t80 -159.62 161.76 35.1 Favored 'General case' 0 C--N 1.32 -0.681 0 N-CA-C 109.084 -0.71 . . . . 1.0 109.084 179.199 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 46' ' ' PHE . . . . . 0.737 ' O ' ' HB2' ' A' ' 47' ' ' ARG . 2.3 m-30 132.65 91.43 0.0 OUTLIER 'General case' 0 N--CA 1.474 0.756 0 O-C-N 125.367 1.667 . . . . 1.0 107.109 -179.476 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 47' ' ' ARG . . . . . 0.737 ' HB2' ' O ' ' A' ' 46' ' ' PHE . 0.0 OUTLIER 125.96 139.71 0.0 OUTLIER 'General case' 0 N--CA 1.48 1.05 0 C-N-CA 124.52 1.128 . . . . 1.0 109.402 179.574 . . . . . . . . 3 3 . 1 . 023 nuclear orig core ' A' A ' 48' ' ' CYS . . . . . 0.535 ' SG ' ' C ' ' A' ' 47' ' ' ARG . 0.0 OUTLIER 71.01 73.41 0.19 Allowed 'General case' 0 C--O 1.218 -0.584 0 N-CA-C 108.759 -0.83 . . . . 1.0 108.759 -178.759 . . . . . . . . 3 3 . 1 . 023 nuclear orig core ' A' A ' 49' ' ' ASN . . . . . 0.612 ' O ' ' N ' ' A' ' 51' ' ' GLU . 0.0 OUTLIER -132.51 130.13 21.68 Favored Pre-proline 0 CA--C 1.537 0.458 0 N-CA-C 108.629 -0.878 . . . . 1.0 108.629 -179.426 . . . . . . . . 3 3 . 1 . 023 nuclear orig core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_exo -53.22 58.04 0.02 OUTLIER 'Trans proline' 0 N--CA 1.507 2.274 0 C-N-CA 122.593 2.195 . . . . 1.0 113.696 178.656 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . 0.612 ' N ' ' O ' ' A' ' 49' ' ' ASN . 6.0 mp0 67.27 3.44 3.24 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.525 -0.307 . . . . 1.0 111.002 -179.974 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 28.8 mtt-85 -80.25 152.87 28.85 Favored 'General case' 0 CA--C 1.531 0.22 0 N-CA-C 109.751 -0.462 . . . . 1.0 109.751 179.776 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . 0.465 ' O ' ' N ' ' A' ' 55' ' ' ILE . 3.6 tp -69.8 136.37 26.3 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-O 120.736 0.303 . . . . 1.0 111.209 -179.469 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 54' ' ' GLN . . . . . 0.523 ' CD ' ' H ' ' A' ' 54' ' ' GLN . 0.0 OUTLIER -60.07 82.82 0.01 OUTLIER 'General case' 0 CA--C 1.54 0.568 0 C-N-CA 120.195 -0.602 . . . . 1.0 110.279 -176.643 . . . . . . . . 3 3 . 1 . 023 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . 0.465 ' N ' ' O ' ' A' ' 53' ' ' ILE . 20.3 tt -149.5 159.98 5.34 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.372 0 CA-C-N 116.145 -0.479 . . . . 1.0 110.89 178.138 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 112.55 -2.42 26.3 Favored Glycine 0 N--CA 1.47 0.942 0 N-CA-C 111.184 -0.767 . . . . 1.0 111.184 -179.814 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 3.6 p-10 -80.07 98.09 7.11 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-O 121.45 0.643 . . . . 1.0 111.239 178.988 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 58' ' ' TRP . . . . . . . . . . . . . 7.1 m95 -85.96 171.72 11.23 Favored 'General case' 0 C--N 1.319 -0.755 0 CA-C-O 123.212 1.482 . . . . 1.0 111.541 -179.464 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -84.24 -60.92 1.94 Allowed 'General case' 0 C--N 1.305 -1.342 0 CA-C-N 111.146 -2.752 . . . . 1.0 112.786 -176.825 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -91.04 -15.28 29.83 Favored 'General case' 0 C--N 1.312 -1.064 0 CA-C-N 114.839 -1.073 . . . . 1.0 112.539 -179.055 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . 0.431 ' O ' ' N ' ' A' ' 65' ' ' ASP . 4.0 tt0 -80.93 -14.75 57.7 Favored 'General case' 0 C--N 1.312 -1.032 0 O-C-N 121.901 -0.499 . . . . 1.0 110.244 -179.473 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 62' ' ' VAL . . . . . 0.593 ' O ' ' N ' ' A' ' 66' ' ' GLY . 29.0 m -47.16 -54.38 2.72 Favored 'Isoleucine or valine' 0 C--O 1.209 -1.057 0 C-N-CA 119.754 -0.778 . . . . 1.0 109.767 -176.851 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 63' ' ' ALA . . . . . 0.466 ' O ' ' HG2' ' A' ' 67' ' ' ARG . . . -66.62 -52.61 43.28 Favored 'General case' 0 C--N 1.306 -1.283 0 N-CA-C 109.559 -0.534 . . . . 1.0 109.559 -179.81 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 64' ' ' HIS . . . . . 0.443 ' O ' ' CG ' ' A' ' 67' ' ' ARG . 9.7 t60 -50.59 -58.8 4.98 Favored 'General case' 0 CA--C 1.542 0.66 0 CA-C-O 122.175 0.988 . . . . 1.0 109.933 -179.168 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 65' ' ' ASP . . . . . 0.609 ' C ' ' H ' ' A' ' 67' ' ' ARG . 58.9 t0 -67.83 -50.31 57.39 Favored 'General case' 0 C--N 1.31 -1.129 0 CA-C-O 122.492 1.139 . . . . 1.0 109.455 177.947 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . 0.593 ' N ' ' O ' ' A' ' 62' ' ' VAL . . . -68.23 30.84 0.26 Allowed Glycine 0 C--O 1.224 -0.497 0 O-C-N 121.069 -1.02 . . . . 1.0 111.795 178.487 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 67' ' ' ARG . . . . . 0.609 ' H ' ' C ' ' A' ' 65' ' ' ASP . 4.7 mmm180 -74.22 5.47 4.43 Favored 'General case' 0 C--N 1.306 -1.323 0 N-CA-C 108.72 -0.845 . . . . 1.0 108.72 176.279 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . 0.475 ' C ' ' O ' ' A' ' 67' ' ' ARG . 0.0 OUTLIER -34.22 -29.28 0.01 OUTLIER 'General case' 0 N--CA 1.481 1.09 0 N-CA-C 108.298 -1.001 . . . . 1.0 108.298 -176.671 . . . . . . . . 3 3 . 1 . 023 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . 0.607 ' N ' ' O ' ' A' ' 67' ' ' ARG . 0.5 OUTLIER -68.36 -68.4 0.39 Allowed 'General case' 0 CA--C 1.546 0.817 0 C-N-CA 119.336 -0.946 . . . . 1.0 110.357 179.633 . . . . . . . . 3 3 . 1 . 023 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . 0.693 ' C ' ' H ' ' A' ' 72' ' ' HIS . . . -78.29 -77.09 0.17 Allowed 'General case' 0 CA--C 1.51 -0.575 0 N-CA-C 108.344 -0.984 . . . . 1.0 108.344 179.925 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 71' ' ' ALA . . . . . 0.546 ' O ' ' N ' ' A' ' 74' ' ' VAL . . . -51.86 10.3 0.0 OUTLIER 'General case' 0 CA--C 1.537 0.458 0 C-N-CA 125.007 1.323 . . . . 1.0 111.953 178.188 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 72' ' ' HIS . . . . . 0.975 ' CD2' ' H ' ' A' ' 73' ' ' MET . 0.3 OUTLIER -21.37 -61.78 0.03 OUTLIER 'General case' 0 CA--C 1.519 -0.244 0 N-CA-C 113.9 1.074 . . . . 1.0 113.9 -178.957 . . . . . . . . 3 3 . 1 . 023 nuclear orig core ' A' A ' 73' ' ' MET . . . . . 0.975 ' H ' ' CD2' ' A' ' 72' ' ' HIS . 5.3 ptm -71.14 -45.6 63.23 Favored 'General case' 0 C--N 1.313 -0.978 0 N-CA-C 108.954 -0.758 . . . . 1.0 108.954 179.114 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . 0.795 ' O ' ' N ' ' A' ' 76' ' ' GLY . 79.7 t -40.88 -40.77 0.59 Allowed 'Isoleucine or valine' 0 CA--C 1.507 -0.697 0 CA-C-O 117.854 -1.07 . . . . 1.0 109.916 -175.937 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 75' ' ' ASN . . . . . 0.418 ' C ' ' N ' ' A' ' 77' ' ' ILE . 1.7 t-20 -33.59 -15.52 0.0 OUTLIER 'General case' 0 N--CA 1.482 1.136 0 CA-C-O 122.259 1.028 . . . . 1.0 110.891 178.305 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 76' ' ' GLY . . . . . 0.795 ' N ' ' O ' ' A' ' 74' ' ' VAL . . . -49.71 -22.04 3.87 Favored Glycine 0 N--CA 1.435 -1.414 0 N-CA-C 107.227 -2.349 . . . . 1.0 107.227 173.901 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 77' ' ' ILE . . . . . 0.418 ' N ' ' C ' ' A' ' 75' ' ' ASN . 85.2 mt -59.49 -52.84 56.24 Favored 'Isoleucine or valine' 0 C--N 1.351 0.658 0 CA-C-O 118.259 -0.876 . . . . 1.0 111.986 -179.927 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 33.0 t -51.04 -21.86 1.48 Allowed 'Isoleucine or valine' 0 C--N 1.351 0.659 0 CA-C-N 121.279 1.854 . . . . 1.0 112.477 -179.445 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . 0.43 HD11 ' H ' ' A' ' 127' ' ' PHE . 0.1 OUTLIER -94.88 -40.57 11.35 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.576 0 CA-C-N 116.102 -0.499 . . . . 1.0 109.888 179.713 . . . . . . . . 3 3 . 1 . 023 nuclear orig core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -77.32 -19.16 56.78 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.647 -0.706 . . . . 1.0 111.41 -179.232 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 22.5 tt0 -87.19 -67.6 0.81 Allowed 'General case' 0 N--CA 1.438 -1.047 0 N-CA-C 109.616 -0.513 . . . . 1.0 109.616 178.961 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 82' ' ' ASP . . . . . 0.817 ' O ' ' N ' ' A' ' 84' ' ' LEU . 15.6 m-20 -60.46 -61.18 2.78 Favored 'General case' 0 C--N 1.352 0.682 0 C-N-CA 118.91 -1.116 . . . . 1.0 109.267 -179.391 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . 0.428 ' C ' ' O ' ' A' ' 82' ' ' ASP . . . 23.69 -67.29 0.0 OUTLIER 'General case' 0 N--CA 1.486 1.371 0 O-C-N 124.752 1.283 . . . . 1.0 112.063 179.868 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . 0.817 ' N ' ' O ' ' A' ' 82' ' ' ASP . 0.8 OUTLIER -33.21 -41.76 0.08 Allowed 'General case' 0 N--CA 1.476 0.843 0 C-N-CA 122.728 0.411 . . . . 1.0 111.934 -178.09 . . . . . . . . 3 3 . 1 . 023 nuclear orig core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 18.2 pt -95.2 -41.64 12.06 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.615 0 N-CA-C 109.146 -0.687 . . . . 1.0 109.146 178.675 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 86' ' ' ALA . . . . . 0.43 ' C ' ' H ' ' A' ' 88' ' ' ALA . . . -54.43 -57.87 9.64 Favored 'General case' 0 CA--C 1.54 0.585 0 CA-C-N 115.399 -0.818 . . . . 1.0 110.305 -179.448 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -71.16 10.58 0.55 Allowed 'General case' 0 CA--C 1.538 0.505 0 N-CA-C 111.838 0.31 . . . . 1.0 111.838 -179.023 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 88' ' ' ALA . . . . . 0.43 ' H ' ' C ' ' A' ' 86' ' ' ALA . . . -99.28 -19.89 16.84 Favored 'General case' 0 N--CA 1.48 1.044 0 CA-C-O 122.738 1.256 . . . . 1.0 109.156 179.281 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 28.6 m -104.32 37.46 0.31 Allowed 'Isoleucine or valine' 0 C--N 1.313 -1.018 0 CA-C-N 111.832 -2.44 . . . . 1.0 110.004 178.259 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 90' ' ' GLY . . . . . 0.624 ' O ' ' N ' ' A' ' 92' ' ' HIS . . . -65.17 -41.02 97.16 Favored Glycine 0 CA--C 1.537 1.456 0 CA-C-O 118.853 -0.97 . . . . 1.0 111.671 177.144 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 91' ' ' PRO . . . . . 0.471 ' CD ' ' N ' ' A' ' 90' ' ' GLY . 88.3 Cg_exo -41.47 -11.71 0.03 OUTLIER 'Trans proline' 0 N--CA 1.5 1.879 0 C-N-CA 122.349 2.033 . . . . 1.0 112.008 178.923 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 92' ' ' HIS . . . . . 0.624 ' N ' ' O ' ' A' ' 90' ' ' GLY . 6.5 p-80 -55.08 -18.75 5.87 Favored 'General case' 0 C--O 1.194 -1.833 0 N-CA-C 108.615 -0.883 . . . . 1.0 108.615 -179.736 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 93' ' ' LEU . . . . . 0.504 ' HG ' ' H ' ' A' ' 94' ' ' ALA . 0.8 OUTLIER -62.53 -57.9 9.51 Favored 'General case' 0 C--N 1.317 -0.806 0 N-CA-C 108.763 -0.828 . . . . 1.0 108.763 179.225 . . . . . . . . 3 3 . 1 . 023 nuclear orig core ' A' A ' 94' ' ' ALA . . . . . 0.504 ' H ' ' HG ' ' A' ' 93' ' ' LEU . . . -58.27 -57.76 11.46 Favored 'General case' 0 N--CA 1.452 -0.369 0 CA-C-N 115.293 -0.867 . . . . 1.0 109.335 179.265 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 95' ' ' ARG . . . . . 0.588 ' O ' ' N ' ' A' ' 97' ' ' LEU . 37.4 mtp-105 -56.84 -59.67 4.69 Favored 'General case' 0 C--O 1.242 0.681 0 CA-C-O 123.098 1.428 . . . . 1.0 108.041 179.288 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 96' ' ' ALA . . . . . 0.84 ' O ' ' N ' ' A' ' 98' ' ' GLY . . . -47.32 -15.82 0.05 OUTLIER 'General case' 0 C--N 1.301 -1.502 0 O-C-N 118.572 -2.58 . . . . 1.0 111.042 -179.051 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 97' ' ' LEU . . . . . 0.641 ' O ' ' N ' ' A' ' 100' ' ' ILE 0.279 16.1 tp 6.17 -54.07 0.0 OUTLIER 'General case' 0 N--CA 1.477 0.906 0 CA-C-O 118.116 -0.945 . . . . 1.0 112.287 -168.266 . . . . . . . . 3 3 . 1 . 023 nuclear orig core ' A' A ' 98' ' ' GLY . . . . . 0.84 ' N ' ' O ' ' A' ' 96' ' ' ALA . . . -49.38 -24.44 5.24 Favored Glycine 0 C--N 1.295 -1.708 0 CA-C-N 122.303 2.32 . . . . 1.0 108.417 175.16 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 99' ' ' GLN . . . . . 0.452 ' N ' ' O ' ' A' ' 96' ' ' ALA . 40.9 mm-40 -71.39 -20.7 62.11 Favored 'General case' 0 C--N 1.371 1.538 0 C-N-CA 117.477 -1.689 . . . . 1.0 107.882 177.344 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 100' ' ' ILE . . . . . 0.641 ' N ' ' O ' ' A' ' 97' ' ' LEU . 0.3 OUTLIER -67.45 -40.66 84.96 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.499 0 N-CA-C 108.131 -1.063 . . . . 1.0 108.131 177.392 . . . . . . . . 3 3 . 1 . 023 nuclear orig core ' A' A ' 101' ' ' VAL . . . . . 0.678 ' O ' ' N ' ' A' ' 105' ' ' GLY . 0.4 OUTLIER -57.4 -58.35 6.41 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.605 0 N-CA-C 106.561 -1.644 . . . . 1.0 106.561 179.959 . . . . . . . . 3 3 . 1 . 023 nuclear orig core ' A' A ' 102' ' ' CYS . . . . . 0.482 ' N ' ' CG1' ' A' ' 101' ' ' VAL . 4.6 t -47.07 -21.87 0.28 Allowed 'General case' 0 C--O 1.209 -1.043 0 CA-C-N 115.666 -0.697 . . . . 1.0 110.649 -179.801 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 103' ' ' ARG . . . . . 0.421 ' H ' ' C ' ' A' ' 101' ' ' VAL . 2.1 tmm_? -88.57 -43.32 11.47 Favored 'General case' 0 N--CA 1.486 1.326 0 CA-C-O 122.689 1.233 . . . . 1.0 111.779 178.118 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 104' ' ' TYR . . . . . 0.779 ' CG ' ' O ' ' A' ' 104' ' ' TYR . 1.3 t80 -98.14 23.19 8.51 Favored 'General case' 0 C--N 1.31 -1.121 0 CA-C-N 112.373 -2.194 . . . . 1.0 108.572 177.238 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 105' ' ' GLY . . . . . 0.678 ' N ' ' O ' ' A' ' 101' ' ' VAL . . . -167.68 -92.19 0.08 OUTLIER Glycine 0 N--CA 1.446 -0.695 0 N-CA-C 107.104 -2.398 . . . . 1.0 107.104 177.756 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 106' ' ' ALA . . . . . 0.453 ' CB ' ' O ' ' A' ' 102' ' ' CYS . . . 67.36 63.18 0.44 Allowed 'General case' 0 N--CA 1.443 -0.793 0 N-CA-C 112.418 0.525 . . . . 1.0 112.418 179.83 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 107' ' ' THR . . . . . 0.458 ' O ' ' HD2' ' A' ' 110' ' ' PRO . 19.1 m -83.1 -65.05 1.06 Allowed 'General case' 0 CA--C 1.541 0.632 0 O-C-N 121.449 -0.782 . . . . 1.0 111.603 179.96 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 9.1 m -71.63 28.54 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.322 -0.616 0 O-C-N 121.078 -1.014 . . . . 1.0 111.644 -177.107 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 109' ' ' ILE . . . . . 0.738 ' H ' ' HD2' ' A' ' 110' ' ' PRO . 0.1 OUTLIER -112.48 -53.05 0.05 OUTLIER Pre-proline 0 CA--C 1.553 1.061 0 N-CA-C 108.167 -1.049 . . . . 1.0 108.167 176.117 . . . . . . . . 3 3 . 1 . 023 nuclear orig core ' A' A ' 110' ' ' PRO . . . . . 0.738 ' HD2' ' H ' ' A' ' 109' ' ' ILE . 19.1 Cg_endo -51.48 -29.78 32.8 Favored 'Trans proline' 0 N--CA 1.494 1.501 0 C-N-CA 122.563 2.176 . . . . 1.0 111.259 178.634 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 11.0 t-20 -63.01 -69.4 0.27 Allowed 'General case' 0 N--CA 1.466 0.356 0 C-N-CA 120.511 -0.476 . . . . 1.0 110.392 -179.339 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 112' ' ' ILE . . . . . 0.461 HG13 ' N ' ' A' ' 113' ' ' ASN . 26.6 pt -51.62 -31.13 12.27 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.457 0 CA-C-O 123.228 1.49 . . . . 1.0 109.717 179.502 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 113' ' ' ASN . . . . . 0.461 ' N ' HG13 ' A' ' 112' ' ' ILE . 0.0 OUTLIER -52.87 -52.58 56.85 Favored 'General case' 0 C--N 1.301 -1.511 0 CA-C-N 112.077 -2.329 . . . . 1.0 107.746 -177.858 . . . . . . . . 3 3 . 1 . 023 nuclear orig core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -60.09 -32.64 71.16 Favored 'General case' 0 N--CA 1.442 -0.848 0 N-CA-C 112.182 0.438 . . . . 1.0 112.182 179.625 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -81.27 -57.19 3.61 Favored 'General case' 0 C--O 1.215 -0.751 0 CA-C-O 121.499 0.666 . . . . 1.0 111.702 178.732 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 116' ' ' ILE . . . . . 0.529 ' O ' ' N ' ' A' ' 120' ' ' GLY . 3.4 mm -51.72 -57.86 2.94 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.715 0 CA-C-O 122.479 1.133 . . . . 1.0 108.043 -177.907 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 117' ' ' GLU . . . . . 0.485 ' C ' ' O ' ' A' ' 116' ' ' ILE . 6.5 mt-10 -40.15 -53.17 2.5 Favored 'General case' 0 C--N 1.315 -0.919 0 CA-C-N 112.285 -2.234 . . . . 1.0 105.927 -178.29 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 78.0 t -60.26 -52.04 65.91 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.608 0 C-N-CA 119.459 -0.896 . . . . 1.0 109.065 177.261 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 119' ' ' LEU . . . . . 0.488 ' N ' ' O ' ' A' ' 116' ' ' ILE . 0.9 OUTLIER -58.39 -70.31 0.15 Allowed 'General case' 0 N--CA 1.454 -0.253 0 C-N-CA 119.209 -0.997 . . . . 1.0 108.387 -177.656 . . . . . . . . 3 3 . 1 . 023 nuclear orig core ' A' A ' 120' ' ' GLY . . . . . 0.655 ' O ' ' OG1' ' A' ' 121' ' ' THR . . . -66.19 -84.99 0.08 OUTLIER Glycine 0 C--N 1.351 1.362 0 C-N-CA 118.127 -1.987 . . . . 1.0 109.159 178.41 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 121' ' ' THR . . . . . 0.655 ' OG1' ' O ' ' A' ' 120' ' ' GLY . 18.5 m 160.46 -34.55 0.0 OUTLIER 'General case' 0 N--CA 1.482 1.164 0 O-C-N 125.373 1.278 . . . . 1.0 112.858 179.421 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 122' ' ' GLY . . . . . 0.643 ' O ' ' N ' ' A' ' 124' ' ' ASP . . . 105.64 -14.19 46.31 Favored Glycine 0 N--CA 1.461 0.313 0 N-CA-C 107.285 -2.326 . . . . 1.0 107.285 -175.832 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 123' ' ' THR . . . . . 0.44 ' OG1' ' CG2' ' A' ' 121' ' ' THR . 2.8 m -54.89 82.39 0.0 OUTLIER 'General case' 0 N--CA 1.465 0.311 0 N-CA-C 106.037 -1.838 . . . . 1.0 106.037 178.59 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 124' ' ' ASP . . . . . 0.643 ' N ' ' O ' ' A' ' 122' ' ' GLY . 18.2 t70 -164.29 170.34 16.33 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 114.057 -1.429 . . . . 1.0 112.117 -179.338 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 125' ' ' TYR . . . . . . . . . . . . . 33.5 t80 -151.32 149.01 28.85 Favored 'General case' 0 CA--C 1.535 0.391 0 CA-C-N 115.637 -0.71 . . . . 1.0 109.937 177.298 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 14.6 tpp180 -149.13 150.08 32.1 Favored 'General case' 0 CA--C 1.532 0.283 0 CA-C-N 115.792 -0.64 . . . . 1.0 110.169 177.785 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 127' ' ' PHE . . . . . 0.43 ' H ' HD11 ' A' ' 79' ' ' ILE . 20.4 t80 . . . . . 0 C--O 1.22 -0.469 0 CA-C-O 118.036 -0.983 . . . . 1.0 109.366 178.687 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 62.1 mtt . . . . . 0 N--CA 1.489 1.509 0 N-CA-C 108.961 -0.755 . . . . 1.0 108.961 . . . . . . . . . 0 0 . 1 . 024 nuclear orig core ' A' A ' 2' ' ' SER . . . . . 0.458 ' O ' ' CB ' ' A' ' 3' ' ' ASP . 91.4 p -93.78 10.29 33.64 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.19 -0.459 . . . . 1.0 110.692 -179.793 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 3' ' ' ASP . . . . . 0.458 ' CB ' ' O ' ' A' ' 2' ' ' SER . 7.1 m-20 157.62 111.34 0.0 OUTLIER 'General case' 0 N--CA 1.471 0.618 0 O-C-N 123.82 0.7 . . . . 1.0 110.256 178.643 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 60.6 t80 -153.66 149.19 27.29 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-N 116.263 -0.426 . . . . 1.0 110.743 179.792 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 5' ' ' ASP . . . . . 0.528 ' N ' ' OD1' ' A' ' 5' ' ' ASP . 0.3 OUTLIER -155.31 150.77 27.22 Favored 'General case' 0 CA--C 1.533 0.312 0 CA-C-N 116.373 -0.376 . . . . 1.0 110.874 -179.057 . . . . . . . . 3 3 . 1 . 024 nuclear orig core ' A' A ' 6' ' ' THR . . . . . 0.408 HG21 ' H ' ' A' ' 7' ' ' GLU . 0.2 OUTLIER -61.38 -158.29 0.01 OUTLIER 'General case' 0 N--CA 1.464 0.264 0 C-N-CA 120.762 -0.375 . . . . 1.0 110.637 -179.532 . . . . . . . . 3 3 . 1 . 024 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . 0.408 ' H ' HG21 ' A' ' 6' ' ' THR . 42.8 tt0 -74.34 -66.49 0.72 Allowed 'General case' 0 CA--C 1.502 -0.894 0 C-N-CA 120.699 -0.4 . . . . 1.0 110.047 -178.95 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 8' ' ' ARG . . . . . 0.534 ' O ' ' CB ' ' A' ' 12' ' ' ALA . 13.0 ttm105 -52.54 -44.98 66.16 Favored 'General case' 0 N--CA 1.437 -1.123 0 N-CA-C 112.432 0.53 . . . . 1.0 112.432 -177.057 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 97.7 t -64.78 -51.12 71.2 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.148 0 C-N-CA 117.986 -1.486 . . . . 1.0 109.212 179.284 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 34.3 t -63.49 -40.73 97.85 Favored 'General case' 0 N--CA 1.474 0.749 0 N-CA-C 114.355 1.243 . . . . 1.0 114.355 -179.066 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 11' ' ' ARG . . . . . 0.559 ' O ' ' N ' ' A' ' 15' ' ' ALA . 59.3 ttm-85 -80.16 -54.92 5.31 Favored 'General case' 0 CA--C 1.536 0.442 0 CA-C-O 122.714 1.245 . . . . 1.0 109.732 178.047 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . 0.534 ' CB ' ' O ' ' A' ' 8' ' ' ARG . . . -46.26 -48.59 17.96 Favored 'General case' 0 N--CA 1.483 1.213 0 CA-C-N 112.907 -1.951 . . . . 1.0 106.14 -176.218 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . 0.636 ' O ' ' CB ' ' A' ' 17' ' ' LEU . 34.0 m -60.63 -52.45 61.34 Favored 'Isoleucine or valine' 0 C--O 1.197 -1.663 0 C-N-CA 116.873 -1.931 . . . . 1.0 108.046 176.757 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . 0.433 ' N ' ' O ' ' A' ' 11' ' ' ARG . . . -58.53 -64.59 0.87 Allowed 'General case' 0 N--CA 1.472 0.632 0 C-N-CA 118.428 -1.309 . . . . 1.0 111.736 179.911 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . 0.563 ' O ' ' N ' ' A' ' 19' ' ' GLY . . . -53.19 -55.99 19.91 Favored 'General case' 0 N--CA 1.475 0.802 0 CA-C-O 121.731 0.777 . . . . 1.0 110.161 -177.55 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . 0.489 ' CB ' ' O ' ' A' ' 12' ' ' ALA . . . -63.96 -53.84 43.92 Favored 'General case' 0 C--N 1.311 -1.098 0 CA-C-N 114.56 -1.2 . . . . 1.0 109.066 -178.985 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . 0.636 ' CB ' ' O ' ' A' ' 13' ' ' VAL . 33.0 tp -56.83 -53.73 54.48 Favored 'General case' 0 N--CA 1.484 1.232 0 C-N-CA 119.047 -1.061 . . . . 1.0 108.637 -177.505 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . 0.543 HG23 ' H ' ' A' ' 19' ' ' GLY . 1.7 m -69.94 -57.44 8.19 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.457 0 C-N-CA 119.778 -0.769 . . . . 1.0 110.032 179.515 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . 0.563 ' N ' ' O ' ' A' ' 15' ' ' ALA . . . -64.93 -172.76 3.36 Favored Glycine 0 CA--C 1.526 0.761 0 N-CA-C 110.816 -0.914 . . . . 1.0 110.816 -179.532 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 20' ' ' PRO . . . . . 0.587 ' O ' ' N ' ' A' ' 24' ' ' ALA . 6.0 Cg_exo -76.46 -22.95 11.9 Favored 'Trans proline' 0 N--CA 1.503 2.036 0 C-N-CA 123.481 2.787 . . . . 1.0 114.651 -178.442 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -59.82 -57.73 17.89 Favored Glycine 0 N--CA 1.475 1.264 0 C-N-CA 119.576 -1.297 . . . . 1.0 111.831 -176.505 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . 0.468 ' H ' ' CA ' ' A' ' 16' ' ' ALA . . . -58.24 -55.51 30.28 Favored Glycine 0 N--CA 1.464 0.547 0 N-CA-C 108.07 -2.012 . . . . 1.0 108.07 -177.249 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . 0.532 ' CG2' ' O ' ' A' ' 19' ' ' GLY . 0.0 OUTLIER -61.5 -35.34 66.19 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.137 0 CA-C-N 114.918 -0.641 . . . . 1.0 109.771 -179.963 . . . . . . . . 3 3 . 1 . 024 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . 0.587 ' N ' ' O ' ' A' ' 20' ' ' PRO . . . -54.6 -60.84 2.81 Favored 'General case' 0 CA--C 1.537 0.462 0 C-N-CA 118.223 -1.391 . . . . 1.0 108.893 -179.989 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 15.1 tp -63.01 -45.23 93.36 Favored 'General case' 0 C--N 1.341 0.229 0 CA-C-N 118.386 0.539 . . . . 1.0 112.192 -179.302 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 82.0 t -59.86 -60.02 3.13 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.227 0 C-N-CA 118.664 -1.215 . . . . 1.0 110.052 -177.138 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 2.6 t -59.19 -37.39 68.33 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.309 0 N-CA-C 112.024 0.379 . . . . 1.0 112.024 -178.341 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 25.2 tttm -65.25 -54.43 29.39 Favored 'General case' 0 C--N 1.319 -0.727 0 C-N-CA 119.936 -0.705 . . . . 1.0 109.275 -179.121 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 43.4 t -63.38 -47.1 93.42 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.993 0 CA-C-N 114.719 -1.128 . . . . 1.0 110.603 -178.332 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 30' ' ' CYS . . . . . 0.521 ' SG ' ' N ' ' A' ' 31' ' ' ALA . 0.0 OUTLIER -67.61 -61.09 2.06 Favored 'General case' 0 CA--C 1.533 0.3 0 C-N-CA 118.474 -1.29 . . . . 1.0 110.152 -179.714 . . . . . . . . 3 3 . 1 . 024 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . 0.521 ' N ' ' SG ' ' A' ' 30' ' ' CYS . . . -64.3 -53.68 45.13 Favored 'General case' 0 CA--C 1.514 -0.429 0 N-CA-C 113.893 1.071 . . . . 1.0 113.893 -176.014 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 82.26 72.37 1.26 Allowed Glycine 0 CA--C 1.528 0.902 0 N-CA-C 109.018 -1.633 . . . . 1.0 109.018 -177.056 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . 0.445 ' O ' ' O ' ' A' ' 36' ' ' VAL . 2.9 mt 85.86 86.05 0.05 OUTLIER Pre-proline 0 N--CA 1.476 0.856 0 C-N-CA 123.409 0.683 . . . . 1.0 111.447 -179.788 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 52.7 Cg_exo -56.98 -26.76 69.93 Favored 'Trans proline' 0 N--CA 1.506 2.223 0 C-N-CA 123.366 2.71 . . . . 1.0 113.517 179.251 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -54.92 -57.0 20.15 Favored Glycine 0 CA--C 1.521 0.424 0 N-CA-C 108.224 -1.95 . . . . 1.0 108.224 -179.355 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . 0.537 ' O ' ' CB ' ' A' ' 37' ' ' ILE . 14.5 p -97.07 163.01 2.51 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 N-CA-C 107.521 -1.289 . . . . 1.0 107.521 177.755 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . 0.537 ' CB ' ' O ' ' A' ' 36' ' ' VAL . 3.7 mm 122.12 116.54 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.484 1.267 0 O-C-N 124.4 1.062 . . . . 1.0 109.499 -179.322 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 38' ' ' HIS . . . . . 0.405 ' CD2' ' N ' ' A' ' 38' ' ' HIS . 0.0 OUTLIER -138.63 129.29 26.29 Favored 'General case' 0 C--N 1.329 -0.286 0 N-CA-C 107.55 -1.278 . . . . 1.0 107.55 178.704 . . . . . . . . 3 3 . 1 . 024 nuclear orig core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -95.95 154.07 39.06 Favored Pre-proline 0 N--CA 1.467 0.391 0 N-CA-C 109.87 -0.419 . . . . 1.0 109.87 -179.435 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 97.6 Cg_endo -77.52 -42.27 0.29 Allowed 'Trans proline' 0 C--N 1.311 -1.4 0 C-N-CA 122.25 1.966 . . . . 1.0 113.787 -179.101 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -125.2 131.58 53.15 Favored 'General case' 0 N--CA 1.466 0.351 0 CA-C-O 119.626 -0.226 . . . . 1.0 110.464 179.313 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . 0.66 ' C ' ' H ' ' A' ' 44' ' ' GLY . 0.4 OUTLIER -166.96 163.72 16.06 Favored 'General case' 0 C--N 1.326 -0.435 0 C-N-CA 119.756 -0.778 . . . . 1.0 110.433 178.037 . . . . . . . . 3 3 . 1 . 024 nuclear orig core ' A' A ' 43' ' ' ARG . . . . . 0.474 ' C ' ' H ' ' A' ' 45' ' ' PHE . 3.3 tpt85 -63.87 22.09 0.01 OUTLIER 'General case' 0 CA--C 1.538 0.505 0 CA-C-N 115.857 -0.61 . . . . 1.0 111.088 -179.204 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . 0.66 ' H ' ' C ' ' A' ' 42' ' ' ARG . . . 71.63 -27.92 0.61 Allowed Glycine 0 CA--C 1.527 0.819 0 N-CA-C 111.745 -0.542 . . . . 1.0 111.745 179.705 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . 0.474 ' H ' ' C ' ' A' ' 43' ' ' ARG . 20.9 t80 -151.34 149.68 29.62 Favored 'General case' 0 C--O 1.218 -0.587 0 CA-C-N 117.166 0.483 . . . . 1.0 109.741 -179.258 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 46' ' ' PHE . . . . . 0.555 ' O ' ' CG ' ' A' ' 47' ' ' ARG . 1.8 m-85 141.14 83.66 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.836 0 C-N-CA 124.378 1.071 . . . . 1.0 109.736 179.154 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 47' ' ' ARG . . . . . 0.555 ' CG ' ' O ' ' A' ' 46' ' ' PHE . 3.9 mmp_? 137.63 134.44 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.51 0 C-N-CA 123.715 0.806 . . . . 1.0 109.186 179.489 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 48' ' ' CYS . . . . . 0.471 ' SG ' ' C ' ' A' ' 47' ' ' ARG . 2.0 m 77.22 69.45 0.05 Allowed 'General case' 0 C--O 1.218 -0.572 0 CA-C-N 118.409 0.549 . . . . 1.0 110.195 179.785 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -114.6 147.86 39.04 Favored Pre-proline 0 N--CA 1.464 0.265 0 O-C-N 120.748 -1.22 . . . . 1.0 108.864 179.543 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -73.02 59.26 3.58 Favored 'Trans proline' 0 C--N 1.308 -1.58 0 C-N-CA 121.836 1.691 . . . . 1.0 111.101 -179.975 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 22.7 mm-40 58.8 59.33 2.89 Favored 'General case' 0 N--CA 1.454 -0.259 0 CA-C-N 116.25 -0.432 . . . . 1.0 111.074 179.453 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 16.6 ptt180 -146.13 178.72 8.01 Favored 'General case' 0 N--CA 1.466 0.359 0 CA-C-N 116.24 -0.437 . . . . 1.0 110.377 179.724 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . 0.438 ' O ' ' N ' ' A' ' 55' ' ' ILE . 0.1 OUTLIER -86.61 138.61 18.74 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.334 0 CA-C-O 121.655 0.741 . . . . 1.0 110.484 179.671 . . . . . . . . 3 3 . 1 . 024 nuclear orig core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -62.34 82.84 0.02 OUTLIER 'General case' 0 C--N 1.319 -0.742 0 CA-C-N 114.701 -1.136 . . . . 1.0 109.033 -177.961 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . 0.438 ' N ' ' O ' ' A' ' 53' ' ' ILE . 21.2 tt -149.48 158.23 6.17 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.457 0 CA-C-N 115.858 -0.61 . . . . 1.0 110.611 178.156 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 109.31 -5.97 31.89 Favored Glycine 0 N--CA 1.473 1.129 0 N-CA-C 110.95 -0.86 . . . . 1.0 110.95 -179.969 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 13.1 p-10 -77.94 100.78 6.56 Favored 'General case' 0 C--N 1.323 -0.563 0 N-CA-C 109.026 -0.731 . . . . 1.0 109.026 178.751 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 58' ' ' TRP . . . . . . . . . . . . . 0.3 OUTLIER -88.75 174.75 7.83 Favored 'General case' 0 CA--C 1.542 0.656 0 CA-C-O 123.18 1.466 . . . . 1.0 113.364 -177.625 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 9.0 mtm180 -80.5 -59.32 2.74 Favored 'General case' 0 C--N 1.315 -0.899 0 CA-C-N 111.416 -2.629 . . . . 1.0 113.418 -178.381 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 1.2 p90 -88.67 -10.03 49.97 Favored 'General case' 0 C--O 1.248 1.012 0 CA-C-N 114.81 -1.086 . . . . 1.0 113.573 -177.673 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . 0.513 ' O ' ' N ' ' A' ' 65' ' ' ASP . 13.5 pt-20 -71.8 -14.26 61.93 Favored 'General case' 0 C--N 1.313 -0.991 0 N-CA-C 113.198 0.814 . . . . 1.0 113.198 -177.767 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 62' ' ' VAL . . . . . 0.623 ' O ' ' N ' ' A' ' 66' ' ' GLY . 0.1 OUTLIER -48.72 -58.94 0.97 Allowed 'Isoleucine or valine' 0 C--O 1.204 -1.293 0 C-N-CA 119.195 -1.002 . . . . 1.0 108.5 -174.317 . . . . . . . . 3 3 . 1 . 024 nuclear orig core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -66.33 -56.67 10.02 Favored 'General case' 0 C--N 1.295 -1.799 0 O-C-N 121.797 -0.564 . . . . 1.0 110.867 -179.325 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 64' ' ' HIS . . . . . 0.518 ' O ' ' HB2' ' A' ' 67' ' ' ARG . 67.3 m-70 -53.39 -56.36 17.42 Favored 'General case' 0 N--CA 1.465 0.312 0 C-N-CA 119.148 -1.021 . . . . 1.0 109.59 -179.247 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 65' ' ' ASP . . . . . 0.628 ' C ' ' H ' ' A' ' 67' ' ' ARG . 10.0 t0 -77.63 -50.9 11.54 Favored 'General case' 0 C--N 1.312 -1.032 0 O-C-N 121.889 -0.507 . . . . 1.0 111.667 179.984 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . 0.623 ' N ' ' O ' ' A' ' 62' ' ' VAL . . . -71.83 26.84 0.63 Allowed Glycine 0 CA--C 1.524 0.655 0 O-C-N 120.608 -1.307 . . . . 1.0 110.412 178.042 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 67' ' ' ARG . . . . . 0.628 ' H ' ' C ' ' A' ' 65' ' ' ASP . 4.1 tpt85 -74.93 4.38 6.64 Favored 'General case' 0 N--CA 1.448 -0.566 0 N-CA-C 107.183 -1.414 . . . . 1.0 107.183 176.074 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . 0.537 ' H ' ' C ' ' A' ' 66' ' ' GLY . 12.9 mt -33.55 -28.13 0.01 OUTLIER 'General case' 0 N--CA 1.475 0.79 0 CA-C-N 114.687 -1.142 . . . . 1.0 108.871 -177.622 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . 0.613 ' N ' ' O ' ' A' ' 67' ' ' ARG . 3.0 tt -65.86 -66.03 0.6 Allowed 'General case' 0 CA--C 1.546 0.821 0 C-N-CA 119.293 -0.963 . . . . 1.0 110.085 -179.17 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . 0.644 ' C ' ' H ' ' A' ' 72' ' ' HIS . . . -79.1 -78.36 0.15 Allowed 'General case' 0 N--CA 1.475 0.819 0 C-N-CA 118.766 -1.174 . . . . 1.0 108.439 -179.842 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 71' ' ' ALA . . . . . 0.528 ' O ' ' N ' ' A' ' 74' ' ' VAL . . . -50.32 9.53 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.285 0 C-N-CA 125.651 1.581 . . . . 1.0 113.005 179.342 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 72' ' ' HIS . . . . . 0.955 ' CD2' ' H ' ' A' ' 73' ' ' MET . 0.3 OUTLIER -24.21 -58.75 0.05 Allowed 'General case' 0 C--N 1.33 -0.247 0 N-CA-C 113.765 1.024 . . . . 1.0 113.765 -177.197 . . . . . . . . 3 3 . 1 . 024 nuclear orig core ' A' A ' 73' ' ' MET . . . . . 0.955 ' H ' ' CD2' ' A' ' 72' ' ' HIS . 95.0 mtp -68.94 -45.99 69.34 Favored 'General case' 0 C--N 1.319 -0.746 0 C-N-CA 119.604 -0.838 . . . . 1.0 109.145 179.34 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . 0.723 ' C ' ' H ' ' A' ' 76' ' ' GLY . 39.2 t -45.26 -43.92 3.3 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.255 0 CA-C-O 117.658 -1.163 . . . . 1.0 111.685 -176.365 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 75' ' ' ASN . . . . . 0.651 HD22 HH22 ' A' ' 126' ' ' ARG . 0.7 OUTLIER -39.6 -11.14 0.01 OUTLIER 'General case' 0 C--N 1.362 1.134 0 CA-C-N 121.05 1.75 . . . . 1.0 111.419 178.994 . . . . . . . . 3 3 . 1 . 024 nuclear orig core ' A' A ' 76' ' ' GLY . . . . . 0.723 ' H ' ' C ' ' A' ' 74' ' ' VAL . . . -42.12 -27.3 0.41 Allowed Glycine 0 CA--C 1.536 1.384 0 N-CA-C 107.301 -2.32 . . . . 1.0 107.301 177.988 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 77' ' ' ILE . . . . . 0.637 ' O ' ' N ' ' A' ' 80' ' ' ALA . 7.1 pt -68.76 -49.45 64.09 Favored 'Isoleucine or valine' 0 C--O 1.212 -0.881 0 N-CA-C 108.663 -0.866 . . . . 1.0 108.663 176.653 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . 0.636 ' N ' ' O ' ' A' ' 75' ' ' ASN . 2.0 p -32.35 -39.09 0.04 OUTLIER 'Isoleucine or valine' 0 CA--C 1.545 0.769 0 N-CA-C 108.846 -0.798 . . . . 1.0 108.846 -176.369 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . 0.463 ' N ' ' O ' ' A' ' 77' ' ' ILE . 2.9 pp -97.71 -24.72 4.28 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.709 0 CA-C-O 121.153 0.501 . . . . 1.0 110.751 178.041 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 80' ' ' ALA . . . . . 0.637 ' N ' ' O ' ' A' ' 77' ' ' ILE . . . -86.98 -10.37 53.36 Favored 'General case' 0 CA--C 1.551 1.014 0 N-CA-C 113.381 0.882 . . . . 1.0 113.381 177.568 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 81' ' ' GLU . . . . . 0.596 ' N ' ' O ' ' A' ' 77' ' ' ILE . 81.9 tt0 -87.65 -71.22 0.58 Allowed 'General case' 0 N--CA 1.445 -0.699 0 CA-C-N 118.942 0.792 . . . . 1.0 109.426 -179.826 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 82' ' ' ASP . . . . . 0.648 ' O ' ' N ' ' A' ' 84' ' ' LEU . 0.7 OUTLIER -70.32 -11.63 61.04 Favored 'General case' 0 N--CA 1.444 -0.733 0 CA-C-N 119.109 0.868 . . . . 1.0 110.294 179.069 . . . . . . . . 3 3 . 1 . 024 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . 0.805 ' O ' ' N ' ' A' ' 86' ' ' ALA . . . -18.79 -43.22 0.0 OUTLIER 'General case' 0 C--O 1.197 -1.668 0 O-C-N 124.072 0.858 . . . . 1.0 111.804 177.941 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . 0.648 ' N ' ' O ' ' A' ' 82' ' ' ASP . 19.1 mt -26.72 -30.55 0.0 OUTLIER 'General case' 0 N--CA 1.472 0.664 0 O-C-N 121.901 -0.5 . . . . 1.0 111.902 -175.801 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 85' ' ' ILE . . . . . 0.714 ' N ' ' O ' ' A' ' 83' ' ' ALA . 0.1 OUTLIER -98.57 -31.33 3.64 Favored 'Isoleucine or valine' 0 CA--C 1.551 1.009 0 N-CA-C 109.541 -0.54 . . . . 1.0 109.541 175.42 . . . . . . . . 3 3 . 1 . 024 nuclear orig core ' A' A ' 86' ' ' ALA . . . . . 0.805 ' N ' ' O ' ' A' ' 83' ' ' ALA . . . -91.89 -27.33 17.99 Favored 'General case' 0 N--CA 1.486 1.352 0 CA-C-O 121.897 0.856 . . . . 1.0 112.652 179.063 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 87' ' ' GLU . . . . . 0.48 ' N ' ' O ' ' A' ' 83' ' ' ALA . 3.3 pt-20 -47.33 -28.55 2.06 Favored 'General case' 0 C--N 1.313 -1.008 0 CA-C-N 114.089 -1.414 . . . . 1.0 109.963 -178.859 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -141.7 24.99 2.02 Favored 'General case' 0 N--CA 1.475 0.8 0 CA-C-O 121.585 0.707 . . . . 1.0 111.118 -178.99 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 89' ' ' VAL . . . . . 0.571 ' O ' ' ND1' ' A' ' 92' ' ' HIS . 4.8 p -75.62 36.38 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.315 -0.921 0 CA-C-N 114.905 -1.043 . . . . 1.0 109.518 178.423 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 90' ' ' GLY . . . . . 0.529 ' O ' ' N ' ' A' ' 92' ' ' HIS . . . -66.77 -39.87 93.67 Favored Glycine 0 N--CA 1.439 -1.129 0 C-N-CA 119.055 -1.545 . . . . 1.0 111.138 178.693 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 91' ' ' PRO . . . . . 0.522 ' CD ' ' N ' ' A' ' 90' ' ' GLY . 95.8 Cg_exo -43.78 -20.1 0.23 Allowed 'Trans proline' 0 N--CA 1.49 1.293 0 CA-C-N 119.897 1.848 . . . . 1.0 110.003 179.777 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 92' ' ' HIS . . . . . 0.571 ' ND1' ' O ' ' A' ' 89' ' ' VAL . 7.7 p-80 -60.65 -25.84 66.62 Favored 'General case' 0 C--O 1.218 -0.599 0 CA-C-N 114.724 -1.126 . . . . 1.0 109.396 179.649 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 93' ' ' LEU . . . . . 0.581 ' HG ' ' H ' ' A' ' 94' ' ' ALA . 2.2 pp -63.47 -58.7 6.2 Favored 'General case' 0 C--N 1.325 -0.494 0 N-CA-C 108.353 -0.98 . . . . 1.0 108.353 178.451 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 94' ' ' ALA . . . . . 0.581 ' H ' ' HG ' ' A' ' 93' ' ' LEU . . . -56.23 -55.93 27.2 Favored 'General case' 0 N--CA 1.452 -0.369 0 N-CA-C 109.26 -0.645 . . . . 1.0 109.26 179.096 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 95' ' ' ARG . . . . . 0.613 ' O ' ' N ' ' A' ' 97' ' ' LEU . 10.8 ttp180 -59.07 -61.04 2.94 Favored 'General case' 0 C--O 1.239 0.542 0 CA-C-O 122.333 1.064 . . . . 1.0 108.819 179.586 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 96' ' ' ALA . . . . . 0.871 ' O ' ' N ' ' A' ' 98' ' ' GLY . . . -47.68 -12.51 0.03 OUTLIER 'General case' 0 C--N 1.306 -1.319 0 O-C-N 118.56 -2.587 . . . . 1.0 112.072 -179.154 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 97' ' ' LEU . . . . . 0.799 ' O ' ' N ' ' A' ' 100' ' ' ILE . 3.5 pp 5.34 -52.53 0.0 OUTLIER 'General case' 0 C--O 1.204 -1.328 0 CA-C-O 116.767 -1.587 . . . . 1.0 111.262 -166.595 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 98' ' ' GLY . . . . . 0.871 ' N ' ' O ' ' A' ' 96' ' ' ALA . . . -47.22 -24.14 2.13 Favored Glycine 0 C--N 1.303 -1.301 0 CA-C-N 123.381 2.809 . . . . 1.0 107.473 176.018 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 99' ' ' GLN . . . . . 0.462 ' N ' ' C ' ' A' ' 97' ' ' LEU . 57.5 mm-40 -64.44 -17.99 64.33 Favored 'General case' 0 C--N 1.361 1.098 0 C-N-CA 117.415 -1.714 . . . . 1.0 107.424 176.049 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 100' ' ' ILE . . . . . 0.799 ' N ' ' O ' ' A' ' 97' ' ' LEU . 12.1 tt -64.67 -44.75 96.63 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.629 0 N-CA-C 107.87 -1.159 . . . . 1.0 107.87 177.881 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 101' ' ' VAL . . . . . 0.801 ' O ' ' N ' ' A' ' 105' ' ' GLY . 68.9 t -60.14 -61.06 1.67 Allowed 'Isoleucine or valine' 0 C--O 1.209 -1.059 0 N-CA-C 107.585 -1.265 . . . . 1.0 107.585 179.499 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 102' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -44.21 -19.02 0.02 OUTLIER 'General case' 0 C--N 1.319 -0.732 0 CA-C-O 121.399 0.619 . . . . 1.0 110.988 -179.458 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 103' ' ' ARG . . . . . 0.518 ' N ' ' O ' ' A' ' 101' ' ' VAL . 12.1 ttp-105 -95.44 -43.96 7.75 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-O 122.034 0.921 . . . . 1.0 111.889 177.383 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 104' ' ' TYR . . . . . 0.709 ' CG ' ' O ' ' A' ' 104' ' ' TYR . 0.1 OUTLIER -107.43 19.16 20.65 Favored 'General case' 0 CA--C 1.552 1.038 0 C-N-CA 126.628 1.971 . . . . 1.0 110.619 178.477 . . . . . . . . 3 3 . 1 . 024 nuclear orig core ' A' A ' 105' ' ' GLY . . . . . 0.801 ' N ' ' O ' ' A' ' 101' ' ' VAL . . . -162.64 -10.89 0.03 OUTLIER Glycine 0 C--N 1.332 0.324 0 C-N-CA 118.898 -1.62 . . . . 1.0 112.514 179.785 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 106' ' ' ALA . . . . . 0.492 ' C ' ' O ' ' A' ' 105' ' ' GLY . . . -29.81 118.7 0.15 Allowed 'General case' 0 N--CA 1.463 0.219 0 CA-C-N 117.017 0.408 . . . . 1.0 110.081 179.391 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 107' ' ' THR . . . . . 0.686 ' O ' ' HD2' ' A' ' 110' ' ' PRO . 10.7 m -133.98 -62.48 0.76 Allowed 'General case' 0 C--O 1.192 -1.951 0 N-CA-C 105.542 -2.021 . . . . 1.0 105.542 178.042 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 26.1 m -61.89 28.57 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.309 -1.181 0 O-C-N 121.034 -1.041 . . . . 1.0 110.194 -179.878 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 109' ' ' ILE . . . . . 0.546 ' N ' ' O ' ' A' ' 107' ' ' THR . 0.1 OUTLIER -111.81 -42.98 0.09 OUTLIER Pre-proline 0 C--N 1.372 1.545 0 CA-C-N 119.634 1.107 . . . . 1.0 111.381 177.575 . . . . . . . . 3 3 . 1 . 024 nuclear orig core ' A' A ' 110' ' ' PRO . . . . . 0.686 ' HD2' ' O ' ' A' ' 107' ' ' THR . 31.3 Cg_exo -65.1 -28.49 56.83 Favored 'Trans proline' 0 N--CA 1.499 1.799 0 C-N-CA 122.457 2.105 . . . . 1.0 111.869 -179.569 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 111' ' ' ASN . . . . . 0.437 ' C ' ' N ' ' A' ' 113' ' ' ASN . 0.1 OUTLIER -69.12 -69.08 0.36 Allowed 'General case' 0 CA--C 1.538 0.49 0 C-N-CA 119.687 -0.805 . . . . 1.0 109.851 -179.242 . . . . . . . . 3 3 . 1 . 024 nuclear orig core ' A' A ' 112' ' ' ILE . . . . . 0.535 ' O ' ' N ' ' A' ' 116' ' ' ILE . 13.1 pt -47.8 -28.29 1.57 Allowed 'Isoleucine or valine' 0 C--O 1.214 -0.785 0 CA-C-O 123.414 1.578 . . . . 1.0 108.531 179.593 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 113' ' ' ASN . . . . . 0.558 ' ND2' ' OE2' ' A' ' 117' ' ' GLU . 0.1 OUTLIER -56.85 -52.74 63.91 Favored 'General case' 0 C--N 1.293 -1.864 0 CA-C-N 111.526 -2.579 . . . . 1.0 106.906 -178.935 . . . . . . . . 3 3 . 1 . 024 nuclear orig core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -62.37 -35.04 77.9 Favored 'General case' 0 C--N 1.322 -0.595 0 N-CA-C 112.842 0.682 . . . . 1.0 112.842 -179.914 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -82.8 -56.25 3.94 Favored 'General case' 0 C--O 1.21 -1.002 0 CA-C-N 119.486 1.039 . . . . 1.0 110.538 178.503 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 116' ' ' ILE . . . . . 0.541 ' O ' ' N ' ' A' ' 120' ' ' GLY . 50.8 mt -48.74 -60.88 0.61 Allowed 'Isoleucine or valine' 0 N--CA 1.478 0.954 0 CA-C-O 122.522 1.153 . . . . 1.0 108.107 -179.208 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 117' ' ' GLU . . . . . 0.558 ' OE2' ' ND2' ' A' ' 113' ' ' ASN . 91.5 mt-10 -42.67 -53.56 4.42 Favored 'General case' 0 C--N 1.313 -0.988 0 CA-C-N 112.488 -2.142 . . . . 1.0 107.17 -178.761 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 69.1 t -60.72 -54.84 29.75 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.516 0 N-CA-C 109.143 -0.688 . . . . 1.0 109.143 177.281 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 3.3 tp -53.49 -71.66 0.07 Allowed 'General case' 0 N--CA 1.464 0.234 0 N-CA-C 108.038 -1.097 . . . . 1.0 108.038 -179.424 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 120' ' ' GLY . . . . . 0.541 ' N ' ' O ' ' A' ' 116' ' ' ILE . . . -66.62 -85.37 0.09 OUTLIER Glycine 0 CA--C 1.533 1.21 0 C-N-CA 118.567 -1.777 . . . . 1.0 110.063 179.369 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 121' ' ' THR . . . . . 0.491 ' OG1' ' OG1' ' A' ' 123' ' ' THR . 1.6 t 168.67 -39.9 0.0 OUTLIER 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 112.633 -1.783 . . . . 1.0 112.756 -179.802 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 122' ' ' GLY . . . . . 0.619 ' O ' ' N ' ' A' ' 124' ' ' ASP . . . 100.99 -18.72 54.32 Favored Glycine 0 N--CA 1.469 0.856 0 N-CA-C 107.037 -2.425 . . . . 1.0 107.037 -176.884 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 123' ' ' THR . . . . . 0.491 ' OG1' ' OG1' ' A' ' 121' ' ' THR . 25.5 m -51.63 86.71 0.0 OUTLIER 'General case' 0 N--CA 1.471 0.617 0 CA-C-N 111.884 -2.158 . . . . 1.0 105.463 178.261 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 124' ' ' ASP . . . . . 0.619 ' N ' ' O ' ' A' ' 122' ' ' GLY . 9.5 m-20 -160.3 165.1 31.95 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 114.372 -1.285 . . . . 1.0 112.062 -178.305 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 125' ' ' TYR . . . . . 0.576 ' O ' ' NH2' ' A' ' 126' ' ' ARG . 0.0 OUTLIER -151.13 146.98 26.51 Favored 'General case' 0 CA--C 1.541 0.61 0 N-CA-C 108.92 -0.771 . . . . 1.0 108.92 177.901 . . . . . . . . 3 3 . 1 . 024 nuclear orig core ' A' A ' 126' ' ' ARG . . . . . 0.651 HH22 HD22 ' A' ' 75' ' ' ASN . 0.1 OUTLIER -148.01 150.58 34.23 Favored 'General case' 0 CA--C 1.541 0.613 0 CA-C-N 115.762 -0.654 . . . . 1.0 109.718 177.453 . . . . . . . . 3 3 . 1 . 024 nuclear orig core ' A' A ' 127' ' ' PHE . . . . . . . . . . . . . 85.8 t80 . . . . . 0 N--CA 1.468 0.459 0 CA-C-O 118.011 -0.995 . . . . 1.0 110.726 178.918 . . . . . . . . 0 0 . 1 . 025 nuclear orig core ' A' A ' 1' ' ' MET . . . . . 0.492 ' SD ' ' CB ' ' A' ' 4' ' ' PHE . 19.6 mtp . . . . . 0 N--CA 1.492 1.63 0 N-CA-C 108.179 -1.045 . . . . 1.0 108.179 . . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 2' ' ' SER . . . . . 0.423 ' O ' ' CG ' ' A' ' 3' ' ' ASP . 88.6 p -107.7 7.87 28.68 Favored 'General case' 0 N--CA 1.468 0.452 0 CA-C-O 120.705 0.288 . . . . 1.0 110.412 -179.753 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 3' ' ' ASP . . . . . 0.423 ' CG ' ' O ' ' A' ' 2' ' ' SER . 12.1 m-20 168.35 94.25 0.0 OUTLIER 'General case' 0 N--CA 1.47 0.557 0 CA-C-N 115.469 -0.787 . . . . 1.0 110.468 179.014 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . 0.492 ' CB ' ' SD ' ' A' ' 1' ' ' MET . 37.9 t80 -149.8 145.56 26.68 Favored 'General case' 0 CA--C 1.517 -0.326 0 CA-C-N 116.212 -0.449 . . . . 1.0 110.516 179.501 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 61.5 m-20 -154.75 151.01 28.19 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 121.134 0.492 . . . . 1.0 110.007 179.763 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 6' ' ' THR . . . . . 0.678 ' O ' ' N ' ' A' ' 10' ' ' SER . 0.2 OUTLIER -67.17 173.23 3.95 Favored 'General case' 0 C--O 1.208 -1.123 0 CA-C-N 115.707 -0.679 . . . . 1.0 110.126 179.855 . . . . . . . . 3 3 . 1 . 025 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . 0.595 ' O ' ' N ' ' A' ' 11' ' ' ARG . 1.5 tm-20 -58.07 -54.29 48.6 Favored 'General case' 0 C--N 1.309 -1.191 0 CA-C-O 121.877 0.846 . . . . 1.0 109.423 -179.303 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 8' ' ' ARG . . . . . 0.516 ' O ' ' CB ' ' A' ' 12' ' ' ALA . 27.9 ttp180 -53.82 -57.85 9.41 Favored 'General case' 0 C--N 1.311 -1.099 0 N-CA-C 107.967 -1.123 . . . . 1.0 107.967 -178.44 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . 0.526 ' O ' ' CG1' ' A' ' 13' ' ' VAL . 0.0 OUTLIER -63.61 -48.08 88.41 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.359 0 CA-C-N 114.772 -1.104 . . . . 1.0 109.807 179.27 . . . . . . . . 3 3 . 1 . 025 nuclear orig core ' A' A ' 10' ' ' SER . . . . . 0.678 ' N ' ' O ' ' A' ' 6' ' ' THR . 48.0 t -63.15 -60.74 3.01 Favored 'General case' 0 N--CA 1.481 1.107 0 C-N-CA 120.048 -0.661 . . . . 1.0 110.467 179.266 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 11' ' ' ARG . . . . . 0.595 ' N ' ' O ' ' A' ' 7' ' ' GLU . 11.2 ttt180 -62.77 -55.38 27.05 Favored 'General case' 0 C--N 1.316 -0.862 0 CA-C-O 121.707 0.765 . . . . 1.0 110.072 -177.005 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . 0.516 ' CB ' ' O ' ' A' ' 8' ' ' ARG . . . -52.37 -51.57 58.2 Favored 'General case' 0 C--N 1.316 -0.856 0 N-CA-C 107.015 -1.476 . . . . 1.0 107.015 -178.322 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . 0.607 ' O ' ' CB ' ' A' ' 17' ' ' LEU . 3.5 m -63.0 -45.84 97.86 Favored 'Isoleucine or valine' 0 C--O 1.2 -1.524 0 C-N-CA 117.387 -1.725 . . . . 1.0 108.888 177.839 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -59.79 -62.01 2.19 Favored 'General case' 0 N--CA 1.481 1.109 0 O-C-N 120.61 -1.306 . . . . 1.0 110.26 178.654 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . 0.542 ' N ' ' O ' ' A' ' 11' ' ' ARG . . . -52.15 -55.36 21.44 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-O 121.984 0.897 . . . . 1.0 109.415 -177.932 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . 0.482 ' CA ' ' H ' ' A' ' 22' ' ' GLY . . . -62.29 -53.85 49.19 Favored 'General case' 0 C--N 1.31 -1.112 0 CA-C-N 114.233 -1.348 . . . . 1.0 108.811 -179.194 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . 0.607 ' CB ' ' O ' ' A' ' 13' ' ' VAL . 7.9 tt -57.1 -54.85 42.12 Favored 'General case' 0 N--CA 1.481 1.084 0 CA-C-N 114.738 -1.119 . . . . 1.0 109.462 -177.75 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . 0.498 ' CG2' ' N ' ' A' ' 19' ' ' GLY . 1.8 m -69.68 -57.25 8.84 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.63 0 C-N-CA 119.682 -0.807 . . . . 1.0 109.673 178.932 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . 0.543 ' O ' ' CG2' ' A' ' 23' ' ' VAL . . . -65.2 -166.99 1.57 Allowed Glycine 0 CA--C 1.537 1.432 0 N-CA-C 111.477 -0.649 . . . . 1.0 111.477 -179.875 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 20' ' ' PRO . . . . . 0.527 ' O ' ' N ' ' A' ' 24' ' ' ALA . 83.5 Cg_endo -78.18 -24.87 7.7 Favored 'Trans proline' 0 N--CA 1.509 2.407 0 C-N-CA 123.628 2.885 . . . . 1.0 115.138 -177.825 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -57.32 -57.26 20.72 Favored Glycine 0 N--CA 1.478 1.448 0 C-N-CA 120.221 -0.99 . . . . 1.0 111.694 -176.765 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . 0.482 ' H ' ' CA ' ' A' ' 16' ' ' ALA . . . -60.33 -56.21 25.77 Favored Glycine 0 N--CA 1.468 0.819 0 N-CA-C 109.274 -1.531 . . . . 1.0 109.274 -177.234 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . 0.543 ' CG2' ' O ' ' A' ' 19' ' ' GLY . 0.0 OUTLIER -61.89 -35.98 71.22 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.958 0 CA-C-N 114.867 -0.666 . . . . 1.0 110.106 -178.845 . . . . . . . . 3 3 . 1 . 025 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . 0.527 ' N ' ' O ' ' A' ' 20' ' ' PRO . . . -56.23 -59.97 4.17 Favored 'General case' 0 CA--C 1.538 0.51 0 C-N-CA 117.779 -1.568 . . . . 1.0 108.325 179.531 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 14.3 tp -66.66 -43.87 83.38 Favored 'General case' 0 C--N 1.348 0.505 0 N-CA-C 113.113 0.783 . . . . 1.0 113.113 -178.635 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 79.2 t -60.71 -58.7 6.24 Favored 'Isoleucine or valine' 0 C--N 1.34 0.188 0 C-N-CA 118.137 -1.425 . . . . 1.0 109.253 -177.243 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 60.7 t -61.14 -37.76 78.16 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.374 0 N-CA-C 112.96 0.726 . . . . 1.0 112.96 -177.914 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . 0.406 ' CG ' ' O ' ' A' ' 24' ' ' ALA . 30.0 mmtm -64.23 -52.68 57.59 Favored 'General case' 0 CA--C 1.509 -0.631 0 N-CA-C 108.372 -0.973 . . . . 1.0 108.372 -179.812 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 92.8 t -65.07 -47.91 86.0 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.874 0 CA-C-N 113.445 -1.707 . . . . 1.0 110.797 -177.361 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 30' ' ' CYS . . . . . . . . . . . . . 11.5 t -65.8 -61.11 2.25 Favored 'General case' 0 N--CA 1.445 -0.684 0 C-N-CA 118.685 -1.206 . . . . 1.0 109.86 -179.747 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -66.62 -53.95 28.63 Favored 'General case' 0 CA--C 1.518 -0.261 0 N-CA-C 113.668 0.988 . . . . 1.0 113.668 -176.221 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 85.1 73.57 1.27 Allowed Glycine 0 CA--C 1.533 1.17 0 N-CA-C 109.913 -1.275 . . . . 1.0 109.913 -177.253 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 4.7 mt 76.78 106.26 0.03 OUTLIER Pre-proline 0 N--CA 1.475 0.8 0 C-N-CA 123.416 0.686 . . . . 1.0 111.524 -179.706 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 74.9 Cg_exo -51.42 -15.6 2.63 Favored 'Trans proline' 0 N--CA 1.506 2.243 0 C-N-CA 122.889 2.393 . . . . 1.0 114.967 179.365 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -56.7 -57.87 17.33 Favored Glycine 0 CA--C 1.526 0.746 0 N-CA-C 107.584 -2.207 . . . . 1.0 107.584 -179.791 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . 0.544 ' O ' ' CG2' ' A' ' 37' ' ' ILE . 5.6 p -79.01 -147.2 0.01 OUTLIER 'Isoleucine or valine' 0 C--O 1.22 -0.459 0 N-CA-C 108.247 -1.019 . . . . 1.0 108.247 178.572 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . 0.544 ' CG2' ' O ' ' A' ' 36' ' ' VAL . 9.1 tp 70.52 79.74 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.475 0.814 0 CA-C-O 122.157 0.98 . . . . 1.0 112.969 -179.217 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 60.3 m80 -137.79 132.08 32.15 Favored 'General case' 0 N--CA 1.453 -0.283 0 N-CA-C 108.183 -1.043 . . . . 1.0 108.183 177.267 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 10.0 m -128.99 115.71 18.94 Favored Pre-proline 0 C--N 1.326 -0.434 0 N-CA-C 108.38 -0.97 . . . . 1.0 108.38 -179.284 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_exo -42.94 -66.65 0.15 Allowed 'Trans proline' 0 C--N 1.317 -1.122 0 C-N-CA 121.017 1.145 . . . . 1.0 111.558 -178.503 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -75.6 115.33 15.17 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 115.262 -0.881 . . . . 1.0 112.848 -177.292 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . 0.668 ' C ' ' H ' ' A' ' 44' ' ' GLY . 32.9 ptt180 -166.12 162.4 17.7 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 114.817 -1.083 . . . . 1.0 109.987 179.225 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 43' ' ' ARG . . . . . 0.515 ' C ' ' H ' ' A' ' 45' ' ' PHE . 0.2 OUTLIER -65.99 18.63 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.318 -0.401 . . . . 1.0 110.235 -179.263 . . . . . . . . 3 3 . 1 . 025 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . 0.668 ' H ' ' C ' ' A' ' 42' ' ' ARG . . . 70.57 -26.59 0.48 Allowed Glycine 0 N--CA 1.448 -0.531 0 N-CA-C 110.824 -0.91 . . . . 1.0 110.824 179.846 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . 0.515 ' H ' ' C ' ' A' ' 43' ' ' ARG . 7.6 t80 -155.33 150.65 27.05 Favored 'General case' 0 CA--C 1.541 0.622 0 N-CA-C 108.892 -0.781 . . . . 1.0 108.892 -178.906 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 46' ' ' PHE . . . . . 0.497 ' CE1' ' NE2' ' A' ' 54' ' ' GLN . 15.3 t80 172.21 7.15 0.0 OUTLIER 'General case' 0 N--CA 1.483 1.208 0 O-C-N 124.014 0.821 . . . . 1.0 113.155 176.273 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 172.2 -176.0 0.05 Allowed 'General case' 0 C--N 1.328 -0.334 0 N-CA-C 109.765 -0.457 . . . . 1.0 109.765 179.689 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER 70.64 63.01 0.19 Allowed 'General case' 0 CA--C 1.546 0.819 0 N-CA-C 108.901 -0.777 . . . . 1.0 108.901 179.938 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 49' ' ' ASN . . . . . 0.593 ' ND2' ' NH2' ' A' ' 52' ' ' ARG . 1.6 t30 -151.06 133.21 8.17 Favored Pre-proline 0 CA--C 1.546 0.818 0 N-CA-C 108.169 -1.048 . . . . 1.0 108.169 178.891 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 50' ' ' PRO . . . . . 0.533 ' HD2' HH21 ' A' ' 52' ' ' ARG . 16.3 Cg_endo -55.13 73.86 0.03 OUTLIER 'Trans proline' 0 N--CA 1.502 1.999 0 CA-C-N 120.995 1.391 . . . . 1.0 113.833 -179.816 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . 0.553 ' N ' ' O ' ' A' ' 49' ' ' ASN . 40.2 mm-40 62.01 69.8 0.61 Allowed 'General case' 0 N--CA 1.468 0.441 0 N-CA-C 113.428 0.899 . . . . 1.0 113.428 177.975 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . 0.593 ' NH2' ' ND2' ' A' ' 49' ' ' ASN . 0.0 OUTLIER -141.67 150.68 42.22 Favored 'General case' 0 N--CA 1.471 0.579 0 N-CA-C 108.772 -0.825 . . . . 1.0 108.772 178.155 . . . . . . . . 3 3 . 1 . 025 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . 0.444 HD13 HG22 ' A' ' 53' ' ' ILE . 0.4 OUTLIER -74.44 136.37 25.38 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.372 0 CA-C-O 121.623 0.725 . . . . 1.0 111.43 -178.679 . . . . . . . . 3 3 . 1 . 025 nuclear orig core ' A' A ' 54' ' ' GLN . . . . . 0.497 ' NE2' ' CE1' ' A' ' 46' ' ' PHE . 1.9 pt20 -62.9 82.21 0.02 OUTLIER 'General case' 0 N--CA 1.469 0.492 0 CA-C-N 114.611 -1.177 . . . . 1.0 110.143 -177.172 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 16.0 tt -149.52 159.07 5.68 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.27 0 CA-C-N 115.97 -0.559 . . . . 1.0 110.141 178.113 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 112.26 -2.92 26.73 Favored Glycine 0 N--CA 1.472 1.043 0 N-CA-C 110.669 -0.973 . . . . 1.0 110.669 -179.713 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . 0.484 ' OD2' ' O ' ' A' ' 43' ' ' ARG . 25.3 t70 -82.91 98.71 9.34 Favored 'General case' 0 C--N 1.323 -0.554 0 N-CA-C 109.619 -0.511 . . . . 1.0 109.619 179.426 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 58' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -87.3 174.49 8.54 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-O 122.615 1.198 . . . . 1.0 112.764 -177.899 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 59' ' ' ARG . . . . . 0.447 ' CG ' ' N ' ' A' ' 60' ' ' TYR . 2.1 ptt180 -86.17 -56.96 3.21 Favored 'General case' 0 C--N 1.318 -0.783 0 CA-C-N 111.824 -2.444 . . . . 1.0 112.259 -179.538 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 60' ' ' TYR . . . . . 0.447 ' N ' ' CG ' ' A' ' 59' ' ' ARG . 41.4 t80 -92.42 -17.28 24.8 Favored 'General case' 0 C--O 1.249 1.052 0 N-CA-C 113.521 0.934 . . . . 1.0 113.521 -179.181 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 5.3 tt0 -79.51 -13.9 59.25 Favored 'General case' 0 C--N 1.313 -0.996 0 CA-C-N 115.973 -0.558 . . . . 1.0 110.482 -179.292 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 62' ' ' VAL . . . . . 0.645 ' O ' ' N ' ' A' ' 66' ' ' GLY . 27.4 m -47.39 -55.32 2.22 Favored 'Isoleucine or valine' 0 C--O 1.201 -1.498 0 C-N-CA 119.326 -0.95 . . . . 1.0 110.107 -176.608 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 63' ' ' ALA . . . . . 0.527 ' O ' ' N ' ' A' ' 67' ' ' ARG . . . -68.77 -54.87 13.43 Favored 'General case' 0 C--N 1.306 -1.292 0 C-N-CA 119.338 -0.945 . . . . 1.0 109.416 -178.466 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 64' ' ' HIS . . . . . 0.455 ' O ' ' HB2' ' A' ' 67' ' ' ARG . 6.6 t-80 -44.98 -58.38 3.2 Favored 'General case' 0 N--CA 1.472 0.645 0 CA-C-O 121.519 0.676 . . . . 1.0 109.99 179.516 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 65' ' ' ASP . . . . . 0.579 ' C ' ' H ' ' A' ' 67' ' ' ARG . 0.5 OUTLIER -73.18 -47.02 47.23 Favored 'General case' 0 C--N 1.313 -1.006 0 CA-C-N 115.551 -0.75 . . . . 1.0 109.991 177.917 . . . . . . . . 3 3 . 1 . 025 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . 0.645 ' N ' ' O ' ' A' ' 62' ' ' VAL . . . -75.4 25.46 1.34 Allowed Glycine 0 CA--C 1.53 0.977 0 O-C-N 120.526 -1.359 . . . . 1.0 110.354 177.5 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 67' ' ' ARG . . . . . 0.603 ' O ' ' N ' ' A' ' 69' ' ' LEU . 5.5 mmt180 -72.02 5.26 2.8 Favored 'General case' 0 CA--C 1.508 -0.655 0 N-CA-C 105.969 -1.863 . . . . 1.0 105.969 175.115 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . 0.601 ' H ' ' C ' ' A' ' 66' ' ' GLY . 0.7 OUTLIER -33.94 -28.1 0.01 OUTLIER 'General case' 0 C--N 1.354 0.787 0 O-C-N 124.181 0.926 . . . . 1.0 109.173 -176.709 . . . . . . . . 3 3 . 1 . 025 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . 0.603 ' N ' ' O ' ' A' ' 67' ' ' ARG . 9.0 mp -62.47 -64.94 0.77 Allowed 'General case' 0 N--CA 1.471 0.624 0 C-N-CA 118.885 -1.126 . . . . 1.0 108.237 177.362 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . 0.691 ' O ' ' CD2' ' A' ' 72' ' ' HIS . . . -76.71 -74.28 0.25 Allowed 'General case' 0 C--O 1.217 -0.634 0 N-CA-C 104.833 -2.284 . . . . 1.0 104.833 177.126 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 71' ' ' ALA . . . . . 0.463 ' O ' ' OD1' ' A' ' 75' ' ' ASN . . . -40.66 2.65 0.0 OUTLIER 'General case' 0 N--CA 1.473 0.707 0 N-CA-C 115.27 1.582 . . . . 1.0 115.27 179.832 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 72' ' ' HIS . . . . . 0.857 ' CD2' ' H ' ' A' ' 73' ' ' MET . 0.3 OUTLIER -30.45 -81.97 0.01 OUTLIER 'General case' 0 CA--C 1.532 0.284 0 CA-C-N 119.954 1.252 . . . . 1.0 114.114 -176.425 . . . . . . . . 3 3 . 1 . 025 nuclear orig core ' A' A ' 73' ' ' MET . . . . . 0.857 ' H ' ' CD2' ' A' ' 72' ' ' HIS . 72.1 mtm -63.9 -53.64 47.34 Favored 'General case' 0 N--CA 1.439 -0.979 0 C-N-CA 120.002 -0.679 . . . . 1.0 110.066 -179.443 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . 0.729 ' C ' ' H ' ' A' ' 76' ' ' GLY . 0.6 OUTLIER -46.25 -35.86 2.49 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.718 0 CA-C-O 117.533 -1.222 . . . . 1.0 111.644 -176.092 . . . . . . . . 3 3 . 1 . 025 nuclear orig core ' A' A ' 75' ' ' ASN . . . . . 0.569 ' C ' ' N ' ' A' ' 77' ' ' ILE . 16.1 m120 -39.95 -9.46 0.01 OUTLIER 'General case' 0 N--CA 1.497 1.9 0 CA-C-N 121.055 1.752 . . . . 1.0 112.363 177.759 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 76' ' ' GLY . . . . . 0.729 ' H ' ' C ' ' A' ' 74' ' ' VAL . . . -41.95 -21.67 0.08 OUTLIER Glycine 0 CA--C 1.542 1.732 0 N-CA-C 107.533 -2.227 . . . . 1.0 107.533 177.051 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 77' ' ' ILE . . . . . 0.713 ' O ' ' N ' ' A' ' 80' ' ' ALA . 13.4 pt -74.87 -53.2 17.08 Favored 'Isoleucine or valine' 0 C--O 1.213 -0.86 0 CA-C-N 114.968 -0.616 . . . . 1.0 109.536 177.565 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . 0.531 ' N ' ' O ' ' A' ' 75' ' ' ASN . 3.2 p -36.15 -30.14 0.04 OUTLIER 'Isoleucine or valine' 0 CA--C 1.554 1.12 0 N-CA-C 108.631 -0.877 . . . . 1.0 108.631 -174.332 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . 0.538 ' N ' ' O ' ' A' ' 77' ' ' ILE . 0.0 OUTLIER -94.64 -28.16 4.2 Favored 'Isoleucine or valine' 0 CA--C 1.555 1.135 0 CA-C-O 121.186 0.517 . . . . 1.0 109.978 176.907 . . . . . . . . 3 3 . 1 . 025 nuclear orig core ' A' A ' 80' ' ' ALA . . . . . 0.713 ' N ' ' O ' ' A' ' 77' ' ' ILE . . . -87.48 -10.88 50.6 Favored 'General case' 0 CA--C 1.553 1.063 0 C-N-CA 124.153 0.981 . . . . 1.0 113.419 177.752 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 81' ' ' GLU . . . . . 0.542 ' N ' ' O ' ' A' ' 77' ' ' ILE . 2.3 mt-10 -83.2 -70.55 0.55 Allowed 'General case' 0 C--N 1.354 0.803 0 CA-C-N 119.309 0.959 . . . . 1.0 108.561 178.759 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 82' ' ' ASP . . . . . 0.491 ' O ' ' N ' ' A' ' 84' ' ' LEU . 8.8 p-10 -78.07 -12.29 59.98 Favored 'General case' 0 N--CA 1.445 -0.683 0 CA-C-N 118.315 0.507 . . . . 1.0 111.565 -179.637 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . 0.525 ' O ' ' N ' ' A' ' 87' ' ' GLU . . . -22.48 -44.16 0.01 OUTLIER 'General case' 0 N--CA 1.475 0.818 0 N-CA-C 113.207 0.817 . . . . 1.0 113.207 177.683 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . 0.491 ' N ' ' O ' ' A' ' 82' ' ' ASP . 0.4 OUTLIER -36.9 -34.94 0.08 Allowed 'General case' 0 N--CA 1.469 0.518 0 N-CA-C 112.576 0.584 . . . . 1.0 112.576 -176.782 . . . . . . . . 3 3 . 1 . 025 nuclear orig core ' A' A ' 85' ' ' ILE . . . . . 0.463 HG13 ' H ' ' A' ' 86' ' ' ALA . 2.0 pt -99.95 -41.72 9.63 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.669 0 N-CA-C 108.391 -0.966 . . . . 1.0 108.391 177.444 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 86' ' ' ALA . . . . . 0.463 ' H ' HG13 ' A' ' 85' ' ' ILE . . . -59.58 -56.87 16.45 Favored 'General case' 0 CA--C 1.537 0.479 0 CA-C-N 113.93 -1.487 . . . . 1.0 109.639 -179.01 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 87' ' ' GLU . . . . . 0.525 ' N ' ' O ' ' A' ' 83' ' ' ALA . 14.4 tt0 -70.92 -21.48 62.36 Favored 'General case' 0 CA--C 1.544 0.744 0 O-C-N 121.184 -0.947 . . . . 1.0 112.951 -177.439 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -74.43 -5.41 42.32 Favored 'General case' 0 N--CA 1.48 1.049 0 CA-C-O 122.931 1.348 . . . . 1.0 108.759 179.711 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 89' ' ' VAL . . . . . 0.449 ' CG2' ' O ' ' A' ' 86' ' ' ALA . 11.7 m -109.85 37.34 0.52 Allowed 'Isoleucine or valine' 0 C--N 1.312 -1.036 0 CA-C-N 112.351 -2.204 . . . . 1.0 109.896 178.017 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 90' ' ' GLY . . . . . 0.596 ' C ' ' H ' ' A' ' 92' ' ' HIS . . . -75.86 -36.35 42.26 Favored Glycine 0 C--N 1.349 1.254 0 N-CA-C 110.63 -0.988 . . . . 1.0 110.63 178.803 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 91' ' ' PRO . . . . . 0.581 ' CD ' ' N ' ' A' ' 90' ' ' GLY . 82.8 Cg_exo -48.26 -9.21 0.07 OUTLIER 'Trans proline' 0 N--CA 1.499 1.798 0 C-N-CA 122.191 1.928 . . . . 1.0 109.971 176.982 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 92' ' ' HIS . . . . . 0.596 ' H ' ' C ' ' A' ' 90' ' ' GLY . 1.8 p80 -55.99 -17.35 6.55 Favored 'General case' 0 N--CA 1.445 -0.717 0 N-CA-C 107.519 -1.289 . . . . 1.0 107.519 179.253 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 1.4 pp -63.32 -58.76 6.08 Favored 'General case' 0 N--CA 1.451 -0.405 0 N-CA-C 108.995 -0.743 . . . . 1.0 108.995 177.542 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -57.1 -50.91 71.33 Favored 'General case' 0 CA--C 1.515 -0.377 0 C-N-CA 120.318 -0.553 . . . . 1.0 110.095 -179.996 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 95' ' ' ARG . . . . . 0.652 ' O ' ' N ' ' A' ' 97' ' ' LEU . 83.7 mtt85 -59.36 -55.95 28.23 Favored 'General case' 0 C--N 1.322 -0.623 0 N-CA-C 107.516 -1.29 . . . . 1.0 107.516 178.781 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 96' ' ' ALA . . . . . 0.87 ' O ' ' N ' ' A' ' 98' ' ' GLY . . . -46.8 -13.42 0.03 OUTLIER 'General case' 0 N--CA 1.427 -1.575 0 O-C-N 119.118 -2.238 . . . . 1.0 110.15 179.846 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 97' ' ' LEU . . . . . 0.714 ' O ' ' N ' ' A' ' 100' ' ' ILE . 0.4 OUTLIER 7.38 -54.71 0.0 OUTLIER 'General case' 0 C--N 1.372 1.544 0 CA-C-O 117.547 -1.216 . . . . 1.0 109.993 -169.298 . . . . . . . . 3 3 . 1 . 025 nuclear orig core ' A' A ' 98' ' ' GLY . . . . . 0.87 ' N ' ' O ' ' A' ' 96' ' ' ALA . . . -49.01 -24.0 4.14 Favored Glycine 0 C--N 1.289 -2.079 0 CA-C-N 122.833 2.561 . . . . 1.0 108.849 174.767 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 99' ' ' GLN . . . . . 0.576 ' N ' ' O ' ' A' ' 96' ' ' ALA . 1.9 tp60 -66.36 -15.89 63.63 Favored 'General case' 0 C--N 1.364 1.223 0 N-CA-C 106.405 -1.702 . . . . 1.0 106.405 177.249 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 100' ' ' ILE . . . . . 0.714 ' N ' ' O ' ' A' ' 97' ' ' LEU . 0.4 OUTLIER -64.04 -45.58 96.24 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.52 0 N-CA-C 108.088 -1.079 . . . . 1.0 108.088 177.089 . . . . . . . . 3 3 . 1 . 025 nuclear orig core ' A' A ' 101' ' ' VAL . . . . . 0.651 ' O ' ' N ' ' A' ' 105' ' ' GLY . 71.9 t -53.74 -61.61 0.87 Allowed 'Isoleucine or valine' 0 CA--C 1.5 -0.963 0 N-CA-C 108.433 -0.951 . . . . 1.0 108.433 179.411 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 102' ' ' CYS . . . . . . . . . . . . . 4.2 t -46.07 -21.75 0.17 Allowed 'General case' 0 N--CA 1.427 -1.625 0 CA-C-N 115.569 -0.741 . . . . 1.0 112.317 -178.031 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 103' ' ' ARG . . . . . 0.416 ' H ' ' C ' ' A' ' 101' ' ' VAL . 0.1 OUTLIER -88.69 -43.78 11.06 Favored 'General case' 0 N--CA 1.484 1.255 0 O-C-N 124.194 0.934 . . . . 1.0 112.02 176.554 . . . . . . . . 3 3 . 1 . 025 nuclear orig core ' A' A ' 104' ' ' TYR . . . . . 0.643 ' O ' ' CD1' ' A' ' 104' ' ' TYR . 0.1 OUTLIER -101.3 21.23 14.4 Favored 'General case' 0 N--CA 1.473 0.692 0 CA-C-N 113.956 -1.475 . . . . 1.0 109.736 178.367 . . . . . . . . 3 3 . 1 . 025 nuclear orig core ' A' A ' 105' ' ' GLY . . . . . 0.651 ' N ' ' O ' ' A' ' 101' ' ' VAL . . . -159.59 -94.34 0.1 Allowed Glycine 0 C--N 1.345 1.051 0 N-CA-C 105.232 -3.147 . . . . 1.0 105.232 176.771 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 106' ' ' ALA . . . . . 0.551 ' O ' ' CD ' ' A' ' 110' ' ' PRO . . . 72.0 60.34 0.14 Allowed 'General case' 0 N--CA 1.446 -0.625 0 CA-C-O 119.333 -0.365 . . . . 1.0 111.729 -179.345 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 107' ' ' THR . . . . . 0.591 ' HG1' ' H ' ' A' ' 108' ' ' VAL . 44.6 p -81.91 -62.54 1.6 Allowed 'General case' 0 C--N 1.353 0.724 0 O-C-N 120.375 -1.453 . . . . 1.0 109.521 179.403 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 108' ' ' VAL . . . . . 0.591 ' H ' ' HG1' ' A' ' 107' ' ' THR . 15.5 m -65.2 22.45 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.35 0.599 0 N-CA-C 113.025 0.75 . . . . 1.0 113.025 -176.799 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 109' ' ' ILE . . . . . 0.68 ' H ' ' HD2' ' A' ' 110' ' ' PRO . 0.1 OUTLIER -114.92 -56.96 0.04 OUTLIER Pre-proline 0 CA--C 1.561 1.4 0 CA-C-N 119.089 0.859 . . . . 1.0 108.946 173.954 . . . . . . . . 3 3 . 1 . 025 nuclear orig core ' A' A ' 110' ' ' PRO . . . . . 0.68 ' HD2' ' H ' ' A' ' 109' ' ' ILE . 19.4 Cg_endo -52.24 -38.54 72.23 Favored 'Trans proline' 0 N--CA 1.497 1.696 0 C-N-CA 123.243 2.628 . . . . 1.0 112.723 -179.838 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 12.4 m120 -67.01 -68.06 0.41 Allowed 'General case' 0 CA--C 1.51 -0.577 0 C-N-CA 119.268 -0.973 . . . . 1.0 108.76 -177.762 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 112' ' ' ILE . . . . . 0.579 ' O ' ' N ' ' A' ' 115' ' ' ALA . 18.6 pt -51.64 -40.8 26.77 Favored 'Isoleucine or valine' 0 C--O 1.215 -0.749 0 N-CA-C 106.718 -1.586 . . . . 1.0 106.718 178.207 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 113' ' ' ASN . . . . . 0.446 ' N ' ' O ' ' A' ' 109' ' ' ILE . 26.5 t-20 -45.78 -51.83 12.1 Favored 'General case' 0 CA--C 1.503 -0.836 0 CA-C-N 114.047 -1.433 . . . . 1.0 108.041 -176.49 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -64.02 -27.36 69.07 Favored 'General case' 0 N--CA 1.435 -1.195 0 C-N-CA 119.494 -0.882 . . . . 1.0 109.957 177.763 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 115' ' ' ALA . . . . . 0.579 ' N ' ' O ' ' A' ' 112' ' ' ILE . . . -76.08 -60.56 2.28 Favored 'General case' 0 N--CA 1.444 -0.757 0 N-CA-C 107.546 -1.279 . . . . 1.0 107.546 177.852 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 116' ' ' ILE . . . . . 0.577 ' O ' ' C ' ' A' ' 117' ' ' GLU . 1.3 mp -47.69 -42.47 9.03 Favored 'Isoleucine or valine' 0 C--N 1.363 1.184 0 N-CA-C 108.198 -1.038 . . . . 1.0 108.198 178.768 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 117' ' ' GLU . . . . . 0.577 ' C ' ' O ' ' A' ' 116' ' ' ILE . 23.6 tt0 -38.92 -55.57 1.52 Allowed 'General case' 0 N--CA 1.472 0.671 0 N-CA-C 104.607 -2.368 . . . . 1.0 104.607 178.439 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 118' ' ' VAL . . . . . 0.434 ' N ' ' O ' ' A' ' 115' ' ' ALA . 40.5 t -70.13 -55.07 15.96 Favored 'Isoleucine or valine' 0 CA--C 1.559 1.306 0 CA-C-N 113.954 -1.476 . . . . 1.0 110.77 176.11 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -60.39 -19.62 56.56 Favored 'General case' 0 N--CA 1.49 1.565 0 N-CA-C 115.491 1.663 . . . . 1.0 115.491 -177.735 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 120' ' ' GLY . . . . . 0.512 ' O ' ' CB ' ' A' ' 121' ' ' THR . . . -121.09 -43.95 0.42 Allowed Glycine 0 C--N 1.354 1.554 0 N-CA-C 108.618 -1.793 . . . . 1.0 108.618 176.581 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 121' ' ' THR . . . . . 0.512 ' CB ' ' O ' ' A' ' 120' ' ' GLY . 45.8 m 127.54 -46.33 0.01 OUTLIER 'General case' 0 N--CA 1.48 1.057 0 C-N-CA 124.962 1.305 . . . . 1.0 108.5 -179.55 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 122' ' ' GLY . . . . . 0.666 ' O ' ' N ' ' A' ' 124' ' ' ASP . . . 104.33 -15.55 50.2 Favored Glycine 0 N--CA 1.472 1.093 0 N-CA-C 108.499 -1.84 . . . . 1.0 108.499 -178.448 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 123' ' ' THR . . . . . 0.402 ' O ' ' CG2' ' A' ' 123' ' ' THR . 9.5 t -55.43 82.84 0.0 OUTLIER 'General case' 0 C--N 1.322 -0.628 0 N-CA-C 105.436 -2.061 . . . . 1.0 105.436 178.576 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 124' ' ' ASP . . . . . 0.666 ' N ' ' O ' ' A' ' 122' ' ' GLY . 53.0 p30 -167.68 176.11 6.6 Favored 'General case' 0 C--N 1.342 0.281 0 CA-C-N 114.581 -1.19 . . . . 1.0 112.17 179.825 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 125' ' ' TYR . . . . . . . . . . . . . 2.3 t80 -138.83 138.85 37.89 Favored 'General case' 0 CA--C 1.535 0.395 0 N-CA-C 107.914 -1.143 . . . . 1.0 107.914 175.827 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 126' ' ' ARG . . . . . 0.438 HH22 HG22 ' A' ' 79' ' ' ILE . 1.3 mmp_? -145.63 145.12 30.82 Favored 'General case' 0 N--CA 1.47 0.555 0 N-CA-C 109.187 -0.671 . . . . 1.0 109.187 179.399 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 127' ' ' PHE . . . . . . . . . . . . . 6.5 p90 . . . . . 0 N--CA 1.47 0.571 0 CA-C-O 117.958 -1.02 . . . . 1.0 110.734 -179.651 . . . . . . . . 0 0 . 1 . 026 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 62.2 mtt . . . . . 0 N--CA 1.491 1.615 0 N-CA-C 109.025 -0.731 . . . . 1.0 109.025 . . . . . . . . . 0 0 . 1 . 026 nuclear orig core ' A' A ' 2' ' ' SER . . . . . 0.413 ' O ' ' CB ' ' A' ' 3' ' ' ASP . 61.2 p -104.65 9.4 35.2 Favored 'General case' 0 N--CA 1.467 0.389 0 C-N-CA 122.578 0.351 . . . . 1.0 110.925 -179.548 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 3' ' ' ASP . . . . . 0.413 ' CB ' ' O ' ' A' ' 2' ' ' SER . 0.9 OUTLIER 166.15 99.2 0.0 OUTLIER 'General case' 0 N--CA 1.466 0.357 0 O-C-N 123.411 0.444 . . . . 1.0 110.842 179.25 . . . . . . . . 3 3 . 1 . 026 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 65.9 t80 -149.97 144.67 25.99 Favored 'General case' 0 C--O 1.233 0.185 0 N-CA-C 110.045 -0.354 . . . . 1.0 110.045 179.446 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 45.2 m-20 -151.8 147.89 27.2 Favored 'General case' 0 C--N 1.331 -0.226 0 N-CA-C 109.909 -0.404 . . . . 1.0 109.909 -179.976 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 6' ' ' THR . . . . . 0.647 ' O ' ' N ' ' A' ' 10' ' ' SER . 18.9 m -68.9 174.64 4.24 Favored 'General case' 0 C--O 1.214 -0.801 0 C-N-CA 120.188 -0.605 . . . . 1.0 109.868 -179.924 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . 0.585 ' O ' ' N ' ' A' ' 11' ' ' ARG . 80.1 tt0 -60.76 -53.91 51.57 Favored 'General case' 0 C--N 1.314 -0.935 0 CA-C-O 121.814 0.816 . . . . 1.0 109.862 -177.982 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 8' ' ' ARG . . . . . 0.499 ' O ' ' CB ' ' A' ' 12' ' ' ALA . 18.3 ttm105 -53.19 -57.63 9.83 Favored 'General case' 0 C--N 1.309 -1.17 0 C-N-CA 119.103 -1.039 . . . . 1.0 108.283 -178.456 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . 0.471 ' O ' ' CG2' ' A' ' 13' ' ' VAL . 0.0 OUTLIER -65.09 -47.44 87.78 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.807 0 CA-C-N 113.913 -1.494 . . . . 1.0 110.227 179.687 . . . . . . . . 3 3 . 1 . 026 nuclear orig core ' A' A ' 10' ' ' SER . . . . . 0.647 ' N ' ' O ' ' A' ' 6' ' ' THR . 35.0 t -62.99 -59.78 4.35 Favored 'General case' 0 N--CA 1.477 0.877 0 C-N-CA 119.504 -0.879 . . . . 1.0 109.0 179.575 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 11' ' ' ARG . . . . . 0.59 ' O ' ' N ' ' A' ' 15' ' ' ALA . 2.6 tpt180 -64.62 -56.13 15.87 Favored 'General case' 0 N--CA 1.474 0.747 0 CA-C-O 120.796 0.331 . . . . 1.0 111.094 -177.667 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . 0.499 ' CB ' ' O ' ' A' ' 8' ' ' ARG . . . -51.57 -51.12 58.01 Favored 'General case' 0 N--CA 1.485 1.318 0 N-CA-C 106.714 -1.588 . . . . 1.0 106.714 -178.952 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . 0.595 ' O ' ' CB ' ' A' ' 17' ' ' LEU . 64.1 t -61.67 -50.06 81.79 Favored 'Isoleucine or valine' 0 C--O 1.202 -1.408 0 C-N-CA 118.448 -1.301 . . . . 1.0 108.542 178.044 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . 0.464 ' N ' ' O ' ' A' ' 10' ' ' SER . . . -58.72 -61.12 2.85 Favored 'General case' 0 C--O 1.214 -0.78 0 C-N-CA 118.273 -1.371 . . . . 1.0 109.51 179.511 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . 0.59 ' N ' ' O ' ' A' ' 11' ' ' ARG . . . -53.06 -57.02 11.82 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-O 121.727 0.775 . . . . 1.0 110.499 -178.461 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . 0.441 ' CB ' ' O ' ' A' ' 12' ' ' ALA . . . -62.14 -53.2 58.79 Favored 'General case' 0 C--N 1.31 -1.151 0 CA-C-N 114.666 -1.152 . . . . 1.0 108.658 -179.086 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . 0.595 ' CB ' ' O ' ' A' ' 13' ' ' VAL . 6.3 tp -57.19 -52.84 63.71 Favored 'General case' 0 N--CA 1.475 0.814 0 CA-C-N 114.335 -1.302 . . . . 1.0 108.832 -177.918 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . 0.562 HG23 ' H ' ' A' ' 19' ' ' GLY . 3.1 m -68.62 -56.12 13.46 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.521 0 C-N-CA 119.498 -0.881 . . . . 1.0 109.693 179.215 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . 0.572 ' N ' ' O ' ' A' ' 15' ' ' ALA . . . -63.73 -169.52 1.49 Allowed Glycine 0 CA--C 1.525 0.695 0 N-CA-C 112.118 -0.393 . . . . 1.0 112.118 -178.966 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 20' ' ' PRO . . . . . 0.603 ' O ' ' N ' ' A' ' 24' ' ' ALA . 1.0 OUTLIER -79.42 -23.88 6.94 Favored 'Trans proline' 0 C--N 1.311 -1.401 0 C-N-CA 122.925 2.417 . . . . 1.0 112.993 -179.1 . . . . . . . . 3 3 . 1 . 026 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -59.71 -58.6 13.41 Favored Glycine 0 N--CA 1.475 1.3 0 C-N-CA 119.789 -1.196 . . . . 1.0 111.877 -176.674 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . 0.401 ' H ' ' CA ' ' A' ' 16' ' ' ALA . . . -59.74 -51.76 57.04 Favored Glycine 0 CA--C 1.501 -0.815 0 N-CA-C 106.86 -2.496 . . . . 1.0 106.86 -178.012 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 29.5 t -58.32 -35.78 55.25 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.032 0 CA-C-N 114.126 -1.037 . . . . 1.0 108.941 -179.758 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . 0.603 ' N ' ' O ' ' A' ' 20' ' ' PRO . . . -61.92 -60.48 3.57 Favored 'General case' 0 CA--C 1.536 0.429 0 C-N-CA 118.524 -1.27 . . . . 1.0 110.255 -179.921 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 9.9 mp -65.02 -44.96 87.43 Favored 'General case' 0 C--N 1.344 0.332 0 CA-C-N 119.257 0.935 . . . . 1.0 112.408 -177.69 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 89.6 t -62.17 -58.79 5.99 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.308 0 C-N-CA 118.826 -1.149 . . . . 1.0 110.268 -177.311 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 1.3 p -60.28 -35.31 61.42 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 O-C-N 121.802 -0.561 . . . . 1.0 112.269 -177.476 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 14.0 tmtt? -67.88 -54.58 17.78 Favored 'General case' 0 C--N 1.318 -0.788 0 CA-C-O 121.449 0.643 . . . . 1.0 110.077 -178.591 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 9.9 p -63.11 -45.21 99.22 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.834 0 C-N-CA 119.338 -0.945 . . . . 1.0 110.508 -178.333 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 30' ' ' CYS . . . . . . . . . . . . . 1.4 t -66.3 -60.94 2.3 Favored 'General case' 0 CA--C 1.532 0.256 0 C-N-CA 119.123 -1.031 . . . . 1.0 110.004 -179.607 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -64.65 -52.81 55.4 Favored 'General case' 0 CA--C 1.511 -0.536 0 N-CA-C 112.923 0.712 . . . . 1.0 112.923 -176.44 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 85.02 74.38 1.25 Allowed Glycine 0 CA--C 1.526 0.764 0 N-CA-C 109.135 -1.586 . . . . 1.0 109.135 -177.256 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 23.1 mt 86.09 95.49 0.03 OUTLIER Pre-proline 0 N--CA 1.479 0.983 0 C-N-CA 123.676 0.79 . . . . 1.0 110.521 -179.17 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 47.5 Cg_endo -68.3 -27.76 34.11 Favored 'Trans proline' 0 N--CA 1.506 2.26 0 C-N-CA 122.221 1.947 . . . . 1.0 115.085 -177.843 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -62.08 -58.72 11.46 Favored Glycine 0 CA--C 1.53 1.029 0 C-N-CA 118.233 -1.937 . . . . 1.0 109.383 -178.678 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . 0.499 ' O ' ' CB ' ' A' ' 37' ' ' ILE . 11.3 p -88.88 162.09 2.61 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.462 0 N-CA-C 106.231 -1.766 . . . . 1.0 106.231 177.215 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . 0.499 ' CB ' ' O ' ' A' ' 36' ' ' VAL . 0.0 OUTLIER 118.99 120.01 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.476 0.865 0 C-N-CA 124.322 1.049 . . . . 1.0 108.506 -179.238 . . . . . . . . 3 3 . 1 . 026 nuclear orig core ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 46.8 m80 -142.11 133.85 27.01 Favored 'General case' 0 C--N 1.332 -0.154 0 N-CA-C 108.412 -0.958 . . . . 1.0 108.412 179.072 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -110.38 134.87 20.69 Favored Pre-proline 0 C--N 1.325 -0.464 0 N-CA-C 108.439 -0.949 . . . . 1.0 108.439 -179.716 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 37.1 Cg_endo -66.36 -85.55 0.01 OUTLIER 'Trans proline' 0 N--CA 1.49 1.31 0 CA-C-N 119.994 1.034 . . . . 1.0 111.469 -179.047 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -66.16 121.9 16.22 Favored 'General case' 0 C--N 1.317 -0.808 0 CA-C-N 114.991 -1.004 . . . . 1.0 110.298 -178.714 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . 0.672 ' C ' ' H ' ' A' ' 44' ' ' GLY . 34.2 ptt180 -169.15 166.04 10.9 Favored 'General case' 0 N--CA 1.434 -1.27 0 N-CA-C 109.133 -0.691 . . . . 1.0 109.133 179.062 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 43' ' ' ARG . . . . . 0.587 ' HG3' ' O ' ' A' ' 45' ' ' PHE . 0.0 OUTLIER -65.33 25.07 0.02 OUTLIER 'General case' 0 C--N 1.311 -1.078 0 CA-C-N 115.717 -0.674 . . . . 1.0 110.249 -179.067 . . . . . . . . 3 3 . 1 . 026 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . 0.672 ' H ' ' C ' ' A' ' 42' ' ' ARG . . . 76.63 -24.92 1.78 Allowed Glycine 0 C--N 1.345 1.072 0 N-CA-C 111.869 -0.492 . . . . 1.0 111.869 179.27 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . 0.739 ' O ' ' HB2' ' A' ' 46' ' ' PHE . 35.2 t80 -162.76 164.81 26.11 Favored 'General case' 0 C--O 1.198 -1.606 0 CA-C-O 119.003 -0.522 . . . . 1.0 110.155 -179.268 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 46' ' ' PHE . . . . . 0.739 ' HB2' ' O ' ' A' ' 45' ' ' PHE . 2.7 t80 131.18 93.07 0.0 OUTLIER 'General case' 0 N--CA 1.517 2.894 0 C-N-CA 124.396 1.078 . . . . 1.0 111.134 178.125 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 47' ' ' ARG . . . . . 0.531 ' CB ' ' O ' ' A' ' 46' ' ' PHE . 2.1 tmm_? 118.46 151.82 0.0 OUTLIER 'General case' 0 N--CA 1.482 1.13 0 C-N-CA 124.697 1.199 . . . . 1.0 108.842 -179.981 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER 70.3 70.98 0.21 Allowed 'General case' 0 CA--C 1.534 0.357 0 N-CA-C 108.316 -0.994 . . . . 1.0 108.316 -177.918 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -134.75 140.11 34.37 Favored Pre-proline 0 CA--C 1.541 0.597 0 N-CA-C 108.467 -0.938 . . . . 1.0 108.467 -179.018 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 50' ' ' PRO . . . . . 0.444 ' C ' ' H ' ' A' ' 52' ' ' ARG . 55.3 Cg_endo -66.9 69.22 0.53 Allowed 'Trans proline' 0 N--CA 1.5 1.887 0 C-N-CA 121.793 1.662 . . . . 1.0 112.74 -179.032 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . 0.452 ' N ' ' CD ' ' A' ' 51' ' ' GLU . 0.7 OUTLIER 63.64 -9.16 0.14 Allowed 'General case' 0 N--CA 1.468 0.439 0 N-CA-C 112.574 0.583 . . . . 1.0 112.574 179.868 . . . . . . . . 3 3 . 1 . 026 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . 0.444 ' H ' ' C ' ' A' ' 50' ' ' PRO . 0.0 OUTLIER -76.6 168.99 19.11 Favored 'General case' 0 N--CA 1.466 0.36 0 C-N-CA 119.781 -0.768 . . . . 1.0 110.5 179.747 . . . . . . . . 3 3 . 1 . 026 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . 0.457 ' O ' ' N ' ' A' ' 55' ' ' ILE . 8.2 pt -81.42 135.77 24.41 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.464 0 CA-C-O 122.018 0.913 . . . . 1.0 110.97 -179.974 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 6.3 pm0 -61.42 83.14 0.01 OUTLIER 'General case' 0 C--N 1.314 -0.967 0 CA-C-N 113.712 -1.585 . . . . 1.0 108.82 -178.303 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . 0.457 ' N ' ' O ' ' A' ' 53' ' ' ILE . 20.8 tt -150.47 158.74 5.1 Favored 'Isoleucine or valine' 0 C--N 1.354 0.776 0 CA-C-N 116.429 -0.35 . . . . 1.0 110.654 178.255 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 107.72 -5.94 35.21 Favored Glycine 0 N--CA 1.486 2.017 0 N-CA-C 111.491 -0.644 . . . . 1.0 111.491 179.319 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . 0.445 ' CG ' ' NH1' ' A' ' 43' ' ' ARG . 8.4 p-10 -78.56 103.54 8.57 Favored 'General case' 0 C--N 1.311 -1.102 0 CA-C-N 114.501 -0.85 . . . . 1.0 109.91 178.604 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 58' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -89.74 173.15 8.44 Favored 'General case' 0 CA--C 1.555 1.169 0 CA-C-O 123.375 1.559 . . . . 1.0 114.417 -176.976 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 59' ' ' ARG . . . . . 0.501 ' HE ' ' N ' ' A' ' 59' ' ' ARG . 0.0 OUTLIER -74.04 -61.04 1.99 Allowed 'General case' 0 N--CA 1.479 0.993 0 CA-C-N 111.414 -2.63 . . . . 1.0 111.694 -178.825 . . . . . . . . 3 3 . 1 . 026 nuclear orig core ' A' A ' 60' ' ' TYR . . . . . 0.544 ' CG ' ' O ' ' A' ' 60' ' ' TYR . 65.9 t80 -92.17 -8.91 44.22 Favored 'General case' 0 C--O 1.244 0.813 0 C-N-CA 124.593 1.157 . . . . 1.0 113.241 -179.661 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -79.12 -17.32 55.3 Favored 'General case' 0 N--CA 1.432 -1.346 0 O-C-N 121.348 -0.845 . . . . 1.0 111.366 -178.347 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 62' ' ' VAL . . . . . 0.655 ' O ' ' N ' ' A' ' 66' ' ' GLY . 25.9 m -49.02 -54.49 5.28 Favored 'Isoleucine or valine' 0 C--O 1.199 -1.603 0 C-N-CA 119.802 -0.759 . . . . 1.0 110.512 -174.954 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 63' ' ' ALA . . . . . 0.403 ' O ' ' N ' ' A' ' 67' ' ' ARG . . . -69.03 -49.7 55.3 Favored 'General case' 0 C--N 1.308 -1.225 0 O-C-N 121.498 -0.751 . . . . 1.0 109.539 -179.427 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 1.0 OUTLIER -50.18 -56.57 10.49 Favored 'General case' 0 CA--C 1.54 0.592 0 CA-C-N 115.226 -0.897 . . . . 1.0 108.613 -179.005 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 65' ' ' ASP . . . . . 0.617 ' C ' ' H ' ' A' ' 67' ' ' ARG . 32.7 t0 -74.69 -46.46 37.64 Favored 'General case' 0 C--N 1.317 -0.832 0 CA-C-N 115.594 -0.73 . . . . 1.0 110.115 178.094 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . 0.655 ' N ' ' O ' ' A' ' 62' ' ' VAL . . . -72.92 25.19 0.8 Allowed Glycine 0 N--CA 1.444 -0.822 0 N-CA-C 109.663 -1.375 . . . . 1.0 109.663 177.556 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 67' ' ' ARG . . . . . 0.627 ' O ' ' N ' ' A' ' 69' ' ' LEU . 0.0 OUTLIER -72.49 6.2 2.52 Favored 'General case' 0 N--CA 1.452 -0.335 0 N-CA-C 105.477 -2.045 . . . . 1.0 105.477 174.761 . . . . . . . . 3 3 . 1 . 026 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . 0.584 ' H ' ' C ' ' A' ' 66' ' ' GLY . 0.0 OUTLIER -33.1 -28.45 0.01 OUTLIER 'General case' 0 N--CA 1.483 1.202 0 N-CA-C 108.565 -0.902 . . . . 1.0 108.565 -175.746 . . . . . . . . 3 3 . 1 . 026 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . 0.627 ' N ' ' O ' ' A' ' 67' ' ' ARG . 8.5 tt -62.77 -64.33 0.95 Allowed 'General case' 0 C--N 1.323 -0.581 0 C-N-CA 118.797 -1.161 . . . . 1.0 108.988 178.476 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . 0.59 ' C ' ' H ' ' A' ' 72' ' ' HIS . . . -78.76 -74.45 0.28 Allowed 'General case' 0 N--CA 1.475 0.802 0 N-CA-C 105.485 -2.042 . . . . 1.0 105.485 176.657 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 71' ' ' ALA . . . . . 0.457 ' O ' ' C ' ' A' ' 72' ' ' HIS . . . -44.14 2.99 0.0 OUTLIER 'General case' 0 C--N 1.332 -0.158 0 C-N-CA 125.255 1.422 . . . . 1.0 114.352 179.687 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 72' ' ' HIS . . . . . 0.626 ' CG ' ' N ' ' A' ' 73' ' ' MET . 0.0 OUTLIER -28.49 -64.8 0.09 Allowed 'General case' 0 N--CA 1.47 0.564 0 CA-C-N 118.834 0.743 . . . . 1.0 111.585 -178.335 . . . . . . . . 3 3 . 1 . 026 nuclear orig core ' A' A ' 73' ' ' MET . . . . . 0.626 ' N ' ' CG ' ' A' ' 72' ' ' HIS . 2.9 ptp -69.65 -50.69 41.67 Favored 'General case' 0 C--N 1.32 -0.685 0 C-N-CA 119.279 -0.968 . . . . 1.0 108.881 179.042 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . 0.711 ' C ' ' H ' ' A' ' 76' ' ' GLY . 86.2 t -44.85 -41.84 2.3 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.329 0 CA-C-O 117.628 -1.177 . . . . 1.0 111.433 -176.385 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 75' ' ' ASN . . . . . 0.523 ' O ' ' N ' ' A' ' 78' ' ' VAL . 4.1 t30 -37.03 -13.45 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.703 0 CA-C-N 121.307 1.867 . . . . 1.0 112.802 179.431 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 76' ' ' GLY . . . . . 0.711 ' H ' ' C ' ' A' ' 74' ' ' VAL . . . -44.56 -25.98 0.96 Allowed Glycine 0 CA--C 1.544 1.897 0 CA-C-N 113.294 -1.776 . . . . 1.0 108.711 177.898 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 77' ' ' ILE . . . . . 0.627 ' O ' ' N ' ' A' ' 80' ' ' ALA . 0.2 OUTLIER -69.03 -48.07 71.89 Favored 'Isoleucine or valine' 0 C--O 1.209 -1.052 0 N-CA-C 107.519 -1.289 . . . . 1.0 107.519 178.07 . . . . . . . . 3 3 . 1 . 026 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . 0.524 ' C ' ' O ' ' A' ' 77' ' ' ILE . 77.3 t -32.89 -35.59 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.476 0.856 0 CA-C-N 114.658 -1.155 . . . . 1.0 108.036 -176.391 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . 0.531 ' N ' ' O ' ' A' ' 77' ' ' ILE . 39.0 pt -98.61 -28.44 3.56 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.948 0 CA-C-O 121.261 0.553 . . . . 1.0 111.813 176.932 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 80' ' ' ALA . . . . . 0.627 ' N ' ' O ' ' A' ' 77' ' ' ILE . . . -86.77 -13.76 44.26 Favored 'General case' 0 N--CA 1.477 0.922 0 N-CA-C 114.06 1.133 . . . . 1.0 114.06 178.557 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 81' ' ' GLU . . . . . 0.628 ' CG ' ' H ' ' A' ' 82' ' ' ASP . 16.1 pt-20 -83.13 -69.26 0.64 Allowed 'General case' 0 C--N 1.345 0.373 0 CA-C-N 119.042 0.837 . . . . 1.0 108.797 -179.676 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 82' ' ' ASP . . . . . 0.628 ' H ' ' CG ' ' A' ' 81' ' ' GLU . 67.1 m-20 -75.64 -10.79 59.74 Favored 'General case' 0 N--CA 1.442 -0.844 0 CA-C-N 118.075 0.398 . . . . 1.0 110.833 179.453 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . 0.601 ' O ' ' N ' ' A' ' 86' ' ' ALA . . . -19.84 -44.37 0.0 OUTLIER 'General case' 0 N--CA 1.472 0.643 0 N-CA-C 112.577 0.584 . . . . 1.0 112.577 177.029 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . 0.579 ' N ' ' O ' ' A' ' 82' ' ' ASP . 5.9 tp -31.65 -33.53 0.01 OUTLIER 'General case' 0 N--CA 1.473 0.702 0 CA-C-N 118.319 0.509 . . . . 1.0 111.746 -177.961 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 85' ' ' ILE . . . . . 0.597 ' O ' ' CG2' ' A' ' 89' ' ' VAL . 47.8 pt -100.51 -37.19 5.46 Favored 'Isoleucine or valine' 0 C--O 1.208 -1.108 0 N-CA-C 109.096 -0.705 . . . . 1.0 109.096 176.133 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 86' ' ' ALA . . . . . 0.601 ' N ' ' O ' ' A' ' 83' ' ' ALA . . . -66.24 -59.41 3.76 Favored 'General case' 0 C--N 1.317 -0.805 0 C-N-CA 119.647 -0.821 . . . . 1.0 111.381 -179.908 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -69.43 -18.36 63.73 Favored 'General case' 0 N--CA 1.47 0.544 0 CA-C-N 120.344 1.429 . . . . 1.0 112.294 -179.627 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -88.64 -13.1 40.67 Favored 'General case' 0 N--CA 1.475 0.817 0 CA-C-O 122.645 1.212 . . . . 1.0 108.141 179.358 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 89' ' ' VAL . . . . . 0.597 ' CG2' ' O ' ' A' ' 85' ' ' ILE . 53.3 t -92.22 39.66 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.32 -0.7 0 CA-C-N 111.953 -2.385 . . . . 1.0 109.474 177.654 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 90' ' ' GLY . . . . . 0.776 ' O ' ' N ' ' A' ' 92' ' ' HIS . . . -64.22 -30.17 77.05 Favored Glycine 0 C--N 1.371 2.476 0 CA-C-O 117.902 -1.499 . . . . 1.0 109.969 176.893 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 91' ' ' PRO . . . . . 0.55 ' HD2' ' N ' ' A' ' 90' ' ' GLY . 72.6 Cg_exo -40.26 -5.78 0.01 OUTLIER 'Trans proline' 0 N--CA 1.488 1.205 0 CA-C-N 120.926 2.363 . . . . 1.0 111.111 174.556 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 92' ' ' HIS . . . . . 0.776 ' N ' ' O ' ' A' ' 90' ' ' GLY . 2.5 p-80 -48.82 -24.48 1.45 Allowed 'General case' 0 N--CA 1.435 -1.211 0 N-CA-C 106.593 -1.632 . . . . 1.0 106.593 179.731 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 93' ' ' LEU . . . . . 0.505 ' HG ' ' H ' ' A' ' 94' ' ' ALA . 1.2 pp -60.54 -53.48 56.95 Favored 'General case' 0 N--CA 1.445 -0.697 0 N-CA-C 106.493 -1.669 . . . . 1.0 106.493 176.088 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 94' ' ' ALA . . . . . 0.533 ' N ' ' O ' ' A' ' 91' ' ' PRO . . . -51.09 -53.17 36.45 Favored 'General case' 0 C--O 1.212 -0.899 0 N-CA-C 107.409 -1.33 . . . . 1.0 107.409 179.465 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 95' ' ' ARG . . . . . 0.445 ' HE ' ' HD3' ' A' ' 20' ' ' PRO . 4.5 mmp_? -61.94 -28.43 69.53 Favored 'General case' 0 CA--C 1.549 0.924 0 CA-C-O 122.297 1.046 . . . . 1.0 110.09 178.27 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 96' ' ' ALA . . . . . 0.905 ' O ' ' N ' ' A' ' 100' ' ' ILE . . . -50.4 -36.68 33.86 Favored 'General case' 0 C--O 1.195 -1.783 0 N-CA-C 107.105 -1.442 . . . . 1.0 107.105 -176.364 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 97' ' ' LEU . . . . . 0.441 ' C ' ' O ' ' A' ' 96' ' ' ALA . 0.4 OUTLIER -35.0 -23.9 0.01 OUTLIER 'General case' 0 CA--C 1.587 2.403 0 CA-C-N 113.48 -1.691 . . . . 1.0 108.512 -177.214 . . . . . . . . 3 3 . 1 . 026 nuclear orig core ' A' A ' 98' ' ' GLY . . . . . 0.657 ' N ' ' O ' ' A' ' 96' ' ' ALA . . . -88.8 -53.02 2.65 Favored Glycine 0 CA--C 1.55 2.221 0 CA-C-O 123.223 1.457 . . . . 1.0 110.644 171.577 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 99' ' ' GLN . . . . . 0.586 ' N ' ' O ' ' A' ' 96' ' ' ALA . 12.2 mp0 -76.99 7.05 5.28 Favored 'General case' 0 N--CA 1.435 -1.178 0 N-CA-C 106.373 -1.714 . . . . 1.0 106.373 176.787 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 100' ' ' ILE . . . . . 0.905 ' N ' ' O ' ' A' ' 96' ' ' ALA . 0.3 OUTLIER -60.23 -52.99 54.87 Favored 'Isoleucine or valine' 0 CA--C 1.487 -1.476 0 N-CA-C 104.806 -2.294 . . . . 1.0 104.806 178.185 . . . . . . . . 3 3 . 1 . 026 nuclear orig core ' A' A ' 101' ' ' VAL . . . . . 0.556 ' O ' ' N ' ' A' ' 105' ' ' GLY . 21.5 t -49.3 -60.41 0.74 Allowed 'Isoleucine or valine' 0 C--O 1.222 -0.394 0 C-N-CA 117.752 -1.579 . . . . 1.0 107.837 178.581 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 102' ' ' CYS . . . . . 0.413 ' SG ' ' O ' ' A' ' 99' ' ' GLN . 0.5 OUTLIER -50.17 -30.46 11.4 Favored 'General case' 0 C--N 1.317 -0.825 0 CA-C-N 114.931 -1.031 . . . . 1.0 110.961 -178.265 . . . . . . . . 3 3 . 1 . 026 nuclear orig core ' A' A ' 103' ' ' ARG . . . . . 0.426 ' N ' ' O ' ' A' ' 99' ' ' GLN . 0.0 OUTLIER -83.69 -53.84 5.35 Favored 'General case' 0 N--CA 1.486 1.335 0 N-CA-C 114.205 1.187 . . . . 1.0 114.205 -179.322 . . . . . . . . 3 3 . 1 . 026 nuclear orig core ' A' A ' 104' ' ' TYR . . . . . 0.662 ' CG ' ' O ' ' A' ' 104' ' ' TYR . 0.0 OUTLIER -94.1 21.5 6.76 Favored 'General case' 0 C--N 1.311 -1.09 0 C-N-CA 126.469 1.908 . . . . 1.0 107.871 179.122 . . . . . . . . 3 3 . 1 . 026 nuclear orig core ' A' A ' 105' ' ' GLY . . . . . 0.556 ' N ' ' O ' ' A' ' 101' ' ' VAL . . . -156.76 -91.14 0.08 OUTLIER Glycine 0 N--CA 1.445 -0.733 0 N-CA-C 106.822 -2.511 . . . . 1.0 106.822 177.2 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 106' ' ' ALA . . . . . 0.46 ' C ' ' H ' ' A' ' 108' ' ' VAL . . . 72.81 46.76 0.24 Allowed 'General case' 0 N--CA 1.449 -0.498 0 N-CA-C 112.076 0.398 . . . . 1.0 112.076 -179.94 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 10.3 t -76.67 7.22 4.83 Favored 'General case' 0 CA--C 1.513 -0.479 0 O-C-N 119.986 -1.696 . . . . 1.0 107.045 176.402 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 108' ' ' VAL . . . . . 0.46 ' H ' ' C ' ' A' ' 106' ' ' ALA . 18.7 m -86.78 -52.53 11.65 Favored 'Isoleucine or valine' 0 C--N 1.35 0.615 0 CA-C-O 117.945 -1.026 . . . . 1.0 110.298 177.51 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 109' ' ' ILE . . . . . 0.448 ' O ' ' OD1' ' A' ' 113' ' ' ASN . 0.1 OUTLIER -47.91 -33.93 4.99 Favored Pre-proline 0 C--N 1.368 1.394 0 N-CA-C 116.8 2.148 . . . . 1.0 116.8 -177.587 . . . . . . . . 3 3 . 1 . 026 nuclear orig core ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 50.4 Cg_exo -54.79 -47.42 26.81 Favored 'Trans proline' 0 C--N 1.308 -1.564 0 CA-C-N 122.558 1.949 . . . . 1.0 112.439 -176.942 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 111' ' ' ASN . . . . . 0.4 ' O ' ' N ' ' A' ' 114' ' ' ALA . 24.7 t-20 -72.29 -67.35 0.55 Allowed 'General case' 0 N--CA 1.467 0.4 0 C-N-CA 119.995 -0.682 . . . . 1.0 111.491 -177.184 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 112' ' ' ILE . . . . . 0.626 ' O ' ' N ' ' A' ' 116' ' ' ILE . 0.9 OUTLIER -46.42 -28.85 0.97 Allowed 'Isoleucine or valine' 0 C--O 1.192 -1.948 0 O-C-N 121.927 -0.483 . . . . 1.0 111.99 -178.3 . . . . . . . . 3 3 . 1 . 026 nuclear orig core ' A' A ' 113' ' ' ASN . . . . . 0.448 ' OD1' ' O ' ' A' ' 109' ' ' ILE . 4.3 m120 -72.0 -40.2 68.7 Favored 'General case' 0 N--CA 1.483 1.217 0 CA-C-O 123.544 1.64 . . . . 1.0 108.231 179.859 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 114' ' ' ALA . . . . . 0.4 ' N ' ' O ' ' A' ' 111' ' ' ASN . . . -54.59 -50.0 69.07 Favored 'General case' 0 C--N 1.295 -1.796 0 CA-C-N 111.015 -2.812 . . . . 1.0 107.376 178.727 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 115' ' ' ALA . . . . . 0.722 ' O ' ' N ' ' A' ' 119' ' ' LEU . . . -85.13 -49.09 8.53 Favored 'General case' 0 C--O 1.199 -1.579 0 N-CA-C 114.402 1.26 . . . . 1.0 114.402 177.652 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 116' ' ' ILE . . . . . 0.626 ' N ' ' O ' ' A' ' 112' ' ' ILE . 0.6 OUTLIER -42.79 -49.15 1.15 Allowed 'Isoleucine or valine' 0 N--CA 1.513 2.714 0 N-CA-C 106.109 -1.811 . . . . 1.0 106.109 179.569 . . . . . . . . 3 3 . 1 . 026 nuclear orig core ' A' A ' 117' ' ' GLU . . . . . 0.439 ' C ' ' O ' ' A' ' 116' ' ' ILE . 68.3 mt-10 -45.99 -59.87 2.59 Favored 'General case' 0 C--N 1.308 -1.2 0 N-CA-C 105.573 -2.01 . . . . 1.0 105.573 177.907 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 118' ' ' VAL . . . . . 0.544 ' N ' ' O ' ' A' ' 115' ' ' ALA . 6.9 t -77.52 -57.37 5.83 Favored 'Isoleucine or valine' 0 CA--C 1.557 1.23 0 N-CA-C 113.558 0.947 . . . . 1.0 113.558 178.505 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 119' ' ' LEU . . . . . 0.722 ' N ' ' O ' ' A' ' 115' ' ' ALA . 1.3 tp -61.55 -24.44 66.64 Favored 'General case' 0 C--N 1.351 0.652 0 N-CA-C 116.218 1.933 . . . . 1.0 116.218 -178.728 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 120' ' ' GLY . . . . . 0.485 ' O ' ' CB ' ' A' ' 121' ' ' THR . . . -126.48 -54.93 0.15 Allowed Glycine 0 C--N 1.354 1.549 0 CA-C-N 120.506 1.503 . . . . 1.0 110.869 176.976 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 121' ' ' THR . . . . . 0.533 ' CG2' ' H ' ' A' ' 122' ' ' GLY . 2.1 t 143.39 -56.18 0.0 OUTLIER 'General case' 0 N--CA 1.477 0.907 0 C-N-CA 124.089 0.956 . . . . 1.0 112.036 -177.915 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 122' ' ' GLY . . . . . 0.592 ' O ' ' N ' ' A' ' 124' ' ' ASP . . . 92.6 -23.27 28.97 Favored Glycine 0 CA--C 1.531 1.053 0 N-CA-C 107.725 -2.15 . . . . 1.0 107.725 -176.583 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 123' ' ' THR . . . . . 0.49 ' H ' ' C ' ' A' ' 121' ' ' THR . 5.8 t -46.94 91.94 0.01 OUTLIER 'General case' 0 N--CA 1.477 0.918 0 N-CA-C 105.64 -1.985 . . . . 1.0 105.64 179.239 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 124' ' ' ASP . . . . . 0.592 ' N ' ' O ' ' A' ' 122' ' ' GLY . 48.2 p30 -169.76 -174.82 1.94 Allowed 'General case' 0 CA--C 1.537 0.458 0 CA-C-N 114.904 -1.044 . . . . 1.0 112.38 178.739 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 125' ' ' TYR . . . . . . . . . . . . . 16.9 t80 -148.59 147.63 29.22 Favored 'General case' 0 CA--C 1.542 0.644 0 CA-C-N 114.385 -1.28 . . . . 1.0 109.059 175.686 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 13.8 mtp85 -146.94 150.41 35.14 Favored 'General case' 0 N--CA 1.476 0.85 0 N-CA-C 109.812 -0.44 . . . . 1.0 109.812 177.38 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 127' ' ' PHE . . . . . . . . . . . . . 26.7 p90 . . . . . 0 C--O 1.22 -0.449 0 CA-C-O 118.176 -0.916 . . . . 1.0 111.231 -179.353 . . . . . . . . 0 0 . 1 . 027 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.488 1.456 0 N-CA-C 108.667 -0.864 . . . . 1.0 108.667 . . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 93.4 p -88.4 0.58 56.07 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.576 -0.284 . . . . 1.0 111.316 -179.967 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 2.0 t70 164.65 118.65 0.01 OUTLIER 'General case' 0 N--CA 1.479 0.988 0 O-C-N 123.391 0.432 . . . . 1.0 111.277 178.916 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 58.2 t80 -151.74 148.39 27.83 Favored 'General case' 0 N--CA 1.465 0.322 0 CA-C-O 121.078 0.466 . . . . 1.0 110.191 177.997 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 30.9 m-20 -152.29 148.12 27.16 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.596 -0.729 . . . . 1.0 109.788 179.754 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 6' ' ' THR . . . . . 0.72 ' O ' ' N ' ' A' ' 10' ' ' SER . 0.2 OUTLIER -106.72 -168.7 1.45 Allowed 'General case' 0 C--O 1.205 -1.286 0 CA-C-O 121.602 0.715 . . . . 1.0 109.832 -179.967 . . . . . . . . 3 3 . 1 . 027 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . 0.502 ' O ' ' CB ' ' A' ' 11' ' ' ARG . 71.6 mm-40 -57.66 -46.59 84.03 Favored 'General case' 0 C--N 1.297 -1.68 0 N-CA-C 109.438 -0.578 . . . . 1.0 109.438 179.77 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 8' ' ' ARG . . . . . 0.544 ' O ' ' CB ' ' A' ' 12' ' ' ALA . 16.8 mtt85 -66.58 -61.64 1.88 Allowed 'General case' 0 C--N 1.316 -0.864 0 C-N-CA 117.373 -1.731 . . . . 1.0 109.595 179.609 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . 0.657 ' CG2' ' H ' ' A' ' 6' ' ' THR . 0.0 OUTLIER -61.73 -52.86 55.83 Favored 'Isoleucine or valine' 0 C--O 1.204 -1.311 0 CA-C-N 114.769 -1.105 . . . . 1.0 110.703 -179.679 . . . . . . . . 3 3 . 1 . 027 nuclear orig core ' A' A ' 10' ' ' SER . . . . . 0.72 ' N ' ' O ' ' A' ' 6' ' ' THR . 4.9 t -65.3 -61.5 2.08 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 122.074 -0.391 . . . . 1.0 111.619 178.761 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 11' ' ' ARG . . . . . 0.502 ' CB ' ' O ' ' A' ' 7' ' ' GLU . 29.4 ttt180 -62.06 -43.96 97.71 Favored 'General case' 0 C--N 1.31 -1.123 0 O-C-N 121.462 -0.774 . . . . 1.0 109.561 -175.698 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . 0.544 ' CB ' ' O ' ' A' ' 8' ' ' ARG . . . -70.33 -56.58 6.36 Favored 'General case' 0 N--CA 1.477 0.919 0 C-N-CA 118.825 -1.15 . . . . 1.0 109.161 176.801 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . 0.673 ' O ' ' CB ' ' A' ' 17' ' ' LEU . 55.0 t -61.46 -53.46 48.27 Favored 'Isoleucine or valine' 0 C--O 1.192 -1.961 0 C-N-CA 117.498 -1.681 . . . . 1.0 107.461 -178.779 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . 0.61 ' N ' ' O ' ' A' ' 10' ' ' SER . . . -62.82 -65.28 0.71 Allowed 'General case' 0 C--N 1.308 -1.217 0 C-N-CA 116.075 -2.25 . . . . 1.0 111.892 -179.814 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . 0.531 ' O ' ' N ' ' A' ' 19' ' ' GLY . . . -55.35 -55.49 30.92 Favored 'General case' 0 C--O 1.217 -0.64 0 C-N-CA 118.321 -1.352 . . . . 1.0 111.545 -176.7 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . 0.61 ' O ' ' N ' ' A' ' 22' ' ' GLY . . . -65.6 -58.67 5.2 Favored 'General case' 0 C--N 1.301 -1.502 0 C-N-CA 118.35 -1.34 . . . . 1.0 110.804 -178.491 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . 0.673 ' CB ' ' O ' ' A' ' 13' ' ' VAL . 5.7 tp -53.62 -55.3 27.02 Favored 'General case' 0 N--CA 1.489 1.504 0 N-CA-C 108.536 -0.913 . . . . 1.0 108.536 -179.294 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . 0.653 HG21 ' H ' ' A' ' 19' ' ' GLY . 2.2 m -71.03 -60.42 2.45 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.43 0 C-N-CA 118.975 -1.09 . . . . 1.0 110.85 -179.509 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . 0.653 ' H ' HG21 ' A' ' 18' ' ' VAL . . . -54.54 -163.26 0.01 OUTLIER Glycine 0 N--CA 1.438 -1.218 0 CA-C-O 121.567 0.537 . . . . 1.0 113.179 -176.969 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 20' ' ' PRO . . . . . 0.72 ' O ' ' N ' ' A' ' 24' ' ' ALA . 90.6 Cg_endo -80.48 -24.75 5.06 Favored 'Trans proline' 0 C--N 1.302 -1.884 0 C-N-CA 122.246 1.964 . . . . 1.0 111.712 -179.112 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -62.11 -60.84 7.35 Favored Glycine 0 N--CA 1.47 0.914 0 C-N-CA 118.685 -1.721 . . . . 1.0 111.059 -176.921 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . 0.61 ' N ' ' O ' ' A' ' 16' ' ' ALA . . . -60.71 -50.39 68.1 Favored Glycine 0 C--N 1.304 -1.207 0 N-CA-C 106.954 -2.459 . . . . 1.0 106.954 179.017 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 83.2 t -58.41 -34.05 49.52 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.582 0 C-N-CA 118.837 -1.145 . . . . 1.0 107.991 -179.72 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . 0.72 ' N ' ' O ' ' A' ' 20' ' ' PRO . . . -61.71 -61.23 2.66 Favored 'General case' 0 N--CA 1.468 0.468 0 C-N-CA 118.685 -1.206 . . . . 1.0 109.376 179.402 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 58.0 mt -60.42 -45.19 94.49 Favored 'General case' 0 CA--C 1.508 -0.673 0 C-N-CA 119.59 -0.844 . . . . 1.0 110.478 -176.512 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 55.4 t -59.83 -60.34 2.66 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.512 0 C-N-CA 119.325 -0.95 . . . . 1.0 109.692 -178.278 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . 0.443 ' O ' ' CB ' ' A' ' 31' ' ' ALA . 62.1 t -58.57 -40.16 78.02 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.363 0 C-N-CA 120.543 -0.463 . . . . 1.0 110.534 -177.828 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 10.9 tttm -66.56 -55.26 16.27 Favored 'General case' 0 C--N 1.314 -0.946 0 C-N-CA 119.855 -0.738 . . . . 1.0 109.82 -178.701 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . 0.476 ' CG1' ' N ' ' A' ' 30' ' ' CYS . 3.2 p -65.82 -50.8 68.13 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 CA-C-N 115.294 -0.866 . . . . 1.0 111.011 -177.32 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 30' ' ' CYS . . . . . 0.476 ' N ' ' CG1' ' A' ' 29' ' ' VAL . 42.0 t -67.59 -62.61 1.34 Allowed 'General case' 0 N--CA 1.44 -0.945 0 C-N-CA 119.837 -0.745 . . . . 1.0 110.597 -179.208 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . 0.443 ' CB ' ' O ' ' A' ' 27' ' ' VAL . . . -62.74 -53.33 55.96 Favored 'General case' 0 N--CA 1.434 -1.273 0 C-N-CA 120.578 -0.449 . . . . 1.0 111.378 -175.459 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 69.8 66.23 2.3 Favored Glycine 0 N--CA 1.441 -1.022 0 C-N-CA 119.225 -1.464 . . . . 1.0 109.828 -179.428 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . 0.509 ' O ' ' CD1' ' A' ' 37' ' ' ILE . 6.2 mt 87.55 96.15 0.03 OUTLIER Pre-proline 0 N--CA 1.481 1.108 0 O-C-N 126.232 1.784 . . . . 1.0 112.049 -179.535 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 54.4 Cg_exo -46.23 -8.21 0.04 OUTLIER 'Trans proline' 0 N--CA 1.497 1.681 0 C-N-CA 122.39 2.06 . . . . 1.0 114.184 -179.825 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . 0.467 ' N ' ' O ' ' A' ' 33' ' ' LEU . . . -61.25 -60.27 8.59 Favored Glycine 0 CA--C 1.538 1.472 0 C-N-CA 118.466 -1.826 . . . . 1.0 109.867 -178.668 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . 0.628 ' CG2' ' H ' ' A' ' 37' ' ' ILE . 7.1 p -88.55 -139.84 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.473 0.687 0 CA-C-N 117.87 0.835 . . . . 1.0 109.072 179.369 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . 0.628 ' H ' ' CG2' ' A' ' 36' ' ' VAL . 2.5 mp 68.27 79.65 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.47 0.554 0 N-CA-C 112.575 0.583 . . . . 1.0 112.575 179.655 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 38' ' ' HIS . . . . . 0.515 ' CD2' ' N ' ' A' ' 38' ' ' HIS . 0.0 OUTLIER -138.86 132.47 30.54 Favored 'General case' 0 CA--C 1.532 0.266 0 N-CA-C 108.383 -0.969 . . . . 1.0 108.383 178.397 . . . . . . . . 3 3 . 1 . 027 nuclear orig core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -107.43 159.3 30.7 Favored Pre-proline 0 N--CA 1.472 0.671 0 CA-C-N 116.515 -0.312 . . . . 1.0 110.182 -178.353 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 59.6 Cg_endo -71.97 -23.44 21.89 Favored 'Trans proline' 0 C--N 1.306 -1.668 0 C-N-CA 121.736 1.624 . . . . 1.0 111.947 178.668 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -119.76 83.99 2.13 Favored 'General case' 0 C--N 1.343 0.3 0 C-N-CA 120.553 -0.459 . . . . 1.0 110.582 179.281 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . 0.701 ' C ' ' H ' ' A' ' 44' ' ' GLY . 0.0 OUTLIER -103.86 135.26 45.73 Favored 'General case' 0 C--N 1.318 -0.803 0 CA-C-N 116.003 -0.544 . . . . 1.0 110.171 -177.644 . . . . . . . . 3 3 . 1 . 027 nuclear orig core ' A' A ' 43' ' ' ARG . . . . . 0.649 ' C ' ' H ' ' A' ' 45' ' ' PHE . 42.9 tpt85 -64.31 22.65 0.01 OUTLIER 'General case' 0 C--N 1.314 -0.943 0 C-N-CA 119.913 -0.715 . . . . 1.0 109.763 179.092 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . 0.701 ' H ' ' C ' ' A' ' 42' ' ' ARG . . . 70.45 -28.04 0.46 Allowed Glycine 0 C--N 1.345 1.053 0 N-CA-C 110.764 -0.934 . . . . 1.0 110.764 179.223 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . 0.649 ' H ' ' C ' ' A' ' 43' ' ' ARG . 31.0 p90 -164.71 172.61 12.83 Favored 'General case' 0 N--CA 1.45 -0.47 0 N-CA-C 108.521 -0.918 . . . . 1.0 108.521 -179.807 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 46' ' ' PHE . . . . . 0.569 ' HB2' ' O ' ' A' ' 45' ' ' PHE . 1.7 t80 116.16 96.41 0.0 OUTLIER 'General case' 0 N--CA 1.484 1.236 0 O-C-N 125.701 1.875 . . . . 1.0 108.153 -178.499 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 47' ' ' ARG . . . . . 0.547 ' O ' ' CB ' ' A' ' 48' ' ' CYS . 3.9 mmp_? 115.16 133.41 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.611 0 O-C-N 125.06 1.475 . . . . 1.0 109.859 -179.551 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 48' ' ' CYS . . . . . 0.547 ' CB ' ' O ' ' A' ' 47' ' ' ARG . 43.7 t 121.95 -5.59 0.0 OUTLIER 'General case' 0 CA--C 1.51 -0.595 0 O-C-N 125.305 1.628 . . . . 1.0 111.059 177.406 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -120.59 149.89 51.16 Favored Pre-proline 0 CA--C 1.534 0.356 0 N-CA-C 109.84 -0.43 . . . . 1.0 109.84 179.867 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 50' ' ' PRO . . . . . 0.573 ' C ' ' H ' ' A' ' 52' ' ' ARG . 98.9 Cg_endo -76.46 87.16 1.47 Allowed 'Trans proline' 0 N--CA 1.493 1.47 0 C-N-CA 122.277 1.985 . . . . 1.0 114.041 -179.888 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . 0.433 ' CD ' ' O ' ' A' ' 50' ' ' PRO . 0.0 OUTLIER 66.44 -32.7 0.18 Allowed 'General case' 0 N--CA 1.472 0.649 0 N-CA-C 112.09 0.404 . . . . 1.0 112.09 176.269 . . . . . . . . 3 3 . 1 . 027 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . 0.573 ' H ' ' C ' ' A' ' 50' ' ' PRO . 5.4 mtm180 -45.39 140.08 3.29 Favored 'General case' 0 C--N 1.315 -0.903 0 CA-C-O 121.941 0.877 . . . . 1.0 112.198 -178.094 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 2.2 tp -82.22 166.07 2.4 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 114.35 -1.295 . . . . 1.0 108.7 177.999 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 16.7 mt-30 -135.73 134.6 39.23 Favored 'General case' 0 N--CA 1.453 -0.288 0 N-CA-C 108.423 -0.954 . . . . 1.0 108.423 179.795 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 2.3 pp -142.68 153.66 17.6 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.366 0 N-CA-C 109.881 -0.414 . . . . 1.0 109.881 178.288 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 105.1 2.36 41.89 Favored Glycine 0 CA--C 1.529 0.95 0 N-CA-C 110.077 -1.209 . . . . 1.0 110.077 -178.348 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 58.0 m-20 -86.78 103.99 15.73 Favored 'General case' 0 N--CA 1.471 0.605 0 CA-C-O 122.141 0.972 . . . . 1.0 112.722 -178.333 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 58' ' ' TRP . . . . . . . . . . . . . 13.3 m95 -78.78 178.41 7.93 Favored 'General case' 0 C--N 1.315 -0.922 0 CA-C-N 113.484 -1.689 . . . . 1.0 108.937 177.879 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 59' ' ' ARG . . . . . 0.493 ' HG2' ' H ' ' A' ' 60' ' ' TYR . 0.0 OUTLIER -101.23 -56.95 2.19 Favored 'General case' 0 CA--C 1.557 1.244 0 CA-C-N 119.494 1.043 . . . . 1.0 112.533 178.814 . . . . . . . . 3 3 . 1 . 027 nuclear orig core ' A' A ' 60' ' ' TYR . . . . . 0.493 ' H ' ' HG2' ' A' ' 59' ' ' ARG . 63.2 t80 -80.5 -13.5 59.05 Favored 'General case' 0 N--CA 1.485 1.305 0 C-N-CA 125.341 1.456 . . . . 1.0 112.581 -178.209 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . 0.496 ' O ' ' N ' ' A' ' 64' ' ' HIS . 10.1 mt-10 -79.49 -14.59 58.79 Favored 'General case' 0 C--N 1.298 -1.641 0 CA-C-N 114.963 -1.017 . . . . 1.0 108.903 178.244 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 62' ' ' VAL . . . . . 0.456 ' O ' ' N ' ' A' ' 66' ' ' GLY . 13.4 m -44.26 -44.39 2.22 Favored 'Isoleucine or valine' 0 CA--C 1.491 -1.317 0 N-CA-C 109.331 -0.618 . . . . 1.0 109.331 -176.41 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 63' ' ' ALA . . . . . 0.529 ' O ' ' HG2' ' A' ' 67' ' ' ARG . . . -69.2 -46.74 66.71 Favored 'General case' 0 N--CA 1.411 -2.423 0 N-CA-C 107.947 -1.131 . . . . 1.0 107.947 177.61 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 64' ' ' HIS . . . . . 0.496 ' N ' ' O ' ' A' ' 61' ' ' GLU . 1.3 t-80 -56.04 -60.42 3.51 Favored 'General case' 0 CA--C 1.546 0.805 0 CA-C-N 115.512 -0.767 . . . . 1.0 111.049 178.891 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 65' ' ' ASP . . . . . 0.665 ' C ' ' H ' ' A' ' 67' ' ' ARG . 10.4 t70 -66.15 -54.69 22.35 Favored 'General case' 0 C--O 1.248 0.974 0 O-C-N 121.489 -0.757 . . . . 1.0 109.639 178.062 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . 0.456 ' N ' ' O ' ' A' ' 62' ' ' VAL . . . -63.22 32.49 0.08 OUTLIER Glycine 0 N--CA 1.471 0.982 0 N-CA-C 110.603 -0.999 . . . . 1.0 110.603 177.526 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 67' ' ' ARG . . . . . 0.665 ' H ' ' C ' ' A' ' 65' ' ' ASP . 0.2 OUTLIER -75.75 1.74 13.97 Favored 'General case' 0 N--CA 1.435 -1.197 0 CA-C-N 114.639 -0.781 . . . . 1.0 109.113 175.71 . . . . . . . . 3 3 . 1 . 027 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . 0.564 ' O ' ' HA ' ' A' ' 72' ' ' HIS . 10.2 mp -33.72 -29.67 0.01 OUTLIER 'General case' 0 N--CA 1.501 2.118 0 N-CA-C 106.848 -1.538 . . . . 1.0 106.848 -177.597 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . 0.63 ' N ' ' O ' ' A' ' 67' ' ' ARG . 5.2 tp -61.85 -65.61 0.66 Allowed 'General case' 0 CA--C 1.553 1.06 0 C-N-CA 117.825 -1.55 . . . . 1.0 107.441 175.439 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . 0.655 ' C ' ' H ' ' A' ' 72' ' ' HIS . . . -75.32 -68.59 0.54 Allowed 'General case' 0 N--CA 1.477 0.9 0 N-CA-C 106.456 -1.683 . . . . 1.0 106.456 175.684 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 71' ' ' ALA . . . . . 0.634 ' H ' ' HB3' ' A' ' 67' ' ' ARG . . . -47.17 2.54 0.0 OUTLIER 'General case' 0 N--CA 1.477 0.922 0 C-N-CA 124.686 1.194 . . . . 1.0 113.48 178.876 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 72' ' ' HIS . . . . . 0.655 ' H ' ' C ' ' A' ' 70' ' ' ALA . 0.3 OUTLIER -19.94 -82.63 0.0 OUTLIER 'General case' 0 C--N 1.324 -0.525 0 N-CA-C 113.589 0.959 . . . . 1.0 113.589 -174.259 . . . . . . . . 3 3 . 1 . 027 nuclear orig core ' A' A ' 73' ' ' MET . . . . . 0.647 ' H ' ' CD2' ' A' ' 72' ' ' HIS . 0.7 OUTLIER -74.29 -41.79 60.62 Favored 'General case' 0 C--N 1.3 -1.545 0 CA-C-N 118.928 0.786 . . . . 1.0 111.122 178.389 . . . . . . . . 3 3 . 1 . 027 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . 0.606 ' C ' ' H ' ' A' ' 76' ' ' GLY . 0.8 OUTLIER -44.74 -41.78 2.22 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.796 0 C-N-CA 119.694 -0.803 . . . . 1.0 110.441 -174.62 . . . . . . . . 3 3 . 1 . 027 nuclear orig core ' A' A ' 75' ' ' ASN . . . . . 0.581 ' C ' ' H ' ' A' ' 77' ' ' ILE . 28.2 t30 -39.16 -17.9 0.01 OUTLIER 'General case' 0 N--CA 1.48 1.033 0 CA-C-O 122.401 1.096 . . . . 1.0 110.964 178.029 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 76' ' ' GLY . . . . . 0.606 ' H ' ' C ' ' A' ' 74' ' ' VAL . . . -43.41 -16.14 0.03 OUTLIER Glycine 0 CA--C 1.564 3.095 0 N-CA-C 108.634 -1.786 . . . . 1.0 108.634 176.051 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 77' ' ' ILE . . . . . 0.784 ' O ' ' N ' ' A' ' 80' ' ' ALA . 2.6 pp -89.91 -46.0 15.08 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.227 0 N-CA-C 108.428 -0.953 . . . . 1.0 108.428 -179.354 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . 0.492 ' C ' ' O ' ' A' ' 77' ' ' ILE . 1.0 OUTLIER -34.34 -27.94 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.571 1.766 0 N-CA-C 108.775 -0.824 . . . . 1.0 108.775 -174.816 . . . . . . . . 3 3 . 1 . 027 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . 0.589 ' N ' ' O ' ' A' ' 77' ' ' ILE . 0.0 OUTLIER -92.0 -17.32 7.64 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.907 0 C-N-CA 124.86 1.264 . . . . 1.0 111.765 177.383 . . . . . . . . 3 3 . 1 . 027 nuclear orig core ' A' A ' 80' ' ' ALA . . . . . 0.784 ' N ' ' O ' ' A' ' 77' ' ' ILE . . . -65.86 -14.05 60.74 Favored 'General case' 0 C--N 1.321 -0.639 0 O-C-N 122.156 -0.34 . . . . 1.0 111.215 178.105 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 34.6 mt-10 -122.78 -47.89 2.05 Favored 'General case' 0 N--CA 1.47 0.534 0 CA-C-O 121.767 0.794 . . . . 1.0 109.435 175.759 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -59.94 -62.08 2.13 Favored 'General case' 0 CA--C 1.53 0.209 0 CA-C-N 115.22 -0.9 . . . . 1.0 109.314 -179.745 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . 0.443 ' O ' ' C ' ' A' ' 84' ' ' LEU . . . -47.5 -45.23 26.21 Favored 'General case' 0 N--CA 1.467 0.42 0 CA-C-N 116.587 -0.279 . . . . 1.0 110.798 -179.248 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . 0.443 ' C ' ' O ' ' A' ' 83' ' ' ALA . 1.5 tp -28.83 -44.85 0.03 OUTLIER 'General case' 0 N--CA 1.483 1.187 0 CA-C-N 116.36 -0.382 . . . . 1.0 111.636 -174.683 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 85' ' ' ILE . . . . . 0.493 HG13 ' H ' ' A' ' 86' ' ' ALA . 3.4 pt -91.57 -49.77 13.07 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.742 0 N-CA-C 109.102 -0.703 . . . . 1.0 109.102 177.138 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 86' ' ' ALA . . . . . 0.493 ' H ' HG13 ' A' ' 85' ' ' ILE . . . -48.22 -36.0 12.97 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.608 -0.724 . . . . 1.0 110.261 -178.723 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 5.3 mm-40 -57.51 -23.56 50.93 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.864 -0.607 . . . . 1.0 110.051 179.213 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -73.26 -9.51 58.79 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 121.22 0.533 . . . . 1.0 109.733 179.505 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 89' ' ' VAL . . . . . 0.407 ' O ' ' CG1' ' A' ' 89' ' ' VAL . 40.5 t -105.46 36.91 0.37 Allowed 'Isoleucine or valine' 0 C--O 1.234 0.268 0 CA-C-N 115.433 -0.803 . . . . 1.0 109.413 179.198 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 90' ' ' GLY . . . . . 0.537 ' O ' ' N ' ' A' ' 92' ' ' HIS . . . -66.71 -43.11 92.65 Favored Glycine 0 CA--C 1.539 1.531 0 N-CA-C 111.205 -0.758 . . . . 1.0 111.205 178.859 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 91' ' ' PRO . . . . . 0.472 ' CD ' ' N ' ' A' ' 90' ' ' GLY . 87.3 Cg_exo -42.3 -15.33 0.05 OUTLIER 'Trans proline' 0 N--CA 1.497 1.71 0 C-N-CA 122.03 1.82 . . . . 1.0 112.386 179.982 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 92' ' ' HIS . . . . . 0.537 ' N ' ' O ' ' A' ' 90' ' ' GLY . 5.6 p-80 -60.52 -15.51 28.05 Favored 'General case' 0 C--N 1.322 -0.601 0 N-CA-C 108.662 -0.866 . . . . 1.0 108.662 179.52 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 93' ' ' LEU . . . . . 0.474 ' HG ' ' H ' ' A' ' 94' ' ' ALA . 2.3 pp -72.95 -58.48 3.29 Favored 'General case' 0 C--N 1.323 -0.557 0 N-CA-C 108.836 -0.801 . . . . 1.0 108.836 179.915 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 94' ' ' ALA . . . . . 0.474 ' H ' ' HG ' ' A' ' 93' ' ' LEU . . . -59.23 -55.8 30.25 Favored 'General case' 0 C--O 1.236 0.391 0 CA-C-O 120.907 0.384 . . . . 1.0 109.997 179.744 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 95' ' ' ARG . . . . . 0.73 ' O ' ' N ' ' A' ' 97' ' ' LEU . 11.1 ttm180 -52.85 -59.3 4.67 Favored 'General case' 0 C--O 1.24 0.558 0 N-CA-C 107.079 -1.452 . . . . 1.0 107.079 178.777 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 96' ' ' ALA . . . . . 0.875 ' O ' ' N ' ' A' ' 98' ' ' GLY . . . -46.4 -7.67 0.01 OUTLIER 'General case' 0 N--CA 1.427 -1.616 0 O-C-N 119.029 -2.295 . . . . 1.0 112.525 -177.33 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 97' ' ' LEU . . . . . 0.73 ' N ' ' O ' ' A' ' 95' ' ' ARG . 0.4 OUTLIER 2.85 -50.57 0.0 OUTLIER 'General case' 0 C--N 1.36 1.062 0 O-C-N 124.776 1.297 . . . . 1.0 110.522 -169.447 . . . . . . . . 3 3 . 1 . 027 nuclear orig core ' A' A ' 98' ' ' GLY . . . . . 0.875 ' N ' ' O ' ' A' ' 96' ' ' ALA . . . -52.65 -17.52 4.67 Favored Glycine 0 N--CA 1.422 -2.265 0 CA-C-N 122.088 2.222 . . . . 1.0 107.902 174.001 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 99' ' ' GLN . . . . . 0.697 ' N ' ' O ' ' A' ' 96' ' ' ALA . 68.8 tp60 -73.96 -25.31 59.88 Favored 'General case' 0 CA--C 1.512 -0.5 0 C-N-CA 117.746 -1.582 . . . . 1.0 107.066 178.69 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 100' ' ' ILE . . . . . 0.619 ' N ' ' O ' ' A' ' 97' ' ' LEU . 4.9 tt -62.55 -35.51 70.49 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.883 0 CA-C-N 114.522 -1.217 . . . . 1.0 110.207 178.617 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 101' ' ' VAL . . . . . 0.733 HG12 ' O ' ' A' ' 98' ' ' GLY . 8.7 p -61.83 -58.69 6.42 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.698 0 C-N-CA 118.514 -1.274 . . . . 1.0 108.976 -179.599 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 102' ' ' CYS . . . . . 0.574 ' H ' HG12 ' A' ' 101' ' ' VAL . 0.1 OUTLIER -42.23 -24.53 0.05 Allowed 'General case' 0 N--CA 1.437 -1.104 0 N-CA-C 112.109 0.411 . . . . 1.0 112.109 -177.451 . . . . . . . . 3 3 . 1 . 027 nuclear orig core ' A' A ' 103' ' ' ARG . . . . . 0.428 ' N ' ' O ' ' A' ' 101' ' ' VAL . 9.4 ttp180 -88.81 -33.15 17.52 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-O 122.435 1.112 . . . . 1.0 111.207 178.39 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 104' ' ' TYR . . . . . 0.689 ' CG ' ' O ' ' A' ' 104' ' ' TYR . 0.3 OUTLIER -100.71 17.49 21.81 Favored 'General case' 0 C--N 1.312 -1.044 0 CA-C-N 113.365 -1.743 . . . . 1.0 109.822 177.352 . . . . . . . . 3 3 . 1 . 027 nuclear orig core ' A' A ' 105' ' ' GLY . . . . . 0.528 ' N ' ' O ' ' A' ' 101' ' ' VAL . . . -165.29 -82.3 0.05 OUTLIER Glycine 0 N--CA 1.447 -0.599 0 N-CA-C 106.945 -2.462 . . . . 1.0 106.945 175.97 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 106' ' ' ALA . . . . . 0.536 ' O ' ' CD ' ' A' ' 110' ' ' PRO . . . 70.47 68.89 0.2 Allowed 'General case' 0 N--CA 1.437 -1.094 0 N-CA-C 112.256 0.465 . . . . 1.0 112.256 179.043 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 107' ' ' THR . . . . . 0.511 ' O ' ' HG2' ' A' ' 110' ' ' PRO . 25.2 m -76.27 -55.46 5.55 Favored 'General case' 0 C--O 1.213 -0.819 0 O-C-N 120.737 -1.227 . . . . 1.0 109.433 177.907 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 108' ' ' VAL . . . . . 0.574 ' O ' ' HB2' ' A' ' 111' ' ' ASN . 35.7 m -72.54 -48.39 47.2 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.205 0 CA-C-O 121.283 0.563 . . . . 1.0 111.692 -178.72 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 109' ' ' ILE . . . . . 0.451 ' C ' ' O ' ' A' ' 108' ' ' VAL . 0.0 OUTLIER -41.31 -45.6 7.19 Favored Pre-proline 0 C--N 1.316 -0.854 0 CA-C-O 118.001 -0.999 . . . . 1.0 109.737 -178.027 . . . . . . . . 3 3 . 1 . 027 nuclear orig core ' A' A ' 110' ' ' PRO . . . . . 0.536 ' CD ' ' O ' ' A' ' 106' ' ' ALA . 72.6 Cg_endo -63.21 -18.06 63.08 Favored 'Trans proline' 0 C--O 1.2 -1.418 0 CA-C-N 122.388 1.889 . . . . 1.0 111.25 177.65 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 111' ' ' ASN . . . . . 0.574 ' HB2' ' O ' ' A' ' 108' ' ' VAL . 0.4 OUTLIER -62.2 -66.26 0.57 Allowed 'General case' 0 N--CA 1.478 0.974 0 N-CA-C 108.375 -0.972 . . . . 1.0 108.375 178.803 . . . . . . . . 3 3 . 1 . 027 nuclear orig core ' A' A ' 112' ' ' ILE . . . . . 0.589 ' O ' ' HB ' ' A' ' 116' ' ' ILE . 1.5 pt -48.27 -22.78 0.66 Allowed 'Isoleucine or valine' 0 C--O 1.219 -0.51 0 N-CA-C 107.864 -1.161 . . . . 1.0 107.864 179.714 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 113' ' ' ASN . . . . . 0.642 ' O ' ' HB2' ' A' ' 117' ' ' GLU . 11.8 m-20 -84.61 -53.68 5.23 Favored 'General case' 0 N--CA 1.44 -0.935 0 CA-C-O 124.01 1.862 . . . . 1.0 110.063 177.474 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 114' ' ' ALA . . . . . 0.453 ' N ' ' O ' ' A' ' 110' ' ' PRO . . . -56.12 -55.78 28.92 Favored 'General case' 0 C--N 1.29 -1.979 0 CA-C-N 114.376 -1.284 . . . . 1.0 109.619 -178.952 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -80.38 -61.02 2.1 Favored 'General case' 0 C--O 1.244 0.81 0 N-CA-C 114.554 1.316 . . . . 1.0 114.554 179.706 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 116' ' ' ILE . . . . . 0.589 ' HB ' ' O ' ' A' ' 112' ' ' ILE . 36.4 mm -72.46 -40.03 63.18 Favored 'Isoleucine or valine' 0 C--O 1.211 -0.938 0 N-CA-C 114.35 1.241 . . . . 1.0 114.35 -175.234 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 117' ' ' GLU . . . . . 0.642 ' HB2' ' O ' ' A' ' 113' ' ' ASN . 1.2 tt0 -51.85 -62.78 1.41 Allowed 'General case' 0 CA--C 1.486 -1.484 0 CA-C-N 118.12 0.418 . . . . 1.0 110.611 -176.334 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 38.8 t -55.54 -14.23 1.31 Allowed 'Isoleucine or valine' 0 N--CA 1.424 -1.774 0 C-N-CA 117.836 -1.546 . . . . 1.0 109.253 -177.244 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 119' ' ' LEU . . . . . 0.416 ' N ' ' C ' ' A' ' 117' ' ' GLU . 1.1 tp -92.54 -56.66 2.94 Favored 'General case' 0 CA--C 1.552 1.044 0 N-CA-C 113.682 0.993 . . . . 1.0 113.682 176.857 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -68.75 -50.52 35.58 Favored Glycine 0 C--N 1.358 1.764 0 C-N-CA 120.062 -1.066 . . . . 1.0 114.47 -174.68 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 1.9 t 155.56 -40.0 0.01 OUTLIER 'General case' 0 N--CA 1.476 0.865 0 N-CA-C 106.396 -1.705 . . . . 1.0 106.396 -178.273 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 122' ' ' GLY . . . . . 0.51 ' O ' ' N ' ' A' ' 124' ' ' ASP . . . 113.62 -34.37 5.05 Favored Glycine 0 CA--C 1.532 1.108 0 C-N-CA 126.217 1.865 . . . . 1.0 112.862 179.684 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 123' ' ' THR . . . . . 0.446 ' C ' ' O ' ' A' ' 122' ' ' GLY . 33.4 m -32.84 90.91 0.0 OUTLIER 'General case' 0 N--CA 1.486 1.341 0 CA-C-N 120.219 2.009 . . . . 1.0 112.01 -178.698 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 124' ' ' ASP . . . . . 0.51 ' N ' ' O ' ' A' ' 122' ' ' GLY . 39.7 m-20 -145.52 146.16 31.33 Favored 'General case' 0 CA--C 1.537 0.457 0 N-CA-C 108.763 -0.828 . . . . 1.0 108.763 178.089 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 125' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -153.7 150.58 28.71 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-O 120.85 0.357 . . . . 1.0 110.195 -178.851 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 2.7 tpt180 -149.08 151.26 34.13 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.894 -0.594 . . . . 1.0 109.801 177.059 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 127' ' ' PHE . . . . . . . . . . . . . 19.5 m-85 . . . . . 0 C--O 1.218 -0.583 0 CA-C-O 117.973 -1.013 . . . . 1.0 112.043 -178.864 . . . . . . . . 0 0 . 1 . 028 nuclear orig core ' A' A ' 1' ' ' MET . . . . . 0.444 ' SD ' ' CD2' ' A' ' 4' ' ' PHE . 38.2 mtt . . . . . 0 N--CA 1.49 1.545 0 N-CA-C 108.503 -0.925 . . . . 1.0 108.503 . . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 2' ' ' SER . . . . . 0.46 ' O ' ' CB ' ' A' ' 3' ' ' ASP . 14.8 m -95.31 10.5 35.96 Favored 'General case' 0 N--CA 1.466 0.357 0 C-N-CA 122.628 0.371 . . . . 1.0 110.939 -179.503 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 3' ' ' ASP . . . . . 0.46 ' CB ' ' O ' ' A' ' 2' ' ' SER . 0.2 OUTLIER 157.4 109.21 0.0 OUTLIER 'General case' 0 N--CA 1.473 0.687 0 O-C-N 124.077 0.861 . . . . 1.0 109.999 178.87 . . . . . . . . 3 3 . 1 . 028 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . 0.444 ' CD2' ' SD ' ' A' ' 1' ' ' MET . 14.9 t80 -152.99 148.21 26.82 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.121 -0.49 . . . . 1.0 110.515 179.695 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 5' ' ' ASP . . . . . 0.4 ' OD1' ' O ' ' A' ' 4' ' ' PHE . 9.5 m-20 -154.23 150.16 27.76 Favored 'General case' 0 CA--C 1.536 0.407 0 N-CA-C 109.404 -0.591 . . . . 1.0 109.404 179.761 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 6' ' ' THR . . . . . 0.587 ' O ' ' N ' ' A' ' 10' ' ' SER . 0.2 OUTLIER -62.2 167.51 3.99 Favored 'General case' 0 C--O 1.218 -0.603 0 C-N-CA 120.126 -0.63 . . . . 1.0 110.216 -178.804 . . . . . . . . 3 3 . 1 . 028 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . 0.589 ' O ' ' N ' ' A' ' 11' ' ' ARG . 3.1 tt0 -59.69 -58.37 8.86 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-O 121.401 0.62 . . . . 1.0 110.45 -177.947 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 8' ' ' ARG . . . . . 0.485 ' O ' ' CB ' ' A' ' 12' ' ' ALA . 18.2 ttm180 -51.16 -54.85 21.51 Favored 'General case' 0 C--N 1.311 -1.083 0 N-CA-C 108.174 -1.047 . . . . 1.0 108.174 -177.159 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . 0.487 ' O ' ' CG1' ' A' ' 13' ' ' VAL . 6.8 p -62.09 -48.82 86.71 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.127 0 CA-C-N 114.067 -1.424 . . . . 1.0 109.819 178.901 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 10' ' ' SER . . . . . 0.587 ' N ' ' O ' ' A' ' 6' ' ' THR . 42.8 t -62.43 -59.58 4.77 Favored 'General case' 0 N--CA 1.481 1.105 0 C-N-CA 120.198 -0.601 . . . . 1.0 109.702 -179.995 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 11' ' ' ARG . . . . . 0.589 ' N ' ' O ' ' A' ' 7' ' ' GLU . 0.4 OUTLIER -62.59 -57.44 11.09 Favored 'General case' 0 C--N 1.317 -0.823 0 O-C-N 121.742 -0.599 . . . . 1.0 110.19 -178.324 . . . . . . . . 3 3 . 1 . 028 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . 0.485 ' CB ' ' O ' ' A' ' 8' ' ' ARG . . . -50.36 -51.58 44.58 Favored 'General case' 0 N--CA 1.476 0.861 0 N-CA-C 108.004 -1.11 . . . . 1.0 108.004 -178.091 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . 0.599 ' O ' ' CB ' ' A' ' 17' ' ' LEU . 4.5 m -60.78 -50.13 81.75 Favored 'Isoleucine or valine' 0 C--O 1.203 -1.344 0 C-N-CA 116.92 -1.912 . . . . 1.0 108.029 177.632 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -57.44 -62.68 1.6 Allowed 'General case' 0 N--CA 1.479 1.008 0 C-N-CA 118.633 -1.227 . . . . 1.0 110.929 179.013 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . 0.549 ' N ' ' O ' ' A' ' 11' ' ' ARG . . . -55.51 -55.8 27.65 Favored 'General case' 0 N--CA 1.47 0.557 0 CA-C-O 121.413 0.625 . . . . 1.0 110.208 -178.473 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . 0.461 ' CB ' ' O ' ' A' ' 12' ' ' ALA . . . -58.05 -53.94 52.58 Favored 'General case' 0 C--N 1.317 -0.811 0 N-CA-C 108.138 -1.06 . . . . 1.0 108.138 -179.313 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . 0.599 ' CB ' ' O ' ' A' ' 13' ' ' VAL . 39.4 tp -53.86 -48.96 69.48 Favored 'General case' 0 N--CA 1.482 1.135 0 CA-C-N 113.513 -1.676 . . . . 1.0 107.662 -178.059 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 54.1 t -67.3 -58.4 6.41 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.504 0 CA-C-O 121.076 0.465 . . . . 1.0 110.223 179.94 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . 0.54 ' N ' ' O ' ' A' ' 15' ' ' ALA . . . -71.03 -163.96 5.47 Favored Glycine 0 CA--C 1.526 0.765 0 CA-C-N 115.5 -0.773 . . . . 1.0 112.054 -178.64 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 20' ' ' PRO . . . . . 0.571 ' O ' ' N ' ' A' ' 24' ' ' ALA . 57.5 Cg_endo -79.59 -27.23 4.24 Favored 'Trans proline' 0 N--CA 1.492 1.39 0 C-N-CA 122.72 2.28 . . . . 1.0 115.443 -178.098 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -59.0 -58.45 14.52 Favored Glycine 0 N--CA 1.477 1.414 0 C-N-CA 119.097 -1.525 . . . . 1.0 110.965 -177.01 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -59.21 -54.91 33.94 Favored Glycine 0 N--CA 1.467 0.749 0 N-CA-C 107.843 -2.103 . . . . 1.0 107.843 -178.387 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 54.1 t -57.36 -36.96 54.61 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.907 0 CA-C-N 114.721 -0.74 . . . . 1.0 109.814 -179.472 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . 0.571 ' N ' ' O ' ' A' ' 20' ' ' PRO . . . -57.66 -60.58 3.46 Favored 'General case' 0 C--N 1.325 -0.483 0 C-N-CA 118.93 -1.108 . . . . 1.0 109.182 -179.851 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 9.3 tp -63.19 -44.05 96.48 Favored 'General case' 0 C--N 1.347 0.47 0 CA-C-N 119.325 0.966 . . . . 1.0 111.73 -178.907 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 72.6 t -61.05 -60.77 2.13 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.176 0 C-N-CA 118.364 -1.334 . . . . 1.0 110.504 -177.748 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . 0.447 HG21 ' HE ' ' A' ' 47' ' ' ARG . 2.4 p -58.57 -37.41 64.78 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.417 0 N-CA-C 113.264 0.838 . . . . 1.0 113.264 -177.539 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 35.9 ttmt -67.67 -53.27 29.13 Favored 'General case' 0 C--N 1.315 -0.899 0 CA-C-O 122.102 0.953 . . . . 1.0 108.811 -178.719 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 80.2 t -63.82 -48.93 84.18 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.074 0 CA-C-N 113.743 -1.571 . . . . 1.0 110.891 -177.542 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 30' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -65.34 -60.88 2.51 Favored 'General case' 0 N--CA 1.449 -0.487 0 C-N-CA 118.868 -1.133 . . . . 1.0 109.496 -179.756 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -64.83 -54.44 30.99 Favored 'General case' 0 C--N 1.331 -0.225 0 N-CA-C 113.605 0.965 . . . . 1.0 113.605 -175.901 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 84.36 75.77 1.2 Allowed Glycine 0 CA--C 1.527 0.798 0 N-CA-C 109.421 -1.472 . . . . 1.0 109.421 -177.81 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . 0.52 ' O ' ' O ' ' A' ' 36' ' ' VAL . 12.3 mt 85.55 85.37 0.05 OUTLIER Pre-proline 0 N--CA 1.479 0.983 0 C-N-CA 123.711 0.804 . . . . 1.0 110.49 -178.9 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 53.0 Cg_exo -54.93 -30.89 71.13 Favored 'Trans proline' 0 N--CA 1.508 2.342 0 C-N-CA 123.253 2.635 . . . . 1.0 114.307 -179.832 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -58.81 -58.04 16.67 Favored Glycine 0 CA--C 1.525 0.678 0 C-N-CA 118.759 -1.686 . . . . 1.0 109.651 -178.369 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . 0.536 ' O ' ' CB ' ' A' ' 37' ' ' ILE . 7.1 p -97.82 165.27 2.17 Favored 'Isoleucine or valine' 0 C--O 1.219 -0.55 0 N-CA-C 106.71 -1.589 . . . . 1.0 106.71 178.266 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . 0.536 ' CB ' ' O ' ' A' ' 36' ' ' VAL . 8.1 tt 117.82 123.23 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.481 1.097 0 C-N-CA 123.927 0.891 . . . . 1.0 109.596 -179.19 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 21.9 m80 -140.64 131.41 25.81 Favored 'General case' 0 C--N 1.324 -0.513 0 N-CA-C 107.902 -1.147 . . . . 1.0 107.902 178.724 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -90.03 146.45 35.09 Favored Pre-proline 0 C--N 1.33 -0.247 0 N-CA-C 108.955 -0.757 . . . . 1.0 108.955 -179.747 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -72.92 -44.01 0.69 Allowed 'Trans proline' 0 C--N 1.307 -1.619 0 C-N-CA 121.641 1.56 . . . . 1.0 112.579 -179.24 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -126.17 130.06 50.25 Favored 'General case' 0 CA--C 1.518 -0.266 0 CA-C-N 116.254 -0.43 . . . . 1.0 110.118 -179.608 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . 0.635 ' C ' ' H ' ' A' ' 44' ' ' GLY . 0.0 OUTLIER -169.49 157.27 7.17 Favored 'General case' 0 C--N 1.313 -0.997 0 N-CA-C 106.016 -1.846 . . . . 1.0 106.016 177.976 . . . . . . . . 3 3 . 1 . 028 nuclear orig core ' A' A ' 43' ' ' ARG . . . . . 0.436 ' CG ' ' O ' ' A' ' 43' ' ' ARG . 10.3 ttt85 -64.82 33.81 0.02 OUTLIER 'General case' 0 CA--C 1.529 0.137 0 CA-C-N 119.866 1.212 . . . . 1.0 112.115 -178.266 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . 0.635 ' H ' ' C ' ' A' ' 42' ' ' ARG . . . 91.42 -24.3 20.39 Favored Glycine 0 CA--C 1.522 0.484 0 N-CA-C 110.426 -1.069 . . . . 1.0 110.426 179.995 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . 0.526 ' CZ ' ' OD2' ' A' ' 57' ' ' ASP . 50.0 p90 -177.49 -178.93 0.79 Allowed 'General case' 0 CA--C 1.54 0.576 0 CA-C-O 120.85 0.357 . . . . 1.0 111.623 -179.941 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER 165.03 15.46 0.0 OUTLIER 'General case' 0 N--CA 1.487 1.389 0 CA-C-N 114.947 -1.024 . . . . 1.0 113.139 177.073 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 47' ' ' ARG . . . . . 0.639 ' O ' ' SG ' ' A' ' 48' ' ' CYS . 2.5 mtp-105 -176.38 -179.12 1.02 Allowed 'General case' 0 C--N 1.315 -0.905 0 N-CA-C 108.591 -0.892 . . . . 1.0 108.591 -179.072 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 48' ' ' CYS . . . . . 0.674 ' SG ' ' O ' ' A' ' 48' ' ' CYS . 1.5 p 61.43 63.49 1.19 Allowed 'General case' 0 C--N 1.341 0.206 0 CA-C-O 121.68 0.752 . . . . 1.0 110.084 -179.326 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 49' ' ' ASN . . . . . 0.449 ' OD1' ' NE2' ' A' ' 54' ' ' GLN . 0.2 OUTLIER -137.14 143.53 42.31 Favored Pre-proline 0 CA--C 1.535 0.39 0 N-CA-C 108.552 -0.907 . . . . 1.0 108.552 179.418 . . . . . . . . 3 3 . 1 . 028 nuclear orig core ' A' A ' 50' ' ' PRO . . . . . 0.444 ' HG2' HH11 ' A' ' 52' ' ' ARG . 94.7 Cg_endo -73.01 61.85 3.94 Favored 'Trans proline' 0 N--CA 1.497 1.719 0 C-N-CA 122.251 1.967 . . . . 1.0 112.431 -179.476 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 97.8 mt-10 59.34 6.13 0.71 Allowed 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.975 -0.557 . . . . 1.0 111.84 179.595 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . 0.444 HH11 ' HG2' ' A' ' 50' ' ' PRO . 75.0 mtt85 -82.91 139.12 33.58 Favored 'General case' 0 N--CA 1.465 0.291 0 N-CA-C 109.029 -0.73 . . . . 1.0 109.029 177.971 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 13.0 tt -67.42 137.92 23.78 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.276 0 CA-C-O 122.647 1.213 . . . . 1.0 113.691 -177.314 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 54' ' ' GLN . . . . . 0.449 ' NE2' ' OD1' ' A' ' 49' ' ' ASN . 1.8 mp0 -64.13 78.59 0.04 OUTLIER 'General case' 0 CA--C 1.545 0.753 0 CA-C-N 112.38 -2.191 . . . . 1.0 108.984 -178.464 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 18.0 tt -148.15 154.96 10.06 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.667 0 CA-C-N 115.997 -0.547 . . . . 1.0 109.99 178.251 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 109.59 -3.46 30.8 Favored Glycine 0 N--CA 1.471 0.998 0 N-CA-C 109.914 -1.274 . . . . 1.0 109.914 -179.594 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . 0.526 ' OD2' ' CZ ' ' A' ' 45' ' ' PHE . 37.6 m-20 -83.96 100.93 11.35 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 114.249 -0.975 . . . . 1.0 110.091 179.448 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 58' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -86.52 173.68 9.44 Favored 'General case' 0 N--CA 1.471 0.595 0 CA-C-O 123.65 1.69 . . . . 1.0 113.41 -178.287 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 24.9 mtm180 -79.44 -56.23 4.47 Favored 'General case' 0 C--N 1.309 -1.175 0 CA-C-N 110.402 -3.09 . . . . 1.0 112.161 -179.428 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -91.1 -11.73 37.72 Favored 'General case' 0 C--O 1.249 1.046 0 CA-C-N 114.81 -1.086 . . . . 1.0 113.916 -178.372 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . 0.449 ' O ' ' N ' ' A' ' 65' ' ' ASP . 9.3 pt-20 -76.57 -13.95 60.04 Favored 'General case' 0 C--N 1.318 -0.784 0 N-CA-C 113.298 0.851 . . . . 1.0 113.298 -177.615 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 62' ' ' VAL . . . . . 0.623 ' O ' ' N ' ' A' ' 66' ' ' GLY . 0.2 OUTLIER -49.52 -58.7 1.25 Allowed 'Isoleucine or valine' 0 C--O 1.207 -1.165 0 C-N-CA 118.857 -1.137 . . . . 1.0 109.209 -175.829 . . . . . . . . 3 3 . 1 . 028 nuclear orig core ' A' A ' 63' ' ' ALA . . . . . 0.453 ' H ' HG23 ' A' ' 62' ' ' VAL . . . -66.77 -61.5 1.93 Allowed 'General case' 0 C--N 1.302 -1.459 0 CA-C-O 120.874 0.369 . . . . 1.0 110.907 -179.01 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 2.3 t-80 -48.4 -56.72 7.43 Favored 'General case' 0 CA--C 1.535 0.389 0 C-N-CA 119.419 -0.912 . . . . 1.0 108.93 -178.916 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 65' ' ' ASP . . . . . 0.502 ' O ' ' CD2' ' A' ' 68' ' ' LEU . 19.2 t70 -70.08 -45.5 66.89 Favored 'General case' 0 C--O 1.207 -1.171 0 CA-C-N 115.072 -0.967 . . . . 1.0 111.197 179.761 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . 0.623 ' N ' ' O ' ' A' ' 62' ' ' VAL . . . -77.49 26.35 1.93 Allowed Glycine 0 N--CA 1.471 1.002 0 N-CA-C 111.018 -0.833 . . . . 1.0 111.018 179.715 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 67' ' ' ARG . . . . . 0.484 ' H ' ' C ' ' A' ' 65' ' ' ASP . 57.7 ttt180 -95.76 -9.95 30.4 Favored 'General case' 0 CA--C 1.536 0.406 0 N-CA-C 107.971 -1.122 . . . . 1.0 107.971 172.832 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . 0.826 ' O ' ' N ' ' A' ' 72' ' ' HIS . 0.0 OUTLIER -69.87 -37.81 76.22 Favored 'General case' 0 C--O 1.197 -1.681 0 CA-C-N 114.303 -1.317 . . . . 1.0 112.974 -178.044 . . . . . . . . 3 3 . 1 . 028 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . 0.519 ' O ' ' ND1' ' A' ' 72' ' ' HIS . 7.8 tt -44.81 -58.31 3.19 Favored 'General case' 0 N--CA 1.475 0.794 0 C-N-CA 118.302 -1.359 . . . . 1.0 108.869 -176.121 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . 0.578 ' O ' ' CE1' ' A' ' 72' ' ' HIS . . . -51.61 -72.3 0.05 Allowed 'General case' 0 C--N 1.317 -0.837 0 N-CA-C 104.937 -2.246 . . . . 1.0 104.937 177.884 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 71' ' ' ALA . . . . . 0.729 ' O ' ' N ' ' A' ' 73' ' ' MET . . . -64.87 18.21 0.02 OUTLIER 'General case' 0 C--N 1.316 -0.877 0 C-N-CA 128.04 2.536 . . . . 1.0 114.251 178.385 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 72' ' ' HIS . . . . . 0.826 ' N ' ' O ' ' A' ' 68' ' ' LEU . 0.0 OUTLIER -24.78 -17.95 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.557 0 N-CA-C 115.589 1.7 . . . . 1.0 115.589 -174.461 . . . . . . . . 3 3 . 1 . 028 nuclear orig core ' A' A ' 73' ' ' MET . . . . . 0.729 ' N ' ' O ' ' A' ' 71' ' ' ALA . 72.5 mtp -73.39 -25.09 60.42 Favored 'General case' 0 CA--C 1.545 0.768 0 CA-C-N 119.986 1.266 . . . . 1.0 108.551 176.965 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . 0.725 ' O ' ' N ' ' A' ' 76' ' ' GLY . 90.8 t -61.53 -52.66 58.46 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.672 0 CA-C-N 114.444 -1.253 . . . . 1.0 108.84 178.857 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 27.5 t-20 -32.61 -13.75 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.667 0 N-CA-C 113.444 0.905 . . . . 1.0 113.444 -178.26 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 76' ' ' GLY . . . . . 0.725 ' N ' ' O ' ' A' ' 74' ' ' VAL . . . -50.88 -22.26 5.88 Favored Glycine 0 CA--C 1.539 1.539 0 N-CA-C 109.344 -1.502 . . . . 1.0 109.344 176.045 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 77' ' ' ILE . . . . . 0.646 HG13 ' H ' ' A' ' 78' ' ' VAL . 0.5 OUTLIER -78.0 -63.95 1.0 Allowed 'Isoleucine or valine' 0 C--O 1.218 -0.568 0 CA-C-O 121.947 0.88 . . . . 1.0 109.432 179.203 . . . . . . . . 3 3 . 1 . 028 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . 0.646 ' H ' HG13 ' A' ' 77' ' ' ILE . 74.8 t -34.87 -33.66 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.318 -0.766 0 CA-C-N 112.719 -2.037 . . . . 1.0 106.309 -177.105 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . 0.542 ' N ' ' O ' ' A' ' 77' ' ' ILE . 0.0 OUTLIER -97.39 -34.42 4.82 Favored 'Isoleucine or valine' 0 CA--C 1.569 1.699 0 CA-C-N 115.585 -0.734 . . . . 1.0 111.905 175.134 . . . . . . . . 3 3 . 1 . 028 nuclear orig core ' A' A ' 80' ' ' ALA . . . . . 0.558 ' N ' ' O ' ' A' ' 77' ' ' ILE . . . -84.82 -10.35 57.26 Favored 'General case' 0 N--CA 1.492 1.642 0 N-CA-C 114.471 1.285 . . . . 1.0 114.471 179.452 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 81' ' ' GLU . . . . . 0.42 ' N ' ' O ' ' A' ' 77' ' ' ILE . 86.6 tt0 -89.4 -70.98 0.63 Allowed 'General case' 0 N--CA 1.438 -1.038 0 O-C-N 121.786 -0.571 . . . . 1.0 111.09 179.775 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 25.4 m-20 -91.02 -15.6 29.32 Favored 'General case' 0 CA--C 1.549 0.923 0 N-CA-C 115.864 1.801 . . . . 1.0 115.864 -178.796 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . 0.554 ' O ' ' N ' ' A' ' 85' ' ' ILE . . . -52.84 -42.48 65.21 Favored 'General case' 0 N--CA 1.475 0.779 0 C-N-CA 118.248 -1.381 . . . . 1.0 111.454 -177.863 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 11.2 mp -39.87 -20.83 0.01 OUTLIER 'General case' 0 N--CA 1.469 0.508 0 CA-C-N 118.447 0.567 . . . . 1.0 111.307 -179.049 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 85' ' ' ILE . . . . . 0.554 ' N ' ' O ' ' A' ' 83' ' ' ALA . 54.1 mt -93.43 -34.99 6.13 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.587 -0.279 . . . . 1.0 111.154 -179.866 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 86' ' ' ALA . . . . . 0.506 ' C ' ' H ' ' A' ' 88' ' ' ALA . . . -92.91 -26.27 17.68 Favored 'General case' 0 C--O 1.222 -0.371 0 CA-C-O 120.597 0.237 . . . . 1.0 111.582 179.734 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -56.06 -7.12 0.3 Allowed 'General case' 0 C--N 1.328 -0.347 0 C-N-CA 119.73 -0.788 . . . . 1.0 110.418 -178.83 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 88' ' ' ALA . . . . . 0.506 ' H ' ' C ' ' A' ' 86' ' ' ALA . . . -84.17 -2.58 57.1 Favored 'General case' 0 N--CA 1.472 0.663 0 CA-C-O 122.407 1.099 . . . . 1.0 108.79 178.543 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 89' ' ' VAL . . . . . 0.537 ' O ' ' CD2' ' A' ' 92' ' ' HIS . 3.1 m -97.6 34.9 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.432 0 CA-C-N 113.042 -1.89 . . . . 1.0 110.59 179.098 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 90' ' ' GLY . . . . . 0.558 ' C ' ' H ' ' A' ' 92' ' ' HIS . . . -78.13 -36.62 30.94 Favored Glycine 0 C--N 1.347 1.194 0 N-CA-C 111.6 -0.6 . . . . 1.0 111.6 178.932 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 91' ' ' PRO . . . . . 0.551 ' CD ' ' N ' ' A' ' 90' ' ' GLY . 93.4 Cg_exo -46.55 -15.11 0.16 Allowed 'Trans proline' 0 N--CA 1.496 1.665 0 C-N-CA 121.872 1.715 . . . . 1.0 109.07 177.913 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 92' ' ' HIS . . . . . 0.612 ' ND1' ' N ' ' A' ' 93' ' ' LEU . 0.0 OUTLIER -56.01 -15.76 3.98 Favored 'General case' 0 N--CA 1.442 -0.875 0 CA-C-N 113.922 -1.49 . . . . 1.0 107.754 179.148 . . . . . . . . 3 3 . 1 . 028 nuclear orig core ' A' A ' 93' ' ' LEU . . . . . 0.612 ' N ' ' ND1' ' A' ' 92' ' ' HIS . 2.1 pp -64.04 -58.22 7.32 Favored 'General case' 0 C--O 1.232 0.14 0 N-CA-C 108.997 -0.742 . . . . 1.0 108.997 176.822 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 94' ' ' ALA . . . . . 0.446 ' N ' ' CD1' ' A' ' 93' ' ' LEU . . . -57.34 -52.62 64.61 Favored 'General case' 0 CA--C 1.517 -0.323 0 N-CA-C 108.851 -0.796 . . . . 1.0 108.851 179.719 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 95' ' ' ARG . . . . . 0.621 ' O ' ' N ' ' A' ' 97' ' ' LEU . 4.9 tmm_? -60.16 -60.91 3.06 Favored 'General case' 0 N--CA 1.446 -0.628 0 N-CA-C 108.506 -0.924 . . . . 1.0 108.506 -179.792 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 96' ' ' ALA . . . . . 0.986 ' O ' ' N ' ' A' ' 98' ' ' GLY . . . -47.66 -12.09 0.03 OUTLIER 'General case' 0 N--CA 1.432 -1.343 0 O-C-N 118.532 -2.605 . . . . 1.0 111.478 179.484 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 97' ' ' LEU . . . . . 0.706 ' O ' ' N ' ' A' ' 100' ' ' ILE . 7.7 tp 6.87 -48.9 0.0 OUTLIER 'General case' 0 C--N 1.378 1.809 0 CA-C-O 117.584 -1.198 . . . . 1.0 109.937 -166.771 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 98' ' ' GLY . . . . . 0.986 ' N ' ' O ' ' A' ' 96' ' ' ALA . . . -49.57 -24.12 5.32 Favored Glycine 0 CA--C 1.548 2.106 0 CA-C-N 122.507 2.412 . . . . 1.0 107.417 173.493 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 99' ' ' GLN . . . . . 0.521 ' N ' ' O ' ' A' ' 96' ' ' ALA . 12.3 mt-30 -64.36 -19.38 65.44 Favored 'General case' 0 C--N 1.379 1.878 0 C-N-CA 117.324 -1.75 . . . . 1.0 107.058 176.829 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 100' ' ' ILE . . . . . 0.706 ' N ' ' O ' ' A' ' 97' ' ' LEU . 1.5 tp -65.3 -39.22 84.66 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.817 0 N-CA-C 108.228 -1.027 . . . . 1.0 108.228 179.724 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 101' ' ' VAL . . . . . 0.723 ' O ' ' N ' ' A' ' 105' ' ' GLY . 97.7 t -59.19 -62.72 0.91 Allowed 'Isoleucine or valine' 0 C--O 1.217 -0.627 0 C-N-CA 119.537 -0.865 . . . . 1.0 110.59 -178.44 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 102' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -48.26 -18.63 0.23 Allowed 'General case' 0 N--CA 1.477 0.883 0 C-N-CA 119.093 -1.043 . . . . 1.0 110.826 -178.31 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 103' ' ' ARG . . . . . 0.488 ' CG ' HH11 ' A' ' 103' ' ' ARG . 0.0 OUTLIER -88.63 -49.3 6.96 Favored 'General case' 0 N--CA 1.479 1.014 0 CA-C-O 121.783 0.802 . . . . 1.0 112.071 177.638 . . . . . . . . 3 3 . 1 . 028 nuclear orig core ' A' A ' 104' ' ' TYR . . . . . . . . . . . . . 22.8 t80 -105.84 21.53 17.12 Favored 'General case' 0 N--CA 1.472 0.644 0 C-N-CA 125.935 1.694 . . . . 1.0 111.413 178.43 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 105' ' ' GLY . . . . . 0.723 ' N ' ' O ' ' A' ' 101' ' ' VAL . . . -159.33 -8.32 0.05 OUTLIER Glycine 0 CA--C 1.527 0.835 0 C-N-CA 120.394 -0.907 . . . . 1.0 112.081 -179.791 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 106' ' ' ALA . . . . . 0.424 ' C ' ' O ' ' A' ' 105' ' ' GLY . . . -29.03 114.16 0.09 Allowed 'General case' 0 N--CA 1.466 0.327 0 N-CA-C 112.209 0.448 . . . . 1.0 112.209 179.51 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 107' ' ' THR . . . . . 0.575 ' C ' ' H ' ' A' ' 109' ' ' ILE . 26.7 m -134.55 -62.64 0.73 Allowed 'General case' 0 C--O 1.224 -0.247 0 N-CA-C 105.609 -1.997 . . . . 1.0 105.609 176.782 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 12.7 p -64.44 23.25 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.437 -1.078 0 O-C-N 121.792 -0.568 . . . . 1.0 109.539 179.33 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 109' ' ' ILE . . . . . 0.581 ' H ' ' HD2' ' A' ' 110' ' ' PRO . 0.1 OUTLIER -115.81 -53.98 0.04 OUTLIER Pre-proline 0 CA--C 1.562 1.405 0 N-CA-C 107.708 -1.219 . . . . 1.0 107.708 174.658 . . . . . . . . 3 3 . 1 . 028 nuclear orig core ' A' A ' 110' ' ' PRO . . . . . 0.581 ' HD2' ' H ' ' A' ' 109' ' ' ILE . 18.3 Cg_endo -52.85 -36.65 75.04 Favored 'Trans proline' 0 N--CA 1.51 2.446 0 CA-C-N 121.92 1.721 . . . . 1.0 112.199 175.869 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 111' ' ' ASN . . . . . 0.429 ' C ' ' N ' ' A' ' 113' ' ' ASN . 6.2 t30 -68.25 -68.42 0.39 Allowed 'General case' 0 C--N 1.328 -0.356 0 C-N-CA 119.448 -0.901 . . . . 1.0 110.106 -177.907 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 112' ' ' ILE . . . . . 0.477 ' O ' ' N ' ' A' ' 116' ' ' ILE . 3.9 pt -51.0 -25.99 4.01 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.263 0 CA-C-O 123.07 1.414 . . . . 1.0 108.098 179.262 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 113' ' ' ASN . . . . . 0.558 ' ND2' ' OE2' ' A' ' 117' ' ' GLU . 15.4 t-20 -59.21 -52.37 65.96 Favored 'General case' 0 C--N 1.306 -1.286 0 CA-C-N 111.987 -2.369 . . . . 1.0 107.982 -177.886 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 114' ' ' ALA . . . . . 0.498 ' O ' ' CG2' ' A' ' 118' ' ' VAL . . . -64.08 -31.17 72.26 Favored 'General case' 0 C--N 1.323 -0.562 0 N-CA-C 113.103 0.779 . . . . 1.0 113.103 179.675 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 115' ' ' ALA . . . . . 0.454 ' O ' ' N ' ' A' ' 119' ' ' LEU . . . -85.15 -58.42 2.69 Favored 'General case' 0 N--CA 1.476 0.848 0 CA-C-N 119.36 0.982 . . . . 1.0 111.655 178.494 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 116' ' ' ILE . . . . . 0.477 ' N ' ' O ' ' A' ' 112' ' ' ILE . 31.2 mt -51.11 -57.71 2.67 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.402 0 N-CA-C 107.217 -1.401 . . . . 1.0 107.217 -178.375 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 117' ' ' GLU . . . . . 0.558 ' OE2' ' ND2' ' A' ' 113' ' ' ASN . 56.0 mt-10 -51.68 -50.37 60.56 Favored 'General case' 0 C--N 1.307 -1.277 0 CA-C-N 112.771 -2.013 . . . . 1.0 107.056 -179.15 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 118' ' ' VAL . . . . . 0.498 ' CG2' ' O ' ' A' ' 114' ' ' ALA . 17.0 t -59.83 -28.86 41.79 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.8 0 C-N-CA 119.642 -0.823 . . . . 1.0 110.021 178.378 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 119' ' ' LEU . . . . . 0.454 ' N ' ' O ' ' A' ' 115' ' ' ALA . 3.9 tt -78.42 -61.58 1.96 Allowed 'General case' 0 C--N 1.354 0.8 0 CA-C-N 120.396 1.453 . . . . 1.0 107.466 177.962 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 120' ' ' GLY . . . . . 0.446 ' O ' ' OG1' ' A' ' 121' ' ' THR . . . -64.31 -82.25 0.1 Allowed Glycine 0 C--N 1.358 1.771 0 C-N-CA 119.036 -1.554 . . . . 1.0 109.299 178.291 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 121' ' ' THR . . . . . 0.446 ' OG1' ' O ' ' A' ' 120' ' ' GLY . 0.0 OUTLIER 167.76 -38.85 0.0 OUTLIER 'General case' 0 CA--C 1.542 0.659 0 CA-C-N 113.968 -1.116 . . . . 1.0 113.041 178.817 . . . . . . . . 3 3 . 1 . 028 nuclear orig core ' A' A ' 122' ' ' GLY . . . . . 0.643 ' O ' ' N ' ' A' ' 124' ' ' ASP . . . 103.28 -15.91 53.74 Favored Glycine 0 N--CA 1.478 1.475 0 N-CA-C 107.243 -2.343 . . . . 1.0 107.243 -176.345 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 123' ' ' THR . . . . . 0.426 ' HG1' ' CD2' ' A' ' 72' ' ' HIS . 9.1 t -58.38 81.19 0.01 OUTLIER 'General case' 0 CA--C 1.545 0.787 0 CA-C-N 111.272 -2.464 . . . . 1.0 105.36 178.279 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 124' ' ' ASP . . . . . 0.643 ' N ' ' O ' ' A' ' 122' ' ' GLY . 35.8 m-20 -165.39 174.55 9.94 Favored 'General case' 0 N--CA 1.475 0.79 0 CA-C-N 112.818 -1.992 . . . . 1.0 112.457 179.989 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 125' ' ' TYR . . . . . . . . . . . . . 6.1 t80 -142.85 138.83 30.58 Favored 'General case' 0 CA--C 1.54 0.596 0 N-CA-C 107.655 -1.239 . . . . 1.0 107.655 175.588 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 9.6 tpt180 -149.88 153.12 36.19 Favored 'General case' 0 N--CA 1.467 0.39 0 N-CA-C 110.236 -0.283 . . . . 1.0 110.236 178.075 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 127' ' ' PHE . . . . . . . . . . . . . 22.4 p90 . . . . . 0 N--CA 1.469 0.486 0 CA-C-O 118.034 -0.984 . . . . 1.0 110.743 179.926 . . . . . . . . 0 0 . 1 . 029 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 4.6 tpp . . . . . 0 N--CA 1.489 1.498 0 N-CA-C 109.194 -0.669 . . . . 1.0 109.194 . . . . . . . . . 0 0 . 1 . 029 nuclear orig core ' A' A ' 2' ' ' SER . . . . . 0.484 ' O ' ' CB ' ' A' ' 3' ' ' ASP . 87.7 p -89.61 12.42 16.82 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.877 -0.602 . . . . 1.0 110.499 -179.951 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 3' ' ' ASP . . . . . 0.484 ' CB ' ' O ' ' A' ' 2' ' ' SER . 4.7 t0 151.22 116.58 0.0 OUTLIER 'General case' 0 N--CA 1.473 0.699 0 O-C-N 124.075 0.86 . . . . 1.0 109.963 178.606 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . 0.434 ' O ' ' OD1' ' A' ' 5' ' ' ASP . 13.8 t80 -152.38 148.05 27.02 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.645 -0.707 . . . . 1.0 110.305 179.559 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 5' ' ' ASP . . . . . 0.434 ' OD1' ' O ' ' A' ' 4' ' ' PHE . 2.2 m-20 -154.78 151.52 28.78 Favored 'General case' 0 C--O 1.234 0.242 0 N-CA-C 109.703 -0.48 . . . . 1.0 109.703 179.634 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 6' ' ' THR . . . . . 0.416 ' C ' ' O ' ' A' ' 5' ' ' ASP . 3.0 m -38.76 143.07 0.16 Allowed 'General case' 0 N--CA 1.467 0.4 0 N-CA-C 109.53 -0.544 . . . . 1.0 109.53 179.994 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 35.9 tt0 -47.27 -52.4 16.27 Favored 'General case' 0 C--N 1.316 -0.86 0 CA-C-O 118.347 -0.835 . . . . 1.0 112.698 -174.934 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 8' ' ' ARG . . . . . 0.52 ' O ' ' CB ' ' A' ' 12' ' ' ALA . 24.3 ptt180 -63.48 -35.5 80.66 Favored 'General case' 0 N--CA 1.447 -0.59 0 CA-C-N 120.824 1.647 . . . . 1.0 109.816 179.022 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . 0.52 ' O ' ' CG2' ' A' ' 13' ' ' VAL . 93.6 t -62.34 -52.23 62.58 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.714 0 C-N-CA 118.665 -1.214 . . . . 1.0 108.009 178.481 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 80.0 p -67.61 -38.72 84.35 Favored 'General case' 0 CA--C 1.543 0.696 0 N-CA-C 113.353 0.872 . . . . 1.0 113.353 179.384 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 11' ' ' ARG . . . . . 0.596 ' O ' ' N ' ' A' ' 14' ' ' ALA . 5.0 tpp180 -75.77 -63.0 1.4 Allowed 'General case' 0 N--CA 1.472 0.649 0 CA-C-O 122.335 1.064 . . . . 1.0 109.098 178.039 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . 0.52 ' CB ' ' O ' ' A' ' 8' ' ' ARG . . . -46.67 -37.56 8.48 Favored 'General case' 0 N--CA 1.474 0.762 0 CA-C-N 112.724 -2.034 . . . . 1.0 105.955 -175.323 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . 0.599 ' O ' ' CB ' ' A' ' 17' ' ' LEU . 11.9 t -59.8 -50.84 78.53 Favored 'Isoleucine or valine' 0 C--O 1.206 -1.215 0 C-N-CA 118.574 -1.25 . . . . 1.0 107.869 175.68 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . 0.596 ' N ' ' O ' ' A' ' 11' ' ' ARG . . . -60.85 -63.59 1.24 Allowed 'General case' 0 C--O 1.219 -0.531 0 C-N-CA 118.717 -1.193 . . . . 1.0 111.235 179.178 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . 0.532 ' O ' ' N ' ' A' ' 19' ' ' GLY . . . -52.48 -54.93 25.96 Favored 'General case' 0 N--CA 1.479 1.003 0 CA-C-O 121.826 0.822 . . . . 1.0 110.143 -176.735 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . 0.468 ' CB ' ' O ' ' A' ' 12' ' ' ALA . . . -61.97 -53.36 56.77 Favored 'General case' 0 C--N 1.308 -1.201 0 CA-C-N 113.877 -1.511 . . . . 1.0 108.685 -179.239 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . 0.599 ' CB ' ' O ' ' A' ' 13' ' ' VAL . 3.1 tp -57.06 -51.75 68.02 Favored 'General case' 0 N--CA 1.479 1.016 0 C-N-CA 118.944 -1.102 . . . . 1.0 109.083 -177.336 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . 0.527 HG23 ' H ' ' A' ' 19' ' ' GLY . 3.2 m -68.78 -56.5 11.95 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.269 0 C-N-CA 119.04 -1.064 . . . . 1.0 108.864 179.397 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . 0.532 ' N ' ' O ' ' A' ' 15' ' ' ALA . . . -60.73 -169.25 0.51 Allowed Glycine 0 CA--C 1.532 1.133 0 N-CA-C 111.786 -0.526 . . . . 1.0 111.786 179.881 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 20' ' ' PRO . . . . . 0.611 ' O ' ' N ' ' A' ' 24' ' ' ALA . 27.7 Cg_endo -81.57 -32.89 0.76 Allowed 'Trans proline' 0 N--CA 1.493 1.49 0 C-N-CA 123.323 2.682 . . . . 1.0 115.154 -178.656 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -57.64 -57.29 20.59 Favored Glycine 0 N--CA 1.479 1.539 0 C-N-CA 120.246 -0.978 . . . . 1.0 111.623 -176.565 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -56.69 -50.47 63.11 Favored Glycine 0 N--CA 1.472 1.039 0 N-CA-C 107.075 -2.41 . . . . 1.0 107.075 -178.17 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 41.8 t -61.7 -34.95 64.56 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.051 0 CA-C-N 114.834 -0.683 . . . . 1.0 109.85 179.371 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . 0.611 ' N ' ' O ' ' A' ' 20' ' ' PRO . . . -57.07 -61.14 2.66 Favored 'General case' 0 N--CA 1.454 -0.231 0 C-N-CA 118.978 -1.089 . . . . 1.0 109.404 -179.145 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 8.4 tt -65.98 -42.48 89.8 Favored 'General case' 0 C--N 1.342 0.283 0 C-N-CA 119.657 -0.817 . . . . 1.0 111.922 -178.715 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 59.3 t -59.37 -58.69 5.88 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.182 0 C-N-CA 118.472 -1.291 . . . . 1.0 109.501 -178.017 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 1.8 p -63.4 -36.75 77.4 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.454 0 N-CA-C 112.953 0.723 . . . . 1.0 112.953 -177.706 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 24.7 tttm -64.68 -53.28 49.91 Favored 'General case' 0 C--N 1.324 -0.533 0 N-CA-C 108.293 -1.003 . . . . 1.0 108.293 -178.597 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 74.1 t -59.65 -44.83 94.33 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.829 0 CA-C-N 114.523 -1.217 . . . . 1.0 109.906 -178.81 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 30' ' ' CYS . . . . . 0.566 ' SG ' ' N ' ' A' ' 31' ' ' ALA . 0.5 OUTLIER -64.56 -57.25 9.67 Favored 'General case' 0 CA--C 1.539 0.543 0 C-N-CA 118.43 -1.308 . . . . 1.0 109.143 -179.804 . . . . . . . . 3 3 . 1 . 029 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . 0.566 ' N ' ' SG ' ' A' ' 30' ' ' CYS . . . -64.35 -56.09 16.74 Favored 'General case' 0 N--CA 1.468 0.436 0 N-CA-C 116.276 1.954 . . . . 1.0 116.276 -175.984 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . 0.455 ' O ' ' HB2' ' A' ' 33' ' ' LEU . . . 81.5 73.44 1.2 Allowed Glycine 0 CA--C 1.537 1.425 0 N-CA-C 108.694 -1.762 . . . . 1.0 108.694 -175.539 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . 0.455 ' HB2' ' O ' ' A' ' 32' ' ' GLY . 15.8 mt 81.34 110.04 0.03 OUTLIER Pre-proline 0 N--CA 1.486 1.345 0 C-N-CA 124.68 1.192 . . . . 1.0 111.745 -178.657 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 52.4 Cg_exo -54.62 -14.48 7.45 Favored 'Trans proline' 0 N--CA 1.507 2.308 0 C-N-CA 122.348 2.032 . . . . 1.0 113.325 178.355 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -56.46 -55.87 27.43 Favored Glycine 0 CA--C 1.534 1.236 0 C-N-CA 119.159 -1.496 . . . . 1.0 109.588 -178.458 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . 0.563 ' CG1' ' H ' ' A' ' 37' ' ' ILE . 6.1 p -69.78 -70.08 0.25 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.5 0 N-CA-C 112.958 0.725 . . . . 1.0 112.958 -177.53 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . 0.569 ' O ' ' CG2' ' A' ' 37' ' ' ILE . 53.1 mt 9.46 68.16 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.486 1.373 0 N-CA-C 114.035 1.124 . . . . 1.0 114.035 -178.061 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 38' ' ' HIS . . . . . 0.633 ' H ' ' CD2' ' A' ' 38' ' ' HIS . 0.3 OUTLIER -131.75 118.47 19.99 Favored 'General case' 0 N--CA 1.447 -0.587 0 CA-C-N 122.161 2.255 . . . . 1.0 106.477 177.484 . . . . . . . . 3 3 . 1 . 029 nuclear orig core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 3.9 m -101.88 122.65 46.59 Favored Pre-proline 0 C--N 1.323 -0.56 0 C-N-CA 120.478 -0.489 . . . . 1.0 110.508 -178.684 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 58.3 Cg_exo -48.85 -37.43 36.15 Favored 'Trans proline' 0 N--CA 1.491 1.346 0 C-N-CA 121.133 1.222 . . . . 1.0 112.829 179.896 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -124.71 131.03 53.49 Favored 'General case' 0 N--CA 1.467 0.379 0 N-CA-C 109.831 -0.433 . . . . 1.0 109.831 178.479 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . 0.691 ' C ' ' H ' ' A' ' 44' ' ' GLY . 28.7 ptt-85 -168.27 165.57 12.93 Favored 'General case' 0 C--N 1.322 -0.614 0 C-N-CA 119.608 -0.837 . . . . 1.0 110.628 178.094 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 21.1 ttt180 -65.63 17.75 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.464 0 N-CA-C 108.795 -0.817 . . . . 1.0 108.795 179.206 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . 0.691 ' H ' ' C ' ' A' ' 42' ' ' ARG . . . 82.91 -24.59 5.14 Favored Glycine 0 N--CA 1.447 -0.627 0 N-CA-C 110.857 -0.897 . . . . 1.0 110.857 -179.947 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . 0.653 ' CD1' ' N ' ' A' ' 45' ' ' PHE . 0.0 OUTLIER -163.78 164.1 23.78 Favored 'General case' 0 CA--C 1.551 1.008 0 CA-C-N 116.98 0.39 . . . . 1.0 110.137 -178.633 . . . . . . . . 3 3 . 1 . 029 nuclear orig core ' A' A ' 46' ' ' PHE . . . . . 0.534 ' N ' ' HE ' ' A' ' 47' ' ' ARG . 0.6 OUTLIER 144.01 4.31 0.0 OUTLIER 'General case' 0 N--CA 1.505 2.297 0 O-C-N 125.065 1.478 . . . . 1.0 111.92 177.531 . . . . . . . . 3 3 . 1 . 029 nuclear orig core ' A' A ' 47' ' ' ARG . . . . . 0.537 ' O ' ' C ' ' A' ' 48' ' ' CYS . 0.0 OUTLIER -117.27 -149.49 0.44 Allowed 'General case' 0 N--CA 1.472 0.65 0 CA-C-N 117.912 0.324 . . . . 1.0 110.182 -179.183 . . . . . . . . 3 3 . 1 . 029 nuclear orig core ' A' A ' 48' ' ' CYS . . . . . 0.537 ' C ' ' O ' ' A' ' 47' ' ' ARG . 25.8 p -15.32 93.98 0.01 OUTLIER 'General case' 0 N--CA 1.484 1.239 0 O-C-N 124.346 1.029 . . . . 1.0 110.456 179.872 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 49' ' ' ASN . . . . . 0.507 ' ND2' ' O ' ' A' ' 52' ' ' ARG . 0.1 OUTLIER -123.31 140.73 34.43 Favored Pre-proline 0 CA--C 1.541 0.607 0 N-CA-C 108.746 -0.835 . . . . 1.0 108.746 -178.1 . . . . . . . . 3 3 . 1 . 029 nuclear orig core ' A' A ' 50' ' ' PRO . . . . . 0.508 ' C ' ' H ' ' A' ' 52' ' ' ARG . 64.9 Cg_endo -73.44 59.91 4.03 Favored 'Trans proline' 0 N--CA 1.493 1.445 0 C-N-CA 121.613 1.542 . . . . 1.0 112.047 -179.861 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 20.8 mp0 68.04 -24.85 0.13 Allowed 'General case' 0 N--CA 1.469 0.478 0 CA-C-N 115.677 -0.692 . . . . 1.0 112.055 179.614 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . 0.508 ' H ' ' C ' ' A' ' 50' ' ' PRO . 47.1 mmt-85 -59.24 174.95 0.35 Allowed 'General case' 0 CA--C 1.518 -0.252 0 C-N-CA 120.299 -0.561 . . . . 1.0 109.731 -179.928 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -99.15 145.31 10.54 Favored 'Isoleucine or valine' 0 C--O 1.232 0.133 0 CA-C-O 122.133 0.968 . . . . 1.0 111.141 -179.199 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 54' ' ' GLN . . . . . 0.479 ' CD ' ' H ' ' A' ' 54' ' ' GLN . 0.0 OUTLIER -63.91 79.27 0.03 OUTLIER 'General case' 0 C--N 1.316 -0.862 0 CA-C-N 113.345 -1.752 . . . . 1.0 110.363 -177.532 . . . . . . . . 3 3 . 1 . 029 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -148.91 156.51 7.76 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.412 0 N-CA-C 108.984 -0.747 . . . . 1.0 108.984 176.914 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . 0.567 ' O ' ' CD1' ' A' ' 58' ' ' TRP . . . 110.17 -4.99 30.17 Favored Glycine 0 N--CA 1.469 0.891 0 N-CA-C 109.767 -1.333 . . . . 1.0 109.767 -178.821 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . 0.533 ' N ' ' OD1' ' A' ' 57' ' ' ASP . 12.7 p-10 -80.02 98.54 7.25 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 114.914 -0.643 . . . . 1.0 109.469 178.885 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 58' ' ' TRP . . . . . 0.567 ' CD1' ' O ' ' A' ' 56' ' ' GLY . 18.4 m95 -84.84 176.79 8.28 Favored 'General case' 0 N--CA 1.464 0.239 0 CA-C-O 122.561 1.172 . . . . 1.0 113.084 -178.521 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 1.3 mpp_? -90.11 -60.06 2.03 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 112.26 -2.246 . . . . 1.0 111.494 179.781 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -90.68 -18.18 25.51 Favored 'General case' 0 N--CA 1.48 1.069 0 N-CA-C 113.925 1.083 . . . . 1.0 113.925 -179.462 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 3.4 tt0 -82.66 -13.91 55.6 Favored 'General case' 0 C--N 1.318 -0.784 0 O-C-N 121.397 -0.815 . . . . 1.0 110.719 -179.48 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 62' ' ' VAL . . . . . 0.655 ' O ' ' N ' ' A' ' 66' ' ' GLY . 28.2 m -51.51 -54.58 11.55 Favored 'Isoleucine or valine' 0 C--O 1.203 -1.377 0 C-N-CA 120.263 -0.575 . . . . 1.0 111.212 -176.77 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 63' ' ' ALA . . . . . 0.455 ' O ' ' N ' ' A' ' 67' ' ' ARG . . . -71.25 -53.84 12.96 Favored 'General case' 0 C--N 1.315 -0.894 0 CA-C-N 119.59 1.086 . . . . 1.0 109.282 -177.747 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 64' ' ' HIS . . . . . 0.72 ' CD2' HH12 ' A' ' 67' ' ' ARG . 0.5 OUTLIER -45.2 -54.61 6.73 Favored 'General case' 0 CA--C 1.536 0.409 0 N-CA-C 107.969 -1.123 . . . . 1.0 107.969 179.157 . . . . . . . . 3 3 . 1 . 029 nuclear orig core ' A' A ' 65' ' ' ASP . . . . . 0.614 ' C ' ' H ' ' A' ' 67' ' ' ARG . 11.1 t70 -73.83 -49.07 26.94 Favored 'General case' 0 C--N 1.314 -0.975 0 CA-C-N 114.428 -1.26 . . . . 1.0 111.16 179.343 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . 0.688 ' C ' ' H ' ' A' ' 68' ' ' LEU . . . -75.13 26.81 1.19 Allowed Glycine 0 C--N 1.317 -0.509 0 N-CA-C 109.88 -1.288 . . . . 1.0 109.88 177.41 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 67' ' ' ARG . . . . . 0.72 HH12 ' CD2' ' A' ' 64' ' ' HIS . 21.5 mtt85 -71.57 8.2 1.19 Allowed 'General case' 0 CA--C 1.504 -0.826 0 N-CA-C 105.22 -2.141 . . . . 1.0 105.22 173.629 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . 0.688 ' H ' ' C ' ' A' ' 66' ' ' GLY . 1.5 pp -32.27 -29.83 0.01 OUTLIER 'General case' 0 C--N 1.347 0.498 0 O-C-N 124.112 0.883 . . . . 1.0 108.982 -177.252 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . 0.631 ' N ' ' O ' ' A' ' 67' ' ' ARG . 2.1 tt -62.38 -64.36 0.95 Allowed 'General case' 0 C--N 1.321 -0.632 0 C-N-CA 119.095 -1.042 . . . . 1.0 108.423 177.14 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . 0.592 ' O ' ' N ' ' A' ' 72' ' ' HIS . . . -77.45 -73.17 0.32 Allowed 'General case' 0 N--CA 1.47 0.537 0 N-CA-C 104.319 -2.475 . . . . 1.0 104.319 176.161 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 71' ' ' ALA . . . . . 0.504 ' O ' ' C ' ' A' ' 72' ' ' HIS . . . -41.22 2.8 0.0 OUTLIER 'General case' 0 C--N 1.322 -0.619 0 N-CA-C 115.533 1.679 . . . . 1.0 115.533 179.77 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 72' ' ' HIS . . . . . 0.606 ' CD2' ' H ' ' A' ' 73' ' ' MET . 1.9 p-80 -29.06 -63.84 0.11 Allowed 'General case' 0 N--CA 1.47 0.528 0 CA-C-N 120.6 1.545 . . . . 1.0 112.458 -176.29 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 73' ' ' MET . . . . . 0.606 ' H ' ' CD2' ' A' ' 72' ' ' HIS . 0.0 OUTLIER -71.72 -48.69 45.43 Favored 'General case' 0 C--N 1.325 -0.473 0 C-N-CA 119.236 -0.986 . . . . 1.0 109.84 177.765 . . . . . . . . 3 3 . 1 . 029 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . 0.746 ' O ' ' N ' ' A' ' 76' ' ' GLY . 58.0 t -45.62 -43.32 3.93 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.387 0 CA-C-O 117.397 -1.287 . . . . 1.0 112.08 -175.843 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 75' ' ' ASN . . . . . 0.424 ' O ' ' N ' ' A' ' 78' ' ' VAL . 16.2 t30 -35.75 -12.17 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.613 0 CA-C-N 121.265 1.848 . . . . 1.0 112.467 178.549 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 76' ' ' GLY . . . . . 0.746 ' N ' ' O ' ' A' ' 74' ' ' VAL . . . -46.04 -25.02 1.58 Allowed Glycine 0 CA--C 1.54 1.654 0 N-CA-C 108.349 -1.9 . . . . 1.0 108.349 176.721 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 77' ' ' ILE . . . . . 0.67 ' CG1' ' H ' ' A' ' 78' ' ' VAL . 5.5 pt -63.24 -54.76 28.98 Favored 'Isoleucine or valine' 0 C--O 1.219 -0.511 0 N-CA-C 107.873 -1.158 . . . . 1.0 107.873 178.421 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . 0.67 ' H ' ' CG1' ' A' ' 77' ' ' ILE . 59.7 t -36.04 -33.07 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.316 -0.885 0 CA-C-N 112.186 -2.279 . . . . 1.0 106.962 -177.108 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . 0.502 ' N ' ' O ' ' A' ' 77' ' ' ILE . 0.0 OUTLIER -98.39 -33.44 4.18 Favored 'Isoleucine or valine' 0 CA--C 1.556 1.178 0 CA-C-N 115.795 -0.639 . . . . 1.0 111.018 177.828 . . . . . . . . 3 3 . 1 . 029 nuclear orig core ' A' A ' 80' ' ' ALA . . . . . 0.56 ' N ' ' O ' ' A' ' 77' ' ' ILE . . . -84.86 -13.37 51.16 Favored 'General case' 0 N--CA 1.48 1.048 0 N-CA-C 114.842 1.423 . . . . 1.0 114.842 -179.096 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 81' ' ' GLU . . . . . 0.452 ' N ' ' O ' ' A' ' 77' ' ' ILE . 41.8 mt-10 -88.48 -67.33 0.84 Allowed 'General case' 0 CA--C 1.506 -0.724 0 O-C-N 121.656 -0.652 . . . . 1.0 109.383 178.098 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 82' ' ' ASP . . . . . 0.541 ' O ' ' N ' ' A' ' 84' ' ' LEU . 24.3 t0 -73.25 -13.92 61.23 Favored 'General case' 0 N--CA 1.442 -0.858 0 CA-C-N 119.043 0.838 . . . . 1.0 111.908 179.792 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . 0.518 ' C ' ' O ' ' A' ' 82' ' ' ASP . . . -20.47 -47.2 0.01 OUTLIER 'General case' 0 N--CA 1.478 0.96 0 CA-C-N 118.39 0.541 . . . . 1.0 112.032 178.221 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . 0.541 ' N ' ' O ' ' A' ' 82' ' ' ASP . 3.7 mm? -34.29 -35.91 0.04 OUTLIER 'General case' 0 N--CA 1.478 0.949 0 N-CA-C 113.209 0.818 . . . . 1.0 113.209 -178.163 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 11.2 tp -100.42 -36.86 5.28 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.66 0 N-CA-C 108.548 -0.908 . . . . 1.0 108.548 177.88 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 86' ' ' ALA . . . . . 0.47 ' C ' ' H ' ' A' ' 88' ' ' ALA . . . -61.21 -58.82 6.73 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 114.426 -1.261 . . . . 1.0 109.132 179.973 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 87' ' ' GLU . . . . . 0.473 ' N ' ' O ' ' A' ' 83' ' ' ALA . 2.5 tt0 -71.5 24.04 0.04 OUTLIER 'General case' 0 CA--C 1.542 0.642 0 O-C-N 121.321 -0.862 . . . . 1.0 112.364 -178.931 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 88' ' ' ALA . . . . . 0.47 ' H ' ' C ' ' A' ' 86' ' ' ALA . . . -126.64 -16.63 5.23 Favored 'General case' 0 N--CA 1.478 0.971 0 CA-C-O 122.213 1.006 . . . . 1.0 108.999 179.131 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 21.2 m -101.48 33.89 0.37 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.456 0 CA-C-N 113.406 -1.724 . . . . 1.0 109.09 178.328 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 90' ' ' GLY . . . . . 0.592 ' C ' ' H ' ' A' ' 92' ' ' HIS . . . -69.3 -35.45 76.69 Favored Glycine 0 C--N 1.345 1.044 0 N-CA-C 111.16 -0.776 . . . . 1.0 111.16 179.009 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 91' ' ' PRO . . . . . 0.583 ' CD ' ' N ' ' A' ' 90' ' ' GLY . 89.4 Cg_exo -48.35 -8.08 0.06 OUTLIER 'Trans proline' 0 N--CA 1.498 1.746 0 C-N-CA 122.002 1.801 . . . . 1.0 110.702 177.897 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 92' ' ' HIS . . . . . 0.601 ' ND1' ' N ' ' A' ' 93' ' ' LEU . 0.9 OUTLIER -57.54 -20.11 29.56 Favored 'General case' 0 N--CA 1.444 -0.746 0 N-CA-C 107.771 -1.196 . . . . 1.0 107.771 179.367 . . . . . . . . 3 3 . 1 . 029 nuclear orig core ' A' A ' 93' ' ' LEU . . . . . 0.601 ' N ' ' ND1' ' A' ' 92' ' ' HIS . 2.2 pp -65.63 -58.09 6.56 Favored 'General case' 0 N--CA 1.451 -0.393 0 N-CA-C 108.507 -0.923 . . . . 1.0 108.507 178.507 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 94' ' ' ALA . . . . . 0.422 ' H ' ' HG ' ' A' ' 93' ' ' LEU . . . -55.11 -54.21 46.03 Favored 'General case' 0 N--CA 1.452 -0.336 0 N-CA-C 108.962 -0.755 . . . . 1.0 108.962 179.305 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 95' ' ' ARG . . . . . 0.579 ' O ' ' N ' ' A' ' 97' ' ' LEU . 29.2 mtm180 -58.69 -58.86 6.73 Favored 'General case' 0 C--O 1.242 0.689 0 CA-C-O 122.529 1.157 . . . . 1.0 108.254 179.461 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 96' ' ' ALA . . . . . 0.886 ' O ' ' N ' ' A' ' 98' ' ' GLY . . . -48.55 -14.1 0.06 Allowed 'General case' 0 N--CA 1.424 -1.754 0 O-C-N 118.961 -2.337 . . . . 1.0 111.297 -178.856 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 97' ' ' LEU . . . . . 0.735 ' O ' ' N ' ' A' ' 100' ' ' ILE . 1.9 tp 5.23 -52.34 0.0 OUTLIER 'General case' 0 C--N 1.367 1.358 0 CA-C-O 116.427 -1.749 . . . . 1.0 110.447 -167.765 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 98' ' ' GLY . . . . . 0.886 ' N ' ' O ' ' A' ' 96' ' ' ALA . . . -48.66 -23.65 3.49 Favored Glycine 0 CA--C 1.542 1.735 0 CA-C-N 123.916 3.053 . . . . 1.0 108.034 174.733 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 99' ' ' GLN . . . . . 0.572 ' N ' ' O ' ' A' ' 96' ' ' ALA . 59.0 tt0 -68.81 -19.22 64.27 Favored 'General case' 0 C--N 1.364 1.211 0 N-CA-C 107.285 -1.376 . . . . 1.0 107.285 177.536 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 100' ' ' ILE . . . . . 0.735 ' N ' ' O ' ' A' ' 97' ' ' LEU . 1.9 tp -65.54 -42.58 93.43 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 N-CA-C 107.103 -1.443 . . . . 1.0 107.103 177.128 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 101' ' ' VAL . . . . . 0.743 ' O ' ' N ' ' A' ' 105' ' ' GLY . 61.0 t -55.68 -60.03 2.1 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.43 0 N-CA-C 106.931 -1.507 . . . . 1.0 106.931 178.704 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 102' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -46.35 -18.37 0.06 Allowed 'General case' 0 C--N 1.32 -0.708 0 CA-C-N 116.433 -0.349 . . . . 1.0 111.622 -179.666 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 103' ' ' ARG . . . . . 0.418 ' H ' ' C ' ' A' ' 101' ' ' VAL . 1.1 ttp180 -92.77 -44.65 8.41 Favored 'General case' 0 N--CA 1.478 0.946 0 CA-C-O 121.948 0.88 . . . . 1.0 111.068 176.951 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 104' ' ' TYR . . . . . 0.583 ' CG ' ' O ' ' A' ' 104' ' ' TYR . 0.0 OUTLIER -106.57 21.85 16.79 Favored 'General case' 0 C--N 1.317 -0.808 0 C-N-CA 126.297 1.839 . . . . 1.0 111.215 179.416 . . . . . . . . 3 3 . 1 . 029 nuclear orig core ' A' A ' 105' ' ' GLY . . . . . 0.769 ' O ' ' N ' ' A' ' 107' ' ' THR . . . -170.12 -7.33 0.03 OUTLIER Glycine 0 C--N 1.339 0.747 0 C-N-CA 118.495 -1.812 . . . . 1.0 113.481 178.619 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 106' ' ' ALA . . . . . 0.435 ' O ' ' CD ' ' A' ' 110' ' ' PRO . . . -31.64 69.49 0.0 OUTLIER 'General case' 0 N--CA 1.467 0.387 0 N-CA-C 113.752 1.019 . . . . 1.0 113.752 -177.738 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 107' ' ' THR . . . . . 0.769 ' N ' ' O ' ' A' ' 105' ' ' GLY . 4.8 t -91.84 4.22 53.38 Favored 'General case' 0 N--CA 1.436 -1.171 0 N-CA-C 105.668 -1.975 . . . . 1.0 105.668 176.151 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 11.2 p -87.77 -57.35 4.31 Favored 'Isoleucine or valine' 0 C--N 1.357 0.928 0 CA-C-N 115.851 -0.613 . . . . 1.0 110.624 178.333 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 109' ' ' ILE . . . . . 0.432 ' N ' ' CD ' ' A' ' 110' ' ' PRO . 0.1 OUTLIER -62.95 -37.98 38.5 Favored Pre-proline 0 C--N 1.359 0.987 0 N-CA-C 114.476 1.288 . . . . 1.0 114.476 -176.911 . . . . . . . . 3 3 . 1 . 029 nuclear orig core ' A' A ' 110' ' ' PRO . . . . . 0.435 ' CD ' ' O ' ' A' ' 106' ' ' ALA . 62.5 Cg_exo -49.04 -44.9 31.2 Favored 'Trans proline' 0 N--CA 1.497 1.703 0 CA-C-N 121.158 1.449 . . . . 1.0 113.649 -176.418 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 9.0 t30 -68.03 -67.55 0.45 Allowed 'General case' 0 C--N 1.326 -0.422 0 C-N-CA 118.735 -1.186 . . . . 1.0 110.435 -177.815 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 6.3 pt -52.89 -23.2 4.99 Favored 'Isoleucine or valine' 0 C--O 1.214 -0.778 0 N-CA-C 108.78 -0.822 . . . . 1.0 108.78 179.391 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 113' ' ' ASN . . . . . 0.418 ' CB ' ' O ' ' A' ' 109' ' ' ILE . 20.2 t30 -59.43 -51.45 69.84 Favored 'General case' 0 C--N 1.314 -0.943 0 CA-C-N 113.731 -1.577 . . . . 1.0 108.334 -178.423 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -58.64 -28.9 66.11 Favored 'General case' 0 N--CA 1.443 -0.805 0 C-N-CA 120.345 -0.542 . . . . 1.0 111.202 179.874 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 115' ' ' ALA . . . . . 0.578 ' O ' ' N ' ' A' ' 119' ' ' LEU . . . -81.12 -50.29 9.8 Favored 'General case' 0 C--O 1.208 -1.123 0 C-N-CA 120.084 -0.646 . . . . 1.0 109.292 177.275 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 116' ' ' ILE . . . . . 0.413 ' C ' ' O ' ' A' ' 115' ' ' ALA . 35.8 mt -42.85 -48.39 1.19 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.408 0 N-CA-C 104.997 -2.223 . . . . 1.0 104.997 179.104 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 117' ' ' GLU . . . . . 0.459 ' O ' ' HA ' ' A' ' 121' ' ' THR . 55.7 tt0 -46.51 -58.32 3.89 Favored 'General case' 0 C--N 1.314 -0.951 0 CA-C-N 111.294 -2.685 . . . . 1.0 106.332 177.814 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 118' ' ' VAL . . . . . 0.574 ' N ' ' O ' ' A' ' 115' ' ' ALA . 15.8 t -64.44 -56.23 17.34 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.747 0 C-N-CA 120.085 -0.646 . . . . 1.0 110.486 177.398 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 119' ' ' LEU . . . . . 0.578 ' N ' ' O ' ' A' ' 115' ' ' ALA . 1.1 mm? -51.77 -20.63 2.26 Favored 'General case' 0 N--CA 1.451 -0.377 0 N-CA-C 113.984 1.105 . . . . 1.0 113.984 -178.532 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 120' ' ' GLY . . . . . 0.484 ' O ' ' OG1' ' A' ' 121' ' ' THR . . . -134.16 -68.64 0.07 OUTLIER Glycine 0 CA--C 1.554 2.486 0 N-CA-C 105.996 -2.842 . . . . 1.0 105.996 173.974 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 121' ' ' THR . . . . . 0.484 ' OG1' ' O ' ' A' ' 120' ' ' GLY . 2.3 m 152.7 -31.96 0.01 OUTLIER 'General case' 0 N--CA 1.481 1.101 0 CA-C-N 112.656 -1.772 . . . . 1.0 112.01 178.478 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 122' ' ' GLY . . . . . 0.67 ' O ' ' N ' ' A' ' 124' ' ' ASP . . . 104.02 -17.03 49.5 Favored Glycine 0 N--CA 1.471 1.016 0 N-CA-C 108.875 -1.69 . . . . 1.0 108.875 -177.973 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -55.4 84.98 0.0 OUTLIER 'General case' 0 CA--C 1.539 0.527 0 N-CA-C 105.566 -2.013 . . . . 1.0 105.566 178.548 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 124' ' ' ASP . . . . . 0.67 ' N ' ' O ' ' A' ' 122' ' ' GLY . 63.7 m-20 -163.56 170.81 16.7 Favored 'General case' 0 N--CA 1.471 0.575 0 CA-C-N 113.428 -1.715 . . . . 1.0 112.342 -179.086 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 125' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -144.15 138.73 28.36 Favored 'General case' 0 CA--C 1.547 0.846 0 N-CA-C 107.377 -1.342 . . . . 1.0 107.377 176.449 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 25.6 mmm180 -149.31 153.85 38.12 Favored 'General case' 0 N--CA 1.476 0.851 0 N-CA-C 109.872 -0.418 . . . . 1.0 109.872 178.575 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 127' ' ' PHE . . . . . 0.478 ' OXT' ' CD1' ' A' ' 127' ' ' PHE . 0.1 OUTLIER . . . . . 0 N--CA 1.471 0.589 0 CA-C-O 118.076 -0.964 . . . . 1.0 110.269 178.862 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 1' ' ' MET . . . . . 0.427 ' N ' ' SD ' ' A' ' 1' ' ' MET . 0.0 OUTLIER . . . . . 0 N--CA 1.495 1.8 0 N-CA-C 109.92 -0.4 . . . . 1.0 109.92 . . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 2' ' ' SER . . . . . 0.49 ' O ' ' CB ' ' A' ' 3' ' ' ASP . 9.0 t -86.49 13.78 7.82 Favored 'General case' 0 C--O 1.225 -0.23 0 CA-C-N 115.786 -0.643 . . . . 1.0 111.264 -179.918 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 3' ' ' ASP . . . . . 0.49 ' CB ' ' O ' ' A' ' 2' ' ' SER . 21.5 m-20 146.43 122.27 0.0 OUTLIER 'General case' 0 N--CA 1.478 0.955 0 O-C-N 124.577 1.173 . . . . 1.0 110.524 178.948 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 47.8 t80 -154.78 150.52 27.63 Favored 'General case' 0 N--CA 1.466 0.361 0 CA-C-N 116.062 -0.517 . . . . 1.0 110.573 179.028 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -152.39 147.97 26.92 Favored 'General case' 0 CA--C 1.543 0.694 0 CA-C-N 116.364 -0.38 . . . . 1.0 110.263 -178.529 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 6' ' ' THR . . . . . 0.456 ' H ' ' HG1' ' A' ' 6' ' ' THR . 0.2 OUTLIER -61.49 -157.6 0.01 OUTLIER 'General case' 0 N--CA 1.472 0.671 0 C-N-CA 121.032 -0.267 . . . . 1.0 111.037 -179.187 . . . . . . . . 3 3 . 1 . 030 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . 0.454 ' CG ' ' H ' ' A' ' 8' ' ' ARG . 3.2 pt-20 -75.76 -67.57 0.66 Allowed 'General case' 0 C--O 1.216 -0.698 0 CA-C-O 118.553 -0.737 . . . . 1.0 110.245 -179.367 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 8' ' ' ARG . . . . . 0.454 ' H ' ' CG ' ' A' ' 7' ' ' GLU . 7.0 tmm_? -47.08 -43.01 19.81 Favored 'General case' 0 CA--C 1.493 -1.214 0 CA-C-N 119.645 1.111 . . . . 1.0 111.781 -177.858 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -68.96 -52.99 28.74 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.94 0 C-N-CA 118.933 -1.107 . . . . 1.0 108.779 179.063 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 39.5 t -58.67 -42.75 89.18 Favored 'General case' 0 N--CA 1.455 -0.207 0 CA-C-O 118.868 -0.587 . . . . 1.0 111.968 179.528 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 11' ' ' ARG . . . . . 0.678 ' O ' ' N ' ' A' ' 14' ' ' ALA . 0.0 OUTLIER -74.17 -59.97 2.48 Favored 'General case' 0 CA--C 1.492 -1.256 0 N-CA-C 106.85 -1.537 . . . . 1.0 106.85 178.051 . . . . . . . . 3 3 . 1 . 030 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . 0.461 ' C ' ' O ' ' A' ' 11' ' ' ARG . . . -38.91 -43.08 0.92 Allowed 'General case' 0 CA--C 1.487 -1.475 0 CA-C-N 119.108 0.867 . . . . 1.0 108.783 -175.879 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . 0.642 ' O ' ' CB ' ' A' ' 17' ' ' LEU . 71.5 t -60.12 -52.53 60.21 Favored 'Isoleucine or valine' 0 C--O 1.186 -2.252 0 C-N-CA 115.984 -2.286 . . . . 1.0 106.822 177.664 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . 0.678 ' N ' ' O ' ' A' ' 11' ' ' ARG . . . -66.1 -64.89 0.76 Allowed 'General case' 0 C--O 1.209 -1.041 0 O-C-N 120.329 -1.482 . . . . 1.0 113.122 177.954 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . 0.546 ' O ' ' N ' ' A' ' 19' ' ' GLY . . . -57.19 -59.13 5.56 Favored 'General case' 0 N--CA 1.497 1.878 0 C-N-CA 119.739 -0.784 . . . . 1.0 112.86 -175.263 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -61.62 -54.89 36.86 Favored 'General case' 0 CA--C 1.556 1.206 0 CA-C-O 122.533 1.158 . . . . 1.0 109.866 -177.678 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . 0.642 ' CB ' ' O ' ' A' ' 13' ' ' VAL . 21.1 tp -57.57 -51.17 70.56 Favored 'General case' 0 N--CA 1.481 1.102 0 CA-C-N 113.57 -1.65 . . . . 1.0 108.194 -177.452 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . 0.623 HG22 ' H ' ' A' ' 19' ' ' GLY . 3.0 m -70.34 -57.08 8.92 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.461 0 C-N-CA 118.927 -1.109 . . . . 1.0 110.168 179.636 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . 0.623 ' H ' HG22 ' A' ' 18' ' ' VAL . . . -61.62 -177.43 2.53 Favored Glycine 0 N--CA 1.446 -0.697 0 N-CA-C 111.718 -0.553 . . . . 1.0 111.718 -178.045 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 20' ' ' PRO . . . . . 0.569 ' O ' ' N ' ' A' ' 24' ' ' ALA . 54.4 Cg_endo -82.81 -23.63 3.76 Favored 'Trans proline' 0 C--N 1.303 -1.85 0 C-N-CA 123.045 2.497 . . . . 1.0 112.065 -179.271 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -60.51 -59.22 10.66 Favored Glycine 0 CA--C 1.535 1.301 0 C-N-CA 120.046 -1.073 . . . . 1.0 111.321 -176.952 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -56.14 -52.91 46.34 Favored Glycine 0 N--CA 1.469 0.893 0 N-CA-C 107.101 -2.399 . . . . 1.0 107.101 -178.411 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 36.7 t -59.28 -33.25 50.34 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.185 0 C-N-CA 119.774 -0.77 . . . . 1.0 109.143 179.836 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . 0.569 ' N ' ' O ' ' A' ' 20' ' ' PRO . . . -55.33 -62.29 1.77 Allowed 'General case' 0 N--CA 1.479 1.018 0 C-N-CA 119.239 -0.984 . . . . 1.0 110.568 -179.886 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 18.3 mt -63.66 -43.3 97.12 Favored 'General case' 0 C--N 1.345 0.392 0 C-N-CA 119.919 -0.712 . . . . 1.0 112.39 -177.854 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 95.2 t -60.22 -60.53 2.42 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.79 0 C-N-CA 118.591 -1.244 . . . . 1.0 111.279 -177.608 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . 0.443 ' CG2' ' NH1' ' A' ' 47' ' ' ARG . 3.1 p -59.61 -34.26 54.48 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.2 0 N-CA-C 112.681 0.623 . . . . 1.0 112.681 -177.58 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 71.3 tttt -66.79 -54.71 19.9 Favored 'General case' 0 C--N 1.312 -1.034 0 CA-C-O 122.317 1.056 . . . . 1.0 108.79 -179.68 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 98.6 t -62.88 -47.67 91.72 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.145 0 CA-C-N 113.553 -1.658 . . . . 1.0 110.499 -177.092 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 30' ' ' CYS . . . . . 0.561 ' SG ' ' N ' ' A' ' 31' ' ' ALA . 0.0 OUTLIER -67.48 -61.17 2.03 Favored 'General case' 0 CA--C 1.533 0.326 0 C-N-CA 118.729 -1.188 . . . . 1.0 110.198 -179.692 . . . . . . . . 3 3 . 1 . 030 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . 0.561 ' N ' ' SG ' ' A' ' 30' ' ' CYS . . . -60.38 -53.85 52.71 Favored 'General case' 0 CA--C 1.509 -0.6 0 CA-C-N 118.25 0.477 . . . . 1.0 111.99 -177.001 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . 0.495 ' O ' ' CB ' ' A' ' 33' ' ' LEU . . . 87.33 74.36 1.28 Allowed Glycine 0 CA--C 1.521 0.416 0 N-CA-C 108.632 -1.787 . . . . 1.0 108.632 -178.529 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . 0.495 ' CB ' ' O ' ' A' ' 32' ' ' GLY . 1.1 tt 85.81 85.31 0.05 OUTLIER Pre-proline 0 CA--C 1.546 0.792 0 CA-C-O 120.692 0.282 . . . . 1.0 110.414 -179.343 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 51.7 Cg_exo -53.23 -30.4 51.11 Favored 'Trans proline' 0 N--CA 1.502 1.99 0 C-N-CA 123.005 2.47 . . . . 1.0 114.227 -179.679 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -57.23 -60.75 8.45 Favored Glycine 0 N--CA 1.469 0.856 0 C-N-CA 119.062 -1.542 . . . . 1.0 110.185 -178.653 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . 0.538 ' O ' ' CB ' ' A' ' 37' ' ' ILE . 2.7 p -88.77 160.49 2.82 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.479 0 N-CA-C 105.77 -1.937 . . . . 1.0 105.77 177.808 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . 0.538 ' CB ' ' O ' ' A' ' 36' ' ' VAL . 0.7 OUTLIER 125.61 113.56 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.479 0.996 0 O-C-N 124.682 1.239 . . . . 1.0 110.373 179.711 . . . . . . . . 3 3 . 1 . 030 nuclear orig core ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 22.5 m80 -139.83 131.81 27.79 Favored 'General case' 0 N--CA 1.467 0.418 0 N-CA-C 108.557 -0.905 . . . . 1.0 108.557 179.263 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 9.2 p -99.37 149.4 35.8 Favored Pre-proline 0 N--CA 1.469 0.478 0 CA-C-N 116.969 -0.105 . . . . 1.0 110.743 -179.46 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 91.2 Cg_endo -75.29 -37.98 1.66 Allowed 'Trans proline' 0 N--CA 1.494 1.539 0 C-N-CA 122.317 2.012 . . . . 1.0 113.345 -179.123 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -128.2 134.38 49.02 Favored 'General case' 0 N--CA 1.472 0.665 0 N-CA-C 111.555 0.206 . . . . 1.0 111.555 179.611 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . 0.679 ' C ' ' H ' ' A' ' 44' ' ' GLY . 0.0 OUTLIER -169.86 165.95 9.61 Favored 'General case' 0 C--N 1.325 -0.487 0 C-N-CA 120.17 -0.612 . . . . 1.0 109.697 178.391 . . . . . . . . 3 3 . 1 . 030 nuclear orig core ' A' A ' 43' ' ' ARG . . . . . 0.493 ' C ' ' H ' ' A' ' 45' ' ' PHE . 0.0 OUTLIER -61.89 24.92 0.01 OUTLIER 'General case' 0 CA--C 1.548 0.896 0 CA-C-N 115.494 -0.775 . . . . 1.0 110.553 179.82 . . . . . . . . 3 3 . 1 . 030 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . 0.679 ' H ' ' C ' ' A' ' 42' ' ' ARG . . . 76.42 -26.08 1.61 Allowed Glycine 0 C--N 1.345 1.073 0 N-CA-C 110.452 -1.059 . . . . 1.0 110.452 -179.948 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . 0.54 ' O ' ' HB2' ' A' ' 46' ' ' PHE . 6.6 p90 -169.37 172.12 7.37 Favored 'General case' 0 C--O 1.219 -0.518 0 N-CA-C 109.966 -0.383 . . . . 1.0 109.966 179.743 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 46' ' ' PHE . . . . . 0.54 ' HB2' ' O ' ' A' ' 45' ' ' PHE . 1.1 m-85 131.63 99.57 0.0 OUTLIER 'General case' 0 N--CA 1.501 2.083 0 O-C-N 125.763 1.914 . . . . 1.0 109.802 178.695 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 47' ' ' ARG . . . . . 0.627 ' HG2' ' H ' ' A' ' 48' ' ' CYS . 15.6 ttp85 93.88 175.27 0.01 OUTLIER 'General case' 0 N--CA 1.468 0.446 0 O-C-N 123.596 0.56 . . . . 1.0 110.254 179.09 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 48' ' ' CYS . . . . . 0.627 ' H ' ' HG2' ' A' ' 47' ' ' ARG . 2.5 t 67.53 62.68 0.43 Allowed 'General case' 0 N--CA 1.445 -0.707 0 N-CA-C 106.373 -1.714 . . . . 1.0 106.373 -178.351 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 49' ' ' ASN . . . . . 0.559 ' N ' ' OD1' ' A' ' 49' ' ' ASN . 1.1 p30 -156.21 155.74 29.41 Favored Pre-proline 0 N--CA 1.449 -0.508 0 N-CA-C 108.097 -1.075 . . . . 1.0 108.097 178.865 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 50' ' ' PRO . . . . . 0.428 ' O ' ' NH1' ' A' ' 52' ' ' ARG . 50.8 Cg_endo -67.59 76.5 0.54 Allowed 'Trans proline' 0 C--N 1.303 -1.828 0 C-N-CA 121.967 1.778 . . . . 1.0 112.272 177.238 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 9.0 pt-20 40.12 63.97 0.98 Allowed 'General case' 0 N--CA 1.477 0.921 0 N-CA-C 112.532 0.567 . . . . 1.0 112.532 -179.95 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . 0.666 HH22 ' CE1' ' A' ' 92' ' ' HIS . 77.6 mtt85 -147.28 136.02 22.05 Favored 'General case' 0 N--CA 1.472 0.627 0 CA-C-N 116.049 -0.523 . . . . 1.0 111.844 178.896 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -54.44 164.75 0.29 Allowed 'Isoleucine or valine' 0 N--CA 1.478 0.942 0 N-CA-C 107.212 -1.403 . . . . 1.0 107.212 177.455 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 39.9 mm-40 -121.0 115.04 22.4 Favored 'General case' 0 CA--C 1.548 0.891 0 CA-C-N 121.845 2.111 . . . . 1.0 109.245 179.949 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -146.7 157.73 10.8 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.017 0 CA-C-N 118.476 0.58 . . . . 1.0 109.532 177.704 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 110.84 -6.81 29.45 Favored Glycine 0 N--CA 1.481 1.68 0 CA-C-N 118.752 0.706 . . . . 1.0 112.3 -179.595 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -112.64 127.88 56.23 Favored 'General case' 0 C--N 1.32 -0.682 0 N-CA-C 108.677 -0.86 . . . . 1.0 108.677 178.126 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 58' ' ' TRP . . . . . 0.482 ' O ' ' N ' ' A' ' 62' ' ' VAL . 5.0 m0 -139.18 158.48 44.1 Favored 'General case' 0 N--CA 1.455 -0.216 0 CA-C-O 122.808 1.29 . . . . 1.0 109.529 179.298 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 34.9 ptt-85 -41.03 -36.41 0.67 Allowed 'General case' 0 C--N 1.296 -1.728 0 CA-C-N 112.318 -2.219 . . . . 1.0 109.181 -178.616 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 42.8 t80 -90.94 -35.67 14.58 Favored 'General case' 0 N--CA 1.481 1.09 0 CA-C-O 121.687 0.756 . . . . 1.0 112.449 178.82 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . 0.477 ' O ' ' N ' ' A' ' 65' ' ' ASP . 92.5 mt-10 -77.67 -13.92 59.77 Favored 'General case' 0 N--CA 1.443 -0.812 0 O-C-N 121.757 -0.589 . . . . 1.0 110.53 179.926 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 62' ' ' VAL . . . . . 0.584 ' O ' ' N ' ' A' ' 66' ' ' GLY . 7.3 p -46.71 -56.2 1.42 Allowed 'Isoleucine or valine' 0 C--O 1.213 -0.858 0 C-N-CA 119.444 -0.902 . . . . 1.0 109.318 -175.664 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 63' ' ' ALA . . . . . 0.49 ' H ' ' CG1' ' A' ' 62' ' ' VAL . . . -64.77 -54.29 33.6 Favored 'General case' 0 C--N 1.302 -1.483 0 O-C-N 121.966 -0.459 . . . . 1.0 110.059 179.94 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 2.9 m-70 -53.16 -57.74 9.44 Favored 'General case' 0 CA--C 1.549 0.917 0 C-N-CA 119.591 -0.844 . . . . 1.0 109.813 -179.205 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 65' ' ' ASP . . . . . 0.642 ' C ' ' H ' ' A' ' 67' ' ' ARG . 33.8 t0 -72.72 -52.07 16.68 Favored 'General case' 0 C--O 1.245 0.854 0 CA-C-O 121.899 0.857 . . . . 1.0 111.48 179.111 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . 0.584 ' N ' ' O ' ' A' ' 62' ' ' VAL . . . -69.51 27.71 0.36 Allowed Glycine 0 C--O 1.226 -0.374 0 O-C-N 120.74 -1.225 . . . . 1.0 110.66 177.04 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 67' ' ' ARG . . . . . 0.709 ' O ' ' N ' ' A' ' 69' ' ' LEU . 8.0 mtm-85 -75.63 5.58 5.91 Favored 'General case' 0 CA--C 1.507 -0.673 0 N-CA-C 108.011 -1.107 . . . . 1.0 108.011 176.049 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . 0.486 ' H ' ' C ' ' A' ' 66' ' ' GLY . 2.7 mt -31.43 -25.5 0.0 OUTLIER 'General case' 0 N--CA 1.486 1.35 0 N-CA-C 108.311 -0.996 . . . . 1.0 108.311 -177.694 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . 0.709 ' N ' ' O ' ' A' ' 67' ' ' ARG . 48.1 tp -64.85 -65.35 0.69 Allowed 'General case' 0 N--CA 1.472 0.637 0 N-CA-C 108.662 -0.866 . . . . 1.0 108.662 177.655 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . 0.651 ' C ' ' H ' ' A' ' 72' ' ' HIS . . . -80.66 -73.96 0.34 Allowed 'General case' 0 N--CA 1.47 0.55 0 N-CA-C 104.438 -2.43 . . . . 1.0 104.438 176.906 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 71' ' ' ALA . . . . . 0.489 ' O ' ' C ' ' A' ' 72' ' ' HIS . . . -42.83 0.89 0.0 OUTLIER 'General case' 0 CA--C 1.513 -0.47 0 C-N-CA 124.864 1.265 . . . . 1.0 113.647 179.493 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 72' ' ' HIS . . . . . 0.671 ' CG ' ' N ' ' A' ' 73' ' ' MET . 0.0 OUTLIER -26.65 -63.5 0.08 Allowed 'General case' 0 C--N 1.346 0.434 0 CA-C-N 118.243 0.474 . . . . 1.0 110.421 -179.825 . . . . . . . . 3 3 . 1 . 030 nuclear orig core ' A' A ' 73' ' ' MET . . . . . 0.671 ' N ' ' CG ' ' A' ' 72' ' ' HIS . 12.5 ttm -74.32 -50.86 17.06 Favored 'General case' 0 C--N 1.323 -0.563 0 C-N-CA 119.043 -1.063 . . . . 1.0 109.917 178.668 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . 0.587 ' C ' ' H ' ' A' ' 76' ' ' GLY . 41.2 t -46.09 -45.78 5.77 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.269 0 CA-C-O 117.604 -1.189 . . . . 1.0 112.589 -175.018 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 75' ' ' ASN . . . . . 0.432 ' C ' ' N ' ' A' ' 77' ' ' ILE . 8.2 t-20 -42.54 -15.71 0.01 OUTLIER 'General case' 0 C--N 1.35 0.6 0 CA-C-N 121.227 1.83 . . . . 1.0 111.425 177.336 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 76' ' ' GLY . . . . . 0.587 ' H ' ' C ' ' A' ' 74' ' ' VAL . . . -46.18 -25.65 1.92 Allowed Glycine 0 CA--C 1.531 1.084 0 N-CA-C 108.984 -1.646 . . . . 1.0 108.984 -179.921 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 77' ' ' ILE . . . . . 0.526 ' O ' ' N ' ' A' ' 79' ' ' ILE . 0.9 OUTLIER -86.32 -61.96 1.65 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.699 0 CA-C-N 113.886 -1.157 . . . . 1.0 110.615 -178.099 . . . . . . . . 3 3 . 1 . 030 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . 0.427 ' C ' ' O ' ' A' ' 77' ' ' ILE . 12.2 t -37.86 -27.34 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.443 -0.789 0 N-CA-C 109.221 -0.659 . . . . 1.0 109.221 -178.308 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . 0.537 ' O ' ' CB ' ' A' ' 83' ' ' ALA . 0.9 OUTLIER -67.99 -51.87 44.93 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.788 0 C-N-CA 119.827 -0.749 . . . . 1.0 110.857 178.916 . . . . . . . . 3 3 . 1 . 030 nuclear orig core ' A' A ' 80' ' ' ALA . . . . . 0.512 ' N ' ' CG1' ' A' ' 79' ' ' ILE . . . -61.48 -63.14 1.37 Allowed 'General case' 0 C--O 1.231 0.097 0 C-N-CA 119.131 -1.028 . . . . 1.0 110.89 -178.656 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -49.28 -72.64 0.05 OUTLIER 'General case' 0 CA--C 1.536 0.437 0 C-N-CA 119.57 -0.852 . . . . 1.0 109.924 -179.495 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 82' ' ' ASP . . . . . 0.471 ' O ' ' N ' ' A' ' 84' ' ' LEU . 33.4 m-20 -59.6 -63.31 1.35 Allowed 'General case' 0 C--N 1.331 -0.227 0 C-N-CA 118.233 -1.387 . . . . 1.0 109.897 -178.285 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . 0.537 ' CB ' ' O ' ' A' ' 79' ' ' ILE . . . -68.82 57.95 0.09 Allowed 'General case' 0 C--N 1.317 -0.814 0 C-N-CA 119.416 -0.914 . . . . 1.0 110.395 -179.61 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . 0.471 ' N ' ' O ' ' A' ' 82' ' ' ASP . 0.2 OUTLIER -79.68 7.09 9.11 Favored 'General case' 0 C--N 1.351 0.672 0 N-CA-C 108.62 -0.881 . . . . 1.0 108.62 179.033 . . . . . . . . 3 3 . 1 . 030 nuclear orig core ' A' A ' 85' ' ' ILE . . . . . 0.757 ' O ' ' HB ' ' A' ' 89' ' ' VAL . 0.0 OUTLIER -92.06 -7.96 10.42 Favored 'Isoleucine or valine' 0 C--O 1.193 -1.88 0 CA-C-N 114.647 -1.161 . . . . 1.0 108.652 178.648 . . . . . . . . 3 3 . 1 . 030 nuclear orig core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -96.76 -12.96 23.01 Favored 'General case' 0 CA--C 1.544 0.747 0 CA-C-O 120.696 0.284 . . . . 1.0 111.709 179.704 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -88.53 -37.13 15.97 Favored 'General case' 0 N--CA 1.481 1.076 0 N-CA-C 113.321 0.86 . . . . 1.0 113.321 -178.493 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -112.88 -8.41 13.71 Favored 'General case' 0 N--CA 1.482 1.129 0 CA-C-O 121.57 0.7 . . . . 1.0 110.971 -178.629 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 89' ' ' VAL . . . . . 0.757 ' HB ' ' O ' ' A' ' 85' ' ' ILE . 14.9 t -99.43 33.34 0.31 Allowed 'Isoleucine or valine' 0 CA--C 1.503 -0.861 0 CA-C-N 115.144 -0.935 . . . . 1.0 109.425 178.095 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 90' ' ' GLY . . . . . 0.607 ' N ' ' HD2' ' A' ' 91' ' ' PRO . . . -67.42 -42.35 89.56 Favored Glycine 0 CA--C 1.537 1.414 0 N-CA-C 110.091 -1.204 . . . . 1.0 110.091 176.531 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 91' ' ' PRO . . . . . 0.607 ' HD2' ' N ' ' A' ' 90' ' ' GLY . 5.8 Cg_exo -42.09 -13.93 0.04 OUTLIER 'Trans proline' 0 N--CA 1.496 1.655 0 C-N-CA 122.152 1.901 . . . . 1.0 111.034 177.753 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 92' ' ' HIS . . . . . 0.666 ' CE1' HH22 ' A' ' 52' ' ' ARG . 47.9 p-80 -57.16 -18.42 15.21 Favored 'General case' 0 C--O 1.202 -1.397 0 N-CA-C 107.94 -1.133 . . . . 1.0 107.94 179.928 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 93' ' ' LEU . . . . . 0.467 ' HG ' ' H ' ' A' ' 94' ' ' ALA . 1.3 pp -65.67 -57.69 7.48 Favored 'General case' 0 C--N 1.325 -0.495 0 N-CA-C 108.785 -0.82 . . . . 1.0 108.785 179.537 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 94' ' ' ALA . . . . . 0.467 ' H ' ' HG ' ' A' ' 93' ' ' LEU . . . -58.35 -53.95 52.53 Favored 'General case' 0 CA--C 1.515 -0.396 0 N-CA-C 108.78 -0.822 . . . . 1.0 108.78 179.031 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 95' ' ' ARG . . . . . 0.692 ' O ' ' N ' ' A' ' 97' ' ' LEU . 6.8 mtm-85 -58.09 -58.3 9.02 Favored 'General case' 0 N--CA 1.449 -0.486 0 N-CA-C 107.322 -1.362 . . . . 1.0 107.322 178.732 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 96' ' ' ALA . . . . . 0.942 ' O ' ' N ' ' A' ' 98' ' ' GLY . . . -46.14 -11.62 0.02 OUTLIER 'General case' 0 C--N 1.308 -1.224 0 O-C-N 118.49 -2.631 . . . . 1.0 110.807 -179.687 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 97' ' ' LEU . . . . . 0.718 ' O ' ' N ' ' A' ' 100' ' ' ILE . 4.3 tt 9.22 -54.09 0.0 OUTLIER 'General case' 0 N--CA 1.476 0.873 0 CA-C-O 117.474 -1.25 . . . . 1.0 109.817 -168.19 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 98' ' ' GLY . . . . . 0.942 ' N ' ' O ' ' A' ' 96' ' ' ALA . . . -47.63 -22.46 1.8 Allowed Glycine 0 CA--C 1.547 2.086 0 CA-C-N 122.328 2.331 . . . . 1.0 107.295 174.908 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 99' ' ' GLN . . . . . 0.479 ' N ' ' O ' ' A' ' 96' ' ' ALA . 4.3 tp-100 -65.34 -20.5 66.42 Favored 'General case' 0 C--N 1.378 1.813 0 C-N-CA 117.975 -1.49 . . . . 1.0 108.439 176.922 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 100' ' ' ILE . . . . . 0.718 ' N ' ' O ' ' A' ' 97' ' ' LEU . 18.7 mm -64.13 -47.05 91.81 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.753 0 CA-C-N 114.438 -1.255 . . . . 1.0 108.325 177.489 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 101' ' ' VAL . . . . . 0.709 ' O ' ' N ' ' A' ' 105' ' ' GLY . 57.4 t -60.44 -58.96 4.99 Favored 'Isoleucine or valine' 0 C--O 1.219 -0.526 0 N-CA-C 106.945 -1.502 . . . . 1.0 106.945 179.58 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 102' ' ' CYS . . . . . 0.466 ' O ' ' CB ' ' A' ' 106' ' ' ALA . 0.0 OUTLIER -45.22 -17.92 0.03 OUTLIER 'General case' 0 N--CA 1.444 -0.726 0 CA-C-O 121.423 0.63 . . . . 1.0 110.268 -179.889 . . . . . . . . 3 3 . 1 . 030 nuclear orig core ' A' A ' 103' ' ' ARG . . . . . 0.62 ' NH2' ' CZ ' ' A' ' 104' ' ' TYR . 0.1 OUTLIER -95.48 -44.43 7.53 Favored 'General case' 0 N--CA 1.474 0.759 0 CA-C-O 122.47 1.129 . . . . 1.0 112.359 177.985 . . . . . . . . 3 3 . 1 . 030 nuclear orig core ' A' A ' 104' ' ' TYR . . . . . 0.62 ' CZ ' ' NH2' ' A' ' 103' ' ' ARG . 12.1 m-85 -107.16 21.41 17.57 Favored 'General case' 0 C--N 1.318 -0.761 0 C-N-CA 127.251 2.22 . . . . 1.0 111.861 179.507 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 105' ' ' GLY . . . . . 0.709 ' N ' ' O ' ' A' ' 101' ' ' VAL . . . -170.83 -10.68 0.02 OUTLIER Glycine 0 C--N 1.341 0.806 0 C-N-CA 119.356 -1.402 . . . . 1.0 112.155 179.664 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 106' ' ' ALA . . . . . 0.466 ' CB ' ' O ' ' A' ' 102' ' ' CYS . . . -28.77 75.13 0.0 OUTLIER 'General case' 0 CA--C 1.512 -0.492 0 N-CA-C 113.805 1.039 . . . . 1.0 113.805 -179.472 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 107' ' ' THR . . . . . 0.693 ' N ' ' O ' ' A' ' 105' ' ' GLY . 15.2 t -91.22 5.95 47.08 Favored 'General case' 0 N--CA 1.434 -1.264 0 N-CA-C 106.045 -1.835 . . . . 1.0 106.045 178.177 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 108' ' ' VAL . . . . . 0.485 ' O ' ' CG2' ' A' ' 108' ' ' VAL . 11.8 p -95.84 17.01 2.02 Favored 'Isoleucine or valine' 0 C--N 1.352 0.687 0 CA-C-O 118.493 -0.765 . . . . 1.0 110.873 177.077 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 109' ' ' ILE . . . . . 0.676 ' N ' ' CD ' ' A' ' 110' ' ' PRO . 40.5 pt -105.77 -14.85 0.15 Allowed Pre-proline 0 N--CA 1.438 -1.073 0 CA-C-N 121.255 1.843 . . . . 1.0 110.457 177.915 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 110' ' ' PRO . . . . . 0.676 ' CD ' ' N ' ' A' ' 109' ' ' ILE . 55.7 Cg_endo -67.36 -48.21 1.8 Allowed 'Trans proline' 0 N--CA 1.493 1.465 0 CA-C-N 121.163 1.451 . . . . 1.0 113.094 -175.728 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 15.6 t-20 -67.47 -66.36 0.57 Allowed 'General case' 0 N--CA 1.453 -0.304 0 C-N-CA 119.756 -0.777 . . . . 1.0 109.874 -179.125 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 112' ' ' ILE . . . . . 0.482 ' O ' ' HB ' ' A' ' 116' ' ' ILE . 2.9 tt -43.56 -40.52 1.37 Allowed 'Isoleucine or valine' 0 CA--C 1.548 0.904 0 N-CA-C 113.093 0.775 . . . . 1.0 113.093 -178.247 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 5.8 m-80 -67.86 -41.12 83.39 Favored 'General case' 0 C--N 1.31 -1.134 0 CA-C-O 122.449 1.119 . . . . 1.0 109.295 178.061 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -59.62 -52.02 67.31 Favored 'General case' 0 C--N 1.296 -1.74 0 CA-C-N 113.386 -1.734 . . . . 1.0 108.95 179.912 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -78.81 -57.04 3.96 Favored 'General case' 0 CA--C 1.537 0.456 0 N-CA-C 114.047 1.128 . . . . 1.0 114.047 179.517 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 116' ' ' ILE . . . . . 0.586 ' O ' ' N ' ' A' ' 120' ' ' GLY . 4.5 mm -52.05 -51.16 31.76 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.209 0 CA-C-O 122.008 0.909 . . . . 1.0 112.445 -176.55 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 117' ' ' GLU . . . . . 0.489 ' C ' ' O ' ' A' ' 116' ' ' ILE . 65.4 mt-10 -45.07 -56.92 4.24 Favored 'General case' 0 C--N 1.313 -0.982 0 N-CA-C 105.516 -2.031 . . . . 1.0 105.516 -176.662 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 96.7 t -58.07 -53.92 39.24 Favored 'Isoleucine or valine' 0 CA--C 1.554 1.129 0 C-N-CA 119.919 -0.712 . . . . 1.0 109.444 177.49 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 4.6 tt -51.92 -68.91 0.13 Allowed 'General case' 0 N--CA 1.48 1.033 0 N-CA-C 106.82 -1.548 . . . . 1.0 106.82 -178.628 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 120' ' ' GLY . . . . . 0.586 ' N ' ' O ' ' A' ' 116' ' ' ILE . . . -73.33 -82.65 0.33 Allowed Glycine 0 CA--C 1.548 2.156 0 C-N-CA 120.897 -0.668 . . . . 1.0 112.34 -179.158 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 121' ' ' THR . . . . . 0.559 ' OG1' ' O ' ' A' ' 120' ' ' GLY . 4.2 m 155.6 -34.31 0.01 OUTLIER 'General case' 0 N--CA 1.482 1.155 0 CA-C-N 112.435 -1.883 . . . . 1.0 112.355 179.397 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 122' ' ' GLY . . . . . 0.684 ' O ' ' N ' ' A' ' 124' ' ' ASP . . . 103.96 -17.76 47.98 Favored Glycine 0 N--CA 1.461 0.313 0 N-CA-C 106.198 -2.761 . . . . 1.0 106.198 -176.589 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 123' ' ' THR . . . . . 0.468 ' O ' ' CG ' ' A' ' 124' ' ' ASP . 9.6 t -55.98 81.31 0.0 OUTLIER 'General case' 0 N--CA 1.468 0.475 0 N-CA-C 105.519 -2.03 . . . . 1.0 105.519 178.758 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 124' ' ' ASP . . . . . 0.684 ' N ' ' O ' ' A' ' 122' ' ' GLY . 40.7 m-20 -166.81 178.85 5.64 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 112.871 -1.968 . . . . 1.0 111.66 179.041 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 125' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -147.34 143.76 28.26 Favored 'General case' 0 CA--C 1.545 0.78 0 N-CA-C 108.154 -1.054 . . . . 1.0 108.154 176.473 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 72.2 mtt-85 -150.92 155.8 39.88 Favored 'General case' 0 N--CA 1.47 0.569 0 CA-C-O 120.801 0.334 . . . . 1.0 111.011 176.535 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 127' ' ' PHE . . . . . 0.473 ' OXT' ' CG ' ' A' ' 127' ' ' PHE . 5.8 p90 . . . . . 0 C--O 1.218 -0.603 0 CA-C-O 118.188 -0.91 . . . . 1.0 110.159 179.276 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 N--CA 1.488 1.468 0 N-CA-C 108.866 -0.79 . . . . 1.0 108.866 . . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 85.5 p -106.87 10.47 30.62 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.297 -0.41 . . . . 1.0 110.405 -179.575 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 1.7 t70 166.07 94.37 0.0 OUTLIER 'General case' 0 N--CA 1.465 0.322 0 CA-C-N 115.965 -0.561 . . . . 1.0 110.003 179.646 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 54.7 t80 -149.04 144.77 26.92 Favored 'General case' 0 C--N 1.33 -0.262 0 N-CA-C 110.293 -0.262 . . . . 1.0 110.293 179.369 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' ASP . . . . . 0.516 ' N ' ' OD1' ' A' ' 5' ' ' ASP . 0.6 OUTLIER -154.95 151.48 28.57 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.799 0.333 . . . . 1.0 110.554 -179.285 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' THR . . . . . 0.672 ' O ' ' N ' ' A' ' 10' ' ' SER . 0.2 OUTLIER -67.99 176.18 2.75 Favored 'General case' 0 C--O 1.206 -1.223 0 CA-C-N 116.352 -0.385 . . . . 1.0 110.526 -179.617 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . 0.528 ' O ' ' N ' ' A' ' 11' ' ' ARG . 82.2 tt0 -58.49 -58.76 7.12 Favored 'General case' 0 C--N 1.318 -0.769 0 CA-C-O 121.466 0.651 . . . . 1.0 110.254 -177.558 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' ARG . . . . . 0.494 ' O ' ' CB ' ' A' ' 12' ' ' ALA . 26.9 mtp180 -47.86 -55.06 10.64 Favored 'General case' 0 C--O 1.213 -0.82 0 N-CA-C 107.06 -1.459 . . . . 1.0 107.06 -178.874 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . 0.585 ' O ' ' CG2' ' A' ' 13' ' ' VAL . 63.1 t -64.89 -49.17 81.15 Favored 'Isoleucine or valine' 0 C--O 1.199 -1.589 0 CA-C-N 114.356 -1.293 . . . . 1.0 110.702 177.971 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' SER . . . . . 0.672 ' N ' ' O ' ' A' ' 6' ' ' THR . 75.2 m -67.82 -65.54 0.68 Allowed 'General case' 0 C--N 1.316 -0.882 0 C-N-CA 119.764 -0.774 . . . . 1.0 112.098 -178.302 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' ARG . . . . . 0.528 ' N ' ' O ' ' A' ' 7' ' ' GLU . 11.2 ttm180 -64.35 -58.48 6.38 Favored 'General case' 0 C--N 1.324 -0.519 0 C-N-CA 119.839 -0.744 . . . . 1.0 111.764 -176.066 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . 0.494 ' CB ' ' O ' ' A' ' 8' ' ' ARG . . . -47.9 -48.64 31.42 Favored 'General case' 0 CA--C 1.539 0.547 0 N-CA-C 106.71 -1.589 . . . . 1.0 106.71 -177.907 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . 0.659 ' O ' ' N ' ' A' ' 17' ' ' LEU . 97.6 t -62.07 -50.9 78.2 Favored 'Isoleucine or valine' 0 C--O 1.194 -1.846 0 C-N-CA 118.839 -1.145 . . . . 1.0 109.28 177.281 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -56.85 -62.21 1.9 Allowed 'General case' 0 C--O 1.207 -1.151 0 O-C-N 120.871 -1.143 . . . . 1.0 109.572 -179.938 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . 0.558 ' O ' ' N ' ' A' ' 19' ' ' GLY . . . -51.36 -54.3 27.78 Favored 'General case' 0 C--N 1.319 -0.754 0 CA-C-O 121.79 0.805 . . . . 1.0 109.248 -178.521 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . 0.466 ' CB ' ' O ' ' A' ' 12' ' ' ALA . . . -61.52 -54.63 40.73 Favored 'General case' 0 C--N 1.308 -1.218 0 CA-C-N 114.62 -1.173 . . . . 1.0 108.508 -179.207 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . 0.659 ' N ' ' O ' ' A' ' 13' ' ' VAL . 42.4 tp -55.46 -54.29 45.72 Favored 'General case' 0 N--CA 1.478 0.961 0 CA-C-N 113.574 -1.648 . . . . 1.0 109.053 -177.16 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . 0.603 HG21 ' H ' ' A' ' 19' ' ' GLY . 3.6 m -68.65 -57.0 10.24 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.235 0 N-CA-C 108.992 -0.744 . . . . 1.0 108.992 178.912 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . 0.603 ' H ' HG21 ' A' ' 18' ' ' VAL . . . -63.04 -170.72 1.37 Allowed Glycine 0 CA--C 1.525 0.66 0 N-CA-C 110.829 -0.908 . . . . 1.0 110.829 -179.992 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' PRO . . . . . 0.648 ' O ' ' N ' ' A' ' 24' ' ' ALA . 93.0 Cg_endo -79.25 -27.02 4.65 Favored 'Trans proline' 0 C--N 1.308 -1.591 0 C-N-CA 122.797 2.331 . . . . 1.0 114.129 -178.33 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -57.16 -56.21 26.23 Favored Glycine 0 N--CA 1.477 1.375 0 C-N-CA 119.822 -1.18 . . . . 1.0 111.064 -177.624 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . 0.453 ' N ' ' O ' ' A' ' 16' ' ' ALA . . . -60.38 -55.83 27.85 Favored Glycine 0 N--CA 1.468 0.803 0 N-CA-C 108.587 -1.805 . . . . 1.0 108.587 -178.39 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -59.77 -35.15 58.41 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.204 0 CA-C-N 114.561 -0.82 . . . . 1.0 109.417 -179.94 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . 0.648 ' N ' ' O ' ' A' ' 20' ' ' PRO . . . -57.89 -61.92 2.19 Favored 'General case' 0 N--CA 1.452 -0.36 0 C-N-CA 118.99 -1.084 . . . . 1.0 109.739 -178.704 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 16.2 tp -65.38 -42.11 93.04 Favored 'General case' 0 N--CA 1.451 -0.411 0 C-N-CA 119.853 -0.739 . . . . 1.0 111.904 -178.326 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 89.6 t -61.57 -60.39 2.78 Favored 'Isoleucine or valine' 0 CA--C 1.522 -0.104 0 C-N-CA 118.834 -1.147 . . . . 1.0 110.307 -177.931 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . 0.411 ' O ' ' CB ' ' A' ' 31' ' ' ALA . 93.4 t -62.57 -38.26 81.03 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 N-CA-C 112.814 0.672 . . . . 1.0 112.814 -178.316 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 3.3 ttmp? -64.34 -55.02 24.05 Favored 'General case' 0 C--N 1.314 -0.95 0 CA-C-O 121.929 0.871 . . . . 1.0 108.775 -178.213 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 55.6 t -64.58 -45.15 96.35 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.008 0 CA-C-N 113.632 -1.622 . . . . 1.0 109.801 -178.533 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' CYS . . . . . . . . . . . . . 43.1 t -65.85 -61.16 2.22 Favored 'General case' 0 N--CA 1.445 -0.715 0 C-N-CA 118.666 -1.213 . . . . 1.0 108.743 179.729 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . 0.411 ' CB ' ' O ' ' A' ' 27' ' ' VAL . . . -63.73 -57.09 11.06 Favored 'General case' 0 CA--C 1.512 -0.514 0 N-CA-C 113.486 0.921 . . . . 1.0 113.486 -176.358 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . 0.475 ' O ' ' CB ' ' A' ' 33' ' ' LEU . . . 89.92 74.02 1.28 Allowed Glycine 0 CA--C 1.526 0.737 0 N-CA-C 110.862 -0.895 . . . . 1.0 110.862 -178.92 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . 0.475 ' CB ' ' O ' ' A' ' 32' ' ' GLY . 4.7 tp 87.43 84.08 0.04 OUTLIER Pre-proline 0 CA--C 1.544 0.746 0 CA-C-O 120.999 0.428 . . . . 1.0 111.204 179.578 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 52.1 Cg_exo -55.48 -33.3 85.69 Favored 'Trans proline' 0 N--CA 1.503 2.037 0 C-N-CA 123.798 2.998 . . . . 1.0 115.298 -179.528 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -55.39 -58.65 12.88 Favored Glycine 0 N--CA 1.469 0.871 0 C-N-CA 118.462 -1.827 . . . . 1.0 108.616 -178.804 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . 0.558 ' O ' ' CB ' ' A' ' 37' ' ' ILE . 23.2 m -86.77 160.05 3.06 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.649 0 N-CA-C 107.081 -1.451 . . . . 1.0 107.081 177.616 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . 0.558 ' CB ' ' O ' ' A' ' 36' ' ' VAL . 14.3 tt 126.97 115.35 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.477 0.886 0 O-C-N 124.195 0.934 . . . . 1.0 110.503 -179.741 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' HIS . . . . . 0.438 ' ND1' ' O ' ' A' ' 37' ' ' ILE . 0.1 OUTLIER -141.04 133.14 27.88 Favored 'General case' 0 C--N 1.325 -0.494 0 N-CA-C 108.154 -1.054 . . . . 1.0 108.154 177.518 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 38.8 p -115.03 143.55 30.38 Favored Pre-proline 0 C--N 1.33 -0.265 0 N-CA-C 108.771 -0.826 . . . . 1.0 108.771 179.501 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 40' ' ' PRO . . . . . 0.427 ' HG2' ' H ' ' A' ' 41' ' ' ALA . 57.1 Cg_endo -72.22 -82.73 0.01 OUTLIER 'Trans proline' 0 C--N 1.306 -1.699 0 C-N-CA 121.708 1.605 . . . . 1.0 112.551 -179.363 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . 0.427 ' H ' ' HG2' ' A' ' 40' ' ' PRO . . . -78.34 124.11 27.74 Favored 'General case' 0 C--N 1.311 -1.074 0 CA-C-N 114.436 -1.256 . . . . 1.0 111.686 -176.7 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . 0.723 ' C ' ' H ' ' A' ' 44' ' ' GLY . 13.6 ptt180 -170.9 169.71 6.66 Favored 'General case' 0 C--N 1.313 -0.981 0 CA-C-N 114.634 -1.167 . . . . 1.0 109.696 178.786 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 7.2 tpt180 -61.65 18.04 0.01 OUTLIER 'General case' 0 C--N 1.322 -0.608 0 C-N-CA 120.568 -0.453 . . . . 1.0 109.957 178.321 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . 0.723 ' H ' ' C ' ' A' ' 42' ' ' ARG . . . 82.98 -24.83 5.04 Favored Glycine 0 N--CA 1.446 -0.634 0 N-CA-C 110.506 -1.038 . . . . 1.0 110.506 -179.658 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . 0.759 ' O ' ' CG ' ' A' ' 46' ' ' PHE . 0.2 OUTLIER -164.5 172.82 12.81 Favored 'General case' 0 C--O 1.221 -0.403 0 C-N-CA 121.101 -0.24 . . . . 1.0 110.656 -179.553 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 46' ' ' PHE . . . . . 0.759 ' CG ' ' O ' ' A' ' 45' ' ' PHE . 22.0 m-30 127.1 90.41 0.0 OUTLIER 'General case' 0 N--CA 1.484 1.256 0 O-C-N 125.534 1.771 . . . . 1.0 111.688 179.391 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 47' ' ' ARG . . . . . 0.721 ' O ' ' SG ' ' A' ' 48' ' ' CYS . 2.2 ptm180 121.09 156.49 0.0 OUTLIER 'General case' 0 N--CA 1.477 0.895 0 O-C-N 125.449 1.718 . . . . 1.0 109.187 179.355 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 48' ' ' CYS . . . . . 0.721 ' SG ' ' O ' ' A' ' 47' ' ' ARG . 2.0 p 67.74 68.85 0.36 Allowed 'General case' 0 CA--C 1.532 0.284 0 CA-C-O 121.897 0.856 . . . . 1.0 109.523 -179.156 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -142.91 151.84 57.31 Favored Pre-proline 0 CA--C 1.534 0.361 0 N-CA-C 108.297 -1.001 . . . . 1.0 108.297 179.864 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 89.3 Cg_endo -77.31 69.9 6.98 Favored 'Trans proline' 0 C--N 1.308 -1.58 0 C-N-CA 122.015 1.81 . . . . 1.0 112.608 -179.728 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 5.4 tp10 64.68 26.93 13.19 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 120.697 0.284 . . . . 1.0 111.462 179.198 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -102.28 138.92 38.57 Favored 'General case' 0 N--CA 1.466 0.373 0 CA-C-N 116.474 -0.33 . . . . 1.0 110.262 179.066 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . 0.445 ' O ' ' N ' ' A' ' 55' ' ' ILE . 19.6 tt -66.61 139.64 20.8 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.251 0 CA-C-O 121.423 0.63 . . . . 1.0 110.718 179.553 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 4.2 pt20 -63.41 80.41 0.02 OUTLIER 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 114.781 -1.1 . . . . 1.0 109.586 -178.458 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . 0.445 ' N ' ' O ' ' A' ' 53' ' ' ILE . 1.8 tt -148.03 156.89 8.9 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.415 0 N-CA-C 109.902 -0.407 . . . . 1.0 109.902 178.242 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 113.57 -4.67 24.69 Favored Glycine 0 N--CA 1.467 0.705 0 N-CA-C 110.606 -0.998 . . . . 1.0 110.606 -179.765 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 14.8 p-10 -79.36 96.48 6.01 Favored 'General case' 0 C--N 1.325 -0.464 0 N-CA-C 109.318 -0.623 . . . . 1.0 109.318 177.625 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 58' ' ' TRP . . . . . 0.519 ' CE3' ' NH1' ' A' ' 59' ' ' ARG . 0.8 OUTLIER -86.54 176.36 7.86 Favored 'General case' 0 N--CA 1.467 0.421 0 CA-C-O 122.229 1.014 . . . . 1.0 112.647 -178.37 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 59' ' ' ARG . . . . . 0.519 ' NH1' ' CE3' ' A' ' 58' ' ' TRP . 0.0 OUTLIER -87.29 -56.28 3.43 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 113.326 -1.761 . . . . 1.0 112.388 -179.394 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 73.6 t80 -93.81 -16.86 23.7 Favored 'General case' 0 C--O 1.249 1.044 0 CA-C-O 121.813 0.816 . . . . 1.0 113.153 -179.112 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . 0.459 ' O ' ' N ' ' A' ' 65' ' ' ASP . 6.5 tt0 -78.79 -13.23 59.92 Favored 'General case' 0 N--CA 1.444 -0.766 0 O-C-N 121.418 -0.801 . . . . 1.0 111.516 -178.24 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . 0.596 ' O ' ' N ' ' A' ' 66' ' ' GLY . 0.0 OUTLIER -47.8 -55.63 2.38 Favored 'Isoleucine or valine' 0 C--O 1.208 -1.11 0 C-N-CA 119.244 -0.983 . . . . 1.0 109.589 -175.559 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -65.01 -52.42 56.19 Favored 'General case' 0 C--N 1.31 -1.136 0 C-N-CA 119.335 -0.946 . . . . 1.0 109.192 -179.984 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 64' ' ' HIS . . . . . 0.475 ' O ' ' HB2' ' A' ' 67' ' ' ARG . 6.0 t-80 -50.78 -57.78 7.54 Favored 'General case' 0 CA--C 1.536 0.43 0 C-N-CA 119.463 -0.895 . . . . 1.0 109.894 -179.534 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . 0.577 ' O ' ' ND2' ' A' ' 75' ' ' ASN . 3.3 t0 -70.1 -47.05 63.46 Favored 'General case' 0 C--N 1.314 -0.963 0 CA-C-O 122.065 0.935 . . . . 1.0 110.303 179.188 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . 0.596 ' N ' ' O ' ' A' ' 62' ' ' VAL . . . -70.13 28.25 0.43 Allowed Glycine 0 C--N 1.316 -0.572 0 O-C-N 121.47 -0.769 . . . . 1.0 111.642 179.725 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 67' ' ' ARG . . . . . 0.565 ' H ' ' C ' ' A' ' 65' ' ' ASP . 0.0 OUTLIER -81.25 -3.01 51.08 Favored 'General case' 0 C--N 1.319 -0.755 0 N-CA-C 107.964 -1.124 . . . . 1.0 107.964 176.559 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . 0.4 ' O ' ' HB3' ' A' ' 72' ' ' HIS . 8.7 tp -42.25 -31.67 0.42 Allowed 'General case' 0 C--O 1.216 -0.679 0 CA-C-N 115.567 -0.742 . . . . 1.0 109.495 -179.904 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 3.8 tt -67.83 -68.66 0.37 Allowed 'General case' 0 CA--C 1.54 0.581 0 C-N-CA 118.434 -1.306 . . . . 1.0 112.877 -177.347 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . 0.601 ' C ' ' H ' ' A' ' 72' ' ' HIS . . . -74.58 -84.36 0.05 OUTLIER 'General case' 0 N--CA 1.47 0.563 0 C-N-CA 116.757 -1.977 . . . . 1.0 109.03 -176.426 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . 0.884 ' O ' ' N ' ' A' ' 73' ' ' MET . . . -56.37 16.28 0.0 OUTLIER 'General case' 0 C--N 1.308 -1.233 0 C-N-CA 124.993 1.317 . . . . 1.0 113.588 -179.738 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 72' ' ' HIS . . . . . 0.601 ' H ' ' C ' ' A' ' 70' ' ' ALA . 0.0 OUTLIER -17.92 -29.32 0.0 OUTLIER 'General case' 0 N--CA 1.473 0.676 0 N-CA-C 112.758 0.651 . . . . 1.0 112.758 -175.048 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 73' ' ' MET . . . . . 0.884 ' N ' ' O ' ' A' ' 71' ' ' ALA . 19.0 mmt -64.81 -56.59 12.59 Favored 'General case' 0 N--CA 1.446 -0.646 0 C-N-CA 119.667 -0.813 . . . . 1.0 108.84 176.4 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . 0.665 ' O ' ' N ' ' A' ' 76' ' ' GLY . 34.8 m -43.96 -50.97 1.62 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.821 0 CA-C-O 117.814 -1.089 . . . . 1.0 111.565 -174.815 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 75' ' ' ASN . . . . . 0.577 ' ND2' ' O ' ' A' ' 65' ' ' ASP . 2.0 t-20 -36.42 -18.24 0.0 OUTLIER 'General case' 0 N--CA 1.47 0.533 0 CA-C-N 121.042 1.746 . . . . 1.0 112.299 -179.831 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . 0.665 ' N ' ' O ' ' A' ' 74' ' ' VAL . . . -47.72 -28.19 5.1 Favored Glycine 0 CA--C 1.537 1.437 0 N-CA-C 109.16 -1.576 . . . . 1.0 109.16 177.681 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . 0.621 ' CG1' ' H ' ' A' ' 78' ' ' VAL . 6.9 pt -69.29 -51.77 39.7 Favored 'Isoleucine or valine' 0 C--O 1.21 -1.009 0 CA-C-O 122.114 0.959 . . . . 1.0 108.828 -179.967 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . 0.621 ' H ' ' CG1' ' A' ' 77' ' ' ILE . 77.0 t -36.25 -33.12 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.313 -0.979 0 CA-C-N 113.003 -1.908 . . . . 1.0 107.292 -176.701 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . 0.502 ' N ' ' O ' ' A' ' 77' ' ' ILE . 0.7 OUTLIER -96.77 -31.68 4.02 Favored 'Isoleucine or valine' 0 C--O 1.213 -0.842 0 CA-C-N 115.606 -0.724 . . . . 1.0 110.938 176.653 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 80' ' ' ALA . . . . . 0.604 ' N ' ' O ' ' A' ' 77' ' ' ILE . . . -82.45 -8.78 59.61 Favored 'General case' 0 N--CA 1.473 0.68 0 N-CA-C 112.521 0.563 . . . . 1.0 112.521 179.367 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . 0.553 ' N ' ' O ' ' A' ' 77' ' ' ILE . 7.6 mm-40 -91.15 -72.69 0.57 Allowed 'General case' 0 N--CA 1.439 -0.982 0 O-C-N 122.036 -0.415 . . . . 1.0 112.018 -178.258 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 8.3 t70 -92.68 -14.4 28.12 Favored 'General case' 0 C--N 1.346 0.423 0 N-CA-C 115.024 1.49 . . . . 1.0 115.024 -178.89 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . 0.583 ' O ' ' N ' ' A' ' 85' ' ' ILE . . . -54.26 -44.8 72.14 Favored 'General case' 0 CA--C 1.54 0.595 0 C-N-CA 118.464 -1.294 . . . . 1.0 112.894 -177.505 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . 0.747 ' H ' ' CD1' ' A' ' 84' ' ' LEU . 0.0 OUTLIER -42.75 -14.74 0.01 OUTLIER 'General case' 0 N--CA 1.474 0.752 0 CA-C-N 119.018 0.826 . . . . 1.0 111.079 -177.682 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 85' ' ' ILE . . . . . 0.583 ' N ' ' O ' ' A' ' 83' ' ' ALA . 3.5 mm -94.04 -29.81 4.27 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.25 0 C-N-CA 120.674 -0.41 . . . . 1.0 110.223 179.056 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . 0.695 ' C ' ' H ' ' A' ' 88' ' ' ALA . . . -93.02 -24.24 18.4 Favored 'General case' 0 CA--C 1.522 -0.125 0 CA-C-O 121.513 0.673 . . . . 1.0 109.732 179.26 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 20.3 tt0 -63.82 25.85 0.01 OUTLIER 'General case' 0 C--N 1.32 -0.714 0 CA-C-O 121.491 0.662 . . . . 1.0 110.474 -179.036 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . 0.695 ' H ' ' C ' ' A' ' 86' ' ' ALA . . . -123.31 -7.31 8.19 Favored 'General case' 0 N--CA 1.474 0.766 0 CA-C-O 122.207 1.004 . . . . 1.0 108.519 178.836 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 2.4 t -84.31 36.9 0.05 OUTLIER 'Isoleucine or valine' 0 C--O 1.216 -0.659 0 CA-C-N 112.77 -2.014 . . . . 1.0 109.172 178.383 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 90' ' ' GLY . . . . . 0.513 ' N ' ' CD ' ' A' ' 91' ' ' PRO . . . -74.26 -40.52 40.98 Favored Glycine 0 C--N 1.345 1.052 0 C-N-CA 120.504 -0.855 . . . . 1.0 111.382 179.57 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 91' ' ' PRO . . . . . 0.513 ' CD ' ' N ' ' A' ' 90' ' ' GLY . 98.3 Cg_exo -43.51 -21.64 0.31 Allowed 'Trans proline' 0 N--CA 1.497 1.698 0 CA-C-N 119.572 1.686 . . . . 1.0 109.788 -179.701 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 92' ' ' HIS . . . . . 0.799 ' O ' ' N ' ' A' ' 96' ' ' ALA . 0.3 OUTLIER -55.34 -18.4 6.49 Favored 'General case' 0 C--O 1.194 -1.832 0 N-CA-C 107.167 -1.42 . . . . 1.0 107.167 179.897 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . 0.457 ' HG ' ' H ' ' A' ' 94' ' ' ALA . 2.8 pp -51.01 -53.66 31.45 Favored 'General case' 0 CA--C 1.541 0.612 0 N-CA-C 108.669 -0.863 . . . . 1.0 108.669 178.556 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 94' ' ' ALA . . . . . 0.457 ' H ' ' HG ' ' A' ' 93' ' ' LEU . . . -52.23 -44.87 65.06 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-N 114.521 -1.218 . . . . 1.0 108.972 -179.279 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 95' ' ' ARG . . . . . 0.529 ' C ' ' H ' ' A' ' 97' ' ' LEU . 0.0 OUTLIER -78.18 -49.87 13.01 Favored 'General case' 0 CA--C 1.553 1.077 0 CA-C-O 125.921 2.772 . . . . 1.0 109.142 178.619 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 96' ' ' ALA . . . . . 0.799 ' N ' ' O ' ' A' ' 92' ' ' HIS . . . -68.49 28.0 0.03 OUTLIER 'General case' 0 C--N 1.259 -3.335 0 CA-C-N 112.901 -1.954 . . . . 1.0 107.264 173.028 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . 0.744 ' O ' ' N ' ' A' ' 100' ' ' ILE . 0.0 OUTLIER -43.71 -46.34 7.45 Favored 'General case' 0 C--O 1.202 -1.444 0 N-CA-C 108.861 -0.792 . . . . 1.0 108.861 178.64 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 98' ' ' GLY . . . . . 0.628 ' H ' HD11 ' A' ' 97' ' ' LEU . . . -49.22 -28.2 8.32 Favored Glycine 0 CA--C 1.5 -0.891 0 N-CA-C 107.867 -2.093 . . . . 1.0 107.867 -179.862 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 99' ' ' GLN . . . . . 0.661 ' O ' ' S1 ' ' A' ' 130' ' ' MTN . 0.0 OUTLIER -59.41 -22.19 61.05 Favored 'General case' 0 C--O 1.216 -0.7 0 N-CA-C 106.693 -1.595 . . . . 1.0 106.693 176.811 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 100' ' ' ILE . . . . . 0.744 ' N ' ' O ' ' A' ' 97' ' ' LEU . 6.1 mm -67.68 -51.55 49.73 Favored 'Isoleucine or valine' 0 C--O 1.207 -1.155 0 CA-C-N 115.387 -0.824 . . . . 1.0 110.045 178.704 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 101' ' ' VAL . . . . . 0.698 ' O ' ' N ' ' A' ' 105' ' ' GLY . 0.4 OUTLIER -52.87 -61.06 0.89 Allowed 'Isoleucine or valine' 0 C--O 1.213 -0.835 0 C-N-CA 119.085 -1.046 . . . . 1.0 110.412 -178.296 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 102' ' ' CYS . . . . . 0.572 ' N ' ' CG1' ' A' ' 101' ' ' VAL . 1.4 p -56.06 -21.77 23.74 Favored 'General case' 0 C--N 1.316 -0.881 0 C-N-CA 118.942 -1.103 . . . . 1.0 110.062 -176.98 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -84.51 -53.89 5.12 Favored 'General case' 0 N--CA 1.481 1.082 0 O-C-N 124.339 1.025 . . . . 1.0 112.399 178.888 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 104' ' ' TYR . . . . . . . . . . . . . 17.9 t80 -96.37 21.18 9.41 Favored 'General case' 0 C--N 1.309 -1.19 0 C-N-CA 126.44 1.896 . . . . 1.0 108.753 178.636 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 105' ' ' GLY . . . . . 0.698 ' N ' ' O ' ' A' ' 101' ' ' VAL . . . -153.62 -96.49 0.13 Allowed Glycine 0 C--N 1.335 0.492 0 N-CA-C 107.893 -2.083 . . . . 1.0 107.893 178.926 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . 67.2 109.37 0.04 OUTLIER 'General case' 0 CA--C 1.541 0.622 0 O-C-N 122.988 -0.125 . . . . 1.0 111.297 -178.976 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 107' ' ' THR . . . . . 0.649 ' C ' ' H ' ' A' ' 109' ' ' ILE . 0.3 OUTLIER -134.66 -63.69 0.7 Allowed 'General case' 0 C--N 1.353 0.731 0 N-CA-C 105.932 -1.877 . . . . 1.0 105.932 176.926 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 26.9 m -67.16 23.61 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.324 -0.519 0 O-C-N 121.657 -0.652 . . . . 1.0 109.453 179.686 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 109' ' ' ILE . . . . . 0.649 ' H ' ' C ' ' A' ' 107' ' ' THR . 0.1 OUTLIER -115.5 -57.09 0.04 OUTLIER Pre-proline 0 CA--C 1.552 1.032 0 N-CA-C 108.278 -1.008 . . . . 1.0 108.278 175.79 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 110' ' ' PRO . . . . . 0.603 ' HD2' ' H ' ' A' ' 109' ' ' ILE . 18.6 Cg_endo -53.82 -39.46 84.05 Favored 'Trans proline' 0 N--CA 1.506 2.237 0 C-N-CA 122.673 2.249 . . . . 1.0 112.046 177.584 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 111' ' ' ASN . . . . . 0.447 ' C ' ' N ' ' A' ' 113' ' ' ASN . 39.3 t30 -67.68 -67.62 0.45 Allowed 'General case' 0 C--O 1.238 0.45 0 C-N-CA 119.91 -0.716 . . . . 1.0 110.463 -178.342 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 112' ' ' ILE . . . . . 0.417 ' CD1' ' C ' ' A' ' 112' ' ' ILE . 1.4 pp -52.88 -21.45 3.11 Favored 'Isoleucine or valine' 0 C--O 1.212 -0.87 0 CA-C-O 121.998 0.904 . . . . 1.0 108.647 -179.924 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 113' ' ' ASN . . . . . 0.447 ' N ' ' C ' ' A' ' 111' ' ' ASN . 0.0 OUTLIER -60.58 -52.82 63.52 Favored 'General case' 0 C--N 1.311 -1.093 0 CA-C-N 112.698 -2.046 . . . . 1.0 108.813 -179.894 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -58.18 -28.83 65.13 Favored 'General case' 0 N--CA 1.455 -0.194 0 CA-C-N 119.01 0.823 . . . . 1.0 111.48 179.226 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 115' ' ' ALA . . . . . 0.555 ' O ' ' N ' ' A' ' 118' ' ' VAL . . . -81.1 -52.06 7.8 Favored 'General case' 0 C--O 1.219 -0.53 0 N-CA-C 109.108 -0.701 . . . . 1.0 109.108 177.552 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 116' ' ' ILE . . . . . 0.425 ' O ' ' N ' ' A' ' 120' ' ' GLY . 1.2 tp -42.13 -49.7 0.96 Allowed 'Isoleucine or valine' 0 N--CA 1.478 0.943 0 N-CA-C 105.611 -1.996 . . . . 1.0 105.611 179.766 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 117' ' ' GLU . . . . . 0.417 ' O ' ' CA ' ' A' ' 121' ' ' THR . 62.7 mt-10 -45.1 -57.53 3.82 Favored 'General case' 0 C--N 1.312 -1.036 0 CA-C-N 110.493 -3.049 . . . . 1.0 105.857 178.341 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 118' ' ' VAL . . . . . 0.555 ' N ' ' O ' ' A' ' 115' ' ' ALA . 54.9 t -68.15 -57.13 10.22 Favored 'Isoleucine or valine' 0 CA--C 1.551 1.004 0 C-N-CA 120.684 -0.406 . . . . 1.0 111.046 178.042 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 119' ' ' LEU . . . . . 0.506 ' N ' ' O ' ' A' ' 115' ' ' ALA . 59.2 tp -52.77 -19.85 2.77 Favored 'General case' 0 CA--C 1.538 0.492 0 N-CA-C 113.78 1.03 . . . . 1.0 113.78 -178.666 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 120' ' ' GLY . . . . . 0.607 ' O ' ' OG1' ' A' ' 121' ' ' THR . . . -127.3 -73.81 0.19 Allowed Glycine 0 CA--C 1.547 2.076 0 N-CA-C 106.535 -2.626 . . . . 1.0 106.535 172.719 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 121' ' ' THR . . . . . 0.607 ' OG1' ' O ' ' A' ' 120' ' ' GLY . 17.6 m 161.9 -44.62 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.772 0 CA-C-N 112.686 -1.757 . . . . 1.0 112.796 179.444 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 122' ' ' GLY . . . . . 0.68 ' O ' ' N ' ' A' ' 124' ' ' ASP . . . 104.76 -15.22 49.07 Favored Glycine 0 N--CA 1.471 0.985 0 N-CA-C 108.282 -1.927 . . . . 1.0 108.282 -175.98 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 123' ' ' THR . . . . . 0.453 ' O ' ' CG ' ' A' ' 124' ' ' ASP . 8.4 t -56.95 81.11 0.01 OUTLIER 'General case' 0 N--CA 1.469 0.511 0 N-CA-C 104.615 -2.365 . . . . 1.0 104.615 178.438 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 124' ' ' ASP . . . . . 0.68 ' N ' ' O ' ' A' ' 122' ' ' GLY . 28.6 m-20 -166.93 178.37 5.83 Favored 'General case' 0 N--CA 1.465 0.307 0 CA-C-N 113.464 -1.698 . . . . 1.0 111.552 179.815 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 125' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -142.06 143.07 32.93 Favored 'General case' 0 CA--C 1.54 0.564 0 N-CA-C 108.086 -1.079 . . . . 1.0 108.086 175.766 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 3.0 tpm_? -147.43 146.02 29.42 Favored 'General case' 0 C--N 1.332 -0.185 0 N-CA-C 110.049 -0.352 . . . . 1.0 110.049 179.43 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 127' ' ' PHE . . . . . . . . . . . . . 1.5 t80 . . . . . 0 C--O 1.221 -0.411 0 CA-C-O 117.94 -1.028 . . . . 1.0 109.528 179.498 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 128' ' ' MTN . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 129' ' ' MTN . . . . . 0.49 ' C6 ' ' SG ' ' A' ' 48' ' ' CYS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 130' ' ' MTN . . . . . 0.661 ' S1 ' ' O ' ' A' ' 99' ' ' GLN . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 11.8 mtt . . . . . 0 N--CA 1.49 1.55 0 N-CA-C 108.918 -0.771 . . . . 1.0 108.918 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 93.1 p -90.12 3.64 52.76 Favored 'General case' 0 N--CA 1.464 0.238 0 CA-C-N 116.564 -0.289 . . . . 1.0 110.933 -179.555 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 2.1 t70 163.14 114.96 0.0 OUTLIER 'General case' 0 N--CA 1.465 0.296 0 O-C-N 123.675 0.609 . . . . 1.0 110.04 179.162 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 92.8 t80 -147.57 143.99 28.16 Favored 'General case' 0 CA--C 1.513 -0.446 0 N-CA-C 109.133 -0.691 . . . . 1.0 109.133 178.861 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 5' ' ' ASP . . . . . 0.424 ' HB2' ' N ' ' A' ' 10' ' ' SER . 1.0 OUTLIER -153.32 148.64 27.01 Favored 'General case' 0 C--N 1.326 -0.444 0 C-N-CA 120.557 -0.457 . . . . 1.0 110.512 -179.39 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 6' ' ' THR . . . . . 0.696 ' O ' ' N ' ' A' ' 10' ' ' SER . 0.2 OUTLIER -116.72 -152.7 0.51 Allowed 'General case' 0 C--O 1.209 -1.031 0 CA-C-O 121.425 0.631 . . . . 1.0 110.313 179.896 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . 0.579 ' OE1' ' N ' ' A' ' 8' ' ' ARG . 0.0 OUTLIER -59.34 -49.64 77.05 Favored 'General case' 0 C--N 1.309 -1.196 0 CA-C-O 121.872 0.844 . . . . 1.0 110.603 -177.895 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 8' ' ' ARG . . . . . 0.579 ' N ' ' OE1' ' A' ' 7' ' ' GLU . 5.0 ptt180 -67.35 -57.79 5.98 Favored 'General case' 0 C--N 1.302 -1.487 0 C-N-CA 118.725 -1.19 . . . . 1.0 108.759 178.43 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . 0.528 ' H ' ' HG3' ' A' ' 8' ' ' ARG . 6.7 t -66.08 -53.45 37.27 Favored 'Isoleucine or valine' 0 C--O 1.197 -1.665 0 C-N-CA 119.219 -0.992 . . . . 1.0 111.427 -178.322 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 10' ' ' SER . . . . . 0.696 ' N ' ' O ' ' A' ' 6' ' ' THR . 1.4 t -69.23 -62.46 1.37 Allowed 'General case' 0 C--N 1.309 -1.188 0 C-N-CA 119.363 -0.935 . . . . 1.0 111.974 -178.972 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 11' ' ' ARG . . . . . 0.511 ' HB2' ' O ' ' A' ' 7' ' ' GLU . 1.7 mmt180 -65.3 -45.55 83.96 Favored 'General case' 0 N--CA 1.474 0.74 0 N-CA-C 112.53 0.567 . . . . 1.0 112.53 -176.229 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . 0.471 ' CB ' ' O ' ' A' ' 8' ' ' ARG . . . -68.57 -55.59 11.12 Favored 'General case' 0 C--N 1.326 -0.45 0 C-N-CA 118.068 -1.453 . . . . 1.0 108.412 178.463 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . 0.642 ' O ' ' CB ' ' A' ' 17' ' ' LEU . 0.4 OUTLIER -62.44 -52.59 58.14 Favored 'Isoleucine or valine' 0 C--O 1.201 -1.471 0 C-N-CA 118.225 -1.39 . . . . 1.0 109.145 -179.264 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . 0.533 ' N ' ' O ' ' A' ' 10' ' ' SER . . . -61.05 -61.35 2.64 Favored 'General case' 0 C--N 1.314 -0.978 0 C-N-CA 117.177 -1.809 . . . . 1.0 110.429 179.929 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . 0.53 ' O ' ' N ' ' A' ' 19' ' ' GLY . . . -54.17 -56.12 21.25 Favored 'General case' 0 N--CA 1.475 0.815 0 C-N-CA 119.268 -0.973 . . . . 1.0 110.141 -178.058 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . 0.575 ' CA ' ' H ' ' A' ' 22' ' ' GLY . . . -65.43 -55.71 16.49 Favored 'General case' 0 C--N 1.315 -0.909 0 C-N-CA 118.793 -1.163 . . . . 1.0 110.364 -179.271 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . 0.642 ' CB ' ' O ' ' A' ' 13' ' ' VAL . 10.8 tp -57.16 -56.14 25.58 Favored 'General case' 0 N--CA 1.485 1.293 0 C-N-CA 119.341 -0.944 . . . . 1.0 108.665 -178.184 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . 0.602 HG22 ' H ' ' A' ' 19' ' ' GLY . 1.3 m -71.68 -57.75 6.7 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.571 0 C-N-CA 119.519 -0.872 . . . . 1.0 110.557 -179.711 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . 0.602 ' H ' HG22 ' A' ' 18' ' ' VAL . . . -62.9 -163.33 0.38 Allowed Glycine 0 CA--C 1.522 0.503 0 N-CA-C 111.748 -0.541 . . . . 1.0 111.748 -178.041 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' PRO . . . . . 0.601 ' O ' ' N ' ' A' ' 24' ' ' ALA . 69.3 Cg_endo -80.51 -21.91 7.09 Favored 'Trans proline' 0 C--N 1.304 -1.797 0 C-N-CA 122.419 2.079 . . . . 1.0 114.472 -178.044 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -60.66 -61.04 7.48 Favored Glycine 0 N--CA 1.476 1.326 0 C-N-CA 118.945 -1.598 . . . . 1.0 111.489 -177.165 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . 0.575 ' H ' ' CA ' ' A' ' 16' ' ' ALA . . . -59.63 -54.65 35.9 Favored Glycine 0 N--CA 1.466 0.66 0 N-CA-C 107.903 -2.079 . . . . 1.0 107.903 179.674 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . 0.411 ' O ' ' CG1' ' A' ' 27' ' ' VAL . 85.0 t -56.57 -34.15 41.27 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 C-N-CA 119.46 -0.896 . . . . 1.0 109.411 -179.273 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . 0.601 ' N ' ' O ' ' A' ' 20' ' ' PRO . . . -64.65 -61.35 2.25 Favored 'General case' 0 N--CA 1.47 0.533 0 C-N-CA 118.879 -1.129 . . . . 1.0 110.341 179.314 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 13.4 tp -61.05 -49.45 77.33 Favored 'General case' 0 CA--C 1.519 -0.219 0 C-N-CA 120.049 -0.66 . . . . 1.0 112.119 -177.015 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 70.0 t -59.18 -60.05 2.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 C-N-CA 119.095 -1.042 . . . . 1.0 110.476 -177.521 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . 0.411 ' CG1' ' O ' ' A' ' 23' ' ' VAL . 1.4 p -59.54 -38.46 75.48 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 C-N-CA 120.406 -0.517 . . . . 1.0 111.709 -177.163 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 88.5 tttt -69.28 -55.81 9.4 Favored 'General case' 0 C--N 1.317 -0.847 0 C-N-CA 120.161 -0.616 . . . . 1.0 110.113 -179.174 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 53.8 t -66.25 -52.09 51.55 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.619 0 CA-C-N 115.318 -0.855 . . . . 1.0 111.633 -176.499 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 30' ' ' CYS . . . . . . . . . . . . . 49.4 t -66.55 -60.79 2.4 Favored 'General case' 0 N--CA 1.445 -0.723 0 C-N-CA 118.761 -1.175 . . . . 1.0 110.589 -178.086 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -64.5 -49.97 69.24 Favored 'General case' 0 CA--C 1.513 -0.463 0 C-N-CA 120.691 -0.404 . . . . 1.0 111.78 -175.627 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . 0.512 ' O ' ' CB ' ' A' ' 33' ' ' LEU . . . 77.78 62.57 2.35 Favored Glycine 0 N--CA 1.447 -0.622 0 N-CA-C 107.923 -2.071 . . . . 1.0 107.923 -177.492 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . 0.512 ' CB ' ' O ' ' A' ' 32' ' ' GLY . 9.8 tp 90.32 94.43 0.03 OUTLIER Pre-proline 0 CA--C 1.541 0.625 0 CA-C-N 115.093 -0.553 . . . . 1.0 110.076 -179.064 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 59.4 Cg_endo -74.15 -11.27 23.13 Favored 'Trans proline' 0 N--CA 1.495 1.61 0 C-N-CA 122.012 1.808 . . . . 1.0 112.56 -179.212 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -58.04 -60.81 8.27 Favored Glycine 0 CA--C 1.534 1.235 0 C-N-CA 118.834 -1.65 . . . . 1.0 109.401 -178.847 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . 0.523 ' O ' ' CB ' ' A' ' 37' ' ' ILE . 1.6 m -90.19 176.4 0.66 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.47 0 N-CA-C 106.496 -1.668 . . . . 1.0 106.496 176.676 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . 0.523 ' CB ' ' O ' ' A' ' 36' ' ' VAL . 9.5 tt 107.72 115.49 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.481 1.089 0 O-C-N 124.787 1.304 . . . . 1.0 110.234 179.564 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 76.6 m80 -143.62 136.91 27.91 Favored 'General case' 0 C--O 1.231 0.093 0 CA-C-O 120.862 0.363 . . . . 1.0 110.024 179.995 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 39' ' ' THR . . . . . 0.426 ' OG1' ' O ' ' A' ' 41' ' ' ALA . 0.0 OUTLIER -106.93 118.62 53.67 Favored Pre-proline 0 CA--C 1.535 0.399 0 N-CA-C 109.17 -0.678 . . . . 1.0 109.17 179.167 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 65.8 Cg_exo -47.13 -24.22 3.37 Favored 'Trans proline' 0 N--CA 1.493 1.483 0 C-N-CA 121.629 1.553 . . . . 1.0 113.549 -179.403 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . 0.426 ' O ' ' OG1' ' A' ' 39' ' ' THR . . . -127.94 135.95 50.66 Favored 'General case' 0 N--CA 1.467 0.377 0 CA-C-O 119.911 -0.09 . . . . 1.0 110.824 179.013 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . 0.729 ' C ' ' H ' ' A' ' 44' ' ' GLY . 14.0 ptm180 -167.16 166.42 14.97 Favored 'General case' 0 C--N 1.319 -0.726 0 C-N-CA 120.015 -0.674 . . . . 1.0 110.485 178.226 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 43' ' ' ARG . . . . . 0.673 ' C ' ' H ' ' A' ' 45' ' ' PHE . 25.6 tpt180 -62.13 22.54 0.01 OUTLIER 'General case' 0 CA--C 1.545 0.769 0 CA-C-O 121.63 0.728 . . . . 1.0 109.826 -179.92 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . 0.729 ' H ' ' C ' ' A' ' 42' ' ' ARG . . . 66.85 -30.28 0.18 Allowed Glycine 0 C--N 1.337 0.599 0 N-CA-C 110.663 -0.975 . . . . 1.0 110.663 179.125 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . 0.673 ' H ' ' C ' ' A' ' 43' ' ' ARG . 0.7 OUTLIER -166.43 173.12 10.22 Favored 'General case' 0 N--CA 1.446 -0.649 0 N-CA-C 108.939 -0.763 . . . . 1.0 108.939 -179.194 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 46' ' ' PHE . . . . . 0.547 ' CB ' ' O ' ' A' ' 45' ' ' PHE . 6.8 t80 110.4 106.67 0.0 OUTLIER 'General case' 0 N--CA 1.48 1.053 0 O-C-N 125.278 1.611 . . . . 1.0 109.495 179.555 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 47' ' ' ARG . . . . . 0.564 ' HE ' ' C9 ' ' A' ' 128' ' ' MTN . 2.5 ptm180 102.67 150.61 0.01 OUTLIER 'General case' 0 N--CA 1.48 1.03 0 O-C-N 125.012 1.445 . . . . 1.0 110.695 -179.452 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 37.5 t 60.84 67.49 0.81 Allowed 'General case' 0 CA--C 1.509 -0.619 0 N-CA-C 108.256 -1.016 . . . . 1.0 108.256 179.453 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 49' ' ' ASN . . . . . 0.426 ' O ' ' N ' ' A' ' 51' ' ' GLU . 0.5 OUTLIER -130.73 160.97 63.94 Favored Pre-proline 0 C--N 1.327 -0.395 0 CA-C-N 115.892 -0.595 . . . . 1.0 109.912 -178.842 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . 0.539 ' CG ' HH21 ' A' ' 52' ' ' ARG . 17.9 Cg_endo -62.12 52.59 0.11 Allowed 'Trans proline' 0 N--CA 1.494 1.557 0 C-N-CA 123.049 2.5 . . . . 1.0 112.061 179.394 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . 0.426 ' N ' ' O ' ' A' ' 49' ' ' ASN . 1.4 pm0 29.72 44.38 0.02 OUTLIER 'General case' 0 N--CA 1.471 0.599 0 CA-C-N 115.991 -0.549 . . . . 1.0 112.355 179.64 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . 0.539 HH21 ' CG ' ' A' ' 50' ' ' PRO . 75.5 mtm180 -122.85 141.56 51.74 Favored 'General case' 0 N--CA 1.476 0.846 0 N-CA-C 109.86 -0.422 . . . . 1.0 109.86 178.808 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 8.8 tp -37.66 135.68 0.24 Allowed 'Isoleucine or valine' 0 CA--C 1.53 0.179 0 CA-C-O 122.666 1.222 . . . . 1.0 112.745 -174.923 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -92.03 77.29 5.38 Favored 'General case' 0 C--N 1.339 0.121 0 CA-C-N 112.589 -2.096 . . . . 1.0 113.076 -177.899 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 3.8 tp -144.26 150.33 16.78 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.365 0 N-CA-C 108.471 -0.937 . . . . 1.0 108.471 176.82 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 104.27 2.29 44.6 Favored Glycine 0 CA--C 1.527 0.806 0 N-CA-C 109.495 -1.442 . . . . 1.0 109.495 -179.056 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . 0.443 ' CG ' ' CE2' ' A' ' 45' ' ' PHE . 22.6 m-20 -86.13 107.07 17.68 Favored 'General case' 0 CA--C 1.538 0.516 0 N-CA-C 113.032 0.753 . . . . 1.0 113.032 -178.69 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 58' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -80.56 178.74 8.13 Favored 'General case' 0 N--CA 1.469 0.515 0 CA-C-N 114.387 -1.279 . . . . 1.0 108.324 177.997 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 59' ' ' ARG . . . . . 0.815 ' H ' ' HE ' ' A' ' 59' ' ' ARG . 0.0 OUTLIER -101.23 -54.2 2.84 Favored 'General case' 0 CA--C 1.545 0.755 0 CA-C-N 119.246 0.93 . . . . 1.0 110.576 178.295 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -79.19 -13.26 59.81 Favored 'General case' 0 N--CA 1.482 1.151 0 CA-C-N 114.52 -1.218 . . . . 1.0 111.3 -178.914 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 42.5 tt0 -69.25 -13.92 62.67 Favored 'General case' 0 C--N 1.303 -1.44 0 CA-C-N 115.124 -0.943 . . . . 1.0 108.459 179.11 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . 0.498 ' O ' ' N ' ' A' ' 66' ' ' GLY . 11.6 m -44.59 -51.64 1.81 Allowed 'Isoleucine or valine' 0 C--N 1.317 -0.844 0 CA-C-N 115.787 -0.642 . . . . 1.0 110.516 -175.757 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 63' ' ' ALA . . . . . 0.597 ' O ' ' HG2' ' A' ' 67' ' ' ARG . . . -67.38 -47.28 70.81 Favored 'General case' 0 N--CA 1.423 -1.798 0 C-N-CA 119.608 -0.837 . . . . 1.0 109.028 179.871 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 64' ' ' HIS . . . . . 0.437 ' O ' ' CG ' ' A' ' 67' ' ' ARG . 0.2 OUTLIER -54.04 -59.59 4.45 Favored 'General case' 0 CA--C 1.542 0.649 0 CA-C-N 115.756 -0.657 . . . . 1.0 110.301 179.612 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . 0.629 ' C ' ' H ' ' A' ' 67' ' ' ARG . 1.1 t70 -65.99 -52.24 51.21 Favored 'General case' 0 C--O 1.242 0.666 0 CA-C-O 121.658 0.742 . . . . 1.0 109.21 177.864 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . 0.498 ' N ' ' O ' ' A' ' 62' ' ' VAL . . . -64.27 29.18 0.1 OUTLIER Glycine 0 CA--C 1.53 1.031 0 N-CA-C 110.979 -0.849 . . . . 1.0 110.979 178.002 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 67' ' ' ARG . . . . . 0.629 ' H ' ' C ' ' A' ' 65' ' ' ASP . 5.5 mmm180 -78.9 -4.18 48.43 Favored 'General case' 0 C--N 1.323 -0.566 0 N-CA-C 108.056 -1.09 . . . . 1.0 108.056 175.836 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . 0.456 ' C ' ' O ' ' A' ' 67' ' ' ARG . 0.6 OUTLIER -35.45 -29.16 0.01 OUTLIER 'General case' 0 N--CA 1.48 1.075 0 N-CA-C 108.033 -1.099 . . . . 1.0 108.033 -177.298 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . 0.576 ' N ' ' O ' ' A' ' 67' ' ' ARG . 8.4 tt -62.83 -64.86 0.79 Allowed 'General case' 0 C--N 1.313 -1.02 0 N-CA-C 106.914 -1.513 . . . . 1.0 106.914 177.224 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . 0.646 ' C ' ' H ' ' A' ' 72' ' ' HIS . . . -76.96 -71.43 0.4 Allowed 'General case' 0 N--CA 1.467 0.388 0 N-CA-C 106.642 -1.614 . . . . 1.0 106.642 177.187 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . 0.531 ' O ' ' C ' ' A' ' 72' ' ' HIS . . . -45.07 0.39 0.0 OUTLIER 'General case' 0 N--CA 1.475 0.775 0 C-N-CA 124.188 0.995 . . . . 1.0 113.404 178.384 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 72' ' ' HIS . . . . . 0.646 ' H ' ' C ' ' A' ' 70' ' ' ALA . 0.0 OUTLIER -22.09 -62.67 0.03 OUTLIER 'General case' 0 C--O 1.231 0.13 0 CA-C-N 117.951 0.342 . . . . 1.0 111.311 -176.142 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 73' ' ' MET . . . . . 0.638 ' N ' ' CG ' ' A' ' 72' ' ' HIS . 31.6 ttm -75.54 -50.07 16.75 Favored 'General case' 0 C--N 1.319 -0.752 0 C-N-CA 118.881 -1.127 . . . . 1.0 109.667 177.823 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . 0.643 ' O ' ' N ' ' A' ' 76' ' ' GLY . 97.2 t -43.75 -46.18 1.89 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.375 0 CA-C-O 118.472 -0.775 . . . . 1.0 110.378 -175.434 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 75' ' ' ASN . . . . . 0.499 ' O ' ' N ' ' A' ' 77' ' ' ILE . 0.5 OUTLIER -36.81 -19.37 0.01 OUTLIER 'General case' 0 N--CA 1.487 1.414 0 CA-C-N 119.779 1.172 . . . . 1.0 111.356 179.232 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . 0.643 ' N ' ' O ' ' A' ' 74' ' ' VAL . . . -44.03 -19.58 0.13 Allowed Glycine 0 CA--C 1.544 1.855 0 N-CA-C 108.967 -1.653 . . . . 1.0 108.967 177.237 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . 0.666 ' O ' ' N ' ' A' ' 80' ' ' ALA . 12.2 pt -90.13 -51.45 11.95 Favored 'Isoleucine or valine' 0 C--N 1.346 0.433 0 N-CA-C 108.621 -0.881 . . . . 1.0 108.621 179.371 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . 0.465 ' C ' ' O ' ' A' ' 77' ' ' ILE . 42.3 t -34.86 -36.86 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.446 -0.642 0 N-CA-C 109.003 -0.74 . . . . 1.0 109.003 -177.796 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . 0.414 ' N ' ' O ' ' A' ' 77' ' ' ILE . 33.0 pt -90.44 -21.06 6.75 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.575 0 CA-C-N 116.159 -0.473 . . . . 1.0 111.934 179.788 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 80' ' ' ALA . . . . . 0.666 ' N ' ' O ' ' A' ' 77' ' ' ILE . . . -82.99 -7.31 59.68 Favored 'General case' 0 CA--C 1.536 0.404 0 C-N-CA 123.771 0.828 . . . . 1.0 111.244 177.102 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 3.7 mm-40 -74.0 -68.72 0.49 Allowed 'General case' 0 N--CA 1.452 -0.356 0 N-CA-C 108.771 -0.826 . . . . 1.0 108.771 178.444 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 82' ' ' ASP . . . . . 0.594 ' O ' ' N ' ' A' ' 84' ' ' LEU . 18.8 p-10 -59.23 -59.19 5.85 Favored 'General case' 0 CA--C 1.512 -0.511 0 C-N-CA 119.489 -0.884 . . . . 1.0 108.941 179.578 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . 0.535 ' C ' ' O ' ' A' ' 82' ' ' ASP . . . 3.35 -70.47 0.0 OUTLIER 'General case' 0 N--CA 1.486 1.365 0 O-C-N 124.469 1.105 . . . . 1.0 111.069 -179.913 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . 0.594 ' N ' ' O ' ' A' ' 82' ' ' ASP . 58.8 mt -26.78 -44.68 0.02 OUTLIER 'General case' 0 N--CA 1.474 0.746 0 CA-C-N 115.435 -0.802 . . . . 1.0 111.044 -176.64 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 85' ' ' ILE . . . . . 0.436 ' N ' ' O ' ' A' ' 83' ' ' ALA . 1.3 pp -97.65 -49.5 11.84 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.293 0 N-CA-C 108.299 -1.0 . . . . 1.0 108.299 177.636 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . 0.708 ' C ' ' H ' ' A' ' 88' ' ' ALA . . . -44.45 -41.94 6.66 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 114.453 -1.249 . . . . 1.0 110.333 179.938 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 10.6 pt-20 -60.54 24.84 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.361 -0.381 . . . . 1.0 111.061 179.922 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . 0.708 ' H ' ' C ' ' A' ' 86' ' ' ALA . . . -122.76 -9.15 8.39 Favored 'General case' 0 N--CA 1.456 -0.173 0 CA-C-N 116.229 -0.441 . . . . 1.0 109.854 179.592 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 4.0 m -107.66 34.69 0.59 Allowed 'Isoleucine or valine' 0 C--O 1.224 -0.267 0 N-CA-C 109.093 -0.706 . . . . 1.0 109.093 179.377 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 90' ' ' GLY . . . . . 0.558 ' O ' ' N ' ' A' ' 92' ' ' HIS . . . -67.49 -40.42 91.09 Favored Glycine 0 CA--C 1.532 1.118 0 CA-C-O 119.616 -0.547 . . . . 1.0 111.957 179.16 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 91' ' ' PRO . . . . . 0.508 ' CD ' ' N ' ' A' ' 90' ' ' GLY . 80.4 Cg_exo -44.06 -13.19 0.05 OUTLIER 'Trans proline' 0 N--CA 1.494 1.549 0 C-N-CA 122.066 1.844 . . . . 1.0 111.483 179.294 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 92' ' ' HIS . . . . . 0.558 ' N ' ' O ' ' A' ' 90' ' ' GLY . 2.8 p80 -58.15 -17.13 16.39 Favored 'General case' 0 N--CA 1.44 -0.928 0 CA-C-N 115.676 -0.693 . . . . 1.0 109.201 179.396 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . 0.444 ' HG ' ' H ' ' A' ' 94' ' ' ALA . 1.5 pp -69.71 -59.18 3.11 Favored 'General case' 0 C--O 1.234 0.276 0 N-CA-C 109.759 -0.46 . . . . 1.0 109.759 178.993 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 94' ' ' ALA . . . . . 0.444 ' H ' ' HG ' ' A' ' 93' ' ' LEU . . . -55.87 -51.42 67.6 Favored 'General case' 0 CA--C 1.512 -0.508 0 N-CA-C 108.854 -0.795 . . . . 1.0 108.854 179.509 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 95' ' ' ARG . . . . . 0.657 ' O ' ' N ' ' A' ' 97' ' ' LEU . 7.1 mmm-85 -54.09 -59.02 5.2 Favored 'General case' 0 C--O 1.246 0.882 0 CA-C-O 122.985 1.374 . . . . 1.0 107.642 178.572 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 96' ' ' ALA . . . . . 0.77 ' O ' ' N ' ' A' ' 98' ' ' GLY . . . -46.33 -12.14 0.02 OUTLIER 'General case' 0 C--N 1.304 -1.375 0 O-C-N 119.524 -1.985 . . . . 1.0 111.556 -177.262 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . 0.657 ' N ' ' O ' ' A' ' 95' ' ' ARG . 0.3 OUTLIER 1.17 -53.76 0.0 OUTLIER 'General case' 0 N--CA 1.482 1.147 0 C-N-CA 124.246 1.018 . . . . 1.0 112.011 -169.101 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 98' ' ' GLY . . . . . 0.77 ' N ' ' O ' ' A' ' 96' ' ' ALA . . . -50.71 -23.27 6.58 Favored Glycine 0 C--N 1.3 -1.427 0 CA-C-N 121.905 2.138 . . . . 1.0 108.918 175.642 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 99' ' ' GLN . . . . . 0.607 ' N ' ' O ' ' A' ' 96' ' ' ALA . 9.4 tt0 -69.25 -24.07 63.94 Favored 'General case' 0 C--N 1.353 0.742 0 N-CA-C 107.872 -1.158 . . . . 1.0 107.872 178.011 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 100' ' ' ILE . . . . . 0.588 ' N ' ' O ' ' A' ' 97' ' ' LEU . 0.9 OUTLIER -63.6 -38.61 82.7 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.676 0 CA-C-N 114.471 -1.241 . . . . 1.0 108.895 178.442 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 101' ' ' VAL . . . . . 0.542 ' O ' ' N ' ' A' ' 105' ' ' GLY . 86.9 t -61.72 -60.01 3.39 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.199 0 N-CA-C 109.156 -0.683 . . . . 1.0 109.156 179.987 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 102' ' ' CYS . . . . . 0.402 ' O ' ' CB ' ' A' ' 106' ' ' ALA . 0.0 OUTLIER -44.41 -20.53 0.03 OUTLIER 'General case' 0 C--O 1.22 -0.478 0 CA-C-O 119.641 -0.218 . . . . 1.0 111.2 -178.574 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 103' ' ' ARG . . . . . 0.449 ' H ' ' C ' ' A' ' 101' ' ' VAL . 17.1 ttm180 -88.82 -37.36 15.45 Favored 'General case' 0 N--CA 1.484 1.239 0 CA-C-O 122.766 1.27 . . . . 1.0 110.664 178.316 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 104' ' ' TYR . . . . . 0.588 ' CG ' ' O ' ' A' ' 104' ' ' TYR . 50.9 t80 -99.79 20.99 13.16 Favored 'General case' 0 C--N 1.31 -1.116 0 CA-C-N 112.117 -2.31 . . . . 1.0 110.342 177.184 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 105' ' ' GLY . . . . . 0.542 ' N ' ' O ' ' A' ' 101' ' ' VAL . . . -163.5 -88.81 0.07 OUTLIER Glycine 0 N--CA 1.445 -0.719 0 N-CA-C 108.023 -2.031 . . . . 1.0 108.023 178.073 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 106' ' ' ALA . . . . . 0.584 ' O ' ' CD ' ' A' ' 110' ' ' PRO . . . 66.46 66.62 0.46 Allowed 'General case' 0 N--CA 1.441 -0.892 0 CA-C-N 115.654 -0.273 . . . . 1.0 111.545 -179.857 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 14.0 m -77.47 -60.97 2.14 Favored 'General case' 0 N--CA 1.473 0.718 0 O-C-N 121.325 -0.859 . . . . 1.0 109.388 179.711 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 32.3 m -66.51 -43.92 90.56 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.171 0 CA-C-O 121.293 0.568 . . . . 1.0 109.511 -179.158 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 109' ' ' ILE . . . . . 0.46 ' O ' ' CB ' ' A' ' 113' ' ' ASN . 1.8 mm -36.5 -61.23 0.64 Allowed Pre-proline 0 CA--C 1.549 0.932 0 CA-C-O 118.171 -0.919 . . . . 1.0 111.095 -178.269 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 110' ' ' PRO . . . . . 0.584 ' CD ' ' O ' ' A' ' 106' ' ' ALA . 55.5 Cg_endo -63.85 -21.33 69.17 Favored 'Trans proline' 0 N--CA 1.505 2.149 0 C-N-CA 124.013 3.142 . . . . 1.0 113.11 179.875 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 14.7 t-20 -63.31 -69.9 0.24 Allowed 'General case' 0 N--CA 1.467 0.392 0 C-N-CA 120.387 -0.525 . . . . 1.0 111.175 -178.191 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -73.07 -25.33 21.65 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.567 0 CA-C-O 121.969 0.89 . . . . 1.0 109.499 -179.643 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 113' ' ' ASN . . . . . 0.566 ' ND2' ' OE1' ' A' ' 117' ' ' GLU . 0.4 OUTLIER -52.02 -59.2 4.63 Favored 'General case' 0 C--N 1.3 -1.552 0 CA-C-N 114.002 -1.453 . . . . 1.0 108.908 -177.45 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -66.26 -20.46 66.12 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 115.891 -0.595 . . . . 1.0 110.954 179.107 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -76.41 -60.81 2.18 Favored 'General case' 0 N--CA 1.443 -0.804 0 C-N-CA 120.282 -0.567 . . . . 1.0 111.171 178.001 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 116' ' ' ILE . . . . . 0.526 ' O ' ' N ' ' A' ' 119' ' ' LEU . 7.6 tt -72.39 -41.54 64.97 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.213 0 O-C-N 121.213 -0.93 . . . . 1.0 111.981 -178.236 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 117' ' ' GLU . . . . . 0.566 ' OE1' ' ND2' ' A' ' 113' ' ' ASN . 1.0 OUTLIER -48.81 -58.61 4.53 Favored 'General case' 0 CA--C 1.508 -0.671 0 N-CA-C 108.288 -1.005 . . . . 1.0 108.288 -178.476 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 86.9 t -54.71 -14.26 0.96 Allowed 'Isoleucine or valine' 0 N--CA 1.436 -1.131 0 C-N-CA 120.253 -0.579 . . . . 1.0 109.442 179.52 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 119' ' ' LEU . . . . . 0.526 ' N ' ' O ' ' A' ' 116' ' ' ILE . 0.2 OUTLIER -76.33 -60.18 2.45 Favored 'General case' 0 C--N 1.347 0.477 0 N-CA-C 107.77 -1.196 . . . . 1.0 107.77 175.796 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -68.25 -83.08 0.15 Allowed Glycine 0 C--N 1.364 2.114 0 C-N-CA 117.57 -2.253 . . . . 1.0 111.23 179.449 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 18.8 m -161.36 -17.97 0.05 OUTLIER 'General case' 0 C--N 1.326 -0.427 0 N-CA-C 108.564 -0.902 . . . . 1.0 108.564 -179.639 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 122' ' ' GLY . . . . . 0.416 ' O ' ' C ' ' A' ' 123' ' ' THR . . . 111.26 -35.91 4.49 Favored Glycine 0 CA--C 1.523 0.577 0 CA-C-N 113.959 -1.473 . . . . 1.0 112.1 179.569 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 123' ' ' THR . . . . . 0.416 ' C ' ' O ' ' A' ' 122' ' ' GLY . 0.1 OUTLIER -33.43 95.4 0.01 OUTLIER 'General case' 0 N--CA 1.471 0.614 0 CA-C-N 118.342 1.071 . . . . 1.0 112.489 -178.618 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 124' ' ' ASP . . . . . 0.414 ' N ' ' O ' ' A' ' 122' ' ' GLY . 55.6 m-20 -148.59 147.88 29.51 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 115.484 -0.78 . . . . 1.0 109.548 179.26 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 125' ' ' TYR . . . . . 0.418 ' CD1' ' C ' ' A' ' 125' ' ' TYR . 0.0 OUTLIER -151.85 150.25 29.89 Favored 'General case' 0 CA--C 1.532 0.279 0 CA-C-O 120.863 0.363 . . . . 1.0 110.124 179.946 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -149.67 150.55 32.32 Favored 'General case' 0 CA--C 1.537 0.45 0 CA-C-N 116.07 -0.513 . . . . 1.0 110.019 177.719 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 127' ' ' PHE . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 C--O 1.22 -0.467 0 CA-C-O 118.172 -0.918 . . . . 1.0 109.249 179.44 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 128' ' ' MTN . . . . . 0.564 ' C9 ' ' HE ' ' A' ' 47' ' ' ARG . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 129' ' ' MTN . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 130' ' ' MTN . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 N--CA 1.493 1.715 0 N-CA-C 109.259 -0.645 . . . . 1.0 109.259 . . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 2' ' ' SER . . . . . 0.487 ' O ' ' CG ' ' A' ' 3' ' ' ASP . 55.1 p -83.28 5.63 22.48 Favored 'General case' 0 CA--C 1.531 0.246 0 CA-C-N 116.489 -0.323 . . . . 1.0 111.478 -179.062 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . 0.487 ' CG ' ' O ' ' A' ' 2' ' ' SER . 24.0 m-20 153.69 127.41 0.0 OUTLIER 'General case' 0 N--CA 1.477 0.876 0 O-C-N 123.904 0.753 . . . . 1.0 111.2 178.94 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 60.9 t80 -155.92 151.19 26.73 Favored 'General case' 0 N--CA 1.462 0.145 0 CA-C-N 116.089 -0.505 . . . . 1.0 110.953 179.235 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 4.2 p30 -153.7 148.63 26.63 Favored 'General case' 0 CA--C 1.536 0.419 0 CA-C-N 116.308 -0.406 . . . . 1.0 110.158 -179.692 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 6' ' ' THR . . . . . 0.816 ' O ' ' N ' ' A' ' 10' ' ' SER . 0.1 OUTLIER -80.76 170.4 16.35 Favored 'General case' 0 C--O 1.188 -2.165 0 C-N-CA 120.856 -0.338 . . . . 1.0 110.305 -179.39 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . 0.542 ' O ' ' N ' ' A' ' 11' ' ' ARG . 39.2 tt0 -56.87 -57.05 14.16 Favored 'General case' 0 C--N 1.313 -0.984 0 CA-C-O 121.775 0.797 . . . . 1.0 110.54 -177.974 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 8' ' ' ARG . . . . . 0.431 ' O ' ' CB ' ' A' ' 12' ' ' ALA . 0.0 OUTLIER -54.02 -55.51 26.66 Favored 'General case' 0 C--N 1.313 -1.01 0 N-CA-C 106.96 -1.496 . . . . 1.0 106.96 -178.079 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . 0.646 ' O ' ' HB ' ' A' ' 13' ' ' VAL . 0.2 OUTLIER -66.41 -51.89 52.97 Favored 'Isoleucine or valine' 0 C--O 1.189 -2.124 0 CA-C-N 114.35 -1.296 . . . . 1.0 109.659 179.651 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 10' ' ' SER . . . . . 0.816 ' N ' ' O ' ' A' ' 6' ' ' THR . 22.5 t -65.78 -64.89 0.76 Allowed 'General case' 0 N--CA 1.482 1.139 0 C-N-CA 120.256 -0.578 . . . . 1.0 111.649 -178.924 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 11' ' ' ARG . . . . . 0.542 ' N ' ' O ' ' A' ' 7' ' ' GLU . 0.3 OUTLIER -65.52 -57.82 7.3 Favored 'General case' 0 C--O 1.218 -0.589 0 N-CA-C 112.313 0.486 . . . . 1.0 112.313 -176.81 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . 0.431 ' CB ' ' O ' ' A' ' 8' ' ' ARG . . . -54.12 -49.69 68.59 Favored 'General case' 0 N--CA 1.476 0.856 0 C-N-CA 117.874 -1.53 . . . . 1.0 107.41 -176.497 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . 0.646 ' HB ' ' O ' ' A' ' 9' ' ' VAL . 91.2 t -62.34 -50.05 81.49 Favored 'Isoleucine or valine' 0 C--O 1.197 -1.679 0 N-CA-C 107.585 -1.265 . . . . 1.0 107.585 178.476 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . 0.503 ' O ' ' N ' ' A' ' 18' ' ' VAL . . . -56.41 -60.24 3.8 Favored 'General case' 0 C--O 1.207 -1.143 0 C-N-CA 117.57 -1.652 . . . . 1.0 108.508 -178.806 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . 0.573 ' O ' ' N ' ' A' ' 19' ' ' GLY . . . -53.63 -53.65 48.91 Favored 'General case' 0 C--N 1.322 -0.618 0 O-C-N 123.718 0.636 . . . . 1.0 109.726 -178.855 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . 0.437 ' O ' ' N ' ' A' ' 22' ' ' GLY . . . -63.72 -57.98 8.31 Favored 'General case' 0 N--CA 1.474 0.745 0 CA-C-O 121.693 0.759 . . . . 1.0 109.707 -179.547 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . 0.628 ' N ' ' O ' ' A' ' 13' ' ' VAL . 7.5 tt -55.42 -54.46 43.47 Favored 'General case' 0 N--CA 1.477 0.903 0 CA-C-N 114.422 -1.263 . . . . 1.0 108.652 -178.578 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . 0.7 HG23 ' H ' ' A' ' 19' ' ' GLY . 2.3 m -69.16 -57.45 8.56 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.568 0 C-N-CA 119.335 -0.946 . . . . 1.0 109.166 179.857 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . 0.7 ' H ' HG23 ' A' ' 18' ' ' VAL . . . -56.78 -162.95 0.03 OUTLIER Glycine 0 C--O 1.22 -0.77 0 N-CA-C 111.225 -0.75 . . . . 1.0 111.225 -178.317 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' PRO . . . . . 0.441 ' O ' ' N ' ' A' ' 24' ' ' ALA . 83.0 Cg_endo -82.76 -30.34 1.05 Allowed 'Trans proline' 0 C--N 1.303 -1.836 0 C-N-CA 122.508 2.139 . . . . 1.0 113.988 -178.619 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . 0.401 ' O ' ' N ' ' A' ' 24' ' ' ALA . . . -62.87 -61.52 6.38 Favored Glycine 0 N--CA 1.48 1.57 0 C-N-CA 119.897 -1.144 . . . . 1.0 113.364 -176.508 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . 0.437 ' N ' ' O ' ' A' ' 16' ' ' ALA . . . -54.16 -52.81 41.27 Favored Glycine 0 N--CA 1.471 0.997 0 N-CA-C 106.6 -2.6 . . . . 1.0 106.6 -177.11 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 12.3 t -57.06 -29.17 30.92 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.853 0 C-N-CA 119.569 -0.852 . . . . 1.0 109.096 177.696 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . 0.441 ' N ' ' O ' ' A' ' 20' ' ' PRO . . . -61.89 -63.63 1.2 Allowed 'General case' 0 C--N 1.349 0.568 0 C-N-CA 118.106 -1.437 . . . . 1.0 111.138 179.922 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . 0.423 ' N ' ' CD1' ' A' ' 25' ' ' LEU . 9.6 mp -63.6 -47.72 80.28 Favored 'General case' 0 N--CA 1.472 0.649 0 CA-C-N 119.008 0.822 . . . . 1.0 112.651 -177.486 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 94.9 t -58.01 -58.84 4.67 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.575 0 C-N-CA 119.169 -1.013 . . . . 1.0 110.061 -177.416 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . 0.483 ' O ' ' CB ' ' A' ' 31' ' ' ALA . 0.5 OUTLIER -61.41 -36.33 72.35 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.601 0 CA-C-O 121.224 0.535 . . . . 1.0 110.322 -178.505 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . 0.405 ' CB ' ' O ' ' A' ' 24' ' ' ALA . 33.0 tttm -67.52 -58.52 4.57 Favored 'General case' 0 C--N 1.316 -0.891 0 C-N-CA 119.461 -0.896 . . . . 1.0 110.424 -178.918 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 95.8 t -65.32 -49.85 76.43 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.116 0 C-N-CA 119.821 -0.752 . . . . 1.0 111.221 -177.283 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 30' ' ' CYS . . . . . . . . . . . . . 4.9 t -65.65 -61.64 1.97 Allowed 'General case' 0 N--CA 1.44 -0.969 0 C-N-CA 119.197 -1.001 . . . . 1.0 109.826 -179.344 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . 0.483 ' CB ' ' O ' ' A' ' 27' ' ' VAL . . . -63.07 -49.47 74.4 Favored 'General case' 0 C--N 1.322 -0.621 0 C-N-CA 119.968 -0.693 . . . . 1.0 110.714 -177.244 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . 0.487 ' O ' ' HB2' ' A' ' 33' ' ' LEU . . . 58.44 60.02 9.71 Favored Glycine 0 C--O 1.222 -0.62 0 CA-C-O 118.165 -1.353 . . . . 1.0 111.003 179.644 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . 0.487 ' HB2' ' O ' ' A' ' 32' ' ' GLY . 6.3 mp 100.21 140.62 0.02 OUTLIER Pre-proline 0 N--CA 1.484 1.26 0 C-N-CA 125.478 1.511 . . . . 1.0 111.65 179.761 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 31.3 Cg_exo -51.76 -57.76 1.98 Allowed 'Trans proline' 0 N--CA 1.501 1.936 0 C-N-CA 122.17 1.913 . . . . 1.0 113.763 -178.505 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . 0.464 ' O ' ' C ' ' A' ' 36' ' ' VAL . . . -65.85 -59.65 7.34 Favored Glycine 0 C--N 1.338 0.678 0 C-N-CA 117.944 -2.074 . . . . 1.0 109.223 -178.404 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . 0.583 ' O ' ' CG2' ' A' ' 37' ' ' ILE . 70.4 t -38.94 139.36 0.23 Allowed 'Isoleucine or valine' 0 C--O 1.215 -0.73 0 N-CA-C 107.398 -1.334 . . . . 1.0 107.398 178.658 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . 0.692 HG22 ' O ' ' A' ' 37' ' ' ILE . 2.3 tp 71.96 73.3 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.476 0.831 0 CA-C-O 122.266 1.031 . . . . 1.0 110.15 -177.201 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 7.2 p80 -139.42 136.04 34.25 Favored 'General case' 0 C--N 1.322 -0.592 0 O-C-N 120.514 -1.366 . . . . 1.0 109.489 179.988 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -113.77 140.0 24.16 Favored Pre-proline 0 CA--C 1.533 0.32 0 N-CA-C 109.251 -0.648 . . . . 1.0 109.251 179.528 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 59.8 Cg_endo -71.28 -7.36 21.17 Favored 'Trans proline' 0 C--N 1.311 -1.41 0 C-N-CA 122.058 1.838 . . . . 1.0 112.187 -179.38 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -112.78 91.91 3.82 Favored 'General case' 0 CA--C 1.507 -0.691 0 C-N-CA 120.591 -0.444 . . . . 1.0 111.13 -178.078 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . 0.658 ' C ' ' H ' ' A' ' 44' ' ' GLY . 0.6 OUTLIER -123.58 140.3 53.14 Favored 'General case' 0 CA--C 1.537 0.453 0 CA-C-O 121.744 0.783 . . . . 1.0 111.576 -178.361 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 43' ' ' ARG . . . . . 0.675 ' C ' ' H ' ' A' ' 45' ' ' PHE . 1.5 tpp180 -59.31 37.74 0.01 OUTLIER 'General case' 0 CA--C 1.562 1.415 0 CA-C-N 112.976 -1.92 . . . . 1.0 108.303 -179.714 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . 0.658 ' H ' ' C ' ' A' ' 42' ' ' ARG . . . 67.8 -30.13 0.23 Allowed Glycine 0 C--N 1.338 0.656 0 N-CA-C 109.605 -1.398 . . . . 1.0 109.605 -179.11 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . 0.675 ' H ' ' C ' ' A' ' 43' ' ' ARG . 0.2 OUTLIER -170.39 175.28 4.87 Favored 'General case' 0 N--CA 1.443 -0.821 0 CA-C-N 114.749 -0.725 . . . . 1.0 109.126 179.379 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 46' ' ' PHE . . . . . 0.516 ' HB2' ' O ' ' A' ' 45' ' ' PHE . 8.6 m-85 114.84 110.56 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.668 0 C-N-CA 126.868 2.067 . . . . 1.0 108.432 -179.272 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 47' ' ' ARG . . . . . 0.496 ' HB2' ' O ' ' A' ' 46' ' ' PHE . 3.6 mmp_? 100.11 153.36 0.01 OUTLIER 'General case' 0 N--CA 1.469 0.516 0 O-C-N 124.94 1.4 . . . . 1.0 111.266 179.62 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER 66.44 70.51 0.41 Allowed 'General case' 0 N--CA 1.449 -0.48 0 CA-C-N 114.778 -1.101 . . . . 1.0 109.315 179.825 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 49' ' ' ASN . . . . . 0.5 ' O ' ' N ' ' A' ' 51' ' ' GLU . 0.7 OUTLIER -136.45 160.73 65.66 Favored Pre-proline 0 N--CA 1.466 0.367 0 CA-C-N 116.455 -0.339 . . . . 1.0 110.473 -179.175 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 25.1 Cg_endo -60.54 58.74 0.09 OUTLIER 'Trans proline' 0 N--CA 1.499 1.798 0 C-N-CA 123.265 2.643 . . . . 1.0 111.886 179.054 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . 0.5 ' N ' ' O ' ' A' ' 49' ' ' ASN . 2.9 tt0 45.33 29.85 0.62 Allowed 'General case' 0 CA--C 1.536 0.407 0 CA-C-O 121.121 0.486 . . . . 1.0 110.442 179.13 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . 0.632 ' NH2' ' CE1' ' A' ' 92' ' ' HIS . 49.5 mtt180 -124.59 151.84 44.3 Favored 'General case' 0 N--CA 1.472 0.637 0 CA-C-O 121.541 0.686 . . . . 1.0 110.978 179.527 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 7.2 tp -55.87 139.99 14.46 Favored 'Isoleucine or valine' 0 CA--C 1.555 1.141 0 CA-C-O 123.935 1.826 . . . . 1.0 115.217 -177.407 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -86.53 86.11 7.33 Favored 'General case' 0 C--N 1.316 -0.864 0 CA-C-N 110.229 -3.168 . . . . 1.0 112.258 179.833 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 19.6 tt -143.92 151.0 16.55 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.032 0 N-CA-C 109.522 -0.548 . . . . 1.0 109.522 177.578 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 102.13 1.3 51.37 Favored Glycine 0 C--N 1.343 0.964 0 N-CA-C 110.753 -0.939 . . . . 1.0 110.753 179.837 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 1.3 p30 -89.71 113.28 24.76 Favored 'General case' 0 CA--C 1.54 0.566 0 CA-C-O 122.294 1.045 . . . . 1.0 113.226 -177.881 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 58' ' ' TRP . . . . . . . . . . . . . 36.4 m0 -81.74 -177.27 6.49 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 113.952 -1.476 . . . . 1.0 108.287 177.696 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 59' ' ' ARG . . . . . 0.58 ' HD2' ' H ' ' A' ' 59' ' ' ARG . 0.0 OUTLIER -97.3 -53.58 3.43 Favored 'General case' 0 CA--C 1.556 1.196 0 CA-C-N 119.18 0.9 . . . . 1.0 110.642 179.717 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 60' ' ' TYR . . . . . 0.485 ' CG ' ' O ' ' A' ' 60' ' ' TYR . 77.0 t80 -77.47 -6.0 51.92 Favored 'General case' 0 N--CA 1.483 1.207 0 C-N-CA 125.778 1.631 . . . . 1.0 111.833 -179.367 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -70.1 -16.7 63.16 Favored 'General case' 0 C--N 1.307 -1.244 0 CA-C-O 121.575 0.703 . . . . 1.0 109.453 179.181 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . 0.489 ' O ' ' N ' ' A' ' 66' ' ' GLY . 6.1 m -45.81 -52.37 2.8 Favored 'Isoleucine or valine' 0 CA--C 1.5 -0.961 0 C-N-CA 120.067 -0.653 . . . . 1.0 110.512 -174.774 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 63' ' ' ALA . . . . . 0.414 ' O ' ' HG2' ' A' ' 67' ' ' ARG . . . -65.2 -47.75 75.82 Favored 'General case' 0 N--CA 1.424 -1.768 0 N-CA-C 109.447 -0.575 . . . . 1.0 109.447 179.414 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 64' ' ' HIS . . . . . 0.407 ' O ' ' CG ' ' A' ' 67' ' ' ARG . 0.1 OUTLIER -54.71 -59.46 4.68 Favored 'General case' 0 CA--C 1.549 0.907 0 CA-C-N 115.474 -0.785 . . . . 1.0 110.54 179.837 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . 0.622 ' C ' ' H ' ' A' ' 67' ' ' ARG . 13.4 m-20 -67.72 -50.0 59.7 Favored 'General case' 0 C--O 1.243 0.751 0 N-CA-C 108.322 -0.992 . . . . 1.0 108.322 178.36 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . 0.489 ' N ' ' O ' ' A' ' 62' ' ' VAL . . . -63.23 30.24 0.08 OUTLIER Glycine 0 C--N 1.336 0.533 0 O-C-N 121.873 -0.517 . . . . 1.0 112.097 179.013 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 67' ' ' ARG . . . . . 0.622 ' H ' ' C ' ' A' ' 65' ' ' ASP . 14.9 mmt180 -78.96 -3.0 42.76 Favored 'General case' 0 C--N 1.308 -1.219 0 N-CA-C 108.322 -0.992 . . . . 1.0 108.322 175.927 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . 0.473 HD22 ' H ' ' A' ' 69' ' ' LEU . 1.8 pt? -36.11 -29.95 0.02 OUTLIER 'General case' 0 N--CA 1.477 0.921 0 N-CA-C 108.57 -0.9 . . . . 1.0 108.57 -176.948 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . 0.558 ' N ' ' O ' ' A' ' 67' ' ' ARG . 0.5 OUTLIER -71.91 -69.52 0.39 Allowed 'General case' 0 CA--C 1.538 0.5 0 CA-C-N 115.15 -0.932 . . . . 1.0 111.206 -178.583 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . 0.629 ' C ' ' H ' ' A' ' 72' ' ' HIS . . . -76.53 -78.16 0.13 Allowed 'General case' 0 N--CA 1.463 0.221 0 C-N-CA 119.201 -1.0 . . . . 1.0 109.2 -179.458 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . 0.462 ' O ' ' C ' ' A' ' 72' ' ' HIS . . . -58.84 13.05 0.01 OUTLIER 'General case' 0 C--N 1.321 -0.643 0 C-N-CA 124.444 1.098 . . . . 1.0 113.159 -179.019 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 72' ' ' HIS . . . . . 0.68 ' CD2' ' OG1' ' A' ' 123' ' ' THR . 0.0 OUTLIER -18.1 -60.05 0.02 OUTLIER 'General case' 0 CA--C 1.534 0.353 0 N-CA-C 113.32 0.859 . . . . 1.0 113.32 -177.429 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 73' ' ' MET . . . . . 0.649 ' N ' ' CG ' ' A' ' 72' ' ' HIS . 0.0 OUTLIER -64.82 -53.96 38.59 Favored 'General case' 0 C--N 1.317 -0.81 0 C-N-CA 119.831 -0.748 . . . . 1.0 111.341 -177.842 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . 0.635 ' O ' ' N ' ' A' ' 76' ' ' GLY . 0.8 OUTLIER -44.31 -46.31 2.36 Favored 'Isoleucine or valine' 0 C--O 1.215 -0.75 0 CA-C-O 117.989 -1.005 . . . . 1.0 111.219 -174.566 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 75' ' ' ASN . . . . . 0.48 ' C ' ' N ' ' A' ' 77' ' ' ILE . 2.3 t30 -37.66 -21.47 0.01 OUTLIER 'General case' 0 N--CA 1.482 1.16 0 CA-C-O 122.972 1.368 . . . . 1.0 110.026 178.3 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . 0.635 ' N ' ' O ' ' A' ' 74' ' ' VAL . . . -49.49 -20.41 2.51 Favored Glycine 0 C--O 1.21 -1.361 0 N-CA-C 107.666 -2.174 . . . . 1.0 107.666 175.235 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . 0.496 ' O ' ' N ' ' A' ' 79' ' ' ILE . 7.9 pt -56.84 -46.93 83.65 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.454 0 CA-C-N 115.301 -0.45 . . . . 1.0 111.75 -177.556 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 57.9 t -44.14 -17.99 0.06 OUTLIER 'Isoleucine or valine' 0 CA--C 1.51 -0.562 0 CA-C-N 118.775 0.716 . . . . 1.0 112.39 179.805 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . 0.496 ' N ' ' O ' ' A' ' 77' ' ' ILE . 0.6 OUTLIER -91.33 -40.17 12.28 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.759 0 C-N-CA 119.593 -0.843 . . . . 1.0 112.506 179.555 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 80' ' ' ALA . . . . . 0.416 ' N ' ' CG1' ' A' ' 79' ' ' ILE . . . -82.01 -24.41 35.41 Favored 'General case' 0 C--N 1.328 -0.344 0 N-CA-C 114.279 1.215 . . . . 1.0 114.279 -178.241 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . 0.472 ' CG ' ' O ' ' A' ' 77' ' ' ILE . 0.0 OUTLIER -92.24 -74.45 0.51 Allowed 'General case' 0 N--CA 1.469 0.515 0 N-CA-C 113.998 1.11 . . . . 1.0 113.998 -177.591 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 9.3 m-20 -92.17 -22.2 19.97 Favored 'General case' 0 C--O 1.217 -0.627 0 N-CA-C 115.291 1.589 . . . . 1.0 115.291 -177.993 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . 0.582 ' O ' ' N ' ' A' ' 85' ' ' ILE . . . -58.68 -40.77 84.53 Favored 'General case' 0 N--CA 1.461 0.108 0 C-N-CA 118.405 -1.318 . . . . 1.0 112.101 -176.005 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . 0.455 ' C ' ' CD2' ' A' ' 84' ' ' LEU . 0.0 OUTLIER -41.45 -14.81 0.01 OUTLIER 'General case' 0 CA--C 1.536 0.406 0 N-CA-C 112.742 0.645 . . . . 1.0 112.742 -178.488 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 85' ' ' ILE . . . . . 0.582 ' N ' ' O ' ' A' ' 83' ' ' ALA . 3.5 tt -90.07 -43.95 14.79 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.408 0 N-CA-C 112.029 0.381 . . . . 1.0 112.029 179.87 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . 0.492 ' H ' HG21 ' A' ' 85' ' ' ILE . . . -94.2 -23.48 17.88 Favored 'General case' 0 CA--C 1.527 0.082 0 CA-C-O 120.681 0.277 . . . . 1.0 111.337 -178.826 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . 0.581 ' OE1' ' N ' ' A' ' 88' ' ' ALA . 0.0 OUTLIER -83.72 -26.97 29.29 Favored 'General case' 0 C--N 1.332 -0.187 0 N-CA-C 109.277 -0.638 . . . . 1.0 109.277 179.813 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . 0.581 ' N ' ' OE1' ' A' ' 87' ' ' GLU . . . -62.95 13.44 0.02 OUTLIER 'General case' 0 N--CA 1.445 -0.717 0 CA-C-N 115.669 -0.696 . . . . 1.0 110.717 -179.689 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 89' ' ' VAL . . . . . 0.588 ' O ' ' N ' ' A' ' 92' ' ' HIS . 33.5 t -84.89 45.2 0.06 OUTLIER 'Isoleucine or valine' 0 C--O 1.218 -0.558 0 CA-C-N 118.385 0.539 . . . . 1.0 110.996 -179.942 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 90' ' ' GLY . . . . . 0.724 ' O ' ' N ' ' A' ' 92' ' ' HIS . . . -30.08 -42.22 0.05 OUTLIER Glycine 0 CA--C 1.539 1.553 0 CA-C-O 117.575 -1.68 . . . . 1.0 111.149 -174.782 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 91' ' ' PRO . . . . . 0.502 ' C ' ' N ' ' A' ' 93' ' ' LEU . 95.3 Cg_exo -43.11 -4.0 0.01 OUTLIER 'Trans proline' 0 N--CA 1.499 1.842 0 CA-C-N 121.807 2.804 . . . . 1.0 111.602 170.475 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 92' ' ' HIS . . . . . 0.724 ' N ' ' O ' ' A' ' 90' ' ' GLY . 0.4 OUTLIER -48.47 -15.83 0.09 Allowed 'General case' 0 C--N 1.343 0.308 0 N-CA-C 107.873 -1.158 . . . . 1.0 107.873 -177.308 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . 0.625 ' O ' ' N ' ' A' ' 96' ' ' ALA . 7.1 tp -58.49 -50.27 74.36 Favored 'General case' 0 N--CA 1.447 -0.592 0 N-CA-C 106.62 -1.622 . . . . 1.0 106.62 176.183 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 94' ' ' ALA . . . . . 0.447 ' N ' ' O ' ' A' ' 91' ' ' PRO . . . -46.91 -50.43 18.79 Favored 'General case' 0 CA--C 1.518 -0.267 0 N-CA-C 107.685 -1.228 . . . . 1.0 107.685 -178.089 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 95' ' ' ARG . . . . . 0.466 ' HE ' ' HA ' ' A' ' 92' ' ' HIS . 4.5 mtm-85 -61.33 -28.48 69.24 Favored 'General case' 0 N--CA 1.443 -0.78 0 N-CA-C 109.057 -0.72 . . . . 1.0 109.057 176.122 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 96' ' ' ALA . . . . . 0.675 ' O ' ' N ' ' A' ' 100' ' ' ILE . . . -54.34 -52.06 62.76 Favored 'General case' 0 N--CA 1.475 0.822 0 N-CA-C 107.104 -1.443 . . . . 1.0 107.104 -179.946 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . 0.497 ' O ' ' CG2' ' A' ' 100' ' ' ILE . 0.7 OUTLIER -36.57 -26.18 0.01 OUTLIER 'General case' 0 CA--C 1.577 1.992 0 CA-C-N 114.274 -1.33 . . . . 1.0 108.485 -178.04 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 98' ' ' GLY . . . . . 0.572 ' N ' ' O ' ' A' ' 96' ' ' ALA . . . -84.68 -51.09 3.96 Favored Glycine 0 CA--C 1.55 2.279 0 CA-C-O 123.814 1.786 . . . . 1.0 110.749 173.939 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 99' ' ' GLN . . . . . 0.558 ' N ' ' O ' ' A' ' 96' ' ' ALA . 30.2 mm100 -75.84 9.71 2.22 Favored 'General case' 0 N--CA 1.428 -1.543 0 CA-C-N 113.514 -1.343 . . . . 1.0 107.649 177.037 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 100' ' ' ILE . . . . . 0.675 ' N ' ' O ' ' A' ' 96' ' ' ALA . 9.7 tt -61.62 -55.8 22.01 Favored 'Isoleucine or valine' 0 CA--C 1.482 -1.651 0 N-CA-C 109.307 -0.627 . . . . 1.0 109.307 179.063 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 101' ' ' VAL . . . . . 0.612 ' N ' ' CG2' ' A' ' 100' ' ' ILE . 5.8 p -56.68 -59.48 2.96 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.739 0 C-N-CA 117.485 -1.686 . . . . 1.0 107.739 179.789 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 102' ' ' CYS . . . . . 0.536 ' H ' ' CG1' ' A' ' 101' ' ' VAL . 0.5 OUTLIER -44.24 -18.13 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.438 0 C-N-CA 120.5 -0.48 . . . . 1.0 111.448 -177.001 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 103' ' ' ARG . . . . . 0.496 ' H ' ' C ' ' A' ' 101' ' ' VAL . 6.1 ttp180 -98.07 -37.42 9.75 Favored 'General case' 0 N--CA 1.474 0.739 0 CA-C-O 121.944 0.878 . . . . 1.0 112.859 178.127 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 104' ' ' TYR . . . . . 0.637 ' CG ' ' O ' ' A' ' 104' ' ' TYR . 51.5 t80 -101.84 21.69 14.17 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-N 113.785 -1.552 . . . . 1.0 110.552 179.206 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 105' ' ' GLY . . . . . 0.769 ' O ' ' N ' ' A' ' 107' ' ' THR . . . -171.36 -12.26 0.02 OUTLIER Glycine 0 C--O 1.22 -0.741 0 C-N-CA 119.145 -1.503 . . . . 1.0 112.286 179.516 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 106' ' ' ALA . . . . . 0.473 ' C ' ' O ' ' A' ' 105' ' ' GLY . . . -16.53 67.38 0.0 OUTLIER 'General case' 0 N--CA 1.476 0.874 0 O-C-N 124.432 0.725 . . . . 1.0 111.989 -179.8 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 107' ' ' THR . . . . . 0.769 ' N ' ' O ' ' A' ' 105' ' ' GLY . 9.9 t -117.78 -7.01 11.03 Favored 'General case' 0 CA--C 1.516 -0.33 0 N-CA-C 109.448 -0.575 . . . . 1.0 109.448 -179.621 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 11.5 m -87.14 17.7 0.57 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.452 0 N-CA-C 109.546 -0.538 . . . . 1.0 109.546 179.76 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 109' ' ' ILE . . . . . 0.671 ' N ' ' CD ' ' A' ' 110' ' ' PRO . 48.5 pt -113.71 -19.02 0.11 Allowed Pre-proline 0 CA--C 1.576 1.953 0 N-CA-C 113.773 1.027 . . . . 1.0 113.773 177.58 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 110' ' ' PRO . . . . . 0.671 ' CD ' ' N ' ' A' ' 109' ' ' ILE . 14.2 Cg_endo -53.73 -38.64 85.03 Favored 'Trans proline' 0 N--CA 1.497 1.703 0 C-N-CA 123.736 2.957 . . . . 1.0 113.991 -172.684 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 23.7 t30 -63.24 -67.95 0.38 Allowed 'General case' 0 N--CA 1.441 -0.881 0 C-N-CA 118.526 -1.27 . . . . 1.0 109.278 -179.268 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -63.35 -29.54 47.5 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.387 0 CA-C-O 121.416 0.627 . . . . 1.0 110.016 -178.261 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 113' ' ' ASN . . . . . 0.503 ' OD1' ' OE2' ' A' ' 117' ' ' GLU . 0.7 OUTLIER -58.76 -64.02 1.08 Allowed 'General case' 0 C--N 1.309 -1.169 0 C-N-CA 118.874 -1.13 . . . . 1.0 110.044 -175.882 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 114' ' ' ALA . . . . . 0.5 ' N ' HD21 ' A' ' 113' ' ' ASN . . . -62.65 -25.74 68.28 Favored 'General case' 0 C--N 1.319 -0.73 0 C-N-CA 119.936 -0.706 . . . . 1.0 111.986 -179.708 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -77.39 -59.33 2.82 Favored 'General case' 0 C--O 1.232 0.173 0 C-N-CA 119.463 -0.895 . . . . 1.0 110.459 179.176 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 116' ' ' ILE . . . . . 0.417 ' O ' ' N ' ' A' ' 119' ' ' LEU . 50.4 mt -63.58 -48.34 87.29 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.398 0 C-N-CA 119.954 -0.698 . . . . 1.0 109.604 -179.379 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 117' ' ' GLU . . . . . 0.503 ' OE2' ' OD1' ' A' ' 113' ' ' ASN . 93.4 mt-10 -46.94 -67.0 0.32 Allowed 'General case' 0 CA--C 1.503 -0.865 0 C-N-CA 119.835 -0.746 . . . . 1.0 109.195 -178.245 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 39.5 t -48.48 -22.53 0.68 Allowed 'Isoleucine or valine' 0 N--CA 1.44 -0.936 0 C-N-CA 120.114 -0.634 . . . . 1.0 109.971 179.744 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 119' ' ' LEU . . . . . 0.417 ' N ' ' O ' ' A' ' 116' ' ' ILE . 0.4 OUTLIER -78.45 -60.03 2.54 Favored 'General case' 0 C--N 1.346 0.431 0 N-CA-C 107.736 -1.209 . . . . 1.0 107.736 178.721 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 120' ' ' GLY . . . . . 0.436 ' O ' ' CB ' ' A' ' 121' ' ' THR . . . -62.28 -81.43 0.09 OUTLIER Glycine 0 C--N 1.354 1.537 0 C-N-CA 117.907 -2.092 . . . . 1.0 108.292 176.51 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 121' ' ' THR . . . . . 0.436 ' CB ' ' O ' ' A' ' 120' ' ' GLY . 1.4 t 151.08 -16.12 0.0 OUTLIER 'General case' 0 N--CA 1.486 1.37 0 O-C-N 125.322 1.248 . . . . 1.0 113.505 178.28 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 122' ' ' GLY . . . . . 0.657 ' O ' ' N ' ' A' ' 124' ' ' ASP . . . 109.74 -13.18 32.44 Favored Glycine 0 N--CA 1.47 0.919 0 N-CA-C 108.521 -1.831 . . . . 1.0 108.521 -176.195 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 123' ' ' THR . . . . . 0.68 ' OG1' ' CD2' ' A' ' 72' ' ' HIS . 15.1 t -58.58 80.0 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.202 0 N-CA-C 106.755 -1.572 . . . . 1.0 106.755 178.735 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 124' ' ' ASP . . . . . 0.657 ' N ' ' O ' ' A' ' 122' ' ' GLY . 14.9 t70 -164.62 169.09 17.43 Favored 'General case' 0 N--CA 1.444 -0.76 0 CA-C-N 113.719 -1.582 . . . . 1.0 112.107 -179.631 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 125' ' ' TYR . . . . . 0.551 ' CD1' ' C ' ' A' ' 125' ' ' TYR . 0.0 OUTLIER -146.68 145.47 30.02 Favored 'General case' 0 CA--C 1.54 0.584 0 N-CA-C 108.889 -0.782 . . . . 1.0 108.889 177.393 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -148.84 149.06 30.65 Favored 'General case' 0 CA--C 1.536 0.418 0 N-CA-C 110.166 -0.309 . . . . 1.0 110.166 178.266 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 127' ' ' PHE . . . . . . . . . . . . . 27.2 p90 . . . . . 0 N--CA 1.471 0.595 0 CA-C-O 117.864 -1.065 . . . . 1.0 110.249 179.08 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 128' ' ' MTN . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 129' ' ' MTN . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 130' ' ' MTN . . . . . 0.407 ' S1 ' ' C7 ' ' A' ' 130' ' ' MTN . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 39.0 mtt . . . . . 0 N--CA 1.489 1.475 0 N-CA-C 108.704 -0.851 . . . . 1.0 108.704 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 78.3 p -109.16 -3.79 17.03 Favored 'General case' 0 N--CA 1.466 0.334 0 CA-C-N 116.336 -0.393 . . . . 1.0 110.575 178.912 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . 0.44 ' OD1' ' N ' ' A' ' 3' ' ' ASP . 7.8 p-10 -174.66 91.96 0.07 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.28 -0.418 . . . . 1.0 111.785 -179.72 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 52.2 t80 -150.2 144.31 25.56 Favored 'General case' 0 C--N 1.328 -0.335 0 N-CA-C 109.367 -0.605 . . . . 1.0 109.367 179.162 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 5' ' ' ASP . . . . . 0.834 ' OD1' ' N ' ' A' ' 10' ' ' SER . 31.8 t0 -150.66 146.82 26.73 Favored 'General case' 0 C--N 1.328 -0.337 0 N-CA-C 110.082 -0.34 . . . . 1.0 110.082 -179.29 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 6' ' ' THR . . . . . 0.681 ' O ' ' N ' ' A' ' 10' ' ' SER . 0.2 OUTLIER -100.79 -178.1 3.67 Favored 'General case' 0 C--O 1.199 -1.599 0 CA-C-O 121.103 0.478 . . . . 1.0 110.782 179.904 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . 0.509 ' O ' ' HB3' ' A' ' 11' ' ' ARG . 29.0 tt0 -55.04 -41.23 71.15 Favored 'General case' 0 C--N 1.303 -1.442 0 CA-C-N 116.477 -0.329 . . . . 1.0 111.488 179.181 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 8' ' ' ARG . . . . . 0.578 ' O ' ' CB ' ' A' ' 12' ' ' ALA . 31.3 mtp180 -69.02 -63.98 0.96 Allowed 'General case' 0 C--N 1.313 -0.996 0 CA-C-O 123.086 1.422 . . . . 1.0 110.249 178.886 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . 0.617 ' O ' ' HB ' ' A' ' 13' ' ' VAL . 12.2 t -57.63 -43.67 83.91 Favored 'Isoleucine or valine' 0 C--N 1.282 -2.358 0 CA-C-N 114.464 -1.244 . . . . 1.0 109.188 178.304 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 10' ' ' SER . . . . . 0.834 ' N ' ' OD1' ' A' ' 5' ' ' ASP . 14.9 t -68.6 -65.92 0.64 Allowed 'General case' 0 C--N 1.305 -1.337 0 O-C-N 121.256 -0.902 . . . . 1.0 111.282 -179.02 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 11' ' ' ARG . . . . . 0.509 ' HB3' ' O ' ' A' ' 7' ' ' GLU . 23.1 tpp180 -60.94 -42.41 98.13 Favored 'General case' 0 C--N 1.314 -0.973 0 CA-C-N 116.278 -0.419 . . . . 1.0 110.566 -177.562 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . 0.578 ' CB ' ' O ' ' A' ' 8' ' ' ARG . . . -69.56 -61.04 1.95 Allowed 'General case' 0 C--N 1.319 -0.752 0 C-N-CA 119.106 -1.038 . . . . 1.0 111.169 -179.602 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . 0.798 ' O ' ' CB ' ' A' ' 17' ' ' LEU . 0.3 OUTLIER -56.8 -45.9 83.21 Favored 'Isoleucine or valine' 0 C--O 1.187 -2.228 0 N-CA-C 106.602 -1.629 . . . . 1.0 106.602 179.921 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . 0.728 ' O ' HG22 ' A' ' 18' ' ' VAL . . . -66.47 -65.51 0.67 Allowed 'General case' 0 C--N 1.307 -1.263 0 C-N-CA 117.094 -1.842 . . . . 1.0 112.731 -178.745 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . 0.524 ' O ' ' N ' ' A' ' 19' ' ' GLY . . . -50.16 -53.45 27.6 Favored 'General case' 0 C--N 1.32 -0.708 0 N-CA-C 108.088 -1.079 . . . . 1.0 108.088 179.897 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . 0.484 ' CB ' ' O ' ' A' ' 12' ' ' ALA . . . -66.34 -59.95 3.23 Favored 'General case' 0 C--N 1.298 -1.667 0 C-N-CA 118.27 -1.372 . . . . 1.0 111.41 179.512 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . 0.798 ' CB ' ' O ' ' A' ' 13' ' ' VAL . 7.7 tt -55.01 -55.55 29.66 Favored 'General case' 0 N--CA 1.481 1.114 0 CA-C-N 114.777 -1.101 . . . . 1.0 108.625 -176.884 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . 0.829 HG22 ' H ' ' A' ' 19' ' ' GLY . 2.0 m -71.12 -59.36 3.52 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.658 0 CA-C-N 116.146 -0.479 . . . . 1.0 110.692 179.603 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . 0.829 ' H ' HG22 ' A' ' 18' ' ' VAL . . . -55.48 -171.69 0.1 OUTLIER Glycine 0 CA--C 1.486 -1.741 0 N-CA-C 109.593 -1.403 . . . . 1.0 109.593 -176.986 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' PRO . . . . . 0.632 ' O ' ' HB2' ' A' ' 24' ' ' ALA . 81.1 Cg_endo -81.69 -26.88 2.89 Favored 'Trans proline' 0 C--N 1.286 -2.758 0 C-N-CA 122.025 1.817 . . . . 1.0 113.894 -177.555 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . 0.413 ' O ' ' HB1' ' A' ' 24' ' ' ALA . . . -59.81 -59.05 11.2 Favored Glycine 0 N--CA 1.473 1.159 0 O-C-N 124.156 0.91 . . . . 1.0 111.357 -178.903 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . 0.423 ' H ' ' HA ' ' A' ' 16' ' ' ALA . . . -55.79 -56.99 21.03 Favored Glycine 0 CA--C 1.5 -0.848 0 C-N-CA 117.083 -2.484 . . . . 1.0 107.577 -177.823 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 93.2 t -53.94 -29.59 18.57 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.145 0 CA-C-N 113.97 -1.115 . . . . 1.0 108.201 178.573 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . 0.632 ' HB2' ' O ' ' A' ' 20' ' ' PRO . . . -63.63 -65.53 0.67 Allowed 'General case' 0 C--O 1.213 -0.825 0 C-N-CA 119.503 -0.879 . . . . 1.0 111.291 -178.939 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -58.35 -48.68 79.81 Favored 'General case' 0 C--N 1.311 -1.092 0 C-N-CA 119.632 -0.827 . . . . 1.0 111.131 -179.139 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 81.5 t -58.26 -61.42 1.37 Allowed 'Isoleucine or valine' 0 CA--C 1.503 -0.849 0 C-N-CA 119.517 -0.873 . . . . 1.0 110.471 -174.404 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . 0.437 ' O ' ' CB ' ' A' ' 31' ' ' ALA . 2.0 p -56.35 -36.59 47.25 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.97 0 C-N-CA 120.081 -0.648 . . . . 1.0 109.632 -178.969 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 20.1 mtpp -68.13 -59.3 3.34 Favored 'General case' 0 C--N 1.318 -0.775 0 C-N-CA 119.452 -0.899 . . . . 1.0 111.932 -176.84 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 2.9 t -62.24 -50.22 80.85 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.379 0 CA-C-N 114.504 -1.225 . . . . 1.0 110.191 -177.688 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 30' ' ' CYS . . . . . . . . . . . . . 21.2 t -64.32 -62.36 1.65 Allowed 'General case' 0 N--CA 1.442 -0.857 0 C-N-CA 119.214 -0.994 . . . . 1.0 110.484 -177.598 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . 0.437 ' CB ' ' O ' ' A' ' 27' ' ' VAL . . . -56.46 -48.19 77.59 Favored 'General case' 0 CA--C 1.502 -0.878 0 CA-C-O 121.536 0.684 . . . . 1.0 110.076 -176.879 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . 0.609 ' O ' ' HB2' ' A' ' 33' ' ' LEU . . . 76.78 68.37 1.54 Allowed Glycine 0 CA--C 1.496 -1.114 0 N-CA-C 109.915 -1.274 . . . . 1.0 109.915 -179.657 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . 0.609 ' HB2' ' O ' ' A' ' 32' ' ' GLY . 5.2 mt 86.04 123.29 0.03 OUTLIER Pre-proline 0 CA--C 1.544 0.742 0 O-C-N 124.965 1.038 . . . . 1.0 110.402 -179.159 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 49.2 Cg_endo -69.22 -17.94 39.78 Favored 'Trans proline' 0 N--CA 1.493 1.456 0 C-N-CA 122.131 1.887 . . . . 1.0 112.903 -178.324 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -62.95 -63.62 4.45 Favored Glycine 0 CA--C 1.527 0.806 0 C-N-CA 118.497 -1.811 . . . . 1.0 111.187 -178.093 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . 0.688 ' O ' HG23 ' A' ' 37' ' ' ILE . 5.1 p -77.5 -152.73 0.02 OUTLIER 'Isoleucine or valine' 0 CA--C 1.491 -1.304 0 N-CA-C 107.334 -1.358 . . . . 1.0 107.334 -179.641 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . 0.688 HG23 ' O ' ' A' ' 36' ' ' VAL . 0.3 OUTLIER 75.62 76.69 0.04 OUTLIER 'Isoleucine or valine' 0 C--O 1.218 -0.574 0 O-C-N 125.132 1.52 . . . . 1.0 111.534 178.069 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 38' ' ' HIS . . . . . 0.564 ' ND1' ' O ' ' A' ' 37' ' ' ILE . 1.8 m80 -137.64 133.93 34.9 Favored 'General case' 0 CA--C 1.487 -1.453 0 O-C-N 119.304 -2.122 . . . . 1.0 107.594 179.781 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 39' ' ' THR . . . . . 0.563 ' OG1' ' O ' ' A' ' 41' ' ' ALA . 0.5 OUTLIER -107.99 122.78 39.67 Favored Pre-proline 0 CA--C 1.54 0.568 0 O-C-N 123.74 0.65 . . . . 1.0 110.549 -178.963 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 32.6 Cg_exo -61.83 -23.57 76.22 Favored 'Trans proline' 0 N--CA 1.495 1.57 0 C-N-CA 122.483 2.122 . . . . 1.0 112.378 178.046 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . 0.563 ' O ' ' OG1' ' A' ' 39' ' ' THR . . . -128.14 132.62 48.92 Favored 'General case' 0 N--CA 1.475 0.783 0 C-N-CA 122.394 0.278 . . . . 1.0 110.421 178.301 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . 0.435 ' CD ' ' O ' ' A' ' 39' ' ' THR . 0.0 OUTLIER -177.56 -177.59 0.68 Allowed 'General case' 0 N--CA 1.465 0.278 0 CA-C-N 117.962 0.346 . . . . 1.0 110.893 179.721 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 77.1 ttt180 -57.16 -46.1 83.04 Favored 'General case' 0 CA--C 1.536 0.427 0 N-CA-C 107.911 -1.144 . . . . 1.0 107.911 177.873 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . 0.516 ' C ' ' CG ' ' A' ' 45' ' ' PHE . . . 118.09 -25.57 8.27 Favored Glycine 0 N--CA 1.474 1.184 0 CA-C-O 120.067 -0.296 . . . . 1.0 112.642 178.912 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . 0.677 ' O ' ' HB2' ' A' ' 46' ' ' PHE . 0.1 OUTLIER -159.19 166.42 31.47 Favored 'General case' 0 CA--C 1.486 -1.496 0 N-CA-C 106.966 -1.494 . . . . 1.0 106.966 -179.258 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 46' ' ' PHE . . . . . 0.677 ' HB2' ' O ' ' A' ' 45' ' ' PHE . 31.2 m-85 104.1 116.95 0.01 OUTLIER 'General case' 0 N--CA 1.487 1.379 0 O-C-N 126.134 2.147 . . . . 1.0 110.589 179.815 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 47' ' ' ARG . . . . . 0.594 ' HE ' ' C9 ' ' A' ' 128' ' ' MTN . 0.0 OUTLIER 87.29 161.36 0.08 Allowed 'General case' 0 C--N 1.348 0.531 0 O-C-N 124.487 1.117 . . . . 1.0 110.499 179.366 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 48' ' ' CYS . . . . . 0.452 ' N ' ' HD3' ' A' ' 47' ' ' ARG . 41.2 t 61.67 67.19 0.78 Allowed 'General case' 0 CA--C 1.506 -0.723 0 N-CA-C 109.629 -0.508 . . . . 1.0 109.629 178.379 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 49' ' ' ASN . . . . . 0.769 ' O ' ' N ' ' A' ' 51' ' ' GLU . 10.5 m-80 -150.76 157.66 35.79 Favored Pre-proline 0 C--N 1.319 -0.721 0 CA-C-O 118.333 -0.842 . . . . 1.0 109.323 179.053 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . 0.561 ' HB2' ' HE ' ' A' ' 52' ' ' ARG . 50.1 Cg_exo -45.52 54.5 0.01 OUTLIER 'Trans proline' 0 N--CA 1.506 2.259 0 C-N-CA 123.768 2.979 . . . . 1.0 112.724 178.173 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . 0.769 ' N ' ' O ' ' A' ' 49' ' ' ASN . 1.6 mt-10 47.48 54.67 9.33 Favored 'General case' 0 C--N 1.33 -0.263 0 C-N-CA 123.357 0.663 . . . . 1.0 111.616 179.332 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . 0.561 ' HE ' ' HB2' ' A' ' 50' ' ' PRO . 34.3 mtm105 -152.24 167.2 29.38 Favored 'General case' 0 N--CA 1.469 0.507 0 CA-C-N 116.429 -0.35 . . . . 1.0 110.732 -179.125 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . 0.505 ' C ' ' NE2' ' A' ' 54' ' ' GLN . 2.2 tp -83.5 169.45 1.55 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.342 0 N-CA-C 108.531 -0.915 . . . . 1.0 108.531 178.536 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 54' ' ' GLN . . . . . 0.505 ' NE2' ' C ' ' A' ' 53' ' ' ILE . 0.0 OUTLIER -135.35 132.18 37.31 Favored 'General case' 0 N--CA 1.466 0.333 0 N-CA-C 109.294 -0.632 . . . . 1.0 109.294 -179.395 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . 0.482 ' N ' HD13 ' A' ' 55' ' ' ILE . 0.2 OUTLIER -145.4 154.63 13.62 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 N-CA-C 110.243 -0.28 . . . . 1.0 110.243 179.695 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 100.63 4.62 54.61 Favored Glycine 0 C--N 1.335 0.501 0 N-CA-C 109.975 -1.25 . . . . 1.0 109.975 179.47 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 73.1 m-20 -95.1 116.77 29.15 Favored 'General case' 0 CA--C 1.541 0.627 0 CA-C-O 122.842 1.306 . . . . 1.0 113.095 -179.68 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 58' ' ' TRP . . . . . 0.439 ' CD1' ' N ' ' A' ' 58' ' ' TRP . 17.8 m0 -79.19 179.46 7.37 Favored 'General case' 0 N--CA 1.483 1.206 0 CA-C-N 112.731 -2.031 . . . . 1.0 110.185 178.191 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 59' ' ' ARG . . . . . 0.513 ' HG2' ' H ' ' A' ' 60' ' ' TYR . 0.0 OUTLIER -93.22 -55.9 3.15 Favored 'General case' 0 CA--C 1.544 0.715 0 CA-C-N 118.434 0.561 . . . . 1.0 111.111 178.65 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 60' ' ' TYR . . . . . 0.513 ' H ' ' HG2' ' A' ' 59' ' ' ARG . 34.4 p90 -69.99 0.67 5.58 Favored 'General case' 0 C--O 1.239 0.53 0 C-N-CA 124.171 0.988 . . . . 1.0 108.866 178.676 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . 0.548 ' O ' ' N ' ' A' ' 65' ' ' ASP . 1.3 tt0 -61.63 -17.92 57.29 Favored 'General case' 0 C--O 1.21 -1.0 0 CA-C-N 115.348 -0.842 . . . . 1.0 112.447 -178.76 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . 0.521 ' CG2' ' H ' ' A' ' 63' ' ' ALA . 17.4 m -46.61 -56.29 1.36 Allowed 'Isoleucine or valine' 0 C--N 1.304 -1.394 0 N-CA-C 109.299 -0.63 . . . . 1.0 109.299 -174.724 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 63' ' ' ALA . . . . . 0.522 ' O ' ' HG3' ' A' ' 67' ' ' ARG . . . -60.9 -51.22 70.22 Favored 'General case' 0 N--CA 1.423 -1.796 0 N-CA-C 108.493 -0.928 . . . . 1.0 108.493 178.786 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 64' ' ' HIS . . . . . 0.522 ' HA ' ' HE ' ' A' ' 67' ' ' ARG . 19.1 t-80 -57.61 -60.62 3.4 Favored 'General case' 0 CA--C 1.548 0.903 0 CA-C-O 121.809 0.814 . . . . 1.0 112.356 -179.643 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . 0.586 ' C ' ' H ' ' A' ' 67' ' ' ARG . 29.7 t70 -66.83 -53.47 32.33 Favored 'General case' 0 C--N 1.312 -1.051 0 O-C-N 121.264 -0.897 . . . . 1.0 110.246 -179.267 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . 0.447 ' N ' ' O ' ' A' ' 62' ' ' VAL . . . -60.96 30.4 0.05 OUTLIER Glycine 0 CA--C 1.527 0.841 0 CA-C-N 115.734 -0.666 . . . . 1.0 112.593 -179.212 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 67' ' ' ARG . . . . . 0.611 ' O ' ' N ' ' A' ' 70' ' ' ALA . 94.8 mtt-85 -82.83 -5.09 58.8 Favored 'General case' 0 C--N 1.321 -0.672 0 O-C-N 122.746 -0.267 . . . . 1.0 111.647 175.697 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . 0.69 ' O ' ' HA ' ' A' ' 72' ' ' HIS . 0.2 OUTLIER -38.11 -28.74 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.524 0 CA-C-O 123.33 1.538 . . . . 1.0 107.084 178.907 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . 0.623 ' CG ' ' H ' ' A' ' 70' ' ' ALA . 0.9 OUTLIER -65.89 -64.01 0.96 Allowed 'General case' 0 CA--C 1.552 1.024 0 N-CA-C 105.847 -1.909 . . . . 1.0 105.847 175.716 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . 0.751 ' C ' ' H ' ' A' ' 72' ' ' HIS . . . -77.57 -73.36 0.31 Allowed 'General case' 0 C--N 1.364 1.232 0 N-CA-C 107.458 -1.312 . . . . 1.0 107.458 178.712 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . 0.708 ' HB1' ' HB ' ' A' ' 74' ' ' VAL . . . -50.17 7.4 0.0 OUTLIER 'General case' 0 C--N 1.351 0.671 0 C-N-CA 124.746 1.218 . . . . 1.0 110.744 177.834 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 72' ' ' HIS . . . . . 0.751 ' H ' ' C ' ' A' ' 70' ' ' ALA . 0.0 OUTLIER -17.56 -65.11 0.02 OUTLIER 'General case' 0 CA--C 1.492 -1.271 0 C-N-CA 123.565 0.746 . . . . 1.0 111.208 -175.852 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 73' ' ' MET . . . . . 0.465 ' H ' ' CG ' ' A' ' 72' ' ' HIS . 0.0 OUTLIER -77.24 -48.57 17.18 Favored 'General case' 0 C--N 1.292 -1.914 0 C-N-CA 120.275 -0.57 . . . . 1.0 110.452 178.264 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . 0.708 ' HB ' ' HB1' ' A' ' 71' ' ' ALA . 69.3 t -42.08 -44.45 0.98 Allowed 'Isoleucine or valine' 0 C--O 1.221 -0.405 0 CA-C-O 117.64 -1.172 . . . . 1.0 109.388 -174.7 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 75' ' ' ASN . . . . . 0.406 ' C ' ' N ' ' A' ' 77' ' ' ILE . 27.7 t-20 -36.75 -19.26 0.01 OUTLIER 'General case' 0 CA--C 1.553 1.094 0 CA-C-O 123.327 1.537 . . . . 1.0 110.639 179.342 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . 0.669 ' O ' HG12 ' A' ' 79' ' ' ILE . . . -49.05 -20.97 2.22 Favored Glycine 0 CA--C 1.543 1.827 0 N-CA-C 108.657 -1.777 . . . . 1.0 108.657 174.864 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . 0.457 HG13 ' H ' ' A' ' 78' ' ' VAL . 4.7 pt -47.4 -50.31 7.99 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.64 0 O-C-N 120.972 -1.31 . . . . 1.0 113.059 -179.02 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . 0.457 ' H ' HG13 ' A' ' 77' ' ' ILE . 12.0 p -55.1 -22.1 10.0 Favored 'Isoleucine or valine' 0 CA--C 1.504 -0.791 0 CA-C-O 120.832 0.348 . . . . 1.0 111.11 -178.024 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . 0.669 HG12 ' O ' ' A' ' 76' ' ' GLY . 0.5 OUTLIER -83.44 -46.01 18.56 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.867 0 C-N-CA 119.871 -0.731 . . . . 1.0 110.873 179.885 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 80' ' ' ALA . . . . . 0.507 ' N ' ' CG1' ' A' ' 79' ' ' ILE . . . -76.99 -21.84 54.08 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 115.633 -0.712 . . . . 1.0 111.007 -178.74 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . 0.547 ' OE1' ' N ' ' A' ' 81' ' ' GLU . 0.7 OUTLIER -83.07 -69.24 0.64 Allowed 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.011 -0.54 . . . . 1.0 111.093 -179.569 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 82' ' ' ASP . . . . . 0.636 ' O ' ' N ' ' A' ' 84' ' ' LEU . 88.9 m-20 -60.54 -60.86 3.13 Favored 'General case' 0 CA--C 1.496 -1.104 0 CA-C-O 118.048 -0.977 . . . . 1.0 110.376 -177.622 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . 0.568 ' O ' ' N ' ' A' ' 87' ' ' GLU . . . 0.94 -66.22 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.773 0 O-C-N 125.475 1.735 . . . . 1.0 110.312 -179.793 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . 0.636 ' N ' ' O ' ' A' ' 82' ' ' ASP . 4.4 mm? -25.15 -49.87 0.03 OUTLIER 'General case' 0 N--CA 1.473 0.687 0 CA-C-N 115.521 -0.763 . . . . 1.0 109.802 -176.713 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 85' ' ' ILE . . . . . 0.468 ' CG2' ' N ' ' A' ' 86' ' ' ALA . 13.7 tt -98.29 -51.0 10.76 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.699 0 N-CA-C 109.438 -0.579 . . . . 1.0 109.438 177.014 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . 0.468 ' N ' ' CG2' ' A' ' 85' ' ' ILE . . . -50.39 -46.95 56.47 Favored 'General case' 0 C--O 1.224 -0.267 0 CA-C-N 116.026 -0.533 . . . . 1.0 110.747 -179.184 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . 0.568 ' N ' ' O ' ' A' ' 83' ' ' ALA . 22.6 tp10 -47.7 -18.32 0.14 Allowed 'General case' 0 C--N 1.323 -0.577 0 CA-C-O 120.987 0.422 . . . . 1.0 110.328 179.601 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . 0.816 ' C ' ' H ' ' A' ' 90' ' ' GLY . . . -74.45 6.11 4.04 Favored 'General case' 0 CA--C 1.491 -1.309 0 CA-C-N 115.745 -0.661 . . . . 1.0 110.818 -179.718 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 89' ' ' VAL . . . . . 0.715 ' O ' ' N ' ' A' ' 92' ' ' HIS . 19.3 m -48.63 15.88 0.0 OUTLIER 'Isoleucine or valine' 0 C--O 1.216 -0.685 0 O-C-N 124.529 1.143 . . . . 1.0 111.616 -179.746 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 90' ' ' GLY . . . . . 0.816 ' H ' ' C ' ' A' ' 88' ' ' ALA . . . -33.58 -50.65 0.57 Allowed Glycine 0 C--N 1.351 1.386 0 N-CA-C 108.05 -2.02 . . . . 1.0 108.05 -177.08 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 91' ' ' PRO . . . . . 0.466 ' O ' ' N ' ' A' ' 94' ' ' ALA . 73.0 Cg_exo -48.11 0.35 0.02 OUTLIER 'Trans proline' 0 N--CA 1.495 1.565 0 C-N-CA 122.463 2.109 . . . . 1.0 112.216 173.163 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 92' ' ' HIS . . . . . 0.715 ' N ' ' O ' ' A' ' 89' ' ' VAL . 0.0 OUTLIER -47.57 -37.05 11.55 Favored 'General case' 0 N--CA 1.445 -0.707 0 N-CA-C 107.794 -1.187 . . . . 1.0 107.794 -176.053 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 1.5 pp -61.78 -37.8 85.67 Favored 'General case' 0 N--CA 1.436 -1.145 0 CA-C-O 121.702 0.763 . . . . 1.0 111.107 178.59 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 94' ' ' ALA . . . . . 0.466 ' N ' ' O ' ' A' ' 91' ' ' PRO . . . -62.57 -62.4 1.77 Allowed 'General case' 0 C--N 1.33 -0.26 0 N-CA-C 107.795 -1.187 . . . . 1.0 107.795 179.279 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 63.4 mmt-85 -59.52 -28.84 67.43 Favored 'General case' 0 N--CA 1.438 -1.059 0 N-CA-C 109.237 -0.653 . . . . 1.0 109.237 179.71 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 96' ' ' ALA . . . . . 0.797 ' O ' ' N ' ' A' ' 100' ' ' ILE . . . -59.49 -53.87 53.09 Favored 'General case' 0 CA--C 1.496 -1.13 0 N-CA-C 107.114 -1.439 . . . . 1.0 107.114 179.915 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . 0.567 ' O ' ' CG2' ' A' ' 100' ' ' ILE . 0.9 OUTLIER -37.78 -32.17 0.05 Allowed 'General case' 0 CA--C 1.556 1.175 0 N-CA-C 108.217 -1.031 . . . . 1.0 108.217 -179.191 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 98' ' ' GLY . . . . . 0.485 ' N ' ' O ' ' A' ' 96' ' ' ALA . . . -82.17 -52.72 3.92 Favored Glycine 0 CA--C 1.564 3.152 0 CA-C-O 123.692 1.718 . . . . 1.0 112.131 173.875 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 99' ' ' GLN . . . . . 0.442 ' N ' ' O ' ' A' ' 96' ' ' ALA . 60.9 mm-40 -77.71 9.59 3.34 Favored 'General case' 0 N--CA 1.44 -0.932 0 N-CA-C 107.978 -1.119 . . . . 1.0 107.978 178.895 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 100' ' ' ILE . . . . . 0.797 ' N ' ' O ' ' A' ' 96' ' ' ALA . 18.9 tt -59.74 -55.1 26.13 Favored 'Isoleucine or valine' 0 CA--C 1.493 -1.215 0 N-CA-C 109.578 -0.527 . . . . 1.0 109.578 -178.51 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 101' ' ' VAL . . . . . 0.63 ' CG1' ' H ' ' A' ' 102' ' ' CYS . 4.2 p -58.58 -58.85 4.88 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.535 0 C-N-CA 118.862 -1.135 . . . . 1.0 108.26 178.636 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 102' ' ' CYS . . . . . 0.63 ' H ' ' CG1' ' A' ' 101' ' ' VAL . 13.1 t -45.61 -26.57 0.63 Allowed 'General case' 0 C--O 1.215 -0.75 0 C-N-CA 120.212 -0.595 . . . . 1.0 109.525 -177.835 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 103' ' ' ARG . . . . . 0.431 ' N ' ' C ' ' A' ' 101' ' ' VAL . 0.0 OUTLIER -88.63 -41.96 12.32 Favored 'General case' 0 CA--C 1.549 0.911 0 CA-C-O 122.347 1.07 . . . . 1.0 113.846 179.598 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 104' ' ' TYR . . . . . 0.748 ' CG ' ' O ' ' A' ' 104' ' ' TYR . 4.0 t80 -95.25 23.0 6.16 Favored 'General case' 0 C--N 1.303 -1.445 0 C-N-CA 127.05 2.14 . . . . 1.0 108.722 178.128 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 105' ' ' GLY . . . . . 0.522 ' N ' ' O ' ' A' ' 101' ' ' VAL . . . -163.15 -86.29 0.06 OUTLIER Glycine 0 N--CA 1.442 -0.93 0 N-CA-C 108.058 -2.017 . . . . 1.0 108.058 178.102 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 106' ' ' ALA . . . . . 0.458 ' HB2' ' O ' ' A' ' 102' ' ' CYS . . . 64.08 66.66 0.63 Allowed 'General case' 0 C--N 1.32 -0.681 0 N-CA-C 112.42 0.526 . . . . 1.0 112.42 179.854 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 107' ' ' THR . . . . . 0.483 ' C ' ' HD2' ' A' ' 110' ' ' PRO . 0.5 OUTLIER -109.61 -9.93 14.86 Favored 'General case' 0 CA--C 1.536 0.431 0 O-C-N 122.136 -0.352 . . . . 1.0 110.438 179.086 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . 0.553 ' C ' ' HD2' ' A' ' 110' ' ' PRO . 0.0 OUTLIER -82.6 -62.81 1.34 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.694 0 N-CA-C 113.595 0.961 . . . . 1.0 113.595 -176.359 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 109' ' ' ILE . . . . . 0.594 ' N ' ' CD ' ' A' ' 110' ' ' PRO . 0.6 OUTLIER -54.61 -35.99 38.56 Favored Pre-proline 0 C--N 1.321 -0.673 0 N-CA-C 112.161 0.43 . . . . 1.0 112.161 179.933 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 110' ' ' PRO . . . . . 0.594 ' CD ' ' N ' ' A' ' 109' ' ' ILE . 81.4 Cg_exo -45.81 -32.48 9.19 Favored 'Trans proline' 0 C--N 1.323 -0.779 0 C-N-CA 122.258 1.972 . . . . 1.0 112.565 -174.697 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 111' ' ' ASN . . . . . 0.755 ' CG ' ' H ' ' A' ' 112' ' ' ILE . 12.5 p-10 -61.66 -68.62 0.3 Allowed 'General case' 0 CA--C 1.545 0.753 0 C-N-CA 119.699 -0.801 . . . . 1.0 110.355 -179.674 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 112' ' ' ILE . . . . . 0.755 ' H ' ' CG ' ' A' ' 111' ' ' ASN . 2.9 mm -74.7 -24.8 18.54 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.746 0 CA-C-O 121.851 0.834 . . . . 1.0 110.026 -178.122 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 18.9 t30 -51.72 -58.89 5.11 Favored 'General case' 0 C--N 1.298 -1.651 0 CA-C-N 114.159 -1.382 . . . . 1.0 109.933 -178.416 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -66.09 -19.5 65.86 Favored 'General case' 0 N--CA 1.447 -0.584 0 CA-C-N 116.22 -0.445 . . . . 1.0 110.359 179.197 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -75.13 -61.03 2.03 Favored 'General case' 0 CA--C 1.544 0.72 0 C-N-CA 120.312 -0.555 . . . . 1.0 111.242 178.388 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 116' ' ' ILE . . . . . 0.477 ' O ' ' CB ' ' A' ' 119' ' ' LEU . 15.1 tt -67.57 -38.94 81.41 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.334 0 O-C-N 121.052 -1.03 . . . . 1.0 110.918 -178.851 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 117' ' ' GLU . . . . . 0.494 ' C ' ' H ' ' A' ' 119' ' ' LEU . 1.0 OUTLIER -46.67 -68.06 0.23 Allowed 'General case' 0 C--N 1.3 -1.583 0 CA-C-N 115.334 -0.848 . . . . 1.0 110.493 -178.249 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 89.8 t -47.31 -14.03 0.08 OUTLIER 'Isoleucine or valine' 0 CA--C 1.505 -0.757 0 CA-C-N 114.838 -1.073 . . . . 1.0 109.515 -178.396 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 119' ' ' LEU . . . . . 0.494 ' H ' ' C ' ' A' ' 117' ' ' GLU . 3.2 tp -77.19 -61.6 1.93 Allowed 'General case' 0 N--CA 1.45 -0.447 0 C-N-CA 119.464 -0.894 . . . . 1.0 110.43 179.101 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -73.36 -81.13 0.41 Allowed Glycine 0 C--N 1.362 2.013 0 C-N-CA 117.891 -2.1 . . . . 1.0 111.339 -178.348 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 1.2 t -158.53 -18.63 0.07 Allowed 'General case' 0 C--N 1.322 -0.601 0 CA-C-O 121.237 0.542 . . . . 1.0 110.601 -179.033 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 122' ' ' GLY . . . . . 0.453 ' O ' ' C ' ' A' ' 123' ' ' THR . . . 107.7 -38.45 3.32 Favored Glycine 0 N--CA 1.472 1.076 0 C-N-CA 125.026 1.298 . . . . 1.0 112.758 178.889 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 123' ' ' THR . . . . . 0.453 ' C ' ' O ' ' A' ' 122' ' ' GLY . 8.5 m -30.62 102.73 0.02 OUTLIER 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 118.49 1.145 . . . . 1.0 112.427 -177.128 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 38.0 p-10 -143.72 139.72 29.62 Favored 'General case' 0 C--N 1.332 -0.158 0 N-CA-C 106.985 -1.487 . . . . 1.0 106.985 178.744 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 125' ' ' TYR . . . . . 0.538 ' OH ' ' CE1' ' A' ' 127' ' ' PHE . 0.0 OUTLIER -153.95 150.72 28.61 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 116.185 -0.461 . . . . 1.0 110.165 -177.848 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 126' ' ' ARG . . . . . 0.487 ' HG2' ' O ' ' A' ' 125' ' ' TYR . 2.0 mmp_? -152.07 156.97 40.97 Favored 'General case' 0 CA--C 1.538 0.483 0 O-C-N 124.497 1.123 . . . . 1.0 111.962 176.829 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 127' ' ' PHE . . . . . 0.538 ' CE1' ' OH ' ' A' ' 125' ' ' TYR . 1.1 p90 . . . . . 0 C--O 1.222 -0.377 0 CA-C-O 118.007 -0.997 . . . . 1.0 110.465 178.886 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 128' ' ' MTN . . . . . 0.594 ' C9 ' ' HE ' ' A' ' 47' ' ' ARG . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 129' ' ' MTN . . . . . 0.514 ' C8 ' HD22 ' A' ' 49' ' ' ASN . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 130' ' ' MTN . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.458 ' N ' ' SD ' ' A' ' 1' ' ' MET . 0.0 OUTLIER . . . . . 0 N--CA 1.493 1.696 0 N-CA-C 109.236 -0.654 . . . . 1.0 109.236 . . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 2' ' ' SER . . . . . 0.517 ' O ' ' CB ' ' A' ' 3' ' ' ASP . 87.6 p -86.47 9.09 19.31 Favored 'General case' 0 N--CA 1.463 0.209 0 CA-C-N 116.554 -0.294 . . . . 1.0 111.204 -179.818 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . 0.517 ' CB ' ' O ' ' A' ' 2' ' ' SER . 3.5 t70 149.99 123.81 0.0 OUTLIER 'General case' 0 N--CA 1.479 0.995 0 O-C-N 124.16 0.912 . . . . 1.0 111.189 178.551 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . 0.412 ' O ' ' OD1' ' A' ' 5' ' ' ASP . 83.9 t80 -155.25 150.92 27.48 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.408 -0.814 . . . . 1.0 110.403 178.812 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 5' ' ' ASP . . . . . 0.412 ' OD1' ' O ' ' A' ' 4' ' ' PHE . 74.9 m-20 -150.8 148.12 28.12 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.065 -0.516 . . . . 1.0 109.703 179.513 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 6' ' ' THR . . . . . 0.71 ' O ' ' N ' ' A' ' 10' ' ' SER . 0.2 OUTLIER -70.19 167.85 16.98 Favored 'General case' 0 C--O 1.195 -1.802 0 CA-C-O 121.156 0.503 . . . . 1.0 110.274 -179.461 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . 0.633 ' CG ' ' H ' ' A' ' 8' ' ' ARG . 5.4 pt-20 -57.62 -57.78 11.21 Favored 'General case' 0 C--N 1.299 -1.587 0 CA-C-O 121.271 0.558 . . . . 1.0 110.369 -179.26 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 8' ' ' ARG . . . . . 0.633 ' H ' ' CG ' ' A' ' 7' ' ' GLU . 7.9 ttm180 -52.64 -56.07 18.01 Favored 'General case' 0 C--N 1.316 -0.87 0 N-CA-C 107.805 -1.183 . . . . 1.0 107.805 -178.187 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . 0.543 ' O ' ' CG2' ' A' ' 13' ' ' VAL . 0.0 OUTLIER -64.46 -50.42 76.2 Favored 'Isoleucine or valine' 0 C--O 1.203 -1.355 0 C-N-CA 119.488 -0.885 . . . . 1.0 109.816 178.718 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 10' ' ' SER . . . . . 0.71 ' N ' ' O ' ' A' ' 6' ' ' THR . 20.9 t -65.41 -63.92 0.98 Allowed 'General case' 0 C--N 1.316 -0.884 0 C-N-CA 119.42 -0.912 . . . . 1.0 111.257 -178.565 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 11' ' ' ARG . . . . . 0.593 ' N ' ' O ' ' A' ' 7' ' ' GLU . 4.1 tpp180 -63.9 -59.03 5.02 Favored 'General case' 0 N--CA 1.471 0.624 0 CA-C-O 121.103 0.477 . . . . 1.0 111.888 -176.804 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . 0.487 ' CB ' ' O ' ' A' ' 8' ' ' ARG . . . -50.18 -49.38 52.58 Favored 'General case' 0 C--N 1.317 -0.82 0 N-CA-C 107.458 -1.312 . . . . 1.0 107.458 -177.232 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . 0.6 ' O ' ' N ' ' A' ' 17' ' ' LEU . 93.4 t -60.92 -49.47 84.52 Favored 'Isoleucine or valine' 0 C--O 1.198 -1.607 0 C-N-CA 118.733 -1.187 . . . . 1.0 107.946 177.347 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . 0.411 ' O ' ' N ' ' A' ' 18' ' ' VAL . . . -57.53 -62.11 2.02 Favored 'General case' 0 C--O 1.212 -0.889 0 C-N-CA 118.519 -1.273 . . . . 1.0 109.913 -179.8 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . 0.57 ' O ' ' N ' ' A' ' 19' ' ' GLY . . . -51.28 -53.57 34.36 Favored 'General case' 0 N--CA 1.472 0.648 0 CA-C-O 121.706 0.765 . . . . 1.0 109.287 -178.245 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -62.94 -55.08 29.01 Favored 'General case' 0 C--N 1.309 -1.186 0 CA-C-N 114.603 -1.18 . . . . 1.0 109.037 -178.988 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . 0.6 ' N ' ' O ' ' A' ' 13' ' ' VAL . 4.8 tt -55.91 -54.16 48.11 Favored 'General case' 0 N--CA 1.478 0.966 0 CA-C-N 113.921 -1.49 . . . . 1.0 109.063 -177.413 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . 0.554 HG21 ' H ' ' A' ' 19' ' ' GLY . 2.3 m -69.29 -57.4 8.62 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.359 0 N-CA-C 108.939 -0.763 . . . . 1.0 108.939 178.426 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . 0.57 ' N ' ' O ' ' A' ' 15' ' ' ALA . . . -58.03 -169.45 0.18 Allowed Glycine 0 C--O 1.216 -1.027 0 N-CA-C 110.67 -0.972 . . . . 1.0 110.67 179.722 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' PRO . . . . . 0.499 ' O ' ' N ' ' A' ' 24' ' ' ALA . 3.5 Cg_endo -79.62 -31.07 2.13 Favored 'Trans proline' 0 N--CA 1.499 1.798 0 C-N-CA 123.052 2.501 . . . . 1.0 115.154 -178.06 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -59.88 -57.43 19.39 Favored Glycine 0 N--CA 1.475 1.298 0 C-N-CA 120.699 -0.763 . . . . 1.0 112.665 -176.8 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -55.99 -54.16 37.28 Favored Glycine 0 N--CA 1.469 0.844 0 N-CA-C 107.74 -2.144 . . . . 1.0 107.74 -175.534 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . 0.554 ' CG2' ' O ' ' A' ' 19' ' ' GLY . 0.0 OUTLIER -60.84 -32.23 51.61 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.391 0 CA-C-N 114.617 -0.792 . . . . 1.0 109.607 178.923 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . 0.499 ' N ' ' O ' ' A' ' 20' ' ' PRO . . . -56.01 -62.12 1.92 Allowed 'General case' 0 CA--C 1.532 0.28 0 C-N-CA 117.993 -1.483 . . . . 1.0 109.408 179.791 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -65.56 -45.16 84.39 Favored 'General case' 0 C--N 1.341 0.23 0 N-CA-C 112.82 0.674 . . . . 1.0 112.82 -178.464 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 98.5 t -60.22 -59.11 4.57 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.192 0 C-N-CA 118.849 -1.14 . . . . 1.0 110.21 -177.375 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 1.2 p -59.74 -35.16 58.33 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.286 0 CA-C-O 120.982 0.42 . . . . 1.0 111.95 -178.341 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 32.2 ttpt -66.54 -53.92 29.44 Favored 'General case' 0 C--N 1.315 -0.921 0 CA-C-O 121.906 0.86 . . . . 1.0 109.069 -178.376 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 91.1 t -64.37 -48.59 84.62 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.1 0 CA-C-N 113.668 -1.605 . . . . 1.0 111.557 -177.413 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 30' ' ' CYS . . . . . 0.572 ' SG ' ' N ' ' A' ' 31' ' ' ALA . 0.0 OUTLIER -63.82 -58.58 6.37 Favored 'General case' 0 N--CA 1.452 -0.336 0 C-N-CA 118.86 -1.136 . . . . 1.0 108.518 -179.299 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . 0.572 ' N ' ' SG ' ' A' ' 30' ' ' CYS . . . -61.7 -53.52 55.02 Favored 'General case' 0 C--N 1.326 -0.415 0 N-CA-C 112.422 0.527 . . . . 1.0 112.422 -177.515 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . 0.473 ' O ' ' CB ' ' A' ' 33' ' ' LEU . . . 86.86 74.42 1.27 Allowed Glycine 0 CA--C 1.522 0.481 0 N-CA-C 110.656 -0.978 . . . . 1.0 110.656 -178.87 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . 0.473 ' CB ' ' O ' ' A' ' 32' ' ' GLY . 1.0 OUTLIER 86.06 101.84 0.03 OUTLIER Pre-proline 0 CA--C 1.547 0.841 0 N-CA-C 109.813 -0.44 . . . . 1.0 109.813 -179.876 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 55.9 Cg_endo -71.48 -26.02 20.64 Favored 'Trans proline' 0 N--CA 1.501 1.96 0 C-N-CA 122.087 1.858 . . . . 1.0 114.055 -177.955 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -59.84 -59.45 10.47 Favored Glycine 0 CA--C 1.523 0.554 0 C-N-CA 118.081 -2.009 . . . . 1.0 108.884 -178.539 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . 0.525 ' O ' ' CB ' ' A' ' 37' ' ' ILE . 10.8 p -90.53 161.92 2.54 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.541 0 N-CA-C 107.277 -1.379 . . . . 1.0 107.277 177.565 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . 0.525 ' CB ' ' O ' ' A' ' 36' ' ' VAL . 14.8 tt 120.0 113.17 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.472 0.626 0 O-C-N 124.85 1.344 . . . . 1.0 110.061 179.615 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 22.7 m-70 -140.61 135.46 31.76 Favored 'General case' 0 C--N 1.322 -0.625 0 N-CA-C 108.874 -0.787 . . . . 1.0 108.874 178.87 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 42.5 p -112.54 139.8 23.1 Favored Pre-proline 0 C--N 1.331 -0.23 0 N-CA-C 109.146 -0.687 . . . . 1.0 109.146 179.716 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 40' ' ' PRO . . . . . 0.404 ' HG2' ' H ' ' A' ' 41' ' ' ALA . 57.6 Cg_endo -70.88 -87.15 0.0 OUTLIER 'Trans proline' 0 C--N 1.312 -1.367 0 C-N-CA 121.747 1.631 . . . . 1.0 112.015 -179.433 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . 0.404 ' H ' ' HG2' ' A' ' 40' ' ' PRO . . . -66.6 125.07 24.62 Favored 'General case' 0 C--N 1.315 -0.93 0 CA-C-N 114.786 -1.097 . . . . 1.0 110.623 -178.902 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . 0.676 ' C ' ' H ' ' A' ' 44' ' ' GLY . 4.2 ptt180 -170.7 168.42 7.44 Favored 'General case' 0 N--CA 1.445 -0.711 0 CA-C-N 115.556 -0.747 . . . . 1.0 109.779 179.893 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -63.31 24.86 0.01 OUTLIER 'General case' 0 C--N 1.317 -0.826 0 CA-C-N 115.88 -0.6 . . . . 1.0 110.369 179.83 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . 0.676 ' H ' ' C ' ' A' ' 42' ' ' ARG . . . 87.14 -26.2 7.1 Favored Glycine 0 C--N 1.333 0.402 0 N-CA-C 110.605 -0.998 . . . . 1.0 110.605 179.4 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . 0.646 ' CG ' ' O ' ' A' ' 44' ' ' GLY . 74.0 m-85 -167.37 175.15 7.45 Favored 'General case' 0 C--O 1.216 -0.675 0 O-C-N 124.759 0.917 . . . . 1.0 110.696 178.551 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 46' ' ' PHE . . . . . 0.524 ' HB2' ' O ' ' A' ' 45' ' ' PHE . 2.0 m-85 132.58 89.02 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.611 0 C-N-CA 125.625 1.57 . . . . 1.0 109.432 179.01 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 47' ' ' ARG . . . . . 0.508 ' CB ' ' O ' ' A' ' 46' ' ' PHE . 48.6 mmt-85 124.53 142.06 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.509 0 C-N-CA 124.33 1.052 . . . . 1.0 110.781 178.666 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 2.6 t 69.45 70.62 0.25 Allowed 'General case' 0 C--N 1.331 -0.226 0 N-CA-C 108.355 -0.98 . . . . 1.0 108.355 -178.916 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 49' ' ' ASN . . . . . 0.559 ' CG ' HE22 ' A' ' 54' ' ' GLN . 1.7 p30 -125.17 152.79 71.34 Favored Pre-proline 0 C--O 1.233 0.232 0 CA-C-N 116.448 -0.342 . . . . 1.0 110.551 -178.969 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . 0.469 ' HG2' HH11 ' A' ' 52' ' ' ARG . 78.7 Cg_endo -73.17 55.84 3.03 Favored 'Trans proline' 0 C--N 1.311 -1.427 0 C-N-CA 122.022 1.815 . . . . 1.0 110.812 178.889 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 46.8 mm-40 68.18 -2.5 1.5 Allowed 'General case' 0 CA--C 1.528 0.127 0 CA-C-N 116.149 -0.478 . . . . 1.0 111.08 -179.635 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . 0.469 HH11 ' HG2' ' A' ' 50' ' ' PRO . 80.0 mtt85 -77.85 159.71 28.78 Favored 'General case' 0 N--CA 1.466 0.329 0 CA-C-O 120.999 0.428 . . . . 1.0 110.581 179.095 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . 0.429 ' O ' ' N ' ' A' ' 55' ' ' ILE . 19.4 tt -78.13 138.71 19.77 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.187 0 CA-C-N 115.906 -0.588 . . . . 1.0 111.218 -179.324 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 54' ' ' GLN . . . . . 0.559 HE22 ' CG ' ' A' ' 49' ' ' ASN . 29.2 mm-40 -63.16 81.4 0.02 OUTLIER 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 115.273 -0.876 . . . . 1.0 110.468 -177.973 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . 0.429 ' N ' ' O ' ' A' ' 53' ' ' ILE . 15.4 tt -147.01 156.02 11.01 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.152 0 CA-C-N 115.264 -0.88 . . . . 1.0 109.613 177.63 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 109.97 -2.13 30.12 Favored Glycine 0 N--CA 1.466 0.634 0 N-CA-C 110.683 -0.967 . . . . 1.0 110.683 -179.748 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . 0.418 ' O ' ' CG ' ' A' ' 57' ' ' ASP . 18.9 p-10 -79.43 99.56 7.25 Favored 'General case' 0 C--N 1.325 -0.468 0 N-CA-C 109.33 -0.619 . . . . 1.0 109.33 178.891 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 58' ' ' TRP . . . . . . . . . . . . . 3.9 m0 -89.99 170.58 10.23 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 123.753 1.739 . . . . 1.0 113.337 -177.052 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 59' ' ' ARG . . . . . 0.42 ' HG3' ' N ' ' A' ' 60' ' ' TYR . 48.3 ptt85 -82.29 -57.89 3.18 Favored 'General case' 0 C--N 1.312 -1.062 0 CA-C-N 110.393 -3.094 . . . . 1.0 112.779 -178.865 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 60' ' ' TYR . . . . . 0.42 ' N ' ' HG3' ' A' ' 59' ' ' ARG . 79.9 t80 -92.67 -15.68 26.46 Favored 'General case' 0 N--CA 1.485 1.285 0 N-CA-C 113.406 0.891 . . . . 1.0 113.406 -179.979 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 6.3 tt0 -77.49 -14.03 59.78 Favored 'General case' 0 C--N 1.313 -1.005 0 CA-C-N 116.065 -0.516 . . . . 1.0 111.073 -178.852 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . 0.638 ' O ' ' N ' ' A' ' 66' ' ' GLY . 27.5 m -48.22 -54.65 3.86 Favored 'Isoleucine or valine' 0 C--O 1.198 -1.616 0 C-N-CA 119.485 -0.886 . . . . 1.0 109.84 -175.346 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -68.01 -50.65 54.23 Favored 'General case' 0 C--N 1.306 -1.297 0 O-C-N 121.32 -0.862 . . . . 1.0 109.022 -179.968 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -48.5 -58.59 4.44 Favored 'General case' 0 N--CA 1.465 0.307 0 C-N-CA 119.594 -0.842 . . . . 1.0 109.274 -179.893 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . 0.581 ' C ' ' H ' ' A' ' 67' ' ' ARG . 18.5 t0 -71.63 -49.97 35.14 Favored 'General case' 0 C--N 1.314 -0.968 0 CA-C-N 115.147 -0.933 . . . . 1.0 110.159 178.832 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . 0.638 ' N ' ' O ' ' A' ' 62' ' ' VAL . . . -71.69 25.83 0.62 Allowed Glycine 0 CA--C 1.52 0.393 0 N-CA-C 110.915 -0.874 . . . . 1.0 110.915 178.241 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 67' ' ' ARG . . . . . 0.628 ' O ' ' N ' ' A' ' 69' ' ' LEU . 0.2 OUTLIER -75.89 2.49 12.31 Favored 'General case' 0 C--N 1.323 -0.564 0 N-CA-C 105.706 -1.961 . . . . 1.0 105.706 175.607 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . 0.51 ' H ' ' C ' ' A' ' 66' ' ' GLY . 0.0 OUTLIER -35.23 -27.32 0.01 OUTLIER 'General case' 0 N--CA 1.482 1.169 0 N-CA-C 107.991 -1.114 . . . . 1.0 107.991 -176.559 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . 0.628 ' N ' ' O ' ' A' ' 67' ' ' ARG . 2.9 tm? -62.68 -64.49 0.9 Allowed 'General case' 0 C--N 1.323 -0.56 0 C-N-CA 117.679 -1.608 . . . . 1.0 107.732 177.772 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . 0.706 ' C ' ' H ' ' A' ' 72' ' ' HIS . . . -79.01 -74.52 0.28 Allowed 'General case' 0 N--CA 1.479 0.995 0 N-CA-C 107.385 -1.339 . . . . 1.0 107.385 178.509 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . 0.435 ' O ' ' C ' ' A' ' 72' ' ' HIS . . . -45.15 4.16 0.0 OUTLIER 'General case' 0 C--O 1.224 -0.239 0 C-N-CA 124.849 1.26 . . . . 1.0 112.479 178.754 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 72' ' ' HIS . . . . . 0.706 ' H ' ' C ' ' A' ' 70' ' ' ALA . 1.9 t60 -29.83 -73.85 0.03 OUTLIER 'General case' 0 C--N 1.333 -0.123 0 N-CA-C 112.261 0.467 . . . . 1.0 112.261 -179.373 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 73' ' ' MET . . . . . 0.598 ' N ' ' SD ' ' A' ' 73' ' ' MET . 0.0 OUTLIER -58.34 -54.51 46.24 Favored 'General case' 0 C--N 1.329 -0.32 0 N-CA-C 106.521 -1.659 . . . . 1.0 106.521 178.655 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . 0.765 ' O ' ' N ' ' A' ' 76' ' ' GLY . 61.4 t -42.38 -39.83 0.87 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-O 117.271 -1.347 . . . . 1.0 111.681 -176.13 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 75' ' ' ASN . . . . . 0.492 ' C ' ' N ' ' A' ' 77' ' ' ILE . 33.4 p-10 -35.15 -15.18 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.607 0 CA-C-N 120.824 1.647 . . . . 1.0 110.806 179.558 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . 0.765 ' N ' ' O ' ' A' ' 74' ' ' VAL . . . -49.6 -19.93 2.38 Favored Glycine 0 N--CA 1.436 -1.328 0 N-CA-C 107.244 -2.343 . . . . 1.0 107.244 173.394 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . 0.492 ' N ' ' C ' ' A' ' 75' ' ' ASN . 14.1 pt -56.49 -50.59 72.17 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.032 0 CA-C-O 117.747 -1.12 . . . . 1.0 110.384 -179.334 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 24.4 t -54.71 -20.69 5.82 Favored 'Isoleucine or valine' 0 C--N 1.352 0.699 0 CA-C-N 121.095 1.77 . . . . 1.0 113.427 179.701 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . 0.567 ' CG2' HH22 ' A' ' 126' ' ' ARG . 44.8 pt -91.68 -40.27 12.25 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.34 0 C-N-CA 118.888 -1.125 . . . . 1.0 109.677 178.012 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -79.56 -19.85 48.46 Favored 'General case' 0 CA--C 1.538 0.494 0 N-CA-C 113.604 0.964 . . . . 1.0 113.604 179.495 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . 0.542 ' CG ' ' H ' ' A' ' 82' ' ' ASP . 1.1 pp20? -94.15 -71.52 0.66 Allowed 'General case' 0 C--N 1.345 0.4 0 N-CA-C 114.47 1.285 . . . . 1.0 114.47 -177.474 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 82' ' ' ASP . . . . . 0.542 ' H ' ' CG ' ' A' ' 81' ' ' GLU . 27.4 t70 -88.93 -15.04 35.31 Favored 'General case' 0 CA--C 1.538 0.493 0 N-CA-C 114.447 1.277 . . . . 1.0 114.447 -178.237 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . 0.523 ' O ' ' N ' ' A' ' 87' ' ' GLU . . . -49.75 -46.21 50.27 Favored 'General case' 0 C--O 1.214 -0.813 0 C-N-CA 118.116 -1.434 . . . . 1.0 112.352 -177.816 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 2.7 tm? -39.77 -45.47 1.75 Allowed 'General case' 0 N--CA 1.471 0.586 0 CA-C-N 118.207 0.458 . . . . 1.0 111.602 -178.026 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 6.4 tt -66.36 -34.64 71.5 Favored 'Isoleucine or valine' 0 C--O 1.235 0.296 0 C-N-CA 119.698 -0.801 . . . . 1.0 111.022 -179.583 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . 0.552 ' O ' ' N ' ' A' ' 89' ' ' VAL . . . -93.64 -23.88 18.1 Favored 'General case' 0 C--O 1.211 -0.967 0 N-CA-C 111.728 0.27 . . . . 1.0 111.728 179.904 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . 0.523 ' N ' ' O ' ' A' ' 83' ' ' ALA . 38.9 tp10 -54.51 -18.81 4.76 Favored 'General case' 0 C--N 1.324 -0.509 0 O-C-N 121.447 -0.783 . . . . 1.0 109.946 -178.818 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -75.49 -5.83 47.12 Favored 'General case' 0 N--CA 1.473 0.687 0 CA-C-O 122.762 1.268 . . . . 1.0 108.097 178.329 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 89' ' ' VAL . . . . . 0.552 ' N ' ' O ' ' A' ' 86' ' ' ALA . 3.2 m -86.05 36.31 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.318 -0.785 0 CA-C-N 112.173 -2.285 . . . . 1.0 107.962 177.085 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 90' ' ' GLY . . . . . 0.882 ' O ' ' N ' ' A' ' 92' ' ' HIS . . . -56.26 -19.66 25.72 Favored Glycine 0 C--N 1.373 2.601 0 CA-C-O 117.049 -1.973 . . . . 1.0 113.465 178.362 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 91' ' ' PRO . . . . . 0.632 ' HD2' ' N ' ' A' ' 90' ' ' GLY . 3.0 Cg_exo -34.38 3.42 0.0 OUTLIER 'Trans proline' 0 N--CA 1.499 1.817 0 CA-C-N 121.618 2.709 . . . . 1.0 113.693 172.409 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 92' ' ' HIS . . . . . 0.882 ' N ' ' O ' ' A' ' 90' ' ' GLY . 1.4 t-160 -47.2 -35.15 7.12 Favored 'General case' 0 N--CA 1.443 -0.816 0 N-CA-C 106.04 -1.837 . . . . 1.0 106.04 179.484 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . 0.409 ' O ' ' HB1' ' A' ' 96' ' ' ALA . 5.6 tp -62.57 -45.86 91.0 Favored 'General case' 0 C--N 1.35 0.609 0 N-CA-C 108.652 -0.869 . . . . 1.0 108.652 176.058 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 94' ' ' ALA . . . . . 0.545 ' N ' ' O ' ' A' ' 91' ' ' PRO . . . -53.69 -58.17 8.18 Favored 'General case' 0 C--N 1.333 -0.15 0 N-CA-C 106.344 -1.724 . . . . 1.0 106.344 178.685 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -58.32 -29.73 66.14 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-N 114.65 -1.159 . . . . 1.0 109.314 177.981 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 96' ' ' ALA . . . . . 0.855 ' O ' ' N ' ' A' ' 100' ' ' ILE . . . -54.35 -51.21 65.47 Favored 'General case' 0 C--O 1.199 -1.57 0 N-CA-C 107.84 -1.17 . . . . 1.0 107.84 -176.145 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . 0.508 ' C ' ' O ' ' A' ' 96' ' ' ALA . 2.7 tm? -34.02 -28.37 0.01 OUTLIER 'General case' 0 CA--C 1.567 1.622 0 CA-C-N 113.788 -1.551 . . . . 1.0 108.052 -178.03 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 98' ' ' GLY . . . . . 0.648 ' N ' ' O ' ' A' ' 96' ' ' ALA . . . -89.37 -53.32 2.49 Favored Glycine 0 CA--C 1.56 2.866 0 CA-C-O 123.279 1.488 . . . . 1.0 111.956 170.46 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 99' ' ' GLN . . . . . 0.541 ' N ' ' O ' ' A' ' 96' ' ' ALA . 5.4 mm100 -75.93 6.48 5.09 Favored 'General case' 0 N--CA 1.439 -0.986 0 N-CA-C 107.64 -1.244 . . . . 1.0 107.64 179.156 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 100' ' ' ILE . . . . . 0.855 ' N ' ' O ' ' A' ' 96' ' ' ALA . 19.2 tt -63.46 -50.6 77.86 Favored 'Isoleucine or valine' 0 CA--C 1.471 -2.069 0 N-CA-C 107.784 -1.191 . . . . 1.0 107.784 -179.956 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 101' ' ' VAL . . . . . 0.673 ' O ' ' N ' ' A' ' 105' ' ' GLY . 76.1 t -51.84 -60.16 1.14 Allowed 'Isoleucine or valine' 0 C--O 1.212 -0.893 0 C-N-CA 118.292 -1.363 . . . . 1.0 107.389 178.691 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 102' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -53.63 -25.39 17.55 Favored 'General case' 0 C--N 1.306 -1.299 0 CA-C-N 115.428 -0.806 . . . . 1.0 111.434 -176.78 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 51.1 ttm-85 -84.36 -52.05 6.49 Favored 'General case' 0 N--CA 1.488 1.471 0 CA-C-O 122.415 1.102 . . . . 1.0 113.337 -179.407 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 104' ' ' TYR . . . . . 0.671 ' CG ' ' O ' ' A' ' 104' ' ' TYR . 0.0 OUTLIER -96.33 21.79 8.61 Favored 'General case' 0 C--N 1.302 -1.488 0 C-N-CA 127.378 2.271 . . . . 1.0 106.819 177.874 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 105' ' ' GLY . . . . . 0.673 ' N ' ' O ' ' A' ' 101' ' ' VAL . . . -159.08 -97.88 0.13 Allowed Glycine 0 CA--C 1.53 0.99 0 N-CA-C 109.442 -1.463 . . . . 1.0 109.442 179.028 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . 60.64 114.38 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.253 0 N-CA-C 108.985 -0.746 . . . . 1.0 108.985 -176.254 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 107' ' ' THR . . . . . 0.745 ' O ' ' HD2' ' A' ' 110' ' ' PRO . 22.0 m -133.28 -61.61 0.82 Allowed 'General case' 0 C--O 1.194 -1.819 0 N-CA-C 106.789 -1.56 . . . . 1.0 106.789 177.78 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 32.7 m -71.5 30.66 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.318 -0.795 0 O-C-N 121.22 -0.925 . . . . 1.0 109.251 -178.239 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 109' ' ' ILE . . . . . 0.529 ' H ' ' CD ' ' A' ' 110' ' ' PRO . 0.1 OUTLIER -111.8 -40.46 0.1 Allowed Pre-proline 0 CA--C 1.56 1.346 0 CA-C-N 118.573 0.624 . . . . 1.0 110.882 177.969 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 110' ' ' PRO . . . . . 0.745 ' HD2' ' O ' ' A' ' 107' ' ' THR . 31.2 Cg_exo -65.33 -23.83 58.49 Favored 'Trans proline' 0 N--CA 1.496 1.62 0 C-N-CA 122.609 2.206 . . . . 1.0 111.82 179.72 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 111' ' ' ASN . . . . . 0.549 ' CG ' ' N ' ' A' ' 112' ' ' ILE . 0.0 OUTLIER -66.43 -66.77 0.51 Allowed 'General case' 0 CA--C 1.535 0.384 0 C-N-CA 119.51 -0.876 . . . . 1.0 109.132 -179.353 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 112' ' ' ILE . . . . . 0.549 ' N ' ' CG ' ' A' ' 111' ' ' ASN . 0.0 OUTLIER -52.43 -32.47 16.49 Favored 'Isoleucine or valine' 0 C--O 1.213 -0.821 0 CA-C-O 122.253 1.025 . . . . 1.0 109.139 178.783 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 8.4 m-20 -55.39 -55.29 33.28 Favored 'General case' 0 C--N 1.296 -1.722 0 CA-C-N 113.345 -1.752 . . . . 1.0 107.581 -179.105 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -60.51 -29.31 69.01 Favored 'General case' 0 N--CA 1.44 -0.958 0 C-N-CA 119.383 -0.927 . . . . 1.0 110.995 178.934 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -77.93 -59.56 2.73 Favored 'General case' 0 N--CA 1.451 -0.413 0 C-N-CA 119.558 -0.857 . . . . 1.0 110.031 178.949 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 116' ' ' ILE . . . . . 0.64 ' O ' ' N ' ' A' ' 120' ' ' GLY . 1.4 tp -50.8 -48.21 28.34 Favored 'Isoleucine or valine' 0 CA--C 1.498 -1.055 0 N-CA-C 108.859 -0.793 . . . . 1.0 108.859 -179.096 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 117' ' ' GLU . . . . . 0.53 ' N ' ' CG2' ' A' ' 116' ' ' ILE . 51.6 mt-10 -38.9 -58.53 1.08 Allowed 'General case' 0 C--N 1.317 -0.838 0 N-CA-C 104.707 -2.331 . . . . 1.0 104.707 179.424 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 99.4 t -58.62 -52.02 64.81 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.716 0 C-N-CA 119.608 -0.837 . . . . 1.0 109.076 176.951 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 119' ' ' LEU . . . . . 0.474 ' N ' ' O ' ' A' ' 116' ' ' ILE . 0.3 OUTLIER -56.34 -69.64 0.14 Allowed 'General case' 0 N--CA 1.47 0.561 0 C-N-CA 118.362 -1.335 . . . . 1.0 107.641 -178.594 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 120' ' ' GLY . . . . . 0.64 ' N ' ' O ' ' A' ' 116' ' ' ILE . . . -72.0 -85.11 0.2 Allowed Glycine 0 CA--C 1.55 2.223 0 C-N-CA 119.172 -1.489 . . . . 1.0 111.25 178.229 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 121' ' ' THR . . . . . 0.402 ' HA ' ' O ' ' A' ' 117' ' ' GLU . 1.5 t 160.96 -27.66 0.0 OUTLIER 'General case' 0 N--CA 1.486 1.375 0 CA-C-N 113.797 -1.202 . . . . 1.0 113.362 -178.715 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 122' ' ' GLY . . . . . 0.632 ' O ' ' N ' ' A' ' 124' ' ' ASP . . . 97.38 -21.74 44.54 Favored Glycine 0 N--CA 1.476 1.36 0 N-CA-C 107.884 -2.086 . . . . 1.0 107.884 -177.511 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 123' ' ' THR . . . . . 0.542 ' O ' ' NE2' ' A' ' 72' ' ' HIS . 7.6 m -47.7 89.41 0.0 OUTLIER 'General case' 0 N--CA 1.467 0.413 0 N-CA-C 105.21 -2.144 . . . . 1.0 105.21 177.603 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 124' ' ' ASP . . . . . 0.632 ' N ' ' O ' ' A' ' 122' ' ' GLY . 29.8 t70 -166.32 175.57 8.14 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 114.856 -1.065 . . . . 1.0 112.361 -179.505 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 125' ' ' TYR . . . . . 0.521 ' H ' ' CG ' ' A' ' 124' ' ' ASP . 56.2 t80 -146.71 145.32 29.95 Favored 'General case' 0 CA--C 1.533 0.298 0 CA-C-N 115.102 -0.954 . . . . 1.0 109.106 176.7 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 126' ' ' ARG . . . . . 0.567 HH22 ' CG2' ' A' ' 79' ' ' ILE . 0.8 OUTLIER -147.18 146.46 29.86 Favored 'General case' 0 C--N 1.327 -0.387 0 N-CA-C 108.701 -0.851 . . . . 1.0 108.701 178.91 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 127' ' ' PHE . . . . . . . . . . . . . 29.2 p90 . . . . . 0 N--CA 1.47 0.573 0 CA-C-O 117.899 -1.048 . . . . 1.0 110.297 179.737 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 128' ' ' MTN . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 129' ' ' MTN . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 130' ' ' MTN . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.622 ' N ' ' SD ' ' A' ' 1' ' ' MET . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.619 0 N-CA-C 108.998 -0.742 . . . . 1.0 108.998 . . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 2' ' ' SER . . . . . 0.466 ' O ' ' CB ' ' A' ' 3' ' ' ASP . 78.2 p -81.07 5.92 15.15 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.854 -0.612 . . . . 1.0 110.771 -179.805 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . 0.478 ' N ' ' OD1' ' A' ' 3' ' ' ASP . 5.1 p30 154.17 127.72 0.0 OUTLIER 'General case' 0 N--CA 1.472 0.629 0 O-C-N 123.669 0.606 . . . . 1.0 110.556 178.965 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 71.9 t80 -154.1 149.7 27.41 Favored 'General case' 0 N--CA 1.466 0.338 0 CA-C-O 120.789 0.328 . . . . 1.0 110.762 179.33 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 68.4 m-20 -152.92 147.96 26.58 Favored 'General case' 0 CA--C 1.535 0.389 0 N-CA-C 109.555 -0.535 . . . . 1.0 109.555 179.747 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 6' ' ' THR . . . . . 0.809 ' O ' ' N ' ' A' ' 10' ' ' SER . 0.2 OUTLIER -93.64 -177.61 4.44 Favored 'General case' 0 C--O 1.187 -2.225 0 CA-C-N 116.68 -0.236 . . . . 1.0 110.972 -179.485 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . 0.532 ' O ' ' N ' ' A' ' 11' ' ' ARG . 66.5 tt0 -59.93 -55.44 34.1 Favored 'General case' 0 N--CA 1.476 0.849 0 CA-C-O 121.518 0.675 . . . . 1.0 110.933 -179.274 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 8' ' ' ARG . . . . . 0.531 ' O ' ' CB ' ' A' ' 12' ' ' ALA . 0.6 OUTLIER -53.58 -58.98 5.22 Favored 'General case' 0 C--N 1.304 -1.409 0 N-CA-C 107.749 -1.204 . . . . 1.0 107.749 179.865 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . 0.552 ' O ' ' N ' ' A' ' 13' ' ' VAL . 0.0 OUTLIER -65.47 -49.32 78.96 Favored 'Isoleucine or valine' 0 CA--C 1.559 1.308 0 CA-C-N 114.575 -1.193 . . . . 1.0 110.978 179.816 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 10' ' ' SER . . . . . 0.809 ' N ' ' O ' ' A' ' 6' ' ' THR . 32.2 t -61.11 -57.94 10.42 Favored 'General case' 0 N--CA 1.492 1.668 0 CA-C-O 122.23 1.014 . . . . 1.0 108.315 179.057 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 11' ' ' ARG . . . . . 0.532 ' N ' ' O ' ' A' ' 7' ' ' GLU . 7.6 tpt180 -61.97 -40.79 96.8 Favored 'General case' 0 C--N 1.315 -0.92 0 CA-C-N 115.412 -0.813 . . . . 1.0 109.167 -177.578 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . 0.531 ' CB ' ' O ' ' A' ' 8' ' ' ARG . . . -68.05 -55.44 12.55 Favored 'General case' 0 N--CA 1.475 0.825 0 C-N-CA 119.193 -1.003 . . . . 1.0 108.557 176.164 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . 0.625 ' O ' ' CB ' ' A' ' 17' ' ' LEU . 4.5 m -63.28 -53.03 51.09 Favored 'Isoleucine or valine' 0 C--O 1.205 -1.246 0 C-N-CA 118.241 -1.384 . . . . 1.0 108.894 -178.957 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . 0.587 ' N ' ' O ' ' A' ' 10' ' ' SER . . . -60.8 -64.35 0.98 Allowed 'General case' 0 C--N 1.305 -1.347 0 C-N-CA 117.953 -1.499 . . . . 1.0 110.464 179.668 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . 0.515 ' O ' ' N ' ' A' ' 19' ' ' GLY . . . -56.52 -56.45 21.05 Favored 'General case' 0 N--CA 1.479 0.992 0 C-N-CA 119.522 -0.871 . . . . 1.0 111.375 -177.883 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . 0.509 ' CB ' ' O ' ' A' ' 12' ' ' ALA . . . -65.6 -56.42 12.31 Favored 'General case' 0 C--N 1.318 -0.791 0 C-N-CA 119.068 -1.053 . . . . 1.0 110.298 -178.596 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . 0.625 ' CB ' ' O ' ' A' ' 13' ' ' VAL . 5.2 tt -58.36 -54.94 41.39 Favored 'General case' 0 N--CA 1.485 1.293 0 C-N-CA 118.869 -1.132 . . . . 1.0 108.853 -178.289 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . 0.594 HG22 ' H ' ' A' ' 19' ' ' GLY . 1.3 m -71.88 -57.75 6.65 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.858 0 C-N-CA 119.112 -1.035 . . . . 1.0 110.851 -179.823 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . 0.594 ' H ' HG22 ' A' ' 18' ' ' VAL . . . -57.33 -175.22 0.34 Allowed Glycine 0 N--CA 1.444 -0.808 0 C-N-CA 121.23 -0.509 . . . . 1.0 112.076 -177.036 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 20' ' ' PRO . . . . . 0.641 ' O ' ' N ' ' A' ' 24' ' ' ALA . 4.1 Cg_endo -81.06 -27.03 3.16 Favored 'Trans proline' 0 C--N 1.307 -1.647 0 C-N-CA 122.749 2.3 . . . . 1.0 113.172 -178.433 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -63.05 -61.26 6.57 Favored Glycine 0 N--CA 1.474 1.17 0 C-N-CA 119.279 -1.439 . . . . 1.0 112.432 -176.33 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . 0.415 ' H ' ' HA ' ' A' ' 16' ' ' ALA . . . -53.08 -51.87 43.55 Favored Glycine 0 N--CA 1.472 1.087 0 N-CA-C 106.14 -2.784 . . . . 1.0 106.14 -177.697 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 40.5 t -61.61 -31.5 50.91 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.089 0 C-N-CA 119.42 -0.912 . . . . 1.0 109.811 178.517 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . 0.641 ' N ' ' O ' ' A' ' 20' ' ' PRO . . . -57.68 -62.49 1.76 Allowed 'General case' 0 C--N 1.353 0.756 0 C-N-CA 118.551 -1.26 . . . . 1.0 109.703 -179.501 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . 0.444 ' HG ' ' N ' ' A' ' 26' ' ' VAL . 0.5 OUTLIER -61.42 -44.72 96.64 Favored 'General case' 0 N--CA 1.464 0.251 0 C-N-CA 119.902 -0.719 . . . . 1.0 111.93 -178.237 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . 0.444 ' N ' ' HG ' ' A' ' 25' ' ' LEU . 31.6 t -58.98 -58.35 7.27 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.819 0 C-N-CA 119.455 -0.898 . . . . 1.0 110.278 -177.843 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . 0.402 ' O ' ' CB ' ' A' ' 31' ' ' ALA . 1.4 p -63.01 -36.67 76.78 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.716 0 C-N-CA 120.393 -0.523 . . . . 1.0 110.971 -177.999 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 2.0 tppp? -65.47 -57.81 7.37 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-O 121.756 0.788 . . . . 1.0 109.199 -179.237 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 79.3 t -63.56 -47.78 89.9 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.023 0 CA-C-N 114.622 -1.172 . . . . 1.0 110.208 -177.351 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 30' ' ' CYS . . . . . . . . . . . . . 51.4 t -65.56 -61.02 2.34 Favored 'General case' 0 N--CA 1.446 -0.64 0 C-N-CA 119.355 -0.938 . . . . 1.0 110.358 -179.397 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . 0.402 ' CB ' ' O ' ' A' ' 27' ' ' VAL . . . -59.71 -47.8 84.21 Favored 'General case' 0 CA--C 1.515 -0.378 0 O-C-N 122.083 -0.385 . . . . 1.0 111.158 -176.954 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . 0.483 ' O ' ' HB2' ' A' ' 33' ' ' LEU . . . 72.89 64.62 2.51 Favored Glycine 0 N--CA 1.449 -0.492 0 N-CA-C 108.788 -1.725 . . . . 1.0 108.788 -178.144 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . 0.483 ' HB2' ' O ' ' A' ' 32' ' ' GLY . 27.2 mt 83.77 129.88 0.03 OUTLIER Pre-proline 0 CA--C 1.544 0.739 0 O-C-N 125.295 1.233 . . . . 1.0 111.12 -178.465 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 58.7 Cg_endo -72.13 -5.26 16.76 Favored 'Trans proline' 0 N--CA 1.495 1.594 0 C-N-CA 122.788 2.325 . . . . 1.0 112.599 179.028 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -62.12 -62.16 5.94 Favored Glycine 0 C--N 1.336 0.568 0 C-N-CA 118.405 -1.855 . . . . 1.0 111.095 -178.565 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . 0.636 ' CG2' ' H ' ' A' ' 37' ' ' ILE . 8.7 p -87.26 -142.71 0.01 OUTLIER 'Isoleucine or valine' 0 C--O 1.216 -0.683 0 N-CA-C 107.552 -1.277 . . . . 1.0 107.552 178.793 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . 0.636 ' H ' ' CG2' ' A' ' 36' ' ' VAL . 0.3 OUTLIER 70.54 76.46 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.473 0.716 0 CA-C-O 122.344 1.069 . . . . 1.0 111.42 179.842 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 95.4 m-70 -139.75 133.2 30.12 Favored 'General case' 0 C--N 1.33 -0.269 0 O-C-N 120.989 -1.069 . . . . 1.0 109.18 179.311 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -108.57 124.79 33.39 Favored Pre-proline 0 CA--C 1.541 0.615 0 N-CA-C 109.67 -0.493 . . . . 1.0 109.67 179.789 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 52.0 Cg_exo -49.94 -23.08 8.39 Favored 'Trans proline' 0 N--CA 1.5 1.866 0 C-N-CA 121.796 1.664 . . . . 1.0 113.827 179.985 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -126.17 134.86 51.15 Favored 'General case' 0 N--CA 1.469 0.506 0 N-CA-C 111.311 0.115 . . . . 1.0 111.311 178.54 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . 0.704 ' C ' ' H ' ' A' ' 44' ' ' GLY . 19.3 ttp-105 -164.68 164.46 21.37 Favored 'General case' 0 C--N 1.328 -0.353 0 C-N-CA 120.197 -0.601 . . . . 1.0 109.787 177.172 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 43' ' ' ARG . . . . . 0.658 ' C ' ' H ' ' A' ' 45' ' ' PHE . 4.7 tpt180 -60.92 24.59 0.01 OUTLIER 'General case' 0 CA--C 1.545 0.75 0 CA-C-N 115.789 -0.642 . . . . 1.0 110.623 -178.864 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . 0.704 ' H ' ' C ' ' A' ' 42' ' ' ARG . . . 66.27 -32.12 0.16 Allowed Glycine 0 C--N 1.34 0.769 0 N-CA-C 110.65 -0.98 . . . . 1.0 110.65 179.456 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . 0.658 ' H ' ' C ' ' A' ' 43' ' ' ARG . 11.8 t80 -169.34 170.81 8.24 Favored 'General case' 0 N--CA 1.446 -0.642 0 N-CA-C 108.378 -0.971 . . . . 1.0 108.378 179.141 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 46' ' ' PHE . . . . . 0.587 ' HB2' ' O ' ' A' ' 45' ' ' PHE . 1.0 OUTLIER 120.8 106.64 0.0 OUTLIER 'General case' 0 N--CA 1.497 1.921 0 C-N-CA 127.333 2.253 . . . . 1.0 106.34 -179.346 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 47' ' ' ARG . . . . . 0.529 ' O ' ' S1 ' ' A' ' 129' ' ' MTN . 0.1 OUTLIER 103.24 149.84 0.01 OUTLIER 'General case' 0 N--CA 1.479 1.0 0 C-N-CA 124.827 1.251 . . . . 1.0 109.86 -178.602 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 48' ' ' CYS . . . . . 0.511 ' SG ' ' C ' ' A' ' 47' ' ' ARG . 0.0 OUTLIER 64.3 71.92 0.46 Allowed 'General case' 0 CA--C 1.534 0.361 0 CA-C-N 114.984 -1.007 . . . . 1.0 110.396 -178.892 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 49' ' ' ASN . . . . . 0.413 ' C ' ' H ' ' A' ' 51' ' ' GLU . 0.0 OUTLIER -140.85 163.53 42.13 Favored Pre-proline 0 C--N 1.33 -0.269 0 O-C-N 121.92 -0.487 . . . . 1.0 110.747 -179.22 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 38.4 Cg_endo -66.18 47.08 0.22 Allowed 'Trans proline' 0 N--CA 1.498 1.773 0 C-N-CA 123.107 2.538 . . . . 1.0 111.78 178.738 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . 0.531 ' OE1' ' NH2' ' A' ' 95' ' ' ARG . 7.6 mt-10 57.02 12.4 1.22 Allowed 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 115.37 -0.832 . . . . 1.0 111.393 179.593 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 24.9 ptt85 -85.87 147.31 26.33 Favored 'General case' 0 C--N 1.333 -0.119 0 N-CA-C 107.296 -1.372 . . . . 1.0 107.296 177.846 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 8.8 tp -49.46 138.4 4.89 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.496 0 CA-C-O 122.012 0.91 . . . . 1.0 113.033 -177.893 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 54' ' ' GLN . . . . . 0.478 ' CD ' ' H ' ' A' ' 54' ' ' GLN . 0.0 OUTLIER -76.17 79.51 2.98 Favored 'General case' 0 CA--C 1.534 0.351 0 CA-C-N 114.074 -1.421 . . . . 1.0 109.222 179.613 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 1.8 mt -147.38 157.12 9.88 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.75 0 CA-C-N 115.244 -0.889 . . . . 1.0 110.211 178.094 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 108.5 -0.24 32.67 Favored Glycine 0 C--N 1.338 0.691 0 N-CA-C 110.553 -1.019 . . . . 1.0 110.553 179.766 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . 0.424 ' OD1' ' O ' ' A' ' 57' ' ' ASP . 31.1 p-10 -80.27 101.74 9.08 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 121.584 0.707 . . . . 1.0 112.393 -178.816 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 58' ' ' TRP . . . . . . . . . . . . . 10.0 m0 -78.61 179.12 7.3 Favored 'General case' 0 C--N 1.323 -0.548 0 N-CA-C 108.028 -1.101 . . . . 1.0 108.028 178.34 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 59' ' ' ARG . . . . . 0.577 ' O ' ' CG2' ' A' ' 62' ' ' VAL . 1.0 OUTLIER -100.28 -49.12 4.36 Favored 'General case' 0 CA--C 1.546 0.81 0 CA-C-N 121.522 1.965 . . . . 1.0 111.613 178.535 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 60' ' ' TYR . . . . . 0.411 ' CD1' ' C ' ' A' ' 60' ' ' TYR . 3.7 p90 -85.98 -9.6 56.55 Favored 'General case' 0 N--CA 1.488 1.43 0 C-N-CA 124.997 1.319 . . . . 1.0 113.281 -177.98 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . 0.402 ' O ' ' N ' ' A' ' 65' ' ' ASP . 27.1 tt0 -75.32 -14.07 60.46 Favored 'General case' 0 C--N 1.308 -1.219 0 O-C-N 121.554 -0.716 . . . . 1.0 110.622 -178.952 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . 0.577 ' CG2' ' O ' ' A' ' 59' ' ' ARG . 0.0 OUTLIER -44.28 -50.34 1.92 Allowed 'Isoleucine or valine' 0 C--N 1.315 -0.901 0 N-CA-C 109.715 -0.476 . . . . 1.0 109.715 -175.69 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 63' ' ' ALA . . . . . 0.485 ' O ' ' HG2' ' A' ' 67' ' ' ARG . . . -67.6 -47.15 70.52 Favored 'General case' 0 N--CA 1.425 -1.683 0 N-CA-C 108.587 -0.894 . . . . 1.0 108.587 -179.878 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 64' ' ' HIS . . . . . 0.449 ' O ' ' CG ' ' A' ' 67' ' ' ARG . 0.5 OUTLIER -55.21 -59.22 5.07 Favored 'General case' 0 CA--C 1.547 0.841 0 CA-C-N 115.292 -0.867 . . . . 1.0 109.871 179.683 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . 0.639 ' C ' ' H ' ' A' ' 67' ' ' ARG . 29.6 t70 -67.08 -53.39 31.38 Favored 'General case' 0 C--O 1.243 0.739 0 CA-C-O 121.667 0.746 . . . . 1.0 109.27 178.438 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . 0.551 ' N ' ' O ' ' A' ' 62' ' ' VAL . . . -63.3 31.14 0.08 OUTLIER Glycine 0 CA--C 1.523 0.573 0 N-CA-C 111.477 -0.649 . . . . 1.0 111.477 178.263 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 67' ' ' ARG . . . . . 0.639 ' H ' ' C ' ' A' ' 65' ' ' ASP . 6.3 mmt180 -76.34 -2.59 32.47 Favored 'General case' 0 C--N 1.315 -0.901 0 N-CA-C 108.07 -1.085 . . . . 1.0 108.07 174.876 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . 0.483 ' C ' ' O ' ' A' ' 67' ' ' ARG . 5.8 tt -35.16 -30.35 0.01 OUTLIER 'General case' 0 N--CA 1.475 0.82 0 N-CA-C 108.63 -0.878 . . . . 1.0 108.63 -176.403 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . 0.57 ' N ' ' O ' ' A' ' 67' ' ' ARG . 9.9 mp -69.24 -68.57 0.39 Allowed 'General case' 0 CA--C 1.549 0.921 0 CA-C-N 115.09 -0.959 . . . . 1.0 111.063 179.686 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . 0.632 ' C ' ' H ' ' A' ' 72' ' ' HIS . . . -77.16 -76.85 0.16 Allowed 'General case' 0 N--CA 1.473 0.723 0 C-N-CA 119.016 -1.074 . . . . 1.0 109.457 -178.373 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . 0.549 ' O ' ' N ' ' A' ' 74' ' ' VAL . . . -57.31 10.48 0.01 OUTLIER 'General case' 0 C--N 1.324 -0.502 0 C-N-CA 124.652 1.181 . . . . 1.0 112.574 179.784 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 72' ' ' HIS . . . . . 0.861 ' CD2' ' H ' ' A' ' 73' ' ' MET . 1.3 p80 -19.84 -48.23 0.01 OUTLIER 'General case' 0 N--CA 1.465 0.323 0 N-CA-C 114.669 1.359 . . . . 1.0 114.669 -177.197 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 73' ' ' MET . . . . . 0.861 ' H ' ' CD2' ' A' ' 72' ' ' HIS . 15.4 ptp -74.87 -47.91 27.67 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 119.275 0.943 . . . . 1.0 109.353 179.058 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . 0.661 ' O ' ' N ' ' A' ' 76' ' ' GLY . 59.3 t -43.23 -48.46 1.41 Allowed 'Isoleucine or valine' 0 C--O 1.214 -0.79 0 CA-C-O 117.736 -1.126 . . . . 1.0 110.972 -175.389 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 75' ' ' ASN . . . . . 0.402 ' C ' ' O ' ' A' ' 74' ' ' VAL . 3.9 m120 -37.52 -19.66 0.01 OUTLIER 'General case' 0 N--CA 1.48 1.075 0 CA-C-O 122.714 1.245 . . . . 1.0 109.987 178.507 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . 0.661 ' N ' ' O ' ' A' ' 74' ' ' VAL . . . -50.99 -24.3 8.3 Favored Glycine 0 C--O 1.213 -1.177 0 N-CA-C 108.143 -1.983 . . . . 1.0 108.143 176.207 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 9.5 pt -45.64 -43.78 4.1 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.323 0 O-C-N 122.289 -0.536 . . . . 1.0 110.9 179.523 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 57.5 t -55.65 -22.04 11.5 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.343 0 CA-C-N 118.649 0.659 . . . . 1.0 111.05 -179.67 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . 0.41 HG12 ' O ' ' A' ' 76' ' ' GLY . 0.3 OUTLIER -88.03 -42.49 15.0 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.715 0 C-N-CA 119.32 -0.952 . . . . 1.0 110.058 178.556 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -78.93 -23.03 44.95 Favored 'General case' 0 CA--C 1.537 0.444 0 N-CA-C 112.262 0.467 . . . . 1.0 112.262 -178.892 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 94.8 mt-10 -91.11 -68.25 0.8 Allowed 'General case' 0 CA--C 1.533 0.289 0 N-CA-C 112.475 0.546 . . . . 1.0 112.475 178.718 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 82' ' ' ASP . . . . . 0.46 ' O ' ' C ' ' A' ' 83' ' ' ALA . 1.2 m-20 -74.76 -21.49 59.31 Favored 'General case' 0 C--N 1.349 0.555 0 N-CA-C 114.991 1.478 . . . . 1.0 114.991 -176.35 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . 0.505 ' O ' ' N ' ' A' ' 85' ' ' ILE . . . -37.38 -50.08 1.03 Allowed 'General case' 0 N--CA 1.483 1.187 0 CA-C-N 120.253 1.388 . . . . 1.0 111.355 178.743 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . 0.49 ' C ' ' O ' ' A' ' 83' ' ' ALA . 0.1 OUTLIER -26.88 -41.74 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.609 0 CA-C-O 120.62 0.248 . . . . 1.0 110.645 -175.327 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 85' ' ' ILE . . . . . 0.505 ' N ' ' O ' ' A' ' 83' ' ' ALA . 2.9 pt -98.63 -46.65 12.39 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 N-CA-C 109.468 -0.568 . . . . 1.0 109.468 177.605 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . 0.437 ' H ' HG13 ' A' ' 85' ' ' ILE . . . -49.54 -44.27 46.44 Favored 'General case' 0 N--CA 1.461 0.102 0 CA-C-N 115.931 -0.577 . . . . 1.0 110.14 -177.913 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 21.6 pt-20 -53.73 -21.9 8.1 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.929 0.395 . . . . 1.0 110.54 179.62 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -82.36 -13.84 56.23 Favored 'General case' 0 CA--C 1.517 -0.316 0 CA-C-O 121.289 0.566 . . . . 1.0 109.889 -179.476 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 89' ' ' VAL . . . . . 0.465 ' O ' ' ND1' ' A' ' 92' ' ' HIS . 18.5 t -93.06 34.74 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.553 0 CA-C-N 114.964 -1.016 . . . . 1.0 109.419 178.972 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 90' ' ' GLY . . . . . 0.534 ' O ' ' N ' ' A' ' 92' ' ' HIS . . . -74.66 -41.44 35.17 Favored Glycine 0 CA--C 1.539 1.555 0 N-CA-C 111.501 -0.64 . . . . 1.0 111.501 179.09 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 91' ' ' PRO . . . . . 0.48 ' CD ' ' N ' ' A' ' 90' ' ' GLY . 91.0 Cg_exo -41.35 -20.89 0.11 Allowed 'Trans proline' 0 N--CA 1.492 1.391 0 CA-C-N 119.354 1.577 . . . . 1.0 111.177 -179.795 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 92' ' ' HIS . . . . . 0.692 ' O ' ' N ' ' A' ' 96' ' ' ALA . 27.6 p-80 -53.73 -38.7 64.6 Favored 'General case' 0 C--O 1.196 -1.733 0 N-CA-C 106.489 -1.671 . . . . 1.0 106.489 -179.162 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . 0.508 ' CD1' ' N ' ' A' ' 94' ' ' ALA . 2.6 pp -46.17 -58.98 3.18 Favored 'General case' 0 C--N 1.319 -0.745 0 C-N-CA 120.183 -0.607 . . . . 1.0 110.428 -179.757 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 94' ' ' ALA . . . . . 0.508 ' N ' ' CD1' ' A' ' 93' ' ' LEU . . . -59.5 -56.79 17.59 Favored 'General case' 0 N--CA 1.465 0.275 0 CA-C-N 118.514 0.597 . . . . 1.0 109.692 -179.953 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 95' ' ' ARG . . . . . 0.668 ' O ' ' N ' ' A' ' 97' ' ' LEU . 5.8 mtp-105 -54.53 -58.61 6.82 Favored 'General case' 0 C--O 1.238 0.494 0 N-CA-C 107.789 -1.189 . . . . 1.0 107.789 178.347 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 96' ' ' ALA . . . . . 0.745 ' O ' ' N ' ' A' ' 98' ' ' GLY . . . -45.15 -12.99 0.02 OUTLIER 'General case' 0 C--N 1.294 -1.821 0 O-C-N 119.383 -2.073 . . . . 1.0 110.627 179.558 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . 0.668 ' N ' ' O ' ' A' ' 95' ' ' ARG . 0.8 OUTLIER 1.91 -54.71 0.0 OUTLIER 'General case' 0 N--CA 1.48 1.026 0 C-N-CA 124.407 1.083 . . . . 1.0 111.987 -169.958 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 98' ' ' GLY . . . . . 0.745 ' N ' ' O ' ' A' ' 96' ' ' ALA . . . -48.85 -23.05 3.25 Favored Glycine 0 CA--C 1.539 1.554 0 CA-C-N 122.233 2.288 . . . . 1.0 108.62 175.173 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 99' ' ' GLN . . . . . 0.627 ' N ' ' O ' ' A' ' 96' ' ' ALA . 1.2 mp0 -69.68 -24.14 63.55 Favored 'General case' 0 C--N 1.364 1.204 0 C-N-CA 118.338 -1.345 . . . . 1.0 107.776 178.47 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 100' ' ' ILE . . . . . 0.584 ' N ' ' O ' ' A' ' 97' ' ' LEU . 4.7 mm -65.23 -40.03 87.36 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.755 0 CA-C-N 115.026 -0.988 . . . . 1.0 108.762 177.945 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 101' ' ' VAL . . . . . 0.565 ' O ' ' N ' ' A' ' 105' ' ' GLY . 0.5 OUTLIER -58.52 -57.28 11.67 Favored 'Isoleucine or valine' 0 C--N 1.343 0.289 0 N-CA-C 107.407 -1.331 . . . . 1.0 107.407 179.669 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 102' ' ' CYS . . . . . 0.453 ' O ' ' CB ' ' A' ' 106' ' ' ALA . 0.7 OUTLIER -41.6 -17.61 0.01 OUTLIER 'General case' 0 CA--C 1.536 0.417 0 CA-C-O 120.763 0.316 . . . . 1.0 111.107 -179.537 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 103' ' ' ARG . . . . . 0.528 ' N ' ' O ' ' A' ' 101' ' ' VAL . 4.3 ttm180 -93.29 -35.01 13.3 Favored 'General case' 0 N--CA 1.478 0.954 0 CA-C-O 122.327 1.061 . . . . 1.0 111.523 177.71 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 104' ' ' TYR . . . . . 0.75 ' CG ' ' O ' ' A' ' 104' ' ' TYR . 1.2 t80 -106.44 19.08 21.04 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 112.722 -2.035 . . . . 1.0 109.746 177.817 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 105' ' ' GLY . . . . . 0.735 ' O ' ' N ' ' A' ' 107' ' ' THR . . . -165.76 -18.88 0.02 OUTLIER Glycine 0 C--O 1.223 -0.538 0 C-N-CA 117.461 -2.304 . . . . 1.0 113.035 179.263 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 106' ' ' ALA . . . . . 0.48 ' C ' ' O ' ' A' ' 105' ' ' GLY . . . -11.39 65.0 0.0 OUTLIER 'General case' 0 N--CA 1.477 0.915 0 O-C-N 124.778 0.928 . . . . 1.0 111.93 -179.55 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 107' ' ' THR . . . . . 0.735 ' N ' ' O ' ' A' ' 105' ' ' GLY . 99.4 m -98.42 -4.41 34.7 Favored 'General case' 0 CA--C 1.511 -0.55 0 O-C-N 121.678 -0.639 . . . . 1.0 109.347 -178.999 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . 0.462 ' C ' ' HD2' ' A' ' 110' ' ' PRO . 41.2 t -81.86 -54.05 10.67 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.494 0 CA-C-N 116.288 -0.414 . . . . 1.0 110.105 178.466 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 109' ' ' ILE . . . . . 0.507 ' O ' ' CB ' ' A' ' 113' ' ' ASN . 0.2 OUTLIER -47.49 -38.86 17.82 Favored Pre-proline 0 N--CA 1.473 0.699 0 N-CA-C 114.822 1.415 . . . . 1.0 114.822 -179.095 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 110' ' ' PRO . . . . . 0.482 ' CD ' ' N ' ' A' ' 109' ' ' ILE . 83.7 Cg_exo -47.02 -41.49 26.19 Favored 'Trans proline' 0 C--N 1.31 -1.48 0 C-N-CA 121.929 1.753 . . . . 1.0 112.623 -174.818 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 1.2 t-20 -63.49 -69.39 0.27 Allowed 'General case' 0 CA--C 1.536 0.421 0 C-N-CA 118.877 -1.129 . . . . 1.0 110.29 179.88 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 112' ' ' ILE . . . . . 0.465 ' O ' ' N ' ' A' ' 116' ' ' ILE . 0.1 OUTLIER -61.84 -44.74 99.28 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.539 0 CA-C-O 121.325 0.583 . . . . 1.0 110.543 -178.1 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 113' ' ' ASN . . . . . 0.507 ' CB ' ' O ' ' A' ' 109' ' ' ILE . 20.9 t30 -45.79 -62.17 1.42 Allowed 'General case' 0 C--N 1.309 -1.168 0 CA-C-N 115.3 -0.864 . . . . 1.0 111.511 -174.733 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -61.67 -24.59 66.85 Favored 'General case' 0 N--CA 1.433 -1.294 0 C-N-CA 118.873 -1.131 . . . . 1.0 110.703 179.586 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -82.32 -61.43 1.9 Allowed 'General case' 0 C--O 1.239 0.504 0 N-CA-C 113.95 1.093 . . . . 1.0 113.95 178.323 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 116' ' ' ILE . . . . . 0.589 ' O ' ' N ' ' A' ' 119' ' ' LEU . 47.0 mt -69.82 -49.03 60.71 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.678 0 O-C-N 120.501 -1.374 . . . . 1.0 111.596 -177.985 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 117' ' ' GLU . . . . . 0.479 ' OE1' ' OD1' ' A' ' 113' ' ' ASN . 18.5 tt0 -46.2 -61.58 1.71 Allowed 'General case' 0 C--N 1.312 -1.05 0 N-CA-C 108.393 -0.966 . . . . 1.0 108.393 -177.106 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 97.5 t -54.28 -16.02 1.31 Allowed 'Isoleucine or valine' 0 N--CA 1.44 -0.96 0 O-C-N 124.408 1.068 . . . . 1.0 109.317 178.453 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 119' ' ' LEU . . . . . 0.589 ' N ' ' O ' ' A' ' 116' ' ' ILE . 0.2 OUTLIER -80.01 -61.31 2.03 Favored 'General case' 0 C--N 1.349 0.551 0 C-N-CA 119.793 -0.763 . . . . 1.0 110.453 178.342 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 120' ' ' GLY . . . . . 0.458 ' C ' ' HG1' ' A' ' 121' ' ' THR . . . -66.62 -85.52 0.08 OUTLIER Glycine 0 C--N 1.361 1.96 0 C-N-CA 117.519 -2.277 . . . . 1.0 112.103 179.916 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 121' ' ' THR . . . . . 0.458 ' HG1' ' C ' ' A' ' 120' ' ' GLY . 0.2 OUTLIER -163.73 -27.18 0.04 OUTLIER 'General case' 0 N--CA 1.473 0.713 0 N-CA-C 107.422 -1.325 . . . . 1.0 107.422 -178.604 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 122' ' ' GLY . . . . . 0.554 ' O ' ' N ' ' A' ' 124' ' ' ASP . . . 116.76 -36.2 3.86 Favored Glycine 0 CA--C 1.531 1.033 0 CA-C-N 113.933 -1.485 . . . . 1.0 113.432 179.699 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 123' ' ' THR . . . . . 0.454 ' C ' ' O ' ' A' ' 122' ' ' GLY . 0.1 OUTLIER -32.78 89.64 0.0 OUTLIER 'General case' 0 N--CA 1.476 0.839 0 CA-C-N 120.578 2.189 . . . . 1.0 112.774 -178.652 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 124' ' ' ASP . . . . . 0.554 ' N ' ' O ' ' A' ' 122' ' ' GLY . 11.6 t0 -147.45 143.86 28.21 Favored 'General case' 0 CA--C 1.521 -0.162 0 N-CA-C 108.454 -0.943 . . . . 1.0 108.454 179.94 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 125' ' ' TYR . . . . . 0.471 ' O ' ' CD1' ' A' ' 125' ' ' TYR . 0.1 OUTLIER -150.79 148.43 28.5 Favored 'General case' 0 C--N 1.324 -0.526 0 N-CA-C 109.596 -0.52 . . . . 1.0 109.596 179.891 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 126' ' ' ARG . . . . . 0.423 ' CZ ' ' O ' ' A' ' 125' ' ' TYR . 10.8 mmp_? -145.74 148.4 32.95 Favored 'General case' 0 N--CA 1.471 0.623 0 N-CA-C 109.592 -0.521 . . . . 1.0 109.592 177.264 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 127' ' ' PHE . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 C--O 1.218 -0.575 0 CA-C-O 118.049 -0.977 . . . . 1.0 110.008 -179.9 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 128' ' ' MTN . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 129' ' ' MTN . . . . . 0.529 ' S1 ' ' O ' ' A' ' 47' ' ' ARG . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 130' ' ' MTN . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 60.1 mtt . . . . . 0 N--CA 1.491 1.584 0 N-CA-C 109.013 -0.736 . . . . 1.0 109.013 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 48.7 m -107.78 -0.97 21.33 Favored 'General case' 0 N--CA 1.466 0.351 0 CA-C-N 116.404 -0.362 . . . . 1.0 110.692 179.553 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . 0.526 ' N ' ' OD1' ' A' ' 3' ' ' ASP . 8.1 p-10 -178.83 92.66 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.478 -0.328 . . . . 1.0 110.854 -179.747 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 37.2 t80 -151.59 147.75 27.16 Favored 'General case' 0 CA--C 1.513 -0.444 0 CA-C-O 120.899 0.38 . . . . 1.0 110.112 179.358 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 5' ' ' ASP . . . . . 0.498 ' C ' ' OG ' ' A' ' 10' ' ' SER . 32.1 p30 -156.58 153.05 28.02 Favored 'General case' 0 N--CA 1.448 -0.538 0 CA-C-N 116.058 -0.519 . . . . 1.0 110.748 179.472 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 6' ' ' THR . . . . . 0.725 ' H ' ' CG2' ' A' ' 9' ' ' VAL . 0.2 OUTLIER -102.69 -170.2 1.77 Allowed 'General case' 0 C--O 1.199 -1.605 0 CA-C-O 121.661 0.743 . . . . 1.0 110.467 178.131 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . 0.433 ' O ' ' HB2' ' A' ' 11' ' ' ARG . 33.4 tt0 -56.25 -40.97 75.0 Favored 'General case' 0 C--N 1.304 -1.391 0 CA-C-O 121.653 0.74 . . . . 1.0 110.586 -179.555 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 8' ' ' ARG . . . . . 0.713 ' CG ' ' H ' ' A' ' 9' ' ' VAL . 0.9 OUTLIER -70.01 -62.78 1.25 Allowed 'General case' 0 C--N 1.31 -1.122 0 C-N-CA 118.654 -1.218 . . . . 1.0 111.252 179.548 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . 0.725 ' CG2' ' H ' ' A' ' 6' ' ' THR . 0.0 OUTLIER -62.7 -48.45 88.08 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.712 0 CA-C-N 114.113 -1.403 . . . . 1.0 108.229 179.144 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 10' ' ' SER . . . . . 0.669 ' N ' ' O ' ' A' ' 6' ' ' THR . 1.6 m -67.8 -68.35 0.39 Allowed 'General case' 0 C--O 1.189 -2.128 0 C-N-CA 118.3 -1.36 . . . . 1.0 112.915 179.857 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 11' ' ' ARG . . . . . 0.57 ' O ' ' N ' ' A' ' 15' ' ' ALA . 2.3 mmt85 -67.83 -49.93 59.46 Favored 'General case' 0 N--CA 1.48 1.072 0 N-CA-C 113.965 1.098 . . . . 1.0 113.965 -176.551 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . 0.464 ' O ' ' CB ' ' A' ' 16' ' ' ALA . . . -60.69 -58.74 7.16 Favored 'General case' 0 C--N 1.314 -0.956 0 C-N-CA 117.866 -1.534 . . . . 1.0 107.526 -178.873 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . 0.696 ' O ' ' N ' ' A' ' 17' ' ' LEU . 0.5 OUTLIER -60.0 -50.36 80.46 Favored 'Isoleucine or valine' 0 C--O 1.184 -2.393 0 N-CA-C 106.561 -1.644 . . . . 1.0 106.561 179.215 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . 0.632 ' CB ' ' O ' ' A' ' 10' ' ' SER . . . -58.76 -64.05 1.07 Allowed 'General case' 0 C--O 1.199 -1.599 0 C-N-CA 116.493 -2.083 . . . . 1.0 111.497 -179.101 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . 0.575 ' O ' ' N ' ' A' ' 19' ' ' GLY . . . -52.21 -55.04 23.69 Favored 'General case' 0 C--N 1.314 -0.949 0 N-CA-C 108.46 -0.941 . . . . 1.0 108.46 -178.622 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . 0.464 ' CB ' ' O ' ' A' ' 12' ' ' ALA . . . -64.36 -57.86 8.13 Favored 'General case' 0 C--N 1.304 -1.395 0 C-N-CA 118.886 -1.126 . . . . 1.0 111.042 -179.95 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . 0.696 ' N ' ' O ' ' A' ' 13' ' ' VAL . 19.1 tp -55.78 -55.27 34.4 Favored 'General case' 0 N--CA 1.49 1.569 0 N-CA-C 107.909 -1.145 . . . . 1.0 107.909 -177.768 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . 0.709 HG23 ' H ' ' A' ' 19' ' ' GLY . 1.5 m -71.29 -59.13 3.75 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.411 0 CA-C-N 116.045 -0.525 . . . . 1.0 110.471 179.925 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . 0.709 ' H ' HG23 ' A' ' 18' ' ' VAL . . . -56.67 -169.27 0.1 OUTLIER Glycine 0 N--CA 1.438 -1.187 0 N-CA-C 111.225 -0.75 . . . . 1.0 111.225 -177.655 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 20' ' ' PRO . . . . . 0.642 ' O ' ' N ' ' A' ' 24' ' ' ALA . 58.6 Cg_endo -85.32 -29.24 0.66 Allowed 'Trans proline' 0 C--N 1.29 -2.5 0 C-N-CA 122.456 2.104 . . . . 1.0 113.455 -177.564 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -60.42 -59.73 9.79 Favored Glycine 0 N--CA 1.471 0.993 0 C-N-CA 120.143 -1.027 . . . . 1.0 112.26 -177.747 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . 0.461 ' H ' ' HA ' ' A' ' 16' ' ' ALA . . . -56.51 -53.33 44.24 Favored Glycine 0 CA--C 1.497 -1.072 0 N-CA-C 106.53 -2.628 . . . . 1.0 106.53 -176.374 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 22.4 t -56.74 -31.22 34.62 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.242 0 N-CA-C 108.216 -1.031 . . . . 1.0 108.216 178.043 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . 0.642 ' N ' ' O ' ' A' ' 20' ' ' PRO . . . -59.18 -63.21 1.38 Allowed 'General case' 0 C--N 1.354 0.791 0 C-N-CA 118.712 -1.195 . . . . 1.0 110.331 -178.823 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 1.2 mt -62.27 -46.04 90.59 Favored 'General case' 0 C--N 1.325 -0.458 0 C-N-CA 120.335 -0.546 . . . . 1.0 111.333 -177.063 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 88.0 t -59.64 -58.94 4.87 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.669 0 C-N-CA 119.898 -0.721 . . . . 1.0 109.604 -177.78 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . 0.453 ' O ' ' CB ' ' A' ' 31' ' ' ALA . 1.5 p -60.62 -37.45 75.53 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.508 0 C-N-CA 120.076 -0.65 . . . . 1.0 110.245 -177.99 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 27.2 ttpp -65.29 -56.96 9.75 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 115.89 -0.595 . . . . 1.0 110.462 -179.018 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 84.1 t -63.27 -47.88 90.05 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.784 0 CA-C-N 114.936 -1.029 . . . . 1.0 109.692 -177.715 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 30' ' ' CYS . . . . . . . . . . . . . 36.8 t -65.01 -60.82 2.62 Favored 'General case' 0 N--CA 1.441 -0.884 0 C-N-CA 119.787 -0.765 . . . . 1.0 109.588 -178.82 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . 0.453 ' CB ' ' O ' ' A' ' 27' ' ' VAL . . . -57.8 -47.62 82.07 Favored 'General case' 0 CA--C 1.497 -1.091 0 CA-C-O 121.29 0.567 . . . . 1.0 109.769 -176.427 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . 0.454 ' O ' ' HB2' ' A' ' 33' ' ' LEU . . . 74.2 67.92 1.67 Allowed Glycine 0 N--CA 1.439 -1.131 0 N-CA-C 108.982 -1.647 . . . . 1.0 108.982 -178.525 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . 0.478 ' O ' ' O ' ' A' ' 36' ' ' VAL . 17.7 mt 97.41 78.52 0.02 OUTLIER Pre-proline 0 N--CA 1.47 0.54 0 C-N-CA 124.542 1.137 . . . . 1.0 110.645 -179.452 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 76.5 Cg_exo -45.93 -29.45 5.99 Favored 'Trans proline' 0 C--N 1.312 -1.386 0 C-N-CA 121.973 1.782 . . . . 1.0 112.672 179.793 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -60.38 -60.61 8.26 Favored Glycine 0 CA--C 1.536 1.37 0 C-N-CA 118.756 -1.687 . . . . 1.0 109.894 -178.375 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . 0.624 ' CG2' ' H ' ' A' ' 37' ' ' ILE . 8.5 p -98.81 177.87 0.66 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.68 0 N-CA-C 107.36 -1.348 . . . . 1.0 107.36 177.793 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . 0.624 ' H ' ' CG2' ' A' ' 36' ' ' VAL . 2.9 mm 101.15 120.34 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.479 1.01 0 O-C-N 124.818 1.323 . . . . 1.0 110.952 179.609 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 79.8 m80 -142.75 136.97 29.44 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 115.572 -0.74 . . . . 1.0 109.508 178.456 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 11.1 m -91.95 127.48 49.52 Favored Pre-proline 0 CA--C 1.537 0.474 0 N-CA-C 108.966 -0.753 . . . . 1.0 108.966 179.678 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 29.7 Cg_endo -62.94 -30.55 76.97 Favored 'Trans proline' 0 N--CA 1.498 1.745 0 C-N-CA 121.752 1.635 . . . . 1.0 113.368 -178.192 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -110.36 90.93 3.46 Favored 'General case' 0 CA--C 1.507 -0.696 0 CA-C-O 121.599 0.714 . . . . 1.0 112.664 -176.498 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 16.3 ptm180 -139.82 143.0 36.61 Favored 'General case' 0 C--N 1.318 -0.768 0 CA-C-N 114.552 -1.204 . . . . 1.0 108.479 178.927 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 76.5 ttt180 -50.91 -15.61 0.32 Allowed 'General case' 0 N--CA 1.451 -0.41 0 O-C-N 121.958 -0.464 . . . . 1.0 111.299 -176.003 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 119.11 -25.34 7.89 Favored Glycine 0 N--CA 1.468 0.792 0 N-CA-C 111.148 -0.781 . . . . 1.0 111.148 178.885 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . 0.565 ' O ' ' CD1' ' A' ' 46' ' ' PHE . 0.6 OUTLIER -156.84 161.53 39.72 Favored 'General case' 0 C--N 1.323 -0.557 0 N-CA-C 108.171 -1.048 . . . . 1.0 108.171 178.446 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 46' ' ' PHE . . . . . 0.834 ' O ' ' CD1' ' A' ' 46' ' ' PHE . 0.0 OUTLIER 115.66 120.46 0.0 OUTLIER 'General case' 0 N--CA 1.479 1.024 0 O-C-N 125.288 1.618 . . . . 1.0 112.433 179.342 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 47' ' ' ARG . . . . . 0.556 ' HB2' ' O ' ' A' ' 46' ' ' PHE . 5.9 mtm180 76.75 163.32 0.24 Allowed 'General case' 0 N--CA 1.479 1.023 0 O-C-N 119.266 -2.146 . . . . 1.0 110.727 -178.67 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 48' ' ' CYS . . . . . 0.441 ' C ' ' S1 ' ' A' ' 129' ' ' MTN . 4.1 t 61.35 70.03 0.63 Allowed 'General case' 0 C--O 1.232 0.147 0 N-CA-C 108.786 -0.82 . . . . 1.0 108.786 -178.196 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 49' ' ' ASN . . . . . 0.605 ' O ' ' N ' ' A' ' 51' ' ' GLU . 0.0 OUTLIER -146.1 163.95 27.75 Favored Pre-proline 0 CA--C 1.538 0.511 0 N-CA-C 109.519 -0.549 . . . . 1.0 109.519 -178.726 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . 0.512 ' O ' ' NE ' ' A' ' 52' ' ' ARG . 11.2 Cg_endo -54.41 58.48 0.03 OUTLIER 'Trans proline' 0 N--CA 1.514 2.68 0 C-N-CA 123.32 2.68 . . . . 1.0 112.057 179.611 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . 0.605 ' N ' ' O ' ' A' ' 49' ' ' ASN . 40.5 mt-10 55.02 37.39 28.84 Favored 'General case' 0 N--CA 1.475 0.797 0 O-C-N 121.192 -0.943 . . . . 1.0 112.678 176.956 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . 0.551 ' O ' ' ND2' ' A' ' 49' ' ' ASN . 0.0 OUTLIER -151.69 179.9 8.0 Favored 'General case' 0 N--CA 1.476 0.829 0 CA-C-O 121.71 0.767 . . . . 1.0 110.439 179.069 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . 0.419 HG13 ' H ' ' A' ' 54' ' ' GLN . 4.6 tp -82.25 168.72 1.74 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 114.869 -1.059 . . . . 1.0 108.993 177.78 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 54' ' ' GLN . . . . . 0.419 ' H ' HG13 ' A' ' 53' ' ' ILE . 1.1 tp60 -132.44 131.98 42.29 Favored 'General case' 0 CA--C 1.533 0.318 0 N-CA-C 108.793 -0.817 . . . . 1.0 108.793 178.624 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 20.4 tt -144.91 155.08 14.13 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.661 0 N-CA-C 110.334 -0.247 . . . . 1.0 110.334 178.563 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 101.38 1.57 53.74 Favored Glycine 0 C--N 1.341 0.842 0 N-CA-C 110.157 -1.177 . . . . 1.0 110.157 -179.827 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 9.4 t70 -93.2 115.55 28.16 Favored 'General case' 0 CA--C 1.539 0.521 0 CA-C-O 122.229 1.014 . . . . 1.0 113.035 -178.214 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 58' ' ' TRP . . . . . 0.502 ' HB2' ' HB2' ' A' ' 61' ' ' GLU . 37.7 m0 -82.92 -178.4 7.1 Favored 'General case' 0 C--N 1.318 -0.799 0 CA-C-N 112.673 -2.058 . . . . 1.0 109.411 177.682 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 59' ' ' ARG . . . . . 0.408 ' HG3' ' H ' ' A' ' 60' ' ' TYR . 13.7 ptt-85 -94.61 -55.39 3.16 Favored 'General case' 0 CA--C 1.543 0.701 0 CA-C-O 121.24 0.543 . . . . 1.0 111.333 179.412 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 60' ' ' TYR . . . . . 0.573 ' CG ' ' O ' ' A' ' 60' ' ' TYR . 17.3 t80 -76.68 -4.03 41.04 Favored 'General case' 0 N--CA 1.476 0.836 0 C-N-CA 124.327 1.051 . . . . 1.0 111.255 179.231 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . 0.502 ' HB2' ' HB2' ' A' ' 58' ' ' TRP . 31.8 tt0 -77.36 -17.33 58.33 Favored 'General case' 0 C--N 1.309 -1.16 0 O-C-N 121.447 -0.783 . . . . 1.0 111.089 -179.994 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . 0.439 ' O ' ' N ' ' A' ' 66' ' ' GLY . 91.0 t -46.08 -49.33 5.2 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.03 0 N-CA-C 109.043 -0.725 . . . . 1.0 109.043 -175.639 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 63' ' ' ALA . . . . . 0.505 ' O ' ' HG3' ' A' ' 67' ' ' ARG . . . -64.91 -49.33 70.86 Favored 'General case' 0 N--CA 1.419 -1.993 0 N-CA-C 108.624 -0.88 . . . . 1.0 108.624 177.358 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 4.3 t-80 -56.0 -61.65 2.24 Favored 'General case' 0 CA--C 1.547 0.85 0 CA-C-N 115.977 -0.556 . . . . 1.0 111.904 179.52 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . 0.628 ' C ' ' H ' ' A' ' 67' ' ' ARG . 13.7 t70 -66.79 -54.34 23.67 Favored 'General case' 0 C--O 1.246 0.918 0 O-C-N 121.226 -0.921 . . . . 1.0 110.31 178.507 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . 0.439 ' N ' ' O ' ' A' ' 62' ' ' VAL . . . -62.91 32.9 0.07 OUTLIER Glycine 0 CA--C 1.523 0.587 0 N-CA-C 111.52 -0.632 . . . . 1.0 111.52 178.825 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 67' ' ' ARG . . . . . 0.635 ' HB3' ' H ' ' A' ' 71' ' ' ALA . 50.5 mtt180 -77.03 4.16 10.71 Favored 'General case' 0 C--N 1.313 -0.986 0 C-N-CA 123.739 0.816 . . . . 1.0 110.352 175.641 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . 0.609 ' O ' ' HA ' ' A' ' 72' ' ' HIS . 0.8 OUTLIER -33.95 -31.1 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.651 0 N-CA-C 107.335 -1.357 . . . . 1.0 107.335 -179.267 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . 0.611 ' N ' ' O ' ' A' ' 67' ' ' ARG . 0.3 OUTLIER -63.48 -65.14 0.73 Allowed 'General case' 0 C--N 1.312 -1.064 0 C-N-CA 118.037 -1.465 . . . . 1.0 107.213 175.838 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . 0.692 ' C ' ' H ' ' A' ' 72' ' ' HIS . . . -76.64 -73.67 0.27 Allowed 'General case' 0 N--CA 1.474 0.749 0 N-CA-C 107.537 -1.283 . . . . 1.0 107.537 178.627 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . 0.635 ' H ' ' HB3' ' A' ' 67' ' ' ARG . . . -49.7 4.63 0.01 OUTLIER 'General case' 0 N--CA 1.476 0.835 0 C-N-CA 125.907 1.683 . . . . 1.0 112.07 178.475 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 72' ' ' HIS . . . . . 0.962 ' CD2' ' H ' ' A' ' 73' ' ' MET . 1.4 p80 -17.74 -62.56 0.02 OUTLIER 'General case' 0 CA--C 1.519 -0.225 0 O-C-N 123.755 0.66 . . . . 1.0 112.519 -175.899 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 73' ' ' MET . . . . . 0.962 ' H ' ' CD2' ' A' ' 72' ' ' HIS . 16.6 ptm -80.89 -45.63 16.5 Favored 'General case' 0 C--N 1.298 -1.644 0 CA-C-N 117.968 0.349 . . . . 1.0 110.56 177.41 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . 0.672 ' O ' ' N ' ' A' ' 76' ' ' GLY . 97.3 t -40.7 -43.41 0.63 Allowed 'Isoleucine or valine' 0 C--N 1.35 0.592 0 CA-C-O 118.687 -0.673 . . . . 1.0 110.076 -174.164 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 19.4 t-20 -36.75 -19.64 0.01 OUTLIER 'General case' 0 N--CA 1.477 0.882 0 CA-C-O 122.491 1.139 . . . . 1.0 110.533 179.107 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . 0.672 ' N ' ' O ' ' A' ' 74' ' ' VAL . . . -50.38 -21.02 4.06 Favored Glycine 0 C--O 1.205 -1.709 0 N-CA-C 108.991 -1.644 . . . . 1.0 108.991 174.321 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . 0.437 ' N ' ' O ' ' A' ' 74' ' ' VAL . 6.1 pt -54.49 -46.82 71.39 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.555 0 O-C-N 121.637 -0.92 . . . . 1.0 112.446 -176.934 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 3.7 t -59.29 -19.24 15.73 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.716 0 O-C-N 121.925 -0.484 . . . . 1.0 111.93 -178.406 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . 0.576 HG12 ' O ' ' A' ' 76' ' ' GLY . 0.3 OUTLIER -81.39 -46.06 20.46 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.702 0 C-N-CA 119.941 -0.704 . . . . 1.0 111.493 -179.748 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 80' ' ' ALA . . . . . 0.466 ' N ' ' CG1' ' A' ' 79' ' ' ILE . . . -84.17 -18.66 35.94 Favored 'General case' 0 N--CA 1.467 0.384 0 N-CA-C 112.791 0.663 . . . . 1.0 112.791 179.41 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 64.5 mt-10 -84.7 -71.85 0.5 Allowed 'General case' 0 C--O 1.231 0.124 0 N-CA-C 112.964 0.727 . . . . 1.0 112.964 -178.813 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 82' ' ' ASP . . . . . 0.432 ' O ' ' C ' ' A' ' 83' ' ' ALA . 93.4 m-20 -71.05 -18.08 62.58 Favored 'General case' 0 CA--C 1.515 -0.403 0 N-CA-C 111.612 0.227 . . . . 1.0 111.612 -177.669 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . 0.442 ' O ' ' C ' ' A' ' 84' ' ' LEU . . . -36.14 -50.81 0.73 Allowed 'General case' 0 N--CA 1.47 0.575 0 C-N-CA 120.612 -0.435 . . . . 1.0 110.907 177.898 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . 0.442 ' C ' ' O ' ' A' ' 83' ' ' ALA . 0.2 OUTLIER -28.79 -46.88 0.05 OUTLIER 'General case' 0 N--CA 1.48 1.054 0 CA-C-N 116.175 -0.466 . . . . 1.0 111.257 -173.825 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 73.8 mt -95.11 -54.67 6.89 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.704 0 N-CA-C 109.831 -0.433 . . . . 1.0 109.831 178.061 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -43.38 -39.98 3.45 Favored 'General case' 0 N--CA 1.465 0.298 0 CA-C-N 115.759 -0.655 . . . . 1.0 110.317 -178.83 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 79.7 tt0 -54.74 -29.74 54.41 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.785 -0.643 . . . . 1.0 110.65 -179.879 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -77.77 -12.46 59.98 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.632 -0.713 . . . . 1.0 109.377 -179.909 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 89' ' ' VAL . . . . . 0.4 ' C ' ' HD2' ' A' ' 91' ' ' PRO . 3.5 t -86.92 39.12 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.448 -0.553 0 N-CA-C 108.172 -1.047 . . . . 1.0 108.172 178.556 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 90' ' ' GLY . . . . . 0.859 ' O ' ' N ' ' A' ' 92' ' ' HIS . . . -55.69 -24.63 40.96 Favored Glycine 0 C--N 1.362 1.997 0 CA-C-O 117.294 -1.837 . . . . 1.0 111.156 176.934 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 91' ' ' PRO . . . . . 0.633 ' HD2' ' N ' ' A' ' 90' ' ' GLY . 26.0 Cg_exo -32.27 -3.74 0.0 OUTLIER 'Trans proline' 0 N--CA 1.507 2.299 0 C-N-CA 123.828 3.018 . . . . 1.0 113.495 173.365 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 92' ' ' HIS . . . . . 0.859 ' N ' ' O ' ' A' ' 90' ' ' GLY . 20.6 t60 -50.95 -30.83 15.98 Favored 'General case' 0 N--CA 1.443 -0.791 0 N-CA-C 107.098 -1.445 . . . . 1.0 107.098 177.34 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . 0.634 ' O ' ' N ' ' A' ' 96' ' ' ALA . 0.4 OUTLIER -59.42 -58.37 8.91 Favored 'General case' 0 C--O 1.214 -0.809 0 CA-C-N 119.064 0.847 . . . . 1.0 109.27 176.808 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 94' ' ' ALA . . . . . 0.533 ' H ' ' HG ' ' A' ' 93' ' ' LEU . . . -48.28 -53.3 17.7 Favored 'General case' 0 C--O 1.221 -0.406 0 N-CA-C 106.56 -1.644 . . . . 1.0 106.56 -178.712 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 95' ' ' ARG . . . . . 0.503 HH21 ' HB3' ' A' ' 91' ' ' PRO . 0.0 OUTLIER -59.5 -26.5 65.34 Favored 'General case' 0 C--N 1.305 -1.339 0 N-CA-C 108.699 -0.852 . . . . 1.0 108.699 176.328 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 96' ' ' ALA . . . . . 0.84 ' O ' ' N ' ' A' ' 100' ' ' ILE . . . -59.31 -52.55 65.16 Favored 'General case' 0 C--O 1.202 -1.43 0 N-CA-C 106.735 -1.58 . . . . 1.0 106.735 179.624 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . 0.51 ' C ' ' O ' ' A' ' 96' ' ' ALA . 1.5 mt -38.3 -32.11 0.06 Allowed 'General case' 0 CA--C 1.576 1.976 0 N-CA-C 107.401 -1.333 . . . . 1.0 107.401 -179.439 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 98' ' ' GLY . . . . . 0.479 ' N ' ' O ' ' A' ' 96' ' ' ALA . . . -82.09 -52.14 4.17 Favored Glycine 0 CA--C 1.551 2.332 0 CA-C-O 123.422 1.568 . . . . 1.0 111.356 173.897 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 99' ' ' GLN . . . . . 0.435 ' N ' ' O ' ' A' ' 96' ' ' ALA . 76.1 mm-40 -78.39 9.63 3.76 Favored 'General case' 0 N--CA 1.434 -1.235 0 N-CA-C 108.185 -1.042 . . . . 1.0 108.185 178.794 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 100' ' ' ILE . . . . . 0.84 ' N ' ' O ' ' A' ' 96' ' ' ALA . 1.1 tt -59.49 -51.46 72.39 Favored 'Isoleucine or valine' 0 CA--C 1.477 -1.85 0 N-CA-C 108.015 -1.106 . . . . 1.0 108.015 179.917 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 101' ' ' VAL . . . . . 0.602 ' O ' ' N ' ' A' ' 105' ' ' GLY . 70.6 t -57.2 -57.23 10.84 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.768 0 C-N-CA 116.666 -2.014 . . . . 1.0 106.627 178.307 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 102' ' ' CYS . . . . . 0.467 ' O ' ' CB ' ' A' ' 106' ' ' ALA . 1.9 t -45.13 -23.09 0.13 Allowed 'General case' 0 C--O 1.218 -0.584 0 C-N-CA 119.559 -0.857 . . . . 1.0 110.809 -177.573 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 103' ' ' ARG . . . . . 0.409 ' HG3' HH11 ' A' ' 103' ' ' ARG . 0.0 OUTLIER -91.29 -43.19 9.95 Favored 'General case' 0 CA--C 1.541 0.627 0 CA-C-O 122.095 0.95 . . . . 1.0 113.147 179.302 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 104' ' ' TYR . . . . . 0.746 ' CG ' ' O ' ' A' ' 104' ' ' TYR . 0.2 OUTLIER -102.88 21.55 15.41 Favored 'General case' 0 C--N 1.31 -1.146 0 CA-C-N 113.292 -1.776 . . . . 1.0 109.886 179.813 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 105' ' ' GLY . . . . . 0.766 ' O ' ' N ' ' A' ' 107' ' ' THR . . . -166.01 -14.52 0.02 OUTLIER Glycine 0 C--O 1.215 -1.093 0 C-N-CA 118.381 -1.866 . . . . 1.0 111.39 178.193 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 106' ' ' ALA . . . . . 0.482 ' C ' ' O ' ' A' ' 105' ' ' GLY . . . -13.87 65.86 0.0 OUTLIER 'General case' 0 N--CA 1.478 0.933 0 O-C-N 124.742 0.907 . . . . 1.0 112.002 -179.876 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 107' ' ' THR . . . . . 0.766 ' N ' ' O ' ' A' ' 105' ' ' GLY . 99.5 m -101.25 -4.37 27.25 Favored 'General case' 0 N--CA 1.452 -0.348 0 CA-C-N 115.869 -0.605 . . . . 1.0 110.048 -179.419 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . 0.496 ' CG2' ' N ' ' A' ' 109' ' ' ILE . 33.3 m -85.19 -58.22 3.68 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.466 0 N-CA-C 111.647 0.24 . . . . 1.0 111.647 -178.579 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 109' ' ' ILE . . . . . 0.564 ' N ' ' HD2' ' A' ' 110' ' ' PRO . 0.3 OUTLIER -47.79 -43.37 52.08 Favored Pre-proline 0 C--N 1.353 0.754 0 N-CA-C 112.709 0.633 . . . . 1.0 112.709 179.244 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 110' ' ' PRO . . . . . 0.564 ' HD2' ' N ' ' A' ' 109' ' ' ILE . 7.9 Cg_endo -40.51 -38.32 2.43 Favored 'Trans proline' 0 N--CA 1.482 0.81 0 C-N-CA 121.154 1.236 . . . . 1.0 113.126 -175.4 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 16.8 t-20 -64.56 -68.26 0.37 Allowed 'General case' 0 C--N 1.315 -0.906 0 C-N-CA 118.601 -1.24 . . . . 1.0 110.726 -178.344 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 112' ' ' ILE . . . . . 0.404 ' H ' HG23 ' A' ' 112' ' ' ILE . 2.0 pt -67.59 -27.8 39.63 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.54 0 CA-C-O 121.841 0.829 . . . . 1.0 111.547 -178.004 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 113' ' ' ASN . . . . . 0.59 HD21 ' N ' ' A' ' 114' ' ' ALA . 0.3 OUTLIER -54.98 -61.51 2.26 Favored 'General case' 0 C--N 1.306 -1.304 0 CA-C-N 114.075 -1.42 . . . . 1.0 109.837 -175.281 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 114' ' ' ALA . . . . . 0.59 ' N ' HD21 ' A' ' 113' ' ' ASN . . . -61.81 -22.55 65.56 Favored 'General case' 0 C--N 1.306 -1.301 0 CA-C-N 116.063 -0.517 . . . . 1.0 110.709 -179.979 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -78.48 -60.74 2.25 Favored 'General case' 0 N--CA 1.448 -0.532 0 N-CA-C 112.715 0.635 . . . . 1.0 112.715 178.278 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 116' ' ' ILE . . . . . 0.476 ' O ' ' CB ' ' A' ' 119' ' ' LEU . 95.3 mt -69.4 -46.21 77.03 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.323 0 O-C-N 120.477 -1.39 . . . . 1.0 112.359 -177.094 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 117' ' ' GLU . . . . . 0.462 ' OE1' ' ND2' ' A' ' 113' ' ' ASN . 94.9 mt-10 -47.59 -64.37 0.8 Allowed 'General case' 0 C--N 1.316 -0.856 0 CA-C-N 115.538 -0.755 . . . . 1.0 110.109 -176.994 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 4.1 p -51.71 -15.14 0.48 Allowed 'Isoleucine or valine' 0 N--CA 1.437 -1.107 0 CA-C-N 115.4 -0.818 . . . . 1.0 109.251 -179.662 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 119' ' ' LEU . . . . . 0.476 ' CB ' ' O ' ' A' ' 116' ' ' ILE . 1.6 tt -77.13 -61.07 2.11 Favored 'General case' 0 C--N 1.348 0.508 0 C-N-CA 119.116 -1.033 . . . . 1.0 109.328 177.949 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -70.39 -81.21 0.26 Allowed Glycine 0 C--N 1.355 1.618 0 C-N-CA 117.259 -2.4 . . . . 1.0 111.076 179.55 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 45.2 m -160.41 -17.82 0.06 Allowed 'General case' 0 CA--C 1.54 0.592 0 CA-C-O 121.414 0.626 . . . . 1.0 109.97 -179.595 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 122' ' ' GLY . . . . . 0.441 ' O ' ' C ' ' A' ' 123' ' ' THR . . . 109.88 -36.8 4.09 Favored Glycine 0 N--CA 1.476 1.327 0 C-N-CA 125.215 1.388 . . . . 1.0 111.888 179.96 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 123' ' ' THR . . . . . 0.441 ' C ' ' O ' ' A' ' 122' ' ' GLY . 4.2 t -31.17 94.98 0.01 OUTLIER 'General case' 0 N--CA 1.473 0.676 0 CA-C-N 118.47 1.135 . . . . 1.0 112.675 -178.708 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 124' ' ' ASP . . . . . 0.407 ' N ' ' O ' ' A' ' 122' ' ' GLY . 73.1 m-20 -143.67 144.58 31.93 Favored 'General case' 0 C--N 1.33 -0.275 0 N-CA-C 108.56 -0.904 . . . . 1.0 108.56 178.571 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 125' ' ' TYR . . . . . 0.433 ' O ' ' NE ' ' A' ' 126' ' ' ARG . 0.0 OUTLIER -151.74 148.96 28.52 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.763 0.316 . . . . 1.0 110.305 -178.525 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 126' ' ' ARG . . . . . 0.433 ' NE ' ' O ' ' A' ' 125' ' ' TYR . 0.0 OUTLIER -149.85 151.78 34.05 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.167 -0.47 . . . . 1.0 110.006 177.928 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 127' ' ' PHE . . . . . 0.548 ' O ' ' CD2' ' A' ' 92' ' ' HIS . 0.1 OUTLIER . . . . . 0 C--O 1.22 -0.481 0 CA-C-O 117.873 -1.06 . . . . 1.0 110.398 -178.57 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 128' ' ' MTN . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 129' ' ' MTN . . . . . 0.441 ' S1 ' ' C ' ' A' ' 48' ' ' CYS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 130' ' ' MTN . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 2.2 mpt? . . . . . 0 N--CA 1.491 1.612 0 N-CA-C 109.139 -0.689 . . . . 1.0 109.139 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 51.9 m -95.64 1.72 53.75 Favored 'General case' 0 N--CA 1.463 0.187 0 CA-C-N 116.449 -0.341 . . . . 1.0 110.913 -179.825 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER 169.56 106.68 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.361 -0.381 . . . . 1.0 110.274 -179.94 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 18.2 t80 -149.21 145.53 27.17 Favored 'General case' 0 C--N 1.33 -0.254 0 N-CA-C 109.723 -0.473 . . . . 1.0 109.723 178.896 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 14.4 m-20 -152.82 147.71 26.34 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.359 -0.382 . . . . 1.0 110.117 -179.025 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 6' ' ' THR . . . . . 0.657 ' O ' ' N ' ' A' ' 10' ' ' SER . 0.2 OUTLIER -103.88 -165.97 1.21 Allowed 'General case' 0 C--O 1.206 -1.191 0 CA-C-O 121.51 0.671 . . . . 1.0 109.386 178.931 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . 0.679 ' O ' ' HB2' ' A' ' 11' ' ' ARG . 27.5 tt0 -58.92 -45.31 90.67 Favored 'General case' 0 C--N 1.304 -1.371 0 CA-C-O 121.891 0.853 . . . . 1.0 110.548 -179.801 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 8' ' ' ARG . . . . . 0.531 ' O ' ' CB ' ' A' ' 12' ' ' ALA . 0.1 OUTLIER -67.9 -60.13 2.75 Favored 'General case' 0 C--N 1.306 -1.301 0 C-N-CA 118.953 -1.099 . . . . 1.0 109.482 179.065 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . 0.6 HG22 ' H ' ' A' ' 6' ' ' THR . 0.0 OUTLIER -66.32 -50.69 65.9 Favored 'Isoleucine or valine' 0 C--O 1.201 -1.449 0 CA-C-N 115.107 -0.951 . . . . 1.0 110.686 -178.777 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 10' ' ' SER . . . . . 0.657 ' N ' ' O ' ' A' ' 6' ' ' THR . 2.5 t -65.69 -62.23 1.63 Allowed 'General case' 0 N--CA 1.488 1.447 0 C-N-CA 120.025 -0.67 . . . . 1.0 111.176 179.185 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 11' ' ' ARG . . . . . 0.679 ' HB2' ' O ' ' A' ' 7' ' ' GLU . 4.6 mmt85 -64.87 -41.18 95.88 Favored 'General case' 0 CA--C 1.547 0.861 0 CA-C-O 119.302 -0.38 . . . . 1.0 111.792 -177.213 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . 0.531 ' CB ' ' O ' ' A' ' 8' ' ' ARG . . . -69.61 -54.17 15.28 Favored 'General case' 0 N--CA 1.483 1.19 0 C-N-CA 118.165 -1.414 . . . . 1.0 108.125 175.84 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . 0.643 ' O ' ' CB ' ' A' ' 17' ' ' LEU . 60.3 t -61.67 -55.02 27.07 Favored 'Isoleucine or valine' 0 C--O 1.198 -1.647 0 C-N-CA 117.423 -1.711 . . . . 1.0 108.438 -179.033 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . 0.6 ' O ' HG22 ' A' ' 18' ' ' VAL . . . -57.1 -62.27 1.87 Allowed 'General case' 0 C--O 1.211 -0.925 0 C-N-CA 118.542 -1.263 . . . . 1.0 109.95 179.653 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . 0.489 ' O ' ' N ' ' A' ' 19' ' ' GLY . . . -55.34 -55.66 28.94 Favored 'General case' 0 N--CA 1.475 0.805 0 C-N-CA 118.807 -1.157 . . . . 1.0 110.517 -176.952 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . 0.549 ' HA ' ' H ' ' A' ' 22' ' ' GLY . . . -65.66 -55.98 14.58 Favored 'General case' 0 CA--C 1.547 0.847 0 C-N-CA 119.761 -0.776 . . . . 1.0 110.033 -178.889 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . 0.643 ' CB ' ' O ' ' A' ' 13' ' ' VAL . 7.3 tp -56.8 -57.58 11.83 Favored 'General case' 0 N--CA 1.483 1.186 0 CA-C-N 115.397 -0.819 . . . . 1.0 108.827 -178.965 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . 0.6 HG22 ' O ' ' A' ' 14' ' ' ALA . 1.3 m -71.82 -58.22 5.61 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.423 0 C-N-CA 119.282 -0.967 . . . . 1.0 110.772 -179.536 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . 0.556 ' H ' HG22 ' A' ' 18' ' ' VAL . . . -56.34 -172.94 0.16 Allowed Glycine 0 CA--C 1.519 0.341 0 C-N-CA 120.924 -0.655 . . . . 1.0 112.109 -177.768 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 20' ' ' PRO . . . . . 0.605 ' O ' ' N ' ' A' ' 24' ' ' ALA . 1.7 Cg_endo -81.05 -21.96 6.36 Favored 'Trans proline' 0 C--N 1.308 -1.581 0 C-N-CA 123.122 2.548 . . . . 1.0 112.501 -178.841 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -63.35 -62.03 5.76 Favored Glycine 0 N--CA 1.478 1.437 0 C-N-CA 119.687 -1.245 . . . . 1.0 112.906 -176.492 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . 0.549 ' H ' ' HA ' ' A' ' 16' ' ' ALA . . . -55.44 -52.03 50.56 Favored Glycine 0 N--CA 1.472 1.048 0 N-CA-C 106.277 -2.729 . . . . 1.0 106.277 -179.255 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 26.7 t -58.23 -31.81 43.12 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.731 0 C-N-CA 119.455 -0.898 . . . . 1.0 108.966 178.326 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . 0.605 ' N ' ' O ' ' A' ' 20' ' ' PRO . . . -60.2 -61.97 2.21 Favored 'General case' 0 N--CA 1.481 1.09 0 C-N-CA 118.616 -1.233 . . . . 1.0 109.677 178.614 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -60.33 -50.35 73.98 Favored 'General case' 0 N--CA 1.478 0.938 0 N-CA-C 112.633 0.605 . . . . 1.0 112.633 -178.482 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 86.0 t -57.89 -59.44 3.42 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.021 0 C-N-CA 118.986 -1.086 . . . . 1.0 110.612 -177.204 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . 0.415 ' O ' ' CB ' ' A' ' 31' ' ' ALA . 1.2 p -58.41 -36.54 59.18 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.687 0 C-N-CA 120.672 -0.411 . . . . 1.0 111.16 -178.089 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 20.9 tttt -65.84 -56.57 11.2 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-O 121.463 0.649 . . . . 1.0 109.884 -179.706 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 25.1 t -63.51 -49.27 83.3 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.54 0 CA-C-N 115.292 -0.867 . . . . 1.0 111.088 -177.776 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 30' ' ' CYS . . . . . . . . . . . . . 14.0 t -63.54 -61.61 2.21 Favored 'General case' 0 C--N 1.316 -0.849 0 C-N-CA 118.901 -1.12 . . . . 1.0 109.43 -179.396 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . 0.415 ' CB ' ' O ' ' A' ' 27' ' ' VAL . . . -58.44 -50.89 72.07 Favored 'General case' 0 C--N 1.319 -0.718 0 C-N-CA 120.553 -0.459 . . . . 1.0 110.847 -178.416 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . 0.527 ' O ' ' CB ' ' A' ' 33' ' ' LEU . . . 74.51 67.85 1.67 Allowed Glycine 0 CA--C 1.518 0.238 0 N-CA-C 108.158 -1.977 . . . . 1.0 108.158 -178.383 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . 0.527 ' CB ' ' O ' ' A' ' 32' ' ' GLY . 13.5 tp 94.34 81.31 0.03 OUTLIER Pre-proline 0 CA--C 1.54 0.588 0 CA-C-N 114.457 -0.871 . . . . 1.0 109.663 -177.719 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 13.0 Cg_endo -54.53 -23.08 30.35 Favored 'Trans proline' 0 N--CA 1.502 2.027 0 C-N-CA 121.637 1.558 . . . . 1.0 113.952 -179.276 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . 0.452 ' O ' ' CD1' ' A' ' 112' ' ' ILE . . . -62.56 -61.61 6.37 Favored Glycine 0 CA--C 1.536 1.356 0 C-N-CA 117.873 -2.108 . . . . 1.0 109.863 -178.403 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . 0.5 ' O ' ' CB ' ' A' ' 37' ' ' ILE . 2.6 m -95.57 178.39 0.59 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.519 0 N-CA-C 107.965 -1.124 . . . . 1.0 107.965 176.579 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . 0.5 ' CB ' ' O ' ' A' ' 36' ' ' VAL . 0.1 OUTLIER 102.56 121.94 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.479 0.989 0 O-C-N 124.297 0.998 . . . . 1.0 112.036 179.601 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 81.3 m-70 -143.2 135.29 26.98 Favored 'General case' 0 N--CA 1.463 0.198 0 N-CA-C 109.073 -0.714 . . . . 1.0 109.073 178.445 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 39' ' ' THR . . . . . 0.403 ' O ' ' CG ' ' A' ' 42' ' ' ARG . 0.0 OUTLIER -90.62 115.83 65.05 Favored Pre-proline 0 CA--C 1.546 0.804 0 N-CA-C 109.329 -0.619 . . . . 1.0 109.329 179.774 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 50.2 Cg_exo -49.01 -32.63 23.97 Favored 'Trans proline' 0 N--CA 1.496 1.619 0 C-N-CA 121.678 1.585 . . . . 1.0 113.569 -179.053 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -111.34 93.67 4.59 Favored 'General case' 0 CA--C 1.513 -0.459 0 N-CA-C 114.051 1.13 . . . . 1.0 114.051 -175.12 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . 0.42 ' C ' ' N ' ' A' ' 44' ' ' GLY . 0.2 OUTLIER -141.6 143.06 33.49 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 114.589 -1.187 . . . . 1.0 108.271 178.806 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 43' ' ' ARG . . . . . 0.417 HH22 ' HB3' ' A' ' 59' ' ' ARG . 14.9 tpt85 -50.49 -13.35 0.12 Allowed 'General case' 0 C--N 1.322 -0.6 0 C-N-CA 120.447 -0.501 . . . . 1.0 110.806 -177.164 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . 0.42 ' N ' ' C ' ' A' ' 42' ' ' ARG . . . 121.08 -23.52 7.68 Favored Glycine 0 N--CA 1.472 1.095 0 N-CA-C 110.346 -1.102 . . . . 1.0 110.346 179.823 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . 0.541 ' O ' ' CB ' ' A' ' 46' ' ' PHE . 36.0 p90 -152.25 159.6 43.51 Favored 'General case' 0 C--N 1.327 -0.391 0 N-CA-C 108.601 -0.889 . . . . 1.0 108.601 177.618 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 46' ' ' PHE . . . . . 0.541 ' CB ' ' O ' ' A' ' 45' ' ' PHE . 4.7 t80 117.24 103.11 0.0 OUTLIER 'General case' 0 N--CA 1.487 1.41 0 O-C-N 124.61 1.194 . . . . 1.0 110.274 -179.954 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 47' ' ' ARG . . . . . 0.491 ' CB ' ' O ' ' A' ' 46' ' ' PHE . 6.5 ptp180 120.5 135.68 0.0 OUTLIER 'General case' 0 N--CA 1.488 1.453 0 C-N-CA 124.886 1.274 . . . . 1.0 110.557 179.609 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 48' ' ' CYS . . . . . 0.445 ' O ' ' H63' ' A' ' 129' ' ' MTN . 2.6 t 67.61 73.68 0.32 Allowed 'General case' 0 C--O 1.218 -0.588 0 C-N-CA 119.718 -0.793 . . . . 1.0 110.229 177.939 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 49' ' ' ASN . . . . . 0.659 ' H ' HD21 ' A' ' 49' ' ' ASN . 0.0 OUTLIER -135.82 153.56 77.29 Favored Pre-proline 0 N--CA 1.47 0.542 0 CA-C-O 119.427 -0.321 . . . . 1.0 110.173 -178.634 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . 0.462 ' C ' ' H ' ' A' ' 52' ' ' ARG . 33.7 Cg_endo -60.31 47.84 0.07 OUTLIER 'Trans proline' 0 N--CA 1.509 2.431 0 C-N-CA 122.763 2.308 . . . . 1.0 113.278 179.503 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . 0.491 ' N ' ' O ' ' A' ' 49' ' ' ASN . 15.8 mp0 70.77 -18.5 0.25 Allowed 'General case' 0 N--CA 1.47 0.561 0 C-N-CA 123.571 0.748 . . . . 1.0 111.486 179.697 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . 0.462 ' H ' ' C ' ' A' ' 50' ' ' PRO . 1.6 mpp_? -56.92 138.78 53.44 Favored 'General case' 0 CA--C 1.531 0.242 0 N-CA-C 109.436 -0.579 . . . . 1.0 109.436 179.445 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . 0.6 ' O ' ' N ' ' A' ' 55' ' ' ILE . 2.6 tp -58.91 129.83 21.54 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-N 115.551 -0.75 . . . . 1.0 110.917 -179.188 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 54' ' ' GLN . . . . . 0.511 ' NE2' ' OD1' ' A' ' 49' ' ' ASN . 0.0 OUTLIER -59.34 79.26 0.01 OUTLIER 'General case' 0 CA--C 1.537 0.474 0 N-CA-C 108.28 -1.007 . . . . 1.0 108.28 -178.014 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . 0.6 ' N ' ' O ' ' A' ' 53' ' ' ILE . 13.9 tt -154.49 162.97 1.79 Allowed 'Isoleucine or valine' 0 CA--C 1.523 -0.066 0 CA-C-N 114.802 -1.09 . . . . 1.0 111.325 178.438 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 100.81 -28.07 17.67 Favored Glycine 0 N--CA 1.452 -0.25 0 N-CA-C 111.943 -0.463 . . . . 1.0 111.943 176.849 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 12.9 m-20 -67.81 135.53 52.74 Favored 'General case' 0 N--CA 1.446 -0.646 0 CA-C-O 122.807 1.289 . . . . 1.0 113.661 -177.42 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 58' ' ' TRP . . . . . . . . . . . . . 32.4 m0 -78.13 -179.06 5.93 Favored 'General case' 0 N--CA 1.44 -0.964 0 CA-C-N 112.484 -2.143 . . . . 1.0 107.235 177.293 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 59' ' ' ARG . . . . . 0.563 ' CD ' ' H ' ' A' ' 59' ' ' ARG . 0.0 OUTLIER -99.05 -56.12 2.51 Favored 'General case' 0 CA--C 1.557 1.232 0 CA-C-N 119.646 1.112 . . . . 1.0 111.896 -179.734 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 24.8 t80 -78.66 -7.24 57.47 Favored 'General case' 0 N--CA 1.481 1.119 0 C-N-CA 125.429 1.492 . . . . 1.0 111.688 -178.418 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 69.4 tt0 -71.36 -13.89 62.01 Favored 'General case' 0 C--N 1.296 -1.749 0 CA-C-N 114.944 -1.025 . . . . 1.0 109.358 179.814 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . 0.513 ' O ' ' N ' ' A' ' 66' ' ' GLY . 10.4 m -44.51 -51.83 1.73 Allowed 'Isoleucine or valine' 0 CA--C 1.496 -1.133 0 C-N-CA 120.449 -0.501 . . . . 1.0 110.36 -175.448 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 63' ' ' ALA . . . . . 0.637 ' O ' ' HG2' ' A' ' 67' ' ' ARG . . . -65.51 -48.15 73.51 Favored 'General case' 0 N--CA 1.421 -1.919 0 N-CA-C 109.223 -0.658 . . . . 1.0 109.223 179.517 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 64' ' ' HIS . . . . . 0.408 ' O ' ' CG ' ' A' ' 67' ' ' ARG . 1.2 m-70 -54.57 -58.47 7.35 Favored 'General case' 0 CA--C 1.548 0.89 0 O-C-N 123.913 0.758 . . . . 1.0 110.368 179.829 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . 0.636 ' C ' ' H ' ' A' ' 67' ' ' ARG . 23.8 t70 -67.45 -53.38 29.43 Favored 'General case' 0 C--O 1.24 0.604 0 CA-C-O 121.15 0.5 . . . . 1.0 109.751 178.264 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . 0.513 ' N ' ' O ' ' A' ' 62' ' ' VAL . . . -63.72 30.94 0.09 OUTLIER Glycine 0 CA--C 1.527 0.826 0 N-CA-C 110.866 -0.894 . . . . 1.0 110.866 177.65 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 67' ' ' ARG . . . . . 0.637 ' HG2' ' O ' ' A' ' 63' ' ' ALA . 24.1 mmm-85 -80.25 -3.73 50.39 Favored 'General case' 0 N--CA 1.448 -0.567 0 N-CA-C 107.704 -1.221 . . . . 1.0 107.704 175.855 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . 0.489 ' O ' ' HA ' ' A' ' 72' ' ' HIS . 4.9 tt -35.1 -29.86 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.792 0 N-CA-C 107.705 -1.22 . . . . 1.0 107.705 -178.741 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . 0.691 ' CD2' ' H ' ' A' ' 70' ' ' ALA . 1.2 pt? -62.92 -62.34 1.78 Allowed 'General case' 0 N--CA 1.48 1.048 0 C-N-CA 117.121 -1.832 . . . . 1.0 106.914 177.689 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . 0.697 ' C ' ' H ' ' A' ' 72' ' ' HIS . . . -77.56 -72.55 0.35 Allowed 'General case' 0 C--O 1.214 -0.777 0 N-CA-C 106.663 -1.606 . . . . 1.0 106.663 178.057 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . 0.511 ' O ' ' C ' ' A' ' 72' ' ' HIS . . . -45.06 3.72 0.0 OUTLIER 'General case' 0 CA--C 1.516 -0.355 0 C-N-CA 124.402 1.081 . . . . 1.0 112.847 177.633 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 72' ' ' HIS . . . . . 0.697 ' H ' ' C ' ' A' ' 70' ' ' ALA . 0.0 OUTLIER -21.57 -68.29 0.03 OUTLIER 'General case' 0 CA--C 1.518 -0.275 0 C-N-CA 122.872 0.469 . . . . 1.0 111.437 -176.8 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 73' ' ' MET . . . . . 0.563 ' N ' ' ND1' ' A' ' 72' ' ' HIS . 32.6 mtt -73.51 -48.02 36.51 Favored 'General case' 0 C--N 1.31 -1.148 0 C-N-CA 119.069 -1.052 . . . . 1.0 109.151 177.355 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . 0.677 ' O ' ' N ' ' A' ' 76' ' ' GLY . 65.5 t -43.79 -49.21 1.78 Allowed 'Isoleucine or valine' 0 C--O 1.22 -0.497 0 CA-C-O 118.141 -0.933 . . . . 1.0 111.04 -176.146 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 75' ' ' ASN . . . . . 0.47 ' C ' ' N ' ' A' ' 77' ' ' ILE . 21.8 t30 -36.52 -20.34 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.746 0 CA-C-N 120.238 1.381 . . . . 1.0 110.312 177.755 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . 0.677 ' N ' ' O ' ' A' ' 74' ' ' VAL . . . -49.3 -20.87 2.51 Favored Glycine 0 C--O 1.216 -1.019 0 N-CA-C 107.948 -2.061 . . . . 1.0 107.948 174.885 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . 0.477 ' N ' ' O ' ' A' ' 74' ' ' VAL . 82.2 mt -53.27 -43.77 51.49 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.133 0 O-C-N 122.635 -0.333 . . . . 1.0 111.019 -178.044 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 42.5 t -50.44 -19.78 0.79 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.424 0 CA-C-N 118.667 0.667 . . . . 1.0 111.978 -179.445 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . 0.424 HG12 ' O ' ' A' ' 76' ' ' GLY . 0.3 OUTLIER -90.15 -38.67 11.27 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.077 0 C-N-CA 120.007 -0.677 . . . . 1.0 111.543 179.466 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -82.37 -27.36 32.17 Favored 'General case' 0 CA--C 1.541 0.633 0 N-CA-C 113.116 0.784 . . . . 1.0 113.116 -179.255 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . 0.648 ' CG ' ' H ' ' A' ' 82' ' ' ASP . 12.6 pt-20 -84.3 -67.63 0.78 Allowed 'General case' 0 CA--C 1.544 0.72 0 N-CA-C 110.152 -0.314 . . . . 1.0 110.152 178.171 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 82' ' ' ASP . . . . . 0.648 ' H ' ' CG ' ' A' ' 81' ' ' GLU . 67.1 m-20 -66.25 -20.05 66.0 Favored 'General case' 0 CA--C 1.495 -1.164 0 O-C-N 121.269 -0.894 . . . . 1.0 112.384 -177.664 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . 0.555 ' C ' ' O ' ' A' ' 82' ' ' ASP . . . -18.65 -55.03 0.01 OUTLIER 'General case' 0 N--CA 1.468 0.465 0 CA-C-O 118.946 -0.549 . . . . 1.0 111.846 176.642 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . 0.449 ' N ' ' O ' ' A' ' 82' ' ' ASP . 3.8 mm? -28.0 -53.78 0.09 Allowed 'General case' 0 N--CA 1.484 1.227 0 CA-C-N 119.657 1.117 . . . . 1.0 113.43 -177.896 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 15.6 pt -91.05 -35.43 7.15 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 C-N-CA 120.587 -0.445 . . . . 1.0 109.811 -179.404 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . 0.481 ' O ' ' CG1' ' A' ' 89' ' ' VAL . . . -52.92 -54.92 27.79 Favored 'General case' 0 C--N 1.33 -0.244 0 C-N-CA 120.376 -0.529 . . . . 1.0 109.685 -179.514 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . 0.405 ' OE1' ' C ' ' A' ' 87' ' ' GLU . 9.0 tm-20 -57.4 -21.04 33.67 Favored 'General case' 0 C--N 1.33 -0.277 0 C-N-CA 120.062 -0.655 . . . . 1.0 109.508 179.304 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . 0.733 ' C ' ' H ' ' A' ' 90' ' ' GLY . . . -73.36 -13.51 61.11 Favored 'General case' 0 C--O 1.225 -0.192 0 C-N-CA 120.352 -0.539 . . . . 1.0 109.923 179.457 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 89' ' ' VAL . . . . . 0.549 ' O ' ' N ' ' A' ' 92' ' ' HIS . 27.8 m -49.09 11.4 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.48 1.037 0 N-CA-C 113.27 0.841 . . . . 1.0 113.27 -178.979 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 90' ' ' GLY . . . . . 0.733 ' H ' ' C ' ' A' ' 88' ' ' ALA . . . -34.37 -42.12 0.27 Allowed Glycine 0 CA--C 1.543 1.83 0 CA-C-O 117.871 -1.516 . . . . 1.0 110.561 -177.26 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 91' ' ' PRO . . . . . 0.462 ' HD2' ' N ' ' A' ' 90' ' ' GLY . 1.1 Cg_endo -44.64 0.76 0.01 OUTLIER 'Trans proline' 0 N--CA 1.5 1.911 0 CA-C-N 121.292 2.546 . . . . 1.0 110.925 170.724 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 92' ' ' HIS . . . . . 0.73 ' N ' ' O ' ' A' ' 90' ' ' GLY . 16.4 t-80 -51.17 -41.7 60.33 Favored 'General case' 0 CA--C 1.51 -0.589 0 N-CA-C 109.21 -0.663 . . . . 1.0 109.21 -177.454 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 39.0 tp -63.03 -39.86 96.0 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 119.17 0.895 . . . . 1.0 110.349 177.718 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -61.8 -60.21 4.0 Favored 'General case' 0 CA--C 1.496 -1.116 0 N-CA-C 106.085 -1.82 . . . . 1.0 106.085 -179.398 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 3.7 mmp_? -57.8 -29.92 65.27 Favored 'General case' 0 N--CA 1.432 -1.34 0 CA-C-N 115.29 -0.868 . . . . 1.0 108.738 177.825 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 96' ' ' ALA . . . . . 0.813 ' O ' ' N ' ' A' ' 100' ' ' ILE . . . -59.04 -53.81 54.21 Favored 'General case' 0 C--O 1.198 -1.617 0 C-N-CA 118.127 -1.429 . . . . 1.0 108.558 -176.73 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . 0.487 ' C ' ' O ' ' A' ' 96' ' ' ALA . 1.2 tt -34.46 -28.82 0.01 OUTLIER 'General case' 0 CA--C 1.565 1.521 0 O-C-N 124.341 1.026 . . . . 1.0 108.59 -177.929 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 98' ' ' GLY . . . . . 0.616 ' N ' ' O ' ' A' ' 96' ' ' ALA . . . -88.62 -53.08 2.67 Favored Glycine 0 CA--C 1.543 1.829 0 CA-C-O 123.589 1.66 . . . . 1.0 111.401 174.144 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 99' ' ' GLN . . . . . 0.487 ' N ' ' O ' ' A' ' 96' ' ' ALA . 6.1 tt0 -78.73 6.18 9.52 Favored 'General case' 0 N--CA 1.433 -1.309 0 CA-C-N 114.473 -0.864 . . . . 1.0 108.991 178.693 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 100' ' ' ILE . . . . . 0.813 ' N ' ' O ' ' A' ' 96' ' ' ALA . 0.2 OUTLIER -63.8 -47.09 92.46 Favored 'Isoleucine or valine' 0 CA--C 1.495 -1.159 0 N-CA-C 108.022 -1.103 . . . . 1.0 108.022 179.948 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 101' ' ' VAL . . . . . 0.521 ' CG2' ' H ' ' A' ' 102' ' ' CYS . 17.6 m -55.54 -60.01 2.08 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.477 0 C-N-CA 117.035 -1.866 . . . . 1.0 108.958 179.65 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 102' ' ' CYS . . . . . 0.627 ' O ' ' S1 ' ' A' ' 130' ' ' MTN . 42.3 t -41.11 -19.71 0.01 OUTLIER 'General case' 0 C--N 1.311 -1.075 0 N-CA-C 113.217 0.821 . . . . 1.0 113.217 -176.231 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 103' ' ' ARG . . . . . 0.517 ' N ' ' O ' ' A' ' 101' ' ' VAL . 7.6 ttp180 -89.98 -35.27 15.64 Favored 'General case' 0 N--CA 1.497 1.922 0 N-CA-C 114.534 1.309 . . . . 1.0 114.534 178.956 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 104' ' ' TYR . . . . . 0.649 ' CG ' ' O ' ' A' ' 104' ' ' TYR . 0.0 OUTLIER -100.18 22.97 10.63 Favored 'General case' 0 C--N 1.303 -1.45 0 CA-C-N 113.188 -1.824 . . . . 1.0 110.076 -179.816 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -161.5 -88.15 0.07 OUTLIER Glycine 0 N--CA 1.451 -0.33 0 N-CA-C 107.413 -2.275 . . . . 1.0 107.413 179.64 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 106' ' ' ALA . . . . . 0.561 ' O ' ' CD ' ' A' ' 110' ' ' PRO . . . 69.53 58.17 0.32 Allowed 'General case' 0 CA--C 1.548 0.895 0 N-CA-C 112.704 0.631 . . . . 1.0 112.704 179.334 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 107' ' ' THR . . . . . 0.473 ' O ' ' HD2' ' A' ' 110' ' ' PRO . 20.0 m -76.41 -57.84 3.63 Favored 'General case' 0 N--CA 1.48 1.037 0 O-C-N 121.257 -0.902 . . . . 1.0 109.384 179.555 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . 0.521 ' O ' ' N ' ' A' ' 111' ' ' ASN . 16.5 m -68.61 -45.45 81.53 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.747 0 N-CA-C 110.405 -0.22 . . . . 1.0 110.405 -179.371 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -36.83 -54.01 1.79 Allowed Pre-proline 0 CA--C 1.568 1.659 0 CA-C-N 116.159 -0.473 . . . . 1.0 110.199 -178.694 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 110' ' ' PRO . . . . . 0.561 ' CD ' ' O ' ' A' ' 106' ' ' ALA . 31.4 Cg_exo -57.14 -24.52 59.1 Favored 'Trans proline' 0 N--CA 1.504 2.141 0 C-N-CA 123.296 2.664 . . . . 1.0 113.087 176.284 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 111' ' ' ASN . . . . . 0.567 ' CG ' ' N ' ' A' ' 112' ' ' ILE . 0.1 OUTLIER -63.04 -66.19 0.58 Allowed 'General case' 0 CA--C 1.54 0.587 0 C-N-CA 120.114 -0.634 . . . . 1.0 109.8 -178.531 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 112' ' ' ILE . . . . . 0.567 ' N ' ' CG ' ' A' ' 111' ' ' ASN . 1.9 tt -61.56 -27.84 42.86 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.493 0 CA-C-O 121.308 0.575 . . . . 1.0 110.804 178.707 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 113' ' ' ASN . . . . . 0.434 ' O ' ' CG ' ' A' ' 117' ' ' GLU . 1.6 m120 -57.54 -64.88 0.75 Allowed 'General case' 0 C--N 1.305 -1.341 0 CA-C-N 115.066 -0.97 . . . . 1.0 111.275 -175.203 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -67.63 -23.86 65.39 Favored 'General case' 0 C--N 1.318 -0.796 0 N-CA-C 112.124 0.416 . . . . 1.0 112.124 -178.926 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -78.97 -62.91 1.55 Allowed 'General case' 0 CA--C 1.536 0.422 0 N-CA-C 112.828 0.677 . . . . 1.0 112.828 178.988 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 116' ' ' ILE . . . . . 0.583 ' O ' ' N ' ' A' ' 119' ' ' LEU . 19.7 mt -69.68 -47.09 72.86 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.651 0 O-C-N 121.414 -0.804 . . . . 1.0 112.532 -178.329 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 117' ' ' GLU . . . . . 0.434 ' CG ' ' O ' ' A' ' 113' ' ' ASN . 73.9 mt-10 -46.84 -59.73 2.88 Favored 'General case' 0 CA--C 1.498 -1.04 0 N-CA-C 108.681 -0.859 . . . . 1.0 108.681 -177.001 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 88.9 t -55.59 -16.19 2.3 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.314 0 CA-C-N 115.407 -0.815 . . . . 1.0 109.191 179.052 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 119' ' ' LEU . . . . . 0.583 ' N ' ' O ' ' A' ' 116' ' ' ILE . 0.2 OUTLIER -79.87 -61.11 2.09 Favored 'General case' 0 C--N 1.351 0.633 0 C-N-CA 119.691 -0.803 . . . . 1.0 109.362 176.964 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -67.15 -84.39 0.1 Allowed Glycine 0 C--N 1.361 1.97 0 C-N-CA 117.154 -2.451 . . . . 1.0 110.874 178.705 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 9.3 p -159.27 -23.71 0.07 Allowed 'General case' 0 C--N 1.32 -0.688 0 N-CA-C 108.274 -1.01 . . . . 1.0 108.274 -179.564 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 122' ' ' GLY . . . . . 0.462 ' O ' ' C ' ' A' ' 123' ' ' THR . . . 112.54 -37.09 3.8 Favored Glycine 0 CA--C 1.525 0.681 0 CA-C-N 113.895 -1.502 . . . . 1.0 111.913 179.368 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 123' ' ' THR . . . . . 0.462 ' C ' ' O ' ' A' ' 122' ' ' GLY . 4.2 t -30.46 93.22 0.01 OUTLIER 'General case' 0 N--CA 1.472 0.675 0 CA-C-N 118.781 1.291 . . . . 1.0 112.33 -178.932 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 124' ' ' ASP . . . . . 0.46 ' N ' ' O ' ' A' ' 122' ' ' GLY . 40.9 m-20 -146.35 143.43 29.09 Favored 'General case' 0 C--N 1.332 -0.159 0 N-CA-C 108.946 -0.761 . . . . 1.0 108.946 179.238 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 125' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -148.01 147.16 29.32 Favored 'General case' 0 CA--C 1.535 0.385 0 N-CA-C 109.695 -0.483 . . . . 1.0 109.695 179.725 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 8.3 mmm180 -146.15 146.24 30.78 Favored 'General case' 0 CA--C 1.536 0.414 0 N-CA-C 109.018 -0.734 . . . . 1.0 109.018 178.622 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 127' ' ' PHE . . . . . 0.534 ' CD2' ' OXT' ' A' ' 127' ' ' PHE . 87.4 t80 . . . . . 0 N--CA 1.473 0.713 0 CA-C-O 118.069 -0.967 . . . . 1.0 110.865 179.557 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 128' ' ' MTN . . . . . 0.43 ' H92' HH12 ' A' ' 47' ' ' ARG . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 129' ' ' MTN . . . . . 0.497 ' S1 ' ' C6 ' ' A' ' 129' ' ' MTN . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 130' ' ' MTN . . . . . 0.627 ' S1 ' ' O ' ' A' ' 102' ' ' CYS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.494 ' C ' ' H ' ' A' ' 3' ' ' ASP . 0.4 OUTLIER . . . . . 0 N--CA 1.489 1.495 0 N-CA-C 108.19 -1.041 . . . . 1.0 108.19 . . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 2' ' ' SER . . . . . 0.55 ' O ' ' CB ' ' A' ' 3' ' ' ASP . 75.0 m -75.61 13.48 0.79 Allowed 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 116.25 -0.432 . . . . 1.0 110.852 179.709 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . 0.55 ' CB ' ' O ' ' A' ' 2' ' ' SER . 21.4 t0 135.69 134.15 0.0 OUTLIER 'General case' 0 N--CA 1.478 0.954 0 O-C-N 124.68 1.238 . . . . 1.0 110.346 179.066 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . 0.521 ' N ' ' OD1' ' A' ' 3' ' ' ASP . 71.1 t80 -167.36 91.8 0.38 Allowed 'General case' 0 C--N 1.329 -0.3 0 N-CA-C 114.833 1.42 . . . . 1.0 114.833 175.164 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 65.6 m-20 -73.61 146.78 44.4 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 114.684 -1.144 . . . . 1.0 109.212 178.898 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 6' ' ' THR . . . . . 0.577 ' O ' ' N ' ' A' ' 10' ' ' SER . 58.6 m -56.59 160.48 3.23 Favored 'General case' 0 C--O 1.217 -0.649 0 C-N-CA 120.076 -0.649 . . . . 1.0 109.505 179.519 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . 0.559 ' O ' ' N ' ' A' ' 11' ' ' ARG . 30.6 tt0 -57.07 -60.43 3.6 Favored 'General case' 0 C--N 1.316 -0.855 0 CA-C-O 121.565 0.697 . . . . 1.0 109.372 -178.072 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 8' ' ' ARG . . . . . 0.545 ' CG ' ' H ' ' A' ' 9' ' ' VAL . 48.0 ptt85 -49.36 -52.31 29.08 Favored 'General case' 0 C--N 1.313 -0.987 0 N-CA-C 108.082 -1.081 . . . . 1.0 108.082 -177.472 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . 0.545 ' H ' ' CG ' ' A' ' 8' ' ' ARG . 57.0 t -62.74 -48.02 90.09 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.36 0 CA-C-N 114.837 -1.074 . . . . 1.0 109.262 179.814 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 10' ' ' SER . . . . . 0.577 ' N ' ' O ' ' A' ' 6' ' ' THR . 48.3 t -63.41 -62.31 1.76 Allowed 'General case' 0 N--CA 1.476 0.836 0 CA-C-N 115.835 -0.621 . . . . 1.0 109.979 -179.214 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 11' ' ' ARG . . . . . 0.559 ' N ' ' O ' ' A' ' 7' ' ' GLU . 0.0 OUTLIER -57.42 -57.56 12.13 Favored 'General case' 0 N--CA 1.47 0.55 0 N-CA-C 109.062 -0.718 . . . . 1.0 109.062 -178.671 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . 0.513 ' CB ' ' O ' ' A' ' 8' ' ' ARG . . . -47.99 -48.09 32.74 Favored 'General case' 0 N--CA 1.478 0.954 0 N-CA-C 106.193 -1.78 . . . . 1.0 106.193 -178.198 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . 0.583 ' O ' ' CB ' ' A' ' 17' ' ' LEU . 45.1 t -60.5 -47.89 90.78 Favored 'Isoleucine or valine' 0 C--O 1.203 -1.392 0 C-N-CA 119.078 -1.049 . . . . 1.0 108.886 176.817 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -60.96 -61.91 2.23 Favored 'General case' 0 C--O 1.212 -0.903 0 C-N-CA 119.017 -1.073 . . . . 1.0 110.018 179.145 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . 0.536 ' N ' ' O ' ' A' ' 11' ' ' ARG . . . -51.84 -55.06 22.27 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-O 121.932 0.872 . . . . 1.0 109.228 -177.902 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . 0.479 ' CA ' ' H ' ' A' ' 22' ' ' GLY . . . -61.57 -54.4 43.51 Favored 'General case' 0 C--N 1.311 -1.07 0 CA-C-N 114.135 -1.393 . . . . 1.0 109.113 -179.43 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . 0.583 ' CB ' ' O ' ' A' ' 13' ' ' VAL . 6.8 tt -57.19 -54.16 49.91 Favored 'General case' 0 N--CA 1.484 1.257 0 CA-C-N 114.411 -1.268 . . . . 1.0 109.312 -177.711 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . 0.539 HG23 ' H ' ' A' ' 19' ' ' GLY . 2.6 m -68.45 -56.46 12.4 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.501 0 C-N-CA 119.384 -0.926 . . . . 1.0 109.324 178.893 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . 0.539 ' H ' HG23 ' A' ' 18' ' ' VAL . . . -64.17 -170.7 2.06 Favored Glycine 0 CA--C 1.526 0.731 0 N-CA-C 111.352 -0.699 . . . . 1.0 111.352 -179.568 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 20' ' ' PRO . . . . . 0.522 ' O ' ' N ' ' A' ' 24' ' ' ALA . 1.8 Cg_endo -77.41 -25.12 8.58 Favored 'Trans proline' 0 N--CA 1.494 1.53 0 C-N-CA 123.011 2.474 . . . . 1.0 114.522 -178.561 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -59.33 -58.48 14.19 Favored Glycine 0 N--CA 1.476 1.322 0 C-N-CA 119.894 -1.146 . . . . 1.0 111.358 -177.22 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . 0.479 ' H ' ' CA ' ' A' ' 16' ' ' ALA . . . -57.64 -54.16 39.42 Favored Glycine 0 N--CA 1.471 0.975 0 N-CA-C 106.813 -2.515 . . . . 1.0 106.813 -178.136 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 53.9 t -53.96 -33.03 23.28 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.059 0 CA-C-N 114.543 -0.828 . . . . 1.0 109.069 179.313 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . 0.522 ' N ' ' O ' ' A' ' 20' ' ' PRO . . . -60.73 -61.02 2.89 Favored 'General case' 0 CA--C 1.53 0.204 0 C-N-CA 118.554 -1.258 . . . . 1.0 109.486 179.559 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 3.7 tp -64.34 -47.43 79.4 Favored 'General case' 0 C--N 1.344 0.346 0 N-CA-C 113.497 0.925 . . . . 1.0 113.497 -177.985 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 98.6 t -60.23 -60.58 2.34 Favored 'Isoleucine or valine' 0 C--N 1.339 0.137 0 C-N-CA 118.366 -1.334 . . . . 1.0 110.231 -176.976 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 1.4 p -55.14 -35.23 34.75 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.244 0 CA-C-O 120.869 0.366 . . . . 1.0 111.798 -178.209 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 8.2 tttm -67.56 -54.02 23.41 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-O 121.51 0.671 . . . . 1.0 109.436 -179.016 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 44.2 t -61.75 -49.67 83.34 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.887 0 CA-C-N 114.68 -1.146 . . . . 1.0 111.246 -178.527 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 30' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -64.96 -61.18 2.32 Favored 'General case' 0 CA--C 1.534 0.346 0 C-N-CA 118.542 -1.263 . . . . 1.0 109.905 -179.218 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -60.84 -51.65 68.42 Favored 'General case' 0 CA--C 1.515 -0.396 0 N-CA-C 112.535 0.569 . . . . 1.0 112.535 -176.702 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . 0.489 ' O ' ' CB ' ' A' ' 33' ' ' LEU . . . 81.57 77.19 1.04 Allowed Glycine 0 CA--C 1.523 0.534 0 N-CA-C 108.856 -1.698 . . . . 1.0 108.856 -178.069 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . 0.491 ' O ' ' O ' ' A' ' 36' ' ' VAL . 1.3 tt 84.74 85.41 0.05 OUTLIER Pre-proline 0 CA--C 1.543 0.676 0 N-CA-C 109.523 -0.547 . . . . 1.0 109.523 -178.961 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 77.8 Cg_exo -52.35 -33.05 54.38 Favored 'Trans proline' 0 N--CA 1.51 2.496 0 C-N-CA 123.564 2.842 . . . . 1.0 114.556 -178.504 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -58.98 -58.79 12.69 Favored Glycine 0 CA--C 1.527 0.84 0 C-N-CA 118.974 -1.584 . . . . 1.0 109.843 -178.083 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . 0.547 ' O ' ' CB ' ' A' ' 37' ' ' ILE . 0.4 OUTLIER -94.38 160.62 2.69 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.453 0 N-CA-C 107.083 -1.451 . . . . 1.0 107.083 178.641 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . 0.547 ' CB ' ' O ' ' A' ' 36' ' ' VAL . 5.9 tp 124.63 111.27 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.484 1.272 0 O-C-N 124.141 0.901 . . . . 1.0 109.069 -178.944 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 57.0 m80 -138.39 130.72 28.82 Favored 'General case' 0 C--N 1.329 -0.304 0 N-CA-C 108.044 -1.095 . . . . 1.0 108.044 178.865 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 11.2 t -91.79 153.19 43.69 Favored Pre-proline 0 N--CA 1.467 0.418 0 CA-C-O 119.391 -0.338 . . . . 1.0 110.363 -179.023 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 6.1 Cg_endo -86.11 -38.74 0.09 OUTLIER 'Trans proline' 0 N--CA 1.483 0.881 0 C-N-CA 121.213 1.275 . . . . 1.0 112.828 -179.786 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -125.53 129.88 50.62 Favored 'General case' 0 N--CA 1.47 0.561 0 CA-C-N 116.203 -0.453 . . . . 1.0 109.918 179.361 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . 0.688 HH12 ' CD ' ' A' ' 47' ' ' ARG . 42.0 ttp180 -176.18 168.95 2.84 Favored 'General case' 0 C--N 1.323 -0.584 0 N-CA-C 107.12 -1.437 . . . . 1.0 107.12 177.294 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 43' ' ' ARG . . . . . 0.434 ' N ' ' CG ' ' A' ' 42' ' ' ARG . 0.0 OUTLIER -52.51 -37.34 57.27 Favored 'General case' 0 N--CA 1.449 -0.478 0 CA-C-N 120.114 1.325 . . . . 1.0 109.132 -179.642 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 125.16 -19.62 6.79 Favored Glycine 0 C--N 1.34 0.773 0 N-CA-C 111.079 -0.809 . . . . 1.0 111.079 -179.106 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . 0.499 ' O ' ' CB ' ' A' ' 46' ' ' PHE . 4.5 t80 -149.7 149.94 31.35 Favored 'General case' 0 CA--C 1.538 0.509 0 CA-C-N 117.815 0.808 . . . . 1.0 109.019 179.76 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 46' ' ' PHE . . . . . 0.499 ' CB ' ' O ' ' A' ' 45' ' ' PHE . 3.8 m-30 132.31 86.17 0.0 OUTLIER 'General case' 0 N--CA 1.484 1.239 0 N-CA-C 107.384 -1.339 . . . . 1.0 107.384 -179.559 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 47' ' ' ARG . . . . . 0.688 ' CD ' HH12 ' A' ' 42' ' ' ARG . 5.7 ptp180 132.87 141.91 0.0 OUTLIER 'General case' 0 N--CA 1.485 1.279 0 O-C-N 124.434 1.084 . . . . 1.0 110.932 178.188 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 3.3 m 71.03 71.5 0.18 Allowed 'General case' 0 N--CA 1.455 -0.179 0 N-CA-C 110.286 -0.264 . . . . 1.0 110.286 -179.992 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 69.4 m-80 -132.44 140.32 37.52 Favored Pre-proline 0 C--N 1.33 -0.263 0 N-CA-C 108.007 -1.108 . . . . 1.0 108.007 179.226 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 44.1 Cg_endo -67.86 65.55 0.91 Allowed 'Trans proline' 0 C--N 1.312 -1.394 0 C-N-CA 121.54 1.493 . . . . 1.0 111.374 -179.339 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . 0.525 ' N ' ' OE1' ' A' ' 51' ' ' GLU . 0.0 OUTLIER 64.11 7.48 3.45 Favored 'General case' 0 N--CA 1.463 0.196 0 CA-C-N 114.92 -1.036 . . . . 1.0 111.061 -179.638 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . 0.411 ' HG2' HH11 ' A' ' 52' ' ' ARG . 33.1 mtt-85 -87.97 159.85 18.14 Favored 'General case' 0 C--N 1.331 -0.233 0 N-CA-C 109.572 -0.529 . . . . 1.0 109.572 179.278 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . 0.468 ' O ' ' N ' ' A' ' 55' ' ' ILE . 10.7 tt -79.85 135.54 25.29 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-O 121.87 0.843 . . . . 1.0 111.605 -179.245 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 54' ' ' GLN . . . . . 0.453 ' OE1' ' CE2' ' A' ' 46' ' ' PHE . 5.0 pt20 -61.04 83.24 0.01 OUTLIER 'General case' 0 C--N 1.32 -0.68 0 CA-C-N 114.267 -1.333 . . . . 1.0 109.013 -178.487 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . 0.468 ' N ' ' O ' ' A' ' 53' ' ' ILE . 13.1 tt -149.65 158.64 5.81 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.472 0 CA-C-N 115.717 -0.674 . . . . 1.0 110.547 178.164 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 107.13 -5.33 36.06 Favored Glycine 0 N--CA 1.473 1.15 0 N-CA-C 110.991 -0.844 . . . . 1.0 110.991 179.187 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 3.7 p-10 -81.2 105.58 12.51 Favored 'General case' 0 C--N 1.316 -0.877 0 CA-C-N 114.912 -0.644 . . . . 1.0 110.256 179.769 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 58' ' ' TRP . . . . . . . . . . . . . 1.4 m95 -91.09 173.9 7.7 Favored 'General case' 0 CA--C 1.541 0.6 0 CA-C-O 124.289 1.995 . . . . 1.0 114.836 -177.011 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 31.2 mtm180 -78.54 -62.64 1.62 Allowed 'General case' 0 C--N 1.312 -1.053 0 CA-C-N 109.266 -3.606 . . . . 1.0 111.654 -179.096 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 60' ' ' TYR . . . . . 0.499 ' CG ' ' O ' ' A' ' 60' ' ' TYR . 47.1 t80 -91.95 -11.87 34.98 Favored 'General case' 0 C--O 1.249 1.078 0 N-CA-C 113.621 0.971 . . . . 1.0 113.621 179.612 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 6.7 tt0 -81.63 -15.78 53.55 Favored 'General case' 0 N--CA 1.443 -0.82 0 O-C-N 120.686 -1.259 . . . . 1.0 111.804 -178.689 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . 0.568 ' O ' ' N ' ' A' ' 66' ' ' GLY . 0.0 OUTLIER -46.57 -52.65 3.47 Favored 'Isoleucine or valine' 0 C--O 1.208 -1.095 0 C-N-CA 120.231 -0.588 . . . . 1.0 111.719 -174.524 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -69.1 -46.4 67.82 Favored 'General case' 0 C--N 1.311 -1.098 0 C-N-CA 119.376 -0.93 . . . . 1.0 109.616 -179.218 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 3.0 m-70 -50.57 -55.4 16.41 Favored 'General case' 0 N--CA 1.469 0.483 0 C-N-CA 119.08 -1.048 . . . . 1.0 108.823 179.222 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . 0.74 ' C ' ' H ' ' A' ' 67' ' ' ARG . 34.3 m-20 -73.58 -48.99 28.53 Favored 'General case' 0 C--O 1.244 0.765 0 CA-C-O 121.214 0.53 . . . . 1.0 109.886 178.714 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . 0.568 ' N ' ' O ' ' A' ' 62' ' ' VAL . . . -65.77 27.92 0.14 Allowed Glycine 0 N--CA 1.451 -0.351 0 N-CA-C 110.152 -1.179 . . . . 1.0 110.152 177.396 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 67' ' ' ARG . . . . . 0.74 ' H ' ' C ' ' A' ' 65' ' ' ASP . 0.0 OUTLIER -73.4 0.34 12.51 Favored 'General case' 0 N--CA 1.433 -1.321 0 N-CA-C 105.869 -1.901 . . . . 1.0 105.869 174.058 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . 0.466 ' H ' ' C ' ' A' ' 66' ' ' GLY . 1.0 OUTLIER -39.05 -39.3 0.54 Allowed 'General case' 0 C--N 1.346 0.434 0 CA-C-N 116.162 -0.472 . . . . 1.0 110.478 -177.978 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -64.5 -69.08 0.31 Allowed 'General case' 0 N--CA 1.48 1.044 0 C-N-CA 119.258 -0.977 . . . . 1.0 113.34 -175.662 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . 0.536 ' C ' ' H ' ' A' ' 72' ' ' HIS . . . -77.07 -79.07 0.11 Allowed 'General case' 0 CA--C 1.512 -0.483 0 C-N-CA 117.957 -1.497 . . . . 1.0 110.107 -176.037 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . 0.778 ' O ' ' N ' ' A' ' 73' ' ' MET . . . -65.24 14.95 0.03 OUTLIER 'General case' 0 C--N 1.312 -1.035 0 C-N-CA 124.784 1.234 . . . . 1.0 112.85 -178.365 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 72' ' ' HIS . . . . . 0.536 ' H ' ' C ' ' A' ' 70' ' ' ALA . 0.8 OUTLIER -18.55 -32.97 0.0 OUTLIER 'General case' 0 N--CA 1.467 0.404 0 O-C-N 124.315 1.01 . . . . 1.0 113.197 -175.036 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 73' ' ' MET . . . . . 0.778 ' N ' ' O ' ' A' ' 71' ' ' ALA . 8.6 ptp -61.15 -53.13 60.8 Favored 'General case' 0 C--N 1.319 -0.76 0 C-N-CA 118.755 -1.178 . . . . 1.0 108.465 176.49 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . 0.713 ' O ' ' N ' ' A' ' 76' ' ' GLY . 34.2 m -44.65 -51.64 1.84 Allowed 'Isoleucine or valine' 0 C--O 1.206 -1.219 0 CA-C-O 116.363 -1.78 . . . . 1.0 112.426 -175.112 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 75' ' ' ASN . . . . . 0.413 ' C ' ' O ' ' A' ' 74' ' ' VAL . 5.9 t30 -36.68 -17.21 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.49 0 CA-C-N 122.472 2.396 . . . . 1.0 111.604 -179.231 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . 0.713 ' N ' ' O ' ' A' ' 74' ' ' VAL . . . -54.39 -23.66 27.54 Favored Glycine 0 CA--C 1.532 1.115 0 N-CA-C 107.178 -2.369 . . . . 1.0 107.178 174.252 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . 0.484 ' N ' ' O ' ' A' ' 74' ' ' VAL . 18.2 pt -51.06 -48.98 29.55 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.033 0 CA-C-O 118.457 -0.782 . . . . 1.0 109.874 -179.793 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 19.3 t -55.97 -19.73 7.65 Favored 'Isoleucine or valine' 0 C--N 1.345 0.409 0 CA-C-N 120.94 1.7 . . . . 1.0 112.833 178.775 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . 0.459 HG13 ' N ' ' A' ' 80' ' ' ALA . 0.6 OUTLIER -90.6 -44.71 14.79 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.402 0 C-N-CA 119.683 -0.807 . . . . 1.0 109.855 179.077 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 80' ' ' ALA . . . . . 0.459 ' N ' HG13 ' A' ' 79' ' ' ILE . . . -80.04 -17.59 52.37 Favored 'General case' 0 C--N 1.323 -0.546 0 N-CA-C 113.267 0.84 . . . . 1.0 113.267 -179.587 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . 0.587 ' CG ' ' H ' ' A' ' 82' ' ' ASP . 10.2 pt-20 -94.18 -70.66 0.7 Allowed 'General case' 0 CA--C 1.537 0.463 0 C-N-CA 119.624 -0.83 . . . . 1.0 113.206 -177.987 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 82' ' ' ASP . . . . . 0.587 ' H ' ' CG ' ' A' ' 81' ' ' GLU . 13.4 t70 -90.62 -14.27 32.71 Favored 'General case' 0 CA--C 1.537 0.472 0 N-CA-C 114.821 1.415 . . . . 1.0 114.821 -178.49 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . 0.515 ' O ' ' N ' ' A' ' 86' ' ' ALA . . . -52.16 -46.32 65.41 Favored 'General case' 0 C--O 1.22 -0.498 0 C-N-CA 117.644 -1.622 . . . . 1.0 111.203 -178.924 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . 0.404 ' C ' ' O ' ' A' ' 83' ' ' ALA . 0.1 OUTLIER -39.34 -25.79 0.02 OUTLIER 'General case' 0 N--CA 1.469 0.499 0 O-C-N 121.427 -0.795 . . . . 1.0 111.533 -179.605 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 85' ' ' ILE . . . . . 0.499 ' N ' ' O ' ' A' ' 83' ' ' ALA . 3.2 tt -91.18 -34.41 6.34 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.327 0 C-N-CA 120.851 -0.339 . . . . 1.0 110.236 179.119 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . 0.515 ' N ' ' O ' ' A' ' 83' ' ' ALA . . . -95.52 -29.0 14.6 Favored 'General case' 0 C--O 1.207 -1.16 0 O-C-N 122.038 -0.414 . . . . 1.0 111.572 178.994 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . 0.557 ' C ' ' H ' ' A' ' 89' ' ' VAL . 0.3 OUTLIER -61.59 -17.34 54.72 Favored 'General case' 0 C--N 1.321 -0.673 0 O-C-N 121.237 -0.914 . . . . 1.0 110.077 -179.262 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . 0.422 ' N ' ' OE1' ' A' ' 87' ' ' GLU . . . -73.89 -4.59 35.94 Favored 'General case' 0 N--CA 1.477 0.888 0 CA-C-O 123.549 1.643 . . . . 1.0 106.759 177.163 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 89' ' ' VAL . . . . . 0.557 ' H ' ' C ' ' A' ' 87' ' ' GLU . 26.0 t -80.96 39.51 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.44 -0.964 0 CA-C-N 110.91 -2.859 . . . . 1.0 108.178 175.866 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 90' ' ' GLY . . . . . 0.844 ' O ' ' N ' ' A' ' 92' ' ' HIS . . . -56.91 -29.02 58.46 Favored Glycine 0 C--N 1.37 2.461 0 CA-C-O 117.423 -1.765 . . . . 1.0 111.844 177.337 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 91' ' ' PRO . . . . . 0.547 ' HD2' ' N ' ' A' ' 90' ' ' GLY . 52.2 Cg_exo -38.36 -2.19 0.0 OUTLIER 'Trans proline' 0 N--CA 1.498 1.75 0 CA-C-N 121.672 2.736 . . . . 1.0 111.728 173.945 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 92' ' ' HIS . . . . . 0.844 ' N ' ' O ' ' A' ' 90' ' ' GLY . 18.1 p-80 -50.19 -31.3 13.44 Favored 'General case' 0 N--CA 1.432 -1.365 0 N-CA-C 106.966 -1.494 . . . . 1.0 106.966 179.243 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . 0.403 ' O ' ' HB2' ' A' ' 96' ' ' ALA . 1.5 tt -61.02 -50.13 74.6 Favored 'General case' 0 C--O 1.222 -0.36 0 N-CA-C 106.995 -1.483 . . . . 1.0 106.995 176.367 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 94' ' ' ALA . . . . . 0.479 ' N ' ' O ' ' A' ' 91' ' ' PRO . . . -52.04 -54.91 24.41 Favored 'General case' 0 C--N 1.322 -0.628 0 N-CA-C 107.586 -1.264 . . . . 1.0 107.586 179.644 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -63.63 -29.72 70.93 Favored 'General case' 0 CA--C 1.543 0.685 0 CA-C-O 121.537 0.684 . . . . 1.0 109.574 178.405 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 96' ' ' ALA . . . . . 0.783 ' O ' ' N ' ' A' ' 100' ' ' ILE . . . -50.9 -42.94 59.65 Favored 'General case' 0 C--O 1.197 -1.691 0 N-CA-C 106.799 -1.556 . . . . 1.0 106.799 -177.754 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . 0.517 ' O ' ' CG2' ' A' ' 100' ' ' ILE . 0.3 OUTLIER -35.61 -23.05 0.01 OUTLIER 'General case' 0 CA--C 1.594 2.641 0 CA-C-N 114.18 -1.373 . . . . 1.0 108.005 -177.156 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 98' ' ' GLY . . . . . 0.674 ' N ' ' O ' ' A' ' 96' ' ' ALA . . . -86.06 -50.23 3.97 Favored Glycine 0 CA--C 1.562 3.011 0 CA-C-O 123.057 1.365 . . . . 1.0 111.286 169.713 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 99' ' ' GLN . . . . . 0.692 ' N ' ' O ' ' A' ' 96' ' ' ALA . 0.0 OUTLIER -76.59 7.16 4.82 Favored 'General case' 0 N--CA 1.441 -0.878 0 N-CA-C 106.391 -1.707 . . . . 1.0 106.391 177.142 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 100' ' ' ILE . . . . . 0.783 ' N ' ' O ' ' A' ' 96' ' ' ALA . 17.7 tt -58.12 -55.4 22.31 Favored 'Isoleucine or valine' 0 CA--C 1.481 -1.69 0 N-CA-C 106.232 -1.766 . . . . 1.0 106.232 177.438 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 101' ' ' VAL . . . . . 0.684 ' O ' ' N ' ' A' ' 105' ' ' GLY . 7.0 p -57.49 -60.04 2.58 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.579 0 C-N-CA 118.368 -1.333 . . . . 1.0 107.871 178.668 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 102' ' ' CYS . . . . . 0.552 ' H ' ' CG1' ' A' ' 101' ' ' VAL . 18.2 t -52.48 -26.26 12.45 Favored 'General case' 0 C--N 1.32 -0.707 0 N-CA-C 112.712 0.634 . . . . 1.0 112.712 -177.324 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 103' ' ' ARG . . . . . 0.536 ' N ' ' O ' ' A' ' 99' ' ' GLN . 45.6 ttt180 -86.23 -49.31 7.8 Favored 'General case' 0 N--CA 1.49 1.568 0 CA-C-O 122.763 1.268 . . . . 1.0 112.686 179.019 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 104' ' ' TYR . . . . . 0.686 ' CG ' ' O ' ' A' ' 104' ' ' TYR . 0.0 OUTLIER -97.04 24.13 6.59 Favored 'General case' 0 C--N 1.295 -1.8 0 CA-C-N 112.258 -2.246 . . . . 1.0 107.571 178.618 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 105' ' ' GLY . . . . . 0.684 ' N ' ' O ' ' A' ' 101' ' ' VAL . . . -164.92 -96.84 0.11 Allowed Glycine 0 CA--C 1.533 1.206 0 N-CA-C 108.166 -1.974 . . . . 1.0 108.166 179.081 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 106' ' ' ALA . . . . . 0.422 ' C ' ' H ' ' A' ' 108' ' ' VAL . . . 68.4 55.68 0.5 Allowed 'General case' 0 CA--C 1.534 0.351 0 C-N-CA 122.989 0.515 . . . . 1.0 111.747 -178.886 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 91.8 m -80.32 6.1 12.96 Favored 'General case' 0 CA--C 1.514 -0.407 0 N-CA-C 107.222 -1.399 . . . . 1.0 107.222 177.033 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . 0.422 ' H ' ' C ' ' A' ' 106' ' ' ALA . 18.0 m -84.4 -54.03 9.68 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.242 0 CA-C-N 115.575 -0.739 . . . . 1.0 110.472 178.721 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 109' ' ' ILE . . . . . 0.477 ' O ' ' N ' ' A' ' 113' ' ' ASN . 85.4 mt -41.99 -51.89 9.69 Favored Pre-proline 0 C--N 1.347 0.46 0 N-CA-C 114.805 1.409 . . . . 1.0 114.805 -179.446 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 110' ' ' PRO . . . . . 0.445 ' HD2' ' N ' ' A' ' 109' ' ' ILE . 2.3 Cg_endo -40.68 -52.02 3.34 Favored 'Trans proline' 0 C--N 1.314 -1.286 0 CA-C-N 120.618 1.257 . . . . 1.0 113.293 -176.407 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 111' ' ' ASN . . . . . 0.439 ' ND2' ' H ' ' A' ' 112' ' ' ILE . 0.8 OUTLIER -69.51 -69.12 0.36 Allowed 'General case' 0 C--O 1.233 0.222 0 C-N-CA 118.229 -1.389 . . . . 1.0 110.444 -178.403 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 112' ' ' ILE . . . . . 0.439 ' H ' ' ND2' ' A' ' 111' ' ' ASN . 0.0 OUTLIER -46.97 -27.62 0.91 Allowed 'Isoleucine or valine' 0 C--O 1.216 -0.672 0 N-CA-C 109.174 -0.676 . . . . 1.0 109.174 -179.947 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 113' ' ' ASN . . . . . 0.477 ' N ' ' O ' ' A' ' 109' ' ' ILE . 16.4 t-20 -58.19 -54.55 45.76 Favored 'General case' 0 C--N 1.308 -1.198 0 C-N-CA 118.131 -1.428 . . . . 1.0 108.096 -177.928 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 114' ' ' ALA . . . . . 0.438 ' O ' ' HG2' ' A' ' 117' ' ' GLU . . . -58.69 -33.9 70.67 Favored 'General case' 0 N--CA 1.447 -0.611 0 N-CA-C 113.116 0.784 . . . . 1.0 113.116 -178.633 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -82.99 -49.44 9.58 Favored 'General case' 0 C--O 1.215 -0.761 0 O-C-N 120.426 -1.421 . . . . 1.0 110.8 179.173 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 116' ' ' ILE . . . . . 0.461 ' O ' ' N ' ' A' ' 120' ' ' GLY . 0.6 OUTLIER -50.91 -54.92 8.51 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.184 0 N-CA-C 107.345 -1.354 . . . . 1.0 107.345 -179.415 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 117' ' ' GLU . . . . . 0.466 ' CG ' ' N ' ' A' ' 118' ' ' VAL . 17.5 pt-20 -45.96 -58.11 3.83 Favored 'General case' 0 C--O 1.212 -0.898 0 CA-C-N 113.175 -1.83 . . . . 1.0 106.136 -179.052 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 118' ' ' VAL . . . . . 0.466 ' N ' ' CG ' ' A' ' 117' ' ' GLU . 57.7 t -58.36 -53.35 47.51 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.133 0 C-N-CA 119.89 -0.724 . . . . 1.0 110.207 179.068 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 13.2 tp -53.76 -73.04 0.05 OUTLIER 'General case' 0 CA--C 1.54 0.581 0 N-CA-C 108.129 -1.063 . . . . 1.0 108.129 -178.66 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 120' ' ' GLY . . . . . 0.512 ' O ' ' CB ' ' A' ' 121' ' ' THR . . . -67.82 -76.11 0.43 Allowed Glycine 0 CA--C 1.54 1.603 0 C-N-CA 118.948 -1.596 . . . . 1.0 111.026 179.165 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 121' ' ' THR . . . . . 0.512 ' CB ' ' O ' ' A' ' 120' ' ' GLY . 2.3 m 144.92 -27.4 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.434 0 CA-C-N 112.536 -1.832 . . . . 1.0 111.026 -178.381 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 122' ' ' GLY . . . . . 0.659 ' O ' ' N ' ' A' ' 124' ' ' ASP . . . 104.72 -17.94 44.87 Favored Glycine 0 C--O 1.223 -0.577 0 N-CA-C 107.944 -2.062 . . . . 1.0 107.944 -177.0 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 123' ' ' THR . . . . . 0.438 ' O ' ' CG2' ' A' ' 123' ' ' THR . 11.0 t -54.41 83.52 0.0 OUTLIER 'General case' 0 CA--C 1.532 0.275 0 N-CA-C 106.351 -1.722 . . . . 1.0 106.351 178.617 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 124' ' ' ASP . . . . . 0.659 ' N ' ' O ' ' A' ' 122' ' ' GLY . 48.5 p-10 -166.93 176.77 6.77 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 113.539 -1.664 . . . . 1.0 111.375 179.285 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 125' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -146.76 144.63 29.53 Favored 'General case' 0 CA--C 1.541 0.605 0 N-CA-C 108.364 -0.976 . . . . 1.0 108.364 176.904 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 38.0 ttm180 -149.84 151.74 34.0 Favored 'General case' 0 N--CA 1.471 0.588 0 CA-C-O 120.534 0.207 . . . . 1.0 110.935 178.844 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 127' ' ' PHE . . . . . . . . . . . . . 13.9 p90 . . . . . 0 C--O 1.219 -0.506 0 CA-C-O 117.958 -1.02 . . . . 1.0 110.646 -179.985 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 128' ' ' MTN . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 129' ' ' MTN . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 130' ' ' MTN . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.513 ' N ' ' SD ' ' A' ' 1' ' ' MET . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.558 0 N-CA-C 108.862 -0.792 . . . . 1.0 108.862 . . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 2' ' ' SER . . . . . 0.508 ' O ' ' CG ' ' A' ' 3' ' ' ASP . 70.8 m -72.4 7.71 1.68 Allowed 'General case' 0 C--O 1.223 -0.31 0 CA-C-O 119.43 -0.319 . . . . 1.0 110.844 179.474 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . 0.508 ' CG ' ' O ' ' A' ' 2' ' ' SER . 62.1 m-20 144.16 137.39 0.0 OUTLIER 'General case' 0 N--CA 1.482 1.141 0 O-C-N 124.189 0.93 . . . . 1.0 110.097 179.239 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 91.4 t80 -154.92 150.46 27.44 Favored 'General case' 0 N--CA 1.465 0.296 0 CA-C-N 116.073 -0.512 . . . . 1.0 110.88 179.214 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -150.13 145.23 26.19 Favored 'General case' 0 CA--C 1.543 0.686 0 N-CA-C 109.553 -0.536 . . . . 1.0 109.553 179.465 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 6' ' ' THR . . . . . 0.843 ' O ' ' N ' ' A' ' 10' ' ' SER . 0.2 OUTLIER -87.14 176.71 7.46 Favored 'General case' 0 C--O 1.179 -2.627 0 CA-C-O 120.43 0.157 . . . . 1.0 111.236 -179.27 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . 0.598 ' O ' ' N ' ' A' ' 11' ' ' ARG . 10.9 mt-10 -60.65 -50.68 72.53 Favored 'General case' 0 C--N 1.312 -1.056 0 CA-C-O 121.194 0.521 . . . . 1.0 109.713 -179.405 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 8' ' ' ARG . . . . . 0.496 ' O ' ' CB ' ' A' ' 12' ' ' ALA . 18.6 mtp-105 -57.95 -58.93 6.23 Favored 'General case' 0 C--N 1.315 -0.916 0 C-N-CA 118.416 -1.313 . . . . 1.0 107.536 -179.011 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . 0.639 ' O ' ' HB ' ' A' ' 13' ' ' VAL . 0.0 OUTLIER -66.82 -50.83 61.82 Favored 'Isoleucine or valine' 0 C--O 1.183 -2.418 0 CA-C-N 114.267 -1.333 . . . . 1.0 109.287 179.686 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 10' ' ' SER . . . . . 0.843 ' N ' ' O ' ' A' ' 6' ' ' THR . 19.3 t -63.84 -61.16 2.47 Favored 'General case' 0 N--CA 1.492 1.669 0 C-N-CA 119.437 -0.905 . . . . 1.0 110.268 179.171 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 11' ' ' ARG . . . . . 0.598 ' N ' ' O ' ' A' ' 7' ' ' GLU . 5.3 tpt180 -67.39 -54.32 21.5 Favored 'General case' 0 C--O 1.214 -0.797 0 N-CA-C 112.546 0.573 . . . . 1.0 112.546 -176.674 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . 0.496 ' CB ' ' O ' ' A' ' 8' ' ' ARG . . . -56.06 -50.7 70.22 Favored 'General case' 0 N--CA 1.476 0.862 0 C-N-CA 117.023 -1.871 . . . . 1.0 106.565 -178.09 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . 0.676 ' O ' ' N ' ' A' ' 17' ' ' LEU . 65.7 t -61.25 -48.49 88.7 Favored 'Isoleucine or valine' 0 C--O 1.18 -2.593 0 N-CA-C 107.033 -1.469 . . . . 1.0 107.033 178.659 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . 0.556 ' N ' ' O ' ' A' ' 10' ' ' SER . . . -59.32 -61.56 2.53 Favored 'General case' 0 C--O 1.201 -1.467 0 C-N-CA 118.132 -1.427 . . . . 1.0 109.696 179.253 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . 0.597 ' N ' ' O ' ' A' ' 11' ' ' ARG . . . -52.57 -53.38 47.29 Favored 'General case' 0 C--O 1.216 -0.685 0 N-CA-C 108.576 -0.898 . . . . 1.0 108.576 -178.456 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . 0.636 ' CA ' ' H ' ' A' ' 22' ' ' GLY . . . -65.42 -57.15 9.02 Favored 'General case' 0 CA--C 1.546 0.792 0 CA-C-O 121.663 0.744 . . . . 1.0 109.951 -179.747 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . 0.676 ' N ' ' O ' ' A' ' 13' ' ' VAL . 18.7 tp -55.74 -55.98 25.93 Favored 'General case' 0 N--CA 1.491 1.582 0 N-CA-C 107.953 -1.128 . . . . 1.0 107.953 -178.929 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . 0.619 HG22 ' H ' ' A' ' 19' ' ' GLY . 1.2 m -70.89 -59.02 3.87 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.397 0 C-N-CA 119.854 -0.738 . . . . 1.0 110.136 -179.896 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . 0.619 ' H ' HG22 ' A' ' 18' ' ' VAL . . . -60.75 -161.93 0.13 Allowed Glycine 0 C--N 1.338 0.651 0 N-CA-C 111.819 -0.512 . . . . 1.0 111.819 -178.399 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 20' ' ' PRO . . . . . 0.509 ' O ' ' CB ' ' A' ' 24' ' ' ALA . 86.3 Cg_endo -81.23 -23.1 5.43 Favored 'Trans proline' 0 C--N 1.318 -1.04 0 C-N-CA 123.165 2.577 . . . . 1.0 113.682 -177.979 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -63.35 -62.29 5.52 Favored Glycine 0 N--CA 1.484 1.847 0 C-N-CA 120.178 -1.01 . . . . 1.0 112.996 -176.406 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . 0.636 ' H ' ' CA ' ' A' ' 16' ' ' ALA . . . -57.61 -57.61 18.87 Favored Glycine 0 C--N 1.312 -0.784 0 N-CA-C 107.349 -2.301 . . . . 1.0 107.349 -177.845 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 34.3 m -56.63 -32.28 36.94 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.744 0 C-N-CA 118.773 -1.171 . . . . 1.0 109.294 -179.977 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . 0.509 ' CB ' ' O ' ' A' ' 20' ' ' PRO . . . -60.5 -62.13 2.09 Favored 'General case' 0 N--CA 1.471 0.6 0 C-N-CA 118.142 -1.423 . . . . 1.0 110.117 179.745 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 18.4 mt -61.38 -47.8 84.17 Favored 'General case' 0 CA--C 1.514 -0.43 0 CA-C-N 118.616 0.644 . . . . 1.0 112.137 -177.28 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 90.5 t -58.55 -59.14 4.04 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.535 0 C-N-CA 119.29 -0.964 . . . . 1.0 109.61 -177.846 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . 0.452 ' O ' ' CB ' ' A' ' 31' ' ' ALA . 84.8 t -57.28 -38.65 63.12 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.462 0 CA-C-O 120.866 0.365 . . . . 1.0 110.482 -178.236 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 9.2 ttmt -66.37 -55.33 16.38 Favored 'General case' 0 C--N 1.316 -0.876 0 C-N-CA 119.686 -0.806 . . . . 1.0 109.956 -178.873 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 92.3 t -63.73 -51.39 70.53 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.777 0 CA-C-N 114.903 -1.044 . . . . 1.0 110.917 -176.541 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 30' ' ' CYS . . . . . . . . . . . . . 50.1 t -64.54 -61.55 2.14 Favored 'General case' 0 N--CA 1.443 -0.779 0 C-N-CA 119.407 -0.917 . . . . 1.0 109.889 -179.084 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . 0.452 ' CB ' ' O ' ' A' ' 27' ' ' VAL . . . -59.3 -53.54 57.12 Favored 'General case' 0 C--N 1.318 -0.773 0 CA-C-O 120.874 0.369 . . . . 1.0 111.354 -177.295 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . 0.519 ' O ' ' CB ' ' A' ' 33' ' ' LEU . . . 80.29 69.68 1.38 Allowed Glycine 0 CA--C 1.521 0.418 0 N-CA-C 109.898 -1.281 . . . . 1.0 109.898 -179.77 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . 0.568 ' CD2' ' H ' ' A' ' 35' ' ' GLY . 2.0 tt 88.96 101.6 0.03 OUTLIER Pre-proline 0 CA--C 1.545 0.781 0 CA-C-N 115.442 -0.379 . . . . 1.0 110.553 -179.821 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 51.7 Cg_exo -51.86 -21.97 12.94 Favored 'Trans proline' 0 N--CA 1.503 2.05 0 C-N-CA 122.328 2.018 . . . . 1.0 113.939 179.745 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . 0.568 ' H ' ' CD2' ' A' ' 33' ' ' LEU . . . -62.12 -62.3 5.8 Favored Glycine 0 C--N 1.34 0.796 0 C-N-CA 119.263 -1.446 . . . . 1.0 109.952 -178.389 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . 0.609 ' CG2' ' H ' ' A' ' 37' ' ' ILE . 8.4 p -73.37 -152.88 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.325 -0.488 0 N-CA-C 107.96 -1.126 . . . . 1.0 107.96 178.333 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . 0.609 ' H ' ' CG2' ' A' ' 36' ' ' VAL . 2.1 mm 70.96 79.33 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.475 0.804 0 CA-C-O 122.069 0.938 . . . . 1.0 112.79 179.598 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 88.0 m-70 -135.32 129.56 33.68 Favored 'General case' 0 C--N 1.318 -0.763 0 N-CA-C 106.826 -1.546 . . . . 1.0 106.826 176.971 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 25.1 m -120.44 132.2 24.21 Favored Pre-proline 0 N--CA 1.465 0.297 0 N-CA-C 110.073 -0.343 . . . . 1.0 110.073 -178.883 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 27.7 Cg_endo -62.98 -78.17 0.01 OUTLIER 'Trans proline' 0 N--CA 1.49 1.311 0 CA-C-N 119.654 0.912 . . . . 1.0 111.898 -179.457 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -67.72 125.65 26.9 Favored 'General case' 0 C--N 1.317 -0.844 0 CA-C-N 114.859 -1.064 . . . . 1.0 110.613 -178.805 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . 0.526 ' HG2' ' H ' ' A' ' 43' ' ' ARG . 31.0 ttp180 -173.28 174.52 3.33 Favored 'General case' 0 C--N 1.32 -0.674 0 CA-C-N 115.832 -0.622 . . . . 1.0 109.982 179.516 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 43' ' ' ARG . . . . . 0.56 ' NH1' ' OD2' ' A' ' 57' ' ' ASP . 1.1 tmt_? -58.08 -45.19 87.55 Favored 'General case' 0 CA--C 1.541 0.598 0 N-CA-C 107.1 -1.444 . . . . 1.0 107.1 179.528 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . 0.476 ' O ' ' CD1' ' A' ' 45' ' ' PHE . . . 123.58 -25.12 6.31 Favored Glycine 0 CA--C 1.533 1.173 0 CA-C-O 119.852 -0.416 . . . . 1.0 112.147 179.138 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . 0.593 ' O ' ' HB2' ' A' ' 46' ' ' PHE . 7.5 m-85 -156.52 162.92 39.91 Favored 'General case' 0 N--CA 1.474 0.749 0 N-CA-C 109.111 -0.7 . . . . 1.0 109.111 177.726 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 46' ' ' PHE . . . . . 0.65 ' O ' ' CG ' ' A' ' 47' ' ' ARG . 6.9 m-85 118.41 104.08 0.0 OUTLIER 'General case' 0 N--CA 1.499 2.001 0 O-C-N 125.375 1.672 . . . . 1.0 110.592 -179.743 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 47' ' ' ARG . . . . . 0.756 ' O ' ' SG ' ' A' ' 48' ' ' CYS . 0.0 OUTLIER 98.42 162.78 0.01 OUTLIER 'General case' 0 N--CA 1.472 0.64 0 O-C-N 125.08 1.488 . . . . 1.0 111.434 178.232 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 48' ' ' CYS . . . . . 0.756 ' SG ' ' O ' ' A' ' 47' ' ' ARG . 7.0 p 56.66 72.08 0.53 Allowed 'General case' 0 C--O 1.202 -1.416 0 O-C-N 125.081 1.488 . . . . 1.0 110.567 -177.591 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 49' ' ' ASN . . . . . 0.697 ' O ' ' N ' ' A' ' 51' ' ' GLU . 0.5 OUTLIER -144.66 155.45 56.53 Favored Pre-proline 0 N--CA 1.474 0.728 0 CA-C-O 118.753 -0.642 . . . . 1.0 110.438 179.752 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . 0.501 ' C ' ' H ' ' A' ' 52' ' ' ARG . 53.9 Cg_exo -51.8 57.75 0.02 OUTLIER 'Trans proline' 0 N--CA 1.509 2.419 0 C-N-CA 122.688 2.259 . . . . 1.0 112.138 177.775 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . 0.697 ' N ' ' O ' ' A' ' 49' ' ' ASN . 59.2 mm-40 47.93 13.56 0.04 OUTLIER 'General case' 0 C--N 1.321 -0.658 0 N-CA-C 110.029 -0.36 . . . . 1.0 110.029 -179.129 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . 0.634 HH11 ' CE1' ' A' ' 92' ' ' HIS . 23.5 mtm-85 -100.08 142.86 30.99 Favored 'General case' 0 N--CA 1.475 0.806 0 CA-C-O 121.204 0.526 . . . . 1.0 112.052 -179.857 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 9.6 tp -53.29 135.89 14.92 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.648 0 CA-C-O 124.426 2.06 . . . . 1.0 114.579 -178.661 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -88.62 88.02 7.47 Favored 'General case' 0 C--N 1.312 -1.022 0 CA-C-N 110.063 -3.244 . . . . 1.0 113.643 179.567 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 18.6 tt -144.47 153.34 15.06 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.67 0 CA-C-N 115.478 -0.783 . . . . 1.0 109.678 177.273 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 107.76 3.1 34.61 Favored Glycine 0 C--N 1.348 1.226 0 N-CA-C 110.878 -0.889 . . . . 1.0 110.878 -179.891 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . 0.56 ' OD2' ' NH1' ' A' ' 43' ' ' ARG . 5.6 p-10 -86.88 103.38 15.22 Favored 'General case' 0 CA--C 1.533 0.292 0 CA-C-O 122.185 0.993 . . . . 1.0 112.651 -178.834 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 58' ' ' TRP . . . . . . . . . . . . . 38.4 m0 -81.39 -177.97 6.73 Favored 'General case' 0 N--CA 1.47 0.563 0 CA-C-N 114.023 -1.444 . . . . 1.0 108.154 178.205 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 59' ' ' ARG . . . . . 0.673 ' HD2' ' H ' ' A' ' 59' ' ' ARG . 0.0 OUTLIER -101.85 -54.86 2.63 Favored 'General case' 0 CA--C 1.56 1.359 0 CA-C-N 121.91 2.141 . . . . 1.0 110.74 179.676 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 60' ' ' TYR . . . . . 0.461 ' H ' ' HD2' ' A' ' 59' ' ' ARG . 93.2 t80 -79.45 -14.34 58.98 Favored 'General case' 0 N--CA 1.485 1.305 0 C-N-CA 125.723 1.609 . . . . 1.0 112.225 -178.283 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 31.9 tt0 -70.77 -14.11 62.31 Favored 'General case' 0 C--N 1.304 -1.387 0 N-CA-C 108.635 -0.876 . . . . 1.0 108.635 -179.874 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . 0.416 ' O ' ' N ' ' A' ' 66' ' ' GLY . 13.4 m -45.7 -53.07 2.29 Favored 'Isoleucine or valine' 0 CA--C 1.493 -1.244 0 CA-C-N 115.811 -0.632 . . . . 1.0 109.972 -174.495 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 63' ' ' ALA . . . . . 0.789 ' O ' ' HD2' ' A' ' 67' ' ' ARG . . . -65.2 -50.39 66.06 Favored 'General case' 0 N--CA 1.415 -2.189 0 N-CA-C 108.943 -0.762 . . . . 1.0 108.943 179.364 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -51.03 -59.39 4.21 Favored 'General case' 0 CA--C 1.548 0.904 0 C-N-CA 119.795 -0.762 . . . . 1.0 110.715 -179.996 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . 0.59 ' C ' ' H ' ' A' ' 67' ' ' ARG . 28.9 t70 -64.79 -50.34 67.16 Favored 'General case' 0 C--O 1.241 0.632 0 CA-C-O 121.694 0.759 . . . . 1.0 109.704 178.371 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . 0.416 ' N ' ' O ' ' A' ' 62' ' ' VAL . . . -61.34 29.53 0.05 OUTLIER Glycine 0 CA--C 1.535 1.325 0 O-C-N 121.801 -0.562 . . . . 1.0 112.016 178.106 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 67' ' ' ARG . . . . . 0.789 ' HD2' ' O ' ' A' ' 63' ' ' ALA . 0.0 OUTLIER -79.58 -2.84 44.29 Favored 'General case' 0 CA--C 1.5 -0.946 0 CA-C-O 118.632 -0.699 . . . . 1.0 109.371 175.206 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . 0.555 ' O ' ' CG ' ' A' ' 72' ' ' HIS . 11.1 mp -33.94 -28.06 0.01 OUTLIER 'General case' 0 N--CA 1.486 1.327 0 N-CA-C 107.023 -1.473 . . . . 1.0 107.023 -179.012 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . 0.674 ' N ' ' O ' ' A' ' 67' ' ' ARG . 3.4 tt -64.83 -64.23 0.92 Allowed 'General case' 0 CA--C 1.548 0.898 0 N-CA-C 106.572 -1.64 . . . . 1.0 106.572 175.573 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . 0.704 ' C ' ' H ' ' A' ' 72' ' ' HIS . . . -78.76 -73.53 0.32 Allowed 'General case' 0 N--CA 1.478 0.948 0 N-CA-C 107.828 -1.175 . . . . 1.0 107.828 177.865 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . 0.628 ' H ' ' HB3' ' A' ' 67' ' ' ARG . . . -46.23 2.34 0.0 OUTLIER 'General case' 0 N--CA 1.469 0.499 0 C-N-CA 124.435 1.094 . . . . 1.0 112.747 178.402 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 72' ' ' HIS . . . . . 0.704 ' H ' ' C ' ' A' ' 70' ' ' ALA . 0.2 OUTLIER -20.02 -70.53 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.227 0 C-N-CA 123.179 0.592 . . . . 1.0 111.139 -177.993 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 73' ' ' MET . . . . . . . . . . . . . 16.4 mtm -73.9 -47.63 36.55 Favored 'General case' 0 C--N 1.31 -1.131 0 C-N-CA 118.967 -1.093 . . . . 1.0 109.611 177.149 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . 0.577 ' O ' ' N ' ' A' ' 76' ' ' GLY . 24.4 t -46.68 -48.98 6.94 Favored 'Isoleucine or valine' 0 C--N 1.344 0.354 0 CA-C-O 118.456 -0.783 . . . . 1.0 110.958 -176.599 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 75' ' ' ASN . . . . . 0.53 ' O ' ' N ' ' A' ' 77' ' ' ILE . 26.9 t-20 -39.18 -21.56 0.01 OUTLIER 'General case' 0 C--N 1.352 0.705 0 CA-C-O 122.895 1.331 . . . . 1.0 110.435 177.401 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . 0.577 ' N ' ' O ' ' A' ' 74' ' ' VAL . . . -42.31 -19.89 0.06 OUTLIER Glycine 0 CA--C 1.539 1.533 0 CA-C-N 113.55 -1.659 . . . . 1.0 109.248 178.864 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . 0.689 ' O ' ' N ' ' A' ' 80' ' ' ALA . 7.7 pt -71.24 -45.41 70.71 Favored 'Isoleucine or valine' 0 C--O 1.207 -1.174 0 CA-C-O 122.01 0.91 . . . . 1.0 109.458 -179.341 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . 0.485 ' C ' ' O ' ' A' ' 77' ' ' ILE . 26.8 m -35.21 -32.43 0.04 OUTLIER 'Isoleucine or valine' 0 CA--C 1.556 1.178 0 CA-C-N 113.058 -1.883 . . . . 1.0 107.359 -176.483 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . 0.529 ' N ' ' O ' ' A' ' 77' ' ' ILE . 1.1 pp -92.94 -26.97 4.66 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 CA-C-O 121.511 0.672 . . . . 1.0 111.571 177.525 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 80' ' ' ALA . . . . . 0.689 ' N ' ' O ' ' A' ' 77' ' ' ILE . . . -87.24 -18.78 29.46 Favored 'General case' 0 CA--C 1.55 0.949 0 N-CA-C 113.35 0.87 . . . . 1.0 113.35 178.976 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . 0.424 ' N ' ' O ' ' A' ' 77' ' ' ILE . 9.3 mm-40 -82.46 -71.87 0.47 Allowed 'General case' 0 N--CA 1.45 -0.426 0 C-N-CA 122.667 0.387 . . . . 1.0 110.169 -179.908 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 82' ' ' ASP . . . . . 0.549 ' O ' ' N ' ' A' ' 84' ' ' LEU . 92.9 m-20 -66.42 -16.81 64.39 Favored 'General case' 0 N--CA 1.444 -0.761 0 CA-C-O 119.09 -0.481 . . . . 1.0 110.261 -179.382 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . 0.501 ' O ' ' N ' ' A' ' 86' ' ' ALA . . . -15.19 -50.09 0.0 OUTLIER 'General case' 0 C--N 1.355 0.811 0 N-CA-C 113.04 0.755 . . . . 1.0 113.04 178.05 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . 0.549 ' N ' ' O ' ' A' ' 82' ' ' ASP . 0.2 OUTLIER -27.58 -50.78 0.06 Allowed 'General case' 0 C--N 1.355 0.827 0 N-CA-C 113.046 0.758 . . . . 1.0 113.046 -177.057 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 19.9 pt -85.57 -37.78 12.32 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.664 0 N-CA-C 109.584 -0.524 . . . . 1.0 109.584 179.235 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . 0.682 ' O ' ' N ' ' A' ' 88' ' ' ALA . . . -47.46 -54.86 10.31 Favored 'General case' 0 CA--C 1.518 -0.287 0 C-N-CA 120.329 -0.548 . . . . 1.0 110.333 -179.341 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . 0.558 ' C ' ' H ' ' A' ' 89' ' ' VAL . 0.5 OUTLIER -38.21 -14.81 0.01 OUTLIER 'General case' 0 CA--C 1.539 0.525 0 CA-C-N 117.768 0.258 . . . . 1.0 111.214 -179.686 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . 0.682 ' N ' ' O ' ' A' ' 86' ' ' ALA . . . -54.8 -5.26 0.08 Allowed 'General case' 0 C--O 1.218 -0.577 0 N-CA-C 108.811 -0.811 . . . . 1.0 108.811 177.213 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 89' ' ' VAL . . . . . 0.558 ' H ' ' C ' ' A' ' 87' ' ' GLU . 4.4 m -33.13 -31.53 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.551 0.991 0 CA-C-O 121.099 0.476 . . . . 1.0 110.787 -177.591 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 90' ' ' GLY . . . . . 0.523 ' N ' ' O ' ' A' ' 88' ' ' ALA . . . -49.33 -75.2 0.21 Allowed Glycine 0 CA--C 1.549 2.2 0 C-N-CA 119.889 -1.148 . . . . 1.0 111.21 -178.734 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 91' ' ' PRO . . . . . 0.466 ' HD2' ' O ' ' A' ' 88' ' ' ALA . 9.9 Cg_endo -52.05 -28.88 34.14 Favored 'Trans proline' 0 N--CA 1.504 2.114 0 C-N-CA 122.955 2.437 . . . . 1.0 111.229 176.663 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 92' ' ' HIS . . . . . 0.634 ' CE1' HH11 ' A' ' 52' ' ' ARG . 26.9 m80 -54.14 -19.37 4.91 Favored 'General case' 0 CA--C 1.514 -0.424 0 N-CA-C 107.4 -1.333 . . . . 1.0 107.4 -176.473 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . 0.549 ' O ' ' N ' ' A' ' 96' ' ' ALA . 20.7 tp -57.03 -49.98 74.13 Favored 'General case' 0 N--CA 1.45 -0.425 0 N-CA-C 106.59 -1.633 . . . . 1.0 106.59 176.797 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -49.13 -51.9 29.36 Favored 'General case' 0 CA--C 1.517 -0.301 0 N-CA-C 106.662 -1.607 . . . . 1.0 106.662 -179.352 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 3.0 mmt180 -61.03 -32.13 71.75 Favored 'General case' 0 C--N 1.316 -0.849 0 N-CA-C 108.622 -0.881 . . . . 1.0 108.622 177.191 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 96' ' ' ALA . . . . . 0.777 ' O ' ' N ' ' A' ' 100' ' ' ILE . . . -55.82 -51.44 67.47 Favored 'General case' 0 C--O 1.199 -1.556 0 C-N-CA 118.817 -1.153 . . . . 1.0 107.918 -178.947 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . 0.466 ' C ' ' O ' ' A' ' 96' ' ' ALA . 0.2 OUTLIER -34.15 -26.15 0.01 OUTLIER 'General case' 0 CA--C 1.587 2.399 0 N-CA-C 107.58 -1.267 . . . . 1.0 107.58 -178.325 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 98' ' ' GLY . . . . . 0.659 ' N ' ' O ' ' A' ' 96' ' ' ALA . . . -86.48 -52.77 3.1 Favored Glycine 0 CA--C 1.546 1.981 0 CA-C-O 123.967 1.871 . . . . 1.0 110.617 173.963 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 99' ' ' GLN . . . . . 0.612 ' N ' ' O ' ' A' ' 96' ' ' ALA . 24.6 tt0 -76.97 7.56 4.74 Favored 'General case' 0 N--CA 1.418 -2.047 0 N-CA-C 107.837 -1.171 . . . . 1.0 107.837 177.177 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 100' ' ' ILE . . . . . 0.777 ' N ' ' O ' ' A' ' 96' ' ' ALA . 6.8 tp -62.48 -47.91 90.77 Favored 'Isoleucine or valine' 0 CA--C 1.481 -1.678 0 N-CA-C 108.66 -0.867 . . . . 1.0 108.66 179.82 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 101' ' ' VAL . . . . . 0.57 ' N ' ' CG2' ' A' ' 100' ' ' ILE . 46.3 t -53.57 -59.92 1.61 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.622 0 C-N-CA 117.352 -1.739 . . . . 1.0 108.341 179.095 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 102' ' ' CYS . . . . . 0.489 ' SG ' ' CG ' ' A' ' 99' ' ' GLN . 0.0 OUTLIER -52.41 -31.7 35.52 Favored 'General case' 0 CA--C 1.545 0.767 0 C-N-CA 119.831 -0.748 . . . . 1.0 111.215 -176.743 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 103' ' ' ARG . . . . . 0.431 ' NH2' ' CB ' ' A' ' 96' ' ' ALA . 11.8 ttp180 -82.15 -47.89 11.98 Favored 'General case' 0 N--CA 1.494 1.759 0 CA-C-O 122.287 1.041 . . . . 1.0 113.014 178.666 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 104' ' ' TYR . . . . . 0.439 ' O ' ' CD2' ' A' ' 104' ' ' TYR . 50.6 t80 -92.08 22.73 4.17 Favored 'General case' 0 C--N 1.29 -1.98 0 CA-C-N 113.653 -1.612 . . . . 1.0 108.502 178.802 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 105' ' ' GLY . . . . . 0.527 ' N ' ' O ' ' A' ' 101' ' ' VAL . . . -159.81 -86.98 0.06 OUTLIER Glycine 0 CA--C 1.526 0.779 0 N-CA-C 110.337 -1.105 . . . . 1.0 110.337 178.618 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 106' ' ' ALA . . . . . 0.404 ' O ' ' O ' ' A' ' 105' ' ' GLY . . . 57.13 106.65 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.17 0 N-CA-C 109.22 -0.659 . . . . 1.0 109.22 -177.117 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 107' ' ' THR . . . . . 0.633 ' O ' ' CD ' ' A' ' 110' ' ' PRO . 26.0 m -134.24 -60.59 0.8 Allowed 'General case' 0 C--O 1.205 -1.276 0 CA-C-O 118.606 -0.711 . . . . 1.0 110.076 179.086 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 12.3 p -82.83 34.97 0.04 OUTLIER 'Isoleucine or valine' 0 C--O 1.235 0.29 0 C-N-CA 123.659 0.784 . . . . 1.0 111.265 -175.812 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 109' ' ' ILE . . . . . 0.665 ' N ' ' CD ' ' A' ' 110' ' ' PRO . 31.5 pt -104.7 -22.87 0.19 Allowed Pre-proline 0 CA--C 1.568 1.641 0 CA-C-N 115.876 -0.602 . . . . 1.0 111.363 177.55 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 110' ' ' PRO . . . . . 0.665 ' CD ' ' N ' ' A' ' 109' ' ' ILE . 71.6 Cg_endo -73.14 -15.66 25.6 Favored 'Trans proline' 0 N--CA 1.483 0.883 0 C-N-CA 123.292 2.661 . . . . 1.0 113.674 -177.402 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 6.3 t30 -61.72 -69.2 0.26 Allowed 'General case' 0 C--O 1.237 0.401 0 C-N-CA 120.357 -0.537 . . . . 1.0 110.472 -177.941 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -65.53 -28.68 44.92 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.413 0 CA-C-O 122.015 0.912 . . . . 1.0 109.996 179.614 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 113' ' ' ASN . . . . . 0.487 ' O ' ' OE1' ' A' ' 117' ' ' GLU . 42.1 t30 -55.16 -63.86 1.02 Allowed 'General case' 0 C--N 1.306 -1.32 0 CA-C-N 115.062 -0.972 . . . . 1.0 110.519 -176.738 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -61.49 -23.06 65.63 Favored 'General case' 0 C--N 1.31 -1.132 0 C-N-CA 120.788 -0.365 . . . . 1.0 111.383 179.832 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -79.34 -60.01 2.54 Favored 'General case' 0 CA--C 1.536 0.433 0 N-CA-C 112.485 0.55 . . . . 1.0 112.485 178.733 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 116' ' ' ILE . . . . . 0.54 ' O ' ' N ' ' A' ' 119' ' ' LEU . 3.3 mm -70.3 -49.11 56.74 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.365 0 O-C-N 121.102 -0.999 . . . . 1.0 112.187 -177.982 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 117' ' ' GLU . . . . . 0.612 ' OE1' ' N ' ' A' ' 117' ' ' GLU . 10.3 mp0 -46.96 -61.55 1.82 Allowed 'General case' 0 C--N 1.317 -0.846 0 N-CA-C 108.728 -0.841 . . . . 1.0 108.728 -176.815 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 2.0 p -51.9 -16.35 0.64 Allowed 'Isoleucine or valine' 0 N--CA 1.443 -0.797 0 C-N-CA 119.896 -0.721 . . . . 1.0 109.078 179.157 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 119' ' ' LEU . . . . . 0.54 ' N ' ' O ' ' A' ' 116' ' ' ILE . 0.3 OUTLIER -78.39 -60.45 2.37 Favored 'General case' 0 C--N 1.356 0.87 0 N-CA-C 108.808 -0.812 . . . . 1.0 108.808 176.802 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -68.29 -83.07 0.15 Allowed Glycine 0 C--N 1.367 2.251 0 C-N-CA 116.759 -2.639 . . . . 1.0 110.747 178.671 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 121' ' ' THR . . . . . 0.628 ' HG1' ' HE2' ' A' ' 72' ' ' HIS . 13.3 m -159.75 -18.83 0.06 Allowed 'General case' 0 N--CA 1.475 0.801 0 CA-C-O 122.107 0.956 . . . . 1.0 109.307 -179.645 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 122' ' ' GLY . . . . . 0.45 ' O ' ' C ' ' A' ' 123' ' ' THR . . . 111.48 -36.73 4.04 Favored Glycine 0 CA--C 1.523 0.588 0 CA-C-N 113.365 -1.743 . . . . 1.0 112.098 179.733 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 123' ' ' THR . . . . . 0.45 ' C ' ' O ' ' A' ' 122' ' ' GLY . 91.1 m -31.4 95.15 0.01 OUTLIER 'General case' 0 N--CA 1.477 0.904 0 CA-C-N 118.913 1.356 . . . . 1.0 112.369 -178.267 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 124' ' ' ASP . . . . . 0.406 ' N ' ' O ' ' A' ' 122' ' ' GLY . 0.0 OUTLIER -146.02 144.6 30.19 Favored 'General case' 0 C--N 1.347 0.494 0 N-CA-C 108.259 -1.015 . . . . 1.0 108.259 178.596 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 125' ' ' TYR . . . . . 0.451 ' O ' ' NE ' ' A' ' 126' ' ' ARG . 1.1 p90 -149.57 148.79 29.76 Favored 'General case' 0 C--N 1.325 -0.498 0 N-CA-C 109.951 -0.389 . . . . 1.0 109.951 179.817 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 126' ' ' ARG . . . . . 0.495 ' HA ' ' HE ' ' A' ' 126' ' ' ARG . 0.0 OUTLIER -146.73 149.48 33.49 Favored 'General case' 0 N--CA 1.465 0.302 0 N-CA-C 109.2 -0.667 . . . . 1.0 109.2 177.081 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 127' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.222 -0.389 0 CA-C-O 117.998 -1.001 . . . . 1.0 111.057 -178.507 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 128' ' ' MTN . . . . . 0.454 ' C9 ' ' HE ' ' A' ' 47' ' ' ARG . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 129' ' ' MTN . . . . . 0.528 ' S1 ' ' C7 ' ' A' ' 129' ' ' MTN . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 130' ' ' MTN . . . . . 0.479 ' H73' ' SG ' ' A' ' 102' ' ' CYS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.492 1.633 0 N-CA-C 109.219 -0.66 . . . . 1.0 109.219 . . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 2' ' ' SER . . . . . 0.462 ' O ' ' CG ' ' A' ' 3' ' ' ASP . 86.7 p -89.19 4.48 48.47 Favored 'General case' 0 N--CA 1.463 0.212 0 CA-C-N 115.97 -0.559 . . . . 1.0 111.338 -179.56 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . 0.462 ' CG ' ' O ' ' A' ' 2' ' ' SER . 11.4 m-20 160.39 118.46 0.0 OUTLIER 'General case' 0 N--CA 1.465 0.316 0 O-C-N 123.578 0.549 . . . . 1.0 110.833 179.44 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . 0.443 ' O ' ' OD1' ' A' ' 5' ' ' ASP . 72.9 t80 -149.79 145.57 26.69 Favored 'General case' 0 CA--C 1.518 -0.261 0 N-CA-C 109.073 -0.714 . . . . 1.0 109.073 178.027 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 5' ' ' ASP . . . . . 0.443 ' OD1' ' O ' ' A' ' 4' ' ' PHE . 72.0 m-20 -149.92 146.5 27.1 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.963 -0.562 . . . . 1.0 110.472 -179.054 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 6' ' ' THR . . . . . 0.696 ' O ' ' N ' ' A' ' 10' ' ' SER . 0.2 OUTLIER -114.31 -156.23 0.59 Allowed 'General case' 0 C--O 1.206 -1.219 0 CA-C-O 121.699 0.762 . . . . 1.0 110.245 179.291 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . 0.503 ' O ' ' CB ' ' A' ' 11' ' ' ARG . 10.5 tm-20 -57.04 -48.37 78.68 Favored 'General case' 0 C--N 1.306 -1.323 0 O-C-N 121.67 -0.643 . . . . 1.0 110.361 -178.443 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 8' ' ' ARG . . . . . 0.498 ' O ' ' CB ' ' A' ' 12' ' ' ALA . 39.1 ttm180 -67.28 -58.23 5.21 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-O 122.046 0.927 . . . . 1.0 109.781 178.506 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . 0.589 ' O ' ' HB ' ' A' ' 13' ' ' VAL . 0.2 OUTLIER -65.2 -51.16 68.76 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.847 0 CA-C-N 114.64 -1.163 . . . . 1.0 109.456 -178.243 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 10' ' ' SER . . . . . 0.696 ' N ' ' O ' ' A' ' 6' ' ' THR . 1.1 m -69.43 -64.07 0.95 Allowed 'General case' 0 C--N 1.302 -1.462 0 O-C-N 120.78 -1.2 . . . . 1.0 111.325 178.801 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 11' ' ' ARG . . . . . 0.503 ' CB ' ' O ' ' A' ' 7' ' ' GLU . 30.5 ttm-85 -63.97 -48.65 75.63 Favored 'General case' 0 N--CA 1.472 0.633 0 O-C-N 121.396 -0.815 . . . . 1.0 112.735 -176.206 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . 0.498 ' CB ' ' O ' ' A' ' 8' ' ' ARG . . . -70.03 -58.61 3.63 Favored 'General case' 0 N--CA 1.472 0.663 0 C-N-CA 118.96 -1.096 . . . . 1.0 109.284 178.286 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . 0.705 ' O ' ' CB ' ' A' ' 17' ' ' LEU . 1.0 OUTLIER -63.18 -54.08 37.78 Favored 'Isoleucine or valine' 0 C--O 1.195 -1.788 0 C-N-CA 117.773 -1.571 . . . . 1.0 108.921 -179.662 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . 0.607 ' O ' HG23 ' A' ' 18' ' ' VAL . . . -63.48 -62.87 1.39 Allowed 'General case' 0 N--CA 1.48 1.073 0 C-N-CA 117.123 -1.831 . . . . 1.0 111.353 179.888 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . 0.543 ' O ' ' N ' ' A' ' 19' ' ' GLY . . . -54.93 -55.98 24.61 Favored 'General case' 0 N--CA 1.485 1.286 0 C-N-CA 118.877 -1.129 . . . . 1.0 111.311 -177.327 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . 0.462 ' CB ' ' O ' ' A' ' 12' ' ' ALA . . . -66.06 -57.16 8.34 Favored 'General case' 0 CA--C 1.548 0.874 0 C-N-CA 119.589 -0.844 . . . . 1.0 109.935 -178.425 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . 0.705 ' CB ' ' O ' ' A' ' 13' ' ' VAL . 7.0 tt -56.29 -54.07 49.77 Favored 'General case' 0 N--CA 1.483 1.206 0 CA-C-N 115.065 -0.97 . . . . 1.0 108.421 -178.224 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . 0.7 HG23 ' H ' ' A' ' 19' ' ' GLY . 1.8 m -71.14 -57.81 6.71 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.602 0 C-N-CA 119.307 -0.957 . . . . 1.0 110.169 179.868 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . 0.7 ' H ' HG23 ' A' ' 18' ' ' VAL . . . -57.88 -171.54 0.25 Allowed Glycine 0 N--CA 1.448 -0.526 0 N-CA-C 111.17 -0.772 . . . . 1.0 111.17 -177.911 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 20' ' ' PRO . . . . . 0.585 ' O ' ' N ' ' A' ' 24' ' ' ALA . 89.8 Cg_endo -81.76 -24.51 4.12 Favored 'Trans proline' 0 C--N 1.298 -2.1 0 C-N-CA 122.691 2.261 . . . . 1.0 113.276 -178.583 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . 0.441 ' O ' ' N ' ' A' ' 24' ' ' ALA . . . -63.96 -61.89 5.71 Favored Glycine 0 N--CA 1.484 1.856 0 C-N-CA 119.237 -1.458 . . . . 1.0 111.981 -176.992 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . 0.442 ' H ' ' HA ' ' A' ' 16' ' ' ALA . . . -53.01 -51.83 43.55 Favored Glycine 0 N--CA 1.47 0.927 0 N-CA-C 106.212 -2.755 . . . . 1.0 106.212 179.69 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 34.3 t -56.88 -30.74 34.12 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.733 0 N-CA-C 108.832 -0.803 . . . . 1.0 108.832 178.332 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . 0.585 ' N ' ' O ' ' A' ' 20' ' ' PRO . . . -58.22 -61.37 2.62 Favored 'General case' 0 C--N 1.352 0.706 0 C-N-CA 118.354 -1.339 . . . . 1.0 109.499 179.638 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 9.0 mp -57.59 -44.27 85.24 Favored 'General case' 0 C--O 1.223 -0.315 0 C-N-CA 119.629 -0.829 . . . . 1.0 110.341 -177.893 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 65.5 t -58.6 -60.33 2.46 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.861 0 C-N-CA 119.087 -1.045 . . . . 1.0 111.053 -178.61 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 18.1 t -58.51 -41.83 82.88 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.231 0 N-CA-C 112.843 0.683 . . . . 1.0 112.843 -177.64 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . 0.528 ' HZ3' ' CG2' ' A' ' 29' ' ' VAL . 3.9 pptp? -68.33 -54.41 17.56 Favored 'General case' 0 C--N 1.325 -0.459 0 C-N-CA 119.078 -1.049 . . . . 1.0 109.966 -178.027 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . 0.528 ' CG2' ' HZ3' ' A' ' 28' ' ' LYS . 1.3 t -60.58 -50.71 79.32 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.6 0 C-N-CA 119.748 -0.781 . . . . 1.0 110.576 179.862 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 30' ' ' CYS . . . . . . . . . . . . . 8.6 t -65.14 -63.1 1.19 Allowed 'General case' 0 N--CA 1.447 -0.6 0 C-N-CA 119.425 -0.91 . . . . 1.0 110.51 -179.184 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -56.19 -50.38 71.39 Favored 'General case' 0 CA--C 1.517 -0.323 0 C-N-CA 120.3 -0.56 . . . . 1.0 111.168 -177.53 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . 0.419 ' O ' ' HB2' ' A' ' 33' ' ' LEU . . . 74.3 70.44 1.25 Allowed Glycine 0 N--CA 1.45 -0.43 0 N-CA-C 108.621 -1.791 . . . . 1.0 108.621 -178.182 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . 0.433 ' O ' ' N ' ' A' ' 35' ' ' GLY . 0.1 OUTLIER 84.75 93.8 0.04 OUTLIER Pre-proline 0 CA--C 1.55 0.968 0 O-C-N 124.477 0.751 . . . . 1.0 109.657 -178.286 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 74.7 Cg_exo -45.69 -13.55 0.08 OUTLIER 'Trans proline' 0 N--CA 1.491 1.378 0 C-N-CA 121.919 1.746 . . . . 1.0 113.634 -179.56 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . 0.433 ' N ' ' O ' ' A' ' 33' ' ' LEU . . . -62.81 -61.85 6.07 Favored Glycine 0 N--CA 1.471 0.989 0 C-N-CA 118.885 -1.626 . . . . 1.0 110.422 -178.263 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . 0.609 ' O ' HG23 ' A' ' 37' ' ' ILE . 34.3 m -76.94 -147.01 0.01 OUTLIER 'Isoleucine or valine' 0 C--O 1.213 -0.858 0 N-CA-C 107.58 -1.267 . . . . 1.0 107.58 178.431 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . 0.609 HG23 ' O ' ' A' ' 36' ' ' VAL . 0.3 OUTLIER 71.93 75.4 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.474 0.741 0 CA-C-O 122.993 1.378 . . . . 1.0 111.675 179.934 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 38' ' ' HIS . . . . . 0.433 ' CD2' ' O ' ' A' ' 37' ' ' ILE . 35.1 m170 -137.75 131.97 32.06 Favored 'General case' 0 C--N 1.327 -0.376 0 O-C-N 120.707 -1.246 . . . . 1.0 109.103 178.997 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 1.7 t -128.65 112.99 19.19 Favored Pre-proline 0 CA--C 1.542 0.642 0 N-CA-C 109.015 -0.735 . . . . 1.0 109.015 179.745 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 40' ' ' PRO . . . . . 0.547 ' O ' ' NE ' ' A' ' 42' ' ' ARG . 83.8 Cg_exo -42.63 -68.05 0.11 Allowed 'Trans proline' 0 N--CA 1.49 1.293 0 C-N-CA 121.542 1.495 . . . . 1.0 112.569 -178.673 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -74.7 128.02 34.54 Favored 'General case' 0 C--N 1.316 -0.889 0 CA-C-N 115.173 -0.921 . . . . 1.0 111.244 -177.694 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . 0.657 ' C ' ' H ' ' A' ' 44' ' ' GLY . 0.1 OUTLIER -173.78 175.44 2.89 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 114.859 -1.064 . . . . 1.0 110.726 179.631 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 43' ' ' ARG . . . . . 0.601 ' C ' ' H ' ' A' ' 45' ' ' PHE . 25.3 tpt180 -63.51 19.11 0.01 OUTLIER 'General case' 0 CA--C 1.549 0.905 0 CA-C-O 121.254 0.549 . . . . 1.0 109.927 178.532 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . 0.657 ' H ' ' C ' ' A' ' 42' ' ' ARG . . . 69.93 -27.94 0.41 Allowed Glycine 0 C--N 1.342 0.906 0 N-CA-C 110.66 -0.976 . . . . 1.0 110.66 -179.715 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . 0.63 ' O ' ' HB2' ' A' ' 46' ' ' PHE . 1.1 p90 -159.79 161.01 34.52 Favored 'General case' 0 C--N 1.326 -0.415 0 N-CA-C 109.022 -0.733 . . . . 1.0 109.022 179.77 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 46' ' ' PHE . . . . . 0.63 ' HB2' ' O ' ' A' ' 45' ' ' PHE . 0.7 OUTLIER 131.87 94.35 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.506 0 O-C-N 125.414 1.696 . . . . 1.0 109.604 179.153 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 47' ' ' ARG . . . . . 0.581 ' CB ' ' O ' ' A' ' 46' ' ' PHE . 0.0 OUTLIER 112.58 143.14 0.0 OUTLIER 'General case' 0 N--CA 1.48 1.072 0 O-C-N 124.415 1.072 . . . . 1.0 111.709 178.229 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 35.8 t 66.96 73.18 0.35 Allowed 'General case' 0 C--O 1.22 -0.463 0 O-C-N 124.317 1.011 . . . . 1.0 110.579 179.257 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 49' ' ' ASN . . . . . 0.516 ' O ' ' N ' ' A' ' 51' ' ' GLU . 0.4 OUTLIER -136.44 153.89 76.54 Favored Pre-proline 0 CA--C 1.536 0.435 0 N-CA-C 109.863 -0.421 . . . . 1.0 109.863 -179.19 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . 0.569 ' C ' ' H ' ' A' ' 52' ' ' ARG . 27.9 Cg_endo -58.64 56.67 0.06 OUTLIER 'Trans proline' 0 N--CA 1.51 2.455 0 C-N-CA 123.219 2.612 . . . . 1.0 113.516 179.931 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . 0.558 ' OE1' ' ND1' ' A' ' 92' ' ' HIS . 49.1 mt-10 63.85 -34.44 0.14 Allowed 'General case' 0 N--CA 1.47 0.541 0 CA-C-N 116.129 -0.487 . . . . 1.0 111.984 179.855 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . 0.569 ' H ' ' C ' ' A' ' 50' ' ' PRO . 75.7 mtt85 -45.9 136.3 6.5 Favored 'General case' 0 C--N 1.325 -0.468 0 N-CA-C 109.588 -0.523 . . . . 1.0 109.588 179.696 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . 0.607 ' O ' ' N ' ' A' ' 55' ' ' ILE . 3.0 tp -49.73 125.56 3.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 N-CA-C 109.615 -0.513 . . . . 1.0 109.615 -178.713 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -57.17 80.37 0.01 OUTLIER 'General case' 0 C--N 1.322 -0.588 0 CA-C-O 121.931 0.872 . . . . 1.0 109.054 -177.393 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . 0.607 ' N ' ' O ' ' A' ' 53' ' ' ILE . 3.3 tt -155.12 165.01 1.26 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.249 0 CA-C-N 114.687 -1.142 . . . . 1.0 111.449 178.501 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 105.55 -28.83 12.77 Favored Glycine 0 C--O 1.226 -0.405 0 CA-C-N 115.916 -0.584 . . . . 1.0 112.134 176.737 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -52.56 117.61 3.01 Favored 'General case' 0 CA--C 1.537 0.478 0 CA-C-N 118.013 0.906 . . . . 1.0 112.627 -178.783 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 58' ' ' TRP . . . . . . . . . . . . . 36.1 m95 -79.83 168.26 19.51 Favored 'General case' 0 CA--C 1.556 1.182 0 CA-C-O 124.214 1.959 . . . . 1.0 111.045 178.649 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -86.17 -64.14 1.2 Allowed 'General case' 0 N--CA 1.509 2.518 0 CA-C-N 110.745 -2.934 . . . . 1.0 112.902 -176.989 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 60' ' ' TYR . . . . . 0.415 ' O ' ' CG ' ' A' ' 60' ' ' TYR . 17.5 t80 -88.07 -16.44 33.56 Favored 'General case' 0 N--CA 1.483 1.205 0 N-CA-C 113.171 0.804 . . . . 1.0 113.171 179.728 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . 0.49 ' O ' ' N ' ' A' ' 65' ' ' ASP . 11.3 tt0 -79.42 -12.88 59.89 Favored 'General case' 0 C--N 1.313 -1.002 0 O-C-N 121.704 -0.622 . . . . 1.0 109.64 179.941 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . 0.557 ' O ' ' N ' ' A' ' 66' ' ' GLY . 12.2 m -45.42 -51.4 2.74 Favored 'Isoleucine or valine' 0 CA--C 1.5 -0.974 0 C-N-CA 120.04 -0.664 . . . . 1.0 110.354 -176.126 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 63' ' ' ALA . . . . . 0.435 ' O ' ' HG3' ' A' ' 67' ' ' ARG . . . -68.29 -48.35 65.19 Favored 'General case' 0 N--CA 1.426 -1.66 0 C-N-CA 119.752 -0.779 . . . . 1.0 109.325 179.763 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 1.8 t-80 -56.49 -59.65 4.68 Favored 'General case' 0 CA--C 1.545 0.755 0 CA-C-N 115.358 -0.837 . . . . 1.0 110.37 -179.645 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . 0.593 ' C ' ' H ' ' A' ' 67' ' ' ARG . 1.0 OUTLIER -69.42 -55.46 10.25 Favored 'General case' 0 CA--C 1.549 0.917 0 CA-C-O 121.976 0.893 . . . . 1.0 109.756 177.767 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . 0.557 ' N ' ' O ' ' A' ' 62' ' ' VAL . . . -67.34 33.3 0.2 Allowed Glycine 0 CA--C 1.529 0.939 0 O-C-N 120.726 -1.234 . . . . 1.0 111.227 178.957 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 67' ' ' ARG . . . . . 0.644 ' O ' ' N ' ' A' ' 69' ' ' LEU . 0.8 OUTLIER -77.98 5.93 8.82 Favored 'General case' 0 C--N 1.32 -0.678 0 N-CA-C 108.85 -0.796 . . . . 1.0 108.85 177.045 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . 0.537 ' O ' ' HA ' ' A' ' 72' ' ' HIS . 0.3 OUTLIER -32.86 -28.36 0.01 OUTLIER 'General case' 0 N--CA 1.487 1.396 0 N-CA-C 108.226 -1.027 . . . . 1.0 108.226 -177.879 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . 0.644 ' N ' ' O ' ' A' ' 67' ' ' ARG . 2.4 mp -64.4 -65.2 0.71 Allowed 'General case' 0 N--CA 1.469 0.488 0 C-N-CA 117.922 -1.511 . . . . 1.0 107.301 177.16 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . 0.681 ' C ' ' H ' ' A' ' 72' ' ' HIS . . . -76.09 -72.22 0.34 Allowed 'General case' 0 CA--C 1.51 -0.573 0 N-CA-C 106.157 -1.794 . . . . 1.0 106.157 178.249 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . 0.523 ' H ' ' HB3' ' A' ' 67' ' ' ARG . . . -43.87 3.22 0.0 OUTLIER 'General case' 0 N--CA 1.472 0.634 0 C-N-CA 125.135 1.374 . . . . 1.0 113.798 176.897 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 72' ' ' HIS . . . . . 1.004 ' CD2' ' H ' ' A' ' 73' ' ' MET . 0.4 OUTLIER -19.41 -65.92 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.314 0 N-CA-C 112.728 0.64 . . . . 1.0 112.728 -176.372 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 73' ' ' MET . . . . . 1.004 ' H ' ' CD2' ' A' ' 72' ' ' HIS . 28.1 mtt -76.64 -45.78 28.56 Favored 'General case' 0 N--CA 1.438 -1.059 0 CA-C-N 119.023 0.828 . . . . 1.0 109.22 177.557 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . 0.591 ' O ' ' N ' ' A' ' 76' ' ' GLY . 94.5 t -45.27 -50.37 2.9 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.306 0 CA-C-O 118.082 -0.961 . . . . 1.0 109.894 -177.099 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 75' ' ' ASN . . . . . 0.512 ' C ' ' N ' ' A' ' 77' ' ' ILE . 19.0 t-20 -39.44 -21.18 0.01 OUTLIER 'General case' 0 C--N 1.357 0.925 0 CA-C-N 120.312 1.415 . . . . 1.0 110.715 177.346 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . 0.591 ' N ' ' O ' ' A' ' 74' ' ' VAL . . . -43.48 -20.95 0.14 Allowed Glycine 0 CA--C 1.534 1.237 0 N-CA-C 108.675 -1.77 . . . . 1.0 108.675 178.934 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . 0.763 ' O ' ' N ' ' A' ' 80' ' ' ALA . 96.7 mt -82.43 -50.04 16.49 Favored 'Isoleucine or valine' 0 C--O 1.213 -0.855 0 N-CA-C 108.766 -0.827 . . . . 1.0 108.766 179.421 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . 0.467 ' C ' ' O ' ' A' ' 77' ' ' ILE . 43.8 t -35.4 -34.49 0.06 OUTLIER 'Isoleucine or valine' 0 CA--C 1.541 0.603 0 N-CA-C 108.481 -0.933 . . . . 1.0 108.481 -178.254 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . 0.46 ' N ' ' O ' ' A' ' 77' ' ' ILE . 0.1 OUTLIER -88.16 -24.7 6.1 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.602 0 CA-C-O 121.007 0.432 . . . . 1.0 110.104 178.789 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 80' ' ' ALA . . . . . 0.763 ' N ' ' O ' ' A' ' 77' ' ' ILE . . . -89.78 -9.25 49.96 Favored 'General case' 0 CA--C 1.539 0.522 0 C-N-CA 123.843 0.857 . . . . 1.0 111.653 177.061 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . 0.544 ' N ' ' O ' ' A' ' 77' ' ' ILE . 51.2 tp10 -77.86 -71.77 0.4 Allowed 'General case' 0 N--CA 1.444 -0.765 0 CA-C-O 118.477 -0.773 . . . . 1.0 111.516 -179.288 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 82' ' ' ASP . . . . . 0.549 ' O ' HG13 ' A' ' 85' ' ' ILE . 1.7 m-20 -81.67 -18.72 43.53 Favored 'General case' 0 C--O 1.21 -0.983 0 O-C-N 123.517 0.51 . . . . 1.0 112.226 -178.095 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . 0.596 ' O ' ' N ' ' A' ' 85' ' ' ILE . . . -45.05 -52.41 9.0 Favored 'General case' 0 N--CA 1.469 0.491 0 N-CA-C 115.093 1.516 . . . . 1.0 115.093 -179.813 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . 0.822 ' H ' ' CD1' ' A' ' 84' ' ' LEU . 0.0 OUTLIER -31.78 -28.67 0.01 OUTLIER 'General case' 0 N--CA 1.48 1.048 0 CA-C-O 118.962 -0.542 . . . . 1.0 112.408 -174.304 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 85' ' ' ILE . . . . . 0.596 ' N ' ' O ' ' A' ' 83' ' ' ALA . 1.4 pp -100.02 -58.9 3.58 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.878 0 CA-C-N 118.631 0.65 . . . . 1.0 109.262 177.565 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . 0.578 ' H ' HG13 ' A' ' 85' ' ' ILE . . . -53.22 -37.53 62.11 Favored 'General case' 0 C--O 1.222 -0.347 0 CA-C-N 115.6 -0.727 . . . . 1.0 110.745 179.869 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 9.8 tt0 -47.5 -11.86 0.03 OUTLIER 'General case' 0 N--CA 1.465 0.295 0 CA-C-O 121.07 0.462 . . . . 1.0 110.046 179.649 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . 0.565 ' H ' ' C ' ' A' ' 86' ' ' ALA . . . -84.16 -2.33 56.65 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.754 -0.657 . . . . 1.0 110.103 179.657 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 89' ' ' VAL . . . . . 0.484 ' N ' ' O ' ' A' ' 86' ' ' ALA . 54.2 t -93.25 33.03 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.62 0 CA-C-N 115.414 -0.812 . . . . 1.0 109.231 179.079 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 90' ' ' GLY . . . . . 0.607 ' N ' ' HD2' ' A' ' 91' ' ' PRO . . . -67.22 -44.81 85.27 Favored Glycine 0 CA--C 1.535 1.342 0 CA-C-O 119.163 -0.798 . . . . 1.0 112.005 178.134 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 91' ' ' PRO . . . . . 0.607 ' HD2' ' N ' ' A' ' 90' ' ' GLY . 7.7 Cg_exo -39.3 -18.55 0.04 OUTLIER 'Trans proline' 0 N--CA 1.493 1.445 0 C-N-CA 122.236 1.957 . . . . 1.0 111.336 179.263 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 92' ' ' HIS . . . . . 0.713 ' O ' ' N ' ' A' ' 96' ' ' ALA . 3.3 p80 -53.95 -44.83 71.04 Favored 'General case' 0 N--CA 1.441 -0.923 0 N-CA-C 106.357 -1.72 . . . . 1.0 106.357 -179.568 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . 0.573 ' N ' ' CG ' ' A' ' 92' ' ' HIS . 2.3 pp -41.51 -61.38 1.07 Allowed 'General case' 0 CA--C 1.566 1.572 0 C-N-CA 119.578 -0.849 . . . . 1.0 111.762 177.682 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 94' ' ' ALA . . . . . 0.534 ' H ' ' HG ' ' A' ' 93' ' ' LEU . . . -58.29 -58.76 7.07 Favored 'General case' 0 C--O 1.219 -0.547 0 CA-C-N 119.229 0.922 . . . . 1.0 108.763 179.67 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 95' ' ' ARG . . . . . 0.578 ' O ' ' N ' ' A' ' 97' ' ' LEU . 44.7 mtp85 -51.56 -61.38 2.28 Favored 'General case' 0 C--O 1.246 0.885 0 CA-C-O 123.359 1.552 . . . . 1.0 108.658 178.177 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 96' ' ' ALA . . . . . 0.845 ' O ' ' N ' ' A' ' 98' ' ' GLY . . . -47.82 -14.37 0.05 OUTLIER 'General case' 0 N--CA 1.43 -1.429 0 O-C-N 118.186 -2.821 . . . . 1.0 111.206 -178.446 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . 0.628 ' O ' ' N ' ' A' ' 100' ' ' ILE 0.258 6.1 tt 3.68 -51.28 0.0 OUTLIER 'General case' 0 C--N 1.368 1.393 0 C-N-CA 124.109 0.964 . . . . 1.0 112.736 -170.72 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 98' ' ' GLY . . . . . 0.845 ' N ' ' O ' ' A' ' 96' ' ' ALA . . . -49.56 -23.05 4.36 Favored Glycine 0 N--CA 1.434 -1.479 0 CA-C-N 122.187 2.267 . . . . 1.0 108.152 174.589 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 99' ' ' GLN . . . . . 0.6 ' NE2' ' S1 ' ' A' ' 130' ' ' MTN . 25.2 mm100 -68.88 -19.81 64.24 Favored 'General case' 0 C--N 1.363 1.162 0 C-N-CA 117.308 -1.757 . . . . 1.0 108.58 177.765 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 100' ' ' ILE . . . . . 0.628 ' N ' ' O ' ' A' ' 97' ' ' LEU . 10.3 mt -65.41 -32.72 59.45 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.813 0 C-N-CA 119.749 -0.781 . . . . 1.0 110.214 177.179 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 101' ' ' VAL . . . . . 0.648 HG13 ' H ' ' A' ' 102' ' ' CYS . 3.8 p -60.13 -62.09 1.22 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.509 0 C-N-CA 119.355 -0.938 . . . . 1.0 110.622 -178.847 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 102' ' ' CYS . . . . . 0.648 ' H ' HG13 ' A' ' 101' ' ' VAL . 1.2 p -48.72 -19.29 0.34 Allowed 'General case' 0 C--O 1.217 -0.627 0 O-C-N 122.122 -0.361 . . . . 1.0 111.655 -178.364 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 103' ' ' ARG . . . . . 0.601 ' CG ' HH11 ' A' ' 103' ' ' ARG . 0.0 OUTLIER -85.9 -42.61 13.93 Favored 'General case' 0 N--CA 1.498 1.943 0 CA-C-O 124.419 2.057 . . . . 1.0 111.235 -179.98 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 104' ' ' TYR . . . . . 0.803 ' O ' ' CD1' ' A' ' 104' ' ' TYR . 0.0 OUTLIER -97.62 22.48 8.93 Favored 'General case' 0 C--N 1.267 -2.995 0 CA-C-N 110.561 -3.018 . . . . 1.0 107.332 176.949 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 105' ' ' GLY . . . . . 0.512 ' N ' ' O ' ' A' ' 101' ' ' VAL . . . -165.5 -88.3 0.07 OUTLIER Glycine 0 CA--C 1.529 0.913 0 O-C-N 119.634 -1.916 . . . . 1.0 109.081 179.13 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . 65.52 58.58 0.82 Allowed 'General case' 0 CA--C 1.533 0.308 0 CA-C-O 120.885 0.374 . . . . 1.0 110.688 -178.713 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 13.1 t -89.49 -5.34 57.4 Favored 'General case' 0 CA--C 1.514 -0.412 0 N-CA-C 108.614 -0.884 . . . . 1.0 108.614 178.593 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . 0.442 ' CG2' ' N ' ' A' ' 109' ' ' ILE . 14.7 m -87.53 -53.54 9.76 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.626 0 C-N-CA 120.842 -0.343 . . . . 1.0 110.608 178.537 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 109' ' ' ILE . . . . . 0.507 ' N ' ' CD ' ' A' ' 110' ' ' PRO . 0.2 OUTLIER -50.34 -34.34 10.65 Favored Pre-proline 0 C--N 1.351 0.658 0 N-CA-C 115.086 1.513 . . . . 1.0 115.086 -178.921 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 110' ' ' PRO . . . . . 0.507 ' CD ' ' N ' ' A' ' 109' ' ' ILE . 76.8 Cg_exo -53.07 -37.89 79.78 Favored 'Trans proline' 0 C--N 1.307 -1.612 0 CA-C-N 120.458 1.199 . . . . 1.0 111.276 -175.212 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -64.76 -67.48 0.43 Allowed 'General case' 0 C--N 1.325 -0.471 0 C-N-CA 119.639 -0.824 . . . . 1.0 109.326 179.647 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 112' ' ' ILE . . . . . 0.485 ' CG1' ' N ' ' A' ' 113' ' ' ASN . 0.3 OUTLIER -60.28 -44.91 96.7 Favored 'Isoleucine or valine' 0 C--O 1.213 -0.817 0 C-N-CA 120.245 -0.582 . . . . 1.0 110.527 -178.819 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 113' ' ' ASN . . . . . 0.498 ' CB ' ' O ' ' A' ' 109' ' ' ILE . 18.0 t30 -44.14 -63.07 0.94 Allowed 'General case' 0 C--N 1.31 -1.118 0 CA-C-N 115.181 -0.918 . . . . 1.0 112.113 -174.659 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -57.18 -23.8 50.05 Favored 'General case' 0 C--N 1.312 -1.061 0 C-N-CA 119.743 -0.783 . . . . 1.0 111.555 -179.664 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -84.21 -58.46 2.75 Favored 'General case' 0 CA--C 1.555 1.162 0 CA-C-O 122.503 1.144 . . . . 1.0 113.846 178.191 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 116' ' ' ILE . . . . . 0.497 ' O ' ' N ' ' A' ' 119' ' ' LEU . 76.0 mt -65.88 -59.8 3.52 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.863 0 CA-C-N 113.814 -1.539 . . . . 1.0 110.825 -177.254 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 117' ' ' GLU . . . . . 0.418 ' HB3' ' O ' ' A' ' 113' ' ' ASN . 11.3 tt0 -45.1 -62.49 1.22 Allowed 'General case' 0 C--N 1.307 -1.257 0 CA-C-N 116.058 -0.519 . . . . 1.0 109.743 -178.285 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 48.7 t -53.49 -14.88 0.76 Allowed 'Isoleucine or valine' 0 N--CA 1.437 -1.119 0 C-N-CA 119.922 -0.711 . . . . 1.0 109.628 -179.782 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 119' ' ' LEU . . . . . 0.497 ' N ' ' O ' ' A' ' 116' ' ' ILE . 3.7 tp -79.79 -60.79 2.21 Favored 'General case' 0 C--N 1.348 0.527 0 C-N-CA 119.776 -0.77 . . . . 1.0 109.966 178.261 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -70.3 -85.1 0.16 Allowed Glycine 0 C--N 1.357 1.735 0 C-N-CA 118.626 -1.75 . . . . 1.0 111.285 179.925 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 7.7 m -164.57 -22.79 0.03 OUTLIER 'General case' 0 C--N 1.325 -0.478 0 N-CA-C 108.121 -1.066 . . . . 1.0 108.121 -179.035 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 122' ' ' GLY . . . . . 0.53 ' O ' ' N ' ' A' ' 124' ' ' ASP . . . 114.37 -36.42 3.98 Favored Glycine 0 CA--C 1.523 0.562 0 CA-C-O 118.125 -1.375 . . . . 1.0 113.028 179.308 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 123' ' ' THR . . . . . 0.461 ' C ' ' O ' ' A' ' 122' ' ' GLY . 0.0 OUTLIER -32.54 91.32 0.0 OUTLIER 'General case' 0 N--CA 1.47 0.573 0 CA-C-N 119.609 1.705 . . . . 1.0 112.065 -179.565 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 124' ' ' ASP . . . . . 0.53 ' N ' ' O ' ' A' ' 122' ' ' GLY . 11.6 p-10 -146.43 144.39 29.67 Favored 'General case' 0 N--CA 1.463 0.222 0 N-CA-C 108.986 -0.746 . . . . 1.0 108.986 179.051 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 125' ' ' TYR . . . . . 0.419 ' CD1' ' C ' ' A' ' 125' ' ' TYR . 0.2 OUTLIER -151.07 148.99 28.99 Favored 'General case' 0 CA--C 1.536 0.442 0 CA-C-O 121.367 0.603 . . . . 1.0 110.247 -179.962 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 74.8 mtt85 -149.57 150.88 32.92 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.59 -0.732 . . . . 1.0 110.245 178.077 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 127' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--O 1.22 -0.476 0 CA-C-O 118.042 -0.98 . . . . 1.0 109.291 178.83 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 128' ' ' MTN . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 129' ' ' MTN . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 130' ' ' MTN . . . . . 0.6 ' S1 ' ' NE2' ' A' ' 99' ' ' GLN . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.7 mpt? . . . . . 0 N--CA 1.492 1.633 0 N-CA-C 109.061 -0.718 . . . . 1.0 109.061 . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 33.4 m -107.69 7.68 28.6 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.322 -0.399 . . . . 1.0 110.402 179.872 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . 0.408 ' N ' ' OD1' ' A' ' 3' ' ' ASP . 1.2 p30 170.72 93.12 0.0 OUTLIER 'General case' 0 N--CA 1.463 0.213 0 CA-C-N 116.288 -0.415 . . . . 1.0 110.414 179.77 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 72.8 t80 -150.84 145.59 25.78 Favored 'General case' 0 N--CA 1.462 0.15 0 CA-C-O 120.684 0.278 . . . . 1.0 110.51 -179.998 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 5' ' ' ASP . . . . . 0.479 ' N ' ' OD1' ' A' ' 5' ' ' ASP . 3.4 p30 -155.53 151.68 27.94 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.434 -0.348 . . . . 1.0 110.444 179.901 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 6' ' ' THR . . . . . 0.617 ' O ' ' N ' ' A' ' 10' ' ' SER . 0.2 OUTLIER -64.7 169.16 5.26 Favored 'General case' 0 C--O 1.208 -1.119 0 N-CA-C 109.556 -0.535 . . . . 1.0 109.556 179.979 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . 0.527 ' O ' ' N ' ' A' ' 11' ' ' ARG . 0.0 OUTLIER -59.33 -58.05 10.33 Favored 'General case' 0 C--N 1.315 -0.93 0 CA-C-O 121.359 0.6 . . . . 1.0 110.213 -178.44 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 8' ' ' ARG . . . . . 0.509 ' O ' ' CB ' ' A' ' 12' ' ' ALA . 1.8 ptm180 -50.83 -56.31 12.8 Favored 'General case' 0 C--O 1.212 -0.899 0 N-CA-C 107.994 -1.113 . . . . 1.0 107.994 -177.825 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . 0.508 ' H ' ' HG3' ' A' ' 8' ' ' ARG . 0.0 OUTLIER -64.12 -47.46 90.06 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.966 0 CA-C-N 115.037 -0.983 . . . . 1.0 110.364 179.502 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 10' ' ' SER . . . . . 0.617 ' N ' ' O ' ' A' ' 6' ' ' THR . 47.9 t -63.81 -63.06 1.27 Allowed 'General case' 0 N--CA 1.48 1.037 0 O-C-N 123.454 0.471 . . . . 1.0 110.905 -178.968 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 11' ' ' ARG . . . . . 0.527 ' N ' ' O ' ' A' ' 7' ' ' GLU . 12.1 ttt180 -58.68 -54.82 42.8 Favored 'General case' 0 N--CA 1.469 0.489 0 N-CA-C 109.404 -0.591 . . . . 1.0 109.404 -177.069 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . 0.509 ' CB ' ' O ' ' A' ' 8' ' ' ARG . . . -46.48 -46.82 19.24 Favored 'General case' 0 N--CA 1.477 0.923 0 N-CA-C 105.762 -1.94 . . . . 1.0 105.762 -178.13 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . 0.604 ' O ' ' CB ' ' A' ' 17' ' ' LEU . 1.5 t -61.32 -52.02 66.21 Favored 'Isoleucine or valine' 0 C--O 1.206 -1.196 0 CA-C-N 114.495 -1.23 . . . . 1.0 108.147 176.004 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . 0.44 ' O ' ' CG1' ' A' ' 18' ' ' VAL . . . -57.21 -63.65 1.15 Allowed 'General case' 0 C--O 1.213 -0.86 0 C-N-CA 117.763 -1.575 . . . . 1.0 110.232 -179.876 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . 0.557 ' O ' ' N ' ' A' ' 19' ' ' GLY . . . -53.8 -56.26 19.07 Favored 'General case' 0 N--CA 1.473 0.71 0 CA-C-O 121.559 0.695 . . . . 1.0 110.916 -177.956 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . 0.459 ' CB ' ' O ' ' A' ' 12' ' ' ALA . . . -64.63 -55.57 19.4 Favored 'General case' 0 C--N 1.31 -1.112 0 CA-C-N 115.135 -0.938 . . . . 1.0 109.611 -178.419 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . 0.604 ' CB ' ' O ' ' A' ' 13' ' ' VAL . 0.3 OUTLIER -57.85 -52.14 66.73 Favored 'General case' 0 N--CA 1.474 0.766 0 CA-C-N 114.506 -1.224 . . . . 1.0 108.004 -177.516 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . 0.602 HG22 ' H ' ' A' ' 19' ' ' GLY . 2.3 m -68.37 -57.28 9.59 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.605 0 C-N-CA 118.86 -1.136 . . . . 1.0 109.706 178.685 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . 0.602 ' H ' HG22 ' A' ' 18' ' ' VAL . . . -61.95 -171.84 1.21 Allowed Glycine 0 C--N 1.332 0.319 0 N-CA-C 110.941 -0.863 . . . . 1.0 110.941 -179.059 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 20' ' ' PRO . . . . . 0.609 ' O ' ' N ' ' A' ' 24' ' ' ALA . 2.1 Cg_endo -78.24 -26.3 6.38 Favored 'Trans proline' 0 C--N 1.309 -1.514 0 C-N-CA 122.636 2.224 . . . . 1.0 113.993 -178.752 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -59.62 -58.06 16.26 Favored Glycine 0 N--CA 1.48 1.591 0 C-N-CA 120.256 -0.973 . . . . 1.0 111.808 -177.031 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -57.91 -52.12 54.13 Favored Glycine 0 N--CA 1.469 0.859 0 N-CA-C 107.112 -2.395 . . . . 1.0 107.112 -177.901 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 9.6 t -58.91 -32.66 47.79 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.078 0 CA-C-N 114.487 -0.856 . . . . 1.0 109.513 179.115 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . 0.609 ' N ' ' O ' ' A' ' 20' ' ' PRO . . . -58.51 -61.27 2.72 Favored 'General case' 0 CA--C 1.533 0.307 0 C-N-CA 118.503 -1.279 . . . . 1.0 109.579 -179.947 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -65.04 -43.85 91.03 Favored 'General case' 0 CA--C 1.535 0.387 0 N-CA-C 112.763 0.653 . . . . 1.0 112.763 -177.939 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 53.4 t -61.46 -59.83 3.66 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.171 0 C-N-CA 118.77 -1.172 . . . . 1.0 110.011 -177.626 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 2.3 p -58.39 -35.6 54.79 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.217 0 N-CA-C 112.016 0.376 . . . . 1.0 112.016 -178.071 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 6.7 ttmm -67.29 -55.09 15.33 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-O 121.727 0.775 . . . . 1.0 109.477 -179.017 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 94.9 t -64.39 -48.22 86.18 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.673 0 CA-C-N 114.281 -1.327 . . . . 1.0 111.131 -177.689 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 30' ' ' CYS . . . . . . . . . . . . . 2.2 t -65.05 -61.23 2.28 Favored 'General case' 0 N--CA 1.447 -0.601 0 C-N-CA 118.807 -1.157 . . . . 1.0 109.189 -179.255 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -62.46 -51.87 65.77 Favored 'General case' 0 CA--C 1.51 -0.56 0 N-CA-C 112.29 0.478 . . . . 1.0 112.29 -177.06 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . 0.43 ' O ' ' CB ' ' A' ' 33' ' ' LEU . . . 81.46 71.62 1.28 Allowed Glycine 0 CA--C 1.523 0.581 0 N-CA-C 108.432 -1.867 . . . . 1.0 108.432 -177.967 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . 0.44 ' O ' ' O ' ' A' ' 36' ' ' VAL . 5.2 mt 89.06 73.42 0.05 OUTLIER Pre-proline 0 N--CA 1.476 0.835 0 C-N-CA 123.293 0.637 . . . . 1.0 109.809 -179.502 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 76.6 Cg_exo -50.74 -32.14 35.45 Favored 'Trans proline' 0 N--CA 1.507 2.31 0 C-N-CA 123.728 2.952 . . . . 1.0 114.954 -179.076 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -58.43 -57.44 19.86 Favored Glycine 0 CA--C 1.533 1.161 0 C-N-CA 118.492 -1.813 . . . . 1.0 108.9 -178.828 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . 0.508 ' O ' ' HB ' ' A' ' 37' ' ' ILE . 13.9 p -92.48 167.45 1.64 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.579 0 N-CA-C 106.917 -1.512 . . . . 1.0 106.917 177.447 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . 0.508 ' HB ' ' O ' ' A' ' 36' ' ' VAL . 91.4 mt 111.22 127.09 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.478 0.971 0 C-N-CA 123.827 0.851 . . . . 1.0 109.581 -179.529 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -141.59 132.38 25.78 Favored 'General case' 0 C--N 1.331 -0.236 0 N-CA-C 108.085 -1.08 . . . . 1.0 108.085 179.792 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 7.3 p -93.31 124.43 57.69 Favored Pre-proline 0 CA--C 1.534 0.35 0 N-CA-C 109.656 -0.498 . . . . 1.0 109.656 -179.792 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 52.5 Cg_exo -50.27 -37.62 50.06 Favored 'Trans proline' 0 N--CA 1.488 1.192 0 C-N-CA 121.399 1.399 . . . . 1.0 113.21 -179.702 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -121.47 101.43 7.61 Favored 'General case' 0 N--CA 1.47 0.535 0 N-CA-C 112.614 0.598 . . . . 1.0 112.614 -177.659 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . 0.727 ' C ' ' H ' ' A' ' 44' ' ' GLY . 14.4 ptm180 -135.84 152.86 51.49 Favored 'General case' 0 C--N 1.316 -0.868 0 CA-C-O 121.735 0.779 . . . . 1.0 112.834 179.773 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 43' ' ' ARG . . . . . 0.53 ' C ' ' H ' ' A' ' 45' ' ' PHE . 61.0 ttt180 -61.18 28.97 0.01 OUTLIER 'General case' 0 CA--C 1.539 0.552 0 CA-C-N 113.531 -1.668 . . . . 1.0 109.225 -179.84 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . 0.727 ' H ' ' C ' ' A' ' 42' ' ' ARG . . . 75.65 -26.46 1.36 Allowed Glycine 0 N--CA 1.448 -0.527 0 N-CA-C 110.396 -1.081 . . . . 1.0 110.396 179.899 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . 0.699 ' CD1' ' N ' ' A' ' 45' ' ' PHE . 0.0 OUTLIER -172.79 172.61 4.07 Favored 'General case' 0 CA--C 1.536 0.423 0 CA-C-O 119.293 -0.384 . . . . 1.0 110.125 -177.867 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 46' ' ' PHE . . . . . 0.623 ' HB2' ' O ' ' A' ' 45' ' ' PHE . 0.4 OUTLIER 126.17 102.31 0.0 OUTLIER 'General case' 0 N--CA 1.505 2.296 0 O-C-N 125.675 1.859 . . . . 1.0 109.724 179.583 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 47' ' ' ARG . . . . . 0.567 ' NE ' ' O ' ' A' ' 46' ' ' PHE . 1.6 ptp180 108.1 162.37 0.0 OUTLIER 'General case' 0 N--CA 1.487 1.395 0 O-C-N 124.302 1.002 . . . . 1.0 110.669 178.942 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER 69.2 70.46 0.26 Allowed 'General case' 0 N--CA 1.453 -0.293 0 N-CA-C 108.343 -0.984 . . . . 1.0 108.343 -179.366 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 49' ' ' ASN . . . . . 0.581 ' O ' ' N ' ' A' ' 51' ' ' GLU . 2.7 p30 -147.13 138.87 13.54 Favored Pre-proline 0 CA--C 1.542 0.645 0 N-CA-C 108.252 -1.018 . . . . 1.0 108.252 179.82 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . 0.49 ' C ' ' H ' ' A' ' 52' ' ' ARG . 34.8 Cg_exo -54.61 72.05 0.03 OUTLIER 'Trans proline' 0 N--CA 1.502 1.987 0 C-N-CA 121.495 1.463 . . . . 1.0 112.299 179.456 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . 0.581 ' N ' ' O ' ' A' ' 49' ' ' ASN . 1.2 mp0 57.24 4.5 0.21 Allowed 'General case' 0 C--N 1.324 -0.514 0 O-C-N 121.736 -0.603 . . . . 1.0 111.091 179.304 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . 0.49 ' H ' ' C ' ' A' ' 50' ' ' PRO . 92.5 mtt180 -84.89 141.16 30.61 Favored 'General case' 0 CA--C 1.513 -0.452 0 N-CA-C 109.325 -0.62 . . . . 1.0 109.325 178.774 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 14.2 tt -66.48 146.91 12.9 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.704 0 CA-C-O 123.146 1.451 . . . . 1.0 113.355 -177.544 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -74.95 81.01 2.17 Favored 'General case' 0 C--N 1.311 -1.104 0 CA-C-N 111.309 -2.678 . . . . 1.0 111.071 -178.952 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 2.4 pp -148.49 156.89 8.13 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.888 0 N-CA-C 109.78 -0.452 . . . . 1.0 109.78 176.708 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 106.51 -3.84 37.11 Favored Glycine 0 N--CA 1.474 1.176 0 N-CA-C 110.266 -1.134 . . . . 1.0 110.266 179.575 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . 0.403 ' HB3' ' CD1' ' A' ' 45' ' ' PHE . 18.9 m-20 -80.94 103.98 11.14 Favored 'General case' 0 C--N 1.317 -0.831 0 CA-C-N 114.279 -0.96 . . . . 1.0 110.06 178.963 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 58' ' ' TRP . . . . . . . . . . . . . 5.9 m0 -90.09 172.24 8.97 Favored 'General case' 0 CA--C 1.542 0.659 0 CA-C-O 123.678 1.704 . . . . 1.0 114.288 -177.283 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 59' ' ' ARG . . . . . 0.478 ' CG ' ' N ' ' A' ' 60' ' ' TYR . 28.5 ptt-85 -78.6 -60.18 2.48 Favored 'General case' 0 CA--C 1.55 0.946 0 CA-C-N 110.451 -3.068 . . . . 1.0 113.865 -177.661 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 60' ' ' TYR . . . . . 0.478 ' N ' ' CG ' ' A' ' 59' ' ' ARG . 0.3 OUTLIER -92.21 -9.94 40.45 Favored 'General case' 0 N--CA 1.483 1.191 0 C-N-CA 124.122 0.969 . . . . 1.0 113.151 -179.728 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 22.3 tt0 -77.26 -14.73 59.7 Favored 'General case' 0 C--N 1.31 -1.133 0 CA-C-N 115.886 -0.597 . . . . 1.0 111.688 -178.3 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . 0.605 ' O ' ' N ' ' A' ' 66' ' ' GLY . 0.6 OUTLIER -48.05 -55.85 2.43 Favored 'Isoleucine or valine' 0 C--O 1.207 -1.14 0 C-N-CA 119.825 -0.75 . . . . 1.0 110.265 -175.156 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 63' ' ' ALA . . . . . 0.508 ' O ' ' HG3' ' A' ' 67' ' ' ARG . . . -65.98 -52.73 46.93 Favored 'General case' 0 C--N 1.307 -1.269 0 C-N-CA 119.722 -0.791 . . . . 1.0 109.75 -178.966 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 85.4 m-70 -48.9 -57.37 6.55 Favored 'General case' 0 N--CA 1.472 0.626 0 O-C-N 124.093 0.871 . . . . 1.0 109.964 -179.72 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . 0.644 ' C ' ' H ' ' A' ' 67' ' ' ARG . 5.8 t0 -72.45 -47.83 45.78 Favored 'General case' 0 C--N 1.313 -1.001 0 CA-C-O 121.582 0.706 . . . . 1.0 110.362 178.8 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . 0.605 ' N ' ' O ' ' A' ' 62' ' ' VAL . . . -70.71 26.47 0.5 Allowed Glycine 0 C--N 1.32 -0.322 0 O-C-N 120.868 -1.145 . . . . 1.0 110.636 177.985 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 67' ' ' ARG . . . . . 0.644 ' H ' ' C ' ' A' ' 65' ' ' ASP . 6.0 mtp85 -73.11 3.89 5.02 Favored 'General case' 0 N--CA 1.445 -0.688 0 N-CA-C 106.514 -1.661 . . . . 1.0 106.514 175.418 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . 0.529 ' H ' ' C ' ' A' ' 66' ' ' GLY . 0.0 OUTLIER -33.21 -29.65 0.01 OUTLIER 'General case' 0 N--CA 1.486 1.367 0 N-CA-C 108.489 -0.93 . . . . 1.0 108.489 -176.794 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . 0.606 ' N ' ' O ' ' A' ' 67' ' ' ARG . 22.2 mt -61.87 -63.39 1.27 Allowed 'General case' 0 C--N 1.315 -0.933 0 C-N-CA 118.542 -1.263 . . . . 1.0 107.814 178.289 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . 0.648 ' C ' ' H ' ' A' ' 72' ' ' HIS . . . -79.18 -75.28 0.25 Allowed 'General case' 0 N--CA 1.465 0.303 0 N-CA-C 106.271 -1.752 . . . . 1.0 106.271 176.635 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . 0.459 ' O ' ' C ' ' A' ' 72' ' ' HIS . . . -44.1 3.71 0.0 OUTLIER 'General case' 0 CA--C 1.519 -0.223 0 C-N-CA 124.826 1.25 . . . . 1.0 113.831 178.947 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 72' ' ' HIS . . . . . 0.648 ' H ' ' C ' ' A' ' 70' ' ' ALA . 0.2 OUTLIER -28.4 -67.85 0.07 Allowed 'General case' 0 N--CA 1.463 0.19 0 CA-C-N 118.36 0.527 . . . . 1.0 111.589 -178.658 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 73' ' ' MET . . . . . . . . . . . . . 13.8 ptp -69.57 -48.57 59.82 Favored 'General case' 0 C--N 1.325 -0.469 0 C-N-CA 118.983 -1.087 . . . . 1.0 108.968 178.525 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . 0.767 ' C ' ' H ' ' A' ' 76' ' ' GLY . 68.8 t -43.76 -40.54 1.48 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.265 0 CA-C-O 117.351 -1.309 . . . . 1.0 111.539 -176.35 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 75' ' ' ASN . . . . . 0.47 ' C ' ' N ' ' A' ' 77' ' ' ILE . 3.0 m120 -35.14 -12.62 0.0 OUTLIER 'General case' 0 N--CA 1.501 2.078 0 CA-C-N 121.244 1.838 . . . . 1.0 112.257 179.277 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . 0.767 ' H ' ' C ' ' A' ' 74' ' ' VAL . . . -45.72 -21.44 0.55 Allowed Glycine 0 CA--C 1.542 1.739 0 N-CA-C 107.844 -2.102 . . . . 1.0 107.844 175.173 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . 0.639 HG13 ' H ' ' A' ' 78' ' ' VAL . 1.2 pt -72.11 -55.9 11.86 Favored 'Isoleucine or valine' 0 C--O 1.216 -0.692 0 N-CA-C 107.696 -1.224 . . . . 1.0 107.696 178.021 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . 0.639 ' H ' HG13 ' A' ' 77' ' ' ILE . 95.8 t -33.79 -34.99 0.04 OUTLIER 'Isoleucine or valine' 0 CA--C 1.546 0.794 0 CA-C-N 113.2 -1.818 . . . . 1.0 106.849 -177.565 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . 0.538 ' N ' ' O ' ' A' ' 77' ' ' ILE . 0.0 OUTLIER -98.31 -33.24 4.12 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.878 0 CA-C-N 115.605 -0.725 . . . . 1.0 112.416 176.556 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 80' ' ' ALA . . . . . 0.537 ' N ' ' O ' ' A' ' 77' ' ' ILE . . . -84.2 -10.71 57.5 Favored 'General case' 0 N--CA 1.478 0.974 0 O-C-N 121.257 -0.902 . . . . 1.0 113.184 179.662 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . 0.445 ' N ' ' O ' ' A' ' 77' ' ' ILE . 0.0 OUTLIER -89.27 -73.89 0.49 Allowed 'General case' 0 N--CA 1.451 -0.424 0 N-CA-C 112.115 0.413 . . . . 1.0 112.115 -177.629 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 24.3 m-20 -91.75 -16.8 26.35 Favored 'General case' 0 C--N 1.346 0.437 0 N-CA-C 114.532 1.308 . . . . 1.0 114.532 -179.096 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . 0.569 ' O ' ' N ' ' A' ' 86' ' ' ALA . . . -49.67 -42.12 44.68 Favored 'General case' 0 C--O 1.211 -0.965 0 C-N-CA 118.304 -1.358 . . . . 1.0 110.792 -177.391 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -40.33 -35.13 0.39 Allowed 'General case' 0 CA--C 1.543 0.7 0 CA-C-O 120.819 0.342 . . . . 1.0 111.131 -179.789 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 1.2 pp -74.4 -33.69 34.21 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.433 0 C-N-CA 119.999 -0.68 . . . . 1.0 110.125 178.477 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . 0.569 ' N ' ' O ' ' A' ' 83' ' ' ALA . . . -96.23 -26.36 15.46 Favored 'General case' 0 CA--C 1.54 0.573 0 CA-C-O 120.798 0.333 . . . . 1.0 111.698 179.175 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . 0.567 ' C ' ' H ' ' A' ' 89' ' ' VAL . 44.8 tt0 -57.9 -20.25 35.75 Favored 'General case' 0 C--N 1.329 -0.318 0 O-C-N 121.667 -0.646 . . . . 1.0 110.103 -178.833 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -71.98 -1.6 15.13 Favored 'General case' 0 N--CA 1.47 0.533 0 N-CA-C 107.494 -1.299 . . . . 1.0 107.494 178.095 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 89' ' ' VAL . . . . . 0.567 ' H ' ' C ' ' A' ' 87' ' ' GLU . 3.5 t -98.54 36.02 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.447 -0.616 0 CA-C-N 111.922 -2.399 . . . . 1.0 107.831 177.029 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 90' ' ' GLY . . . . . 0.844 ' O ' ' N ' ' A' ' 92' ' ' HIS . . . -55.95 -26.91 49.56 Favored Glycine 0 C--N 1.367 2.26 0 CA-C-O 117.609 -1.662 . . . . 1.0 111.519 176.672 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 91' ' ' PRO . . . . . 0.664 ' HD2' ' N ' ' A' ' 90' ' ' GLY . 11.5 Cg_exo -36.48 3.09 0.0 OUTLIER 'Trans proline' 0 N--CA 1.499 1.803 0 C-N-CA 123.084 2.523 . . . . 1.0 113.68 173.913 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 92' ' ' HIS . . . . . 0.844 ' N ' ' O ' ' A' ' 90' ' ' GLY . 0.0 OUTLIER -47.48 -27.91 1.95 Allowed 'General case' 0 N--CA 1.436 -1.141 0 N-CA-C 106.942 -1.503 . . . . 1.0 106.942 -179.887 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . 0.608 ' HG ' ' H ' ' A' ' 94' ' ' ALA . 2.0 pp -58.49 -52.46 65.55 Favored 'General case' 0 N--CA 1.448 -0.545 0 N-CA-C 106.931 -1.507 . . . . 1.0 106.931 176.417 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 94' ' ' ALA . . . . . 0.608 ' H ' ' HG ' ' A' ' 93' ' ' LEU . . . -49.8 -52.05 35.05 Favored 'General case' 0 C--O 1.221 -0.447 0 N-CA-C 107.457 -1.312 . . . . 1.0 107.457 -179.84 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 1.3 mpt_? -64.37 -31.44 72.64 Favored 'General case' 0 C--N 1.321 -0.666 0 N-CA-C 109.386 -0.598 . . . . 1.0 109.386 178.146 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 96' ' ' ALA . . . . . 0.842 ' O ' ' N ' ' A' ' 100' ' ' ILE . . . -50.87 -44.17 59.63 Favored 'General case' 0 C--O 1.197 -1.673 0 N-CA-C 106.368 -1.716 . . . . 1.0 106.368 -176.448 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . 0.488 ' O ' ' CG2' ' A' ' 100' ' ' ILE . 2.1 tt -35.05 -24.84 0.01 OUTLIER 'General case' 0 CA--C 1.588 2.423 0 CA-C-N 112.585 -2.098 . . . . 1.0 107.625 -178.937 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 98' ' ' GLY . . . . . 0.674 ' N ' ' O ' ' A' ' 96' ' ' ALA . . . -89.32 -51.84 2.85 Favored Glycine 0 CA--C 1.563 3.043 0 CA-C-O 123.312 1.507 . . . . 1.0 111.686 170.763 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 99' ' ' GLN . . . . . 0.562 ' N ' ' O ' ' A' ' 96' ' ' ALA . 6.3 mt-30 -76.72 8.43 3.66 Favored 'General case' 0 N--CA 1.437 -1.111 0 N-CA-C 106.607 -1.627 . . . . 1.0 106.607 177.676 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 100' ' ' ILE . . . . . 0.842 ' N ' ' O ' ' A' ' 96' ' ' ALA . 20.3 tt -59.36 -52.98 54.47 Favored 'Isoleucine or valine' 0 CA--C 1.474 -1.971 0 N-CA-C 106.276 -1.75 . . . . 1.0 106.276 178.296 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 101' ' ' VAL . . . . . 0.584 ' O ' ' N ' ' A' ' 105' ' ' GLY . 0.2 OUTLIER -57.05 -61.03 1.4 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.658 0 C-N-CA 118.273 -1.371 . . . . 1.0 108.299 179.415 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 102' ' ' CYS . . . . . 0.512 ' H ' HG11 ' A' ' 101' ' ' VAL . 0.1 OUTLIER -50.63 -25.03 3.73 Favored 'General case' 0 C--N 1.317 -0.845 0 C-N-CA 120.588 -0.445 . . . . 1.0 111.179 -177.15 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 68.8 ttp85 -85.74 -49.0 8.29 Favored 'General case' 0 N--CA 1.482 1.158 0 O-C-N 124.731 1.269 . . . . 1.0 112.566 179.238 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 104' ' ' TYR . . . . . 0.735 ' CG ' ' O ' ' A' ' 104' ' ' TYR . 0.1 OUTLIER -96.38 23.63 6.55 Favored 'General case' 0 C--N 1.302 -1.457 0 C-N-CA 126.918 2.087 . . . . 1.0 108.788 179.401 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 105' ' ' GLY . . . . . 0.584 ' N ' ' O ' ' A' ' 101' ' ' VAL . . . -162.56 -93.4 0.09 OUTLIER Glycine 0 N--CA 1.45 -0.402 0 N-CA-C 106.608 -2.597 . . . . 1.0 106.608 178.313 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 106' ' ' ALA . . . . . 0.638 ' O ' ' CD ' ' A' ' 110' ' ' PRO . . . 69.06 64.14 0.29 Allowed 'General case' 0 C--O 1.219 -0.548 0 N-CA-C 113.146 0.795 . . . . 1.0 113.146 179.267 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 96.2 m -78.21 -58.73 3.1 Favored 'General case' 0 CA--C 1.547 0.829 0 O-C-N 121.152 -0.967 . . . . 1.0 109.353 179.529 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 3.8 p -58.64 -44.38 89.52 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-O 121.856 0.836 . . . . 1.0 109.662 -177.376 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 3.3 mm -41.41 -61.41 1.4 Allowed Pre-proline 0 CA--C 1.569 1.689 0 CA-C-N 114.134 -1.394 . . . . 1.0 109.217 179.769 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 110' ' ' PRO . . . . . 0.638 ' CD ' ' O ' ' A' ' 106' ' ' ALA . 21.5 Cg_exo -47.64 -36.92 26.23 Favored 'Trans proline' 0 N--CA 1.502 1.998 0 C-N-CA 123.511 2.807 . . . . 1.0 113.401 174.802 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 111' ' ' ASN . . . . . 0.431 ' C ' ' N ' ' A' ' 113' ' ' ASN . 5.4 t30 -67.7 -67.78 0.43 Allowed 'General case' 0 C--O 1.236 0.381 0 O-C-N 121.082 -1.011 . . . . 1.0 109.946 -177.999 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 2.1 pt -49.02 -24.37 1.11 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-O 122.481 1.134 . . . . 1.0 109.154 -179.531 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 113' ' ' ASN . . . . . 0.436 ' HB3' ' O ' ' A' ' 110' ' ' PRO . 40.1 t30 -59.72 -53.71 54.77 Favored 'General case' 0 C--N 1.307 -1.264 0 CA-C-N 112.649 -2.069 . . . . 1.0 107.778 -177.695 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -56.92 -32.42 65.92 Favored 'General case' 0 N--CA 1.445 -0.687 0 CA-C-O 119.04 -0.505 . . . . 1.0 112.262 -179.652 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -78.83 -47.25 16.99 Favored 'General case' 0 C--O 1.211 -0.925 0 CA-C-O 122.314 1.054 . . . . 1.0 110.109 178.487 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 116' ' ' ILE . . . . . 0.468 ' O ' ' N ' ' A' ' 120' ' ' GLY . 32.2 mt -53.67 -53.09 28.27 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.101 0 CA-C-N 113.507 -1.679 . . . . 1.0 107.452 -179.148 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 10.6 tt0 -44.36 -64.68 0.63 Allowed 'General case' 0 C--N 1.317 -0.816 0 CA-C-N 112.915 -1.948 . . . . 1.0 108.385 -179.249 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 29.2 m -59.6 -50.7 79.0 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.663 0 C-N-CA 119.652 -0.819 . . . . 1.0 109.723 179.885 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -52.54 -71.29 0.07 Allowed 'General case' 0 CA--C 1.539 0.534 0 N-CA-C 106.845 -1.539 . . . . 1.0 106.845 -178.083 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 120' ' ' GLY . . . . . 0.706 ' O ' ' OG1' ' A' ' 121' ' ' THR . . . -69.28 -79.2 0.3 Allowed Glycine 0 CA--C 1.539 1.537 0 C-N-CA 119.133 -1.508 . . . . 1.0 111.023 179.964 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 121' ' ' THR . . . . . 0.706 ' OG1' ' O ' ' A' ' 120' ' ' GLY . 51.8 m 157.3 -32.01 0.0 OUTLIER 'General case' 0 N--CA 1.487 1.417 0 CA-C-N 112.422 -1.889 . . . . 1.0 111.818 179.859 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 122' ' ' GLY . . . . . 0.621 ' O ' ' N ' ' A' ' 124' ' ' ASP . . . 98.0 -21.81 44.12 Favored Glycine 0 N--CA 1.465 0.613 0 N-CA-C 108.027 -2.029 . . . . 1.0 108.027 -177.291 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 123' ' ' THR . . . . . 0.547 ' O ' ' CE1' ' A' ' 72' ' ' HIS . 58.3 m -46.22 90.61 0.0 OUTLIER 'General case' 0 N--CA 1.476 0.839 0 N-CA-C 105.928 -1.878 . . . . 1.0 105.928 177.832 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 124' ' ' ASP . . . . . 0.621 ' N ' ' O ' ' A' ' 122' ' ' GLY . 51.4 p-10 -162.86 171.1 17.19 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 115.596 -0.729 . . . . 1.0 112.177 -179.343 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 125' ' ' TYR . . . . . . . . . . . . . 86.0 t80 -142.55 141.91 32.11 Favored 'General case' 0 C--N 1.329 -0.315 0 N-CA-C 108.758 -0.831 . . . . 1.0 108.758 176.593 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 126' ' ' ARG . . . . . 0.423 HH12 ' CG2' ' A' ' 79' ' ' ILE . 14.3 mmm180 -147.75 147.87 30.35 Favored 'General case' 0 CA--C 1.533 0.306 0 N-CA-C 109.876 -0.416 . . . . 1.0 109.876 179.218 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 127' ' ' PHE . . . . . . . . . . . . . 23.2 t80 . . . . . 0 N--CA 1.471 0.607 0 CA-C-O 117.995 -1.003 . . . . 1.0 110.824 179.775 . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 128' ' ' MTN . . . . . 0.488 ' C7 ' HH12 ' A' ' 47' ' ' ARG . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 129' ' ' MTN . . . . . 0.479 ' S1 ' ' C6 ' ' A' ' 129' ' ' MTN . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 130' ' ' MTN . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 2.7 mmt . . . . . 0 N--CA 1.489 1.479 0 N-CA-C 108.838 -0.801 . . . . 1.0 108.838 . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 2' ' ' SER . . . . . 0.503 ' O ' ' CB ' ' A' ' 3' ' ' ASP . 47.1 t -73.36 4.94 4.07 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.218 -0.446 . . . . 1.0 110.732 179.777 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . 0.503 ' CB ' ' O ' ' A' ' 2' ' ' SER . 12.0 p30 149.22 135.57 0.0 OUTLIER 'General case' 0 N--CA 1.478 0.928 0 O-C-N 123.725 0.64 . . . . 1.0 110.81 179.759 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 87.3 t80 -154.15 149.43 27.07 Favored 'General case' 0 CA--C 1.518 -0.268 0 CA-C-O 121.014 0.435 . . . . 1.0 110.365 178.982 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -150.78 147.33 27.16 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.133 -0.485 . . . . 1.0 110.055 179.935 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 6' ' ' THR . . . . . 0.731 ' O ' ' N ' ' A' ' 10' ' ' SER . 0.2 OUTLIER -112.21 -162.74 0.81 Allowed 'General case' 0 C--O 1.207 -1.172 0 CA-C-O 121.629 0.728 . . . . 1.0 110.749 -178.639 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . 0.489 ' O ' ' HB2' ' A' ' 11' ' ' ARG . 73.2 mm-40 -54.41 -43.45 71.52 Favored 'General case' 0 C--N 1.304 -1.399 0 CA-C-O 121.984 0.897 . . . . 1.0 108.733 -179.233 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 8' ' ' ARG . . . . . 0.541 ' O ' ' CB ' ' A' ' 12' ' ' ALA . 60.0 mtp180 -72.73 -60.68 2.12 Favored 'General case' 0 C--N 1.313 -0.987 0 C-N-CA 118.095 -1.442 . . . . 1.0 110.487 177.713 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . 0.956 ' O ' ' HB ' ' A' ' 13' ' ' VAL . 10.7 t -60.51 -51.11 76.91 Favored 'Isoleucine or valine' 0 C--O 1.196 -1.761 0 C-N-CA 117.921 -1.512 . . . . 1.0 110.639 179.963 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 10' ' ' SER . . . . . 0.731 ' N ' ' O ' ' A' ' 6' ' ' THR . 2.6 t -70.09 -66.25 0.62 Allowed 'General case' 0 C--N 1.303 -1.445 0 O-C-N 121.271 -0.893 . . . . 1.0 113.03 -178.775 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 11' ' ' ARG . . . . . 0.489 ' HB2' ' O ' ' A' ' 7' ' ' GLU . 1.7 mmt85 -62.11 -43.87 97.89 Favored 'General case' 0 C--N 1.318 -0.787 0 CA-C-O 120.455 0.169 . . . . 1.0 111.4 -176.496 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . 0.541 ' CB ' ' O ' ' A' ' 8' ' ' ARG . . . -70.74 -59.7 2.66 Favored 'General case' 0 C--N 1.32 -0.68 0 C-N-CA 118.4 -1.32 . . . . 1.0 110.241 -179.993 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . 0.956 ' HB ' ' O ' ' A' ' 9' ' ' VAL . 4.6 t -57.35 -51.3 71.28 Favored 'Isoleucine or valine' 0 C--O 1.199 -1.605 0 N-CA-C 107.029 -1.471 . . . . 1.0 107.029 179.503 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . 0.675 ' O ' HG23 ' A' ' 18' ' ' VAL . . . -62.06 -66.5 0.53 Allowed 'General case' 0 C--N 1.306 -1.284 0 C-N-CA 115.549 -2.461 . . . . 1.0 113.061 -178.765 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . 0.543 ' O ' ' N ' ' A' ' 19' ' ' GLY . . . -51.18 -55.27 18.82 Favored 'General case' 0 C--N 1.319 -0.737 0 C-N-CA 119.706 -0.797 . . . . 1.0 109.257 -178.728 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . 0.644 ' O ' ' N ' ' A' ' 22' ' ' GLY . . . -64.35 -59.17 4.69 Favored 'General case' 0 C--N 1.299 -1.605 0 C-N-CA 118.101 -1.44 . . . . 1.0 111.346 -179.924 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . 0.701 ' CB ' ' O ' ' A' ' 13' ' ' VAL . 6.8 tt -55.09 -55.23 33.36 Favored 'General case' 0 N--CA 1.477 0.876 0 N-CA-C 108.832 -0.803 . . . . 1.0 108.832 -177.051 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . 0.781 HG23 ' H ' ' A' ' 19' ' ' GLY . 2.3 m -71.26 -58.86 4.22 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 CA-C-N 115.895 -0.593 . . . . 1.0 110.212 -179.817 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . 0.781 ' H ' HG23 ' A' ' 18' ' ' VAL . . . -58.16 -166.44 0.12 Allowed Glycine 0 CA--C 1.491 -1.454 0 N-CA-C 110.815 -0.914 . . . . 1.0 110.815 -177.322 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 20' ' ' PRO . . . . . 0.607 ' O ' ' N ' ' A' ' 24' ' ' ALA . 1.0 OUTLIER -79.85 -26.18 4.72 Favored 'Trans proline' 0 C--N 1.292 -2.421 0 C-N-CA 122.032 1.822 . . . . 1.0 113.59 -177.657 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . 0.432 ' O ' ' HB2' ' A' ' 24' ' ' ALA . . . -62.68 -58.49 11.97 Favored Glycine 0 N--CA 1.473 1.156 0 C-N-CA 119.496 -1.335 . . . . 1.0 111.877 -178.217 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . 0.644 ' N ' ' O ' ' A' ' 16' ' ' ALA . . . -57.61 -54.15 39.53 Favored Glycine 0 C--N 1.307 -1.068 0 C-N-CA 116.447 -2.787 . . . . 1.0 107.073 -178.778 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 54.0 t -52.63 -31.26 15.8 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.042 0 N-CA-C 107.859 -1.163 . . . . 1.0 107.859 178.564 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . 0.607 ' N ' ' O ' ' A' ' 20' ' ' PRO . . . -63.72 -63.9 1.04 Allowed 'General case' 0 C--O 1.218 -0.593 0 C-N-CA 119.416 -0.914 . . . . 1.0 110.969 -179.467 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 61.6 mt -61.64 -46.47 89.63 Favored 'General case' 0 C--N 1.321 -0.64 0 C-N-CA 119.666 -0.814 . . . . 1.0 111.881 -176.571 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 92.1 t -60.35 -60.75 2.1 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.531 0 C-N-CA 119.708 -0.797 . . . . 1.0 110.041 -177.004 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . 0.479 ' O ' ' CB ' ' A' ' 31' ' ' ALA . 2.2 p -54.81 -36.68 38.05 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.736 0 C-N-CA 119.622 -0.831 . . . . 1.0 109.203 -177.819 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . 0.401 ' HB2' ' O ' ' A' ' 24' ' ' ALA . 3.7 tmmm? -66.2 -55.52 15.85 Favored 'General case' 0 C--N 1.315 -0.892 0 C-N-CA 119.254 -0.979 . . . . 1.0 110.713 -177.532 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 82.3 t -62.95 -49.9 81.76 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.973 0 CA-C-N 114.641 -1.163 . . . . 1.0 110.135 -177.517 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 30' ' ' CYS . . . . . . . . . . . . . 4.1 t -65.27 -62.11 1.73 Allowed 'General case' 0 N--CA 1.443 -0.822 0 C-N-CA 119.675 -0.81 . . . . 1.0 109.458 -178.544 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . 0.479 ' CB ' ' O ' ' A' ' 27' ' ' VAL . . . -51.71 -46.44 63.93 Favored 'General case' 0 CA--C 1.5 -0.97 0 CA-C-O 121.282 0.563 . . . . 1.0 110.568 -176.23 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . 0.462 ' O ' ' CB ' ' A' ' 33' ' ' LEU . . . 66.56 67.05 2.13 Favored Glycine 0 N--CA 1.443 -0.896 0 N-CA-C 109.627 -1.389 . . . . 1.0 109.627 -179.998 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . 0.462 ' CB ' ' O ' ' A' ' 32' ' ' GLY . 0.3 OUTLIER 82.88 104.26 0.03 OUTLIER Pre-proline 0 CA--C 1.542 0.644 0 CA-C-N 113.048 -1.576 . . . . 1.0 108.343 -178.622 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 52.2 Cg_exo -48.64 -20.34 2.64 Favored 'Trans proline' 0 N--CA 1.499 1.825 0 C-N-CA 122.504 2.136 . . . . 1.0 114.293 -178.259 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -67.54 -62.72 4.16 Favored Glycine 0 N--CA 1.467 0.74 0 C-N-CA 118.357 -1.877 . . . . 1.0 112.27 -176.73 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . 0.622 ' O ' HG21 ' A' ' 37' ' ' ILE . 18.3 m -78.83 -153.88 0.03 OUTLIER 'Isoleucine or valine' 0 C--O 1.216 -0.696 0 N-CA-C 108.121 -1.066 . . . . 1.0 108.121 -179.119 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . 0.64 ' O ' ' CG2' ' A' ' 37' ' ' ILE . 0.3 OUTLIER 73.63 77.06 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.32 -0.688 0 O-C-N 124.2 0.938 . . . . 1.0 111.553 178.97 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 1.3 t60 -139.32 135.73 34.08 Favored 'General case' 0 CA--C 1.492 -1.278 0 O-C-N 120.906 -1.121 . . . . 1.0 109.329 179.4 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 3.3 m -115.32 132.19 23.2 Favored Pre-proline 0 N--CA 1.451 -0.409 0 C-N-CA 120.413 -0.515 . . . . 1.0 109.984 -178.913 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 23.6 Cg_endo -62.14 -15.21 42.56 Favored 'Trans proline' 0 N--CA 1.494 1.52 0 C-N-CA 122.039 1.826 . . . . 1.0 112.179 179.356 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -128.79 135.11 48.7 Favored 'General case' 0 N--CA 1.468 0.438 0 CA-C-N 116.729 -0.214 . . . . 1.0 110.504 178.399 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . 0.566 ' CG ' ' H ' ' A' ' 43' ' ' ARG . 39.1 ttp180 -173.16 174.25 3.45 Favored 'General case' 0 C--N 1.328 -0.339 0 C-N-CA 120.558 -0.457 . . . . 1.0 111.14 178.718 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 43' ' ' ARG . . . . . 0.566 ' H ' ' CG ' ' A' ' 42' ' ' ARG . 67.1 ttt-85 -57.61 -45.97 84.68 Favored 'General case' 0 CA--C 1.538 0.517 0 N-CA-C 107.697 -1.224 . . . . 1.0 107.697 178.53 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . 0.436 ' O ' ' CD1' ' A' ' 45' ' ' PHE . . . 121.58 -25.03 7.04 Favored Glycine 0 N--CA 1.481 1.675 0 CA-C-N 116.925 -0.125 . . . . 1.0 112.829 179.653 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . 0.75 ' O ' ' HB2' ' A' ' 46' ' ' PHE . 1.5 m-85 -158.58 167.52 29.38 Favored 'General case' 0 C--N 1.306 -1.314 0 N-CA-C 108.23 -1.026 . . . . 1.0 108.23 179.564 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 46' ' ' PHE . . . . . 0.75 ' HB2' ' O ' ' A' ' 45' ' ' PHE . 0.2 OUTLIER 107.45 116.7 0.01 OUTLIER 'General case' 0 N--CA 1.472 0.66 0 O-C-N 125.094 1.496 . . . . 1.0 111.367 179.408 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 47' ' ' ARG . . . . . 0.459 ' CB ' ' O ' ' A' ' 46' ' ' PHE . 9.5 ptt85 90.36 156.5 0.04 OUTLIER 'General case' 0 N--CA 1.479 1.01 0 O-C-N 123.64 0.587 . . . . 1.0 111.405 179.325 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 37.3 t 61.15 68.08 0.76 Allowed 'General case' 0 CA--C 1.509 -0.609 0 CA-C-N 116.151 -0.477 . . . . 1.0 109.851 179.145 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 49' ' ' ASN . . . . . 0.667 ' O ' ' N ' ' A' ' 51' ' ' GLU . 0.2 OUTLIER -149.56 159.14 36.97 Favored Pre-proline 0 C--N 1.315 -0.898 0 CA-C-N 115.869 -0.605 . . . . 1.0 109.381 179.203 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 4.1 Cg_endo -48.87 53.34 0.02 OUTLIER 'Trans proline' 0 N--CA 1.511 2.527 0 C-N-CA 123.981 3.121 . . . . 1.0 113.919 177.544 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . 0.667 ' N ' ' O ' ' A' ' 49' ' ' ASN . 2.7 mm-40 42.56 57.71 3.37 Favored 'General case' 0 CA--C 1.536 0.414 0 CA-C-O 121.246 0.546 . . . . 1.0 111.756 178.038 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . 0.647 HH21 ' CD1' ' A' ' 85' ' ' ILE . 2.5 ptm180 -156.36 168.83 26.12 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.308 -0.406 . . . . 1.0 111.501 179.225 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . 0.42 HG13 ' N ' ' A' ' 54' ' ' GLN . 7.4 tp -83.44 166.94 2.06 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 N-CA-C 108.612 -0.884 . . . . 1.0 108.612 176.65 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 54' ' ' GLN . . . . . 0.42 ' N ' HG13 ' A' ' 53' ' ' ILE . 35.8 mt-30 -134.72 134.31 40.88 Favored 'General case' 0 N--CA 1.467 0.415 0 O-C-N 121.775 -0.578 . . . . 1.0 109.551 179.419 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 19.9 tt -144.36 154.06 15.12 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.637 0 N-CA-C 110.139 -0.319 . . . . 1.0 110.139 178.948 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 103.23 4.51 47.29 Favored Glycine 0 N--CA 1.469 0.866 0 N-CA-C 110.178 -1.169 . . . . 1.0 110.178 -179.059 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 29.3 t70 -95.49 114.16 25.89 Favored 'General case' 0 CA--C 1.54 0.589 0 N-CA-C 113.632 0.975 . . . . 1.0 113.632 -178.886 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 58' ' ' TRP . . . . . 0.442 ' HB2' ' HB2' ' A' ' 61' ' ' GLU . 35.4 m95 -83.07 -176.69 6.46 Favored 'General case' 0 C--O 1.236 0.375 0 CA-C-N 112.527 -2.124 . . . . 1.0 109.677 176.15 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 59' ' ' ARG . . . . . 0.572 ' HD2' ' H ' ' A' ' 59' ' ' ARG . 0.0 OUTLIER -94.45 -55.61 3.1 Favored 'General case' 0 CA--C 1.547 0.844 0 CA-C-O 121.545 0.688 . . . . 1.0 110.471 179.566 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 60' ' ' TYR . . . . . 0.544 ' CG ' ' O ' ' A' ' 60' ' ' TYR . 4.7 t80 -73.96 -5.69 42.78 Favored 'General case' 0 N--CA 1.469 0.481 0 C-N-CA 124.338 1.055 . . . . 1.0 110.146 178.317 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . 0.529 ' O ' ' N ' ' A' ' 64' ' ' HIS . 4.7 tt0 -68.57 -17.91 64.23 Favored 'General case' 0 C--N 1.312 -1.058 0 O-C-N 121.07 -1.019 . . . . 1.0 111.444 -179.56 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . 0.443 ' C ' ' O ' ' A' ' 61' ' ' GLU . 16.1 m -42.01 -49.63 0.93 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.504 0 CA-C-O 121.118 0.485 . . . . 1.0 109.706 -174.42 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -64.23 -45.25 89.0 Favored 'General case' 0 N--CA 1.42 -1.958 0 N-CA-C 108.316 -0.994 . . . . 1.0 108.316 177.039 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 64' ' ' HIS . . . . . 0.529 ' N ' ' O ' ' A' ' 61' ' ' GLU . 0.1 OUTLIER -56.68 -61.3 2.52 Favored 'General case' 0 CA--C 1.537 0.455 0 C-N-CA 118.927 -1.109 . . . . 1.0 111.108 179.803 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . 0.693 ' C ' ' H ' ' A' ' 67' ' ' ARG . 4.6 m-20 -63.19 -48.44 78.32 Favored 'General case' 0 C--O 1.24 0.594 0 CA-C-O 121.526 0.679 . . . . 1.0 109.808 179.139 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -62.2 28.76 0.06 OUTLIER Glycine 0 C--N 1.317 -0.499 0 N-CA-C 110.87 -0.892 . . . . 1.0 110.87 -179.09 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 67' ' ' ARG . . . . . 0.693 ' H ' ' C ' ' A' ' 65' ' ' ASP . 0.0 OUTLIER -82.92 -13.82 55.33 Favored 'General case' 0 N--CA 1.436 -1.153 0 C-N-CA 122.766 0.426 . . . . 1.0 111.558 176.394 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . 0.671 ' O ' ' HA ' ' A' ' 72' ' ' HIS . 0.8 OUTLIER -40.24 -30.11 0.09 Allowed 'General case' 0 C--O 1.22 -0.451 0 N-CA-C 107.009 -1.478 . . . . 1.0 107.009 179.05 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . 0.488 ' N ' ' C ' ' A' ' 67' ' ' ARG . 3.4 tt -65.67 -66.12 0.59 Allowed 'General case' 0 C--N 1.311 -1.071 0 C-N-CA 117.39 -1.724 . . . . 1.0 108.267 177.877 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . 0.706 ' C ' ' H ' ' A' ' 72' ' ' HIS . . . -76.32 -74.45 0.23 Allowed 'General case' 0 N--CA 1.466 0.346 0 N-CA-C 108.895 -0.78 . . . . 1.0 108.895 -179.753 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . 0.589 ' O ' ' N ' ' A' ' 74' ' ' VAL . . . -58.0 13.51 0.01 OUTLIER 'General case' 0 C--N 1.321 -0.65 0 C-N-CA 124.25 1.02 . . . . 1.0 110.851 -178.163 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 72' ' ' HIS . . . . . 0.706 ' H ' ' C ' ' A' ' 70' ' ' ALA . 0.3 OUTLIER -12.07 -74.53 0.01 OUTLIER 'General case' 0 N--CA 1.478 0.959 0 C-N-CA 124.295 1.038 . . . . 1.0 113.113 -174.654 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 73' ' ' MET . . . . . . . . . . . . . 1.4 mpt? -62.63 -41.91 99.29 Favored 'General case' 0 C--N 1.285 -2.216 0 C-N-CA 119.164 -1.014 . . . . 1.0 111.565 -178.431 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . 0.589 ' N ' ' O ' ' A' ' 71' ' ' ALA . 41.4 t -44.27 -49.3 2.12 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.346 0 C-N-CA 119.864 -0.734 . . . . 1.0 110.103 -175.515 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 75' ' ' ASN . . . . . 0.499 ' C ' ' H ' ' A' ' 77' ' ' ILE . 14.0 t-20 -39.52 -21.57 0.01 OUTLIER 'General case' 0 N--CA 1.472 0.664 0 CA-C-O 122.787 1.279 . . . . 1.0 111.441 -179.815 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . 0.569 ' N ' ' O ' ' A' ' 74' ' ' VAL . . . -43.87 -19.5 0.11 Allowed Glycine 0 CA--C 1.539 1.585 0 CA-C-N 113.662 -1.608 . . . . 1.0 109.827 178.674 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . 0.65 ' O ' ' N ' ' A' ' 80' ' ' ALA . 10.3 pt -88.17 -47.0 15.72 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.45 0 N-CA-C 108.386 -0.968 . . . . 1.0 108.386 -178.674 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . 0.506 ' O ' ' HB3' ' A' ' 82' ' ' ASP . 21.6 t -37.74 -35.7 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.433 -1.3 0 N-CA-C 108.14 -1.059 . . . . 1.0 108.14 -177.165 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . 0.484 ' O ' ' HB2' ' A' ' 83' ' ' ALA . 0.3 OUTLIER -87.07 -24.48 6.39 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.34 0 CA-C-O 121.03 0.443 . . . . 1.0 111.083 179.577 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 80' ' ' ALA . . . . . 0.65 ' N ' ' O ' ' A' ' 77' ' ' ILE . . . -73.29 -10.48 59.8 Favored 'General case' 0 C--N 1.319 -0.737 0 O-C-N 122.21 -0.306 . . . . 1.0 111.809 179.119 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 71.8 mt-10 -120.99 -62.79 1.41 Allowed 'General case' 0 CA--C 1.531 0.247 0 CA-C-O 121.705 0.764 . . . . 1.0 111.133 176.953 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 82' ' ' ASP . . . . . 0.797 ' O ' HG13 ' A' ' 85' ' ' ILE . 0.0 OUTLIER -58.73 -62.83 1.58 Allowed 'General case' 0 C--O 1.202 -1.401 0 CA-C-N 114.939 -1.028 . . . . 1.0 109.561 -179.54 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . 0.484 ' HB2' ' O ' ' A' ' 79' ' ' ILE . . . -56.63 -38.08 71.63 Favored 'General case' 0 CA--C 1.506 -0.718 0 C-N-CA 119.803 -0.759 . . . . 1.0 110.14 -176.087 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . 0.542 ' O ' ' N ' ' A' ' 86' ' ' ALA . 3.4 tm? -32.01 -35.32 0.02 OUTLIER 'General case' 0 CA--C 1.51 -0.564 0 CA-C-N 115.525 -0.762 . . . . 1.0 111.839 -174.647 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 85' ' ' ILE . . . . . 0.797 HG13 ' O ' ' A' ' 82' ' ' ASP . 4.7 mt -43.96 -17.83 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.323 -0.544 0 C-N-CA 120.492 -0.483 . . . . 1.0 110.205 179.622 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . 0.674 ' O ' ' N ' ' A' ' 90' ' ' GLY . . . -60.61 -58.46 8.37 Favored 'General case' 0 C--O 1.221 -0.446 0 C-N-CA 119.898 -0.721 . . . . 1.0 109.768 179.852 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . 0.444 ' OE1' ' N ' ' A' ' 87' ' ' GLU . 0.2 OUTLIER -35.64 -24.15 0.01 OUTLIER 'General case' 0 N--CA 1.468 0.468 0 CA-C-O 121.023 0.44 . . . . 1.0 110.663 -177.981 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . 0.621 ' N ' ' O ' ' A' ' 86' ' ' ALA . . . -101.31 -43.46 5.95 Favored 'General case' 0 C--O 1.237 0.444 0 N-CA-C 109.099 -0.704 . . . . 1.0 109.099 177.324 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 89' ' ' VAL . . . . . 0.544 ' C ' ' HD2' ' A' ' 91' ' ' PRO . 3.0 t -100.19 38.26 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.34 0.186 0 N-CA-C 108.775 -0.824 . . . . 1.0 108.775 178.01 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 90' ' ' GLY . . . . . 0.889 ' O ' ' N ' ' A' ' 92' ' ' HIS . . . -62.08 -17.59 55.78 Favored Glycine 0 C--N 1.358 1.801 0 CA-C-O 117.553 -1.693 . . . . 1.0 111.92 177.83 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 91' ' ' PRO . . . . . 0.72 ' HD2' ' N ' ' A' ' 90' ' ' GLY . 75.3 Cg_exo -32.62 1.01 0.0 OUTLIER 'Trans proline' 0 N--CA 1.513 2.659 0 C-N-CA 124.382 3.388 . . . . 1.0 113.694 171.811 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 92' ' ' HIS . . . . . 0.889 ' N ' ' O ' ' A' ' 90' ' ' GLY . 42.1 t-80 -49.88 -30.11 9.43 Favored 'General case' 0 N--CA 1.427 -1.591 0 N-CA-C 108.357 -0.979 . . . . 1.0 108.357 176.479 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . 0.672 ' O ' ' N ' ' A' ' 96' ' ' ALA . 0.8 OUTLIER -61.17 -60.64 3.45 Favored 'General case' 0 C--O 1.222 -0.367 0 N-CA-C 107.358 -1.349 . . . . 1.0 107.358 177.684 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 94' ' ' ALA . . . . . 0.569 ' CB ' HH21 ' A' ' 95' ' ' ARG . . . -45.75 -51.18 13.01 Favored 'General case' 0 N--CA 1.437 -1.104 0 N-CA-C 108.064 -1.087 . . . . 1.0 108.064 -179.193 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 95' ' ' ARG . . . . . 0.569 HH21 ' CB ' ' A' ' 94' ' ' ALA . 0.0 OUTLIER -60.21 -25.27 65.48 Favored 'General case' 0 N--CA 1.434 -1.226 0 C-N-CA 120.013 -0.675 . . . . 1.0 109.334 176.494 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 96' ' ' ALA . . . . . 0.759 ' O ' ' N ' ' A' ' 100' ' ' ILE . . . -57.05 -52.1 66.61 Favored 'General case' 0 C--O 1.207 -1.135 0 N-CA-C 107.227 -1.397 . . . . 1.0 107.227 179.511 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . 0.565 ' O ' ' CG2' ' A' ' 100' ' ' ILE . 0.1 OUTLIER -35.55 -29.16 0.01 OUTLIER 'General case' 0 CA--C 1.567 1.63 0 N-CA-C 107.238 -1.393 . . . . 1.0 107.238 -179.716 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 98' ' ' GLY . . . . . 0.611 ' N ' ' O ' ' A' ' 96' ' ' ALA . . . -81.51 -52.9 4.01 Favored Glycine 0 CA--C 1.551 2.309 0 CA-C-O 123.083 1.379 . . . . 1.0 110.831 174.422 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 99' ' ' GLN . . . . . 0.612 ' N ' ' O ' ' A' ' 96' ' ' ALA . 27.0 mt-30 -79.19 7.66 7.24 Favored 'General case' 0 N--CA 1.438 -1.028 0 N-CA-C 108.548 -0.908 . . . . 1.0 108.548 178.366 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 100' ' ' ILE . . . . . 0.759 ' N ' ' O ' ' A' ' 96' ' ' ALA . 16.7 tt -60.39 -51.25 75.2 Favored 'Isoleucine or valine' 0 CA--C 1.493 -1.233 0 N-CA-C 108.71 -0.848 . . . . 1.0 108.71 179.826 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 101' ' ' VAL . . . . . 0.566 ' O ' ' N ' ' A' ' 105' ' ' GLY . 24.1 t -55.05 -57.12 7.87 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.977 0 C-N-CA 117.083 -1.847 . . . . 1.0 107.058 178.058 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 102' ' ' CYS . . . . . 0.628 ' O ' ' S1 ' ' A' ' 130' ' ' MTN . 4.9 t -44.47 -25.63 0.28 Allowed 'General case' 0 C--O 1.214 -0.791 0 C-N-CA 120.085 -0.646 . . . . 1.0 109.854 -178.944 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 103' ' ' ARG . . . . . 0.426 ' N ' ' C ' ' A' ' 101' ' ' VAL . 1.7 tpp85 -87.19 -45.06 11.0 Favored 'General case' 0 N--CA 1.476 0.862 0 N-CA-C 113.444 0.905 . . . . 1.0 113.444 179.459 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 104' ' ' TYR . . . . . 0.747 ' CG ' ' O ' ' A' ' 104' ' ' TYR . 3.0 t80 -99.19 19.63 14.98 Favored 'General case' 0 C--N 1.31 -1.121 0 C-N-CA 127.066 2.146 . . . . 1.0 110.137 -179.623 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 105' ' ' GLY . . . . . 0.823 ' O ' ' N ' ' A' ' 107' ' ' THR . . . -164.27 -7.79 0.03 OUTLIER Glycine 0 N--CA 1.441 -0.975 0 C-N-CA 117.891 -2.1 . . . . 1.0 111.588 177.337 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 106' ' ' ALA . . . . . 0.454 ' C ' ' O ' ' A' ' 105' ' ' GLY . . . -15.53 62.7 0.0 OUTLIER 'General case' 0 N--CA 1.471 0.6 0 O-C-N 125.147 1.145 . . . . 1.0 111.997 -179.034 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 107' ' ' THR . . . . . 0.823 ' N ' ' O ' ' A' ' 105' ' ' GLY . 11.4 p -100.38 -2.81 32.47 Favored 'General case' 0 CA--C 1.534 0.339 0 CA-C-N 116.265 -0.425 . . . . 1.0 110.119 -179.425 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . 0.524 ' CG1' ' N ' ' A' ' 109' ' ' ILE . 8.1 p -84.72 -57.84 4.03 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.427 0 CA-C-N 116.389 -0.369 . . . . 1.0 111.057 -178.194 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 109' ' ' ILE . . . . . 0.574 ' N ' ' HD2' ' A' ' 110' ' ' PRO . 0.2 OUTLIER -47.22 -47.76 56.03 Favored Pre-proline 0 CA--C 1.503 -0.842 0 C-N-CA 122.756 0.422 . . . . 1.0 111.852 179.458 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 110' ' ' PRO . . . . . 0.574 ' HD2' ' N ' ' A' ' 109' ' ' ILE . 6.0 Cg_endo -40.65 -39.84 3.15 Favored 'Trans proline' 0 CA--C 1.507 -0.85 0 C-N-CA 121.025 1.15 . . . . 1.0 114.081 -172.414 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 19.6 m-20 -65.09 -68.0 0.39 Allowed 'General case' 0 C--N 1.305 -1.33 0 C-N-CA 119.047 -1.061 . . . . 1.0 110.475 -176.967 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -69.21 -25.48 29.65 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.788 0 CA-C-N 115.498 -0.773 . . . . 1.0 110.594 -178.012 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 113' ' ' ASN . . . . . 0.499 ' N ' ' O ' ' A' ' 109' ' ' ILE . 7.0 t30 -54.65 -61.83 2.05 Favored 'General case' 0 CA--C 1.488 -1.438 0 CA-C-N 114.268 -1.333 . . . . 1.0 110.854 -174.882 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -65.12 -20.46 66.47 Favored 'General case' 0 N--CA 1.432 -1.35 0 O-C-N 124.233 0.958 . . . . 1.0 110.255 -179.723 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -75.33 -61.78 1.79 Allowed 'General case' 0 C--O 1.241 0.624 0 C-N-CA 120.255 -0.578 . . . . 1.0 112.078 178.86 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 116' ' ' ILE . . . . . 0.484 ' O ' ' CB ' ' A' ' 119' ' ' LEU . 26.5 pt -68.52 -40.92 82.72 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.498 0 O-C-N 121.079 -1.013 . . . . 1.0 111.589 -177.895 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 117' ' ' GLU . . . . . 0.471 ' C ' ' N ' ' A' ' 119' ' ' LEU . 2.6 tt0 -47.21 -66.2 0.44 Allowed 'General case' 0 C--N 1.317 -0.823 0 CA-C-N 115.42 -0.809 . . . . 1.0 110.432 -177.18 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 72.0 t -50.11 -14.58 0.26 Allowed 'Isoleucine or valine' 0 N--CA 1.437 -1.121 0 O-C-N 124.572 1.17 . . . . 1.0 109.332 -178.822 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 119' ' ' LEU . . . . . 0.484 ' CB ' ' O ' ' A' ' 116' ' ' ILE . 0.2 OUTLIER -79.04 -62.6 1.64 Allowed 'General case' 0 N--CA 1.451 -0.413 0 C-N-CA 119.316 -0.954 . . . . 1.0 109.514 176.345 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -70.18 -84.98 0.16 Allowed Glycine 0 N--CA 1.481 1.689 0 C-N-CA 117.53 -2.271 . . . . 1.0 112.052 -179.139 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 34.0 m -161.8 -19.73 0.05 OUTLIER 'General case' 0 CA--C 1.542 0.651 0 CA-C-O 120.769 0.319 . . . . 1.0 110.231 -179.139 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 122' ' ' GLY . . . . . 0.481 ' O ' ' N ' ' A' ' 124' ' ' ASP . . . 111.59 -36.13 4.35 Favored Glycine 0 N--CA 1.477 1.387 0 C-N-CA 125.202 1.382 . . . . 1.0 112.138 179.752 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 123' ' ' THR . . . . . 0.464 ' C ' ' O ' ' A' ' 122' ' ' GLY . 0.0 OUTLIER -32.09 93.21 0.01 OUTLIER 'General case' 0 N--CA 1.469 0.523 0 CA-C-N 118.867 1.333 . . . . 1.0 112.461 -177.888 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 124' ' ' ASP . . . . . 0.481 ' N ' ' O ' ' A' ' 122' ' ' GLY . 8.7 t70 -141.49 141.6 33.62 Favored 'General case' 0 C--N 1.328 -0.352 0 N-CA-C 107.425 -1.324 . . . . 1.0 107.425 177.452 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 125' ' ' TYR . . . . . . . . . . . . . 9.7 t80 -153.58 147.24 25.16 Favored 'General case' 0 C--N 1.324 -0.532 0 N-CA-C 109.692 -0.484 . . . . 1.0 109.692 -177.569 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 9.0 mmp_? -147.5 152.08 37.43 Favored 'General case' 0 CA--C 1.542 0.646 0 CA-C-N 115.532 -0.758 . . . . 1.0 110.777 177.281 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 127' ' ' PHE . . . . . . . . . . . . . 22.6 p90 . . . . . 0 N--CA 1.47 0.574 0 CA-C-O 118.275 -0.869 . . . . 1.0 110.253 179.608 . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 128' ' ' MTN . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 129' ' ' MTN . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 130' ' ' MTN . . . . . 0.628 ' S1 ' ' O ' ' A' ' 102' ' ' CYS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 64.6 mtt . . . . . 0 N--CA 1.491 1.577 0 N-CA-C 109.332 -0.618 . . . . 1.0 109.332 . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 88.9 p -103.63 7.7 37.51 Favored 'General case' 0 N--CA 1.467 0.398 0 CA-C-N 116.097 -0.501 . . . . 1.0 110.751 -179.723 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . 0.459 ' N ' ' OD1' ' A' ' 3' ' ' ASP . 1.6 p30 167.42 99.87 0.0 OUTLIER 'General case' 0 N--CA 1.466 0.342 0 CA-C-N 116.109 -0.496 . . . . 1.0 110.42 179.096 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 16.6 t80 -150.21 145.82 26.47 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.219 -0.446 . . . . 1.0 110.059 179.329 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 5' ' ' ASP . . . . . 0.615 ' OD1' ' N ' ' A' ' 10' ' ' SER . 0.3 OUTLIER -157.21 153.42 27.58 Favored 'General case' 0 C--N 1.327 -0.377 0 N-CA-C 109.887 -0.412 . . . . 1.0 109.887 179.674 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 6' ' ' THR . . . . . 0.676 ' O ' ' N ' ' A' ' 10' ' ' SER . 0.2 OUTLIER -75.01 175.74 7.87 Favored 'General case' 0 C--O 1.212 -0.872 0 CA-C-N 116.112 -0.495 . . . . 1.0 111.802 -178.123 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . 0.504 ' O ' ' N ' ' A' ' 11' ' ' ARG . 0.5 OUTLIER -58.7 -56.21 25.19 Favored 'General case' 0 N--CA 1.478 0.974 0 CA-C-N 115.72 -0.673 . . . . 1.0 109.863 -178.781 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 8' ' ' ARG . . . . . 0.462 ' O ' ' CB ' ' A' ' 12' ' ' ALA . 0.0 OUTLIER -49.39 -54.77 15.67 Favored 'General case' 0 C--N 1.318 -0.794 0 N-CA-C 106.349 -1.723 . . . . 1.0 106.349 -178.034 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . 0.778 ' O ' ' HB ' ' A' ' 13' ' ' VAL . 1.3 t -63.74 -46.46 94.49 Favored 'Isoleucine or valine' 0 C--O 1.193 -1.914 0 CA-C-N 111.834 -2.439 . . . . 1.0 109.165 -179.705 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 10' ' ' SER . . . . . 0.676 ' N ' ' O ' ' A' ' 6' ' ' THR . 6.6 t -69.67 -63.32 1.1 Allowed 'General case' 0 N--CA 1.487 1.405 0 N-CA-C 112.648 0.61 . . . . 1.0 112.648 -178.279 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 11' ' ' ARG . . . . . 0.537 ' O ' ' N ' ' A' ' 15' ' ' ALA . 3.6 mmt85 -64.07 -55.39 22.42 Favored 'General case' 0 N--CA 1.478 0.963 0 CA-C-O 121.119 0.485 . . . . 1.0 110.866 -176.402 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . 0.47 ' O ' ' CB ' ' A' ' 16' ' ' ALA . . . -51.24 -50.73 58.61 Favored 'General case' 0 C--N 1.314 -0.953 0 N-CA-C 106.363 -1.717 . . . . 1.0 106.363 -178.756 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . 0.778 ' HB ' ' O ' ' A' ' 9' ' ' VAL . 8.1 t -60.62 -52.26 63.54 Favored 'Isoleucine or valine' 0 C--O 1.197 -1.662 0 C-N-CA 119.419 -0.912 . . . . 1.0 109.184 176.823 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . 0.461 ' O ' ' N ' ' A' ' 18' ' ' VAL . . . -58.24 -62.13 2.06 Favored 'General case' 0 C--O 1.21 -1.019 0 C-N-CA 118.682 -1.207 . . . . 1.0 110.185 -179.352 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . 0.563 ' O ' ' N ' ' A' ' 19' ' ' GLY . . . -52.25 -55.64 19.98 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-O 121.918 0.866 . . . . 1.0 109.943 -178.245 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . 0.524 ' CA ' ' H ' ' A' ' 22' ' ' GLY . . . -61.27 -54.76 39.94 Favored 'General case' 0 C--N 1.311 -1.101 0 CA-C-N 114.413 -1.267 . . . . 1.0 109.097 -179.269 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . 0.581 ' N ' ' O ' ' A' ' 13' ' ' VAL . 7.0 tt -57.79 -53.7 55.24 Favored 'General case' 0 N--CA 1.482 1.153 0 CA-C-N 114.001 -1.454 . . . . 1.0 109.294 -177.693 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . 0.594 HG23 ' H ' ' A' ' 19' ' ' GLY . 2.6 m -68.98 -56.67 11.17 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.501 0 C-N-CA 119.268 -0.973 . . . . 1.0 109.274 178.978 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . 0.594 ' H ' HG23 ' A' ' 18' ' ' VAL . . . -66.74 -160.59 1.0 Allowed Glycine 0 CA--C 1.534 1.248 0 CA-C-N 116.771 -0.195 . . . . 1.0 113.162 -178.037 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 20' ' ' PRO . . . . . 0.498 ' O ' ' CB ' ' A' ' 24' ' ' ALA . 90.8 Cg_endo -79.87 -30.02 2.49 Favored 'Trans proline' 0 N--CA 1.502 2.026 0 C-N-CA 123.476 2.784 . . . . 1.0 115.117 -177.42 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -60.15 -58.21 15.21 Favored Glycine 0 N--CA 1.478 1.437 0 C-N-CA 119.864 -1.16 . . . . 1.0 112.458 -176.296 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . 0.524 ' H ' ' CA ' ' A' ' 16' ' ' ALA . . . -59.16 -56.26 26.21 Favored Glycine 0 C--N 1.312 -0.757 0 N-CA-C 108.403 -1.879 . . . . 1.0 108.403 -177.243 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 34.6 m -59.77 -34.39 55.46 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.84 0 C-N-CA 120.109 -0.636 . . . . 1.0 109.713 -179.489 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . 0.498 ' CB ' ' O ' ' A' ' 20' ' ' PRO . . . -57.38 -61.52 2.43 Favored 'General case' 0 CA--C 1.534 0.337 0 C-N-CA 118.078 -1.449 . . . . 1.0 109.011 179.884 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 5.2 mp -63.85 -44.18 93.91 Favored 'General case' 0 C--N 1.347 0.465 0 C-N-CA 120.24 -0.584 . . . . 1.0 112.19 -178.598 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 73.8 t -60.87 -59.59 3.99 Favored 'Isoleucine or valine' 0 CA--C 1.527 0.083 0 C-N-CA 118.776 -1.169 . . . . 1.0 109.793 -177.991 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 83.9 t -59.97 -39.16 79.43 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.212 0 N-CA-C 112.19 0.441 . . . . 1.0 112.19 -178.429 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 27.5 tttm -65.94 -54.42 26.59 Favored 'General case' 0 C--N 1.319 -0.739 0 N-CA-C 108.941 -0.763 . . . . 1.0 108.941 -179.223 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 59.5 t -63.98 -48.44 86.05 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.825 0 CA-C-N 114.599 -1.182 . . . . 1.0 110.587 -177.892 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 30' ' ' CYS . . . . . . . . . . . . . 20.0 t -65.16 -61.23 2.26 Favored 'General case' 0 N--CA 1.446 -0.664 0 C-N-CA 119.245 -0.982 . . . . 1.0 109.566 -179.51 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -65.18 -53.2 48.49 Favored 'General case' 0 N--CA 1.453 -0.309 0 N-CA-C 113.487 0.921 . . . . 1.0 113.487 -176.24 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 84.6 77.89 1.15 Allowed Glycine 0 CA--C 1.527 0.822 0 C-N-CA 120.338 -0.934 . . . . 1.0 111.474 -179.76 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . 0.445 ' O ' ' N ' ' A' ' 35' ' ' GLY . 10.0 mp 69.89 101.37 0.04 OUTLIER Pre-proline 0 CA--C 1.548 0.88 0 C-N-CA 123.207 0.603 . . . . 1.0 110.25 -179.131 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 1.1 Cg_endo -45.26 -10.13 0.04 OUTLIER 'Trans proline' 0 N--CA 1.501 1.944 0 C-N-CA 122.109 1.872 . . . . 1.0 114.818 -179.247 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . 0.445 ' N ' ' O ' ' A' ' 33' ' ' LEU . . . -60.82 -59.76 9.62 Favored Glycine 0 N--CA 1.468 0.823 0 C-N-CA 118.223 -1.941 . . . . 1.0 110.088 -178.037 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . 0.604 ' CG2' ' H ' ' A' ' 37' ' ' ILE . 9.4 p -83.87 -146.58 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.465 0.324 0 N-CA-C 109.303 -0.629 . . . . 1.0 109.303 -179.945 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . 0.604 ' H ' ' CG2' ' A' ' 36' ' ' VAL . 2.2 mp 73.71 76.8 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.474 0.727 0 CA-C-N 117.949 0.341 . . . . 1.0 111.578 -179.551 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 98.9 m-70 -134.94 127.2 30.15 Favored 'General case' 0 N--CA 1.451 -0.385 0 N-CA-C 106.902 -1.518 . . . . 1.0 106.902 177.777 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 27.7 p -109.1 146.55 34.09 Favored Pre-proline 0 C--N 1.328 -0.349 0 N-CA-C 109.631 -0.507 . . . . 1.0 109.631 -179.037 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 51.0 Cg_endo -66.0 -24.94 52.23 Favored 'Trans proline' 0 C--N 1.306 -1.659 0 C-N-CA 121.502 1.468 . . . . 1.0 112.819 -178.854 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -126.81 130.15 49.69 Favored 'General case' 0 CA--C 1.516 -0.349 0 N-CA-C 109.567 -0.531 . . . . 1.0 109.567 178.921 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . 0.695 ' C ' ' H ' ' A' ' 44' ' ' GLY . 4.0 tmm_? -159.27 156.05 28.04 Favored 'General case' 0 C--N 1.318 -0.781 0 C-N-CA 119.908 -0.717 . . . . 1.0 109.175 178.05 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 43' ' ' ARG . . . . . 0.425 ' C ' ' H ' ' A' ' 45' ' ' PHE . 0.2 OUTLIER -62.97 17.95 0.01 OUTLIER 'General case' 0 C--N 1.32 -0.7 0 CA-C-N 115.963 -0.562 . . . . 1.0 110.147 179.204 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . 0.695 ' H ' ' C ' ' A' ' 42' ' ' ARG . . . 76.59 -27.19 1.58 Allowed Glycine 0 C--N 1.337 0.617 0 N-CA-C 111.306 -0.718 . . . . 1.0 111.306 179.389 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . 0.564 ' CD1' ' N ' ' A' ' 45' ' ' PHE . 0.1 OUTLIER -155.59 156.58 35.33 Favored 'General case' 0 CA--C 1.548 0.868 0 N-CA-C 109.795 -0.446 . . . . 1.0 109.795 -179.684 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 46' ' ' PHE . . . . . 0.576 ' O ' ' HB2' ' A' ' 47' ' ' ARG . 0.5 OUTLIER 139.66 85.36 0.0 OUTLIER 'General case' 0 N--CA 1.5 2.068 0 C-N-CA 126.23 1.812 . . . . 1.0 109.05 179.251 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 47' ' ' ARG . . . . . 0.583 HH12 ' H92' ' A' ' 128' ' ' MTN . 2.5 mtm-85 131.89 138.24 0.0 OUTLIER 'General case' 0 N--CA 1.505 2.294 0 C-N-CA 125.189 1.396 . . . . 1.0 109.989 178.528 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 48' ' ' CYS . . . . . 0.546 ' SG ' ' C ' ' A' ' 47' ' ' ARG . 0.0 OUTLIER 75.5 70.66 0.08 Allowed 'General case' 0 C--O 1.219 -0.531 0 N-CA-C 108.988 -0.745 . . . . 1.0 108.988 179.662 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 49' ' ' ASN . . . . . 0.649 ' O ' ' N ' ' A' ' 51' ' ' GLU . 1.2 p-10 -143.32 116.09 5.95 Favored Pre-proline 0 C--N 1.327 -0.407 0 N-CA-C 107.988 -1.116 . . . . 1.0 107.988 -179.733 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 74.7 Cg_exo -47.42 63.52 0.01 OUTLIER 'Trans proline' 0 N--CA 1.509 2.399 0 C-N-CA 122.688 2.258 . . . . 1.0 114.788 -178.801 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . 0.649 ' N ' ' O ' ' A' ' 49' ' ' ASN . 17.1 mp0 62.02 28.49 17.26 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.463 -0.335 . . . . 1.0 111.064 -179.644 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -102.71 134.34 46.25 Favored 'General case' 0 CA--C 1.516 -0.329 0 N-CA-C 109.206 -0.664 . . . . 1.0 109.206 178.55 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . 0.419 ' O ' ' N ' ' A' ' 55' ' ' ILE . 13.0 tt -57.92 138.58 18.68 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.374 0 CA-C-O 122.273 1.035 . . . . 1.0 112.066 -178.056 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 54' ' ' GLN . . . . . 0.544 ' OE1' ' CE2' ' A' ' 46' ' ' PHE . 0.0 OUTLIER -65.98 80.62 0.08 Allowed 'General case' 0 C--N 1.318 -0.794 0 CA-C-N 113.75 -1.568 . . . . 1.0 108.067 -179.761 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . 0.427 ' CG2' ' N ' ' A' ' 56' ' ' GLY . 11.7 mt -149.12 158.06 6.54 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.657 0 CA-C-N 115.864 -0.607 . . . . 1.0 109.835 178.694 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . 0.427 ' N ' ' CG2' ' A' ' 55' ' ' ILE . . . 111.62 -2.14 27.65 Favored Glycine 0 N--CA 1.468 0.817 0 N-CA-C 110.205 -1.158 . . . . 1.0 110.205 -179.865 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . 0.464 ' OD1' ' CG ' ' A' ' 45' ' ' PHE . 36.3 m-20 -79.19 97.95 6.41 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 115.234 -0.483 . . . . 1.0 110.533 179.533 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 58' ' ' TRP . . . . . . . . . . . . . 6.5 m0 -87.99 172.27 9.69 Favored 'General case' 0 CA--C 1.539 0.525 0 CA-C-O 123.0 1.381 . . . . 1.0 112.58 -177.956 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 59' ' ' ARG . . . . . 0.52 ' CD ' ' H ' ' A' ' 59' ' ' ARG . 0.0 OUTLIER -82.49 -60.43 2.2 Favored 'General case' 0 C--N 1.311 -1.097 0 CA-C-N 111.622 -2.535 . . . . 1.0 112.839 -179.31 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 44.8 t80 -91.69 -14.04 30.71 Favored 'General case' 0 C--N 1.317 -0.824 0 N-CA-C 113.777 1.028 . . . . 1.0 113.777 -179.118 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . 0.442 ' O ' ' N ' ' A' ' 65' ' ' ASP . 4.6 tt0 -80.18 -14.61 58.32 Favored 'General case' 0 C--O 1.214 -0.804 0 O-C-N 121.709 -0.619 . . . . 1.0 110.592 -179.493 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . 0.637 ' O ' ' N ' ' A' ' 66' ' ' GLY . 28.9 m -46.46 -54.25 2.24 Favored 'Isoleucine or valine' 0 C--O 1.212 -0.92 0 C-N-CA 119.268 -0.973 . . . . 1.0 110.46 -175.715 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 63' ' ' ALA . . . . . 0.498 ' O ' ' CG ' ' A' ' 67' ' ' ARG . . . -67.42 -48.39 67.44 Favored 'General case' 0 C--N 1.303 -1.428 0 O-C-N 121.402 -0.811 . . . . 1.0 108.962 179.824 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 11.0 t-80 -51.56 -58.09 7.28 Favored 'General case' 0 CA--C 1.541 0.627 0 C-N-CA 119.463 -0.895 . . . . 1.0 109.419 -179.649 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . 0.62 ' C ' ' H ' ' A' ' 67' ' ' ARG . 22.8 m-20 -75.38 -52.03 11.74 Favored 'General case' 0 C--O 1.245 0.826 0 CA-C-N 115.733 -0.667 . . . . 1.0 111.24 178.837 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . 0.637 ' N ' ' O ' ' A' ' 62' ' ' VAL . . . -71.76 25.97 0.63 Allowed Glycine 0 CA--C 1.522 0.483 0 O-C-N 120.345 -1.472 . . . . 1.0 110.337 177.423 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 67' ' ' ARG . . . . . 0.671 ' O ' ' N ' ' A' ' 69' ' ' LEU . 0.6 OUTLIER -71.71 7.2 1.58 Allowed 'General case' 0 CA--C 1.507 -0.687 0 N-CA-C 106.197 -1.779 . . . . 1.0 106.197 174.47 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . 0.628 ' H ' ' C ' ' A' ' 66' ' ' GLY . 3.1 mt -30.48 -30.11 0.01 OUTLIER 'General case' 0 N--CA 1.472 0.669 0 O-C-N 124.045 0.84 . . . . 1.0 108.767 -177.653 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . 0.671 ' N ' ' O ' ' A' ' 67' ' ' ARG . 10.9 mp -62.35 -66.15 0.58 Allowed 'General case' 0 N--CA 1.476 0.842 0 C-N-CA 119.296 -0.961 . . . . 1.0 109.016 178.401 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . 0.645 ' C ' ' H ' ' A' ' 72' ' ' HIS . . . -79.49 -75.63 0.24 Allowed 'General case' 0 N--CA 1.476 0.835 0 N-CA-C 107.36 -1.348 . . . . 1.0 107.36 178.051 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . 0.44 ' O ' ' C ' ' A' ' 72' ' ' HIS . . . -46.44 5.87 0.0 OUTLIER 'General case' 0 CA--C 1.536 0.409 0 C-N-CA 124.837 1.255 . . . . 1.0 113.539 177.671 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 72' ' ' HIS . . . . . 0.645 ' H ' ' C ' ' A' ' 70' ' ' ALA . 1.1 t-80 -28.69 -68.17 0.07 Allowed 'General case' 0 N--CA 1.467 0.414 0 C-N-CA 122.827 0.451 . . . . 1.0 111.788 -179.449 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 73' ' ' MET . . . . . 0.549 ' N ' ' SD ' ' A' ' 73' ' ' MET . 0.0 OUTLIER -66.83 -47.58 71.58 Favored 'General case' 0 C--N 1.329 -0.325 0 C-N-CA 118.263 -1.375 . . . . 1.0 109.133 178.966 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . 0.793 ' O ' ' N ' ' A' ' 76' ' ' GLY . 72.9 t -42.2 -41.17 0.91 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.26 0 CA-C-O 117.621 -1.18 . . . . 1.0 111.524 -176.089 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 3.0 t-20 -33.63 -12.22 0.0 OUTLIER 'General case' 0 N--CA 1.498 1.947 0 CA-C-N 120.175 1.352 . . . . 1.0 112.315 179.25 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . 0.793 ' N ' ' O ' ' A' ' 74' ' ' VAL . . . -48.86 -22.67 3.04 Favored Glycine 0 CA--C 1.542 1.736 0 N-CA-C 108.455 -1.858 . . . . 1.0 108.455 174.629 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . 0.667 ' O ' ' N ' ' A' ' 80' ' ' ALA . 0.9 OUTLIER -75.54 -59.86 2.88 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.588 0 N-CA-C 108.068 -1.086 . . . . 1.0 108.068 178.36 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . 0.547 ' H ' HG13 ' A' ' 77' ' ' ILE . 75.6 t -34.39 -31.18 0.02 OUTLIER 'Isoleucine or valine' 0 CA--C 1.547 0.828 0 CA-C-N 113.532 -1.667 . . . . 1.0 107.947 -176.207 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . 0.553 ' N ' ' O ' ' A' ' 77' ' ' ILE . 40.3 pt -95.45 -29.9 4.03 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.843 0 CA-C-N 115.989 -0.55 . . . . 1.0 111.595 178.392 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 80' ' ' ALA . . . . . 0.667 ' N ' ' O ' ' A' ' 77' ' ' ILE . . . -86.14 -10.79 54.17 Favored 'General case' 0 CA--C 1.548 0.882 0 N-CA-C 113.284 0.846 . . . . 1.0 113.284 178.387 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . 0.442 ' N ' ' O ' ' A' ' 77' ' ' ILE . 8.5 mt-10 -83.1 -68.56 0.7 Allowed 'General case' 0 C--N 1.355 0.805 0 CA-C-N 118.855 0.752 . . . . 1.0 109.067 178.254 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 82' ' ' ASP . . . . . 0.512 ' O ' ' C ' ' A' ' 83' ' ' ALA . 49.7 p-10 -74.95 -14.2 60.61 Favored 'General case' 0 N--CA 1.443 -0.796 0 CA-C-O 118.846 -0.597 . . . . 1.0 112.136 -179.48 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . 0.533 ' O ' ' N ' ' A' ' 87' ' ' GLU . . . -23.08 -47.35 0.01 OUTLIER 'General case' 0 N--CA 1.473 0.698 0 CA-C-N 118.436 0.562 . . . . 1.0 112.013 177.746 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . 0.48 ' N ' ' O ' ' A' ' 82' ' ' ASP . 2.9 tt -37.7 -36.2 0.17 Allowed 'General case' 0 N--CA 1.465 0.324 0 N-CA-C 112.85 0.685 . . . . 1.0 112.85 -177.617 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 11.2 pt -98.68 -43.1 11.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 N-CA-C 108.436 -0.95 . . . . 1.0 108.436 177.526 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . 0.478 ' O ' HG21 ' A' ' 89' ' ' VAL . . . -56.36 -57.45 12.2 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 114.142 -1.39 . . . . 1.0 109.503 179.45 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . 0.533 ' N ' ' O ' ' A' ' 83' ' ' ALA . 19.8 tt0 -79.3 26.41 0.28 Allowed 'General case' 0 CA--C 1.544 0.723 0 O-C-N 120.851 -1.156 . . . . 1.0 112.202 -178.149 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -116.49 -15.75 10.86 Favored 'General case' 0 N--CA 1.489 1.504 0 CA-C-O 123.415 1.579 . . . . 1.0 107.896 177.68 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 89' ' ' VAL . . . . . 0.478 HG21 ' O ' ' A' ' 86' ' ' ALA . 5.3 m -100.44 39.23 0.15 Allowed 'Isoleucine or valine' 0 C--O 1.205 -1.238 0 CA-C-N 110.83 -2.896 . . . . 1.0 109.987 178.573 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 90' ' ' GLY . . . . . 0.541 ' C ' ' H ' ' A' ' 92' ' ' HIS . . . -71.59 -39.15 61.13 Favored Glycine 0 C--N 1.351 1.381 0 N-CA-C 111.023 -0.831 . . . . 1.0 111.023 178.329 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 91' ' ' PRO . . . . . 0.528 ' CD ' ' N ' ' A' ' 90' ' ' GLY . 89.6 Cg_exo -46.45 -12.82 0.09 OUTLIER 'Trans proline' 0 N--CA 1.497 1.712 0 C-N-CA 121.572 1.515 . . . . 1.0 110.346 178.406 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 92' ' ' HIS . . . . . 0.541 ' H ' ' C ' ' A' ' 90' ' ' GLY . 3.5 p80 -57.54 -17.15 12.35 Favored 'General case' 0 C--O 1.208 -1.108 0 N-CA-C 107.56 -1.274 . . . . 1.0 107.56 179.675 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . 0.44 ' CD1' ' N ' ' A' ' 94' ' ' ALA . 2.1 pp -67.84 -59.37 3.35 Favored 'General case' 0 N--CA 1.455 -0.215 0 N-CA-C 108.817 -0.809 . . . . 1.0 108.817 178.884 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 94' ' ' ALA . . . . . 0.44 ' N ' ' CD1' ' A' ' 93' ' ' LEU . . . -56.45 -53.36 58.31 Favored 'General case' 0 N--CA 1.454 -0.265 0 N-CA-C 108.914 -0.773 . . . . 1.0 108.914 178.701 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 95' ' ' ARG . . . . . 0.643 ' O ' ' N ' ' A' ' 97' ' ' LEU . 42.8 mtm105 -57.54 -57.44 12.69 Favored 'General case' 0 C--O 1.241 0.653 0 N-CA-C 107.822 -1.177 . . . . 1.0 107.822 178.846 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 96' ' ' ALA . . . . . 0.885 ' O ' ' N ' ' A' ' 98' ' ' GLY . . . -47.47 -12.35 0.03 OUTLIER 'General case' 0 N--CA 1.436 -1.128 0 O-C-N 118.905 -2.372 . . . . 1.0 110.375 -179.195 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . 0.692 ' O ' ' N ' ' A' ' 100' ' ' ILE . 16.2 tp 5.96 -53.25 0.0 OUTLIER 'General case' 0 C--N 1.377 1.801 0 CA-C-O 117.481 -1.247 . . . . 1.0 110.275 -167.843 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 98' ' ' GLY . . . . . 0.885 ' N ' ' O ' ' A' ' 96' ' ' ALA . . . -49.06 -23.75 4.06 Favored Glycine 0 CA--C 1.543 1.784 0 CA-C-N 122.572 2.442 . . . . 1.0 107.902 175.331 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 99' ' ' GLN . . . . . 0.552 ' N ' ' O ' ' A' ' 96' ' ' ALA . 0.0 OUTLIER -63.88 -17.45 63.2 Favored 'General case' 0 C--N 1.36 1.026 0 N-CA-C 107.046 -1.465 . . . . 1.0 107.046 176.706 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 100' ' ' ILE . . . . . 0.692 ' N ' ' O ' ' A' ' 97' ' ' LEU . 1.9 tp -66.42 -43.33 91.18 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.518 0 N-CA-C 108.746 -0.835 . . . . 1.0 108.746 178.98 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 101' ' ' VAL . . . . . 0.672 ' O ' ' N ' ' A' ' 105' ' ' GLY . 0.5 OUTLIER -54.48 -58.28 4.25 Favored 'Isoleucine or valine' 0 C--O 1.219 -0.546 0 N-CA-C 106.844 -1.539 . . . . 1.0 106.844 178.69 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 102' ' ' CYS . . . . . 0.548 ' N ' ' CG1' ' A' ' 101' ' ' VAL . 17.1 t -44.74 -20.6 0.04 OUTLIER 'General case' 0 C--N 1.314 -0.974 0 CA-C-N 115.961 -0.563 . . . . 1.0 111.977 -179.932 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 103' ' ' ARG . . . . . 0.507 ' CG ' HH11 ' A' ' 103' ' ' ARG . 0.0 OUTLIER -92.76 -44.69 8.4 Favored 'General case' 0 N--CA 1.472 0.646 0 CA-C-O 122.328 1.061 . . . . 1.0 111.521 178.299 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 104' ' ' TYR . . . . . 0.581 ' O ' ' CD2' ' A' ' 104' ' ' TYR . 0.0 OUTLIER -105.72 22.39 15.64 Favored 'General case' 0 C--N 1.312 -1.027 0 CA-C-N 113.625 -1.625 . . . . 1.0 111.325 179.294 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 105' ' ' GLY . . . . . 0.776 ' O ' ' N ' ' A' ' 107' ' ' THR . . . -171.67 -9.29 0.02 OUTLIER Glycine 0 C--N 1.345 1.028 0 C-N-CA 118.437 -1.84 . . . . 1.0 113.125 178.987 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 106' ' ' ALA . . . . . 0.547 ' O ' ' CD ' ' A' ' 110' ' ' PRO . . . -27.71 68.68 0.0 OUTLIER 'General case' 0 N--CA 1.475 0.793 0 N-CA-C 113.521 0.934 . . . . 1.0 113.521 -178.707 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 107' ' ' THR . . . . . 0.776 ' N ' ' O ' ' A' ' 105' ' ' GLY . 8.8 t -91.9 2.66 56.39 Favored 'General case' 0 CA--C 1.51 -0.595 0 N-CA-C 106.902 -1.518 . . . . 1.0 106.902 177.601 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 60.2 t -85.37 -57.73 4.09 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.76 0 CA-C-N 115.475 -0.784 . . . . 1.0 110.514 178.547 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 109' ' ' ILE . . . . . 0.491 ' N ' ' HD2' ' A' ' 110' ' ' PRO . 0.1 OUTLIER -65.98 -39.8 32.76 Favored Pre-proline 0 CA--C 1.555 1.158 0 N-CA-C 114.552 1.316 . . . . 1.0 114.552 -177.971 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 110' ' ' PRO . . . . . 0.547 ' CD ' ' O ' ' A' ' 106' ' ' ALA . 6.8 Cg_endo -48.13 -47.7 18.71 Favored 'Trans proline' 0 N--CA 1.504 2.096 0 CA-C-N 122.397 1.892 . . . . 1.0 113.065 -178.283 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 23.4 t30 -64.79 -67.03 0.47 Allowed 'General case' 0 N--CA 1.464 0.248 0 C-N-CA 119.47 -0.892 . . . . 1.0 109.434 -178.267 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 112' ' ' ILE . . . . . 0.458 ' O ' ' N ' ' A' ' 115' ' ' ALA . 28.3 mm -49.25 -39.92 13.3 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.575 0 CA-C-O 122.813 1.292 . . . . 1.0 108.459 179.737 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 113' ' ' ASN . . . . . 0.484 ' N ' ' O ' ' A' ' 109' ' ' ILE . 6.4 t-20 -47.14 -51.14 18.9 Favored 'General case' 0 C--N 1.31 -1.121 0 CA-C-N 112.273 -2.24 . . . . 1.0 108.03 -176.892 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -62.21 -29.81 70.64 Favored 'General case' 0 N--CA 1.441 -0.894 0 C-N-CA 119.611 -0.835 . . . . 1.0 110.343 178.772 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 115' ' ' ALA . . . . . 0.458 ' N ' ' O ' ' A' ' 112' ' ' ILE . . . -77.34 -60.44 2.36 Favored 'General case' 0 C--N 1.347 0.477 0 C-N-CA 119.659 -0.817 . . . . 1.0 110.031 179.077 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 116' ' ' ILE . . . . . 0.506 ' O ' ' N ' ' A' ' 120' ' ' GLY . 1.0 OUTLIER -49.95 -50.07 19.93 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.707 0 CA-C-O 122.013 0.911 . . . . 1.0 109.562 -179.41 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 117' ' ' GLU . . . . . 0.449 ' C ' ' O ' ' A' ' 116' ' ' ILE . 17.8 mt-10 -42.53 -55.73 3.37 Favored 'General case' 0 C--N 1.316 -0.887 0 N-CA-C 106.106 -1.812 . . . . 1.0 106.106 -179.394 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 98.8 t -58.82 -53.11 51.95 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.677 0 C-N-CA 119.428 -0.909 . . . . 1.0 108.787 176.875 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -51.74 -72.62 0.05 OUTLIER 'General case' 0 CA--C 1.543 0.707 0 N-CA-C 108.083 -1.081 . . . . 1.0 108.083 -178.699 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 120' ' ' GLY . . . . . 0.552 ' O ' ' OG1' ' A' ' 121' ' ' THR . . . -64.9 -79.03 0.19 Allowed Glycine 0 CA--C 1.541 1.698 0 C-N-CA 119.055 -1.545 . . . . 1.0 110.3 179.308 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 121' ' ' THR . . . . . 0.552 ' OG1' ' O ' ' A' ' 120' ' ' GLY . 2.8 m 154.27 -31.57 0.01 OUTLIER 'General case' 0 N--CA 1.481 1.098 0 CA-C-N 112.371 -1.914 . . . . 1.0 111.463 179.974 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 122' ' ' GLY . . . . . 0.669 ' O ' ' N ' ' A' ' 124' ' ' ASP . . . 104.25 -17.5 47.54 Favored Glycine 0 N--CA 1.462 0.373 0 N-CA-C 107.319 -2.312 . . . . 1.0 107.319 -176.46 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 123' ' ' THR . . . . . 0.45 ' O ' ' CG2' ' A' ' 123' ' ' THR . 12.7 t -56.37 82.3 0.01 OUTLIER 'General case' 0 N--CA 1.469 0.509 0 N-CA-C 106.031 -1.84 . . . . 1.0 106.031 178.647 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 124' ' ' ASP . . . . . 0.669 ' N ' ' O ' ' A' ' 122' ' ' GLY . 34.6 m-20 -167.26 178.05 5.79 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 112.826 -1.988 . . . . 1.0 111.516 179.01 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 125' ' ' TYR . . . . . . . . . . . . . 21.3 t80 -141.96 140.22 32.67 Favored 'General case' 0 CA--C 1.536 0.417 0 N-CA-C 107.328 -1.36 . . . . 1.0 107.328 174.932 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 24.0 mmm-85 -146.18 148.1 32.18 Favored 'General case' 0 N--CA 1.471 0.598 0 N-CA-C 109.879 -0.415 . . . . 1.0 109.879 178.594 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 127' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 C--N 1.327 -0.409 0 CA-C-O 117.982 -1.009 . . . . 1.0 110.079 179.3 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 128' ' ' MTN . . . . . 0.583 ' H92' HH12 ' A' ' 47' ' ' ARG . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 129' ' ' MTN . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 130' ' ' MTN . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.455 ' C ' ' H ' ' A' ' 3' ' ' ASP . 0.0 OUTLIER . . . . . 0 N--CA 1.494 1.75 0 N-CA-C 108.103 -1.073 . . . . 1.0 108.103 . . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 2' ' ' SER . . . . . 0.46 ' O ' ' CB ' ' A' ' 3' ' ' ASP . 93.9 p -70.66 7.1 1.19 Allowed 'General case' 0 C--O 1.223 -0.316 0 CA-C-O 119.449 -0.31 . . . . 1.0 111.352 179.615 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . 0.46 ' CB ' ' O ' ' A' ' 2' ' ' SER . 12.7 p-10 142.55 142.19 0.0 OUTLIER 'General case' 0 N--CA 1.481 1.079 0 O-C-N 124.126 0.891 . . . . 1.0 110.349 179.07 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 42.1 t80 -155.59 151.33 27.41 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 121.134 0.492 . . . . 1.0 110.532 178.701 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 5' ' ' ASP . . . . . 0.482 ' C ' ' OG ' ' A' ' 10' ' ' SER . 51.3 m-20 -148.46 144.6 27.5 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.562 -0.745 . . . . 1.0 109.53 179.84 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 6' ' ' THR . . . . . 0.674 ' O ' ' N ' ' A' ' 10' ' ' SER . 5.6 m -109.46 -161.57 0.77 Allowed 'General case' 0 C--O 1.206 -1.188 0 CA-C-O 121.656 0.741 . . . . 1.0 110.48 -179.776 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . 0.656 ' H ' ' CG2' ' A' ' 6' ' ' THR . 28.5 tt0 -58.26 -44.37 88.31 Favored 'General case' 0 C--N 1.302 -1.497 0 CA-C-O 121.872 0.844 . . . . 1.0 109.447 -178.5 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 8' ' ' ARG . . . . . 0.55 ' O ' ' CB ' ' A' ' 12' ' ' ALA . 21.8 ttp-105 -69.87 -60.64 2.18 Favored 'General case' 0 C--N 1.307 -1.241 0 C-N-CA 117.916 -1.514 . . . . 1.0 110.089 178.242 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . 0.623 HG23 ' H ' ' A' ' 6' ' ' THR . 0.1 OUTLIER -61.38 -52.61 59.27 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.412 0 CA-C-N 115.11 -0.95 . . . . 1.0 110.129 -179.6 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 10' ' ' SER . . . . . 0.674 ' N ' ' O ' ' A' ' 6' ' ' THR . 1.2 m -68.21 -65.21 0.72 Allowed 'General case' 0 N--CA 1.487 1.409 0 C-N-CA 120.166 -0.614 . . . . 1.0 112.525 179.66 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 11' ' ' ARG . . . . . 0.543 ' HB2' ' O ' ' A' ' 7' ' ' GLU . 5.0 mtt-85 -61.9 -43.41 98.89 Favored 'General case' 0 C--N 1.317 -0.841 0 C-N-CA 120.419 -0.512 . . . . 1.0 111.382 -176.955 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . 0.55 ' CB ' ' O ' ' A' ' 8' ' ' ARG . . . -69.87 -57.58 4.88 Favored 'General case' 0 N--CA 1.468 0.443 0 C-N-CA 118.334 -1.346 . . . . 1.0 108.998 178.719 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . 0.673 ' O ' ' CB ' ' A' ' 17' ' ' LEU . 41.7 t -61.84 -55.44 24.24 Favored 'Isoleucine or valine' 0 C--O 1.198 -1.623 0 C-N-CA 117.51 -1.676 . . . . 1.0 107.879 -179.266 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . 0.623 ' O ' HG22 ' A' ' 18' ' ' VAL . . . -57.96 -64.92 0.74 Allowed 'General case' 0 C--N 1.313 -1.009 0 C-N-CA 116.53 -2.068 . . . . 1.0 111.457 -179.94 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . 0.559 ' O ' ' N ' ' A' ' 19' ' ' GLY . . . -54.59 -54.71 37.74 Favored 'General case' 0 C--O 1.218 -0.601 0 C-N-CA 118.596 -1.242 . . . . 1.0 110.334 -177.187 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . 0.57 ' HA ' ' H ' ' A' ' 22' ' ' GLY . . . -65.69 -55.64 16.34 Favored 'General case' 0 C--N 1.309 -1.176 0 C-N-CA 118.676 -1.21 . . . . 1.0 110.569 -179.109 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . 0.673 ' CB ' ' O ' ' A' ' 13' ' ' VAL . 2.2 tp -56.51 -54.56 44.4 Favored 'General case' 0 N--CA 1.491 1.591 0 N-CA-C 108.087 -1.079 . . . . 1.0 108.087 -177.728 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . 0.708 HG22 ' H ' ' A' ' 19' ' ' GLY . 1.8 m -71.88 -58.59 4.77 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.405 0 C-N-CA 120.371 -0.531 . . . . 1.0 110.446 -179.953 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . 0.708 ' H ' HG22 ' A' ' 18' ' ' VAL . . . -60.67 -168.39 0.43 Allowed Glycine 0 N--CA 1.439 -1.131 0 N-CA-C 111.969 -0.452 . . . . 1.0 111.969 -177.288 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 20' ' ' PRO . . . . . 0.677 ' O ' ' N ' ' A' ' 24' ' ' ALA . 4.2 Cg_endo -81.73 -25.96 3.34 Favored 'Trans proline' 0 C--N 1.294 -2.339 0 C-N-CA 121.847 1.698 . . . . 1.0 113.72 -178.041 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -63.51 -60.01 8.03 Favored Glycine 0 N--CA 1.473 1.134 0 C-N-CA 118.984 -1.579 . . . . 1.0 112.679 -176.004 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . 0.57 ' H ' ' HA ' ' A' ' 16' ' ' ALA . . . -57.31 -53.01 48.15 Favored Glycine 0 C--N 1.31 -0.874 0 N-CA-C 106.259 -2.736 . . . . 1.0 106.259 -178.848 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 21.3 t -56.37 -32.29 35.31 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.849 0 N-CA-C 108.177 -1.045 . . . . 1.0 108.177 178.428 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . 0.677 ' N ' ' O ' ' A' ' 20' ' ' PRO . . . -60.4 -62.88 1.54 Allowed 'General case' 0 C--N 1.352 0.716 0 C-N-CA 118.573 -1.251 . . . . 1.0 110.087 -179.47 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 86.5 mt -61.91 -46.32 89.89 Favored 'General case' 0 CA--C 1.516 -0.336 0 C-N-CA 120.202 -0.599 . . . . 1.0 111.612 -177.223 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 97.9 t -59.85 -59.85 3.39 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.582 0 C-N-CA 119.332 -0.947 . . . . 1.0 110.393 -177.617 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . 0.436 ' O ' ' CB ' ' A' ' 31' ' ' ALA . 1.4 p -58.65 -36.93 62.49 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.442 0 C-N-CA 120.571 -0.452 . . . . 1.0 110.345 -177.353 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 8.7 tttm -65.69 -56.19 13.41 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 115.646 -0.706 . . . . 1.0 109.869 -179.882 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 97.6 t -62.29 -48.73 86.99 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.699 0 CA-C-N 115.314 -0.857 . . . . 1.0 110.002 -177.699 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 30' ' ' CYS . . . . . . . . . . . . . 49.2 t -65.45 -62.1 1.72 Allowed 'General case' 0 N--CA 1.443 -0.796 0 C-N-CA 119.849 -0.74 . . . . 1.0 110.206 -178.815 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . 0.436 ' CB ' ' O ' ' A' ' 27' ' ' VAL . . . -57.15 -50.21 73.52 Favored 'General case' 0 CA--C 1.507 -0.697 0 CA-C-O 120.879 0.371 . . . . 1.0 110.26 -176.668 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . 0.403 ' O ' ' CB ' ' A' ' 33' ' ' LEU . . . 74.82 70.66 1.22 Allowed Glycine 0 N--CA 1.443 -0.859 0 N-CA-C 109.001 -1.64 . . . . 1.0 109.001 -178.106 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . 0.403 ' CB ' ' O ' ' A' ' 32' ' ' GLY . 5.2 mt 91.79 82.81 0.04 OUTLIER Pre-proline 0 C--N 1.332 -0.192 0 O-C-N 124.963 1.037 . . . . 1.0 109.453 -178.281 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 50.8 Cg_exo -50.39 -28.85 22.11 Favored 'Trans proline' 0 C--N 1.312 -1.37 0 C-N-CA 122.481 2.121 . . . . 1.0 113.555 -179.333 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -62.36 -61.02 7.01 Favored Glycine 0 N--CA 1.47 0.932 0 C-N-CA 118.353 -1.88 . . . . 1.0 109.909 -178.027 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . 0.534 ' O ' ' CB ' ' A' ' 37' ' ' ILE . 11.4 p -86.47 167.11 1.84 Allowed 'Isoleucine or valine' 0 CA--C 1.507 -0.698 0 N-CA-C 107.719 -1.215 . . . . 1.0 107.719 178.41 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . 0.534 ' CB ' ' O ' ' A' ' 36' ' ' VAL . 8.2 tt 115.91 107.37 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.484 1.257 0 O-C-N 125.403 1.689 . . . . 1.0 110.6 179.752 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 60.8 m80 -140.39 135.67 32.32 Favored 'General case' 0 C--N 1.328 -0.337 0 O-C-N 121.95 -0.469 . . . . 1.0 109.782 179.153 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 6.1 m -106.42 130.93 22.18 Favored Pre-proline 0 CA--C 1.534 0.342 0 N-CA-C 110.278 -0.268 . . . . 1.0 110.278 -179.582 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 37.0 Cg_endo -65.69 -24.07 55.56 Favored 'Trans proline' 0 N--CA 1.493 1.465 0 C-N-CA 121.141 1.227 . . . . 1.0 112.702 -179.684 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -128.47 135.99 50.22 Favored 'General case' 0 N--CA 1.466 0.361 0 N-CA-C 110.376 -0.231 . . . . 1.0 110.376 177.839 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . 0.712 ' C ' ' H ' ' A' ' 44' ' ' GLY . 11.8 ptm180 -171.23 172.09 5.42 Favored 'General case' 0 C--N 1.322 -0.608 0 C-N-CA 120.2 -0.6 . . . . 1.0 110.941 178.342 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 43' ' ' ARG . . . . . 0.553 ' C ' ' H ' ' A' ' 45' ' ' PHE . 37.2 tpt85 -63.33 24.13 0.01 OUTLIER 'General case' 0 CA--C 1.55 0.953 0 CA-C-O 121.518 0.675 . . . . 1.0 109.816 179.296 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . 0.712 ' H ' ' C ' ' A' ' 42' ' ' ARG . . . 76.98 -26.78 1.72 Allowed Glycine 0 C--N 1.338 0.686 0 N-CA-C 110.533 -1.027 . . . . 1.0 110.533 179.394 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . 0.553 ' H ' ' C ' ' A' ' 43' ' ' ARG . 11.8 p90 -175.32 -174.15 0.71 Allowed 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 114.352 -0.924 . . . . 1.0 109.451 179.87 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 46' ' ' PHE . . . . . 0.534 ' HB2' ' O ' ' A' ' 45' ' ' PHE . 0.7 OUTLIER 110.81 107.38 0.0 OUTLIER 'General case' 0 N--CA 1.479 1.015 0 O-C-N 125.398 1.686 . . . . 1.0 109.851 -179.78 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 47' ' ' ARG . . . . . 0.515 ' CB ' ' O ' ' A' ' 46' ' ' PHE . 34.3 ttm-85 97.69 154.21 0.02 OUTLIER 'General case' 0 N--CA 1.472 0.655 0 O-C-N 123.966 0.791 . . . . 1.0 110.964 179.7 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 4.4 t 67.2 86.5 0.13 Allowed 'General case' 0 C--N 1.328 -0.335 0 N-CA-C 108.161 -1.051 . . . . 1.0 108.161 -177.685 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 49' ' ' ASN . . . . . 0.501 ' O ' ' N ' ' A' ' 51' ' ' GLU . 0.0 OUTLIER -153.0 160.71 30.6 Favored Pre-proline 0 N--CA 1.466 0.364 0 CA-C-N 115.675 -0.693 . . . . 1.0 111.33 -179.352 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 30.8 Cg_endo -63.13 60.94 0.17 Allowed 'Trans proline' 0 C--N 1.311 -1.409 0 C-N-CA 122.545 2.163 . . . . 1.0 111.403 177.976 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . 0.501 ' N ' ' O ' ' A' ' 49' ' ' ASN . 40.9 mt-10 41.91 37.72 0.87 Allowed 'General case' 0 C--O 1.233 0.227 0 CA-C-O 120.68 0.276 . . . . 1.0 111.501 178.31 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . 0.675 ' HE ' ' HB ' ' A' ' 89' ' ' VAL . 73.9 mtt85 -146.62 167.78 22.9 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 121.025 0.44 . . . . 1.0 111.702 -179.119 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 21.0 tt -76.22 164.13 3.67 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.324 0 N-CA-C 108.061 -1.088 . . . . 1.0 108.061 176.891 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 56.1 tt0 -132.82 131.2 40.78 Favored 'General case' 0 CA--C 1.535 0.399 0 N-CA-C 108.857 -0.794 . . . . 1.0 108.857 179.057 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 10.5 tt -143.48 153.82 16.37 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.728 0 N-CA-C 110.169 -0.308 . . . . 1.0 110.169 178.852 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 104.14 2.35 45.03 Favored Glycine 0 C--N 1.341 0.848 0 N-CA-C 109.851 -1.3 . . . . 1.0 109.851 -179.108 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 18.2 m-20 -90.57 109.8 20.95 Favored 'General case' 0 CA--C 1.542 0.642 0 CA-C-O 122.138 0.971 . . . . 1.0 113.09 -178.152 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 58' ' ' TRP . . . . . 0.56 ' CD1' ' OE1' ' A' ' 61' ' ' GLU . 9.2 m95 -82.8 -176.92 6.54 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 113.43 -1.714 . . . . 1.0 108.678 176.599 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 59' ' ' ARG . . . . . 0.457 ' CG ' ' H ' ' A' ' 60' ' ' TYR . 8.0 ptm180 -98.64 -54.28 3.07 Favored 'General case' 0 CA--C 1.552 1.042 0 CA-C-N 118.955 0.798 . . . . 1.0 111.188 178.21 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 60' ' ' TYR . . . . . 0.457 ' H ' ' CG ' ' A' ' 59' ' ' ARG . 0.2 OUTLIER -80.29 -11.24 59.74 Favored 'General case' 0 N--CA 1.479 1.007 0 C-N-CA 124.561 1.145 . . . . 1.0 112.397 -178.511 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . 0.56 ' OE1' ' CD1' ' A' ' 58' ' ' TRP . 86.6 mt-10 -80.08 -16.47 54.94 Favored 'General case' 0 CA--C 1.496 -1.127 0 O-C-N 121.58 -0.7 . . . . 1.0 110.413 179.302 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . 0.478 ' O ' ' N ' ' A' ' 66' ' ' GLY . 28.7 m -44.24 -46.52 2.3 Favored 'Isoleucine or valine' 0 CA--C 1.499 -1.01 0 N-CA-C 109.215 -0.661 . . . . 1.0 109.215 -175.798 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 63' ' ' ALA . . . . . 0.422 ' O ' ' CG ' ' A' ' 67' ' ' ARG . . . -66.19 -46.29 77.84 Favored 'General case' 0 N--CA 1.415 -2.206 0 N-CA-C 108.109 -1.071 . . . . 1.0 108.109 177.147 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 64' ' ' HIS . . . . . 0.485 ' N ' ' O ' ' A' ' 61' ' ' GLU . 4.2 t-80 -57.96 -60.65 3.4 Favored 'General case' 0 CA--C 1.547 0.83 0 CA-C-N 115.572 -0.74 . . . . 1.0 111.269 179.322 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . 0.596 ' C ' ' H ' ' A' ' 67' ' ' ARG . 0.7 OUTLIER -69.96 -55.63 9.11 Favored 'General case' 0 CA--C 1.554 1.116 0 O-C-N 121.128 -0.983 . . . . 1.0 110.24 178.632 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . 0.478 ' N ' ' O ' ' A' ' 62' ' ' VAL . . . -64.84 32.59 0.1 Allowed Glycine 0 N--CA 1.471 1.008 0 O-C-N 121.475 -0.765 . . . . 1.0 111.421 178.461 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 67' ' ' ARG . . . . . 0.63 ' O ' ' N ' ' A' ' 69' ' ' LEU . 0.0 OUTLIER -77.45 6.4 7.07 Favored 'General case' 0 C--N 1.316 -0.863 0 C-N-CA 123.605 0.762 . . . . 1.0 110.08 176.173 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . 0.63 ' O ' ' HA ' ' A' ' 72' ' ' HIS . 0.8 OUTLIER -33.15 -30.16 0.01 OUTLIER 'General case' 0 N--CA 1.486 1.366 0 N-CA-C 107.481 -1.303 . . . . 1.0 107.481 -179.072 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . 0.63 ' N ' ' O ' ' A' ' 67' ' ' ARG . 2.3 mt -63.25 -64.68 0.84 Allowed 'General case' 0 C--N 1.317 -0.847 0 C-N-CA 117.509 -1.676 . . . . 1.0 107.558 176.754 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . 0.695 ' C ' ' H ' ' A' ' 72' ' ' HIS . . . -77.17 -72.25 0.36 Allowed 'General case' 0 N--CA 1.478 0.932 0 N-CA-C 106.671 -1.603 . . . . 1.0 106.671 177.615 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . 0.601 ' H ' ' HB3' ' A' ' 67' ' ' ARG . . . -49.16 4.19 0.01 OUTLIER 'General case' 0 N--CA 1.467 0.418 0 C-N-CA 125.203 1.401 . . . . 1.0 112.31 178.536 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 72' ' ' HIS . . . . . 0.729 ' CG ' ' H ' ' A' ' 73' ' ' MET . 0.0 OUTLIER -18.11 -72.87 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.396 0 C-N-CA 123.155 0.582 . . . . 1.0 112.527 -176.592 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 73' ' ' MET . . . . . 0.729 ' H ' ' CG ' ' A' ' 72' ' ' HIS . 45.4 mtt -71.28 -43.04 67.93 Favored 'General case' 0 C--N 1.298 -1.658 0 C-N-CA 119.309 -0.957 . . . . 1.0 110.239 178.082 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . 0.618 ' O ' ' N ' ' A' ' 76' ' ' GLY . 42.3 t -43.08 -45.99 1.32 Allowed 'Isoleucine or valine' 0 N--CA 1.463 0.21 0 CA-C-O 118.822 -0.609 . . . . 1.0 110.248 -175.4 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 75' ' ' ASN . . . . . 0.508 ' O ' ' N ' ' A' ' 77' ' ' ILE . 5.2 t30 -38.45 -18.96 0.01 OUTLIER 'General case' 0 N--CA 1.473 0.693 0 CA-C-O 122.025 0.917 . . . . 1.0 111.815 179.192 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . 0.618 ' N ' ' O ' ' A' ' 74' ' ' VAL . . . -43.35 -19.05 0.07 OUTLIER Glycine 0 CA--C 1.54 1.641 0 N-CA-C 109.344 -1.503 . . . . 1.0 109.344 177.89 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . 0.767 ' O ' ' N ' ' A' ' 80' ' ' ALA . 9.7 pt -89.9 -49.7 13.61 Favored 'Isoleucine or valine' 0 C--O 1.211 -0.952 0 N-CA-C 107.982 -1.118 . . . . 1.0 107.982 179.963 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . 0.484 ' C ' ' O ' ' A' ' 77' ' ' ILE . 6.0 t -35.15 -35.04 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.447 -0.583 0 N-CA-C 108.532 -0.914 . . . . 1.0 108.532 -177.268 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . 0.583 ' O ' ' CB ' ' A' ' 83' ' ' ALA . 1.3 pp -91.56 -21.92 6.28 Favored 'Isoleucine or valine' 0 C--O 1.198 -1.638 0 CA-C-N 115.824 -0.626 . . . . 1.0 110.26 178.511 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 80' ' ' ALA . . . . . 0.767 ' N ' ' O ' ' A' ' 77' ' ' ILE . . . -92.65 -9.64 40.21 Favored 'General case' 0 CA--C 1.554 1.111 0 O-C-N 121.368 -0.832 . . . . 1.0 112.682 176.258 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . 0.531 ' N ' ' O ' ' A' ' 77' ' ' ILE . 4.9 mm-40 -79.15 -76.76 0.19 Allowed 'General case' 0 C--N 1.344 0.328 0 N-CA-C 112.583 0.586 . . . . 1.0 112.583 -176.121 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 82' ' ' ASP . . . . . 0.721 ' O ' HG12 ' A' ' 85' ' ' ILE . 5.9 m-20 -86.42 -17.34 34.58 Favored 'General case' 0 C--O 1.206 -1.205 0 CA-C-N 116.455 -0.339 . . . . 1.0 111.201 -179.795 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . 0.583 ' CB ' ' O ' ' A' ' 79' ' ' ILE . . . -58.47 -40.09 81.74 Favored 'General case' 0 C--N 1.316 -0.854 0 C-N-CA 118.188 -1.405 . . . . 1.0 111.944 -175.888 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . 0.422 ' CD1' ' C ' ' A' ' 84' ' ' LEU . 3.4 tm? -37.72 -37.07 0.21 Allowed 'General case' 0 N--CA 1.467 0.399 0 N-CA-C 112.719 0.637 . . . . 1.0 112.719 -175.65 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 85' ' ' ILE . . . . . 0.721 HG12 ' O ' ' A' ' 82' ' ' ASP . 22.4 pt -69.49 -26.49 31.28 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.568 0 C-N-CA 120.341 -0.544 . . . . 1.0 111.547 -179.804 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . 0.532 ' C ' ' H ' ' A' ' 88' ' ' ALA . . . -86.34 -15.16 41.4 Favored 'General case' 0 C--N 1.33 -0.249 0 N-CA-C 111.935 0.346 . . . . 1.0 111.935 -179.328 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 3.4 tt0 -53.04 -8.88 0.11 Allowed 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 120.868 0.366 . . . . 1.0 110.034 -179.467 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . 0.532 ' H ' ' C ' ' A' ' 86' ' ' ALA . . . -93.26 -8.1 43.16 Favored 'General case' 0 N--CA 1.47 0.573 0 CA-C-O 121.529 0.681 . . . . 1.0 109.421 -179.914 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 89' ' ' VAL . . . . . 0.675 ' HB ' ' HE ' ' A' ' 52' ' ' ARG . 4.5 t -92.61 36.22 0.1 OUTLIER 'Isoleucine or valine' 0 N--CA 1.438 -1.058 0 N-CA-C 108.103 -1.073 . . . . 1.0 108.103 178.602 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 90' ' ' GLY . . . . . 0.866 ' O ' ' N ' ' A' ' 92' ' ' HIS . . . -50.88 -28.15 15.79 Favored Glycine 0 C--N 1.355 1.585 0 CA-C-O 117.303 -1.832 . . . . 1.0 111.247 176.309 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 91' ' ' PRO . . . . . 0.601 ' HD2' ' N ' ' A' ' 90' ' ' GLY . 27.9 Cg_exo -32.73 -1.76 0.0 OUTLIER 'Trans proline' 0 N--CA 1.506 2.232 0 C-N-CA 123.388 2.725 . . . . 1.0 114.112 173.644 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 92' ' ' HIS . . . . . 0.866 ' N ' ' O ' ' A' ' 90' ' ' GLY . 1.5 t-80 -50.4 -29.73 10.81 Favored 'General case' 0 N--CA 1.443 -0.817 0 N-CA-C 107.094 -1.447 . . . . 1.0 107.094 178.897 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . 0.58 ' HG ' ' H ' ' A' ' 94' ' ' ALA . 2.0 pp -60.04 -52.29 66.01 Favored 'General case' 0 N--CA 1.448 -0.565 0 N-CA-C 108.404 -0.962 . . . . 1.0 108.404 177.185 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 94' ' ' ALA . . . . . 0.58 ' H ' ' HG ' ' A' ' 93' ' ' LEU . . . -50.61 -56.02 13.69 Favored 'General case' 0 CA--C 1.515 -0.394 0 N-CA-C 107.236 -1.394 . . . . 1.0 107.236 -179.433 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 95' ' ' ARG . . . . . 0.403 HH11 ' HG3' ' A' ' 20' ' ' PRO . 89.8 mtt-85 -59.41 -32.18 69.93 Favored 'General case' 0 C--N 1.313 -0.999 0 N-CA-C 108.325 -0.991 . . . . 1.0 108.325 177.538 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 96' ' ' ALA . . . . . 0.768 ' O ' ' N ' ' A' ' 100' ' ' ILE . . . -55.75 -49.77 72.21 Favored 'General case' 0 C--O 1.207 -1.156 0 N-CA-C 106.824 -1.547 . . . . 1.0 106.824 -178.741 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . 0.47 ' C ' ' O ' ' A' ' 96' ' ' ALA . 0.6 OUTLIER -36.88 -26.58 0.01 OUTLIER 'General case' 0 CA--C 1.568 1.669 0 N-CA-C 107.216 -1.401 . . . . 1.0 107.216 -179.912 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 98' ' ' GLY . . . . . 0.606 ' N ' ' O ' ' A' ' 96' ' ' ALA . . . -84.95 -52.87 3.32 Favored Glycine 0 CA--C 1.55 2.261 0 CA-C-O 123.119 1.399 . . . . 1.0 111.19 173.816 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 99' ' ' GLN . . . . . 0.563 ' N ' ' O ' ' A' ' 96' ' ' ALA . 24.9 mt-30 -79.07 7.97 6.52 Favored 'General case' 0 N--CA 1.438 -1.073 0 CA-C-N 114.742 -0.729 . . . . 1.0 109.521 177.989 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 100' ' ' ILE . . . . . 0.768 ' N ' ' O ' ' A' ' 96' ' ' ALA . 14.7 tt -60.3 -49.77 82.9 Favored 'Isoleucine or valine' 0 CA--C 1.484 -1.561 0 N-CA-C 107.936 -1.135 . . . . 1.0 107.936 179.694 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 101' ' ' VAL . . . . . 0.551 ' N ' ' CG2' ' A' ' 100' ' ' ILE . 22.7 t -60.12 -56.7 15.78 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.636 0 C-N-CA 116.495 -2.082 . . . . 1.0 107.763 178.135 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 102' ' ' CYS . . . . . 0.531 ' O ' ' O ' ' A' ' 105' ' ' GLY . 0.5 OUTLIER -46.53 -38.17 8.98 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 114.971 -1.013 . . . . 1.0 110.663 -175.869 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 7.3 ttp180 -65.05 -54.62 27.32 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 125.595 1.809 . . . . 1.0 113.302 176.844 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 104' ' ' TYR . . . . . 0.656 ' CG ' ' O ' ' A' ' 104' ' ' TYR . 50.8 t80 -93.28 32.0 1.4 Allowed 'General case' 0 C--N 1.311 -1.096 0 C-N-CA 126.082 1.753 . . . . 1.0 107.441 178.969 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 105' ' ' GLY . . . . . 0.539 ' O ' ' CB ' ' A' ' 106' ' ' ALA . . . 172.56 -141.78 6.43 Favored Glycine 0 N--CA 1.431 -1.649 0 N-CA-C 107.199 -2.36 . . . . 1.0 107.199 178.665 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 106' ' ' ALA . . . . . 0.539 ' CB ' ' O ' ' A' ' 105' ' ' GLY . . . 109.67 107.63 0.0 OUTLIER 'General case' 0 C--N 1.315 -0.896 0 C-N-CA 126.736 2.014 . . . . 1.0 116.237 178.712 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 107' ' ' THR . . . . . 0.494 ' O ' ' HG2' ' A' ' 110' ' ' PRO . 27.7 m -72.44 -52.06 17.54 Favored 'General case' 0 N--CA 1.476 0.842 0 CA-C-N 115.614 -0.721 . . . . 1.0 110.12 175.252 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . 0.422 ' O ' ' C ' ' A' ' 109' ' ' ILE . 8.7 p -61.46 -46.12 97.22 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.035 0 O-C-N 121.639 -0.663 . . . . 1.0 112.019 -178.452 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 109' ' ' ILE . . . . . 0.422 ' C ' ' O ' ' A' ' 108' ' ' VAL . 2.6 mt -38.0 -59.6 1.15 Allowed Pre-proline 0 N--CA 1.484 1.253 0 CA-C-N 116.399 -0.364 . . . . 1.0 110.778 -178.401 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 110' ' ' PRO . . . . . 0.494 ' HG2' ' O ' ' A' ' 107' ' ' THR . 31.9 Cg_endo -56.18 -21.82 37.35 Favored 'Trans proline' 0 C--N 1.314 -1.25 0 C-N-CA 120.895 1.064 . . . . 1.0 112.177 -177.888 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 4.0 m-80 -64.37 -65.7 0.64 Allowed 'General case' 0 N--CA 1.469 0.522 0 C-N-CA 119.631 -0.827 . . . . 1.0 109.808 178.77 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 112' ' ' ILE . . . . . 0.627 ' O ' ' HB ' ' A' ' 116' ' ' ILE . 2.0 tt -45.72 -27.45 0.64 Allowed 'Isoleucine or valine' 0 C--O 1.22 -0.474 0 CA-C-O 122.383 1.087 . . . . 1.0 109.121 -179.166 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 113' ' ' ASN . . . . . 0.709 ' O ' ' HB3' ' A' ' 117' ' ' GLU . 25.4 t-20 -84.05 -53.03 5.83 Favored 'General case' 0 C--N 1.308 -1.199 0 CA-C-O 122.953 1.359 . . . . 1.0 110.018 178.949 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -56.07 -58.04 9.58 Favored 'General case' 0 C--N 1.295 -1.793 0 C-N-CA 119.257 -0.977 . . . . 1.0 110.261 -178.688 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -79.89 -59.59 2.67 Favored 'General case' 0 C--O 1.246 0.893 0 N-CA-C 114.465 1.283 . . . . 1.0 114.465 179.921 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 116' ' ' ILE . . . . . 0.627 ' HB ' ' O ' ' A' ' 112' ' ' ILE . 11.2 mt -68.23 -55.36 16.67 Favored 'Isoleucine or valine' 0 C--O 1.217 -0.638 0 C-N-CA 117.919 -1.512 . . . . 1.0 113.055 -175.183 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 117' ' ' GLU . . . . . 0.709 ' HB3' ' O ' ' A' ' 113' ' ' ASN . 0.0 OUTLIER -39.56 -65.6 0.37 Allowed 'General case' 0 C--O 1.251 1.166 0 C-N-CA 121.079 -0.248 . . . . 1.0 110.453 -174.271 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 2.5 t -45.36 -18.63 0.1 Allowed 'Isoleucine or valine' 0 N--CA 1.446 -0.643 0 C-N-CA 119.124 -1.031 . . . . 1.0 109.81 -178.963 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 119' ' ' LEU . . . . . 0.603 ' N ' ' O ' ' A' ' 116' ' ' ILE . 4.7 tt -88.57 -54.92 3.94 Favored 'General case' 0 CA--C 1.538 0.504 0 N-CA-C 112.566 0.58 . . . . 1.0 112.566 176.899 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 120' ' ' GLY . . . . . 0.564 ' C ' ' H ' ' A' ' 122' ' ' GLY . . . -93.3 44.87 2.44 Favored Glycine 0 C--N 1.367 2.251 0 C-N-CA 119.821 -1.18 . . . . 1.0 113.937 -175.968 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 41.5 m 73.66 -27.85 0.19 Allowed 'General case' 0 N--CA 1.476 0.848 0 C-N-CA 123.432 0.693 . . . . 1.0 109.92 177.742 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 122' ' ' GLY . . . . . 0.564 ' H ' ' C ' ' A' ' 120' ' ' GLY . . . 106.81 -36.07 4.64 Favored Glycine 0 C--N 1.319 -0.405 0 C-N-CA 124.777 1.179 . . . . 1.0 110.634 179.811 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 123' ' ' THR . . . . . 0.434 ' C ' ' O ' ' A' ' 122' ' ' GLY . 81.4 m -31.42 98.96 0.01 OUTLIER 'General case' 0 N--CA 1.465 0.281 0 CA-C-N 117.643 0.722 . . . . 1.0 112.421 -178.07 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 12.1 p-10 -142.83 143.25 32.05 Favored 'General case' 0 N--CA 1.45 -0.439 0 N-CA-C 108.058 -1.09 . . . . 1.0 108.058 177.352 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 125' ' ' TYR . . . . . 0.519 ' OH ' ' CD1' ' A' ' 127' ' ' PHE . 0.0 OUTLIER -153.03 149.1 27.81 Favored 'General case' 0 CA--C 1.542 0.646 0 C-N-CA 122.95 0.5 . . . . 1.0 109.682 -178.498 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 126' ' ' ARG . . . . . 0.465 ' NE ' ' O ' ' A' ' 125' ' ' TYR . 9.6 mmp_? -149.58 152.85 36.17 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.857 -0.61 . . . . 1.0 109.92 177.24 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 127' ' ' PHE . . . . . 0.519 ' CD1' ' OH ' ' A' ' 125' ' ' TYR . 10.6 p90 . . . . . 0 C--O 1.221 -0.436 0 CA-C-O 118.041 -0.981 . . . . 1.0 110.152 179.262 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 128' ' ' MTN . . . . . 0.409 ' S1 ' ' C7 ' ' A' ' 128' ' ' MTN . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 129' ' ' MTN . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 130' ' ' MTN . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.586 0 N-CA-C 109.083 -0.71 . . . . 1.0 109.083 . . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 2' ' ' SER . . . . . 0.414 ' O ' ' CG ' ' A' ' 3' ' ' ASP . 87.3 p -104.18 8.92 36.34 Favored 'General case' 0 N--CA 1.465 0.31 0 CA-C-N 115.672 -0.694 . . . . 1.0 110.187 -179.708 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . 0.414 ' CG ' ' O ' ' A' ' 2' ' ' SER . 1.6 m-20 166.44 98.32 0.0 OUTLIER 'General case' 0 CA--C 1.532 0.258 0 CA-C-N 116.163 -0.471 . . . . 1.0 109.963 178.974 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 3.4 t80 -149.68 145.84 26.93 Favored 'General case' 0 C--N 1.33 -0.251 0 N-CA-C 109.612 -0.514 . . . . 1.0 109.612 179.122 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 5' ' ' ASP . . . . . 0.631 ' O ' ' O ' ' A' ' 6' ' ' THR . 0.1 OUTLIER -155.06 154.31 32.25 Favored 'General case' 0 C--N 1.327 -0.413 0 N-CA-C 109.229 -0.656 . . . . 1.0 109.229 -179.95 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 6' ' ' THR . . . . . 0.631 ' O ' ' O ' ' A' ' 5' ' ' ASP . 3.1 m -37.1 177.51 0.0 OUTLIER 'General case' 0 N--CA 1.469 0.501 0 CA-C-O 121.656 0.741 . . . . 1.0 111.646 -178.23 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . 0.433 ' H ' ' CG2' ' A' ' 6' ' ' THR . 50.9 mt-10 -66.29 -58.44 5.34 Favored 'General case' 0 C--N 1.319 -0.759 0 CA-C-N 116.231 -0.44 . . . . 1.0 110.758 -178.808 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -68.55 -31.49 70.74 Favored 'General case' 0 N--CA 1.451 -0.41 0 CA-C-N 119.01 0.823 . . . . 1.0 111.029 179.477 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . 0.518 ' O ' ' CG2' ' A' ' 13' ' ' VAL . 60.0 t -66.69 -55.07 19.7 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.705 0 N-CA-C 108.228 -1.027 . . . . 1.0 108.228 179.651 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 22.9 t -68.49 -38.46 81.0 Favored 'General case' 0 C--N 1.321 -0.658 0 O-C-N 121.912 -0.493 . . . . 1.0 111.626 178.251 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 14.3 ttt-85 -74.12 -64.09 1.09 Allowed 'General case' 0 N--CA 1.453 -0.314 0 CA-C-O 118.488 -0.768 . . . . 1.0 111.361 -179.505 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . 0.528 ' O ' ' N ' ' A' ' 16' ' ' ALA . . . -52.29 -30.77 29.72 Favored 'General case' 0 CA--C 1.501 -0.914 0 CA-C-N 120.319 1.418 . . . . 1.0 110.09 -179.48 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . 0.607 ' O ' ' CB ' ' A' ' 17' ' ' LEU . 3.6 t -56.27 -52.0 56.76 Favored 'Isoleucine or valine' 0 C--O 1.202 -1.43 0 N-CA-C 106.15 -1.796 . . . . 1.0 106.15 176.922 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -59.16 -63.54 1.26 Allowed 'General case' 0 CA--C 1.544 0.743 0 C-N-CA 117.395 -1.722 . . . . 1.0 110.983 177.72 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . 0.528 ' O ' ' N ' ' A' ' 19' ' ' GLY . . . -53.13 -54.73 31.38 Favored 'General case' 0 N--CA 1.484 1.225 0 CA-C-O 122.16 0.981 . . . . 1.0 110.844 -177.139 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . 0.528 ' N ' ' O ' ' A' ' 12' ' ' ALA . . . -63.07 -53.75 48.71 Favored 'General case' 0 C--N 1.303 -1.439 0 CA-C-N 113.915 -1.493 . . . . 1.0 108.984 -178.47 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . 0.607 ' CB ' ' O ' ' A' ' 13' ' ' VAL . 10.0 tp -57.47 -52.46 65.3 Favored 'General case' 0 N--CA 1.484 1.267 0 CA-C-N 114.48 -1.236 . . . . 1.0 108.576 -176.759 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . 0.577 HG23 ' H ' ' A' ' 19' ' ' GLY . 3.5 m -67.46 -56.56 12.9 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.245 0 C-N-CA 119.043 -1.063 . . . . 1.0 108.763 179.153 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . 0.577 ' H ' HG23 ' A' ' 18' ' ' VAL . . . -61.61 -167.1 0.47 Allowed Glycine 0 CA--C 1.522 0.499 0 N-CA-C 111.58 -0.608 . . . . 1.0 111.58 -179.704 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 20' ' ' PRO . . . . . 0.627 ' O ' ' N ' ' A' ' 24' ' ' ALA . 56.1 Cg_endo -81.86 -32.71 0.75 Allowed 'Trans proline' 0 C--N 1.304 -1.773 0 C-N-CA 122.72 2.28 . . . . 1.0 114.467 -178.2 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -58.17 -57.41 19.98 Favored Glycine 0 N--CA 1.479 1.525 0 C-N-CA 120.481 -0.866 . . . . 1.0 112.318 -177.328 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -58.65 -49.7 74.67 Favored Glycine 0 N--CA 1.472 1.034 0 N-CA-C 105.849 -2.9 . . . . 1.0 105.849 -176.123 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 2.5 t -58.7 -33.76 49.85 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.079 0 CA-C-N 114.035 -1.082 . . . . 1.0 108.355 178.334 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . 0.627 ' N ' ' O ' ' A' ' 20' ' ' PRO . . . -58.2 -61.9 2.22 Favored 'General case' 0 CA--C 1.536 0.413 0 C-N-CA 118.276 -1.37 . . . . 1.0 110.309 -179.511 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 56.5 mt -64.73 -42.67 95.04 Favored 'General case' 0 CA--C 1.52 -0.211 0 CA-C-N 118.982 0.81 . . . . 1.0 112.374 -177.49 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 75.1 t -60.68 -58.69 6.29 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.358 0 C-N-CA 119.096 -1.042 . . . . 1.0 109.327 -177.313 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 1.9 p -60.35 -34.66 58.44 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.518 0 N-CA-C 112.286 0.476 . . . . 1.0 112.286 -177.86 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 7.6 tppt? -65.55 -53.6 39.76 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-O 122.246 1.022 . . . . 1.0 109.094 -178.494 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 88.1 t -63.11 -46.58 95.68 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.125 0 CA-C-N 113.216 -1.811 . . . . 1.0 109.863 -177.231 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 30' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -65.35 -59.83 3.62 Favored 'General case' 0 N--CA 1.447 -0.602 0 C-N-CA 118.455 -1.298 . . . . 1.0 109.054 -179.419 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -60.27 -52.36 65.63 Favored 'General case' 0 CA--C 1.509 -0.619 0 N-CA-C 112.118 0.414 . . . . 1.0 112.118 -176.708 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . 0.471 ' O ' ' CB ' ' A' ' 33' ' ' LEU . . . 83.57 77.58 1.11 Allowed Glycine 0 CA--C 1.524 0.642 0 N-CA-C 109.918 -1.273 . . . . 1.0 109.918 -178.55 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . 0.471 ' CB ' ' O ' ' A' ' 32' ' ' GLY . 4.0 tp 85.02 107.84 0.03 OUTLIER Pre-proline 0 CA--C 1.548 0.884 0 O-C-N 123.885 0.403 . . . . 1.0 110.685 -179.927 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 37.6 Cg_endo -67.83 -27.51 37.32 Favored 'Trans proline' 0 N--CA 1.499 1.837 0 C-N-CA 121.632 1.555 . . . . 1.0 113.711 -179.001 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -60.83 -59.72 9.68 Favored Glycine 0 CA--C 1.525 0.694 0 C-N-CA 118.516 -1.802 . . . . 1.0 109.551 -177.564 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . 0.585 ' O ' ' CG2' ' A' ' 37' ' ' ILE . 1.7 p -84.01 142.71 13.04 Favored 'Isoleucine or valine' 0 C--O 1.211 -0.924 0 N-CA-C 106.822 -1.547 . . . . 1.0 106.822 178.011 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . 0.585 ' CG2' ' O ' ' A' ' 36' ' ' VAL . 0.6 OUTLIER 150.54 88.87 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.475 0.809 0 O-C-N 123.556 0.535 . . . . 1.0 109.75 179.694 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 26.2 m-70 -134.64 128.0 32.25 Favored 'General case' 0 C--O 1.233 0.195 0 N-CA-C 107.277 -1.379 . . . . 1.0 107.277 176.91 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 39' ' ' THR . . . . . 0.553 ' O ' ' NH2' ' A' ' 42' ' ' ARG . 1.0 OUTLIER -121.6 158.5 53.85 Favored Pre-proline 0 N--CA 1.468 0.463 0 N-CA-C 109.43 -0.581 . . . . 1.0 109.43 -179.189 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 40' ' ' PRO . . . . . 0.486 ' HG2' ' H ' ' A' ' 41' ' ' ALA . 97.4 Cg_endo -85.41 -78.76 0.0 OUTLIER 'Trans proline' 0 C--N 1.31 -1.456 0 C-N-CA 121.36 1.374 . . . . 1.0 113.306 179.99 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . 0.486 ' H ' ' HG2' ' A' ' 40' ' ' PRO . . . -76.11 123.3 25.59 Favored 'General case' 0 C--N 1.319 -0.737 0 CA-C-N 114.955 -1.021 . . . . 1.0 111.875 -176.802 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . 0.679 ' C ' ' H ' ' A' ' 44' ' ' GLY . 0.0 OUTLIER -171.14 171.06 5.89 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 114.493 -1.23 . . . . 1.0 109.502 179.071 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 43' ' ' ARG . . . . . 0.414 ' C ' ' H ' ' A' ' 45' ' ' PHE . 8.6 tpt180 -63.53 18.07 0.01 OUTLIER 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.512 -0.767 . . . . 1.0 109.761 178.989 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . 0.679 ' H ' ' C ' ' A' ' 42' ' ' ARG . . . 81.38 -25.48 3.77 Favored Glycine 0 C--N 1.336 0.542 0 N-CA-C 110.731 -0.948 . . . . 1.0 110.731 179.343 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . 0.538 ' O ' ' CD1' ' A' ' 46' ' ' PHE . 84.9 t80 -161.72 163.23 29.81 Favored 'General case' 0 CA--C 1.535 0.388 0 N-CA-C 110.5 -0.185 . . . . 1.0 110.5 -179.328 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 46' ' ' PHE . . . . . 0.538 ' CD1' ' O ' ' A' ' 45' ' ' PHE . 3.9 m-30 136.61 86.49 0.0 OUTLIER 'General case' 0 N--CA 1.487 1.405 0 O-C-N 124.782 1.301 . . . . 1.0 110.308 179.369 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 47' ' ' ARG . . . . . 0.509 ' CB ' ' O ' ' A' ' 46' ' ' PHE . 5.2 mmp_? 132.57 140.77 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.512 0 C-N-CA 124.392 1.077 . . . . 1.0 109.642 178.568 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 1.9 t 72.74 72.02 0.14 Allowed 'General case' 0 N--CA 1.451 -0.386 0 C-N-CA 120.277 -0.569 . . . . 1.0 109.672 -179.631 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 49' ' ' ASN . . . . . 0.655 ' O ' ' N ' ' A' ' 51' ' ' GLU . 0.0 OUTLIER -136.37 121.9 13.38 Favored Pre-proline 0 C--O 1.221 -0.439 0 N-CA-C 107.923 -1.14 . . . . 1.0 107.923 -179.464 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 52.4 Cg_exo -52.21 63.96 0.02 OUTLIER 'Trans proline' 0 N--CA 1.503 2.03 0 C-N-CA 121.94 1.76 . . . . 1.0 113.311 178.786 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . 0.655 ' N ' ' O ' ' A' ' 49' ' ' ASN . 2.5 mp0 65.05 36.79 7.15 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 120.523 0.202 . . . . 1.0 110.81 -179.978 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 4.7 mtp85 -111.21 138.58 47.48 Favored 'General case' 0 N--CA 1.466 0.367 0 CA-C-N 116.515 -0.311 . . . . 1.0 110.176 179.634 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 4.7 tp -66.54 141.38 18.07 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-O 121.836 0.826 . . . . 1.0 110.611 179.97 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 54' ' ' GLN . . . . . 0.521 ' CG ' ' O ' ' A' ' 54' ' ' GLN . 0.0 OUTLIER -63.03 80.78 0.02 OUTLIER 'General case' 0 CA--C 1.55 0.977 0 CA-C-N 113.739 -1.573 . . . . 1.0 109.915 -176.433 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -150.05 158.38 5.65 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.875 0 O-C-N 121.038 -1.039 . . . . 1.0 110.224 178.091 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 110.43 -7.26 30.29 Favored Glycine 0 N--CA 1.474 1.17 0 N-CA-C 111.05 -0.82 . . . . 1.0 111.05 -179.522 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . 0.452 ' OD1' ' O ' ' A' ' 57' ' ' ASP . 42.3 p-10 -77.22 97.88 4.95 Favored 'General case' 0 C--N 1.318 -0.769 0 N-CA-C 108.079 -1.082 . . . . 1.0 108.079 177.59 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 58' ' ' TRP . . . . . . . . . . . . . 0.6 OUTLIER -88.88 175.19 7.55 Favored 'General case' 0 CA--C 1.538 0.506 0 CA-C-O 122.757 1.265 . . . . 1.0 112.321 -177.753 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -88.52 -57.69 2.83 Favored 'General case' 0 C--N 1.318 -0.79 0 CA-C-N 112.479 -2.146 . . . . 1.0 112.985 179.963 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 79.0 t80 -90.73 -17.73 26.2 Favored 'General case' 0 C--O 1.245 0.866 0 CA-C-N 115.115 -0.948 . . . . 1.0 113.012 -178.553 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . 0.485 ' O ' ' N ' ' A' ' 65' ' ' ASP . 17.6 tt0 -77.19 -12.9 60.0 Favored 'General case' 0 N--CA 1.435 -1.214 0 O-C-N 121.844 -0.535 . . . . 1.0 110.275 -178.605 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . 0.521 ' O ' ' N ' ' A' ' 66' ' ' GLY . 16.1 m -45.45 -55.73 1.18 Allowed 'Isoleucine or valine' 0 C--O 1.21 -1.01 0 C-N-CA 119.602 -0.839 . . . . 1.0 109.126 -175.385 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -65.43 -48.86 71.29 Favored 'General case' 0 C--N 1.306 -1.315 0 N-CA-C 109.306 -0.627 . . . . 1.0 109.306 178.721 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER -53.15 -58.85 5.61 Favored 'General case' 0 CA--C 1.539 0.533 0 C-N-CA 119.28 -0.968 . . . . 1.0 109.429 -179.084 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . 0.558 ' C ' ' H ' ' A' ' 67' ' ' ARG . 19.0 m-20 -65.28 -45.67 83.52 Favored 'General case' 0 C--N 1.324 -0.524 0 N-CA-C 108.849 -0.797 . . . . 1.0 108.849 178.085 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . 0.521 ' N ' ' O ' ' A' ' 62' ' ' VAL . . . -67.49 24.44 0.22 Allowed Glycine 0 C--N 1.338 0.655 0 N-CA-C 111.629 -0.588 . . . . 1.0 111.629 -179.976 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 67' ' ' ARG . . . . . 0.558 ' H ' ' C ' ' A' ' 65' ' ' ASP . 0.0 OUTLIER -86.36 -9.89 55.47 Favored 'General case' 0 C--N 1.315 -0.893 0 N-CA-C 108.587 -0.894 . . . . 1.0 108.587 175.602 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . 0.513 ' O ' ' CA ' ' A' ' 72' ' ' HIS . 1.4 pt? -63.35 -34.92 78.77 Favored 'General case' 0 N--CA 1.472 0.632 0 N-CA-C 112.97 0.73 . . . . 1.0 112.97 -177.868 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -52.29 -65.51 0.55 Allowed 'General case' 0 C--N 1.317 -0.828 0 C-N-CA 117.433 -1.707 . . . . 1.0 109.25 -177.622 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -64.7 -75.76 0.08 Allowed 'General case' 0 C--N 1.312 -1.029 0 N-CA-C 106.511 -1.662 . . . . 1.0 106.511 -179.811 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . 0.745 ' O ' ' N ' ' A' ' 73' ' ' MET . . . -59.56 15.74 0.01 OUTLIER 'General case' 0 C--N 1.321 -0.636 0 C-N-CA 127.172 2.189 . . . . 1.0 116.084 179.94 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 72' ' ' HIS . . . . . 0.513 ' CA ' ' O ' ' A' ' 68' ' ' LEU . 0.0 OUTLIER -21.94 -28.48 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.588 0 CA-C-N 119.638 1.108 . . . . 1.0 113.756 -176.11 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 73' ' ' MET . . . . . 0.745 ' N ' ' O ' ' A' ' 71' ' ' ALA . 4.0 mmt -63.72 -56.65 14.03 Favored 'General case' 0 C--N 1.317 -0.816 0 C-N-CA 117.64 -1.624 . . . . 1.0 106.875 174.789 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . 0.783 ' O ' ' N ' ' A' ' 76' ' ' GLY . 27.9 t -36.92 -51.08 0.3 Allowed 'Isoleucine or valine' 0 N--CA 1.48 1.037 0 CA-C-O 118.483 -0.77 . . . . 1.0 111.155 -175.86 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 75' ' ' ASN . . . . . 0.465 ' ND2' HH12 ' A' ' 126' ' ' ARG . 26.0 t30 -30.71 -16.64 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.492 0 CA-C-N 119.302 0.956 . . . . 1.0 113.382 -178.2 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . 0.783 ' N ' ' O ' ' A' ' 74' ' ' VAL . . . -48.2 -25.05 3.85 Favored Glycine 0 CA--C 1.543 1.822 0 N-CA-C 109.991 -1.243 . . . . 1.0 109.991 176.404 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . 0.664 HG13 ' H ' ' A' ' 78' ' ' VAL . 3.0 pt -73.29 -55.55 12.3 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.679 0 CA-C-O 122.366 1.079 . . . . 1.0 109.078 178.552 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . 0.664 ' H ' HG13 ' A' ' 77' ' ' ILE . 1.4 p -38.59 -34.85 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.311 -1.083 0 CA-C-N 112.395 -2.184 . . . . 1.0 105.405 -175.666 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . 0.484 ' N ' ' C ' ' A' ' 77' ' ' ILE . 16.2 pt -100.06 -37.58 5.92 Favored 'Isoleucine or valine' 0 CA--C 1.554 1.126 0 N-CA-C 113.924 1.083 . . . . 1.0 113.924 176.712 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 80' ' ' ALA . . . . . 0.575 ' N ' ' O ' ' A' ' 76' ' ' GLY . . . -82.39 -12.78 57.7 Favored 'General case' 0 N--CA 1.478 0.969 0 N-CA-C 113.645 0.98 . . . . 1.0 113.645 -178.86 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 45.5 tt0 -92.17 -73.14 0.56 Allowed 'General case' 0 N--CA 1.439 -0.995 0 CA-C-O 118.918 -0.563 . . . . 1.0 112.507 -178.636 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 28.3 m-20 -93.82 -16.84 23.72 Favored 'General case' 0 C--N 1.352 0.69 0 N-CA-C 114.843 1.423 . . . . 1.0 114.843 -178.551 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . 0.62 ' O ' ' N ' ' A' ' 85' ' ' ILE . . . -52.94 -41.46 64.51 Favored 'General case' 0 N--CA 1.468 0.44 0 C-N-CA 118.713 -1.195 . . . . 1.0 111.205 -177.588 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 49.5 mt -39.37 -15.71 0.01 OUTLIER 'General case' 0 CA--C 1.538 0.505 0 N-CA-C 111.869 0.322 . . . . 1.0 111.869 -179.577 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 85' ' ' ILE . . . . . 0.62 ' N ' ' O ' ' A' ' 83' ' ' ALA . 0.8 OUTLIER -96.68 -31.55 4.01 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.618 0 C-N-CA 120.973 -0.291 . . . . 1.0 111.246 178.285 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . 0.533 ' C ' ' H ' ' A' ' 88' ' ' ALA . . . -94.64 -28.66 15.25 Favored 'General case' 0 N--CA 1.466 0.375 0 CA-C-O 120.811 0.339 . . . . 1.0 111.842 -179.408 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -54.54 -7.7 0.18 Allowed 'General case' 0 C--N 1.32 -0.703 0 C-N-CA 119.308 -0.957 . . . . 1.0 110.196 -178.781 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . 0.533 ' H ' ' C ' ' A' ' 86' ' ' ALA . . . -79.73 -0.85 35.93 Favored 'General case' 0 N--CA 1.472 0.655 0 CA-C-O 122.209 1.004 . . . . 1.0 109.245 179.324 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 3.2 m -102.01 34.53 0.36 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.54 0 CA-C-N 113.025 -1.898 . . . . 1.0 109.744 178.548 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 90' ' ' GLY . . . . . 0.619 ' C ' ' H ' ' A' ' 92' ' ' HIS . . . -67.06 -38.27 92.38 Favored Glycine 0 C--N 1.345 1.052 0 N-CA-C 111.146 -0.782 . . . . 1.0 111.146 178.575 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 91' ' ' PRO . . . . . 0.539 ' CD ' ' N ' ' A' ' 90' ' ' GLY . 80.6 Cg_exo -46.96 -8.0 0.04 OUTLIER 'Trans proline' 0 N--CA 1.488 1.199 0 C-N-CA 121.75 1.633 . . . . 1.0 110.712 177.995 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 92' ' ' HIS . . . . . 0.619 ' H ' ' C ' ' A' ' 90' ' ' GLY . 2.6 p80 -57.42 -21.05 33.95 Favored 'General case' 0 N--CA 1.439 -1.0 0 N-CA-C 108.051 -1.092 . . . . 1.0 108.051 179.949 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . 0.55 ' N ' ' ND1' ' A' ' 92' ' ' HIS . 2.3 pp -61.64 -58.52 7.76 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.764 -0.653 . . . . 1.0 109.345 178.307 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 94' ' ' ALA . . . . . 0.528 ' H ' ' HG ' ' A' ' 93' ' ' LEU . . . -56.01 -52.39 64.38 Favored 'General case' 0 CA--C 1.515 -0.374 0 N-CA-C 108.983 -0.747 . . . . 1.0 108.983 179.532 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 95' ' ' ARG . . . . . 0.627 ' O ' ' N ' ' A' ' 97' ' ' LEU . 33.5 ttp180 -58.95 -60.25 4.16 Favored 'General case' 0 N--CA 1.442 -0.86 0 N-CA-C 107.565 -1.272 . . . . 1.0 107.565 178.39 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 96' ' ' ALA . . . . . 0.978 ' O ' ' N ' ' A' ' 98' ' ' GLY . . . -47.18 -13.71 0.03 OUTLIER 'General case' 0 C--N 1.301 -1.533 0 O-C-N 119.104 -2.247 . . . . 1.0 111.153 -178.689 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . 0.688 ' O ' ' N ' ' A' ' 100' ' ' ILE . 1.3 tm? 6.91 -52.53 0.0 OUTLIER 'General case' 0 C--N 1.365 1.242 0 CA-C-O 118.13 -0.938 . . . . 1.0 108.881 -166.886 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 98' ' ' GLY . . . . . 0.978 ' N ' ' O ' ' A' ' 96' ' ' ALA . . . -49.93 -24.29 6.19 Favored Glycine 0 CA--C 1.545 1.934 0 N-CA-C 107.898 -2.081 . . . . 1.0 107.898 174.218 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 99' ' ' GLN . . . . . 0.645 ' N ' ' O ' ' A' ' 96' ' ' ALA . 19.0 mt-30 -67.68 -19.32 65.16 Favored 'General case' 0 C--N 1.364 1.222 0 C-N-CA 116.073 -2.251 . . . . 1.0 107.263 176.375 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 100' ' ' ILE . . . . . 0.688 ' N ' ' O ' ' A' ' 97' ' ' LEU . 3.4 mm -66.67 -43.6 90.16 Favored 'Isoleucine or valine' 0 C--O 1.212 -0.872 0 C-N-CA 119.171 -1.012 . . . . 1.0 109.519 177.594 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 101' ' ' VAL . . . . . 0.48 ' CG1' ' N ' ' A' ' 102' ' ' CYS . 4.6 p -60.27 -56.8 15.19 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.32 0 C-N-CA 116.684 -2.006 . . . . 1.0 107.483 -179.924 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 102' ' ' CYS . . . . . 0.509 ' O ' ' CB ' ' A' ' 106' ' ' ALA . 0.5 OUTLIER -51.09 -31.67 19.78 Favored 'General case' 0 C--O 1.214 -0.812 0 CA-C-O 121.223 0.535 . . . . 1.0 112.019 179.845 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 103' ' ' ARG . . . . . 0.437 HH22 ' HB3' ' A' ' 93' ' ' LEU . 3.2 ttp180 -85.34 -47.46 10.0 Favored 'General case' 0 N--CA 1.477 0.904 0 CA-C-N 115.254 -0.884 . . . . 1.0 111.745 179.545 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 104' ' ' TYR . . . . . 0.436 ' N ' ' O ' ' A' ' 100' ' ' ILE . 8.7 t80 -49.73 -19.36 0.62 Allowed 'General case' 0 C--N 1.3 -1.571 0 CA-C-N 114.086 -1.416 . . . . 1.0 108.937 179.28 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -173.64 -46.52 0.05 OUTLIER Glycine 0 N--CA 1.448 -0.526 0 C-N-CA 117.967 -2.063 . . . . 1.0 110.828 179.379 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 106' ' ' ALA . . . . . 0.509 ' CB ' ' O ' ' A' ' 102' ' ' CYS . . . 69.7 82.63 0.16 Allowed 'General case' 0 N--CA 1.44 -0.963 0 N-CA-C 111.628 0.232 . . . . 1.0 111.628 -179.081 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 107' ' ' THR . . . . . 0.426 ' O ' ' CD ' ' A' ' 110' ' ' PRO . 9.4 t -92.26 3.49 55.27 Favored 'General case' 0 CA--C 1.514 -0.44 0 N-CA-C 107.304 -1.369 . . . . 1.0 107.304 177.164 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . 0.516 ' CG1' ' O ' ' A' ' 108' ' ' VAL . 62.2 t -90.65 20.11 0.64 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.526 0 CA-C-N 114.883 -1.053 . . . . 1.0 111.352 178.593 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 109' ' ' ILE . . . . . 0.688 ' N ' ' CD ' ' A' ' 110' ' ' PRO . 0.1 OUTLIER -106.07 -18.26 0.17 Allowed Pre-proline 0 CA--C 1.548 0.869 0 O-C-N 120.162 -1.586 . . . . 1.0 110.954 177.994 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 110' ' ' PRO . . . . . 0.688 ' CD ' ' N ' ' A' ' 109' ' ' ILE . 19.5 Cg_endo -59.5 -49.56 10.2 Favored 'Trans proline' 0 N--CA 1.482 0.851 0 CA-C-N 120.5 1.214 . . . . 1.0 113.095 -174.533 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 111' ' ' ASN . . . . . 0.427 HD21 ' C ' ' A' ' 111' ' ' ASN . 0.2 OUTLIER -68.66 -66.78 0.53 Allowed 'General case' 0 C--O 1.217 -0.617 0 C-N-CA 118.542 -1.263 . . . . 1.0 109.55 -178.526 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 112' ' ' ILE . . . . . 0.537 ' O ' ' HB ' ' A' ' 116' ' ' ILE . 0.9 OUTLIER -48.41 -38.64 9.08 Favored 'Isoleucine or valine' 0 C--O 1.213 -0.862 0 CA-C-O 121.127 0.489 . . . . 1.0 111.659 -177.854 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 113' ' ' ASN . . . . . 0.477 ' N ' ' CG2' ' A' ' 112' ' ' ILE . 1.6 t-20 -67.59 -40.61 84.8 Favored 'General case' 0 C--N 1.313 -1.019 0 N-CA-C 106.502 -1.666 . . . . 1.0 106.502 178.585 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 114' ' ' ALA . . . . . 0.407 ' N ' ' O ' ' A' ' 111' ' ' ASN . . . -61.16 -51.4 69.21 Favored 'General case' 0 C--N 1.306 -1.307 0 CA-C-N 112.956 -1.929 . . . . 1.0 108.249 179.198 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -80.09 -59.7 2.62 Favored 'General case' 0 CA--C 1.544 0.725 0 N-CA-C 114.782 1.401 . . . . 1.0 114.782 179.582 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 116' ' ' ILE . . . . . 0.537 ' HB ' ' O ' ' A' ' 112' ' ' ILE . 0.7 OUTLIER -47.34 -50.53 7.52 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.884 0 CA-C-N 119.483 1.038 . . . . 1.0 111.52 -178.202 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 117' ' ' GLU . . . . . 0.498 ' CG ' ' N ' ' A' ' 118' ' ' VAL . 13.3 pt-20 -43.3 -58.57 2.47 Favored 'General case' 0 C--N 1.322 -0.623 0 N-CA-C 105.701 -1.962 . . . . 1.0 105.701 -179.365 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 118' ' ' VAL . . . . . 0.498 ' N ' ' CG ' ' A' ' 117' ' ' GLU . 88.1 t -58.43 -53.37 47.5 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.069 0 C-N-CA 119.24 -0.984 . . . . 1.0 110.043 177.757 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -52.31 -71.75 0.06 Allowed 'General case' 0 CA--C 1.545 0.765 0 N-CA-C 107.805 -1.183 . . . . 1.0 107.805 -177.922 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 120' ' ' GLY . . . . . 0.531 ' N ' ' O ' ' A' ' 116' ' ' ILE . . . -70.18 -76.05 0.55 Allowed Glycine 0 CA--C 1.546 2.002 0 C-N-CA 119.737 -1.221 . . . . 1.0 111.267 -179.87 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 121' ' ' THR . . . . . 0.498 ' OG1' ' O ' ' A' ' 120' ' ' GLY . 1.9 m 148.33 -28.68 0.01 OUTLIER 'General case' 0 N--CA 1.487 1.404 0 CA-C-N 112.294 -1.953 . . . . 1.0 110.914 -178.414 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 122' ' ' GLY . . . . . 0.643 ' O ' ' N ' ' A' ' 124' ' ' ASP . . . 102.59 -17.25 53.67 Favored Glycine 0 C--O 1.224 -0.497 0 N-CA-C 107.629 -2.188 . . . . 1.0 107.629 -176.856 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 123' ' ' THR . . . . . 0.407 ' O ' ' CG ' ' A' ' 124' ' ' ASP . 8.1 t -53.99 85.34 0.0 OUTLIER 'General case' 0 N--CA 1.466 0.34 0 N-CA-C 106.043 -1.836 . . . . 1.0 106.043 178.379 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 124' ' ' ASP . . . . . 0.643 ' N ' ' O ' ' A' ' 122' ' ' GLY . 45.3 m-20 -163.41 169.45 18.91 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 113.344 -1.753 . . . . 1.0 111.972 -179.537 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 125' ' ' TYR . . . . . . . . . . . . . 2.0 t80 -146.47 144.52 29.72 Favored 'General case' 0 CA--C 1.542 0.662 0 N-CA-C 108.461 -0.94 . . . . 1.0 108.461 176.258 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 126' ' ' ARG . . . . . 0.465 HH12 ' ND2' ' A' ' 75' ' ' ASN . 1.9 mtp85 -146.44 149.33 33.5 Favored 'General case' 0 N--CA 1.466 0.326 0 N-CA-C 109.446 -0.576 . . . . 1.0 109.446 177.611 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 127' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.219 -0.506 0 CA-C-O 117.869 -1.062 . . . . 1.0 109.112 179.252 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 128' ' ' MTN . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 129' ' ' MTN . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 130' ' ' MTN . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.587 ' N ' ' SD ' ' A' ' 1' ' ' MET . 0.0 OUTLIER . . . . . 0 N--CA 1.493 1.682 0 N-CA-C 108.561 -0.903 . . . . 1.0 108.561 . . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 35.9 t -106.18 7.96 31.83 Favored 'General case' 0 N--CA 1.466 0.337 0 CA-C-N 116.317 -0.401 . . . . 1.0 110.361 -179.867 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 3.9 t0 167.5 96.86 0.0 OUTLIER 'General case' 0 N--CA 1.47 0.551 0 O-C-N 123.728 0.642 . . . . 1.0 110.242 179.244 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 82.7 t80 -150.34 146.29 26.65 Favored 'General case' 0 N--CA 1.463 0.191 0 CA-C-N 116.161 -0.472 . . . . 1.0 110.568 179.7 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 5' ' ' ASP . . . . . 0.51 ' N ' ' OD1' ' A' ' 5' ' ' ASP . 1.5 p30 -158.55 153.95 25.86 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 121.129 0.49 . . . . 1.0 110.407 179.984 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 6' ' ' THR . . . . . 0.614 ' O ' ' N ' ' A' ' 10' ' ' SER . 0.2 OUTLIER -69.72 170.55 10.7 Favored 'General case' 0 C--O 1.205 -1.251 0 CA-C-N 115.777 -0.647 . . . . 1.0 110.359 -179.453 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 1.6 tm-20 -55.31 -58.36 8.03 Favored 'General case' 0 C--N 1.31 -1.144 0 CA-C-N 115.367 -0.833 . . . . 1.0 109.72 -178.719 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 8' ' ' ARG . . . . . 0.486 ' O ' ' CB ' ' A' ' 12' ' ' ALA . 5.5 tmm_? -51.52 -54.7 24.58 Favored 'General case' 0 C--N 1.311 -1.072 0 C-N-CA 119.17 -1.012 . . . . 1.0 108.599 -177.553 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . 0.408 HG13 HH11 ' A' ' 8' ' ' ARG . 0.0 OUTLIER -65.51 -48.76 81.69 Favored 'Isoleucine or valine' 0 CA--C 1.551 0.991 0 CA-C-N 115.673 -0.694 . . . . 1.0 110.718 178.896 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 10' ' ' SER . . . . . 0.614 ' N ' ' O ' ' A' ' 6' ' ' THR . 35.5 t -63.41 -41.11 98.71 Favored 'General case' 0 C--N 1.318 -0.778 0 N-CA-C 115.007 1.484 . . . . 1.0 115.007 -178.18 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 11' ' ' ARG . . . . . 0.597 ' O ' ' N ' ' A' ' 15' ' ' ALA . 56.9 ttm-85 -79.99 -55.11 5.19 Favored 'General case' 0 C--O 1.216 -0.704 0 CA-C-O 122.478 1.133 . . . . 1.0 108.988 176.808 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . 0.486 ' CB ' ' O ' ' A' ' 8' ' ' ARG . . . -45.85 -50.31 14.4 Favored 'General case' 0 N--CA 1.469 0.489 0 N-CA-C 106.361 -1.718 . . . . 1.0 106.361 -177.605 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . 0.602 ' O ' ' CB ' ' A' ' 17' ' ' LEU . 75.0 t -60.24 -49.8 82.75 Favored 'Isoleucine or valine' 0 C--O 1.202 -1.433 0 C-N-CA 118.265 -1.374 . . . . 1.0 107.686 177.568 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . 0.432 ' N ' ' O ' ' A' ' 11' ' ' ARG . . . -59.01 -62.84 1.58 Allowed 'General case' 0 N--CA 1.48 1.072 0 C-N-CA 119.356 -0.938 . . . . 1.0 111.443 178.821 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . 0.597 ' N ' ' O ' ' A' ' 11' ' ' ARG . . . -53.43 -55.38 25.66 Favored 'General case' 0 N--CA 1.473 0.71 0 CA-C-O 121.586 0.707 . . . . 1.0 109.902 -177.77 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . 0.44 ' CB ' ' O ' ' A' ' 12' ' ' ALA . . . -63.91 -53.99 41.77 Favored 'General case' 0 C--N 1.314 -0.935 0 CA-C-N 114.39 -1.277 . . . . 1.0 108.879 -179.272 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . 0.602 ' CB ' ' O ' ' A' ' 13' ' ' VAL . 8.2 tt -56.57 -53.71 54.41 Favored 'General case' 0 N--CA 1.477 0.907 0 C-N-CA 118.698 -1.201 . . . . 1.0 109.026 -177.477 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . 0.523 HG21 ' H ' ' A' ' 19' ' ' GLY . 2.4 m -68.4 -55.78 14.94 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.798 0 C-N-CA 119.436 -0.906 . . . . 1.0 109.84 179.599 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . 0.532 ' N ' ' O ' ' A' ' 15' ' ' ALA . . . -65.88 -174.46 5.28 Favored Glycine 0 CA--C 1.531 1.071 0 N-CA-C 111.825 -0.51 . . . . 1.0 111.825 -178.617 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 20' ' ' PRO . . . . . 0.597 ' O ' ' N ' ' A' ' 24' ' ' ALA . 1.3 Cg_endo -77.22 -23.15 10.55 Favored 'Trans proline' 0 N--CA 1.492 1.394 0 C-N-CA 123.065 2.51 . . . . 1.0 114.501 -179.123 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -59.73 -58.56 13.6 Favored Glycine 0 N--CA 1.474 1.185 0 C-N-CA 119.517 -1.325 . . . . 1.0 110.893 -177.205 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -56.63 -53.37 44.23 Favored Glycine 0 C--N 1.314 -0.659 0 N-CA-C 107.231 -2.348 . . . . 1.0 107.231 -178.743 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 60.9 t -58.01 -31.74 42.01 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.883 0 CA-C-N 114.789 -0.705 . . . . 1.0 110.245 179.598 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . 0.597 ' N ' ' O ' ' A' ' 20' ' ' PRO . . . -61.54 -59.96 4.42 Favored 'General case' 0 CA--C 1.533 0.307 0 C-N-CA 118.884 -1.126 . . . . 1.0 108.61 179.888 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 19.1 tp -61.94 -47.6 84.16 Favored 'General case' 0 C--N 1.342 0.282 0 N-CA-C 112.852 0.686 . . . . 1.0 112.852 -179.099 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 89.9 t -60.03 -60.19 2.91 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.189 0 C-N-CA 119.055 -1.058 . . . . 1.0 110.105 -177.669 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 1.8 p -58.91 -35.33 55.92 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.352 0 N-CA-C 112.456 0.539 . . . . 1.0 112.456 -178.52 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 1.1 mmmm -66.08 -54.48 25.24 Favored 'General case' 0 CA--C 1.517 -0.298 0 C-N-CA 119.499 -0.881 . . . . 1.0 108.874 -178.745 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 4.0 t -65.89 -48.78 80.78 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.842 0 CA-C-N 114.016 -1.447 . . . . 1.0 111.017 -177.242 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 30' ' ' CYS . . . . . . . . . . . . . 4.8 t -64.45 -60.51 3.07 Favored 'General case' 0 N--CA 1.445 -0.721 0 C-N-CA 117.685 -1.606 . . . . 1.0 109.61 -179.837 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -68.2 -55.59 11.76 Favored 'General case' 0 C--N 1.331 -0.235 0 N-CA-C 114.846 1.425 . . . . 1.0 114.846 -175.163 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . 0.41 ' O ' ' CB ' ' A' ' 33' ' ' LEU . . . 85.69 72.9 1.28 Allowed Glycine 0 CA--C 1.534 1.223 0 C-N-CA 120.673 -0.775 . . . . 1.0 111.56 -178.76 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . 0.436 ' O ' ' N ' ' A' ' 35' ' ' GLY . 0.9 OUTLIER 73.0 99.36 0.04 OUTLIER Pre-proline 0 CA--C 1.554 1.101 0 C-N-CA 120.985 -0.286 . . . . 1.0 111.304 178.107 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_exo -43.45 -9.98 0.03 OUTLIER 'Trans proline' 0 N--CA 1.511 2.525 0 C-N-CA 123.92 3.08 . . . . 1.0 115.57 -179.218 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . 0.436 ' N ' ' O ' ' A' ' 33' ' ' LEU . . . -59.54 -59.04 11.3 Favored Glycine 0 CA--C 1.529 0.952 0 C-N-CA 118.562 -1.78 . . . . 1.0 109.189 -179.047 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 6.1 m -85.96 -148.1 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.332 -0.177 0 N-CA-C 109.199 -0.667 . . . . 1.0 109.199 179.422 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 2.1 mp 74.71 80.03 0.04 OUTLIER 'Isoleucine or valine' 0 CA--C 1.514 -0.436 0 N-CA-C 112.819 0.674 . . . . 1.0 112.819 179.415 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 55.6 m80 -135.71 126.74 27.85 Favored 'General case' 0 C--N 1.329 -0.29 0 N-CA-C 106.514 -1.661 . . . . 1.0 106.514 176.979 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 39' ' ' THR . . . . . 0.576 ' OG1' ' NE ' ' A' ' 42' ' ' ARG . 0.0 OUTLIER -103.36 136.63 19.19 Favored Pre-proline 0 N--CA 1.469 0.492 0 N-CA-C 109.835 -0.431 . . . . 1.0 109.835 -178.968 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 32.3 Cg_exo -53.92 -32.53 68.11 Favored 'Trans proline' 0 N--CA 1.486 1.088 0 C-N-CA 121.076 1.184 . . . . 1.0 113.529 -179.68 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -128.21 132.06 48.82 Favored 'General case' 0 N--CA 1.463 0.192 0 O-C-N 122.191 -0.318 . . . . 1.0 111.226 -179.864 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . 0.71 ' C ' ' H ' ' A' ' 44' ' ' GLY . 12.1 mtm180 -160.39 158.57 29.78 Favored 'General case' 0 C--N 1.321 -0.665 0 N-CA-C 109.151 -0.685 . . . . 1.0 109.151 176.131 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 43' ' ' ARG . . . . . 0.47 ' C ' ' H ' ' A' ' 45' ' ' PHE . 41.9 ttt85 -60.28 23.46 0.01 OUTLIER 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 115.487 -0.779 . . . . 1.0 110.142 179.933 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . 0.71 ' H ' ' C ' ' A' ' 42' ' ' ARG . . . 80.68 -26.38 3.17 Favored Glycine 0 N--CA 1.445 -0.72 0 N-CA-C 110.126 -1.19 . . . . 1.0 110.126 -179.645 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . 0.588 ' CG ' ' C ' ' A' ' 44' ' ' GLY . 0.1 OUTLIER -179.33 -174.13 0.3 Allowed 'General case' 0 CA--C 1.537 0.464 0 C-N-CA 120.91 -0.316 . . . . 1.0 111.083 -178.801 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 46' ' ' PHE . . . . . 0.549 ' CB ' ' O ' ' A' ' 45' ' ' PHE . 15.2 t80 117.64 107.05 0.0 OUTLIER 'General case' 0 N--CA 1.488 1.428 0 O-C-N 125.044 1.465 . . . . 1.0 109.359 -179.454 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 47' ' ' ARG . . . . . 0.496 ' CB ' ' O ' ' A' ' 46' ' ' PHE . 3.9 tmm_? 100.09 167.3 0.01 OUTLIER 'General case' 0 N--CA 1.467 0.395 0 CA-C-N 115.141 -0.936 . . . . 1.0 108.632 -178.244 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 7.7 t 75.6 -18.03 0.48 Allowed 'General case' 0 N--CA 1.472 0.643 0 CA-C-O 120.646 0.26 . . . . 1.0 111.332 -179.158 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 49' ' ' ASN . . . . . 0.693 ' ND2' ' H ' ' A' ' 52' ' ' ARG . 0.2 OUTLIER -62.2 146.27 92.69 Favored Pre-proline 0 CA--C 1.547 0.838 0 CA-C-N 116.317 -0.402 . . . . 1.0 111.909 -179.17 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . 0.417 ' N ' ' ND2' ' A' ' 49' ' ' ASN . 25.2 Cg_exo -60.68 66.65 0.08 OUTLIER 'Trans proline' 0 N--CA 1.501 1.94 0 C-N-CA 121.918 1.746 . . . . 1.0 111.703 177.289 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . 0.522 ' N ' ' O ' ' A' ' 49' ' ' ASN . 23.1 mm-40 46.76 55.73 7.44 Favored 'General case' 0 CA--C 1.554 1.096 0 N-CA-C 113.074 0.768 . . . . 1.0 113.074 177.979 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . 0.697 ' NH2' ' NE2' ' A' ' 92' ' ' HIS . 7.7 mtt-85 -143.57 155.72 44.38 Favored 'General case' 0 N--CA 1.498 1.928 0 CA-C-O 119.494 -0.289 . . . . 1.0 110.555 178.225 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 10.4 tp -75.75 127.94 37.24 Favored 'Isoleucine or valine' 0 CA--C 1.56 1.358 0 N-CA-C 116.258 1.947 . . . . 1.0 116.258 -174.361 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 47.3 tp60 -65.2 86.0 0.06 Allowed 'General case' 0 N--CA 1.476 0.848 0 CA-C-N 109.728 -3.396 . . . . 1.0 109.457 -177.716 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -147.27 155.58 10.86 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.845 0 N-CA-C 109.692 -0.484 . . . . 1.0 109.692 178.151 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 107.51 -5.38 35.29 Favored Glycine 0 N--CA 1.48 1.621 0 N-CA-C 111.262 -0.735 . . . . 1.0 111.262 179.452 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -112.7 129.61 56.34 Favored 'General case' 0 C--N 1.317 -0.808 0 N-CA-C 108.206 -1.035 . . . . 1.0 108.206 178.071 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 58' ' ' TRP . . . . . 0.54 ' H ' ' HB2' ' A' ' 61' ' ' GLU . 11.5 m0 -134.25 152.36 51.78 Favored 'General case' 0 C--N 1.348 0.536 0 CA-C-O 122.333 1.063 . . . . 1.0 109.834 -179.829 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -37.73 -39.79 0.37 Allowed 'General case' 0 CA--C 1.558 1.252 0 CA-C-N 113.047 -1.888 . . . . 1.0 110.767 -177.015 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 7.3 t80 -86.29 -27.4 24.4 Favored 'General case' 0 N--CA 1.481 1.099 0 CA-C-O 121.953 0.882 . . . . 1.0 112.626 -179.434 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . 0.54 ' HB2' ' H ' ' A' ' 58' ' ' TRP . 39.9 mt-10 -78.64 -13.0 60.04 Favored 'General case' 0 CA--C 1.509 -0.613 0 CA-C-N 115.639 -0.709 . . . . 1.0 110.377 179.015 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . 0.654 ' O ' ' N ' ' A' ' 66' ' ' GLY . 49.5 t -50.01 -57.06 2.51 Favored 'Isoleucine or valine' 0 C--O 1.202 -1.401 0 C-N-CA 119.328 -0.949 . . . . 1.0 109.8 -176.806 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 63' ' ' ALA . . . . . 0.441 ' O ' ' HG3' ' A' ' 67' ' ' ARG . . . -65.27 -57.36 8.64 Favored 'General case' 0 C--N 1.307 -1.278 0 O-C-N 121.33 -0.856 . . . . 1.0 110.21 -178.669 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 40.3 t-80 -47.44 -56.92 6.01 Favored 'General case' 0 N--CA 1.472 0.67 0 O-C-N 124.171 0.919 . . . . 1.0 109.573 179.976 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . 0.629 ' C ' ' H ' ' A' ' 67' ' ' ARG . 30.0 t0 -74.56 -48.99 23.58 Favored 'General case' 0 C--N 1.316 -0.853 0 CA-C-N 115.476 -0.784 . . . . 1.0 111.167 179.511 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . 0.654 ' N ' ' O ' ' A' ' 62' ' ' VAL . . . -74.3 26.42 1.04 Allowed Glycine 0 CA--C 1.521 0.427 0 N-CA-C 109.905 -1.278 . . . . 1.0 109.905 177.35 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 67' ' ' ARG . . . . . 0.647 ' O ' ' N ' ' A' ' 69' ' ' LEU . 33.4 mtm180 -71.97 5.51 2.62 Favored 'General case' 0 CA--C 1.512 -0.516 0 N-CA-C 104.996 -2.224 . . . . 1.0 104.996 174.032 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . 0.643 ' H ' ' C ' ' A' ' 66' ' ' GLY . 7.9 tt -31.76 -29.13 0.01 OUTLIER 'General case' 0 N--CA 1.473 0.686 0 O-C-N 124.11 0.881 . . . . 1.0 108.948 -177.417 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . 0.647 ' N ' ' O ' ' A' ' 67' ' ' ARG . 1.3 mt -64.35 -65.66 0.65 Allowed 'General case' 0 C--N 1.322 -0.628 0 C-N-CA 119.341 -0.943 . . . . 1.0 108.825 178.895 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . 0.622 ' O ' ' N ' ' A' ' 72' ' ' HIS . . . -78.62 -76.68 0.19 Allowed 'General case' 0 N--CA 1.47 0.554 0 N-CA-C 106.376 -1.712 . . . . 1.0 106.376 177.793 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . 0.482 ' O ' ' C ' ' A' ' 72' ' ' HIS . . . -43.06 4.13 0.0 OUTLIER 'General case' 0 C--N 1.326 -0.437 0 N-CA-C 114.336 1.235 . . . . 1.0 114.336 177.906 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 72' ' ' HIS . . . . . 0.682 ' CD2' ' H ' ' A' ' 73' ' ' MET . 1.4 p80 -32.21 -53.8 0.3 Allowed 'General case' 0 N--CA 1.467 0.407 0 CA-C-N 120.126 1.33 . . . . 1.0 112.11 -177.851 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 73' ' ' MET . . . . . 0.682 ' H ' ' CD2' ' A' ' 72' ' ' HIS . 4.9 tpp -73.57 -56.85 4.5 Favored 'General case' 0 C--N 1.331 -0.219 0 N-CA-C 108.017 -1.105 . . . . 1.0 108.017 177.926 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . 0.758 ' C ' ' H ' ' A' ' 76' ' ' GLY . 62.1 t -45.47 -42.72 3.44 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.319 0 CA-C-O 116.964 -1.493 . . . . 1.0 111.316 -176.515 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 75' ' ' ASN . . . . . 0.485 ' C ' ' N ' ' A' ' 77' ' ' ILE . 1.2 m-20 -36.55 -13.84 0.0 OUTLIER 'General case' 0 N--CA 1.501 2.078 0 CA-C-N 121.77 2.077 . . . . 1.0 111.318 177.907 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . 0.758 ' H ' ' C ' ' A' ' 74' ' ' VAL . . . -49.12 -20.7 2.19 Favored Glycine 0 CA--C 1.535 1.321 0 N-CA-C 106.624 -2.591 . . . . 1.0 106.624 173.035 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . 0.512 ' O ' ' N ' ' A' ' 81' ' ' GLU . 25.4 pt -61.21 -48.81 87.29 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.925 0 CA-C-O 117.043 -1.456 . . . . 1.0 112.159 -179.114 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 9.9 p -57.5 -18.49 9.22 Favored 'Isoleucine or valine' 0 C--N 1.363 1.162 0 CA-C-N 122.925 2.602 . . . . 1.0 113.069 179.444 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -89.67 -38.63 11.38 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 N-CA-C 107.042 -1.466 . . . . 1.0 107.042 177.904 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -80.9 -16.67 52.96 Favored 'General case' 0 CA--C 1.538 0.483 0 CA-C-N 114.822 -1.081 . . . . 1.0 113.496 178.589 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . 0.512 ' N ' ' O ' ' A' ' 77' ' ' ILE . 48.2 tt0 -93.68 -71.94 0.63 Allowed 'General case' 0 N--CA 1.448 -0.543 0 CA-C-N 118.882 0.764 . . . . 1.0 112.47 -178.385 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 25.2 m-20 -89.29 -15.82 32.61 Favored 'General case' 0 CA--C 1.549 0.907 0 N-CA-C 115.717 1.747 . . . . 1.0 115.717 -178.137 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . 0.497 ' O ' ' N ' ' A' ' 86' ' ' ALA . . . -54.51 -44.94 73.17 Favored 'General case' 0 N--CA 1.475 0.802 0 C-N-CA 118.747 -1.181 . . . . 1.0 111.897 -177.821 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -40.0 -28.74 0.06 Allowed 'General case' 0 CA--C 1.54 0.588 0 CA-C-N 119.141 0.882 . . . . 1.0 111.119 179.686 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 85' ' ' ILE . . . . . 0.421 ' N ' ' O ' ' A' ' 83' ' ' ALA . 68.1 mt -83.75 -37.13 12.99 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.509 0 CA-C-N 116.543 -0.298 . . . . 1.0 110.884 178.419 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . 0.497 ' N ' ' O ' ' A' ' 83' ' ' ALA . . . -93.41 -26.83 17.06 Favored 'General case' 0 N--CA 1.471 0.623 0 CA-C-O 120.863 0.363 . . . . 1.0 111.324 179.855 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . 0.567 ' C ' ' H ' ' A' ' 89' ' ' VAL . 40.6 tp10 -54.26 -11.31 0.48 Allowed 'General case' 0 C--N 1.324 -0.514 0 CA-C-O 121.134 0.492 . . . . 1.0 110.081 -179.456 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . 0.459 ' H ' ' C ' ' A' ' 86' ' ' ALA . . . -74.8 2.25 10.57 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-O 122.439 1.114 . . . . 1.0 108.342 178.382 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 89' ' ' VAL . . . . . 0.567 ' H ' ' C ' ' A' ' 87' ' ' GLU . 2.1 m -114.5 36.21 0.84 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.516 0 CA-C-N 112.766 -2.015 . . . . 1.0 110.334 178.914 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 90' ' ' GLY . . . . . 0.593 ' N ' ' CD ' ' A' ' 91' ' ' PRO . . . -77.59 -37.66 30.15 Favored Glycine 0 CA--C 1.534 1.26 0 N-CA-C 110.548 -1.021 . . . . 1.0 110.548 179.032 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 91' ' ' PRO . . . . . 0.593 ' CD ' ' N ' ' A' ' 90' ' ' GLY . 77.1 Cg_exo -50.63 -7.87 0.13 Allowed 'Trans proline' 0 N--CA 1.499 1.823 0 C-N-CA 122.459 2.106 . . . . 1.0 110.552 178.513 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 92' ' ' HIS . . . . . 0.697 ' NE2' ' NH2' ' A' ' 52' ' ' ARG . 0.2 OUTLIER -56.38 -12.22 1.57 Allowed 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 114.211 -1.359 . . . . 1.0 107.847 178.805 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . 0.519 ' H ' ' C ' ' A' ' 91' ' ' PRO . 1.7 pp -68.34 -59.57 3.09 Favored 'General case' 0 CA--C 1.528 0.107 0 CA-C-N 115.493 -0.776 . . . . 1.0 109.172 178.158 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 94' ' ' ALA . . . . . 0.412 ' H ' ' HG ' ' A' ' 93' ' ' LEU . . . -58.22 -50.06 74.89 Favored 'General case' 0 CA--C 1.52 -0.208 0 C-N-CA 120.017 -0.673 . . . . 1.0 109.363 179.761 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 95' ' ' ARG . . . . . 0.594 ' O ' ' N ' ' A' ' 97' ' ' LEU . 17.2 tpt180 -56.72 -57.62 11.64 Favored 'General case' 0 CA--C 1.534 0.335 0 CA-C-O 123.034 1.397 . . . . 1.0 107.609 179.314 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 96' ' ' ALA . . . . . 1.046 ' O ' ' N ' ' A' ' 98' ' ' GLY . . . -49.21 -9.62 0.03 OUTLIER 'General case' 0 C--N 1.304 -1.403 0 O-C-N 118.643 -2.536 . . . . 1.0 111.126 179.395 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . 0.72 ' O ' ' N ' ' A' ' 100' ' ' ILE . 0.0 OUTLIER 8.23 -47.81 0.0 OUTLIER 'General case' 0 N--CA 1.498 1.969 0 CA-C-O 117.361 -1.304 . . . . 1.0 109.105 -166.703 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 98' ' ' GLY . . . . . 1.046 ' N ' ' O ' ' A' ' 96' ' ' ALA . . . -48.03 -24.13 3.08 Favored Glycine 0 CA--C 1.551 2.313 0 CA-C-N 122.975 2.625 . . . . 1.0 107.071 171.998 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 99' ' ' GLN . . . . . 0.485 ' N ' ' O ' ' A' ' 96' ' ' ALA . 5.7 mm100 -69.82 -24.32 63.45 Favored 'General case' 0 C--N 1.386 2.17 0 C-N-CA 117.863 -1.535 . . . . 1.0 107.759 175.701 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 100' ' ' ILE . . . . . 0.72 ' N ' ' O ' ' A' ' 97' ' ' LEU . 10.2 mt -65.48 -45.61 92.32 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.837 0 C-N-CA 119.829 -0.748 . . . . 1.0 109.107 177.209 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 101' ' ' VAL . . . . . 0.699 ' O ' ' N ' ' A' ' 105' ' ' GLY . 21.7 t -55.23 -60.73 1.41 Allowed 'Isoleucine or valine' 0 C--O 1.214 -0.806 0 N-CA-C 108.065 -1.087 . . . . 1.0 108.065 178.723 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 102' ' ' CYS . . . . . 0.475 ' O ' ' HB1' ' A' ' 106' ' ' ALA . 0.5 OUTLIER -49.91 -22.16 1.42 Allowed 'General case' 0 C--O 1.204 -1.325 0 N-CA-C 112.768 0.655 . . . . 1.0 112.768 -179.163 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 58.8 ttt-85 -89.09 -48.13 7.62 Favored 'General case' 0 N--CA 1.485 1.292 0 CA-C-O 123.229 1.49 . . . . 1.0 112.194 179.418 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 104' ' ' TYR . . . . . 0.664 ' CG ' ' O ' ' A' ' 104' ' ' TYR . 0.0 OUTLIER -98.52 25.31 6.49 Favored 'General case' 0 C--N 1.297 -1.684 0 CA-C-N 111.663 -2.517 . . . . 1.0 107.157 177.849 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 105' ' ' GLY . . . . . 0.699 ' N ' ' O ' ' A' ' 101' ' ' VAL . . . -167.59 -100.61 0.14 Allowed Glycine 0 N--CA 1.441 -0.972 0 N-CA-C 108.725 -1.75 . . . . 1.0 108.725 179.363 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 106' ' ' ALA . . . . . 0.475 ' HB1' ' O ' ' A' ' 102' ' ' CYS . . . 73.6 59.14 0.09 Allowed 'General case' 0 N--CA 1.442 -0.827 0 CA-C-O 119.262 -0.399 . . . . 1.0 111.22 -178.6 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -80.11 5.37 14.49 Favored 'General case' 0 CA--C 1.51 -0.594 0 O-C-N 119.764 -1.835 . . . . 1.0 106.319 176.341 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . 0.416 ' H ' ' C ' ' A' ' 106' ' ' ALA . 17.4 m -83.77 -53.52 11.03 Favored 'Isoleucine or valine' 0 C--N 1.347 0.472 0 C-N-CA 120.338 -0.545 . . . . 1.0 110.591 178.138 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 109' ' ' ILE . . . . . 0.484 ' O ' ' CB ' ' A' ' 113' ' ' ASN . 0.1 OUTLIER -49.02 -37.7 21.01 Favored Pre-proline 0 N--CA 1.472 0.666 0 N-CA-C 115.308 1.596 . . . . 1.0 115.308 -176.894 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_exo -51.52 -49.36 17.43 Favored 'Trans proline' 0 C--N 1.311 -1.433 0 CA-C-N 122.386 1.888 . . . . 1.0 113.126 -176.475 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 87.2 m-20 -70.7 -69.05 0.39 Allowed 'General case' 0 CA--C 1.53 0.199 0 C-N-CA 118.829 -1.148 . . . . 1.0 110.915 -178.833 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 6.4 pt -46.22 -28.37 0.86 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.467 0 CA-C-O 121.826 0.822 . . . . 1.0 109.736 -179.477 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 113' ' ' ASN . . . . . 0.484 ' CB ' ' O ' ' A' ' 109' ' ' ILE . 34.2 t30 -61.92 -55.15 32.57 Favored 'General case' 0 CA--C 1.506 -0.733 0 CA-C-N 114.301 -1.318 . . . . 1.0 107.811 -178.976 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -61.98 -36.5 81.64 Favored 'General case' 0 N--CA 1.439 -0.976 0 CA-C-N 118.86 0.755 . . . . 1.0 112.387 -179.036 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -75.48 -58.92 2.99 Favored 'General case' 0 C--N 1.349 0.557 0 CA-C-N 120.402 1.455 . . . . 1.0 110.114 179.572 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 116' ' ' ILE . . . . . 0.537 ' O ' ' N ' ' A' ' 120' ' ' GLY . 5.0 mm -49.37 -48.87 18.63 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.663 0 CA-C-O 121.619 0.723 . . . . 1.0 109.182 -178.173 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 117' ' ' GLU . . . . . 0.485 ' C ' ' O ' ' A' ' 116' ' ' ILE . 37.7 tt0 -39.96 -60.74 0.97 Allowed 'General case' 0 C--O 1.215 -0.735 0 N-CA-C 106.213 -1.773 . . . . 1.0 106.213 179.279 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 94.2 t -59.14 -53.96 40.85 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.873 0 CA-C-N 114.973 -1.012 . . . . 1.0 109.824 178.559 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -53.09 -71.44 0.07 Allowed 'General case' 0 CA--C 1.552 1.021 0 N-CA-C 108.087 -1.079 . . . . 1.0 108.087 -178.395 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 120' ' ' GLY . . . . . 0.537 ' N ' ' O ' ' A' ' 116' ' ' ILE . . . -66.68 -76.85 0.33 Allowed Glycine 0 CA--C 1.538 1.502 0 C-N-CA 119.54 -1.314 . . . . 1.0 110.635 179.713 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 121' ' ' THR . . . . . 0.522 ' CB ' ' O ' ' A' ' 120' ' ' GLY . 2.2 m 145.43 -29.16 0.01 OUTLIER 'General case' 0 N--CA 1.486 1.359 0 CA-C-N 111.516 -2.342 . . . . 1.0 111.015 -178.451 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 122' ' ' GLY . . . . . 0.625 ' O ' ' N ' ' A' ' 124' ' ' ASP . . . 106.6 -16.12 41.0 Favored Glycine 0 C--O 1.226 -0.372 0 N-CA-C 107.763 -2.135 . . . . 1.0 107.763 -176.541 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 12.6 t -59.65 82.23 0.01 OUTLIER 'General case' 0 CA--C 1.537 0.471 0 N-CA-C 107.02 -1.474 . . . . 1.0 107.02 178.94 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 124' ' ' ASP . . . . . 0.625 ' N ' ' O ' ' A' ' 122' ' ' GLY . 27.8 m-20 -163.5 172.27 14.69 Favored 'General case' 0 N--CA 1.453 -0.302 0 CA-C-N 112.074 -2.33 . . . . 1.0 110.745 178.859 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 125' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -143.9 142.04 30.58 Favored 'General case' 0 C--N 1.32 -0.691 0 N-CA-C 107.298 -1.371 . . . . 1.0 107.298 175.846 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 1.3 tpm_? -149.67 152.0 34.63 Favored 'General case' 0 C--N 1.33 -0.244 0 N-CA-C 110.111 -0.329 . . . . 1.0 110.111 178.772 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 127' ' ' PHE . . . . . . . . . . . . . 2.4 p90 . . . . . 0 N--CA 1.471 0.585 0 CA-C-O 117.874 -1.06 . . . . 1.0 111.12 -179.86 . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 128' ' ' MTN . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 129' ' ' MTN . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 130' ' ' MTN . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.404 ' N ' ' SD ' ' A' ' 1' ' ' MET . 4.7 mmt . . . . . 0 N--CA 1.491 1.613 0 N-CA-C 109.686 -0.487 . . . . 1.0 109.686 . . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 34.6 t -107.45 5.06 26.88 Favored 'General case' 0 N--CA 1.467 0.422 0 CA-C-N 116.11 -0.495 . . . . 1.0 110.273 179.33 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 1.3 p30 173.96 94.59 0.01 OUTLIER 'General case' 0 CA--C 1.53 0.182 0 CA-C-N 116.032 -0.531 . . . . 1.0 111.823 -179.893 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . 0.429 ' O ' ' OD1' ' A' ' 5' ' ' ASP . 1.4 t80 -151.27 146.75 26.26 Favored 'General case' 0 N--CA 1.464 0.255 0 CA-C-N 116.341 -0.39 . . . . 1.0 110.25 178.937 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 5' ' ' ASP . . . . . 0.429 ' OD1' ' O ' ' A' ' 4' ' ' PHE . 0.0 OUTLIER -155.95 151.95 27.61 Favored 'General case' 0 CA--C 1.538 0.51 0 N-CA-C 109.453 -0.573 . . . . 1.0 109.453 179.523 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 6' ' ' THR . . . . . 0.71 ' O ' ' N ' ' A' ' 10' ' ' SER . 0.3 OUTLIER -69.24 168.5 14.04 Favored 'General case' 0 C--O 1.204 -1.339 0 CA-C-N 116.206 -0.452 . . . . 1.0 110.143 -179.234 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . 0.563 ' O ' ' N ' ' A' ' 11' ' ' ARG . 0.9 OUTLIER -58.14 -60.11 4.26 Favored 'General case' 0 C--N 1.317 -0.82 0 CA-C-O 121.352 0.596 . . . . 1.0 109.567 -177.646 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 8' ' ' ARG . . . . . 0.49 ' HG2' ' N ' ' A' ' 9' ' ' VAL . 0.0 OUTLIER -49.23 -53.78 19.84 Favored 'General case' 0 CA--C 1.545 0.751 0 N-CA-C 107.637 -1.245 . . . . 1.0 107.637 -178.304 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . 0.574 ' O ' ' CG2' ' A' ' 13' ' ' VAL . 0.0 OUTLIER -66.97 -50.64 62.68 Favored 'Isoleucine or valine' 0 C--O 1.196 -1.734 0 CA-C-N 115.155 -0.93 . . . . 1.0 109.794 179.294 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 10' ' ' SER . . . . . 0.71 ' N ' ' O ' ' A' ' 6' ' ' THR . 25.6 t -62.83 -63.79 1.11 Allowed 'General case' 0 C--N 1.313 -0.985 0 C-N-CA 119.595 -0.842 . . . . 1.0 111.055 -179.582 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 11' ' ' ARG . . . . . 0.563 ' N ' ' O ' ' A' ' 7' ' ' GLU . 38.2 ttm-85 -65.9 -61.35 2.11 Favored 'General case' 0 N--CA 1.466 0.366 0 C-N-CA 120.463 -0.495 . . . . 1.0 111.88 -175.945 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . 0.446 ' CB ' ' O ' ' A' ' 8' ' ' ARG . . . -48.66 -47.49 40.54 Favored 'General case' 0 N--CA 1.474 0.739 0 N-CA-C 107.257 -1.386 . . . . 1.0 107.257 -177.868 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . 0.615 ' O ' ' N ' ' A' ' 17' ' ' LEU . 84.2 t -62.24 -51.04 77.21 Favored 'Isoleucine or valine' 0 C--O 1.205 -1.241 0 C-N-CA 118.548 -1.261 . . . . 1.0 108.187 177.098 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . 0.476 ' O ' ' N ' ' A' ' 18' ' ' VAL . . . -55.94 -61.29 2.47 Favored 'General case' 0 C--O 1.21 -1.023 0 C-N-CA 117.933 -1.507 . . . . 1.0 108.775 -179.712 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . 0.579 ' O ' ' N ' ' A' ' 19' ' ' GLY . . . -52.17 -54.56 29.2 Favored 'General case' 0 N--CA 1.47 0.564 0 CA-C-O 121.467 0.651 . . . . 1.0 109.855 -178.849 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . 0.432 ' CB ' ' O ' ' A' ' 12' ' ' ALA . . . -63.73 -57.23 10.61 Favored 'General case' 0 C--N 1.316 -0.877 0 CA-C-N 114.994 -1.003 . . . . 1.0 109.943 -179.011 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . 0.615 ' N ' ' O ' ' A' ' 13' ' ' VAL . 1.2 tt -57.0 -53.29 59.71 Favored 'General case' 0 C--N 1.315 -0.916 0 CA-C-N 114.51 -1.223 . . . . 1.0 108.017 -177.85 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . 0.661 HG21 ' H ' ' A' ' 19' ' ' GLY . 2.4 m -68.57 -58.44 5.86 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.526 0 C-N-CA 119.446 -0.902 . . . . 1.0 109.592 178.923 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . 0.661 ' H ' HG21 ' A' ' 18' ' ' VAL . . . -55.7 -169.31 0.07 OUTLIER Glycine 0 C--O 1.213 -1.179 0 N-CA-C 110.287 -1.125 . . . . 1.0 110.287 -179.515 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 20' ' ' PRO . . . . . 0.465 ' O ' ' N ' ' A' ' 24' ' ' ALA . 1.9 Cg_endo -78.96 -32.55 1.84 Allowed 'Trans proline' 0 C--N 1.305 -1.721 0 C-N-CA 123.114 2.543 . . . . 1.0 114.625 -178.524 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -60.19 -57.88 16.89 Favored Glycine 0 N--CA 1.478 1.48 0 C-N-CA 120.164 -1.017 . . . . 1.0 113.348 -176.192 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . 0.408 ' N ' ' O ' ' A' ' 16' ' ' ALA . . . -55.37 -51.76 52.24 Favored Glycine 0 N--CA 1.469 0.867 0 N-CA-C 107.401 -2.28 . . . . 1.0 107.401 -176.851 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . 0.598 ' CG2' ' O ' ' A' ' 19' ' ' GLY . 0.1 OUTLIER -60.81 -31.45 49.52 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.999 0 N-CA-C 108.692 -0.855 . . . . 1.0 108.692 178.277 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . 0.465 ' N ' ' O ' ' A' ' 20' ' ' PRO . . . -58.11 -62.07 2.09 Favored 'General case' 0 C--N 1.34 0.17 0 C-N-CA 117.766 -1.573 . . . . 1.0 109.487 -179.655 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . 0.438 ' CD2' ' H ' ' A' ' 25' ' ' LEU . 0.0 OUTLIER -62.95 -46.35 88.15 Favored 'General case' 0 CA--C 1.53 0.209 0 O-C-N 121.377 -0.827 . . . . 1.0 111.599 -178.168 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 79.5 t -57.49 -57.99 7.95 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 C-N-CA 119.562 -0.855 . . . . 1.0 109.338 -178.033 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . 0.451 ' O ' ' CB ' ' A' ' 31' ' ' ALA . 49.0 t -60.64 -37.27 75.09 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.65 0 CA-C-O 120.663 0.268 . . . . 1.0 110.743 -178.977 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . 0.434 ' CG ' ' O ' ' A' ' 24' ' ' ALA . 32.5 mmtt -65.91 -56.6 10.94 Favored 'General case' 0 CA--C 1.513 -0.453 0 C-N-CA 119.693 -0.803 . . . . 1.0 109.662 -178.573 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 94.7 t -63.37 -48.21 88.31 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.011 0 CA-C-N 114.365 -1.289 . . . . 1.0 109.942 -177.624 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 30' ' ' CYS . . . . . . . . . . . . . 20.2 t -66.33 -61.1 2.19 Favored 'General case' 0 N--CA 1.443 -0.814 0 C-N-CA 118.936 -1.106 . . . . 1.0 110.372 -179.417 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . 0.451 ' CB ' ' O ' ' A' ' 27' ' ' VAL . . . -63.1 -52.0 64.37 Favored 'General case' 0 CA--C 1.514 -0.434 0 N-CA-C 112.057 0.392 . . . . 1.0 112.057 -176.583 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . 0.423 ' O ' ' HB2' ' A' ' 33' ' ' LEU . . . 82.31 69.26 1.4 Allowed Glycine 0 CA--C 1.521 0.447 0 N-CA-C 109.696 -1.362 . . . . 1.0 109.696 -178.978 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . 0.491 ' O ' ' O ' ' A' ' 36' ' ' VAL . 3.9 mt 90.38 82.97 0.04 OUTLIER Pre-proline 0 N--CA 1.475 0.795 0 C-N-CA 123.565 0.746 . . . . 1.0 111.858 179.583 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 53.0 Cg_exo -54.89 -25.85 45.7 Favored 'Trans proline' 0 N--CA 1.499 1.796 0 C-N-CA 123.008 2.472 . . . . 1.0 112.73 178.562 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -57.15 -58.96 11.88 Favored Glycine 0 CA--C 1.531 1.06 0 N-CA-C 108.86 -1.696 . . . . 1.0 108.86 -179.349 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . 0.555 ' O ' ' CB ' ' A' ' 37' ' ' ILE . 14.1 p -98.09 169.44 1.51 Allowed 'Isoleucine or valine' 0 C--O 1.219 -0.516 0 N-CA-C 106.602 -1.629 . . . . 1.0 106.602 176.71 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . 0.555 ' CB ' ' O ' ' A' ' 36' ' ' VAL . 8.9 tt 117.14 116.52 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.486 1.337 0 O-C-N 124.532 1.145 . . . . 1.0 110.366 -179.725 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 38' ' ' HIS . . . . . 0.496 ' CD2' ' N ' ' A' ' 38' ' ' HIS . 0.4 OUTLIER -138.03 129.13 27.34 Favored 'General case' 0 N--CA 1.463 0.193 0 N-CA-C 108.215 -1.031 . . . . 1.0 108.215 178.983 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 12.8 m -99.53 133.22 22.05 Favored Pre-proline 0 C--N 1.328 -0.367 0 N-CA-C 109.049 -0.722 . . . . 1.0 109.049 179.251 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 42.1 Cg_endo -66.33 -96.3 0.0 OUTLIER 'Trans proline' 0 N--CA 1.492 1.423 0 C-N-CA 120.926 1.084 . . . . 1.0 111.827 -179.451 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -62.48 123.78 19.22 Favored 'General case' 0 C--N 1.319 -0.748 0 CA-C-N 115.895 -0.593 . . . . 1.0 110.092 -179.06 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . 0.622 ' C ' ' H ' ' A' ' 44' ' ' GLY . 2.8 mmm-85 -169.75 167.32 9.46 Favored 'General case' 0 C--N 1.32 -0.713 0 N-CA-C 108.798 -0.816 . . . . 1.0 108.798 179.332 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 43' ' ' ARG . . . . . 0.575 ' HG3' ' O ' ' A' ' 45' ' ' PHE . 0.3 OUTLIER -66.48 26.71 0.02 OUTLIER 'General case' 0 C--N 1.316 -0.857 0 CA-C-N 115.157 -0.929 . . . . 1.0 110.721 179.696 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . 0.622 ' H ' ' C ' ' A' ' 42' ' ' ARG . . . 80.68 -26.19 3.21 Favored Glycine 0 CA--C 1.528 0.883 0 N-CA-C 111.677 -0.569 . . . . 1.0 111.677 179.758 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . 0.741 ' CG ' ' N ' ' A' ' 46' ' ' PHE . 0.5 OUTLIER -174.88 175.36 2.38 Favored 'General case' 0 C--O 1.2 -1.531 0 C-N-CA 120.888 -0.325 . . . . 1.0 110.95 -179.157 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 46' ' ' PHE . . . . . 0.741 ' N ' ' CG ' ' A' ' 45' ' ' PHE . 13.8 t80 161.13 13.86 0.0 OUTLIER 'General case' 0 N--CA 1.478 0.964 0 CA-C-N 116.296 -0.411 . . . . 1.0 110.997 176.429 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 47' ' ' ARG . . . . . 0.48 ' C ' ' SG ' ' A' ' 48' ' ' CYS . 3.9 mtp180 -175.64 169.24 3.08 Favored 'General case' 0 C--N 1.325 -0.462 0 C-N-CA 119.831 -0.748 . . . . 1.0 110.692 -178.61 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 48' ' ' CYS . . . . . 0.48 ' SG ' ' C ' ' A' ' 47' ' ' ARG . 1.2 m 72.62 69.32 0.13 Allowed 'General case' 0 N--CA 1.452 -0.373 0 N-CA-C 108.246 -1.02 . . . . 1.0 108.246 -178.437 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 49' ' ' ASN . . . . . 0.687 ' N ' ' OD1' ' A' ' 49' ' ' ASN . 0.0 OUTLIER -132.21 123.76 18.97 Favored Pre-proline 0 N--CA 1.468 0.472 0 CA-C-O 118.628 -0.701 . . . . 1.0 109.465 -179.215 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . 0.589 ' O ' ' CD ' ' A' ' 51' ' ' GLU . 75.0 Cg_exo -45.82 68.82 0.01 OUTLIER 'Trans proline' 0 N--CA 1.495 1.597 0 C-N-CA 121.928 1.752 . . . . 1.0 114.992 179.98 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . 0.668 ' N ' ' O ' ' A' ' 49' ' ' ASN . 10.3 pm0 62.98 23.39 13.99 Favored 'General case' 0 N--CA 1.472 0.653 0 C-N-CA 123.251 0.62 . . . . 1.0 112.365 -179.305 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 25.4 mtp85 -103.65 159.39 15.65 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 120.934 0.397 . . . . 1.0 111.71 -178.926 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . 0.479 ' O ' ' N ' ' A' ' 55' ' ' ILE . 6.8 tp -75.15 137.51 22.83 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.167 0 CA-C-O 120.95 0.405 . . . . 1.0 110.916 -179.657 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 54' ' ' GLN . . . . . 0.439 ' OE1' ' O ' ' A' ' 46' ' ' PHE . 28.0 mt-30 -60.85 81.78 0.01 OUTLIER 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.763 -0.653 . . . . 1.0 110.935 -176.507 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . 0.479 ' N ' ' O ' ' A' ' 53' ' ' ILE . 11.1 tt -148.58 158.8 6.98 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.358 0 CA-C-N 115.684 -0.689 . . . . 1.0 110.453 177.69 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 111.98 -2.3 27.13 Favored Glycine 0 N--CA 1.468 0.826 0 N-CA-C 111.277 -0.729 . . . . 1.0 111.277 -179.566 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . 0.503 ' OD2' ' NH1' ' A' ' 43' ' ' ARG . 1.6 p-10 -80.91 97.6 7.49 Favored 'General case' 0 CA--C 1.516 -0.338 0 C-N-CA 119.968 -0.693 . . . . 1.0 109.307 178.281 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 58' ' ' TRP . . . . . . . . . . . . . 6.2 m0 -88.62 173.09 8.82 Favored 'General case' 0 C--N 1.319 -0.741 0 CA-C-O 122.8 1.286 . . . . 1.0 112.526 -178.146 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -85.26 -60.31 2.07 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 111.896 -2.411 . . . . 1.0 113.306 -178.433 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 75.2 t80 -90.83 -16.95 27.4 Favored 'General case' 0 N--CA 1.479 1.025 0 N-CA-C 113.74 1.015 . . . . 1.0 113.74 -178.883 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . 0.516 ' O ' ' N ' ' A' ' 65' ' ' ASP . 0.0 OUTLIER -77.91 -13.16 59.98 Favored 'General case' 0 C--N 1.318 -0.8 0 O-C-N 121.92 -0.487 . . . . 1.0 110.304 -179.149 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . 0.604 ' O ' ' N ' ' A' ' 66' ' ' GLY . 2.5 m -47.17 -55.45 1.96 Allowed 'Isoleucine or valine' 0 C--O 1.209 -1.074 0 C-N-CA 119.442 -0.903 . . . . 1.0 110.12 -176.431 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -67.2 -50.97 58.91 Favored 'General case' 0 C--N 1.307 -1.271 0 O-C-N 121.325 -0.859 . . . . 1.0 110.443 179.959 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 64' ' ' HIS . . . . . 0.479 ' O ' ' HB2' ' A' ' 67' ' ' ARG . 0.5 OUTLIER -56.3 -56.94 14.88 Favored 'General case' 0 CA--C 1.54 0.594 0 C-N-CA 119.192 -1.003 . . . . 1.0 109.359 -179.953 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . 0.604 ' C ' ' H ' ' A' ' 67' ' ' ARG . 25.7 t70 -72.34 -53.04 13.49 Favored 'General case' 0 C--N 1.316 -0.887 0 O-C-N 121.486 -0.759 . . . . 1.0 110.601 178.556 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . 0.604 ' N ' ' O ' ' A' ' 62' ' ' VAL . . . -65.25 30.35 0.12 Allowed Glycine 0 CA--C 1.526 0.753 0 O-C-N 121.151 -0.968 . . . . 1.0 111.457 179.051 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 67' ' ' ARG . . . . . 0.604 ' H ' ' C ' ' A' ' 65' ' ' ASP . 7.6 ttt85 -81.19 1.27 32.79 Favored 'General case' 0 C--N 1.32 -0.71 0 N-CA-C 107.34 -1.356 . . . . 1.0 107.34 175.662 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . 0.537 ' N ' ' OD1' ' A' ' 75' ' ' ASN . 2.1 pt? -39.52 -31.14 0.08 Allowed 'General case' 0 C--N 1.35 0.617 0 CA-C-O 121.275 0.56 . . . . 1.0 109.837 -178.459 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . 0.414 ' H ' HD22 ' A' ' 68' ' ' LEU . 4.3 tt -67.91 -68.58 0.38 Allowed 'General case' 0 CA--C 1.545 0.753 0 C-N-CA 119.32 -0.952 . . . . 1.0 112.65 -175.782 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . 0.554 ' C ' ' H ' ' A' ' 72' ' ' HIS . . . -73.6 -78.42 0.09 Allowed 'General case' 0 N--CA 1.474 0.76 0 C-N-CA 118.653 -1.219 . . . . 1.0 109.878 -176.981 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . 0.809 ' O ' ' N ' ' A' ' 73' ' ' MET . . . -62.43 14.82 0.01 OUTLIER 'General case' 0 C--N 1.318 -0.779 0 C-N-CA 125.964 1.705 . . . . 1.0 112.55 179.221 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 72' ' ' HIS . . . . . 0.554 ' H ' ' C ' ' A' ' 70' ' ' ALA . 52.8 p-80 -19.02 -29.68 0.0 OUTLIER 'General case' 0 N--CA 1.468 0.452 0 N-CA-C 114.056 1.132 . . . . 1.0 114.056 -174.744 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 73' ' ' MET . . . . . 0.809 ' N ' ' O ' ' A' ' 71' ' ' ALA . 20.9 mtt -66.25 -54.91 19.38 Favored 'General case' 0 C--N 1.318 -0.789 0 C-N-CA 119.118 -1.033 . . . . 1.0 109.336 176.123 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . 0.634 ' O ' ' N ' ' A' ' 76' ' ' GLY . 34.6 m -43.57 -52.95 1.13 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.579 0 CA-C-O 117.298 -1.334 . . . . 1.0 111.614 -174.74 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 75' ' ' ASN . . . . . 0.537 ' OD1' ' N ' ' A' ' 68' ' ' LEU . 3.4 m120 -38.53 -19.79 0.01 OUTLIER 'General case' 0 N--CA 1.482 1.138 0 CA-C-N 120.603 1.547 . . . . 1.0 110.992 -179.666 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . 0.634 ' N ' ' O ' ' A' ' 74' ' ' VAL . . . -48.22 -24.45 3.51 Favored Glycine 0 CA--C 1.532 1.141 0 N-CA-C 107.214 -2.354 . . . . 1.0 107.214 176.664 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . 0.54 ' O ' ' N ' ' A' ' 81' ' ' GLU . 24.1 pt -59.02 -43.21 88.44 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.056 0 C-N-CA 119.722 -0.791 . . . . 1.0 110.941 -179.309 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . 0.419 ' CG2' ' OD1' ' A' ' 65' ' ' ASP . 60.6 t -56.64 -25.25 20.94 Favored 'Isoleucine or valine' 0 C--O 1.24 0.601 0 CA-C-N 121.708 2.049 . . . . 1.0 114.147 -178.887 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . 0.413 HG13 ' N ' ' A' ' 80' ' ' ALA . 0.8 OUTLIER -91.08 -37.09 8.78 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.452 0 N-CA-C 108.005 -1.109 . . . . 1.0 108.005 178.804 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 80' ' ' ALA . . . . . 0.413 ' N ' HG13 ' A' ' 79' ' ' ILE . . . -79.8 -17.54 53.13 Favored 'General case' 0 CA--C 1.545 0.772 0 CA-C-N 115.469 -0.787 . . . . 1.0 112.033 178.927 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . 0.54 ' N ' ' O ' ' A' ' 77' ' ' ILE . 62.5 mm-40 -91.91 -67.36 0.86 Allowed 'General case' 0 N--CA 1.447 -0.582 0 O-C-N 121.748 -0.595 . . . . 1.0 110.581 178.492 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 82' ' ' ASP . . . . . 0.519 ' O ' ' C ' ' A' ' 83' ' ' ALA . 1.5 m-20 -72.2 -18.06 61.88 Favored 'General case' 0 N--CA 1.45 -0.464 0 O-C-N 121.11 -0.994 . . . . 1.0 112.794 -178.272 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . 0.519 ' C ' ' O ' ' A' ' 82' ' ' ASP . . . -21.08 -51.31 0.01 OUTLIER 'General case' 0 N--CA 1.479 0.998 0 CA-C-N 119.048 0.84 . . . . 1.0 112.464 178.656 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . 0.46 ' N ' ' O ' ' A' ' 82' ' ' ASP . 3.6 mm? -31.94 -39.64 0.03 OUTLIER 'General case' 0 N--CA 1.479 0.988 0 N-CA-C 111.805 0.298 . . . . 1.0 111.805 -176.627 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 67.9 mt -94.95 -40.36 11.09 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.452 0 CA-C-O 120.896 0.379 . . . . 1.0 110.764 178.407 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -53.64 -59.33 4.74 Favored 'General case' 0 CA--C 1.533 0.309 0 CA-C-N 115.951 -0.568 . . . . 1.0 111.537 -178.159 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 15.1 pt-20 -62.32 -14.21 36.97 Favored 'General case' 0 CA--C 1.518 -0.276 0 C-N-CA 120.96 -0.296 . . . . 1.0 110.681 -178.996 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -77.18 -18.92 57.41 Favored 'General case' 0 C--N 1.325 -0.497 0 N-CA-C 108.586 -0.894 . . . . 1.0 108.586 179.109 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 89' ' ' VAL . . . . . 0.431 ' O ' ' OE2' ' A' ' 51' ' ' GLU . 35.6 m -113.97 35.19 0.91 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.22 0 CA-C-N 113.61 -1.632 . . . . 1.0 110.781 178.705 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 90' ' ' GLY . . . . . 0.623 ' C ' ' H ' ' A' ' 92' ' ' HIS . . . -69.61 -33.44 71.78 Favored Glycine 0 C--N 1.351 1.407 0 CA-C-O 119.205 -0.775 . . . . 1.0 111.99 178.243 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 91' ' ' PRO . . . . . 0.552 ' CD ' ' N ' ' A' ' 90' ' ' GLY . 78.6 Cg_exo -45.57 -4.0 0.02 OUTLIER 'Trans proline' 0 N--CA 1.501 1.941 0 C-N-CA 122.379 2.053 . . . . 1.0 112.659 177.703 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 92' ' ' HIS . . . . . 0.639 ' ND1' ' N ' ' A' ' 93' ' ' LEU . 0.0 OUTLIER -49.31 -15.52 0.14 Allowed 'General case' 0 N--CA 1.448 -0.531 0 O-C-N 123.794 0.684 . . . . 1.0 110.047 -178.718 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . 0.639 ' N ' ' ND1' ' A' ' 92' ' ' HIS . 1.7 pp -66.28 -58.06 6.17 Favored 'General case' 0 N--CA 1.445 -0.692 0 N-CA-C 108.892 -0.781 . . . . 1.0 108.892 177.095 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 94' ' ' ALA . . . . . 0.563 ' H ' ' HG ' ' A' ' 93' ' ' LEU . . . -59.77 -58.19 9.64 Favored 'General case' 0 N--CA 1.449 -0.489 0 N-CA-C 109.959 -0.386 . . . . 1.0 109.959 179.725 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 95' ' ' ARG . . . . . 0.613 ' O ' ' N ' ' A' ' 97' ' ' LEU . 0.0 OUTLIER -61.47 -63.53 1.24 Allowed 'General case' 0 N--CA 1.449 -0.492 0 CA-C-O 121.428 0.632 . . . . 1.0 109.572 -178.592 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 96' ' ' ALA . . . . . 0.957 ' O ' ' N ' ' A' ' 98' ' ' GLY . . . -49.44 -11.08 0.04 OUTLIER 'General case' 0 N--CA 1.438 -1.064 0 O-C-N 118.791 -2.443 . . . . 1.0 111.266 -178.911 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . 0.745 ' O ' ' N ' ' A' ' 100' ' ' ILE . 0.3 OUTLIER 5.89 -48.0 0.0 OUTLIER 'General case' 0 N--CA 1.487 1.419 0 C-N-CA 124.426 1.09 . . . . 1.0 110.38 -167.96 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 98' ' ' GLY . . . . . 0.957 ' N ' ' O ' ' A' ' 96' ' ' ALA . . . -51.35 -24.28 10.28 Favored Glycine 0 C--N 1.286 -2.214 0 N-CA-C 106.488 -2.645 . . . . 1.0 106.488 173.273 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 99' ' ' GLN . . . . . 0.689 ' O ' ' S1 ' ' A' ' 130' ' ' MTN . 35.1 mt-30 -65.57 -23.16 66.79 Favored 'General case' 0 C--N 1.377 1.766 0 N-CA-C 105.94 -1.874 . . . . 1.0 105.94 175.983 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 100' ' ' ILE . . . . . 0.745 ' N ' ' O ' ' A' ' 97' ' ' LEU . 1.4 tp -64.59 -37.06 79.11 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.21 0 C-N-CA 118.87 -1.132 . . . . 1.0 108.118 178.884 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 101' ' ' VAL . . . . . 0.711 ' O ' ' N ' ' A' ' 105' ' ' GLY . 88.1 t -57.62 -63.13 0.71 Allowed 'Isoleucine or valine' 0 C--O 1.216 -0.704 0 C-N-CA 119.923 -0.711 . . . . 1.0 109.687 178.713 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 102' ' ' CYS . . . . . 0.448 ' SG ' ' HA ' ' A' ' 99' ' ' GLN . 0.9 OUTLIER -49.22 -17.34 0.23 Allowed 'General case' 0 CA--C 1.545 0.754 0 C-N-CA 118.36 -1.336 . . . . 1.0 111.579 -178.446 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 24.0 ttm180 -89.64 -46.71 8.44 Favored 'General case' 0 N--CA 1.479 0.998 0 CA-C-O 122.573 1.178 . . . . 1.0 111.851 178.275 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 104' ' ' TYR . . . . . 0.622 ' CG ' ' O ' ' A' ' 104' ' ' TYR . 0.0 OUTLIER -104.47 21.83 16.01 Favored 'General case' 0 CA--C 1.549 0.931 0 CA-C-N 112.684 -2.053 . . . . 1.0 110.208 178.262 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 105' ' ' GLY . . . . . 0.756 ' O ' ' N ' ' A' ' 107' ' ' THR . . . -168.26 -12.5 0.02 OUTLIER Glycine 0 C--N 1.345 1.03 0 C-N-CA 118.523 -1.798 . . . . 1.0 113.969 178.769 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 106' ' ' ALA . . . . . 0.447 ' CB ' ' O ' ' A' ' 102' ' ' CYS . . . -20.08 64.8 0.0 OUTLIER 'General case' 0 N--CA 1.479 0.98 0 N-CA-C 114.671 1.36 . . . . 1.0 114.671 -179.601 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 107' ' ' THR . . . . . 0.756 ' N ' ' O ' ' A' ' 105' ' ' GLY . 96.4 m -102.28 -4.96 24.84 Favored 'General case' 0 N--CA 1.447 -0.585 0 N-CA-C 107.532 -1.285 . . . . 1.0 107.532 177.008 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 16.9 m -95.59 11.69 4.36 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.511 0 CA-C-N 116.084 -0.507 . . . . 1.0 110.053 176.325 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 109' ' ' ILE . . . . . 0.717 ' H ' ' CD ' ' A' ' 110' ' ' PRO . 0.1 OUTLIER -112.81 -27.94 0.12 Allowed Pre-proline 0 CA--C 1.555 1.161 0 CA-C-N 119.187 0.903 . . . . 1.0 111.64 177.523 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 110' ' ' PRO . . . . . 0.717 ' CD ' ' H ' ' A' ' 109' ' ' ILE . 48.7 Cg_endo -65.86 -37.41 27.36 Favored 'Trans proline' 0 N--CA 1.496 1.643 0 C-N-CA 122.827 2.351 . . . . 1.0 113.579 -173.19 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 34.3 t30 -64.57 -67.95 0.39 Allowed 'General case' 0 CA--C 1.507 -0.686 0 C-N-CA 119.061 -1.056 . . . . 1.0 109.078 -178.186 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 112' ' ' ILE . . . . . 0.575 ' O ' ' N ' ' A' ' 116' ' ' ILE . 6.3 pt -52.01 -42.54 34.64 Favored 'Isoleucine or valine' 0 C--O 1.209 -1.038 0 CA-C-O 122.065 0.936 . . . . 1.0 108.857 179.907 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 113' ' ' ASN . . . . . 0.544 ' N ' ' CG1' ' A' ' 112' ' ' ILE . 2.8 m120 -50.19 -53.57 26.98 Favored 'General case' 0 C--N 1.315 -0.922 0 CA-C-N 113.929 -1.487 . . . . 1.0 108.745 -176.738 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 114' ' ' ALA . . . . . 0.444 ' O ' ' CG2' ' A' ' 118' ' ' VAL . . . -62.97 -34.36 77.35 Favored 'General case' 0 C--N 1.311 -1.083 0 O-C-N 121.035 -1.04 . . . . 1.0 112.501 179.551 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -84.63 -60.02 2.19 Favored 'General case' 0 N--CA 1.471 0.605 0 CA-C-N 118.672 0.669 . . . . 1.0 112.684 179.095 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 116' ' ' ILE . . . . . 0.693 HG22 ' H ' ' A' ' 117' ' ' GLU . 9.9 tt -54.57 -61.87 0.89 Allowed 'Isoleucine or valine' 0 C--O 1.223 -0.313 0 CA-C-N 115.336 -0.847 . . . . 1.0 108.795 -176.998 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 117' ' ' GLU . . . . . 0.693 ' H ' HG22 ' A' ' 116' ' ' ILE . 98.2 mt-10 -45.46 -49.3 13.58 Favored 'General case' 0 C--N 1.314 -0.935 0 N-CA-C 106.501 -1.666 . . . . 1.0 106.501 -178.236 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 118' ' ' VAL . . . . . 0.444 ' CG2' ' O ' ' A' ' 114' ' ' ALA . 23.8 t -62.77 -30.18 48.8 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.689 0 CA-C-O 118.88 -0.581 . . . . 1.0 109.913 178.164 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 119' ' ' LEU . . . . . 0.562 ' N ' ' O ' ' A' ' 116' ' ' ILE . 14.3 tp -80.66 -63.01 1.5 Allowed 'General case' 0 C--N 1.351 0.653 0 CA-C-N 120.028 1.285 . . . . 1.0 108.032 178.548 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 120' ' ' GLY . . . . . 0.465 ' N ' ' O ' ' A' ' 116' ' ' ILE . . . -61.65 -86.81 0.04 OUTLIER Glycine 0 N--CA 1.434 -1.462 0 C-N-CA 117.991 -2.052 . . . . 1.0 108.415 177.839 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 121' ' ' THR . . . . . 0.405 ' HG1' ' HB ' ' A' ' 123' ' ' THR . 0.0 OUTLIER 171.96 -41.4 0.01 OUTLIER 'General case' 0 C--N 1.316 -0.849 0 CA-C-N 113.947 -1.127 . . . . 1.0 113.755 179.737 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 122' ' ' GLY . . . . . 0.651 ' O ' ' N ' ' A' ' 124' ' ' ASP . . . 102.17 -16.78 55.18 Favored Glycine 0 N--CA 1.472 1.069 0 N-CA-C 108.015 -2.034 . . . . 1.0 108.015 -176.959 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 123' ' ' THR . . . . . 0.536 ' O ' ' CG2' ' A' ' 123' ' ' THR . 1.7 t -52.62 86.84 0.0 OUTLIER 'General case' 0 CA--C 1.538 0.505 0 N-CA-C 105.479 -2.045 . . . . 1.0 105.479 179.063 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 124' ' ' ASP . . . . . 0.651 ' N ' ' O ' ' A' ' 122' ' ' GLY . 37.5 m-20 -164.48 171.65 14.35 Favored 'General case' 0 CA--C 1.522 -0.107 0 CA-C-N 114.107 -1.406 . . . . 1.0 112.018 -178.462 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 125' ' ' TYR . . . . . . . . . . . . . 26.1 t80 -148.38 145.42 28.06 Favored 'General case' 0 CA--C 1.536 0.415 0 CA-C-N 114.785 -1.098 . . . . 1.0 108.633 175.678 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 126' ' ' ARG . . . . . 0.404 HH21 ' CG2' ' A' ' 79' ' ' ILE . 2.6 mmp_? -145.5 149.4 34.56 Favored 'General case' 0 N--CA 1.474 0.765 0 N-CA-C 109.5 -0.556 . . . . 1.0 109.5 178.16 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 127' ' ' PHE . . . . . . . . . . . . . 40.4 p90 . . . . . 0 C--O 1.22 -0.454 0 CA-C-O 118.086 -0.959 . . . . 1.0 110.709 179.713 . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 128' ' ' MTN . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 129' ' ' MTN . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 130' ' ' MTN . . . . . 0.689 ' S1 ' ' O ' ' A' ' 99' ' ' GLN . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.511 ' C ' ' H ' ' A' ' 3' ' ' ASP . 57.9 mtt . . . . . 0 N--CA 1.493 1.68 0 N-CA-C 108.902 -0.777 . . . . 1.0 108.902 . . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 2' ' ' SER . . . . . 0.531 ' O ' ' CG ' ' A' ' 3' ' ' ASP . 6.9 t -69.44 10.01 0.4 Allowed 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.309 -0.405 . . . . 1.0 111.013 178.915 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . 0.531 ' CG ' ' O ' ' A' ' 2' ' ' SER . 80.9 m-20 138.3 142.82 0.0 OUTLIER 'General case' 0 N--CA 1.486 1.326 0 O-C-N 124.564 1.165 . . . . 1.0 109.954 179.075 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 60.9 t80 -156.4 152.5 27.6 Favored 'General case' 0 N--CA 1.463 0.225 0 CA-C-N 115.932 -0.576 . . . . 1.0 110.642 179.341 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 69.9 m-20 -150.07 146.19 26.8 Favored 'General case' 0 CA--C 1.534 0.334 0 N-CA-C 109.09 -0.707 . . . . 1.0 109.09 179.435 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 6' ' ' THR . . . . . 0.802 ' O ' ' N ' ' A' ' 10' ' ' SER . 0.2 OUTLIER -87.74 177.67 6.95 Favored 'General case' 0 C--O 1.194 -1.859 0 CA-C-O 121.094 0.473 . . . . 1.0 111.314 -178.702 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . 0.413 ' O ' ' N ' ' A' ' 11' ' ' ARG . 7.7 tm-20 -56.54 -58.18 9.15 Favored 'General case' 0 C--N 1.312 -1.052 0 CA-C-O 121.687 0.755 . . . . 1.0 110.932 -177.894 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 8' ' ' ARG . . . . . 0.426 ' O ' ' CB ' ' A' ' 12' ' ' ALA . 48.6 ttp85 -55.01 -57.28 12.32 Favored 'General case' 0 C--N 1.318 -0.777 0 CA-C-N 114.089 -1.414 . . . . 1.0 107.8 -178.02 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . 0.645 ' O ' ' HB ' ' A' ' 13' ' ' VAL . 0.0 OUTLIER -66.31 -54.06 30.14 Favored 'Isoleucine or valine' 0 C--O 1.188 -2.164 0 CA-C-N 114.499 -1.228 . . . . 1.0 110.655 178.883 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 10' ' ' SER . . . . . 0.802 ' N ' ' O ' ' A' ' 6' ' ' THR . 11.0 t -67.03 -64.58 0.82 Allowed 'General case' 0 N--CA 1.486 1.369 0 CA-C-N 118.769 0.713 . . . . 1.0 112.406 -178.132 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 11' ' ' ARG . . . . . 0.511 ' O ' ' N ' ' A' ' 15' ' ' ALA . 6.7 tpt180 -63.57 -59.07 5.1 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-O 121.083 0.468 . . . . 1.0 111.371 -175.104 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . 0.488 ' O ' ' CB ' ' A' ' 16' ' ' ALA . . . -51.58 -46.76 63.61 Favored 'General case' 0 C--N 1.322 -0.619 0 N-CA-C 106.512 -1.662 . . . . 1.0 106.512 -176.022 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . 0.659 ' O ' ' N ' ' A' ' 17' ' ' LEU . 67.6 t -62.3 -50.99 77.72 Favored 'Isoleucine or valine' 0 C--O 1.2 -1.532 0 CA-C-N 114.664 -1.153 . . . . 1.0 107.931 177.499 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . 0.547 ' O ' HG23 ' A' ' 18' ' ' VAL . . . -57.17 -62.39 1.79 Allowed 'General case' 0 C--O 1.207 -1.138 0 C-N-CA 117.335 -1.746 . . . . 1.0 109.097 -178.723 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . 0.589 ' O ' ' N ' ' A' ' 19' ' ' GLY . . . -53.73 -53.91 45.57 Favored 'General case' 0 C--O 1.215 -0.753 0 O-C-N 123.843 0.714 . . . . 1.0 109.703 -178.684 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . 0.488 ' CB ' ' O ' ' A' ' 12' ' ' ALA . . . -63.8 -57.8 8.8 Favored 'General case' 0 N--CA 1.474 0.738 0 C-N-CA 120.022 -0.671 . . . . 1.0 110.215 -179.737 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . 0.659 ' N ' ' O ' ' A' ' 13' ' ' VAL . 6.1 tt -55.91 -54.53 43.61 Favored 'General case' 0 N--CA 1.48 1.072 0 CA-C-N 114.752 -1.113 . . . . 1.0 108.012 -178.013 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . 0.735 HG23 ' H ' ' A' ' 19' ' ' GLY . 2.2 m -69.39 -58.34 5.91 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 C-N-CA 119.374 -0.93 . . . . 1.0 109.104 179.913 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . 0.735 ' H ' HG23 ' A' ' 18' ' ' VAL . . . -54.97 -167.11 0.03 OUTLIER Glycine 0 C--O 1.225 -0.44 0 N-CA-C 111.298 -0.721 . . . . 1.0 111.298 -178.276 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 20' ' ' PRO . . . . . 0.673 ' O ' ' N ' ' A' ' 24' ' ' ALA . 74.0 Cg_endo -83.6 -28.97 1.19 Allowed 'Trans proline' 0 C--N 1.296 -2.184 0 C-N-CA 122.73 2.287 . . . . 1.0 112.556 -178.582 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -62.11 -59.63 9.24 Favored Glycine 0 N--CA 1.475 1.24 0 C-N-CA 119.508 -1.33 . . . . 1.0 111.902 -176.671 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . 0.459 ' N ' ' O ' ' A' ' 16' ' ' ALA . . . -55.72 -51.17 56.83 Favored Glycine 0 N--CA 1.47 0.909 0 N-CA-C 106.503 -2.639 . . . . 1.0 106.503 -178.608 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 38.3 t -60.41 -32.58 51.47 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.607 0 C-N-CA 119.493 -0.883 . . . . 1.0 109.19 178.415 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . 0.673 ' N ' ' O ' ' A' ' 20' ' ' PRO . . . -59.37 -63.85 1.15 Allowed 'General case' 0 C--N 1.349 0.552 0 C-N-CA 118.761 -1.176 . . . . 1.0 110.425 -178.709 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 19.5 mt -62.18 -44.19 97.15 Favored 'General case' 0 CA--C 1.509 -0.63 0 C-N-CA 119.581 -0.848 . . . . 1.0 110.845 -177.878 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 71.1 t -57.88 -60.4 2.23 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.695 0 C-N-CA 119.004 -1.078 . . . . 1.0 110.012 -178.186 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . 0.421 ' O ' ' CB ' ' A' ' 31' ' ' ALA . 1.4 p -60.46 -36.07 67.18 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-O 120.81 0.338 . . . . 1.0 111.645 -178.31 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 21.6 ttpp -65.72 -56.27 12.93 Favored 'General case' 0 C--N 1.321 -0.673 0 N-CA-C 109.004 -0.739 . . . . 1.0 109.004 -179.645 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 94.6 t -61.06 -47.7 92.38 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.614 0 CA-C-N 115.001 -1.0 . . . . 1.0 109.743 -178.328 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 30' ' ' CYS . . . . . 0.659 ' SG ' ' N ' ' A' ' 31' ' ' ALA . 0.0 OUTLIER -66.1 -60.38 2.87 Favored 'General case' 0 C--N 1.326 -0.446 0 C-N-CA 118.79 -1.164 . . . . 1.0 110.132 -179.511 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . 0.659 ' N ' ' SG ' ' A' ' 30' ' ' CYS . . . -60.43 -50.98 71.42 Favored 'General case' 0 CA--C 1.507 -0.697 0 C-N-CA 120.986 -0.286 . . . . 1.0 111.093 -176.003 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . 0.53 ' O ' ' CB ' ' A' ' 33' ' ' LEU . . . 78.23 69.58 1.38 Allowed Glycine 0 N--CA 1.448 -0.541 0 N-CA-C 109.516 -1.434 . . . . 1.0 109.516 -178.616 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . 0.53 ' CB ' ' O ' ' A' ' 32' ' ' GLY . 1.2 tt 90.31 77.21 0.04 OUTLIER Pre-proline 0 CA--C 1.534 0.359 0 CA-C-N 115.176 -0.512 . . . . 1.0 110.388 -179.58 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 58.8 Cg_exo -50.47 -23.09 9.95 Favored 'Trans proline' 0 N--CA 1.492 1.415 0 C-N-CA 122.839 2.359 . . . . 1.0 112.491 179.578 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -58.03 -61.08 7.84 Favored Glycine 0 CA--C 1.538 1.53 0 C-N-CA 119.102 -1.523 . . . . 1.0 109.538 -178.616 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . 0.545 ' O ' ' CB ' ' A' ' 37' ' ' ILE . 13.5 p -94.93 171.73 1.1 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.651 0 N-CA-C 107.108 -1.441 . . . . 1.0 107.108 176.901 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . 0.545 ' CB ' ' O ' ' A' ' 36' ' ' VAL . 4.1 mm 112.79 113.54 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.484 1.249 0 O-C-N 124.614 1.196 . . . . 1.0 110.009 -179.73 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 16.9 m-70 -139.98 133.58 30.27 Favored 'General case' 0 C--N 1.332 -0.17 0 N-CA-C 108.651 -0.87 . . . . 1.0 108.651 179.2 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 11.4 m -107.84 109.79 62.27 Favored Pre-proline 0 N--CA 1.469 0.492 0 N-CA-C 109.975 -0.38 . . . . 1.0 109.975 179.99 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 40' ' ' PRO . . . . . 0.449 ' HB2' ' H ' ' A' ' 41' ' ' ALA . 79.0 Cg_exo -42.6 -90.9 0.0 OUTLIER 'Trans proline' 0 N--CA 1.493 1.444 0 C-N-CA 121.471 1.447 . . . . 1.0 112.252 -179.127 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . 0.449 ' H ' ' HB2' ' A' ' 40' ' ' PRO . . . -65.56 125.02 23.89 Favored 'General case' 0 C--N 1.324 -0.541 0 N-CA-C 109.447 -0.575 . . . . 1.0 109.447 -179.389 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 34.5 ptt180 -174.2 177.05 2.37 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.205 -0.452 . . . . 1.0 110.617 179.394 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 4.3 tpp180 -58.58 -45.55 88.83 Favored 'General case' 0 C--N 1.324 -0.53 0 N-CA-C 107.965 -1.124 . . . . 1.0 107.965 178.711 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 122.24 -25.11 6.77 Favored Glycine 0 N--CA 1.471 1.016 0 N-CA-C 111.134 -0.786 . . . . 1.0 111.134 -179.788 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . 0.5 ' O ' ' HB2' ' A' ' 46' ' ' PHE . 64.7 t80 -149.98 153.66 36.93 Favored 'General case' 0 N--CA 1.466 0.368 0 N-CA-C 107.726 -1.213 . . . . 1.0 107.726 176.812 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 46' ' ' PHE . . . . . 0.732 ' O ' ' HB2' ' A' ' 47' ' ' ARG . 2.1 m-85 128.59 95.99 0.0 OUTLIER 'General case' 0 N--CA 1.481 1.109 0 C-N-CA 126.054 1.742 . . . . 1.0 108.317 -178.735 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 47' ' ' ARG . . . . . 0.732 ' HB2' ' O ' ' A' ' 46' ' ' PHE . 0.1 OUTLIER 118.16 137.79 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.825 0 C-N-CA 124.766 1.227 . . . . 1.0 110.151 179.308 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 5.4 t 71.07 78.64 0.17 Allowed 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 116.074 -0.512 . . . . 1.0 110.413 179.287 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 49' ' ' ASN . . . . . 0.523 ' O ' ' N ' ' A' ' 51' ' ' GLU . 9.4 p30 -144.66 145.43 28.23 Favored Pre-proline 0 C--N 1.324 -0.515 0 CA-C-N 115.632 -0.713 . . . . 1.0 110.838 179.753 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . 0.502 ' HD2' HH12 ' A' ' 52' ' ' ARG . 20.5 Cg_endo -61.27 55.48 0.1 Allowed 'Trans proline' 0 N--CA 1.494 1.524 0 C-N-CA 121.979 1.786 . . . . 1.0 113.239 179.901 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . 0.523 ' N ' ' O ' ' A' ' 49' ' ' ASN . 2.3 mp0 65.9 68.34 0.46 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.679 -0.691 . . . . 1.0 111.497 177.967 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . 0.502 HH12 ' HD2' ' A' ' 50' ' ' PRO . 7.8 mtm-85 -145.95 153.57 40.95 Favored 'General case' 0 N--CA 1.467 0.379 0 CA-C-N 115.685 -0.689 . . . . 1.0 110.468 179.157 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . 0.519 ' O ' ' N ' ' A' ' 55' ' ' ILE . 12.3 pt -65.65 127.99 27.72 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 CA-C-N 115.829 -0.623 . . . . 1.0 111.073 179.799 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 54' ' ' GLN . . . . . 0.769 HE21 ' H ' ' A' ' 54' ' ' GLN . 0.0 OUTLIER -57.74 85.49 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 121.426 0.632 . . . . 1.0 109.714 -177.367 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . 0.519 ' N ' ' O ' ' A' ' 53' ' ' ILE . 0.5 OUTLIER -146.83 159.17 9.96 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.157 0 CA-C-N 115.066 -0.97 . . . . 1.0 110.043 178.269 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 114.23 0.61 23.75 Favored Glycine 0 C--N 1.332 0.36 0 N-CA-C 110.178 -1.169 . . . . 1.0 110.178 -178.183 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . 0.432 ' O ' ' CG ' ' A' ' 57' ' ' ASP . 13.2 p-10 -80.82 93.57 6.27 Favored 'General case' 0 N--CA 1.455 -0.197 0 C-N-CA 119.379 -0.929 . . . . 1.0 109.845 178.791 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 58' ' ' TRP . . . . . . . . . . . . . 10.8 m0 -88.7 169.21 11.86 Favored 'General case' 0 CA--C 1.547 0.856 0 CA-C-O 122.618 1.199 . . . . 1.0 111.63 -178.103 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 59' ' ' ARG . . . . . 0.472 ' CG ' ' H ' ' A' ' 60' ' ' TYR . 6.8 ptt85 -83.86 -60.91 1.96 Allowed 'General case' 0 C--N 1.31 -1.129 0 CA-C-N 112.119 -2.309 . . . . 1.0 113.5 -178.495 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 60' ' ' TYR . . . . . 0.472 ' H ' ' CG ' ' A' ' 59' ' ' ARG . 0.0 OUTLIER -89.19 -18.26 27.48 Favored 'General case' 0 C--O 1.248 0.998 0 N-CA-C 113.167 0.803 . . . . 1.0 113.167 -179.005 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . 0.519 ' O ' ' N ' ' A' ' 65' ' ' ASP . 25.0 tt0 -71.14 -12.95 61.77 Favored 'General case' 0 C--N 1.31 -1.149 0 O-C-N 121.973 -0.454 . . . . 1.0 110.662 -177.86 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . 0.566 ' O ' ' N ' ' A' ' 66' ' ' GLY . 17.0 m -45.13 -56.26 0.96 Allowed 'Isoleucine or valine' 0 C--N 1.309 -1.188 0 C-N-CA 120.121 -0.632 . . . . 1.0 110.025 -175.124 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 63' ' ' ALA . . . . . 0.434 ' H ' ' CG2' ' A' ' 62' ' ' VAL . . . -65.91 -49.84 66.59 Favored 'General case' 0 N--CA 1.428 -1.53 0 CA-C-O 121.349 0.595 . . . . 1.0 109.435 179.728 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 1.8 t60 -54.04 -59.95 3.98 Favored 'General case' 0 CA--C 1.547 0.849 0 C-N-CA 119.474 -0.891 . . . . 1.0 109.934 -179.747 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . 0.576 ' C ' ' H ' ' A' ' 67' ' ' ARG . 2.6 t70 -66.94 -54.72 19.2 Favored 'General case' 0 C--O 1.244 0.808 0 CA-C-O 121.848 0.832 . . . . 1.0 110.729 177.851 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . 0.566 ' N ' ' O ' ' A' ' 62' ' ' VAL . . . -65.72 27.74 0.14 Allowed Glycine 0 CA--C 1.524 0.617 0 O-C-N 121.163 -0.961 . . . . 1.0 112.489 179.078 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 67' ' ' ARG . . . . . 0.718 ' O ' ' N ' ' A' ' 69' ' ' LEU . 1.1 mtt-85 -76.43 -1.11 25.44 Favored 'General case' 0 C--N 1.322 -0.619 0 N-CA-C 108.72 -0.844 . . . . 1.0 108.72 175.775 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . 0.48 ' C ' ' O ' ' A' ' 67' ' ' ARG . 0.8 OUTLIER -32.39 -26.01 0.0 OUTLIER 'General case' 0 N--CA 1.488 1.44 0 N-CA-C 107.732 -1.21 . . . . 1.0 107.732 -177.486 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . 0.718 ' N ' ' O ' ' A' ' 67' ' ' ARG . 20.0 tp -66.91 -67.67 0.43 Allowed 'General case' 0 CA--C 1.548 0.875 0 C-N-CA 119.342 -0.943 . . . . 1.0 108.853 177.029 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . 0.702 ' C ' ' H ' ' A' ' 72' ' ' HIS . . . -78.1 -73.45 0.31 Allowed 'General case' 0 N--CA 1.472 0.653 0 N-CA-C 107.577 -1.268 . . . . 1.0 107.577 179.084 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . 0.476 ' O ' ' C ' ' A' ' 72' ' ' HIS . . . -48.02 5.51 0.0 OUTLIER 'General case' 0 N--CA 1.469 0.522 0 C-N-CA 124.273 1.029 . . . . 1.0 112.261 177.81 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 72' ' ' HIS . . . . . 0.702 ' H ' ' C ' ' A' ' 70' ' ' ALA . 0.0 OUTLIER -21.87 -75.92 0.01 OUTLIER 'General case' 0 CA--C 1.516 -0.351 0 C-N-CA 123.332 0.653 . . . . 1.0 112.328 -177.956 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 73' ' ' MET . . . . . 0.657 ' H ' ' CG ' ' A' ' 72' ' ' HIS . 57.9 mtm -69.29 -45.31 69.94 Favored 'General case' 0 C--N 1.311 -1.097 0 C-N-CA 118.692 -1.203 . . . . 1.0 109.463 178.065 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . 0.729 ' O ' ' N ' ' A' ' 76' ' ' GLY . 85.3 t -41.1 -42.27 0.67 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.384 0 CA-C-O 118.604 -0.712 . . . . 1.0 110.167 -176.553 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 75' ' ' ASN . . . . . 0.479 ' C ' ' N ' ' A' ' 77' ' ' ILE . 1.0 OUTLIER -36.66 -15.58 0.0 OUTLIER 'General case' 0 N--CA 1.48 1.067 0 CA-C-O 121.497 0.665 . . . . 1.0 110.721 178.363 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . 0.729 ' N ' ' O ' ' A' ' 74' ' ' VAL . . . -43.92 -20.14 0.14 Allowed Glycine 0 CA--C 1.539 1.549 0 N-CA-C 108.734 -1.747 . . . . 1.0 108.734 176.971 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . 0.627 ' O ' ' N ' ' A' ' 80' ' ' ALA . 0.2 OUTLIER -73.45 -50.33 31.28 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.14 0 CA-C-O 122.274 1.035 . . . . 1.0 108.524 178.85 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . 0.472 ' N ' ' O ' ' A' ' 75' ' ' ASN . 93.5 t -35.54 -36.3 0.08 OUTLIER 'Isoleucine or valine' 0 CA--C 1.553 1.083 0 CA-C-N 112.092 -2.322 . . . . 1.0 107.956 -176.254 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . 0.53 HG13 ' O ' ' A' ' 76' ' ' GLY . 1.4 pp -95.37 -24.97 4.59 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.852 0 CA-C-N 116.195 -0.457 . . . . 1.0 111.355 177.614 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 80' ' ' ALA . . . . . 0.627 ' N ' ' O ' ' A' ' 77' ' ' ILE . . . -80.67 -14.96 57.69 Favored 'General case' 0 N--CA 1.475 0.779 0 O-C-N 122.261 -0.274 . . . . 1.0 111.564 179.278 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 33.1 tt0 -81.17 -67.88 0.74 Allowed 'General case' 0 N--CA 1.444 -0.74 0 N-CA-C 109.448 -0.575 . . . . 1.0 109.448 177.668 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 82' ' ' ASP . . . . . 0.815 ' O ' ' N ' ' A' ' 84' ' ' LEU . 89.1 m-20 -59.35 -60.52 3.73 Favored 'General case' 0 CA--C 1.504 -0.801 0 C-N-CA 119.075 -1.05 . . . . 1.0 109.039 -179.454 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . 0.527 ' O ' ' N ' ' A' ' 86' ' ' ALA . . . 22.83 -68.21 0.0 OUTLIER 'General case' 0 N--CA 1.484 1.235 0 O-C-N 124.852 1.345 . . . . 1.0 111.386 -179.957 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . 0.815 ' N ' ' O ' ' A' ' 82' ' ' ASP . 4.8 tt -29.31 -45.3 0.04 OUTLIER 'General case' 0 N--CA 1.478 0.95 0 C-N-CA 123.512 0.725 . . . . 1.0 112.666 -178.288 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 3.3 pt -91.12 -36.55 8.21 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.87 0 N-CA-C 109.384 -0.598 . . . . 1.0 109.384 178.081 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . 0.604 ' C ' ' H ' ' A' ' 88' ' ' ALA . . . -51.16 -55.78 16.13 Favored 'General case' 0 CA--C 1.534 0.34 0 C-N-CA 120.42 -0.512 . . . . 1.0 110.086 -178.749 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 27.3 mt-10 -61.55 5.66 0.07 Allowed 'General case' 0 C--N 1.326 -0.419 0 C-N-CA 120.656 -0.417 . . . . 1.0 110.664 -179.433 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . 0.604 ' H ' ' C ' ' A' ' 86' ' ' ALA . . . -105.76 -23.98 12.6 Favored 'General case' 0 C--O 1.237 0.4 0 CA-C-N 116.402 -0.363 . . . . 1.0 110.506 179.55 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 9.3 m -88.63 -8.79 10.9 Favored 'Isoleucine or valine' 0 C--O 1.236 0.367 0 CA-C-N 115.98 -0.555 . . . . 1.0 109.716 179.307 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -40.92 -49.67 4.21 Favored Glycine 0 CA--C 1.535 1.301 0 CA-C-O 119.466 -0.63 . . . . 1.0 111.633 -177.999 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 85.7 Cg_exo -45.38 -27.83 3.48 Favored 'Trans proline' 0 N--CA 1.495 1.608 0 CA-C-N 120.072 1.936 . . . . 1.0 112.052 177.726 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 92' ' ' HIS . . . . . 0.492 ' ND1' ' HG2' ' A' ' 51' ' ' GLU . 25.9 t-80 -56.36 -33.91 66.13 Favored 'General case' 0 C--O 1.22 -0.476 0 N-CA-C 107.849 -1.167 . . . . 1.0 107.849 -177.607 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . 0.636 ' CD2' ' H ' ' A' ' 94' ' ' ALA . 0.5 OUTLIER -42.45 -51.85 4.85 Favored 'General case' 0 N--CA 1.473 0.697 0 C-N-CA 120.375 -0.53 . . . . 1.0 109.592 -179.833 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 94' ' ' ALA . . . . . 0.636 ' H ' ' CD2' ' A' ' 93' ' ' LEU . . . -56.1 -53.9 51.51 Favored 'General case' 0 N--CA 1.449 -0.513 0 N-CA-C 107.998 -1.112 . . . . 1.0 107.998 178.877 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 95' ' ' ARG . . . . . 0.592 ' O ' ' N ' ' A' ' 97' ' ' LEU . 0.2 OUTLIER -51.3 -58.57 5.83 Favored 'General case' 0 C--O 1.241 0.649 0 CA-C-O 123.358 1.551 . . . . 1.0 107.075 177.614 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 96' ' ' ALA . . . . . 0.85 ' O ' ' N ' ' A' ' 98' ' ' GLY . . . -49.24 -11.88 0.05 OUTLIER 'General case' 0 N--CA 1.427 -1.622 0 O-C-N 118.731 -2.481 . . . . 1.0 110.895 -179.842 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . 0.66 ' O ' ' N ' ' A' ' 100' ' ' ILE . 0.4 OUTLIER 4.79 -49.52 0.0 OUTLIER 'General case' 0 CA--C 1.511 -0.549 0 C-N-CA 124.9 1.28 . . . . 1.0 112.865 -170.101 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 98' ' ' GLY . . . . . 0.85 ' N ' ' O ' ' A' ' 96' ' ' ALA . . . -53.24 -22.41 14.43 Favored Glycine 0 N--CA 1.426 -2.008 0 N-CA-C 107.817 -2.113 . . . . 1.0 107.817 174.806 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 99' ' ' GLN . . . . . 0.596 ' O ' ' HG3' ' A' ' 103' ' ' ARG . 15.2 mm100 -71.54 -22.95 61.69 Favored 'General case' 0 CA--C 1.5 -0.975 0 C-N-CA 116.551 -2.06 . . . . 1.0 107.127 177.576 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 100' ' ' ILE . . . . . 0.66 ' N ' ' O ' ' A' ' 97' ' ' LEU . 2.8 tt -66.05 -34.78 72.54 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.135 0 O-C-N 124.797 1.311 . . . . 1.0 109.453 178.779 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 101' ' ' VAL . . . . . 0.557 ' CG1' ' N ' ' A' ' 102' ' ' CYS . 0.4 OUTLIER -57.96 -57.97 8.32 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 N-CA-C 106.852 -1.536 . . . . 1.0 106.852 -178.757 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 102' ' ' CYS . . . . . 0.557 ' N ' ' CG1' ' A' ' 101' ' ' VAL . 0.1 OUTLIER -48.99 -28.89 4.23 Favored 'General case' 0 N--CA 1.441 -0.883 0 CA-C-N 115.224 -0.898 . . . . 1.0 110.078 178.954 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 103' ' ' ARG . . . . . 0.596 ' HG3' ' O ' ' A' ' 99' ' ' GLN . 74.7 mtt-85 -72.58 -56.61 5.09 Favored 'General case' 0 N--CA 1.478 0.972 0 O-C-N 123.984 0.803 . . . . 1.0 110.085 179.063 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 104' ' ' TYR . . . . . 0.712 ' HD1' ' O ' ' A' ' 104' ' ' TYR . 0.5 OUTLIER -90.34 25.77 2.13 Favored 'General case' 0 CA--C 1.494 -1.187 0 C-N-CA 125.435 1.494 . . . . 1.0 108.44 177.291 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 105' ' ' GLY . . . . . 0.529 ' N ' ' O ' ' A' ' 101' ' ' VAL . . . -155.43 -91.02 0.08 OUTLIER Glycine 0 N--CA 1.443 -0.841 0 C-N-CA 118.793 -1.67 . . . . 1.0 109.86 176.932 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 106' ' ' ALA . . . . . 0.472 ' O ' ' O ' ' A' ' 105' ' ' GLY . . . 58.18 114.36 0.01 OUTLIER 'General case' 0 CA--C 1.551 0.993 0 N-CA-C 108.92 -0.77 . . . . 1.0 108.92 -179.309 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 107' ' ' THR . . . . . 0.76 ' O ' ' HD2' ' A' ' 110' ' ' PRO . 5.2 m -134.7 -54.4 0.82 Allowed 'General case' 0 N--CA 1.481 1.115 0 N-CA-C 108.548 -0.908 . . . . 1.0 108.548 178.751 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . 0.525 ' O ' ' N ' ' A' ' 111' ' ' ASN . 16.7 m -70.85 -43.82 76.63 Favored 'Isoleucine or valine' 0 C--N 1.348 0.53 0 CA-C-O 121.993 0.901 . . . . 1.0 108.873 -179.574 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 109' ' ' ILE . . . . . 0.488 ' N ' ' CD ' ' A' ' 110' ' ' PRO . 0.0 OUTLIER -39.06 -46.72 3.62 Favored Pre-proline 0 CA--C 1.553 1.065 0 CA-C-N 114.2 -1.364 . . . . 1.0 109.919 -178.179 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 110' ' ' PRO . . . . . 0.76 ' HD2' ' O ' ' A' ' 107' ' ' THR . 28.1 Cg_exo -64.43 -24.27 64.27 Favored 'Trans proline' 0 N--CA 1.504 2.108 0 C-N-CA 124.44 3.427 . . . . 1.0 111.871 177.675 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 111' ' ' ASN . . . . . 0.525 ' N ' ' O ' ' A' ' 108' ' ' VAL . 2.9 t-20 -62.3 -69.04 0.28 Allowed 'General case' 0 C--O 1.236 0.374 0 CA-C-N 115.996 -0.547 . . . . 1.0 109.74 -179.007 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 112' ' ' ILE . . . . . 0.505 ' O ' ' N ' ' A' ' 115' ' ' ALA . 0.0 OUTLIER -67.43 -36.55 76.78 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.538 0 CA-C-O 121.924 0.869 . . . . 1.0 110.13 178.777 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 113' ' ' ASN . . . . . 0.419 ' O ' ' HB3' ' A' ' 117' ' ' GLU . 10.3 t30 -48.27 -52.42 21.32 Favored 'General case' 0 C--N 1.309 -1.165 0 N-CA-C 107.266 -1.383 . . . . 1.0 107.266 -178.264 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -62.2 -24.72 67.38 Favored 'General case' 0 N--CA 1.451 -0.419 0 CA-C-N 116.378 -0.374 . . . . 1.0 110.432 177.307 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 115' ' ' ALA . . . . . 0.505 ' N ' ' O ' ' A' ' 112' ' ' ILE . . . -77.07 -59.1 2.92 Favored 'General case' 0 C--O 1.235 0.292 0 C-N-CA 119.957 -0.697 . . . . 1.0 110.799 178.419 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 116' ' ' ILE . . . . . 0.623 ' O ' ' N ' ' A' ' 119' ' ' LEU . 11.5 tt -67.31 -50.54 61.79 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.571 0 CA-C-O 120.983 0.42 . . . . 1.0 110.906 -178.378 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 117' ' ' GLU . . . . . 0.486 ' N ' ' CG2' ' A' ' 116' ' ' ILE . 23.6 tt0 -42.63 -60.47 1.54 Allowed 'General case' 0 C--O 1.244 0.794 0 N-CA-C 108.074 -1.084 . . . . 1.0 108.074 -177.471 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 18.7 t -51.71 -23.48 3.38 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.086 0 CA-C-N 114.261 -1.336 . . . . 1.0 109.357 177.662 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 119' ' ' LEU . . . . . 0.623 ' N ' ' O ' ' A' ' 116' ' ' ILE . 2.5 tp -81.68 -62.67 1.58 Allowed 'General case' 0 C--N 1.344 0.328 0 C-N-CA 120.304 -0.558 . . . . 1.0 111.468 179.108 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -67.6 -86.77 0.08 OUTLIER Glycine 0 C--N 1.355 1.622 0 C-N-CA 117.421 -2.323 . . . . 1.0 110.417 179.756 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 38.3 m -162.61 -25.45 0.04 OUTLIER 'General case' 0 C--N 1.32 -0.682 0 N-CA-C 107.364 -1.347 . . . . 1.0 107.364 -179.962 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 122' ' ' GLY . . . . . 0.479 ' O ' ' N ' ' A' ' 124' ' ' ASP . . . 114.32 -35.79 4.28 Favored Glycine 0 C--N 1.347 1.152 0 C-N-CA 125.32 1.438 . . . . 1.0 113.539 178.907 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 123' ' ' THR . . . . . 0.436 ' C ' ' O ' ' A' ' 122' ' ' GLY . 1.8 t -33.21 92.12 0.01 OUTLIER 'General case' 0 N--CA 1.473 0.705 0 CA-C-N 120.124 1.962 . . . . 1.0 113.344 -179.124 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 124' ' ' ASP . . . . . 0.479 ' N ' ' O ' ' A' ' 122' ' ' GLY . 22.6 m-20 -142.65 143.22 32.27 Favored 'General case' 0 C--N 1.328 -0.344 0 N-CA-C 108.49 -0.93 . . . . 1.0 108.49 177.655 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 125' ' ' TYR . . . . . . . . . . . . . 11.2 t80 -148.64 143.19 26.37 Favored 'General case' 0 CA--C 1.536 0.412 0 N-CA-C 109.247 -0.649 . . . . 1.0 109.247 -179.591 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 4.0 mmp_? -151.76 155.15 37.67 Favored 'General case' 0 CA--C 1.535 0.372 0 CA-C-N 116.259 -0.428 . . . . 1.0 110.59 178.54 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 127' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--O 1.218 -0.576 0 CA-C-O 118.193 -0.908 . . . . 1.0 109.726 178.476 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 128' ' ' MTN . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 129' ' ' MTN . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 130' ' ' MTN . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 24.5 mmt . . . . . 0 N--CA 1.495 1.802 0 N-CA-C 109.081 -0.711 . . . . 1.0 109.081 . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 2' ' ' SER . . . . . 0.438 ' O ' ' OD1' ' A' ' 3' ' ' ASP . 58.3 p -108.84 11.23 26.29 Favored 'General case' 0 N--CA 1.469 0.495 0 C-N-CA 122.957 0.503 . . . . 1.0 110.247 179.489 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . 0.438 ' OD1' ' O ' ' A' ' 2' ' ' SER . 2.2 m-20 166.67 91.54 0.0 OUTLIER 'General case' 0 N--CA 1.468 0.429 0 CA-C-N 116.321 -0.4 . . . . 1.0 110.044 179.615 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 76.2 t80 -147.98 143.68 27.46 Favored 'General case' 0 C--N 1.332 -0.156 0 N-CA-C 109.993 -0.373 . . . . 1.0 109.993 179.364 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 5' ' ' ASP . . . . . 0.451 ' N ' ' OD1' ' A' ' 5' ' ' ASP . 0.3 OUTLIER -153.38 149.0 27.36 Favored 'General case' 0 CA--C 1.534 0.359 0 CA-C-N 116.657 -0.247 . . . . 1.0 110.361 -178.916 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 6' ' ' THR . . . . . 0.733 ' O ' ' N ' ' A' ' 10' ' ' SER . 62.6 p -70.39 -178.56 1.77 Allowed 'General case' 0 C--O 1.202 -1.439 0 C-N-CA 121.155 -0.218 . . . . 1.0 110.838 179.888 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . 0.483 ' O ' ' N ' ' A' ' 11' ' ' ARG . 0.0 OUTLIER -58.71 -56.14 25.99 Favored 'General case' 0 N--CA 1.48 1.025 0 CA-C-O 121.645 0.736 . . . . 1.0 110.785 -177.631 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 8' ' ' ARG . . . . . 0.441 ' O ' ' CB ' ' A' ' 12' ' ' ALA . 65.1 ttt180 -50.95 -56.49 12.15 Favored 'General case' 0 C--N 1.32 -0.716 0 N-CA-C 106.723 -1.584 . . . . 1.0 106.723 -178.562 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . 0.577 ' O ' ' CG2' ' A' ' 13' ' ' VAL . 48.7 t -65.91 -49.72 75.0 Favored 'Isoleucine or valine' 0 C--O 1.2 -1.514 0 CA-C-N 113.641 -1.618 . . . . 1.0 110.761 179.136 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 10' ' ' SER . . . . . 0.733 ' N ' ' O ' ' A' ' 6' ' ' THR . 38.9 t -67.68 -65.41 0.69 Allowed 'General case' 0 N--CA 1.478 0.97 0 O-C-N 121.585 -0.697 . . . . 1.0 112.436 -178.391 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 11' ' ' ARG . . . . . 0.52 ' O ' ' N ' ' A' ' 15' ' ' ALA . 21.6 ttt180 -65.38 -58.61 5.44 Favored 'General case' 0 N--CA 1.467 0.399 0 C-N-CA 120.749 -0.381 . . . . 1.0 111.491 -175.966 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . 0.441 ' CB ' ' O ' ' A' ' 8' ' ' ARG . . . -49.82 -49.2 49.8 Favored 'General case' 0 N--CA 1.473 0.703 0 N-CA-C 106.449 -1.686 . . . . 1.0 106.449 -176.937 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . 0.602 ' O ' ' N ' ' A' ' 17' ' ' LEU . 93.9 t -60.71 -48.55 88.26 Favored 'Isoleucine or valine' 0 C--O 1.202 -1.412 0 C-N-CA 118.061 -1.456 . . . . 1.0 108.149 176.745 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -57.25 -61.96 2.1 Favored 'General case' 0 C--O 1.211 -0.934 0 C-N-CA 118.088 -1.445 . . . . 1.0 109.636 -179.849 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . 0.549 ' O ' ' N ' ' A' ' 19' ' ' GLY . . . -52.42 -54.64 29.43 Favored 'General case' 0 N--CA 1.473 0.721 0 CA-C-O 121.702 0.763 . . . . 1.0 109.857 -178.342 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . 0.491 ' CA ' ' H ' ' A' ' 22' ' ' GLY . . . -61.88 -55.11 33.16 Favored 'General case' 0 C--N 1.309 -1.154 0 CA-C-N 114.57 -1.196 . . . . 1.0 109.051 -179.023 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . 0.602 ' N ' ' O ' ' A' ' 13' ' ' VAL . 6.7 tp -56.41 -53.22 59.94 Favored 'General case' 0 N--CA 1.478 0.96 0 CA-C-N 113.726 -1.579 . . . . 1.0 108.638 -177.504 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . 0.609 HG23 ' H ' ' A' ' 19' ' ' GLY . 3.5 m -68.02 -56.43 12.89 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.258 0 N-CA-C 108.63 -0.878 . . . . 1.0 108.63 179.262 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . 0.609 ' H ' HG23 ' A' ' 18' ' ' VAL . . . -64.77 -171.69 2.81 Favored Glycine 0 CA--C 1.521 0.423 0 N-CA-C 110.28 -1.128 . . . . 1.0 110.28 179.571 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 20' ' ' PRO . . . . . 0.657 ' O ' ' N ' ' A' ' 24' ' ' ALA . 43.7 Cg_endo -80.63 -21.37 7.31 Favored 'Trans proline' 0 C--N 1.301 -1.942 0 C-N-CA 122.115 1.876 . . . . 1.0 113.097 -179.316 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -56.73 -58.13 16.03 Favored Glycine 0 CA--C 1.535 1.33 0 C-N-CA 119.488 -1.339 . . . . 1.0 110.355 -177.725 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . 0.491 ' H ' ' CA ' ' A' ' 16' ' ' ALA . . . -62.68 -53.1 43.79 Favored Glycine 0 N--CA 1.471 0.976 0 N-CA-C 108.13 -1.988 . . . . 1.0 108.13 -179.845 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -56.44 -38.38 55.76 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.737 0 N-CA-C 108.316 -0.994 . . . . 1.0 108.316 -179.411 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . 0.657 ' N ' ' O ' ' A' ' 20' ' ' PRO . . . -58.14 -59.99 4.44 Favored 'General case' 0 N--CA 1.468 0.436 0 C-N-CA 119.484 -0.886 . . . . 1.0 109.652 -179.301 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -62.74 -42.57 99.73 Favored 'General case' 0 CA--C 1.519 -0.217 0 C-N-CA 119.685 -0.806 . . . . 1.0 111.041 -178.642 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 69.9 t -61.93 -61.11 1.76 Allowed 'Isoleucine or valine' 0 N--CA 1.448 -0.536 0 C-N-CA 118.606 -1.238 . . . . 1.0 110.711 -178.33 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 9.8 p -60.21 -37.6 74.1 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.333 0 N-CA-C 112.749 0.648 . . . . 1.0 112.749 -176.706 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 59.8 tttm -69.0 -54.11 16.95 Favored 'General case' 0 C--N 1.315 -0.895 0 CA-C-O 121.815 0.816 . . . . 1.0 109.378 -178.916 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 95.0 t -64.17 -49.26 82.1 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.83 0 CA-C-N 114.216 -1.357 . . . . 1.0 110.29 -177.7 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 30' ' ' CYS . . . . . . . . . . . . . 44.5 t -67.03 -61.44 1.93 Allowed 'General case' 0 N--CA 1.444 -0.767 0 C-N-CA 119.07 -1.052 . . . . 1.0 110.416 -179.247 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -64.94 -53.79 40.81 Favored 'General case' 0 CA--C 1.514 -0.441 0 N-CA-C 112.726 0.639 . . . . 1.0 112.726 -175.427 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . 0.413 ' O ' ' CB ' ' A' ' 33' ' ' LEU . . . 89.05 72.02 1.27 Allowed Glycine 0 CA--C 1.522 0.506 0 N-CA-C 108.403 -1.879 . . . . 1.0 108.403 -177.446 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . 0.413 ' CB ' ' O ' ' A' ' 32' ' ' GLY . 6.1 tp 81.65 122.28 0.03 OUTLIER Pre-proline 0 CA--C 1.54 0.587 0 C-N-CA 122.858 0.463 . . . . 1.0 111.268 -179.547 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 39.8 Cg_endo -68.45 -18.36 43.69 Favored 'Trans proline' 0 N--CA 1.495 1.574 0 C-N-CA 121.433 1.422 . . . . 1.0 113.56 179.668 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -57.22 -61.03 7.97 Favored Glycine 0 C--N 1.338 0.677 0 C-N-CA 118.126 -1.987 . . . . 1.0 108.802 -179.022 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . 0.599 ' CG2' ' H ' ' A' ' 37' ' ' ILE . 9.0 p -69.25 -150.78 0.0 OUTLIER 'Isoleucine or valine' 0 C--O 1.215 -0.721 0 N-CA-C 106.057 -1.831 . . . . 1.0 106.057 177.869 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . 0.599 ' H ' ' CG2' ' A' ' 36' ' ' VAL . 6.8 tp 79.15 75.25 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.483 1.186 0 O-C-N 124.281 0.988 . . . . 1.0 112.597 179.444 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 10.3 m80 -136.23 130.46 33.14 Favored 'General case' 0 C--N 1.334 -0.08 0 O-C-N 120.858 -1.151 . . . . 1.0 108.653 177.619 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 39' ' ' THR . . . . . 0.67 ' HG1' ' NE ' ' A' ' 42' ' ' ARG . 20.0 p -110.19 144.54 30.28 Favored Pre-proline 0 N--CA 1.464 0.228 0 N-CA-C 109.65 -0.5 . . . . 1.0 109.65 -179.859 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 90.7 Cg_endo -73.27 -29.22 11.66 Favored 'Trans proline' 0 N--CA 1.493 1.497 0 C-N-CA 122.144 1.896 . . . . 1.0 113.425 -178.818 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -127.59 133.39 49.73 Favored 'General case' 0 N--CA 1.468 0.457 0 CA-C-N 116.767 -0.197 . . . . 1.0 110.786 179.123 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . 0.67 ' NE ' ' HG1' ' A' ' 39' ' ' THR . 4.4 mtm180 -171.67 171.64 5.23 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-O 121.461 0.648 . . . . 1.0 109.529 176.391 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -69.51 15.92 0.07 Allowed 'General case' 0 C--N 1.315 -0.898 0 CA-C-N 114.805 -1.089 . . . . 1.0 108.981 179.422 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . 0.62 ' H ' ' C ' ' A' ' 42' ' ' ARG . . . 93.9 -19.91 50.31 Favored Glycine 0 C--N 1.336 0.558 0 N-CA-C 110.035 -1.226 . . . . 1.0 110.035 179.232 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . 0.689 ' O ' ' HB2' ' A' ' 46' ' ' PHE . 1.1 p90 -167.23 169.08 12.88 Favored 'General case' 0 CA--C 1.538 0.485 0 N-CA-C 109.884 -0.414 . . . . 1.0 109.884 179.868 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 46' ' ' PHE . . . . . 0.689 ' HB2' ' O ' ' A' ' 45' ' ' PHE . 0.2 OUTLIER 148.12 71.24 0.0 OUTLIER 'General case' 0 N--CA 1.504 2.257 0 O-C-N 125.772 1.92 . . . . 1.0 110.176 178.555 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 47' ' ' ARG . . . . . 0.503 ' CB ' ' O ' ' A' ' 46' ' ' PHE . 4.2 mmt-85 142.94 142.87 0.0 OUTLIER 'General case' 0 N--CA 1.483 1.202 0 N-CA-C 108.831 -0.803 . . . . 1.0 108.831 179.082 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 1.8 t 70.75 68.6 0.19 Allowed 'General case' 0 N--CA 1.446 -0.661 0 N-CA-C 108.7 -0.852 . . . . 1.0 108.7 -179.594 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 49' ' ' ASN . . . . . 0.605 ' ND2' ' O ' ' A' ' 49' ' ' ASN . 3.2 p-10 -140.71 105.7 6.36 Favored Pre-proline 0 CA--C 1.54 0.579 0 N-CA-C 107.929 -1.137 . . . . 1.0 107.929 -179.89 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . 0.538 ' C ' ' H ' ' A' ' 52' ' ' ARG . 62.8 Cg_exo -49.72 68.64 0.02 OUTLIER 'Trans proline' 0 N--CA 1.505 2.174 0 C-N-CA 122.733 2.289 . . . . 1.0 114.533 -178.749 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . 0.6 ' N ' ' O ' ' A' ' 49' ' ' ASN . 42.6 mm-40 71.52 -23.13 0.19 Allowed 'General case' 0 N--CA 1.468 0.451 0 C-N-CA 122.636 0.375 . . . . 1.0 110.711 -179.695 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . 0.572 ' NH2' HH22 ' A' ' 126' ' ' ARG . 17.0 mmt180 -48.05 114.14 0.87 Allowed 'General case' 0 C--N 1.329 -0.319 0 N-CA-C 109.302 -0.629 . . . . 1.0 109.302 179.98 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . 0.466 ' O ' ' N ' ' A' ' 55' ' ' ILE . 21.5 tt -54.71 143.58 6.92 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-O 121.385 0.612 . . . . 1.0 110.482 -179.292 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 11.4 mm100 -64.65 77.64 0.04 OUTLIER 'General case' 0 C--N 1.318 -0.788 0 C-N-CA 119.123 -1.031 . . . . 1.0 109.683 -177.917 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . 0.466 ' N ' ' O ' ' A' ' 53' ' ' ILE . 3.2 tp -150.11 158.05 5.79 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.299 0 N-CA-C 110.406 -0.22 . . . . 1.0 110.406 178.179 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 113.44 -27.42 9.41 Favored Glycine 0 CA--C 1.519 0.296 0 N-CA-C 110.305 -1.118 . . . . 1.0 110.305 179.3 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . 0.453 ' N ' ' OD1' ' A' ' 57' ' ' ASP . 11.4 p-10 -57.43 101.95 0.08 Allowed 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 117.638 0.719 . . . . 1.0 110.254 179.529 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 58' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -86.25 176.06 8.14 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-O 122.526 1.155 . . . . 1.0 111.843 -179.169 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 59' ' ' ARG . . . . . 0.503 ' CG ' ' N ' ' A' ' 60' ' ' TYR . 22.2 ptt-85 -90.82 -56.38 3.2 Favored 'General case' 0 C--N 1.316 -0.884 0 CA-C-N 112.756 -2.02 . . . . 1.0 112.224 179.841 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 60' ' ' TYR . . . . . 0.503 ' N ' ' CG ' ' A' ' 59' ' ' ARG . 0.4 OUTLIER -91.22 -20.64 21.72 Favored 'General case' 0 C--O 1.247 0.967 0 CA-C-O 121.948 0.88 . . . . 1.0 113.046 -179.107 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . 0.4 ' O ' ' N ' ' A' ' 65' ' ' ASP . 3.5 tt0 -79.21 -12.77 59.97 Favored 'General case' 0 N--CA 1.436 -1.157 0 N-CA-C 109.425 -0.583 . . . . 1.0 109.425 -179.893 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . 0.568 ' O ' ' N ' ' A' ' 66' ' ' GLY . 6.1 p -46.84 -55.85 1.59 Allowed 'Isoleucine or valine' 0 C--O 1.212 -0.899 0 C-N-CA 119.656 -0.817 . . . . 1.0 109.811 -175.69 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 63' ' ' ALA . . . . . 0.463 ' O ' ' HG2' ' A' ' 67' ' ' ARG . . . -64.87 -54.63 27.96 Favored 'General case' 0 N--CA 1.435 -1.199 0 C-N-CA 120.177 -0.609 . . . . 1.0 109.509 -179.68 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 64' ' ' HIS . . . . . 0.424 ' O ' ' CG ' ' A' ' 67' ' ' ARG . 0.2 OUTLIER -48.45 -57.95 5.35 Favored 'General case' 0 CA--C 1.538 0.495 0 CA-C-N 115.484 -0.78 . . . . 1.0 110.153 -179.567 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . 0.662 ' C ' ' H ' ' A' ' 67' ' ' ARG . 0.8 OUTLIER -69.78 -46.49 65.65 Favored 'General case' 0 C--N 1.316 -0.858 0 CA-C-O 122.309 1.052 . . . . 1.0 110.222 179.19 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . 0.568 ' N ' ' O ' ' A' ' 62' ' ' VAL . . . -71.08 27.38 0.54 Allowed Glycine 0 N--CA 1.447 -0.621 0 N-CA-C 109.585 -1.406 . . . . 1.0 109.585 177.755 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 67' ' ' ARG . . . . . 0.697 ' O ' ' N ' ' A' ' 69' ' ' LEU . 14.5 mmt85 -74.9 1.26 13.16 Favored 'General case' 0 N--CA 1.441 -0.909 0 N-CA-C 107.87 -1.159 . . . . 1.0 107.87 176.23 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . 0.453 ' C ' ' O ' ' A' ' 67' ' ' ARG . 0.8 OUTLIER -33.05 -24.46 0.0 OUTLIER 'General case' 0 N--CA 1.475 0.79 0 O-C-N 123.745 0.653 . . . . 1.0 109.5 -175.99 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . 0.697 ' N ' ' O ' ' A' ' 67' ' ' ARG . 4.8 mp -67.31 -64.64 0.81 Allowed 'General case' 0 CA--C 1.54 0.571 0 C-N-CA 119.326 -0.95 . . . . 1.0 109.681 177.999 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . 0.676 ' C ' ' H ' ' A' ' 72' ' ' HIS . . . -80.53 -76.93 0.21 Allowed 'General case' 0 N--CA 1.473 0.685 0 N-CA-C 106.035 -1.839 . . . . 1.0 106.035 177.173 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . 0.471 ' O ' ' C ' ' A' ' 72' ' ' HIS . . . -42.6 0.59 0.0 OUTLIER 'General case' 0 N--CA 1.469 0.499 0 C-N-CA 124.631 1.173 . . . . 1.0 113.089 179.723 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 72' ' ' HIS . . . . . 0.676 ' H ' ' C ' ' A' ' 70' ' ' ALA . 1.2 p-80 -26.27 -58.71 0.08 Allowed 'General case' 0 C--N 1.342 0.251 0 C-N-CA 122.747 0.419 . . . . 1.0 111.541 -178.738 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 73' ' ' MET . . . . . 0.618 ' H ' ' CG ' ' A' ' 72' ' ' HIS . 49.5 mtt -75.37 -49.79 17.93 Favored 'General case' 0 C--N 1.321 -0.65 0 C-N-CA 120.545 -0.462 . . . . 1.0 109.878 177.408 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . 0.63 ' O ' ' N ' ' A' ' 76' ' ' GLY . 57.5 t -44.63 -42.07 2.19 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.167 0 CA-C-O 117.883 -1.056 . . . . 1.0 111.954 -175.409 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 75' ' ' ASN . . . . . 0.462 ' C ' ' N ' ' A' ' 77' ' ' ILE . 40.7 t30 -40.13 -14.72 0.01 OUTLIER 'General case' 0 N--CA 1.478 0.938 0 CA-C-N 121.071 1.759 . . . . 1.0 112.195 176.796 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . 0.63 ' N ' ' O ' ' A' ' 74' ' ' VAL . . . -45.43 -24.04 0.95 Allowed Glycine 0 CA--C 1.539 1.566 0 N-CA-C 108.734 -1.746 . . . . 1.0 108.734 178.866 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . 0.535 ' O ' ' N ' ' A' ' 80' ' ' ALA . 2.2 pt -89.87 -61.62 1.86 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.719 0 CA-C-N 114.261 -0.97 . . . . 1.0 110.672 -178.837 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . 0.501 ' H ' ' CG1' ' A' ' 77' ' ' ILE . 56.0 t -36.89 -29.91 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.448 -0.53 0 N-CA-C 109.267 -0.642 . . . . 1.0 109.267 -177.27 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . 0.566 ' O ' ' CB ' ' A' ' 83' ' ' ALA . 2.5 pt -64.75 -52.75 50.51 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.03 0 C-N-CA 119.151 -1.02 . . . . 1.0 109.626 178.786 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 80' ' ' ALA . . . . . 0.544 ' N ' ' CG1' ' A' ' 79' ' ' ILE . . . -55.86 -63.42 1.18 Allowed 'General case' 0 C--O 1.214 -0.768 0 C-N-CA 118.245 -1.382 . . . . 1.0 111.156 -178.489 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 47.5 mt-10 -50.1 -71.18 0.07 Allowed 'General case' 0 CA--C 1.531 0.216 0 C-N-CA 119.587 -0.845 . . . . 1.0 110.335 -179.151 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 21.2 t70 -62.88 -63.88 1.08 Allowed 'General case' 0 C--N 1.323 -0.582 0 C-N-CA 118.529 -1.268 . . . . 1.0 109.953 -177.997 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . 0.58 ' O ' ' N ' ' A' ' 85' ' ' ILE . . . -53.04 -13.97 0.54 Allowed 'General case' 0 CA--C 1.536 0.409 0 C-N-CA 118.672 -1.211 . . . . 1.0 111.043 -177.801 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . 0.485 ' N ' ' O ' ' A' ' 80' ' ' ALA . 1.0 OUTLIER -40.73 -16.54 0.01 OUTLIER 'General case' 0 C--N 1.37 1.495 0 CA-C-N 120.463 1.483 . . . . 1.0 112.047 -179.756 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 85' ' ' ILE . . . . . 0.58 ' N ' ' O ' ' A' ' 83' ' ' ALA . 19.8 pt -62.25 -41.65 92.29 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.245 0 N-CA-C 109.123 -0.695 . . . . 1.0 109.123 179.806 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . 0.438 ' CB ' ' CZ ' ' A' ' 52' ' ' ARG . . . -97.07 -2.7 42.74 Favored 'General case' 0 CA--C 1.539 0.523 0 C-N-CA 123.286 0.634 . . . . 1.0 112.506 179.896 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 34.1 tp10 -51.25 -20.89 1.79 Allowed 'General case' 0 C--N 1.32 -0.709 0 CA-C-N 115.307 -0.86 . . . . 1.0 109.842 -179.927 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -123.18 14.63 9.77 Favored 'General case' 0 N--CA 1.475 0.816 0 CA-C-O 121.459 0.647 . . . . 1.0 109.792 178.765 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 24.1 t -109.01 29.24 1.48 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.453 0 CA-C-N 114.579 -1.191 . . . . 1.0 109.655 177.861 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 90' ' ' GLY . . . . . 0.534 ' N ' ' CD ' ' A' ' 91' ' ' PRO . . . -68.78 -43.2 76.07 Favored Glycine 0 CA--C 1.525 0.694 0 N-CA-C 109.632 -1.387 . . . . 1.0 109.632 177.156 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 91' ' ' PRO . . . . . 0.534 ' CD ' ' N ' ' A' ' 90' ' ' GLY . 81.7 Cg_exo -45.71 -14.09 0.1 OUTLIER 'Trans proline' 0 N--CA 1.489 1.217 0 C-N-CA 121.686 1.591 . . . . 1.0 110.686 178.733 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 92' ' ' HIS . . . . . 0.654 ' CD2' HH21 ' A' ' 95' ' ' ARG . 40.9 t-80 -57.1 -17.38 10.32 Favored 'General case' 0 C--O 1.204 -1.32 0 N-CA-C 107.941 -1.133 . . . . 1.0 107.941 -179.886 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . 0.517 ' HG ' ' H ' ' A' ' 94' ' ' ALA . 2.9 pp -62.41 -55.7 25.33 Favored 'General case' 0 C--N 1.325 -0.468 0 N-CA-C 109.081 -0.711 . . . . 1.0 109.081 178.083 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 94' ' ' ALA . . . . . 0.517 ' H ' ' HG ' ' A' ' 93' ' ' LEU . . . -57.92 -52.52 65.14 Favored 'General case' 0 CA--C 1.513 -0.46 0 N-CA-C 108.64 -0.874 . . . . 1.0 108.64 179.476 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 95' ' ' ARG . . . . . 0.654 HH21 ' CD2' ' A' ' 92' ' ' HIS . 18.3 ttp180 -57.82 -58.37 8.65 Favored 'General case' 0 N--CA 1.446 -0.633 0 N-CA-C 106.692 -1.596 . . . . 1.0 106.692 178.482 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 96' ' ' ALA . . . . . 1.005 ' O ' ' N ' ' A' ' 98' ' ' GLY . . . -47.36 -10.95 0.02 OUTLIER 'General case' 0 C--N 1.299 -1.625 0 O-C-N 118.887 -2.383 . . . . 1.0 111.504 178.236 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . 0.661 ' O ' ' N ' ' A' ' 100' ' ' ILE . 3.5 pp 9.49 -45.32 0.0 OUTLIER 'General case' 0 N--CA 1.475 0.796 0 C-N-CA 124.202 1.001 . . . . 1.0 112.177 -164.879 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 98' ' ' GLY . . . . . 1.005 ' N ' ' O ' ' A' ' 96' ' ' ALA . . . -53.33 -23.71 19.64 Favored Glycine 0 C--N 1.295 -1.736 0 N-CA-C 106.423 -2.671 . . . . 1.0 106.423 173.269 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 99' ' ' GLN . . . . . 0.513 ' O ' ' SG ' ' A' ' 102' ' ' CYS . 1.1 tp-100 -58.27 -21.17 47.64 Favored 'General case' 0 C--N 1.367 1.346 0 N-CA-C 106.523 -1.658 . . . . 1.0 106.523 177.167 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 100' ' ' ILE . . . . . 0.661 ' N ' ' O ' ' A' ' 97' ' ' LEU . 84.3 mt -65.72 -42.49 92.64 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.925 0 CA-C-N 113.51 -1.677 . . . . 1.0 109.532 178.0 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 101' ' ' VAL . . . . . 0.611 HG11 ' H ' ' A' ' 102' ' ' CYS . 2.8 p -52.74 -62.84 0.55 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.383 0 C-N-CA 119.03 -1.068 . . . . 1.0 111.647 -177.055 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 102' ' ' CYS . . . . . 0.611 ' H ' HG11 ' A' ' 101' ' ' VAL . 0.8 OUTLIER -49.77 -22.5 1.44 Allowed 'General case' 0 C--N 1.316 -0.849 0 N-CA-C 112.421 0.526 . . . . 1.0 112.421 -177.572 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 60.1 ttt-85 -85.2 -46.89 10.64 Favored 'General case' 0 N--CA 1.482 1.146 0 CA-C-O 122.303 1.049 . . . . 1.0 112.344 179.584 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 104' ' ' TYR . . . . . 0.714 ' CG ' ' O ' ' A' ' 104' ' ' TYR . 0.0 OUTLIER -96.53 19.67 11.88 Favored 'General case' 0 C--N 1.308 -1.234 0 CA-C-N 113.341 -1.754 . . . . 1.0 109.539 178.591 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 105' ' ' GLY . . . . . 0.473 ' N ' ' O ' ' A' ' 101' ' ' VAL . . . -153.06 -85.28 0.05 OUTLIER Glycine 0 C--N 1.342 0.888 1 N-CA-C 102.268 -4.333 . . . . 1.0 102.268 175.955 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 106' ' ' ALA . . . . . 0.709 ' O ' ' CD ' ' A' ' 110' ' ' PRO . . . 73.99 60.41 0.08 Allowed 'General case' 0 C--O 1.206 -1.232 0 N-CA-C 115.046 1.499 . . . . 1.0 115.046 176.568 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 75.6 m -82.53 -57.38 3.37 Favored 'General case' 0 CA--C 1.548 0.887 0 O-C-N 120.859 -1.151 . . . . 1.0 109.649 179.866 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 27.2 m -66.44 -7.17 5.1 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.056 0 CA-C-O 121.565 0.698 . . . . 1.0 111.525 -179.59 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 1.5 mp -83.16 -64.18 0.25 Allowed Pre-proline 0 CA--C 1.55 0.975 0 CA-C-N 114.607 -1.179 . . . . 1.0 111.401 -179.831 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 110' ' ' PRO . . . . . 0.709 ' CD ' ' O ' ' A' ' 106' ' ' ALA . 58.6 Cg_endo -66.35 -33.95 36.7 Favored 'Trans proline' 0 N--CA 1.504 2.115 0 C-N-CA 124.407 3.405 . . . . 1.0 113.131 179.753 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 111' ' ' ASN . . . . . 0.436 ' C ' ' N ' ' A' ' 113' ' ' ASN . 39.8 t30 -66.48 -67.73 0.43 Allowed 'General case' 0 C--O 1.237 0.417 0 C-N-CA 120.61 -0.436 . . . . 1.0 110.029 -178.012 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 7.4 mm -51.93 -22.2 2.69 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.639 0 CA-C-O 122.135 0.969 . . . . 1.0 108.511 178.651 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 113' ' ' ASN . . . . . 0.456 ' O ' HG22 ' A' ' 116' ' ' ILE . 0.9 OUTLIER -61.25 -53.3 58.62 Favored 'General case' 0 C--N 1.305 -1.34 0 CA-C-N 113.358 -1.746 . . . . 1.0 108.174 -178.188 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -55.52 -29.23 58.51 Favored 'General case' 0 C--N 1.313 -1.011 0 O-C-N 120.668 -1.27 . . . . 1.0 111.775 -179.617 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -83.29 -50.09 8.74 Favored 'General case' 0 C--O 1.212 -0.89 0 CA-C-O 121.777 0.798 . . . . 1.0 111.584 177.527 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 116' ' ' ILE . . . . . 0.556 ' CG2' ' N ' ' A' ' 117' ' ' GLU . 1.5 tp -46.21 -53.93 2.27 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.704 0 CA-C-N 114.194 -1.367 . . . . 1.0 107.676 -179.005 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 117' ' ' GLU . . . . . 0.556 ' N ' ' CG2' ' A' ' 116' ' ' ILE . 44.2 tt0 -40.05 -50.95 2.6 Favored 'General case' 0 N--CA 1.478 0.928 0 N-CA-C 105.034 -2.21 . . . . 1.0 105.034 -178.812 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 43.3 t -70.26 -53.16 24.39 Favored 'Isoleucine or valine' 0 CA--C 1.558 1.286 0 CA-C-N 113.3 -1.773 . . . . 1.0 111.08 178.192 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -59.65 -24.87 64.22 Favored 'General case' 0 N--CA 1.482 1.138 0 N-CA-C 115.145 1.535 . . . . 1.0 115.145 -177.268 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -135.71 -48.43 0.08 OUTLIER Glycine 0 CA--C 1.542 1.759 0 CA-C-N 120.418 1.463 . . . . 1.0 113.035 177.234 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 1.2 m 160.56 -39.38 0.0 OUTLIER 'General case' 0 N--CA 1.468 0.472 0 N-CA-C 101.414 -3.55 . . . . 1.0 101.414 -177.268 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 122' ' ' GLY . . . . . 0.441 ' O ' ' N ' ' A' ' 124' ' ' ASP . . . 115.06 -32.89 5.57 Favored Glycine 0 CA--C 1.526 0.748 0 CA-C-N 111.114 -2.766 . . . . 1.0 116.869 175.638 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 123' ' ' THR . . . . . 0.44 ' C ' ' O ' ' A' ' 122' ' ' GLY . 43.8 m -40.63 98.35 0.01 OUTLIER 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 121.225 2.513 . . . . 1.0 112.967 -178.661 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 124' ' ' ASP . . . . . 0.441 ' N ' ' O ' ' A' ' 122' ' ' GLY . 31.8 m-20 -137.21 138.4 40.13 Favored 'General case' 0 N--CA 1.465 0.284 0 N-CA-C 107.207 -1.405 . . . . 1.0 107.207 177.112 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 125' ' ' TYR . . . . . 0.47 ' O ' ' CD1' ' A' ' 125' ' ' TYR . 0.1 OUTLIER -155.34 153.74 30.96 Favored 'General case' 0 CA--C 1.537 0.481 0 CA-C-O 121.18 0.514 . . . . 1.0 110.719 -179.581 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 126' ' ' ARG . . . . . 0.572 HH22 ' NH2' ' A' ' 52' ' ' ARG . 4.4 mtp85 -150.42 153.89 36.75 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.324 -0.853 . . . . 1.0 111.506 177.467 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 127' ' ' PHE . . . . . . . . . . . . . 47.3 p90 . . . . . 0 C--O 1.22 -0.451 0 CA-C-O 117.931 -1.033 . . . . 1.0 110.489 -179.474 . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 128' ' ' MTN . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 129' ' ' MTN . . . . . 0.41 ' S1 ' ' C6 ' ' A' ' 129' ' ' MTN . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 130' ' ' MTN . . . . . 0.467 ' O1 ' ' O ' ' A' ' 126' ' ' ARG . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 20.1 mmt . . . . . 0 N--CA 1.493 1.679 0 N-CA-C 108.779 -0.822 . . . . 1.0 108.779 . . . . . . . . . 0 0 . 1 . 021 nuclear orig full ' A' A ' 2' ' ' SER . . . . . 0.431 ' O ' ' OD2' ' A' ' 3' ' ' ASP . 50.6 m -107.77 8.78 29.0 Favored 'General case' 0 N--CA 1.466 0.329 0 C-N-CA 122.322 0.249 . . . . 1.0 110.544 179.943 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . 0.431 ' OD2' ' O ' ' A' ' 2' ' ' SER . 0.4 OUTLIER 169.59 93.99 0.0 OUTLIER 'General case' 0 CA--C 1.534 0.338 0 N-CA-C 110.284 -0.265 . . . . 1.0 110.284 179.966 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 70.4 t80 -150.15 144.53 25.74 Favored 'General case' 0 N--CA 1.466 0.353 0 N-CA-C 110.228 -0.286 . . . . 1.0 110.228 179.587 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 47.9 m-20 -153.07 149.26 27.94 Favored 'General case' 0 N--CA 1.465 0.309 0 N-CA-C 110.233 -0.284 . . . . 1.0 110.233 179.888 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 6' ' ' THR . . . . . 0.649 ' O ' ' N ' ' A' ' 10' ' ' SER . 11.2 m -69.07 174.48 4.52 Favored 'General case' 0 C--O 1.205 -1.267 0 N-CA-C 109.793 -0.447 . . . . 1.0 109.793 179.774 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . 0.576 ' O ' ' N ' ' A' ' 11' ' ' ARG . 39.6 tt0 -61.55 -55.59 29.28 Favored 'General case' 0 C--N 1.317 -0.847 0 CA-C-O 121.475 0.655 . . . . 1.0 110.349 -177.822 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 8' ' ' ARG . . . . . 0.544 ' O ' ' CB ' ' A' ' 12' ' ' ALA . 7.4 ttp-105 -51.27 -57.81 7.86 Favored 'General case' 0 C--O 1.209 -1.072 0 N-CA-C 107.788 -1.19 . . . . 1.0 107.788 -178.188 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . 0.47 ' O ' ' CG1' ' A' ' 13' ' ' VAL . 0.0 OUTLIER -66.14 -47.0 86.19 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.071 0 CA-C-N 114.435 -1.257 . . . . 1.0 110.99 179.554 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 10' ' ' SER . . . . . 0.649 ' N ' ' O ' ' A' ' 6' ' ' THR . 35.4 t -62.93 -59.06 5.35 Favored 'General case' 0 N--CA 1.482 1.155 0 N-CA-C 108.582 -0.895 . . . . 1.0 108.582 179.636 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 11' ' ' ARG . . . . . 0.576 ' N ' ' O ' ' A' ' 7' ' ' GLU . 20.9 ttm180 -66.09 -55.06 18.4 Favored 'General case' 0 C--N 1.314 -0.944 0 O-C-N 121.732 -0.605 . . . . 1.0 110.815 -178.06 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . 0.544 ' CB ' ' O ' ' A' ' 8' ' ' ARG . . . -49.64 -53.31 24.93 Favored 'General case' 0 N--CA 1.485 1.276 0 C-N-CA 118.467 -1.293 . . . . 1.0 108.043 -176.566 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . 0.62 ' O ' ' N ' ' A' ' 17' ' ' LEU . 4.5 m -60.58 -47.34 93.25 Favored 'Isoleucine or valine' 0 C--O 1.203 -1.377 0 C-N-CA 118.067 -1.453 . . . . 1.0 107.342 178.204 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . 0.475 ' O ' HG22 ' A' ' 18' ' ' VAL . . . -56.31 -62.11 1.94 Allowed 'General case' 0 C--O 1.206 -1.201 0 C-N-CA 117.062 -1.855 . . . . 1.0 109.706 179.645 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . 0.595 ' O ' ' N ' ' A' ' 19' ' ' GLY . . . -54.14 -56.26 19.91 Favored 'General case' 0 N--CA 1.472 0.659 0 CA-C-O 121.474 0.654 . . . . 1.0 110.097 -178.246 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . 0.427 ' N ' ' O ' ' A' ' 12' ' ' ALA . . . -62.28 -56.01 22.68 Favored 'General case' 0 CA--C 1.552 1.037 0 CA-C-N 115.25 -0.886 . . . . 1.0 109.281 -179.419 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . 0.62 ' N ' ' O ' ' A' ' 13' ' ' VAL . 4.3 tt -57.17 -52.43 65.36 Favored 'General case' 0 N--CA 1.484 1.244 0 CA-C-N 114.675 -1.148 . . . . 1.0 108.275 -177.965 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . 0.684 HG22 ' H ' ' A' ' 19' ' ' GLY . 2.8 m -69.26 -57.87 7.29 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.349 0 C-N-CA 119.737 -0.785 . . . . 1.0 109.806 179.095 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . 0.684 ' H ' HG22 ' A' ' 18' ' ' VAL . . . -59.86 -175.84 1.08 Allowed Glycine 0 N--CA 1.447 -0.585 0 N-CA-C 111.106 -0.798 . . . . 1.0 111.106 -179.261 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 20' ' ' PRO . . . . . 0.576 ' O ' ' N ' ' A' ' 24' ' ' ALA . 36.8 Cg_endo -83.47 -26.79 2.01 Favored 'Trans proline' 0 C--N 1.299 -2.044 0 C-N-CA 122.658 2.239 . . . . 1.0 112.988 -178.507 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -59.02 -58.65 13.41 Favored Glycine 0 N--CA 1.475 1.25 0 C-N-CA 120.066 -1.064 . . . . 1.0 111.536 -176.995 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -55.96 -51.59 54.46 Favored Glycine 0 N--CA 1.474 1.23 0 N-CA-C 106.981 -2.448 . . . . 1.0 106.981 -178.158 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 47.9 t -59.56 -31.54 47.04 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.427 0 N-CA-C 108.735 -0.839 . . . . 1.0 108.735 178.792 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . 0.576 ' N ' ' O ' ' A' ' 20' ' ' PRO . . . -58.17 -63.09 1.38 Allowed 'General case' 0 C--N 1.348 0.502 0 C-N-CA 118.858 -1.137 . . . . 1.0 110.659 -178.742 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -64.52 -43.37 94.28 Favored 'General case' 0 CA--C 1.517 -0.309 0 C-N-CA 119.858 -0.737 . . . . 1.0 111.814 -178.1 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 93.0 t -59.59 -59.63 3.64 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.544 0 C-N-CA 118.818 -1.153 . . . . 1.0 110.102 -177.927 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER -58.87 -34.76 53.33 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 O-C-N 122.235 -0.291 . . . . 1.0 111.1 -178.283 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 37.5 ttpt -67.16 -55.85 12.41 Favored 'General case' 0 C--N 1.325 -0.482 0 N-CA-C 109.391 -0.596 . . . . 1.0 109.391 -179.297 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 42.2 t -62.24 -47.82 91.32 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.605 0 CA-C-N 115.162 -0.926 . . . . 1.0 109.989 -179.07 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 30' ' ' CYS . . . . . . . . . . . . . 0.7 OUTLIER -67.47 -62.53 1.38 Allowed 'General case' 0 N--CA 1.446 -0.628 0 C-N-CA 119.052 -1.059 . . . . 1.0 110.841 -179.098 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -60.3 -51.61 68.82 Favored 'General case' 0 CA--C 1.506 -0.737 0 O-C-N 122.055 -0.403 . . . . 1.0 111.091 -176.697 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . 0.452 ' O ' ' HB2' ' A' ' 33' ' ' LEU . . . 84.66 75.04 1.23 Allowed Glycine 0 N--CA 1.442 -0.941 0 N-CA-C 109.828 -1.309 . . . . 1.0 109.828 -178.662 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . 0.452 ' HB2' ' O ' ' A' ' 32' ' ' GLY . 0.9 OUTLIER 87.21 100.39 0.03 OUTLIER Pre-proline 0 CA--C 1.549 0.917 0 C-N-CA 124.015 0.926 . . . . 1.0 110.654 -179.238 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 58.6 Cg_endo -71.4 -31.51 13.87 Favored 'Trans proline' 0 N--CA 1.502 1.997 0 C-N-CA 121.925 1.75 . . . . 1.0 114.807 -178.652 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -58.02 -58.96 11.85 Favored Glycine 0 N--CA 1.472 1.077 0 C-N-CA 118.466 -1.826 . . . . 1.0 108.957 -178.4 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . 0.542 ' O ' ' CB ' ' A' ' 37' ' ' ILE . 7.9 p -93.43 165.89 1.86 Allowed 'Isoleucine or valine' 0 CA--C 1.514 -0.415 0 N-CA-C 106.75 -1.574 . . . . 1.0 106.75 177.318 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . 0.542 ' CB ' ' O ' ' A' ' 36' ' ' VAL . 8.8 tp 115.81 121.57 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.476 0.842 0 O-C-N 124.523 1.139 . . . . 1.0 110.244 -179.841 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 0.9 OUTLIER -143.33 135.8 27.29 Favored 'General case' 0 CA--C 1.533 0.293 0 N-CA-C 109.146 -0.687 . . . . 1.0 109.146 179.461 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 10.4 m -111.47 111.2 55.11 Favored Pre-proline 0 N--CA 1.468 0.444 0 N-CA-C 109.55 -0.537 . . . . 1.0 109.55 179.266 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 40' ' ' PRO . . . . . 0.413 ' HB2' ' H ' ' A' ' 41' ' ' ALA . 72.1 Cg_exo -43.09 -85.83 0.01 OUTLIER 'Trans proline' 0 N--CA 1.491 1.366 0 C-N-CA 121.662 1.575 . . . . 1.0 112.834 -178.637 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . 0.413 ' H ' ' HB2' ' A' ' 40' ' ' PRO . . . -67.28 120.15 13.34 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 116.108 -0.496 . . . . 1.0 111.313 -177.784 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 3.6 ptm180 -174.04 175.39 2.77 Favored 'General case' 0 N--CA 1.448 -0.563 0 CA-C-N 116.101 -0.499 . . . . 1.0 110.01 178.46 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 5.3 tpt85 -57.53 -43.35 84.27 Favored 'General case' 0 C--N 1.32 -0.691 0 N-CA-C 107.452 -1.314 . . . . 1.0 107.452 179.919 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . 0.43 ' O ' ' CD1' ' A' ' 45' ' ' PHE . . . 121.5 -21.55 8.05 Favored Glycine 0 N--CA 1.465 0.613 0 N-CA-C 110.715 -0.954 . . . . 1.0 110.715 -179.127 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . 0.528 ' O ' ' HB2' ' A' ' 46' ' ' PHE . 42.6 m-85 -150.34 153.82 36.74 Favored 'General case' 0 C--O 1.216 -0.707 0 N-CA-C 109.006 -0.739 . . . . 1.0 109.006 177.795 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 46' ' ' PHE . . . . . 0.609 ' O ' ' NE ' ' A' ' 47' ' ' ARG . 8.6 m-85 128.59 96.33 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.582 0 O-C-N 124.939 1.399 . . . . 1.0 110.287 -179.933 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 47' ' ' ARG . . . . . 0.609 ' NE ' ' O ' ' A' ' 46' ' ' PHE . 0.7 OUTLIER 110.1 160.85 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.503 0 C-N-CA 125.464 1.506 . . . . 1.0 109.884 -179.809 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 0.9 OUTLIER 67.8 70.64 0.34 Allowed 'General case' 0 C--O 1.224 -0.246 0 N-CA-C 108.811 -0.811 . . . . 1.0 108.811 -178.455 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 49' ' ' ASN . . . . . 0.606 ' O ' ' N ' ' A' ' 51' ' ' GLU . 39.4 m-80 -136.13 129.37 17.93 Favored Pre-proline 0 CA--C 1.534 0.364 0 O-C-N 121.787 -0.571 . . . . 1.0 109.509 -178.979 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . 0.453 ' C ' ' H ' ' A' ' 52' ' ' ARG . 68.8 Cg_exo -46.75 74.57 0.01 OUTLIER 'Trans proline' 0 N--CA 1.498 1.78 0 C-N-CA 121.964 1.776 . . . . 1.0 113.476 179.927 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . 0.606 ' N ' ' O ' ' A' ' 49' ' ' ASN . 7.4 mm-40 48.84 14.09 0.07 Allowed 'General case' 0 C--N 1.331 -0.209 0 O-C-N 121.867 -0.521 . . . . 1.0 110.999 179.408 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . 0.453 ' H ' ' C ' ' A' ' 50' ' ' PRO . 1.4 ptp180 -116.45 162.23 17.88 Favored 'General case' 0 N--CA 1.472 0.65 0 CA-C-N 116.554 -0.294 . . . . 1.0 110.874 -179.573 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 19.4 tt -71.25 136.54 25.63 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.779 0 CA-C-O 123.508 1.623 . . . . 1.0 115.325 -177.146 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 54' ' ' GLN . . . . . 0.601 ' CG ' HD22 ' A' ' 49' ' ' ASN . 0.5 OUTLIER -74.93 87.6 2.31 Favored 'General case' 0 C--N 1.314 -0.973 0 CA-C-N 110.233 -3.167 . . . . 1.0 110.247 -178.985 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . 0.425 ' CG2' ' N ' ' A' ' 56' ' ' GLY . 5.9 mm -146.05 156.9 12.19 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.789 0 CA-C-N 115.703 -0.681 . . . . 1.0 109.883 177.495 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . 0.425 ' N ' ' CG2' ' A' ' 55' ' ' ILE . . . 110.52 -2.29 29.28 Favored Glycine 0 N--CA 1.475 1.243 0 N-CA-C 111.379 -0.688 . . . . 1.0 111.379 -179.897 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 13.9 p-10 -87.44 104.95 16.94 Favored 'General case' 0 N--CA 1.466 0.357 0 CA-C-O 121.396 0.617 . . . . 1.0 111.435 -179.815 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 58' ' ' TRP . . . . . . . . . . . . . 9.0 m0 -89.14 171.56 9.73 Favored 'General case' 0 CA--C 1.567 1.603 0 CA-C-O 122.941 1.353 . . . . 1.0 112.354 -178.634 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -76.83 -61.71 1.88 Allowed 'General case' 0 N--CA 1.49 1.556 0 CA-C-N 111.12 -2.764 . . . . 1.0 113.902 -176.941 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 4.0 t80 -90.56 -9.03 48.64 Favored 'General case' 0 N--CA 1.484 1.23 0 CA-C-O 122.348 1.07 . . . . 1.0 112.753 -179.295 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . 0.477 ' O ' ' N ' ' A' ' 65' ' ' ASP . 2.7 tt0 -78.45 -14.48 59.35 Favored 'General case' 0 C--N 1.306 -1.3 0 CA-C-N 114.895 -1.048 . . . . 1.0 110.291 -179.637 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . 0.627 ' O ' ' N ' ' A' ' 66' ' ' GLY . 11.1 m -48.26 -55.79 2.63 Favored 'Isoleucine or valine' 0 C--O 1.204 -1.295 0 C-N-CA 119.566 -0.854 . . . . 1.0 109.241 -176.723 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 63' ' ' ALA . . . . . 0.427 ' O ' ' CG ' ' A' ' 67' ' ' ARG . . . -63.26 -54.65 34.01 Favored 'General case' 0 C--N 1.297 -1.677 0 O-C-N 121.588 -0.695 . . . . 1.0 109.359 179.438 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -50.56 -59.5 3.97 Favored 'General case' 0 CA--C 1.545 0.786 0 CA-C-N 115.342 -0.845 . . . . 1.0 110.234 -179.342 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . 0.579 ' C ' ' H ' ' A' ' 67' ' ' ARG . 26.8 t70 -72.42 -50.82 23.61 Favored 'General case' 0 C--N 1.312 -1.049 0 CA-C-O 121.91 0.862 . . . . 1.0 111.504 178.77 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . 0.627 ' N ' ' O ' ' A' ' 62' ' ' VAL . . . -69.96 29.5 0.41 Allowed Glycine 0 C--O 1.227 -0.329 0 O-C-N 120.986 -1.071 . . . . 1.0 111.046 177.661 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 67' ' ' ARG . . . . . 0.608 ' O ' ' N ' ' A' ' 69' ' ' LEU . 0.0 OUTLIER -77.96 8.41 4.73 Favored 'General case' 0 C--N 1.316 -0.856 0 N-CA-C 107.984 -1.117 . . . . 1.0 107.984 176.877 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . 0.492 ' CD2' ' O ' ' A' ' 66' ' ' GLY . 1.5 pt? -34.19 -27.96 0.01 OUTLIER 'General case' 0 N--CA 1.483 1.218 0 CA-C-O 121.757 0.789 . . . . 1.0 108.88 -178.158 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . 0.608 ' N ' ' O ' ' A' ' 67' ' ' ARG . 1.3 mt -64.57 -65.15 0.71 Allowed 'General case' 0 N--CA 1.473 0.715 0 C-N-CA 118.833 -1.147 . . . . 1.0 107.918 178.761 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . 0.667 ' C ' ' H ' ' A' ' 72' ' ' HIS . . . -78.22 -75.09 0.24 Allowed 'General case' 0 N--CA 1.469 0.494 0 N-CA-C 105.108 -2.182 . . . . 1.0 105.108 176.919 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . 0.46 ' O ' ' C ' ' A' ' 72' ' ' HIS . . . -44.87 4.1 0.0 OUTLIER 'General case' 0 CA--C 1.52 -0.209 0 C-N-CA 124.694 1.197 . . . . 1.0 113.425 178.57 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 72' ' ' HIS . . . . . 0.763 ' CD2' ' H ' ' A' ' 73' ' ' MET . 1.5 p80 -28.22 -55.05 0.11 Allowed 'General case' 0 C--N 1.335 -0.065 0 CA-C-N 118.067 0.394 . . . . 1.0 111.967 -179.408 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 73' ' ' MET . . . . . 0.763 ' H ' ' CD2' ' A' ' 72' ' ' HIS . 3.8 ppp? -76.84 -53.5 7.82 Favored 'General case' 0 C--N 1.316 -0.858 0 N-CA-C 108.483 -0.932 . . . . 1.0 108.483 177.278 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . 0.725 ' O ' ' N ' ' A' ' 76' ' ' GLY . 65.8 t -44.51 -41.87 2.1 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.424 0 CA-C-O 117.748 -1.12 . . . . 1.0 110.775 -176.122 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 75' ' ' ASN . . . . . 0.533 ' C ' ' N ' ' A' ' 77' ' ' ILE . 1.8 t-20 -35.09 -14.58 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.7 0 CA-C-N 120.857 1.662 . . . . 1.0 112.836 178.403 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . 0.725 ' N ' ' O ' ' A' ' 74' ' ' VAL . . . -44.04 -19.21 0.11 Allowed Glycine 0 CA--C 1.543 1.82 0 N-CA-C 107.846 -2.102 . . . . 1.0 107.846 175.917 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . 0.548 HG13 ' H ' ' A' ' 78' ' ' VAL . 0.8 OUTLIER -72.11 -54.98 14.85 Favored 'Isoleucine or valine' 0 C--O 1.207 -1.138 0 N-CA-C 107.683 -1.228 . . . . 1.0 107.683 178.267 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . 0.548 ' H ' HG13 ' A' ' 77' ' ' ILE . 55.5 t -33.52 -37.51 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.314 -0.973 0 CA-C-N 113.252 -1.795 . . . . 1.0 106.849 -178.391 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . 0.527 ' N ' ' O ' ' A' ' 77' ' ' ILE . 23.7 pt -97.77 -34.49 4.76 Favored 'Isoleucine or valine' 0 C--O 1.207 -1.146 0 CA-C-N 115.287 -0.869 . . . . 1.0 112.005 176.846 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 80' ' ' ALA . . . . . 0.501 ' N ' ' O ' ' A' ' 77' ' ' ILE . . . -84.78 -9.35 58.27 Favored 'General case' 0 N--CA 1.482 1.151 0 O-C-N 120.955 -1.091 . . . . 1.0 113.588 179.674 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . 0.495 ' N ' ' O ' ' A' ' 77' ' ' ILE . 82.3 tt0 -90.63 -75.77 0.45 Allowed 'General case' 0 N--CA 1.453 -0.314 0 N-CA-C 113.572 0.953 . . . . 1.0 113.572 -176.769 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 6.7 m-20 -91.04 -16.71 27.46 Favored 'General case' 0 C--O 1.22 -0.45 0 N-CA-C 113.463 0.912 . . . . 1.0 113.463 -179.141 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . 0.527 ' O ' ' N ' ' A' ' 86' ' ' ALA . . . -46.7 -42.21 16.24 Favored 'General case' 0 C--O 1.22 -0.479 0 C-N-CA 119.369 -0.933 . . . . 1.0 111.348 -177.681 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 14.3 tp -37.46 -46.02 0.77 Allowed 'General case' 0 N--CA 1.47 0.55 0 CA-C-O 121.48 0.657 . . . . 1.0 110.613 -178.349 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -65.46 -37.1 79.24 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.855 0 CA-C-N 114.75 -1.114 . . . . 1.0 110.564 -179.127 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . 0.542 ' O ' ' N ' ' A' ' 89' ' ' VAL . . . -90.61 -26.03 19.86 Favored 'General case' 0 C--O 1.222 -0.372 0 CA-C-O 120.641 0.258 . . . . 1.0 111.668 -179.762 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . 0.426 ' N ' ' O ' ' A' ' 83' ' ' ALA . 30.6 tp10 -54.71 -24.94 24.33 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 121.423 0.63 . . . . 1.0 109.659 -179.068 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -72.25 -8.56 55.48 Favored 'General case' 0 C--N 1.324 -0.503 0 N-CA-C 107.823 -1.177 . . . . 1.0 107.823 178.89 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 89' ' ' VAL . . . . . 0.542 ' N ' ' O ' ' A' ' 86' ' ' ALA . 3.2 t -92.49 36.03 0.1 OUTLIER 'Isoleucine or valine' 0 C--N 1.315 -0.909 0 CA-C-N 112.759 -2.019 . . . . 1.0 107.414 177.478 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 90' ' ' GLY . . . . . 0.902 ' O ' ' N ' ' A' ' 92' ' ' HIS . . . -55.82 -25.27 44.09 Favored Glycine 0 C--N 1.366 2.237 0 CA-C-O 117.346 -1.808 . . . . 1.0 112.082 176.955 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 91' ' ' PRO . . . . . 0.667 ' HD2' ' N ' ' A' ' 90' ' ' GLY . 20.8 Cg_exo -32.99 1.28 0.0 OUTLIER 'Trans proline' 0 N--CA 1.496 1.641 0 C-N-CA 123.41 2.74 . . . . 1.0 113.526 173.295 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 92' ' ' HIS . . . . . 0.902 ' N ' ' O ' ' A' ' 90' ' ' GLY . 0.0 OUTLIER -49.82 -33.27 16.2 Favored 'General case' 0 N--CA 1.431 -1.412 0 N-CA-C 106.91 -1.515 . . . . 1.0 106.91 178.346 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 24.8 tp -59.8 -57.1 14.35 Favored 'General case' 0 N--CA 1.453 -0.284 0 N-CA-C 107.537 -1.283 . . . . 1.0 107.537 177.396 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -51.72 -53.9 34.2 Favored 'General case' 0 C--N 1.323 -0.561 0 N-CA-C 107.953 -1.128 . . . . 1.0 107.953 -178.955 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 6.2 mmp_? -64.81 -32.93 74.85 Favored 'General case' 0 N--CA 1.47 0.562 0 CA-C-O 121.894 0.854 . . . . 1.0 110.911 178.225 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 96' ' ' ALA . . . . . 0.811 ' O ' ' N ' ' A' ' 100' ' ' ILE . . . -48.16 -39.2 20.02 Favored 'General case' 0 N--CA 1.493 1.711 0 N-CA-C 105.489 -2.041 . . . . 1.0 105.489 -177.31 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . 0.451 ' C ' ' O ' ' A' ' 96' ' ' ALA . 1.6 tm? -33.14 -24.34 0.0 OUTLIER 'General case' 0 CA--C 1.576 1.957 0 CA-C-N 112.693 -2.049 . . . . 1.0 107.219 -179.798 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 98' ' ' GLY . . . . . 0.722 ' N ' ' O ' ' A' ' 96' ' ' ALA . . . -90.04 -53.69 2.31 Favored Glycine 0 CA--C 1.557 2.665 0 CA-C-O 123.033 1.352 . . . . 1.0 111.796 171.226 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 99' ' ' GLN . . . . . 0.6 ' N ' ' O ' ' A' ' 96' ' ' ALA . 0.1 OUTLIER -77.97 8.02 5.27 Favored 'General case' 0 N--CA 1.443 -0.803 0 N-CA-C 107.458 -1.312 . . . . 1.0 107.458 177.691 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 100' ' ' ILE . . . . . 0.811 ' N ' ' O ' ' A' ' 96' ' ' ALA . 3.8 tp -61.73 -52.03 65.71 Favored 'Isoleucine or valine' 0 CA--C 1.48 -1.744 0 N-CA-C 107.076 -1.453 . . . . 1.0 107.076 179.416 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 101' ' ' VAL . . . . . 0.596 ' O ' ' N ' ' A' ' 105' ' ' GLY . 62.7 t -52.93 -57.09 5.07 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 N-CA-C 106.464 -1.68 . . . . 1.0 106.464 177.654 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 102' ' ' CYS . . . . . 0.417 ' O ' ' CB ' ' A' ' 106' ' ' ALA . 0.0 OUTLIER -46.43 -19.8 0.09 Allowed 'General case' 0 CA--C 1.541 0.606 0 C-N-CA 120.038 -0.665 . . . . 1.0 109.423 -179.226 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 103' ' ' ARG . . . . . 0.563 HH21 ' CB ' ' A' ' 96' ' ' ALA . 11.4 mtm-85 -94.13 -48.28 6.28 Favored 'General case' 0 N--CA 1.474 0.763 0 N-CA-C 113.793 1.035 . . . . 1.0 113.793 178.228 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 104' ' ' TYR . . . . . 0.57 ' CG ' ' O ' ' A' ' 104' ' ' TYR . 60.8 t80 -103.92 21.44 16.33 Favored 'General case' 0 C--N 1.32 -0.706 0 C-N-CA 125.724 1.61 . . . . 1.0 110.895 -179.73 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 105' ' ' GLY . . . . . 0.596 ' N ' ' O ' ' A' ' 101' ' ' VAL . . . -165.08 -8.03 0.03 OUTLIER Glycine 0 N--CA 1.453 -0.169 0 C-N-CA 119.606 -1.283 . . . . 1.0 111.072 -179.8 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 106' ' ' ALA . . . . . 0.464 ' C ' ' O ' ' A' ' 105' ' ' GLY . . . -28.72 117.65 0.11 Allowed 'General case' 0 CA--C 1.534 0.362 0 C-N-CA 122.117 0.167 . . . . 1.0 111.06 178.671 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 107' ' ' THR . . . . . 0.883 ' O ' ' HD2' ' A' ' 110' ' ' PRO . 6.6 m -135.7 -58.35 0.77 Allowed 'General case' 0 C--O 1.195 -1.777 0 N-CA-C 107.787 -1.19 . . . . 1.0 107.787 178.616 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 26.9 m -70.28 28.66 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.312 -1.061 0 O-C-N 120.735 -1.228 . . . . 1.0 108.847 -178.39 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 109' ' ' ILE . . . . . 0.578 ' H ' ' CD ' ' A' ' 110' ' ' PRO . 0.0 OUTLIER -111.01 -45.18 0.08 OUTLIER Pre-proline 0 CA--C 1.55 0.969 0 O-C-N 121.834 -0.542 . . . . 1.0 110.277 178.86 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 110' ' ' PRO . . . . . 0.883 ' HD2' ' O ' ' A' ' 107' ' ' THR . 24.6 Cg_exo -66.72 -29.12 43.26 Favored 'Trans proline' 0 N--CA 1.496 1.675 0 C-N-CA 123.453 2.769 . . . . 1.0 111.262 -178.7 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 4.9 t30 -68.35 -68.47 0.39 Allowed 'General case' 0 N--CA 1.455 -0.211 0 C-N-CA 120.405 -0.518 . . . . 1.0 109.847 -178.763 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 21.3 pt -51.39 -28.57 8.15 Favored 'Isoleucine or valine' 0 C--O 1.217 -0.61 0 CA-C-O 122.623 1.202 . . . . 1.0 109.367 179.09 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 1.6 t30 -59.25 -51.89 68.01 Favored 'General case' 0 C--N 1.294 -1.814 0 CA-C-N 112.62 -2.082 . . . . 1.0 107.752 -177.855 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -59.59 -32.69 70.62 Favored 'General case' 0 N--CA 1.45 -0.464 0 N-CA-C 112.368 0.507 . . . . 1.0 112.368 -179.646 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -80.81 -53.47 6.46 Favored 'General case' 0 C--O 1.21 -0.977 0 CA-C-O 121.7 0.762 . . . . 1.0 110.398 178.141 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 116' ' ' ILE . . . . . 0.524 ' O ' ' N ' ' A' ' 120' ' ' GLY . 28.5 mt -50.32 -61.26 0.65 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.707 0 CA-C-N 114.143 -1.39 . . . . 1.0 108.6 -178.823 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 117' ' ' GLU . . . . . 0.422 ' C ' ' O ' ' A' ' 116' ' ' ILE . 49.2 mt-10 -42.16 -52.83 4.24 Favored 'General case' 0 C--N 1.307 -1.274 0 CA-C-N 112.239 -2.255 . . . . 1.0 106.791 -177.969 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 94.6 t -60.63 -53.05 54.3 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.492 0 N-CA-C 108.355 -0.98 . . . . 1.0 108.355 177.187 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 2.9 tp -51.29 -69.38 0.11 Allowed 'General case' 0 CA--C 1.536 0.414 0 N-CA-C 106.687 -1.597 . . . . 1.0 106.687 -178.775 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 120' ' ' GLY . . . . . 0.658 ' O ' ' OG1' ' A' ' 121' ' ' THR . . . -73.05 -84.59 0.25 Allowed Glycine 0 CA--C 1.537 1.419 0 C-N-CA 119.356 -1.402 . . . . 1.0 111.102 -179.555 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 121' ' ' THR . . . . . 0.658 ' OG1' ' O ' ' A' ' 120' ' ' GLY . 41.6 m 170.37 -39.72 0.0 OUTLIER 'General case' 0 N--CA 1.476 0.862 0 CA-C-N 113.649 -1.276 . . . . 1.0 112.67 179.156 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 122' ' ' GLY . . . . . 0.695 ' O ' ' N ' ' A' ' 124' ' ' ASP . . . 100.6 -18.78 54.64 Favored Glycine 0 N--CA 1.469 0.836 0 N-CA-C 106.815 -2.514 . . . . 1.0 106.815 -176.242 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 123' ' ' THR . . . . . 0.475 ' O ' ' CG2' ' A' ' 123' ' ' THR . 8.9 t -52.52 83.74 0.0 OUTLIER 'General case' 0 N--CA 1.477 0.875 0 N-CA-C 104.733 -2.321 . . . . 1.0 104.733 178.414 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 124' ' ' ASP . . . . . 0.695 ' N ' ' O ' ' A' ' 122' ' ' GLY . 4.9 m-20 -171.49 -175.43 1.61 Allowed 'General case' 0 CA--C 1.53 0.181 0 CA-C-N 113.976 -1.465 . . . . 1.0 111.434 179.523 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 125' ' ' TYR . . . . . . . . . . . . . 78.4 t80 -145.98 144.71 30.28 Favored 'General case' 0 CA--C 1.538 0.483 0 CA-C-N 114.749 -1.114 . . . . 1.0 109.011 175.813 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 36.4 mmt-85 -146.34 147.02 30.9 Favored 'General case' 0 N--CA 1.474 0.727 0 N-CA-C 109.794 -0.447 . . . . 1.0 109.794 179.848 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 127' ' ' PHE . . . . . 0.412 ' CD1' ' C ' ' A' ' 127' ' ' PHE . 0.1 OUTLIER . . . . . 0 C--O 1.221 -0.412 0 CA-C-O 117.937 -1.03 . . . . 1.0 110.558 179.328 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 128' ' ' MTN . . . . . 0.428 ' C8 ' ' NH2' ' A' ' 47' ' ' ARG . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 129' ' ' MTN . . . . . 0.416 ' S1 ' ' C6 ' ' A' ' 129' ' ' MTN . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 130' ' ' MTN . . . . . 0.438 ' C7 ' ' NH1' ' A' ' 103' ' ' ARG . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 13.8 mmt . . . . . 0 N--CA 1.496 1.837 0 N-CA-C 109.691 -0.485 . . . . 1.0 109.691 . . . . . . . . . 0 0 . 1 . 022 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 98.1 p -106.35 9.44 31.86 Favored 'General case' 0 N--CA 1.469 0.482 0 CA-C-N 115.945 -0.57 . . . . 1.0 110.455 -179.946 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER 166.29 97.1 0.0 OUTLIER 'General case' 0 N--CA 1.466 0.362 0 CA-C-N 116.019 -0.537 . . . . 1.0 110.451 179.382 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 85.2 t80 -149.26 144.98 26.85 Favored 'General case' 0 N--CA 1.466 0.343 0 CA-C-N 116.053 -0.522 . . . . 1.0 110.104 179.441 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 5' ' ' ASP . . . . . 0.445 ' N ' ' OD1' ' A' ' 5' ' ' ASP . 5.1 p30 -153.54 148.65 26.8 Favored 'General case' 0 C--N 1.33 -0.274 0 N-CA-C 109.997 -0.372 . . . . 1.0 109.997 -179.761 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 6' ' ' THR . . . . . 0.63 ' O ' ' N ' ' A' ' 10' ' ' SER . 0.2 OUTLIER -70.87 177.15 3.79 Favored 'General case' 0 C--O 1.211 -0.95 0 C-N-CA 120.337 -0.545 . . . . 1.0 110.038 -179.979 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . 0.549 ' O ' ' N ' ' A' ' 11' ' ' ARG . 0.6 OUTLIER -59.62 -55.46 34.18 Favored 'General case' 0 C--N 1.317 -0.845 0 CA-C-O 121.566 0.698 . . . . 1.0 109.804 -178.436 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 8' ' ' ARG . . . . . 0.462 ' O ' ' CB ' ' A' ' 12' ' ' ALA . 0.2 OUTLIER -51.61 -57.11 10.06 Favored 'General case' 0 C--N 1.318 -0.761 0 N-CA-C 107.613 -1.255 . . . . 1.0 107.613 -178.182 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . 0.533 ' O ' ' CG1' ' A' ' 13' ' ' VAL . 0.0 OUTLIER -66.26 -47.9 82.87 Favored 'Isoleucine or valine' 0 CA--C 1.556 1.18 0 CA-C-N 114.036 -1.438 . . . . 1.0 110.127 -178.857 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 10' ' ' SER . . . . . 0.63 ' N ' ' O ' ' A' ' 6' ' ' THR . 32.6 t -62.45 -59.48 4.9 Favored 'General case' 0 N--CA 1.491 1.604 0 CA-C-O 121.022 0.439 . . . . 1.0 109.998 179.148 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 11' ' ' ARG . . . . . 0.577 ' O ' ' N ' ' A' ' 15' ' ' ALA . 20.2 tpp180 -66.08 -55.16 17.9 Favored 'General case' 0 CA--C 1.547 0.835 0 O-C-N 121.539 -0.726 . . . . 1.0 110.404 -177.397 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . 0.462 ' CB ' ' O ' ' A' ' 8' ' ' ARG . . . -50.97 -52.24 44.58 Favored 'General case' 0 N--CA 1.481 1.103 0 C-N-CA 118.228 -1.389 . . . . 1.0 107.307 -178.893 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . 0.604 ' O ' ' N ' ' A' ' 17' ' ' LEU . 3.2 m -63.21 -48.91 85.36 Favored 'Isoleucine or valine' 0 C--O 1.199 -1.593 0 C-N-CA 117.796 -1.562 . . . . 1.0 108.791 177.576 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . 0.423 ' O ' ' N ' ' A' ' 18' ' ' VAL . . . -57.12 -61.88 2.15 Favored 'General case' 0 C--O 1.211 -0.964 0 C-N-CA 117.621 -1.632 . . . . 1.0 109.638 179.039 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . 0.577 ' N ' ' O ' ' A' ' 11' ' ' ARG . . . -53.07 -55.78 21.21 Favored 'General case' 0 N--CA 1.475 0.82 0 CA-C-O 121.552 0.691 . . . . 1.0 110.263 -177.702 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . 0.509 ' CA ' ' H ' ' A' ' 22' ' ' GLY . . . -62.85 -54.55 37.11 Favored 'General case' 0 C--N 1.312 -1.055 0 CA-C-N 114.598 -1.183 . . . . 1.0 108.999 -179.346 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . 0.604 ' N ' ' O ' ' A' ' 13' ' ' VAL . 24.2 tp -56.75 -53.96 51.75 Favored 'General case' 0 N--CA 1.477 0.922 0 CA-C-N 114.606 -1.179 . . . . 1.0 108.752 -177.284 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . 0.6 HG23 ' H ' ' A' ' 19' ' ' GLY . 2.5 m -68.58 -55.98 14.02 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.355 0 C-N-CA 119.511 -0.876 . . . . 1.0 109.139 179.637 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . 0.6 ' H ' HG23 ' A' ' 18' ' ' VAL . . . -64.9 -165.28 1.07 Allowed Glycine 0 CA--C 1.525 0.693 0 CA-C-N 116.292 -0.413 . . . . 1.0 112.81 -178.596 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 20' ' ' PRO . . . . . 0.594 ' O ' ' N ' ' A' ' 24' ' ' ALA . 3.2 Cg_endo -81.17 -25.65 3.86 Favored 'Trans proline' 0 C--N 1.312 -1.374 0 C-N-CA 123.134 2.556 . . . . 1.0 112.486 -178.716 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -57.65 -58.75 12.93 Favored Glycine 0 CA--C 1.532 1.125 0 C-N-CA 119.522 -1.323 . . . . 1.0 110.924 -176.663 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . 0.509 ' H ' ' CA ' ' A' ' 16' ' ' ALA . . . -61.94 -54.36 35.78 Favored Glycine 0 N--CA 1.47 0.936 0 N-CA-C 108.152 -1.979 . . . . 1.0 108.152 -178.94 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 24.2 t -56.17 -38.66 55.1 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.636 0 N-CA-C 109.166 -0.679 . . . . 1.0 109.166 -179.794 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . 0.594 ' N ' ' O ' ' A' ' 20' ' ' PRO . . . -60.28 -61.06 2.88 Favored 'General case' 0 CA--C 1.536 0.414 0 C-N-CA 119.272 -0.971 . . . . 1.0 111.011 -179.488 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 16.3 mt -64.1 -46.88 82.27 Favored 'General case' 0 N--CA 1.468 0.447 0 N-CA-C 113.446 0.906 . . . . 1.0 113.446 -177.009 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . 0.493 ' CG2' ' H ' ' A' ' 27' ' ' VAL . 18.9 m -61.51 -58.26 8.38 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 C-N-CA 118.845 -1.142 . . . . 1.0 110.297 -177.688 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . 0.493 ' H ' ' CG2' ' A' ' 26' ' ' VAL . 1.1 p -63.07 -37.73 80.16 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 N-CA-C 112.518 0.562 . . . . 1.0 112.518 -177.377 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 7.9 tmtm? -67.52 -54.69 17.92 Favored 'General case' 0 C--N 1.319 -0.737 0 N-CA-C 108.556 -0.905 . . . . 1.0 108.556 -178.764 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 93.2 t -63.64 -48.48 86.52 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.972 0 CA-C-N 114.394 -1.275 . . . . 1.0 110.331 -178.294 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 30' ' ' CYS . . . . . . . . . . . . . 34.9 t -64.77 -60.8 2.68 Favored 'General case' 0 C--N 1.326 -0.445 0 C-N-CA 119.231 -0.988 . . . . 1.0 109.944 -179.106 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -64.11 -51.88 61.86 Favored 'General case' 0 C--N 1.325 -0.493 0 N-CA-C 111.992 0.367 . . . . 1.0 111.992 -176.074 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 88.48 74.09 1.28 Allowed Glycine 0 CA--C 1.527 0.805 0 N-CA-C 109.994 -1.242 . . . . 1.0 109.994 -179.196 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 38.6 mt 75.29 126.15 0.03 OUTLIER Pre-proline 0 N--CA 1.476 0.846 0 C-N-CA 122.815 0.446 . . . . 1.0 110.562 -179.422 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 56.6 Cg_endo -72.26 -13.01 28.13 Favored 'Trans proline' 0 N--CA 1.505 2.15 0 C-N-CA 122.227 1.952 . . . . 1.0 114.762 -179.316 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -60.19 -59.57 10.13 Favored Glycine 0 N--CA 1.468 0.804 0 C-N-CA 118.156 -1.973 . . . . 1.0 109.584 -178.787 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . 0.437 HG12 ' H ' ' A' ' 37' ' ' ILE . 1.5 t -78.64 -145.56 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.323 -0.572 0 N-CA-C 107.089 -1.449 . . . . 1.0 107.089 178.095 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . 0.437 ' H ' HG12 ' A' ' 36' ' ' VAL . 5.4 mm 76.71 78.36 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 N-CA-C 112.762 0.653 . . . . 1.0 112.762 177.756 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 38' ' ' HIS . . . . . 0.409 ' HE2' ' HA ' ' A' ' 36' ' ' VAL . 0.0 OUTLIER -135.99 126.99 27.77 Favored 'General case' 0 CA--C 1.538 0.484 0 N-CA-C 106.809 -1.552 . . . . 1.0 106.809 177.904 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 39' ' ' THR . . . . . 0.528 ' OG1' ' NH2' ' A' ' 47' ' ' ARG . 23.9 p -104.54 149.68 37.68 Favored Pre-proline 0 N--CA 1.47 0.57 0 N-CA-C 110.103 -0.332 . . . . 1.0 110.103 -178.972 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 89.6 Cg_endo -75.79 -34.31 3.28 Favored 'Trans proline' 0 C--N 1.311 -1.402 0 C-N-CA 121.675 1.583 . . . . 1.0 114.211 -178.685 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -128.82 134.64 48.41 Favored 'General case' 0 N--CA 1.477 0.88 0 CA-C-N 118.089 0.404 . . . . 1.0 111.548 179.035 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . 0.669 HH21 ' N ' ' A' ' 46' ' ' PHE . 16.6 ptm180 -169.37 167.89 9.83 Favored 'General case' 0 C--N 1.325 -0.491 0 C-N-CA 119.789 -0.765 . . . . 1.0 111.266 177.071 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -67.48 18.9 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.051 -0.522 . . . . 1.0 109.988 179.377 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . 0.651 ' H ' ' C ' ' A' ' 42' ' ' ARG . . . 79.45 -24.62 3.03 Favored Glycine 0 CA--C 1.522 0.502 0 N-CA-C 111.278 -0.729 . . . . 1.0 111.278 179.803 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . 0.532 ' O ' ' CD1' ' A' ' 46' ' ' PHE . 0.2 OUTLIER -150.54 149.14 29.54 Favored 'General case' 0 CA--C 1.542 0.65 0 N-CA-C 109.061 -0.718 . . . . 1.0 109.061 -178.886 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 46' ' ' PHE . . . . . 0.669 ' N ' HH21 ' A' ' 42' ' ' ARG . 1.9 m-30 144.53 73.45 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.826 0 O-C-N 124.408 1.067 . . . . 1.0 111.664 179.006 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 47' ' ' ARG . . . . . 1.028 ' O ' ' S1 ' ' A' ' 129' ' ' MTN . 2.2 ptt-85 135.2 151.09 0.0 OUTLIER 'General case' 0 N--CA 1.5 2.03 0 CA-C-O 116.905 -1.521 . . . . 1.0 108.643 -179.758 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 48' ' ' CYS . . . . . 0.685 ' O ' ' S1 ' ' A' ' 129' ' ' MTN . 6.2 p 51.1 62.31 2.78 Favored 'General case' 0 N--CA 1.482 1.161 0 CA-C-N 120.717 1.599 . . . . 1.0 111.982 -179.258 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -110.79 147.21 36.01 Favored Pre-proline 0 N--CA 1.473 0.702 0 N-CA-C 110.144 -0.317 . . . . 1.0 110.144 177.921 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . 0.414 ' C ' ' H ' ' A' ' 52' ' ' ARG . 72.4 Cg_endo -71.99 55.08 2.26 Favored 'Trans proline' 0 N--CA 1.494 1.516 0 C-N-CA 122.369 2.046 . . . . 1.0 111.762 179.959 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER 67.43 -3.42 1.07 Allowed 'General case' 0 N--CA 1.468 0.427 0 CA-C-N 115.071 -0.968 . . . . 1.0 111.474 179.189 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . 0.414 ' H ' ' C ' ' A' ' 50' ' ' PRO . 16.3 mtm-85 -85.92 154.03 21.78 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 121.377 0.608 . . . . 1.0 111.839 -179.557 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . 0.51 ' O ' ' N ' ' A' ' 55' ' ' ILE . 8.5 tp -68.22 137.0 25.39 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.306 0 CA-C-N 115.208 -0.905 . . . . 1.0 110.177 179.705 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -59.76 80.44 0.01 OUTLIER 'General case' 0 C--N 1.316 -0.858 0 CA-C-N 114.52 -1.218 . . . . 1.0 109.289 -177.548 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . 0.51 ' N ' ' O ' ' A' ' 53' ' ' ILE . 18.2 tt -149.17 157.91 6.58 Favored 'Isoleucine or valine' 0 C--N 1.348 0.538 0 N-CA-C 110.109 -0.33 . . . . 1.0 110.109 177.991 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 110.48 -6.38 29.99 Favored Glycine 0 N--CA 1.472 1.047 0 N-CA-C 110.698 -0.961 . . . . 1.0 110.698 -179.722 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 16.1 p-10 -76.46 98.31 4.56 Favored 'General case' 0 C--N 1.323 -0.58 0 N-CA-C 108.855 -0.794 . . . . 1.0 108.855 177.788 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 58' ' ' TRP . . . . . . . . . . . . . 24.1 m0 -87.84 174.54 8.3 Favored 'General case' 0 CA--C 1.533 0.324 0 CA-C-O 122.531 1.157 . . . . 1.0 112.513 -177.636 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 12.9 mtm180 -84.5 -62.03 1.65 Allowed 'General case' 0 C--N 1.317 -0.837 0 CA-C-N 112.523 -2.126 . . . . 1.0 112.628 -178.958 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 9.3 p90 -90.53 -15.25 31.04 Favored 'General case' 0 C--O 1.247 0.924 0 N-CA-C 113.615 0.969 . . . . 1.0 113.615 -178.861 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 4.8 tt0 -78.72 -14.44 59.28 Favored 'General case' 0 C--N 1.323 -0.554 0 O-C-N 121.569 -0.707 . . . . 1.0 110.53 -179.318 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . 0.566 ' O ' ' N ' ' A' ' 66' ' ' GLY . 27.8 m -46.26 -55.13 1.64 Allowed 'Isoleucine or valine' 0 C--O 1.209 -1.053 0 C-N-CA 119.931 -0.707 . . . . 1.0 110.099 -175.281 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 63' ' ' ALA . . . . . 0.404 ' H ' ' CG2' ' A' ' 62' ' ' VAL . . . -67.44 -52.17 42.78 Favored 'General case' 0 C--N 1.307 -1.273 0 CA-C-N 117.968 0.349 . . . . 1.0 110.25 -179.728 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 64' ' ' HIS . . . . . 0.498 ' O ' ' CG ' ' A' ' 67' ' ' ARG . 0.1 OUTLIER -50.3 -56.25 12.03 Favored 'General case' 0 CA--C 1.544 0.714 0 N-CA-C 108.595 -0.891 . . . . 1.0 108.595 -179.713 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . 0.705 ' C ' ' H ' ' A' ' 67' ' ' ARG . 21.0 t0 -69.8 -48.45 59.05 Favored 'General case' 0 C--N 1.318 -0.762 0 CA-C-O 121.813 0.816 . . . . 1.0 110.011 178.386 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . 0.566 ' N ' ' O ' ' A' ' 62' ' ' VAL . . . -68.74 27.2 0.29 Allowed Glycine 0 CA--C 1.516 0.153 0 N-CA-C 109.68 -1.368 . . . . 1.0 109.68 177.468 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 67' ' ' ARG . . . . . 0.705 ' H ' ' C ' ' A' ' 65' ' ' ASP . 29.0 mmt-85 -70.83 -0.74 9.71 Favored 'General case' 0 N--CA 1.438 -1.06 0 N-CA-C 106.486 -1.672 . . . . 1.0 106.486 174.771 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . 0.496 ' H ' ' C ' ' A' ' 66' ' ' GLY . 4.8 tt -32.95 -29.86 0.01 OUTLIER 'General case' 0 C--N 1.354 0.786 0 O-C-N 123.757 0.661 . . . . 1.0 109.327 -175.221 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . 0.617 ' N ' ' O ' ' A' ' 67' ' ' ARG . 4.3 tp -68.4 -66.94 0.51 Allowed 'General case' 0 CA--C 1.548 0.876 0 CA-C-N 114.554 -1.203 . . . . 1.0 111.224 179.748 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . 0.67 ' C ' ' H ' ' A' ' 72' ' ' HIS . . . -80.29 -78.56 0.17 Allowed 'General case' 0 N--CA 1.478 0.938 0 C-N-CA 118.145 -1.422 . . . . 1.0 108.862 179.814 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . 0.538 ' O ' ' N ' ' A' ' 74' ' ' VAL . . . -52.14 7.98 0.0 OUTLIER 'General case' 0 C--N 1.324 -0.522 0 C-N-CA 123.985 0.914 . . . . 1.0 112.468 -179.808 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 72' ' ' HIS . . . . . 0.76 ' CD2' ' H ' ' A' ' 73' ' ' MET . 1.3 p80 -24.93 -51.91 0.03 OUTLIER 'General case' 0 N--CA 1.469 0.481 0 N-CA-C 113.034 0.753 . . . . 1.0 113.034 -178.907 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 73' ' ' MET . . . . . 0.76 ' H ' ' CD2' ' A' ' 72' ' ' HIS . 2.2 tpp -73.53 -49.32 27.09 Favored 'General case' 0 C--N 1.322 -0.606 0 C-N-CA 119.309 -0.956 . . . . 1.0 108.901 178.936 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . 0.667 ' O ' ' N ' ' A' ' 76' ' ' GLY . 61.8 t -43.46 -42.53 1.49 Allowed 'Isoleucine or valine' 0 CA--C 1.517 -0.3 0 CA-C-O 118.43 -0.795 . . . . 1.0 111.804 -175.706 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 75' ' ' ASN . . . . . 0.633 ' O ' ' N ' ' A' ' 78' ' ' VAL . 0.7 OUTLIER -39.37 -13.86 0.01 OUTLIER 'General case' 0 N--CA 1.478 0.926 0 CA-C-N 120.01 1.277 . . . . 1.0 111.68 178.582 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . 0.667 ' N ' ' O ' ' A' ' 74' ' ' VAL . . . -43.31 -23.98 0.31 Allowed Glycine 0 CA--C 1.546 1.979 0 N-CA-C 108.068 -2.013 . . . . 1.0 108.068 178.412 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . 0.587 ' O ' ' N ' ' A' ' 80' ' ' ALA . 9.8 pt -69.75 -48.81 62.62 Favored 'Isoleucine or valine' 0 C--O 1.214 -0.799 0 N-CA-C 107.385 -1.339 . . . . 1.0 107.385 177.274 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . 0.633 ' N ' ' O ' ' A' ' 75' ' ' ASN . 3.7 p -34.26 -36.68 0.06 OUTLIER 'Isoleucine or valine' 0 CA--C 1.542 0.643 0 N-CA-C 107.399 -1.334 . . . . 1.0 107.399 -177.076 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . 0.464 ' N ' ' O ' ' A' ' 77' ' ' ILE . 43.9 pt -97.65 -26.49 3.93 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.862 0 N-CA-C 111.924 0.342 . . . . 1.0 111.924 178.077 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 80' ' ' ALA . . . . . 0.587 ' N ' ' O ' ' A' ' 77' ' ' ILE . . . -86.6 -10.72 53.29 Favored 'General case' 0 N--CA 1.48 1.039 0 N-CA-C 113.475 0.917 . . . . 1.0 113.475 178.681 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . 0.489 ' N ' ' O ' ' A' ' 77' ' ' ILE . 2.6 mt-10 -78.56 -68.96 0.6 Allowed 'General case' 0 N--CA 1.436 -1.126 0 N-CA-C 107.405 -1.331 . . . . 1.0 107.405 178.041 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 82' ' ' ASP . . . . . 0.9 ' O ' ' N ' ' A' ' 84' ' ' LEU . 0.5 OUTLIER -59.58 -60.87 3.16 Favored 'General case' 0 N--CA 1.437 -1.101 0 N-CA-C 107.928 -1.138 . . . . 1.0 107.928 178.705 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . 0.424 ' O ' ' N ' ' A' ' 86' ' ' ALA . . . 31.8 -64.52 0.0 OUTLIER 'General case' 0 N--CA 1.478 0.946 0 O-C-N 124.501 1.126 . . . . 1.0 111.812 179.32 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . 0.9 ' N ' ' O ' ' A' ' 82' ' ' ASP . 19.9 mt -33.78 -37.48 0.04 OUTLIER 'General case' 0 N--CA 1.475 0.788 0 N-CA-C 112.8 0.667 . . . . 1.0 112.8 -177.68 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 85' ' ' ILE . . . . . 0.548 ' CD1' ' N ' ' A' ' 86' ' ' ALA . 0.0 OUTLIER -100.43 -34.44 4.09 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.473 0 N-CA-C 108.584 -0.895 . . . . 1.0 108.584 177.857 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . 0.626 ' C ' ' H ' ' A' ' 88' ' ' ALA . . . -62.78 -61.25 2.54 Favored 'General case' 0 CA--C 1.539 0.55 0 CA-C-N 115.104 -0.953 . . . . 1.0 109.849 -179.413 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -64.66 16.35 0.02 OUTLIER 'General case' 0 CA--C 1.537 0.457 0 O-C-N 121.836 -0.54 . . . . 1.0 110.84 -179.206 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . 0.626 ' H ' ' C ' ' A' ' 86' ' ' ALA . . . -115.97 -14.94 11.23 Favored 'General case' 0 N--CA 1.466 0.353 0 N-CA-C 108.626 -0.879 . . . . 1.0 108.626 178.116 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 21.5 m -109.79 31.54 1.11 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.238 0 CA-C-N 115.11 -0.95 . . . . 1.0 109.775 177.734 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 90' ' ' GLY . . . . . 0.577 ' C ' ' H ' ' A' ' 92' ' ' HIS . . . -69.29 -39.76 81.5 Favored Glycine 0 CA--C 1.529 0.907 0 N-CA-C 111.059 -0.817 . . . . 1.0 111.059 178.216 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 91' ' ' PRO . . . . . 0.55 ' CD ' ' N ' ' A' ' 90' ' ' GLY . 81.0 Cg_exo -48.24 -8.53 0.06 OUTLIER 'Trans proline' 0 N--CA 1.493 1.466 0 C-N-CA 121.836 1.691 . . . . 1.0 111.048 179.266 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 92' ' ' HIS . . . . . 0.577 ' H ' ' C ' ' A' ' 90' ' ' GLY . 28.9 t60 -58.05 -14.37 6.49 Favored 'General case' 0 C--O 1.214 -0.804 0 N-CA-C 108.245 -1.02 . . . . 1.0 108.245 179.893 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . 0.464 ' HG ' ' H ' ' A' ' 94' ' ' ALA . 1.2 pp -63.44 -55.97 19.92 Favored 'General case' 0 CA--C 1.531 0.24 0 N-CA-C 108.128 -1.064 . . . . 1.0 108.128 177.464 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 94' ' ' ALA . . . . . 0.464 ' H ' ' HG ' ' A' ' 93' ' ' LEU . . . -56.45 -50.57 71.32 Favored 'General case' 0 CA--C 1.515 -0.376 0 N-CA-C 108.804 -0.813 . . . . 1.0 108.804 178.861 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 95' ' ' ARG . . . . . 0.611 ' O ' ' N ' ' A' ' 97' ' ' LEU . 7.8 ttt180 -59.65 -59.61 5.17 Favored 'General case' 0 CA--C 1.507 -0.68 0 N-CA-C 106.994 -1.484 . . . . 1.0 106.994 178.472 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 96' ' ' ALA . . . . . 0.924 ' O ' ' N ' ' A' ' 98' ' ' GLY . . . -47.21 -14.2 0.03 OUTLIER 'General case' 0 N--CA 1.418 -2.035 0 O-C-N 119.026 -2.296 . . . . 1.0 111.23 -179.976 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . 0.671 ' O ' ' N ' ' A' ' 100' ' ' ILE . 16.4 tp 7.1 -51.94 0.0 OUTLIER 'General case' 0 N--CA 1.487 1.394 0 CA-C-O 118.133 -0.937 . . . . 1.0 110.407 -168.103 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 98' ' ' GLY . . . . . 0.924 ' N ' ' O ' ' A' ' 96' ' ' ALA . . . -50.74 -23.55 6.95 Favored Glycine 0 CA--C 1.548 2.122 0 CA-C-N 122.221 2.282 . . . . 1.0 107.618 173.753 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 99' ' ' GLN . . . . . 0.577 ' N ' ' O ' ' A' ' 96' ' ' ALA . 1.4 tp-100 -67.02 -20.48 65.87 Favored 'General case' 0 C--N 1.377 1.788 0 N-CA-C 106.665 -1.605 . . . . 1.0 106.665 176.805 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 100' ' ' ILE . . . . . 0.671 ' N ' ' O ' ' A' ' 97' ' ' LEU . 2.7 tp -63.57 -39.59 85.93 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.867 0 N-CA-C 107.245 -1.391 . . . . 1.0 107.245 177.664 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 101' ' ' VAL . . . . . 0.662 ' O ' ' N ' ' A' ' 105' ' ' GLY . 97.6 t -59.26 -61.71 1.33 Allowed 'Isoleucine or valine' 0 C--O 1.215 -0.731 0 N-CA-C 108.894 -0.78 . . . . 1.0 108.894 178.954 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 102' ' ' CYS . . . . . 0.461 ' O ' ' S1 ' ' A' ' 130' ' ' MTN . 3.5 t -45.46 -26.99 0.64 Allowed 'General case' 0 C--N 1.315 -0.928 0 N-CA-C 112.368 0.507 . . . . 1.0 112.368 -179.089 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 53.8 ttt-85 -86.78 -47.39 9.12 Favored 'General case' 0 N--CA 1.494 1.752 0 CA-C-O 122.632 1.206 . . . . 1.0 112.891 179.639 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 104' ' ' TYR . . . . . 0.668 ' CG ' ' O ' ' A' ' 104' ' ' TYR . 0.0 OUTLIER -98.62 24.19 7.77 Favored 'General case' 0 C--N 1.299 -1.596 0 CA-C-N 112.203 -2.271 . . . . 1.0 107.88 178.09 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 105' ' ' GLY . . . . . 0.662 ' N ' ' O ' ' A' ' 101' ' ' VAL . . . -162.62 -94.82 0.1 Allowed Glycine 0 CA--C 1.533 1.206 0 N-CA-C 106.589 -2.604 . . . . 1.0 106.589 177.987 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . 70.69 63.18 0.19 Allowed 'General case' 0 CA--C 1.543 0.679 0 N-CA-C 114.021 1.119 . . . . 1.0 114.021 -179.362 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 107' ' ' THR . . . . . 0.643 ' O ' ' HD2' ' A' ' 110' ' ' PRO . 97.9 m -79.96 -57.76 3.49 Favored 'General case' 0 C--O 1.212 -0.881 0 O-C-N 120.349 -1.469 . . . . 1.0 109.435 177.845 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . 0.415 ' CG1' ' O ' ' A' ' 108' ' ' VAL . 21.4 t -80.22 25.04 0.08 OUTLIER 'Isoleucine or valine' 0 CA--C 1.538 0.486 0 O-C-N 121.254 -0.903 . . . . 1.0 113.079 -175.997 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 109' ' ' ILE . . . . . 0.553 ' H ' ' CD ' ' A' ' 110' ' ' PRO . 0.5 OUTLIER -109.38 -38.25 0.13 Allowed Pre-proline 0 CA--C 1.561 1.381 0 CA-C-N 118.909 0.777 . . . . 1.0 110.71 176.683 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 110' ' ' PRO . . . . . 0.643 ' HD2' ' O ' ' A' ' 107' ' ' THR . 23.0 Cg_exo -67.88 -23.15 41.53 Favored 'Trans proline' 0 N--CA 1.507 2.296 0 C-N-CA 123.642 2.894 . . . . 1.0 110.794 178.291 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 21.3 t-20 -69.17 -67.84 0.45 Allowed 'General case' 0 C--O 1.237 0.423 0 N-CA-C 109.169 -0.678 . . . . 1.0 109.169 -179.624 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -49.03 -30.39 3.55 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.596 0 CA-C-O 121.911 0.863 . . . . 1.0 108.701 177.861 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 113' ' ' ASN . . . . . 0.438 ' HB3' ' O ' ' A' ' 110' ' ' PRO . 20.4 t30 -55.25 -55.56 30.0 Favored 'General case' 0 C--N 1.309 -1.153 0 CA-C-N 113.833 -1.53 . . . . 1.0 108.31 -178.111 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -56.75 -31.78 64.92 Favored 'General case' 0 CA--C 1.537 0.458 0 N-CA-C 113.116 0.784 . . . . 1.0 113.116 -179.469 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -81.04 -50.4 9.72 Favored 'General case' 0 N--CA 1.472 0.664 0 CA-C-O 121.988 0.899 . . . . 1.0 110.951 178.237 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 116' ' ' ILE . . . . . 0.497 ' O ' ' N ' ' A' ' 119' ' ' LEU . 0.4 OUTLIER -49.07 -57.84 1.52 Allowed 'Isoleucine or valine' 0 C--N 1.314 -0.95 0 CA-C-N 113.969 -1.468 . . . . 1.0 107.562 -179.961 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 117' ' ' GLU . . . . . 0.461 ' C ' ' O ' ' A' ' 116' ' ' ILE . 2.4 tt0 -37.89 -55.99 1.16 Allowed 'General case' 0 N--CA 1.475 0.808 0 CA-C-N 113.187 -1.824 . . . . 1.0 106.526 -178.711 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 84.6 t -58.58 -50.58 78.5 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.723 0 CA-C-N 113.314 -1.767 . . . . 1.0 108.386 178.818 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 119' ' ' LEU . . . . . 0.497 ' N ' ' O ' ' A' ' 116' ' ' ILE . 1.2 tp -57.38 -73.98 0.06 Allowed 'General case' 0 CA--C 1.547 0.861 0 C-N-CA 119.823 -0.751 . . . . 1.0 109.666 -178.239 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -77.62 -82.21 0.6 Allowed Glycine 0 CA--C 1.543 1.837 0 C-N-CA 118.55 -1.786 . . . . 1.0 113.209 -178.904 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 121' ' ' THR . . . . . 0.411 ' H ' ' H ' ' A' ' 122' ' ' GLY . 27.3 m -168.5 -22.92 0.02 OUTLIER 'General case' 0 C--N 1.303 -1.425 0 N-CA-C 105.2 -2.148 . . . . 1.0 105.2 -176.621 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 122' ' ' GLY . . . . . 0.411 ' H ' ' H ' ' A' ' 121' ' ' THR . . . 109.1 -33.61 6.04 Favored Glycine 0 N--CA 1.449 -0.472 0 CA-C-N 112.472 -2.149 . . . . 1.0 114.686 177.37 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 123' ' ' THR . . . . . 0.408 ' C ' ' O ' ' A' ' 122' ' ' GLY . 0.2 OUTLIER -41.75 106.89 0.07 Allowed 'General case' 0 CA--C 1.538 0.49 0 CA-C-N 120.351 2.075 . . . . 1.0 113.05 -177.515 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 28.8 m-20 -142.6 145.03 33.12 Favored 'General case' 0 N--CA 1.465 0.298 0 CA-C-N 114.276 -1.329 . . . . 1.0 108.768 178.082 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 125' ' ' TYR . . . . . 0.421 ' CD1' ' C ' ' A' ' 125' ' ' TYR . 0.0 OUTLIER -151.5 146.64 26.05 Favored 'General case' 0 CA--C 1.546 0.801 0 N-CA-C 109.061 -0.718 . . . . 1.0 109.061 179.191 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 11.9 mmp_? -146.92 151.68 37.43 Favored 'General case' 0 N--CA 1.472 0.645 0 CA-C-N 115.112 -0.949 . . . . 1.0 109.341 177.534 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 127' ' ' PHE . . . . . . . . . . . . . 7.9 p90 . . . . . 0 C--O 1.219 -0.539 0 CA-C-O 118.173 -0.918 . . . . 1.0 110.533 178.726 . . . . . . . . 0 0 . 1 . 022 nuclear orig full ' A' A ' 128' ' ' MTN . . . . . 0.477 ' S1 ' ' C6 ' ' A' ' 128' ' ' MTN . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 129' ' ' MTN . . . . . 1.028 ' S1 ' ' O ' ' A' ' 47' ' ' ARG . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 130' ' ' MTN . . . . . 0.461 ' S1 ' ' O ' ' A' ' 102' ' ' CYS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.494 1.73 0 CA-C-O 121.226 0.536 . . . . 1.0 109.963 . . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 2' ' ' SER . . . . . 0.49 ' O ' ' CB ' ' A' ' 3' ' ' ASP . 6.7 m -83.92 9.14 12.93 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.448 -0.796 . . . . 1.0 110.892 179.825 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . 0.49 ' CB ' ' O ' ' A' ' 2' ' ' SER . 1.4 m-20 150.35 126.96 0.0 OUTLIER 'General case' 0 N--CA 1.478 0.956 0 O-C-N 124.088 0.867 . . . . 1.0 111.208 178.713 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 27.4 t80 -157.26 152.58 26.27 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.829 -0.623 . . . . 1.0 110.506 178.428 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 8.4 p30 -151.75 147.5 26.75 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.726 -0.67 . . . . 1.0 109.201 179.806 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 6' ' ' THR . . . . . 0.527 ' O ' ' N ' ' A' ' 10' ' ' SER . 0.2 OUTLIER -71.5 171.29 11.62 Favored 'General case' 0 C--O 1.211 -0.968 0 C-N-CA 120.917 -0.313 . . . . 1.0 110.179 -179.325 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . 0.527 ' O ' ' CG ' ' A' ' 11' ' ' ARG . 90.7 mt-10 -53.83 -69.58 0.12 Allowed 'General case' 0 C--N 1.31 -1.137 0 C-N-CA 120.645 -0.422 . . . . 1.0 110.2 -176.697 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 8' ' ' ARG . . . . . 0.493 ' O ' ' CB ' ' A' ' 12' ' ' ALA . 0.0 OUTLIER -42.22 -51.18 4.8 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-N 115.397 -0.819 . . . . 1.0 109.298 -176.299 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -66.83 -50.1 68.25 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.462 0 CA-C-N 115.151 -0.931 . . . . 1.0 111.055 177.657 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 10' ' ' SER . . . . . 0.527 ' N ' ' O ' ' A' ' 6' ' ' THR . 28.2 t -56.79 -40.24 75.54 Favored 'General case' 0 C--N 1.323 -0.564 0 N-CA-C 113.467 0.914 . . . . 1.0 113.467 -178.566 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 11' ' ' ARG . . . . . 0.677 ' O ' ' N ' ' A' ' 15' ' ' ALA . 2.3 ptp180 -85.76 -54.28 4.62 Favored 'General case' 0 C--O 1.213 -0.849 0 CA-C-O 121.743 0.783 . . . . 1.0 110.313 175.334 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . 0.521 ' H ' ' HG3' ' A' ' 11' ' ' ARG . . . -47.9 -52.83 17.85 Favored 'General case' 0 CA--C 1.496 -1.104 0 N-CA-C 106.896 -1.52 . . . . 1.0 106.896 -175.343 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . 0.626 ' O ' ' CB ' ' A' ' 17' ' ' LEU . 93.1 t -61.68 -54.86 29.09 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.466 0 C-N-CA 117.01 -1.876 . . . . 1.0 108.76 178.085 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . 0.534 ' O ' HG22 ' A' ' 18' ' ' VAL . . . -58.03 -64.64 0.84 Allowed 'General case' 0 C--O 1.207 -1.136 0 C-N-CA 117.81 -1.556 . . . . 1.0 110.755 -179.127 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . 0.677 ' N ' ' O ' ' A' ' 11' ' ' ARG . . . -52.78 -56.08 18.28 Favored 'General case' 0 N--CA 1.473 0.683 0 CA-C-O 121.053 0.454 . . . . 1.0 110.924 -179.23 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . 0.507 ' CB ' ' O ' ' A' ' 12' ' ' ALA . . . -63.96 -56.19 16.95 Favored 'General case' 0 C--N 1.312 -1.035 0 C-N-CA 119.172 -1.011 . . . . 1.0 109.199 -179.219 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . 0.626 ' CB ' ' O ' ' A' ' 13' ' ' VAL . 28.5 tp -55.85 -53.68 53.76 Favored 'General case' 0 N--CA 1.484 1.258 0 CA-C-N 114.95 -1.023 . . . . 1.0 108.705 -177.326 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . 0.731 HG22 ' H ' ' A' ' 19' ' ' GLY . 2.6 m -68.83 -58.2 6.49 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.365 0 N-CA-C 109.22 -0.659 . . . . 1.0 109.22 179.603 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . 0.731 ' H ' HG22 ' A' ' 18' ' ' VAL . . . -58.83 -165.04 0.1 Allowed Glycine 0 N--CA 1.442 -0.915 0 N-CA-C 110.607 -0.997 . . . . 1.0 110.607 -178.844 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 20' ' ' PRO . . . . . 0.579 ' O ' ' N ' ' A' ' 24' ' ' ALA . 65.4 Cg_endo -82.86 -31.4 0.74 Allowed 'Trans proline' 0 C--N 1.296 -2.235 0 C-N-CA 122.632 2.222 . . . . 1.0 113.847 -177.788 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -61.56 -59.6 9.56 Favored Glycine 0 CA--C 1.539 1.573 0 C-N-CA 119.881 -1.152 . . . . 1.0 112.987 -176.683 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . 0.483 ' H ' ' CA ' ' A' ' 16' ' ' ALA . . . -56.36 -53.63 41.72 Favored Glycine 0 N--CA 1.47 0.939 0 N-CA-C 107.304 -2.318 . . . . 1.0 107.304 -176.564 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 1.1 p -62.64 -30.63 49.73 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.184 0 C-N-CA 119.211 -0.995 . . . . 1.0 109.394 179.116 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . 0.579 ' N ' ' O ' ' A' ' 20' ' ' PRO . . . -56.63 -63.75 1.1 Allowed 'General case' 0 C--N 1.357 0.906 0 C-N-CA 118.86 -1.136 . . . . 1.0 110.867 -178.376 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 10.4 mt -63.93 -42.84 97.25 Favored 'General case' 0 CA--C 1.517 -0.303 0 C-N-CA 120.404 -0.518 . . . . 1.0 111.54 -177.92 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 78.8 t -58.41 -59.98 2.88 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.519 0 C-N-CA 119.25 -0.98 . . . . 1.0 110.211 -178.13 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . 0.418 ' O ' ' CB ' ' A' ' 31' ' ' ALA . 1.9 p -63.42 -36.52 76.53 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 C-N-CA 120.643 -0.423 . . . . 1.0 111.627 -178.433 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 59.2 tttm -66.26 -57.2 8.05 Favored 'General case' 0 C--N 1.318 -0.774 0 C-N-CA 119.749 -0.78 . . . . 1.0 109.28 -178.742 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 96.2 t -64.51 -47.23 90.07 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.127 0 CA-C-N 114.716 -1.129 . . . . 1.0 110.046 -178.345 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 30' ' ' CYS . . . . . . . . . . . . . 54.1 t -66.81 -61.92 1.71 Allowed 'General case' 0 N--CA 1.448 -0.548 0 C-N-CA 119.475 -0.89 . . . . 1.0 110.613 -179.71 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . 0.418 ' CB ' ' O ' ' A' ' 27' ' ' VAL . . . -62.08 -46.02 90.93 Favored 'General case' 0 CA--C 1.506 -0.733 0 CA-C-O 121.061 0.458 . . . . 1.0 111.18 -176.45 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . 0.504 ' O ' ' HB2' ' A' ' 33' ' ' LEU . . . 77.77 69.13 1.43 Allowed Glycine 0 N--CA 1.444 -0.813 0 N-CA-C 110.122 -1.191 . . . . 1.0 110.122 -179.357 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . 0.504 ' HB2' ' O ' ' A' ' 32' ' ' GLY . 3.8 mp 84.61 86.99 0.05 OUTLIER Pre-proline 0 N--CA 1.477 0.907 0 O-C-N 124.769 0.923 . . . . 1.0 111.617 -179.21 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 29.4 Cg_endo -64.2 -15.88 51.94 Favored 'Trans proline' 0 N--CA 1.497 1.716 0 C-N-CA 121.525 1.484 . . . . 1.0 111.824 178.519 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -55.95 -59.63 10.3 Favored Glycine 0 CA--C 1.522 0.524 0 C-N-CA 119.02 -1.562 . . . . 1.0 109.435 -179.092 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . 0.549 ' O ' ' CB ' ' A' ' 37' ' ' ILE . 1.3 p -97.81 172.87 1.04 Allowed 'Isoleucine or valine' 0 CA--C 1.51 -0.587 0 N-CA-C 105.215 -2.143 . . . . 1.0 105.215 177.131 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . 0.549 ' CB ' ' O ' ' A' ' 36' ' ' VAL . 6.8 tp 113.07 120.02 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.477 0.907 0 O-C-N 124.689 1.243 . . . . 1.0 110.38 179.411 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 59.5 m80 -141.12 131.42 25.04 Favored 'General case' 0 C--N 1.328 -0.337 0 N-CA-C 108.484 -0.932 . . . . 1.0 108.484 179.395 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -94.64 132.75 27.99 Favored Pre-proline 0 CA--C 1.543 0.679 0 C-N-CA 121.047 -0.261 . . . . 1.0 110.775 -178.849 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 44.8 Cg_exo -54.36 -42.86 63.94 Favored 'Trans proline' 0 N--CA 1.495 1.567 0 C-N-CA 121.902 1.735 . . . . 1.0 113.726 179.363 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -126.38 132.79 51.47 Favored 'General case' 0 N--CA 1.468 0.44 0 CA-C-N 116.602 -0.272 . . . . 1.0 110.861 179.805 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . 0.675 ' C ' ' H ' ' A' ' 44' ' ' GLY . 17.6 ptm180 -166.32 163.73 17.56 Favored 'General case' 0 C--N 1.323 -0.548 0 C-N-CA 120.115 -0.634 . . . . 1.0 109.931 178.1 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 43' ' ' ARG . . . . . 0.554 ' C ' ' H ' ' A' ' 45' ' ' PHE . 0.1 OUTLIER -62.76 24.47 0.01 OUTLIER 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 115.872 -0.604 . . . . 1.0 110.348 -179.973 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . 0.675 ' H ' ' C ' ' A' ' 42' ' ' ARG . . . 70.32 -28.56 0.45 Allowed Glycine 0 C--N 1.339 0.723 0 N-CA-C 111.376 -0.69 . . . . 1.0 111.376 179.982 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . 0.554 ' H ' ' C ' ' A' ' 43' ' ' ARG . 27.6 t80 -159.62 161.76 35.1 Favored 'General case' 0 C--N 1.32 -0.681 0 N-CA-C 109.084 -0.71 . . . . 1.0 109.084 179.199 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 46' ' ' PHE . . . . . 0.737 ' O ' ' HB2' ' A' ' 47' ' ' ARG . 2.3 m-30 132.65 91.43 0.0 OUTLIER 'General case' 0 N--CA 1.474 0.756 0 O-C-N 125.367 1.667 . . . . 1.0 107.109 -179.476 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 47' ' ' ARG . . . . . 0.737 ' HB2' ' O ' ' A' ' 46' ' ' PHE . 0.0 OUTLIER 125.96 139.71 0.0 OUTLIER 'General case' 0 N--CA 1.48 1.05 0 C-N-CA 124.52 1.128 . . . . 1.0 109.402 179.574 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 48' ' ' CYS . . . . . 0.535 ' SG ' ' C ' ' A' ' 47' ' ' ARG . 0.0 OUTLIER 71.01 73.41 0.19 Allowed 'General case' 0 C--O 1.218 -0.584 0 N-CA-C 108.759 -0.83 . . . . 1.0 108.759 -178.759 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 49' ' ' ASN . . . . . 0.612 ' O ' ' N ' ' A' ' 51' ' ' GLU . 0.0 OUTLIER -132.51 130.13 21.68 Favored Pre-proline 0 CA--C 1.537 0.458 0 N-CA-C 108.629 -0.878 . . . . 1.0 108.629 -179.426 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_exo -53.22 58.04 0.02 OUTLIER 'Trans proline' 0 N--CA 1.507 2.274 0 C-N-CA 122.593 2.195 . . . . 1.0 113.696 178.656 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . 0.612 ' N ' ' O ' ' A' ' 49' ' ' ASN . 6.0 mp0 67.27 3.44 3.24 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.525 -0.307 . . . . 1.0 111.002 -179.974 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 28.8 mtt-85 -80.25 152.87 28.85 Favored 'General case' 0 CA--C 1.531 0.22 0 N-CA-C 109.751 -0.462 . . . . 1.0 109.751 179.776 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . 0.465 ' O ' ' N ' ' A' ' 55' ' ' ILE . 3.6 tp -69.8 136.37 26.3 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-O 120.736 0.303 . . . . 1.0 111.209 -179.469 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 54' ' ' GLN . . . . . 0.523 ' CD ' ' H ' ' A' ' 54' ' ' GLN . 0.0 OUTLIER -60.07 82.82 0.01 OUTLIER 'General case' 0 CA--C 1.54 0.568 0 C-N-CA 120.195 -0.602 . . . . 1.0 110.279 -176.643 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . 0.465 ' N ' ' O ' ' A' ' 53' ' ' ILE . 20.3 tt -149.5 159.98 5.34 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.372 0 CA-C-N 116.145 -0.479 . . . . 1.0 110.89 178.138 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 112.55 -2.42 26.3 Favored Glycine 0 N--CA 1.47 0.942 0 N-CA-C 111.184 -0.767 . . . . 1.0 111.184 -179.814 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 3.6 p-10 -80.07 98.09 7.11 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-O 121.45 0.643 . . . . 1.0 111.239 178.988 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 58' ' ' TRP . . . . . . . . . . . . . 7.1 m95 -85.96 171.72 11.23 Favored 'General case' 0 C--N 1.319 -0.755 0 CA-C-O 123.212 1.482 . . . . 1.0 111.541 -179.464 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -84.24 -60.92 1.94 Allowed 'General case' 0 C--N 1.305 -1.342 0 CA-C-N 111.146 -2.752 . . . . 1.0 112.786 -176.825 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -91.04 -15.28 29.83 Favored 'General case' 0 C--N 1.312 -1.064 0 CA-C-N 114.839 -1.073 . . . . 1.0 112.539 -179.055 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . 0.431 ' O ' ' N ' ' A' ' 65' ' ' ASP . 4.0 tt0 -80.93 -14.75 57.7 Favored 'General case' 0 C--N 1.312 -1.032 0 O-C-N 121.901 -0.499 . . . . 1.0 110.244 -179.473 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . 0.593 ' O ' ' N ' ' A' ' 66' ' ' GLY . 29.0 m -47.16 -54.38 2.72 Favored 'Isoleucine or valine' 0 C--O 1.209 -1.057 0 C-N-CA 119.754 -0.778 . . . . 1.0 109.767 -176.851 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 63' ' ' ALA . . . . . 0.466 ' O ' ' HG2' ' A' ' 67' ' ' ARG . . . -66.62 -52.61 43.28 Favored 'General case' 0 C--N 1.306 -1.283 0 N-CA-C 109.559 -0.534 . . . . 1.0 109.559 -179.81 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 64' ' ' HIS . . . . . 0.443 ' O ' ' CG ' ' A' ' 67' ' ' ARG . 9.7 t60 -50.59 -58.8 4.98 Favored 'General case' 0 CA--C 1.542 0.66 0 CA-C-O 122.175 0.988 . . . . 1.0 109.933 -179.168 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . 0.609 ' C ' ' H ' ' A' ' 67' ' ' ARG . 58.9 t0 -67.83 -50.31 57.39 Favored 'General case' 0 C--N 1.31 -1.129 0 CA-C-O 122.492 1.139 . . . . 1.0 109.455 177.947 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . 0.593 ' N ' ' O ' ' A' ' 62' ' ' VAL . . . -68.23 30.84 0.26 Allowed Glycine 0 C--O 1.224 -0.497 0 O-C-N 121.069 -1.02 . . . . 1.0 111.795 178.487 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 67' ' ' ARG . . . . . 0.609 ' H ' ' C ' ' A' ' 65' ' ' ASP . 4.7 mmm180 -74.22 5.47 4.43 Favored 'General case' 0 C--N 1.306 -1.323 0 N-CA-C 108.72 -0.845 . . . . 1.0 108.72 176.279 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . 0.475 ' C ' ' O ' ' A' ' 67' ' ' ARG . 0.0 OUTLIER -34.22 -29.28 0.01 OUTLIER 'General case' 0 N--CA 1.481 1.09 0 N-CA-C 108.298 -1.001 . . . . 1.0 108.298 -176.671 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . 0.607 ' N ' ' O ' ' A' ' 67' ' ' ARG . 0.5 OUTLIER -68.36 -68.4 0.39 Allowed 'General case' 0 CA--C 1.546 0.817 0 C-N-CA 119.336 -0.946 . . . . 1.0 110.357 179.633 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . 0.693 ' C ' ' H ' ' A' ' 72' ' ' HIS . . . -78.29 -77.09 0.17 Allowed 'General case' 0 CA--C 1.51 -0.575 0 N-CA-C 108.344 -0.984 . . . . 1.0 108.344 179.925 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . 0.546 ' O ' ' N ' ' A' ' 74' ' ' VAL . . . -51.86 10.3 0.0 OUTLIER 'General case' 0 CA--C 1.537 0.458 0 C-N-CA 125.007 1.323 . . . . 1.0 111.953 178.188 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 72' ' ' HIS . . . . . 0.975 ' CD2' ' H ' ' A' ' 73' ' ' MET . 0.3 OUTLIER -21.37 -61.78 0.03 OUTLIER 'General case' 0 CA--C 1.519 -0.244 0 N-CA-C 113.9 1.074 . . . . 1.0 113.9 -178.957 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 73' ' ' MET . . . . . 0.975 ' H ' ' CD2' ' A' ' 72' ' ' HIS . 5.3 ptm -71.14 -45.6 63.23 Favored 'General case' 0 C--N 1.313 -0.978 0 N-CA-C 108.954 -0.758 . . . . 1.0 108.954 179.114 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . 0.795 ' O ' ' N ' ' A' ' 76' ' ' GLY . 79.7 t -40.88 -40.77 0.59 Allowed 'Isoleucine or valine' 0 CA--C 1.507 -0.697 0 CA-C-O 117.854 -1.07 . . . . 1.0 109.916 -175.937 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 75' ' ' ASN . . . . . 0.418 ' C ' ' N ' ' A' ' 77' ' ' ILE . 1.7 t-20 -33.59 -15.52 0.0 OUTLIER 'General case' 0 N--CA 1.482 1.136 0 CA-C-O 122.259 1.028 . . . . 1.0 110.891 178.305 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . 0.795 ' N ' ' O ' ' A' ' 74' ' ' VAL . . . -49.71 -22.04 3.87 Favored Glycine 0 N--CA 1.435 -1.414 0 N-CA-C 107.227 -2.349 . . . . 1.0 107.227 173.901 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . 0.418 ' N ' ' C ' ' A' ' 75' ' ' ASN . 85.2 mt -59.49 -52.84 56.24 Favored 'Isoleucine or valine' 0 C--N 1.351 0.658 0 CA-C-O 118.259 -0.876 . . . . 1.0 111.986 -179.927 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 33.0 t -51.04 -21.86 1.48 Allowed 'Isoleucine or valine' 0 C--N 1.351 0.659 0 CA-C-N 121.279 1.854 . . . . 1.0 112.477 -179.445 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . 0.43 HD11 ' H ' ' A' ' 127' ' ' PHE . 0.1 OUTLIER -94.88 -40.57 11.35 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.576 0 CA-C-N 116.102 -0.499 . . . . 1.0 109.888 179.713 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -77.32 -19.16 56.78 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.647 -0.706 . . . . 1.0 111.41 -179.232 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 22.5 tt0 -87.19 -67.6 0.81 Allowed 'General case' 0 N--CA 1.438 -1.047 0 N-CA-C 109.616 -0.513 . . . . 1.0 109.616 178.961 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 82' ' ' ASP . . . . . 0.817 ' O ' ' N ' ' A' ' 84' ' ' LEU . 15.6 m-20 -60.46 -61.18 2.78 Favored 'General case' 0 C--N 1.352 0.682 0 C-N-CA 118.91 -1.116 . . . . 1.0 109.267 -179.391 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . 0.428 ' C ' ' O ' ' A' ' 82' ' ' ASP . . . 23.69 -67.29 0.0 OUTLIER 'General case' 0 N--CA 1.486 1.371 0 O-C-N 124.752 1.283 . . . . 1.0 112.063 179.868 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . 0.817 ' N ' ' O ' ' A' ' 82' ' ' ASP . 0.8 OUTLIER -33.21 -41.76 0.08 Allowed 'General case' 0 N--CA 1.476 0.843 0 C-N-CA 122.728 0.411 . . . . 1.0 111.934 -178.09 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 18.2 pt -95.2 -41.64 12.06 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.615 0 N-CA-C 109.146 -0.687 . . . . 1.0 109.146 178.675 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . 0.43 ' C ' ' H ' ' A' ' 88' ' ' ALA . . . -54.43 -57.87 9.64 Favored 'General case' 0 CA--C 1.54 0.585 0 CA-C-N 115.399 -0.818 . . . . 1.0 110.305 -179.448 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -71.16 10.58 0.55 Allowed 'General case' 0 CA--C 1.538 0.505 0 N-CA-C 111.838 0.31 . . . . 1.0 111.838 -179.023 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . 0.43 ' H ' ' C ' ' A' ' 86' ' ' ALA . . . -99.28 -19.89 16.84 Favored 'General case' 0 N--CA 1.48 1.044 0 CA-C-O 122.738 1.256 . . . . 1.0 109.156 179.281 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 28.6 m -104.32 37.46 0.31 Allowed 'Isoleucine or valine' 0 C--N 1.313 -1.018 0 CA-C-N 111.832 -2.44 . . . . 1.0 110.004 178.259 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 90' ' ' GLY . . . . . 0.624 ' O ' ' N ' ' A' ' 92' ' ' HIS . . . -65.17 -41.02 97.16 Favored Glycine 0 CA--C 1.537 1.456 0 CA-C-O 118.853 -0.97 . . . . 1.0 111.671 177.144 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 91' ' ' PRO . . . . . 0.471 ' CD ' ' N ' ' A' ' 90' ' ' GLY . 88.3 Cg_exo -41.47 -11.71 0.03 OUTLIER 'Trans proline' 0 N--CA 1.5 1.879 0 C-N-CA 122.349 2.033 . . . . 1.0 112.008 178.923 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 92' ' ' HIS . . . . . 0.624 ' N ' ' O ' ' A' ' 90' ' ' GLY . 6.5 p-80 -55.08 -18.75 5.87 Favored 'General case' 0 C--O 1.194 -1.833 0 N-CA-C 108.615 -0.883 . . . . 1.0 108.615 -179.736 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . 0.504 ' HG ' ' H ' ' A' ' 94' ' ' ALA . 0.8 OUTLIER -62.53 -57.9 9.51 Favored 'General case' 0 C--N 1.317 -0.806 0 N-CA-C 108.763 -0.828 . . . . 1.0 108.763 179.225 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 94' ' ' ALA . . . . . 0.504 ' H ' ' HG ' ' A' ' 93' ' ' LEU . . . -58.27 -57.76 11.46 Favored 'General case' 0 N--CA 1.452 -0.369 0 CA-C-N 115.293 -0.867 . . . . 1.0 109.335 179.265 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 95' ' ' ARG . . . . . 0.588 ' O ' ' N ' ' A' ' 97' ' ' LEU . 37.4 mtp-105 -56.84 -59.67 4.69 Favored 'General case' 0 C--O 1.242 0.681 0 CA-C-O 123.098 1.428 . . . . 1.0 108.041 179.288 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 96' ' ' ALA . . . . . 0.84 ' O ' ' N ' ' A' ' 98' ' ' GLY . . . -47.32 -15.82 0.05 OUTLIER 'General case' 0 C--N 1.301 -1.502 0 O-C-N 118.572 -2.58 . . . . 1.0 111.042 -179.051 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . 0.641 ' O ' ' N ' ' A' ' 100' ' ' ILE 0.279 16.1 tp 6.17 -54.07 0.0 OUTLIER 'General case' 0 N--CA 1.477 0.906 0 CA-C-O 118.116 -0.945 . . . . 1.0 112.287 -168.266 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 98' ' ' GLY . . . . . 0.84 ' N ' ' O ' ' A' ' 96' ' ' ALA . . . -49.38 -24.44 5.24 Favored Glycine 0 C--N 1.295 -1.708 0 CA-C-N 122.303 2.32 . . . . 1.0 108.417 175.16 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 99' ' ' GLN . . . . . 0.452 ' N ' ' O ' ' A' ' 96' ' ' ALA . 40.9 mm-40 -71.39 -20.7 62.11 Favored 'General case' 0 C--N 1.371 1.538 0 C-N-CA 117.477 -1.689 . . . . 1.0 107.882 177.344 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 100' ' ' ILE . . . . . 0.641 ' N ' ' O ' ' A' ' 97' ' ' LEU . 0.3 OUTLIER -67.45 -40.66 84.96 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.499 0 N-CA-C 108.131 -1.063 . . . . 1.0 108.131 177.392 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 101' ' ' VAL . . . . . 0.678 ' O ' ' N ' ' A' ' 105' ' ' GLY . 0.4 OUTLIER -57.4 -58.35 6.41 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.605 0 N-CA-C 106.561 -1.644 . . . . 1.0 106.561 179.959 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 102' ' ' CYS . . . . . 0.482 ' N ' ' CG1' ' A' ' 101' ' ' VAL . 4.6 t -47.07 -21.87 0.28 Allowed 'General case' 0 C--O 1.209 -1.043 0 CA-C-N 115.666 -0.697 . . . . 1.0 110.649 -179.801 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 103' ' ' ARG . . . . . 0.421 ' H ' ' C ' ' A' ' 101' ' ' VAL . 2.1 tmm_? -88.57 -43.32 11.47 Favored 'General case' 0 N--CA 1.486 1.326 0 CA-C-O 122.689 1.233 . . . . 1.0 111.779 178.118 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 104' ' ' TYR . . . . . 0.779 ' CG ' ' O ' ' A' ' 104' ' ' TYR . 1.3 t80 -98.14 23.19 8.51 Favored 'General case' 0 C--N 1.31 -1.121 0 CA-C-N 112.373 -2.194 . . . . 1.0 108.572 177.238 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 105' ' ' GLY . . . . . 0.678 ' N ' ' O ' ' A' ' 101' ' ' VAL . . . -167.68 -92.19 0.08 OUTLIER Glycine 0 N--CA 1.446 -0.695 0 N-CA-C 107.104 -2.398 . . . . 1.0 107.104 177.756 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 106' ' ' ALA . . . . . 0.453 ' CB ' ' O ' ' A' ' 102' ' ' CYS . . . 67.36 63.18 0.44 Allowed 'General case' 0 N--CA 1.443 -0.793 0 N-CA-C 112.418 0.525 . . . . 1.0 112.418 179.83 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 107' ' ' THR . . . . . 0.458 ' O ' ' HD2' ' A' ' 110' ' ' PRO . 19.1 m -83.1 -65.05 1.06 Allowed 'General case' 0 CA--C 1.541 0.632 0 O-C-N 121.449 -0.782 . . . . 1.0 111.603 179.96 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 9.1 m -71.63 28.54 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.322 -0.616 0 O-C-N 121.078 -1.014 . . . . 1.0 111.644 -177.107 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 109' ' ' ILE . . . . . 0.738 ' H ' ' HD2' ' A' ' 110' ' ' PRO . 0.1 OUTLIER -112.48 -53.05 0.05 OUTLIER Pre-proline 0 CA--C 1.553 1.061 0 N-CA-C 108.167 -1.049 . . . . 1.0 108.167 176.117 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 110' ' ' PRO . . . . . 0.738 ' HD2' ' H ' ' A' ' 109' ' ' ILE . 19.1 Cg_endo -51.48 -29.78 32.8 Favored 'Trans proline' 0 N--CA 1.494 1.501 0 C-N-CA 122.563 2.176 . . . . 1.0 111.259 178.634 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 11.0 t-20 -63.01 -69.4 0.27 Allowed 'General case' 0 N--CA 1.466 0.356 0 C-N-CA 120.511 -0.476 . . . . 1.0 110.392 -179.339 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 112' ' ' ILE . . . . . 0.461 HG13 ' N ' ' A' ' 113' ' ' ASN . 26.6 pt -51.62 -31.13 12.27 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.457 0 CA-C-O 123.228 1.49 . . . . 1.0 109.717 179.502 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 113' ' ' ASN . . . . . 0.461 ' N ' HG13 ' A' ' 112' ' ' ILE . 0.0 OUTLIER -52.87 -52.58 56.85 Favored 'General case' 0 C--N 1.301 -1.511 0 CA-C-N 112.077 -2.329 . . . . 1.0 107.746 -177.858 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -60.09 -32.64 71.16 Favored 'General case' 0 N--CA 1.442 -0.848 0 N-CA-C 112.182 0.438 . . . . 1.0 112.182 179.625 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -81.27 -57.19 3.61 Favored 'General case' 0 C--O 1.215 -0.751 0 CA-C-O 121.499 0.666 . . . . 1.0 111.702 178.732 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 116' ' ' ILE . . . . . 0.529 ' O ' ' N ' ' A' ' 120' ' ' GLY . 3.4 mm -51.72 -57.86 2.94 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.715 0 CA-C-O 122.479 1.133 . . . . 1.0 108.043 -177.907 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 117' ' ' GLU . . . . . 0.485 ' C ' ' O ' ' A' ' 116' ' ' ILE . 6.5 mt-10 -40.15 -53.17 2.5 Favored 'General case' 0 C--N 1.315 -0.919 0 CA-C-N 112.285 -2.234 . . . . 1.0 105.927 -178.29 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 78.0 t -60.26 -52.04 65.91 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.608 0 C-N-CA 119.459 -0.896 . . . . 1.0 109.065 177.261 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 119' ' ' LEU . . . . . 0.488 ' N ' ' O ' ' A' ' 116' ' ' ILE . 0.9 OUTLIER -58.39 -70.31 0.15 Allowed 'General case' 0 N--CA 1.454 -0.253 0 C-N-CA 119.209 -0.997 . . . . 1.0 108.387 -177.656 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 120' ' ' GLY . . . . . 0.655 ' O ' ' OG1' ' A' ' 121' ' ' THR . . . -66.19 -84.99 0.08 OUTLIER Glycine 0 C--N 1.351 1.362 0 C-N-CA 118.127 -1.987 . . . . 1.0 109.159 178.41 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 121' ' ' THR . . . . . 0.655 ' OG1' ' O ' ' A' ' 120' ' ' GLY . 18.5 m 160.46 -34.55 0.0 OUTLIER 'General case' 0 N--CA 1.482 1.164 0 O-C-N 125.373 1.278 . . . . 1.0 112.858 179.421 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 122' ' ' GLY . . . . . 0.643 ' O ' ' N ' ' A' ' 124' ' ' ASP . . . 105.64 -14.19 46.31 Favored Glycine 0 N--CA 1.461 0.313 0 N-CA-C 107.285 -2.326 . . . . 1.0 107.285 -175.832 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 123' ' ' THR . . . . . 0.44 ' OG1' ' CG2' ' A' ' 121' ' ' THR . 2.8 m -54.89 82.39 0.0 OUTLIER 'General case' 0 N--CA 1.465 0.311 0 N-CA-C 106.037 -1.838 . . . . 1.0 106.037 178.59 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 124' ' ' ASP . . . . . 0.643 ' N ' ' O ' ' A' ' 122' ' ' GLY . 18.2 t70 -164.29 170.34 16.33 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 114.057 -1.429 . . . . 1.0 112.117 -179.338 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 125' ' ' TYR . . . . . . . . . . . . . 33.5 t80 -151.32 149.01 28.85 Favored 'General case' 0 CA--C 1.535 0.391 0 CA-C-N 115.637 -0.71 . . . . 1.0 109.937 177.298 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 14.6 tpp180 -149.13 150.08 32.1 Favored 'General case' 0 CA--C 1.532 0.283 0 CA-C-N 115.792 -0.64 . . . . 1.0 110.169 177.785 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 127' ' ' PHE . . . . . 0.43 ' H ' HD11 ' A' ' 79' ' ' ILE . 20.4 t80 . . . . . 0 C--O 1.22 -0.469 0 CA-C-O 118.036 -0.983 . . . . 1.0 109.366 178.687 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 128' ' ' MTN . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 023 nuclear orig full ' A' A ' 129' ' ' MTN . . . . . 0.418 ' C8 ' ' O ' ' A' ' 48' ' ' CYS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 130' ' ' MTN . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 024 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 62.1 mtt . . . . . 0 N--CA 1.489 1.509 0 N-CA-C 108.961 -0.755 . . . . 1.0 108.961 . . . . . . . . . 0 0 . 1 . 024 nuclear orig full ' A' A ' 2' ' ' SER . . . . . 0.458 ' O ' ' CB ' ' A' ' 3' ' ' ASP . 91.4 p -93.78 10.29 33.64 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.19 -0.459 . . . . 1.0 110.692 -179.793 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . 0.458 ' CB ' ' O ' ' A' ' 2' ' ' SER . 7.1 m-20 157.62 111.34 0.0 OUTLIER 'General case' 0 N--CA 1.471 0.618 0 O-C-N 123.82 0.7 . . . . 1.0 110.256 178.643 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 60.6 t80 -153.66 149.19 27.29 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-N 116.263 -0.426 . . . . 1.0 110.743 179.792 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 5' ' ' ASP . . . . . 0.528 ' N ' ' OD1' ' A' ' 5' ' ' ASP . 0.3 OUTLIER -155.31 150.77 27.22 Favored 'General case' 0 CA--C 1.533 0.312 0 CA-C-N 116.373 -0.376 . . . . 1.0 110.874 -179.057 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 6' ' ' THR . . . . . 0.408 HG21 ' H ' ' A' ' 7' ' ' GLU . 0.2 OUTLIER -61.38 -158.29 0.01 OUTLIER 'General case' 0 N--CA 1.464 0.264 0 C-N-CA 120.762 -0.375 . . . . 1.0 110.637 -179.532 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . 0.408 ' H ' HG21 ' A' ' 6' ' ' THR . 42.8 tt0 -74.34 -66.49 0.72 Allowed 'General case' 0 CA--C 1.502 -0.894 0 C-N-CA 120.699 -0.4 . . . . 1.0 110.047 -178.95 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 8' ' ' ARG . . . . . 0.534 ' O ' ' CB ' ' A' ' 12' ' ' ALA . 13.0 ttm105 -52.54 -44.98 66.16 Favored 'General case' 0 N--CA 1.437 -1.123 0 N-CA-C 112.432 0.53 . . . . 1.0 112.432 -177.057 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 97.7 t -64.78 -51.12 71.2 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.148 0 C-N-CA 117.986 -1.486 . . . . 1.0 109.212 179.284 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 34.3 t -63.49 -40.73 97.85 Favored 'General case' 0 N--CA 1.474 0.749 0 N-CA-C 114.355 1.243 . . . . 1.0 114.355 -179.066 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 11' ' ' ARG . . . . . 0.559 ' O ' ' N ' ' A' ' 15' ' ' ALA . 59.3 ttm-85 -80.16 -54.92 5.31 Favored 'General case' 0 CA--C 1.536 0.442 0 CA-C-O 122.714 1.245 . . . . 1.0 109.732 178.047 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . 0.534 ' CB ' ' O ' ' A' ' 8' ' ' ARG . . . -46.26 -48.59 17.96 Favored 'General case' 0 N--CA 1.483 1.213 0 CA-C-N 112.907 -1.951 . . . . 1.0 106.14 -176.218 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . 0.636 ' O ' ' CB ' ' A' ' 17' ' ' LEU . 34.0 m -60.63 -52.45 61.34 Favored 'Isoleucine or valine' 0 C--O 1.197 -1.663 0 C-N-CA 116.873 -1.931 . . . . 1.0 108.046 176.757 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . 0.433 ' N ' ' O ' ' A' ' 11' ' ' ARG . . . -58.53 -64.59 0.87 Allowed 'General case' 0 N--CA 1.472 0.632 0 C-N-CA 118.428 -1.309 . . . . 1.0 111.736 179.911 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . 0.563 ' O ' ' N ' ' A' ' 19' ' ' GLY . . . -53.19 -55.99 19.91 Favored 'General case' 0 N--CA 1.475 0.802 0 CA-C-O 121.731 0.777 . . . . 1.0 110.161 -177.55 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . 0.489 ' CB ' ' O ' ' A' ' 12' ' ' ALA . . . -63.96 -53.84 43.92 Favored 'General case' 0 C--N 1.311 -1.098 0 CA-C-N 114.56 -1.2 . . . . 1.0 109.066 -178.985 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . 0.636 ' CB ' ' O ' ' A' ' 13' ' ' VAL . 33.0 tp -56.83 -53.73 54.48 Favored 'General case' 0 N--CA 1.484 1.232 0 C-N-CA 119.047 -1.061 . . . . 1.0 108.637 -177.505 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . 0.543 HG23 ' H ' ' A' ' 19' ' ' GLY . 1.7 m -69.94 -57.44 8.19 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.457 0 C-N-CA 119.778 -0.769 . . . . 1.0 110.032 179.515 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . 0.563 ' N ' ' O ' ' A' ' 15' ' ' ALA . . . -64.93 -172.76 3.36 Favored Glycine 0 CA--C 1.526 0.761 0 N-CA-C 110.816 -0.914 . . . . 1.0 110.816 -179.532 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 20' ' ' PRO . . . . . 0.587 ' O ' ' N ' ' A' ' 24' ' ' ALA . 6.0 Cg_exo -76.46 -22.95 11.9 Favored 'Trans proline' 0 N--CA 1.503 2.036 0 C-N-CA 123.481 2.787 . . . . 1.0 114.651 -178.442 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -59.82 -57.73 17.89 Favored Glycine 0 N--CA 1.475 1.264 0 C-N-CA 119.576 -1.297 . . . . 1.0 111.831 -176.505 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . 0.468 ' H ' ' CA ' ' A' ' 16' ' ' ALA . . . -58.24 -55.51 30.28 Favored Glycine 0 N--CA 1.464 0.547 0 N-CA-C 108.07 -2.012 . . . . 1.0 108.07 -177.249 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . 0.532 ' CG2' ' O ' ' A' ' 19' ' ' GLY . 0.0 OUTLIER -61.5 -35.34 66.19 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.137 0 CA-C-N 114.918 -0.641 . . . . 1.0 109.771 -179.963 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . 0.587 ' N ' ' O ' ' A' ' 20' ' ' PRO . . . -54.6 -60.84 2.81 Favored 'General case' 0 CA--C 1.537 0.462 0 C-N-CA 118.223 -1.391 . . . . 1.0 108.893 -179.989 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 15.1 tp -63.01 -45.23 93.36 Favored 'General case' 0 C--N 1.341 0.229 0 CA-C-N 118.386 0.539 . . . . 1.0 112.192 -179.302 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 82.0 t -59.86 -60.02 3.13 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.227 0 C-N-CA 118.664 -1.215 . . . . 1.0 110.052 -177.138 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 2.6 t -59.19 -37.39 68.33 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.309 0 N-CA-C 112.024 0.379 . . . . 1.0 112.024 -178.341 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 25.2 tttm -65.25 -54.43 29.39 Favored 'General case' 0 C--N 1.319 -0.727 0 C-N-CA 119.936 -0.705 . . . . 1.0 109.275 -179.121 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 43.4 t -63.38 -47.1 93.42 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.993 0 CA-C-N 114.719 -1.128 . . . . 1.0 110.603 -178.332 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 30' ' ' CYS . . . . . 0.521 ' SG ' ' N ' ' A' ' 31' ' ' ALA . 0.0 OUTLIER -67.61 -61.09 2.06 Favored 'General case' 0 CA--C 1.533 0.3 0 C-N-CA 118.474 -1.29 . . . . 1.0 110.152 -179.714 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . 0.521 ' N ' ' SG ' ' A' ' 30' ' ' CYS . . . -64.3 -53.68 45.13 Favored 'General case' 0 CA--C 1.514 -0.429 0 N-CA-C 113.893 1.071 . . . . 1.0 113.893 -176.014 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 82.26 72.37 1.26 Allowed Glycine 0 CA--C 1.528 0.902 0 N-CA-C 109.018 -1.633 . . . . 1.0 109.018 -177.056 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . 0.445 ' O ' ' O ' ' A' ' 36' ' ' VAL . 2.9 mt 85.86 86.05 0.05 OUTLIER Pre-proline 0 N--CA 1.476 0.856 0 C-N-CA 123.409 0.683 . . . . 1.0 111.447 -179.788 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 52.7 Cg_exo -56.98 -26.76 69.93 Favored 'Trans proline' 0 N--CA 1.506 2.223 0 C-N-CA 123.366 2.71 . . . . 1.0 113.517 179.251 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -54.92 -57.0 20.15 Favored Glycine 0 CA--C 1.521 0.424 0 N-CA-C 108.224 -1.95 . . . . 1.0 108.224 -179.355 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . 0.537 ' O ' ' CB ' ' A' ' 37' ' ' ILE . 14.5 p -97.07 163.01 2.51 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 N-CA-C 107.521 -1.289 . . . . 1.0 107.521 177.755 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . 0.537 ' CB ' ' O ' ' A' ' 36' ' ' VAL . 3.7 mm 122.12 116.54 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.484 1.267 0 O-C-N 124.4 1.062 . . . . 1.0 109.499 -179.322 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 38' ' ' HIS . . . . . 0.405 ' CD2' ' N ' ' A' ' 38' ' ' HIS . 0.0 OUTLIER -138.63 129.29 26.29 Favored 'General case' 0 C--N 1.329 -0.286 0 N-CA-C 107.55 -1.278 . . . . 1.0 107.55 178.704 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -95.95 154.07 39.06 Favored Pre-proline 0 N--CA 1.467 0.391 0 N-CA-C 109.87 -0.419 . . . . 1.0 109.87 -179.435 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 97.6 Cg_endo -77.52 -42.27 0.29 Allowed 'Trans proline' 0 C--N 1.311 -1.4 0 C-N-CA 122.25 1.966 . . . . 1.0 113.787 -179.101 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -125.2 131.58 53.15 Favored 'General case' 0 N--CA 1.466 0.351 0 CA-C-O 119.626 -0.226 . . . . 1.0 110.464 179.313 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . 0.66 ' C ' ' H ' ' A' ' 44' ' ' GLY . 0.4 OUTLIER -166.96 163.72 16.06 Favored 'General case' 0 C--N 1.326 -0.435 0 C-N-CA 119.756 -0.778 . . . . 1.0 110.433 178.037 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 43' ' ' ARG . . . . . 0.474 ' C ' ' H ' ' A' ' 45' ' ' PHE . 3.3 tpt85 -63.87 22.09 0.01 OUTLIER 'General case' 0 CA--C 1.538 0.505 0 CA-C-N 115.857 -0.61 . . . . 1.0 111.088 -179.204 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . 0.66 ' H ' ' C ' ' A' ' 42' ' ' ARG . . . 71.63 -27.92 0.61 Allowed Glycine 0 CA--C 1.527 0.819 0 N-CA-C 111.745 -0.542 . . . . 1.0 111.745 179.705 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . 0.474 ' H ' ' C ' ' A' ' 43' ' ' ARG . 20.9 t80 -151.34 149.68 29.62 Favored 'General case' 0 C--O 1.218 -0.587 0 CA-C-N 117.166 0.483 . . . . 1.0 109.741 -179.258 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 46' ' ' PHE . . . . . 0.555 ' O ' ' CG ' ' A' ' 47' ' ' ARG . 1.8 m-85 141.14 83.66 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.836 0 C-N-CA 124.378 1.071 . . . . 1.0 109.736 179.154 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 47' ' ' ARG . . . . . 0.555 ' CG ' ' O ' ' A' ' 46' ' ' PHE . 3.9 mmp_? 137.63 134.44 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.51 0 C-N-CA 123.715 0.806 . . . . 1.0 109.186 179.489 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 48' ' ' CYS . . . . . 0.471 ' SG ' ' C ' ' A' ' 47' ' ' ARG . 2.0 m 77.22 69.45 0.05 Allowed 'General case' 0 C--O 1.218 -0.572 0 CA-C-N 118.409 0.549 . . . . 1.0 110.195 179.785 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -114.6 147.86 39.04 Favored Pre-proline 0 N--CA 1.464 0.265 0 O-C-N 120.748 -1.22 . . . . 1.0 108.864 179.543 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -73.02 59.26 3.58 Favored 'Trans proline' 0 C--N 1.308 -1.58 0 C-N-CA 121.836 1.691 . . . . 1.0 111.101 -179.975 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 22.7 mm-40 58.8 59.33 2.89 Favored 'General case' 0 N--CA 1.454 -0.259 0 CA-C-N 116.25 -0.432 . . . . 1.0 111.074 179.453 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 16.6 ptt180 -146.13 178.72 8.01 Favored 'General case' 0 N--CA 1.466 0.359 0 CA-C-N 116.24 -0.437 . . . . 1.0 110.377 179.724 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . 0.438 ' O ' ' N ' ' A' ' 55' ' ' ILE . 0.1 OUTLIER -86.61 138.61 18.74 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.334 0 CA-C-O 121.655 0.741 . . . . 1.0 110.484 179.671 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -62.34 82.84 0.02 OUTLIER 'General case' 0 C--N 1.319 -0.742 0 CA-C-N 114.701 -1.136 . . . . 1.0 109.033 -177.961 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . 0.438 ' N ' ' O ' ' A' ' 53' ' ' ILE . 21.2 tt -149.48 158.23 6.17 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.457 0 CA-C-N 115.858 -0.61 . . . . 1.0 110.611 178.156 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 109.31 -5.97 31.89 Favored Glycine 0 N--CA 1.473 1.129 0 N-CA-C 110.95 -0.86 . . . . 1.0 110.95 -179.969 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 13.1 p-10 -77.94 100.78 6.56 Favored 'General case' 0 C--N 1.323 -0.563 0 N-CA-C 109.026 -0.731 . . . . 1.0 109.026 178.751 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 58' ' ' TRP . . . . . . . . . . . . . 0.3 OUTLIER -88.75 174.75 7.83 Favored 'General case' 0 CA--C 1.542 0.656 0 CA-C-O 123.18 1.466 . . . . 1.0 113.364 -177.625 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 9.0 mtm180 -80.5 -59.32 2.74 Favored 'General case' 0 C--N 1.315 -0.899 0 CA-C-N 111.416 -2.629 . . . . 1.0 113.418 -178.381 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 1.2 p90 -88.67 -10.03 49.97 Favored 'General case' 0 C--O 1.248 1.012 0 CA-C-N 114.81 -1.086 . . . . 1.0 113.573 -177.673 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . 0.513 ' O ' ' N ' ' A' ' 65' ' ' ASP . 13.5 pt-20 -71.8 -14.26 61.93 Favored 'General case' 0 C--N 1.313 -0.991 0 N-CA-C 113.198 0.814 . . . . 1.0 113.198 -177.767 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . 0.623 ' O ' ' N ' ' A' ' 66' ' ' GLY . 0.1 OUTLIER -48.72 -58.94 0.97 Allowed 'Isoleucine or valine' 0 C--O 1.204 -1.293 0 C-N-CA 119.195 -1.002 . . . . 1.0 108.5 -174.317 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -66.33 -56.67 10.02 Favored 'General case' 0 C--N 1.295 -1.799 0 O-C-N 121.797 -0.564 . . . . 1.0 110.867 -179.325 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 64' ' ' HIS . . . . . 0.518 ' O ' ' HB2' ' A' ' 67' ' ' ARG . 67.3 m-70 -53.39 -56.36 17.42 Favored 'General case' 0 N--CA 1.465 0.312 0 C-N-CA 119.148 -1.021 . . . . 1.0 109.59 -179.247 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . 0.628 ' C ' ' H ' ' A' ' 67' ' ' ARG . 10.0 t0 -77.63 -50.9 11.54 Favored 'General case' 0 C--N 1.312 -1.032 0 O-C-N 121.889 -0.507 . . . . 1.0 111.667 179.984 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . 0.623 ' N ' ' O ' ' A' ' 62' ' ' VAL . . . -71.83 26.84 0.63 Allowed Glycine 0 CA--C 1.524 0.655 0 O-C-N 120.608 -1.307 . . . . 1.0 110.412 178.042 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 67' ' ' ARG . . . . . 0.628 ' H ' ' C ' ' A' ' 65' ' ' ASP . 4.1 tpt85 -74.93 4.38 6.64 Favored 'General case' 0 N--CA 1.448 -0.566 0 N-CA-C 107.183 -1.414 . . . . 1.0 107.183 176.074 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . 0.537 ' H ' ' C ' ' A' ' 66' ' ' GLY . 12.9 mt -33.55 -28.13 0.01 OUTLIER 'General case' 0 N--CA 1.475 0.79 0 CA-C-N 114.687 -1.142 . . . . 1.0 108.871 -177.622 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . 0.613 ' N ' ' O ' ' A' ' 67' ' ' ARG . 3.0 tt -65.86 -66.03 0.6 Allowed 'General case' 0 CA--C 1.546 0.821 0 C-N-CA 119.293 -0.963 . . . . 1.0 110.085 -179.17 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . 0.644 ' C ' ' H ' ' A' ' 72' ' ' HIS . . . -79.1 -78.36 0.15 Allowed 'General case' 0 N--CA 1.475 0.819 0 C-N-CA 118.766 -1.174 . . . . 1.0 108.439 -179.842 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . 0.528 ' O ' ' N ' ' A' ' 74' ' ' VAL . . . -50.32 9.53 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.285 0 C-N-CA 125.651 1.581 . . . . 1.0 113.005 179.342 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 72' ' ' HIS . . . . . 0.955 ' CD2' ' H ' ' A' ' 73' ' ' MET . 0.3 OUTLIER -24.21 -58.75 0.05 Allowed 'General case' 0 C--N 1.33 -0.247 0 N-CA-C 113.765 1.024 . . . . 1.0 113.765 -177.197 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 73' ' ' MET . . . . . 0.955 ' H ' ' CD2' ' A' ' 72' ' ' HIS . 95.0 mtp -68.94 -45.99 69.34 Favored 'General case' 0 C--N 1.319 -0.746 0 C-N-CA 119.604 -0.838 . . . . 1.0 109.145 179.34 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . 0.723 ' C ' ' H ' ' A' ' 76' ' ' GLY . 39.2 t -45.26 -43.92 3.3 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.255 0 CA-C-O 117.658 -1.163 . . . . 1.0 111.685 -176.365 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 75' ' ' ASN . . . . . 0.651 HD22 HH22 ' A' ' 126' ' ' ARG . 0.7 OUTLIER -39.6 -11.14 0.01 OUTLIER 'General case' 0 C--N 1.362 1.134 0 CA-C-N 121.05 1.75 . . . . 1.0 111.419 178.994 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . 0.723 ' H ' ' C ' ' A' ' 74' ' ' VAL . . . -42.12 -27.3 0.41 Allowed Glycine 0 CA--C 1.536 1.384 0 N-CA-C 107.301 -2.32 . . . . 1.0 107.301 177.988 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . 0.637 ' O ' ' N ' ' A' ' 80' ' ' ALA . 7.1 pt -68.76 -49.45 64.09 Favored 'Isoleucine or valine' 0 C--O 1.212 -0.881 0 N-CA-C 108.663 -0.866 . . . . 1.0 108.663 176.653 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . 0.636 ' N ' ' O ' ' A' ' 75' ' ' ASN . 2.0 p -32.35 -39.09 0.04 OUTLIER 'Isoleucine or valine' 0 CA--C 1.545 0.769 0 N-CA-C 108.846 -0.798 . . . . 1.0 108.846 -176.369 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . 0.463 ' N ' ' O ' ' A' ' 77' ' ' ILE . 2.9 pp -97.71 -24.72 4.28 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.709 0 CA-C-O 121.153 0.501 . . . . 1.0 110.751 178.041 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 80' ' ' ALA . . . . . 0.637 ' N ' ' O ' ' A' ' 77' ' ' ILE . . . -86.98 -10.37 53.36 Favored 'General case' 0 CA--C 1.551 1.014 0 N-CA-C 113.381 0.882 . . . . 1.0 113.381 177.568 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . 0.596 ' N ' ' O ' ' A' ' 77' ' ' ILE . 81.9 tt0 -87.65 -71.22 0.58 Allowed 'General case' 0 N--CA 1.445 -0.699 0 CA-C-N 118.942 0.792 . . . . 1.0 109.426 -179.826 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 82' ' ' ASP . . . . . 0.648 ' O ' ' N ' ' A' ' 84' ' ' LEU . 0.7 OUTLIER -70.32 -11.63 61.04 Favored 'General case' 0 N--CA 1.444 -0.733 0 CA-C-N 119.109 0.868 . . . . 1.0 110.294 179.069 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . 0.805 ' O ' ' N ' ' A' ' 86' ' ' ALA . . . -18.79 -43.22 0.0 OUTLIER 'General case' 0 C--O 1.197 -1.668 0 O-C-N 124.072 0.858 . . . . 1.0 111.804 177.941 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . 0.648 ' N ' ' O ' ' A' ' 82' ' ' ASP . 19.1 mt -26.72 -30.55 0.0 OUTLIER 'General case' 0 N--CA 1.472 0.664 0 O-C-N 121.901 -0.5 . . . . 1.0 111.902 -175.801 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 85' ' ' ILE . . . . . 0.714 ' N ' ' O ' ' A' ' 83' ' ' ALA . 0.1 OUTLIER -98.57 -31.33 3.64 Favored 'Isoleucine or valine' 0 CA--C 1.551 1.009 0 N-CA-C 109.541 -0.54 . . . . 1.0 109.541 175.42 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . 0.805 ' N ' ' O ' ' A' ' 83' ' ' ALA . . . -91.89 -27.33 17.99 Favored 'General case' 0 N--CA 1.486 1.352 0 CA-C-O 121.897 0.856 . . . . 1.0 112.652 179.063 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . 0.48 ' N ' ' O ' ' A' ' 83' ' ' ALA . 3.3 pt-20 -47.33 -28.55 2.06 Favored 'General case' 0 C--N 1.313 -1.008 0 CA-C-N 114.089 -1.414 . . . . 1.0 109.963 -178.859 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -141.7 24.99 2.02 Favored 'General case' 0 N--CA 1.475 0.8 0 CA-C-O 121.585 0.707 . . . . 1.0 111.118 -178.99 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 89' ' ' VAL . . . . . 0.571 ' O ' ' ND1' ' A' ' 92' ' ' HIS . 4.8 p -75.62 36.38 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.315 -0.921 0 CA-C-N 114.905 -1.043 . . . . 1.0 109.518 178.423 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 90' ' ' GLY . . . . . 0.529 ' O ' ' N ' ' A' ' 92' ' ' HIS . . . -66.77 -39.87 93.67 Favored Glycine 0 N--CA 1.439 -1.129 0 C-N-CA 119.055 -1.545 . . . . 1.0 111.138 178.693 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 91' ' ' PRO . . . . . 0.522 ' CD ' ' N ' ' A' ' 90' ' ' GLY . 95.8 Cg_exo -43.78 -20.1 0.23 Allowed 'Trans proline' 0 N--CA 1.49 1.293 0 CA-C-N 119.897 1.848 . . . . 1.0 110.003 179.777 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 92' ' ' HIS . . . . . 0.571 ' ND1' ' O ' ' A' ' 89' ' ' VAL . 7.7 p-80 -60.65 -25.84 66.62 Favored 'General case' 0 C--O 1.218 -0.599 0 CA-C-N 114.724 -1.126 . . . . 1.0 109.396 179.649 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . 0.581 ' HG ' ' H ' ' A' ' 94' ' ' ALA . 2.2 pp -63.47 -58.7 6.2 Favored 'General case' 0 C--N 1.325 -0.494 0 N-CA-C 108.353 -0.98 . . . . 1.0 108.353 178.451 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 94' ' ' ALA . . . . . 0.581 ' H ' ' HG ' ' A' ' 93' ' ' LEU . . . -56.23 -55.93 27.2 Favored 'General case' 0 N--CA 1.452 -0.369 0 N-CA-C 109.26 -0.645 . . . . 1.0 109.26 179.096 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 95' ' ' ARG . . . . . 0.613 ' O ' ' N ' ' A' ' 97' ' ' LEU . 10.8 ttp180 -59.07 -61.04 2.94 Favored 'General case' 0 C--O 1.239 0.542 0 CA-C-O 122.333 1.064 . . . . 1.0 108.819 179.586 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 96' ' ' ALA . . . . . 0.871 ' O ' ' N ' ' A' ' 98' ' ' GLY . . . -47.68 -12.51 0.03 OUTLIER 'General case' 0 C--N 1.306 -1.319 0 O-C-N 118.56 -2.587 . . . . 1.0 112.072 -179.154 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . 0.799 ' O ' ' N ' ' A' ' 100' ' ' ILE . 3.5 pp 5.34 -52.53 0.0 OUTLIER 'General case' 0 C--O 1.204 -1.328 0 CA-C-O 116.767 -1.587 . . . . 1.0 111.262 -166.595 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 98' ' ' GLY . . . . . 0.871 ' N ' ' O ' ' A' ' 96' ' ' ALA . . . -47.22 -24.14 2.13 Favored Glycine 0 C--N 1.303 -1.301 0 CA-C-N 123.381 2.809 . . . . 1.0 107.473 176.018 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 99' ' ' GLN . . . . . 0.462 ' N ' ' C ' ' A' ' 97' ' ' LEU . 57.5 mm-40 -64.44 -17.99 64.33 Favored 'General case' 0 C--N 1.361 1.098 0 C-N-CA 117.415 -1.714 . . . . 1.0 107.424 176.049 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 100' ' ' ILE . . . . . 0.799 ' N ' ' O ' ' A' ' 97' ' ' LEU . 12.1 tt -64.67 -44.75 96.63 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.629 0 N-CA-C 107.87 -1.159 . . . . 1.0 107.87 177.881 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 101' ' ' VAL . . . . . 0.801 ' O ' ' N ' ' A' ' 105' ' ' GLY . 68.9 t -60.14 -61.06 1.67 Allowed 'Isoleucine or valine' 0 C--O 1.209 -1.059 0 N-CA-C 107.585 -1.265 . . . . 1.0 107.585 179.499 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 102' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -44.21 -19.02 0.02 OUTLIER 'General case' 0 C--N 1.319 -0.732 0 CA-C-O 121.399 0.619 . . . . 1.0 110.988 -179.458 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 103' ' ' ARG . . . . . 0.518 ' N ' ' O ' ' A' ' 101' ' ' VAL . 12.1 ttp-105 -95.44 -43.96 7.75 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-O 122.034 0.921 . . . . 1.0 111.889 177.383 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 104' ' ' TYR . . . . . 0.709 ' CG ' ' O ' ' A' ' 104' ' ' TYR . 0.1 OUTLIER -107.43 19.16 20.65 Favored 'General case' 0 CA--C 1.552 1.038 0 C-N-CA 126.628 1.971 . . . . 1.0 110.619 178.477 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 105' ' ' GLY . . . . . 0.801 ' N ' ' O ' ' A' ' 101' ' ' VAL . . . -162.64 -10.89 0.03 OUTLIER Glycine 0 C--N 1.332 0.324 0 C-N-CA 118.898 -1.62 . . . . 1.0 112.514 179.785 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 106' ' ' ALA . . . . . 0.492 ' C ' ' O ' ' A' ' 105' ' ' GLY . . . -29.81 118.7 0.15 Allowed 'General case' 0 N--CA 1.463 0.219 0 CA-C-N 117.017 0.408 . . . . 1.0 110.081 179.391 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 107' ' ' THR . . . . . 0.686 ' O ' ' HD2' ' A' ' 110' ' ' PRO . 10.7 m -133.98 -62.48 0.76 Allowed 'General case' 0 C--O 1.192 -1.951 0 N-CA-C 105.542 -2.021 . . . . 1.0 105.542 178.042 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 26.1 m -61.89 28.57 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.309 -1.181 0 O-C-N 121.034 -1.041 . . . . 1.0 110.194 -179.878 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 109' ' ' ILE . . . . . 0.546 ' N ' ' O ' ' A' ' 107' ' ' THR . 0.1 OUTLIER -111.81 -42.98 0.09 OUTLIER Pre-proline 0 C--N 1.372 1.545 0 CA-C-N 119.634 1.107 . . . . 1.0 111.381 177.575 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 110' ' ' PRO . . . . . 0.686 ' HD2' ' O ' ' A' ' 107' ' ' THR . 31.3 Cg_exo -65.1 -28.49 56.83 Favored 'Trans proline' 0 N--CA 1.499 1.799 0 C-N-CA 122.457 2.105 . . . . 1.0 111.869 -179.569 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 111' ' ' ASN . . . . . 0.437 ' C ' ' N ' ' A' ' 113' ' ' ASN . 0.1 OUTLIER -69.12 -69.08 0.36 Allowed 'General case' 0 CA--C 1.538 0.49 0 C-N-CA 119.687 -0.805 . . . . 1.0 109.851 -179.242 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 112' ' ' ILE . . . . . 0.535 ' O ' ' N ' ' A' ' 116' ' ' ILE . 13.1 pt -47.8 -28.29 1.57 Allowed 'Isoleucine or valine' 0 C--O 1.214 -0.785 0 CA-C-O 123.414 1.578 . . . . 1.0 108.531 179.593 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 113' ' ' ASN . . . . . 0.558 ' ND2' ' OE2' ' A' ' 117' ' ' GLU . 0.1 OUTLIER -56.85 -52.74 63.91 Favored 'General case' 0 C--N 1.293 -1.864 0 CA-C-N 111.526 -2.579 . . . . 1.0 106.906 -178.935 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -62.37 -35.04 77.9 Favored 'General case' 0 C--N 1.322 -0.595 0 N-CA-C 112.842 0.682 . . . . 1.0 112.842 -179.914 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -82.8 -56.25 3.94 Favored 'General case' 0 C--O 1.21 -1.002 0 CA-C-N 119.486 1.039 . . . . 1.0 110.538 178.503 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 116' ' ' ILE . . . . . 0.541 ' O ' ' N ' ' A' ' 120' ' ' GLY . 50.8 mt -48.74 -60.88 0.61 Allowed 'Isoleucine or valine' 0 N--CA 1.478 0.954 0 CA-C-O 122.522 1.153 . . . . 1.0 108.107 -179.208 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 117' ' ' GLU . . . . . 0.558 ' OE2' ' ND2' ' A' ' 113' ' ' ASN . 91.5 mt-10 -42.67 -53.56 4.42 Favored 'General case' 0 C--N 1.313 -0.988 0 CA-C-N 112.488 -2.142 . . . . 1.0 107.17 -178.761 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 69.1 t -60.72 -54.84 29.75 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.516 0 N-CA-C 109.143 -0.688 . . . . 1.0 109.143 177.281 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 3.3 tp -53.49 -71.66 0.07 Allowed 'General case' 0 N--CA 1.464 0.234 0 N-CA-C 108.038 -1.097 . . . . 1.0 108.038 -179.424 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 120' ' ' GLY . . . . . 0.541 ' N ' ' O ' ' A' ' 116' ' ' ILE . . . -66.62 -85.37 0.09 OUTLIER Glycine 0 CA--C 1.533 1.21 0 C-N-CA 118.567 -1.777 . . . . 1.0 110.063 179.369 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 121' ' ' THR . . . . . 0.491 ' OG1' ' OG1' ' A' ' 123' ' ' THR . 1.6 t 168.67 -39.9 0.0 OUTLIER 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 112.633 -1.783 . . . . 1.0 112.756 -179.802 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 122' ' ' GLY . . . . . 0.619 ' O ' ' N ' ' A' ' 124' ' ' ASP . . . 100.99 -18.72 54.32 Favored Glycine 0 N--CA 1.469 0.856 0 N-CA-C 107.037 -2.425 . . . . 1.0 107.037 -176.884 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 123' ' ' THR . . . . . 0.491 ' OG1' ' OG1' ' A' ' 121' ' ' THR . 25.5 m -51.63 86.71 0.0 OUTLIER 'General case' 0 N--CA 1.471 0.617 0 CA-C-N 111.884 -2.158 . . . . 1.0 105.463 178.261 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 124' ' ' ASP . . . . . 0.619 ' N ' ' O ' ' A' ' 122' ' ' GLY . 9.5 m-20 -160.3 165.1 31.95 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 114.372 -1.285 . . . . 1.0 112.062 -178.305 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 125' ' ' TYR . . . . . 0.576 ' O ' ' NH2' ' A' ' 126' ' ' ARG . 0.0 OUTLIER -151.13 146.98 26.51 Favored 'General case' 0 CA--C 1.541 0.61 0 N-CA-C 108.92 -0.771 . . . . 1.0 108.92 177.901 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 126' ' ' ARG . . . . . 0.651 HH22 HD22 ' A' ' 75' ' ' ASN . 0.1 OUTLIER -148.01 150.58 34.23 Favored 'General case' 0 CA--C 1.541 0.613 0 CA-C-N 115.762 -0.654 . . . . 1.0 109.718 177.453 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 127' ' ' PHE . . . . . . . . . . . . . 85.8 t80 . . . . . 0 N--CA 1.468 0.459 0 CA-C-O 118.011 -0.995 . . . . 1.0 110.726 178.918 . . . . . . . . 0 0 . 1 . 024 nuclear orig full ' A' A ' 128' ' ' MTN . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 024 nuclear orig full ' A' A ' 129' ' ' MTN . . . . . 0.441 ' H81' ' O ' ' A' ' 48' ' ' CYS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 130' ' ' MTN . . . . . 0.403 ' S1 ' ' C7 ' ' A' ' 130' ' ' MTN . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.492 ' SD ' ' CB ' ' A' ' 4' ' ' PHE . 19.6 mtp . . . . . 0 N--CA 1.492 1.63 0 N-CA-C 108.179 -1.045 . . . . 1.0 108.179 . . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 2' ' ' SER . . . . . 0.423 ' O ' ' CG ' ' A' ' 3' ' ' ASP . 88.6 p -107.7 7.87 28.68 Favored 'General case' 0 N--CA 1.468 0.452 0 CA-C-O 120.705 0.288 . . . . 1.0 110.412 -179.753 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . 0.423 ' CG ' ' O ' ' A' ' 2' ' ' SER . 12.1 m-20 168.35 94.25 0.0 OUTLIER 'General case' 0 N--CA 1.47 0.557 0 CA-C-N 115.469 -0.787 . . . . 1.0 110.468 179.014 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . 0.492 ' CB ' ' SD ' ' A' ' 1' ' ' MET . 37.9 t80 -149.8 145.56 26.68 Favored 'General case' 0 CA--C 1.517 -0.326 0 CA-C-N 116.212 -0.449 . . . . 1.0 110.516 179.501 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 61.5 m-20 -154.75 151.01 28.19 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 121.134 0.492 . . . . 1.0 110.007 179.763 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 6' ' ' THR . . . . . 0.678 ' O ' ' N ' ' A' ' 10' ' ' SER . 0.2 OUTLIER -67.17 173.23 3.95 Favored 'General case' 0 C--O 1.208 -1.123 0 CA-C-N 115.707 -0.679 . . . . 1.0 110.126 179.855 . . . . . . . . 3 3 . 1 . 025 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . 0.595 ' O ' ' N ' ' A' ' 11' ' ' ARG . 1.5 tm-20 -58.07 -54.29 48.6 Favored 'General case' 0 C--N 1.309 -1.191 0 CA-C-O 121.877 0.846 . . . . 1.0 109.423 -179.303 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 8' ' ' ARG . . . . . 0.516 ' O ' ' CB ' ' A' ' 12' ' ' ALA . 27.9 ttp180 -53.82 -57.85 9.41 Favored 'General case' 0 C--N 1.311 -1.099 0 N-CA-C 107.967 -1.123 . . . . 1.0 107.967 -178.44 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . 0.526 ' O ' ' CG1' ' A' ' 13' ' ' VAL . 0.0 OUTLIER -63.61 -48.08 88.41 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.359 0 CA-C-N 114.772 -1.104 . . . . 1.0 109.807 179.27 . . . . . . . . 3 3 . 1 . 025 nuclear orig full ' A' A ' 10' ' ' SER . . . . . 0.678 ' N ' ' O ' ' A' ' 6' ' ' THR . 48.0 t -63.15 -60.74 3.01 Favored 'General case' 0 N--CA 1.481 1.107 0 C-N-CA 120.048 -0.661 . . . . 1.0 110.467 179.266 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 11' ' ' ARG . . . . . 0.595 ' N ' ' O ' ' A' ' 7' ' ' GLU . 11.2 ttt180 -62.77 -55.38 27.05 Favored 'General case' 0 C--N 1.316 -0.862 0 CA-C-O 121.707 0.765 . . . . 1.0 110.072 -177.005 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . 0.516 ' CB ' ' O ' ' A' ' 8' ' ' ARG . . . -52.37 -51.57 58.2 Favored 'General case' 0 C--N 1.316 -0.856 0 N-CA-C 107.015 -1.476 . . . . 1.0 107.015 -178.322 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . 0.607 ' O ' ' CB ' ' A' ' 17' ' ' LEU . 3.5 m -63.0 -45.84 97.86 Favored 'Isoleucine or valine' 0 C--O 1.2 -1.524 0 C-N-CA 117.387 -1.725 . . . . 1.0 108.888 177.839 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -59.79 -62.01 2.19 Favored 'General case' 0 N--CA 1.481 1.109 0 O-C-N 120.61 -1.306 . . . . 1.0 110.26 178.654 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . 0.542 ' N ' ' O ' ' A' ' 11' ' ' ARG . . . -52.15 -55.36 21.44 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-O 121.984 0.897 . . . . 1.0 109.415 -177.932 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . 0.482 ' CA ' ' H ' ' A' ' 22' ' ' GLY . . . -62.29 -53.85 49.19 Favored 'General case' 0 C--N 1.31 -1.112 0 CA-C-N 114.233 -1.348 . . . . 1.0 108.811 -179.194 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . 0.607 ' CB ' ' O ' ' A' ' 13' ' ' VAL . 7.9 tt -57.1 -54.85 42.12 Favored 'General case' 0 N--CA 1.481 1.084 0 CA-C-N 114.738 -1.119 . . . . 1.0 109.462 -177.75 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . 0.498 ' CG2' ' N ' ' A' ' 19' ' ' GLY . 1.8 m -69.68 -57.25 8.84 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.63 0 C-N-CA 119.682 -0.807 . . . . 1.0 109.673 178.932 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . 0.543 ' O ' ' CG2' ' A' ' 23' ' ' VAL . . . -65.2 -166.99 1.57 Allowed Glycine 0 CA--C 1.537 1.432 0 N-CA-C 111.477 -0.649 . . . . 1.0 111.477 -179.875 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 20' ' ' PRO . . . . . 0.527 ' O ' ' N ' ' A' ' 24' ' ' ALA . 83.5 Cg_endo -78.18 -24.87 7.7 Favored 'Trans proline' 0 N--CA 1.509 2.407 0 C-N-CA 123.628 2.885 . . . . 1.0 115.138 -177.825 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -57.32 -57.26 20.72 Favored Glycine 0 N--CA 1.478 1.448 0 C-N-CA 120.221 -0.99 . . . . 1.0 111.694 -176.765 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . 0.482 ' H ' ' CA ' ' A' ' 16' ' ' ALA . . . -60.33 -56.21 25.77 Favored Glycine 0 N--CA 1.468 0.819 0 N-CA-C 109.274 -1.531 . . . . 1.0 109.274 -177.234 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . 0.543 ' CG2' ' O ' ' A' ' 19' ' ' GLY . 0.0 OUTLIER -61.89 -35.98 71.22 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.958 0 CA-C-N 114.867 -0.666 . . . . 1.0 110.106 -178.845 . . . . . . . . 3 3 . 1 . 025 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . 0.527 ' N ' ' O ' ' A' ' 20' ' ' PRO . . . -56.23 -59.97 4.17 Favored 'General case' 0 CA--C 1.538 0.51 0 C-N-CA 117.779 -1.568 . . . . 1.0 108.325 179.531 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 14.3 tp -66.66 -43.87 83.38 Favored 'General case' 0 C--N 1.348 0.505 0 N-CA-C 113.113 0.783 . . . . 1.0 113.113 -178.635 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 79.2 t -60.71 -58.7 6.24 Favored 'Isoleucine or valine' 0 C--N 1.34 0.188 0 C-N-CA 118.137 -1.425 . . . . 1.0 109.253 -177.243 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 60.7 t -61.14 -37.76 78.16 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.374 0 N-CA-C 112.96 0.726 . . . . 1.0 112.96 -177.914 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . 0.406 ' CG ' ' O ' ' A' ' 24' ' ' ALA . 30.0 mmtm -64.23 -52.68 57.59 Favored 'General case' 0 CA--C 1.509 -0.631 0 N-CA-C 108.372 -0.973 . . . . 1.0 108.372 -179.812 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 92.8 t -65.07 -47.91 86.0 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.874 0 CA-C-N 113.445 -1.707 . . . . 1.0 110.797 -177.361 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 30' ' ' CYS . . . . . . . . . . . . . 11.5 t -65.8 -61.11 2.25 Favored 'General case' 0 N--CA 1.445 -0.684 0 C-N-CA 118.685 -1.206 . . . . 1.0 109.86 -179.747 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -66.62 -53.95 28.63 Favored 'General case' 0 CA--C 1.518 -0.261 0 N-CA-C 113.668 0.988 . . . . 1.0 113.668 -176.221 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 85.1 73.57 1.27 Allowed Glycine 0 CA--C 1.533 1.17 0 N-CA-C 109.913 -1.275 . . . . 1.0 109.913 -177.253 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 4.7 mt 76.78 106.26 0.03 OUTLIER Pre-proline 0 N--CA 1.475 0.8 0 C-N-CA 123.416 0.686 . . . . 1.0 111.524 -179.706 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 74.9 Cg_exo -51.42 -15.6 2.63 Favored 'Trans proline' 0 N--CA 1.506 2.243 0 C-N-CA 122.889 2.393 . . . . 1.0 114.967 179.365 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -56.7 -57.87 17.33 Favored Glycine 0 CA--C 1.526 0.746 0 N-CA-C 107.584 -2.207 . . . . 1.0 107.584 -179.791 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . 0.544 ' O ' ' CG2' ' A' ' 37' ' ' ILE . 5.6 p -79.01 -147.2 0.01 OUTLIER 'Isoleucine or valine' 0 C--O 1.22 -0.459 0 N-CA-C 108.247 -1.019 . . . . 1.0 108.247 178.572 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . 0.544 ' CG2' ' O ' ' A' ' 36' ' ' VAL . 9.1 tp 70.52 79.74 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.475 0.814 0 CA-C-O 122.157 0.98 . . . . 1.0 112.969 -179.217 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 60.3 m80 -137.79 132.08 32.15 Favored 'General case' 0 N--CA 1.453 -0.283 0 N-CA-C 108.183 -1.043 . . . . 1.0 108.183 177.267 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 10.0 m -128.99 115.71 18.94 Favored Pre-proline 0 C--N 1.326 -0.434 0 N-CA-C 108.38 -0.97 . . . . 1.0 108.38 -179.284 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_exo -42.94 -66.65 0.15 Allowed 'Trans proline' 0 C--N 1.317 -1.122 0 C-N-CA 121.017 1.145 . . . . 1.0 111.558 -178.503 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -75.6 115.33 15.17 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 115.262 -0.881 . . . . 1.0 112.848 -177.292 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . 0.668 ' C ' ' H ' ' A' ' 44' ' ' GLY . 32.9 ptt180 -166.12 162.4 17.7 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 114.817 -1.083 . . . . 1.0 109.987 179.225 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 43' ' ' ARG . . . . . 0.515 ' C ' ' H ' ' A' ' 45' ' ' PHE . 0.2 OUTLIER -65.99 18.63 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.318 -0.401 . . . . 1.0 110.235 -179.263 . . . . . . . . 3 3 . 1 . 025 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . 0.668 ' H ' ' C ' ' A' ' 42' ' ' ARG . . . 70.57 -26.59 0.48 Allowed Glycine 0 N--CA 1.448 -0.531 0 N-CA-C 110.824 -0.91 . . . . 1.0 110.824 179.846 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . 0.515 ' H ' ' C ' ' A' ' 43' ' ' ARG . 7.6 t80 -155.33 150.65 27.05 Favored 'General case' 0 CA--C 1.541 0.622 0 N-CA-C 108.892 -0.781 . . . . 1.0 108.892 -178.906 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 46' ' ' PHE . . . . . 0.497 ' CE1' ' NE2' ' A' ' 54' ' ' GLN . 15.3 t80 172.21 7.15 0.0 OUTLIER 'General case' 0 N--CA 1.483 1.208 0 O-C-N 124.014 0.821 . . . . 1.0 113.155 176.273 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 172.2 -176.0 0.05 Allowed 'General case' 0 C--N 1.328 -0.334 0 N-CA-C 109.765 -0.457 . . . . 1.0 109.765 179.689 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER 70.64 63.01 0.19 Allowed 'General case' 0 CA--C 1.546 0.819 0 N-CA-C 108.901 -0.777 . . . . 1.0 108.901 179.938 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 49' ' ' ASN . . . . . 0.593 ' ND2' ' NH2' ' A' ' 52' ' ' ARG . 1.6 t30 -151.06 133.21 8.17 Favored Pre-proline 0 CA--C 1.546 0.818 0 N-CA-C 108.169 -1.048 . . . . 1.0 108.169 178.891 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . 0.533 ' HD2' HH21 ' A' ' 52' ' ' ARG . 16.3 Cg_endo -55.13 73.86 0.03 OUTLIER 'Trans proline' 0 N--CA 1.502 1.999 0 CA-C-N 120.995 1.391 . . . . 1.0 113.833 -179.816 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . 0.553 ' N ' ' O ' ' A' ' 49' ' ' ASN . 40.2 mm-40 62.01 69.8 0.61 Allowed 'General case' 0 N--CA 1.468 0.441 0 N-CA-C 113.428 0.899 . . . . 1.0 113.428 177.975 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . 0.593 ' NH2' ' ND2' ' A' ' 49' ' ' ASN . 0.0 OUTLIER -141.67 150.68 42.22 Favored 'General case' 0 N--CA 1.471 0.579 0 N-CA-C 108.772 -0.825 . . . . 1.0 108.772 178.155 . . . . . . . . 3 3 . 1 . 025 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . 0.444 HD13 HG22 ' A' ' 53' ' ' ILE . 0.4 OUTLIER -74.44 136.37 25.38 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.372 0 CA-C-O 121.623 0.725 . . . . 1.0 111.43 -178.679 . . . . . . . . 3 3 . 1 . 025 nuclear orig full ' A' A ' 54' ' ' GLN . . . . . 0.497 ' NE2' ' CE1' ' A' ' 46' ' ' PHE . 1.9 pt20 -62.9 82.21 0.02 OUTLIER 'General case' 0 N--CA 1.469 0.492 0 CA-C-N 114.611 -1.177 . . . . 1.0 110.143 -177.172 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 16.0 tt -149.52 159.07 5.68 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.27 0 CA-C-N 115.97 -0.559 . . . . 1.0 110.141 178.113 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 112.26 -2.92 26.73 Favored Glycine 0 N--CA 1.472 1.043 0 N-CA-C 110.669 -0.973 . . . . 1.0 110.669 -179.713 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . 0.484 ' OD2' ' O ' ' A' ' 43' ' ' ARG . 25.3 t70 -82.91 98.71 9.34 Favored 'General case' 0 C--N 1.323 -0.554 0 N-CA-C 109.619 -0.511 . . . . 1.0 109.619 179.426 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 58' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -87.3 174.49 8.54 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-O 122.615 1.198 . . . . 1.0 112.764 -177.899 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 59' ' ' ARG . . . . . 0.447 ' CG ' ' N ' ' A' ' 60' ' ' TYR . 2.1 ptt180 -86.17 -56.96 3.21 Favored 'General case' 0 C--N 1.318 -0.783 0 CA-C-N 111.824 -2.444 . . . . 1.0 112.259 -179.538 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 60' ' ' TYR . . . . . 0.447 ' N ' ' CG ' ' A' ' 59' ' ' ARG . 41.4 t80 -92.42 -17.28 24.8 Favored 'General case' 0 C--O 1.249 1.052 0 N-CA-C 113.521 0.934 . . . . 1.0 113.521 -179.181 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 5.3 tt0 -79.51 -13.9 59.25 Favored 'General case' 0 C--N 1.313 -0.996 0 CA-C-N 115.973 -0.558 . . . . 1.0 110.482 -179.292 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . 0.645 ' O ' ' N ' ' A' ' 66' ' ' GLY . 27.4 m -47.39 -55.32 2.22 Favored 'Isoleucine or valine' 0 C--O 1.201 -1.498 0 C-N-CA 119.326 -0.95 . . . . 1.0 110.107 -176.608 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 63' ' ' ALA . . . . . 0.527 ' O ' ' N ' ' A' ' 67' ' ' ARG . . . -68.77 -54.87 13.43 Favored 'General case' 0 C--N 1.306 -1.292 0 C-N-CA 119.338 -0.945 . . . . 1.0 109.416 -178.466 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 64' ' ' HIS . . . . . 0.455 ' O ' ' HB2' ' A' ' 67' ' ' ARG . 6.6 t-80 -44.98 -58.38 3.2 Favored 'General case' 0 N--CA 1.472 0.645 0 CA-C-O 121.519 0.676 . . . . 1.0 109.99 179.516 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . 0.579 ' C ' ' H ' ' A' ' 67' ' ' ARG . 0.5 OUTLIER -73.18 -47.02 47.23 Favored 'General case' 0 C--N 1.313 -1.006 0 CA-C-N 115.551 -0.75 . . . . 1.0 109.991 177.917 . . . . . . . . 3 3 . 1 . 025 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . 0.645 ' N ' ' O ' ' A' ' 62' ' ' VAL . . . -75.4 25.46 1.34 Allowed Glycine 0 CA--C 1.53 0.977 0 O-C-N 120.526 -1.359 . . . . 1.0 110.354 177.5 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 67' ' ' ARG . . . . . 0.603 ' O ' ' N ' ' A' ' 69' ' ' LEU . 5.5 mmt180 -72.02 5.26 2.8 Favored 'General case' 0 CA--C 1.508 -0.655 0 N-CA-C 105.969 -1.863 . . . . 1.0 105.969 175.115 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . 0.601 ' H ' ' C ' ' A' ' 66' ' ' GLY . 0.7 OUTLIER -33.94 -28.1 0.01 OUTLIER 'General case' 0 C--N 1.354 0.787 0 O-C-N 124.181 0.926 . . . . 1.0 109.173 -176.709 . . . . . . . . 3 3 . 1 . 025 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . 0.603 ' N ' ' O ' ' A' ' 67' ' ' ARG . 9.0 mp -62.47 -64.94 0.77 Allowed 'General case' 0 N--CA 1.471 0.624 0 C-N-CA 118.885 -1.126 . . . . 1.0 108.237 177.362 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . 0.691 ' O ' ' CD2' ' A' ' 72' ' ' HIS . . . -76.71 -74.28 0.25 Allowed 'General case' 0 C--O 1.217 -0.634 0 N-CA-C 104.833 -2.284 . . . . 1.0 104.833 177.126 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . 0.463 ' O ' ' OD1' ' A' ' 75' ' ' ASN . . . -40.66 2.65 0.0 OUTLIER 'General case' 0 N--CA 1.473 0.707 0 N-CA-C 115.27 1.582 . . . . 1.0 115.27 179.832 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 72' ' ' HIS . . . . . 0.857 ' CD2' ' H ' ' A' ' 73' ' ' MET . 0.3 OUTLIER -30.45 -81.97 0.01 OUTLIER 'General case' 0 CA--C 1.532 0.284 0 CA-C-N 119.954 1.252 . . . . 1.0 114.114 -176.425 . . . . . . . . 3 3 . 1 . 025 nuclear orig full ' A' A ' 73' ' ' MET . . . . . 0.857 ' H ' ' CD2' ' A' ' 72' ' ' HIS . 72.1 mtm -63.9 -53.64 47.34 Favored 'General case' 0 N--CA 1.439 -0.979 0 C-N-CA 120.002 -0.679 . . . . 1.0 110.066 -179.443 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . 0.729 ' C ' ' H ' ' A' ' 76' ' ' GLY . 0.6 OUTLIER -46.25 -35.86 2.49 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.718 0 CA-C-O 117.533 -1.222 . . . . 1.0 111.644 -176.092 . . . . . . . . 3 3 . 1 . 025 nuclear orig full ' A' A ' 75' ' ' ASN . . . . . 0.569 ' C ' ' N ' ' A' ' 77' ' ' ILE . 16.1 m120 -39.95 -9.46 0.01 OUTLIER 'General case' 0 N--CA 1.497 1.9 0 CA-C-N 121.055 1.752 . . . . 1.0 112.363 177.759 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . 0.729 ' H ' ' C ' ' A' ' 74' ' ' VAL . . . -41.95 -21.67 0.08 OUTLIER Glycine 0 CA--C 1.542 1.732 0 N-CA-C 107.533 -2.227 . . . . 1.0 107.533 177.051 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . 0.713 ' O ' ' N ' ' A' ' 80' ' ' ALA . 13.4 pt -74.87 -53.2 17.08 Favored 'Isoleucine or valine' 0 C--O 1.213 -0.86 0 CA-C-N 114.968 -0.616 . . . . 1.0 109.536 177.565 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . 0.531 ' N ' ' O ' ' A' ' 75' ' ' ASN . 3.2 p -36.15 -30.14 0.04 OUTLIER 'Isoleucine or valine' 0 CA--C 1.554 1.12 0 N-CA-C 108.631 -0.877 . . . . 1.0 108.631 -174.332 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . 0.538 ' N ' ' O ' ' A' ' 77' ' ' ILE . 0.0 OUTLIER -94.64 -28.16 4.2 Favored 'Isoleucine or valine' 0 CA--C 1.555 1.135 0 CA-C-O 121.186 0.517 . . . . 1.0 109.978 176.907 . . . . . . . . 3 3 . 1 . 025 nuclear orig full ' A' A ' 80' ' ' ALA . . . . . 0.713 ' N ' ' O ' ' A' ' 77' ' ' ILE . . . -87.48 -10.88 50.6 Favored 'General case' 0 CA--C 1.553 1.063 0 C-N-CA 124.153 0.981 . . . . 1.0 113.419 177.752 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . 0.542 ' N ' ' O ' ' A' ' 77' ' ' ILE . 2.3 mt-10 -83.2 -70.55 0.55 Allowed 'General case' 0 C--N 1.354 0.803 0 CA-C-N 119.309 0.959 . . . . 1.0 108.561 178.759 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 82' ' ' ASP . . . . . 0.491 ' O ' ' N ' ' A' ' 84' ' ' LEU . 8.8 p-10 -78.07 -12.29 59.98 Favored 'General case' 0 N--CA 1.445 -0.683 0 CA-C-N 118.315 0.507 . . . . 1.0 111.565 -179.637 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . 0.525 ' O ' ' N ' ' A' ' 87' ' ' GLU . . . -22.48 -44.16 0.01 OUTLIER 'General case' 0 N--CA 1.475 0.818 0 N-CA-C 113.207 0.817 . . . . 1.0 113.207 177.683 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . 0.491 ' N ' ' O ' ' A' ' 82' ' ' ASP . 0.4 OUTLIER -36.9 -34.94 0.08 Allowed 'General case' 0 N--CA 1.469 0.518 0 N-CA-C 112.576 0.584 . . . . 1.0 112.576 -176.782 . . . . . . . . 3 3 . 1 . 025 nuclear orig full ' A' A ' 85' ' ' ILE . . . . . 0.463 HG13 ' H ' ' A' ' 86' ' ' ALA . 2.0 pt -99.95 -41.72 9.63 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.669 0 N-CA-C 108.391 -0.966 . . . . 1.0 108.391 177.444 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . 0.463 ' H ' HG13 ' A' ' 85' ' ' ILE . . . -59.58 -56.87 16.45 Favored 'General case' 0 CA--C 1.537 0.479 0 CA-C-N 113.93 -1.487 . . . . 1.0 109.639 -179.01 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . 0.525 ' N ' ' O ' ' A' ' 83' ' ' ALA . 14.4 tt0 -70.92 -21.48 62.36 Favored 'General case' 0 CA--C 1.544 0.744 0 O-C-N 121.184 -0.947 . . . . 1.0 112.951 -177.439 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -74.43 -5.41 42.32 Favored 'General case' 0 N--CA 1.48 1.049 0 CA-C-O 122.931 1.348 . . . . 1.0 108.759 179.711 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 89' ' ' VAL . . . . . 0.449 ' CG2' ' O ' ' A' ' 86' ' ' ALA . 11.7 m -109.85 37.34 0.52 Allowed 'Isoleucine or valine' 0 C--N 1.312 -1.036 0 CA-C-N 112.351 -2.204 . . . . 1.0 109.896 178.017 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 90' ' ' GLY . . . . . 0.596 ' C ' ' H ' ' A' ' 92' ' ' HIS . . . -75.86 -36.35 42.26 Favored Glycine 0 C--N 1.349 1.254 0 N-CA-C 110.63 -0.988 . . . . 1.0 110.63 178.803 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 91' ' ' PRO . . . . . 0.581 ' CD ' ' N ' ' A' ' 90' ' ' GLY . 82.8 Cg_exo -48.26 -9.21 0.07 OUTLIER 'Trans proline' 0 N--CA 1.499 1.798 0 C-N-CA 122.191 1.928 . . . . 1.0 109.971 176.982 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 92' ' ' HIS . . . . . 0.596 ' H ' ' C ' ' A' ' 90' ' ' GLY . 1.8 p80 -55.99 -17.35 6.55 Favored 'General case' 0 N--CA 1.445 -0.717 0 N-CA-C 107.519 -1.289 . . . . 1.0 107.519 179.253 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 1.4 pp -63.32 -58.76 6.08 Favored 'General case' 0 N--CA 1.451 -0.405 0 N-CA-C 108.995 -0.743 . . . . 1.0 108.995 177.542 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -57.1 -50.91 71.33 Favored 'General case' 0 CA--C 1.515 -0.377 0 C-N-CA 120.318 -0.553 . . . . 1.0 110.095 -179.996 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 95' ' ' ARG . . . . . 0.652 ' O ' ' N ' ' A' ' 97' ' ' LEU . 83.7 mtt85 -59.36 -55.95 28.23 Favored 'General case' 0 C--N 1.322 -0.623 0 N-CA-C 107.516 -1.29 . . . . 1.0 107.516 178.781 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 96' ' ' ALA . . . . . 0.87 ' O ' ' N ' ' A' ' 98' ' ' GLY . . . -46.8 -13.42 0.03 OUTLIER 'General case' 0 N--CA 1.427 -1.575 0 O-C-N 119.118 -2.238 . . . . 1.0 110.15 179.846 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . 0.714 ' O ' ' N ' ' A' ' 100' ' ' ILE . 0.4 OUTLIER 7.38 -54.71 0.0 OUTLIER 'General case' 0 C--N 1.372 1.544 0 CA-C-O 117.547 -1.216 . . . . 1.0 109.993 -169.298 . . . . . . . . 3 3 . 1 . 025 nuclear orig full ' A' A ' 98' ' ' GLY . . . . . 0.87 ' N ' ' O ' ' A' ' 96' ' ' ALA . . . -49.01 -24.0 4.14 Favored Glycine 0 C--N 1.289 -2.079 0 CA-C-N 122.833 2.561 . . . . 1.0 108.849 174.767 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 99' ' ' GLN . . . . . 0.576 ' N ' ' O ' ' A' ' 96' ' ' ALA . 1.9 tp60 -66.36 -15.89 63.63 Favored 'General case' 0 C--N 1.364 1.223 0 N-CA-C 106.405 -1.702 . . . . 1.0 106.405 177.249 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 100' ' ' ILE . . . . . 0.714 ' N ' ' O ' ' A' ' 97' ' ' LEU . 0.4 OUTLIER -64.04 -45.58 96.24 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.52 0 N-CA-C 108.088 -1.079 . . . . 1.0 108.088 177.089 . . . . . . . . 3 3 . 1 . 025 nuclear orig full ' A' A ' 101' ' ' VAL . . . . . 0.651 ' O ' ' N ' ' A' ' 105' ' ' GLY . 71.9 t -53.74 -61.61 0.87 Allowed 'Isoleucine or valine' 0 CA--C 1.5 -0.963 0 N-CA-C 108.433 -0.951 . . . . 1.0 108.433 179.411 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 102' ' ' CYS . . . . . . . . . . . . . 4.2 t -46.07 -21.75 0.17 Allowed 'General case' 0 N--CA 1.427 -1.625 0 CA-C-N 115.569 -0.741 . . . . 1.0 112.317 -178.031 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 103' ' ' ARG . . . . . 0.416 ' H ' ' C ' ' A' ' 101' ' ' VAL . 0.1 OUTLIER -88.69 -43.78 11.06 Favored 'General case' 0 N--CA 1.484 1.255 0 O-C-N 124.194 0.934 . . . . 1.0 112.02 176.554 . . . . . . . . 3 3 . 1 . 025 nuclear orig full ' A' A ' 104' ' ' TYR . . . . . 0.643 ' O ' ' CD1' ' A' ' 104' ' ' TYR . 0.1 OUTLIER -101.3 21.23 14.4 Favored 'General case' 0 N--CA 1.473 0.692 0 CA-C-N 113.956 -1.475 . . . . 1.0 109.736 178.367 . . . . . . . . 3 3 . 1 . 025 nuclear orig full ' A' A ' 105' ' ' GLY . . . . . 0.651 ' N ' ' O ' ' A' ' 101' ' ' VAL . . . -159.59 -94.34 0.1 Allowed Glycine 0 C--N 1.345 1.051 0 N-CA-C 105.232 -3.147 . . . . 1.0 105.232 176.771 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 106' ' ' ALA . . . . . 0.551 ' O ' ' CD ' ' A' ' 110' ' ' PRO . . . 72.0 60.34 0.14 Allowed 'General case' 0 N--CA 1.446 -0.625 0 CA-C-O 119.333 -0.365 . . . . 1.0 111.729 -179.345 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 107' ' ' THR . . . . . 0.591 ' HG1' ' H ' ' A' ' 108' ' ' VAL . 44.6 p -81.91 -62.54 1.6 Allowed 'General case' 0 C--N 1.353 0.724 0 O-C-N 120.375 -1.453 . . . . 1.0 109.521 179.403 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . 0.591 ' H ' ' HG1' ' A' ' 107' ' ' THR . 15.5 m -65.2 22.45 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.35 0.599 0 N-CA-C 113.025 0.75 . . . . 1.0 113.025 -176.799 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 109' ' ' ILE . . . . . 0.68 ' H ' ' HD2' ' A' ' 110' ' ' PRO . 0.1 OUTLIER -114.92 -56.96 0.04 OUTLIER Pre-proline 0 CA--C 1.561 1.4 0 CA-C-N 119.089 0.859 . . . . 1.0 108.946 173.954 . . . . . . . . 3 3 . 1 . 025 nuclear orig full ' A' A ' 110' ' ' PRO . . . . . 0.68 ' HD2' ' H ' ' A' ' 109' ' ' ILE . 19.4 Cg_endo -52.24 -38.54 72.23 Favored 'Trans proline' 0 N--CA 1.497 1.696 0 C-N-CA 123.243 2.628 . . . . 1.0 112.723 -179.838 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 12.4 m120 -67.01 -68.06 0.41 Allowed 'General case' 0 CA--C 1.51 -0.577 0 C-N-CA 119.268 -0.973 . . . . 1.0 108.76 -177.762 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 112' ' ' ILE . . . . . 0.579 ' O ' ' N ' ' A' ' 115' ' ' ALA . 18.6 pt -51.64 -40.8 26.77 Favored 'Isoleucine or valine' 0 C--O 1.215 -0.749 0 N-CA-C 106.718 -1.586 . . . . 1.0 106.718 178.207 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 113' ' ' ASN . . . . . 0.446 ' N ' ' O ' ' A' ' 109' ' ' ILE . 26.5 t-20 -45.78 -51.83 12.1 Favored 'General case' 0 CA--C 1.503 -0.836 0 CA-C-N 114.047 -1.433 . . . . 1.0 108.041 -176.49 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -64.02 -27.36 69.07 Favored 'General case' 0 N--CA 1.435 -1.195 0 C-N-CA 119.494 -0.882 . . . . 1.0 109.957 177.763 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 115' ' ' ALA . . . . . 0.579 ' N ' ' O ' ' A' ' 112' ' ' ILE . . . -76.08 -60.56 2.28 Favored 'General case' 0 N--CA 1.444 -0.757 0 N-CA-C 107.546 -1.279 . . . . 1.0 107.546 177.852 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 116' ' ' ILE . . . . . 0.577 ' O ' ' C ' ' A' ' 117' ' ' GLU . 1.3 mp -47.69 -42.47 9.03 Favored 'Isoleucine or valine' 0 C--N 1.363 1.184 0 N-CA-C 108.198 -1.038 . . . . 1.0 108.198 178.768 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 117' ' ' GLU . . . . . 0.577 ' C ' ' O ' ' A' ' 116' ' ' ILE . 23.6 tt0 -38.92 -55.57 1.52 Allowed 'General case' 0 N--CA 1.472 0.671 0 N-CA-C 104.607 -2.368 . . . . 1.0 104.607 178.439 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 118' ' ' VAL . . . . . 0.434 ' N ' ' O ' ' A' ' 115' ' ' ALA . 40.5 t -70.13 -55.07 15.96 Favored 'Isoleucine or valine' 0 CA--C 1.559 1.306 0 CA-C-N 113.954 -1.476 . . . . 1.0 110.77 176.11 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -60.39 -19.62 56.56 Favored 'General case' 0 N--CA 1.49 1.565 0 N-CA-C 115.491 1.663 . . . . 1.0 115.491 -177.735 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 120' ' ' GLY . . . . . 0.512 ' O ' ' CB ' ' A' ' 121' ' ' THR . . . -121.09 -43.95 0.42 Allowed Glycine 0 C--N 1.354 1.554 0 N-CA-C 108.618 -1.793 . . . . 1.0 108.618 176.581 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 121' ' ' THR . . . . . 0.512 ' CB ' ' O ' ' A' ' 120' ' ' GLY . 45.8 m 127.54 -46.33 0.01 OUTLIER 'General case' 0 N--CA 1.48 1.057 0 C-N-CA 124.962 1.305 . . . . 1.0 108.5 -179.55 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 122' ' ' GLY . . . . . 0.666 ' O ' ' N ' ' A' ' 124' ' ' ASP . . . 104.33 -15.55 50.2 Favored Glycine 0 N--CA 1.472 1.093 0 N-CA-C 108.499 -1.84 . . . . 1.0 108.499 -178.448 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 123' ' ' THR . . . . . 0.402 ' O ' ' CG2' ' A' ' 123' ' ' THR . 9.5 t -55.43 82.84 0.0 OUTLIER 'General case' 0 C--N 1.322 -0.628 0 N-CA-C 105.436 -2.061 . . . . 1.0 105.436 178.576 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 124' ' ' ASP . . . . . 0.666 ' N ' ' O ' ' A' ' 122' ' ' GLY . 53.0 p30 -167.68 176.11 6.6 Favored 'General case' 0 C--N 1.342 0.281 0 CA-C-N 114.581 -1.19 . . . . 1.0 112.17 179.825 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 125' ' ' TYR . . . . . . . . . . . . . 2.3 t80 -138.83 138.85 37.89 Favored 'General case' 0 CA--C 1.535 0.395 0 N-CA-C 107.914 -1.143 . . . . 1.0 107.914 175.827 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 126' ' ' ARG . . . . . 0.438 HH22 HG22 ' A' ' 79' ' ' ILE . 1.3 mmp_? -145.63 145.12 30.82 Favored 'General case' 0 N--CA 1.47 0.555 0 N-CA-C 109.187 -0.671 . . . . 1.0 109.187 179.399 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 127' ' ' PHE . . . . . . . . . . . . . 6.5 p90 . . . . . 0 N--CA 1.47 0.571 0 CA-C-O 117.958 -1.02 . . . . 1.0 110.734 -179.651 . . . . . . . . 0 0 . 1 . 025 nuclear orig full ' A' A ' 128' ' ' MTN . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 025 nuclear orig full ' A' A ' 129' ' ' MTN . . . . . 0.432 ' S1 ' ' C6 ' ' A' ' 129' ' ' MTN . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 130' ' ' MTN . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 026 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 62.2 mtt . . . . . 0 N--CA 1.491 1.615 0 N-CA-C 109.025 -0.731 . . . . 1.0 109.025 . . . . . . . . . 0 0 . 1 . 026 nuclear orig full ' A' A ' 2' ' ' SER . . . . . 0.413 ' O ' ' CB ' ' A' ' 3' ' ' ASP . 61.2 p -104.65 9.4 35.2 Favored 'General case' 0 N--CA 1.467 0.389 0 C-N-CA 122.578 0.351 . . . . 1.0 110.925 -179.548 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . 0.413 ' CB ' ' O ' ' A' ' 2' ' ' SER . 0.9 OUTLIER 166.15 99.2 0.0 OUTLIER 'General case' 0 N--CA 1.466 0.357 0 O-C-N 123.411 0.444 . . . . 1.0 110.842 179.25 . . . . . . . . 3 3 . 1 . 026 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 65.9 t80 -149.97 144.67 25.99 Favored 'General case' 0 C--O 1.233 0.185 0 N-CA-C 110.045 -0.354 . . . . 1.0 110.045 179.446 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 45.2 m-20 -151.8 147.89 27.2 Favored 'General case' 0 C--N 1.331 -0.226 0 N-CA-C 109.909 -0.404 . . . . 1.0 109.909 -179.976 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 6' ' ' THR . . . . . 0.647 ' O ' ' N ' ' A' ' 10' ' ' SER . 18.9 m -68.9 174.64 4.24 Favored 'General case' 0 C--O 1.214 -0.801 0 C-N-CA 120.188 -0.605 . . . . 1.0 109.868 -179.924 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . 0.585 ' O ' ' N ' ' A' ' 11' ' ' ARG . 80.1 tt0 -60.76 -53.91 51.57 Favored 'General case' 0 C--N 1.314 -0.935 0 CA-C-O 121.814 0.816 . . . . 1.0 109.862 -177.982 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 8' ' ' ARG . . . . . 0.499 ' O ' ' CB ' ' A' ' 12' ' ' ALA . 18.3 ttm105 -53.19 -57.63 9.83 Favored 'General case' 0 C--N 1.309 -1.17 0 C-N-CA 119.103 -1.039 . . . . 1.0 108.283 -178.456 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . 0.471 ' O ' ' CG2' ' A' ' 13' ' ' VAL . 0.0 OUTLIER -65.09 -47.44 87.78 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.807 0 CA-C-N 113.913 -1.494 . . . . 1.0 110.227 179.687 . . . . . . . . 3 3 . 1 . 026 nuclear orig full ' A' A ' 10' ' ' SER . . . . . 0.647 ' N ' ' O ' ' A' ' 6' ' ' THR . 35.0 t -62.99 -59.78 4.35 Favored 'General case' 0 N--CA 1.477 0.877 0 C-N-CA 119.504 -0.879 . . . . 1.0 109.0 179.575 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 11' ' ' ARG . . . . . 0.59 ' O ' ' N ' ' A' ' 15' ' ' ALA . 2.6 tpt180 -64.62 -56.13 15.87 Favored 'General case' 0 N--CA 1.474 0.747 0 CA-C-O 120.796 0.331 . . . . 1.0 111.094 -177.667 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . 0.499 ' CB ' ' O ' ' A' ' 8' ' ' ARG . . . -51.57 -51.12 58.01 Favored 'General case' 0 N--CA 1.485 1.318 0 N-CA-C 106.714 -1.588 . . . . 1.0 106.714 -178.952 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . 0.595 ' O ' ' CB ' ' A' ' 17' ' ' LEU . 64.1 t -61.67 -50.06 81.79 Favored 'Isoleucine or valine' 0 C--O 1.202 -1.408 0 C-N-CA 118.448 -1.301 . . . . 1.0 108.542 178.044 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . 0.464 ' N ' ' O ' ' A' ' 10' ' ' SER . . . -58.72 -61.12 2.85 Favored 'General case' 0 C--O 1.214 -0.78 0 C-N-CA 118.273 -1.371 . . . . 1.0 109.51 179.511 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . 0.59 ' N ' ' O ' ' A' ' 11' ' ' ARG . . . -53.06 -57.02 11.82 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-O 121.727 0.775 . . . . 1.0 110.499 -178.461 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . 0.441 ' CB ' ' O ' ' A' ' 12' ' ' ALA . . . -62.14 -53.2 58.79 Favored 'General case' 0 C--N 1.31 -1.151 0 CA-C-N 114.666 -1.152 . . . . 1.0 108.658 -179.086 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . 0.595 ' CB ' ' O ' ' A' ' 13' ' ' VAL . 6.3 tp -57.19 -52.84 63.71 Favored 'General case' 0 N--CA 1.475 0.814 0 CA-C-N 114.335 -1.302 . . . . 1.0 108.832 -177.918 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . 0.562 HG23 ' H ' ' A' ' 19' ' ' GLY . 3.1 m -68.62 -56.12 13.46 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.521 0 C-N-CA 119.498 -0.881 . . . . 1.0 109.693 179.215 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . 0.572 ' N ' ' O ' ' A' ' 15' ' ' ALA . . . -63.73 -169.52 1.49 Allowed Glycine 0 CA--C 1.525 0.695 0 N-CA-C 112.118 -0.393 . . . . 1.0 112.118 -178.966 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 20' ' ' PRO . . . . . 0.603 ' O ' ' N ' ' A' ' 24' ' ' ALA . 1.0 OUTLIER -79.42 -23.88 6.94 Favored 'Trans proline' 0 C--N 1.311 -1.401 0 C-N-CA 122.925 2.417 . . . . 1.0 112.993 -179.1 . . . . . . . . 3 3 . 1 . 026 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -59.71 -58.6 13.41 Favored Glycine 0 N--CA 1.475 1.3 0 C-N-CA 119.789 -1.196 . . . . 1.0 111.877 -176.674 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . 0.401 ' H ' ' CA ' ' A' ' 16' ' ' ALA . . . -59.74 -51.76 57.04 Favored Glycine 0 CA--C 1.501 -0.815 0 N-CA-C 106.86 -2.496 . . . . 1.0 106.86 -178.012 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 29.5 t -58.32 -35.78 55.25 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.032 0 CA-C-N 114.126 -1.037 . . . . 1.0 108.941 -179.758 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . 0.603 ' N ' ' O ' ' A' ' 20' ' ' PRO . . . -61.92 -60.48 3.57 Favored 'General case' 0 CA--C 1.536 0.429 0 C-N-CA 118.524 -1.27 . . . . 1.0 110.255 -179.921 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 9.9 mp -65.02 -44.96 87.43 Favored 'General case' 0 C--N 1.344 0.332 0 CA-C-N 119.257 0.935 . . . . 1.0 112.408 -177.69 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 89.6 t -62.17 -58.79 5.99 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.308 0 C-N-CA 118.826 -1.149 . . . . 1.0 110.268 -177.311 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 1.3 p -60.28 -35.31 61.42 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 O-C-N 121.802 -0.561 . . . . 1.0 112.269 -177.476 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 14.0 tmtt? -67.88 -54.58 17.78 Favored 'General case' 0 C--N 1.318 -0.788 0 CA-C-O 121.449 0.643 . . . . 1.0 110.077 -178.591 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 9.9 p -63.11 -45.21 99.22 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.834 0 C-N-CA 119.338 -0.945 . . . . 1.0 110.508 -178.333 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 30' ' ' CYS . . . . . . . . . . . . . 1.4 t -66.3 -60.94 2.3 Favored 'General case' 0 CA--C 1.532 0.256 0 C-N-CA 119.123 -1.031 . . . . 1.0 110.004 -179.607 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -64.65 -52.81 55.4 Favored 'General case' 0 CA--C 1.511 -0.536 0 N-CA-C 112.923 0.712 . . . . 1.0 112.923 -176.44 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 85.02 74.38 1.25 Allowed Glycine 0 CA--C 1.526 0.764 0 N-CA-C 109.135 -1.586 . . . . 1.0 109.135 -177.256 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 23.1 mt 86.09 95.49 0.03 OUTLIER Pre-proline 0 N--CA 1.479 0.983 0 C-N-CA 123.676 0.79 . . . . 1.0 110.521 -179.17 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 47.5 Cg_endo -68.3 -27.76 34.11 Favored 'Trans proline' 0 N--CA 1.506 2.26 0 C-N-CA 122.221 1.947 . . . . 1.0 115.085 -177.843 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -62.08 -58.72 11.46 Favored Glycine 0 CA--C 1.53 1.029 0 C-N-CA 118.233 -1.937 . . . . 1.0 109.383 -178.678 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . 0.499 ' O ' ' CB ' ' A' ' 37' ' ' ILE . 11.3 p -88.88 162.09 2.61 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.462 0 N-CA-C 106.231 -1.766 . . . . 1.0 106.231 177.215 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . 0.499 ' CB ' ' O ' ' A' ' 36' ' ' VAL . 0.0 OUTLIER 118.99 120.01 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.476 0.865 0 C-N-CA 124.322 1.049 . . . . 1.0 108.506 -179.238 . . . . . . . . 3 3 . 1 . 026 nuclear orig full ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 46.8 m80 -142.11 133.85 27.01 Favored 'General case' 0 C--N 1.332 -0.154 0 N-CA-C 108.412 -0.958 . . . . 1.0 108.412 179.072 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -110.38 134.87 20.69 Favored Pre-proline 0 C--N 1.325 -0.464 0 N-CA-C 108.439 -0.949 . . . . 1.0 108.439 -179.716 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 37.1 Cg_endo -66.36 -85.55 0.01 OUTLIER 'Trans proline' 0 N--CA 1.49 1.31 0 CA-C-N 119.994 1.034 . . . . 1.0 111.469 -179.047 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -66.16 121.9 16.22 Favored 'General case' 0 C--N 1.317 -0.808 0 CA-C-N 114.991 -1.004 . . . . 1.0 110.298 -178.714 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . 0.672 ' C ' ' H ' ' A' ' 44' ' ' GLY . 34.2 ptt180 -169.15 166.04 10.9 Favored 'General case' 0 N--CA 1.434 -1.27 0 N-CA-C 109.133 -0.691 . . . . 1.0 109.133 179.062 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 43' ' ' ARG . . . . . 0.587 ' HG3' ' O ' ' A' ' 45' ' ' PHE . 0.0 OUTLIER -65.33 25.07 0.02 OUTLIER 'General case' 0 C--N 1.311 -1.078 0 CA-C-N 115.717 -0.674 . . . . 1.0 110.249 -179.067 . . . . . . . . 3 3 . 1 . 026 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . 0.672 ' H ' ' C ' ' A' ' 42' ' ' ARG . . . 76.63 -24.92 1.78 Allowed Glycine 0 C--N 1.345 1.072 0 N-CA-C 111.869 -0.492 . . . . 1.0 111.869 179.27 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . 0.739 ' O ' ' HB2' ' A' ' 46' ' ' PHE . 35.2 t80 -162.76 164.81 26.11 Favored 'General case' 0 C--O 1.198 -1.606 0 CA-C-O 119.003 -0.522 . . . . 1.0 110.155 -179.268 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 46' ' ' PHE . . . . . 0.739 ' HB2' ' O ' ' A' ' 45' ' ' PHE . 2.7 t80 131.18 93.07 0.0 OUTLIER 'General case' 0 N--CA 1.517 2.894 0 C-N-CA 124.396 1.078 . . . . 1.0 111.134 178.125 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 47' ' ' ARG . . . . . 0.531 ' CB ' ' O ' ' A' ' 46' ' ' PHE . 2.1 tmm_? 118.46 151.82 0.0 OUTLIER 'General case' 0 N--CA 1.482 1.13 0 C-N-CA 124.697 1.199 . . . . 1.0 108.842 -179.981 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER 70.3 70.98 0.21 Allowed 'General case' 0 CA--C 1.534 0.357 0 N-CA-C 108.316 -0.994 . . . . 1.0 108.316 -177.918 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -134.75 140.11 34.37 Favored Pre-proline 0 CA--C 1.541 0.597 0 N-CA-C 108.467 -0.938 . . . . 1.0 108.467 -179.018 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . 0.444 ' C ' ' H ' ' A' ' 52' ' ' ARG . 55.3 Cg_endo -66.9 69.22 0.53 Allowed 'Trans proline' 0 N--CA 1.5 1.887 0 C-N-CA 121.793 1.662 . . . . 1.0 112.74 -179.032 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . 0.452 ' N ' ' CD ' ' A' ' 51' ' ' GLU . 0.7 OUTLIER 63.64 -9.16 0.14 Allowed 'General case' 0 N--CA 1.468 0.439 0 N-CA-C 112.574 0.583 . . . . 1.0 112.574 179.868 . . . . . . . . 3 3 . 1 . 026 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . 0.444 ' H ' ' C ' ' A' ' 50' ' ' PRO . 0.0 OUTLIER -76.6 168.99 19.11 Favored 'General case' 0 N--CA 1.466 0.36 0 C-N-CA 119.781 -0.768 . . . . 1.0 110.5 179.747 . . . . . . . . 3 3 . 1 . 026 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . 0.457 ' O ' ' N ' ' A' ' 55' ' ' ILE . 8.2 pt -81.42 135.77 24.41 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.464 0 CA-C-O 122.018 0.913 . . . . 1.0 110.97 -179.974 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 6.3 pm0 -61.42 83.14 0.01 OUTLIER 'General case' 0 C--N 1.314 -0.967 0 CA-C-N 113.712 -1.585 . . . . 1.0 108.82 -178.303 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . 0.457 ' N ' ' O ' ' A' ' 53' ' ' ILE . 20.8 tt -150.47 158.74 5.1 Favored 'Isoleucine or valine' 0 C--N 1.354 0.776 0 CA-C-N 116.429 -0.35 . . . . 1.0 110.654 178.255 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 107.72 -5.94 35.21 Favored Glycine 0 N--CA 1.486 2.017 0 N-CA-C 111.491 -0.644 . . . . 1.0 111.491 179.319 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . 0.445 ' CG ' ' NH1' ' A' ' 43' ' ' ARG . 8.4 p-10 -78.56 103.54 8.57 Favored 'General case' 0 C--N 1.311 -1.102 0 CA-C-N 114.501 -0.85 . . . . 1.0 109.91 178.604 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 58' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -89.74 173.15 8.44 Favored 'General case' 0 CA--C 1.555 1.169 0 CA-C-O 123.375 1.559 . . . . 1.0 114.417 -176.976 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 59' ' ' ARG . . . . . 0.501 ' HE ' ' N ' ' A' ' 59' ' ' ARG . 0.0 OUTLIER -74.04 -61.04 1.99 Allowed 'General case' 0 N--CA 1.479 0.993 0 CA-C-N 111.414 -2.63 . . . . 1.0 111.694 -178.825 . . . . . . . . 3 3 . 1 . 026 nuclear orig full ' A' A ' 60' ' ' TYR . . . . . 0.544 ' CG ' ' O ' ' A' ' 60' ' ' TYR . 65.9 t80 -92.17 -8.91 44.22 Favored 'General case' 0 C--O 1.244 0.813 0 C-N-CA 124.593 1.157 . . . . 1.0 113.241 -179.661 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -79.12 -17.32 55.3 Favored 'General case' 0 N--CA 1.432 -1.346 0 O-C-N 121.348 -0.845 . . . . 1.0 111.366 -178.347 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . 0.655 ' O ' ' N ' ' A' ' 66' ' ' GLY . 25.9 m -49.02 -54.49 5.28 Favored 'Isoleucine or valine' 0 C--O 1.199 -1.603 0 C-N-CA 119.802 -0.759 . . . . 1.0 110.512 -174.954 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 63' ' ' ALA . . . . . 0.403 ' O ' ' N ' ' A' ' 67' ' ' ARG . . . -69.03 -49.7 55.3 Favored 'General case' 0 C--N 1.308 -1.225 0 O-C-N 121.498 -0.751 . . . . 1.0 109.539 -179.427 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 1.0 OUTLIER -50.18 -56.57 10.49 Favored 'General case' 0 CA--C 1.54 0.592 0 CA-C-N 115.226 -0.897 . . . . 1.0 108.613 -179.005 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . 0.617 ' C ' ' H ' ' A' ' 67' ' ' ARG . 32.7 t0 -74.69 -46.46 37.64 Favored 'General case' 0 C--N 1.317 -0.832 0 CA-C-N 115.594 -0.73 . . . . 1.0 110.115 178.094 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . 0.655 ' N ' ' O ' ' A' ' 62' ' ' VAL . . . -72.92 25.19 0.8 Allowed Glycine 0 N--CA 1.444 -0.822 0 N-CA-C 109.663 -1.375 . . . . 1.0 109.663 177.556 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 67' ' ' ARG . . . . . 0.627 ' O ' ' N ' ' A' ' 69' ' ' LEU . 0.0 OUTLIER -72.49 6.2 2.52 Favored 'General case' 0 N--CA 1.452 -0.335 0 N-CA-C 105.477 -2.045 . . . . 1.0 105.477 174.761 . . . . . . . . 3 3 . 1 . 026 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . 0.584 ' H ' ' C ' ' A' ' 66' ' ' GLY . 0.0 OUTLIER -33.1 -28.45 0.01 OUTLIER 'General case' 0 N--CA 1.483 1.202 0 N-CA-C 108.565 -0.902 . . . . 1.0 108.565 -175.746 . . . . . . . . 3 3 . 1 . 026 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . 0.627 ' N ' ' O ' ' A' ' 67' ' ' ARG . 8.5 tt -62.77 -64.33 0.95 Allowed 'General case' 0 C--N 1.323 -0.581 0 C-N-CA 118.797 -1.161 . . . . 1.0 108.988 178.476 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . 0.59 ' C ' ' H ' ' A' ' 72' ' ' HIS . . . -78.76 -74.45 0.28 Allowed 'General case' 0 N--CA 1.475 0.802 0 N-CA-C 105.485 -2.042 . . . . 1.0 105.485 176.657 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . 0.457 ' O ' ' C ' ' A' ' 72' ' ' HIS . . . -44.14 2.99 0.0 OUTLIER 'General case' 0 C--N 1.332 -0.158 0 C-N-CA 125.255 1.422 . . . . 1.0 114.352 179.687 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 72' ' ' HIS . . . . . 0.626 ' CG ' ' N ' ' A' ' 73' ' ' MET . 0.0 OUTLIER -28.49 -64.8 0.09 Allowed 'General case' 0 N--CA 1.47 0.564 0 CA-C-N 118.834 0.743 . . . . 1.0 111.585 -178.335 . . . . . . . . 3 3 . 1 . 026 nuclear orig full ' A' A ' 73' ' ' MET . . . . . 0.626 ' N ' ' CG ' ' A' ' 72' ' ' HIS . 2.9 ptp -69.65 -50.69 41.67 Favored 'General case' 0 C--N 1.32 -0.685 0 C-N-CA 119.279 -0.968 . . . . 1.0 108.881 179.042 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . 0.711 ' C ' ' H ' ' A' ' 76' ' ' GLY . 86.2 t -44.85 -41.84 2.3 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.329 0 CA-C-O 117.628 -1.177 . . . . 1.0 111.433 -176.385 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 75' ' ' ASN . . . . . 0.523 ' O ' ' N ' ' A' ' 78' ' ' VAL . 4.1 t30 -37.03 -13.45 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.703 0 CA-C-N 121.307 1.867 . . . . 1.0 112.802 179.431 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . 0.711 ' H ' ' C ' ' A' ' 74' ' ' VAL . . . -44.56 -25.98 0.96 Allowed Glycine 0 CA--C 1.544 1.897 0 CA-C-N 113.294 -1.776 . . . . 1.0 108.711 177.898 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . 0.627 ' O ' ' N ' ' A' ' 80' ' ' ALA . 0.2 OUTLIER -69.03 -48.07 71.89 Favored 'Isoleucine or valine' 0 C--O 1.209 -1.052 0 N-CA-C 107.519 -1.289 . . . . 1.0 107.519 178.07 . . . . . . . . 3 3 . 1 . 026 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . 0.524 ' C ' ' O ' ' A' ' 77' ' ' ILE . 77.3 t -32.89 -35.59 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.476 0.856 0 CA-C-N 114.658 -1.155 . . . . 1.0 108.036 -176.391 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . 0.531 ' N ' ' O ' ' A' ' 77' ' ' ILE . 39.0 pt -98.61 -28.44 3.56 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.948 0 CA-C-O 121.261 0.553 . . . . 1.0 111.813 176.932 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 80' ' ' ALA . . . . . 0.627 ' N ' ' O ' ' A' ' 77' ' ' ILE . . . -86.77 -13.76 44.26 Favored 'General case' 0 N--CA 1.477 0.922 0 N-CA-C 114.06 1.133 . . . . 1.0 114.06 178.557 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . 0.628 ' CG ' ' H ' ' A' ' 82' ' ' ASP . 16.1 pt-20 -83.13 -69.26 0.64 Allowed 'General case' 0 C--N 1.345 0.373 0 CA-C-N 119.042 0.837 . . . . 1.0 108.797 -179.676 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 82' ' ' ASP . . . . . 0.628 ' H ' ' CG ' ' A' ' 81' ' ' GLU . 67.1 m-20 -75.64 -10.79 59.74 Favored 'General case' 0 N--CA 1.442 -0.844 0 CA-C-N 118.075 0.398 . . . . 1.0 110.833 179.453 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . 0.601 ' O ' ' N ' ' A' ' 86' ' ' ALA . . . -19.84 -44.37 0.0 OUTLIER 'General case' 0 N--CA 1.472 0.643 0 N-CA-C 112.577 0.584 . . . . 1.0 112.577 177.029 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . 0.579 ' N ' ' O ' ' A' ' 82' ' ' ASP . 5.9 tp -31.65 -33.53 0.01 OUTLIER 'General case' 0 N--CA 1.473 0.702 0 CA-C-N 118.319 0.509 . . . . 1.0 111.746 -177.961 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 85' ' ' ILE . . . . . 0.597 ' O ' ' CG2' ' A' ' 89' ' ' VAL . 47.8 pt -100.51 -37.19 5.46 Favored 'Isoleucine or valine' 0 C--O 1.208 -1.108 0 N-CA-C 109.096 -0.705 . . . . 1.0 109.096 176.133 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . 0.601 ' N ' ' O ' ' A' ' 83' ' ' ALA . . . -66.24 -59.41 3.76 Favored 'General case' 0 C--N 1.317 -0.805 0 C-N-CA 119.647 -0.821 . . . . 1.0 111.381 -179.908 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -69.43 -18.36 63.73 Favored 'General case' 0 N--CA 1.47 0.544 0 CA-C-N 120.344 1.429 . . . . 1.0 112.294 -179.627 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -88.64 -13.1 40.67 Favored 'General case' 0 N--CA 1.475 0.817 0 CA-C-O 122.645 1.212 . . . . 1.0 108.141 179.358 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 89' ' ' VAL . . . . . 0.597 ' CG2' ' O ' ' A' ' 85' ' ' ILE . 53.3 t -92.22 39.66 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.32 -0.7 0 CA-C-N 111.953 -2.385 . . . . 1.0 109.474 177.654 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 90' ' ' GLY . . . . . 0.776 ' O ' ' N ' ' A' ' 92' ' ' HIS . . . -64.22 -30.17 77.05 Favored Glycine 0 C--N 1.371 2.476 0 CA-C-O 117.902 -1.499 . . . . 1.0 109.969 176.893 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 91' ' ' PRO . . . . . 0.55 ' HD2' ' N ' ' A' ' 90' ' ' GLY . 72.6 Cg_exo -40.26 -5.78 0.01 OUTLIER 'Trans proline' 0 N--CA 1.488 1.205 0 CA-C-N 120.926 2.363 . . . . 1.0 111.111 174.556 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 92' ' ' HIS . . . . . 0.776 ' N ' ' O ' ' A' ' 90' ' ' GLY . 2.5 p-80 -48.82 -24.48 1.45 Allowed 'General case' 0 N--CA 1.435 -1.211 0 N-CA-C 106.593 -1.632 . . . . 1.0 106.593 179.731 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . 0.505 ' HG ' ' H ' ' A' ' 94' ' ' ALA . 1.2 pp -60.54 -53.48 56.95 Favored 'General case' 0 N--CA 1.445 -0.697 0 N-CA-C 106.493 -1.669 . . . . 1.0 106.493 176.088 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 94' ' ' ALA . . . . . 0.533 ' N ' ' O ' ' A' ' 91' ' ' PRO . . . -51.09 -53.17 36.45 Favored 'General case' 0 C--O 1.212 -0.899 0 N-CA-C 107.409 -1.33 . . . . 1.0 107.409 179.465 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 95' ' ' ARG . . . . . 0.445 ' HE ' ' HD3' ' A' ' 20' ' ' PRO . 4.5 mmp_? -61.94 -28.43 69.53 Favored 'General case' 0 CA--C 1.549 0.924 0 CA-C-O 122.297 1.046 . . . . 1.0 110.09 178.27 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 96' ' ' ALA . . . . . 0.905 ' O ' ' N ' ' A' ' 100' ' ' ILE . . . -50.4 -36.68 33.86 Favored 'General case' 0 C--O 1.195 -1.783 0 N-CA-C 107.105 -1.442 . . . . 1.0 107.105 -176.364 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . 0.441 ' C ' ' O ' ' A' ' 96' ' ' ALA . 0.4 OUTLIER -35.0 -23.9 0.01 OUTLIER 'General case' 0 CA--C 1.587 2.403 0 CA-C-N 113.48 -1.691 . . . . 1.0 108.512 -177.214 . . . . . . . . 3 3 . 1 . 026 nuclear orig full ' A' A ' 98' ' ' GLY . . . . . 0.657 ' N ' ' O ' ' A' ' 96' ' ' ALA . . . -88.8 -53.02 2.65 Favored Glycine 0 CA--C 1.55 2.221 0 CA-C-O 123.223 1.457 . . . . 1.0 110.644 171.577 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 99' ' ' GLN . . . . . 0.586 ' N ' ' O ' ' A' ' 96' ' ' ALA . 12.2 mp0 -76.99 7.05 5.28 Favored 'General case' 0 N--CA 1.435 -1.178 0 N-CA-C 106.373 -1.714 . . . . 1.0 106.373 176.787 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 100' ' ' ILE . . . . . 0.905 ' N ' ' O ' ' A' ' 96' ' ' ALA . 0.3 OUTLIER -60.23 -52.99 54.87 Favored 'Isoleucine or valine' 0 CA--C 1.487 -1.476 0 N-CA-C 104.806 -2.294 . . . . 1.0 104.806 178.185 . . . . . . . . 3 3 . 1 . 026 nuclear orig full ' A' A ' 101' ' ' VAL . . . . . 0.556 ' O ' ' N ' ' A' ' 105' ' ' GLY . 21.5 t -49.3 -60.41 0.74 Allowed 'Isoleucine or valine' 0 C--O 1.222 -0.394 0 C-N-CA 117.752 -1.579 . . . . 1.0 107.837 178.581 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 102' ' ' CYS . . . . . 0.413 ' SG ' ' O ' ' A' ' 99' ' ' GLN . 0.5 OUTLIER -50.17 -30.46 11.4 Favored 'General case' 0 C--N 1.317 -0.825 0 CA-C-N 114.931 -1.031 . . . . 1.0 110.961 -178.265 . . . . . . . . 3 3 . 1 . 026 nuclear orig full ' A' A ' 103' ' ' ARG . . . . . 0.426 ' N ' ' O ' ' A' ' 99' ' ' GLN . 0.0 OUTLIER -83.69 -53.84 5.35 Favored 'General case' 0 N--CA 1.486 1.335 0 N-CA-C 114.205 1.187 . . . . 1.0 114.205 -179.322 . . . . . . . . 3 3 . 1 . 026 nuclear orig full ' A' A ' 104' ' ' TYR . . . . . 0.662 ' CG ' ' O ' ' A' ' 104' ' ' TYR . 0.0 OUTLIER -94.1 21.5 6.76 Favored 'General case' 0 C--N 1.311 -1.09 0 C-N-CA 126.469 1.908 . . . . 1.0 107.871 179.122 . . . . . . . . 3 3 . 1 . 026 nuclear orig full ' A' A ' 105' ' ' GLY . . . . . 0.556 ' N ' ' O ' ' A' ' 101' ' ' VAL . . . -156.76 -91.14 0.08 OUTLIER Glycine 0 N--CA 1.445 -0.733 0 N-CA-C 106.822 -2.511 . . . . 1.0 106.822 177.2 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 106' ' ' ALA . . . . . 0.46 ' C ' ' H ' ' A' ' 108' ' ' VAL . . . 72.81 46.76 0.24 Allowed 'General case' 0 N--CA 1.449 -0.498 0 N-CA-C 112.076 0.398 . . . . 1.0 112.076 -179.94 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 10.3 t -76.67 7.22 4.83 Favored 'General case' 0 CA--C 1.513 -0.479 0 O-C-N 119.986 -1.696 . . . . 1.0 107.045 176.402 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . 0.46 ' H ' ' C ' ' A' ' 106' ' ' ALA . 18.7 m -86.78 -52.53 11.65 Favored 'Isoleucine or valine' 0 C--N 1.35 0.615 0 CA-C-O 117.945 -1.026 . . . . 1.0 110.298 177.51 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 109' ' ' ILE . . . . . 0.448 ' O ' ' OD1' ' A' ' 113' ' ' ASN . 0.1 OUTLIER -47.91 -33.93 4.99 Favored Pre-proline 0 C--N 1.368 1.394 0 N-CA-C 116.8 2.148 . . . . 1.0 116.8 -177.587 . . . . . . . . 3 3 . 1 . 026 nuclear orig full ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 50.4 Cg_exo -54.79 -47.42 26.81 Favored 'Trans proline' 0 C--N 1.308 -1.564 0 CA-C-N 122.558 1.949 . . . . 1.0 112.439 -176.942 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 111' ' ' ASN . . . . . 0.4 ' O ' ' N ' ' A' ' 114' ' ' ALA . 24.7 t-20 -72.29 -67.35 0.55 Allowed 'General case' 0 N--CA 1.467 0.4 0 C-N-CA 119.995 -0.682 . . . . 1.0 111.491 -177.184 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 112' ' ' ILE . . . . . 0.626 ' O ' ' N ' ' A' ' 116' ' ' ILE . 0.9 OUTLIER -46.42 -28.85 0.97 Allowed 'Isoleucine or valine' 0 C--O 1.192 -1.948 0 O-C-N 121.927 -0.483 . . . . 1.0 111.99 -178.3 . . . . . . . . 3 3 . 1 . 026 nuclear orig full ' A' A ' 113' ' ' ASN . . . . . 0.448 ' OD1' ' O ' ' A' ' 109' ' ' ILE . 4.3 m120 -72.0 -40.2 68.7 Favored 'General case' 0 N--CA 1.483 1.217 0 CA-C-O 123.544 1.64 . . . . 1.0 108.231 179.859 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 114' ' ' ALA . . . . . 0.4 ' N ' ' O ' ' A' ' 111' ' ' ASN . . . -54.59 -50.0 69.07 Favored 'General case' 0 C--N 1.295 -1.796 0 CA-C-N 111.015 -2.812 . . . . 1.0 107.376 178.727 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 115' ' ' ALA . . . . . 0.722 ' O ' ' N ' ' A' ' 119' ' ' LEU . . . -85.13 -49.09 8.53 Favored 'General case' 0 C--O 1.199 -1.579 0 N-CA-C 114.402 1.26 . . . . 1.0 114.402 177.652 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 116' ' ' ILE . . . . . 0.626 ' N ' ' O ' ' A' ' 112' ' ' ILE . 0.6 OUTLIER -42.79 -49.15 1.15 Allowed 'Isoleucine or valine' 0 N--CA 1.513 2.714 0 N-CA-C 106.109 -1.811 . . . . 1.0 106.109 179.569 . . . . . . . . 3 3 . 1 . 026 nuclear orig full ' A' A ' 117' ' ' GLU . . . . . 0.439 ' C ' ' O ' ' A' ' 116' ' ' ILE . 68.3 mt-10 -45.99 -59.87 2.59 Favored 'General case' 0 C--N 1.308 -1.2 0 N-CA-C 105.573 -2.01 . . . . 1.0 105.573 177.907 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 118' ' ' VAL . . . . . 0.544 ' N ' ' O ' ' A' ' 115' ' ' ALA . 6.9 t -77.52 -57.37 5.83 Favored 'Isoleucine or valine' 0 CA--C 1.557 1.23 0 N-CA-C 113.558 0.947 . . . . 1.0 113.558 178.505 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 119' ' ' LEU . . . . . 0.722 ' N ' ' O ' ' A' ' 115' ' ' ALA . 1.3 tp -61.55 -24.44 66.64 Favored 'General case' 0 C--N 1.351 0.652 0 N-CA-C 116.218 1.933 . . . . 1.0 116.218 -178.728 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 120' ' ' GLY . . . . . 0.485 ' O ' ' CB ' ' A' ' 121' ' ' THR . . . -126.48 -54.93 0.15 Allowed Glycine 0 C--N 1.354 1.549 0 CA-C-N 120.506 1.503 . . . . 1.0 110.869 176.976 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 121' ' ' THR . . . . . 0.533 ' CG2' ' H ' ' A' ' 122' ' ' GLY . 2.1 t 143.39 -56.18 0.0 OUTLIER 'General case' 0 N--CA 1.477 0.907 0 C-N-CA 124.089 0.956 . . . . 1.0 112.036 -177.915 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 122' ' ' GLY . . . . . 0.592 ' O ' ' N ' ' A' ' 124' ' ' ASP . . . 92.6 -23.27 28.97 Favored Glycine 0 CA--C 1.531 1.053 0 N-CA-C 107.725 -2.15 . . . . 1.0 107.725 -176.583 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 123' ' ' THR . . . . . 0.49 ' H ' ' C ' ' A' ' 121' ' ' THR . 5.8 t -46.94 91.94 0.01 OUTLIER 'General case' 0 N--CA 1.477 0.918 0 N-CA-C 105.64 -1.985 . . . . 1.0 105.64 179.239 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 124' ' ' ASP . . . . . 0.592 ' N ' ' O ' ' A' ' 122' ' ' GLY . 48.2 p30 -169.76 -174.82 1.94 Allowed 'General case' 0 CA--C 1.537 0.458 0 CA-C-N 114.904 -1.044 . . . . 1.0 112.38 178.739 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 125' ' ' TYR . . . . . . . . . . . . . 16.9 t80 -148.59 147.63 29.22 Favored 'General case' 0 CA--C 1.542 0.644 0 CA-C-N 114.385 -1.28 . . . . 1.0 109.059 175.686 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 13.8 mtp85 -146.94 150.41 35.14 Favored 'General case' 0 N--CA 1.476 0.85 0 N-CA-C 109.812 -0.44 . . . . 1.0 109.812 177.38 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 127' ' ' PHE . . . . . . . . . . . . . 26.7 p90 . . . . . 0 C--O 1.22 -0.449 0 CA-C-O 118.176 -0.916 . . . . 1.0 111.231 -179.353 . . . . . . . . 0 0 . 1 . 026 nuclear orig full ' A' A ' 128' ' ' MTN . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 026 nuclear orig full ' A' A ' 129' ' ' MTN . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 026 nuclear orig full ' A' A ' 130' ' ' MTN . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 027 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.488 1.456 0 N-CA-C 108.667 -0.864 . . . . 1.0 108.667 . . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 93.4 p -88.4 0.58 56.07 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.576 -0.284 . . . . 1.0 111.316 -179.967 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 2.0 t70 164.65 118.65 0.01 OUTLIER 'General case' 0 N--CA 1.479 0.988 0 O-C-N 123.391 0.432 . . . . 1.0 111.277 178.916 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 58.2 t80 -151.74 148.39 27.83 Favored 'General case' 0 N--CA 1.465 0.322 0 CA-C-O 121.078 0.466 . . . . 1.0 110.191 177.997 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 30.9 m-20 -152.29 148.12 27.16 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.596 -0.729 . . . . 1.0 109.788 179.754 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 6' ' ' THR . . . . . 0.72 ' O ' ' N ' ' A' ' 10' ' ' SER . 0.2 OUTLIER -106.72 -168.7 1.45 Allowed 'General case' 0 C--O 1.205 -1.286 0 CA-C-O 121.602 0.715 . . . . 1.0 109.832 -179.967 . . . . . . . . 3 3 . 1 . 027 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . 0.502 ' O ' ' CB ' ' A' ' 11' ' ' ARG . 71.6 mm-40 -57.66 -46.59 84.03 Favored 'General case' 0 C--N 1.297 -1.68 0 N-CA-C 109.438 -0.578 . . . . 1.0 109.438 179.77 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 8' ' ' ARG . . . . . 0.544 ' O ' ' CB ' ' A' ' 12' ' ' ALA . 16.8 mtt85 -66.58 -61.64 1.88 Allowed 'General case' 0 C--N 1.316 -0.864 0 C-N-CA 117.373 -1.731 . . . . 1.0 109.595 179.609 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . 0.657 ' CG2' ' H ' ' A' ' 6' ' ' THR . 0.0 OUTLIER -61.73 -52.86 55.83 Favored 'Isoleucine or valine' 0 C--O 1.204 -1.311 0 CA-C-N 114.769 -1.105 . . . . 1.0 110.703 -179.679 . . . . . . . . 3 3 . 1 . 027 nuclear orig full ' A' A ' 10' ' ' SER . . . . . 0.72 ' N ' ' O ' ' A' ' 6' ' ' THR . 4.9 t -65.3 -61.5 2.08 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 122.074 -0.391 . . . . 1.0 111.619 178.761 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 11' ' ' ARG . . . . . 0.502 ' CB ' ' O ' ' A' ' 7' ' ' GLU . 29.4 ttt180 -62.06 -43.96 97.71 Favored 'General case' 0 C--N 1.31 -1.123 0 O-C-N 121.462 -0.774 . . . . 1.0 109.561 -175.698 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . 0.544 ' CB ' ' O ' ' A' ' 8' ' ' ARG . . . -70.33 -56.58 6.36 Favored 'General case' 0 N--CA 1.477 0.919 0 C-N-CA 118.825 -1.15 . . . . 1.0 109.161 176.801 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . 0.673 ' O ' ' CB ' ' A' ' 17' ' ' LEU . 55.0 t -61.46 -53.46 48.27 Favored 'Isoleucine or valine' 0 C--O 1.192 -1.961 0 C-N-CA 117.498 -1.681 . . . . 1.0 107.461 -178.779 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . 0.61 ' N ' ' O ' ' A' ' 10' ' ' SER . . . -62.82 -65.28 0.71 Allowed 'General case' 0 C--N 1.308 -1.217 0 C-N-CA 116.075 -2.25 . . . . 1.0 111.892 -179.814 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . 0.531 ' O ' ' N ' ' A' ' 19' ' ' GLY . . . -55.35 -55.49 30.92 Favored 'General case' 0 C--O 1.217 -0.64 0 C-N-CA 118.321 -1.352 . . . . 1.0 111.545 -176.7 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . 0.61 ' O ' ' N ' ' A' ' 22' ' ' GLY . . . -65.6 -58.67 5.2 Favored 'General case' 0 C--N 1.301 -1.502 0 C-N-CA 118.35 -1.34 . . . . 1.0 110.804 -178.491 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . 0.673 ' CB ' ' O ' ' A' ' 13' ' ' VAL . 5.7 tp -53.62 -55.3 27.02 Favored 'General case' 0 N--CA 1.489 1.504 0 N-CA-C 108.536 -0.913 . . . . 1.0 108.536 -179.294 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . 0.653 HG21 ' H ' ' A' ' 19' ' ' GLY . 2.2 m -71.03 -60.42 2.45 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.43 0 C-N-CA 118.975 -1.09 . . . . 1.0 110.85 -179.509 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . 0.653 ' H ' HG21 ' A' ' 18' ' ' VAL . . . -54.54 -163.26 0.01 OUTLIER Glycine 0 N--CA 1.438 -1.218 0 CA-C-O 121.567 0.537 . . . . 1.0 113.179 -176.969 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 20' ' ' PRO . . . . . 0.72 ' O ' ' N ' ' A' ' 24' ' ' ALA . 90.6 Cg_endo -80.48 -24.75 5.06 Favored 'Trans proline' 0 C--N 1.302 -1.884 0 C-N-CA 122.246 1.964 . . . . 1.0 111.712 -179.112 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -62.11 -60.84 7.35 Favored Glycine 0 N--CA 1.47 0.914 0 C-N-CA 118.685 -1.721 . . . . 1.0 111.059 -176.921 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . 0.61 ' N ' ' O ' ' A' ' 16' ' ' ALA . . . -60.71 -50.39 68.1 Favored Glycine 0 C--N 1.304 -1.207 0 N-CA-C 106.954 -2.459 . . . . 1.0 106.954 179.017 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 83.2 t -58.41 -34.05 49.52 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.582 0 C-N-CA 118.837 -1.145 . . . . 1.0 107.991 -179.72 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . 0.72 ' N ' ' O ' ' A' ' 20' ' ' PRO . . . -61.71 -61.23 2.66 Favored 'General case' 0 N--CA 1.468 0.468 0 C-N-CA 118.685 -1.206 . . . . 1.0 109.376 179.402 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 58.0 mt -60.42 -45.19 94.49 Favored 'General case' 0 CA--C 1.508 -0.673 0 C-N-CA 119.59 -0.844 . . . . 1.0 110.478 -176.512 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 55.4 t -59.83 -60.34 2.66 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.512 0 C-N-CA 119.325 -0.95 . . . . 1.0 109.692 -178.278 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . 0.443 ' O ' ' CB ' ' A' ' 31' ' ' ALA . 62.1 t -58.57 -40.16 78.02 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.363 0 C-N-CA 120.543 -0.463 . . . . 1.0 110.534 -177.828 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 10.9 tttm -66.56 -55.26 16.27 Favored 'General case' 0 C--N 1.314 -0.946 0 C-N-CA 119.855 -0.738 . . . . 1.0 109.82 -178.701 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . 0.476 ' CG1' ' N ' ' A' ' 30' ' ' CYS . 3.2 p -65.82 -50.8 68.13 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 CA-C-N 115.294 -0.866 . . . . 1.0 111.011 -177.32 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 30' ' ' CYS . . . . . 0.476 ' N ' ' CG1' ' A' ' 29' ' ' VAL . 42.0 t -67.59 -62.61 1.34 Allowed 'General case' 0 N--CA 1.44 -0.945 0 C-N-CA 119.837 -0.745 . . . . 1.0 110.597 -179.208 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . 0.443 ' CB ' ' O ' ' A' ' 27' ' ' VAL . . . -62.74 -53.33 55.96 Favored 'General case' 0 N--CA 1.434 -1.273 0 C-N-CA 120.578 -0.449 . . . . 1.0 111.378 -175.459 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 69.8 66.23 2.3 Favored Glycine 0 N--CA 1.441 -1.022 0 C-N-CA 119.225 -1.464 . . . . 1.0 109.828 -179.428 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . 0.509 ' O ' ' CD1' ' A' ' 37' ' ' ILE . 6.2 mt 87.55 96.15 0.03 OUTLIER Pre-proline 0 N--CA 1.481 1.108 0 O-C-N 126.232 1.784 . . . . 1.0 112.049 -179.535 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 54.4 Cg_exo -46.23 -8.21 0.04 OUTLIER 'Trans proline' 0 N--CA 1.497 1.681 0 C-N-CA 122.39 2.06 . . . . 1.0 114.184 -179.825 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . 0.467 ' N ' ' O ' ' A' ' 33' ' ' LEU . . . -61.25 -60.27 8.59 Favored Glycine 0 CA--C 1.538 1.472 0 C-N-CA 118.466 -1.826 . . . . 1.0 109.867 -178.668 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . 0.628 ' CG2' ' H ' ' A' ' 37' ' ' ILE . 7.1 p -88.55 -139.84 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.473 0.687 0 CA-C-N 117.87 0.835 . . . . 1.0 109.072 179.369 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . 0.628 ' H ' ' CG2' ' A' ' 36' ' ' VAL . 2.5 mp 68.27 79.65 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.47 0.554 0 N-CA-C 112.575 0.583 . . . . 1.0 112.575 179.655 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 38' ' ' HIS . . . . . 0.515 ' CD2' ' N ' ' A' ' 38' ' ' HIS . 0.0 OUTLIER -138.86 132.47 30.54 Favored 'General case' 0 CA--C 1.532 0.266 0 N-CA-C 108.383 -0.969 . . . . 1.0 108.383 178.397 . . . . . . . . 3 3 . 1 . 027 nuclear orig full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -107.43 159.3 30.7 Favored Pre-proline 0 N--CA 1.472 0.671 0 CA-C-N 116.515 -0.312 . . . . 1.0 110.182 -178.353 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 59.6 Cg_endo -71.97 -23.44 21.89 Favored 'Trans proline' 0 C--N 1.306 -1.668 0 C-N-CA 121.736 1.624 . . . . 1.0 111.947 178.668 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -119.76 83.99 2.13 Favored 'General case' 0 C--N 1.343 0.3 0 C-N-CA 120.553 -0.459 . . . . 1.0 110.582 179.281 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . 0.701 ' C ' ' H ' ' A' ' 44' ' ' GLY . 0.0 OUTLIER -103.86 135.26 45.73 Favored 'General case' 0 C--N 1.318 -0.803 0 CA-C-N 116.003 -0.544 . . . . 1.0 110.171 -177.644 . . . . . . . . 3 3 . 1 . 027 nuclear orig full ' A' A ' 43' ' ' ARG . . . . . 0.649 ' C ' ' H ' ' A' ' 45' ' ' PHE . 42.9 tpt85 -64.31 22.65 0.01 OUTLIER 'General case' 0 C--N 1.314 -0.943 0 C-N-CA 119.913 -0.715 . . . . 1.0 109.763 179.092 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . 0.701 ' H ' ' C ' ' A' ' 42' ' ' ARG . . . 70.45 -28.04 0.46 Allowed Glycine 0 C--N 1.345 1.053 0 N-CA-C 110.764 -0.934 . . . . 1.0 110.764 179.223 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . 0.649 ' H ' ' C ' ' A' ' 43' ' ' ARG . 31.0 p90 -164.71 172.61 12.83 Favored 'General case' 0 N--CA 1.45 -0.47 0 N-CA-C 108.521 -0.918 . . . . 1.0 108.521 -179.807 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 46' ' ' PHE . . . . . 0.569 ' HB2' ' O ' ' A' ' 45' ' ' PHE . 1.7 t80 116.16 96.41 0.0 OUTLIER 'General case' 0 N--CA 1.484 1.236 0 O-C-N 125.701 1.875 . . . . 1.0 108.153 -178.499 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 47' ' ' ARG . . . . . 0.547 ' O ' ' CB ' ' A' ' 48' ' ' CYS . 3.9 mmp_? 115.16 133.41 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.611 0 O-C-N 125.06 1.475 . . . . 1.0 109.859 -179.551 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 48' ' ' CYS . . . . . 0.547 ' CB ' ' O ' ' A' ' 47' ' ' ARG . 43.7 t 121.95 -5.59 0.0 OUTLIER 'General case' 0 CA--C 1.51 -0.595 0 O-C-N 125.305 1.628 . . . . 1.0 111.059 177.406 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -120.59 149.89 51.16 Favored Pre-proline 0 CA--C 1.534 0.356 0 N-CA-C 109.84 -0.43 . . . . 1.0 109.84 179.867 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . 0.573 ' C ' ' H ' ' A' ' 52' ' ' ARG . 98.9 Cg_endo -76.46 87.16 1.47 Allowed 'Trans proline' 0 N--CA 1.493 1.47 0 C-N-CA 122.277 1.985 . . . . 1.0 114.041 -179.888 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . 0.433 ' CD ' ' O ' ' A' ' 50' ' ' PRO . 0.0 OUTLIER 66.44 -32.7 0.18 Allowed 'General case' 0 N--CA 1.472 0.649 0 N-CA-C 112.09 0.404 . . . . 1.0 112.09 176.269 . . . . . . . . 3 3 . 1 . 027 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . 0.573 ' H ' ' C ' ' A' ' 50' ' ' PRO . 5.4 mtm180 -45.39 140.08 3.29 Favored 'General case' 0 C--N 1.315 -0.903 0 CA-C-O 121.941 0.877 . . . . 1.0 112.198 -178.094 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 2.2 tp -82.22 166.07 2.4 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 114.35 -1.295 . . . . 1.0 108.7 177.999 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 16.7 mt-30 -135.73 134.6 39.23 Favored 'General case' 0 N--CA 1.453 -0.288 0 N-CA-C 108.423 -0.954 . . . . 1.0 108.423 179.795 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 2.3 pp -142.68 153.66 17.6 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.366 0 N-CA-C 109.881 -0.414 . . . . 1.0 109.881 178.288 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 105.1 2.36 41.89 Favored Glycine 0 CA--C 1.529 0.95 0 N-CA-C 110.077 -1.209 . . . . 1.0 110.077 -178.348 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 58.0 m-20 -86.78 103.99 15.73 Favored 'General case' 0 N--CA 1.471 0.605 0 CA-C-O 122.141 0.972 . . . . 1.0 112.722 -178.333 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 58' ' ' TRP . . . . . . . . . . . . . 13.3 m95 -78.78 178.41 7.93 Favored 'General case' 0 C--N 1.315 -0.922 0 CA-C-N 113.484 -1.689 . . . . 1.0 108.937 177.879 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 59' ' ' ARG . . . . . 0.493 ' HG2' ' H ' ' A' ' 60' ' ' TYR . 0.0 OUTLIER -101.23 -56.95 2.19 Favored 'General case' 0 CA--C 1.557 1.244 0 CA-C-N 119.494 1.043 . . . . 1.0 112.533 178.814 . . . . . . . . 3 3 . 1 . 027 nuclear orig full ' A' A ' 60' ' ' TYR . . . . . 0.493 ' H ' ' HG2' ' A' ' 59' ' ' ARG . 63.2 t80 -80.5 -13.5 59.05 Favored 'General case' 0 N--CA 1.485 1.305 0 C-N-CA 125.341 1.456 . . . . 1.0 112.581 -178.209 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . 0.496 ' O ' ' N ' ' A' ' 64' ' ' HIS . 10.1 mt-10 -79.49 -14.59 58.79 Favored 'General case' 0 C--N 1.298 -1.641 0 CA-C-N 114.963 -1.017 . . . . 1.0 108.903 178.244 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . 0.456 ' O ' ' N ' ' A' ' 66' ' ' GLY . 13.4 m -44.26 -44.39 2.22 Favored 'Isoleucine or valine' 0 CA--C 1.491 -1.317 0 N-CA-C 109.331 -0.618 . . . . 1.0 109.331 -176.41 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 63' ' ' ALA . . . . . 0.529 ' O ' ' HG2' ' A' ' 67' ' ' ARG . . . -69.2 -46.74 66.71 Favored 'General case' 0 N--CA 1.411 -2.423 0 N-CA-C 107.947 -1.131 . . . . 1.0 107.947 177.61 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 64' ' ' HIS . . . . . 0.496 ' N ' ' O ' ' A' ' 61' ' ' GLU . 1.3 t-80 -56.04 -60.42 3.51 Favored 'General case' 0 CA--C 1.546 0.805 0 CA-C-N 115.512 -0.767 . . . . 1.0 111.049 178.891 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . 0.665 ' C ' ' H ' ' A' ' 67' ' ' ARG . 10.4 t70 -66.15 -54.69 22.35 Favored 'General case' 0 C--O 1.248 0.974 0 O-C-N 121.489 -0.757 . . . . 1.0 109.639 178.062 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . 0.456 ' N ' ' O ' ' A' ' 62' ' ' VAL . . . -63.22 32.49 0.08 OUTLIER Glycine 0 N--CA 1.471 0.982 0 N-CA-C 110.603 -0.999 . . . . 1.0 110.603 177.526 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 67' ' ' ARG . . . . . 0.665 ' H ' ' C ' ' A' ' 65' ' ' ASP . 0.2 OUTLIER -75.75 1.74 13.97 Favored 'General case' 0 N--CA 1.435 -1.197 0 CA-C-N 114.639 -0.781 . . . . 1.0 109.113 175.71 . . . . . . . . 3 3 . 1 . 027 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . 0.564 ' O ' ' HA ' ' A' ' 72' ' ' HIS . 10.2 mp -33.72 -29.67 0.01 OUTLIER 'General case' 0 N--CA 1.501 2.118 0 N-CA-C 106.848 -1.538 . . . . 1.0 106.848 -177.597 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . 0.63 ' N ' ' O ' ' A' ' 67' ' ' ARG . 5.2 tp -61.85 -65.61 0.66 Allowed 'General case' 0 CA--C 1.553 1.06 0 C-N-CA 117.825 -1.55 . . . . 1.0 107.441 175.439 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . 0.655 ' C ' ' H ' ' A' ' 72' ' ' HIS . . . -75.32 -68.59 0.54 Allowed 'General case' 0 N--CA 1.477 0.9 0 N-CA-C 106.456 -1.683 . . . . 1.0 106.456 175.684 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . 0.634 ' H ' ' HB3' ' A' ' 67' ' ' ARG . . . -47.17 2.54 0.0 OUTLIER 'General case' 0 N--CA 1.477 0.922 0 C-N-CA 124.686 1.194 . . . . 1.0 113.48 178.876 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 72' ' ' HIS . . . . . 0.655 ' H ' ' C ' ' A' ' 70' ' ' ALA . 0.3 OUTLIER -19.94 -82.63 0.0 OUTLIER 'General case' 0 C--N 1.324 -0.525 0 N-CA-C 113.589 0.959 . . . . 1.0 113.589 -174.259 . . . . . . . . 3 3 . 1 . 027 nuclear orig full ' A' A ' 73' ' ' MET . . . . . 0.647 ' H ' ' CD2' ' A' ' 72' ' ' HIS . 0.7 OUTLIER -74.29 -41.79 60.62 Favored 'General case' 0 C--N 1.3 -1.545 0 CA-C-N 118.928 0.786 . . . . 1.0 111.122 178.389 . . . . . . . . 3 3 . 1 . 027 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . 0.606 ' C ' ' H ' ' A' ' 76' ' ' GLY . 0.8 OUTLIER -44.74 -41.78 2.22 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.796 0 C-N-CA 119.694 -0.803 . . . . 1.0 110.441 -174.62 . . . . . . . . 3 3 . 1 . 027 nuclear orig full ' A' A ' 75' ' ' ASN . . . . . 0.581 ' C ' ' H ' ' A' ' 77' ' ' ILE . 28.2 t30 -39.16 -17.9 0.01 OUTLIER 'General case' 0 N--CA 1.48 1.033 0 CA-C-O 122.401 1.096 . . . . 1.0 110.964 178.029 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . 0.606 ' H ' ' C ' ' A' ' 74' ' ' VAL . . . -43.41 -16.14 0.03 OUTLIER Glycine 0 CA--C 1.564 3.095 0 N-CA-C 108.634 -1.786 . . . . 1.0 108.634 176.051 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . 0.784 ' O ' ' N ' ' A' ' 80' ' ' ALA . 2.6 pp -89.91 -46.0 15.08 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.227 0 N-CA-C 108.428 -0.953 . . . . 1.0 108.428 -179.354 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . 0.492 ' C ' ' O ' ' A' ' 77' ' ' ILE . 1.0 OUTLIER -34.34 -27.94 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.571 1.766 0 N-CA-C 108.775 -0.824 . . . . 1.0 108.775 -174.816 . . . . . . . . 3 3 . 1 . 027 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . 0.589 ' N ' ' O ' ' A' ' 77' ' ' ILE . 0.0 OUTLIER -92.0 -17.32 7.64 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.907 0 C-N-CA 124.86 1.264 . . . . 1.0 111.765 177.383 . . . . . . . . 3 3 . 1 . 027 nuclear orig full ' A' A ' 80' ' ' ALA . . . . . 0.784 ' N ' ' O ' ' A' ' 77' ' ' ILE . . . -65.86 -14.05 60.74 Favored 'General case' 0 C--N 1.321 -0.639 0 O-C-N 122.156 -0.34 . . . . 1.0 111.215 178.105 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 34.6 mt-10 -122.78 -47.89 2.05 Favored 'General case' 0 N--CA 1.47 0.534 0 CA-C-O 121.767 0.794 . . . . 1.0 109.435 175.759 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -59.94 -62.08 2.13 Favored 'General case' 0 CA--C 1.53 0.209 0 CA-C-N 115.22 -0.9 . . . . 1.0 109.314 -179.745 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . 0.443 ' O ' ' C ' ' A' ' 84' ' ' LEU . . . -47.5 -45.23 26.21 Favored 'General case' 0 N--CA 1.467 0.42 0 CA-C-N 116.587 -0.279 . . . . 1.0 110.798 -179.248 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . 0.443 ' C ' ' O ' ' A' ' 83' ' ' ALA . 1.5 tp -28.83 -44.85 0.03 OUTLIER 'General case' 0 N--CA 1.483 1.187 0 CA-C-N 116.36 -0.382 . . . . 1.0 111.636 -174.683 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 85' ' ' ILE . . . . . 0.493 HG13 ' H ' ' A' ' 86' ' ' ALA . 3.4 pt -91.57 -49.77 13.07 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.742 0 N-CA-C 109.102 -0.703 . . . . 1.0 109.102 177.138 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . 0.493 ' H ' HG13 ' A' ' 85' ' ' ILE . . . -48.22 -36.0 12.97 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.608 -0.724 . . . . 1.0 110.261 -178.723 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 5.3 mm-40 -57.51 -23.56 50.93 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.864 -0.607 . . . . 1.0 110.051 179.213 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -73.26 -9.51 58.79 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 121.22 0.533 . . . . 1.0 109.733 179.505 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 89' ' ' VAL . . . . . 0.407 ' O ' ' CG1' ' A' ' 89' ' ' VAL . 40.5 t -105.46 36.91 0.37 Allowed 'Isoleucine or valine' 0 C--O 1.234 0.268 0 CA-C-N 115.433 -0.803 . . . . 1.0 109.413 179.198 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 90' ' ' GLY . . . . . 0.537 ' O ' ' N ' ' A' ' 92' ' ' HIS . . . -66.71 -43.11 92.65 Favored Glycine 0 CA--C 1.539 1.531 0 N-CA-C 111.205 -0.758 . . . . 1.0 111.205 178.859 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 91' ' ' PRO . . . . . 0.472 ' CD ' ' N ' ' A' ' 90' ' ' GLY . 87.3 Cg_exo -42.3 -15.33 0.05 OUTLIER 'Trans proline' 0 N--CA 1.497 1.71 0 C-N-CA 122.03 1.82 . . . . 1.0 112.386 179.982 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 92' ' ' HIS . . . . . 0.537 ' N ' ' O ' ' A' ' 90' ' ' GLY . 5.6 p-80 -60.52 -15.51 28.05 Favored 'General case' 0 C--N 1.322 -0.601 0 N-CA-C 108.662 -0.866 . . . . 1.0 108.662 179.52 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . 0.474 ' HG ' ' H ' ' A' ' 94' ' ' ALA . 2.3 pp -72.95 -58.48 3.29 Favored 'General case' 0 C--N 1.323 -0.557 0 N-CA-C 108.836 -0.801 . . . . 1.0 108.836 179.915 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 94' ' ' ALA . . . . . 0.474 ' H ' ' HG ' ' A' ' 93' ' ' LEU . . . -59.23 -55.8 30.25 Favored 'General case' 0 C--O 1.236 0.391 0 CA-C-O 120.907 0.384 . . . . 1.0 109.997 179.744 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 95' ' ' ARG . . . . . 0.73 ' O ' ' N ' ' A' ' 97' ' ' LEU . 11.1 ttm180 -52.85 -59.3 4.67 Favored 'General case' 0 C--O 1.24 0.558 0 N-CA-C 107.079 -1.452 . . . . 1.0 107.079 178.777 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 96' ' ' ALA . . . . . 0.875 ' O ' ' N ' ' A' ' 98' ' ' GLY . . . -46.4 -7.67 0.01 OUTLIER 'General case' 0 N--CA 1.427 -1.616 0 O-C-N 119.029 -2.295 . . . . 1.0 112.525 -177.33 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . 0.73 ' N ' ' O ' ' A' ' 95' ' ' ARG . 0.4 OUTLIER 2.85 -50.57 0.0 OUTLIER 'General case' 0 C--N 1.36 1.062 0 O-C-N 124.776 1.297 . . . . 1.0 110.522 -169.447 . . . . . . . . 3 3 . 1 . 027 nuclear orig full ' A' A ' 98' ' ' GLY . . . . . 0.875 ' N ' ' O ' ' A' ' 96' ' ' ALA . . . -52.65 -17.52 4.67 Favored Glycine 0 N--CA 1.422 -2.265 0 CA-C-N 122.088 2.222 . . . . 1.0 107.902 174.001 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 99' ' ' GLN . . . . . 0.697 ' N ' ' O ' ' A' ' 96' ' ' ALA . 68.8 tp60 -73.96 -25.31 59.88 Favored 'General case' 0 CA--C 1.512 -0.5 0 C-N-CA 117.746 -1.582 . . . . 1.0 107.066 178.69 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 100' ' ' ILE . . . . . 0.619 ' N ' ' O ' ' A' ' 97' ' ' LEU . 4.9 tt -62.55 -35.51 70.49 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.883 0 CA-C-N 114.522 -1.217 . . . . 1.0 110.207 178.617 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 101' ' ' VAL . . . . . 0.733 HG12 ' O ' ' A' ' 98' ' ' GLY . 8.7 p -61.83 -58.69 6.42 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.698 0 C-N-CA 118.514 -1.274 . . . . 1.0 108.976 -179.599 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 102' ' ' CYS . . . . . 0.574 ' H ' HG12 ' A' ' 101' ' ' VAL . 0.1 OUTLIER -42.23 -24.53 0.05 Allowed 'General case' 0 N--CA 1.437 -1.104 0 N-CA-C 112.109 0.411 . . . . 1.0 112.109 -177.451 . . . . . . . . 3 3 . 1 . 027 nuclear orig full ' A' A ' 103' ' ' ARG . . . . . 0.428 ' N ' ' O ' ' A' ' 101' ' ' VAL . 9.4 ttp180 -88.81 -33.15 17.52 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-O 122.435 1.112 . . . . 1.0 111.207 178.39 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 104' ' ' TYR . . . . . 0.689 ' CG ' ' O ' ' A' ' 104' ' ' TYR . 0.3 OUTLIER -100.71 17.49 21.81 Favored 'General case' 0 C--N 1.312 -1.044 0 CA-C-N 113.365 -1.743 . . . . 1.0 109.822 177.352 . . . . . . . . 3 3 . 1 . 027 nuclear orig full ' A' A ' 105' ' ' GLY . . . . . 0.528 ' N ' ' O ' ' A' ' 101' ' ' VAL . . . -165.29 -82.3 0.05 OUTLIER Glycine 0 N--CA 1.447 -0.599 0 N-CA-C 106.945 -2.462 . . . . 1.0 106.945 175.97 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 106' ' ' ALA . . . . . 0.536 ' O ' ' CD ' ' A' ' 110' ' ' PRO . . . 70.47 68.89 0.2 Allowed 'General case' 0 N--CA 1.437 -1.094 0 N-CA-C 112.256 0.465 . . . . 1.0 112.256 179.043 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 107' ' ' THR . . . . . 0.511 ' O ' ' HG2' ' A' ' 110' ' ' PRO . 25.2 m -76.27 -55.46 5.55 Favored 'General case' 0 C--O 1.213 -0.819 0 O-C-N 120.737 -1.227 . . . . 1.0 109.433 177.907 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . 0.574 ' O ' ' HB2' ' A' ' 111' ' ' ASN . 35.7 m -72.54 -48.39 47.2 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.205 0 CA-C-O 121.283 0.563 . . . . 1.0 111.692 -178.72 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 109' ' ' ILE . . . . . 0.451 ' C ' ' O ' ' A' ' 108' ' ' VAL . 0.0 OUTLIER -41.31 -45.6 7.19 Favored Pre-proline 0 C--N 1.316 -0.854 0 CA-C-O 118.001 -0.999 . . . . 1.0 109.737 -178.027 . . . . . . . . 3 3 . 1 . 027 nuclear orig full ' A' A ' 110' ' ' PRO . . . . . 0.536 ' CD ' ' O ' ' A' ' 106' ' ' ALA . 72.6 Cg_endo -63.21 -18.06 63.08 Favored 'Trans proline' 0 C--O 1.2 -1.418 0 CA-C-N 122.388 1.889 . . . . 1.0 111.25 177.65 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 111' ' ' ASN . . . . . 0.574 ' HB2' ' O ' ' A' ' 108' ' ' VAL . 0.4 OUTLIER -62.2 -66.26 0.57 Allowed 'General case' 0 N--CA 1.478 0.974 0 N-CA-C 108.375 -0.972 . . . . 1.0 108.375 178.803 . . . . . . . . 3 3 . 1 . 027 nuclear orig full ' A' A ' 112' ' ' ILE . . . . . 0.589 ' O ' ' HB ' ' A' ' 116' ' ' ILE . 1.5 pt -48.27 -22.78 0.66 Allowed 'Isoleucine or valine' 0 C--O 1.219 -0.51 0 N-CA-C 107.864 -1.161 . . . . 1.0 107.864 179.714 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 113' ' ' ASN . . . . . 0.642 ' O ' ' HB2' ' A' ' 117' ' ' GLU . 11.8 m-20 -84.61 -53.68 5.23 Favored 'General case' 0 N--CA 1.44 -0.935 0 CA-C-O 124.01 1.862 . . . . 1.0 110.063 177.474 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 114' ' ' ALA . . . . . 0.453 ' N ' ' O ' ' A' ' 110' ' ' PRO . . . -56.12 -55.78 28.92 Favored 'General case' 0 C--N 1.29 -1.979 0 CA-C-N 114.376 -1.284 . . . . 1.0 109.619 -178.952 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -80.38 -61.02 2.1 Favored 'General case' 0 C--O 1.244 0.81 0 N-CA-C 114.554 1.316 . . . . 1.0 114.554 179.706 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 116' ' ' ILE . . . . . 0.589 ' HB ' ' O ' ' A' ' 112' ' ' ILE . 36.4 mm -72.46 -40.03 63.18 Favored 'Isoleucine or valine' 0 C--O 1.211 -0.938 0 N-CA-C 114.35 1.241 . . . . 1.0 114.35 -175.234 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 117' ' ' GLU . . . . . 0.642 ' HB2' ' O ' ' A' ' 113' ' ' ASN . 1.2 tt0 -51.85 -62.78 1.41 Allowed 'General case' 0 CA--C 1.486 -1.484 0 CA-C-N 118.12 0.418 . . . . 1.0 110.611 -176.334 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 38.8 t -55.54 -14.23 1.31 Allowed 'Isoleucine or valine' 0 N--CA 1.424 -1.774 0 C-N-CA 117.836 -1.546 . . . . 1.0 109.253 -177.244 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 119' ' ' LEU . . . . . 0.416 ' N ' ' C ' ' A' ' 117' ' ' GLU . 1.1 tp -92.54 -56.66 2.94 Favored 'General case' 0 CA--C 1.552 1.044 0 N-CA-C 113.682 0.993 . . . . 1.0 113.682 176.857 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -68.75 -50.52 35.58 Favored Glycine 0 C--N 1.358 1.764 0 C-N-CA 120.062 -1.066 . . . . 1.0 114.47 -174.68 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 1.9 t 155.56 -40.0 0.01 OUTLIER 'General case' 0 N--CA 1.476 0.865 0 N-CA-C 106.396 -1.705 . . . . 1.0 106.396 -178.273 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 122' ' ' GLY . . . . . 0.51 ' O ' ' N ' ' A' ' 124' ' ' ASP . . . 113.62 -34.37 5.05 Favored Glycine 0 CA--C 1.532 1.108 0 C-N-CA 126.217 1.865 . . . . 1.0 112.862 179.684 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 123' ' ' THR . . . . . 0.446 ' C ' ' O ' ' A' ' 122' ' ' GLY . 33.4 m -32.84 90.91 0.0 OUTLIER 'General case' 0 N--CA 1.486 1.341 0 CA-C-N 120.219 2.009 . . . . 1.0 112.01 -178.698 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 124' ' ' ASP . . . . . 0.51 ' N ' ' O ' ' A' ' 122' ' ' GLY . 39.7 m-20 -145.52 146.16 31.33 Favored 'General case' 0 CA--C 1.537 0.457 0 N-CA-C 108.763 -0.828 . . . . 1.0 108.763 178.089 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 125' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -153.7 150.58 28.71 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-O 120.85 0.357 . . . . 1.0 110.195 -178.851 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 2.7 tpt180 -149.08 151.26 34.13 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.894 -0.594 . . . . 1.0 109.801 177.059 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 127' ' ' PHE . . . . . . . . . . . . . 19.5 m-85 . . . . . 0 C--O 1.218 -0.583 0 CA-C-O 117.973 -1.013 . . . . 1.0 112.043 -178.864 . . . . . . . . 0 0 . 1 . 027 nuclear orig full ' A' A ' 128' ' ' MTN . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 027 nuclear orig full ' A' A ' 129' ' ' MTN . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 027 nuclear orig full ' A' A ' 130' ' ' MTN . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 028 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.444 ' SD ' ' CD2' ' A' ' 4' ' ' PHE . 38.2 mtt . . . . . 0 N--CA 1.49 1.545 0 N-CA-C 108.503 -0.925 . . . . 1.0 108.503 . . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 2' ' ' SER . . . . . 0.46 ' O ' ' CB ' ' A' ' 3' ' ' ASP . 14.8 m -95.31 10.5 35.96 Favored 'General case' 0 N--CA 1.466 0.357 0 C-N-CA 122.628 0.371 . . . . 1.0 110.939 -179.503 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . 0.46 ' CB ' ' O ' ' A' ' 2' ' ' SER . 0.2 OUTLIER 157.4 109.21 0.0 OUTLIER 'General case' 0 N--CA 1.473 0.687 0 O-C-N 124.077 0.861 . . . . 1.0 109.999 178.87 . . . . . . . . 3 3 . 1 . 028 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . 0.444 ' CD2' ' SD ' ' A' ' 1' ' ' MET . 14.9 t80 -152.99 148.21 26.82 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.121 -0.49 . . . . 1.0 110.515 179.695 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 5' ' ' ASP . . . . . 0.4 ' OD1' ' O ' ' A' ' 4' ' ' PHE . 9.5 m-20 -154.23 150.16 27.76 Favored 'General case' 0 CA--C 1.536 0.407 0 N-CA-C 109.404 -0.591 . . . . 1.0 109.404 179.761 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 6' ' ' THR . . . . . 0.587 ' O ' ' N ' ' A' ' 10' ' ' SER . 0.2 OUTLIER -62.2 167.51 3.99 Favored 'General case' 0 C--O 1.218 -0.603 0 C-N-CA 120.126 -0.63 . . . . 1.0 110.216 -178.804 . . . . . . . . 3 3 . 1 . 028 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . 0.589 ' O ' ' N ' ' A' ' 11' ' ' ARG . 3.1 tt0 -59.69 -58.37 8.86 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-O 121.401 0.62 . . . . 1.0 110.45 -177.947 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 8' ' ' ARG . . . . . 0.485 ' O ' ' CB ' ' A' ' 12' ' ' ALA . 18.2 ttm180 -51.16 -54.85 21.51 Favored 'General case' 0 C--N 1.311 -1.083 0 N-CA-C 108.174 -1.047 . . . . 1.0 108.174 -177.159 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . 0.487 ' O ' ' CG1' ' A' ' 13' ' ' VAL . 6.8 p -62.09 -48.82 86.71 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.127 0 CA-C-N 114.067 -1.424 . . . . 1.0 109.819 178.901 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 10' ' ' SER . . . . . 0.587 ' N ' ' O ' ' A' ' 6' ' ' THR . 42.8 t -62.43 -59.58 4.77 Favored 'General case' 0 N--CA 1.481 1.105 0 C-N-CA 120.198 -0.601 . . . . 1.0 109.702 -179.995 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 11' ' ' ARG . . . . . 0.589 ' N ' ' O ' ' A' ' 7' ' ' GLU . 0.4 OUTLIER -62.59 -57.44 11.09 Favored 'General case' 0 C--N 1.317 -0.823 0 O-C-N 121.742 -0.599 . . . . 1.0 110.19 -178.324 . . . . . . . . 3 3 . 1 . 028 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . 0.485 ' CB ' ' O ' ' A' ' 8' ' ' ARG . . . -50.36 -51.58 44.58 Favored 'General case' 0 N--CA 1.476 0.861 0 N-CA-C 108.004 -1.11 . . . . 1.0 108.004 -178.091 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . 0.599 ' O ' ' CB ' ' A' ' 17' ' ' LEU . 4.5 m -60.78 -50.13 81.75 Favored 'Isoleucine or valine' 0 C--O 1.203 -1.344 0 C-N-CA 116.92 -1.912 . . . . 1.0 108.029 177.632 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -57.44 -62.68 1.6 Allowed 'General case' 0 N--CA 1.479 1.008 0 C-N-CA 118.633 -1.227 . . . . 1.0 110.929 179.013 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . 0.549 ' N ' ' O ' ' A' ' 11' ' ' ARG . . . -55.51 -55.8 27.65 Favored 'General case' 0 N--CA 1.47 0.557 0 CA-C-O 121.413 0.625 . . . . 1.0 110.208 -178.473 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . 0.461 ' CB ' ' O ' ' A' ' 12' ' ' ALA . . . -58.05 -53.94 52.58 Favored 'General case' 0 C--N 1.317 -0.811 0 N-CA-C 108.138 -1.06 . . . . 1.0 108.138 -179.313 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . 0.599 ' CB ' ' O ' ' A' ' 13' ' ' VAL . 39.4 tp -53.86 -48.96 69.48 Favored 'General case' 0 N--CA 1.482 1.135 0 CA-C-N 113.513 -1.676 . . . . 1.0 107.662 -178.059 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 54.1 t -67.3 -58.4 6.41 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.504 0 CA-C-O 121.076 0.465 . . . . 1.0 110.223 179.94 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . 0.54 ' N ' ' O ' ' A' ' 15' ' ' ALA . . . -71.03 -163.96 5.47 Favored Glycine 0 CA--C 1.526 0.765 0 CA-C-N 115.5 -0.773 . . . . 1.0 112.054 -178.64 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 20' ' ' PRO . . . . . 0.571 ' O ' ' N ' ' A' ' 24' ' ' ALA . 57.5 Cg_endo -79.59 -27.23 4.24 Favored 'Trans proline' 0 N--CA 1.492 1.39 0 C-N-CA 122.72 2.28 . . . . 1.0 115.443 -178.098 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -59.0 -58.45 14.52 Favored Glycine 0 N--CA 1.477 1.414 0 C-N-CA 119.097 -1.525 . . . . 1.0 110.965 -177.01 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -59.21 -54.91 33.94 Favored Glycine 0 N--CA 1.467 0.749 0 N-CA-C 107.843 -2.103 . . . . 1.0 107.843 -178.387 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 54.1 t -57.36 -36.96 54.61 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.907 0 CA-C-N 114.721 -0.74 . . . . 1.0 109.814 -179.472 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . 0.571 ' N ' ' O ' ' A' ' 20' ' ' PRO . . . -57.66 -60.58 3.46 Favored 'General case' 0 C--N 1.325 -0.483 0 C-N-CA 118.93 -1.108 . . . . 1.0 109.182 -179.851 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 9.3 tp -63.19 -44.05 96.48 Favored 'General case' 0 C--N 1.347 0.47 0 CA-C-N 119.325 0.966 . . . . 1.0 111.73 -178.907 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 72.6 t -61.05 -60.77 2.13 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.176 0 C-N-CA 118.364 -1.334 . . . . 1.0 110.504 -177.748 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . 0.447 HG21 ' HE ' ' A' ' 47' ' ' ARG . 2.4 p -58.57 -37.41 64.78 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.417 0 N-CA-C 113.264 0.838 . . . . 1.0 113.264 -177.539 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 35.9 ttmt -67.67 -53.27 29.13 Favored 'General case' 0 C--N 1.315 -0.899 0 CA-C-O 122.102 0.953 . . . . 1.0 108.811 -178.719 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 80.2 t -63.82 -48.93 84.18 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.074 0 CA-C-N 113.743 -1.571 . . . . 1.0 110.891 -177.542 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 30' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -65.34 -60.88 2.51 Favored 'General case' 0 N--CA 1.449 -0.487 0 C-N-CA 118.868 -1.133 . . . . 1.0 109.496 -179.756 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -64.83 -54.44 30.99 Favored 'General case' 0 C--N 1.331 -0.225 0 N-CA-C 113.605 0.965 . . . . 1.0 113.605 -175.901 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 84.36 75.77 1.2 Allowed Glycine 0 CA--C 1.527 0.798 0 N-CA-C 109.421 -1.472 . . . . 1.0 109.421 -177.81 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . 0.52 ' O ' ' O ' ' A' ' 36' ' ' VAL . 12.3 mt 85.55 85.37 0.05 OUTLIER Pre-proline 0 N--CA 1.479 0.983 0 C-N-CA 123.711 0.804 . . . . 1.0 110.49 -178.9 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 53.0 Cg_exo -54.93 -30.89 71.13 Favored 'Trans proline' 0 N--CA 1.508 2.342 0 C-N-CA 123.253 2.635 . . . . 1.0 114.307 -179.832 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -58.81 -58.04 16.67 Favored Glycine 0 CA--C 1.525 0.678 0 C-N-CA 118.759 -1.686 . . . . 1.0 109.651 -178.369 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . 0.536 ' O ' ' CB ' ' A' ' 37' ' ' ILE . 7.1 p -97.82 165.27 2.17 Favored 'Isoleucine or valine' 0 C--O 1.219 -0.55 0 N-CA-C 106.71 -1.589 . . . . 1.0 106.71 178.266 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . 0.536 ' CB ' ' O ' ' A' ' 36' ' ' VAL . 8.1 tt 117.82 123.23 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.481 1.097 0 C-N-CA 123.927 0.891 . . . . 1.0 109.596 -179.19 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 21.9 m80 -140.64 131.41 25.81 Favored 'General case' 0 C--N 1.324 -0.513 0 N-CA-C 107.902 -1.147 . . . . 1.0 107.902 178.724 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -90.03 146.45 35.09 Favored Pre-proline 0 C--N 1.33 -0.247 0 N-CA-C 108.955 -0.757 . . . . 1.0 108.955 -179.747 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -72.92 -44.01 0.69 Allowed 'Trans proline' 0 C--N 1.307 -1.619 0 C-N-CA 121.641 1.56 . . . . 1.0 112.579 -179.24 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -126.17 130.06 50.25 Favored 'General case' 0 CA--C 1.518 -0.266 0 CA-C-N 116.254 -0.43 . . . . 1.0 110.118 -179.608 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . 0.635 ' C ' ' H ' ' A' ' 44' ' ' GLY . 0.0 OUTLIER -169.49 157.27 7.17 Favored 'General case' 0 C--N 1.313 -0.997 0 N-CA-C 106.016 -1.846 . . . . 1.0 106.016 177.976 . . . . . . . . 3 3 . 1 . 028 nuclear orig full ' A' A ' 43' ' ' ARG . . . . . 0.436 ' CG ' ' O ' ' A' ' 43' ' ' ARG . 10.3 ttt85 -64.82 33.81 0.02 OUTLIER 'General case' 0 CA--C 1.529 0.137 0 CA-C-N 119.866 1.212 . . . . 1.0 112.115 -178.266 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . 0.635 ' H ' ' C ' ' A' ' 42' ' ' ARG . . . 91.42 -24.3 20.39 Favored Glycine 0 CA--C 1.522 0.484 0 N-CA-C 110.426 -1.069 . . . . 1.0 110.426 179.995 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . 0.526 ' CZ ' ' OD2' ' A' ' 57' ' ' ASP . 50.0 p90 -177.49 -178.93 0.79 Allowed 'General case' 0 CA--C 1.54 0.576 0 CA-C-O 120.85 0.357 . . . . 1.0 111.623 -179.941 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER 165.03 15.46 0.0 OUTLIER 'General case' 0 N--CA 1.487 1.389 0 CA-C-N 114.947 -1.024 . . . . 1.0 113.139 177.073 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 47' ' ' ARG . . . . . 0.639 ' O ' ' SG ' ' A' ' 48' ' ' CYS . 2.5 mtp-105 -176.38 -179.12 1.02 Allowed 'General case' 0 C--N 1.315 -0.905 0 N-CA-C 108.591 -0.892 . . . . 1.0 108.591 -179.072 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 48' ' ' CYS . . . . . 0.674 ' SG ' ' O ' ' A' ' 48' ' ' CYS . 1.5 p 61.43 63.49 1.19 Allowed 'General case' 0 C--N 1.341 0.206 0 CA-C-O 121.68 0.752 . . . . 1.0 110.084 -179.326 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 49' ' ' ASN . . . . . 0.449 ' OD1' ' NE2' ' A' ' 54' ' ' GLN . 0.2 OUTLIER -137.14 143.53 42.31 Favored Pre-proline 0 CA--C 1.535 0.39 0 N-CA-C 108.552 -0.907 . . . . 1.0 108.552 179.418 . . . . . . . . 3 3 . 1 . 028 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . 0.444 ' HG2' HH11 ' A' ' 52' ' ' ARG . 94.7 Cg_endo -73.01 61.85 3.94 Favored 'Trans proline' 0 N--CA 1.497 1.719 0 C-N-CA 122.251 1.967 . . . . 1.0 112.431 -179.476 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 97.8 mt-10 59.34 6.13 0.71 Allowed 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.975 -0.557 . . . . 1.0 111.84 179.595 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . 0.444 HH11 ' HG2' ' A' ' 50' ' ' PRO . 75.0 mtt85 -82.91 139.12 33.58 Favored 'General case' 0 N--CA 1.465 0.291 0 N-CA-C 109.029 -0.73 . . . . 1.0 109.029 177.971 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 13.0 tt -67.42 137.92 23.78 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.276 0 CA-C-O 122.647 1.213 . . . . 1.0 113.691 -177.314 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 54' ' ' GLN . . . . . 0.449 ' NE2' ' OD1' ' A' ' 49' ' ' ASN . 1.8 mp0 -64.13 78.59 0.04 OUTLIER 'General case' 0 CA--C 1.545 0.753 0 CA-C-N 112.38 -2.191 . . . . 1.0 108.984 -178.464 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 18.0 tt -148.15 154.96 10.06 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.667 0 CA-C-N 115.997 -0.547 . . . . 1.0 109.99 178.251 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 109.59 -3.46 30.8 Favored Glycine 0 N--CA 1.471 0.998 0 N-CA-C 109.914 -1.274 . . . . 1.0 109.914 -179.594 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . 0.526 ' OD2' ' CZ ' ' A' ' 45' ' ' PHE . 37.6 m-20 -83.96 100.93 11.35 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 114.249 -0.975 . . . . 1.0 110.091 179.448 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 58' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -86.52 173.68 9.44 Favored 'General case' 0 N--CA 1.471 0.595 0 CA-C-O 123.65 1.69 . . . . 1.0 113.41 -178.287 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 24.9 mtm180 -79.44 -56.23 4.47 Favored 'General case' 0 C--N 1.309 -1.175 0 CA-C-N 110.402 -3.09 . . . . 1.0 112.161 -179.428 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -91.1 -11.73 37.72 Favored 'General case' 0 C--O 1.249 1.046 0 CA-C-N 114.81 -1.086 . . . . 1.0 113.916 -178.372 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . 0.449 ' O ' ' N ' ' A' ' 65' ' ' ASP . 9.3 pt-20 -76.57 -13.95 60.04 Favored 'General case' 0 C--N 1.318 -0.784 0 N-CA-C 113.298 0.851 . . . . 1.0 113.298 -177.615 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . 0.623 ' O ' ' N ' ' A' ' 66' ' ' GLY . 0.2 OUTLIER -49.52 -58.7 1.25 Allowed 'Isoleucine or valine' 0 C--O 1.207 -1.165 0 C-N-CA 118.857 -1.137 . . . . 1.0 109.209 -175.829 . . . . . . . . 3 3 . 1 . 028 nuclear orig full ' A' A ' 63' ' ' ALA . . . . . 0.453 ' H ' HG23 ' A' ' 62' ' ' VAL . . . -66.77 -61.5 1.93 Allowed 'General case' 0 C--N 1.302 -1.459 0 CA-C-O 120.874 0.369 . . . . 1.0 110.907 -179.01 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 2.3 t-80 -48.4 -56.72 7.43 Favored 'General case' 0 CA--C 1.535 0.389 0 C-N-CA 119.419 -0.912 . . . . 1.0 108.93 -178.916 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . 0.502 ' O ' ' CD2' ' A' ' 68' ' ' LEU . 19.2 t70 -70.08 -45.5 66.89 Favored 'General case' 0 C--O 1.207 -1.171 0 CA-C-N 115.072 -0.967 . . . . 1.0 111.197 179.761 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . 0.623 ' N ' ' O ' ' A' ' 62' ' ' VAL . . . -77.49 26.35 1.93 Allowed Glycine 0 N--CA 1.471 1.002 0 N-CA-C 111.018 -0.833 . . . . 1.0 111.018 179.715 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 67' ' ' ARG . . . . . 0.484 ' H ' ' C ' ' A' ' 65' ' ' ASP . 57.7 ttt180 -95.76 -9.95 30.4 Favored 'General case' 0 CA--C 1.536 0.406 0 N-CA-C 107.971 -1.122 . . . . 1.0 107.971 172.832 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . 0.826 ' O ' ' N ' ' A' ' 72' ' ' HIS . 0.0 OUTLIER -69.87 -37.81 76.22 Favored 'General case' 0 C--O 1.197 -1.681 0 CA-C-N 114.303 -1.317 . . . . 1.0 112.974 -178.044 . . . . . . . . 3 3 . 1 . 028 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . 0.519 ' O ' ' ND1' ' A' ' 72' ' ' HIS . 7.8 tt -44.81 -58.31 3.19 Favored 'General case' 0 N--CA 1.475 0.794 0 C-N-CA 118.302 -1.359 . . . . 1.0 108.869 -176.121 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . 0.578 ' O ' ' CE1' ' A' ' 72' ' ' HIS . . . -51.61 -72.3 0.05 Allowed 'General case' 0 C--N 1.317 -0.837 0 N-CA-C 104.937 -2.246 . . . . 1.0 104.937 177.884 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . 0.729 ' O ' ' N ' ' A' ' 73' ' ' MET . . . -64.87 18.21 0.02 OUTLIER 'General case' 0 C--N 1.316 -0.877 0 C-N-CA 128.04 2.536 . . . . 1.0 114.251 178.385 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 72' ' ' HIS . . . . . 0.826 ' N ' ' O ' ' A' ' 68' ' ' LEU . 0.0 OUTLIER -24.78 -17.95 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.557 0 N-CA-C 115.589 1.7 . . . . 1.0 115.589 -174.461 . . . . . . . . 3 3 . 1 . 028 nuclear orig full ' A' A ' 73' ' ' MET . . . . . 0.729 ' N ' ' O ' ' A' ' 71' ' ' ALA . 72.5 mtp -73.39 -25.09 60.42 Favored 'General case' 0 CA--C 1.545 0.768 0 CA-C-N 119.986 1.266 . . . . 1.0 108.551 176.965 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . 0.725 ' O ' ' N ' ' A' ' 76' ' ' GLY . 90.8 t -61.53 -52.66 58.46 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.672 0 CA-C-N 114.444 -1.253 . . . . 1.0 108.84 178.857 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 27.5 t-20 -32.61 -13.75 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.667 0 N-CA-C 113.444 0.905 . . . . 1.0 113.444 -178.26 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . 0.725 ' N ' ' O ' ' A' ' 74' ' ' VAL . . . -50.88 -22.26 5.88 Favored Glycine 0 CA--C 1.539 1.539 0 N-CA-C 109.344 -1.502 . . . . 1.0 109.344 176.045 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . 0.646 HG13 ' H ' ' A' ' 78' ' ' VAL . 0.5 OUTLIER -78.0 -63.95 1.0 Allowed 'Isoleucine or valine' 0 C--O 1.218 -0.568 0 CA-C-O 121.947 0.88 . . . . 1.0 109.432 179.203 . . . . . . . . 3 3 . 1 . 028 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . 0.646 ' H ' HG13 ' A' ' 77' ' ' ILE . 74.8 t -34.87 -33.66 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.318 -0.766 0 CA-C-N 112.719 -2.037 . . . . 1.0 106.309 -177.105 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . 0.542 ' N ' ' O ' ' A' ' 77' ' ' ILE . 0.0 OUTLIER -97.39 -34.42 4.82 Favored 'Isoleucine or valine' 0 CA--C 1.569 1.699 0 CA-C-N 115.585 -0.734 . . . . 1.0 111.905 175.134 . . . . . . . . 3 3 . 1 . 028 nuclear orig full ' A' A ' 80' ' ' ALA . . . . . 0.558 ' N ' ' O ' ' A' ' 77' ' ' ILE . . . -84.82 -10.35 57.26 Favored 'General case' 0 N--CA 1.492 1.642 0 N-CA-C 114.471 1.285 . . . . 1.0 114.471 179.452 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . 0.42 ' N ' ' O ' ' A' ' 77' ' ' ILE . 86.6 tt0 -89.4 -70.98 0.63 Allowed 'General case' 0 N--CA 1.438 -1.038 0 O-C-N 121.786 -0.571 . . . . 1.0 111.09 179.775 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 25.4 m-20 -91.02 -15.6 29.32 Favored 'General case' 0 CA--C 1.549 0.923 0 N-CA-C 115.864 1.801 . . . . 1.0 115.864 -178.796 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . 0.554 ' O ' ' N ' ' A' ' 85' ' ' ILE . . . -52.84 -42.48 65.21 Favored 'General case' 0 N--CA 1.475 0.779 0 C-N-CA 118.248 -1.381 . . . . 1.0 111.454 -177.863 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 11.2 mp -39.87 -20.83 0.01 OUTLIER 'General case' 0 N--CA 1.469 0.508 0 CA-C-N 118.447 0.567 . . . . 1.0 111.307 -179.049 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 85' ' ' ILE . . . . . 0.554 ' N ' ' O ' ' A' ' 83' ' ' ALA . 54.1 mt -93.43 -34.99 6.13 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.587 -0.279 . . . . 1.0 111.154 -179.866 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . 0.506 ' C ' ' H ' ' A' ' 88' ' ' ALA . . . -92.91 -26.27 17.68 Favored 'General case' 0 C--O 1.222 -0.371 0 CA-C-O 120.597 0.237 . . . . 1.0 111.582 179.734 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -56.06 -7.12 0.3 Allowed 'General case' 0 C--N 1.328 -0.347 0 C-N-CA 119.73 -0.788 . . . . 1.0 110.418 -178.83 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . 0.506 ' H ' ' C ' ' A' ' 86' ' ' ALA . . . -84.17 -2.58 57.1 Favored 'General case' 0 N--CA 1.472 0.663 0 CA-C-O 122.407 1.099 . . . . 1.0 108.79 178.543 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 89' ' ' VAL . . . . . 0.537 ' O ' ' CD2' ' A' ' 92' ' ' HIS . 3.1 m -97.6 34.9 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.432 0 CA-C-N 113.042 -1.89 . . . . 1.0 110.59 179.098 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 90' ' ' GLY . . . . . 0.558 ' C ' ' H ' ' A' ' 92' ' ' HIS . . . -78.13 -36.62 30.94 Favored Glycine 0 C--N 1.347 1.194 0 N-CA-C 111.6 -0.6 . . . . 1.0 111.6 178.932 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 91' ' ' PRO . . . . . 0.551 ' CD ' ' N ' ' A' ' 90' ' ' GLY . 93.4 Cg_exo -46.55 -15.11 0.16 Allowed 'Trans proline' 0 N--CA 1.496 1.665 0 C-N-CA 121.872 1.715 . . . . 1.0 109.07 177.913 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 92' ' ' HIS . . . . . 0.612 ' ND1' ' N ' ' A' ' 93' ' ' LEU . 0.0 OUTLIER -56.01 -15.76 3.98 Favored 'General case' 0 N--CA 1.442 -0.875 0 CA-C-N 113.922 -1.49 . . . . 1.0 107.754 179.148 . . . . . . . . 3 3 . 1 . 028 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . 0.612 ' N ' ' ND1' ' A' ' 92' ' ' HIS . 2.1 pp -64.04 -58.22 7.32 Favored 'General case' 0 C--O 1.232 0.14 0 N-CA-C 108.997 -0.742 . . . . 1.0 108.997 176.822 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 94' ' ' ALA . . . . . 0.446 ' N ' ' CD1' ' A' ' 93' ' ' LEU . . . -57.34 -52.62 64.61 Favored 'General case' 0 CA--C 1.517 -0.323 0 N-CA-C 108.851 -0.796 . . . . 1.0 108.851 179.719 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 95' ' ' ARG . . . . . 0.621 ' O ' ' N ' ' A' ' 97' ' ' LEU . 4.9 tmm_? -60.16 -60.91 3.06 Favored 'General case' 0 N--CA 1.446 -0.628 0 N-CA-C 108.506 -0.924 . . . . 1.0 108.506 -179.792 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 96' ' ' ALA . . . . . 0.986 ' O ' ' N ' ' A' ' 98' ' ' GLY . . . -47.66 -12.09 0.03 OUTLIER 'General case' 0 N--CA 1.432 -1.343 0 O-C-N 118.532 -2.605 . . . . 1.0 111.478 179.484 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . 0.706 ' O ' ' N ' ' A' ' 100' ' ' ILE . 7.7 tp 6.87 -48.9 0.0 OUTLIER 'General case' 0 C--N 1.378 1.809 0 CA-C-O 117.584 -1.198 . . . . 1.0 109.937 -166.771 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 98' ' ' GLY . . . . . 0.986 ' N ' ' O ' ' A' ' 96' ' ' ALA . . . -49.57 -24.12 5.32 Favored Glycine 0 CA--C 1.548 2.106 0 CA-C-N 122.507 2.412 . . . . 1.0 107.417 173.493 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 99' ' ' GLN . . . . . 0.563 ' O ' ' S1 ' ' A' ' 130' ' ' MTN . 12.3 mt-30 -64.36 -19.38 65.44 Favored 'General case' 0 C--N 1.379 1.878 0 C-N-CA 117.324 -1.75 . . . . 1.0 107.058 176.829 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 100' ' ' ILE . . . . . 0.706 ' N ' ' O ' ' A' ' 97' ' ' LEU . 1.5 tp -65.3 -39.22 84.66 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.817 0 N-CA-C 108.228 -1.027 . . . . 1.0 108.228 179.724 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 101' ' ' VAL . . . . . 0.723 ' O ' ' N ' ' A' ' 105' ' ' GLY . 97.7 t -59.19 -62.72 0.91 Allowed 'Isoleucine or valine' 0 C--O 1.217 -0.627 0 C-N-CA 119.537 -0.865 . . . . 1.0 110.59 -178.44 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 102' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -48.26 -18.63 0.23 Allowed 'General case' 0 N--CA 1.477 0.883 0 C-N-CA 119.093 -1.043 . . . . 1.0 110.826 -178.31 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 103' ' ' ARG . . . . . 0.488 ' CG ' HH11 ' A' ' 103' ' ' ARG . 0.0 OUTLIER -88.63 -49.3 6.96 Favored 'General case' 0 N--CA 1.479 1.014 0 CA-C-O 121.783 0.802 . . . . 1.0 112.071 177.638 . . . . . . . . 3 3 . 1 . 028 nuclear orig full ' A' A ' 104' ' ' TYR . . . . . . . . . . . . . 22.8 t80 -105.84 21.53 17.12 Favored 'General case' 0 N--CA 1.472 0.644 0 C-N-CA 125.935 1.694 . . . . 1.0 111.413 178.43 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 105' ' ' GLY . . . . . 0.723 ' N ' ' O ' ' A' ' 101' ' ' VAL . . . -159.33 -8.32 0.05 OUTLIER Glycine 0 CA--C 1.527 0.835 0 C-N-CA 120.394 -0.907 . . . . 1.0 112.081 -179.791 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 106' ' ' ALA . . . . . 0.424 ' C ' ' O ' ' A' ' 105' ' ' GLY . . . -29.03 114.16 0.09 Allowed 'General case' 0 N--CA 1.466 0.327 0 N-CA-C 112.209 0.448 . . . . 1.0 112.209 179.51 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 107' ' ' THR . . . . . 0.575 ' C ' ' H ' ' A' ' 109' ' ' ILE . 26.7 m -134.55 -62.64 0.73 Allowed 'General case' 0 C--O 1.224 -0.247 0 N-CA-C 105.609 -1.997 . . . . 1.0 105.609 176.782 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 12.7 p -64.44 23.25 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.437 -1.078 0 O-C-N 121.792 -0.568 . . . . 1.0 109.539 179.33 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 109' ' ' ILE . . . . . 0.581 ' H ' ' HD2' ' A' ' 110' ' ' PRO . 0.1 OUTLIER -115.81 -53.98 0.04 OUTLIER Pre-proline 0 CA--C 1.562 1.405 0 N-CA-C 107.708 -1.219 . . . . 1.0 107.708 174.658 . . . . . . . . 3 3 . 1 . 028 nuclear orig full ' A' A ' 110' ' ' PRO . . . . . 0.581 ' HD2' ' H ' ' A' ' 109' ' ' ILE . 18.3 Cg_endo -52.85 -36.65 75.04 Favored 'Trans proline' 0 N--CA 1.51 2.446 0 CA-C-N 121.92 1.721 . . . . 1.0 112.199 175.869 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 111' ' ' ASN . . . . . 0.429 ' C ' ' N ' ' A' ' 113' ' ' ASN . 6.2 t30 -68.25 -68.42 0.39 Allowed 'General case' 0 C--N 1.328 -0.356 0 C-N-CA 119.448 -0.901 . . . . 1.0 110.106 -177.907 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 112' ' ' ILE . . . . . 0.477 ' O ' ' N ' ' A' ' 116' ' ' ILE . 3.9 pt -51.0 -25.99 4.01 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.263 0 CA-C-O 123.07 1.414 . . . . 1.0 108.098 179.262 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 113' ' ' ASN . . . . . 0.558 ' ND2' ' OE2' ' A' ' 117' ' ' GLU . 15.4 t-20 -59.21 -52.37 65.96 Favored 'General case' 0 C--N 1.306 -1.286 0 CA-C-N 111.987 -2.369 . . . . 1.0 107.982 -177.886 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 114' ' ' ALA . . . . . 0.498 ' O ' ' CG2' ' A' ' 118' ' ' VAL . . . -64.08 -31.17 72.26 Favored 'General case' 0 C--N 1.323 -0.562 0 N-CA-C 113.103 0.779 . . . . 1.0 113.103 179.675 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 115' ' ' ALA . . . . . 0.454 ' O ' ' N ' ' A' ' 119' ' ' LEU . . . -85.15 -58.42 2.69 Favored 'General case' 0 N--CA 1.476 0.848 0 CA-C-N 119.36 0.982 . . . . 1.0 111.655 178.494 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 116' ' ' ILE . . . . . 0.477 ' N ' ' O ' ' A' ' 112' ' ' ILE . 31.2 mt -51.11 -57.71 2.67 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.402 0 N-CA-C 107.217 -1.401 . . . . 1.0 107.217 -178.375 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 117' ' ' GLU . . . . . 0.558 ' OE2' ' ND2' ' A' ' 113' ' ' ASN . 56.0 mt-10 -51.68 -50.37 60.56 Favored 'General case' 0 C--N 1.307 -1.277 0 CA-C-N 112.771 -2.013 . . . . 1.0 107.056 -179.15 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 118' ' ' VAL . . . . . 0.498 ' CG2' ' O ' ' A' ' 114' ' ' ALA . 17.0 t -59.83 -28.86 41.79 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.8 0 C-N-CA 119.642 -0.823 . . . . 1.0 110.021 178.378 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 119' ' ' LEU . . . . . 0.454 ' N ' ' O ' ' A' ' 115' ' ' ALA . 3.9 tt -78.42 -61.58 1.96 Allowed 'General case' 0 C--N 1.354 0.8 0 CA-C-N 120.396 1.453 . . . . 1.0 107.466 177.962 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 120' ' ' GLY . . . . . 0.446 ' O ' ' OG1' ' A' ' 121' ' ' THR . . . -64.31 -82.25 0.1 Allowed Glycine 0 C--N 1.358 1.771 0 C-N-CA 119.036 -1.554 . . . . 1.0 109.299 178.291 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 121' ' ' THR . . . . . 0.446 ' OG1' ' O ' ' A' ' 120' ' ' GLY . 0.0 OUTLIER 167.76 -38.85 0.0 OUTLIER 'General case' 0 CA--C 1.542 0.659 0 CA-C-N 113.968 -1.116 . . . . 1.0 113.041 178.817 . . . . . . . . 3 3 . 1 . 028 nuclear orig full ' A' A ' 122' ' ' GLY . . . . . 0.643 ' O ' ' N ' ' A' ' 124' ' ' ASP . . . 103.28 -15.91 53.74 Favored Glycine 0 N--CA 1.478 1.475 0 N-CA-C 107.243 -2.343 . . . . 1.0 107.243 -176.345 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 123' ' ' THR . . . . . 0.426 ' HG1' ' CD2' ' A' ' 72' ' ' HIS . 9.1 t -58.38 81.19 0.01 OUTLIER 'General case' 0 CA--C 1.545 0.787 0 CA-C-N 111.272 -2.464 . . . . 1.0 105.36 178.279 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 124' ' ' ASP . . . . . 0.643 ' N ' ' O ' ' A' ' 122' ' ' GLY . 35.8 m-20 -165.39 174.55 9.94 Favored 'General case' 0 N--CA 1.475 0.79 0 CA-C-N 112.818 -1.992 . . . . 1.0 112.457 179.989 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 125' ' ' TYR . . . . . . . . . . . . . 6.1 t80 -142.85 138.83 30.58 Favored 'General case' 0 CA--C 1.54 0.596 0 N-CA-C 107.655 -1.239 . . . . 1.0 107.655 175.588 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 9.6 tpt180 -149.88 153.12 36.19 Favored 'General case' 0 N--CA 1.467 0.39 0 N-CA-C 110.236 -0.283 . . . . 1.0 110.236 178.075 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 127' ' ' PHE . . . . . . . . . . . . . 22.4 p90 . . . . . 0 N--CA 1.469 0.486 0 CA-C-O 118.034 -0.984 . . . . 1.0 110.743 179.926 . . . . . . . . 0 0 . 1 . 028 nuclear orig full ' A' A ' 128' ' ' MTN . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 028 nuclear orig full ' A' A ' 129' ' ' MTN . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 028 nuclear orig full ' A' A ' 130' ' ' MTN . . . . . 0.563 ' S1 ' ' O ' ' A' ' 99' ' ' GLN . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 4.6 tpp . . . . . 0 N--CA 1.489 1.498 0 N-CA-C 109.194 -0.669 . . . . 1.0 109.194 . . . . . . . . . 0 0 . 1 . 029 nuclear orig full ' A' A ' 2' ' ' SER . . . . . 0.484 ' O ' ' CB ' ' A' ' 3' ' ' ASP . 87.7 p -89.61 12.42 16.82 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.877 -0.602 . . . . 1.0 110.499 -179.951 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . 0.484 ' CB ' ' O ' ' A' ' 2' ' ' SER . 4.7 t0 151.22 116.58 0.0 OUTLIER 'General case' 0 N--CA 1.473 0.699 0 O-C-N 124.075 0.86 . . . . 1.0 109.963 178.606 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . 0.434 ' O ' ' OD1' ' A' ' 5' ' ' ASP . 13.8 t80 -152.38 148.05 27.02 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.645 -0.707 . . . . 1.0 110.305 179.559 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 5' ' ' ASP . . . . . 0.434 ' OD1' ' O ' ' A' ' 4' ' ' PHE . 2.2 m-20 -154.78 151.52 28.78 Favored 'General case' 0 C--O 1.234 0.242 0 N-CA-C 109.703 -0.48 . . . . 1.0 109.703 179.634 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 6' ' ' THR . . . . . 0.416 ' C ' ' O ' ' A' ' 5' ' ' ASP . 3.0 m -38.76 143.07 0.16 Allowed 'General case' 0 N--CA 1.467 0.4 0 N-CA-C 109.53 -0.544 . . . . 1.0 109.53 179.994 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 35.9 tt0 -47.27 -52.4 16.27 Favored 'General case' 0 C--N 1.316 -0.86 0 CA-C-O 118.347 -0.835 . . . . 1.0 112.698 -174.934 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 8' ' ' ARG . . . . . 0.52 ' O ' ' CB ' ' A' ' 12' ' ' ALA . 24.3 ptt180 -63.48 -35.5 80.66 Favored 'General case' 0 N--CA 1.447 -0.59 0 CA-C-N 120.824 1.647 . . . . 1.0 109.816 179.022 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . 0.52 ' O ' ' CG2' ' A' ' 13' ' ' VAL . 93.6 t -62.34 -52.23 62.58 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.714 0 C-N-CA 118.665 -1.214 . . . . 1.0 108.009 178.481 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 80.0 p -67.61 -38.72 84.35 Favored 'General case' 0 CA--C 1.543 0.696 0 N-CA-C 113.353 0.872 . . . . 1.0 113.353 179.384 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 11' ' ' ARG . . . . . 0.596 ' O ' ' N ' ' A' ' 14' ' ' ALA . 5.0 tpp180 -75.77 -63.0 1.4 Allowed 'General case' 0 N--CA 1.472 0.649 0 CA-C-O 122.335 1.064 . . . . 1.0 109.098 178.039 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . 0.52 ' CB ' ' O ' ' A' ' 8' ' ' ARG . . . -46.67 -37.56 8.48 Favored 'General case' 0 N--CA 1.474 0.762 0 CA-C-N 112.724 -2.034 . . . . 1.0 105.955 -175.323 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . 0.599 ' O ' ' CB ' ' A' ' 17' ' ' LEU . 11.9 t -59.8 -50.84 78.53 Favored 'Isoleucine or valine' 0 C--O 1.206 -1.215 0 C-N-CA 118.574 -1.25 . . . . 1.0 107.869 175.68 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . 0.596 ' N ' ' O ' ' A' ' 11' ' ' ARG . . . -60.85 -63.59 1.24 Allowed 'General case' 0 C--O 1.219 -0.531 0 C-N-CA 118.717 -1.193 . . . . 1.0 111.235 179.178 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . 0.532 ' O ' ' N ' ' A' ' 19' ' ' GLY . . . -52.48 -54.93 25.96 Favored 'General case' 0 N--CA 1.479 1.003 0 CA-C-O 121.826 0.822 . . . . 1.0 110.143 -176.735 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . 0.468 ' CB ' ' O ' ' A' ' 12' ' ' ALA . . . -61.97 -53.36 56.77 Favored 'General case' 0 C--N 1.308 -1.201 0 CA-C-N 113.877 -1.511 . . . . 1.0 108.685 -179.239 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . 0.599 ' CB ' ' O ' ' A' ' 13' ' ' VAL . 3.1 tp -57.06 -51.75 68.02 Favored 'General case' 0 N--CA 1.479 1.016 0 C-N-CA 118.944 -1.102 . . . . 1.0 109.083 -177.336 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . 0.527 HG23 ' H ' ' A' ' 19' ' ' GLY . 3.2 m -68.78 -56.5 11.95 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.269 0 C-N-CA 119.04 -1.064 . . . . 1.0 108.864 179.397 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . 0.532 ' N ' ' O ' ' A' ' 15' ' ' ALA . . . -60.73 -169.25 0.51 Allowed Glycine 0 CA--C 1.532 1.133 0 N-CA-C 111.786 -0.526 . . . . 1.0 111.786 179.881 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 20' ' ' PRO . . . . . 0.611 ' O ' ' N ' ' A' ' 24' ' ' ALA . 27.7 Cg_endo -81.57 -32.89 0.76 Allowed 'Trans proline' 0 N--CA 1.493 1.49 0 C-N-CA 123.323 2.682 . . . . 1.0 115.154 -178.656 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -57.64 -57.29 20.59 Favored Glycine 0 N--CA 1.479 1.539 0 C-N-CA 120.246 -0.978 . . . . 1.0 111.623 -176.565 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -56.69 -50.47 63.11 Favored Glycine 0 N--CA 1.472 1.039 0 N-CA-C 107.075 -2.41 . . . . 1.0 107.075 -178.17 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 41.8 t -61.7 -34.95 64.56 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.051 0 CA-C-N 114.834 -0.683 . . . . 1.0 109.85 179.371 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . 0.611 ' N ' ' O ' ' A' ' 20' ' ' PRO . . . -57.07 -61.14 2.66 Favored 'General case' 0 N--CA 1.454 -0.231 0 C-N-CA 118.978 -1.089 . . . . 1.0 109.404 -179.145 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 8.4 tt -65.98 -42.48 89.8 Favored 'General case' 0 C--N 1.342 0.283 0 C-N-CA 119.657 -0.817 . . . . 1.0 111.922 -178.715 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 59.3 t -59.37 -58.69 5.88 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.182 0 C-N-CA 118.472 -1.291 . . . . 1.0 109.501 -178.017 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 1.8 p -63.4 -36.75 77.4 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.454 0 N-CA-C 112.953 0.723 . . . . 1.0 112.953 -177.706 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 24.7 tttm -64.68 -53.28 49.91 Favored 'General case' 0 C--N 1.324 -0.533 0 N-CA-C 108.293 -1.003 . . . . 1.0 108.293 -178.597 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 74.1 t -59.65 -44.83 94.33 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.829 0 CA-C-N 114.523 -1.217 . . . . 1.0 109.906 -178.81 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 30' ' ' CYS . . . . . 0.566 ' SG ' ' N ' ' A' ' 31' ' ' ALA . 0.5 OUTLIER -64.56 -57.25 9.67 Favored 'General case' 0 CA--C 1.539 0.543 0 C-N-CA 118.43 -1.308 . . . . 1.0 109.143 -179.804 . . . . . . . . 3 3 . 1 . 029 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . 0.566 ' N ' ' SG ' ' A' ' 30' ' ' CYS . . . -64.35 -56.09 16.74 Favored 'General case' 0 N--CA 1.468 0.436 0 N-CA-C 116.276 1.954 . . . . 1.0 116.276 -175.984 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . 0.455 ' O ' ' HB2' ' A' ' 33' ' ' LEU . . . 81.5 73.44 1.2 Allowed Glycine 0 CA--C 1.537 1.425 0 N-CA-C 108.694 -1.762 . . . . 1.0 108.694 -175.539 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . 0.455 ' HB2' ' O ' ' A' ' 32' ' ' GLY . 15.8 mt 81.34 110.04 0.03 OUTLIER Pre-proline 0 N--CA 1.486 1.345 0 C-N-CA 124.68 1.192 . . . . 1.0 111.745 -178.657 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 52.4 Cg_exo -54.62 -14.48 7.45 Favored 'Trans proline' 0 N--CA 1.507 2.308 0 C-N-CA 122.348 2.032 . . . . 1.0 113.325 178.355 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -56.46 -55.87 27.43 Favored Glycine 0 CA--C 1.534 1.236 0 C-N-CA 119.159 -1.496 . . . . 1.0 109.588 -178.458 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . 0.563 ' CG1' ' H ' ' A' ' 37' ' ' ILE . 6.1 p -69.78 -70.08 0.25 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.5 0 N-CA-C 112.958 0.725 . . . . 1.0 112.958 -177.53 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . 0.569 ' O ' ' CG2' ' A' ' 37' ' ' ILE . 53.1 mt 9.46 68.16 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.486 1.373 0 N-CA-C 114.035 1.124 . . . . 1.0 114.035 -178.061 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 38' ' ' HIS . . . . . 0.633 ' H ' ' CD2' ' A' ' 38' ' ' HIS . 0.3 OUTLIER -131.75 118.47 19.99 Favored 'General case' 0 N--CA 1.447 -0.587 0 CA-C-N 122.161 2.255 . . . . 1.0 106.477 177.484 . . . . . . . . 3 3 . 1 . 029 nuclear orig full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 3.9 m -101.88 122.65 46.59 Favored Pre-proline 0 C--N 1.323 -0.56 0 C-N-CA 120.478 -0.489 . . . . 1.0 110.508 -178.684 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 58.3 Cg_exo -48.85 -37.43 36.15 Favored 'Trans proline' 0 N--CA 1.491 1.346 0 C-N-CA 121.133 1.222 . . . . 1.0 112.829 179.896 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -124.71 131.03 53.49 Favored 'General case' 0 N--CA 1.467 0.379 0 N-CA-C 109.831 -0.433 . . . . 1.0 109.831 178.479 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . 0.691 ' C ' ' H ' ' A' ' 44' ' ' GLY . 28.7 ptt-85 -168.27 165.57 12.93 Favored 'General case' 0 C--N 1.322 -0.614 0 C-N-CA 119.608 -0.837 . . . . 1.0 110.628 178.094 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 21.1 ttt180 -65.63 17.75 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.464 0 N-CA-C 108.795 -0.817 . . . . 1.0 108.795 179.206 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . 0.691 ' H ' ' C ' ' A' ' 42' ' ' ARG . . . 82.91 -24.59 5.14 Favored Glycine 0 N--CA 1.447 -0.627 0 N-CA-C 110.857 -0.897 . . . . 1.0 110.857 -179.947 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . 0.653 ' CD1' ' N ' ' A' ' 45' ' ' PHE . 0.0 OUTLIER -163.78 164.1 23.78 Favored 'General case' 0 CA--C 1.551 1.008 0 CA-C-N 116.98 0.39 . . . . 1.0 110.137 -178.633 . . . . . . . . 3 3 . 1 . 029 nuclear orig full ' A' A ' 46' ' ' PHE . . . . . 0.534 ' N ' ' HE ' ' A' ' 47' ' ' ARG . 0.6 OUTLIER 144.01 4.31 0.0 OUTLIER 'General case' 0 N--CA 1.505 2.297 0 O-C-N 125.065 1.478 . . . . 1.0 111.92 177.531 . . . . . . . . 3 3 . 1 . 029 nuclear orig full ' A' A ' 47' ' ' ARG . . . . . 0.537 ' O ' ' C ' ' A' ' 48' ' ' CYS . 0.0 OUTLIER -117.27 -149.49 0.44 Allowed 'General case' 0 N--CA 1.472 0.65 0 CA-C-N 117.912 0.324 . . . . 1.0 110.182 -179.183 . . . . . . . . 3 3 . 1 . 029 nuclear orig full ' A' A ' 48' ' ' CYS . . . . . 0.537 ' C ' ' O ' ' A' ' 47' ' ' ARG . 25.8 p -15.32 93.98 0.01 OUTLIER 'General case' 0 N--CA 1.484 1.239 0 O-C-N 124.346 1.029 . . . . 1.0 110.456 179.872 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 49' ' ' ASN . . . . . 0.507 ' ND2' ' O ' ' A' ' 52' ' ' ARG . 0.1 OUTLIER -123.31 140.73 34.43 Favored Pre-proline 0 CA--C 1.541 0.607 0 N-CA-C 108.746 -0.835 . . . . 1.0 108.746 -178.1 . . . . . . . . 3 3 . 1 . 029 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . 0.508 ' C ' ' H ' ' A' ' 52' ' ' ARG . 64.9 Cg_endo -73.44 59.91 4.03 Favored 'Trans proline' 0 N--CA 1.493 1.445 0 C-N-CA 121.613 1.542 . . . . 1.0 112.047 -179.861 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 20.8 mp0 68.04 -24.85 0.13 Allowed 'General case' 0 N--CA 1.469 0.478 0 CA-C-N 115.677 -0.692 . . . . 1.0 112.055 179.614 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . 0.508 ' H ' ' C ' ' A' ' 50' ' ' PRO . 47.1 mmt-85 -59.24 174.95 0.35 Allowed 'General case' 0 CA--C 1.518 -0.252 0 C-N-CA 120.299 -0.561 . . . . 1.0 109.731 -179.928 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -99.15 145.31 10.54 Favored 'Isoleucine or valine' 0 C--O 1.232 0.133 0 CA-C-O 122.133 0.968 . . . . 1.0 111.141 -179.199 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 54' ' ' GLN . . . . . 0.479 ' CD ' ' H ' ' A' ' 54' ' ' GLN . 0.0 OUTLIER -63.91 79.27 0.03 OUTLIER 'General case' 0 C--N 1.316 -0.862 0 CA-C-N 113.345 -1.752 . . . . 1.0 110.363 -177.532 . . . . . . . . 3 3 . 1 . 029 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -148.91 156.51 7.76 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.412 0 N-CA-C 108.984 -0.747 . . . . 1.0 108.984 176.914 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . 0.567 ' O ' ' CD1' ' A' ' 58' ' ' TRP . . . 110.17 -4.99 30.17 Favored Glycine 0 N--CA 1.469 0.891 0 N-CA-C 109.767 -1.333 . . . . 1.0 109.767 -178.821 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . 0.533 ' N ' ' OD1' ' A' ' 57' ' ' ASP . 12.7 p-10 -80.02 98.54 7.25 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 114.914 -0.643 . . . . 1.0 109.469 178.885 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 58' ' ' TRP . . . . . 0.567 ' CD1' ' O ' ' A' ' 56' ' ' GLY . 18.4 m95 -84.84 176.79 8.28 Favored 'General case' 0 N--CA 1.464 0.239 0 CA-C-O 122.561 1.172 . . . . 1.0 113.084 -178.521 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 1.3 mpp_? -90.11 -60.06 2.03 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 112.26 -2.246 . . . . 1.0 111.494 179.781 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -90.68 -18.18 25.51 Favored 'General case' 0 N--CA 1.48 1.069 0 N-CA-C 113.925 1.083 . . . . 1.0 113.925 -179.462 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 3.4 tt0 -82.66 -13.91 55.6 Favored 'General case' 0 C--N 1.318 -0.784 0 O-C-N 121.397 -0.815 . . . . 1.0 110.719 -179.48 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . 0.655 ' O ' ' N ' ' A' ' 66' ' ' GLY . 28.2 m -51.51 -54.58 11.55 Favored 'Isoleucine or valine' 0 C--O 1.203 -1.377 0 C-N-CA 120.263 -0.575 . . . . 1.0 111.212 -176.77 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 63' ' ' ALA . . . . . 0.455 ' O ' ' N ' ' A' ' 67' ' ' ARG . . . -71.25 -53.84 12.96 Favored 'General case' 0 C--N 1.315 -0.894 0 CA-C-N 119.59 1.086 . . . . 1.0 109.282 -177.747 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 64' ' ' HIS . . . . . 0.72 ' CD2' HH12 ' A' ' 67' ' ' ARG . 0.5 OUTLIER -45.2 -54.61 6.73 Favored 'General case' 0 CA--C 1.536 0.409 0 N-CA-C 107.969 -1.123 . . . . 1.0 107.969 179.157 . . . . . . . . 3 3 . 1 . 029 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . 0.614 ' C ' ' H ' ' A' ' 67' ' ' ARG . 11.1 t70 -73.83 -49.07 26.94 Favored 'General case' 0 C--N 1.314 -0.975 0 CA-C-N 114.428 -1.26 . . . . 1.0 111.16 179.343 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . 0.688 ' C ' ' H ' ' A' ' 68' ' ' LEU . . . -75.13 26.81 1.19 Allowed Glycine 0 C--N 1.317 -0.509 0 N-CA-C 109.88 -1.288 . . . . 1.0 109.88 177.41 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 67' ' ' ARG . . . . . 0.72 HH12 ' CD2' ' A' ' 64' ' ' HIS . 21.5 mtt85 -71.57 8.2 1.19 Allowed 'General case' 0 CA--C 1.504 -0.826 0 N-CA-C 105.22 -2.141 . . . . 1.0 105.22 173.629 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . 0.688 ' H ' ' C ' ' A' ' 66' ' ' GLY . 1.5 pp -32.27 -29.83 0.01 OUTLIER 'General case' 0 C--N 1.347 0.498 0 O-C-N 124.112 0.883 . . . . 1.0 108.982 -177.252 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . 0.631 ' N ' ' O ' ' A' ' 67' ' ' ARG . 2.1 tt -62.38 -64.36 0.95 Allowed 'General case' 0 C--N 1.321 -0.632 0 C-N-CA 119.095 -1.042 . . . . 1.0 108.423 177.14 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . 0.592 ' O ' ' N ' ' A' ' 72' ' ' HIS . . . -77.45 -73.17 0.32 Allowed 'General case' 0 N--CA 1.47 0.537 0 N-CA-C 104.319 -2.475 . . . . 1.0 104.319 176.161 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . 0.504 ' O ' ' C ' ' A' ' 72' ' ' HIS . . . -41.22 2.8 0.0 OUTLIER 'General case' 0 C--N 1.322 -0.619 0 N-CA-C 115.533 1.679 . . . . 1.0 115.533 179.77 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 72' ' ' HIS . . . . . 0.606 ' CD2' ' H ' ' A' ' 73' ' ' MET . 1.9 p-80 -29.06 -63.84 0.11 Allowed 'General case' 0 N--CA 1.47 0.528 0 CA-C-N 120.6 1.545 . . . . 1.0 112.458 -176.29 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 73' ' ' MET . . . . . 0.606 ' H ' ' CD2' ' A' ' 72' ' ' HIS . 0.0 OUTLIER -71.72 -48.69 45.43 Favored 'General case' 0 C--N 1.325 -0.473 0 C-N-CA 119.236 -0.986 . . . . 1.0 109.84 177.765 . . . . . . . . 3 3 . 1 . 029 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . 0.746 ' O ' ' N ' ' A' ' 76' ' ' GLY . 58.0 t -45.62 -43.32 3.93 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.387 0 CA-C-O 117.397 -1.287 . . . . 1.0 112.08 -175.843 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 75' ' ' ASN . . . . . 0.424 ' O ' ' N ' ' A' ' 78' ' ' VAL . 16.2 t30 -35.75 -12.17 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.613 0 CA-C-N 121.265 1.848 . . . . 1.0 112.467 178.549 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . 0.746 ' N ' ' O ' ' A' ' 74' ' ' VAL . . . -46.04 -25.02 1.58 Allowed Glycine 0 CA--C 1.54 1.654 0 N-CA-C 108.349 -1.9 . . . . 1.0 108.349 176.721 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . 0.67 ' CG1' ' H ' ' A' ' 78' ' ' VAL . 5.5 pt -63.24 -54.76 28.98 Favored 'Isoleucine or valine' 0 C--O 1.219 -0.511 0 N-CA-C 107.873 -1.158 . . . . 1.0 107.873 178.421 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . 0.67 ' H ' ' CG1' ' A' ' 77' ' ' ILE . 59.7 t -36.04 -33.07 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.316 -0.885 0 CA-C-N 112.186 -2.279 . . . . 1.0 106.962 -177.108 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . 0.502 ' N ' ' O ' ' A' ' 77' ' ' ILE . 0.0 OUTLIER -98.39 -33.44 4.18 Favored 'Isoleucine or valine' 0 CA--C 1.556 1.178 0 CA-C-N 115.795 -0.639 . . . . 1.0 111.018 177.828 . . . . . . . . 3 3 . 1 . 029 nuclear orig full ' A' A ' 80' ' ' ALA . . . . . 0.56 ' N ' ' O ' ' A' ' 77' ' ' ILE . . . -84.86 -13.37 51.16 Favored 'General case' 0 N--CA 1.48 1.048 0 N-CA-C 114.842 1.423 . . . . 1.0 114.842 -179.096 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . 0.452 ' N ' ' O ' ' A' ' 77' ' ' ILE . 41.8 mt-10 -88.48 -67.33 0.84 Allowed 'General case' 0 CA--C 1.506 -0.724 0 O-C-N 121.656 -0.652 . . . . 1.0 109.383 178.098 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 82' ' ' ASP . . . . . 0.541 ' O ' ' N ' ' A' ' 84' ' ' LEU . 24.3 t0 -73.25 -13.92 61.23 Favored 'General case' 0 N--CA 1.442 -0.858 0 CA-C-N 119.043 0.838 . . . . 1.0 111.908 179.792 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . 0.518 ' C ' ' O ' ' A' ' 82' ' ' ASP . . . -20.47 -47.2 0.01 OUTLIER 'General case' 0 N--CA 1.478 0.96 0 CA-C-N 118.39 0.541 . . . . 1.0 112.032 178.221 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . 0.541 ' N ' ' O ' ' A' ' 82' ' ' ASP . 3.7 mm? -34.29 -35.91 0.04 OUTLIER 'General case' 0 N--CA 1.478 0.949 0 N-CA-C 113.209 0.818 . . . . 1.0 113.209 -178.163 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 11.2 tp -100.42 -36.86 5.28 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.66 0 N-CA-C 108.548 -0.908 . . . . 1.0 108.548 177.88 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . 0.47 ' C ' ' H ' ' A' ' 88' ' ' ALA . . . -61.21 -58.82 6.73 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 114.426 -1.261 . . . . 1.0 109.132 179.973 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . 0.473 ' N ' ' O ' ' A' ' 83' ' ' ALA . 2.5 tt0 -71.5 24.04 0.04 OUTLIER 'General case' 0 CA--C 1.542 0.642 0 O-C-N 121.321 -0.862 . . . . 1.0 112.364 -178.931 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . 0.47 ' H ' ' C ' ' A' ' 86' ' ' ALA . . . -126.64 -16.63 5.23 Favored 'General case' 0 N--CA 1.478 0.971 0 CA-C-O 122.213 1.006 . . . . 1.0 108.999 179.131 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 21.2 m -101.48 33.89 0.37 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.456 0 CA-C-N 113.406 -1.724 . . . . 1.0 109.09 178.328 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 90' ' ' GLY . . . . . 0.592 ' C ' ' H ' ' A' ' 92' ' ' HIS . . . -69.3 -35.45 76.69 Favored Glycine 0 C--N 1.345 1.044 0 N-CA-C 111.16 -0.776 . . . . 1.0 111.16 179.009 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 91' ' ' PRO . . . . . 0.583 ' CD ' ' N ' ' A' ' 90' ' ' GLY . 89.4 Cg_exo -48.35 -8.08 0.06 OUTLIER 'Trans proline' 0 N--CA 1.498 1.746 0 C-N-CA 122.002 1.801 . . . . 1.0 110.702 177.897 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 92' ' ' HIS . . . . . 0.601 ' ND1' ' N ' ' A' ' 93' ' ' LEU . 0.9 OUTLIER -57.54 -20.11 29.56 Favored 'General case' 0 N--CA 1.444 -0.746 0 N-CA-C 107.771 -1.196 . . . . 1.0 107.771 179.367 . . . . . . . . 3 3 . 1 . 029 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . 0.601 ' N ' ' ND1' ' A' ' 92' ' ' HIS . 2.2 pp -65.63 -58.09 6.56 Favored 'General case' 0 N--CA 1.451 -0.393 0 N-CA-C 108.507 -0.923 . . . . 1.0 108.507 178.507 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 94' ' ' ALA . . . . . 0.422 ' H ' ' HG ' ' A' ' 93' ' ' LEU . . . -55.11 -54.21 46.03 Favored 'General case' 0 N--CA 1.452 -0.336 0 N-CA-C 108.962 -0.755 . . . . 1.0 108.962 179.305 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 95' ' ' ARG . . . . . 0.579 ' O ' ' N ' ' A' ' 97' ' ' LEU . 29.2 mtm180 -58.69 -58.86 6.73 Favored 'General case' 0 C--O 1.242 0.689 0 CA-C-O 122.529 1.157 . . . . 1.0 108.254 179.461 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 96' ' ' ALA . . . . . 0.886 ' O ' ' N ' ' A' ' 98' ' ' GLY . . . -48.55 -14.1 0.06 Allowed 'General case' 0 N--CA 1.424 -1.754 0 O-C-N 118.961 -2.337 . . . . 1.0 111.297 -178.856 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . 0.735 ' O ' ' N ' ' A' ' 100' ' ' ILE . 1.9 tp 5.23 -52.34 0.0 OUTLIER 'General case' 0 C--N 1.367 1.358 0 CA-C-O 116.427 -1.749 . . . . 1.0 110.447 -167.765 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 98' ' ' GLY . . . . . 0.886 ' N ' ' O ' ' A' ' 96' ' ' ALA . . . -48.66 -23.65 3.49 Favored Glycine 0 CA--C 1.542 1.735 0 CA-C-N 123.916 3.053 . . . . 1.0 108.034 174.733 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 99' ' ' GLN . . . . . 0.572 ' N ' ' O ' ' A' ' 96' ' ' ALA . 59.0 tt0 -68.81 -19.22 64.27 Favored 'General case' 0 C--N 1.364 1.211 0 N-CA-C 107.285 -1.376 . . . . 1.0 107.285 177.536 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 100' ' ' ILE . . . . . 0.735 ' N ' ' O ' ' A' ' 97' ' ' LEU . 1.9 tp -65.54 -42.58 93.43 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 N-CA-C 107.103 -1.443 . . . . 1.0 107.103 177.128 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 101' ' ' VAL . . . . . 0.743 ' O ' ' N ' ' A' ' 105' ' ' GLY . 61.0 t -55.68 -60.03 2.1 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.43 0 N-CA-C 106.931 -1.507 . . . . 1.0 106.931 178.704 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 102' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -46.35 -18.37 0.06 Allowed 'General case' 0 C--N 1.32 -0.708 0 CA-C-N 116.433 -0.349 . . . . 1.0 111.622 -179.666 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 103' ' ' ARG . . . . . 0.418 ' H ' ' C ' ' A' ' 101' ' ' VAL . 1.1 ttp180 -92.77 -44.65 8.41 Favored 'General case' 0 N--CA 1.478 0.946 0 CA-C-O 121.948 0.88 . . . . 1.0 111.068 176.951 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 104' ' ' TYR . . . . . 0.583 ' CG ' ' O ' ' A' ' 104' ' ' TYR . 0.0 OUTLIER -106.57 21.85 16.79 Favored 'General case' 0 C--N 1.317 -0.808 0 C-N-CA 126.297 1.839 . . . . 1.0 111.215 179.416 . . . . . . . . 3 3 . 1 . 029 nuclear orig full ' A' A ' 105' ' ' GLY . . . . . 0.769 ' O ' ' N ' ' A' ' 107' ' ' THR . . . -170.12 -7.33 0.03 OUTLIER Glycine 0 C--N 1.339 0.747 0 C-N-CA 118.495 -1.812 . . . . 1.0 113.481 178.619 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 106' ' ' ALA . . . . . 0.435 ' O ' ' CD ' ' A' ' 110' ' ' PRO . . . -31.64 69.49 0.0 OUTLIER 'General case' 0 N--CA 1.467 0.387 0 N-CA-C 113.752 1.019 . . . . 1.0 113.752 -177.738 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 107' ' ' THR . . . . . 0.769 ' N ' ' O ' ' A' ' 105' ' ' GLY . 4.8 t -91.84 4.22 53.38 Favored 'General case' 0 N--CA 1.436 -1.171 0 N-CA-C 105.668 -1.975 . . . . 1.0 105.668 176.151 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 11.2 p -87.77 -57.35 4.31 Favored 'Isoleucine or valine' 0 C--N 1.357 0.928 0 CA-C-N 115.851 -0.613 . . . . 1.0 110.624 178.333 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 109' ' ' ILE . . . . . 0.432 ' N ' ' CD ' ' A' ' 110' ' ' PRO . 0.1 OUTLIER -62.95 -37.98 38.5 Favored Pre-proline 0 C--N 1.359 0.987 0 N-CA-C 114.476 1.288 . . . . 1.0 114.476 -176.911 . . . . . . . . 3 3 . 1 . 029 nuclear orig full ' A' A ' 110' ' ' PRO . . . . . 0.435 ' CD ' ' O ' ' A' ' 106' ' ' ALA . 62.5 Cg_exo -49.04 -44.9 31.2 Favored 'Trans proline' 0 N--CA 1.497 1.703 0 CA-C-N 121.158 1.449 . . . . 1.0 113.649 -176.418 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 9.0 t30 -68.03 -67.55 0.45 Allowed 'General case' 0 C--N 1.326 -0.422 0 C-N-CA 118.735 -1.186 . . . . 1.0 110.435 -177.815 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 6.3 pt -52.89 -23.2 4.99 Favored 'Isoleucine or valine' 0 C--O 1.214 -0.778 0 N-CA-C 108.78 -0.822 . . . . 1.0 108.78 179.391 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 113' ' ' ASN . . . . . 0.418 ' CB ' ' O ' ' A' ' 109' ' ' ILE . 20.2 t30 -59.43 -51.45 69.84 Favored 'General case' 0 C--N 1.314 -0.943 0 CA-C-N 113.731 -1.577 . . . . 1.0 108.334 -178.423 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -58.64 -28.9 66.11 Favored 'General case' 0 N--CA 1.443 -0.805 0 C-N-CA 120.345 -0.542 . . . . 1.0 111.202 179.874 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 115' ' ' ALA . . . . . 0.578 ' O ' ' N ' ' A' ' 119' ' ' LEU . . . -81.12 -50.29 9.8 Favored 'General case' 0 C--O 1.208 -1.123 0 C-N-CA 120.084 -0.646 . . . . 1.0 109.292 177.275 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 116' ' ' ILE . . . . . 0.413 ' C ' ' O ' ' A' ' 115' ' ' ALA . 35.8 mt -42.85 -48.39 1.19 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.408 0 N-CA-C 104.997 -2.223 . . . . 1.0 104.997 179.104 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 117' ' ' GLU . . . . . 0.459 ' O ' ' HA ' ' A' ' 121' ' ' THR . 55.7 tt0 -46.51 -58.32 3.89 Favored 'General case' 0 C--N 1.314 -0.951 0 CA-C-N 111.294 -2.685 . . . . 1.0 106.332 177.814 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 118' ' ' VAL . . . . . 0.574 ' N ' ' O ' ' A' ' 115' ' ' ALA . 15.8 t -64.44 -56.23 17.34 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.747 0 C-N-CA 120.085 -0.646 . . . . 1.0 110.486 177.398 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 119' ' ' LEU . . . . . 0.578 ' N ' ' O ' ' A' ' 115' ' ' ALA . 1.1 mm? -51.77 -20.63 2.26 Favored 'General case' 0 N--CA 1.451 -0.377 0 N-CA-C 113.984 1.105 . . . . 1.0 113.984 -178.532 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 120' ' ' GLY . . . . . 0.484 ' O ' ' OG1' ' A' ' 121' ' ' THR . . . -134.16 -68.64 0.07 OUTLIER Glycine 0 CA--C 1.554 2.486 0 N-CA-C 105.996 -2.842 . . . . 1.0 105.996 173.974 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 121' ' ' THR . . . . . 0.484 ' OG1' ' O ' ' A' ' 120' ' ' GLY . 2.3 m 152.7 -31.96 0.01 OUTLIER 'General case' 0 N--CA 1.481 1.101 0 CA-C-N 112.656 -1.772 . . . . 1.0 112.01 178.478 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 122' ' ' GLY . . . . . 0.67 ' O ' ' N ' ' A' ' 124' ' ' ASP . . . 104.02 -17.03 49.5 Favored Glycine 0 N--CA 1.471 1.016 0 N-CA-C 108.875 -1.69 . . . . 1.0 108.875 -177.973 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -55.4 84.98 0.0 OUTLIER 'General case' 0 CA--C 1.539 0.527 0 N-CA-C 105.566 -2.013 . . . . 1.0 105.566 178.548 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 124' ' ' ASP . . . . . 0.67 ' N ' ' O ' ' A' ' 122' ' ' GLY . 63.7 m-20 -163.56 170.81 16.7 Favored 'General case' 0 N--CA 1.471 0.575 0 CA-C-N 113.428 -1.715 . . . . 1.0 112.342 -179.086 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 125' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -144.15 138.73 28.36 Favored 'General case' 0 CA--C 1.547 0.846 0 N-CA-C 107.377 -1.342 . . . . 1.0 107.377 176.449 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 25.6 mmm180 -149.31 153.85 38.12 Favored 'General case' 0 N--CA 1.476 0.851 0 N-CA-C 109.872 -0.418 . . . . 1.0 109.872 178.575 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 127' ' ' PHE . . . . . 0.478 ' OXT' ' CD1' ' A' ' 127' ' ' PHE . 0.1 OUTLIER . . . . . 0 N--CA 1.471 0.589 0 CA-C-O 118.076 -0.964 . . . . 1.0 110.269 178.862 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 128' ' ' MTN . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 029 nuclear orig full ' A' A ' 129' ' ' MTN . . . . . 0.488 ' C2 ' ' SG ' ' A' ' 48' ' ' CYS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 130' ' ' MTN . . . . . 0.464 ' H63' HE21 ' A' ' 99' ' ' GLN . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.427 ' N ' ' SD ' ' A' ' 1' ' ' MET . 0.0 OUTLIER . . . . . 0 N--CA 1.495 1.8 0 N-CA-C 109.92 -0.4 . . . . 1.0 109.92 . . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 2' ' ' SER . . . . . 0.49 ' O ' ' CB ' ' A' ' 3' ' ' ASP . 9.0 t -86.49 13.78 7.82 Favored 'General case' 0 C--O 1.225 -0.23 0 CA-C-N 115.786 -0.643 . . . . 1.0 111.264 -179.918 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . 0.49 ' CB ' ' O ' ' A' ' 2' ' ' SER . 21.5 m-20 146.43 122.27 0.0 OUTLIER 'General case' 0 N--CA 1.478 0.955 0 O-C-N 124.577 1.173 . . . . 1.0 110.524 178.948 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 47.8 t80 -154.78 150.52 27.63 Favored 'General case' 0 N--CA 1.466 0.361 0 CA-C-N 116.062 -0.517 . . . . 1.0 110.573 179.028 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -152.39 147.97 26.92 Favored 'General case' 0 CA--C 1.543 0.694 0 CA-C-N 116.364 -0.38 . . . . 1.0 110.263 -178.529 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 6' ' ' THR . . . . . 0.456 ' H ' ' HG1' ' A' ' 6' ' ' THR . 0.2 OUTLIER -61.49 -157.6 0.01 OUTLIER 'General case' 0 N--CA 1.472 0.671 0 C-N-CA 121.032 -0.267 . . . . 1.0 111.037 -179.187 . . . . . . . . 3 3 . 1 . 030 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . 0.454 ' CG ' ' H ' ' A' ' 8' ' ' ARG . 3.2 pt-20 -75.76 -67.57 0.66 Allowed 'General case' 0 C--O 1.216 -0.698 0 CA-C-O 118.553 -0.737 . . . . 1.0 110.245 -179.367 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 8' ' ' ARG . . . . . 0.454 ' H ' ' CG ' ' A' ' 7' ' ' GLU . 7.0 tmm_? -47.08 -43.01 19.81 Favored 'General case' 0 CA--C 1.493 -1.214 0 CA-C-N 119.645 1.111 . . . . 1.0 111.781 -177.858 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -68.96 -52.99 28.74 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.94 0 C-N-CA 118.933 -1.107 . . . . 1.0 108.779 179.063 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 39.5 t -58.67 -42.75 89.18 Favored 'General case' 0 N--CA 1.455 -0.207 0 CA-C-O 118.868 -0.587 . . . . 1.0 111.968 179.528 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 11' ' ' ARG . . . . . 0.678 ' O ' ' N ' ' A' ' 14' ' ' ALA . 0.0 OUTLIER -74.17 -59.97 2.48 Favored 'General case' 0 CA--C 1.492 -1.256 0 N-CA-C 106.85 -1.537 . . . . 1.0 106.85 178.051 . . . . . . . . 3 3 . 1 . 030 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . 0.461 ' C ' ' O ' ' A' ' 11' ' ' ARG . . . -38.91 -43.08 0.92 Allowed 'General case' 0 CA--C 1.487 -1.475 0 CA-C-N 119.108 0.867 . . . . 1.0 108.783 -175.879 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . 0.642 ' O ' ' CB ' ' A' ' 17' ' ' LEU . 71.5 t -60.12 -52.53 60.21 Favored 'Isoleucine or valine' 0 C--O 1.186 -2.252 0 C-N-CA 115.984 -2.286 . . . . 1.0 106.822 177.664 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . 0.678 ' N ' ' O ' ' A' ' 11' ' ' ARG . . . -66.1 -64.89 0.76 Allowed 'General case' 0 C--O 1.209 -1.041 0 O-C-N 120.329 -1.482 . . . . 1.0 113.122 177.954 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . 0.546 ' O ' ' N ' ' A' ' 19' ' ' GLY . . . -57.19 -59.13 5.56 Favored 'General case' 0 N--CA 1.497 1.878 0 C-N-CA 119.739 -0.784 . . . . 1.0 112.86 -175.263 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -61.62 -54.89 36.86 Favored 'General case' 0 CA--C 1.556 1.206 0 CA-C-O 122.533 1.158 . . . . 1.0 109.866 -177.678 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . 0.642 ' CB ' ' O ' ' A' ' 13' ' ' VAL . 21.1 tp -57.57 -51.17 70.56 Favored 'General case' 0 N--CA 1.481 1.102 0 CA-C-N 113.57 -1.65 . . . . 1.0 108.194 -177.452 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . 0.623 HG22 ' H ' ' A' ' 19' ' ' GLY . 3.0 m -70.34 -57.08 8.92 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.461 0 C-N-CA 118.927 -1.109 . . . . 1.0 110.168 179.636 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . 0.623 ' H ' HG22 ' A' ' 18' ' ' VAL . . . -61.62 -177.43 2.53 Favored Glycine 0 N--CA 1.446 -0.697 0 N-CA-C 111.718 -0.553 . . . . 1.0 111.718 -178.045 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 20' ' ' PRO . . . . . 0.569 ' O ' ' N ' ' A' ' 24' ' ' ALA . 54.4 Cg_endo -82.81 -23.63 3.76 Favored 'Trans proline' 0 C--N 1.303 -1.85 0 C-N-CA 123.045 2.497 . . . . 1.0 112.065 -179.271 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -60.51 -59.22 10.66 Favored Glycine 0 CA--C 1.535 1.301 0 C-N-CA 120.046 -1.073 . . . . 1.0 111.321 -176.952 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -56.14 -52.91 46.34 Favored Glycine 0 N--CA 1.469 0.893 0 N-CA-C 107.101 -2.399 . . . . 1.0 107.101 -178.411 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 36.7 t -59.28 -33.25 50.34 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.185 0 C-N-CA 119.774 -0.77 . . . . 1.0 109.143 179.836 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . 0.569 ' N ' ' O ' ' A' ' 20' ' ' PRO . . . -55.33 -62.29 1.77 Allowed 'General case' 0 N--CA 1.479 1.018 0 C-N-CA 119.239 -0.984 . . . . 1.0 110.568 -179.886 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 18.3 mt -63.66 -43.3 97.12 Favored 'General case' 0 C--N 1.345 0.392 0 C-N-CA 119.919 -0.712 . . . . 1.0 112.39 -177.854 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 95.2 t -60.22 -60.53 2.42 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.79 0 C-N-CA 118.591 -1.244 . . . . 1.0 111.279 -177.608 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . 0.443 ' CG2' ' NH1' ' A' ' 47' ' ' ARG . 3.1 p -59.61 -34.26 54.48 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.2 0 N-CA-C 112.681 0.623 . . . . 1.0 112.681 -177.58 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 71.3 tttt -66.79 -54.71 19.9 Favored 'General case' 0 C--N 1.312 -1.034 0 CA-C-O 122.317 1.056 . . . . 1.0 108.79 -179.68 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 98.6 t -62.88 -47.67 91.72 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.145 0 CA-C-N 113.553 -1.658 . . . . 1.0 110.499 -177.092 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 30' ' ' CYS . . . . . 0.561 ' SG ' ' N ' ' A' ' 31' ' ' ALA . 0.0 OUTLIER -67.48 -61.17 2.03 Favored 'General case' 0 CA--C 1.533 0.326 0 C-N-CA 118.729 -1.188 . . . . 1.0 110.198 -179.692 . . . . . . . . 3 3 . 1 . 030 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . 0.561 ' N ' ' SG ' ' A' ' 30' ' ' CYS . . . -60.38 -53.85 52.71 Favored 'General case' 0 CA--C 1.509 -0.6 0 CA-C-N 118.25 0.477 . . . . 1.0 111.99 -177.001 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . 0.495 ' O ' ' CB ' ' A' ' 33' ' ' LEU . . . 87.33 74.36 1.28 Allowed Glycine 0 CA--C 1.521 0.416 0 N-CA-C 108.632 -1.787 . . . . 1.0 108.632 -178.529 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . 0.495 ' CB ' ' O ' ' A' ' 32' ' ' GLY . 1.1 tt 85.81 85.31 0.05 OUTLIER Pre-proline 0 CA--C 1.546 0.792 0 CA-C-O 120.692 0.282 . . . . 1.0 110.414 -179.343 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 51.7 Cg_exo -53.23 -30.4 51.11 Favored 'Trans proline' 0 N--CA 1.502 1.99 0 C-N-CA 123.005 2.47 . . . . 1.0 114.227 -179.679 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -57.23 -60.75 8.45 Favored Glycine 0 N--CA 1.469 0.856 0 C-N-CA 119.062 -1.542 . . . . 1.0 110.185 -178.653 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . 0.538 ' O ' ' CB ' ' A' ' 37' ' ' ILE . 2.7 p -88.77 160.49 2.82 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.479 0 N-CA-C 105.77 -1.937 . . . . 1.0 105.77 177.808 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . 0.538 ' CB ' ' O ' ' A' ' 36' ' ' VAL . 0.7 OUTLIER 125.61 113.56 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.479 0.996 0 O-C-N 124.682 1.239 . . . . 1.0 110.373 179.711 . . . . . . . . 3 3 . 1 . 030 nuclear orig full ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 22.5 m80 -139.83 131.81 27.79 Favored 'General case' 0 N--CA 1.467 0.418 0 N-CA-C 108.557 -0.905 . . . . 1.0 108.557 179.263 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 9.2 p -99.37 149.4 35.8 Favored Pre-proline 0 N--CA 1.469 0.478 0 CA-C-N 116.969 -0.105 . . . . 1.0 110.743 -179.46 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 91.2 Cg_endo -75.29 -37.98 1.66 Allowed 'Trans proline' 0 N--CA 1.494 1.539 0 C-N-CA 122.317 2.012 . . . . 1.0 113.345 -179.123 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -128.2 134.38 49.02 Favored 'General case' 0 N--CA 1.472 0.665 0 N-CA-C 111.555 0.206 . . . . 1.0 111.555 179.611 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . 0.679 ' C ' ' H ' ' A' ' 44' ' ' GLY . 0.0 OUTLIER -169.86 165.95 9.61 Favored 'General case' 0 C--N 1.325 -0.487 0 C-N-CA 120.17 -0.612 . . . . 1.0 109.697 178.391 . . . . . . . . 3 3 . 1 . 030 nuclear orig full ' A' A ' 43' ' ' ARG . . . . . 0.493 ' C ' ' H ' ' A' ' 45' ' ' PHE . 0.0 OUTLIER -61.89 24.92 0.01 OUTLIER 'General case' 0 CA--C 1.548 0.896 0 CA-C-N 115.494 -0.775 . . . . 1.0 110.553 179.82 . . . . . . . . 3 3 . 1 . 030 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . 0.679 ' H ' ' C ' ' A' ' 42' ' ' ARG . . . 76.42 -26.08 1.61 Allowed Glycine 0 C--N 1.345 1.073 0 N-CA-C 110.452 -1.059 . . . . 1.0 110.452 -179.948 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . 0.54 ' O ' ' HB2' ' A' ' 46' ' ' PHE . 6.6 p90 -169.37 172.12 7.37 Favored 'General case' 0 C--O 1.219 -0.518 0 N-CA-C 109.966 -0.383 . . . . 1.0 109.966 179.743 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 46' ' ' PHE . . . . . 0.54 ' HB2' ' O ' ' A' ' 45' ' ' PHE . 1.1 m-85 131.63 99.57 0.0 OUTLIER 'General case' 0 N--CA 1.501 2.083 0 O-C-N 125.763 1.914 . . . . 1.0 109.802 178.695 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 47' ' ' ARG . . . . . 0.627 ' HG2' ' H ' ' A' ' 48' ' ' CYS . 15.6 ttp85 93.88 175.27 0.01 OUTLIER 'General case' 0 N--CA 1.468 0.446 0 O-C-N 123.596 0.56 . . . . 1.0 110.254 179.09 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 48' ' ' CYS . . . . . 0.627 ' H ' ' HG2' ' A' ' 47' ' ' ARG . 2.5 t 67.53 62.68 0.43 Allowed 'General case' 0 N--CA 1.445 -0.707 0 N-CA-C 106.373 -1.714 . . . . 1.0 106.373 -178.351 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 49' ' ' ASN . . . . . 0.559 ' N ' ' OD1' ' A' ' 49' ' ' ASN . 1.1 p30 -156.21 155.74 29.41 Favored Pre-proline 0 N--CA 1.449 -0.508 0 N-CA-C 108.097 -1.075 . . . . 1.0 108.097 178.865 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . 0.428 ' O ' ' NH1' ' A' ' 52' ' ' ARG . 50.8 Cg_endo -67.59 76.5 0.54 Allowed 'Trans proline' 0 C--N 1.303 -1.828 0 C-N-CA 121.967 1.778 . . . . 1.0 112.272 177.238 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 9.0 pt-20 40.12 63.97 0.98 Allowed 'General case' 0 N--CA 1.477 0.921 0 N-CA-C 112.532 0.567 . . . . 1.0 112.532 -179.95 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . 0.666 HH22 ' CE1' ' A' ' 92' ' ' HIS . 77.6 mtt85 -147.28 136.02 22.05 Favored 'General case' 0 N--CA 1.472 0.627 0 CA-C-N 116.049 -0.523 . . . . 1.0 111.844 178.896 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -54.44 164.75 0.29 Allowed 'Isoleucine or valine' 0 N--CA 1.478 0.942 0 N-CA-C 107.212 -1.403 . . . . 1.0 107.212 177.455 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 39.9 mm-40 -121.0 115.04 22.4 Favored 'General case' 0 CA--C 1.548 0.891 0 CA-C-N 121.845 2.111 . . . . 1.0 109.245 179.949 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -146.7 157.73 10.8 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.017 0 CA-C-N 118.476 0.58 . . . . 1.0 109.532 177.704 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 110.84 -6.81 29.45 Favored Glycine 0 N--CA 1.481 1.68 0 CA-C-N 118.752 0.706 . . . . 1.0 112.3 -179.595 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -112.64 127.88 56.23 Favored 'General case' 0 C--N 1.32 -0.682 0 N-CA-C 108.677 -0.86 . . . . 1.0 108.677 178.126 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 58' ' ' TRP . . . . . 0.482 ' O ' ' N ' ' A' ' 62' ' ' VAL . 5.0 m0 -139.18 158.48 44.1 Favored 'General case' 0 N--CA 1.455 -0.216 0 CA-C-O 122.808 1.29 . . . . 1.0 109.529 179.298 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 34.9 ptt-85 -41.03 -36.41 0.67 Allowed 'General case' 0 C--N 1.296 -1.728 0 CA-C-N 112.318 -2.219 . . . . 1.0 109.181 -178.616 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 42.8 t80 -90.94 -35.67 14.58 Favored 'General case' 0 N--CA 1.481 1.09 0 CA-C-O 121.687 0.756 . . . . 1.0 112.449 178.82 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . 0.477 ' O ' ' N ' ' A' ' 65' ' ' ASP . 92.5 mt-10 -77.67 -13.92 59.77 Favored 'General case' 0 N--CA 1.443 -0.812 0 O-C-N 121.757 -0.589 . . . . 1.0 110.53 179.926 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . 0.584 ' O ' ' N ' ' A' ' 66' ' ' GLY . 7.3 p -46.71 -56.2 1.42 Allowed 'Isoleucine or valine' 0 C--O 1.213 -0.858 0 C-N-CA 119.444 -0.902 . . . . 1.0 109.318 -175.664 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 63' ' ' ALA . . . . . 0.49 ' H ' ' CG1' ' A' ' 62' ' ' VAL . . . -64.77 -54.29 33.6 Favored 'General case' 0 C--N 1.302 -1.483 0 O-C-N 121.966 -0.459 . . . . 1.0 110.059 179.94 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 2.9 m-70 -53.16 -57.74 9.44 Favored 'General case' 0 CA--C 1.549 0.917 0 C-N-CA 119.591 -0.844 . . . . 1.0 109.813 -179.205 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . 0.642 ' C ' ' H ' ' A' ' 67' ' ' ARG . 33.8 t0 -72.72 -52.07 16.68 Favored 'General case' 0 C--O 1.245 0.854 0 CA-C-O 121.899 0.857 . . . . 1.0 111.48 179.111 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . 0.584 ' N ' ' O ' ' A' ' 62' ' ' VAL . . . -69.51 27.71 0.36 Allowed Glycine 0 C--O 1.226 -0.374 0 O-C-N 120.74 -1.225 . . . . 1.0 110.66 177.04 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 67' ' ' ARG . . . . . 0.709 ' O ' ' N ' ' A' ' 69' ' ' LEU . 8.0 mtm-85 -75.63 5.58 5.91 Favored 'General case' 0 CA--C 1.507 -0.673 0 N-CA-C 108.011 -1.107 . . . . 1.0 108.011 176.049 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . 0.486 ' H ' ' C ' ' A' ' 66' ' ' GLY . 2.7 mt -31.43 -25.5 0.0 OUTLIER 'General case' 0 N--CA 1.486 1.35 0 N-CA-C 108.311 -0.996 . . . . 1.0 108.311 -177.694 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . 0.709 ' N ' ' O ' ' A' ' 67' ' ' ARG . 48.1 tp -64.85 -65.35 0.69 Allowed 'General case' 0 N--CA 1.472 0.637 0 N-CA-C 108.662 -0.866 . . . . 1.0 108.662 177.655 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . 0.651 ' C ' ' H ' ' A' ' 72' ' ' HIS . . . -80.66 -73.96 0.34 Allowed 'General case' 0 N--CA 1.47 0.55 0 N-CA-C 104.438 -2.43 . . . . 1.0 104.438 176.906 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . 0.489 ' O ' ' C ' ' A' ' 72' ' ' HIS . . . -42.83 0.89 0.0 OUTLIER 'General case' 0 CA--C 1.513 -0.47 0 C-N-CA 124.864 1.265 . . . . 1.0 113.647 179.493 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 72' ' ' HIS . . . . . 0.671 ' CG ' ' N ' ' A' ' 73' ' ' MET . 0.0 OUTLIER -26.65 -63.5 0.08 Allowed 'General case' 0 C--N 1.346 0.434 0 CA-C-N 118.243 0.474 . . . . 1.0 110.421 -179.825 . . . . . . . . 3 3 . 1 . 030 nuclear orig full ' A' A ' 73' ' ' MET . . . . . 0.671 ' N ' ' CG ' ' A' ' 72' ' ' HIS . 12.5 ttm -74.32 -50.86 17.06 Favored 'General case' 0 C--N 1.323 -0.563 0 C-N-CA 119.043 -1.063 . . . . 1.0 109.917 178.668 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . 0.587 ' C ' ' H ' ' A' ' 76' ' ' GLY . 41.2 t -46.09 -45.78 5.77 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.269 0 CA-C-O 117.604 -1.189 . . . . 1.0 112.589 -175.018 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 75' ' ' ASN . . . . . 0.432 ' C ' ' N ' ' A' ' 77' ' ' ILE . 8.2 t-20 -42.54 -15.71 0.01 OUTLIER 'General case' 0 C--N 1.35 0.6 0 CA-C-N 121.227 1.83 . . . . 1.0 111.425 177.336 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . 0.587 ' H ' ' C ' ' A' ' 74' ' ' VAL . . . -46.18 -25.65 1.92 Allowed Glycine 0 CA--C 1.531 1.084 0 N-CA-C 108.984 -1.646 . . . . 1.0 108.984 -179.921 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . 0.526 ' O ' ' N ' ' A' ' 79' ' ' ILE . 0.9 OUTLIER -86.32 -61.96 1.65 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.699 0 CA-C-N 113.886 -1.157 . . . . 1.0 110.615 -178.099 . . . . . . . . 3 3 . 1 . 030 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . 0.427 ' C ' ' O ' ' A' ' 77' ' ' ILE . 12.2 t -37.86 -27.34 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.443 -0.789 0 N-CA-C 109.221 -0.659 . . . . 1.0 109.221 -178.308 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . 0.537 ' O ' ' CB ' ' A' ' 83' ' ' ALA . 0.9 OUTLIER -67.99 -51.87 44.93 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.788 0 C-N-CA 119.827 -0.749 . . . . 1.0 110.857 178.916 . . . . . . . . 3 3 . 1 . 030 nuclear orig full ' A' A ' 80' ' ' ALA . . . . . 0.512 ' N ' ' CG1' ' A' ' 79' ' ' ILE . . . -61.48 -63.14 1.37 Allowed 'General case' 0 C--O 1.231 0.097 0 C-N-CA 119.131 -1.028 . . . . 1.0 110.89 -178.656 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -49.28 -72.64 0.05 OUTLIER 'General case' 0 CA--C 1.536 0.437 0 C-N-CA 119.57 -0.852 . . . . 1.0 109.924 -179.495 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 82' ' ' ASP . . . . . 0.471 ' O ' ' N ' ' A' ' 84' ' ' LEU . 33.4 m-20 -59.6 -63.31 1.35 Allowed 'General case' 0 C--N 1.331 -0.227 0 C-N-CA 118.233 -1.387 . . . . 1.0 109.897 -178.285 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . 0.537 ' CB ' ' O ' ' A' ' 79' ' ' ILE . . . -68.82 57.95 0.09 Allowed 'General case' 0 C--N 1.317 -0.814 0 C-N-CA 119.416 -0.914 . . . . 1.0 110.395 -179.61 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . 0.471 ' N ' ' O ' ' A' ' 82' ' ' ASP . 0.2 OUTLIER -79.68 7.09 9.11 Favored 'General case' 0 C--N 1.351 0.672 0 N-CA-C 108.62 -0.881 . . . . 1.0 108.62 179.033 . . . . . . . . 3 3 . 1 . 030 nuclear orig full ' A' A ' 85' ' ' ILE . . . . . 0.757 ' O ' ' HB ' ' A' ' 89' ' ' VAL . 0.0 OUTLIER -92.06 -7.96 10.42 Favored 'Isoleucine or valine' 0 C--O 1.193 -1.88 0 CA-C-N 114.647 -1.161 . . . . 1.0 108.652 178.648 . . . . . . . . 3 3 . 1 . 030 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -96.76 -12.96 23.01 Favored 'General case' 0 CA--C 1.544 0.747 0 CA-C-O 120.696 0.284 . . . . 1.0 111.709 179.704 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -88.53 -37.13 15.97 Favored 'General case' 0 N--CA 1.481 1.076 0 N-CA-C 113.321 0.86 . . . . 1.0 113.321 -178.493 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -112.88 -8.41 13.71 Favored 'General case' 0 N--CA 1.482 1.129 0 CA-C-O 121.57 0.7 . . . . 1.0 110.971 -178.629 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 89' ' ' VAL . . . . . 0.757 ' HB ' ' O ' ' A' ' 85' ' ' ILE . 14.9 t -99.43 33.34 0.31 Allowed 'Isoleucine or valine' 0 CA--C 1.503 -0.861 0 CA-C-N 115.144 -0.935 . . . . 1.0 109.425 178.095 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 90' ' ' GLY . . . . . 0.607 ' N ' ' HD2' ' A' ' 91' ' ' PRO . . . -67.42 -42.35 89.56 Favored Glycine 0 CA--C 1.537 1.414 0 N-CA-C 110.091 -1.204 . . . . 1.0 110.091 176.531 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 91' ' ' PRO . . . . . 0.607 ' HD2' ' N ' ' A' ' 90' ' ' GLY . 5.8 Cg_exo -42.09 -13.93 0.04 OUTLIER 'Trans proline' 0 N--CA 1.496 1.655 0 C-N-CA 122.152 1.901 . . . . 1.0 111.034 177.753 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 92' ' ' HIS . . . . . 0.666 ' CE1' HH22 ' A' ' 52' ' ' ARG . 47.9 p-80 -57.16 -18.42 15.21 Favored 'General case' 0 C--O 1.202 -1.397 0 N-CA-C 107.94 -1.133 . . . . 1.0 107.94 179.928 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . 0.467 ' HG ' ' H ' ' A' ' 94' ' ' ALA . 1.3 pp -65.67 -57.69 7.48 Favored 'General case' 0 C--N 1.325 -0.495 0 N-CA-C 108.785 -0.82 . . . . 1.0 108.785 179.537 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 94' ' ' ALA . . . . . 0.467 ' H ' ' HG ' ' A' ' 93' ' ' LEU . . . -58.35 -53.95 52.53 Favored 'General case' 0 CA--C 1.515 -0.396 0 N-CA-C 108.78 -0.822 . . . . 1.0 108.78 179.031 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 95' ' ' ARG . . . . . 0.692 ' O ' ' N ' ' A' ' 97' ' ' LEU . 6.8 mtm-85 -58.09 -58.3 9.02 Favored 'General case' 0 N--CA 1.449 -0.486 0 N-CA-C 107.322 -1.362 . . . . 1.0 107.322 178.732 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 96' ' ' ALA . . . . . 0.942 ' O ' ' N ' ' A' ' 98' ' ' GLY . . . -46.14 -11.62 0.02 OUTLIER 'General case' 0 C--N 1.308 -1.224 0 O-C-N 118.49 -2.631 . . . . 1.0 110.807 -179.687 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . 0.718 ' O ' ' N ' ' A' ' 100' ' ' ILE . 4.3 tt 9.22 -54.09 0.0 OUTLIER 'General case' 0 N--CA 1.476 0.873 0 CA-C-O 117.474 -1.25 . . . . 1.0 109.817 -168.19 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 98' ' ' GLY . . . . . 0.942 ' N ' ' O ' ' A' ' 96' ' ' ALA . . . -47.63 -22.46 1.8 Allowed Glycine 0 CA--C 1.547 2.086 0 CA-C-N 122.328 2.331 . . . . 1.0 107.295 174.908 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 99' ' ' GLN . . . . . 0.479 ' N ' ' O ' ' A' ' 96' ' ' ALA . 4.3 tp-100 -65.34 -20.5 66.42 Favored 'General case' 0 C--N 1.378 1.813 0 C-N-CA 117.975 -1.49 . . . . 1.0 108.439 176.922 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 100' ' ' ILE . . . . . 0.718 ' N ' ' O ' ' A' ' 97' ' ' LEU . 18.7 mm -64.13 -47.05 91.81 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.753 0 CA-C-N 114.438 -1.255 . . . . 1.0 108.325 177.489 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 101' ' ' VAL . . . . . 0.709 ' O ' ' N ' ' A' ' 105' ' ' GLY . 57.4 t -60.44 -58.96 4.99 Favored 'Isoleucine or valine' 0 C--O 1.219 -0.526 0 N-CA-C 106.945 -1.502 . . . . 1.0 106.945 179.58 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 102' ' ' CYS . . . . . 0.466 ' O ' ' CB ' ' A' ' 106' ' ' ALA . 0.0 OUTLIER -45.22 -17.92 0.03 OUTLIER 'General case' 0 N--CA 1.444 -0.726 0 CA-C-O 121.423 0.63 . . . . 1.0 110.268 -179.889 . . . . . . . . 3 3 . 1 . 030 nuclear orig full ' A' A ' 103' ' ' ARG . . . . . 0.62 ' NH2' ' CZ ' ' A' ' 104' ' ' TYR . 0.1 OUTLIER -95.48 -44.43 7.53 Favored 'General case' 0 N--CA 1.474 0.759 0 CA-C-O 122.47 1.129 . . . . 1.0 112.359 177.985 . . . . . . . . 3 3 . 1 . 030 nuclear orig full ' A' A ' 104' ' ' TYR . . . . . 0.62 ' CZ ' ' NH2' ' A' ' 103' ' ' ARG . 12.1 m-85 -107.16 21.41 17.57 Favored 'General case' 0 C--N 1.318 -0.761 0 C-N-CA 127.251 2.22 . . . . 1.0 111.861 179.507 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 105' ' ' GLY . . . . . 0.709 ' N ' ' O ' ' A' ' 101' ' ' VAL . . . -170.83 -10.68 0.02 OUTLIER Glycine 0 C--N 1.341 0.806 0 C-N-CA 119.356 -1.402 . . . . 1.0 112.155 179.664 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 106' ' ' ALA . . . . . 0.466 ' CB ' ' O ' ' A' ' 102' ' ' CYS . . . -28.77 75.13 0.0 OUTLIER 'General case' 0 CA--C 1.512 -0.492 0 N-CA-C 113.805 1.039 . . . . 1.0 113.805 -179.472 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 107' ' ' THR . . . . . 0.693 ' N ' ' O ' ' A' ' 105' ' ' GLY . 15.2 t -91.22 5.95 47.08 Favored 'General case' 0 N--CA 1.434 -1.264 0 N-CA-C 106.045 -1.835 . . . . 1.0 106.045 178.177 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . 0.485 ' O ' ' CG2' ' A' ' 108' ' ' VAL . 11.8 p -95.84 17.01 2.02 Favored 'Isoleucine or valine' 0 C--N 1.352 0.687 0 CA-C-O 118.493 -0.765 . . . . 1.0 110.873 177.077 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 109' ' ' ILE . . . . . 0.676 ' N ' ' CD ' ' A' ' 110' ' ' PRO . 40.5 pt -105.77 -14.85 0.15 Allowed Pre-proline 0 N--CA 1.438 -1.073 0 CA-C-N 121.255 1.843 . . . . 1.0 110.457 177.915 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 110' ' ' PRO . . . . . 0.676 ' CD ' ' N ' ' A' ' 109' ' ' ILE . 55.7 Cg_endo -67.36 -48.21 1.8 Allowed 'Trans proline' 0 N--CA 1.493 1.465 0 CA-C-N 121.163 1.451 . . . . 1.0 113.094 -175.728 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 15.6 t-20 -67.47 -66.36 0.57 Allowed 'General case' 0 N--CA 1.453 -0.304 0 C-N-CA 119.756 -0.777 . . . . 1.0 109.874 -179.125 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 112' ' ' ILE . . . . . 0.482 ' O ' ' HB ' ' A' ' 116' ' ' ILE . 2.9 tt -43.56 -40.52 1.37 Allowed 'Isoleucine or valine' 0 CA--C 1.548 0.904 0 N-CA-C 113.093 0.775 . . . . 1.0 113.093 -178.247 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 5.8 m-80 -67.86 -41.12 83.39 Favored 'General case' 0 C--N 1.31 -1.134 0 CA-C-O 122.449 1.119 . . . . 1.0 109.295 178.061 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -59.62 -52.02 67.31 Favored 'General case' 0 C--N 1.296 -1.74 0 CA-C-N 113.386 -1.734 . . . . 1.0 108.95 179.912 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -78.81 -57.04 3.96 Favored 'General case' 0 CA--C 1.537 0.456 0 N-CA-C 114.047 1.128 . . . . 1.0 114.047 179.517 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 116' ' ' ILE . . . . . 0.586 ' O ' ' N ' ' A' ' 120' ' ' GLY . 4.5 mm -52.05 -51.16 31.76 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.209 0 CA-C-O 122.008 0.909 . . . . 1.0 112.445 -176.55 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 117' ' ' GLU . . . . . 0.489 ' C ' ' O ' ' A' ' 116' ' ' ILE . 65.4 mt-10 -45.07 -56.92 4.24 Favored 'General case' 0 C--N 1.313 -0.982 0 N-CA-C 105.516 -2.031 . . . . 1.0 105.516 -176.662 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 96.7 t -58.07 -53.92 39.24 Favored 'Isoleucine or valine' 0 CA--C 1.554 1.129 0 C-N-CA 119.919 -0.712 . . . . 1.0 109.444 177.49 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 4.6 tt -51.92 -68.91 0.13 Allowed 'General case' 0 N--CA 1.48 1.033 0 N-CA-C 106.82 -1.548 . . . . 1.0 106.82 -178.628 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 120' ' ' GLY . . . . . 0.586 ' N ' ' O ' ' A' ' 116' ' ' ILE . . . -73.33 -82.65 0.33 Allowed Glycine 0 CA--C 1.548 2.156 0 C-N-CA 120.897 -0.668 . . . . 1.0 112.34 -179.158 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 121' ' ' THR . . . . . 0.559 ' OG1' ' O ' ' A' ' 120' ' ' GLY . 4.2 m 155.6 -34.31 0.01 OUTLIER 'General case' 0 N--CA 1.482 1.155 0 CA-C-N 112.435 -1.883 . . . . 1.0 112.355 179.397 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 122' ' ' GLY . . . . . 0.684 ' O ' ' N ' ' A' ' 124' ' ' ASP . . . 103.96 -17.76 47.98 Favored Glycine 0 N--CA 1.461 0.313 0 N-CA-C 106.198 -2.761 . . . . 1.0 106.198 -176.589 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 123' ' ' THR . . . . . 0.468 ' O ' ' CG ' ' A' ' 124' ' ' ASP . 9.6 t -55.98 81.31 0.0 OUTLIER 'General case' 0 N--CA 1.468 0.475 0 N-CA-C 105.519 -2.03 . . . . 1.0 105.519 178.758 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 124' ' ' ASP . . . . . 0.684 ' N ' ' O ' ' A' ' 122' ' ' GLY . 40.7 m-20 -166.81 178.85 5.64 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 112.871 -1.968 . . . . 1.0 111.66 179.041 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 125' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -147.34 143.76 28.26 Favored 'General case' 0 CA--C 1.545 0.78 0 N-CA-C 108.154 -1.054 . . . . 1.0 108.154 176.473 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 72.2 mtt-85 -150.92 155.8 39.88 Favored 'General case' 0 N--CA 1.47 0.569 0 CA-C-O 120.801 0.334 . . . . 1.0 111.011 176.535 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 127' ' ' PHE . . . . . 0.473 ' OXT' ' CG ' ' A' ' 127' ' ' PHE . 5.8 p90 . . . . . 0 C--O 1.218 -0.603 0 CA-C-O 118.188 -0.91 . . . . 1.0 110.159 179.276 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 128' ' ' MTN . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 030 nuclear orig full ' A' A ' 129' ' ' MTN . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 030 nuclear orig full ' A' A ' 130' ' ' MTN . . . . . 0.414 ' C6 ' ' SG ' ' A' ' 102' ' ' CYS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 N--CA 1.488 1.468 0 N-CA-C 108.866 -0.79 . . . . 1.0 108.866 . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 85.5 p -106.87 10.47 30.62 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.297 -0.41 . . . . 1.0 110.405 -179.575 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 1.7 t70 166.07 94.37 0.0 OUTLIER 'General case' 0 N--CA 1.465 0.322 0 CA-C-N 115.965 -0.561 . . . . 1.0 110.003 179.646 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 54.7 t80 -149.04 144.77 26.92 Favored 'General case' 0 C--N 1.33 -0.262 0 N-CA-C 110.293 -0.262 . . . . 1.0 110.293 179.369 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 5' ' ' ASP . . . . . 0.516 ' N ' ' OD1' ' A' ' 5' ' ' ASP . 0.6 OUTLIER -154.95 151.48 28.57 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.799 0.333 . . . . 1.0 110.554 -179.285 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 6' ' ' THR . . . . . 0.672 ' O ' ' N ' ' A' ' 10' ' ' SER . 0.2 OUTLIER -67.99 176.18 2.75 Favored 'General case' 0 C--O 1.206 -1.223 0 CA-C-N 116.352 -0.385 . . . . 1.0 110.526 -179.617 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 7' ' ' GLU . . . . . 0.527 ' O ' ' N ' ' A' ' 11' ' ' ARG . 82.2 tt0 -58.49 -58.76 7.12 Favored 'General case' 0 C--N 1.318 -0.769 0 CA-C-O 121.466 0.651 . . . . 1.0 110.254 -177.558 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 8' ' ' ARG . . . . . 0.825 ' O ' ' HB3' ' A' ' 12' ' ' ALA . 26.9 mtp180 -47.86 -55.06 10.64 Favored 'General case' 0 C--O 1.213 -0.82 0 N-CA-C 107.06 -1.459 . . . . 1.0 107.06 -178.874 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 9' ' ' VAL . . . . . 0.585 ' O ' ' CG2' ' A' ' 13' ' ' VAL . 63.1 t -64.89 -49.17 81.15 Favored 'Isoleucine or valine' 0 C--O 1.199 -1.589 0 CA-C-N 114.356 -1.293 . . . . 1.0 110.702 177.971 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 10' ' ' SER . . . . . 0.672 ' N ' ' O ' ' A' ' 6' ' ' THR . 75.2 m -67.82 -65.54 0.68 Allowed 'General case' 0 C--N 1.316 -0.882 0 C-N-CA 119.764 -0.774 . . . . 1.0 112.098 -178.302 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 11' ' ' ARG . . . . . 0.527 ' N ' ' O ' ' A' ' 7' ' ' GLU . 11.2 ttm180 -64.35 -58.48 6.38 Favored 'General case' 0 C--N 1.324 -0.519 0 C-N-CA 119.839 -0.744 . . . . 1.0 111.764 -176.066 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 12' ' ' ALA . . . . . 0.825 ' HB3' ' O ' ' A' ' 8' ' ' ARG . . . -47.9 -48.64 31.42 Favored 'General case' 0 CA--C 1.539 0.547 0 N-CA-C 106.71 -1.589 . . . . 1.0 106.71 -177.907 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 13' ' ' VAL . . . . . 0.659 ' O ' ' N ' ' A' ' 17' ' ' LEU . 97.6 t -62.07 -50.9 78.2 Favored 'Isoleucine or valine' 0 C--O 1.194 -1.846 0 C-N-CA 118.839 -1.145 . . . . 1.0 109.28 177.281 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 14' ' ' ALA . . . . . 0.578 ' O ' HG13 ' A' ' 18' ' ' VAL . . . -56.85 -62.21 1.9 Allowed 'General case' 0 C--O 1.207 -1.151 0 O-C-N 120.871 -1.143 . . . . 1.0 109.572 -179.938 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 15' ' ' ALA . . . . . 0.558 ' O ' ' N ' ' A' ' 19' ' ' GLY . . . -51.36 -54.3 27.78 Favored 'General case' 0 C--N 1.319 -0.754 0 CA-C-O 121.79 0.805 . . . . 1.0 109.248 -178.521 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 16' ' ' ALA . . . . . 0.466 ' CB ' ' O ' ' A' ' 12' ' ' ALA . . . -61.52 -54.63 40.73 Favored 'General case' 0 C--N 1.308 -1.218 0 CA-C-N 114.62 -1.173 . . . . 1.0 108.508 -179.207 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 17' ' ' LEU . . . . . 0.659 ' N ' ' O ' ' A' ' 13' ' ' VAL . 42.4 tp -55.46 -54.29 45.72 Favored 'General case' 0 N--CA 1.478 0.961 0 CA-C-N 113.574 -1.648 . . . . 1.0 109.053 -177.16 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 18' ' ' VAL . . . . . 0.582 HG23 ' N ' ' A' ' 19' ' ' GLY . 3.6 m -68.65 -57.0 10.24 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.235 0 N-CA-C 108.992 -0.744 . . . . 1.0 108.992 178.912 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 19' ' ' GLY . . . . . 0.582 ' N ' HG23 ' A' ' 18' ' ' VAL . . . -63.04 -170.72 1.37 Allowed Glycine 0 CA--C 1.525 0.66 0 N-CA-C 110.829 -0.908 . . . . 1.0 110.829 -179.992 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 20' ' ' PRO . . . . . 0.648 ' O ' ' N ' ' A' ' 24' ' ' ALA . 93.0 Cg_endo -79.25 -27.02 4.65 Favored 'Trans proline' 0 C--N 1.308 -1.591 0 C-N-CA 122.797 2.331 . . . . 1.0 114.129 -178.33 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -57.16 -56.21 26.23 Favored Glycine 0 N--CA 1.477 1.375 0 C-N-CA 119.822 -1.18 . . . . 1.0 111.064 -177.624 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 22' ' ' GLY . . . . . 0.465 ' H ' ' C ' ' A' ' 16' ' ' ALA . . . -60.38 -55.83 27.85 Favored Glycine 0 N--CA 1.468 0.803 0 N-CA-C 108.587 -1.805 . . . . 1.0 108.587 -178.39 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -59.77 -35.15 58.41 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.204 0 CA-C-N 114.561 -0.82 . . . . 1.0 109.417 -179.94 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 24' ' ' ALA . . . . . 0.648 ' N ' ' O ' ' A' ' 20' ' ' PRO . . . -57.89 -61.92 2.19 Favored 'General case' 0 N--CA 1.452 -0.36 0 C-N-CA 118.99 -1.084 . . . . 1.0 109.739 -178.704 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 16.2 tp -65.38 -42.11 93.04 Favored 'General case' 0 N--CA 1.451 -0.411 0 C-N-CA 119.853 -0.739 . . . . 1.0 111.904 -178.326 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 89.6 t -61.57 -60.39 2.78 Favored 'Isoleucine or valine' 0 CA--C 1.522 -0.104 0 C-N-CA 118.834 -1.147 . . . . 1.0 110.307 -177.931 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 27' ' ' VAL . . . . . 0.558 ' O ' ' HB3' ' A' ' 31' ' ' ALA . 93.4 t -62.57 -38.26 81.03 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 N-CA-C 112.814 0.672 . . . . 1.0 112.814 -178.316 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 3.3 ttmp? -64.34 -55.02 24.05 Favored 'General case' 0 C--N 1.314 -0.95 0 CA-C-O 121.929 0.871 . . . . 1.0 108.775 -178.213 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 55.6 t -64.58 -45.15 96.35 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.008 0 CA-C-N 113.632 -1.622 . . . . 1.0 109.801 -178.533 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 30' ' ' CYS . . . . . . . . . . . . . 43.1 t -65.85 -61.16 2.22 Favored 'General case' 0 N--CA 1.445 -0.715 0 C-N-CA 118.666 -1.213 . . . . 1.0 108.743 179.729 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 31' ' ' ALA . . . . . 0.558 ' HB3' ' O ' ' A' ' 27' ' ' VAL . . . -63.73 -57.09 11.06 Favored 'General case' 0 CA--C 1.512 -0.514 0 N-CA-C 113.486 0.921 . . . . 1.0 113.486 -176.358 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 32' ' ' GLY . . . . . 0.475 ' O ' ' CB ' ' A' ' 33' ' ' LEU . . . 89.92 74.02 1.28 Allowed Glycine 0 CA--C 1.526 0.737 0 N-CA-C 110.862 -0.895 . . . . 1.0 110.862 -178.92 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 33' ' ' LEU . . . . . 0.475 ' CB ' ' O ' ' A' ' 32' ' ' GLY . 4.7 tp 87.43 84.08 0.04 OUTLIER Pre-proline 0 CA--C 1.544 0.746 0 CA-C-O 120.999 0.428 . . . . 1.0 111.204 179.578 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 52.1 Cg_exo -55.48 -33.3 85.69 Favored 'Trans proline' 0 N--CA 1.503 2.037 0 C-N-CA 123.798 2.998 . . . . 1.0 115.298 -179.528 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -55.39 -58.65 12.88 Favored Glycine 0 N--CA 1.469 0.871 0 C-N-CA 118.462 -1.827 . . . . 1.0 108.616 -178.804 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 36' ' ' VAL . . . . . 0.639 ' O ' HG22 ' A' ' 37' ' ' ILE . 23.2 m -86.77 160.05 3.06 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.649 0 N-CA-C 107.081 -1.451 . . . . 1.0 107.081 177.616 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 37' ' ' ILE . . . . . 0.7 HG23 ' O ' ' A' ' 37' ' ' ILE . 14.3 tt 126.97 115.35 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.477 0.886 0 O-C-N 124.195 0.934 . . . . 1.0 110.503 -179.741 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -141.04 133.14 27.88 Favored 'General case' 0 C--N 1.325 -0.494 0 N-CA-C 108.154 -1.054 . . . . 1.0 108.154 177.518 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 38.8 p -115.03 143.55 30.38 Favored Pre-proline 0 C--N 1.33 -0.265 0 N-CA-C 108.771 -0.826 . . . . 1.0 108.771 179.501 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 40' ' ' PRO . . . . . 0.458 ' HG2' ' H ' ' A' ' 41' ' ' ALA . 57.1 Cg_endo -72.22 -82.73 0.01 OUTLIER 'Trans proline' 0 C--N 1.306 -1.699 0 C-N-CA 121.708 1.605 . . . . 1.0 112.551 -179.363 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 41' ' ' ALA . . . . . 0.458 ' H ' ' HG2' ' A' ' 40' ' ' PRO . . . -78.34 124.11 27.74 Favored 'General case' 0 C--N 1.311 -1.074 0 CA-C-N 114.436 -1.256 . . . . 1.0 111.686 -176.7 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 42' ' ' ARG . . . . . 0.699 ' C ' ' H ' ' A' ' 44' ' ' GLY . 13.6 ptt180 -170.9 169.71 6.66 Favored 'General case' 0 C--N 1.313 -0.981 0 CA-C-N 114.634 -1.167 . . . . 1.0 109.696 178.786 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 7.2 tpt180 -61.65 18.04 0.01 OUTLIER 'General case' 0 C--N 1.322 -0.608 0 C-N-CA 120.568 -0.453 . . . . 1.0 109.957 178.321 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 44' ' ' GLY . . . . . 0.699 ' H ' ' C ' ' A' ' 42' ' ' ARG . . . 82.98 -24.83 5.04 Favored Glycine 0 N--CA 1.446 -0.634 0 N-CA-C 110.506 -1.038 . . . . 1.0 110.506 -179.658 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 45' ' ' PHE . . . . . 0.759 ' O ' ' CG ' ' A' ' 46' ' ' PHE . 0.2 OUTLIER -164.5 172.82 12.81 Favored 'General case' 0 C--O 1.221 -0.403 0 C-N-CA 121.101 -0.24 . . . . 1.0 110.656 -179.553 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 46' ' ' PHE . . . . . 0.759 ' CG ' ' O ' ' A' ' 45' ' ' PHE . 22.0 m-30 127.1 90.41 0.0 OUTLIER 'General case' 0 N--CA 1.484 1.256 0 O-C-N 125.534 1.771 . . . . 1.0 111.688 179.391 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 47' ' ' ARG . . . . . 0.721 ' O ' ' SG ' ' A' ' 48' ' ' CYS . 2.2 ptm180 121.09 156.49 0.0 OUTLIER 'General case' 0 N--CA 1.477 0.895 0 O-C-N 125.449 1.718 . . . . 1.0 109.187 179.355 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 48' ' ' CYS . . . . . 0.721 ' SG ' ' O ' ' A' ' 47' ' ' ARG . 2.0 p 67.74 68.85 0.36 Allowed 'General case' 0 CA--C 1.532 0.284 0 CA-C-O 121.897 0.856 . . . . 1.0 109.523 -179.156 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -142.91 151.84 57.31 Favored Pre-proline 0 CA--C 1.534 0.361 0 N-CA-C 108.297 -1.001 . . . . 1.0 108.297 179.864 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 89.3 Cg_endo -77.31 69.9 6.98 Favored 'Trans proline' 0 C--N 1.308 -1.58 0 C-N-CA 122.015 1.81 . . . . 1.0 112.608 -179.728 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 5.4 tp10 64.68 26.93 13.19 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 120.697 0.284 . . . . 1.0 111.462 179.198 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -102.28 138.92 38.57 Favored 'General case' 0 N--CA 1.466 0.373 0 CA-C-N 116.474 -0.33 . . . . 1.0 110.262 179.066 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 53' ' ' ILE . . . . . 0.445 ' O ' ' N ' ' A' ' 55' ' ' ILE . 19.6 tt -66.61 139.64 20.8 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.251 0 CA-C-O 121.423 0.63 . . . . 1.0 110.718 179.553 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 4.2 pt20 -63.41 80.41 0.02 OUTLIER 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 114.781 -1.1 . . . . 1.0 109.586 -178.458 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 55' ' ' ILE . . . . . 0.445 ' N ' ' O ' ' A' ' 53' ' ' ILE . 1.8 tt -148.03 156.89 8.9 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.415 0 N-CA-C 109.902 -0.407 . . . . 1.0 109.902 178.242 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 113.57 -4.67 24.69 Favored Glycine 0 N--CA 1.467 0.705 0 N-CA-C 110.606 -0.998 . . . . 1.0 110.606 -179.765 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 14.8 p-10 -79.36 96.48 6.01 Favored 'General case' 0 C--N 1.325 -0.464 0 N-CA-C 109.318 -0.623 . . . . 1.0 109.318 177.625 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 58' ' ' TRP . . . . . 0.519 ' CE3' ' NH1' ' A' ' 59' ' ' ARG . 0.8 OUTLIER -86.54 176.36 7.86 Favored 'General case' 0 N--CA 1.467 0.421 0 CA-C-O 122.229 1.014 . . . . 1.0 112.647 -178.37 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 59' ' ' ARG . . . . . 0.519 ' NH1' ' CE3' ' A' ' 58' ' ' TRP . 0.0 OUTLIER -87.29 -56.28 3.43 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 113.326 -1.761 . . . . 1.0 112.388 -179.394 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 73.6 t80 -93.81 -16.86 23.7 Favored 'General case' 0 C--O 1.249 1.044 0 CA-C-O 121.813 0.816 . . . . 1.0 113.153 -179.112 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 61' ' ' GLU . . . . . 0.459 ' O ' ' N ' ' A' ' 65' ' ' ASP . 6.5 tt0 -78.79 -13.23 59.92 Favored 'General case' 0 N--CA 1.444 -0.766 0 O-C-N 121.418 -0.801 . . . . 1.0 111.516 -178.24 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 62' ' ' VAL . . . . . 0.596 ' O ' ' N ' ' A' ' 66' ' ' GLY . 0.0 OUTLIER -47.8 -55.63 2.38 Favored 'Isoleucine or valine' 0 C--O 1.208 -1.11 0 C-N-CA 119.244 -0.983 . . . . 1.0 109.589 -175.559 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -65.01 -52.42 56.19 Favored 'General case' 0 C--N 1.31 -1.136 0 C-N-CA 119.335 -0.946 . . . . 1.0 109.192 -179.984 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 64' ' ' HIS . . . . . 0.504 ' O ' ' HB2' ' A' ' 67' ' ' ARG . 6.0 t-80 -50.78 -57.78 7.54 Favored 'General case' 0 CA--C 1.536 0.43 0 C-N-CA 119.463 -0.895 . . . . 1.0 109.894 -179.534 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 65' ' ' ASP . . . . . 0.557 ' C ' ' H ' ' A' ' 67' ' ' ARG . 3.3 t0 -70.1 -47.05 63.46 Favored 'General case' 0 C--N 1.314 -0.963 0 CA-C-O 122.065 0.935 . . . . 1.0 110.303 179.188 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 66' ' ' GLY . . . . . 0.596 ' N ' ' O ' ' A' ' 62' ' ' VAL . . . -70.13 28.25 0.43 Allowed Glycine 0 C--N 1.316 -0.572 0 O-C-N 121.47 -0.769 . . . . 1.0 111.642 179.725 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 67' ' ' ARG . . . . . 0.557 ' H ' ' C ' ' A' ' 65' ' ' ASP . 0.0 OUTLIER -81.25 -3.01 51.08 Favored 'General case' 0 C--N 1.319 -0.755 0 N-CA-C 107.964 -1.124 . . . . 1.0 107.964 176.559 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 68' ' ' LEU . . . . . 0.417 ' O ' ' HB3' ' A' ' 72' ' ' HIS . 8.7 tp -42.25 -31.67 0.42 Allowed 'General case' 0 C--O 1.216 -0.679 0 CA-C-N 115.567 -0.742 . . . . 1.0 109.495 -179.904 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 3.8 tt -67.83 -68.66 0.37 Allowed 'General case' 0 CA--C 1.54 0.581 0 C-N-CA 118.434 -1.306 . . . . 1.0 112.877 -177.347 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 70' ' ' ALA . . . . . 0.572 ' C ' ' H ' ' A' ' 72' ' ' HIS . . . -74.58 -84.36 0.05 OUTLIER 'General case' 0 N--CA 1.47 0.563 0 C-N-CA 116.757 -1.977 . . . . 1.0 109.03 -176.426 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 71' ' ' ALA . . . . . 0.884 ' O ' ' N ' ' A' ' 73' ' ' MET . . . -56.37 16.28 0.0 OUTLIER 'General case' 0 C--N 1.308 -1.233 0 C-N-CA 124.993 1.317 . . . . 1.0 113.588 -179.738 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 72' ' ' HIS . . . . . 0.572 ' H ' ' C ' ' A' ' 70' ' ' ALA . 0.0 OUTLIER -17.92 -29.32 0.0 OUTLIER 'General case' 0 N--CA 1.473 0.676 0 N-CA-C 112.758 0.651 . . . . 1.0 112.758 -175.048 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 73' ' ' MET . . . . . 0.884 ' N ' ' O ' ' A' ' 71' ' ' ALA . 19.0 mmt -64.81 -56.59 12.59 Favored 'General case' 0 N--CA 1.446 -0.646 0 C-N-CA 119.667 -0.813 . . . . 1.0 108.84 176.4 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 74' ' ' VAL . . . . . 0.665 ' O ' ' N ' ' A' ' 76' ' ' GLY . 34.8 m -43.96 -50.97 1.62 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.821 0 CA-C-O 117.814 -1.089 . . . . 1.0 111.565 -174.815 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 75' ' ' ASN . . . . . 0.519 ' N ' HG23 ' A' ' 74' ' ' VAL . 6.3 t30 -36.42 -18.24 0.0 OUTLIER 'General case' 0 N--CA 1.47 0.533 0 CA-C-N 121.042 1.746 . . . . 1.0 112.299 -179.831 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 76' ' ' GLY . . . . . 0.665 ' N ' ' O ' ' A' ' 74' ' ' VAL . . . -47.72 -28.19 5.1 Favored Glycine 0 CA--C 1.537 1.437 0 N-CA-C 109.16 -1.576 . . . . 1.0 109.16 177.681 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 77' ' ' ILE . . . . . 0.612 ' HA ' ' HB3' ' A' ' 80' ' ' ALA . 6.9 pt -69.29 -51.77 39.7 Favored 'Isoleucine or valine' 0 C--O 1.21 -1.009 0 CA-C-O 122.114 0.959 . . . . 1.0 108.828 -179.967 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 78' ' ' VAL . . . . . 0.484 ' C ' ' O ' ' A' ' 77' ' ' ILE . 77.0 t -36.25 -33.12 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.313 -0.979 0 CA-C-N 113.003 -1.908 . . . . 1.0 107.292 -176.701 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 79' ' ' ILE . . . . . 0.624 ' O ' ' HB3' ' A' ' 83' ' ' ALA . 0.7 OUTLIER -96.77 -31.68 4.02 Favored 'Isoleucine or valine' 0 C--O 1.213 -0.842 0 CA-C-N 115.606 -0.724 . . . . 1.0 110.938 176.653 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 80' ' ' ALA . . . . . 0.612 ' HB3' ' HA ' ' A' ' 77' ' ' ILE . . . -82.45 -8.78 59.61 Favored 'General case' 0 N--CA 1.473 0.68 0 N-CA-C 112.521 0.563 . . . . 1.0 112.521 179.367 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 81' ' ' GLU . . . . . 0.806 ' O ' HD21 ' A' ' 84' ' ' LEU . 7.6 mm-40 -91.15 -72.69 0.57 Allowed 'General case' 0 N--CA 1.439 -0.982 0 O-C-N 122.036 -0.415 . . . . 1.0 112.018 -178.258 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 8.3 t70 -92.68 -14.4 28.12 Favored 'General case' 0 C--N 1.346 0.423 0 N-CA-C 115.024 1.49 . . . . 1.0 115.024 -178.89 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 83' ' ' ALA . . . . . 0.624 ' HB3' ' O ' ' A' ' 79' ' ' ILE . . . -54.26 -44.8 72.14 Favored 'General case' 0 CA--C 1.54 0.595 0 C-N-CA 118.464 -1.294 . . . . 1.0 112.894 -177.505 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 84' ' ' LEU . . . . . 1.019 ' H ' HD13 ' A' ' 84' ' ' LEU . 0.0 OUTLIER -42.75 -14.74 0.01 OUTLIER 'General case' 0 N--CA 1.474 0.752 0 CA-C-N 119.018 0.826 . . . . 1.0 111.079 -177.682 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 85' ' ' ILE . . . . . 0.583 ' N ' ' O ' ' A' ' 83' ' ' ALA . 3.5 mm -94.04 -29.81 4.27 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.25 0 C-N-CA 120.674 -0.41 . . . . 1.0 110.223 179.056 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 86' ' ' ALA . . . . . 0.672 ' C ' ' H ' ' A' ' 88' ' ' ALA . . . -93.02 -24.24 18.4 Favored 'General case' 0 CA--C 1.522 -0.125 0 CA-C-O 121.513 0.673 . . . . 1.0 109.732 179.26 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 20.3 tt0 -63.82 25.85 0.01 OUTLIER 'General case' 0 C--N 1.32 -0.714 0 CA-C-O 121.491 0.662 . . . . 1.0 110.474 -179.036 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 88' ' ' ALA . . . . . 0.672 ' H ' ' C ' ' A' ' 86' ' ' ALA . . . -123.31 -7.31 8.19 Favored 'General case' 0 N--CA 1.474 0.766 0 CA-C-O 122.207 1.004 . . . . 1.0 108.519 178.836 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 89' ' ' VAL . . . . . 0.498 HG23 ' O ' ' A' ' 86' ' ' ALA . 2.4 t -84.31 36.9 0.05 OUTLIER 'Isoleucine or valine' 0 C--O 1.216 -0.659 0 CA-C-N 112.77 -2.014 . . . . 1.0 109.172 178.383 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 90' ' ' GLY . . . . . 0.513 ' N ' ' CD ' ' A' ' 91' ' ' PRO . . . -74.26 -40.52 40.98 Favored Glycine 0 C--N 1.345 1.052 0 C-N-CA 120.504 -0.855 . . . . 1.0 111.382 179.57 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 91' ' ' PRO . . . . . 0.513 ' CD ' ' N ' ' A' ' 90' ' ' GLY . 98.3 Cg_exo -43.51 -21.64 0.31 Allowed 'Trans proline' 0 N--CA 1.497 1.698 0 CA-C-N 119.572 1.686 . . . . 1.0 109.788 -179.701 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 92' ' ' HIS . . . . . 0.799 ' O ' ' N ' ' A' ' 96' ' ' ALA . 0.3 OUTLIER -55.34 -18.4 6.49 Favored 'General case' 0 C--O 1.194 -1.832 0 N-CA-C 107.167 -1.42 . . . . 1.0 107.167 179.897 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 93' ' ' LEU . . . . . 0.656 HD12 ' N ' ' A' ' 94' ' ' ALA . 2.8 pp -51.01 -53.66 31.45 Favored 'General case' 0 CA--C 1.541 0.612 0 N-CA-C 108.669 -0.863 . . . . 1.0 108.669 178.556 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 94' ' ' ALA . . . . . 0.656 ' N ' HD12 ' A' ' 93' ' ' LEU . . . -52.23 -44.87 65.06 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-N 114.521 -1.218 . . . . 1.0 108.972 -179.279 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 95' ' ' ARG . . . . . 0.579 ' C ' ' H ' ' A' ' 97' ' ' LEU . 0.0 OUTLIER -78.18 -49.87 13.01 Favored 'General case' 0 CA--C 1.553 1.077 0 CA-C-O 125.921 2.772 . . . . 1.0 109.142 178.619 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 96' ' ' ALA . . . . . 0.799 ' N ' ' O ' ' A' ' 92' ' ' HIS . . . -68.49 28.0 0.03 OUTLIER 'General case' 0 C--N 1.259 -3.335 0 CA-C-N 112.901 -1.954 . . . . 1.0 107.264 173.028 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 97' ' ' LEU . . . . . 1.034 HD13 ' H ' ' A' ' 98' ' ' GLY . 0.0 OUTLIER -43.71 -46.34 7.45 Favored 'General case' 0 C--O 1.202 -1.444 0 N-CA-C 108.861 -0.792 . . . . 1.0 108.861 178.64 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 98' ' ' GLY . . . . . 1.034 ' H ' HD13 ' A' ' 97' ' ' LEU . . . -49.22 -28.2 8.32 Favored Glycine 0 CA--C 1.5 -0.891 0 N-CA-C 107.867 -2.093 . . . . 1.0 107.867 -179.862 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 99' ' ' GLN . . . . . 0.62 ' N ' ' O ' ' A' ' 96' ' ' ALA . 0.0 OUTLIER -59.41 -22.19 61.05 Favored 'General case' 0 C--O 1.216 -0.7 0 N-CA-C 106.693 -1.595 . . . . 1.0 106.693 176.811 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 100' ' ' ILE . . . . . 0.744 ' N ' ' O ' ' A' ' 97' ' ' LEU . 6.1 mm -67.68 -51.55 49.73 Favored 'Isoleucine or valine' 0 C--O 1.207 -1.155 0 CA-C-N 115.387 -0.824 . . . . 1.0 110.045 178.704 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 101' ' ' VAL . . . . . 0.698 ' O ' ' N ' ' A' ' 105' ' ' GLY . 0.4 OUTLIER -52.87 -61.06 0.89 Allowed 'Isoleucine or valine' 0 C--O 1.213 -0.835 0 C-N-CA 119.085 -1.046 . . . . 1.0 110.412 -178.296 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 102' ' ' CYS . . . . . 0.878 ' O ' ' HB2' ' A' ' 106' ' ' ALA . 1.4 p -56.06 -21.77 23.74 Favored 'General case' 0 C--N 1.316 -0.881 0 C-N-CA 118.942 -1.103 . . . . 1.0 110.062 -176.98 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -84.51 -53.89 5.12 Favored 'General case' 0 N--CA 1.481 1.082 0 O-C-N 124.339 1.025 . . . . 1.0 112.399 178.888 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 104' ' ' TYR . . . . . . . . . . . . . 17.9 t80 -96.37 21.18 9.41 Favored 'General case' 0 C--N 1.309 -1.19 0 C-N-CA 126.44 1.896 . . . . 1.0 108.753 178.636 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 105' ' ' GLY . . . . . 0.698 ' N ' ' O ' ' A' ' 101' ' ' VAL . . . -153.62 -96.49 0.13 Allowed Glycine 0 C--N 1.335 0.492 0 N-CA-C 107.893 -2.083 . . . . 1.0 107.893 178.926 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 106' ' ' ALA . . . . . 0.878 ' HB2' ' O ' ' A' ' 102' ' ' CYS . . . 67.2 109.37 0.04 OUTLIER 'General case' 0 CA--C 1.541 0.622 0 O-C-N 122.988 -0.125 . . . . 1.0 111.297 -178.976 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 107' ' ' THR . . . . . 0.65 ' C ' ' H ' ' A' ' 109' ' ' ILE . 0.3 OUTLIER -134.66 -63.69 0.7 Allowed 'General case' 0 C--N 1.353 0.731 0 N-CA-C 105.932 -1.877 . . . . 1.0 105.932 176.926 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 26.9 m -67.16 23.61 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.324 -0.519 0 O-C-N 121.657 -0.652 . . . . 1.0 109.453 179.686 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 109' ' ' ILE . . . . . 0.713 ' H ' ' HD2' ' A' ' 110' ' ' PRO . 0.1 OUTLIER -115.5 -57.09 0.04 OUTLIER Pre-proline 0 CA--C 1.552 1.032 0 N-CA-C 108.278 -1.008 . . . . 1.0 108.278 175.79 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 110' ' ' PRO . . . . . 0.713 ' HD2' ' H ' ' A' ' 109' ' ' ILE . 18.6 Cg_endo -53.82 -39.46 84.05 Favored 'Trans proline' 0 N--CA 1.506 2.237 0 C-N-CA 122.673 2.249 . . . . 1.0 112.046 177.584 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 111' ' ' ASN . . . . . 0.447 ' C ' ' N ' ' A' ' 113' ' ' ASN . 39.3 t30 -67.68 -67.62 0.45 Allowed 'General case' 0 C--O 1.238 0.45 0 C-N-CA 119.91 -0.716 . . . . 1.0 110.463 -178.342 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 112' ' ' ILE . . . . . 0.647 ' C ' HD12 ' A' ' 112' ' ' ILE . 1.4 pp -52.88 -21.45 3.11 Favored 'Isoleucine or valine' 0 C--O 1.212 -0.87 0 CA-C-O 121.998 0.904 . . . . 1.0 108.647 -179.924 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 113' ' ' ASN . . . . . 0.447 ' N ' ' C ' ' A' ' 111' ' ' ASN . 0.1 OUTLIER -60.58 -52.82 63.52 Favored 'General case' 0 C--N 1.311 -1.093 0 CA-C-N 112.698 -2.046 . . . . 1.0 108.813 -179.894 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -58.18 -28.83 65.13 Favored 'General case' 0 N--CA 1.455 -0.194 0 CA-C-N 119.01 0.823 . . . . 1.0 111.48 179.226 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 115' ' ' ALA . . . . . 0.555 ' O ' ' N ' ' A' ' 118' ' ' VAL . . . -81.1 -52.06 7.8 Favored 'General case' 0 C--O 1.219 -0.53 0 N-CA-C 109.108 -0.701 . . . . 1.0 109.108 177.552 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 116' ' ' ILE . . . . . 0.454 HD13 HD13 ' A' ' 112' ' ' ILE . 1.2 tp -42.13 -49.7 0.96 Allowed 'Isoleucine or valine' 0 N--CA 1.478 0.943 0 N-CA-C 105.611 -1.996 . . . . 1.0 105.611 179.766 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 117' ' ' GLU . . . . . 0.471 ' O ' ' HA ' ' A' ' 121' ' ' THR . 62.7 mt-10 -45.1 -57.53 3.82 Favored 'General case' 0 C--N 1.312 -1.036 0 CA-C-N 110.493 -3.049 . . . . 1.0 105.857 178.341 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 118' ' ' VAL . . . . . 0.555 ' N ' ' O ' ' A' ' 115' ' ' ALA . 54.9 t -68.15 -57.13 10.22 Favored 'Isoleucine or valine' 0 CA--C 1.551 1.004 0 C-N-CA 120.684 -0.406 . . . . 1.0 111.046 178.042 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 119' ' ' LEU . . . . . 0.506 ' N ' ' O ' ' A' ' 115' ' ' ALA . 59.2 tp -52.77 -19.85 2.77 Favored 'General case' 0 CA--C 1.538 0.492 0 N-CA-C 113.78 1.03 . . . . 1.0 113.78 -178.666 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 120' ' ' GLY . . . . . 0.607 ' O ' ' OG1' ' A' ' 121' ' ' THR . . . -127.3 -73.81 0.19 Allowed Glycine 0 CA--C 1.547 2.076 0 N-CA-C 106.535 -2.626 . . . . 1.0 106.535 172.719 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 121' ' ' THR . . . . . 0.607 ' OG1' ' O ' ' A' ' 120' ' ' GLY . 17.6 m 161.9 -44.62 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.772 0 CA-C-N 112.686 -1.757 . . . . 1.0 112.796 179.444 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 122' ' ' GLY . . . . . 0.68 ' O ' ' N ' ' A' ' 124' ' ' ASP . . . 104.76 -15.22 49.07 Favored Glycine 0 N--CA 1.471 0.985 0 N-CA-C 108.282 -1.927 . . . . 1.0 108.282 -175.98 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 123' ' ' THR . . . . . 0.689 HG23 ' O ' ' A' ' 123' ' ' THR . 8.4 t -56.95 81.11 0.01 OUTLIER 'General case' 0 N--CA 1.469 0.511 0 N-CA-C 104.615 -2.365 . . . . 1.0 104.615 178.438 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 124' ' ' ASP . . . . . 0.68 ' N ' ' O ' ' A' ' 122' ' ' GLY . 28.6 m-20 -166.93 178.37 5.83 Favored 'General case' 0 N--CA 1.465 0.307 0 CA-C-N 113.464 -1.698 . . . . 1.0 111.552 179.815 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 125' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -142.06 143.07 32.93 Favored 'General case' 0 CA--C 1.54 0.564 0 N-CA-C 108.086 -1.079 . . . . 1.0 108.086 175.766 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 3.0 tpm_? -147.43 146.02 29.42 Favored 'General case' 0 C--N 1.332 -0.185 0 N-CA-C 110.049 -0.352 . . . . 1.0 110.049 179.43 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 127' ' ' PHE . . . . . . . . . . . . . 1.5 t80 . . . . . 0 C--O 1.221 -0.411 0 CA-C-O 117.94 -1.028 . . . . 1.0 109.528 179.498 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 11.8 mtt . . . . . 0 N--CA 1.49 1.55 0 N-CA-C 108.918 -0.771 . . . . 1.0 108.918 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 93.1 p -90.12 3.64 52.76 Favored 'General case' 0 N--CA 1.464 0.238 0 CA-C-N 116.564 -0.289 . . . . 1.0 110.933 -179.555 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 2.1 t70 163.14 114.96 0.0 OUTLIER 'General case' 0 N--CA 1.465 0.296 0 O-C-N 123.675 0.609 . . . . 1.0 110.04 179.162 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 92.8 t80 -147.57 143.99 28.16 Favored 'General case' 0 CA--C 1.513 -0.446 0 N-CA-C 109.133 -0.691 . . . . 1.0 109.133 178.861 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 5' ' ' ASP . . . . . 0.44 ' HB2' ' N ' ' A' ' 10' ' ' SER . 1.0 OUTLIER -153.32 148.64 27.01 Favored 'General case' 0 C--N 1.326 -0.444 0 C-N-CA 120.557 -0.457 . . . . 1.0 110.512 -179.39 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 6' ' ' THR . . . . . 0.696 ' O ' ' N ' ' A' ' 10' ' ' SER . 0.2 OUTLIER -116.72 -152.7 0.51 Allowed 'General case' 0 C--O 1.209 -1.031 0 CA-C-O 121.425 0.631 . . . . 1.0 110.313 179.896 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 7' ' ' GLU . . . . . 0.579 ' OE1' ' N ' ' A' ' 8' ' ' ARG . 0.0 OUTLIER -59.34 -49.64 77.05 Favored 'General case' 0 C--N 1.309 -1.196 0 CA-C-O 121.872 0.844 . . . . 1.0 110.603 -177.895 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 8' ' ' ARG . . . . . 0.855 ' O ' ' HB3' ' A' ' 12' ' ' ALA . 5.0 ptt180 -67.35 -57.79 5.98 Favored 'General case' 0 C--N 1.302 -1.487 0 C-N-CA 118.725 -1.19 . . . . 1.0 108.759 178.43 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 9' ' ' VAL . . . . . 0.55 ' O ' HG12 ' A' ' 13' ' ' VAL . 6.7 t -66.08 -53.45 37.27 Favored 'Isoleucine or valine' 0 C--O 1.197 -1.665 0 C-N-CA 119.219 -0.992 . . . . 1.0 111.427 -178.322 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 10' ' ' SER . . . . . 0.696 ' N ' ' O ' ' A' ' 6' ' ' THR . 1.4 t -69.23 -62.46 1.37 Allowed 'General case' 0 C--N 1.309 -1.188 0 C-N-CA 119.363 -0.935 . . . . 1.0 111.974 -178.972 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 11' ' ' ARG . . . . . 0.597 ' O ' ' HB3' ' A' ' 15' ' ' ALA . 1.7 mmt180 -65.3 -45.55 83.96 Favored 'General case' 0 N--CA 1.474 0.74 0 N-CA-C 112.53 0.567 . . . . 1.0 112.53 -176.229 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 12' ' ' ALA . . . . . 0.855 ' HB3' ' O ' ' A' ' 8' ' ' ARG . . . -68.57 -55.59 11.12 Favored 'General case' 0 C--N 1.326 -0.45 0 C-N-CA 118.068 -1.453 . . . . 1.0 108.412 178.463 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 13' ' ' VAL . . . . . 0.642 ' O ' ' CB ' ' A' ' 17' ' ' LEU . 0.4 OUTLIER -62.44 -52.59 58.14 Favored 'Isoleucine or valine' 0 C--O 1.201 -1.471 0 C-N-CA 118.225 -1.39 . . . . 1.0 109.145 -179.264 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 14' ' ' ALA . . . . . 0.734 ' O ' HG22 ' A' ' 18' ' ' VAL . . . -61.05 -61.35 2.64 Favored 'General case' 0 C--N 1.314 -0.978 0 C-N-CA 117.177 -1.809 . . . . 1.0 110.429 179.929 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 15' ' ' ALA . . . . . 0.597 ' HB3' ' O ' ' A' ' 11' ' ' ARG . . . -54.17 -56.12 21.25 Favored 'General case' 0 N--CA 1.475 0.815 0 C-N-CA 119.268 -0.973 . . . . 1.0 110.141 -178.058 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 16' ' ' ALA . . . . . 0.623 ' HB3' ' O ' ' A' ' 12' ' ' ALA . . . -65.43 -55.71 16.49 Favored 'General case' 0 C--N 1.315 -0.909 0 C-N-CA 118.793 -1.163 . . . . 1.0 110.364 -179.271 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 17' ' ' LEU . . . . . 0.642 ' CB ' ' O ' ' A' ' 13' ' ' VAL . 10.8 tp -57.16 -56.14 25.58 Favored 'General case' 0 N--CA 1.485 1.293 0 C-N-CA 119.341 -0.944 . . . . 1.0 108.665 -178.184 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 18' ' ' VAL . . . . . 0.734 HG22 ' O ' ' A' ' 14' ' ' ALA . 1.3 m -71.68 -57.75 6.7 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.571 0 C-N-CA 119.519 -0.872 . . . . 1.0 110.557 -179.711 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 19' ' ' GLY . . . . . 0.53 ' N ' ' O ' ' A' ' 15' ' ' ALA . . . -62.9 -163.33 0.38 Allowed Glycine 0 CA--C 1.522 0.503 0 N-CA-C 111.748 -0.541 . . . . 1.0 111.748 -178.041 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 20' ' ' PRO . . . . . 0.601 ' O ' ' N ' ' A' ' 24' ' ' ALA . 69.3 Cg_endo -80.51 -21.91 7.09 Favored 'Trans proline' 0 C--N 1.304 -1.797 0 C-N-CA 122.419 2.079 . . . . 1.0 114.472 -178.044 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -60.66 -61.04 7.48 Favored Glycine 0 N--CA 1.476 1.326 0 C-N-CA 118.945 -1.598 . . . . 1.0 111.489 -177.165 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 22' ' ' GLY . . . . . 0.607 ' H ' ' CA ' ' A' ' 16' ' ' ALA . . . -59.63 -54.65 35.9 Favored Glycine 0 N--CA 1.466 0.66 0 N-CA-C 107.903 -2.079 . . . . 1.0 107.903 179.674 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 23' ' ' VAL . . . . . 0.605 ' O ' HG12 ' A' ' 27' ' ' VAL . 85.0 t -56.57 -34.15 41.27 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 C-N-CA 119.46 -0.896 . . . . 1.0 109.411 -179.273 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 24' ' ' ALA . . . . . 0.601 ' N ' ' O ' ' A' ' 20' ' ' PRO . . . -64.65 -61.35 2.25 Favored 'General case' 0 N--CA 1.47 0.533 0 C-N-CA 118.879 -1.129 . . . . 1.0 110.341 179.314 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 13.4 tp -61.05 -49.45 77.33 Favored 'General case' 0 CA--C 1.519 -0.219 0 C-N-CA 120.049 -0.66 . . . . 1.0 112.119 -177.015 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 70.0 t -59.18 -60.05 2.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 C-N-CA 119.095 -1.042 . . . . 1.0 110.476 -177.521 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 27' ' ' VAL . . . . . 0.72 ' O ' ' HB3' ' A' ' 31' ' ' ALA . 1.4 p -59.54 -38.46 75.48 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 C-N-CA 120.406 -0.517 . . . . 1.0 111.709 -177.163 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 88.5 tttt -69.28 -55.81 9.4 Favored 'General case' 0 C--N 1.317 -0.847 0 C-N-CA 120.161 -0.616 . . . . 1.0 110.113 -179.174 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 53.8 t -66.25 -52.09 51.55 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.619 0 CA-C-N 115.318 -0.855 . . . . 1.0 111.633 -176.499 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 30' ' ' CYS . . . . . . . . . . . . . 49.4 t -66.55 -60.79 2.4 Favored 'General case' 0 N--CA 1.445 -0.723 0 C-N-CA 118.761 -1.175 . . . . 1.0 110.589 -178.086 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 31' ' ' ALA . . . . . 0.72 ' HB3' ' O ' ' A' ' 27' ' ' VAL . . . -64.5 -49.97 69.24 Favored 'General case' 0 CA--C 1.513 -0.463 0 C-N-CA 120.691 -0.404 . . . . 1.0 111.78 -175.627 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 32' ' ' GLY . . . . . 0.512 ' O ' ' CB ' ' A' ' 33' ' ' LEU . . . 77.78 62.57 2.35 Favored Glycine 0 N--CA 1.447 -0.622 0 N-CA-C 107.923 -2.071 . . . . 1.0 107.923 -177.492 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 33' ' ' LEU . . . . . 0.512 ' CB ' ' O ' ' A' ' 32' ' ' GLY . 9.8 tp 90.32 94.43 0.03 OUTLIER Pre-proline 0 CA--C 1.541 0.625 0 CA-C-N 115.093 -0.553 . . . . 1.0 110.076 -179.064 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 59.4 Cg_endo -74.15 -11.27 23.13 Favored 'Trans proline' 0 N--CA 1.495 1.61 0 C-N-CA 122.012 1.808 . . . . 1.0 112.56 -179.212 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -58.04 -60.81 8.27 Favored Glycine 0 CA--C 1.534 1.235 0 C-N-CA 118.834 -1.65 . . . . 1.0 109.401 -178.847 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 36' ' ' VAL . . . . . 0.638 ' O ' HG22 ' A' ' 37' ' ' ILE . 1.6 m -90.19 176.4 0.66 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.47 0 N-CA-C 106.496 -1.668 . . . . 1.0 106.496 176.676 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 37' ' ' ILE . . . . . 0.638 HG22 ' O ' ' A' ' 36' ' ' VAL . 9.5 tt 107.72 115.49 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.481 1.089 0 O-C-N 124.787 1.304 . . . . 1.0 110.234 179.564 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 76.6 m80 -143.62 136.91 27.91 Favored 'General case' 0 C--O 1.231 0.093 0 CA-C-O 120.862 0.363 . . . . 1.0 110.024 179.995 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -106.93 118.62 53.67 Favored Pre-proline 0 CA--C 1.535 0.399 0 N-CA-C 109.17 -0.678 . . . . 1.0 109.17 179.167 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 65.8 Cg_exo -47.13 -24.22 3.37 Favored 'Trans proline' 0 N--CA 1.493 1.483 0 C-N-CA 121.629 1.553 . . . . 1.0 113.549 -179.403 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -127.94 135.95 50.66 Favored 'General case' 0 N--CA 1.467 0.377 0 CA-C-O 119.911 -0.09 . . . . 1.0 110.824 179.013 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 42' ' ' ARG . . . . . 0.718 ' C ' ' H ' ' A' ' 44' ' ' GLY . 14.0 ptm180 -167.16 166.42 14.97 Favored 'General case' 0 C--N 1.319 -0.726 0 C-N-CA 120.015 -0.674 . . . . 1.0 110.485 178.226 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 43' ' ' ARG . . . . . 0.649 ' C ' ' H ' ' A' ' 45' ' ' PHE . 25.6 tpt180 -62.13 22.54 0.01 OUTLIER 'General case' 0 CA--C 1.545 0.769 0 CA-C-O 121.63 0.728 . . . . 1.0 109.826 -179.92 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 44' ' ' GLY . . . . . 0.718 ' H ' ' C ' ' A' ' 42' ' ' ARG . . . 66.85 -30.28 0.18 Allowed Glycine 0 C--N 1.337 0.599 0 N-CA-C 110.663 -0.975 . . . . 1.0 110.663 179.125 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 45' ' ' PHE . . . . . 0.649 ' H ' ' C ' ' A' ' 43' ' ' ARG . 0.7 OUTLIER -166.43 173.12 10.22 Favored 'General case' 0 N--CA 1.446 -0.649 0 N-CA-C 108.939 -0.763 . . . . 1.0 108.939 -179.194 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 46' ' ' PHE . . . . . 0.547 ' CB ' ' O ' ' A' ' 45' ' ' PHE . 6.8 t80 110.4 106.67 0.0 OUTLIER 'General case' 0 N--CA 1.48 1.053 0 O-C-N 125.278 1.611 . . . . 1.0 109.495 179.555 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 47' ' ' ARG . . . . . 0.42 ' CB ' ' O ' ' A' ' 46' ' ' PHE . 2.5 ptm180 102.67 150.61 0.01 OUTLIER 'General case' 0 N--CA 1.48 1.03 0 O-C-N 125.012 1.445 . . . . 1.0 110.695 -179.452 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 37.5 t 60.84 67.49 0.81 Allowed 'General case' 0 CA--C 1.509 -0.619 0 N-CA-C 108.256 -1.016 . . . . 1.0 108.256 179.453 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 49' ' ' ASN . . . . . 0.526 ' O ' ' N ' ' A' ' 51' ' ' GLU . 0.5 OUTLIER -130.73 160.97 63.94 Favored Pre-proline 0 C--N 1.327 -0.395 0 CA-C-N 115.892 -0.595 . . . . 1.0 109.912 -178.842 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 50' ' ' PRO . . . . . 0.565 ' HG3' HH21 ' A' ' 52' ' ' ARG . 17.9 Cg_endo -62.12 52.59 0.11 Allowed 'Trans proline' 0 N--CA 1.494 1.557 0 C-N-CA 123.049 2.5 . . . . 1.0 112.061 179.394 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 51' ' ' GLU . . . . . 0.526 ' N ' ' O ' ' A' ' 49' ' ' ASN . 1.4 pm0 29.72 44.38 0.02 OUTLIER 'General case' 0 N--CA 1.471 0.599 0 CA-C-N 115.991 -0.549 . . . . 1.0 112.355 179.64 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 52' ' ' ARG . . . . . 0.569 ' HD2' ' HB1' ' A' ' 86' ' ' ALA . 75.5 mtm180 -122.85 141.56 51.74 Favored 'General case' 0 N--CA 1.476 0.846 0 N-CA-C 109.86 -0.422 . . . . 1.0 109.86 178.808 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 8.8 tp -37.66 135.68 0.24 Allowed 'Isoleucine or valine' 0 CA--C 1.53 0.179 0 CA-C-O 122.666 1.222 . . . . 1.0 112.745 -174.923 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -92.03 77.29 5.38 Favored 'General case' 0 C--N 1.339 0.121 0 CA-C-N 112.589 -2.096 . . . . 1.0 113.076 -177.899 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 3.8 tp -144.26 150.33 16.78 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.365 0 N-CA-C 108.471 -0.937 . . . . 1.0 108.471 176.82 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 104.27 2.29 44.6 Favored Glycine 0 CA--C 1.527 0.806 0 N-CA-C 109.495 -1.442 . . . . 1.0 109.495 -179.056 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 57' ' ' ASP . . . . . 0.443 ' CG ' ' CE2' ' A' ' 45' ' ' PHE . 22.6 m-20 -86.13 107.07 17.68 Favored 'General case' 0 CA--C 1.538 0.516 0 N-CA-C 113.032 0.753 . . . . 1.0 113.032 -178.69 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 58' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -80.56 178.74 8.13 Favored 'General case' 0 N--CA 1.469 0.515 0 CA-C-N 114.387 -1.279 . . . . 1.0 108.324 177.997 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 59' ' ' ARG . . . . . 0.826 ' HE ' ' H ' ' A' ' 59' ' ' ARG . 0.0 OUTLIER -101.23 -54.2 2.84 Favored 'General case' 0 CA--C 1.545 0.755 0 CA-C-N 119.246 0.93 . . . . 1.0 110.576 178.295 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -79.19 -13.26 59.81 Favored 'General case' 0 N--CA 1.482 1.151 0 CA-C-N 114.52 -1.218 . . . . 1.0 111.3 -178.914 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 61' ' ' GLU . . . . . 0.413 ' O ' ' N ' ' A' ' 65' ' ' ASP . 42.5 tt0 -69.25 -13.92 62.67 Favored 'General case' 0 C--N 1.303 -1.44 0 CA-C-N 115.124 -0.943 . . . . 1.0 108.459 179.11 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 62' ' ' VAL . . . . . 0.654 HG13 ' O ' ' A' ' 59' ' ' ARG . 11.6 m -44.59 -51.64 1.81 Allowed 'Isoleucine or valine' 0 C--N 1.317 -0.844 0 CA-C-N 115.787 -0.642 . . . . 1.0 110.516 -175.757 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 63' ' ' ALA . . . . . 0.626 ' O ' ' HG2' ' A' ' 67' ' ' ARG . . . -67.38 -47.28 70.81 Favored 'General case' 0 N--CA 1.423 -1.798 0 C-N-CA 119.608 -0.837 . . . . 1.0 109.028 179.871 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 64' ' ' HIS . . . . . 0.437 ' O ' ' CG ' ' A' ' 67' ' ' ARG . 0.2 OUTLIER -54.04 -59.59 4.45 Favored 'General case' 0 CA--C 1.542 0.649 0 CA-C-N 115.756 -0.657 . . . . 1.0 110.301 179.612 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 65' ' ' ASP . . . . . 0.64 ' C ' ' H ' ' A' ' 67' ' ' ARG . 1.1 t70 -65.99 -52.24 51.21 Favored 'General case' 0 C--O 1.242 0.666 0 CA-C-O 121.658 0.742 . . . . 1.0 109.21 177.864 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 66' ' ' GLY . . . . . 0.498 ' N ' ' O ' ' A' ' 62' ' ' VAL . . . -64.27 29.18 0.1 OUTLIER Glycine 0 CA--C 1.53 1.031 0 N-CA-C 110.979 -0.849 . . . . 1.0 110.979 178.002 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 67' ' ' ARG . . . . . 0.64 ' H ' ' C ' ' A' ' 65' ' ' ASP . 5.5 mmm180 -78.9 -4.18 48.43 Favored 'General case' 0 C--N 1.323 -0.566 0 N-CA-C 108.056 -1.09 . . . . 1.0 108.056 175.836 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 68' ' ' LEU . . . . . 0.456 ' C ' ' O ' ' A' ' 67' ' ' ARG . 0.6 OUTLIER -35.45 -29.16 0.01 OUTLIER 'General case' 0 N--CA 1.48 1.075 0 N-CA-C 108.033 -1.099 . . . . 1.0 108.033 -177.298 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 69' ' ' LEU . . . . . 0.576 ' N ' ' O ' ' A' ' 67' ' ' ARG . 8.4 tt -62.83 -64.86 0.79 Allowed 'General case' 0 C--N 1.313 -1.02 0 N-CA-C 106.914 -1.513 . . . . 1.0 106.914 177.224 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 70' ' ' ALA . . . . . 0.621 ' C ' ' H ' ' A' ' 72' ' ' HIS . . . -76.96 -71.43 0.4 Allowed 'General case' 0 N--CA 1.467 0.388 0 N-CA-C 106.642 -1.614 . . . . 1.0 106.642 177.187 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 71' ' ' ALA . . . . . 0.531 ' O ' ' C ' ' A' ' 72' ' ' HIS . . . -45.07 0.39 0.0 OUTLIER 'General case' 0 N--CA 1.475 0.775 0 C-N-CA 124.188 0.995 . . . . 1.0 113.404 178.384 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 72' ' ' HIS . . . . . 0.638 ' CG ' ' N ' ' A' ' 73' ' ' MET . 0.0 OUTLIER -22.09 -62.67 0.03 OUTLIER 'General case' 0 C--O 1.231 0.13 0 CA-C-N 117.951 0.342 . . . . 1.0 111.311 -176.142 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 73' ' ' MET . . . . . 0.638 ' N ' ' CG ' ' A' ' 72' ' ' HIS . 31.6 ttm -75.54 -50.07 16.75 Favored 'General case' 0 C--N 1.319 -0.752 0 C-N-CA 118.881 -1.127 . . . . 1.0 109.667 177.823 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 74' ' ' VAL . . . . . 0.643 ' O ' ' N ' ' A' ' 76' ' ' GLY . 97.2 t -43.75 -46.18 1.89 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.375 0 CA-C-O 118.472 -0.775 . . . . 1.0 110.378 -175.434 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 75' ' ' ASN . . . . . 0.499 ' O ' ' N ' ' A' ' 77' ' ' ILE . 0.5 OUTLIER -36.81 -19.37 0.01 OUTLIER 'General case' 0 N--CA 1.487 1.414 0 CA-C-N 119.779 1.172 . . . . 1.0 111.356 179.232 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 76' ' ' GLY . . . . . 0.643 ' N ' ' O ' ' A' ' 74' ' ' VAL . . . -44.03 -19.58 0.13 Allowed Glycine 0 CA--C 1.544 1.855 0 N-CA-C 108.967 -1.653 . . . . 1.0 108.967 177.237 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 77' ' ' ILE . . . . . 0.666 ' O ' ' N ' ' A' ' 80' ' ' ALA . 12.2 pt -90.13 -51.45 11.95 Favored 'Isoleucine or valine' 0 C--N 1.346 0.433 0 N-CA-C 108.621 -0.881 . . . . 1.0 108.621 179.371 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 78' ' ' VAL . . . . . 0.465 ' C ' ' O ' ' A' ' 77' ' ' ILE . 42.3 t -34.86 -36.86 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.446 -0.642 0 N-CA-C 109.003 -0.74 . . . . 1.0 109.003 -177.796 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 79' ' ' ILE . . . . . 0.414 ' N ' ' O ' ' A' ' 77' ' ' ILE . 33.0 pt -90.44 -21.06 6.75 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.575 0 CA-C-N 116.159 -0.473 . . . . 1.0 111.934 179.788 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 80' ' ' ALA . . . . . 0.666 ' N ' ' O ' ' A' ' 77' ' ' ILE . . . -82.99 -7.31 59.68 Favored 'General case' 0 CA--C 1.536 0.404 0 C-N-CA 123.771 0.828 . . . . 1.0 111.244 177.102 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 3.7 mm-40 -74.0 -68.72 0.49 Allowed 'General case' 0 N--CA 1.452 -0.356 0 N-CA-C 108.771 -0.826 . . . . 1.0 108.771 178.444 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 82' ' ' ASP . . . . . 0.594 ' O ' ' N ' ' A' ' 84' ' ' LEU . 18.8 p-10 -59.23 -59.19 5.85 Favored 'General case' 0 CA--C 1.512 -0.511 0 C-N-CA 119.489 -0.884 . . . . 1.0 108.941 179.578 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 83' ' ' ALA . . . . . 0.535 ' C ' ' O ' ' A' ' 82' ' ' ASP . . . 3.35 -70.47 0.0 OUTLIER 'General case' 0 N--CA 1.486 1.365 0 O-C-N 124.469 1.105 . . . . 1.0 111.069 -179.913 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 84' ' ' LEU . . . . . 0.594 ' N ' ' O ' ' A' ' 82' ' ' ASP . 58.8 mt -26.78 -44.68 0.02 OUTLIER 'General case' 0 N--CA 1.474 0.746 0 CA-C-N 115.435 -0.802 . . . . 1.0 111.044 -176.64 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 85' ' ' ILE . . . . . 0.45 ' H ' HG13 ' A' ' 85' ' ' ILE . 1.3 pp -97.65 -49.5 11.84 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.293 0 N-CA-C 108.299 -1.0 . . . . 1.0 108.299 177.636 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 86' ' ' ALA . . . . . 0.692 ' C ' ' H ' ' A' ' 88' ' ' ALA . . . -44.45 -41.94 6.66 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 114.453 -1.249 . . . . 1.0 110.333 179.938 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 10.6 pt-20 -60.54 24.84 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.361 -0.381 . . . . 1.0 111.061 179.922 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 88' ' ' ALA . . . . . 0.692 ' H ' ' C ' ' A' ' 86' ' ' ALA . . . -122.76 -9.15 8.39 Favored 'General case' 0 N--CA 1.456 -0.173 0 CA-C-N 116.229 -0.441 . . . . 1.0 109.854 179.592 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 89' ' ' VAL . . . . . 0.509 HG23 ' O ' ' A' ' 89' ' ' VAL . 4.0 m -107.66 34.69 0.59 Allowed 'Isoleucine or valine' 0 C--O 1.224 -0.267 0 N-CA-C 109.093 -0.706 . . . . 1.0 109.093 179.377 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 90' ' ' GLY . . . . . 0.558 ' O ' ' N ' ' A' ' 92' ' ' HIS . . . -67.49 -40.42 91.09 Favored Glycine 0 CA--C 1.532 1.118 0 CA-C-O 119.616 -0.547 . . . . 1.0 111.957 179.16 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 91' ' ' PRO . . . . . 0.508 ' CD ' ' N ' ' A' ' 90' ' ' GLY . 80.4 Cg_exo -44.06 -13.19 0.05 OUTLIER 'Trans proline' 0 N--CA 1.494 1.549 0 C-N-CA 122.066 1.844 . . . . 1.0 111.483 179.294 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 92' ' ' HIS . . . . . 0.558 ' N ' ' O ' ' A' ' 90' ' ' GLY . 2.8 p80 -58.15 -17.13 16.39 Favored 'General case' 0 N--CA 1.44 -0.928 0 CA-C-N 115.676 -0.693 . . . . 1.0 109.201 179.396 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 93' ' ' LEU . . . . . 0.676 HD12 ' N ' ' A' ' 94' ' ' ALA . 1.5 pp -69.71 -59.18 3.11 Favored 'General case' 0 C--O 1.234 0.276 0 N-CA-C 109.759 -0.46 . . . . 1.0 109.759 178.993 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 94' ' ' ALA . . . . . 0.676 ' N ' HD12 ' A' ' 93' ' ' LEU . . . -55.87 -51.42 67.6 Favored 'General case' 0 CA--C 1.512 -0.508 0 N-CA-C 108.854 -0.795 . . . . 1.0 108.854 179.509 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 95' ' ' ARG . . . . . 0.657 ' O ' ' N ' ' A' ' 97' ' ' LEU . 7.1 mmm-85 -54.09 -59.02 5.2 Favored 'General case' 0 C--O 1.246 0.882 0 CA-C-O 122.985 1.374 . . . . 1.0 107.642 178.572 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 96' ' ' ALA . . . . . 0.77 ' O ' ' N ' ' A' ' 98' ' ' GLY . . . -46.33 -12.14 0.02 OUTLIER 'General case' 0 C--N 1.304 -1.375 0 O-C-N 119.524 -1.985 . . . . 1.0 111.556 -177.262 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 97' ' ' LEU . . . . . 0.657 ' N ' ' O ' ' A' ' 95' ' ' ARG . 0.3 OUTLIER 1.17 -53.76 0.0 OUTLIER 'General case' 0 N--CA 1.482 1.147 0 C-N-CA 124.246 1.018 . . . . 1.0 112.011 -169.101 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 98' ' ' GLY . . . . . 0.77 ' N ' ' O ' ' A' ' 96' ' ' ALA . . . -50.71 -23.27 6.58 Favored Glycine 0 C--N 1.3 -1.427 0 CA-C-N 121.905 2.138 . . . . 1.0 108.918 175.642 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 99' ' ' GLN . . . . . 0.615 ' HB2' ' HB1' ' A' ' 96' ' ' ALA . 9.4 tt0 -69.25 -24.07 63.94 Favored 'General case' 0 C--N 1.353 0.742 0 N-CA-C 107.872 -1.158 . . . . 1.0 107.872 178.011 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 100' ' ' ILE . . . . . 0.588 ' N ' ' O ' ' A' ' 97' ' ' LEU . 0.9 OUTLIER -63.6 -38.61 82.7 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.676 0 CA-C-N 114.471 -1.241 . . . . 1.0 108.895 178.442 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 101' ' ' VAL . . . . . 0.542 ' O ' ' N ' ' A' ' 105' ' ' GLY . 86.9 t -61.72 -60.01 3.39 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.199 0 N-CA-C 109.156 -0.683 . . . . 1.0 109.156 179.987 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 102' ' ' CYS . . . . . 0.897 ' O ' ' HB2' ' A' ' 106' ' ' ALA . 0.0 OUTLIER -44.41 -20.53 0.03 OUTLIER 'General case' 0 C--O 1.22 -0.478 0 CA-C-O 119.641 -0.218 . . . . 1.0 111.2 -178.574 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 103' ' ' ARG . . . . . 0.441 ' N ' ' O ' ' A' ' 101' ' ' VAL . 17.1 ttm180 -88.82 -37.36 15.45 Favored 'General case' 0 N--CA 1.484 1.239 0 CA-C-O 122.766 1.27 . . . . 1.0 110.664 178.316 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 104' ' ' TYR . . . . . 0.588 ' O ' ' CG ' ' A' ' 104' ' ' TYR . 50.9 t80 -99.79 20.99 13.16 Favored 'General case' 0 C--N 1.31 -1.116 0 CA-C-N 112.117 -2.31 . . . . 1.0 110.342 177.184 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 105' ' ' GLY . . . . . 0.542 ' N ' ' O ' ' A' ' 101' ' ' VAL . . . -163.5 -88.81 0.07 OUTLIER Glycine 0 N--CA 1.445 -0.719 0 N-CA-C 108.023 -2.031 . . . . 1.0 108.023 178.073 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 106' ' ' ALA . . . . . 0.897 ' HB2' ' O ' ' A' ' 102' ' ' CYS . . . 66.46 66.62 0.46 Allowed 'General case' 0 N--CA 1.441 -0.892 0 CA-C-N 115.654 -0.273 . . . . 1.0 111.545 -179.857 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 14.0 m -77.47 -60.97 2.14 Favored 'General case' 0 N--CA 1.473 0.718 0 O-C-N 121.325 -0.859 . . . . 1.0 109.388 179.711 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 108' ' ' VAL . . . . . 0.491 HG23 ' N ' ' A' ' 109' ' ' ILE . 32.3 m -66.51 -43.92 90.56 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.171 0 CA-C-O 121.293 0.568 . . . . 1.0 109.511 -179.158 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 109' ' ' ILE . . . . . 0.491 ' N ' HG23 ' A' ' 108' ' ' VAL . 1.8 mm -36.5 -61.23 0.64 Allowed Pre-proline 0 CA--C 1.549 0.932 0 CA-C-O 118.171 -0.919 . . . . 1.0 111.095 -178.269 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 110' ' ' PRO . . . . . 0.584 ' CD ' ' O ' ' A' ' 106' ' ' ALA . 55.5 Cg_endo -63.85 -21.33 69.17 Favored 'Trans proline' 0 N--CA 1.505 2.149 0 C-N-CA 124.013 3.142 . . . . 1.0 113.11 179.875 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 14.7 t-20 -63.31 -69.9 0.24 Allowed 'General case' 0 N--CA 1.467 0.392 0 C-N-CA 120.387 -0.525 . . . . 1.0 111.175 -178.191 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 112' ' ' ILE . . . . . 0.821 HD13 ' N ' ' A' ' 113' ' ' ASN . 0.0 OUTLIER -73.07 -25.33 21.65 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.567 0 CA-C-O 121.969 0.89 . . . . 1.0 109.499 -179.643 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 113' ' ' ASN . . . . . 0.821 ' N ' HD13 ' A' ' 112' ' ' ILE . 0.4 OUTLIER -52.02 -59.2 4.63 Favored 'General case' 0 C--N 1.3 -1.552 0 CA-C-N 114.002 -1.453 . . . . 1.0 108.908 -177.45 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -66.26 -20.46 66.12 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 115.891 -0.595 . . . . 1.0 110.954 179.107 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -76.41 -60.81 2.18 Favored 'General case' 0 N--CA 1.443 -0.804 0 C-N-CA 120.282 -0.567 . . . . 1.0 111.171 178.001 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 116' ' ' ILE . . . . . 0.526 ' O ' ' N ' ' A' ' 119' ' ' LEU . 7.6 tt -72.39 -41.54 64.97 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.213 0 O-C-N 121.213 -0.93 . . . . 1.0 111.981 -178.236 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 117' ' ' GLU . . . . . 0.566 ' OE1' ' ND2' ' A' ' 113' ' ' ASN . 1.0 OUTLIER -48.81 -58.61 4.53 Favored 'General case' 0 CA--C 1.508 -0.671 0 N-CA-C 108.288 -1.005 . . . . 1.0 108.288 -178.476 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 86.9 t -54.71 -14.26 0.96 Allowed 'Isoleucine or valine' 0 N--CA 1.436 -1.131 0 C-N-CA 120.253 -0.579 . . . . 1.0 109.442 179.52 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 119' ' ' LEU . . . . . 0.526 ' N ' ' O ' ' A' ' 116' ' ' ILE . 0.2 OUTLIER -76.33 -60.18 2.45 Favored 'General case' 0 C--N 1.347 0.477 0 N-CA-C 107.77 -1.196 . . . . 1.0 107.77 175.796 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -68.25 -83.08 0.15 Allowed Glycine 0 C--N 1.364 2.114 0 C-N-CA 117.57 -2.253 . . . . 1.0 111.23 179.449 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 121' ' ' THR . . . . . 0.444 ' H ' ' H ' ' A' ' 122' ' ' GLY . 18.8 m -161.36 -17.97 0.05 OUTLIER 'General case' 0 C--N 1.326 -0.427 0 N-CA-C 108.564 -0.902 . . . . 1.0 108.564 -179.639 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 122' ' ' GLY . . . . . 0.444 ' H ' ' H ' ' A' ' 121' ' ' THR . . . 111.26 -35.91 4.49 Favored Glycine 0 CA--C 1.523 0.577 0 CA-C-N 113.959 -1.473 . . . . 1.0 112.1 179.569 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 123' ' ' THR . . . . . 0.416 ' C ' ' O ' ' A' ' 122' ' ' GLY . 0.1 OUTLIER -33.43 95.4 0.01 OUTLIER 'General case' 0 N--CA 1.471 0.614 0 CA-C-N 118.342 1.071 . . . . 1.0 112.489 -178.618 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 124' ' ' ASP . . . . . 0.414 ' N ' ' O ' ' A' ' 122' ' ' GLY . 55.6 m-20 -148.59 147.88 29.51 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 115.484 -0.78 . . . . 1.0 109.548 179.26 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 125' ' ' TYR . . . . . 0.418 ' CD1' ' C ' ' A' ' 125' ' ' TYR . 0.0 OUTLIER -151.85 150.25 29.89 Favored 'General case' 0 CA--C 1.532 0.279 0 CA-C-O 120.863 0.363 . . . . 1.0 110.124 179.946 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -149.67 150.55 32.32 Favored 'General case' 0 CA--C 1.537 0.45 0 CA-C-N 116.07 -0.513 . . . . 1.0 110.019 177.719 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 127' ' ' PHE . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 C--O 1.22 -0.467 0 CA-C-O 118.172 -0.918 . . . . 1.0 109.249 179.44 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 N--CA 1.493 1.715 0 N-CA-C 109.259 -0.645 . . . . 1.0 109.259 . . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 2' ' ' SER . . . . . 0.487 ' O ' ' CG ' ' A' ' 3' ' ' ASP . 55.1 p -83.28 5.63 22.48 Favored 'General case' 0 CA--C 1.531 0.246 0 CA-C-N 116.489 -0.323 . . . . 1.0 111.478 -179.062 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 3' ' ' ASP . . . . . 0.487 ' CG ' ' O ' ' A' ' 2' ' ' SER . 24.0 m-20 153.69 127.41 0.0 OUTLIER 'General case' 0 N--CA 1.477 0.876 0 O-C-N 123.904 0.753 . . . . 1.0 111.2 178.94 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 60.9 t80 -155.92 151.19 26.73 Favored 'General case' 0 N--CA 1.462 0.145 0 CA-C-N 116.089 -0.505 . . . . 1.0 110.953 179.235 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 4.2 p30 -153.7 148.63 26.63 Favored 'General case' 0 CA--C 1.536 0.419 0 CA-C-N 116.308 -0.406 . . . . 1.0 110.158 -179.692 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 6' ' ' THR . . . . . 0.816 ' O ' ' N ' ' A' ' 10' ' ' SER . 0.1 OUTLIER -80.76 170.4 16.35 Favored 'General case' 0 C--O 1.188 -2.165 0 C-N-CA 120.856 -0.338 . . . . 1.0 110.305 -179.39 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 7' ' ' GLU . . . . . 0.541 ' O ' ' N ' ' A' ' 11' ' ' ARG . 39.2 tt0 -56.87 -57.05 14.16 Favored 'General case' 0 C--N 1.313 -0.984 0 CA-C-O 121.775 0.797 . . . . 1.0 110.54 -177.974 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 8' ' ' ARG . . . . . 0.757 ' O ' ' HB3' ' A' ' 12' ' ' ALA . 0.0 OUTLIER -54.02 -55.51 26.66 Favored 'General case' 0 C--N 1.313 -1.01 0 N-CA-C 106.96 -1.496 . . . . 1.0 106.96 -178.079 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 9' ' ' VAL . . . . . 0.683 ' O ' ' HB ' ' A' ' 13' ' ' VAL . 0.2 OUTLIER -66.41 -51.89 52.97 Favored 'Isoleucine or valine' 0 C--O 1.189 -2.124 0 CA-C-N 114.35 -1.296 . . . . 1.0 109.659 179.651 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 10' ' ' SER . . . . . 0.816 ' N ' ' O ' ' A' ' 6' ' ' THR . 22.5 t -65.78 -64.89 0.76 Allowed 'General case' 0 N--CA 1.482 1.139 0 C-N-CA 120.256 -0.578 . . . . 1.0 111.649 -178.924 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 11' ' ' ARG . . . . . 0.541 ' N ' ' O ' ' A' ' 7' ' ' GLU . 0.3 OUTLIER -65.52 -57.82 7.3 Favored 'General case' 0 C--O 1.218 -0.589 0 N-CA-C 112.313 0.486 . . . . 1.0 112.313 -176.81 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 12' ' ' ALA . . . . . 0.757 ' HB3' ' O ' ' A' ' 8' ' ' ARG . . . -54.12 -49.69 68.59 Favored 'General case' 0 N--CA 1.476 0.856 0 C-N-CA 117.874 -1.53 . . . . 1.0 107.41 -176.497 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 13' ' ' VAL . . . . . 0.683 ' HB ' ' O ' ' A' ' 9' ' ' VAL . 91.2 t -62.34 -50.05 81.49 Favored 'Isoleucine or valine' 0 C--O 1.197 -1.679 0 N-CA-C 107.585 -1.265 . . . . 1.0 107.585 178.476 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 14' ' ' ALA . . . . . 0.776 ' O ' HG22 ' A' ' 18' ' ' VAL . . . -56.41 -60.24 3.8 Favored 'General case' 0 C--O 1.207 -1.143 0 C-N-CA 117.57 -1.652 . . . . 1.0 108.508 -178.806 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 15' ' ' ALA . . . . . 0.55 ' O ' ' N ' ' A' ' 19' ' ' GLY . . . -53.63 -53.65 48.91 Favored 'General case' 0 C--N 1.322 -0.618 0 O-C-N 123.718 0.636 . . . . 1.0 109.726 -178.855 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 16' ' ' ALA . . . . . 0.46 ' C ' ' H ' ' A' ' 22' ' ' GLY . . . -63.72 -57.98 8.31 Favored 'General case' 0 N--CA 1.474 0.745 0 CA-C-O 121.693 0.759 . . . . 1.0 109.707 -179.547 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 17' ' ' LEU . . . . . 0.61 ' N ' ' O ' ' A' ' 13' ' ' VAL . 7.5 tt -55.42 -54.46 43.47 Favored 'General case' 0 N--CA 1.477 0.903 0 CA-C-N 114.422 -1.263 . . . . 1.0 108.652 -178.578 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 18' ' ' VAL . . . . . 0.776 HG22 ' O ' ' A' ' 14' ' ' ALA . 2.3 m -69.16 -57.45 8.56 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.568 0 C-N-CA 119.335 -0.946 . . . . 1.0 109.166 179.857 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 19' ' ' GLY . . . . . 0.55 ' N ' ' O ' ' A' ' 15' ' ' ALA . . . -56.78 -162.95 0.03 OUTLIER Glycine 0 C--O 1.22 -0.77 0 N-CA-C 111.225 -0.75 . . . . 1.0 111.225 -178.317 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 20' ' ' PRO . . . . . 0.441 ' O ' ' N ' ' A' ' 24' ' ' ALA . 83.0 Cg_endo -82.76 -30.34 1.05 Allowed 'Trans proline' 0 C--N 1.303 -1.836 0 C-N-CA 122.508 2.139 . . . . 1.0 113.988 -178.619 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 21' ' ' GLY . . . . . 0.42 ' O ' ' HB3' ' A' ' 24' ' ' ALA . . . -62.87 -61.52 6.38 Favored Glycine 0 N--CA 1.48 1.57 0 C-N-CA 119.897 -1.144 . . . . 1.0 113.364 -176.508 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 22' ' ' GLY . . . . . 0.46 ' H ' ' C ' ' A' ' 16' ' ' ALA . . . -54.16 -52.81 41.27 Favored Glycine 0 N--CA 1.471 0.997 0 N-CA-C 106.6 -2.6 . . . . 1.0 106.6 -177.11 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 23' ' ' VAL . . . . . 0.547 ' O ' HG12 ' A' ' 27' ' ' VAL . 12.3 t -57.06 -29.17 30.92 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.853 0 C-N-CA 119.569 -0.852 . . . . 1.0 109.096 177.696 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 24' ' ' ALA . . . . . 0.441 ' N ' ' O ' ' A' ' 20' ' ' PRO . . . -61.89 -63.63 1.2 Allowed 'General case' 0 C--N 1.349 0.568 0 C-N-CA 118.106 -1.437 . . . . 1.0 111.138 179.922 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 25' ' ' LEU . . . . . 0.588 ' N ' HD12 ' A' ' 25' ' ' LEU . 9.6 mp -63.6 -47.72 80.28 Favored 'General case' 0 N--CA 1.472 0.649 0 CA-C-N 119.008 0.822 . . . . 1.0 112.651 -177.486 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 94.9 t -58.01 -58.84 4.67 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.575 0 C-N-CA 119.169 -1.013 . . . . 1.0 110.061 -177.416 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 27' ' ' VAL . . . . . 0.809 ' O ' ' HB3' ' A' ' 31' ' ' ALA . 0.5 OUTLIER -61.41 -36.33 72.35 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.601 0 CA-C-O 121.224 0.535 . . . . 1.0 110.322 -178.505 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 28' ' ' LYS . . . . . 0.405 ' CB ' ' O ' ' A' ' 24' ' ' ALA . 33.0 tttm -67.52 -58.52 4.57 Favored 'General case' 0 C--N 1.316 -0.891 0 C-N-CA 119.461 -0.896 . . . . 1.0 110.424 -178.918 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 95.8 t -65.32 -49.85 76.43 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.116 0 C-N-CA 119.821 -0.752 . . . . 1.0 111.221 -177.283 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 30' ' ' CYS . . . . . . . . . . . . . 4.9 t -65.65 -61.64 1.97 Allowed 'General case' 0 N--CA 1.44 -0.969 0 C-N-CA 119.197 -1.001 . . . . 1.0 109.826 -179.344 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 31' ' ' ALA . . . . . 0.809 ' HB3' ' O ' ' A' ' 27' ' ' VAL . . . -63.07 -49.47 74.4 Favored 'General case' 0 C--N 1.322 -0.621 0 C-N-CA 119.968 -0.693 . . . . 1.0 110.714 -177.244 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 32' ' ' GLY . . . . . 0.53 ' O ' ' HB2' ' A' ' 33' ' ' LEU . . . 58.44 60.02 9.71 Favored Glycine 0 C--O 1.222 -0.62 0 CA-C-O 118.165 -1.353 . . . . 1.0 111.003 179.644 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 33' ' ' LEU . . . . . 0.664 HD23 HG22 ' A' ' 112' ' ' ILE . 6.3 mp 100.21 140.62 0.02 OUTLIER Pre-proline 0 N--CA 1.484 1.26 0 C-N-CA 125.478 1.511 . . . . 1.0 111.65 179.761 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 31.3 Cg_exo -51.76 -57.76 1.98 Allowed 'Trans proline' 0 N--CA 1.501 1.936 0 C-N-CA 122.17 1.913 . . . . 1.0 113.763 -178.505 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 35' ' ' GLY . . . . . 0.464 ' O ' ' C ' ' A' ' 36' ' ' VAL . . . -65.85 -59.65 7.34 Favored Glycine 0 C--N 1.338 0.678 0 C-N-CA 117.944 -2.074 . . . . 1.0 109.223 -178.404 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 36' ' ' VAL . . . . . 0.976 ' O ' HG22 ' A' ' 37' ' ' ILE . 70.4 t -38.94 139.36 0.23 Allowed 'Isoleucine or valine' 0 C--O 1.215 -0.73 0 N-CA-C 107.398 -1.334 . . . . 1.0 107.398 178.658 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 37' ' ' ILE . . . . . 0.976 HG22 ' O ' ' A' ' 36' ' ' VAL . 2.3 tp 71.96 73.3 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.476 0.831 0 CA-C-O 122.266 1.031 . . . . 1.0 110.15 -177.201 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 25.1 p-80 -139.42 136.04 34.25 Favored 'General case' 0 C--N 1.322 -0.592 0 O-C-N 120.514 -1.366 . . . . 1.0 109.489 179.988 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -113.77 140.0 24.16 Favored Pre-proline 0 CA--C 1.533 0.32 0 N-CA-C 109.251 -0.648 . . . . 1.0 109.251 179.528 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 59.8 Cg_endo -71.28 -7.36 21.17 Favored 'Trans proline' 0 C--N 1.311 -1.41 0 C-N-CA 122.058 1.838 . . . . 1.0 112.187 -179.38 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -112.78 91.91 3.82 Favored 'General case' 0 CA--C 1.507 -0.691 0 C-N-CA 120.591 -0.444 . . . . 1.0 111.13 -178.078 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 42' ' ' ARG . . . . . 0.656 ' C ' ' H ' ' A' ' 44' ' ' GLY . 0.6 OUTLIER -123.58 140.3 53.14 Favored 'General case' 0 CA--C 1.537 0.453 0 CA-C-O 121.744 0.783 . . . . 1.0 111.576 -178.361 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 43' ' ' ARG . . . . . 0.686 ' C ' ' H ' ' A' ' 45' ' ' PHE . 1.5 tpp180 -59.31 37.74 0.01 OUTLIER 'General case' 0 CA--C 1.562 1.415 0 CA-C-N 112.976 -1.92 . . . . 1.0 108.303 -179.714 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 44' ' ' GLY . . . . . 0.656 ' H ' ' C ' ' A' ' 42' ' ' ARG . . . 67.8 -30.13 0.23 Allowed Glycine 0 C--N 1.338 0.656 0 N-CA-C 109.605 -1.398 . . . . 1.0 109.605 -179.11 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 45' ' ' PHE . . . . . 0.686 ' H ' ' C ' ' A' ' 43' ' ' ARG . 0.2 OUTLIER -170.39 175.28 4.87 Favored 'General case' 0 N--CA 1.443 -0.821 0 CA-C-N 114.749 -0.725 . . . . 1.0 109.126 179.379 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 46' ' ' PHE . . . . . 0.549 ' HB2' ' O ' ' A' ' 45' ' ' PHE . 8.6 m-85 114.84 110.56 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.668 0 C-N-CA 126.868 2.067 . . . . 1.0 108.432 -179.272 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 47' ' ' ARG . . . . . 0.512 ' HB2' ' O ' ' A' ' 46' ' ' PHE . 3.6 mmp_? 100.11 153.36 0.01 OUTLIER 'General case' 0 N--CA 1.469 0.516 0 O-C-N 124.94 1.4 . . . . 1.0 111.266 179.62 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER 66.44 70.51 0.41 Allowed 'General case' 0 N--CA 1.449 -0.48 0 CA-C-N 114.778 -1.101 . . . . 1.0 109.315 179.825 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 49' ' ' ASN . . . . . 0.5 ' O ' ' N ' ' A' ' 51' ' ' GLU . 0.7 OUTLIER -136.45 160.73 65.66 Favored Pre-proline 0 N--CA 1.466 0.367 0 CA-C-N 116.455 -0.339 . . . . 1.0 110.473 -179.175 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 25.1 Cg_endo -60.54 58.74 0.09 OUTLIER 'Trans proline' 0 N--CA 1.499 1.798 0 C-N-CA 123.265 2.643 . . . . 1.0 111.886 179.054 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 51' ' ' GLU . . . . . 0.5 ' N ' ' O ' ' A' ' 49' ' ' ASN . 2.9 tt0 45.33 29.85 0.62 Allowed 'General case' 0 CA--C 1.536 0.407 0 CA-C-O 121.121 0.486 . . . . 1.0 110.442 179.13 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 52' ' ' ARG . . . . . 0.632 ' NH2' ' CE1' ' A' ' 92' ' ' HIS . 49.5 mtt180 -124.59 151.84 44.3 Favored 'General case' 0 N--CA 1.472 0.637 0 CA-C-O 121.541 0.686 . . . . 1.0 110.978 179.527 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 7.2 tp -55.87 139.99 14.46 Favored 'Isoleucine or valine' 0 CA--C 1.555 1.141 0 CA-C-O 123.935 1.826 . . . . 1.0 115.217 -177.407 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 54' ' ' GLN . . . . . 0.431 ' H ' ' CD ' ' A' ' 54' ' ' GLN . 0.2 OUTLIER -86.53 86.11 7.33 Favored 'General case' 0 C--N 1.316 -0.864 0 CA-C-N 110.229 -3.168 . . . . 1.0 112.258 179.833 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 19.6 tt -143.92 151.0 16.55 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.032 0 N-CA-C 109.522 -0.548 . . . . 1.0 109.522 177.578 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 102.13 1.3 51.37 Favored Glycine 0 C--N 1.343 0.964 0 N-CA-C 110.753 -0.939 . . . . 1.0 110.753 179.837 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 1.3 p30 -89.71 113.28 24.76 Favored 'General case' 0 CA--C 1.54 0.566 0 CA-C-O 122.294 1.045 . . . . 1.0 113.226 -177.881 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 58' ' ' TRP . . . . . . . . . . . . . 36.4 m0 -81.74 -177.27 6.49 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 113.952 -1.476 . . . . 1.0 108.287 177.696 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 59' ' ' ARG . . . . . 0.649 ' HD2' ' H ' ' A' ' 59' ' ' ARG . 0.0 OUTLIER -97.3 -53.58 3.43 Favored 'General case' 0 CA--C 1.556 1.196 0 CA-C-N 119.18 0.9 . . . . 1.0 110.642 179.717 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 60' ' ' TYR . . . . . 0.485 ' O ' ' CG ' ' A' ' 60' ' ' TYR . 77.0 t80 -77.47 -6.0 51.92 Favored 'General case' 0 N--CA 1.483 1.207 0 C-N-CA 125.778 1.631 . . . . 1.0 111.833 -179.367 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -70.1 -16.7 63.16 Favored 'General case' 0 C--N 1.307 -1.244 0 CA-C-O 121.575 0.703 . . . . 1.0 109.453 179.181 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 62' ' ' VAL . . . . . 0.489 ' O ' ' N ' ' A' ' 66' ' ' GLY . 6.1 m -45.81 -52.37 2.8 Favored 'Isoleucine or valine' 0 CA--C 1.5 -0.961 0 C-N-CA 120.067 -0.653 . . . . 1.0 110.512 -174.774 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 63' ' ' ALA . . . . . 0.435 ' O ' ' HG2' ' A' ' 67' ' ' ARG . . . -65.2 -47.75 75.82 Favored 'General case' 0 N--CA 1.424 -1.768 0 N-CA-C 109.447 -0.575 . . . . 1.0 109.447 179.414 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 64' ' ' HIS . . . . . 0.407 ' O ' ' CG ' ' A' ' 67' ' ' ARG . 0.1 OUTLIER -54.71 -59.46 4.68 Favored 'General case' 0 CA--C 1.549 0.907 0 CA-C-N 115.474 -0.785 . . . . 1.0 110.54 179.837 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 65' ' ' ASP . . . . . 0.642 ' C ' ' H ' ' A' ' 67' ' ' ARG . 13.4 m-20 -67.72 -50.0 59.7 Favored 'General case' 0 C--O 1.243 0.751 0 N-CA-C 108.322 -0.992 . . . . 1.0 108.322 178.36 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 66' ' ' GLY . . . . . 0.489 ' N ' ' O ' ' A' ' 62' ' ' VAL . . . -63.23 30.24 0.08 OUTLIER Glycine 0 C--N 1.336 0.533 0 O-C-N 121.873 -0.517 . . . . 1.0 112.097 179.013 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 67' ' ' ARG . . . . . 0.793 ' HB3' ' HB3' ' A' ' 71' ' ' ALA . 14.9 mmt180 -78.96 -3.0 42.76 Favored 'General case' 0 C--N 1.308 -1.219 0 N-CA-C 108.322 -0.992 . . . . 1.0 108.322 175.927 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 68' ' ' LEU . . . . . 0.6 HD23 ' N ' ' A' ' 68' ' ' LEU . 1.8 pt? -36.11 -29.95 0.02 OUTLIER 'General case' 0 N--CA 1.477 0.921 0 N-CA-C 108.57 -0.9 . . . . 1.0 108.57 -176.948 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 69' ' ' LEU . . . . . 0.558 ' N ' ' O ' ' A' ' 67' ' ' ARG . 0.5 OUTLIER -71.91 -69.52 0.39 Allowed 'General case' 0 CA--C 1.538 0.5 0 CA-C-N 115.15 -0.932 . . . . 1.0 111.206 -178.583 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 70' ' ' ALA . . . . . 0.6 ' C ' ' H ' ' A' ' 72' ' ' HIS . . . -76.53 -78.16 0.13 Allowed 'General case' 0 N--CA 1.463 0.221 0 C-N-CA 119.201 -1.0 . . . . 1.0 109.2 -179.458 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 71' ' ' ALA . . . . . 0.793 ' HB3' ' HB3' ' A' ' 67' ' ' ARG . . . -58.84 13.05 0.01 OUTLIER 'General case' 0 C--N 1.321 -0.643 0 C-N-CA 124.444 1.098 . . . . 1.0 113.159 -179.019 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 72' ' ' HIS . . . . . 0.68 ' CD2' ' OG1' ' A' ' 123' ' ' THR . 0.0 OUTLIER -18.1 -60.05 0.02 OUTLIER 'General case' 0 CA--C 1.534 0.353 0 N-CA-C 113.32 0.859 . . . . 1.0 113.32 -177.429 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 73' ' ' MET . . . . . 0.649 ' N ' ' CG ' ' A' ' 72' ' ' HIS . 0.0 OUTLIER -64.82 -53.96 38.59 Favored 'General case' 0 C--N 1.317 -0.81 0 C-N-CA 119.831 -0.748 . . . . 1.0 111.341 -177.842 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 74' ' ' VAL . . . . . 0.635 ' O ' ' N ' ' A' ' 76' ' ' GLY . 0.8 OUTLIER -44.31 -46.31 2.36 Favored 'Isoleucine or valine' 0 C--O 1.215 -0.75 0 CA-C-O 117.989 -1.005 . . . . 1.0 111.219 -174.566 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 75' ' ' ASN . . . . . 0.48 ' C ' ' N ' ' A' ' 77' ' ' ILE . 2.3 t30 -37.66 -21.47 0.01 OUTLIER 'General case' 0 N--CA 1.482 1.16 0 CA-C-O 122.972 1.368 . . . . 1.0 110.026 178.3 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 76' ' ' GLY . . . . . 0.635 ' N ' ' O ' ' A' ' 74' ' ' VAL . . . -49.49 -20.41 2.51 Favored Glycine 0 C--O 1.21 -1.361 0 N-CA-C 107.666 -2.174 . . . . 1.0 107.666 175.235 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 77' ' ' ILE . . . . . 0.538 ' N ' ' O ' ' A' ' 74' ' ' VAL . 7.9 pt -56.84 -46.93 83.65 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.454 0 CA-C-N 115.301 -0.45 . . . . 1.0 111.75 -177.556 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 57.9 t -44.14 -17.99 0.06 OUTLIER 'Isoleucine or valine' 0 CA--C 1.51 -0.562 0 CA-C-N 118.775 0.716 . . . . 1.0 112.39 179.805 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 79' ' ' ILE . . . . . 0.496 ' N ' ' O ' ' A' ' 77' ' ' ILE . 0.6 OUTLIER -91.33 -40.17 12.28 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.759 0 C-N-CA 119.593 -0.843 . . . . 1.0 112.506 179.555 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 80' ' ' ALA . . . . . 0.416 ' N ' ' CG1' ' A' ' 79' ' ' ILE . . . -82.01 -24.41 35.41 Favored 'General case' 0 C--N 1.328 -0.344 0 N-CA-C 114.279 1.215 . . . . 1.0 114.279 -178.241 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 81' ' ' GLU . . . . . 0.613 ' O ' HD12 ' A' ' 84' ' ' LEU . 0.0 OUTLIER -92.24 -74.45 0.51 Allowed 'General case' 0 N--CA 1.469 0.515 0 N-CA-C 113.998 1.11 . . . . 1.0 113.998 -177.591 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 82' ' ' ASP . . . . . 0.716 ' O ' HG22 ' A' ' 85' ' ' ILE . 9.3 m-20 -92.17 -22.2 19.97 Favored 'General case' 0 C--O 1.217 -0.627 0 N-CA-C 115.291 1.589 . . . . 1.0 115.291 -177.993 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 83' ' ' ALA . . . . . 0.582 ' O ' ' N ' ' A' ' 85' ' ' ILE . . . -58.68 -40.77 84.53 Favored 'General case' 0 N--CA 1.461 0.108 0 C-N-CA 118.405 -1.318 . . . . 1.0 112.101 -176.005 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 84' ' ' LEU . . . . . 0.715 ' C ' HD22 ' A' ' 84' ' ' LEU . 0.0 OUTLIER -41.45 -14.81 0.01 OUTLIER 'General case' 0 CA--C 1.536 0.406 0 N-CA-C 112.742 0.645 . . . . 1.0 112.742 -178.488 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 85' ' ' ILE . . . . . 0.716 HG22 ' O ' ' A' ' 82' ' ' ASP . 3.5 tt -90.07 -43.95 14.79 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.408 0 N-CA-C 112.029 0.381 . . . . 1.0 112.029 179.87 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 86' ' ' ALA . . . . . 0.483 ' N ' HG23 ' A' ' 85' ' ' ILE . . . -94.2 -23.48 17.88 Favored 'General case' 0 CA--C 1.527 0.082 0 CA-C-O 120.681 0.277 . . . . 1.0 111.337 -178.826 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 87' ' ' GLU . . . . . 0.581 ' OE1' ' N ' ' A' ' 88' ' ' ALA . 0.0 OUTLIER -83.72 -26.97 29.29 Favored 'General case' 0 C--N 1.332 -0.187 0 N-CA-C 109.277 -0.638 . . . . 1.0 109.277 179.813 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 88' ' ' ALA . . . . . 0.581 ' N ' ' OE1' ' A' ' 87' ' ' GLU . . . -62.95 13.44 0.02 OUTLIER 'General case' 0 N--CA 1.445 -0.717 0 CA-C-N 115.669 -0.696 . . . . 1.0 110.717 -179.689 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 89' ' ' VAL . . . . . 0.588 ' O ' ' N ' ' A' ' 92' ' ' HIS . 33.5 t -84.89 45.2 0.06 OUTLIER 'Isoleucine or valine' 0 C--O 1.218 -0.558 0 CA-C-N 118.385 0.539 . . . . 1.0 110.996 -179.942 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 90' ' ' GLY . . . . . 0.724 ' O ' ' N ' ' A' ' 92' ' ' HIS . . . -30.08 -42.22 0.05 OUTLIER Glycine 0 CA--C 1.539 1.553 0 CA-C-O 117.575 -1.68 . . . . 1.0 111.149 -174.782 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 91' ' ' PRO . . . . . 0.502 ' C ' ' N ' ' A' ' 93' ' ' LEU . 95.3 Cg_exo -43.11 -4.0 0.01 OUTLIER 'Trans proline' 0 N--CA 1.499 1.842 0 CA-C-N 121.807 2.804 . . . . 1.0 111.602 170.475 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 92' ' ' HIS . . . . . 0.724 ' N ' ' O ' ' A' ' 90' ' ' GLY . 0.4 OUTLIER -48.47 -15.83 0.09 Allowed 'General case' 0 C--N 1.343 0.308 0 N-CA-C 107.873 -1.158 . . . . 1.0 107.873 -177.308 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 93' ' ' LEU . . . . . 0.625 ' O ' ' N ' ' A' ' 96' ' ' ALA . 7.1 tp -58.49 -50.27 74.36 Favored 'General case' 0 N--CA 1.447 -0.592 0 N-CA-C 106.62 -1.622 . . . . 1.0 106.62 176.183 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 94' ' ' ALA . . . . . 0.447 ' N ' ' O ' ' A' ' 91' ' ' PRO . . . -46.91 -50.43 18.79 Favored 'General case' 0 CA--C 1.518 -0.267 0 N-CA-C 107.685 -1.228 . . . . 1.0 107.685 -178.089 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 95' ' ' ARG . . . . . 0.51 ' HE ' ' HA ' ' A' ' 92' ' ' HIS . 4.5 mtm-85 -61.33 -28.48 69.24 Favored 'General case' 0 N--CA 1.443 -0.78 0 N-CA-C 109.057 -0.72 . . . . 1.0 109.057 176.122 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 96' ' ' ALA . . . . . 0.675 ' O ' ' N ' ' A' ' 100' ' ' ILE . . . -54.34 -52.06 62.76 Favored 'General case' 0 N--CA 1.475 0.822 0 N-CA-C 107.104 -1.443 . . . . 1.0 107.104 -179.946 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 97' ' ' LEU . . . . . 0.555 ' O ' HG22 ' A' ' 100' ' ' ILE . 0.7 OUTLIER -36.57 -26.18 0.01 OUTLIER 'General case' 0 CA--C 1.577 1.992 0 CA-C-N 114.274 -1.33 . . . . 1.0 108.485 -178.04 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 98' ' ' GLY . . . . . 0.572 ' N ' ' O ' ' A' ' 96' ' ' ALA . . . -84.68 -51.09 3.96 Favored Glycine 0 CA--C 1.55 2.279 0 CA-C-O 123.814 1.786 . . . . 1.0 110.749 173.939 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 99' ' ' GLN . . . . . 0.558 ' N ' ' O ' ' A' ' 96' ' ' ALA . 99.0 mm-40 -75.84 9.71 2.22 Favored 'General case' 0 N--CA 1.428 -1.543 0 CA-C-N 113.514 -1.343 . . . . 1.0 107.649 177.037 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 100' ' ' ILE . . . . . 0.788 HG23 ' N ' ' A' ' 101' ' ' VAL . 9.7 tt -61.62 -55.8 22.01 Favored 'Isoleucine or valine' 0 CA--C 1.482 -1.651 0 N-CA-C 109.307 -0.627 . . . . 1.0 109.307 179.063 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 101' ' ' VAL . . . . . 0.788 ' N ' HG23 ' A' ' 100' ' ' ILE . 5.8 p -56.68 -59.48 2.96 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.739 0 C-N-CA 117.485 -1.686 . . . . 1.0 107.739 179.789 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 102' ' ' CYS . . . . . 0.949 ' O ' ' HB2' ' A' ' 106' ' ' ALA . 0.5 OUTLIER -44.24 -18.13 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.438 0 C-N-CA 120.5 -0.48 . . . . 1.0 111.448 -177.001 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 103' ' ' ARG . . . . . 0.497 ' NH2' ' HB1' ' A' ' 96' ' ' ALA . 6.1 ttp180 -98.07 -37.42 9.75 Favored 'General case' 0 N--CA 1.474 0.739 0 CA-C-O 121.944 0.878 . . . . 1.0 112.859 178.127 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 104' ' ' TYR . . . . . 0.637 ' O ' ' CG ' ' A' ' 104' ' ' TYR . 51.5 t80 -101.84 21.69 14.17 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-N 113.785 -1.552 . . . . 1.0 110.552 179.206 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 105' ' ' GLY . . . . . 0.769 ' O ' ' N ' ' A' ' 107' ' ' THR . . . -171.36 -12.26 0.02 OUTLIER Glycine 0 C--O 1.22 -0.741 0 C-N-CA 119.145 -1.503 . . . . 1.0 112.286 179.516 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 106' ' ' ALA . . . . . 0.949 ' HB2' ' O ' ' A' ' 102' ' ' CYS . . . -16.53 67.38 0.0 OUTLIER 'General case' 0 N--CA 1.476 0.874 0 O-C-N 124.432 0.725 . . . . 1.0 111.989 -179.8 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 107' ' ' THR . . . . . 0.769 ' N ' ' O ' ' A' ' 105' ' ' GLY . 9.9 t -117.78 -7.01 11.03 Favored 'General case' 0 CA--C 1.516 -0.33 0 N-CA-C 109.448 -0.575 . . . . 1.0 109.448 -179.621 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 11.5 m -87.14 17.7 0.57 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.452 0 N-CA-C 109.546 -0.538 . . . . 1.0 109.546 179.76 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 109' ' ' ILE . . . . . 0.723 ' N ' ' HD2' ' A' ' 110' ' ' PRO . 48.5 pt -113.71 -19.02 0.11 Allowed Pre-proline 0 CA--C 1.576 1.953 0 N-CA-C 113.773 1.027 . . . . 1.0 113.773 177.58 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 110' ' ' PRO . . . . . 0.723 ' HD2' ' N ' ' A' ' 109' ' ' ILE . 14.2 Cg_endo -53.73 -38.64 85.03 Favored 'Trans proline' 0 N--CA 1.497 1.703 0 C-N-CA 123.736 2.957 . . . . 1.0 113.991 -172.684 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 23.7 t30 -63.24 -67.95 0.38 Allowed 'General case' 0 N--CA 1.441 -0.881 0 C-N-CA 118.526 -1.27 . . . . 1.0 109.278 -179.268 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 112' ' ' ILE . . . . . 0.664 HG22 HD23 ' A' ' 33' ' ' LEU . 0.1 OUTLIER -63.35 -29.54 47.5 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.387 0 CA-C-O 121.416 0.627 . . . . 1.0 110.016 -178.261 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 113' ' ' ASN . . . . . 0.651 ' ND2' ' OE2' ' A' ' 117' ' ' GLU . 7.2 t-20 -58.76 -64.02 1.08 Allowed 'General case' 0 C--N 1.309 -1.169 0 C-N-CA 118.874 -1.13 . . . . 1.0 110.044 -175.882 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -62.65 -25.74 68.28 Favored 'General case' 0 C--N 1.319 -0.73 0 C-N-CA 119.936 -0.706 . . . . 1.0 111.986 -179.708 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -77.39 -59.33 2.82 Favored 'General case' 0 C--O 1.232 0.173 0 C-N-CA 119.463 -0.895 . . . . 1.0 110.459 179.176 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 116' ' ' ILE . . . . . 0.417 ' O ' ' N ' ' A' ' 119' ' ' LEU . 50.4 mt -63.58 -48.34 87.29 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.398 0 C-N-CA 119.954 -0.698 . . . . 1.0 109.604 -179.379 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 117' ' ' GLU . . . . . 0.651 ' OE2' ' ND2' ' A' ' 113' ' ' ASN . 93.4 mt-10 -46.94 -67.0 0.32 Allowed 'General case' 0 CA--C 1.503 -0.865 0 C-N-CA 119.835 -0.746 . . . . 1.0 109.195 -178.245 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 39.5 t -48.48 -22.53 0.68 Allowed 'Isoleucine or valine' 0 N--CA 1.44 -0.936 0 C-N-CA 120.114 -0.634 . . . . 1.0 109.971 179.744 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 119' ' ' LEU . . . . . 0.417 ' N ' ' O ' ' A' ' 116' ' ' ILE . 0.4 OUTLIER -78.45 -60.03 2.54 Favored 'General case' 0 C--N 1.346 0.431 0 N-CA-C 107.736 -1.209 . . . . 1.0 107.736 178.721 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 120' ' ' GLY . . . . . 0.561 ' C ' HG22 ' A' ' 121' ' ' THR . . . -62.28 -81.43 0.09 OUTLIER Glycine 0 C--N 1.354 1.537 0 C-N-CA 117.907 -2.092 . . . . 1.0 108.292 176.51 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 121' ' ' THR . . . . . 0.722 HG23 ' H ' ' A' ' 123' ' ' THR . 1.4 t 151.08 -16.12 0.0 OUTLIER 'General case' 0 N--CA 1.486 1.37 0 O-C-N 125.322 1.248 . . . . 1.0 113.505 178.28 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 122' ' ' GLY . . . . . 0.657 ' O ' ' N ' ' A' ' 124' ' ' ASP . . . 109.74 -13.18 32.44 Favored Glycine 0 N--CA 1.47 0.919 0 N-CA-C 108.521 -1.831 . . . . 1.0 108.521 -176.195 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 123' ' ' THR . . . . . 0.746 HG23 ' O ' ' A' ' 123' ' ' THR . 15.1 t -58.58 80.0 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.202 0 N-CA-C 106.755 -1.572 . . . . 1.0 106.755 178.735 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 124' ' ' ASP . . . . . 0.657 ' N ' ' O ' ' A' ' 122' ' ' GLY . 14.9 t70 -164.62 169.09 17.43 Favored 'General case' 0 N--CA 1.444 -0.76 0 CA-C-N 113.719 -1.582 . . . . 1.0 112.107 -179.631 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 125' ' ' TYR . . . . . 0.551 ' C ' ' CD1' ' A' ' 125' ' ' TYR . 0.0 OUTLIER -146.68 145.47 30.02 Favored 'General case' 0 CA--C 1.54 0.584 0 N-CA-C 108.889 -0.782 . . . . 1.0 108.889 177.393 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -148.84 149.06 30.65 Favored 'General case' 0 CA--C 1.536 0.418 0 N-CA-C 110.166 -0.309 . . . . 1.0 110.166 178.266 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 127' ' ' PHE . . . . . . . . . . . . . 27.2 p90 . . . . . 0 N--CA 1.471 0.595 0 CA-C-O 117.864 -1.065 . . . . 1.0 110.249 179.08 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 39.0 mtt . . . . . 0 N--CA 1.489 1.475 0 N-CA-C 108.704 -0.851 . . . . 1.0 108.704 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 78.3 p -109.16 -3.79 17.03 Favored 'General case' 0 N--CA 1.466 0.334 0 CA-C-N 116.336 -0.393 . . . . 1.0 110.575 178.912 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 3' ' ' ASP . . . . . 0.44 ' OD1' ' N ' ' A' ' 3' ' ' ASP . 7.8 p-10 -174.66 91.96 0.07 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.28 -0.418 . . . . 1.0 111.785 -179.72 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 52.2 t80 -150.2 144.31 25.56 Favored 'General case' 0 C--N 1.328 -0.335 0 N-CA-C 109.367 -0.605 . . . . 1.0 109.367 179.162 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 5' ' ' ASP . . . . . 0.834 ' OD1' ' N ' ' A' ' 10' ' ' SER . 31.8 t0 -150.66 146.82 26.73 Favored 'General case' 0 C--N 1.328 -0.337 0 N-CA-C 110.082 -0.34 . . . . 1.0 110.082 -179.29 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 6' ' ' THR . . . . . 0.663 ' N ' ' OD1' ' A' ' 5' ' ' ASP . 0.2 OUTLIER -100.79 -178.1 3.67 Favored 'General case' 0 C--O 1.199 -1.599 0 CA-C-O 121.103 0.478 . . . . 1.0 110.782 179.904 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 7' ' ' GLU . . . . . 0.553 ' O ' ' HB3' ' A' ' 11' ' ' ARG . 29.0 tt0 -55.04 -41.23 71.15 Favored 'General case' 0 C--N 1.303 -1.442 0 CA-C-N 116.477 -0.329 . . . . 1.0 111.488 179.181 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 8' ' ' ARG . . . . . 0.713 ' O ' ' HB3' ' A' ' 12' ' ' ALA . 31.3 mtp180 -69.02 -63.98 0.96 Allowed 'General case' 0 C--N 1.313 -0.996 0 CA-C-O 123.086 1.422 . . . . 1.0 110.249 178.886 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 9' ' ' VAL . . . . . 0.643 ' O ' ' HB ' ' A' ' 13' ' ' VAL . 12.2 t -57.63 -43.67 83.91 Favored 'Isoleucine or valine' 0 C--N 1.282 -2.358 0 CA-C-N 114.464 -1.244 . . . . 1.0 109.188 178.304 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 10' ' ' SER . . . . . 0.834 ' N ' ' OD1' ' A' ' 5' ' ' ASP . 14.9 t -68.6 -65.92 0.64 Allowed 'General case' 0 C--N 1.305 -1.337 0 O-C-N 121.256 -0.902 . . . . 1.0 111.282 -179.02 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 11' ' ' ARG . . . . . 0.553 ' HB3' ' O ' ' A' ' 7' ' ' GLU . 23.1 tpp180 -60.94 -42.41 98.13 Favored 'General case' 0 C--N 1.314 -0.973 0 CA-C-N 116.278 -0.419 . . . . 1.0 110.566 -177.562 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 12' ' ' ALA . . . . . 0.713 ' HB3' ' O ' ' A' ' 8' ' ' ARG . . . -69.56 -61.04 1.95 Allowed 'General case' 0 C--N 1.319 -0.752 0 C-N-CA 119.106 -1.038 . . . . 1.0 111.169 -179.602 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 13' ' ' VAL . . . . . 0.798 ' O ' ' CB ' ' A' ' 17' ' ' LEU . 0.3 OUTLIER -56.8 -45.9 83.21 Favored 'Isoleucine or valine' 0 C--O 1.187 -2.228 0 N-CA-C 106.602 -1.629 . . . . 1.0 106.602 179.921 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 14' ' ' ALA . . . . . 0.965 ' O ' HG22 ' A' ' 18' ' ' VAL . . . -66.47 -65.51 0.67 Allowed 'General case' 0 C--N 1.307 -1.263 0 C-N-CA 117.094 -1.842 . . . . 1.0 112.731 -178.745 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 15' ' ' ALA . . . . . 0.524 ' O ' ' N ' ' A' ' 19' ' ' GLY . . . -50.16 -53.45 27.6 Favored 'General case' 0 C--N 1.32 -0.708 0 N-CA-C 108.088 -1.079 . . . . 1.0 108.088 179.897 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 16' ' ' ALA . . . . . 0.607 ' HB3' ' O ' ' A' ' 12' ' ' ALA . . . -66.34 -59.95 3.23 Favored 'General case' 0 C--N 1.298 -1.667 0 C-N-CA 118.27 -1.372 . . . . 1.0 111.41 179.512 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 17' ' ' LEU . . . . . 0.798 ' CB ' ' O ' ' A' ' 13' ' ' VAL . 7.7 tt -55.01 -55.55 29.66 Favored 'General case' 0 N--CA 1.481 1.114 0 CA-C-N 114.777 -1.101 . . . . 1.0 108.625 -176.884 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 18' ' ' VAL . . . . . 0.965 HG22 ' O ' ' A' ' 14' ' ' ALA . 2.0 m -71.12 -59.36 3.52 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.658 0 CA-C-N 116.146 -0.479 . . . . 1.0 110.692 179.603 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 19' ' ' GLY . . . . . 0.592 ' N ' ' CG2' ' A' ' 18' ' ' VAL . . . -55.48 -171.69 0.1 OUTLIER Glycine 0 CA--C 1.486 -1.741 0 N-CA-C 109.593 -1.403 . . . . 1.0 109.593 -176.986 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 20' ' ' PRO . . . . . 0.613 ' O ' ' N ' ' A' ' 24' ' ' ALA . 81.1 Cg_endo -81.69 -26.88 2.89 Favored 'Trans proline' 0 C--N 1.286 -2.758 0 C-N-CA 122.025 1.817 . . . . 1.0 113.894 -177.555 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 21' ' ' GLY . . . . . 0.583 ' O ' ' HB3' ' A' ' 24' ' ' ALA . . . -59.81 -59.05 11.2 Favored Glycine 0 N--CA 1.473 1.159 0 O-C-N 124.156 0.91 . . . . 1.0 111.357 -178.903 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -55.79 -56.99 21.03 Favored Glycine 0 CA--C 1.5 -0.848 0 C-N-CA 117.083 -2.484 . . . . 1.0 107.577 -177.823 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 23' ' ' VAL . . . . . 0.543 ' O ' HG12 ' A' ' 27' ' ' VAL . 93.2 t -53.94 -29.59 18.57 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.145 0 CA-C-N 113.97 -1.115 . . . . 1.0 108.201 178.573 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 24' ' ' ALA . . . . . 0.613 ' N ' ' O ' ' A' ' 20' ' ' PRO . . . -63.63 -65.53 0.67 Allowed 'General case' 0 C--O 1.213 -0.825 0 C-N-CA 119.503 -0.879 . . . . 1.0 111.291 -178.939 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 25' ' ' LEU . . . . . 0.557 ' O ' HD12 ' A' ' 25' ' ' LEU . 0.4 OUTLIER -58.35 -48.68 79.81 Favored 'General case' 0 C--N 1.311 -1.092 0 C-N-CA 119.632 -0.827 . . . . 1.0 111.131 -179.139 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 26' ' ' VAL . . . . . 0.426 ' N ' ' HG ' ' A' ' 25' ' ' LEU . 81.5 t -58.26 -61.42 1.37 Allowed 'Isoleucine or valine' 0 CA--C 1.503 -0.849 0 C-N-CA 119.517 -0.873 . . . . 1.0 110.471 -174.404 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 27' ' ' VAL . . . . . 0.643 ' O ' ' HB3' ' A' ' 31' ' ' ALA . 2.0 p -56.35 -36.59 47.25 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.97 0 C-N-CA 120.081 -0.648 . . . . 1.0 109.632 -178.969 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 20.1 mtpp -68.13 -59.3 3.34 Favored 'General case' 0 C--N 1.318 -0.775 0 C-N-CA 119.452 -0.899 . . . . 1.0 111.932 -176.84 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 2.9 t -62.24 -50.22 80.85 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.379 0 CA-C-N 114.504 -1.225 . . . . 1.0 110.191 -177.688 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 30' ' ' CYS . . . . . . . . . . . . . 21.2 t -64.32 -62.36 1.65 Allowed 'General case' 0 N--CA 1.442 -0.857 0 C-N-CA 119.214 -0.994 . . . . 1.0 110.484 -177.598 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 31' ' ' ALA . . . . . 0.643 ' HB3' ' O ' ' A' ' 27' ' ' VAL . . . -56.46 -48.19 77.59 Favored 'General case' 0 CA--C 1.502 -0.878 0 CA-C-O 121.536 0.684 . . . . 1.0 110.076 -176.879 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 32' ' ' GLY . . . . . 0.64 ' O ' ' HB2' ' A' ' 33' ' ' LEU . . . 76.78 68.37 1.54 Allowed Glycine 0 CA--C 1.496 -1.114 0 N-CA-C 109.915 -1.274 . . . . 1.0 109.915 -179.657 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 33' ' ' LEU . . . . . 0.64 ' HB2' ' O ' ' A' ' 32' ' ' GLY . 5.2 mt 86.04 123.29 0.03 OUTLIER Pre-proline 0 CA--C 1.544 0.742 0 O-C-N 124.965 1.038 . . . . 1.0 110.402 -179.159 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 34' ' ' PRO . . . . . 0.541 ' HD2' HD23 ' A' ' 33' ' ' LEU . 49.2 Cg_endo -69.22 -17.94 39.78 Favored 'Trans proline' 0 N--CA 1.493 1.456 0 C-N-CA 122.131 1.887 . . . . 1.0 112.903 -178.324 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 35' ' ' GLY . . . . . 0.439 ' C ' HG21 ' A' ' 112' ' ' ILE . . . -62.95 -63.62 4.45 Favored Glycine 0 CA--C 1.527 0.806 0 C-N-CA 118.497 -1.811 . . . . 1.0 111.187 -178.093 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 36' ' ' VAL . . . . . 0.881 HG22 ' H ' ' A' ' 37' ' ' ILE . 5.1 p -77.5 -152.73 0.02 OUTLIER 'Isoleucine or valine' 0 CA--C 1.491 -1.304 0 N-CA-C 107.334 -1.358 . . . . 1.0 107.334 -179.641 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 37' ' ' ILE . . . . . 0.881 ' H ' HG22 ' A' ' 36' ' ' VAL . 0.3 OUTLIER 75.62 76.69 0.04 OUTLIER 'Isoleucine or valine' 0 C--O 1.218 -0.574 0 O-C-N 125.132 1.52 . . . . 1.0 111.534 178.069 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 38' ' ' HIS . . . . . 0.564 ' ND1' ' O ' ' A' ' 37' ' ' ILE . 1.8 m80 -137.64 133.93 34.9 Favored 'General case' 0 CA--C 1.487 -1.453 0 O-C-N 119.304 -2.122 . . . . 1.0 107.594 179.781 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 39' ' ' THR . . . . . 0.563 ' OG1' ' O ' ' A' ' 41' ' ' ALA . 0.5 OUTLIER -107.99 122.78 39.67 Favored Pre-proline 0 CA--C 1.54 0.568 0 O-C-N 123.74 0.65 . . . . 1.0 110.549 -178.963 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 32.6 Cg_exo -61.83 -23.57 76.22 Favored 'Trans proline' 0 N--CA 1.495 1.57 0 C-N-CA 122.483 2.122 . . . . 1.0 112.378 178.046 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 41' ' ' ALA . . . . . 0.563 ' O ' ' OG1' ' A' ' 39' ' ' THR . . . -128.14 132.62 48.92 Favored 'General case' 0 N--CA 1.475 0.783 0 C-N-CA 122.394 0.278 . . . . 1.0 110.421 178.301 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 42' ' ' ARG . . . . . 0.435 ' CD ' ' O ' ' A' ' 39' ' ' THR . 0.0 OUTLIER -177.56 -177.59 0.68 Allowed 'General case' 0 N--CA 1.465 0.278 0 CA-C-N 117.962 0.346 . . . . 1.0 110.893 179.721 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 77.1 ttt180 -57.16 -46.1 83.04 Favored 'General case' 0 CA--C 1.536 0.427 0 N-CA-C 107.911 -1.144 . . . . 1.0 107.911 177.873 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 44' ' ' GLY . . . . . 0.516 ' C ' ' CG ' ' A' ' 45' ' ' PHE . . . 118.09 -25.57 8.27 Favored Glycine 0 N--CA 1.474 1.184 0 CA-C-O 120.067 -0.296 . . . . 1.0 112.642 178.912 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 45' ' ' PHE . . . . . 0.71 ' O ' ' HB2' ' A' ' 46' ' ' PHE . 0.1 OUTLIER -159.19 166.42 31.47 Favored 'General case' 0 CA--C 1.486 -1.496 0 N-CA-C 106.966 -1.494 . . . . 1.0 106.966 -179.258 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 46' ' ' PHE . . . . . 0.71 ' HB2' ' O ' ' A' ' 45' ' ' PHE . 31.2 m-85 104.1 116.95 0.01 OUTLIER 'General case' 0 N--CA 1.487 1.379 0 O-C-N 126.134 2.147 . . . . 1.0 110.589 179.815 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 47' ' ' ARG . . . . . 0.564 ' CG ' ' O ' ' A' ' 46' ' ' PHE . 0.0 OUTLIER 87.29 161.36 0.08 Allowed 'General case' 0 C--N 1.348 0.531 0 O-C-N 124.487 1.117 . . . . 1.0 110.499 179.366 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 48' ' ' CYS . . . . . 0.449 ' N ' ' HD3' ' A' ' 47' ' ' ARG . 41.2 t 61.67 67.19 0.78 Allowed 'General case' 0 CA--C 1.506 -0.723 0 N-CA-C 109.629 -0.508 . . . . 1.0 109.629 178.379 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 49' ' ' ASN . . . . . 0.769 ' O ' ' N ' ' A' ' 51' ' ' GLU . 10.5 m-80 -150.76 157.66 35.79 Favored Pre-proline 0 C--N 1.319 -0.721 0 CA-C-O 118.333 -0.842 . . . . 1.0 109.323 179.053 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 50' ' ' PRO . . . . . 0.6 ' HB2' ' HE ' ' A' ' 52' ' ' ARG . 50.1 Cg_exo -45.52 54.5 0.01 OUTLIER 'Trans proline' 0 N--CA 1.506 2.259 0 C-N-CA 123.768 2.979 . . . . 1.0 112.724 178.173 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 51' ' ' GLU . . . . . 0.769 ' N ' ' O ' ' A' ' 49' ' ' ASN . 1.6 mt-10 47.48 54.67 9.33 Favored 'General case' 0 C--N 1.33 -0.263 0 C-N-CA 123.357 0.663 . . . . 1.0 111.616 179.332 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 52' ' ' ARG . . . . . 0.6 ' HE ' ' HB2' ' A' ' 50' ' ' PRO . 34.3 mtm105 -152.24 167.2 29.38 Favored 'General case' 0 N--CA 1.469 0.507 0 CA-C-N 116.429 -0.35 . . . . 1.0 110.732 -179.125 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 53' ' ' ILE . . . . . 0.461 HG13 ' H ' ' A' ' 54' ' ' GLN . 2.2 tp -83.5 169.45 1.55 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.342 0 N-CA-C 108.531 -0.915 . . . . 1.0 108.531 178.536 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 54' ' ' GLN . . . . . 0.461 ' H ' HG13 ' A' ' 53' ' ' ILE . 0.0 OUTLIER -135.35 132.18 37.31 Favored 'General case' 0 N--CA 1.466 0.333 0 N-CA-C 109.294 -0.632 . . . . 1.0 109.294 -179.395 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 55' ' ' ILE . . . . . 0.467 ' N ' HD13 ' A' ' 55' ' ' ILE . 0.2 OUTLIER -145.4 154.63 13.62 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 N-CA-C 110.243 -0.28 . . . . 1.0 110.243 179.695 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 100.63 4.62 54.61 Favored Glycine 0 C--N 1.335 0.501 0 N-CA-C 109.975 -1.25 . . . . 1.0 109.975 179.47 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 73.1 m-20 -95.1 116.77 29.15 Favored 'General case' 0 CA--C 1.541 0.627 0 CA-C-O 122.842 1.306 . . . . 1.0 113.095 -179.68 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 58' ' ' TRP . . . . . 0.466 ' H ' ' CD ' ' A' ' 61' ' ' GLU . 17.8 m0 -79.19 179.46 7.37 Favored 'General case' 0 N--CA 1.483 1.206 0 CA-C-N 112.731 -2.031 . . . . 1.0 110.185 178.191 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 59' ' ' ARG . . . . . 0.537 ' HG2' ' H ' ' A' ' 60' ' ' TYR . 0.0 OUTLIER -93.22 -55.9 3.15 Favored 'General case' 0 CA--C 1.544 0.715 0 CA-C-N 118.434 0.561 . . . . 1.0 111.111 178.65 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 60' ' ' TYR . . . . . 0.537 ' H ' ' HG2' ' A' ' 59' ' ' ARG . 34.4 p90 -69.99 0.67 5.58 Favored 'General case' 0 C--O 1.239 0.53 0 C-N-CA 124.171 0.988 . . . . 1.0 108.866 178.676 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 61' ' ' GLU . . . . . 0.548 ' O ' ' N ' ' A' ' 65' ' ' ASP . 1.3 tt0 -61.63 -17.92 57.29 Favored 'General case' 0 C--O 1.21 -1.0 0 CA-C-N 115.348 -0.842 . . . . 1.0 112.447 -178.76 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 62' ' ' VAL . . . . . 0.719 HG23 ' H ' ' A' ' 63' ' ' ALA . 17.4 m -46.61 -56.29 1.36 Allowed 'Isoleucine or valine' 0 C--N 1.304 -1.394 0 N-CA-C 109.299 -0.63 . . . . 1.0 109.299 -174.724 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 63' ' ' ALA . . . . . 0.719 ' H ' HG23 ' A' ' 62' ' ' VAL . . . -60.9 -51.22 70.22 Favored 'General case' 0 N--CA 1.423 -1.796 0 N-CA-C 108.493 -0.928 . . . . 1.0 108.493 178.786 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 64' ' ' HIS . . . . . 0.562 ' HA ' ' HE ' ' A' ' 67' ' ' ARG . 19.1 t-80 -57.61 -60.62 3.4 Favored 'General case' 0 CA--C 1.548 0.903 0 CA-C-O 121.809 0.814 . . . . 1.0 112.356 -179.643 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 65' ' ' ASP . . . . . 0.613 ' C ' ' H ' ' A' ' 67' ' ' ARG . 29.7 t70 -66.83 -53.47 32.33 Favored 'General case' 0 C--N 1.312 -1.051 0 O-C-N 121.264 -0.897 . . . . 1.0 110.246 -179.267 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 66' ' ' GLY . . . . . 0.447 ' N ' ' O ' ' A' ' 62' ' ' VAL . . . -60.96 30.4 0.05 OUTLIER Glycine 0 CA--C 1.527 0.841 0 CA-C-N 115.734 -0.666 . . . . 1.0 112.593 -179.212 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 67' ' ' ARG . . . . . 0.613 ' H ' ' C ' ' A' ' 65' ' ' ASP . 94.8 mtt-85 -82.83 -5.09 58.8 Favored 'General case' 0 C--N 1.321 -0.672 0 O-C-N 122.746 -0.267 . . . . 1.0 111.647 175.697 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 68' ' ' LEU . . . . . 0.711 ' O ' ' HA ' ' A' ' 72' ' ' HIS . 0.2 OUTLIER -38.11 -28.74 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.524 0 CA-C-O 123.33 1.538 . . . . 1.0 107.084 178.907 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 69' ' ' LEU . . . . . 0.656 HD12 ' N ' ' A' ' 70' ' ' ALA . 0.9 OUTLIER -65.89 -64.01 0.96 Allowed 'General case' 0 CA--C 1.552 1.024 0 N-CA-C 105.847 -1.909 . . . . 1.0 105.847 175.716 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 70' ' ' ALA . . . . . 0.738 ' C ' ' H ' ' A' ' 72' ' ' HIS . . . -77.57 -73.36 0.31 Allowed 'General case' 0 C--N 1.364 1.232 0 N-CA-C 107.458 -1.312 . . . . 1.0 107.458 178.712 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 71' ' ' ALA . . . . . 0.757 ' HB1' ' HB ' ' A' ' 74' ' ' VAL . . . -50.17 7.4 0.0 OUTLIER 'General case' 0 C--N 1.351 0.671 0 C-N-CA 124.746 1.218 . . . . 1.0 110.744 177.834 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 72' ' ' HIS . . . . . 0.738 ' H ' ' C ' ' A' ' 70' ' ' ALA . 0.0 OUTLIER -17.56 -65.11 0.02 OUTLIER 'General case' 0 CA--C 1.492 -1.271 0 C-N-CA 123.565 0.746 . . . . 1.0 111.208 -175.852 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 73' ' ' MET . . . . . 0.499 ' N ' ' ND1' ' A' ' 72' ' ' HIS . 0.0 OUTLIER -77.24 -48.57 17.18 Favored 'General case' 0 C--N 1.292 -1.914 0 C-N-CA 120.275 -0.57 . . . . 1.0 110.452 178.264 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 74' ' ' VAL . . . . . 0.757 ' HB ' ' HB1' ' A' ' 71' ' ' ALA . 69.3 t -42.08 -44.45 0.98 Allowed 'Isoleucine or valine' 0 C--O 1.221 -0.405 0 CA-C-O 117.64 -1.172 . . . . 1.0 109.388 -174.7 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 75' ' ' ASN . . . . . 0.406 ' C ' ' N ' ' A' ' 77' ' ' ILE . 27.7 t-20 -36.75 -19.26 0.01 OUTLIER 'General case' 0 CA--C 1.553 1.094 0 CA-C-O 123.327 1.537 . . . . 1.0 110.639 179.342 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 76' ' ' GLY . . . . . 0.692 ' O ' HG12 ' A' ' 79' ' ' ILE . . . -49.05 -20.97 2.22 Favored Glycine 0 CA--C 1.543 1.827 0 N-CA-C 108.657 -1.777 . . . . 1.0 108.657 174.864 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 77' ' ' ILE . . . . . 0.485 HG13 ' H ' ' A' ' 78' ' ' VAL . 4.7 pt -47.4 -50.31 7.99 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.64 0 O-C-N 120.972 -1.31 . . . . 1.0 113.059 -179.02 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 78' ' ' VAL . . . . . 0.485 ' H ' HG13 ' A' ' 77' ' ' ILE . 12.0 p -55.1 -22.1 10.0 Favored 'Isoleucine or valine' 0 CA--C 1.504 -0.791 0 CA-C-O 120.832 0.348 . . . . 1.0 111.11 -178.024 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 79' ' ' ILE . . . . . 0.803 ' O ' ' HB2' ' A' ' 83' ' ' ALA . 0.5 OUTLIER -83.44 -46.01 18.56 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.867 0 C-N-CA 119.871 -0.731 . . . . 1.0 110.873 179.885 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 80' ' ' ALA . . . . . 0.507 ' N ' ' CG1' ' A' ' 79' ' ' ILE . . . -76.99 -21.84 54.08 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 115.633 -0.712 . . . . 1.0 111.007 -178.74 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 81' ' ' GLU . . . . . 0.547 ' OE1' ' N ' ' A' ' 81' ' ' GLU . 0.7 OUTLIER -83.07 -69.24 0.64 Allowed 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.011 -0.54 . . . . 1.0 111.093 -179.569 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 82' ' ' ASP . . . . . 0.636 ' O ' ' N ' ' A' ' 84' ' ' LEU . 88.9 m-20 -60.54 -60.86 3.13 Favored 'General case' 0 CA--C 1.496 -1.104 0 CA-C-O 118.048 -0.977 . . . . 1.0 110.376 -177.622 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 83' ' ' ALA . . . . . 0.803 ' HB2' ' O ' ' A' ' 79' ' ' ILE . . . 0.94 -66.22 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.773 0 O-C-N 125.475 1.735 . . . . 1.0 110.312 -179.793 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 84' ' ' LEU . . . . . 0.636 ' N ' ' O ' ' A' ' 82' ' ' ASP . 4.4 mm? -25.15 -49.87 0.03 OUTLIER 'General case' 0 N--CA 1.473 0.687 0 CA-C-N 115.521 -0.763 . . . . 1.0 109.802 -176.713 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 85' ' ' ILE . . . . . 0.627 HG23 ' N ' ' A' ' 86' ' ' ALA . 13.7 tt -98.29 -51.0 10.76 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.699 0 N-CA-C 109.438 -0.579 . . . . 1.0 109.438 177.014 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 86' ' ' ALA . . . . . 0.952 ' O ' HG13 ' A' ' 89' ' ' VAL . . . -50.39 -46.95 56.47 Favored 'General case' 0 C--O 1.224 -0.267 0 CA-C-N 116.026 -0.533 . . . . 1.0 110.747 -179.184 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 87' ' ' GLU . . . . . 0.568 ' N ' ' O ' ' A' ' 83' ' ' ALA . 22.6 tp10 -47.7 -18.32 0.14 Allowed 'General case' 0 C--N 1.323 -0.577 0 CA-C-O 120.987 0.422 . . . . 1.0 110.328 179.601 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 88' ' ' ALA . . . . . 0.84 ' C ' ' H ' ' A' ' 90' ' ' GLY . . . -74.45 6.11 4.04 Favored 'General case' 0 CA--C 1.491 -1.309 0 CA-C-N 115.745 -0.661 . . . . 1.0 110.818 -179.718 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 89' ' ' VAL . . . . . 0.952 HG13 ' O ' ' A' ' 86' ' ' ALA . 19.3 m -48.63 15.88 0.0 OUTLIER 'Isoleucine or valine' 0 C--O 1.216 -0.685 0 O-C-N 124.529 1.143 . . . . 1.0 111.616 -179.746 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 90' ' ' GLY . . . . . 0.84 ' H ' ' C ' ' A' ' 88' ' ' ALA . . . -33.58 -50.65 0.57 Allowed Glycine 0 C--N 1.351 1.386 0 N-CA-C 108.05 -2.02 . . . . 1.0 108.05 -177.08 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 91' ' ' PRO . . . . . 0.466 ' O ' ' N ' ' A' ' 94' ' ' ALA . 73.0 Cg_exo -48.11 0.35 0.02 OUTLIER 'Trans proline' 0 N--CA 1.495 1.565 0 C-N-CA 122.463 2.109 . . . . 1.0 112.216 173.163 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 92' ' ' HIS . . . . . 0.715 ' N ' ' O ' ' A' ' 89' ' ' VAL . 0.0 OUTLIER -47.57 -37.05 11.55 Favored 'General case' 0 N--CA 1.445 -0.707 0 N-CA-C 107.794 -1.187 . . . . 1.0 107.794 -176.053 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 1.5 pp -61.78 -37.8 85.67 Favored 'General case' 0 N--CA 1.436 -1.145 0 CA-C-O 121.702 0.763 . . . . 1.0 111.107 178.59 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 94' ' ' ALA . . . . . 0.466 ' N ' ' O ' ' A' ' 91' ' ' PRO . . . -62.57 -62.4 1.77 Allowed 'General case' 0 C--N 1.33 -0.26 0 N-CA-C 107.795 -1.187 . . . . 1.0 107.795 179.279 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 63.4 mmt-85 -59.52 -28.84 67.43 Favored 'General case' 0 N--CA 1.438 -1.059 0 N-CA-C 109.237 -0.653 . . . . 1.0 109.237 179.71 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 96' ' ' ALA . . . . . 0.797 ' O ' ' N ' ' A' ' 100' ' ' ILE . . . -59.49 -53.87 53.09 Favored 'General case' 0 CA--C 1.496 -1.13 0 N-CA-C 107.114 -1.439 . . . . 1.0 107.114 179.915 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 97' ' ' LEU . . . . . 0.643 ' O ' HG22 ' A' ' 100' ' ' ILE . 0.9 OUTLIER -37.78 -32.17 0.05 Allowed 'General case' 0 CA--C 1.556 1.175 0 N-CA-C 108.217 -1.031 . . . . 1.0 108.217 -179.191 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 98' ' ' GLY . . . . . 0.485 ' N ' ' O ' ' A' ' 96' ' ' ALA . . . -82.17 -52.72 3.92 Favored Glycine 0 CA--C 1.564 3.152 0 CA-C-O 123.692 1.718 . . . . 1.0 112.131 173.875 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 99' ' ' GLN . . . . . 0.442 ' N ' ' O ' ' A' ' 96' ' ' ALA . 60.9 mm-40 -77.71 9.59 3.34 Favored 'General case' 0 N--CA 1.44 -0.932 0 N-CA-C 107.978 -1.119 . . . . 1.0 107.978 178.895 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 100' ' ' ILE . . . . . 0.797 ' N ' ' O ' ' A' ' 96' ' ' ALA . 18.9 tt -59.74 -55.1 26.13 Favored 'Isoleucine or valine' 0 CA--C 1.493 -1.215 0 N-CA-C 109.578 -0.527 . . . . 1.0 109.578 -178.51 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 101' ' ' VAL . . . . . 0.728 HG13 ' H ' ' A' ' 102' ' ' CYS . 4.2 p -58.58 -58.85 4.88 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.535 0 C-N-CA 118.862 -1.135 . . . . 1.0 108.26 178.636 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 102' ' ' CYS . . . . . 0.728 ' H ' HG13 ' A' ' 101' ' ' VAL . 13.1 t -45.61 -26.57 0.63 Allowed 'General case' 0 C--O 1.215 -0.75 0 C-N-CA 120.212 -0.595 . . . . 1.0 109.525 -177.835 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 103' ' ' ARG . . . . . 0.431 ' N ' ' C ' ' A' ' 101' ' ' VAL . 0.0 OUTLIER -88.63 -41.96 12.32 Favored 'General case' 0 CA--C 1.549 0.911 0 CA-C-O 122.347 1.07 . . . . 1.0 113.846 179.598 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 104' ' ' TYR . . . . . 0.748 ' CG ' ' O ' ' A' ' 104' ' ' TYR . 4.0 t80 -95.25 23.0 6.16 Favored 'General case' 0 C--N 1.303 -1.445 0 C-N-CA 127.05 2.14 . . . . 1.0 108.722 178.128 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 105' ' ' GLY . . . . . 0.522 ' N ' ' O ' ' A' ' 101' ' ' VAL . . . -163.15 -86.29 0.06 OUTLIER Glycine 0 N--CA 1.442 -0.93 0 N-CA-C 108.058 -2.017 . . . . 1.0 108.058 178.102 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 106' ' ' ALA . . . . . 0.695 ' HB2' ' O ' ' A' ' 102' ' ' CYS . . . 64.08 66.66 0.63 Allowed 'General case' 0 C--N 1.32 -0.681 0 N-CA-C 112.42 0.526 . . . . 1.0 112.42 179.854 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 107' ' ' THR . . . . . 0.505 ' C ' ' HD2' ' A' ' 110' ' ' PRO . 0.5 OUTLIER -109.61 -9.93 14.86 Favored 'General case' 0 CA--C 1.536 0.431 0 O-C-N 122.136 -0.352 . . . . 1.0 110.438 179.086 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 108' ' ' VAL . . . . . 0.613 ' C ' ' HD2' ' A' ' 110' ' ' PRO . 0.0 OUTLIER -82.6 -62.81 1.34 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.694 0 N-CA-C 113.595 0.961 . . . . 1.0 113.595 -176.359 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 109' ' ' ILE . . . . . 0.594 ' N ' ' CD ' ' A' ' 110' ' ' PRO . 0.6 OUTLIER -54.61 -35.99 38.56 Favored Pre-proline 0 C--N 1.321 -0.673 0 N-CA-C 112.161 0.43 . . . . 1.0 112.161 179.933 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 110' ' ' PRO . . . . . 0.613 ' HD2' ' C ' ' A' ' 108' ' ' VAL . 81.4 Cg_exo -45.81 -32.48 9.19 Favored 'Trans proline' 0 C--N 1.323 -0.779 0 C-N-CA 122.258 1.972 . . . . 1.0 112.565 -174.697 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 111' ' ' ASN . . . . . 0.687 ' CG ' ' H ' ' A' ' 112' ' ' ILE . 12.5 p-10 -61.66 -68.62 0.3 Allowed 'General case' 0 CA--C 1.545 0.753 0 C-N-CA 119.699 -0.801 . . . . 1.0 110.355 -179.674 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 112' ' ' ILE . . . . . 0.687 ' H ' ' CG ' ' A' ' 111' ' ' ASN . 2.9 mm -74.7 -24.8 18.54 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.746 0 CA-C-O 121.851 0.834 . . . . 1.0 110.026 -178.122 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 18.9 t30 -51.72 -58.89 5.11 Favored 'General case' 0 C--N 1.298 -1.651 0 CA-C-N 114.159 -1.382 . . . . 1.0 109.933 -178.416 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -66.09 -19.5 65.86 Favored 'General case' 0 N--CA 1.447 -0.584 0 CA-C-N 116.22 -0.445 . . . . 1.0 110.359 179.197 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -75.13 -61.03 2.03 Favored 'General case' 0 CA--C 1.544 0.72 0 C-N-CA 120.312 -0.555 . . . . 1.0 111.242 178.388 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 116' ' ' ILE . . . . . 0.477 ' O ' ' CB ' ' A' ' 119' ' ' LEU . 15.1 tt -67.57 -38.94 81.41 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.334 0 O-C-N 121.052 -1.03 . . . . 1.0 110.918 -178.851 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 117' ' ' GLU . . . . . 0.472 ' C ' ' N ' ' A' ' 119' ' ' LEU . 1.0 OUTLIER -46.67 -68.06 0.23 Allowed 'General case' 0 C--N 1.3 -1.583 0 CA-C-N 115.334 -0.848 . . . . 1.0 110.493 -178.249 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 118' ' ' VAL . . . . . 0.44 HG12 ' O ' ' A' ' 118' ' ' VAL . 89.8 t -47.31 -14.03 0.08 OUTLIER 'Isoleucine or valine' 0 CA--C 1.505 -0.757 0 CA-C-N 114.838 -1.073 . . . . 1.0 109.515 -178.396 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 119' ' ' LEU . . . . . 0.477 ' CB ' ' O ' ' A' ' 116' ' ' ILE . 3.2 tp -77.19 -61.6 1.93 Allowed 'General case' 0 N--CA 1.45 -0.447 0 C-N-CA 119.464 -0.894 . . . . 1.0 110.43 179.101 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -73.36 -81.13 0.41 Allowed Glycine 0 C--N 1.362 2.013 0 C-N-CA 117.891 -2.1 . . . . 1.0 111.339 -178.348 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 1.2 t -158.53 -18.63 0.07 Allowed 'General case' 0 C--N 1.322 -0.601 0 CA-C-O 121.237 0.542 . . . . 1.0 110.601 -179.033 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 122' ' ' GLY . . . . . 0.453 ' O ' ' C ' ' A' ' 123' ' ' THR . . . 107.7 -38.45 3.32 Favored Glycine 0 N--CA 1.472 1.076 0 C-N-CA 125.026 1.298 . . . . 1.0 112.758 178.889 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 123' ' ' THR . . . . . 0.453 ' C ' ' O ' ' A' ' 122' ' ' GLY . 8.5 m -30.62 102.73 0.02 OUTLIER 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 118.49 1.145 . . . . 1.0 112.427 -177.128 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 38.0 p-10 -143.72 139.72 29.62 Favored 'General case' 0 C--N 1.332 -0.158 0 N-CA-C 106.985 -1.487 . . . . 1.0 106.985 178.744 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 125' ' ' TYR . . . . . 0.535 ' OH ' ' CE1' ' A' ' 127' ' ' PHE . 0.0 OUTLIER -153.95 150.72 28.61 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 116.185 -0.461 . . . . 1.0 110.165 -177.848 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 126' ' ' ARG . . . . . 0.509 ' HG2' ' O ' ' A' ' 125' ' ' TYR . 2.0 mmp_? -152.07 156.97 40.97 Favored 'General case' 0 CA--C 1.538 0.483 0 O-C-N 124.497 1.123 . . . . 1.0 111.962 176.829 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 127' ' ' PHE . . . . . 0.535 ' CE1' ' OH ' ' A' ' 125' ' ' TYR . 1.1 p90 . . . . . 0 C--O 1.222 -0.377 0 CA-C-O 118.007 -0.997 . . . . 1.0 110.465 178.886 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 1' ' ' MET . . . . . 0.457 ' SD ' ' N ' ' A' ' 1' ' ' MET . 0.0 OUTLIER . . . . . 0 N--CA 1.493 1.696 0 N-CA-C 109.236 -0.654 . . . . 1.0 109.236 . . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 2' ' ' SER . . . . . 0.517 ' O ' ' CB ' ' A' ' 3' ' ' ASP . 87.6 p -86.47 9.09 19.31 Favored 'General case' 0 N--CA 1.463 0.209 0 CA-C-N 116.554 -0.294 . . . . 1.0 111.204 -179.818 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 3' ' ' ASP . . . . . 0.517 ' CB ' ' O ' ' A' ' 2' ' ' SER . 3.5 t70 149.99 123.81 0.0 OUTLIER 'General case' 0 N--CA 1.479 0.995 0 O-C-N 124.16 0.912 . . . . 1.0 111.189 178.551 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 4' ' ' PHE . . . . . 0.412 ' O ' ' OD1' ' A' ' 5' ' ' ASP . 83.9 t80 -155.25 150.92 27.48 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.408 -0.814 . . . . 1.0 110.403 178.812 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 5' ' ' ASP . . . . . 0.412 ' OD1' ' O ' ' A' ' 4' ' ' PHE . 74.9 m-20 -150.8 148.12 28.12 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.065 -0.516 . . . . 1.0 109.703 179.513 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 6' ' ' THR . . . . . 0.71 ' O ' ' N ' ' A' ' 10' ' ' SER . 0.2 OUTLIER -70.19 167.85 16.98 Favored 'General case' 0 C--O 1.195 -1.802 0 CA-C-O 121.156 0.503 . . . . 1.0 110.274 -179.461 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 7' ' ' GLU . . . . . 0.593 ' O ' ' N ' ' A' ' 11' ' ' ARG . 5.4 pt-20 -57.62 -57.78 11.21 Favored 'General case' 0 C--N 1.299 -1.587 0 CA-C-O 121.271 0.558 . . . . 1.0 110.369 -179.26 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 8' ' ' ARG . . . . . 0.79 ' O ' ' HB3' ' A' ' 12' ' ' ALA . 7.9 ttm180 -52.64 -56.07 18.01 Favored 'General case' 0 C--N 1.316 -0.87 0 N-CA-C 107.805 -1.183 . . . . 1.0 107.805 -178.187 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 9' ' ' VAL . . . . . 0.543 ' O ' ' CG2' ' A' ' 13' ' ' VAL . 0.0 OUTLIER -64.46 -50.42 76.2 Favored 'Isoleucine or valine' 0 C--O 1.203 -1.355 0 C-N-CA 119.488 -0.885 . . . . 1.0 109.816 178.718 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 10' ' ' SER . . . . . 0.71 ' N ' ' O ' ' A' ' 6' ' ' THR . 20.9 t -65.41 -63.92 0.98 Allowed 'General case' 0 C--N 1.316 -0.884 0 C-N-CA 119.42 -0.912 . . . . 1.0 111.257 -178.565 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 11' ' ' ARG . . . . . 0.593 ' N ' ' O ' ' A' ' 7' ' ' GLU . 4.1 tpp180 -63.9 -59.03 5.02 Favored 'General case' 0 N--CA 1.471 0.624 0 CA-C-O 121.103 0.477 . . . . 1.0 111.888 -176.804 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 12' ' ' ALA . . . . . 0.79 ' HB3' ' O ' ' A' ' 8' ' ' ARG . . . -50.18 -49.38 52.58 Favored 'General case' 0 C--N 1.317 -0.82 0 N-CA-C 107.458 -1.312 . . . . 1.0 107.458 -177.232 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 13' ' ' VAL . . . . . 0.6 ' O ' ' N ' ' A' ' 17' ' ' LEU . 93.4 t -60.92 -49.47 84.52 Favored 'Isoleucine or valine' 0 C--O 1.198 -1.607 0 C-N-CA 118.733 -1.187 . . . . 1.0 107.946 177.347 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 14' ' ' ALA . . . . . 0.631 ' O ' HG13 ' A' ' 18' ' ' VAL . . . -57.53 -62.11 2.02 Favored 'General case' 0 C--O 1.212 -0.889 0 C-N-CA 118.519 -1.273 . . . . 1.0 109.913 -179.8 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 15' ' ' ALA . . . . . 0.57 ' O ' ' N ' ' A' ' 19' ' ' GLY . . . -51.28 -53.57 34.36 Favored 'General case' 0 N--CA 1.472 0.648 0 CA-C-O 121.706 0.765 . . . . 1.0 109.287 -178.245 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 16' ' ' ALA . . . . . 0.412 ' HB1' ' CA ' ' A' ' 22' ' ' GLY . . . -62.94 -55.08 29.01 Favored 'General case' 0 C--N 1.309 -1.186 0 CA-C-N 114.603 -1.18 . . . . 1.0 109.037 -178.988 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 17' ' ' LEU . . . . . 0.6 ' N ' ' O ' ' A' ' 13' ' ' VAL . 4.8 tt -55.91 -54.16 48.11 Favored 'General case' 0 N--CA 1.478 0.966 0 CA-C-N 113.921 -1.49 . . . . 1.0 109.063 -177.413 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 18' ' ' VAL . . . . . 0.631 HG13 ' O ' ' A' ' 14' ' ' ALA . 2.3 m -69.29 -57.4 8.62 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.359 0 N-CA-C 108.939 -0.763 . . . . 1.0 108.939 178.426 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 19' ' ' GLY . . . . . 0.57 ' N ' ' O ' ' A' ' 15' ' ' ALA . . . -58.03 -169.45 0.18 Allowed Glycine 0 C--O 1.216 -1.027 0 N-CA-C 110.67 -0.972 . . . . 1.0 110.67 179.722 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 20' ' ' PRO . . . . . 0.499 ' O ' ' N ' ' A' ' 24' ' ' ALA . 3.5 Cg_endo -79.62 -31.07 2.13 Favored 'Trans proline' 0 N--CA 1.499 1.798 0 C-N-CA 123.052 2.501 . . . . 1.0 115.154 -178.06 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -59.88 -57.43 19.39 Favored Glycine 0 N--CA 1.475 1.298 0 C-N-CA 120.699 -0.763 . . . . 1.0 112.665 -176.8 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 22' ' ' GLY . . . . . 0.412 ' CA ' ' HB1' ' A' ' 16' ' ' ALA . . . -55.99 -54.16 37.28 Favored Glycine 0 N--CA 1.469 0.844 0 N-CA-C 107.74 -2.144 . . . . 1.0 107.74 -175.534 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 23' ' ' VAL . . . . . 0.576 ' O ' HG12 ' A' ' 27' ' ' VAL . 0.0 OUTLIER -60.84 -32.23 51.61 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.391 0 CA-C-N 114.617 -0.792 . . . . 1.0 109.607 178.923 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 24' ' ' ALA . . . . . 0.499 ' N ' ' O ' ' A' ' 20' ' ' PRO . . . -56.01 -62.12 1.92 Allowed 'General case' 0 CA--C 1.532 0.28 0 C-N-CA 117.993 -1.483 . . . . 1.0 109.408 179.791 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -65.56 -45.16 84.39 Favored 'General case' 0 C--N 1.341 0.23 0 N-CA-C 112.82 0.674 . . . . 1.0 112.82 -178.464 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 98.5 t -60.22 -59.11 4.57 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.192 0 C-N-CA 118.849 -1.14 . . . . 1.0 110.21 -177.375 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 27' ' ' VAL . . . . . 0.576 HG12 ' O ' ' A' ' 23' ' ' VAL . 1.2 p -59.74 -35.16 58.33 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.286 0 CA-C-O 120.982 0.42 . . . . 1.0 111.95 -178.341 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 32.2 ttpt -66.54 -53.92 29.44 Favored 'General case' 0 C--N 1.315 -0.921 0 CA-C-O 121.906 0.86 . . . . 1.0 109.069 -178.376 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 91.1 t -64.37 -48.59 84.62 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.1 0 CA-C-N 113.668 -1.605 . . . . 1.0 111.557 -177.413 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 30' ' ' CYS . . . . . 0.572 ' SG ' ' N ' ' A' ' 31' ' ' ALA . 0.0 OUTLIER -63.82 -58.58 6.37 Favored 'General case' 0 N--CA 1.452 -0.336 0 C-N-CA 118.86 -1.136 . . . . 1.0 108.518 -179.299 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 31' ' ' ALA . . . . . 0.572 ' N ' ' SG ' ' A' ' 30' ' ' CYS . . . -61.7 -53.52 55.02 Favored 'General case' 0 C--N 1.326 -0.415 0 N-CA-C 112.422 0.527 . . . . 1.0 112.422 -177.515 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 32' ' ' GLY . . . . . 0.473 ' O ' ' CB ' ' A' ' 33' ' ' LEU . . . 86.86 74.42 1.27 Allowed Glycine 0 CA--C 1.522 0.481 0 N-CA-C 110.656 -0.978 . . . . 1.0 110.656 -178.87 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 33' ' ' LEU . . . . . 0.473 ' CB ' ' O ' ' A' ' 32' ' ' GLY . 1.0 OUTLIER 86.06 101.84 0.03 OUTLIER Pre-proline 0 CA--C 1.547 0.841 0 N-CA-C 109.813 -0.44 . . . . 1.0 109.813 -179.876 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 55.9 Cg_endo -71.48 -26.02 20.64 Favored 'Trans proline' 0 N--CA 1.501 1.96 0 C-N-CA 122.087 1.858 . . . . 1.0 114.055 -177.955 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -59.84 -59.45 10.47 Favored Glycine 0 CA--C 1.523 0.554 0 C-N-CA 118.081 -2.009 . . . . 1.0 108.884 -178.539 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 36' ' ' VAL . . . . . 0.64 ' O ' HG22 ' A' ' 37' ' ' ILE . 10.8 p -90.53 161.92 2.54 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.541 0 N-CA-C 107.277 -1.379 . . . . 1.0 107.277 177.565 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 37' ' ' ILE . . . . . 0.64 HG22 ' O ' ' A' ' 36' ' ' VAL . 14.8 tt 120.0 113.17 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.472 0.626 0 O-C-N 124.85 1.344 . . . . 1.0 110.061 179.615 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 22.7 m-70 -140.61 135.46 31.76 Favored 'General case' 0 C--N 1.322 -0.625 0 N-CA-C 108.874 -0.787 . . . . 1.0 108.874 178.87 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 42.5 p -112.54 139.8 23.1 Favored Pre-proline 0 C--N 1.331 -0.23 0 N-CA-C 109.146 -0.687 . . . . 1.0 109.146 179.716 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 40' ' ' PRO . . . . . 0.42 ' HG2' ' H ' ' A' ' 41' ' ' ALA . 57.6 Cg_endo -70.88 -87.15 0.0 OUTLIER 'Trans proline' 0 C--N 1.312 -1.367 0 C-N-CA 121.747 1.631 . . . . 1.0 112.015 -179.433 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 41' ' ' ALA . . . . . 0.42 ' H ' ' HG2' ' A' ' 40' ' ' PRO . . . -66.6 125.07 24.62 Favored 'General case' 0 C--N 1.315 -0.93 0 CA-C-N 114.786 -1.097 . . . . 1.0 110.623 -178.902 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 42' ' ' ARG . . . . . 0.657 ' C ' ' H ' ' A' ' 44' ' ' GLY . 4.2 ptt180 -170.7 168.42 7.44 Favored 'General case' 0 N--CA 1.445 -0.711 0 CA-C-N 115.556 -0.747 . . . . 1.0 109.779 179.893 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -63.31 24.86 0.01 OUTLIER 'General case' 0 C--N 1.317 -0.826 0 CA-C-N 115.88 -0.6 . . . . 1.0 110.369 179.83 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 44' ' ' GLY . . . . . 0.657 ' H ' ' C ' ' A' ' 42' ' ' ARG . . . 87.14 -26.2 7.1 Favored Glycine 0 C--N 1.333 0.402 0 N-CA-C 110.605 -0.998 . . . . 1.0 110.605 179.4 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 45' ' ' PHE . . . . . 0.646 ' CG ' ' O ' ' A' ' 44' ' ' GLY . 74.0 m-85 -167.37 175.15 7.45 Favored 'General case' 0 C--O 1.216 -0.675 0 O-C-N 124.759 0.917 . . . . 1.0 110.696 178.551 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 46' ' ' PHE . . . . . 0.577 ' HB2' ' O ' ' A' ' 45' ' ' PHE . 2.0 m-85 132.58 89.02 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.611 0 C-N-CA 125.625 1.57 . . . . 1.0 109.432 179.01 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 47' ' ' ARG . . . . . 0.79 ' H ' ' NE2' ' A' ' 54' ' ' GLN . 48.6 mmt-85 124.53 142.06 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.509 0 C-N-CA 124.33 1.052 . . . . 1.0 110.781 178.666 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 2.6 t 69.45 70.62 0.25 Allowed 'General case' 0 C--N 1.331 -0.226 0 N-CA-C 108.355 -0.98 . . . . 1.0 108.355 -178.916 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 2.2 p-10 -125.17 152.79 71.34 Favored Pre-proline 0 C--O 1.233 0.232 0 CA-C-N 116.448 -0.342 . . . . 1.0 110.551 -178.969 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 50' ' ' PRO . . . . . 0.527 ' HG2' HH11 ' A' ' 52' ' ' ARG . 78.7 Cg_endo -73.17 55.84 3.03 Favored 'Trans proline' 0 C--N 1.311 -1.427 0 C-N-CA 122.022 1.815 . . . . 1.0 110.812 178.889 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 46.8 mm-40 68.18 -2.5 1.5 Allowed 'General case' 0 CA--C 1.528 0.127 0 CA-C-N 116.149 -0.478 . . . . 1.0 111.08 -179.635 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 52' ' ' ARG . . . . . 0.527 HH11 ' HG2' ' A' ' 50' ' ' PRO . 80.0 mtt85 -77.85 159.71 28.78 Favored 'General case' 0 N--CA 1.466 0.329 0 CA-C-O 120.999 0.428 . . . . 1.0 110.581 179.095 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 53' ' ' ILE . . . . . 0.429 ' O ' ' N ' ' A' ' 55' ' ' ILE . 19.4 tt -78.13 138.71 19.77 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.187 0 CA-C-N 115.906 -0.588 . . . . 1.0 111.218 -179.324 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 54' ' ' GLN . . . . . 0.79 ' NE2' ' H ' ' A' ' 47' ' ' ARG . 8.4 mm100 -63.16 81.4 0.02 OUTLIER 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 115.273 -0.876 . . . . 1.0 110.468 -177.973 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 55' ' ' ILE . . . . . 0.429 ' N ' ' O ' ' A' ' 53' ' ' ILE . 15.4 tt -147.01 156.02 11.01 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.152 0 CA-C-N 115.264 -0.88 . . . . 1.0 109.613 177.63 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 109.97 -2.13 30.12 Favored Glycine 0 N--CA 1.466 0.634 0 N-CA-C 110.683 -0.967 . . . . 1.0 110.683 -179.748 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 57' ' ' ASP . . . . . 0.418 ' O ' ' CG ' ' A' ' 57' ' ' ASP . 18.9 p-10 -79.43 99.56 7.25 Favored 'General case' 0 C--N 1.325 -0.468 0 N-CA-C 109.33 -0.619 . . . . 1.0 109.33 178.891 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 58' ' ' TRP . . . . . . . . . . . . . 3.9 m0 -89.99 170.58 10.23 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 123.753 1.739 . . . . 1.0 113.337 -177.052 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 59' ' ' ARG . . . . . 0.444 ' HG3' ' N ' ' A' ' 60' ' ' TYR . 48.3 ptt85 -82.29 -57.89 3.18 Favored 'General case' 0 C--N 1.312 -1.062 0 CA-C-N 110.393 -3.094 . . . . 1.0 112.779 -178.865 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 60' ' ' TYR . . . . . 0.444 ' N ' ' HG3' ' A' ' 59' ' ' ARG . 79.9 t80 -92.67 -15.68 26.46 Favored 'General case' 0 N--CA 1.485 1.285 0 N-CA-C 113.406 0.891 . . . . 1.0 113.406 -179.979 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 6.3 tt0 -77.49 -14.03 59.78 Favored 'General case' 0 C--N 1.313 -1.005 0 CA-C-N 116.065 -0.516 . . . . 1.0 111.073 -178.852 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 62' ' ' VAL . . . . . 0.638 ' O ' ' N ' ' A' ' 66' ' ' GLY . 27.5 m -48.22 -54.65 3.86 Favored 'Isoleucine or valine' 0 C--O 1.198 -1.616 0 C-N-CA 119.485 -0.886 . . . . 1.0 109.84 -175.346 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 63' ' ' ALA . . . . . 0.583 ' N ' HG23 ' A' ' 62' ' ' VAL . . . -68.01 -50.65 54.23 Favored 'General case' 0 C--N 1.306 -1.297 0 O-C-N 121.32 -0.862 . . . . 1.0 109.022 -179.968 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -48.5 -58.59 4.44 Favored 'General case' 0 N--CA 1.465 0.307 0 C-N-CA 119.594 -0.842 . . . . 1.0 109.274 -179.893 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 65' ' ' ASP . . . . . 0.538 ' C ' ' H ' ' A' ' 67' ' ' ARG . 18.5 t0 -71.63 -49.97 35.14 Favored 'General case' 0 C--N 1.314 -0.968 0 CA-C-N 115.147 -0.933 . . . . 1.0 110.159 178.832 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 66' ' ' GLY . . . . . 0.638 ' N ' ' O ' ' A' ' 62' ' ' VAL . . . -71.69 25.83 0.62 Allowed Glycine 0 CA--C 1.52 0.393 0 N-CA-C 110.915 -0.874 . . . . 1.0 110.915 178.241 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 67' ' ' ARG . . . . . 0.628 ' O ' ' N ' ' A' ' 69' ' ' LEU . 0.2 OUTLIER -75.89 2.49 12.31 Favored 'General case' 0 C--N 1.323 -0.564 0 N-CA-C 105.706 -1.961 . . . . 1.0 105.706 175.607 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 68' ' ' LEU . . . . . 0.519 HD12 ' O ' ' A' ' 66' ' ' GLY . 0.0 OUTLIER -35.23 -27.32 0.01 OUTLIER 'General case' 0 N--CA 1.482 1.169 0 N-CA-C 107.991 -1.114 . . . . 1.0 107.991 -176.559 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 69' ' ' LEU . . . . . 0.639 HD13 ' C ' ' A' ' 69' ' ' LEU . 2.9 tm? -62.68 -64.49 0.9 Allowed 'General case' 0 C--N 1.323 -0.56 0 C-N-CA 117.679 -1.608 . . . . 1.0 107.732 177.772 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 70' ' ' ALA . . . . . 0.689 ' C ' ' H ' ' A' ' 72' ' ' HIS . . . -79.01 -74.52 0.28 Allowed 'General case' 0 N--CA 1.479 0.995 0 N-CA-C 107.385 -1.339 . . . . 1.0 107.385 178.509 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 71' ' ' ALA . . . . . 0.435 ' O ' ' C ' ' A' ' 72' ' ' HIS . . . -45.15 4.16 0.0 OUTLIER 'General case' 0 C--O 1.224 -0.239 0 C-N-CA 124.849 1.26 . . . . 1.0 112.479 178.754 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 72' ' ' HIS . . . . . 0.689 ' H ' ' C ' ' A' ' 70' ' ' ALA . 1.9 t60 -29.83 -73.85 0.03 OUTLIER 'General case' 0 C--N 1.333 -0.123 0 N-CA-C 112.261 0.467 . . . . 1.0 112.261 -179.373 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 73' ' ' MET . . . . . 0.598 ' N ' ' SD ' ' A' ' 73' ' ' MET . 0.0 OUTLIER -58.34 -54.51 46.24 Favored 'General case' 0 C--N 1.329 -0.32 0 N-CA-C 106.521 -1.659 . . . . 1.0 106.521 178.655 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 74' ' ' VAL . . . . . 0.765 ' O ' ' N ' ' A' ' 76' ' ' GLY . 61.4 t -42.38 -39.83 0.87 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-O 117.271 -1.347 . . . . 1.0 111.681 -176.13 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 75' ' ' ASN . . . . . 0.492 ' C ' ' N ' ' A' ' 77' ' ' ILE . 33.4 p-10 -35.15 -15.18 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.607 0 CA-C-N 120.824 1.647 . . . . 1.0 110.806 179.558 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 76' ' ' GLY . . . . . 0.765 ' N ' ' O ' ' A' ' 74' ' ' VAL . . . -49.6 -19.93 2.38 Favored Glycine 0 N--CA 1.436 -1.328 0 N-CA-C 107.244 -2.343 . . . . 1.0 107.244 173.394 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 77' ' ' ILE . . . . . 0.492 ' N ' ' C ' ' A' ' 75' ' ' ASN . 14.1 pt -56.49 -50.59 72.17 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.032 0 CA-C-O 117.747 -1.12 . . . . 1.0 110.384 -179.334 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 24.4 t -54.71 -20.69 5.82 Favored 'Isoleucine or valine' 0 C--N 1.352 0.699 0 CA-C-N 121.095 1.77 . . . . 1.0 113.427 179.701 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 79' ' ' ILE . . . . . 0.593 ' CG2' HH22 ' A' ' 126' ' ' ARG . 44.8 pt -91.68 -40.27 12.25 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.34 0 C-N-CA 118.888 -1.125 . . . . 1.0 109.677 178.012 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -79.56 -19.85 48.46 Favored 'General case' 0 CA--C 1.538 0.494 0 N-CA-C 113.604 0.964 . . . . 1.0 113.604 179.495 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 81' ' ' GLU . . . . . 0.538 ' CG ' ' H ' ' A' ' 82' ' ' ASP . 1.1 pp20? -94.15 -71.52 0.66 Allowed 'General case' 0 C--N 1.345 0.4 0 N-CA-C 114.47 1.285 . . . . 1.0 114.47 -177.474 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 82' ' ' ASP . . . . . 0.538 ' H ' ' CG ' ' A' ' 81' ' ' GLU . 27.4 t70 -88.93 -15.04 35.31 Favored 'General case' 0 CA--C 1.538 0.493 0 N-CA-C 114.447 1.277 . . . . 1.0 114.447 -178.237 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 83' ' ' ALA . . . . . 0.59 ' O ' ' N ' ' A' ' 87' ' ' GLU . . . -49.75 -46.21 50.27 Favored 'General case' 0 C--O 1.214 -0.813 0 C-N-CA 118.116 -1.434 . . . . 1.0 112.352 -177.816 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 84' ' ' LEU . . . . . 0.648 HD13 ' O ' ' A' ' 84' ' ' LEU . 2.7 tm? -39.77 -45.47 1.75 Allowed 'General case' 0 N--CA 1.471 0.586 0 CA-C-N 118.207 0.458 . . . . 1.0 111.602 -178.026 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 85' ' ' ILE . . . . . 0.422 HG22 ' O ' ' A' ' 82' ' ' ASP . 6.4 tt -66.36 -34.64 71.5 Favored 'Isoleucine or valine' 0 C--O 1.235 0.296 0 C-N-CA 119.698 -0.801 . . . . 1.0 111.022 -179.583 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 86' ' ' ALA . . . . . 0.867 ' O ' HG22 ' A' ' 89' ' ' VAL . . . -93.64 -23.88 18.1 Favored 'General case' 0 C--O 1.211 -0.967 0 N-CA-C 111.728 0.27 . . . . 1.0 111.728 179.904 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 87' ' ' GLU . . . . . 0.59 ' N ' ' O ' ' A' ' 83' ' ' ALA . 38.9 tp10 -54.51 -18.81 4.76 Favored 'General case' 0 C--N 1.324 -0.509 0 O-C-N 121.447 -0.783 . . . . 1.0 109.946 -178.818 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -75.49 -5.83 47.12 Favored 'General case' 0 N--CA 1.473 0.687 0 CA-C-O 122.762 1.268 . . . . 1.0 108.097 178.329 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 89' ' ' VAL . . . . . 0.867 HG22 ' O ' ' A' ' 86' ' ' ALA . 3.2 m -86.05 36.31 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.318 -0.785 0 CA-C-N 112.173 -2.285 . . . . 1.0 107.962 177.085 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 90' ' ' GLY . . . . . 0.882 ' O ' ' N ' ' A' ' 92' ' ' HIS . . . -56.26 -19.66 25.72 Favored Glycine 0 C--N 1.373 2.601 0 CA-C-O 117.049 -1.973 . . . . 1.0 113.465 178.362 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 91' ' ' PRO . . . . . 0.699 ' HD2' ' N ' ' A' ' 90' ' ' GLY . 3.0 Cg_exo -34.38 3.42 0.0 OUTLIER 'Trans proline' 0 N--CA 1.499 1.817 0 CA-C-N 121.618 2.709 . . . . 1.0 113.693 172.409 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 92' ' ' HIS . . . . . 0.882 ' N ' ' O ' ' A' ' 90' ' ' GLY . 1.4 t-160 -47.2 -35.15 7.12 Favored 'General case' 0 N--CA 1.443 -0.816 0 N-CA-C 106.04 -1.837 . . . . 1.0 106.04 179.484 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 93' ' ' LEU . . . . . 0.439 ' O ' ' HB3' ' A' ' 96' ' ' ALA . 5.6 tp -62.57 -45.86 91.0 Favored 'General case' 0 C--N 1.35 0.609 0 N-CA-C 108.652 -0.869 . . . . 1.0 108.652 176.058 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 94' ' ' ALA . . . . . 0.545 ' N ' ' O ' ' A' ' 91' ' ' PRO . . . -53.69 -58.17 8.18 Favored 'General case' 0 C--N 1.333 -0.15 0 N-CA-C 106.344 -1.724 . . . . 1.0 106.344 178.685 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -58.32 -29.73 66.14 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-N 114.65 -1.159 . . . . 1.0 109.314 177.981 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 96' ' ' ALA . . . . . 0.855 ' O ' ' N ' ' A' ' 100' ' ' ILE . . . -54.35 -51.21 65.47 Favored 'General case' 0 C--O 1.199 -1.57 0 N-CA-C 107.84 -1.17 . . . . 1.0 107.84 -176.145 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 97' ' ' LEU . . . . . 0.583 ' O ' HG22 ' A' ' 100' ' ' ILE . 2.7 tm? -34.02 -28.37 0.01 OUTLIER 'General case' 0 CA--C 1.567 1.622 0 CA-C-N 113.788 -1.551 . . . . 1.0 108.052 -178.03 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 98' ' ' GLY . . . . . 0.648 ' N ' ' O ' ' A' ' 96' ' ' ALA . . . -89.37 -53.32 2.49 Favored Glycine 0 CA--C 1.56 2.866 0 CA-C-O 123.279 1.488 . . . . 1.0 111.956 170.46 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 99' ' ' GLN . . . . . 0.541 ' N ' ' O ' ' A' ' 96' ' ' ALA . 5.4 mm100 -75.93 6.48 5.09 Favored 'General case' 0 N--CA 1.439 -0.986 0 N-CA-C 107.64 -1.244 . . . . 1.0 107.64 179.156 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 100' ' ' ILE . . . . . 0.855 ' N ' ' O ' ' A' ' 96' ' ' ALA . 19.2 tt -63.46 -50.6 77.86 Favored 'Isoleucine or valine' 0 CA--C 1.471 -2.069 0 N-CA-C 107.784 -1.191 . . . . 1.0 107.784 -179.956 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 101' ' ' VAL . . . . . 0.673 ' O ' ' N ' ' A' ' 105' ' ' GLY . 76.1 t -51.84 -60.16 1.14 Allowed 'Isoleucine or valine' 0 C--O 1.212 -0.893 0 C-N-CA 118.292 -1.363 . . . . 1.0 107.389 178.691 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 102' ' ' CYS . . . . . 0.808 ' O ' ' HB2' ' A' ' 106' ' ' ALA . 0.0 OUTLIER -53.63 -25.39 17.55 Favored 'General case' 0 C--N 1.306 -1.299 0 CA-C-N 115.428 -0.806 . . . . 1.0 111.434 -176.78 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 51.1 ttm-85 -84.36 -52.05 6.49 Favored 'General case' 0 N--CA 1.488 1.471 0 CA-C-O 122.415 1.102 . . . . 1.0 113.337 -179.407 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 104' ' ' TYR . . . . . 0.671 ' O ' ' CG ' ' A' ' 104' ' ' TYR . 0.0 OUTLIER -96.33 21.79 8.61 Favored 'General case' 0 C--N 1.302 -1.488 0 C-N-CA 127.378 2.271 . . . . 1.0 106.819 177.874 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 105' ' ' GLY . . . . . 0.673 ' N ' ' O ' ' A' ' 101' ' ' VAL . . . -159.08 -97.88 0.13 Allowed Glycine 0 CA--C 1.53 0.99 0 N-CA-C 109.442 -1.463 . . . . 1.0 109.442 179.028 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 106' ' ' ALA . . . . . 0.808 ' HB2' ' O ' ' A' ' 102' ' ' CYS . . . 60.64 114.38 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.253 0 N-CA-C 108.985 -0.746 . . . . 1.0 108.985 -176.254 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 107' ' ' THR . . . . . 0.852 ' O ' ' HD2' ' A' ' 110' ' ' PRO . 22.0 m -133.28 -61.61 0.82 Allowed 'General case' 0 C--O 1.194 -1.819 0 N-CA-C 106.789 -1.56 . . . . 1.0 106.789 177.78 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 32.7 m -71.5 30.66 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.318 -0.795 0 O-C-N 121.22 -0.925 . . . . 1.0 109.251 -178.239 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 109' ' ' ILE . . . . . 0.65 HD13 ' HB1' ' A' ' 106' ' ' ALA . 0.1 OUTLIER -111.8 -40.46 0.1 Allowed Pre-proline 0 CA--C 1.56 1.346 0 CA-C-N 118.573 0.624 . . . . 1.0 110.882 177.969 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 110' ' ' PRO . . . . . 0.852 ' HD2' ' O ' ' A' ' 107' ' ' THR . 31.2 Cg_exo -65.33 -23.83 58.49 Favored 'Trans proline' 0 N--CA 1.496 1.62 0 C-N-CA 122.609 2.206 . . . . 1.0 111.82 179.72 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 111' ' ' ASN . . . . . 0.549 ' CG ' ' N ' ' A' ' 112' ' ' ILE . 0.0 OUTLIER -66.43 -66.77 0.51 Allowed 'General case' 0 CA--C 1.535 0.384 0 C-N-CA 119.51 -0.876 . . . . 1.0 109.132 -179.353 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 112' ' ' ILE . . . . . 0.549 ' N ' ' CG ' ' A' ' 111' ' ' ASN . 0.0 OUTLIER -52.43 -32.47 16.49 Favored 'Isoleucine or valine' 0 C--O 1.213 -0.821 0 CA-C-O 122.253 1.025 . . . . 1.0 109.139 178.783 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 113' ' ' ASN . . . . . 0.483 ' HB2' ' HA ' ' A' ' 110' ' ' PRO . 8.4 m-20 -55.39 -55.29 33.28 Favored 'General case' 0 C--N 1.296 -1.722 0 CA-C-N 113.345 -1.752 . . . . 1.0 107.581 -179.105 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -60.51 -29.31 69.01 Favored 'General case' 0 N--CA 1.44 -0.958 0 C-N-CA 119.383 -0.927 . . . . 1.0 110.995 178.934 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -77.93 -59.56 2.73 Favored 'General case' 0 N--CA 1.451 -0.413 0 C-N-CA 119.558 -0.857 . . . . 1.0 110.031 178.949 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 116' ' ' ILE . . . . . 0.64 ' O ' ' N ' ' A' ' 120' ' ' GLY . 1.4 tp -50.8 -48.21 28.34 Favored 'Isoleucine or valine' 0 CA--C 1.498 -1.055 0 N-CA-C 108.859 -0.793 . . . . 1.0 108.859 -179.096 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 117' ' ' GLU . . . . . 0.53 ' N ' ' CG2' ' A' ' 116' ' ' ILE . 51.6 mt-10 -38.9 -58.53 1.08 Allowed 'General case' 0 C--N 1.317 -0.838 0 N-CA-C 104.707 -2.331 . . . . 1.0 104.707 179.424 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 99.4 t -58.62 -52.02 64.81 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.716 0 C-N-CA 119.608 -0.837 . . . . 1.0 109.076 176.951 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 119' ' ' LEU . . . . . 0.474 ' N ' ' O ' ' A' ' 116' ' ' ILE . 0.3 OUTLIER -56.34 -69.64 0.14 Allowed 'General case' 0 N--CA 1.47 0.561 0 C-N-CA 118.362 -1.335 . . . . 1.0 107.641 -178.594 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 120' ' ' GLY . . . . . 0.64 ' N ' ' O ' ' A' ' 116' ' ' ILE . . . -72.0 -85.11 0.2 Allowed Glycine 0 CA--C 1.55 2.223 0 C-N-CA 119.172 -1.489 . . . . 1.0 111.25 178.229 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 121' ' ' THR . . . . . 0.487 ' HA ' ' O ' ' A' ' 117' ' ' GLU . 1.5 t 160.96 -27.66 0.0 OUTLIER 'General case' 0 N--CA 1.486 1.375 0 CA-C-N 113.797 -1.202 . . . . 1.0 113.362 -178.715 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 122' ' ' GLY . . . . . 0.632 ' O ' ' N ' ' A' ' 124' ' ' ASP . . . 97.38 -21.74 44.54 Favored Glycine 0 N--CA 1.476 1.36 0 N-CA-C 107.884 -2.086 . . . . 1.0 107.884 -177.511 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 123' ' ' THR . . . . . 0.542 ' O ' ' NE2' ' A' ' 72' ' ' HIS . 7.6 m -47.7 89.41 0.0 OUTLIER 'General case' 0 N--CA 1.467 0.413 0 N-CA-C 105.21 -2.144 . . . . 1.0 105.21 177.603 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 124' ' ' ASP . . . . . 0.632 ' N ' ' O ' ' A' ' 122' ' ' GLY . 29.8 t70 -166.32 175.57 8.14 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 114.856 -1.065 . . . . 1.0 112.361 -179.505 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 125' ' ' TYR . . . . . 0.488 ' N ' ' CG ' ' A' ' 124' ' ' ASP . 56.2 t80 -146.71 145.32 29.95 Favored 'General case' 0 CA--C 1.533 0.298 0 CA-C-N 115.102 -0.954 . . . . 1.0 109.106 176.7 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 126' ' ' ARG . . . . . 0.593 HH22 ' CG2' ' A' ' 79' ' ' ILE . 0.8 OUTLIER -147.18 146.46 29.86 Favored 'General case' 0 C--N 1.327 -0.387 0 N-CA-C 108.701 -0.851 . . . . 1.0 108.701 178.91 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 127' ' ' PHE . . . . . . . . . . . . . 29.2 p90 . . . . . 0 N--CA 1.47 0.573 0 CA-C-O 117.899 -1.048 . . . . 1.0 110.297 179.737 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 1' ' ' MET . . . . . 0.591 ' SD ' ' N ' ' A' ' 1' ' ' MET . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.619 0 N-CA-C 108.998 -0.742 . . . . 1.0 108.998 . . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 2' ' ' SER . . . . . 0.466 ' O ' ' CB ' ' A' ' 3' ' ' ASP . 78.2 p -81.07 5.92 15.15 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.854 -0.612 . . . . 1.0 110.771 -179.805 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 3' ' ' ASP . . . . . 0.478 ' N ' ' OD1' ' A' ' 3' ' ' ASP . 5.1 p30 154.17 127.72 0.0 OUTLIER 'General case' 0 N--CA 1.472 0.629 0 O-C-N 123.669 0.606 . . . . 1.0 110.556 178.965 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 71.9 t80 -154.1 149.7 27.41 Favored 'General case' 0 N--CA 1.466 0.338 0 CA-C-O 120.789 0.328 . . . . 1.0 110.762 179.33 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 68.4 m-20 -152.92 147.96 26.58 Favored 'General case' 0 CA--C 1.535 0.389 0 N-CA-C 109.555 -0.535 . . . . 1.0 109.555 179.747 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 6' ' ' THR . . . . . 0.809 ' O ' ' N ' ' A' ' 10' ' ' SER . 0.2 OUTLIER -93.64 -177.61 4.44 Favored 'General case' 0 C--O 1.187 -2.225 0 CA-C-N 116.68 -0.236 . . . . 1.0 110.972 -179.485 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 7' ' ' GLU . . . . . 0.532 ' O ' ' N ' ' A' ' 11' ' ' ARG . 66.5 tt0 -59.93 -55.44 34.1 Favored 'General case' 0 N--CA 1.476 0.849 0 CA-C-O 121.518 0.675 . . . . 1.0 110.933 -179.274 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 8' ' ' ARG . . . . . 0.531 ' O ' ' CB ' ' A' ' 12' ' ' ALA . 0.6 OUTLIER -53.58 -58.98 5.22 Favored 'General case' 0 C--N 1.304 -1.409 0 N-CA-C 107.749 -1.204 . . . . 1.0 107.749 179.865 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 9' ' ' VAL . . . . . 0.849 ' O ' HG13 ' A' ' 13' ' ' VAL . 0.0 OUTLIER -65.47 -49.32 78.96 Favored 'Isoleucine or valine' 0 CA--C 1.559 1.308 0 CA-C-N 114.575 -1.193 . . . . 1.0 110.978 179.816 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 10' ' ' SER . . . . . 0.809 ' N ' ' O ' ' A' ' 6' ' ' THR . 32.2 t -61.11 -57.94 10.42 Favored 'General case' 0 N--CA 1.492 1.668 0 CA-C-O 122.23 1.014 . . . . 1.0 108.315 179.057 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 11' ' ' ARG . . . . . 0.677 ' O ' ' HB3' ' A' ' 15' ' ' ALA . 7.6 tpt180 -61.97 -40.79 96.8 Favored 'General case' 0 C--N 1.315 -0.92 0 CA-C-N 115.412 -0.813 . . . . 1.0 109.167 -177.578 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 12' ' ' ALA . . . . . 0.756 ' O ' ' HB3' ' A' ' 16' ' ' ALA . . . -68.05 -55.44 12.55 Favored 'General case' 0 N--CA 1.475 0.825 0 C-N-CA 119.193 -1.003 . . . . 1.0 108.557 176.164 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 13' ' ' VAL . . . . . 0.849 HG13 ' O ' ' A' ' 9' ' ' VAL . 4.5 m -63.28 -53.03 51.09 Favored 'Isoleucine or valine' 0 C--O 1.205 -1.246 0 C-N-CA 118.241 -1.384 . . . . 1.0 108.894 -178.957 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 14' ' ' ALA . . . . . 0.838 ' O ' HG22 ' A' ' 18' ' ' VAL . . . -60.8 -64.35 0.98 Allowed 'General case' 0 C--N 1.305 -1.347 0 C-N-CA 117.953 -1.499 . . . . 1.0 110.464 179.668 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 15' ' ' ALA . . . . . 0.677 ' HB3' ' O ' ' A' ' 11' ' ' ARG . . . -56.52 -56.45 21.05 Favored 'General case' 0 N--CA 1.479 0.992 0 C-N-CA 119.522 -0.871 . . . . 1.0 111.375 -177.883 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 16' ' ' ALA . . . . . 0.756 ' HB3' ' O ' ' A' ' 12' ' ' ALA . . . -65.6 -56.42 12.31 Favored 'General case' 0 C--N 1.318 -0.791 0 C-N-CA 119.068 -1.053 . . . . 1.0 110.298 -178.596 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 17' ' ' LEU . . . . . 0.625 ' CB ' ' O ' ' A' ' 13' ' ' VAL . 5.2 tt -58.36 -54.94 41.39 Favored 'General case' 0 N--CA 1.485 1.293 0 C-N-CA 118.869 -1.132 . . . . 1.0 108.853 -178.289 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 18' ' ' VAL . . . . . 0.838 HG22 ' O ' ' A' ' 14' ' ' ALA . 1.3 m -71.88 -57.75 6.65 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.858 0 C-N-CA 119.112 -1.035 . . . . 1.0 110.851 -179.823 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 19' ' ' GLY . . . . . 0.515 ' N ' ' O ' ' A' ' 15' ' ' ALA . . . -57.33 -175.22 0.34 Allowed Glycine 0 N--CA 1.444 -0.808 0 C-N-CA 121.23 -0.509 . . . . 1.0 112.076 -177.036 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 20' ' ' PRO . . . . . 0.638 ' O ' ' N ' ' A' ' 24' ' ' ALA . 4.1 Cg_endo -81.06 -27.03 3.16 Favored 'Trans proline' 0 C--N 1.307 -1.647 0 C-N-CA 122.749 2.3 . . . . 1.0 113.172 -178.433 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -63.05 -61.26 6.57 Favored Glycine 0 N--CA 1.474 1.17 0 C-N-CA 119.279 -1.439 . . . . 1.0 112.432 -176.33 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 22' ' ' GLY . . . . . 0.529 ' H ' ' HA ' ' A' ' 16' ' ' ALA . . . -53.08 -51.87 43.55 Favored Glycine 0 N--CA 1.472 1.087 0 N-CA-C 106.14 -2.784 . . . . 1.0 106.14 -177.697 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 23' ' ' VAL . . . . . 0.414 ' O ' HG12 ' A' ' 27' ' ' VAL . 40.5 t -61.61 -31.5 50.91 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.089 0 C-N-CA 119.42 -0.912 . . . . 1.0 109.811 178.517 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 24' ' ' ALA . . . . . 0.638 ' N ' ' O ' ' A' ' 20' ' ' PRO . . . -57.68 -62.49 1.76 Allowed 'General case' 0 C--N 1.353 0.756 0 C-N-CA 118.551 -1.26 . . . . 1.0 109.703 -179.501 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 25' ' ' LEU . . . . . 0.498 ' C ' HD12 ' A' ' 25' ' ' LEU . 0.5 OUTLIER -61.42 -44.72 96.64 Favored 'General case' 0 N--CA 1.464 0.251 0 C-N-CA 119.902 -0.719 . . . . 1.0 111.93 -178.237 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 26' ' ' VAL . . . . . 0.479 ' N ' ' HG ' ' A' ' 25' ' ' LEU . 31.6 t -58.98 -58.35 7.27 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.819 0 C-N-CA 119.455 -0.898 . . . . 1.0 110.278 -177.843 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 27' ' ' VAL . . . . . 0.566 ' O ' ' HB3' ' A' ' 31' ' ' ALA . 1.4 p -63.01 -36.67 76.78 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.716 0 C-N-CA 120.393 -0.523 . . . . 1.0 110.971 -177.999 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 2.0 tppp? -65.47 -57.81 7.37 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-O 121.756 0.788 . . . . 1.0 109.199 -179.237 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 79.3 t -63.56 -47.78 89.9 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.023 0 CA-C-N 114.622 -1.172 . . . . 1.0 110.208 -177.351 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 30' ' ' CYS . . . . . . . . . . . . . 51.4 t -65.56 -61.02 2.34 Favored 'General case' 0 N--CA 1.446 -0.64 0 C-N-CA 119.355 -0.938 . . . . 1.0 110.358 -179.397 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 31' ' ' ALA . . . . . 0.566 ' HB3' ' O ' ' A' ' 27' ' ' VAL . . . -59.71 -47.8 84.21 Favored 'General case' 0 CA--C 1.515 -0.378 0 O-C-N 122.083 -0.385 . . . . 1.0 111.158 -176.954 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 32' ' ' GLY . . . . . 0.497 ' O ' ' HB2' ' A' ' 33' ' ' LEU . . . 72.89 64.62 2.51 Favored Glycine 0 N--CA 1.449 -0.492 0 N-CA-C 108.788 -1.725 . . . . 1.0 108.788 -178.144 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 33' ' ' LEU . . . . . 0.497 ' HB2' ' O ' ' A' ' 32' ' ' GLY . 27.2 mt 83.77 129.88 0.03 OUTLIER Pre-proline 0 CA--C 1.544 0.739 0 O-C-N 125.295 1.233 . . . . 1.0 111.12 -178.465 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 58.7 Cg_endo -72.13 -5.26 16.76 Favored 'Trans proline' 0 N--CA 1.495 1.594 0 C-N-CA 122.788 2.325 . . . . 1.0 112.599 179.028 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 35' ' ' GLY . . . . . 0.404 ' HA2' HD12 ' A' ' 112' ' ' ILE . . . -62.12 -62.16 5.94 Favored Glycine 0 C--N 1.336 0.568 0 C-N-CA 118.405 -1.855 . . . . 1.0 111.095 -178.565 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 36' ' ' VAL . . . . . 0.834 HG22 ' H ' ' A' ' 37' ' ' ILE . 8.7 p -87.26 -142.71 0.01 OUTLIER 'Isoleucine or valine' 0 C--O 1.216 -0.683 0 N-CA-C 107.552 -1.277 . . . . 1.0 107.552 178.793 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 37' ' ' ILE . . . . . 0.834 ' H ' HG22 ' A' ' 36' ' ' VAL . 0.3 OUTLIER 70.54 76.46 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.473 0.716 0 CA-C-O 122.344 1.069 . . . . 1.0 111.42 179.842 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 95.4 m-70 -139.75 133.2 30.12 Favored 'General case' 0 C--N 1.33 -0.269 0 O-C-N 120.989 -1.069 . . . . 1.0 109.18 179.311 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -108.57 124.79 33.39 Favored Pre-proline 0 CA--C 1.541 0.615 0 N-CA-C 109.67 -0.493 . . . . 1.0 109.67 179.789 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 52.0 Cg_exo -49.94 -23.08 8.39 Favored 'Trans proline' 0 N--CA 1.5 1.866 0 C-N-CA 121.796 1.664 . . . . 1.0 113.827 179.985 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -126.17 134.86 51.15 Favored 'General case' 0 N--CA 1.469 0.506 0 N-CA-C 111.311 0.115 . . . . 1.0 111.311 178.54 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 42' ' ' ARG . . . . . 0.682 ' C ' ' H ' ' A' ' 44' ' ' GLY . 19.3 ttp-105 -164.68 164.46 21.37 Favored 'General case' 0 C--N 1.328 -0.353 0 C-N-CA 120.197 -0.601 . . . . 1.0 109.787 177.172 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 43' ' ' ARG . . . . . 0.625 ' C ' ' H ' ' A' ' 45' ' ' PHE . 4.7 tpt180 -60.92 24.59 0.01 OUTLIER 'General case' 0 CA--C 1.545 0.75 0 CA-C-N 115.789 -0.642 . . . . 1.0 110.623 -178.864 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 44' ' ' GLY . . . . . 0.682 ' H ' ' C ' ' A' ' 42' ' ' ARG . . . 66.27 -32.12 0.16 Allowed Glycine 0 C--N 1.34 0.769 0 N-CA-C 110.65 -0.98 . . . . 1.0 110.65 179.456 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 45' ' ' PHE . . . . . 0.637 ' O ' ' HB2' ' A' ' 46' ' ' PHE . 11.8 t80 -169.34 170.81 8.24 Favored 'General case' 0 N--CA 1.446 -0.642 0 N-CA-C 108.378 -0.971 . . . . 1.0 108.378 179.141 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 46' ' ' PHE . . . . . 0.637 ' HB2' ' O ' ' A' ' 45' ' ' PHE . 1.0 OUTLIER 120.8 106.64 0.0 OUTLIER 'General case' 0 N--CA 1.497 1.921 0 C-N-CA 127.333 2.253 . . . . 1.0 106.34 -179.346 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 47' ' ' ARG . . . . . 0.531 ' HB2' ' O ' ' A' ' 46' ' ' PHE . 0.1 OUTLIER 103.24 149.84 0.01 OUTLIER 'General case' 0 N--CA 1.479 1.0 0 C-N-CA 124.827 1.251 . . . . 1.0 109.86 -178.602 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 48' ' ' CYS . . . . . 0.511 ' SG ' ' C ' ' A' ' 47' ' ' ARG . 0.0 OUTLIER 64.3 71.92 0.46 Allowed 'General case' 0 CA--C 1.534 0.361 0 CA-C-N 114.984 -1.007 . . . . 1.0 110.396 -178.892 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -140.85 163.53 42.13 Favored Pre-proline 0 C--N 1.33 -0.269 0 O-C-N 121.92 -0.487 . . . . 1.0 110.747 -179.22 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 38.4 Cg_endo -66.18 47.08 0.22 Allowed 'Trans proline' 0 N--CA 1.498 1.773 0 C-N-CA 123.107 2.538 . . . . 1.0 111.78 178.738 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 51' ' ' GLU . . . . . 0.531 ' OE1' ' NH2' ' A' ' 95' ' ' ARG . 7.6 mt-10 57.02 12.4 1.22 Allowed 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 115.37 -0.832 . . . . 1.0 111.393 179.593 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 24.9 ptt85 -85.87 147.31 26.33 Favored 'General case' 0 C--N 1.333 -0.119 0 N-CA-C 107.296 -1.372 . . . . 1.0 107.296 177.846 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 8.8 tp -49.46 138.4 4.89 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.496 0 CA-C-O 122.012 0.91 . . . . 1.0 113.033 -177.893 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 54' ' ' GLN . . . . . 0.587 ' H ' ' CD ' ' A' ' 54' ' ' GLN . 0.0 OUTLIER -76.17 79.51 2.98 Favored 'General case' 0 CA--C 1.534 0.351 0 CA-C-N 114.074 -1.421 . . . . 1.0 109.222 179.613 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 1.8 mt -147.38 157.12 9.88 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.75 0 CA-C-N 115.244 -0.889 . . . . 1.0 110.211 178.094 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 108.5 -0.24 32.67 Favored Glycine 0 C--N 1.338 0.691 0 N-CA-C 110.553 -1.019 . . . . 1.0 110.553 179.766 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 57' ' ' ASP . . . . . 0.424 ' O ' ' OD1' ' A' ' 57' ' ' ASP . 31.1 p-10 -80.27 101.74 9.08 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 121.584 0.707 . . . . 1.0 112.393 -178.816 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 58' ' ' TRP . . . . . . . . . . . . . 10.0 m0 -78.61 179.12 7.3 Favored 'General case' 0 C--N 1.323 -0.548 0 N-CA-C 108.028 -1.101 . . . . 1.0 108.028 178.34 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 59' ' ' ARG . . . . . 0.577 ' O ' ' CG2' ' A' ' 62' ' ' VAL . 1.0 OUTLIER -100.28 -49.12 4.36 Favored 'General case' 0 CA--C 1.546 0.81 0 CA-C-N 121.522 1.965 . . . . 1.0 111.613 178.535 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 60' ' ' TYR . . . . . 0.411 ' CD1' ' C ' ' A' ' 60' ' ' TYR . 3.7 p90 -85.98 -9.6 56.55 Favored 'General case' 0 N--CA 1.488 1.43 0 C-N-CA 124.997 1.319 . . . . 1.0 113.281 -177.98 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 61' ' ' GLU . . . . . 0.402 ' O ' ' N ' ' A' ' 65' ' ' ASP . 27.1 tt0 -75.32 -14.07 60.46 Favored 'General case' 0 C--N 1.308 -1.219 0 O-C-N 121.554 -0.716 . . . . 1.0 110.622 -178.952 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 62' ' ' VAL . . . . . 0.577 ' CG2' ' O ' ' A' ' 59' ' ' ARG . 0.0 OUTLIER -44.28 -50.34 1.92 Allowed 'Isoleucine or valine' 0 C--N 1.315 -0.901 0 N-CA-C 109.715 -0.476 . . . . 1.0 109.715 -175.69 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 63' ' ' ALA . . . . . 0.508 ' O ' ' HG2' ' A' ' 67' ' ' ARG . . . -67.6 -47.15 70.52 Favored 'General case' 0 N--CA 1.425 -1.683 0 N-CA-C 108.587 -0.894 . . . . 1.0 108.587 -179.878 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 64' ' ' HIS . . . . . 0.449 ' O ' ' CG ' ' A' ' 67' ' ' ARG . 0.5 OUTLIER -55.21 -59.22 5.07 Favored 'General case' 0 CA--C 1.547 0.841 0 CA-C-N 115.292 -0.867 . . . . 1.0 109.871 179.683 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 65' ' ' ASP . . . . . 0.639 ' C ' ' H ' ' A' ' 67' ' ' ARG . 29.6 t70 -67.08 -53.39 31.38 Favored 'General case' 0 C--O 1.243 0.739 0 CA-C-O 121.667 0.746 . . . . 1.0 109.27 178.438 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 66' ' ' GLY . . . . . 0.551 ' N ' ' O ' ' A' ' 62' ' ' VAL . . . -63.3 31.14 0.08 OUTLIER Glycine 0 CA--C 1.523 0.573 0 N-CA-C 111.477 -0.649 . . . . 1.0 111.477 178.263 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 67' ' ' ARG . . . . . 0.77 ' HB3' ' HB3' ' A' ' 71' ' ' ALA . 6.3 mmt180 -76.34 -2.59 32.47 Favored 'General case' 0 C--N 1.315 -0.901 0 N-CA-C 108.07 -1.085 . . . . 1.0 108.07 174.876 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 68' ' ' LEU . . . . . 0.483 ' C ' ' O ' ' A' ' 67' ' ' ARG . 5.8 tt -35.16 -30.35 0.01 OUTLIER 'General case' 0 N--CA 1.475 0.82 0 N-CA-C 108.63 -0.878 . . . . 1.0 108.63 -176.403 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 69' ' ' LEU . . . . . 0.57 ' N ' ' O ' ' A' ' 67' ' ' ARG . 9.9 mp -69.24 -68.57 0.39 Allowed 'General case' 0 CA--C 1.549 0.921 0 CA-C-N 115.09 -0.959 . . . . 1.0 111.063 179.686 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 70' ' ' ALA . . . . . 0.613 ' C ' ' H ' ' A' ' 72' ' ' HIS . . . -77.16 -76.85 0.16 Allowed 'General case' 0 N--CA 1.473 0.723 0 C-N-CA 119.016 -1.074 . . . . 1.0 109.457 -178.373 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 71' ' ' ALA . . . . . 0.77 ' HB3' ' HB3' ' A' ' 67' ' ' ARG . . . -57.31 10.48 0.01 OUTLIER 'General case' 0 C--N 1.324 -0.502 0 C-N-CA 124.652 1.181 . . . . 1.0 112.574 179.784 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 72' ' ' HIS . . . . . 0.878 ' CD2' ' H ' ' A' ' 73' ' ' MET . 1.3 p80 -19.84 -48.23 0.01 OUTLIER 'General case' 0 N--CA 1.465 0.323 0 N-CA-C 114.669 1.359 . . . . 1.0 114.669 -177.197 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 73' ' ' MET . . . . . 0.878 ' H ' ' CD2' ' A' ' 72' ' ' HIS . 15.4 ptp -74.87 -47.91 27.67 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 119.275 0.943 . . . . 1.0 109.353 179.058 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 74' ' ' VAL . . . . . 0.705 ' HB ' ' HB1' ' A' ' 71' ' ' ALA . 59.3 t -43.23 -48.46 1.41 Allowed 'Isoleucine or valine' 0 C--O 1.214 -0.79 0 CA-C-O 117.736 -1.126 . . . . 1.0 110.972 -175.389 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 75' ' ' ASN . . . . . 0.402 ' C ' ' O ' ' A' ' 74' ' ' VAL . 3.9 m120 -37.52 -19.66 0.01 OUTLIER 'General case' 0 N--CA 1.48 1.075 0 CA-C-O 122.714 1.245 . . . . 1.0 109.987 178.507 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 76' ' ' GLY . . . . . 0.661 ' N ' ' O ' ' A' ' 74' ' ' VAL . . . -50.99 -24.3 8.3 Favored Glycine 0 C--O 1.213 -1.177 0 N-CA-C 108.143 -1.983 . . . . 1.0 108.143 176.207 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 77' ' ' ILE . . . . . 0.444 ' N ' ' O ' ' A' ' 74' ' ' VAL . 9.5 pt -45.64 -43.78 4.1 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.323 0 O-C-N 122.289 -0.536 . . . . 1.0 110.9 179.523 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 57.5 t -55.65 -22.04 11.5 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.343 0 CA-C-N 118.649 0.659 . . . . 1.0 111.05 -179.67 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 79' ' ' ILE . . . . . 0.611 ' O ' ' HB2' ' A' ' 83' ' ' ALA . 0.3 OUTLIER -88.03 -42.49 15.0 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.715 0 C-N-CA 119.32 -0.952 . . . . 1.0 110.058 178.556 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -78.93 -23.03 44.95 Favored 'General case' 0 CA--C 1.537 0.444 0 N-CA-C 112.262 0.467 . . . . 1.0 112.262 -178.892 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 94.8 mt-10 -91.11 -68.25 0.8 Allowed 'General case' 0 CA--C 1.533 0.289 0 N-CA-C 112.475 0.546 . . . . 1.0 112.475 178.718 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 82' ' ' ASP . . . . . 0.46 ' O ' ' C ' ' A' ' 83' ' ' ALA . 1.2 m-20 -74.76 -21.49 59.31 Favored 'General case' 0 C--N 1.349 0.555 0 N-CA-C 114.991 1.478 . . . . 1.0 114.991 -176.35 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 83' ' ' ALA . . . . . 0.682 ' HA ' ' HB3' ' A' ' 86' ' ' ALA . . . -37.38 -50.08 1.03 Allowed 'General case' 0 N--CA 1.483 1.187 0 CA-C-N 120.253 1.388 . . . . 1.0 111.355 178.743 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 84' ' ' LEU . . . . . 0.49 ' C ' ' O ' ' A' ' 83' ' ' ALA . 0.1 OUTLIER -26.88 -41.74 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.609 0 CA-C-O 120.62 0.248 . . . . 1.0 110.645 -175.327 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 85' ' ' ILE . . . . . 0.505 ' N ' ' O ' ' A' ' 83' ' ' ALA . 2.9 pt -98.63 -46.65 12.39 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 N-CA-C 109.468 -0.568 . . . . 1.0 109.468 177.605 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 86' ' ' ALA . . . . . 0.682 ' HB3' ' HA ' ' A' ' 83' ' ' ALA . . . -49.54 -44.27 46.44 Favored 'General case' 0 N--CA 1.461 0.102 0 CA-C-N 115.931 -0.577 . . . . 1.0 110.14 -177.913 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 21.6 pt-20 -53.73 -21.9 8.1 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.929 0.395 . . . . 1.0 110.54 179.62 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -82.36 -13.84 56.23 Favored 'General case' 0 CA--C 1.517 -0.316 0 CA-C-O 121.289 0.566 . . . . 1.0 109.889 -179.476 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 89' ' ' VAL . . . . . 0.513 ' O ' HG12 ' A' ' 89' ' ' VAL . 18.5 t -93.06 34.74 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.553 0 CA-C-N 114.964 -1.016 . . . . 1.0 109.419 178.972 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 90' ' ' GLY . . . . . 0.534 ' O ' ' N ' ' A' ' 92' ' ' HIS . . . -74.66 -41.44 35.17 Favored Glycine 0 CA--C 1.539 1.555 0 N-CA-C 111.501 -0.64 . . . . 1.0 111.501 179.09 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 91' ' ' PRO . . . . . 0.48 ' CD ' ' N ' ' A' ' 90' ' ' GLY . 91.0 Cg_exo -41.35 -20.89 0.11 Allowed 'Trans proline' 0 N--CA 1.492 1.391 0 CA-C-N 119.354 1.577 . . . . 1.0 111.177 -179.795 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 92' ' ' HIS . . . . . 0.692 ' O ' ' N ' ' A' ' 96' ' ' ALA . 27.6 p-80 -53.73 -38.7 64.6 Favored 'General case' 0 C--O 1.196 -1.733 0 N-CA-C 106.489 -1.671 . . . . 1.0 106.489 -179.162 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 93' ' ' LEU . . . . . 0.777 HD12 ' N ' ' A' ' 94' ' ' ALA . 2.6 pp -46.17 -58.98 3.18 Favored 'General case' 0 C--N 1.319 -0.745 0 C-N-CA 120.183 -0.607 . . . . 1.0 110.428 -179.757 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 94' ' ' ALA . . . . . 0.777 ' N ' HD12 ' A' ' 93' ' ' LEU . . . -59.5 -56.79 17.59 Favored 'General case' 0 N--CA 1.465 0.275 0 CA-C-N 118.514 0.597 . . . . 1.0 109.692 -179.953 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 95' ' ' ARG . . . . . 0.668 ' O ' ' N ' ' A' ' 97' ' ' LEU . 5.8 mtp-105 -54.53 -58.61 6.82 Favored 'General case' 0 C--O 1.238 0.494 0 N-CA-C 107.789 -1.189 . . . . 1.0 107.789 178.347 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 96' ' ' ALA . . . . . 0.745 ' O ' ' N ' ' A' ' 98' ' ' GLY . . . -45.15 -12.99 0.02 OUTLIER 'General case' 0 C--N 1.294 -1.821 0 O-C-N 119.383 -2.073 . . . . 1.0 110.627 179.558 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 97' ' ' LEU . . . . . 0.668 ' N ' ' O ' ' A' ' 95' ' ' ARG . 0.8 OUTLIER 1.91 -54.71 0.0 OUTLIER 'General case' 0 N--CA 1.48 1.026 0 C-N-CA 124.407 1.083 . . . . 1.0 111.987 -169.958 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 98' ' ' GLY . . . . . 0.745 ' N ' ' O ' ' A' ' 96' ' ' ALA . . . -48.85 -23.05 3.25 Favored Glycine 0 CA--C 1.539 1.554 0 CA-C-N 122.233 2.288 . . . . 1.0 108.62 175.173 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 99' ' ' GLN . . . . . 0.627 ' N ' ' O ' ' A' ' 96' ' ' ALA . 1.2 mp0 -69.68 -24.14 63.55 Favored 'General case' 0 C--N 1.364 1.204 0 C-N-CA 118.338 -1.345 . . . . 1.0 107.776 178.47 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 100' ' ' ILE . . . . . 0.584 ' N ' ' O ' ' A' ' 97' ' ' LEU . 4.7 mm -65.23 -40.03 87.36 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.755 0 CA-C-N 115.026 -0.988 . . . . 1.0 108.762 177.945 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 101' ' ' VAL . . . . . 0.565 ' O ' ' N ' ' A' ' 105' ' ' GLY . 0.5 OUTLIER -58.52 -57.28 11.67 Favored 'Isoleucine or valine' 0 C--N 1.343 0.289 0 N-CA-C 107.407 -1.331 . . . . 1.0 107.407 179.669 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 102' ' ' CYS . . . . . 0.944 ' O ' ' HB2' ' A' ' 106' ' ' ALA . 0.7 OUTLIER -41.6 -17.61 0.01 OUTLIER 'General case' 0 CA--C 1.536 0.417 0 CA-C-O 120.763 0.316 . . . . 1.0 111.107 -179.537 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 103' ' ' ARG . . . . . 0.528 ' N ' ' O ' ' A' ' 101' ' ' VAL . 4.3 ttm180 -93.29 -35.01 13.3 Favored 'General case' 0 N--CA 1.478 0.954 0 CA-C-O 122.327 1.061 . . . . 1.0 111.523 177.71 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 104' ' ' TYR . . . . . 0.75 ' O ' ' CG ' ' A' ' 104' ' ' TYR . 1.2 t80 -106.44 19.08 21.04 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 112.722 -2.035 . . . . 1.0 109.746 177.817 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 105' ' ' GLY . . . . . 0.735 ' O ' ' N ' ' A' ' 107' ' ' THR . . . -165.76 -18.88 0.02 OUTLIER Glycine 0 C--O 1.223 -0.538 0 C-N-CA 117.461 -2.304 . . . . 1.0 113.035 179.263 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 106' ' ' ALA . . . . . 0.944 ' HB2' ' O ' ' A' ' 102' ' ' CYS . . . -11.39 65.0 0.0 OUTLIER 'General case' 0 N--CA 1.477 0.915 0 O-C-N 124.778 0.928 . . . . 1.0 111.93 -179.55 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 107' ' ' THR . . . . . 0.735 ' N ' ' O ' ' A' ' 105' ' ' GLY . 99.4 m -98.42 -4.41 34.7 Favored 'General case' 0 CA--C 1.511 -0.55 0 O-C-N 121.678 -0.639 . . . . 1.0 109.347 -178.999 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 108' ' ' VAL . . . . . 0.518 ' C ' ' HD2' ' A' ' 110' ' ' PRO . 41.2 t -81.86 -54.05 10.67 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.494 0 CA-C-N 116.288 -0.414 . . . . 1.0 110.105 178.466 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 109' ' ' ILE . . . . . 0.507 ' O ' ' CB ' ' A' ' 113' ' ' ASN . 0.2 OUTLIER -47.49 -38.86 17.82 Favored Pre-proline 0 N--CA 1.473 0.699 0 N-CA-C 114.822 1.415 . . . . 1.0 114.822 -179.095 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 110' ' ' PRO . . . . . 0.518 ' HD2' ' C ' ' A' ' 108' ' ' VAL . 83.7 Cg_exo -47.02 -41.49 26.19 Favored 'Trans proline' 0 C--N 1.31 -1.48 0 C-N-CA 121.929 1.753 . . . . 1.0 112.623 -174.818 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 1.2 t-20 -63.49 -69.39 0.27 Allowed 'General case' 0 CA--C 1.536 0.421 0 C-N-CA 118.877 -1.129 . . . . 1.0 110.29 179.88 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 112' ' ' ILE . . . . . 0.448 ' O ' ' N ' ' A' ' 116' ' ' ILE . 0.1 OUTLIER -61.84 -44.74 99.28 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.539 0 CA-C-O 121.325 0.583 . . . . 1.0 110.543 -178.1 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 113' ' ' ASN . . . . . 0.507 ' CB ' ' O ' ' A' ' 109' ' ' ILE . 20.9 t30 -45.79 -62.17 1.42 Allowed 'General case' 0 C--N 1.309 -1.168 0 CA-C-N 115.3 -0.864 . . . . 1.0 111.511 -174.733 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -61.67 -24.59 66.85 Favored 'General case' 0 N--CA 1.433 -1.294 0 C-N-CA 118.873 -1.131 . . . . 1.0 110.703 179.586 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -82.32 -61.43 1.9 Allowed 'General case' 0 C--O 1.239 0.504 0 N-CA-C 113.95 1.093 . . . . 1.0 113.95 178.323 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 116' ' ' ILE . . . . . 0.589 ' O ' ' N ' ' A' ' 119' ' ' LEU . 47.0 mt -69.82 -49.03 60.71 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.678 0 O-C-N 120.501 -1.374 . . . . 1.0 111.596 -177.985 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 117' ' ' GLU . . . . . 0.479 ' OE1' ' OD1' ' A' ' 113' ' ' ASN . 18.5 tt0 -46.2 -61.58 1.71 Allowed 'General case' 0 C--N 1.312 -1.05 0 N-CA-C 108.393 -0.966 . . . . 1.0 108.393 -177.106 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 97.5 t -54.28 -16.02 1.31 Allowed 'Isoleucine or valine' 0 N--CA 1.44 -0.96 0 O-C-N 124.408 1.068 . . . . 1.0 109.317 178.453 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 119' ' ' LEU . . . . . 0.589 ' N ' ' O ' ' A' ' 116' ' ' ILE . 0.2 OUTLIER -80.01 -61.31 2.03 Favored 'General case' 0 C--N 1.349 0.551 0 C-N-CA 119.793 -0.763 . . . . 1.0 110.453 178.342 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -66.62 -85.52 0.08 OUTLIER Glycine 0 C--N 1.361 1.96 0 C-N-CA 117.519 -2.277 . . . . 1.0 112.103 179.916 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -163.73 -27.18 0.04 OUTLIER 'General case' 0 N--CA 1.473 0.713 0 N-CA-C 107.422 -1.325 . . . . 1.0 107.422 -178.604 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 122' ' ' GLY . . . . . 0.554 ' O ' ' N ' ' A' ' 124' ' ' ASP . . . 116.76 -36.2 3.86 Favored Glycine 0 CA--C 1.531 1.033 0 CA-C-N 113.933 -1.485 . . . . 1.0 113.432 179.699 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 123' ' ' THR . . . . . 0.454 ' C ' ' O ' ' A' ' 122' ' ' GLY . 0.1 OUTLIER -32.78 89.64 0.0 OUTLIER 'General case' 0 N--CA 1.476 0.839 0 CA-C-N 120.578 2.189 . . . . 1.0 112.774 -178.652 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 124' ' ' ASP . . . . . 0.554 ' N ' ' O ' ' A' ' 122' ' ' GLY . 11.6 t0 -147.45 143.86 28.21 Favored 'General case' 0 CA--C 1.521 -0.162 0 N-CA-C 108.454 -0.943 . . . . 1.0 108.454 179.94 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 125' ' ' TYR . . . . . 0.471 ' O ' ' CD1' ' A' ' 125' ' ' TYR . 0.1 OUTLIER -150.79 148.43 28.5 Favored 'General case' 0 C--N 1.324 -0.526 0 N-CA-C 109.596 -0.52 . . . . 1.0 109.596 179.891 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 126' ' ' ARG . . . . . 0.435 ' NE ' ' HA ' ' A' ' 126' ' ' ARG . 10.8 mmp_? -145.74 148.4 32.95 Favored 'General case' 0 N--CA 1.471 0.623 0 N-CA-C 109.592 -0.521 . . . . 1.0 109.592 177.264 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 127' ' ' PHE . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 C--O 1.218 -0.575 0 CA-C-O 118.049 -0.977 . . . . 1.0 110.008 -179.9 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 60.1 mtt . . . . . 0 N--CA 1.491 1.584 0 N-CA-C 109.013 -0.736 . . . . 1.0 109.013 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 48.7 m -107.78 -0.97 21.33 Favored 'General case' 0 N--CA 1.466 0.351 0 CA-C-N 116.404 -0.362 . . . . 1.0 110.692 179.553 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 3' ' ' ASP . . . . . 0.526 ' N ' ' OD1' ' A' ' 3' ' ' ASP . 8.1 p-10 -178.83 92.66 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.478 -0.328 . . . . 1.0 110.854 -179.747 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 37.2 t80 -151.59 147.75 27.16 Favored 'General case' 0 CA--C 1.513 -0.444 0 CA-C-O 120.899 0.38 . . . . 1.0 110.112 179.358 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 5' ' ' ASP . . . . . 0.498 ' C ' ' OG ' ' A' ' 10' ' ' SER . 32.1 p30 -156.58 153.05 28.02 Favored 'General case' 0 N--CA 1.448 -0.538 0 CA-C-N 116.058 -0.519 . . . . 1.0 110.748 179.472 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 6' ' ' THR . . . . . 0.957 ' H ' HG23 ' A' ' 9' ' ' VAL . 0.2 OUTLIER -102.69 -170.2 1.77 Allowed 'General case' 0 C--O 1.199 -1.605 0 CA-C-O 121.661 0.743 . . . . 1.0 110.467 178.131 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 7' ' ' GLU . . . . . 0.464 ' O ' ' HB2' ' A' ' 11' ' ' ARG . 33.4 tt0 -56.25 -40.97 75.0 Favored 'General case' 0 C--N 1.304 -1.391 0 CA-C-O 121.653 0.74 . . . . 1.0 110.586 -179.555 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 8' ' ' ARG . . . . . 0.82 ' O ' ' HB3' ' A' ' 12' ' ' ALA . 0.9 OUTLIER -70.01 -62.78 1.25 Allowed 'General case' 0 C--N 1.31 -1.122 0 C-N-CA 118.654 -1.218 . . . . 1.0 111.252 179.548 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 9' ' ' VAL . . . . . 0.957 HG23 ' H ' ' A' ' 6' ' ' THR . 0.0 OUTLIER -62.7 -48.45 88.08 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.712 0 CA-C-N 114.113 -1.403 . . . . 1.0 108.229 179.144 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 10' ' ' SER . . . . . 0.669 ' N ' ' O ' ' A' ' 6' ' ' THR . 1.6 m -67.8 -68.35 0.39 Allowed 'General case' 0 C--O 1.189 -2.128 0 C-N-CA 118.3 -1.36 . . . . 1.0 112.915 179.857 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 11' ' ' ARG . . . . . 0.57 ' O ' ' N ' ' A' ' 15' ' ' ALA . 2.3 mmt85 -67.83 -49.93 59.46 Favored 'General case' 0 N--CA 1.48 1.072 0 N-CA-C 113.965 1.098 . . . . 1.0 113.965 -176.551 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 12' ' ' ALA . . . . . 0.82 ' HB3' ' O ' ' A' ' 8' ' ' ARG . . . -60.69 -58.74 7.16 Favored 'General case' 0 C--N 1.314 -0.956 0 C-N-CA 117.866 -1.534 . . . . 1.0 107.526 -178.873 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 13' ' ' VAL . . . . . 0.696 ' O ' ' N ' ' A' ' 17' ' ' LEU . 0.5 OUTLIER -60.0 -50.36 80.46 Favored 'Isoleucine or valine' 0 C--O 1.184 -2.393 0 N-CA-C 106.561 -1.644 . . . . 1.0 106.561 179.215 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 14' ' ' ALA . . . . . 0.844 ' O ' HG22 ' A' ' 18' ' ' VAL . . . -58.76 -64.05 1.07 Allowed 'General case' 0 C--O 1.199 -1.599 0 C-N-CA 116.493 -2.083 . . . . 1.0 111.497 -179.101 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 15' ' ' ALA . . . . . 0.575 ' O ' ' N ' ' A' ' 19' ' ' GLY . . . -52.21 -55.04 23.69 Favored 'General case' 0 C--N 1.314 -0.949 0 N-CA-C 108.46 -0.941 . . . . 1.0 108.46 -178.622 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 16' ' ' ALA . . . . . 0.559 ' HB3' ' O ' ' A' ' 12' ' ' ALA . . . -64.36 -57.86 8.13 Favored 'General case' 0 C--N 1.304 -1.395 0 C-N-CA 118.886 -1.126 . . . . 1.0 111.042 -179.95 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 17' ' ' LEU . . . . . 0.696 ' N ' ' O ' ' A' ' 13' ' ' VAL . 19.1 tp -55.78 -55.27 34.4 Favored 'General case' 0 N--CA 1.49 1.569 0 N-CA-C 107.909 -1.145 . . . . 1.0 107.909 -177.768 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 18' ' ' VAL . . . . . 0.844 HG22 ' O ' ' A' ' 14' ' ' ALA . 1.5 m -71.29 -59.13 3.75 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.411 0 CA-C-N 116.045 -0.525 . . . . 1.0 110.471 179.925 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 19' ' ' GLY . . . . . 0.575 ' N ' ' O ' ' A' ' 15' ' ' ALA . . . -56.67 -169.27 0.1 OUTLIER Glycine 0 N--CA 1.438 -1.187 0 N-CA-C 111.225 -0.75 . . . . 1.0 111.225 -177.655 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 20' ' ' PRO . . . . . 0.642 ' O ' ' N ' ' A' ' 24' ' ' ALA . 58.6 Cg_endo -85.32 -29.24 0.66 Allowed 'Trans proline' 0 C--N 1.29 -2.5 0 C-N-CA 122.456 2.104 . . . . 1.0 113.455 -177.564 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 21' ' ' GLY . . . . . 0.443 ' O ' ' HB3' ' A' ' 24' ' ' ALA . . . -60.42 -59.73 9.79 Favored Glycine 0 N--CA 1.471 0.993 0 C-N-CA 120.143 -1.027 . . . . 1.0 112.26 -177.747 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 22' ' ' GLY . . . . . 0.495 ' H ' ' HA ' ' A' ' 16' ' ' ALA . . . -56.51 -53.33 44.24 Favored Glycine 0 CA--C 1.497 -1.072 0 N-CA-C 106.53 -2.628 . . . . 1.0 106.53 -176.374 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 23' ' ' VAL . . . . . 0.526 ' O ' HG12 ' A' ' 27' ' ' VAL . 22.4 t -56.74 -31.22 34.62 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.242 0 N-CA-C 108.216 -1.031 . . . . 1.0 108.216 178.043 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 24' ' ' ALA . . . . . 0.642 ' N ' ' O ' ' A' ' 20' ' ' PRO . . . -59.18 -63.21 1.38 Allowed 'General case' 0 C--N 1.354 0.791 0 C-N-CA 118.712 -1.195 . . . . 1.0 110.331 -178.823 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 25' ' ' LEU . . . . . 0.44 ' H ' ' HG ' ' A' ' 25' ' ' LEU . 1.2 mt -62.27 -46.04 90.59 Favored 'General case' 0 C--N 1.325 -0.458 0 C-N-CA 120.335 -0.546 . . . . 1.0 111.333 -177.063 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 88.0 t -59.64 -58.94 4.87 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.669 0 C-N-CA 119.898 -0.721 . . . . 1.0 109.604 -177.78 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 27' ' ' VAL . . . . . 0.526 HG12 ' O ' ' A' ' 23' ' ' VAL . 1.5 p -60.62 -37.45 75.53 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.508 0 C-N-CA 120.076 -0.65 . . . . 1.0 110.245 -177.99 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 27.2 ttpp -65.29 -56.96 9.75 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 115.89 -0.595 . . . . 1.0 110.462 -179.018 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 84.1 t -63.27 -47.88 90.05 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.784 0 CA-C-N 114.936 -1.029 . . . . 1.0 109.692 -177.715 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 30' ' ' CYS . . . . . . . . . . . . . 36.8 t -65.01 -60.82 2.62 Favored 'General case' 0 N--CA 1.441 -0.884 0 C-N-CA 119.787 -0.765 . . . . 1.0 109.588 -178.82 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 31' ' ' ALA . . . . . 0.523 ' HB3' ' O ' ' A' ' 27' ' ' VAL . . . -57.8 -47.62 82.07 Favored 'General case' 0 CA--C 1.497 -1.091 0 CA-C-O 121.29 0.567 . . . . 1.0 109.769 -176.427 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 32' ' ' GLY . . . . . 0.468 ' O ' ' HB2' ' A' ' 33' ' ' LEU . . . 74.2 67.92 1.67 Allowed Glycine 0 N--CA 1.439 -1.131 0 N-CA-C 108.982 -1.647 . . . . 1.0 108.982 -178.525 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 33' ' ' LEU . . . . . 0.478 ' O ' ' O ' ' A' ' 36' ' ' VAL . 17.7 mt 97.41 78.52 0.02 OUTLIER Pre-proline 0 N--CA 1.47 0.54 0 C-N-CA 124.542 1.137 . . . . 1.0 110.645 -179.452 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 76.5 Cg_exo -45.93 -29.45 5.99 Favored 'Trans proline' 0 C--N 1.312 -1.386 0 C-N-CA 121.973 1.782 . . . . 1.0 112.672 179.793 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -60.38 -60.61 8.26 Favored Glycine 0 CA--C 1.536 1.37 0 C-N-CA 118.756 -1.687 . . . . 1.0 109.894 -178.375 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 36' ' ' VAL . . . . . 0.703 HG22 ' H ' ' A' ' 37' ' ' ILE . 8.5 p -98.81 177.87 0.66 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.68 0 N-CA-C 107.36 -1.348 . . . . 1.0 107.36 177.793 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 37' ' ' ILE . . . . . 0.703 ' H ' HG22 ' A' ' 36' ' ' VAL . 2.9 mm 101.15 120.34 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.479 1.01 0 O-C-N 124.818 1.323 . . . . 1.0 110.952 179.609 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 79.8 m80 -142.75 136.97 29.44 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 115.572 -0.74 . . . . 1.0 109.508 178.456 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 11.1 m -91.95 127.48 49.52 Favored Pre-proline 0 CA--C 1.537 0.474 0 N-CA-C 108.966 -0.753 . . . . 1.0 108.966 179.678 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 29.7 Cg_endo -62.94 -30.55 76.97 Favored 'Trans proline' 0 N--CA 1.498 1.745 0 C-N-CA 121.752 1.635 . . . . 1.0 113.368 -178.192 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -110.36 90.93 3.46 Favored 'General case' 0 CA--C 1.507 -0.696 0 CA-C-O 121.599 0.714 . . . . 1.0 112.664 -176.498 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 16.3 ptm180 -139.82 143.0 36.61 Favored 'General case' 0 C--N 1.318 -0.768 0 CA-C-N 114.552 -1.204 . . . . 1.0 108.479 178.927 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 76.5 ttt180 -50.91 -15.61 0.32 Allowed 'General case' 0 N--CA 1.451 -0.41 0 O-C-N 121.958 -0.464 . . . . 1.0 111.299 -176.003 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 119.11 -25.34 7.89 Favored Glycine 0 N--CA 1.468 0.792 0 N-CA-C 111.148 -0.781 . . . . 1.0 111.148 178.885 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 45' ' ' PHE . . . . . 0.565 ' O ' ' CD1' ' A' ' 46' ' ' PHE . 0.6 OUTLIER -156.84 161.53 39.72 Favored 'General case' 0 C--N 1.323 -0.557 0 N-CA-C 108.171 -1.048 . . . . 1.0 108.171 178.446 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 46' ' ' PHE . . . . . 0.834 ' O ' ' CD1' ' A' ' 46' ' ' PHE . 0.0 OUTLIER 115.66 120.46 0.0 OUTLIER 'General case' 0 N--CA 1.479 1.024 0 O-C-N 125.288 1.618 . . . . 1.0 112.433 179.342 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 47' ' ' ARG . . . . . 0.594 ' HB2' ' O ' ' A' ' 46' ' ' PHE . 5.9 mtm180 76.75 163.32 0.24 Allowed 'General case' 0 N--CA 1.479 1.023 0 O-C-N 119.266 -2.146 . . . . 1.0 110.727 -178.67 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 4.1 t 61.35 70.03 0.63 Allowed 'General case' 0 C--O 1.232 0.147 0 N-CA-C 108.786 -0.82 . . . . 1.0 108.786 -178.196 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 49' ' ' ASN . . . . . 0.605 ' O ' ' N ' ' A' ' 51' ' ' GLU . 0.0 OUTLIER -146.1 163.95 27.75 Favored Pre-proline 0 CA--C 1.538 0.511 0 N-CA-C 109.519 -0.549 . . . . 1.0 109.519 -178.726 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 50' ' ' PRO . . . . . 0.512 ' O ' ' NE ' ' A' ' 52' ' ' ARG . 11.2 Cg_endo -54.41 58.48 0.03 OUTLIER 'Trans proline' 0 N--CA 1.514 2.68 0 C-N-CA 123.32 2.68 . . . . 1.0 112.057 179.611 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 51' ' ' GLU . . . . . 0.605 ' N ' ' O ' ' A' ' 49' ' ' ASN . 40.5 mt-10 55.02 37.39 28.84 Favored 'General case' 0 N--CA 1.475 0.797 0 O-C-N 121.192 -0.943 . . . . 1.0 112.678 176.956 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 52' ' ' ARG . . . . . 0.551 ' O ' ' ND2' ' A' ' 49' ' ' ASN . 0.0 OUTLIER -151.69 179.9 8.0 Favored 'General case' 0 N--CA 1.476 0.829 0 CA-C-O 121.71 0.767 . . . . 1.0 110.439 179.069 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 4.6 tp -82.25 168.72 1.74 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 114.869 -1.059 . . . . 1.0 108.993 177.78 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 1.1 tp60 -132.44 131.98 42.29 Favored 'General case' 0 CA--C 1.533 0.318 0 N-CA-C 108.793 -0.817 . . . . 1.0 108.793 178.624 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 20.4 tt -144.91 155.08 14.13 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.661 0 N-CA-C 110.334 -0.247 . . . . 1.0 110.334 178.563 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 101.38 1.57 53.74 Favored Glycine 0 C--N 1.341 0.842 0 N-CA-C 110.157 -1.177 . . . . 1.0 110.157 -179.827 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 9.4 t70 -93.2 115.55 28.16 Favored 'General case' 0 CA--C 1.539 0.521 0 CA-C-O 122.229 1.014 . . . . 1.0 113.035 -178.214 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 58' ' ' TRP . . . . . 0.649 ' HB2' ' HB2' ' A' ' 61' ' ' GLU . 37.7 m0 -82.92 -178.4 7.1 Favored 'General case' 0 C--N 1.318 -0.799 0 CA-C-N 112.673 -2.058 . . . . 1.0 109.411 177.682 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 59' ' ' ARG . . . . . 0.445 ' HG3' ' H ' ' A' ' 60' ' ' TYR . 13.7 ptt-85 -94.61 -55.39 3.16 Favored 'General case' 0 CA--C 1.543 0.701 0 CA-C-O 121.24 0.543 . . . . 1.0 111.333 179.412 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 60' ' ' TYR . . . . . 0.573 ' O ' ' CG ' ' A' ' 60' ' ' TYR . 17.3 t80 -76.68 -4.03 41.04 Favored 'General case' 0 N--CA 1.476 0.836 0 C-N-CA 124.327 1.051 . . . . 1.0 111.255 179.231 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 61' ' ' GLU . . . . . 0.649 ' HB2' ' HB2' ' A' ' 58' ' ' TRP . 31.8 tt0 -77.36 -17.33 58.33 Favored 'General case' 0 C--N 1.309 -1.16 0 O-C-N 121.447 -0.783 . . . . 1.0 111.089 -179.994 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 62' ' ' VAL . . . . . 0.439 ' O ' ' N ' ' A' ' 66' ' ' GLY . 91.0 t -46.08 -49.33 5.2 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.03 0 N-CA-C 109.043 -0.725 . . . . 1.0 109.043 -175.639 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 63' ' ' ALA . . . . . 0.546 ' O ' ' HG3' ' A' ' 67' ' ' ARG . . . -64.91 -49.33 70.86 Favored 'General case' 0 N--CA 1.419 -1.993 0 N-CA-C 108.624 -0.88 . . . . 1.0 108.624 177.358 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 4.3 t-80 -56.0 -61.65 2.24 Favored 'General case' 0 CA--C 1.547 0.85 0 CA-C-N 115.977 -0.556 . . . . 1.0 111.904 179.52 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 65' ' ' ASP . . . . . 0.648 ' C ' ' H ' ' A' ' 67' ' ' ARG . 13.7 t70 -66.79 -54.34 23.67 Favored 'General case' 0 C--O 1.246 0.918 0 O-C-N 121.226 -0.921 . . . . 1.0 110.31 178.507 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 66' ' ' GLY . . . . . 0.439 ' N ' ' O ' ' A' ' 62' ' ' VAL . . . -62.91 32.9 0.07 OUTLIER Glycine 0 CA--C 1.523 0.587 0 N-CA-C 111.52 -0.632 . . . . 1.0 111.52 178.825 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 67' ' ' ARG . . . . . 0.75 ' HB3' ' H ' ' A' ' 71' ' ' ALA . 50.5 mtt180 -77.03 4.16 10.71 Favored 'General case' 0 C--N 1.313 -0.986 0 C-N-CA 123.739 0.816 . . . . 1.0 110.352 175.641 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 68' ' ' LEU . . . . . 0.582 ' O ' ' HA ' ' A' ' 72' ' ' HIS . 0.8 OUTLIER -33.95 -31.1 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.651 0 N-CA-C 107.335 -1.357 . . . . 1.0 107.335 -179.267 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 69' ' ' LEU . . . . . 0.611 ' N ' ' O ' ' A' ' 67' ' ' ARG . 0.3 OUTLIER -63.48 -65.14 0.73 Allowed 'General case' 0 C--N 1.312 -1.064 0 C-N-CA 118.037 -1.465 . . . . 1.0 107.213 175.838 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 70' ' ' ALA . . . . . 0.68 ' C ' ' H ' ' A' ' 72' ' ' HIS . . . -76.64 -73.67 0.27 Allowed 'General case' 0 N--CA 1.474 0.749 0 N-CA-C 107.537 -1.283 . . . . 1.0 107.537 178.627 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 71' ' ' ALA . . . . . 0.75 ' H ' ' HB3' ' A' ' 67' ' ' ARG . . . -49.7 4.63 0.01 OUTLIER 'General case' 0 N--CA 1.476 0.835 0 C-N-CA 125.907 1.683 . . . . 1.0 112.07 178.475 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 72' ' ' HIS . . . . . 0.768 ' CG ' ' H ' ' A' ' 73' ' ' MET . 4.4 p-80 -17.74 -62.56 0.02 OUTLIER 'General case' 0 CA--C 1.519 -0.225 0 O-C-N 123.755 0.66 . . . . 1.0 112.519 -175.899 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 73' ' ' MET . . . . . 0.768 ' H ' ' CG ' ' A' ' 72' ' ' HIS . 16.6 ptm -80.89 -45.63 16.5 Favored 'General case' 0 C--N 1.298 -1.644 0 CA-C-N 117.968 0.349 . . . . 1.0 110.56 177.41 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 74' ' ' VAL . . . . . 0.672 ' O ' ' N ' ' A' ' 76' ' ' GLY . 97.3 t -40.7 -43.41 0.63 Allowed 'Isoleucine or valine' 0 C--N 1.35 0.592 0 CA-C-O 118.687 -0.673 . . . . 1.0 110.076 -174.164 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 19.4 t-20 -36.75 -19.64 0.01 OUTLIER 'General case' 0 N--CA 1.477 0.882 0 CA-C-O 122.491 1.139 . . . . 1.0 110.533 179.107 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 76' ' ' GLY . . . . . 0.672 ' N ' ' O ' ' A' ' 74' ' ' VAL . . . -50.38 -21.02 4.06 Favored Glycine 0 C--O 1.205 -1.709 0 N-CA-C 108.991 -1.644 . . . . 1.0 108.991 174.321 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 77' ' ' ILE . . . . . 0.437 ' N ' ' O ' ' A' ' 74' ' ' VAL . 6.1 pt -54.49 -46.82 71.39 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.555 0 O-C-N 121.637 -0.92 . . . . 1.0 112.446 -176.934 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 78' ' ' VAL . . . . . 0.405 ' N ' HG13 ' A' ' 77' ' ' ILE . 3.7 t -59.29 -19.24 15.73 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.716 0 O-C-N 121.925 -0.484 . . . . 1.0 111.93 -178.406 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 79' ' ' ILE . . . . . 0.935 ' O ' ' HB2' ' A' ' 83' ' ' ALA . 0.3 OUTLIER -81.39 -46.06 20.46 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.702 0 C-N-CA 119.941 -0.704 . . . . 1.0 111.493 -179.748 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 80' ' ' ALA . . . . . 0.466 ' N ' ' CG1' ' A' ' 79' ' ' ILE . . . -84.17 -18.66 35.94 Favored 'General case' 0 N--CA 1.467 0.384 0 N-CA-C 112.791 0.663 . . . . 1.0 112.791 179.41 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 64.5 mt-10 -84.7 -71.85 0.5 Allowed 'General case' 0 C--O 1.231 0.124 0 N-CA-C 112.964 0.727 . . . . 1.0 112.964 -178.813 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 82' ' ' ASP . . . . . 0.432 ' O ' ' C ' ' A' ' 83' ' ' ALA . 93.4 m-20 -71.05 -18.08 62.58 Favored 'General case' 0 CA--C 1.515 -0.403 0 N-CA-C 111.612 0.227 . . . . 1.0 111.612 -177.669 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 83' ' ' ALA . . . . . 0.935 ' HB2' ' O ' ' A' ' 79' ' ' ILE . . . -36.14 -50.81 0.73 Allowed 'General case' 0 N--CA 1.47 0.575 0 C-N-CA 120.612 -0.435 . . . . 1.0 110.907 177.898 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 84' ' ' LEU . . . . . 0.442 ' C ' ' O ' ' A' ' 83' ' ' ALA . 0.2 OUTLIER -28.79 -46.88 0.05 OUTLIER 'General case' 0 N--CA 1.48 1.054 0 CA-C-N 116.175 -0.466 . . . . 1.0 111.257 -173.825 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 73.8 mt -95.11 -54.67 6.89 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.704 0 N-CA-C 109.831 -0.433 . . . . 1.0 109.831 178.061 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -43.38 -39.98 3.45 Favored 'General case' 0 N--CA 1.465 0.298 0 CA-C-N 115.759 -0.655 . . . . 1.0 110.317 -178.83 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 79.7 tt0 -54.74 -29.74 54.41 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.785 -0.643 . . . . 1.0 110.65 -179.879 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -77.77 -12.46 59.98 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.632 -0.713 . . . . 1.0 109.377 -179.909 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 89' ' ' VAL . . . . . 0.458 ' C ' ' HD2' ' A' ' 91' ' ' PRO . 3.5 t -86.92 39.12 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.448 -0.553 0 N-CA-C 108.172 -1.047 . . . . 1.0 108.172 178.556 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 90' ' ' GLY . . . . . 0.859 ' O ' ' N ' ' A' ' 92' ' ' HIS . . . -55.69 -24.63 40.96 Favored Glycine 0 C--N 1.362 1.997 0 CA-C-O 117.294 -1.837 . . . . 1.0 111.156 176.934 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 91' ' ' PRO . . . . . 0.692 ' HD2' ' N ' ' A' ' 90' ' ' GLY . 26.0 Cg_exo -32.27 -3.74 0.0 OUTLIER 'Trans proline' 0 N--CA 1.507 2.299 0 C-N-CA 123.828 3.018 . . . . 1.0 113.495 173.365 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 92' ' ' HIS . . . . . 0.859 ' N ' ' O ' ' A' ' 90' ' ' GLY . 7.3 t-80 -50.95 -30.83 15.98 Favored 'General case' 0 N--CA 1.443 -0.791 0 N-CA-C 107.098 -1.445 . . . . 1.0 107.098 177.34 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 93' ' ' LEU . . . . . 0.634 ' O ' ' N ' ' A' ' 96' ' ' ALA . 0.4 OUTLIER -59.42 -58.37 8.91 Favored 'General case' 0 C--O 1.214 -0.809 0 CA-C-N 119.064 0.847 . . . . 1.0 109.27 176.808 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 94' ' ' ALA . . . . . 0.503 ' H ' ' HG ' ' A' ' 93' ' ' LEU . . . -48.28 -53.3 17.7 Favored 'General case' 0 C--O 1.221 -0.406 0 N-CA-C 106.56 -1.644 . . . . 1.0 106.56 -178.712 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 95' ' ' ARG . . . . . 0.557 HH21 ' HB3' ' A' ' 91' ' ' PRO . 0.0 OUTLIER -59.5 -26.5 65.34 Favored 'General case' 0 C--N 1.305 -1.339 0 N-CA-C 108.699 -0.852 . . . . 1.0 108.699 176.328 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 96' ' ' ALA . . . . . 0.84 ' O ' ' N ' ' A' ' 100' ' ' ILE . . . -59.31 -52.55 65.16 Favored 'General case' 0 C--O 1.202 -1.43 0 N-CA-C 106.735 -1.58 . . . . 1.0 106.735 179.624 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 97' ' ' LEU . . . . . 0.532 ' O ' HG22 ' A' ' 100' ' ' ILE . 1.5 mt -38.3 -32.11 0.06 Allowed 'General case' 0 CA--C 1.576 1.976 0 N-CA-C 107.401 -1.333 . . . . 1.0 107.401 -179.439 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 98' ' ' GLY . . . . . 0.479 ' N ' ' O ' ' A' ' 96' ' ' ALA . . . -82.09 -52.14 4.17 Favored Glycine 0 CA--C 1.551 2.332 0 CA-C-O 123.422 1.568 . . . . 1.0 111.356 173.897 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 99' ' ' GLN . . . . . 0.435 ' N ' ' O ' ' A' ' 96' ' ' ALA . 76.1 mm-40 -78.39 9.63 3.76 Favored 'General case' 0 N--CA 1.434 -1.235 0 N-CA-C 108.185 -1.042 . . . . 1.0 108.185 178.794 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 100' ' ' ILE . . . . . 0.84 ' N ' ' O ' ' A' ' 96' ' ' ALA . 1.1 tt -59.49 -51.46 72.39 Favored 'Isoleucine or valine' 0 CA--C 1.477 -1.85 0 N-CA-C 108.015 -1.106 . . . . 1.0 108.015 179.917 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 101' ' ' VAL . . . . . 0.687 ' N ' HG23 ' A' ' 100' ' ' ILE . 70.6 t -57.2 -57.23 10.84 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.768 0 C-N-CA 116.666 -2.014 . . . . 1.0 106.627 178.307 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 102' ' ' CYS . . . . . 0.969 ' O ' ' HB2' ' A' ' 106' ' ' ALA . 1.9 t -45.13 -23.09 0.13 Allowed 'General case' 0 C--O 1.218 -0.584 0 C-N-CA 119.559 -0.857 . . . . 1.0 110.809 -177.573 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 103' ' ' ARG . . . . . 0.417 HH11 ' HG3' ' A' ' 103' ' ' ARG . 0.0 OUTLIER -91.29 -43.19 9.95 Favored 'General case' 0 CA--C 1.541 0.627 0 CA-C-O 122.095 0.95 . . . . 1.0 113.147 179.302 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 104' ' ' TYR . . . . . 0.746 ' O ' ' CG ' ' A' ' 104' ' ' TYR . 0.2 OUTLIER -102.88 21.55 15.41 Favored 'General case' 0 C--N 1.31 -1.146 0 CA-C-N 113.292 -1.776 . . . . 1.0 109.886 179.813 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 105' ' ' GLY . . . . . 0.766 ' O ' ' N ' ' A' ' 107' ' ' THR . . . -166.01 -14.52 0.02 OUTLIER Glycine 0 C--O 1.215 -1.093 0 C-N-CA 118.381 -1.866 . . . . 1.0 111.39 178.193 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 106' ' ' ALA . . . . . 0.969 ' HB2' ' O ' ' A' ' 102' ' ' CYS . . . -13.87 65.86 0.0 OUTLIER 'General case' 0 N--CA 1.478 0.933 0 O-C-N 124.742 0.907 . . . . 1.0 112.002 -179.876 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 107' ' ' THR . . . . . 0.766 ' N ' ' O ' ' A' ' 105' ' ' GLY . 99.5 m -101.25 -4.37 27.25 Favored 'General case' 0 N--CA 1.452 -0.348 0 CA-C-N 115.869 -0.605 . . . . 1.0 110.048 -179.419 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 108' ' ' VAL . . . . . 0.714 HG23 ' N ' ' A' ' 109' ' ' ILE . 33.3 m -85.19 -58.22 3.68 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.466 0 N-CA-C 111.647 0.24 . . . . 1.0 111.647 -178.579 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 109' ' ' ILE . . . . . 0.714 ' N ' HG23 ' A' ' 108' ' ' VAL . 0.3 OUTLIER -47.79 -43.37 52.08 Favored Pre-proline 0 C--N 1.353 0.754 0 N-CA-C 112.709 0.633 . . . . 1.0 112.709 179.244 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 110' ' ' PRO . . . . . 0.61 ' HD2' ' N ' ' A' ' 109' ' ' ILE . 7.9 Cg_endo -40.51 -38.32 2.43 Favored 'Trans proline' 0 N--CA 1.482 0.81 0 C-N-CA 121.154 1.236 . . . . 1.0 113.126 -175.4 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 16.8 t-20 -64.56 -68.26 0.37 Allowed 'General case' 0 C--N 1.315 -0.906 0 C-N-CA 118.601 -1.24 . . . . 1.0 110.726 -178.344 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 112' ' ' ILE . . . . . 0.42 ' H ' HG23 ' A' ' 112' ' ' ILE . 2.0 pt -67.59 -27.8 39.63 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.54 0 CA-C-O 121.841 0.829 . . . . 1.0 111.547 -178.004 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 113' ' ' ASN . . . . . 0.622 HD22 ' N ' ' A' ' 114' ' ' ALA . 0.3 OUTLIER -54.98 -61.51 2.26 Favored 'General case' 0 C--N 1.306 -1.304 0 CA-C-N 114.075 -1.42 . . . . 1.0 109.837 -175.281 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 114' ' ' ALA . . . . . 0.622 ' N ' HD22 ' A' ' 113' ' ' ASN . . . -61.81 -22.55 65.56 Favored 'General case' 0 C--N 1.306 -1.301 0 CA-C-N 116.063 -0.517 . . . . 1.0 110.709 -179.979 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -78.48 -60.74 2.25 Favored 'General case' 0 N--CA 1.448 -0.532 0 N-CA-C 112.715 0.635 . . . . 1.0 112.715 178.278 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 116' ' ' ILE . . . . . 0.476 ' O ' ' CB ' ' A' ' 119' ' ' LEU . 95.3 mt -69.4 -46.21 77.03 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.323 0 O-C-N 120.477 -1.39 . . . . 1.0 112.359 -177.094 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 117' ' ' GLU . . . . . 0.462 ' OE1' ' ND2' ' A' ' 113' ' ' ASN . 94.9 mt-10 -47.59 -64.37 0.8 Allowed 'General case' 0 C--N 1.316 -0.856 0 CA-C-N 115.538 -0.755 . . . . 1.0 110.109 -176.994 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 4.1 p -51.71 -15.14 0.48 Allowed 'Isoleucine or valine' 0 N--CA 1.437 -1.107 0 CA-C-N 115.4 -0.818 . . . . 1.0 109.251 -179.662 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 119' ' ' LEU . . . . . 0.476 ' CB ' ' O ' ' A' ' 116' ' ' ILE . 1.6 tt -77.13 -61.07 2.11 Favored 'General case' 0 C--N 1.348 0.508 0 C-N-CA 119.116 -1.033 . . . . 1.0 109.328 177.949 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -70.39 -81.21 0.26 Allowed Glycine 0 C--N 1.355 1.618 0 C-N-CA 117.259 -2.4 . . . . 1.0 111.076 179.55 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 121' ' ' THR . . . . . 0.4 ' H ' ' H ' ' A' ' 122' ' ' GLY . 45.2 m -160.41 -17.82 0.06 Allowed 'General case' 0 CA--C 1.54 0.592 0 CA-C-O 121.414 0.626 . . . . 1.0 109.97 -179.595 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 122' ' ' GLY . . . . . 0.441 ' O ' ' C ' ' A' ' 123' ' ' THR . . . 109.88 -36.8 4.09 Favored Glycine 0 N--CA 1.476 1.327 0 C-N-CA 125.215 1.388 . . . . 1.0 111.888 179.96 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 123' ' ' THR . . . . . 0.599 HG23 ' O ' ' A' ' 123' ' ' THR . 4.2 t -31.17 94.98 0.01 OUTLIER 'General case' 0 N--CA 1.473 0.676 0 CA-C-N 118.47 1.135 . . . . 1.0 112.675 -178.708 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 124' ' ' ASP . . . . . 0.407 ' N ' ' O ' ' A' ' 122' ' ' GLY . 73.1 m-20 -143.67 144.58 31.93 Favored 'General case' 0 C--N 1.33 -0.275 0 N-CA-C 108.56 -0.904 . . . . 1.0 108.56 178.571 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 125' ' ' TYR . . . . . 0.433 ' O ' ' NE ' ' A' ' 126' ' ' ARG . 0.0 OUTLIER -151.74 148.96 28.52 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.763 0.316 . . . . 1.0 110.305 -178.525 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 126' ' ' ARG . . . . . 0.433 ' NE ' ' O ' ' A' ' 125' ' ' TYR . 0.0 OUTLIER -149.85 151.78 34.05 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.167 -0.47 . . . . 1.0 110.006 177.928 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 127' ' ' PHE . . . . . 0.43 ' OXT' ' CD2' ' A' ' 92' ' ' HIS . 0.1 OUTLIER . . . . . 0 C--O 1.22 -0.481 0 CA-C-O 117.873 -1.06 . . . . 1.0 110.398 -178.57 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 2.2 mpt? . . . . . 0 N--CA 1.491 1.612 0 N-CA-C 109.139 -0.689 . . . . 1.0 109.139 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 51.9 m -95.64 1.72 53.75 Favored 'General case' 0 N--CA 1.463 0.187 0 CA-C-N 116.449 -0.341 . . . . 1.0 110.913 -179.825 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER 169.56 106.68 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.361 -0.381 . . . . 1.0 110.274 -179.94 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 18.2 t80 -149.21 145.53 27.17 Favored 'General case' 0 C--N 1.33 -0.254 0 N-CA-C 109.723 -0.473 . . . . 1.0 109.723 178.896 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 14.4 m-20 -152.82 147.71 26.34 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.359 -0.382 . . . . 1.0 110.117 -179.025 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 6' ' ' THR . . . . . 1.008 ' H ' HG23 ' A' ' 9' ' ' VAL . 0.2 OUTLIER -103.88 -165.97 1.21 Allowed 'General case' 0 C--O 1.206 -1.191 0 CA-C-O 121.51 0.671 . . . . 1.0 109.386 178.931 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 7' ' ' GLU . . . . . 0.728 ' O ' ' HB2' ' A' ' 11' ' ' ARG . 27.5 tt0 -58.92 -45.31 90.67 Favored 'General case' 0 C--N 1.304 -1.371 0 CA-C-O 121.891 0.853 . . . . 1.0 110.548 -179.801 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 8' ' ' ARG . . . . . 0.693 ' O ' ' HB3' ' A' ' 12' ' ' ALA . 0.1 OUTLIER -67.9 -60.13 2.75 Favored 'General case' 0 C--N 1.306 -1.301 0 C-N-CA 118.953 -1.099 . . . . 1.0 109.482 179.065 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 9' ' ' VAL . . . . . 1.008 HG23 ' H ' ' A' ' 6' ' ' THR . 0.0 OUTLIER -66.32 -50.69 65.9 Favored 'Isoleucine or valine' 0 C--O 1.201 -1.449 0 CA-C-N 115.107 -0.951 . . . . 1.0 110.686 -178.777 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 10' ' ' SER . . . . . 0.657 ' N ' ' O ' ' A' ' 6' ' ' THR . 2.5 t -65.69 -62.23 1.63 Allowed 'General case' 0 N--CA 1.488 1.447 0 C-N-CA 120.025 -0.67 . . . . 1.0 111.176 179.185 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 11' ' ' ARG . . . . . 0.728 ' HB2' ' O ' ' A' ' 7' ' ' GLU . 4.6 mmt85 -64.87 -41.18 95.88 Favored 'General case' 0 CA--C 1.547 0.861 0 CA-C-O 119.302 -0.38 . . . . 1.0 111.792 -177.213 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 12' ' ' ALA . . . . . 0.693 ' HB3' ' O ' ' A' ' 8' ' ' ARG . . . -69.61 -54.17 15.28 Favored 'General case' 0 N--CA 1.483 1.19 0 C-N-CA 118.165 -1.414 . . . . 1.0 108.125 175.84 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 13' ' ' VAL . . . . . 0.643 ' O ' ' CB ' ' A' ' 17' ' ' LEU . 60.3 t -61.67 -55.02 27.07 Favored 'Isoleucine or valine' 0 C--O 1.198 -1.647 0 C-N-CA 117.423 -1.711 . . . . 1.0 108.438 -179.033 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 14' ' ' ALA . . . . . 0.793 ' O ' HG22 ' A' ' 18' ' ' VAL . . . -57.1 -62.27 1.87 Allowed 'General case' 0 C--O 1.211 -0.925 0 C-N-CA 118.542 -1.263 . . . . 1.0 109.95 179.653 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 15' ' ' ALA . . . . . 0.537 ' HB3' ' O ' ' A' ' 11' ' ' ARG . . . -55.34 -55.66 28.94 Favored 'General case' 0 N--CA 1.475 0.805 0 C-N-CA 118.807 -1.157 . . . . 1.0 110.517 -176.952 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 16' ' ' ALA . . . . . 0.612 ' HB3' ' O ' ' A' ' 12' ' ' ALA . . . -65.66 -55.98 14.58 Favored 'General case' 0 CA--C 1.547 0.847 0 C-N-CA 119.761 -0.776 . . . . 1.0 110.033 -178.889 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 17' ' ' LEU . . . . . 0.643 ' CB ' ' O ' ' A' ' 13' ' ' VAL . 7.3 tp -56.8 -57.58 11.83 Favored 'General case' 0 N--CA 1.483 1.186 0 CA-C-N 115.397 -0.819 . . . . 1.0 108.827 -178.965 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 18' ' ' VAL . . . . . 0.793 HG22 ' O ' ' A' ' 14' ' ' ALA . 1.3 m -71.82 -58.22 5.61 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.423 0 C-N-CA 119.282 -0.967 . . . . 1.0 110.772 -179.536 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 19' ' ' GLY . . . . . 0.489 ' N ' ' O ' ' A' ' 15' ' ' ALA . . . -56.34 -172.94 0.16 Allowed Glycine 0 CA--C 1.519 0.341 0 C-N-CA 120.924 -0.655 . . . . 1.0 112.109 -177.768 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 20' ' ' PRO . . . . . 0.605 ' O ' ' N ' ' A' ' 24' ' ' ALA . 1.7 Cg_endo -81.05 -21.96 6.36 Favored 'Trans proline' 0 C--N 1.308 -1.581 0 C-N-CA 123.122 2.548 . . . . 1.0 112.501 -178.841 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -63.35 -62.03 5.76 Favored Glycine 0 N--CA 1.478 1.437 0 C-N-CA 119.687 -1.245 . . . . 1.0 112.906 -176.492 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 22' ' ' GLY . . . . . 0.587 ' H ' ' HA ' ' A' ' 16' ' ' ALA . . . -55.44 -52.03 50.56 Favored Glycine 0 N--CA 1.472 1.048 0 N-CA-C 106.277 -2.729 . . . . 1.0 106.277 -179.255 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 23' ' ' VAL . . . . . 0.488 ' O ' HG12 ' A' ' 27' ' ' VAL . 26.7 t -58.23 -31.81 43.12 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.731 0 C-N-CA 119.455 -0.898 . . . . 1.0 108.966 178.326 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 24' ' ' ALA . . . . . 0.605 ' N ' ' O ' ' A' ' 20' ' ' PRO . . . -60.2 -61.97 2.21 Favored 'General case' 0 N--CA 1.481 1.09 0 C-N-CA 118.616 -1.233 . . . . 1.0 109.677 178.614 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 25' ' ' LEU . . . . . 0.724 HD12 ' O ' ' A' ' 25' ' ' LEU . 0.9 OUTLIER -60.33 -50.35 73.98 Favored 'General case' 0 N--CA 1.478 0.938 0 N-CA-C 112.633 0.605 . . . . 1.0 112.633 -178.482 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 86.0 t -57.89 -59.44 3.42 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.021 0 C-N-CA 118.986 -1.086 . . . . 1.0 110.612 -177.204 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 27' ' ' VAL . . . . . 0.598 ' O ' ' HB3' ' A' ' 31' ' ' ALA . 1.2 p -58.41 -36.54 59.18 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.687 0 C-N-CA 120.672 -0.411 . . . . 1.0 111.16 -178.089 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 20.9 tttt -65.84 -56.57 11.2 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-O 121.463 0.649 . . . . 1.0 109.884 -179.706 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 25.1 t -63.51 -49.27 83.3 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.54 0 CA-C-N 115.292 -0.867 . . . . 1.0 111.088 -177.776 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 30' ' ' CYS . . . . . . . . . . . . . 14.0 t -63.54 -61.61 2.21 Favored 'General case' 0 C--N 1.316 -0.849 0 C-N-CA 118.901 -1.12 . . . . 1.0 109.43 -179.396 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 31' ' ' ALA . . . . . 0.628 ' O ' HD12 ' A' ' 37' ' ' ILE . . . -58.44 -50.89 72.07 Favored 'General case' 0 C--N 1.319 -0.718 0 C-N-CA 120.553 -0.459 . . . . 1.0 110.847 -178.416 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 32' ' ' GLY . . . . . 0.527 ' O ' ' CB ' ' A' ' 33' ' ' LEU . . . 74.51 67.85 1.67 Allowed Glycine 0 CA--C 1.518 0.238 0 N-CA-C 108.158 -1.977 . . . . 1.0 108.158 -178.383 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 33' ' ' LEU . . . . . 0.601 HD23 ' CG2' ' A' ' 36' ' ' VAL . 13.5 tp 94.34 81.31 0.03 OUTLIER Pre-proline 0 CA--C 1.54 0.588 0 CA-C-N 114.457 -0.871 . . . . 1.0 109.663 -177.719 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 13.0 Cg_endo -54.53 -23.08 30.35 Favored 'Trans proline' 0 N--CA 1.502 2.027 0 C-N-CA 121.637 1.558 . . . . 1.0 113.952 -179.276 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 35' ' ' GLY . . . . . 0.949 ' O ' HD12 ' A' ' 112' ' ' ILE . . . -62.56 -61.61 6.37 Favored Glycine 0 CA--C 1.536 1.356 0 C-N-CA 117.873 -2.108 . . . . 1.0 109.863 -178.403 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 36' ' ' VAL . . . . . 0.641 ' O ' HG22 ' A' ' 37' ' ' ILE . 2.6 m -95.57 178.39 0.59 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.519 0 N-CA-C 107.965 -1.124 . . . . 1.0 107.965 176.579 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 37' ' ' ILE . . . . . 0.641 HG22 ' O ' ' A' ' 36' ' ' VAL . 0.1 OUTLIER 102.56 121.94 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.479 0.989 0 O-C-N 124.297 0.998 . . . . 1.0 112.036 179.601 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 81.3 m-70 -143.2 135.29 26.98 Favored 'General case' 0 N--CA 1.463 0.198 0 N-CA-C 109.073 -0.714 . . . . 1.0 109.073 178.445 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 39' ' ' THR . . . . . 0.403 ' O ' ' CG ' ' A' ' 42' ' ' ARG . 0.0 OUTLIER -90.62 115.83 65.05 Favored Pre-proline 0 CA--C 1.546 0.804 0 N-CA-C 109.329 -0.619 . . . . 1.0 109.329 179.774 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 50.2 Cg_exo -49.01 -32.63 23.97 Favored 'Trans proline' 0 N--CA 1.496 1.619 0 C-N-CA 121.678 1.585 . . . . 1.0 113.569 -179.053 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -111.34 93.67 4.59 Favored 'General case' 0 CA--C 1.513 -0.459 0 N-CA-C 114.051 1.13 . . . . 1.0 114.051 -175.12 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 42' ' ' ARG . . . . . 0.42 ' C ' ' N ' ' A' ' 44' ' ' GLY . 0.2 OUTLIER -141.6 143.06 33.49 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 114.589 -1.187 . . . . 1.0 108.271 178.806 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 43' ' ' ARG . . . . . 0.441 HH22 ' HB3' ' A' ' 59' ' ' ARG . 14.9 tpt85 -50.49 -13.35 0.12 Allowed 'General case' 0 C--N 1.322 -0.6 0 C-N-CA 120.447 -0.501 . . . . 1.0 110.806 -177.164 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 44' ' ' GLY . . . . . 0.42 ' N ' ' C ' ' A' ' 42' ' ' ARG . . . 121.08 -23.52 7.68 Favored Glycine 0 N--CA 1.472 1.095 0 N-CA-C 110.346 -1.102 . . . . 1.0 110.346 179.823 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 45' ' ' PHE . . . . . 0.541 ' O ' ' CB ' ' A' ' 46' ' ' PHE . 36.0 p90 -152.25 159.6 43.51 Favored 'General case' 0 C--N 1.327 -0.391 0 N-CA-C 108.601 -0.889 . . . . 1.0 108.601 177.618 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 46' ' ' PHE . . . . . 0.541 ' CB ' ' O ' ' A' ' 45' ' ' PHE . 4.7 t80 117.24 103.11 0.0 OUTLIER 'General case' 0 N--CA 1.487 1.41 0 O-C-N 124.61 1.194 . . . . 1.0 110.274 -179.954 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 47' ' ' ARG . . . . . 0.491 ' CB ' ' O ' ' A' ' 46' ' ' PHE . 6.5 ptp180 120.5 135.68 0.0 OUTLIER 'General case' 0 N--CA 1.488 1.453 0 C-N-CA 124.886 1.274 . . . . 1.0 110.557 179.609 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 2.6 t 67.61 73.68 0.32 Allowed 'General case' 0 C--O 1.218 -0.588 0 C-N-CA 119.718 -0.793 . . . . 1.0 110.229 177.939 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 49' ' ' ASN . . . . . 0.767 ' H ' HD22 ' A' ' 49' ' ' ASN . 0.0 OUTLIER -135.82 153.56 77.29 Favored Pre-proline 0 N--CA 1.47 0.542 0 CA-C-O 119.427 -0.321 . . . . 1.0 110.173 -178.634 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 50' ' ' PRO . . . . . 0.42 ' C ' ' H ' ' A' ' 52' ' ' ARG . 33.7 Cg_endo -60.31 47.84 0.07 OUTLIER 'Trans proline' 0 N--CA 1.509 2.431 0 C-N-CA 122.763 2.308 . . . . 1.0 113.278 179.503 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 51' ' ' GLU . . . . . 0.491 ' N ' ' O ' ' A' ' 49' ' ' ASN . 15.8 mp0 70.77 -18.5 0.25 Allowed 'General case' 0 N--CA 1.47 0.561 0 C-N-CA 123.571 0.748 . . . . 1.0 111.486 179.697 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 52' ' ' ARG . . . . . 0.42 ' H ' ' C ' ' A' ' 50' ' ' PRO . 1.6 mpp_? -56.92 138.78 53.44 Favored 'General case' 0 CA--C 1.531 0.242 0 N-CA-C 109.436 -0.579 . . . . 1.0 109.436 179.445 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 53' ' ' ILE . . . . . 0.647 HG23 HG22 ' A' ' 55' ' ' ILE . 2.6 tp -58.91 129.83 21.54 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-N 115.551 -0.75 . . . . 1.0 110.917 -179.188 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 54' ' ' GLN . . . . . 0.511 ' NE2' ' OD1' ' A' ' 49' ' ' ASN . 0.0 OUTLIER -59.34 79.26 0.01 OUTLIER 'General case' 0 CA--C 1.537 0.474 0 N-CA-C 108.28 -1.007 . . . . 1.0 108.28 -178.014 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 55' ' ' ILE . . . . . 0.647 HG22 HG23 ' A' ' 53' ' ' ILE . 13.9 tt -154.49 162.97 1.79 Allowed 'Isoleucine or valine' 0 CA--C 1.523 -0.066 0 CA-C-N 114.802 -1.09 . . . . 1.0 111.325 178.438 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 100.81 -28.07 17.67 Favored Glycine 0 N--CA 1.452 -0.25 0 N-CA-C 111.943 -0.463 . . . . 1.0 111.943 176.849 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 12.9 m-20 -67.81 135.53 52.74 Favored 'General case' 0 N--CA 1.446 -0.646 0 CA-C-O 122.807 1.289 . . . . 1.0 113.661 -177.42 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 58' ' ' TRP . . . . . . . . . . . . . 32.4 m0 -78.13 -179.06 5.93 Favored 'General case' 0 N--CA 1.44 -0.964 0 CA-C-N 112.484 -2.143 . . . . 1.0 107.235 177.293 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 59' ' ' ARG . . . . . 0.65 ' H ' ' CD ' ' A' ' 59' ' ' ARG . 0.0 OUTLIER -99.05 -56.12 2.51 Favored 'General case' 0 CA--C 1.557 1.232 0 CA-C-N 119.646 1.112 . . . . 1.0 111.896 -179.734 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 60' ' ' TYR . . . . . 0.401 ' H ' ' HD2' ' A' ' 59' ' ' ARG . 24.8 t80 -78.66 -7.24 57.47 Favored 'General case' 0 N--CA 1.481 1.119 0 C-N-CA 125.429 1.492 . . . . 1.0 111.688 -178.418 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 69.4 tt0 -71.36 -13.89 62.01 Favored 'General case' 0 C--N 1.296 -1.749 0 CA-C-N 114.944 -1.025 . . . . 1.0 109.358 179.814 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 62' ' ' VAL . . . . . 0.513 ' O ' ' N ' ' A' ' 66' ' ' GLY . 10.4 m -44.51 -51.83 1.73 Allowed 'Isoleucine or valine' 0 CA--C 1.496 -1.133 0 C-N-CA 120.449 -0.501 . . . . 1.0 110.36 -175.448 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 63' ' ' ALA . . . . . 0.669 ' O ' ' HG2' ' A' ' 67' ' ' ARG . . . -65.51 -48.15 73.51 Favored 'General case' 0 N--CA 1.421 -1.919 0 N-CA-C 109.223 -0.658 . . . . 1.0 109.223 179.517 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 64' ' ' HIS . . . . . 0.408 ' O ' ' CG ' ' A' ' 67' ' ' ARG . 1.2 m-70 -54.57 -58.47 7.35 Favored 'General case' 0 CA--C 1.548 0.89 0 O-C-N 123.913 0.758 . . . . 1.0 110.368 179.829 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 65' ' ' ASP . . . . . 0.65 ' C ' ' H ' ' A' ' 67' ' ' ARG . 23.8 t70 -67.45 -53.38 29.43 Favored 'General case' 0 C--O 1.24 0.604 0 CA-C-O 121.15 0.5 . . . . 1.0 109.751 178.264 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 66' ' ' GLY . . . . . 0.513 ' N ' ' O ' ' A' ' 62' ' ' VAL . . . -63.72 30.94 0.09 OUTLIER Glycine 0 CA--C 1.527 0.826 0 N-CA-C 110.866 -0.894 . . . . 1.0 110.866 177.65 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 67' ' ' ARG . . . . . 0.669 ' HG2' ' O ' ' A' ' 63' ' ' ALA . 24.1 mmm-85 -80.25 -3.73 50.39 Favored 'General case' 0 N--CA 1.448 -0.567 0 N-CA-C 107.704 -1.221 . . . . 1.0 107.704 175.855 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 68' ' ' LEU . . . . . 0.476 ' O ' ' HA ' ' A' ' 72' ' ' HIS . 4.9 tt -35.1 -29.86 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.792 0 N-CA-C 107.705 -1.22 . . . . 1.0 107.705 -178.741 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 69' ' ' LEU . . . . . 0.818 HD23 ' H ' ' A' ' 70' ' ' ALA . 1.2 pt? -62.92 -62.34 1.78 Allowed 'General case' 0 N--CA 1.48 1.048 0 C-N-CA 117.121 -1.832 . . . . 1.0 106.914 177.689 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 70' ' ' ALA . . . . . 0.818 ' H ' HD23 ' A' ' 69' ' ' LEU . . . -77.56 -72.55 0.35 Allowed 'General case' 0 C--O 1.214 -0.777 0 N-CA-C 106.663 -1.606 . . . . 1.0 106.663 178.057 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 71' ' ' ALA . . . . . 0.511 ' O ' ' C ' ' A' ' 72' ' ' HIS . . . -45.06 3.72 0.0 OUTLIER 'General case' 0 CA--C 1.516 -0.355 0 C-N-CA 124.402 1.081 . . . . 1.0 112.847 177.633 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 72' ' ' HIS . . . . . 0.687 ' H ' ' C ' ' A' ' 70' ' ' ALA . 0.0 OUTLIER -21.57 -68.29 0.03 OUTLIER 'General case' 0 CA--C 1.518 -0.275 0 C-N-CA 122.872 0.469 . . . . 1.0 111.437 -176.8 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 73' ' ' MET . . . . . 0.563 ' N ' ' ND1' ' A' ' 72' ' ' HIS . 32.6 mtt -73.51 -48.02 36.51 Favored 'General case' 0 C--N 1.31 -1.148 0 C-N-CA 119.069 -1.052 . . . . 1.0 109.151 177.355 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 74' ' ' VAL . . . . . 0.677 ' O ' ' N ' ' A' ' 76' ' ' GLY . 65.5 t -43.79 -49.21 1.78 Allowed 'Isoleucine or valine' 0 C--O 1.22 -0.497 0 CA-C-O 118.141 -0.933 . . . . 1.0 111.04 -176.146 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 75' ' ' ASN . . . . . 0.47 ' C ' ' N ' ' A' ' 77' ' ' ILE . 21.8 t30 -36.52 -20.34 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.746 0 CA-C-N 120.238 1.381 . . . . 1.0 110.312 177.755 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 76' ' ' GLY . . . . . 0.677 ' N ' ' O ' ' A' ' 74' ' ' VAL . . . -49.3 -20.87 2.51 Favored Glycine 0 C--O 1.216 -1.019 0 N-CA-C 107.948 -2.061 . . . . 1.0 107.948 174.885 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 77' ' ' ILE . . . . . 0.477 ' N ' ' O ' ' A' ' 74' ' ' VAL . 82.2 mt -53.27 -43.77 51.49 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.133 0 O-C-N 122.635 -0.333 . . . . 1.0 111.019 -178.044 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 42.5 t -50.44 -19.78 0.79 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.424 0 CA-C-N 118.667 0.667 . . . . 1.0 111.978 -179.445 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 79' ' ' ILE . . . . . 0.747 ' O ' ' HB2' ' A' ' 83' ' ' ALA . 0.3 OUTLIER -90.15 -38.67 11.27 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.077 0 C-N-CA 120.007 -0.677 . . . . 1.0 111.543 179.466 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -82.37 -27.36 32.17 Favored 'General case' 0 CA--C 1.541 0.633 0 N-CA-C 113.116 0.784 . . . . 1.0 113.116 -179.255 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 81' ' ' GLU . . . . . 0.644 ' CG ' ' N ' ' A' ' 82' ' ' ASP . 12.6 pt-20 -84.3 -67.63 0.78 Allowed 'General case' 0 CA--C 1.544 0.72 0 N-CA-C 110.152 -0.314 . . . . 1.0 110.152 178.171 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 82' ' ' ASP . . . . . 0.644 ' N ' ' CG ' ' A' ' 81' ' ' GLU . 67.1 m-20 -66.25 -20.05 66.0 Favored 'General case' 0 CA--C 1.495 -1.164 0 O-C-N 121.269 -0.894 . . . . 1.0 112.384 -177.664 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 83' ' ' ALA . . . . . 0.747 ' HB2' ' O ' ' A' ' 79' ' ' ILE . . . -18.65 -55.03 0.01 OUTLIER 'General case' 0 N--CA 1.468 0.465 0 CA-C-O 118.946 -0.549 . . . . 1.0 111.846 176.642 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 84' ' ' LEU . . . . . 0.449 ' N ' ' O ' ' A' ' 82' ' ' ASP . 3.8 mm? -28.0 -53.78 0.09 Allowed 'General case' 0 N--CA 1.484 1.227 0 CA-C-N 119.657 1.117 . . . . 1.0 113.43 -177.896 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 85' ' ' ILE . . . . . 0.599 ' O ' ' HB3' ' A' ' 88' ' ' ALA . 15.6 pt -91.05 -35.43 7.15 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 C-N-CA 120.587 -0.445 . . . . 1.0 109.811 -179.404 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 86' ' ' ALA . . . . . 0.797 ' O ' HG13 ' A' ' 89' ' ' VAL . . . -52.92 -54.92 27.79 Favored 'General case' 0 C--N 1.33 -0.244 0 C-N-CA 120.376 -0.529 . . . . 1.0 109.685 -179.514 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 87' ' ' GLU . . . . . 0.405 ' OE1' ' C ' ' A' ' 87' ' ' GLU . 9.0 tm-20 -57.4 -21.04 33.67 Favored 'General case' 0 C--N 1.33 -0.277 0 C-N-CA 120.062 -0.655 . . . . 1.0 109.508 179.304 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 88' ' ' ALA . . . . . 0.696 ' C ' ' H ' ' A' ' 90' ' ' GLY . . . -73.36 -13.51 61.11 Favored 'General case' 0 C--O 1.225 -0.192 0 C-N-CA 120.352 -0.539 . . . . 1.0 109.923 179.457 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 89' ' ' VAL . . . . . 0.797 HG13 ' O ' ' A' ' 86' ' ' ALA . 27.8 m -49.09 11.4 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.48 1.037 0 N-CA-C 113.27 0.841 . . . . 1.0 113.27 -178.979 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 90' ' ' GLY . . . . . 0.73 ' O ' ' N ' ' A' ' 92' ' ' HIS . . . -34.37 -42.12 0.27 Allowed Glycine 0 CA--C 1.543 1.83 0 CA-C-O 117.871 -1.516 . . . . 1.0 110.561 -177.26 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 91' ' ' PRO . . . . . 0.495 ' HD2' ' N ' ' A' ' 90' ' ' GLY . 1.1 Cg_endo -44.64 0.76 0.01 OUTLIER 'Trans proline' 0 N--CA 1.5 1.911 0 CA-C-N 121.292 2.546 . . . . 1.0 110.925 170.724 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 92' ' ' HIS . . . . . 0.73 ' N ' ' O ' ' A' ' 90' ' ' GLY . 55.6 t60 -51.17 -41.7 60.33 Favored 'General case' 0 CA--C 1.51 -0.589 0 N-CA-C 109.21 -0.663 . . . . 1.0 109.21 -177.454 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 39.0 tp -63.03 -39.86 96.0 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 119.17 0.895 . . . . 1.0 110.349 177.718 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -61.8 -60.21 4.0 Favored 'General case' 0 CA--C 1.496 -1.116 0 N-CA-C 106.085 -1.82 . . . . 1.0 106.085 -179.398 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 95' ' ' ARG . . . . . 0.417 HH12 ' HD3' ' A' ' 20' ' ' PRO . 3.7 mmp_? -57.8 -29.92 65.27 Favored 'General case' 0 N--CA 1.432 -1.34 0 CA-C-N 115.29 -0.868 . . . . 1.0 108.738 177.825 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 96' ' ' ALA . . . . . 0.806 ' O ' ' N ' ' A' ' 100' ' ' ILE . . . -59.04 -53.81 54.21 Favored 'General case' 0 C--O 1.198 -1.617 0 C-N-CA 118.127 -1.429 . . . . 1.0 108.558 -176.73 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 97' ' ' LEU . . . . . 0.487 ' C ' ' O ' ' A' ' 96' ' ' ALA . 1.2 tt -34.46 -28.82 0.01 OUTLIER 'General case' 0 CA--C 1.565 1.521 0 O-C-N 124.341 1.026 . . . . 1.0 108.59 -177.929 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 98' ' ' GLY . . . . . 0.616 ' N ' ' O ' ' A' ' 96' ' ' ALA . . . -88.62 -53.08 2.67 Favored Glycine 0 CA--C 1.543 1.829 0 CA-C-O 123.589 1.66 . . . . 1.0 111.401 174.144 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 99' ' ' GLN . . . . . 0.487 ' N ' ' O ' ' A' ' 96' ' ' ALA . 6.1 tt0 -78.73 6.18 9.52 Favored 'General case' 0 N--CA 1.433 -1.309 0 CA-C-N 114.473 -0.864 . . . . 1.0 108.991 178.693 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 100' ' ' ILE . . . . . 0.806 ' N ' ' O ' ' A' ' 96' ' ' ALA . 0.2 OUTLIER -63.8 -47.09 92.46 Favored 'Isoleucine or valine' 0 CA--C 1.495 -1.159 0 N-CA-C 108.022 -1.103 . . . . 1.0 108.022 179.948 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 101' ' ' VAL . . . . . 0.628 HG23 ' H ' ' A' ' 102' ' ' CYS . 17.6 m -55.54 -60.01 2.08 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.477 0 C-N-CA 117.035 -1.866 . . . . 1.0 108.958 179.65 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 102' ' ' CYS . . . . . 0.628 ' H ' HG23 ' A' ' 101' ' ' VAL . 42.3 t -41.11 -19.71 0.01 OUTLIER 'General case' 0 C--N 1.311 -1.075 0 N-CA-C 113.217 0.821 . . . . 1.0 113.217 -176.231 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 103' ' ' ARG . . . . . 0.517 ' N ' ' O ' ' A' ' 101' ' ' VAL . 7.6 ttp180 -89.98 -35.27 15.64 Favored 'General case' 0 N--CA 1.497 1.922 0 N-CA-C 114.534 1.309 . . . . 1.0 114.534 178.956 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 104' ' ' TYR . . . . . 0.649 ' O ' ' CG ' ' A' ' 104' ' ' TYR . 0.0 OUTLIER -100.18 22.97 10.63 Favored 'General case' 0 C--N 1.303 -1.45 0 CA-C-N 113.188 -1.824 . . . . 1.0 110.076 -179.816 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 105' ' ' GLY . . . . . 0.535 ' O ' ' HB3' ' A' ' 106' ' ' ALA . . . -161.5 -88.15 0.07 OUTLIER Glycine 0 N--CA 1.451 -0.33 0 N-CA-C 107.413 -2.275 . . . . 1.0 107.413 179.64 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 106' ' ' ALA . . . . . 0.561 ' O ' ' CD ' ' A' ' 110' ' ' PRO . . . 69.53 58.17 0.32 Allowed 'General case' 0 CA--C 1.548 0.895 0 N-CA-C 112.704 0.631 . . . . 1.0 112.704 179.334 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 107' ' ' THR . . . . . 0.498 ' O ' ' HD2' ' A' ' 110' ' ' PRO . 20.0 m -76.41 -57.84 3.63 Favored 'General case' 0 N--CA 1.48 1.037 0 O-C-N 121.257 -0.902 . . . . 1.0 109.384 179.555 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 108' ' ' VAL . . . . . 0.525 HG23 ' N ' ' A' ' 109' ' ' ILE . 16.5 m -68.61 -45.45 81.53 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.747 0 N-CA-C 110.405 -0.22 . . . . 1.0 110.405 -179.371 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 109' ' ' ILE . . . . . 0.525 ' N ' HG23 ' A' ' 108' ' ' VAL . 0.8 OUTLIER -36.83 -54.01 1.79 Allowed Pre-proline 0 CA--C 1.568 1.659 0 CA-C-N 116.159 -0.473 . . . . 1.0 110.199 -178.694 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 110' ' ' PRO . . . . . 0.561 ' CD ' ' O ' ' A' ' 106' ' ' ALA . 31.4 Cg_exo -57.14 -24.52 59.1 Favored 'Trans proline' 0 N--CA 1.504 2.141 0 C-N-CA 123.296 2.664 . . . . 1.0 113.087 176.284 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 111' ' ' ASN . . . . . 0.567 ' CG ' ' N ' ' A' ' 112' ' ' ILE . 0.6 OUTLIER -63.04 -66.19 0.58 Allowed 'General case' 0 CA--C 1.54 0.587 0 C-N-CA 120.114 -0.634 . . . . 1.0 109.8 -178.531 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 112' ' ' ILE . . . . . 0.949 HD12 ' O ' ' A' ' 35' ' ' GLY . 1.9 tt -61.56 -27.84 42.86 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.493 0 CA-C-O 121.308 0.575 . . . . 1.0 110.804 178.707 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 113' ' ' ASN . . . . . 0.445 ' O ' ' HB2' ' A' ' 117' ' ' GLU . 20.6 m-20 -57.54 -64.88 0.75 Allowed 'General case' 0 C--N 1.305 -1.341 0 CA-C-N 115.066 -0.97 . . . . 1.0 111.275 -175.203 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -67.63 -23.86 65.39 Favored 'General case' 0 C--N 1.318 -0.796 0 N-CA-C 112.124 0.416 . . . . 1.0 112.124 -178.926 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -78.97 -62.91 1.55 Allowed 'General case' 0 CA--C 1.536 0.422 0 N-CA-C 112.828 0.677 . . . . 1.0 112.828 178.988 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 116' ' ' ILE . . . . . 0.606 HD12 HG13 ' A' ' 112' ' ' ILE . 19.7 mt -69.68 -47.09 72.86 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.651 0 O-C-N 121.414 -0.804 . . . . 1.0 112.532 -178.329 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 117' ' ' GLU . . . . . 0.445 ' HB2' ' O ' ' A' ' 113' ' ' ASN . 73.9 mt-10 -46.84 -59.73 2.88 Favored 'General case' 0 CA--C 1.498 -1.04 0 N-CA-C 108.681 -0.859 . . . . 1.0 108.681 -177.001 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 88.9 t -55.59 -16.19 2.3 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.314 0 CA-C-N 115.407 -0.815 . . . . 1.0 109.191 179.052 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 119' ' ' LEU . . . . . 0.583 ' N ' ' O ' ' A' ' 116' ' ' ILE . 0.2 OUTLIER -79.87 -61.11 2.09 Favored 'General case' 0 C--N 1.351 0.633 0 C-N-CA 119.691 -0.803 . . . . 1.0 109.362 176.964 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 120' ' ' GLY . . . . . 0.547 ' O ' HG23 ' A' ' 121' ' ' THR . . . -67.15 -84.39 0.1 Allowed Glycine 0 C--N 1.361 1.97 0 C-N-CA 117.154 -2.451 . . . . 1.0 110.874 178.705 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 121' ' ' THR . . . . . 0.547 HG23 ' O ' ' A' ' 120' ' ' GLY . 9.3 p -159.27 -23.71 0.07 Allowed 'General case' 0 C--N 1.32 -0.688 0 N-CA-C 108.274 -1.01 . . . . 1.0 108.274 -179.564 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 122' ' ' GLY . . . . . 0.462 ' O ' ' C ' ' A' ' 123' ' ' THR . . . 112.54 -37.09 3.8 Favored Glycine 0 CA--C 1.525 0.681 0 CA-C-N 113.895 -1.502 . . . . 1.0 111.913 179.368 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 123' ' ' THR . . . . . 0.586 HG23 ' O ' ' A' ' 123' ' ' THR . 4.2 t -30.46 93.22 0.01 OUTLIER 'General case' 0 N--CA 1.472 0.675 0 CA-C-N 118.781 1.291 . . . . 1.0 112.33 -178.932 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 124' ' ' ASP . . . . . 0.46 ' N ' ' O ' ' A' ' 122' ' ' GLY . 40.9 m-20 -146.35 143.43 29.09 Favored 'General case' 0 C--N 1.332 -0.159 0 N-CA-C 108.946 -0.761 . . . . 1.0 108.946 179.238 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 125' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -148.01 147.16 29.32 Favored 'General case' 0 CA--C 1.535 0.385 0 N-CA-C 109.695 -0.483 . . . . 1.0 109.695 179.725 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 8.3 mmm180 -146.15 146.24 30.78 Favored 'General case' 0 CA--C 1.536 0.414 0 N-CA-C 109.018 -0.734 . . . . 1.0 109.018 178.622 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 127' ' ' PHE . . . . . 0.534 ' OXT' ' CD2' ' A' ' 127' ' ' PHE . 87.4 t80 . . . . . 0 N--CA 1.473 0.713 0 CA-C-O 118.069 -0.967 . . . . 1.0 110.865 179.557 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 1' ' ' MET . . . . . 0.42 ' C ' ' H ' ' A' ' 3' ' ' ASP . 0.4 OUTLIER . . . . . 0 N--CA 1.489 1.495 0 N-CA-C 108.19 -1.041 . . . . 1.0 108.19 . . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 2' ' ' SER . . . . . 0.55 ' O ' ' CB ' ' A' ' 3' ' ' ASP . 75.0 m -75.61 13.48 0.79 Allowed 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 116.25 -0.432 . . . . 1.0 110.852 179.709 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 3' ' ' ASP . . . . . 0.55 ' CB ' ' O ' ' A' ' 2' ' ' SER . 21.4 t0 135.69 134.15 0.0 OUTLIER 'General case' 0 N--CA 1.478 0.954 0 O-C-N 124.68 1.238 . . . . 1.0 110.346 179.066 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 4' ' ' PHE . . . . . 0.521 ' N ' ' OD1' ' A' ' 3' ' ' ASP . 71.1 t80 -167.36 91.8 0.38 Allowed 'General case' 0 C--N 1.329 -0.3 0 N-CA-C 114.833 1.42 . . . . 1.0 114.833 175.164 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 65.6 m-20 -73.61 146.78 44.4 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 114.684 -1.144 . . . . 1.0 109.212 178.898 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 6' ' ' THR . . . . . 0.483 ' O ' ' N ' ' A' ' 10' ' ' SER . 58.6 m -56.59 160.48 3.23 Favored 'General case' 0 C--O 1.217 -0.649 0 C-N-CA 120.076 -0.649 . . . . 1.0 109.505 179.519 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 7' ' ' GLU . . . . . 0.559 ' O ' ' N ' ' A' ' 11' ' ' ARG . 30.6 tt0 -57.07 -60.43 3.6 Favored 'General case' 0 C--N 1.316 -0.855 0 CA-C-O 121.565 0.697 . . . . 1.0 109.372 -178.072 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 8' ' ' ARG . . . . . 0.538 ' CG ' ' N ' ' A' ' 9' ' ' VAL . 48.0 ptt85 -49.36 -52.31 29.08 Favored 'General case' 0 C--N 1.313 -0.987 0 N-CA-C 108.082 -1.081 . . . . 1.0 108.082 -177.472 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 9' ' ' VAL . . . . . 0.584 ' O ' HG23 ' A' ' 13' ' ' VAL . 57.0 t -62.74 -48.02 90.09 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.36 0 CA-C-N 114.837 -1.074 . . . . 1.0 109.262 179.814 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 10' ' ' SER . . . . . 0.483 ' N ' ' O ' ' A' ' 6' ' ' THR . 48.3 t -63.41 -62.31 1.76 Allowed 'General case' 0 N--CA 1.476 0.836 0 CA-C-N 115.835 -0.621 . . . . 1.0 109.979 -179.214 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 11' ' ' ARG . . . . . 0.559 ' N ' ' O ' ' A' ' 7' ' ' GLU . 0.0 OUTLIER -57.42 -57.56 12.13 Favored 'General case' 0 N--CA 1.47 0.55 0 N-CA-C 109.062 -0.718 . . . . 1.0 109.062 -178.671 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 12' ' ' ALA . . . . . 0.513 ' CB ' ' O ' ' A' ' 8' ' ' ARG . . . -47.99 -48.09 32.74 Favored 'General case' 0 N--CA 1.478 0.954 0 N-CA-C 106.193 -1.78 . . . . 1.0 106.193 -178.198 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 13' ' ' VAL . . . . . 0.584 HG23 ' O ' ' A' ' 9' ' ' VAL . 45.1 t -60.5 -47.89 90.78 Favored 'Isoleucine or valine' 0 C--O 1.203 -1.392 0 C-N-CA 119.078 -1.049 . . . . 1.0 108.886 176.817 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 14' ' ' ALA . . . . . 0.564 ' O ' HG13 ' A' ' 18' ' ' VAL . . . -60.96 -61.91 2.23 Favored 'General case' 0 C--O 1.212 -0.903 0 C-N-CA 119.017 -1.073 . . . . 1.0 110.018 179.145 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 15' ' ' ALA . . . . . 0.533 ' O ' ' N ' ' A' ' 19' ' ' GLY . . . -51.84 -55.06 22.27 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-O 121.932 0.872 . . . . 1.0 109.228 -177.902 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 16' ' ' ALA . . . . . 0.511 ' C ' ' H ' ' A' ' 22' ' ' GLY . . . -61.57 -54.4 43.51 Favored 'General case' 0 C--N 1.311 -1.07 0 CA-C-N 114.135 -1.393 . . . . 1.0 109.113 -179.43 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 17' ' ' LEU . . . . . 0.668 HD23 ' C ' ' A' ' 17' ' ' LEU . 6.8 tt -57.19 -54.16 49.91 Favored 'General case' 0 N--CA 1.484 1.257 0 CA-C-N 114.411 -1.268 . . . . 1.0 109.312 -177.711 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 18' ' ' VAL . . . . . 0.564 HG13 ' O ' ' A' ' 14' ' ' ALA . 2.6 m -68.45 -56.46 12.4 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.501 0 C-N-CA 119.384 -0.926 . . . . 1.0 109.324 178.893 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 19' ' ' GLY . . . . . 0.533 ' N ' ' O ' ' A' ' 15' ' ' ALA . . . -64.17 -170.7 2.06 Favored Glycine 0 CA--C 1.526 0.731 0 N-CA-C 111.352 -0.699 . . . . 1.0 111.352 -179.568 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 20' ' ' PRO . . . . . 0.522 ' O ' ' N ' ' A' ' 24' ' ' ALA . 1.8 Cg_endo -77.41 -25.12 8.58 Favored 'Trans proline' 0 N--CA 1.494 1.53 0 C-N-CA 123.011 2.474 . . . . 1.0 114.522 -178.561 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 21' ' ' GLY . . . . . 0.433 ' O ' ' HB3' ' A' ' 24' ' ' ALA . . . -59.33 -58.48 14.19 Favored Glycine 0 N--CA 1.476 1.322 0 C-N-CA 119.894 -1.146 . . . . 1.0 111.358 -177.22 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 22' ' ' GLY . . . . . 0.511 ' H ' ' C ' ' A' ' 16' ' ' ALA . . . -57.64 -54.16 39.42 Favored Glycine 0 N--CA 1.471 0.975 0 N-CA-C 106.813 -2.515 . . . . 1.0 106.813 -178.136 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 23' ' ' VAL . . . . . 0.586 ' O ' HG12 ' A' ' 27' ' ' VAL . 53.9 t -53.96 -33.03 23.28 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.059 0 CA-C-N 114.543 -0.828 . . . . 1.0 109.069 179.313 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 24' ' ' ALA . . . . . 0.522 ' N ' ' O ' ' A' ' 20' ' ' PRO . . . -60.73 -61.02 2.89 Favored 'General case' 0 CA--C 1.53 0.204 0 C-N-CA 118.554 -1.258 . . . . 1.0 109.486 179.559 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 3.7 tp -64.34 -47.43 79.4 Favored 'General case' 0 C--N 1.344 0.346 0 N-CA-C 113.497 0.925 . . . . 1.0 113.497 -177.985 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 98.6 t -60.23 -60.58 2.34 Favored 'Isoleucine or valine' 0 C--N 1.339 0.137 0 C-N-CA 118.366 -1.334 . . . . 1.0 110.231 -176.976 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 27' ' ' VAL . . . . . 0.586 HG12 ' O ' ' A' ' 23' ' ' VAL . 1.4 p -55.14 -35.23 34.75 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.244 0 CA-C-O 120.869 0.366 . . . . 1.0 111.798 -178.209 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 8.2 tttm -67.56 -54.02 23.41 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-O 121.51 0.671 . . . . 1.0 109.436 -179.016 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 44.2 t -61.75 -49.67 83.34 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.887 0 CA-C-N 114.68 -1.146 . . . . 1.0 111.246 -178.527 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 30' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -64.96 -61.18 2.32 Favored 'General case' 0 CA--C 1.534 0.346 0 C-N-CA 118.542 -1.263 . . . . 1.0 109.905 -179.218 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 31' ' ' ALA . . . . . 0.509 ' HB2' HH12 ' A' ' 47' ' ' ARG . . . -60.84 -51.65 68.42 Favored 'General case' 0 CA--C 1.515 -0.396 0 N-CA-C 112.535 0.569 . . . . 1.0 112.535 -176.702 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 32' ' ' GLY . . . . . 0.489 ' O ' ' CB ' ' A' ' 33' ' ' LEU . . . 81.57 77.19 1.04 Allowed Glycine 0 CA--C 1.523 0.534 0 N-CA-C 108.856 -1.698 . . . . 1.0 108.856 -178.069 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 33' ' ' LEU . . . . . 0.5 HD22 ' H ' ' A' ' 36' ' ' VAL . 1.3 tt 84.74 85.41 0.05 OUTLIER Pre-proline 0 CA--C 1.543 0.676 0 N-CA-C 109.523 -0.547 . . . . 1.0 109.523 -178.961 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 77.8 Cg_exo -52.35 -33.05 54.38 Favored 'Trans proline' 0 N--CA 1.51 2.496 0 C-N-CA 123.564 2.842 . . . . 1.0 114.556 -178.504 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -58.98 -58.79 12.69 Favored Glycine 0 CA--C 1.527 0.84 0 C-N-CA 118.974 -1.584 . . . . 1.0 109.843 -178.083 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 36' ' ' VAL . . . . . 0.614 ' O ' HG22 ' A' ' 37' ' ' ILE . 0.4 OUTLIER -94.38 160.62 2.69 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.453 0 N-CA-C 107.083 -1.451 . . . . 1.0 107.083 178.641 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 37' ' ' ILE . . . . . 0.686 HG23 ' O ' ' A' ' 37' ' ' ILE . 5.9 tp 124.63 111.27 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.484 1.272 0 O-C-N 124.141 0.901 . . . . 1.0 109.069 -178.944 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 57.0 m80 -138.39 130.72 28.82 Favored 'General case' 0 C--N 1.329 -0.304 0 N-CA-C 108.044 -1.095 . . . . 1.0 108.044 178.865 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 11.2 t -91.79 153.19 43.69 Favored Pre-proline 0 N--CA 1.467 0.418 0 CA-C-O 119.391 -0.338 . . . . 1.0 110.363 -179.023 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 6.1 Cg_endo -86.11 -38.74 0.09 OUTLIER 'Trans proline' 0 N--CA 1.483 0.881 0 C-N-CA 121.213 1.275 . . . . 1.0 112.828 -179.786 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -125.53 129.88 50.62 Favored 'General case' 0 N--CA 1.47 0.561 0 CA-C-N 116.203 -0.453 . . . . 1.0 109.918 179.361 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 42' ' ' ARG . . . . . 0.717 HH12 ' CD ' ' A' ' 47' ' ' ARG . 42.0 ttp180 -176.18 168.95 2.84 Favored 'General case' 0 C--N 1.323 -0.584 0 N-CA-C 107.12 -1.437 . . . . 1.0 107.12 177.294 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 43' ' ' ARG . . . . . 0.457 ' N ' ' HG2' ' A' ' 42' ' ' ARG . 0.0 OUTLIER -52.51 -37.34 57.27 Favored 'General case' 0 N--CA 1.449 -0.478 0 CA-C-N 120.114 1.325 . . . . 1.0 109.132 -179.642 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 125.16 -19.62 6.79 Favored Glycine 0 C--N 1.34 0.773 0 N-CA-C 111.079 -0.809 . . . . 1.0 111.079 -179.106 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 45' ' ' PHE . . . . . 0.499 ' O ' ' CB ' ' A' ' 46' ' ' PHE . 4.5 t80 -149.7 149.94 31.35 Favored 'General case' 0 CA--C 1.538 0.509 0 CA-C-N 117.815 0.808 . . . . 1.0 109.019 179.76 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 46' ' ' PHE . . . . . 0.604 ' CE2' ' NE2' ' A' ' 54' ' ' GLN . 3.8 m-30 132.31 86.17 0.0 OUTLIER 'General case' 0 N--CA 1.484 1.239 0 N-CA-C 107.384 -1.339 . . . . 1.0 107.384 -179.559 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 47' ' ' ARG . . . . . 0.717 ' CD ' HH12 ' A' ' 42' ' ' ARG . 5.7 ptp180 132.87 141.91 0.0 OUTLIER 'General case' 0 N--CA 1.485 1.279 0 O-C-N 124.434 1.084 . . . . 1.0 110.932 178.188 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 3.3 m 71.03 71.5 0.18 Allowed 'General case' 0 N--CA 1.455 -0.179 0 N-CA-C 110.286 -0.264 . . . . 1.0 110.286 -179.992 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 49' ' ' ASN . . . . . 0.452 ' O ' ' N ' ' A' ' 51' ' ' GLU . 28.0 m120 -132.44 140.32 37.52 Favored Pre-proline 0 C--N 1.33 -0.263 0 N-CA-C 108.007 -1.108 . . . . 1.0 108.007 179.226 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 44.1 Cg_endo -67.86 65.55 0.91 Allowed 'Trans proline' 0 C--N 1.312 -1.394 0 C-N-CA 121.54 1.493 . . . . 1.0 111.374 -179.339 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 51' ' ' GLU . . . . . 0.525 ' N ' ' OE1' ' A' ' 51' ' ' GLU . 0.0 OUTLIER 64.11 7.48 3.45 Favored 'General case' 0 N--CA 1.463 0.196 0 CA-C-N 114.92 -1.036 . . . . 1.0 111.061 -179.638 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 52' ' ' ARG . . . . . 0.551 HH11 ' HB1' ' A' ' 86' ' ' ALA . 33.1 mtt-85 -87.97 159.85 18.14 Favored 'General case' 0 C--N 1.331 -0.233 0 N-CA-C 109.572 -0.529 . . . . 1.0 109.572 179.278 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 53' ' ' ILE . . . . . 0.468 ' O ' ' N ' ' A' ' 55' ' ' ILE . 10.7 tt -79.85 135.54 25.29 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-O 121.87 0.843 . . . . 1.0 111.605 -179.245 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 54' ' ' GLN . . . . . 0.604 ' NE2' ' CE2' ' A' ' 46' ' ' PHE . 1.9 pt20 -61.04 83.24 0.01 OUTLIER 'General case' 0 C--N 1.32 -0.68 0 CA-C-N 114.267 -1.333 . . . . 1.0 109.013 -178.487 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 55' ' ' ILE . . . . . 0.468 ' N ' ' O ' ' A' ' 53' ' ' ILE . 13.1 tt -149.65 158.64 5.81 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.472 0 CA-C-N 115.717 -0.674 . . . . 1.0 110.547 178.164 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 107.13 -5.33 36.06 Favored Glycine 0 N--CA 1.473 1.15 0 N-CA-C 110.991 -0.844 . . . . 1.0 110.991 179.187 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 57' ' ' ASP . . . . . 0.41 ' HB3' ' CB ' ' A' ' 45' ' ' PHE . 3.7 p-10 -81.2 105.58 12.51 Favored 'General case' 0 C--N 1.316 -0.877 0 CA-C-N 114.912 -0.644 . . . . 1.0 110.256 179.769 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 58' ' ' TRP . . . . . . . . . . . . . 1.4 m95 -91.09 173.9 7.7 Favored 'General case' 0 CA--C 1.541 0.6 0 CA-C-O 124.289 1.995 . . . . 1.0 114.836 -177.011 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 31.2 mtm180 -78.54 -62.64 1.62 Allowed 'General case' 0 C--N 1.312 -1.053 0 CA-C-N 109.266 -3.606 . . . . 1.0 111.654 -179.096 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 60' ' ' TYR . . . . . 0.499 ' O ' ' CG ' ' A' ' 60' ' ' TYR . 47.1 t80 -91.95 -11.87 34.98 Favored 'General case' 0 C--O 1.249 1.078 0 N-CA-C 113.621 0.971 . . . . 1.0 113.621 179.612 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 6.7 tt0 -81.63 -15.78 53.55 Favored 'General case' 0 N--CA 1.443 -0.82 0 O-C-N 120.686 -1.259 . . . . 1.0 111.804 -178.689 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 62' ' ' VAL . . . . . 0.568 ' O ' ' N ' ' A' ' 66' ' ' GLY . 0.0 OUTLIER -46.57 -52.65 3.47 Favored 'Isoleucine or valine' 0 C--O 1.208 -1.095 0 C-N-CA 120.231 -0.588 . . . . 1.0 111.719 -174.524 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -69.1 -46.4 67.82 Favored 'General case' 0 C--N 1.311 -1.098 0 C-N-CA 119.376 -0.93 . . . . 1.0 109.616 -179.218 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 3.0 m-70 -50.57 -55.4 16.41 Favored 'General case' 0 N--CA 1.469 0.483 0 C-N-CA 119.08 -1.048 . . . . 1.0 108.823 179.222 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 65' ' ' ASP . . . . . 0.748 ' C ' ' H ' ' A' ' 67' ' ' ARG . 34.3 m-20 -73.58 -48.99 28.53 Favored 'General case' 0 C--O 1.244 0.765 0 CA-C-O 121.214 0.53 . . . . 1.0 109.886 178.714 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 66' ' ' GLY . . . . . 0.568 ' N ' ' O ' ' A' ' 62' ' ' VAL . . . -65.77 27.92 0.14 Allowed Glycine 0 N--CA 1.451 -0.351 0 N-CA-C 110.152 -1.179 . . . . 1.0 110.152 177.396 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 67' ' ' ARG . . . . . 0.748 ' H ' ' C ' ' A' ' 65' ' ' ASP . 0.0 OUTLIER -73.4 0.34 12.51 Favored 'General case' 0 N--CA 1.433 -1.321 0 N-CA-C 105.869 -1.901 . . . . 1.0 105.869 174.058 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 68' ' ' LEU . . . . . 0.44 ' H ' ' C ' ' A' ' 66' ' ' GLY . 1.0 OUTLIER -39.05 -39.3 0.54 Allowed 'General case' 0 C--N 1.346 0.434 0 CA-C-N 116.162 -0.472 . . . . 1.0 110.478 -177.978 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -64.5 -69.08 0.31 Allowed 'General case' 0 N--CA 1.48 1.044 0 C-N-CA 119.258 -0.977 . . . . 1.0 113.34 -175.662 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 70' ' ' ALA . . . . . 0.509 ' C ' ' H ' ' A' ' 72' ' ' HIS . . . -77.07 -79.07 0.11 Allowed 'General case' 0 CA--C 1.512 -0.483 0 C-N-CA 117.957 -1.497 . . . . 1.0 110.107 -176.037 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 71' ' ' ALA . . . . . 0.778 ' O ' ' N ' ' A' ' 73' ' ' MET . . . -65.24 14.95 0.03 OUTLIER 'General case' 0 C--N 1.312 -1.035 0 C-N-CA 124.784 1.234 . . . . 1.0 112.85 -178.365 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 72' ' ' HIS . . . . . 0.509 ' H ' ' C ' ' A' ' 70' ' ' ALA . 0.8 OUTLIER -18.55 -32.97 0.0 OUTLIER 'General case' 0 N--CA 1.467 0.404 0 O-C-N 124.315 1.01 . . . . 1.0 113.197 -175.036 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 73' ' ' MET . . . . . 0.778 ' N ' ' O ' ' A' ' 71' ' ' ALA . 8.6 ptp -61.15 -53.13 60.8 Favored 'General case' 0 C--N 1.319 -0.76 0 C-N-CA 118.755 -1.178 . . . . 1.0 108.465 176.49 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 74' ' ' VAL . . . . . 0.713 ' O ' ' N ' ' A' ' 76' ' ' GLY . 34.2 m -44.65 -51.64 1.84 Allowed 'Isoleucine or valine' 0 C--O 1.206 -1.219 0 CA-C-O 116.363 -1.78 . . . . 1.0 112.426 -175.112 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 75' ' ' ASN . . . . . 0.413 ' C ' ' O ' ' A' ' 74' ' ' VAL . 4.3 t-20 -36.68 -17.21 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.49 0 CA-C-N 122.472 2.396 . . . . 1.0 111.604 -179.231 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 76' ' ' GLY . . . . . 0.713 ' N ' ' O ' ' A' ' 74' ' ' VAL . . . -54.39 -23.66 27.54 Favored Glycine 0 CA--C 1.532 1.115 0 N-CA-C 107.178 -2.369 . . . . 1.0 107.178 174.252 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 77' ' ' ILE . . . . . 0.568 ' N ' ' O ' ' A' ' 74' ' ' VAL . 18.2 pt -51.06 -48.98 29.55 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.033 0 CA-C-O 118.457 -0.782 . . . . 1.0 109.874 -179.793 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 19.3 t -55.97 -19.73 7.65 Favored 'Isoleucine or valine' 0 C--N 1.345 0.409 0 CA-C-N 120.94 1.7 . . . . 1.0 112.833 178.775 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 79' ' ' ILE . . . . . 0.588 ' O ' ' HB3' ' A' ' 83' ' ' ALA . 0.6 OUTLIER -90.6 -44.71 14.79 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.402 0 C-N-CA 119.683 -0.807 . . . . 1.0 109.855 179.077 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 80' ' ' ALA . . . . . 0.475 ' N ' HG13 ' A' ' 79' ' ' ILE . . . -80.04 -17.59 52.37 Favored 'General case' 0 C--N 1.323 -0.546 0 N-CA-C 113.267 0.84 . . . . 1.0 113.267 -179.587 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 81' ' ' GLU . . . . . 0.574 ' CG ' ' H ' ' A' ' 82' ' ' ASP . 10.2 pt-20 -94.18 -70.66 0.7 Allowed 'General case' 0 CA--C 1.537 0.463 0 C-N-CA 119.624 -0.83 . . . . 1.0 113.206 -177.987 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 82' ' ' ASP . . . . . 0.574 ' H ' ' CG ' ' A' ' 81' ' ' GLU . 13.4 t70 -90.62 -14.27 32.71 Favored 'General case' 0 CA--C 1.537 0.472 0 N-CA-C 114.821 1.415 . . . . 1.0 114.821 -178.49 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 83' ' ' ALA . . . . . 0.588 ' HB3' ' O ' ' A' ' 79' ' ' ILE . . . -52.16 -46.32 65.41 Favored 'General case' 0 C--O 1.22 -0.498 0 C-N-CA 117.644 -1.622 . . . . 1.0 111.203 -178.924 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 84' ' ' LEU . . . . . 0.491 ' O ' HD12 ' A' ' 84' ' ' LEU . 0.1 OUTLIER -39.34 -25.79 0.02 OUTLIER 'General case' 0 N--CA 1.469 0.499 0 O-C-N 121.427 -0.795 . . . . 1.0 111.533 -179.605 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 85' ' ' ILE . . . . . 0.499 ' N ' ' O ' ' A' ' 83' ' ' ALA . 3.2 tt -91.18 -34.41 6.34 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.327 0 C-N-CA 120.851 -0.339 . . . . 1.0 110.236 179.119 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 86' ' ' ALA . . . . . 0.551 ' HB1' HH11 ' A' ' 52' ' ' ARG . . . -95.52 -29.0 14.6 Favored 'General case' 0 C--O 1.207 -1.16 0 O-C-N 122.038 -0.414 . . . . 1.0 111.572 178.994 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 87' ' ' GLU . . . . . 0.422 ' OE1' ' N ' ' A' ' 88' ' ' ALA . 0.3 OUTLIER -61.59 -17.34 54.72 Favored 'General case' 0 C--N 1.321 -0.673 0 O-C-N 121.237 -0.914 . . . . 1.0 110.077 -179.262 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 88' ' ' ALA . . . . . 0.422 ' N ' ' OE1' ' A' ' 87' ' ' GLU . . . -73.89 -4.59 35.94 Favored 'General case' 0 N--CA 1.477 0.888 0 CA-C-O 123.549 1.643 . . . . 1.0 106.759 177.163 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 89' ' ' VAL . . . . . 0.566 ' O ' HG12 ' A' ' 89' ' ' VAL . 26.0 t -80.96 39.51 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.44 -0.964 0 CA-C-N 110.91 -2.859 . . . . 1.0 108.178 175.866 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 90' ' ' GLY . . . . . 0.844 ' O ' ' N ' ' A' ' 92' ' ' HIS . . . -56.91 -29.02 58.46 Favored Glycine 0 C--N 1.37 2.461 0 CA-C-O 117.423 -1.765 . . . . 1.0 111.844 177.337 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 91' ' ' PRO . . . . . 0.603 ' HD2' ' N ' ' A' ' 90' ' ' GLY . 52.2 Cg_exo -38.36 -2.19 0.0 OUTLIER 'Trans proline' 0 N--CA 1.498 1.75 0 CA-C-N 121.672 2.736 . . . . 1.0 111.728 173.945 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 92' ' ' HIS . . . . . 0.844 ' N ' ' O ' ' A' ' 90' ' ' GLY . 18.1 p-80 -50.19 -31.3 13.44 Favored 'General case' 0 N--CA 1.432 -1.365 0 N-CA-C 106.966 -1.494 . . . . 1.0 106.966 179.243 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 93' ' ' LEU . . . . . 0.432 ' O ' ' HB3' ' A' ' 96' ' ' ALA . 1.5 tt -61.02 -50.13 74.6 Favored 'General case' 0 C--O 1.222 -0.36 0 N-CA-C 106.995 -1.483 . . . . 1.0 106.995 176.367 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 94' ' ' ALA . . . . . 0.479 ' N ' ' O ' ' A' ' 91' ' ' PRO . . . -52.04 -54.91 24.41 Favored 'General case' 0 C--N 1.322 -0.628 0 N-CA-C 107.586 -1.264 . . . . 1.0 107.586 179.644 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -63.63 -29.72 70.93 Favored 'General case' 0 CA--C 1.543 0.685 0 CA-C-O 121.537 0.684 . . . . 1.0 109.574 178.405 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 96' ' ' ALA . . . . . 0.783 ' O ' ' N ' ' A' ' 100' ' ' ILE . . . -50.9 -42.94 59.65 Favored 'General case' 0 C--O 1.197 -1.691 0 N-CA-C 106.799 -1.556 . . . . 1.0 106.799 -177.754 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 97' ' ' LEU . . . . . 0.517 ' O ' ' CG2' ' A' ' 100' ' ' ILE . 0.3 OUTLIER -35.61 -23.05 0.01 OUTLIER 'General case' 0 CA--C 1.594 2.641 0 CA-C-N 114.18 -1.373 . . . . 1.0 108.005 -177.156 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 98' ' ' GLY . . . . . 0.674 ' N ' ' O ' ' A' ' 96' ' ' ALA . . . -86.06 -50.23 3.97 Favored Glycine 0 CA--C 1.562 3.011 0 CA-C-O 123.057 1.365 . . . . 1.0 111.286 169.713 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 99' ' ' GLN . . . . . 0.692 ' N ' ' O ' ' A' ' 96' ' ' ALA . 0.0 OUTLIER -76.59 7.16 4.82 Favored 'General case' 0 N--CA 1.441 -0.878 0 N-CA-C 106.391 -1.707 . . . . 1.0 106.391 177.142 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 100' ' ' ILE . . . . . 0.783 ' N ' ' O ' ' A' ' 96' ' ' ALA . 17.7 tt -58.12 -55.4 22.31 Favored 'Isoleucine or valine' 0 CA--C 1.481 -1.69 0 N-CA-C 106.232 -1.766 . . . . 1.0 106.232 177.438 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 101' ' ' VAL . . . . . 0.684 ' O ' ' N ' ' A' ' 105' ' ' GLY . 7.0 p -57.49 -60.04 2.58 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.579 0 C-N-CA 118.368 -1.333 . . . . 1.0 107.871 178.668 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 102' ' ' CYS . . . . . 0.885 ' O ' ' HB2' ' A' ' 106' ' ' ALA . 18.2 t -52.48 -26.26 12.45 Favored 'General case' 0 C--N 1.32 -0.707 0 N-CA-C 112.712 0.634 . . . . 1.0 112.712 -177.324 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 103' ' ' ARG . . . . . 0.536 ' N ' ' O ' ' A' ' 99' ' ' GLN . 45.6 ttt180 -86.23 -49.31 7.8 Favored 'General case' 0 N--CA 1.49 1.568 0 CA-C-O 122.763 1.268 . . . . 1.0 112.686 179.019 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 104' ' ' TYR . . . . . 0.686 ' O ' ' CG ' ' A' ' 104' ' ' TYR . 0.0 OUTLIER -97.04 24.13 6.59 Favored 'General case' 0 C--N 1.295 -1.8 0 CA-C-N 112.258 -2.246 . . . . 1.0 107.571 178.618 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 105' ' ' GLY . . . . . 0.684 ' N ' ' O ' ' A' ' 101' ' ' VAL . . . -164.92 -96.84 0.11 Allowed Glycine 0 CA--C 1.533 1.206 0 N-CA-C 108.166 -1.974 . . . . 1.0 108.166 179.081 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 106' ' ' ALA . . . . . 0.885 ' HB2' ' O ' ' A' ' 102' ' ' CYS . . . 68.4 55.68 0.5 Allowed 'General case' 0 CA--C 1.534 0.351 0 C-N-CA 122.989 0.515 . . . . 1.0 111.747 -178.886 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 107' ' ' THR . . . . . 0.548 HG22 ' O ' ' A' ' 107' ' ' THR . 91.8 m -80.32 6.1 12.96 Favored 'General case' 0 CA--C 1.514 -0.407 0 N-CA-C 107.222 -1.399 . . . . 1.0 107.222 177.033 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 108' ' ' VAL . . . . . 0.455 HG23 ' N ' ' A' ' 109' ' ' ILE . 18.0 m -84.4 -54.03 9.68 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.242 0 CA-C-N 115.575 -0.739 . . . . 1.0 110.472 178.721 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 109' ' ' ILE . . . . . 0.468 ' N ' ' HD2' ' A' ' 110' ' ' PRO . 85.4 mt -41.99 -51.89 9.69 Favored Pre-proline 0 C--N 1.347 0.46 0 N-CA-C 114.805 1.409 . . . . 1.0 114.805 -179.446 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 110' ' ' PRO . . . . . 0.468 ' HD2' ' N ' ' A' ' 109' ' ' ILE . 2.3 Cg_endo -40.68 -52.02 3.34 Favored 'Trans proline' 0 C--N 1.314 -1.286 0 CA-C-N 120.618 1.257 . . . . 1.0 113.293 -176.407 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 111' ' ' ASN . . . . . 0.434 ' ND2' ' H ' ' A' ' 112' ' ' ILE . 0.8 OUTLIER -69.51 -69.12 0.36 Allowed 'General case' 0 C--O 1.233 0.222 0 C-N-CA 118.229 -1.389 . . . . 1.0 110.444 -178.403 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 112' ' ' ILE . . . . . 0.625 HD13 ' N ' ' A' ' 113' ' ' ASN . 0.0 OUTLIER -46.97 -27.62 0.91 Allowed 'Isoleucine or valine' 0 C--O 1.216 -0.672 0 N-CA-C 109.174 -0.676 . . . . 1.0 109.174 -179.947 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 113' ' ' ASN . . . . . 0.625 ' N ' HD13 ' A' ' 112' ' ' ILE . 16.4 t-20 -58.19 -54.55 45.76 Favored 'General case' 0 C--N 1.308 -1.198 0 C-N-CA 118.131 -1.428 . . . . 1.0 108.096 -177.928 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 114' ' ' ALA . . . . . 0.477 ' O ' ' HG2' ' A' ' 117' ' ' GLU . . . -58.69 -33.9 70.67 Favored 'General case' 0 N--CA 1.447 -0.611 0 N-CA-C 113.116 0.784 . . . . 1.0 113.116 -178.633 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -82.99 -49.44 9.58 Favored 'General case' 0 C--O 1.215 -0.761 0 O-C-N 120.426 -1.421 . . . . 1.0 110.8 179.173 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 116' ' ' ILE . . . . . 0.53 HD12 HD11 ' A' ' 112' ' ' ILE . 0.6 OUTLIER -50.91 -54.92 8.51 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.184 0 N-CA-C 107.345 -1.354 . . . . 1.0 107.345 -179.415 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 117' ' ' GLU . . . . . 0.504 ' O ' ' HA ' ' A' ' 121' ' ' THR . 17.5 pt-20 -45.96 -58.11 3.83 Favored 'General case' 0 C--O 1.212 -0.898 0 CA-C-N 113.175 -1.83 . . . . 1.0 106.136 -179.052 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 118' ' ' VAL . . . . . 0.466 ' N ' ' CG ' ' A' ' 117' ' ' GLU . 57.7 t -58.36 -53.35 47.51 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.133 0 C-N-CA 119.89 -0.724 . . . . 1.0 110.207 179.068 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 13.2 tp -53.76 -73.04 0.05 OUTLIER 'General case' 0 CA--C 1.54 0.581 0 N-CA-C 108.129 -1.063 . . . . 1.0 108.129 -178.66 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 120' ' ' GLY . . . . . 0.512 ' O ' ' CB ' ' A' ' 121' ' ' THR . . . -67.82 -76.11 0.43 Allowed Glycine 0 CA--C 1.54 1.603 0 C-N-CA 118.948 -1.596 . . . . 1.0 111.026 179.165 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 121' ' ' THR . . . . . 0.512 ' CB ' ' O ' ' A' ' 120' ' ' GLY . 2.3 m 144.92 -27.4 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.434 0 CA-C-N 112.536 -1.832 . . . . 1.0 111.026 -178.381 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 122' ' ' GLY . . . . . 0.659 ' O ' ' N ' ' A' ' 124' ' ' ASP . . . 104.72 -17.94 44.87 Favored Glycine 0 C--O 1.223 -0.577 0 N-CA-C 107.944 -2.062 . . . . 1.0 107.944 -177.0 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 123' ' ' THR . . . . . 0.683 HG23 ' O ' ' A' ' 123' ' ' THR . 11.0 t -54.41 83.52 0.0 OUTLIER 'General case' 0 CA--C 1.532 0.275 0 N-CA-C 106.351 -1.722 . . . . 1.0 106.351 178.617 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 124' ' ' ASP . . . . . 0.659 ' N ' ' O ' ' A' ' 122' ' ' GLY . 48.5 p-10 -166.93 176.77 6.77 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 113.539 -1.664 . . . . 1.0 111.375 179.285 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 125' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -146.76 144.63 29.53 Favored 'General case' 0 CA--C 1.541 0.605 0 N-CA-C 108.364 -0.976 . . . . 1.0 108.364 176.904 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 38.0 ttm180 -149.84 151.74 34.0 Favored 'General case' 0 N--CA 1.471 0.588 0 CA-C-O 120.534 0.207 . . . . 1.0 110.935 178.844 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 127' ' ' PHE . . . . . . . . . . . . . 13.9 p90 . . . . . 0 C--O 1.219 -0.506 0 CA-C-O 117.958 -1.02 . . . . 1.0 110.646 -179.985 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 1' ' ' MET . . . . . 0.513 ' SD ' ' N ' ' A' ' 1' ' ' MET . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.558 0 N-CA-C 108.862 -0.792 . . . . 1.0 108.862 . . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 2' ' ' SER . . . . . 0.508 ' O ' ' CG ' ' A' ' 3' ' ' ASP . 70.8 m -72.4 7.71 1.68 Allowed 'General case' 0 C--O 1.223 -0.31 0 CA-C-O 119.43 -0.319 . . . . 1.0 110.844 179.474 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 3' ' ' ASP . . . . . 0.508 ' CG ' ' O ' ' A' ' 2' ' ' SER . 62.1 m-20 144.16 137.39 0.0 OUTLIER 'General case' 0 N--CA 1.482 1.141 0 O-C-N 124.189 0.93 . . . . 1.0 110.097 179.239 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 91.4 t80 -154.92 150.46 27.44 Favored 'General case' 0 N--CA 1.465 0.296 0 CA-C-N 116.073 -0.512 . . . . 1.0 110.88 179.214 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -150.13 145.23 26.19 Favored 'General case' 0 CA--C 1.543 0.686 0 N-CA-C 109.553 -0.536 . . . . 1.0 109.553 179.465 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 6' ' ' THR . . . . . 0.843 ' O ' ' N ' ' A' ' 10' ' ' SER . 0.2 OUTLIER -87.14 176.71 7.46 Favored 'General case' 0 C--O 1.179 -2.627 0 CA-C-O 120.43 0.157 . . . . 1.0 111.236 -179.27 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 7' ' ' GLU . . . . . 0.588 ' O ' ' N ' ' A' ' 11' ' ' ARG . 10.9 mt-10 -60.65 -50.68 72.53 Favored 'General case' 0 C--N 1.312 -1.056 0 CA-C-O 121.194 0.521 . . . . 1.0 109.713 -179.405 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 8' ' ' ARG . . . . . 0.671 ' O ' ' HB3' ' A' ' 12' ' ' ALA . 18.6 mtp-105 -57.95 -58.93 6.23 Favored 'General case' 0 C--N 1.315 -0.916 0 C-N-CA 118.416 -1.313 . . . . 1.0 107.536 -179.011 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 9' ' ' VAL . . . . . 0.693 ' O ' ' HB ' ' A' ' 13' ' ' VAL . 0.0 OUTLIER -66.82 -50.83 61.82 Favored 'Isoleucine or valine' 0 C--O 1.183 -2.418 0 CA-C-N 114.267 -1.333 . . . . 1.0 109.287 179.686 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 10' ' ' SER . . . . . 0.843 ' N ' ' O ' ' A' ' 6' ' ' THR . 19.3 t -63.84 -61.16 2.47 Favored 'General case' 0 N--CA 1.492 1.669 0 C-N-CA 119.437 -0.905 . . . . 1.0 110.268 179.171 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 11' ' ' ARG . . . . . 0.588 ' N ' ' O ' ' A' ' 7' ' ' GLU . 5.3 tpt180 -67.39 -54.32 21.5 Favored 'General case' 0 C--O 1.214 -0.797 0 N-CA-C 112.546 0.573 . . . . 1.0 112.546 -176.674 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 12' ' ' ALA . . . . . 0.671 ' HB3' ' O ' ' A' ' 8' ' ' ARG . . . -56.06 -50.7 70.22 Favored 'General case' 0 N--CA 1.476 0.862 0 C-N-CA 117.023 -1.871 . . . . 1.0 106.565 -178.09 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 13' ' ' VAL . . . . . 0.693 ' HB ' ' O ' ' A' ' 9' ' ' VAL . 65.7 t -61.25 -48.49 88.7 Favored 'Isoleucine or valine' 0 C--O 1.18 -2.593 0 N-CA-C 107.033 -1.469 . . . . 1.0 107.033 178.659 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 14' ' ' ALA . . . . . 0.746 ' O ' HG13 ' A' ' 18' ' ' VAL . . . -59.32 -61.56 2.53 Favored 'General case' 0 C--O 1.201 -1.467 0 C-N-CA 118.132 -1.427 . . . . 1.0 109.696 179.253 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 15' ' ' ALA . . . . . 0.572 ' O ' ' N ' ' A' ' 19' ' ' GLY . . . -52.57 -53.38 47.29 Favored 'General case' 0 C--O 1.216 -0.685 0 N-CA-C 108.576 -0.898 . . . . 1.0 108.576 -178.456 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 16' ' ' ALA . . . . . 0.662 ' CA ' ' H ' ' A' ' 22' ' ' GLY . . . -65.42 -57.15 9.02 Favored 'General case' 0 CA--C 1.546 0.792 0 CA-C-O 121.663 0.744 . . . . 1.0 109.951 -179.747 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 17' ' ' LEU . . . . . 0.676 ' N ' ' O ' ' A' ' 13' ' ' VAL . 18.7 tp -55.74 -55.98 25.93 Favored 'General case' 0 N--CA 1.491 1.582 0 N-CA-C 107.953 -1.128 . . . . 1.0 107.953 -178.929 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 18' ' ' VAL . . . . . 0.746 HG13 ' O ' ' A' ' 14' ' ' ALA . 1.2 m -70.89 -59.02 3.87 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.397 0 C-N-CA 119.854 -0.738 . . . . 1.0 110.136 -179.896 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 19' ' ' GLY . . . . . 0.572 ' N ' ' O ' ' A' ' 15' ' ' ALA . . . -60.75 -161.93 0.13 Allowed Glycine 0 C--N 1.338 0.651 0 N-CA-C 111.819 -0.512 . . . . 1.0 111.819 -178.399 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 20' ' ' PRO . . . . . 0.654 ' O ' ' HB2' ' A' ' 24' ' ' ALA . 86.3 Cg_endo -81.23 -23.1 5.43 Favored 'Trans proline' 0 C--N 1.318 -1.04 0 C-N-CA 123.165 2.577 . . . . 1.0 113.682 -177.979 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -63.35 -62.29 5.52 Favored Glycine 0 N--CA 1.484 1.847 0 C-N-CA 120.178 -1.01 . . . . 1.0 112.996 -176.406 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 22' ' ' GLY . . . . . 0.662 ' H ' ' CA ' ' A' ' 16' ' ' ALA . . . -57.61 -57.61 18.87 Favored Glycine 0 C--N 1.312 -0.784 0 N-CA-C 107.349 -2.301 . . . . 1.0 107.349 -177.845 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 23' ' ' VAL . . . . . 0.488 HG22 ' O ' ' A' ' 19' ' ' GLY . 34.3 m -56.63 -32.28 36.94 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.744 0 C-N-CA 118.773 -1.171 . . . . 1.0 109.294 -179.977 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 24' ' ' ALA . . . . . 0.654 ' HB2' ' O ' ' A' ' 20' ' ' PRO . . . -60.5 -62.13 2.09 Favored 'General case' 0 N--CA 1.471 0.6 0 C-N-CA 118.142 -1.423 . . . . 1.0 110.117 179.745 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 18.4 mt -61.38 -47.8 84.17 Favored 'General case' 0 CA--C 1.514 -0.43 0 CA-C-N 118.616 0.644 . . . . 1.0 112.137 -177.28 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 90.5 t -58.55 -59.14 4.04 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.535 0 C-N-CA 119.29 -0.964 . . . . 1.0 109.61 -177.846 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 27' ' ' VAL . . . . . 0.725 ' O ' ' HB3' ' A' ' 31' ' ' ALA . 84.8 t -57.28 -38.65 63.12 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.462 0 CA-C-O 120.866 0.365 . . . . 1.0 110.482 -178.236 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 9.2 ttmt -66.37 -55.33 16.38 Favored 'General case' 0 C--N 1.316 -0.876 0 C-N-CA 119.686 -0.806 . . . . 1.0 109.956 -178.873 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 92.3 t -63.73 -51.39 70.53 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.777 0 CA-C-N 114.903 -1.044 . . . . 1.0 110.917 -176.541 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 30' ' ' CYS . . . . . . . . . . . . . 50.1 t -64.54 -61.55 2.14 Favored 'General case' 0 N--CA 1.443 -0.779 0 C-N-CA 119.407 -0.917 . . . . 1.0 109.889 -179.084 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 31' ' ' ALA . . . . . 0.725 ' HB3' ' O ' ' A' ' 27' ' ' VAL . . . -59.3 -53.54 57.12 Favored 'General case' 0 C--N 1.318 -0.773 0 CA-C-O 120.874 0.369 . . . . 1.0 111.354 -177.295 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 32' ' ' GLY . . . . . 0.519 ' O ' ' CB ' ' A' ' 33' ' ' LEU . . . 80.29 69.68 1.38 Allowed Glycine 0 CA--C 1.521 0.418 0 N-CA-C 109.898 -1.281 . . . . 1.0 109.898 -179.77 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 33' ' ' LEU . . . . . 0.659 ' CD2' ' H ' ' A' ' 35' ' ' GLY . 2.0 tt 88.96 101.6 0.03 OUTLIER Pre-proline 0 CA--C 1.545 0.781 0 CA-C-N 115.442 -0.379 . . . . 1.0 110.553 -179.821 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 51.7 Cg_exo -51.86 -21.97 12.94 Favored 'Trans proline' 0 N--CA 1.503 2.05 0 C-N-CA 122.328 2.018 . . . . 1.0 113.939 179.745 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 35' ' ' GLY . . . . . 0.659 ' H ' ' CD2' ' A' ' 33' ' ' LEU . . . -62.12 -62.3 5.8 Favored Glycine 0 C--N 1.34 0.796 0 C-N-CA 119.263 -1.446 . . . . 1.0 109.952 -178.389 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 36' ' ' VAL . . . . . 0.919 HG22 ' H ' ' A' ' 37' ' ' ILE . 8.4 p -73.37 -152.88 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.325 -0.488 0 N-CA-C 107.96 -1.126 . . . . 1.0 107.96 178.333 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 37' ' ' ILE . . . . . 0.919 ' H ' HG22 ' A' ' 36' ' ' VAL . 2.1 mm 70.96 79.33 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.475 0.804 0 CA-C-O 122.069 0.938 . . . . 1.0 112.79 179.598 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 88.0 m-70 -135.32 129.56 33.68 Favored 'General case' 0 C--N 1.318 -0.763 0 N-CA-C 106.826 -1.546 . . . . 1.0 106.826 176.971 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 25.1 m -120.44 132.2 24.21 Favored Pre-proline 0 N--CA 1.465 0.297 0 N-CA-C 110.073 -0.343 . . . . 1.0 110.073 -178.883 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 27.7 Cg_endo -62.98 -78.17 0.01 OUTLIER 'Trans proline' 0 N--CA 1.49 1.311 0 CA-C-N 119.654 0.912 . . . . 1.0 111.898 -179.457 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -67.72 125.65 26.9 Favored 'General case' 0 C--N 1.317 -0.844 0 CA-C-N 114.859 -1.064 . . . . 1.0 110.613 -178.805 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 42' ' ' ARG . . . . . 0.531 ' HG2' ' H ' ' A' ' 43' ' ' ARG . 31.0 ttp180 -173.28 174.52 3.33 Favored 'General case' 0 C--N 1.32 -0.674 0 CA-C-N 115.832 -0.622 . . . . 1.0 109.982 179.516 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 43' ' ' ARG . . . . . 0.56 ' NH1' ' OD2' ' A' ' 57' ' ' ASP . 1.1 tmt_? -58.08 -45.19 87.55 Favored 'General case' 0 CA--C 1.541 0.598 0 N-CA-C 107.1 -1.444 . . . . 1.0 107.1 179.528 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 44' ' ' GLY . . . . . 0.476 ' O ' ' CD1' ' A' ' 45' ' ' PHE . . . 123.58 -25.12 6.31 Favored Glycine 0 CA--C 1.533 1.173 0 CA-C-O 119.852 -0.416 . . . . 1.0 112.147 179.138 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 45' ' ' PHE . . . . . 0.64 ' O ' ' HB2' ' A' ' 46' ' ' PHE . 7.5 m-85 -156.52 162.92 39.91 Favored 'General case' 0 N--CA 1.474 0.749 0 N-CA-C 109.111 -0.7 . . . . 1.0 109.111 177.726 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 46' ' ' PHE . . . . . 0.65 ' O ' ' CG ' ' A' ' 47' ' ' ARG . 6.9 m-85 118.41 104.08 0.0 OUTLIER 'General case' 0 N--CA 1.499 2.001 0 O-C-N 125.375 1.672 . . . . 1.0 110.592 -179.743 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 47' ' ' ARG . . . . . 0.756 ' O ' ' SG ' ' A' ' 48' ' ' CYS . 0.0 OUTLIER 98.42 162.78 0.01 OUTLIER 'General case' 0 N--CA 1.472 0.64 0 O-C-N 125.08 1.488 . . . . 1.0 111.434 178.232 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 48' ' ' CYS . . . . . 0.756 ' SG ' ' O ' ' A' ' 47' ' ' ARG . 7.0 p 56.66 72.08 0.53 Allowed 'General case' 0 C--O 1.202 -1.416 0 O-C-N 125.081 1.488 . . . . 1.0 110.567 -177.591 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 49' ' ' ASN . . . . . 0.697 ' O ' ' N ' ' A' ' 51' ' ' GLU . 0.5 OUTLIER -144.66 155.45 56.53 Favored Pre-proline 0 N--CA 1.474 0.728 0 CA-C-O 118.753 -0.642 . . . . 1.0 110.438 179.752 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 50' ' ' PRO . . . . . 0.475 ' C ' ' H ' ' A' ' 52' ' ' ARG . 53.9 Cg_exo -51.8 57.75 0.02 OUTLIER 'Trans proline' 0 N--CA 1.509 2.419 0 C-N-CA 122.688 2.259 . . . . 1.0 112.138 177.775 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 51' ' ' GLU . . . . . 0.697 ' N ' ' O ' ' A' ' 49' ' ' ASN . 59.2 mm-40 47.93 13.56 0.04 OUTLIER 'General case' 0 C--N 1.321 -0.658 0 N-CA-C 110.029 -0.36 . . . . 1.0 110.029 -179.129 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 52' ' ' ARG . . . . . 0.639 HH11 ' CE1' ' A' ' 92' ' ' HIS . 23.5 mtm-85 -100.08 142.86 30.99 Favored 'General case' 0 N--CA 1.475 0.806 0 CA-C-O 121.204 0.526 . . . . 1.0 112.052 -179.857 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 9.6 tp -53.29 135.89 14.92 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.648 0 CA-C-O 124.426 2.06 . . . . 1.0 114.579 -178.661 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -88.62 88.02 7.47 Favored 'General case' 0 C--N 1.312 -1.022 0 CA-C-N 110.063 -3.244 . . . . 1.0 113.643 179.567 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 18.6 tt -144.47 153.34 15.06 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.67 0 CA-C-N 115.478 -0.783 . . . . 1.0 109.678 177.273 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 107.76 3.1 34.61 Favored Glycine 0 C--N 1.348 1.226 0 N-CA-C 110.878 -0.889 . . . . 1.0 110.878 -179.891 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 57' ' ' ASP . . . . . 0.56 ' OD2' ' NH1' ' A' ' 43' ' ' ARG . 5.6 p-10 -86.88 103.38 15.22 Favored 'General case' 0 CA--C 1.533 0.292 0 CA-C-O 122.185 0.993 . . . . 1.0 112.651 -178.834 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 58' ' ' TRP . . . . . . . . . . . . . 38.4 m0 -81.39 -177.97 6.73 Favored 'General case' 0 N--CA 1.47 0.563 0 CA-C-N 114.023 -1.444 . . . . 1.0 108.154 178.205 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 59' ' ' ARG . . . . . 0.659 ' HD2' ' H ' ' A' ' 59' ' ' ARG . 0.0 OUTLIER -101.85 -54.86 2.63 Favored 'General case' 0 CA--C 1.56 1.359 0 CA-C-N 121.91 2.141 . . . . 1.0 110.74 179.676 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 60' ' ' TYR . . . . . 0.517 ' H ' ' HD2' ' A' ' 59' ' ' ARG . 93.2 t80 -79.45 -14.34 58.98 Favored 'General case' 0 N--CA 1.485 1.305 0 C-N-CA 125.723 1.609 . . . . 1.0 112.225 -178.283 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 31.9 tt0 -70.77 -14.11 62.31 Favored 'General case' 0 C--N 1.304 -1.387 0 N-CA-C 108.635 -0.876 . . . . 1.0 108.635 -179.874 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 62' ' ' VAL . . . . . 0.518 HG13 ' O ' ' A' ' 59' ' ' ARG . 13.4 m -45.7 -53.07 2.29 Favored 'Isoleucine or valine' 0 CA--C 1.493 -1.244 0 CA-C-N 115.811 -0.632 . . . . 1.0 109.972 -174.495 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 63' ' ' ALA . . . . . 0.85 ' O ' ' HD2' ' A' ' 67' ' ' ARG . . . -65.2 -50.39 66.06 Favored 'General case' 0 N--CA 1.415 -2.189 0 N-CA-C 108.943 -0.762 . . . . 1.0 108.943 179.364 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -51.03 -59.39 4.21 Favored 'General case' 0 CA--C 1.548 0.904 0 C-N-CA 119.795 -0.762 . . . . 1.0 110.715 -179.996 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 65' ' ' ASP . . . . . 0.6 ' C ' ' H ' ' A' ' 67' ' ' ARG . 28.9 t70 -64.79 -50.34 67.16 Favored 'General case' 0 C--O 1.241 0.632 0 CA-C-O 121.694 0.759 . . . . 1.0 109.704 178.371 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 66' ' ' GLY . . . . . 0.416 ' N ' ' O ' ' A' ' 62' ' ' VAL . . . -61.34 29.53 0.05 OUTLIER Glycine 0 CA--C 1.535 1.325 0 O-C-N 121.801 -0.562 . . . . 1.0 112.016 178.106 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 67' ' ' ARG . . . . . 0.85 ' HD2' ' O ' ' A' ' 63' ' ' ALA . 0.0 OUTLIER -79.58 -2.84 44.29 Favored 'General case' 0 CA--C 1.5 -0.946 0 CA-C-O 118.632 -0.699 . . . . 1.0 109.371 175.206 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 68' ' ' LEU . . . . . 0.555 ' O ' ' CG ' ' A' ' 72' ' ' HIS . 11.1 mp -33.94 -28.06 0.01 OUTLIER 'General case' 0 N--CA 1.486 1.327 0 N-CA-C 107.023 -1.473 . . . . 1.0 107.023 -179.012 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 69' ' ' LEU . . . . . 0.674 ' N ' ' O ' ' A' ' 67' ' ' ARG . 3.4 tt -64.83 -64.23 0.92 Allowed 'General case' 0 CA--C 1.548 0.898 0 N-CA-C 106.572 -1.64 . . . . 1.0 106.572 175.573 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 70' ' ' ALA . . . . . 0.68 ' C ' ' H ' ' A' ' 72' ' ' HIS . . . -78.76 -73.53 0.32 Allowed 'General case' 0 N--CA 1.478 0.948 0 N-CA-C 107.828 -1.175 . . . . 1.0 107.828 177.865 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 71' ' ' ALA . . . . . 0.735 ' H ' ' HB3' ' A' ' 67' ' ' ARG . . . -46.23 2.34 0.0 OUTLIER 'General case' 0 N--CA 1.469 0.499 0 C-N-CA 124.435 1.094 . . . . 1.0 112.747 178.402 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 72' ' ' HIS . . . . . 0.68 ' H ' ' C ' ' A' ' 70' ' ' ALA . 0.2 OUTLIER -20.02 -70.53 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.227 0 C-N-CA 123.179 0.592 . . . . 1.0 111.139 -177.993 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 73' ' ' MET . . . . . . . . . . . . . 16.4 mtm -73.9 -47.63 36.55 Favored 'General case' 0 C--N 1.31 -1.131 0 C-N-CA 118.967 -1.093 . . . . 1.0 109.611 177.149 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 74' ' ' VAL . . . . . 0.577 ' O ' ' N ' ' A' ' 76' ' ' GLY . 24.4 t -46.68 -48.98 6.94 Favored 'Isoleucine or valine' 0 C--N 1.344 0.354 0 CA-C-O 118.456 -0.783 . . . . 1.0 110.958 -176.599 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 75' ' ' ASN . . . . . 0.888 ' O ' HG22 ' A' ' 78' ' ' VAL . 15.4 t30 -39.18 -21.56 0.01 OUTLIER 'General case' 0 C--N 1.352 0.705 0 CA-C-O 122.895 1.331 . . . . 1.0 110.435 177.401 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 76' ' ' GLY . . . . . 0.577 ' N ' ' O ' ' A' ' 74' ' ' VAL . . . -42.31 -19.89 0.06 OUTLIER Glycine 0 CA--C 1.539 1.533 0 CA-C-N 113.55 -1.659 . . . . 1.0 109.248 178.864 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 77' ' ' ILE . . . . . 0.689 ' O ' ' N ' ' A' ' 80' ' ' ALA . 7.7 pt -71.24 -45.41 70.71 Favored 'Isoleucine or valine' 0 C--O 1.207 -1.174 0 CA-C-O 122.01 0.91 . . . . 1.0 109.458 -179.341 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 78' ' ' VAL . . . . . 0.888 HG22 ' O ' ' A' ' 75' ' ' ASN . 26.8 m -35.21 -32.43 0.04 OUTLIER 'Isoleucine or valine' 0 CA--C 1.556 1.178 0 CA-C-N 113.058 -1.883 . . . . 1.0 107.359 -176.483 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 79' ' ' ILE . . . . . 0.529 ' N ' ' O ' ' A' ' 77' ' ' ILE . 1.1 pp -92.94 -26.97 4.66 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 CA-C-O 121.511 0.672 . . . . 1.0 111.571 177.525 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 80' ' ' ALA . . . . . 0.689 ' N ' ' O ' ' A' ' 77' ' ' ILE . . . -87.24 -18.78 29.46 Favored 'General case' 0 CA--C 1.55 0.949 0 N-CA-C 113.35 0.87 . . . . 1.0 113.35 178.976 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 81' ' ' GLU . . . . . 0.424 ' N ' ' O ' ' A' ' 77' ' ' ILE . 9.3 mm-40 -82.46 -71.87 0.47 Allowed 'General case' 0 N--CA 1.45 -0.426 0 C-N-CA 122.667 0.387 . . . . 1.0 110.169 -179.908 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 82' ' ' ASP . . . . . 0.549 ' O ' ' N ' ' A' ' 84' ' ' LEU . 92.9 m-20 -66.42 -16.81 64.39 Favored 'General case' 0 N--CA 1.444 -0.761 0 CA-C-O 119.09 -0.481 . . . . 1.0 110.261 -179.382 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 83' ' ' ALA . . . . . 0.501 ' O ' ' N ' ' A' ' 86' ' ' ALA . . . -15.19 -50.09 0.0 OUTLIER 'General case' 0 C--N 1.355 0.811 0 N-CA-C 113.04 0.755 . . . . 1.0 113.04 178.05 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 84' ' ' LEU . . . . . 0.549 ' N ' ' O ' ' A' ' 82' ' ' ASP . 0.2 OUTLIER -27.58 -50.78 0.06 Allowed 'General case' 0 C--N 1.355 0.827 0 N-CA-C 113.046 0.758 . . . . 1.0 113.046 -177.057 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 19.9 pt -85.57 -37.78 12.32 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.664 0 N-CA-C 109.584 -0.524 . . . . 1.0 109.584 179.235 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 86' ' ' ALA . . . . . 0.682 ' O ' ' N ' ' A' ' 88' ' ' ALA . . . -47.46 -54.86 10.31 Favored 'General case' 0 CA--C 1.518 -0.287 0 C-N-CA 120.329 -0.548 . . . . 1.0 110.333 -179.341 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 87' ' ' GLU . . . . . 0.573 ' C ' ' H ' ' A' ' 89' ' ' VAL . 0.5 OUTLIER -38.21 -14.81 0.01 OUTLIER 'General case' 0 CA--C 1.539 0.525 0 CA-C-N 117.768 0.258 . . . . 1.0 111.214 -179.686 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 88' ' ' ALA . . . . . 0.682 ' N ' ' O ' ' A' ' 86' ' ' ALA . . . -54.8 -5.26 0.08 Allowed 'General case' 0 C--O 1.218 -0.577 0 N-CA-C 108.811 -0.811 . . . . 1.0 108.811 177.213 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 89' ' ' VAL . . . . . 0.573 ' H ' ' C ' ' A' ' 87' ' ' GLU . 4.4 m -33.13 -31.53 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.551 0.991 0 CA-C-O 121.099 0.476 . . . . 1.0 110.787 -177.591 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 90' ' ' GLY . . . . . 0.523 ' N ' ' O ' ' A' ' 88' ' ' ALA . . . -49.33 -75.2 0.21 Allowed Glycine 0 CA--C 1.549 2.2 0 C-N-CA 119.889 -1.148 . . . . 1.0 111.21 -178.734 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 91' ' ' PRO . . . . . 0.473 ' HD2' ' O ' ' A' ' 88' ' ' ALA . 9.9 Cg_endo -52.05 -28.88 34.14 Favored 'Trans proline' 0 N--CA 1.504 2.114 0 C-N-CA 122.955 2.437 . . . . 1.0 111.229 176.663 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 92' ' ' HIS . . . . . 0.639 ' CE1' HH11 ' A' ' 52' ' ' ARG . 26.9 m80 -54.14 -19.37 4.91 Favored 'General case' 0 CA--C 1.514 -0.424 0 N-CA-C 107.4 -1.333 . . . . 1.0 107.4 -176.473 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 93' ' ' LEU . . . . . 0.549 ' O ' ' N ' ' A' ' 96' ' ' ALA . 20.7 tp -57.03 -49.98 74.13 Favored 'General case' 0 N--CA 1.45 -0.425 0 N-CA-C 106.59 -1.633 . . . . 1.0 106.59 176.797 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -49.13 -51.9 29.36 Favored 'General case' 0 CA--C 1.517 -0.301 0 N-CA-C 106.662 -1.607 . . . . 1.0 106.662 -179.352 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 3.0 mmt180 -61.03 -32.13 71.75 Favored 'General case' 0 C--N 1.316 -0.849 0 N-CA-C 108.622 -0.881 . . . . 1.0 108.622 177.191 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 96' ' ' ALA . . . . . 0.777 ' O ' ' N ' ' A' ' 100' ' ' ILE . . . -55.82 -51.44 67.47 Favored 'General case' 0 C--O 1.199 -1.556 0 C-N-CA 118.817 -1.153 . . . . 1.0 107.918 -178.947 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 97' ' ' LEU . . . . . 0.466 ' C ' ' O ' ' A' ' 96' ' ' ALA . 0.2 OUTLIER -34.15 -26.15 0.01 OUTLIER 'General case' 0 CA--C 1.587 2.399 0 N-CA-C 107.58 -1.267 . . . . 1.0 107.58 -178.325 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 98' ' ' GLY . . . . . 0.659 ' N ' ' O ' ' A' ' 96' ' ' ALA . . . -86.48 -52.77 3.1 Favored Glycine 0 CA--C 1.546 1.981 0 CA-C-O 123.967 1.871 . . . . 1.0 110.617 173.963 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 99' ' ' GLN . . . . . 0.612 ' N ' ' O ' ' A' ' 96' ' ' ALA . 24.6 tt0 -76.97 7.56 4.74 Favored 'General case' 0 N--CA 1.418 -2.047 0 N-CA-C 107.837 -1.171 . . . . 1.0 107.837 177.177 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 100' ' ' ILE . . . . . 0.777 ' N ' ' O ' ' A' ' 96' ' ' ALA . 6.8 tp -62.48 -47.91 90.77 Favored 'Isoleucine or valine' 0 CA--C 1.481 -1.678 0 N-CA-C 108.66 -0.867 . . . . 1.0 108.66 179.82 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 101' ' ' VAL . . . . . 0.57 ' N ' ' CG2' ' A' ' 100' ' ' ILE . 46.3 t -53.57 -59.92 1.61 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.622 0 C-N-CA 117.352 -1.739 . . . . 1.0 108.341 179.095 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 102' ' ' CYS . . . . . 0.687 ' O ' ' HB2' ' A' ' 106' ' ' ALA . 0.0 OUTLIER -52.41 -31.7 35.52 Favored 'General case' 0 CA--C 1.545 0.767 0 C-N-CA 119.831 -0.748 . . . . 1.0 111.215 -176.743 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 103' ' ' ARG . . . . . 0.431 ' NH2' ' CB ' ' A' ' 96' ' ' ALA . 11.8 ttp180 -82.15 -47.89 11.98 Favored 'General case' 0 N--CA 1.494 1.759 0 CA-C-O 122.287 1.041 . . . . 1.0 113.014 178.666 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 104' ' ' TYR . . . . . 0.439 ' CD2' ' O ' ' A' ' 104' ' ' TYR . 50.6 t80 -92.08 22.73 4.17 Favored 'General case' 0 C--N 1.29 -1.98 0 CA-C-N 113.653 -1.612 . . . . 1.0 108.502 178.802 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 105' ' ' GLY . . . . . 0.527 ' N ' ' O ' ' A' ' 101' ' ' VAL . . . -159.81 -86.98 0.06 OUTLIER Glycine 0 CA--C 1.526 0.779 0 N-CA-C 110.337 -1.105 . . . . 1.0 110.337 178.618 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 106' ' ' ALA . . . . . 0.687 ' HB2' ' O ' ' A' ' 102' ' ' CYS . . . 57.13 106.65 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.17 0 N-CA-C 109.22 -0.659 . . . . 1.0 109.22 -177.117 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 107' ' ' THR . . . . . 0.633 ' O ' ' CD ' ' A' ' 110' ' ' PRO . 26.0 m -134.24 -60.59 0.8 Allowed 'General case' 0 C--O 1.205 -1.276 0 CA-C-O 118.606 -0.711 . . . . 1.0 110.076 179.086 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 108' ' ' VAL . . . . . 0.65 ' O ' HG22 ' A' ' 108' ' ' VAL . 12.3 p -82.83 34.97 0.04 OUTLIER 'Isoleucine or valine' 0 C--O 1.235 0.29 0 C-N-CA 123.659 0.784 . . . . 1.0 111.265 -175.812 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 109' ' ' ILE . . . . . 0.665 ' N ' ' CD ' ' A' ' 110' ' ' PRO . 31.5 pt -104.7 -22.87 0.19 Allowed Pre-proline 0 CA--C 1.568 1.641 0 CA-C-N 115.876 -0.602 . . . . 1.0 111.363 177.55 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 110' ' ' PRO . . . . . 0.665 ' CD ' ' N ' ' A' ' 109' ' ' ILE . 71.6 Cg_endo -73.14 -15.66 25.6 Favored 'Trans proline' 0 N--CA 1.483 0.883 0 C-N-CA 123.292 2.661 . . . . 1.0 113.674 -177.402 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 24.2 t-20 -61.72 -69.2 0.26 Allowed 'General case' 0 C--O 1.237 0.401 0 C-N-CA 120.357 -0.537 . . . . 1.0 110.472 -177.941 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 112' ' ' ILE . . . . . 0.472 HG21 ' HA3' ' A' ' 35' ' ' GLY . 0.0 OUTLIER -65.53 -28.68 44.92 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.413 0 CA-C-O 122.015 0.912 . . . . 1.0 109.996 179.614 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 113' ' ' ASN . . . . . 0.487 ' O ' ' OE1' ' A' ' 117' ' ' GLU . 42.1 t30 -55.16 -63.86 1.02 Allowed 'General case' 0 C--N 1.306 -1.32 0 CA-C-N 115.062 -0.972 . . . . 1.0 110.519 -176.738 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -61.49 -23.06 65.63 Favored 'General case' 0 C--N 1.31 -1.132 0 C-N-CA 120.788 -0.365 . . . . 1.0 111.383 179.832 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 115' ' ' ALA . . . . . 0.475 ' O ' HG12 ' A' ' 118' ' ' VAL . . . -79.34 -60.01 2.54 Favored 'General case' 0 CA--C 1.536 0.433 0 N-CA-C 112.485 0.55 . . . . 1.0 112.485 178.733 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 116' ' ' ILE . . . . . 0.549 ' O ' ' N ' ' A' ' 119' ' ' LEU . 3.3 mm -70.3 -49.11 56.74 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.365 0 O-C-N 121.102 -0.999 . . . . 1.0 112.187 -177.982 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 117' ' ' GLU . . . . . 0.612 ' N ' ' OE1' ' A' ' 117' ' ' GLU . 10.3 mp0 -46.96 -61.55 1.82 Allowed 'General case' 0 C--N 1.317 -0.846 0 N-CA-C 108.728 -0.841 . . . . 1.0 108.728 -176.815 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 118' ' ' VAL . . . . . 0.475 HG12 ' O ' ' A' ' 115' ' ' ALA . 2.0 p -51.9 -16.35 0.64 Allowed 'Isoleucine or valine' 0 N--CA 1.443 -0.797 0 C-N-CA 119.896 -0.721 . . . . 1.0 109.078 179.157 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 119' ' ' LEU . . . . . 0.549 ' N ' ' O ' ' A' ' 116' ' ' ILE . 0.3 OUTLIER -78.39 -60.45 2.37 Favored 'General case' 0 C--N 1.356 0.87 0 N-CA-C 108.808 -0.812 . . . . 1.0 108.808 176.802 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -68.29 -83.07 0.15 Allowed Glycine 0 C--N 1.367 2.251 0 C-N-CA 116.759 -2.639 . . . . 1.0 110.747 178.671 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 121' ' ' THR . . . . . 0.441 ' OG1' ' NE2' ' A' ' 72' ' ' HIS . 13.3 m -159.75 -18.83 0.06 Allowed 'General case' 0 N--CA 1.475 0.801 0 CA-C-O 122.107 0.956 . . . . 1.0 109.307 -179.645 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 122' ' ' GLY . . . . . 0.45 ' O ' ' C ' ' A' ' 123' ' ' THR . . . 111.48 -36.73 4.04 Favored Glycine 0 CA--C 1.523 0.588 0 CA-C-N 113.365 -1.743 . . . . 1.0 112.098 179.733 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 123' ' ' THR . . . . . 0.45 ' C ' ' O ' ' A' ' 122' ' ' GLY . 91.1 m -31.4 95.15 0.01 OUTLIER 'General case' 0 N--CA 1.477 0.904 0 CA-C-N 118.913 1.356 . . . . 1.0 112.369 -178.267 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 124' ' ' ASP . . . . . 0.406 ' N ' ' O ' ' A' ' 122' ' ' GLY . 0.0 OUTLIER -146.02 144.6 30.19 Favored 'General case' 0 C--N 1.347 0.494 0 N-CA-C 108.259 -1.015 . . . . 1.0 108.259 178.596 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 125' ' ' TYR . . . . . 0.451 ' O ' ' NE ' ' A' ' 126' ' ' ARG . 1.1 p90 -149.57 148.79 29.76 Favored 'General case' 0 C--N 1.325 -0.498 0 N-CA-C 109.951 -0.389 . . . . 1.0 109.951 179.817 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 126' ' ' ARG . . . . . 0.574 ' HA ' ' HE ' ' A' ' 126' ' ' ARG . 0.0 OUTLIER -146.73 149.48 33.49 Favored 'General case' 0 N--CA 1.465 0.302 0 N-CA-C 109.2 -0.667 . . . . 1.0 109.2 177.081 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 127' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.222 -0.389 0 CA-C-O 117.998 -1.001 . . . . 1.0 111.057 -178.507 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.492 1.633 0 N-CA-C 109.219 -0.66 . . . . 1.0 109.219 . . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 2' ' ' SER . . . . . 0.462 ' O ' ' CG ' ' A' ' 3' ' ' ASP . 86.7 p -89.19 4.48 48.47 Favored 'General case' 0 N--CA 1.463 0.212 0 CA-C-N 115.97 -0.559 . . . . 1.0 111.338 -179.56 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 3' ' ' ASP . . . . . 0.462 ' CG ' ' O ' ' A' ' 2' ' ' SER . 11.4 m-20 160.39 118.46 0.0 OUTLIER 'General case' 0 N--CA 1.465 0.316 0 O-C-N 123.578 0.549 . . . . 1.0 110.833 179.44 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 4' ' ' PHE . . . . . 0.443 ' O ' ' OD1' ' A' ' 5' ' ' ASP . 72.9 t80 -149.79 145.57 26.69 Favored 'General case' 0 CA--C 1.518 -0.261 0 N-CA-C 109.073 -0.714 . . . . 1.0 109.073 178.027 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 5' ' ' ASP . . . . . 0.443 ' OD1' ' O ' ' A' ' 4' ' ' PHE . 72.0 m-20 -149.92 146.5 27.1 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.963 -0.562 . . . . 1.0 110.472 -179.054 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 6' ' ' THR . . . . . 0.696 ' O ' ' N ' ' A' ' 10' ' ' SER . 0.2 OUTLIER -114.31 -156.23 0.59 Allowed 'General case' 0 C--O 1.206 -1.219 0 CA-C-O 121.699 0.762 . . . . 1.0 110.245 179.291 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 7' ' ' GLU . . . . . 0.503 ' O ' ' CB ' ' A' ' 11' ' ' ARG . 10.5 tm-20 -57.04 -48.37 78.68 Favored 'General case' 0 C--N 1.306 -1.323 0 O-C-N 121.67 -0.643 . . . . 1.0 110.361 -178.443 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 8' ' ' ARG . . . . . 0.849 ' O ' ' HB3' ' A' ' 12' ' ' ALA . 39.1 ttm180 -67.28 -58.23 5.21 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-O 122.046 0.927 . . . . 1.0 109.781 178.506 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 9' ' ' VAL . . . . . 0.65 ' O ' ' HB ' ' A' ' 13' ' ' VAL . 0.2 OUTLIER -65.2 -51.16 68.76 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.847 0 CA-C-N 114.64 -1.163 . . . . 1.0 109.456 -178.243 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 10' ' ' SER . . . . . 0.697 ' O ' ' HB3' ' A' ' 14' ' ' ALA . 1.1 m -69.43 -64.07 0.95 Allowed 'General case' 0 C--N 1.302 -1.462 0 O-C-N 120.78 -1.2 . . . . 1.0 111.325 178.801 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 11' ' ' ARG . . . . . 0.741 ' O ' ' HB3' ' A' ' 15' ' ' ALA . 30.5 ttm-85 -63.97 -48.65 75.63 Favored 'General case' 0 N--CA 1.472 0.633 0 O-C-N 121.396 -0.815 . . . . 1.0 112.735 -176.206 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 12' ' ' ALA . . . . . 0.849 ' HB3' ' O ' ' A' ' 8' ' ' ARG . . . -70.03 -58.61 3.63 Favored 'General case' 0 N--CA 1.472 0.663 0 C-N-CA 118.96 -1.096 . . . . 1.0 109.284 178.286 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 13' ' ' VAL . . . . . 0.722 ' O ' ' HB3' ' A' ' 17' ' ' LEU . 1.0 OUTLIER -63.18 -54.08 37.78 Favored 'Isoleucine or valine' 0 C--O 1.195 -1.788 0 C-N-CA 117.773 -1.571 . . . . 1.0 108.921 -179.662 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 14' ' ' ALA . . . . . 0.946 ' O ' HG22 ' A' ' 18' ' ' VAL . . . -63.48 -62.87 1.39 Allowed 'General case' 0 N--CA 1.48 1.073 0 C-N-CA 117.123 -1.831 . . . . 1.0 111.353 179.888 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 15' ' ' ALA . . . . . 0.741 ' HB3' ' O ' ' A' ' 11' ' ' ARG . . . -54.93 -55.98 24.61 Favored 'General case' 0 N--CA 1.485 1.286 0 C-N-CA 118.877 -1.129 . . . . 1.0 111.311 -177.327 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 16' ' ' ALA . . . . . 0.761 ' HB3' ' O ' ' A' ' 12' ' ' ALA . . . -66.06 -57.16 8.34 Favored 'General case' 0 CA--C 1.548 0.874 0 C-N-CA 119.589 -0.844 . . . . 1.0 109.935 -178.425 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 17' ' ' LEU . . . . . 0.722 ' HB3' ' O ' ' A' ' 13' ' ' VAL . 7.0 tt -56.29 -54.07 49.77 Favored 'General case' 0 N--CA 1.483 1.206 0 CA-C-N 115.065 -0.97 . . . . 1.0 108.421 -178.224 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 18' ' ' VAL . . . . . 0.946 HG22 ' O ' ' A' ' 14' ' ' ALA . 1.8 m -71.14 -57.81 6.71 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.602 0 C-N-CA 119.307 -0.957 . . . . 1.0 110.169 179.868 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 19' ' ' GLY . . . . . 0.539 ' N ' ' O ' ' A' ' 15' ' ' ALA . . . -57.88 -171.54 0.25 Allowed Glycine 0 N--CA 1.448 -0.526 0 N-CA-C 111.17 -0.772 . . . . 1.0 111.17 -177.911 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 20' ' ' PRO . . . . . 0.585 ' O ' ' N ' ' A' ' 24' ' ' ALA . 89.8 Cg_endo -81.76 -24.51 4.12 Favored 'Trans proline' 0 C--N 1.298 -2.1 0 C-N-CA 122.691 2.261 . . . . 1.0 113.276 -178.583 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 21' ' ' GLY . . . . . 0.445 ' O ' ' HB3' ' A' ' 24' ' ' ALA . . . -63.96 -61.89 5.71 Favored Glycine 0 N--CA 1.484 1.856 0 C-N-CA 119.237 -1.458 . . . . 1.0 111.981 -176.992 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 22' ' ' GLY . . . . . 0.512 ' H ' ' HA ' ' A' ' 16' ' ' ALA . . . -53.01 -51.83 43.55 Favored Glycine 0 N--CA 1.47 0.927 0 N-CA-C 106.212 -2.755 . . . . 1.0 106.212 179.69 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 34.3 t -56.88 -30.74 34.12 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.733 0 N-CA-C 108.832 -0.803 . . . . 1.0 108.832 178.332 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 24' ' ' ALA . . . . . 0.585 ' N ' ' O ' ' A' ' 20' ' ' PRO . . . -58.22 -61.37 2.62 Favored 'General case' 0 C--N 1.352 0.706 0 C-N-CA 118.354 -1.339 . . . . 1.0 109.499 179.638 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 25' ' ' LEU . . . . . 0.516 ' N ' HD12 ' A' ' 25' ' ' LEU . 9.0 mp -57.59 -44.27 85.24 Favored 'General case' 0 C--O 1.223 -0.315 0 C-N-CA 119.629 -0.829 . . . . 1.0 110.341 -177.893 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 65.5 t -58.6 -60.33 2.46 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.861 0 C-N-CA 119.087 -1.045 . . . . 1.0 111.053 -178.61 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 27' ' ' VAL . . . . . 0.553 ' O ' ' HB3' ' A' ' 31' ' ' ALA . 18.1 t -58.51 -41.83 82.88 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.231 0 N-CA-C 112.843 0.683 . . . . 1.0 112.843 -177.64 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 28' ' ' LYS . . . . . 0.616 ' NZ ' HG23 ' A' ' 29' ' ' VAL . 3.9 pptp? -68.33 -54.41 17.56 Favored 'General case' 0 C--N 1.325 -0.459 0 C-N-CA 119.078 -1.049 . . . . 1.0 109.966 -178.027 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 29' ' ' VAL . . . . . 0.616 HG23 ' NZ ' ' A' ' 28' ' ' LYS . 1.3 t -60.58 -50.71 79.32 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.6 0 C-N-CA 119.748 -0.781 . . . . 1.0 110.576 179.862 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 30' ' ' CYS . . . . . . . . . . . . . 8.6 t -65.14 -63.1 1.19 Allowed 'General case' 0 N--CA 1.447 -0.6 0 C-N-CA 119.425 -0.91 . . . . 1.0 110.51 -179.184 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 31' ' ' ALA . . . . . 0.553 ' HB3' ' O ' ' A' ' 27' ' ' VAL . . . -56.19 -50.38 71.39 Favored 'General case' 0 CA--C 1.517 -0.323 0 C-N-CA 120.3 -0.56 . . . . 1.0 111.168 -177.53 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 32' ' ' GLY . . . . . 0.45 ' O ' ' HB2' ' A' ' 33' ' ' LEU . . . 74.3 70.44 1.25 Allowed Glycine 0 N--CA 1.45 -0.43 0 N-CA-C 108.621 -1.791 . . . . 1.0 108.621 -178.182 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 33' ' ' LEU . . . . . 0.45 ' HB2' ' O ' ' A' ' 32' ' ' GLY . 0.1 OUTLIER 84.75 93.8 0.04 OUTLIER Pre-proline 0 CA--C 1.55 0.968 0 O-C-N 124.477 0.751 . . . . 1.0 109.657 -178.286 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 74.7 Cg_exo -45.69 -13.55 0.08 OUTLIER 'Trans proline' 0 N--CA 1.491 1.378 0 C-N-CA 121.919 1.746 . . . . 1.0 113.634 -179.56 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 35' ' ' GLY . . . . . 0.433 ' N ' ' O ' ' A' ' 33' ' ' LEU . . . -62.81 -61.85 6.07 Favored Glycine 0 N--CA 1.471 0.989 0 C-N-CA 118.885 -1.626 . . . . 1.0 110.422 -178.263 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 36' ' ' VAL . . . . . 0.762 ' O ' HG22 ' A' ' 37' ' ' ILE . 34.3 m -76.94 -147.01 0.01 OUTLIER 'Isoleucine or valine' 0 C--O 1.213 -0.858 0 N-CA-C 107.58 -1.267 . . . . 1.0 107.58 178.431 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 37' ' ' ILE . . . . . 0.762 HG22 ' O ' ' A' ' 36' ' ' VAL . 0.3 OUTLIER 71.93 75.4 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.474 0.741 0 CA-C-O 122.993 1.378 . . . . 1.0 111.675 179.934 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 53.8 m-70 -137.75 131.97 32.06 Favored 'General case' 0 C--N 1.327 -0.376 0 O-C-N 120.707 -1.246 . . . . 1.0 109.103 178.997 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 39' ' ' THR . . . . . 0.406 HG23 ' O ' ' A' ' 39' ' ' THR . 1.7 t -128.65 112.99 19.19 Favored Pre-proline 0 CA--C 1.542 0.642 0 N-CA-C 109.015 -0.735 . . . . 1.0 109.015 179.745 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 40' ' ' PRO . . . . . 0.547 ' O ' ' NE ' ' A' ' 42' ' ' ARG . 83.8 Cg_exo -42.63 -68.05 0.11 Allowed 'Trans proline' 0 N--CA 1.49 1.293 0 C-N-CA 121.542 1.495 . . . . 1.0 112.569 -178.673 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -74.7 128.02 34.54 Favored 'General case' 0 C--N 1.316 -0.889 0 CA-C-N 115.173 -0.921 . . . . 1.0 111.244 -177.694 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 42' ' ' ARG . . . . . 0.643 ' C ' ' H ' ' A' ' 44' ' ' GLY . 0.1 OUTLIER -173.78 175.44 2.89 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 114.859 -1.064 . . . . 1.0 110.726 179.631 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 43' ' ' ARG . . . . . 0.573 ' C ' ' H ' ' A' ' 45' ' ' PHE . 25.3 tpt180 -63.51 19.11 0.01 OUTLIER 'General case' 0 CA--C 1.549 0.905 0 CA-C-O 121.254 0.549 . . . . 1.0 109.927 178.532 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 44' ' ' GLY . . . . . 0.643 ' H ' ' C ' ' A' ' 42' ' ' ARG . . . 69.93 -27.94 0.41 Allowed Glycine 0 C--N 1.342 0.906 0 N-CA-C 110.66 -0.976 . . . . 1.0 110.66 -179.715 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 45' ' ' PHE . . . . . 0.668 ' O ' ' HB2' ' A' ' 46' ' ' PHE . 1.1 p90 -159.79 161.01 34.52 Favored 'General case' 0 C--N 1.326 -0.415 0 N-CA-C 109.022 -0.733 . . . . 1.0 109.022 179.77 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 46' ' ' PHE . . . . . 0.668 ' HB2' ' O ' ' A' ' 45' ' ' PHE . 0.7 OUTLIER 131.87 94.35 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.506 0 O-C-N 125.414 1.696 . . . . 1.0 109.604 179.153 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 47' ' ' ARG . . . . . 0.581 ' CB ' ' O ' ' A' ' 46' ' ' PHE . 0.0 OUTLIER 112.58 143.14 0.0 OUTLIER 'General case' 0 N--CA 1.48 1.072 0 O-C-N 124.415 1.072 . . . . 1.0 111.709 178.229 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 35.8 t 66.96 73.18 0.35 Allowed 'General case' 0 C--O 1.22 -0.463 0 O-C-N 124.317 1.011 . . . . 1.0 110.579 179.257 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 49' ' ' ASN . . . . . 0.528 ' C ' HD22 ' A' ' 49' ' ' ASN . 0.4 OUTLIER -136.44 153.89 76.54 Favored Pre-proline 0 CA--C 1.536 0.435 0 N-CA-C 109.863 -0.421 . . . . 1.0 109.863 -179.19 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 50' ' ' PRO . . . . . 0.534 ' C ' ' H ' ' A' ' 52' ' ' ARG . 27.9 Cg_endo -58.64 56.67 0.06 OUTLIER 'Trans proline' 0 N--CA 1.51 2.455 0 C-N-CA 123.219 2.612 . . . . 1.0 113.516 179.931 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 51' ' ' GLU . . . . . 0.558 ' OE1' ' ND1' ' A' ' 92' ' ' HIS . 49.1 mt-10 63.85 -34.44 0.14 Allowed 'General case' 0 N--CA 1.47 0.541 0 CA-C-N 116.129 -0.487 . . . . 1.0 111.984 179.855 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 52' ' ' ARG . . . . . 0.534 ' H ' ' C ' ' A' ' 50' ' ' PRO . 75.7 mtt85 -45.9 136.3 6.5 Favored 'General case' 0 C--N 1.325 -0.468 0 N-CA-C 109.588 -0.523 . . . . 1.0 109.588 179.696 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 53' ' ' ILE . . . . . 0.607 ' O ' ' N ' ' A' ' 55' ' ' ILE . 3.0 tp -49.73 125.56 3.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 N-CA-C 109.615 -0.513 . . . . 1.0 109.615 -178.713 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -57.17 80.37 0.01 OUTLIER 'General case' 0 C--N 1.322 -0.588 0 CA-C-O 121.931 0.872 . . . . 1.0 109.054 -177.393 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 55' ' ' ILE . . . . . 0.607 ' N ' ' O ' ' A' ' 53' ' ' ILE . 3.3 tt -155.12 165.01 1.26 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.249 0 CA-C-N 114.687 -1.142 . . . . 1.0 111.449 178.501 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 105.55 -28.83 12.77 Favored Glycine 0 C--O 1.226 -0.405 0 CA-C-N 115.916 -0.584 . . . . 1.0 112.134 176.737 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -52.56 117.61 3.01 Favored 'General case' 0 CA--C 1.537 0.478 0 CA-C-N 118.013 0.906 . . . . 1.0 112.627 -178.783 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 58' ' ' TRP . . . . . 0.447 ' HB2' ' HB3' ' A' ' 61' ' ' GLU . 36.1 m95 -79.83 168.26 19.51 Favored 'General case' 0 CA--C 1.556 1.182 0 CA-C-O 124.214 1.959 . . . . 1.0 111.045 178.649 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 59' ' ' ARG . . . . . 0.545 ' HD3' ' H ' ' A' ' 59' ' ' ARG . 0.0 OUTLIER -86.17 -64.14 1.2 Allowed 'General case' 0 N--CA 1.509 2.518 0 CA-C-N 110.745 -2.934 . . . . 1.0 112.902 -176.989 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 60' ' ' TYR . . . . . 0.415 ' O ' ' CG ' ' A' ' 60' ' ' TYR . 17.5 t80 -88.07 -16.44 33.56 Favored 'General case' 0 N--CA 1.483 1.205 0 N-CA-C 113.171 0.804 . . . . 1.0 113.171 179.728 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 61' ' ' GLU . . . . . 0.531 ' O ' ' N ' ' A' ' 65' ' ' ASP . 11.3 tt0 -79.42 -12.88 59.89 Favored 'General case' 0 C--N 1.313 -1.002 0 O-C-N 121.704 -0.622 . . . . 1.0 109.64 179.941 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 62' ' ' VAL . . . . . 0.557 ' O ' ' N ' ' A' ' 66' ' ' GLY . 12.2 m -45.42 -51.4 2.74 Favored 'Isoleucine or valine' 0 CA--C 1.5 -0.974 0 C-N-CA 120.04 -0.664 . . . . 1.0 110.354 -176.126 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 63' ' ' ALA . . . . . 0.487 ' N ' HG23 ' A' ' 62' ' ' VAL . . . -68.29 -48.35 65.19 Favored 'General case' 0 N--CA 1.426 -1.66 0 C-N-CA 119.752 -0.779 . . . . 1.0 109.325 179.763 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 1.8 t-80 -56.49 -59.65 4.68 Favored 'General case' 0 CA--C 1.545 0.755 0 CA-C-N 115.358 -0.837 . . . . 1.0 110.37 -179.645 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 65' ' ' ASP . . . . . 0.586 ' C ' ' H ' ' A' ' 67' ' ' ARG . 1.0 OUTLIER -69.42 -55.46 10.25 Favored 'General case' 0 CA--C 1.549 0.917 0 CA-C-O 121.976 0.893 . . . . 1.0 109.756 177.767 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 66' ' ' GLY . . . . . 0.557 ' N ' ' O ' ' A' ' 62' ' ' VAL . . . -67.34 33.3 0.2 Allowed Glycine 0 CA--C 1.529 0.939 0 O-C-N 120.726 -1.234 . . . . 1.0 111.227 178.957 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 67' ' ' ARG . . . . . 0.644 ' O ' ' N ' ' A' ' 69' ' ' LEU . 0.8 OUTLIER -77.98 5.93 8.82 Favored 'General case' 0 C--N 1.32 -0.678 0 N-CA-C 108.85 -0.796 . . . . 1.0 108.85 177.045 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 68' ' ' LEU . . . . . 0.506 ' O ' ' HA ' ' A' ' 72' ' ' HIS . 0.3 OUTLIER -32.86 -28.36 0.01 OUTLIER 'General case' 0 N--CA 1.487 1.396 0 N-CA-C 108.226 -1.027 . . . . 1.0 108.226 -177.879 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 69' ' ' LEU . . . . . 0.644 ' N ' ' O ' ' A' ' 67' ' ' ARG . 2.4 mp -64.4 -65.2 0.71 Allowed 'General case' 0 N--CA 1.469 0.488 0 C-N-CA 117.922 -1.511 . . . . 1.0 107.301 177.16 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 70' ' ' ALA . . . . . 0.662 ' C ' ' H ' ' A' ' 72' ' ' HIS . . . -76.09 -72.22 0.34 Allowed 'General case' 0 CA--C 1.51 -0.573 0 N-CA-C 106.157 -1.794 . . . . 1.0 106.157 178.249 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 71' ' ' ALA . . . . . 0.612 ' H ' ' HB3' ' A' ' 67' ' ' ARG . . . -43.87 3.22 0.0 OUTLIER 'General case' 0 N--CA 1.472 0.634 0 C-N-CA 125.135 1.374 . . . . 1.0 113.798 176.897 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 72' ' ' HIS . . . . . 0.786 ' CG ' ' H ' ' A' ' 73' ' ' MET . 2.5 p-80 -19.41 -65.92 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.314 0 N-CA-C 112.728 0.64 . . . . 1.0 112.728 -176.372 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 73' ' ' MET . . . . . 0.786 ' H ' ' CG ' ' A' ' 72' ' ' HIS . 28.1 mtt -76.64 -45.78 28.56 Favored 'General case' 0 N--CA 1.438 -1.059 0 CA-C-N 119.023 0.828 . . . . 1.0 109.22 177.557 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 74' ' ' VAL . . . . . 0.591 ' O ' ' N ' ' A' ' 76' ' ' GLY . 94.5 t -45.27 -50.37 2.9 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.306 0 CA-C-O 118.082 -0.961 . . . . 1.0 109.894 -177.099 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 75' ' ' ASN . . . . . 0.512 ' C ' ' N ' ' A' ' 77' ' ' ILE . 19.0 t-20 -39.44 -21.18 0.01 OUTLIER 'General case' 0 C--N 1.357 0.925 0 CA-C-N 120.312 1.415 . . . . 1.0 110.715 177.346 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 76' ' ' GLY . . . . . 0.591 ' N ' ' O ' ' A' ' 74' ' ' VAL . . . -43.48 -20.95 0.14 Allowed Glycine 0 CA--C 1.534 1.237 0 N-CA-C 108.675 -1.77 . . . . 1.0 108.675 178.934 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 77' ' ' ILE . . . . . 0.772 ' O ' ' N ' ' A' ' 80' ' ' ALA . 96.7 mt -82.43 -50.04 16.49 Favored 'Isoleucine or valine' 0 C--O 1.213 -0.855 0 N-CA-C 108.766 -0.827 . . . . 1.0 108.766 179.421 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 78' ' ' VAL . . . . . 0.467 ' C ' ' O ' ' A' ' 77' ' ' ILE . 43.8 t -35.4 -34.49 0.06 OUTLIER 'Isoleucine or valine' 0 CA--C 1.541 0.603 0 N-CA-C 108.481 -0.933 . . . . 1.0 108.481 -178.254 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 79' ' ' ILE . . . . . 0.744 ' O ' ' HB2' ' A' ' 83' ' ' ALA . 0.1 OUTLIER -88.16 -24.7 6.1 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.602 0 CA-C-O 121.007 0.432 . . . . 1.0 110.104 178.789 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 80' ' ' ALA . . . . . 0.772 ' N ' ' O ' ' A' ' 77' ' ' ILE . . . -89.78 -9.25 49.96 Favored 'General case' 0 CA--C 1.539 0.522 0 C-N-CA 123.843 0.857 . . . . 1.0 111.653 177.061 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 81' ' ' GLU . . . . . 0.62 ' O ' HD11 ' A' ' 84' ' ' LEU . 51.2 tp10 -77.86 -71.77 0.4 Allowed 'General case' 0 N--CA 1.444 -0.765 0 CA-C-O 118.477 -0.773 . . . . 1.0 111.516 -179.288 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 82' ' ' ASP . . . . . 0.589 ' O ' HG13 ' A' ' 85' ' ' ILE . 1.7 m-20 -81.67 -18.72 43.53 Favored 'General case' 0 C--O 1.21 -0.983 0 O-C-N 123.517 0.51 . . . . 1.0 112.226 -178.095 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 83' ' ' ALA . . . . . 0.744 ' HB2' ' O ' ' A' ' 79' ' ' ILE . . . -45.05 -52.41 9.0 Favored 'General case' 0 N--CA 1.469 0.491 0 N-CA-C 115.093 1.516 . . . . 1.0 115.093 -179.813 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 84' ' ' LEU . . . . . 0.985 ' H ' HD13 ' A' ' 84' ' ' LEU . 0.0 OUTLIER -31.78 -28.67 0.01 OUTLIER 'General case' 0 N--CA 1.48 1.048 0 CA-C-O 118.962 -0.542 . . . . 1.0 112.408 -174.304 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 85' ' ' ILE . . . . . 0.596 ' N ' ' O ' ' A' ' 83' ' ' ALA . 1.4 pp -100.02 -58.9 3.58 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.878 0 CA-C-N 118.631 0.65 . . . . 1.0 109.262 177.565 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 86' ' ' ALA . . . . . 0.538 ' H ' HG13 ' A' ' 85' ' ' ILE . . . -53.22 -37.53 62.11 Favored 'General case' 0 C--O 1.222 -0.347 0 CA-C-N 115.6 -0.727 . . . . 1.0 110.745 179.869 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 9.8 tt0 -47.5 -11.86 0.03 OUTLIER 'General case' 0 N--CA 1.465 0.295 0 CA-C-O 121.07 0.462 . . . . 1.0 110.046 179.649 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 88' ' ' ALA . . . . . 0.521 ' H ' ' C ' ' A' ' 86' ' ' ALA . . . -84.16 -2.33 56.65 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.754 -0.657 . . . . 1.0 110.103 179.657 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 89' ' ' VAL . . . . . 0.688 ' O ' HG12 ' A' ' 89' ' ' VAL . 54.2 t -93.25 33.03 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.62 0 CA-C-N 115.414 -0.812 . . . . 1.0 109.231 179.079 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 90' ' ' GLY . . . . . 0.633 ' N ' ' HD2' ' A' ' 91' ' ' PRO . . . -67.22 -44.81 85.27 Favored Glycine 0 CA--C 1.535 1.342 0 CA-C-O 119.163 -0.798 . . . . 1.0 112.005 178.134 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 91' ' ' PRO . . . . . 0.633 ' HD2' ' N ' ' A' ' 90' ' ' GLY . 7.7 Cg_exo -39.3 -18.55 0.04 OUTLIER 'Trans proline' 0 N--CA 1.493 1.445 0 C-N-CA 122.236 1.957 . . . . 1.0 111.336 179.263 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 92' ' ' HIS . . . . . 0.713 ' O ' ' N ' ' A' ' 96' ' ' ALA . 3.3 p80 -53.95 -44.83 71.04 Favored 'General case' 0 N--CA 1.441 -0.923 0 N-CA-C 106.357 -1.72 . . . . 1.0 106.357 -179.568 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 93' ' ' LEU . . . . . 0.747 HD12 ' N ' ' A' ' 94' ' ' ALA . 2.3 pp -41.51 -61.38 1.07 Allowed 'General case' 0 CA--C 1.566 1.572 0 C-N-CA 119.578 -0.849 . . . . 1.0 111.762 177.682 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 94' ' ' ALA . . . . . 0.747 ' N ' HD12 ' A' ' 93' ' ' LEU . . . -58.29 -58.76 7.07 Favored 'General case' 0 C--O 1.219 -0.547 0 CA-C-N 119.229 0.922 . . . . 1.0 108.763 179.67 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 95' ' ' ARG . . . . . 0.578 ' O ' ' N ' ' A' ' 97' ' ' LEU . 44.7 mtp85 -51.56 -61.38 2.28 Favored 'General case' 0 C--O 1.246 0.885 0 CA-C-O 123.359 1.552 . . . . 1.0 108.658 178.177 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 96' ' ' ALA . . . . . 0.845 ' O ' ' N ' ' A' ' 98' ' ' GLY . . . -47.82 -14.37 0.05 OUTLIER 'General case' 0 N--CA 1.43 -1.429 0 O-C-N 118.186 -2.821 . . . . 1.0 111.206 -178.446 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 97' ' ' LEU . . . . . 0.628 ' O ' ' N ' ' A' ' 100' ' ' ILE 0.258 6.1 tt 3.68 -51.28 0.0 OUTLIER 'General case' 0 C--N 1.368 1.393 0 C-N-CA 124.109 0.964 . . . . 1.0 112.736 -170.72 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 98' ' ' GLY . . . . . 0.845 ' N ' ' O ' ' A' ' 96' ' ' ALA . . . -49.56 -23.05 4.36 Favored Glycine 0 N--CA 1.434 -1.479 0 CA-C-N 122.187 2.267 . . . . 1.0 108.152 174.589 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 99' ' ' GLN . . . . . 0.522 ' N ' ' O ' ' A' ' 96' ' ' ALA . 25.2 mm100 -68.88 -19.81 64.24 Favored 'General case' 0 C--N 1.363 1.162 0 C-N-CA 117.308 -1.757 . . . . 1.0 108.58 177.765 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 100' ' ' ILE . . . . . 0.628 ' N ' ' O ' ' A' ' 97' ' ' LEU . 10.3 mt -65.41 -32.72 59.45 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.813 0 C-N-CA 119.749 -0.781 . . . . 1.0 110.214 177.179 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 101' ' ' VAL . . . . . 0.744 HG12 ' O ' ' A' ' 98' ' ' GLY . 3.8 p -60.13 -62.09 1.22 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.509 0 C-N-CA 119.355 -0.938 . . . . 1.0 110.622 -178.847 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 102' ' ' CYS . . . . . 0.867 ' O ' ' HB2' ' A' ' 106' ' ' ALA . 1.2 p -48.72 -19.29 0.34 Allowed 'General case' 0 C--O 1.217 -0.627 0 O-C-N 122.122 -0.361 . . . . 1.0 111.655 -178.364 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 103' ' ' ARG . . . . . 0.61 HH11 ' CG ' ' A' ' 103' ' ' ARG . 0.0 OUTLIER -85.9 -42.61 13.93 Favored 'General case' 0 N--CA 1.498 1.943 0 CA-C-O 124.419 2.057 . . . . 1.0 111.235 -179.98 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 104' ' ' TYR . . . . . 0.803 ' O ' ' CD1' ' A' ' 104' ' ' TYR . 0.0 OUTLIER -97.62 22.48 8.93 Favored 'General case' 0 C--N 1.267 -2.995 0 CA-C-N 110.561 -3.018 . . . . 1.0 107.332 176.949 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 105' ' ' GLY . . . . . 0.512 ' N ' ' O ' ' A' ' 101' ' ' VAL . . . -165.5 -88.3 0.07 OUTLIER Glycine 0 CA--C 1.529 0.913 0 O-C-N 119.634 -1.916 . . . . 1.0 109.081 179.13 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 106' ' ' ALA . . . . . 0.867 ' HB2' ' O ' ' A' ' 102' ' ' CYS . . . 65.52 58.58 0.82 Allowed 'General case' 0 CA--C 1.533 0.308 0 CA-C-O 120.885 0.374 . . . . 1.0 110.688 -178.713 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 13.1 t -89.49 -5.34 57.4 Favored 'General case' 0 CA--C 1.514 -0.412 0 N-CA-C 108.614 -0.884 . . . . 1.0 108.614 178.593 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 108' ' ' VAL . . . . . 0.618 HG23 ' N ' ' A' ' 109' ' ' ILE . 14.7 m -87.53 -53.54 9.76 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.626 0 C-N-CA 120.842 -0.343 . . . . 1.0 110.608 178.537 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 109' ' ' ILE . . . . . 0.618 ' N ' HG23 ' A' ' 108' ' ' VAL . 0.2 OUTLIER -50.34 -34.34 10.65 Favored Pre-proline 0 C--N 1.351 0.658 0 N-CA-C 115.086 1.513 . . . . 1.0 115.086 -178.921 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 110' ' ' PRO . . . . . 0.507 ' CD ' ' N ' ' A' ' 109' ' ' ILE . 76.8 Cg_exo -53.07 -37.89 79.78 Favored 'Trans proline' 0 C--N 1.307 -1.612 0 CA-C-N 120.458 1.199 . . . . 1.0 111.276 -175.212 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -64.76 -67.48 0.43 Allowed 'General case' 0 C--N 1.325 -0.471 0 C-N-CA 119.639 -0.824 . . . . 1.0 109.326 179.647 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 112' ' ' ILE . . . . . 0.485 ' CG1' ' N ' ' A' ' 113' ' ' ASN . 0.3 OUTLIER -60.28 -44.91 96.7 Favored 'Isoleucine or valine' 0 C--O 1.213 -0.817 0 C-N-CA 120.245 -0.582 . . . . 1.0 110.527 -178.819 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 113' ' ' ASN . . . . . 0.498 ' CB ' ' O ' ' A' ' 109' ' ' ILE . 18.0 t30 -44.14 -63.07 0.94 Allowed 'General case' 0 C--N 1.31 -1.118 0 CA-C-N 115.181 -0.918 . . . . 1.0 112.113 -174.659 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -57.18 -23.8 50.05 Favored 'General case' 0 C--N 1.312 -1.061 0 C-N-CA 119.743 -0.783 . . . . 1.0 111.555 -179.664 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -84.21 -58.46 2.75 Favored 'General case' 0 CA--C 1.555 1.162 0 CA-C-O 122.503 1.144 . . . . 1.0 113.846 178.191 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 116' ' ' ILE . . . . . 0.497 ' O ' ' N ' ' A' ' 119' ' ' LEU . 76.0 mt -65.88 -59.8 3.52 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.863 0 CA-C-N 113.814 -1.539 . . . . 1.0 110.825 -177.254 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 117' ' ' GLU . . . . . 0.448 ' HB3' ' O ' ' A' ' 113' ' ' ASN . 11.3 tt0 -45.1 -62.49 1.22 Allowed 'General case' 0 C--N 1.307 -1.257 0 CA-C-N 116.058 -0.519 . . . . 1.0 109.743 -178.285 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 48.7 t -53.49 -14.88 0.76 Allowed 'Isoleucine or valine' 0 N--CA 1.437 -1.119 0 C-N-CA 119.922 -0.711 . . . . 1.0 109.628 -179.782 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 119' ' ' LEU . . . . . 0.497 ' N ' ' O ' ' A' ' 116' ' ' ILE . 3.7 tp -79.79 -60.79 2.21 Favored 'General case' 0 C--N 1.348 0.527 0 C-N-CA 119.776 -0.77 . . . . 1.0 109.966 178.261 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -70.3 -85.1 0.16 Allowed Glycine 0 C--N 1.357 1.735 0 C-N-CA 118.626 -1.75 . . . . 1.0 111.285 179.925 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 121' ' ' THR . . . . . 0.428 ' H ' ' H ' ' A' ' 122' ' ' GLY . 7.7 m -164.57 -22.79 0.03 OUTLIER 'General case' 0 C--N 1.325 -0.478 0 N-CA-C 108.121 -1.066 . . . . 1.0 108.121 -179.035 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 122' ' ' GLY . . . . . 0.53 ' O ' ' N ' ' A' ' 124' ' ' ASP . . . 114.37 -36.42 3.98 Favored Glycine 0 CA--C 1.523 0.562 0 CA-C-O 118.125 -1.375 . . . . 1.0 113.028 179.308 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 123' ' ' THR . . . . . 0.461 ' C ' ' O ' ' A' ' 122' ' ' GLY . 0.0 OUTLIER -32.54 91.32 0.0 OUTLIER 'General case' 0 N--CA 1.47 0.573 0 CA-C-N 119.609 1.705 . . . . 1.0 112.065 -179.565 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 124' ' ' ASP . . . . . 0.53 ' N ' ' O ' ' A' ' 122' ' ' GLY . 11.6 p-10 -146.43 144.39 29.67 Favored 'General case' 0 N--CA 1.463 0.222 0 N-CA-C 108.986 -0.746 . . . . 1.0 108.986 179.051 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 125' ' ' TYR . . . . . 0.419 ' CD1' ' C ' ' A' ' 125' ' ' TYR . 0.2 OUTLIER -151.07 148.99 28.99 Favored 'General case' 0 CA--C 1.536 0.442 0 CA-C-O 121.367 0.603 . . . . 1.0 110.247 -179.962 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 74.8 mtt85 -149.57 150.88 32.92 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.59 -0.732 . . . . 1.0 110.245 178.077 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 127' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--O 1.22 -0.476 0 CA-C-O 118.042 -0.98 . . . . 1.0 109.291 178.83 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.7 mpt? . . . . . 0 N--CA 1.492 1.633 0 N-CA-C 109.061 -0.718 . . . . 1.0 109.061 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 33.4 m -107.69 7.68 28.6 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.322 -0.399 . . . . 1.0 110.402 179.872 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 3' ' ' ASP . . . . . 0.408 ' N ' ' OD1' ' A' ' 3' ' ' ASP . 1.2 p30 170.72 93.12 0.0 OUTLIER 'General case' 0 N--CA 1.463 0.213 0 CA-C-N 116.288 -0.415 . . . . 1.0 110.414 179.77 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 72.8 t80 -150.84 145.59 25.78 Favored 'General case' 0 N--CA 1.462 0.15 0 CA-C-O 120.684 0.278 . . . . 1.0 110.51 -179.998 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 5' ' ' ASP . . . . . 0.479 ' N ' ' OD1' ' A' ' 5' ' ' ASP . 3.4 p30 -155.53 151.68 27.94 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.434 -0.348 . . . . 1.0 110.444 179.901 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 6' ' ' THR . . . . . 0.552 ' O ' ' N ' ' A' ' 10' ' ' SER . 0.2 OUTLIER -64.7 169.16 5.26 Favored 'General case' 0 C--O 1.208 -1.119 0 N-CA-C 109.556 -0.535 . . . . 1.0 109.556 179.979 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 7' ' ' GLU . . . . . 0.497 ' O ' ' N ' ' A' ' 11' ' ' ARG . 0.0 OUTLIER -59.33 -58.05 10.33 Favored 'General case' 0 C--N 1.315 -0.93 0 CA-C-O 121.359 0.6 . . . . 1.0 110.213 -178.44 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 8' ' ' ARG . . . . . 0.509 ' O ' ' CB ' ' A' ' 12' ' ' ALA . 1.8 ptm180 -50.83 -56.31 12.8 Favored 'General case' 0 C--O 1.212 -0.899 0 N-CA-C 107.994 -1.113 . . . . 1.0 107.994 -177.825 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 9' ' ' VAL . . . . . 0.436 ' H ' ' HG3' ' A' ' 8' ' ' ARG . 0.0 OUTLIER -64.12 -47.46 90.06 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.966 0 CA-C-N 115.037 -0.983 . . . . 1.0 110.364 179.502 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 10' ' ' SER . . . . . 0.552 ' N ' ' O ' ' A' ' 6' ' ' THR . 47.9 t -63.81 -63.06 1.27 Allowed 'General case' 0 N--CA 1.48 1.037 0 O-C-N 123.454 0.471 . . . . 1.0 110.905 -178.968 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 11' ' ' ARG . . . . . 0.497 ' N ' ' O ' ' A' ' 7' ' ' GLU . 12.1 ttt180 -58.68 -54.82 42.8 Favored 'General case' 0 N--CA 1.469 0.489 0 N-CA-C 109.404 -0.591 . . . . 1.0 109.404 -177.069 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 12' ' ' ALA . . . . . 0.588 ' O ' ' HB3' ' A' ' 16' ' ' ALA . . . -46.48 -46.82 19.24 Favored 'General case' 0 N--CA 1.477 0.923 0 N-CA-C 105.762 -1.94 . . . . 1.0 105.762 -178.13 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 13' ' ' VAL . . . . . 0.604 ' O ' ' CB ' ' A' ' 17' ' ' LEU . 1.5 t -61.32 -52.02 66.21 Favored 'Isoleucine or valine' 0 C--O 1.206 -1.196 0 CA-C-N 114.495 -1.23 . . . . 1.0 108.147 176.004 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 14' ' ' ALA . . . . . 0.769 ' O ' HG13 ' A' ' 18' ' ' VAL . . . -57.21 -63.65 1.15 Allowed 'General case' 0 C--O 1.213 -0.86 0 C-N-CA 117.763 -1.575 . . . . 1.0 110.232 -179.876 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 15' ' ' ALA . . . . . 0.557 ' O ' ' N ' ' A' ' 19' ' ' GLY . . . -53.8 -56.26 19.07 Favored 'General case' 0 N--CA 1.473 0.71 0 CA-C-O 121.559 0.695 . . . . 1.0 110.916 -177.956 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 16' ' ' ALA . . . . . 0.588 ' HB3' ' O ' ' A' ' 12' ' ' ALA . . . -64.63 -55.57 19.4 Favored 'General case' 0 C--N 1.31 -1.112 0 CA-C-N 115.135 -0.938 . . . . 1.0 109.611 -178.419 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 17' ' ' LEU . . . . . 0.612 HD13 ' O ' ' A' ' 17' ' ' LEU . 0.3 OUTLIER -57.85 -52.14 66.73 Favored 'General case' 0 N--CA 1.474 0.766 0 CA-C-N 114.506 -1.224 . . . . 1.0 108.004 -177.516 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 18' ' ' VAL . . . . . 0.769 HG13 ' O ' ' A' ' 14' ' ' ALA . 2.3 m -68.37 -57.28 9.59 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.605 0 C-N-CA 118.86 -1.136 . . . . 1.0 109.706 178.685 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 19' ' ' GLY . . . . . 0.557 ' N ' ' O ' ' A' ' 15' ' ' ALA . . . -61.95 -171.84 1.21 Allowed Glycine 0 C--N 1.332 0.319 0 N-CA-C 110.941 -0.863 . . . . 1.0 110.941 -179.059 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 20' ' ' PRO . . . . . 0.603 ' O ' ' N ' ' A' ' 24' ' ' ALA . 2.1 Cg_endo -78.24 -26.3 6.38 Favored 'Trans proline' 0 C--N 1.309 -1.514 0 C-N-CA 122.636 2.224 . . . . 1.0 113.993 -178.752 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -59.62 -58.06 16.26 Favored Glycine 0 N--CA 1.48 1.591 0 C-N-CA 120.256 -0.973 . . . . 1.0 111.808 -177.031 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 22' ' ' GLY . . . . . 0.507 ' CA ' ' HB1' ' A' ' 16' ' ' ALA . . . -57.91 -52.12 54.13 Favored Glycine 0 N--CA 1.469 0.859 0 N-CA-C 107.112 -2.395 . . . . 1.0 107.112 -177.901 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 23' ' ' VAL . . . . . 0.612 ' O ' HG12 ' A' ' 27' ' ' VAL . 9.6 t -58.91 -32.66 47.79 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.078 0 CA-C-N 114.487 -0.856 . . . . 1.0 109.513 179.115 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 24' ' ' ALA . . . . . 0.603 ' N ' ' O ' ' A' ' 20' ' ' PRO . . . -58.51 -61.27 2.72 Favored 'General case' 0 CA--C 1.533 0.307 0 C-N-CA 118.503 -1.279 . . . . 1.0 109.579 -179.947 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 25' ' ' LEU . . . . . 0.554 ' C ' HD12 ' A' ' 25' ' ' LEU . 0.3 OUTLIER -65.04 -43.85 91.03 Favored 'General case' 0 CA--C 1.535 0.387 0 N-CA-C 112.763 0.653 . . . . 1.0 112.763 -177.939 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 26' ' ' VAL . . . . . 0.412 ' N ' ' HG ' ' A' ' 25' ' ' LEU . 53.4 t -61.46 -59.83 3.66 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.171 0 C-N-CA 118.77 -1.172 . . . . 1.0 110.011 -177.626 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 27' ' ' VAL . . . . . 0.612 HG12 ' O ' ' A' ' 23' ' ' VAL . 2.3 p -58.39 -35.6 54.79 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.217 0 N-CA-C 112.016 0.376 . . . . 1.0 112.016 -178.071 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 6.7 ttmm -67.29 -55.09 15.33 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-O 121.727 0.775 . . . . 1.0 109.477 -179.017 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 94.9 t -64.39 -48.22 86.18 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.673 0 CA-C-N 114.281 -1.327 . . . . 1.0 111.131 -177.689 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 30' ' ' CYS . . . . . . . . . . . . . 2.2 t -65.05 -61.23 2.28 Favored 'General case' 0 N--CA 1.447 -0.601 0 C-N-CA 118.807 -1.157 . . . . 1.0 109.189 -179.255 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 31' ' ' ALA . . . . . 0.564 ' HB3' ' O ' ' A' ' 27' ' ' VAL . . . -62.46 -51.87 65.77 Favored 'General case' 0 CA--C 1.51 -0.56 0 N-CA-C 112.29 0.478 . . . . 1.0 112.29 -177.06 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 32' ' ' GLY . . . . . 0.705 ' O ' HD11 ' A' ' 37' ' ' ILE . . . 81.46 71.62 1.28 Allowed Glycine 0 CA--C 1.523 0.581 0 N-CA-C 108.432 -1.867 . . . . 1.0 108.432 -177.967 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 33' ' ' LEU . . . . . 0.44 ' O ' ' O ' ' A' ' 36' ' ' VAL . 5.2 mt 89.06 73.42 0.05 OUTLIER Pre-proline 0 N--CA 1.476 0.835 0 C-N-CA 123.293 0.637 . . . . 1.0 109.809 -179.502 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 76.6 Cg_exo -50.74 -32.14 35.45 Favored 'Trans proline' 0 N--CA 1.507 2.31 0 C-N-CA 123.728 2.952 . . . . 1.0 114.954 -179.076 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -58.43 -57.44 19.86 Favored Glycine 0 CA--C 1.533 1.161 0 C-N-CA 118.492 -1.813 . . . . 1.0 108.9 -178.828 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 36' ' ' VAL . . . . . 0.536 ' O ' ' HB ' ' A' ' 37' ' ' ILE . 13.9 p -92.48 167.45 1.64 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.579 0 N-CA-C 106.917 -1.512 . . . . 1.0 106.917 177.447 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 37' ' ' ILE . . . . . 0.705 HD11 ' O ' ' A' ' 32' ' ' GLY . 91.4 mt 111.22 127.09 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.478 0.971 0 C-N-CA 123.827 0.851 . . . . 1.0 109.581 -179.529 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -141.59 132.38 25.78 Favored 'General case' 0 C--N 1.331 -0.236 0 N-CA-C 108.085 -1.08 . . . . 1.0 108.085 179.792 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 7.3 p -93.31 124.43 57.69 Favored Pre-proline 0 CA--C 1.534 0.35 0 N-CA-C 109.656 -0.498 . . . . 1.0 109.656 -179.792 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 52.5 Cg_exo -50.27 -37.62 50.06 Favored 'Trans proline' 0 N--CA 1.488 1.192 0 C-N-CA 121.399 1.399 . . . . 1.0 113.21 -179.702 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -121.47 101.43 7.61 Favored 'General case' 0 N--CA 1.47 0.535 0 N-CA-C 112.614 0.598 . . . . 1.0 112.614 -177.659 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 42' ' ' ARG . . . . . 0.746 ' C ' ' H ' ' A' ' 44' ' ' GLY . 14.4 ptm180 -135.84 152.86 51.49 Favored 'General case' 0 C--N 1.316 -0.868 0 CA-C-O 121.735 0.779 . . . . 1.0 112.834 179.773 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 43' ' ' ARG . . . . . 0.526 ' O ' ' CD1' ' A' ' 45' ' ' PHE . 61.0 ttt180 -61.18 28.97 0.01 OUTLIER 'General case' 0 CA--C 1.539 0.552 0 CA-C-N 113.531 -1.668 . . . . 1.0 109.225 -179.84 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 44' ' ' GLY . . . . . 0.746 ' H ' ' C ' ' A' ' 42' ' ' ARG . . . 75.65 -26.46 1.36 Allowed Glycine 0 N--CA 1.448 -0.527 0 N-CA-C 110.396 -1.081 . . . . 1.0 110.396 179.899 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 45' ' ' PHE . . . . . 0.699 ' N ' ' CD1' ' A' ' 45' ' ' PHE . 0.0 OUTLIER -172.79 172.61 4.07 Favored 'General case' 0 CA--C 1.536 0.423 0 CA-C-O 119.293 -0.384 . . . . 1.0 110.125 -177.867 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 46' ' ' PHE . . . . . 0.666 ' HB2' ' O ' ' A' ' 45' ' ' PHE . 0.4 OUTLIER 126.17 102.31 0.0 OUTLIER 'General case' 0 N--CA 1.505 2.296 0 O-C-N 125.675 1.859 . . . . 1.0 109.724 179.583 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 47' ' ' ARG . . . . . 0.567 ' NE ' ' O ' ' A' ' 46' ' ' PHE . 1.6 ptp180 108.1 162.37 0.0 OUTLIER 'General case' 0 N--CA 1.487 1.395 0 O-C-N 124.302 1.002 . . . . 1.0 110.669 178.942 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER 69.2 70.46 0.26 Allowed 'General case' 0 N--CA 1.453 -0.293 0 N-CA-C 108.343 -0.984 . . . . 1.0 108.343 -179.366 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 49' ' ' ASN . . . . . 0.581 ' O ' ' N ' ' A' ' 51' ' ' GLU . 2.7 p30 -147.13 138.87 13.54 Favored Pre-proline 0 CA--C 1.542 0.645 0 N-CA-C 108.252 -1.018 . . . . 1.0 108.252 179.82 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 50' ' ' PRO . . . . . 0.459 ' C ' ' H ' ' A' ' 52' ' ' ARG . 34.8 Cg_exo -54.61 72.05 0.03 OUTLIER 'Trans proline' 0 N--CA 1.502 1.987 0 C-N-CA 121.495 1.463 . . . . 1.0 112.299 179.456 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 51' ' ' GLU . . . . . 0.581 ' N ' ' O ' ' A' ' 49' ' ' ASN . 1.2 mp0 57.24 4.5 0.21 Allowed 'General case' 0 C--N 1.324 -0.514 0 O-C-N 121.736 -0.603 . . . . 1.0 111.091 179.304 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 52' ' ' ARG . . . . . 0.459 ' H ' ' C ' ' A' ' 50' ' ' PRO . 92.5 mtt180 -84.89 141.16 30.61 Favored 'General case' 0 CA--C 1.513 -0.452 0 N-CA-C 109.325 -0.62 . . . . 1.0 109.325 178.774 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 14.2 tt -66.48 146.91 12.9 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.704 0 CA-C-O 123.146 1.451 . . . . 1.0 113.355 -177.544 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 54' ' ' GLN . . . . . 0.418 ' NE2' ' CD2' ' A' ' 46' ' ' PHE . 3.3 pt20 -74.95 81.01 2.17 Favored 'General case' 0 C--N 1.311 -1.104 0 CA-C-N 111.309 -2.678 . . . . 1.0 111.071 -178.952 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 2.4 pp -148.49 156.89 8.13 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.888 0 N-CA-C 109.78 -0.452 . . . . 1.0 109.78 176.708 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 106.51 -3.84 37.11 Favored Glycine 0 N--CA 1.474 1.176 0 N-CA-C 110.266 -1.134 . . . . 1.0 110.266 179.575 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 57' ' ' ASP . . . . . 0.434 ' HB3' ' CD1' ' A' ' 45' ' ' PHE . 18.9 m-20 -80.94 103.98 11.14 Favored 'General case' 0 C--N 1.317 -0.831 0 CA-C-N 114.279 -0.96 . . . . 1.0 110.06 178.963 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 58' ' ' TRP . . . . . . . . . . . . . 5.9 m0 -90.09 172.24 8.97 Favored 'General case' 0 CA--C 1.542 0.659 0 CA-C-O 123.678 1.704 . . . . 1.0 114.288 -177.283 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 59' ' ' ARG . . . . . 0.478 ' CG ' ' N ' ' A' ' 60' ' ' TYR . 28.5 ptt-85 -78.6 -60.18 2.48 Favored 'General case' 0 CA--C 1.55 0.946 0 CA-C-N 110.451 -3.068 . . . . 1.0 113.865 -177.661 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 60' ' ' TYR . . . . . 0.478 ' N ' ' CG ' ' A' ' 59' ' ' ARG . 0.3 OUTLIER -92.21 -9.94 40.45 Favored 'General case' 0 N--CA 1.483 1.191 0 C-N-CA 124.122 0.969 . . . . 1.0 113.151 -179.728 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 22.3 tt0 -77.26 -14.73 59.7 Favored 'General case' 0 C--N 1.31 -1.133 0 CA-C-N 115.886 -0.597 . . . . 1.0 111.688 -178.3 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 62' ' ' VAL . . . . . 0.605 ' O ' ' N ' ' A' ' 66' ' ' GLY . 0.6 OUTLIER -48.05 -55.85 2.43 Favored 'Isoleucine or valine' 0 C--O 1.207 -1.14 0 C-N-CA 119.825 -0.75 . . . . 1.0 110.265 -175.156 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 63' ' ' ALA . . . . . 0.543 ' O ' ' HG3' ' A' ' 67' ' ' ARG . . . -65.98 -52.73 46.93 Favored 'General case' 0 C--N 1.307 -1.269 0 C-N-CA 119.722 -0.791 . . . . 1.0 109.75 -178.966 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 85.4 m-70 -48.9 -57.37 6.55 Favored 'General case' 0 N--CA 1.472 0.626 0 O-C-N 124.093 0.871 . . . . 1.0 109.964 -179.72 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 65' ' ' ASP . . . . . 0.615 ' C ' ' H ' ' A' ' 67' ' ' ARG . 5.8 t0 -72.45 -47.83 45.78 Favored 'General case' 0 C--N 1.313 -1.001 0 CA-C-O 121.582 0.706 . . . . 1.0 110.362 178.8 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 66' ' ' GLY . . . . . 0.605 ' N ' ' O ' ' A' ' 62' ' ' VAL . . . -70.71 26.47 0.5 Allowed Glycine 0 C--N 1.32 -0.322 0 O-C-N 120.868 -1.145 . . . . 1.0 110.636 177.985 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 67' ' ' ARG . . . . . 0.615 ' H ' ' C ' ' A' ' 65' ' ' ASP . 6.0 mtp85 -73.11 3.89 5.02 Favored 'General case' 0 N--CA 1.445 -0.688 0 N-CA-C 106.514 -1.661 . . . . 1.0 106.514 175.418 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 68' ' ' LEU . . . . . 0.484 ' H ' ' C ' ' A' ' 66' ' ' GLY . 0.0 OUTLIER -33.21 -29.65 0.01 OUTLIER 'General case' 0 N--CA 1.486 1.367 0 N-CA-C 108.489 -0.93 . . . . 1.0 108.489 -176.794 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 69' ' ' LEU . . . . . 0.606 ' N ' ' O ' ' A' ' 67' ' ' ARG . 22.2 mt -61.87 -63.39 1.27 Allowed 'General case' 0 C--N 1.315 -0.933 0 C-N-CA 118.542 -1.263 . . . . 1.0 107.814 178.289 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 70' ' ' ALA . . . . . 0.637 ' C ' ' H ' ' A' ' 72' ' ' HIS . . . -79.18 -75.28 0.25 Allowed 'General case' 0 N--CA 1.465 0.303 0 N-CA-C 106.271 -1.752 . . . . 1.0 106.271 176.635 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 71' ' ' ALA . . . . . 0.459 ' O ' ' C ' ' A' ' 72' ' ' HIS . . . -44.1 3.71 0.0 OUTLIER 'General case' 0 CA--C 1.519 -0.223 0 C-N-CA 124.826 1.25 . . . . 1.0 113.831 178.947 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 72' ' ' HIS . . . . . 0.637 ' H ' ' C ' ' A' ' 70' ' ' ALA . 0.2 OUTLIER -28.4 -67.85 0.07 Allowed 'General case' 0 N--CA 1.463 0.19 0 CA-C-N 118.36 0.527 . . . . 1.0 111.589 -178.658 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 73' ' ' MET . . . . . . . . . . . . . 13.8 ptp -69.57 -48.57 59.82 Favored 'General case' 0 C--N 1.325 -0.469 0 C-N-CA 118.983 -1.087 . . . . 1.0 108.968 178.525 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 74' ' ' VAL . . . . . 0.753 ' O ' ' N ' ' A' ' 76' ' ' GLY . 68.8 t -43.76 -40.54 1.48 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.265 0 CA-C-O 117.351 -1.309 . . . . 1.0 111.539 -176.35 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 75' ' ' ASN . . . . . 0.47 ' C ' ' N ' ' A' ' 77' ' ' ILE . 3.0 m120 -35.14 -12.62 0.0 OUTLIER 'General case' 0 N--CA 1.501 2.078 0 CA-C-N 121.244 1.838 . . . . 1.0 112.257 179.277 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 76' ' ' GLY . . . . . 0.753 ' N ' ' O ' ' A' ' 74' ' ' VAL . . . -45.72 -21.44 0.55 Allowed Glycine 0 CA--C 1.542 1.739 0 N-CA-C 107.844 -2.102 . . . . 1.0 107.844 175.173 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 77' ' ' ILE . . . . . 0.575 HG13 ' H ' ' A' ' 78' ' ' VAL . 1.2 pt -72.11 -55.9 11.86 Favored 'Isoleucine or valine' 0 C--O 1.216 -0.692 0 N-CA-C 107.696 -1.224 . . . . 1.0 107.696 178.021 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 78' ' ' VAL . . . . . 0.575 ' H ' HG13 ' A' ' 77' ' ' ILE . 95.8 t -33.79 -34.99 0.04 OUTLIER 'Isoleucine or valine' 0 CA--C 1.546 0.794 0 CA-C-N 113.2 -1.818 . . . . 1.0 106.849 -177.565 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 79' ' ' ILE . . . . . 0.633 ' O ' ' HB3' ' A' ' 83' ' ' ALA . 0.0 OUTLIER -98.31 -33.24 4.12 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.878 0 CA-C-N 115.605 -0.725 . . . . 1.0 112.416 176.556 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 80' ' ' ALA . . . . . 0.537 ' N ' ' O ' ' A' ' 77' ' ' ILE . . . -84.2 -10.71 57.5 Favored 'General case' 0 N--CA 1.478 0.974 0 O-C-N 121.257 -0.902 . . . . 1.0 113.184 179.662 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 81' ' ' GLU . . . . . 0.445 ' N ' ' O ' ' A' ' 77' ' ' ILE . 0.0 OUTLIER -89.27 -73.89 0.49 Allowed 'General case' 0 N--CA 1.451 -0.424 0 N-CA-C 112.115 0.413 . . . . 1.0 112.115 -177.629 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 24.3 m-20 -91.75 -16.8 26.35 Favored 'General case' 0 C--N 1.346 0.437 0 N-CA-C 114.532 1.308 . . . . 1.0 114.532 -179.096 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 83' ' ' ALA . . . . . 0.633 ' HB3' ' O ' ' A' ' 79' ' ' ILE . . . -49.67 -42.12 44.68 Favored 'General case' 0 C--O 1.211 -0.965 0 C-N-CA 118.304 -1.358 . . . . 1.0 110.792 -177.391 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 84' ' ' LEU . . . . . 0.564 HD13 ' O ' ' A' ' 84' ' ' LEU . 0.2 OUTLIER -40.33 -35.13 0.39 Allowed 'General case' 0 CA--C 1.543 0.7 0 CA-C-O 120.819 0.342 . . . . 1.0 111.131 -179.789 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 1.2 pp -74.4 -33.69 34.21 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.433 0 C-N-CA 119.999 -0.68 . . . . 1.0 110.125 178.477 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 86' ' ' ALA . . . . . 0.569 ' N ' ' O ' ' A' ' 83' ' ' ALA . . . -96.23 -26.36 15.46 Favored 'General case' 0 CA--C 1.54 0.573 0 CA-C-O 120.798 0.333 . . . . 1.0 111.698 179.175 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 87' ' ' GLU . . . . . 0.542 ' N ' ' O ' ' A' ' 83' ' ' ALA . 44.8 tt0 -57.9 -20.25 35.75 Favored 'General case' 0 C--N 1.329 -0.318 0 O-C-N 121.667 -0.646 . . . . 1.0 110.103 -178.833 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -71.98 -1.6 15.13 Favored 'General case' 0 N--CA 1.47 0.533 0 N-CA-C 107.494 -1.299 . . . . 1.0 107.494 178.095 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 89' ' ' VAL . . . . . 0.481 ' H ' ' C ' ' A' ' 87' ' ' GLU . 3.5 t -98.54 36.02 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.447 -0.616 0 CA-C-N 111.922 -2.399 . . . . 1.0 107.831 177.029 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 90' ' ' GLY . . . . . 0.844 ' O ' ' N ' ' A' ' 92' ' ' HIS . . . -55.95 -26.91 49.56 Favored Glycine 0 C--N 1.367 2.26 0 CA-C-O 117.609 -1.662 . . . . 1.0 111.519 176.672 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 91' ' ' PRO . . . . . 0.727 ' HD2' ' N ' ' A' ' 90' ' ' GLY . 11.5 Cg_exo -36.48 3.09 0.0 OUTLIER 'Trans proline' 0 N--CA 1.499 1.803 0 C-N-CA 123.084 2.523 . . . . 1.0 113.68 173.913 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 92' ' ' HIS . . . . . 0.844 ' N ' ' O ' ' A' ' 90' ' ' GLY . 0.0 OUTLIER -47.48 -27.91 1.95 Allowed 'General case' 0 N--CA 1.436 -1.141 0 N-CA-C 106.942 -1.503 . . . . 1.0 106.942 -179.887 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 93' ' ' LEU . . . . . 0.593 HD12 ' N ' ' A' ' 94' ' ' ALA . 2.0 pp -58.49 -52.46 65.55 Favored 'General case' 0 N--CA 1.448 -0.545 0 N-CA-C 106.931 -1.507 . . . . 1.0 106.931 176.417 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 94' ' ' ALA . . . . . 0.593 ' N ' HD12 ' A' ' 93' ' ' LEU . . . -49.8 -52.05 35.05 Favored 'General case' 0 C--O 1.221 -0.447 0 N-CA-C 107.457 -1.312 . . . . 1.0 107.457 -179.84 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 1.3 mpt_? -64.37 -31.44 72.64 Favored 'General case' 0 C--N 1.321 -0.666 0 N-CA-C 109.386 -0.598 . . . . 1.0 109.386 178.146 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 96' ' ' ALA . . . . . 0.842 ' O ' ' N ' ' A' ' 100' ' ' ILE . . . -50.87 -44.17 59.63 Favored 'General case' 0 C--O 1.197 -1.673 0 N-CA-C 106.368 -1.716 . . . . 1.0 106.368 -176.448 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 97' ' ' LEU . . . . . 0.506 ' O ' HG22 ' A' ' 100' ' ' ILE . 2.1 tt -35.05 -24.84 0.01 OUTLIER 'General case' 0 CA--C 1.588 2.423 0 CA-C-N 112.585 -2.098 . . . . 1.0 107.625 -178.937 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 98' ' ' GLY . . . . . 0.674 ' N ' ' O ' ' A' ' 96' ' ' ALA . . . -89.32 -51.84 2.85 Favored Glycine 0 CA--C 1.563 3.043 0 CA-C-O 123.312 1.507 . . . . 1.0 111.686 170.763 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 99' ' ' GLN . . . . . 0.562 ' N ' ' O ' ' A' ' 96' ' ' ALA . 6.3 mt-30 -76.72 8.43 3.66 Favored 'General case' 0 N--CA 1.437 -1.111 0 N-CA-C 106.607 -1.627 . . . . 1.0 106.607 177.676 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 100' ' ' ILE . . . . . 0.842 ' N ' ' O ' ' A' ' 96' ' ' ALA . 20.3 tt -59.36 -52.98 54.47 Favored 'Isoleucine or valine' 0 CA--C 1.474 -1.971 0 N-CA-C 106.276 -1.75 . . . . 1.0 106.276 178.296 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 101' ' ' VAL . . . . . 0.676 ' N ' HG23 ' A' ' 100' ' ' ILE . 0.2 OUTLIER -57.05 -61.03 1.4 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.658 0 C-N-CA 118.273 -1.371 . . . . 1.0 108.299 179.415 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 102' ' ' CYS . . . . . 0.879 ' O ' ' HB2' ' A' ' 106' ' ' ALA . 0.1 OUTLIER -50.63 -25.03 3.73 Favored 'General case' 0 C--N 1.317 -0.845 0 C-N-CA 120.588 -0.445 . . . . 1.0 111.179 -177.15 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 68.8 ttp85 -85.74 -49.0 8.29 Favored 'General case' 0 N--CA 1.482 1.158 0 O-C-N 124.731 1.269 . . . . 1.0 112.566 179.238 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 104' ' ' TYR . . . . . 0.735 ' O ' ' CG ' ' A' ' 104' ' ' TYR . 0.1 OUTLIER -96.38 23.63 6.55 Favored 'General case' 0 C--N 1.302 -1.457 0 C-N-CA 126.918 2.087 . . . . 1.0 108.788 179.401 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 105' ' ' GLY . . . . . 0.584 ' N ' ' O ' ' A' ' 101' ' ' VAL . . . -162.56 -93.4 0.09 OUTLIER Glycine 0 N--CA 1.45 -0.402 0 N-CA-C 106.608 -2.597 . . . . 1.0 106.608 178.313 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 106' ' ' ALA . . . . . 0.879 ' HB2' ' O ' ' A' ' 102' ' ' CYS . . . 69.06 64.14 0.29 Allowed 'General case' 0 C--O 1.219 -0.548 0 N-CA-C 113.146 0.795 . . . . 1.0 113.146 179.267 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 96.2 m -78.21 -58.73 3.1 Favored 'General case' 0 CA--C 1.547 0.829 0 O-C-N 121.152 -0.967 . . . . 1.0 109.353 179.529 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 108' ' ' VAL . . . . . 0.44 HG13 ' N ' ' A' ' 109' ' ' ILE . 3.8 p -58.64 -44.38 89.52 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-O 121.856 0.836 . . . . 1.0 109.662 -177.376 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 109' ' ' ILE . . . . . 0.449 ' HB ' ' HB1' ' A' ' 106' ' ' ALA . 3.3 mm -41.41 -61.41 1.4 Allowed Pre-proline 0 CA--C 1.569 1.689 0 CA-C-N 114.134 -1.394 . . . . 1.0 109.217 179.769 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 110' ' ' PRO . . . . . 0.638 ' CD ' ' O ' ' A' ' 106' ' ' ALA . 21.5 Cg_exo -47.64 -36.92 26.23 Favored 'Trans proline' 0 N--CA 1.502 1.998 0 C-N-CA 123.511 2.807 . . . . 1.0 113.401 174.802 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 111' ' ' ASN . . . . . 0.431 ' C ' ' N ' ' A' ' 113' ' ' ASN . 5.4 t30 -67.7 -67.78 0.43 Allowed 'General case' 0 C--O 1.236 0.381 0 O-C-N 121.082 -1.011 . . . . 1.0 109.946 -177.999 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 112' ' ' ILE . . . . . 0.452 ' H ' HG23 ' A' ' 112' ' ' ILE . 2.1 pt -49.02 -24.37 1.11 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-O 122.481 1.134 . . . . 1.0 109.154 -179.531 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 113' ' ' ASN . . . . . 0.466 ' HB3' ' O ' ' A' ' 110' ' ' PRO . 40.1 t30 -59.72 -53.71 54.77 Favored 'General case' 0 C--N 1.307 -1.264 0 CA-C-N 112.649 -2.069 . . . . 1.0 107.778 -177.695 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 114' ' ' ALA . . . . . 0.43 ' O ' HG22 ' A' ' 118' ' ' VAL . . . -56.92 -32.42 65.92 Favored 'General case' 0 N--CA 1.445 -0.687 0 CA-C-O 119.04 -0.505 . . . . 1.0 112.262 -179.652 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -78.83 -47.25 16.99 Favored 'General case' 0 C--O 1.211 -0.925 0 CA-C-O 122.314 1.054 . . . . 1.0 110.109 178.487 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 116' ' ' ILE . . . . . 0.468 ' O ' ' N ' ' A' ' 120' ' ' GLY . 32.2 mt -53.67 -53.09 28.27 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.101 0 CA-C-N 113.507 -1.679 . . . . 1.0 107.452 -179.148 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 117' ' ' GLU . . . . . 0.433 ' O ' ' HA ' ' A' ' 121' ' ' THR . 10.6 tt0 -44.36 -64.68 0.63 Allowed 'General case' 0 C--N 1.317 -0.816 0 CA-C-N 112.915 -1.948 . . . . 1.0 108.385 -179.249 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 118' ' ' VAL . . . . . 0.43 HG22 ' O ' ' A' ' 114' ' ' ALA . 29.2 m -59.6 -50.7 79.0 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.663 0 C-N-CA 119.652 -0.819 . . . . 1.0 109.723 179.885 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 119' ' ' LEU . . . . . 0.408 ' N ' HG23 ' A' ' 118' ' ' VAL . 0.4 OUTLIER -52.54 -71.29 0.07 Allowed 'General case' 0 CA--C 1.539 0.534 0 N-CA-C 106.845 -1.539 . . . . 1.0 106.845 -178.083 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 120' ' ' GLY . . . . . 0.701 ' O ' ' OG1' ' A' ' 121' ' ' THR . . . -69.28 -79.2 0.3 Allowed Glycine 0 CA--C 1.539 1.537 0 C-N-CA 119.133 -1.508 . . . . 1.0 111.023 179.964 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 121' ' ' THR . . . . . 0.701 ' OG1' ' O ' ' A' ' 120' ' ' GLY . 51.8 m 157.3 -32.01 0.0 OUTLIER 'General case' 0 N--CA 1.487 1.417 0 CA-C-N 112.422 -1.889 . . . . 1.0 111.818 179.859 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 122' ' ' GLY . . . . . 0.621 ' O ' ' N ' ' A' ' 124' ' ' ASP . . . 98.0 -21.81 44.12 Favored Glycine 0 N--CA 1.465 0.613 0 N-CA-C 108.027 -2.029 . . . . 1.0 108.027 -177.291 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 123' ' ' THR . . . . . 0.547 ' O ' ' CE1' ' A' ' 72' ' ' HIS . 58.3 m -46.22 90.61 0.0 OUTLIER 'General case' 0 N--CA 1.476 0.839 0 N-CA-C 105.928 -1.878 . . . . 1.0 105.928 177.832 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 124' ' ' ASP . . . . . 0.621 ' N ' ' O ' ' A' ' 122' ' ' GLY . 51.4 p-10 -162.86 171.1 17.19 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 115.596 -0.729 . . . . 1.0 112.177 -179.343 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 125' ' ' TYR . . . . . . . . . . . . . 86.0 t80 -142.55 141.91 32.11 Favored 'General case' 0 C--N 1.329 -0.315 0 N-CA-C 108.758 -0.831 . . . . 1.0 108.758 176.593 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 126' ' ' ARG . . . . . 0.442 HH22 ' HB ' ' A' ' 79' ' ' ILE . 14.3 mmm180 -147.75 147.87 30.35 Favored 'General case' 0 CA--C 1.533 0.306 0 N-CA-C 109.876 -0.416 . . . . 1.0 109.876 179.218 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 127' ' ' PHE . . . . . . . . . . . . . 23.2 t80 . . . . . 0 N--CA 1.471 0.607 0 CA-C-O 117.995 -1.003 . . . . 1.0 110.824 179.775 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 2.7 mmt . . . . . 0 N--CA 1.489 1.479 0 N-CA-C 108.838 -0.801 . . . . 1.0 108.838 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 2' ' ' SER . . . . . 0.503 ' O ' ' CB ' ' A' ' 3' ' ' ASP . 47.1 t -73.36 4.94 4.07 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.218 -0.446 . . . . 1.0 110.732 179.777 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 3' ' ' ASP . . . . . 0.503 ' CB ' ' O ' ' A' ' 2' ' ' SER . 12.0 p30 149.22 135.57 0.0 OUTLIER 'General case' 0 N--CA 1.478 0.928 0 O-C-N 123.725 0.64 . . . . 1.0 110.81 179.759 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 87.3 t80 -154.15 149.43 27.07 Favored 'General case' 0 CA--C 1.518 -0.268 0 CA-C-O 121.014 0.435 . . . . 1.0 110.365 178.982 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 5' ' ' ASP . . . . . 0.417 ' HB2' ' N ' ' A' ' 10' ' ' SER . 0.9 OUTLIER -150.78 147.33 27.16 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.133 -0.485 . . . . 1.0 110.055 179.935 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 6' ' ' THR . . . . . 0.731 ' O ' ' N ' ' A' ' 10' ' ' SER . 0.2 OUTLIER -112.21 -162.74 0.81 Allowed 'General case' 0 C--O 1.207 -1.172 0 CA-C-O 121.629 0.728 . . . . 1.0 110.749 -178.639 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 7' ' ' GLU . . . . . 0.548 ' O ' ' HB2' ' A' ' 11' ' ' ARG . 73.2 mm-40 -54.41 -43.45 71.52 Favored 'General case' 0 C--N 1.304 -1.399 0 CA-C-O 121.984 0.897 . . . . 1.0 108.733 -179.233 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 8' ' ' ARG . . . . . 0.902 ' O ' ' HB3' ' A' ' 12' ' ' ALA . 60.0 mtp180 -72.73 -60.68 2.12 Favored 'General case' 0 C--N 1.313 -0.987 0 C-N-CA 118.095 -1.442 . . . . 1.0 110.487 177.713 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 9' ' ' VAL . . . . . 1.005 ' O ' ' HB ' ' A' ' 13' ' ' VAL . 10.7 t -60.51 -51.11 76.91 Favored 'Isoleucine or valine' 0 C--O 1.196 -1.761 0 C-N-CA 117.921 -1.512 . . . . 1.0 110.639 179.963 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 10' ' ' SER . . . . . 0.731 ' N ' ' O ' ' A' ' 6' ' ' THR . 2.6 t -70.09 -66.25 0.62 Allowed 'General case' 0 C--N 1.303 -1.445 0 O-C-N 121.271 -0.893 . . . . 1.0 113.03 -178.775 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 11' ' ' ARG . . . . . 0.548 ' HB2' ' O ' ' A' ' 7' ' ' GLU . 1.7 mmt85 -62.11 -43.87 97.89 Favored 'General case' 0 C--N 1.318 -0.787 0 CA-C-O 120.455 0.169 . . . . 1.0 111.4 -176.496 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 12' ' ' ALA . . . . . 0.902 ' HB3' ' O ' ' A' ' 8' ' ' ARG . . . -70.74 -59.7 2.66 Favored 'General case' 0 C--N 1.32 -0.68 0 C-N-CA 118.4 -1.32 . . . . 1.0 110.241 -179.993 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 13' ' ' VAL . . . . . 1.005 ' HB ' ' O ' ' A' ' 9' ' ' VAL . 4.6 t -57.35 -51.3 71.28 Favored 'Isoleucine or valine' 0 C--O 1.199 -1.605 0 N-CA-C 107.029 -1.471 . . . . 1.0 107.029 179.503 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 14' ' ' ALA . . . . . 0.954 ' O ' HG22 ' A' ' 18' ' ' VAL . . . -62.06 -66.5 0.53 Allowed 'General case' 0 C--N 1.306 -1.284 0 C-N-CA 115.549 -2.461 . . . . 1.0 113.061 -178.765 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 15' ' ' ALA . . . . . 0.546 ' HB3' ' O ' ' A' ' 11' ' ' ARG . . . -51.18 -55.27 18.82 Favored 'General case' 0 C--N 1.319 -0.737 0 C-N-CA 119.706 -0.797 . . . . 1.0 109.257 -178.728 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 16' ' ' ALA . . . . . 0.659 ' HB3' ' O ' ' A' ' 12' ' ' ALA . . . -64.35 -59.17 4.69 Favored 'General case' 0 C--N 1.299 -1.605 0 C-N-CA 118.101 -1.44 . . . . 1.0 111.346 -179.924 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 17' ' ' LEU . . . . . 0.701 ' CB ' ' O ' ' A' ' 13' ' ' VAL . 6.8 tt -55.09 -55.23 33.36 Favored 'General case' 0 N--CA 1.477 0.876 0 N-CA-C 108.832 -0.803 . . . . 1.0 108.832 -177.051 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 18' ' ' VAL . . . . . 0.954 HG22 ' O ' ' A' ' 14' ' ' ALA . 2.3 m -71.26 -58.86 4.22 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 CA-C-N 115.895 -0.593 . . . . 1.0 110.212 -179.817 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 19' ' ' GLY . . . . . 0.558 ' N ' ' CG2' ' A' ' 18' ' ' VAL . . . -58.16 -166.44 0.12 Allowed Glycine 0 CA--C 1.491 -1.454 0 N-CA-C 110.815 -0.914 . . . . 1.0 110.815 -177.322 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 20' ' ' PRO . . . . . 0.607 ' O ' ' N ' ' A' ' 24' ' ' ALA . 1.0 OUTLIER -79.85 -26.18 4.72 Favored 'Trans proline' 0 C--N 1.292 -2.421 0 C-N-CA 122.032 1.822 . . . . 1.0 113.59 -177.657 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 21' ' ' GLY . . . . . 0.518 ' O ' ' HB3' ' A' ' 24' ' ' ALA . . . -62.68 -58.49 11.97 Favored Glycine 0 N--CA 1.473 1.156 0 C-N-CA 119.496 -1.335 . . . . 1.0 111.877 -178.217 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 22' ' ' GLY . . . . . 0.644 ' N ' ' O ' ' A' ' 16' ' ' ALA . . . -57.61 -54.15 39.53 Favored Glycine 0 C--N 1.307 -1.068 0 C-N-CA 116.447 -2.787 . . . . 1.0 107.073 -178.778 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 23' ' ' VAL . . . . . 0.516 ' O ' HG12 ' A' ' 27' ' ' VAL . 54.0 t -52.63 -31.26 15.8 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.042 0 N-CA-C 107.859 -1.163 . . . . 1.0 107.859 178.564 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 24' ' ' ALA . . . . . 0.607 ' N ' ' O ' ' A' ' 20' ' ' PRO . . . -63.72 -63.9 1.04 Allowed 'General case' 0 C--O 1.218 -0.593 0 C-N-CA 119.416 -0.914 . . . . 1.0 110.969 -179.467 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 61.6 mt -61.64 -46.47 89.63 Favored 'General case' 0 C--N 1.321 -0.64 0 C-N-CA 119.666 -0.814 . . . . 1.0 111.881 -176.571 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 92.1 t -60.35 -60.75 2.1 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.531 0 C-N-CA 119.708 -0.797 . . . . 1.0 110.041 -177.004 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 27' ' ' VAL . . . . . 0.551 ' O ' ' HB3' ' A' ' 31' ' ' ALA . 2.2 p -54.81 -36.68 38.05 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.736 0 C-N-CA 119.622 -0.831 . . . . 1.0 109.203 -177.819 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 28' ' ' LYS . . . . . 0.44 ' HB2' ' O ' ' A' ' 24' ' ' ALA . 3.7 tmmm? -66.2 -55.52 15.85 Favored 'General case' 0 C--N 1.315 -0.892 0 C-N-CA 119.254 -0.979 . . . . 1.0 110.713 -177.532 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 82.3 t -62.95 -49.9 81.76 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.973 0 CA-C-N 114.641 -1.163 . . . . 1.0 110.135 -177.517 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 30' ' ' CYS . . . . . . . . . . . . . 4.1 t -65.27 -62.11 1.73 Allowed 'General case' 0 N--CA 1.443 -0.822 0 C-N-CA 119.675 -0.81 . . . . 1.0 109.458 -178.544 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 31' ' ' ALA . . . . . 0.551 ' HB3' ' O ' ' A' ' 27' ' ' VAL . . . -51.71 -46.44 63.93 Favored 'General case' 0 CA--C 1.5 -0.97 0 CA-C-O 121.282 0.563 . . . . 1.0 110.568 -176.23 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 32' ' ' GLY . . . . . 0.462 ' O ' ' CB ' ' A' ' 33' ' ' LEU . . . 66.56 67.05 2.13 Favored Glycine 0 N--CA 1.443 -0.896 0 N-CA-C 109.627 -1.389 . . . . 1.0 109.627 -179.998 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 33' ' ' LEU . . . . . 0.462 ' CB ' ' O ' ' A' ' 32' ' ' GLY . 0.3 OUTLIER 82.88 104.26 0.03 OUTLIER Pre-proline 0 CA--C 1.542 0.644 0 CA-C-N 113.048 -1.576 . . . . 1.0 108.343 -178.622 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 52.2 Cg_exo -48.64 -20.34 2.64 Favored 'Trans proline' 0 N--CA 1.499 1.825 0 C-N-CA 122.504 2.136 . . . . 1.0 114.293 -178.259 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 35' ' ' GLY . . . . . 0.527 ' CA ' HD12 ' A' ' 112' ' ' ILE . . . -67.54 -62.72 4.16 Favored Glycine 0 N--CA 1.467 0.74 0 C-N-CA 118.357 -1.877 . . . . 1.0 112.27 -176.73 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 36' ' ' VAL . . . . . 0.75 ' O ' HG22 ' A' ' 37' ' ' ILE . 18.3 m -78.83 -153.88 0.03 OUTLIER 'Isoleucine or valine' 0 C--O 1.216 -0.696 0 N-CA-C 108.121 -1.066 . . . . 1.0 108.121 -179.119 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 37' ' ' ILE . . . . . 0.75 HG22 ' O ' ' A' ' 36' ' ' VAL . 0.3 OUTLIER 73.63 77.06 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.32 -0.688 0 O-C-N 124.2 0.938 . . . . 1.0 111.553 178.97 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 1.3 t60 -139.32 135.73 34.08 Favored 'General case' 0 CA--C 1.492 -1.278 0 O-C-N 120.906 -1.121 . . . . 1.0 109.329 179.4 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 3.3 m -115.32 132.19 23.2 Favored Pre-proline 0 N--CA 1.451 -0.409 0 C-N-CA 120.413 -0.515 . . . . 1.0 109.984 -178.913 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 23.6 Cg_endo -62.14 -15.21 42.56 Favored 'Trans proline' 0 N--CA 1.494 1.52 0 C-N-CA 122.039 1.826 . . . . 1.0 112.179 179.356 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -128.79 135.11 48.7 Favored 'General case' 0 N--CA 1.468 0.438 0 CA-C-N 116.729 -0.214 . . . . 1.0 110.504 178.399 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 42' ' ' ARG . . . . . 0.573 ' HG2' ' N ' ' A' ' 43' ' ' ARG . 39.1 ttp180 -173.16 174.25 3.45 Favored 'General case' 0 C--N 1.328 -0.339 0 C-N-CA 120.558 -0.457 . . . . 1.0 111.14 178.718 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 43' ' ' ARG . . . . . 0.573 ' N ' ' HG2' ' A' ' 42' ' ' ARG . 67.1 ttt-85 -57.61 -45.97 84.68 Favored 'General case' 0 CA--C 1.538 0.517 0 N-CA-C 107.697 -1.224 . . . . 1.0 107.697 178.53 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 44' ' ' GLY . . . . . 0.436 ' O ' ' CD1' ' A' ' 45' ' ' PHE . . . 121.58 -25.03 7.04 Favored Glycine 0 N--CA 1.481 1.675 0 CA-C-N 116.925 -0.125 . . . . 1.0 112.829 179.653 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 45' ' ' PHE . . . . . 0.815 ' O ' ' HB2' ' A' ' 46' ' ' PHE . 1.5 m-85 -158.58 167.52 29.38 Favored 'General case' 0 C--N 1.306 -1.314 0 N-CA-C 108.23 -1.026 . . . . 1.0 108.23 179.564 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 46' ' ' PHE . . . . . 0.815 ' HB2' ' O ' ' A' ' 45' ' ' PHE . 0.2 OUTLIER 107.45 116.7 0.01 OUTLIER 'General case' 0 N--CA 1.472 0.66 0 O-C-N 125.094 1.496 . . . . 1.0 111.367 179.408 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 47' ' ' ARG . . . . . 0.459 ' CB ' ' O ' ' A' ' 46' ' ' PHE . 9.5 ptt85 90.36 156.5 0.04 OUTLIER 'General case' 0 N--CA 1.479 1.01 0 O-C-N 123.64 0.587 . . . . 1.0 111.405 179.325 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 37.3 t 61.15 68.08 0.76 Allowed 'General case' 0 CA--C 1.509 -0.609 0 CA-C-N 116.151 -0.477 . . . . 1.0 109.851 179.145 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 49' ' ' ASN . . . . . 0.667 ' O ' ' N ' ' A' ' 51' ' ' GLU . 1.6 p30 -149.56 159.14 36.97 Favored Pre-proline 0 C--N 1.315 -0.898 0 CA-C-N 115.869 -0.605 . . . . 1.0 109.381 179.203 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 4.1 Cg_endo -48.87 53.34 0.02 OUTLIER 'Trans proline' 0 N--CA 1.511 2.527 0 C-N-CA 123.981 3.121 . . . . 1.0 113.919 177.544 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 51' ' ' GLU . . . . . 0.667 ' N ' ' O ' ' A' ' 49' ' ' ASN . 2.7 mm-40 42.56 57.71 3.37 Favored 'General case' 0 CA--C 1.536 0.414 0 CA-C-O 121.246 0.546 . . . . 1.0 111.756 178.038 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 52' ' ' ARG . . . . . 0.854 HH21 HD12 ' A' ' 85' ' ' ILE . 2.5 ptm180 -156.36 168.83 26.12 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.308 -0.406 . . . . 1.0 111.501 179.225 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 53' ' ' ILE . . . . . 0.427 HG13 ' N ' ' A' ' 54' ' ' GLN . 7.4 tp -83.44 166.94 2.06 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 N-CA-C 108.612 -0.884 . . . . 1.0 108.612 176.65 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 54' ' ' GLN . . . . . 0.427 ' N ' HG13 ' A' ' 53' ' ' ILE . 35.8 mt-30 -134.72 134.31 40.88 Favored 'General case' 0 N--CA 1.467 0.415 0 O-C-N 121.775 -0.578 . . . . 1.0 109.551 179.419 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 55' ' ' ILE . . . . . 0.476 HG22 HD11 ' A' ' 85' ' ' ILE . 19.9 tt -144.36 154.06 15.12 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.637 0 N-CA-C 110.139 -0.319 . . . . 1.0 110.139 178.948 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 103.23 4.51 47.29 Favored Glycine 0 N--CA 1.469 0.866 0 N-CA-C 110.178 -1.169 . . . . 1.0 110.178 -179.059 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 29.3 t70 -95.49 114.16 25.89 Favored 'General case' 0 CA--C 1.54 0.589 0 N-CA-C 113.632 0.975 . . . . 1.0 113.632 -178.886 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 58' ' ' TRP . . . . . 0.539 ' HB2' ' HB2' ' A' ' 61' ' ' GLU . 35.4 m95 -83.07 -176.69 6.46 Favored 'General case' 0 C--O 1.236 0.375 0 CA-C-N 112.527 -2.124 . . . . 1.0 109.677 176.15 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 59' ' ' ARG . . . . . 0.584 ' HD2' ' H ' ' A' ' 59' ' ' ARG . 0.0 OUTLIER -94.45 -55.61 3.1 Favored 'General case' 0 CA--C 1.547 0.844 0 CA-C-O 121.545 0.688 . . . . 1.0 110.471 179.566 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 60' ' ' TYR . . . . . 0.544 ' O ' ' CG ' ' A' ' 60' ' ' TYR . 4.7 t80 -73.96 -5.69 42.78 Favored 'General case' 0 N--CA 1.469 0.481 0 C-N-CA 124.338 1.055 . . . . 1.0 110.146 178.317 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 61' ' ' GLU . . . . . 0.539 ' HB2' ' HB2' ' A' ' 58' ' ' TRP . 4.7 tt0 -68.57 -17.91 64.23 Favored 'General case' 0 C--N 1.312 -1.058 0 O-C-N 121.07 -1.019 . . . . 1.0 111.444 -179.56 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 62' ' ' VAL . . . . . 0.496 HG23 ' N ' ' A' ' 63' ' ' ALA . 16.1 m -42.01 -49.63 0.93 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.504 0 CA-C-O 121.118 0.485 . . . . 1.0 109.706 -174.42 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 63' ' ' ALA . . . . . 0.496 ' N ' HG23 ' A' ' 62' ' ' VAL . . . -64.23 -45.25 89.0 Favored 'General case' 0 N--CA 1.42 -1.958 0 N-CA-C 108.316 -0.994 . . . . 1.0 108.316 177.039 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 64' ' ' HIS . . . . . 0.529 ' N ' ' O ' ' A' ' 61' ' ' GLU . 0.1 OUTLIER -56.68 -61.3 2.52 Favored 'General case' 0 CA--C 1.537 0.455 0 C-N-CA 118.927 -1.109 . . . . 1.0 111.108 179.803 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 65' ' ' ASP . . . . . 0.715 ' C ' ' H ' ' A' ' 67' ' ' ARG . 4.6 m-20 -63.19 -48.44 78.32 Favored 'General case' 0 C--O 1.24 0.594 0 CA-C-O 121.526 0.679 . . . . 1.0 109.808 179.139 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -62.2 28.76 0.06 OUTLIER Glycine 0 C--N 1.317 -0.499 0 N-CA-C 110.87 -0.892 . . . . 1.0 110.87 -179.09 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 67' ' ' ARG . . . . . 0.715 ' H ' ' C ' ' A' ' 65' ' ' ASP . 0.0 OUTLIER -82.92 -13.82 55.33 Favored 'General case' 0 N--CA 1.436 -1.153 0 C-N-CA 122.766 0.426 . . . . 1.0 111.558 176.394 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 68' ' ' LEU . . . . . 0.672 ' O ' ' HA ' ' A' ' 72' ' ' HIS . 0.8 OUTLIER -40.24 -30.11 0.09 Allowed 'General case' 0 C--O 1.22 -0.451 0 N-CA-C 107.009 -1.478 . . . . 1.0 107.009 179.05 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 69' ' ' LEU . . . . . 0.488 ' N ' ' C ' ' A' ' 67' ' ' ARG . 3.4 tt -65.67 -66.12 0.59 Allowed 'General case' 0 C--N 1.311 -1.071 0 C-N-CA 117.39 -1.724 . . . . 1.0 108.267 177.877 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 70' ' ' ALA . . . . . 0.697 ' C ' ' H ' ' A' ' 72' ' ' HIS . . . -76.32 -74.45 0.23 Allowed 'General case' 0 N--CA 1.466 0.346 0 N-CA-C 108.895 -0.78 . . . . 1.0 108.895 -179.753 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 71' ' ' ALA . . . . . 0.695 ' HB1' ' HB ' ' A' ' 74' ' ' VAL . . . -58.0 13.51 0.01 OUTLIER 'General case' 0 C--N 1.321 -0.65 0 C-N-CA 124.25 1.02 . . . . 1.0 110.851 -178.163 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 72' ' ' HIS . . . . . 0.697 ' H ' ' C ' ' A' ' 70' ' ' ALA . 0.3 OUTLIER -12.07 -74.53 0.01 OUTLIER 'General case' 0 N--CA 1.478 0.959 0 C-N-CA 124.295 1.038 . . . . 1.0 113.113 -174.654 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 73' ' ' MET . . . . . . . . . . . . . 1.4 mpt? -62.63 -41.91 99.29 Favored 'General case' 0 C--N 1.285 -2.216 0 C-N-CA 119.164 -1.014 . . . . 1.0 111.565 -178.431 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 74' ' ' VAL . . . . . 0.695 ' HB ' ' HB1' ' A' ' 71' ' ' ALA . 41.4 t -44.27 -49.3 2.12 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.346 0 C-N-CA 119.864 -0.734 . . . . 1.0 110.103 -175.515 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 75' ' ' ASN . . . . . 0.498 ' O ' ' N ' ' A' ' 77' ' ' ILE . 14.0 t-20 -39.52 -21.57 0.01 OUTLIER 'General case' 0 N--CA 1.472 0.664 0 CA-C-O 122.787 1.279 . . . . 1.0 111.441 -179.815 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 76' ' ' GLY . . . . . 0.569 ' N ' ' O ' ' A' ' 74' ' ' VAL . . . -43.87 -19.5 0.11 Allowed Glycine 0 CA--C 1.539 1.585 0 CA-C-N 113.662 -1.608 . . . . 1.0 109.827 178.674 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 77' ' ' ILE . . . . . 0.655 ' O ' ' N ' ' A' ' 80' ' ' ALA . 10.3 pt -88.17 -47.0 15.72 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.45 0 N-CA-C 108.386 -0.968 . . . . 1.0 108.386 -178.674 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 78' ' ' VAL . . . . . 0.524 ' O ' ' HB3' ' A' ' 82' ' ' ASP . 21.6 t -37.74 -35.7 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.433 -1.3 0 N-CA-C 108.14 -1.059 . . . . 1.0 108.14 -177.165 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 79' ' ' ILE . . . . . 0.551 ' O ' ' HB3' ' A' ' 83' ' ' ALA . 0.3 OUTLIER -87.07 -24.48 6.39 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.34 0 CA-C-O 121.03 0.443 . . . . 1.0 111.083 179.577 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 80' ' ' ALA . . . . . 0.655 ' N ' ' O ' ' A' ' 77' ' ' ILE . . . -73.29 -10.48 59.8 Favored 'General case' 0 C--N 1.319 -0.737 0 O-C-N 122.21 -0.306 . . . . 1.0 111.809 179.119 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 71.8 mt-10 -120.99 -62.79 1.41 Allowed 'General case' 0 CA--C 1.531 0.247 0 CA-C-O 121.705 0.764 . . . . 1.0 111.133 176.953 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 82' ' ' ASP . . . . . 0.839 ' O ' HG13 ' A' ' 85' ' ' ILE . 0.0 OUTLIER -58.73 -62.83 1.58 Allowed 'General case' 0 C--O 1.202 -1.401 0 CA-C-N 114.939 -1.028 . . . . 1.0 109.561 -179.54 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 83' ' ' ALA . . . . . 0.551 ' HB3' ' O ' ' A' ' 79' ' ' ILE . . . -56.63 -38.08 71.63 Favored 'General case' 0 CA--C 1.506 -0.718 0 C-N-CA 119.803 -0.759 . . . . 1.0 110.14 -176.087 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 84' ' ' LEU . . . . . 0.713 HD13 ' O ' ' A' ' 84' ' ' LEU . 3.4 tm? -32.01 -35.32 0.02 OUTLIER 'General case' 0 CA--C 1.51 -0.564 0 CA-C-N 115.525 -0.762 . . . . 1.0 111.839 -174.647 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 85' ' ' ILE . . . . . 0.854 HD12 HH21 ' A' ' 52' ' ' ARG . 4.7 mt -43.96 -17.83 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.323 -0.544 0 C-N-CA 120.492 -0.483 . . . . 1.0 110.205 179.622 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 86' ' ' ALA . . . . . 0.674 ' O ' ' N ' ' A' ' 90' ' ' GLY . . . -60.61 -58.46 8.37 Favored 'General case' 0 C--O 1.221 -0.446 0 C-N-CA 119.898 -0.721 . . . . 1.0 109.768 179.852 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 87' ' ' GLU . . . . . 0.444 ' OE1' ' N ' ' A' ' 87' ' ' GLU . 0.2 OUTLIER -35.64 -24.15 0.01 OUTLIER 'General case' 0 N--CA 1.468 0.468 0 CA-C-O 121.023 0.44 . . . . 1.0 110.663 -177.981 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 88' ' ' ALA . . . . . 0.621 ' N ' ' O ' ' A' ' 86' ' ' ALA . . . -101.31 -43.46 5.95 Favored 'General case' 0 C--O 1.237 0.444 0 N-CA-C 109.099 -0.704 . . . . 1.0 109.099 177.324 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 89' ' ' VAL . . . . . 0.634 ' C ' ' HD2' ' A' ' 91' ' ' PRO . 3.0 t -100.19 38.26 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.34 0.186 0 N-CA-C 108.775 -0.824 . . . . 1.0 108.775 178.01 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 90' ' ' GLY . . . . . 0.889 ' O ' ' N ' ' A' ' 92' ' ' HIS . . . -62.08 -17.59 55.78 Favored Glycine 0 C--N 1.358 1.801 0 CA-C-O 117.553 -1.693 . . . . 1.0 111.92 177.83 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 91' ' ' PRO . . . . . 0.783 ' HD2' ' N ' ' A' ' 90' ' ' GLY . 75.3 Cg_exo -32.62 1.01 0.0 OUTLIER 'Trans proline' 0 N--CA 1.513 2.659 0 C-N-CA 124.382 3.388 . . . . 1.0 113.694 171.811 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 92' ' ' HIS . . . . . 0.889 ' N ' ' O ' ' A' ' 90' ' ' GLY . 42.1 t-80 -49.88 -30.11 9.43 Favored 'General case' 0 N--CA 1.427 -1.591 0 N-CA-C 108.357 -0.979 . . . . 1.0 108.357 176.479 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 93' ' ' LEU . . . . . 0.672 ' O ' ' N ' ' A' ' 96' ' ' ALA . 0.8 OUTLIER -61.17 -60.64 3.45 Favored 'General case' 0 C--O 1.222 -0.367 0 N-CA-C 107.358 -1.349 . . . . 1.0 107.358 177.684 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 94' ' ' ALA . . . . . 0.607 ' HB3' HH21 ' A' ' 95' ' ' ARG . . . -45.75 -51.18 13.01 Favored 'General case' 0 N--CA 1.437 -1.104 0 N-CA-C 108.064 -1.087 . . . . 1.0 108.064 -179.193 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 95' ' ' ARG . . . . . 0.607 HH21 ' HB3' ' A' ' 94' ' ' ALA . 0.0 OUTLIER -60.21 -25.27 65.48 Favored 'General case' 0 N--CA 1.434 -1.226 0 C-N-CA 120.013 -0.675 . . . . 1.0 109.334 176.494 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 96' ' ' ALA . . . . . 0.759 ' O ' ' N ' ' A' ' 100' ' ' ILE . . . -57.05 -52.1 66.61 Favored 'General case' 0 C--O 1.207 -1.135 0 N-CA-C 107.227 -1.397 . . . . 1.0 107.227 179.511 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 97' ' ' LEU . . . . . 0.705 ' O ' HG22 ' A' ' 100' ' ' ILE . 0.1 OUTLIER -35.55 -29.16 0.01 OUTLIER 'General case' 0 CA--C 1.567 1.63 0 N-CA-C 107.238 -1.393 . . . . 1.0 107.238 -179.716 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 98' ' ' GLY . . . . . 0.611 ' N ' ' O ' ' A' ' 96' ' ' ALA . . . -81.51 -52.9 4.01 Favored Glycine 0 CA--C 1.551 2.309 0 CA-C-O 123.083 1.379 . . . . 1.0 110.831 174.422 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 99' ' ' GLN . . . . . 0.612 ' N ' ' O ' ' A' ' 96' ' ' ALA . 27.0 mt-30 -79.19 7.66 7.24 Favored 'General case' 0 N--CA 1.438 -1.028 0 N-CA-C 108.548 -0.908 . . . . 1.0 108.548 178.366 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 100' ' ' ILE . . . . . 0.759 ' N ' ' O ' ' A' ' 96' ' ' ALA . 16.7 tt -60.39 -51.25 75.2 Favored 'Isoleucine or valine' 0 CA--C 1.493 -1.233 0 N-CA-C 108.71 -0.848 . . . . 1.0 108.71 179.826 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 101' ' ' VAL . . . . . 0.674 ' N ' HG23 ' A' ' 100' ' ' ILE . 24.1 t -55.05 -57.12 7.87 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.977 0 C-N-CA 117.083 -1.847 . . . . 1.0 107.058 178.058 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 102' ' ' CYS . . . . . 0.786 ' O ' ' HB2' ' A' ' 106' ' ' ALA . 4.9 t -44.47 -25.63 0.28 Allowed 'General case' 0 C--O 1.214 -0.791 0 C-N-CA 120.085 -0.646 . . . . 1.0 109.854 -178.944 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 103' ' ' ARG . . . . . 0.426 ' N ' ' C ' ' A' ' 101' ' ' VAL . 1.7 tpp85 -87.19 -45.06 11.0 Favored 'General case' 0 N--CA 1.476 0.862 0 N-CA-C 113.444 0.905 . . . . 1.0 113.444 179.459 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 104' ' ' TYR . . . . . 0.747 ' O ' ' CG ' ' A' ' 104' ' ' TYR . 3.0 t80 -99.19 19.63 14.98 Favored 'General case' 0 C--N 1.31 -1.121 0 C-N-CA 127.066 2.146 . . . . 1.0 110.137 -179.623 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 105' ' ' GLY . . . . . 0.869 ' O ' HG23 ' A' ' 107' ' ' THR . . . -164.27 -7.79 0.03 OUTLIER Glycine 0 N--CA 1.441 -0.975 0 C-N-CA 117.891 -2.1 . . . . 1.0 111.588 177.337 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 106' ' ' ALA . . . . . 0.786 ' HB2' ' O ' ' A' ' 102' ' ' CYS . . . -15.53 62.7 0.0 OUTLIER 'General case' 0 N--CA 1.471 0.6 0 O-C-N 125.147 1.145 . . . . 1.0 111.997 -179.034 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 107' ' ' THR . . . . . 0.869 HG23 ' O ' ' A' ' 105' ' ' GLY . 11.4 p -100.38 -2.81 32.47 Favored 'General case' 0 CA--C 1.534 0.339 0 CA-C-N 116.265 -0.425 . . . . 1.0 110.119 -179.425 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 108' ' ' VAL . . . . . 0.732 HG13 ' N ' ' A' ' 109' ' ' ILE . 8.1 p -84.72 -57.84 4.03 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.427 0 CA-C-N 116.389 -0.369 . . . . 1.0 111.057 -178.194 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 109' ' ' ILE . . . . . 0.732 ' N ' HG13 ' A' ' 108' ' ' VAL . 0.2 OUTLIER -47.22 -47.76 56.03 Favored Pre-proline 0 CA--C 1.503 -0.842 0 C-N-CA 122.756 0.422 . . . . 1.0 111.852 179.458 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 110' ' ' PRO . . . . . 0.618 ' HD2' ' N ' ' A' ' 109' ' ' ILE . 6.0 Cg_endo -40.65 -39.84 3.15 Favored 'Trans proline' 0 CA--C 1.507 -0.85 0 C-N-CA 121.025 1.15 . . . . 1.0 114.081 -172.414 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 19.6 m-20 -65.09 -68.0 0.39 Allowed 'General case' 0 C--N 1.305 -1.33 0 C-N-CA 119.047 -1.061 . . . . 1.0 110.475 -176.967 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 112' ' ' ILE . . . . . 0.527 HD12 ' CA ' ' A' ' 35' ' ' GLY . 0.0 OUTLIER -69.21 -25.48 29.65 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.788 0 CA-C-N 115.498 -0.773 . . . . 1.0 110.594 -178.012 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 113' ' ' ASN . . . . . 0.485 ' CB ' ' O ' ' A' ' 109' ' ' ILE . 7.0 t30 -54.65 -61.83 2.05 Favored 'General case' 0 CA--C 1.488 -1.438 0 CA-C-N 114.268 -1.333 . . . . 1.0 110.854 -174.882 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -65.12 -20.46 66.47 Favored 'General case' 0 N--CA 1.432 -1.35 0 O-C-N 124.233 0.958 . . . . 1.0 110.255 -179.723 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -75.33 -61.78 1.79 Allowed 'General case' 0 C--O 1.241 0.624 0 C-N-CA 120.255 -0.578 . . . . 1.0 112.078 178.86 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 116' ' ' ILE . . . . . 0.484 ' O ' ' CB ' ' A' ' 119' ' ' LEU . 26.5 pt -68.52 -40.92 82.72 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.498 0 O-C-N 121.079 -1.013 . . . . 1.0 111.589 -177.895 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 117' ' ' GLU . . . . . 0.471 ' C ' ' N ' ' A' ' 119' ' ' LEU . 2.6 tt0 -47.21 -66.2 0.44 Allowed 'General case' 0 C--N 1.317 -0.823 0 CA-C-N 115.42 -0.809 . . . . 1.0 110.432 -177.18 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 72.0 t -50.11 -14.58 0.26 Allowed 'Isoleucine or valine' 0 N--CA 1.437 -1.121 0 O-C-N 124.572 1.17 . . . . 1.0 109.332 -178.822 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 119' ' ' LEU . . . . . 0.484 ' CB ' ' O ' ' A' ' 116' ' ' ILE . 0.2 OUTLIER -79.04 -62.6 1.64 Allowed 'General case' 0 N--CA 1.451 -0.413 0 C-N-CA 119.316 -0.954 . . . . 1.0 109.514 176.345 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -70.18 -84.98 0.16 Allowed Glycine 0 N--CA 1.481 1.689 0 C-N-CA 117.53 -2.271 . . . . 1.0 112.052 -179.139 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 34.0 m -161.8 -19.73 0.05 OUTLIER 'General case' 0 CA--C 1.542 0.651 0 CA-C-O 120.769 0.319 . . . . 1.0 110.231 -179.139 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 122' ' ' GLY . . . . . 0.481 ' O ' ' N ' ' A' ' 124' ' ' ASP . . . 111.59 -36.13 4.35 Favored Glycine 0 N--CA 1.477 1.387 0 C-N-CA 125.202 1.382 . . . . 1.0 112.138 179.752 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 123' ' ' THR . . . . . 0.464 ' C ' ' O ' ' A' ' 122' ' ' GLY . 0.0 OUTLIER -32.09 93.21 0.01 OUTLIER 'General case' 0 N--CA 1.469 0.523 0 CA-C-N 118.867 1.333 . . . . 1.0 112.461 -177.888 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 124' ' ' ASP . . . . . 0.481 ' N ' ' O ' ' A' ' 122' ' ' GLY . 8.7 t70 -141.49 141.6 33.62 Favored 'General case' 0 C--N 1.328 -0.352 0 N-CA-C 107.425 -1.324 . . . . 1.0 107.425 177.452 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 125' ' ' TYR . . . . . . . . . . . . . 9.7 t80 -153.58 147.24 25.16 Favored 'General case' 0 C--N 1.324 -0.532 0 N-CA-C 109.692 -0.484 . . . . 1.0 109.692 -177.569 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 9.0 mmp_? -147.5 152.08 37.43 Favored 'General case' 0 CA--C 1.542 0.646 0 CA-C-N 115.532 -0.758 . . . . 1.0 110.777 177.281 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 127' ' ' PHE . . . . . . . . . . . . . 22.6 p90 . . . . . 0 N--CA 1.47 0.574 0 CA-C-O 118.275 -0.869 . . . . 1.0 110.253 179.608 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 64.6 mtt . . . . . 0 N--CA 1.491 1.577 0 N-CA-C 109.332 -0.618 . . . . 1.0 109.332 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 88.9 p -103.63 7.7 37.51 Favored 'General case' 0 N--CA 1.467 0.398 0 CA-C-N 116.097 -0.501 . . . . 1.0 110.751 -179.723 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 3' ' ' ASP . . . . . 0.459 ' N ' ' OD1' ' A' ' 3' ' ' ASP . 1.6 p30 167.42 99.87 0.0 OUTLIER 'General case' 0 N--CA 1.466 0.342 0 CA-C-N 116.109 -0.496 . . . . 1.0 110.42 179.096 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 16.6 t80 -150.21 145.82 26.47 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.219 -0.446 . . . . 1.0 110.059 179.329 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 5' ' ' ASP . . . . . 0.615 ' OD1' ' N ' ' A' ' 10' ' ' SER . 0.3 OUTLIER -157.21 153.42 27.58 Favored 'General case' 0 C--N 1.327 -0.377 0 N-CA-C 109.887 -0.412 . . . . 1.0 109.887 179.674 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 6' ' ' THR . . . . . 0.657 ' O ' ' N ' ' A' ' 10' ' ' SER . 0.2 OUTLIER -75.01 175.74 7.87 Favored 'General case' 0 C--O 1.212 -0.872 0 CA-C-N 116.112 -0.495 . . . . 1.0 111.802 -178.123 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 7' ' ' GLU . . . . . 0.504 ' O ' ' N ' ' A' ' 11' ' ' ARG . 0.5 OUTLIER -58.7 -56.21 25.19 Favored 'General case' 0 N--CA 1.478 0.974 0 CA-C-N 115.72 -0.673 . . . . 1.0 109.863 -178.781 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 8' ' ' ARG . . . . . 0.725 ' O ' ' HB3' ' A' ' 12' ' ' ALA . 0.0 OUTLIER -49.39 -54.77 15.67 Favored 'General case' 0 C--N 1.318 -0.794 0 N-CA-C 106.349 -1.723 . . . . 1.0 106.349 -178.034 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 9' ' ' VAL . . . . . 0.792 ' O ' ' HB ' ' A' ' 13' ' ' VAL . 1.3 t -63.74 -46.46 94.49 Favored 'Isoleucine or valine' 0 C--O 1.193 -1.914 0 CA-C-N 111.834 -2.439 . . . . 1.0 109.165 -179.705 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 10' ' ' SER . . . . . 0.657 ' N ' ' O ' ' A' ' 6' ' ' THR . 6.6 t -69.67 -63.32 1.1 Allowed 'General case' 0 N--CA 1.487 1.405 0 N-CA-C 112.648 0.61 . . . . 1.0 112.648 -178.279 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 11' ' ' ARG . . . . . 0.519 ' O ' ' N ' ' A' ' 15' ' ' ALA . 3.6 mmt85 -64.07 -55.39 22.42 Favored 'General case' 0 N--CA 1.478 0.963 0 CA-C-O 121.119 0.485 . . . . 1.0 110.866 -176.402 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 12' ' ' ALA . . . . . 0.725 ' HB3' ' O ' ' A' ' 8' ' ' ARG . . . -51.24 -50.73 58.61 Favored 'General case' 0 C--N 1.314 -0.953 0 N-CA-C 106.363 -1.717 . . . . 1.0 106.363 -178.756 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 13' ' ' VAL . . . . . 0.792 ' HB ' ' O ' ' A' ' 9' ' ' VAL . 8.1 t -60.62 -52.26 63.54 Favored 'Isoleucine or valine' 0 C--O 1.197 -1.662 0 C-N-CA 119.419 -0.912 . . . . 1.0 109.184 176.823 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 14' ' ' ALA . . . . . 0.651 ' O ' HG13 ' A' ' 18' ' ' VAL . . . -58.24 -62.13 2.06 Favored 'General case' 0 C--O 1.21 -1.019 0 C-N-CA 118.682 -1.207 . . . . 1.0 110.185 -179.352 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 15' ' ' ALA . . . . . 0.563 ' O ' ' N ' ' A' ' 19' ' ' GLY . . . -52.25 -55.64 19.98 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-O 121.918 0.866 . . . . 1.0 109.943 -178.245 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 16' ' ' ALA . . . . . 0.553 ' CA ' ' H ' ' A' ' 22' ' ' GLY . . . -61.27 -54.76 39.94 Favored 'General case' 0 C--N 1.311 -1.101 0 CA-C-N 114.413 -1.267 . . . . 1.0 109.097 -179.269 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 17' ' ' LEU . . . . . 0.578 ' CB ' ' O ' ' A' ' 13' ' ' VAL . 7.0 tt -57.79 -53.7 55.24 Favored 'General case' 0 N--CA 1.482 1.153 0 CA-C-N 114.001 -1.454 . . . . 1.0 109.294 -177.693 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 18' ' ' VAL . . . . . 0.651 HG13 ' O ' ' A' ' 14' ' ' ALA . 2.6 m -68.98 -56.67 11.17 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.501 0 C-N-CA 119.268 -0.973 . . . . 1.0 109.274 178.978 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 19' ' ' GLY . . . . . 0.563 ' N ' ' O ' ' A' ' 15' ' ' ALA . . . -66.74 -160.59 1.0 Allowed Glycine 0 CA--C 1.534 1.248 0 CA-C-N 116.771 -0.195 . . . . 1.0 113.162 -178.037 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 20' ' ' PRO . . . . . 0.588 ' O ' ' HB2' ' A' ' 24' ' ' ALA . 90.8 Cg_endo -79.87 -30.02 2.49 Favored 'Trans proline' 0 N--CA 1.502 2.026 0 C-N-CA 123.476 2.784 . . . . 1.0 115.117 -177.42 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -60.15 -58.21 15.21 Favored Glycine 0 N--CA 1.478 1.437 0 C-N-CA 119.864 -1.16 . . . . 1.0 112.458 -176.296 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 22' ' ' GLY . . . . . 0.553 ' H ' ' CA ' ' A' ' 16' ' ' ALA . . . -59.16 -56.26 26.21 Favored Glycine 0 C--N 1.312 -0.757 0 N-CA-C 108.403 -1.879 . . . . 1.0 108.403 -177.243 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 23' ' ' VAL . . . . . 0.462 HG22 ' O ' ' A' ' 19' ' ' GLY . 34.6 m -59.77 -34.39 55.46 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.84 0 C-N-CA 120.109 -0.636 . . . . 1.0 109.713 -179.489 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 24' ' ' ALA . . . . . 0.588 ' HB2' ' O ' ' A' ' 20' ' ' PRO . . . -57.38 -61.52 2.43 Favored 'General case' 0 CA--C 1.534 0.337 0 C-N-CA 118.078 -1.449 . . . . 1.0 109.011 179.884 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 5.2 mp -63.85 -44.18 93.91 Favored 'General case' 0 C--N 1.347 0.465 0 C-N-CA 120.24 -0.584 . . . . 1.0 112.19 -178.598 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 73.8 t -60.87 -59.59 3.99 Favored 'Isoleucine or valine' 0 CA--C 1.527 0.083 0 C-N-CA 118.776 -1.169 . . . . 1.0 109.793 -177.991 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 27' ' ' VAL . . . . . 0.651 ' O ' ' HB3' ' A' ' 31' ' ' ALA . 83.9 t -59.97 -39.16 79.43 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.212 0 N-CA-C 112.19 0.441 . . . . 1.0 112.19 -178.429 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 27.5 tttm -65.94 -54.42 26.59 Favored 'General case' 0 C--N 1.319 -0.739 0 N-CA-C 108.941 -0.763 . . . . 1.0 108.941 -179.223 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 59.5 t -63.98 -48.44 86.05 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.825 0 CA-C-N 114.599 -1.182 . . . . 1.0 110.587 -177.892 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 30' ' ' CYS . . . . . . . . . . . . . 20.0 t -65.16 -61.23 2.26 Favored 'General case' 0 N--CA 1.446 -0.664 0 C-N-CA 119.245 -0.982 . . . . 1.0 109.566 -179.51 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 31' ' ' ALA . . . . . 0.651 ' HB3' ' O ' ' A' ' 27' ' ' VAL . . . -65.18 -53.2 48.49 Favored 'General case' 0 N--CA 1.453 -0.309 0 N-CA-C 113.487 0.921 . . . . 1.0 113.487 -176.24 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 84.6 77.89 1.15 Allowed Glycine 0 CA--C 1.527 0.822 0 C-N-CA 120.338 -0.934 . . . . 1.0 111.474 -179.76 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 33' ' ' LEU . . . . . 0.445 ' O ' ' N ' ' A' ' 35' ' ' GLY . 10.0 mp 69.89 101.37 0.04 OUTLIER Pre-proline 0 CA--C 1.548 0.88 0 C-N-CA 123.207 0.603 . . . . 1.0 110.25 -179.131 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 1.1 Cg_endo -45.26 -10.13 0.04 OUTLIER 'Trans proline' 0 N--CA 1.501 1.944 0 C-N-CA 122.109 1.872 . . . . 1.0 114.818 -179.247 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 35' ' ' GLY . . . . . 0.445 ' N ' ' O ' ' A' ' 33' ' ' LEU . . . -60.82 -59.76 9.62 Favored Glycine 0 N--CA 1.468 0.823 0 C-N-CA 118.223 -1.941 . . . . 1.0 110.088 -178.037 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 36' ' ' VAL . . . . . 0.884 HG22 ' H ' ' A' ' 37' ' ' ILE . 9.4 p -83.87 -146.58 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.465 0.324 0 N-CA-C 109.303 -0.629 . . . . 1.0 109.303 -179.945 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 37' ' ' ILE . . . . . 0.884 ' H ' HG22 ' A' ' 36' ' ' VAL . 2.2 mp 73.71 76.8 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.474 0.727 0 CA-C-N 117.949 0.341 . . . . 1.0 111.578 -179.551 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 98.9 m-70 -134.94 127.2 30.15 Favored 'General case' 0 N--CA 1.451 -0.385 0 N-CA-C 106.902 -1.518 . . . . 1.0 106.902 177.777 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 27.7 p -109.1 146.55 34.09 Favored Pre-proline 0 C--N 1.328 -0.349 0 N-CA-C 109.631 -0.507 . . . . 1.0 109.631 -179.037 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 51.0 Cg_endo -66.0 -24.94 52.23 Favored 'Trans proline' 0 C--N 1.306 -1.659 0 C-N-CA 121.502 1.468 . . . . 1.0 112.819 -178.854 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -126.81 130.15 49.69 Favored 'General case' 0 CA--C 1.516 -0.349 0 N-CA-C 109.567 -0.531 . . . . 1.0 109.567 178.921 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 42' ' ' ARG . . . . . 0.67 ' C ' ' H ' ' A' ' 44' ' ' GLY . 4.0 tmm_? -159.27 156.05 28.04 Favored 'General case' 0 C--N 1.318 -0.781 0 C-N-CA 119.908 -0.717 . . . . 1.0 109.175 178.05 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 43' ' ' ARG . . . . . 0.409 ' C ' ' H ' ' A' ' 45' ' ' PHE . 0.2 OUTLIER -62.97 17.95 0.01 OUTLIER 'General case' 0 C--N 1.32 -0.7 0 CA-C-N 115.963 -0.562 . . . . 1.0 110.147 179.204 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 44' ' ' GLY . . . . . 0.67 ' H ' ' C ' ' A' ' 42' ' ' ARG . . . 76.59 -27.19 1.58 Allowed Glycine 0 C--N 1.337 0.617 0 N-CA-C 111.306 -0.718 . . . . 1.0 111.306 179.389 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 45' ' ' PHE . . . . . 0.564 ' N ' ' CD1' ' A' ' 45' ' ' PHE . 0.1 OUTLIER -155.59 156.58 35.33 Favored 'General case' 0 CA--C 1.548 0.868 0 N-CA-C 109.795 -0.446 . . . . 1.0 109.795 -179.684 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 46' ' ' PHE . . . . . 0.613 ' O ' ' HB2' ' A' ' 47' ' ' ARG . 0.5 OUTLIER 139.66 85.36 0.0 OUTLIER 'General case' 0 N--CA 1.5 2.068 0 C-N-CA 126.23 1.812 . . . . 1.0 109.05 179.251 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 47' ' ' ARG . . . . . 0.613 ' HB2' ' O ' ' A' ' 46' ' ' PHE . 2.5 mtm-85 131.89 138.24 0.0 OUTLIER 'General case' 0 N--CA 1.505 2.294 0 C-N-CA 125.189 1.396 . . . . 1.0 109.989 178.528 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 48' ' ' CYS . . . . . 0.546 ' SG ' ' C ' ' A' ' 47' ' ' ARG . 0.0 OUTLIER 75.5 70.66 0.08 Allowed 'General case' 0 C--O 1.219 -0.531 0 N-CA-C 108.988 -0.745 . . . . 1.0 108.988 179.662 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 49' ' ' ASN . . . . . 0.649 ' O ' ' N ' ' A' ' 51' ' ' GLU . 1.2 p-10 -143.32 116.09 5.95 Favored Pre-proline 0 C--N 1.327 -0.407 0 N-CA-C 107.988 -1.116 . . . . 1.0 107.988 -179.733 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 74.7 Cg_exo -47.42 63.52 0.01 OUTLIER 'Trans proline' 0 N--CA 1.509 2.399 0 C-N-CA 122.688 2.258 . . . . 1.0 114.788 -178.801 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 51' ' ' GLU . . . . . 0.649 ' N ' ' O ' ' A' ' 49' ' ' ASN . 17.1 mp0 62.02 28.49 17.26 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.463 -0.335 . . . . 1.0 111.064 -179.644 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -102.71 134.34 46.25 Favored 'General case' 0 CA--C 1.516 -0.329 0 N-CA-C 109.206 -0.664 . . . . 1.0 109.206 178.55 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 53' ' ' ILE . . . . . 0.419 ' O ' ' N ' ' A' ' 55' ' ' ILE . 13.0 tt -57.92 138.58 18.68 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.374 0 CA-C-O 122.273 1.035 . . . . 1.0 112.066 -178.056 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 54' ' ' GLN . . . . . 0.544 ' OE1' ' CE2' ' A' ' 46' ' ' PHE . 0.0 OUTLIER -65.98 80.62 0.08 Allowed 'General case' 0 C--N 1.318 -0.794 0 CA-C-N 113.75 -1.568 . . . . 1.0 108.067 -179.761 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 55' ' ' ILE . . . . . 0.427 ' CG2' ' N ' ' A' ' 56' ' ' GLY . 11.7 mt -149.12 158.06 6.54 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.657 0 CA-C-N 115.864 -0.607 . . . . 1.0 109.835 178.694 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 56' ' ' GLY . . . . . 0.427 ' N ' ' CG2' ' A' ' 55' ' ' ILE . . . 111.62 -2.14 27.65 Favored Glycine 0 N--CA 1.468 0.817 0 N-CA-C 110.205 -1.158 . . . . 1.0 110.205 -179.865 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 57' ' ' ASP . . . . . 0.464 ' OD1' ' CG ' ' A' ' 45' ' ' PHE . 36.3 m-20 -79.19 97.95 6.41 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 115.234 -0.483 . . . . 1.0 110.533 179.533 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 58' ' ' TRP . . . . . . . . . . . . . 6.5 m0 -87.99 172.27 9.69 Favored 'General case' 0 CA--C 1.539 0.525 0 CA-C-O 123.0 1.381 . . . . 1.0 112.58 -177.956 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 59' ' ' ARG . . . . . 0.677 ' H ' ' CD ' ' A' ' 59' ' ' ARG . 0.0 OUTLIER -82.49 -60.43 2.2 Favored 'General case' 0 C--N 1.311 -1.097 0 CA-C-N 111.622 -2.535 . . . . 1.0 112.839 -179.31 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 44.8 t80 -91.69 -14.04 30.71 Favored 'General case' 0 C--N 1.317 -0.824 0 N-CA-C 113.777 1.028 . . . . 1.0 113.777 -179.118 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 4.6 tt0 -80.18 -14.61 58.32 Favored 'General case' 0 C--O 1.214 -0.804 0 O-C-N 121.709 -0.619 . . . . 1.0 110.592 -179.493 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 62' ' ' VAL . . . . . 0.637 ' O ' ' N ' ' A' ' 66' ' ' GLY . 28.9 m -46.46 -54.25 2.24 Favored 'Isoleucine or valine' 0 C--O 1.212 -0.92 0 C-N-CA 119.268 -0.973 . . . . 1.0 110.46 -175.715 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 63' ' ' ALA . . . . . 0.567 ' N ' HG23 ' A' ' 62' ' ' VAL . . . -67.42 -48.39 67.44 Favored 'General case' 0 C--N 1.303 -1.428 0 O-C-N 121.402 -0.811 . . . . 1.0 108.962 179.824 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 11.0 t-80 -51.56 -58.09 7.28 Favored 'General case' 0 CA--C 1.541 0.627 0 C-N-CA 119.463 -0.895 . . . . 1.0 109.419 -179.649 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 65' ' ' ASP . . . . . 0.592 ' C ' ' H ' ' A' ' 67' ' ' ARG . 22.8 m-20 -75.38 -52.03 11.74 Favored 'General case' 0 C--O 1.245 0.826 0 CA-C-N 115.733 -0.667 . . . . 1.0 111.24 178.837 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 66' ' ' GLY . . . . . 0.637 ' N ' ' O ' ' A' ' 62' ' ' VAL . . . -71.76 25.97 0.63 Allowed Glycine 0 CA--C 1.522 0.483 0 O-C-N 120.345 -1.472 . . . . 1.0 110.337 177.423 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 67' ' ' ARG . . . . . 0.671 ' O ' ' N ' ' A' ' 69' ' ' LEU . 0.6 OUTLIER -71.71 7.2 1.58 Allowed 'General case' 0 CA--C 1.507 -0.687 0 N-CA-C 106.197 -1.779 . . . . 1.0 106.197 174.47 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 68' ' ' LEU . . . . . 0.588 ' H ' ' C ' ' A' ' 66' ' ' GLY . 3.1 mt -30.48 -30.11 0.01 OUTLIER 'General case' 0 N--CA 1.472 0.669 0 O-C-N 124.045 0.84 . . . . 1.0 108.767 -177.653 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 69' ' ' LEU . . . . . 0.671 ' N ' ' O ' ' A' ' 67' ' ' ARG . 10.9 mp -62.35 -66.15 0.58 Allowed 'General case' 0 N--CA 1.476 0.842 0 C-N-CA 119.296 -0.961 . . . . 1.0 109.016 178.401 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 70' ' ' ALA . . . . . 0.627 ' C ' ' H ' ' A' ' 72' ' ' HIS . . . -79.49 -75.63 0.24 Allowed 'General case' 0 N--CA 1.476 0.835 0 N-CA-C 107.36 -1.348 . . . . 1.0 107.36 178.051 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 71' ' ' ALA . . . . . 0.474 ' HB3' ' CB ' ' A' ' 67' ' ' ARG . . . -46.44 5.87 0.0 OUTLIER 'General case' 0 CA--C 1.536 0.409 0 C-N-CA 124.837 1.255 . . . . 1.0 113.539 177.671 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 72' ' ' HIS . . . . . 0.627 ' H ' ' C ' ' A' ' 70' ' ' ALA . 1.1 t-80 -28.69 -68.17 0.07 Allowed 'General case' 0 N--CA 1.467 0.414 0 C-N-CA 122.827 0.451 . . . . 1.0 111.788 -179.449 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 73' ' ' MET . . . . . 0.549 ' N ' ' SD ' ' A' ' 73' ' ' MET . 0.0 OUTLIER -66.83 -47.58 71.58 Favored 'General case' 0 C--N 1.329 -0.325 0 C-N-CA 118.263 -1.375 . . . . 1.0 109.133 178.966 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 74' ' ' VAL . . . . . 0.793 ' O ' ' N ' ' A' ' 76' ' ' GLY . 72.9 t -42.2 -41.17 0.91 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.26 0 CA-C-O 117.621 -1.18 . . . . 1.0 111.524 -176.089 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 75' ' ' ASN . . . . . 0.446 ' OD1' HG21 ' A' ' 78' ' ' VAL . 8.2 t30 -33.63 -12.22 0.0 OUTLIER 'General case' 0 N--CA 1.498 1.947 0 CA-C-N 120.175 1.352 . . . . 1.0 112.315 179.25 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 76' ' ' GLY . . . . . 0.793 ' N ' ' O ' ' A' ' 74' ' ' VAL . . . -48.86 -22.67 3.04 Favored Glycine 0 CA--C 1.542 1.736 0 N-CA-C 108.455 -1.858 . . . . 1.0 108.455 174.629 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 77' ' ' ILE . . . . . 0.667 ' O ' ' N ' ' A' ' 80' ' ' ALA . 0.9 OUTLIER -75.54 -59.86 2.88 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.588 0 N-CA-C 108.068 -1.086 . . . . 1.0 108.068 178.36 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 78' ' ' VAL . . . . . 0.466 ' C ' ' O ' ' A' ' 77' ' ' ILE . 75.6 t -34.39 -31.18 0.02 OUTLIER 'Isoleucine or valine' 0 CA--C 1.547 0.828 0 CA-C-N 113.532 -1.667 . . . . 1.0 107.947 -176.207 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 79' ' ' ILE . . . . . 0.665 ' O ' ' HB2' ' A' ' 83' ' ' ALA . 40.3 pt -95.45 -29.9 4.03 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.843 0 CA-C-N 115.989 -0.55 . . . . 1.0 111.595 178.392 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 80' ' ' ALA . . . . . 0.667 ' N ' ' O ' ' A' ' 77' ' ' ILE . . . -86.14 -10.79 54.17 Favored 'General case' 0 CA--C 1.548 0.882 0 N-CA-C 113.284 0.846 . . . . 1.0 113.284 178.387 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 8.5 mt-10 -83.1 -68.56 0.7 Allowed 'General case' 0 C--N 1.355 0.805 0 CA-C-N 118.855 0.752 . . . . 1.0 109.067 178.254 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 82' ' ' ASP . . . . . 0.512 ' O ' ' C ' ' A' ' 83' ' ' ALA . 49.7 p-10 -74.95 -14.2 60.61 Favored 'General case' 0 N--CA 1.443 -0.796 0 CA-C-O 118.846 -0.597 . . . . 1.0 112.136 -179.48 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 83' ' ' ALA . . . . . 0.704 ' HA ' ' HB3' ' A' ' 86' ' ' ALA . . . -23.08 -47.35 0.01 OUTLIER 'General case' 0 N--CA 1.473 0.698 0 CA-C-N 118.436 0.562 . . . . 1.0 112.013 177.746 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 84' ' ' LEU . . . . . 0.48 ' N ' ' O ' ' A' ' 82' ' ' ASP . 2.9 tt -37.7 -36.2 0.17 Allowed 'General case' 0 N--CA 1.465 0.324 0 N-CA-C 112.85 0.685 . . . . 1.0 112.85 -177.617 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 85' ' ' ILE . . . . . 0.407 HG21 HD13 ' A' ' 85' ' ' ILE . 11.2 pt -98.68 -43.1 11.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 N-CA-C 108.436 -0.95 . . . . 1.0 108.436 177.526 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 86' ' ' ALA . . . . . 0.704 ' HB3' ' HA ' ' A' ' 83' ' ' ALA . . . -56.36 -57.45 12.2 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 114.142 -1.39 . . . . 1.0 109.503 179.45 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 87' ' ' GLU . . . . . 0.533 ' N ' ' O ' ' A' ' 83' ' ' ALA . 19.8 tt0 -79.3 26.41 0.28 Allowed 'General case' 0 CA--C 1.544 0.723 0 O-C-N 120.851 -1.156 . . . . 1.0 112.202 -178.149 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -116.49 -15.75 10.86 Favored 'General case' 0 N--CA 1.489 1.504 0 CA-C-O 123.415 1.579 . . . . 1.0 107.896 177.68 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 89' ' ' VAL . . . . . 0.415 HG22 ' O ' ' A' ' 86' ' ' ALA . 5.3 m -100.44 39.23 0.15 Allowed 'Isoleucine or valine' 0 C--O 1.205 -1.238 0 CA-C-N 110.83 -2.896 . . . . 1.0 109.987 178.573 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 90' ' ' GLY . . . . . 0.536 ' O ' ' N ' ' A' ' 92' ' ' HIS . . . -71.59 -39.15 61.13 Favored Glycine 0 C--N 1.351 1.381 0 N-CA-C 111.023 -0.831 . . . . 1.0 111.023 178.329 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 91' ' ' PRO . . . . . 0.528 ' CD ' ' N ' ' A' ' 90' ' ' GLY . 89.6 Cg_exo -46.45 -12.82 0.09 OUTLIER 'Trans proline' 0 N--CA 1.497 1.712 0 C-N-CA 121.572 1.515 . . . . 1.0 110.346 178.406 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 92' ' ' HIS . . . . . 0.536 ' N ' ' O ' ' A' ' 90' ' ' GLY . 3.5 p80 -57.54 -17.15 12.35 Favored 'General case' 0 C--O 1.208 -1.108 0 N-CA-C 107.56 -1.274 . . . . 1.0 107.56 179.675 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 93' ' ' LEU . . . . . 0.712 HD12 ' N ' ' A' ' 94' ' ' ALA . 2.1 pp -67.84 -59.37 3.35 Favored 'General case' 0 N--CA 1.455 -0.215 0 N-CA-C 108.817 -0.809 . . . . 1.0 108.817 178.884 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 94' ' ' ALA . . . . . 0.712 ' N ' HD12 ' A' ' 93' ' ' LEU . . . -56.45 -53.36 58.31 Favored 'General case' 0 N--CA 1.454 -0.265 0 N-CA-C 108.914 -0.773 . . . . 1.0 108.914 178.701 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 95' ' ' ARG . . . . . 0.643 ' O ' ' N ' ' A' ' 97' ' ' LEU . 42.8 mtm105 -57.54 -57.44 12.69 Favored 'General case' 0 C--O 1.241 0.653 0 N-CA-C 107.822 -1.177 . . . . 1.0 107.822 178.846 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 96' ' ' ALA . . . . . 0.885 ' O ' ' N ' ' A' ' 98' ' ' GLY . . . -47.47 -12.35 0.03 OUTLIER 'General case' 0 N--CA 1.436 -1.128 0 O-C-N 118.905 -2.372 . . . . 1.0 110.375 -179.195 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 97' ' ' LEU . . . . . 0.692 ' O ' ' N ' ' A' ' 100' ' ' ILE . 16.2 tp 5.96 -53.25 0.0 OUTLIER 'General case' 0 C--N 1.377 1.801 0 CA-C-O 117.481 -1.247 . . . . 1.0 110.275 -167.843 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 98' ' ' GLY . . . . . 0.885 ' N ' ' O ' ' A' ' 96' ' ' ALA . . . -49.06 -23.75 4.06 Favored Glycine 0 CA--C 1.543 1.784 0 CA-C-N 122.572 2.442 . . . . 1.0 107.902 175.331 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 99' ' ' GLN . . . . . 0.552 ' N ' ' O ' ' A' ' 96' ' ' ALA . 0.0 OUTLIER -63.88 -17.45 63.2 Favored 'General case' 0 C--N 1.36 1.026 0 N-CA-C 107.046 -1.465 . . . . 1.0 107.046 176.706 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 100' ' ' ILE . . . . . 0.692 ' N ' ' O ' ' A' ' 97' ' ' LEU . 1.9 tp -66.42 -43.33 91.18 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.518 0 N-CA-C 108.746 -0.835 . . . . 1.0 108.746 178.98 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 101' ' ' VAL . . . . . 0.672 ' O ' ' N ' ' A' ' 105' ' ' GLY . 0.5 OUTLIER -54.48 -58.28 4.25 Favored 'Isoleucine or valine' 0 C--O 1.219 -0.546 0 N-CA-C 106.844 -1.539 . . . . 1.0 106.844 178.69 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 102' ' ' CYS . . . . . 0.838 ' O ' ' HB2' ' A' ' 106' ' ' ALA . 17.1 t -44.74 -20.6 0.04 OUTLIER 'General case' 0 C--N 1.314 -0.974 0 CA-C-N 115.961 -0.563 . . . . 1.0 111.977 -179.932 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 103' ' ' ARG . . . . . 0.522 HH11 ' CG ' ' A' ' 103' ' ' ARG . 0.0 OUTLIER -92.76 -44.69 8.4 Favored 'General case' 0 N--CA 1.472 0.646 0 CA-C-O 122.328 1.061 . . . . 1.0 111.521 178.299 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 104' ' ' TYR . . . . . 0.581 ' CD2' ' O ' ' A' ' 104' ' ' TYR . 0.0 OUTLIER -105.72 22.39 15.64 Favored 'General case' 0 C--N 1.312 -1.027 0 CA-C-N 113.625 -1.625 . . . . 1.0 111.325 179.294 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 105' ' ' GLY . . . . . 0.776 ' O ' ' N ' ' A' ' 107' ' ' THR . . . -171.67 -9.29 0.02 OUTLIER Glycine 0 C--N 1.345 1.028 0 C-N-CA 118.437 -1.84 . . . . 1.0 113.125 178.987 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 106' ' ' ALA . . . . . 0.838 ' HB2' ' O ' ' A' ' 102' ' ' CYS . . . -27.71 68.68 0.0 OUTLIER 'General case' 0 N--CA 1.475 0.793 0 N-CA-C 113.521 0.934 . . . . 1.0 113.521 -178.707 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 107' ' ' THR . . . . . 0.776 ' N ' ' O ' ' A' ' 105' ' ' GLY . 8.8 t -91.9 2.66 56.39 Favored 'General case' 0 CA--C 1.51 -0.595 0 N-CA-C 106.902 -1.518 . . . . 1.0 106.902 177.601 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 60.2 t -85.37 -57.73 4.09 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.76 0 CA-C-N 115.475 -0.784 . . . . 1.0 110.514 178.547 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 109' ' ' ILE . . . . . 0.523 ' N ' ' HD2' ' A' ' 110' ' ' PRO . 0.1 OUTLIER -65.98 -39.8 32.76 Favored Pre-proline 0 CA--C 1.555 1.158 0 N-CA-C 114.552 1.316 . . . . 1.0 114.552 -177.971 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 110' ' ' PRO . . . . . 0.547 ' CD ' ' O ' ' A' ' 106' ' ' ALA . 6.8 Cg_endo -48.13 -47.7 18.71 Favored 'Trans proline' 0 N--CA 1.504 2.096 0 CA-C-N 122.397 1.892 . . . . 1.0 113.065 -178.283 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 23.4 t30 -64.79 -67.03 0.47 Allowed 'General case' 0 N--CA 1.464 0.248 0 C-N-CA 119.47 -0.892 . . . . 1.0 109.434 -178.267 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 112' ' ' ILE . . . . . 0.458 ' O ' ' N ' ' A' ' 115' ' ' ALA . 28.3 mm -49.25 -39.92 13.3 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.575 0 CA-C-O 122.813 1.292 . . . . 1.0 108.459 179.737 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 113' ' ' ASN . . . . . 0.483 ' CB ' ' O ' ' A' ' 109' ' ' ILE . 6.4 t-20 -47.14 -51.14 18.9 Favored 'General case' 0 C--N 1.31 -1.121 0 CA-C-N 112.273 -2.24 . . . . 1.0 108.03 -176.892 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -62.21 -29.81 70.64 Favored 'General case' 0 N--CA 1.441 -0.894 0 C-N-CA 119.611 -0.835 . . . . 1.0 110.343 178.772 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 115' ' ' ALA . . . . . 0.458 ' N ' ' O ' ' A' ' 112' ' ' ILE . . . -77.34 -60.44 2.36 Favored 'General case' 0 C--N 1.347 0.477 0 C-N-CA 119.659 -0.817 . . . . 1.0 110.031 179.077 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 116' ' ' ILE . . . . . 0.506 ' O ' ' N ' ' A' ' 120' ' ' GLY . 1.0 OUTLIER -49.95 -50.07 19.93 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.707 0 CA-C-O 122.013 0.911 . . . . 1.0 109.562 -179.41 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 117' ' ' GLU . . . . . 0.476 ' N ' HG22 ' A' ' 116' ' ' ILE . 17.8 mt-10 -42.53 -55.73 3.37 Favored 'General case' 0 C--N 1.316 -0.887 0 N-CA-C 106.106 -1.812 . . . . 1.0 106.106 -179.394 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 98.8 t -58.82 -53.11 51.95 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.677 0 C-N-CA 119.428 -0.909 . . . . 1.0 108.787 176.875 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -51.74 -72.62 0.05 OUTLIER 'General case' 0 CA--C 1.543 0.707 0 N-CA-C 108.083 -1.081 . . . . 1.0 108.083 -178.699 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 120' ' ' GLY . . . . . 0.506 ' N ' ' O ' ' A' ' 116' ' ' ILE . . . -64.9 -79.03 0.19 Allowed Glycine 0 CA--C 1.541 1.698 0 C-N-CA 119.055 -1.545 . . . . 1.0 110.3 179.308 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 121' ' ' THR . . . . . 0.494 ' OG1' ' O ' ' A' ' 120' ' ' GLY . 2.8 m 154.27 -31.57 0.01 OUTLIER 'General case' 0 N--CA 1.481 1.098 0 CA-C-N 112.371 -1.914 . . . . 1.0 111.463 179.974 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 122' ' ' GLY . . . . . 0.669 ' O ' ' N ' ' A' ' 124' ' ' ASP . . . 104.25 -17.5 47.54 Favored Glycine 0 N--CA 1.462 0.373 0 N-CA-C 107.319 -2.312 . . . . 1.0 107.319 -176.46 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 123' ' ' THR . . . . . 0.702 HG23 ' O ' ' A' ' 123' ' ' THR . 12.7 t -56.37 82.3 0.01 OUTLIER 'General case' 0 N--CA 1.469 0.509 0 N-CA-C 106.031 -1.84 . . . . 1.0 106.031 178.647 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 124' ' ' ASP . . . . . 0.669 ' N ' ' O ' ' A' ' 122' ' ' GLY . 34.6 m-20 -167.26 178.05 5.79 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 112.826 -1.988 . . . . 1.0 111.516 179.01 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 125' ' ' TYR . . . . . . . . . . . . . 21.3 t80 -141.96 140.22 32.67 Favored 'General case' 0 CA--C 1.536 0.417 0 N-CA-C 107.328 -1.36 . . . . 1.0 107.328 174.932 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 24.0 mmm-85 -146.18 148.1 32.18 Favored 'General case' 0 N--CA 1.471 0.598 0 N-CA-C 109.879 -0.415 . . . . 1.0 109.879 178.594 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 127' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 C--N 1.327 -0.409 0 CA-C-O 117.982 -1.009 . . . . 1.0 110.079 179.3 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.494 1.75 0 N-CA-C 108.103 -1.073 . . . . 1.0 108.103 . . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 2' ' ' SER . . . . . 0.46 ' O ' ' CB ' ' A' ' 3' ' ' ASP . 93.9 p -70.66 7.1 1.19 Allowed 'General case' 0 C--O 1.223 -0.316 0 CA-C-O 119.449 -0.31 . . . . 1.0 111.352 179.615 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 3' ' ' ASP . . . . . 0.46 ' CB ' ' O ' ' A' ' 2' ' ' SER . 12.7 p-10 142.55 142.19 0.0 OUTLIER 'General case' 0 N--CA 1.481 1.079 0 O-C-N 124.126 0.891 . . . . 1.0 110.349 179.07 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 42.1 t80 -155.59 151.33 27.41 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 121.134 0.492 . . . . 1.0 110.532 178.701 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 5' ' ' ASP . . . . . 0.482 ' C ' ' OG ' ' A' ' 10' ' ' SER . 51.3 m-20 -148.46 144.6 27.5 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.562 -0.745 . . . . 1.0 109.53 179.84 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 6' ' ' THR . . . . . 1.009 HG22 ' H ' ' A' ' 7' ' ' GLU . 5.6 m -109.46 -161.57 0.77 Allowed 'General case' 0 C--O 1.206 -1.188 0 CA-C-O 121.656 0.741 . . . . 1.0 110.48 -179.776 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 7' ' ' GLU . . . . . 1.009 ' H ' HG22 ' A' ' 6' ' ' THR . 28.5 tt0 -58.26 -44.37 88.31 Favored 'General case' 0 C--N 1.302 -1.497 0 CA-C-O 121.872 0.844 . . . . 1.0 109.447 -178.5 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 8' ' ' ARG . . . . . 0.836 ' O ' ' HB3' ' A' ' 12' ' ' ALA . 21.8 ttp-105 -69.87 -60.64 2.18 Favored 'General case' 0 C--N 1.307 -1.241 0 C-N-CA 117.916 -1.514 . . . . 1.0 110.089 178.242 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 9' ' ' VAL . . . . . 0.957 HG23 ' H ' ' A' ' 6' ' ' THR . 0.1 OUTLIER -61.38 -52.61 59.27 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.412 0 CA-C-N 115.11 -0.95 . . . . 1.0 110.129 -179.6 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 10' ' ' SER . . . . . 0.674 ' N ' ' O ' ' A' ' 6' ' ' THR . 1.2 m -68.21 -65.21 0.72 Allowed 'General case' 0 N--CA 1.487 1.409 0 C-N-CA 120.166 -0.614 . . . . 1.0 112.525 179.66 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 11' ' ' ARG . . . . . 0.643 ' O ' ' HB3' ' A' ' 15' ' ' ALA . 5.0 mtt-85 -61.9 -43.41 98.89 Favored 'General case' 0 C--N 1.317 -0.841 0 C-N-CA 120.419 -0.512 . . . . 1.0 111.382 -176.955 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 12' ' ' ALA . . . . . 0.836 ' HB3' ' O ' ' A' ' 8' ' ' ARG . . . -69.87 -57.58 4.88 Favored 'General case' 0 N--CA 1.468 0.443 0 C-N-CA 118.334 -1.346 . . . . 1.0 108.998 178.719 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 13' ' ' VAL . . . . . 0.673 ' O ' ' CB ' ' A' ' 17' ' ' LEU . 41.7 t -61.84 -55.44 24.24 Favored 'Isoleucine or valine' 0 C--O 1.198 -1.623 0 C-N-CA 117.51 -1.676 . . . . 1.0 107.879 -179.266 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 14' ' ' ALA . . . . . 0.892 ' O ' HG22 ' A' ' 18' ' ' VAL . . . -57.96 -64.92 0.74 Allowed 'General case' 0 C--N 1.313 -1.009 0 C-N-CA 116.53 -2.068 . . . . 1.0 111.457 -179.94 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 15' ' ' ALA . . . . . 0.643 ' HB3' ' O ' ' A' ' 11' ' ' ARG . . . -54.59 -54.71 37.74 Favored 'General case' 0 C--O 1.218 -0.601 0 C-N-CA 118.596 -1.242 . . . . 1.0 110.334 -177.187 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 16' ' ' ALA . . . . . 0.711 ' HB3' ' O ' ' A' ' 12' ' ' ALA . . . -65.69 -55.64 16.34 Favored 'General case' 0 C--N 1.309 -1.176 0 C-N-CA 118.676 -1.21 . . . . 1.0 110.569 -179.109 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 17' ' ' LEU . . . . . 0.673 ' CB ' ' O ' ' A' ' 13' ' ' VAL . 2.2 tp -56.51 -54.56 44.4 Favored 'General case' 0 N--CA 1.491 1.591 0 N-CA-C 108.087 -1.079 . . . . 1.0 108.087 -177.728 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 18' ' ' VAL . . . . . 0.892 HG22 ' O ' ' A' ' 14' ' ' ALA . 1.8 m -71.88 -58.59 4.77 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.405 0 C-N-CA 120.371 -0.531 . . . . 1.0 110.446 -179.953 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 19' ' ' GLY . . . . . 0.559 ' N ' ' O ' ' A' ' 15' ' ' ALA . . . -60.67 -168.39 0.43 Allowed Glycine 0 N--CA 1.439 -1.131 0 N-CA-C 111.969 -0.452 . . . . 1.0 111.969 -177.288 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 20' ' ' PRO . . . . . 0.677 ' O ' ' N ' ' A' ' 24' ' ' ALA . 4.2 Cg_endo -81.73 -25.96 3.34 Favored 'Trans proline' 0 C--N 1.294 -2.339 0 C-N-CA 121.847 1.698 . . . . 1.0 113.72 -178.041 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -63.51 -60.01 8.03 Favored Glycine 0 N--CA 1.473 1.134 0 C-N-CA 118.984 -1.579 . . . . 1.0 112.679 -176.004 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 22' ' ' GLY . . . . . 0.605 ' H ' ' HA ' ' A' ' 16' ' ' ALA . . . -57.31 -53.01 48.15 Favored Glycine 0 C--N 1.31 -0.874 0 N-CA-C 106.259 -2.736 . . . . 1.0 106.259 -178.848 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 23' ' ' VAL . . . . . 0.497 ' O ' HG12 ' A' ' 27' ' ' VAL . 21.3 t -56.37 -32.29 35.31 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.849 0 N-CA-C 108.177 -1.045 . . . . 1.0 108.177 178.428 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 24' ' ' ALA . . . . . 0.677 ' N ' ' O ' ' A' ' 20' ' ' PRO . . . -60.4 -62.88 1.54 Allowed 'General case' 0 C--N 1.352 0.716 0 C-N-CA 118.573 -1.251 . . . . 1.0 110.087 -179.47 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 86.5 mt -61.91 -46.32 89.89 Favored 'General case' 0 CA--C 1.516 -0.336 0 C-N-CA 120.202 -0.599 . . . . 1.0 111.612 -177.223 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 97.9 t -59.85 -59.85 3.39 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.582 0 C-N-CA 119.332 -0.947 . . . . 1.0 110.393 -177.617 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 27' ' ' VAL . . . . . 0.552 ' O ' ' HB3' ' A' ' 31' ' ' ALA . 1.4 p -58.65 -36.93 62.49 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.442 0 C-N-CA 120.571 -0.452 . . . . 1.0 110.345 -177.353 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 8.7 tttm -65.69 -56.19 13.41 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 115.646 -0.706 . . . . 1.0 109.869 -179.882 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 97.6 t -62.29 -48.73 86.99 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.699 0 CA-C-N 115.314 -0.857 . . . . 1.0 110.002 -177.699 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 30' ' ' CYS . . . . . . . . . . . . . 49.2 t -65.45 -62.1 1.72 Allowed 'General case' 0 N--CA 1.443 -0.796 0 C-N-CA 119.849 -0.74 . . . . 1.0 110.206 -178.815 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 31' ' ' ALA . . . . . 0.552 ' HB3' ' O ' ' A' ' 27' ' ' VAL . . . -57.15 -50.21 73.52 Favored 'General case' 0 CA--C 1.507 -0.697 0 CA-C-O 120.879 0.371 . . . . 1.0 110.26 -176.668 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 32' ' ' GLY . . . . . 0.417 ' O ' ' HB2' ' A' ' 33' ' ' LEU . . . 74.82 70.66 1.22 Allowed Glycine 0 N--CA 1.443 -0.859 0 N-CA-C 109.001 -1.64 . . . . 1.0 109.001 -178.106 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 33' ' ' LEU . . . . . 0.417 ' HB2' ' O ' ' A' ' 32' ' ' GLY . 5.2 mt 91.79 82.81 0.04 OUTLIER Pre-proline 0 C--N 1.332 -0.192 0 O-C-N 124.963 1.037 . . . . 1.0 109.453 -178.281 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 50.8 Cg_exo -50.39 -28.85 22.11 Favored 'Trans proline' 0 C--N 1.312 -1.37 0 C-N-CA 122.481 2.121 . . . . 1.0 113.555 -179.333 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -62.36 -61.02 7.01 Favored Glycine 0 N--CA 1.47 0.932 0 C-N-CA 118.353 -1.88 . . . . 1.0 109.909 -178.027 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 36' ' ' VAL . . . . . 0.643 ' O ' HG22 ' A' ' 37' ' ' ILE . 11.4 p -86.47 167.11 1.84 Allowed 'Isoleucine or valine' 0 CA--C 1.507 -0.698 0 N-CA-C 107.719 -1.215 . . . . 1.0 107.719 178.41 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 37' ' ' ILE . . . . . 0.656 HG23 ' O ' ' A' ' 37' ' ' ILE . 8.2 tt 115.91 107.37 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.484 1.257 0 O-C-N 125.403 1.689 . . . . 1.0 110.6 179.752 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 60.8 m80 -140.39 135.67 32.32 Favored 'General case' 0 C--N 1.328 -0.337 0 O-C-N 121.95 -0.469 . . . . 1.0 109.782 179.153 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 6.1 m -106.42 130.93 22.18 Favored Pre-proline 0 CA--C 1.534 0.342 0 N-CA-C 110.278 -0.268 . . . . 1.0 110.278 -179.582 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 37.0 Cg_endo -65.69 -24.07 55.56 Favored 'Trans proline' 0 N--CA 1.493 1.465 0 C-N-CA 121.141 1.227 . . . . 1.0 112.702 -179.684 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -128.47 135.99 50.22 Favored 'General case' 0 N--CA 1.466 0.361 0 N-CA-C 110.376 -0.231 . . . . 1.0 110.376 177.839 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 42' ' ' ARG . . . . . 0.693 ' C ' ' H ' ' A' ' 44' ' ' GLY . 11.8 ptm180 -171.23 172.09 5.42 Favored 'General case' 0 C--N 1.322 -0.608 0 C-N-CA 120.2 -0.6 . . . . 1.0 110.941 178.342 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 43' ' ' ARG . . . . . 0.518 ' C ' ' H ' ' A' ' 45' ' ' PHE . 37.2 tpt85 -63.33 24.13 0.01 OUTLIER 'General case' 0 CA--C 1.55 0.953 0 CA-C-O 121.518 0.675 . . . . 1.0 109.816 179.296 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 44' ' ' GLY . . . . . 0.693 ' H ' ' C ' ' A' ' 42' ' ' ARG . . . 76.98 -26.78 1.72 Allowed Glycine 0 C--N 1.338 0.686 0 N-CA-C 110.533 -1.027 . . . . 1.0 110.533 179.394 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 45' ' ' PHE . . . . . 0.572 ' O ' ' HB2' ' A' ' 46' ' ' PHE . 11.8 p90 -175.32 -174.15 0.71 Allowed 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 114.352 -0.924 . . . . 1.0 109.451 179.87 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 46' ' ' PHE . . . . . 0.572 ' HB2' ' O ' ' A' ' 45' ' ' PHE . 0.7 OUTLIER 110.81 107.38 0.0 OUTLIER 'General case' 0 N--CA 1.479 1.015 0 O-C-N 125.398 1.686 . . . . 1.0 109.851 -179.78 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 47' ' ' ARG . . . . . 0.515 ' CB ' ' O ' ' A' ' 46' ' ' PHE . 34.3 ttm-85 97.69 154.21 0.02 OUTLIER 'General case' 0 N--CA 1.472 0.655 0 O-C-N 123.966 0.791 . . . . 1.0 110.964 179.7 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 4.4 t 67.2 86.5 0.13 Allowed 'General case' 0 C--N 1.328 -0.335 0 N-CA-C 108.161 -1.051 . . . . 1.0 108.161 -177.685 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 49' ' ' ASN . . . . . 0.501 ' O ' ' N ' ' A' ' 51' ' ' GLU . 0.0 OUTLIER -153.0 160.71 30.6 Favored Pre-proline 0 N--CA 1.466 0.364 0 CA-C-N 115.675 -0.693 . . . . 1.0 111.33 -179.352 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 30.8 Cg_endo -63.13 60.94 0.17 Allowed 'Trans proline' 0 C--N 1.311 -1.409 0 C-N-CA 122.545 2.163 . . . . 1.0 111.403 177.976 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 51' ' ' GLU . . . . . 0.501 ' N ' ' O ' ' A' ' 49' ' ' ASN . 40.9 mt-10 41.91 37.72 0.87 Allowed 'General case' 0 C--O 1.233 0.227 0 CA-C-O 120.68 0.276 . . . . 1.0 111.501 178.31 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 52' ' ' ARG . . . . . 0.726 ' HE ' ' HB ' ' A' ' 89' ' ' VAL . 73.9 mtt85 -146.62 167.78 22.9 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 121.025 0.44 . . . . 1.0 111.702 -179.119 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 21.0 tt -76.22 164.13 3.67 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.324 0 N-CA-C 108.061 -1.088 . . . . 1.0 108.061 176.891 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 56.1 tt0 -132.82 131.2 40.78 Favored 'General case' 0 CA--C 1.535 0.399 0 N-CA-C 108.857 -0.794 . . . . 1.0 108.857 179.057 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 10.5 tt -143.48 153.82 16.37 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.728 0 N-CA-C 110.169 -0.308 . . . . 1.0 110.169 178.852 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 104.14 2.35 45.03 Favored Glycine 0 C--N 1.341 0.848 0 N-CA-C 109.851 -1.3 . . . . 1.0 109.851 -179.108 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 18.2 m-20 -90.57 109.8 20.95 Favored 'General case' 0 CA--C 1.542 0.642 0 CA-C-O 122.138 0.971 . . . . 1.0 113.09 -178.152 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 58' ' ' TRP . . . . . 0.56 ' CD1' ' OE1' ' A' ' 61' ' ' GLU . 9.2 m95 -82.8 -176.92 6.54 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 113.43 -1.714 . . . . 1.0 108.678 176.599 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 59' ' ' ARG . . . . . 0.431 ' HG2' ' H ' ' A' ' 59' ' ' ARG . 8.0 ptm180 -98.64 -54.28 3.07 Favored 'General case' 0 CA--C 1.552 1.042 0 CA-C-N 118.955 0.798 . . . . 1.0 111.188 178.21 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 60' ' ' TYR . . . . . 0.411 ' H ' ' CG ' ' A' ' 59' ' ' ARG . 0.2 OUTLIER -80.29 -11.24 59.74 Favored 'General case' 0 N--CA 1.479 1.007 0 C-N-CA 124.561 1.145 . . . . 1.0 112.397 -178.511 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 61' ' ' GLU . . . . . 0.56 ' OE1' ' CD1' ' A' ' 58' ' ' TRP . 86.6 mt-10 -80.08 -16.47 54.94 Favored 'General case' 0 CA--C 1.496 -1.127 0 O-C-N 121.58 -0.7 . . . . 1.0 110.413 179.302 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 62' ' ' VAL . . . . . 0.516 HG23 ' N ' ' A' ' 63' ' ' ALA . 28.7 m -44.24 -46.52 2.3 Favored 'Isoleucine or valine' 0 CA--C 1.499 -1.01 0 N-CA-C 109.215 -0.661 . . . . 1.0 109.215 -175.798 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 63' ' ' ALA . . . . . 0.516 ' N ' HG23 ' A' ' 62' ' ' VAL . . . -66.19 -46.29 77.84 Favored 'General case' 0 N--CA 1.415 -2.206 0 N-CA-C 108.109 -1.071 . . . . 1.0 108.109 177.147 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 64' ' ' HIS . . . . . 0.485 ' N ' ' O ' ' A' ' 61' ' ' GLU . 4.2 t-80 -57.96 -60.65 3.4 Favored 'General case' 0 CA--C 1.547 0.83 0 CA-C-N 115.572 -0.74 . . . . 1.0 111.269 179.322 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 65' ' ' ASP . . . . . 0.609 ' C ' ' H ' ' A' ' 67' ' ' ARG . 0.7 OUTLIER -69.96 -55.63 9.11 Favored 'General case' 0 CA--C 1.554 1.116 0 O-C-N 121.128 -0.983 . . . . 1.0 110.24 178.632 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 66' ' ' GLY . . . . . 0.478 ' N ' ' O ' ' A' ' 62' ' ' VAL . . . -64.84 32.59 0.1 Allowed Glycine 0 N--CA 1.471 1.008 0 O-C-N 121.475 -0.765 . . . . 1.0 111.421 178.461 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 67' ' ' ARG . . . . . 0.714 ' HB3' ' H ' ' A' ' 71' ' ' ALA . 0.0 OUTLIER -77.45 6.4 7.07 Favored 'General case' 0 C--N 1.316 -0.863 0 C-N-CA 123.605 0.762 . . . . 1.0 110.08 176.173 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 68' ' ' LEU . . . . . 0.613 ' O ' ' HA ' ' A' ' 72' ' ' HIS . 0.8 OUTLIER -33.15 -30.16 0.01 OUTLIER 'General case' 0 N--CA 1.486 1.366 0 N-CA-C 107.481 -1.303 . . . . 1.0 107.481 -179.072 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 69' ' ' LEU . . . . . 0.63 ' N ' ' O ' ' A' ' 67' ' ' ARG . 2.3 mt -63.25 -64.68 0.84 Allowed 'General case' 0 C--N 1.317 -0.847 0 C-N-CA 117.509 -1.676 . . . . 1.0 107.558 176.754 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 70' ' ' ALA . . . . . 0.677 ' C ' ' H ' ' A' ' 72' ' ' HIS . . . -77.17 -72.25 0.36 Allowed 'General case' 0 N--CA 1.478 0.932 0 N-CA-C 106.671 -1.603 . . . . 1.0 106.671 177.615 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 71' ' ' ALA . . . . . 0.714 ' H ' ' HB3' ' A' ' 67' ' ' ARG . . . -49.16 4.19 0.01 OUTLIER 'General case' 0 N--CA 1.467 0.418 0 C-N-CA 125.203 1.401 . . . . 1.0 112.31 178.536 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 72' ' ' HIS . . . . . 0.707 ' CG ' ' H ' ' A' ' 73' ' ' MET . 0.0 OUTLIER -18.11 -72.87 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.396 0 C-N-CA 123.155 0.582 . . . . 1.0 112.527 -176.592 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 73' ' ' MET . . . . . 0.707 ' H ' ' CG ' ' A' ' 72' ' ' HIS . 45.4 mtt -71.28 -43.04 67.93 Favored 'General case' 0 C--N 1.298 -1.658 0 C-N-CA 119.309 -0.957 . . . . 1.0 110.239 178.082 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 74' ' ' VAL . . . . . 0.618 ' O ' ' N ' ' A' ' 76' ' ' GLY . 42.3 t -43.08 -45.99 1.32 Allowed 'Isoleucine or valine' 0 N--CA 1.463 0.21 0 CA-C-O 118.822 -0.609 . . . . 1.0 110.248 -175.4 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 75' ' ' ASN . . . . . 0.508 ' O ' ' N ' ' A' ' 77' ' ' ILE . 5.2 t30 -38.45 -18.96 0.01 OUTLIER 'General case' 0 N--CA 1.473 0.693 0 CA-C-O 122.025 0.917 . . . . 1.0 111.815 179.192 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 76' ' ' GLY . . . . . 0.618 ' N ' ' O ' ' A' ' 74' ' ' VAL . . . -43.35 -19.05 0.07 OUTLIER Glycine 0 CA--C 1.54 1.641 0 N-CA-C 109.344 -1.503 . . . . 1.0 109.344 177.89 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 77' ' ' ILE . . . . . 0.767 ' O ' ' N ' ' A' ' 80' ' ' ALA . 9.7 pt -89.9 -49.7 13.61 Favored 'Isoleucine or valine' 0 C--O 1.211 -0.952 0 N-CA-C 107.982 -1.118 . . . . 1.0 107.982 179.963 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 78' ' ' VAL . . . . . 0.484 ' C ' ' O ' ' A' ' 77' ' ' ILE . 6.0 t -35.15 -35.04 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.447 -0.583 0 N-CA-C 108.532 -0.914 . . . . 1.0 108.532 -177.268 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 79' ' ' ILE . . . . . 0.616 ' O ' ' HB3' ' A' ' 83' ' ' ALA . 1.3 pp -91.56 -21.92 6.28 Favored 'Isoleucine or valine' 0 C--O 1.198 -1.638 0 CA-C-N 115.824 -0.626 . . . . 1.0 110.26 178.511 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 80' ' ' ALA . . . . . 0.767 ' N ' ' O ' ' A' ' 77' ' ' ILE . . . -92.65 -9.64 40.21 Favored 'General case' 0 CA--C 1.554 1.111 0 O-C-N 121.368 -0.832 . . . . 1.0 112.682 176.258 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 81' ' ' GLU . . . . . 0.531 ' N ' ' O ' ' A' ' 77' ' ' ILE . 4.9 mm-40 -79.15 -76.76 0.19 Allowed 'General case' 0 C--N 1.344 0.328 0 N-CA-C 112.583 0.586 . . . . 1.0 112.583 -176.121 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 82' ' ' ASP . . . . . 0.78 ' O ' HG12 ' A' ' 85' ' ' ILE . 5.9 m-20 -86.42 -17.34 34.58 Favored 'General case' 0 C--O 1.206 -1.205 0 CA-C-N 116.455 -0.339 . . . . 1.0 111.201 -179.795 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 83' ' ' ALA . . . . . 0.616 ' HB3' ' O ' ' A' ' 79' ' ' ILE . . . -58.47 -40.09 81.74 Favored 'General case' 0 C--N 1.316 -0.854 0 C-N-CA 118.188 -1.405 . . . . 1.0 111.944 -175.888 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 84' ' ' LEU . . . . . 0.727 HD13 ' O ' ' A' ' 84' ' ' LEU . 3.4 tm? -37.72 -37.07 0.21 Allowed 'General case' 0 N--CA 1.467 0.399 0 N-CA-C 112.719 0.637 . . . . 1.0 112.719 -175.65 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 85' ' ' ILE . . . . . 0.78 HG12 ' O ' ' A' ' 82' ' ' ASP . 22.4 pt -69.49 -26.49 31.28 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.568 0 C-N-CA 120.341 -0.544 . . . . 1.0 111.547 -179.804 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 86' ' ' ALA . . . . . 0.528 ' N ' ' O ' ' A' ' 83' ' ' ALA . . . -86.34 -15.16 41.4 Favored 'General case' 0 C--N 1.33 -0.249 0 N-CA-C 111.935 0.346 . . . . 1.0 111.935 -179.328 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 3.4 tt0 -53.04 -8.88 0.11 Allowed 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 120.868 0.366 . . . . 1.0 110.034 -179.467 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 88' ' ' ALA . . . . . 0.475 ' H ' ' C ' ' A' ' 86' ' ' ALA . . . -93.26 -8.1 43.16 Favored 'General case' 0 N--CA 1.47 0.573 0 CA-C-O 121.529 0.681 . . . . 1.0 109.421 -179.914 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 89' ' ' VAL . . . . . 0.726 ' HB ' ' HE ' ' A' ' 52' ' ' ARG . 4.5 t -92.61 36.22 0.1 OUTLIER 'Isoleucine or valine' 0 N--CA 1.438 -1.058 0 N-CA-C 108.103 -1.073 . . . . 1.0 108.103 178.602 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 90' ' ' GLY . . . . . 0.866 ' O ' ' N ' ' A' ' 92' ' ' HIS . . . -50.88 -28.15 15.79 Favored Glycine 0 C--N 1.355 1.585 0 CA-C-O 117.303 -1.832 . . . . 1.0 111.247 176.309 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 91' ' ' PRO . . . . . 0.667 ' HD2' ' N ' ' A' ' 90' ' ' GLY . 27.9 Cg_exo -32.73 -1.76 0.0 OUTLIER 'Trans proline' 0 N--CA 1.506 2.232 0 C-N-CA 123.388 2.725 . . . . 1.0 114.112 173.644 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 92' ' ' HIS . . . . . 0.866 ' N ' ' O ' ' A' ' 90' ' ' GLY . 1.1 t60 -50.4 -29.73 10.81 Favored 'General case' 0 N--CA 1.443 -0.817 0 N-CA-C 107.094 -1.447 . . . . 1.0 107.094 178.897 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 93' ' ' LEU . . . . . 0.635 HD12 ' N ' ' A' ' 94' ' ' ALA . 2.0 pp -60.04 -52.29 66.01 Favored 'General case' 0 N--CA 1.448 -0.565 0 N-CA-C 108.404 -0.962 . . . . 1.0 108.404 177.185 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 94' ' ' ALA . . . . . 0.635 ' N ' HD12 ' A' ' 93' ' ' LEU . . . -50.61 -56.02 13.69 Favored 'General case' 0 CA--C 1.515 -0.394 0 N-CA-C 107.236 -1.394 . . . . 1.0 107.236 -179.433 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 95' ' ' ARG . . . . . 0.42 HH11 ' HG3' ' A' ' 20' ' ' PRO . 89.8 mtt-85 -59.41 -32.18 69.93 Favored 'General case' 0 C--N 1.313 -0.999 0 N-CA-C 108.325 -0.991 . . . . 1.0 108.325 177.538 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 96' ' ' ALA . . . . . 0.768 ' O ' ' N ' ' A' ' 100' ' ' ILE . . . -55.75 -49.77 72.21 Favored 'General case' 0 C--O 1.207 -1.156 0 N-CA-C 106.824 -1.547 . . . . 1.0 106.824 -178.741 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 97' ' ' LEU . . . . . 0.552 ' O ' HG22 ' A' ' 100' ' ' ILE . 0.6 OUTLIER -36.88 -26.58 0.01 OUTLIER 'General case' 0 CA--C 1.568 1.669 0 N-CA-C 107.216 -1.401 . . . . 1.0 107.216 -179.912 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 98' ' ' GLY . . . . . 0.606 ' N ' ' O ' ' A' ' 96' ' ' ALA . . . -84.95 -52.87 3.32 Favored Glycine 0 CA--C 1.55 2.261 0 CA-C-O 123.119 1.399 . . . . 1.0 111.19 173.816 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 99' ' ' GLN . . . . . 0.563 ' N ' ' O ' ' A' ' 96' ' ' ALA . 86.4 mt-30 -79.07 7.97 6.52 Favored 'General case' 0 N--CA 1.438 -1.073 0 CA-C-N 114.742 -0.729 . . . . 1.0 109.521 177.989 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 100' ' ' ILE . . . . . 0.768 ' N ' ' O ' ' A' ' 96' ' ' ALA . 14.7 tt -60.3 -49.77 82.9 Favored 'Isoleucine or valine' 0 CA--C 1.484 -1.561 0 N-CA-C 107.936 -1.135 . . . . 1.0 107.936 179.694 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 101' ' ' VAL . . . . . 0.705 ' N ' HG23 ' A' ' 100' ' ' ILE . 22.7 t -60.12 -56.7 15.78 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.636 0 C-N-CA 116.495 -2.082 . . . . 1.0 107.763 178.135 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 102' ' ' CYS . . . . . 0.531 ' O ' ' O ' ' A' ' 105' ' ' GLY . 0.5 OUTLIER -46.53 -38.17 8.98 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 114.971 -1.013 . . . . 1.0 110.663 -175.869 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 7.3 ttp180 -65.05 -54.62 27.32 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 125.595 1.809 . . . . 1.0 113.302 176.844 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 104' ' ' TYR . . . . . 0.656 ' O ' ' CG ' ' A' ' 104' ' ' TYR . 50.8 t80 -93.28 32.0 1.4 Allowed 'General case' 0 C--N 1.311 -1.096 0 C-N-CA 126.082 1.753 . . . . 1.0 107.441 178.969 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 105' ' ' GLY . . . . . 0.539 ' O ' ' CB ' ' A' ' 106' ' ' ALA . . . 172.56 -141.78 6.43 Favored Glycine 0 N--CA 1.431 -1.649 0 N-CA-C 107.199 -2.36 . . . . 1.0 107.199 178.665 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 106' ' ' ALA . . . . . 0.539 ' CB ' ' O ' ' A' ' 105' ' ' GLY . . . 109.67 107.63 0.0 OUTLIER 'General case' 0 C--N 1.315 -0.896 0 C-N-CA 126.736 2.014 . . . . 1.0 116.237 178.712 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 107' ' ' THR . . . . . 0.532 ' O ' ' HG2' ' A' ' 110' ' ' PRO . 27.7 m -72.44 -52.06 17.54 Favored 'General case' 0 N--CA 1.476 0.842 0 CA-C-N 115.614 -0.721 . . . . 1.0 110.12 175.252 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 108' ' ' VAL . . . . . 0.561 HG13 ' N ' ' A' ' 109' ' ' ILE . 8.7 p -61.46 -46.12 97.22 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.035 0 O-C-N 121.639 -0.663 . . . . 1.0 112.019 -178.452 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 109' ' ' ILE . . . . . 0.561 ' N ' HG13 ' A' ' 108' ' ' VAL . 2.6 mt -38.0 -59.6 1.15 Allowed Pre-proline 0 N--CA 1.484 1.253 0 CA-C-N 116.399 -0.364 . . . . 1.0 110.778 -178.401 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 110' ' ' PRO . . . . . 0.532 ' HG2' ' O ' ' A' ' 107' ' ' THR . 31.9 Cg_endo -56.18 -21.82 37.35 Favored 'Trans proline' 0 C--N 1.314 -1.25 0 C-N-CA 120.895 1.064 . . . . 1.0 112.177 -177.888 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 7.8 m120 -64.37 -65.7 0.64 Allowed 'General case' 0 N--CA 1.469 0.522 0 C-N-CA 119.631 -0.827 . . . . 1.0 109.808 178.77 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 112' ' ' ILE . . . . . 0.662 ' O ' ' HB ' ' A' ' 116' ' ' ILE . 2.0 tt -45.72 -27.45 0.64 Allowed 'Isoleucine or valine' 0 C--O 1.22 -0.474 0 CA-C-O 122.383 1.087 . . . . 1.0 109.121 -179.166 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 113' ' ' ASN . . . . . 0.754 ' O ' ' HB3' ' A' ' 117' ' ' GLU . 25.4 t-20 -84.05 -53.03 5.83 Favored 'General case' 0 C--N 1.308 -1.199 0 CA-C-O 122.953 1.359 . . . . 1.0 110.018 178.949 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -56.07 -58.04 9.58 Favored 'General case' 0 C--N 1.295 -1.793 0 C-N-CA 119.257 -0.977 . . . . 1.0 110.261 -178.688 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -79.89 -59.59 2.67 Favored 'General case' 0 C--O 1.246 0.893 0 N-CA-C 114.465 1.283 . . . . 1.0 114.465 179.921 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 116' ' ' ILE . . . . . 0.662 ' HB ' ' O ' ' A' ' 112' ' ' ILE . 11.2 mt -68.23 -55.36 16.67 Favored 'Isoleucine or valine' 0 C--O 1.217 -0.638 0 C-N-CA 117.919 -1.512 . . . . 1.0 113.055 -175.183 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 117' ' ' GLU . . . . . 0.754 ' HB3' ' O ' ' A' ' 113' ' ' ASN . 0.0 OUTLIER -39.56 -65.6 0.37 Allowed 'General case' 0 C--O 1.251 1.166 0 C-N-CA 121.079 -0.248 . . . . 1.0 110.453 -174.271 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 2.5 t -45.36 -18.63 0.1 Allowed 'Isoleucine or valine' 0 N--CA 1.446 -0.643 0 C-N-CA 119.124 -1.031 . . . . 1.0 109.81 -178.963 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 119' ' ' LEU . . . . . 0.603 ' N ' ' O ' ' A' ' 116' ' ' ILE . 4.7 tt -88.57 -54.92 3.94 Favored 'General case' 0 CA--C 1.538 0.504 0 N-CA-C 112.566 0.58 . . . . 1.0 112.566 176.899 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 120' ' ' GLY . . . . . 0.575 ' C ' ' H ' ' A' ' 122' ' ' GLY . . . -93.3 44.87 2.44 Favored Glycine 0 C--N 1.367 2.251 0 C-N-CA 119.821 -1.18 . . . . 1.0 113.937 -175.968 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 121' ' ' THR . . . . . 0.427 ' HB ' ' O ' ' A' ' 120' ' ' GLY . 41.5 m 73.66 -27.85 0.19 Allowed 'General case' 0 N--CA 1.476 0.848 0 C-N-CA 123.432 0.693 . . . . 1.0 109.92 177.742 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 122' ' ' GLY . . . . . 0.575 ' H ' ' C ' ' A' ' 120' ' ' GLY . . . 106.81 -36.07 4.64 Favored Glycine 0 C--N 1.319 -0.405 0 C-N-CA 124.777 1.179 . . . . 1.0 110.634 179.811 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 123' ' ' THR . . . . . 0.434 ' C ' ' O ' ' A' ' 122' ' ' GLY . 81.4 m -31.42 98.96 0.01 OUTLIER 'General case' 0 N--CA 1.465 0.281 0 CA-C-N 117.643 0.722 . . . . 1.0 112.421 -178.07 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 12.1 p-10 -142.83 143.25 32.05 Favored 'General case' 0 N--CA 1.45 -0.439 0 N-CA-C 108.058 -1.09 . . . . 1.0 108.058 177.352 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 125' ' ' TYR . . . . . 0.517 ' OH ' ' CD1' ' A' ' 127' ' ' PHE . 0.0 OUTLIER -153.03 149.1 27.81 Favored 'General case' 0 CA--C 1.542 0.646 0 C-N-CA 122.95 0.5 . . . . 1.0 109.682 -178.498 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 126' ' ' ARG . . . . . 0.465 ' NE ' ' O ' ' A' ' 125' ' ' TYR . 9.6 mmp_? -149.58 152.85 36.17 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.857 -0.61 . . . . 1.0 109.92 177.24 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 127' ' ' PHE . . . . . 0.517 ' CD1' ' OH ' ' A' ' 125' ' ' TYR . 10.6 p90 . . . . . 0 C--O 1.221 -0.436 0 CA-C-O 118.041 -0.981 . . . . 1.0 110.152 179.262 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.586 0 N-CA-C 109.083 -0.71 . . . . 1.0 109.083 . . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 2' ' ' SER . . . . . 0.414 ' O ' ' CG ' ' A' ' 3' ' ' ASP . 87.3 p -104.18 8.92 36.34 Favored 'General case' 0 N--CA 1.465 0.31 0 CA-C-N 115.672 -0.694 . . . . 1.0 110.187 -179.708 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 3' ' ' ASP . . . . . 0.414 ' CG ' ' O ' ' A' ' 2' ' ' SER . 1.6 m-20 166.44 98.32 0.0 OUTLIER 'General case' 0 CA--C 1.532 0.258 0 CA-C-N 116.163 -0.471 . . . . 1.0 109.963 178.974 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 3.4 t80 -149.68 145.84 26.93 Favored 'General case' 0 C--N 1.33 -0.251 0 N-CA-C 109.612 -0.514 . . . . 1.0 109.612 179.122 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 5' ' ' ASP . . . . . 0.631 ' O ' ' O ' ' A' ' 6' ' ' THR . 0.1 OUTLIER -155.06 154.31 32.25 Favored 'General case' 0 C--N 1.327 -0.413 0 N-CA-C 109.229 -0.656 . . . . 1.0 109.229 -179.95 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 6' ' ' THR . . . . . 0.726 HG22 ' H ' ' A' ' 7' ' ' GLU . 3.1 m -37.1 177.51 0.0 OUTLIER 'General case' 0 N--CA 1.469 0.501 0 CA-C-O 121.656 0.741 . . . . 1.0 111.646 -178.23 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 7' ' ' GLU . . . . . 0.726 ' H ' HG22 ' A' ' 6' ' ' THR . 50.9 mt-10 -66.29 -58.44 5.34 Favored 'General case' 0 C--N 1.319 -0.759 0 CA-C-N 116.231 -0.44 . . . . 1.0 110.758 -178.808 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 8' ' ' ARG . . . . . 0.409 ' HG3' ' N ' ' A' ' 9' ' ' VAL . 0.0 OUTLIER -68.55 -31.49 70.74 Favored 'General case' 0 N--CA 1.451 -0.41 0 CA-C-N 119.01 0.823 . . . . 1.0 111.029 179.477 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 9' ' ' VAL . . . . . 0.629 ' O ' HG23 ' A' ' 13' ' ' VAL . 60.0 t -66.69 -55.07 19.7 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.705 0 N-CA-C 108.228 -1.027 . . . . 1.0 108.228 179.651 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 22.9 t -68.49 -38.46 81.0 Favored 'General case' 0 C--N 1.321 -0.658 0 O-C-N 121.912 -0.493 . . . . 1.0 111.626 178.251 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 14.3 ttt-85 -74.12 -64.09 1.09 Allowed 'General case' 0 N--CA 1.453 -0.314 0 CA-C-O 118.488 -0.768 . . . . 1.0 111.361 -179.505 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 12' ' ' ALA . . . . . 0.547 ' O ' ' HB3' ' A' ' 16' ' ' ALA . . . -52.29 -30.77 29.72 Favored 'General case' 0 CA--C 1.501 -0.914 0 CA-C-N 120.319 1.418 . . . . 1.0 110.09 -179.48 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 13' ' ' VAL . . . . . 0.629 HG23 ' O ' ' A' ' 9' ' ' VAL . 3.6 t -56.27 -52.0 56.76 Favored 'Isoleucine or valine' 0 C--O 1.202 -1.43 0 N-CA-C 106.15 -1.796 . . . . 1.0 106.15 176.922 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 14' ' ' ALA . . . . . 0.615 ' O ' HG13 ' A' ' 18' ' ' VAL . . . -59.16 -63.54 1.26 Allowed 'General case' 0 CA--C 1.544 0.743 0 C-N-CA 117.395 -1.722 . . . . 1.0 110.983 177.72 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 15' ' ' ALA . . . . . 0.528 ' O ' ' N ' ' A' ' 19' ' ' GLY . . . -53.13 -54.73 31.38 Favored 'General case' 0 N--CA 1.484 1.225 0 CA-C-O 122.16 0.981 . . . . 1.0 110.844 -177.139 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 16' ' ' ALA . . . . . 0.579 ' HB1' ' CA ' ' A' ' 22' ' ' GLY . . . -63.07 -53.75 48.71 Favored 'General case' 0 C--N 1.303 -1.439 0 CA-C-N 113.915 -1.493 . . . . 1.0 108.984 -178.47 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 17' ' ' LEU . . . . . 0.607 ' CB ' ' O ' ' A' ' 13' ' ' VAL . 10.0 tp -57.47 -52.46 65.3 Favored 'General case' 0 N--CA 1.484 1.267 0 CA-C-N 114.48 -1.236 . . . . 1.0 108.576 -176.759 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 18' ' ' VAL . . . . . 0.615 HG13 ' O ' ' A' ' 14' ' ' ALA . 3.5 m -67.46 -56.56 12.9 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.245 0 C-N-CA 119.043 -1.063 . . . . 1.0 108.763 179.153 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 19' ' ' GLY . . . . . 0.528 ' N ' ' O ' ' A' ' 15' ' ' ALA . . . -61.61 -167.1 0.47 Allowed Glycine 0 CA--C 1.522 0.499 0 N-CA-C 111.58 -0.608 . . . . 1.0 111.58 -179.704 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 20' ' ' PRO . . . . . 0.627 ' O ' ' N ' ' A' ' 24' ' ' ALA . 56.1 Cg_endo -81.86 -32.71 0.75 Allowed 'Trans proline' 0 C--N 1.304 -1.773 0 C-N-CA 122.72 2.28 . . . . 1.0 114.467 -178.2 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -58.17 -57.41 19.98 Favored Glycine 0 N--CA 1.479 1.525 0 C-N-CA 120.481 -0.866 . . . . 1.0 112.318 -177.328 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 22' ' ' GLY . . . . . 0.579 ' CA ' ' HB1' ' A' ' 16' ' ' ALA . . . -58.65 -49.7 74.67 Favored Glycine 0 N--CA 1.472 1.034 0 N-CA-C 105.849 -2.9 . . . . 1.0 105.849 -176.123 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 23' ' ' VAL . . . . . 0.509 ' O ' HG12 ' A' ' 27' ' ' VAL . 2.5 t -58.7 -33.76 49.85 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.079 0 CA-C-N 114.035 -1.082 . . . . 1.0 108.355 178.334 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 24' ' ' ALA . . . . . 0.627 ' N ' ' O ' ' A' ' 20' ' ' PRO . . . -58.2 -61.9 2.22 Favored 'General case' 0 CA--C 1.536 0.413 0 C-N-CA 118.276 -1.37 . . . . 1.0 110.309 -179.511 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 56.5 mt -64.73 -42.67 95.04 Favored 'General case' 0 CA--C 1.52 -0.211 0 CA-C-N 118.982 0.81 . . . . 1.0 112.374 -177.49 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 75.1 t -60.68 -58.69 6.29 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.358 0 C-N-CA 119.096 -1.042 . . . . 1.0 109.327 -177.313 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 27' ' ' VAL . . . . . 0.509 HG12 ' O ' ' A' ' 23' ' ' VAL . 1.9 p -60.35 -34.66 58.44 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.518 0 N-CA-C 112.286 0.476 . . . . 1.0 112.286 -177.86 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 7.6 tppt? -65.55 -53.6 39.76 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-O 122.246 1.022 . . . . 1.0 109.094 -178.494 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 88.1 t -63.11 -46.58 95.68 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.125 0 CA-C-N 113.216 -1.811 . . . . 1.0 109.863 -177.231 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 30' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -65.35 -59.83 3.62 Favored 'General case' 0 N--CA 1.447 -0.602 0 C-N-CA 118.455 -1.298 . . . . 1.0 109.054 -179.419 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -60.27 -52.36 65.63 Favored 'General case' 0 CA--C 1.509 -0.619 0 N-CA-C 112.118 0.414 . . . . 1.0 112.118 -176.708 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 32' ' ' GLY . . . . . 0.471 ' O ' ' CB ' ' A' ' 33' ' ' LEU . . . 83.57 77.58 1.11 Allowed Glycine 0 CA--C 1.524 0.642 0 N-CA-C 109.918 -1.273 . . . . 1.0 109.918 -178.55 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 33' ' ' LEU . . . . . 0.471 ' CB ' ' O ' ' A' ' 32' ' ' GLY . 4.0 tp 85.02 107.84 0.03 OUTLIER Pre-proline 0 CA--C 1.548 0.884 0 O-C-N 123.885 0.403 . . . . 1.0 110.685 -179.927 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 37.6 Cg_endo -67.83 -27.51 37.32 Favored 'Trans proline' 0 N--CA 1.499 1.837 0 C-N-CA 121.632 1.555 . . . . 1.0 113.711 -179.001 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -60.83 -59.72 9.68 Favored Glycine 0 CA--C 1.525 0.694 0 C-N-CA 118.516 -1.802 . . . . 1.0 109.551 -177.564 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 36' ' ' VAL . . . . . 0.864 ' O ' HG23 ' A' ' 37' ' ' ILE . 1.7 p -84.01 142.71 13.04 Favored 'Isoleucine or valine' 0 C--O 1.211 -0.924 0 N-CA-C 106.822 -1.547 . . . . 1.0 106.822 178.011 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 37' ' ' ILE . . . . . 0.864 HG23 ' O ' ' A' ' 36' ' ' VAL . 0.6 OUTLIER 150.54 88.87 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.475 0.809 0 O-C-N 123.556 0.535 . . . . 1.0 109.75 179.694 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 26.2 m-70 -134.64 128.0 32.25 Favored 'General case' 0 C--O 1.233 0.195 0 N-CA-C 107.277 -1.379 . . . . 1.0 107.277 176.91 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 39' ' ' THR . . . . . 0.553 ' O ' ' NH2' ' A' ' 42' ' ' ARG . 1.0 OUTLIER -121.6 158.5 53.85 Favored Pre-proline 0 N--CA 1.468 0.463 0 N-CA-C 109.43 -0.581 . . . . 1.0 109.43 -179.189 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 40' ' ' PRO . . . . . 0.508 ' HG2' ' H ' ' A' ' 41' ' ' ALA . 97.4 Cg_endo -85.41 -78.76 0.0 OUTLIER 'Trans proline' 0 C--N 1.31 -1.456 0 C-N-CA 121.36 1.374 . . . . 1.0 113.306 179.99 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 41' ' ' ALA . . . . . 0.508 ' H ' ' HG2' ' A' ' 40' ' ' PRO . . . -76.11 123.3 25.59 Favored 'General case' 0 C--N 1.319 -0.737 0 CA-C-N 114.955 -1.021 . . . . 1.0 111.875 -176.802 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 42' ' ' ARG . . . . . 0.655 ' C ' ' H ' ' A' ' 44' ' ' GLY . 0.0 OUTLIER -171.14 171.06 5.89 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 114.493 -1.23 . . . . 1.0 109.502 179.071 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 8.6 tpt180 -63.53 18.07 0.01 OUTLIER 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.512 -0.767 . . . . 1.0 109.761 178.989 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 44' ' ' GLY . . . . . 0.655 ' H ' ' C ' ' A' ' 42' ' ' ARG . . . 81.38 -25.48 3.77 Favored Glycine 0 C--N 1.336 0.542 0 N-CA-C 110.731 -0.948 . . . . 1.0 110.731 179.343 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 45' ' ' PHE . . . . . 0.538 ' O ' ' CD1' ' A' ' 46' ' ' PHE . 84.9 t80 -161.72 163.23 29.81 Favored 'General case' 0 CA--C 1.535 0.388 0 N-CA-C 110.5 -0.185 . . . . 1.0 110.5 -179.328 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 46' ' ' PHE . . . . . 0.538 ' CD1' ' O ' ' A' ' 45' ' ' PHE . 3.9 m-30 136.61 86.49 0.0 OUTLIER 'General case' 0 N--CA 1.487 1.405 0 O-C-N 124.782 1.301 . . . . 1.0 110.308 179.369 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 47' ' ' ARG . . . . . 0.509 ' CB ' ' O ' ' A' ' 46' ' ' PHE . 5.2 mmp_? 132.57 140.77 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.512 0 C-N-CA 124.392 1.077 . . . . 1.0 109.642 178.568 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 1.9 t 72.74 72.02 0.14 Allowed 'General case' 0 N--CA 1.451 -0.386 0 C-N-CA 120.277 -0.569 . . . . 1.0 109.672 -179.631 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 49' ' ' ASN . . . . . 0.655 ' O ' ' N ' ' A' ' 51' ' ' GLU . 0.0 OUTLIER -136.37 121.9 13.38 Favored Pre-proline 0 C--O 1.221 -0.439 0 N-CA-C 107.923 -1.14 . . . . 1.0 107.923 -179.464 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 52.4 Cg_exo -52.21 63.96 0.02 OUTLIER 'Trans proline' 0 N--CA 1.503 2.03 0 C-N-CA 121.94 1.76 . . . . 1.0 113.311 178.786 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 51' ' ' GLU . . . . . 0.655 ' N ' ' O ' ' A' ' 49' ' ' ASN . 2.5 mp0 65.05 36.79 7.15 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 120.523 0.202 . . . . 1.0 110.81 -179.978 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 52' ' ' ARG . . . . . 0.489 HH21 ' HB3' ' A' ' 86' ' ' ALA . 4.7 mtp85 -111.21 138.58 47.48 Favored 'General case' 0 N--CA 1.466 0.367 0 CA-C-N 116.515 -0.311 . . . . 1.0 110.176 179.634 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 53' ' ' ILE . . . . . 0.578 HG23 HG23 ' A' ' 55' ' ' ILE . 4.7 tp -66.54 141.38 18.07 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-O 121.836 0.826 . . . . 1.0 110.611 179.97 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 54' ' ' GLN . . . . . 0.521 ' O ' ' CG ' ' A' ' 54' ' ' GLN . 0.0 OUTLIER -63.03 80.78 0.02 OUTLIER 'General case' 0 CA--C 1.55 0.977 0 CA-C-N 113.739 -1.573 . . . . 1.0 109.915 -176.433 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 55' ' ' ILE . . . . . 0.827 HD13 ' O ' ' A' ' 55' ' ' ILE . 0.0 OUTLIER -150.05 158.38 5.65 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.875 0 O-C-N 121.038 -1.039 . . . . 1.0 110.224 178.091 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 110.43 -7.26 30.29 Favored Glycine 0 N--CA 1.474 1.17 0 N-CA-C 111.05 -0.82 . . . . 1.0 111.05 -179.522 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 57' ' ' ASP . . . . . 0.452 ' O ' ' OD1' ' A' ' 57' ' ' ASP . 42.3 p-10 -77.22 97.88 4.95 Favored 'General case' 0 C--N 1.318 -0.769 0 N-CA-C 108.079 -1.082 . . . . 1.0 108.079 177.59 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 58' ' ' TRP . . . . . . . . . . . . . 0.6 OUTLIER -88.88 175.19 7.55 Favored 'General case' 0 CA--C 1.538 0.506 0 CA-C-O 122.757 1.265 . . . . 1.0 112.321 -177.753 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 59' ' ' ARG . . . . . 0.52 ' HD2' ' H ' ' A' ' 59' ' ' ARG . 0.6 OUTLIER -88.52 -57.69 2.83 Favored 'General case' 0 C--N 1.318 -0.79 0 CA-C-N 112.479 -2.146 . . . . 1.0 112.985 179.963 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 79.0 t80 -90.73 -17.73 26.2 Favored 'General case' 0 C--O 1.245 0.866 0 CA-C-N 115.115 -0.948 . . . . 1.0 113.012 -178.553 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 61' ' ' GLU . . . . . 0.485 ' O ' ' N ' ' A' ' 65' ' ' ASP . 17.6 tt0 -77.19 -12.9 60.0 Favored 'General case' 0 N--CA 1.435 -1.214 0 O-C-N 121.844 -0.535 . . . . 1.0 110.275 -178.605 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 62' ' ' VAL . . . . . 0.576 HG23 ' H ' ' A' ' 63' ' ' ALA . 16.1 m -45.45 -55.73 1.18 Allowed 'Isoleucine or valine' 0 C--O 1.21 -1.01 0 C-N-CA 119.602 -0.839 . . . . 1.0 109.126 -175.385 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 63' ' ' ALA . . . . . 0.576 ' H ' HG23 ' A' ' 62' ' ' VAL . . . -65.43 -48.86 71.29 Favored 'General case' 0 C--N 1.306 -1.315 0 N-CA-C 109.306 -0.627 . . . . 1.0 109.306 178.721 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER -53.15 -58.85 5.61 Favored 'General case' 0 CA--C 1.539 0.533 0 C-N-CA 119.28 -0.968 . . . . 1.0 109.429 -179.084 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 65' ' ' ASP . . . . . 0.54 ' C ' ' H ' ' A' ' 67' ' ' ARG . 19.0 m-20 -65.28 -45.67 83.52 Favored 'General case' 0 C--N 1.324 -0.524 0 N-CA-C 108.849 -0.797 . . . . 1.0 108.849 178.085 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 66' ' ' GLY . . . . . 0.521 ' N ' ' O ' ' A' ' 62' ' ' VAL . . . -67.49 24.44 0.22 Allowed Glycine 0 C--N 1.338 0.655 0 N-CA-C 111.629 -0.588 . . . . 1.0 111.629 -179.976 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 67' ' ' ARG . . . . . 0.54 ' H ' ' C ' ' A' ' 65' ' ' ASP . 0.0 OUTLIER -86.36 -9.89 55.47 Favored 'General case' 0 C--N 1.315 -0.893 0 N-CA-C 108.587 -0.894 . . . . 1.0 108.587 175.602 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 68' ' ' LEU . . . . . 0.513 ' O ' ' CA ' ' A' ' 72' ' ' HIS . 1.4 pt? -63.35 -34.92 78.77 Favored 'General case' 0 N--CA 1.472 0.632 0 N-CA-C 112.97 0.73 . . . . 1.0 112.97 -177.868 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -52.29 -65.51 0.55 Allowed 'General case' 0 C--N 1.317 -0.828 0 C-N-CA 117.433 -1.707 . . . . 1.0 109.25 -177.622 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -64.7 -75.76 0.08 Allowed 'General case' 0 C--N 1.312 -1.029 0 N-CA-C 106.511 -1.662 . . . . 1.0 106.511 -179.811 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 71' ' ' ALA . . . . . 0.745 ' O ' ' N ' ' A' ' 73' ' ' MET . . . -59.56 15.74 0.01 OUTLIER 'General case' 0 C--N 1.321 -0.636 0 C-N-CA 127.172 2.189 . . . . 1.0 116.084 179.94 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 72' ' ' HIS . . . . . 0.513 ' CA ' ' O ' ' A' ' 68' ' ' LEU . 0.0 OUTLIER -21.94 -28.48 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.588 0 CA-C-N 119.638 1.108 . . . . 1.0 113.756 -176.11 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 73' ' ' MET . . . . . 0.745 ' N ' ' O ' ' A' ' 71' ' ' ALA . 4.0 mmt -63.72 -56.65 14.03 Favored 'General case' 0 C--N 1.317 -0.816 0 C-N-CA 117.64 -1.624 . . . . 1.0 106.875 174.789 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 74' ' ' VAL . . . . . 0.783 ' O ' ' N ' ' A' ' 76' ' ' GLY . 27.9 t -36.92 -51.08 0.3 Allowed 'Isoleucine or valine' 0 N--CA 1.48 1.037 0 CA-C-O 118.483 -0.77 . . . . 1.0 111.155 -175.86 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 75' ' ' ASN . . . . . 0.524 ' O ' HG12 ' A' ' 78' ' ' VAL . 1.5 t-20 -30.71 -16.64 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.492 0 CA-C-N 119.302 0.956 . . . . 1.0 113.382 -178.2 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 76' ' ' GLY . . . . . 0.783 ' N ' ' O ' ' A' ' 74' ' ' VAL . . . -48.2 -25.05 3.85 Favored Glycine 0 CA--C 1.543 1.822 0 N-CA-C 109.991 -1.243 . . . . 1.0 109.991 176.404 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 77' ' ' ILE . . . . . 0.578 HG13 ' H ' ' A' ' 78' ' ' VAL . 3.0 pt -73.29 -55.55 12.3 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.679 0 CA-C-O 122.366 1.079 . . . . 1.0 109.078 178.552 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 78' ' ' VAL . . . . . 0.578 ' H ' HG13 ' A' ' 77' ' ' ILE . 1.4 p -38.59 -34.85 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.311 -1.083 0 CA-C-N 112.395 -2.184 . . . . 1.0 105.405 -175.666 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 79' ' ' ILE . . . . . 0.728 ' O ' ' HB3' ' A' ' 83' ' ' ALA . 16.2 pt -100.06 -37.58 5.92 Favored 'Isoleucine or valine' 0 CA--C 1.554 1.126 0 N-CA-C 113.924 1.083 . . . . 1.0 113.924 176.712 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 80' ' ' ALA . . . . . 0.519 ' N ' ' O ' ' A' ' 76' ' ' GLY . . . -82.39 -12.78 57.7 Favored 'General case' 0 N--CA 1.478 0.969 0 N-CA-C 113.645 0.98 . . . . 1.0 113.645 -178.86 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 45.5 tt0 -92.17 -73.14 0.56 Allowed 'General case' 0 N--CA 1.439 -0.995 0 CA-C-O 118.918 -0.563 . . . . 1.0 112.507 -178.636 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 28.3 m-20 -93.82 -16.84 23.72 Favored 'General case' 0 C--N 1.352 0.69 0 N-CA-C 114.843 1.423 . . . . 1.0 114.843 -178.551 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 83' ' ' ALA . . . . . 0.728 ' HB3' ' O ' ' A' ' 79' ' ' ILE . . . -52.94 -41.46 64.51 Favored 'General case' 0 N--CA 1.468 0.44 0 C-N-CA 118.713 -1.195 . . . . 1.0 111.205 -177.588 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 49.5 mt -39.37 -15.71 0.01 OUTLIER 'General case' 0 CA--C 1.538 0.505 0 N-CA-C 111.869 0.322 . . . . 1.0 111.869 -179.577 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 85' ' ' ILE . . . . . 0.62 ' N ' ' O ' ' A' ' 83' ' ' ALA . 0.8 OUTLIER -96.68 -31.55 4.01 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.618 0 C-N-CA 120.973 -0.291 . . . . 1.0 111.246 178.285 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 86' ' ' ALA . . . . . 0.658 ' O ' HG22 ' A' ' 89' ' ' VAL . . . -94.64 -28.66 15.25 Favored 'General case' 0 N--CA 1.466 0.375 0 CA-C-O 120.811 0.339 . . . . 1.0 111.842 -179.408 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -54.54 -7.7 0.18 Allowed 'General case' 0 C--N 1.32 -0.703 0 C-N-CA 119.308 -0.957 . . . . 1.0 110.196 -178.781 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 88' ' ' ALA . . . . . 0.483 ' H ' ' C ' ' A' ' 86' ' ' ALA . . . -79.73 -0.85 35.93 Favored 'General case' 0 N--CA 1.472 0.655 0 CA-C-O 122.209 1.004 . . . . 1.0 109.245 179.324 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 89' ' ' VAL . . . . . 0.658 HG22 ' O ' ' A' ' 86' ' ' ALA . 3.2 m -102.01 34.53 0.36 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.54 0 CA-C-N 113.025 -1.898 . . . . 1.0 109.744 178.548 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 90' ' ' GLY . . . . . 0.612 ' C ' ' H ' ' A' ' 92' ' ' HIS . . . -67.06 -38.27 92.38 Favored Glycine 0 C--N 1.345 1.052 0 N-CA-C 111.146 -0.782 . . . . 1.0 111.146 178.575 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 91' ' ' PRO . . . . . 0.539 ' CD ' ' N ' ' A' ' 90' ' ' GLY . 80.6 Cg_exo -46.96 -8.0 0.04 OUTLIER 'Trans proline' 0 N--CA 1.488 1.199 0 C-N-CA 121.75 1.633 . . . . 1.0 110.712 177.995 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 92' ' ' HIS . . . . . 0.612 ' H ' ' C ' ' A' ' 90' ' ' GLY . 2.6 p80 -57.42 -21.05 33.95 Favored 'General case' 0 N--CA 1.439 -1.0 0 N-CA-C 108.051 -1.092 . . . . 1.0 108.051 179.949 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 93' ' ' LEU . . . . . 0.656 HD12 ' N ' ' A' ' 94' ' ' ALA . 2.3 pp -61.64 -58.52 7.76 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.764 -0.653 . . . . 1.0 109.345 178.307 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 94' ' ' ALA . . . . . 0.656 ' N ' HD12 ' A' ' 93' ' ' LEU . . . -56.01 -52.39 64.38 Favored 'General case' 0 CA--C 1.515 -0.374 0 N-CA-C 108.983 -0.747 . . . . 1.0 108.983 179.532 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 95' ' ' ARG . . . . . 0.627 ' O ' ' N ' ' A' ' 97' ' ' LEU . 33.5 ttp180 -58.95 -60.25 4.16 Favored 'General case' 0 N--CA 1.442 -0.86 0 N-CA-C 107.565 -1.272 . . . . 1.0 107.565 178.39 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 96' ' ' ALA . . . . . 0.978 ' O ' ' N ' ' A' ' 98' ' ' GLY . . . -47.18 -13.71 0.03 OUTLIER 'General case' 0 C--N 1.301 -1.533 0 O-C-N 119.104 -2.247 . . . . 1.0 111.153 -178.689 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 97' ' ' LEU . . . . . 0.688 ' O ' ' N ' ' A' ' 100' ' ' ILE . 1.3 tm? 6.91 -52.53 0.0 OUTLIER 'General case' 0 C--N 1.365 1.242 0 CA-C-O 118.13 -0.938 . . . . 1.0 108.881 -166.886 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 98' ' ' GLY . . . . . 0.978 ' N ' ' O ' ' A' ' 96' ' ' ALA . . . -49.93 -24.29 6.19 Favored Glycine 0 CA--C 1.545 1.934 0 N-CA-C 107.898 -2.081 . . . . 1.0 107.898 174.218 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 99' ' ' GLN . . . . . 0.645 ' N ' ' O ' ' A' ' 96' ' ' ALA . 19.0 mt-30 -67.68 -19.32 65.16 Favored 'General case' 0 C--N 1.364 1.222 0 C-N-CA 116.073 -2.251 . . . . 1.0 107.263 176.375 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 100' ' ' ILE . . . . . 0.688 ' N ' ' O ' ' A' ' 97' ' ' LEU . 3.4 mm -66.67 -43.6 90.16 Favored 'Isoleucine or valine' 0 C--O 1.212 -0.872 0 C-N-CA 119.171 -1.012 . . . . 1.0 109.519 177.594 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 101' ' ' VAL . . . . . 0.503 HG13 ' N ' ' A' ' 102' ' ' CYS . 4.6 p -60.27 -56.8 15.19 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.32 0 C-N-CA 116.684 -2.006 . . . . 1.0 107.483 -179.924 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 102' ' ' CYS . . . . . 0.953 ' O ' ' HB2' ' A' ' 106' ' ' ALA . 0.5 OUTLIER -51.09 -31.67 19.78 Favored 'General case' 0 C--O 1.214 -0.812 0 CA-C-O 121.223 0.535 . . . . 1.0 112.019 179.845 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 103' ' ' ARG . . . . . 0.484 HH22 ' HB3' ' A' ' 93' ' ' LEU . 3.2 ttp180 -85.34 -47.46 10.0 Favored 'General case' 0 N--CA 1.477 0.904 0 CA-C-N 115.254 -0.884 . . . . 1.0 111.745 179.545 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 104' ' ' TYR . . . . . 0.401 ' O ' ' CG ' ' A' ' 104' ' ' TYR . 8.7 t80 -49.73 -19.36 0.62 Allowed 'General case' 0 C--N 1.3 -1.571 0 CA-C-N 114.086 -1.416 . . . . 1.0 108.937 179.28 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 105' ' ' GLY . . . . . 0.475 ' O ' ' HB3' ' A' ' 106' ' ' ALA . . . -173.64 -46.52 0.05 OUTLIER Glycine 0 N--CA 1.448 -0.526 0 C-N-CA 117.967 -2.063 . . . . 1.0 110.828 179.379 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 106' ' ' ALA . . . . . 0.953 ' HB2' ' O ' ' A' ' 102' ' ' CYS . . . 69.7 82.63 0.16 Allowed 'General case' 0 N--CA 1.44 -0.963 0 N-CA-C 111.628 0.232 . . . . 1.0 111.628 -179.081 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 107' ' ' THR . . . . . 0.426 ' O ' ' CD ' ' A' ' 110' ' ' PRO . 9.4 t -92.26 3.49 55.27 Favored 'General case' 0 CA--C 1.514 -0.44 0 N-CA-C 107.304 -1.369 . . . . 1.0 107.304 177.164 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 108' ' ' VAL . . . . . 0.76 ' O ' HG12 ' A' ' 108' ' ' VAL . 62.2 t -90.65 20.11 0.64 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.526 0 CA-C-N 114.883 -1.053 . . . . 1.0 111.352 178.593 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 109' ' ' ILE . . . . . 0.688 ' N ' ' CD ' ' A' ' 110' ' ' PRO . 0.1 OUTLIER -106.07 -18.26 0.17 Allowed Pre-proline 0 CA--C 1.548 0.869 0 O-C-N 120.162 -1.586 . . . . 1.0 110.954 177.994 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 110' ' ' PRO . . . . . 0.688 ' CD ' ' N ' ' A' ' 109' ' ' ILE . 19.5 Cg_endo -59.5 -49.56 10.2 Favored 'Trans proline' 0 N--CA 1.482 0.851 0 CA-C-N 120.5 1.214 . . . . 1.0 113.095 -174.533 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 111' ' ' ASN . . . . . 0.407 ' O ' ' N ' ' A' ' 114' ' ' ALA . 29.4 t-20 -68.66 -66.78 0.53 Allowed 'General case' 0 C--O 1.217 -0.617 0 C-N-CA 118.542 -1.263 . . . . 1.0 109.55 -178.526 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 112' ' ' ILE . . . . . 0.581 ' O ' ' HB ' ' A' ' 116' ' ' ILE . 0.9 OUTLIER -48.41 -38.64 9.08 Favored 'Isoleucine or valine' 0 C--O 1.213 -0.862 0 CA-C-O 121.127 0.489 . . . . 1.0 111.659 -177.854 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 113' ' ' ASN . . . . . 0.556 ' N ' HG23 ' A' ' 112' ' ' ILE . 48.9 t30 -67.59 -40.61 84.8 Favored 'General case' 0 C--N 1.313 -1.019 0 N-CA-C 106.502 -1.666 . . . . 1.0 106.502 178.585 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 114' ' ' ALA . . . . . 0.407 ' N ' ' O ' ' A' ' 111' ' ' ASN . . . -61.16 -51.4 69.21 Favored 'General case' 0 C--N 1.306 -1.307 0 CA-C-N 112.956 -1.929 . . . . 1.0 108.249 179.198 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -80.09 -59.7 2.62 Favored 'General case' 0 CA--C 1.544 0.725 0 N-CA-C 114.782 1.401 . . . . 1.0 114.782 179.582 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 116' ' ' ILE . . . . . 0.581 ' HB ' ' O ' ' A' ' 112' ' ' ILE . 0.7 OUTLIER -47.34 -50.53 7.52 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.884 0 CA-C-N 119.483 1.038 . . . . 1.0 111.52 -178.202 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 117' ' ' GLU . . . . . 0.498 ' CG ' ' N ' ' A' ' 118' ' ' VAL . 13.3 pt-20 -43.3 -58.57 2.47 Favored 'General case' 0 C--N 1.322 -0.623 0 N-CA-C 105.701 -1.962 . . . . 1.0 105.701 -179.365 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 118' ' ' VAL . . . . . 0.498 ' N ' ' CG ' ' A' ' 117' ' ' GLU . 88.1 t -58.43 -53.37 47.5 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.069 0 C-N-CA 119.24 -0.984 . . . . 1.0 110.043 177.757 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -52.31 -71.75 0.06 Allowed 'General case' 0 CA--C 1.545 0.765 0 N-CA-C 107.805 -1.183 . . . . 1.0 107.805 -177.922 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 120' ' ' GLY . . . . . 0.531 ' N ' ' O ' ' A' ' 116' ' ' ILE . . . -70.18 -76.05 0.55 Allowed Glycine 0 CA--C 1.546 2.002 0 C-N-CA 119.737 -1.221 . . . . 1.0 111.267 -179.87 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 121' ' ' THR . . . . . 0.493 ' CB ' ' O ' ' A' ' 120' ' ' GLY . 1.9 m 148.33 -28.68 0.01 OUTLIER 'General case' 0 N--CA 1.487 1.404 0 CA-C-N 112.294 -1.953 . . . . 1.0 110.914 -178.414 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 122' ' ' GLY . . . . . 0.643 ' O ' ' N ' ' A' ' 124' ' ' ASP . . . 102.59 -17.25 53.67 Favored Glycine 0 C--O 1.224 -0.497 0 N-CA-C 107.629 -2.188 . . . . 1.0 107.629 -176.856 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 123' ' ' THR . . . . . 0.6 HG23 ' O ' ' A' ' 123' ' ' THR . 8.1 t -53.99 85.34 0.0 OUTLIER 'General case' 0 N--CA 1.466 0.34 0 N-CA-C 106.043 -1.836 . . . . 1.0 106.043 178.379 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 124' ' ' ASP . . . . . 0.643 ' N ' ' O ' ' A' ' 122' ' ' GLY . 45.3 m-20 -163.41 169.45 18.91 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 113.344 -1.753 . . . . 1.0 111.972 -179.537 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 125' ' ' TYR . . . . . . . . . . . . . 2.0 t80 -146.47 144.52 29.72 Favored 'General case' 0 CA--C 1.542 0.662 0 N-CA-C 108.461 -0.94 . . . . 1.0 108.461 176.258 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 126' ' ' ARG . . . . . 0.641 HH21 HG21 ' A' ' 79' ' ' ILE . 1.9 mtp85 -146.44 149.33 33.5 Favored 'General case' 0 N--CA 1.466 0.326 0 N-CA-C 109.446 -0.576 . . . . 1.0 109.446 177.611 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 127' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.219 -0.506 0 CA-C-O 117.869 -1.062 . . . . 1.0 109.112 179.252 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 1' ' ' MET . . . . . 0.587 ' SD ' ' N ' ' A' ' 1' ' ' MET . 0.0 OUTLIER . . . . . 0 N--CA 1.493 1.682 0 N-CA-C 108.561 -0.903 . . . . 1.0 108.561 . . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 35.9 t -106.18 7.96 31.83 Favored 'General case' 0 N--CA 1.466 0.337 0 CA-C-N 116.317 -0.401 . . . . 1.0 110.361 -179.867 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 3.9 t0 167.5 96.86 0.0 OUTLIER 'General case' 0 N--CA 1.47 0.551 0 O-C-N 123.728 0.642 . . . . 1.0 110.242 179.244 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 82.7 t80 -150.34 146.29 26.65 Favored 'General case' 0 N--CA 1.463 0.191 0 CA-C-N 116.161 -0.472 . . . . 1.0 110.568 179.7 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 5' ' ' ASP . . . . . 0.51 ' N ' ' OD1' ' A' ' 5' ' ' ASP . 1.5 p30 -158.55 153.95 25.86 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 121.129 0.49 . . . . 1.0 110.407 179.984 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 6' ' ' THR . . . . . 0.614 ' O ' ' N ' ' A' ' 10' ' ' SER . 0.2 OUTLIER -69.72 170.55 10.7 Favored 'General case' 0 C--O 1.205 -1.251 0 CA-C-N 115.777 -0.647 . . . . 1.0 110.359 -179.453 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 1.6 tm-20 -55.31 -58.36 8.03 Favored 'General case' 0 C--N 1.31 -1.144 0 CA-C-N 115.367 -0.833 . . . . 1.0 109.72 -178.719 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 8' ' ' ARG . . . . . 0.583 HH11 HG13 ' A' ' 9' ' ' VAL . 5.5 tmm_? -51.52 -54.7 24.58 Favored 'General case' 0 C--N 1.311 -1.072 0 C-N-CA 119.17 -1.012 . . . . 1.0 108.599 -177.553 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 9' ' ' VAL . . . . . 0.583 HG13 HH11 ' A' ' 8' ' ' ARG . 0.0 OUTLIER -65.51 -48.76 81.69 Favored 'Isoleucine or valine' 0 CA--C 1.551 0.991 0 CA-C-N 115.673 -0.694 . . . . 1.0 110.718 178.896 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 10' ' ' SER . . . . . 0.614 ' N ' ' O ' ' A' ' 6' ' ' THR . 35.5 t -63.41 -41.11 98.71 Favored 'General case' 0 C--N 1.318 -0.778 0 N-CA-C 115.007 1.484 . . . . 1.0 115.007 -178.18 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 11' ' ' ARG . . . . . 0.597 ' O ' ' N ' ' A' ' 15' ' ' ALA . 56.9 ttm-85 -79.99 -55.11 5.19 Favored 'General case' 0 C--O 1.216 -0.704 0 CA-C-O 122.478 1.133 . . . . 1.0 108.988 176.808 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 12' ' ' ALA . . . . . 0.563 ' O ' ' HB3' ' A' ' 16' ' ' ALA . . . -45.85 -50.31 14.4 Favored 'General case' 0 N--CA 1.469 0.489 0 N-CA-C 106.361 -1.718 . . . . 1.0 106.361 -177.605 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 13' ' ' VAL . . . . . 0.602 ' O ' ' CB ' ' A' ' 17' ' ' LEU . 75.0 t -60.24 -49.8 82.75 Favored 'Isoleucine or valine' 0 C--O 1.202 -1.433 0 C-N-CA 118.265 -1.374 . . . . 1.0 107.686 177.568 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 14' ' ' ALA . . . . . 0.676 ' O ' HG13 ' A' ' 18' ' ' VAL . . . -59.01 -62.84 1.58 Allowed 'General case' 0 N--CA 1.48 1.072 0 C-N-CA 119.356 -0.938 . . . . 1.0 111.443 178.821 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 15' ' ' ALA . . . . . 0.597 ' N ' ' O ' ' A' ' 11' ' ' ARG . . . -53.43 -55.38 25.66 Favored 'General case' 0 N--CA 1.473 0.71 0 CA-C-O 121.586 0.707 . . . . 1.0 109.902 -177.77 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 16' ' ' ALA . . . . . 0.563 ' HB3' ' O ' ' A' ' 12' ' ' ALA . . . -63.91 -53.99 41.77 Favored 'General case' 0 C--N 1.314 -0.935 0 CA-C-N 114.39 -1.277 . . . . 1.0 108.879 -179.272 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 17' ' ' LEU . . . . . 0.602 ' CB ' ' O ' ' A' ' 13' ' ' VAL . 8.2 tt -56.57 -53.71 54.41 Favored 'General case' 0 N--CA 1.477 0.907 0 C-N-CA 118.698 -1.201 . . . . 1.0 109.026 -177.477 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 18' ' ' VAL . . . . . 0.676 HG13 ' O ' ' A' ' 14' ' ' ALA . 2.4 m -68.4 -55.78 14.94 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.798 0 C-N-CA 119.436 -0.906 . . . . 1.0 109.84 179.599 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 19' ' ' GLY . . . . . 0.505 ' N ' ' CG2' ' A' ' 18' ' ' VAL . . . -65.88 -174.46 5.28 Favored Glycine 0 CA--C 1.531 1.071 0 N-CA-C 111.825 -0.51 . . . . 1.0 111.825 -178.617 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 20' ' ' PRO . . . . . 0.597 ' O ' ' N ' ' A' ' 24' ' ' ALA . 1.3 Cg_endo -77.22 -23.15 10.55 Favored 'Trans proline' 0 N--CA 1.492 1.394 0 C-N-CA 123.065 2.51 . . . . 1.0 114.501 -179.123 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -59.73 -58.56 13.6 Favored Glycine 0 N--CA 1.474 1.185 0 C-N-CA 119.517 -1.325 . . . . 1.0 110.893 -177.205 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 22' ' ' GLY . . . . . 0.512 ' CA ' ' HB1' ' A' ' 16' ' ' ALA . . . -56.63 -53.37 44.23 Favored Glycine 0 C--N 1.314 -0.659 0 N-CA-C 107.231 -2.348 . . . . 1.0 107.231 -178.743 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 23' ' ' VAL . . . . . 0.586 ' O ' HG12 ' A' ' 27' ' ' VAL . 60.9 t -58.01 -31.74 42.01 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.883 0 CA-C-N 114.789 -0.705 . . . . 1.0 110.245 179.598 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 24' ' ' ALA . . . . . 0.597 ' N ' ' O ' ' A' ' 20' ' ' PRO . . . -61.54 -59.96 4.42 Favored 'General case' 0 CA--C 1.533 0.307 0 C-N-CA 118.884 -1.126 . . . . 1.0 108.61 179.888 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 19.1 tp -61.94 -47.6 84.16 Favored 'General case' 0 C--N 1.342 0.282 0 N-CA-C 112.852 0.686 . . . . 1.0 112.852 -179.099 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 89.9 t -60.03 -60.19 2.91 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.189 0 C-N-CA 119.055 -1.058 . . . . 1.0 110.105 -177.669 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 27' ' ' VAL . . . . . 0.661 ' O ' ' HB3' ' A' ' 31' ' ' ALA . 1.8 p -58.91 -35.33 55.92 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.352 0 N-CA-C 112.456 0.539 . . . . 1.0 112.456 -178.52 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 1.1 mmmm -66.08 -54.48 25.24 Favored 'General case' 0 CA--C 1.517 -0.298 0 C-N-CA 119.499 -0.881 . . . . 1.0 108.874 -178.745 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 4.0 t -65.89 -48.78 80.78 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.842 0 CA-C-N 114.016 -1.447 . . . . 1.0 111.017 -177.242 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 30' ' ' CYS . . . . . . . . . . . . . 4.8 t -64.45 -60.51 3.07 Favored 'General case' 0 N--CA 1.445 -0.721 0 C-N-CA 117.685 -1.606 . . . . 1.0 109.61 -179.837 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 31' ' ' ALA . . . . . 0.661 ' HB3' ' O ' ' A' ' 27' ' ' VAL . . . -68.2 -55.59 11.76 Favored 'General case' 0 C--N 1.331 -0.235 0 N-CA-C 114.846 1.425 . . . . 1.0 114.846 -175.163 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 32' ' ' GLY . . . . . 0.41 ' O ' ' CB ' ' A' ' 33' ' ' LEU . . . 85.69 72.9 1.28 Allowed Glycine 0 CA--C 1.534 1.223 0 C-N-CA 120.673 -0.775 . . . . 1.0 111.56 -178.76 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 33' ' ' LEU . . . . . 0.436 ' O ' ' N ' ' A' ' 35' ' ' GLY . 0.9 OUTLIER 73.0 99.36 0.04 OUTLIER Pre-proline 0 CA--C 1.554 1.101 0 C-N-CA 120.985 -0.286 . . . . 1.0 111.304 178.107 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_exo -43.45 -9.98 0.03 OUTLIER 'Trans proline' 0 N--CA 1.511 2.525 0 C-N-CA 123.92 3.08 . . . . 1.0 115.57 -179.218 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 35' ' ' GLY . . . . . 0.436 ' N ' ' O ' ' A' ' 33' ' ' LEU . . . -59.54 -59.04 11.3 Favored Glycine 0 CA--C 1.529 0.952 0 C-N-CA 118.562 -1.78 . . . . 1.0 109.189 -179.047 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 36' ' ' VAL . . . . . 0.446 HG22 ' H ' ' A' ' 36' ' ' VAL . 6.1 m -85.96 -148.1 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.332 -0.177 0 N-CA-C 109.199 -0.667 . . . . 1.0 109.199 179.422 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 37' ' ' ILE . . . . . 0.48 HD13 ' HB1' ' A' ' 31' ' ' ALA . 2.1 mp 74.71 80.03 0.04 OUTLIER 'Isoleucine or valine' 0 CA--C 1.514 -0.436 0 N-CA-C 112.819 0.674 . . . . 1.0 112.819 179.415 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 55.6 m80 -135.71 126.74 27.85 Favored 'General case' 0 C--N 1.329 -0.29 0 N-CA-C 106.514 -1.661 . . . . 1.0 106.514 176.979 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 39' ' ' THR . . . . . 0.576 ' OG1' ' NE ' ' A' ' 42' ' ' ARG . 0.0 OUTLIER -103.36 136.63 19.19 Favored Pre-proline 0 N--CA 1.469 0.492 0 N-CA-C 109.835 -0.431 . . . . 1.0 109.835 -178.968 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 32.3 Cg_exo -53.92 -32.53 68.11 Favored 'Trans proline' 0 N--CA 1.486 1.088 0 C-N-CA 121.076 1.184 . . . . 1.0 113.529 -179.68 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -128.21 132.06 48.82 Favored 'General case' 0 N--CA 1.463 0.192 0 O-C-N 122.191 -0.318 . . . . 1.0 111.226 -179.864 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 42' ' ' ARG . . . . . 0.708 ' C ' ' H ' ' A' ' 44' ' ' GLY . 12.1 mtm180 -160.39 158.57 29.78 Favored 'General case' 0 C--N 1.321 -0.665 0 N-CA-C 109.151 -0.685 . . . . 1.0 109.151 176.131 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 43' ' ' ARG . . . . . 0.416 ' C ' ' H ' ' A' ' 45' ' ' PHE . 41.9 ttt85 -60.28 23.46 0.01 OUTLIER 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 115.487 -0.779 . . . . 1.0 110.142 179.933 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 44' ' ' GLY . . . . . 0.708 ' H ' ' C ' ' A' ' 42' ' ' ARG . . . 80.68 -26.38 3.17 Favored Glycine 0 N--CA 1.445 -0.72 0 N-CA-C 110.126 -1.19 . . . . 1.0 110.126 -179.645 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 45' ' ' PHE . . . . . 0.588 ' CG ' ' C ' ' A' ' 44' ' ' GLY . 0.1 OUTLIER -179.33 -174.13 0.3 Allowed 'General case' 0 CA--C 1.537 0.464 0 C-N-CA 120.91 -0.316 . . . . 1.0 111.083 -178.801 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 46' ' ' PHE . . . . . 0.549 ' CB ' ' O ' ' A' ' 45' ' ' PHE . 15.2 t80 117.64 107.05 0.0 OUTLIER 'General case' 0 N--CA 1.488 1.428 0 O-C-N 125.044 1.465 . . . . 1.0 109.359 -179.454 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 47' ' ' ARG . . . . . 0.496 ' CB ' ' O ' ' A' ' 46' ' ' PHE . 3.9 tmm_? 100.09 167.3 0.01 OUTLIER 'General case' 0 N--CA 1.467 0.395 0 CA-C-N 115.141 -0.936 . . . . 1.0 108.632 -178.244 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 7.7 t 75.6 -18.03 0.48 Allowed 'General case' 0 N--CA 1.472 0.643 0 CA-C-O 120.646 0.26 . . . . 1.0 111.332 -179.158 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 49' ' ' ASN . . . . . 0.522 ' O ' ' N ' ' A' ' 51' ' ' GLU . 2.9 t-20 -62.2 146.27 92.69 Favored Pre-proline 0 CA--C 1.547 0.838 0 CA-C-N 116.317 -0.402 . . . . 1.0 111.909 -179.17 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 25.2 Cg_exo -60.68 66.65 0.08 OUTLIER 'Trans proline' 0 N--CA 1.501 1.94 0 C-N-CA 121.918 1.746 . . . . 1.0 111.703 177.289 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 51' ' ' GLU . . . . . 0.522 ' N ' ' O ' ' A' ' 49' ' ' ASN . 23.1 mm-40 46.76 55.73 7.44 Favored 'General case' 0 CA--C 1.554 1.096 0 N-CA-C 113.074 0.768 . . . . 1.0 113.074 177.979 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 52' ' ' ARG . . . . . 0.697 ' NH2' ' NE2' ' A' ' 92' ' ' HIS . 7.7 mtt-85 -143.57 155.72 44.38 Favored 'General case' 0 N--CA 1.498 1.928 0 CA-C-O 119.494 -0.289 . . . . 1.0 110.555 178.225 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 10.4 tp -75.75 127.94 37.24 Favored 'Isoleucine or valine' 0 CA--C 1.56 1.358 0 N-CA-C 116.258 1.947 . . . . 1.0 116.258 -174.361 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 47.3 tp60 -65.2 86.0 0.06 Allowed 'General case' 0 N--CA 1.476 0.848 0 CA-C-N 109.728 -3.396 . . . . 1.0 109.457 -177.716 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 55' ' ' ILE . . . . . 0.486 HD13 ' N ' ' A' ' 56' ' ' GLY . 0.0 OUTLIER -147.27 155.58 10.86 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.845 0 N-CA-C 109.692 -0.484 . . . . 1.0 109.692 178.151 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 56' ' ' GLY . . . . . 0.486 ' N ' HD13 ' A' ' 55' ' ' ILE . . . 107.51 -5.38 35.29 Favored Glycine 0 N--CA 1.48 1.621 0 N-CA-C 111.262 -0.735 . . . . 1.0 111.262 179.452 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -112.7 129.61 56.34 Favored 'General case' 0 C--N 1.317 -0.808 0 N-CA-C 108.206 -1.035 . . . . 1.0 108.206 178.071 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 58' ' ' TRP . . . . . 0.6 ' H ' ' HB2' ' A' ' 61' ' ' GLU . 11.5 m0 -134.25 152.36 51.78 Favored 'General case' 0 C--N 1.348 0.536 0 CA-C-O 122.333 1.063 . . . . 1.0 109.834 -179.829 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -37.73 -39.79 0.37 Allowed 'General case' 0 CA--C 1.558 1.252 0 CA-C-N 113.047 -1.888 . . . . 1.0 110.767 -177.015 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 7.3 t80 -86.29 -27.4 24.4 Favored 'General case' 0 N--CA 1.481 1.099 0 CA-C-O 121.953 0.882 . . . . 1.0 112.626 -179.434 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 61' ' ' GLU . . . . . 0.6 ' HB2' ' H ' ' A' ' 58' ' ' TRP . 39.9 mt-10 -78.64 -13.0 60.04 Favored 'General case' 0 CA--C 1.509 -0.613 0 CA-C-N 115.639 -0.709 . . . . 1.0 110.377 179.015 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 62' ' ' VAL . . . . . 0.654 ' O ' ' N ' ' A' ' 66' ' ' GLY . 49.5 t -50.01 -57.06 2.51 Favored 'Isoleucine or valine' 0 C--O 1.202 -1.401 0 C-N-CA 119.328 -0.949 . . . . 1.0 109.8 -176.806 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 63' ' ' ALA . . . . . 0.48 ' O ' ' HG3' ' A' ' 67' ' ' ARG . . . -65.27 -57.36 8.64 Favored 'General case' 0 C--N 1.307 -1.278 0 O-C-N 121.33 -0.856 . . . . 1.0 110.21 -178.669 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 40.3 t-80 -47.44 -56.92 6.01 Favored 'General case' 0 N--CA 1.472 0.67 0 O-C-N 124.171 0.919 . . . . 1.0 109.573 179.976 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 65' ' ' ASP . . . . . 0.585 ' C ' ' H ' ' A' ' 67' ' ' ARG . 30.0 t0 -74.56 -48.99 23.58 Favored 'General case' 0 C--N 1.316 -0.853 0 CA-C-N 115.476 -0.784 . . . . 1.0 111.167 179.511 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 66' ' ' GLY . . . . . 0.654 ' N ' ' O ' ' A' ' 62' ' ' VAL . . . -74.3 26.42 1.04 Allowed Glycine 0 CA--C 1.521 0.427 0 N-CA-C 109.905 -1.278 . . . . 1.0 109.905 177.35 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 67' ' ' ARG . . . . . 0.647 ' O ' ' N ' ' A' ' 69' ' ' LEU . 33.4 mtm180 -71.97 5.51 2.62 Favored 'General case' 0 CA--C 1.512 -0.516 0 N-CA-C 104.996 -2.224 . . . . 1.0 104.996 174.032 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 68' ' ' LEU . . . . . 0.578 ' H ' ' C ' ' A' ' 66' ' ' GLY . 7.9 tt -31.76 -29.13 0.01 OUTLIER 'General case' 0 N--CA 1.473 0.686 0 O-C-N 124.11 0.881 . . . . 1.0 108.948 -177.417 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 69' ' ' LEU . . . . . 0.647 ' N ' ' O ' ' A' ' 67' ' ' ARG . 1.3 mt -64.35 -65.66 0.65 Allowed 'General case' 0 C--N 1.322 -0.628 0 C-N-CA 119.341 -0.943 . . . . 1.0 108.825 178.895 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 70' ' ' ALA . . . . . 0.622 ' O ' ' N ' ' A' ' 72' ' ' HIS . . . -78.62 -76.68 0.19 Allowed 'General case' 0 N--CA 1.47 0.554 0 N-CA-C 106.376 -1.712 . . . . 1.0 106.376 177.793 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 71' ' ' ALA . . . . . 0.482 ' O ' ' C ' ' A' ' 72' ' ' HIS . . . -43.06 4.13 0.0 OUTLIER 'General case' 0 C--N 1.326 -0.437 0 N-CA-C 114.336 1.235 . . . . 1.0 114.336 177.906 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 72' ' ' HIS . . . . . 0.622 ' N ' ' O ' ' A' ' 70' ' ' ALA . 5.4 p-80 -32.21 -53.8 0.3 Allowed 'General case' 0 N--CA 1.467 0.407 0 CA-C-N 120.126 1.33 . . . . 1.0 112.11 -177.851 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 73' ' ' MET . . . . . 0.602 ' N ' ' CG ' ' A' ' 72' ' ' HIS . 4.9 tpp -73.57 -56.85 4.5 Favored 'General case' 0 C--N 1.331 -0.219 0 N-CA-C 108.017 -1.105 . . . . 1.0 108.017 177.926 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 74' ' ' VAL . . . . . 0.74 ' O ' ' N ' ' A' ' 76' ' ' GLY . 62.1 t -45.47 -42.72 3.44 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.319 0 CA-C-O 116.964 -1.493 . . . . 1.0 111.316 -176.515 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 75' ' ' ASN . . . . . 0.485 ' C ' ' N ' ' A' ' 77' ' ' ILE . 1.2 m-20 -36.55 -13.84 0.0 OUTLIER 'General case' 0 N--CA 1.501 2.078 0 CA-C-N 121.77 2.077 . . . . 1.0 111.318 177.907 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 76' ' ' GLY . . . . . 0.74 ' N ' ' O ' ' A' ' 74' ' ' VAL . . . -49.12 -20.7 2.19 Favored Glycine 0 CA--C 1.535 1.321 0 N-CA-C 106.624 -2.591 . . . . 1.0 106.624 173.035 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 77' ' ' ILE . . . . . 0.512 ' O ' ' N ' ' A' ' 81' ' ' GLU . 25.4 pt -61.21 -48.81 87.29 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.925 0 CA-C-O 117.043 -1.456 . . . . 1.0 112.159 -179.114 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 78' ' ' VAL . . . . . 0.409 HG12 ' O ' ' A' ' 75' ' ' ASN . 9.9 p -57.5 -18.49 9.22 Favored 'Isoleucine or valine' 0 C--N 1.363 1.162 0 CA-C-N 122.925 2.602 . . . . 1.0 113.069 179.444 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 79' ' ' ILE . . . . . 0.673 ' O ' ' HB3' ' A' ' 83' ' ' ALA . 0.1 OUTLIER -89.67 -38.63 11.38 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 N-CA-C 107.042 -1.466 . . . . 1.0 107.042 177.904 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -80.9 -16.67 52.96 Favored 'General case' 0 CA--C 1.538 0.483 0 CA-C-N 114.822 -1.081 . . . . 1.0 113.496 178.589 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 81' ' ' GLU . . . . . 0.512 ' N ' ' O ' ' A' ' 77' ' ' ILE . 48.2 tt0 -93.68 -71.94 0.63 Allowed 'General case' 0 N--CA 1.448 -0.543 0 CA-C-N 118.882 0.764 . . . . 1.0 112.47 -178.385 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 25.2 m-20 -89.29 -15.82 32.61 Favored 'General case' 0 CA--C 1.549 0.907 0 N-CA-C 115.717 1.747 . . . . 1.0 115.717 -178.137 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 83' ' ' ALA . . . . . 0.673 ' HB3' ' O ' ' A' ' 79' ' ' ILE . . . -54.51 -44.94 73.17 Favored 'General case' 0 N--CA 1.475 0.802 0 C-N-CA 118.747 -1.181 . . . . 1.0 111.897 -177.821 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 84' ' ' LEU . . . . . 0.741 HD13 ' O ' ' A' ' 84' ' ' LEU . 3.4 tm? -40.0 -28.74 0.06 Allowed 'General case' 0 CA--C 1.54 0.588 0 CA-C-N 119.141 0.882 . . . . 1.0 111.119 179.686 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 85' ' ' ILE . . . . . 0.421 ' N ' ' O ' ' A' ' 83' ' ' ALA . 68.1 mt -83.75 -37.13 12.99 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.509 0 CA-C-N 116.543 -0.298 . . . . 1.0 110.884 178.419 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 86' ' ' ALA . . . . . 0.77 ' O ' HG22 ' A' ' 89' ' ' VAL . . . -93.41 -26.83 17.06 Favored 'General case' 0 N--CA 1.471 0.623 0 CA-C-O 120.863 0.363 . . . . 1.0 111.324 179.855 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 87' ' ' GLU . . . . . 0.474 ' C ' ' H ' ' A' ' 89' ' ' VAL . 40.6 tp10 -54.26 -11.31 0.48 Allowed 'General case' 0 C--N 1.324 -0.514 0 CA-C-O 121.134 0.492 . . . . 1.0 110.081 -179.456 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 88' ' ' ALA . . . . . 0.407 ' N ' ' C ' ' A' ' 86' ' ' ALA . . . -74.8 2.25 10.57 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-O 122.439 1.114 . . . . 1.0 108.342 178.382 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 89' ' ' VAL . . . . . 0.77 HG22 ' O ' ' A' ' 86' ' ' ALA . 2.1 m -114.5 36.21 0.84 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.516 0 CA-C-N 112.766 -2.015 . . . . 1.0 110.334 178.914 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 90' ' ' GLY . . . . . 0.593 ' N ' ' CD ' ' A' ' 91' ' ' PRO . . . -77.59 -37.66 30.15 Favored Glycine 0 CA--C 1.534 1.26 0 N-CA-C 110.548 -1.021 . . . . 1.0 110.548 179.032 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 91' ' ' PRO . . . . . 0.593 ' CD ' ' N ' ' A' ' 90' ' ' GLY . 77.1 Cg_exo -50.63 -7.87 0.13 Allowed 'Trans proline' 0 N--CA 1.499 1.823 0 C-N-CA 122.459 2.106 . . . . 1.0 110.552 178.513 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 92' ' ' HIS . . . . . 0.697 ' NE2' ' NH2' ' A' ' 52' ' ' ARG . 0.2 OUTLIER -56.38 -12.22 1.57 Allowed 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 114.211 -1.359 . . . . 1.0 107.847 178.805 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 93' ' ' LEU . . . . . 0.62 HD12 ' N ' ' A' ' 94' ' ' ALA . 1.7 pp -68.34 -59.57 3.09 Favored 'General case' 0 CA--C 1.528 0.107 0 CA-C-N 115.493 -0.776 . . . . 1.0 109.172 178.158 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 94' ' ' ALA . . . . . 0.62 ' N ' HD12 ' A' ' 93' ' ' LEU . . . -58.22 -50.06 74.89 Favored 'General case' 0 CA--C 1.52 -0.208 0 C-N-CA 120.017 -0.673 . . . . 1.0 109.363 179.761 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 95' ' ' ARG . . . . . 0.594 ' O ' ' N ' ' A' ' 97' ' ' LEU . 17.2 tpt180 -56.72 -57.62 11.64 Favored 'General case' 0 CA--C 1.534 0.335 0 CA-C-O 123.034 1.397 . . . . 1.0 107.609 179.314 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 96' ' ' ALA . . . . . 1.046 ' O ' ' N ' ' A' ' 98' ' ' GLY . . . -49.21 -9.62 0.03 OUTLIER 'General case' 0 C--N 1.304 -1.403 0 O-C-N 118.643 -2.536 . . . . 1.0 111.126 179.395 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 97' ' ' LEU . . . . . 0.973 HD13 ' N ' ' A' ' 98' ' ' GLY . 0.0 OUTLIER 8.23 -47.81 0.0 OUTLIER 'General case' 0 N--CA 1.498 1.969 0 CA-C-O 117.361 -1.304 . . . . 1.0 109.105 -166.703 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 98' ' ' GLY . . . . . 1.046 ' N ' ' O ' ' A' ' 96' ' ' ALA . . . -48.03 -24.13 3.08 Favored Glycine 0 CA--C 1.551 2.313 0 CA-C-N 122.975 2.625 . . . . 1.0 107.071 171.998 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 99' ' ' GLN . . . . . 0.485 ' N ' ' O ' ' A' ' 96' ' ' ALA . 5.7 mm100 -69.82 -24.32 63.45 Favored 'General case' 0 C--N 1.386 2.17 0 C-N-CA 117.863 -1.535 . . . . 1.0 107.759 175.701 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 100' ' ' ILE . . . . . 0.72 ' N ' ' O ' ' A' ' 97' ' ' LEU . 10.2 mt -65.48 -45.61 92.32 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.837 0 C-N-CA 119.829 -0.748 . . . . 1.0 109.107 177.209 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 101' ' ' VAL . . . . . 0.699 ' O ' ' N ' ' A' ' 105' ' ' GLY . 21.7 t -55.23 -60.73 1.41 Allowed 'Isoleucine or valine' 0 C--O 1.214 -0.806 0 N-CA-C 108.065 -1.087 . . . . 1.0 108.065 178.723 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 102' ' ' CYS . . . . . 0.687 ' O ' ' HB2' ' A' ' 106' ' ' ALA . 0.5 OUTLIER -49.91 -22.16 1.42 Allowed 'General case' 0 C--O 1.204 -1.325 0 N-CA-C 112.768 0.655 . . . . 1.0 112.768 -179.163 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 58.8 ttt-85 -89.09 -48.13 7.62 Favored 'General case' 0 N--CA 1.485 1.292 0 CA-C-O 123.229 1.49 . . . . 1.0 112.194 179.418 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 104' ' ' TYR . . . . . 0.664 ' O ' ' CG ' ' A' ' 104' ' ' TYR . 0.0 OUTLIER -98.52 25.31 6.49 Favored 'General case' 0 C--N 1.297 -1.684 0 CA-C-N 111.663 -2.517 . . . . 1.0 107.157 177.849 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 105' ' ' GLY . . . . . 0.699 ' N ' ' O ' ' A' ' 101' ' ' VAL . . . -167.59 -100.61 0.14 Allowed Glycine 0 N--CA 1.441 -0.972 0 N-CA-C 108.725 -1.75 . . . . 1.0 108.725 179.363 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 106' ' ' ALA . . . . . 0.687 ' HB2' ' O ' ' A' ' 102' ' ' CYS . . . 73.6 59.14 0.09 Allowed 'General case' 0 N--CA 1.442 -0.827 0 CA-C-O 119.262 -0.399 . . . . 1.0 111.22 -178.6 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -80.11 5.37 14.49 Favored 'General case' 0 CA--C 1.51 -0.594 0 O-C-N 119.764 -1.835 . . . . 1.0 106.319 176.341 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 17.4 m -83.77 -53.52 11.03 Favored 'Isoleucine or valine' 0 C--N 1.347 0.472 0 C-N-CA 120.338 -0.545 . . . . 1.0 110.591 178.138 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 109' ' ' ILE . . . . . 0.654 HG23 ' HB1' ' A' ' 106' ' ' ALA . 0.1 OUTLIER -49.02 -37.7 21.01 Favored Pre-proline 0 N--CA 1.472 0.666 0 N-CA-C 115.308 1.596 . . . . 1.0 115.308 -176.894 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_exo -51.52 -49.36 17.43 Favored 'Trans proline' 0 C--N 1.311 -1.433 0 CA-C-N 122.386 1.888 . . . . 1.0 113.126 -176.475 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 87.2 m-20 -70.7 -69.05 0.39 Allowed 'General case' 0 CA--C 1.53 0.199 0 C-N-CA 118.829 -1.148 . . . . 1.0 110.915 -178.833 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 112' ' ' ILE . . . . . 0.404 HG23 ' H ' ' A' ' 112' ' ' ILE . 6.4 pt -46.22 -28.37 0.86 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.467 0 CA-C-O 121.826 0.822 . . . . 1.0 109.736 -179.477 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 113' ' ' ASN . . . . . 0.484 ' CB ' ' O ' ' A' ' 109' ' ' ILE . 34.2 t30 -61.92 -55.15 32.57 Favored 'General case' 0 CA--C 1.506 -0.733 0 CA-C-N 114.301 -1.318 . . . . 1.0 107.811 -178.976 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -61.98 -36.5 81.64 Favored 'General case' 0 N--CA 1.439 -0.976 0 CA-C-N 118.86 0.755 . . . . 1.0 112.387 -179.036 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -75.48 -58.92 2.99 Favored 'General case' 0 C--N 1.349 0.557 0 CA-C-N 120.402 1.455 . . . . 1.0 110.114 179.572 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 116' ' ' ILE . . . . . 0.537 ' O ' ' N ' ' A' ' 120' ' ' GLY . 5.0 mm -49.37 -48.87 18.63 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.663 0 CA-C-O 121.619 0.723 . . . . 1.0 109.182 -178.173 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 117' ' ' GLU . . . . . 0.501 ' O ' ' HA ' ' A' ' 121' ' ' THR . 37.7 tt0 -39.96 -60.74 0.97 Allowed 'General case' 0 C--O 1.215 -0.735 0 N-CA-C 106.213 -1.773 . . . . 1.0 106.213 179.279 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 94.2 t -59.14 -53.96 40.85 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.873 0 CA-C-N 114.973 -1.012 . . . . 1.0 109.824 178.559 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -53.09 -71.44 0.07 Allowed 'General case' 0 CA--C 1.552 1.021 0 N-CA-C 108.087 -1.079 . . . . 1.0 108.087 -178.395 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 120' ' ' GLY . . . . . 0.537 ' N ' ' O ' ' A' ' 116' ' ' ILE . . . -66.68 -76.85 0.33 Allowed Glycine 0 CA--C 1.538 1.502 0 C-N-CA 119.54 -1.314 . . . . 1.0 110.635 179.713 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 121' ' ' THR . . . . . 0.522 ' CB ' ' O ' ' A' ' 120' ' ' GLY . 2.2 m 145.43 -29.16 0.01 OUTLIER 'General case' 0 N--CA 1.486 1.359 0 CA-C-N 111.516 -2.342 . . . . 1.0 111.015 -178.451 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 122' ' ' GLY . . . . . 0.625 ' O ' ' N ' ' A' ' 124' ' ' ASP . . . 106.6 -16.12 41.0 Favored Glycine 0 C--O 1.226 -0.372 0 N-CA-C 107.763 -2.135 . . . . 1.0 107.763 -176.541 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 123' ' ' THR . . . . . 0.584 HG23 ' O ' ' A' ' 123' ' ' THR . 12.6 t -59.65 82.23 0.01 OUTLIER 'General case' 0 CA--C 1.537 0.471 0 N-CA-C 107.02 -1.474 . . . . 1.0 107.02 178.94 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 124' ' ' ASP . . . . . 0.625 ' N ' ' O ' ' A' ' 122' ' ' GLY . 27.8 m-20 -163.5 172.27 14.69 Favored 'General case' 0 N--CA 1.453 -0.302 0 CA-C-N 112.074 -2.33 . . . . 1.0 110.745 178.859 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 125' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -143.9 142.04 30.58 Favored 'General case' 0 C--N 1.32 -0.691 0 N-CA-C 107.298 -1.371 . . . . 1.0 107.298 175.846 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 126' ' ' ARG . . . . . 0.408 ' HA ' ' NE ' ' A' ' 126' ' ' ARG . 1.3 tpm_? -149.67 152.0 34.63 Favored 'General case' 0 C--N 1.33 -0.244 0 N-CA-C 110.111 -0.329 . . . . 1.0 110.111 178.772 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 127' ' ' PHE . . . . . . . . . . . . . 2.4 p90 . . . . . 0 N--CA 1.471 0.585 0 CA-C-O 117.874 -1.06 . . . . 1.0 111.12 -179.86 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 4.7 mmt . . . . . 0 N--CA 1.491 1.613 0 N-CA-C 109.686 -0.487 . . . . 1.0 109.686 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 34.6 t -107.45 5.06 26.88 Favored 'General case' 0 N--CA 1.467 0.422 0 CA-C-N 116.11 -0.495 . . . . 1.0 110.273 179.33 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 1.3 p30 173.96 94.59 0.01 OUTLIER 'General case' 0 CA--C 1.53 0.182 0 CA-C-N 116.032 -0.531 . . . . 1.0 111.823 -179.893 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 4' ' ' PHE . . . . . 0.429 ' O ' ' OD1' ' A' ' 5' ' ' ASP . 1.4 t80 -151.27 146.75 26.26 Favored 'General case' 0 N--CA 1.464 0.255 0 CA-C-N 116.341 -0.39 . . . . 1.0 110.25 178.937 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 5' ' ' ASP . . . . . 0.429 ' OD1' ' O ' ' A' ' 4' ' ' PHE . 0.0 OUTLIER -155.95 151.95 27.61 Favored 'General case' 0 CA--C 1.538 0.51 0 N-CA-C 109.453 -0.573 . . . . 1.0 109.453 179.523 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 6' ' ' THR . . . . . 0.685 ' O ' ' N ' ' A' ' 10' ' ' SER . 0.3 OUTLIER -69.24 168.5 14.04 Favored 'General case' 0 C--O 1.204 -1.339 0 CA-C-N 116.206 -0.452 . . . . 1.0 110.143 -179.234 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 7' ' ' GLU . . . . . 0.562 ' O ' ' N ' ' A' ' 11' ' ' ARG . 0.9 OUTLIER -58.14 -60.11 4.26 Favored 'General case' 0 C--N 1.317 -0.82 0 CA-C-O 121.352 0.596 . . . . 1.0 109.567 -177.646 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 8' ' ' ARG . . . . . 0.749 ' O ' ' HB3' ' A' ' 12' ' ' ALA . 0.0 OUTLIER -49.23 -53.78 19.84 Favored 'General case' 0 CA--C 1.545 0.751 0 N-CA-C 107.637 -1.245 . . . . 1.0 107.637 -178.304 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 9' ' ' VAL . . . . . 0.598 ' O ' ' HB ' ' A' ' 13' ' ' VAL . 0.0 OUTLIER -66.97 -50.64 62.68 Favored 'Isoleucine or valine' 0 C--O 1.196 -1.734 0 CA-C-N 115.155 -0.93 . . . . 1.0 109.794 179.294 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 10' ' ' SER . . . . . 0.685 ' N ' ' O ' ' A' ' 6' ' ' THR . 25.6 t -62.83 -63.79 1.11 Allowed 'General case' 0 C--N 1.313 -0.985 0 C-N-CA 119.595 -0.842 . . . . 1.0 111.055 -179.582 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 11' ' ' ARG . . . . . 0.562 ' N ' ' O ' ' A' ' 7' ' ' GLU . 38.2 ttm-85 -65.9 -61.35 2.11 Favored 'General case' 0 N--CA 1.466 0.366 0 C-N-CA 120.463 -0.495 . . . . 1.0 111.88 -175.945 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 12' ' ' ALA . . . . . 0.749 ' HB3' ' O ' ' A' ' 8' ' ' ARG . . . -48.66 -47.49 40.54 Favored 'General case' 0 N--CA 1.474 0.739 0 N-CA-C 107.257 -1.386 . . . . 1.0 107.257 -177.868 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 13' ' ' VAL . . . . . 0.598 ' HB ' ' O ' ' A' ' 9' ' ' VAL . 84.2 t -62.24 -51.04 77.21 Favored 'Isoleucine or valine' 0 C--O 1.205 -1.241 0 C-N-CA 118.548 -1.261 . . . . 1.0 108.187 177.098 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 14' ' ' ALA . . . . . 0.754 ' O ' HG13 ' A' ' 18' ' ' VAL . . . -55.94 -61.29 2.47 Favored 'General case' 0 C--O 1.21 -1.023 0 C-N-CA 117.933 -1.507 . . . . 1.0 108.775 -179.712 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 15' ' ' ALA . . . . . 0.578 ' O ' ' N ' ' A' ' 19' ' ' GLY . . . -52.17 -54.56 29.2 Favored 'General case' 0 N--CA 1.47 0.564 0 CA-C-O 121.467 0.651 . . . . 1.0 109.855 -178.849 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 16' ' ' ALA . . . . . 0.432 ' CB ' ' O ' ' A' ' 12' ' ' ALA . . . -63.73 -57.23 10.61 Favored 'General case' 0 C--N 1.316 -0.877 0 CA-C-N 114.994 -1.003 . . . . 1.0 109.943 -179.011 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 17' ' ' LEU . . . . . 0.586 ' N ' ' O ' ' A' ' 13' ' ' VAL . 1.2 tt -57.0 -53.29 59.71 Favored 'General case' 0 C--N 1.315 -0.916 0 CA-C-N 114.51 -1.223 . . . . 1.0 108.017 -177.85 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 18' ' ' VAL . . . . . 0.754 HG13 ' O ' ' A' ' 14' ' ' ALA . 2.4 m -68.57 -58.44 5.86 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.526 0 C-N-CA 119.446 -0.902 . . . . 1.0 109.592 178.923 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 19' ' ' GLY . . . . . 0.598 ' O ' ' CG2' ' A' ' 23' ' ' VAL . . . -55.7 -169.31 0.07 OUTLIER Glycine 0 C--O 1.213 -1.179 0 N-CA-C 110.287 -1.125 . . . . 1.0 110.287 -179.515 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 20' ' ' PRO . . . . . 0.465 ' O ' ' N ' ' A' ' 24' ' ' ALA . 1.9 Cg_endo -78.96 -32.55 1.84 Allowed 'Trans proline' 0 C--N 1.305 -1.721 0 C-N-CA 123.114 2.543 . . . . 1.0 114.625 -178.524 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -60.19 -57.88 16.89 Favored Glycine 0 N--CA 1.478 1.48 0 C-N-CA 120.164 -1.017 . . . . 1.0 113.348 -176.192 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 22' ' ' GLY . . . . . 0.408 ' N ' ' O ' ' A' ' 16' ' ' ALA . . . -55.37 -51.76 52.24 Favored Glycine 0 N--CA 1.469 0.867 0 N-CA-C 107.401 -2.28 . . . . 1.0 107.401 -176.851 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 23' ' ' VAL . . . . . 0.598 ' CG2' ' O ' ' A' ' 19' ' ' GLY . 0.1 OUTLIER -60.81 -31.45 49.52 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.999 0 N-CA-C 108.692 -0.855 . . . . 1.0 108.692 178.277 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 24' ' ' ALA . . . . . 0.465 ' N ' ' O ' ' A' ' 20' ' ' PRO . . . -58.11 -62.07 2.09 Favored 'General case' 0 C--N 1.34 0.17 0 C-N-CA 117.766 -1.573 . . . . 1.0 109.487 -179.655 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 25' ' ' LEU . . . . . 0.473 HD23 ' N ' ' A' ' 25' ' ' LEU . 0.0 OUTLIER -62.95 -46.35 88.15 Favored 'General case' 0 CA--C 1.53 0.209 0 O-C-N 121.377 -0.827 . . . . 1.0 111.599 -178.168 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 79.5 t -57.49 -57.99 7.95 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 C-N-CA 119.562 -0.855 . . . . 1.0 109.338 -178.033 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 27' ' ' VAL . . . . . 0.663 ' O ' ' HB3' ' A' ' 31' ' ' ALA . 49.0 t -60.64 -37.27 75.09 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.65 0 CA-C-O 120.663 0.268 . . . . 1.0 110.743 -178.977 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 28' ' ' LYS . . . . . 0.434 ' CG ' ' O ' ' A' ' 24' ' ' ALA . 32.5 mmtt -65.91 -56.6 10.94 Favored 'General case' 0 CA--C 1.513 -0.453 0 C-N-CA 119.693 -0.803 . . . . 1.0 109.662 -178.573 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 94.7 t -63.37 -48.21 88.31 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.011 0 CA-C-N 114.365 -1.289 . . . . 1.0 109.942 -177.624 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 30' ' ' CYS . . . . . . . . . . . . . 20.2 t -66.33 -61.1 2.19 Favored 'General case' 0 N--CA 1.443 -0.814 0 C-N-CA 118.936 -1.106 . . . . 1.0 110.372 -179.417 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 31' ' ' ALA . . . . . 0.663 ' HB3' ' O ' ' A' ' 27' ' ' VAL . . . -63.1 -52.0 64.37 Favored 'General case' 0 CA--C 1.514 -0.434 0 N-CA-C 112.057 0.392 . . . . 1.0 112.057 -176.583 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 32' ' ' GLY . . . . . 0.437 ' O ' ' HB2' ' A' ' 33' ' ' LEU . . . 82.31 69.26 1.4 Allowed Glycine 0 CA--C 1.521 0.447 0 N-CA-C 109.696 -1.362 . . . . 1.0 109.696 -178.978 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 33' ' ' LEU . . . . . 0.491 ' O ' ' O ' ' A' ' 36' ' ' VAL . 3.9 mt 90.38 82.97 0.04 OUTLIER Pre-proline 0 N--CA 1.475 0.795 0 C-N-CA 123.565 0.746 . . . . 1.0 111.858 179.583 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 53.0 Cg_exo -54.89 -25.85 45.7 Favored 'Trans proline' 0 N--CA 1.499 1.796 0 C-N-CA 123.008 2.472 . . . . 1.0 112.73 178.562 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -57.15 -58.96 11.88 Favored Glycine 0 CA--C 1.531 1.06 0 N-CA-C 108.86 -1.696 . . . . 1.0 108.86 -179.349 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 36' ' ' VAL . . . . . 0.666 ' O ' HG22 ' A' ' 37' ' ' ILE . 14.1 p -98.09 169.44 1.51 Allowed 'Isoleucine or valine' 0 C--O 1.219 -0.516 0 N-CA-C 106.602 -1.629 . . . . 1.0 106.602 176.71 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 37' ' ' ILE . . . . . 0.666 HG22 ' O ' ' A' ' 36' ' ' VAL . 8.9 tt 117.14 116.52 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.486 1.337 0 O-C-N 124.532 1.145 . . . . 1.0 110.366 -179.725 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 38' ' ' HIS . . . . . 0.496 ' CD2' ' N ' ' A' ' 38' ' ' HIS . 0.4 OUTLIER -138.03 129.13 27.34 Favored 'General case' 0 N--CA 1.463 0.193 0 N-CA-C 108.215 -1.031 . . . . 1.0 108.215 178.983 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 12.8 m -99.53 133.22 22.05 Favored Pre-proline 0 C--N 1.328 -0.367 0 N-CA-C 109.049 -0.722 . . . . 1.0 109.049 179.251 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 42.1 Cg_endo -66.33 -96.3 0.0 OUTLIER 'Trans proline' 0 N--CA 1.492 1.423 0 C-N-CA 120.926 1.084 . . . . 1.0 111.827 -179.451 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -62.48 123.78 19.22 Favored 'General case' 0 C--N 1.319 -0.748 0 CA-C-N 115.895 -0.593 . . . . 1.0 110.092 -179.06 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 42' ' ' ARG . . . . . 0.598 ' C ' ' H ' ' A' ' 44' ' ' GLY . 2.8 mmm-85 -169.75 167.32 9.46 Favored 'General case' 0 C--N 1.32 -0.713 0 N-CA-C 108.798 -0.816 . . . . 1.0 108.798 179.332 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 43' ' ' ARG . . . . . 0.586 ' HG3' ' O ' ' A' ' 45' ' ' PHE . 0.3 OUTLIER -66.48 26.71 0.02 OUTLIER 'General case' 0 C--N 1.316 -0.857 0 CA-C-N 115.157 -0.929 . . . . 1.0 110.721 179.696 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 44' ' ' GLY . . . . . 0.598 ' H ' ' C ' ' A' ' 42' ' ' ARG . . . 80.68 -26.19 3.21 Favored Glycine 0 CA--C 1.528 0.883 0 N-CA-C 111.677 -0.569 . . . . 1.0 111.677 179.758 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 45' ' ' PHE . . . . . 0.741 ' CG ' ' N ' ' A' ' 46' ' ' PHE . 0.5 OUTLIER -174.88 175.36 2.38 Favored 'General case' 0 C--O 1.2 -1.531 0 C-N-CA 120.888 -0.325 . . . . 1.0 110.95 -179.157 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 46' ' ' PHE . . . . . 0.741 ' N ' ' CG ' ' A' ' 45' ' ' PHE . 13.8 t80 161.13 13.86 0.0 OUTLIER 'General case' 0 N--CA 1.478 0.964 0 CA-C-N 116.296 -0.411 . . . . 1.0 110.997 176.429 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 47' ' ' ARG . . . . . 0.62 HH22 ' HB2' ' A' ' 31' ' ' ALA . 3.9 mtp180 -175.64 169.24 3.08 Favored 'General case' 0 C--N 1.325 -0.462 0 C-N-CA 119.831 -0.748 . . . . 1.0 110.692 -178.61 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 48' ' ' CYS . . . . . 0.48 ' SG ' ' C ' ' A' ' 47' ' ' ARG . 1.2 m 72.62 69.32 0.13 Allowed 'General case' 0 N--CA 1.452 -0.373 0 N-CA-C 108.246 -1.02 . . . . 1.0 108.246 -178.437 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 49' ' ' ASN . . . . . 0.687 ' N ' ' OD1' ' A' ' 49' ' ' ASN . 0.0 OUTLIER -132.21 123.76 18.97 Favored Pre-proline 0 N--CA 1.468 0.472 0 CA-C-O 118.628 -0.701 . . . . 1.0 109.465 -179.215 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 50' ' ' PRO . . . . . 0.589 ' O ' ' CD ' ' A' ' 51' ' ' GLU . 75.0 Cg_exo -45.82 68.82 0.01 OUTLIER 'Trans proline' 0 N--CA 1.495 1.597 0 C-N-CA 121.928 1.752 . . . . 1.0 114.992 179.98 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 51' ' ' GLU . . . . . 0.668 ' N ' ' O ' ' A' ' 49' ' ' ASN . 10.3 pm0 62.98 23.39 13.99 Favored 'General case' 0 N--CA 1.472 0.653 0 C-N-CA 123.251 0.62 . . . . 1.0 112.365 -179.305 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 25.4 mtp85 -103.65 159.39 15.65 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 120.934 0.397 . . . . 1.0 111.71 -178.926 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 53' ' ' ILE . . . . . 0.479 ' O ' ' N ' ' A' ' 55' ' ' ILE . 6.8 tp -75.15 137.51 22.83 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.167 0 CA-C-O 120.95 0.405 . . . . 1.0 110.916 -179.657 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 54' ' ' GLN . . . . . 0.589 ' NE2' ' O ' ' A' ' 46' ' ' PHE . 61.8 mt-30 -60.85 81.78 0.01 OUTLIER 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.763 -0.653 . . . . 1.0 110.935 -176.507 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 55' ' ' ILE . . . . . 0.479 ' N ' ' O ' ' A' ' 53' ' ' ILE . 11.1 tt -148.58 158.8 6.98 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.358 0 CA-C-N 115.684 -0.689 . . . . 1.0 110.453 177.69 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 111.98 -2.3 27.13 Favored Glycine 0 N--CA 1.468 0.826 0 N-CA-C 111.277 -0.729 . . . . 1.0 111.277 -179.566 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 57' ' ' ASP . . . . . 0.503 ' OD2' ' NH1' ' A' ' 43' ' ' ARG . 1.6 p-10 -80.91 97.6 7.49 Favored 'General case' 0 CA--C 1.516 -0.338 0 C-N-CA 119.968 -0.693 . . . . 1.0 109.307 178.281 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 58' ' ' TRP . . . . . . . . . . . . . 6.2 m0 -88.62 173.09 8.82 Favored 'General case' 0 C--N 1.319 -0.741 0 CA-C-O 122.8 1.286 . . . . 1.0 112.526 -178.146 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 59' ' ' ARG . . . . . 0.401 ' H ' ' HD3' ' A' ' 59' ' ' ARG . 0.4 OUTLIER -85.26 -60.31 2.07 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 111.896 -2.411 . . . . 1.0 113.306 -178.433 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 75.2 t80 -90.83 -16.95 27.4 Favored 'General case' 0 N--CA 1.479 1.025 0 N-CA-C 113.74 1.015 . . . . 1.0 113.74 -178.883 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 61' ' ' GLU . . . . . 0.516 ' O ' ' N ' ' A' ' 65' ' ' ASP . 0.0 OUTLIER -77.91 -13.16 59.98 Favored 'General case' 0 C--N 1.318 -0.8 0 O-C-N 121.92 -0.487 . . . . 1.0 110.304 -179.149 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 62' ' ' VAL . . . . . 0.604 ' O ' ' N ' ' A' ' 66' ' ' GLY . 2.5 m -47.17 -55.45 1.96 Allowed 'Isoleucine or valine' 0 C--O 1.209 -1.074 0 C-N-CA 119.442 -0.903 . . . . 1.0 110.12 -176.431 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 63' ' ' ALA . . . . . 0.456 ' H ' HG23 ' A' ' 62' ' ' VAL . . . -67.2 -50.97 58.91 Favored 'General case' 0 C--N 1.307 -1.271 0 O-C-N 121.325 -0.859 . . . . 1.0 110.443 179.959 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 64' ' ' HIS . . . . . 0.513 ' O ' ' HB2' ' A' ' 67' ' ' ARG . 0.5 OUTLIER -56.3 -56.94 14.88 Favored 'General case' 0 CA--C 1.54 0.594 0 C-N-CA 119.192 -1.003 . . . . 1.0 109.359 -179.953 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 65' ' ' ASP . . . . . 0.601 ' C ' ' H ' ' A' ' 67' ' ' ARG . 25.7 t70 -72.34 -53.04 13.49 Favored 'General case' 0 C--N 1.316 -0.887 0 O-C-N 121.486 -0.759 . . . . 1.0 110.601 178.556 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 66' ' ' GLY . . . . . 0.604 ' N ' ' O ' ' A' ' 62' ' ' VAL . . . -65.25 30.35 0.12 Allowed Glycine 0 CA--C 1.526 0.753 0 O-C-N 121.151 -0.968 . . . . 1.0 111.457 179.051 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 67' ' ' ARG . . . . . 0.601 ' H ' ' C ' ' A' ' 65' ' ' ASP . 7.6 ttt85 -81.19 1.27 32.79 Favored 'General case' 0 C--N 1.32 -0.71 0 N-CA-C 107.34 -1.356 . . . . 1.0 107.34 175.662 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 68' ' ' LEU . . . . . 0.55 HD23 ' N ' ' A' ' 68' ' ' LEU . 2.1 pt? -39.52 -31.14 0.08 Allowed 'General case' 0 C--N 1.35 0.617 0 CA-C-O 121.275 0.56 . . . . 1.0 109.837 -178.459 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 69' ' ' LEU . . . . . 0.412 ' N ' ' O ' ' A' ' 67' ' ' ARG . 4.3 tt -67.91 -68.58 0.38 Allowed 'General case' 0 CA--C 1.545 0.753 0 C-N-CA 119.32 -0.952 . . . . 1.0 112.65 -175.782 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 70' ' ' ALA . . . . . 0.53 ' C ' ' H ' ' A' ' 72' ' ' HIS . . . -73.6 -78.42 0.09 Allowed 'General case' 0 N--CA 1.474 0.76 0 C-N-CA 118.653 -1.219 . . . . 1.0 109.878 -176.981 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 71' ' ' ALA . . . . . 0.809 ' O ' ' N ' ' A' ' 73' ' ' MET . . . -62.43 14.82 0.01 OUTLIER 'General case' 0 C--N 1.318 -0.779 0 C-N-CA 125.964 1.705 . . . . 1.0 112.55 179.221 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 72' ' ' HIS . . . . . 0.53 ' H ' ' C ' ' A' ' 70' ' ' ALA . 52.8 p-80 -19.02 -29.68 0.0 OUTLIER 'General case' 0 N--CA 1.468 0.452 0 N-CA-C 114.056 1.132 . . . . 1.0 114.056 -174.744 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 73' ' ' MET . . . . . 0.809 ' N ' ' O ' ' A' ' 71' ' ' ALA . 20.9 mtt -66.25 -54.91 19.38 Favored 'General case' 0 C--N 1.318 -0.789 0 C-N-CA 119.118 -1.033 . . . . 1.0 109.336 176.123 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 74' ' ' VAL . . . . . 0.634 ' O ' ' N ' ' A' ' 76' ' ' GLY . 34.6 m -43.57 -52.95 1.13 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.579 0 CA-C-O 117.298 -1.334 . . . . 1.0 111.614 -174.74 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 75' ' ' ASN . . . . . 0.575 ' N ' HG23 ' A' ' 74' ' ' VAL . 3.4 m120 -38.53 -19.79 0.01 OUTLIER 'General case' 0 N--CA 1.482 1.138 0 CA-C-N 120.603 1.547 . . . . 1.0 110.992 -179.666 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 76' ' ' GLY . . . . . 0.634 ' N ' ' O ' ' A' ' 74' ' ' VAL . . . -48.22 -24.45 3.51 Favored Glycine 0 CA--C 1.532 1.141 0 N-CA-C 107.214 -2.354 . . . . 1.0 107.214 176.664 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 77' ' ' ILE . . . . . 0.54 ' O ' ' N ' ' A' ' 81' ' ' GLU . 24.1 pt -59.02 -43.21 88.44 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.056 0 C-N-CA 119.722 -0.791 . . . . 1.0 110.941 -179.309 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 78' ' ' VAL . . . . . 0.419 ' CG2' ' OD1' ' A' ' 65' ' ' ASP . 60.6 t -56.64 -25.25 20.94 Favored 'Isoleucine or valine' 0 C--O 1.24 0.601 0 CA-C-N 121.708 2.049 . . . . 1.0 114.147 -178.887 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 79' ' ' ILE . . . . . 0.854 ' O ' ' HB2' ' A' ' 83' ' ' ALA . 0.8 OUTLIER -91.08 -37.09 8.78 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.452 0 N-CA-C 108.005 -1.109 . . . . 1.0 108.005 178.804 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 80' ' ' ALA . . . . . 0.418 ' N ' HG13 ' A' ' 79' ' ' ILE . . . -79.8 -17.54 53.13 Favored 'General case' 0 CA--C 1.545 0.772 0 CA-C-N 115.469 -0.787 . . . . 1.0 112.033 178.927 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 81' ' ' GLU . . . . . 0.54 ' N ' ' O ' ' A' ' 77' ' ' ILE . 62.5 mm-40 -91.91 -67.36 0.86 Allowed 'General case' 0 N--CA 1.447 -0.582 0 O-C-N 121.748 -0.595 . . . . 1.0 110.581 178.492 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 82' ' ' ASP . . . . . 0.519 ' O ' ' C ' ' A' ' 83' ' ' ALA . 1.5 m-20 -72.2 -18.06 61.88 Favored 'General case' 0 N--CA 1.45 -0.464 0 O-C-N 121.11 -0.994 . . . . 1.0 112.794 -178.272 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 83' ' ' ALA . . . . . 0.854 ' HB2' ' O ' ' A' ' 79' ' ' ILE . . . -21.08 -51.31 0.01 OUTLIER 'General case' 0 N--CA 1.479 0.998 0 CA-C-N 119.048 0.84 . . . . 1.0 112.464 178.656 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 84' ' ' LEU . . . . . 0.46 ' N ' ' O ' ' A' ' 82' ' ' ASP . 3.6 mm? -31.94 -39.64 0.03 OUTLIER 'General case' 0 N--CA 1.479 0.988 0 N-CA-C 111.805 0.298 . . . . 1.0 111.805 -176.627 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 85' ' ' ILE . . . . . 0.49 ' O ' ' HB3' ' A' ' 88' ' ' ALA . 67.9 mt -94.95 -40.36 11.09 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.452 0 CA-C-O 120.896 0.379 . . . . 1.0 110.764 178.407 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 86' ' ' ALA . . . . . 0.527 ' HB3' ' HA ' ' A' ' 83' ' ' ALA . . . -53.64 -59.33 4.74 Favored 'General case' 0 CA--C 1.533 0.309 0 CA-C-N 115.951 -0.568 . . . . 1.0 111.537 -178.159 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 15.1 pt-20 -62.32 -14.21 36.97 Favored 'General case' 0 CA--C 1.518 -0.276 0 C-N-CA 120.96 -0.296 . . . . 1.0 110.681 -178.996 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 88' ' ' ALA . . . . . 0.49 ' HB3' ' O ' ' A' ' 85' ' ' ILE . . . -77.18 -18.92 57.41 Favored 'General case' 0 C--N 1.325 -0.497 0 N-CA-C 108.586 -0.894 . . . . 1.0 108.586 179.109 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 89' ' ' VAL . . . . . 0.431 ' O ' ' OE2' ' A' ' 51' ' ' GLU . 35.6 m -113.97 35.19 0.91 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.22 0 CA-C-N 113.61 -1.632 . . . . 1.0 110.781 178.705 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 90' ' ' GLY . . . . . 0.633 ' C ' ' H ' ' A' ' 92' ' ' HIS . . . -69.61 -33.44 71.78 Favored Glycine 0 C--N 1.351 1.407 0 CA-C-O 119.205 -0.775 . . . . 1.0 111.99 178.243 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 91' ' ' PRO . . . . . 0.552 ' CD ' ' N ' ' A' ' 90' ' ' GLY . 78.6 Cg_exo -45.57 -4.0 0.02 OUTLIER 'Trans proline' 0 N--CA 1.501 1.941 0 C-N-CA 122.379 2.053 . . . . 1.0 112.659 177.703 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 92' ' ' HIS . . . . . 0.65 ' O ' ' HB3' ' A' ' 96' ' ' ALA . 0.0 OUTLIER -49.31 -15.52 0.14 Allowed 'General case' 0 N--CA 1.448 -0.531 0 O-C-N 123.794 0.684 . . . . 1.0 110.047 -178.718 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 93' ' ' LEU . . . . . 0.661 HD12 ' N ' ' A' ' 94' ' ' ALA . 1.7 pp -66.28 -58.06 6.17 Favored 'General case' 0 N--CA 1.445 -0.692 0 N-CA-C 108.892 -0.781 . . . . 1.0 108.892 177.095 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 94' ' ' ALA . . . . . 0.661 ' N ' HD12 ' A' ' 93' ' ' LEU . . . -59.77 -58.19 9.64 Favored 'General case' 0 N--CA 1.449 -0.489 0 N-CA-C 109.959 -0.386 . . . . 1.0 109.959 179.725 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 95' ' ' ARG . . . . . 0.613 ' O ' ' N ' ' A' ' 97' ' ' LEU . 0.0 OUTLIER -61.47 -63.53 1.24 Allowed 'General case' 0 N--CA 1.449 -0.492 0 CA-C-O 121.428 0.632 . . . . 1.0 109.572 -178.592 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 96' ' ' ALA . . . . . 0.957 ' O ' ' N ' ' A' ' 98' ' ' GLY . . . -49.44 -11.08 0.04 OUTLIER 'General case' 0 N--CA 1.438 -1.064 0 O-C-N 118.791 -2.443 . . . . 1.0 111.266 -178.911 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 97' ' ' LEU . . . . . 0.745 ' O ' ' N ' ' A' ' 100' ' ' ILE . 0.3 OUTLIER 5.89 -48.0 0.0 OUTLIER 'General case' 0 N--CA 1.487 1.419 0 C-N-CA 124.426 1.09 . . . . 1.0 110.38 -167.96 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 98' ' ' GLY . . . . . 0.957 ' N ' ' O ' ' A' ' 96' ' ' ALA . . . -51.35 -24.28 10.28 Favored Glycine 0 C--N 1.286 -2.214 0 N-CA-C 106.488 -2.645 . . . . 1.0 106.488 173.273 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 99' ' ' GLN . . . . . 0.625 ' N ' ' O ' ' A' ' 96' ' ' ALA . 35.1 mt-30 -65.57 -23.16 66.79 Favored 'General case' 0 C--N 1.377 1.766 0 N-CA-C 105.94 -1.874 . . . . 1.0 105.94 175.983 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 100' ' ' ILE . . . . . 0.745 ' N ' ' O ' ' A' ' 97' ' ' LEU . 1.4 tp -64.59 -37.06 79.11 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.21 0 C-N-CA 118.87 -1.132 . . . . 1.0 108.118 178.884 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 101' ' ' VAL . . . . . 0.711 ' O ' ' N ' ' A' ' 105' ' ' GLY . 88.1 t -57.62 -63.13 0.71 Allowed 'Isoleucine or valine' 0 C--O 1.216 -0.704 0 C-N-CA 119.923 -0.711 . . . . 1.0 109.687 178.713 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 102' ' ' CYS . . . . . 0.957 ' O ' ' HB2' ' A' ' 106' ' ' ALA . 0.9 OUTLIER -49.22 -17.34 0.23 Allowed 'General case' 0 CA--C 1.545 0.754 0 C-N-CA 118.36 -1.336 . . . . 1.0 111.579 -178.446 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 24.0 ttm180 -89.64 -46.71 8.44 Favored 'General case' 0 N--CA 1.479 0.998 0 CA-C-O 122.573 1.178 . . . . 1.0 111.851 178.275 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 104' ' ' TYR . . . . . 0.622 ' O ' ' CG ' ' A' ' 104' ' ' TYR . 0.0 OUTLIER -104.47 21.83 16.01 Favored 'General case' 0 CA--C 1.549 0.931 0 CA-C-N 112.684 -2.053 . . . . 1.0 110.208 178.262 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 105' ' ' GLY . . . . . 0.756 ' O ' ' N ' ' A' ' 107' ' ' THR . . . -168.26 -12.5 0.02 OUTLIER Glycine 0 C--N 1.345 1.03 0 C-N-CA 118.523 -1.798 . . . . 1.0 113.969 178.769 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 106' ' ' ALA . . . . . 0.957 ' HB2' ' O ' ' A' ' 102' ' ' CYS . . . -20.08 64.8 0.0 OUTLIER 'General case' 0 N--CA 1.479 0.98 0 N-CA-C 114.671 1.36 . . . . 1.0 114.671 -179.601 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 107' ' ' THR . . . . . 0.756 ' N ' ' O ' ' A' ' 105' ' ' GLY . 96.4 m -102.28 -4.96 24.84 Favored 'General case' 0 N--CA 1.447 -0.585 0 N-CA-C 107.532 -1.285 . . . . 1.0 107.532 177.008 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 16.9 m -95.59 11.69 4.36 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.511 0 CA-C-N 116.084 -0.507 . . . . 1.0 110.053 176.325 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 109' ' ' ILE . . . . . 0.646 ' N ' ' CD ' ' A' ' 110' ' ' PRO . 0.1 OUTLIER -112.81 -27.94 0.12 Allowed Pre-proline 0 CA--C 1.555 1.161 0 CA-C-N 119.187 0.903 . . . . 1.0 111.64 177.523 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 110' ' ' PRO . . . . . 0.646 ' CD ' ' N ' ' A' ' 109' ' ' ILE . 48.7 Cg_endo -65.86 -37.41 27.36 Favored 'Trans proline' 0 N--CA 1.496 1.643 0 C-N-CA 122.827 2.351 . . . . 1.0 113.579 -173.19 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 34.3 t30 -64.57 -67.95 0.39 Allowed 'General case' 0 CA--C 1.507 -0.686 0 C-N-CA 119.061 -1.056 . . . . 1.0 109.078 -178.186 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 112' ' ' ILE . . . . . 0.596 ' O ' HG22 ' A' ' 116' ' ' ILE . 6.3 pt -52.01 -42.54 34.64 Favored 'Isoleucine or valine' 0 C--O 1.209 -1.038 0 CA-C-O 122.065 0.936 . . . . 1.0 108.857 179.907 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 113' ' ' ASN . . . . . 0.544 ' N ' ' CG1' ' A' ' 112' ' ' ILE . 2.8 m120 -50.19 -53.57 26.98 Favored 'General case' 0 C--N 1.315 -0.922 0 CA-C-N 113.929 -1.487 . . . . 1.0 108.745 -176.738 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 114' ' ' ALA . . . . . 0.444 ' O ' ' CG2' ' A' ' 118' ' ' VAL . . . -62.97 -34.36 77.35 Favored 'General case' 0 C--N 1.311 -1.083 0 O-C-N 121.035 -1.04 . . . . 1.0 112.501 179.551 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -84.63 -60.02 2.19 Favored 'General case' 0 N--CA 1.471 0.605 0 CA-C-N 118.672 0.669 . . . . 1.0 112.684 179.095 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 116' ' ' ILE . . . . . 0.622 HG23 ' N ' ' A' ' 117' ' ' GLU . 9.9 tt -54.57 -61.87 0.89 Allowed 'Isoleucine or valine' 0 C--O 1.223 -0.313 0 CA-C-N 115.336 -0.847 . . . . 1.0 108.795 -176.998 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 117' ' ' GLU . . . . . 0.622 ' N ' HG23 ' A' ' 116' ' ' ILE . 98.2 mt-10 -45.46 -49.3 13.58 Favored 'General case' 0 C--N 1.314 -0.935 0 N-CA-C 106.501 -1.666 . . . . 1.0 106.501 -178.236 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 118' ' ' VAL . . . . . 0.444 ' CG2' ' O ' ' A' ' 114' ' ' ALA . 23.8 t -62.77 -30.18 48.8 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.689 0 CA-C-O 118.88 -0.581 . . . . 1.0 109.913 178.164 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 119' ' ' LEU . . . . . 0.573 ' N ' ' O ' ' A' ' 116' ' ' ILE . 14.3 tp -80.66 -63.01 1.5 Allowed 'General case' 0 C--N 1.351 0.653 0 CA-C-N 120.028 1.285 . . . . 1.0 108.032 178.548 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 120' ' ' GLY . . . . . 0.465 ' N ' ' O ' ' A' ' 116' ' ' ILE . . . -61.65 -86.81 0.04 OUTLIER Glycine 0 N--CA 1.434 -1.462 0 C-N-CA 117.991 -2.052 . . . . 1.0 108.415 177.839 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 121' ' ' THR . . . . . 0.433 HG22 ' C ' ' A' ' 120' ' ' GLY . 0.0 OUTLIER 171.96 -41.4 0.01 OUTLIER 'General case' 0 C--N 1.316 -0.849 0 CA-C-N 113.947 -1.127 . . . . 1.0 113.755 179.737 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 122' ' ' GLY . . . . . 0.651 ' O ' ' N ' ' A' ' 124' ' ' ASP . . . 102.17 -16.78 55.18 Favored Glycine 0 N--CA 1.472 1.069 0 N-CA-C 108.015 -2.034 . . . . 1.0 108.015 -176.959 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 123' ' ' THR . . . . . 0.663 HG23 ' O ' ' A' ' 123' ' ' THR . 1.7 t -52.62 86.84 0.0 OUTLIER 'General case' 0 CA--C 1.538 0.505 0 N-CA-C 105.479 -2.045 . . . . 1.0 105.479 179.063 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 124' ' ' ASP . . . . . 0.651 ' N ' ' O ' ' A' ' 122' ' ' GLY . 37.5 m-20 -164.48 171.65 14.35 Favored 'General case' 0 CA--C 1.522 -0.107 0 CA-C-N 114.107 -1.406 . . . . 1.0 112.018 -178.462 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 125' ' ' TYR . . . . . . . . . . . . . 26.1 t80 -148.38 145.42 28.06 Favored 'General case' 0 CA--C 1.536 0.415 0 CA-C-N 114.785 -1.098 . . . . 1.0 108.633 175.678 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 126' ' ' ARG . . . . . 0.42 HH21 ' CG2' ' A' ' 79' ' ' ILE . 2.6 mmp_? -145.5 149.4 34.56 Favored 'General case' 0 N--CA 1.474 0.765 0 N-CA-C 109.5 -0.556 . . . . 1.0 109.5 178.16 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 127' ' ' PHE . . . . . . . . . . . . . 40.4 p90 . . . . . 0 C--O 1.22 -0.454 0 CA-C-O 118.086 -0.959 . . . . 1.0 110.709 179.713 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 1' ' ' MET . . . . . 0.467 ' C ' ' H ' ' A' ' 3' ' ' ASP . 57.9 mtt . . . . . 0 N--CA 1.493 1.68 0 N-CA-C 108.902 -0.777 . . . . 1.0 108.902 . . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 2' ' ' SER . . . . . 0.531 ' O ' ' CG ' ' A' ' 3' ' ' ASP . 6.9 t -69.44 10.01 0.4 Allowed 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.309 -0.405 . . . . 1.0 111.013 178.915 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 3' ' ' ASP . . . . . 0.531 ' CG ' ' O ' ' A' ' 2' ' ' SER . 80.9 m-20 138.3 142.82 0.0 OUTLIER 'General case' 0 N--CA 1.486 1.326 0 O-C-N 124.564 1.165 . . . . 1.0 109.954 179.075 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 60.9 t80 -156.4 152.5 27.6 Favored 'General case' 0 N--CA 1.463 0.225 0 CA-C-N 115.932 -0.576 . . . . 1.0 110.642 179.341 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 69.9 m-20 -150.07 146.19 26.8 Favored 'General case' 0 CA--C 1.534 0.334 0 N-CA-C 109.09 -0.707 . . . . 1.0 109.09 179.435 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 6' ' ' THR . . . . . 0.802 ' O ' ' N ' ' A' ' 10' ' ' SER . 0.2 OUTLIER -87.74 177.67 6.95 Favored 'General case' 0 C--O 1.194 -1.859 0 CA-C-O 121.094 0.473 . . . . 1.0 111.314 -178.702 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 7' ' ' GLU . . . . . 0.413 ' O ' ' N ' ' A' ' 11' ' ' ARG . 7.7 tm-20 -56.54 -58.18 9.15 Favored 'General case' 0 C--N 1.312 -1.052 0 CA-C-O 121.687 0.755 . . . . 1.0 110.932 -177.894 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 8' ' ' ARG . . . . . 0.803 ' O ' ' HB3' ' A' ' 12' ' ' ALA . 48.6 ttp85 -55.01 -57.28 12.32 Favored 'General case' 0 C--N 1.318 -0.777 0 CA-C-N 114.089 -1.414 . . . . 1.0 107.8 -178.02 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 9' ' ' VAL . . . . . 0.65 ' O ' ' HB ' ' A' ' 13' ' ' VAL . 0.0 OUTLIER -66.31 -54.06 30.14 Favored 'Isoleucine or valine' 0 C--O 1.188 -2.164 0 CA-C-N 114.499 -1.228 . . . . 1.0 110.655 178.883 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 10' ' ' SER . . . . . 0.802 ' N ' ' O ' ' A' ' 6' ' ' THR . 11.0 t -67.03 -64.58 0.82 Allowed 'General case' 0 N--CA 1.486 1.369 0 CA-C-N 118.769 0.713 . . . . 1.0 112.406 -178.132 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 11' ' ' ARG . . . . . 0.511 ' O ' ' N ' ' A' ' 15' ' ' ALA . 6.7 tpt180 -63.57 -59.07 5.1 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-O 121.083 0.468 . . . . 1.0 111.371 -175.104 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 12' ' ' ALA . . . . . 0.803 ' HB3' ' O ' ' A' ' 8' ' ' ARG . . . -51.58 -46.76 63.61 Favored 'General case' 0 C--N 1.322 -0.619 0 N-CA-C 106.512 -1.662 . . . . 1.0 106.512 -176.022 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 13' ' ' VAL . . . . . 0.659 ' O ' ' N ' ' A' ' 17' ' ' LEU . 67.6 t -62.3 -50.99 77.72 Favored 'Isoleucine or valine' 0 C--O 1.2 -1.532 0 CA-C-N 114.664 -1.153 . . . . 1.0 107.931 177.499 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 14' ' ' ALA . . . . . 0.819 ' O ' HG22 ' A' ' 18' ' ' VAL . . . -57.17 -62.39 1.79 Allowed 'General case' 0 C--O 1.207 -1.138 0 C-N-CA 117.335 -1.746 . . . . 1.0 109.097 -178.723 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 15' ' ' ALA . . . . . 0.585 ' O ' ' N ' ' A' ' 19' ' ' GLY . . . -53.73 -53.91 45.57 Favored 'General case' 0 C--O 1.215 -0.753 0 O-C-N 123.843 0.714 . . . . 1.0 109.703 -178.684 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 16' ' ' ALA . . . . . 0.488 ' CB ' ' O ' ' A' ' 12' ' ' ALA . . . -63.8 -57.8 8.8 Favored 'General case' 0 N--CA 1.474 0.738 0 C-N-CA 120.022 -0.671 . . . . 1.0 110.215 -179.737 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 17' ' ' LEU . . . . . 0.659 ' N ' ' O ' ' A' ' 13' ' ' VAL . 6.1 tt -55.91 -54.53 43.61 Favored 'General case' 0 N--CA 1.48 1.072 0 CA-C-N 114.752 -1.113 . . . . 1.0 108.012 -178.013 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 18' ' ' VAL . . . . . 0.819 HG22 ' O ' ' A' ' 14' ' ' ALA . 2.2 m -69.39 -58.34 5.91 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 C-N-CA 119.374 -0.93 . . . . 1.0 109.104 179.913 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 19' ' ' GLY . . . . . 0.585 ' N ' ' O ' ' A' ' 15' ' ' ALA . . . -54.97 -167.11 0.03 OUTLIER Glycine 0 C--O 1.225 -0.44 0 N-CA-C 111.298 -0.721 . . . . 1.0 111.298 -178.276 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 20' ' ' PRO . . . . . 0.673 ' O ' ' N ' ' A' ' 24' ' ' ALA . 74.0 Cg_endo -83.6 -28.97 1.19 Allowed 'Trans proline' 0 C--N 1.296 -2.184 0 C-N-CA 122.73 2.287 . . . . 1.0 112.556 -178.582 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -62.11 -59.63 9.24 Favored Glycine 0 N--CA 1.475 1.24 0 C-N-CA 119.508 -1.33 . . . . 1.0 111.902 -176.671 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 22' ' ' GLY . . . . . 0.459 ' N ' ' O ' ' A' ' 16' ' ' ALA . . . -55.72 -51.17 56.83 Favored Glycine 0 N--CA 1.47 0.909 0 N-CA-C 106.503 -2.639 . . . . 1.0 106.503 -178.608 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 23' ' ' VAL . . . . . 0.462 ' O ' HG12 ' A' ' 27' ' ' VAL . 38.3 t -60.41 -32.58 51.47 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.607 0 C-N-CA 119.493 -0.883 . . . . 1.0 109.19 178.415 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 24' ' ' ALA . . . . . 0.673 ' N ' ' O ' ' A' ' 20' ' ' PRO . . . -59.37 -63.85 1.15 Allowed 'General case' 0 C--N 1.349 0.552 0 C-N-CA 118.761 -1.176 . . . . 1.0 110.425 -178.709 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 19.5 mt -62.18 -44.19 97.15 Favored 'General case' 0 CA--C 1.509 -0.63 0 C-N-CA 119.581 -0.848 . . . . 1.0 110.845 -177.878 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 26' ' ' VAL . . . . . 0.415 HG23 ' O ' ' A' ' 22' ' ' GLY . 71.1 t -57.88 -60.4 2.23 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.695 0 C-N-CA 119.004 -1.078 . . . . 1.0 110.012 -178.186 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 27' ' ' VAL . . . . . 0.522 ' O ' ' HB3' ' A' ' 31' ' ' ALA . 1.4 p -60.46 -36.07 67.18 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-O 120.81 0.338 . . . . 1.0 111.645 -178.31 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 21.6 ttpp -65.72 -56.27 12.93 Favored 'General case' 0 C--N 1.321 -0.673 0 N-CA-C 109.004 -0.739 . . . . 1.0 109.004 -179.645 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 94.6 t -61.06 -47.7 92.38 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.614 0 CA-C-N 115.001 -1.0 . . . . 1.0 109.743 -178.328 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 30' ' ' CYS . . . . . 0.659 ' SG ' ' N ' ' A' ' 31' ' ' ALA . 0.0 OUTLIER -66.1 -60.38 2.87 Favored 'General case' 0 C--N 1.326 -0.446 0 C-N-CA 118.79 -1.164 . . . . 1.0 110.132 -179.511 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 31' ' ' ALA . . . . . 0.659 ' N ' ' SG ' ' A' ' 30' ' ' CYS . . . -60.43 -50.98 71.42 Favored 'General case' 0 CA--C 1.507 -0.697 0 C-N-CA 120.986 -0.286 . . . . 1.0 111.093 -176.003 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 32' ' ' GLY . . . . . 0.53 ' O ' ' CB ' ' A' ' 33' ' ' LEU . . . 78.23 69.58 1.38 Allowed Glycine 0 N--CA 1.448 -0.541 0 N-CA-C 109.516 -1.434 . . . . 1.0 109.516 -178.616 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 33' ' ' LEU . . . . . 0.53 ' CB ' ' O ' ' A' ' 32' ' ' GLY . 1.2 tt 90.31 77.21 0.04 OUTLIER Pre-proline 0 CA--C 1.534 0.359 0 CA-C-N 115.176 -0.512 . . . . 1.0 110.388 -179.58 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 58.8 Cg_exo -50.47 -23.09 9.95 Favored 'Trans proline' 0 N--CA 1.492 1.415 0 C-N-CA 122.839 2.359 . . . . 1.0 112.491 179.578 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 35' ' ' GLY . . . . . 0.524 ' H ' HD23 ' A' ' 33' ' ' LEU . . . -58.03 -61.08 7.84 Favored Glycine 0 CA--C 1.538 1.53 0 C-N-CA 119.102 -1.523 . . . . 1.0 109.538 -178.616 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 36' ' ' VAL . . . . . 0.613 HG22 ' N ' ' A' ' 37' ' ' ILE . 13.5 p -94.93 171.73 1.1 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.651 0 N-CA-C 107.108 -1.441 . . . . 1.0 107.108 176.901 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 37' ' ' ILE . . . . . 0.613 ' N ' HG22 ' A' ' 36' ' ' VAL . 4.1 mm 112.79 113.54 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.484 1.249 0 O-C-N 124.614 1.196 . . . . 1.0 110.009 -179.73 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 16.9 m-70 -139.98 133.58 30.27 Favored 'General case' 0 C--N 1.332 -0.17 0 N-CA-C 108.651 -0.87 . . . . 1.0 108.651 179.2 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 11.4 m -107.84 109.79 62.27 Favored Pre-proline 0 N--CA 1.469 0.492 0 N-CA-C 109.975 -0.38 . . . . 1.0 109.975 179.99 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 40' ' ' PRO . . . . . 0.459 ' HB2' ' H ' ' A' ' 41' ' ' ALA . 79.0 Cg_exo -42.6 -90.9 0.0 OUTLIER 'Trans proline' 0 N--CA 1.493 1.444 0 C-N-CA 121.471 1.447 . . . . 1.0 112.252 -179.127 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 41' ' ' ALA . . . . . 0.459 ' H ' ' HB2' ' A' ' 40' ' ' PRO . . . -65.56 125.02 23.89 Favored 'General case' 0 C--N 1.324 -0.541 0 N-CA-C 109.447 -0.575 . . . . 1.0 109.447 -179.389 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 34.5 ptt180 -174.2 177.05 2.37 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.205 -0.452 . . . . 1.0 110.617 179.394 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 4.3 tpp180 -58.58 -45.55 88.83 Favored 'General case' 0 C--N 1.324 -0.53 0 N-CA-C 107.965 -1.124 . . . . 1.0 107.965 178.711 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 122.24 -25.11 6.77 Favored Glycine 0 N--CA 1.471 1.016 0 N-CA-C 111.134 -0.786 . . . . 1.0 111.134 -179.788 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 45' ' ' PHE . . . . . 0.543 ' O ' ' HB2' ' A' ' 46' ' ' PHE . 64.7 t80 -149.98 153.66 36.93 Favored 'General case' 0 N--CA 1.466 0.368 0 N-CA-C 107.726 -1.213 . . . . 1.0 107.726 176.812 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 46' ' ' PHE . . . . . 0.79 ' O ' ' HB2' ' A' ' 47' ' ' ARG . 2.1 m-85 128.59 95.99 0.0 OUTLIER 'General case' 0 N--CA 1.481 1.109 0 C-N-CA 126.054 1.742 . . . . 1.0 108.317 -178.735 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 47' ' ' ARG . . . . . 0.79 ' HB2' ' O ' ' A' ' 46' ' ' PHE . 0.1 OUTLIER 118.16 137.79 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.825 0 C-N-CA 124.766 1.227 . . . . 1.0 110.151 179.308 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 5.4 t 71.07 78.64 0.17 Allowed 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 116.074 -0.512 . . . . 1.0 110.413 179.287 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 49' ' ' ASN . . . . . 0.523 ' O ' ' N ' ' A' ' 51' ' ' GLU . 9.4 p30 -144.66 145.43 28.23 Favored Pre-proline 0 C--N 1.324 -0.515 0 CA-C-N 115.632 -0.713 . . . . 1.0 110.838 179.753 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 50' ' ' PRO . . . . . 0.514 ' HD2' HH12 ' A' ' 52' ' ' ARG . 20.5 Cg_endo -61.27 55.48 0.1 Allowed 'Trans proline' 0 N--CA 1.494 1.524 0 C-N-CA 121.979 1.786 . . . . 1.0 113.239 179.901 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 51' ' ' GLU . . . . . 0.523 ' N ' ' O ' ' A' ' 49' ' ' ASN . 2.3 mp0 65.9 68.34 0.46 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.679 -0.691 . . . . 1.0 111.497 177.967 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 52' ' ' ARG . . . . . 0.514 HH12 ' HD2' ' A' ' 50' ' ' PRO . 7.8 mtm-85 -145.95 153.57 40.95 Favored 'General case' 0 N--CA 1.467 0.379 0 CA-C-N 115.685 -0.689 . . . . 1.0 110.468 179.157 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 53' ' ' ILE . . . . . 0.519 ' O ' ' N ' ' A' ' 55' ' ' ILE . 12.3 pt -65.65 127.99 27.72 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 CA-C-N 115.829 -0.623 . . . . 1.0 111.073 179.799 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 54' ' ' GLN . . . . . 0.468 ' O ' ' CZ ' ' A' ' 46' ' ' PHE . 4.9 pm0 -57.74 85.49 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 121.426 0.632 . . . . 1.0 109.714 -177.367 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 55' ' ' ILE . . . . . 0.519 ' N ' ' O ' ' A' ' 53' ' ' ILE . 0.5 OUTLIER -146.83 159.17 9.96 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.157 0 CA-C-N 115.066 -0.97 . . . . 1.0 110.043 178.269 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 56' ' ' GLY . . . . . 0.42 ' H ' HG13 ' A' ' 55' ' ' ILE . . . 114.23 0.61 23.75 Favored Glycine 0 C--N 1.332 0.36 0 N-CA-C 110.178 -1.169 . . . . 1.0 110.178 -178.183 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 57' ' ' ASP . . . . . 0.432 ' CG ' ' O ' ' A' ' 57' ' ' ASP . 13.2 p-10 -80.82 93.57 6.27 Favored 'General case' 0 N--CA 1.455 -0.197 0 C-N-CA 119.379 -0.929 . . . . 1.0 109.845 178.791 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 58' ' ' TRP . . . . . . . . . . . . . 10.8 m0 -88.7 169.21 11.86 Favored 'General case' 0 CA--C 1.547 0.856 0 CA-C-O 122.618 1.199 . . . . 1.0 111.63 -178.103 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 59' ' ' ARG . . . . . 0.425 ' CG ' ' H ' ' A' ' 60' ' ' TYR . 6.8 ptt85 -83.86 -60.91 1.96 Allowed 'General case' 0 C--N 1.31 -1.129 0 CA-C-N 112.119 -2.309 . . . . 1.0 113.5 -178.495 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 60' ' ' TYR . . . . . 0.425 ' H ' ' CG ' ' A' ' 59' ' ' ARG . 0.0 OUTLIER -89.19 -18.26 27.48 Favored 'General case' 0 C--O 1.248 0.998 0 N-CA-C 113.167 0.803 . . . . 1.0 113.167 -179.005 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 61' ' ' GLU . . . . . 0.519 ' O ' ' N ' ' A' ' 65' ' ' ASP . 25.0 tt0 -71.14 -12.95 61.77 Favored 'General case' 0 C--N 1.31 -1.149 0 O-C-N 121.973 -0.454 . . . . 1.0 110.662 -177.86 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 62' ' ' VAL . . . . . 0.613 HG23 ' H ' ' A' ' 63' ' ' ALA . 17.0 m -45.13 -56.26 0.96 Allowed 'Isoleucine or valine' 0 C--N 1.309 -1.188 0 C-N-CA 120.121 -0.632 . . . . 1.0 110.025 -175.124 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 63' ' ' ALA . . . . . 0.613 ' H ' HG23 ' A' ' 62' ' ' VAL . . . -65.91 -49.84 66.59 Favored 'General case' 0 N--CA 1.428 -1.53 0 CA-C-O 121.349 0.595 . . . . 1.0 109.435 179.728 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 1.8 t60 -54.04 -59.95 3.98 Favored 'General case' 0 CA--C 1.547 0.849 0 C-N-CA 119.474 -0.891 . . . . 1.0 109.934 -179.747 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 65' ' ' ASP . . . . . 0.556 ' C ' ' H ' ' A' ' 67' ' ' ARG . 2.6 t70 -66.94 -54.72 19.2 Favored 'General case' 0 C--O 1.244 0.808 0 CA-C-O 121.848 0.832 . . . . 1.0 110.729 177.851 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 66' ' ' GLY . . . . . 0.566 ' N ' ' O ' ' A' ' 62' ' ' VAL . . . -65.72 27.74 0.14 Allowed Glycine 0 CA--C 1.524 0.617 0 O-C-N 121.163 -0.961 . . . . 1.0 112.489 179.078 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 67' ' ' ARG . . . . . 0.718 ' O ' ' N ' ' A' ' 69' ' ' LEU . 1.1 mtt-85 -76.43 -1.11 25.44 Favored 'General case' 0 C--N 1.322 -0.619 0 N-CA-C 108.72 -0.844 . . . . 1.0 108.72 175.775 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 68' ' ' LEU . . . . . 0.48 ' C ' ' O ' ' A' ' 67' ' ' ARG . 0.8 OUTLIER -32.39 -26.01 0.0 OUTLIER 'General case' 0 N--CA 1.488 1.44 0 N-CA-C 107.732 -1.21 . . . . 1.0 107.732 -177.486 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 69' ' ' LEU . . . . . 0.718 ' N ' ' O ' ' A' ' 67' ' ' ARG . 20.0 tp -66.91 -67.67 0.43 Allowed 'General case' 0 CA--C 1.548 0.875 0 C-N-CA 119.342 -0.943 . . . . 1.0 108.853 177.029 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 70' ' ' ALA . . . . . 0.702 ' C ' ' H ' ' A' ' 72' ' ' HIS . . . -78.1 -73.45 0.31 Allowed 'General case' 0 N--CA 1.472 0.653 0 N-CA-C 107.577 -1.268 . . . . 1.0 107.577 179.084 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 71' ' ' ALA . . . . . 0.484 ' HB3' ' CB ' ' A' ' 67' ' ' ARG . . . -48.02 5.51 0.0 OUTLIER 'General case' 0 N--CA 1.469 0.522 0 C-N-CA 124.273 1.029 . . . . 1.0 112.261 177.81 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 72' ' ' HIS . . . . . 0.702 ' H ' ' C ' ' A' ' 70' ' ' ALA . 0.0 OUTLIER -21.87 -75.92 0.01 OUTLIER 'General case' 0 CA--C 1.516 -0.351 0 C-N-CA 123.332 0.653 . . . . 1.0 112.328 -177.956 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 73' ' ' MET . . . . . 0.636 ' H ' ' CG ' ' A' ' 72' ' ' HIS . 57.9 mtm -69.29 -45.31 69.94 Favored 'General case' 0 C--N 1.311 -1.097 0 C-N-CA 118.692 -1.203 . . . . 1.0 109.463 178.065 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 74' ' ' VAL . . . . . 0.729 ' O ' ' N ' ' A' ' 76' ' ' GLY . 85.3 t -41.1 -42.27 0.67 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.384 0 CA-C-O 118.604 -0.712 . . . . 1.0 110.167 -176.553 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 75' ' ' ASN . . . . . 0.513 ' OD1' HG21 ' A' ' 78' ' ' VAL . 0.8 OUTLIER -36.66 -15.58 0.0 OUTLIER 'General case' 0 N--CA 1.48 1.067 0 CA-C-O 121.497 0.665 . . . . 1.0 110.721 178.363 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 76' ' ' GLY . . . . . 0.729 ' N ' ' O ' ' A' ' 74' ' ' VAL . . . -43.92 -20.14 0.14 Allowed Glycine 0 CA--C 1.539 1.549 0 N-CA-C 108.734 -1.747 . . . . 1.0 108.734 176.971 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 77' ' ' ILE . . . . . 0.627 ' O ' ' N ' ' A' ' 80' ' ' ALA . 0.2 OUTLIER -73.45 -50.33 31.28 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.14 0 CA-C-O 122.274 1.035 . . . . 1.0 108.524 178.85 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 78' ' ' VAL . . . . . 0.513 HG21 ' OD1' ' A' ' 75' ' ' ASN . 93.5 t -35.54 -36.3 0.08 OUTLIER 'Isoleucine or valine' 0 CA--C 1.553 1.083 0 CA-C-N 112.092 -2.322 . . . . 1.0 107.956 -176.254 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 79' ' ' ILE . . . . . 0.563 HG13 ' O ' ' A' ' 76' ' ' GLY . 1.4 pp -95.37 -24.97 4.59 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.852 0 CA-C-N 116.195 -0.457 . . . . 1.0 111.355 177.614 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 80' ' ' ALA . . . . . 0.627 ' N ' ' O ' ' A' ' 77' ' ' ILE . . . -80.67 -14.96 57.69 Favored 'General case' 0 N--CA 1.475 0.779 0 O-C-N 122.261 -0.274 . . . . 1.0 111.564 179.278 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 33.1 tt0 -81.17 -67.88 0.74 Allowed 'General case' 0 N--CA 1.444 -0.74 0 N-CA-C 109.448 -0.575 . . . . 1.0 109.448 177.668 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 82' ' ' ASP . . . . . 0.815 ' O ' ' N ' ' A' ' 84' ' ' LEU . 89.1 m-20 -59.35 -60.52 3.73 Favored 'General case' 0 CA--C 1.504 -0.801 0 C-N-CA 119.075 -1.05 . . . . 1.0 109.039 -179.454 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 83' ' ' ALA . . . . . 0.527 ' O ' ' N ' ' A' ' 86' ' ' ALA . . . 22.83 -68.21 0.0 OUTLIER 'General case' 0 N--CA 1.484 1.235 0 O-C-N 124.852 1.345 . . . . 1.0 111.386 -179.957 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 84' ' ' LEU . . . . . 0.815 ' N ' ' O ' ' A' ' 82' ' ' ASP . 4.8 tt -29.31 -45.3 0.04 OUTLIER 'General case' 0 N--CA 1.478 0.95 0 C-N-CA 123.512 0.725 . . . . 1.0 112.666 -178.288 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 85' ' ' ILE . . . . . 0.616 ' O ' ' HB3' ' A' ' 88' ' ' ALA . 3.3 pt -91.12 -36.55 8.21 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.87 0 N-CA-C 109.384 -0.598 . . . . 1.0 109.384 178.081 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 86' ' ' ALA . . . . . 0.547 ' C ' ' H ' ' A' ' 88' ' ' ALA . . . -51.16 -55.78 16.13 Favored 'General case' 0 CA--C 1.534 0.34 0 C-N-CA 120.42 -0.512 . . . . 1.0 110.086 -178.749 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 27.3 mt-10 -61.55 5.66 0.07 Allowed 'General case' 0 C--N 1.326 -0.419 0 C-N-CA 120.656 -0.417 . . . . 1.0 110.664 -179.433 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 88' ' ' ALA . . . . . 0.616 ' HB3' ' O ' ' A' ' 85' ' ' ILE . . . -105.76 -23.98 12.6 Favored 'General case' 0 C--O 1.237 0.4 0 CA-C-N 116.402 -0.363 . . . . 1.0 110.506 179.55 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 89' ' ' VAL . . . . . 0.462 HG22 ' O ' ' A' ' 86' ' ' ALA . 9.3 m -88.63 -8.79 10.9 Favored 'Isoleucine or valine' 0 C--O 1.236 0.367 0 CA-C-N 115.98 -0.555 . . . . 1.0 109.716 179.307 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -40.92 -49.67 4.21 Favored Glycine 0 CA--C 1.535 1.301 0 CA-C-O 119.466 -0.63 . . . . 1.0 111.633 -177.999 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 85.7 Cg_exo -45.38 -27.83 3.48 Favored 'Trans proline' 0 N--CA 1.495 1.608 0 CA-C-N 120.072 1.936 . . . . 1.0 112.052 177.726 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 92' ' ' HIS . . . . . 0.51 ' ND1' ' HG2' ' A' ' 51' ' ' GLU . 25.9 t-80 -56.36 -33.91 66.13 Favored 'General case' 0 C--O 1.22 -0.476 0 N-CA-C 107.849 -1.167 . . . . 1.0 107.849 -177.607 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 93' ' ' LEU . . . . . 0.976 HD23 ' H ' ' A' ' 94' ' ' ALA . 0.5 OUTLIER -42.45 -51.85 4.85 Favored 'General case' 0 N--CA 1.473 0.697 0 C-N-CA 120.375 -0.53 . . . . 1.0 109.592 -179.833 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 94' ' ' ALA . . . . . 0.976 ' H ' HD23 ' A' ' 93' ' ' LEU . . . -56.1 -53.9 51.51 Favored 'General case' 0 N--CA 1.449 -0.513 0 N-CA-C 107.998 -1.112 . . . . 1.0 107.998 178.877 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 95' ' ' ARG . . . . . 0.596 ' C ' ' H ' ' A' ' 97' ' ' LEU . 0.2 OUTLIER -51.3 -58.57 5.83 Favored 'General case' 0 C--O 1.241 0.649 0 CA-C-O 123.358 1.551 . . . . 1.0 107.075 177.614 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 96' ' ' ALA . . . . . 0.85 ' O ' ' N ' ' A' ' 98' ' ' GLY . . . -49.24 -11.88 0.05 OUTLIER 'General case' 0 N--CA 1.427 -1.622 0 O-C-N 118.731 -2.481 . . . . 1.0 110.895 -179.842 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 97' ' ' LEU . . . . . 0.66 ' O ' ' N ' ' A' ' 100' ' ' ILE . 0.4 OUTLIER 4.79 -49.52 0.0 OUTLIER 'General case' 0 CA--C 1.511 -0.549 0 C-N-CA 124.9 1.28 . . . . 1.0 112.865 -170.101 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 98' ' ' GLY . . . . . 0.85 ' N ' ' O ' ' A' ' 96' ' ' ALA . . . -53.24 -22.41 14.43 Favored Glycine 0 N--CA 1.426 -2.008 0 N-CA-C 107.817 -2.113 . . . . 1.0 107.817 174.806 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 99' ' ' GLN . . . . . 0.652 ' O ' ' HG3' ' A' ' 103' ' ' ARG . 15.2 mm100 -71.54 -22.95 61.69 Favored 'General case' 0 CA--C 1.5 -0.975 0 C-N-CA 116.551 -2.06 . . . . 1.0 107.127 177.576 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 100' ' ' ILE . . . . . 0.66 ' N ' ' O ' ' A' ' 97' ' ' LEU . 2.8 tt -66.05 -34.78 72.54 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.135 0 O-C-N 124.797 1.311 . . . . 1.0 109.453 178.779 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 101' ' ' VAL . . . . . 0.557 ' CG1' ' N ' ' A' ' 102' ' ' CYS . 0.4 OUTLIER -57.96 -57.97 8.32 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 N-CA-C 106.852 -1.536 . . . . 1.0 106.852 -178.757 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 102' ' ' CYS . . . . . 0.681 ' O ' ' HB2' ' A' ' 106' ' ' ALA . 0.1 OUTLIER -48.99 -28.89 4.23 Favored 'General case' 0 N--CA 1.441 -0.883 0 CA-C-N 115.224 -0.898 . . . . 1.0 110.078 178.954 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 103' ' ' ARG . . . . . 0.652 ' HG3' ' O ' ' A' ' 99' ' ' GLN . 74.7 mtt-85 -72.58 -56.61 5.09 Favored 'General case' 0 N--CA 1.478 0.972 0 O-C-N 123.984 0.803 . . . . 1.0 110.085 179.063 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 104' ' ' TYR . . . . . 0.774 ' O ' ' HD1' ' A' ' 104' ' ' TYR . 0.5 OUTLIER -90.34 25.77 2.13 Favored 'General case' 0 CA--C 1.494 -1.187 0 C-N-CA 125.435 1.494 . . . . 1.0 108.44 177.291 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 105' ' ' GLY . . . . . 0.529 ' N ' ' O ' ' A' ' 101' ' ' VAL . . . -155.43 -91.02 0.08 OUTLIER Glycine 0 N--CA 1.443 -0.841 0 C-N-CA 118.793 -1.67 . . . . 1.0 109.86 176.932 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 106' ' ' ALA . . . . . 0.681 ' HB2' ' O ' ' A' ' 102' ' ' CYS . . . 58.18 114.36 0.01 OUTLIER 'General case' 0 CA--C 1.551 0.993 0 N-CA-C 108.92 -0.77 . . . . 1.0 108.92 -179.309 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 107' ' ' THR . . . . . 0.826 ' O ' ' HD2' ' A' ' 110' ' ' PRO . 5.2 m -134.7 -54.4 0.82 Allowed 'General case' 0 N--CA 1.481 1.115 0 N-CA-C 108.548 -0.908 . . . . 1.0 108.548 178.751 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 108' ' ' VAL . . . . . 0.525 ' O ' ' N ' ' A' ' 111' ' ' ASN . 16.7 m -70.85 -43.82 76.63 Favored 'Isoleucine or valine' 0 C--N 1.348 0.53 0 CA-C-O 121.993 0.901 . . . . 1.0 108.873 -179.574 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 109' ' ' ILE . . . . . 0.604 HG23 ' HD3' ' A' ' 110' ' ' PRO . 0.0 OUTLIER -39.06 -46.72 3.62 Favored Pre-proline 0 CA--C 1.553 1.065 0 CA-C-N 114.2 -1.364 . . . . 1.0 109.919 -178.179 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 110' ' ' PRO . . . . . 0.826 ' HD2' ' O ' ' A' ' 107' ' ' THR . 28.1 Cg_exo -64.43 -24.27 64.27 Favored 'Trans proline' 0 N--CA 1.504 2.108 0 C-N-CA 124.44 3.427 . . . . 1.0 111.871 177.675 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 111' ' ' ASN . . . . . 0.525 ' N ' ' O ' ' A' ' 108' ' ' VAL . 2.9 t-20 -62.3 -69.04 0.28 Allowed 'General case' 0 C--O 1.236 0.374 0 CA-C-N 115.996 -0.547 . . . . 1.0 109.74 -179.007 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 112' ' ' ILE . . . . . 0.505 ' O ' ' N ' ' A' ' 115' ' ' ALA . 0.0 OUTLIER -67.43 -36.55 76.78 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.538 0 CA-C-O 121.924 0.869 . . . . 1.0 110.13 178.777 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 113' ' ' ASN . . . . . 0.456 ' O ' ' HB3' ' A' ' 117' ' ' GLU . 10.3 t30 -48.27 -52.42 21.32 Favored 'General case' 0 C--N 1.309 -1.165 0 N-CA-C 107.266 -1.383 . . . . 1.0 107.266 -178.264 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -62.2 -24.72 67.38 Favored 'General case' 0 N--CA 1.451 -0.419 0 CA-C-N 116.378 -0.374 . . . . 1.0 110.432 177.307 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 115' ' ' ALA . . . . . 0.505 ' N ' ' O ' ' A' ' 112' ' ' ILE . . . -77.07 -59.1 2.92 Favored 'General case' 0 C--O 1.235 0.292 0 C-N-CA 119.957 -0.697 . . . . 1.0 110.799 178.419 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 116' ' ' ILE . . . . . 0.64 HG23 ' N ' ' A' ' 117' ' ' GLU . 11.5 tt -67.31 -50.54 61.79 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.571 0 CA-C-O 120.983 0.42 . . . . 1.0 110.906 -178.378 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 117' ' ' GLU . . . . . 0.64 ' N ' HG23 ' A' ' 116' ' ' ILE . 23.6 tt0 -42.63 -60.47 1.54 Allowed 'General case' 0 C--O 1.244 0.794 0 N-CA-C 108.074 -1.084 . . . . 1.0 108.074 -177.471 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 18.7 t -51.71 -23.48 3.38 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.086 0 CA-C-N 114.261 -1.336 . . . . 1.0 109.357 177.662 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 119' ' ' LEU . . . . . 0.623 ' N ' ' O ' ' A' ' 116' ' ' ILE . 2.5 tp -81.68 -62.67 1.58 Allowed 'General case' 0 C--N 1.344 0.328 0 C-N-CA 120.304 -0.558 . . . . 1.0 111.468 179.108 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -67.6 -86.77 0.08 OUTLIER Glycine 0 C--N 1.355 1.622 0 C-N-CA 117.421 -2.323 . . . . 1.0 110.417 179.756 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 38.3 m -162.61 -25.45 0.04 OUTLIER 'General case' 0 C--N 1.32 -0.682 0 N-CA-C 107.364 -1.347 . . . . 1.0 107.364 -179.962 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 122' ' ' GLY . . . . . 0.479 ' O ' ' N ' ' A' ' 124' ' ' ASP . . . 114.32 -35.79 4.28 Favored Glycine 0 C--N 1.347 1.152 0 C-N-CA 125.32 1.438 . . . . 1.0 113.539 178.907 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 123' ' ' THR . . . . . 0.458 HG23 ' O ' ' A' ' 123' ' ' THR . 1.8 t -33.21 92.12 0.01 OUTLIER 'General case' 0 N--CA 1.473 0.705 0 CA-C-N 120.124 1.962 . . . . 1.0 113.344 -179.124 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 124' ' ' ASP . . . . . 0.479 ' N ' ' O ' ' A' ' 122' ' ' GLY . 22.6 m-20 -142.65 143.22 32.27 Favored 'General case' 0 C--N 1.328 -0.344 0 N-CA-C 108.49 -0.93 . . . . 1.0 108.49 177.655 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 125' ' ' TYR . . . . . . . . . . . . . 11.2 t80 -148.64 143.19 26.37 Favored 'General case' 0 CA--C 1.536 0.412 0 N-CA-C 109.247 -0.649 . . . . 1.0 109.247 -179.591 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 4.0 mmp_? -151.76 155.15 37.67 Favored 'General case' 0 CA--C 1.535 0.372 0 CA-C-N 116.259 -0.428 . . . . 1.0 110.59 178.54 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 127' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--O 1.218 -0.576 0 CA-C-O 118.193 -0.908 . . . . 1.0 109.726 178.476 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 24.5 mmt . . . . . 0 N--CA 1.495 1.802 0 N-CA-C 109.081 -0.711 . . . . 1.0 109.081 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 2' ' ' SER . . . . . 0.438 ' O ' ' OD1' ' A' ' 3' ' ' ASP . 58.3 p -108.84 11.23 26.29 Favored 'General case' 0 N--CA 1.469 0.495 0 C-N-CA 122.957 0.503 . . . . 1.0 110.247 179.489 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 3' ' ' ASP . . . . . 0.438 ' OD1' ' O ' ' A' ' 2' ' ' SER . 2.2 m-20 166.67 91.54 0.0 OUTLIER 'General case' 0 N--CA 1.468 0.429 0 CA-C-N 116.321 -0.4 . . . . 1.0 110.044 179.615 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 76.2 t80 -147.98 143.68 27.46 Favored 'General case' 0 C--N 1.332 -0.156 0 N-CA-C 109.993 -0.373 . . . . 1.0 109.993 179.364 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 5' ' ' ASP . . . . . 0.451 ' N ' ' OD1' ' A' ' 5' ' ' ASP . 0.3 OUTLIER -153.38 149.0 27.36 Favored 'General case' 0 CA--C 1.534 0.359 0 CA-C-N 116.657 -0.247 . . . . 1.0 110.361 -178.916 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 6' ' ' THR . . . . . 0.733 ' O ' ' N ' ' A' ' 10' ' ' SER . 62.6 p -70.39 -178.56 1.77 Allowed 'General case' 0 C--O 1.202 -1.439 0 C-N-CA 121.155 -0.218 . . . . 1.0 110.838 179.888 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 7' ' ' GLU . . . . . 0.483 ' O ' ' N ' ' A' ' 11' ' ' ARG . 0.0 OUTLIER -58.71 -56.14 25.99 Favored 'General case' 0 N--CA 1.48 1.025 0 CA-C-O 121.645 0.736 . . . . 1.0 110.785 -177.631 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 8' ' ' ARG . . . . . 0.806 ' O ' ' HB3' ' A' ' 12' ' ' ALA . 65.1 ttt180 -50.95 -56.49 12.15 Favored 'General case' 0 C--N 1.32 -0.716 0 N-CA-C 106.723 -1.584 . . . . 1.0 106.723 -178.562 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 9' ' ' VAL . . . . . 0.577 ' O ' ' CG2' ' A' ' 13' ' ' VAL . 48.7 t -65.91 -49.72 75.0 Favored 'Isoleucine or valine' 0 C--O 1.2 -1.514 0 CA-C-N 113.641 -1.618 . . . . 1.0 110.761 179.136 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 10' ' ' SER . . . . . 0.733 ' N ' ' O ' ' A' ' 6' ' ' THR . 38.9 t -67.68 -65.41 0.69 Allowed 'General case' 0 N--CA 1.478 0.97 0 O-C-N 121.585 -0.697 . . . . 1.0 112.436 -178.391 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 11' ' ' ARG . . . . . 0.52 ' O ' ' N ' ' A' ' 15' ' ' ALA . 21.6 ttt180 -65.38 -58.61 5.44 Favored 'General case' 0 N--CA 1.467 0.399 0 C-N-CA 120.749 -0.381 . . . . 1.0 111.491 -175.966 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 12' ' ' ALA . . . . . 0.806 ' HB3' ' O ' ' A' ' 8' ' ' ARG . . . -49.82 -49.2 49.8 Favored 'General case' 0 N--CA 1.473 0.703 0 N-CA-C 106.449 -1.686 . . . . 1.0 106.449 -176.937 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 13' ' ' VAL . . . . . 0.577 ' CG2' ' O ' ' A' ' 9' ' ' VAL . 93.9 t -60.71 -48.55 88.26 Favored 'Isoleucine or valine' 0 C--O 1.202 -1.412 0 C-N-CA 118.061 -1.456 . . . . 1.0 108.149 176.745 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 14' ' ' ALA . . . . . 0.667 ' O ' HG13 ' A' ' 18' ' ' VAL . . . -57.25 -61.96 2.1 Favored 'General case' 0 C--O 1.211 -0.934 0 C-N-CA 118.088 -1.445 . . . . 1.0 109.636 -179.849 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 15' ' ' ALA . . . . . 0.527 ' O ' ' N ' ' A' ' 19' ' ' GLY . . . -52.42 -54.64 29.43 Favored 'General case' 0 N--CA 1.473 0.721 0 CA-C-O 121.702 0.763 . . . . 1.0 109.857 -178.342 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 16' ' ' ALA . . . . . 0.567 ' C ' ' H ' ' A' ' 22' ' ' GLY . . . -61.88 -55.11 33.16 Favored 'General case' 0 C--N 1.309 -1.154 0 CA-C-N 114.57 -1.196 . . . . 1.0 109.051 -179.023 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 17' ' ' LEU . . . . . 0.567 ' N ' ' O ' ' A' ' 13' ' ' VAL . 6.7 tp -56.41 -53.22 59.94 Favored 'General case' 0 N--CA 1.478 0.96 0 CA-C-N 113.726 -1.579 . . . . 1.0 108.638 -177.504 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 18' ' ' VAL . . . . . 0.667 HG13 ' O ' ' A' ' 14' ' ' ALA . 3.5 m -68.02 -56.43 12.89 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.258 0 N-CA-C 108.63 -0.878 . . . . 1.0 108.63 179.262 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 19' ' ' GLY . . . . . 0.527 ' N ' ' O ' ' A' ' 15' ' ' ALA . . . -64.77 -171.69 2.81 Favored Glycine 0 CA--C 1.521 0.423 0 N-CA-C 110.28 -1.128 . . . . 1.0 110.28 179.571 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 20' ' ' PRO . . . . . 0.657 ' O ' ' N ' ' A' ' 24' ' ' ALA . 43.7 Cg_endo -80.63 -21.37 7.31 Favored 'Trans proline' 0 C--N 1.301 -1.942 0 C-N-CA 122.115 1.876 . . . . 1.0 113.097 -179.316 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -56.73 -58.13 16.03 Favored Glycine 0 CA--C 1.535 1.33 0 C-N-CA 119.488 -1.339 . . . . 1.0 110.355 -177.725 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 22' ' ' GLY . . . . . 0.567 ' H ' ' C ' ' A' ' 16' ' ' ALA . . . -62.68 -53.1 43.79 Favored Glycine 0 N--CA 1.471 0.976 0 N-CA-C 108.13 -1.988 . . . . 1.0 108.13 -179.845 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 23' ' ' VAL . . . . . 0.705 ' O ' HG12 ' A' ' 27' ' ' VAL . 0.5 OUTLIER -56.44 -38.38 55.76 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.737 0 N-CA-C 108.316 -0.994 . . . . 1.0 108.316 -179.411 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 24' ' ' ALA . . . . . 0.657 ' N ' ' O ' ' A' ' 20' ' ' PRO . . . -58.14 -59.99 4.44 Favored 'General case' 0 N--CA 1.468 0.436 0 C-N-CA 119.484 -0.886 . . . . 1.0 109.652 -179.301 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -62.74 -42.57 99.73 Favored 'General case' 0 CA--C 1.519 -0.217 0 C-N-CA 119.685 -0.806 . . . . 1.0 111.041 -178.642 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 69.9 t -61.93 -61.11 1.76 Allowed 'Isoleucine or valine' 0 N--CA 1.448 -0.536 0 C-N-CA 118.606 -1.238 . . . . 1.0 110.711 -178.33 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 27' ' ' VAL . . . . . 0.705 HG12 ' O ' ' A' ' 23' ' ' VAL . 9.8 p -60.21 -37.6 74.1 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.333 0 N-CA-C 112.749 0.648 . . . . 1.0 112.749 -176.706 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 28' ' ' LYS . . . . . 0.412 ' N ' HG13 ' A' ' 27' ' ' VAL . 59.8 tttm -69.0 -54.11 16.95 Favored 'General case' 0 C--N 1.315 -0.895 0 CA-C-O 121.815 0.816 . . . . 1.0 109.378 -178.916 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 95.0 t -64.17 -49.26 82.1 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.83 0 CA-C-N 114.216 -1.357 . . . . 1.0 110.29 -177.7 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 30' ' ' CYS . . . . . . . . . . . . . 44.5 t -67.03 -61.44 1.93 Allowed 'General case' 0 N--CA 1.444 -0.767 0 C-N-CA 119.07 -1.052 . . . . 1.0 110.416 -179.247 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 31' ' ' ALA . . . . . 0.655 ' HB3' ' O ' ' A' ' 27' ' ' VAL . . . -64.94 -53.79 40.81 Favored 'General case' 0 CA--C 1.514 -0.441 0 N-CA-C 112.726 0.639 . . . . 1.0 112.726 -175.427 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 32' ' ' GLY . . . . . 0.413 ' O ' ' CB ' ' A' ' 33' ' ' LEU . . . 89.05 72.02 1.27 Allowed Glycine 0 CA--C 1.522 0.506 0 N-CA-C 108.403 -1.879 . . . . 1.0 108.403 -177.446 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 33' ' ' LEU . . . . . 0.413 ' CB ' ' O ' ' A' ' 32' ' ' GLY . 6.1 tp 81.65 122.28 0.03 OUTLIER Pre-proline 0 CA--C 1.54 0.587 0 C-N-CA 122.858 0.463 . . . . 1.0 111.268 -179.547 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 39.8 Cg_endo -68.45 -18.36 43.69 Favored 'Trans proline' 0 N--CA 1.495 1.574 0 C-N-CA 121.433 1.422 . . . . 1.0 113.56 179.668 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -57.22 -61.03 7.97 Favored Glycine 0 C--N 1.338 0.677 0 C-N-CA 118.126 -1.987 . . . . 1.0 108.802 -179.022 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 36' ' ' VAL . . . . . 0.916 ' O ' HG22 ' A' ' 37' ' ' ILE . 9.0 p -69.25 -150.78 0.0 OUTLIER 'Isoleucine or valine' 0 C--O 1.215 -0.721 0 N-CA-C 106.057 -1.831 . . . . 1.0 106.057 177.869 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 37' ' ' ILE . . . . . 0.916 HG22 ' O ' ' A' ' 36' ' ' VAL . 6.8 tp 79.15 75.25 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.483 1.186 0 O-C-N 124.281 0.988 . . . . 1.0 112.597 179.444 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 10.3 m80 -136.23 130.46 33.14 Favored 'General case' 0 C--N 1.334 -0.08 0 O-C-N 120.858 -1.151 . . . . 1.0 108.653 177.619 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 39' ' ' THR . . . . . 0.501 ' OG1' ' NE ' ' A' ' 42' ' ' ARG . 20.0 p -110.19 144.54 30.28 Favored Pre-proline 0 N--CA 1.464 0.228 0 N-CA-C 109.65 -0.5 . . . . 1.0 109.65 -179.859 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 90.7 Cg_endo -73.27 -29.22 11.66 Favored 'Trans proline' 0 N--CA 1.493 1.497 0 C-N-CA 122.144 1.896 . . . . 1.0 113.425 -178.818 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -127.59 133.39 49.73 Favored 'General case' 0 N--CA 1.468 0.457 0 CA-C-N 116.767 -0.197 . . . . 1.0 110.786 179.123 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 42' ' ' ARG . . . . . 0.602 ' C ' ' H ' ' A' ' 44' ' ' GLY . 4.4 mtm180 -171.67 171.64 5.23 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-O 121.461 0.648 . . . . 1.0 109.529 176.391 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 43' ' ' ARG . . . . . 0.411 ' HG3' ' O ' ' A' ' 43' ' ' ARG . 0.0 OUTLIER -69.51 15.92 0.07 Allowed 'General case' 0 C--N 1.315 -0.898 0 CA-C-N 114.805 -1.089 . . . . 1.0 108.981 179.422 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 44' ' ' GLY . . . . . 0.602 ' H ' ' C ' ' A' ' 42' ' ' ARG . . . 93.9 -19.91 50.31 Favored Glycine 0 C--N 1.336 0.558 0 N-CA-C 110.035 -1.226 . . . . 1.0 110.035 179.232 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 45' ' ' PHE . . . . . 0.729 ' O ' ' HB2' ' A' ' 46' ' ' PHE . 1.1 p90 -167.23 169.08 12.88 Favored 'General case' 0 CA--C 1.538 0.485 0 N-CA-C 109.884 -0.414 . . . . 1.0 109.884 179.868 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 46' ' ' PHE . . . . . 0.729 ' HB2' ' O ' ' A' ' 45' ' ' PHE . 0.2 OUTLIER 148.12 71.24 0.0 OUTLIER 'General case' 0 N--CA 1.504 2.257 0 O-C-N 125.772 1.92 . . . . 1.0 110.176 178.555 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 47' ' ' ARG . . . . . 0.503 ' CB ' ' O ' ' A' ' 46' ' ' PHE . 4.2 mmt-85 142.94 142.87 0.0 OUTLIER 'General case' 0 N--CA 1.483 1.202 0 N-CA-C 108.831 -0.803 . . . . 1.0 108.831 179.082 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 1.8 t 70.75 68.6 0.19 Allowed 'General case' 0 N--CA 1.446 -0.661 0 N-CA-C 108.7 -0.852 . . . . 1.0 108.7 -179.594 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 49' ' ' ASN . . . . . 0.6 ' O ' ' N ' ' A' ' 51' ' ' GLU . 7.0 p30 -140.71 105.7 6.36 Favored Pre-proline 0 CA--C 1.54 0.579 0 N-CA-C 107.929 -1.137 . . . . 1.0 107.929 -179.89 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 50' ' ' PRO . . . . . 0.518 ' C ' ' H ' ' A' ' 52' ' ' ARG . 62.8 Cg_exo -49.72 68.64 0.02 OUTLIER 'Trans proline' 0 N--CA 1.505 2.174 0 C-N-CA 122.733 2.289 . . . . 1.0 114.533 -178.749 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 51' ' ' GLU . . . . . 0.6 ' N ' ' O ' ' A' ' 49' ' ' ASN . 42.6 mm-40 71.52 -23.13 0.19 Allowed 'General case' 0 N--CA 1.468 0.451 0 C-N-CA 122.636 0.375 . . . . 1.0 110.711 -179.695 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 52' ' ' ARG . . . . . 0.591 ' NH2' HH22 ' A' ' 126' ' ' ARG . 17.0 mmt180 -48.05 114.14 0.87 Allowed 'General case' 0 C--N 1.329 -0.319 0 N-CA-C 109.302 -0.629 . . . . 1.0 109.302 179.98 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 53' ' ' ILE . . . . . 0.466 ' O ' ' N ' ' A' ' 55' ' ' ILE . 21.5 tt -54.71 143.58 6.92 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-O 121.385 0.612 . . . . 1.0 110.482 -179.292 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 11.4 mm100 -64.65 77.64 0.04 OUTLIER 'General case' 0 C--N 1.318 -0.788 0 C-N-CA 119.123 -1.031 . . . . 1.0 109.683 -177.917 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 55' ' ' ILE . . . . . 0.466 ' N ' ' O ' ' A' ' 53' ' ' ILE . 3.2 tp -150.11 158.05 5.79 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.299 0 N-CA-C 110.406 -0.22 . . . . 1.0 110.406 178.179 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 113.44 -27.42 9.41 Favored Glycine 0 CA--C 1.519 0.296 0 N-CA-C 110.305 -1.118 . . . . 1.0 110.305 179.3 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 57' ' ' ASP . . . . . 0.453 ' OD1' ' N ' ' A' ' 57' ' ' ASP . 11.4 p-10 -57.43 101.95 0.08 Allowed 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 117.638 0.719 . . . . 1.0 110.254 179.529 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 58' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -86.25 176.06 8.14 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-O 122.526 1.155 . . . . 1.0 111.843 -179.169 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 59' ' ' ARG . . . . . 0.503 ' CG ' ' N ' ' A' ' 60' ' ' TYR . 22.2 ptt-85 -90.82 -56.38 3.2 Favored 'General case' 0 C--N 1.316 -0.884 0 CA-C-N 112.756 -2.02 . . . . 1.0 112.224 179.841 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 60' ' ' TYR . . . . . 0.503 ' N ' ' CG ' ' A' ' 59' ' ' ARG . 0.4 OUTLIER -91.22 -20.64 21.72 Favored 'General case' 0 C--O 1.247 0.967 0 CA-C-O 121.948 0.88 . . . . 1.0 113.046 -179.107 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 3.5 tt0 -79.21 -12.77 59.97 Favored 'General case' 0 N--CA 1.436 -1.157 0 N-CA-C 109.425 -0.583 . . . . 1.0 109.425 -179.893 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 62' ' ' VAL . . . . . 0.615 HG13 ' N ' ' A' ' 63' ' ' ALA . 6.1 p -46.84 -55.85 1.59 Allowed 'Isoleucine or valine' 0 C--O 1.212 -0.899 0 C-N-CA 119.656 -0.817 . . . . 1.0 109.811 -175.69 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 63' ' ' ALA . . . . . 0.615 ' N ' HG13 ' A' ' 62' ' ' VAL . . . -64.87 -54.63 27.96 Favored 'General case' 0 N--CA 1.435 -1.199 0 C-N-CA 120.177 -0.609 . . . . 1.0 109.509 -179.68 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 64' ' ' HIS . . . . . 0.424 ' O ' ' CG ' ' A' ' 67' ' ' ARG . 0.2 OUTLIER -48.45 -57.95 5.35 Favored 'General case' 0 CA--C 1.538 0.495 0 CA-C-N 115.484 -0.78 . . . . 1.0 110.153 -179.567 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 65' ' ' ASP . . . . . 0.659 ' C ' ' H ' ' A' ' 67' ' ' ARG . 0.8 OUTLIER -69.78 -46.49 65.65 Favored 'General case' 0 C--N 1.316 -0.858 0 CA-C-O 122.309 1.052 . . . . 1.0 110.222 179.19 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 66' ' ' GLY . . . . . 0.568 ' N ' ' O ' ' A' ' 62' ' ' VAL . . . -71.08 27.38 0.54 Allowed Glycine 0 N--CA 1.447 -0.621 0 N-CA-C 109.585 -1.406 . . . . 1.0 109.585 177.755 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 67' ' ' ARG . . . . . 0.697 ' O ' ' N ' ' A' ' 69' ' ' LEU . 14.5 mmt85 -74.9 1.26 13.16 Favored 'General case' 0 N--CA 1.441 -0.909 0 N-CA-C 107.87 -1.159 . . . . 1.0 107.87 176.23 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 68' ' ' LEU . . . . . 0.453 ' C ' ' O ' ' A' ' 67' ' ' ARG . 0.8 OUTLIER -33.05 -24.46 0.0 OUTLIER 'General case' 0 N--CA 1.475 0.79 0 O-C-N 123.745 0.653 . . . . 1.0 109.5 -175.99 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 69' ' ' LEU . . . . . 0.697 ' N ' ' O ' ' A' ' 67' ' ' ARG . 4.8 mp -67.31 -64.64 0.81 Allowed 'General case' 0 CA--C 1.54 0.571 0 C-N-CA 119.326 -0.95 . . . . 1.0 109.681 177.999 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 70' ' ' ALA . . . . . 0.664 ' C ' ' H ' ' A' ' 72' ' ' HIS . . . -80.53 -76.93 0.21 Allowed 'General case' 0 N--CA 1.473 0.685 0 N-CA-C 106.035 -1.839 . . . . 1.0 106.035 177.173 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 71' ' ' ALA . . . . . 0.473 ' HB3' ' CB ' ' A' ' 67' ' ' ARG . . . -42.6 0.59 0.0 OUTLIER 'General case' 0 N--CA 1.469 0.499 0 C-N-CA 124.631 1.173 . . . . 1.0 113.089 179.723 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 72' ' ' HIS . . . . . 0.664 ' H ' ' C ' ' A' ' 70' ' ' ALA . 1.2 p-80 -26.27 -58.71 0.08 Allowed 'General case' 0 C--N 1.342 0.251 0 C-N-CA 122.747 0.419 . . . . 1.0 111.541 -178.738 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 73' ' ' MET . . . . . 0.618 ' N ' ' CG ' ' A' ' 72' ' ' HIS . 49.5 mtt -75.37 -49.79 17.93 Favored 'General case' 0 C--N 1.321 -0.65 0 C-N-CA 120.545 -0.462 . . . . 1.0 109.878 177.408 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 74' ' ' VAL . . . . . 0.63 ' O ' ' N ' ' A' ' 76' ' ' GLY . 57.5 t -44.63 -42.07 2.19 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.167 0 CA-C-O 117.883 -1.056 . . . . 1.0 111.954 -175.409 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 75' ' ' ASN . . . . . 0.532 ' O ' HG23 ' A' ' 79' ' ' ILE . 40.7 t30 -40.13 -14.72 0.01 OUTLIER 'General case' 0 N--CA 1.478 0.938 0 CA-C-N 121.071 1.759 . . . . 1.0 112.195 176.796 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 76' ' ' GLY . . . . . 0.63 ' N ' ' O ' ' A' ' 74' ' ' VAL . . . -45.43 -24.04 0.95 Allowed Glycine 0 CA--C 1.539 1.566 0 N-CA-C 108.734 -1.746 . . . . 1.0 108.734 178.866 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 77' ' ' ILE . . . . . 0.535 ' O ' ' N ' ' A' ' 80' ' ' ALA . 2.2 pt -89.87 -61.62 1.86 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.719 0 CA-C-N 114.261 -0.97 . . . . 1.0 110.672 -178.837 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 78' ' ' VAL . . . . . 0.496 HG11 ' OD1' ' A' ' 65' ' ' ASP . 56.0 t -36.89 -29.91 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.448 -0.53 0 N-CA-C 109.267 -0.642 . . . . 1.0 109.267 -177.27 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 79' ' ' ILE . . . . . 0.82 ' O ' ' HB3' ' A' ' 83' ' ' ALA . 2.5 pt -64.75 -52.75 50.51 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.03 0 C-N-CA 119.151 -1.02 . . . . 1.0 109.626 178.786 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 80' ' ' ALA . . . . . 0.544 ' N ' ' CG1' ' A' ' 79' ' ' ILE . . . -55.86 -63.42 1.18 Allowed 'General case' 0 C--O 1.214 -0.768 0 C-N-CA 118.245 -1.382 . . . . 1.0 111.156 -178.489 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 47.5 mt-10 -50.1 -71.18 0.07 Allowed 'General case' 0 CA--C 1.531 0.216 0 C-N-CA 119.587 -0.845 . . . . 1.0 110.335 -179.151 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 21.2 t70 -62.88 -63.88 1.08 Allowed 'General case' 0 C--N 1.323 -0.582 0 C-N-CA 118.529 -1.268 . . . . 1.0 109.953 -177.997 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 83' ' ' ALA . . . . . 0.82 ' HB3' ' O ' ' A' ' 79' ' ' ILE . . . -53.04 -13.97 0.54 Allowed 'General case' 0 CA--C 1.536 0.409 0 C-N-CA 118.672 -1.211 . . . . 1.0 111.043 -177.801 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 84' ' ' LEU . . . . . 0.491 ' HB2' ' O ' ' A' ' 80' ' ' ALA . 1.0 OUTLIER -40.73 -16.54 0.01 OUTLIER 'General case' 0 C--N 1.37 1.495 0 CA-C-N 120.463 1.483 . . . . 1.0 112.047 -179.756 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 85' ' ' ILE . . . . . 0.58 ' N ' ' O ' ' A' ' 83' ' ' ALA . 19.8 pt -62.25 -41.65 92.29 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.245 0 N-CA-C 109.123 -0.695 . . . . 1.0 109.123 179.806 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 86' ' ' ALA . . . . . 0.438 ' CB ' ' CZ ' ' A' ' 52' ' ' ARG . . . -97.07 -2.7 42.74 Favored 'General case' 0 CA--C 1.539 0.523 0 C-N-CA 123.286 0.634 . . . . 1.0 112.506 179.896 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 34.1 tp10 -51.25 -20.89 1.79 Allowed 'General case' 0 C--N 1.32 -0.709 0 CA-C-N 115.307 -0.86 . . . . 1.0 109.842 -179.927 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -123.18 14.63 9.77 Favored 'General case' 0 N--CA 1.475 0.816 0 CA-C-O 121.459 0.647 . . . . 1.0 109.792 178.765 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 89' ' ' VAL . . . . . 0.595 ' O ' HG12 ' A' ' 89' ' ' VAL . 24.1 t -109.01 29.24 1.48 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.453 0 CA-C-N 114.579 -1.191 . . . . 1.0 109.655 177.861 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 90' ' ' GLY . . . . . 0.534 ' N ' ' CD ' ' A' ' 91' ' ' PRO . . . -68.78 -43.2 76.07 Favored Glycine 0 CA--C 1.525 0.694 0 N-CA-C 109.632 -1.387 . . . . 1.0 109.632 177.156 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 91' ' ' PRO . . . . . 0.534 ' CD ' ' N ' ' A' ' 90' ' ' GLY . 81.7 Cg_exo -45.71 -14.09 0.1 OUTLIER 'Trans proline' 0 N--CA 1.489 1.217 0 C-N-CA 121.686 1.591 . . . . 1.0 110.686 178.733 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 92' ' ' HIS . . . . . 0.671 ' CD2' HH21 ' A' ' 95' ' ' ARG . 40.9 t-80 -57.1 -17.38 10.32 Favored 'General case' 0 C--O 1.204 -1.32 0 N-CA-C 107.941 -1.133 . . . . 1.0 107.941 -179.886 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 93' ' ' LEU . . . . . 0.703 HD12 ' N ' ' A' ' 94' ' ' ALA . 2.9 pp -62.41 -55.7 25.33 Favored 'General case' 0 C--N 1.325 -0.468 0 N-CA-C 109.081 -0.711 . . . . 1.0 109.081 178.083 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 94' ' ' ALA . . . . . 0.703 ' N ' HD12 ' A' ' 93' ' ' LEU . . . -57.92 -52.52 65.14 Favored 'General case' 0 CA--C 1.513 -0.46 0 N-CA-C 108.64 -0.874 . . . . 1.0 108.64 179.476 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 95' ' ' ARG . . . . . 0.671 HH21 ' CD2' ' A' ' 92' ' ' HIS . 18.3 ttp180 -57.82 -58.37 8.65 Favored 'General case' 0 N--CA 1.446 -0.633 0 N-CA-C 106.692 -1.596 . . . . 1.0 106.692 178.482 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 96' ' ' ALA . . . . . 1.005 ' O ' ' N ' ' A' ' 98' ' ' GLY . . . -47.36 -10.95 0.02 OUTLIER 'General case' 0 C--N 1.299 -1.625 0 O-C-N 118.887 -2.383 . . . . 1.0 111.504 178.236 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 97' ' ' LEU . . . . . 0.734 HD12 ' N ' ' A' ' 98' ' ' GLY . 3.5 pp 9.49 -45.32 0.0 OUTLIER 'General case' 0 N--CA 1.475 0.796 0 C-N-CA 124.202 1.001 . . . . 1.0 112.177 -164.879 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 98' ' ' GLY . . . . . 1.005 ' N ' ' O ' ' A' ' 96' ' ' ALA . . . -53.33 -23.71 19.64 Favored Glycine 0 C--N 1.295 -1.736 0 N-CA-C 106.423 -2.671 . . . . 1.0 106.423 173.269 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 99' ' ' GLN . . . . . 0.536 ' HB2' ' HB3' ' A' ' 96' ' ' ALA . 1.1 tp-100 -58.27 -21.17 47.64 Favored 'General case' 0 C--N 1.367 1.346 0 N-CA-C 106.523 -1.658 . . . . 1.0 106.523 177.167 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 100' ' ' ILE . . . . . 0.661 ' N ' ' O ' ' A' ' 97' ' ' LEU . 84.3 mt -65.72 -42.49 92.64 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.925 0 CA-C-N 113.51 -1.677 . . . . 1.0 109.532 178.0 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 101' ' ' VAL . . . . . 0.601 HG13 ' N ' ' A' ' 102' ' ' CYS . 2.8 p -52.74 -62.84 0.55 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.383 0 C-N-CA 119.03 -1.068 . . . . 1.0 111.647 -177.055 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 102' ' ' CYS . . . . . 0.898 ' O ' ' HB2' ' A' ' 106' ' ' ALA . 0.8 OUTLIER -49.77 -22.5 1.44 Allowed 'General case' 0 C--N 1.316 -0.849 0 N-CA-C 112.421 0.526 . . . . 1.0 112.421 -177.572 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 60.1 ttt-85 -85.2 -46.89 10.64 Favored 'General case' 0 N--CA 1.482 1.146 0 CA-C-O 122.303 1.049 . . . . 1.0 112.344 179.584 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 104' ' ' TYR . . . . . 0.714 ' O ' ' CG ' ' A' ' 104' ' ' TYR . 0.0 OUTLIER -96.53 19.67 11.88 Favored 'General case' 0 C--N 1.308 -1.234 0 CA-C-N 113.341 -1.754 . . . . 1.0 109.539 178.591 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 105' ' ' GLY . . . . . 0.481 ' O ' ' HB3' ' A' ' 106' ' ' ALA . . . -153.06 -85.28 0.05 OUTLIER Glycine 0 C--N 1.342 0.888 1 N-CA-C 102.268 -4.333 . . . . 1.0 102.268 175.955 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 106' ' ' ALA . . . . . 0.898 ' HB2' ' O ' ' A' ' 102' ' ' CYS . . . 73.99 60.41 0.08 Allowed 'General case' 0 C--O 1.206 -1.232 0 N-CA-C 115.046 1.499 . . . . 1.0 115.046 176.568 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 75.6 m -82.53 -57.38 3.37 Favored 'General case' 0 CA--C 1.548 0.887 0 O-C-N 120.859 -1.151 . . . . 1.0 109.649 179.866 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 27.2 m -66.44 -7.17 5.1 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.056 0 CA-C-O 121.565 0.698 . . . . 1.0 111.525 -179.59 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 1.5 mp -83.16 -64.18 0.25 Allowed Pre-proline 0 CA--C 1.55 0.975 0 CA-C-N 114.607 -1.179 . . . . 1.0 111.401 -179.831 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 110' ' ' PRO . . . . . 0.709 ' CD ' ' O ' ' A' ' 106' ' ' ALA . 58.6 Cg_endo -66.35 -33.95 36.7 Favored 'Trans proline' 0 N--CA 1.504 2.115 0 C-N-CA 124.407 3.405 . . . . 1.0 113.131 179.753 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 111' ' ' ASN . . . . . 0.436 ' C ' ' N ' ' A' ' 113' ' ' ASN . 39.8 t30 -66.48 -67.73 0.43 Allowed 'General case' 0 C--O 1.237 0.417 0 C-N-CA 120.61 -0.436 . . . . 1.0 110.029 -178.012 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 7.4 mm -51.93 -22.2 2.69 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.639 0 CA-C-O 122.135 0.969 . . . . 1.0 108.511 178.651 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 113' ' ' ASN . . . . . 0.492 ' O ' HG22 ' A' ' 116' ' ' ILE . 0.9 OUTLIER -61.25 -53.3 58.62 Favored 'General case' 0 C--N 1.305 -1.34 0 CA-C-N 113.358 -1.746 . . . . 1.0 108.174 -178.188 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -55.52 -29.23 58.51 Favored 'General case' 0 C--N 1.313 -1.011 0 O-C-N 120.668 -1.27 . . . . 1.0 111.775 -179.617 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -83.29 -50.09 8.74 Favored 'General case' 0 C--O 1.212 -0.89 0 CA-C-O 121.777 0.798 . . . . 1.0 111.584 177.527 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 116' ' ' ILE . . . . . 0.556 ' CG2' ' N ' ' A' ' 117' ' ' GLU . 1.5 tp -46.21 -53.93 2.27 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.704 0 CA-C-N 114.194 -1.367 . . . . 1.0 107.676 -179.005 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 117' ' ' GLU . . . . . 0.556 ' N ' ' CG2' ' A' ' 116' ' ' ILE . 44.2 tt0 -40.05 -50.95 2.6 Favored 'General case' 0 N--CA 1.478 0.928 0 N-CA-C 105.034 -2.21 . . . . 1.0 105.034 -178.812 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 43.3 t -70.26 -53.16 24.39 Favored 'Isoleucine or valine' 0 CA--C 1.558 1.286 0 CA-C-N 113.3 -1.773 . . . . 1.0 111.08 178.192 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 119' ' ' LEU . . . . . 0.502 ' O ' HD13 ' A' ' 119' ' ' LEU . 0.1 OUTLIER -59.65 -24.87 64.22 Favored 'General case' 0 N--CA 1.482 1.138 0 N-CA-C 115.145 1.535 . . . . 1.0 115.145 -177.268 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -135.71 -48.43 0.08 OUTLIER Glycine 0 CA--C 1.542 1.759 0 CA-C-N 120.418 1.463 . . . . 1.0 113.035 177.234 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 1.2 m 160.56 -39.38 0.0 OUTLIER 'General case' 0 N--CA 1.468 0.472 0 N-CA-C 101.414 -3.55 . . . . 1.0 101.414 -177.268 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 122' ' ' GLY . . . . . 0.444 ' HA2' HG23 ' A' ' 116' ' ' ILE . . . 115.06 -32.89 5.57 Favored Glycine 0 CA--C 1.526 0.748 0 CA-C-N 111.114 -2.766 . . . . 1.0 116.869 175.638 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 123' ' ' THR . . . . . 0.44 ' C ' ' O ' ' A' ' 122' ' ' GLY . 43.8 m -40.63 98.35 0.01 OUTLIER 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 121.225 2.513 . . . . 1.0 112.967 -178.661 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 124' ' ' ASP . . . . . 0.441 ' N ' ' O ' ' A' ' 122' ' ' GLY . 31.8 m-20 -137.21 138.4 40.13 Favored 'General case' 0 N--CA 1.465 0.284 0 N-CA-C 107.207 -1.405 . . . . 1.0 107.207 177.112 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 125' ' ' TYR . . . . . 0.47 ' O ' ' CD1' ' A' ' 125' ' ' TYR . 0.1 OUTLIER -155.34 153.74 30.96 Favored 'General case' 0 CA--C 1.537 0.481 0 CA-C-O 121.18 0.514 . . . . 1.0 110.719 -179.581 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 126' ' ' ARG . . . . . 0.591 HH22 ' NH2' ' A' ' 52' ' ' ARG . 4.4 mtp85 -150.42 153.89 36.75 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.324 -0.853 . . . . 1.0 111.506 177.467 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 127' ' ' PHE . . . . . . . . . . . . . 47.3 p90 . . . . . 0 C--O 1.22 -0.451 0 CA-C-O 117.931 -1.033 . . . . 1.0 110.489 -179.474 . . . . . . . . 0 0 . 1 . 021 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 20.1 mmt . . . . . 0 N--CA 1.493 1.679 0 N-CA-C 108.779 -0.822 . . . . 1.0 108.779 . . . . . . . . . 0 0 . 1 . 021 nuclear build core ' A' A ' 2' ' ' SER . . . . . 0.431 ' O ' ' OD2' ' A' ' 3' ' ' ASP . 50.6 m -107.77 8.78 29.0 Favored 'General case' 0 N--CA 1.466 0.329 0 C-N-CA 122.322 0.249 . . . . 1.0 110.544 179.943 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 3' ' ' ASP . . . . . 0.431 ' OD2' ' O ' ' A' ' 2' ' ' SER . 0.4 OUTLIER 169.59 93.99 0.0 OUTLIER 'General case' 0 CA--C 1.534 0.338 0 N-CA-C 110.284 -0.265 . . . . 1.0 110.284 179.966 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 70.4 t80 -150.15 144.53 25.74 Favored 'General case' 0 N--CA 1.466 0.353 0 N-CA-C 110.228 -0.286 . . . . 1.0 110.228 179.587 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 47.9 m-20 -153.07 149.26 27.94 Favored 'General case' 0 N--CA 1.465 0.309 0 N-CA-C 110.233 -0.284 . . . . 1.0 110.233 179.888 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 6' ' ' THR . . . . . 0.669 HG22 ' H ' ' A' ' 7' ' ' GLU . 11.2 m -69.07 174.48 4.52 Favored 'General case' 0 C--O 1.205 -1.267 0 N-CA-C 109.793 -0.447 . . . . 1.0 109.793 179.774 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 7' ' ' GLU . . . . . 0.669 ' H ' HG22 ' A' ' 6' ' ' THR . 39.6 tt0 -61.55 -55.59 29.28 Favored 'General case' 0 C--N 1.317 -0.847 0 CA-C-O 121.475 0.655 . . . . 1.0 110.349 -177.822 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 8' ' ' ARG . . . . . 0.544 ' O ' ' CB ' ' A' ' 12' ' ' ALA . 7.4 ttp-105 -51.27 -57.81 7.86 Favored 'General case' 0 C--O 1.209 -1.072 0 N-CA-C 107.788 -1.19 . . . . 1.0 107.788 -178.188 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 9' ' ' VAL . . . . . 0.762 ' O ' HG13 ' A' ' 13' ' ' VAL . 0.0 OUTLIER -66.14 -47.0 86.19 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.071 0 CA-C-N 114.435 -1.257 . . . . 1.0 110.99 179.554 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 10' ' ' SER . . . . . 0.606 ' N ' ' O ' ' A' ' 6' ' ' THR . 35.4 t -62.93 -59.06 5.35 Favored 'General case' 0 N--CA 1.482 1.155 0 N-CA-C 108.582 -0.895 . . . . 1.0 108.582 179.636 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 11' ' ' ARG . . . . . 0.526 ' N ' ' O ' ' A' ' 7' ' ' GLU . 20.9 ttm180 -66.09 -55.06 18.4 Favored 'General case' 0 C--N 1.314 -0.944 0 O-C-N 121.732 -0.605 . . . . 1.0 110.815 -178.06 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 12' ' ' ALA . . . . . 0.544 ' CB ' ' O ' ' A' ' 8' ' ' ARG . . . -49.64 -53.31 24.93 Favored 'General case' 0 N--CA 1.485 1.276 0 C-N-CA 118.467 -1.293 . . . . 1.0 108.043 -176.566 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 13' ' ' VAL . . . . . 0.762 HG13 ' O ' ' A' ' 9' ' ' VAL . 4.5 m -60.58 -47.34 93.25 Favored 'Isoleucine or valine' 0 C--O 1.203 -1.377 0 C-N-CA 118.067 -1.453 . . . . 1.0 107.342 178.204 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 14' ' ' ALA . . . . . 0.779 ' O ' HG13 ' A' ' 18' ' ' VAL . . . -56.31 -62.11 1.94 Allowed 'General case' 0 C--O 1.206 -1.201 0 C-N-CA 117.062 -1.855 . . . . 1.0 109.706 179.645 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 15' ' ' ALA . . . . . 0.595 ' O ' ' N ' ' A' ' 19' ' ' GLY . . . -54.14 -56.26 19.91 Favored 'General case' 0 N--CA 1.472 0.659 0 CA-C-O 121.474 0.654 . . . . 1.0 110.097 -178.246 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 16' ' ' ALA . . . . . 0.668 ' HB1' ' CA ' ' A' ' 22' ' ' GLY . . . -62.28 -56.01 22.68 Favored 'General case' 0 CA--C 1.552 1.037 0 CA-C-N 115.25 -0.886 . . . . 1.0 109.281 -179.419 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 17' ' ' LEU . . . . . 0.661 ' O ' HD23 ' A' ' 17' ' ' LEU . 4.3 tt -57.17 -52.43 65.36 Favored 'General case' 0 N--CA 1.484 1.244 0 CA-C-N 114.675 -1.148 . . . . 1.0 108.275 -177.965 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 18' ' ' VAL . . . . . 0.779 HG13 ' O ' ' A' ' 14' ' ' ALA . 2.8 m -69.26 -57.87 7.29 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.349 0 C-N-CA 119.737 -0.785 . . . . 1.0 109.806 179.095 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 19' ' ' GLY . . . . . 0.595 ' N ' ' O ' ' A' ' 15' ' ' ALA . . . -59.86 -175.84 1.08 Allowed Glycine 0 N--CA 1.447 -0.585 0 N-CA-C 111.106 -0.798 . . . . 1.0 111.106 -179.261 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 20' ' ' PRO . . . . . 0.576 ' O ' ' N ' ' A' ' 24' ' ' ALA . 36.8 Cg_endo -83.47 -26.79 2.01 Favored 'Trans proline' 0 C--N 1.299 -2.044 0 C-N-CA 122.658 2.239 . . . . 1.0 112.988 -178.507 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 21' ' ' GLY . . . . . 0.46 ' O ' ' HB3' ' A' ' 24' ' ' ALA . . . -59.02 -58.65 13.41 Favored Glycine 0 N--CA 1.475 1.25 0 C-N-CA 120.066 -1.064 . . . . 1.0 111.536 -176.995 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 22' ' ' GLY . . . . . 0.668 ' CA ' ' HB1' ' A' ' 16' ' ' ALA . . . -55.96 -51.59 54.46 Favored Glycine 0 N--CA 1.474 1.23 0 N-CA-C 106.981 -2.448 . . . . 1.0 106.981 -178.158 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 47.9 t -59.56 -31.54 47.04 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.427 0 N-CA-C 108.735 -0.839 . . . . 1.0 108.735 178.792 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 24' ' ' ALA . . . . . 0.576 ' N ' ' O ' ' A' ' 20' ' ' PRO . . . -58.17 -63.09 1.38 Allowed 'General case' 0 C--N 1.348 0.502 0 C-N-CA 118.858 -1.137 . . . . 1.0 110.659 -178.742 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 25' ' ' LEU . . . . . 0.441 HD23 ' H ' ' A' ' 25' ' ' LEU . 0.1 OUTLIER -64.52 -43.37 94.28 Favored 'General case' 0 CA--C 1.517 -0.309 0 C-N-CA 119.858 -0.737 . . . . 1.0 111.814 -178.1 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 93.0 t -59.59 -59.63 3.64 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.544 0 C-N-CA 118.818 -1.153 . . . . 1.0 110.102 -177.927 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 27' ' ' VAL . . . . . 0.579 ' O ' ' HB3' ' A' ' 31' ' ' ALA . 0.6 OUTLIER -58.87 -34.76 53.33 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 O-C-N 122.235 -0.291 . . . . 1.0 111.1 -178.283 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 37.5 ttpt -67.16 -55.85 12.41 Favored 'General case' 0 C--N 1.325 -0.482 0 N-CA-C 109.391 -0.596 . . . . 1.0 109.391 -179.297 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 42.2 t -62.24 -47.82 91.32 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.605 0 CA-C-N 115.162 -0.926 . . . . 1.0 109.989 -179.07 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 30' ' ' CYS . . . . . . . . . . . . . 0.7 OUTLIER -67.47 -62.53 1.38 Allowed 'General case' 0 N--CA 1.446 -0.628 0 C-N-CA 119.052 -1.059 . . . . 1.0 110.841 -179.098 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 31' ' ' ALA . . . . . 0.579 ' HB3' ' O ' ' A' ' 27' ' ' VAL . . . -60.3 -51.61 68.82 Favored 'General case' 0 CA--C 1.506 -0.737 0 O-C-N 122.055 -0.403 . . . . 1.0 111.091 -176.697 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 32' ' ' GLY . . . . . 0.498 ' O ' ' HB2' ' A' ' 33' ' ' LEU . . . 84.66 75.04 1.23 Allowed Glycine 0 N--CA 1.442 -0.941 0 N-CA-C 109.828 -1.309 . . . . 1.0 109.828 -178.662 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 33' ' ' LEU . . . . . 0.498 ' HB2' ' O ' ' A' ' 32' ' ' GLY . 0.9 OUTLIER 87.21 100.39 0.03 OUTLIER Pre-proline 0 CA--C 1.549 0.917 0 C-N-CA 124.015 0.926 . . . . 1.0 110.654 -179.238 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 58.6 Cg_endo -71.4 -31.51 13.87 Favored 'Trans proline' 0 N--CA 1.502 1.997 0 C-N-CA 121.925 1.75 . . . . 1.0 114.807 -178.652 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -58.02 -58.96 11.85 Favored Glycine 0 N--CA 1.472 1.077 0 C-N-CA 118.466 -1.826 . . . . 1.0 108.957 -178.4 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 36' ' ' VAL . . . . . 0.587 HG22 ' N ' ' A' ' 37' ' ' ILE . 7.9 p -93.43 165.89 1.86 Allowed 'Isoleucine or valine' 0 CA--C 1.514 -0.415 0 N-CA-C 106.75 -1.574 . . . . 1.0 106.75 177.318 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 37' ' ' ILE . . . . . 0.587 ' N ' HG22 ' A' ' 36' ' ' VAL . 8.8 tp 115.81 121.57 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.476 0.842 0 O-C-N 124.523 1.139 . . . . 1.0 110.244 -179.841 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 0.9 OUTLIER -143.33 135.8 27.29 Favored 'General case' 0 CA--C 1.533 0.293 0 N-CA-C 109.146 -0.687 . . . . 1.0 109.146 179.461 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 10.4 m -111.47 111.2 55.11 Favored Pre-proline 0 N--CA 1.468 0.444 0 N-CA-C 109.55 -0.537 . . . . 1.0 109.55 179.266 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_exo -43.09 -85.83 0.01 OUTLIER 'Trans proline' 0 N--CA 1.491 1.366 0 C-N-CA 121.662 1.575 . . . . 1.0 112.834 -178.637 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -67.28 120.15 13.34 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 116.108 -0.496 . . . . 1.0 111.313 -177.784 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 3.6 ptm180 -174.04 175.39 2.77 Favored 'General case' 0 N--CA 1.448 -0.563 0 CA-C-N 116.101 -0.499 . . . . 1.0 110.01 178.46 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 5.3 tpt85 -57.53 -43.35 84.27 Favored 'General case' 0 C--N 1.32 -0.691 0 N-CA-C 107.452 -1.314 . . . . 1.0 107.452 179.919 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 44' ' ' GLY . . . . . 0.43 ' O ' ' CD1' ' A' ' 45' ' ' PHE . . . 121.5 -21.55 8.05 Favored Glycine 0 N--CA 1.465 0.613 0 N-CA-C 110.715 -0.954 . . . . 1.0 110.715 -179.127 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 45' ' ' PHE . . . . . 0.581 ' O ' ' HB2' ' A' ' 46' ' ' PHE . 42.6 m-85 -150.34 153.82 36.74 Favored 'General case' 0 C--O 1.216 -0.707 0 N-CA-C 109.006 -0.739 . . . . 1.0 109.006 177.795 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 46' ' ' PHE . . . . . 0.655 ' O ' ' HB2' ' A' ' 47' ' ' ARG . 8.6 m-85 128.59 96.33 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.582 0 O-C-N 124.939 1.399 . . . . 1.0 110.287 -179.933 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 47' ' ' ARG . . . . . 0.655 ' HB2' ' O ' ' A' ' 46' ' ' PHE . 0.7 OUTLIER 110.1 160.85 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.503 0 C-N-CA 125.464 1.506 . . . . 1.0 109.884 -179.809 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 0.9 OUTLIER 67.8 70.64 0.34 Allowed 'General case' 0 C--O 1.224 -0.246 0 N-CA-C 108.811 -0.811 . . . . 1.0 108.811 -178.455 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 49' ' ' ASN . . . . . 0.654 HD22 ' HG2' ' A' ' 54' ' ' GLN . 16.8 m120 -136.13 129.37 17.93 Favored Pre-proline 0 CA--C 1.534 0.364 0 O-C-N 121.787 -0.571 . . . . 1.0 109.509 -178.979 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 50' ' ' PRO . . . . . 0.427 ' C ' ' N ' ' A' ' 52' ' ' ARG . 68.8 Cg_exo -46.75 74.57 0.01 OUTLIER 'Trans proline' 0 N--CA 1.498 1.78 0 C-N-CA 121.964 1.776 . . . . 1.0 113.476 179.927 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 51' ' ' GLU . . . . . 0.606 ' N ' ' O ' ' A' ' 49' ' ' ASN . 7.4 mm-40 48.84 14.09 0.07 Allowed 'General case' 0 C--N 1.331 -0.209 0 O-C-N 121.867 -0.521 . . . . 1.0 110.999 179.408 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 52' ' ' ARG . . . . . 0.427 ' N ' ' C ' ' A' ' 50' ' ' PRO . 1.4 ptp180 -116.45 162.23 17.88 Favored 'General case' 0 N--CA 1.472 0.65 0 CA-C-N 116.554 -0.294 . . . . 1.0 110.874 -179.573 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 19.4 tt -71.25 136.54 25.63 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.779 0 CA-C-O 123.508 1.623 . . . . 1.0 115.325 -177.146 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 54' ' ' GLN . . . . . 0.654 ' HG2' HD22 ' A' ' 49' ' ' ASN . 0.5 OUTLIER -74.93 87.6 2.31 Favored 'General case' 0 C--N 1.314 -0.973 0 CA-C-N 110.233 -3.167 . . . . 1.0 110.247 -178.985 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 55' ' ' ILE . . . . . 0.425 ' CG2' ' N ' ' A' ' 56' ' ' GLY . 5.9 mm -146.05 156.9 12.19 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.789 0 CA-C-N 115.703 -0.681 . . . . 1.0 109.883 177.495 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 56' ' ' GLY . . . . . 0.425 ' N ' ' CG2' ' A' ' 55' ' ' ILE . . . 110.52 -2.29 29.28 Favored Glycine 0 N--CA 1.475 1.243 0 N-CA-C 111.379 -0.688 . . . . 1.0 111.379 -179.897 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 13.9 p-10 -87.44 104.95 16.94 Favored 'General case' 0 N--CA 1.466 0.357 0 CA-C-O 121.396 0.617 . . . . 1.0 111.435 -179.815 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 58' ' ' TRP . . . . . . . . . . . . . 9.0 m0 -89.14 171.56 9.73 Favored 'General case' 0 CA--C 1.567 1.603 0 CA-C-O 122.941 1.353 . . . . 1.0 112.354 -178.634 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 59' ' ' ARG . . . . . 0.454 ' HE ' ' H ' ' A' ' 59' ' ' ARG . 0.0 OUTLIER -76.83 -61.71 1.88 Allowed 'General case' 0 N--CA 1.49 1.556 0 CA-C-N 111.12 -2.764 . . . . 1.0 113.902 -176.941 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 4.0 t80 -90.56 -9.03 48.64 Favored 'General case' 0 N--CA 1.484 1.23 0 CA-C-O 122.348 1.07 . . . . 1.0 112.753 -179.295 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 61' ' ' GLU . . . . . 0.477 ' O ' ' N ' ' A' ' 65' ' ' ASP . 2.7 tt0 -78.45 -14.48 59.35 Favored 'General case' 0 C--N 1.306 -1.3 0 CA-C-N 114.895 -1.048 . . . . 1.0 110.291 -179.637 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 62' ' ' VAL . . . . . 0.627 ' O ' ' N ' ' A' ' 66' ' ' GLY . 11.1 m -48.26 -55.79 2.63 Favored 'Isoleucine or valine' 0 C--O 1.204 -1.295 0 C-N-CA 119.566 -0.854 . . . . 1.0 109.241 -176.723 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 63' ' ' ALA . . . . . 0.587 ' H ' HG23 ' A' ' 62' ' ' VAL . . . -63.26 -54.65 34.01 Favored 'General case' 0 C--N 1.297 -1.677 0 O-C-N 121.588 -0.695 . . . . 1.0 109.359 179.438 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -50.56 -59.5 3.97 Favored 'General case' 0 CA--C 1.545 0.786 0 CA-C-N 115.342 -0.845 . . . . 1.0 110.234 -179.342 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 65' ' ' ASP . . . . . 0.591 ' C ' ' H ' ' A' ' 67' ' ' ARG . 26.8 t70 -72.42 -50.82 23.61 Favored 'General case' 0 C--N 1.312 -1.049 0 CA-C-O 121.91 0.862 . . . . 1.0 111.504 178.77 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 66' ' ' GLY . . . . . 0.627 ' N ' ' O ' ' A' ' 62' ' ' VAL . . . -69.96 29.5 0.41 Allowed Glycine 0 C--O 1.227 -0.329 0 O-C-N 120.986 -1.071 . . . . 1.0 111.046 177.661 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 67' ' ' ARG . . . . . 0.608 ' O ' ' N ' ' A' ' 69' ' ' LEU . 0.0 OUTLIER -77.96 8.41 4.73 Favored 'General case' 0 C--N 1.316 -0.856 0 N-CA-C 107.984 -1.117 . . . . 1.0 107.984 176.877 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 68' ' ' LEU . . . . . 0.646 HD23 ' N ' ' A' ' 68' ' ' LEU . 1.5 pt? -34.19 -27.96 0.01 OUTLIER 'General case' 0 N--CA 1.483 1.218 0 CA-C-O 121.757 0.789 . . . . 1.0 108.88 -178.158 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 69' ' ' LEU . . . . . 0.608 ' N ' ' O ' ' A' ' 67' ' ' ARG . 1.3 mt -64.57 -65.15 0.71 Allowed 'General case' 0 N--CA 1.473 0.715 0 C-N-CA 118.833 -1.147 . . . . 1.0 107.918 178.761 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 70' ' ' ALA . . . . . 0.653 ' C ' ' H ' ' A' ' 72' ' ' HIS . . . -78.22 -75.09 0.24 Allowed 'General case' 0 N--CA 1.469 0.494 0 N-CA-C 105.108 -2.182 . . . . 1.0 105.108 176.919 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 71' ' ' ALA . . . . . 0.46 ' O ' ' C ' ' A' ' 72' ' ' HIS . . . -44.87 4.1 0.0 OUTLIER 'General case' 0 CA--C 1.52 -0.209 0 C-N-CA 124.694 1.197 . . . . 1.0 113.425 178.57 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 72' ' ' HIS . . . . . 0.671 ' CG ' ' N ' ' A' ' 73' ' ' MET . 4.2 p-80 -28.22 -55.05 0.11 Allowed 'General case' 0 C--N 1.335 -0.065 0 CA-C-N 118.067 0.394 . . . . 1.0 111.967 -179.408 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 73' ' ' MET . . . . . 0.671 ' N ' ' CG ' ' A' ' 72' ' ' HIS . 3.8 ppp? -76.84 -53.5 7.82 Favored 'General case' 0 C--N 1.316 -0.858 0 N-CA-C 108.483 -0.932 . . . . 1.0 108.483 177.278 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 74' ' ' VAL . . . . . 0.725 ' O ' ' N ' ' A' ' 76' ' ' GLY . 65.8 t -44.51 -41.87 2.1 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.424 0 CA-C-O 117.748 -1.12 . . . . 1.0 110.775 -176.122 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 75' ' ' ASN . . . . . 0.533 ' C ' ' N ' ' A' ' 77' ' ' ILE . 1.8 t-20 -35.09 -14.58 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.7 0 CA-C-N 120.857 1.662 . . . . 1.0 112.836 178.403 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 76' ' ' GLY . . . . . 0.725 ' N ' ' O ' ' A' ' 74' ' ' VAL . . . -44.04 -19.21 0.11 Allowed Glycine 0 CA--C 1.543 1.82 0 N-CA-C 107.846 -2.102 . . . . 1.0 107.846 175.917 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 77' ' ' ILE . . . . . 0.533 ' N ' ' C ' ' A' ' 75' ' ' ASN . 0.8 OUTLIER -72.11 -54.98 14.85 Favored 'Isoleucine or valine' 0 C--O 1.207 -1.138 0 N-CA-C 107.683 -1.228 . . . . 1.0 107.683 178.267 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 78' ' ' VAL . . . . . 0.528 ' C ' ' O ' ' A' ' 77' ' ' ILE . 55.5 t -33.52 -37.51 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.314 -0.973 0 CA-C-N 113.252 -1.795 . . . . 1.0 106.849 -178.391 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 79' ' ' ILE . . . . . 0.546 ' O ' ' HB3' ' A' ' 83' ' ' ALA . 23.7 pt -97.77 -34.49 4.76 Favored 'Isoleucine or valine' 0 C--O 1.207 -1.146 0 CA-C-N 115.287 -0.869 . . . . 1.0 112.005 176.846 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 80' ' ' ALA . . . . . 0.501 ' N ' ' O ' ' A' ' 77' ' ' ILE . . . -84.78 -9.35 58.27 Favored 'General case' 0 N--CA 1.482 1.151 0 O-C-N 120.955 -1.091 . . . . 1.0 113.588 179.674 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 81' ' ' GLU . . . . . 0.495 ' N ' ' O ' ' A' ' 77' ' ' ILE . 82.3 tt0 -90.63 -75.77 0.45 Allowed 'General case' 0 N--CA 1.453 -0.314 0 N-CA-C 113.572 0.953 . . . . 1.0 113.572 -176.769 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 6.7 m-20 -91.04 -16.71 27.46 Favored 'General case' 0 C--O 1.22 -0.45 0 N-CA-C 113.463 0.912 . . . . 1.0 113.463 -179.141 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 83' ' ' ALA . . . . . 0.546 ' HB3' ' O ' ' A' ' 79' ' ' ILE . . . -46.7 -42.21 16.24 Favored 'General case' 0 C--O 1.22 -0.479 0 C-N-CA 119.369 -0.933 . . . . 1.0 111.348 -177.681 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 14.3 tp -37.46 -46.02 0.77 Allowed 'General case' 0 N--CA 1.47 0.55 0 CA-C-O 121.48 0.657 . . . . 1.0 110.613 -178.349 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -65.46 -37.1 79.24 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.855 0 CA-C-N 114.75 -1.114 . . . . 1.0 110.564 -179.127 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 86' ' ' ALA . . . . . 0.527 ' N ' ' O ' ' A' ' 83' ' ' ALA . . . -90.61 -26.03 19.86 Favored 'General case' 0 C--O 1.222 -0.372 0 CA-C-O 120.641 0.258 . . . . 1.0 111.668 -179.762 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 87' ' ' GLU . . . . . 0.534 ' N ' ' O ' ' A' ' 83' ' ' ALA . 30.6 tp10 -54.71 -24.94 24.33 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 121.423 0.63 . . . . 1.0 109.659 -179.068 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -72.25 -8.56 55.48 Favored 'General case' 0 C--N 1.324 -0.503 0 N-CA-C 107.823 -1.177 . . . . 1.0 107.823 178.89 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 89' ' ' VAL . . . . . 0.494 ' N ' ' O ' ' A' ' 86' ' ' ALA . 3.2 t -92.49 36.03 0.1 OUTLIER 'Isoleucine or valine' 0 C--N 1.315 -0.909 0 CA-C-N 112.759 -2.019 . . . . 1.0 107.414 177.478 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 90' ' ' GLY . . . . . 0.902 ' O ' ' N ' ' A' ' 92' ' ' HIS . . . -55.82 -25.27 44.09 Favored Glycine 0 C--N 1.366 2.237 0 CA-C-O 117.346 -1.808 . . . . 1.0 112.082 176.955 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 91' ' ' PRO . . . . . 0.729 ' HD2' ' N ' ' A' ' 90' ' ' GLY . 20.8 Cg_exo -32.99 1.28 0.0 OUTLIER 'Trans proline' 0 N--CA 1.496 1.641 0 C-N-CA 123.41 2.74 . . . . 1.0 113.526 173.295 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 92' ' ' HIS . . . . . 0.902 ' N ' ' O ' ' A' ' 90' ' ' GLY . 0.0 OUTLIER -49.82 -33.27 16.2 Favored 'General case' 0 N--CA 1.431 -1.412 0 N-CA-C 106.91 -1.515 . . . . 1.0 106.91 178.346 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 24.8 tp -59.8 -57.1 14.35 Favored 'General case' 0 N--CA 1.453 -0.284 0 N-CA-C 107.537 -1.283 . . . . 1.0 107.537 177.396 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -51.72 -53.9 34.2 Favored 'General case' 0 C--N 1.323 -0.561 0 N-CA-C 107.953 -1.128 . . . . 1.0 107.953 -178.955 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 6.2 mmp_? -64.81 -32.93 74.85 Favored 'General case' 0 N--CA 1.47 0.562 0 CA-C-O 121.894 0.854 . . . . 1.0 110.911 178.225 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 96' ' ' ALA . . . . . 0.811 ' O ' ' N ' ' A' ' 100' ' ' ILE . . . -48.16 -39.2 20.02 Favored 'General case' 0 N--CA 1.493 1.711 0 N-CA-C 105.489 -2.041 . . . . 1.0 105.489 -177.31 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 97' ' ' LEU . . . . . 0.536 HD13 ' C ' ' A' ' 97' ' ' LEU . 1.6 tm? -33.14 -24.34 0.0 OUTLIER 'General case' 0 CA--C 1.576 1.957 0 CA-C-N 112.693 -2.049 . . . . 1.0 107.219 -179.798 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 98' ' ' GLY . . . . . 0.722 ' N ' ' O ' ' A' ' 96' ' ' ALA . . . -90.04 -53.69 2.31 Favored Glycine 0 CA--C 1.557 2.665 0 CA-C-O 123.033 1.352 . . . . 1.0 111.796 171.226 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 99' ' ' GLN . . . . . 0.6 ' N ' ' O ' ' A' ' 96' ' ' ALA . 0.1 OUTLIER -77.97 8.02 5.27 Favored 'General case' 0 N--CA 1.443 -0.803 0 N-CA-C 107.458 -1.312 . . . . 1.0 107.458 177.691 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 100' ' ' ILE . . . . . 0.811 ' N ' ' O ' ' A' ' 96' ' ' ALA . 3.8 tp -61.73 -52.03 65.71 Favored 'Isoleucine or valine' 0 CA--C 1.48 -1.744 0 N-CA-C 107.076 -1.453 . . . . 1.0 107.076 179.416 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 101' ' ' VAL . . . . . 0.613 ' N ' HG23 ' A' ' 100' ' ' ILE . 62.7 t -52.93 -57.09 5.07 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 N-CA-C 106.464 -1.68 . . . . 1.0 106.464 177.654 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 102' ' ' CYS . . . . . 0.97 ' O ' ' HB2' ' A' ' 106' ' ' ALA . 0.0 OUTLIER -46.43 -19.8 0.09 Allowed 'General case' 0 CA--C 1.541 0.606 0 C-N-CA 120.038 -0.665 . . . . 1.0 109.423 -179.226 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 103' ' ' ARG . . . . . 0.574 HH21 ' CB ' ' A' ' 96' ' ' ALA . 11.4 mtm-85 -94.13 -48.28 6.28 Favored 'General case' 0 N--CA 1.474 0.763 0 N-CA-C 113.793 1.035 . . . . 1.0 113.793 178.228 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 104' ' ' TYR . . . . . 0.57 ' O ' ' CG ' ' A' ' 104' ' ' TYR . 60.8 t80 -103.92 21.44 16.33 Favored 'General case' 0 C--N 1.32 -0.706 0 C-N-CA 125.724 1.61 . . . . 1.0 110.895 -179.73 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 105' ' ' GLY . . . . . 0.596 ' N ' ' O ' ' A' ' 101' ' ' VAL . . . -165.08 -8.03 0.03 OUTLIER Glycine 0 N--CA 1.453 -0.169 0 C-N-CA 119.606 -1.283 . . . . 1.0 111.072 -179.8 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 106' ' ' ALA . . . . . 0.97 ' HB2' ' O ' ' A' ' 102' ' ' CYS . . . -28.72 117.65 0.11 Allowed 'General case' 0 CA--C 1.534 0.362 0 C-N-CA 122.117 0.167 . . . . 1.0 111.06 178.671 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 107' ' ' THR . . . . . 0.981 ' O ' ' HD2' ' A' ' 110' ' ' PRO . 6.6 m -135.7 -58.35 0.77 Allowed 'General case' 0 C--O 1.195 -1.777 0 N-CA-C 107.787 -1.19 . . . . 1.0 107.787 178.616 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 26.9 m -70.28 28.66 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.312 -1.061 0 O-C-N 120.735 -1.228 . . . . 1.0 108.847 -178.39 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 109' ' ' ILE . . . . . 0.681 HG21 ' HB1' ' A' ' 106' ' ' ALA . 0.0 OUTLIER -111.01 -45.18 0.08 OUTLIER Pre-proline 0 CA--C 1.55 0.969 0 O-C-N 121.834 -0.542 . . . . 1.0 110.277 178.86 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 110' ' ' PRO . . . . . 0.981 ' HD2' ' O ' ' A' ' 107' ' ' THR . 24.6 Cg_exo -66.72 -29.12 43.26 Favored 'Trans proline' 0 N--CA 1.496 1.675 0 C-N-CA 123.453 2.769 . . . . 1.0 111.262 -178.7 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 17.4 t-20 -68.35 -68.47 0.39 Allowed 'General case' 0 N--CA 1.455 -0.211 0 C-N-CA 120.405 -0.518 . . . . 1.0 109.847 -178.763 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 112' ' ' ILE . . . . . 0.41 HD13 HG21 ' A' ' 112' ' ' ILE . 21.3 pt -51.39 -28.57 8.15 Favored 'Isoleucine or valine' 0 C--O 1.217 -0.61 0 CA-C-O 122.623 1.202 . . . . 1.0 109.367 179.09 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 1.6 t30 -59.25 -51.89 68.01 Favored 'General case' 0 C--N 1.294 -1.814 0 CA-C-N 112.62 -2.082 . . . . 1.0 107.752 -177.855 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 114' ' ' ALA . . . . . 0.519 ' O ' HG23 ' A' ' 118' ' ' VAL . . . -59.59 -32.69 70.62 Favored 'General case' 0 N--CA 1.45 -0.464 0 N-CA-C 112.368 0.507 . . . . 1.0 112.368 -179.646 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -80.81 -53.47 6.46 Favored 'General case' 0 C--O 1.21 -0.977 0 CA-C-O 121.7 0.762 . . . . 1.0 110.398 178.141 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 116' ' ' ILE . . . . . 0.524 ' O ' ' N ' ' A' ' 120' ' ' GLY . 28.5 mt -50.32 -61.26 0.65 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.707 0 CA-C-N 114.143 -1.39 . . . . 1.0 108.6 -178.823 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 117' ' ' GLU . . . . . 0.422 ' C ' ' O ' ' A' ' 116' ' ' ILE . 49.2 mt-10 -42.16 -52.83 4.24 Favored 'General case' 0 C--N 1.307 -1.274 0 CA-C-N 112.239 -2.255 . . . . 1.0 106.791 -177.969 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 118' ' ' VAL . . . . . 0.519 HG23 ' O ' ' A' ' 114' ' ' ALA . 94.6 t -60.63 -53.05 54.3 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.492 0 N-CA-C 108.355 -0.98 . . . . 1.0 108.355 177.187 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 2.9 tp -51.29 -69.38 0.11 Allowed 'General case' 0 CA--C 1.536 0.414 0 N-CA-C 106.687 -1.597 . . . . 1.0 106.687 -178.775 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 120' ' ' GLY . . . . . 0.657 ' O ' ' OG1' ' A' ' 121' ' ' THR . . . -73.05 -84.59 0.25 Allowed Glycine 0 CA--C 1.537 1.419 0 C-N-CA 119.356 -1.402 . . . . 1.0 111.102 -179.555 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 121' ' ' THR . . . . . 0.657 ' OG1' ' O ' ' A' ' 120' ' ' GLY . 41.6 m 170.37 -39.72 0.0 OUTLIER 'General case' 0 N--CA 1.476 0.862 0 CA-C-N 113.649 -1.276 . . . . 1.0 112.67 179.156 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 122' ' ' GLY . . . . . 0.695 ' O ' ' N ' ' A' ' 124' ' ' ASP . . . 100.6 -18.78 54.64 Favored Glycine 0 N--CA 1.469 0.836 0 N-CA-C 106.815 -2.514 . . . . 1.0 106.815 -176.242 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 123' ' ' THR . . . . . 0.723 HG23 ' O ' ' A' ' 123' ' ' THR . 8.9 t -52.52 83.74 0.0 OUTLIER 'General case' 0 N--CA 1.477 0.875 0 N-CA-C 104.733 -2.321 . . . . 1.0 104.733 178.414 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 124' ' ' ASP . . . . . 0.695 ' N ' ' O ' ' A' ' 122' ' ' GLY . 4.9 m-20 -171.49 -175.43 1.61 Allowed 'General case' 0 CA--C 1.53 0.181 0 CA-C-N 113.976 -1.465 . . . . 1.0 111.434 179.523 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 125' ' ' TYR . . . . . . . . . . . . . 78.4 t80 -145.98 144.71 30.28 Favored 'General case' 0 CA--C 1.538 0.483 0 CA-C-N 114.749 -1.114 . . . . 1.0 109.011 175.813 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 36.4 mmt-85 -146.34 147.02 30.9 Favored 'General case' 0 N--CA 1.474 0.727 0 N-CA-C 109.794 -0.447 . . . . 1.0 109.794 179.848 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 127' ' ' PHE . . . . . 0.412 ' CD1' ' C ' ' A' ' 127' ' ' PHE . 0.1 OUTLIER . . . . . 0 C--O 1.221 -0.412 0 CA-C-O 117.937 -1.03 . . . . 1.0 110.558 179.328 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 13.8 mmt . . . . . 0 N--CA 1.496 1.837 0 N-CA-C 109.691 -0.485 . . . . 1.0 109.691 . . . . . . . . . 0 0 . 1 . 022 nuclear build core ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 98.1 p -106.35 9.44 31.86 Favored 'General case' 0 N--CA 1.469 0.482 0 CA-C-N 115.945 -0.57 . . . . 1.0 110.455 -179.946 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER 166.29 97.1 0.0 OUTLIER 'General case' 0 N--CA 1.466 0.362 0 CA-C-N 116.019 -0.537 . . . . 1.0 110.451 179.382 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 85.2 t80 -149.26 144.98 26.85 Favored 'General case' 0 N--CA 1.466 0.343 0 CA-C-N 116.053 -0.522 . . . . 1.0 110.104 179.441 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 5' ' ' ASP . . . . . 0.445 ' N ' ' OD1' ' A' ' 5' ' ' ASP . 5.1 p30 -153.54 148.65 26.8 Favored 'General case' 0 C--N 1.33 -0.274 0 N-CA-C 109.997 -0.372 . . . . 1.0 109.997 -179.761 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 6' ' ' THR . . . . . 0.577 ' O ' ' N ' ' A' ' 10' ' ' SER . 0.2 OUTLIER -70.87 177.15 3.79 Favored 'General case' 0 C--O 1.211 -0.95 0 C-N-CA 120.337 -0.545 . . . . 1.0 110.038 -179.979 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 7' ' ' GLU . . . . . 0.519 ' O ' ' N ' ' A' ' 11' ' ' ARG . 0.6 OUTLIER -59.62 -55.46 34.18 Favored 'General case' 0 C--N 1.317 -0.845 0 CA-C-O 121.566 0.698 . . . . 1.0 109.804 -178.436 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 8' ' ' ARG . . . . . 0.467 ' O ' ' HB3' ' A' ' 12' ' ' ALA . 0.2 OUTLIER -51.61 -57.11 10.06 Favored 'General case' 0 C--N 1.318 -0.761 0 N-CA-C 107.613 -1.255 . . . . 1.0 107.613 -178.182 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 9' ' ' VAL . . . . . 0.85 ' O ' HG13 ' A' ' 13' ' ' VAL . 0.0 OUTLIER -66.26 -47.9 82.87 Favored 'Isoleucine or valine' 0 CA--C 1.556 1.18 0 CA-C-N 114.036 -1.438 . . . . 1.0 110.127 -178.857 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 10' ' ' SER . . . . . 0.577 ' N ' ' O ' ' A' ' 6' ' ' THR . 32.6 t -62.45 -59.48 4.9 Favored 'General case' 0 N--CA 1.491 1.604 0 CA-C-O 121.022 0.439 . . . . 1.0 109.998 179.148 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 11' ' ' ARG . . . . . 0.553 ' O ' ' N ' ' A' ' 15' ' ' ALA . 20.2 tpp180 -66.08 -55.16 17.9 Favored 'General case' 0 CA--C 1.547 0.835 0 O-C-N 121.539 -0.726 . . . . 1.0 110.404 -177.397 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 12' ' ' ALA . . . . . 0.511 ' O ' ' HB3' ' A' ' 16' ' ' ALA . . . -50.97 -52.24 44.58 Favored 'General case' 0 N--CA 1.481 1.103 0 C-N-CA 118.228 -1.389 . . . . 1.0 107.307 -178.893 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 13' ' ' VAL . . . . . 0.85 HG13 ' O ' ' A' ' 9' ' ' VAL . 3.2 m -63.21 -48.91 85.36 Favored 'Isoleucine or valine' 0 C--O 1.199 -1.593 0 C-N-CA 117.796 -1.562 . . . . 1.0 108.791 177.576 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 14' ' ' ALA . . . . . 0.713 ' O ' HG13 ' A' ' 18' ' ' VAL . . . -57.12 -61.88 2.15 Favored 'General case' 0 C--O 1.211 -0.964 0 C-N-CA 117.621 -1.632 . . . . 1.0 109.638 179.039 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 15' ' ' ALA . . . . . 0.566 ' O ' ' N ' ' A' ' 19' ' ' GLY . . . -53.07 -55.78 21.21 Favored 'General case' 0 N--CA 1.475 0.82 0 CA-C-O 121.552 0.691 . . . . 1.0 110.263 -177.702 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 16' ' ' ALA . . . . . 0.541 ' CA ' ' H ' ' A' ' 22' ' ' GLY . . . -62.85 -54.55 37.11 Favored 'General case' 0 C--N 1.312 -1.055 0 CA-C-N 114.598 -1.183 . . . . 1.0 108.999 -179.346 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 17' ' ' LEU . . . . . 0.586 ' CB ' ' O ' ' A' ' 13' ' ' VAL . 24.2 tp -56.75 -53.96 51.75 Favored 'General case' 0 N--CA 1.477 0.922 0 CA-C-N 114.606 -1.179 . . . . 1.0 108.752 -177.284 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 18' ' ' VAL . . . . . 0.713 HG13 ' O ' ' A' ' 14' ' ' ALA . 2.5 m -68.58 -55.98 14.02 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.355 0 C-N-CA 119.511 -0.876 . . . . 1.0 109.139 179.637 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 19' ' ' GLY . . . . . 0.566 ' N ' ' O ' ' A' ' 15' ' ' ALA . . . -64.9 -165.28 1.07 Allowed Glycine 0 CA--C 1.525 0.693 0 CA-C-N 116.292 -0.413 . . . . 1.0 112.81 -178.596 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 20' ' ' PRO . . . . . 0.594 ' O ' ' N ' ' A' ' 24' ' ' ALA . 3.2 Cg_endo -81.17 -25.65 3.86 Favored 'Trans proline' 0 C--N 1.312 -1.374 0 C-N-CA 123.134 2.556 . . . . 1.0 112.486 -178.716 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -57.65 -58.75 12.93 Favored Glycine 0 CA--C 1.532 1.125 0 C-N-CA 119.522 -1.323 . . . . 1.0 110.924 -176.663 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 22' ' ' GLY . . . . . 0.678 ' O ' HG22 ' A' ' 26' ' ' VAL . . . -61.94 -54.36 35.78 Favored Glycine 0 N--CA 1.47 0.936 0 N-CA-C 108.152 -1.979 . . . . 1.0 108.152 -178.94 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 23' ' ' VAL . . . . . 0.566 ' O ' HG12 ' A' ' 27' ' ' VAL . 24.2 t -56.17 -38.66 55.1 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.636 0 N-CA-C 109.166 -0.679 . . . . 1.0 109.166 -179.794 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 24' ' ' ALA . . . . . 0.594 ' N ' ' O ' ' A' ' 20' ' ' PRO . . . -60.28 -61.06 2.88 Favored 'General case' 0 CA--C 1.536 0.414 0 C-N-CA 119.272 -0.971 . . . . 1.0 111.011 -179.488 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 16.3 mt -64.1 -46.88 82.27 Favored 'General case' 0 N--CA 1.468 0.447 0 N-CA-C 113.446 0.906 . . . . 1.0 113.446 -177.009 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 26' ' ' VAL . . . . . 0.678 HG22 ' O ' ' A' ' 22' ' ' GLY . 18.9 m -61.51 -58.26 8.38 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 C-N-CA 118.845 -1.142 . . . . 1.0 110.297 -177.688 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 27' ' ' VAL . . . . . 0.631 ' N ' HG23 ' A' ' 26' ' ' VAL . 1.1 p -63.07 -37.73 80.16 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 N-CA-C 112.518 0.562 . . . . 1.0 112.518 -177.377 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 7.9 tmtm? -67.52 -54.69 17.92 Favored 'General case' 0 C--N 1.319 -0.737 0 N-CA-C 108.556 -0.905 . . . . 1.0 108.556 -178.764 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 93.2 t -63.64 -48.48 86.52 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.972 0 CA-C-N 114.394 -1.275 . . . . 1.0 110.331 -178.294 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 30' ' ' CYS . . . . . . . . . . . . . 34.9 t -64.77 -60.8 2.68 Favored 'General case' 0 C--N 1.326 -0.445 0 C-N-CA 119.231 -0.988 . . . . 1.0 109.944 -179.106 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 31' ' ' ALA . . . . . 0.607 ' HB3' ' O ' ' A' ' 27' ' ' VAL . . . -64.11 -51.88 61.86 Favored 'General case' 0 C--N 1.325 -0.493 0 N-CA-C 111.992 0.367 . . . . 1.0 111.992 -176.074 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 88.48 74.09 1.28 Allowed Glycine 0 CA--C 1.527 0.805 0 N-CA-C 109.994 -1.242 . . . . 1.0 109.994 -179.196 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 38.6 mt 75.29 126.15 0.03 OUTLIER Pre-proline 0 N--CA 1.476 0.846 0 C-N-CA 122.815 0.446 . . . . 1.0 110.562 -179.422 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 56.6 Cg_endo -72.26 -13.01 28.13 Favored 'Trans proline' 0 N--CA 1.505 2.15 0 C-N-CA 122.227 1.952 . . . . 1.0 114.762 -179.316 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 35' ' ' GLY . . . . . 0.674 ' HA2' HD12 ' A' ' 112' ' ' ILE . . . -60.19 -59.57 10.13 Favored Glycine 0 N--CA 1.468 0.804 0 C-N-CA 118.156 -1.973 . . . . 1.0 109.584 -178.787 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 36' ' ' VAL . . . . . 0.425 HG12 ' H ' ' A' ' 37' ' ' ILE . 1.5 t -78.64 -145.56 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.323 -0.572 0 N-CA-C 107.089 -1.449 . . . . 1.0 107.089 178.095 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 37' ' ' ILE . . . . . 0.461 HG13 ' HB1' ' A' ' 31' ' ' ALA . 5.4 mm 76.71 78.36 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 N-CA-C 112.762 0.653 . . . . 1.0 112.762 177.756 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -135.99 126.99 27.77 Favored 'General case' 0 CA--C 1.538 0.484 0 N-CA-C 106.809 -1.552 . . . . 1.0 106.809 177.904 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 39' ' ' THR . . . . . 0.528 ' OG1' ' NH2' ' A' ' 47' ' ' ARG . 23.9 p -104.54 149.68 37.68 Favored Pre-proline 0 N--CA 1.47 0.57 0 N-CA-C 110.103 -0.332 . . . . 1.0 110.103 -178.972 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 89.6 Cg_endo -75.79 -34.31 3.28 Favored 'Trans proline' 0 C--N 1.311 -1.402 0 C-N-CA 121.675 1.583 . . . . 1.0 114.211 -178.685 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -128.82 134.64 48.41 Favored 'General case' 0 N--CA 1.477 0.88 0 CA-C-N 118.089 0.404 . . . . 1.0 111.548 179.035 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 42' ' ' ARG . . . . . 0.684 HH21 ' N ' ' A' ' 46' ' ' PHE . 16.6 ptm180 -169.37 167.89 9.83 Favored 'General case' 0 C--N 1.325 -0.491 0 C-N-CA 119.789 -0.765 . . . . 1.0 111.266 177.071 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -67.48 18.9 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.051 -0.522 . . . . 1.0 109.988 179.377 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 44' ' ' GLY . . . . . 0.635 ' H ' ' C ' ' A' ' 42' ' ' ARG . . . 79.45 -24.62 3.03 Favored Glycine 0 CA--C 1.522 0.502 0 N-CA-C 111.278 -0.729 . . . . 1.0 111.278 179.803 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 45' ' ' PHE . . . . . 0.541 ' C ' HH21 ' A' ' 42' ' ' ARG . 0.2 OUTLIER -150.54 149.14 29.54 Favored 'General case' 0 CA--C 1.542 0.65 0 N-CA-C 109.061 -0.718 . . . . 1.0 109.061 -178.886 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 46' ' ' PHE . . . . . 0.684 ' N ' HH21 ' A' ' 42' ' ' ARG . 1.9 m-30 144.53 73.45 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.826 0 O-C-N 124.408 1.067 . . . . 1.0 111.664 179.006 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 47' ' ' ARG . . . . . 0.559 ' O ' ' SG ' ' A' ' 48' ' ' CYS . 2.2 ptt-85 135.2 151.09 0.0 OUTLIER 'General case' 0 N--CA 1.5 2.03 0 CA-C-O 116.905 -1.521 . . . . 1.0 108.643 -179.758 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 48' ' ' CYS . . . . . 0.559 ' SG ' ' O ' ' A' ' 47' ' ' ARG . 6.2 p 51.1 62.31 2.78 Favored 'General case' 0 N--CA 1.482 1.161 0 CA-C-N 120.717 1.599 . . . . 1.0 111.982 -179.258 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -110.79 147.21 36.01 Favored Pre-proline 0 N--CA 1.473 0.702 0 N-CA-C 110.144 -0.317 . . . . 1.0 110.144 177.921 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 50' ' ' PRO . . . . . 0.408 ' HG2' ' HE ' ' A' ' 52' ' ' ARG . 72.4 Cg_endo -71.99 55.08 2.26 Favored 'Trans proline' 0 N--CA 1.494 1.516 0 C-N-CA 122.369 2.046 . . . . 1.0 111.762 179.959 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER 67.43 -3.42 1.07 Allowed 'General case' 0 N--CA 1.468 0.427 0 CA-C-N 115.071 -0.968 . . . . 1.0 111.474 179.189 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 52' ' ' ARG . . . . . 0.408 ' HE ' ' HG2' ' A' ' 50' ' ' PRO . 16.3 mtm-85 -85.92 154.03 21.78 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 121.377 0.608 . . . . 1.0 111.839 -179.557 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 53' ' ' ILE . . . . . 0.526 HG23 HG22 ' A' ' 55' ' ' ILE . 8.5 tp -68.22 137.0 25.39 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.306 0 CA-C-N 115.208 -0.905 . . . . 1.0 110.177 179.705 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -59.76 80.44 0.01 OUTLIER 'General case' 0 C--N 1.316 -0.858 0 CA-C-N 114.52 -1.218 . . . . 1.0 109.289 -177.548 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 55' ' ' ILE . . . . . 0.526 HG22 HG23 ' A' ' 53' ' ' ILE . 18.2 tt -149.17 157.91 6.58 Favored 'Isoleucine or valine' 0 C--N 1.348 0.538 0 N-CA-C 110.109 -0.33 . . . . 1.0 110.109 177.991 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 110.48 -6.38 29.99 Favored Glycine 0 N--CA 1.472 1.047 0 N-CA-C 110.698 -0.961 . . . . 1.0 110.698 -179.722 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 16.1 p-10 -76.46 98.31 4.56 Favored 'General case' 0 C--N 1.323 -0.58 0 N-CA-C 108.855 -0.794 . . . . 1.0 108.855 177.788 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 58' ' ' TRP . . . . . . . . . . . . . 24.1 m0 -87.84 174.54 8.3 Favored 'General case' 0 CA--C 1.533 0.324 0 CA-C-O 122.531 1.157 . . . . 1.0 112.513 -177.636 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 12.9 mtm180 -84.5 -62.03 1.65 Allowed 'General case' 0 C--N 1.317 -0.837 0 CA-C-N 112.523 -2.126 . . . . 1.0 112.628 -178.958 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 9.3 p90 -90.53 -15.25 31.04 Favored 'General case' 0 C--O 1.247 0.924 0 N-CA-C 113.615 0.969 . . . . 1.0 113.615 -178.861 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 4.8 tt0 -78.72 -14.44 59.28 Favored 'General case' 0 C--N 1.323 -0.554 0 O-C-N 121.569 -0.707 . . . . 1.0 110.53 -179.318 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 62' ' ' VAL . . . . . 0.566 ' O ' ' N ' ' A' ' 66' ' ' GLY . 27.8 m -46.26 -55.13 1.64 Allowed 'Isoleucine or valine' 0 C--O 1.209 -1.053 0 C-N-CA 119.931 -0.707 . . . . 1.0 110.099 -175.281 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 63' ' ' ALA . . . . . 0.554 ' N ' HG23 ' A' ' 62' ' ' VAL . . . -67.44 -52.17 42.78 Favored 'General case' 0 C--N 1.307 -1.273 0 CA-C-N 117.968 0.349 . . . . 1.0 110.25 -179.728 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 64' ' ' HIS . . . . . 0.498 ' O ' ' CG ' ' A' ' 67' ' ' ARG . 0.1 OUTLIER -50.3 -56.25 12.03 Favored 'General case' 0 CA--C 1.544 0.714 0 N-CA-C 108.595 -0.891 . . . . 1.0 108.595 -179.713 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 65' ' ' ASP . . . . . 0.697 ' C ' ' H ' ' A' ' 67' ' ' ARG . 21.0 t0 -69.8 -48.45 59.05 Favored 'General case' 0 C--N 1.318 -0.762 0 CA-C-O 121.813 0.816 . . . . 1.0 110.011 178.386 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 66' ' ' GLY . . . . . 0.566 ' N ' ' O ' ' A' ' 62' ' ' VAL . . . -68.74 27.2 0.29 Allowed Glycine 0 CA--C 1.516 0.153 0 N-CA-C 109.68 -1.368 . . . . 1.0 109.68 177.468 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 67' ' ' ARG . . . . . 0.748 ' HB3' ' HB3' ' A' ' 71' ' ' ALA . 29.0 mmt-85 -70.83 -0.74 9.71 Favored 'General case' 0 N--CA 1.438 -1.06 0 N-CA-C 106.486 -1.672 . . . . 1.0 106.486 174.771 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 68' ' ' LEU . . . . . 0.477 ' H ' ' C ' ' A' ' 66' ' ' GLY . 4.8 tt -32.95 -29.86 0.01 OUTLIER 'General case' 0 C--N 1.354 0.786 0 O-C-N 123.757 0.661 . . . . 1.0 109.327 -175.221 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 69' ' ' LEU . . . . . 0.617 ' N ' ' O ' ' A' ' 67' ' ' ARG . 4.3 tp -68.4 -66.94 0.51 Allowed 'General case' 0 CA--C 1.548 0.876 0 CA-C-N 114.554 -1.203 . . . . 1.0 111.224 179.748 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 70' ' ' ALA . . . . . 0.648 ' C ' ' H ' ' A' ' 72' ' ' HIS . . . -80.29 -78.56 0.17 Allowed 'General case' 0 N--CA 1.478 0.938 0 C-N-CA 118.145 -1.422 . . . . 1.0 108.862 179.814 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 71' ' ' ALA . . . . . 0.787 ' HB1' ' HB ' ' A' ' 74' ' ' VAL . . . -52.14 7.98 0.0 OUTLIER 'General case' 0 C--N 1.324 -0.522 0 C-N-CA 123.985 0.914 . . . . 1.0 112.468 -179.808 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 72' ' ' HIS . . . . . 0.648 ' H ' ' C ' ' A' ' 70' ' ' ALA . 6.2 p-80 -24.93 -51.91 0.03 OUTLIER 'General case' 0 N--CA 1.469 0.481 0 N-CA-C 113.034 0.753 . . . . 1.0 113.034 -178.907 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 73' ' ' MET . . . . . 0.615 ' N ' ' CG ' ' A' ' 72' ' ' HIS . 2.2 tpp -73.53 -49.32 27.09 Favored 'General case' 0 C--N 1.322 -0.606 0 C-N-CA 119.309 -0.956 . . . . 1.0 108.901 178.936 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 74' ' ' VAL . . . . . 0.787 ' HB ' ' HB1' ' A' ' 71' ' ' ALA . 61.8 t -43.46 -42.53 1.49 Allowed 'Isoleucine or valine' 0 CA--C 1.517 -0.3 0 CA-C-O 118.43 -0.795 . . . . 1.0 111.804 -175.706 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 75' ' ' ASN . . . . . 0.639 ' O ' HG12 ' A' ' 78' ' ' VAL . 0.4 OUTLIER -39.37 -13.86 0.01 OUTLIER 'General case' 0 N--CA 1.478 0.926 0 CA-C-N 120.01 1.277 . . . . 1.0 111.68 178.582 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 76' ' ' GLY . . . . . 0.667 ' N ' ' O ' ' A' ' 74' ' ' VAL . . . -43.31 -23.98 0.31 Allowed Glycine 0 CA--C 1.546 1.979 0 N-CA-C 108.068 -2.013 . . . . 1.0 108.068 178.412 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 77' ' ' ILE . . . . . 0.619 ' HA ' ' HB3' ' A' ' 80' ' ' ALA . 9.8 pt -69.75 -48.81 62.62 Favored 'Isoleucine or valine' 0 C--O 1.214 -0.799 0 N-CA-C 107.385 -1.339 . . . . 1.0 107.385 177.274 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 78' ' ' VAL . . . . . 0.639 HG12 ' O ' ' A' ' 75' ' ' ASN . 3.7 p -34.26 -36.68 0.06 OUTLIER 'Isoleucine or valine' 0 CA--C 1.542 0.643 0 N-CA-C 107.399 -1.334 . . . . 1.0 107.399 -177.076 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 79' ' ' ILE . . . . . 0.534 HG23 HG13 ' A' ' 78' ' ' VAL . 43.9 pt -97.65 -26.49 3.93 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.862 0 N-CA-C 111.924 0.342 . . . . 1.0 111.924 178.077 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 80' ' ' ALA . . . . . 0.619 ' HB3' ' HA ' ' A' ' 77' ' ' ILE . . . -86.6 -10.72 53.29 Favored 'General case' 0 N--CA 1.48 1.039 0 N-CA-C 113.475 0.917 . . . . 1.0 113.475 178.681 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 81' ' ' GLU . . . . . 0.489 ' N ' ' O ' ' A' ' 77' ' ' ILE . 2.6 mt-10 -78.56 -68.96 0.6 Allowed 'General case' 0 N--CA 1.436 -1.126 0 N-CA-C 107.405 -1.331 . . . . 1.0 107.405 178.041 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 82' ' ' ASP . . . . . 0.9 ' O ' ' N ' ' A' ' 84' ' ' LEU . 0.5 OUTLIER -59.58 -60.87 3.16 Favored 'General case' 0 N--CA 1.437 -1.101 0 N-CA-C 107.928 -1.138 . . . . 1.0 107.928 178.705 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 83' ' ' ALA . . . . . 0.638 ' HA ' ' HB3' ' A' ' 86' ' ' ALA . . . 31.8 -64.52 0.0 OUTLIER 'General case' 0 N--CA 1.478 0.946 0 O-C-N 124.501 1.126 . . . . 1.0 111.812 179.32 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 84' ' ' LEU . . . . . 0.9 ' N ' ' O ' ' A' ' 82' ' ' ASP . 19.9 mt -33.78 -37.48 0.04 OUTLIER 'General case' 0 N--CA 1.475 0.788 0 N-CA-C 112.8 0.667 . . . . 1.0 112.8 -177.68 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 85' ' ' ILE . . . . . 1.019 HD13 ' N ' ' A' ' 86' ' ' ALA . 0.0 OUTLIER -100.43 -34.44 4.09 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.473 0 N-CA-C 108.584 -0.895 . . . . 1.0 108.584 177.857 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 86' ' ' ALA . . . . . 1.019 ' N ' HD13 ' A' ' 85' ' ' ILE . . . -62.78 -61.25 2.54 Favored 'General case' 0 CA--C 1.539 0.55 0 CA-C-N 115.104 -0.953 . . . . 1.0 109.849 -179.413 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -64.66 16.35 0.02 OUTLIER 'General case' 0 CA--C 1.537 0.457 0 O-C-N 121.836 -0.54 . . . . 1.0 110.84 -179.206 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 88' ' ' ALA . . . . . 0.58 ' H ' ' C ' ' A' ' 86' ' ' ALA . . . -115.97 -14.94 11.23 Favored 'General case' 0 N--CA 1.466 0.353 0 N-CA-C 108.626 -0.879 . . . . 1.0 108.626 178.116 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 21.5 m -109.79 31.54 1.11 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.238 0 CA-C-N 115.11 -0.95 . . . . 1.0 109.775 177.734 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 90' ' ' GLY . . . . . 0.55 ' N ' ' CD ' ' A' ' 91' ' ' PRO . . . -69.29 -39.76 81.5 Favored Glycine 0 CA--C 1.529 0.907 0 N-CA-C 111.059 -0.817 . . . . 1.0 111.059 178.216 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 91' ' ' PRO . . . . . 0.55 ' CD ' ' N ' ' A' ' 90' ' ' GLY . 81.0 Cg_exo -48.24 -8.53 0.06 OUTLIER 'Trans proline' 0 N--CA 1.493 1.466 0 C-N-CA 121.836 1.691 . . . . 1.0 111.048 179.266 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 92' ' ' HIS . . . . . 0.549 ' H ' ' C ' ' A' ' 90' ' ' GLY . 28.9 t60 -58.05 -14.37 6.49 Favored 'General case' 0 C--O 1.214 -0.804 0 N-CA-C 108.245 -1.02 . . . . 1.0 108.245 179.893 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 93' ' ' LEU . . . . . 0.58 HD12 ' N ' ' A' ' 94' ' ' ALA . 1.2 pp -63.44 -55.97 19.92 Favored 'General case' 0 CA--C 1.531 0.24 0 N-CA-C 108.128 -1.064 . . . . 1.0 108.128 177.464 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 94' ' ' ALA . . . . . 0.58 ' N ' HD12 ' A' ' 93' ' ' LEU . . . -56.45 -50.57 71.32 Favored 'General case' 0 CA--C 1.515 -0.376 0 N-CA-C 108.804 -0.813 . . . . 1.0 108.804 178.861 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 95' ' ' ARG . . . . . 0.611 ' O ' ' N ' ' A' ' 97' ' ' LEU . 7.8 ttt180 -59.65 -59.61 5.17 Favored 'General case' 0 CA--C 1.507 -0.68 0 N-CA-C 106.994 -1.484 . . . . 1.0 106.994 178.472 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 96' ' ' ALA . . . . . 0.924 ' O ' ' N ' ' A' ' 98' ' ' GLY . . . -47.21 -14.2 0.03 OUTLIER 'General case' 0 N--CA 1.418 -2.035 0 O-C-N 119.026 -2.296 . . . . 1.0 111.23 -179.976 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 97' ' ' LEU . . . . . 0.693 ' O ' ' N ' ' A' ' 100' ' ' ILE . 16.4 tp 7.1 -51.94 0.0 OUTLIER 'General case' 0 N--CA 1.487 1.394 0 CA-C-O 118.133 -0.937 . . . . 1.0 110.407 -168.103 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 98' ' ' GLY . . . . . 0.924 ' N ' ' O ' ' A' ' 96' ' ' ALA . . . -50.74 -23.55 6.95 Favored Glycine 0 CA--C 1.548 2.122 0 CA-C-N 122.221 2.282 . . . . 1.0 107.618 173.753 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 99' ' ' GLN . . . . . 0.577 ' N ' ' O ' ' A' ' 96' ' ' ALA . 1.4 tp-100 -67.02 -20.48 65.87 Favored 'General case' 0 C--N 1.377 1.788 0 N-CA-C 106.665 -1.605 . . . . 1.0 106.665 176.805 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 100' ' ' ILE . . . . . 0.693 ' N ' ' O ' ' A' ' 97' ' ' LEU . 2.7 tp -63.57 -39.59 85.93 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.867 0 N-CA-C 107.245 -1.391 . . . . 1.0 107.245 177.664 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 101' ' ' VAL . . . . . 0.662 ' O ' ' N ' ' A' ' 105' ' ' GLY . 97.6 t -59.26 -61.71 1.33 Allowed 'Isoleucine or valine' 0 C--O 1.215 -0.731 0 N-CA-C 108.894 -0.78 . . . . 1.0 108.894 178.954 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 102' ' ' CYS . . . . . 0.818 ' O ' ' HB2' ' A' ' 106' ' ' ALA . 3.5 t -45.46 -26.99 0.64 Allowed 'General case' 0 C--N 1.315 -0.928 0 N-CA-C 112.368 0.507 . . . . 1.0 112.368 -179.089 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 53.8 ttt-85 -86.78 -47.39 9.12 Favored 'General case' 0 N--CA 1.494 1.752 0 CA-C-O 122.632 1.206 . . . . 1.0 112.891 179.639 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 104' ' ' TYR . . . . . 0.668 ' O ' ' CG ' ' A' ' 104' ' ' TYR . 0.0 OUTLIER -98.62 24.19 7.77 Favored 'General case' 0 C--N 1.299 -1.596 0 CA-C-N 112.203 -2.271 . . . . 1.0 107.88 178.09 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 105' ' ' GLY . . . . . 0.662 ' N ' ' O ' ' A' ' 101' ' ' VAL . . . -162.62 -94.82 0.1 Allowed Glycine 0 CA--C 1.533 1.206 0 N-CA-C 106.589 -2.604 . . . . 1.0 106.589 177.987 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 106' ' ' ALA . . . . . 0.818 ' HB2' ' O ' ' A' ' 102' ' ' CYS . . . 70.69 63.18 0.19 Allowed 'General case' 0 CA--C 1.543 0.679 0 N-CA-C 114.021 1.119 . . . . 1.0 114.021 -179.362 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 107' ' ' THR . . . . . 0.719 ' O ' ' HD2' ' A' ' 110' ' ' PRO . 97.9 m -79.96 -57.76 3.49 Favored 'General case' 0 C--O 1.212 -0.881 0 O-C-N 120.349 -1.469 . . . . 1.0 109.435 177.845 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 108' ' ' VAL . . . . . 0.659 ' O ' HG12 ' A' ' 108' ' ' VAL . 21.4 t -80.22 25.04 0.08 OUTLIER 'Isoleucine or valine' 0 CA--C 1.538 0.486 0 O-C-N 121.254 -0.903 . . . . 1.0 113.079 -175.997 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 109' ' ' ILE . . . . . 0.541 ' H ' ' HD3' ' A' ' 110' ' ' PRO . 0.5 OUTLIER -109.38 -38.25 0.13 Allowed Pre-proline 0 CA--C 1.561 1.381 0 CA-C-N 118.909 0.777 . . . . 1.0 110.71 176.683 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 110' ' ' PRO . . . . . 0.719 ' HD2' ' O ' ' A' ' 107' ' ' THR . 23.0 Cg_exo -67.88 -23.15 41.53 Favored 'Trans proline' 0 N--CA 1.507 2.296 0 C-N-CA 123.642 2.894 . . . . 1.0 110.794 178.291 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 21.3 t-20 -69.17 -67.84 0.45 Allowed 'General case' 0 C--O 1.237 0.423 0 N-CA-C 109.169 -0.678 . . . . 1.0 109.169 -179.624 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 112' ' ' ILE . . . . . 0.674 HD12 ' HA2' ' A' ' 35' ' ' GLY . 0.5 OUTLIER -49.03 -30.39 3.55 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.596 0 CA-C-O 121.911 0.863 . . . . 1.0 108.701 177.861 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 113' ' ' ASN . . . . . 0.468 ' HB3' ' O ' ' A' ' 110' ' ' PRO . 20.4 t30 -55.25 -55.56 30.0 Favored 'General case' 0 C--N 1.309 -1.153 0 CA-C-N 113.833 -1.53 . . . . 1.0 108.31 -178.111 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -56.75 -31.78 64.92 Favored 'General case' 0 CA--C 1.537 0.458 0 N-CA-C 113.116 0.784 . . . . 1.0 113.116 -179.469 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -81.04 -50.4 9.72 Favored 'General case' 0 N--CA 1.472 0.664 0 CA-C-O 121.988 0.899 . . . . 1.0 110.951 178.237 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 116' ' ' ILE . . . . . 0.541 HG22 ' N ' ' A' ' 117' ' ' GLU . 0.4 OUTLIER -49.07 -57.84 1.52 Allowed 'Isoleucine or valine' 0 C--N 1.314 -0.95 0 CA-C-N 113.969 -1.468 . . . . 1.0 107.562 -179.961 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 117' ' ' GLU . . . . . 0.541 ' N ' HG22 ' A' ' 116' ' ' ILE . 2.4 tt0 -37.89 -55.99 1.16 Allowed 'General case' 0 N--CA 1.475 0.808 0 CA-C-N 113.187 -1.824 . . . . 1.0 106.526 -178.711 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 84.6 t -58.58 -50.58 78.5 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.723 0 CA-C-N 113.314 -1.767 . . . . 1.0 108.386 178.818 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 119' ' ' LEU . . . . . 0.497 ' N ' ' O ' ' A' ' 116' ' ' ILE . 1.2 tp -57.38 -73.98 0.06 Allowed 'General case' 0 CA--C 1.547 0.861 0 C-N-CA 119.823 -0.751 . . . . 1.0 109.666 -178.239 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -77.62 -82.21 0.6 Allowed Glycine 0 CA--C 1.543 1.837 0 C-N-CA 118.55 -1.786 . . . . 1.0 113.209 -178.904 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 121' ' ' THR . . . . . 0.412 ' H ' ' H ' ' A' ' 122' ' ' GLY . 27.3 m -168.5 -22.92 0.02 OUTLIER 'General case' 0 C--N 1.303 -1.425 0 N-CA-C 105.2 -2.148 . . . . 1.0 105.2 -176.621 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 122' ' ' GLY . . . . . 0.412 ' H ' ' H ' ' A' ' 121' ' ' THR . . . 109.1 -33.61 6.04 Favored Glycine 0 N--CA 1.449 -0.472 0 CA-C-N 112.472 -2.149 . . . . 1.0 114.686 177.37 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 123' ' ' THR . . . . . 0.408 ' C ' ' O ' ' A' ' 122' ' ' GLY . 0.2 OUTLIER -41.75 106.89 0.07 Allowed 'General case' 0 CA--C 1.538 0.49 0 CA-C-N 120.351 2.075 . . . . 1.0 113.05 -177.515 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 28.8 m-20 -142.6 145.03 33.12 Favored 'General case' 0 N--CA 1.465 0.298 0 CA-C-N 114.276 -1.329 . . . . 1.0 108.768 178.082 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 125' ' ' TYR . . . . . 0.421 ' CD1' ' C ' ' A' ' 125' ' ' TYR . 0.0 OUTLIER -151.5 146.64 26.05 Favored 'General case' 0 CA--C 1.546 0.801 0 N-CA-C 109.061 -0.718 . . . . 1.0 109.061 179.191 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 11.9 mmp_? -146.92 151.68 37.43 Favored 'General case' 0 N--CA 1.472 0.645 0 CA-C-N 115.112 -0.949 . . . . 1.0 109.341 177.534 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 127' ' ' PHE . . . . . . . . . . . . . 7.9 p90 . . . . . 0 C--O 1.219 -0.539 0 CA-C-O 118.173 -0.918 . . . . 1.0 110.533 178.726 . . . . . . . . 0 0 . 1 . 023 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.494 1.73 0 CA-C-O 121.226 0.536 . . . . 1.0 109.963 . . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 2' ' ' SER . . . . . 0.49 ' O ' ' CB ' ' A' ' 3' ' ' ASP . 6.7 m -83.92 9.14 12.93 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.448 -0.796 . . . . 1.0 110.892 179.825 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 3' ' ' ASP . . . . . 0.49 ' CB ' ' O ' ' A' ' 2' ' ' SER . 1.4 m-20 150.35 126.96 0.0 OUTLIER 'General case' 0 N--CA 1.478 0.956 0 O-C-N 124.088 0.867 . . . . 1.0 111.208 178.713 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 27.4 t80 -157.26 152.58 26.27 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.829 -0.623 . . . . 1.0 110.506 178.428 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 8.4 p30 -151.75 147.5 26.75 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.726 -0.67 . . . . 1.0 109.201 179.806 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 6' ' ' THR . . . . . 0.504 ' O ' ' N ' ' A' ' 10' ' ' SER . 0.2 OUTLIER -71.5 171.29 11.62 Favored 'General case' 0 C--O 1.211 -0.968 0 C-N-CA 120.917 -0.313 . . . . 1.0 110.179 -179.325 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' A' A ' 7' ' ' GLU . . . . . 0.529 ' O ' ' HG2' ' A' ' 11' ' ' ARG . 90.7 mt-10 -53.83 -69.58 0.12 Allowed 'General case' 0 C--N 1.31 -1.137 0 C-N-CA 120.645 -0.422 . . . . 1.0 110.2 -176.697 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 8' ' ' ARG . . . . . 0.493 ' O ' ' CB ' ' A' ' 12' ' ' ALA . 0.0 OUTLIER -42.22 -51.18 4.8 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-N 115.397 -0.819 . . . . 1.0 109.298 -176.299 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -66.83 -50.1 68.25 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.462 0 CA-C-N 115.151 -0.931 . . . . 1.0 111.055 177.657 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 10' ' ' SER . . . . . 0.504 ' N ' ' O ' ' A' ' 6' ' ' THR . 28.2 t -56.79 -40.24 75.54 Favored 'General case' 0 C--N 1.323 -0.564 0 N-CA-C 113.467 0.914 . . . . 1.0 113.467 -178.566 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 11' ' ' ARG . . . . . 0.677 ' O ' ' N ' ' A' ' 15' ' ' ALA . 2.3 ptp180 -85.76 -54.28 4.62 Favored 'General case' 0 C--O 1.213 -0.849 0 CA-C-O 121.743 0.783 . . . . 1.0 110.313 175.334 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 12' ' ' ALA . . . . . 0.678 ' O ' ' HB3' ' A' ' 16' ' ' ALA . . . -47.9 -52.83 17.85 Favored 'General case' 0 CA--C 1.496 -1.104 0 N-CA-C 106.896 -1.52 . . . . 1.0 106.896 -175.343 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 13' ' ' VAL . . . . . 0.626 ' O ' ' CB ' ' A' ' 17' ' ' LEU . 93.1 t -61.68 -54.86 29.09 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.466 0 C-N-CA 117.01 -1.876 . . . . 1.0 108.76 178.085 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 14' ' ' ALA . . . . . 0.828 ' O ' HG22 ' A' ' 18' ' ' VAL . . . -58.03 -64.64 0.84 Allowed 'General case' 0 C--O 1.207 -1.136 0 C-N-CA 117.81 -1.556 . . . . 1.0 110.755 -179.127 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 15' ' ' ALA . . . . . 0.677 ' N ' ' O ' ' A' ' 11' ' ' ARG . . . -52.78 -56.08 18.28 Favored 'General case' 0 N--CA 1.473 0.683 0 CA-C-O 121.053 0.454 . . . . 1.0 110.924 -179.23 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 16' ' ' ALA . . . . . 0.678 ' HB3' ' O ' ' A' ' 12' ' ' ALA . . . -63.96 -56.19 16.95 Favored 'General case' 0 C--N 1.312 -1.035 0 C-N-CA 119.172 -1.011 . . . . 1.0 109.199 -179.219 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 17' ' ' LEU . . . . . 0.626 ' CB ' ' O ' ' A' ' 13' ' ' VAL . 28.5 tp -55.85 -53.68 53.76 Favored 'General case' 0 N--CA 1.484 1.258 0 CA-C-N 114.95 -1.023 . . . . 1.0 108.705 -177.326 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 18' ' ' VAL . . . . . 0.828 HG22 ' O ' ' A' ' 14' ' ' ALA . 2.6 m -68.83 -58.2 6.49 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.365 0 N-CA-C 109.22 -0.659 . . . . 1.0 109.22 179.603 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 19' ' ' GLY . . . . . 0.575 ' N ' ' O ' ' A' ' 15' ' ' ALA . . . -58.83 -165.04 0.1 Allowed Glycine 0 N--CA 1.442 -0.915 0 N-CA-C 110.607 -0.997 . . . . 1.0 110.607 -178.844 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 20' ' ' PRO . . . . . 0.579 ' O ' ' N ' ' A' ' 24' ' ' ALA . 65.4 Cg_endo -82.86 -31.4 0.74 Allowed 'Trans proline' 0 C--N 1.296 -2.235 0 C-N-CA 122.632 2.222 . . . . 1.0 113.847 -177.788 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -61.56 -59.6 9.56 Favored Glycine 0 CA--C 1.539 1.573 0 C-N-CA 119.881 -1.152 . . . . 1.0 112.987 -176.683 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 22' ' ' GLY . . . . . 0.55 ' H ' ' CA ' ' A' ' 16' ' ' ALA . . . -56.36 -53.63 41.72 Favored Glycine 0 N--CA 1.47 0.939 0 N-CA-C 107.304 -2.318 . . . . 1.0 107.304 -176.564 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 23' ' ' VAL . . . . . 0.476 ' O ' HG12 ' A' ' 27' ' ' VAL . 1.1 p -62.64 -30.63 49.73 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.184 0 C-N-CA 119.211 -0.995 . . . . 1.0 109.394 179.116 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 24' ' ' ALA . . . . . 0.579 ' N ' ' O ' ' A' ' 20' ' ' PRO . . . -56.63 -63.75 1.1 Allowed 'General case' 0 C--N 1.357 0.906 0 C-N-CA 118.86 -1.136 . . . . 1.0 110.867 -178.376 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 10.4 mt -63.93 -42.84 97.25 Favored 'General case' 0 CA--C 1.517 -0.303 0 C-N-CA 120.404 -0.518 . . . . 1.0 111.54 -177.92 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 26' ' ' VAL . . . . . 0.4 HG23 ' O ' ' A' ' 22' ' ' GLY . 78.8 t -58.41 -59.98 2.88 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.519 0 C-N-CA 119.25 -0.98 . . . . 1.0 110.211 -178.13 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 27' ' ' VAL . . . . . 0.634 ' O ' ' HB3' ' A' ' 31' ' ' ALA . 1.9 p -63.42 -36.52 76.53 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 C-N-CA 120.643 -0.423 . . . . 1.0 111.627 -178.433 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 59.2 tttm -66.26 -57.2 8.05 Favored 'General case' 0 C--N 1.318 -0.774 0 C-N-CA 119.749 -0.78 . . . . 1.0 109.28 -178.742 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 96.2 t -64.51 -47.23 90.07 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.127 0 CA-C-N 114.716 -1.129 . . . . 1.0 110.046 -178.345 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 30' ' ' CYS . . . . . . . . . . . . . 54.1 t -66.81 -61.92 1.71 Allowed 'General case' 0 N--CA 1.448 -0.548 0 C-N-CA 119.475 -0.89 . . . . 1.0 110.613 -179.71 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 31' ' ' ALA . . . . . 0.634 ' HB3' ' O ' ' A' ' 27' ' ' VAL . . . -62.08 -46.02 90.93 Favored 'General case' 0 CA--C 1.506 -0.733 0 CA-C-O 121.061 0.458 . . . . 1.0 111.18 -176.45 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 32' ' ' GLY . . . . . 0.546 ' O ' ' HB2' ' A' ' 33' ' ' LEU . . . 77.77 69.13 1.43 Allowed Glycine 0 N--CA 1.444 -0.813 0 N-CA-C 110.122 -1.191 . . . . 1.0 110.122 -179.357 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 33' ' ' LEU . . . . . 0.546 ' HB2' ' O ' ' A' ' 32' ' ' GLY . 3.8 mp 84.61 86.99 0.05 OUTLIER Pre-proline 0 N--CA 1.477 0.907 0 O-C-N 124.769 0.923 . . . . 1.0 111.617 -179.21 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 29.4 Cg_endo -64.2 -15.88 51.94 Favored 'Trans proline' 0 N--CA 1.497 1.716 0 C-N-CA 121.525 1.484 . . . . 1.0 111.824 178.519 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -55.95 -59.63 10.3 Favored Glycine 0 CA--C 1.522 0.524 0 C-N-CA 119.02 -1.562 . . . . 1.0 109.435 -179.092 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 36' ' ' VAL . . . . . 0.588 ' O ' HG22 ' A' ' 37' ' ' ILE . 1.3 p -97.81 172.87 1.04 Allowed 'Isoleucine or valine' 0 CA--C 1.51 -0.587 0 N-CA-C 105.215 -2.143 . . . . 1.0 105.215 177.131 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 37' ' ' ILE . . . . . 0.588 HG22 ' O ' ' A' ' 36' ' ' VAL . 6.8 tp 113.07 120.02 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.477 0.907 0 O-C-N 124.689 1.243 . . . . 1.0 110.38 179.411 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 59.5 m80 -141.12 131.42 25.04 Favored 'General case' 0 C--N 1.328 -0.337 0 N-CA-C 108.484 -0.932 . . . . 1.0 108.484 179.395 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -94.64 132.75 27.99 Favored Pre-proline 0 CA--C 1.543 0.679 0 C-N-CA 121.047 -0.261 . . . . 1.0 110.775 -178.849 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 44.8 Cg_exo -54.36 -42.86 63.94 Favored 'Trans proline' 0 N--CA 1.495 1.567 0 C-N-CA 121.902 1.735 . . . . 1.0 113.726 179.363 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -126.38 132.79 51.47 Favored 'General case' 0 N--CA 1.468 0.44 0 CA-C-N 116.602 -0.272 . . . . 1.0 110.861 179.805 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 42' ' ' ARG . . . . . 0.663 ' C ' ' H ' ' A' ' 44' ' ' GLY . 17.6 ptm180 -166.32 163.73 17.56 Favored 'General case' 0 C--N 1.323 -0.548 0 C-N-CA 120.115 -0.634 . . . . 1.0 109.931 178.1 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 43' ' ' ARG . . . . . 0.529 ' C ' ' H ' ' A' ' 45' ' ' PHE . 0.1 OUTLIER -62.76 24.47 0.01 OUTLIER 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 115.872 -0.604 . . . . 1.0 110.348 -179.973 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' A' A ' 44' ' ' GLY . . . . . 0.663 ' H ' ' C ' ' A' ' 42' ' ' ARG . . . 70.32 -28.56 0.45 Allowed Glycine 0 C--N 1.339 0.723 0 N-CA-C 111.376 -0.69 . . . . 1.0 111.376 179.982 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 45' ' ' PHE . . . . . 0.552 ' CG ' ' N ' ' A' ' 46' ' ' PHE . 27.6 t80 -159.62 161.76 35.1 Favored 'General case' 0 C--N 1.32 -0.681 0 N-CA-C 109.084 -0.71 . . . . 1.0 109.084 179.199 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 46' ' ' PHE . . . . . 0.793 ' O ' ' HB2' ' A' ' 47' ' ' ARG . 2.3 m-30 132.65 91.43 0.0 OUTLIER 'General case' 0 N--CA 1.474 0.756 0 O-C-N 125.367 1.667 . . . . 1.0 107.109 -179.476 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 47' ' ' ARG . . . . . 0.793 ' HB2' ' O ' ' A' ' 46' ' ' PHE . 0.0 OUTLIER 125.96 139.71 0.0 OUTLIER 'General case' 0 N--CA 1.48 1.05 0 C-N-CA 124.52 1.128 . . . . 1.0 109.402 179.574 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' A' A ' 48' ' ' CYS . . . . . 0.535 ' SG ' ' C ' ' A' ' 47' ' ' ARG . 0.0 OUTLIER 71.01 73.41 0.19 Allowed 'General case' 0 C--O 1.218 -0.584 0 N-CA-C 108.759 -0.83 . . . . 1.0 108.759 -178.759 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' A' A ' 49' ' ' ASN . . . . . 0.639 ' O ' ' N ' ' A' ' 51' ' ' GLU . 0.0 OUTLIER -132.51 130.13 21.68 Favored Pre-proline 0 CA--C 1.537 0.458 0 N-CA-C 108.629 -0.878 . . . . 1.0 108.629 -179.426 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_exo -53.22 58.04 0.02 OUTLIER 'Trans proline' 0 N--CA 1.507 2.274 0 C-N-CA 122.593 2.195 . . . . 1.0 113.696 178.656 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 51' ' ' GLU . . . . . 0.639 ' N ' ' O ' ' A' ' 49' ' ' ASN . 6.0 mp0 67.27 3.44 3.24 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.525 -0.307 . . . . 1.0 111.002 -179.974 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 28.8 mtt-85 -80.25 152.87 28.85 Favored 'General case' 0 CA--C 1.531 0.22 0 N-CA-C 109.751 -0.462 . . . . 1.0 109.751 179.776 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 53' ' ' ILE . . . . . 0.465 ' O ' ' N ' ' A' ' 55' ' ' ILE . 3.6 tp -69.8 136.37 26.3 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-O 120.736 0.303 . . . . 1.0 111.209 -179.469 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 54' ' ' GLN . . . . . 0.61 ' H ' ' CD ' ' A' ' 54' ' ' GLN . 1.8 mp0 -60.07 82.82 0.01 OUTLIER 'General case' 0 CA--C 1.54 0.568 0 C-N-CA 120.195 -0.602 . . . . 1.0 110.279 -176.643 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 55' ' ' ILE . . . . . 0.465 ' N ' ' O ' ' A' ' 53' ' ' ILE . 20.3 tt -149.5 159.98 5.34 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.372 0 CA-C-N 116.145 -0.479 . . . . 1.0 110.89 178.138 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 112.55 -2.42 26.3 Favored Glycine 0 N--CA 1.47 0.942 0 N-CA-C 111.184 -0.767 . . . . 1.0 111.184 -179.814 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 3.6 p-10 -80.07 98.09 7.11 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-O 121.45 0.643 . . . . 1.0 111.239 178.988 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 58' ' ' TRP . . . . . . . . . . . . . 7.1 m95 -85.96 171.72 11.23 Favored 'General case' 0 C--N 1.319 -0.755 0 CA-C-O 123.212 1.482 . . . . 1.0 111.541 -179.464 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -84.24 -60.92 1.94 Allowed 'General case' 0 C--N 1.305 -1.342 0 CA-C-N 111.146 -2.752 . . . . 1.0 112.786 -176.825 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -91.04 -15.28 29.83 Favored 'General case' 0 C--N 1.312 -1.064 0 CA-C-N 114.839 -1.073 . . . . 1.0 112.539 -179.055 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 61' ' ' GLU . . . . . 0.424 ' O ' ' N ' ' A' ' 65' ' ' ASP . 4.0 tt0 -80.93 -14.75 57.7 Favored 'General case' 0 C--N 1.312 -1.032 0 O-C-N 121.901 -0.499 . . . . 1.0 110.244 -179.473 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 62' ' ' VAL . . . . . 0.635 HG23 ' N ' ' A' ' 63' ' ' ALA . 29.0 m -47.16 -54.38 2.72 Favored 'Isoleucine or valine' 0 C--O 1.209 -1.057 0 C-N-CA 119.754 -0.778 . . . . 1.0 109.767 -176.851 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 63' ' ' ALA . . . . . 0.635 ' N ' HG23 ' A' ' 62' ' ' VAL . . . -66.62 -52.61 43.28 Favored 'General case' 0 C--N 1.306 -1.283 0 N-CA-C 109.559 -0.534 . . . . 1.0 109.559 -179.81 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 64' ' ' HIS . . . . . 0.443 ' O ' ' CG ' ' A' ' 67' ' ' ARG . 9.7 t60 -50.59 -58.8 4.98 Favored 'General case' 0 CA--C 1.542 0.66 0 CA-C-O 122.175 0.988 . . . . 1.0 109.933 -179.168 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 65' ' ' ASP . . . . . 0.606 ' C ' ' H ' ' A' ' 67' ' ' ARG . 58.9 t0 -67.83 -50.31 57.39 Favored 'General case' 0 C--N 1.31 -1.129 0 CA-C-O 122.492 1.139 . . . . 1.0 109.455 177.947 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 66' ' ' GLY . . . . . 0.658 ' O ' HD12 ' A' ' 68' ' ' LEU . . . -68.23 30.84 0.26 Allowed Glycine 0 C--O 1.224 -0.497 0 O-C-N 121.069 -1.02 . . . . 1.0 111.795 178.487 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 67' ' ' ARG . . . . . 0.709 ' CB ' ' HB3' ' A' ' 71' ' ' ALA . 4.7 mmm180 -74.22 5.47 4.43 Favored 'General case' 0 C--N 1.306 -1.323 0 N-CA-C 108.72 -0.845 . . . . 1.0 108.72 176.279 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 68' ' ' LEU . . . . . 0.658 HD12 ' O ' ' A' ' 66' ' ' GLY . 0.0 OUTLIER -34.22 -29.28 0.01 OUTLIER 'General case' 0 N--CA 1.481 1.09 0 N-CA-C 108.298 -1.001 . . . . 1.0 108.298 -176.671 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' A' A ' 69' ' ' LEU . . . . . 0.607 ' N ' ' O ' ' A' ' 67' ' ' ARG . 0.5 OUTLIER -68.36 -68.4 0.39 Allowed 'General case' 0 CA--C 1.546 0.817 0 C-N-CA 119.336 -0.946 . . . . 1.0 110.357 179.633 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' A' A ' 70' ' ' ALA . . . . . 0.69 ' C ' ' H ' ' A' ' 72' ' ' HIS . . . -78.29 -77.09 0.17 Allowed 'General case' 0 CA--C 1.51 -0.575 0 N-CA-C 108.344 -0.984 . . . . 1.0 108.344 179.925 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 71' ' ' ALA . . . . . 0.806 ' HB1' ' HB ' ' A' ' 74' ' ' VAL . . . -51.86 10.3 0.0 OUTLIER 'General case' 0 CA--C 1.537 0.458 0 C-N-CA 125.007 1.323 . . . . 1.0 111.953 178.188 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 72' ' ' HIS . . . . . 0.71 ' CG ' ' H ' ' A' ' 73' ' ' MET . 0.4 OUTLIER -21.37 -61.78 0.03 OUTLIER 'General case' 0 CA--C 1.519 -0.244 0 N-CA-C 113.9 1.074 . . . . 1.0 113.9 -178.957 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' A' A ' 73' ' ' MET . . . . . 0.71 ' H ' ' CG ' ' A' ' 72' ' ' HIS . 5.3 ptm -71.14 -45.6 63.23 Favored 'General case' 0 C--N 1.313 -0.978 0 N-CA-C 108.954 -0.758 . . . . 1.0 108.954 179.114 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 74' ' ' VAL . . . . . 0.806 ' HB ' ' HB1' ' A' ' 71' ' ' ALA . 79.7 t -40.88 -40.77 0.59 Allowed 'Isoleucine or valine' 0 CA--C 1.507 -0.697 0 CA-C-O 117.854 -1.07 . . . . 1.0 109.916 -175.937 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 75' ' ' ASN . . . . . 0.418 ' C ' ' N ' ' A' ' 77' ' ' ILE . 1.7 t-20 -33.59 -15.52 0.0 OUTLIER 'General case' 0 N--CA 1.482 1.136 0 CA-C-O 122.259 1.028 . . . . 1.0 110.891 178.305 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 76' ' ' GLY . . . . . 0.795 ' N ' ' O ' ' A' ' 74' ' ' VAL . . . -49.71 -22.04 3.87 Favored Glycine 0 N--CA 1.435 -1.414 0 N-CA-C 107.227 -2.349 . . . . 1.0 107.227 173.901 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 77' ' ' ILE . . . . . 0.418 ' N ' ' C ' ' A' ' 75' ' ' ASN . 85.2 mt -59.49 -52.84 56.24 Favored 'Isoleucine or valine' 0 C--N 1.351 0.658 0 CA-C-O 118.259 -0.876 . . . . 1.0 111.986 -179.927 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 33.0 t -51.04 -21.86 1.48 Allowed 'Isoleucine or valine' 0 C--N 1.351 0.659 0 CA-C-N 121.279 1.854 . . . . 1.0 112.477 -179.445 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 79' ' ' ILE . . . . . 0.72 ' O ' ' HB2' ' A' ' 83' ' ' ALA . 0.1 OUTLIER -94.88 -40.57 11.35 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.576 0 CA-C-N 116.102 -0.499 . . . . 1.0 109.888 179.713 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -77.32 -19.16 56.78 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.647 -0.706 . . . . 1.0 111.41 -179.232 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 22.5 tt0 -87.19 -67.6 0.81 Allowed 'General case' 0 N--CA 1.438 -1.047 0 N-CA-C 109.616 -0.513 . . . . 1.0 109.616 178.961 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 82' ' ' ASP . . . . . 0.817 ' O ' ' N ' ' A' ' 84' ' ' LEU . 15.6 m-20 -60.46 -61.18 2.78 Favored 'General case' 0 C--N 1.352 0.682 0 C-N-CA 118.91 -1.116 . . . . 1.0 109.267 -179.391 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 83' ' ' ALA . . . . . 0.72 ' HB2' ' O ' ' A' ' 79' ' ' ILE . . . 23.69 -67.29 0.0 OUTLIER 'General case' 0 N--CA 1.486 1.371 0 O-C-N 124.752 1.283 . . . . 1.0 112.063 179.868 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 84' ' ' LEU . . . . . 0.817 ' N ' ' O ' ' A' ' 82' ' ' ASP . 0.8 OUTLIER -33.21 -41.76 0.08 Allowed 'General case' 0 N--CA 1.476 0.843 0 C-N-CA 122.728 0.411 . . . . 1.0 111.934 -178.09 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' A' A ' 85' ' ' ILE . . . . . 0.523 ' O ' ' HB3' ' A' ' 88' ' ' ALA . 18.2 pt -95.2 -41.64 12.06 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.615 0 N-CA-C 109.146 -0.687 . . . . 1.0 109.146 178.675 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 86' ' ' ALA . . . . . 0.569 ' HB3' ' HA ' ' A' ' 83' ' ' ALA . . . -54.43 -57.87 9.64 Favored 'General case' 0 CA--C 1.54 0.585 0 CA-C-N 115.399 -0.818 . . . . 1.0 110.305 -179.448 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -71.16 10.58 0.55 Allowed 'General case' 0 CA--C 1.538 0.505 0 N-CA-C 111.838 0.31 . . . . 1.0 111.838 -179.023 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 88' ' ' ALA . . . . . 0.523 ' HB3' ' O ' ' A' ' 85' ' ' ILE . . . -99.28 -19.89 16.84 Favored 'General case' 0 N--CA 1.48 1.044 0 CA-C-O 122.738 1.256 . . . . 1.0 109.156 179.281 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 28.6 m -104.32 37.46 0.31 Allowed 'Isoleucine or valine' 0 C--N 1.313 -1.018 0 CA-C-N 111.832 -2.44 . . . . 1.0 110.004 178.259 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 90' ' ' GLY . . . . . 0.624 ' O ' ' N ' ' A' ' 92' ' ' HIS . . . -65.17 -41.02 97.16 Favored Glycine 0 CA--C 1.537 1.456 0 CA-C-O 118.853 -0.97 . . . . 1.0 111.671 177.144 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 91' ' ' PRO . . . . . 0.498 ' HD2' ' N ' ' A' ' 90' ' ' GLY . 88.3 Cg_exo -41.47 -11.71 0.03 OUTLIER 'Trans proline' 0 N--CA 1.5 1.879 0 C-N-CA 122.349 2.033 . . . . 1.0 112.008 178.923 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 92' ' ' HIS . . . . . 0.624 ' N ' ' O ' ' A' ' 90' ' ' GLY . 6.5 p-80 -55.08 -18.75 5.87 Favored 'General case' 0 C--O 1.194 -1.833 0 N-CA-C 108.615 -0.883 . . . . 1.0 108.615 -179.736 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 93' ' ' LEU . . . . . 0.568 HD12 ' N ' ' A' ' 94' ' ' ALA . 0.8 OUTLIER -62.53 -57.9 9.51 Favored 'General case' 0 C--N 1.317 -0.806 0 N-CA-C 108.763 -0.828 . . . . 1.0 108.763 179.225 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' A' A ' 94' ' ' ALA . . . . . 0.568 ' N ' HD12 ' A' ' 93' ' ' LEU . . . -58.27 -57.76 11.46 Favored 'General case' 0 N--CA 1.452 -0.369 0 CA-C-N 115.293 -0.867 . . . . 1.0 109.335 179.265 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 95' ' ' ARG . . . . . 0.588 ' O ' ' N ' ' A' ' 97' ' ' LEU . 37.4 mtp-105 -56.84 -59.67 4.69 Favored 'General case' 0 C--O 1.242 0.681 0 CA-C-O 123.098 1.428 . . . . 1.0 108.041 179.288 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 96' ' ' ALA . . . . . 0.84 ' O ' ' N ' ' A' ' 98' ' ' GLY . . . -47.32 -15.82 0.05 OUTLIER 'General case' 0 C--N 1.301 -1.502 0 O-C-N 118.572 -2.58 . . . . 1.0 111.042 -179.051 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 97' ' ' LEU . . . . . 0.641 ' O ' ' N ' ' A' ' 100' ' ' ILE 0.279 16.1 tp 6.17 -54.07 0.0 OUTLIER 'General case' 0 N--CA 1.477 0.906 0 CA-C-O 118.116 -0.945 . . . . 1.0 112.287 -168.266 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' A' A ' 98' ' ' GLY . . . . . 0.84 ' N ' ' O ' ' A' ' 96' ' ' ALA . . . -49.38 -24.44 5.24 Favored Glycine 0 C--N 1.295 -1.708 0 CA-C-N 122.303 2.32 . . . . 1.0 108.417 175.16 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 99' ' ' GLN . . . . . 0.509 ' N ' ' O ' ' A' ' 96' ' ' ALA . 40.9 mm-40 -71.39 -20.7 62.11 Favored 'General case' 0 C--N 1.371 1.538 0 C-N-CA 117.477 -1.689 . . . . 1.0 107.882 177.344 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 100' ' ' ILE . . . . . 0.641 ' N ' ' O ' ' A' ' 97' ' ' LEU . 0.3 OUTLIER -67.45 -40.66 84.96 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.499 0 N-CA-C 108.131 -1.063 . . . . 1.0 108.131 177.392 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' A' A ' 101' ' ' VAL . . . . . 0.678 ' O ' ' N ' ' A' ' 105' ' ' GLY . 0.4 OUTLIER -57.4 -58.35 6.41 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.605 0 N-CA-C 106.561 -1.644 . . . . 1.0 106.561 179.959 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' A' A ' 102' ' ' CYS . . . . . 0.969 ' O ' ' HB2' ' A' ' 106' ' ' ALA . 4.6 t -47.07 -21.87 0.28 Allowed 'General case' 0 C--O 1.209 -1.043 0 CA-C-N 115.666 -0.697 . . . . 1.0 110.649 -179.801 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 103' ' ' ARG . . . . . 0.402 ' N ' ' C ' ' A' ' 101' ' ' VAL . 2.1 tmm_? -88.57 -43.32 11.47 Favored 'General case' 0 N--CA 1.486 1.326 0 CA-C-O 122.689 1.233 . . . . 1.0 111.779 178.118 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 104' ' ' TYR . . . . . 0.779 ' O ' ' CG ' ' A' ' 104' ' ' TYR . 1.3 t80 -98.14 23.19 8.51 Favored 'General case' 0 C--N 1.31 -1.121 0 CA-C-N 112.373 -2.194 . . . . 1.0 108.572 177.238 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 105' ' ' GLY . . . . . 0.678 ' N ' ' O ' ' A' ' 101' ' ' VAL . . . -167.68 -92.19 0.08 OUTLIER Glycine 0 N--CA 1.446 -0.695 0 N-CA-C 107.104 -2.398 . . . . 1.0 107.104 177.756 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 106' ' ' ALA . . . . . 0.969 ' HB2' ' O ' ' A' ' 102' ' ' CYS . . . 67.36 63.18 0.44 Allowed 'General case' 0 N--CA 1.443 -0.793 0 N-CA-C 112.418 0.525 . . . . 1.0 112.418 179.83 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 107' ' ' THR . . . . . 0.475 ' O ' ' HD2' ' A' ' 110' ' ' PRO . 19.1 m -83.1 -65.05 1.06 Allowed 'General case' 0 CA--C 1.541 0.632 0 O-C-N 121.449 -0.782 . . . . 1.0 111.603 179.96 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 9.1 m -71.63 28.54 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.322 -0.616 0 O-C-N 121.078 -1.014 . . . . 1.0 111.644 -177.107 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 109' ' ' ILE . . . . . 0.756 ' H ' ' HD2' ' A' ' 110' ' ' PRO . 0.1 OUTLIER -112.48 -53.05 0.05 OUTLIER Pre-proline 0 CA--C 1.553 1.061 0 N-CA-C 108.167 -1.049 . . . . 1.0 108.167 176.117 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' A' A ' 110' ' ' PRO . . . . . 0.756 ' HD2' ' H ' ' A' ' 109' ' ' ILE . 19.1 Cg_endo -51.48 -29.78 32.8 Favored 'Trans proline' 0 N--CA 1.494 1.501 0 C-N-CA 122.563 2.176 . . . . 1.0 111.259 178.634 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 11.0 t-20 -63.01 -69.4 0.27 Allowed 'General case' 0 N--CA 1.466 0.356 0 C-N-CA 120.511 -0.476 . . . . 1.0 110.392 -179.339 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 112' ' ' ILE . . . . . 0.486 HG13 ' N ' ' A' ' 113' ' ' ASN . 26.6 pt -51.62 -31.13 12.27 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.457 0 CA-C-O 123.228 1.49 . . . . 1.0 109.717 179.502 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 113' ' ' ASN . . . . . 0.486 ' N ' HG13 ' A' ' 112' ' ' ILE . 0.0 OUTLIER -52.87 -52.58 56.85 Favored 'General case' 0 C--N 1.301 -1.511 0 CA-C-N 112.077 -2.329 . . . . 1.0 107.746 -177.858 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' A' A ' 114' ' ' ALA . . . . . 0.437 ' O ' HG23 ' A' ' 118' ' ' VAL . . . -60.09 -32.64 71.16 Favored 'General case' 0 N--CA 1.442 -0.848 0 N-CA-C 112.182 0.438 . . . . 1.0 112.182 179.625 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -81.27 -57.19 3.61 Favored 'General case' 0 C--O 1.215 -0.751 0 CA-C-O 121.499 0.666 . . . . 1.0 111.702 178.732 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 116' ' ' ILE . . . . . 0.529 ' O ' ' N ' ' A' ' 120' ' ' GLY . 3.4 mm -51.72 -57.86 2.94 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.715 0 CA-C-O 122.479 1.133 . . . . 1.0 108.043 -177.907 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 117' ' ' GLU . . . . . 0.537 ' O ' ' HA ' ' A' ' 121' ' ' THR . 6.5 mt-10 -40.15 -53.17 2.5 Favored 'General case' 0 C--N 1.315 -0.919 0 CA-C-N 112.285 -2.234 . . . . 1.0 105.927 -178.29 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 118' ' ' VAL . . . . . 0.437 HG23 ' O ' ' A' ' 114' ' ' ALA . 78.0 t -60.26 -52.04 65.91 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.608 0 C-N-CA 119.459 -0.896 . . . . 1.0 109.065 177.261 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 119' ' ' LEU . . . . . 0.488 ' N ' ' O ' ' A' ' 116' ' ' ILE . 0.9 OUTLIER -58.39 -70.31 0.15 Allowed 'General case' 0 N--CA 1.454 -0.253 0 C-N-CA 119.209 -0.997 . . . . 1.0 108.387 -177.656 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' A' A ' 120' ' ' GLY . . . . . 0.613 ' O ' ' OG1' ' A' ' 121' ' ' THR . . . -66.19 -84.99 0.08 OUTLIER Glycine 0 C--N 1.351 1.362 0 C-N-CA 118.127 -1.987 . . . . 1.0 109.159 178.41 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 121' ' ' THR . . . . . 0.613 ' OG1' ' O ' ' A' ' 120' ' ' GLY . 18.5 m 160.46 -34.55 0.0 OUTLIER 'General case' 0 N--CA 1.482 1.164 0 O-C-N 125.373 1.278 . . . . 1.0 112.858 179.421 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 122' ' ' GLY . . . . . 0.643 ' O ' ' N ' ' A' ' 124' ' ' ASP . . . 105.64 -14.19 46.31 Favored Glycine 0 N--CA 1.461 0.313 0 N-CA-C 107.285 -2.326 . . . . 1.0 107.285 -175.832 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 123' ' ' THR . . . . . 0.478 HG22 ' CD2' ' A' ' 72' ' ' HIS . 2.8 m -54.89 82.39 0.0 OUTLIER 'General case' 0 N--CA 1.465 0.311 0 N-CA-C 106.037 -1.838 . . . . 1.0 106.037 178.59 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 124' ' ' ASP . . . . . 0.643 ' N ' ' O ' ' A' ' 122' ' ' GLY . 18.2 t70 -164.29 170.34 16.33 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 114.057 -1.429 . . . . 1.0 112.117 -179.338 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 125' ' ' TYR . . . . . . . . . . . . . 33.5 t80 -151.32 149.01 28.85 Favored 'General case' 0 CA--C 1.535 0.391 0 CA-C-N 115.637 -0.71 . . . . 1.0 109.937 177.298 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 14.6 tpp180 -149.13 150.08 32.1 Favored 'General case' 0 CA--C 1.532 0.283 0 CA-C-N 115.792 -0.64 . . . . 1.0 110.169 177.785 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 127' ' ' PHE . . . . . 0.559 ' H ' HD12 ' A' ' 79' ' ' ILE . 20.4 t80 . . . . . 0 C--O 1.22 -0.469 0 CA-C-O 118.036 -0.983 . . . . 1.0 109.366 178.687 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 62.1 mtt . . . . . 0 N--CA 1.489 1.509 0 N-CA-C 108.961 -0.755 . . . . 1.0 108.961 . . . . . . . . . 0 0 . 1 . 024 nuclear build core ' A' A ' 2' ' ' SER . . . . . 0.458 ' O ' ' CB ' ' A' ' 3' ' ' ASP . 91.4 p -93.78 10.29 33.64 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.19 -0.459 . . . . 1.0 110.692 -179.793 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 3' ' ' ASP . . . . . 0.458 ' CB ' ' O ' ' A' ' 2' ' ' SER . 7.1 m-20 157.62 111.34 0.0 OUTLIER 'General case' 0 N--CA 1.471 0.618 0 O-C-N 123.82 0.7 . . . . 1.0 110.256 178.643 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 60.6 t80 -153.66 149.19 27.29 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-N 116.263 -0.426 . . . . 1.0 110.743 179.792 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 5' ' ' ASP . . . . . 0.528 ' N ' ' OD1' ' A' ' 5' ' ' ASP . 0.3 OUTLIER -155.31 150.77 27.22 Favored 'General case' 0 CA--C 1.533 0.312 0 CA-C-N 116.373 -0.376 . . . . 1.0 110.874 -179.057 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' A' A ' 6' ' ' THR . . . . . 0.564 HG22 ' H ' ' A' ' 7' ' ' GLU . 0.2 OUTLIER -61.38 -158.29 0.01 OUTLIER 'General case' 0 N--CA 1.464 0.264 0 C-N-CA 120.762 -0.375 . . . . 1.0 110.637 -179.532 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' A' A ' 7' ' ' GLU . . . . . 0.564 ' H ' HG22 ' A' ' 6' ' ' THR . 42.8 tt0 -74.34 -66.49 0.72 Allowed 'General case' 0 CA--C 1.502 -0.894 0 C-N-CA 120.699 -0.4 . . . . 1.0 110.047 -178.95 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 8' ' ' ARG . . . . . 0.534 ' O ' ' CB ' ' A' ' 12' ' ' ALA . 13.0 ttm105 -52.54 -44.98 66.16 Favored 'General case' 0 N--CA 1.437 -1.123 0 N-CA-C 112.432 0.53 . . . . 1.0 112.432 -177.057 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 9' ' ' VAL . . . . . 0.663 ' O ' HG22 ' A' ' 13' ' ' VAL . 97.7 t -64.78 -51.12 71.2 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.148 0 C-N-CA 117.986 -1.486 . . . . 1.0 109.212 179.284 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 34.3 t -63.49 -40.73 97.85 Favored 'General case' 0 N--CA 1.474 0.749 0 N-CA-C 114.355 1.243 . . . . 1.0 114.355 -179.066 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 11' ' ' ARG . . . . . 0.544 ' O ' ' N ' ' A' ' 15' ' ' ALA . 59.3 ttm-85 -80.16 -54.92 5.31 Favored 'General case' 0 CA--C 1.536 0.442 0 CA-C-O 122.714 1.245 . . . . 1.0 109.732 178.047 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 12' ' ' ALA . . . . . 0.716 ' O ' ' HB3' ' A' ' 16' ' ' ALA . . . -46.26 -48.59 17.96 Favored 'General case' 0 N--CA 1.483 1.213 0 CA-C-N 112.907 -1.951 . . . . 1.0 106.14 -176.218 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 13' ' ' VAL . . . . . 0.663 HG22 ' O ' ' A' ' 9' ' ' VAL . 34.0 m -60.63 -52.45 61.34 Favored 'Isoleucine or valine' 0 C--O 1.197 -1.663 0 C-N-CA 116.873 -1.931 . . . . 1.0 108.046 176.757 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 14' ' ' ALA . . . . . 0.715 ' O ' HG13 ' A' ' 18' ' ' VAL . . . -58.53 -64.59 0.87 Allowed 'General case' 0 N--CA 1.472 0.632 0 C-N-CA 118.428 -1.309 . . . . 1.0 111.736 179.911 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 15' ' ' ALA . . . . . 0.563 ' O ' ' N ' ' A' ' 19' ' ' GLY . . . -53.19 -55.99 19.91 Favored 'General case' 0 N--CA 1.475 0.802 0 CA-C-O 121.731 0.777 . . . . 1.0 110.161 -177.55 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 16' ' ' ALA . . . . . 0.716 ' HB3' ' O ' ' A' ' 12' ' ' ALA . . . -63.96 -53.84 43.92 Favored 'General case' 0 C--N 1.311 -1.098 0 CA-C-N 114.56 -1.2 . . . . 1.0 109.066 -178.985 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 17' ' ' LEU . . . . . 0.636 ' CB ' ' O ' ' A' ' 13' ' ' VAL . 33.0 tp -56.83 -53.73 54.48 Favored 'General case' 0 N--CA 1.484 1.232 0 C-N-CA 119.047 -1.061 . . . . 1.0 108.637 -177.505 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 18' ' ' VAL . . . . . 0.715 HG13 ' O ' ' A' ' 14' ' ' ALA . 1.7 m -69.94 -57.44 8.19 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.457 0 C-N-CA 119.778 -0.769 . . . . 1.0 110.032 179.515 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 19' ' ' GLY . . . . . 0.563 ' N ' ' O ' ' A' ' 15' ' ' ALA . . . -64.93 -172.76 3.36 Favored Glycine 0 CA--C 1.526 0.761 0 N-CA-C 110.816 -0.914 . . . . 1.0 110.816 -179.532 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 20' ' ' PRO . . . . . 0.587 ' O ' ' N ' ' A' ' 24' ' ' ALA . 6.0 Cg_exo -76.46 -22.95 11.9 Favored 'Trans proline' 0 N--CA 1.503 2.036 0 C-N-CA 123.481 2.787 . . . . 1.0 114.651 -178.442 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -59.82 -57.73 17.89 Favored Glycine 0 N--CA 1.475 1.264 0 C-N-CA 119.576 -1.297 . . . . 1.0 111.831 -176.505 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 22' ' ' GLY . . . . . 0.572 ' CA ' ' HB1' ' A' ' 16' ' ' ALA . . . -58.24 -55.51 30.28 Favored Glycine 0 N--CA 1.464 0.547 0 N-CA-C 108.07 -2.012 . . . . 1.0 108.07 -177.249 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 23' ' ' VAL . . . . . 0.532 ' CG2' ' O ' ' A' ' 19' ' ' GLY . 0.0 OUTLIER -61.5 -35.34 66.19 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.137 0 CA-C-N 114.918 -0.641 . . . . 1.0 109.771 -179.963 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' A' A ' 24' ' ' ALA . . . . . 0.587 ' N ' ' O ' ' A' ' 20' ' ' PRO . . . -54.6 -60.84 2.81 Favored 'General case' 0 CA--C 1.537 0.462 0 C-N-CA 118.223 -1.391 . . . . 1.0 108.893 -179.989 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 15.1 tp -63.01 -45.23 93.36 Favored 'General case' 0 C--N 1.341 0.229 0 CA-C-N 118.386 0.539 . . . . 1.0 112.192 -179.302 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 82.0 t -59.86 -60.02 3.13 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.227 0 C-N-CA 118.664 -1.215 . . . . 1.0 110.052 -177.138 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 27' ' ' VAL . . . . . 0.431 ' O ' ' HB3' ' A' ' 31' ' ' ALA . 2.6 t -59.19 -37.39 68.33 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.309 0 N-CA-C 112.024 0.379 . . . . 1.0 112.024 -178.341 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 25.2 tttm -65.25 -54.43 29.39 Favored 'General case' 0 C--N 1.319 -0.727 0 C-N-CA 119.936 -0.705 . . . . 1.0 109.275 -179.121 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 43.4 t -63.38 -47.1 93.42 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.993 0 CA-C-N 114.719 -1.128 . . . . 1.0 110.603 -178.332 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 30' ' ' CYS . . . . . 0.521 ' SG ' ' N ' ' A' ' 31' ' ' ALA . 0.0 OUTLIER -67.61 -61.09 2.06 Favored 'General case' 0 CA--C 1.533 0.3 0 C-N-CA 118.474 -1.29 . . . . 1.0 110.152 -179.714 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' A' A ' 31' ' ' ALA . . . . . 0.521 ' N ' ' SG ' ' A' ' 30' ' ' CYS . . . -64.3 -53.68 45.13 Favored 'General case' 0 CA--C 1.514 -0.429 0 N-CA-C 113.893 1.071 . . . . 1.0 113.893 -176.014 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 82.26 72.37 1.26 Allowed Glycine 0 CA--C 1.528 0.902 0 N-CA-C 109.018 -1.633 . . . . 1.0 109.018 -177.056 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 33' ' ' LEU . . . . . 0.445 ' O ' ' O ' ' A' ' 36' ' ' VAL . 2.9 mt 85.86 86.05 0.05 OUTLIER Pre-proline 0 N--CA 1.476 0.856 0 C-N-CA 123.409 0.683 . . . . 1.0 111.447 -179.788 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 52.7 Cg_exo -56.98 -26.76 69.93 Favored 'Trans proline' 0 N--CA 1.506 2.223 0 C-N-CA 123.366 2.71 . . . . 1.0 113.517 179.251 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -54.92 -57.0 20.15 Favored Glycine 0 CA--C 1.521 0.424 0 N-CA-C 108.224 -1.95 . . . . 1.0 108.224 -179.355 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 36' ' ' VAL . . . . . 0.537 ' O ' ' CB ' ' A' ' 37' ' ' ILE . 14.5 p -97.07 163.01 2.51 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 N-CA-C 107.521 -1.289 . . . . 1.0 107.521 177.755 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 37' ' ' ILE . . . . . 0.537 ' CB ' ' O ' ' A' ' 36' ' ' VAL . 3.7 mm 122.12 116.54 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.484 1.267 0 O-C-N 124.4 1.062 . . . . 1.0 109.499 -179.322 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -138.63 129.29 26.29 Favored 'General case' 0 C--N 1.329 -0.286 0 N-CA-C 107.55 -1.278 . . . . 1.0 107.55 178.704 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -95.95 154.07 39.06 Favored Pre-proline 0 N--CA 1.467 0.391 0 N-CA-C 109.87 -0.419 . . . . 1.0 109.87 -179.435 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 97.6 Cg_endo -77.52 -42.27 0.29 Allowed 'Trans proline' 0 C--N 1.311 -1.4 0 C-N-CA 122.25 1.966 . . . . 1.0 113.787 -179.101 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -125.2 131.58 53.15 Favored 'General case' 0 N--CA 1.466 0.351 0 CA-C-O 119.626 -0.226 . . . . 1.0 110.464 179.313 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 42' ' ' ARG . . . . . 0.629 ' C ' ' H ' ' A' ' 44' ' ' GLY . 0.4 OUTLIER -166.96 163.72 16.06 Favored 'General case' 0 C--N 1.326 -0.435 0 C-N-CA 119.756 -0.778 . . . . 1.0 110.433 178.037 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' A' A ' 43' ' ' ARG . . . . . 0.462 ' C ' ' H ' ' A' ' 45' ' ' PHE . 3.3 tpt85 -63.87 22.09 0.01 OUTLIER 'General case' 0 CA--C 1.538 0.505 0 CA-C-N 115.857 -0.61 . . . . 1.0 111.088 -179.204 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 44' ' ' GLY . . . . . 0.629 ' H ' ' C ' ' A' ' 42' ' ' ARG . . . 71.63 -27.92 0.61 Allowed Glycine 0 CA--C 1.527 0.819 0 N-CA-C 111.745 -0.542 . . . . 1.0 111.745 179.705 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 45' ' ' PHE . . . . . 0.485 ' O ' ' HB2' ' A' ' 46' ' ' PHE . 20.9 t80 -151.34 149.68 29.62 Favored 'General case' 0 C--O 1.218 -0.587 0 CA-C-N 117.166 0.483 . . . . 1.0 109.741 -179.258 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 46' ' ' PHE . . . . . 0.555 ' O ' ' CG ' ' A' ' 47' ' ' ARG . 1.8 m-85 141.14 83.66 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.836 0 C-N-CA 124.378 1.071 . . . . 1.0 109.736 179.154 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 47' ' ' ARG . . . . . 0.555 ' CG ' ' O ' ' A' ' 46' ' ' PHE . 3.9 mmp_? 137.63 134.44 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.51 0 C-N-CA 123.715 0.806 . . . . 1.0 109.186 179.489 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 48' ' ' CYS . . . . . 0.471 ' SG ' ' C ' ' A' ' 47' ' ' ARG . 2.0 m 77.22 69.45 0.05 Allowed 'General case' 0 C--O 1.218 -0.572 0 CA-C-N 118.409 0.549 . . . . 1.0 110.195 179.785 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -114.6 147.86 39.04 Favored Pre-proline 0 N--CA 1.464 0.265 0 O-C-N 120.748 -1.22 . . . . 1.0 108.864 179.543 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -73.02 59.26 3.58 Favored 'Trans proline' 0 C--N 1.308 -1.58 0 C-N-CA 121.836 1.691 . . . . 1.0 111.101 -179.975 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 22.7 mm-40 58.8 59.33 2.89 Favored 'General case' 0 N--CA 1.454 -0.259 0 CA-C-N 116.25 -0.432 . . . . 1.0 111.074 179.453 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 16.6 ptt180 -146.13 178.72 8.01 Favored 'General case' 0 N--CA 1.466 0.359 0 CA-C-N 116.24 -0.437 . . . . 1.0 110.377 179.724 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 53' ' ' ILE . . . . . 0.771 HD12 ' N ' ' A' ' 54' ' ' GLN . 0.1 OUTLIER -86.61 138.61 18.74 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.334 0 CA-C-O 121.655 0.741 . . . . 1.0 110.484 179.671 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' A' A ' 54' ' ' GLN . . . . . 0.771 ' N ' HD12 ' A' ' 53' ' ' ILE . 0.0 OUTLIER -62.34 82.84 0.02 OUTLIER 'General case' 0 C--N 1.319 -0.742 0 CA-C-N 114.701 -1.136 . . . . 1.0 109.033 -177.961 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' A' A ' 55' ' ' ILE . . . . . 0.438 ' N ' ' O ' ' A' ' 53' ' ' ILE . 21.2 tt -149.48 158.23 6.17 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.457 0 CA-C-N 115.858 -0.61 . . . . 1.0 110.611 178.156 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 109.31 -5.97 31.89 Favored Glycine 0 N--CA 1.473 1.129 0 N-CA-C 110.95 -0.86 . . . . 1.0 110.95 -179.969 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 13.1 p-10 -77.94 100.78 6.56 Favored 'General case' 0 C--N 1.323 -0.563 0 N-CA-C 109.026 -0.731 . . . . 1.0 109.026 178.751 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 58' ' ' TRP . . . . . 0.47 ' H ' ' CD ' ' A' ' 61' ' ' GLU . 0.3 OUTLIER -88.75 174.75 7.83 Favored 'General case' 0 CA--C 1.542 0.656 0 CA-C-O 123.18 1.466 . . . . 1.0 113.364 -177.625 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 9.0 mtm180 -80.5 -59.32 2.74 Favored 'General case' 0 C--N 1.315 -0.899 0 CA-C-N 111.416 -2.629 . . . . 1.0 113.418 -178.381 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 1.2 p90 -88.67 -10.03 49.97 Favored 'General case' 0 C--O 1.248 1.012 0 CA-C-N 114.81 -1.086 . . . . 1.0 113.573 -177.673 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 61' ' ' GLU . . . . . 0.513 ' O ' ' N ' ' A' ' 65' ' ' ASP . 13.5 pt-20 -71.8 -14.26 61.93 Favored 'General case' 0 C--N 1.313 -0.991 0 N-CA-C 113.198 0.814 . . . . 1.0 113.198 -177.767 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 62' ' ' VAL . . . . . 0.623 ' O ' ' N ' ' A' ' 66' ' ' GLY . 0.1 OUTLIER -48.72 -58.94 0.97 Allowed 'Isoleucine or valine' 0 C--O 1.204 -1.293 0 C-N-CA 119.195 -1.002 . . . . 1.0 108.5 -174.317 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -66.33 -56.67 10.02 Favored 'General case' 0 C--N 1.295 -1.799 0 O-C-N 121.797 -0.564 . . . . 1.0 110.867 -179.325 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 64' ' ' HIS . . . . . 0.56 ' O ' ' HB2' ' A' ' 67' ' ' ARG . 67.3 m-70 -53.39 -56.36 17.42 Favored 'General case' 0 N--CA 1.465 0.312 0 C-N-CA 119.148 -1.021 . . . . 1.0 109.59 -179.247 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 65' ' ' ASP . . . . . 0.609 ' C ' ' H ' ' A' ' 67' ' ' ARG . 10.0 t0 -77.63 -50.9 11.54 Favored 'General case' 0 C--N 1.312 -1.032 0 O-C-N 121.889 -0.507 . . . . 1.0 111.667 179.984 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 66' ' ' GLY . . . . . 0.623 ' N ' ' O ' ' A' ' 62' ' ' VAL . . . -71.83 26.84 0.63 Allowed Glycine 0 CA--C 1.524 0.655 0 O-C-N 120.608 -1.307 . . . . 1.0 110.412 178.042 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 67' ' ' ARG . . . . . 0.613 ' O ' ' N ' ' A' ' 69' ' ' LEU . 4.1 tpt85 -74.93 4.38 6.64 Favored 'General case' 0 N--CA 1.448 -0.566 0 N-CA-C 107.183 -1.414 . . . . 1.0 107.183 176.074 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 68' ' ' LEU . . . . . 0.493 ' H ' ' C ' ' A' ' 66' ' ' GLY . 12.9 mt -33.55 -28.13 0.01 OUTLIER 'General case' 0 N--CA 1.475 0.79 0 CA-C-N 114.687 -1.142 . . . . 1.0 108.871 -177.622 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 69' ' ' LEU . . . . . 0.613 ' N ' ' O ' ' A' ' 67' ' ' ARG . 3.0 tt -65.86 -66.03 0.6 Allowed 'General case' 0 CA--C 1.546 0.821 0 C-N-CA 119.293 -0.963 . . . . 1.0 110.085 -179.17 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 70' ' ' ALA . . . . . 0.64 ' C ' ' H ' ' A' ' 72' ' ' HIS . . . -79.1 -78.36 0.15 Allowed 'General case' 0 N--CA 1.475 0.819 0 C-N-CA 118.766 -1.174 . . . . 1.0 108.439 -179.842 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 71' ' ' ALA . . . . . 0.785 ' HB1' ' HB ' ' A' ' 74' ' ' VAL . . . -50.32 9.53 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.285 0 C-N-CA 125.651 1.581 . . . . 1.0 113.005 179.342 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 72' ' ' HIS . . . . . 0.64 ' H ' ' C ' ' A' ' 70' ' ' ALA . 0.4 OUTLIER -24.21 -58.75 0.05 Allowed 'General case' 0 C--N 1.33 -0.247 0 N-CA-C 113.765 1.024 . . . . 1.0 113.765 -177.197 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' A' A ' 73' ' ' MET . . . . . 0.563 ' H ' ' CG ' ' A' ' 72' ' ' HIS . 95.0 mtp -68.94 -45.99 69.34 Favored 'General case' 0 C--N 1.319 -0.746 0 C-N-CA 119.604 -0.838 . . . . 1.0 109.145 179.34 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 74' ' ' VAL . . . . . 0.785 ' HB ' ' HB1' ' A' ' 71' ' ' ALA . 39.2 t -45.26 -43.92 3.3 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.255 0 CA-C-O 117.658 -1.163 . . . . 1.0 111.685 -176.365 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 75' ' ' ASN . . . . . 0.702 HD21 HH22 ' A' ' 126' ' ' ARG . 0.7 OUTLIER -39.6 -11.14 0.01 OUTLIER 'General case' 0 C--N 1.362 1.134 0 CA-C-N 121.05 1.75 . . . . 1.0 111.419 178.994 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' A' A ' 76' ' ' GLY . . . . . 0.719 ' N ' ' O ' ' A' ' 74' ' ' VAL . . . -42.12 -27.3 0.41 Allowed Glycine 0 CA--C 1.536 1.384 0 N-CA-C 107.301 -2.32 . . . . 1.0 107.301 177.988 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 77' ' ' ILE . . . . . 0.668 ' HA ' ' HB3' ' A' ' 80' ' ' ALA . 7.1 pt -68.76 -49.45 64.09 Favored 'Isoleucine or valine' 0 C--O 1.212 -0.881 0 N-CA-C 108.663 -0.866 . . . . 1.0 108.663 176.653 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 78' ' ' VAL . . . . . 0.636 ' N ' ' O ' ' A' ' 75' ' ' ASN . 2.0 p -32.35 -39.09 0.04 OUTLIER 'Isoleucine or valine' 0 CA--C 1.545 0.769 0 N-CA-C 108.846 -0.798 . . . . 1.0 108.846 -176.369 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 79' ' ' ILE . . . . . 0.566 HG23 HG13 ' A' ' 78' ' ' VAL . 2.9 pp -97.71 -24.72 4.28 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.709 0 CA-C-O 121.153 0.501 . . . . 1.0 110.751 178.041 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 80' ' ' ALA . . . . . 0.668 ' HB3' ' HA ' ' A' ' 77' ' ' ILE . . . -86.98 -10.37 53.36 Favored 'General case' 0 CA--C 1.551 1.014 0 N-CA-C 113.381 0.882 . . . . 1.0 113.381 177.568 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 81' ' ' GLU . . . . . 0.596 ' N ' ' O ' ' A' ' 77' ' ' ILE . 81.9 tt0 -87.65 -71.22 0.58 Allowed 'General case' 0 N--CA 1.445 -0.699 0 CA-C-N 118.942 0.792 . . . . 1.0 109.426 -179.826 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 82' ' ' ASP . . . . . 0.648 ' O ' ' N ' ' A' ' 84' ' ' LEU . 0.7 OUTLIER -70.32 -11.63 61.04 Favored 'General case' 0 N--CA 1.444 -0.733 0 CA-C-N 119.109 0.868 . . . . 1.0 110.294 179.069 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' A' A ' 83' ' ' ALA . . . . . 0.805 ' O ' ' N ' ' A' ' 86' ' ' ALA . . . -18.79 -43.22 0.0 OUTLIER 'General case' 0 C--O 1.197 -1.668 0 O-C-N 124.072 0.858 . . . . 1.0 111.804 177.941 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 84' ' ' LEU . . . . . 0.648 ' N ' ' O ' ' A' ' 82' ' ' ASP . 19.1 mt -26.72 -30.55 0.0 OUTLIER 'General case' 0 N--CA 1.472 0.664 0 O-C-N 121.901 -0.5 . . . . 1.0 111.902 -175.801 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 85' ' ' ILE . . . . . 0.714 ' N ' ' O ' ' A' ' 83' ' ' ALA . 0.1 OUTLIER -98.57 -31.33 3.64 Favored 'Isoleucine or valine' 0 CA--C 1.551 1.009 0 N-CA-C 109.541 -0.54 . . . . 1.0 109.541 175.42 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' A' A ' 86' ' ' ALA . . . . . 0.805 ' N ' ' O ' ' A' ' 83' ' ' ALA . . . -91.89 -27.33 17.99 Favored 'General case' 0 N--CA 1.486 1.352 0 CA-C-O 121.897 0.856 . . . . 1.0 112.652 179.063 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 87' ' ' GLU . . . . . 0.604 ' N ' ' O ' ' A' ' 83' ' ' ALA . 3.3 pt-20 -47.33 -28.55 2.06 Favored 'General case' 0 C--N 1.313 -1.008 0 CA-C-N 114.089 -1.414 . . . . 1.0 109.963 -178.859 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -141.7 24.99 2.02 Favored 'General case' 0 N--CA 1.475 0.8 0 CA-C-O 121.585 0.707 . . . . 1.0 111.118 -178.99 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 89' ' ' VAL . . . . . 0.693 HG22 ' HB3' ' A' ' 92' ' ' HIS . 4.8 p -75.62 36.38 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.315 -0.921 0 CA-C-N 114.905 -1.043 . . . . 1.0 109.518 178.423 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 90' ' ' GLY . . . . . 0.529 ' O ' ' N ' ' A' ' 92' ' ' HIS . . . -66.77 -39.87 93.67 Favored Glycine 0 N--CA 1.439 -1.129 0 C-N-CA 119.055 -1.545 . . . . 1.0 111.138 178.693 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 91' ' ' PRO . . . . . 0.522 ' CD ' ' N ' ' A' ' 90' ' ' GLY . 95.8 Cg_exo -43.78 -20.1 0.23 Allowed 'Trans proline' 0 N--CA 1.49 1.293 0 CA-C-N 119.897 1.848 . . . . 1.0 110.003 179.777 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 92' ' ' HIS . . . . . 0.693 ' HB3' HG22 ' A' ' 89' ' ' VAL . 7.7 p-80 -60.65 -25.84 66.62 Favored 'General case' 0 C--O 1.218 -0.599 0 CA-C-N 114.724 -1.126 . . . . 1.0 109.396 179.649 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 93' ' ' LEU . . . . . 0.663 HD12 ' N ' ' A' ' 94' ' ' ALA . 2.2 pp -63.47 -58.7 6.2 Favored 'General case' 0 C--N 1.325 -0.494 0 N-CA-C 108.353 -0.98 . . . . 1.0 108.353 178.451 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 94' ' ' ALA . . . . . 0.663 ' N ' HD12 ' A' ' 93' ' ' LEU . . . -56.23 -55.93 27.2 Favored 'General case' 0 N--CA 1.452 -0.369 0 N-CA-C 109.26 -0.645 . . . . 1.0 109.26 179.096 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 95' ' ' ARG . . . . . 0.613 ' O ' ' N ' ' A' ' 97' ' ' LEU . 10.8 ttp180 -59.07 -61.04 2.94 Favored 'General case' 0 C--O 1.239 0.542 0 CA-C-O 122.333 1.064 . . . . 1.0 108.819 179.586 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 96' ' ' ALA . . . . . 0.871 ' O ' ' N ' ' A' ' 98' ' ' GLY . . . -47.68 -12.51 0.03 OUTLIER 'General case' 0 C--N 1.306 -1.319 0 O-C-N 118.56 -2.587 . . . . 1.0 112.072 -179.154 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 97' ' ' LEU . . . . . 0.829 HD12 ' N ' ' A' ' 98' ' ' GLY . 3.5 pp 5.34 -52.53 0.0 OUTLIER 'General case' 0 C--O 1.204 -1.328 0 CA-C-O 116.767 -1.587 . . . . 1.0 111.262 -166.595 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 98' ' ' GLY . . . . . 0.871 ' N ' ' O ' ' A' ' 96' ' ' ALA . . . -47.22 -24.14 2.13 Favored Glycine 0 C--N 1.303 -1.301 0 CA-C-N 123.381 2.809 . . . . 1.0 107.473 176.018 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 99' ' ' GLN . . . . . 0.524 ' HG2' ' HB1' ' A' ' 96' ' ' ALA . 57.5 mm-40 -64.44 -17.99 64.33 Favored 'General case' 0 C--N 1.361 1.098 0 C-N-CA 117.415 -1.714 . . . . 1.0 107.424 176.049 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 100' ' ' ILE . . . . . 0.799 ' N ' ' O ' ' A' ' 97' ' ' LEU . 12.1 tt -64.67 -44.75 96.63 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.629 0 N-CA-C 107.87 -1.159 . . . . 1.0 107.87 177.881 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 101' ' ' VAL . . . . . 0.801 ' O ' ' N ' ' A' ' 105' ' ' GLY . 68.9 t -60.14 -61.06 1.67 Allowed 'Isoleucine or valine' 0 C--O 1.209 -1.059 0 N-CA-C 107.585 -1.265 . . . . 1.0 107.585 179.499 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 102' ' ' CYS . . . . . 0.888 ' O ' ' HB2' ' A' ' 106' ' ' ALA . 0.5 OUTLIER -44.21 -19.02 0.02 OUTLIER 'General case' 0 C--N 1.319 -0.732 0 CA-C-O 121.399 0.619 . . . . 1.0 110.988 -179.458 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' A' A ' 103' ' ' ARG . . . . . 0.518 ' N ' ' O ' ' A' ' 101' ' ' VAL . 12.1 ttp-105 -95.44 -43.96 7.75 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-O 122.034 0.921 . . . . 1.0 111.889 177.383 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 104' ' ' TYR . . . . . 0.709 ' O ' ' CG ' ' A' ' 104' ' ' TYR . 0.1 OUTLIER -107.43 19.16 20.65 Favored 'General case' 0 CA--C 1.552 1.038 0 C-N-CA 126.628 1.971 . . . . 1.0 110.619 178.477 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' A' A ' 105' ' ' GLY . . . . . 0.801 ' N ' ' O ' ' A' ' 101' ' ' VAL . . . -162.64 -10.89 0.03 OUTLIER Glycine 0 C--N 1.332 0.324 0 C-N-CA 118.898 -1.62 . . . . 1.0 112.514 179.785 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 106' ' ' ALA . . . . . 0.888 ' HB2' ' O ' ' A' ' 102' ' ' CYS . . . -29.81 118.7 0.15 Allowed 'General case' 0 N--CA 1.463 0.219 0 CA-C-N 117.017 0.408 . . . . 1.0 110.081 179.391 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 107' ' ' THR . . . . . 0.798 ' O ' ' HD2' ' A' ' 110' ' ' PRO . 10.7 m -133.98 -62.48 0.76 Allowed 'General case' 0 C--O 1.192 -1.951 0 N-CA-C 105.542 -2.021 . . . . 1.0 105.542 178.042 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 26.1 m -61.89 28.57 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.309 -1.181 0 O-C-N 121.034 -1.041 . . . . 1.0 110.194 -179.878 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 109' ' ' ILE . . . . . 0.666 HG21 ' HB1' ' A' ' 106' ' ' ALA . 0.1 OUTLIER -111.81 -42.98 0.09 OUTLIER Pre-proline 0 C--N 1.372 1.545 0 CA-C-N 119.634 1.107 . . . . 1.0 111.381 177.575 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' A' A ' 110' ' ' PRO . . . . . 0.798 ' HD2' ' O ' ' A' ' 107' ' ' THR . 31.3 Cg_exo -65.1 -28.49 56.83 Favored 'Trans proline' 0 N--CA 1.499 1.799 0 C-N-CA 122.457 2.105 . . . . 1.0 111.869 -179.569 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 111' ' ' ASN . . . . . 0.437 ' C ' ' N ' ' A' ' 113' ' ' ASN . 0.1 OUTLIER -69.12 -69.08 0.36 Allowed 'General case' 0 CA--C 1.538 0.49 0 C-N-CA 119.687 -0.805 . . . . 1.0 109.851 -179.242 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' A' A ' 112' ' ' ILE . . . . . 0.5 ' O ' ' N ' ' A' ' 116' ' ' ILE . 13.1 pt -47.8 -28.29 1.57 Allowed 'Isoleucine or valine' 0 C--O 1.214 -0.785 0 CA-C-O 123.414 1.578 . . . . 1.0 108.531 179.593 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 113' ' ' ASN . . . . . 0.466 ' ND2' ' O ' ' A' ' 110' ' ' PRO . 0.0 OUTLIER -56.85 -52.74 63.91 Favored 'General case' 0 C--N 1.293 -1.864 0 CA-C-N 111.526 -2.579 . . . . 1.0 106.906 -178.935 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' A' A ' 114' ' ' ALA . . . . . 0.559 ' O ' HG23 ' A' ' 118' ' ' VAL . . . -62.37 -35.04 77.9 Favored 'General case' 0 C--N 1.322 -0.595 0 N-CA-C 112.842 0.682 . . . . 1.0 112.842 -179.914 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -82.8 -56.25 3.94 Favored 'General case' 0 C--O 1.21 -1.002 0 CA-C-N 119.486 1.039 . . . . 1.0 110.538 178.503 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 116' ' ' ILE . . . . . 0.541 ' O ' ' N ' ' A' ' 120' ' ' GLY . 50.8 mt -48.74 -60.88 0.61 Allowed 'Isoleucine or valine' 0 N--CA 1.478 0.954 0 CA-C-O 122.522 1.153 . . . . 1.0 108.107 -179.208 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 117' ' ' GLU . . . . . 0.445 ' HB2' ' O ' ' A' ' 113' ' ' ASN . 91.5 mt-10 -42.67 -53.56 4.42 Favored 'General case' 0 C--N 1.313 -0.988 0 CA-C-N 112.488 -2.142 . . . . 1.0 107.17 -178.761 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 118' ' ' VAL . . . . . 0.559 HG23 ' O ' ' A' ' 114' ' ' ALA . 69.1 t -60.72 -54.84 29.75 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.516 0 N-CA-C 109.143 -0.688 . . . . 1.0 109.143 177.281 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 3.3 tp -53.49 -71.66 0.07 Allowed 'General case' 0 N--CA 1.464 0.234 0 N-CA-C 108.038 -1.097 . . . . 1.0 108.038 -179.424 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 120' ' ' GLY . . . . . 0.541 ' N ' ' O ' ' A' ' 116' ' ' ILE . . . -66.62 -85.37 0.09 OUTLIER Glycine 0 CA--C 1.533 1.21 0 C-N-CA 118.567 -1.777 . . . . 1.0 110.063 179.369 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 121' ' ' THR . . . . . 0.419 HG23 ' H ' ' A' ' 123' ' ' THR . 1.6 t 168.67 -39.9 0.0 OUTLIER 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 112.633 -1.783 . . . . 1.0 112.756 -179.802 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 122' ' ' GLY . . . . . 0.619 ' O ' ' N ' ' A' ' 124' ' ' ASP . . . 100.99 -18.72 54.32 Favored Glycine 0 N--CA 1.469 0.856 0 N-CA-C 107.037 -2.425 . . . . 1.0 107.037 -176.884 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 123' ' ' THR . . . . . 0.419 ' H ' HG23 ' A' ' 121' ' ' THR . 25.5 m -51.63 86.71 0.0 OUTLIER 'General case' 0 N--CA 1.471 0.617 0 CA-C-N 111.884 -2.158 . . . . 1.0 105.463 178.261 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 124' ' ' ASP . . . . . 0.619 ' N ' ' O ' ' A' ' 122' ' ' GLY . 9.5 m-20 -160.3 165.1 31.95 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 114.372 -1.285 . . . . 1.0 112.062 -178.305 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 125' ' ' TYR . . . . . 0.576 ' O ' ' NH2' ' A' ' 126' ' ' ARG . 0.0 OUTLIER -151.13 146.98 26.51 Favored 'General case' 0 CA--C 1.541 0.61 0 N-CA-C 108.92 -0.771 . . . . 1.0 108.92 177.901 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' A' A ' 126' ' ' ARG . . . . . 0.702 HH22 HD21 ' A' ' 75' ' ' ASN . 0.1 OUTLIER -148.01 150.58 34.23 Favored 'General case' 0 CA--C 1.541 0.613 0 CA-C-N 115.762 -0.654 . . . . 1.0 109.718 177.453 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' A' A ' 127' ' ' PHE . . . . . . . . . . . . . 85.8 t80 . . . . . 0 N--CA 1.468 0.459 0 CA-C-O 118.011 -0.995 . . . . 1.0 110.726 178.918 . . . . . . . . 0 0 . 1 . 025 nuclear build core ' A' A ' 1' ' ' MET . . . . . 0.492 ' SD ' ' CB ' ' A' ' 4' ' ' PHE . 19.6 mtp . . . . . 0 N--CA 1.492 1.63 0 N-CA-C 108.179 -1.045 . . . . 1.0 108.179 . . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 2' ' ' SER . . . . . 0.423 ' O ' ' CG ' ' A' ' 3' ' ' ASP . 88.6 p -107.7 7.87 28.68 Favored 'General case' 0 N--CA 1.468 0.452 0 CA-C-O 120.705 0.288 . . . . 1.0 110.412 -179.753 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 3' ' ' ASP . . . . . 0.423 ' CG ' ' O ' ' A' ' 2' ' ' SER . 12.1 m-20 168.35 94.25 0.0 OUTLIER 'General case' 0 N--CA 1.47 0.557 0 CA-C-N 115.469 -0.787 . . . . 1.0 110.468 179.014 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 4' ' ' PHE . . . . . 0.492 ' CB ' ' SD ' ' A' ' 1' ' ' MET . 37.9 t80 -149.8 145.56 26.68 Favored 'General case' 0 CA--C 1.517 -0.326 0 CA-C-N 116.212 -0.449 . . . . 1.0 110.516 179.501 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 61.5 m-20 -154.75 151.01 28.19 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 121.134 0.492 . . . . 1.0 110.007 179.763 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 6' ' ' THR . . . . . 0.644 ' O ' ' N ' ' A' ' 10' ' ' SER . 0.2 OUTLIER -67.17 173.23 3.95 Favored 'General case' 0 C--O 1.208 -1.123 0 CA-C-N 115.707 -0.679 . . . . 1.0 110.126 179.855 . . . . . . . . 3 3 . 1 . 025 nuclear build core ' A' A ' 7' ' ' GLU . . . . . 0.595 ' O ' ' N ' ' A' ' 11' ' ' ARG . 1.5 tm-20 -58.07 -54.29 48.6 Favored 'General case' 0 C--N 1.309 -1.191 0 CA-C-O 121.877 0.846 . . . . 1.0 109.423 -179.303 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 8' ' ' ARG . . . . . 0.58 ' O ' ' HB3' ' A' ' 12' ' ' ALA . 27.9 ttp180 -53.82 -57.85 9.41 Favored 'General case' 0 C--N 1.311 -1.099 0 N-CA-C 107.967 -1.123 . . . . 1.0 107.967 -178.44 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 9' ' ' VAL . . . . . 0.853 ' O ' HG13 ' A' ' 13' ' ' VAL . 0.0 OUTLIER -63.61 -48.08 88.41 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.359 0 CA-C-N 114.772 -1.104 . . . . 1.0 109.807 179.27 . . . . . . . . 3 3 . 1 . 025 nuclear build core ' A' A ' 10' ' ' SER . . . . . 0.644 ' N ' ' O ' ' A' ' 6' ' ' THR . 48.0 t -63.15 -60.74 3.01 Favored 'General case' 0 N--CA 1.481 1.107 0 C-N-CA 120.048 -0.661 . . . . 1.0 110.467 179.266 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 11' ' ' ARG . . . . . 0.595 ' N ' ' O ' ' A' ' 7' ' ' GLU . 11.2 ttt180 -62.77 -55.38 27.05 Favored 'General case' 0 C--N 1.316 -0.862 0 CA-C-O 121.707 0.765 . . . . 1.0 110.072 -177.005 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 12' ' ' ALA . . . . . 0.58 ' HB3' ' O ' ' A' ' 8' ' ' ARG . . . -52.37 -51.57 58.2 Favored 'General case' 0 C--N 1.316 -0.856 0 N-CA-C 107.015 -1.476 . . . . 1.0 107.015 -178.322 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 13' ' ' VAL . . . . . 0.853 HG13 ' O ' ' A' ' 9' ' ' VAL . 3.5 m -63.0 -45.84 97.86 Favored 'Isoleucine or valine' 0 C--O 1.2 -1.524 0 C-N-CA 117.387 -1.725 . . . . 1.0 108.888 177.839 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 14' ' ' ALA . . . . . 0.585 ' O ' HG13 ' A' ' 18' ' ' VAL . . . -59.79 -62.01 2.19 Favored 'General case' 0 N--CA 1.481 1.109 0 O-C-N 120.61 -1.306 . . . . 1.0 110.26 178.654 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 15' ' ' ALA . . . . . 0.542 ' N ' ' O ' ' A' ' 11' ' ' ARG . . . -52.15 -55.36 21.44 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-O 121.984 0.897 . . . . 1.0 109.415 -177.932 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 16' ' ' ALA . . . . . 0.51 ' C ' ' H ' ' A' ' 22' ' ' GLY . . . -62.29 -53.85 49.19 Favored 'General case' 0 C--N 1.31 -1.112 0 CA-C-N 114.233 -1.348 . . . . 1.0 108.811 -179.194 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 17' ' ' LEU . . . . . 0.607 ' CB ' ' O ' ' A' ' 13' ' ' VAL . 7.9 tt -57.1 -54.85 42.12 Favored 'General case' 0 N--CA 1.481 1.084 0 CA-C-N 114.738 -1.119 . . . . 1.0 109.462 -177.75 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 18' ' ' VAL . . . . . 0.585 HG13 ' O ' ' A' ' 14' ' ' ALA . 1.8 m -69.68 -57.25 8.84 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.63 0 C-N-CA 119.682 -0.807 . . . . 1.0 109.673 178.932 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 19' ' ' GLY . . . . . 0.543 ' O ' ' CG2' ' A' ' 23' ' ' VAL . . . -65.2 -166.99 1.57 Allowed Glycine 0 CA--C 1.537 1.432 0 N-CA-C 111.477 -0.649 . . . . 1.0 111.477 -179.875 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 20' ' ' PRO . . . . . 0.498 ' O ' ' HB2' ' A' ' 24' ' ' ALA . 83.5 Cg_endo -78.18 -24.87 7.7 Favored 'Trans proline' 0 N--CA 1.509 2.407 0 C-N-CA 123.628 2.885 . . . . 1.0 115.138 -177.825 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -57.32 -57.26 20.72 Favored Glycine 0 N--CA 1.478 1.448 0 C-N-CA 120.221 -0.99 . . . . 1.0 111.694 -176.765 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 22' ' ' GLY . . . . . 0.51 ' H ' ' C ' ' A' ' 16' ' ' ALA . . . -60.33 -56.21 25.77 Favored Glycine 0 N--CA 1.468 0.819 0 N-CA-C 109.274 -1.531 . . . . 1.0 109.274 -177.234 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 23' ' ' VAL . . . . . 0.543 ' CG2' ' O ' ' A' ' 19' ' ' GLY . 0.0 OUTLIER -61.89 -35.98 71.22 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.958 0 CA-C-N 114.867 -0.666 . . . . 1.0 110.106 -178.845 . . . . . . . . 3 3 . 1 . 025 nuclear build core ' A' A ' 24' ' ' ALA . . . . . 0.498 ' HB2' ' O ' ' A' ' 20' ' ' PRO . . . -56.23 -59.97 4.17 Favored 'General case' 0 CA--C 1.538 0.51 0 C-N-CA 117.779 -1.568 . . . . 1.0 108.325 179.531 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 14.3 tp -66.66 -43.87 83.38 Favored 'General case' 0 C--N 1.348 0.505 0 N-CA-C 113.113 0.783 . . . . 1.0 113.113 -178.635 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 79.2 t -60.71 -58.7 6.24 Favored 'Isoleucine or valine' 0 C--N 1.34 0.188 0 C-N-CA 118.137 -1.425 . . . . 1.0 109.253 -177.243 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 27' ' ' VAL . . . . . 0.422 ' O ' ' HB3' ' A' ' 31' ' ' ALA . 60.7 t -61.14 -37.76 78.16 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.374 0 N-CA-C 112.96 0.726 . . . . 1.0 112.96 -177.914 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 28' ' ' LYS . . . . . 0.406 ' CG ' ' O ' ' A' ' 24' ' ' ALA . 30.0 mmtm -64.23 -52.68 57.59 Favored 'General case' 0 CA--C 1.509 -0.631 0 N-CA-C 108.372 -0.973 . . . . 1.0 108.372 -179.812 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 92.8 t -65.07 -47.91 86.0 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.874 0 CA-C-N 113.445 -1.707 . . . . 1.0 110.797 -177.361 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 30' ' ' CYS . . . . . . . . . . . . . 11.5 t -65.8 -61.11 2.25 Favored 'General case' 0 N--CA 1.445 -0.684 0 C-N-CA 118.685 -1.206 . . . . 1.0 109.86 -179.747 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 31' ' ' ALA . . . . . 0.438 ' HA ' HD13 ' A' ' 37' ' ' ILE . . . -66.62 -53.95 28.63 Favored 'General case' 0 CA--C 1.518 -0.261 0 N-CA-C 113.668 0.988 . . . . 1.0 113.668 -176.221 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 85.1 73.57 1.27 Allowed Glycine 0 CA--C 1.533 1.17 0 N-CA-C 109.913 -1.275 . . . . 1.0 109.913 -177.253 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 4.7 mt 76.78 106.26 0.03 OUTLIER Pre-proline 0 N--CA 1.475 0.8 0 C-N-CA 123.416 0.686 . . . . 1.0 111.524 -179.706 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 74.9 Cg_exo -51.42 -15.6 2.63 Favored 'Trans proline' 0 N--CA 1.506 2.243 0 C-N-CA 122.889 2.393 . . . . 1.0 114.967 179.365 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -56.7 -57.87 17.33 Favored Glycine 0 CA--C 1.526 0.746 0 N-CA-C 107.584 -2.207 . . . . 1.0 107.584 -179.791 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 36' ' ' VAL . . . . . 0.848 ' O ' HG22 ' A' ' 37' ' ' ILE . 5.6 p -79.01 -147.2 0.01 OUTLIER 'Isoleucine or valine' 0 C--O 1.22 -0.459 0 N-CA-C 108.247 -1.019 . . . . 1.0 108.247 178.572 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 37' ' ' ILE . . . . . 0.848 HG22 ' O ' ' A' ' 36' ' ' VAL . 9.1 tp 70.52 79.74 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.475 0.814 0 CA-C-O 122.157 0.98 . . . . 1.0 112.969 -179.217 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 60.3 m80 -137.79 132.08 32.15 Favored 'General case' 0 N--CA 1.453 -0.283 0 N-CA-C 108.183 -1.043 . . . . 1.0 108.183 177.267 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 10.0 m -128.99 115.71 18.94 Favored Pre-proline 0 C--N 1.326 -0.434 0 N-CA-C 108.38 -0.97 . . . . 1.0 108.38 -179.284 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_exo -42.94 -66.65 0.15 Allowed 'Trans proline' 0 C--N 1.317 -1.122 0 C-N-CA 121.017 1.145 . . . . 1.0 111.558 -178.503 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -75.6 115.33 15.17 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 115.262 -0.881 . . . . 1.0 112.848 -177.292 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 42' ' ' ARG . . . . . 0.628 ' C ' ' H ' ' A' ' 44' ' ' GLY . 32.9 ptt180 -166.12 162.4 17.7 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 114.817 -1.083 . . . . 1.0 109.987 179.225 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 43' ' ' ARG . . . . . 0.522 ' C ' ' H ' ' A' ' 45' ' ' PHE . 0.2 OUTLIER -65.99 18.63 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.318 -0.401 . . . . 1.0 110.235 -179.263 . . . . . . . . 3 3 . 1 . 025 nuclear build core ' A' A ' 44' ' ' GLY . . . . . 0.628 ' H ' ' C ' ' A' ' 42' ' ' ARG . . . 70.57 -26.59 0.48 Allowed Glycine 0 N--CA 1.448 -0.531 0 N-CA-C 110.824 -0.91 . . . . 1.0 110.824 179.846 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 45' ' ' PHE . . . . . 0.522 ' H ' ' C ' ' A' ' 43' ' ' ARG . 7.6 t80 -155.33 150.65 27.05 Favored 'General case' 0 CA--C 1.541 0.622 0 N-CA-C 108.892 -0.781 . . . . 1.0 108.892 -178.906 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 46' ' ' PHE . . . . . 0.497 ' CE1' ' NE2' ' A' ' 54' ' ' GLN . 15.3 t80 172.21 7.15 0.0 OUTLIER 'General case' 0 N--CA 1.483 1.208 0 O-C-N 124.014 0.821 . . . . 1.0 113.155 176.273 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 47' ' ' ARG . . . . . 0.403 ' HB3' ' O ' ' A' ' 46' ' ' PHE . 0.0 OUTLIER 172.2 -176.0 0.05 Allowed 'General case' 0 C--N 1.328 -0.334 0 N-CA-C 109.765 -0.457 . . . . 1.0 109.765 179.689 . . . . . . . . 3 3 . 1 . 025 nuclear build core ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER 70.64 63.01 0.19 Allowed 'General case' 0 CA--C 1.546 0.819 0 N-CA-C 108.901 -0.777 . . . . 1.0 108.901 179.938 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 49' ' ' ASN . . . . . 0.553 ' O ' ' N ' ' A' ' 51' ' ' GLU . 0.1 OUTLIER -151.06 133.21 8.17 Favored Pre-proline 0 CA--C 1.546 0.818 0 N-CA-C 108.169 -1.048 . . . . 1.0 108.169 178.891 . . . . . . . . 3 3 . 1 . 025 nuclear build core ' A' A ' 50' ' ' PRO . . . . . 0.551 ' HD2' HH21 ' A' ' 52' ' ' ARG . 16.3 Cg_endo -55.13 73.86 0.03 OUTLIER 'Trans proline' 0 N--CA 1.502 1.999 0 CA-C-N 120.995 1.391 . . . . 1.0 113.833 -179.816 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 51' ' ' GLU . . . . . 0.553 ' N ' ' O ' ' A' ' 49' ' ' ASN . 40.2 mm-40 62.01 69.8 0.61 Allowed 'General case' 0 N--CA 1.468 0.441 0 N-CA-C 113.428 0.899 . . . . 1.0 113.428 177.975 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 52' ' ' ARG . . . . . 0.551 HH21 ' HD2' ' A' ' 50' ' ' PRO . 0.0 OUTLIER -141.67 150.68 42.22 Favored 'General case' 0 N--CA 1.471 0.579 0 N-CA-C 108.772 -0.825 . . . . 1.0 108.772 178.155 . . . . . . . . 3 3 . 1 . 025 nuclear build core ' A' A ' 53' ' ' ILE . . . . . 0.553 HD13 ' H ' ' A' ' 54' ' ' GLN . 0.4 OUTLIER -74.44 136.37 25.38 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.372 0 CA-C-O 121.623 0.725 . . . . 1.0 111.43 -178.679 . . . . . . . . 3 3 . 1 . 025 nuclear build core ' A' A ' 54' ' ' GLN . . . . . 0.553 ' H ' HD13 ' A' ' 53' ' ' ILE . 1.9 pt20 -62.9 82.21 0.02 OUTLIER 'General case' 0 N--CA 1.469 0.492 0 CA-C-N 114.611 -1.177 . . . . 1.0 110.143 -177.172 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 16.0 tt -149.52 159.07 5.68 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.27 0 CA-C-N 115.97 -0.559 . . . . 1.0 110.141 178.113 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 112.26 -2.92 26.73 Favored Glycine 0 N--CA 1.472 1.043 0 N-CA-C 110.669 -0.973 . . . . 1.0 110.669 -179.713 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 57' ' ' ASP . . . . . 0.484 ' OD2' ' O ' ' A' ' 43' ' ' ARG . 25.3 t70 -82.91 98.71 9.34 Favored 'General case' 0 C--N 1.323 -0.554 0 N-CA-C 109.619 -0.511 . . . . 1.0 109.619 179.426 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 58' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -87.3 174.49 8.54 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-O 122.615 1.198 . . . . 1.0 112.764 -177.899 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 59' ' ' ARG . . . . . 0.447 ' HG3' ' N ' ' A' ' 60' ' ' TYR . 2.1 ptt180 -86.17 -56.96 3.21 Favored 'General case' 0 C--N 1.318 -0.783 0 CA-C-N 111.824 -2.444 . . . . 1.0 112.259 -179.538 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 60' ' ' TYR . . . . . 0.447 ' N ' ' HG3' ' A' ' 59' ' ' ARG . 41.4 t80 -92.42 -17.28 24.8 Favored 'General case' 0 C--O 1.249 1.052 0 N-CA-C 113.521 0.934 . . . . 1.0 113.521 -179.181 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 5.3 tt0 -79.51 -13.9 59.25 Favored 'General case' 0 C--N 1.313 -0.996 0 CA-C-N 115.973 -0.558 . . . . 1.0 110.482 -179.292 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 62' ' ' VAL . . . . . 0.645 ' O ' ' N ' ' A' ' 66' ' ' GLY . 27.4 m -47.39 -55.32 2.22 Favored 'Isoleucine or valine' 0 C--O 1.201 -1.498 0 C-N-CA 119.326 -0.95 . . . . 1.0 110.107 -176.608 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 63' ' ' ALA . . . . . 0.619 ' N ' HG23 ' A' ' 62' ' ' VAL . . . -68.77 -54.87 13.43 Favored 'General case' 0 C--N 1.306 -1.292 0 C-N-CA 119.338 -0.945 . . . . 1.0 109.416 -178.466 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 64' ' ' HIS . . . . . 0.474 ' O ' ' HB2' ' A' ' 67' ' ' ARG . 6.6 t-80 -44.98 -58.38 3.2 Favored 'General case' 0 N--CA 1.472 0.645 0 CA-C-O 121.519 0.676 . . . . 1.0 109.99 179.516 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 65' ' ' ASP . . . . . 0.529 ' C ' ' H ' ' A' ' 67' ' ' ARG . 0.5 OUTLIER -73.18 -47.02 47.23 Favored 'General case' 0 C--N 1.313 -1.006 0 CA-C-N 115.551 -0.75 . . . . 1.0 109.991 177.917 . . . . . . . . 3 3 . 1 . 025 nuclear build core ' A' A ' 66' ' ' GLY . . . . . 0.645 ' N ' ' O ' ' A' ' 62' ' ' VAL . . . -75.4 25.46 1.34 Allowed Glycine 0 CA--C 1.53 0.977 0 O-C-N 120.526 -1.359 . . . . 1.0 110.354 177.5 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 67' ' ' ARG . . . . . 0.603 ' O ' ' N ' ' A' ' 69' ' ' LEU . 5.5 mmt180 -72.02 5.26 2.8 Favored 'General case' 0 CA--C 1.508 -0.655 0 N-CA-C 105.969 -1.863 . . . . 1.0 105.969 175.115 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 68' ' ' LEU . . . . . 0.553 ' H ' ' C ' ' A' ' 66' ' ' GLY . 0.7 OUTLIER -33.94 -28.1 0.01 OUTLIER 'General case' 0 C--N 1.354 0.787 0 O-C-N 124.181 0.926 . . . . 1.0 109.173 -176.709 . . . . . . . . 3 3 . 1 . 025 nuclear build core ' A' A ' 69' ' ' LEU . . . . . 0.603 ' N ' ' O ' ' A' ' 67' ' ' ARG . 9.0 mp -62.47 -64.94 0.77 Allowed 'General case' 0 N--CA 1.471 0.624 0 C-N-CA 118.885 -1.126 . . . . 1.0 108.237 177.362 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 70' ' ' ALA . . . . . 0.586 ' O ' ' N ' ' A' ' 72' ' ' HIS . . . -76.71 -74.28 0.25 Allowed 'General case' 0 C--O 1.217 -0.634 0 N-CA-C 104.833 -2.284 . . . . 1.0 104.833 177.126 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 71' ' ' ALA . . . . . 0.463 ' O ' ' OD1' ' A' ' 75' ' ' ASN . . . -40.66 2.65 0.0 OUTLIER 'General case' 0 N--CA 1.473 0.707 0 N-CA-C 115.27 1.582 . . . . 1.0 115.27 179.832 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 72' ' ' HIS . . . . . 0.645 ' CG ' ' H ' ' A' ' 73' ' ' MET . 0.0 OUTLIER -30.45 -81.97 0.01 OUTLIER 'General case' 0 CA--C 1.532 0.284 0 CA-C-N 119.954 1.252 . . . . 1.0 114.114 -176.425 . . . . . . . . 3 3 . 1 . 025 nuclear build core ' A' A ' 73' ' ' MET . . . . . 0.645 ' H ' ' CG ' ' A' ' 72' ' ' HIS . 72.1 mtm -63.9 -53.64 47.34 Favored 'General case' 0 N--CA 1.439 -0.979 0 C-N-CA 120.002 -0.679 . . . . 1.0 110.066 -179.443 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 74' ' ' VAL . . . . . 0.683 ' O ' ' N ' ' A' ' 76' ' ' GLY . 0.6 OUTLIER -46.25 -35.86 2.49 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.718 0 CA-C-O 117.533 -1.222 . . . . 1.0 111.644 -176.092 . . . . . . . . 3 3 . 1 . 025 nuclear build core ' A' A ' 75' ' ' ASN . . . . . 0.569 ' C ' ' N ' ' A' ' 77' ' ' ILE . 16.1 m120 -39.95 -9.46 0.01 OUTLIER 'General case' 0 N--CA 1.497 1.9 0 CA-C-N 121.055 1.752 . . . . 1.0 112.363 177.759 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 76' ' ' GLY . . . . . 0.683 ' N ' ' O ' ' A' ' 74' ' ' VAL . . . -41.95 -21.67 0.08 OUTLIER Glycine 0 CA--C 1.542 1.732 0 N-CA-C 107.533 -2.227 . . . . 1.0 107.533 177.051 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 77' ' ' ILE . . . . . 0.756 ' HA ' ' HB3' ' A' ' 80' ' ' ALA . 13.4 pt -74.87 -53.2 17.08 Favored 'Isoleucine or valine' 0 C--O 1.213 -0.86 0 CA-C-N 114.968 -0.616 . . . . 1.0 109.536 177.565 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 78' ' ' VAL . . . . . 0.531 ' N ' ' O ' ' A' ' 75' ' ' ASN . 3.2 p -36.15 -30.14 0.04 OUTLIER 'Isoleucine or valine' 0 CA--C 1.554 1.12 0 N-CA-C 108.631 -0.877 . . . . 1.0 108.631 -174.332 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 79' ' ' ILE . . . . . 0.882 ' O ' ' HB2' ' A' ' 83' ' ' ALA . 0.0 OUTLIER -94.64 -28.16 4.2 Favored 'Isoleucine or valine' 0 CA--C 1.555 1.135 0 CA-C-O 121.186 0.517 . . . . 1.0 109.978 176.907 . . . . . . . . 3 3 . 1 . 025 nuclear build core ' A' A ' 80' ' ' ALA . . . . . 0.756 ' HB3' ' HA ' ' A' ' 77' ' ' ILE . . . -87.48 -10.88 50.6 Favored 'General case' 0 CA--C 1.553 1.063 0 C-N-CA 124.153 0.981 . . . . 1.0 113.419 177.752 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 81' ' ' GLU . . . . . 0.542 ' N ' ' O ' ' A' ' 77' ' ' ILE . 2.3 mt-10 -83.2 -70.55 0.55 Allowed 'General case' 0 C--N 1.354 0.803 0 CA-C-N 119.309 0.959 . . . . 1.0 108.561 178.759 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 82' ' ' ASP . . . . . 0.491 ' O ' ' N ' ' A' ' 84' ' ' LEU . 8.8 p-10 -78.07 -12.29 59.98 Favored 'General case' 0 N--CA 1.445 -0.683 0 CA-C-N 118.315 0.507 . . . . 1.0 111.565 -179.637 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 83' ' ' ALA . . . . . 0.882 ' HB2' ' O ' ' A' ' 79' ' ' ILE . . . -22.48 -44.16 0.01 OUTLIER 'General case' 0 N--CA 1.475 0.818 0 N-CA-C 113.207 0.817 . . . . 1.0 113.207 177.683 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 84' ' ' LEU . . . . . 0.491 ' N ' ' O ' ' A' ' 82' ' ' ASP . 0.4 OUTLIER -36.9 -34.94 0.08 Allowed 'General case' 0 N--CA 1.469 0.518 0 N-CA-C 112.576 0.584 . . . . 1.0 112.576 -176.782 . . . . . . . . 3 3 . 1 . 025 nuclear build core ' A' A ' 85' ' ' ILE . . . . . 0.444 ' O ' HG13 ' A' ' 89' ' ' VAL . 2.0 pt -99.95 -41.72 9.63 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.669 0 N-CA-C 108.391 -0.966 . . . . 1.0 108.391 177.444 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 86' ' ' ALA . . . . . 0.764 ' HB3' ' HA ' ' A' ' 83' ' ' ALA . . . -59.58 -56.87 16.45 Favored 'General case' 0 CA--C 1.537 0.479 0 CA-C-N 113.93 -1.487 . . . . 1.0 109.639 -179.01 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 87' ' ' GLU . . . . . 0.492 ' N ' ' O ' ' A' ' 83' ' ' ALA . 14.4 tt0 -70.92 -21.48 62.36 Favored 'General case' 0 CA--C 1.544 0.744 0 O-C-N 121.184 -0.947 . . . . 1.0 112.951 -177.439 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -74.43 -5.41 42.32 Favored 'General case' 0 N--CA 1.48 1.049 0 CA-C-O 122.931 1.348 . . . . 1.0 108.759 179.711 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 89' ' ' VAL . . . . . 0.728 HG22 ' O ' ' A' ' 86' ' ' ALA . 11.7 m -109.85 37.34 0.52 Allowed 'Isoleucine or valine' 0 C--N 1.312 -1.036 0 CA-C-N 112.351 -2.204 . . . . 1.0 109.896 178.017 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 90' ' ' GLY . . . . . 0.596 ' C ' ' H ' ' A' ' 92' ' ' HIS . . . -75.86 -36.35 42.26 Favored Glycine 0 C--N 1.349 1.254 0 N-CA-C 110.63 -0.988 . . . . 1.0 110.63 178.803 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 91' ' ' PRO . . . . . 0.581 ' CD ' ' N ' ' A' ' 90' ' ' GLY . 82.8 Cg_exo -48.26 -9.21 0.07 OUTLIER 'Trans proline' 0 N--CA 1.499 1.798 0 C-N-CA 122.191 1.928 . . . . 1.0 109.971 176.982 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 92' ' ' HIS . . . . . 0.596 ' H ' ' C ' ' A' ' 90' ' ' GLY . 1.8 p80 -55.99 -17.35 6.55 Favored 'General case' 0 N--CA 1.445 -0.717 0 N-CA-C 107.519 -1.289 . . . . 1.0 107.519 179.253 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 93' ' ' LEU . . . . . 0.579 HD12 ' N ' ' A' ' 94' ' ' ALA . 1.4 pp -63.32 -58.76 6.08 Favored 'General case' 0 N--CA 1.451 -0.405 0 N-CA-C 108.995 -0.743 . . . . 1.0 108.995 177.542 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 94' ' ' ALA . . . . . 0.579 ' N ' HD12 ' A' ' 93' ' ' LEU . . . -57.1 -50.91 71.33 Favored 'General case' 0 CA--C 1.515 -0.377 0 C-N-CA 120.318 -0.553 . . . . 1.0 110.095 -179.996 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 95' ' ' ARG . . . . . 0.652 ' O ' ' N ' ' A' ' 97' ' ' LEU . 83.7 mtt85 -59.36 -55.95 28.23 Favored 'General case' 0 C--N 1.322 -0.623 0 N-CA-C 107.516 -1.29 . . . . 1.0 107.516 178.781 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 96' ' ' ALA . . . . . 0.87 ' O ' ' N ' ' A' ' 98' ' ' GLY . . . -46.8 -13.42 0.03 OUTLIER 'General case' 0 N--CA 1.427 -1.575 0 O-C-N 119.118 -2.238 . . . . 1.0 110.15 179.846 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 97' ' ' LEU . . . . . 0.744 ' O ' ' N ' ' A' ' 100' ' ' ILE . 0.4 OUTLIER 7.38 -54.71 0.0 OUTLIER 'General case' 0 C--N 1.372 1.544 0 CA-C-O 117.547 -1.216 . . . . 1.0 109.993 -169.298 . . . . . . . . 3 3 . 1 . 025 nuclear build core ' A' A ' 98' ' ' GLY . . . . . 0.87 ' N ' ' O ' ' A' ' 96' ' ' ALA . . . -49.01 -24.0 4.14 Favored Glycine 0 C--N 1.289 -2.079 0 CA-C-N 122.833 2.561 . . . . 1.0 108.849 174.767 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 99' ' ' GLN . . . . . 0.576 ' N ' ' O ' ' A' ' 96' ' ' ALA . 1.9 tp60 -66.36 -15.89 63.63 Favored 'General case' 0 C--N 1.364 1.223 0 N-CA-C 106.405 -1.702 . . . . 1.0 106.405 177.249 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 100' ' ' ILE . . . . . 0.744 ' N ' ' O ' ' A' ' 97' ' ' LEU . 0.4 OUTLIER -64.04 -45.58 96.24 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.52 0 N-CA-C 108.088 -1.079 . . . . 1.0 108.088 177.089 . . . . . . . . 3 3 . 1 . 025 nuclear build core ' A' A ' 101' ' ' VAL . . . . . 0.651 ' O ' ' N ' ' A' ' 105' ' ' GLY . 71.9 t -53.74 -61.61 0.87 Allowed 'Isoleucine or valine' 0 CA--C 1.5 -0.963 0 N-CA-C 108.433 -0.951 . . . . 1.0 108.433 179.411 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 102' ' ' CYS . . . . . 0.902 ' O ' ' HB2' ' A' ' 106' ' ' ALA . 4.2 t -46.07 -21.75 0.17 Allowed 'General case' 0 N--CA 1.427 -1.625 0 CA-C-N 115.569 -0.741 . . . . 1.0 112.317 -178.031 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -88.69 -43.78 11.06 Favored 'General case' 0 N--CA 1.484 1.255 0 O-C-N 124.194 0.934 . . . . 1.0 112.02 176.554 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 104' ' ' TYR . . . . . 0.643 ' O ' ' CD1' ' A' ' 104' ' ' TYR . 0.1 OUTLIER -101.3 21.23 14.4 Favored 'General case' 0 N--CA 1.473 0.692 0 CA-C-N 113.956 -1.475 . . . . 1.0 109.736 178.367 . . . . . . . . 3 3 . 1 . 025 nuclear build core ' A' A ' 105' ' ' GLY . . . . . 0.651 ' N ' ' O ' ' A' ' 101' ' ' VAL . . . -159.59 -94.34 0.1 Allowed Glycine 0 C--N 1.345 1.051 0 N-CA-C 105.232 -3.147 . . . . 1.0 105.232 176.771 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 106' ' ' ALA . . . . . 0.902 ' HB2' ' O ' ' A' ' 102' ' ' CYS . . . 72.0 60.34 0.14 Allowed 'General case' 0 N--CA 1.446 -0.625 0 CA-C-O 119.333 -0.365 . . . . 1.0 111.729 -179.345 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 107' ' ' THR . . . . . 0.446 ' C ' ' H ' ' A' ' 109' ' ' ILE . 44.6 p -81.91 -62.54 1.6 Allowed 'General case' 0 C--N 1.353 0.724 0 O-C-N 120.375 -1.453 . . . . 1.0 109.521 179.403 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 15.5 m -65.2 22.45 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.35 0.599 0 N-CA-C 113.025 0.75 . . . . 1.0 113.025 -176.799 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 109' ' ' ILE . . . . . 0.7 ' H ' ' HD2' ' A' ' 110' ' ' PRO . 0.1 OUTLIER -114.92 -56.96 0.04 OUTLIER Pre-proline 0 CA--C 1.561 1.4 0 CA-C-N 119.089 0.859 . . . . 1.0 108.946 173.954 . . . . . . . . 3 3 . 1 . 025 nuclear build core ' A' A ' 110' ' ' PRO . . . . . 0.7 ' HD2' ' H ' ' A' ' 109' ' ' ILE . 19.4 Cg_endo -52.24 -38.54 72.23 Favored 'Trans proline' 0 N--CA 1.497 1.696 0 C-N-CA 123.243 2.628 . . . . 1.0 112.723 -179.838 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 12.4 m120 -67.01 -68.06 0.41 Allowed 'General case' 0 CA--C 1.51 -0.577 0 C-N-CA 119.268 -0.973 . . . . 1.0 108.76 -177.762 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 112' ' ' ILE . . . . . 0.579 ' O ' ' N ' ' A' ' 115' ' ' ALA . 18.6 pt -51.64 -40.8 26.77 Favored 'Isoleucine or valine' 0 C--O 1.215 -0.749 0 N-CA-C 106.718 -1.586 . . . . 1.0 106.718 178.207 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 113' ' ' ASN . . . . . 0.459 ' HB2' ' O ' ' A' ' 109' ' ' ILE . 26.5 t-20 -45.78 -51.83 12.1 Favored 'General case' 0 CA--C 1.503 -0.836 0 CA-C-N 114.047 -1.433 . . . . 1.0 108.041 -176.49 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -64.02 -27.36 69.07 Favored 'General case' 0 N--CA 1.435 -1.195 0 C-N-CA 119.494 -0.882 . . . . 1.0 109.957 177.763 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 115' ' ' ALA . . . . . 0.579 ' N ' ' O ' ' A' ' 112' ' ' ILE . . . -76.08 -60.56 2.28 Favored 'General case' 0 N--CA 1.444 -0.757 0 N-CA-C 107.546 -1.279 . . . . 1.0 107.546 177.852 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 116' ' ' ILE . . . . . 0.577 ' O ' ' C ' ' A' ' 117' ' ' GLU . 1.3 mp -47.69 -42.47 9.03 Favored 'Isoleucine or valine' 0 C--N 1.363 1.184 0 N-CA-C 108.198 -1.038 . . . . 1.0 108.198 178.768 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 117' ' ' GLU . . . . . 0.577 ' C ' ' O ' ' A' ' 116' ' ' ILE . 23.6 tt0 -38.92 -55.57 1.52 Allowed 'General case' 0 N--CA 1.472 0.671 0 N-CA-C 104.607 -2.368 . . . . 1.0 104.607 178.439 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 118' ' ' VAL . . . . . 0.434 ' N ' ' O ' ' A' ' 115' ' ' ALA . 40.5 t -70.13 -55.07 15.96 Favored 'Isoleucine or valine' 0 CA--C 1.559 1.306 0 CA-C-N 113.954 -1.476 . . . . 1.0 110.77 176.11 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -60.39 -19.62 56.56 Favored 'General case' 0 N--CA 1.49 1.565 0 N-CA-C 115.491 1.663 . . . . 1.0 115.491 -177.735 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 120' ' ' GLY . . . . . 0.512 ' O ' ' CB ' ' A' ' 121' ' ' THR . . . -121.09 -43.95 0.42 Allowed Glycine 0 C--N 1.354 1.554 0 N-CA-C 108.618 -1.793 . . . . 1.0 108.618 176.581 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 121' ' ' THR . . . . . 0.552 ' HB ' HG22 ' A' ' 123' ' ' THR . 45.8 m 127.54 -46.33 0.01 OUTLIER 'General case' 0 N--CA 1.48 1.057 0 C-N-CA 124.962 1.305 . . . . 1.0 108.5 -179.55 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 122' ' ' GLY . . . . . 0.666 ' O ' ' N ' ' A' ' 124' ' ' ASP . . . 104.33 -15.55 50.2 Favored Glycine 0 N--CA 1.472 1.093 0 N-CA-C 108.499 -1.84 . . . . 1.0 108.499 -178.448 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 123' ' ' THR . . . . . 0.651 HG23 ' O ' ' A' ' 123' ' ' THR . 9.5 t -55.43 82.84 0.0 OUTLIER 'General case' 0 C--N 1.322 -0.628 0 N-CA-C 105.436 -2.061 . . . . 1.0 105.436 178.576 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 124' ' ' ASP . . . . . 0.666 ' N ' ' O ' ' A' ' 122' ' ' GLY . 53.0 p30 -167.68 176.11 6.6 Favored 'General case' 0 C--N 1.342 0.281 0 CA-C-N 114.581 -1.19 . . . . 1.0 112.17 179.825 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 125' ' ' TYR . . . . . . . . . . . . . 2.3 t80 -138.83 138.85 37.89 Favored 'General case' 0 CA--C 1.535 0.395 0 N-CA-C 107.914 -1.143 . . . . 1.0 107.914 175.827 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 1.3 mmp_? -145.63 145.12 30.82 Favored 'General case' 0 N--CA 1.47 0.555 0 N-CA-C 109.187 -0.671 . . . . 1.0 109.187 179.399 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 127' ' ' PHE . . . . . . . . . . . . . 6.5 p90 . . . . . 0 N--CA 1.47 0.571 0 CA-C-O 117.958 -1.02 . . . . 1.0 110.734 -179.651 . . . . . . . . 0 0 . 1 . 026 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 62.2 mtt . . . . . 0 N--CA 1.491 1.615 0 N-CA-C 109.025 -0.731 . . . . 1.0 109.025 . . . . . . . . . 0 0 . 1 . 026 nuclear build core ' A' A ' 2' ' ' SER . . . . . 0.413 ' O ' ' CB ' ' A' ' 3' ' ' ASP . 61.2 p -104.65 9.4 35.2 Favored 'General case' 0 N--CA 1.467 0.389 0 C-N-CA 122.578 0.351 . . . . 1.0 110.925 -179.548 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 3' ' ' ASP . . . . . 0.413 ' CB ' ' O ' ' A' ' 2' ' ' SER . 0.9 OUTLIER 166.15 99.2 0.0 OUTLIER 'General case' 0 N--CA 1.466 0.357 0 O-C-N 123.411 0.444 . . . . 1.0 110.842 179.25 . . . . . . . . 3 3 . 1 . 026 nuclear build core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 65.9 t80 -149.97 144.67 25.99 Favored 'General case' 0 C--O 1.233 0.185 0 N-CA-C 110.045 -0.354 . . . . 1.0 110.045 179.446 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 45.2 m-20 -151.8 147.89 27.2 Favored 'General case' 0 C--N 1.331 -0.226 0 N-CA-C 109.909 -0.404 . . . . 1.0 109.909 -179.976 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 6' ' ' THR . . . . . 0.68 HG22 ' H ' ' A' ' 7' ' ' GLU . 18.9 m -68.9 174.64 4.24 Favored 'General case' 0 C--O 1.214 -0.801 0 C-N-CA 120.188 -0.605 . . . . 1.0 109.868 -179.924 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 7' ' ' GLU . . . . . 0.68 ' H ' HG22 ' A' ' 6' ' ' THR . 80.1 tt0 -60.76 -53.91 51.57 Favored 'General case' 0 C--N 1.314 -0.935 0 CA-C-O 121.814 0.816 . . . . 1.0 109.862 -177.982 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 8' ' ' ARG . . . . . 0.499 ' O ' ' CB ' ' A' ' 12' ' ' ALA . 18.3 ttm105 -53.19 -57.63 9.83 Favored 'General case' 0 C--N 1.309 -1.17 0 C-N-CA 119.103 -1.039 . . . . 1.0 108.283 -178.456 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 9' ' ' VAL . . . . . 0.543 ' O ' HG23 ' A' ' 13' ' ' VAL . 0.0 OUTLIER -65.09 -47.44 87.78 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.807 0 CA-C-N 113.913 -1.494 . . . . 1.0 110.227 179.687 . . . . . . . . 3 3 . 1 . 026 nuclear build core ' A' A ' 10' ' ' SER . . . . . 0.617 ' N ' ' O ' ' A' ' 6' ' ' THR . 35.0 t -62.99 -59.78 4.35 Favored 'General case' 0 N--CA 1.477 0.877 0 C-N-CA 119.504 -0.879 . . . . 1.0 109.0 179.575 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 11' ' ' ARG . . . . . 0.56 ' O ' ' N ' ' A' ' 15' ' ' ALA . 2.6 tpt180 -64.62 -56.13 15.87 Favored 'General case' 0 N--CA 1.474 0.747 0 CA-C-O 120.796 0.331 . . . . 1.0 111.094 -177.667 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 12' ' ' ALA . . . . . 0.507 ' O ' ' HB3' ' A' ' 16' ' ' ALA . . . -51.57 -51.12 58.01 Favored 'General case' 0 N--CA 1.485 1.318 0 N-CA-C 106.714 -1.588 . . . . 1.0 106.714 -178.952 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 13' ' ' VAL . . . . . 0.595 ' O ' ' CB ' ' A' ' 17' ' ' LEU . 64.1 t -61.67 -50.06 81.79 Favored 'Isoleucine or valine' 0 C--O 1.202 -1.408 0 C-N-CA 118.448 -1.301 . . . . 1.0 108.542 178.044 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 14' ' ' ALA . . . . . 0.669 ' O ' HG13 ' A' ' 18' ' ' VAL . . . -58.72 -61.12 2.85 Favored 'General case' 0 C--O 1.214 -0.78 0 C-N-CA 118.273 -1.371 . . . . 1.0 109.51 179.511 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 15' ' ' ALA . . . . . 0.572 ' O ' ' N ' ' A' ' 19' ' ' GLY . . . -53.06 -57.02 11.82 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-O 121.727 0.775 . . . . 1.0 110.499 -178.461 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 16' ' ' ALA . . . . . 0.507 ' HB3' ' O ' ' A' ' 12' ' ' ALA . . . -62.14 -53.2 58.79 Favored 'General case' 0 C--N 1.31 -1.151 0 CA-C-N 114.666 -1.152 . . . . 1.0 108.658 -179.086 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 17' ' ' LEU . . . . . 0.595 ' CB ' ' O ' ' A' ' 13' ' ' VAL . 6.3 tp -57.19 -52.84 63.71 Favored 'General case' 0 N--CA 1.475 0.814 0 CA-C-N 114.335 -1.302 . . . . 1.0 108.832 -177.918 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 18' ' ' VAL . . . . . 0.669 HG13 ' O ' ' A' ' 14' ' ' ALA . 3.1 m -68.62 -56.12 13.46 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.521 0 C-N-CA 119.498 -0.881 . . . . 1.0 109.693 179.215 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 19' ' ' GLY . . . . . 0.572 ' N ' ' O ' ' A' ' 15' ' ' ALA . . . -63.73 -169.52 1.49 Allowed Glycine 0 CA--C 1.525 0.695 0 N-CA-C 112.118 -0.393 . . . . 1.0 112.118 -178.966 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 20' ' ' PRO . . . . . 0.603 ' O ' ' N ' ' A' ' 24' ' ' ALA . 1.0 OUTLIER -79.42 -23.88 6.94 Favored 'Trans proline' 0 C--N 1.311 -1.401 0 C-N-CA 122.925 2.417 . . . . 1.0 112.993 -179.1 . . . . . . . . 3 3 . 1 . 026 nuclear build core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -59.71 -58.6 13.41 Favored Glycine 0 N--CA 1.475 1.3 0 C-N-CA 119.789 -1.196 . . . . 1.0 111.877 -176.674 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 22' ' ' GLY . . . . . 0.455 ' CA ' ' HB1' ' A' ' 16' ' ' ALA . . . -59.74 -51.76 57.04 Favored Glycine 0 CA--C 1.501 -0.815 0 N-CA-C 106.86 -2.496 . . . . 1.0 106.86 -178.012 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 23' ' ' VAL . . . . . 0.599 ' O ' HG12 ' A' ' 27' ' ' VAL . 29.5 t -58.32 -35.78 55.25 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.032 0 CA-C-N 114.126 -1.037 . . . . 1.0 108.941 -179.758 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 24' ' ' ALA . . . . . 0.603 ' N ' ' O ' ' A' ' 20' ' ' PRO . . . -61.92 -60.48 3.57 Favored 'General case' 0 CA--C 1.536 0.429 0 C-N-CA 118.524 -1.27 . . . . 1.0 110.255 -179.921 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 25' ' ' LEU . . . . . 0.531 ' N ' HD12 ' A' ' 25' ' ' LEU . 9.9 mp -65.02 -44.96 87.43 Favored 'General case' 0 C--N 1.344 0.332 0 CA-C-N 119.257 0.935 . . . . 1.0 112.408 -177.69 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 89.6 t -62.17 -58.79 5.99 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.308 0 C-N-CA 118.826 -1.149 . . . . 1.0 110.268 -177.311 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 27' ' ' VAL . . . . . 0.599 HG12 ' O ' ' A' ' 23' ' ' VAL . 1.3 p -60.28 -35.31 61.42 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 O-C-N 121.802 -0.561 . . . . 1.0 112.269 -177.476 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 14.0 tmtt? -67.88 -54.58 17.78 Favored 'General case' 0 C--N 1.318 -0.788 0 CA-C-O 121.449 0.643 . . . . 1.0 110.077 -178.591 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 29' ' ' VAL . . . . . 0.407 HG12 ' O ' ' A' ' 25' ' ' LEU . 9.9 p -63.11 -45.21 99.22 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.834 0 C-N-CA 119.338 -0.945 . . . . 1.0 110.508 -178.333 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 30' ' ' CYS . . . . . . . . . . . . . 1.4 t -66.3 -60.94 2.3 Favored 'General case' 0 CA--C 1.532 0.256 0 C-N-CA 119.123 -1.031 . . . . 1.0 110.004 -179.607 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 31' ' ' ALA . . . . . 0.5 ' HB2' ' NH1' ' A' ' 47' ' ' ARG . . . -64.65 -52.81 55.4 Favored 'General case' 0 CA--C 1.511 -0.536 0 N-CA-C 112.923 0.712 . . . . 1.0 112.923 -176.44 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 85.02 74.38 1.25 Allowed Glycine 0 CA--C 1.526 0.764 0 N-CA-C 109.135 -1.586 . . . . 1.0 109.135 -177.256 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 23.1 mt 86.09 95.49 0.03 OUTLIER Pre-proline 0 N--CA 1.479 0.983 0 C-N-CA 123.676 0.79 . . . . 1.0 110.521 -179.17 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 47.5 Cg_endo -68.3 -27.76 34.11 Favored 'Trans proline' 0 N--CA 1.506 2.26 0 C-N-CA 122.221 1.947 . . . . 1.0 115.085 -177.843 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 35' ' ' GLY . . . . . 0.402 ' HA3' HD12 ' A' ' 112' ' ' ILE . . . -62.08 -58.72 11.46 Favored Glycine 0 CA--C 1.53 1.029 0 C-N-CA 118.233 -1.937 . . . . 1.0 109.383 -178.678 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 36' ' ' VAL . . . . . 0.519 ' O ' HG22 ' A' ' 37' ' ' ILE . 11.3 p -88.88 162.09 2.61 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.462 0 N-CA-C 106.231 -1.766 . . . . 1.0 106.231 177.215 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 37' ' ' ILE . . . . . 0.519 HG22 ' O ' ' A' ' 36' ' ' VAL . 0.0 OUTLIER 118.99 120.01 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.476 0.865 0 C-N-CA 124.322 1.049 . . . . 1.0 108.506 -179.238 . . . . . . . . 3 3 . 1 . 026 nuclear build core ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 46.8 m80 -142.11 133.85 27.01 Favored 'General case' 0 C--N 1.332 -0.154 0 N-CA-C 108.412 -0.958 . . . . 1.0 108.412 179.072 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -110.38 134.87 20.69 Favored Pre-proline 0 C--N 1.325 -0.464 0 N-CA-C 108.439 -0.949 . . . . 1.0 108.439 -179.716 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 37.1 Cg_endo -66.36 -85.55 0.01 OUTLIER 'Trans proline' 0 N--CA 1.49 1.31 0 CA-C-N 119.994 1.034 . . . . 1.0 111.469 -179.047 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -66.16 121.9 16.22 Favored 'General case' 0 C--N 1.317 -0.808 0 CA-C-N 114.991 -1.004 . . . . 1.0 110.298 -178.714 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 42' ' ' ARG . . . . . 0.648 ' C ' ' H ' ' A' ' 44' ' ' GLY . 34.2 ptt180 -169.15 166.04 10.9 Favored 'General case' 0 N--CA 1.434 -1.27 0 N-CA-C 109.133 -0.691 . . . . 1.0 109.133 179.062 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 43' ' ' ARG . . . . . 0.611 ' HG3' ' O ' ' A' ' 45' ' ' PHE . 0.0 OUTLIER -65.33 25.07 0.02 OUTLIER 'General case' 0 C--N 1.311 -1.078 0 CA-C-N 115.717 -0.674 . . . . 1.0 110.249 -179.067 . . . . . . . . 3 3 . 1 . 026 nuclear build core ' A' A ' 44' ' ' GLY . . . . . 0.648 ' H ' ' C ' ' A' ' 42' ' ' ARG . . . 76.63 -24.92 1.78 Allowed Glycine 0 C--N 1.345 1.072 0 N-CA-C 111.869 -0.492 . . . . 1.0 111.869 179.27 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 45' ' ' PHE . . . . . 0.804 ' O ' ' HB2' ' A' ' 46' ' ' PHE . 35.2 t80 -162.76 164.81 26.11 Favored 'General case' 0 C--O 1.198 -1.606 0 CA-C-O 119.003 -0.522 . . . . 1.0 110.155 -179.268 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 46' ' ' PHE . . . . . 0.804 ' HB2' ' O ' ' A' ' 45' ' ' PHE . 2.7 t80 131.18 93.07 0.0 OUTLIER 'General case' 0 N--CA 1.517 2.894 0 C-N-CA 124.396 1.078 . . . . 1.0 111.134 178.125 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 47' ' ' ARG . . . . . 0.531 ' CB ' ' O ' ' A' ' 46' ' ' PHE . 2.1 tmm_? 118.46 151.82 0.0 OUTLIER 'General case' 0 N--CA 1.482 1.13 0 C-N-CA 124.697 1.199 . . . . 1.0 108.842 -179.981 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER 70.3 70.98 0.21 Allowed 'General case' 0 CA--C 1.534 0.357 0 N-CA-C 108.316 -0.994 . . . . 1.0 108.316 -177.918 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -134.75 140.11 34.37 Favored Pre-proline 0 CA--C 1.541 0.597 0 N-CA-C 108.467 -0.938 . . . . 1.0 108.467 -179.018 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 50' ' ' PRO . . . . . 0.413 ' C ' ' H ' ' A' ' 52' ' ' ARG . 55.3 Cg_endo -66.9 69.22 0.53 Allowed 'Trans proline' 0 N--CA 1.5 1.887 0 C-N-CA 121.793 1.662 . . . . 1.0 112.74 -179.032 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 51' ' ' GLU . . . . . 0.452 ' N ' ' CD ' ' A' ' 51' ' ' GLU . 0.7 OUTLIER 63.64 -9.16 0.14 Allowed 'General case' 0 N--CA 1.468 0.439 0 N-CA-C 112.574 0.583 . . . . 1.0 112.574 179.868 . . . . . . . . 3 3 . 1 . 026 nuclear build core ' A' A ' 52' ' ' ARG . . . . . 0.413 ' H ' ' C ' ' A' ' 50' ' ' PRO . 0.0 OUTLIER -76.6 168.99 19.11 Favored 'General case' 0 N--CA 1.466 0.36 0 C-N-CA 119.781 -0.768 . . . . 1.0 110.5 179.747 . . . . . . . . 3 3 . 1 . 026 nuclear build core ' A' A ' 53' ' ' ILE . . . . . 0.457 ' O ' ' N ' ' A' ' 55' ' ' ILE . 8.2 pt -81.42 135.77 24.41 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.464 0 CA-C-O 122.018 0.913 . . . . 1.0 110.97 -179.974 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 6.3 pm0 -61.42 83.14 0.01 OUTLIER 'General case' 0 C--N 1.314 -0.967 0 CA-C-N 113.712 -1.585 . . . . 1.0 108.82 -178.303 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 55' ' ' ILE . . . . . 0.457 ' N ' ' O ' ' A' ' 53' ' ' ILE . 20.8 tt -150.47 158.74 5.1 Favored 'Isoleucine or valine' 0 C--N 1.354 0.776 0 CA-C-N 116.429 -0.35 . . . . 1.0 110.654 178.255 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 107.72 -5.94 35.21 Favored Glycine 0 N--CA 1.486 2.017 0 N-CA-C 111.491 -0.644 . . . . 1.0 111.491 179.319 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 57' ' ' ASP . . . . . 0.445 ' CG ' ' NH1' ' A' ' 43' ' ' ARG . 8.4 p-10 -78.56 103.54 8.57 Favored 'General case' 0 C--N 1.311 -1.102 0 CA-C-N 114.501 -0.85 . . . . 1.0 109.91 178.604 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 58' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -89.74 173.15 8.44 Favored 'General case' 0 CA--C 1.555 1.169 0 CA-C-O 123.375 1.559 . . . . 1.0 114.417 -176.976 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 59' ' ' ARG . . . . . 0.705 ' HE ' ' H ' ' A' ' 59' ' ' ARG . 0.0 OUTLIER -74.04 -61.04 1.99 Allowed 'General case' 0 N--CA 1.479 0.993 0 CA-C-N 111.414 -2.63 . . . . 1.0 111.694 -178.825 . . . . . . . . 3 3 . 1 . 026 nuclear build core ' A' A ' 60' ' ' TYR . . . . . 0.544 ' O ' ' CG ' ' A' ' 60' ' ' TYR . 65.9 t80 -92.17 -8.91 44.22 Favored 'General case' 0 C--O 1.244 0.813 0 C-N-CA 124.593 1.157 . . . . 1.0 113.241 -179.661 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -79.12 -17.32 55.3 Favored 'General case' 0 N--CA 1.432 -1.346 0 O-C-N 121.348 -0.845 . . . . 1.0 111.366 -178.347 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 62' ' ' VAL . . . . . 0.655 ' O ' ' N ' ' A' ' 66' ' ' GLY . 25.9 m -49.02 -54.49 5.28 Favored 'Isoleucine or valine' 0 C--O 1.199 -1.603 0 C-N-CA 119.802 -0.759 . . . . 1.0 110.512 -174.954 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 63' ' ' ALA . . . . . 0.493 ' N ' HG23 ' A' ' 62' ' ' VAL . . . -69.03 -49.7 55.3 Favored 'General case' 0 C--N 1.308 -1.225 0 O-C-N 121.498 -0.751 . . . . 1.0 109.539 -179.427 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 64' ' ' HIS . . . . . 0.4 ' O ' ' HB2' ' A' ' 67' ' ' ARG . 1.0 OUTLIER -50.18 -56.57 10.49 Favored 'General case' 0 CA--C 1.54 0.592 0 CA-C-N 115.226 -0.897 . . . . 1.0 108.613 -179.005 . . . . . . . . 3 3 . 1 . 026 nuclear build core ' A' A ' 65' ' ' ASP . . . . . 0.599 ' C ' ' H ' ' A' ' 67' ' ' ARG . 32.7 t0 -74.69 -46.46 37.64 Favored 'General case' 0 C--N 1.317 -0.832 0 CA-C-N 115.594 -0.73 . . . . 1.0 110.115 178.094 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 66' ' ' GLY . . . . . 0.655 ' N ' ' O ' ' A' ' 62' ' ' VAL . . . -72.92 25.19 0.8 Allowed Glycine 0 N--CA 1.444 -0.822 0 N-CA-C 109.663 -1.375 . . . . 1.0 109.663 177.556 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 67' ' ' ARG . . . . . 0.627 ' O ' ' N ' ' A' ' 69' ' ' LEU . 0.0 OUTLIER -72.49 6.2 2.52 Favored 'General case' 0 N--CA 1.452 -0.335 0 N-CA-C 105.477 -2.045 . . . . 1.0 105.477 174.761 . . . . . . . . 3 3 . 1 . 026 nuclear build core ' A' A ' 68' ' ' LEU . . . . . 0.549 ' H ' ' C ' ' A' ' 66' ' ' GLY . 0.0 OUTLIER -33.1 -28.45 0.01 OUTLIER 'General case' 0 N--CA 1.483 1.202 0 N-CA-C 108.565 -0.902 . . . . 1.0 108.565 -175.746 . . . . . . . . 3 3 . 1 . 026 nuclear build core ' A' A ' 69' ' ' LEU . . . . . 0.627 ' N ' ' O ' ' A' ' 67' ' ' ARG . 8.5 tt -62.77 -64.33 0.95 Allowed 'General case' 0 C--N 1.323 -0.581 0 C-N-CA 118.797 -1.161 . . . . 1.0 108.988 178.476 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 70' ' ' ALA . . . . . 0.575 ' O ' ' N ' ' A' ' 72' ' ' HIS . . . -78.76 -74.45 0.28 Allowed 'General case' 0 N--CA 1.475 0.802 0 N-CA-C 105.485 -2.042 . . . . 1.0 105.485 176.657 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 71' ' ' ALA . . . . . 0.457 ' O ' ' C ' ' A' ' 72' ' ' HIS . . . -44.14 2.99 0.0 OUTLIER 'General case' 0 C--N 1.332 -0.158 0 C-N-CA 125.255 1.422 . . . . 1.0 114.352 179.687 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 72' ' ' HIS . . . . . 0.626 ' CG ' ' N ' ' A' ' 73' ' ' MET . 0.0 OUTLIER -28.49 -64.8 0.09 Allowed 'General case' 0 N--CA 1.47 0.564 0 CA-C-N 118.834 0.743 . . . . 1.0 111.585 -178.335 . . . . . . . . 3 3 . 1 . 026 nuclear build core ' A' A ' 73' ' ' MET . . . . . 0.626 ' N ' ' CG ' ' A' ' 72' ' ' HIS . 2.9 ptp -69.65 -50.69 41.67 Favored 'General case' 0 C--N 1.32 -0.685 0 C-N-CA 119.279 -0.968 . . . . 1.0 108.881 179.042 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 74' ' ' VAL . . . . . 0.693 ' O ' ' N ' ' A' ' 76' ' ' GLY . 86.2 t -44.85 -41.84 2.3 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.329 0 CA-C-O 117.628 -1.177 . . . . 1.0 111.433 -176.385 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 75' ' ' ASN . . . . . 0.523 ' O ' ' N ' ' A' ' 78' ' ' VAL . 1.3 t-20 -37.03 -13.45 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.703 0 CA-C-N 121.307 1.867 . . . . 1.0 112.802 179.431 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 76' ' ' GLY . . . . . 0.693 ' N ' ' O ' ' A' ' 74' ' ' VAL . . . -44.56 -25.98 0.96 Allowed Glycine 0 CA--C 1.544 1.897 0 CA-C-N 113.294 -1.776 . . . . 1.0 108.711 177.898 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 77' ' ' ILE . . . . . 0.688 ' HA ' ' HB3' ' A' ' 80' ' ' ALA . 0.2 OUTLIER -69.03 -48.07 71.89 Favored 'Isoleucine or valine' 0 C--O 1.209 -1.052 0 N-CA-C 107.519 -1.289 . . . . 1.0 107.519 178.07 . . . . . . . . 3 3 . 1 . 026 nuclear build core ' A' A ' 78' ' ' VAL . . . . . 0.639 ' H ' HD13 ' A' ' 77' ' ' ILE . 77.3 t -32.89 -35.59 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.476 0.856 0 CA-C-N 114.658 -1.155 . . . . 1.0 108.036 -176.391 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 79' ' ' ILE . . . . . 0.721 ' O ' ' HB2' ' A' ' 83' ' ' ALA . 39.0 pt -98.61 -28.44 3.56 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.948 0 CA-C-O 121.261 0.553 . . . . 1.0 111.813 176.932 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 80' ' ' ALA . . . . . 0.688 ' HB3' ' HA ' ' A' ' 77' ' ' ILE . . . -86.77 -13.76 44.26 Favored 'General case' 0 N--CA 1.477 0.922 0 N-CA-C 114.06 1.133 . . . . 1.0 114.06 178.557 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 81' ' ' GLU . . . . . 0.629 ' CG ' ' H ' ' A' ' 82' ' ' ASP . 16.1 pt-20 -83.13 -69.26 0.64 Allowed 'General case' 0 C--N 1.345 0.373 0 CA-C-N 119.042 0.837 . . . . 1.0 108.797 -179.676 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 82' ' ' ASP . . . . . 0.629 ' H ' ' CG ' ' A' ' 81' ' ' GLU . 67.1 m-20 -75.64 -10.79 59.74 Favored 'General case' 0 N--CA 1.442 -0.844 0 CA-C-N 118.075 0.398 . . . . 1.0 110.833 179.453 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 83' ' ' ALA . . . . . 0.746 ' HA ' ' HB3' ' A' ' 86' ' ' ALA . . . -19.84 -44.37 0.0 OUTLIER 'General case' 0 N--CA 1.472 0.643 0 N-CA-C 112.577 0.584 . . . . 1.0 112.577 177.029 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 84' ' ' LEU . . . . . 0.579 ' N ' ' O ' ' A' ' 82' ' ' ASP . 5.9 tp -31.65 -33.53 0.01 OUTLIER 'General case' 0 N--CA 1.473 0.702 0 CA-C-N 118.319 0.509 . . . . 1.0 111.746 -177.961 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 85' ' ' ILE . . . . . 0.716 ' O ' HG23 ' A' ' 89' ' ' VAL . 47.8 pt -100.51 -37.19 5.46 Favored 'Isoleucine or valine' 0 C--O 1.208 -1.108 0 N-CA-C 109.096 -0.705 . . . . 1.0 109.096 176.133 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 86' ' ' ALA . . . . . 0.746 ' HB3' ' HA ' ' A' ' 83' ' ' ALA . . . -66.24 -59.41 3.76 Favored 'General case' 0 C--N 1.317 -0.805 0 C-N-CA 119.647 -0.821 . . . . 1.0 111.381 -179.908 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -69.43 -18.36 63.73 Favored 'General case' 0 N--CA 1.47 0.544 0 CA-C-N 120.344 1.429 . . . . 1.0 112.294 -179.627 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -88.64 -13.1 40.67 Favored 'General case' 0 N--CA 1.475 0.817 0 CA-C-O 122.645 1.212 . . . . 1.0 108.141 179.358 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 89' ' ' VAL . . . . . 0.765 ' O ' HG12 ' A' ' 89' ' ' VAL . 53.3 t -92.22 39.66 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.32 -0.7 0 CA-C-N 111.953 -2.385 . . . . 1.0 109.474 177.654 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 90' ' ' GLY . . . . . 0.776 ' O ' ' N ' ' A' ' 92' ' ' HIS . . . -64.22 -30.17 77.05 Favored Glycine 0 C--N 1.371 2.476 0 CA-C-O 117.902 -1.499 . . . . 1.0 109.969 176.893 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 91' ' ' PRO . . . . . 0.599 ' HD2' ' N ' ' A' ' 90' ' ' GLY . 72.6 Cg_exo -40.26 -5.78 0.01 OUTLIER 'Trans proline' 0 N--CA 1.488 1.205 0 CA-C-N 120.926 2.363 . . . . 1.0 111.111 174.556 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 92' ' ' HIS . . . . . 0.776 ' N ' ' O ' ' A' ' 90' ' ' GLY . 2.5 p-80 -48.82 -24.48 1.45 Allowed 'General case' 0 N--CA 1.435 -1.211 0 N-CA-C 106.593 -1.632 . . . . 1.0 106.593 179.731 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 93' ' ' LEU . . . . . 0.553 HD12 ' N ' ' A' ' 94' ' ' ALA . 1.2 pp -60.54 -53.48 56.95 Favored 'General case' 0 N--CA 1.445 -0.697 0 N-CA-C 106.493 -1.669 . . . . 1.0 106.493 176.088 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 94' ' ' ALA . . . . . 0.553 ' N ' HD12 ' A' ' 93' ' ' LEU . . . -51.09 -53.17 36.45 Favored 'General case' 0 C--O 1.212 -0.899 0 N-CA-C 107.409 -1.33 . . . . 1.0 107.409 179.465 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 95' ' ' ARG . . . . . 0.489 ' HE ' ' HD3' ' A' ' 20' ' ' PRO . 4.5 mmp_? -61.94 -28.43 69.53 Favored 'General case' 0 CA--C 1.549 0.924 0 CA-C-O 122.297 1.046 . . . . 1.0 110.09 178.27 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 96' ' ' ALA . . . . . 0.905 ' O ' ' N ' ' A' ' 100' ' ' ILE . . . -50.4 -36.68 33.86 Favored 'General case' 0 C--O 1.195 -1.783 0 N-CA-C 107.105 -1.442 . . . . 1.0 107.105 -176.364 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 97' ' ' LEU . . . . . 0.441 ' C ' ' O ' ' A' ' 96' ' ' ALA . 0.4 OUTLIER -35.0 -23.9 0.01 OUTLIER 'General case' 0 CA--C 1.587 2.403 0 CA-C-N 113.48 -1.691 . . . . 1.0 108.512 -177.214 . . . . . . . . 3 3 . 1 . 026 nuclear build core ' A' A ' 98' ' ' GLY . . . . . 0.657 ' N ' ' O ' ' A' ' 96' ' ' ALA . . . -88.8 -53.02 2.65 Favored Glycine 0 CA--C 1.55 2.221 0 CA-C-O 123.223 1.457 . . . . 1.0 110.644 171.577 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 99' ' ' GLN . . . . . 0.586 ' N ' ' O ' ' A' ' 96' ' ' ALA . 12.2 mp0 -76.99 7.05 5.28 Favored 'General case' 0 N--CA 1.435 -1.178 0 N-CA-C 106.373 -1.714 . . . . 1.0 106.373 176.787 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 100' ' ' ILE . . . . . 0.905 ' N ' ' O ' ' A' ' 96' ' ' ALA . 0.3 OUTLIER -60.23 -52.99 54.87 Favored 'Isoleucine or valine' 0 CA--C 1.487 -1.476 0 N-CA-C 104.806 -2.294 . . . . 1.0 104.806 178.185 . . . . . . . . 3 3 . 1 . 026 nuclear build core ' A' A ' 101' ' ' VAL . . . . . 0.556 ' O ' ' N ' ' A' ' 105' ' ' GLY . 21.5 t -49.3 -60.41 0.74 Allowed 'Isoleucine or valine' 0 C--O 1.222 -0.394 0 C-N-CA 117.752 -1.579 . . . . 1.0 107.837 178.581 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 102' ' ' CYS . . . . . 0.858 ' O ' ' HB2' ' A' ' 106' ' ' ALA . 0.5 OUTLIER -50.17 -30.46 11.4 Favored 'General case' 0 C--N 1.317 -0.825 0 CA-C-N 114.931 -1.031 . . . . 1.0 110.961 -178.265 . . . . . . . . 3 3 . 1 . 026 nuclear build core ' A' A ' 103' ' ' ARG . . . . . 0.426 ' N ' ' O ' ' A' ' 99' ' ' GLN . 0.0 OUTLIER -83.69 -53.84 5.35 Favored 'General case' 0 N--CA 1.486 1.335 0 N-CA-C 114.205 1.187 . . . . 1.0 114.205 -179.322 . . . . . . . . 3 3 . 1 . 026 nuclear build core ' A' A ' 104' ' ' TYR . . . . . 0.662 ' O ' ' CG ' ' A' ' 104' ' ' TYR . 0.0 OUTLIER -94.1 21.5 6.76 Favored 'General case' 0 C--N 1.311 -1.09 0 C-N-CA 126.469 1.908 . . . . 1.0 107.871 179.122 . . . . . . . . 3 3 . 1 . 026 nuclear build core ' A' A ' 105' ' ' GLY . . . . . 0.556 ' N ' ' O ' ' A' ' 101' ' ' VAL . . . -156.76 -91.14 0.08 OUTLIER Glycine 0 N--CA 1.445 -0.733 0 N-CA-C 106.822 -2.511 . . . . 1.0 106.822 177.2 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 106' ' ' ALA . . . . . 0.858 ' HB2' ' O ' ' A' ' 102' ' ' CYS . . . 72.81 46.76 0.24 Allowed 'General case' 0 N--CA 1.449 -0.498 0 N-CA-C 112.076 0.398 . . . . 1.0 112.076 -179.94 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 10.3 t -76.67 7.22 4.83 Favored 'General case' 0 CA--C 1.513 -0.479 0 O-C-N 119.986 -1.696 . . . . 1.0 107.045 176.402 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 18.7 m -86.78 -52.53 11.65 Favored 'Isoleucine or valine' 0 C--N 1.35 0.615 0 CA-C-O 117.945 -1.026 . . . . 1.0 110.298 177.51 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 109' ' ' ILE . . . . . 0.566 ' CG2' ' HB1' ' A' ' 106' ' ' ALA . 0.1 OUTLIER -47.91 -33.93 4.99 Favored Pre-proline 0 C--N 1.368 1.394 0 N-CA-C 116.8 2.148 . . . . 1.0 116.8 -177.587 . . . . . . . . 3 3 . 1 . 026 nuclear build core ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 50.4 Cg_exo -54.79 -47.42 26.81 Favored 'Trans proline' 0 C--N 1.308 -1.564 0 CA-C-N 122.558 1.949 . . . . 1.0 112.439 -176.942 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 111' ' ' ASN . . . . . 0.462 ' O ' ' HB3' ' A' ' 114' ' ' ALA . 24.7 t-20 -72.29 -67.35 0.55 Allowed 'General case' 0 N--CA 1.467 0.4 0 C-N-CA 119.995 -0.682 . . . . 1.0 111.491 -177.184 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 112' ' ' ILE . . . . . 0.688 ' O ' ' HB ' ' A' ' 116' ' ' ILE . 0.9 OUTLIER -46.42 -28.85 0.97 Allowed 'Isoleucine or valine' 0 C--O 1.192 -1.948 0 O-C-N 121.927 -0.483 . . . . 1.0 111.99 -178.3 . . . . . . . . 3 3 . 1 . 026 nuclear build core ' A' A ' 113' ' ' ASN . . . . . 0.448 ' OD1' ' O ' ' A' ' 109' ' ' ILE . 4.3 m120 -72.0 -40.2 68.7 Favored 'General case' 0 N--CA 1.483 1.217 0 CA-C-O 123.544 1.64 . . . . 1.0 108.231 179.859 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 114' ' ' ALA . . . . . 0.462 ' HB3' ' O ' ' A' ' 111' ' ' ASN . . . -54.59 -50.0 69.07 Favored 'General case' 0 C--N 1.295 -1.796 0 CA-C-N 111.015 -2.812 . . . . 1.0 107.376 178.727 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 115' ' ' ALA . . . . . 0.722 ' O ' ' N ' ' A' ' 119' ' ' LEU . . . -85.13 -49.09 8.53 Favored 'General case' 0 C--O 1.199 -1.579 0 N-CA-C 114.402 1.26 . . . . 1.0 114.402 177.652 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 116' ' ' ILE . . . . . 0.688 ' HB ' ' O ' ' A' ' 112' ' ' ILE . 0.6 OUTLIER -42.79 -49.15 1.15 Allowed 'Isoleucine or valine' 0 N--CA 1.513 2.714 0 N-CA-C 106.109 -1.811 . . . . 1.0 106.109 179.569 . . . . . . . . 3 3 . 1 . 026 nuclear build core ' A' A ' 117' ' ' GLU . . . . . 0.439 ' C ' ' O ' ' A' ' 116' ' ' ILE . 68.3 mt-10 -45.99 -59.87 2.59 Favored 'General case' 0 C--N 1.308 -1.2 0 N-CA-C 105.573 -2.01 . . . . 1.0 105.573 177.907 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 118' ' ' VAL . . . . . 0.544 ' N ' ' O ' ' A' ' 115' ' ' ALA . 6.9 t -77.52 -57.37 5.83 Favored 'Isoleucine or valine' 0 CA--C 1.557 1.23 0 N-CA-C 113.558 0.947 . . . . 1.0 113.558 178.505 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 119' ' ' LEU . . . . . 0.722 ' N ' ' O ' ' A' ' 115' ' ' ALA . 1.3 tp -61.55 -24.44 66.64 Favored 'General case' 0 C--N 1.351 0.652 0 N-CA-C 116.218 1.933 . . . . 1.0 116.218 -178.728 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 120' ' ' GLY . . . . . 0.502 ' C ' HG22 ' A' ' 121' ' ' THR . . . -126.48 -54.93 0.15 Allowed Glycine 0 C--N 1.354 1.549 0 CA-C-N 120.506 1.503 . . . . 1.0 110.869 176.976 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 121' ' ' THR . . . . . 0.672 HG23 ' N ' ' A' ' 122' ' ' GLY . 2.1 t 143.39 -56.18 0.0 OUTLIER 'General case' 0 N--CA 1.477 0.907 0 C-N-CA 124.089 0.956 . . . . 1.0 112.036 -177.915 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 122' ' ' GLY . . . . . 0.672 ' N ' HG23 ' A' ' 121' ' ' THR . . . 92.6 -23.27 28.97 Favored Glycine 0 CA--C 1.531 1.053 0 N-CA-C 107.725 -2.15 . . . . 1.0 107.725 -176.583 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 123' ' ' THR . . . . . 0.615 HG22 HG21 ' A' ' 121' ' ' THR . 5.8 t -46.94 91.94 0.01 OUTLIER 'General case' 0 N--CA 1.477 0.918 0 N-CA-C 105.64 -1.985 . . . . 1.0 105.64 179.239 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 124' ' ' ASP . . . . . 0.592 ' N ' ' O ' ' A' ' 122' ' ' GLY . 48.2 p30 -169.76 -174.82 1.94 Allowed 'General case' 0 CA--C 1.537 0.458 0 CA-C-N 114.904 -1.044 . . . . 1.0 112.38 178.739 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 125' ' ' TYR . . . . . . . . . . . . . 16.9 t80 -148.59 147.63 29.22 Favored 'General case' 0 CA--C 1.542 0.644 0 CA-C-N 114.385 -1.28 . . . . 1.0 109.059 175.686 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 13.8 mtp85 -146.94 150.41 35.14 Favored 'General case' 0 N--CA 1.476 0.85 0 N-CA-C 109.812 -0.44 . . . . 1.0 109.812 177.38 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 127' ' ' PHE . . . . . . . . . . . . . 26.7 p90 . . . . . 0 C--O 1.22 -0.449 0 CA-C-O 118.176 -0.916 . . . . 1.0 111.231 -179.353 . . . . . . . . 0 0 . 1 . 027 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.488 1.456 0 N-CA-C 108.667 -0.864 . . . . 1.0 108.667 . . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 93.4 p -88.4 0.58 56.07 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.576 -0.284 . . . . 1.0 111.316 -179.967 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 2.0 t70 164.65 118.65 0.01 OUTLIER 'General case' 0 N--CA 1.479 0.988 0 O-C-N 123.391 0.432 . . . . 1.0 111.277 178.916 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 58.2 t80 -151.74 148.39 27.83 Favored 'General case' 0 N--CA 1.465 0.322 0 CA-C-O 121.078 0.466 . . . . 1.0 110.191 177.997 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 30.9 m-20 -152.29 148.12 27.16 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.596 -0.729 . . . . 1.0 109.788 179.754 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 6' ' ' THR . . . . . 1.038 ' H ' HG23 ' A' ' 9' ' ' VAL . 0.2 OUTLIER -106.72 -168.7 1.45 Allowed 'General case' 0 C--O 1.205 -1.286 0 CA-C-O 121.602 0.715 . . . . 1.0 109.832 -179.967 . . . . . . . . 3 3 . 1 . 027 nuclear build core ' A' A ' 7' ' ' GLU . . . . . 0.502 ' O ' ' CB ' ' A' ' 11' ' ' ARG . 71.6 mm-40 -57.66 -46.59 84.03 Favored 'General case' 0 C--N 1.297 -1.68 0 N-CA-C 109.438 -0.578 . . . . 1.0 109.438 179.77 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 8' ' ' ARG . . . . . 0.695 ' O ' ' HB3' ' A' ' 12' ' ' ALA . 16.8 mtt85 -66.58 -61.64 1.88 Allowed 'General case' 0 C--N 1.316 -0.864 0 C-N-CA 117.373 -1.731 . . . . 1.0 109.595 179.609 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 9' ' ' VAL . . . . . 1.038 HG23 ' H ' ' A' ' 6' ' ' THR . 0.0 OUTLIER -61.73 -52.86 55.83 Favored 'Isoleucine or valine' 0 C--O 1.204 -1.311 0 CA-C-N 114.769 -1.105 . . . . 1.0 110.703 -179.679 . . . . . . . . 3 3 . 1 . 027 nuclear build core ' A' A ' 10' ' ' SER . . . . . 0.72 ' N ' ' O ' ' A' ' 6' ' ' THR . 4.9 t -65.3 -61.5 2.08 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 122.074 -0.391 . . . . 1.0 111.619 178.761 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 11' ' ' ARG . . . . . 0.648 ' O ' ' HB3' ' A' ' 15' ' ' ALA . 29.4 ttt180 -62.06 -43.96 97.71 Favored 'General case' 0 C--N 1.31 -1.123 0 O-C-N 121.462 -0.774 . . . . 1.0 109.561 -175.698 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 12' ' ' ALA . . . . . 0.735 ' O ' ' HB3' ' A' ' 16' ' ' ALA . . . -70.33 -56.58 6.36 Favored 'General case' 0 N--CA 1.477 0.919 0 C-N-CA 118.825 -1.15 . . . . 1.0 109.161 176.801 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 13' ' ' VAL . . . . . 0.673 ' O ' ' CB ' ' A' ' 17' ' ' LEU . 55.0 t -61.46 -53.46 48.27 Favored 'Isoleucine or valine' 0 C--O 1.192 -1.961 0 C-N-CA 117.498 -1.681 . . . . 1.0 107.461 -178.779 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 14' ' ' ALA . . . . . 0.935 ' O ' HG22 ' A' ' 18' ' ' VAL . . . -62.82 -65.28 0.71 Allowed 'General case' 0 C--N 1.308 -1.217 0 C-N-CA 116.075 -2.25 . . . . 1.0 111.892 -179.814 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 15' ' ' ALA . . . . . 0.648 ' HB3' ' O ' ' A' ' 11' ' ' ARG . . . -55.35 -55.49 30.92 Favored 'General case' 0 C--O 1.217 -0.64 0 C-N-CA 118.321 -1.352 . . . . 1.0 111.545 -176.7 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 16' ' ' ALA . . . . . 0.735 ' HB3' ' O ' ' A' ' 12' ' ' ALA . . . -65.6 -58.67 5.2 Favored 'General case' 0 C--N 1.301 -1.502 0 C-N-CA 118.35 -1.34 . . . . 1.0 110.804 -178.491 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 17' ' ' LEU . . . . . 0.673 ' CB ' ' O ' ' A' ' 13' ' ' VAL . 5.7 tp -53.62 -55.3 27.02 Favored 'General case' 0 N--CA 1.489 1.504 0 N-CA-C 108.536 -0.913 . . . . 1.0 108.536 -179.294 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 18' ' ' VAL . . . . . 0.935 HG22 ' O ' ' A' ' 14' ' ' ALA . 2.2 m -71.03 -60.42 2.45 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.43 0 C-N-CA 118.975 -1.09 . . . . 1.0 110.85 -179.509 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 19' ' ' GLY . . . . . 0.528 ' N ' ' O ' ' A' ' 15' ' ' ALA . . . -54.54 -163.26 0.01 OUTLIER Glycine 0 N--CA 1.438 -1.218 0 CA-C-O 121.567 0.537 . . . . 1.0 113.179 -176.969 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 20' ' ' PRO . . . . . 0.72 ' O ' ' N ' ' A' ' 24' ' ' ALA . 90.6 Cg_endo -80.48 -24.75 5.06 Favored 'Trans proline' 0 C--N 1.302 -1.884 0 C-N-CA 122.246 1.964 . . . . 1.0 111.712 -179.112 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -62.11 -60.84 7.35 Favored Glycine 0 N--CA 1.47 0.914 0 C-N-CA 118.685 -1.721 . . . . 1.0 111.059 -176.921 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 22' ' ' GLY . . . . . 0.61 ' N ' ' O ' ' A' ' 16' ' ' ALA . . . -60.71 -50.39 68.1 Favored Glycine 0 C--N 1.304 -1.207 0 N-CA-C 106.954 -2.459 . . . . 1.0 106.954 179.017 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 83.2 t -58.41 -34.05 49.52 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.582 0 C-N-CA 118.837 -1.145 . . . . 1.0 107.991 -179.72 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 24' ' ' ALA . . . . . 0.72 ' N ' ' O ' ' A' ' 20' ' ' PRO . . . -61.71 -61.23 2.66 Favored 'General case' 0 N--CA 1.468 0.468 0 C-N-CA 118.685 -1.206 . . . . 1.0 109.376 179.402 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 25' ' ' LEU . . . . . 0.425 ' O ' HG12 ' A' ' 29' ' ' VAL . 58.0 mt -60.42 -45.19 94.49 Favored 'General case' 0 CA--C 1.508 -0.673 0 C-N-CA 119.59 -0.844 . . . . 1.0 110.478 -176.512 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 55.4 t -59.83 -60.34 2.66 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.512 0 C-N-CA 119.325 -0.95 . . . . 1.0 109.692 -178.278 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 27' ' ' VAL . . . . . 0.802 ' O ' ' HB3' ' A' ' 31' ' ' ALA . 62.1 t -58.57 -40.16 78.02 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.363 0 C-N-CA 120.543 -0.463 . . . . 1.0 110.534 -177.828 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 10.9 tttm -66.56 -55.26 16.27 Favored 'General case' 0 C--N 1.314 -0.946 0 C-N-CA 119.855 -0.738 . . . . 1.0 109.82 -178.701 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 29' ' ' VAL . . . . . 0.483 HG13 ' N ' ' A' ' 30' ' ' CYS . 3.2 p -65.82 -50.8 68.13 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 CA-C-N 115.294 -0.866 . . . . 1.0 111.011 -177.32 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 30' ' ' CYS . . . . . 0.483 ' N ' HG13 ' A' ' 29' ' ' VAL . 42.0 t -67.59 -62.61 1.34 Allowed 'General case' 0 N--CA 1.44 -0.945 0 C-N-CA 119.837 -0.745 . . . . 1.0 110.597 -179.208 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 31' ' ' ALA . . . . . 0.802 ' HB3' ' O ' ' A' ' 27' ' ' VAL . . . -62.74 -53.33 55.96 Favored 'General case' 0 N--CA 1.434 -1.273 0 C-N-CA 120.578 -0.449 . . . . 1.0 111.378 -175.459 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 69.8 66.23 2.3 Favored Glycine 0 N--CA 1.441 -1.022 0 C-N-CA 119.225 -1.464 . . . . 1.0 109.828 -179.428 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 33' ' ' LEU . . . . . 0.509 ' O ' ' CD1' ' A' ' 37' ' ' ILE . 6.2 mt 87.55 96.15 0.03 OUTLIER Pre-proline 0 N--CA 1.481 1.108 0 O-C-N 126.232 1.784 . . . . 1.0 112.049 -179.535 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 54.4 Cg_exo -46.23 -8.21 0.04 OUTLIER 'Trans proline' 0 N--CA 1.497 1.681 0 C-N-CA 122.39 2.06 . . . . 1.0 114.184 -179.825 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 35' ' ' GLY . . . . . 0.467 ' N ' ' O ' ' A' ' 33' ' ' LEU . . . -61.25 -60.27 8.59 Favored Glycine 0 CA--C 1.538 1.472 0 C-N-CA 118.466 -1.826 . . . . 1.0 109.867 -178.668 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 36' ' ' VAL . . . . . 0.855 HG22 ' H ' ' A' ' 37' ' ' ILE . 7.1 p -88.55 -139.84 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.473 0.687 0 CA-C-N 117.87 0.835 . . . . 1.0 109.072 179.369 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 37' ' ' ILE . . . . . 0.855 ' H ' HG22 ' A' ' 36' ' ' VAL . 2.5 mp 68.27 79.65 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.47 0.554 0 N-CA-C 112.575 0.583 . . . . 1.0 112.575 179.655 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -138.86 132.47 30.54 Favored 'General case' 0 CA--C 1.532 0.266 0 N-CA-C 108.383 -0.969 . . . . 1.0 108.383 178.397 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -107.43 159.3 30.7 Favored Pre-proline 0 N--CA 1.472 0.671 0 CA-C-N 116.515 -0.312 . . . . 1.0 110.182 -178.353 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 59.6 Cg_endo -71.97 -23.44 21.89 Favored 'Trans proline' 0 C--N 1.306 -1.668 0 C-N-CA 121.736 1.624 . . . . 1.0 111.947 178.668 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -119.76 83.99 2.13 Favored 'General case' 0 C--N 1.343 0.3 0 C-N-CA 120.553 -0.459 . . . . 1.0 110.582 179.281 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 42' ' ' ARG . . . . . 0.673 ' C ' ' H ' ' A' ' 44' ' ' GLY . 0.0 OUTLIER -103.86 135.26 45.73 Favored 'General case' 0 C--N 1.318 -0.803 0 CA-C-N 116.003 -0.544 . . . . 1.0 110.171 -177.644 . . . . . . . . 3 3 . 1 . 027 nuclear build core ' A' A ' 43' ' ' ARG . . . . . 0.619 ' C ' ' H ' ' A' ' 45' ' ' PHE . 42.9 tpt85 -64.31 22.65 0.01 OUTLIER 'General case' 0 C--N 1.314 -0.943 0 C-N-CA 119.913 -0.715 . . . . 1.0 109.763 179.092 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 44' ' ' GLY . . . . . 0.673 ' H ' ' C ' ' A' ' 42' ' ' ARG . . . 70.45 -28.04 0.46 Allowed Glycine 0 C--N 1.345 1.053 0 N-CA-C 110.764 -0.934 . . . . 1.0 110.764 179.223 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 45' ' ' PHE . . . . . 0.621 ' O ' ' HB2' ' A' ' 46' ' ' PHE . 31.0 p90 -164.71 172.61 12.83 Favored 'General case' 0 N--CA 1.45 -0.47 0 N-CA-C 108.521 -0.918 . . . . 1.0 108.521 -179.807 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 46' ' ' PHE . . . . . 0.621 ' HB2' ' O ' ' A' ' 45' ' ' PHE . 1.7 t80 116.16 96.41 0.0 OUTLIER 'General case' 0 N--CA 1.484 1.236 0 O-C-N 125.701 1.875 . . . . 1.0 108.153 -178.499 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 47' ' ' ARG . . . . . 0.547 ' O ' ' CB ' ' A' ' 48' ' ' CYS . 3.9 mmp_? 115.16 133.41 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.611 0 O-C-N 125.06 1.475 . . . . 1.0 109.859 -179.551 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 48' ' ' CYS . . . . . 0.547 ' CB ' ' O ' ' A' ' 47' ' ' ARG . 43.7 t 121.95 -5.59 0.0 OUTLIER 'General case' 0 CA--C 1.51 -0.595 0 O-C-N 125.305 1.628 . . . . 1.0 111.059 177.406 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -120.59 149.89 51.16 Favored Pre-proline 0 CA--C 1.534 0.356 0 N-CA-C 109.84 -0.43 . . . . 1.0 109.84 179.867 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 50' ' ' PRO . . . . . 0.562 ' C ' ' H ' ' A' ' 52' ' ' ARG . 98.9 Cg_endo -76.46 87.16 1.47 Allowed 'Trans proline' 0 N--CA 1.493 1.47 0 C-N-CA 122.277 1.985 . . . . 1.0 114.041 -179.888 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 51' ' ' GLU . . . . . 0.433 ' CD ' ' O ' ' A' ' 50' ' ' PRO . 0.0 OUTLIER 66.44 -32.7 0.18 Allowed 'General case' 0 N--CA 1.472 0.649 0 N-CA-C 112.09 0.404 . . . . 1.0 112.09 176.269 . . . . . . . . 3 3 . 1 . 027 nuclear build core ' A' A ' 52' ' ' ARG . . . . . 0.856 HH11 ' HB1' ' A' ' 86' ' ' ALA . 5.4 mtm180 -45.39 140.08 3.29 Favored 'General case' 0 C--N 1.315 -0.903 0 CA-C-O 121.941 0.877 . . . . 1.0 112.198 -178.094 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 2.2 tp -82.22 166.07 2.4 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 114.35 -1.295 . . . . 1.0 108.7 177.999 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 16.7 mt-30 -135.73 134.6 39.23 Favored 'General case' 0 N--CA 1.453 -0.288 0 N-CA-C 108.423 -0.954 . . . . 1.0 108.423 179.795 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 2.3 pp -142.68 153.66 17.6 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.366 0 N-CA-C 109.881 -0.414 . . . . 1.0 109.881 178.288 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 105.1 2.36 41.89 Favored Glycine 0 CA--C 1.529 0.95 0 N-CA-C 110.077 -1.209 . . . . 1.0 110.077 -178.348 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 58.0 m-20 -86.78 103.99 15.73 Favored 'General case' 0 N--CA 1.471 0.605 0 CA-C-O 122.141 0.972 . . . . 1.0 112.722 -178.333 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 58' ' ' TRP . . . . . 0.54 ' HB2' ' HB2' ' A' ' 61' ' ' GLU . 13.3 m95 -78.78 178.41 7.93 Favored 'General case' 0 C--N 1.315 -0.922 0 CA-C-N 113.484 -1.689 . . . . 1.0 108.937 177.879 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 59' ' ' ARG . . . . . 0.506 ' HG2' ' H ' ' A' ' 60' ' ' TYR . 0.0 OUTLIER -101.23 -56.95 2.19 Favored 'General case' 0 CA--C 1.557 1.244 0 CA-C-N 119.494 1.043 . . . . 1.0 112.533 178.814 . . . . . . . . 3 3 . 1 . 027 nuclear build core ' A' A ' 60' ' ' TYR . . . . . 0.506 ' H ' ' HG2' ' A' ' 59' ' ' ARG . 63.2 t80 -80.5 -13.5 59.05 Favored 'General case' 0 N--CA 1.485 1.305 0 C-N-CA 125.341 1.456 . . . . 1.0 112.581 -178.209 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 61' ' ' GLU . . . . . 0.541 ' O ' ' N ' ' A' ' 65' ' ' ASP . 10.1 mt-10 -79.49 -14.59 58.79 Favored 'General case' 0 C--N 1.298 -1.641 0 CA-C-N 114.963 -1.017 . . . . 1.0 108.903 178.244 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 62' ' ' VAL . . . . . 0.502 HG13 ' O ' ' A' ' 59' ' ' ARG . 13.4 m -44.26 -44.39 2.22 Favored 'Isoleucine or valine' 0 CA--C 1.491 -1.317 0 N-CA-C 109.331 -0.618 . . . . 1.0 109.331 -176.41 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 63' ' ' ALA . . . . . 0.548 ' O ' ' HG2' ' A' ' 67' ' ' ARG . . . -69.2 -46.74 66.71 Favored 'General case' 0 N--CA 1.411 -2.423 0 N-CA-C 107.947 -1.131 . . . . 1.0 107.947 177.61 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 64' ' ' HIS . . . . . 0.496 ' N ' ' O ' ' A' ' 61' ' ' GLU . 1.3 t-80 -56.04 -60.42 3.51 Favored 'General case' 0 CA--C 1.546 0.805 0 CA-C-N 115.512 -0.767 . . . . 1.0 111.049 178.891 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 65' ' ' ASP . . . . . 0.69 ' C ' ' H ' ' A' ' 67' ' ' ARG . 10.4 t70 -66.15 -54.69 22.35 Favored 'General case' 0 C--O 1.248 0.974 0 O-C-N 121.489 -0.757 . . . . 1.0 109.639 178.062 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 66' ' ' GLY . . . . . 0.456 ' N ' ' O ' ' A' ' 62' ' ' VAL . . . -63.22 32.49 0.08 OUTLIER Glycine 0 N--CA 1.471 0.982 0 N-CA-C 110.603 -0.999 . . . . 1.0 110.603 177.526 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 67' ' ' ARG . . . . . 0.723 ' HB3' ' H ' ' A' ' 71' ' ' ALA . 0.2 OUTLIER -75.75 1.74 13.97 Favored 'General case' 0 N--CA 1.435 -1.197 0 CA-C-N 114.639 -0.781 . . . . 1.0 109.113 175.71 . . . . . . . . 3 3 . 1 . 027 nuclear build core ' A' A ' 68' ' ' LEU . . . . . 0.538 ' O ' ' HA ' ' A' ' 72' ' ' HIS . 10.2 mp -33.72 -29.67 0.01 OUTLIER 'General case' 0 N--CA 1.501 2.118 0 N-CA-C 106.848 -1.538 . . . . 1.0 106.848 -177.597 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 69' ' ' LEU . . . . . 0.63 ' N ' ' O ' ' A' ' 67' ' ' ARG . 5.2 tp -61.85 -65.61 0.66 Allowed 'General case' 0 CA--C 1.553 1.06 0 C-N-CA 117.825 -1.55 . . . . 1.0 107.441 175.439 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 70' ' ' ALA . . . . . 0.642 ' O ' ' CG ' ' A' ' 72' ' ' HIS . . . -75.32 -68.59 0.54 Allowed 'General case' 0 N--CA 1.477 0.9 0 N-CA-C 106.456 -1.683 . . . . 1.0 106.456 175.684 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 71' ' ' ALA . . . . . 0.723 ' H ' ' HB3' ' A' ' 67' ' ' ARG . . . -47.17 2.54 0.0 OUTLIER 'General case' 0 N--CA 1.477 0.922 0 C-N-CA 124.686 1.194 . . . . 1.0 113.48 178.876 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 72' ' ' HIS . . . . . 0.642 ' CG ' ' O ' ' A' ' 70' ' ' ALA . 0.2 OUTLIER -19.94 -82.63 0.0 OUTLIER 'General case' 0 C--N 1.324 -0.525 0 N-CA-C 113.589 0.959 . . . . 1.0 113.589 -174.259 . . . . . . . . 3 3 . 1 . 027 nuclear build core ' A' A ' 73' ' ' MET . . . . . 0.521 ' N ' ' SD ' ' A' ' 73' ' ' MET . 0.7 OUTLIER -74.29 -41.79 60.62 Favored 'General case' 0 C--N 1.3 -1.545 0 CA-C-N 118.928 0.786 . . . . 1.0 111.122 178.389 . . . . . . . . 3 3 . 1 . 027 nuclear build core ' A' A ' 74' ' ' VAL . . . . . 0.594 ' O ' ' N ' ' A' ' 76' ' ' GLY . 0.8 OUTLIER -44.74 -41.78 2.22 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.796 0 C-N-CA 119.694 -0.803 . . . . 1.0 110.441 -174.62 . . . . . . . . 3 3 . 1 . 027 nuclear build core ' A' A ' 75' ' ' ASN . . . . . 0.567 ' O ' ' N ' ' A' ' 77' ' ' ILE . 28.2 t30 -39.16 -17.9 0.01 OUTLIER 'General case' 0 N--CA 1.48 1.033 0 CA-C-O 122.401 1.096 . . . . 1.0 110.964 178.029 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 76' ' ' GLY . . . . . 0.728 ' O ' HD12 ' A' ' 79' ' ' ILE . . . -43.41 -16.14 0.03 OUTLIER Glycine 0 CA--C 1.564 3.095 0 N-CA-C 108.634 -1.786 . . . . 1.0 108.634 176.051 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 77' ' ' ILE . . . . . 0.784 ' O ' ' N ' ' A' ' 80' ' ' ALA . 2.6 pp -89.91 -46.0 15.08 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.227 0 N-CA-C 108.428 -0.953 . . . . 1.0 108.428 -179.354 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 78' ' ' VAL . . . . . 0.501 ' N ' HD12 ' A' ' 77' ' ' ILE . 1.0 OUTLIER -34.34 -27.94 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.571 1.766 0 N-CA-C 108.775 -0.824 . . . . 1.0 108.775 -174.816 . . . . . . . . 3 3 . 1 . 027 nuclear build core ' A' A ' 79' ' ' ILE . . . . . 0.934 HD13 ' N ' ' A' ' 80' ' ' ALA . 0.0 OUTLIER -92.0 -17.32 7.64 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.907 0 C-N-CA 124.86 1.264 . . . . 1.0 111.765 177.383 . . . . . . . . 3 3 . 1 . 027 nuclear build core ' A' A ' 80' ' ' ALA . . . . . 0.934 ' N ' HD13 ' A' ' 79' ' ' ILE . . . -65.86 -14.05 60.74 Favored 'General case' 0 C--N 1.321 -0.639 0 O-C-N 122.156 -0.34 . . . . 1.0 111.215 178.105 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 34.6 mt-10 -122.78 -47.89 2.05 Favored 'General case' 0 N--CA 1.47 0.534 0 CA-C-O 121.767 0.794 . . . . 1.0 109.435 175.759 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -59.94 -62.08 2.13 Favored 'General case' 0 CA--C 1.53 0.209 0 CA-C-N 115.22 -0.9 . . . . 1.0 109.314 -179.745 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 83' ' ' ALA . . . . . 0.648 ' HB3' ' O ' ' A' ' 79' ' ' ILE . . . -47.5 -45.23 26.21 Favored 'General case' 0 N--CA 1.467 0.42 0 CA-C-N 116.587 -0.279 . . . . 1.0 110.798 -179.248 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 84' ' ' LEU . . . . . 0.545 HD13 ' O ' ' A' ' 80' ' ' ALA . 1.5 tp -28.83 -44.85 0.03 OUTLIER 'General case' 0 N--CA 1.483 1.187 0 CA-C-N 116.36 -0.382 . . . . 1.0 111.636 -174.683 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 85' ' ' ILE . . . . . 0.438 HG13 ' H ' ' A' ' 86' ' ' ALA . 3.4 pt -91.57 -49.77 13.07 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.742 0 N-CA-C 109.102 -0.703 . . . . 1.0 109.102 177.138 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 86' ' ' ALA . . . . . 0.856 ' HB1' HH11 ' A' ' 52' ' ' ARG . . . -48.22 -36.0 12.97 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.608 -0.724 . . . . 1.0 110.261 -178.723 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 5.3 mm-40 -57.51 -23.56 50.93 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.864 -0.607 . . . . 1.0 110.051 179.213 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -73.26 -9.51 58.79 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 121.22 0.533 . . . . 1.0 109.733 179.505 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 89' ' ' VAL . . . . . 0.629 ' O ' HG12 ' A' ' 89' ' ' VAL . 40.5 t -105.46 36.91 0.37 Allowed 'Isoleucine or valine' 0 C--O 1.234 0.268 0 CA-C-N 115.433 -0.803 . . . . 1.0 109.413 179.198 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 90' ' ' GLY . . . . . 0.537 ' O ' ' N ' ' A' ' 92' ' ' HIS . . . -66.71 -43.11 92.65 Favored Glycine 0 CA--C 1.539 1.531 0 N-CA-C 111.205 -0.758 . . . . 1.0 111.205 178.859 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 91' ' ' PRO . . . . . 0.472 ' CD ' ' N ' ' A' ' 90' ' ' GLY . 87.3 Cg_exo -42.3 -15.33 0.05 OUTLIER 'Trans proline' 0 N--CA 1.497 1.71 0 C-N-CA 122.03 1.82 . . . . 1.0 112.386 179.982 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 92' ' ' HIS . . . . . 0.537 ' N ' ' O ' ' A' ' 90' ' ' GLY . 5.6 p-80 -60.52 -15.51 28.05 Favored 'General case' 0 C--N 1.322 -0.601 0 N-CA-C 108.662 -0.866 . . . . 1.0 108.662 179.52 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 93' ' ' LEU . . . . . 0.737 HD12 ' N ' ' A' ' 94' ' ' ALA . 2.3 pp -72.95 -58.48 3.29 Favored 'General case' 0 C--N 1.323 -0.557 0 N-CA-C 108.836 -0.801 . . . . 1.0 108.836 179.915 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 94' ' ' ALA . . . . . 0.737 ' N ' HD12 ' A' ' 93' ' ' LEU . . . -59.23 -55.8 30.25 Favored 'General case' 0 C--O 1.236 0.391 0 CA-C-O 120.907 0.384 . . . . 1.0 109.997 179.744 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 95' ' ' ARG . . . . . 0.73 ' O ' ' N ' ' A' ' 97' ' ' LEU . 11.1 ttm180 -52.85 -59.3 4.67 Favored 'General case' 0 C--O 1.24 0.558 0 N-CA-C 107.079 -1.452 . . . . 1.0 107.079 178.777 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 96' ' ' ALA . . . . . 0.875 ' O ' ' N ' ' A' ' 98' ' ' GLY . . . -46.4 -7.67 0.01 OUTLIER 'General case' 0 N--CA 1.427 -1.616 0 O-C-N 119.029 -2.295 . . . . 1.0 112.525 -177.33 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 97' ' ' LEU . . . . . 0.73 ' N ' ' O ' ' A' ' 95' ' ' ARG . 0.4 OUTLIER 2.85 -50.57 0.0 OUTLIER 'General case' 0 C--N 1.36 1.062 0 O-C-N 124.776 1.297 . . . . 1.0 110.522 -169.447 . . . . . . . . 3 3 . 1 . 027 nuclear build core ' A' A ' 98' ' ' GLY . . . . . 0.952 ' O ' HG12 ' A' ' 101' ' ' VAL . . . -52.65 -17.52 4.67 Favored Glycine 0 N--CA 1.422 -2.265 0 CA-C-N 122.088 2.222 . . . . 1.0 107.902 174.001 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 99' ' ' GLN . . . . . 0.697 ' N ' ' O ' ' A' ' 96' ' ' ALA . 10.3 tp-100 -73.96 -25.31 59.88 Favored 'General case' 0 CA--C 1.512 -0.5 0 C-N-CA 117.746 -1.582 . . . . 1.0 107.066 178.69 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 100' ' ' ILE . . . . . 0.619 ' N ' ' O ' ' A' ' 97' ' ' LEU . 4.9 tt -62.55 -35.51 70.49 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.883 0 CA-C-N 114.522 -1.217 . . . . 1.0 110.207 178.617 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 101' ' ' VAL . . . . . 0.952 HG12 ' O ' ' A' ' 98' ' ' GLY . 8.7 p -61.83 -58.69 6.42 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.698 0 C-N-CA 118.514 -1.274 . . . . 1.0 108.976 -179.599 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 102' ' ' CYS . . . . . 0.994 ' O ' ' HB2' ' A' ' 106' ' ' ALA . 0.1 OUTLIER -42.23 -24.53 0.05 Allowed 'General case' 0 N--CA 1.437 -1.104 0 N-CA-C 112.109 0.411 . . . . 1.0 112.109 -177.451 . . . . . . . . 3 3 . 1 . 027 nuclear build core ' A' A ' 103' ' ' ARG . . . . . 0.428 ' N ' ' O ' ' A' ' 101' ' ' VAL . 9.4 ttp180 -88.81 -33.15 17.52 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-O 122.435 1.112 . . . . 1.0 111.207 178.39 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 104' ' ' TYR . . . . . 0.689 ' O ' ' CG ' ' A' ' 104' ' ' TYR . 0.3 OUTLIER -100.71 17.49 21.81 Favored 'General case' 0 C--N 1.312 -1.044 0 CA-C-N 113.365 -1.743 . . . . 1.0 109.822 177.352 . . . . . . . . 3 3 . 1 . 027 nuclear build core ' A' A ' 105' ' ' GLY . . . . . 0.528 ' N ' ' O ' ' A' ' 101' ' ' VAL . . . -165.29 -82.3 0.05 OUTLIER Glycine 0 N--CA 1.447 -0.599 0 N-CA-C 106.945 -2.462 . . . . 1.0 106.945 175.97 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 106' ' ' ALA . . . . . 0.994 ' HB2' ' O ' ' A' ' 102' ' ' CYS . . . 70.47 68.89 0.2 Allowed 'General case' 0 N--CA 1.437 -1.094 0 N-CA-C 112.256 0.465 . . . . 1.0 112.256 179.043 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 107' ' ' THR . . . . . 0.575 ' O ' ' HG2' ' A' ' 110' ' ' PRO . 25.2 m -76.27 -55.46 5.55 Favored 'General case' 0 C--O 1.213 -0.819 0 O-C-N 120.737 -1.227 . . . . 1.0 109.433 177.907 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 108' ' ' VAL . . . . . 0.604 ' O ' ' HB2' ' A' ' 111' ' ' ASN . 35.7 m -72.54 -48.39 47.2 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.205 0 CA-C-O 121.283 0.563 . . . . 1.0 111.692 -178.72 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 109' ' ' ILE . . . . . 0.57 ' N ' HG23 ' A' ' 108' ' ' VAL . 0.0 OUTLIER -41.31 -45.6 7.19 Favored Pre-proline 0 C--N 1.316 -0.854 0 CA-C-O 118.001 -0.999 . . . . 1.0 109.737 -178.027 . . . . . . . . 3 3 . 1 . 027 nuclear build core ' A' A ' 110' ' ' PRO . . . . . 0.575 ' HG2' ' O ' ' A' ' 107' ' ' THR . 72.6 Cg_endo -63.21 -18.06 63.08 Favored 'Trans proline' 0 C--O 1.2 -1.418 0 CA-C-N 122.388 1.889 . . . . 1.0 111.25 177.65 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 111' ' ' ASN . . . . . 0.604 ' HB2' ' O ' ' A' ' 108' ' ' VAL . 0.4 OUTLIER -62.2 -66.26 0.57 Allowed 'General case' 0 N--CA 1.478 0.974 0 N-CA-C 108.375 -0.972 . . . . 1.0 108.375 178.803 . . . . . . . . 3 3 . 1 . 027 nuclear build core ' A' A ' 112' ' ' ILE . . . . . 0.61 ' O ' ' HB ' ' A' ' 116' ' ' ILE . 1.5 pt -48.27 -22.78 0.66 Allowed 'Isoleucine or valine' 0 C--O 1.219 -0.51 0 N-CA-C 107.864 -1.161 . . . . 1.0 107.864 179.714 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 113' ' ' ASN . . . . . 0.726 ' O ' ' HB2' ' A' ' 117' ' ' GLU . 11.8 m-20 -84.61 -53.68 5.23 Favored 'General case' 0 N--CA 1.44 -0.935 0 CA-C-O 124.01 1.862 . . . . 1.0 110.063 177.474 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 114' ' ' ALA . . . . . 0.449 ' N ' ' O ' ' A' ' 110' ' ' PRO . . . -56.12 -55.78 28.92 Favored 'General case' 0 C--N 1.29 -1.979 0 CA-C-N 114.376 -1.284 . . . . 1.0 109.619 -178.952 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -80.38 -61.02 2.1 Favored 'General case' 0 C--O 1.244 0.81 0 N-CA-C 114.554 1.316 . . . . 1.0 114.554 179.706 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 116' ' ' ILE . . . . . 0.61 ' HB ' ' O ' ' A' ' 112' ' ' ILE . 36.4 mm -72.46 -40.03 63.18 Favored 'Isoleucine or valine' 0 C--O 1.211 -0.938 0 N-CA-C 114.35 1.241 . . . . 1.0 114.35 -175.234 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 117' ' ' GLU . . . . . 0.726 ' HB2' ' O ' ' A' ' 113' ' ' ASN . 1.2 tt0 -51.85 -62.78 1.41 Allowed 'General case' 0 CA--C 1.486 -1.484 0 CA-C-N 118.12 0.418 . . . . 1.0 110.611 -176.334 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 38.8 t -55.54 -14.23 1.31 Allowed 'Isoleucine or valine' 0 N--CA 1.424 -1.774 0 C-N-CA 117.836 -1.546 . . . . 1.0 109.253 -177.244 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 119' ' ' LEU . . . . . 0.416 ' N ' ' C ' ' A' ' 117' ' ' GLU . 1.1 tp -92.54 -56.66 2.94 Favored 'General case' 0 CA--C 1.552 1.044 0 N-CA-C 113.682 0.993 . . . . 1.0 113.682 176.857 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -68.75 -50.52 35.58 Favored Glycine 0 C--N 1.358 1.764 0 C-N-CA 120.062 -1.066 . . . . 1.0 114.47 -174.68 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 1.9 t 155.56 -40.0 0.01 OUTLIER 'General case' 0 N--CA 1.476 0.865 0 N-CA-C 106.396 -1.705 . . . . 1.0 106.396 -178.273 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 122' ' ' GLY . . . . . 0.51 ' O ' ' N ' ' A' ' 124' ' ' ASP . . . 113.62 -34.37 5.05 Favored Glycine 0 CA--C 1.532 1.108 0 C-N-CA 126.217 1.865 . . . . 1.0 112.862 179.684 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 123' ' ' THR . . . . . 0.446 ' C ' ' O ' ' A' ' 122' ' ' GLY . 33.4 m -32.84 90.91 0.0 OUTLIER 'General case' 0 N--CA 1.486 1.341 0 CA-C-N 120.219 2.009 . . . . 1.0 112.01 -178.698 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 124' ' ' ASP . . . . . 0.51 ' N ' ' O ' ' A' ' 122' ' ' GLY . 39.7 m-20 -145.52 146.16 31.33 Favored 'General case' 0 CA--C 1.537 0.457 0 N-CA-C 108.763 -0.828 . . . . 1.0 108.763 178.089 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 125' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -153.7 150.58 28.71 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-O 120.85 0.357 . . . . 1.0 110.195 -178.851 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 2.7 tpt180 -149.08 151.26 34.13 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.894 -0.594 . . . . 1.0 109.801 177.059 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 127' ' ' PHE . . . . . . . . . . . . . 19.5 m-85 . . . . . 0 C--O 1.218 -0.583 0 CA-C-O 117.973 -1.013 . . . . 1.0 112.043 -178.864 . . . . . . . . 0 0 . 1 . 028 nuclear build core ' A' A ' 1' ' ' MET . . . . . 0.444 ' SD ' ' CD2' ' A' ' 4' ' ' PHE . 38.2 mtt . . . . . 0 N--CA 1.49 1.545 0 N-CA-C 108.503 -0.925 . . . . 1.0 108.503 . . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 2' ' ' SER . . . . . 0.46 ' O ' ' CB ' ' A' ' 3' ' ' ASP . 14.8 m -95.31 10.5 35.96 Favored 'General case' 0 N--CA 1.466 0.357 0 C-N-CA 122.628 0.371 . . . . 1.0 110.939 -179.503 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 3' ' ' ASP . . . . . 0.46 ' CB ' ' O ' ' A' ' 2' ' ' SER . 0.2 OUTLIER 157.4 109.21 0.0 OUTLIER 'General case' 0 N--CA 1.473 0.687 0 O-C-N 124.077 0.861 . . . . 1.0 109.999 178.87 . . . . . . . . 3 3 . 1 . 028 nuclear build core ' A' A ' 4' ' ' PHE . . . . . 0.444 ' CD2' ' SD ' ' A' ' 1' ' ' MET . 14.9 t80 -152.99 148.21 26.82 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.121 -0.49 . . . . 1.0 110.515 179.695 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 5' ' ' ASP . . . . . 0.4 ' OD1' ' O ' ' A' ' 4' ' ' PHE . 9.5 m-20 -154.23 150.16 27.76 Favored 'General case' 0 CA--C 1.536 0.407 0 N-CA-C 109.404 -0.591 . . . . 1.0 109.404 179.761 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 6' ' ' THR . . . . . 0.511 ' O ' ' N ' ' A' ' 10' ' ' SER . 0.2 OUTLIER -62.2 167.51 3.99 Favored 'General case' 0 C--O 1.218 -0.603 0 C-N-CA 120.126 -0.63 . . . . 1.0 110.216 -178.804 . . . . . . . . 3 3 . 1 . 028 nuclear build core ' A' A ' 7' ' ' GLU . . . . . 0.582 ' O ' ' N ' ' A' ' 11' ' ' ARG . 3.1 tt0 -59.69 -58.37 8.86 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-O 121.401 0.62 . . . . 1.0 110.45 -177.947 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 8' ' ' ARG . . . . . 0.485 ' O ' ' CB ' ' A' ' 12' ' ' ALA . 18.2 ttm180 -51.16 -54.85 21.51 Favored 'General case' 0 C--N 1.311 -1.083 0 N-CA-C 108.174 -1.047 . . . . 1.0 108.174 -177.159 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 9' ' ' VAL . . . . . 0.823 ' O ' HG13 ' A' ' 13' ' ' VAL . 6.8 p -62.09 -48.82 86.71 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.127 0 CA-C-N 114.067 -1.424 . . . . 1.0 109.819 178.901 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 10' ' ' SER . . . . . 0.511 ' N ' ' O ' ' A' ' 6' ' ' THR . 42.8 t -62.43 -59.58 4.77 Favored 'General case' 0 N--CA 1.481 1.105 0 C-N-CA 120.198 -0.601 . . . . 1.0 109.702 -179.995 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 11' ' ' ARG . . . . . 0.582 ' N ' ' O ' ' A' ' 7' ' ' GLU . 0.4 OUTLIER -62.59 -57.44 11.09 Favored 'General case' 0 C--N 1.317 -0.823 0 O-C-N 121.742 -0.599 . . . . 1.0 110.19 -178.324 . . . . . . . . 3 3 . 1 . 028 nuclear build core ' A' A ' 12' ' ' ALA . . . . . 0.531 ' O ' ' HB3' ' A' ' 16' ' ' ALA . . . -50.36 -51.58 44.58 Favored 'General case' 0 N--CA 1.476 0.861 0 N-CA-C 108.004 -1.11 . . . . 1.0 108.004 -178.091 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 13' ' ' VAL . . . . . 0.823 HG13 ' O ' ' A' ' 9' ' ' VAL . 4.5 m -60.78 -50.13 81.75 Favored 'Isoleucine or valine' 0 C--O 1.203 -1.344 0 C-N-CA 116.92 -1.912 . . . . 1.0 108.029 177.632 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 14' ' ' ALA . . . . . 0.502 ' O ' HG23 ' A' ' 18' ' ' VAL . . . -57.44 -62.68 1.6 Allowed 'General case' 0 N--CA 1.479 1.008 0 C-N-CA 118.633 -1.227 . . . . 1.0 110.929 179.013 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 15' ' ' ALA . . . . . 0.549 ' N ' ' O ' ' A' ' 11' ' ' ARG . . . -55.51 -55.8 27.65 Favored 'General case' 0 N--CA 1.47 0.557 0 CA-C-O 121.413 0.625 . . . . 1.0 110.208 -178.473 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 16' ' ' ALA . . . . . 0.531 ' HB3' ' O ' ' A' ' 12' ' ' ALA . . . -58.05 -53.94 52.58 Favored 'General case' 0 C--N 1.317 -0.811 0 N-CA-C 108.138 -1.06 . . . . 1.0 108.138 -179.313 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 17' ' ' LEU . . . . . 0.599 ' CB ' ' O ' ' A' ' 13' ' ' VAL . 39.4 tp -53.86 -48.96 69.48 Favored 'General case' 0 N--CA 1.482 1.135 0 CA-C-N 113.513 -1.676 . . . . 1.0 107.662 -178.059 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 18' ' ' VAL . . . . . 0.502 HG23 ' O ' ' A' ' 14' ' ' ALA . 54.1 t -67.3 -58.4 6.41 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.504 0 CA-C-O 121.076 0.465 . . . . 1.0 110.223 179.94 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 19' ' ' GLY . . . . . 0.528 ' N ' ' O ' ' A' ' 15' ' ' ALA . . . -71.03 -163.96 5.47 Favored Glycine 0 CA--C 1.526 0.765 0 CA-C-N 115.5 -0.773 . . . . 1.0 112.054 -178.64 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 20' ' ' PRO . . . . . 0.571 ' O ' ' N ' ' A' ' 24' ' ' ALA . 57.5 Cg_endo -79.59 -27.23 4.24 Favored 'Trans proline' 0 N--CA 1.492 1.39 0 C-N-CA 122.72 2.28 . . . . 1.0 115.443 -178.098 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -59.0 -58.45 14.52 Favored Glycine 0 N--CA 1.477 1.414 0 C-N-CA 119.097 -1.525 . . . . 1.0 110.965 -177.01 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 22' ' ' GLY . . . . . 0.499 ' N ' ' HB1' ' A' ' 16' ' ' ALA . . . -59.21 -54.91 33.94 Favored Glycine 0 N--CA 1.467 0.749 0 N-CA-C 107.843 -2.103 . . . . 1.0 107.843 -178.387 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 23' ' ' VAL . . . . . 0.557 ' O ' HG12 ' A' ' 27' ' ' VAL . 54.1 t -57.36 -36.96 54.61 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.907 0 CA-C-N 114.721 -0.74 . . . . 1.0 109.814 -179.472 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 24' ' ' ALA . . . . . 0.571 ' N ' ' O ' ' A' ' 20' ' ' PRO . . . -57.66 -60.58 3.46 Favored 'General case' 0 C--N 1.325 -0.483 0 C-N-CA 118.93 -1.108 . . . . 1.0 109.182 -179.851 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 9.3 tp -63.19 -44.05 96.48 Favored 'General case' 0 C--N 1.347 0.47 0 CA-C-N 119.325 0.966 . . . . 1.0 111.73 -178.907 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 72.6 t -61.05 -60.77 2.13 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.176 0 C-N-CA 118.364 -1.334 . . . . 1.0 110.504 -177.748 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 27' ' ' VAL . . . . . 0.603 ' O ' ' HB3' ' A' ' 31' ' ' ALA . 2.4 p -58.57 -37.41 64.78 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.417 0 N-CA-C 113.264 0.838 . . . . 1.0 113.264 -177.539 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 35.9 ttmt -67.67 -53.27 29.13 Favored 'General case' 0 C--N 1.315 -0.899 0 CA-C-O 122.102 0.953 . . . . 1.0 108.811 -178.719 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 80.2 t -63.82 -48.93 84.18 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.074 0 CA-C-N 113.743 -1.571 . . . . 1.0 110.891 -177.542 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 30' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -65.34 -60.88 2.51 Favored 'General case' 0 N--CA 1.449 -0.487 0 C-N-CA 118.868 -1.133 . . . . 1.0 109.496 -179.756 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 31' ' ' ALA . . . . . 0.603 ' HB3' ' O ' ' A' ' 27' ' ' VAL . . . -64.83 -54.44 30.99 Favored 'General case' 0 C--N 1.331 -0.225 0 N-CA-C 113.605 0.965 . . . . 1.0 113.605 -175.901 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 84.36 75.77 1.2 Allowed Glycine 0 CA--C 1.527 0.798 0 N-CA-C 109.421 -1.472 . . . . 1.0 109.421 -177.81 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 33' ' ' LEU . . . . . 0.52 ' O ' ' O ' ' A' ' 36' ' ' VAL . 12.3 mt 85.55 85.37 0.05 OUTLIER Pre-proline 0 N--CA 1.479 0.983 0 C-N-CA 123.711 0.804 . . . . 1.0 110.49 -178.9 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 53.0 Cg_exo -54.93 -30.89 71.13 Favored 'Trans proline' 0 N--CA 1.508 2.342 0 C-N-CA 123.253 2.635 . . . . 1.0 114.307 -179.832 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 35' ' ' GLY . . . . . 0.407 ' C ' HD11 ' A' ' 116' ' ' ILE . . . -58.81 -58.04 16.67 Favored Glycine 0 CA--C 1.525 0.678 0 C-N-CA 118.759 -1.686 . . . . 1.0 109.651 -178.369 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 36' ' ' VAL . . . . . 0.657 ' O ' HG22 ' A' ' 37' ' ' ILE . 7.1 p -97.82 165.27 2.17 Favored 'Isoleucine or valine' 0 C--O 1.219 -0.55 0 N-CA-C 106.71 -1.589 . . . . 1.0 106.71 178.266 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 37' ' ' ILE . . . . . 0.657 HG22 ' O ' ' A' ' 36' ' ' VAL . 8.1 tt 117.82 123.23 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.481 1.097 0 C-N-CA 123.927 0.891 . . . . 1.0 109.596 -179.19 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 21.9 m80 -140.64 131.41 25.81 Favored 'General case' 0 C--N 1.324 -0.513 0 N-CA-C 107.902 -1.147 . . . . 1.0 107.902 178.724 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -90.03 146.45 35.09 Favored Pre-proline 0 C--N 1.33 -0.247 0 N-CA-C 108.955 -0.757 . . . . 1.0 108.955 -179.747 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -72.92 -44.01 0.69 Allowed 'Trans proline' 0 C--N 1.307 -1.619 0 C-N-CA 121.641 1.56 . . . . 1.0 112.579 -179.24 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -126.17 130.06 50.25 Favored 'General case' 0 CA--C 1.518 -0.266 0 CA-C-N 116.254 -0.43 . . . . 1.0 110.118 -179.608 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 42' ' ' ARG . . . . . 0.609 ' C ' ' H ' ' A' ' 44' ' ' GLY . 0.0 OUTLIER -169.49 157.27 7.17 Favored 'General case' 0 C--N 1.313 -0.997 0 N-CA-C 106.016 -1.846 . . . . 1.0 106.016 177.976 . . . . . . . . 3 3 . 1 . 028 nuclear build core ' A' A ' 43' ' ' ARG . . . . . 0.436 ' O ' ' CG ' ' A' ' 43' ' ' ARG . 10.3 ttt85 -64.82 33.81 0.02 OUTLIER 'General case' 0 CA--C 1.529 0.137 0 CA-C-N 119.866 1.212 . . . . 1.0 112.115 -178.266 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 44' ' ' GLY . . . . . 0.609 ' H ' ' C ' ' A' ' 42' ' ' ARG . . . 91.42 -24.3 20.39 Favored Glycine 0 CA--C 1.522 0.484 0 N-CA-C 110.426 -1.069 . . . . 1.0 110.426 179.995 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 45' ' ' PHE . . . . . 0.526 ' CZ ' ' OD2' ' A' ' 57' ' ' ASP . 50.0 p90 -177.49 -178.93 0.79 Allowed 'General case' 0 CA--C 1.54 0.576 0 CA-C-O 120.85 0.357 . . . . 1.0 111.623 -179.941 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER 165.03 15.46 0.0 OUTLIER 'General case' 0 N--CA 1.487 1.389 0 CA-C-N 114.947 -1.024 . . . . 1.0 113.139 177.073 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 47' ' ' ARG . . . . . 0.639 ' O ' ' SG ' ' A' ' 48' ' ' CYS . 2.5 mtp-105 -176.38 -179.12 1.02 Allowed 'General case' 0 C--N 1.315 -0.905 0 N-CA-C 108.591 -0.892 . . . . 1.0 108.591 -179.072 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 48' ' ' CYS . . . . . 0.674 ' O ' ' SG ' ' A' ' 48' ' ' CYS . 1.5 p 61.43 63.49 1.19 Allowed 'General case' 0 C--N 1.341 0.206 0 CA-C-O 121.68 0.752 . . . . 1.0 110.084 -179.326 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -137.14 143.53 42.31 Favored Pre-proline 0 CA--C 1.535 0.39 0 N-CA-C 108.552 -0.907 . . . . 1.0 108.552 179.418 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 50' ' ' PRO . . . . . 0.494 ' HG2' HH11 ' A' ' 52' ' ' ARG . 94.7 Cg_endo -73.01 61.85 3.94 Favored 'Trans proline' 0 N--CA 1.497 1.719 0 C-N-CA 122.251 1.967 . . . . 1.0 112.431 -179.476 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 97.8 mt-10 59.34 6.13 0.71 Allowed 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.975 -0.557 . . . . 1.0 111.84 179.595 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 52' ' ' ARG . . . . . 0.494 HH11 ' HG2' ' A' ' 50' ' ' PRO . 75.0 mtt85 -82.91 139.12 33.58 Favored 'General case' 0 N--CA 1.465 0.291 0 N-CA-C 109.029 -0.73 . . . . 1.0 109.029 177.971 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 53' ' ' ILE . . . . . 0.465 HG23 HG22 ' A' ' 55' ' ' ILE . 13.0 tt -67.42 137.92 23.78 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.276 0 CA-C-O 122.647 1.213 . . . . 1.0 113.691 -177.314 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -64.13 78.59 0.04 OUTLIER 'General case' 0 CA--C 1.545 0.753 0 CA-C-N 112.38 -2.191 . . . . 1.0 108.984 -178.464 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 55' ' ' ILE . . . . . 0.465 HG22 HG23 ' A' ' 53' ' ' ILE . 18.0 tt -148.15 154.96 10.06 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.667 0 CA-C-N 115.997 -0.547 . . . . 1.0 109.99 178.251 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 109.59 -3.46 30.8 Favored Glycine 0 N--CA 1.471 0.998 0 N-CA-C 109.914 -1.274 . . . . 1.0 109.914 -179.594 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 57' ' ' ASP . . . . . 0.526 ' OD2' ' CZ ' ' A' ' 45' ' ' PHE . 37.6 m-20 -83.96 100.93 11.35 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 114.249 -0.975 . . . . 1.0 110.091 179.448 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 58' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -86.52 173.68 9.44 Favored 'General case' 0 N--CA 1.471 0.595 0 CA-C-O 123.65 1.69 . . . . 1.0 113.41 -178.287 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 59' ' ' ARG . . . . . 0.423 HH11 ' HD2' ' A' ' 59' ' ' ARG . 24.9 mtm180 -79.44 -56.23 4.47 Favored 'General case' 0 C--N 1.309 -1.175 0 CA-C-N 110.402 -3.09 . . . . 1.0 112.161 -179.428 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -91.1 -11.73 37.72 Favored 'General case' 0 C--O 1.249 1.046 0 CA-C-N 114.81 -1.086 . . . . 1.0 113.916 -178.372 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 61' ' ' GLU . . . . . 0.405 ' O ' ' N ' ' A' ' 65' ' ' ASP . 9.3 pt-20 -76.57 -13.95 60.04 Favored 'General case' 0 C--N 1.318 -0.784 0 N-CA-C 113.298 0.851 . . . . 1.0 113.298 -177.615 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 62' ' ' VAL . . . . . 0.623 ' O ' ' N ' ' A' ' 66' ' ' GLY . 0.2 OUTLIER -49.52 -58.7 1.25 Allowed 'Isoleucine or valine' 0 C--O 1.207 -1.165 0 C-N-CA 118.857 -1.137 . . . . 1.0 109.209 -175.829 . . . . . . . . 3 3 . 1 . 028 nuclear build core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -66.77 -61.5 1.93 Allowed 'General case' 0 C--N 1.302 -1.459 0 CA-C-O 120.874 0.369 . . . . 1.0 110.907 -179.01 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 2.3 t-80 -48.4 -56.72 7.43 Favored 'General case' 0 CA--C 1.535 0.389 0 C-N-CA 119.419 -0.912 . . . . 1.0 108.93 -178.916 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 65' ' ' ASP . . . . . 0.866 ' O ' HD22 ' A' ' 68' ' ' LEU . 19.2 t70 -70.08 -45.5 66.89 Favored 'General case' 0 C--O 1.207 -1.171 0 CA-C-N 115.072 -0.967 . . . . 1.0 111.197 179.761 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 66' ' ' GLY . . . . . 0.623 ' N ' ' O ' ' A' ' 62' ' ' VAL . . . -77.49 26.35 1.93 Allowed Glycine 0 N--CA 1.471 1.002 0 N-CA-C 111.018 -0.833 . . . . 1.0 111.018 179.715 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 67' ' ' ARG . . . . . 0.438 ' H ' ' C ' ' A' ' 65' ' ' ASP . 57.7 ttt180 -95.76 -9.95 30.4 Favored 'General case' 0 CA--C 1.536 0.406 0 N-CA-C 107.971 -1.122 . . . . 1.0 107.971 172.832 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 68' ' ' LEU . . . . . 0.866 HD22 ' O ' ' A' ' 65' ' ' ASP . 0.0 OUTLIER -69.87 -37.81 76.22 Favored 'General case' 0 C--O 1.197 -1.681 0 CA-C-N 114.303 -1.317 . . . . 1.0 112.974 -178.044 . . . . . . . . 3 3 . 1 . 028 nuclear build core ' A' A ' 69' ' ' LEU . . . . . 0.519 ' O ' ' ND1' ' A' ' 72' ' ' HIS . 7.8 tt -44.81 -58.31 3.19 Favored 'General case' 0 N--CA 1.475 0.794 0 C-N-CA 118.302 -1.359 . . . . 1.0 108.869 -176.121 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 70' ' ' ALA . . . . . 0.578 ' O ' ' CE1' ' A' ' 72' ' ' HIS . . . -51.61 -72.3 0.05 Allowed 'General case' 0 C--N 1.317 -0.837 0 N-CA-C 104.937 -2.246 . . . . 1.0 104.937 177.884 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 71' ' ' ALA . . . . . 0.729 ' O ' ' N ' ' A' ' 73' ' ' MET . . . -64.87 18.21 0.02 OUTLIER 'General case' 0 C--N 1.316 -0.877 0 C-N-CA 128.04 2.536 . . . . 1.0 114.251 178.385 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 72' ' ' HIS . . . . . 0.826 ' N ' ' O ' ' A' ' 68' ' ' LEU . 0.0 OUTLIER -24.78 -17.95 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.557 0 N-CA-C 115.589 1.7 . . . . 1.0 115.589 -174.461 . . . . . . . . 3 3 . 1 . 028 nuclear build core ' A' A ' 73' ' ' MET . . . . . 0.729 ' N ' ' O ' ' A' ' 71' ' ' ALA . 72.5 mtp -73.39 -25.09 60.42 Favored 'General case' 0 CA--C 1.545 0.768 0 CA-C-N 119.986 1.266 . . . . 1.0 108.551 176.965 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 74' ' ' VAL . . . . . 0.725 ' O ' ' N ' ' A' ' 76' ' ' GLY . 90.8 t -61.53 -52.66 58.46 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.672 0 CA-C-N 114.444 -1.253 . . . . 1.0 108.84 178.857 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 75' ' ' ASN . . . . . 0.439 ' O ' HG22 ' A' ' 79' ' ' ILE . 17.3 t30 -32.61 -13.75 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.667 0 N-CA-C 113.444 0.905 . . . . 1.0 113.444 -178.26 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 76' ' ' GLY . . . . . 0.725 ' N ' ' O ' ' A' ' 74' ' ' VAL . . . -50.88 -22.26 5.88 Favored Glycine 0 CA--C 1.539 1.539 0 N-CA-C 109.344 -1.502 . . . . 1.0 109.344 176.045 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 77' ' ' ILE . . . . . 0.566 HG13 ' H ' ' A' ' 78' ' ' VAL . 0.5 OUTLIER -78.0 -63.95 1.0 Allowed 'Isoleucine or valine' 0 C--O 1.218 -0.568 0 CA-C-O 121.947 0.88 . . . . 1.0 109.432 179.203 . . . . . . . . 3 3 . 1 . 028 nuclear build core ' A' A ' 78' ' ' VAL . . . . . 0.566 ' H ' HG13 ' A' ' 77' ' ' ILE . 74.8 t -34.87 -33.66 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.318 -0.766 0 CA-C-N 112.719 -2.037 . . . . 1.0 106.309 -177.105 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 79' ' ' ILE . . . . . 0.622 HD13 ' N ' ' A' ' 80' ' ' ALA . 0.0 OUTLIER -97.39 -34.42 4.82 Favored 'Isoleucine or valine' 0 CA--C 1.569 1.699 0 CA-C-N 115.585 -0.734 . . . . 1.0 111.905 175.134 . . . . . . . . 3 3 . 1 . 028 nuclear build core ' A' A ' 80' ' ' ALA . . . . . 0.622 ' N ' HD13 ' A' ' 79' ' ' ILE . . . -84.82 -10.35 57.26 Favored 'General case' 0 N--CA 1.492 1.642 0 N-CA-C 114.471 1.285 . . . . 1.0 114.471 179.452 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 81' ' ' GLU . . . . . 0.418 ' N ' ' O ' ' A' ' 77' ' ' ILE . 86.6 tt0 -89.4 -70.98 0.63 Allowed 'General case' 0 N--CA 1.438 -1.038 0 O-C-N 121.786 -0.571 . . . . 1.0 111.09 179.775 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 25.4 m-20 -91.02 -15.6 29.32 Favored 'General case' 0 CA--C 1.549 0.923 0 N-CA-C 115.864 1.801 . . . . 1.0 115.864 -178.796 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 83' ' ' ALA . . . . . 0.554 ' O ' ' N ' ' A' ' 85' ' ' ILE . . . -52.84 -42.48 65.21 Favored 'General case' 0 N--CA 1.475 0.779 0 C-N-CA 118.248 -1.381 . . . . 1.0 111.454 -177.863 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 11.2 mp -39.87 -20.83 0.01 OUTLIER 'General case' 0 N--CA 1.469 0.508 0 CA-C-N 118.447 0.567 . . . . 1.0 111.307 -179.049 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 85' ' ' ILE . . . . . 0.554 ' N ' ' O ' ' A' ' 83' ' ' ALA . 54.1 mt -93.43 -34.99 6.13 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.587 -0.279 . . . . 1.0 111.154 -179.866 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 86' ' ' ALA . . . . . 0.822 ' O ' HG22 ' A' ' 89' ' ' VAL . . . -92.91 -26.27 17.68 Favored 'General case' 0 C--O 1.222 -0.371 0 CA-C-O 120.597 0.237 . . . . 1.0 111.582 179.734 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -56.06 -7.12 0.3 Allowed 'General case' 0 C--N 1.328 -0.347 0 C-N-CA 119.73 -0.788 . . . . 1.0 110.418 -178.83 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 88' ' ' ALA . . . . . 0.45 ' H ' ' C ' ' A' ' 86' ' ' ALA . . . -84.17 -2.58 57.1 Favored 'General case' 0 N--CA 1.472 0.663 0 CA-C-O 122.407 1.099 . . . . 1.0 108.79 178.543 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 89' ' ' VAL . . . . . 0.822 HG22 ' O ' ' A' ' 86' ' ' ALA . 3.1 m -97.6 34.9 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.432 0 CA-C-N 113.042 -1.89 . . . . 1.0 110.59 179.098 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 90' ' ' GLY . . . . . 0.551 ' N ' ' CD ' ' A' ' 91' ' ' PRO . . . -78.13 -36.62 30.94 Favored Glycine 0 C--N 1.347 1.194 0 N-CA-C 111.6 -0.6 . . . . 1.0 111.6 178.932 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 91' ' ' PRO . . . . . 0.551 ' CD ' ' N ' ' A' ' 90' ' ' GLY . 93.4 Cg_exo -46.55 -15.11 0.16 Allowed 'Trans proline' 0 N--CA 1.496 1.665 0 C-N-CA 121.872 1.715 . . . . 1.0 109.07 177.913 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 92' ' ' HIS . . . . . 0.612 ' ND1' ' N ' ' A' ' 93' ' ' LEU . 0.0 OUTLIER -56.01 -15.76 3.98 Favored 'General case' 0 N--CA 1.442 -0.875 0 CA-C-N 113.922 -1.49 . . . . 1.0 107.754 179.148 . . . . . . . . 3 3 . 1 . 028 nuclear build core ' A' A ' 93' ' ' LEU . . . . . 0.725 HD12 ' N ' ' A' ' 94' ' ' ALA . 2.1 pp -64.04 -58.22 7.32 Favored 'General case' 0 C--O 1.232 0.14 0 N-CA-C 108.997 -0.742 . . . . 1.0 108.997 176.822 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 94' ' ' ALA . . . . . 0.725 ' N ' HD12 ' A' ' 93' ' ' LEU . . . -57.34 -52.62 64.61 Favored 'General case' 0 CA--C 1.517 -0.323 0 N-CA-C 108.851 -0.796 . . . . 1.0 108.851 179.719 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 95' ' ' ARG . . . . . 0.621 ' O ' ' N ' ' A' ' 97' ' ' LEU . 4.9 tmm_? -60.16 -60.91 3.06 Favored 'General case' 0 N--CA 1.446 -0.628 0 N-CA-C 108.506 -0.924 . . . . 1.0 108.506 -179.792 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 96' ' ' ALA . . . . . 0.986 ' O ' ' N ' ' A' ' 98' ' ' GLY . . . -47.66 -12.09 0.03 OUTLIER 'General case' 0 N--CA 1.432 -1.343 0 O-C-N 118.532 -2.605 . . . . 1.0 111.478 179.484 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 97' ' ' LEU . . . . . 0.706 ' O ' ' N ' ' A' ' 100' ' ' ILE . 7.7 tp 6.87 -48.9 0.0 OUTLIER 'General case' 0 C--N 1.378 1.809 0 CA-C-O 117.584 -1.198 . . . . 1.0 109.937 -166.771 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 98' ' ' GLY . . . . . 0.986 ' N ' ' O ' ' A' ' 96' ' ' ALA . . . -49.57 -24.12 5.32 Favored Glycine 0 CA--C 1.548 2.106 0 CA-C-N 122.507 2.412 . . . . 1.0 107.417 173.493 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 99' ' ' GLN . . . . . 0.543 ' N ' ' O ' ' A' ' 96' ' ' ALA . 12.3 mt-30 -64.36 -19.38 65.44 Favored 'General case' 0 C--N 1.379 1.878 0 C-N-CA 117.324 -1.75 . . . . 1.0 107.058 176.829 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 100' ' ' ILE . . . . . 0.706 ' N ' ' O ' ' A' ' 97' ' ' LEU . 1.5 tp -65.3 -39.22 84.66 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.817 0 N-CA-C 108.228 -1.027 . . . . 1.0 108.228 179.724 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 101' ' ' VAL . . . . . 0.723 ' O ' ' N ' ' A' ' 105' ' ' GLY . 97.7 t -59.19 -62.72 0.91 Allowed 'Isoleucine or valine' 0 C--O 1.217 -0.627 0 C-N-CA 119.537 -0.865 . . . . 1.0 110.59 -178.44 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 102' ' ' CYS . . . . . 0.879 ' O ' ' HB2' ' A' ' 106' ' ' ALA . 0.5 OUTLIER -48.26 -18.63 0.23 Allowed 'General case' 0 N--CA 1.477 0.883 0 C-N-CA 119.093 -1.043 . . . . 1.0 110.826 -178.31 . . . . . . . . 3 3 . 1 . 028 nuclear build core ' A' A ' 103' ' ' ARG . . . . . 0.497 HH11 ' CG ' ' A' ' 103' ' ' ARG . 0.0 OUTLIER -88.63 -49.3 6.96 Favored 'General case' 0 N--CA 1.479 1.014 0 CA-C-O 121.783 0.802 . . . . 1.0 112.071 177.638 . . . . . . . . 3 3 . 1 . 028 nuclear build core ' A' A ' 104' ' ' TYR . . . . . . . . . . . . . 22.8 t80 -105.84 21.53 17.12 Favored 'General case' 0 N--CA 1.472 0.644 0 C-N-CA 125.935 1.694 . . . . 1.0 111.413 178.43 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 105' ' ' GLY . . . . . 0.723 ' N ' ' O ' ' A' ' 101' ' ' VAL . . . -159.33 -8.32 0.05 OUTLIER Glycine 0 CA--C 1.527 0.835 0 C-N-CA 120.394 -0.907 . . . . 1.0 112.081 -179.791 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 106' ' ' ALA . . . . . 0.879 ' HB2' ' O ' ' A' ' 102' ' ' CYS . . . -29.03 114.16 0.09 Allowed 'General case' 0 N--CA 1.466 0.327 0 N-CA-C 112.209 0.448 . . . . 1.0 112.209 179.51 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 107' ' ' THR . . . . . 0.607 ' C ' ' H ' ' A' ' 109' ' ' ILE . 26.7 m -134.55 -62.64 0.73 Allowed 'General case' 0 C--O 1.224 -0.247 0 N-CA-C 105.609 -1.997 . . . . 1.0 105.609 176.782 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 108' ' ' VAL . . . . . 0.631 ' O ' HG22 ' A' ' 108' ' ' VAL . 12.7 p -64.44 23.25 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.437 -1.078 0 O-C-N 121.792 -0.568 . . . . 1.0 109.539 179.33 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 109' ' ' ILE . . . . . 0.628 ' H ' ' HD2' ' A' ' 110' ' ' PRO . 0.1 OUTLIER -115.81 -53.98 0.04 OUTLIER Pre-proline 0 CA--C 1.562 1.405 0 N-CA-C 107.708 -1.219 . . . . 1.0 107.708 174.658 . . . . . . . . 3 3 . 1 . 028 nuclear build core ' A' A ' 110' ' ' PRO . . . . . 0.628 ' HD2' ' H ' ' A' ' 109' ' ' ILE . 18.3 Cg_endo -52.85 -36.65 75.04 Favored 'Trans proline' 0 N--CA 1.51 2.446 0 CA-C-N 121.92 1.721 . . . . 1.0 112.199 175.869 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 111' ' ' ASN . . . . . 0.429 ' C ' ' N ' ' A' ' 113' ' ' ASN . 6.2 t30 -68.25 -68.42 0.39 Allowed 'General case' 0 C--N 1.328 -0.356 0 C-N-CA 119.448 -0.901 . . . . 1.0 110.106 -177.907 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 112' ' ' ILE . . . . . 0.448 ' O ' ' N ' ' A' ' 116' ' ' ILE . 3.9 pt -51.0 -25.99 4.01 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.263 0 CA-C-O 123.07 1.414 . . . . 1.0 108.098 179.262 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 113' ' ' ASN . . . . . 0.558 ' ND2' ' OE2' ' A' ' 117' ' ' GLU . 15.4 t-20 -59.21 -52.37 65.96 Favored 'General case' 0 C--N 1.306 -1.286 0 CA-C-N 111.987 -2.369 . . . . 1.0 107.982 -177.886 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 114' ' ' ALA . . . . . 0.54 ' O ' HG23 ' A' ' 118' ' ' VAL . . . -64.08 -31.17 72.26 Favored 'General case' 0 C--N 1.323 -0.562 0 N-CA-C 113.103 0.779 . . . . 1.0 113.103 179.675 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 115' ' ' ALA . . . . . 0.454 ' O ' ' N ' ' A' ' 119' ' ' LEU . . . -85.15 -58.42 2.69 Favored 'General case' 0 N--CA 1.476 0.848 0 CA-C-N 119.36 0.982 . . . . 1.0 111.655 178.494 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 116' ' ' ILE . . . . . 0.448 ' N ' ' O ' ' A' ' 112' ' ' ILE . 31.2 mt -51.11 -57.71 2.67 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.402 0 N-CA-C 107.217 -1.401 . . . . 1.0 107.217 -178.375 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 117' ' ' GLU . . . . . 0.558 ' OE2' ' ND2' ' A' ' 113' ' ' ASN . 56.0 mt-10 -51.68 -50.37 60.56 Favored 'General case' 0 C--N 1.307 -1.277 0 CA-C-N 112.771 -2.013 . . . . 1.0 107.056 -179.15 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 118' ' ' VAL . . . . . 0.54 HG23 ' O ' ' A' ' 114' ' ' ALA . 17.0 t -59.83 -28.86 41.79 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.8 0 C-N-CA 119.642 -0.823 . . . . 1.0 110.021 178.378 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 119' ' ' LEU . . . . . 0.454 ' N ' ' O ' ' A' ' 115' ' ' ALA . 3.9 tt -78.42 -61.58 1.96 Allowed 'General case' 0 C--N 1.354 0.8 0 CA-C-N 120.396 1.453 . . . . 1.0 107.466 177.962 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 120' ' ' GLY . . . . . 0.444 ' C ' ' OG1' ' A' ' 121' ' ' THR . . . -64.31 -82.25 0.1 Allowed Glycine 0 C--N 1.358 1.771 0 C-N-CA 119.036 -1.554 . . . . 1.0 109.299 178.291 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 121' ' ' THR . . . . . 0.491 ' OG1' HG22 ' A' ' 123' ' ' THR . 0.0 OUTLIER 167.76 -38.85 0.0 OUTLIER 'General case' 0 CA--C 1.542 0.659 0 CA-C-N 113.968 -1.116 . . . . 1.0 113.041 178.817 . . . . . . . . 3 3 . 1 . 028 nuclear build core ' A' A ' 122' ' ' GLY . . . . . 0.643 ' O ' ' N ' ' A' ' 124' ' ' ASP . . . 103.28 -15.91 53.74 Favored Glycine 0 N--CA 1.478 1.475 0 N-CA-C 107.243 -2.343 . . . . 1.0 107.243 -176.345 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 123' ' ' THR . . . . . 0.538 HG23 ' O ' ' A' ' 123' ' ' THR . 9.1 t -58.38 81.19 0.01 OUTLIER 'General case' 0 CA--C 1.545 0.787 0 CA-C-N 111.272 -2.464 . . . . 1.0 105.36 178.279 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 124' ' ' ASP . . . . . 0.643 ' N ' ' O ' ' A' ' 122' ' ' GLY . 35.8 m-20 -165.39 174.55 9.94 Favored 'General case' 0 N--CA 1.475 0.79 0 CA-C-N 112.818 -1.992 . . . . 1.0 112.457 179.989 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 125' ' ' TYR . . . . . . . . . . . . . 6.1 t80 -142.85 138.83 30.58 Favored 'General case' 0 CA--C 1.54 0.596 0 N-CA-C 107.655 -1.239 . . . . 1.0 107.655 175.588 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 9.6 tpt180 -149.88 153.12 36.19 Favored 'General case' 0 N--CA 1.467 0.39 0 N-CA-C 110.236 -0.283 . . . . 1.0 110.236 178.075 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 127' ' ' PHE . . . . . . . . . . . . . 22.4 p90 . . . . . 0 N--CA 1.469 0.486 0 CA-C-O 118.034 -0.984 . . . . 1.0 110.743 179.926 . . . . . . . . 0 0 . 1 . 029 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 4.6 tpp . . . . . 0 N--CA 1.489 1.498 0 N-CA-C 109.194 -0.669 . . . . 1.0 109.194 . . . . . . . . . 0 0 . 1 . 029 nuclear build core ' A' A ' 2' ' ' SER . . . . . 0.484 ' O ' ' CB ' ' A' ' 3' ' ' ASP . 87.7 p -89.61 12.42 16.82 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.877 -0.602 . . . . 1.0 110.499 -179.951 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 3' ' ' ASP . . . . . 0.484 ' CB ' ' O ' ' A' ' 2' ' ' SER . 4.7 t0 151.22 116.58 0.0 OUTLIER 'General case' 0 N--CA 1.473 0.699 0 O-C-N 124.075 0.86 . . . . 1.0 109.963 178.606 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 4' ' ' PHE . . . . . 0.434 ' O ' ' OD1' ' A' ' 5' ' ' ASP . 13.8 t80 -152.38 148.05 27.02 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.645 -0.707 . . . . 1.0 110.305 179.559 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 5' ' ' ASP . . . . . 0.434 ' OD1' ' O ' ' A' ' 4' ' ' PHE . 2.2 m-20 -154.78 151.52 28.78 Favored 'General case' 0 C--O 1.234 0.242 0 N-CA-C 109.703 -0.48 . . . . 1.0 109.703 179.634 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 6' ' ' THR . . . . . 0.416 ' C ' ' O ' ' A' ' 5' ' ' ASP . 3.0 m -38.76 143.07 0.16 Allowed 'General case' 0 N--CA 1.467 0.4 0 N-CA-C 109.53 -0.544 . . . . 1.0 109.53 179.994 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 35.9 tt0 -47.27 -52.4 16.27 Favored 'General case' 0 C--N 1.316 -0.86 0 CA-C-O 118.347 -0.835 . . . . 1.0 112.698 -174.934 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 8' ' ' ARG . . . . . 0.524 ' O ' ' HB3' ' A' ' 12' ' ' ALA . 24.3 ptt180 -63.48 -35.5 80.66 Favored 'General case' 0 N--CA 1.447 -0.59 0 CA-C-N 120.824 1.647 . . . . 1.0 109.816 179.022 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 9' ' ' VAL . . . . . 0.658 ' O ' HG23 ' A' ' 13' ' ' VAL . 93.6 t -62.34 -52.23 62.58 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.714 0 C-N-CA 118.665 -1.214 . . . . 1.0 108.009 178.481 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 80.0 p -67.61 -38.72 84.35 Favored 'General case' 0 CA--C 1.543 0.696 0 N-CA-C 113.353 0.872 . . . . 1.0 113.353 179.384 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 11' ' ' ARG . . . . . 0.596 ' O ' ' N ' ' A' ' 14' ' ' ALA . 5.0 tpp180 -75.77 -63.0 1.4 Allowed 'General case' 0 N--CA 1.472 0.649 0 CA-C-O 122.335 1.064 . . . . 1.0 109.098 178.039 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 12' ' ' ALA . . . . . 0.621 ' O ' ' HB3' ' A' ' 16' ' ' ALA . . . -46.67 -37.56 8.48 Favored 'General case' 0 N--CA 1.474 0.762 0 CA-C-N 112.724 -2.034 . . . . 1.0 105.955 -175.323 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 13' ' ' VAL . . . . . 0.658 HG23 ' O ' ' A' ' 9' ' ' VAL . 11.9 t -59.8 -50.84 78.53 Favored 'Isoleucine or valine' 0 C--O 1.206 -1.215 0 C-N-CA 118.574 -1.25 . . . . 1.0 107.869 175.68 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 14' ' ' ALA . . . . . 0.596 ' N ' ' O ' ' A' ' 11' ' ' ARG . . . -60.85 -63.59 1.24 Allowed 'General case' 0 C--O 1.219 -0.531 0 C-N-CA 118.717 -1.193 . . . . 1.0 111.235 179.178 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 15' ' ' ALA . . . . . 0.495 ' O ' ' N ' ' A' ' 19' ' ' GLY . . . -52.48 -54.93 25.96 Favored 'General case' 0 N--CA 1.479 1.003 0 CA-C-O 121.826 0.822 . . . . 1.0 110.143 -176.735 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 16' ' ' ALA . . . . . 0.621 ' HB3' ' O ' ' A' ' 12' ' ' ALA . . . -61.97 -53.36 56.77 Favored 'General case' 0 C--N 1.308 -1.201 0 CA-C-N 113.877 -1.511 . . . . 1.0 108.685 -179.239 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 17' ' ' LEU . . . . . 0.599 ' CB ' ' O ' ' A' ' 13' ' ' VAL . 3.1 tp -57.06 -51.75 68.02 Favored 'General case' 0 N--CA 1.479 1.016 0 C-N-CA 118.944 -1.102 . . . . 1.0 109.083 -177.336 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 18' ' ' VAL . . . . . 0.574 HG13 ' O ' ' A' ' 14' ' ' ALA . 3.2 m -68.78 -56.5 11.95 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.269 0 C-N-CA 119.04 -1.064 . . . . 1.0 108.864 179.397 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 19' ' ' GLY . . . . . 0.559 ' N ' HG23 ' A' ' 18' ' ' VAL . . . -60.73 -169.25 0.51 Allowed Glycine 0 CA--C 1.532 1.133 0 N-CA-C 111.786 -0.526 . . . . 1.0 111.786 179.881 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 20' ' ' PRO . . . . . 0.611 ' O ' ' N ' ' A' ' 24' ' ' ALA . 27.7 Cg_endo -81.57 -32.89 0.76 Allowed 'Trans proline' 0 N--CA 1.493 1.49 0 C-N-CA 123.323 2.682 . . . . 1.0 115.154 -178.656 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -57.64 -57.29 20.59 Favored Glycine 0 N--CA 1.479 1.539 0 C-N-CA 120.246 -0.978 . . . . 1.0 111.623 -176.565 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 22' ' ' GLY . . . . . 0.584 ' CA ' ' HB1' ' A' ' 16' ' ' ALA . . . -56.69 -50.47 63.11 Favored Glycine 0 N--CA 1.472 1.039 0 N-CA-C 107.075 -2.41 . . . . 1.0 107.075 -178.17 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 23' ' ' VAL . . . . . 0.526 ' O ' HG12 ' A' ' 27' ' ' VAL . 41.8 t -61.7 -34.95 64.56 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.051 0 CA-C-N 114.834 -0.683 . . . . 1.0 109.85 179.371 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 24' ' ' ALA . . . . . 0.611 ' N ' ' O ' ' A' ' 20' ' ' PRO . . . -57.07 -61.14 2.66 Favored 'General case' 0 N--CA 1.454 -0.231 0 C-N-CA 118.978 -1.089 . . . . 1.0 109.404 -179.145 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 8.4 tt -65.98 -42.48 89.8 Favored 'General case' 0 C--N 1.342 0.283 0 C-N-CA 119.657 -0.817 . . . . 1.0 111.922 -178.715 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 59.3 t -59.37 -58.69 5.88 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.182 0 C-N-CA 118.472 -1.291 . . . . 1.0 109.501 -178.017 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 27' ' ' VAL . . . . . 0.526 HG12 ' O ' ' A' ' 23' ' ' VAL . 1.8 p -63.4 -36.75 77.4 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.454 0 N-CA-C 112.953 0.723 . . . . 1.0 112.953 -177.706 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 24.7 tttm -64.68 -53.28 49.91 Favored 'General case' 0 C--N 1.324 -0.533 0 N-CA-C 108.293 -1.003 . . . . 1.0 108.293 -178.597 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 74.1 t -59.65 -44.83 94.33 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.829 0 CA-C-N 114.523 -1.217 . . . . 1.0 109.906 -178.81 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 30' ' ' CYS . . . . . 0.566 ' SG ' ' N ' ' A' ' 31' ' ' ALA . 0.5 OUTLIER -64.56 -57.25 9.67 Favored 'General case' 0 CA--C 1.539 0.543 0 C-N-CA 118.43 -1.308 . . . . 1.0 109.143 -179.804 . . . . . . . . 3 3 . 1 . 029 nuclear build core ' A' A ' 31' ' ' ALA . . . . . 0.566 ' N ' ' SG ' ' A' ' 30' ' ' CYS . . . -64.35 -56.09 16.74 Favored 'General case' 0 N--CA 1.468 0.436 0 N-CA-C 116.276 1.954 . . . . 1.0 116.276 -175.984 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 32' ' ' GLY . . . . . 0.472 ' O ' ' HB2' ' A' ' 33' ' ' LEU . . . 81.5 73.44 1.2 Allowed Glycine 0 CA--C 1.537 1.425 0 N-CA-C 108.694 -1.762 . . . . 1.0 108.694 -175.539 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 33' ' ' LEU . . . . . 0.472 ' HB2' ' O ' ' A' ' 32' ' ' GLY . 15.8 mt 81.34 110.04 0.03 OUTLIER Pre-proline 0 N--CA 1.486 1.345 0 C-N-CA 124.68 1.192 . . . . 1.0 111.745 -178.657 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 52.4 Cg_exo -54.62 -14.48 7.45 Favored 'Trans proline' 0 N--CA 1.507 2.308 0 C-N-CA 122.348 2.032 . . . . 1.0 113.325 178.355 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -56.46 -55.87 27.43 Favored Glycine 0 CA--C 1.534 1.236 0 C-N-CA 119.159 -1.496 . . . . 1.0 109.588 -178.458 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 36' ' ' VAL . . . . . 0.832 HG13 ' H ' ' A' ' 37' ' ' ILE . 6.1 p -69.78 -70.08 0.25 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.5 0 N-CA-C 112.958 0.725 . . . . 1.0 112.958 -177.53 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 37' ' ' ILE . . . . . 0.832 ' H ' HG13 ' A' ' 36' ' ' VAL . 53.1 mt 9.46 68.16 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.486 1.373 0 N-CA-C 114.035 1.124 . . . . 1.0 114.035 -178.061 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 38' ' ' HIS . . . . . 0.433 ' O ' ' CG ' ' A' ' 38' ' ' HIS . 0.0 OUTLIER -131.75 118.47 19.99 Favored 'General case' 0 N--CA 1.447 -0.587 0 CA-C-N 122.161 2.255 . . . . 1.0 106.477 177.484 . . . . . . . . 3 3 . 1 . 029 nuclear build core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 3.9 m -101.88 122.65 46.59 Favored Pre-proline 0 C--N 1.323 -0.56 0 C-N-CA 120.478 -0.489 . . . . 1.0 110.508 -178.684 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 58.3 Cg_exo -48.85 -37.43 36.15 Favored 'Trans proline' 0 N--CA 1.491 1.346 0 C-N-CA 121.133 1.222 . . . . 1.0 112.829 179.896 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -124.71 131.03 53.49 Favored 'General case' 0 N--CA 1.467 0.379 0 N-CA-C 109.831 -0.433 . . . . 1.0 109.831 178.479 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 42' ' ' ARG . . . . . 0.671 ' C ' ' H ' ' A' ' 44' ' ' GLY . 28.7 ptt-85 -168.27 165.57 12.93 Favored 'General case' 0 C--N 1.322 -0.614 0 C-N-CA 119.608 -0.837 . . . . 1.0 110.628 178.094 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 43' ' ' ARG . . . . . 0.41 ' O ' ' HG2' ' A' ' 43' ' ' ARG . 21.1 ttt180 -65.63 17.75 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.464 0 N-CA-C 108.795 -0.817 . . . . 1.0 108.795 179.206 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 44' ' ' GLY . . . . . 0.671 ' H ' ' C ' ' A' ' 42' ' ' ARG . . . 82.91 -24.59 5.14 Favored Glycine 0 N--CA 1.447 -0.627 0 N-CA-C 110.857 -0.897 . . . . 1.0 110.857 -179.947 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 45' ' ' PHE . . . . . 0.653 ' N ' ' CD1' ' A' ' 45' ' ' PHE . 0.0 OUTLIER -163.78 164.1 23.78 Favored 'General case' 0 CA--C 1.551 1.008 0 CA-C-N 116.98 0.39 . . . . 1.0 110.137 -178.633 . . . . . . . . 3 3 . 1 . 029 nuclear build core ' A' A ' 46' ' ' PHE . . . . . 0.576 ' N ' ' HE ' ' A' ' 47' ' ' ARG . 0.6 OUTLIER 144.01 4.31 0.0 OUTLIER 'General case' 0 N--CA 1.505 2.297 0 O-C-N 125.065 1.478 . . . . 1.0 111.92 177.531 . . . . . . . . 3 3 . 1 . 029 nuclear build core ' A' A ' 47' ' ' ARG . . . . . 0.576 ' HE ' ' N ' ' A' ' 46' ' ' PHE . 0.0 OUTLIER -117.27 -149.49 0.44 Allowed 'General case' 0 N--CA 1.472 0.65 0 CA-C-N 117.912 0.324 . . . . 1.0 110.182 -179.183 . . . . . . . . 3 3 . 1 . 029 nuclear build core ' A' A ' 48' ' ' CYS . . . . . 0.537 ' C ' ' O ' ' A' ' 47' ' ' ARG . 25.8 p -15.32 93.98 0.01 OUTLIER 'General case' 0 N--CA 1.484 1.239 0 O-C-N 124.346 1.029 . . . . 1.0 110.456 179.872 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 49' ' ' ASN . . . . . 0.507 ' ND2' ' O ' ' A' ' 52' ' ' ARG . 0.1 OUTLIER -123.31 140.73 34.43 Favored Pre-proline 0 CA--C 1.541 0.607 0 N-CA-C 108.746 -0.835 . . . . 1.0 108.746 -178.1 . . . . . . . . 3 3 . 1 . 029 nuclear build core ' A' A ' 50' ' ' PRO . . . . . 0.48 ' C ' ' H ' ' A' ' 52' ' ' ARG . 64.9 Cg_endo -73.44 59.91 4.03 Favored 'Trans proline' 0 N--CA 1.493 1.445 0 C-N-CA 121.613 1.542 . . . . 1.0 112.047 -179.861 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 20.8 mp0 68.04 -24.85 0.13 Allowed 'General case' 0 N--CA 1.469 0.478 0 CA-C-N 115.677 -0.692 . . . . 1.0 112.055 179.614 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 52' ' ' ARG . . . . . 0.507 ' O ' ' ND2' ' A' ' 49' ' ' ASN . 47.1 mmt-85 -59.24 174.95 0.35 Allowed 'General case' 0 CA--C 1.518 -0.252 0 C-N-CA 120.299 -0.561 . . . . 1.0 109.731 -179.928 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -99.15 145.31 10.54 Favored 'Isoleucine or valine' 0 C--O 1.232 0.133 0 CA-C-O 122.133 0.968 . . . . 1.0 111.141 -179.199 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 54' ' ' GLN . . . . . 0.613 ' H ' ' CD ' ' A' ' 54' ' ' GLN . 0.0 OUTLIER -63.91 79.27 0.03 OUTLIER 'General case' 0 C--N 1.316 -0.862 0 CA-C-N 113.345 -1.752 . . . . 1.0 110.363 -177.532 . . . . . . . . 3 3 . 1 . 029 nuclear build core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -148.91 156.51 7.76 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.412 0 N-CA-C 108.984 -0.747 . . . . 1.0 108.984 176.914 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 56' ' ' GLY . . . . . 0.567 ' O ' ' CD1' ' A' ' 58' ' ' TRP . . . 110.17 -4.99 30.17 Favored Glycine 0 N--CA 1.469 0.891 0 N-CA-C 109.767 -1.333 . . . . 1.0 109.767 -178.821 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 57' ' ' ASP . . . . . 0.533 ' OD1' ' N ' ' A' ' 57' ' ' ASP . 12.7 p-10 -80.02 98.54 7.25 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 114.914 -0.643 . . . . 1.0 109.469 178.885 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 58' ' ' TRP . . . . . 0.567 ' CD1' ' O ' ' A' ' 56' ' ' GLY . 18.4 m95 -84.84 176.79 8.28 Favored 'General case' 0 N--CA 1.464 0.239 0 CA-C-O 122.561 1.172 . . . . 1.0 113.084 -178.521 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 1.3 mpp_? -90.11 -60.06 2.03 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 112.26 -2.246 . . . . 1.0 111.494 179.781 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -90.68 -18.18 25.51 Favored 'General case' 0 N--CA 1.48 1.069 0 N-CA-C 113.925 1.083 . . . . 1.0 113.925 -179.462 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 3.4 tt0 -82.66 -13.91 55.6 Favored 'General case' 0 C--N 1.318 -0.784 0 O-C-N 121.397 -0.815 . . . . 1.0 110.719 -179.48 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 62' ' ' VAL . . . . . 0.655 ' O ' ' N ' ' A' ' 66' ' ' GLY . 28.2 m -51.51 -54.58 11.55 Favored 'Isoleucine or valine' 0 C--O 1.203 -1.377 0 C-N-CA 120.263 -0.575 . . . . 1.0 111.212 -176.77 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 63' ' ' ALA . . . . . 0.625 ' N ' HG23 ' A' ' 62' ' ' VAL . . . -71.25 -53.84 12.96 Favored 'General case' 0 C--N 1.315 -0.894 0 CA-C-N 119.59 1.086 . . . . 1.0 109.282 -177.747 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 64' ' ' HIS . . . . . 0.741 ' CD2' HH12 ' A' ' 67' ' ' ARG . 0.5 OUTLIER -45.2 -54.61 6.73 Favored 'General case' 0 CA--C 1.536 0.409 0 N-CA-C 107.969 -1.123 . . . . 1.0 107.969 179.157 . . . . . . . . 3 3 . 1 . 029 nuclear build core ' A' A ' 65' ' ' ASP . . . . . 0.562 ' C ' ' H ' ' A' ' 67' ' ' ARG . 11.1 t70 -73.83 -49.07 26.94 Favored 'General case' 0 C--N 1.314 -0.975 0 CA-C-N 114.428 -1.26 . . . . 1.0 111.16 179.343 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 66' ' ' GLY . . . . . 0.655 ' N ' ' O ' ' A' ' 62' ' ' VAL . . . -75.13 26.81 1.19 Allowed Glycine 0 C--N 1.317 -0.509 0 N-CA-C 109.88 -1.288 . . . . 1.0 109.88 177.41 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 67' ' ' ARG . . . . . 0.741 HH12 ' CD2' ' A' ' 64' ' ' HIS . 21.5 mtt85 -71.57 8.2 1.19 Allowed 'General case' 0 CA--C 1.504 -0.826 0 N-CA-C 105.22 -2.141 . . . . 1.0 105.22 173.629 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 68' ' ' LEU . . . . . 0.654 ' H ' ' C ' ' A' ' 66' ' ' GLY . 1.5 pp -32.27 -29.83 0.01 OUTLIER 'General case' 0 C--N 1.347 0.498 0 O-C-N 124.112 0.883 . . . . 1.0 108.982 -177.252 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 69' ' ' LEU . . . . . 0.631 ' N ' ' O ' ' A' ' 67' ' ' ARG . 2.1 tt -62.38 -64.36 0.95 Allowed 'General case' 0 C--N 1.321 -0.632 0 C-N-CA 119.095 -1.042 . . . . 1.0 108.423 177.14 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 70' ' ' ALA . . . . . 0.592 ' O ' ' N ' ' A' ' 72' ' ' HIS . . . -77.45 -73.17 0.32 Allowed 'General case' 0 N--CA 1.47 0.537 0 N-CA-C 104.319 -2.475 . . . . 1.0 104.319 176.161 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 71' ' ' ALA . . . . . 0.504 ' O ' ' C ' ' A' ' 72' ' ' HIS . . . -41.22 2.8 0.0 OUTLIER 'General case' 0 C--N 1.322 -0.619 0 N-CA-C 115.533 1.679 . . . . 1.0 115.533 179.77 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 72' ' ' HIS . . . . . 0.633 ' CD2' ' H ' ' A' ' 73' ' ' MET . 1.9 p-80 -29.06 -63.84 0.11 Allowed 'General case' 0 N--CA 1.47 0.528 0 CA-C-N 120.6 1.545 . . . . 1.0 112.458 -176.29 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 73' ' ' MET . . . . . 0.633 ' H ' ' CD2' ' A' ' 72' ' ' HIS . 0.0 OUTLIER -71.72 -48.69 45.43 Favored 'General case' 0 C--N 1.325 -0.473 0 C-N-CA 119.236 -0.986 . . . . 1.0 109.84 177.765 . . . . . . . . 3 3 . 1 . 029 nuclear build core ' A' A ' 74' ' ' VAL . . . . . 0.746 ' O ' ' N ' ' A' ' 76' ' ' GLY . 58.0 t -45.62 -43.32 3.93 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.387 0 CA-C-O 117.397 -1.287 . . . . 1.0 112.08 -175.843 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 75' ' ' ASN . . . . . 0.424 ' O ' ' N ' ' A' ' 78' ' ' VAL . 16.2 t30 -35.75 -12.17 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.613 0 CA-C-N 121.265 1.848 . . . . 1.0 112.467 178.549 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 76' ' ' GLY . . . . . 0.746 ' N ' ' O ' ' A' ' 74' ' ' VAL . . . -46.04 -25.02 1.58 Allowed Glycine 0 CA--C 1.54 1.654 0 N-CA-C 108.349 -1.9 . . . . 1.0 108.349 176.721 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 77' ' ' ILE . . . . . 0.56 ' O ' ' N ' ' A' ' 80' ' ' ALA . 5.5 pt -63.24 -54.76 28.98 Favored 'Isoleucine or valine' 0 C--O 1.219 -0.511 0 N-CA-C 107.873 -1.158 . . . . 1.0 107.873 178.421 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 78' ' ' VAL . . . . . 0.471 ' C ' ' O ' ' A' ' 77' ' ' ILE . 59.7 t -36.04 -33.07 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.316 -0.885 0 CA-C-N 112.186 -2.279 . . . . 1.0 106.962 -177.108 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 79' ' ' ILE . . . . . 0.716 ' O ' ' HB2' ' A' ' 83' ' ' ALA . 0.0 OUTLIER -98.39 -33.44 4.18 Favored 'Isoleucine or valine' 0 CA--C 1.556 1.178 0 CA-C-N 115.795 -0.639 . . . . 1.0 111.018 177.828 . . . . . . . . 3 3 . 1 . 029 nuclear build core ' A' A ' 80' ' ' ALA . . . . . 0.56 ' N ' ' O ' ' A' ' 77' ' ' ILE . . . -84.86 -13.37 51.16 Favored 'General case' 0 N--CA 1.48 1.048 0 N-CA-C 114.842 1.423 . . . . 1.0 114.842 -179.096 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 81' ' ' GLU . . . . . 0.452 ' N ' ' O ' ' A' ' 77' ' ' ILE . 41.8 mt-10 -88.48 -67.33 0.84 Allowed 'General case' 0 CA--C 1.506 -0.724 0 O-C-N 121.656 -0.652 . . . . 1.0 109.383 178.098 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 82' ' ' ASP . . . . . 0.541 ' O ' ' N ' ' A' ' 84' ' ' LEU . 24.3 t0 -73.25 -13.92 61.23 Favored 'General case' 0 N--CA 1.442 -0.858 0 CA-C-N 119.043 0.838 . . . . 1.0 111.908 179.792 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 83' ' ' ALA . . . . . 0.737 ' HA ' ' HB3' ' A' ' 86' ' ' ALA . . . -20.47 -47.2 0.01 OUTLIER 'General case' 0 N--CA 1.478 0.96 0 CA-C-N 118.39 0.541 . . . . 1.0 112.032 178.221 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 84' ' ' LEU . . . . . 0.541 ' N ' ' O ' ' A' ' 82' ' ' ASP . 3.7 mm? -34.29 -35.91 0.04 OUTLIER 'General case' 0 N--CA 1.478 0.949 0 N-CA-C 113.209 0.818 . . . . 1.0 113.209 -178.163 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 85' ' ' ILE . . . . . 0.417 HD12 ' HA ' ' A' ' 85' ' ' ILE . 11.2 tp -100.42 -36.86 5.28 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.66 0 N-CA-C 108.548 -0.908 . . . . 1.0 108.548 177.88 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 86' ' ' ALA . . . . . 0.737 ' HB3' ' HA ' ' A' ' 83' ' ' ALA . . . -61.21 -58.82 6.73 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 114.426 -1.261 . . . . 1.0 109.132 179.973 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 87' ' ' GLU . . . . . 0.408 ' N ' ' O ' ' A' ' 83' ' ' ALA . 2.5 tt0 -71.5 24.04 0.04 OUTLIER 'General case' 0 CA--C 1.542 0.642 0 O-C-N 121.321 -0.862 . . . . 1.0 112.364 -178.931 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 88' ' ' ALA . . . . . 0.43 ' H ' ' C ' ' A' ' 86' ' ' ALA . . . -126.64 -16.63 5.23 Favored 'General case' 0 N--CA 1.478 0.971 0 CA-C-O 122.213 1.006 . . . . 1.0 108.999 179.131 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 21.2 m -101.48 33.89 0.37 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.456 0 CA-C-N 113.406 -1.724 . . . . 1.0 109.09 178.328 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 90' ' ' GLY . . . . . 0.595 ' C ' ' H ' ' A' ' 92' ' ' HIS . . . -69.3 -35.45 76.69 Favored Glycine 0 C--N 1.345 1.044 0 N-CA-C 111.16 -0.776 . . . . 1.0 111.16 179.009 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 91' ' ' PRO . . . . . 0.583 ' CD ' ' N ' ' A' ' 90' ' ' GLY . 89.4 Cg_exo -48.35 -8.08 0.06 OUTLIER 'Trans proline' 0 N--CA 1.498 1.746 0 C-N-CA 122.002 1.801 . . . . 1.0 110.702 177.897 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 92' ' ' HIS . . . . . 0.601 ' ND1' ' N ' ' A' ' 93' ' ' LEU . 0.9 OUTLIER -57.54 -20.11 29.56 Favored 'General case' 0 N--CA 1.444 -0.746 0 N-CA-C 107.771 -1.196 . . . . 1.0 107.771 179.367 . . . . . . . . 3 3 . 1 . 029 nuclear build core ' A' A ' 93' ' ' LEU . . . . . 0.693 HD12 ' N ' ' A' ' 94' ' ' ALA . 2.2 pp -65.63 -58.09 6.56 Favored 'General case' 0 N--CA 1.451 -0.393 0 N-CA-C 108.507 -0.923 . . . . 1.0 108.507 178.507 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 94' ' ' ALA . . . . . 0.693 ' N ' HD12 ' A' ' 93' ' ' LEU . . . -55.11 -54.21 46.03 Favored 'General case' 0 N--CA 1.452 -0.336 0 N-CA-C 108.962 -0.755 . . . . 1.0 108.962 179.305 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 95' ' ' ARG . . . . . 0.579 ' O ' ' N ' ' A' ' 97' ' ' LEU . 29.2 mtm180 -58.69 -58.86 6.73 Favored 'General case' 0 C--O 1.242 0.689 0 CA-C-O 122.529 1.157 . . . . 1.0 108.254 179.461 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 96' ' ' ALA . . . . . 0.886 ' O ' ' N ' ' A' ' 98' ' ' GLY . . . -48.55 -14.1 0.06 Allowed 'General case' 0 N--CA 1.424 -1.754 0 O-C-N 118.961 -2.337 . . . . 1.0 111.297 -178.856 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 97' ' ' LEU . . . . . 0.735 ' O ' ' N ' ' A' ' 100' ' ' ILE . 1.9 tp 5.23 -52.34 0.0 OUTLIER 'General case' 0 C--N 1.367 1.358 0 CA-C-O 116.427 -1.749 . . . . 1.0 110.447 -167.765 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 98' ' ' GLY . . . . . 0.886 ' N ' ' O ' ' A' ' 96' ' ' ALA . . . -48.66 -23.65 3.49 Favored Glycine 0 CA--C 1.542 1.735 0 CA-C-N 123.916 3.053 . . . . 1.0 108.034 174.733 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 99' ' ' GLN . . . . . 0.572 ' N ' ' O ' ' A' ' 96' ' ' ALA . 59.0 tt0 -68.81 -19.22 64.27 Favored 'General case' 0 C--N 1.364 1.211 0 N-CA-C 107.285 -1.376 . . . . 1.0 107.285 177.536 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 100' ' ' ILE . . . . . 0.735 ' N ' ' O ' ' A' ' 97' ' ' LEU . 1.9 tp -65.54 -42.58 93.43 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 N-CA-C 107.103 -1.443 . . . . 1.0 107.103 177.128 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 101' ' ' VAL . . . . . 0.743 ' O ' ' N ' ' A' ' 105' ' ' GLY . 61.0 t -55.68 -60.03 2.1 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.43 0 N-CA-C 106.931 -1.507 . . . . 1.0 106.931 178.704 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 102' ' ' CYS . . . . . 0.859 ' O ' ' HB2' ' A' ' 106' ' ' ALA . 0.5 OUTLIER -46.35 -18.37 0.06 Allowed 'General case' 0 C--N 1.32 -0.708 0 CA-C-N 116.433 -0.349 . . . . 1.0 111.622 -179.666 . . . . . . . . 3 3 . 1 . 029 nuclear build core ' A' A ' 103' ' ' ARG . . . . . 0.416 ' N ' ' O ' ' A' ' 101' ' ' VAL . 1.1 ttp180 -92.77 -44.65 8.41 Favored 'General case' 0 N--CA 1.478 0.946 0 CA-C-O 121.948 0.88 . . . . 1.0 111.068 176.951 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 104' ' ' TYR . . . . . 0.583 ' O ' ' CG ' ' A' ' 104' ' ' TYR . 0.0 OUTLIER -106.57 21.85 16.79 Favored 'General case' 0 C--N 1.317 -0.808 0 C-N-CA 126.297 1.839 . . . . 1.0 111.215 179.416 . . . . . . . . 3 3 . 1 . 029 nuclear build core ' A' A ' 105' ' ' GLY . . . . . 0.769 ' O ' ' N ' ' A' ' 107' ' ' THR . . . -170.12 -7.33 0.03 OUTLIER Glycine 0 C--N 1.339 0.747 0 C-N-CA 118.495 -1.812 . . . . 1.0 113.481 178.619 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 106' ' ' ALA . . . . . 0.859 ' HB2' ' O ' ' A' ' 102' ' ' CYS . . . -31.64 69.49 0.0 OUTLIER 'General case' 0 N--CA 1.467 0.387 0 N-CA-C 113.752 1.019 . . . . 1.0 113.752 -177.738 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 107' ' ' THR . . . . . 0.769 ' N ' ' O ' ' A' ' 105' ' ' GLY . 4.8 t -91.84 4.22 53.38 Favored 'General case' 0 N--CA 1.436 -1.171 0 N-CA-C 105.668 -1.975 . . . . 1.0 105.668 176.151 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 108' ' ' VAL . . . . . 0.529 HG13 ' N ' ' A' ' 109' ' ' ILE . 11.2 p -87.77 -57.35 4.31 Favored 'Isoleucine or valine' 0 C--N 1.357 0.928 0 CA-C-N 115.851 -0.613 . . . . 1.0 110.624 178.333 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 109' ' ' ILE . . . . . 0.529 ' N ' HG13 ' A' ' 108' ' ' VAL . 0.1 OUTLIER -62.95 -37.98 38.5 Favored Pre-proline 0 C--N 1.359 0.987 0 N-CA-C 114.476 1.288 . . . . 1.0 114.476 -176.911 . . . . . . . . 3 3 . 1 . 029 nuclear build core ' A' A ' 110' ' ' PRO . . . . . 0.435 ' CD ' ' O ' ' A' ' 106' ' ' ALA . 62.5 Cg_exo -49.04 -44.9 31.2 Favored 'Trans proline' 0 N--CA 1.497 1.703 0 CA-C-N 121.158 1.449 . . . . 1.0 113.649 -176.418 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 9.0 t30 -68.03 -67.55 0.45 Allowed 'General case' 0 C--N 1.326 -0.422 0 C-N-CA 118.735 -1.186 . . . . 1.0 110.435 -177.815 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 6.3 pt -52.89 -23.2 4.99 Favored 'Isoleucine or valine' 0 C--O 1.214 -0.778 0 N-CA-C 108.78 -0.822 . . . . 1.0 108.78 179.391 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 113' ' ' ASN . . . . . 0.456 ' HB2' ' O ' ' A' ' 109' ' ' ILE . 20.2 t30 -59.43 -51.45 69.84 Favored 'General case' 0 C--N 1.314 -0.943 0 CA-C-N 113.731 -1.577 . . . . 1.0 108.334 -178.423 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -58.64 -28.9 66.11 Favored 'General case' 0 N--CA 1.443 -0.805 0 C-N-CA 120.345 -0.542 . . . . 1.0 111.202 179.874 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 115' ' ' ALA . . . . . 0.578 ' O ' ' N ' ' A' ' 119' ' ' LEU . . . -81.12 -50.29 9.8 Favored 'General case' 0 C--O 1.208 -1.123 0 C-N-CA 120.084 -0.646 . . . . 1.0 109.292 177.275 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 116' ' ' ILE . . . . . 0.413 ' C ' ' O ' ' A' ' 115' ' ' ALA . 35.8 mt -42.85 -48.39 1.19 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.408 0 N-CA-C 104.997 -2.223 . . . . 1.0 104.997 179.104 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 117' ' ' GLU . . . . . 0.493 ' O ' ' HA ' ' A' ' 121' ' ' THR . 55.7 tt0 -46.51 -58.32 3.89 Favored 'General case' 0 C--N 1.314 -0.951 0 CA-C-N 111.294 -2.685 . . . . 1.0 106.332 177.814 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 118' ' ' VAL . . . . . 0.574 ' N ' ' O ' ' A' ' 115' ' ' ALA . 15.8 t -64.44 -56.23 17.34 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.747 0 C-N-CA 120.085 -0.646 . . . . 1.0 110.486 177.398 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 119' ' ' LEU . . . . . 0.578 ' N ' ' O ' ' A' ' 115' ' ' ALA . 1.1 mm? -51.77 -20.63 2.26 Favored 'General case' 0 N--CA 1.451 -0.377 0 N-CA-C 113.984 1.105 . . . . 1.0 113.984 -178.532 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 120' ' ' GLY . . . . . 0.448 ' O ' ' CB ' ' A' ' 121' ' ' THR . . . -134.16 -68.64 0.07 OUTLIER Glycine 0 CA--C 1.554 2.486 0 N-CA-C 105.996 -2.842 . . . . 1.0 105.996 173.974 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 121' ' ' THR . . . . . 0.495 ' CG2' HG22 ' A' ' 123' ' ' THR . 2.3 m 152.7 -31.96 0.01 OUTLIER 'General case' 0 N--CA 1.481 1.101 0 CA-C-N 112.656 -1.772 . . . . 1.0 112.01 178.478 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 122' ' ' GLY . . . . . 0.67 ' O ' ' N ' ' A' ' 124' ' ' ASP . . . 104.02 -17.03 49.5 Favored Glycine 0 N--CA 1.471 1.016 0 N-CA-C 108.875 -1.69 . . . . 1.0 108.875 -177.973 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 123' ' ' THR . . . . . 0.495 HG22 ' CG2' ' A' ' 121' ' ' THR . 0.0 OUTLIER -55.4 84.98 0.0 OUTLIER 'General case' 0 CA--C 1.539 0.527 0 N-CA-C 105.566 -2.013 . . . . 1.0 105.566 178.548 . . . . . . . . 3 3 . 1 . 029 nuclear build core ' A' A ' 124' ' ' ASP . . . . . 0.67 ' N ' ' O ' ' A' ' 122' ' ' GLY . 63.7 m-20 -163.56 170.81 16.7 Favored 'General case' 0 N--CA 1.471 0.575 0 CA-C-N 113.428 -1.715 . . . . 1.0 112.342 -179.086 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 125' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -144.15 138.73 28.36 Favored 'General case' 0 CA--C 1.547 0.846 0 N-CA-C 107.377 -1.342 . . . . 1.0 107.377 176.449 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 25.6 mmm180 -149.31 153.85 38.12 Favored 'General case' 0 N--CA 1.476 0.851 0 N-CA-C 109.872 -0.418 . . . . 1.0 109.872 178.575 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 127' ' ' PHE . . . . . 0.478 ' OXT' ' CD1' ' A' ' 127' ' ' PHE . 0.1 OUTLIER . . . . . 0 N--CA 1.471 0.589 0 CA-C-O 118.076 -0.964 . . . . 1.0 110.269 178.862 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.495 1.8 0 N-CA-C 109.92 -0.4 . . . . 1.0 109.92 . . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 2' ' ' SER . . . . . 0.49 ' O ' ' CB ' ' A' ' 3' ' ' ASP . 9.0 t -86.49 13.78 7.82 Favored 'General case' 0 C--O 1.225 -0.23 0 CA-C-N 115.786 -0.643 . . . . 1.0 111.264 -179.918 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 3' ' ' ASP . . . . . 0.49 ' CB ' ' O ' ' A' ' 2' ' ' SER . 21.5 m-20 146.43 122.27 0.0 OUTLIER 'General case' 0 N--CA 1.478 0.955 0 O-C-N 124.577 1.173 . . . . 1.0 110.524 178.948 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 47.8 t80 -154.78 150.52 27.63 Favored 'General case' 0 N--CA 1.466 0.361 0 CA-C-N 116.062 -0.517 . . . . 1.0 110.573 179.028 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -152.39 147.97 26.92 Favored 'General case' 0 CA--C 1.543 0.694 0 CA-C-N 116.364 -0.38 . . . . 1.0 110.263 -178.529 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 6' ' ' THR . . . . . 0.479 HG22 ' H ' ' A' ' 7' ' ' GLU . 0.2 OUTLIER -61.49 -157.6 0.01 OUTLIER 'General case' 0 N--CA 1.472 0.671 0 C-N-CA 121.032 -0.267 . . . . 1.0 111.037 -179.187 . . . . . . . . 3 3 . 1 . 030 nuclear build core ' A' A ' 7' ' ' GLU . . . . . 0.479 ' H ' HG22 ' A' ' 6' ' ' THR . 3.2 pt-20 -75.76 -67.57 0.66 Allowed 'General case' 0 C--O 1.216 -0.698 0 CA-C-O 118.553 -0.737 . . . . 1.0 110.245 -179.367 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 8' ' ' ARG . . . . . 0.473 ' H ' ' CG ' ' A' ' 7' ' ' GLU . 7.0 tmm_? -47.08 -43.01 19.81 Favored 'General case' 0 CA--C 1.493 -1.214 0 CA-C-N 119.645 1.111 . . . . 1.0 111.781 -177.858 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 9' ' ' VAL . . . . . 0.438 ' O ' HG23 ' A' ' 13' ' ' VAL . 0.1 OUTLIER -68.96 -52.99 28.74 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.94 0 C-N-CA 118.933 -1.107 . . . . 1.0 108.779 179.063 . . . . . . . . 3 3 . 1 . 030 nuclear build core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 39.5 t -58.67 -42.75 89.18 Favored 'General case' 0 N--CA 1.455 -0.207 0 CA-C-O 118.868 -0.587 . . . . 1.0 111.968 179.528 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 11' ' ' ARG . . . . . 0.678 ' O ' ' N ' ' A' ' 14' ' ' ALA . 0.0 OUTLIER -74.17 -59.97 2.48 Favored 'General case' 0 CA--C 1.492 -1.256 0 N-CA-C 106.85 -1.537 . . . . 1.0 106.85 178.051 . . . . . . . . 3 3 . 1 . 030 nuclear build core ' A' A ' 12' ' ' ALA . . . . . 0.651 ' O ' ' HB3' ' A' ' 16' ' ' ALA . . . -38.91 -43.08 0.92 Allowed 'General case' 0 CA--C 1.487 -1.475 0 CA-C-N 119.108 0.867 . . . . 1.0 108.783 -175.879 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 13' ' ' VAL . . . . . 0.693 ' O ' ' HB3' ' A' ' 17' ' ' LEU . 71.5 t -60.12 -52.53 60.21 Favored 'Isoleucine or valine' 0 C--O 1.186 -2.252 0 C-N-CA 115.984 -2.286 . . . . 1.0 106.822 177.664 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 14' ' ' ALA . . . . . 0.796 ' O ' HG13 ' A' ' 18' ' ' VAL . . . -66.1 -64.89 0.76 Allowed 'General case' 0 C--O 1.209 -1.041 0 O-C-N 120.329 -1.482 . . . . 1.0 113.122 177.954 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 15' ' ' ALA . . . . . 0.525 ' O ' ' N ' ' A' ' 19' ' ' GLY . . . -57.19 -59.13 5.56 Favored 'General case' 0 N--CA 1.497 1.878 0 C-N-CA 119.739 -0.784 . . . . 1.0 112.86 -175.263 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 16' ' ' ALA . . . . . 0.668 ' HB1' ' CA ' ' A' ' 22' ' ' GLY . . . -61.62 -54.89 36.86 Favored 'General case' 0 CA--C 1.556 1.206 0 CA-C-O 122.533 1.158 . . . . 1.0 109.866 -177.678 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 17' ' ' LEU . . . . . 0.693 ' HB3' ' O ' ' A' ' 13' ' ' VAL . 21.1 tp -57.57 -51.17 70.56 Favored 'General case' 0 N--CA 1.481 1.102 0 CA-C-N 113.57 -1.65 . . . . 1.0 108.194 -177.452 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 18' ' ' VAL . . . . . 0.796 HG13 ' O ' ' A' ' 14' ' ' ALA . 3.0 m -70.34 -57.08 8.92 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.461 0 C-N-CA 118.927 -1.109 . . . . 1.0 110.168 179.636 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 19' ' ' GLY . . . . . 0.525 ' N ' ' O ' ' A' ' 15' ' ' ALA . . . -61.62 -177.43 2.53 Favored Glycine 0 N--CA 1.446 -0.697 0 N-CA-C 111.718 -0.553 . . . . 1.0 111.718 -178.045 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 20' ' ' PRO . . . . . 0.569 ' O ' ' N ' ' A' ' 24' ' ' ALA . 54.4 Cg_endo -82.81 -23.63 3.76 Favored 'Trans proline' 0 C--N 1.303 -1.85 0 C-N-CA 123.045 2.497 . . . . 1.0 112.065 -179.271 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -60.51 -59.22 10.66 Favored Glycine 0 CA--C 1.535 1.301 0 C-N-CA 120.046 -1.073 . . . . 1.0 111.321 -176.952 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 22' ' ' GLY . . . . . 0.668 ' CA ' ' HB1' ' A' ' 16' ' ' ALA . . . -56.14 -52.91 46.34 Favored Glycine 0 N--CA 1.469 0.893 0 N-CA-C 107.101 -2.399 . . . . 1.0 107.101 -178.411 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 23' ' ' VAL . . . . . 0.479 ' O ' HG12 ' A' ' 27' ' ' VAL . 36.7 t -59.28 -33.25 50.34 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.185 0 C-N-CA 119.774 -0.77 . . . . 1.0 109.143 179.836 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 24' ' ' ALA . . . . . 0.569 ' N ' ' O ' ' A' ' 20' ' ' PRO . . . -55.33 -62.29 1.77 Allowed 'General case' 0 N--CA 1.479 1.018 0 C-N-CA 119.239 -0.984 . . . . 1.0 110.568 -179.886 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 18.3 mt -63.66 -43.3 97.12 Favored 'General case' 0 C--N 1.345 0.392 0 C-N-CA 119.919 -0.712 . . . . 1.0 112.39 -177.854 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 95.2 t -60.22 -60.53 2.42 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.79 0 C-N-CA 118.591 -1.244 . . . . 1.0 111.279 -177.608 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 27' ' ' VAL . . . . . 0.513 ' O ' ' HB3' ' A' ' 31' ' ' ALA . 3.1 p -59.61 -34.26 54.48 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.2 0 N-CA-C 112.681 0.623 . . . . 1.0 112.681 -177.58 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 71.3 tttt -66.79 -54.71 19.9 Favored 'General case' 0 C--N 1.312 -1.034 0 CA-C-O 122.317 1.056 . . . . 1.0 108.79 -179.68 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 98.6 t -62.88 -47.67 91.72 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.145 0 CA-C-N 113.553 -1.658 . . . . 1.0 110.499 -177.092 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 30' ' ' CYS . . . . . 0.561 ' SG ' ' N ' ' A' ' 31' ' ' ALA . 0.0 OUTLIER -67.48 -61.17 2.03 Favored 'General case' 0 CA--C 1.533 0.326 0 C-N-CA 118.729 -1.188 . . . . 1.0 110.198 -179.692 . . . . . . . . 3 3 . 1 . 030 nuclear build core ' A' A ' 31' ' ' ALA . . . . . 0.561 ' N ' ' SG ' ' A' ' 30' ' ' CYS . . . -60.38 -53.85 52.71 Favored 'General case' 0 CA--C 1.509 -0.6 0 CA-C-N 118.25 0.477 . . . . 1.0 111.99 -177.001 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 32' ' ' GLY . . . . . 0.495 ' O ' ' CB ' ' A' ' 33' ' ' LEU . . . 87.33 74.36 1.28 Allowed Glycine 0 CA--C 1.521 0.416 0 N-CA-C 108.632 -1.787 . . . . 1.0 108.632 -178.529 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 33' ' ' LEU . . . . . 0.501 HD22 ' H ' ' A' ' 36' ' ' VAL . 1.1 tt 85.81 85.31 0.05 OUTLIER Pre-proline 0 CA--C 1.546 0.792 0 CA-C-O 120.692 0.282 . . . . 1.0 110.414 -179.343 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 51.7 Cg_exo -53.23 -30.4 51.11 Favored 'Trans proline' 0 N--CA 1.502 1.99 0 C-N-CA 123.005 2.47 . . . . 1.0 114.227 -179.679 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -57.23 -60.75 8.45 Favored Glycine 0 N--CA 1.469 0.856 0 C-N-CA 119.062 -1.542 . . . . 1.0 110.185 -178.653 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 36' ' ' VAL . . . . . 0.585 ' O ' HG22 ' A' ' 37' ' ' ILE . 2.7 p -88.77 160.49 2.82 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.479 0 N-CA-C 105.77 -1.937 . . . . 1.0 105.77 177.808 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 37' ' ' ILE . . . . . 0.663 HG23 ' O ' ' A' ' 37' ' ' ILE . 0.7 OUTLIER 125.61 113.56 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.479 0.996 0 O-C-N 124.682 1.239 . . . . 1.0 110.373 179.711 . . . . . . . . 3 3 . 1 . 030 nuclear build core ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 22.5 m80 -139.83 131.81 27.79 Favored 'General case' 0 N--CA 1.467 0.418 0 N-CA-C 108.557 -0.905 . . . . 1.0 108.557 179.263 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 9.2 p -99.37 149.4 35.8 Favored Pre-proline 0 N--CA 1.469 0.478 0 CA-C-N 116.969 -0.105 . . . . 1.0 110.743 -179.46 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 91.2 Cg_endo -75.29 -37.98 1.66 Allowed 'Trans proline' 0 N--CA 1.494 1.539 0 C-N-CA 122.317 2.012 . . . . 1.0 113.345 -179.123 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -128.2 134.38 49.02 Favored 'General case' 0 N--CA 1.472 0.665 0 N-CA-C 111.555 0.206 . . . . 1.0 111.555 179.611 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 42' ' ' ARG . . . . . 0.683 ' C ' ' H ' ' A' ' 44' ' ' GLY . 0.0 OUTLIER -169.86 165.95 9.61 Favored 'General case' 0 C--N 1.325 -0.487 0 C-N-CA 120.17 -0.612 . . . . 1.0 109.697 178.391 . . . . . . . . 3 3 . 1 . 030 nuclear build core ' A' A ' 43' ' ' ARG . . . . . 0.463 ' C ' ' H ' ' A' ' 45' ' ' PHE . 0.0 OUTLIER -61.89 24.92 0.01 OUTLIER 'General case' 0 CA--C 1.548 0.896 0 CA-C-N 115.494 -0.775 . . . . 1.0 110.553 179.82 . . . . . . . . 3 3 . 1 . 030 nuclear build core ' A' A ' 44' ' ' GLY . . . . . 0.683 ' H ' ' C ' ' A' ' 42' ' ' ARG . . . 76.42 -26.08 1.61 Allowed Glycine 0 C--N 1.345 1.073 0 N-CA-C 110.452 -1.059 . . . . 1.0 110.452 -179.948 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 45' ' ' PHE . . . . . 0.578 ' O ' ' HB2' ' A' ' 46' ' ' PHE . 6.6 p90 -169.37 172.12 7.37 Favored 'General case' 0 C--O 1.219 -0.518 0 N-CA-C 109.966 -0.383 . . . . 1.0 109.966 179.743 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 46' ' ' PHE . . . . . 0.578 ' HB2' ' O ' ' A' ' 45' ' ' PHE . 1.1 m-85 131.63 99.57 0.0 OUTLIER 'General case' 0 N--CA 1.501 2.083 0 O-C-N 125.763 1.914 . . . . 1.0 109.802 178.695 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 47' ' ' ARG . . . . . 0.644 ' HG2' ' H ' ' A' ' 48' ' ' CYS . 15.6 ttp85 93.88 175.27 0.01 OUTLIER 'General case' 0 N--CA 1.468 0.446 0 O-C-N 123.596 0.56 . . . . 1.0 110.254 179.09 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 48' ' ' CYS . . . . . 0.644 ' H ' ' HG2' ' A' ' 47' ' ' ARG . 2.5 t 67.53 62.68 0.43 Allowed 'General case' 0 N--CA 1.445 -0.707 0 N-CA-C 106.373 -1.714 . . . . 1.0 106.373 -178.351 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 49' ' ' ASN . . . . . 0.559 ' N ' ' OD1' ' A' ' 49' ' ' ASN . 1.1 p30 -156.21 155.74 29.41 Favored Pre-proline 0 N--CA 1.449 -0.508 0 N-CA-C 108.097 -1.075 . . . . 1.0 108.097 178.865 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 50' ' ' PRO . . . . . 0.428 ' O ' ' NH1' ' A' ' 52' ' ' ARG . 50.8 Cg_endo -67.59 76.5 0.54 Allowed 'Trans proline' 0 C--N 1.303 -1.828 0 C-N-CA 121.967 1.778 . . . . 1.0 112.272 177.238 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 9.0 pt-20 40.12 63.97 0.98 Allowed 'General case' 0 N--CA 1.477 0.921 0 N-CA-C 112.532 0.567 . . . . 1.0 112.532 -179.95 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 52' ' ' ARG . . . . . 0.68 HH22 ' CE1' ' A' ' 92' ' ' HIS . 77.6 mtt85 -147.28 136.02 22.05 Favored 'General case' 0 N--CA 1.472 0.627 0 CA-C-N 116.049 -0.523 . . . . 1.0 111.844 178.896 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -54.44 164.75 0.29 Allowed 'Isoleucine or valine' 0 N--CA 1.478 0.942 0 N-CA-C 107.212 -1.403 . . . . 1.0 107.212 177.455 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 39.9 mm-40 -121.0 115.04 22.4 Favored 'General case' 0 CA--C 1.548 0.891 0 CA-C-N 121.845 2.111 . . . . 1.0 109.245 179.949 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 55' ' ' ILE . . . . . 0.457 HD12 ' N ' ' A' ' 56' ' ' GLY . 0.7 OUTLIER -146.7 157.73 10.8 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.017 0 CA-C-N 118.476 0.58 . . . . 1.0 109.532 177.704 . . . . . . . . 3 3 . 1 . 030 nuclear build core ' A' A ' 56' ' ' GLY . . . . . 0.457 ' N ' HD12 ' A' ' 55' ' ' ILE . . . 110.84 -6.81 29.45 Favored Glycine 0 N--CA 1.481 1.68 0 CA-C-N 118.752 0.706 . . . . 1.0 112.3 -179.595 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -112.64 127.88 56.23 Favored 'General case' 0 C--N 1.32 -0.682 0 N-CA-C 108.677 -0.86 . . . . 1.0 108.677 178.126 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 58' ' ' TRP . . . . . 0.538 ' H ' ' HB2' ' A' ' 61' ' ' GLU . 5.0 m0 -139.18 158.48 44.1 Favored 'General case' 0 N--CA 1.455 -0.216 0 CA-C-O 122.808 1.29 . . . . 1.0 109.529 179.298 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 34.9 ptt-85 -41.03 -36.41 0.67 Allowed 'General case' 0 C--N 1.296 -1.728 0 CA-C-N 112.318 -2.219 . . . . 1.0 109.181 -178.616 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 42.8 t80 -90.94 -35.67 14.58 Favored 'General case' 0 N--CA 1.481 1.09 0 CA-C-O 121.687 0.756 . . . . 1.0 112.449 178.82 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 61' ' ' GLU . . . . . 0.538 ' HB2' ' H ' ' A' ' 58' ' ' TRP . 92.5 mt-10 -77.67 -13.92 59.77 Favored 'General case' 0 N--CA 1.443 -0.812 0 O-C-N 121.757 -0.589 . . . . 1.0 110.53 179.926 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 62' ' ' VAL . . . . . 0.628 HG13 ' N ' ' A' ' 63' ' ' ALA . 7.3 p -46.71 -56.2 1.42 Allowed 'Isoleucine or valine' 0 C--O 1.213 -0.858 0 C-N-CA 119.444 -0.902 . . . . 1.0 109.318 -175.664 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 63' ' ' ALA . . . . . 0.628 ' N ' HG13 ' A' ' 62' ' ' VAL . . . -64.77 -54.29 33.6 Favored 'General case' 0 C--N 1.302 -1.483 0 O-C-N 121.966 -0.459 . . . . 1.0 110.059 179.94 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 2.9 m-70 -53.16 -57.74 9.44 Favored 'General case' 0 CA--C 1.549 0.917 0 C-N-CA 119.591 -0.844 . . . . 1.0 109.813 -179.205 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 65' ' ' ASP . . . . . 0.623 ' C ' ' H ' ' A' ' 67' ' ' ARG . 33.8 t0 -72.72 -52.07 16.68 Favored 'General case' 0 C--O 1.245 0.854 0 CA-C-O 121.899 0.857 . . . . 1.0 111.48 179.111 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 66' ' ' GLY . . . . . 0.584 ' N ' ' O ' ' A' ' 62' ' ' VAL . . . -69.51 27.71 0.36 Allowed Glycine 0 C--O 1.226 -0.374 0 O-C-N 120.74 -1.225 . . . . 1.0 110.66 177.04 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 67' ' ' ARG . . . . . 0.709 ' O ' ' N ' ' A' ' 69' ' ' LEU . 8.0 mtm-85 -75.63 5.58 5.91 Favored 'General case' 0 CA--C 1.507 -0.673 0 N-CA-C 108.011 -1.107 . . . . 1.0 108.011 176.049 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 68' ' ' LEU . . . . . 0.46 ' C ' ' O ' ' A' ' 67' ' ' ARG . 2.7 mt -31.43 -25.5 0.0 OUTLIER 'General case' 0 N--CA 1.486 1.35 0 N-CA-C 108.311 -0.996 . . . . 1.0 108.311 -177.694 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 69' ' ' LEU . . . . . 0.709 ' N ' ' O ' ' A' ' 67' ' ' ARG . 48.1 tp -64.85 -65.35 0.69 Allowed 'General case' 0 N--CA 1.472 0.637 0 N-CA-C 108.662 -0.866 . . . . 1.0 108.662 177.655 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 70' ' ' ALA . . . . . 0.631 ' O ' ' N ' ' A' ' 72' ' ' HIS . . . -80.66 -73.96 0.34 Allowed 'General case' 0 N--CA 1.47 0.55 0 N-CA-C 104.438 -2.43 . . . . 1.0 104.438 176.906 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 71' ' ' ALA . . . . . 0.489 ' O ' ' C ' ' A' ' 72' ' ' HIS . . . -42.83 0.89 0.0 OUTLIER 'General case' 0 CA--C 1.513 -0.47 0 C-N-CA 124.864 1.265 . . . . 1.0 113.647 179.493 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 72' ' ' HIS . . . . . 0.671 ' CG ' ' N ' ' A' ' 73' ' ' MET . 0.0 OUTLIER -26.65 -63.5 0.08 Allowed 'General case' 0 C--N 1.346 0.434 0 CA-C-N 118.243 0.474 . . . . 1.0 110.421 -179.825 . . . . . . . . 3 3 . 1 . 030 nuclear build core ' A' A ' 73' ' ' MET . . . . . 0.671 ' N ' ' CG ' ' A' ' 72' ' ' HIS . 12.5 ttm -74.32 -50.86 17.06 Favored 'General case' 0 C--N 1.323 -0.563 0 C-N-CA 119.043 -1.063 . . . . 1.0 109.917 178.668 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 74' ' ' VAL . . . . . 0.564 ' O ' ' N ' ' A' ' 76' ' ' GLY . 41.2 t -46.09 -45.78 5.77 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.269 0 CA-C-O 117.604 -1.189 . . . . 1.0 112.589 -175.018 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 75' ' ' ASN . . . . . 0.674 ' O ' HG23 ' A' ' 79' ' ' ILE . 8.2 t-20 -42.54 -15.71 0.01 OUTLIER 'General case' 0 C--N 1.35 0.6 0 CA-C-N 121.227 1.83 . . . . 1.0 111.425 177.336 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 76' ' ' GLY . . . . . 0.564 ' N ' ' O ' ' A' ' 74' ' ' VAL . . . -46.18 -25.65 1.92 Allowed Glycine 0 CA--C 1.531 1.084 0 N-CA-C 108.984 -1.646 . . . . 1.0 108.984 -179.921 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 77' ' ' ILE . . . . . 0.526 ' O ' ' N ' ' A' ' 79' ' ' ILE . 0.9 OUTLIER -86.32 -61.96 1.65 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.699 0 CA-C-N 113.886 -1.157 . . . . 1.0 110.615 -178.099 . . . . . . . . 3 3 . 1 . 030 nuclear build core ' A' A ' 78' ' ' VAL . . . . . 0.427 ' C ' ' O ' ' A' ' 77' ' ' ILE . 12.2 t -37.86 -27.34 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.443 -0.789 0 N-CA-C 109.221 -0.659 . . . . 1.0 109.221 -178.308 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 79' ' ' ILE . . . . . 0.832 ' O ' ' HB3' ' A' ' 83' ' ' ALA . 0.9 OUTLIER -67.99 -51.87 44.93 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.788 0 C-N-CA 119.827 -0.749 . . . . 1.0 110.857 178.916 . . . . . . . . 3 3 . 1 . 030 nuclear build core ' A' A ' 80' ' ' ALA . . . . . 0.512 ' N ' ' CG1' ' A' ' 79' ' ' ILE . . . -61.48 -63.14 1.37 Allowed 'General case' 0 C--O 1.231 0.097 0 C-N-CA 119.131 -1.028 . . . . 1.0 110.89 -178.656 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 81' ' ' GLU . . . . . 0.434 ' HG2' ' H ' ' A' ' 81' ' ' GLU . 0.2 OUTLIER -49.28 -72.64 0.05 OUTLIER 'General case' 0 CA--C 1.536 0.437 0 C-N-CA 119.57 -0.852 . . . . 1.0 109.924 -179.495 . . . . . . . . 3 3 . 1 . 030 nuclear build core ' A' A ' 82' ' ' ASP . . . . . 0.471 ' O ' ' N ' ' A' ' 84' ' ' LEU . 33.4 m-20 -59.6 -63.31 1.35 Allowed 'General case' 0 C--N 1.331 -0.227 0 C-N-CA 118.233 -1.387 . . . . 1.0 109.897 -178.285 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 83' ' ' ALA . . . . . 0.832 ' HB3' ' O ' ' A' ' 79' ' ' ILE . . . -68.82 57.95 0.09 Allowed 'General case' 0 C--N 1.317 -0.814 0 C-N-CA 119.416 -0.914 . . . . 1.0 110.395 -179.61 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 84' ' ' LEU . . . . . 0.471 ' N ' ' O ' ' A' ' 82' ' ' ASP . 0.2 OUTLIER -79.68 7.09 9.11 Favored 'General case' 0 C--N 1.351 0.672 0 N-CA-C 108.62 -0.881 . . . . 1.0 108.62 179.033 . . . . . . . . 3 3 . 1 . 030 nuclear build core ' A' A ' 85' ' ' ILE . . . . . 0.782 ' O ' ' HB ' ' A' ' 89' ' ' VAL . 0.0 OUTLIER -92.06 -7.96 10.42 Favored 'Isoleucine or valine' 0 C--O 1.193 -1.88 0 CA-C-N 114.647 -1.161 . . . . 1.0 108.652 178.648 . . . . . . . . 3 3 . 1 . 030 nuclear build core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -96.76 -12.96 23.01 Favored 'General case' 0 CA--C 1.544 0.747 0 CA-C-O 120.696 0.284 . . . . 1.0 111.709 179.704 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -88.53 -37.13 15.97 Favored 'General case' 0 N--CA 1.481 1.076 0 N-CA-C 113.321 0.86 . . . . 1.0 113.321 -178.493 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -112.88 -8.41 13.71 Favored 'General case' 0 N--CA 1.482 1.129 0 CA-C-O 121.57 0.7 . . . . 1.0 110.971 -178.629 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 89' ' ' VAL . . . . . 0.782 ' HB ' ' O ' ' A' ' 85' ' ' ILE . 14.9 t -99.43 33.34 0.31 Allowed 'Isoleucine or valine' 0 CA--C 1.503 -0.861 0 CA-C-N 115.144 -0.935 . . . . 1.0 109.425 178.095 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 90' ' ' GLY . . . . . 0.644 ' N ' ' HD2' ' A' ' 91' ' ' PRO . . . -67.42 -42.35 89.56 Favored Glycine 0 CA--C 1.537 1.414 0 N-CA-C 110.091 -1.204 . . . . 1.0 110.091 176.531 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 91' ' ' PRO . . . . . 0.644 ' HD2' ' N ' ' A' ' 90' ' ' GLY . 5.8 Cg_exo -42.09 -13.93 0.04 OUTLIER 'Trans proline' 0 N--CA 1.496 1.655 0 C-N-CA 122.152 1.901 . . . . 1.0 111.034 177.753 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 92' ' ' HIS . . . . . 0.68 ' CE1' HH22 ' A' ' 52' ' ' ARG . 47.9 p-80 -57.16 -18.42 15.21 Favored 'General case' 0 C--O 1.202 -1.397 0 N-CA-C 107.94 -1.133 . . . . 1.0 107.94 179.928 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 93' ' ' LEU . . . . . 0.646 HD12 ' N ' ' A' ' 94' ' ' ALA . 1.3 pp -65.67 -57.69 7.48 Favored 'General case' 0 C--N 1.325 -0.495 0 N-CA-C 108.785 -0.82 . . . . 1.0 108.785 179.537 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 94' ' ' ALA . . . . . 0.646 ' N ' HD12 ' A' ' 93' ' ' LEU . . . -58.35 -53.95 52.53 Favored 'General case' 0 CA--C 1.515 -0.396 0 N-CA-C 108.78 -0.822 . . . . 1.0 108.78 179.031 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 95' ' ' ARG . . . . . 0.692 ' O ' ' N ' ' A' ' 97' ' ' LEU . 6.8 mtm-85 -58.09 -58.3 9.02 Favored 'General case' 0 N--CA 1.449 -0.486 0 N-CA-C 107.322 -1.362 . . . . 1.0 107.322 178.732 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 96' ' ' ALA . . . . . 0.942 ' O ' ' N ' ' A' ' 98' ' ' GLY . . . -46.14 -11.62 0.02 OUTLIER 'General case' 0 C--N 1.308 -1.224 0 O-C-N 118.49 -2.631 . . . . 1.0 110.807 -179.687 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 97' ' ' LEU . . . . . 0.718 ' O ' ' N ' ' A' ' 100' ' ' ILE . 4.3 tt 9.22 -54.09 0.0 OUTLIER 'General case' 0 N--CA 1.476 0.873 0 CA-C-O 117.474 -1.25 . . . . 1.0 109.817 -168.19 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 98' ' ' GLY . . . . . 0.942 ' N ' ' O ' ' A' ' 96' ' ' ALA . . . -47.63 -22.46 1.8 Allowed Glycine 0 CA--C 1.547 2.086 0 CA-C-N 122.328 2.331 . . . . 1.0 107.295 174.908 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 99' ' ' GLN . . . . . 0.533 ' N ' ' O ' ' A' ' 96' ' ' ALA . 4.3 tp-100 -65.34 -20.5 66.42 Favored 'General case' 0 C--N 1.378 1.813 0 C-N-CA 117.975 -1.49 . . . . 1.0 108.439 176.922 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 100' ' ' ILE . . . . . 0.718 ' N ' ' O ' ' A' ' 97' ' ' LEU . 18.7 mm -64.13 -47.05 91.81 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.753 0 CA-C-N 114.438 -1.255 . . . . 1.0 108.325 177.489 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 101' ' ' VAL . . . . . 0.709 ' O ' ' N ' ' A' ' 105' ' ' GLY . 57.4 t -60.44 -58.96 4.99 Favored 'Isoleucine or valine' 0 C--O 1.219 -0.526 0 N-CA-C 106.945 -1.502 . . . . 1.0 106.945 179.58 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 102' ' ' CYS . . . . . 0.966 ' O ' ' HB2' ' A' ' 106' ' ' ALA . 0.0 OUTLIER -45.22 -17.92 0.03 OUTLIER 'General case' 0 N--CA 1.444 -0.726 0 CA-C-O 121.423 0.63 . . . . 1.0 110.268 -179.889 . . . . . . . . 3 3 . 1 . 030 nuclear build core ' A' A ' 103' ' ' ARG . . . . . 0.62 ' NH2' ' CZ ' ' A' ' 104' ' ' TYR . 0.1 OUTLIER -95.48 -44.43 7.53 Favored 'General case' 0 N--CA 1.474 0.759 0 CA-C-O 122.47 1.129 . . . . 1.0 112.359 177.985 . . . . . . . . 3 3 . 1 . 030 nuclear build core ' A' A ' 104' ' ' TYR . . . . . 0.62 ' CZ ' ' NH2' ' A' ' 103' ' ' ARG . 12.1 m-85 -107.16 21.41 17.57 Favored 'General case' 0 C--N 1.318 -0.761 0 C-N-CA 127.251 2.22 . . . . 1.0 111.861 179.507 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 105' ' ' GLY . . . . . 0.709 ' N ' ' O ' ' A' ' 101' ' ' VAL . . . -170.83 -10.68 0.02 OUTLIER Glycine 0 C--N 1.341 0.806 0 C-N-CA 119.356 -1.402 . . . . 1.0 112.155 179.664 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 106' ' ' ALA . . . . . 0.966 ' HB2' ' O ' ' A' ' 102' ' ' CYS . . . -28.77 75.13 0.0 OUTLIER 'General case' 0 CA--C 1.512 -0.492 0 N-CA-C 113.805 1.039 . . . . 1.0 113.805 -179.472 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 107' ' ' THR . . . . . 0.693 ' N ' ' O ' ' A' ' 105' ' ' GLY . 15.2 t -91.22 5.95 47.08 Favored 'General case' 0 N--CA 1.434 -1.264 0 N-CA-C 106.045 -1.835 . . . . 1.0 106.045 178.177 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 108' ' ' VAL . . . . . 0.724 ' O ' HG22 ' A' ' 108' ' ' VAL . 11.8 p -95.84 17.01 2.02 Favored 'Isoleucine or valine' 0 C--N 1.352 0.687 0 CA-C-O 118.493 -0.765 . . . . 1.0 110.873 177.077 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 109' ' ' ILE . . . . . 0.676 ' N ' ' CD ' ' A' ' 110' ' ' PRO . 40.5 pt -105.77 -14.85 0.15 Allowed Pre-proline 0 N--CA 1.438 -1.073 0 CA-C-N 121.255 1.843 . . . . 1.0 110.457 177.915 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 110' ' ' PRO . . . . . 0.676 ' CD ' ' N ' ' A' ' 109' ' ' ILE . 55.7 Cg_endo -67.36 -48.21 1.8 Allowed 'Trans proline' 0 N--CA 1.493 1.465 0 CA-C-N 121.163 1.451 . . . . 1.0 113.094 -175.728 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 15.6 t-20 -67.47 -66.36 0.57 Allowed 'General case' 0 N--CA 1.453 -0.304 0 C-N-CA 119.756 -0.777 . . . . 1.0 109.874 -179.125 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 112' ' ' ILE . . . . . 0.515 ' O ' ' HB ' ' A' ' 116' ' ' ILE . 2.9 tt -43.56 -40.52 1.37 Allowed 'Isoleucine or valine' 0 CA--C 1.548 0.904 0 N-CA-C 113.093 0.775 . . . . 1.0 113.093 -178.247 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 5.8 m-80 -67.86 -41.12 83.39 Favored 'General case' 0 C--N 1.31 -1.134 0 CA-C-O 122.449 1.119 . . . . 1.0 109.295 178.061 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -59.62 -52.02 67.31 Favored 'General case' 0 C--N 1.296 -1.74 0 CA-C-N 113.386 -1.734 . . . . 1.0 108.95 179.912 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -78.81 -57.04 3.96 Favored 'General case' 0 CA--C 1.537 0.456 0 N-CA-C 114.047 1.128 . . . . 1.0 114.047 179.517 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 116' ' ' ILE . . . . . 0.586 ' O ' ' N ' ' A' ' 120' ' ' GLY . 4.5 mm -52.05 -51.16 31.76 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.209 0 CA-C-O 122.008 0.909 . . . . 1.0 112.445 -176.55 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 117' ' ' GLU . . . . . 0.489 ' C ' ' O ' ' A' ' 116' ' ' ILE . 65.4 mt-10 -45.07 -56.92 4.24 Favored 'General case' 0 C--N 1.313 -0.982 0 N-CA-C 105.516 -2.031 . . . . 1.0 105.516 -176.662 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 96.7 t -58.07 -53.92 39.24 Favored 'Isoleucine or valine' 0 CA--C 1.554 1.129 0 C-N-CA 119.919 -0.712 . . . . 1.0 109.444 177.49 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 4.6 tt -51.92 -68.91 0.13 Allowed 'General case' 0 N--CA 1.48 1.033 0 N-CA-C 106.82 -1.548 . . . . 1.0 106.82 -178.628 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 120' ' ' GLY . . . . . 0.586 ' N ' ' O ' ' A' ' 116' ' ' ILE . . . -73.33 -82.65 0.33 Allowed Glycine 0 CA--C 1.548 2.156 0 C-N-CA 120.897 -0.668 . . . . 1.0 112.34 -179.158 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 121' ' ' THR . . . . . 0.495 ' OG1' ' O ' ' A' ' 120' ' ' GLY . 4.2 m 155.6 -34.31 0.01 OUTLIER 'General case' 0 N--CA 1.482 1.155 0 CA-C-N 112.435 -1.883 . . . . 1.0 112.355 179.397 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 122' ' ' GLY . . . . . 0.684 ' O ' ' N ' ' A' ' 124' ' ' ASP . . . 103.96 -17.76 47.98 Favored Glycine 0 N--CA 1.461 0.313 0 N-CA-C 106.198 -2.761 . . . . 1.0 106.198 -176.589 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 123' ' ' THR . . . . . 0.706 HG23 ' O ' ' A' ' 123' ' ' THR . 9.6 t -55.98 81.31 0.0 OUTLIER 'General case' 0 N--CA 1.468 0.475 0 N-CA-C 105.519 -2.03 . . . . 1.0 105.519 178.758 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 124' ' ' ASP . . . . . 0.684 ' N ' ' O ' ' A' ' 122' ' ' GLY . 40.7 m-20 -166.81 178.85 5.64 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 112.871 -1.968 . . . . 1.0 111.66 179.041 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 125' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -147.34 143.76 28.26 Favored 'General case' 0 CA--C 1.545 0.78 0 N-CA-C 108.154 -1.054 . . . . 1.0 108.154 176.473 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 72.2 mtt-85 -150.92 155.8 39.88 Favored 'General case' 0 N--CA 1.47 0.569 0 CA-C-O 120.801 0.334 . . . . 1.0 111.011 176.535 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 127' ' ' PHE . . . . . 0.473 ' OXT' ' CG ' ' A' ' 127' ' ' PHE . 5.8 p90 . . . . . 0 C--O 1.218 -0.603 0 CA-C-O 118.188 -0.91 . . . . 1.0 110.159 179.276 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 N--CA 1.488 1.468 0 N-CA-C 108.866 -0.79 . . . . 1.0 108.866 . . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 85.5 p -106.87 10.47 30.62 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.297 -0.41 . . . . 1.0 110.405 -179.575 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 1.7 t70 166.07 94.37 0.0 OUTLIER 'General case' 0 N--CA 1.465 0.322 0 CA-C-N 115.965 -0.561 . . . . 1.0 110.003 179.646 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 54.7 t80 -149.04 144.77 26.92 Favored 'General case' 0 C--N 1.33 -0.262 0 N-CA-C 110.293 -0.262 . . . . 1.0 110.293 179.369 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 5' ' ' ASP . . . . . 0.516 ' N ' ' OD1' ' A' ' 5' ' ' ASP . 0.6 OUTLIER -154.95 151.48 28.57 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.799 0.333 . . . . 1.0 110.554 -179.285 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 6' ' ' THR . . . . . 0.672 ' O ' ' N ' ' A' ' 10' ' ' SER . 0.2 OUTLIER -67.99 176.18 2.75 Favored 'General case' 0 C--O 1.206 -1.223 0 CA-C-N 116.352 -0.385 . . . . 1.0 110.526 -179.617 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 7' ' ' GLU . . . . . 0.527 ' O ' ' N ' ' A' ' 11' ' ' ARG . 82.2 tt0 -58.49 -58.76 7.12 Favored 'General case' 0 C--N 1.318 -0.769 0 CA-C-O 121.466 0.651 . . . . 1.0 110.254 -177.558 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 8' ' ' ARG . . . . . 0.825 ' O ' ' HB3' ' A' ' 12' ' ' ALA . 26.9 mtp180 -47.86 -55.06 10.64 Favored 'General case' 0 C--O 1.213 -0.82 0 N-CA-C 107.06 -1.459 . . . . 1.0 107.06 -178.874 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 9' ' ' VAL . . . . . 0.585 ' O ' ' CG2' ' A' ' 13' ' ' VAL . 63.1 t -64.89 -49.17 81.15 Favored 'Isoleucine or valine' 0 C--O 1.199 -1.589 0 CA-C-N 114.356 -1.293 . . . . 1.0 110.702 177.971 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 10' ' ' SER . . . . . 0.672 ' N ' ' O ' ' A' ' 6' ' ' THR . 75.2 m -67.82 -65.54 0.68 Allowed 'General case' 0 C--N 1.316 -0.882 0 C-N-CA 119.764 -0.774 . . . . 1.0 112.098 -178.302 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 11' ' ' ARG . . . . . 0.527 ' N ' ' O ' ' A' ' 7' ' ' GLU . 11.2 ttm180 -64.35 -58.48 6.38 Favored 'General case' 0 C--N 1.324 -0.519 0 C-N-CA 119.839 -0.744 . . . . 1.0 111.764 -176.066 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 12' ' ' ALA . . . . . 0.825 ' HB3' ' O ' ' A' ' 8' ' ' ARG . . . -47.9 -48.64 31.42 Favored 'General case' 0 CA--C 1.539 0.547 0 N-CA-C 106.71 -1.589 . . . . 1.0 106.71 -177.907 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 13' ' ' VAL . . . . . 0.659 ' O ' ' N ' ' A' ' 17' ' ' LEU . 97.6 t -62.07 -50.9 78.2 Favored 'Isoleucine or valine' 0 C--O 1.194 -1.846 0 C-N-CA 118.839 -1.145 . . . . 1.0 109.28 177.281 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 14' ' ' ALA . . . . . 0.578 ' O ' HG13 ' A' ' 18' ' ' VAL . . . -56.85 -62.21 1.9 Allowed 'General case' 0 C--O 1.207 -1.151 0 O-C-N 120.871 -1.143 . . . . 1.0 109.572 -179.938 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 15' ' ' ALA . . . . . 0.558 ' O ' ' N ' ' A' ' 19' ' ' GLY . . . -51.36 -54.3 27.78 Favored 'General case' 0 C--N 1.319 -0.754 0 CA-C-O 121.79 0.805 . . . . 1.0 109.248 -178.521 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 16' ' ' ALA . . . . . 0.466 ' CB ' ' O ' ' A' ' 12' ' ' ALA . . . -61.52 -54.63 40.73 Favored 'General case' 0 C--N 1.308 -1.218 0 CA-C-N 114.62 -1.173 . . . . 1.0 108.508 -179.207 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 17' ' ' LEU . . . . . 0.659 ' N ' ' O ' ' A' ' 13' ' ' VAL . 42.4 tp -55.46 -54.29 45.72 Favored 'General case' 0 N--CA 1.478 0.961 0 CA-C-N 113.574 -1.648 . . . . 1.0 109.053 -177.16 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 18' ' ' VAL . . . . . 0.582 HG23 ' N ' ' A' ' 19' ' ' GLY . 3.6 m -68.65 -57.0 10.24 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.235 0 N-CA-C 108.992 -0.744 . . . . 1.0 108.992 178.912 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 19' ' ' GLY . . . . . 0.582 ' N ' HG23 ' A' ' 18' ' ' VAL . . . -63.04 -170.72 1.37 Allowed Glycine 0 CA--C 1.525 0.66 0 N-CA-C 110.829 -0.908 . . . . 1.0 110.829 -179.992 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 20' ' ' PRO . . . . . 0.648 ' O ' ' N ' ' A' ' 24' ' ' ALA . 93.0 Cg_endo -79.25 -27.02 4.65 Favored 'Trans proline' 0 C--N 1.308 -1.591 0 C-N-CA 122.797 2.331 . . . . 1.0 114.129 -178.33 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -57.16 -56.21 26.23 Favored Glycine 0 N--CA 1.477 1.375 0 C-N-CA 119.822 -1.18 . . . . 1.0 111.064 -177.624 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 22' ' ' GLY . . . . . 0.465 ' H ' ' C ' ' A' ' 16' ' ' ALA . . . -60.38 -55.83 27.85 Favored Glycine 0 N--CA 1.468 0.803 0 N-CA-C 108.587 -1.805 . . . . 1.0 108.587 -178.39 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -59.77 -35.15 58.41 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.204 0 CA-C-N 114.561 -0.82 . . . . 1.0 109.417 -179.94 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 24' ' ' ALA . . . . . 0.648 ' N ' ' O ' ' A' ' 20' ' ' PRO . . . -57.89 -61.92 2.19 Favored 'General case' 0 N--CA 1.452 -0.36 0 C-N-CA 118.99 -1.084 . . . . 1.0 109.739 -178.704 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 16.2 tp -65.38 -42.11 93.04 Favored 'General case' 0 N--CA 1.451 -0.411 0 C-N-CA 119.853 -0.739 . . . . 1.0 111.904 -178.326 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 89.6 t -61.57 -60.39 2.78 Favored 'Isoleucine or valine' 0 CA--C 1.522 -0.104 0 C-N-CA 118.834 -1.147 . . . . 1.0 110.307 -177.931 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 27' ' ' VAL . . . . . 0.558 ' O ' ' HB3' ' A' ' 31' ' ' ALA . 93.4 t -62.57 -38.26 81.03 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 N-CA-C 112.814 0.672 . . . . 1.0 112.814 -178.316 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 3.3 ttmp? -64.34 -55.02 24.05 Favored 'General case' 0 C--N 1.314 -0.95 0 CA-C-O 121.929 0.871 . . . . 1.0 108.775 -178.213 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 55.6 t -64.58 -45.15 96.35 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.008 0 CA-C-N 113.632 -1.622 . . . . 1.0 109.801 -178.533 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 30' ' ' CYS . . . . . . . . . . . . . 43.1 t -65.85 -61.16 2.22 Favored 'General case' 0 N--CA 1.445 -0.715 0 C-N-CA 118.666 -1.213 . . . . 1.0 108.743 179.729 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 31' ' ' ALA . . . . . 0.558 ' HB3' ' O ' ' A' ' 27' ' ' VAL . . . -63.73 -57.09 11.06 Favored 'General case' 0 CA--C 1.512 -0.514 0 N-CA-C 113.486 0.921 . . . . 1.0 113.486 -176.358 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 32' ' ' GLY . . . . . 0.475 ' O ' ' CB ' ' A' ' 33' ' ' LEU . . . 89.92 74.02 1.28 Allowed Glycine 0 CA--C 1.526 0.737 0 N-CA-C 110.862 -0.895 . . . . 1.0 110.862 -178.92 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 33' ' ' LEU . . . . . 0.475 ' CB ' ' O ' ' A' ' 32' ' ' GLY . 4.7 tp 87.43 84.08 0.04 OUTLIER Pre-proline 0 CA--C 1.544 0.746 0 CA-C-O 120.999 0.428 . . . . 1.0 111.204 179.578 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 52.1 Cg_exo -55.48 -33.3 85.69 Favored 'Trans proline' 0 N--CA 1.503 2.037 0 C-N-CA 123.798 2.998 . . . . 1.0 115.298 -179.528 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -55.39 -58.65 12.88 Favored Glycine 0 N--CA 1.469 0.871 0 C-N-CA 118.462 -1.827 . . . . 1.0 108.616 -178.804 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 36' ' ' VAL . . . . . 0.639 ' O ' HG22 ' A' ' 37' ' ' ILE . 23.2 m -86.77 160.05 3.06 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.649 0 N-CA-C 107.081 -1.451 . . . . 1.0 107.081 177.616 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 37' ' ' ILE . . . . . 0.7 HG23 ' O ' ' A' ' 37' ' ' ILE . 14.3 tt 126.97 115.35 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.477 0.886 0 O-C-N 124.195 0.934 . . . . 1.0 110.503 -179.741 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -141.04 133.14 27.88 Favored 'General case' 0 C--N 1.325 -0.494 0 N-CA-C 108.154 -1.054 . . . . 1.0 108.154 177.518 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 38.8 p -115.03 143.55 30.38 Favored Pre-proline 0 C--N 1.33 -0.265 0 N-CA-C 108.771 -0.826 . . . . 1.0 108.771 179.501 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 40' ' ' PRO . . . . . 0.458 ' HG2' ' H ' ' A' ' 41' ' ' ALA . 57.1 Cg_endo -72.22 -82.73 0.01 OUTLIER 'Trans proline' 0 C--N 1.306 -1.699 0 C-N-CA 121.708 1.605 . . . . 1.0 112.551 -179.363 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 41' ' ' ALA . . . . . 0.458 ' H ' ' HG2' ' A' ' 40' ' ' PRO . . . -78.34 124.11 27.74 Favored 'General case' 0 C--N 1.311 -1.074 0 CA-C-N 114.436 -1.256 . . . . 1.0 111.686 -176.7 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 42' ' ' ARG . . . . . 0.699 ' C ' ' H ' ' A' ' 44' ' ' GLY . 13.6 ptt180 -170.9 169.71 6.66 Favored 'General case' 0 C--N 1.313 -0.981 0 CA-C-N 114.634 -1.167 . . . . 1.0 109.696 178.786 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 7.2 tpt180 -61.65 18.04 0.01 OUTLIER 'General case' 0 C--N 1.322 -0.608 0 C-N-CA 120.568 -0.453 . . . . 1.0 109.957 178.321 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 44' ' ' GLY . . . . . 0.699 ' H ' ' C ' ' A' ' 42' ' ' ARG . . . 82.98 -24.83 5.04 Favored Glycine 0 N--CA 1.446 -0.634 0 N-CA-C 110.506 -1.038 . . . . 1.0 110.506 -179.658 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 45' ' ' PHE . . . . . 0.759 ' O ' ' CG ' ' A' ' 46' ' ' PHE . 0.2 OUTLIER -164.5 172.82 12.81 Favored 'General case' 0 C--O 1.221 -0.403 0 C-N-CA 121.101 -0.24 . . . . 1.0 110.656 -179.553 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 46' ' ' PHE . . . . . 0.759 ' CG ' ' O ' ' A' ' 45' ' ' PHE . 22.0 m-30 127.1 90.41 0.0 OUTLIER 'General case' 0 N--CA 1.484 1.256 0 O-C-N 125.534 1.771 . . . . 1.0 111.688 179.391 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 47' ' ' ARG . . . . . 0.721 ' O ' ' SG ' ' A' ' 48' ' ' CYS . 2.2 ptm180 121.09 156.49 0.0 OUTLIER 'General case' 0 N--CA 1.477 0.895 0 O-C-N 125.449 1.718 . . . . 1.0 109.187 179.355 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 48' ' ' CYS . . . . . 0.781 ' SG ' ' H62' ' A' ' 129' ' ' MTN . 2.0 p 67.74 68.85 0.36 Allowed 'General case' 0 CA--C 1.532 0.284 0 CA-C-O 121.897 0.856 . . . . 1.0 109.523 -179.156 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -142.91 151.84 57.31 Favored Pre-proline 0 CA--C 1.534 0.361 0 N-CA-C 108.297 -1.001 . . . . 1.0 108.297 179.864 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 89.3 Cg_endo -77.31 69.9 6.98 Favored 'Trans proline' 0 C--N 1.308 -1.58 0 C-N-CA 122.015 1.81 . . . . 1.0 112.608 -179.728 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 5.4 tp10 64.68 26.93 13.19 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 120.697 0.284 . . . . 1.0 111.462 179.198 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -102.28 138.92 38.57 Favored 'General case' 0 N--CA 1.466 0.373 0 CA-C-N 116.474 -0.33 . . . . 1.0 110.262 179.066 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 53' ' ' ILE . . . . . 0.445 ' O ' ' N ' ' A' ' 55' ' ' ILE . 19.6 tt -66.61 139.64 20.8 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.251 0 CA-C-O 121.423 0.63 . . . . 1.0 110.718 179.553 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 4.2 pt20 -63.41 80.41 0.02 OUTLIER 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 114.781 -1.1 . . . . 1.0 109.586 -178.458 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 55' ' ' ILE . . . . . 0.445 ' N ' ' O ' ' A' ' 53' ' ' ILE . 1.8 tt -148.03 156.89 8.9 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.415 0 N-CA-C 109.902 -0.407 . . . . 1.0 109.902 178.242 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 113.57 -4.67 24.69 Favored Glycine 0 N--CA 1.467 0.705 0 N-CA-C 110.606 -0.998 . . . . 1.0 110.606 -179.765 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 14.8 p-10 -79.36 96.48 6.01 Favored 'General case' 0 C--N 1.325 -0.464 0 N-CA-C 109.318 -0.623 . . . . 1.0 109.318 177.625 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 58' ' ' TRP . . . . . 0.519 ' CE3' ' NH1' ' A' ' 59' ' ' ARG . 0.8 OUTLIER -86.54 176.36 7.86 Favored 'General case' 0 N--CA 1.467 0.421 0 CA-C-O 122.229 1.014 . . . . 1.0 112.647 -178.37 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 59' ' ' ARG . . . . . 0.519 ' NH1' ' CE3' ' A' ' 58' ' ' TRP . 0.0 OUTLIER -87.29 -56.28 3.43 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 113.326 -1.761 . . . . 1.0 112.388 -179.394 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 73.6 t80 -93.81 -16.86 23.7 Favored 'General case' 0 C--O 1.249 1.044 0 CA-C-O 121.813 0.816 . . . . 1.0 113.153 -179.112 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 61' ' ' GLU . . . . . 0.459 ' O ' ' N ' ' A' ' 65' ' ' ASP . 6.5 tt0 -78.79 -13.23 59.92 Favored 'General case' 0 N--CA 1.444 -0.766 0 O-C-N 121.418 -0.801 . . . . 1.0 111.516 -178.24 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 62' ' ' VAL . . . . . 0.596 ' O ' ' N ' ' A' ' 66' ' ' GLY . 0.0 OUTLIER -47.8 -55.63 2.38 Favored 'Isoleucine or valine' 0 C--O 1.208 -1.11 0 C-N-CA 119.244 -0.983 . . . . 1.0 109.589 -175.559 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -65.01 -52.42 56.19 Favored 'General case' 0 C--N 1.31 -1.136 0 C-N-CA 119.335 -0.946 . . . . 1.0 109.192 -179.984 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 64' ' ' HIS . . . . . 0.504 ' O ' ' HB2' ' A' ' 67' ' ' ARG . 6.0 t-80 -50.78 -57.78 7.54 Favored 'General case' 0 CA--C 1.536 0.43 0 C-N-CA 119.463 -0.895 . . . . 1.0 109.894 -179.534 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 65' ' ' ASP . . . . . 0.557 ' C ' ' H ' ' A' ' 67' ' ' ARG . 3.3 t0 -70.1 -47.05 63.46 Favored 'General case' 0 C--N 1.314 -0.963 0 CA-C-O 122.065 0.935 . . . . 1.0 110.303 179.188 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 66' ' ' GLY . . . . . 0.596 ' N ' ' O ' ' A' ' 62' ' ' VAL . . . -70.13 28.25 0.43 Allowed Glycine 0 C--N 1.316 -0.572 0 O-C-N 121.47 -0.769 . . . . 1.0 111.642 179.725 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 67' ' ' ARG . . . . . 0.557 ' H ' ' C ' ' A' ' 65' ' ' ASP . 0.0 OUTLIER -81.25 -3.01 51.08 Favored 'General case' 0 C--N 1.319 -0.755 0 N-CA-C 107.964 -1.124 . . . . 1.0 107.964 176.559 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 68' ' ' LEU . . . . . 0.417 ' O ' ' HB3' ' A' ' 72' ' ' HIS . 8.7 tp -42.25 -31.67 0.42 Allowed 'General case' 0 C--O 1.216 -0.679 0 CA-C-N 115.567 -0.742 . . . . 1.0 109.495 -179.904 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 3.8 tt -67.83 -68.66 0.37 Allowed 'General case' 0 CA--C 1.54 0.581 0 C-N-CA 118.434 -1.306 . . . . 1.0 112.877 -177.347 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 70' ' ' ALA . . . . . 0.572 ' C ' ' H ' ' A' ' 72' ' ' HIS . . . -74.58 -84.36 0.05 OUTLIER 'General case' 0 N--CA 1.47 0.563 0 C-N-CA 116.757 -1.977 . . . . 1.0 109.03 -176.426 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 71' ' ' ALA . . . . . 0.884 ' O ' ' N ' ' A' ' 73' ' ' MET . . . -56.37 16.28 0.0 OUTLIER 'General case' 0 C--N 1.308 -1.233 0 C-N-CA 124.993 1.317 . . . . 1.0 113.588 -179.738 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 72' ' ' HIS . . . . . 0.572 ' H ' ' C ' ' A' ' 70' ' ' ALA . 0.0 OUTLIER -17.92 -29.32 0.0 OUTLIER 'General case' 0 N--CA 1.473 0.676 0 N-CA-C 112.758 0.651 . . . . 1.0 112.758 -175.048 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 73' ' ' MET . . . . . 0.884 ' N ' ' O ' ' A' ' 71' ' ' ALA . 19.0 mmt -64.81 -56.59 12.59 Favored 'General case' 0 N--CA 1.446 -0.646 0 C-N-CA 119.667 -0.813 . . . . 1.0 108.84 176.4 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 74' ' ' VAL . . . . . 0.665 ' O ' ' N ' ' A' ' 76' ' ' GLY . 34.8 m -43.96 -50.97 1.62 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.821 0 CA-C-O 117.814 -1.089 . . . . 1.0 111.565 -174.815 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 75' ' ' ASN . . . . . 0.519 ' N ' HG23 ' A' ' 74' ' ' VAL . 6.3 t30 -36.42 -18.24 0.0 OUTLIER 'General case' 0 N--CA 1.47 0.533 0 CA-C-N 121.042 1.746 . . . . 1.0 112.299 -179.831 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 76' ' ' GLY . . . . . 0.665 ' N ' ' O ' ' A' ' 74' ' ' VAL . . . -47.72 -28.19 5.1 Favored Glycine 0 CA--C 1.537 1.437 0 N-CA-C 109.16 -1.576 . . . . 1.0 109.16 177.681 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 77' ' ' ILE . . . . . 0.612 ' HA ' ' HB3' ' A' ' 80' ' ' ALA . 6.9 pt -69.29 -51.77 39.7 Favored 'Isoleucine or valine' 0 C--O 1.21 -1.009 0 CA-C-O 122.114 0.959 . . . . 1.0 108.828 -179.967 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 78' ' ' VAL . . . . . 0.484 ' C ' ' O ' ' A' ' 77' ' ' ILE . 77.0 t -36.25 -33.12 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.313 -0.979 0 CA-C-N 113.003 -1.908 . . . . 1.0 107.292 -176.701 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 79' ' ' ILE . . . . . 0.624 ' O ' ' HB3' ' A' ' 83' ' ' ALA . 0.7 OUTLIER -96.77 -31.68 4.02 Favored 'Isoleucine or valine' 0 C--O 1.213 -0.842 0 CA-C-N 115.606 -0.724 . . . . 1.0 110.938 176.653 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 80' ' ' ALA . . . . . 0.612 ' HB3' ' HA ' ' A' ' 77' ' ' ILE . . . -82.45 -8.78 59.61 Favored 'General case' 0 N--CA 1.473 0.68 0 N-CA-C 112.521 0.563 . . . . 1.0 112.521 179.367 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 81' ' ' GLU . . . . . 0.806 ' O ' HD21 ' A' ' 84' ' ' LEU . 7.6 mm-40 -91.15 -72.69 0.57 Allowed 'General case' 0 N--CA 1.439 -0.982 0 O-C-N 122.036 -0.415 . . . . 1.0 112.018 -178.258 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 8.3 t70 -92.68 -14.4 28.12 Favored 'General case' 0 C--N 1.346 0.423 0 N-CA-C 115.024 1.49 . . . . 1.0 115.024 -178.89 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 83' ' ' ALA . . . . . 0.624 ' HB3' ' O ' ' A' ' 79' ' ' ILE . . . -54.26 -44.8 72.14 Favored 'General case' 0 CA--C 1.54 0.595 0 C-N-CA 118.464 -1.294 . . . . 1.0 112.894 -177.505 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 84' ' ' LEU . . . . . 1.019 ' H ' HD13 ' A' ' 84' ' ' LEU . 0.0 OUTLIER -42.75 -14.74 0.01 OUTLIER 'General case' 0 N--CA 1.474 0.752 0 CA-C-N 119.018 0.826 . . . . 1.0 111.079 -177.682 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 85' ' ' ILE . . . . . 0.583 ' N ' ' O ' ' A' ' 83' ' ' ALA . 3.5 mm -94.04 -29.81 4.27 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.25 0 C-N-CA 120.674 -0.41 . . . . 1.0 110.223 179.056 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 86' ' ' ALA . . . . . 0.672 ' C ' ' H ' ' A' ' 88' ' ' ALA . . . -93.02 -24.24 18.4 Favored 'General case' 0 CA--C 1.522 -0.125 0 CA-C-O 121.513 0.673 . . . . 1.0 109.732 179.26 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 20.3 tt0 -63.82 25.85 0.01 OUTLIER 'General case' 0 C--N 1.32 -0.714 0 CA-C-O 121.491 0.662 . . . . 1.0 110.474 -179.036 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 88' ' ' ALA . . . . . 0.672 ' H ' ' C ' ' A' ' 86' ' ' ALA . . . -123.31 -7.31 8.19 Favored 'General case' 0 N--CA 1.474 0.766 0 CA-C-O 122.207 1.004 . . . . 1.0 108.519 178.836 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 89' ' ' VAL . . . . . 0.498 HG23 ' O ' ' A' ' 86' ' ' ALA . 2.4 t -84.31 36.9 0.05 OUTLIER 'Isoleucine or valine' 0 C--O 1.216 -0.659 0 CA-C-N 112.77 -2.014 . . . . 1.0 109.172 178.383 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 90' ' ' GLY . . . . . 0.513 ' N ' ' CD ' ' A' ' 91' ' ' PRO . . . -74.26 -40.52 40.98 Favored Glycine 0 C--N 1.345 1.052 0 C-N-CA 120.504 -0.855 . . . . 1.0 111.382 179.57 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 91' ' ' PRO . . . . . 0.513 ' CD ' ' N ' ' A' ' 90' ' ' GLY . 98.3 Cg_exo -43.51 -21.64 0.31 Allowed 'Trans proline' 0 N--CA 1.497 1.698 0 CA-C-N 119.572 1.686 . . . . 1.0 109.788 -179.701 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 92' ' ' HIS . . . . . 0.799 ' O ' ' N ' ' A' ' 96' ' ' ALA . 0.3 OUTLIER -55.34 -18.4 6.49 Favored 'General case' 0 C--O 1.194 -1.832 0 N-CA-C 107.167 -1.42 . . . . 1.0 107.167 179.897 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 93' ' ' LEU . . . . . 0.656 HD12 ' N ' ' A' ' 94' ' ' ALA . 2.8 pp -51.01 -53.66 31.45 Favored 'General case' 0 CA--C 1.541 0.612 0 N-CA-C 108.669 -0.863 . . . . 1.0 108.669 178.556 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 94' ' ' ALA . . . . . 0.656 ' N ' HD12 ' A' ' 93' ' ' LEU . . . -52.23 -44.87 65.06 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-N 114.521 -1.218 . . . . 1.0 108.972 -179.279 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 95' ' ' ARG . . . . . 0.579 ' C ' ' H ' ' A' ' 97' ' ' LEU . 0.0 OUTLIER -78.18 -49.87 13.01 Favored 'General case' 0 CA--C 1.553 1.077 0 CA-C-O 125.921 2.772 . . . . 1.0 109.142 178.619 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 96' ' ' ALA . . . . . 0.799 ' N ' ' O ' ' A' ' 92' ' ' HIS . . . -68.49 28.0 0.03 OUTLIER 'General case' 0 C--N 1.259 -3.335 0 CA-C-N 112.901 -1.954 . . . . 1.0 107.264 173.028 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 97' ' ' LEU . . . . . 1.034 HD13 ' H ' ' A' ' 98' ' ' GLY . 0.0 OUTLIER -43.71 -46.34 7.45 Favored 'General case' 0 C--O 1.202 -1.444 0 N-CA-C 108.861 -0.792 . . . . 1.0 108.861 178.64 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 98' ' ' GLY . . . . . 1.034 ' H ' HD13 ' A' ' 97' ' ' LEU . . . -49.22 -28.2 8.32 Favored Glycine 0 CA--C 1.5 -0.891 0 N-CA-C 107.867 -2.093 . . . . 1.0 107.867 -179.862 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 99' ' ' GLN . . . . . 0.661 ' O ' ' S1 ' ' A' ' 130' ' ' MTN . 0.0 OUTLIER -59.41 -22.19 61.05 Favored 'General case' 0 C--O 1.216 -0.7 0 N-CA-C 106.693 -1.595 . . . . 1.0 106.693 176.811 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 100' ' ' ILE . . . . . 0.744 ' N ' ' O ' ' A' ' 97' ' ' LEU . 6.1 mm -67.68 -51.55 49.73 Favored 'Isoleucine or valine' 0 C--O 1.207 -1.155 0 CA-C-N 115.387 -0.824 . . . . 1.0 110.045 178.704 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 101' ' ' VAL . . . . . 0.698 ' O ' ' N ' ' A' ' 105' ' ' GLY . 0.4 OUTLIER -52.87 -61.06 0.89 Allowed 'Isoleucine or valine' 0 C--O 1.213 -0.835 0 C-N-CA 119.085 -1.046 . . . . 1.0 110.412 -178.296 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 102' ' ' CYS . . . . . 0.878 ' O ' ' HB2' ' A' ' 106' ' ' ALA . 1.4 p -56.06 -21.77 23.74 Favored 'General case' 0 C--N 1.316 -0.881 0 C-N-CA 118.942 -1.103 . . . . 1.0 110.062 -176.98 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -84.51 -53.89 5.12 Favored 'General case' 0 N--CA 1.481 1.082 0 O-C-N 124.339 1.025 . . . . 1.0 112.399 178.888 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 104' ' ' TYR . . . . . . . . . . . . . 17.9 t80 -96.37 21.18 9.41 Favored 'General case' 0 C--N 1.309 -1.19 0 C-N-CA 126.44 1.896 . . . . 1.0 108.753 178.636 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 105' ' ' GLY . . . . . 0.698 ' N ' ' O ' ' A' ' 101' ' ' VAL . . . -153.62 -96.49 0.13 Allowed Glycine 0 C--N 1.335 0.492 0 N-CA-C 107.893 -2.083 . . . . 1.0 107.893 178.926 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 106' ' ' ALA . . . . . 0.878 ' HB2' ' O ' ' A' ' 102' ' ' CYS . . . 67.2 109.37 0.04 OUTLIER 'General case' 0 CA--C 1.541 0.622 0 O-C-N 122.988 -0.125 . . . . 1.0 111.297 -178.976 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 107' ' ' THR . . . . . 0.65 ' C ' ' H ' ' A' ' 109' ' ' ILE . 0.3 OUTLIER -134.66 -63.69 0.7 Allowed 'General case' 0 C--N 1.353 0.731 0 N-CA-C 105.932 -1.877 . . . . 1.0 105.932 176.926 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 26.9 m -67.16 23.61 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.324 -0.519 0 O-C-N 121.657 -0.652 . . . . 1.0 109.453 179.686 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 109' ' ' ILE . . . . . 0.713 ' H ' ' HD2' ' A' ' 110' ' ' PRO . 0.1 OUTLIER -115.5 -57.09 0.04 OUTLIER Pre-proline 0 CA--C 1.552 1.032 0 N-CA-C 108.278 -1.008 . . . . 1.0 108.278 175.79 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 110' ' ' PRO . . . . . 0.713 ' HD2' ' H ' ' A' ' 109' ' ' ILE . 18.6 Cg_endo -53.82 -39.46 84.05 Favored 'Trans proline' 0 N--CA 1.506 2.237 0 C-N-CA 122.673 2.249 . . . . 1.0 112.046 177.584 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 111' ' ' ASN . . . . . 0.447 ' C ' ' N ' ' A' ' 113' ' ' ASN . 39.3 t30 -67.68 -67.62 0.45 Allowed 'General case' 0 C--O 1.238 0.45 0 C-N-CA 119.91 -0.716 . . . . 1.0 110.463 -178.342 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 112' ' ' ILE . . . . . 0.647 ' C ' HD12 ' A' ' 112' ' ' ILE . 1.4 pp -52.88 -21.45 3.11 Favored 'Isoleucine or valine' 0 C--O 1.212 -0.87 0 CA-C-O 121.998 0.904 . . . . 1.0 108.647 -179.924 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 113' ' ' ASN . . . . . 0.447 ' N ' ' C ' ' A' ' 111' ' ' ASN . 0.1 OUTLIER -60.58 -52.82 63.52 Favored 'General case' 0 C--N 1.311 -1.093 0 CA-C-N 112.698 -2.046 . . . . 1.0 108.813 -179.894 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -58.18 -28.83 65.13 Favored 'General case' 0 N--CA 1.455 -0.194 0 CA-C-N 119.01 0.823 . . . . 1.0 111.48 179.226 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 115' ' ' ALA . . . . . 0.555 ' O ' ' N ' ' A' ' 118' ' ' VAL . . . -81.1 -52.06 7.8 Favored 'General case' 0 C--O 1.219 -0.53 0 N-CA-C 109.108 -0.701 . . . . 1.0 109.108 177.552 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 116' ' ' ILE . . . . . 0.454 HD13 HD13 ' A' ' 112' ' ' ILE . 1.2 tp -42.13 -49.7 0.96 Allowed 'Isoleucine or valine' 0 N--CA 1.478 0.943 0 N-CA-C 105.611 -1.996 . . . . 1.0 105.611 179.766 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 117' ' ' GLU . . . . . 0.471 ' O ' ' HA ' ' A' ' 121' ' ' THR . 62.7 mt-10 -45.1 -57.53 3.82 Favored 'General case' 0 C--N 1.312 -1.036 0 CA-C-N 110.493 -3.049 . . . . 1.0 105.857 178.341 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 118' ' ' VAL . . . . . 0.555 ' N ' ' O ' ' A' ' 115' ' ' ALA . 54.9 t -68.15 -57.13 10.22 Favored 'Isoleucine or valine' 0 CA--C 1.551 1.004 0 C-N-CA 120.684 -0.406 . . . . 1.0 111.046 178.042 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 119' ' ' LEU . . . . . 0.506 ' N ' ' O ' ' A' ' 115' ' ' ALA . 59.2 tp -52.77 -19.85 2.77 Favored 'General case' 0 CA--C 1.538 0.492 0 N-CA-C 113.78 1.03 . . . . 1.0 113.78 -178.666 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 120' ' ' GLY . . . . . 0.607 ' O ' ' OG1' ' A' ' 121' ' ' THR . . . -127.3 -73.81 0.19 Allowed Glycine 0 CA--C 1.547 2.076 0 N-CA-C 106.535 -2.626 . . . . 1.0 106.535 172.719 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 121' ' ' THR . . . . . 0.607 ' OG1' ' O ' ' A' ' 120' ' ' GLY . 17.6 m 161.9 -44.62 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.772 0 CA-C-N 112.686 -1.757 . . . . 1.0 112.796 179.444 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 122' ' ' GLY . . . . . 0.68 ' O ' ' N ' ' A' ' 124' ' ' ASP . . . 104.76 -15.22 49.07 Favored Glycine 0 N--CA 1.471 0.985 0 N-CA-C 108.282 -1.927 . . . . 1.0 108.282 -175.98 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 123' ' ' THR . . . . . 0.689 HG23 ' O ' ' A' ' 123' ' ' THR . 8.4 t -56.95 81.11 0.01 OUTLIER 'General case' 0 N--CA 1.469 0.511 0 N-CA-C 104.615 -2.365 . . . . 1.0 104.615 178.438 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 124' ' ' ASP . . . . . 0.68 ' N ' ' O ' ' A' ' 122' ' ' GLY . 28.6 m-20 -166.93 178.37 5.83 Favored 'General case' 0 N--CA 1.465 0.307 0 CA-C-N 113.464 -1.698 . . . . 1.0 111.552 179.815 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 125' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -142.06 143.07 32.93 Favored 'General case' 0 CA--C 1.54 0.564 0 N-CA-C 108.086 -1.079 . . . . 1.0 108.086 175.766 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 3.0 tpm_? -147.43 146.02 29.42 Favored 'General case' 0 C--N 1.332 -0.185 0 N-CA-C 110.049 -0.352 . . . . 1.0 110.049 179.43 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 127' ' ' PHE . . . . . . . . . . . . . 1.5 t80 . . . . . 0 C--O 1.221 -0.411 0 CA-C-O 117.94 -1.028 . . . . 1.0 109.528 179.498 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 128' ' ' MTN . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 129' ' ' MTN . . . . . 0.781 ' H62' ' SG ' ' A' ' 48' ' ' CYS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 130' ' ' MTN . . . . . 0.661 ' S1 ' ' O ' ' A' ' 99' ' ' GLN . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 11.8 mtt . . . . . 0 N--CA 1.49 1.55 0 N-CA-C 108.918 -0.771 . . . . 1.0 108.918 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 93.1 p -90.12 3.64 52.76 Favored 'General case' 0 N--CA 1.464 0.238 0 CA-C-N 116.564 -0.289 . . . . 1.0 110.933 -179.555 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 2.1 t70 163.14 114.96 0.0 OUTLIER 'General case' 0 N--CA 1.465 0.296 0 O-C-N 123.675 0.609 . . . . 1.0 110.04 179.162 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 92.8 t80 -147.57 143.99 28.16 Favored 'General case' 0 CA--C 1.513 -0.446 0 N-CA-C 109.133 -0.691 . . . . 1.0 109.133 178.861 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 5' ' ' ASP . . . . . 0.44 ' HB2' ' N ' ' A' ' 10' ' ' SER . 1.0 OUTLIER -153.32 148.64 27.01 Favored 'General case' 0 C--N 1.326 -0.444 0 C-N-CA 120.557 -0.457 . . . . 1.0 110.512 -179.39 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 6' ' ' THR . . . . . 0.696 ' O ' ' N ' ' A' ' 10' ' ' SER . 0.2 OUTLIER -116.72 -152.7 0.51 Allowed 'General case' 0 C--O 1.209 -1.031 0 CA-C-O 121.425 0.631 . . . . 1.0 110.313 179.896 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 7' ' ' GLU . . . . . 0.579 ' OE1' ' N ' ' A' ' 8' ' ' ARG . 0.0 OUTLIER -59.34 -49.64 77.05 Favored 'General case' 0 C--N 1.309 -1.196 0 CA-C-O 121.872 0.844 . . . . 1.0 110.603 -177.895 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 8' ' ' ARG . . . . . 0.855 ' O ' ' HB3' ' A' ' 12' ' ' ALA . 5.0 ptt180 -67.35 -57.79 5.98 Favored 'General case' 0 C--N 1.302 -1.487 0 C-N-CA 118.725 -1.19 . . . . 1.0 108.759 178.43 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 9' ' ' VAL . . . . . 0.55 ' O ' HG12 ' A' ' 13' ' ' VAL . 6.7 t -66.08 -53.45 37.27 Favored 'Isoleucine or valine' 0 C--O 1.197 -1.665 0 C-N-CA 119.219 -0.992 . . . . 1.0 111.427 -178.322 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 10' ' ' SER . . . . . 0.696 ' N ' ' O ' ' A' ' 6' ' ' THR . 1.4 t -69.23 -62.46 1.37 Allowed 'General case' 0 C--N 1.309 -1.188 0 C-N-CA 119.363 -0.935 . . . . 1.0 111.974 -178.972 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 11' ' ' ARG . . . . . 0.597 ' O ' ' HB3' ' A' ' 15' ' ' ALA . 1.7 mmt180 -65.3 -45.55 83.96 Favored 'General case' 0 N--CA 1.474 0.74 0 N-CA-C 112.53 0.567 . . . . 1.0 112.53 -176.229 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 12' ' ' ALA . . . . . 0.855 ' HB3' ' O ' ' A' ' 8' ' ' ARG . . . -68.57 -55.59 11.12 Favored 'General case' 0 C--N 1.326 -0.45 0 C-N-CA 118.068 -1.453 . . . . 1.0 108.412 178.463 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 13' ' ' VAL . . . . . 0.642 ' O ' ' CB ' ' A' ' 17' ' ' LEU . 0.4 OUTLIER -62.44 -52.59 58.14 Favored 'Isoleucine or valine' 0 C--O 1.201 -1.471 0 C-N-CA 118.225 -1.39 . . . . 1.0 109.145 -179.264 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 14' ' ' ALA . . . . . 0.734 ' O ' HG22 ' A' ' 18' ' ' VAL . . . -61.05 -61.35 2.64 Favored 'General case' 0 C--N 1.314 -0.978 0 C-N-CA 117.177 -1.809 . . . . 1.0 110.429 179.929 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 15' ' ' ALA . . . . . 0.597 ' HB3' ' O ' ' A' ' 11' ' ' ARG . . . -54.17 -56.12 21.25 Favored 'General case' 0 N--CA 1.475 0.815 0 C-N-CA 119.268 -0.973 . . . . 1.0 110.141 -178.058 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 16' ' ' ALA . . . . . 0.623 ' HB3' ' O ' ' A' ' 12' ' ' ALA . . . -65.43 -55.71 16.49 Favored 'General case' 0 C--N 1.315 -0.909 0 C-N-CA 118.793 -1.163 . . . . 1.0 110.364 -179.271 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 17' ' ' LEU . . . . . 0.642 ' CB ' ' O ' ' A' ' 13' ' ' VAL . 10.8 tp -57.16 -56.14 25.58 Favored 'General case' 0 N--CA 1.485 1.293 0 C-N-CA 119.341 -0.944 . . . . 1.0 108.665 -178.184 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 18' ' ' VAL . . . . . 0.734 HG22 ' O ' ' A' ' 14' ' ' ALA . 1.3 m -71.68 -57.75 6.7 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.571 0 C-N-CA 119.519 -0.872 . . . . 1.0 110.557 -179.711 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 19' ' ' GLY . . . . . 0.53 ' N ' ' O ' ' A' ' 15' ' ' ALA . . . -62.9 -163.33 0.38 Allowed Glycine 0 CA--C 1.522 0.503 0 N-CA-C 111.748 -0.541 . . . . 1.0 111.748 -178.041 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 20' ' ' PRO . . . . . 0.601 ' O ' ' N ' ' A' ' 24' ' ' ALA . 69.3 Cg_endo -80.51 -21.91 7.09 Favored 'Trans proline' 0 C--N 1.304 -1.797 0 C-N-CA 122.419 2.079 . . . . 1.0 114.472 -178.044 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -60.66 -61.04 7.48 Favored Glycine 0 N--CA 1.476 1.326 0 C-N-CA 118.945 -1.598 . . . . 1.0 111.489 -177.165 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 22' ' ' GLY . . . . . 0.607 ' H ' ' CA ' ' A' ' 16' ' ' ALA . . . -59.63 -54.65 35.9 Favored Glycine 0 N--CA 1.466 0.66 0 N-CA-C 107.903 -2.079 . . . . 1.0 107.903 179.674 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 23' ' ' VAL . . . . . 0.605 ' O ' HG12 ' A' ' 27' ' ' VAL . 85.0 t -56.57 -34.15 41.27 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 C-N-CA 119.46 -0.896 . . . . 1.0 109.411 -179.273 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 24' ' ' ALA . . . . . 0.601 ' N ' ' O ' ' A' ' 20' ' ' PRO . . . -64.65 -61.35 2.25 Favored 'General case' 0 N--CA 1.47 0.533 0 C-N-CA 118.879 -1.129 . . . . 1.0 110.341 179.314 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 13.4 tp -61.05 -49.45 77.33 Favored 'General case' 0 CA--C 1.519 -0.219 0 C-N-CA 120.049 -0.66 . . . . 1.0 112.119 -177.015 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 70.0 t -59.18 -60.05 2.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 C-N-CA 119.095 -1.042 . . . . 1.0 110.476 -177.521 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 27' ' ' VAL . . . . . 0.72 ' O ' ' HB3' ' A' ' 31' ' ' ALA . 1.4 p -59.54 -38.46 75.48 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 C-N-CA 120.406 -0.517 . . . . 1.0 111.709 -177.163 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 88.5 tttt -69.28 -55.81 9.4 Favored 'General case' 0 C--N 1.317 -0.847 0 C-N-CA 120.161 -0.616 . . . . 1.0 110.113 -179.174 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 53.8 t -66.25 -52.09 51.55 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.619 0 CA-C-N 115.318 -0.855 . . . . 1.0 111.633 -176.499 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 30' ' ' CYS . . . . . . . . . . . . . 49.4 t -66.55 -60.79 2.4 Favored 'General case' 0 N--CA 1.445 -0.723 0 C-N-CA 118.761 -1.175 . . . . 1.0 110.589 -178.086 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 31' ' ' ALA . . . . . 0.72 ' HB3' ' O ' ' A' ' 27' ' ' VAL . . . -64.5 -49.97 69.24 Favored 'General case' 0 CA--C 1.513 -0.463 0 C-N-CA 120.691 -0.404 . . . . 1.0 111.78 -175.627 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 32' ' ' GLY . . . . . 0.512 ' O ' ' CB ' ' A' ' 33' ' ' LEU . . . 77.78 62.57 2.35 Favored Glycine 0 N--CA 1.447 -0.622 0 N-CA-C 107.923 -2.071 . . . . 1.0 107.923 -177.492 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 33' ' ' LEU . . . . . 0.512 ' CB ' ' O ' ' A' ' 32' ' ' GLY . 9.8 tp 90.32 94.43 0.03 OUTLIER Pre-proline 0 CA--C 1.541 0.625 0 CA-C-N 115.093 -0.553 . . . . 1.0 110.076 -179.064 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 59.4 Cg_endo -74.15 -11.27 23.13 Favored 'Trans proline' 0 N--CA 1.495 1.61 0 C-N-CA 122.012 1.808 . . . . 1.0 112.56 -179.212 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -58.04 -60.81 8.27 Favored Glycine 0 CA--C 1.534 1.235 0 C-N-CA 118.834 -1.65 . . . . 1.0 109.401 -178.847 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 36' ' ' VAL . . . . . 0.638 ' O ' HG22 ' A' ' 37' ' ' ILE . 1.6 m -90.19 176.4 0.66 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.47 0 N-CA-C 106.496 -1.668 . . . . 1.0 106.496 176.676 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 37' ' ' ILE . . . . . 0.638 HG22 ' O ' ' A' ' 36' ' ' VAL . 9.5 tt 107.72 115.49 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.481 1.089 0 O-C-N 124.787 1.304 . . . . 1.0 110.234 179.564 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 76.6 m80 -143.62 136.91 27.91 Favored 'General case' 0 C--O 1.231 0.093 0 CA-C-O 120.862 0.363 . . . . 1.0 110.024 179.995 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -106.93 118.62 53.67 Favored Pre-proline 0 CA--C 1.535 0.399 0 N-CA-C 109.17 -0.678 . . . . 1.0 109.17 179.167 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 65.8 Cg_exo -47.13 -24.22 3.37 Favored 'Trans proline' 0 N--CA 1.493 1.483 0 C-N-CA 121.629 1.553 . . . . 1.0 113.549 -179.403 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -127.94 135.95 50.66 Favored 'General case' 0 N--CA 1.467 0.377 0 CA-C-O 119.911 -0.09 . . . . 1.0 110.824 179.013 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 42' ' ' ARG . . . . . 0.718 ' C ' ' H ' ' A' ' 44' ' ' GLY . 14.0 ptm180 -167.16 166.42 14.97 Favored 'General case' 0 C--N 1.319 -0.726 0 C-N-CA 120.015 -0.674 . . . . 1.0 110.485 178.226 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 43' ' ' ARG . . . . . 0.649 ' C ' ' H ' ' A' ' 45' ' ' PHE . 25.6 tpt180 -62.13 22.54 0.01 OUTLIER 'General case' 0 CA--C 1.545 0.769 0 CA-C-O 121.63 0.728 . . . . 1.0 109.826 -179.92 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 44' ' ' GLY . . . . . 0.718 ' H ' ' C ' ' A' ' 42' ' ' ARG . . . 66.85 -30.28 0.18 Allowed Glycine 0 C--N 1.337 0.599 0 N-CA-C 110.663 -0.975 . . . . 1.0 110.663 179.125 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 45' ' ' PHE . . . . . 0.649 ' H ' ' C ' ' A' ' 43' ' ' ARG . 0.7 OUTLIER -166.43 173.12 10.22 Favored 'General case' 0 N--CA 1.446 -0.649 0 N-CA-C 108.939 -0.763 . . . . 1.0 108.939 -179.194 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 46' ' ' PHE . . . . . 0.547 ' CB ' ' O ' ' A' ' 45' ' ' PHE . 6.8 t80 110.4 106.67 0.0 OUTLIER 'General case' 0 N--CA 1.48 1.053 0 O-C-N 125.278 1.611 . . . . 1.0 109.495 179.555 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 47' ' ' ARG . . . . . 1.085 ' HE ' ' H91' ' A' ' 128' ' ' MTN . 2.5 ptm180 102.67 150.61 0.01 OUTLIER 'General case' 0 N--CA 1.48 1.03 0 O-C-N 125.012 1.445 . . . . 1.0 110.695 -179.452 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 48' ' ' CYS . . . . . 0.807 ' O ' ' H62' ' A' ' 129' ' ' MTN . 37.5 t 60.84 67.49 0.81 Allowed 'General case' 0 CA--C 1.509 -0.619 0 N-CA-C 108.256 -1.016 . . . . 1.0 108.256 179.453 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 49' ' ' ASN . . . . . 0.526 ' O ' ' N ' ' A' ' 51' ' ' GLU . 1.5 m-20 -130.73 160.97 63.94 Favored Pre-proline 0 C--N 1.327 -0.395 0 CA-C-N 115.892 -0.595 . . . . 1.0 109.912 -178.842 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 50' ' ' PRO . . . . . 0.565 ' HG3' HH21 ' A' ' 52' ' ' ARG . 17.9 Cg_endo -62.12 52.59 0.11 Allowed 'Trans proline' 0 N--CA 1.494 1.557 0 C-N-CA 123.049 2.5 . . . . 1.0 112.061 179.394 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 51' ' ' GLU . . . . . 0.526 ' N ' ' O ' ' A' ' 49' ' ' ASN . 1.4 pm0 29.72 44.38 0.02 OUTLIER 'General case' 0 N--CA 1.471 0.599 0 CA-C-N 115.991 -0.549 . . . . 1.0 112.355 179.64 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 52' ' ' ARG . . . . . 0.569 ' HD2' ' HB1' ' A' ' 86' ' ' ALA . 75.5 mtm180 -122.85 141.56 51.74 Favored 'General case' 0 N--CA 1.476 0.846 0 N-CA-C 109.86 -0.422 . . . . 1.0 109.86 178.808 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 8.8 tp -37.66 135.68 0.24 Allowed 'Isoleucine or valine' 0 CA--C 1.53 0.179 0 CA-C-O 122.666 1.222 . . . . 1.0 112.745 -174.923 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -92.03 77.29 5.38 Favored 'General case' 0 C--N 1.339 0.121 0 CA-C-N 112.589 -2.096 . . . . 1.0 113.076 -177.899 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 3.8 tp -144.26 150.33 16.78 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.365 0 N-CA-C 108.471 -0.937 . . . . 1.0 108.471 176.82 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 104.27 2.29 44.6 Favored Glycine 0 CA--C 1.527 0.806 0 N-CA-C 109.495 -1.442 . . . . 1.0 109.495 -179.056 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 57' ' ' ASP . . . . . 0.443 ' CG ' ' CE2' ' A' ' 45' ' ' PHE . 22.6 m-20 -86.13 107.07 17.68 Favored 'General case' 0 CA--C 1.538 0.516 0 N-CA-C 113.032 0.753 . . . . 1.0 113.032 -178.69 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 58' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -80.56 178.74 8.13 Favored 'General case' 0 N--CA 1.469 0.515 0 CA-C-N 114.387 -1.279 . . . . 1.0 108.324 177.997 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 59' ' ' ARG . . . . . 0.826 ' HE ' ' H ' ' A' ' 59' ' ' ARG . 0.0 OUTLIER -101.23 -54.2 2.84 Favored 'General case' 0 CA--C 1.545 0.755 0 CA-C-N 119.246 0.93 . . . . 1.0 110.576 178.295 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -79.19 -13.26 59.81 Favored 'General case' 0 N--CA 1.482 1.151 0 CA-C-N 114.52 -1.218 . . . . 1.0 111.3 -178.914 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 61' ' ' GLU . . . . . 0.413 ' O ' ' N ' ' A' ' 65' ' ' ASP . 42.5 tt0 -69.25 -13.92 62.67 Favored 'General case' 0 C--N 1.303 -1.44 0 CA-C-N 115.124 -0.943 . . . . 1.0 108.459 179.11 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 62' ' ' VAL . . . . . 0.654 HG13 ' O ' ' A' ' 59' ' ' ARG . 11.6 m -44.59 -51.64 1.81 Allowed 'Isoleucine or valine' 0 C--N 1.317 -0.844 0 CA-C-N 115.787 -0.642 . . . . 1.0 110.516 -175.757 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 63' ' ' ALA . . . . . 0.626 ' O ' ' HG2' ' A' ' 67' ' ' ARG . . . -67.38 -47.28 70.81 Favored 'General case' 0 N--CA 1.423 -1.798 0 C-N-CA 119.608 -0.837 . . . . 1.0 109.028 179.871 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 64' ' ' HIS . . . . . 0.437 ' O ' ' CG ' ' A' ' 67' ' ' ARG . 0.2 OUTLIER -54.04 -59.59 4.45 Favored 'General case' 0 CA--C 1.542 0.649 0 CA-C-N 115.756 -0.657 . . . . 1.0 110.301 179.612 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 65' ' ' ASP . . . . . 0.64 ' C ' ' H ' ' A' ' 67' ' ' ARG . 1.1 t70 -65.99 -52.24 51.21 Favored 'General case' 0 C--O 1.242 0.666 0 CA-C-O 121.658 0.742 . . . . 1.0 109.21 177.864 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 66' ' ' GLY . . . . . 0.498 ' N ' ' O ' ' A' ' 62' ' ' VAL . . . -64.27 29.18 0.1 OUTLIER Glycine 0 CA--C 1.53 1.031 0 N-CA-C 110.979 -0.849 . . . . 1.0 110.979 178.002 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 67' ' ' ARG . . . . . 0.64 ' H ' ' C ' ' A' ' 65' ' ' ASP . 5.5 mmm180 -78.9 -4.18 48.43 Favored 'General case' 0 C--N 1.323 -0.566 0 N-CA-C 108.056 -1.09 . . . . 1.0 108.056 175.836 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 68' ' ' LEU . . . . . 0.456 ' C ' ' O ' ' A' ' 67' ' ' ARG . 0.6 OUTLIER -35.45 -29.16 0.01 OUTLIER 'General case' 0 N--CA 1.48 1.075 0 N-CA-C 108.033 -1.099 . . . . 1.0 108.033 -177.298 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 69' ' ' LEU . . . . . 0.576 ' N ' ' O ' ' A' ' 67' ' ' ARG . 8.4 tt -62.83 -64.86 0.79 Allowed 'General case' 0 C--N 1.313 -1.02 0 N-CA-C 106.914 -1.513 . . . . 1.0 106.914 177.224 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 70' ' ' ALA . . . . . 0.621 ' C ' ' H ' ' A' ' 72' ' ' HIS . . . -76.96 -71.43 0.4 Allowed 'General case' 0 N--CA 1.467 0.388 0 N-CA-C 106.642 -1.614 . . . . 1.0 106.642 177.187 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 71' ' ' ALA . . . . . 0.531 ' O ' ' C ' ' A' ' 72' ' ' HIS . . . -45.07 0.39 0.0 OUTLIER 'General case' 0 N--CA 1.475 0.775 0 C-N-CA 124.188 0.995 . . . . 1.0 113.404 178.384 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 72' ' ' HIS . . . . . 0.638 ' CG ' ' N ' ' A' ' 73' ' ' MET . 0.0 OUTLIER -22.09 -62.67 0.03 OUTLIER 'General case' 0 C--O 1.231 0.13 0 CA-C-N 117.951 0.342 . . . . 1.0 111.311 -176.142 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 73' ' ' MET . . . . . 0.638 ' N ' ' CG ' ' A' ' 72' ' ' HIS . 31.6 ttm -75.54 -50.07 16.75 Favored 'General case' 0 C--N 1.319 -0.752 0 C-N-CA 118.881 -1.127 . . . . 1.0 109.667 177.823 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 74' ' ' VAL . . . . . 0.643 ' O ' ' N ' ' A' ' 76' ' ' GLY . 97.2 t -43.75 -46.18 1.89 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.375 0 CA-C-O 118.472 -0.775 . . . . 1.0 110.378 -175.434 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 75' ' ' ASN . . . . . 0.499 ' O ' ' N ' ' A' ' 77' ' ' ILE . 0.5 OUTLIER -36.81 -19.37 0.01 OUTLIER 'General case' 0 N--CA 1.487 1.414 0 CA-C-N 119.779 1.172 . . . . 1.0 111.356 179.232 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 76' ' ' GLY . . . . . 0.643 ' N ' ' O ' ' A' ' 74' ' ' VAL . . . -44.03 -19.58 0.13 Allowed Glycine 0 CA--C 1.544 1.855 0 N-CA-C 108.967 -1.653 . . . . 1.0 108.967 177.237 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 77' ' ' ILE . . . . . 0.666 ' O ' ' N ' ' A' ' 80' ' ' ALA . 12.2 pt -90.13 -51.45 11.95 Favored 'Isoleucine or valine' 0 C--N 1.346 0.433 0 N-CA-C 108.621 -0.881 . . . . 1.0 108.621 179.371 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 78' ' ' VAL . . . . . 0.465 ' C ' ' O ' ' A' ' 77' ' ' ILE . 42.3 t -34.86 -36.86 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.446 -0.642 0 N-CA-C 109.003 -0.74 . . . . 1.0 109.003 -177.796 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 79' ' ' ILE . . . . . 0.414 ' N ' ' O ' ' A' ' 77' ' ' ILE . 33.0 pt -90.44 -21.06 6.75 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.575 0 CA-C-N 116.159 -0.473 . . . . 1.0 111.934 179.788 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 80' ' ' ALA . . . . . 0.666 ' N ' ' O ' ' A' ' 77' ' ' ILE . . . -82.99 -7.31 59.68 Favored 'General case' 0 CA--C 1.536 0.404 0 C-N-CA 123.771 0.828 . . . . 1.0 111.244 177.102 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 3.7 mm-40 -74.0 -68.72 0.49 Allowed 'General case' 0 N--CA 1.452 -0.356 0 N-CA-C 108.771 -0.826 . . . . 1.0 108.771 178.444 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 82' ' ' ASP . . . . . 0.594 ' O ' ' N ' ' A' ' 84' ' ' LEU . 18.8 p-10 -59.23 -59.19 5.85 Favored 'General case' 0 CA--C 1.512 -0.511 0 C-N-CA 119.489 -0.884 . . . . 1.0 108.941 179.578 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 83' ' ' ALA . . . . . 0.535 ' C ' ' O ' ' A' ' 82' ' ' ASP . . . 3.35 -70.47 0.0 OUTLIER 'General case' 0 N--CA 1.486 1.365 0 O-C-N 124.469 1.105 . . . . 1.0 111.069 -179.913 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 84' ' ' LEU . . . . . 0.594 ' N ' ' O ' ' A' ' 82' ' ' ASP . 58.8 mt -26.78 -44.68 0.02 OUTLIER 'General case' 0 N--CA 1.474 0.746 0 CA-C-N 115.435 -0.802 . . . . 1.0 111.044 -176.64 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 85' ' ' ILE . . . . . 0.45 ' H ' HG13 ' A' ' 85' ' ' ILE . 1.3 pp -97.65 -49.5 11.84 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.293 0 N-CA-C 108.299 -1.0 . . . . 1.0 108.299 177.636 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 86' ' ' ALA . . . . . 0.692 ' C ' ' H ' ' A' ' 88' ' ' ALA . . . -44.45 -41.94 6.66 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 114.453 -1.249 . . . . 1.0 110.333 179.938 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 10.6 pt-20 -60.54 24.84 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.361 -0.381 . . . . 1.0 111.061 179.922 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 88' ' ' ALA . . . . . 0.692 ' H ' ' C ' ' A' ' 86' ' ' ALA . . . -122.76 -9.15 8.39 Favored 'General case' 0 N--CA 1.456 -0.173 0 CA-C-N 116.229 -0.441 . . . . 1.0 109.854 179.592 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 89' ' ' VAL . . . . . 0.509 HG23 ' O ' ' A' ' 89' ' ' VAL . 4.0 m -107.66 34.69 0.59 Allowed 'Isoleucine or valine' 0 C--O 1.224 -0.267 0 N-CA-C 109.093 -0.706 . . . . 1.0 109.093 179.377 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 90' ' ' GLY . . . . . 0.558 ' O ' ' N ' ' A' ' 92' ' ' HIS . . . -67.49 -40.42 91.09 Favored Glycine 0 CA--C 1.532 1.118 0 CA-C-O 119.616 -0.547 . . . . 1.0 111.957 179.16 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 91' ' ' PRO . . . . . 0.508 ' CD ' ' N ' ' A' ' 90' ' ' GLY . 80.4 Cg_exo -44.06 -13.19 0.05 OUTLIER 'Trans proline' 0 N--CA 1.494 1.549 0 C-N-CA 122.066 1.844 . . . . 1.0 111.483 179.294 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 92' ' ' HIS . . . . . 0.558 ' N ' ' O ' ' A' ' 90' ' ' GLY . 2.8 p80 -58.15 -17.13 16.39 Favored 'General case' 0 N--CA 1.44 -0.928 0 CA-C-N 115.676 -0.693 . . . . 1.0 109.201 179.396 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 93' ' ' LEU . . . . . 0.676 HD12 ' N ' ' A' ' 94' ' ' ALA . 1.5 pp -69.71 -59.18 3.11 Favored 'General case' 0 C--O 1.234 0.276 0 N-CA-C 109.759 -0.46 . . . . 1.0 109.759 178.993 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 94' ' ' ALA . . . . . 0.676 ' N ' HD12 ' A' ' 93' ' ' LEU . . . -55.87 -51.42 67.6 Favored 'General case' 0 CA--C 1.512 -0.508 0 N-CA-C 108.854 -0.795 . . . . 1.0 108.854 179.509 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 95' ' ' ARG . . . . . 0.657 ' O ' ' N ' ' A' ' 97' ' ' LEU . 7.1 mmm-85 -54.09 -59.02 5.2 Favored 'General case' 0 C--O 1.246 0.882 0 CA-C-O 122.985 1.374 . . . . 1.0 107.642 178.572 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 96' ' ' ALA . . . . . 0.77 ' O ' ' N ' ' A' ' 98' ' ' GLY . . . -46.33 -12.14 0.02 OUTLIER 'General case' 0 C--N 1.304 -1.375 0 O-C-N 119.524 -1.985 . . . . 1.0 111.556 -177.262 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 97' ' ' LEU . . . . . 0.657 ' N ' ' O ' ' A' ' 95' ' ' ARG . 0.3 OUTLIER 1.17 -53.76 0.0 OUTLIER 'General case' 0 N--CA 1.482 1.147 0 C-N-CA 124.246 1.018 . . . . 1.0 112.011 -169.101 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 98' ' ' GLY . . . . . 0.77 ' N ' ' O ' ' A' ' 96' ' ' ALA . . . -50.71 -23.27 6.58 Favored Glycine 0 C--N 1.3 -1.427 0 CA-C-N 121.905 2.138 . . . . 1.0 108.918 175.642 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 99' ' ' GLN . . . . . 0.615 ' HB2' ' HB1' ' A' ' 96' ' ' ALA . 0.3 OUTLIER -69.25 -24.07 63.94 Favored 'General case' 0 C--N 1.353 0.742 0 N-CA-C 107.872 -1.158 . . . . 1.0 107.872 178.011 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 100' ' ' ILE . . . . . 0.588 ' N ' ' O ' ' A' ' 97' ' ' LEU . 0.9 OUTLIER -63.6 -38.61 82.7 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.676 0 CA-C-N 114.471 -1.241 . . . . 1.0 108.895 178.442 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 101' ' ' VAL . . . . . 0.542 ' O ' ' N ' ' A' ' 105' ' ' GLY . 86.9 t -61.72 -60.01 3.39 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.199 0 N-CA-C 109.156 -0.683 . . . . 1.0 109.156 179.987 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 102' ' ' CYS . . . . . 0.897 ' O ' ' HB2' ' A' ' 106' ' ' ALA . 0.0 OUTLIER -44.41 -20.53 0.03 OUTLIER 'General case' 0 C--O 1.22 -0.478 0 CA-C-O 119.641 -0.218 . . . . 1.0 111.2 -178.574 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 103' ' ' ARG . . . . . 0.441 ' N ' ' O ' ' A' ' 101' ' ' VAL . 17.1 ttm180 -88.82 -37.36 15.45 Favored 'General case' 0 N--CA 1.484 1.239 0 CA-C-O 122.766 1.27 . . . . 1.0 110.664 178.316 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 104' ' ' TYR . . . . . 0.588 ' O ' ' CG ' ' A' ' 104' ' ' TYR . 50.9 t80 -99.79 20.99 13.16 Favored 'General case' 0 C--N 1.31 -1.116 0 CA-C-N 112.117 -2.31 . . . . 1.0 110.342 177.184 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 105' ' ' GLY . . . . . 0.542 ' N ' ' O ' ' A' ' 101' ' ' VAL . . . -163.5 -88.81 0.07 OUTLIER Glycine 0 N--CA 1.445 -0.719 0 N-CA-C 108.023 -2.031 . . . . 1.0 108.023 178.073 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 106' ' ' ALA . . . . . 0.897 ' HB2' ' O ' ' A' ' 102' ' ' CYS . . . 66.46 66.62 0.46 Allowed 'General case' 0 N--CA 1.441 -0.892 0 CA-C-N 115.654 -0.273 . . . . 1.0 111.545 -179.857 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 14.0 m -77.47 -60.97 2.14 Favored 'General case' 0 N--CA 1.473 0.718 0 O-C-N 121.325 -0.859 . . . . 1.0 109.388 179.711 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 108' ' ' VAL . . . . . 0.491 HG23 ' N ' ' A' ' 109' ' ' ILE . 32.3 m -66.51 -43.92 90.56 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.171 0 CA-C-O 121.293 0.568 . . . . 1.0 109.511 -179.158 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 109' ' ' ILE . . . . . 0.491 ' N ' HG23 ' A' ' 108' ' ' VAL . 1.8 mm -36.5 -61.23 0.64 Allowed Pre-proline 0 CA--C 1.549 0.932 0 CA-C-O 118.171 -0.919 . . . . 1.0 111.095 -178.269 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 110' ' ' PRO . . . . . 0.584 ' CD ' ' O ' ' A' ' 106' ' ' ALA . 55.5 Cg_endo -63.85 -21.33 69.17 Favored 'Trans proline' 0 N--CA 1.505 2.149 0 C-N-CA 124.013 3.142 . . . . 1.0 113.11 179.875 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 14.7 t-20 -63.31 -69.9 0.24 Allowed 'General case' 0 N--CA 1.467 0.392 0 C-N-CA 120.387 -0.525 . . . . 1.0 111.175 -178.191 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 112' ' ' ILE . . . . . 0.821 HD13 ' N ' ' A' ' 113' ' ' ASN . 0.0 OUTLIER -73.07 -25.33 21.65 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.567 0 CA-C-O 121.969 0.89 . . . . 1.0 109.499 -179.643 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 113' ' ' ASN . . . . . 0.821 ' N ' HD13 ' A' ' 112' ' ' ILE . 0.4 OUTLIER -52.02 -59.2 4.63 Favored 'General case' 0 C--N 1.3 -1.552 0 CA-C-N 114.002 -1.453 . . . . 1.0 108.908 -177.45 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -66.26 -20.46 66.12 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 115.891 -0.595 . . . . 1.0 110.954 179.107 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -76.41 -60.81 2.18 Favored 'General case' 0 N--CA 1.443 -0.804 0 C-N-CA 120.282 -0.567 . . . . 1.0 111.171 178.001 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 116' ' ' ILE . . . . . 0.526 ' O ' ' N ' ' A' ' 119' ' ' LEU . 7.6 tt -72.39 -41.54 64.97 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.213 0 O-C-N 121.213 -0.93 . . . . 1.0 111.981 -178.236 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 117' ' ' GLU . . . . . 0.566 ' OE1' ' ND2' ' A' ' 113' ' ' ASN . 1.0 OUTLIER -48.81 -58.61 4.53 Favored 'General case' 0 CA--C 1.508 -0.671 0 N-CA-C 108.288 -1.005 . . . . 1.0 108.288 -178.476 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 86.9 t -54.71 -14.26 0.96 Allowed 'Isoleucine or valine' 0 N--CA 1.436 -1.131 0 C-N-CA 120.253 -0.579 . . . . 1.0 109.442 179.52 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 119' ' ' LEU . . . . . 0.526 ' N ' ' O ' ' A' ' 116' ' ' ILE . 0.2 OUTLIER -76.33 -60.18 2.45 Favored 'General case' 0 C--N 1.347 0.477 0 N-CA-C 107.77 -1.196 . . . . 1.0 107.77 175.796 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -68.25 -83.08 0.15 Allowed Glycine 0 C--N 1.364 2.114 0 C-N-CA 117.57 -2.253 . . . . 1.0 111.23 179.449 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 121' ' ' THR . . . . . 0.444 ' H ' ' H ' ' A' ' 122' ' ' GLY . 18.8 m -161.36 -17.97 0.05 OUTLIER 'General case' 0 C--N 1.326 -0.427 0 N-CA-C 108.564 -0.902 . . . . 1.0 108.564 -179.639 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 122' ' ' GLY . . . . . 0.444 ' H ' ' H ' ' A' ' 121' ' ' THR . . . 111.26 -35.91 4.49 Favored Glycine 0 CA--C 1.523 0.577 0 CA-C-N 113.959 -1.473 . . . . 1.0 112.1 179.569 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 123' ' ' THR . . . . . 0.416 ' C ' ' O ' ' A' ' 122' ' ' GLY . 0.1 OUTLIER -33.43 95.4 0.01 OUTLIER 'General case' 0 N--CA 1.471 0.614 0 CA-C-N 118.342 1.071 . . . . 1.0 112.489 -178.618 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 124' ' ' ASP . . . . . 0.414 ' N ' ' O ' ' A' ' 122' ' ' GLY . 55.6 m-20 -148.59 147.88 29.51 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 115.484 -0.78 . . . . 1.0 109.548 179.26 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 125' ' ' TYR . . . . . 0.418 ' CD1' ' C ' ' A' ' 125' ' ' TYR . 0.0 OUTLIER -151.85 150.25 29.89 Favored 'General case' 0 CA--C 1.532 0.279 0 CA-C-O 120.863 0.363 . . . . 1.0 110.124 179.946 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 126' ' ' ARG . . . . . 0.43 ' HB3' ' H62' ' A' ' 130' ' ' MTN . 0.0 OUTLIER -149.67 150.55 32.32 Favored 'General case' 0 CA--C 1.537 0.45 0 CA-C-N 116.07 -0.513 . . . . 1.0 110.019 177.719 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 127' ' ' PHE . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 C--O 1.22 -0.467 0 CA-C-O 118.172 -0.918 . . . . 1.0 109.249 179.44 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 128' ' ' MTN . . . . . 1.085 ' H91' ' HE ' ' A' ' 47' ' ' ARG . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 129' ' ' MTN . . . . . 0.807 ' H62' ' O ' ' A' ' 48' ' ' CYS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 130' ' ' MTN . . . . . 0.43 ' H62' ' HB3' ' A' ' 126' ' ' ARG . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 N--CA 1.493 1.715 0 N-CA-C 109.259 -0.645 . . . . 1.0 109.259 . . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 2' ' ' SER . . . . . 0.487 ' O ' ' CG ' ' A' ' 3' ' ' ASP . 55.1 p -83.28 5.63 22.48 Favored 'General case' 0 CA--C 1.531 0.246 0 CA-C-N 116.489 -0.323 . . . . 1.0 111.478 -179.062 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 3' ' ' ASP . . . . . 0.487 ' CG ' ' O ' ' A' ' 2' ' ' SER . 24.0 m-20 153.69 127.41 0.0 OUTLIER 'General case' 0 N--CA 1.477 0.876 0 O-C-N 123.904 0.753 . . . . 1.0 111.2 178.94 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 60.9 t80 -155.92 151.19 26.73 Favored 'General case' 0 N--CA 1.462 0.145 0 CA-C-N 116.089 -0.505 . . . . 1.0 110.953 179.235 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 4.2 p30 -153.7 148.63 26.63 Favored 'General case' 0 CA--C 1.536 0.419 0 CA-C-N 116.308 -0.406 . . . . 1.0 110.158 -179.692 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 6' ' ' THR . . . . . 0.816 ' O ' ' N ' ' A' ' 10' ' ' SER . 0.1 OUTLIER -80.76 170.4 16.35 Favored 'General case' 0 C--O 1.188 -2.165 0 C-N-CA 120.856 -0.338 . . . . 1.0 110.305 -179.39 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 7' ' ' GLU . . . . . 0.541 ' O ' ' N ' ' A' ' 11' ' ' ARG . 39.2 tt0 -56.87 -57.05 14.16 Favored 'General case' 0 C--N 1.313 -0.984 0 CA-C-O 121.775 0.797 . . . . 1.0 110.54 -177.974 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 8' ' ' ARG . . . . . 0.757 ' O ' ' HB3' ' A' ' 12' ' ' ALA . 0.0 OUTLIER -54.02 -55.51 26.66 Favored 'General case' 0 C--N 1.313 -1.01 0 N-CA-C 106.96 -1.496 . . . . 1.0 106.96 -178.079 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 9' ' ' VAL . . . . . 0.683 ' O ' ' HB ' ' A' ' 13' ' ' VAL . 0.2 OUTLIER -66.41 -51.89 52.97 Favored 'Isoleucine or valine' 0 C--O 1.189 -2.124 0 CA-C-N 114.35 -1.296 . . . . 1.0 109.659 179.651 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 10' ' ' SER . . . . . 0.816 ' N ' ' O ' ' A' ' 6' ' ' THR . 22.5 t -65.78 -64.89 0.76 Allowed 'General case' 0 N--CA 1.482 1.139 0 C-N-CA 120.256 -0.578 . . . . 1.0 111.649 -178.924 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 11' ' ' ARG . . . . . 0.541 ' N ' ' O ' ' A' ' 7' ' ' GLU . 0.3 OUTLIER -65.52 -57.82 7.3 Favored 'General case' 0 C--O 1.218 -0.589 0 N-CA-C 112.313 0.486 . . . . 1.0 112.313 -176.81 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 12' ' ' ALA . . . . . 0.757 ' HB3' ' O ' ' A' ' 8' ' ' ARG . . . -54.12 -49.69 68.59 Favored 'General case' 0 N--CA 1.476 0.856 0 C-N-CA 117.874 -1.53 . . . . 1.0 107.41 -176.497 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 13' ' ' VAL . . . . . 0.683 ' HB ' ' O ' ' A' ' 9' ' ' VAL . 91.2 t -62.34 -50.05 81.49 Favored 'Isoleucine or valine' 0 C--O 1.197 -1.679 0 N-CA-C 107.585 -1.265 . . . . 1.0 107.585 178.476 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 14' ' ' ALA . . . . . 0.776 ' O ' HG22 ' A' ' 18' ' ' VAL . . . -56.41 -60.24 3.8 Favored 'General case' 0 C--O 1.207 -1.143 0 C-N-CA 117.57 -1.652 . . . . 1.0 108.508 -178.806 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 15' ' ' ALA . . . . . 0.55 ' O ' ' N ' ' A' ' 19' ' ' GLY . . . -53.63 -53.65 48.91 Favored 'General case' 0 C--N 1.322 -0.618 0 O-C-N 123.718 0.636 . . . . 1.0 109.726 -178.855 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 16' ' ' ALA . . . . . 0.46 ' C ' ' H ' ' A' ' 22' ' ' GLY . . . -63.72 -57.98 8.31 Favored 'General case' 0 N--CA 1.474 0.745 0 CA-C-O 121.693 0.759 . . . . 1.0 109.707 -179.547 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 17' ' ' LEU . . . . . 0.61 ' N ' ' O ' ' A' ' 13' ' ' VAL . 7.5 tt -55.42 -54.46 43.47 Favored 'General case' 0 N--CA 1.477 0.903 0 CA-C-N 114.422 -1.263 . . . . 1.0 108.652 -178.578 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 18' ' ' VAL . . . . . 0.776 HG22 ' O ' ' A' ' 14' ' ' ALA . 2.3 m -69.16 -57.45 8.56 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.568 0 C-N-CA 119.335 -0.946 . . . . 1.0 109.166 179.857 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 19' ' ' GLY . . . . . 0.55 ' N ' ' O ' ' A' ' 15' ' ' ALA . . . -56.78 -162.95 0.03 OUTLIER Glycine 0 C--O 1.22 -0.77 0 N-CA-C 111.225 -0.75 . . . . 1.0 111.225 -178.317 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 20' ' ' PRO . . . . . 0.441 ' O ' ' N ' ' A' ' 24' ' ' ALA . 83.0 Cg_endo -82.76 -30.34 1.05 Allowed 'Trans proline' 0 C--N 1.303 -1.836 0 C-N-CA 122.508 2.139 . . . . 1.0 113.988 -178.619 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 21' ' ' GLY . . . . . 0.42 ' O ' ' HB3' ' A' ' 24' ' ' ALA . . . -62.87 -61.52 6.38 Favored Glycine 0 N--CA 1.48 1.57 0 C-N-CA 119.897 -1.144 . . . . 1.0 113.364 -176.508 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 22' ' ' GLY . . . . . 0.46 ' H ' ' C ' ' A' ' 16' ' ' ALA . . . -54.16 -52.81 41.27 Favored Glycine 0 N--CA 1.471 0.997 0 N-CA-C 106.6 -2.6 . . . . 1.0 106.6 -177.11 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 23' ' ' VAL . . . . . 0.547 ' O ' HG12 ' A' ' 27' ' ' VAL . 12.3 t -57.06 -29.17 30.92 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.853 0 C-N-CA 119.569 -0.852 . . . . 1.0 109.096 177.696 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 24' ' ' ALA . . . . . 0.441 ' N ' ' O ' ' A' ' 20' ' ' PRO . . . -61.89 -63.63 1.2 Allowed 'General case' 0 C--N 1.349 0.568 0 C-N-CA 118.106 -1.437 . . . . 1.0 111.138 179.922 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 25' ' ' LEU . . . . . 0.588 ' N ' HD12 ' A' ' 25' ' ' LEU . 9.6 mp -63.6 -47.72 80.28 Favored 'General case' 0 N--CA 1.472 0.649 0 CA-C-N 119.008 0.822 . . . . 1.0 112.651 -177.486 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 94.9 t -58.01 -58.84 4.67 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.575 0 C-N-CA 119.169 -1.013 . . . . 1.0 110.061 -177.416 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 27' ' ' VAL . . . . . 0.809 ' O ' ' HB3' ' A' ' 31' ' ' ALA . 0.5 OUTLIER -61.41 -36.33 72.35 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.601 0 CA-C-O 121.224 0.535 . . . . 1.0 110.322 -178.505 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 28' ' ' LYS . . . . . 0.405 ' CB ' ' O ' ' A' ' 24' ' ' ALA . 33.0 tttm -67.52 -58.52 4.57 Favored 'General case' 0 C--N 1.316 -0.891 0 C-N-CA 119.461 -0.896 . . . . 1.0 110.424 -178.918 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 95.8 t -65.32 -49.85 76.43 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.116 0 C-N-CA 119.821 -0.752 . . . . 1.0 111.221 -177.283 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 30' ' ' CYS . . . . . . . . . . . . . 4.9 t -65.65 -61.64 1.97 Allowed 'General case' 0 N--CA 1.44 -0.969 0 C-N-CA 119.197 -1.001 . . . . 1.0 109.826 -179.344 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 31' ' ' ALA . . . . . 0.809 ' HB3' ' O ' ' A' ' 27' ' ' VAL . . . -63.07 -49.47 74.4 Favored 'General case' 0 C--N 1.322 -0.621 0 C-N-CA 119.968 -0.693 . . . . 1.0 110.714 -177.244 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 32' ' ' GLY . . . . . 0.53 ' O ' ' HB2' ' A' ' 33' ' ' LEU . . . 58.44 60.02 9.71 Favored Glycine 0 C--O 1.222 -0.62 0 CA-C-O 118.165 -1.353 . . . . 1.0 111.003 179.644 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 33' ' ' LEU . . . . . 0.664 HD23 HG22 ' A' ' 112' ' ' ILE . 6.3 mp 100.21 140.62 0.02 OUTLIER Pre-proline 0 N--CA 1.484 1.26 0 C-N-CA 125.478 1.511 . . . . 1.0 111.65 179.761 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 31.3 Cg_exo -51.76 -57.76 1.98 Allowed 'Trans proline' 0 N--CA 1.501 1.936 0 C-N-CA 122.17 1.913 . . . . 1.0 113.763 -178.505 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 35' ' ' GLY . . . . . 0.464 ' O ' ' C ' ' A' ' 36' ' ' VAL . . . -65.85 -59.65 7.34 Favored Glycine 0 C--N 1.338 0.678 0 C-N-CA 117.944 -2.074 . . . . 1.0 109.223 -178.404 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 36' ' ' VAL . . . . . 0.976 ' O ' HG22 ' A' ' 37' ' ' ILE . 70.4 t -38.94 139.36 0.23 Allowed 'Isoleucine or valine' 0 C--O 1.215 -0.73 0 N-CA-C 107.398 -1.334 . . . . 1.0 107.398 178.658 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 37' ' ' ILE . . . . . 0.976 HG22 ' O ' ' A' ' 36' ' ' VAL . 2.3 tp 71.96 73.3 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.476 0.831 0 CA-C-O 122.266 1.031 . . . . 1.0 110.15 -177.201 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 25.1 p-80 -139.42 136.04 34.25 Favored 'General case' 0 C--N 1.322 -0.592 0 O-C-N 120.514 -1.366 . . . . 1.0 109.489 179.988 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -113.77 140.0 24.16 Favored Pre-proline 0 CA--C 1.533 0.32 0 N-CA-C 109.251 -0.648 . . . . 1.0 109.251 179.528 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 59.8 Cg_endo -71.28 -7.36 21.17 Favored 'Trans proline' 0 C--N 1.311 -1.41 0 C-N-CA 122.058 1.838 . . . . 1.0 112.187 -179.38 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -112.78 91.91 3.82 Favored 'General case' 0 CA--C 1.507 -0.691 0 C-N-CA 120.591 -0.444 . . . . 1.0 111.13 -178.078 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 42' ' ' ARG . . . . . 0.656 ' C ' ' H ' ' A' ' 44' ' ' GLY . 0.6 OUTLIER -123.58 140.3 53.14 Favored 'General case' 0 CA--C 1.537 0.453 0 CA-C-O 121.744 0.783 . . . . 1.0 111.576 -178.361 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 43' ' ' ARG . . . . . 0.686 ' C ' ' H ' ' A' ' 45' ' ' PHE . 1.5 tpp180 -59.31 37.74 0.01 OUTLIER 'General case' 0 CA--C 1.562 1.415 0 CA-C-N 112.976 -1.92 . . . . 1.0 108.303 -179.714 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 44' ' ' GLY . . . . . 0.656 ' H ' ' C ' ' A' ' 42' ' ' ARG . . . 67.8 -30.13 0.23 Allowed Glycine 0 C--N 1.338 0.656 0 N-CA-C 109.605 -1.398 . . . . 1.0 109.605 -179.11 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 45' ' ' PHE . . . . . 0.686 ' H ' ' C ' ' A' ' 43' ' ' ARG . 0.2 OUTLIER -170.39 175.28 4.87 Favored 'General case' 0 N--CA 1.443 -0.821 0 CA-C-N 114.749 -0.725 . . . . 1.0 109.126 179.379 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 46' ' ' PHE . . . . . 0.549 ' HB2' ' O ' ' A' ' 45' ' ' PHE . 8.6 m-85 114.84 110.56 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.668 0 C-N-CA 126.868 2.067 . . . . 1.0 108.432 -179.272 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 47' ' ' ARG . . . . . 0.512 ' HB2' ' O ' ' A' ' 46' ' ' PHE . 3.6 mmp_? 100.11 153.36 0.01 OUTLIER 'General case' 0 N--CA 1.469 0.516 0 O-C-N 124.94 1.4 . . . . 1.0 111.266 179.62 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 48' ' ' CYS . . . . . 0.616 ' O ' ' H62' ' A' ' 129' ' ' MTN . 0.5 OUTLIER 66.44 70.51 0.41 Allowed 'General case' 0 N--CA 1.449 -0.48 0 CA-C-N 114.778 -1.101 . . . . 1.0 109.315 179.825 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 49' ' ' ASN . . . . . 0.5 ' O ' ' N ' ' A' ' 51' ' ' GLU . 0.7 OUTLIER -136.45 160.73 65.66 Favored Pre-proline 0 N--CA 1.466 0.367 0 CA-C-N 116.455 -0.339 . . . . 1.0 110.473 -179.175 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 25.1 Cg_endo -60.54 58.74 0.09 OUTLIER 'Trans proline' 0 N--CA 1.499 1.798 0 C-N-CA 123.265 2.643 . . . . 1.0 111.886 179.054 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 51' ' ' GLU . . . . . 0.5 ' N ' ' O ' ' A' ' 49' ' ' ASN . 2.9 tt0 45.33 29.85 0.62 Allowed 'General case' 0 CA--C 1.536 0.407 0 CA-C-O 121.121 0.486 . . . . 1.0 110.442 179.13 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 52' ' ' ARG . . . . . 0.632 ' NH2' ' CE1' ' A' ' 92' ' ' HIS . 49.5 mtt180 -124.59 151.84 44.3 Favored 'General case' 0 N--CA 1.472 0.637 0 CA-C-O 121.541 0.686 . . . . 1.0 110.978 179.527 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 7.2 tp -55.87 139.99 14.46 Favored 'Isoleucine or valine' 0 CA--C 1.555 1.141 0 CA-C-O 123.935 1.826 . . . . 1.0 115.217 -177.407 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 54' ' ' GLN . . . . . 0.431 ' H ' ' CD ' ' A' ' 54' ' ' GLN . 0.2 OUTLIER -86.53 86.11 7.33 Favored 'General case' 0 C--N 1.316 -0.864 0 CA-C-N 110.229 -3.168 . . . . 1.0 112.258 179.833 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 19.6 tt -143.92 151.0 16.55 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.032 0 N-CA-C 109.522 -0.548 . . . . 1.0 109.522 177.578 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 102.13 1.3 51.37 Favored Glycine 0 C--N 1.343 0.964 0 N-CA-C 110.753 -0.939 . . . . 1.0 110.753 179.837 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 1.3 p30 -89.71 113.28 24.76 Favored 'General case' 0 CA--C 1.54 0.566 0 CA-C-O 122.294 1.045 . . . . 1.0 113.226 -177.881 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 58' ' ' TRP . . . . . . . . . . . . . 36.4 m0 -81.74 -177.27 6.49 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 113.952 -1.476 . . . . 1.0 108.287 177.696 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 59' ' ' ARG . . . . . 0.649 ' HD2' ' H ' ' A' ' 59' ' ' ARG . 0.0 OUTLIER -97.3 -53.58 3.43 Favored 'General case' 0 CA--C 1.556 1.196 0 CA-C-N 119.18 0.9 . . . . 1.0 110.642 179.717 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 60' ' ' TYR . . . . . 0.485 ' O ' ' CG ' ' A' ' 60' ' ' TYR . 77.0 t80 -77.47 -6.0 51.92 Favored 'General case' 0 N--CA 1.483 1.207 0 C-N-CA 125.778 1.631 . . . . 1.0 111.833 -179.367 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -70.1 -16.7 63.16 Favored 'General case' 0 C--N 1.307 -1.244 0 CA-C-O 121.575 0.703 . . . . 1.0 109.453 179.181 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 62' ' ' VAL . . . . . 0.489 ' O ' ' N ' ' A' ' 66' ' ' GLY . 6.1 m -45.81 -52.37 2.8 Favored 'Isoleucine or valine' 0 CA--C 1.5 -0.961 0 C-N-CA 120.067 -0.653 . . . . 1.0 110.512 -174.774 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 63' ' ' ALA . . . . . 0.435 ' O ' ' HG2' ' A' ' 67' ' ' ARG . . . -65.2 -47.75 75.82 Favored 'General case' 0 N--CA 1.424 -1.768 0 N-CA-C 109.447 -0.575 . . . . 1.0 109.447 179.414 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 64' ' ' HIS . . . . . 0.407 ' O ' ' CG ' ' A' ' 67' ' ' ARG . 0.1 OUTLIER -54.71 -59.46 4.68 Favored 'General case' 0 CA--C 1.549 0.907 0 CA-C-N 115.474 -0.785 . . . . 1.0 110.54 179.837 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 65' ' ' ASP . . . . . 0.642 ' C ' ' H ' ' A' ' 67' ' ' ARG . 13.4 m-20 -67.72 -50.0 59.7 Favored 'General case' 0 C--O 1.243 0.751 0 N-CA-C 108.322 -0.992 . . . . 1.0 108.322 178.36 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 66' ' ' GLY . . . . . 0.489 ' N ' ' O ' ' A' ' 62' ' ' VAL . . . -63.23 30.24 0.08 OUTLIER Glycine 0 C--N 1.336 0.533 0 O-C-N 121.873 -0.517 . . . . 1.0 112.097 179.013 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 67' ' ' ARG . . . . . 0.793 ' HB3' ' HB3' ' A' ' 71' ' ' ALA . 14.9 mmt180 -78.96 -3.0 42.76 Favored 'General case' 0 C--N 1.308 -1.219 0 N-CA-C 108.322 -0.992 . . . . 1.0 108.322 175.927 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 68' ' ' LEU . . . . . 0.6 HD23 ' N ' ' A' ' 68' ' ' LEU . 1.8 pt? -36.11 -29.95 0.02 OUTLIER 'General case' 0 N--CA 1.477 0.921 0 N-CA-C 108.57 -0.9 . . . . 1.0 108.57 -176.948 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 69' ' ' LEU . . . . . 0.558 ' N ' ' O ' ' A' ' 67' ' ' ARG . 0.5 OUTLIER -71.91 -69.52 0.39 Allowed 'General case' 0 CA--C 1.538 0.5 0 CA-C-N 115.15 -0.932 . . . . 1.0 111.206 -178.583 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 70' ' ' ALA . . . . . 0.6 ' C ' ' H ' ' A' ' 72' ' ' HIS . . . -76.53 -78.16 0.13 Allowed 'General case' 0 N--CA 1.463 0.221 0 C-N-CA 119.201 -1.0 . . . . 1.0 109.2 -179.458 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 71' ' ' ALA . . . . . 0.793 ' HB3' ' HB3' ' A' ' 67' ' ' ARG . . . -58.84 13.05 0.01 OUTLIER 'General case' 0 C--N 1.321 -0.643 0 C-N-CA 124.444 1.098 . . . . 1.0 113.159 -179.019 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 72' ' ' HIS . . . . . 0.68 ' CD2' ' OG1' ' A' ' 123' ' ' THR . 0.0 OUTLIER -18.1 -60.05 0.02 OUTLIER 'General case' 0 CA--C 1.534 0.353 0 N-CA-C 113.32 0.859 . . . . 1.0 113.32 -177.429 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 73' ' ' MET . . . . . 0.649 ' N ' ' CG ' ' A' ' 72' ' ' HIS . 0.0 OUTLIER -64.82 -53.96 38.59 Favored 'General case' 0 C--N 1.317 -0.81 0 C-N-CA 119.831 -0.748 . . . . 1.0 111.341 -177.842 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 74' ' ' VAL . . . . . 0.635 ' O ' ' N ' ' A' ' 76' ' ' GLY . 0.8 OUTLIER -44.31 -46.31 2.36 Favored 'Isoleucine or valine' 0 C--O 1.215 -0.75 0 CA-C-O 117.989 -1.005 . . . . 1.0 111.219 -174.566 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 75' ' ' ASN . . . . . 0.48 ' C ' ' N ' ' A' ' 77' ' ' ILE . 2.3 t30 -37.66 -21.47 0.01 OUTLIER 'General case' 0 N--CA 1.482 1.16 0 CA-C-O 122.972 1.368 . . . . 1.0 110.026 178.3 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 76' ' ' GLY . . . . . 0.635 ' N ' ' O ' ' A' ' 74' ' ' VAL . . . -49.49 -20.41 2.51 Favored Glycine 0 C--O 1.21 -1.361 0 N-CA-C 107.666 -2.174 . . . . 1.0 107.666 175.235 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 77' ' ' ILE . . . . . 0.538 ' N ' ' O ' ' A' ' 74' ' ' VAL . 7.9 pt -56.84 -46.93 83.65 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.454 0 CA-C-N 115.301 -0.45 . . . . 1.0 111.75 -177.556 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 57.9 t -44.14 -17.99 0.06 OUTLIER 'Isoleucine or valine' 0 CA--C 1.51 -0.562 0 CA-C-N 118.775 0.716 . . . . 1.0 112.39 179.805 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 79' ' ' ILE . . . . . 0.496 ' N ' ' O ' ' A' ' 77' ' ' ILE . 0.6 OUTLIER -91.33 -40.17 12.28 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.759 0 C-N-CA 119.593 -0.843 . . . . 1.0 112.506 179.555 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 80' ' ' ALA . . . . . 0.416 ' N ' ' CG1' ' A' ' 79' ' ' ILE . . . -82.01 -24.41 35.41 Favored 'General case' 0 C--N 1.328 -0.344 0 N-CA-C 114.279 1.215 . . . . 1.0 114.279 -178.241 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 81' ' ' GLU . . . . . 0.613 ' O ' HD12 ' A' ' 84' ' ' LEU . 0.0 OUTLIER -92.24 -74.45 0.51 Allowed 'General case' 0 N--CA 1.469 0.515 0 N-CA-C 113.998 1.11 . . . . 1.0 113.998 -177.591 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 82' ' ' ASP . . . . . 0.716 ' O ' HG22 ' A' ' 85' ' ' ILE . 9.3 m-20 -92.17 -22.2 19.97 Favored 'General case' 0 C--O 1.217 -0.627 0 N-CA-C 115.291 1.589 . . . . 1.0 115.291 -177.993 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 83' ' ' ALA . . . . . 0.582 ' O ' ' N ' ' A' ' 85' ' ' ILE . . . -58.68 -40.77 84.53 Favored 'General case' 0 N--CA 1.461 0.108 0 C-N-CA 118.405 -1.318 . . . . 1.0 112.101 -176.005 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 84' ' ' LEU . . . . . 0.715 ' C ' HD22 ' A' ' 84' ' ' LEU . 0.0 OUTLIER -41.45 -14.81 0.01 OUTLIER 'General case' 0 CA--C 1.536 0.406 0 N-CA-C 112.742 0.645 . . . . 1.0 112.742 -178.488 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 85' ' ' ILE . . . . . 0.716 HG22 ' O ' ' A' ' 82' ' ' ASP . 3.5 tt -90.07 -43.95 14.79 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.408 0 N-CA-C 112.029 0.381 . . . . 1.0 112.029 179.87 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 86' ' ' ALA . . . . . 0.483 ' N ' HG23 ' A' ' 85' ' ' ILE . . . -94.2 -23.48 17.88 Favored 'General case' 0 CA--C 1.527 0.082 0 CA-C-O 120.681 0.277 . . . . 1.0 111.337 -178.826 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 87' ' ' GLU . . . . . 0.581 ' OE1' ' N ' ' A' ' 88' ' ' ALA . 0.0 OUTLIER -83.72 -26.97 29.29 Favored 'General case' 0 C--N 1.332 -0.187 0 N-CA-C 109.277 -0.638 . . . . 1.0 109.277 179.813 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 88' ' ' ALA . . . . . 0.581 ' N ' ' OE1' ' A' ' 87' ' ' GLU . . . -62.95 13.44 0.02 OUTLIER 'General case' 0 N--CA 1.445 -0.717 0 CA-C-N 115.669 -0.696 . . . . 1.0 110.717 -179.689 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 89' ' ' VAL . . . . . 0.588 ' O ' ' N ' ' A' ' 92' ' ' HIS . 33.5 t -84.89 45.2 0.06 OUTLIER 'Isoleucine or valine' 0 C--O 1.218 -0.558 0 CA-C-N 118.385 0.539 . . . . 1.0 110.996 -179.942 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 90' ' ' GLY . . . . . 0.724 ' O ' ' N ' ' A' ' 92' ' ' HIS . . . -30.08 -42.22 0.05 OUTLIER Glycine 0 CA--C 1.539 1.553 0 CA-C-O 117.575 -1.68 . . . . 1.0 111.149 -174.782 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 91' ' ' PRO . . . . . 0.502 ' C ' ' N ' ' A' ' 93' ' ' LEU . 95.3 Cg_exo -43.11 -4.0 0.01 OUTLIER 'Trans proline' 0 N--CA 1.499 1.842 0 CA-C-N 121.807 2.804 . . . . 1.0 111.602 170.475 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 92' ' ' HIS . . . . . 0.724 ' N ' ' O ' ' A' ' 90' ' ' GLY . 0.4 OUTLIER -48.47 -15.83 0.09 Allowed 'General case' 0 C--N 1.343 0.308 0 N-CA-C 107.873 -1.158 . . . . 1.0 107.873 -177.308 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 93' ' ' LEU . . . . . 0.625 ' O ' ' N ' ' A' ' 96' ' ' ALA . 7.1 tp -58.49 -50.27 74.36 Favored 'General case' 0 N--CA 1.447 -0.592 0 N-CA-C 106.62 -1.622 . . . . 1.0 106.62 176.183 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 94' ' ' ALA . . . . . 0.447 ' N ' ' O ' ' A' ' 91' ' ' PRO . . . -46.91 -50.43 18.79 Favored 'General case' 0 CA--C 1.518 -0.267 0 N-CA-C 107.685 -1.228 . . . . 1.0 107.685 -178.089 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 95' ' ' ARG . . . . . 0.51 ' HE ' ' HA ' ' A' ' 92' ' ' HIS . 4.5 mtm-85 -61.33 -28.48 69.24 Favored 'General case' 0 N--CA 1.443 -0.78 0 N-CA-C 109.057 -0.72 . . . . 1.0 109.057 176.122 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 96' ' ' ALA . . . . . 0.675 ' O ' ' N ' ' A' ' 100' ' ' ILE . . . -54.34 -52.06 62.76 Favored 'General case' 0 N--CA 1.475 0.822 0 N-CA-C 107.104 -1.443 . . . . 1.0 107.104 -179.946 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 97' ' ' LEU . . . . . 0.555 ' O ' HG22 ' A' ' 100' ' ' ILE . 0.7 OUTLIER -36.57 -26.18 0.01 OUTLIER 'General case' 0 CA--C 1.577 1.992 0 CA-C-N 114.274 -1.33 . . . . 1.0 108.485 -178.04 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 98' ' ' GLY . . . . . 0.572 ' N ' ' O ' ' A' ' 96' ' ' ALA . . . -84.68 -51.09 3.96 Favored Glycine 0 CA--C 1.55 2.279 0 CA-C-O 123.814 1.786 . . . . 1.0 110.749 173.939 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 99' ' ' GLN . . . . . 0.558 ' N ' ' O ' ' A' ' 96' ' ' ALA . 30.2 mm100 -75.84 9.71 2.22 Favored 'General case' 0 N--CA 1.428 -1.543 0 CA-C-N 113.514 -1.343 . . . . 1.0 107.649 177.037 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 100' ' ' ILE . . . . . 0.788 HG23 ' N ' ' A' ' 101' ' ' VAL . 9.7 tt -61.62 -55.8 22.01 Favored 'Isoleucine or valine' 0 CA--C 1.482 -1.651 0 N-CA-C 109.307 -0.627 . . . . 1.0 109.307 179.063 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 101' ' ' VAL . . . . . 0.788 ' N ' HG23 ' A' ' 100' ' ' ILE . 5.8 p -56.68 -59.48 2.96 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.739 0 C-N-CA 117.485 -1.686 . . . . 1.0 107.739 179.789 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 102' ' ' CYS . . . . . 0.949 ' O ' ' HB2' ' A' ' 106' ' ' ALA . 0.5 OUTLIER -44.24 -18.13 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.438 0 C-N-CA 120.5 -0.48 . . . . 1.0 111.448 -177.001 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 103' ' ' ARG . . . . . 0.497 ' NH2' ' HB1' ' A' ' 96' ' ' ALA . 6.1 ttp180 -98.07 -37.42 9.75 Favored 'General case' 0 N--CA 1.474 0.739 0 CA-C-O 121.944 0.878 . . . . 1.0 112.859 178.127 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 104' ' ' TYR . . . . . 0.637 ' O ' ' CG ' ' A' ' 104' ' ' TYR . 51.5 t80 -101.84 21.69 14.17 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-N 113.785 -1.552 . . . . 1.0 110.552 179.206 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 105' ' ' GLY . . . . . 0.769 ' O ' ' N ' ' A' ' 107' ' ' THR . . . -171.36 -12.26 0.02 OUTLIER Glycine 0 C--O 1.22 -0.741 0 C-N-CA 119.145 -1.503 . . . . 1.0 112.286 179.516 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 106' ' ' ALA . . . . . 0.949 ' HB2' ' O ' ' A' ' 102' ' ' CYS . . . -16.53 67.38 0.0 OUTLIER 'General case' 0 N--CA 1.476 0.874 0 O-C-N 124.432 0.725 . . . . 1.0 111.989 -179.8 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 107' ' ' THR . . . . . 0.769 ' N ' ' O ' ' A' ' 105' ' ' GLY . 9.9 t -117.78 -7.01 11.03 Favored 'General case' 0 CA--C 1.516 -0.33 0 N-CA-C 109.448 -0.575 . . . . 1.0 109.448 -179.621 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 11.5 m -87.14 17.7 0.57 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.452 0 N-CA-C 109.546 -0.538 . . . . 1.0 109.546 179.76 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 109' ' ' ILE . . . . . 0.723 ' N ' ' HD2' ' A' ' 110' ' ' PRO . 48.5 pt -113.71 -19.02 0.11 Allowed Pre-proline 0 CA--C 1.576 1.953 0 N-CA-C 113.773 1.027 . . . . 1.0 113.773 177.58 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 110' ' ' PRO . . . . . 0.723 ' HD2' ' N ' ' A' ' 109' ' ' ILE . 14.2 Cg_endo -53.73 -38.64 85.03 Favored 'Trans proline' 0 N--CA 1.497 1.703 0 C-N-CA 123.736 2.957 . . . . 1.0 113.991 -172.684 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 23.7 t30 -63.24 -67.95 0.38 Allowed 'General case' 0 N--CA 1.441 -0.881 0 C-N-CA 118.526 -1.27 . . . . 1.0 109.278 -179.268 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 112' ' ' ILE . . . . . 0.664 HG22 HD23 ' A' ' 33' ' ' LEU . 0.1 OUTLIER -63.35 -29.54 47.5 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.387 0 CA-C-O 121.416 0.627 . . . . 1.0 110.016 -178.261 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 113' ' ' ASN . . . . . 0.651 ' ND2' ' OE2' ' A' ' 117' ' ' GLU . 7.2 t-20 -58.76 -64.02 1.08 Allowed 'General case' 0 C--N 1.309 -1.169 0 C-N-CA 118.874 -1.13 . . . . 1.0 110.044 -175.882 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -62.65 -25.74 68.28 Favored 'General case' 0 C--N 1.319 -0.73 0 C-N-CA 119.936 -0.706 . . . . 1.0 111.986 -179.708 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -77.39 -59.33 2.82 Favored 'General case' 0 C--O 1.232 0.173 0 C-N-CA 119.463 -0.895 . . . . 1.0 110.459 179.176 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 116' ' ' ILE . . . . . 0.417 ' O ' ' N ' ' A' ' 119' ' ' LEU . 50.4 mt -63.58 -48.34 87.29 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.398 0 C-N-CA 119.954 -0.698 . . . . 1.0 109.604 -179.379 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 117' ' ' GLU . . . . . 0.651 ' OE2' ' ND2' ' A' ' 113' ' ' ASN . 93.4 mt-10 -46.94 -67.0 0.32 Allowed 'General case' 0 CA--C 1.503 -0.865 0 C-N-CA 119.835 -0.746 . . . . 1.0 109.195 -178.245 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 39.5 t -48.48 -22.53 0.68 Allowed 'Isoleucine or valine' 0 N--CA 1.44 -0.936 0 C-N-CA 120.114 -0.634 . . . . 1.0 109.971 179.744 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 119' ' ' LEU . . . . . 0.417 ' N ' ' O ' ' A' ' 116' ' ' ILE . 0.4 OUTLIER -78.45 -60.03 2.54 Favored 'General case' 0 C--N 1.346 0.431 0 N-CA-C 107.736 -1.209 . . . . 1.0 107.736 178.721 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 120' ' ' GLY . . . . . 0.561 ' C ' HG22 ' A' ' 121' ' ' THR . . . -62.28 -81.43 0.09 OUTLIER Glycine 0 C--N 1.354 1.537 0 C-N-CA 117.907 -2.092 . . . . 1.0 108.292 176.51 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 121' ' ' THR . . . . . 0.722 HG23 ' H ' ' A' ' 123' ' ' THR . 1.4 t 151.08 -16.12 0.0 OUTLIER 'General case' 0 N--CA 1.486 1.37 0 O-C-N 125.322 1.248 . . . . 1.0 113.505 178.28 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 122' ' ' GLY . . . . . 0.657 ' O ' ' N ' ' A' ' 124' ' ' ASP . . . 109.74 -13.18 32.44 Favored Glycine 0 N--CA 1.47 0.919 0 N-CA-C 108.521 -1.831 . . . . 1.0 108.521 -176.195 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 123' ' ' THR . . . . . 0.746 HG23 ' O ' ' A' ' 123' ' ' THR . 15.1 t -58.58 80.0 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.202 0 N-CA-C 106.755 -1.572 . . . . 1.0 106.755 178.735 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 124' ' ' ASP . . . . . 0.657 ' N ' ' O ' ' A' ' 122' ' ' GLY . 14.9 t70 -164.62 169.09 17.43 Favored 'General case' 0 N--CA 1.444 -0.76 0 CA-C-N 113.719 -1.582 . . . . 1.0 112.107 -179.631 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 125' ' ' TYR . . . . . 0.551 ' C ' ' CD1' ' A' ' 125' ' ' TYR . 0.0 OUTLIER -146.68 145.47 30.02 Favored 'General case' 0 CA--C 1.54 0.584 0 N-CA-C 108.889 -0.782 . . . . 1.0 108.889 177.393 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -148.84 149.06 30.65 Favored 'General case' 0 CA--C 1.536 0.418 0 N-CA-C 110.166 -0.309 . . . . 1.0 110.166 178.266 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 127' ' ' PHE . . . . . . . . . . . . . 27.2 p90 . . . . . 0 N--CA 1.471 0.595 0 CA-C-O 117.864 -1.065 . . . . 1.0 110.249 179.08 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 128' ' ' MTN . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 129' ' ' MTN . . . . . 0.616 ' H62' ' O ' ' A' ' 48' ' ' CYS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 130' ' ' MTN . . . . . 0.597 ' S1 ' ' H71' ' A' ' 130' ' ' MTN . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 39.0 mtt . . . . . 0 N--CA 1.489 1.475 0 N-CA-C 108.704 -0.851 . . . . 1.0 108.704 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 78.3 p -109.16 -3.79 17.03 Favored 'General case' 0 N--CA 1.466 0.334 0 CA-C-N 116.336 -0.393 . . . . 1.0 110.575 178.912 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 3' ' ' ASP . . . . . 0.44 ' OD1' ' N ' ' A' ' 3' ' ' ASP . 7.8 p-10 -174.66 91.96 0.07 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.28 -0.418 . . . . 1.0 111.785 -179.72 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 52.2 t80 -150.2 144.31 25.56 Favored 'General case' 0 C--N 1.328 -0.335 0 N-CA-C 109.367 -0.605 . . . . 1.0 109.367 179.162 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 5' ' ' ASP . . . . . 0.834 ' OD1' ' N ' ' A' ' 10' ' ' SER . 31.8 t0 -150.66 146.82 26.73 Favored 'General case' 0 C--N 1.328 -0.337 0 N-CA-C 110.082 -0.34 . . . . 1.0 110.082 -179.29 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 6' ' ' THR . . . . . 0.663 ' N ' ' OD1' ' A' ' 5' ' ' ASP . 0.2 OUTLIER -100.79 -178.1 3.67 Favored 'General case' 0 C--O 1.199 -1.599 0 CA-C-O 121.103 0.478 . . . . 1.0 110.782 179.904 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 7' ' ' GLU . . . . . 0.553 ' O ' ' HB3' ' A' ' 11' ' ' ARG . 29.0 tt0 -55.04 -41.23 71.15 Favored 'General case' 0 C--N 1.303 -1.442 0 CA-C-N 116.477 -0.329 . . . . 1.0 111.488 179.181 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 8' ' ' ARG . . . . . 0.713 ' O ' ' HB3' ' A' ' 12' ' ' ALA . 31.3 mtp180 -69.02 -63.98 0.96 Allowed 'General case' 0 C--N 1.313 -0.996 0 CA-C-O 123.086 1.422 . . . . 1.0 110.249 178.886 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 9' ' ' VAL . . . . . 0.643 ' O ' ' HB ' ' A' ' 13' ' ' VAL . 12.2 t -57.63 -43.67 83.91 Favored 'Isoleucine or valine' 0 C--N 1.282 -2.358 0 CA-C-N 114.464 -1.244 . . . . 1.0 109.188 178.304 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 10' ' ' SER . . . . . 0.834 ' N ' ' OD1' ' A' ' 5' ' ' ASP . 14.9 t -68.6 -65.92 0.64 Allowed 'General case' 0 C--N 1.305 -1.337 0 O-C-N 121.256 -0.902 . . . . 1.0 111.282 -179.02 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 11' ' ' ARG . . . . . 0.553 ' HB3' ' O ' ' A' ' 7' ' ' GLU . 23.1 tpp180 -60.94 -42.41 98.13 Favored 'General case' 0 C--N 1.314 -0.973 0 CA-C-N 116.278 -0.419 . . . . 1.0 110.566 -177.562 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 12' ' ' ALA . . . . . 0.713 ' HB3' ' O ' ' A' ' 8' ' ' ARG . . . -69.56 -61.04 1.95 Allowed 'General case' 0 C--N 1.319 -0.752 0 C-N-CA 119.106 -1.038 . . . . 1.0 111.169 -179.602 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 13' ' ' VAL . . . . . 0.798 ' O ' ' CB ' ' A' ' 17' ' ' LEU . 0.3 OUTLIER -56.8 -45.9 83.21 Favored 'Isoleucine or valine' 0 C--O 1.187 -2.228 0 N-CA-C 106.602 -1.629 . . . . 1.0 106.602 179.921 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 14' ' ' ALA . . . . . 0.965 ' O ' HG22 ' A' ' 18' ' ' VAL . . . -66.47 -65.51 0.67 Allowed 'General case' 0 C--N 1.307 -1.263 0 C-N-CA 117.094 -1.842 . . . . 1.0 112.731 -178.745 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 15' ' ' ALA . . . . . 0.524 ' O ' ' N ' ' A' ' 19' ' ' GLY . . . -50.16 -53.45 27.6 Favored 'General case' 0 C--N 1.32 -0.708 0 N-CA-C 108.088 -1.079 . . . . 1.0 108.088 179.897 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 16' ' ' ALA . . . . . 0.607 ' HB3' ' O ' ' A' ' 12' ' ' ALA . . . -66.34 -59.95 3.23 Favored 'General case' 0 C--N 1.298 -1.667 0 C-N-CA 118.27 -1.372 . . . . 1.0 111.41 179.512 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 17' ' ' LEU . . . . . 0.798 ' CB ' ' O ' ' A' ' 13' ' ' VAL . 7.7 tt -55.01 -55.55 29.66 Favored 'General case' 0 N--CA 1.481 1.114 0 CA-C-N 114.777 -1.101 . . . . 1.0 108.625 -176.884 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 18' ' ' VAL . . . . . 0.965 HG22 ' O ' ' A' ' 14' ' ' ALA . 2.0 m -71.12 -59.36 3.52 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.658 0 CA-C-N 116.146 -0.479 . . . . 1.0 110.692 179.603 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 19' ' ' GLY . . . . . 0.592 ' N ' ' CG2' ' A' ' 18' ' ' VAL . . . -55.48 -171.69 0.1 OUTLIER Glycine 0 CA--C 1.486 -1.741 0 N-CA-C 109.593 -1.403 . . . . 1.0 109.593 -176.986 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 20' ' ' PRO . . . . . 0.613 ' O ' ' N ' ' A' ' 24' ' ' ALA . 81.1 Cg_endo -81.69 -26.88 2.89 Favored 'Trans proline' 0 C--N 1.286 -2.758 0 C-N-CA 122.025 1.817 . . . . 1.0 113.894 -177.555 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 21' ' ' GLY . . . . . 0.583 ' O ' ' HB3' ' A' ' 24' ' ' ALA . . . -59.81 -59.05 11.2 Favored Glycine 0 N--CA 1.473 1.159 0 O-C-N 124.156 0.91 . . . . 1.0 111.357 -178.903 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -55.79 -56.99 21.03 Favored Glycine 0 CA--C 1.5 -0.848 0 C-N-CA 117.083 -2.484 . . . . 1.0 107.577 -177.823 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 23' ' ' VAL . . . . . 0.543 ' O ' HG12 ' A' ' 27' ' ' VAL . 93.2 t -53.94 -29.59 18.57 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.145 0 CA-C-N 113.97 -1.115 . . . . 1.0 108.201 178.573 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 24' ' ' ALA . . . . . 0.613 ' N ' ' O ' ' A' ' 20' ' ' PRO . . . -63.63 -65.53 0.67 Allowed 'General case' 0 C--O 1.213 -0.825 0 C-N-CA 119.503 -0.879 . . . . 1.0 111.291 -178.939 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 25' ' ' LEU . . . . . 0.557 ' O ' HD12 ' A' ' 25' ' ' LEU . 0.4 OUTLIER -58.35 -48.68 79.81 Favored 'General case' 0 C--N 1.311 -1.092 0 C-N-CA 119.632 -0.827 . . . . 1.0 111.131 -179.139 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 26' ' ' VAL . . . . . 0.426 ' N ' ' HG ' ' A' ' 25' ' ' LEU . 81.5 t -58.26 -61.42 1.37 Allowed 'Isoleucine or valine' 0 CA--C 1.503 -0.849 0 C-N-CA 119.517 -0.873 . . . . 1.0 110.471 -174.404 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 27' ' ' VAL . . . . . 0.643 ' O ' ' HB3' ' A' ' 31' ' ' ALA . 2.0 p -56.35 -36.59 47.25 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.97 0 C-N-CA 120.081 -0.648 . . . . 1.0 109.632 -178.969 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 20.1 mtpp -68.13 -59.3 3.34 Favored 'General case' 0 C--N 1.318 -0.775 0 C-N-CA 119.452 -0.899 . . . . 1.0 111.932 -176.84 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 2.9 t -62.24 -50.22 80.85 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.379 0 CA-C-N 114.504 -1.225 . . . . 1.0 110.191 -177.688 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 30' ' ' CYS . . . . . . . . . . . . . 21.2 t -64.32 -62.36 1.65 Allowed 'General case' 0 N--CA 1.442 -0.857 0 C-N-CA 119.214 -0.994 . . . . 1.0 110.484 -177.598 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 31' ' ' ALA . . . . . 0.643 ' HB3' ' O ' ' A' ' 27' ' ' VAL . . . -56.46 -48.19 77.59 Favored 'General case' 0 CA--C 1.502 -0.878 0 CA-C-O 121.536 0.684 . . . . 1.0 110.076 -176.879 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 32' ' ' GLY . . . . . 0.64 ' O ' ' HB2' ' A' ' 33' ' ' LEU . . . 76.78 68.37 1.54 Allowed Glycine 0 CA--C 1.496 -1.114 0 N-CA-C 109.915 -1.274 . . . . 1.0 109.915 -179.657 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 33' ' ' LEU . . . . . 0.64 ' HB2' ' O ' ' A' ' 32' ' ' GLY . 5.2 mt 86.04 123.29 0.03 OUTLIER Pre-proline 0 CA--C 1.544 0.742 0 O-C-N 124.965 1.038 . . . . 1.0 110.402 -179.159 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 34' ' ' PRO . . . . . 0.541 ' HD2' HD23 ' A' ' 33' ' ' LEU . 49.2 Cg_endo -69.22 -17.94 39.78 Favored 'Trans proline' 0 N--CA 1.493 1.456 0 C-N-CA 122.131 1.887 . . . . 1.0 112.903 -178.324 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 35' ' ' GLY . . . . . 0.439 ' C ' HG21 ' A' ' 112' ' ' ILE . . . -62.95 -63.62 4.45 Favored Glycine 0 CA--C 1.527 0.806 0 C-N-CA 118.497 -1.811 . . . . 1.0 111.187 -178.093 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 36' ' ' VAL . . . . . 0.881 HG22 ' H ' ' A' ' 37' ' ' ILE . 5.1 p -77.5 -152.73 0.02 OUTLIER 'Isoleucine or valine' 0 CA--C 1.491 -1.304 0 N-CA-C 107.334 -1.358 . . . . 1.0 107.334 -179.641 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 37' ' ' ILE . . . . . 0.881 ' H ' HG22 ' A' ' 36' ' ' VAL . 0.3 OUTLIER 75.62 76.69 0.04 OUTLIER 'Isoleucine or valine' 0 C--O 1.218 -0.574 0 O-C-N 125.132 1.52 . . . . 1.0 111.534 178.069 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 38' ' ' HIS . . . . . 0.564 ' ND1' ' O ' ' A' ' 37' ' ' ILE . 1.8 m80 -137.64 133.93 34.9 Favored 'General case' 0 CA--C 1.487 -1.453 0 O-C-N 119.304 -2.122 . . . . 1.0 107.594 179.781 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 39' ' ' THR . . . . . 0.563 ' OG1' ' O ' ' A' ' 41' ' ' ALA . 0.5 OUTLIER -107.99 122.78 39.67 Favored Pre-proline 0 CA--C 1.54 0.568 0 O-C-N 123.74 0.65 . . . . 1.0 110.549 -178.963 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 32.6 Cg_exo -61.83 -23.57 76.22 Favored 'Trans proline' 0 N--CA 1.495 1.57 0 C-N-CA 122.483 2.122 . . . . 1.0 112.378 178.046 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 41' ' ' ALA . . . . . 0.563 ' O ' ' OG1' ' A' ' 39' ' ' THR . . . -128.14 132.62 48.92 Favored 'General case' 0 N--CA 1.475 0.783 0 C-N-CA 122.394 0.278 . . . . 1.0 110.421 178.301 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 42' ' ' ARG . . . . . 0.435 ' CD ' ' O ' ' A' ' 39' ' ' THR . 0.0 OUTLIER -177.56 -177.59 0.68 Allowed 'General case' 0 N--CA 1.465 0.278 0 CA-C-N 117.962 0.346 . . . . 1.0 110.893 179.721 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 77.1 ttt180 -57.16 -46.1 83.04 Favored 'General case' 0 CA--C 1.536 0.427 0 N-CA-C 107.911 -1.144 . . . . 1.0 107.911 177.873 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 44' ' ' GLY . . . . . 0.516 ' C ' ' CG ' ' A' ' 45' ' ' PHE . . . 118.09 -25.57 8.27 Favored Glycine 0 N--CA 1.474 1.184 0 CA-C-O 120.067 -0.296 . . . . 1.0 112.642 178.912 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 45' ' ' PHE . . . . . 0.71 ' O ' ' HB2' ' A' ' 46' ' ' PHE . 0.1 OUTLIER -159.19 166.42 31.47 Favored 'General case' 0 CA--C 1.486 -1.496 0 N-CA-C 106.966 -1.494 . . . . 1.0 106.966 -179.258 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 46' ' ' PHE . . . . . 0.71 ' HB2' ' O ' ' A' ' 45' ' ' PHE . 31.2 m-85 104.1 116.95 0.01 OUTLIER 'General case' 0 N--CA 1.487 1.379 0 O-C-N 126.134 2.147 . . . . 1.0 110.589 179.815 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 47' ' ' ARG . . . . . 0.635 ' HE ' ' C9 ' ' A' ' 128' ' ' MTN . 0.0 OUTLIER 87.29 161.36 0.08 Allowed 'General case' 0 C--N 1.348 0.531 0 O-C-N 124.487 1.117 . . . . 1.0 110.499 179.366 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 48' ' ' CYS . . . . . 0.449 ' N ' ' HD3' ' A' ' 47' ' ' ARG . 41.2 t 61.67 67.19 0.78 Allowed 'General case' 0 CA--C 1.506 -0.723 0 N-CA-C 109.629 -0.508 . . . . 1.0 109.629 178.379 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 49' ' ' ASN . . . . . 0.769 ' O ' ' N ' ' A' ' 51' ' ' GLU . 10.5 m-80 -150.76 157.66 35.79 Favored Pre-proline 0 C--N 1.319 -0.721 0 CA-C-O 118.333 -0.842 . . . . 1.0 109.323 179.053 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 50' ' ' PRO . . . . . 0.6 ' HB2' ' HE ' ' A' ' 52' ' ' ARG . 50.1 Cg_exo -45.52 54.5 0.01 OUTLIER 'Trans proline' 0 N--CA 1.506 2.259 0 C-N-CA 123.768 2.979 . . . . 1.0 112.724 178.173 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 51' ' ' GLU . . . . . 0.769 ' N ' ' O ' ' A' ' 49' ' ' ASN . 1.6 mt-10 47.48 54.67 9.33 Favored 'General case' 0 C--N 1.33 -0.263 0 C-N-CA 123.357 0.663 . . . . 1.0 111.616 179.332 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 52' ' ' ARG . . . . . 0.6 ' HE ' ' HB2' ' A' ' 50' ' ' PRO . 34.3 mtm105 -152.24 167.2 29.38 Favored 'General case' 0 N--CA 1.469 0.507 0 CA-C-N 116.429 -0.35 . . . . 1.0 110.732 -179.125 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 53' ' ' ILE . . . . . 0.461 HG13 ' H ' ' A' ' 54' ' ' GLN . 2.2 tp -83.5 169.45 1.55 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.342 0 N-CA-C 108.531 -0.915 . . . . 1.0 108.531 178.536 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 54' ' ' GLN . . . . . 0.461 ' H ' HG13 ' A' ' 53' ' ' ILE . 0.0 OUTLIER -135.35 132.18 37.31 Favored 'General case' 0 N--CA 1.466 0.333 0 N-CA-C 109.294 -0.632 . . . . 1.0 109.294 -179.395 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 55' ' ' ILE . . . . . 0.467 ' N ' HD13 ' A' ' 55' ' ' ILE . 0.2 OUTLIER -145.4 154.63 13.62 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 N-CA-C 110.243 -0.28 . . . . 1.0 110.243 179.695 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 100.63 4.62 54.61 Favored Glycine 0 C--N 1.335 0.501 0 N-CA-C 109.975 -1.25 . . . . 1.0 109.975 179.47 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 73.1 m-20 -95.1 116.77 29.15 Favored 'General case' 0 CA--C 1.541 0.627 0 CA-C-O 122.842 1.306 . . . . 1.0 113.095 -179.68 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 58' ' ' TRP . . . . . 0.466 ' H ' ' CD ' ' A' ' 61' ' ' GLU . 17.8 m0 -79.19 179.46 7.37 Favored 'General case' 0 N--CA 1.483 1.206 0 CA-C-N 112.731 -2.031 . . . . 1.0 110.185 178.191 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 59' ' ' ARG . . . . . 0.537 ' HG2' ' H ' ' A' ' 60' ' ' TYR . 0.0 OUTLIER -93.22 -55.9 3.15 Favored 'General case' 0 CA--C 1.544 0.715 0 CA-C-N 118.434 0.561 . . . . 1.0 111.111 178.65 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 60' ' ' TYR . . . . . 0.537 ' H ' ' HG2' ' A' ' 59' ' ' ARG . 34.4 p90 -69.99 0.67 5.58 Favored 'General case' 0 C--O 1.239 0.53 0 C-N-CA 124.171 0.988 . . . . 1.0 108.866 178.676 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 61' ' ' GLU . . . . . 0.548 ' O ' ' N ' ' A' ' 65' ' ' ASP . 1.3 tt0 -61.63 -17.92 57.29 Favored 'General case' 0 C--O 1.21 -1.0 0 CA-C-N 115.348 -0.842 . . . . 1.0 112.447 -178.76 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 62' ' ' VAL . . . . . 0.719 HG23 ' H ' ' A' ' 63' ' ' ALA . 17.4 m -46.61 -56.29 1.36 Allowed 'Isoleucine or valine' 0 C--N 1.304 -1.394 0 N-CA-C 109.299 -0.63 . . . . 1.0 109.299 -174.724 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 63' ' ' ALA . . . . . 0.719 ' H ' HG23 ' A' ' 62' ' ' VAL . . . -60.9 -51.22 70.22 Favored 'General case' 0 N--CA 1.423 -1.796 0 N-CA-C 108.493 -0.928 . . . . 1.0 108.493 178.786 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 64' ' ' HIS . . . . . 0.562 ' HA ' ' HE ' ' A' ' 67' ' ' ARG . 19.1 t-80 -57.61 -60.62 3.4 Favored 'General case' 0 CA--C 1.548 0.903 0 CA-C-O 121.809 0.814 . . . . 1.0 112.356 -179.643 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 65' ' ' ASP . . . . . 0.613 ' C ' ' H ' ' A' ' 67' ' ' ARG . 29.7 t70 -66.83 -53.47 32.33 Favored 'General case' 0 C--N 1.312 -1.051 0 O-C-N 121.264 -0.897 . . . . 1.0 110.246 -179.267 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 66' ' ' GLY . . . . . 0.447 ' N ' ' O ' ' A' ' 62' ' ' VAL . . . -60.96 30.4 0.05 OUTLIER Glycine 0 CA--C 1.527 0.841 0 CA-C-N 115.734 -0.666 . . . . 1.0 112.593 -179.212 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 67' ' ' ARG . . . . . 0.613 ' H ' ' C ' ' A' ' 65' ' ' ASP . 94.8 mtt-85 -82.83 -5.09 58.8 Favored 'General case' 0 C--N 1.321 -0.672 0 O-C-N 122.746 -0.267 . . . . 1.0 111.647 175.697 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 68' ' ' LEU . . . . . 0.711 ' O ' ' HA ' ' A' ' 72' ' ' HIS . 0.2 OUTLIER -38.11 -28.74 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.524 0 CA-C-O 123.33 1.538 . . . . 1.0 107.084 178.907 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 69' ' ' LEU . . . . . 0.656 HD12 ' N ' ' A' ' 70' ' ' ALA . 0.9 OUTLIER -65.89 -64.01 0.96 Allowed 'General case' 0 CA--C 1.552 1.024 0 N-CA-C 105.847 -1.909 . . . . 1.0 105.847 175.716 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 70' ' ' ALA . . . . . 0.738 ' C ' ' H ' ' A' ' 72' ' ' HIS . . . -77.57 -73.36 0.31 Allowed 'General case' 0 C--N 1.364 1.232 0 N-CA-C 107.458 -1.312 . . . . 1.0 107.458 178.712 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 71' ' ' ALA . . . . . 0.757 ' HB1' ' HB ' ' A' ' 74' ' ' VAL . . . -50.17 7.4 0.0 OUTLIER 'General case' 0 C--N 1.351 0.671 0 C-N-CA 124.746 1.218 . . . . 1.0 110.744 177.834 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 72' ' ' HIS . . . . . 0.738 ' H ' ' C ' ' A' ' 70' ' ' ALA . 0.0 OUTLIER -17.56 -65.11 0.02 OUTLIER 'General case' 0 CA--C 1.492 -1.271 0 C-N-CA 123.565 0.746 . . . . 1.0 111.208 -175.852 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 73' ' ' MET . . . . . 0.499 ' N ' ' ND1' ' A' ' 72' ' ' HIS . 0.0 OUTLIER -77.24 -48.57 17.18 Favored 'General case' 0 C--N 1.292 -1.914 0 C-N-CA 120.275 -0.57 . . . . 1.0 110.452 178.264 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 74' ' ' VAL . . . . . 0.757 ' HB ' ' HB1' ' A' ' 71' ' ' ALA . 69.3 t -42.08 -44.45 0.98 Allowed 'Isoleucine or valine' 0 C--O 1.221 -0.405 0 CA-C-O 117.64 -1.172 . . . . 1.0 109.388 -174.7 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 75' ' ' ASN . . . . . 0.406 ' C ' ' N ' ' A' ' 77' ' ' ILE . 27.7 t-20 -36.75 -19.26 0.01 OUTLIER 'General case' 0 CA--C 1.553 1.094 0 CA-C-O 123.327 1.537 . . . . 1.0 110.639 179.342 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 76' ' ' GLY . . . . . 0.692 ' O ' HG12 ' A' ' 79' ' ' ILE . . . -49.05 -20.97 2.22 Favored Glycine 0 CA--C 1.543 1.827 0 N-CA-C 108.657 -1.777 . . . . 1.0 108.657 174.864 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 77' ' ' ILE . . . . . 0.485 HG13 ' H ' ' A' ' 78' ' ' VAL . 4.7 pt -47.4 -50.31 7.99 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.64 0 O-C-N 120.972 -1.31 . . . . 1.0 113.059 -179.02 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 78' ' ' VAL . . . . . 0.485 ' H ' HG13 ' A' ' 77' ' ' ILE . 12.0 p -55.1 -22.1 10.0 Favored 'Isoleucine or valine' 0 CA--C 1.504 -0.791 0 CA-C-O 120.832 0.348 . . . . 1.0 111.11 -178.024 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 79' ' ' ILE . . . . . 0.803 ' O ' ' HB2' ' A' ' 83' ' ' ALA . 0.5 OUTLIER -83.44 -46.01 18.56 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.867 0 C-N-CA 119.871 -0.731 . . . . 1.0 110.873 179.885 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 80' ' ' ALA . . . . . 0.507 ' N ' ' CG1' ' A' ' 79' ' ' ILE . . . -76.99 -21.84 54.08 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 115.633 -0.712 . . . . 1.0 111.007 -178.74 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 81' ' ' GLU . . . . . 0.547 ' OE1' ' N ' ' A' ' 81' ' ' GLU . 0.7 OUTLIER -83.07 -69.24 0.64 Allowed 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.011 -0.54 . . . . 1.0 111.093 -179.569 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 82' ' ' ASP . . . . . 0.636 ' O ' ' N ' ' A' ' 84' ' ' LEU . 88.9 m-20 -60.54 -60.86 3.13 Favored 'General case' 0 CA--C 1.496 -1.104 0 CA-C-O 118.048 -0.977 . . . . 1.0 110.376 -177.622 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 83' ' ' ALA . . . . . 0.803 ' HB2' ' O ' ' A' ' 79' ' ' ILE . . . 0.94 -66.22 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.773 0 O-C-N 125.475 1.735 . . . . 1.0 110.312 -179.793 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 84' ' ' LEU . . . . . 0.636 ' N ' ' O ' ' A' ' 82' ' ' ASP . 4.4 mm? -25.15 -49.87 0.03 OUTLIER 'General case' 0 N--CA 1.473 0.687 0 CA-C-N 115.521 -0.763 . . . . 1.0 109.802 -176.713 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 85' ' ' ILE . . . . . 0.627 HG23 ' N ' ' A' ' 86' ' ' ALA . 13.7 tt -98.29 -51.0 10.76 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.699 0 N-CA-C 109.438 -0.579 . . . . 1.0 109.438 177.014 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 86' ' ' ALA . . . . . 0.952 ' O ' HG13 ' A' ' 89' ' ' VAL . . . -50.39 -46.95 56.47 Favored 'General case' 0 C--O 1.224 -0.267 0 CA-C-N 116.026 -0.533 . . . . 1.0 110.747 -179.184 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 87' ' ' GLU . . . . . 0.568 ' N ' ' O ' ' A' ' 83' ' ' ALA . 22.6 tp10 -47.7 -18.32 0.14 Allowed 'General case' 0 C--N 1.323 -0.577 0 CA-C-O 120.987 0.422 . . . . 1.0 110.328 179.601 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 88' ' ' ALA . . . . . 0.84 ' C ' ' H ' ' A' ' 90' ' ' GLY . . . -74.45 6.11 4.04 Favored 'General case' 0 CA--C 1.491 -1.309 0 CA-C-N 115.745 -0.661 . . . . 1.0 110.818 -179.718 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 89' ' ' VAL . . . . . 0.952 HG13 ' O ' ' A' ' 86' ' ' ALA . 19.3 m -48.63 15.88 0.0 OUTLIER 'Isoleucine or valine' 0 C--O 1.216 -0.685 0 O-C-N 124.529 1.143 . . . . 1.0 111.616 -179.746 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 90' ' ' GLY . . . . . 0.84 ' H ' ' C ' ' A' ' 88' ' ' ALA . . . -33.58 -50.65 0.57 Allowed Glycine 0 C--N 1.351 1.386 0 N-CA-C 108.05 -2.02 . . . . 1.0 108.05 -177.08 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 91' ' ' PRO . . . . . 0.466 ' O ' ' N ' ' A' ' 94' ' ' ALA . 73.0 Cg_exo -48.11 0.35 0.02 OUTLIER 'Trans proline' 0 N--CA 1.495 1.565 0 C-N-CA 122.463 2.109 . . . . 1.0 112.216 173.163 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 92' ' ' HIS . . . . . 0.715 ' N ' ' O ' ' A' ' 89' ' ' VAL . 0.0 OUTLIER -47.57 -37.05 11.55 Favored 'General case' 0 N--CA 1.445 -0.707 0 N-CA-C 107.794 -1.187 . . . . 1.0 107.794 -176.053 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 1.5 pp -61.78 -37.8 85.67 Favored 'General case' 0 N--CA 1.436 -1.145 0 CA-C-O 121.702 0.763 . . . . 1.0 111.107 178.59 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 94' ' ' ALA . . . . . 0.466 ' N ' ' O ' ' A' ' 91' ' ' PRO . . . -62.57 -62.4 1.77 Allowed 'General case' 0 C--N 1.33 -0.26 0 N-CA-C 107.795 -1.187 . . . . 1.0 107.795 179.279 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 63.4 mmt-85 -59.52 -28.84 67.43 Favored 'General case' 0 N--CA 1.438 -1.059 0 N-CA-C 109.237 -0.653 . . . . 1.0 109.237 179.71 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 96' ' ' ALA . . . . . 0.797 ' O ' ' N ' ' A' ' 100' ' ' ILE . . . -59.49 -53.87 53.09 Favored 'General case' 0 CA--C 1.496 -1.13 0 N-CA-C 107.114 -1.439 . . . . 1.0 107.114 179.915 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 97' ' ' LEU . . . . . 0.643 ' O ' HG22 ' A' ' 100' ' ' ILE . 0.9 OUTLIER -37.78 -32.17 0.05 Allowed 'General case' 0 CA--C 1.556 1.175 0 N-CA-C 108.217 -1.031 . . . . 1.0 108.217 -179.191 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 98' ' ' GLY . . . . . 0.485 ' N ' ' O ' ' A' ' 96' ' ' ALA . . . -82.17 -52.72 3.92 Favored Glycine 0 CA--C 1.564 3.152 0 CA-C-O 123.692 1.718 . . . . 1.0 112.131 173.875 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 99' ' ' GLN . . . . . 0.442 ' N ' ' O ' ' A' ' 96' ' ' ALA . 60.9 mm-40 -77.71 9.59 3.34 Favored 'General case' 0 N--CA 1.44 -0.932 0 N-CA-C 107.978 -1.119 . . . . 1.0 107.978 178.895 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 100' ' ' ILE . . . . . 0.797 ' N ' ' O ' ' A' ' 96' ' ' ALA . 18.9 tt -59.74 -55.1 26.13 Favored 'Isoleucine or valine' 0 CA--C 1.493 -1.215 0 N-CA-C 109.578 -0.527 . . . . 1.0 109.578 -178.51 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 101' ' ' VAL . . . . . 0.728 HG13 ' H ' ' A' ' 102' ' ' CYS . 4.2 p -58.58 -58.85 4.88 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.535 0 C-N-CA 118.862 -1.135 . . . . 1.0 108.26 178.636 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 102' ' ' CYS . . . . . 0.728 ' H ' HG13 ' A' ' 101' ' ' VAL . 13.1 t -45.61 -26.57 0.63 Allowed 'General case' 0 C--O 1.215 -0.75 0 C-N-CA 120.212 -0.595 . . . . 1.0 109.525 -177.835 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 103' ' ' ARG . . . . . 0.431 ' N ' ' C ' ' A' ' 101' ' ' VAL . 0.0 OUTLIER -88.63 -41.96 12.32 Favored 'General case' 0 CA--C 1.549 0.911 0 CA-C-O 122.347 1.07 . . . . 1.0 113.846 179.598 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 104' ' ' TYR . . . . . 0.748 ' CG ' ' O ' ' A' ' 104' ' ' TYR . 4.0 t80 -95.25 23.0 6.16 Favored 'General case' 0 C--N 1.303 -1.445 0 C-N-CA 127.05 2.14 . . . . 1.0 108.722 178.128 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 105' ' ' GLY . . . . . 0.522 ' N ' ' O ' ' A' ' 101' ' ' VAL . . . -163.15 -86.29 0.06 OUTLIER Glycine 0 N--CA 1.442 -0.93 0 N-CA-C 108.058 -2.017 . . . . 1.0 108.058 178.102 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 106' ' ' ALA . . . . . 0.695 ' HB2' ' O ' ' A' ' 102' ' ' CYS . . . 64.08 66.66 0.63 Allowed 'General case' 0 C--N 1.32 -0.681 0 N-CA-C 112.42 0.526 . . . . 1.0 112.42 179.854 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 107' ' ' THR . . . . . 0.505 ' C ' ' HD2' ' A' ' 110' ' ' PRO . 0.5 OUTLIER -109.61 -9.93 14.86 Favored 'General case' 0 CA--C 1.536 0.431 0 O-C-N 122.136 -0.352 . . . . 1.0 110.438 179.086 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 108' ' ' VAL . . . . . 0.613 ' C ' ' HD2' ' A' ' 110' ' ' PRO . 0.0 OUTLIER -82.6 -62.81 1.34 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.694 0 N-CA-C 113.595 0.961 . . . . 1.0 113.595 -176.359 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 109' ' ' ILE . . . . . 0.594 ' N ' ' CD ' ' A' ' 110' ' ' PRO . 0.6 OUTLIER -54.61 -35.99 38.56 Favored Pre-proline 0 C--N 1.321 -0.673 0 N-CA-C 112.161 0.43 . . . . 1.0 112.161 179.933 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 110' ' ' PRO . . . . . 0.613 ' HD2' ' C ' ' A' ' 108' ' ' VAL . 81.4 Cg_exo -45.81 -32.48 9.19 Favored 'Trans proline' 0 C--N 1.323 -0.779 0 C-N-CA 122.258 1.972 . . . . 1.0 112.565 -174.697 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 111' ' ' ASN . . . . . 0.687 ' CG ' ' H ' ' A' ' 112' ' ' ILE . 12.5 p-10 -61.66 -68.62 0.3 Allowed 'General case' 0 CA--C 1.545 0.753 0 C-N-CA 119.699 -0.801 . . . . 1.0 110.355 -179.674 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 112' ' ' ILE . . . . . 0.687 ' H ' ' CG ' ' A' ' 111' ' ' ASN . 2.9 mm -74.7 -24.8 18.54 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.746 0 CA-C-O 121.851 0.834 . . . . 1.0 110.026 -178.122 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 18.9 t30 -51.72 -58.89 5.11 Favored 'General case' 0 C--N 1.298 -1.651 0 CA-C-N 114.159 -1.382 . . . . 1.0 109.933 -178.416 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -66.09 -19.5 65.86 Favored 'General case' 0 N--CA 1.447 -0.584 0 CA-C-N 116.22 -0.445 . . . . 1.0 110.359 179.197 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -75.13 -61.03 2.03 Favored 'General case' 0 CA--C 1.544 0.72 0 C-N-CA 120.312 -0.555 . . . . 1.0 111.242 178.388 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 116' ' ' ILE . . . . . 0.477 ' O ' ' CB ' ' A' ' 119' ' ' LEU . 15.1 tt -67.57 -38.94 81.41 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.334 0 O-C-N 121.052 -1.03 . . . . 1.0 110.918 -178.851 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 117' ' ' GLU . . . . . 0.472 ' C ' ' N ' ' A' ' 119' ' ' LEU . 1.0 OUTLIER -46.67 -68.06 0.23 Allowed 'General case' 0 C--N 1.3 -1.583 0 CA-C-N 115.334 -0.848 . . . . 1.0 110.493 -178.249 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 118' ' ' VAL . . . . . 0.44 HG12 ' O ' ' A' ' 118' ' ' VAL . 89.8 t -47.31 -14.03 0.08 OUTLIER 'Isoleucine or valine' 0 CA--C 1.505 -0.757 0 CA-C-N 114.838 -1.073 . . . . 1.0 109.515 -178.396 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 119' ' ' LEU . . . . . 0.477 ' CB ' ' O ' ' A' ' 116' ' ' ILE . 3.2 tp -77.19 -61.6 1.93 Allowed 'General case' 0 N--CA 1.45 -0.447 0 C-N-CA 119.464 -0.894 . . . . 1.0 110.43 179.101 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -73.36 -81.13 0.41 Allowed Glycine 0 C--N 1.362 2.013 0 C-N-CA 117.891 -2.1 . . . . 1.0 111.339 -178.348 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 1.2 t -158.53 -18.63 0.07 Allowed 'General case' 0 C--N 1.322 -0.601 0 CA-C-O 121.237 0.542 . . . . 1.0 110.601 -179.033 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 122' ' ' GLY . . . . . 0.453 ' O ' ' C ' ' A' ' 123' ' ' THR . . . 107.7 -38.45 3.32 Favored Glycine 0 N--CA 1.472 1.076 0 C-N-CA 125.026 1.298 . . . . 1.0 112.758 178.889 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 123' ' ' THR . . . . . 0.453 ' C ' ' O ' ' A' ' 122' ' ' GLY . 8.5 m -30.62 102.73 0.02 OUTLIER 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 118.49 1.145 . . . . 1.0 112.427 -177.128 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 38.0 p-10 -143.72 139.72 29.62 Favored 'General case' 0 C--N 1.332 -0.158 0 N-CA-C 106.985 -1.487 . . . . 1.0 106.985 178.744 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 125' ' ' TYR . . . . . 0.535 ' OH ' ' CE1' ' A' ' 127' ' ' PHE . 0.0 OUTLIER -153.95 150.72 28.61 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 116.185 -0.461 . . . . 1.0 110.165 -177.848 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 126' ' ' ARG . . . . . 0.509 ' HG2' ' O ' ' A' ' 125' ' ' TYR . 2.0 mmp_? -152.07 156.97 40.97 Favored 'General case' 0 CA--C 1.538 0.483 0 O-C-N 124.497 1.123 . . . . 1.0 111.962 176.829 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 127' ' ' PHE . . . . . 0.535 ' CE1' ' OH ' ' A' ' 125' ' ' TYR . 1.1 p90 . . . . . 0 C--O 1.222 -0.377 0 CA-C-O 118.007 -0.997 . . . . 1.0 110.465 178.886 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 128' ' ' MTN . . . . . 0.635 ' C9 ' ' HE ' ' A' ' 47' ' ' ARG . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 129' ' ' MTN . . . . . 0.545 ' C8 ' HD21 ' A' ' 49' ' ' ASN . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 130' ' ' MTN . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.457 ' SD ' ' N ' ' A' ' 1' ' ' MET . 0.0 OUTLIER . . . . . 0 N--CA 1.493 1.696 0 N-CA-C 109.236 -0.654 . . . . 1.0 109.236 . . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 2' ' ' SER . . . . . 0.517 ' O ' ' CB ' ' A' ' 3' ' ' ASP . 87.6 p -86.47 9.09 19.31 Favored 'General case' 0 N--CA 1.463 0.209 0 CA-C-N 116.554 -0.294 . . . . 1.0 111.204 -179.818 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 3' ' ' ASP . . . . . 0.517 ' CB ' ' O ' ' A' ' 2' ' ' SER . 3.5 t70 149.99 123.81 0.0 OUTLIER 'General case' 0 N--CA 1.479 0.995 0 O-C-N 124.16 0.912 . . . . 1.0 111.189 178.551 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 4' ' ' PHE . . . . . 0.412 ' O ' ' OD1' ' A' ' 5' ' ' ASP . 83.9 t80 -155.25 150.92 27.48 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.408 -0.814 . . . . 1.0 110.403 178.812 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 5' ' ' ASP . . . . . 0.412 ' OD1' ' O ' ' A' ' 4' ' ' PHE . 74.9 m-20 -150.8 148.12 28.12 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.065 -0.516 . . . . 1.0 109.703 179.513 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 6' ' ' THR . . . . . 0.71 ' O ' ' N ' ' A' ' 10' ' ' SER . 0.2 OUTLIER -70.19 167.85 16.98 Favored 'General case' 0 C--O 1.195 -1.802 0 CA-C-O 121.156 0.503 . . . . 1.0 110.274 -179.461 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 7' ' ' GLU . . . . . 0.593 ' O ' ' N ' ' A' ' 11' ' ' ARG . 5.4 pt-20 -57.62 -57.78 11.21 Favored 'General case' 0 C--N 1.299 -1.587 0 CA-C-O 121.271 0.558 . . . . 1.0 110.369 -179.26 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 8' ' ' ARG . . . . . 0.79 ' O ' ' HB3' ' A' ' 12' ' ' ALA . 7.9 ttm180 -52.64 -56.07 18.01 Favored 'General case' 0 C--N 1.316 -0.87 0 N-CA-C 107.805 -1.183 . . . . 1.0 107.805 -178.187 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 9' ' ' VAL . . . . . 0.543 ' O ' ' CG2' ' A' ' 13' ' ' VAL . 0.0 OUTLIER -64.46 -50.42 76.2 Favored 'Isoleucine or valine' 0 C--O 1.203 -1.355 0 C-N-CA 119.488 -0.885 . . . . 1.0 109.816 178.718 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 10' ' ' SER . . . . . 0.71 ' N ' ' O ' ' A' ' 6' ' ' THR . 20.9 t -65.41 -63.92 0.98 Allowed 'General case' 0 C--N 1.316 -0.884 0 C-N-CA 119.42 -0.912 . . . . 1.0 111.257 -178.565 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 11' ' ' ARG . . . . . 0.593 ' N ' ' O ' ' A' ' 7' ' ' GLU . 4.1 tpp180 -63.9 -59.03 5.02 Favored 'General case' 0 N--CA 1.471 0.624 0 CA-C-O 121.103 0.477 . . . . 1.0 111.888 -176.804 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 12' ' ' ALA . . . . . 0.79 ' HB3' ' O ' ' A' ' 8' ' ' ARG . . . -50.18 -49.38 52.58 Favored 'General case' 0 C--N 1.317 -0.82 0 N-CA-C 107.458 -1.312 . . . . 1.0 107.458 -177.232 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 13' ' ' VAL . . . . . 0.6 ' O ' ' N ' ' A' ' 17' ' ' LEU . 93.4 t -60.92 -49.47 84.52 Favored 'Isoleucine or valine' 0 C--O 1.198 -1.607 0 C-N-CA 118.733 -1.187 . . . . 1.0 107.946 177.347 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 14' ' ' ALA . . . . . 0.631 ' O ' HG13 ' A' ' 18' ' ' VAL . . . -57.53 -62.11 2.02 Favored 'General case' 0 C--O 1.212 -0.889 0 C-N-CA 118.519 -1.273 . . . . 1.0 109.913 -179.8 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 15' ' ' ALA . . . . . 0.57 ' O ' ' N ' ' A' ' 19' ' ' GLY . . . -51.28 -53.57 34.36 Favored 'General case' 0 N--CA 1.472 0.648 0 CA-C-O 121.706 0.765 . . . . 1.0 109.287 -178.245 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 16' ' ' ALA . . . . . 0.412 ' HB1' ' CA ' ' A' ' 22' ' ' GLY . . . -62.94 -55.08 29.01 Favored 'General case' 0 C--N 1.309 -1.186 0 CA-C-N 114.603 -1.18 . . . . 1.0 109.037 -178.988 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 17' ' ' LEU . . . . . 0.6 ' N ' ' O ' ' A' ' 13' ' ' VAL . 4.8 tt -55.91 -54.16 48.11 Favored 'General case' 0 N--CA 1.478 0.966 0 CA-C-N 113.921 -1.49 . . . . 1.0 109.063 -177.413 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 18' ' ' VAL . . . . . 0.631 HG13 ' O ' ' A' ' 14' ' ' ALA . 2.3 m -69.29 -57.4 8.62 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.359 0 N-CA-C 108.939 -0.763 . . . . 1.0 108.939 178.426 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 19' ' ' GLY . . . . . 0.57 ' N ' ' O ' ' A' ' 15' ' ' ALA . . . -58.03 -169.45 0.18 Allowed Glycine 0 C--O 1.216 -1.027 0 N-CA-C 110.67 -0.972 . . . . 1.0 110.67 179.722 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 20' ' ' PRO . . . . . 0.499 ' O ' ' N ' ' A' ' 24' ' ' ALA . 3.5 Cg_endo -79.62 -31.07 2.13 Favored 'Trans proline' 0 N--CA 1.499 1.798 0 C-N-CA 123.052 2.501 . . . . 1.0 115.154 -178.06 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -59.88 -57.43 19.39 Favored Glycine 0 N--CA 1.475 1.298 0 C-N-CA 120.699 -0.763 . . . . 1.0 112.665 -176.8 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 22' ' ' GLY . . . . . 0.412 ' CA ' ' HB1' ' A' ' 16' ' ' ALA . . . -55.99 -54.16 37.28 Favored Glycine 0 N--CA 1.469 0.844 0 N-CA-C 107.74 -2.144 . . . . 1.0 107.74 -175.534 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 23' ' ' VAL . . . . . 0.576 ' O ' HG12 ' A' ' 27' ' ' VAL . 0.0 OUTLIER -60.84 -32.23 51.61 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.391 0 CA-C-N 114.617 -0.792 . . . . 1.0 109.607 178.923 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 24' ' ' ALA . . . . . 0.499 ' N ' ' O ' ' A' ' 20' ' ' PRO . . . -56.01 -62.12 1.92 Allowed 'General case' 0 CA--C 1.532 0.28 0 C-N-CA 117.993 -1.483 . . . . 1.0 109.408 179.791 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -65.56 -45.16 84.39 Favored 'General case' 0 C--N 1.341 0.23 0 N-CA-C 112.82 0.674 . . . . 1.0 112.82 -178.464 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 98.5 t -60.22 -59.11 4.57 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.192 0 C-N-CA 118.849 -1.14 . . . . 1.0 110.21 -177.375 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 27' ' ' VAL . . . . . 0.576 HG12 ' O ' ' A' ' 23' ' ' VAL . 1.2 p -59.74 -35.16 58.33 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.286 0 CA-C-O 120.982 0.42 . . . . 1.0 111.95 -178.341 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 32.2 ttpt -66.54 -53.92 29.44 Favored 'General case' 0 C--N 1.315 -0.921 0 CA-C-O 121.906 0.86 . . . . 1.0 109.069 -178.376 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 91.1 t -64.37 -48.59 84.62 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.1 0 CA-C-N 113.668 -1.605 . . . . 1.0 111.557 -177.413 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 30' ' ' CYS . . . . . 0.572 ' SG ' ' N ' ' A' ' 31' ' ' ALA . 0.0 OUTLIER -63.82 -58.58 6.37 Favored 'General case' 0 N--CA 1.452 -0.336 0 C-N-CA 118.86 -1.136 . . . . 1.0 108.518 -179.299 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 31' ' ' ALA . . . . . 0.572 ' N ' ' SG ' ' A' ' 30' ' ' CYS . . . -61.7 -53.52 55.02 Favored 'General case' 0 C--N 1.326 -0.415 0 N-CA-C 112.422 0.527 . . . . 1.0 112.422 -177.515 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 32' ' ' GLY . . . . . 0.473 ' O ' ' CB ' ' A' ' 33' ' ' LEU . . . 86.86 74.42 1.27 Allowed Glycine 0 CA--C 1.522 0.481 0 N-CA-C 110.656 -0.978 . . . . 1.0 110.656 -178.87 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 33' ' ' LEU . . . . . 0.473 ' CB ' ' O ' ' A' ' 32' ' ' GLY . 1.0 OUTLIER 86.06 101.84 0.03 OUTLIER Pre-proline 0 CA--C 1.547 0.841 0 N-CA-C 109.813 -0.44 . . . . 1.0 109.813 -179.876 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 55.9 Cg_endo -71.48 -26.02 20.64 Favored 'Trans proline' 0 N--CA 1.501 1.96 0 C-N-CA 122.087 1.858 . . . . 1.0 114.055 -177.955 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -59.84 -59.45 10.47 Favored Glycine 0 CA--C 1.523 0.554 0 C-N-CA 118.081 -2.009 . . . . 1.0 108.884 -178.539 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 36' ' ' VAL . . . . . 0.64 ' O ' HG22 ' A' ' 37' ' ' ILE . 10.8 p -90.53 161.92 2.54 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.541 0 N-CA-C 107.277 -1.379 . . . . 1.0 107.277 177.565 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 37' ' ' ILE . . . . . 0.64 HG22 ' O ' ' A' ' 36' ' ' VAL . 14.8 tt 120.0 113.17 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.472 0.626 0 O-C-N 124.85 1.344 . . . . 1.0 110.061 179.615 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 22.7 m-70 -140.61 135.46 31.76 Favored 'General case' 0 C--N 1.322 -0.625 0 N-CA-C 108.874 -0.787 . . . . 1.0 108.874 178.87 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 42.5 p -112.54 139.8 23.1 Favored Pre-proline 0 C--N 1.331 -0.23 0 N-CA-C 109.146 -0.687 . . . . 1.0 109.146 179.716 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 40' ' ' PRO . . . . . 0.42 ' HG2' ' H ' ' A' ' 41' ' ' ALA . 57.6 Cg_endo -70.88 -87.15 0.0 OUTLIER 'Trans proline' 0 C--N 1.312 -1.367 0 C-N-CA 121.747 1.631 . . . . 1.0 112.015 -179.433 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 41' ' ' ALA . . . . . 0.42 ' H ' ' HG2' ' A' ' 40' ' ' PRO . . . -66.6 125.07 24.62 Favored 'General case' 0 C--N 1.315 -0.93 0 CA-C-N 114.786 -1.097 . . . . 1.0 110.623 -178.902 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 42' ' ' ARG . . . . . 0.657 ' C ' ' H ' ' A' ' 44' ' ' GLY . 4.2 ptt180 -170.7 168.42 7.44 Favored 'General case' 0 N--CA 1.445 -0.711 0 CA-C-N 115.556 -0.747 . . . . 1.0 109.779 179.893 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -63.31 24.86 0.01 OUTLIER 'General case' 0 C--N 1.317 -0.826 0 CA-C-N 115.88 -0.6 . . . . 1.0 110.369 179.83 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 44' ' ' GLY . . . . . 0.657 ' H ' ' C ' ' A' ' 42' ' ' ARG . . . 87.14 -26.2 7.1 Favored Glycine 0 C--N 1.333 0.402 0 N-CA-C 110.605 -0.998 . . . . 1.0 110.605 179.4 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 45' ' ' PHE . . . . . 0.646 ' CG ' ' O ' ' A' ' 44' ' ' GLY . 74.0 m-85 -167.37 175.15 7.45 Favored 'General case' 0 C--O 1.216 -0.675 0 O-C-N 124.759 0.917 . . . . 1.0 110.696 178.551 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 46' ' ' PHE . . . . . 0.577 ' HB2' ' O ' ' A' ' 45' ' ' PHE . 2.0 m-85 132.58 89.02 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.611 0 C-N-CA 125.625 1.57 . . . . 1.0 109.432 179.01 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 47' ' ' ARG . . . . . 0.79 ' H ' ' NE2' ' A' ' 54' ' ' GLN . 48.6 mmt-85 124.53 142.06 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.509 0 C-N-CA 124.33 1.052 . . . . 1.0 110.781 178.666 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 48' ' ' CYS . . . . . 0.44 ' O ' ' H62' ' A' ' 129' ' ' MTN . 2.6 t 69.45 70.62 0.25 Allowed 'General case' 0 C--N 1.331 -0.226 0 N-CA-C 108.355 -0.98 . . . . 1.0 108.355 -178.916 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 2.2 p-10 -125.17 152.79 71.34 Favored Pre-proline 0 C--O 1.233 0.232 0 CA-C-N 116.448 -0.342 . . . . 1.0 110.551 -178.969 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 50' ' ' PRO . . . . . 0.527 ' HG2' HH11 ' A' ' 52' ' ' ARG . 78.7 Cg_endo -73.17 55.84 3.03 Favored 'Trans proline' 0 C--N 1.311 -1.427 0 C-N-CA 122.022 1.815 . . . . 1.0 110.812 178.889 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 46.8 mm-40 68.18 -2.5 1.5 Allowed 'General case' 0 CA--C 1.528 0.127 0 CA-C-N 116.149 -0.478 . . . . 1.0 111.08 -179.635 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 52' ' ' ARG . . . . . 0.527 HH11 ' HG2' ' A' ' 50' ' ' PRO . 80.0 mtt85 -77.85 159.71 28.78 Favored 'General case' 0 N--CA 1.466 0.329 0 CA-C-O 120.999 0.428 . . . . 1.0 110.581 179.095 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 53' ' ' ILE . . . . . 0.429 ' O ' ' N ' ' A' ' 55' ' ' ILE . 19.4 tt -78.13 138.71 19.77 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.187 0 CA-C-N 115.906 -0.588 . . . . 1.0 111.218 -179.324 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 54' ' ' GLN . . . . . 0.79 ' NE2' ' H ' ' A' ' 47' ' ' ARG . 8.4 mm100 -63.16 81.4 0.02 OUTLIER 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 115.273 -0.876 . . . . 1.0 110.468 -177.973 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 55' ' ' ILE . . . . . 0.429 ' N ' ' O ' ' A' ' 53' ' ' ILE . 15.4 tt -147.01 156.02 11.01 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.152 0 CA-C-N 115.264 -0.88 . . . . 1.0 109.613 177.63 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 109.97 -2.13 30.12 Favored Glycine 0 N--CA 1.466 0.634 0 N-CA-C 110.683 -0.967 . . . . 1.0 110.683 -179.748 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 57' ' ' ASP . . . . . 0.418 ' O ' ' CG ' ' A' ' 57' ' ' ASP . 18.9 p-10 -79.43 99.56 7.25 Favored 'General case' 0 C--N 1.325 -0.468 0 N-CA-C 109.33 -0.619 . . . . 1.0 109.33 178.891 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 58' ' ' TRP . . . . . . . . . . . . . 3.9 m0 -89.99 170.58 10.23 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 123.753 1.739 . . . . 1.0 113.337 -177.052 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 59' ' ' ARG . . . . . 0.444 ' HG3' ' N ' ' A' ' 60' ' ' TYR . 48.3 ptt85 -82.29 -57.89 3.18 Favored 'General case' 0 C--N 1.312 -1.062 0 CA-C-N 110.393 -3.094 . . . . 1.0 112.779 -178.865 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 60' ' ' TYR . . . . . 0.444 ' N ' ' HG3' ' A' ' 59' ' ' ARG . 79.9 t80 -92.67 -15.68 26.46 Favored 'General case' 0 N--CA 1.485 1.285 0 N-CA-C 113.406 0.891 . . . . 1.0 113.406 -179.979 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 6.3 tt0 -77.49 -14.03 59.78 Favored 'General case' 0 C--N 1.313 -1.005 0 CA-C-N 116.065 -0.516 . . . . 1.0 111.073 -178.852 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 62' ' ' VAL . . . . . 0.638 ' O ' ' N ' ' A' ' 66' ' ' GLY . 27.5 m -48.22 -54.65 3.86 Favored 'Isoleucine or valine' 0 C--O 1.198 -1.616 0 C-N-CA 119.485 -0.886 . . . . 1.0 109.84 -175.346 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 63' ' ' ALA . . . . . 0.583 ' N ' HG23 ' A' ' 62' ' ' VAL . . . -68.01 -50.65 54.23 Favored 'General case' 0 C--N 1.306 -1.297 0 O-C-N 121.32 -0.862 . . . . 1.0 109.022 -179.968 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -48.5 -58.59 4.44 Favored 'General case' 0 N--CA 1.465 0.307 0 C-N-CA 119.594 -0.842 . . . . 1.0 109.274 -179.893 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 65' ' ' ASP . . . . . 0.538 ' C ' ' H ' ' A' ' 67' ' ' ARG . 18.5 t0 -71.63 -49.97 35.14 Favored 'General case' 0 C--N 1.314 -0.968 0 CA-C-N 115.147 -0.933 . . . . 1.0 110.159 178.832 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 66' ' ' GLY . . . . . 0.638 ' N ' ' O ' ' A' ' 62' ' ' VAL . . . -71.69 25.83 0.62 Allowed Glycine 0 CA--C 1.52 0.393 0 N-CA-C 110.915 -0.874 . . . . 1.0 110.915 178.241 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 67' ' ' ARG . . . . . 0.628 ' O ' ' N ' ' A' ' 69' ' ' LEU . 0.2 OUTLIER -75.89 2.49 12.31 Favored 'General case' 0 C--N 1.323 -0.564 0 N-CA-C 105.706 -1.961 . . . . 1.0 105.706 175.607 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 68' ' ' LEU . . . . . 0.519 HD12 ' O ' ' A' ' 66' ' ' GLY . 0.0 OUTLIER -35.23 -27.32 0.01 OUTLIER 'General case' 0 N--CA 1.482 1.169 0 N-CA-C 107.991 -1.114 . . . . 1.0 107.991 -176.559 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 69' ' ' LEU . . . . . 0.639 HD13 ' C ' ' A' ' 69' ' ' LEU . 2.9 tm? -62.68 -64.49 0.9 Allowed 'General case' 0 C--N 1.323 -0.56 0 C-N-CA 117.679 -1.608 . . . . 1.0 107.732 177.772 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 70' ' ' ALA . . . . . 0.689 ' C ' ' H ' ' A' ' 72' ' ' HIS . . . -79.01 -74.52 0.28 Allowed 'General case' 0 N--CA 1.479 0.995 0 N-CA-C 107.385 -1.339 . . . . 1.0 107.385 178.509 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 71' ' ' ALA . . . . . 0.435 ' O ' ' C ' ' A' ' 72' ' ' HIS . . . -45.15 4.16 0.0 OUTLIER 'General case' 0 C--O 1.224 -0.239 0 C-N-CA 124.849 1.26 . . . . 1.0 112.479 178.754 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 72' ' ' HIS . . . . . 0.689 ' H ' ' C ' ' A' ' 70' ' ' ALA . 1.9 t60 -29.83 -73.85 0.03 OUTLIER 'General case' 0 C--N 1.333 -0.123 0 N-CA-C 112.261 0.467 . . . . 1.0 112.261 -179.373 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 73' ' ' MET . . . . . 0.598 ' N ' ' SD ' ' A' ' 73' ' ' MET . 0.0 OUTLIER -58.34 -54.51 46.24 Favored 'General case' 0 C--N 1.329 -0.32 0 N-CA-C 106.521 -1.659 . . . . 1.0 106.521 178.655 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 74' ' ' VAL . . . . . 0.765 ' O ' ' N ' ' A' ' 76' ' ' GLY . 61.4 t -42.38 -39.83 0.87 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-O 117.271 -1.347 . . . . 1.0 111.681 -176.13 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 75' ' ' ASN . . . . . 0.492 ' C ' ' N ' ' A' ' 77' ' ' ILE . 33.4 p-10 -35.15 -15.18 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.607 0 CA-C-N 120.824 1.647 . . . . 1.0 110.806 179.558 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 76' ' ' GLY . . . . . 0.765 ' N ' ' O ' ' A' ' 74' ' ' VAL . . . -49.6 -19.93 2.38 Favored Glycine 0 N--CA 1.436 -1.328 0 N-CA-C 107.244 -2.343 . . . . 1.0 107.244 173.394 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 77' ' ' ILE . . . . . 0.492 ' N ' ' C ' ' A' ' 75' ' ' ASN . 14.1 pt -56.49 -50.59 72.17 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.032 0 CA-C-O 117.747 -1.12 . . . . 1.0 110.384 -179.334 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 24.4 t -54.71 -20.69 5.82 Favored 'Isoleucine or valine' 0 C--N 1.352 0.699 0 CA-C-N 121.095 1.77 . . . . 1.0 113.427 179.701 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 79' ' ' ILE . . . . . 0.593 ' CG2' HH22 ' A' ' 126' ' ' ARG . 44.8 pt -91.68 -40.27 12.25 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.34 0 C-N-CA 118.888 -1.125 . . . . 1.0 109.677 178.012 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -79.56 -19.85 48.46 Favored 'General case' 0 CA--C 1.538 0.494 0 N-CA-C 113.604 0.964 . . . . 1.0 113.604 179.495 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 81' ' ' GLU . . . . . 0.538 ' CG ' ' H ' ' A' ' 82' ' ' ASP . 1.1 pp20? -94.15 -71.52 0.66 Allowed 'General case' 0 C--N 1.345 0.4 0 N-CA-C 114.47 1.285 . . . . 1.0 114.47 -177.474 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 82' ' ' ASP . . . . . 0.538 ' H ' ' CG ' ' A' ' 81' ' ' GLU . 27.4 t70 -88.93 -15.04 35.31 Favored 'General case' 0 CA--C 1.538 0.493 0 N-CA-C 114.447 1.277 . . . . 1.0 114.447 -178.237 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 83' ' ' ALA . . . . . 0.59 ' O ' ' N ' ' A' ' 87' ' ' GLU . . . -49.75 -46.21 50.27 Favored 'General case' 0 C--O 1.214 -0.813 0 C-N-CA 118.116 -1.434 . . . . 1.0 112.352 -177.816 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 84' ' ' LEU . . . . . 0.648 HD13 ' O ' ' A' ' 84' ' ' LEU . 2.7 tm? -39.77 -45.47 1.75 Allowed 'General case' 0 N--CA 1.471 0.586 0 CA-C-N 118.207 0.458 . . . . 1.0 111.602 -178.026 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 85' ' ' ILE . . . . . 0.422 HG22 ' O ' ' A' ' 82' ' ' ASP . 6.4 tt -66.36 -34.64 71.5 Favored 'Isoleucine or valine' 0 C--O 1.235 0.296 0 C-N-CA 119.698 -0.801 . . . . 1.0 111.022 -179.583 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 86' ' ' ALA . . . . . 0.867 ' O ' HG22 ' A' ' 89' ' ' VAL . . . -93.64 -23.88 18.1 Favored 'General case' 0 C--O 1.211 -0.967 0 N-CA-C 111.728 0.27 . . . . 1.0 111.728 179.904 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 87' ' ' GLU . . . . . 0.59 ' N ' ' O ' ' A' ' 83' ' ' ALA . 38.9 tp10 -54.51 -18.81 4.76 Favored 'General case' 0 C--N 1.324 -0.509 0 O-C-N 121.447 -0.783 . . . . 1.0 109.946 -178.818 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -75.49 -5.83 47.12 Favored 'General case' 0 N--CA 1.473 0.687 0 CA-C-O 122.762 1.268 . . . . 1.0 108.097 178.329 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 89' ' ' VAL . . . . . 0.867 HG22 ' O ' ' A' ' 86' ' ' ALA . 3.2 m -86.05 36.31 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.318 -0.785 0 CA-C-N 112.173 -2.285 . . . . 1.0 107.962 177.085 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 90' ' ' GLY . . . . . 0.882 ' O ' ' N ' ' A' ' 92' ' ' HIS . . . -56.26 -19.66 25.72 Favored Glycine 0 C--N 1.373 2.601 0 CA-C-O 117.049 -1.973 . . . . 1.0 113.465 178.362 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 91' ' ' PRO . . . . . 0.699 ' HD2' ' N ' ' A' ' 90' ' ' GLY . 3.0 Cg_exo -34.38 3.42 0.0 OUTLIER 'Trans proline' 0 N--CA 1.499 1.817 0 CA-C-N 121.618 2.709 . . . . 1.0 113.693 172.409 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 92' ' ' HIS . . . . . 0.882 ' N ' ' O ' ' A' ' 90' ' ' GLY . 1.4 t-160 -47.2 -35.15 7.12 Favored 'General case' 0 N--CA 1.443 -0.816 0 N-CA-C 106.04 -1.837 . . . . 1.0 106.04 179.484 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 93' ' ' LEU . . . . . 0.439 ' O ' ' HB3' ' A' ' 96' ' ' ALA . 5.6 tp -62.57 -45.86 91.0 Favored 'General case' 0 C--N 1.35 0.609 0 N-CA-C 108.652 -0.869 . . . . 1.0 108.652 176.058 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 94' ' ' ALA . . . . . 0.545 ' N ' ' O ' ' A' ' 91' ' ' PRO . . . -53.69 -58.17 8.18 Favored 'General case' 0 C--N 1.333 -0.15 0 N-CA-C 106.344 -1.724 . . . . 1.0 106.344 178.685 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -58.32 -29.73 66.14 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-N 114.65 -1.159 . . . . 1.0 109.314 177.981 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 96' ' ' ALA . . . . . 0.855 ' O ' ' N ' ' A' ' 100' ' ' ILE . . . -54.35 -51.21 65.47 Favored 'General case' 0 C--O 1.199 -1.57 0 N-CA-C 107.84 -1.17 . . . . 1.0 107.84 -176.145 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 97' ' ' LEU . . . . . 0.583 ' O ' HG22 ' A' ' 100' ' ' ILE . 2.7 tm? -34.02 -28.37 0.01 OUTLIER 'General case' 0 CA--C 1.567 1.622 0 CA-C-N 113.788 -1.551 . . . . 1.0 108.052 -178.03 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 98' ' ' GLY . . . . . 0.648 ' N ' ' O ' ' A' ' 96' ' ' ALA . . . -89.37 -53.32 2.49 Favored Glycine 0 CA--C 1.56 2.866 0 CA-C-O 123.279 1.488 . . . . 1.0 111.956 170.46 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 99' ' ' GLN . . . . . 0.541 ' N ' ' O ' ' A' ' 96' ' ' ALA . 5.4 mm100 -75.93 6.48 5.09 Favored 'General case' 0 N--CA 1.439 -0.986 0 N-CA-C 107.64 -1.244 . . . . 1.0 107.64 179.156 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 100' ' ' ILE . . . . . 0.855 ' N ' ' O ' ' A' ' 96' ' ' ALA . 19.2 tt -63.46 -50.6 77.86 Favored 'Isoleucine or valine' 0 CA--C 1.471 -2.069 0 N-CA-C 107.784 -1.191 . . . . 1.0 107.784 -179.956 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 101' ' ' VAL . . . . . 0.673 ' O ' ' N ' ' A' ' 105' ' ' GLY . 76.1 t -51.84 -60.16 1.14 Allowed 'Isoleucine or valine' 0 C--O 1.212 -0.893 0 C-N-CA 118.292 -1.363 . . . . 1.0 107.389 178.691 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 102' ' ' CYS . . . . . 0.808 ' O ' ' HB2' ' A' ' 106' ' ' ALA . 0.0 OUTLIER -53.63 -25.39 17.55 Favored 'General case' 0 C--N 1.306 -1.299 0 CA-C-N 115.428 -0.806 . . . . 1.0 111.434 -176.78 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 103' ' ' ARG . . . . . 0.424 ' HG3' ' H81' ' A' ' 130' ' ' MTN . 51.1 ttm-85 -84.36 -52.05 6.49 Favored 'General case' 0 N--CA 1.488 1.471 0 CA-C-O 122.415 1.102 . . . . 1.0 113.337 -179.407 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 104' ' ' TYR . . . . . 0.671 ' O ' ' CG ' ' A' ' 104' ' ' TYR . 0.0 OUTLIER -96.33 21.79 8.61 Favored 'General case' 0 C--N 1.302 -1.488 0 C-N-CA 127.378 2.271 . . . . 1.0 106.819 177.874 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 105' ' ' GLY . . . . . 0.673 ' N ' ' O ' ' A' ' 101' ' ' VAL . . . -159.08 -97.88 0.13 Allowed Glycine 0 CA--C 1.53 0.99 0 N-CA-C 109.442 -1.463 . . . . 1.0 109.442 179.028 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 106' ' ' ALA . . . . . 0.808 ' HB2' ' O ' ' A' ' 102' ' ' CYS . . . 60.64 114.38 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.253 0 N-CA-C 108.985 -0.746 . . . . 1.0 108.985 -176.254 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 107' ' ' THR . . . . . 0.852 ' O ' ' HD2' ' A' ' 110' ' ' PRO . 22.0 m -133.28 -61.61 0.82 Allowed 'General case' 0 C--O 1.194 -1.819 0 N-CA-C 106.789 -1.56 . . . . 1.0 106.789 177.78 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 32.7 m -71.5 30.66 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.318 -0.795 0 O-C-N 121.22 -0.925 . . . . 1.0 109.251 -178.239 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 109' ' ' ILE . . . . . 0.65 HD13 ' HB1' ' A' ' 106' ' ' ALA . 0.1 OUTLIER -111.8 -40.46 0.1 Allowed Pre-proline 0 CA--C 1.56 1.346 0 CA-C-N 118.573 0.624 . . . . 1.0 110.882 177.969 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 110' ' ' PRO . . . . . 0.852 ' HD2' ' O ' ' A' ' 107' ' ' THR . 31.2 Cg_exo -65.33 -23.83 58.49 Favored 'Trans proline' 0 N--CA 1.496 1.62 0 C-N-CA 122.609 2.206 . . . . 1.0 111.82 179.72 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 111' ' ' ASN . . . . . 0.549 ' CG ' ' N ' ' A' ' 112' ' ' ILE . 0.0 OUTLIER -66.43 -66.77 0.51 Allowed 'General case' 0 CA--C 1.535 0.384 0 C-N-CA 119.51 -0.876 . . . . 1.0 109.132 -179.353 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 112' ' ' ILE . . . . . 0.549 ' N ' ' CG ' ' A' ' 111' ' ' ASN . 0.0 OUTLIER -52.43 -32.47 16.49 Favored 'Isoleucine or valine' 0 C--O 1.213 -0.821 0 CA-C-O 122.253 1.025 . . . . 1.0 109.139 178.783 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 113' ' ' ASN . . . . . 0.483 ' HB2' ' HA ' ' A' ' 110' ' ' PRO . 8.4 m-20 -55.39 -55.29 33.28 Favored 'General case' 0 C--N 1.296 -1.722 0 CA-C-N 113.345 -1.752 . . . . 1.0 107.581 -179.105 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -60.51 -29.31 69.01 Favored 'General case' 0 N--CA 1.44 -0.958 0 C-N-CA 119.383 -0.927 . . . . 1.0 110.995 178.934 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -77.93 -59.56 2.73 Favored 'General case' 0 N--CA 1.451 -0.413 0 C-N-CA 119.558 -0.857 . . . . 1.0 110.031 178.949 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 116' ' ' ILE . . . . . 0.64 ' O ' ' N ' ' A' ' 120' ' ' GLY . 1.4 tp -50.8 -48.21 28.34 Favored 'Isoleucine or valine' 0 CA--C 1.498 -1.055 0 N-CA-C 108.859 -0.793 . . . . 1.0 108.859 -179.096 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 117' ' ' GLU . . . . . 0.53 ' N ' ' CG2' ' A' ' 116' ' ' ILE . 51.6 mt-10 -38.9 -58.53 1.08 Allowed 'General case' 0 C--N 1.317 -0.838 0 N-CA-C 104.707 -2.331 . . . . 1.0 104.707 179.424 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 99.4 t -58.62 -52.02 64.81 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.716 0 C-N-CA 119.608 -0.837 . . . . 1.0 109.076 176.951 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 119' ' ' LEU . . . . . 0.474 ' N ' ' O ' ' A' ' 116' ' ' ILE . 0.3 OUTLIER -56.34 -69.64 0.14 Allowed 'General case' 0 N--CA 1.47 0.561 0 C-N-CA 118.362 -1.335 . . . . 1.0 107.641 -178.594 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 120' ' ' GLY . . . . . 0.64 ' N ' ' O ' ' A' ' 116' ' ' ILE . . . -72.0 -85.11 0.2 Allowed Glycine 0 CA--C 1.55 2.223 0 C-N-CA 119.172 -1.489 . . . . 1.0 111.25 178.229 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 121' ' ' THR . . . . . 0.487 ' HA ' ' O ' ' A' ' 117' ' ' GLU . 1.5 t 160.96 -27.66 0.0 OUTLIER 'General case' 0 N--CA 1.486 1.375 0 CA-C-N 113.797 -1.202 . . . . 1.0 113.362 -178.715 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 122' ' ' GLY . . . . . 0.632 ' O ' ' N ' ' A' ' 124' ' ' ASP . . . 97.38 -21.74 44.54 Favored Glycine 0 N--CA 1.476 1.36 0 N-CA-C 107.884 -2.086 . . . . 1.0 107.884 -177.511 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 123' ' ' THR . . . . . 0.542 ' O ' ' NE2' ' A' ' 72' ' ' HIS . 7.6 m -47.7 89.41 0.0 OUTLIER 'General case' 0 N--CA 1.467 0.413 0 N-CA-C 105.21 -2.144 . . . . 1.0 105.21 177.603 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 124' ' ' ASP . . . . . 0.632 ' N ' ' O ' ' A' ' 122' ' ' GLY . 29.8 t70 -166.32 175.57 8.14 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 114.856 -1.065 . . . . 1.0 112.361 -179.505 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 125' ' ' TYR . . . . . 0.488 ' N ' ' CG ' ' A' ' 124' ' ' ASP . 56.2 t80 -146.71 145.32 29.95 Favored 'General case' 0 CA--C 1.533 0.298 0 CA-C-N 115.102 -0.954 . . . . 1.0 109.106 176.7 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 126' ' ' ARG . . . . . 0.593 HH22 ' CG2' ' A' ' 79' ' ' ILE . 0.8 OUTLIER -147.18 146.46 29.86 Favored 'General case' 0 C--N 1.327 -0.387 0 N-CA-C 108.701 -0.851 . . . . 1.0 108.701 178.91 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 127' ' ' PHE . . . . . . . . . . . . . 29.2 p90 . . . . . 0 N--CA 1.47 0.573 0 CA-C-O 117.899 -1.048 . . . . 1.0 110.297 179.737 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 128' ' ' MTN . . . . . 0.468 ' H92' ' NH2' ' A' ' 47' ' ' ARG . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 129' ' ' MTN . . . . . 0.44 ' H62' ' O ' ' A' ' 48' ' ' CYS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 130' ' ' MTN . . . . . 0.424 ' H81' ' HG3' ' A' ' 103' ' ' ARG . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.591 ' SD ' ' N ' ' A' ' 1' ' ' MET . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.619 0 N-CA-C 108.998 -0.742 . . . . 1.0 108.998 . . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 2' ' ' SER . . . . . 0.466 ' O ' ' CB ' ' A' ' 3' ' ' ASP . 78.2 p -81.07 5.92 15.15 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.854 -0.612 . . . . 1.0 110.771 -179.805 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 3' ' ' ASP . . . . . 0.478 ' N ' ' OD1' ' A' ' 3' ' ' ASP . 5.1 p30 154.17 127.72 0.0 OUTLIER 'General case' 0 N--CA 1.472 0.629 0 O-C-N 123.669 0.606 . . . . 1.0 110.556 178.965 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 71.9 t80 -154.1 149.7 27.41 Favored 'General case' 0 N--CA 1.466 0.338 0 CA-C-O 120.789 0.328 . . . . 1.0 110.762 179.33 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 68.4 m-20 -152.92 147.96 26.58 Favored 'General case' 0 CA--C 1.535 0.389 0 N-CA-C 109.555 -0.535 . . . . 1.0 109.555 179.747 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 6' ' ' THR . . . . . 0.809 ' O ' ' N ' ' A' ' 10' ' ' SER . 0.2 OUTLIER -93.64 -177.61 4.44 Favored 'General case' 0 C--O 1.187 -2.225 0 CA-C-N 116.68 -0.236 . . . . 1.0 110.972 -179.485 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 7' ' ' GLU . . . . . 0.532 ' O ' ' N ' ' A' ' 11' ' ' ARG . 66.5 tt0 -59.93 -55.44 34.1 Favored 'General case' 0 N--CA 1.476 0.849 0 CA-C-O 121.518 0.675 . . . . 1.0 110.933 -179.274 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 8' ' ' ARG . . . . . 0.531 ' O ' ' CB ' ' A' ' 12' ' ' ALA . 0.6 OUTLIER -53.58 -58.98 5.22 Favored 'General case' 0 C--N 1.304 -1.409 0 N-CA-C 107.749 -1.204 . . . . 1.0 107.749 179.865 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 9' ' ' VAL . . . . . 0.849 ' O ' HG13 ' A' ' 13' ' ' VAL . 0.0 OUTLIER -65.47 -49.32 78.96 Favored 'Isoleucine or valine' 0 CA--C 1.559 1.308 0 CA-C-N 114.575 -1.193 . . . . 1.0 110.978 179.816 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 10' ' ' SER . . . . . 0.809 ' N ' ' O ' ' A' ' 6' ' ' THR . 32.2 t -61.11 -57.94 10.42 Favored 'General case' 0 N--CA 1.492 1.668 0 CA-C-O 122.23 1.014 . . . . 1.0 108.315 179.057 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 11' ' ' ARG . . . . . 0.677 ' O ' ' HB3' ' A' ' 15' ' ' ALA . 7.6 tpt180 -61.97 -40.79 96.8 Favored 'General case' 0 C--N 1.315 -0.92 0 CA-C-N 115.412 -0.813 . . . . 1.0 109.167 -177.578 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 12' ' ' ALA . . . . . 0.756 ' O ' ' HB3' ' A' ' 16' ' ' ALA . . . -68.05 -55.44 12.55 Favored 'General case' 0 N--CA 1.475 0.825 0 C-N-CA 119.193 -1.003 . . . . 1.0 108.557 176.164 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 13' ' ' VAL . . . . . 0.849 HG13 ' O ' ' A' ' 9' ' ' VAL . 4.5 m -63.28 -53.03 51.09 Favored 'Isoleucine or valine' 0 C--O 1.205 -1.246 0 C-N-CA 118.241 -1.384 . . . . 1.0 108.894 -178.957 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 14' ' ' ALA . . . . . 0.838 ' O ' HG22 ' A' ' 18' ' ' VAL . . . -60.8 -64.35 0.98 Allowed 'General case' 0 C--N 1.305 -1.347 0 C-N-CA 117.953 -1.499 . . . . 1.0 110.464 179.668 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 15' ' ' ALA . . . . . 0.677 ' HB3' ' O ' ' A' ' 11' ' ' ARG . . . -56.52 -56.45 21.05 Favored 'General case' 0 N--CA 1.479 0.992 0 C-N-CA 119.522 -0.871 . . . . 1.0 111.375 -177.883 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 16' ' ' ALA . . . . . 0.756 ' HB3' ' O ' ' A' ' 12' ' ' ALA . . . -65.6 -56.42 12.31 Favored 'General case' 0 C--N 1.318 -0.791 0 C-N-CA 119.068 -1.053 . . . . 1.0 110.298 -178.596 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 17' ' ' LEU . . . . . 0.625 ' CB ' ' O ' ' A' ' 13' ' ' VAL . 5.2 tt -58.36 -54.94 41.39 Favored 'General case' 0 N--CA 1.485 1.293 0 C-N-CA 118.869 -1.132 . . . . 1.0 108.853 -178.289 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 18' ' ' VAL . . . . . 0.838 HG22 ' O ' ' A' ' 14' ' ' ALA . 1.3 m -71.88 -57.75 6.65 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.858 0 C-N-CA 119.112 -1.035 . . . . 1.0 110.851 -179.823 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 19' ' ' GLY . . . . . 0.515 ' N ' ' O ' ' A' ' 15' ' ' ALA . . . -57.33 -175.22 0.34 Allowed Glycine 0 N--CA 1.444 -0.808 0 C-N-CA 121.23 -0.509 . . . . 1.0 112.076 -177.036 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 20' ' ' PRO . . . . . 0.638 ' O ' ' N ' ' A' ' 24' ' ' ALA . 4.1 Cg_endo -81.06 -27.03 3.16 Favored 'Trans proline' 0 C--N 1.307 -1.647 0 C-N-CA 122.749 2.3 . . . . 1.0 113.172 -178.433 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -63.05 -61.26 6.57 Favored Glycine 0 N--CA 1.474 1.17 0 C-N-CA 119.279 -1.439 . . . . 1.0 112.432 -176.33 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 22' ' ' GLY . . . . . 0.529 ' H ' ' HA ' ' A' ' 16' ' ' ALA . . . -53.08 -51.87 43.55 Favored Glycine 0 N--CA 1.472 1.087 0 N-CA-C 106.14 -2.784 . . . . 1.0 106.14 -177.697 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 23' ' ' VAL . . . . . 0.414 ' O ' HG12 ' A' ' 27' ' ' VAL . 40.5 t -61.61 -31.5 50.91 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.089 0 C-N-CA 119.42 -0.912 . . . . 1.0 109.811 178.517 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 24' ' ' ALA . . . . . 0.638 ' N ' ' O ' ' A' ' 20' ' ' PRO . . . -57.68 -62.49 1.76 Allowed 'General case' 0 C--N 1.353 0.756 0 C-N-CA 118.551 -1.26 . . . . 1.0 109.703 -179.501 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 25' ' ' LEU . . . . . 0.498 ' C ' HD12 ' A' ' 25' ' ' LEU . 0.5 OUTLIER -61.42 -44.72 96.64 Favored 'General case' 0 N--CA 1.464 0.251 0 C-N-CA 119.902 -0.719 . . . . 1.0 111.93 -178.237 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 26' ' ' VAL . . . . . 0.479 ' N ' ' HG ' ' A' ' 25' ' ' LEU . 31.6 t -58.98 -58.35 7.27 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.819 0 C-N-CA 119.455 -0.898 . . . . 1.0 110.278 -177.843 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 27' ' ' VAL . . . . . 0.566 ' O ' ' HB3' ' A' ' 31' ' ' ALA . 1.4 p -63.01 -36.67 76.78 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.716 0 C-N-CA 120.393 -0.523 . . . . 1.0 110.971 -177.999 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 2.0 tppp? -65.47 -57.81 7.37 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-O 121.756 0.788 . . . . 1.0 109.199 -179.237 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 79.3 t -63.56 -47.78 89.9 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.023 0 CA-C-N 114.622 -1.172 . . . . 1.0 110.208 -177.351 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 30' ' ' CYS . . . . . . . . . . . . . 51.4 t -65.56 -61.02 2.34 Favored 'General case' 0 N--CA 1.446 -0.64 0 C-N-CA 119.355 -0.938 . . . . 1.0 110.358 -179.397 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 31' ' ' ALA . . . . . 0.566 ' HB3' ' O ' ' A' ' 27' ' ' VAL . . . -59.71 -47.8 84.21 Favored 'General case' 0 CA--C 1.515 -0.378 0 O-C-N 122.083 -0.385 . . . . 1.0 111.158 -176.954 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 32' ' ' GLY . . . . . 0.497 ' O ' ' HB2' ' A' ' 33' ' ' LEU . . . 72.89 64.62 2.51 Favored Glycine 0 N--CA 1.449 -0.492 0 N-CA-C 108.788 -1.725 . . . . 1.0 108.788 -178.144 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 33' ' ' LEU . . . . . 0.497 ' HB2' ' O ' ' A' ' 32' ' ' GLY . 27.2 mt 83.77 129.88 0.03 OUTLIER Pre-proline 0 CA--C 1.544 0.739 0 O-C-N 125.295 1.233 . . . . 1.0 111.12 -178.465 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 58.7 Cg_endo -72.13 -5.26 16.76 Favored 'Trans proline' 0 N--CA 1.495 1.594 0 C-N-CA 122.788 2.325 . . . . 1.0 112.599 179.028 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 35' ' ' GLY . . . . . 0.404 ' HA2' HD12 ' A' ' 112' ' ' ILE . . . -62.12 -62.16 5.94 Favored Glycine 0 C--N 1.336 0.568 0 C-N-CA 118.405 -1.855 . . . . 1.0 111.095 -178.565 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 36' ' ' VAL . . . . . 0.834 HG22 ' H ' ' A' ' 37' ' ' ILE . 8.7 p -87.26 -142.71 0.01 OUTLIER 'Isoleucine or valine' 0 C--O 1.216 -0.683 0 N-CA-C 107.552 -1.277 . . . . 1.0 107.552 178.793 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 37' ' ' ILE . . . . . 0.834 ' H ' HG22 ' A' ' 36' ' ' VAL . 0.3 OUTLIER 70.54 76.46 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.473 0.716 0 CA-C-O 122.344 1.069 . . . . 1.0 111.42 179.842 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 95.4 m-70 -139.75 133.2 30.12 Favored 'General case' 0 C--N 1.33 -0.269 0 O-C-N 120.989 -1.069 . . . . 1.0 109.18 179.311 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -108.57 124.79 33.39 Favored Pre-proline 0 CA--C 1.541 0.615 0 N-CA-C 109.67 -0.493 . . . . 1.0 109.67 179.789 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 52.0 Cg_exo -49.94 -23.08 8.39 Favored 'Trans proline' 0 N--CA 1.5 1.866 0 C-N-CA 121.796 1.664 . . . . 1.0 113.827 179.985 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -126.17 134.86 51.15 Favored 'General case' 0 N--CA 1.469 0.506 0 N-CA-C 111.311 0.115 . . . . 1.0 111.311 178.54 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 42' ' ' ARG . . . . . 0.682 ' C ' ' H ' ' A' ' 44' ' ' GLY . 19.3 ttp-105 -164.68 164.46 21.37 Favored 'General case' 0 C--N 1.328 -0.353 0 C-N-CA 120.197 -0.601 . . . . 1.0 109.787 177.172 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 43' ' ' ARG . . . . . 0.625 ' C ' ' H ' ' A' ' 45' ' ' PHE . 4.7 tpt180 -60.92 24.59 0.01 OUTLIER 'General case' 0 CA--C 1.545 0.75 0 CA-C-N 115.789 -0.642 . . . . 1.0 110.623 -178.864 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 44' ' ' GLY . . . . . 0.682 ' H ' ' C ' ' A' ' 42' ' ' ARG . . . 66.27 -32.12 0.16 Allowed Glycine 0 C--N 1.34 0.769 0 N-CA-C 110.65 -0.98 . . . . 1.0 110.65 179.456 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 45' ' ' PHE . . . . . 0.637 ' O ' ' HB2' ' A' ' 46' ' ' PHE . 11.8 t80 -169.34 170.81 8.24 Favored 'General case' 0 N--CA 1.446 -0.642 0 N-CA-C 108.378 -0.971 . . . . 1.0 108.378 179.141 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 46' ' ' PHE . . . . . 0.637 ' HB2' ' O ' ' A' ' 45' ' ' PHE . 1.0 OUTLIER 120.8 106.64 0.0 OUTLIER 'General case' 0 N--CA 1.497 1.921 0 C-N-CA 127.333 2.253 . . . . 1.0 106.34 -179.346 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 47' ' ' ARG . . . . . 0.531 ' HB2' ' O ' ' A' ' 46' ' ' PHE . 0.1 OUTLIER 103.24 149.84 0.01 OUTLIER 'General case' 0 N--CA 1.479 1.0 0 C-N-CA 124.827 1.251 . . . . 1.0 109.86 -178.602 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 48' ' ' CYS . . . . . 0.511 ' SG ' ' C ' ' A' ' 47' ' ' ARG . 0.0 OUTLIER 64.3 71.92 0.46 Allowed 'General case' 0 CA--C 1.534 0.361 0 CA-C-N 114.984 -1.007 . . . . 1.0 110.396 -178.892 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -140.85 163.53 42.13 Favored Pre-proline 0 C--N 1.33 -0.269 0 O-C-N 121.92 -0.487 . . . . 1.0 110.747 -179.22 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 38.4 Cg_endo -66.18 47.08 0.22 Allowed 'Trans proline' 0 N--CA 1.498 1.773 0 C-N-CA 123.107 2.538 . . . . 1.0 111.78 178.738 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 51' ' ' GLU . . . . . 0.531 ' OE1' ' NH2' ' A' ' 95' ' ' ARG . 7.6 mt-10 57.02 12.4 1.22 Allowed 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 115.37 -0.832 . . . . 1.0 111.393 179.593 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 24.9 ptt85 -85.87 147.31 26.33 Favored 'General case' 0 C--N 1.333 -0.119 0 N-CA-C 107.296 -1.372 . . . . 1.0 107.296 177.846 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 8.8 tp -49.46 138.4 4.89 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.496 0 CA-C-O 122.012 0.91 . . . . 1.0 113.033 -177.893 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 54' ' ' GLN . . . . . 0.587 ' H ' ' CD ' ' A' ' 54' ' ' GLN . 0.0 OUTLIER -76.17 79.51 2.98 Favored 'General case' 0 CA--C 1.534 0.351 0 CA-C-N 114.074 -1.421 . . . . 1.0 109.222 179.613 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 1.8 mt -147.38 157.12 9.88 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.75 0 CA-C-N 115.244 -0.889 . . . . 1.0 110.211 178.094 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 108.5 -0.24 32.67 Favored Glycine 0 C--N 1.338 0.691 0 N-CA-C 110.553 -1.019 . . . . 1.0 110.553 179.766 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 57' ' ' ASP . . . . . 0.424 ' O ' ' OD1' ' A' ' 57' ' ' ASP . 31.1 p-10 -80.27 101.74 9.08 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 121.584 0.707 . . . . 1.0 112.393 -178.816 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 58' ' ' TRP . . . . . . . . . . . . . 10.0 m0 -78.61 179.12 7.3 Favored 'General case' 0 C--N 1.323 -0.548 0 N-CA-C 108.028 -1.101 . . . . 1.0 108.028 178.34 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 59' ' ' ARG . . . . . 0.577 ' O ' ' CG2' ' A' ' 62' ' ' VAL . 1.0 OUTLIER -100.28 -49.12 4.36 Favored 'General case' 0 CA--C 1.546 0.81 0 CA-C-N 121.522 1.965 . . . . 1.0 111.613 178.535 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 60' ' ' TYR . . . . . 0.411 ' CD1' ' C ' ' A' ' 60' ' ' TYR . 3.7 p90 -85.98 -9.6 56.55 Favored 'General case' 0 N--CA 1.488 1.43 0 C-N-CA 124.997 1.319 . . . . 1.0 113.281 -177.98 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 61' ' ' GLU . . . . . 0.402 ' O ' ' N ' ' A' ' 65' ' ' ASP . 27.1 tt0 -75.32 -14.07 60.46 Favored 'General case' 0 C--N 1.308 -1.219 0 O-C-N 121.554 -0.716 . . . . 1.0 110.622 -178.952 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 62' ' ' VAL . . . . . 0.577 ' CG2' ' O ' ' A' ' 59' ' ' ARG . 0.0 OUTLIER -44.28 -50.34 1.92 Allowed 'Isoleucine or valine' 0 C--N 1.315 -0.901 0 N-CA-C 109.715 -0.476 . . . . 1.0 109.715 -175.69 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 63' ' ' ALA . . . . . 0.508 ' O ' ' HG2' ' A' ' 67' ' ' ARG . . . -67.6 -47.15 70.52 Favored 'General case' 0 N--CA 1.425 -1.683 0 N-CA-C 108.587 -0.894 . . . . 1.0 108.587 -179.878 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 64' ' ' HIS . . . . . 0.449 ' O ' ' CG ' ' A' ' 67' ' ' ARG . 0.5 OUTLIER -55.21 -59.22 5.07 Favored 'General case' 0 CA--C 1.547 0.841 0 CA-C-N 115.292 -0.867 . . . . 1.0 109.871 179.683 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 65' ' ' ASP . . . . . 0.639 ' C ' ' H ' ' A' ' 67' ' ' ARG . 29.6 t70 -67.08 -53.39 31.38 Favored 'General case' 0 C--O 1.243 0.739 0 CA-C-O 121.667 0.746 . . . . 1.0 109.27 178.438 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 66' ' ' GLY . . . . . 0.551 ' N ' ' O ' ' A' ' 62' ' ' VAL . . . -63.3 31.14 0.08 OUTLIER Glycine 0 CA--C 1.523 0.573 0 N-CA-C 111.477 -0.649 . . . . 1.0 111.477 178.263 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 67' ' ' ARG . . . . . 0.77 ' HB3' ' HB3' ' A' ' 71' ' ' ALA . 6.3 mmt180 -76.34 -2.59 32.47 Favored 'General case' 0 C--N 1.315 -0.901 0 N-CA-C 108.07 -1.085 . . . . 1.0 108.07 174.876 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 68' ' ' LEU . . . . . 0.483 ' C ' ' O ' ' A' ' 67' ' ' ARG . 5.8 tt -35.16 -30.35 0.01 OUTLIER 'General case' 0 N--CA 1.475 0.82 0 N-CA-C 108.63 -0.878 . . . . 1.0 108.63 -176.403 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 69' ' ' LEU . . . . . 0.57 ' N ' ' O ' ' A' ' 67' ' ' ARG . 9.9 mp -69.24 -68.57 0.39 Allowed 'General case' 0 CA--C 1.549 0.921 0 CA-C-N 115.09 -0.959 . . . . 1.0 111.063 179.686 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 70' ' ' ALA . . . . . 0.613 ' C ' ' H ' ' A' ' 72' ' ' HIS . . . -77.16 -76.85 0.16 Allowed 'General case' 0 N--CA 1.473 0.723 0 C-N-CA 119.016 -1.074 . . . . 1.0 109.457 -178.373 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 71' ' ' ALA . . . . . 0.77 ' HB3' ' HB3' ' A' ' 67' ' ' ARG . . . -57.31 10.48 0.01 OUTLIER 'General case' 0 C--N 1.324 -0.502 0 C-N-CA 124.652 1.181 . . . . 1.0 112.574 179.784 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 72' ' ' HIS . . . . . 0.878 ' CD2' ' H ' ' A' ' 73' ' ' MET . 1.3 p80 -19.84 -48.23 0.01 OUTLIER 'General case' 0 N--CA 1.465 0.323 0 N-CA-C 114.669 1.359 . . . . 1.0 114.669 -177.197 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 73' ' ' MET . . . . . 0.878 ' H ' ' CD2' ' A' ' 72' ' ' HIS . 15.4 ptp -74.87 -47.91 27.67 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 119.275 0.943 . . . . 1.0 109.353 179.058 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 74' ' ' VAL . . . . . 0.705 ' HB ' ' HB1' ' A' ' 71' ' ' ALA . 59.3 t -43.23 -48.46 1.41 Allowed 'Isoleucine or valine' 0 C--O 1.214 -0.79 0 CA-C-O 117.736 -1.126 . . . . 1.0 110.972 -175.389 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 75' ' ' ASN . . . . . 0.402 ' C ' ' O ' ' A' ' 74' ' ' VAL . 3.9 m120 -37.52 -19.66 0.01 OUTLIER 'General case' 0 N--CA 1.48 1.075 0 CA-C-O 122.714 1.245 . . . . 1.0 109.987 178.507 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 76' ' ' GLY . . . . . 0.661 ' N ' ' O ' ' A' ' 74' ' ' VAL . . . -50.99 -24.3 8.3 Favored Glycine 0 C--O 1.213 -1.177 0 N-CA-C 108.143 -1.983 . . . . 1.0 108.143 176.207 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 77' ' ' ILE . . . . . 0.444 ' N ' ' O ' ' A' ' 74' ' ' VAL . 9.5 pt -45.64 -43.78 4.1 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.323 0 O-C-N 122.289 -0.536 . . . . 1.0 110.9 179.523 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 57.5 t -55.65 -22.04 11.5 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.343 0 CA-C-N 118.649 0.659 . . . . 1.0 111.05 -179.67 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 79' ' ' ILE . . . . . 0.611 ' O ' ' HB2' ' A' ' 83' ' ' ALA . 0.3 OUTLIER -88.03 -42.49 15.0 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.715 0 C-N-CA 119.32 -0.952 . . . . 1.0 110.058 178.556 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -78.93 -23.03 44.95 Favored 'General case' 0 CA--C 1.537 0.444 0 N-CA-C 112.262 0.467 . . . . 1.0 112.262 -178.892 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 94.8 mt-10 -91.11 -68.25 0.8 Allowed 'General case' 0 CA--C 1.533 0.289 0 N-CA-C 112.475 0.546 . . . . 1.0 112.475 178.718 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 82' ' ' ASP . . . . . 0.46 ' O ' ' C ' ' A' ' 83' ' ' ALA . 1.2 m-20 -74.76 -21.49 59.31 Favored 'General case' 0 C--N 1.349 0.555 0 N-CA-C 114.991 1.478 . . . . 1.0 114.991 -176.35 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 83' ' ' ALA . . . . . 0.682 ' HA ' ' HB3' ' A' ' 86' ' ' ALA . . . -37.38 -50.08 1.03 Allowed 'General case' 0 N--CA 1.483 1.187 0 CA-C-N 120.253 1.388 . . . . 1.0 111.355 178.743 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 84' ' ' LEU . . . . . 0.49 ' C ' ' O ' ' A' ' 83' ' ' ALA . 0.1 OUTLIER -26.88 -41.74 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.609 0 CA-C-O 120.62 0.248 . . . . 1.0 110.645 -175.327 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 85' ' ' ILE . . . . . 0.505 ' N ' ' O ' ' A' ' 83' ' ' ALA . 2.9 pt -98.63 -46.65 12.39 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 N-CA-C 109.468 -0.568 . . . . 1.0 109.468 177.605 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 86' ' ' ALA . . . . . 0.682 ' HB3' ' HA ' ' A' ' 83' ' ' ALA . . . -49.54 -44.27 46.44 Favored 'General case' 0 N--CA 1.461 0.102 0 CA-C-N 115.931 -0.577 . . . . 1.0 110.14 -177.913 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 21.6 pt-20 -53.73 -21.9 8.1 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.929 0.395 . . . . 1.0 110.54 179.62 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -82.36 -13.84 56.23 Favored 'General case' 0 CA--C 1.517 -0.316 0 CA-C-O 121.289 0.566 . . . . 1.0 109.889 -179.476 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 89' ' ' VAL . . . . . 0.513 ' O ' HG12 ' A' ' 89' ' ' VAL . 18.5 t -93.06 34.74 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.553 0 CA-C-N 114.964 -1.016 . . . . 1.0 109.419 178.972 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 90' ' ' GLY . . . . . 0.534 ' O ' ' N ' ' A' ' 92' ' ' HIS . . . -74.66 -41.44 35.17 Favored Glycine 0 CA--C 1.539 1.555 0 N-CA-C 111.501 -0.64 . . . . 1.0 111.501 179.09 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 91' ' ' PRO . . . . . 0.48 ' CD ' ' N ' ' A' ' 90' ' ' GLY . 91.0 Cg_exo -41.35 -20.89 0.11 Allowed 'Trans proline' 0 N--CA 1.492 1.391 0 CA-C-N 119.354 1.577 . . . . 1.0 111.177 -179.795 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 92' ' ' HIS . . . . . 0.692 ' O ' ' N ' ' A' ' 96' ' ' ALA . 27.6 p-80 -53.73 -38.7 64.6 Favored 'General case' 0 C--O 1.196 -1.733 0 N-CA-C 106.489 -1.671 . . . . 1.0 106.489 -179.162 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 93' ' ' LEU . . . . . 0.777 HD12 ' N ' ' A' ' 94' ' ' ALA . 2.6 pp -46.17 -58.98 3.18 Favored 'General case' 0 C--N 1.319 -0.745 0 C-N-CA 120.183 -0.607 . . . . 1.0 110.428 -179.757 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 94' ' ' ALA . . . . . 0.777 ' N ' HD12 ' A' ' 93' ' ' LEU . . . -59.5 -56.79 17.59 Favored 'General case' 0 N--CA 1.465 0.275 0 CA-C-N 118.514 0.597 . . . . 1.0 109.692 -179.953 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 95' ' ' ARG . . . . . 0.668 ' O ' ' N ' ' A' ' 97' ' ' LEU . 5.8 mtp-105 -54.53 -58.61 6.82 Favored 'General case' 0 C--O 1.238 0.494 0 N-CA-C 107.789 -1.189 . . . . 1.0 107.789 178.347 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 96' ' ' ALA . . . . . 0.745 ' O ' ' N ' ' A' ' 98' ' ' GLY . . . -45.15 -12.99 0.02 OUTLIER 'General case' 0 C--N 1.294 -1.821 0 O-C-N 119.383 -2.073 . . . . 1.0 110.627 179.558 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 97' ' ' LEU . . . . . 0.668 ' N ' ' O ' ' A' ' 95' ' ' ARG . 0.8 OUTLIER 1.91 -54.71 0.0 OUTLIER 'General case' 0 N--CA 1.48 1.026 0 C-N-CA 124.407 1.083 . . . . 1.0 111.987 -169.958 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 98' ' ' GLY . . . . . 0.745 ' N ' ' O ' ' A' ' 96' ' ' ALA . . . -48.85 -23.05 3.25 Favored Glycine 0 CA--C 1.539 1.554 0 CA-C-N 122.233 2.288 . . . . 1.0 108.62 175.173 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 99' ' ' GLN . . . . . 0.627 ' N ' ' O ' ' A' ' 96' ' ' ALA . 1.2 mp0 -69.68 -24.14 63.55 Favored 'General case' 0 C--N 1.364 1.204 0 C-N-CA 118.338 -1.345 . . . . 1.0 107.776 178.47 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 100' ' ' ILE . . . . . 0.584 ' N ' ' O ' ' A' ' 97' ' ' LEU . 4.7 mm -65.23 -40.03 87.36 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.755 0 CA-C-N 115.026 -0.988 . . . . 1.0 108.762 177.945 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 101' ' ' VAL . . . . . 0.565 ' O ' ' N ' ' A' ' 105' ' ' GLY . 0.5 OUTLIER -58.52 -57.28 11.67 Favored 'Isoleucine or valine' 0 C--N 1.343 0.289 0 N-CA-C 107.407 -1.331 . . . . 1.0 107.407 179.669 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 102' ' ' CYS . . . . . 0.944 ' O ' ' HB2' ' A' ' 106' ' ' ALA . 0.7 OUTLIER -41.6 -17.61 0.01 OUTLIER 'General case' 0 CA--C 1.536 0.417 0 CA-C-O 120.763 0.316 . . . . 1.0 111.107 -179.537 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 103' ' ' ARG . . . . . 0.528 ' N ' ' O ' ' A' ' 101' ' ' VAL . 4.3 ttm180 -93.29 -35.01 13.3 Favored 'General case' 0 N--CA 1.478 0.954 0 CA-C-O 122.327 1.061 . . . . 1.0 111.523 177.71 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 104' ' ' TYR . . . . . 0.75 ' O ' ' CG ' ' A' ' 104' ' ' TYR . 1.2 t80 -106.44 19.08 21.04 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 112.722 -2.035 . . . . 1.0 109.746 177.817 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 105' ' ' GLY . . . . . 0.735 ' O ' ' N ' ' A' ' 107' ' ' THR . . . -165.76 -18.88 0.02 OUTLIER Glycine 0 C--O 1.223 -0.538 0 C-N-CA 117.461 -2.304 . . . . 1.0 113.035 179.263 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 106' ' ' ALA . . . . . 0.944 ' HB2' ' O ' ' A' ' 102' ' ' CYS . . . -11.39 65.0 0.0 OUTLIER 'General case' 0 N--CA 1.477 0.915 0 O-C-N 124.778 0.928 . . . . 1.0 111.93 -179.55 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 107' ' ' THR . . . . . 0.735 ' N ' ' O ' ' A' ' 105' ' ' GLY . 99.4 m -98.42 -4.41 34.7 Favored 'General case' 0 CA--C 1.511 -0.55 0 O-C-N 121.678 -0.639 . . . . 1.0 109.347 -178.999 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 108' ' ' VAL . . . . . 0.518 ' C ' ' HD2' ' A' ' 110' ' ' PRO . 41.2 t -81.86 -54.05 10.67 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.494 0 CA-C-N 116.288 -0.414 . . . . 1.0 110.105 178.466 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 109' ' ' ILE . . . . . 0.507 ' O ' ' CB ' ' A' ' 113' ' ' ASN . 0.2 OUTLIER -47.49 -38.86 17.82 Favored Pre-proline 0 N--CA 1.473 0.699 0 N-CA-C 114.822 1.415 . . . . 1.0 114.822 -179.095 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 110' ' ' PRO . . . . . 0.518 ' HD2' ' C ' ' A' ' 108' ' ' VAL . 83.7 Cg_exo -47.02 -41.49 26.19 Favored 'Trans proline' 0 C--N 1.31 -1.48 0 C-N-CA 121.929 1.753 . . . . 1.0 112.623 -174.818 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 1.2 t-20 -63.49 -69.39 0.27 Allowed 'General case' 0 CA--C 1.536 0.421 0 C-N-CA 118.877 -1.129 . . . . 1.0 110.29 179.88 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 112' ' ' ILE . . . . . 0.448 ' O ' ' N ' ' A' ' 116' ' ' ILE . 0.1 OUTLIER -61.84 -44.74 99.28 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.539 0 CA-C-O 121.325 0.583 . . . . 1.0 110.543 -178.1 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 113' ' ' ASN . . . . . 0.507 ' CB ' ' O ' ' A' ' 109' ' ' ILE . 20.9 t30 -45.79 -62.17 1.42 Allowed 'General case' 0 C--N 1.309 -1.168 0 CA-C-N 115.3 -0.864 . . . . 1.0 111.511 -174.733 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -61.67 -24.59 66.85 Favored 'General case' 0 N--CA 1.433 -1.294 0 C-N-CA 118.873 -1.131 . . . . 1.0 110.703 179.586 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -82.32 -61.43 1.9 Allowed 'General case' 0 C--O 1.239 0.504 0 N-CA-C 113.95 1.093 . . . . 1.0 113.95 178.323 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 116' ' ' ILE . . . . . 0.589 ' O ' ' N ' ' A' ' 119' ' ' LEU . 47.0 mt -69.82 -49.03 60.71 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.678 0 O-C-N 120.501 -1.374 . . . . 1.0 111.596 -177.985 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 117' ' ' GLU . . . . . 0.479 ' OE1' ' OD1' ' A' ' 113' ' ' ASN . 18.5 tt0 -46.2 -61.58 1.71 Allowed 'General case' 0 C--N 1.312 -1.05 0 N-CA-C 108.393 -0.966 . . . . 1.0 108.393 -177.106 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 97.5 t -54.28 -16.02 1.31 Allowed 'Isoleucine or valine' 0 N--CA 1.44 -0.96 0 O-C-N 124.408 1.068 . . . . 1.0 109.317 178.453 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 119' ' ' LEU . . . . . 0.589 ' N ' ' O ' ' A' ' 116' ' ' ILE . 0.2 OUTLIER -80.01 -61.31 2.03 Favored 'General case' 0 C--N 1.349 0.551 0 C-N-CA 119.793 -0.763 . . . . 1.0 110.453 178.342 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -66.62 -85.52 0.08 OUTLIER Glycine 0 C--N 1.361 1.96 0 C-N-CA 117.519 -2.277 . . . . 1.0 112.103 179.916 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -163.73 -27.18 0.04 OUTLIER 'General case' 0 N--CA 1.473 0.713 0 N-CA-C 107.422 -1.325 . . . . 1.0 107.422 -178.604 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 122' ' ' GLY . . . . . 0.554 ' O ' ' N ' ' A' ' 124' ' ' ASP . . . 116.76 -36.2 3.86 Favored Glycine 0 CA--C 1.531 1.033 0 CA-C-N 113.933 -1.485 . . . . 1.0 113.432 179.699 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 123' ' ' THR . . . . . 0.454 ' C ' ' O ' ' A' ' 122' ' ' GLY . 0.1 OUTLIER -32.78 89.64 0.0 OUTLIER 'General case' 0 N--CA 1.476 0.839 0 CA-C-N 120.578 2.189 . . . . 1.0 112.774 -178.652 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 124' ' ' ASP . . . . . 0.554 ' N ' ' O ' ' A' ' 122' ' ' GLY . 11.6 t0 -147.45 143.86 28.21 Favored 'General case' 0 CA--C 1.521 -0.162 0 N-CA-C 108.454 -0.943 . . . . 1.0 108.454 179.94 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 125' ' ' TYR . . . . . 0.471 ' O ' ' CD1' ' A' ' 125' ' ' TYR . 0.1 OUTLIER -150.79 148.43 28.5 Favored 'General case' 0 C--N 1.324 -0.526 0 N-CA-C 109.596 -0.52 . . . . 1.0 109.596 179.891 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 126' ' ' ARG . . . . . 0.545 ' CB ' ' H62' ' A' ' 130' ' ' MTN . 10.8 mmp_? -145.74 148.4 32.95 Favored 'General case' 0 N--CA 1.471 0.623 0 N-CA-C 109.592 -0.521 . . . . 1.0 109.592 177.264 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 127' ' ' PHE . . . . . 0.466 ' OXT' ' H63' ' A' ' 130' ' ' MTN . 0.9 OUTLIER . . . . . 0 C--O 1.218 -0.575 0 CA-C-O 118.049 -0.977 . . . . 1.0 110.008 -179.9 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 128' ' ' MTN . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 129' ' ' MTN . . . . . 0.529 ' S1 ' ' O ' ' A' ' 47' ' ' ARG . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 130' ' ' MTN . . . . . 0.545 ' H62' ' CB ' ' A' ' 126' ' ' ARG . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 60.1 mtt . . . . . 0 N--CA 1.491 1.584 0 N-CA-C 109.013 -0.736 . . . . 1.0 109.013 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 48.7 m -107.78 -0.97 21.33 Favored 'General case' 0 N--CA 1.466 0.351 0 CA-C-N 116.404 -0.362 . . . . 1.0 110.692 179.553 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 3' ' ' ASP . . . . . 0.526 ' N ' ' OD1' ' A' ' 3' ' ' ASP . 8.1 p-10 -178.83 92.66 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.478 -0.328 . . . . 1.0 110.854 -179.747 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 37.2 t80 -151.59 147.75 27.16 Favored 'General case' 0 CA--C 1.513 -0.444 0 CA-C-O 120.899 0.38 . . . . 1.0 110.112 179.358 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 5' ' ' ASP . . . . . 0.498 ' C ' ' OG ' ' A' ' 10' ' ' SER . 32.1 p30 -156.58 153.05 28.02 Favored 'General case' 0 N--CA 1.448 -0.538 0 CA-C-N 116.058 -0.519 . . . . 1.0 110.748 179.472 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 6' ' ' THR . . . . . 0.957 ' H ' HG23 ' A' ' 9' ' ' VAL . 0.2 OUTLIER -102.69 -170.2 1.77 Allowed 'General case' 0 C--O 1.199 -1.605 0 CA-C-O 121.661 0.743 . . . . 1.0 110.467 178.131 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 7' ' ' GLU . . . . . 0.464 ' O ' ' HB2' ' A' ' 11' ' ' ARG . 33.4 tt0 -56.25 -40.97 75.0 Favored 'General case' 0 C--N 1.304 -1.391 0 CA-C-O 121.653 0.74 . . . . 1.0 110.586 -179.555 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 8' ' ' ARG . . . . . 0.82 ' O ' ' HB3' ' A' ' 12' ' ' ALA . 0.9 OUTLIER -70.01 -62.78 1.25 Allowed 'General case' 0 C--N 1.31 -1.122 0 C-N-CA 118.654 -1.218 . . . . 1.0 111.252 179.548 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 9' ' ' VAL . . . . . 0.957 HG23 ' H ' ' A' ' 6' ' ' THR . 0.0 OUTLIER -62.7 -48.45 88.08 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.712 0 CA-C-N 114.113 -1.403 . . . . 1.0 108.229 179.144 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 10' ' ' SER . . . . . 0.669 ' N ' ' O ' ' A' ' 6' ' ' THR . 1.6 m -67.8 -68.35 0.39 Allowed 'General case' 0 C--O 1.189 -2.128 0 C-N-CA 118.3 -1.36 . . . . 1.0 112.915 179.857 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 11' ' ' ARG . . . . . 0.57 ' O ' ' N ' ' A' ' 15' ' ' ALA . 2.3 mmt85 -67.83 -49.93 59.46 Favored 'General case' 0 N--CA 1.48 1.072 0 N-CA-C 113.965 1.098 . . . . 1.0 113.965 -176.551 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 12' ' ' ALA . . . . . 0.82 ' HB3' ' O ' ' A' ' 8' ' ' ARG . . . -60.69 -58.74 7.16 Favored 'General case' 0 C--N 1.314 -0.956 0 C-N-CA 117.866 -1.534 . . . . 1.0 107.526 -178.873 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 13' ' ' VAL . . . . . 0.696 ' O ' ' N ' ' A' ' 17' ' ' LEU . 0.5 OUTLIER -60.0 -50.36 80.46 Favored 'Isoleucine or valine' 0 C--O 1.184 -2.393 0 N-CA-C 106.561 -1.644 . . . . 1.0 106.561 179.215 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 14' ' ' ALA . . . . . 0.844 ' O ' HG22 ' A' ' 18' ' ' VAL . . . -58.76 -64.05 1.07 Allowed 'General case' 0 C--O 1.199 -1.599 0 C-N-CA 116.493 -2.083 . . . . 1.0 111.497 -179.101 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 15' ' ' ALA . . . . . 0.575 ' O ' ' N ' ' A' ' 19' ' ' GLY . . . -52.21 -55.04 23.69 Favored 'General case' 0 C--N 1.314 -0.949 0 N-CA-C 108.46 -0.941 . . . . 1.0 108.46 -178.622 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 16' ' ' ALA . . . . . 0.559 ' HB3' ' O ' ' A' ' 12' ' ' ALA . . . -64.36 -57.86 8.13 Favored 'General case' 0 C--N 1.304 -1.395 0 C-N-CA 118.886 -1.126 . . . . 1.0 111.042 -179.95 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 17' ' ' LEU . . . . . 0.696 ' N ' ' O ' ' A' ' 13' ' ' VAL . 19.1 tp -55.78 -55.27 34.4 Favored 'General case' 0 N--CA 1.49 1.569 0 N-CA-C 107.909 -1.145 . . . . 1.0 107.909 -177.768 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 18' ' ' VAL . . . . . 0.844 HG22 ' O ' ' A' ' 14' ' ' ALA . 1.5 m -71.29 -59.13 3.75 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.411 0 CA-C-N 116.045 -0.525 . . . . 1.0 110.471 179.925 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 19' ' ' GLY . . . . . 0.575 ' N ' ' O ' ' A' ' 15' ' ' ALA . . . -56.67 -169.27 0.1 OUTLIER Glycine 0 N--CA 1.438 -1.187 0 N-CA-C 111.225 -0.75 . . . . 1.0 111.225 -177.655 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 20' ' ' PRO . . . . . 0.642 ' O ' ' N ' ' A' ' 24' ' ' ALA . 58.6 Cg_endo -85.32 -29.24 0.66 Allowed 'Trans proline' 0 C--N 1.29 -2.5 0 C-N-CA 122.456 2.104 . . . . 1.0 113.455 -177.564 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 21' ' ' GLY . . . . . 0.443 ' O ' ' HB3' ' A' ' 24' ' ' ALA . . . -60.42 -59.73 9.79 Favored Glycine 0 N--CA 1.471 0.993 0 C-N-CA 120.143 -1.027 . . . . 1.0 112.26 -177.747 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 22' ' ' GLY . . . . . 0.495 ' H ' ' HA ' ' A' ' 16' ' ' ALA . . . -56.51 -53.33 44.24 Favored Glycine 0 CA--C 1.497 -1.072 0 N-CA-C 106.53 -2.628 . . . . 1.0 106.53 -176.374 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 23' ' ' VAL . . . . . 0.526 ' O ' HG12 ' A' ' 27' ' ' VAL . 22.4 t -56.74 -31.22 34.62 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.242 0 N-CA-C 108.216 -1.031 . . . . 1.0 108.216 178.043 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 24' ' ' ALA . . . . . 0.642 ' N ' ' O ' ' A' ' 20' ' ' PRO . . . -59.18 -63.21 1.38 Allowed 'General case' 0 C--N 1.354 0.791 0 C-N-CA 118.712 -1.195 . . . . 1.0 110.331 -178.823 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 25' ' ' LEU . . . . . 0.44 ' H ' ' HG ' ' A' ' 25' ' ' LEU . 1.2 mt -62.27 -46.04 90.59 Favored 'General case' 0 C--N 1.325 -0.458 0 C-N-CA 120.335 -0.546 . . . . 1.0 111.333 -177.063 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 88.0 t -59.64 -58.94 4.87 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.669 0 C-N-CA 119.898 -0.721 . . . . 1.0 109.604 -177.78 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 27' ' ' VAL . . . . . 0.526 HG12 ' O ' ' A' ' 23' ' ' VAL . 1.5 p -60.62 -37.45 75.53 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.508 0 C-N-CA 120.076 -0.65 . . . . 1.0 110.245 -177.99 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 27.2 ttpp -65.29 -56.96 9.75 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 115.89 -0.595 . . . . 1.0 110.462 -179.018 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 84.1 t -63.27 -47.88 90.05 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.784 0 CA-C-N 114.936 -1.029 . . . . 1.0 109.692 -177.715 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 30' ' ' CYS . . . . . . . . . . . . . 36.8 t -65.01 -60.82 2.62 Favored 'General case' 0 N--CA 1.441 -0.884 0 C-N-CA 119.787 -0.765 . . . . 1.0 109.588 -178.82 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 31' ' ' ALA . . . . . 0.523 ' HB3' ' O ' ' A' ' 27' ' ' VAL . . . -57.8 -47.62 82.07 Favored 'General case' 0 CA--C 1.497 -1.091 0 CA-C-O 121.29 0.567 . . . . 1.0 109.769 -176.427 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 32' ' ' GLY . . . . . 0.468 ' O ' ' HB2' ' A' ' 33' ' ' LEU . . . 74.2 67.92 1.67 Allowed Glycine 0 N--CA 1.439 -1.131 0 N-CA-C 108.982 -1.647 . . . . 1.0 108.982 -178.525 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 33' ' ' LEU . . . . . 0.478 ' O ' ' O ' ' A' ' 36' ' ' VAL . 17.7 mt 97.41 78.52 0.02 OUTLIER Pre-proline 0 N--CA 1.47 0.54 0 C-N-CA 124.542 1.137 . . . . 1.0 110.645 -179.452 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 76.5 Cg_exo -45.93 -29.45 5.99 Favored 'Trans proline' 0 C--N 1.312 -1.386 0 C-N-CA 121.973 1.782 . . . . 1.0 112.672 179.793 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -60.38 -60.61 8.26 Favored Glycine 0 CA--C 1.536 1.37 0 C-N-CA 118.756 -1.687 . . . . 1.0 109.894 -178.375 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 36' ' ' VAL . . . . . 0.703 HG22 ' H ' ' A' ' 37' ' ' ILE . 8.5 p -98.81 177.87 0.66 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.68 0 N-CA-C 107.36 -1.348 . . . . 1.0 107.36 177.793 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 37' ' ' ILE . . . . . 0.703 ' H ' HG22 ' A' ' 36' ' ' VAL . 2.9 mm 101.15 120.34 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.479 1.01 0 O-C-N 124.818 1.323 . . . . 1.0 110.952 179.609 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 79.8 m80 -142.75 136.97 29.44 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 115.572 -0.74 . . . . 1.0 109.508 178.456 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 11.1 m -91.95 127.48 49.52 Favored Pre-proline 0 CA--C 1.537 0.474 0 N-CA-C 108.966 -0.753 . . . . 1.0 108.966 179.678 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 29.7 Cg_endo -62.94 -30.55 76.97 Favored 'Trans proline' 0 N--CA 1.498 1.745 0 C-N-CA 121.752 1.635 . . . . 1.0 113.368 -178.192 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -110.36 90.93 3.46 Favored 'General case' 0 CA--C 1.507 -0.696 0 CA-C-O 121.599 0.714 . . . . 1.0 112.664 -176.498 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 16.3 ptm180 -139.82 143.0 36.61 Favored 'General case' 0 C--N 1.318 -0.768 0 CA-C-N 114.552 -1.204 . . . . 1.0 108.479 178.927 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 76.5 ttt180 -50.91 -15.61 0.32 Allowed 'General case' 0 N--CA 1.451 -0.41 0 O-C-N 121.958 -0.464 . . . . 1.0 111.299 -176.003 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 119.11 -25.34 7.89 Favored Glycine 0 N--CA 1.468 0.792 0 N-CA-C 111.148 -0.781 . . . . 1.0 111.148 178.885 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 45' ' ' PHE . . . . . 0.565 ' O ' ' CD1' ' A' ' 46' ' ' PHE . 0.6 OUTLIER -156.84 161.53 39.72 Favored 'General case' 0 C--N 1.323 -0.557 0 N-CA-C 108.171 -1.048 . . . . 1.0 108.171 178.446 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 46' ' ' PHE . . . . . 0.834 ' O ' ' CD1' ' A' ' 46' ' ' PHE . 0.0 OUTLIER 115.66 120.46 0.0 OUTLIER 'General case' 0 N--CA 1.479 1.024 0 O-C-N 125.288 1.618 . . . . 1.0 112.433 179.342 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 47' ' ' ARG . . . . . 0.594 ' HB2' ' O ' ' A' ' 46' ' ' PHE . 5.9 mtm180 76.75 163.32 0.24 Allowed 'General case' 0 N--CA 1.479 1.023 0 O-C-N 119.266 -2.146 . . . . 1.0 110.727 -178.67 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 48' ' ' CYS . . . . . 0.441 ' C ' ' S1 ' ' A' ' 129' ' ' MTN . 4.1 t 61.35 70.03 0.63 Allowed 'General case' 0 C--O 1.232 0.147 0 N-CA-C 108.786 -0.82 . . . . 1.0 108.786 -178.196 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 49' ' ' ASN . . . . . 0.605 ' O ' ' N ' ' A' ' 51' ' ' GLU . 0.0 OUTLIER -146.1 163.95 27.75 Favored Pre-proline 0 CA--C 1.538 0.511 0 N-CA-C 109.519 -0.549 . . . . 1.0 109.519 -178.726 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 50' ' ' PRO . . . . . 0.512 ' O ' ' NE ' ' A' ' 52' ' ' ARG . 11.2 Cg_endo -54.41 58.48 0.03 OUTLIER 'Trans proline' 0 N--CA 1.514 2.68 0 C-N-CA 123.32 2.68 . . . . 1.0 112.057 179.611 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 51' ' ' GLU . . . . . 0.605 ' N ' ' O ' ' A' ' 49' ' ' ASN . 40.5 mt-10 55.02 37.39 28.84 Favored 'General case' 0 N--CA 1.475 0.797 0 O-C-N 121.192 -0.943 . . . . 1.0 112.678 176.956 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 52' ' ' ARG . . . . . 0.551 ' O ' ' ND2' ' A' ' 49' ' ' ASN . 0.0 OUTLIER -151.69 179.9 8.0 Favored 'General case' 0 N--CA 1.476 0.829 0 CA-C-O 121.71 0.767 . . . . 1.0 110.439 179.069 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 4.6 tp -82.25 168.72 1.74 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 114.869 -1.059 . . . . 1.0 108.993 177.78 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 1.1 tp60 -132.44 131.98 42.29 Favored 'General case' 0 CA--C 1.533 0.318 0 N-CA-C 108.793 -0.817 . . . . 1.0 108.793 178.624 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 20.4 tt -144.91 155.08 14.13 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.661 0 N-CA-C 110.334 -0.247 . . . . 1.0 110.334 178.563 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 101.38 1.57 53.74 Favored Glycine 0 C--N 1.341 0.842 0 N-CA-C 110.157 -1.177 . . . . 1.0 110.157 -179.827 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 9.4 t70 -93.2 115.55 28.16 Favored 'General case' 0 CA--C 1.539 0.521 0 CA-C-O 122.229 1.014 . . . . 1.0 113.035 -178.214 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 58' ' ' TRP . . . . . 0.649 ' HB2' ' HB2' ' A' ' 61' ' ' GLU . 37.7 m0 -82.92 -178.4 7.1 Favored 'General case' 0 C--N 1.318 -0.799 0 CA-C-N 112.673 -2.058 . . . . 1.0 109.411 177.682 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 59' ' ' ARG . . . . . 0.445 ' HG3' ' H ' ' A' ' 60' ' ' TYR . 13.7 ptt-85 -94.61 -55.39 3.16 Favored 'General case' 0 CA--C 1.543 0.701 0 CA-C-O 121.24 0.543 . . . . 1.0 111.333 179.412 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 60' ' ' TYR . . . . . 0.573 ' O ' ' CG ' ' A' ' 60' ' ' TYR . 17.3 t80 -76.68 -4.03 41.04 Favored 'General case' 0 N--CA 1.476 0.836 0 C-N-CA 124.327 1.051 . . . . 1.0 111.255 179.231 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 61' ' ' GLU . . . . . 0.649 ' HB2' ' HB2' ' A' ' 58' ' ' TRP . 31.8 tt0 -77.36 -17.33 58.33 Favored 'General case' 0 C--N 1.309 -1.16 0 O-C-N 121.447 -0.783 . . . . 1.0 111.089 -179.994 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 62' ' ' VAL . . . . . 0.439 ' O ' ' N ' ' A' ' 66' ' ' GLY . 91.0 t -46.08 -49.33 5.2 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.03 0 N-CA-C 109.043 -0.725 . . . . 1.0 109.043 -175.639 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 63' ' ' ALA . . . . . 0.546 ' O ' ' HG3' ' A' ' 67' ' ' ARG . . . -64.91 -49.33 70.86 Favored 'General case' 0 N--CA 1.419 -1.993 0 N-CA-C 108.624 -0.88 . . . . 1.0 108.624 177.358 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 4.3 t-80 -56.0 -61.65 2.24 Favored 'General case' 0 CA--C 1.547 0.85 0 CA-C-N 115.977 -0.556 . . . . 1.0 111.904 179.52 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 65' ' ' ASP . . . . . 0.648 ' C ' ' H ' ' A' ' 67' ' ' ARG . 13.7 t70 -66.79 -54.34 23.67 Favored 'General case' 0 C--O 1.246 0.918 0 O-C-N 121.226 -0.921 . . . . 1.0 110.31 178.507 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 66' ' ' GLY . . . . . 0.439 ' N ' ' O ' ' A' ' 62' ' ' VAL . . . -62.91 32.9 0.07 OUTLIER Glycine 0 CA--C 1.523 0.587 0 N-CA-C 111.52 -0.632 . . . . 1.0 111.52 178.825 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 67' ' ' ARG . . . . . 0.75 ' HB3' ' H ' ' A' ' 71' ' ' ALA . 50.5 mtt180 -77.03 4.16 10.71 Favored 'General case' 0 C--N 1.313 -0.986 0 C-N-CA 123.739 0.816 . . . . 1.0 110.352 175.641 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 68' ' ' LEU . . . . . 0.582 ' O ' ' HA ' ' A' ' 72' ' ' HIS . 0.8 OUTLIER -33.95 -31.1 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.651 0 N-CA-C 107.335 -1.357 . . . . 1.0 107.335 -179.267 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 69' ' ' LEU . . . . . 0.611 ' N ' ' O ' ' A' ' 67' ' ' ARG . 0.3 OUTLIER -63.48 -65.14 0.73 Allowed 'General case' 0 C--N 1.312 -1.064 0 C-N-CA 118.037 -1.465 . . . . 1.0 107.213 175.838 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 70' ' ' ALA . . . . . 0.68 ' C ' ' H ' ' A' ' 72' ' ' HIS . . . -76.64 -73.67 0.27 Allowed 'General case' 0 N--CA 1.474 0.749 0 N-CA-C 107.537 -1.283 . . . . 1.0 107.537 178.627 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 71' ' ' ALA . . . . . 0.75 ' H ' ' HB3' ' A' ' 67' ' ' ARG . . . -49.7 4.63 0.01 OUTLIER 'General case' 0 N--CA 1.476 0.835 0 C-N-CA 125.907 1.683 . . . . 1.0 112.07 178.475 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 72' ' ' HIS . . . . . 0.768 ' CG ' ' H ' ' A' ' 73' ' ' MET . 4.4 p-80 -17.74 -62.56 0.02 OUTLIER 'General case' 0 CA--C 1.519 -0.225 0 O-C-N 123.755 0.66 . . . . 1.0 112.519 -175.899 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 73' ' ' MET . . . . . 0.768 ' H ' ' CG ' ' A' ' 72' ' ' HIS . 16.6 ptm -80.89 -45.63 16.5 Favored 'General case' 0 C--N 1.298 -1.644 0 CA-C-N 117.968 0.349 . . . . 1.0 110.56 177.41 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 74' ' ' VAL . . . . . 0.672 ' O ' ' N ' ' A' ' 76' ' ' GLY . 97.3 t -40.7 -43.41 0.63 Allowed 'Isoleucine or valine' 0 C--N 1.35 0.592 0 CA-C-O 118.687 -0.673 . . . . 1.0 110.076 -174.164 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 19.4 t-20 -36.75 -19.64 0.01 OUTLIER 'General case' 0 N--CA 1.477 0.882 0 CA-C-O 122.491 1.139 . . . . 1.0 110.533 179.107 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 76' ' ' GLY . . . . . 0.672 ' N ' ' O ' ' A' ' 74' ' ' VAL . . . -50.38 -21.02 4.06 Favored Glycine 0 C--O 1.205 -1.709 0 N-CA-C 108.991 -1.644 . . . . 1.0 108.991 174.321 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 77' ' ' ILE . . . . . 0.437 ' N ' ' O ' ' A' ' 74' ' ' VAL . 6.1 pt -54.49 -46.82 71.39 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.555 0 O-C-N 121.637 -0.92 . . . . 1.0 112.446 -176.934 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 78' ' ' VAL . . . . . 0.405 ' N ' HG13 ' A' ' 77' ' ' ILE . 3.7 t -59.29 -19.24 15.73 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.716 0 O-C-N 121.925 -0.484 . . . . 1.0 111.93 -178.406 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 79' ' ' ILE . . . . . 0.935 ' O ' ' HB2' ' A' ' 83' ' ' ALA . 0.3 OUTLIER -81.39 -46.06 20.46 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.702 0 C-N-CA 119.941 -0.704 . . . . 1.0 111.493 -179.748 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 80' ' ' ALA . . . . . 0.466 ' N ' ' CG1' ' A' ' 79' ' ' ILE . . . -84.17 -18.66 35.94 Favored 'General case' 0 N--CA 1.467 0.384 0 N-CA-C 112.791 0.663 . . . . 1.0 112.791 179.41 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 64.5 mt-10 -84.7 -71.85 0.5 Allowed 'General case' 0 C--O 1.231 0.124 0 N-CA-C 112.964 0.727 . . . . 1.0 112.964 -178.813 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 82' ' ' ASP . . . . . 0.432 ' O ' ' C ' ' A' ' 83' ' ' ALA . 93.4 m-20 -71.05 -18.08 62.58 Favored 'General case' 0 CA--C 1.515 -0.403 0 N-CA-C 111.612 0.227 . . . . 1.0 111.612 -177.669 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 83' ' ' ALA . . . . . 0.935 ' HB2' ' O ' ' A' ' 79' ' ' ILE . . . -36.14 -50.81 0.73 Allowed 'General case' 0 N--CA 1.47 0.575 0 C-N-CA 120.612 -0.435 . . . . 1.0 110.907 177.898 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 84' ' ' LEU . . . . . 0.442 ' C ' ' O ' ' A' ' 83' ' ' ALA . 0.2 OUTLIER -28.79 -46.88 0.05 OUTLIER 'General case' 0 N--CA 1.48 1.054 0 CA-C-N 116.175 -0.466 . . . . 1.0 111.257 -173.825 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 73.8 mt -95.11 -54.67 6.89 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.704 0 N-CA-C 109.831 -0.433 . . . . 1.0 109.831 178.061 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -43.38 -39.98 3.45 Favored 'General case' 0 N--CA 1.465 0.298 0 CA-C-N 115.759 -0.655 . . . . 1.0 110.317 -178.83 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 79.7 tt0 -54.74 -29.74 54.41 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.785 -0.643 . . . . 1.0 110.65 -179.879 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -77.77 -12.46 59.98 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.632 -0.713 . . . . 1.0 109.377 -179.909 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 89' ' ' VAL . . . . . 0.458 ' C ' ' HD2' ' A' ' 91' ' ' PRO . 3.5 t -86.92 39.12 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.448 -0.553 0 N-CA-C 108.172 -1.047 . . . . 1.0 108.172 178.556 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 90' ' ' GLY . . . . . 0.859 ' O ' ' N ' ' A' ' 92' ' ' HIS . . . -55.69 -24.63 40.96 Favored Glycine 0 C--N 1.362 1.997 0 CA-C-O 117.294 -1.837 . . . . 1.0 111.156 176.934 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 91' ' ' PRO . . . . . 0.692 ' HD2' ' N ' ' A' ' 90' ' ' GLY . 26.0 Cg_exo -32.27 -3.74 0.0 OUTLIER 'Trans proline' 0 N--CA 1.507 2.299 0 C-N-CA 123.828 3.018 . . . . 1.0 113.495 173.365 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 92' ' ' HIS . . . . . 0.859 ' N ' ' O ' ' A' ' 90' ' ' GLY . 7.3 t-80 -50.95 -30.83 15.98 Favored 'General case' 0 N--CA 1.443 -0.791 0 N-CA-C 107.098 -1.445 . . . . 1.0 107.098 177.34 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 93' ' ' LEU . . . . . 0.634 ' O ' ' N ' ' A' ' 96' ' ' ALA . 0.4 OUTLIER -59.42 -58.37 8.91 Favored 'General case' 0 C--O 1.214 -0.809 0 CA-C-N 119.064 0.847 . . . . 1.0 109.27 176.808 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 94' ' ' ALA . . . . . 0.503 ' H ' ' HG ' ' A' ' 93' ' ' LEU . . . -48.28 -53.3 17.7 Favored 'General case' 0 C--O 1.221 -0.406 0 N-CA-C 106.56 -1.644 . . . . 1.0 106.56 -178.712 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 95' ' ' ARG . . . . . 0.557 HH21 ' HB3' ' A' ' 91' ' ' PRO . 0.0 OUTLIER -59.5 -26.5 65.34 Favored 'General case' 0 C--N 1.305 -1.339 0 N-CA-C 108.699 -0.852 . . . . 1.0 108.699 176.328 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 96' ' ' ALA . . . . . 0.84 ' O ' ' N ' ' A' ' 100' ' ' ILE . . . -59.31 -52.55 65.16 Favored 'General case' 0 C--O 1.202 -1.43 0 N-CA-C 106.735 -1.58 . . . . 1.0 106.735 179.624 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 97' ' ' LEU . . . . . 0.532 ' O ' HG22 ' A' ' 100' ' ' ILE . 1.5 mt -38.3 -32.11 0.06 Allowed 'General case' 0 CA--C 1.576 1.976 0 N-CA-C 107.401 -1.333 . . . . 1.0 107.401 -179.439 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 98' ' ' GLY . . . . . 0.479 ' N ' ' O ' ' A' ' 96' ' ' ALA . . . -82.09 -52.14 4.17 Favored Glycine 0 CA--C 1.551 2.332 0 CA-C-O 123.422 1.568 . . . . 1.0 111.356 173.897 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 99' ' ' GLN . . . . . 0.435 ' N ' ' O ' ' A' ' 96' ' ' ALA . 76.1 mm-40 -78.39 9.63 3.76 Favored 'General case' 0 N--CA 1.434 -1.235 0 N-CA-C 108.185 -1.042 . . . . 1.0 108.185 178.794 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 100' ' ' ILE . . . . . 0.84 ' N ' ' O ' ' A' ' 96' ' ' ALA . 1.1 tt -59.49 -51.46 72.39 Favored 'Isoleucine or valine' 0 CA--C 1.477 -1.85 0 N-CA-C 108.015 -1.106 . . . . 1.0 108.015 179.917 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 101' ' ' VAL . . . . . 0.687 ' N ' HG23 ' A' ' 100' ' ' ILE . 70.6 t -57.2 -57.23 10.84 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.768 0 C-N-CA 116.666 -2.014 . . . . 1.0 106.627 178.307 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 102' ' ' CYS . . . . . 0.969 ' O ' ' HB2' ' A' ' 106' ' ' ALA . 1.9 t -45.13 -23.09 0.13 Allowed 'General case' 0 C--O 1.218 -0.584 0 C-N-CA 119.559 -0.857 . . . . 1.0 110.809 -177.573 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 103' ' ' ARG . . . . . 0.417 HH11 ' HG3' ' A' ' 103' ' ' ARG . 0.0 OUTLIER -91.29 -43.19 9.95 Favored 'General case' 0 CA--C 1.541 0.627 0 CA-C-O 122.095 0.95 . . . . 1.0 113.147 179.302 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 104' ' ' TYR . . . . . 0.746 ' O ' ' CG ' ' A' ' 104' ' ' TYR . 0.2 OUTLIER -102.88 21.55 15.41 Favored 'General case' 0 C--N 1.31 -1.146 0 CA-C-N 113.292 -1.776 . . . . 1.0 109.886 179.813 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 105' ' ' GLY . . . . . 0.766 ' O ' ' N ' ' A' ' 107' ' ' THR . . . -166.01 -14.52 0.02 OUTLIER Glycine 0 C--O 1.215 -1.093 0 C-N-CA 118.381 -1.866 . . . . 1.0 111.39 178.193 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 106' ' ' ALA . . . . . 0.969 ' HB2' ' O ' ' A' ' 102' ' ' CYS . . . -13.87 65.86 0.0 OUTLIER 'General case' 0 N--CA 1.478 0.933 0 O-C-N 124.742 0.907 . . . . 1.0 112.002 -179.876 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 107' ' ' THR . . . . . 0.766 ' N ' ' O ' ' A' ' 105' ' ' GLY . 99.5 m -101.25 -4.37 27.25 Favored 'General case' 0 N--CA 1.452 -0.348 0 CA-C-N 115.869 -0.605 . . . . 1.0 110.048 -179.419 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 108' ' ' VAL . . . . . 0.714 HG23 ' N ' ' A' ' 109' ' ' ILE . 33.3 m -85.19 -58.22 3.68 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.466 0 N-CA-C 111.647 0.24 . . . . 1.0 111.647 -178.579 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 109' ' ' ILE . . . . . 0.714 ' N ' HG23 ' A' ' 108' ' ' VAL . 0.3 OUTLIER -47.79 -43.37 52.08 Favored Pre-proline 0 C--N 1.353 0.754 0 N-CA-C 112.709 0.633 . . . . 1.0 112.709 179.244 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 110' ' ' PRO . . . . . 0.61 ' HD2' ' N ' ' A' ' 109' ' ' ILE . 7.9 Cg_endo -40.51 -38.32 2.43 Favored 'Trans proline' 0 N--CA 1.482 0.81 0 C-N-CA 121.154 1.236 . . . . 1.0 113.126 -175.4 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 16.8 t-20 -64.56 -68.26 0.37 Allowed 'General case' 0 C--N 1.315 -0.906 0 C-N-CA 118.601 -1.24 . . . . 1.0 110.726 -178.344 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 112' ' ' ILE . . . . . 0.42 ' H ' HG23 ' A' ' 112' ' ' ILE . 2.0 pt -67.59 -27.8 39.63 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.54 0 CA-C-O 121.841 0.829 . . . . 1.0 111.547 -178.004 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 113' ' ' ASN . . . . . 0.622 HD22 ' N ' ' A' ' 114' ' ' ALA . 0.3 OUTLIER -54.98 -61.51 2.26 Favored 'General case' 0 C--N 1.306 -1.304 0 CA-C-N 114.075 -1.42 . . . . 1.0 109.837 -175.281 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 114' ' ' ALA . . . . . 0.622 ' N ' HD22 ' A' ' 113' ' ' ASN . . . -61.81 -22.55 65.56 Favored 'General case' 0 C--N 1.306 -1.301 0 CA-C-N 116.063 -0.517 . . . . 1.0 110.709 -179.979 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -78.48 -60.74 2.25 Favored 'General case' 0 N--CA 1.448 -0.532 0 N-CA-C 112.715 0.635 . . . . 1.0 112.715 178.278 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 116' ' ' ILE . . . . . 0.476 ' O ' ' CB ' ' A' ' 119' ' ' LEU . 95.3 mt -69.4 -46.21 77.03 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.323 0 O-C-N 120.477 -1.39 . . . . 1.0 112.359 -177.094 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 117' ' ' GLU . . . . . 0.462 ' OE1' ' ND2' ' A' ' 113' ' ' ASN . 94.9 mt-10 -47.59 -64.37 0.8 Allowed 'General case' 0 C--N 1.316 -0.856 0 CA-C-N 115.538 -0.755 . . . . 1.0 110.109 -176.994 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 4.1 p -51.71 -15.14 0.48 Allowed 'Isoleucine or valine' 0 N--CA 1.437 -1.107 0 CA-C-N 115.4 -0.818 . . . . 1.0 109.251 -179.662 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 119' ' ' LEU . . . . . 0.476 ' CB ' ' O ' ' A' ' 116' ' ' ILE . 1.6 tt -77.13 -61.07 2.11 Favored 'General case' 0 C--N 1.348 0.508 0 C-N-CA 119.116 -1.033 . . . . 1.0 109.328 177.949 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -70.39 -81.21 0.26 Allowed Glycine 0 C--N 1.355 1.618 0 C-N-CA 117.259 -2.4 . . . . 1.0 111.076 179.55 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 121' ' ' THR . . . . . 0.4 ' H ' ' H ' ' A' ' 122' ' ' GLY . 45.2 m -160.41 -17.82 0.06 Allowed 'General case' 0 CA--C 1.54 0.592 0 CA-C-O 121.414 0.626 . . . . 1.0 109.97 -179.595 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 122' ' ' GLY . . . . . 0.441 ' O ' ' C ' ' A' ' 123' ' ' THR . . . 109.88 -36.8 4.09 Favored Glycine 0 N--CA 1.476 1.327 0 C-N-CA 125.215 1.388 . . . . 1.0 111.888 179.96 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 123' ' ' THR . . . . . 0.599 HG23 ' O ' ' A' ' 123' ' ' THR . 4.2 t -31.17 94.98 0.01 OUTLIER 'General case' 0 N--CA 1.473 0.676 0 CA-C-N 118.47 1.135 . . . . 1.0 112.675 -178.708 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 124' ' ' ASP . . . . . 0.407 ' N ' ' O ' ' A' ' 122' ' ' GLY . 73.1 m-20 -143.67 144.58 31.93 Favored 'General case' 0 C--N 1.33 -0.275 0 N-CA-C 108.56 -0.904 . . . . 1.0 108.56 178.571 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 125' ' ' TYR . . . . . 0.433 ' O ' ' NE ' ' A' ' 126' ' ' ARG . 0.0 OUTLIER -151.74 148.96 28.52 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.763 0.316 . . . . 1.0 110.305 -178.525 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 126' ' ' ARG . . . . . 0.548 ' HB3' ' H62' ' A' ' 130' ' ' MTN . 0.0 OUTLIER -149.85 151.78 34.05 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.167 -0.47 . . . . 1.0 110.006 177.928 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 127' ' ' PHE . . . . . 0.43 ' OXT' ' CD2' ' A' ' 92' ' ' HIS . 0.1 OUTLIER . . . . . 0 C--O 1.22 -0.481 0 CA-C-O 117.873 -1.06 . . . . 1.0 110.398 -178.57 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 128' ' ' MTN . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 129' ' ' MTN . . . . . 0.441 ' S1 ' ' C ' ' A' ' 48' ' ' CYS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 130' ' ' MTN . . . . . 0.548 ' H62' ' HB3' ' A' ' 126' ' ' ARG . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 2.2 mpt? . . . . . 0 N--CA 1.491 1.612 0 N-CA-C 109.139 -0.689 . . . . 1.0 109.139 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 51.9 m -95.64 1.72 53.75 Favored 'General case' 0 N--CA 1.463 0.187 0 CA-C-N 116.449 -0.341 . . . . 1.0 110.913 -179.825 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER 169.56 106.68 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.361 -0.381 . . . . 1.0 110.274 -179.94 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 18.2 t80 -149.21 145.53 27.17 Favored 'General case' 0 C--N 1.33 -0.254 0 N-CA-C 109.723 -0.473 . . . . 1.0 109.723 178.896 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 14.4 m-20 -152.82 147.71 26.34 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.359 -0.382 . . . . 1.0 110.117 -179.025 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 6' ' ' THR . . . . . 1.008 ' H ' HG23 ' A' ' 9' ' ' VAL . 0.2 OUTLIER -103.88 -165.97 1.21 Allowed 'General case' 0 C--O 1.206 -1.191 0 CA-C-O 121.51 0.671 . . . . 1.0 109.386 178.931 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 7' ' ' GLU . . . . . 0.728 ' O ' ' HB2' ' A' ' 11' ' ' ARG . 27.5 tt0 -58.92 -45.31 90.67 Favored 'General case' 0 C--N 1.304 -1.371 0 CA-C-O 121.891 0.853 . . . . 1.0 110.548 -179.801 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 8' ' ' ARG . . . . . 0.693 ' O ' ' HB3' ' A' ' 12' ' ' ALA . 0.1 OUTLIER -67.9 -60.13 2.75 Favored 'General case' 0 C--N 1.306 -1.301 0 C-N-CA 118.953 -1.099 . . . . 1.0 109.482 179.065 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 9' ' ' VAL . . . . . 1.008 HG23 ' H ' ' A' ' 6' ' ' THR . 0.0 OUTLIER -66.32 -50.69 65.9 Favored 'Isoleucine or valine' 0 C--O 1.201 -1.449 0 CA-C-N 115.107 -0.951 . . . . 1.0 110.686 -178.777 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 10' ' ' SER . . . . . 0.657 ' N ' ' O ' ' A' ' 6' ' ' THR . 2.5 t -65.69 -62.23 1.63 Allowed 'General case' 0 N--CA 1.488 1.447 0 C-N-CA 120.025 -0.67 . . . . 1.0 111.176 179.185 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 11' ' ' ARG . . . . . 0.728 ' HB2' ' O ' ' A' ' 7' ' ' GLU . 4.6 mmt85 -64.87 -41.18 95.88 Favored 'General case' 0 CA--C 1.547 0.861 0 CA-C-O 119.302 -0.38 . . . . 1.0 111.792 -177.213 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 12' ' ' ALA . . . . . 0.693 ' HB3' ' O ' ' A' ' 8' ' ' ARG . . . -69.61 -54.17 15.28 Favored 'General case' 0 N--CA 1.483 1.19 0 C-N-CA 118.165 -1.414 . . . . 1.0 108.125 175.84 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 13' ' ' VAL . . . . . 0.643 ' O ' ' CB ' ' A' ' 17' ' ' LEU . 60.3 t -61.67 -55.02 27.07 Favored 'Isoleucine or valine' 0 C--O 1.198 -1.647 0 C-N-CA 117.423 -1.711 . . . . 1.0 108.438 -179.033 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 14' ' ' ALA . . . . . 0.793 ' O ' HG22 ' A' ' 18' ' ' VAL . . . -57.1 -62.27 1.87 Allowed 'General case' 0 C--O 1.211 -0.925 0 C-N-CA 118.542 -1.263 . . . . 1.0 109.95 179.653 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 15' ' ' ALA . . . . . 0.537 ' HB3' ' O ' ' A' ' 11' ' ' ARG . . . -55.34 -55.66 28.94 Favored 'General case' 0 N--CA 1.475 0.805 0 C-N-CA 118.807 -1.157 . . . . 1.0 110.517 -176.952 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 16' ' ' ALA . . . . . 0.612 ' HB3' ' O ' ' A' ' 12' ' ' ALA . . . -65.66 -55.98 14.58 Favored 'General case' 0 CA--C 1.547 0.847 0 C-N-CA 119.761 -0.776 . . . . 1.0 110.033 -178.889 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 17' ' ' LEU . . . . . 0.643 ' CB ' ' O ' ' A' ' 13' ' ' VAL . 7.3 tp -56.8 -57.58 11.83 Favored 'General case' 0 N--CA 1.483 1.186 0 CA-C-N 115.397 -0.819 . . . . 1.0 108.827 -178.965 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 18' ' ' VAL . . . . . 0.793 HG22 ' O ' ' A' ' 14' ' ' ALA . 1.3 m -71.82 -58.22 5.61 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.423 0 C-N-CA 119.282 -0.967 . . . . 1.0 110.772 -179.536 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 19' ' ' GLY . . . . . 0.489 ' N ' ' O ' ' A' ' 15' ' ' ALA . . . -56.34 -172.94 0.16 Allowed Glycine 0 CA--C 1.519 0.341 0 C-N-CA 120.924 -0.655 . . . . 1.0 112.109 -177.768 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 20' ' ' PRO . . . . . 0.605 ' O ' ' N ' ' A' ' 24' ' ' ALA . 1.7 Cg_endo -81.05 -21.96 6.36 Favored 'Trans proline' 0 C--N 1.308 -1.581 0 C-N-CA 123.122 2.548 . . . . 1.0 112.501 -178.841 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -63.35 -62.03 5.76 Favored Glycine 0 N--CA 1.478 1.437 0 C-N-CA 119.687 -1.245 . . . . 1.0 112.906 -176.492 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 22' ' ' GLY . . . . . 0.587 ' H ' ' HA ' ' A' ' 16' ' ' ALA . . . -55.44 -52.03 50.56 Favored Glycine 0 N--CA 1.472 1.048 0 N-CA-C 106.277 -2.729 . . . . 1.0 106.277 -179.255 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 23' ' ' VAL . . . . . 0.488 ' O ' HG12 ' A' ' 27' ' ' VAL . 26.7 t -58.23 -31.81 43.12 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.731 0 C-N-CA 119.455 -0.898 . . . . 1.0 108.966 178.326 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 24' ' ' ALA . . . . . 0.605 ' N ' ' O ' ' A' ' 20' ' ' PRO . . . -60.2 -61.97 2.21 Favored 'General case' 0 N--CA 1.481 1.09 0 C-N-CA 118.616 -1.233 . . . . 1.0 109.677 178.614 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 25' ' ' LEU . . . . . 0.724 HD12 ' O ' ' A' ' 25' ' ' LEU . 0.9 OUTLIER -60.33 -50.35 73.98 Favored 'General case' 0 N--CA 1.478 0.938 0 N-CA-C 112.633 0.605 . . . . 1.0 112.633 -178.482 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 86.0 t -57.89 -59.44 3.42 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.021 0 C-N-CA 118.986 -1.086 . . . . 1.0 110.612 -177.204 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 27' ' ' VAL . . . . . 0.598 ' O ' ' HB3' ' A' ' 31' ' ' ALA . 1.2 p -58.41 -36.54 59.18 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.687 0 C-N-CA 120.672 -0.411 . . . . 1.0 111.16 -178.089 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 20.9 tttt -65.84 -56.57 11.2 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-O 121.463 0.649 . . . . 1.0 109.884 -179.706 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 25.1 t -63.51 -49.27 83.3 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.54 0 CA-C-N 115.292 -0.867 . . . . 1.0 111.088 -177.776 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 30' ' ' CYS . . . . . . . . . . . . . 14.0 t -63.54 -61.61 2.21 Favored 'General case' 0 C--N 1.316 -0.849 0 C-N-CA 118.901 -1.12 . . . . 1.0 109.43 -179.396 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 31' ' ' ALA . . . . . 0.628 ' O ' HD12 ' A' ' 37' ' ' ILE . . . -58.44 -50.89 72.07 Favored 'General case' 0 C--N 1.319 -0.718 0 C-N-CA 120.553 -0.459 . . . . 1.0 110.847 -178.416 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 32' ' ' GLY . . . . . 0.527 ' O ' ' CB ' ' A' ' 33' ' ' LEU . . . 74.51 67.85 1.67 Allowed Glycine 0 CA--C 1.518 0.238 0 N-CA-C 108.158 -1.977 . . . . 1.0 108.158 -178.383 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 33' ' ' LEU . . . . . 0.601 HD23 ' CG2' ' A' ' 36' ' ' VAL . 13.5 tp 94.34 81.31 0.03 OUTLIER Pre-proline 0 CA--C 1.54 0.588 0 CA-C-N 114.457 -0.871 . . . . 1.0 109.663 -177.719 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 13.0 Cg_endo -54.53 -23.08 30.35 Favored 'Trans proline' 0 N--CA 1.502 2.027 0 C-N-CA 121.637 1.558 . . . . 1.0 113.952 -179.276 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 35' ' ' GLY . . . . . 0.949 ' O ' HD12 ' A' ' 112' ' ' ILE . . . -62.56 -61.61 6.37 Favored Glycine 0 CA--C 1.536 1.356 0 C-N-CA 117.873 -2.108 . . . . 1.0 109.863 -178.403 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 36' ' ' VAL . . . . . 0.641 ' O ' HG22 ' A' ' 37' ' ' ILE . 2.6 m -95.57 178.39 0.59 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.519 0 N-CA-C 107.965 -1.124 . . . . 1.0 107.965 176.579 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 37' ' ' ILE . . . . . 0.641 HG22 ' O ' ' A' ' 36' ' ' VAL . 0.1 OUTLIER 102.56 121.94 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.479 0.989 0 O-C-N 124.297 0.998 . . . . 1.0 112.036 179.601 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 81.3 m-70 -143.2 135.29 26.98 Favored 'General case' 0 N--CA 1.463 0.198 0 N-CA-C 109.073 -0.714 . . . . 1.0 109.073 178.445 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 39' ' ' THR . . . . . 0.403 ' O ' ' CG ' ' A' ' 42' ' ' ARG . 0.0 OUTLIER -90.62 115.83 65.05 Favored Pre-proline 0 CA--C 1.546 0.804 0 N-CA-C 109.329 -0.619 . . . . 1.0 109.329 179.774 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 50.2 Cg_exo -49.01 -32.63 23.97 Favored 'Trans proline' 0 N--CA 1.496 1.619 0 C-N-CA 121.678 1.585 . . . . 1.0 113.569 -179.053 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -111.34 93.67 4.59 Favored 'General case' 0 CA--C 1.513 -0.459 0 N-CA-C 114.051 1.13 . . . . 1.0 114.051 -175.12 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 42' ' ' ARG . . . . . 0.42 ' C ' ' N ' ' A' ' 44' ' ' GLY . 0.2 OUTLIER -141.6 143.06 33.49 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 114.589 -1.187 . . . . 1.0 108.271 178.806 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 43' ' ' ARG . . . . . 0.441 HH22 ' HB3' ' A' ' 59' ' ' ARG . 14.9 tpt85 -50.49 -13.35 0.12 Allowed 'General case' 0 C--N 1.322 -0.6 0 C-N-CA 120.447 -0.501 . . . . 1.0 110.806 -177.164 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 44' ' ' GLY . . . . . 0.42 ' N ' ' C ' ' A' ' 42' ' ' ARG . . . 121.08 -23.52 7.68 Favored Glycine 0 N--CA 1.472 1.095 0 N-CA-C 110.346 -1.102 . . . . 1.0 110.346 179.823 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 45' ' ' PHE . . . . . 0.541 ' O ' ' CB ' ' A' ' 46' ' ' PHE . 36.0 p90 -152.25 159.6 43.51 Favored 'General case' 0 C--N 1.327 -0.391 0 N-CA-C 108.601 -0.889 . . . . 1.0 108.601 177.618 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 46' ' ' PHE . . . . . 0.541 ' CB ' ' O ' ' A' ' 45' ' ' PHE . 4.7 t80 117.24 103.11 0.0 OUTLIER 'General case' 0 N--CA 1.487 1.41 0 O-C-N 124.61 1.194 . . . . 1.0 110.274 -179.954 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 47' ' ' ARG . . . . . 0.541 HH12 ' H91' ' A' ' 128' ' ' MTN . 6.5 ptp180 120.5 135.68 0.0 OUTLIER 'General case' 0 N--CA 1.488 1.453 0 C-N-CA 124.886 1.274 . . . . 1.0 110.557 179.609 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 48' ' ' CYS . . . . . 0.821 ' O ' ' H62' ' A' ' 129' ' ' MTN . 2.6 t 67.61 73.68 0.32 Allowed 'General case' 0 C--O 1.218 -0.588 0 C-N-CA 119.718 -0.793 . . . . 1.0 110.229 177.939 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 49' ' ' ASN . . . . . 0.767 ' H ' HD22 ' A' ' 49' ' ' ASN . 0.0 OUTLIER -135.82 153.56 77.29 Favored Pre-proline 0 N--CA 1.47 0.542 0 CA-C-O 119.427 -0.321 . . . . 1.0 110.173 -178.634 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 50' ' ' PRO . . . . . 0.42 ' C ' ' H ' ' A' ' 52' ' ' ARG . 33.7 Cg_endo -60.31 47.84 0.07 OUTLIER 'Trans proline' 0 N--CA 1.509 2.431 0 C-N-CA 122.763 2.308 . . . . 1.0 113.278 179.503 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 51' ' ' GLU . . . . . 0.491 ' N ' ' O ' ' A' ' 49' ' ' ASN . 15.8 mp0 70.77 -18.5 0.25 Allowed 'General case' 0 N--CA 1.47 0.561 0 C-N-CA 123.571 0.748 . . . . 1.0 111.486 179.697 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 52' ' ' ARG . . . . . 0.42 ' H ' ' C ' ' A' ' 50' ' ' PRO . 1.6 mpp_? -56.92 138.78 53.44 Favored 'General case' 0 CA--C 1.531 0.242 0 N-CA-C 109.436 -0.579 . . . . 1.0 109.436 179.445 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 53' ' ' ILE . . . . . 0.647 HG23 HG22 ' A' ' 55' ' ' ILE . 2.6 tp -58.91 129.83 21.54 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-N 115.551 -0.75 . . . . 1.0 110.917 -179.188 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 54' ' ' GLN . . . . . 0.511 ' NE2' ' OD1' ' A' ' 49' ' ' ASN . 0.0 OUTLIER -59.34 79.26 0.01 OUTLIER 'General case' 0 CA--C 1.537 0.474 0 N-CA-C 108.28 -1.007 . . . . 1.0 108.28 -178.014 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 55' ' ' ILE . . . . . 0.647 HG22 HG23 ' A' ' 53' ' ' ILE . 13.9 tt -154.49 162.97 1.79 Allowed 'Isoleucine or valine' 0 CA--C 1.523 -0.066 0 CA-C-N 114.802 -1.09 . . . . 1.0 111.325 178.438 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 100.81 -28.07 17.67 Favored Glycine 0 N--CA 1.452 -0.25 0 N-CA-C 111.943 -0.463 . . . . 1.0 111.943 176.849 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 12.9 m-20 -67.81 135.53 52.74 Favored 'General case' 0 N--CA 1.446 -0.646 0 CA-C-O 122.807 1.289 . . . . 1.0 113.661 -177.42 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 58' ' ' TRP . . . . . . . . . . . . . 32.4 m0 -78.13 -179.06 5.93 Favored 'General case' 0 N--CA 1.44 -0.964 0 CA-C-N 112.484 -2.143 . . . . 1.0 107.235 177.293 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 59' ' ' ARG . . . . . 0.65 ' H ' ' CD ' ' A' ' 59' ' ' ARG . 0.0 OUTLIER -99.05 -56.12 2.51 Favored 'General case' 0 CA--C 1.557 1.232 0 CA-C-N 119.646 1.112 . . . . 1.0 111.896 -179.734 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 60' ' ' TYR . . . . . 0.401 ' H ' ' HD2' ' A' ' 59' ' ' ARG . 24.8 t80 -78.66 -7.24 57.47 Favored 'General case' 0 N--CA 1.481 1.119 0 C-N-CA 125.429 1.492 . . . . 1.0 111.688 -178.418 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 69.4 tt0 -71.36 -13.89 62.01 Favored 'General case' 0 C--N 1.296 -1.749 0 CA-C-N 114.944 -1.025 . . . . 1.0 109.358 179.814 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 62' ' ' VAL . . . . . 0.513 ' O ' ' N ' ' A' ' 66' ' ' GLY . 10.4 m -44.51 -51.83 1.73 Allowed 'Isoleucine or valine' 0 CA--C 1.496 -1.133 0 C-N-CA 120.449 -0.501 . . . . 1.0 110.36 -175.448 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 63' ' ' ALA . . . . . 0.669 ' O ' ' HG2' ' A' ' 67' ' ' ARG . . . -65.51 -48.15 73.51 Favored 'General case' 0 N--CA 1.421 -1.919 0 N-CA-C 109.223 -0.658 . . . . 1.0 109.223 179.517 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 64' ' ' HIS . . . . . 0.408 ' O ' ' CG ' ' A' ' 67' ' ' ARG . 1.2 m-70 -54.57 -58.47 7.35 Favored 'General case' 0 CA--C 1.548 0.89 0 O-C-N 123.913 0.758 . . . . 1.0 110.368 179.829 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 65' ' ' ASP . . . . . 0.65 ' C ' ' H ' ' A' ' 67' ' ' ARG . 23.8 t70 -67.45 -53.38 29.43 Favored 'General case' 0 C--O 1.24 0.604 0 CA-C-O 121.15 0.5 . . . . 1.0 109.751 178.264 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 66' ' ' GLY . . . . . 0.513 ' N ' ' O ' ' A' ' 62' ' ' VAL . . . -63.72 30.94 0.09 OUTLIER Glycine 0 CA--C 1.527 0.826 0 N-CA-C 110.866 -0.894 . . . . 1.0 110.866 177.65 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 67' ' ' ARG . . . . . 0.669 ' HG2' ' O ' ' A' ' 63' ' ' ALA . 24.1 mmm-85 -80.25 -3.73 50.39 Favored 'General case' 0 N--CA 1.448 -0.567 0 N-CA-C 107.704 -1.221 . . . . 1.0 107.704 175.855 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 68' ' ' LEU . . . . . 0.476 ' O ' ' HA ' ' A' ' 72' ' ' HIS . 4.9 tt -35.1 -29.86 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.792 0 N-CA-C 107.705 -1.22 . . . . 1.0 107.705 -178.741 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 69' ' ' LEU . . . . . 0.818 HD23 ' H ' ' A' ' 70' ' ' ALA . 1.2 pt? -62.92 -62.34 1.78 Allowed 'General case' 0 N--CA 1.48 1.048 0 C-N-CA 117.121 -1.832 . . . . 1.0 106.914 177.689 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 70' ' ' ALA . . . . . 0.818 ' H ' HD23 ' A' ' 69' ' ' LEU . . . -77.56 -72.55 0.35 Allowed 'General case' 0 C--O 1.214 -0.777 0 N-CA-C 106.663 -1.606 . . . . 1.0 106.663 178.057 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 71' ' ' ALA . . . . . 0.511 ' O ' ' C ' ' A' ' 72' ' ' HIS . . . -45.06 3.72 0.0 OUTLIER 'General case' 0 CA--C 1.516 -0.355 0 C-N-CA 124.402 1.081 . . . . 1.0 112.847 177.633 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 72' ' ' HIS . . . . . 0.687 ' H ' ' C ' ' A' ' 70' ' ' ALA . 0.0 OUTLIER -21.57 -68.29 0.03 OUTLIER 'General case' 0 CA--C 1.518 -0.275 0 C-N-CA 122.872 0.469 . . . . 1.0 111.437 -176.8 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 73' ' ' MET . . . . . 0.563 ' N ' ' ND1' ' A' ' 72' ' ' HIS . 32.6 mtt -73.51 -48.02 36.51 Favored 'General case' 0 C--N 1.31 -1.148 0 C-N-CA 119.069 -1.052 . . . . 1.0 109.151 177.355 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 74' ' ' VAL . . . . . 0.677 ' O ' ' N ' ' A' ' 76' ' ' GLY . 65.5 t -43.79 -49.21 1.78 Allowed 'Isoleucine or valine' 0 C--O 1.22 -0.497 0 CA-C-O 118.141 -0.933 . . . . 1.0 111.04 -176.146 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 75' ' ' ASN . . . . . 0.47 ' C ' ' N ' ' A' ' 77' ' ' ILE . 21.8 t30 -36.52 -20.34 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.746 0 CA-C-N 120.238 1.381 . . . . 1.0 110.312 177.755 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 76' ' ' GLY . . . . . 0.677 ' N ' ' O ' ' A' ' 74' ' ' VAL . . . -49.3 -20.87 2.51 Favored Glycine 0 C--O 1.216 -1.019 0 N-CA-C 107.948 -2.061 . . . . 1.0 107.948 174.885 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 77' ' ' ILE . . . . . 0.477 ' N ' ' O ' ' A' ' 74' ' ' VAL . 82.2 mt -53.27 -43.77 51.49 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.133 0 O-C-N 122.635 -0.333 . . . . 1.0 111.019 -178.044 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 42.5 t -50.44 -19.78 0.79 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.424 0 CA-C-N 118.667 0.667 . . . . 1.0 111.978 -179.445 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 79' ' ' ILE . . . . . 0.747 ' O ' ' HB2' ' A' ' 83' ' ' ALA . 0.3 OUTLIER -90.15 -38.67 11.27 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.077 0 C-N-CA 120.007 -0.677 . . . . 1.0 111.543 179.466 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -82.37 -27.36 32.17 Favored 'General case' 0 CA--C 1.541 0.633 0 N-CA-C 113.116 0.784 . . . . 1.0 113.116 -179.255 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 81' ' ' GLU . . . . . 0.644 ' CG ' ' N ' ' A' ' 82' ' ' ASP . 12.6 pt-20 -84.3 -67.63 0.78 Allowed 'General case' 0 CA--C 1.544 0.72 0 N-CA-C 110.152 -0.314 . . . . 1.0 110.152 178.171 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 82' ' ' ASP . . . . . 0.644 ' N ' ' CG ' ' A' ' 81' ' ' GLU . 67.1 m-20 -66.25 -20.05 66.0 Favored 'General case' 0 CA--C 1.495 -1.164 0 O-C-N 121.269 -0.894 . . . . 1.0 112.384 -177.664 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 83' ' ' ALA . . . . . 0.747 ' HB2' ' O ' ' A' ' 79' ' ' ILE . . . -18.65 -55.03 0.01 OUTLIER 'General case' 0 N--CA 1.468 0.465 0 CA-C-O 118.946 -0.549 . . . . 1.0 111.846 176.642 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 84' ' ' LEU . . . . . 0.449 ' N ' ' O ' ' A' ' 82' ' ' ASP . 3.8 mm? -28.0 -53.78 0.09 Allowed 'General case' 0 N--CA 1.484 1.227 0 CA-C-N 119.657 1.117 . . . . 1.0 113.43 -177.896 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 85' ' ' ILE . . . . . 0.599 ' O ' ' HB3' ' A' ' 88' ' ' ALA . 15.6 pt -91.05 -35.43 7.15 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 C-N-CA 120.587 -0.445 . . . . 1.0 109.811 -179.404 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 86' ' ' ALA . . . . . 0.797 ' O ' HG13 ' A' ' 89' ' ' VAL . . . -52.92 -54.92 27.79 Favored 'General case' 0 C--N 1.33 -0.244 0 C-N-CA 120.376 -0.529 . . . . 1.0 109.685 -179.514 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 87' ' ' GLU . . . . . 0.405 ' OE1' ' C ' ' A' ' 87' ' ' GLU . 9.0 tm-20 -57.4 -21.04 33.67 Favored 'General case' 0 C--N 1.33 -0.277 0 C-N-CA 120.062 -0.655 . . . . 1.0 109.508 179.304 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 88' ' ' ALA . . . . . 0.696 ' C ' ' H ' ' A' ' 90' ' ' GLY . . . -73.36 -13.51 61.11 Favored 'General case' 0 C--O 1.225 -0.192 0 C-N-CA 120.352 -0.539 . . . . 1.0 109.923 179.457 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 89' ' ' VAL . . . . . 0.797 HG13 ' O ' ' A' ' 86' ' ' ALA . 27.8 m -49.09 11.4 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.48 1.037 0 N-CA-C 113.27 0.841 . . . . 1.0 113.27 -178.979 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 90' ' ' GLY . . . . . 0.73 ' O ' ' N ' ' A' ' 92' ' ' HIS . . . -34.37 -42.12 0.27 Allowed Glycine 0 CA--C 1.543 1.83 0 CA-C-O 117.871 -1.516 . . . . 1.0 110.561 -177.26 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 91' ' ' PRO . . . . . 0.495 ' HD2' ' N ' ' A' ' 90' ' ' GLY . 1.1 Cg_endo -44.64 0.76 0.01 OUTLIER 'Trans proline' 0 N--CA 1.5 1.911 0 CA-C-N 121.292 2.546 . . . . 1.0 110.925 170.724 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 92' ' ' HIS . . . . . 0.73 ' N ' ' O ' ' A' ' 90' ' ' GLY . 55.6 t60 -51.17 -41.7 60.33 Favored 'General case' 0 CA--C 1.51 -0.589 0 N-CA-C 109.21 -0.663 . . . . 1.0 109.21 -177.454 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 39.0 tp -63.03 -39.86 96.0 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 119.17 0.895 . . . . 1.0 110.349 177.718 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -61.8 -60.21 4.0 Favored 'General case' 0 CA--C 1.496 -1.116 0 N-CA-C 106.085 -1.82 . . . . 1.0 106.085 -179.398 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 95' ' ' ARG . . . . . 0.417 HH12 ' HD3' ' A' ' 20' ' ' PRO . 3.7 mmp_? -57.8 -29.92 65.27 Favored 'General case' 0 N--CA 1.432 -1.34 0 CA-C-N 115.29 -0.868 . . . . 1.0 108.738 177.825 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 96' ' ' ALA . . . . . 0.806 ' O ' ' N ' ' A' ' 100' ' ' ILE . . . -59.04 -53.81 54.21 Favored 'General case' 0 C--O 1.198 -1.617 0 C-N-CA 118.127 -1.429 . . . . 1.0 108.558 -176.73 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 97' ' ' LEU . . . . . 0.487 ' C ' ' O ' ' A' ' 96' ' ' ALA . 1.2 tt -34.46 -28.82 0.01 OUTLIER 'General case' 0 CA--C 1.565 1.521 0 O-C-N 124.341 1.026 . . . . 1.0 108.59 -177.929 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 98' ' ' GLY . . . . . 0.616 ' N ' ' O ' ' A' ' 96' ' ' ALA . . . -88.62 -53.08 2.67 Favored Glycine 0 CA--C 1.543 1.829 0 CA-C-O 123.589 1.66 . . . . 1.0 111.401 174.144 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 99' ' ' GLN . . . . . 0.487 ' N ' ' O ' ' A' ' 96' ' ' ALA . 6.1 tt0 -78.73 6.18 9.52 Favored 'General case' 0 N--CA 1.433 -1.309 0 CA-C-N 114.473 -0.864 . . . . 1.0 108.991 178.693 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 100' ' ' ILE . . . . . 0.806 ' N ' ' O ' ' A' ' 96' ' ' ALA . 0.2 OUTLIER -63.8 -47.09 92.46 Favored 'Isoleucine or valine' 0 CA--C 1.495 -1.159 0 N-CA-C 108.022 -1.103 . . . . 1.0 108.022 179.948 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 101' ' ' VAL . . . . . 0.628 HG23 ' H ' ' A' ' 102' ' ' CYS . 17.6 m -55.54 -60.01 2.08 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.477 0 C-N-CA 117.035 -1.866 . . . . 1.0 108.958 179.65 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 102' ' ' CYS . . . . . 0.628 ' H ' HG23 ' A' ' 101' ' ' VAL . 42.3 t -41.11 -19.71 0.01 OUTLIER 'General case' 0 C--N 1.311 -1.075 0 N-CA-C 113.217 0.821 . . . . 1.0 113.217 -176.231 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 103' ' ' ARG . . . . . 0.517 ' N ' ' O ' ' A' ' 101' ' ' VAL . 7.6 ttp180 -89.98 -35.27 15.64 Favored 'General case' 0 N--CA 1.497 1.922 0 N-CA-C 114.534 1.309 . . . . 1.0 114.534 178.956 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 104' ' ' TYR . . . . . 0.649 ' O ' ' CG ' ' A' ' 104' ' ' TYR . 0.0 OUTLIER -100.18 22.97 10.63 Favored 'General case' 0 C--N 1.303 -1.45 0 CA-C-N 113.188 -1.824 . . . . 1.0 110.076 -179.816 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 105' ' ' GLY . . . . . 0.535 ' O ' ' HB3' ' A' ' 106' ' ' ALA . . . -161.5 -88.15 0.07 OUTLIER Glycine 0 N--CA 1.451 -0.33 0 N-CA-C 107.413 -2.275 . . . . 1.0 107.413 179.64 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 106' ' ' ALA . . . . . 0.561 ' O ' ' CD ' ' A' ' 110' ' ' PRO . . . 69.53 58.17 0.32 Allowed 'General case' 0 CA--C 1.548 0.895 0 N-CA-C 112.704 0.631 . . . . 1.0 112.704 179.334 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 107' ' ' THR . . . . . 0.498 ' O ' ' HD2' ' A' ' 110' ' ' PRO . 20.0 m -76.41 -57.84 3.63 Favored 'General case' 0 N--CA 1.48 1.037 0 O-C-N 121.257 -0.902 . . . . 1.0 109.384 179.555 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 108' ' ' VAL . . . . . 0.525 HG23 ' N ' ' A' ' 109' ' ' ILE . 16.5 m -68.61 -45.45 81.53 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.747 0 N-CA-C 110.405 -0.22 . . . . 1.0 110.405 -179.371 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 109' ' ' ILE . . . . . 0.525 ' N ' HG23 ' A' ' 108' ' ' VAL . 0.8 OUTLIER -36.83 -54.01 1.79 Allowed Pre-proline 0 CA--C 1.568 1.659 0 CA-C-N 116.159 -0.473 . . . . 1.0 110.199 -178.694 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 110' ' ' PRO . . . . . 0.561 ' CD ' ' O ' ' A' ' 106' ' ' ALA . 31.4 Cg_exo -57.14 -24.52 59.1 Favored 'Trans proline' 0 N--CA 1.504 2.141 0 C-N-CA 123.296 2.664 . . . . 1.0 113.087 176.284 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 111' ' ' ASN . . . . . 0.567 ' CG ' ' N ' ' A' ' 112' ' ' ILE . 0.6 OUTLIER -63.04 -66.19 0.58 Allowed 'General case' 0 CA--C 1.54 0.587 0 C-N-CA 120.114 -0.634 . . . . 1.0 109.8 -178.531 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 112' ' ' ILE . . . . . 0.949 HD12 ' O ' ' A' ' 35' ' ' GLY . 1.9 tt -61.56 -27.84 42.86 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.493 0 CA-C-O 121.308 0.575 . . . . 1.0 110.804 178.707 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 113' ' ' ASN . . . . . 0.445 ' O ' ' HB2' ' A' ' 117' ' ' GLU . 20.6 m-20 -57.54 -64.88 0.75 Allowed 'General case' 0 C--N 1.305 -1.341 0 CA-C-N 115.066 -0.97 . . . . 1.0 111.275 -175.203 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -67.63 -23.86 65.39 Favored 'General case' 0 C--N 1.318 -0.796 0 N-CA-C 112.124 0.416 . . . . 1.0 112.124 -178.926 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -78.97 -62.91 1.55 Allowed 'General case' 0 CA--C 1.536 0.422 0 N-CA-C 112.828 0.677 . . . . 1.0 112.828 178.988 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 116' ' ' ILE . . . . . 0.606 HD12 HG13 ' A' ' 112' ' ' ILE . 19.7 mt -69.68 -47.09 72.86 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.651 0 O-C-N 121.414 -0.804 . . . . 1.0 112.532 -178.329 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 117' ' ' GLU . . . . . 0.445 ' HB2' ' O ' ' A' ' 113' ' ' ASN . 73.9 mt-10 -46.84 -59.73 2.88 Favored 'General case' 0 CA--C 1.498 -1.04 0 N-CA-C 108.681 -0.859 . . . . 1.0 108.681 -177.001 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 88.9 t -55.59 -16.19 2.3 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.314 0 CA-C-N 115.407 -0.815 . . . . 1.0 109.191 179.052 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 119' ' ' LEU . . . . . 0.583 ' N ' ' O ' ' A' ' 116' ' ' ILE . 0.2 OUTLIER -79.87 -61.11 2.09 Favored 'General case' 0 C--N 1.351 0.633 0 C-N-CA 119.691 -0.803 . . . . 1.0 109.362 176.964 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 120' ' ' GLY . . . . . 0.547 ' O ' HG23 ' A' ' 121' ' ' THR . . . -67.15 -84.39 0.1 Allowed Glycine 0 C--N 1.361 1.97 0 C-N-CA 117.154 -2.451 . . . . 1.0 110.874 178.705 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 121' ' ' THR . . . . . 0.547 HG23 ' O ' ' A' ' 120' ' ' GLY . 9.3 p -159.27 -23.71 0.07 Allowed 'General case' 0 C--N 1.32 -0.688 0 N-CA-C 108.274 -1.01 . . . . 1.0 108.274 -179.564 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 122' ' ' GLY . . . . . 0.462 ' O ' ' C ' ' A' ' 123' ' ' THR . . . 112.54 -37.09 3.8 Favored Glycine 0 CA--C 1.525 0.681 0 CA-C-N 113.895 -1.502 . . . . 1.0 111.913 179.368 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 123' ' ' THR . . . . . 0.586 HG23 ' O ' ' A' ' 123' ' ' THR . 4.2 t -30.46 93.22 0.01 OUTLIER 'General case' 0 N--CA 1.472 0.675 0 CA-C-N 118.781 1.291 . . . . 1.0 112.33 -178.932 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 124' ' ' ASP . . . . . 0.46 ' N ' ' O ' ' A' ' 122' ' ' GLY . 40.9 m-20 -146.35 143.43 29.09 Favored 'General case' 0 C--N 1.332 -0.159 0 N-CA-C 108.946 -0.761 . . . . 1.0 108.946 179.238 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 125' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -148.01 147.16 29.32 Favored 'General case' 0 CA--C 1.535 0.385 0 N-CA-C 109.695 -0.483 . . . . 1.0 109.695 179.725 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 126' ' ' ARG . . . . . 0.64 ' HB2' ' H63' ' A' ' 130' ' ' MTN . 8.3 mmm180 -146.15 146.24 30.78 Favored 'General case' 0 CA--C 1.536 0.414 0 N-CA-C 109.018 -0.734 . . . . 1.0 109.018 178.622 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 127' ' ' PHE . . . . . 0.534 ' OXT' ' CD2' ' A' ' 127' ' ' PHE . 87.4 t80 . . . . . 0 N--CA 1.473 0.713 0 CA-C-O 118.069 -0.967 . . . . 1.0 110.865 179.557 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 128' ' ' MTN . . . . . 0.541 ' H91' HH12 ' A' ' 47' ' ' ARG . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 129' ' ' MTN . . . . . 0.821 ' H62' ' O ' ' A' ' 48' ' ' CYS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 130' ' ' MTN . . . . . 0.64 ' H63' ' HB2' ' A' ' 126' ' ' ARG . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.42 ' C ' ' H ' ' A' ' 3' ' ' ASP . 0.4 OUTLIER . . . . . 0 N--CA 1.489 1.495 0 N-CA-C 108.19 -1.041 . . . . 1.0 108.19 . . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 2' ' ' SER . . . . . 0.55 ' O ' ' CB ' ' A' ' 3' ' ' ASP . 75.0 m -75.61 13.48 0.79 Allowed 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 116.25 -0.432 . . . . 1.0 110.852 179.709 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 3' ' ' ASP . . . . . 0.55 ' CB ' ' O ' ' A' ' 2' ' ' SER . 21.4 t0 135.69 134.15 0.0 OUTLIER 'General case' 0 N--CA 1.478 0.954 0 O-C-N 124.68 1.238 . . . . 1.0 110.346 179.066 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 4' ' ' PHE . . . . . 0.521 ' N ' ' OD1' ' A' ' 3' ' ' ASP . 71.1 t80 -167.36 91.8 0.38 Allowed 'General case' 0 C--N 1.329 -0.3 0 N-CA-C 114.833 1.42 . . . . 1.0 114.833 175.164 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 65.6 m-20 -73.61 146.78 44.4 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 114.684 -1.144 . . . . 1.0 109.212 178.898 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 6' ' ' THR . . . . . 0.483 ' O ' ' N ' ' A' ' 10' ' ' SER . 58.6 m -56.59 160.48 3.23 Favored 'General case' 0 C--O 1.217 -0.649 0 C-N-CA 120.076 -0.649 . . . . 1.0 109.505 179.519 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 7' ' ' GLU . . . . . 0.559 ' O ' ' N ' ' A' ' 11' ' ' ARG . 30.6 tt0 -57.07 -60.43 3.6 Favored 'General case' 0 C--N 1.316 -0.855 0 CA-C-O 121.565 0.697 . . . . 1.0 109.372 -178.072 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 8' ' ' ARG . . . . . 0.538 ' CG ' ' N ' ' A' ' 9' ' ' VAL . 48.0 ptt85 -49.36 -52.31 29.08 Favored 'General case' 0 C--N 1.313 -0.987 0 N-CA-C 108.082 -1.081 . . . . 1.0 108.082 -177.472 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 9' ' ' VAL . . . . . 0.584 ' O ' HG23 ' A' ' 13' ' ' VAL . 57.0 t -62.74 -48.02 90.09 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.36 0 CA-C-N 114.837 -1.074 . . . . 1.0 109.262 179.814 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 10' ' ' SER . . . . . 0.483 ' N ' ' O ' ' A' ' 6' ' ' THR . 48.3 t -63.41 -62.31 1.76 Allowed 'General case' 0 N--CA 1.476 0.836 0 CA-C-N 115.835 -0.621 . . . . 1.0 109.979 -179.214 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 11' ' ' ARG . . . . . 0.559 ' N ' ' O ' ' A' ' 7' ' ' GLU . 0.0 OUTLIER -57.42 -57.56 12.13 Favored 'General case' 0 N--CA 1.47 0.55 0 N-CA-C 109.062 -0.718 . . . . 1.0 109.062 -178.671 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 12' ' ' ALA . . . . . 0.513 ' CB ' ' O ' ' A' ' 8' ' ' ARG . . . -47.99 -48.09 32.74 Favored 'General case' 0 N--CA 1.478 0.954 0 N-CA-C 106.193 -1.78 . . . . 1.0 106.193 -178.198 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 13' ' ' VAL . . . . . 0.584 HG23 ' O ' ' A' ' 9' ' ' VAL . 45.1 t -60.5 -47.89 90.78 Favored 'Isoleucine or valine' 0 C--O 1.203 -1.392 0 C-N-CA 119.078 -1.049 . . . . 1.0 108.886 176.817 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 14' ' ' ALA . . . . . 0.564 ' O ' HG13 ' A' ' 18' ' ' VAL . . . -60.96 -61.91 2.23 Favored 'General case' 0 C--O 1.212 -0.903 0 C-N-CA 119.017 -1.073 . . . . 1.0 110.018 179.145 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 15' ' ' ALA . . . . . 0.533 ' O ' ' N ' ' A' ' 19' ' ' GLY . . . -51.84 -55.06 22.27 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-O 121.932 0.872 . . . . 1.0 109.228 -177.902 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 16' ' ' ALA . . . . . 0.511 ' C ' ' H ' ' A' ' 22' ' ' GLY . . . -61.57 -54.4 43.51 Favored 'General case' 0 C--N 1.311 -1.07 0 CA-C-N 114.135 -1.393 . . . . 1.0 109.113 -179.43 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 17' ' ' LEU . . . . . 0.668 HD23 ' C ' ' A' ' 17' ' ' LEU . 6.8 tt -57.19 -54.16 49.91 Favored 'General case' 0 N--CA 1.484 1.257 0 CA-C-N 114.411 -1.268 . . . . 1.0 109.312 -177.711 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 18' ' ' VAL . . . . . 0.564 HG13 ' O ' ' A' ' 14' ' ' ALA . 2.6 m -68.45 -56.46 12.4 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.501 0 C-N-CA 119.384 -0.926 . . . . 1.0 109.324 178.893 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 19' ' ' GLY . . . . . 0.533 ' N ' ' O ' ' A' ' 15' ' ' ALA . . . -64.17 -170.7 2.06 Favored Glycine 0 CA--C 1.526 0.731 0 N-CA-C 111.352 -0.699 . . . . 1.0 111.352 -179.568 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 20' ' ' PRO . . . . . 0.522 ' O ' ' N ' ' A' ' 24' ' ' ALA . 1.8 Cg_endo -77.41 -25.12 8.58 Favored 'Trans proline' 0 N--CA 1.494 1.53 0 C-N-CA 123.011 2.474 . . . . 1.0 114.522 -178.561 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 21' ' ' GLY . . . . . 0.433 ' O ' ' HB3' ' A' ' 24' ' ' ALA . . . -59.33 -58.48 14.19 Favored Glycine 0 N--CA 1.476 1.322 0 C-N-CA 119.894 -1.146 . . . . 1.0 111.358 -177.22 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 22' ' ' GLY . . . . . 0.511 ' H ' ' C ' ' A' ' 16' ' ' ALA . . . -57.64 -54.16 39.42 Favored Glycine 0 N--CA 1.471 0.975 0 N-CA-C 106.813 -2.515 . . . . 1.0 106.813 -178.136 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 23' ' ' VAL . . . . . 0.586 ' O ' HG12 ' A' ' 27' ' ' VAL . 53.9 t -53.96 -33.03 23.28 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.059 0 CA-C-N 114.543 -0.828 . . . . 1.0 109.069 179.313 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 24' ' ' ALA . . . . . 0.522 ' N ' ' O ' ' A' ' 20' ' ' PRO . . . -60.73 -61.02 2.89 Favored 'General case' 0 CA--C 1.53 0.204 0 C-N-CA 118.554 -1.258 . . . . 1.0 109.486 179.559 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 3.7 tp -64.34 -47.43 79.4 Favored 'General case' 0 C--N 1.344 0.346 0 N-CA-C 113.497 0.925 . . . . 1.0 113.497 -177.985 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 98.6 t -60.23 -60.58 2.34 Favored 'Isoleucine or valine' 0 C--N 1.339 0.137 0 C-N-CA 118.366 -1.334 . . . . 1.0 110.231 -176.976 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 27' ' ' VAL . . . . . 0.586 HG12 ' O ' ' A' ' 23' ' ' VAL . 1.4 p -55.14 -35.23 34.75 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.244 0 CA-C-O 120.869 0.366 . . . . 1.0 111.798 -178.209 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 8.2 tttm -67.56 -54.02 23.41 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-O 121.51 0.671 . . . . 1.0 109.436 -179.016 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 44.2 t -61.75 -49.67 83.34 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.887 0 CA-C-N 114.68 -1.146 . . . . 1.0 111.246 -178.527 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 30' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -64.96 -61.18 2.32 Favored 'General case' 0 CA--C 1.534 0.346 0 C-N-CA 118.542 -1.263 . . . . 1.0 109.905 -179.218 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 31' ' ' ALA . . . . . 0.509 ' HB2' HH12 ' A' ' 47' ' ' ARG . . . -60.84 -51.65 68.42 Favored 'General case' 0 CA--C 1.515 -0.396 0 N-CA-C 112.535 0.569 . . . . 1.0 112.535 -176.702 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 32' ' ' GLY . . . . . 0.489 ' O ' ' CB ' ' A' ' 33' ' ' LEU . . . 81.57 77.19 1.04 Allowed Glycine 0 CA--C 1.523 0.534 0 N-CA-C 108.856 -1.698 . . . . 1.0 108.856 -178.069 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 33' ' ' LEU . . . . . 0.5 HD22 ' H ' ' A' ' 36' ' ' VAL . 1.3 tt 84.74 85.41 0.05 OUTLIER Pre-proline 0 CA--C 1.543 0.676 0 N-CA-C 109.523 -0.547 . . . . 1.0 109.523 -178.961 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 77.8 Cg_exo -52.35 -33.05 54.38 Favored 'Trans proline' 0 N--CA 1.51 2.496 0 C-N-CA 123.564 2.842 . . . . 1.0 114.556 -178.504 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -58.98 -58.79 12.69 Favored Glycine 0 CA--C 1.527 0.84 0 C-N-CA 118.974 -1.584 . . . . 1.0 109.843 -178.083 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 36' ' ' VAL . . . . . 0.614 ' O ' HG22 ' A' ' 37' ' ' ILE . 0.4 OUTLIER -94.38 160.62 2.69 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.453 0 N-CA-C 107.083 -1.451 . . . . 1.0 107.083 178.641 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 37' ' ' ILE . . . . . 0.686 HG23 ' O ' ' A' ' 37' ' ' ILE . 5.9 tp 124.63 111.27 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.484 1.272 0 O-C-N 124.141 0.901 . . . . 1.0 109.069 -178.944 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 57.0 m80 -138.39 130.72 28.82 Favored 'General case' 0 C--N 1.329 -0.304 0 N-CA-C 108.044 -1.095 . . . . 1.0 108.044 178.865 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 11.2 t -91.79 153.19 43.69 Favored Pre-proline 0 N--CA 1.467 0.418 0 CA-C-O 119.391 -0.338 . . . . 1.0 110.363 -179.023 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 6.1 Cg_endo -86.11 -38.74 0.09 OUTLIER 'Trans proline' 0 N--CA 1.483 0.881 0 C-N-CA 121.213 1.275 . . . . 1.0 112.828 -179.786 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -125.53 129.88 50.62 Favored 'General case' 0 N--CA 1.47 0.561 0 CA-C-N 116.203 -0.453 . . . . 1.0 109.918 179.361 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 42' ' ' ARG . . . . . 0.717 HH12 ' CD ' ' A' ' 47' ' ' ARG . 42.0 ttp180 -176.18 168.95 2.84 Favored 'General case' 0 C--N 1.323 -0.584 0 N-CA-C 107.12 -1.437 . . . . 1.0 107.12 177.294 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 43' ' ' ARG . . . . . 0.457 ' N ' ' HG2' ' A' ' 42' ' ' ARG . 0.0 OUTLIER -52.51 -37.34 57.27 Favored 'General case' 0 N--CA 1.449 -0.478 0 CA-C-N 120.114 1.325 . . . . 1.0 109.132 -179.642 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 125.16 -19.62 6.79 Favored Glycine 0 C--N 1.34 0.773 0 N-CA-C 111.079 -0.809 . . . . 1.0 111.079 -179.106 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 45' ' ' PHE . . . . . 0.499 ' O ' ' CB ' ' A' ' 46' ' ' PHE . 4.5 t80 -149.7 149.94 31.35 Favored 'General case' 0 CA--C 1.538 0.509 0 CA-C-N 117.815 0.808 . . . . 1.0 109.019 179.76 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 46' ' ' PHE . . . . . 0.604 ' CE2' ' NE2' ' A' ' 54' ' ' GLN . 3.8 m-30 132.31 86.17 0.0 OUTLIER 'General case' 0 N--CA 1.484 1.239 0 N-CA-C 107.384 -1.339 . . . . 1.0 107.384 -179.559 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 47' ' ' ARG . . . . . 0.717 ' CD ' HH12 ' A' ' 42' ' ' ARG . 5.7 ptp180 132.87 141.91 0.0 OUTLIER 'General case' 0 N--CA 1.485 1.279 0 O-C-N 124.434 1.084 . . . . 1.0 110.932 178.188 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 3.3 m 71.03 71.5 0.18 Allowed 'General case' 0 N--CA 1.455 -0.179 0 N-CA-C 110.286 -0.264 . . . . 1.0 110.286 -179.992 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 49' ' ' ASN . . . . . 0.452 ' O ' ' N ' ' A' ' 51' ' ' GLU . 28.0 m120 -132.44 140.32 37.52 Favored Pre-proline 0 C--N 1.33 -0.263 0 N-CA-C 108.007 -1.108 . . . . 1.0 108.007 179.226 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 44.1 Cg_endo -67.86 65.55 0.91 Allowed 'Trans proline' 0 C--N 1.312 -1.394 0 C-N-CA 121.54 1.493 . . . . 1.0 111.374 -179.339 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 51' ' ' GLU . . . . . 0.525 ' N ' ' OE1' ' A' ' 51' ' ' GLU . 0.0 OUTLIER 64.11 7.48 3.45 Favored 'General case' 0 N--CA 1.463 0.196 0 CA-C-N 114.92 -1.036 . . . . 1.0 111.061 -179.638 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 52' ' ' ARG . . . . . 0.551 HH11 ' HB1' ' A' ' 86' ' ' ALA . 33.1 mtt-85 -87.97 159.85 18.14 Favored 'General case' 0 C--N 1.331 -0.233 0 N-CA-C 109.572 -0.529 . . . . 1.0 109.572 179.278 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 53' ' ' ILE . . . . . 0.468 ' O ' ' N ' ' A' ' 55' ' ' ILE . 10.7 tt -79.85 135.54 25.29 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-O 121.87 0.843 . . . . 1.0 111.605 -179.245 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 54' ' ' GLN . . . . . 0.604 ' NE2' ' CE2' ' A' ' 46' ' ' PHE . 1.9 pt20 -61.04 83.24 0.01 OUTLIER 'General case' 0 C--N 1.32 -0.68 0 CA-C-N 114.267 -1.333 . . . . 1.0 109.013 -178.487 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 55' ' ' ILE . . . . . 0.468 ' N ' ' O ' ' A' ' 53' ' ' ILE . 13.1 tt -149.65 158.64 5.81 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.472 0 CA-C-N 115.717 -0.674 . . . . 1.0 110.547 178.164 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 107.13 -5.33 36.06 Favored Glycine 0 N--CA 1.473 1.15 0 N-CA-C 110.991 -0.844 . . . . 1.0 110.991 179.187 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 57' ' ' ASP . . . . . 0.41 ' HB3' ' CB ' ' A' ' 45' ' ' PHE . 3.7 p-10 -81.2 105.58 12.51 Favored 'General case' 0 C--N 1.316 -0.877 0 CA-C-N 114.912 -0.644 . . . . 1.0 110.256 179.769 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 58' ' ' TRP . . . . . . . . . . . . . 1.4 m95 -91.09 173.9 7.7 Favored 'General case' 0 CA--C 1.541 0.6 0 CA-C-O 124.289 1.995 . . . . 1.0 114.836 -177.011 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 31.2 mtm180 -78.54 -62.64 1.62 Allowed 'General case' 0 C--N 1.312 -1.053 0 CA-C-N 109.266 -3.606 . . . . 1.0 111.654 -179.096 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 60' ' ' TYR . . . . . 0.499 ' O ' ' CG ' ' A' ' 60' ' ' TYR . 47.1 t80 -91.95 -11.87 34.98 Favored 'General case' 0 C--O 1.249 1.078 0 N-CA-C 113.621 0.971 . . . . 1.0 113.621 179.612 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 6.7 tt0 -81.63 -15.78 53.55 Favored 'General case' 0 N--CA 1.443 -0.82 0 O-C-N 120.686 -1.259 . . . . 1.0 111.804 -178.689 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 62' ' ' VAL . . . . . 0.568 ' O ' ' N ' ' A' ' 66' ' ' GLY . 0.0 OUTLIER -46.57 -52.65 3.47 Favored 'Isoleucine or valine' 0 C--O 1.208 -1.095 0 C-N-CA 120.231 -0.588 . . . . 1.0 111.719 -174.524 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -69.1 -46.4 67.82 Favored 'General case' 0 C--N 1.311 -1.098 0 C-N-CA 119.376 -0.93 . . . . 1.0 109.616 -179.218 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 3.0 m-70 -50.57 -55.4 16.41 Favored 'General case' 0 N--CA 1.469 0.483 0 C-N-CA 119.08 -1.048 . . . . 1.0 108.823 179.222 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 65' ' ' ASP . . . . . 0.748 ' C ' ' H ' ' A' ' 67' ' ' ARG . 34.3 m-20 -73.58 -48.99 28.53 Favored 'General case' 0 C--O 1.244 0.765 0 CA-C-O 121.214 0.53 . . . . 1.0 109.886 178.714 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 66' ' ' GLY . . . . . 0.568 ' N ' ' O ' ' A' ' 62' ' ' VAL . . . -65.77 27.92 0.14 Allowed Glycine 0 N--CA 1.451 -0.351 0 N-CA-C 110.152 -1.179 . . . . 1.0 110.152 177.396 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 67' ' ' ARG . . . . . 0.748 ' H ' ' C ' ' A' ' 65' ' ' ASP . 0.0 OUTLIER -73.4 0.34 12.51 Favored 'General case' 0 N--CA 1.433 -1.321 0 N-CA-C 105.869 -1.901 . . . . 1.0 105.869 174.058 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 68' ' ' LEU . . . . . 0.44 ' H ' ' C ' ' A' ' 66' ' ' GLY . 1.0 OUTLIER -39.05 -39.3 0.54 Allowed 'General case' 0 C--N 1.346 0.434 0 CA-C-N 116.162 -0.472 . . . . 1.0 110.478 -177.978 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -64.5 -69.08 0.31 Allowed 'General case' 0 N--CA 1.48 1.044 0 C-N-CA 119.258 -0.977 . . . . 1.0 113.34 -175.662 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 70' ' ' ALA . . . . . 0.509 ' C ' ' H ' ' A' ' 72' ' ' HIS . . . -77.07 -79.07 0.11 Allowed 'General case' 0 CA--C 1.512 -0.483 0 C-N-CA 117.957 -1.497 . . . . 1.0 110.107 -176.037 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 71' ' ' ALA . . . . . 0.778 ' O ' ' N ' ' A' ' 73' ' ' MET . . . -65.24 14.95 0.03 OUTLIER 'General case' 0 C--N 1.312 -1.035 0 C-N-CA 124.784 1.234 . . . . 1.0 112.85 -178.365 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 72' ' ' HIS . . . . . 0.509 ' H ' ' C ' ' A' ' 70' ' ' ALA . 0.8 OUTLIER -18.55 -32.97 0.0 OUTLIER 'General case' 0 N--CA 1.467 0.404 0 O-C-N 124.315 1.01 . . . . 1.0 113.197 -175.036 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 73' ' ' MET . . . . . 0.778 ' N ' ' O ' ' A' ' 71' ' ' ALA . 8.6 ptp -61.15 -53.13 60.8 Favored 'General case' 0 C--N 1.319 -0.76 0 C-N-CA 118.755 -1.178 . . . . 1.0 108.465 176.49 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 74' ' ' VAL . . . . . 0.713 ' O ' ' N ' ' A' ' 76' ' ' GLY . 34.2 m -44.65 -51.64 1.84 Allowed 'Isoleucine or valine' 0 C--O 1.206 -1.219 0 CA-C-O 116.363 -1.78 . . . . 1.0 112.426 -175.112 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 75' ' ' ASN . . . . . 0.413 ' C ' ' O ' ' A' ' 74' ' ' VAL . 4.3 t-20 -36.68 -17.21 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.49 0 CA-C-N 122.472 2.396 . . . . 1.0 111.604 -179.231 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 76' ' ' GLY . . . . . 0.713 ' N ' ' O ' ' A' ' 74' ' ' VAL . . . -54.39 -23.66 27.54 Favored Glycine 0 CA--C 1.532 1.115 0 N-CA-C 107.178 -2.369 . . . . 1.0 107.178 174.252 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 77' ' ' ILE . . . . . 0.568 ' N ' ' O ' ' A' ' 74' ' ' VAL . 18.2 pt -51.06 -48.98 29.55 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.033 0 CA-C-O 118.457 -0.782 . . . . 1.0 109.874 -179.793 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 19.3 t -55.97 -19.73 7.65 Favored 'Isoleucine or valine' 0 C--N 1.345 0.409 0 CA-C-N 120.94 1.7 . . . . 1.0 112.833 178.775 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 79' ' ' ILE . . . . . 0.588 ' O ' ' HB3' ' A' ' 83' ' ' ALA . 0.6 OUTLIER -90.6 -44.71 14.79 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.402 0 C-N-CA 119.683 -0.807 . . . . 1.0 109.855 179.077 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 80' ' ' ALA . . . . . 0.475 ' N ' HG13 ' A' ' 79' ' ' ILE . . . -80.04 -17.59 52.37 Favored 'General case' 0 C--N 1.323 -0.546 0 N-CA-C 113.267 0.84 . . . . 1.0 113.267 -179.587 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 81' ' ' GLU . . . . . 0.574 ' CG ' ' H ' ' A' ' 82' ' ' ASP . 10.2 pt-20 -94.18 -70.66 0.7 Allowed 'General case' 0 CA--C 1.537 0.463 0 C-N-CA 119.624 -0.83 . . . . 1.0 113.206 -177.987 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 82' ' ' ASP . . . . . 0.574 ' H ' ' CG ' ' A' ' 81' ' ' GLU . 13.4 t70 -90.62 -14.27 32.71 Favored 'General case' 0 CA--C 1.537 0.472 0 N-CA-C 114.821 1.415 . . . . 1.0 114.821 -178.49 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 83' ' ' ALA . . . . . 0.588 ' HB3' ' O ' ' A' ' 79' ' ' ILE . . . -52.16 -46.32 65.41 Favored 'General case' 0 C--O 1.22 -0.498 0 C-N-CA 117.644 -1.622 . . . . 1.0 111.203 -178.924 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 84' ' ' LEU . . . . . 0.491 ' O ' HD12 ' A' ' 84' ' ' LEU . 0.1 OUTLIER -39.34 -25.79 0.02 OUTLIER 'General case' 0 N--CA 1.469 0.499 0 O-C-N 121.427 -0.795 . . . . 1.0 111.533 -179.605 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 85' ' ' ILE . . . . . 0.499 ' N ' ' O ' ' A' ' 83' ' ' ALA . 3.2 tt -91.18 -34.41 6.34 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.327 0 C-N-CA 120.851 -0.339 . . . . 1.0 110.236 179.119 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 86' ' ' ALA . . . . . 0.551 ' HB1' HH11 ' A' ' 52' ' ' ARG . . . -95.52 -29.0 14.6 Favored 'General case' 0 C--O 1.207 -1.16 0 O-C-N 122.038 -0.414 . . . . 1.0 111.572 178.994 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 87' ' ' GLU . . . . . 0.422 ' OE1' ' N ' ' A' ' 88' ' ' ALA . 0.3 OUTLIER -61.59 -17.34 54.72 Favored 'General case' 0 C--N 1.321 -0.673 0 O-C-N 121.237 -0.914 . . . . 1.0 110.077 -179.262 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 88' ' ' ALA . . . . . 0.422 ' N ' ' OE1' ' A' ' 87' ' ' GLU . . . -73.89 -4.59 35.94 Favored 'General case' 0 N--CA 1.477 0.888 0 CA-C-O 123.549 1.643 . . . . 1.0 106.759 177.163 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 89' ' ' VAL . . . . . 0.566 ' O ' HG12 ' A' ' 89' ' ' VAL . 26.0 t -80.96 39.51 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.44 -0.964 0 CA-C-N 110.91 -2.859 . . . . 1.0 108.178 175.866 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 90' ' ' GLY . . . . . 0.844 ' O ' ' N ' ' A' ' 92' ' ' HIS . . . -56.91 -29.02 58.46 Favored Glycine 0 C--N 1.37 2.461 0 CA-C-O 117.423 -1.765 . . . . 1.0 111.844 177.337 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 91' ' ' PRO . . . . . 0.603 ' HD2' ' N ' ' A' ' 90' ' ' GLY . 52.2 Cg_exo -38.36 -2.19 0.0 OUTLIER 'Trans proline' 0 N--CA 1.498 1.75 0 CA-C-N 121.672 2.736 . . . . 1.0 111.728 173.945 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 92' ' ' HIS . . . . . 0.844 ' N ' ' O ' ' A' ' 90' ' ' GLY . 18.1 p-80 -50.19 -31.3 13.44 Favored 'General case' 0 N--CA 1.432 -1.365 0 N-CA-C 106.966 -1.494 . . . . 1.0 106.966 179.243 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 93' ' ' LEU . . . . . 0.432 ' O ' ' HB3' ' A' ' 96' ' ' ALA . 1.5 tt -61.02 -50.13 74.6 Favored 'General case' 0 C--O 1.222 -0.36 0 N-CA-C 106.995 -1.483 . . . . 1.0 106.995 176.367 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 94' ' ' ALA . . . . . 0.479 ' N ' ' O ' ' A' ' 91' ' ' PRO . . . -52.04 -54.91 24.41 Favored 'General case' 0 C--N 1.322 -0.628 0 N-CA-C 107.586 -1.264 . . . . 1.0 107.586 179.644 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -63.63 -29.72 70.93 Favored 'General case' 0 CA--C 1.543 0.685 0 CA-C-O 121.537 0.684 . . . . 1.0 109.574 178.405 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 96' ' ' ALA . . . . . 0.783 ' O ' ' N ' ' A' ' 100' ' ' ILE . . . -50.9 -42.94 59.65 Favored 'General case' 0 C--O 1.197 -1.691 0 N-CA-C 106.799 -1.556 . . . . 1.0 106.799 -177.754 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 97' ' ' LEU . . . . . 0.517 ' O ' ' CG2' ' A' ' 100' ' ' ILE . 0.3 OUTLIER -35.61 -23.05 0.01 OUTLIER 'General case' 0 CA--C 1.594 2.641 0 CA-C-N 114.18 -1.373 . . . . 1.0 108.005 -177.156 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 98' ' ' GLY . . . . . 0.674 ' N ' ' O ' ' A' ' 96' ' ' ALA . . . -86.06 -50.23 3.97 Favored Glycine 0 CA--C 1.562 3.011 0 CA-C-O 123.057 1.365 . . . . 1.0 111.286 169.713 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 99' ' ' GLN . . . . . 0.692 ' N ' ' O ' ' A' ' 96' ' ' ALA . 0.0 OUTLIER -76.59 7.16 4.82 Favored 'General case' 0 N--CA 1.441 -0.878 0 N-CA-C 106.391 -1.707 . . . . 1.0 106.391 177.142 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 100' ' ' ILE . . . . . 0.783 ' N ' ' O ' ' A' ' 96' ' ' ALA . 17.7 tt -58.12 -55.4 22.31 Favored 'Isoleucine or valine' 0 CA--C 1.481 -1.69 0 N-CA-C 106.232 -1.766 . . . . 1.0 106.232 177.438 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 101' ' ' VAL . . . . . 0.684 ' O ' ' N ' ' A' ' 105' ' ' GLY . 7.0 p -57.49 -60.04 2.58 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.579 0 C-N-CA 118.368 -1.333 . . . . 1.0 107.871 178.668 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 102' ' ' CYS . . . . . 0.885 ' O ' ' HB2' ' A' ' 106' ' ' ALA . 18.2 t -52.48 -26.26 12.45 Favored 'General case' 0 C--N 1.32 -0.707 0 N-CA-C 112.712 0.634 . . . . 1.0 112.712 -177.324 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 103' ' ' ARG . . . . . 0.536 ' N ' ' O ' ' A' ' 99' ' ' GLN . 45.6 ttt180 -86.23 -49.31 7.8 Favored 'General case' 0 N--CA 1.49 1.568 0 CA-C-O 122.763 1.268 . . . . 1.0 112.686 179.019 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 104' ' ' TYR . . . . . 0.686 ' O ' ' CG ' ' A' ' 104' ' ' TYR . 0.0 OUTLIER -97.04 24.13 6.59 Favored 'General case' 0 C--N 1.295 -1.8 0 CA-C-N 112.258 -2.246 . . . . 1.0 107.571 178.618 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 105' ' ' GLY . . . . . 0.684 ' N ' ' O ' ' A' ' 101' ' ' VAL . . . -164.92 -96.84 0.11 Allowed Glycine 0 CA--C 1.533 1.206 0 N-CA-C 108.166 -1.974 . . . . 1.0 108.166 179.081 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 106' ' ' ALA . . . . . 0.885 ' HB2' ' O ' ' A' ' 102' ' ' CYS . . . 68.4 55.68 0.5 Allowed 'General case' 0 CA--C 1.534 0.351 0 C-N-CA 122.989 0.515 . . . . 1.0 111.747 -178.886 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 107' ' ' THR . . . . . 0.548 HG22 ' O ' ' A' ' 107' ' ' THR . 91.8 m -80.32 6.1 12.96 Favored 'General case' 0 CA--C 1.514 -0.407 0 N-CA-C 107.222 -1.399 . . . . 1.0 107.222 177.033 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 108' ' ' VAL . . . . . 0.455 HG23 ' N ' ' A' ' 109' ' ' ILE . 18.0 m -84.4 -54.03 9.68 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.242 0 CA-C-N 115.575 -0.739 . . . . 1.0 110.472 178.721 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 109' ' ' ILE . . . . . 0.468 ' N ' ' HD2' ' A' ' 110' ' ' PRO . 85.4 mt -41.99 -51.89 9.69 Favored Pre-proline 0 C--N 1.347 0.46 0 N-CA-C 114.805 1.409 . . . . 1.0 114.805 -179.446 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 110' ' ' PRO . . . . . 0.468 ' HD2' ' N ' ' A' ' 109' ' ' ILE . 2.3 Cg_endo -40.68 -52.02 3.34 Favored 'Trans proline' 0 C--N 1.314 -1.286 0 CA-C-N 120.618 1.257 . . . . 1.0 113.293 -176.407 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 111' ' ' ASN . . . . . 0.434 ' ND2' ' H ' ' A' ' 112' ' ' ILE . 0.8 OUTLIER -69.51 -69.12 0.36 Allowed 'General case' 0 C--O 1.233 0.222 0 C-N-CA 118.229 -1.389 . . . . 1.0 110.444 -178.403 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 112' ' ' ILE . . . . . 0.625 HD13 ' N ' ' A' ' 113' ' ' ASN . 0.0 OUTLIER -46.97 -27.62 0.91 Allowed 'Isoleucine or valine' 0 C--O 1.216 -0.672 0 N-CA-C 109.174 -0.676 . . . . 1.0 109.174 -179.947 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 113' ' ' ASN . . . . . 0.625 ' N ' HD13 ' A' ' 112' ' ' ILE . 16.4 t-20 -58.19 -54.55 45.76 Favored 'General case' 0 C--N 1.308 -1.198 0 C-N-CA 118.131 -1.428 . . . . 1.0 108.096 -177.928 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 114' ' ' ALA . . . . . 0.477 ' O ' ' HG2' ' A' ' 117' ' ' GLU . . . -58.69 -33.9 70.67 Favored 'General case' 0 N--CA 1.447 -0.611 0 N-CA-C 113.116 0.784 . . . . 1.0 113.116 -178.633 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -82.99 -49.44 9.58 Favored 'General case' 0 C--O 1.215 -0.761 0 O-C-N 120.426 -1.421 . . . . 1.0 110.8 179.173 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 116' ' ' ILE . . . . . 0.53 HD12 HD11 ' A' ' 112' ' ' ILE . 0.6 OUTLIER -50.91 -54.92 8.51 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.184 0 N-CA-C 107.345 -1.354 . . . . 1.0 107.345 -179.415 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 117' ' ' GLU . . . . . 0.504 ' O ' ' HA ' ' A' ' 121' ' ' THR . 17.5 pt-20 -45.96 -58.11 3.83 Favored 'General case' 0 C--O 1.212 -0.898 0 CA-C-N 113.175 -1.83 . . . . 1.0 106.136 -179.052 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 118' ' ' VAL . . . . . 0.466 ' N ' ' CG ' ' A' ' 117' ' ' GLU . 57.7 t -58.36 -53.35 47.51 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.133 0 C-N-CA 119.89 -0.724 . . . . 1.0 110.207 179.068 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 13.2 tp -53.76 -73.04 0.05 OUTLIER 'General case' 0 CA--C 1.54 0.581 0 N-CA-C 108.129 -1.063 . . . . 1.0 108.129 -178.66 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 120' ' ' GLY . . . . . 0.512 ' O ' ' CB ' ' A' ' 121' ' ' THR . . . -67.82 -76.11 0.43 Allowed Glycine 0 CA--C 1.54 1.603 0 C-N-CA 118.948 -1.596 . . . . 1.0 111.026 179.165 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 121' ' ' THR . . . . . 0.512 ' CB ' ' O ' ' A' ' 120' ' ' GLY . 2.3 m 144.92 -27.4 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.434 0 CA-C-N 112.536 -1.832 . . . . 1.0 111.026 -178.381 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 122' ' ' GLY . . . . . 0.659 ' O ' ' N ' ' A' ' 124' ' ' ASP . . . 104.72 -17.94 44.87 Favored Glycine 0 C--O 1.223 -0.577 0 N-CA-C 107.944 -2.062 . . . . 1.0 107.944 -177.0 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 123' ' ' THR . . . . . 0.683 HG23 ' O ' ' A' ' 123' ' ' THR . 11.0 t -54.41 83.52 0.0 OUTLIER 'General case' 0 CA--C 1.532 0.275 0 N-CA-C 106.351 -1.722 . . . . 1.0 106.351 178.617 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 124' ' ' ASP . . . . . 0.659 ' N ' ' O ' ' A' ' 122' ' ' GLY . 48.5 p-10 -166.93 176.77 6.77 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 113.539 -1.664 . . . . 1.0 111.375 179.285 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 125' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -146.76 144.63 29.53 Favored 'General case' 0 CA--C 1.541 0.605 0 N-CA-C 108.364 -0.976 . . . . 1.0 108.364 176.904 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 38.0 ttm180 -149.84 151.74 34.0 Favored 'General case' 0 N--CA 1.471 0.588 0 CA-C-O 120.534 0.207 . . . . 1.0 110.935 178.844 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 127' ' ' PHE . . . . . . . . . . . . . 13.9 p90 . . . . . 0 C--O 1.219 -0.506 0 CA-C-O 117.958 -1.02 . . . . 1.0 110.646 -179.985 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 128' ' ' MTN . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 129' ' ' MTN . . . . . 0.489 ' H82' ' CZ ' ' A' ' 45' ' ' PHE . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 130' ' ' MTN . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.513 ' SD ' ' N ' ' A' ' 1' ' ' MET . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.558 0 N-CA-C 108.862 -0.792 . . . . 1.0 108.862 . . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 2' ' ' SER . . . . . 0.508 ' O ' ' CG ' ' A' ' 3' ' ' ASP . 70.8 m -72.4 7.71 1.68 Allowed 'General case' 0 C--O 1.223 -0.31 0 CA-C-O 119.43 -0.319 . . . . 1.0 110.844 179.474 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 3' ' ' ASP . . . . . 0.508 ' CG ' ' O ' ' A' ' 2' ' ' SER . 62.1 m-20 144.16 137.39 0.0 OUTLIER 'General case' 0 N--CA 1.482 1.141 0 O-C-N 124.189 0.93 . . . . 1.0 110.097 179.239 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 91.4 t80 -154.92 150.46 27.44 Favored 'General case' 0 N--CA 1.465 0.296 0 CA-C-N 116.073 -0.512 . . . . 1.0 110.88 179.214 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -150.13 145.23 26.19 Favored 'General case' 0 CA--C 1.543 0.686 0 N-CA-C 109.553 -0.536 . . . . 1.0 109.553 179.465 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 6' ' ' THR . . . . . 0.843 ' O ' ' N ' ' A' ' 10' ' ' SER . 0.2 OUTLIER -87.14 176.71 7.46 Favored 'General case' 0 C--O 1.179 -2.627 0 CA-C-O 120.43 0.157 . . . . 1.0 111.236 -179.27 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 7' ' ' GLU . . . . . 0.588 ' O ' ' N ' ' A' ' 11' ' ' ARG . 10.9 mt-10 -60.65 -50.68 72.53 Favored 'General case' 0 C--N 1.312 -1.056 0 CA-C-O 121.194 0.521 . . . . 1.0 109.713 -179.405 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 8' ' ' ARG . . . . . 0.671 ' O ' ' HB3' ' A' ' 12' ' ' ALA . 18.6 mtp-105 -57.95 -58.93 6.23 Favored 'General case' 0 C--N 1.315 -0.916 0 C-N-CA 118.416 -1.313 . . . . 1.0 107.536 -179.011 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 9' ' ' VAL . . . . . 0.693 ' O ' ' HB ' ' A' ' 13' ' ' VAL . 0.0 OUTLIER -66.82 -50.83 61.82 Favored 'Isoleucine or valine' 0 C--O 1.183 -2.418 0 CA-C-N 114.267 -1.333 . . . . 1.0 109.287 179.686 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 10' ' ' SER . . . . . 0.843 ' N ' ' O ' ' A' ' 6' ' ' THR . 19.3 t -63.84 -61.16 2.47 Favored 'General case' 0 N--CA 1.492 1.669 0 C-N-CA 119.437 -0.905 . . . . 1.0 110.268 179.171 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 11' ' ' ARG . . . . . 0.588 ' N ' ' O ' ' A' ' 7' ' ' GLU . 5.3 tpt180 -67.39 -54.32 21.5 Favored 'General case' 0 C--O 1.214 -0.797 0 N-CA-C 112.546 0.573 . . . . 1.0 112.546 -176.674 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 12' ' ' ALA . . . . . 0.671 ' HB3' ' O ' ' A' ' 8' ' ' ARG . . . -56.06 -50.7 70.22 Favored 'General case' 0 N--CA 1.476 0.862 0 C-N-CA 117.023 -1.871 . . . . 1.0 106.565 -178.09 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 13' ' ' VAL . . . . . 0.693 ' HB ' ' O ' ' A' ' 9' ' ' VAL . 65.7 t -61.25 -48.49 88.7 Favored 'Isoleucine or valine' 0 C--O 1.18 -2.593 0 N-CA-C 107.033 -1.469 . . . . 1.0 107.033 178.659 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 14' ' ' ALA . . . . . 0.746 ' O ' HG13 ' A' ' 18' ' ' VAL . . . -59.32 -61.56 2.53 Favored 'General case' 0 C--O 1.201 -1.467 0 C-N-CA 118.132 -1.427 . . . . 1.0 109.696 179.253 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 15' ' ' ALA . . . . . 0.572 ' O ' ' N ' ' A' ' 19' ' ' GLY . . . -52.57 -53.38 47.29 Favored 'General case' 0 C--O 1.216 -0.685 0 N-CA-C 108.576 -0.898 . . . . 1.0 108.576 -178.456 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 16' ' ' ALA . . . . . 0.662 ' CA ' ' H ' ' A' ' 22' ' ' GLY . . . -65.42 -57.15 9.02 Favored 'General case' 0 CA--C 1.546 0.792 0 CA-C-O 121.663 0.744 . . . . 1.0 109.951 -179.747 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 17' ' ' LEU . . . . . 0.676 ' N ' ' O ' ' A' ' 13' ' ' VAL . 18.7 tp -55.74 -55.98 25.93 Favored 'General case' 0 N--CA 1.491 1.582 0 N-CA-C 107.953 -1.128 . . . . 1.0 107.953 -178.929 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 18' ' ' VAL . . . . . 0.746 HG13 ' O ' ' A' ' 14' ' ' ALA . 1.2 m -70.89 -59.02 3.87 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.397 0 C-N-CA 119.854 -0.738 . . . . 1.0 110.136 -179.896 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 19' ' ' GLY . . . . . 0.572 ' N ' ' O ' ' A' ' 15' ' ' ALA . . . -60.75 -161.93 0.13 Allowed Glycine 0 C--N 1.338 0.651 0 N-CA-C 111.819 -0.512 . . . . 1.0 111.819 -178.399 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 20' ' ' PRO . . . . . 0.654 ' O ' ' HB2' ' A' ' 24' ' ' ALA . 86.3 Cg_endo -81.23 -23.1 5.43 Favored 'Trans proline' 0 C--N 1.318 -1.04 0 C-N-CA 123.165 2.577 . . . . 1.0 113.682 -177.979 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -63.35 -62.29 5.52 Favored Glycine 0 N--CA 1.484 1.847 0 C-N-CA 120.178 -1.01 . . . . 1.0 112.996 -176.406 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 22' ' ' GLY . . . . . 0.662 ' H ' ' CA ' ' A' ' 16' ' ' ALA . . . -57.61 -57.61 18.87 Favored Glycine 0 C--N 1.312 -0.784 0 N-CA-C 107.349 -2.301 . . . . 1.0 107.349 -177.845 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 23' ' ' VAL . . . . . 0.488 HG22 ' O ' ' A' ' 19' ' ' GLY . 34.3 m -56.63 -32.28 36.94 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.744 0 C-N-CA 118.773 -1.171 . . . . 1.0 109.294 -179.977 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 24' ' ' ALA . . . . . 0.654 ' HB2' ' O ' ' A' ' 20' ' ' PRO . . . -60.5 -62.13 2.09 Favored 'General case' 0 N--CA 1.471 0.6 0 C-N-CA 118.142 -1.423 . . . . 1.0 110.117 179.745 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 18.4 mt -61.38 -47.8 84.17 Favored 'General case' 0 CA--C 1.514 -0.43 0 CA-C-N 118.616 0.644 . . . . 1.0 112.137 -177.28 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 90.5 t -58.55 -59.14 4.04 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.535 0 C-N-CA 119.29 -0.964 . . . . 1.0 109.61 -177.846 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 27' ' ' VAL . . . . . 0.725 ' O ' ' HB3' ' A' ' 31' ' ' ALA . 84.8 t -57.28 -38.65 63.12 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.462 0 CA-C-O 120.866 0.365 . . . . 1.0 110.482 -178.236 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 9.2 ttmt -66.37 -55.33 16.38 Favored 'General case' 0 C--N 1.316 -0.876 0 C-N-CA 119.686 -0.806 . . . . 1.0 109.956 -178.873 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 92.3 t -63.73 -51.39 70.53 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.777 0 CA-C-N 114.903 -1.044 . . . . 1.0 110.917 -176.541 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 30' ' ' CYS . . . . . . . . . . . . . 50.1 t -64.54 -61.55 2.14 Favored 'General case' 0 N--CA 1.443 -0.779 0 C-N-CA 119.407 -0.917 . . . . 1.0 109.889 -179.084 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 31' ' ' ALA . . . . . 0.725 ' HB3' ' O ' ' A' ' 27' ' ' VAL . . . -59.3 -53.54 57.12 Favored 'General case' 0 C--N 1.318 -0.773 0 CA-C-O 120.874 0.369 . . . . 1.0 111.354 -177.295 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 32' ' ' GLY . . . . . 0.519 ' O ' ' CB ' ' A' ' 33' ' ' LEU . . . 80.29 69.68 1.38 Allowed Glycine 0 CA--C 1.521 0.418 0 N-CA-C 109.898 -1.281 . . . . 1.0 109.898 -179.77 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 33' ' ' LEU . . . . . 0.659 ' CD2' ' H ' ' A' ' 35' ' ' GLY . 2.0 tt 88.96 101.6 0.03 OUTLIER Pre-proline 0 CA--C 1.545 0.781 0 CA-C-N 115.442 -0.379 . . . . 1.0 110.553 -179.821 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 51.7 Cg_exo -51.86 -21.97 12.94 Favored 'Trans proline' 0 N--CA 1.503 2.05 0 C-N-CA 122.328 2.018 . . . . 1.0 113.939 179.745 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 35' ' ' GLY . . . . . 0.659 ' H ' ' CD2' ' A' ' 33' ' ' LEU . . . -62.12 -62.3 5.8 Favored Glycine 0 C--N 1.34 0.796 0 C-N-CA 119.263 -1.446 . . . . 1.0 109.952 -178.389 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 36' ' ' VAL . . . . . 0.919 HG22 ' H ' ' A' ' 37' ' ' ILE . 8.4 p -73.37 -152.88 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.325 -0.488 0 N-CA-C 107.96 -1.126 . . . . 1.0 107.96 178.333 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 37' ' ' ILE . . . . . 0.919 ' H ' HG22 ' A' ' 36' ' ' VAL . 2.1 mm 70.96 79.33 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.475 0.804 0 CA-C-O 122.069 0.938 . . . . 1.0 112.79 179.598 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 88.0 m-70 -135.32 129.56 33.68 Favored 'General case' 0 C--N 1.318 -0.763 0 N-CA-C 106.826 -1.546 . . . . 1.0 106.826 176.971 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 25.1 m -120.44 132.2 24.21 Favored Pre-proline 0 N--CA 1.465 0.297 0 N-CA-C 110.073 -0.343 . . . . 1.0 110.073 -178.883 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 27.7 Cg_endo -62.98 -78.17 0.01 OUTLIER 'Trans proline' 0 N--CA 1.49 1.311 0 CA-C-N 119.654 0.912 . . . . 1.0 111.898 -179.457 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -67.72 125.65 26.9 Favored 'General case' 0 C--N 1.317 -0.844 0 CA-C-N 114.859 -1.064 . . . . 1.0 110.613 -178.805 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 42' ' ' ARG . . . . . 0.531 ' HG2' ' H ' ' A' ' 43' ' ' ARG . 31.0 ttp180 -173.28 174.52 3.33 Favored 'General case' 0 C--N 1.32 -0.674 0 CA-C-N 115.832 -0.622 . . . . 1.0 109.982 179.516 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 43' ' ' ARG . . . . . 0.56 ' NH1' ' OD2' ' A' ' 57' ' ' ASP . 1.1 tmt_? -58.08 -45.19 87.55 Favored 'General case' 0 CA--C 1.541 0.598 0 N-CA-C 107.1 -1.444 . . . . 1.0 107.1 179.528 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 44' ' ' GLY . . . . . 0.476 ' O ' ' CD1' ' A' ' 45' ' ' PHE . . . 123.58 -25.12 6.31 Favored Glycine 0 CA--C 1.533 1.173 0 CA-C-O 119.852 -0.416 . . . . 1.0 112.147 179.138 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 45' ' ' PHE . . . . . 0.64 ' O ' ' HB2' ' A' ' 46' ' ' PHE . 7.5 m-85 -156.52 162.92 39.91 Favored 'General case' 0 N--CA 1.474 0.749 0 N-CA-C 109.111 -0.7 . . . . 1.0 109.111 177.726 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 46' ' ' PHE . . . . . 0.65 ' O ' ' CG ' ' A' ' 47' ' ' ARG . 6.9 m-85 118.41 104.08 0.0 OUTLIER 'General case' 0 N--CA 1.499 2.001 0 O-C-N 125.375 1.672 . . . . 1.0 110.592 -179.743 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 47' ' ' ARG . . . . . 0.756 ' O ' ' SG ' ' A' ' 48' ' ' CYS . 0.0 OUTLIER 98.42 162.78 0.01 OUTLIER 'General case' 0 N--CA 1.472 0.64 0 O-C-N 125.08 1.488 . . . . 1.0 111.434 178.232 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 48' ' ' CYS . . . . . 0.762 ' O ' ' H61' ' A' ' 129' ' ' MTN . 7.0 p 56.66 72.08 0.53 Allowed 'General case' 0 C--O 1.202 -1.416 0 O-C-N 125.081 1.488 . . . . 1.0 110.567 -177.591 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 49' ' ' ASN . . . . . 0.697 ' O ' ' N ' ' A' ' 51' ' ' GLU . 1.7 t30 -144.66 155.45 56.53 Favored Pre-proline 0 N--CA 1.474 0.728 0 CA-C-O 118.753 -0.642 . . . . 1.0 110.438 179.752 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 50' ' ' PRO . . . . . 0.475 ' C ' ' H ' ' A' ' 52' ' ' ARG . 53.9 Cg_exo -51.8 57.75 0.02 OUTLIER 'Trans proline' 0 N--CA 1.509 2.419 0 C-N-CA 122.688 2.259 . . . . 1.0 112.138 177.775 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 51' ' ' GLU . . . . . 0.697 ' N ' ' O ' ' A' ' 49' ' ' ASN . 59.2 mm-40 47.93 13.56 0.04 OUTLIER 'General case' 0 C--N 1.321 -0.658 0 N-CA-C 110.029 -0.36 . . . . 1.0 110.029 -179.129 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 52' ' ' ARG . . . . . 0.639 HH11 ' CE1' ' A' ' 92' ' ' HIS . 23.5 mtm-85 -100.08 142.86 30.99 Favored 'General case' 0 N--CA 1.475 0.806 0 CA-C-O 121.204 0.526 . . . . 1.0 112.052 -179.857 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 9.6 tp -53.29 135.89 14.92 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.648 0 CA-C-O 124.426 2.06 . . . . 1.0 114.579 -178.661 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -88.62 88.02 7.47 Favored 'General case' 0 C--N 1.312 -1.022 0 CA-C-N 110.063 -3.244 . . . . 1.0 113.643 179.567 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 18.6 tt -144.47 153.34 15.06 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.67 0 CA-C-N 115.478 -0.783 . . . . 1.0 109.678 177.273 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 107.76 3.1 34.61 Favored Glycine 0 C--N 1.348 1.226 0 N-CA-C 110.878 -0.889 . . . . 1.0 110.878 -179.891 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 57' ' ' ASP . . . . . 0.56 ' OD2' ' NH1' ' A' ' 43' ' ' ARG . 5.6 p-10 -86.88 103.38 15.22 Favored 'General case' 0 CA--C 1.533 0.292 0 CA-C-O 122.185 0.993 . . . . 1.0 112.651 -178.834 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 58' ' ' TRP . . . . . . . . . . . . . 38.4 m0 -81.39 -177.97 6.73 Favored 'General case' 0 N--CA 1.47 0.563 0 CA-C-N 114.023 -1.444 . . . . 1.0 108.154 178.205 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 59' ' ' ARG . . . . . 0.659 ' HD2' ' H ' ' A' ' 59' ' ' ARG . 0.0 OUTLIER -101.85 -54.86 2.63 Favored 'General case' 0 CA--C 1.56 1.359 0 CA-C-N 121.91 2.141 . . . . 1.0 110.74 179.676 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 60' ' ' TYR . . . . . 0.517 ' H ' ' HD2' ' A' ' 59' ' ' ARG . 93.2 t80 -79.45 -14.34 58.98 Favored 'General case' 0 N--CA 1.485 1.305 0 C-N-CA 125.723 1.609 . . . . 1.0 112.225 -178.283 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 31.9 tt0 -70.77 -14.11 62.31 Favored 'General case' 0 C--N 1.304 -1.387 0 N-CA-C 108.635 -0.876 . . . . 1.0 108.635 -179.874 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 62' ' ' VAL . . . . . 0.518 HG13 ' O ' ' A' ' 59' ' ' ARG . 13.4 m -45.7 -53.07 2.29 Favored 'Isoleucine or valine' 0 CA--C 1.493 -1.244 0 CA-C-N 115.811 -0.632 . . . . 1.0 109.972 -174.495 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 63' ' ' ALA . . . . . 0.85 ' O ' ' HD2' ' A' ' 67' ' ' ARG . . . -65.2 -50.39 66.06 Favored 'General case' 0 N--CA 1.415 -2.189 0 N-CA-C 108.943 -0.762 . . . . 1.0 108.943 179.364 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -51.03 -59.39 4.21 Favored 'General case' 0 CA--C 1.548 0.904 0 C-N-CA 119.795 -0.762 . . . . 1.0 110.715 -179.996 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 65' ' ' ASP . . . . . 0.6 ' C ' ' H ' ' A' ' 67' ' ' ARG . 28.9 t70 -64.79 -50.34 67.16 Favored 'General case' 0 C--O 1.241 0.632 0 CA-C-O 121.694 0.759 . . . . 1.0 109.704 178.371 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 66' ' ' GLY . . . . . 0.416 ' N ' ' O ' ' A' ' 62' ' ' VAL . . . -61.34 29.53 0.05 OUTLIER Glycine 0 CA--C 1.535 1.325 0 O-C-N 121.801 -0.562 . . . . 1.0 112.016 178.106 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 67' ' ' ARG . . . . . 0.85 ' HD2' ' O ' ' A' ' 63' ' ' ALA . 0.0 OUTLIER -79.58 -2.84 44.29 Favored 'General case' 0 CA--C 1.5 -0.946 0 CA-C-O 118.632 -0.699 . . . . 1.0 109.371 175.206 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 68' ' ' LEU . . . . . 0.555 ' O ' ' CG ' ' A' ' 72' ' ' HIS . 11.1 mp -33.94 -28.06 0.01 OUTLIER 'General case' 0 N--CA 1.486 1.327 0 N-CA-C 107.023 -1.473 . . . . 1.0 107.023 -179.012 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 69' ' ' LEU . . . . . 0.674 ' N ' ' O ' ' A' ' 67' ' ' ARG . 3.4 tt -64.83 -64.23 0.92 Allowed 'General case' 0 CA--C 1.548 0.898 0 N-CA-C 106.572 -1.64 . . . . 1.0 106.572 175.573 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 70' ' ' ALA . . . . . 0.68 ' C ' ' H ' ' A' ' 72' ' ' HIS . . . -78.76 -73.53 0.32 Allowed 'General case' 0 N--CA 1.478 0.948 0 N-CA-C 107.828 -1.175 . . . . 1.0 107.828 177.865 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 71' ' ' ALA . . . . . 0.735 ' H ' ' HB3' ' A' ' 67' ' ' ARG . . . -46.23 2.34 0.0 OUTLIER 'General case' 0 N--CA 1.469 0.499 0 C-N-CA 124.435 1.094 . . . . 1.0 112.747 178.402 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 72' ' ' HIS . . . . . 0.68 ' H ' ' C ' ' A' ' 70' ' ' ALA . 0.2 OUTLIER -20.02 -70.53 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.227 0 C-N-CA 123.179 0.592 . . . . 1.0 111.139 -177.993 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 73' ' ' MET . . . . . . . . . . . . . 16.4 mtm -73.9 -47.63 36.55 Favored 'General case' 0 C--N 1.31 -1.131 0 C-N-CA 118.967 -1.093 . . . . 1.0 109.611 177.149 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 74' ' ' VAL . . . . . 0.577 ' O ' ' N ' ' A' ' 76' ' ' GLY . 24.4 t -46.68 -48.98 6.94 Favored 'Isoleucine or valine' 0 C--N 1.344 0.354 0 CA-C-O 118.456 -0.783 . . . . 1.0 110.958 -176.599 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 75' ' ' ASN . . . . . 0.888 ' O ' HG22 ' A' ' 78' ' ' VAL . 15.4 t30 -39.18 -21.56 0.01 OUTLIER 'General case' 0 C--N 1.352 0.705 0 CA-C-O 122.895 1.331 . . . . 1.0 110.435 177.401 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 76' ' ' GLY . . . . . 0.577 ' N ' ' O ' ' A' ' 74' ' ' VAL . . . -42.31 -19.89 0.06 OUTLIER Glycine 0 CA--C 1.539 1.533 0 CA-C-N 113.55 -1.659 . . . . 1.0 109.248 178.864 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 77' ' ' ILE . . . . . 0.689 ' O ' ' N ' ' A' ' 80' ' ' ALA . 7.7 pt -71.24 -45.41 70.71 Favored 'Isoleucine or valine' 0 C--O 1.207 -1.174 0 CA-C-O 122.01 0.91 . . . . 1.0 109.458 -179.341 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 78' ' ' VAL . . . . . 0.888 HG22 ' O ' ' A' ' 75' ' ' ASN . 26.8 m -35.21 -32.43 0.04 OUTLIER 'Isoleucine or valine' 0 CA--C 1.556 1.178 0 CA-C-N 113.058 -1.883 . . . . 1.0 107.359 -176.483 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 79' ' ' ILE . . . . . 0.529 ' N ' ' O ' ' A' ' 77' ' ' ILE . 1.1 pp -92.94 -26.97 4.66 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 CA-C-O 121.511 0.672 . . . . 1.0 111.571 177.525 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 80' ' ' ALA . . . . . 0.689 ' N ' ' O ' ' A' ' 77' ' ' ILE . . . -87.24 -18.78 29.46 Favored 'General case' 0 CA--C 1.55 0.949 0 N-CA-C 113.35 0.87 . . . . 1.0 113.35 178.976 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 81' ' ' GLU . . . . . 0.424 ' N ' ' O ' ' A' ' 77' ' ' ILE . 9.3 mm-40 -82.46 -71.87 0.47 Allowed 'General case' 0 N--CA 1.45 -0.426 0 C-N-CA 122.667 0.387 . . . . 1.0 110.169 -179.908 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 82' ' ' ASP . . . . . 0.549 ' O ' ' N ' ' A' ' 84' ' ' LEU . 92.9 m-20 -66.42 -16.81 64.39 Favored 'General case' 0 N--CA 1.444 -0.761 0 CA-C-O 119.09 -0.481 . . . . 1.0 110.261 -179.382 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 83' ' ' ALA . . . . . 0.501 ' O ' ' N ' ' A' ' 86' ' ' ALA . . . -15.19 -50.09 0.0 OUTLIER 'General case' 0 C--N 1.355 0.811 0 N-CA-C 113.04 0.755 . . . . 1.0 113.04 178.05 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 84' ' ' LEU . . . . . 0.549 ' N ' ' O ' ' A' ' 82' ' ' ASP . 0.2 OUTLIER -27.58 -50.78 0.06 Allowed 'General case' 0 C--N 1.355 0.827 0 N-CA-C 113.046 0.758 . . . . 1.0 113.046 -177.057 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 19.9 pt -85.57 -37.78 12.32 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.664 0 N-CA-C 109.584 -0.524 . . . . 1.0 109.584 179.235 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 86' ' ' ALA . . . . . 0.682 ' O ' ' N ' ' A' ' 88' ' ' ALA . . . -47.46 -54.86 10.31 Favored 'General case' 0 CA--C 1.518 -0.287 0 C-N-CA 120.329 -0.548 . . . . 1.0 110.333 -179.341 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 87' ' ' GLU . . . . . 0.573 ' C ' ' H ' ' A' ' 89' ' ' VAL . 0.5 OUTLIER -38.21 -14.81 0.01 OUTLIER 'General case' 0 CA--C 1.539 0.525 0 CA-C-N 117.768 0.258 . . . . 1.0 111.214 -179.686 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 88' ' ' ALA . . . . . 0.682 ' N ' ' O ' ' A' ' 86' ' ' ALA . . . -54.8 -5.26 0.08 Allowed 'General case' 0 C--O 1.218 -0.577 0 N-CA-C 108.811 -0.811 . . . . 1.0 108.811 177.213 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 89' ' ' VAL . . . . . 0.573 ' H ' ' C ' ' A' ' 87' ' ' GLU . 4.4 m -33.13 -31.53 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.551 0.991 0 CA-C-O 121.099 0.476 . . . . 1.0 110.787 -177.591 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 90' ' ' GLY . . . . . 0.523 ' N ' ' O ' ' A' ' 88' ' ' ALA . . . -49.33 -75.2 0.21 Allowed Glycine 0 CA--C 1.549 2.2 0 C-N-CA 119.889 -1.148 . . . . 1.0 111.21 -178.734 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 91' ' ' PRO . . . . . 0.473 ' HD2' ' O ' ' A' ' 88' ' ' ALA . 9.9 Cg_endo -52.05 -28.88 34.14 Favored 'Trans proline' 0 N--CA 1.504 2.114 0 C-N-CA 122.955 2.437 . . . . 1.0 111.229 176.663 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 92' ' ' HIS . . . . . 0.639 ' CE1' HH11 ' A' ' 52' ' ' ARG . 26.9 m80 -54.14 -19.37 4.91 Favored 'General case' 0 CA--C 1.514 -0.424 0 N-CA-C 107.4 -1.333 . . . . 1.0 107.4 -176.473 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 93' ' ' LEU . . . . . 0.549 ' O ' ' N ' ' A' ' 96' ' ' ALA . 20.7 tp -57.03 -49.98 74.13 Favored 'General case' 0 N--CA 1.45 -0.425 0 N-CA-C 106.59 -1.633 . . . . 1.0 106.59 176.797 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -49.13 -51.9 29.36 Favored 'General case' 0 CA--C 1.517 -0.301 0 N-CA-C 106.662 -1.607 . . . . 1.0 106.662 -179.352 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 3.0 mmt180 -61.03 -32.13 71.75 Favored 'General case' 0 C--N 1.316 -0.849 0 N-CA-C 108.622 -0.881 . . . . 1.0 108.622 177.191 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 96' ' ' ALA . . . . . 0.777 ' O ' ' N ' ' A' ' 100' ' ' ILE . . . -55.82 -51.44 67.47 Favored 'General case' 0 C--O 1.199 -1.556 0 C-N-CA 118.817 -1.153 . . . . 1.0 107.918 -178.947 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 97' ' ' LEU . . . . . 0.466 ' C ' ' O ' ' A' ' 96' ' ' ALA . 0.2 OUTLIER -34.15 -26.15 0.01 OUTLIER 'General case' 0 CA--C 1.587 2.399 0 N-CA-C 107.58 -1.267 . . . . 1.0 107.58 -178.325 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 98' ' ' GLY . . . . . 0.659 ' N ' ' O ' ' A' ' 96' ' ' ALA . . . -86.48 -52.77 3.1 Favored Glycine 0 CA--C 1.546 1.981 0 CA-C-O 123.967 1.871 . . . . 1.0 110.617 173.963 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 99' ' ' GLN . . . . . 0.612 ' N ' ' O ' ' A' ' 96' ' ' ALA . 24.6 tt0 -76.97 7.56 4.74 Favored 'General case' 0 N--CA 1.418 -2.047 0 N-CA-C 107.837 -1.171 . . . . 1.0 107.837 177.177 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 100' ' ' ILE . . . . . 0.777 ' N ' ' O ' ' A' ' 96' ' ' ALA . 6.8 tp -62.48 -47.91 90.77 Favored 'Isoleucine or valine' 0 CA--C 1.481 -1.678 0 N-CA-C 108.66 -0.867 . . . . 1.0 108.66 179.82 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 101' ' ' VAL . . . . . 0.57 ' N ' ' CG2' ' A' ' 100' ' ' ILE . 46.3 t -53.57 -59.92 1.61 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.622 0 C-N-CA 117.352 -1.739 . . . . 1.0 108.341 179.095 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 102' ' ' CYS . . . . . 0.689 ' SG ' ' H71' ' A' ' 130' ' ' MTN . 0.0 OUTLIER -52.41 -31.7 35.52 Favored 'General case' 0 CA--C 1.545 0.767 0 C-N-CA 119.831 -0.748 . . . . 1.0 111.215 -176.743 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 103' ' ' ARG . . . . . 0.571 ' HA ' ' H73' ' A' ' 130' ' ' MTN . 11.8 ttp180 -82.15 -47.89 11.98 Favored 'General case' 0 N--CA 1.494 1.759 0 CA-C-O 122.287 1.041 . . . . 1.0 113.014 178.666 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 104' ' ' TYR . . . . . 0.439 ' CD2' ' O ' ' A' ' 104' ' ' TYR . 50.6 t80 -92.08 22.73 4.17 Favored 'General case' 0 C--N 1.29 -1.98 0 CA-C-N 113.653 -1.612 . . . . 1.0 108.502 178.802 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 105' ' ' GLY . . . . . 0.527 ' N ' ' O ' ' A' ' 101' ' ' VAL . . . -159.81 -86.98 0.06 OUTLIER Glycine 0 CA--C 1.526 0.779 0 N-CA-C 110.337 -1.105 . . . . 1.0 110.337 178.618 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 106' ' ' ALA . . . . . 0.687 ' HB2' ' O ' ' A' ' 102' ' ' CYS . . . 57.13 106.65 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.17 0 N-CA-C 109.22 -0.659 . . . . 1.0 109.22 -177.117 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 107' ' ' THR . . . . . 0.633 ' O ' ' CD ' ' A' ' 110' ' ' PRO . 26.0 m -134.24 -60.59 0.8 Allowed 'General case' 0 C--O 1.205 -1.276 0 CA-C-O 118.606 -0.711 . . . . 1.0 110.076 179.086 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 108' ' ' VAL . . . . . 0.65 ' O ' HG22 ' A' ' 108' ' ' VAL . 12.3 p -82.83 34.97 0.04 OUTLIER 'Isoleucine or valine' 0 C--O 1.235 0.29 0 C-N-CA 123.659 0.784 . . . . 1.0 111.265 -175.812 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 109' ' ' ILE . . . . . 0.665 ' N ' ' CD ' ' A' ' 110' ' ' PRO . 31.5 pt -104.7 -22.87 0.19 Allowed Pre-proline 0 CA--C 1.568 1.641 0 CA-C-N 115.876 -0.602 . . . . 1.0 111.363 177.55 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 110' ' ' PRO . . . . . 0.665 ' CD ' ' N ' ' A' ' 109' ' ' ILE . 71.6 Cg_endo -73.14 -15.66 25.6 Favored 'Trans proline' 0 N--CA 1.483 0.883 0 C-N-CA 123.292 2.661 . . . . 1.0 113.674 -177.402 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 24.2 t-20 -61.72 -69.2 0.26 Allowed 'General case' 0 C--O 1.237 0.401 0 C-N-CA 120.357 -0.537 . . . . 1.0 110.472 -177.941 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 112' ' ' ILE . . . . . 0.472 HG21 ' HA3' ' A' ' 35' ' ' GLY . 0.0 OUTLIER -65.53 -28.68 44.92 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.413 0 CA-C-O 122.015 0.912 . . . . 1.0 109.996 179.614 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 113' ' ' ASN . . . . . 0.487 ' O ' ' OE1' ' A' ' 117' ' ' GLU . 42.1 t30 -55.16 -63.86 1.02 Allowed 'General case' 0 C--N 1.306 -1.32 0 CA-C-N 115.062 -0.972 . . . . 1.0 110.519 -176.738 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -61.49 -23.06 65.63 Favored 'General case' 0 C--N 1.31 -1.132 0 C-N-CA 120.788 -0.365 . . . . 1.0 111.383 179.832 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 115' ' ' ALA . . . . . 0.475 ' O ' HG12 ' A' ' 118' ' ' VAL . . . -79.34 -60.01 2.54 Favored 'General case' 0 CA--C 1.536 0.433 0 N-CA-C 112.485 0.55 . . . . 1.0 112.485 178.733 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 116' ' ' ILE . . . . . 0.549 ' O ' ' N ' ' A' ' 119' ' ' LEU . 3.3 mm -70.3 -49.11 56.74 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.365 0 O-C-N 121.102 -0.999 . . . . 1.0 112.187 -177.982 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 117' ' ' GLU . . . . . 0.612 ' N ' ' OE1' ' A' ' 117' ' ' GLU . 10.3 mp0 -46.96 -61.55 1.82 Allowed 'General case' 0 C--N 1.317 -0.846 0 N-CA-C 108.728 -0.841 . . . . 1.0 108.728 -176.815 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 118' ' ' VAL . . . . . 0.475 HG12 ' O ' ' A' ' 115' ' ' ALA . 2.0 p -51.9 -16.35 0.64 Allowed 'Isoleucine or valine' 0 N--CA 1.443 -0.797 0 C-N-CA 119.896 -0.721 . . . . 1.0 109.078 179.157 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 119' ' ' LEU . . . . . 0.549 ' N ' ' O ' ' A' ' 116' ' ' ILE . 0.3 OUTLIER -78.39 -60.45 2.37 Favored 'General case' 0 C--N 1.356 0.87 0 N-CA-C 108.808 -0.812 . . . . 1.0 108.808 176.802 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -68.29 -83.07 0.15 Allowed Glycine 0 C--N 1.367 2.251 0 C-N-CA 116.759 -2.639 . . . . 1.0 110.747 178.671 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 121' ' ' THR . . . . . 0.441 ' OG1' ' NE2' ' A' ' 72' ' ' HIS . 13.3 m -159.75 -18.83 0.06 Allowed 'General case' 0 N--CA 1.475 0.801 0 CA-C-O 122.107 0.956 . . . . 1.0 109.307 -179.645 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 122' ' ' GLY . . . . . 0.45 ' O ' ' C ' ' A' ' 123' ' ' THR . . . 111.48 -36.73 4.04 Favored Glycine 0 CA--C 1.523 0.588 0 CA-C-N 113.365 -1.743 . . . . 1.0 112.098 179.733 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 123' ' ' THR . . . . . 0.45 ' C ' ' O ' ' A' ' 122' ' ' GLY . 91.1 m -31.4 95.15 0.01 OUTLIER 'General case' 0 N--CA 1.477 0.904 0 CA-C-N 118.913 1.356 . . . . 1.0 112.369 -178.267 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 124' ' ' ASP . . . . . 0.406 ' N ' ' O ' ' A' ' 122' ' ' GLY . 0.0 OUTLIER -146.02 144.6 30.19 Favored 'General case' 0 C--N 1.347 0.494 0 N-CA-C 108.259 -1.015 . . . . 1.0 108.259 178.596 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 125' ' ' TYR . . . . . 0.451 ' O ' ' NE ' ' A' ' 126' ' ' ARG . 1.1 p90 -149.57 148.79 29.76 Favored 'General case' 0 C--N 1.325 -0.498 0 N-CA-C 109.951 -0.389 . . . . 1.0 109.951 179.817 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 126' ' ' ARG . . . . . 0.574 ' HA ' ' HE ' ' A' ' 126' ' ' ARG . 0.0 OUTLIER -146.73 149.48 33.49 Favored 'General case' 0 N--CA 1.465 0.302 0 N-CA-C 109.2 -0.667 . . . . 1.0 109.2 177.081 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 127' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.222 -0.389 0 CA-C-O 117.998 -1.001 . . . . 1.0 111.057 -178.507 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 128' ' ' MTN . . . . . 0.49 ' H92' ' HE ' ' A' ' 47' ' ' ARG . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 129' ' ' MTN . . . . . 0.776 ' S1 ' ' H71' ' A' ' 129' ' ' MTN . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 130' ' ' MTN . . . . . 0.689 ' H71' ' SG ' ' A' ' 102' ' ' CYS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.492 1.633 0 N-CA-C 109.219 -0.66 . . . . 1.0 109.219 . . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 2' ' ' SER . . . . . 0.462 ' O ' ' CG ' ' A' ' 3' ' ' ASP . 86.7 p -89.19 4.48 48.47 Favored 'General case' 0 N--CA 1.463 0.212 0 CA-C-N 115.97 -0.559 . . . . 1.0 111.338 -179.56 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 3' ' ' ASP . . . . . 0.462 ' CG ' ' O ' ' A' ' 2' ' ' SER . 11.4 m-20 160.39 118.46 0.0 OUTLIER 'General case' 0 N--CA 1.465 0.316 0 O-C-N 123.578 0.549 . . . . 1.0 110.833 179.44 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 4' ' ' PHE . . . . . 0.443 ' O ' ' OD1' ' A' ' 5' ' ' ASP . 72.9 t80 -149.79 145.57 26.69 Favored 'General case' 0 CA--C 1.518 -0.261 0 N-CA-C 109.073 -0.714 . . . . 1.0 109.073 178.027 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 5' ' ' ASP . . . . . 0.443 ' OD1' ' O ' ' A' ' 4' ' ' PHE . 72.0 m-20 -149.92 146.5 27.1 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.963 -0.562 . . . . 1.0 110.472 -179.054 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 6' ' ' THR . . . . . 0.696 ' O ' ' N ' ' A' ' 10' ' ' SER . 0.2 OUTLIER -114.31 -156.23 0.59 Allowed 'General case' 0 C--O 1.206 -1.219 0 CA-C-O 121.699 0.762 . . . . 1.0 110.245 179.291 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 7' ' ' GLU . . . . . 0.503 ' O ' ' CB ' ' A' ' 11' ' ' ARG . 10.5 tm-20 -57.04 -48.37 78.68 Favored 'General case' 0 C--N 1.306 -1.323 0 O-C-N 121.67 -0.643 . . . . 1.0 110.361 -178.443 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 8' ' ' ARG . . . . . 0.849 ' O ' ' HB3' ' A' ' 12' ' ' ALA . 39.1 ttm180 -67.28 -58.23 5.21 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-O 122.046 0.927 . . . . 1.0 109.781 178.506 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 9' ' ' VAL . . . . . 0.65 ' O ' ' HB ' ' A' ' 13' ' ' VAL . 0.2 OUTLIER -65.2 -51.16 68.76 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.847 0 CA-C-N 114.64 -1.163 . . . . 1.0 109.456 -178.243 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 10' ' ' SER . . . . . 0.697 ' O ' ' HB3' ' A' ' 14' ' ' ALA . 1.1 m -69.43 -64.07 0.95 Allowed 'General case' 0 C--N 1.302 -1.462 0 O-C-N 120.78 -1.2 . . . . 1.0 111.325 178.801 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 11' ' ' ARG . . . . . 0.741 ' O ' ' HB3' ' A' ' 15' ' ' ALA . 30.5 ttm-85 -63.97 -48.65 75.63 Favored 'General case' 0 N--CA 1.472 0.633 0 O-C-N 121.396 -0.815 . . . . 1.0 112.735 -176.206 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 12' ' ' ALA . . . . . 0.849 ' HB3' ' O ' ' A' ' 8' ' ' ARG . . . -70.03 -58.61 3.63 Favored 'General case' 0 N--CA 1.472 0.663 0 C-N-CA 118.96 -1.096 . . . . 1.0 109.284 178.286 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 13' ' ' VAL . . . . . 0.722 ' O ' ' HB3' ' A' ' 17' ' ' LEU . 1.0 OUTLIER -63.18 -54.08 37.78 Favored 'Isoleucine or valine' 0 C--O 1.195 -1.788 0 C-N-CA 117.773 -1.571 . . . . 1.0 108.921 -179.662 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 14' ' ' ALA . . . . . 0.946 ' O ' HG22 ' A' ' 18' ' ' VAL . . . -63.48 -62.87 1.39 Allowed 'General case' 0 N--CA 1.48 1.073 0 C-N-CA 117.123 -1.831 . . . . 1.0 111.353 179.888 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 15' ' ' ALA . . . . . 0.741 ' HB3' ' O ' ' A' ' 11' ' ' ARG . . . -54.93 -55.98 24.61 Favored 'General case' 0 N--CA 1.485 1.286 0 C-N-CA 118.877 -1.129 . . . . 1.0 111.311 -177.327 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 16' ' ' ALA . . . . . 0.761 ' HB3' ' O ' ' A' ' 12' ' ' ALA . . . -66.06 -57.16 8.34 Favored 'General case' 0 CA--C 1.548 0.874 0 C-N-CA 119.589 -0.844 . . . . 1.0 109.935 -178.425 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 17' ' ' LEU . . . . . 0.722 ' HB3' ' O ' ' A' ' 13' ' ' VAL . 7.0 tt -56.29 -54.07 49.77 Favored 'General case' 0 N--CA 1.483 1.206 0 CA-C-N 115.065 -0.97 . . . . 1.0 108.421 -178.224 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 18' ' ' VAL . . . . . 0.946 HG22 ' O ' ' A' ' 14' ' ' ALA . 1.8 m -71.14 -57.81 6.71 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.602 0 C-N-CA 119.307 -0.957 . . . . 1.0 110.169 179.868 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 19' ' ' GLY . . . . . 0.539 ' N ' ' O ' ' A' ' 15' ' ' ALA . . . -57.88 -171.54 0.25 Allowed Glycine 0 N--CA 1.448 -0.526 0 N-CA-C 111.17 -0.772 . . . . 1.0 111.17 -177.911 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 20' ' ' PRO . . . . . 0.585 ' O ' ' N ' ' A' ' 24' ' ' ALA . 89.8 Cg_endo -81.76 -24.51 4.12 Favored 'Trans proline' 0 C--N 1.298 -2.1 0 C-N-CA 122.691 2.261 . . . . 1.0 113.276 -178.583 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 21' ' ' GLY . . . . . 0.445 ' O ' ' HB3' ' A' ' 24' ' ' ALA . . . -63.96 -61.89 5.71 Favored Glycine 0 N--CA 1.484 1.856 0 C-N-CA 119.237 -1.458 . . . . 1.0 111.981 -176.992 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 22' ' ' GLY . . . . . 0.512 ' H ' ' HA ' ' A' ' 16' ' ' ALA . . . -53.01 -51.83 43.55 Favored Glycine 0 N--CA 1.47 0.927 0 N-CA-C 106.212 -2.755 . . . . 1.0 106.212 179.69 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 34.3 t -56.88 -30.74 34.12 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.733 0 N-CA-C 108.832 -0.803 . . . . 1.0 108.832 178.332 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 24' ' ' ALA . . . . . 0.585 ' N ' ' O ' ' A' ' 20' ' ' PRO . . . -58.22 -61.37 2.62 Favored 'General case' 0 C--N 1.352 0.706 0 C-N-CA 118.354 -1.339 . . . . 1.0 109.499 179.638 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 25' ' ' LEU . . . . . 0.516 ' N ' HD12 ' A' ' 25' ' ' LEU . 9.0 mp -57.59 -44.27 85.24 Favored 'General case' 0 C--O 1.223 -0.315 0 C-N-CA 119.629 -0.829 . . . . 1.0 110.341 -177.893 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 65.5 t -58.6 -60.33 2.46 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.861 0 C-N-CA 119.087 -1.045 . . . . 1.0 111.053 -178.61 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 27' ' ' VAL . . . . . 0.553 ' O ' ' HB3' ' A' ' 31' ' ' ALA . 18.1 t -58.51 -41.83 82.88 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.231 0 N-CA-C 112.843 0.683 . . . . 1.0 112.843 -177.64 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 28' ' ' LYS . . . . . 0.616 ' NZ ' HG23 ' A' ' 29' ' ' VAL . 3.9 pptp? -68.33 -54.41 17.56 Favored 'General case' 0 C--N 1.325 -0.459 0 C-N-CA 119.078 -1.049 . . . . 1.0 109.966 -178.027 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 29' ' ' VAL . . . . . 0.616 HG23 ' NZ ' ' A' ' 28' ' ' LYS . 1.3 t -60.58 -50.71 79.32 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.6 0 C-N-CA 119.748 -0.781 . . . . 1.0 110.576 179.862 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 30' ' ' CYS . . . . . . . . . . . . . 8.6 t -65.14 -63.1 1.19 Allowed 'General case' 0 N--CA 1.447 -0.6 0 C-N-CA 119.425 -0.91 . . . . 1.0 110.51 -179.184 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 31' ' ' ALA . . . . . 0.553 ' HB3' ' O ' ' A' ' 27' ' ' VAL . . . -56.19 -50.38 71.39 Favored 'General case' 0 CA--C 1.517 -0.323 0 C-N-CA 120.3 -0.56 . . . . 1.0 111.168 -177.53 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 32' ' ' GLY . . . . . 0.45 ' O ' ' HB2' ' A' ' 33' ' ' LEU . . . 74.3 70.44 1.25 Allowed Glycine 0 N--CA 1.45 -0.43 0 N-CA-C 108.621 -1.791 . . . . 1.0 108.621 -178.182 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 33' ' ' LEU . . . . . 0.45 ' HB2' ' O ' ' A' ' 32' ' ' GLY . 0.1 OUTLIER 84.75 93.8 0.04 OUTLIER Pre-proline 0 CA--C 1.55 0.968 0 O-C-N 124.477 0.751 . . . . 1.0 109.657 -178.286 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 74.7 Cg_exo -45.69 -13.55 0.08 OUTLIER 'Trans proline' 0 N--CA 1.491 1.378 0 C-N-CA 121.919 1.746 . . . . 1.0 113.634 -179.56 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 35' ' ' GLY . . . . . 0.433 ' N ' ' O ' ' A' ' 33' ' ' LEU . . . -62.81 -61.85 6.07 Favored Glycine 0 N--CA 1.471 0.989 0 C-N-CA 118.885 -1.626 . . . . 1.0 110.422 -178.263 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 36' ' ' VAL . . . . . 0.762 ' O ' HG22 ' A' ' 37' ' ' ILE . 34.3 m -76.94 -147.01 0.01 OUTLIER 'Isoleucine or valine' 0 C--O 1.213 -0.858 0 N-CA-C 107.58 -1.267 . . . . 1.0 107.58 178.431 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 37' ' ' ILE . . . . . 0.762 HG22 ' O ' ' A' ' 36' ' ' VAL . 0.3 OUTLIER 71.93 75.4 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.474 0.741 0 CA-C-O 122.993 1.378 . . . . 1.0 111.675 179.934 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 53.8 m-70 -137.75 131.97 32.06 Favored 'General case' 0 C--N 1.327 -0.376 0 O-C-N 120.707 -1.246 . . . . 1.0 109.103 178.997 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 39' ' ' THR . . . . . 0.406 HG23 ' O ' ' A' ' 39' ' ' THR . 1.7 t -128.65 112.99 19.19 Favored Pre-proline 0 CA--C 1.542 0.642 0 N-CA-C 109.015 -0.735 . . . . 1.0 109.015 179.745 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 40' ' ' PRO . . . . . 0.547 ' O ' ' NE ' ' A' ' 42' ' ' ARG . 83.8 Cg_exo -42.63 -68.05 0.11 Allowed 'Trans proline' 0 N--CA 1.49 1.293 0 C-N-CA 121.542 1.495 . . . . 1.0 112.569 -178.673 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -74.7 128.02 34.54 Favored 'General case' 0 C--N 1.316 -0.889 0 CA-C-N 115.173 -0.921 . . . . 1.0 111.244 -177.694 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 42' ' ' ARG . . . . . 0.643 ' C ' ' H ' ' A' ' 44' ' ' GLY . 0.1 OUTLIER -173.78 175.44 2.89 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 114.859 -1.064 . . . . 1.0 110.726 179.631 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 43' ' ' ARG . . . . . 0.573 ' C ' ' H ' ' A' ' 45' ' ' PHE . 25.3 tpt180 -63.51 19.11 0.01 OUTLIER 'General case' 0 CA--C 1.549 0.905 0 CA-C-O 121.254 0.549 . . . . 1.0 109.927 178.532 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 44' ' ' GLY . . . . . 0.643 ' H ' ' C ' ' A' ' 42' ' ' ARG . . . 69.93 -27.94 0.41 Allowed Glycine 0 C--N 1.342 0.906 0 N-CA-C 110.66 -0.976 . . . . 1.0 110.66 -179.715 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 45' ' ' PHE . . . . . 0.668 ' O ' ' HB2' ' A' ' 46' ' ' PHE . 1.1 p90 -159.79 161.01 34.52 Favored 'General case' 0 C--N 1.326 -0.415 0 N-CA-C 109.022 -0.733 . . . . 1.0 109.022 179.77 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 46' ' ' PHE . . . . . 0.668 ' HB2' ' O ' ' A' ' 45' ' ' PHE . 0.7 OUTLIER 131.87 94.35 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.506 0 O-C-N 125.414 1.696 . . . . 1.0 109.604 179.153 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 47' ' ' ARG . . . . . 0.581 ' CB ' ' O ' ' A' ' 46' ' ' PHE . 0.0 OUTLIER 112.58 143.14 0.0 OUTLIER 'General case' 0 N--CA 1.48 1.072 0 O-C-N 124.415 1.072 . . . . 1.0 111.709 178.229 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 48' ' ' CYS . . . . . 0.485 ' O ' ' H62' ' A' ' 129' ' ' MTN . 35.8 t 66.96 73.18 0.35 Allowed 'General case' 0 C--O 1.22 -0.463 0 O-C-N 124.317 1.011 . . . . 1.0 110.579 179.257 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 49' ' ' ASN . . . . . 0.528 ' C ' HD22 ' A' ' 49' ' ' ASN . 0.4 OUTLIER -136.44 153.89 76.54 Favored Pre-proline 0 CA--C 1.536 0.435 0 N-CA-C 109.863 -0.421 . . . . 1.0 109.863 -179.19 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 50' ' ' PRO . . . . . 0.534 ' C ' ' H ' ' A' ' 52' ' ' ARG . 27.9 Cg_endo -58.64 56.67 0.06 OUTLIER 'Trans proline' 0 N--CA 1.51 2.455 0 C-N-CA 123.219 2.612 . . . . 1.0 113.516 179.931 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 51' ' ' GLU . . . . . 0.558 ' OE1' ' ND1' ' A' ' 92' ' ' HIS . 49.1 mt-10 63.85 -34.44 0.14 Allowed 'General case' 0 N--CA 1.47 0.541 0 CA-C-N 116.129 -0.487 . . . . 1.0 111.984 179.855 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 52' ' ' ARG . . . . . 0.534 ' H ' ' C ' ' A' ' 50' ' ' PRO . 75.7 mtt85 -45.9 136.3 6.5 Favored 'General case' 0 C--N 1.325 -0.468 0 N-CA-C 109.588 -0.523 . . . . 1.0 109.588 179.696 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 53' ' ' ILE . . . . . 0.607 ' O ' ' N ' ' A' ' 55' ' ' ILE . 3.0 tp -49.73 125.56 3.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 N-CA-C 109.615 -0.513 . . . . 1.0 109.615 -178.713 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -57.17 80.37 0.01 OUTLIER 'General case' 0 C--N 1.322 -0.588 0 CA-C-O 121.931 0.872 . . . . 1.0 109.054 -177.393 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 55' ' ' ILE . . . . . 0.607 ' N ' ' O ' ' A' ' 53' ' ' ILE . 3.3 tt -155.12 165.01 1.26 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.249 0 CA-C-N 114.687 -1.142 . . . . 1.0 111.449 178.501 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 105.55 -28.83 12.77 Favored Glycine 0 C--O 1.226 -0.405 0 CA-C-N 115.916 -0.584 . . . . 1.0 112.134 176.737 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -52.56 117.61 3.01 Favored 'General case' 0 CA--C 1.537 0.478 0 CA-C-N 118.013 0.906 . . . . 1.0 112.627 -178.783 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 58' ' ' TRP . . . . . 0.447 ' HB2' ' HB3' ' A' ' 61' ' ' GLU . 36.1 m95 -79.83 168.26 19.51 Favored 'General case' 0 CA--C 1.556 1.182 0 CA-C-O 124.214 1.959 . . . . 1.0 111.045 178.649 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 59' ' ' ARG . . . . . 0.545 ' HD3' ' H ' ' A' ' 59' ' ' ARG . 0.0 OUTLIER -86.17 -64.14 1.2 Allowed 'General case' 0 N--CA 1.509 2.518 0 CA-C-N 110.745 -2.934 . . . . 1.0 112.902 -176.989 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 60' ' ' TYR . . . . . 0.415 ' O ' ' CG ' ' A' ' 60' ' ' TYR . 17.5 t80 -88.07 -16.44 33.56 Favored 'General case' 0 N--CA 1.483 1.205 0 N-CA-C 113.171 0.804 . . . . 1.0 113.171 179.728 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 61' ' ' GLU . . . . . 0.531 ' O ' ' N ' ' A' ' 65' ' ' ASP . 11.3 tt0 -79.42 -12.88 59.89 Favored 'General case' 0 C--N 1.313 -1.002 0 O-C-N 121.704 -0.622 . . . . 1.0 109.64 179.941 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 62' ' ' VAL . . . . . 0.557 ' O ' ' N ' ' A' ' 66' ' ' GLY . 12.2 m -45.42 -51.4 2.74 Favored 'Isoleucine or valine' 0 CA--C 1.5 -0.974 0 C-N-CA 120.04 -0.664 . . . . 1.0 110.354 -176.126 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 63' ' ' ALA . . . . . 0.487 ' N ' HG23 ' A' ' 62' ' ' VAL . . . -68.29 -48.35 65.19 Favored 'General case' 0 N--CA 1.426 -1.66 0 C-N-CA 119.752 -0.779 . . . . 1.0 109.325 179.763 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 1.8 t-80 -56.49 -59.65 4.68 Favored 'General case' 0 CA--C 1.545 0.755 0 CA-C-N 115.358 -0.837 . . . . 1.0 110.37 -179.645 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 65' ' ' ASP . . . . . 0.586 ' C ' ' H ' ' A' ' 67' ' ' ARG . 1.0 OUTLIER -69.42 -55.46 10.25 Favored 'General case' 0 CA--C 1.549 0.917 0 CA-C-O 121.976 0.893 . . . . 1.0 109.756 177.767 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 66' ' ' GLY . . . . . 0.557 ' N ' ' O ' ' A' ' 62' ' ' VAL . . . -67.34 33.3 0.2 Allowed Glycine 0 CA--C 1.529 0.939 0 O-C-N 120.726 -1.234 . . . . 1.0 111.227 178.957 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 67' ' ' ARG . . . . . 0.644 ' O ' ' N ' ' A' ' 69' ' ' LEU . 0.8 OUTLIER -77.98 5.93 8.82 Favored 'General case' 0 C--N 1.32 -0.678 0 N-CA-C 108.85 -0.796 . . . . 1.0 108.85 177.045 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 68' ' ' LEU . . . . . 0.506 ' O ' ' HA ' ' A' ' 72' ' ' HIS . 0.3 OUTLIER -32.86 -28.36 0.01 OUTLIER 'General case' 0 N--CA 1.487 1.396 0 N-CA-C 108.226 -1.027 . . . . 1.0 108.226 -177.879 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 69' ' ' LEU . . . . . 0.644 ' N ' ' O ' ' A' ' 67' ' ' ARG . 2.4 mp -64.4 -65.2 0.71 Allowed 'General case' 0 N--CA 1.469 0.488 0 C-N-CA 117.922 -1.511 . . . . 1.0 107.301 177.16 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 70' ' ' ALA . . . . . 0.662 ' C ' ' H ' ' A' ' 72' ' ' HIS . . . -76.09 -72.22 0.34 Allowed 'General case' 0 CA--C 1.51 -0.573 0 N-CA-C 106.157 -1.794 . . . . 1.0 106.157 178.249 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 71' ' ' ALA . . . . . 0.612 ' H ' ' HB3' ' A' ' 67' ' ' ARG . . . -43.87 3.22 0.0 OUTLIER 'General case' 0 N--CA 1.472 0.634 0 C-N-CA 125.135 1.374 . . . . 1.0 113.798 176.897 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 72' ' ' HIS . . . . . 0.786 ' CG ' ' H ' ' A' ' 73' ' ' MET . 2.5 p-80 -19.41 -65.92 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.314 0 N-CA-C 112.728 0.64 . . . . 1.0 112.728 -176.372 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 73' ' ' MET . . . . . 0.786 ' H ' ' CG ' ' A' ' 72' ' ' HIS . 28.1 mtt -76.64 -45.78 28.56 Favored 'General case' 0 N--CA 1.438 -1.059 0 CA-C-N 119.023 0.828 . . . . 1.0 109.22 177.557 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 74' ' ' VAL . . . . . 0.591 ' O ' ' N ' ' A' ' 76' ' ' GLY . 94.5 t -45.27 -50.37 2.9 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.306 0 CA-C-O 118.082 -0.961 . . . . 1.0 109.894 -177.099 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 75' ' ' ASN . . . . . 0.512 ' C ' ' N ' ' A' ' 77' ' ' ILE . 19.0 t-20 -39.44 -21.18 0.01 OUTLIER 'General case' 0 C--N 1.357 0.925 0 CA-C-N 120.312 1.415 . . . . 1.0 110.715 177.346 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 76' ' ' GLY . . . . . 0.591 ' N ' ' O ' ' A' ' 74' ' ' VAL . . . -43.48 -20.95 0.14 Allowed Glycine 0 CA--C 1.534 1.237 0 N-CA-C 108.675 -1.77 . . . . 1.0 108.675 178.934 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 77' ' ' ILE . . . . . 0.772 ' O ' ' N ' ' A' ' 80' ' ' ALA . 96.7 mt -82.43 -50.04 16.49 Favored 'Isoleucine or valine' 0 C--O 1.213 -0.855 0 N-CA-C 108.766 -0.827 . . . . 1.0 108.766 179.421 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 78' ' ' VAL . . . . . 0.467 ' C ' ' O ' ' A' ' 77' ' ' ILE . 43.8 t -35.4 -34.49 0.06 OUTLIER 'Isoleucine or valine' 0 CA--C 1.541 0.603 0 N-CA-C 108.481 -0.933 . . . . 1.0 108.481 -178.254 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 79' ' ' ILE . . . . . 0.744 ' O ' ' HB2' ' A' ' 83' ' ' ALA . 0.1 OUTLIER -88.16 -24.7 6.1 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.602 0 CA-C-O 121.007 0.432 . . . . 1.0 110.104 178.789 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 80' ' ' ALA . . . . . 0.772 ' N ' ' O ' ' A' ' 77' ' ' ILE . . . -89.78 -9.25 49.96 Favored 'General case' 0 CA--C 1.539 0.522 0 C-N-CA 123.843 0.857 . . . . 1.0 111.653 177.061 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 81' ' ' GLU . . . . . 0.62 ' O ' HD11 ' A' ' 84' ' ' LEU . 51.2 tp10 -77.86 -71.77 0.4 Allowed 'General case' 0 N--CA 1.444 -0.765 0 CA-C-O 118.477 -0.773 . . . . 1.0 111.516 -179.288 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 82' ' ' ASP . . . . . 0.589 ' O ' HG13 ' A' ' 85' ' ' ILE . 1.7 m-20 -81.67 -18.72 43.53 Favored 'General case' 0 C--O 1.21 -0.983 0 O-C-N 123.517 0.51 . . . . 1.0 112.226 -178.095 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 83' ' ' ALA . . . . . 0.744 ' HB2' ' O ' ' A' ' 79' ' ' ILE . . . -45.05 -52.41 9.0 Favored 'General case' 0 N--CA 1.469 0.491 0 N-CA-C 115.093 1.516 . . . . 1.0 115.093 -179.813 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 84' ' ' LEU . . . . . 0.985 ' H ' HD13 ' A' ' 84' ' ' LEU . 0.0 OUTLIER -31.78 -28.67 0.01 OUTLIER 'General case' 0 N--CA 1.48 1.048 0 CA-C-O 118.962 -0.542 . . . . 1.0 112.408 -174.304 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 85' ' ' ILE . . . . . 0.596 ' N ' ' O ' ' A' ' 83' ' ' ALA . 1.4 pp -100.02 -58.9 3.58 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.878 0 CA-C-N 118.631 0.65 . . . . 1.0 109.262 177.565 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 86' ' ' ALA . . . . . 0.538 ' H ' HG13 ' A' ' 85' ' ' ILE . . . -53.22 -37.53 62.11 Favored 'General case' 0 C--O 1.222 -0.347 0 CA-C-N 115.6 -0.727 . . . . 1.0 110.745 179.869 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 9.8 tt0 -47.5 -11.86 0.03 OUTLIER 'General case' 0 N--CA 1.465 0.295 0 CA-C-O 121.07 0.462 . . . . 1.0 110.046 179.649 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 88' ' ' ALA . . . . . 0.521 ' H ' ' C ' ' A' ' 86' ' ' ALA . . . -84.16 -2.33 56.65 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.754 -0.657 . . . . 1.0 110.103 179.657 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 89' ' ' VAL . . . . . 0.688 ' O ' HG12 ' A' ' 89' ' ' VAL . 54.2 t -93.25 33.03 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.62 0 CA-C-N 115.414 -0.812 . . . . 1.0 109.231 179.079 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 90' ' ' GLY . . . . . 0.633 ' N ' ' HD2' ' A' ' 91' ' ' PRO . . . -67.22 -44.81 85.27 Favored Glycine 0 CA--C 1.535 1.342 0 CA-C-O 119.163 -0.798 . . . . 1.0 112.005 178.134 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 91' ' ' PRO . . . . . 0.633 ' HD2' ' N ' ' A' ' 90' ' ' GLY . 7.7 Cg_exo -39.3 -18.55 0.04 OUTLIER 'Trans proline' 0 N--CA 1.493 1.445 0 C-N-CA 122.236 1.957 . . . . 1.0 111.336 179.263 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 92' ' ' HIS . . . . . 0.713 ' O ' ' N ' ' A' ' 96' ' ' ALA . 3.3 p80 -53.95 -44.83 71.04 Favored 'General case' 0 N--CA 1.441 -0.923 0 N-CA-C 106.357 -1.72 . . . . 1.0 106.357 -179.568 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 93' ' ' LEU . . . . . 0.747 HD12 ' N ' ' A' ' 94' ' ' ALA . 2.3 pp -41.51 -61.38 1.07 Allowed 'General case' 0 CA--C 1.566 1.572 0 C-N-CA 119.578 -0.849 . . . . 1.0 111.762 177.682 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 94' ' ' ALA . . . . . 0.747 ' N ' HD12 ' A' ' 93' ' ' LEU . . . -58.29 -58.76 7.07 Favored 'General case' 0 C--O 1.219 -0.547 0 CA-C-N 119.229 0.922 . . . . 1.0 108.763 179.67 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 95' ' ' ARG . . . . . 0.578 ' O ' ' N ' ' A' ' 97' ' ' LEU . 44.7 mtp85 -51.56 -61.38 2.28 Favored 'General case' 0 C--O 1.246 0.885 0 CA-C-O 123.359 1.552 . . . . 1.0 108.658 178.177 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 96' ' ' ALA . . . . . 0.845 ' O ' ' N ' ' A' ' 98' ' ' GLY . . . -47.82 -14.37 0.05 OUTLIER 'General case' 0 N--CA 1.43 -1.429 0 O-C-N 118.186 -2.821 . . . . 1.0 111.206 -178.446 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 97' ' ' LEU . . . . . 0.628 ' O ' ' N ' ' A' ' 100' ' ' ILE 0.258 6.1 tt 3.68 -51.28 0.0 OUTLIER 'General case' 0 C--N 1.368 1.393 0 C-N-CA 124.109 0.964 . . . . 1.0 112.736 -170.72 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 98' ' ' GLY . . . . . 0.845 ' N ' ' O ' ' A' ' 96' ' ' ALA . . . -49.56 -23.05 4.36 Favored Glycine 0 N--CA 1.434 -1.479 0 CA-C-N 122.187 2.267 . . . . 1.0 108.152 174.589 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 99' ' ' GLN . . . . . 0.532 ' O ' ' H42' ' A' ' 130' ' ' MTN . 83.8 mm-40 -68.88 -19.81 64.24 Favored 'General case' 0 C--N 1.363 1.162 0 C-N-CA 117.308 -1.757 . . . . 1.0 108.58 177.765 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 100' ' ' ILE . . . . . 0.628 ' N ' ' O ' ' A' ' 97' ' ' LEU . 10.3 mt -65.41 -32.72 59.45 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.813 0 C-N-CA 119.749 -0.781 . . . . 1.0 110.214 177.179 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 101' ' ' VAL . . . . . 0.744 HG12 ' O ' ' A' ' 98' ' ' GLY . 3.8 p -60.13 -62.09 1.22 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.509 0 C-N-CA 119.355 -0.938 . . . . 1.0 110.622 -178.847 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 102' ' ' CYS . . . . . 0.867 ' O ' ' HB2' ' A' ' 106' ' ' ALA . 1.2 p -48.72 -19.29 0.34 Allowed 'General case' 0 C--O 1.217 -0.627 0 O-C-N 122.122 -0.361 . . . . 1.0 111.655 -178.364 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 103' ' ' ARG . . . . . 0.61 HH11 ' CG ' ' A' ' 103' ' ' ARG . 0.0 OUTLIER -85.9 -42.61 13.93 Favored 'General case' 0 N--CA 1.498 1.943 0 CA-C-O 124.419 2.057 . . . . 1.0 111.235 -179.98 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 104' ' ' TYR . . . . . 0.803 ' O ' ' CD1' ' A' ' 104' ' ' TYR . 0.0 OUTLIER -97.62 22.48 8.93 Favored 'General case' 0 C--N 1.267 -2.995 0 CA-C-N 110.561 -3.018 . . . . 1.0 107.332 176.949 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 105' ' ' GLY . . . . . 0.512 ' N ' ' O ' ' A' ' 101' ' ' VAL . . . -165.5 -88.3 0.07 OUTLIER Glycine 0 CA--C 1.529 0.913 0 O-C-N 119.634 -1.916 . . . . 1.0 109.081 179.13 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 106' ' ' ALA . . . . . 0.867 ' HB2' ' O ' ' A' ' 102' ' ' CYS . . . 65.52 58.58 0.82 Allowed 'General case' 0 CA--C 1.533 0.308 0 CA-C-O 120.885 0.374 . . . . 1.0 110.688 -178.713 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 13.1 t -89.49 -5.34 57.4 Favored 'General case' 0 CA--C 1.514 -0.412 0 N-CA-C 108.614 -0.884 . . . . 1.0 108.614 178.593 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 108' ' ' VAL . . . . . 0.618 HG23 ' N ' ' A' ' 109' ' ' ILE . 14.7 m -87.53 -53.54 9.76 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.626 0 C-N-CA 120.842 -0.343 . . . . 1.0 110.608 178.537 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 109' ' ' ILE . . . . . 0.618 ' N ' HG23 ' A' ' 108' ' ' VAL . 0.2 OUTLIER -50.34 -34.34 10.65 Favored Pre-proline 0 C--N 1.351 0.658 0 N-CA-C 115.086 1.513 . . . . 1.0 115.086 -178.921 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 110' ' ' PRO . . . . . 0.507 ' CD ' ' N ' ' A' ' 109' ' ' ILE . 76.8 Cg_exo -53.07 -37.89 79.78 Favored 'Trans proline' 0 C--N 1.307 -1.612 0 CA-C-N 120.458 1.199 . . . . 1.0 111.276 -175.212 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -64.76 -67.48 0.43 Allowed 'General case' 0 C--N 1.325 -0.471 0 C-N-CA 119.639 -0.824 . . . . 1.0 109.326 179.647 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 112' ' ' ILE . . . . . 0.485 ' CG1' ' N ' ' A' ' 113' ' ' ASN . 0.3 OUTLIER -60.28 -44.91 96.7 Favored 'Isoleucine or valine' 0 C--O 1.213 -0.817 0 C-N-CA 120.245 -0.582 . . . . 1.0 110.527 -178.819 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 113' ' ' ASN . . . . . 0.498 ' CB ' ' O ' ' A' ' 109' ' ' ILE . 18.0 t30 -44.14 -63.07 0.94 Allowed 'General case' 0 C--N 1.31 -1.118 0 CA-C-N 115.181 -0.918 . . . . 1.0 112.113 -174.659 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -57.18 -23.8 50.05 Favored 'General case' 0 C--N 1.312 -1.061 0 C-N-CA 119.743 -0.783 . . . . 1.0 111.555 -179.664 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -84.21 -58.46 2.75 Favored 'General case' 0 CA--C 1.555 1.162 0 CA-C-O 122.503 1.144 . . . . 1.0 113.846 178.191 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 116' ' ' ILE . . . . . 0.497 ' O ' ' N ' ' A' ' 119' ' ' LEU . 76.0 mt -65.88 -59.8 3.52 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.863 0 CA-C-N 113.814 -1.539 . . . . 1.0 110.825 -177.254 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 117' ' ' GLU . . . . . 0.448 ' HB3' ' O ' ' A' ' 113' ' ' ASN . 11.3 tt0 -45.1 -62.49 1.22 Allowed 'General case' 0 C--N 1.307 -1.257 0 CA-C-N 116.058 -0.519 . . . . 1.0 109.743 -178.285 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 48.7 t -53.49 -14.88 0.76 Allowed 'Isoleucine or valine' 0 N--CA 1.437 -1.119 0 C-N-CA 119.922 -0.711 . . . . 1.0 109.628 -179.782 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 119' ' ' LEU . . . . . 0.497 ' N ' ' O ' ' A' ' 116' ' ' ILE . 3.7 tp -79.79 -60.79 2.21 Favored 'General case' 0 C--N 1.348 0.527 0 C-N-CA 119.776 -0.77 . . . . 1.0 109.966 178.261 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -70.3 -85.1 0.16 Allowed Glycine 0 C--N 1.357 1.735 0 C-N-CA 118.626 -1.75 . . . . 1.0 111.285 179.925 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 121' ' ' THR . . . . . 0.428 ' H ' ' H ' ' A' ' 122' ' ' GLY . 7.7 m -164.57 -22.79 0.03 OUTLIER 'General case' 0 C--N 1.325 -0.478 0 N-CA-C 108.121 -1.066 . . . . 1.0 108.121 -179.035 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 122' ' ' GLY . . . . . 0.53 ' O ' ' N ' ' A' ' 124' ' ' ASP . . . 114.37 -36.42 3.98 Favored Glycine 0 CA--C 1.523 0.562 0 CA-C-O 118.125 -1.375 . . . . 1.0 113.028 179.308 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 123' ' ' THR . . . . . 0.461 ' C ' ' O ' ' A' ' 122' ' ' GLY . 0.0 OUTLIER -32.54 91.32 0.0 OUTLIER 'General case' 0 N--CA 1.47 0.573 0 CA-C-N 119.609 1.705 . . . . 1.0 112.065 -179.565 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 124' ' ' ASP . . . . . 0.53 ' N ' ' O ' ' A' ' 122' ' ' GLY . 11.6 p-10 -146.43 144.39 29.67 Favored 'General case' 0 N--CA 1.463 0.222 0 N-CA-C 108.986 -0.746 . . . . 1.0 108.986 179.051 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 125' ' ' TYR . . . . . 0.419 ' CD1' ' C ' ' A' ' 125' ' ' TYR . 0.2 OUTLIER -151.07 148.99 28.99 Favored 'General case' 0 CA--C 1.536 0.442 0 CA-C-O 121.367 0.603 . . . . 1.0 110.247 -179.962 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 74.8 mtt85 -149.57 150.88 32.92 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.59 -0.732 . . . . 1.0 110.245 178.077 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 127' ' ' PHE . . . . . 0.457 ' C ' ' H63' ' A' ' 130' ' ' MTN . 0.3 OUTLIER . . . . . 0 C--O 1.22 -0.476 0 CA-C-O 118.042 -0.98 . . . . 1.0 109.291 178.83 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 128' ' ' MTN . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 129' ' ' MTN . . . . . 0.485 ' H62' ' O ' ' A' ' 48' ' ' CYS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 130' ' ' MTN . . . . . 0.564 ' H73' ' HB2' ' A' ' 103' ' ' ARG . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.7 mpt? . . . . . 0 N--CA 1.492 1.633 0 N-CA-C 109.061 -0.718 . . . . 1.0 109.061 . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 33.4 m -107.69 7.68 28.6 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.322 -0.399 . . . . 1.0 110.402 179.872 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 3' ' ' ASP . . . . . 0.408 ' N ' ' OD1' ' A' ' 3' ' ' ASP . 1.2 p30 170.72 93.12 0.0 OUTLIER 'General case' 0 N--CA 1.463 0.213 0 CA-C-N 116.288 -0.415 . . . . 1.0 110.414 179.77 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 72.8 t80 -150.84 145.59 25.78 Favored 'General case' 0 N--CA 1.462 0.15 0 CA-C-O 120.684 0.278 . . . . 1.0 110.51 -179.998 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 5' ' ' ASP . . . . . 0.479 ' N ' ' OD1' ' A' ' 5' ' ' ASP . 3.4 p30 -155.53 151.68 27.94 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.434 -0.348 . . . . 1.0 110.444 179.901 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 6' ' ' THR . . . . . 0.552 ' O ' ' N ' ' A' ' 10' ' ' SER . 0.2 OUTLIER -64.7 169.16 5.26 Favored 'General case' 0 C--O 1.208 -1.119 0 N-CA-C 109.556 -0.535 . . . . 1.0 109.556 179.979 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 7' ' ' GLU . . . . . 0.497 ' O ' ' N ' ' A' ' 11' ' ' ARG . 0.0 OUTLIER -59.33 -58.05 10.33 Favored 'General case' 0 C--N 1.315 -0.93 0 CA-C-O 121.359 0.6 . . . . 1.0 110.213 -178.44 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 8' ' ' ARG . . . . . 0.509 ' O ' ' CB ' ' A' ' 12' ' ' ALA . 1.8 ptm180 -50.83 -56.31 12.8 Favored 'General case' 0 C--O 1.212 -0.899 0 N-CA-C 107.994 -1.113 . . . . 1.0 107.994 -177.825 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 9' ' ' VAL . . . . . 0.436 ' H ' ' HG3' ' A' ' 8' ' ' ARG . 0.0 OUTLIER -64.12 -47.46 90.06 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.966 0 CA-C-N 115.037 -0.983 . . . . 1.0 110.364 179.502 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 10' ' ' SER . . . . . 0.552 ' N ' ' O ' ' A' ' 6' ' ' THR . 47.9 t -63.81 -63.06 1.27 Allowed 'General case' 0 N--CA 1.48 1.037 0 O-C-N 123.454 0.471 . . . . 1.0 110.905 -178.968 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 11' ' ' ARG . . . . . 0.497 ' N ' ' O ' ' A' ' 7' ' ' GLU . 12.1 ttt180 -58.68 -54.82 42.8 Favored 'General case' 0 N--CA 1.469 0.489 0 N-CA-C 109.404 -0.591 . . . . 1.0 109.404 -177.069 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 12' ' ' ALA . . . . . 0.588 ' O ' ' HB3' ' A' ' 16' ' ' ALA . . . -46.48 -46.82 19.24 Favored 'General case' 0 N--CA 1.477 0.923 0 N-CA-C 105.762 -1.94 . . . . 1.0 105.762 -178.13 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 13' ' ' VAL . . . . . 0.604 ' O ' ' CB ' ' A' ' 17' ' ' LEU . 1.5 t -61.32 -52.02 66.21 Favored 'Isoleucine or valine' 0 C--O 1.206 -1.196 0 CA-C-N 114.495 -1.23 . . . . 1.0 108.147 176.004 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 14' ' ' ALA . . . . . 0.769 ' O ' HG13 ' A' ' 18' ' ' VAL . . . -57.21 -63.65 1.15 Allowed 'General case' 0 C--O 1.213 -0.86 0 C-N-CA 117.763 -1.575 . . . . 1.0 110.232 -179.876 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 15' ' ' ALA . . . . . 0.557 ' O ' ' N ' ' A' ' 19' ' ' GLY . . . -53.8 -56.26 19.07 Favored 'General case' 0 N--CA 1.473 0.71 0 CA-C-O 121.559 0.695 . . . . 1.0 110.916 -177.956 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 16' ' ' ALA . . . . . 0.588 ' HB3' ' O ' ' A' ' 12' ' ' ALA . . . -64.63 -55.57 19.4 Favored 'General case' 0 C--N 1.31 -1.112 0 CA-C-N 115.135 -0.938 . . . . 1.0 109.611 -178.419 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 17' ' ' LEU . . . . . 0.612 HD13 ' O ' ' A' ' 17' ' ' LEU . 0.3 OUTLIER -57.85 -52.14 66.73 Favored 'General case' 0 N--CA 1.474 0.766 0 CA-C-N 114.506 -1.224 . . . . 1.0 108.004 -177.516 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 18' ' ' VAL . . . . . 0.769 HG13 ' O ' ' A' ' 14' ' ' ALA . 2.3 m -68.37 -57.28 9.59 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.605 0 C-N-CA 118.86 -1.136 . . . . 1.0 109.706 178.685 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 19' ' ' GLY . . . . . 0.557 ' N ' ' O ' ' A' ' 15' ' ' ALA . . . -61.95 -171.84 1.21 Allowed Glycine 0 C--N 1.332 0.319 0 N-CA-C 110.941 -0.863 . . . . 1.0 110.941 -179.059 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 20' ' ' PRO . . . . . 0.603 ' O ' ' N ' ' A' ' 24' ' ' ALA . 2.1 Cg_endo -78.24 -26.3 6.38 Favored 'Trans proline' 0 C--N 1.309 -1.514 0 C-N-CA 122.636 2.224 . . . . 1.0 113.993 -178.752 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -59.62 -58.06 16.26 Favored Glycine 0 N--CA 1.48 1.591 0 C-N-CA 120.256 -0.973 . . . . 1.0 111.808 -177.031 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 22' ' ' GLY . . . . . 0.507 ' CA ' ' HB1' ' A' ' 16' ' ' ALA . . . -57.91 -52.12 54.13 Favored Glycine 0 N--CA 1.469 0.859 0 N-CA-C 107.112 -2.395 . . . . 1.0 107.112 -177.901 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 23' ' ' VAL . . . . . 0.612 ' O ' HG12 ' A' ' 27' ' ' VAL . 9.6 t -58.91 -32.66 47.79 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.078 0 CA-C-N 114.487 -0.856 . . . . 1.0 109.513 179.115 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 24' ' ' ALA . . . . . 0.603 ' N ' ' O ' ' A' ' 20' ' ' PRO . . . -58.51 -61.27 2.72 Favored 'General case' 0 CA--C 1.533 0.307 0 C-N-CA 118.503 -1.279 . . . . 1.0 109.579 -179.947 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 25' ' ' LEU . . . . . 0.554 ' C ' HD12 ' A' ' 25' ' ' LEU . 0.3 OUTLIER -65.04 -43.85 91.03 Favored 'General case' 0 CA--C 1.535 0.387 0 N-CA-C 112.763 0.653 . . . . 1.0 112.763 -177.939 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 26' ' ' VAL . . . . . 0.412 ' N ' ' HG ' ' A' ' 25' ' ' LEU . 53.4 t -61.46 -59.83 3.66 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.171 0 C-N-CA 118.77 -1.172 . . . . 1.0 110.011 -177.626 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 27' ' ' VAL . . . . . 0.612 HG12 ' O ' ' A' ' 23' ' ' VAL . 2.3 p -58.39 -35.6 54.79 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.217 0 N-CA-C 112.016 0.376 . . . . 1.0 112.016 -178.071 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 6.7 ttmm -67.29 -55.09 15.33 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-O 121.727 0.775 . . . . 1.0 109.477 -179.017 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 94.9 t -64.39 -48.22 86.18 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.673 0 CA-C-N 114.281 -1.327 . . . . 1.0 111.131 -177.689 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 30' ' ' CYS . . . . . . . . . . . . . 2.2 t -65.05 -61.23 2.28 Favored 'General case' 0 N--CA 1.447 -0.601 0 C-N-CA 118.807 -1.157 . . . . 1.0 109.189 -179.255 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 31' ' ' ALA . . . . . 0.564 ' HB3' ' O ' ' A' ' 27' ' ' VAL . . . -62.46 -51.87 65.77 Favored 'General case' 0 CA--C 1.51 -0.56 0 N-CA-C 112.29 0.478 . . . . 1.0 112.29 -177.06 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 32' ' ' GLY . . . . . 0.705 ' O ' HD11 ' A' ' 37' ' ' ILE . . . 81.46 71.62 1.28 Allowed Glycine 0 CA--C 1.523 0.581 0 N-CA-C 108.432 -1.867 . . . . 1.0 108.432 -177.967 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 33' ' ' LEU . . . . . 0.44 ' O ' ' O ' ' A' ' 36' ' ' VAL . 5.2 mt 89.06 73.42 0.05 OUTLIER Pre-proline 0 N--CA 1.476 0.835 0 C-N-CA 123.293 0.637 . . . . 1.0 109.809 -179.502 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 76.6 Cg_exo -50.74 -32.14 35.45 Favored 'Trans proline' 0 N--CA 1.507 2.31 0 C-N-CA 123.728 2.952 . . . . 1.0 114.954 -179.076 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -58.43 -57.44 19.86 Favored Glycine 0 CA--C 1.533 1.161 0 C-N-CA 118.492 -1.813 . . . . 1.0 108.9 -178.828 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 36' ' ' VAL . . . . . 0.536 ' O ' ' HB ' ' A' ' 37' ' ' ILE . 13.9 p -92.48 167.45 1.64 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.579 0 N-CA-C 106.917 -1.512 . . . . 1.0 106.917 177.447 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 37' ' ' ILE . . . . . 0.705 HD11 ' O ' ' A' ' 32' ' ' GLY . 91.4 mt 111.22 127.09 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.478 0.971 0 C-N-CA 123.827 0.851 . . . . 1.0 109.581 -179.529 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -141.59 132.38 25.78 Favored 'General case' 0 C--N 1.331 -0.236 0 N-CA-C 108.085 -1.08 . . . . 1.0 108.085 179.792 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 7.3 p -93.31 124.43 57.69 Favored Pre-proline 0 CA--C 1.534 0.35 0 N-CA-C 109.656 -0.498 . . . . 1.0 109.656 -179.792 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 52.5 Cg_exo -50.27 -37.62 50.06 Favored 'Trans proline' 0 N--CA 1.488 1.192 0 C-N-CA 121.399 1.399 . . . . 1.0 113.21 -179.702 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -121.47 101.43 7.61 Favored 'General case' 0 N--CA 1.47 0.535 0 N-CA-C 112.614 0.598 . . . . 1.0 112.614 -177.659 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 42' ' ' ARG . . . . . 0.746 ' C ' ' H ' ' A' ' 44' ' ' GLY . 14.4 ptm180 -135.84 152.86 51.49 Favored 'General case' 0 C--N 1.316 -0.868 0 CA-C-O 121.735 0.779 . . . . 1.0 112.834 179.773 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 43' ' ' ARG . . . . . 0.526 ' O ' ' CD1' ' A' ' 45' ' ' PHE . 61.0 ttt180 -61.18 28.97 0.01 OUTLIER 'General case' 0 CA--C 1.539 0.552 0 CA-C-N 113.531 -1.668 . . . . 1.0 109.225 -179.84 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 44' ' ' GLY . . . . . 0.746 ' H ' ' C ' ' A' ' 42' ' ' ARG . . . 75.65 -26.46 1.36 Allowed Glycine 0 N--CA 1.448 -0.527 0 N-CA-C 110.396 -1.081 . . . . 1.0 110.396 179.899 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 45' ' ' PHE . . . . . 0.699 ' N ' ' CD1' ' A' ' 45' ' ' PHE . 0.0 OUTLIER -172.79 172.61 4.07 Favored 'General case' 0 CA--C 1.536 0.423 0 CA-C-O 119.293 -0.384 . . . . 1.0 110.125 -177.867 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 46' ' ' PHE . . . . . 0.666 ' HB2' ' O ' ' A' ' 45' ' ' PHE . 0.4 OUTLIER 126.17 102.31 0.0 OUTLIER 'General case' 0 N--CA 1.505 2.296 0 O-C-N 125.675 1.859 . . . . 1.0 109.724 179.583 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 47' ' ' ARG . . . . . 0.643 ' NH1' ' H73' ' A' ' 128' ' ' MTN . 1.6 ptp180 108.1 162.37 0.0 OUTLIER 'General case' 0 N--CA 1.487 1.395 0 O-C-N 124.302 1.002 . . . . 1.0 110.669 178.942 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 48' ' ' CYS . . . . . 0.409 ' O ' ' H83' ' A' ' 129' ' ' MTN . 0.1 OUTLIER 69.2 70.46 0.26 Allowed 'General case' 0 N--CA 1.453 -0.293 0 N-CA-C 108.343 -0.984 . . . . 1.0 108.343 -179.366 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 49' ' ' ASN . . . . . 0.581 ' O ' ' N ' ' A' ' 51' ' ' GLU . 2.7 p30 -147.13 138.87 13.54 Favored Pre-proline 0 CA--C 1.542 0.645 0 N-CA-C 108.252 -1.018 . . . . 1.0 108.252 179.82 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 50' ' ' PRO . . . . . 0.459 ' C ' ' H ' ' A' ' 52' ' ' ARG . 34.8 Cg_exo -54.61 72.05 0.03 OUTLIER 'Trans proline' 0 N--CA 1.502 1.987 0 C-N-CA 121.495 1.463 . . . . 1.0 112.299 179.456 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 51' ' ' GLU . . . . . 0.581 ' N ' ' O ' ' A' ' 49' ' ' ASN . 1.2 mp0 57.24 4.5 0.21 Allowed 'General case' 0 C--N 1.324 -0.514 0 O-C-N 121.736 -0.603 . . . . 1.0 111.091 179.304 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 52' ' ' ARG . . . . . 0.459 ' H ' ' C ' ' A' ' 50' ' ' PRO . 92.5 mtt180 -84.89 141.16 30.61 Favored 'General case' 0 CA--C 1.513 -0.452 0 N-CA-C 109.325 -0.62 . . . . 1.0 109.325 178.774 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 14.2 tt -66.48 146.91 12.9 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.704 0 CA-C-O 123.146 1.451 . . . . 1.0 113.355 -177.544 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 54' ' ' GLN . . . . . 0.418 ' NE2' ' CD2' ' A' ' 46' ' ' PHE . 3.3 pt20 -74.95 81.01 2.17 Favored 'General case' 0 C--N 1.311 -1.104 0 CA-C-N 111.309 -2.678 . . . . 1.0 111.071 -178.952 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 2.4 pp -148.49 156.89 8.13 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.888 0 N-CA-C 109.78 -0.452 . . . . 1.0 109.78 176.708 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 106.51 -3.84 37.11 Favored Glycine 0 N--CA 1.474 1.176 0 N-CA-C 110.266 -1.134 . . . . 1.0 110.266 179.575 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 57' ' ' ASP . . . . . 0.434 ' HB3' ' CD1' ' A' ' 45' ' ' PHE . 18.9 m-20 -80.94 103.98 11.14 Favored 'General case' 0 C--N 1.317 -0.831 0 CA-C-N 114.279 -0.96 . . . . 1.0 110.06 178.963 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 58' ' ' TRP . . . . . . . . . . . . . 5.9 m0 -90.09 172.24 8.97 Favored 'General case' 0 CA--C 1.542 0.659 0 CA-C-O 123.678 1.704 . . . . 1.0 114.288 -177.283 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 59' ' ' ARG . . . . . 0.478 ' CG ' ' N ' ' A' ' 60' ' ' TYR . 28.5 ptt-85 -78.6 -60.18 2.48 Favored 'General case' 0 CA--C 1.55 0.946 0 CA-C-N 110.451 -3.068 . . . . 1.0 113.865 -177.661 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 60' ' ' TYR . . . . . 0.478 ' N ' ' CG ' ' A' ' 59' ' ' ARG . 0.3 OUTLIER -92.21 -9.94 40.45 Favored 'General case' 0 N--CA 1.483 1.191 0 C-N-CA 124.122 0.969 . . . . 1.0 113.151 -179.728 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 22.3 tt0 -77.26 -14.73 59.7 Favored 'General case' 0 C--N 1.31 -1.133 0 CA-C-N 115.886 -0.597 . . . . 1.0 111.688 -178.3 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 62' ' ' VAL . . . . . 0.605 ' O ' ' N ' ' A' ' 66' ' ' GLY . 0.6 OUTLIER -48.05 -55.85 2.43 Favored 'Isoleucine or valine' 0 C--O 1.207 -1.14 0 C-N-CA 119.825 -0.75 . . . . 1.0 110.265 -175.156 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 63' ' ' ALA . . . . . 0.543 ' O ' ' HG3' ' A' ' 67' ' ' ARG . . . -65.98 -52.73 46.93 Favored 'General case' 0 C--N 1.307 -1.269 0 C-N-CA 119.722 -0.791 . . . . 1.0 109.75 -178.966 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 85.4 m-70 -48.9 -57.37 6.55 Favored 'General case' 0 N--CA 1.472 0.626 0 O-C-N 124.093 0.871 . . . . 1.0 109.964 -179.72 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 65' ' ' ASP . . . . . 0.615 ' C ' ' H ' ' A' ' 67' ' ' ARG . 5.8 t0 -72.45 -47.83 45.78 Favored 'General case' 0 C--N 1.313 -1.001 0 CA-C-O 121.582 0.706 . . . . 1.0 110.362 178.8 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 66' ' ' GLY . . . . . 0.605 ' N ' ' O ' ' A' ' 62' ' ' VAL . . . -70.71 26.47 0.5 Allowed Glycine 0 C--N 1.32 -0.322 0 O-C-N 120.868 -1.145 . . . . 1.0 110.636 177.985 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 67' ' ' ARG . . . . . 0.615 ' H ' ' C ' ' A' ' 65' ' ' ASP . 6.0 mtp85 -73.11 3.89 5.02 Favored 'General case' 0 N--CA 1.445 -0.688 0 N-CA-C 106.514 -1.661 . . . . 1.0 106.514 175.418 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 68' ' ' LEU . . . . . 0.484 ' H ' ' C ' ' A' ' 66' ' ' GLY . 0.0 OUTLIER -33.21 -29.65 0.01 OUTLIER 'General case' 0 N--CA 1.486 1.367 0 N-CA-C 108.489 -0.93 . . . . 1.0 108.489 -176.794 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 69' ' ' LEU . . . . . 0.606 ' N ' ' O ' ' A' ' 67' ' ' ARG . 22.2 mt -61.87 -63.39 1.27 Allowed 'General case' 0 C--N 1.315 -0.933 0 C-N-CA 118.542 -1.263 . . . . 1.0 107.814 178.289 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 70' ' ' ALA . . . . . 0.637 ' C ' ' H ' ' A' ' 72' ' ' HIS . . . -79.18 -75.28 0.25 Allowed 'General case' 0 N--CA 1.465 0.303 0 N-CA-C 106.271 -1.752 . . . . 1.0 106.271 176.635 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 71' ' ' ALA . . . . . 0.459 ' O ' ' C ' ' A' ' 72' ' ' HIS . . . -44.1 3.71 0.0 OUTLIER 'General case' 0 CA--C 1.519 -0.223 0 C-N-CA 124.826 1.25 . . . . 1.0 113.831 178.947 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 72' ' ' HIS . . . . . 0.637 ' H ' ' C ' ' A' ' 70' ' ' ALA . 0.2 OUTLIER -28.4 -67.85 0.07 Allowed 'General case' 0 N--CA 1.463 0.19 0 CA-C-N 118.36 0.527 . . . . 1.0 111.589 -178.658 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 73' ' ' MET . . . . . . . . . . . . . 13.8 ptp -69.57 -48.57 59.82 Favored 'General case' 0 C--N 1.325 -0.469 0 C-N-CA 118.983 -1.087 . . . . 1.0 108.968 178.525 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 74' ' ' VAL . . . . . 0.753 ' O ' ' N ' ' A' ' 76' ' ' GLY . 68.8 t -43.76 -40.54 1.48 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.265 0 CA-C-O 117.351 -1.309 . . . . 1.0 111.539 -176.35 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 75' ' ' ASN . . . . . 0.47 ' C ' ' N ' ' A' ' 77' ' ' ILE . 3.0 m120 -35.14 -12.62 0.0 OUTLIER 'General case' 0 N--CA 1.501 2.078 0 CA-C-N 121.244 1.838 . . . . 1.0 112.257 179.277 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 76' ' ' GLY . . . . . 0.753 ' N ' ' O ' ' A' ' 74' ' ' VAL . . . -45.72 -21.44 0.55 Allowed Glycine 0 CA--C 1.542 1.739 0 N-CA-C 107.844 -2.102 . . . . 1.0 107.844 175.173 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 77' ' ' ILE . . . . . 0.575 HG13 ' H ' ' A' ' 78' ' ' VAL . 1.2 pt -72.11 -55.9 11.86 Favored 'Isoleucine or valine' 0 C--O 1.216 -0.692 0 N-CA-C 107.696 -1.224 . . . . 1.0 107.696 178.021 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 78' ' ' VAL . . . . . 0.575 ' H ' HG13 ' A' ' 77' ' ' ILE . 95.8 t -33.79 -34.99 0.04 OUTLIER 'Isoleucine or valine' 0 CA--C 1.546 0.794 0 CA-C-N 113.2 -1.818 . . . . 1.0 106.849 -177.565 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 79' ' ' ILE . . . . . 0.633 ' O ' ' HB3' ' A' ' 83' ' ' ALA . 0.0 OUTLIER -98.31 -33.24 4.12 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.878 0 CA-C-N 115.605 -0.725 . . . . 1.0 112.416 176.556 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 80' ' ' ALA . . . . . 0.537 ' N ' ' O ' ' A' ' 77' ' ' ILE . . . -84.2 -10.71 57.5 Favored 'General case' 0 N--CA 1.478 0.974 0 O-C-N 121.257 -0.902 . . . . 1.0 113.184 179.662 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 81' ' ' GLU . . . . . 0.445 ' N ' ' O ' ' A' ' 77' ' ' ILE . 0.0 OUTLIER -89.27 -73.89 0.49 Allowed 'General case' 0 N--CA 1.451 -0.424 0 N-CA-C 112.115 0.413 . . . . 1.0 112.115 -177.629 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 24.3 m-20 -91.75 -16.8 26.35 Favored 'General case' 0 C--N 1.346 0.437 0 N-CA-C 114.532 1.308 . . . . 1.0 114.532 -179.096 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 83' ' ' ALA . . . . . 0.633 ' HB3' ' O ' ' A' ' 79' ' ' ILE . . . -49.67 -42.12 44.68 Favored 'General case' 0 C--O 1.211 -0.965 0 C-N-CA 118.304 -1.358 . . . . 1.0 110.792 -177.391 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 84' ' ' LEU . . . . . 0.564 HD13 ' O ' ' A' ' 84' ' ' LEU . 0.2 OUTLIER -40.33 -35.13 0.39 Allowed 'General case' 0 CA--C 1.543 0.7 0 CA-C-O 120.819 0.342 . . . . 1.0 111.131 -179.789 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 1.2 pp -74.4 -33.69 34.21 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.433 0 C-N-CA 119.999 -0.68 . . . . 1.0 110.125 178.477 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 86' ' ' ALA . . . . . 0.569 ' N ' ' O ' ' A' ' 83' ' ' ALA . . . -96.23 -26.36 15.46 Favored 'General case' 0 CA--C 1.54 0.573 0 CA-C-O 120.798 0.333 . . . . 1.0 111.698 179.175 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 87' ' ' GLU . . . . . 0.542 ' N ' ' O ' ' A' ' 83' ' ' ALA . 44.8 tt0 -57.9 -20.25 35.75 Favored 'General case' 0 C--N 1.329 -0.318 0 O-C-N 121.667 -0.646 . . . . 1.0 110.103 -178.833 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -71.98 -1.6 15.13 Favored 'General case' 0 N--CA 1.47 0.533 0 N-CA-C 107.494 -1.299 . . . . 1.0 107.494 178.095 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 89' ' ' VAL . . . . . 0.481 ' H ' ' C ' ' A' ' 87' ' ' GLU . 3.5 t -98.54 36.02 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.447 -0.616 0 CA-C-N 111.922 -2.399 . . . . 1.0 107.831 177.029 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 90' ' ' GLY . . . . . 0.844 ' O ' ' N ' ' A' ' 92' ' ' HIS . . . -55.95 -26.91 49.56 Favored Glycine 0 C--N 1.367 2.26 0 CA-C-O 117.609 -1.662 . . . . 1.0 111.519 176.672 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 91' ' ' PRO . . . . . 0.727 ' HD2' ' N ' ' A' ' 90' ' ' GLY . 11.5 Cg_exo -36.48 3.09 0.0 OUTLIER 'Trans proline' 0 N--CA 1.499 1.803 0 C-N-CA 123.084 2.523 . . . . 1.0 113.68 173.913 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 92' ' ' HIS . . . . . 0.844 ' N ' ' O ' ' A' ' 90' ' ' GLY . 0.0 OUTLIER -47.48 -27.91 1.95 Allowed 'General case' 0 N--CA 1.436 -1.141 0 N-CA-C 106.942 -1.503 . . . . 1.0 106.942 -179.887 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 93' ' ' LEU . . . . . 0.593 HD12 ' N ' ' A' ' 94' ' ' ALA . 2.0 pp -58.49 -52.46 65.55 Favored 'General case' 0 N--CA 1.448 -0.545 0 N-CA-C 106.931 -1.507 . . . . 1.0 106.931 176.417 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 94' ' ' ALA . . . . . 0.593 ' N ' HD12 ' A' ' 93' ' ' LEU . . . -49.8 -52.05 35.05 Favored 'General case' 0 C--O 1.221 -0.447 0 N-CA-C 107.457 -1.312 . . . . 1.0 107.457 -179.84 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 1.3 mpt_? -64.37 -31.44 72.64 Favored 'General case' 0 C--N 1.321 -0.666 0 N-CA-C 109.386 -0.598 . . . . 1.0 109.386 178.146 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 96' ' ' ALA . . . . . 0.842 ' O ' ' N ' ' A' ' 100' ' ' ILE . . . -50.87 -44.17 59.63 Favored 'General case' 0 C--O 1.197 -1.673 0 N-CA-C 106.368 -1.716 . . . . 1.0 106.368 -176.448 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 97' ' ' LEU . . . . . 0.506 ' O ' HG22 ' A' ' 100' ' ' ILE . 2.1 tt -35.05 -24.84 0.01 OUTLIER 'General case' 0 CA--C 1.588 2.423 0 CA-C-N 112.585 -2.098 . . . . 1.0 107.625 -178.937 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 98' ' ' GLY . . . . . 0.674 ' N ' ' O ' ' A' ' 96' ' ' ALA . . . -89.32 -51.84 2.85 Favored Glycine 0 CA--C 1.563 3.043 0 CA-C-O 123.312 1.507 . . . . 1.0 111.686 170.763 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 99' ' ' GLN . . . . . 0.562 ' N ' ' O ' ' A' ' 96' ' ' ALA . 6.3 mt-30 -76.72 8.43 3.66 Favored 'General case' 0 N--CA 1.437 -1.111 0 N-CA-C 106.607 -1.627 . . . . 1.0 106.607 177.676 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 100' ' ' ILE . . . . . 0.842 ' N ' ' O ' ' A' ' 96' ' ' ALA . 20.3 tt -59.36 -52.98 54.47 Favored 'Isoleucine or valine' 0 CA--C 1.474 -1.971 0 N-CA-C 106.276 -1.75 . . . . 1.0 106.276 178.296 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 101' ' ' VAL . . . . . 0.676 ' N ' HG23 ' A' ' 100' ' ' ILE . 0.2 OUTLIER -57.05 -61.03 1.4 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.658 0 C-N-CA 118.273 -1.371 . . . . 1.0 108.299 179.415 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 102' ' ' CYS . . . . . 0.879 ' O ' ' HB2' ' A' ' 106' ' ' ALA . 0.1 OUTLIER -50.63 -25.03 3.73 Favored 'General case' 0 C--N 1.317 -0.845 0 C-N-CA 120.588 -0.445 . . . . 1.0 111.179 -177.15 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 68.8 ttp85 -85.74 -49.0 8.29 Favored 'General case' 0 N--CA 1.482 1.158 0 O-C-N 124.731 1.269 . . . . 1.0 112.566 179.238 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 104' ' ' TYR . . . . . 0.735 ' O ' ' CG ' ' A' ' 104' ' ' TYR . 0.1 OUTLIER -96.38 23.63 6.55 Favored 'General case' 0 C--N 1.302 -1.457 0 C-N-CA 126.918 2.087 . . . . 1.0 108.788 179.401 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 105' ' ' GLY . . . . . 0.584 ' N ' ' O ' ' A' ' 101' ' ' VAL . . . -162.56 -93.4 0.09 OUTLIER Glycine 0 N--CA 1.45 -0.402 0 N-CA-C 106.608 -2.597 . . . . 1.0 106.608 178.313 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 106' ' ' ALA . . . . . 0.879 ' HB2' ' O ' ' A' ' 102' ' ' CYS . . . 69.06 64.14 0.29 Allowed 'General case' 0 C--O 1.219 -0.548 0 N-CA-C 113.146 0.795 . . . . 1.0 113.146 179.267 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 96.2 m -78.21 -58.73 3.1 Favored 'General case' 0 CA--C 1.547 0.829 0 O-C-N 121.152 -0.967 . . . . 1.0 109.353 179.529 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 108' ' ' VAL . . . . . 0.44 HG13 ' N ' ' A' ' 109' ' ' ILE . 3.8 p -58.64 -44.38 89.52 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-O 121.856 0.836 . . . . 1.0 109.662 -177.376 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 109' ' ' ILE . . . . . 0.449 ' HB ' ' HB1' ' A' ' 106' ' ' ALA . 3.3 mm -41.41 -61.41 1.4 Allowed Pre-proline 0 CA--C 1.569 1.689 0 CA-C-N 114.134 -1.394 . . . . 1.0 109.217 179.769 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 110' ' ' PRO . . . . . 0.638 ' CD ' ' O ' ' A' ' 106' ' ' ALA . 21.5 Cg_exo -47.64 -36.92 26.23 Favored 'Trans proline' 0 N--CA 1.502 1.998 0 C-N-CA 123.511 2.807 . . . . 1.0 113.401 174.802 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 111' ' ' ASN . . . . . 0.431 ' C ' ' N ' ' A' ' 113' ' ' ASN . 5.4 t30 -67.7 -67.78 0.43 Allowed 'General case' 0 C--O 1.236 0.381 0 O-C-N 121.082 -1.011 . . . . 1.0 109.946 -177.999 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 112' ' ' ILE . . . . . 0.452 ' H ' HG23 ' A' ' 112' ' ' ILE . 2.1 pt -49.02 -24.37 1.11 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-O 122.481 1.134 . . . . 1.0 109.154 -179.531 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 113' ' ' ASN . . . . . 0.466 ' HB3' ' O ' ' A' ' 110' ' ' PRO . 40.1 t30 -59.72 -53.71 54.77 Favored 'General case' 0 C--N 1.307 -1.264 0 CA-C-N 112.649 -2.069 . . . . 1.0 107.778 -177.695 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 114' ' ' ALA . . . . . 0.43 ' O ' HG22 ' A' ' 118' ' ' VAL . . . -56.92 -32.42 65.92 Favored 'General case' 0 N--CA 1.445 -0.687 0 CA-C-O 119.04 -0.505 . . . . 1.0 112.262 -179.652 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -78.83 -47.25 16.99 Favored 'General case' 0 C--O 1.211 -0.925 0 CA-C-O 122.314 1.054 . . . . 1.0 110.109 178.487 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 116' ' ' ILE . . . . . 0.468 ' O ' ' N ' ' A' ' 120' ' ' GLY . 32.2 mt -53.67 -53.09 28.27 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.101 0 CA-C-N 113.507 -1.679 . . . . 1.0 107.452 -179.148 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 117' ' ' GLU . . . . . 0.433 ' O ' ' HA ' ' A' ' 121' ' ' THR . 10.6 tt0 -44.36 -64.68 0.63 Allowed 'General case' 0 C--N 1.317 -0.816 0 CA-C-N 112.915 -1.948 . . . . 1.0 108.385 -179.249 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 118' ' ' VAL . . . . . 0.43 HG22 ' O ' ' A' ' 114' ' ' ALA . 29.2 m -59.6 -50.7 79.0 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.663 0 C-N-CA 119.652 -0.819 . . . . 1.0 109.723 179.885 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 119' ' ' LEU . . . . . 0.408 ' N ' HG23 ' A' ' 118' ' ' VAL . 0.4 OUTLIER -52.54 -71.29 0.07 Allowed 'General case' 0 CA--C 1.539 0.534 0 N-CA-C 106.845 -1.539 . . . . 1.0 106.845 -178.083 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 120' ' ' GLY . . . . . 0.701 ' O ' ' OG1' ' A' ' 121' ' ' THR . . . -69.28 -79.2 0.3 Allowed Glycine 0 CA--C 1.539 1.537 0 C-N-CA 119.133 -1.508 . . . . 1.0 111.023 179.964 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 121' ' ' THR . . . . . 0.701 ' OG1' ' O ' ' A' ' 120' ' ' GLY . 51.8 m 157.3 -32.01 0.0 OUTLIER 'General case' 0 N--CA 1.487 1.417 0 CA-C-N 112.422 -1.889 . . . . 1.0 111.818 179.859 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 122' ' ' GLY . . . . . 0.621 ' O ' ' N ' ' A' ' 124' ' ' ASP . . . 98.0 -21.81 44.12 Favored Glycine 0 N--CA 1.465 0.613 0 N-CA-C 108.027 -2.029 . . . . 1.0 108.027 -177.291 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 123' ' ' THR . . . . . 0.547 ' O ' ' CE1' ' A' ' 72' ' ' HIS . 58.3 m -46.22 90.61 0.0 OUTLIER 'General case' 0 N--CA 1.476 0.839 0 N-CA-C 105.928 -1.878 . . . . 1.0 105.928 177.832 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 124' ' ' ASP . . . . . 0.621 ' N ' ' O ' ' A' ' 122' ' ' GLY . 51.4 p-10 -162.86 171.1 17.19 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 115.596 -0.729 . . . . 1.0 112.177 -179.343 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 125' ' ' TYR . . . . . . . . . . . . . 86.0 t80 -142.55 141.91 32.11 Favored 'General case' 0 C--N 1.329 -0.315 0 N-CA-C 108.758 -0.831 . . . . 1.0 108.758 176.593 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 126' ' ' ARG . . . . . 0.442 HH22 ' HB ' ' A' ' 79' ' ' ILE . 14.3 mmm180 -147.75 147.87 30.35 Favored 'General case' 0 CA--C 1.533 0.306 0 N-CA-C 109.876 -0.416 . . . . 1.0 109.876 179.218 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 127' ' ' PHE . . . . . . . . . . . . . 23.2 t80 . . . . . 0 N--CA 1.471 0.607 0 CA-C-O 117.995 -1.003 . . . . 1.0 110.824 179.775 . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 128' ' ' MTN . . . . . 0.647 ' S1 ' ' H71' ' A' ' 128' ' ' MTN . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 129' ' ' MTN . . . . . 0.59 ' H61' ' S1 ' ' A' ' 129' ' ' MTN . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 130' ' ' MTN . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 2.7 mmt . . . . . 0 N--CA 1.489 1.479 0 N-CA-C 108.838 -0.801 . . . . 1.0 108.838 . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 2' ' ' SER . . . . . 0.503 ' O ' ' CB ' ' A' ' 3' ' ' ASP . 47.1 t -73.36 4.94 4.07 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.218 -0.446 . . . . 1.0 110.732 179.777 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 3' ' ' ASP . . . . . 0.503 ' CB ' ' O ' ' A' ' 2' ' ' SER . 12.0 p30 149.22 135.57 0.0 OUTLIER 'General case' 0 N--CA 1.478 0.928 0 O-C-N 123.725 0.64 . . . . 1.0 110.81 179.759 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 87.3 t80 -154.15 149.43 27.07 Favored 'General case' 0 CA--C 1.518 -0.268 0 CA-C-O 121.014 0.435 . . . . 1.0 110.365 178.982 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 5' ' ' ASP . . . . . 0.417 ' HB2' ' N ' ' A' ' 10' ' ' SER . 0.9 OUTLIER -150.78 147.33 27.16 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.133 -0.485 . . . . 1.0 110.055 179.935 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 6' ' ' THR . . . . . 0.731 ' O ' ' N ' ' A' ' 10' ' ' SER . 0.2 OUTLIER -112.21 -162.74 0.81 Allowed 'General case' 0 C--O 1.207 -1.172 0 CA-C-O 121.629 0.728 . . . . 1.0 110.749 -178.639 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 7' ' ' GLU . . . . . 0.548 ' O ' ' HB2' ' A' ' 11' ' ' ARG . 73.2 mm-40 -54.41 -43.45 71.52 Favored 'General case' 0 C--N 1.304 -1.399 0 CA-C-O 121.984 0.897 . . . . 1.0 108.733 -179.233 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 8' ' ' ARG . . . . . 0.902 ' O ' ' HB3' ' A' ' 12' ' ' ALA . 60.0 mtp180 -72.73 -60.68 2.12 Favored 'General case' 0 C--N 1.313 -0.987 0 C-N-CA 118.095 -1.442 . . . . 1.0 110.487 177.713 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 9' ' ' VAL . . . . . 1.005 ' O ' ' HB ' ' A' ' 13' ' ' VAL . 10.7 t -60.51 -51.11 76.91 Favored 'Isoleucine or valine' 0 C--O 1.196 -1.761 0 C-N-CA 117.921 -1.512 . . . . 1.0 110.639 179.963 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 10' ' ' SER . . . . . 0.731 ' N ' ' O ' ' A' ' 6' ' ' THR . 2.6 t -70.09 -66.25 0.62 Allowed 'General case' 0 C--N 1.303 -1.445 0 O-C-N 121.271 -0.893 . . . . 1.0 113.03 -178.775 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 11' ' ' ARG . . . . . 0.548 ' HB2' ' O ' ' A' ' 7' ' ' GLU . 1.7 mmt85 -62.11 -43.87 97.89 Favored 'General case' 0 C--N 1.318 -0.787 0 CA-C-O 120.455 0.169 . . . . 1.0 111.4 -176.496 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 12' ' ' ALA . . . . . 0.902 ' HB3' ' O ' ' A' ' 8' ' ' ARG . . . -70.74 -59.7 2.66 Favored 'General case' 0 C--N 1.32 -0.68 0 C-N-CA 118.4 -1.32 . . . . 1.0 110.241 -179.993 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 13' ' ' VAL . . . . . 1.005 ' HB ' ' O ' ' A' ' 9' ' ' VAL . 4.6 t -57.35 -51.3 71.28 Favored 'Isoleucine or valine' 0 C--O 1.199 -1.605 0 N-CA-C 107.029 -1.471 . . . . 1.0 107.029 179.503 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 14' ' ' ALA . . . . . 0.954 ' O ' HG22 ' A' ' 18' ' ' VAL . . . -62.06 -66.5 0.53 Allowed 'General case' 0 C--N 1.306 -1.284 0 C-N-CA 115.549 -2.461 . . . . 1.0 113.061 -178.765 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 15' ' ' ALA . . . . . 0.546 ' HB3' ' O ' ' A' ' 11' ' ' ARG . . . -51.18 -55.27 18.82 Favored 'General case' 0 C--N 1.319 -0.737 0 C-N-CA 119.706 -0.797 . . . . 1.0 109.257 -178.728 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 16' ' ' ALA . . . . . 0.659 ' HB3' ' O ' ' A' ' 12' ' ' ALA . . . -64.35 -59.17 4.69 Favored 'General case' 0 C--N 1.299 -1.605 0 C-N-CA 118.101 -1.44 . . . . 1.0 111.346 -179.924 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 17' ' ' LEU . . . . . 0.701 ' CB ' ' O ' ' A' ' 13' ' ' VAL . 6.8 tt -55.09 -55.23 33.36 Favored 'General case' 0 N--CA 1.477 0.876 0 N-CA-C 108.832 -0.803 . . . . 1.0 108.832 -177.051 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 18' ' ' VAL . . . . . 0.954 HG22 ' O ' ' A' ' 14' ' ' ALA . 2.3 m -71.26 -58.86 4.22 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 CA-C-N 115.895 -0.593 . . . . 1.0 110.212 -179.817 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 19' ' ' GLY . . . . . 0.558 ' N ' ' CG2' ' A' ' 18' ' ' VAL . . . -58.16 -166.44 0.12 Allowed Glycine 0 CA--C 1.491 -1.454 0 N-CA-C 110.815 -0.914 . . . . 1.0 110.815 -177.322 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 20' ' ' PRO . . . . . 0.607 ' O ' ' N ' ' A' ' 24' ' ' ALA . 1.0 OUTLIER -79.85 -26.18 4.72 Favored 'Trans proline' 0 C--N 1.292 -2.421 0 C-N-CA 122.032 1.822 . . . . 1.0 113.59 -177.657 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 21' ' ' GLY . . . . . 0.518 ' O ' ' HB3' ' A' ' 24' ' ' ALA . . . -62.68 -58.49 11.97 Favored Glycine 0 N--CA 1.473 1.156 0 C-N-CA 119.496 -1.335 . . . . 1.0 111.877 -178.217 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 22' ' ' GLY . . . . . 0.644 ' N ' ' O ' ' A' ' 16' ' ' ALA . . . -57.61 -54.15 39.53 Favored Glycine 0 C--N 1.307 -1.068 0 C-N-CA 116.447 -2.787 . . . . 1.0 107.073 -178.778 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 23' ' ' VAL . . . . . 0.516 ' O ' HG12 ' A' ' 27' ' ' VAL . 54.0 t -52.63 -31.26 15.8 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.042 0 N-CA-C 107.859 -1.163 . . . . 1.0 107.859 178.564 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 24' ' ' ALA . . . . . 0.607 ' N ' ' O ' ' A' ' 20' ' ' PRO . . . -63.72 -63.9 1.04 Allowed 'General case' 0 C--O 1.218 -0.593 0 C-N-CA 119.416 -0.914 . . . . 1.0 110.969 -179.467 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 61.6 mt -61.64 -46.47 89.63 Favored 'General case' 0 C--N 1.321 -0.64 0 C-N-CA 119.666 -0.814 . . . . 1.0 111.881 -176.571 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 92.1 t -60.35 -60.75 2.1 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.531 0 C-N-CA 119.708 -0.797 . . . . 1.0 110.041 -177.004 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 27' ' ' VAL . . . . . 0.551 ' O ' ' HB3' ' A' ' 31' ' ' ALA . 2.2 p -54.81 -36.68 38.05 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.736 0 C-N-CA 119.622 -0.831 . . . . 1.0 109.203 -177.819 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 28' ' ' LYS . . . . . 0.44 ' HB2' ' O ' ' A' ' 24' ' ' ALA . 3.7 tmmm? -66.2 -55.52 15.85 Favored 'General case' 0 C--N 1.315 -0.892 0 C-N-CA 119.254 -0.979 . . . . 1.0 110.713 -177.532 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 82.3 t -62.95 -49.9 81.76 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.973 0 CA-C-N 114.641 -1.163 . . . . 1.0 110.135 -177.517 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 30' ' ' CYS . . . . . . . . . . . . . 4.1 t -65.27 -62.11 1.73 Allowed 'General case' 0 N--CA 1.443 -0.822 0 C-N-CA 119.675 -0.81 . . . . 1.0 109.458 -178.544 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 31' ' ' ALA . . . . . 0.551 ' HB3' ' O ' ' A' ' 27' ' ' VAL . . . -51.71 -46.44 63.93 Favored 'General case' 0 CA--C 1.5 -0.97 0 CA-C-O 121.282 0.563 . . . . 1.0 110.568 -176.23 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 32' ' ' GLY . . . . . 0.462 ' O ' ' CB ' ' A' ' 33' ' ' LEU . . . 66.56 67.05 2.13 Favored Glycine 0 N--CA 1.443 -0.896 0 N-CA-C 109.627 -1.389 . . . . 1.0 109.627 -179.998 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 33' ' ' LEU . . . . . 0.462 ' CB ' ' O ' ' A' ' 32' ' ' GLY . 0.3 OUTLIER 82.88 104.26 0.03 OUTLIER Pre-proline 0 CA--C 1.542 0.644 0 CA-C-N 113.048 -1.576 . . . . 1.0 108.343 -178.622 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 52.2 Cg_exo -48.64 -20.34 2.64 Favored 'Trans proline' 0 N--CA 1.499 1.825 0 C-N-CA 122.504 2.136 . . . . 1.0 114.293 -178.259 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 35' ' ' GLY . . . . . 0.527 ' CA ' HD12 ' A' ' 112' ' ' ILE . . . -67.54 -62.72 4.16 Favored Glycine 0 N--CA 1.467 0.74 0 C-N-CA 118.357 -1.877 . . . . 1.0 112.27 -176.73 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 36' ' ' VAL . . . . . 0.75 ' O ' HG22 ' A' ' 37' ' ' ILE . 18.3 m -78.83 -153.88 0.03 OUTLIER 'Isoleucine or valine' 0 C--O 1.216 -0.696 0 N-CA-C 108.121 -1.066 . . . . 1.0 108.121 -179.119 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 37' ' ' ILE . . . . . 0.75 HG22 ' O ' ' A' ' 36' ' ' VAL . 0.3 OUTLIER 73.63 77.06 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.32 -0.688 0 O-C-N 124.2 0.938 . . . . 1.0 111.553 178.97 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 1.3 t60 -139.32 135.73 34.08 Favored 'General case' 0 CA--C 1.492 -1.278 0 O-C-N 120.906 -1.121 . . . . 1.0 109.329 179.4 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 3.3 m -115.32 132.19 23.2 Favored Pre-proline 0 N--CA 1.451 -0.409 0 C-N-CA 120.413 -0.515 . . . . 1.0 109.984 -178.913 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 23.6 Cg_endo -62.14 -15.21 42.56 Favored 'Trans proline' 0 N--CA 1.494 1.52 0 C-N-CA 122.039 1.826 . . . . 1.0 112.179 179.356 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -128.79 135.11 48.7 Favored 'General case' 0 N--CA 1.468 0.438 0 CA-C-N 116.729 -0.214 . . . . 1.0 110.504 178.399 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 42' ' ' ARG . . . . . 0.573 ' HG2' ' N ' ' A' ' 43' ' ' ARG . 39.1 ttp180 -173.16 174.25 3.45 Favored 'General case' 0 C--N 1.328 -0.339 0 C-N-CA 120.558 -0.457 . . . . 1.0 111.14 178.718 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 43' ' ' ARG . . . . . 0.573 ' N ' ' HG2' ' A' ' 42' ' ' ARG . 67.1 ttt-85 -57.61 -45.97 84.68 Favored 'General case' 0 CA--C 1.538 0.517 0 N-CA-C 107.697 -1.224 . . . . 1.0 107.697 178.53 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 44' ' ' GLY . . . . . 0.436 ' O ' ' CD1' ' A' ' 45' ' ' PHE . . . 121.58 -25.03 7.04 Favored Glycine 0 N--CA 1.481 1.675 0 CA-C-N 116.925 -0.125 . . . . 1.0 112.829 179.653 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 45' ' ' PHE . . . . . 0.815 ' O ' ' HB2' ' A' ' 46' ' ' PHE . 1.5 m-85 -158.58 167.52 29.38 Favored 'General case' 0 C--N 1.306 -1.314 0 N-CA-C 108.23 -1.026 . . . . 1.0 108.23 179.564 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 46' ' ' PHE . . . . . 0.815 ' HB2' ' O ' ' A' ' 45' ' ' PHE . 0.2 OUTLIER 107.45 116.7 0.01 OUTLIER 'General case' 0 N--CA 1.472 0.66 0 O-C-N 125.094 1.496 . . . . 1.0 111.367 179.408 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 47' ' ' ARG . . . . . 0.459 ' CB ' ' O ' ' A' ' 46' ' ' PHE . 9.5 ptt85 90.36 156.5 0.04 OUTLIER 'General case' 0 N--CA 1.479 1.01 0 O-C-N 123.64 0.587 . . . . 1.0 111.405 179.325 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 37.3 t 61.15 68.08 0.76 Allowed 'General case' 0 CA--C 1.509 -0.609 0 CA-C-N 116.151 -0.477 . . . . 1.0 109.851 179.145 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 49' ' ' ASN . . . . . 0.667 ' O ' ' N ' ' A' ' 51' ' ' GLU . 1.6 p30 -149.56 159.14 36.97 Favored Pre-proline 0 C--N 1.315 -0.898 0 CA-C-N 115.869 -0.605 . . . . 1.0 109.381 179.203 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 4.1 Cg_endo -48.87 53.34 0.02 OUTLIER 'Trans proline' 0 N--CA 1.511 2.527 0 C-N-CA 123.981 3.121 . . . . 1.0 113.919 177.544 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 51' ' ' GLU . . . . . 0.667 ' N ' ' O ' ' A' ' 49' ' ' ASN . 2.7 mm-40 42.56 57.71 3.37 Favored 'General case' 0 CA--C 1.536 0.414 0 CA-C-O 121.246 0.546 . . . . 1.0 111.756 178.038 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 52' ' ' ARG . . . . . 0.854 HH21 HD12 ' A' ' 85' ' ' ILE . 2.5 ptm180 -156.36 168.83 26.12 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.308 -0.406 . . . . 1.0 111.501 179.225 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 53' ' ' ILE . . . . . 0.427 HG13 ' N ' ' A' ' 54' ' ' GLN . 7.4 tp -83.44 166.94 2.06 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 N-CA-C 108.612 -0.884 . . . . 1.0 108.612 176.65 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 54' ' ' GLN . . . . . 0.427 ' N ' HG13 ' A' ' 53' ' ' ILE . 35.8 mt-30 -134.72 134.31 40.88 Favored 'General case' 0 N--CA 1.467 0.415 0 O-C-N 121.775 -0.578 . . . . 1.0 109.551 179.419 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 55' ' ' ILE . . . . . 0.476 HG22 HD11 ' A' ' 85' ' ' ILE . 19.9 tt -144.36 154.06 15.12 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.637 0 N-CA-C 110.139 -0.319 . . . . 1.0 110.139 178.948 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 103.23 4.51 47.29 Favored Glycine 0 N--CA 1.469 0.866 0 N-CA-C 110.178 -1.169 . . . . 1.0 110.178 -179.059 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 29.3 t70 -95.49 114.16 25.89 Favored 'General case' 0 CA--C 1.54 0.589 0 N-CA-C 113.632 0.975 . . . . 1.0 113.632 -178.886 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 58' ' ' TRP . . . . . 0.539 ' HB2' ' HB2' ' A' ' 61' ' ' GLU . 35.4 m95 -83.07 -176.69 6.46 Favored 'General case' 0 C--O 1.236 0.375 0 CA-C-N 112.527 -2.124 . . . . 1.0 109.677 176.15 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 59' ' ' ARG . . . . . 0.584 ' HD2' ' H ' ' A' ' 59' ' ' ARG . 0.0 OUTLIER -94.45 -55.61 3.1 Favored 'General case' 0 CA--C 1.547 0.844 0 CA-C-O 121.545 0.688 . . . . 1.0 110.471 179.566 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 60' ' ' TYR . . . . . 0.544 ' O ' ' CG ' ' A' ' 60' ' ' TYR . 4.7 t80 -73.96 -5.69 42.78 Favored 'General case' 0 N--CA 1.469 0.481 0 C-N-CA 124.338 1.055 . . . . 1.0 110.146 178.317 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 61' ' ' GLU . . . . . 0.539 ' HB2' ' HB2' ' A' ' 58' ' ' TRP . 4.7 tt0 -68.57 -17.91 64.23 Favored 'General case' 0 C--N 1.312 -1.058 0 O-C-N 121.07 -1.019 . . . . 1.0 111.444 -179.56 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 62' ' ' VAL . . . . . 0.496 HG23 ' N ' ' A' ' 63' ' ' ALA . 16.1 m -42.01 -49.63 0.93 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.504 0 CA-C-O 121.118 0.485 . . . . 1.0 109.706 -174.42 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 63' ' ' ALA . . . . . 0.496 ' N ' HG23 ' A' ' 62' ' ' VAL . . . -64.23 -45.25 89.0 Favored 'General case' 0 N--CA 1.42 -1.958 0 N-CA-C 108.316 -0.994 . . . . 1.0 108.316 177.039 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 64' ' ' HIS . . . . . 0.529 ' N ' ' O ' ' A' ' 61' ' ' GLU . 0.1 OUTLIER -56.68 -61.3 2.52 Favored 'General case' 0 CA--C 1.537 0.455 0 C-N-CA 118.927 -1.109 . . . . 1.0 111.108 179.803 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 65' ' ' ASP . . . . . 0.715 ' C ' ' H ' ' A' ' 67' ' ' ARG . 4.6 m-20 -63.19 -48.44 78.32 Favored 'General case' 0 C--O 1.24 0.594 0 CA-C-O 121.526 0.679 . . . . 1.0 109.808 179.139 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -62.2 28.76 0.06 OUTLIER Glycine 0 C--N 1.317 -0.499 0 N-CA-C 110.87 -0.892 . . . . 1.0 110.87 -179.09 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 67' ' ' ARG . . . . . 0.715 ' H ' ' C ' ' A' ' 65' ' ' ASP . 0.0 OUTLIER -82.92 -13.82 55.33 Favored 'General case' 0 N--CA 1.436 -1.153 0 C-N-CA 122.766 0.426 . . . . 1.0 111.558 176.394 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 68' ' ' LEU . . . . . 0.672 ' O ' ' HA ' ' A' ' 72' ' ' HIS . 0.8 OUTLIER -40.24 -30.11 0.09 Allowed 'General case' 0 C--O 1.22 -0.451 0 N-CA-C 107.009 -1.478 . . . . 1.0 107.009 179.05 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 69' ' ' LEU . . . . . 0.488 ' N ' ' C ' ' A' ' 67' ' ' ARG . 3.4 tt -65.67 -66.12 0.59 Allowed 'General case' 0 C--N 1.311 -1.071 0 C-N-CA 117.39 -1.724 . . . . 1.0 108.267 177.877 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 70' ' ' ALA . . . . . 0.697 ' C ' ' H ' ' A' ' 72' ' ' HIS . . . -76.32 -74.45 0.23 Allowed 'General case' 0 N--CA 1.466 0.346 0 N-CA-C 108.895 -0.78 . . . . 1.0 108.895 -179.753 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 71' ' ' ALA . . . . . 0.695 ' HB1' ' HB ' ' A' ' 74' ' ' VAL . . . -58.0 13.51 0.01 OUTLIER 'General case' 0 C--N 1.321 -0.65 0 C-N-CA 124.25 1.02 . . . . 1.0 110.851 -178.163 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 72' ' ' HIS . . . . . 0.697 ' H ' ' C ' ' A' ' 70' ' ' ALA . 0.3 OUTLIER -12.07 -74.53 0.01 OUTLIER 'General case' 0 N--CA 1.478 0.959 0 C-N-CA 124.295 1.038 . . . . 1.0 113.113 -174.654 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 73' ' ' MET . . . . . . . . . . . . . 1.4 mpt? -62.63 -41.91 99.29 Favored 'General case' 0 C--N 1.285 -2.216 0 C-N-CA 119.164 -1.014 . . . . 1.0 111.565 -178.431 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 74' ' ' VAL . . . . . 0.695 ' HB ' ' HB1' ' A' ' 71' ' ' ALA . 41.4 t -44.27 -49.3 2.12 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.346 0 C-N-CA 119.864 -0.734 . . . . 1.0 110.103 -175.515 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 75' ' ' ASN . . . . . 0.498 ' O ' ' N ' ' A' ' 77' ' ' ILE . 14.0 t-20 -39.52 -21.57 0.01 OUTLIER 'General case' 0 N--CA 1.472 0.664 0 CA-C-O 122.787 1.279 . . . . 1.0 111.441 -179.815 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 76' ' ' GLY . . . . . 0.569 ' N ' ' O ' ' A' ' 74' ' ' VAL . . . -43.87 -19.5 0.11 Allowed Glycine 0 CA--C 1.539 1.585 0 CA-C-N 113.662 -1.608 . . . . 1.0 109.827 178.674 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 77' ' ' ILE . . . . . 0.655 ' O ' ' N ' ' A' ' 80' ' ' ALA . 10.3 pt -88.17 -47.0 15.72 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.45 0 N-CA-C 108.386 -0.968 . . . . 1.0 108.386 -178.674 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 78' ' ' VAL . . . . . 0.524 ' O ' ' HB3' ' A' ' 82' ' ' ASP . 21.6 t -37.74 -35.7 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.433 -1.3 0 N-CA-C 108.14 -1.059 . . . . 1.0 108.14 -177.165 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 79' ' ' ILE . . . . . 0.551 ' O ' ' HB3' ' A' ' 83' ' ' ALA . 0.3 OUTLIER -87.07 -24.48 6.39 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.34 0 CA-C-O 121.03 0.443 . . . . 1.0 111.083 179.577 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 80' ' ' ALA . . . . . 0.655 ' N ' ' O ' ' A' ' 77' ' ' ILE . . . -73.29 -10.48 59.8 Favored 'General case' 0 C--N 1.319 -0.737 0 O-C-N 122.21 -0.306 . . . . 1.0 111.809 179.119 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 71.8 mt-10 -120.99 -62.79 1.41 Allowed 'General case' 0 CA--C 1.531 0.247 0 CA-C-O 121.705 0.764 . . . . 1.0 111.133 176.953 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 82' ' ' ASP . . . . . 0.839 ' O ' HG13 ' A' ' 85' ' ' ILE . 0.0 OUTLIER -58.73 -62.83 1.58 Allowed 'General case' 0 C--O 1.202 -1.401 0 CA-C-N 114.939 -1.028 . . . . 1.0 109.561 -179.54 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 83' ' ' ALA . . . . . 0.551 ' HB3' ' O ' ' A' ' 79' ' ' ILE . . . -56.63 -38.08 71.63 Favored 'General case' 0 CA--C 1.506 -0.718 0 C-N-CA 119.803 -0.759 . . . . 1.0 110.14 -176.087 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 84' ' ' LEU . . . . . 0.713 HD13 ' O ' ' A' ' 84' ' ' LEU . 3.4 tm? -32.01 -35.32 0.02 OUTLIER 'General case' 0 CA--C 1.51 -0.564 0 CA-C-N 115.525 -0.762 . . . . 1.0 111.839 -174.647 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 85' ' ' ILE . . . . . 0.854 HD12 HH21 ' A' ' 52' ' ' ARG . 4.7 mt -43.96 -17.83 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.323 -0.544 0 C-N-CA 120.492 -0.483 . . . . 1.0 110.205 179.622 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 86' ' ' ALA . . . . . 0.674 ' O ' ' N ' ' A' ' 90' ' ' GLY . . . -60.61 -58.46 8.37 Favored 'General case' 0 C--O 1.221 -0.446 0 C-N-CA 119.898 -0.721 . . . . 1.0 109.768 179.852 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 87' ' ' GLU . . . . . 0.444 ' OE1' ' N ' ' A' ' 87' ' ' GLU . 0.2 OUTLIER -35.64 -24.15 0.01 OUTLIER 'General case' 0 N--CA 1.468 0.468 0 CA-C-O 121.023 0.44 . . . . 1.0 110.663 -177.981 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 88' ' ' ALA . . . . . 0.621 ' N ' ' O ' ' A' ' 86' ' ' ALA . . . -101.31 -43.46 5.95 Favored 'General case' 0 C--O 1.237 0.444 0 N-CA-C 109.099 -0.704 . . . . 1.0 109.099 177.324 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 89' ' ' VAL . . . . . 0.634 ' C ' ' HD2' ' A' ' 91' ' ' PRO . 3.0 t -100.19 38.26 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.34 0.186 0 N-CA-C 108.775 -0.824 . . . . 1.0 108.775 178.01 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 90' ' ' GLY . . . . . 0.889 ' O ' ' N ' ' A' ' 92' ' ' HIS . . . -62.08 -17.59 55.78 Favored Glycine 0 C--N 1.358 1.801 0 CA-C-O 117.553 -1.693 . . . . 1.0 111.92 177.83 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 91' ' ' PRO . . . . . 0.783 ' HD2' ' N ' ' A' ' 90' ' ' GLY . 75.3 Cg_exo -32.62 1.01 0.0 OUTLIER 'Trans proline' 0 N--CA 1.513 2.659 0 C-N-CA 124.382 3.388 . . . . 1.0 113.694 171.811 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 92' ' ' HIS . . . . . 0.889 ' N ' ' O ' ' A' ' 90' ' ' GLY . 42.1 t-80 -49.88 -30.11 9.43 Favored 'General case' 0 N--CA 1.427 -1.591 0 N-CA-C 108.357 -0.979 . . . . 1.0 108.357 176.479 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 93' ' ' LEU . . . . . 0.672 ' O ' ' N ' ' A' ' 96' ' ' ALA . 0.8 OUTLIER -61.17 -60.64 3.45 Favored 'General case' 0 C--O 1.222 -0.367 0 N-CA-C 107.358 -1.349 . . . . 1.0 107.358 177.684 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 94' ' ' ALA . . . . . 0.607 ' HB3' HH21 ' A' ' 95' ' ' ARG . . . -45.75 -51.18 13.01 Favored 'General case' 0 N--CA 1.437 -1.104 0 N-CA-C 108.064 -1.087 . . . . 1.0 108.064 -179.193 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 95' ' ' ARG . . . . . 0.607 HH21 ' HB3' ' A' ' 94' ' ' ALA . 0.0 OUTLIER -60.21 -25.27 65.48 Favored 'General case' 0 N--CA 1.434 -1.226 0 C-N-CA 120.013 -0.675 . . . . 1.0 109.334 176.494 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 96' ' ' ALA . . . . . 0.759 ' O ' ' N ' ' A' ' 100' ' ' ILE . . . -57.05 -52.1 66.61 Favored 'General case' 0 C--O 1.207 -1.135 0 N-CA-C 107.227 -1.397 . . . . 1.0 107.227 179.511 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 97' ' ' LEU . . . . . 0.705 ' O ' HG22 ' A' ' 100' ' ' ILE . 0.1 OUTLIER -35.55 -29.16 0.01 OUTLIER 'General case' 0 CA--C 1.567 1.63 0 N-CA-C 107.238 -1.393 . . . . 1.0 107.238 -179.716 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 98' ' ' GLY . . . . . 0.611 ' N ' ' O ' ' A' ' 96' ' ' ALA . . . -81.51 -52.9 4.01 Favored Glycine 0 CA--C 1.551 2.309 0 CA-C-O 123.083 1.379 . . . . 1.0 110.831 174.422 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 99' ' ' GLN . . . . . 0.612 ' N ' ' O ' ' A' ' 96' ' ' ALA . 27.0 mt-30 -79.19 7.66 7.24 Favored 'General case' 0 N--CA 1.438 -1.028 0 N-CA-C 108.548 -0.908 . . . . 1.0 108.548 178.366 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 100' ' ' ILE . . . . . 0.759 ' N ' ' O ' ' A' ' 96' ' ' ALA . 16.7 tt -60.39 -51.25 75.2 Favored 'Isoleucine or valine' 0 CA--C 1.493 -1.233 0 N-CA-C 108.71 -0.848 . . . . 1.0 108.71 179.826 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 101' ' ' VAL . . . . . 0.674 ' N ' HG23 ' A' ' 100' ' ' ILE . 24.1 t -55.05 -57.12 7.87 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.977 0 C-N-CA 117.083 -1.847 . . . . 1.0 107.058 178.058 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 102' ' ' CYS . . . . . 0.786 ' O ' ' HB2' ' A' ' 106' ' ' ALA . 4.9 t -44.47 -25.63 0.28 Allowed 'General case' 0 C--O 1.214 -0.791 0 C-N-CA 120.085 -0.646 . . . . 1.0 109.854 -178.944 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 103' ' ' ARG . . . . . 0.426 ' N ' ' C ' ' A' ' 101' ' ' VAL . 1.7 tpp85 -87.19 -45.06 11.0 Favored 'General case' 0 N--CA 1.476 0.862 0 N-CA-C 113.444 0.905 . . . . 1.0 113.444 179.459 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 104' ' ' TYR . . . . . 0.747 ' O ' ' CG ' ' A' ' 104' ' ' TYR . 3.0 t80 -99.19 19.63 14.98 Favored 'General case' 0 C--N 1.31 -1.121 0 C-N-CA 127.066 2.146 . . . . 1.0 110.137 -179.623 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 105' ' ' GLY . . . . . 0.869 ' O ' HG23 ' A' ' 107' ' ' THR . . . -164.27 -7.79 0.03 OUTLIER Glycine 0 N--CA 1.441 -0.975 0 C-N-CA 117.891 -2.1 . . . . 1.0 111.588 177.337 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 106' ' ' ALA . . . . . 0.786 ' HB2' ' O ' ' A' ' 102' ' ' CYS . . . -15.53 62.7 0.0 OUTLIER 'General case' 0 N--CA 1.471 0.6 0 O-C-N 125.147 1.145 . . . . 1.0 111.997 -179.034 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 107' ' ' THR . . . . . 0.869 HG23 ' O ' ' A' ' 105' ' ' GLY . 11.4 p -100.38 -2.81 32.47 Favored 'General case' 0 CA--C 1.534 0.339 0 CA-C-N 116.265 -0.425 . . . . 1.0 110.119 -179.425 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 108' ' ' VAL . . . . . 0.732 HG13 ' N ' ' A' ' 109' ' ' ILE . 8.1 p -84.72 -57.84 4.03 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.427 0 CA-C-N 116.389 -0.369 . . . . 1.0 111.057 -178.194 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 109' ' ' ILE . . . . . 0.732 ' N ' HG13 ' A' ' 108' ' ' VAL . 0.2 OUTLIER -47.22 -47.76 56.03 Favored Pre-proline 0 CA--C 1.503 -0.842 0 C-N-CA 122.756 0.422 . . . . 1.0 111.852 179.458 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 110' ' ' PRO . . . . . 0.618 ' HD2' ' N ' ' A' ' 109' ' ' ILE . 6.0 Cg_endo -40.65 -39.84 3.15 Favored 'Trans proline' 0 CA--C 1.507 -0.85 0 C-N-CA 121.025 1.15 . . . . 1.0 114.081 -172.414 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 19.6 m-20 -65.09 -68.0 0.39 Allowed 'General case' 0 C--N 1.305 -1.33 0 C-N-CA 119.047 -1.061 . . . . 1.0 110.475 -176.967 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 112' ' ' ILE . . . . . 0.527 HD12 ' CA ' ' A' ' 35' ' ' GLY . 0.0 OUTLIER -69.21 -25.48 29.65 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.788 0 CA-C-N 115.498 -0.773 . . . . 1.0 110.594 -178.012 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 113' ' ' ASN . . . . . 0.485 ' CB ' ' O ' ' A' ' 109' ' ' ILE . 7.0 t30 -54.65 -61.83 2.05 Favored 'General case' 0 CA--C 1.488 -1.438 0 CA-C-N 114.268 -1.333 . . . . 1.0 110.854 -174.882 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -65.12 -20.46 66.47 Favored 'General case' 0 N--CA 1.432 -1.35 0 O-C-N 124.233 0.958 . . . . 1.0 110.255 -179.723 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -75.33 -61.78 1.79 Allowed 'General case' 0 C--O 1.241 0.624 0 C-N-CA 120.255 -0.578 . . . . 1.0 112.078 178.86 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 116' ' ' ILE . . . . . 0.484 ' O ' ' CB ' ' A' ' 119' ' ' LEU . 26.5 pt -68.52 -40.92 82.72 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.498 0 O-C-N 121.079 -1.013 . . . . 1.0 111.589 -177.895 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 117' ' ' GLU . . . . . 0.471 ' C ' ' N ' ' A' ' 119' ' ' LEU . 2.6 tt0 -47.21 -66.2 0.44 Allowed 'General case' 0 C--N 1.317 -0.823 0 CA-C-N 115.42 -0.809 . . . . 1.0 110.432 -177.18 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 72.0 t -50.11 -14.58 0.26 Allowed 'Isoleucine or valine' 0 N--CA 1.437 -1.121 0 O-C-N 124.572 1.17 . . . . 1.0 109.332 -178.822 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 119' ' ' LEU . . . . . 0.484 ' CB ' ' O ' ' A' ' 116' ' ' ILE . 0.2 OUTLIER -79.04 -62.6 1.64 Allowed 'General case' 0 N--CA 1.451 -0.413 0 C-N-CA 119.316 -0.954 . . . . 1.0 109.514 176.345 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -70.18 -84.98 0.16 Allowed Glycine 0 N--CA 1.481 1.689 0 C-N-CA 117.53 -2.271 . . . . 1.0 112.052 -179.139 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 34.0 m -161.8 -19.73 0.05 OUTLIER 'General case' 0 CA--C 1.542 0.651 0 CA-C-O 120.769 0.319 . . . . 1.0 110.231 -179.139 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 122' ' ' GLY . . . . . 0.481 ' O ' ' N ' ' A' ' 124' ' ' ASP . . . 111.59 -36.13 4.35 Favored Glycine 0 N--CA 1.477 1.387 0 C-N-CA 125.202 1.382 . . . . 1.0 112.138 179.752 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 123' ' ' THR . . . . . 0.464 ' C ' ' O ' ' A' ' 122' ' ' GLY . 0.0 OUTLIER -32.09 93.21 0.01 OUTLIER 'General case' 0 N--CA 1.469 0.523 0 CA-C-N 118.867 1.333 . . . . 1.0 112.461 -177.888 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 124' ' ' ASP . . . . . 0.481 ' N ' ' O ' ' A' ' 122' ' ' GLY . 8.7 t70 -141.49 141.6 33.62 Favored 'General case' 0 C--N 1.328 -0.352 0 N-CA-C 107.425 -1.324 . . . . 1.0 107.425 177.452 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 125' ' ' TYR . . . . . . . . . . . . . 9.7 t80 -153.58 147.24 25.16 Favored 'General case' 0 C--N 1.324 -0.532 0 N-CA-C 109.692 -0.484 . . . . 1.0 109.692 -177.569 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 126' ' ' ARG . . . . . 0.4 ' CB ' ' H62' ' A' ' 130' ' ' MTN . 9.0 mmp_? -147.5 152.08 37.43 Favored 'General case' 0 CA--C 1.542 0.646 0 CA-C-N 115.532 -0.758 . . . . 1.0 110.777 177.281 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 127' ' ' PHE . . . . . . . . . . . . . 22.6 p90 . . . . . 0 N--CA 1.47 0.574 0 CA-C-O 118.275 -0.869 . . . . 1.0 110.253 179.608 . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 128' ' ' MTN . . . . . 0.411 ' H91' ' HD3' ' A' ' 47' ' ' ARG . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 129' ' ' MTN . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 130' ' ' MTN . . . . . 0.628 ' S1 ' ' O ' ' A' ' 102' ' ' CYS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 64.6 mtt . . . . . 0 N--CA 1.491 1.577 0 N-CA-C 109.332 -0.618 . . . . 1.0 109.332 . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 88.9 p -103.63 7.7 37.51 Favored 'General case' 0 N--CA 1.467 0.398 0 CA-C-N 116.097 -0.501 . . . . 1.0 110.751 -179.723 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 3' ' ' ASP . . . . . 0.459 ' N ' ' OD1' ' A' ' 3' ' ' ASP . 1.6 p30 167.42 99.87 0.0 OUTLIER 'General case' 0 N--CA 1.466 0.342 0 CA-C-N 116.109 -0.496 . . . . 1.0 110.42 179.096 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 16.6 t80 -150.21 145.82 26.47 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.219 -0.446 . . . . 1.0 110.059 179.329 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 5' ' ' ASP . . . . . 0.615 ' OD1' ' N ' ' A' ' 10' ' ' SER . 0.3 OUTLIER -157.21 153.42 27.58 Favored 'General case' 0 C--N 1.327 -0.377 0 N-CA-C 109.887 -0.412 . . . . 1.0 109.887 179.674 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 6' ' ' THR . . . . . 0.657 ' O ' ' N ' ' A' ' 10' ' ' SER . 0.2 OUTLIER -75.01 175.74 7.87 Favored 'General case' 0 C--O 1.212 -0.872 0 CA-C-N 116.112 -0.495 . . . . 1.0 111.802 -178.123 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 7' ' ' GLU . . . . . 0.504 ' O ' ' N ' ' A' ' 11' ' ' ARG . 0.5 OUTLIER -58.7 -56.21 25.19 Favored 'General case' 0 N--CA 1.478 0.974 0 CA-C-N 115.72 -0.673 . . . . 1.0 109.863 -178.781 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 8' ' ' ARG . . . . . 0.725 ' O ' ' HB3' ' A' ' 12' ' ' ALA . 0.0 OUTLIER -49.39 -54.77 15.67 Favored 'General case' 0 C--N 1.318 -0.794 0 N-CA-C 106.349 -1.723 . . . . 1.0 106.349 -178.034 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 9' ' ' VAL . . . . . 0.792 ' O ' ' HB ' ' A' ' 13' ' ' VAL . 1.3 t -63.74 -46.46 94.49 Favored 'Isoleucine or valine' 0 C--O 1.193 -1.914 0 CA-C-N 111.834 -2.439 . . . . 1.0 109.165 -179.705 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 10' ' ' SER . . . . . 0.657 ' N ' ' O ' ' A' ' 6' ' ' THR . 6.6 t -69.67 -63.32 1.1 Allowed 'General case' 0 N--CA 1.487 1.405 0 N-CA-C 112.648 0.61 . . . . 1.0 112.648 -178.279 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 11' ' ' ARG . . . . . 0.519 ' O ' ' N ' ' A' ' 15' ' ' ALA . 3.6 mmt85 -64.07 -55.39 22.42 Favored 'General case' 0 N--CA 1.478 0.963 0 CA-C-O 121.119 0.485 . . . . 1.0 110.866 -176.402 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 12' ' ' ALA . . . . . 0.725 ' HB3' ' O ' ' A' ' 8' ' ' ARG . . . -51.24 -50.73 58.61 Favored 'General case' 0 C--N 1.314 -0.953 0 N-CA-C 106.363 -1.717 . . . . 1.0 106.363 -178.756 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 13' ' ' VAL . . . . . 0.792 ' HB ' ' O ' ' A' ' 9' ' ' VAL . 8.1 t -60.62 -52.26 63.54 Favored 'Isoleucine or valine' 0 C--O 1.197 -1.662 0 C-N-CA 119.419 -0.912 . . . . 1.0 109.184 176.823 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 14' ' ' ALA . . . . . 0.651 ' O ' HG13 ' A' ' 18' ' ' VAL . . . -58.24 -62.13 2.06 Favored 'General case' 0 C--O 1.21 -1.019 0 C-N-CA 118.682 -1.207 . . . . 1.0 110.185 -179.352 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 15' ' ' ALA . . . . . 0.563 ' O ' ' N ' ' A' ' 19' ' ' GLY . . . -52.25 -55.64 19.98 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-O 121.918 0.866 . . . . 1.0 109.943 -178.245 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 16' ' ' ALA . . . . . 0.553 ' CA ' ' H ' ' A' ' 22' ' ' GLY . . . -61.27 -54.76 39.94 Favored 'General case' 0 C--N 1.311 -1.101 0 CA-C-N 114.413 -1.267 . . . . 1.0 109.097 -179.269 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 17' ' ' LEU . . . . . 0.578 ' CB ' ' O ' ' A' ' 13' ' ' VAL . 7.0 tt -57.79 -53.7 55.24 Favored 'General case' 0 N--CA 1.482 1.153 0 CA-C-N 114.001 -1.454 . . . . 1.0 109.294 -177.693 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 18' ' ' VAL . . . . . 0.651 HG13 ' O ' ' A' ' 14' ' ' ALA . 2.6 m -68.98 -56.67 11.17 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.501 0 C-N-CA 119.268 -0.973 . . . . 1.0 109.274 178.978 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 19' ' ' GLY . . . . . 0.563 ' N ' ' O ' ' A' ' 15' ' ' ALA . . . -66.74 -160.59 1.0 Allowed Glycine 0 CA--C 1.534 1.248 0 CA-C-N 116.771 -0.195 . . . . 1.0 113.162 -178.037 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 20' ' ' PRO . . . . . 0.588 ' O ' ' HB2' ' A' ' 24' ' ' ALA . 90.8 Cg_endo -79.87 -30.02 2.49 Favored 'Trans proline' 0 N--CA 1.502 2.026 0 C-N-CA 123.476 2.784 . . . . 1.0 115.117 -177.42 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -60.15 -58.21 15.21 Favored Glycine 0 N--CA 1.478 1.437 0 C-N-CA 119.864 -1.16 . . . . 1.0 112.458 -176.296 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 22' ' ' GLY . . . . . 0.553 ' H ' ' CA ' ' A' ' 16' ' ' ALA . . . -59.16 -56.26 26.21 Favored Glycine 0 C--N 1.312 -0.757 0 N-CA-C 108.403 -1.879 . . . . 1.0 108.403 -177.243 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 23' ' ' VAL . . . . . 0.462 HG22 ' O ' ' A' ' 19' ' ' GLY . 34.6 m -59.77 -34.39 55.46 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.84 0 C-N-CA 120.109 -0.636 . . . . 1.0 109.713 -179.489 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 24' ' ' ALA . . . . . 0.588 ' HB2' ' O ' ' A' ' 20' ' ' PRO . . . -57.38 -61.52 2.43 Favored 'General case' 0 CA--C 1.534 0.337 0 C-N-CA 118.078 -1.449 . . . . 1.0 109.011 179.884 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 5.2 mp -63.85 -44.18 93.91 Favored 'General case' 0 C--N 1.347 0.465 0 C-N-CA 120.24 -0.584 . . . . 1.0 112.19 -178.598 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 73.8 t -60.87 -59.59 3.99 Favored 'Isoleucine or valine' 0 CA--C 1.527 0.083 0 C-N-CA 118.776 -1.169 . . . . 1.0 109.793 -177.991 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 27' ' ' VAL . . . . . 0.651 ' O ' ' HB3' ' A' ' 31' ' ' ALA . 83.9 t -59.97 -39.16 79.43 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.212 0 N-CA-C 112.19 0.441 . . . . 1.0 112.19 -178.429 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 27.5 tttm -65.94 -54.42 26.59 Favored 'General case' 0 C--N 1.319 -0.739 0 N-CA-C 108.941 -0.763 . . . . 1.0 108.941 -179.223 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 59.5 t -63.98 -48.44 86.05 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.825 0 CA-C-N 114.599 -1.182 . . . . 1.0 110.587 -177.892 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 30' ' ' CYS . . . . . . . . . . . . . 20.0 t -65.16 -61.23 2.26 Favored 'General case' 0 N--CA 1.446 -0.664 0 C-N-CA 119.245 -0.982 . . . . 1.0 109.566 -179.51 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 31' ' ' ALA . . . . . 0.651 ' HB3' ' O ' ' A' ' 27' ' ' VAL . . . -65.18 -53.2 48.49 Favored 'General case' 0 N--CA 1.453 -0.309 0 N-CA-C 113.487 0.921 . . . . 1.0 113.487 -176.24 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 84.6 77.89 1.15 Allowed Glycine 0 CA--C 1.527 0.822 0 C-N-CA 120.338 -0.934 . . . . 1.0 111.474 -179.76 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 33' ' ' LEU . . . . . 0.445 ' O ' ' N ' ' A' ' 35' ' ' GLY . 10.0 mp 69.89 101.37 0.04 OUTLIER Pre-proline 0 CA--C 1.548 0.88 0 C-N-CA 123.207 0.603 . . . . 1.0 110.25 -179.131 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 1.1 Cg_endo -45.26 -10.13 0.04 OUTLIER 'Trans proline' 0 N--CA 1.501 1.944 0 C-N-CA 122.109 1.872 . . . . 1.0 114.818 -179.247 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 35' ' ' GLY . . . . . 0.445 ' N ' ' O ' ' A' ' 33' ' ' LEU . . . -60.82 -59.76 9.62 Favored Glycine 0 N--CA 1.468 0.823 0 C-N-CA 118.223 -1.941 . . . . 1.0 110.088 -178.037 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 36' ' ' VAL . . . . . 0.884 HG22 ' H ' ' A' ' 37' ' ' ILE . 9.4 p -83.87 -146.58 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.465 0.324 0 N-CA-C 109.303 -0.629 . . . . 1.0 109.303 -179.945 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 37' ' ' ILE . . . . . 0.884 ' H ' HG22 ' A' ' 36' ' ' VAL . 2.2 mp 73.71 76.8 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.474 0.727 0 CA-C-N 117.949 0.341 . . . . 1.0 111.578 -179.551 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 98.9 m-70 -134.94 127.2 30.15 Favored 'General case' 0 N--CA 1.451 -0.385 0 N-CA-C 106.902 -1.518 . . . . 1.0 106.902 177.777 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 27.7 p -109.1 146.55 34.09 Favored Pre-proline 0 C--N 1.328 -0.349 0 N-CA-C 109.631 -0.507 . . . . 1.0 109.631 -179.037 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 51.0 Cg_endo -66.0 -24.94 52.23 Favored 'Trans proline' 0 C--N 1.306 -1.659 0 C-N-CA 121.502 1.468 . . . . 1.0 112.819 -178.854 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -126.81 130.15 49.69 Favored 'General case' 0 CA--C 1.516 -0.349 0 N-CA-C 109.567 -0.531 . . . . 1.0 109.567 178.921 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 42' ' ' ARG . . . . . 0.67 ' C ' ' H ' ' A' ' 44' ' ' GLY . 4.0 tmm_? -159.27 156.05 28.04 Favored 'General case' 0 C--N 1.318 -0.781 0 C-N-CA 119.908 -0.717 . . . . 1.0 109.175 178.05 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 43' ' ' ARG . . . . . 0.409 ' C ' ' H ' ' A' ' 45' ' ' PHE . 0.2 OUTLIER -62.97 17.95 0.01 OUTLIER 'General case' 0 C--N 1.32 -0.7 0 CA-C-N 115.963 -0.562 . . . . 1.0 110.147 179.204 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 44' ' ' GLY . . . . . 0.67 ' H ' ' C ' ' A' ' 42' ' ' ARG . . . 76.59 -27.19 1.58 Allowed Glycine 0 C--N 1.337 0.617 0 N-CA-C 111.306 -0.718 . . . . 1.0 111.306 179.389 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 45' ' ' PHE . . . . . 0.564 ' N ' ' CD1' ' A' ' 45' ' ' PHE . 0.1 OUTLIER -155.59 156.58 35.33 Favored 'General case' 0 CA--C 1.548 0.868 0 N-CA-C 109.795 -0.446 . . . . 1.0 109.795 -179.684 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 46' ' ' PHE . . . . . 0.613 ' O ' ' HB2' ' A' ' 47' ' ' ARG . 0.5 OUTLIER 139.66 85.36 0.0 OUTLIER 'General case' 0 N--CA 1.5 2.068 0 C-N-CA 126.23 1.812 . . . . 1.0 109.05 179.251 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 47' ' ' ARG . . . . . 0.917 HH12 ' H91' ' A' ' 128' ' ' MTN . 2.5 mtm-85 131.89 138.24 0.0 OUTLIER 'General case' 0 N--CA 1.505 2.294 0 C-N-CA 125.189 1.396 . . . . 1.0 109.989 178.528 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 48' ' ' CYS . . . . . 0.853 ' O ' ' H83' ' A' ' 129' ' ' MTN . 0.0 OUTLIER 75.5 70.66 0.08 Allowed 'General case' 0 C--O 1.219 -0.531 0 N-CA-C 108.988 -0.745 . . . . 1.0 108.988 179.662 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 49' ' ' ASN . . . . . 0.649 ' O ' ' N ' ' A' ' 51' ' ' GLU . 1.2 p-10 -143.32 116.09 5.95 Favored Pre-proline 0 C--N 1.327 -0.407 0 N-CA-C 107.988 -1.116 . . . . 1.0 107.988 -179.733 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 74.7 Cg_exo -47.42 63.52 0.01 OUTLIER 'Trans proline' 0 N--CA 1.509 2.399 0 C-N-CA 122.688 2.258 . . . . 1.0 114.788 -178.801 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 51' ' ' GLU . . . . . 0.649 ' N ' ' O ' ' A' ' 49' ' ' ASN . 17.1 mp0 62.02 28.49 17.26 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.463 -0.335 . . . . 1.0 111.064 -179.644 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -102.71 134.34 46.25 Favored 'General case' 0 CA--C 1.516 -0.329 0 N-CA-C 109.206 -0.664 . . . . 1.0 109.206 178.55 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 53' ' ' ILE . . . . . 0.419 ' O ' ' N ' ' A' ' 55' ' ' ILE . 13.0 tt -57.92 138.58 18.68 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.374 0 CA-C-O 122.273 1.035 . . . . 1.0 112.066 -178.056 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 54' ' ' GLN . . . . . 0.544 ' OE1' ' CE2' ' A' ' 46' ' ' PHE . 0.0 OUTLIER -65.98 80.62 0.08 Allowed 'General case' 0 C--N 1.318 -0.794 0 CA-C-N 113.75 -1.568 . . . . 1.0 108.067 -179.761 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 55' ' ' ILE . . . . . 0.427 ' CG2' ' N ' ' A' ' 56' ' ' GLY . 11.7 mt -149.12 158.06 6.54 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.657 0 CA-C-N 115.864 -0.607 . . . . 1.0 109.835 178.694 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 56' ' ' GLY . . . . . 0.427 ' N ' ' CG2' ' A' ' 55' ' ' ILE . . . 111.62 -2.14 27.65 Favored Glycine 0 N--CA 1.468 0.817 0 N-CA-C 110.205 -1.158 . . . . 1.0 110.205 -179.865 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 57' ' ' ASP . . . . . 0.464 ' OD1' ' CG ' ' A' ' 45' ' ' PHE . 36.3 m-20 -79.19 97.95 6.41 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 115.234 -0.483 . . . . 1.0 110.533 179.533 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 58' ' ' TRP . . . . . . . . . . . . . 6.5 m0 -87.99 172.27 9.69 Favored 'General case' 0 CA--C 1.539 0.525 0 CA-C-O 123.0 1.381 . . . . 1.0 112.58 -177.956 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 59' ' ' ARG . . . . . 0.677 ' H ' ' CD ' ' A' ' 59' ' ' ARG . 0.0 OUTLIER -82.49 -60.43 2.2 Favored 'General case' 0 C--N 1.311 -1.097 0 CA-C-N 111.622 -2.535 . . . . 1.0 112.839 -179.31 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 44.8 t80 -91.69 -14.04 30.71 Favored 'General case' 0 C--N 1.317 -0.824 0 N-CA-C 113.777 1.028 . . . . 1.0 113.777 -179.118 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 4.6 tt0 -80.18 -14.61 58.32 Favored 'General case' 0 C--O 1.214 -0.804 0 O-C-N 121.709 -0.619 . . . . 1.0 110.592 -179.493 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 62' ' ' VAL . . . . . 0.637 ' O ' ' N ' ' A' ' 66' ' ' GLY . 28.9 m -46.46 -54.25 2.24 Favored 'Isoleucine or valine' 0 C--O 1.212 -0.92 0 C-N-CA 119.268 -0.973 . . . . 1.0 110.46 -175.715 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 63' ' ' ALA . . . . . 0.567 ' N ' HG23 ' A' ' 62' ' ' VAL . . . -67.42 -48.39 67.44 Favored 'General case' 0 C--N 1.303 -1.428 0 O-C-N 121.402 -0.811 . . . . 1.0 108.962 179.824 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 11.0 t-80 -51.56 -58.09 7.28 Favored 'General case' 0 CA--C 1.541 0.627 0 C-N-CA 119.463 -0.895 . . . . 1.0 109.419 -179.649 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 65' ' ' ASP . . . . . 0.592 ' C ' ' H ' ' A' ' 67' ' ' ARG . 22.8 m-20 -75.38 -52.03 11.74 Favored 'General case' 0 C--O 1.245 0.826 0 CA-C-N 115.733 -0.667 . . . . 1.0 111.24 178.837 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 66' ' ' GLY . . . . . 0.637 ' N ' ' O ' ' A' ' 62' ' ' VAL . . . -71.76 25.97 0.63 Allowed Glycine 0 CA--C 1.522 0.483 0 O-C-N 120.345 -1.472 . . . . 1.0 110.337 177.423 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 67' ' ' ARG . . . . . 0.671 ' O ' ' N ' ' A' ' 69' ' ' LEU . 0.6 OUTLIER -71.71 7.2 1.58 Allowed 'General case' 0 CA--C 1.507 -0.687 0 N-CA-C 106.197 -1.779 . . . . 1.0 106.197 174.47 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 68' ' ' LEU . . . . . 0.588 ' H ' ' C ' ' A' ' 66' ' ' GLY . 3.1 mt -30.48 -30.11 0.01 OUTLIER 'General case' 0 N--CA 1.472 0.669 0 O-C-N 124.045 0.84 . . . . 1.0 108.767 -177.653 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 69' ' ' LEU . . . . . 0.671 ' N ' ' O ' ' A' ' 67' ' ' ARG . 10.9 mp -62.35 -66.15 0.58 Allowed 'General case' 0 N--CA 1.476 0.842 0 C-N-CA 119.296 -0.961 . . . . 1.0 109.016 178.401 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 70' ' ' ALA . . . . . 0.627 ' C ' ' H ' ' A' ' 72' ' ' HIS . . . -79.49 -75.63 0.24 Allowed 'General case' 0 N--CA 1.476 0.835 0 N-CA-C 107.36 -1.348 . . . . 1.0 107.36 178.051 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 71' ' ' ALA . . . . . 0.474 ' HB3' ' CB ' ' A' ' 67' ' ' ARG . . . -46.44 5.87 0.0 OUTLIER 'General case' 0 CA--C 1.536 0.409 0 C-N-CA 124.837 1.255 . . . . 1.0 113.539 177.671 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 72' ' ' HIS . . . . . 0.627 ' H ' ' C ' ' A' ' 70' ' ' ALA . 1.1 t-80 -28.69 -68.17 0.07 Allowed 'General case' 0 N--CA 1.467 0.414 0 C-N-CA 122.827 0.451 . . . . 1.0 111.788 -179.449 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 73' ' ' MET . . . . . 0.549 ' N ' ' SD ' ' A' ' 73' ' ' MET . 0.0 OUTLIER -66.83 -47.58 71.58 Favored 'General case' 0 C--N 1.329 -0.325 0 C-N-CA 118.263 -1.375 . . . . 1.0 109.133 178.966 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 74' ' ' VAL . . . . . 0.793 ' O ' ' N ' ' A' ' 76' ' ' GLY . 72.9 t -42.2 -41.17 0.91 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.26 0 CA-C-O 117.621 -1.18 . . . . 1.0 111.524 -176.089 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 75' ' ' ASN . . . . . 0.446 ' OD1' HG21 ' A' ' 78' ' ' VAL . 8.2 t30 -33.63 -12.22 0.0 OUTLIER 'General case' 0 N--CA 1.498 1.947 0 CA-C-N 120.175 1.352 . . . . 1.0 112.315 179.25 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 76' ' ' GLY . . . . . 0.793 ' N ' ' O ' ' A' ' 74' ' ' VAL . . . -48.86 -22.67 3.04 Favored Glycine 0 CA--C 1.542 1.736 0 N-CA-C 108.455 -1.858 . . . . 1.0 108.455 174.629 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 77' ' ' ILE . . . . . 0.667 ' O ' ' N ' ' A' ' 80' ' ' ALA . 0.9 OUTLIER -75.54 -59.86 2.88 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.588 0 N-CA-C 108.068 -1.086 . . . . 1.0 108.068 178.36 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 78' ' ' VAL . . . . . 0.466 ' C ' ' O ' ' A' ' 77' ' ' ILE . 75.6 t -34.39 -31.18 0.02 OUTLIER 'Isoleucine or valine' 0 CA--C 1.547 0.828 0 CA-C-N 113.532 -1.667 . . . . 1.0 107.947 -176.207 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 79' ' ' ILE . . . . . 0.665 ' O ' ' HB2' ' A' ' 83' ' ' ALA . 40.3 pt -95.45 -29.9 4.03 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.843 0 CA-C-N 115.989 -0.55 . . . . 1.0 111.595 178.392 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 80' ' ' ALA . . . . . 0.667 ' N ' ' O ' ' A' ' 77' ' ' ILE . . . -86.14 -10.79 54.17 Favored 'General case' 0 CA--C 1.548 0.882 0 N-CA-C 113.284 0.846 . . . . 1.0 113.284 178.387 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 8.5 mt-10 -83.1 -68.56 0.7 Allowed 'General case' 0 C--N 1.355 0.805 0 CA-C-N 118.855 0.752 . . . . 1.0 109.067 178.254 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 82' ' ' ASP . . . . . 0.512 ' O ' ' C ' ' A' ' 83' ' ' ALA . 49.7 p-10 -74.95 -14.2 60.61 Favored 'General case' 0 N--CA 1.443 -0.796 0 CA-C-O 118.846 -0.597 . . . . 1.0 112.136 -179.48 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 83' ' ' ALA . . . . . 0.704 ' HA ' ' HB3' ' A' ' 86' ' ' ALA . . . -23.08 -47.35 0.01 OUTLIER 'General case' 0 N--CA 1.473 0.698 0 CA-C-N 118.436 0.562 . . . . 1.0 112.013 177.746 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 84' ' ' LEU . . . . . 0.48 ' N ' ' O ' ' A' ' 82' ' ' ASP . 2.9 tt -37.7 -36.2 0.17 Allowed 'General case' 0 N--CA 1.465 0.324 0 N-CA-C 112.85 0.685 . . . . 1.0 112.85 -177.617 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 85' ' ' ILE . . . . . 0.407 HG21 HD13 ' A' ' 85' ' ' ILE . 11.2 pt -98.68 -43.1 11.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 N-CA-C 108.436 -0.95 . . . . 1.0 108.436 177.526 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 86' ' ' ALA . . . . . 0.704 ' HB3' ' HA ' ' A' ' 83' ' ' ALA . . . -56.36 -57.45 12.2 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 114.142 -1.39 . . . . 1.0 109.503 179.45 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 87' ' ' GLU . . . . . 0.533 ' N ' ' O ' ' A' ' 83' ' ' ALA . 19.8 tt0 -79.3 26.41 0.28 Allowed 'General case' 0 CA--C 1.544 0.723 0 O-C-N 120.851 -1.156 . . . . 1.0 112.202 -178.149 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -116.49 -15.75 10.86 Favored 'General case' 0 N--CA 1.489 1.504 0 CA-C-O 123.415 1.579 . . . . 1.0 107.896 177.68 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 89' ' ' VAL . . . . . 0.415 HG22 ' O ' ' A' ' 86' ' ' ALA . 5.3 m -100.44 39.23 0.15 Allowed 'Isoleucine or valine' 0 C--O 1.205 -1.238 0 CA-C-N 110.83 -2.896 . . . . 1.0 109.987 178.573 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 90' ' ' GLY . . . . . 0.536 ' O ' ' N ' ' A' ' 92' ' ' HIS . . . -71.59 -39.15 61.13 Favored Glycine 0 C--N 1.351 1.381 0 N-CA-C 111.023 -0.831 . . . . 1.0 111.023 178.329 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 91' ' ' PRO . . . . . 0.528 ' CD ' ' N ' ' A' ' 90' ' ' GLY . 89.6 Cg_exo -46.45 -12.82 0.09 OUTLIER 'Trans proline' 0 N--CA 1.497 1.712 0 C-N-CA 121.572 1.515 . . . . 1.0 110.346 178.406 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 92' ' ' HIS . . . . . 0.536 ' N ' ' O ' ' A' ' 90' ' ' GLY . 3.5 p80 -57.54 -17.15 12.35 Favored 'General case' 0 C--O 1.208 -1.108 0 N-CA-C 107.56 -1.274 . . . . 1.0 107.56 179.675 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 93' ' ' LEU . . . . . 0.712 HD12 ' N ' ' A' ' 94' ' ' ALA . 2.1 pp -67.84 -59.37 3.35 Favored 'General case' 0 N--CA 1.455 -0.215 0 N-CA-C 108.817 -0.809 . . . . 1.0 108.817 178.884 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 94' ' ' ALA . . . . . 0.712 ' N ' HD12 ' A' ' 93' ' ' LEU . . . -56.45 -53.36 58.31 Favored 'General case' 0 N--CA 1.454 -0.265 0 N-CA-C 108.914 -0.773 . . . . 1.0 108.914 178.701 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 95' ' ' ARG . . . . . 0.643 ' O ' ' N ' ' A' ' 97' ' ' LEU . 42.8 mtm105 -57.54 -57.44 12.69 Favored 'General case' 0 C--O 1.241 0.653 0 N-CA-C 107.822 -1.177 . . . . 1.0 107.822 178.846 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 96' ' ' ALA . . . . . 0.885 ' O ' ' N ' ' A' ' 98' ' ' GLY . . . -47.47 -12.35 0.03 OUTLIER 'General case' 0 N--CA 1.436 -1.128 0 O-C-N 118.905 -2.372 . . . . 1.0 110.375 -179.195 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 97' ' ' LEU . . . . . 0.692 ' O ' ' N ' ' A' ' 100' ' ' ILE . 16.2 tp 5.96 -53.25 0.0 OUTLIER 'General case' 0 C--N 1.377 1.801 0 CA-C-O 117.481 -1.247 . . . . 1.0 110.275 -167.843 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 98' ' ' GLY . . . . . 0.885 ' N ' ' O ' ' A' ' 96' ' ' ALA . . . -49.06 -23.75 4.06 Favored Glycine 0 CA--C 1.543 1.784 0 CA-C-N 122.572 2.442 . . . . 1.0 107.902 175.331 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 99' ' ' GLN . . . . . 0.552 ' N ' ' O ' ' A' ' 96' ' ' ALA . 0.0 OUTLIER -63.88 -17.45 63.2 Favored 'General case' 0 C--N 1.36 1.026 0 N-CA-C 107.046 -1.465 . . . . 1.0 107.046 176.706 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 100' ' ' ILE . . . . . 0.692 ' N ' ' O ' ' A' ' 97' ' ' LEU . 1.9 tp -66.42 -43.33 91.18 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.518 0 N-CA-C 108.746 -0.835 . . . . 1.0 108.746 178.98 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 101' ' ' VAL . . . . . 0.672 ' O ' ' N ' ' A' ' 105' ' ' GLY . 0.5 OUTLIER -54.48 -58.28 4.25 Favored 'Isoleucine or valine' 0 C--O 1.219 -0.546 0 N-CA-C 106.844 -1.539 . . . . 1.0 106.844 178.69 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 102' ' ' CYS . . . . . 0.838 ' O ' ' HB2' ' A' ' 106' ' ' ALA . 17.1 t -44.74 -20.6 0.04 OUTLIER 'General case' 0 C--N 1.314 -0.974 0 CA-C-N 115.961 -0.563 . . . . 1.0 111.977 -179.932 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 103' ' ' ARG . . . . . 0.522 HH11 ' CG ' ' A' ' 103' ' ' ARG . 0.0 OUTLIER -92.76 -44.69 8.4 Favored 'General case' 0 N--CA 1.472 0.646 0 CA-C-O 122.328 1.061 . . . . 1.0 111.521 178.299 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 104' ' ' TYR . . . . . 0.581 ' CD2' ' O ' ' A' ' 104' ' ' TYR . 0.0 OUTLIER -105.72 22.39 15.64 Favored 'General case' 0 C--N 1.312 -1.027 0 CA-C-N 113.625 -1.625 . . . . 1.0 111.325 179.294 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 105' ' ' GLY . . . . . 0.776 ' O ' ' N ' ' A' ' 107' ' ' THR . . . -171.67 -9.29 0.02 OUTLIER Glycine 0 C--N 1.345 1.028 0 C-N-CA 118.437 -1.84 . . . . 1.0 113.125 178.987 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 106' ' ' ALA . . . . . 0.838 ' HB2' ' O ' ' A' ' 102' ' ' CYS . . . -27.71 68.68 0.0 OUTLIER 'General case' 0 N--CA 1.475 0.793 0 N-CA-C 113.521 0.934 . . . . 1.0 113.521 -178.707 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 107' ' ' THR . . . . . 0.776 ' N ' ' O ' ' A' ' 105' ' ' GLY . 8.8 t -91.9 2.66 56.39 Favored 'General case' 0 CA--C 1.51 -0.595 0 N-CA-C 106.902 -1.518 . . . . 1.0 106.902 177.601 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 60.2 t -85.37 -57.73 4.09 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.76 0 CA-C-N 115.475 -0.784 . . . . 1.0 110.514 178.547 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 109' ' ' ILE . . . . . 0.523 ' N ' ' HD2' ' A' ' 110' ' ' PRO . 0.1 OUTLIER -65.98 -39.8 32.76 Favored Pre-proline 0 CA--C 1.555 1.158 0 N-CA-C 114.552 1.316 . . . . 1.0 114.552 -177.971 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 110' ' ' PRO . . . . . 0.547 ' CD ' ' O ' ' A' ' 106' ' ' ALA . 6.8 Cg_endo -48.13 -47.7 18.71 Favored 'Trans proline' 0 N--CA 1.504 2.096 0 CA-C-N 122.397 1.892 . . . . 1.0 113.065 -178.283 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 23.4 t30 -64.79 -67.03 0.47 Allowed 'General case' 0 N--CA 1.464 0.248 0 C-N-CA 119.47 -0.892 . . . . 1.0 109.434 -178.267 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 112' ' ' ILE . . . . . 0.458 ' O ' ' N ' ' A' ' 115' ' ' ALA . 28.3 mm -49.25 -39.92 13.3 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.575 0 CA-C-O 122.813 1.292 . . . . 1.0 108.459 179.737 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 113' ' ' ASN . . . . . 0.483 ' CB ' ' O ' ' A' ' 109' ' ' ILE . 6.4 t-20 -47.14 -51.14 18.9 Favored 'General case' 0 C--N 1.31 -1.121 0 CA-C-N 112.273 -2.24 . . . . 1.0 108.03 -176.892 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -62.21 -29.81 70.64 Favored 'General case' 0 N--CA 1.441 -0.894 0 C-N-CA 119.611 -0.835 . . . . 1.0 110.343 178.772 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 115' ' ' ALA . . . . . 0.458 ' N ' ' O ' ' A' ' 112' ' ' ILE . . . -77.34 -60.44 2.36 Favored 'General case' 0 C--N 1.347 0.477 0 C-N-CA 119.659 -0.817 . . . . 1.0 110.031 179.077 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 116' ' ' ILE . . . . . 0.506 ' O ' ' N ' ' A' ' 120' ' ' GLY . 1.0 OUTLIER -49.95 -50.07 19.93 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.707 0 CA-C-O 122.013 0.911 . . . . 1.0 109.562 -179.41 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 117' ' ' GLU . . . . . 0.476 ' N ' HG22 ' A' ' 116' ' ' ILE . 17.8 mt-10 -42.53 -55.73 3.37 Favored 'General case' 0 C--N 1.316 -0.887 0 N-CA-C 106.106 -1.812 . . . . 1.0 106.106 -179.394 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 98.8 t -58.82 -53.11 51.95 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.677 0 C-N-CA 119.428 -0.909 . . . . 1.0 108.787 176.875 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -51.74 -72.62 0.05 OUTLIER 'General case' 0 CA--C 1.543 0.707 0 N-CA-C 108.083 -1.081 . . . . 1.0 108.083 -178.699 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 120' ' ' GLY . . . . . 0.506 ' N ' ' O ' ' A' ' 116' ' ' ILE . . . -64.9 -79.03 0.19 Allowed Glycine 0 CA--C 1.541 1.698 0 C-N-CA 119.055 -1.545 . . . . 1.0 110.3 179.308 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 121' ' ' THR . . . . . 0.494 ' OG1' ' O ' ' A' ' 120' ' ' GLY . 2.8 m 154.27 -31.57 0.01 OUTLIER 'General case' 0 N--CA 1.481 1.098 0 CA-C-N 112.371 -1.914 . . . . 1.0 111.463 179.974 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 122' ' ' GLY . . . . . 0.669 ' O ' ' N ' ' A' ' 124' ' ' ASP . . . 104.25 -17.5 47.54 Favored Glycine 0 N--CA 1.462 0.373 0 N-CA-C 107.319 -2.312 . . . . 1.0 107.319 -176.46 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 123' ' ' THR . . . . . 0.702 HG23 ' O ' ' A' ' 123' ' ' THR . 12.7 t -56.37 82.3 0.01 OUTLIER 'General case' 0 N--CA 1.469 0.509 0 N-CA-C 106.031 -1.84 . . . . 1.0 106.031 178.647 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 124' ' ' ASP . . . . . 0.669 ' N ' ' O ' ' A' ' 122' ' ' GLY . 34.6 m-20 -167.26 178.05 5.79 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 112.826 -1.988 . . . . 1.0 111.516 179.01 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 125' ' ' TYR . . . . . . . . . . . . . 21.3 t80 -141.96 140.22 32.67 Favored 'General case' 0 CA--C 1.536 0.417 0 N-CA-C 107.328 -1.36 . . . . 1.0 107.328 174.932 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 24.0 mmm-85 -146.18 148.1 32.18 Favored 'General case' 0 N--CA 1.471 0.598 0 N-CA-C 109.879 -0.415 . . . . 1.0 109.879 178.594 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 127' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 C--N 1.327 -0.409 0 CA-C-O 117.982 -1.009 . . . . 1.0 110.079 179.3 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 128' ' ' MTN . . . . . 0.917 ' H91' HH12 ' A' ' 47' ' ' ARG . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 129' ' ' MTN . . . . . 0.853 ' H83' ' O ' ' A' ' 48' ' ' CYS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 130' ' ' MTN . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.494 1.75 0 N-CA-C 108.103 -1.073 . . . . 1.0 108.103 . . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 2' ' ' SER . . . . . 0.46 ' O ' ' CB ' ' A' ' 3' ' ' ASP . 93.9 p -70.66 7.1 1.19 Allowed 'General case' 0 C--O 1.223 -0.316 0 CA-C-O 119.449 -0.31 . . . . 1.0 111.352 179.615 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 3' ' ' ASP . . . . . 0.46 ' CB ' ' O ' ' A' ' 2' ' ' SER . 12.7 p-10 142.55 142.19 0.0 OUTLIER 'General case' 0 N--CA 1.481 1.079 0 O-C-N 124.126 0.891 . . . . 1.0 110.349 179.07 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 42.1 t80 -155.59 151.33 27.41 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 121.134 0.492 . . . . 1.0 110.532 178.701 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 5' ' ' ASP . . . . . 0.482 ' C ' ' OG ' ' A' ' 10' ' ' SER . 51.3 m-20 -148.46 144.6 27.5 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.562 -0.745 . . . . 1.0 109.53 179.84 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 6' ' ' THR . . . . . 1.009 HG22 ' H ' ' A' ' 7' ' ' GLU . 5.6 m -109.46 -161.57 0.77 Allowed 'General case' 0 C--O 1.206 -1.188 0 CA-C-O 121.656 0.741 . . . . 1.0 110.48 -179.776 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 7' ' ' GLU . . . . . 1.009 ' H ' HG22 ' A' ' 6' ' ' THR . 28.5 tt0 -58.26 -44.37 88.31 Favored 'General case' 0 C--N 1.302 -1.497 0 CA-C-O 121.872 0.844 . . . . 1.0 109.447 -178.5 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 8' ' ' ARG . . . . . 0.836 ' O ' ' HB3' ' A' ' 12' ' ' ALA . 21.8 ttp-105 -69.87 -60.64 2.18 Favored 'General case' 0 C--N 1.307 -1.241 0 C-N-CA 117.916 -1.514 . . . . 1.0 110.089 178.242 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 9' ' ' VAL . . . . . 0.957 HG23 ' H ' ' A' ' 6' ' ' THR . 0.1 OUTLIER -61.38 -52.61 59.27 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.412 0 CA-C-N 115.11 -0.95 . . . . 1.0 110.129 -179.6 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 10' ' ' SER . . . . . 0.674 ' N ' ' O ' ' A' ' 6' ' ' THR . 1.2 m -68.21 -65.21 0.72 Allowed 'General case' 0 N--CA 1.487 1.409 0 C-N-CA 120.166 -0.614 . . . . 1.0 112.525 179.66 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 11' ' ' ARG . . . . . 0.643 ' O ' ' HB3' ' A' ' 15' ' ' ALA . 5.0 mtt-85 -61.9 -43.41 98.89 Favored 'General case' 0 C--N 1.317 -0.841 0 C-N-CA 120.419 -0.512 . . . . 1.0 111.382 -176.955 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 12' ' ' ALA . . . . . 0.836 ' HB3' ' O ' ' A' ' 8' ' ' ARG . . . -69.87 -57.58 4.88 Favored 'General case' 0 N--CA 1.468 0.443 0 C-N-CA 118.334 -1.346 . . . . 1.0 108.998 178.719 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 13' ' ' VAL . . . . . 0.673 ' O ' ' CB ' ' A' ' 17' ' ' LEU . 41.7 t -61.84 -55.44 24.24 Favored 'Isoleucine or valine' 0 C--O 1.198 -1.623 0 C-N-CA 117.51 -1.676 . . . . 1.0 107.879 -179.266 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 14' ' ' ALA . . . . . 0.892 ' O ' HG22 ' A' ' 18' ' ' VAL . . . -57.96 -64.92 0.74 Allowed 'General case' 0 C--N 1.313 -1.009 0 C-N-CA 116.53 -2.068 . . . . 1.0 111.457 -179.94 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 15' ' ' ALA . . . . . 0.643 ' HB3' ' O ' ' A' ' 11' ' ' ARG . . . -54.59 -54.71 37.74 Favored 'General case' 0 C--O 1.218 -0.601 0 C-N-CA 118.596 -1.242 . . . . 1.0 110.334 -177.187 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 16' ' ' ALA . . . . . 0.711 ' HB3' ' O ' ' A' ' 12' ' ' ALA . . . -65.69 -55.64 16.34 Favored 'General case' 0 C--N 1.309 -1.176 0 C-N-CA 118.676 -1.21 . . . . 1.0 110.569 -179.109 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 17' ' ' LEU . . . . . 0.673 ' CB ' ' O ' ' A' ' 13' ' ' VAL . 2.2 tp -56.51 -54.56 44.4 Favored 'General case' 0 N--CA 1.491 1.591 0 N-CA-C 108.087 -1.079 . . . . 1.0 108.087 -177.728 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 18' ' ' VAL . . . . . 0.892 HG22 ' O ' ' A' ' 14' ' ' ALA . 1.8 m -71.88 -58.59 4.77 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.405 0 C-N-CA 120.371 -0.531 . . . . 1.0 110.446 -179.953 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 19' ' ' GLY . . . . . 0.559 ' N ' ' O ' ' A' ' 15' ' ' ALA . . . -60.67 -168.39 0.43 Allowed Glycine 0 N--CA 1.439 -1.131 0 N-CA-C 111.969 -0.452 . . . . 1.0 111.969 -177.288 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 20' ' ' PRO . . . . . 0.677 ' O ' ' N ' ' A' ' 24' ' ' ALA . 4.2 Cg_endo -81.73 -25.96 3.34 Favored 'Trans proline' 0 C--N 1.294 -2.339 0 C-N-CA 121.847 1.698 . . . . 1.0 113.72 -178.041 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -63.51 -60.01 8.03 Favored Glycine 0 N--CA 1.473 1.134 0 C-N-CA 118.984 -1.579 . . . . 1.0 112.679 -176.004 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 22' ' ' GLY . . . . . 0.605 ' H ' ' HA ' ' A' ' 16' ' ' ALA . . . -57.31 -53.01 48.15 Favored Glycine 0 C--N 1.31 -0.874 0 N-CA-C 106.259 -2.736 . . . . 1.0 106.259 -178.848 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 23' ' ' VAL . . . . . 0.497 ' O ' HG12 ' A' ' 27' ' ' VAL . 21.3 t -56.37 -32.29 35.31 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.849 0 N-CA-C 108.177 -1.045 . . . . 1.0 108.177 178.428 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 24' ' ' ALA . . . . . 0.677 ' N ' ' O ' ' A' ' 20' ' ' PRO . . . -60.4 -62.88 1.54 Allowed 'General case' 0 C--N 1.352 0.716 0 C-N-CA 118.573 -1.251 . . . . 1.0 110.087 -179.47 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 86.5 mt -61.91 -46.32 89.89 Favored 'General case' 0 CA--C 1.516 -0.336 0 C-N-CA 120.202 -0.599 . . . . 1.0 111.612 -177.223 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 97.9 t -59.85 -59.85 3.39 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.582 0 C-N-CA 119.332 -0.947 . . . . 1.0 110.393 -177.617 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 27' ' ' VAL . . . . . 0.552 ' O ' ' HB3' ' A' ' 31' ' ' ALA . 1.4 p -58.65 -36.93 62.49 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.442 0 C-N-CA 120.571 -0.452 . . . . 1.0 110.345 -177.353 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 8.7 tttm -65.69 -56.19 13.41 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 115.646 -0.706 . . . . 1.0 109.869 -179.882 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 97.6 t -62.29 -48.73 86.99 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.699 0 CA-C-N 115.314 -0.857 . . . . 1.0 110.002 -177.699 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 30' ' ' CYS . . . . . . . . . . . . . 49.2 t -65.45 -62.1 1.72 Allowed 'General case' 0 N--CA 1.443 -0.796 0 C-N-CA 119.849 -0.74 . . . . 1.0 110.206 -178.815 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 31' ' ' ALA . . . . . 0.552 ' HB3' ' O ' ' A' ' 27' ' ' VAL . . . -57.15 -50.21 73.52 Favored 'General case' 0 CA--C 1.507 -0.697 0 CA-C-O 120.879 0.371 . . . . 1.0 110.26 -176.668 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 32' ' ' GLY . . . . . 0.417 ' O ' ' HB2' ' A' ' 33' ' ' LEU . . . 74.82 70.66 1.22 Allowed Glycine 0 N--CA 1.443 -0.859 0 N-CA-C 109.001 -1.64 . . . . 1.0 109.001 -178.106 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 33' ' ' LEU . . . . . 0.417 ' HB2' ' O ' ' A' ' 32' ' ' GLY . 5.2 mt 91.79 82.81 0.04 OUTLIER Pre-proline 0 C--N 1.332 -0.192 0 O-C-N 124.963 1.037 . . . . 1.0 109.453 -178.281 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 50.8 Cg_exo -50.39 -28.85 22.11 Favored 'Trans proline' 0 C--N 1.312 -1.37 0 C-N-CA 122.481 2.121 . . . . 1.0 113.555 -179.333 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -62.36 -61.02 7.01 Favored Glycine 0 N--CA 1.47 0.932 0 C-N-CA 118.353 -1.88 . . . . 1.0 109.909 -178.027 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 36' ' ' VAL . . . . . 0.643 ' O ' HG22 ' A' ' 37' ' ' ILE . 11.4 p -86.47 167.11 1.84 Allowed 'Isoleucine or valine' 0 CA--C 1.507 -0.698 0 N-CA-C 107.719 -1.215 . . . . 1.0 107.719 178.41 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 37' ' ' ILE . . . . . 0.656 HG23 ' O ' ' A' ' 37' ' ' ILE . 8.2 tt 115.91 107.37 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.484 1.257 0 O-C-N 125.403 1.689 . . . . 1.0 110.6 179.752 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 60.8 m80 -140.39 135.67 32.32 Favored 'General case' 0 C--N 1.328 -0.337 0 O-C-N 121.95 -0.469 . . . . 1.0 109.782 179.153 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 6.1 m -106.42 130.93 22.18 Favored Pre-proline 0 CA--C 1.534 0.342 0 N-CA-C 110.278 -0.268 . . . . 1.0 110.278 -179.582 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 37.0 Cg_endo -65.69 -24.07 55.56 Favored 'Trans proline' 0 N--CA 1.493 1.465 0 C-N-CA 121.141 1.227 . . . . 1.0 112.702 -179.684 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -128.47 135.99 50.22 Favored 'General case' 0 N--CA 1.466 0.361 0 N-CA-C 110.376 -0.231 . . . . 1.0 110.376 177.839 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 42' ' ' ARG . . . . . 0.693 ' C ' ' H ' ' A' ' 44' ' ' GLY . 11.8 ptm180 -171.23 172.09 5.42 Favored 'General case' 0 C--N 1.322 -0.608 0 C-N-CA 120.2 -0.6 . . . . 1.0 110.941 178.342 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 43' ' ' ARG . . . . . 0.518 ' C ' ' H ' ' A' ' 45' ' ' PHE . 37.2 tpt85 -63.33 24.13 0.01 OUTLIER 'General case' 0 CA--C 1.55 0.953 0 CA-C-O 121.518 0.675 . . . . 1.0 109.816 179.296 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 44' ' ' GLY . . . . . 0.693 ' H ' ' C ' ' A' ' 42' ' ' ARG . . . 76.98 -26.78 1.72 Allowed Glycine 0 C--N 1.338 0.686 0 N-CA-C 110.533 -1.027 . . . . 1.0 110.533 179.394 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 45' ' ' PHE . . . . . 0.572 ' O ' ' HB2' ' A' ' 46' ' ' PHE . 11.8 p90 -175.32 -174.15 0.71 Allowed 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 114.352 -0.924 . . . . 1.0 109.451 179.87 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 46' ' ' PHE . . . . . 0.572 ' HB2' ' O ' ' A' ' 45' ' ' PHE . 0.7 OUTLIER 110.81 107.38 0.0 OUTLIER 'General case' 0 N--CA 1.479 1.015 0 O-C-N 125.398 1.686 . . . . 1.0 109.851 -179.78 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 47' ' ' ARG . . . . . 0.72 ' NE ' ' H73' ' A' ' 128' ' ' MTN . 34.3 ttm-85 97.69 154.21 0.02 OUTLIER 'General case' 0 N--CA 1.472 0.655 0 O-C-N 123.966 0.791 . . . . 1.0 110.964 179.7 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 4.4 t 67.2 86.5 0.13 Allowed 'General case' 0 C--N 1.328 -0.335 0 N-CA-C 108.161 -1.051 . . . . 1.0 108.161 -177.685 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 49' ' ' ASN . . . . . 0.501 ' O ' ' N ' ' A' ' 51' ' ' GLU . 0.0 OUTLIER -153.0 160.71 30.6 Favored Pre-proline 0 N--CA 1.466 0.364 0 CA-C-N 115.675 -0.693 . . . . 1.0 111.33 -179.352 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 30.8 Cg_endo -63.13 60.94 0.17 Allowed 'Trans proline' 0 C--N 1.311 -1.409 0 C-N-CA 122.545 2.163 . . . . 1.0 111.403 177.976 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 51' ' ' GLU . . . . . 0.501 ' N ' ' O ' ' A' ' 49' ' ' ASN . 40.9 mt-10 41.91 37.72 0.87 Allowed 'General case' 0 C--O 1.233 0.227 0 CA-C-O 120.68 0.276 . . . . 1.0 111.501 178.31 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 52' ' ' ARG . . . . . 0.726 ' HE ' ' HB ' ' A' ' 89' ' ' VAL . 73.9 mtt85 -146.62 167.78 22.9 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 121.025 0.44 . . . . 1.0 111.702 -179.119 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 21.0 tt -76.22 164.13 3.67 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.324 0 N-CA-C 108.061 -1.088 . . . . 1.0 108.061 176.891 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 56.1 tt0 -132.82 131.2 40.78 Favored 'General case' 0 CA--C 1.535 0.399 0 N-CA-C 108.857 -0.794 . . . . 1.0 108.857 179.057 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 10.5 tt -143.48 153.82 16.37 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.728 0 N-CA-C 110.169 -0.308 . . . . 1.0 110.169 178.852 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 104.14 2.35 45.03 Favored Glycine 0 C--N 1.341 0.848 0 N-CA-C 109.851 -1.3 . . . . 1.0 109.851 -179.108 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 18.2 m-20 -90.57 109.8 20.95 Favored 'General case' 0 CA--C 1.542 0.642 0 CA-C-O 122.138 0.971 . . . . 1.0 113.09 -178.152 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 58' ' ' TRP . . . . . 0.56 ' CD1' ' OE1' ' A' ' 61' ' ' GLU . 9.2 m95 -82.8 -176.92 6.54 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 113.43 -1.714 . . . . 1.0 108.678 176.599 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 59' ' ' ARG . . . . . 0.431 ' HG2' ' H ' ' A' ' 59' ' ' ARG . 8.0 ptm180 -98.64 -54.28 3.07 Favored 'General case' 0 CA--C 1.552 1.042 0 CA-C-N 118.955 0.798 . . . . 1.0 111.188 178.21 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 60' ' ' TYR . . . . . 0.411 ' H ' ' CG ' ' A' ' 59' ' ' ARG . 0.2 OUTLIER -80.29 -11.24 59.74 Favored 'General case' 0 N--CA 1.479 1.007 0 C-N-CA 124.561 1.145 . . . . 1.0 112.397 -178.511 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 61' ' ' GLU . . . . . 0.56 ' OE1' ' CD1' ' A' ' 58' ' ' TRP . 86.6 mt-10 -80.08 -16.47 54.94 Favored 'General case' 0 CA--C 1.496 -1.127 0 O-C-N 121.58 -0.7 . . . . 1.0 110.413 179.302 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 62' ' ' VAL . . . . . 0.516 HG23 ' N ' ' A' ' 63' ' ' ALA . 28.7 m -44.24 -46.52 2.3 Favored 'Isoleucine or valine' 0 CA--C 1.499 -1.01 0 N-CA-C 109.215 -0.661 . . . . 1.0 109.215 -175.798 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 63' ' ' ALA . . . . . 0.516 ' N ' HG23 ' A' ' 62' ' ' VAL . . . -66.19 -46.29 77.84 Favored 'General case' 0 N--CA 1.415 -2.206 0 N-CA-C 108.109 -1.071 . . . . 1.0 108.109 177.147 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 64' ' ' HIS . . . . . 0.485 ' N ' ' O ' ' A' ' 61' ' ' GLU . 4.2 t-80 -57.96 -60.65 3.4 Favored 'General case' 0 CA--C 1.547 0.83 0 CA-C-N 115.572 -0.74 . . . . 1.0 111.269 179.322 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 65' ' ' ASP . . . . . 0.609 ' C ' ' H ' ' A' ' 67' ' ' ARG . 0.7 OUTLIER -69.96 -55.63 9.11 Favored 'General case' 0 CA--C 1.554 1.116 0 O-C-N 121.128 -0.983 . . . . 1.0 110.24 178.632 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 66' ' ' GLY . . . . . 0.478 ' N ' ' O ' ' A' ' 62' ' ' VAL . . . -64.84 32.59 0.1 Allowed Glycine 0 N--CA 1.471 1.008 0 O-C-N 121.475 -0.765 . . . . 1.0 111.421 178.461 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 67' ' ' ARG . . . . . 0.714 ' HB3' ' H ' ' A' ' 71' ' ' ALA . 0.0 OUTLIER -77.45 6.4 7.07 Favored 'General case' 0 C--N 1.316 -0.863 0 C-N-CA 123.605 0.762 . . . . 1.0 110.08 176.173 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 68' ' ' LEU . . . . . 0.613 ' O ' ' HA ' ' A' ' 72' ' ' HIS . 0.8 OUTLIER -33.15 -30.16 0.01 OUTLIER 'General case' 0 N--CA 1.486 1.366 0 N-CA-C 107.481 -1.303 . . . . 1.0 107.481 -179.072 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 69' ' ' LEU . . . . . 0.63 ' N ' ' O ' ' A' ' 67' ' ' ARG . 2.3 mt -63.25 -64.68 0.84 Allowed 'General case' 0 C--N 1.317 -0.847 0 C-N-CA 117.509 -1.676 . . . . 1.0 107.558 176.754 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 70' ' ' ALA . . . . . 0.677 ' C ' ' H ' ' A' ' 72' ' ' HIS . . . -77.17 -72.25 0.36 Allowed 'General case' 0 N--CA 1.478 0.932 0 N-CA-C 106.671 -1.603 . . . . 1.0 106.671 177.615 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 71' ' ' ALA . . . . . 0.714 ' H ' ' HB3' ' A' ' 67' ' ' ARG . . . -49.16 4.19 0.01 OUTLIER 'General case' 0 N--CA 1.467 0.418 0 C-N-CA 125.203 1.401 . . . . 1.0 112.31 178.536 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 72' ' ' HIS . . . . . 0.707 ' CG ' ' H ' ' A' ' 73' ' ' MET . 0.0 OUTLIER -18.11 -72.87 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.396 0 C-N-CA 123.155 0.582 . . . . 1.0 112.527 -176.592 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 73' ' ' MET . . . . . 0.707 ' H ' ' CG ' ' A' ' 72' ' ' HIS . 45.4 mtt -71.28 -43.04 67.93 Favored 'General case' 0 C--N 1.298 -1.658 0 C-N-CA 119.309 -0.957 . . . . 1.0 110.239 178.082 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 74' ' ' VAL . . . . . 0.618 ' O ' ' N ' ' A' ' 76' ' ' GLY . 42.3 t -43.08 -45.99 1.32 Allowed 'Isoleucine or valine' 0 N--CA 1.463 0.21 0 CA-C-O 118.822 -0.609 . . . . 1.0 110.248 -175.4 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 75' ' ' ASN . . . . . 0.508 ' O ' ' N ' ' A' ' 77' ' ' ILE . 5.2 t30 -38.45 -18.96 0.01 OUTLIER 'General case' 0 N--CA 1.473 0.693 0 CA-C-O 122.025 0.917 . . . . 1.0 111.815 179.192 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 76' ' ' GLY . . . . . 0.618 ' N ' ' O ' ' A' ' 74' ' ' VAL . . . -43.35 -19.05 0.07 OUTLIER Glycine 0 CA--C 1.54 1.641 0 N-CA-C 109.344 -1.503 . . . . 1.0 109.344 177.89 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 77' ' ' ILE . . . . . 0.767 ' O ' ' N ' ' A' ' 80' ' ' ALA . 9.7 pt -89.9 -49.7 13.61 Favored 'Isoleucine or valine' 0 C--O 1.211 -0.952 0 N-CA-C 107.982 -1.118 . . . . 1.0 107.982 179.963 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 78' ' ' VAL . . . . . 0.484 ' C ' ' O ' ' A' ' 77' ' ' ILE . 6.0 t -35.15 -35.04 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.447 -0.583 0 N-CA-C 108.532 -0.914 . . . . 1.0 108.532 -177.268 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 79' ' ' ILE . . . . . 0.616 ' O ' ' HB3' ' A' ' 83' ' ' ALA . 1.3 pp -91.56 -21.92 6.28 Favored 'Isoleucine or valine' 0 C--O 1.198 -1.638 0 CA-C-N 115.824 -0.626 . . . . 1.0 110.26 178.511 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 80' ' ' ALA . . . . . 0.767 ' N ' ' O ' ' A' ' 77' ' ' ILE . . . -92.65 -9.64 40.21 Favored 'General case' 0 CA--C 1.554 1.111 0 O-C-N 121.368 -0.832 . . . . 1.0 112.682 176.258 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 81' ' ' GLU . . . . . 0.531 ' N ' ' O ' ' A' ' 77' ' ' ILE . 4.9 mm-40 -79.15 -76.76 0.19 Allowed 'General case' 0 C--N 1.344 0.328 0 N-CA-C 112.583 0.586 . . . . 1.0 112.583 -176.121 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 82' ' ' ASP . . . . . 0.78 ' O ' HG12 ' A' ' 85' ' ' ILE . 5.9 m-20 -86.42 -17.34 34.58 Favored 'General case' 0 C--O 1.206 -1.205 0 CA-C-N 116.455 -0.339 . . . . 1.0 111.201 -179.795 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 83' ' ' ALA . . . . . 0.616 ' HB3' ' O ' ' A' ' 79' ' ' ILE . . . -58.47 -40.09 81.74 Favored 'General case' 0 C--N 1.316 -0.854 0 C-N-CA 118.188 -1.405 . . . . 1.0 111.944 -175.888 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 84' ' ' LEU . . . . . 0.727 HD13 ' O ' ' A' ' 84' ' ' LEU . 3.4 tm? -37.72 -37.07 0.21 Allowed 'General case' 0 N--CA 1.467 0.399 0 N-CA-C 112.719 0.637 . . . . 1.0 112.719 -175.65 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 85' ' ' ILE . . . . . 0.78 HG12 ' O ' ' A' ' 82' ' ' ASP . 22.4 pt -69.49 -26.49 31.28 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.568 0 C-N-CA 120.341 -0.544 . . . . 1.0 111.547 -179.804 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 86' ' ' ALA . . . . . 0.528 ' N ' ' O ' ' A' ' 83' ' ' ALA . . . -86.34 -15.16 41.4 Favored 'General case' 0 C--N 1.33 -0.249 0 N-CA-C 111.935 0.346 . . . . 1.0 111.935 -179.328 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 3.4 tt0 -53.04 -8.88 0.11 Allowed 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 120.868 0.366 . . . . 1.0 110.034 -179.467 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 88' ' ' ALA . . . . . 0.475 ' H ' ' C ' ' A' ' 86' ' ' ALA . . . -93.26 -8.1 43.16 Favored 'General case' 0 N--CA 1.47 0.573 0 CA-C-O 121.529 0.681 . . . . 1.0 109.421 -179.914 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 89' ' ' VAL . . . . . 0.726 ' HB ' ' HE ' ' A' ' 52' ' ' ARG . 4.5 t -92.61 36.22 0.1 OUTLIER 'Isoleucine or valine' 0 N--CA 1.438 -1.058 0 N-CA-C 108.103 -1.073 . . . . 1.0 108.103 178.602 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 90' ' ' GLY . . . . . 0.866 ' O ' ' N ' ' A' ' 92' ' ' HIS . . . -50.88 -28.15 15.79 Favored Glycine 0 C--N 1.355 1.585 0 CA-C-O 117.303 -1.832 . . . . 1.0 111.247 176.309 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 91' ' ' PRO . . . . . 0.667 ' HD2' ' N ' ' A' ' 90' ' ' GLY . 27.9 Cg_exo -32.73 -1.76 0.0 OUTLIER 'Trans proline' 0 N--CA 1.506 2.232 0 C-N-CA 123.388 2.725 . . . . 1.0 114.112 173.644 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 92' ' ' HIS . . . . . 0.866 ' N ' ' O ' ' A' ' 90' ' ' GLY . 1.1 t60 -50.4 -29.73 10.81 Favored 'General case' 0 N--CA 1.443 -0.817 0 N-CA-C 107.094 -1.447 . . . . 1.0 107.094 178.897 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 93' ' ' LEU . . . . . 0.635 HD12 ' N ' ' A' ' 94' ' ' ALA . 2.0 pp -60.04 -52.29 66.01 Favored 'General case' 0 N--CA 1.448 -0.565 0 N-CA-C 108.404 -0.962 . . . . 1.0 108.404 177.185 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 94' ' ' ALA . . . . . 0.635 ' N ' HD12 ' A' ' 93' ' ' LEU . . . -50.61 -56.02 13.69 Favored 'General case' 0 CA--C 1.515 -0.394 0 N-CA-C 107.236 -1.394 . . . . 1.0 107.236 -179.433 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 95' ' ' ARG . . . . . 0.42 HH11 ' HG3' ' A' ' 20' ' ' PRO . 89.8 mtt-85 -59.41 -32.18 69.93 Favored 'General case' 0 C--N 1.313 -0.999 0 N-CA-C 108.325 -0.991 . . . . 1.0 108.325 177.538 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 96' ' ' ALA . . . . . 0.768 ' O ' ' N ' ' A' ' 100' ' ' ILE . . . -55.75 -49.77 72.21 Favored 'General case' 0 C--O 1.207 -1.156 0 N-CA-C 106.824 -1.547 . . . . 1.0 106.824 -178.741 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 97' ' ' LEU . . . . . 0.552 ' O ' HG22 ' A' ' 100' ' ' ILE . 0.6 OUTLIER -36.88 -26.58 0.01 OUTLIER 'General case' 0 CA--C 1.568 1.669 0 N-CA-C 107.216 -1.401 . . . . 1.0 107.216 -179.912 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 98' ' ' GLY . . . . . 0.606 ' N ' ' O ' ' A' ' 96' ' ' ALA . . . -84.95 -52.87 3.32 Favored Glycine 0 CA--C 1.55 2.261 0 CA-C-O 123.119 1.399 . . . . 1.0 111.19 173.816 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 99' ' ' GLN . . . . . 0.563 ' N ' ' O ' ' A' ' 96' ' ' ALA . 86.4 mt-30 -79.07 7.97 6.52 Favored 'General case' 0 N--CA 1.438 -1.073 0 CA-C-N 114.742 -0.729 . . . . 1.0 109.521 177.989 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 100' ' ' ILE . . . . . 0.768 ' N ' ' O ' ' A' ' 96' ' ' ALA . 14.7 tt -60.3 -49.77 82.9 Favored 'Isoleucine or valine' 0 CA--C 1.484 -1.561 0 N-CA-C 107.936 -1.135 . . . . 1.0 107.936 179.694 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 101' ' ' VAL . . . . . 0.705 ' N ' HG23 ' A' ' 100' ' ' ILE . 22.7 t -60.12 -56.7 15.78 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.636 0 C-N-CA 116.495 -2.082 . . . . 1.0 107.763 178.135 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 102' ' ' CYS . . . . . 0.531 ' O ' ' O ' ' A' ' 105' ' ' GLY . 0.5 OUTLIER -46.53 -38.17 8.98 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 114.971 -1.013 . . . . 1.0 110.663 -175.869 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 7.3 ttp180 -65.05 -54.62 27.32 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 125.595 1.809 . . . . 1.0 113.302 176.844 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 104' ' ' TYR . . . . . 0.656 ' O ' ' CG ' ' A' ' 104' ' ' TYR . 50.8 t80 -93.28 32.0 1.4 Allowed 'General case' 0 C--N 1.311 -1.096 0 C-N-CA 126.082 1.753 . . . . 1.0 107.441 178.969 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 105' ' ' GLY . . . . . 0.539 ' O ' ' CB ' ' A' ' 106' ' ' ALA . . . 172.56 -141.78 6.43 Favored Glycine 0 N--CA 1.431 -1.649 0 N-CA-C 107.199 -2.36 . . . . 1.0 107.199 178.665 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 106' ' ' ALA . . . . . 0.539 ' CB ' ' O ' ' A' ' 105' ' ' GLY . . . 109.67 107.63 0.0 OUTLIER 'General case' 0 C--N 1.315 -0.896 0 C-N-CA 126.736 2.014 . . . . 1.0 116.237 178.712 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 107' ' ' THR . . . . . 0.532 ' O ' ' HG2' ' A' ' 110' ' ' PRO . 27.7 m -72.44 -52.06 17.54 Favored 'General case' 0 N--CA 1.476 0.842 0 CA-C-N 115.614 -0.721 . . . . 1.0 110.12 175.252 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 108' ' ' VAL . . . . . 0.561 HG13 ' N ' ' A' ' 109' ' ' ILE . 8.7 p -61.46 -46.12 97.22 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.035 0 O-C-N 121.639 -0.663 . . . . 1.0 112.019 -178.452 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 109' ' ' ILE . . . . . 0.561 ' N ' HG13 ' A' ' 108' ' ' VAL . 2.6 mt -38.0 -59.6 1.15 Allowed Pre-proline 0 N--CA 1.484 1.253 0 CA-C-N 116.399 -0.364 . . . . 1.0 110.778 -178.401 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 110' ' ' PRO . . . . . 0.532 ' HG2' ' O ' ' A' ' 107' ' ' THR . 31.9 Cg_endo -56.18 -21.82 37.35 Favored 'Trans proline' 0 C--N 1.314 -1.25 0 C-N-CA 120.895 1.064 . . . . 1.0 112.177 -177.888 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 7.8 m120 -64.37 -65.7 0.64 Allowed 'General case' 0 N--CA 1.469 0.522 0 C-N-CA 119.631 -0.827 . . . . 1.0 109.808 178.77 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 112' ' ' ILE . . . . . 0.662 ' O ' ' HB ' ' A' ' 116' ' ' ILE . 2.0 tt -45.72 -27.45 0.64 Allowed 'Isoleucine or valine' 0 C--O 1.22 -0.474 0 CA-C-O 122.383 1.087 . . . . 1.0 109.121 -179.166 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 113' ' ' ASN . . . . . 0.754 ' O ' ' HB3' ' A' ' 117' ' ' GLU . 25.4 t-20 -84.05 -53.03 5.83 Favored 'General case' 0 C--N 1.308 -1.199 0 CA-C-O 122.953 1.359 . . . . 1.0 110.018 178.949 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -56.07 -58.04 9.58 Favored 'General case' 0 C--N 1.295 -1.793 0 C-N-CA 119.257 -0.977 . . . . 1.0 110.261 -178.688 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -79.89 -59.59 2.67 Favored 'General case' 0 C--O 1.246 0.893 0 N-CA-C 114.465 1.283 . . . . 1.0 114.465 179.921 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 116' ' ' ILE . . . . . 0.662 ' HB ' ' O ' ' A' ' 112' ' ' ILE . 11.2 mt -68.23 -55.36 16.67 Favored 'Isoleucine or valine' 0 C--O 1.217 -0.638 0 C-N-CA 117.919 -1.512 . . . . 1.0 113.055 -175.183 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 117' ' ' GLU . . . . . 0.754 ' HB3' ' O ' ' A' ' 113' ' ' ASN . 0.0 OUTLIER -39.56 -65.6 0.37 Allowed 'General case' 0 C--O 1.251 1.166 0 C-N-CA 121.079 -0.248 . . . . 1.0 110.453 -174.271 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 2.5 t -45.36 -18.63 0.1 Allowed 'Isoleucine or valine' 0 N--CA 1.446 -0.643 0 C-N-CA 119.124 -1.031 . . . . 1.0 109.81 -178.963 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 119' ' ' LEU . . . . . 0.603 ' N ' ' O ' ' A' ' 116' ' ' ILE . 4.7 tt -88.57 -54.92 3.94 Favored 'General case' 0 CA--C 1.538 0.504 0 N-CA-C 112.566 0.58 . . . . 1.0 112.566 176.899 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 120' ' ' GLY . . . . . 0.575 ' C ' ' H ' ' A' ' 122' ' ' GLY . . . -93.3 44.87 2.44 Favored Glycine 0 C--N 1.367 2.251 0 C-N-CA 119.821 -1.18 . . . . 1.0 113.937 -175.968 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 121' ' ' THR . . . . . 0.427 ' HB ' ' O ' ' A' ' 120' ' ' GLY . 41.5 m 73.66 -27.85 0.19 Allowed 'General case' 0 N--CA 1.476 0.848 0 C-N-CA 123.432 0.693 . . . . 1.0 109.92 177.742 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 122' ' ' GLY . . . . . 0.575 ' H ' ' C ' ' A' ' 120' ' ' GLY . . . 106.81 -36.07 4.64 Favored Glycine 0 C--N 1.319 -0.405 0 C-N-CA 124.777 1.179 . . . . 1.0 110.634 179.811 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 123' ' ' THR . . . . . 0.434 ' C ' ' O ' ' A' ' 122' ' ' GLY . 81.4 m -31.42 98.96 0.01 OUTLIER 'General case' 0 N--CA 1.465 0.281 0 CA-C-N 117.643 0.722 . . . . 1.0 112.421 -178.07 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 12.1 p-10 -142.83 143.25 32.05 Favored 'General case' 0 N--CA 1.45 -0.439 0 N-CA-C 108.058 -1.09 . . . . 1.0 108.058 177.352 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 125' ' ' TYR . . . . . 0.517 ' OH ' ' CD1' ' A' ' 127' ' ' PHE . 0.0 OUTLIER -153.03 149.1 27.81 Favored 'General case' 0 CA--C 1.542 0.646 0 C-N-CA 122.95 0.5 . . . . 1.0 109.682 -178.498 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 126' ' ' ARG . . . . . 0.465 ' NE ' ' O ' ' A' ' 125' ' ' TYR . 9.6 mmp_? -149.58 152.85 36.17 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.857 -0.61 . . . . 1.0 109.92 177.24 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 127' ' ' PHE . . . . . 0.517 ' CD1' ' OH ' ' A' ' 125' ' ' TYR . 10.6 p90 . . . . . 0 C--O 1.221 -0.436 0 CA-C-O 118.041 -0.981 . . . . 1.0 110.152 179.262 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 128' ' ' MTN . . . . . 0.72 ' H73' ' NE ' ' A' ' 47' ' ' ARG . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 129' ' ' MTN . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 130' ' ' MTN . . . . . 0.46 ' H62' ' CB ' ' A' ' 126' ' ' ARG . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.586 0 N-CA-C 109.083 -0.71 . . . . 1.0 109.083 . . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 2' ' ' SER . . . . . 0.414 ' O ' ' CG ' ' A' ' 3' ' ' ASP . 87.3 p -104.18 8.92 36.34 Favored 'General case' 0 N--CA 1.465 0.31 0 CA-C-N 115.672 -0.694 . . . . 1.0 110.187 -179.708 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 3' ' ' ASP . . . . . 0.414 ' CG ' ' O ' ' A' ' 2' ' ' SER . 1.6 m-20 166.44 98.32 0.0 OUTLIER 'General case' 0 CA--C 1.532 0.258 0 CA-C-N 116.163 -0.471 . . . . 1.0 109.963 178.974 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 3.4 t80 -149.68 145.84 26.93 Favored 'General case' 0 C--N 1.33 -0.251 0 N-CA-C 109.612 -0.514 . . . . 1.0 109.612 179.122 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 5' ' ' ASP . . . . . 0.631 ' O ' ' O ' ' A' ' 6' ' ' THR . 0.1 OUTLIER -155.06 154.31 32.25 Favored 'General case' 0 C--N 1.327 -0.413 0 N-CA-C 109.229 -0.656 . . . . 1.0 109.229 -179.95 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 6' ' ' THR . . . . . 0.726 HG22 ' H ' ' A' ' 7' ' ' GLU . 3.1 m -37.1 177.51 0.0 OUTLIER 'General case' 0 N--CA 1.469 0.501 0 CA-C-O 121.656 0.741 . . . . 1.0 111.646 -178.23 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 7' ' ' GLU . . . . . 0.726 ' H ' HG22 ' A' ' 6' ' ' THR . 50.9 mt-10 -66.29 -58.44 5.34 Favored 'General case' 0 C--N 1.319 -0.759 0 CA-C-N 116.231 -0.44 . . . . 1.0 110.758 -178.808 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 8' ' ' ARG . . . . . 0.409 ' HG3' ' N ' ' A' ' 9' ' ' VAL . 0.0 OUTLIER -68.55 -31.49 70.74 Favored 'General case' 0 N--CA 1.451 -0.41 0 CA-C-N 119.01 0.823 . . . . 1.0 111.029 179.477 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 9' ' ' VAL . . . . . 0.629 ' O ' HG23 ' A' ' 13' ' ' VAL . 60.0 t -66.69 -55.07 19.7 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.705 0 N-CA-C 108.228 -1.027 . . . . 1.0 108.228 179.651 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 22.9 t -68.49 -38.46 81.0 Favored 'General case' 0 C--N 1.321 -0.658 0 O-C-N 121.912 -0.493 . . . . 1.0 111.626 178.251 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 14.3 ttt-85 -74.12 -64.09 1.09 Allowed 'General case' 0 N--CA 1.453 -0.314 0 CA-C-O 118.488 -0.768 . . . . 1.0 111.361 -179.505 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 12' ' ' ALA . . . . . 0.547 ' O ' ' HB3' ' A' ' 16' ' ' ALA . . . -52.29 -30.77 29.72 Favored 'General case' 0 CA--C 1.501 -0.914 0 CA-C-N 120.319 1.418 . . . . 1.0 110.09 -179.48 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 13' ' ' VAL . . . . . 0.629 HG23 ' O ' ' A' ' 9' ' ' VAL . 3.6 t -56.27 -52.0 56.76 Favored 'Isoleucine or valine' 0 C--O 1.202 -1.43 0 N-CA-C 106.15 -1.796 . . . . 1.0 106.15 176.922 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 14' ' ' ALA . . . . . 0.615 ' O ' HG13 ' A' ' 18' ' ' VAL . . . -59.16 -63.54 1.26 Allowed 'General case' 0 CA--C 1.544 0.743 0 C-N-CA 117.395 -1.722 . . . . 1.0 110.983 177.72 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 15' ' ' ALA . . . . . 0.528 ' O ' ' N ' ' A' ' 19' ' ' GLY . . . -53.13 -54.73 31.38 Favored 'General case' 0 N--CA 1.484 1.225 0 CA-C-O 122.16 0.981 . . . . 1.0 110.844 -177.139 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 16' ' ' ALA . . . . . 0.579 ' HB1' ' CA ' ' A' ' 22' ' ' GLY . . . -63.07 -53.75 48.71 Favored 'General case' 0 C--N 1.303 -1.439 0 CA-C-N 113.915 -1.493 . . . . 1.0 108.984 -178.47 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 17' ' ' LEU . . . . . 0.607 ' CB ' ' O ' ' A' ' 13' ' ' VAL . 10.0 tp -57.47 -52.46 65.3 Favored 'General case' 0 N--CA 1.484 1.267 0 CA-C-N 114.48 -1.236 . . . . 1.0 108.576 -176.759 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 18' ' ' VAL . . . . . 0.615 HG13 ' O ' ' A' ' 14' ' ' ALA . 3.5 m -67.46 -56.56 12.9 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.245 0 C-N-CA 119.043 -1.063 . . . . 1.0 108.763 179.153 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 19' ' ' GLY . . . . . 0.528 ' N ' ' O ' ' A' ' 15' ' ' ALA . . . -61.61 -167.1 0.47 Allowed Glycine 0 CA--C 1.522 0.499 0 N-CA-C 111.58 -0.608 . . . . 1.0 111.58 -179.704 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 20' ' ' PRO . . . . . 0.627 ' O ' ' N ' ' A' ' 24' ' ' ALA . 56.1 Cg_endo -81.86 -32.71 0.75 Allowed 'Trans proline' 0 C--N 1.304 -1.773 0 C-N-CA 122.72 2.28 . . . . 1.0 114.467 -178.2 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -58.17 -57.41 19.98 Favored Glycine 0 N--CA 1.479 1.525 0 C-N-CA 120.481 -0.866 . . . . 1.0 112.318 -177.328 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 22' ' ' GLY . . . . . 0.579 ' CA ' ' HB1' ' A' ' 16' ' ' ALA . . . -58.65 -49.7 74.67 Favored Glycine 0 N--CA 1.472 1.034 0 N-CA-C 105.849 -2.9 . . . . 1.0 105.849 -176.123 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 23' ' ' VAL . . . . . 0.509 ' O ' HG12 ' A' ' 27' ' ' VAL . 2.5 t -58.7 -33.76 49.85 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.079 0 CA-C-N 114.035 -1.082 . . . . 1.0 108.355 178.334 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 24' ' ' ALA . . . . . 0.627 ' N ' ' O ' ' A' ' 20' ' ' PRO . . . -58.2 -61.9 2.22 Favored 'General case' 0 CA--C 1.536 0.413 0 C-N-CA 118.276 -1.37 . . . . 1.0 110.309 -179.511 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 56.5 mt -64.73 -42.67 95.04 Favored 'General case' 0 CA--C 1.52 -0.211 0 CA-C-N 118.982 0.81 . . . . 1.0 112.374 -177.49 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 75.1 t -60.68 -58.69 6.29 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.358 0 C-N-CA 119.096 -1.042 . . . . 1.0 109.327 -177.313 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 27' ' ' VAL . . . . . 0.509 HG12 ' O ' ' A' ' 23' ' ' VAL . 1.9 p -60.35 -34.66 58.44 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.518 0 N-CA-C 112.286 0.476 . . . . 1.0 112.286 -177.86 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 7.6 tppt? -65.55 -53.6 39.76 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-O 122.246 1.022 . . . . 1.0 109.094 -178.494 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 88.1 t -63.11 -46.58 95.68 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.125 0 CA-C-N 113.216 -1.811 . . . . 1.0 109.863 -177.231 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 30' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -65.35 -59.83 3.62 Favored 'General case' 0 N--CA 1.447 -0.602 0 C-N-CA 118.455 -1.298 . . . . 1.0 109.054 -179.419 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -60.27 -52.36 65.63 Favored 'General case' 0 CA--C 1.509 -0.619 0 N-CA-C 112.118 0.414 . . . . 1.0 112.118 -176.708 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 32' ' ' GLY . . . . . 0.471 ' O ' ' CB ' ' A' ' 33' ' ' LEU . . . 83.57 77.58 1.11 Allowed Glycine 0 CA--C 1.524 0.642 0 N-CA-C 109.918 -1.273 . . . . 1.0 109.918 -178.55 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 33' ' ' LEU . . . . . 0.471 ' CB ' ' O ' ' A' ' 32' ' ' GLY . 4.0 tp 85.02 107.84 0.03 OUTLIER Pre-proline 0 CA--C 1.548 0.884 0 O-C-N 123.885 0.403 . . . . 1.0 110.685 -179.927 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 37.6 Cg_endo -67.83 -27.51 37.32 Favored 'Trans proline' 0 N--CA 1.499 1.837 0 C-N-CA 121.632 1.555 . . . . 1.0 113.711 -179.001 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -60.83 -59.72 9.68 Favored Glycine 0 CA--C 1.525 0.694 0 C-N-CA 118.516 -1.802 . . . . 1.0 109.551 -177.564 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 36' ' ' VAL . . . . . 0.864 ' O ' HG23 ' A' ' 37' ' ' ILE . 1.7 p -84.01 142.71 13.04 Favored 'Isoleucine or valine' 0 C--O 1.211 -0.924 0 N-CA-C 106.822 -1.547 . . . . 1.0 106.822 178.011 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 37' ' ' ILE . . . . . 0.864 HG23 ' O ' ' A' ' 36' ' ' VAL . 0.6 OUTLIER 150.54 88.87 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.475 0.809 0 O-C-N 123.556 0.535 . . . . 1.0 109.75 179.694 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 26.2 m-70 -134.64 128.0 32.25 Favored 'General case' 0 C--O 1.233 0.195 0 N-CA-C 107.277 -1.379 . . . . 1.0 107.277 176.91 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 39' ' ' THR . . . . . 0.553 ' O ' ' NH2' ' A' ' 42' ' ' ARG . 1.0 OUTLIER -121.6 158.5 53.85 Favored Pre-proline 0 N--CA 1.468 0.463 0 N-CA-C 109.43 -0.581 . . . . 1.0 109.43 -179.189 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 40' ' ' PRO . . . . . 0.508 ' HG2' ' H ' ' A' ' 41' ' ' ALA . 97.4 Cg_endo -85.41 -78.76 0.0 OUTLIER 'Trans proline' 0 C--N 1.31 -1.456 0 C-N-CA 121.36 1.374 . . . . 1.0 113.306 179.99 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 41' ' ' ALA . . . . . 0.508 ' H ' ' HG2' ' A' ' 40' ' ' PRO . . . -76.11 123.3 25.59 Favored 'General case' 0 C--N 1.319 -0.737 0 CA-C-N 114.955 -1.021 . . . . 1.0 111.875 -176.802 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 42' ' ' ARG . . . . . 0.655 ' C ' ' H ' ' A' ' 44' ' ' GLY . 0.0 OUTLIER -171.14 171.06 5.89 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 114.493 -1.23 . . . . 1.0 109.502 179.071 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 8.6 tpt180 -63.53 18.07 0.01 OUTLIER 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.512 -0.767 . . . . 1.0 109.761 178.989 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 44' ' ' GLY . . . . . 0.655 ' H ' ' C ' ' A' ' 42' ' ' ARG . . . 81.38 -25.48 3.77 Favored Glycine 0 C--N 1.336 0.542 0 N-CA-C 110.731 -0.948 . . . . 1.0 110.731 179.343 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 45' ' ' PHE . . . . . 0.538 ' O ' ' CD1' ' A' ' 46' ' ' PHE . 84.9 t80 -161.72 163.23 29.81 Favored 'General case' 0 CA--C 1.535 0.388 0 N-CA-C 110.5 -0.185 . . . . 1.0 110.5 -179.328 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 46' ' ' PHE . . . . . 0.538 ' CD1' ' O ' ' A' ' 45' ' ' PHE . 3.9 m-30 136.61 86.49 0.0 OUTLIER 'General case' 0 N--CA 1.487 1.405 0 O-C-N 124.782 1.301 . . . . 1.0 110.308 179.369 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 47' ' ' ARG . . . . . 0.509 ' CB ' ' O ' ' A' ' 46' ' ' PHE . 5.2 mmp_? 132.57 140.77 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.512 0 C-N-CA 124.392 1.077 . . . . 1.0 109.642 178.568 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 48' ' ' CYS . . . . . 0.786 ' O ' ' H62' ' A' ' 129' ' ' MTN . 1.9 t 72.74 72.02 0.14 Allowed 'General case' 0 N--CA 1.451 -0.386 0 C-N-CA 120.277 -0.569 . . . . 1.0 109.672 -179.631 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 49' ' ' ASN . . . . . 0.655 ' O ' ' N ' ' A' ' 51' ' ' GLU . 0.0 OUTLIER -136.37 121.9 13.38 Favored Pre-proline 0 C--O 1.221 -0.439 0 N-CA-C 107.923 -1.14 . . . . 1.0 107.923 -179.464 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 52.4 Cg_exo -52.21 63.96 0.02 OUTLIER 'Trans proline' 0 N--CA 1.503 2.03 0 C-N-CA 121.94 1.76 . . . . 1.0 113.311 178.786 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 51' ' ' GLU . . . . . 0.655 ' N ' ' O ' ' A' ' 49' ' ' ASN . 2.5 mp0 65.05 36.79 7.15 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 120.523 0.202 . . . . 1.0 110.81 -179.978 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 52' ' ' ARG . . . . . 0.489 HH21 ' HB3' ' A' ' 86' ' ' ALA . 4.7 mtp85 -111.21 138.58 47.48 Favored 'General case' 0 N--CA 1.466 0.367 0 CA-C-N 116.515 -0.311 . . . . 1.0 110.176 179.634 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 53' ' ' ILE . . . . . 0.578 HG23 HG23 ' A' ' 55' ' ' ILE . 4.7 tp -66.54 141.38 18.07 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-O 121.836 0.826 . . . . 1.0 110.611 179.97 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 54' ' ' GLN . . . . . 0.521 ' O ' ' CG ' ' A' ' 54' ' ' GLN . 0.0 OUTLIER -63.03 80.78 0.02 OUTLIER 'General case' 0 CA--C 1.55 0.977 0 CA-C-N 113.739 -1.573 . . . . 1.0 109.915 -176.433 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 55' ' ' ILE . . . . . 0.827 HD13 ' O ' ' A' ' 55' ' ' ILE . 0.0 OUTLIER -150.05 158.38 5.65 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.875 0 O-C-N 121.038 -1.039 . . . . 1.0 110.224 178.091 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 110.43 -7.26 30.29 Favored Glycine 0 N--CA 1.474 1.17 0 N-CA-C 111.05 -0.82 . . . . 1.0 111.05 -179.522 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 57' ' ' ASP . . . . . 0.452 ' O ' ' OD1' ' A' ' 57' ' ' ASP . 42.3 p-10 -77.22 97.88 4.95 Favored 'General case' 0 C--N 1.318 -0.769 0 N-CA-C 108.079 -1.082 . . . . 1.0 108.079 177.59 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 58' ' ' TRP . . . . . . . . . . . . . 0.6 OUTLIER -88.88 175.19 7.55 Favored 'General case' 0 CA--C 1.538 0.506 0 CA-C-O 122.757 1.265 . . . . 1.0 112.321 -177.753 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 59' ' ' ARG . . . . . 0.52 ' HD2' ' H ' ' A' ' 59' ' ' ARG . 0.6 OUTLIER -88.52 -57.69 2.83 Favored 'General case' 0 C--N 1.318 -0.79 0 CA-C-N 112.479 -2.146 . . . . 1.0 112.985 179.963 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 79.0 t80 -90.73 -17.73 26.2 Favored 'General case' 0 C--O 1.245 0.866 0 CA-C-N 115.115 -0.948 . . . . 1.0 113.012 -178.553 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 61' ' ' GLU . . . . . 0.485 ' O ' ' N ' ' A' ' 65' ' ' ASP . 17.6 tt0 -77.19 -12.9 60.0 Favored 'General case' 0 N--CA 1.435 -1.214 0 O-C-N 121.844 -0.535 . . . . 1.0 110.275 -178.605 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 62' ' ' VAL . . . . . 0.576 HG23 ' H ' ' A' ' 63' ' ' ALA . 16.1 m -45.45 -55.73 1.18 Allowed 'Isoleucine or valine' 0 C--O 1.21 -1.01 0 C-N-CA 119.602 -0.839 . . . . 1.0 109.126 -175.385 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 63' ' ' ALA . . . . . 0.576 ' H ' HG23 ' A' ' 62' ' ' VAL . . . -65.43 -48.86 71.29 Favored 'General case' 0 C--N 1.306 -1.315 0 N-CA-C 109.306 -0.627 . . . . 1.0 109.306 178.721 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER -53.15 -58.85 5.61 Favored 'General case' 0 CA--C 1.539 0.533 0 C-N-CA 119.28 -0.968 . . . . 1.0 109.429 -179.084 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 65' ' ' ASP . . . . . 0.54 ' C ' ' H ' ' A' ' 67' ' ' ARG . 19.0 m-20 -65.28 -45.67 83.52 Favored 'General case' 0 C--N 1.324 -0.524 0 N-CA-C 108.849 -0.797 . . . . 1.0 108.849 178.085 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 66' ' ' GLY . . . . . 0.521 ' N ' ' O ' ' A' ' 62' ' ' VAL . . . -67.49 24.44 0.22 Allowed Glycine 0 C--N 1.338 0.655 0 N-CA-C 111.629 -0.588 . . . . 1.0 111.629 -179.976 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 67' ' ' ARG . . . . . 0.54 ' H ' ' C ' ' A' ' 65' ' ' ASP . 0.0 OUTLIER -86.36 -9.89 55.47 Favored 'General case' 0 C--N 1.315 -0.893 0 N-CA-C 108.587 -0.894 . . . . 1.0 108.587 175.602 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 68' ' ' LEU . . . . . 0.513 ' O ' ' CA ' ' A' ' 72' ' ' HIS . 1.4 pt? -63.35 -34.92 78.77 Favored 'General case' 0 N--CA 1.472 0.632 0 N-CA-C 112.97 0.73 . . . . 1.0 112.97 -177.868 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -52.29 -65.51 0.55 Allowed 'General case' 0 C--N 1.317 -0.828 0 C-N-CA 117.433 -1.707 . . . . 1.0 109.25 -177.622 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -64.7 -75.76 0.08 Allowed 'General case' 0 C--N 1.312 -1.029 0 N-CA-C 106.511 -1.662 . . . . 1.0 106.511 -179.811 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 71' ' ' ALA . . . . . 0.745 ' O ' ' N ' ' A' ' 73' ' ' MET . . . -59.56 15.74 0.01 OUTLIER 'General case' 0 C--N 1.321 -0.636 0 C-N-CA 127.172 2.189 . . . . 1.0 116.084 179.94 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 72' ' ' HIS . . . . . 0.513 ' CA ' ' O ' ' A' ' 68' ' ' LEU . 0.0 OUTLIER -21.94 -28.48 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.588 0 CA-C-N 119.638 1.108 . . . . 1.0 113.756 -176.11 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 73' ' ' MET . . . . . 0.745 ' N ' ' O ' ' A' ' 71' ' ' ALA . 4.0 mmt -63.72 -56.65 14.03 Favored 'General case' 0 C--N 1.317 -0.816 0 C-N-CA 117.64 -1.624 . . . . 1.0 106.875 174.789 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 74' ' ' VAL . . . . . 0.783 ' O ' ' N ' ' A' ' 76' ' ' GLY . 27.9 t -36.92 -51.08 0.3 Allowed 'Isoleucine or valine' 0 N--CA 1.48 1.037 0 CA-C-O 118.483 -0.77 . . . . 1.0 111.155 -175.86 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 75' ' ' ASN . . . . . 0.524 ' O ' HG12 ' A' ' 78' ' ' VAL . 1.5 t-20 -30.71 -16.64 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.492 0 CA-C-N 119.302 0.956 . . . . 1.0 113.382 -178.2 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 76' ' ' GLY . . . . . 0.783 ' N ' ' O ' ' A' ' 74' ' ' VAL . . . -48.2 -25.05 3.85 Favored Glycine 0 CA--C 1.543 1.822 0 N-CA-C 109.991 -1.243 . . . . 1.0 109.991 176.404 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 77' ' ' ILE . . . . . 0.578 HG13 ' H ' ' A' ' 78' ' ' VAL . 3.0 pt -73.29 -55.55 12.3 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.679 0 CA-C-O 122.366 1.079 . . . . 1.0 109.078 178.552 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 78' ' ' VAL . . . . . 0.578 ' H ' HG13 ' A' ' 77' ' ' ILE . 1.4 p -38.59 -34.85 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.311 -1.083 0 CA-C-N 112.395 -2.184 . . . . 1.0 105.405 -175.666 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 79' ' ' ILE . . . . . 0.728 ' O ' ' HB3' ' A' ' 83' ' ' ALA . 16.2 pt -100.06 -37.58 5.92 Favored 'Isoleucine or valine' 0 CA--C 1.554 1.126 0 N-CA-C 113.924 1.083 . . . . 1.0 113.924 176.712 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 80' ' ' ALA . . . . . 0.519 ' N ' ' O ' ' A' ' 76' ' ' GLY . . . -82.39 -12.78 57.7 Favored 'General case' 0 N--CA 1.478 0.969 0 N-CA-C 113.645 0.98 . . . . 1.0 113.645 -178.86 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 45.5 tt0 -92.17 -73.14 0.56 Allowed 'General case' 0 N--CA 1.439 -0.995 0 CA-C-O 118.918 -0.563 . . . . 1.0 112.507 -178.636 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 28.3 m-20 -93.82 -16.84 23.72 Favored 'General case' 0 C--N 1.352 0.69 0 N-CA-C 114.843 1.423 . . . . 1.0 114.843 -178.551 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 83' ' ' ALA . . . . . 0.728 ' HB3' ' O ' ' A' ' 79' ' ' ILE . . . -52.94 -41.46 64.51 Favored 'General case' 0 N--CA 1.468 0.44 0 C-N-CA 118.713 -1.195 . . . . 1.0 111.205 -177.588 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 49.5 mt -39.37 -15.71 0.01 OUTLIER 'General case' 0 CA--C 1.538 0.505 0 N-CA-C 111.869 0.322 . . . . 1.0 111.869 -179.577 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 85' ' ' ILE . . . . . 0.62 ' N ' ' O ' ' A' ' 83' ' ' ALA . 0.8 OUTLIER -96.68 -31.55 4.01 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.618 0 C-N-CA 120.973 -0.291 . . . . 1.0 111.246 178.285 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 86' ' ' ALA . . . . . 0.658 ' O ' HG22 ' A' ' 89' ' ' VAL . . . -94.64 -28.66 15.25 Favored 'General case' 0 N--CA 1.466 0.375 0 CA-C-O 120.811 0.339 . . . . 1.0 111.842 -179.408 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -54.54 -7.7 0.18 Allowed 'General case' 0 C--N 1.32 -0.703 0 C-N-CA 119.308 -0.957 . . . . 1.0 110.196 -178.781 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 88' ' ' ALA . . . . . 0.483 ' H ' ' C ' ' A' ' 86' ' ' ALA . . . -79.73 -0.85 35.93 Favored 'General case' 0 N--CA 1.472 0.655 0 CA-C-O 122.209 1.004 . . . . 1.0 109.245 179.324 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 89' ' ' VAL . . . . . 0.658 HG22 ' O ' ' A' ' 86' ' ' ALA . 3.2 m -102.01 34.53 0.36 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.54 0 CA-C-N 113.025 -1.898 . . . . 1.0 109.744 178.548 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 90' ' ' GLY . . . . . 0.612 ' C ' ' H ' ' A' ' 92' ' ' HIS . . . -67.06 -38.27 92.38 Favored Glycine 0 C--N 1.345 1.052 0 N-CA-C 111.146 -0.782 . . . . 1.0 111.146 178.575 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 91' ' ' PRO . . . . . 0.539 ' CD ' ' N ' ' A' ' 90' ' ' GLY . 80.6 Cg_exo -46.96 -8.0 0.04 OUTLIER 'Trans proline' 0 N--CA 1.488 1.199 0 C-N-CA 121.75 1.633 . . . . 1.0 110.712 177.995 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 92' ' ' HIS . . . . . 0.612 ' H ' ' C ' ' A' ' 90' ' ' GLY . 2.6 p80 -57.42 -21.05 33.95 Favored 'General case' 0 N--CA 1.439 -1.0 0 N-CA-C 108.051 -1.092 . . . . 1.0 108.051 179.949 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 93' ' ' LEU . . . . . 0.656 HD12 ' N ' ' A' ' 94' ' ' ALA . 2.3 pp -61.64 -58.52 7.76 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.764 -0.653 . . . . 1.0 109.345 178.307 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 94' ' ' ALA . . . . . 0.656 ' N ' HD12 ' A' ' 93' ' ' LEU . . . -56.01 -52.39 64.38 Favored 'General case' 0 CA--C 1.515 -0.374 0 N-CA-C 108.983 -0.747 . . . . 1.0 108.983 179.532 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 95' ' ' ARG . . . . . 0.627 ' O ' ' N ' ' A' ' 97' ' ' LEU . 33.5 ttp180 -58.95 -60.25 4.16 Favored 'General case' 0 N--CA 1.442 -0.86 0 N-CA-C 107.565 -1.272 . . . . 1.0 107.565 178.39 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 96' ' ' ALA . . . . . 0.978 ' O ' ' N ' ' A' ' 98' ' ' GLY . . . -47.18 -13.71 0.03 OUTLIER 'General case' 0 C--N 1.301 -1.533 0 O-C-N 119.104 -2.247 . . . . 1.0 111.153 -178.689 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 97' ' ' LEU . . . . . 0.688 ' O ' ' N ' ' A' ' 100' ' ' ILE . 1.3 tm? 6.91 -52.53 0.0 OUTLIER 'General case' 0 C--N 1.365 1.242 0 CA-C-O 118.13 -0.938 . . . . 1.0 108.881 -166.886 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 98' ' ' GLY . . . . . 0.978 ' N ' ' O ' ' A' ' 96' ' ' ALA . . . -49.93 -24.29 6.19 Favored Glycine 0 CA--C 1.545 1.934 0 N-CA-C 107.898 -2.081 . . . . 1.0 107.898 174.218 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 99' ' ' GLN . . . . . 0.645 ' N ' ' O ' ' A' ' 96' ' ' ALA . 19.0 mt-30 -67.68 -19.32 65.16 Favored 'General case' 0 C--N 1.364 1.222 0 C-N-CA 116.073 -2.251 . . . . 1.0 107.263 176.375 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 100' ' ' ILE . . . . . 0.688 ' N ' ' O ' ' A' ' 97' ' ' LEU . 3.4 mm -66.67 -43.6 90.16 Favored 'Isoleucine or valine' 0 C--O 1.212 -0.872 0 C-N-CA 119.171 -1.012 . . . . 1.0 109.519 177.594 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 101' ' ' VAL . . . . . 0.503 HG13 ' N ' ' A' ' 102' ' ' CYS . 4.6 p -60.27 -56.8 15.19 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.32 0 C-N-CA 116.684 -2.006 . . . . 1.0 107.483 -179.924 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 102' ' ' CYS . . . . . 0.953 ' O ' ' HB2' ' A' ' 106' ' ' ALA . 0.5 OUTLIER -51.09 -31.67 19.78 Favored 'General case' 0 C--O 1.214 -0.812 0 CA-C-O 121.223 0.535 . . . . 1.0 112.019 179.845 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 103' ' ' ARG . . . . . 0.484 HH22 ' HB3' ' A' ' 93' ' ' LEU . 3.2 ttp180 -85.34 -47.46 10.0 Favored 'General case' 0 N--CA 1.477 0.904 0 CA-C-N 115.254 -0.884 . . . . 1.0 111.745 179.545 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 104' ' ' TYR . . . . . 0.401 ' O ' ' CG ' ' A' ' 104' ' ' TYR . 8.7 t80 -49.73 -19.36 0.62 Allowed 'General case' 0 C--N 1.3 -1.571 0 CA-C-N 114.086 -1.416 . . . . 1.0 108.937 179.28 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 105' ' ' GLY . . . . . 0.475 ' O ' ' HB3' ' A' ' 106' ' ' ALA . . . -173.64 -46.52 0.05 OUTLIER Glycine 0 N--CA 1.448 -0.526 0 C-N-CA 117.967 -2.063 . . . . 1.0 110.828 179.379 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 106' ' ' ALA . . . . . 0.953 ' HB2' ' O ' ' A' ' 102' ' ' CYS . . . 69.7 82.63 0.16 Allowed 'General case' 0 N--CA 1.44 -0.963 0 N-CA-C 111.628 0.232 . . . . 1.0 111.628 -179.081 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 107' ' ' THR . . . . . 0.426 ' O ' ' CD ' ' A' ' 110' ' ' PRO . 9.4 t -92.26 3.49 55.27 Favored 'General case' 0 CA--C 1.514 -0.44 0 N-CA-C 107.304 -1.369 . . . . 1.0 107.304 177.164 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 108' ' ' VAL . . . . . 0.76 ' O ' HG12 ' A' ' 108' ' ' VAL . 62.2 t -90.65 20.11 0.64 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.526 0 CA-C-N 114.883 -1.053 . . . . 1.0 111.352 178.593 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 109' ' ' ILE . . . . . 0.688 ' N ' ' CD ' ' A' ' 110' ' ' PRO . 0.1 OUTLIER -106.07 -18.26 0.17 Allowed Pre-proline 0 CA--C 1.548 0.869 0 O-C-N 120.162 -1.586 . . . . 1.0 110.954 177.994 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 110' ' ' PRO . . . . . 0.688 ' CD ' ' N ' ' A' ' 109' ' ' ILE . 19.5 Cg_endo -59.5 -49.56 10.2 Favored 'Trans proline' 0 N--CA 1.482 0.851 0 CA-C-N 120.5 1.214 . . . . 1.0 113.095 -174.533 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 111' ' ' ASN . . . . . 0.407 ' O ' ' N ' ' A' ' 114' ' ' ALA . 29.4 t-20 -68.66 -66.78 0.53 Allowed 'General case' 0 C--O 1.217 -0.617 0 C-N-CA 118.542 -1.263 . . . . 1.0 109.55 -178.526 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 112' ' ' ILE . . . . . 0.581 ' O ' ' HB ' ' A' ' 116' ' ' ILE . 0.9 OUTLIER -48.41 -38.64 9.08 Favored 'Isoleucine or valine' 0 C--O 1.213 -0.862 0 CA-C-O 121.127 0.489 . . . . 1.0 111.659 -177.854 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 113' ' ' ASN . . . . . 0.556 ' N ' HG23 ' A' ' 112' ' ' ILE . 48.9 t30 -67.59 -40.61 84.8 Favored 'General case' 0 C--N 1.313 -1.019 0 N-CA-C 106.502 -1.666 . . . . 1.0 106.502 178.585 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 114' ' ' ALA . . . . . 0.407 ' N ' ' O ' ' A' ' 111' ' ' ASN . . . -61.16 -51.4 69.21 Favored 'General case' 0 C--N 1.306 -1.307 0 CA-C-N 112.956 -1.929 . . . . 1.0 108.249 179.198 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -80.09 -59.7 2.62 Favored 'General case' 0 CA--C 1.544 0.725 0 N-CA-C 114.782 1.401 . . . . 1.0 114.782 179.582 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 116' ' ' ILE . . . . . 0.581 ' HB ' ' O ' ' A' ' 112' ' ' ILE . 0.7 OUTLIER -47.34 -50.53 7.52 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.884 0 CA-C-N 119.483 1.038 . . . . 1.0 111.52 -178.202 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 117' ' ' GLU . . . . . 0.498 ' CG ' ' N ' ' A' ' 118' ' ' VAL . 13.3 pt-20 -43.3 -58.57 2.47 Favored 'General case' 0 C--N 1.322 -0.623 0 N-CA-C 105.701 -1.962 . . . . 1.0 105.701 -179.365 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 118' ' ' VAL . . . . . 0.498 ' N ' ' CG ' ' A' ' 117' ' ' GLU . 88.1 t -58.43 -53.37 47.5 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.069 0 C-N-CA 119.24 -0.984 . . . . 1.0 110.043 177.757 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -52.31 -71.75 0.06 Allowed 'General case' 0 CA--C 1.545 0.765 0 N-CA-C 107.805 -1.183 . . . . 1.0 107.805 -177.922 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 120' ' ' GLY . . . . . 0.531 ' N ' ' O ' ' A' ' 116' ' ' ILE . . . -70.18 -76.05 0.55 Allowed Glycine 0 CA--C 1.546 2.002 0 C-N-CA 119.737 -1.221 . . . . 1.0 111.267 -179.87 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 121' ' ' THR . . . . . 0.493 ' CB ' ' O ' ' A' ' 120' ' ' GLY . 1.9 m 148.33 -28.68 0.01 OUTLIER 'General case' 0 N--CA 1.487 1.404 0 CA-C-N 112.294 -1.953 . . . . 1.0 110.914 -178.414 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 122' ' ' GLY . . . . . 0.643 ' O ' ' N ' ' A' ' 124' ' ' ASP . . . 102.59 -17.25 53.67 Favored Glycine 0 C--O 1.224 -0.497 0 N-CA-C 107.629 -2.188 . . . . 1.0 107.629 -176.856 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 123' ' ' THR . . . . . 0.6 HG23 ' O ' ' A' ' 123' ' ' THR . 8.1 t -53.99 85.34 0.0 OUTLIER 'General case' 0 N--CA 1.466 0.34 0 N-CA-C 106.043 -1.836 . . . . 1.0 106.043 178.379 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 124' ' ' ASP . . . . . 0.643 ' N ' ' O ' ' A' ' 122' ' ' GLY . 45.3 m-20 -163.41 169.45 18.91 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 113.344 -1.753 . . . . 1.0 111.972 -179.537 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 125' ' ' TYR . . . . . . . . . . . . . 2.0 t80 -146.47 144.52 29.72 Favored 'General case' 0 CA--C 1.542 0.662 0 N-CA-C 108.461 -0.94 . . . . 1.0 108.461 176.258 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 126' ' ' ARG . . . . . 0.641 HH21 HG21 ' A' ' 79' ' ' ILE . 1.9 mtp85 -146.44 149.33 33.5 Favored 'General case' 0 N--CA 1.466 0.326 0 N-CA-C 109.446 -0.576 . . . . 1.0 109.446 177.611 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 127' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.219 -0.506 0 CA-C-O 117.869 -1.062 . . . . 1.0 109.112 179.252 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 128' ' ' MTN . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 129' ' ' MTN . . . . . 0.786 ' H62' ' O ' ' A' ' 48' ' ' CYS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 130' ' ' MTN . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.587 ' SD ' ' N ' ' A' ' 1' ' ' MET . 0.0 OUTLIER . . . . . 0 N--CA 1.493 1.682 0 N-CA-C 108.561 -0.903 . . . . 1.0 108.561 . . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 35.9 t -106.18 7.96 31.83 Favored 'General case' 0 N--CA 1.466 0.337 0 CA-C-N 116.317 -0.401 . . . . 1.0 110.361 -179.867 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 3.9 t0 167.5 96.86 0.0 OUTLIER 'General case' 0 N--CA 1.47 0.551 0 O-C-N 123.728 0.642 . . . . 1.0 110.242 179.244 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 82.7 t80 -150.34 146.29 26.65 Favored 'General case' 0 N--CA 1.463 0.191 0 CA-C-N 116.161 -0.472 . . . . 1.0 110.568 179.7 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 5' ' ' ASP . . . . . 0.51 ' N ' ' OD1' ' A' ' 5' ' ' ASP . 1.5 p30 -158.55 153.95 25.86 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 121.129 0.49 . . . . 1.0 110.407 179.984 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 6' ' ' THR . . . . . 0.614 ' O ' ' N ' ' A' ' 10' ' ' SER . 0.2 OUTLIER -69.72 170.55 10.7 Favored 'General case' 0 C--O 1.205 -1.251 0 CA-C-N 115.777 -0.647 . . . . 1.0 110.359 -179.453 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 1.6 tm-20 -55.31 -58.36 8.03 Favored 'General case' 0 C--N 1.31 -1.144 0 CA-C-N 115.367 -0.833 . . . . 1.0 109.72 -178.719 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 8' ' ' ARG . . . . . 0.583 HH11 HG13 ' A' ' 9' ' ' VAL . 5.5 tmm_? -51.52 -54.7 24.58 Favored 'General case' 0 C--N 1.311 -1.072 0 C-N-CA 119.17 -1.012 . . . . 1.0 108.599 -177.553 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 9' ' ' VAL . . . . . 0.583 HG13 HH11 ' A' ' 8' ' ' ARG . 0.0 OUTLIER -65.51 -48.76 81.69 Favored 'Isoleucine or valine' 0 CA--C 1.551 0.991 0 CA-C-N 115.673 -0.694 . . . . 1.0 110.718 178.896 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 10' ' ' SER . . . . . 0.614 ' N ' ' O ' ' A' ' 6' ' ' THR . 35.5 t -63.41 -41.11 98.71 Favored 'General case' 0 C--N 1.318 -0.778 0 N-CA-C 115.007 1.484 . . . . 1.0 115.007 -178.18 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 11' ' ' ARG . . . . . 0.597 ' O ' ' N ' ' A' ' 15' ' ' ALA . 56.9 ttm-85 -79.99 -55.11 5.19 Favored 'General case' 0 C--O 1.216 -0.704 0 CA-C-O 122.478 1.133 . . . . 1.0 108.988 176.808 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 12' ' ' ALA . . . . . 0.563 ' O ' ' HB3' ' A' ' 16' ' ' ALA . . . -45.85 -50.31 14.4 Favored 'General case' 0 N--CA 1.469 0.489 0 N-CA-C 106.361 -1.718 . . . . 1.0 106.361 -177.605 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 13' ' ' VAL . . . . . 0.602 ' O ' ' CB ' ' A' ' 17' ' ' LEU . 75.0 t -60.24 -49.8 82.75 Favored 'Isoleucine or valine' 0 C--O 1.202 -1.433 0 C-N-CA 118.265 -1.374 . . . . 1.0 107.686 177.568 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 14' ' ' ALA . . . . . 0.676 ' O ' HG13 ' A' ' 18' ' ' VAL . . . -59.01 -62.84 1.58 Allowed 'General case' 0 N--CA 1.48 1.072 0 C-N-CA 119.356 -0.938 . . . . 1.0 111.443 178.821 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 15' ' ' ALA . . . . . 0.597 ' N ' ' O ' ' A' ' 11' ' ' ARG . . . -53.43 -55.38 25.66 Favored 'General case' 0 N--CA 1.473 0.71 0 CA-C-O 121.586 0.707 . . . . 1.0 109.902 -177.77 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 16' ' ' ALA . . . . . 0.563 ' HB3' ' O ' ' A' ' 12' ' ' ALA . . . -63.91 -53.99 41.77 Favored 'General case' 0 C--N 1.314 -0.935 0 CA-C-N 114.39 -1.277 . . . . 1.0 108.879 -179.272 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 17' ' ' LEU . . . . . 0.602 ' CB ' ' O ' ' A' ' 13' ' ' VAL . 8.2 tt -56.57 -53.71 54.41 Favored 'General case' 0 N--CA 1.477 0.907 0 C-N-CA 118.698 -1.201 . . . . 1.0 109.026 -177.477 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 18' ' ' VAL . . . . . 0.676 HG13 ' O ' ' A' ' 14' ' ' ALA . 2.4 m -68.4 -55.78 14.94 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.798 0 C-N-CA 119.436 -0.906 . . . . 1.0 109.84 179.599 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 19' ' ' GLY . . . . . 0.505 ' N ' ' CG2' ' A' ' 18' ' ' VAL . . . -65.88 -174.46 5.28 Favored Glycine 0 CA--C 1.531 1.071 0 N-CA-C 111.825 -0.51 . . . . 1.0 111.825 -178.617 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 20' ' ' PRO . . . . . 0.597 ' O ' ' N ' ' A' ' 24' ' ' ALA . 1.3 Cg_endo -77.22 -23.15 10.55 Favored 'Trans proline' 0 N--CA 1.492 1.394 0 C-N-CA 123.065 2.51 . . . . 1.0 114.501 -179.123 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -59.73 -58.56 13.6 Favored Glycine 0 N--CA 1.474 1.185 0 C-N-CA 119.517 -1.325 . . . . 1.0 110.893 -177.205 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 22' ' ' GLY . . . . . 0.512 ' CA ' ' HB1' ' A' ' 16' ' ' ALA . . . -56.63 -53.37 44.23 Favored Glycine 0 C--N 1.314 -0.659 0 N-CA-C 107.231 -2.348 . . . . 1.0 107.231 -178.743 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 23' ' ' VAL . . . . . 0.586 ' O ' HG12 ' A' ' 27' ' ' VAL . 60.9 t -58.01 -31.74 42.01 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.883 0 CA-C-N 114.789 -0.705 . . . . 1.0 110.245 179.598 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 24' ' ' ALA . . . . . 0.597 ' N ' ' O ' ' A' ' 20' ' ' PRO . . . -61.54 -59.96 4.42 Favored 'General case' 0 CA--C 1.533 0.307 0 C-N-CA 118.884 -1.126 . . . . 1.0 108.61 179.888 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 19.1 tp -61.94 -47.6 84.16 Favored 'General case' 0 C--N 1.342 0.282 0 N-CA-C 112.852 0.686 . . . . 1.0 112.852 -179.099 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 89.9 t -60.03 -60.19 2.91 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.189 0 C-N-CA 119.055 -1.058 . . . . 1.0 110.105 -177.669 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 27' ' ' VAL . . . . . 0.661 ' O ' ' HB3' ' A' ' 31' ' ' ALA . 1.8 p -58.91 -35.33 55.92 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.352 0 N-CA-C 112.456 0.539 . . . . 1.0 112.456 -178.52 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 1.1 mmmm -66.08 -54.48 25.24 Favored 'General case' 0 CA--C 1.517 -0.298 0 C-N-CA 119.499 -0.881 . . . . 1.0 108.874 -178.745 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 4.0 t -65.89 -48.78 80.78 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.842 0 CA-C-N 114.016 -1.447 . . . . 1.0 111.017 -177.242 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 30' ' ' CYS . . . . . . . . . . . . . 4.8 t -64.45 -60.51 3.07 Favored 'General case' 0 N--CA 1.445 -0.721 0 C-N-CA 117.685 -1.606 . . . . 1.0 109.61 -179.837 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 31' ' ' ALA . . . . . 0.661 ' HB3' ' O ' ' A' ' 27' ' ' VAL . . . -68.2 -55.59 11.76 Favored 'General case' 0 C--N 1.331 -0.235 0 N-CA-C 114.846 1.425 . . . . 1.0 114.846 -175.163 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 32' ' ' GLY . . . . . 0.41 ' O ' ' CB ' ' A' ' 33' ' ' LEU . . . 85.69 72.9 1.28 Allowed Glycine 0 CA--C 1.534 1.223 0 C-N-CA 120.673 -0.775 . . . . 1.0 111.56 -178.76 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 33' ' ' LEU . . . . . 0.436 ' O ' ' N ' ' A' ' 35' ' ' GLY . 0.9 OUTLIER 73.0 99.36 0.04 OUTLIER Pre-proline 0 CA--C 1.554 1.101 0 C-N-CA 120.985 -0.286 . . . . 1.0 111.304 178.107 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_exo -43.45 -9.98 0.03 OUTLIER 'Trans proline' 0 N--CA 1.511 2.525 0 C-N-CA 123.92 3.08 . . . . 1.0 115.57 -179.218 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 35' ' ' GLY . . . . . 0.436 ' N ' ' O ' ' A' ' 33' ' ' LEU . . . -59.54 -59.04 11.3 Favored Glycine 0 CA--C 1.529 0.952 0 C-N-CA 118.562 -1.78 . . . . 1.0 109.189 -179.047 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 36' ' ' VAL . . . . . 0.446 HG22 ' H ' ' A' ' 36' ' ' VAL . 6.1 m -85.96 -148.1 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.332 -0.177 0 N-CA-C 109.199 -0.667 . . . . 1.0 109.199 179.422 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 37' ' ' ILE . . . . . 0.48 HD13 ' HB1' ' A' ' 31' ' ' ALA . 2.1 mp 74.71 80.03 0.04 OUTLIER 'Isoleucine or valine' 0 CA--C 1.514 -0.436 0 N-CA-C 112.819 0.674 . . . . 1.0 112.819 179.415 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 55.6 m80 -135.71 126.74 27.85 Favored 'General case' 0 C--N 1.329 -0.29 0 N-CA-C 106.514 -1.661 . . . . 1.0 106.514 176.979 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 39' ' ' THR . . . . . 0.576 ' OG1' ' NE ' ' A' ' 42' ' ' ARG . 0.0 OUTLIER -103.36 136.63 19.19 Favored Pre-proline 0 N--CA 1.469 0.492 0 N-CA-C 109.835 -0.431 . . . . 1.0 109.835 -178.968 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 32.3 Cg_exo -53.92 -32.53 68.11 Favored 'Trans proline' 0 N--CA 1.486 1.088 0 C-N-CA 121.076 1.184 . . . . 1.0 113.529 -179.68 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -128.21 132.06 48.82 Favored 'General case' 0 N--CA 1.463 0.192 0 O-C-N 122.191 -0.318 . . . . 1.0 111.226 -179.864 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 42' ' ' ARG . . . . . 0.708 ' C ' ' H ' ' A' ' 44' ' ' GLY . 12.1 mtm180 -160.39 158.57 29.78 Favored 'General case' 0 C--N 1.321 -0.665 0 N-CA-C 109.151 -0.685 . . . . 1.0 109.151 176.131 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 43' ' ' ARG . . . . . 0.416 ' C ' ' H ' ' A' ' 45' ' ' PHE . 41.9 ttt85 -60.28 23.46 0.01 OUTLIER 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 115.487 -0.779 . . . . 1.0 110.142 179.933 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 44' ' ' GLY . . . . . 0.708 ' H ' ' C ' ' A' ' 42' ' ' ARG . . . 80.68 -26.38 3.17 Favored Glycine 0 N--CA 1.445 -0.72 0 N-CA-C 110.126 -1.19 . . . . 1.0 110.126 -179.645 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 45' ' ' PHE . . . . . 0.588 ' CG ' ' C ' ' A' ' 44' ' ' GLY . 0.1 OUTLIER -179.33 -174.13 0.3 Allowed 'General case' 0 CA--C 1.537 0.464 0 C-N-CA 120.91 -0.316 . . . . 1.0 111.083 -178.801 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 46' ' ' PHE . . . . . 0.549 ' CB ' ' O ' ' A' ' 45' ' ' PHE . 15.2 t80 117.64 107.05 0.0 OUTLIER 'General case' 0 N--CA 1.488 1.428 0 O-C-N 125.044 1.465 . . . . 1.0 109.359 -179.454 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 47' ' ' ARG . . . . . 0.496 ' CB ' ' O ' ' A' ' 46' ' ' PHE . 3.9 tmm_? 100.09 167.3 0.01 OUTLIER 'General case' 0 N--CA 1.467 0.395 0 CA-C-N 115.141 -0.936 . . . . 1.0 108.632 -178.244 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 7.7 t 75.6 -18.03 0.48 Allowed 'General case' 0 N--CA 1.472 0.643 0 CA-C-O 120.646 0.26 . . . . 1.0 111.332 -179.158 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 49' ' ' ASN . . . . . 0.522 ' O ' ' N ' ' A' ' 51' ' ' GLU . 2.9 t-20 -62.2 146.27 92.69 Favored Pre-proline 0 CA--C 1.547 0.838 0 CA-C-N 116.317 -0.402 . . . . 1.0 111.909 -179.17 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 25.2 Cg_exo -60.68 66.65 0.08 OUTLIER 'Trans proline' 0 N--CA 1.501 1.94 0 C-N-CA 121.918 1.746 . . . . 1.0 111.703 177.289 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 51' ' ' GLU . . . . . 0.522 ' N ' ' O ' ' A' ' 49' ' ' ASN . 23.1 mm-40 46.76 55.73 7.44 Favored 'General case' 0 CA--C 1.554 1.096 0 N-CA-C 113.074 0.768 . . . . 1.0 113.074 177.979 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 52' ' ' ARG . . . . . 0.697 ' NH2' ' NE2' ' A' ' 92' ' ' HIS . 7.7 mtt-85 -143.57 155.72 44.38 Favored 'General case' 0 N--CA 1.498 1.928 0 CA-C-O 119.494 -0.289 . . . . 1.0 110.555 178.225 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 10.4 tp -75.75 127.94 37.24 Favored 'Isoleucine or valine' 0 CA--C 1.56 1.358 0 N-CA-C 116.258 1.947 . . . . 1.0 116.258 -174.361 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 47.3 tp60 -65.2 86.0 0.06 Allowed 'General case' 0 N--CA 1.476 0.848 0 CA-C-N 109.728 -3.396 . . . . 1.0 109.457 -177.716 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 55' ' ' ILE . . . . . 0.486 HD13 ' N ' ' A' ' 56' ' ' GLY . 0.0 OUTLIER -147.27 155.58 10.86 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.845 0 N-CA-C 109.692 -0.484 . . . . 1.0 109.692 178.151 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 56' ' ' GLY . . . . . 0.486 ' N ' HD13 ' A' ' 55' ' ' ILE . . . 107.51 -5.38 35.29 Favored Glycine 0 N--CA 1.48 1.621 0 N-CA-C 111.262 -0.735 . . . . 1.0 111.262 179.452 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -112.7 129.61 56.34 Favored 'General case' 0 C--N 1.317 -0.808 0 N-CA-C 108.206 -1.035 . . . . 1.0 108.206 178.071 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 58' ' ' TRP . . . . . 0.6 ' H ' ' HB2' ' A' ' 61' ' ' GLU . 11.5 m0 -134.25 152.36 51.78 Favored 'General case' 0 C--N 1.348 0.536 0 CA-C-O 122.333 1.063 . . . . 1.0 109.834 -179.829 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -37.73 -39.79 0.37 Allowed 'General case' 0 CA--C 1.558 1.252 0 CA-C-N 113.047 -1.888 . . . . 1.0 110.767 -177.015 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 7.3 t80 -86.29 -27.4 24.4 Favored 'General case' 0 N--CA 1.481 1.099 0 CA-C-O 121.953 0.882 . . . . 1.0 112.626 -179.434 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 61' ' ' GLU . . . . . 0.6 ' HB2' ' H ' ' A' ' 58' ' ' TRP . 39.9 mt-10 -78.64 -13.0 60.04 Favored 'General case' 0 CA--C 1.509 -0.613 0 CA-C-N 115.639 -0.709 . . . . 1.0 110.377 179.015 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 62' ' ' VAL . . . . . 0.654 ' O ' ' N ' ' A' ' 66' ' ' GLY . 49.5 t -50.01 -57.06 2.51 Favored 'Isoleucine or valine' 0 C--O 1.202 -1.401 0 C-N-CA 119.328 -0.949 . . . . 1.0 109.8 -176.806 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 63' ' ' ALA . . . . . 0.48 ' O ' ' HG3' ' A' ' 67' ' ' ARG . . . -65.27 -57.36 8.64 Favored 'General case' 0 C--N 1.307 -1.278 0 O-C-N 121.33 -0.856 . . . . 1.0 110.21 -178.669 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 40.3 t-80 -47.44 -56.92 6.01 Favored 'General case' 0 N--CA 1.472 0.67 0 O-C-N 124.171 0.919 . . . . 1.0 109.573 179.976 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 65' ' ' ASP . . . . . 0.585 ' C ' ' H ' ' A' ' 67' ' ' ARG . 30.0 t0 -74.56 -48.99 23.58 Favored 'General case' 0 C--N 1.316 -0.853 0 CA-C-N 115.476 -0.784 . . . . 1.0 111.167 179.511 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 66' ' ' GLY . . . . . 0.654 ' N ' ' O ' ' A' ' 62' ' ' VAL . . . -74.3 26.42 1.04 Allowed Glycine 0 CA--C 1.521 0.427 0 N-CA-C 109.905 -1.278 . . . . 1.0 109.905 177.35 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 67' ' ' ARG . . . . . 0.647 ' O ' ' N ' ' A' ' 69' ' ' LEU . 33.4 mtm180 -71.97 5.51 2.62 Favored 'General case' 0 CA--C 1.512 -0.516 0 N-CA-C 104.996 -2.224 . . . . 1.0 104.996 174.032 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 68' ' ' LEU . . . . . 0.578 ' H ' ' C ' ' A' ' 66' ' ' GLY . 7.9 tt -31.76 -29.13 0.01 OUTLIER 'General case' 0 N--CA 1.473 0.686 0 O-C-N 124.11 0.881 . . . . 1.0 108.948 -177.417 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 69' ' ' LEU . . . . . 0.647 ' N ' ' O ' ' A' ' 67' ' ' ARG . 1.3 mt -64.35 -65.66 0.65 Allowed 'General case' 0 C--N 1.322 -0.628 0 C-N-CA 119.341 -0.943 . . . . 1.0 108.825 178.895 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 70' ' ' ALA . . . . . 0.622 ' O ' ' N ' ' A' ' 72' ' ' HIS . . . -78.62 -76.68 0.19 Allowed 'General case' 0 N--CA 1.47 0.554 0 N-CA-C 106.376 -1.712 . . . . 1.0 106.376 177.793 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 71' ' ' ALA . . . . . 0.482 ' O ' ' C ' ' A' ' 72' ' ' HIS . . . -43.06 4.13 0.0 OUTLIER 'General case' 0 C--N 1.326 -0.437 0 N-CA-C 114.336 1.235 . . . . 1.0 114.336 177.906 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 72' ' ' HIS . . . . . 0.622 ' N ' ' O ' ' A' ' 70' ' ' ALA . 5.4 p-80 -32.21 -53.8 0.3 Allowed 'General case' 0 N--CA 1.467 0.407 0 CA-C-N 120.126 1.33 . . . . 1.0 112.11 -177.851 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 73' ' ' MET . . . . . 0.602 ' N ' ' CG ' ' A' ' 72' ' ' HIS . 4.9 tpp -73.57 -56.85 4.5 Favored 'General case' 0 C--N 1.331 -0.219 0 N-CA-C 108.017 -1.105 . . . . 1.0 108.017 177.926 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 74' ' ' VAL . . . . . 0.74 ' O ' ' N ' ' A' ' 76' ' ' GLY . 62.1 t -45.47 -42.72 3.44 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.319 0 CA-C-O 116.964 -1.493 . . . . 1.0 111.316 -176.515 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 75' ' ' ASN . . . . . 0.485 ' C ' ' N ' ' A' ' 77' ' ' ILE . 1.2 m-20 -36.55 -13.84 0.0 OUTLIER 'General case' 0 N--CA 1.501 2.078 0 CA-C-N 121.77 2.077 . . . . 1.0 111.318 177.907 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 76' ' ' GLY . . . . . 0.74 ' N ' ' O ' ' A' ' 74' ' ' VAL . . . -49.12 -20.7 2.19 Favored Glycine 0 CA--C 1.535 1.321 0 N-CA-C 106.624 -2.591 . . . . 1.0 106.624 173.035 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 77' ' ' ILE . . . . . 0.512 ' O ' ' N ' ' A' ' 81' ' ' GLU . 25.4 pt -61.21 -48.81 87.29 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.925 0 CA-C-O 117.043 -1.456 . . . . 1.0 112.159 -179.114 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 78' ' ' VAL . . . . . 0.409 HG12 ' O ' ' A' ' 75' ' ' ASN . 9.9 p -57.5 -18.49 9.22 Favored 'Isoleucine or valine' 0 C--N 1.363 1.162 0 CA-C-N 122.925 2.602 . . . . 1.0 113.069 179.444 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 79' ' ' ILE . . . . . 0.673 ' O ' ' HB3' ' A' ' 83' ' ' ALA . 0.1 OUTLIER -89.67 -38.63 11.38 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 N-CA-C 107.042 -1.466 . . . . 1.0 107.042 177.904 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -80.9 -16.67 52.96 Favored 'General case' 0 CA--C 1.538 0.483 0 CA-C-N 114.822 -1.081 . . . . 1.0 113.496 178.589 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 81' ' ' GLU . . . . . 0.512 ' N ' ' O ' ' A' ' 77' ' ' ILE . 48.2 tt0 -93.68 -71.94 0.63 Allowed 'General case' 0 N--CA 1.448 -0.543 0 CA-C-N 118.882 0.764 . . . . 1.0 112.47 -178.385 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 25.2 m-20 -89.29 -15.82 32.61 Favored 'General case' 0 CA--C 1.549 0.907 0 N-CA-C 115.717 1.747 . . . . 1.0 115.717 -178.137 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 83' ' ' ALA . . . . . 0.673 ' HB3' ' O ' ' A' ' 79' ' ' ILE . . . -54.51 -44.94 73.17 Favored 'General case' 0 N--CA 1.475 0.802 0 C-N-CA 118.747 -1.181 . . . . 1.0 111.897 -177.821 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 84' ' ' LEU . . . . . 0.741 HD13 ' O ' ' A' ' 84' ' ' LEU . 3.4 tm? -40.0 -28.74 0.06 Allowed 'General case' 0 CA--C 1.54 0.588 0 CA-C-N 119.141 0.882 . . . . 1.0 111.119 179.686 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 85' ' ' ILE . . . . . 0.421 ' N ' ' O ' ' A' ' 83' ' ' ALA . 68.1 mt -83.75 -37.13 12.99 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.509 0 CA-C-N 116.543 -0.298 . . . . 1.0 110.884 178.419 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 86' ' ' ALA . . . . . 0.77 ' O ' HG22 ' A' ' 89' ' ' VAL . . . -93.41 -26.83 17.06 Favored 'General case' 0 N--CA 1.471 0.623 0 CA-C-O 120.863 0.363 . . . . 1.0 111.324 179.855 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 87' ' ' GLU . . . . . 0.474 ' C ' ' H ' ' A' ' 89' ' ' VAL . 40.6 tp10 -54.26 -11.31 0.48 Allowed 'General case' 0 C--N 1.324 -0.514 0 CA-C-O 121.134 0.492 . . . . 1.0 110.081 -179.456 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 88' ' ' ALA . . . . . 0.407 ' N ' ' C ' ' A' ' 86' ' ' ALA . . . -74.8 2.25 10.57 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-O 122.439 1.114 . . . . 1.0 108.342 178.382 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 89' ' ' VAL . . . . . 0.77 HG22 ' O ' ' A' ' 86' ' ' ALA . 2.1 m -114.5 36.21 0.84 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.516 0 CA-C-N 112.766 -2.015 . . . . 1.0 110.334 178.914 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 90' ' ' GLY . . . . . 0.593 ' N ' ' CD ' ' A' ' 91' ' ' PRO . . . -77.59 -37.66 30.15 Favored Glycine 0 CA--C 1.534 1.26 0 N-CA-C 110.548 -1.021 . . . . 1.0 110.548 179.032 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 91' ' ' PRO . . . . . 0.593 ' CD ' ' N ' ' A' ' 90' ' ' GLY . 77.1 Cg_exo -50.63 -7.87 0.13 Allowed 'Trans proline' 0 N--CA 1.499 1.823 0 C-N-CA 122.459 2.106 . . . . 1.0 110.552 178.513 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 92' ' ' HIS . . . . . 0.697 ' NE2' ' NH2' ' A' ' 52' ' ' ARG . 0.2 OUTLIER -56.38 -12.22 1.57 Allowed 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 114.211 -1.359 . . . . 1.0 107.847 178.805 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 93' ' ' LEU . . . . . 0.62 HD12 ' N ' ' A' ' 94' ' ' ALA . 1.7 pp -68.34 -59.57 3.09 Favored 'General case' 0 CA--C 1.528 0.107 0 CA-C-N 115.493 -0.776 . . . . 1.0 109.172 178.158 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 94' ' ' ALA . . . . . 0.62 ' N ' HD12 ' A' ' 93' ' ' LEU . . . -58.22 -50.06 74.89 Favored 'General case' 0 CA--C 1.52 -0.208 0 C-N-CA 120.017 -0.673 . . . . 1.0 109.363 179.761 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 95' ' ' ARG . . . . . 0.594 ' O ' ' N ' ' A' ' 97' ' ' LEU . 17.2 tpt180 -56.72 -57.62 11.64 Favored 'General case' 0 CA--C 1.534 0.335 0 CA-C-O 123.034 1.397 . . . . 1.0 107.609 179.314 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 96' ' ' ALA . . . . . 1.046 ' O ' ' N ' ' A' ' 98' ' ' GLY . . . -49.21 -9.62 0.03 OUTLIER 'General case' 0 C--N 1.304 -1.403 0 O-C-N 118.643 -2.536 . . . . 1.0 111.126 179.395 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 97' ' ' LEU . . . . . 0.973 HD13 ' N ' ' A' ' 98' ' ' GLY . 0.0 OUTLIER 8.23 -47.81 0.0 OUTLIER 'General case' 0 N--CA 1.498 1.969 0 CA-C-O 117.361 -1.304 . . . . 1.0 109.105 -166.703 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 98' ' ' GLY . . . . . 1.046 ' N ' ' O ' ' A' ' 96' ' ' ALA . . . -48.03 -24.13 3.08 Favored Glycine 0 CA--C 1.551 2.313 0 CA-C-N 122.975 2.625 . . . . 1.0 107.071 171.998 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 99' ' ' GLN . . . . . 0.485 ' N ' ' O ' ' A' ' 96' ' ' ALA . 5.7 mm100 -69.82 -24.32 63.45 Favored 'General case' 0 C--N 1.386 2.17 0 C-N-CA 117.863 -1.535 . . . . 1.0 107.759 175.701 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 100' ' ' ILE . . . . . 0.72 ' N ' ' O ' ' A' ' 97' ' ' LEU . 10.2 mt -65.48 -45.61 92.32 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.837 0 C-N-CA 119.829 -0.748 . . . . 1.0 109.107 177.209 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 101' ' ' VAL . . . . . 0.699 ' O ' ' N ' ' A' ' 105' ' ' GLY . 21.7 t -55.23 -60.73 1.41 Allowed 'Isoleucine or valine' 0 C--O 1.214 -0.806 0 N-CA-C 108.065 -1.087 . . . . 1.0 108.065 178.723 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 102' ' ' CYS . . . . . 0.687 ' O ' ' HB2' ' A' ' 106' ' ' ALA . 0.5 OUTLIER -49.91 -22.16 1.42 Allowed 'General case' 0 C--O 1.204 -1.325 0 N-CA-C 112.768 0.655 . . . . 1.0 112.768 -179.163 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 58.8 ttt-85 -89.09 -48.13 7.62 Favored 'General case' 0 N--CA 1.485 1.292 0 CA-C-O 123.229 1.49 . . . . 1.0 112.194 179.418 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 104' ' ' TYR . . . . . 0.664 ' O ' ' CG ' ' A' ' 104' ' ' TYR . 0.0 OUTLIER -98.52 25.31 6.49 Favored 'General case' 0 C--N 1.297 -1.684 0 CA-C-N 111.663 -2.517 . . . . 1.0 107.157 177.849 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 105' ' ' GLY . . . . . 0.699 ' N ' ' O ' ' A' ' 101' ' ' VAL . . . -167.59 -100.61 0.14 Allowed Glycine 0 N--CA 1.441 -0.972 0 N-CA-C 108.725 -1.75 . . . . 1.0 108.725 179.363 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 106' ' ' ALA . . . . . 0.687 ' HB2' ' O ' ' A' ' 102' ' ' CYS . . . 73.6 59.14 0.09 Allowed 'General case' 0 N--CA 1.442 -0.827 0 CA-C-O 119.262 -0.399 . . . . 1.0 111.22 -178.6 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -80.11 5.37 14.49 Favored 'General case' 0 CA--C 1.51 -0.594 0 O-C-N 119.764 -1.835 . . . . 1.0 106.319 176.341 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 17.4 m -83.77 -53.52 11.03 Favored 'Isoleucine or valine' 0 C--N 1.347 0.472 0 C-N-CA 120.338 -0.545 . . . . 1.0 110.591 178.138 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 109' ' ' ILE . . . . . 0.654 HG23 ' HB1' ' A' ' 106' ' ' ALA . 0.1 OUTLIER -49.02 -37.7 21.01 Favored Pre-proline 0 N--CA 1.472 0.666 0 N-CA-C 115.308 1.596 . . . . 1.0 115.308 -176.894 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_exo -51.52 -49.36 17.43 Favored 'Trans proline' 0 C--N 1.311 -1.433 0 CA-C-N 122.386 1.888 . . . . 1.0 113.126 -176.475 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 87.2 m-20 -70.7 -69.05 0.39 Allowed 'General case' 0 CA--C 1.53 0.199 0 C-N-CA 118.829 -1.148 . . . . 1.0 110.915 -178.833 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 112' ' ' ILE . . . . . 0.404 HG23 ' H ' ' A' ' 112' ' ' ILE . 6.4 pt -46.22 -28.37 0.86 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.467 0 CA-C-O 121.826 0.822 . . . . 1.0 109.736 -179.477 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 113' ' ' ASN . . . . . 0.484 ' CB ' ' O ' ' A' ' 109' ' ' ILE . 34.2 t30 -61.92 -55.15 32.57 Favored 'General case' 0 CA--C 1.506 -0.733 0 CA-C-N 114.301 -1.318 . . . . 1.0 107.811 -178.976 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -61.98 -36.5 81.64 Favored 'General case' 0 N--CA 1.439 -0.976 0 CA-C-N 118.86 0.755 . . . . 1.0 112.387 -179.036 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -75.48 -58.92 2.99 Favored 'General case' 0 C--N 1.349 0.557 0 CA-C-N 120.402 1.455 . . . . 1.0 110.114 179.572 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 116' ' ' ILE . . . . . 0.537 ' O ' ' N ' ' A' ' 120' ' ' GLY . 5.0 mm -49.37 -48.87 18.63 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.663 0 CA-C-O 121.619 0.723 . . . . 1.0 109.182 -178.173 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 117' ' ' GLU . . . . . 0.501 ' O ' ' HA ' ' A' ' 121' ' ' THR . 37.7 tt0 -39.96 -60.74 0.97 Allowed 'General case' 0 C--O 1.215 -0.735 0 N-CA-C 106.213 -1.773 . . . . 1.0 106.213 179.279 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 94.2 t -59.14 -53.96 40.85 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.873 0 CA-C-N 114.973 -1.012 . . . . 1.0 109.824 178.559 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -53.09 -71.44 0.07 Allowed 'General case' 0 CA--C 1.552 1.021 0 N-CA-C 108.087 -1.079 . . . . 1.0 108.087 -178.395 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 120' ' ' GLY . . . . . 0.537 ' N ' ' O ' ' A' ' 116' ' ' ILE . . . -66.68 -76.85 0.33 Allowed Glycine 0 CA--C 1.538 1.502 0 C-N-CA 119.54 -1.314 . . . . 1.0 110.635 179.713 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 121' ' ' THR . . . . . 0.522 ' CB ' ' O ' ' A' ' 120' ' ' GLY . 2.2 m 145.43 -29.16 0.01 OUTLIER 'General case' 0 N--CA 1.486 1.359 0 CA-C-N 111.516 -2.342 . . . . 1.0 111.015 -178.451 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 122' ' ' GLY . . . . . 0.625 ' O ' ' N ' ' A' ' 124' ' ' ASP . . . 106.6 -16.12 41.0 Favored Glycine 0 C--O 1.226 -0.372 0 N-CA-C 107.763 -2.135 . . . . 1.0 107.763 -176.541 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 123' ' ' THR . . . . . 0.584 HG23 ' O ' ' A' ' 123' ' ' THR . 12.6 t -59.65 82.23 0.01 OUTLIER 'General case' 0 CA--C 1.537 0.471 0 N-CA-C 107.02 -1.474 . . . . 1.0 107.02 178.94 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 124' ' ' ASP . . . . . 0.625 ' N ' ' O ' ' A' ' 122' ' ' GLY . 27.8 m-20 -163.5 172.27 14.69 Favored 'General case' 0 N--CA 1.453 -0.302 0 CA-C-N 112.074 -2.33 . . . . 1.0 110.745 178.859 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 125' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -143.9 142.04 30.58 Favored 'General case' 0 C--N 1.32 -0.691 0 N-CA-C 107.298 -1.371 . . . . 1.0 107.298 175.846 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 126' ' ' ARG . . . . . 0.408 ' HA ' ' NE ' ' A' ' 126' ' ' ARG . 1.3 tpm_? -149.67 152.0 34.63 Favored 'General case' 0 C--N 1.33 -0.244 0 N-CA-C 110.111 -0.329 . . . . 1.0 110.111 178.772 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 127' ' ' PHE . . . . . . . . . . . . . 2.4 p90 . . . . . 0 N--CA 1.471 0.585 0 CA-C-O 117.874 -1.06 . . . . 1.0 111.12 -179.86 . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 128' ' ' MTN . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 129' ' ' MTN . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 130' ' ' MTN . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 4.7 mmt . . . . . 0 N--CA 1.491 1.613 0 N-CA-C 109.686 -0.487 . . . . 1.0 109.686 . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 34.6 t -107.45 5.06 26.88 Favored 'General case' 0 N--CA 1.467 0.422 0 CA-C-N 116.11 -0.495 . . . . 1.0 110.273 179.33 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 1.3 p30 173.96 94.59 0.01 OUTLIER 'General case' 0 CA--C 1.53 0.182 0 CA-C-N 116.032 -0.531 . . . . 1.0 111.823 -179.893 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 4' ' ' PHE . . . . . 0.429 ' O ' ' OD1' ' A' ' 5' ' ' ASP . 1.4 t80 -151.27 146.75 26.26 Favored 'General case' 0 N--CA 1.464 0.255 0 CA-C-N 116.341 -0.39 . . . . 1.0 110.25 178.937 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 5' ' ' ASP . . . . . 0.429 ' OD1' ' O ' ' A' ' 4' ' ' PHE . 0.0 OUTLIER -155.95 151.95 27.61 Favored 'General case' 0 CA--C 1.538 0.51 0 N-CA-C 109.453 -0.573 . . . . 1.0 109.453 179.523 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 6' ' ' THR . . . . . 0.685 ' O ' ' N ' ' A' ' 10' ' ' SER . 0.3 OUTLIER -69.24 168.5 14.04 Favored 'General case' 0 C--O 1.204 -1.339 0 CA-C-N 116.206 -0.452 . . . . 1.0 110.143 -179.234 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 7' ' ' GLU . . . . . 0.562 ' O ' ' N ' ' A' ' 11' ' ' ARG . 0.9 OUTLIER -58.14 -60.11 4.26 Favored 'General case' 0 C--N 1.317 -0.82 0 CA-C-O 121.352 0.596 . . . . 1.0 109.567 -177.646 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 8' ' ' ARG . . . . . 0.749 ' O ' ' HB3' ' A' ' 12' ' ' ALA . 0.0 OUTLIER -49.23 -53.78 19.84 Favored 'General case' 0 CA--C 1.545 0.751 0 N-CA-C 107.637 -1.245 . . . . 1.0 107.637 -178.304 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 9' ' ' VAL . . . . . 0.598 ' O ' ' HB ' ' A' ' 13' ' ' VAL . 0.0 OUTLIER -66.97 -50.64 62.68 Favored 'Isoleucine or valine' 0 C--O 1.196 -1.734 0 CA-C-N 115.155 -0.93 . . . . 1.0 109.794 179.294 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 10' ' ' SER . . . . . 0.685 ' N ' ' O ' ' A' ' 6' ' ' THR . 25.6 t -62.83 -63.79 1.11 Allowed 'General case' 0 C--N 1.313 -0.985 0 C-N-CA 119.595 -0.842 . . . . 1.0 111.055 -179.582 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 11' ' ' ARG . . . . . 0.562 ' N ' ' O ' ' A' ' 7' ' ' GLU . 38.2 ttm-85 -65.9 -61.35 2.11 Favored 'General case' 0 N--CA 1.466 0.366 0 C-N-CA 120.463 -0.495 . . . . 1.0 111.88 -175.945 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 12' ' ' ALA . . . . . 0.749 ' HB3' ' O ' ' A' ' 8' ' ' ARG . . . -48.66 -47.49 40.54 Favored 'General case' 0 N--CA 1.474 0.739 0 N-CA-C 107.257 -1.386 . . . . 1.0 107.257 -177.868 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 13' ' ' VAL . . . . . 0.598 ' HB ' ' O ' ' A' ' 9' ' ' VAL . 84.2 t -62.24 -51.04 77.21 Favored 'Isoleucine or valine' 0 C--O 1.205 -1.241 0 C-N-CA 118.548 -1.261 . . . . 1.0 108.187 177.098 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 14' ' ' ALA . . . . . 0.754 ' O ' HG13 ' A' ' 18' ' ' VAL . . . -55.94 -61.29 2.47 Favored 'General case' 0 C--O 1.21 -1.023 0 C-N-CA 117.933 -1.507 . . . . 1.0 108.775 -179.712 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 15' ' ' ALA . . . . . 0.578 ' O ' ' N ' ' A' ' 19' ' ' GLY . . . -52.17 -54.56 29.2 Favored 'General case' 0 N--CA 1.47 0.564 0 CA-C-O 121.467 0.651 . . . . 1.0 109.855 -178.849 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 16' ' ' ALA . . . . . 0.432 ' CB ' ' O ' ' A' ' 12' ' ' ALA . . . -63.73 -57.23 10.61 Favored 'General case' 0 C--N 1.316 -0.877 0 CA-C-N 114.994 -1.003 . . . . 1.0 109.943 -179.011 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 17' ' ' LEU . . . . . 0.586 ' N ' ' O ' ' A' ' 13' ' ' VAL . 1.2 tt -57.0 -53.29 59.71 Favored 'General case' 0 C--N 1.315 -0.916 0 CA-C-N 114.51 -1.223 . . . . 1.0 108.017 -177.85 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 18' ' ' VAL . . . . . 0.754 HG13 ' O ' ' A' ' 14' ' ' ALA . 2.4 m -68.57 -58.44 5.86 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.526 0 C-N-CA 119.446 -0.902 . . . . 1.0 109.592 178.923 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 19' ' ' GLY . . . . . 0.598 ' O ' ' CG2' ' A' ' 23' ' ' VAL . . . -55.7 -169.31 0.07 OUTLIER Glycine 0 C--O 1.213 -1.179 0 N-CA-C 110.287 -1.125 . . . . 1.0 110.287 -179.515 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 20' ' ' PRO . . . . . 0.465 ' O ' ' N ' ' A' ' 24' ' ' ALA . 1.9 Cg_endo -78.96 -32.55 1.84 Allowed 'Trans proline' 0 C--N 1.305 -1.721 0 C-N-CA 123.114 2.543 . . . . 1.0 114.625 -178.524 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -60.19 -57.88 16.89 Favored Glycine 0 N--CA 1.478 1.48 0 C-N-CA 120.164 -1.017 . . . . 1.0 113.348 -176.192 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 22' ' ' GLY . . . . . 0.408 ' N ' ' O ' ' A' ' 16' ' ' ALA . . . -55.37 -51.76 52.24 Favored Glycine 0 N--CA 1.469 0.867 0 N-CA-C 107.401 -2.28 . . . . 1.0 107.401 -176.851 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 23' ' ' VAL . . . . . 0.598 ' CG2' ' O ' ' A' ' 19' ' ' GLY . 0.1 OUTLIER -60.81 -31.45 49.52 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.999 0 N-CA-C 108.692 -0.855 . . . . 1.0 108.692 178.277 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 24' ' ' ALA . . . . . 0.465 ' N ' ' O ' ' A' ' 20' ' ' PRO . . . -58.11 -62.07 2.09 Favored 'General case' 0 C--N 1.34 0.17 0 C-N-CA 117.766 -1.573 . . . . 1.0 109.487 -179.655 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 25' ' ' LEU . . . . . 0.473 HD23 ' N ' ' A' ' 25' ' ' LEU . 0.0 OUTLIER -62.95 -46.35 88.15 Favored 'General case' 0 CA--C 1.53 0.209 0 O-C-N 121.377 -0.827 . . . . 1.0 111.599 -178.168 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 79.5 t -57.49 -57.99 7.95 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 C-N-CA 119.562 -0.855 . . . . 1.0 109.338 -178.033 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 27' ' ' VAL . . . . . 0.663 ' O ' ' HB3' ' A' ' 31' ' ' ALA . 49.0 t -60.64 -37.27 75.09 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.65 0 CA-C-O 120.663 0.268 . . . . 1.0 110.743 -178.977 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 28' ' ' LYS . . . . . 0.434 ' CG ' ' O ' ' A' ' 24' ' ' ALA . 32.5 mmtt -65.91 -56.6 10.94 Favored 'General case' 0 CA--C 1.513 -0.453 0 C-N-CA 119.693 -0.803 . . . . 1.0 109.662 -178.573 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 94.7 t -63.37 -48.21 88.31 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.011 0 CA-C-N 114.365 -1.289 . . . . 1.0 109.942 -177.624 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 30' ' ' CYS . . . . . . . . . . . . . 20.2 t -66.33 -61.1 2.19 Favored 'General case' 0 N--CA 1.443 -0.814 0 C-N-CA 118.936 -1.106 . . . . 1.0 110.372 -179.417 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 31' ' ' ALA . . . . . 0.663 ' HB3' ' O ' ' A' ' 27' ' ' VAL . . . -63.1 -52.0 64.37 Favored 'General case' 0 CA--C 1.514 -0.434 0 N-CA-C 112.057 0.392 . . . . 1.0 112.057 -176.583 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 32' ' ' GLY . . . . . 0.437 ' O ' ' HB2' ' A' ' 33' ' ' LEU . . . 82.31 69.26 1.4 Allowed Glycine 0 CA--C 1.521 0.447 0 N-CA-C 109.696 -1.362 . . . . 1.0 109.696 -178.978 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 33' ' ' LEU . . . . . 0.491 ' O ' ' O ' ' A' ' 36' ' ' VAL . 3.9 mt 90.38 82.97 0.04 OUTLIER Pre-proline 0 N--CA 1.475 0.795 0 C-N-CA 123.565 0.746 . . . . 1.0 111.858 179.583 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 53.0 Cg_exo -54.89 -25.85 45.7 Favored 'Trans proline' 0 N--CA 1.499 1.796 0 C-N-CA 123.008 2.472 . . . . 1.0 112.73 178.562 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -57.15 -58.96 11.88 Favored Glycine 0 CA--C 1.531 1.06 0 N-CA-C 108.86 -1.696 . . . . 1.0 108.86 -179.349 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 36' ' ' VAL . . . . . 0.666 ' O ' HG22 ' A' ' 37' ' ' ILE . 14.1 p -98.09 169.44 1.51 Allowed 'Isoleucine or valine' 0 C--O 1.219 -0.516 0 N-CA-C 106.602 -1.629 . . . . 1.0 106.602 176.71 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 37' ' ' ILE . . . . . 0.666 HG22 ' O ' ' A' ' 36' ' ' VAL . 8.9 tt 117.14 116.52 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.486 1.337 0 O-C-N 124.532 1.145 . . . . 1.0 110.366 -179.725 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 38' ' ' HIS . . . . . 0.496 ' CD2' ' N ' ' A' ' 38' ' ' HIS . 0.4 OUTLIER -138.03 129.13 27.34 Favored 'General case' 0 N--CA 1.463 0.193 0 N-CA-C 108.215 -1.031 . . . . 1.0 108.215 178.983 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 12.8 m -99.53 133.22 22.05 Favored Pre-proline 0 C--N 1.328 -0.367 0 N-CA-C 109.049 -0.722 . . . . 1.0 109.049 179.251 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 42.1 Cg_endo -66.33 -96.3 0.0 OUTLIER 'Trans proline' 0 N--CA 1.492 1.423 0 C-N-CA 120.926 1.084 . . . . 1.0 111.827 -179.451 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -62.48 123.78 19.22 Favored 'General case' 0 C--N 1.319 -0.748 0 CA-C-N 115.895 -0.593 . . . . 1.0 110.092 -179.06 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 42' ' ' ARG . . . . . 0.598 ' C ' ' H ' ' A' ' 44' ' ' GLY . 2.8 mmm-85 -169.75 167.32 9.46 Favored 'General case' 0 C--N 1.32 -0.713 0 N-CA-C 108.798 -0.816 . . . . 1.0 108.798 179.332 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 43' ' ' ARG . . . . . 0.586 ' HG3' ' O ' ' A' ' 45' ' ' PHE . 0.3 OUTLIER -66.48 26.71 0.02 OUTLIER 'General case' 0 C--N 1.316 -0.857 0 CA-C-N 115.157 -0.929 . . . . 1.0 110.721 179.696 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 44' ' ' GLY . . . . . 0.598 ' H ' ' C ' ' A' ' 42' ' ' ARG . . . 80.68 -26.19 3.21 Favored Glycine 0 CA--C 1.528 0.883 0 N-CA-C 111.677 -0.569 . . . . 1.0 111.677 179.758 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 45' ' ' PHE . . . . . 0.741 ' CG ' ' N ' ' A' ' 46' ' ' PHE . 0.5 OUTLIER -174.88 175.36 2.38 Favored 'General case' 0 C--O 1.2 -1.531 0 C-N-CA 120.888 -0.325 . . . . 1.0 110.95 -179.157 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 46' ' ' PHE . . . . . 0.741 ' N ' ' CG ' ' A' ' 45' ' ' PHE . 13.8 t80 161.13 13.86 0.0 OUTLIER 'General case' 0 N--CA 1.478 0.964 0 CA-C-N 116.296 -0.411 . . . . 1.0 110.997 176.429 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 47' ' ' ARG . . . . . 0.62 HH22 ' HB2' ' A' ' 31' ' ' ALA . 3.9 mtp180 -175.64 169.24 3.08 Favored 'General case' 0 C--N 1.325 -0.462 0 C-N-CA 119.831 -0.748 . . . . 1.0 110.692 -178.61 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 48' ' ' CYS . . . . . 0.868 ' O ' ' H83' ' A' ' 129' ' ' MTN . 1.2 m 72.62 69.32 0.13 Allowed 'General case' 0 N--CA 1.452 -0.373 0 N-CA-C 108.246 -1.02 . . . . 1.0 108.246 -178.437 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 49' ' ' ASN . . . . . 0.687 ' N ' ' OD1' ' A' ' 49' ' ' ASN . 0.0 OUTLIER -132.21 123.76 18.97 Favored Pre-proline 0 N--CA 1.468 0.472 0 CA-C-O 118.628 -0.701 . . . . 1.0 109.465 -179.215 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 50' ' ' PRO . . . . . 0.589 ' O ' ' CD ' ' A' ' 51' ' ' GLU . 75.0 Cg_exo -45.82 68.82 0.01 OUTLIER 'Trans proline' 0 N--CA 1.495 1.597 0 C-N-CA 121.928 1.752 . . . . 1.0 114.992 179.98 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 51' ' ' GLU . . . . . 0.668 ' N ' ' O ' ' A' ' 49' ' ' ASN . 10.3 pm0 62.98 23.39 13.99 Favored 'General case' 0 N--CA 1.472 0.653 0 C-N-CA 123.251 0.62 . . . . 1.0 112.365 -179.305 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 25.4 mtp85 -103.65 159.39 15.65 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 120.934 0.397 . . . . 1.0 111.71 -178.926 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 53' ' ' ILE . . . . . 0.479 ' O ' ' N ' ' A' ' 55' ' ' ILE . 6.8 tp -75.15 137.51 22.83 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.167 0 CA-C-O 120.95 0.405 . . . . 1.0 110.916 -179.657 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 54' ' ' GLN . . . . . 0.589 ' NE2' ' O ' ' A' ' 46' ' ' PHE . 61.8 mt-30 -60.85 81.78 0.01 OUTLIER 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.763 -0.653 . . . . 1.0 110.935 -176.507 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 55' ' ' ILE . . . . . 0.479 ' N ' ' O ' ' A' ' 53' ' ' ILE . 11.1 tt -148.58 158.8 6.98 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.358 0 CA-C-N 115.684 -0.689 . . . . 1.0 110.453 177.69 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 111.98 -2.3 27.13 Favored Glycine 0 N--CA 1.468 0.826 0 N-CA-C 111.277 -0.729 . . . . 1.0 111.277 -179.566 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 57' ' ' ASP . . . . . 0.503 ' OD2' ' NH1' ' A' ' 43' ' ' ARG . 1.6 p-10 -80.91 97.6 7.49 Favored 'General case' 0 CA--C 1.516 -0.338 0 C-N-CA 119.968 -0.693 . . . . 1.0 109.307 178.281 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 58' ' ' TRP . . . . . . . . . . . . . 6.2 m0 -88.62 173.09 8.82 Favored 'General case' 0 C--N 1.319 -0.741 0 CA-C-O 122.8 1.286 . . . . 1.0 112.526 -178.146 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 59' ' ' ARG . . . . . 0.401 ' H ' ' HD3' ' A' ' 59' ' ' ARG . 0.4 OUTLIER -85.26 -60.31 2.07 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 111.896 -2.411 . . . . 1.0 113.306 -178.433 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 75.2 t80 -90.83 -16.95 27.4 Favored 'General case' 0 N--CA 1.479 1.025 0 N-CA-C 113.74 1.015 . . . . 1.0 113.74 -178.883 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 61' ' ' GLU . . . . . 0.516 ' O ' ' N ' ' A' ' 65' ' ' ASP . 0.0 OUTLIER -77.91 -13.16 59.98 Favored 'General case' 0 C--N 1.318 -0.8 0 O-C-N 121.92 -0.487 . . . . 1.0 110.304 -179.149 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 62' ' ' VAL . . . . . 0.604 ' O ' ' N ' ' A' ' 66' ' ' GLY . 2.5 m -47.17 -55.45 1.96 Allowed 'Isoleucine or valine' 0 C--O 1.209 -1.074 0 C-N-CA 119.442 -0.903 . . . . 1.0 110.12 -176.431 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 63' ' ' ALA . . . . . 0.456 ' H ' HG23 ' A' ' 62' ' ' VAL . . . -67.2 -50.97 58.91 Favored 'General case' 0 C--N 1.307 -1.271 0 O-C-N 121.325 -0.859 . . . . 1.0 110.443 179.959 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 64' ' ' HIS . . . . . 0.513 ' O ' ' HB2' ' A' ' 67' ' ' ARG . 0.5 OUTLIER -56.3 -56.94 14.88 Favored 'General case' 0 CA--C 1.54 0.594 0 C-N-CA 119.192 -1.003 . . . . 1.0 109.359 -179.953 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 65' ' ' ASP . . . . . 0.601 ' C ' ' H ' ' A' ' 67' ' ' ARG . 25.7 t70 -72.34 -53.04 13.49 Favored 'General case' 0 C--N 1.316 -0.887 0 O-C-N 121.486 -0.759 . . . . 1.0 110.601 178.556 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 66' ' ' GLY . . . . . 0.604 ' N ' ' O ' ' A' ' 62' ' ' VAL . . . -65.25 30.35 0.12 Allowed Glycine 0 CA--C 1.526 0.753 0 O-C-N 121.151 -0.968 . . . . 1.0 111.457 179.051 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 67' ' ' ARG . . . . . 0.601 ' H ' ' C ' ' A' ' 65' ' ' ASP . 7.6 ttt85 -81.19 1.27 32.79 Favored 'General case' 0 C--N 1.32 -0.71 0 N-CA-C 107.34 -1.356 . . . . 1.0 107.34 175.662 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 68' ' ' LEU . . . . . 0.55 HD23 ' N ' ' A' ' 68' ' ' LEU . 2.1 pt? -39.52 -31.14 0.08 Allowed 'General case' 0 C--N 1.35 0.617 0 CA-C-O 121.275 0.56 . . . . 1.0 109.837 -178.459 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 69' ' ' LEU . . . . . 0.412 ' N ' ' O ' ' A' ' 67' ' ' ARG . 4.3 tt -67.91 -68.58 0.38 Allowed 'General case' 0 CA--C 1.545 0.753 0 C-N-CA 119.32 -0.952 . . . . 1.0 112.65 -175.782 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 70' ' ' ALA . . . . . 0.53 ' C ' ' H ' ' A' ' 72' ' ' HIS . . . -73.6 -78.42 0.09 Allowed 'General case' 0 N--CA 1.474 0.76 0 C-N-CA 118.653 -1.219 . . . . 1.0 109.878 -176.981 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 71' ' ' ALA . . . . . 0.809 ' O ' ' N ' ' A' ' 73' ' ' MET . . . -62.43 14.82 0.01 OUTLIER 'General case' 0 C--N 1.318 -0.779 0 C-N-CA 125.964 1.705 . . . . 1.0 112.55 179.221 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 72' ' ' HIS . . . . . 0.53 ' H ' ' C ' ' A' ' 70' ' ' ALA . 52.8 p-80 -19.02 -29.68 0.0 OUTLIER 'General case' 0 N--CA 1.468 0.452 0 N-CA-C 114.056 1.132 . . . . 1.0 114.056 -174.744 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 73' ' ' MET . . . . . 0.809 ' N ' ' O ' ' A' ' 71' ' ' ALA . 20.9 mtt -66.25 -54.91 19.38 Favored 'General case' 0 C--N 1.318 -0.789 0 C-N-CA 119.118 -1.033 . . . . 1.0 109.336 176.123 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 74' ' ' VAL . . . . . 0.634 ' O ' ' N ' ' A' ' 76' ' ' GLY . 34.6 m -43.57 -52.95 1.13 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.579 0 CA-C-O 117.298 -1.334 . . . . 1.0 111.614 -174.74 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 75' ' ' ASN . . . . . 0.575 ' N ' HG23 ' A' ' 74' ' ' VAL . 3.4 m120 -38.53 -19.79 0.01 OUTLIER 'General case' 0 N--CA 1.482 1.138 0 CA-C-N 120.603 1.547 . . . . 1.0 110.992 -179.666 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 76' ' ' GLY . . . . . 0.634 ' N ' ' O ' ' A' ' 74' ' ' VAL . . . -48.22 -24.45 3.51 Favored Glycine 0 CA--C 1.532 1.141 0 N-CA-C 107.214 -2.354 . . . . 1.0 107.214 176.664 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 77' ' ' ILE . . . . . 0.54 ' O ' ' N ' ' A' ' 81' ' ' GLU . 24.1 pt -59.02 -43.21 88.44 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.056 0 C-N-CA 119.722 -0.791 . . . . 1.0 110.941 -179.309 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 78' ' ' VAL . . . . . 0.419 ' CG2' ' OD1' ' A' ' 65' ' ' ASP . 60.6 t -56.64 -25.25 20.94 Favored 'Isoleucine or valine' 0 C--O 1.24 0.601 0 CA-C-N 121.708 2.049 . . . . 1.0 114.147 -178.887 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 79' ' ' ILE . . . . . 0.854 ' O ' ' HB2' ' A' ' 83' ' ' ALA . 0.8 OUTLIER -91.08 -37.09 8.78 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.452 0 N-CA-C 108.005 -1.109 . . . . 1.0 108.005 178.804 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 80' ' ' ALA . . . . . 0.418 ' N ' HG13 ' A' ' 79' ' ' ILE . . . -79.8 -17.54 53.13 Favored 'General case' 0 CA--C 1.545 0.772 0 CA-C-N 115.469 -0.787 . . . . 1.0 112.033 178.927 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 81' ' ' GLU . . . . . 0.54 ' N ' ' O ' ' A' ' 77' ' ' ILE . 62.5 mm-40 -91.91 -67.36 0.86 Allowed 'General case' 0 N--CA 1.447 -0.582 0 O-C-N 121.748 -0.595 . . . . 1.0 110.581 178.492 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 82' ' ' ASP . . . . . 0.519 ' O ' ' C ' ' A' ' 83' ' ' ALA . 1.5 m-20 -72.2 -18.06 61.88 Favored 'General case' 0 N--CA 1.45 -0.464 0 O-C-N 121.11 -0.994 . . . . 1.0 112.794 -178.272 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 83' ' ' ALA . . . . . 0.854 ' HB2' ' O ' ' A' ' 79' ' ' ILE . . . -21.08 -51.31 0.01 OUTLIER 'General case' 0 N--CA 1.479 0.998 0 CA-C-N 119.048 0.84 . . . . 1.0 112.464 178.656 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 84' ' ' LEU . . . . . 0.46 ' N ' ' O ' ' A' ' 82' ' ' ASP . 3.6 mm? -31.94 -39.64 0.03 OUTLIER 'General case' 0 N--CA 1.479 0.988 0 N-CA-C 111.805 0.298 . . . . 1.0 111.805 -176.627 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 85' ' ' ILE . . . . . 0.49 ' O ' ' HB3' ' A' ' 88' ' ' ALA . 67.9 mt -94.95 -40.36 11.09 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.452 0 CA-C-O 120.896 0.379 . . . . 1.0 110.764 178.407 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 86' ' ' ALA . . . . . 0.527 ' HB3' ' HA ' ' A' ' 83' ' ' ALA . . . -53.64 -59.33 4.74 Favored 'General case' 0 CA--C 1.533 0.309 0 CA-C-N 115.951 -0.568 . . . . 1.0 111.537 -178.159 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 15.1 pt-20 -62.32 -14.21 36.97 Favored 'General case' 0 CA--C 1.518 -0.276 0 C-N-CA 120.96 -0.296 . . . . 1.0 110.681 -178.996 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 88' ' ' ALA . . . . . 0.49 ' HB3' ' O ' ' A' ' 85' ' ' ILE . . . -77.18 -18.92 57.41 Favored 'General case' 0 C--N 1.325 -0.497 0 N-CA-C 108.586 -0.894 . . . . 1.0 108.586 179.109 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 89' ' ' VAL . . . . . 0.431 ' O ' ' OE2' ' A' ' 51' ' ' GLU . 35.6 m -113.97 35.19 0.91 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.22 0 CA-C-N 113.61 -1.632 . . . . 1.0 110.781 178.705 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 90' ' ' GLY . . . . . 0.633 ' C ' ' H ' ' A' ' 92' ' ' HIS . . . -69.61 -33.44 71.78 Favored Glycine 0 C--N 1.351 1.407 0 CA-C-O 119.205 -0.775 . . . . 1.0 111.99 178.243 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 91' ' ' PRO . . . . . 0.552 ' CD ' ' N ' ' A' ' 90' ' ' GLY . 78.6 Cg_exo -45.57 -4.0 0.02 OUTLIER 'Trans proline' 0 N--CA 1.501 1.941 0 C-N-CA 122.379 2.053 . . . . 1.0 112.659 177.703 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 92' ' ' HIS . . . . . 0.65 ' O ' ' HB3' ' A' ' 96' ' ' ALA . 0.0 OUTLIER -49.31 -15.52 0.14 Allowed 'General case' 0 N--CA 1.448 -0.531 0 O-C-N 123.794 0.684 . . . . 1.0 110.047 -178.718 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 93' ' ' LEU . . . . . 0.661 HD12 ' N ' ' A' ' 94' ' ' ALA . 1.7 pp -66.28 -58.06 6.17 Favored 'General case' 0 N--CA 1.445 -0.692 0 N-CA-C 108.892 -0.781 . . . . 1.0 108.892 177.095 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 94' ' ' ALA . . . . . 0.661 ' N ' HD12 ' A' ' 93' ' ' LEU . . . -59.77 -58.19 9.64 Favored 'General case' 0 N--CA 1.449 -0.489 0 N-CA-C 109.959 -0.386 . . . . 1.0 109.959 179.725 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 95' ' ' ARG . . . . . 0.613 ' O ' ' N ' ' A' ' 97' ' ' LEU . 0.0 OUTLIER -61.47 -63.53 1.24 Allowed 'General case' 0 N--CA 1.449 -0.492 0 CA-C-O 121.428 0.632 . . . . 1.0 109.572 -178.592 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 96' ' ' ALA . . . . . 0.957 ' O ' ' N ' ' A' ' 98' ' ' GLY . . . -49.44 -11.08 0.04 OUTLIER 'General case' 0 N--CA 1.438 -1.064 0 O-C-N 118.791 -2.443 . . . . 1.0 111.266 -178.911 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 97' ' ' LEU . . . . . 0.745 ' O ' ' N ' ' A' ' 100' ' ' ILE . 0.3 OUTLIER 5.89 -48.0 0.0 OUTLIER 'General case' 0 N--CA 1.487 1.419 0 C-N-CA 124.426 1.09 . . . . 1.0 110.38 -167.96 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 98' ' ' GLY . . . . . 0.957 ' N ' ' O ' ' A' ' 96' ' ' ALA . . . -51.35 -24.28 10.28 Favored Glycine 0 C--N 1.286 -2.214 0 N-CA-C 106.488 -2.645 . . . . 1.0 106.488 173.273 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 99' ' ' GLN . . . . . 0.689 ' O ' ' S1 ' ' A' ' 130' ' ' MTN . 35.1 mt-30 -65.57 -23.16 66.79 Favored 'General case' 0 C--N 1.377 1.766 0 N-CA-C 105.94 -1.874 . . . . 1.0 105.94 175.983 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 100' ' ' ILE . . . . . 0.745 ' N ' ' O ' ' A' ' 97' ' ' LEU . 1.4 tp -64.59 -37.06 79.11 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.21 0 C-N-CA 118.87 -1.132 . . . . 1.0 108.118 178.884 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 101' ' ' VAL . . . . . 0.711 ' O ' ' N ' ' A' ' 105' ' ' GLY . 88.1 t -57.62 -63.13 0.71 Allowed 'Isoleucine or valine' 0 C--O 1.216 -0.704 0 C-N-CA 119.923 -0.711 . . . . 1.0 109.687 178.713 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 102' ' ' CYS . . . . . 0.957 ' O ' ' HB2' ' A' ' 106' ' ' ALA . 0.9 OUTLIER -49.22 -17.34 0.23 Allowed 'General case' 0 CA--C 1.545 0.754 0 C-N-CA 118.36 -1.336 . . . . 1.0 111.579 -178.446 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 24.0 ttm180 -89.64 -46.71 8.44 Favored 'General case' 0 N--CA 1.479 0.998 0 CA-C-O 122.573 1.178 . . . . 1.0 111.851 178.275 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 104' ' ' TYR . . . . . 0.622 ' O ' ' CG ' ' A' ' 104' ' ' TYR . 0.0 OUTLIER -104.47 21.83 16.01 Favored 'General case' 0 CA--C 1.549 0.931 0 CA-C-N 112.684 -2.053 . . . . 1.0 110.208 178.262 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 105' ' ' GLY . . . . . 0.756 ' O ' ' N ' ' A' ' 107' ' ' THR . . . -168.26 -12.5 0.02 OUTLIER Glycine 0 C--N 1.345 1.03 0 C-N-CA 118.523 -1.798 . . . . 1.0 113.969 178.769 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 106' ' ' ALA . . . . . 0.957 ' HB2' ' O ' ' A' ' 102' ' ' CYS . . . -20.08 64.8 0.0 OUTLIER 'General case' 0 N--CA 1.479 0.98 0 N-CA-C 114.671 1.36 . . . . 1.0 114.671 -179.601 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 107' ' ' THR . . . . . 0.756 ' N ' ' O ' ' A' ' 105' ' ' GLY . 96.4 m -102.28 -4.96 24.84 Favored 'General case' 0 N--CA 1.447 -0.585 0 N-CA-C 107.532 -1.285 . . . . 1.0 107.532 177.008 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 16.9 m -95.59 11.69 4.36 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.511 0 CA-C-N 116.084 -0.507 . . . . 1.0 110.053 176.325 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 109' ' ' ILE . . . . . 0.646 ' N ' ' CD ' ' A' ' 110' ' ' PRO . 0.1 OUTLIER -112.81 -27.94 0.12 Allowed Pre-proline 0 CA--C 1.555 1.161 0 CA-C-N 119.187 0.903 . . . . 1.0 111.64 177.523 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 110' ' ' PRO . . . . . 0.646 ' CD ' ' N ' ' A' ' 109' ' ' ILE . 48.7 Cg_endo -65.86 -37.41 27.36 Favored 'Trans proline' 0 N--CA 1.496 1.643 0 C-N-CA 122.827 2.351 . . . . 1.0 113.579 -173.19 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 34.3 t30 -64.57 -67.95 0.39 Allowed 'General case' 0 CA--C 1.507 -0.686 0 C-N-CA 119.061 -1.056 . . . . 1.0 109.078 -178.186 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 112' ' ' ILE . . . . . 0.596 ' O ' HG22 ' A' ' 116' ' ' ILE . 6.3 pt -52.01 -42.54 34.64 Favored 'Isoleucine or valine' 0 C--O 1.209 -1.038 0 CA-C-O 122.065 0.936 . . . . 1.0 108.857 179.907 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 113' ' ' ASN . . . . . 0.544 ' N ' ' CG1' ' A' ' 112' ' ' ILE . 2.8 m120 -50.19 -53.57 26.98 Favored 'General case' 0 C--N 1.315 -0.922 0 CA-C-N 113.929 -1.487 . . . . 1.0 108.745 -176.738 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 114' ' ' ALA . . . . . 0.444 ' O ' ' CG2' ' A' ' 118' ' ' VAL . . . -62.97 -34.36 77.35 Favored 'General case' 0 C--N 1.311 -1.083 0 O-C-N 121.035 -1.04 . . . . 1.0 112.501 179.551 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -84.63 -60.02 2.19 Favored 'General case' 0 N--CA 1.471 0.605 0 CA-C-N 118.672 0.669 . . . . 1.0 112.684 179.095 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 116' ' ' ILE . . . . . 0.622 HG23 ' N ' ' A' ' 117' ' ' GLU . 9.9 tt -54.57 -61.87 0.89 Allowed 'Isoleucine or valine' 0 C--O 1.223 -0.313 0 CA-C-N 115.336 -0.847 . . . . 1.0 108.795 -176.998 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 117' ' ' GLU . . . . . 0.622 ' N ' HG23 ' A' ' 116' ' ' ILE . 98.2 mt-10 -45.46 -49.3 13.58 Favored 'General case' 0 C--N 1.314 -0.935 0 N-CA-C 106.501 -1.666 . . . . 1.0 106.501 -178.236 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 118' ' ' VAL . . . . . 0.444 ' CG2' ' O ' ' A' ' 114' ' ' ALA . 23.8 t -62.77 -30.18 48.8 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.689 0 CA-C-O 118.88 -0.581 . . . . 1.0 109.913 178.164 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 119' ' ' LEU . . . . . 0.573 ' N ' ' O ' ' A' ' 116' ' ' ILE . 14.3 tp -80.66 -63.01 1.5 Allowed 'General case' 0 C--N 1.351 0.653 0 CA-C-N 120.028 1.285 . . . . 1.0 108.032 178.548 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 120' ' ' GLY . . . . . 0.465 ' N ' ' O ' ' A' ' 116' ' ' ILE . . . -61.65 -86.81 0.04 OUTLIER Glycine 0 N--CA 1.434 -1.462 0 C-N-CA 117.991 -2.052 . . . . 1.0 108.415 177.839 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 121' ' ' THR . . . . . 0.433 HG22 ' C ' ' A' ' 120' ' ' GLY . 0.0 OUTLIER 171.96 -41.4 0.01 OUTLIER 'General case' 0 C--N 1.316 -0.849 0 CA-C-N 113.947 -1.127 . . . . 1.0 113.755 179.737 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 122' ' ' GLY . . . . . 0.651 ' O ' ' N ' ' A' ' 124' ' ' ASP . . . 102.17 -16.78 55.18 Favored Glycine 0 N--CA 1.472 1.069 0 N-CA-C 108.015 -2.034 . . . . 1.0 108.015 -176.959 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 123' ' ' THR . . . . . 0.663 HG23 ' O ' ' A' ' 123' ' ' THR . 1.7 t -52.62 86.84 0.0 OUTLIER 'General case' 0 CA--C 1.538 0.505 0 N-CA-C 105.479 -2.045 . . . . 1.0 105.479 179.063 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 124' ' ' ASP . . . . . 0.651 ' N ' ' O ' ' A' ' 122' ' ' GLY . 37.5 m-20 -164.48 171.65 14.35 Favored 'General case' 0 CA--C 1.522 -0.107 0 CA-C-N 114.107 -1.406 . . . . 1.0 112.018 -178.462 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 125' ' ' TYR . . . . . . . . . . . . . 26.1 t80 -148.38 145.42 28.06 Favored 'General case' 0 CA--C 1.536 0.415 0 CA-C-N 114.785 -1.098 . . . . 1.0 108.633 175.678 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 126' ' ' ARG . . . . . 0.42 HH21 ' CG2' ' A' ' 79' ' ' ILE . 2.6 mmp_? -145.5 149.4 34.56 Favored 'General case' 0 N--CA 1.474 0.765 0 N-CA-C 109.5 -0.556 . . . . 1.0 109.5 178.16 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 127' ' ' PHE . . . . . . . . . . . . . 40.4 p90 . . . . . 0 C--O 1.22 -0.454 0 CA-C-O 118.086 -0.959 . . . . 1.0 110.709 179.713 . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 128' ' ' MTN . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 129' ' ' MTN . . . . . 0.868 ' H83' ' O ' ' A' ' 48' ' ' CYS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 130' ' ' MTN . . . . . 0.689 ' S1 ' ' O ' ' A' ' 99' ' ' GLN . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.467 ' C ' ' H ' ' A' ' 3' ' ' ASP . 57.9 mtt . . . . . 0 N--CA 1.493 1.68 0 N-CA-C 108.902 -0.777 . . . . 1.0 108.902 . . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 2' ' ' SER . . . . . 0.531 ' O ' ' CG ' ' A' ' 3' ' ' ASP . 6.9 t -69.44 10.01 0.4 Allowed 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.309 -0.405 . . . . 1.0 111.013 178.915 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 3' ' ' ASP . . . . . 0.531 ' CG ' ' O ' ' A' ' 2' ' ' SER . 80.9 m-20 138.3 142.82 0.0 OUTLIER 'General case' 0 N--CA 1.486 1.326 0 O-C-N 124.564 1.165 . . . . 1.0 109.954 179.075 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 60.9 t80 -156.4 152.5 27.6 Favored 'General case' 0 N--CA 1.463 0.225 0 CA-C-N 115.932 -0.576 . . . . 1.0 110.642 179.341 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 69.9 m-20 -150.07 146.19 26.8 Favored 'General case' 0 CA--C 1.534 0.334 0 N-CA-C 109.09 -0.707 . . . . 1.0 109.09 179.435 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 6' ' ' THR . . . . . 0.802 ' O ' ' N ' ' A' ' 10' ' ' SER . 0.2 OUTLIER -87.74 177.67 6.95 Favored 'General case' 0 C--O 1.194 -1.859 0 CA-C-O 121.094 0.473 . . . . 1.0 111.314 -178.702 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 7' ' ' GLU . . . . . 0.413 ' O ' ' N ' ' A' ' 11' ' ' ARG . 7.7 tm-20 -56.54 -58.18 9.15 Favored 'General case' 0 C--N 1.312 -1.052 0 CA-C-O 121.687 0.755 . . . . 1.0 110.932 -177.894 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 8' ' ' ARG . . . . . 0.803 ' O ' ' HB3' ' A' ' 12' ' ' ALA . 48.6 ttp85 -55.01 -57.28 12.32 Favored 'General case' 0 C--N 1.318 -0.777 0 CA-C-N 114.089 -1.414 . . . . 1.0 107.8 -178.02 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 9' ' ' VAL . . . . . 0.65 ' O ' ' HB ' ' A' ' 13' ' ' VAL . 0.0 OUTLIER -66.31 -54.06 30.14 Favored 'Isoleucine or valine' 0 C--O 1.188 -2.164 0 CA-C-N 114.499 -1.228 . . . . 1.0 110.655 178.883 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 10' ' ' SER . . . . . 0.802 ' N ' ' O ' ' A' ' 6' ' ' THR . 11.0 t -67.03 -64.58 0.82 Allowed 'General case' 0 N--CA 1.486 1.369 0 CA-C-N 118.769 0.713 . . . . 1.0 112.406 -178.132 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 11' ' ' ARG . . . . . 0.511 ' O ' ' N ' ' A' ' 15' ' ' ALA . 6.7 tpt180 -63.57 -59.07 5.1 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-O 121.083 0.468 . . . . 1.0 111.371 -175.104 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 12' ' ' ALA . . . . . 0.803 ' HB3' ' O ' ' A' ' 8' ' ' ARG . . . -51.58 -46.76 63.61 Favored 'General case' 0 C--N 1.322 -0.619 0 N-CA-C 106.512 -1.662 . . . . 1.0 106.512 -176.022 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 13' ' ' VAL . . . . . 0.659 ' O ' ' N ' ' A' ' 17' ' ' LEU . 67.6 t -62.3 -50.99 77.72 Favored 'Isoleucine or valine' 0 C--O 1.2 -1.532 0 CA-C-N 114.664 -1.153 . . . . 1.0 107.931 177.499 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 14' ' ' ALA . . . . . 0.819 ' O ' HG22 ' A' ' 18' ' ' VAL . . . -57.17 -62.39 1.79 Allowed 'General case' 0 C--O 1.207 -1.138 0 C-N-CA 117.335 -1.746 . . . . 1.0 109.097 -178.723 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 15' ' ' ALA . . . . . 0.585 ' O ' ' N ' ' A' ' 19' ' ' GLY . . . -53.73 -53.91 45.57 Favored 'General case' 0 C--O 1.215 -0.753 0 O-C-N 123.843 0.714 . . . . 1.0 109.703 -178.684 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 16' ' ' ALA . . . . . 0.488 ' CB ' ' O ' ' A' ' 12' ' ' ALA . . . -63.8 -57.8 8.8 Favored 'General case' 0 N--CA 1.474 0.738 0 C-N-CA 120.022 -0.671 . . . . 1.0 110.215 -179.737 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 17' ' ' LEU . . . . . 0.659 ' N ' ' O ' ' A' ' 13' ' ' VAL . 6.1 tt -55.91 -54.53 43.61 Favored 'General case' 0 N--CA 1.48 1.072 0 CA-C-N 114.752 -1.113 . . . . 1.0 108.012 -178.013 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 18' ' ' VAL . . . . . 0.819 HG22 ' O ' ' A' ' 14' ' ' ALA . 2.2 m -69.39 -58.34 5.91 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 C-N-CA 119.374 -0.93 . . . . 1.0 109.104 179.913 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 19' ' ' GLY . . . . . 0.585 ' N ' ' O ' ' A' ' 15' ' ' ALA . . . -54.97 -167.11 0.03 OUTLIER Glycine 0 C--O 1.225 -0.44 0 N-CA-C 111.298 -0.721 . . . . 1.0 111.298 -178.276 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 20' ' ' PRO . . . . . 0.673 ' O ' ' N ' ' A' ' 24' ' ' ALA . 74.0 Cg_endo -83.6 -28.97 1.19 Allowed 'Trans proline' 0 C--N 1.296 -2.184 0 C-N-CA 122.73 2.287 . . . . 1.0 112.556 -178.582 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -62.11 -59.63 9.24 Favored Glycine 0 N--CA 1.475 1.24 0 C-N-CA 119.508 -1.33 . . . . 1.0 111.902 -176.671 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 22' ' ' GLY . . . . . 0.459 ' N ' ' O ' ' A' ' 16' ' ' ALA . . . -55.72 -51.17 56.83 Favored Glycine 0 N--CA 1.47 0.909 0 N-CA-C 106.503 -2.639 . . . . 1.0 106.503 -178.608 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 23' ' ' VAL . . . . . 0.462 ' O ' HG12 ' A' ' 27' ' ' VAL . 38.3 t -60.41 -32.58 51.47 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.607 0 C-N-CA 119.493 -0.883 . . . . 1.0 109.19 178.415 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 24' ' ' ALA . . . . . 0.673 ' N ' ' O ' ' A' ' 20' ' ' PRO . . . -59.37 -63.85 1.15 Allowed 'General case' 0 C--N 1.349 0.552 0 C-N-CA 118.761 -1.176 . . . . 1.0 110.425 -178.709 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 19.5 mt -62.18 -44.19 97.15 Favored 'General case' 0 CA--C 1.509 -0.63 0 C-N-CA 119.581 -0.848 . . . . 1.0 110.845 -177.878 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 26' ' ' VAL . . . . . 0.415 HG23 ' O ' ' A' ' 22' ' ' GLY . 71.1 t -57.88 -60.4 2.23 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.695 0 C-N-CA 119.004 -1.078 . . . . 1.0 110.012 -178.186 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 27' ' ' VAL . . . . . 0.522 ' O ' ' HB3' ' A' ' 31' ' ' ALA . 1.4 p -60.46 -36.07 67.18 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-O 120.81 0.338 . . . . 1.0 111.645 -178.31 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 21.6 ttpp -65.72 -56.27 12.93 Favored 'General case' 0 C--N 1.321 -0.673 0 N-CA-C 109.004 -0.739 . . . . 1.0 109.004 -179.645 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 94.6 t -61.06 -47.7 92.38 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.614 0 CA-C-N 115.001 -1.0 . . . . 1.0 109.743 -178.328 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 30' ' ' CYS . . . . . 0.659 ' SG ' ' N ' ' A' ' 31' ' ' ALA . 0.0 OUTLIER -66.1 -60.38 2.87 Favored 'General case' 0 C--N 1.326 -0.446 0 C-N-CA 118.79 -1.164 . . . . 1.0 110.132 -179.511 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 31' ' ' ALA . . . . . 0.659 ' N ' ' SG ' ' A' ' 30' ' ' CYS . . . -60.43 -50.98 71.42 Favored 'General case' 0 CA--C 1.507 -0.697 0 C-N-CA 120.986 -0.286 . . . . 1.0 111.093 -176.003 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 32' ' ' GLY . . . . . 0.53 ' O ' ' CB ' ' A' ' 33' ' ' LEU . . . 78.23 69.58 1.38 Allowed Glycine 0 N--CA 1.448 -0.541 0 N-CA-C 109.516 -1.434 . . . . 1.0 109.516 -178.616 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 33' ' ' LEU . . . . . 0.53 ' CB ' ' O ' ' A' ' 32' ' ' GLY . 1.2 tt 90.31 77.21 0.04 OUTLIER Pre-proline 0 CA--C 1.534 0.359 0 CA-C-N 115.176 -0.512 . . . . 1.0 110.388 -179.58 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 58.8 Cg_exo -50.47 -23.09 9.95 Favored 'Trans proline' 0 N--CA 1.492 1.415 0 C-N-CA 122.839 2.359 . . . . 1.0 112.491 179.578 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 35' ' ' GLY . . . . . 0.524 ' H ' HD23 ' A' ' 33' ' ' LEU . . . -58.03 -61.08 7.84 Favored Glycine 0 CA--C 1.538 1.53 0 C-N-CA 119.102 -1.523 . . . . 1.0 109.538 -178.616 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 36' ' ' VAL . . . . . 0.613 HG22 ' N ' ' A' ' 37' ' ' ILE . 13.5 p -94.93 171.73 1.1 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.651 0 N-CA-C 107.108 -1.441 . . . . 1.0 107.108 176.901 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 37' ' ' ILE . . . . . 0.613 ' N ' HG22 ' A' ' 36' ' ' VAL . 4.1 mm 112.79 113.54 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.484 1.249 0 O-C-N 124.614 1.196 . . . . 1.0 110.009 -179.73 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 16.9 m-70 -139.98 133.58 30.27 Favored 'General case' 0 C--N 1.332 -0.17 0 N-CA-C 108.651 -0.87 . . . . 1.0 108.651 179.2 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 11.4 m -107.84 109.79 62.27 Favored Pre-proline 0 N--CA 1.469 0.492 0 N-CA-C 109.975 -0.38 . . . . 1.0 109.975 179.99 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 40' ' ' PRO . . . . . 0.459 ' HB2' ' H ' ' A' ' 41' ' ' ALA . 79.0 Cg_exo -42.6 -90.9 0.0 OUTLIER 'Trans proline' 0 N--CA 1.493 1.444 0 C-N-CA 121.471 1.447 . . . . 1.0 112.252 -179.127 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 41' ' ' ALA . . . . . 0.459 ' H ' ' HB2' ' A' ' 40' ' ' PRO . . . -65.56 125.02 23.89 Favored 'General case' 0 C--N 1.324 -0.541 0 N-CA-C 109.447 -0.575 . . . . 1.0 109.447 -179.389 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 34.5 ptt180 -174.2 177.05 2.37 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.205 -0.452 . . . . 1.0 110.617 179.394 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 4.3 tpp180 -58.58 -45.55 88.83 Favored 'General case' 0 C--N 1.324 -0.53 0 N-CA-C 107.965 -1.124 . . . . 1.0 107.965 178.711 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 122.24 -25.11 6.77 Favored Glycine 0 N--CA 1.471 1.016 0 N-CA-C 111.134 -0.786 . . . . 1.0 111.134 -179.788 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 45' ' ' PHE . . . . . 0.543 ' O ' ' HB2' ' A' ' 46' ' ' PHE . 64.7 t80 -149.98 153.66 36.93 Favored 'General case' 0 N--CA 1.466 0.368 0 N-CA-C 107.726 -1.213 . . . . 1.0 107.726 176.812 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 46' ' ' PHE . . . . . 0.79 ' O ' ' HB2' ' A' ' 47' ' ' ARG . 2.1 m-85 128.59 95.99 0.0 OUTLIER 'General case' 0 N--CA 1.481 1.109 0 C-N-CA 126.054 1.742 . . . . 1.0 108.317 -178.735 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 47' ' ' ARG . . . . . 0.79 ' HB2' ' O ' ' A' ' 46' ' ' PHE . 0.1 OUTLIER 118.16 137.79 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.825 0 C-N-CA 124.766 1.227 . . . . 1.0 110.151 179.308 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 48' ' ' CYS . . . . . 0.678 ' O ' ' H62' ' A' ' 129' ' ' MTN . 5.4 t 71.07 78.64 0.17 Allowed 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 116.074 -0.512 . . . . 1.0 110.413 179.287 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 49' ' ' ASN . . . . . 0.523 ' O ' ' N ' ' A' ' 51' ' ' GLU . 9.4 p30 -144.66 145.43 28.23 Favored Pre-proline 0 C--N 1.324 -0.515 0 CA-C-N 115.632 -0.713 . . . . 1.0 110.838 179.753 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 50' ' ' PRO . . . . . 0.514 ' HD2' HH12 ' A' ' 52' ' ' ARG . 20.5 Cg_endo -61.27 55.48 0.1 Allowed 'Trans proline' 0 N--CA 1.494 1.524 0 C-N-CA 121.979 1.786 . . . . 1.0 113.239 179.901 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 51' ' ' GLU . . . . . 0.523 ' N ' ' O ' ' A' ' 49' ' ' ASN . 2.3 mp0 65.9 68.34 0.46 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.679 -0.691 . . . . 1.0 111.497 177.967 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 52' ' ' ARG . . . . . 0.514 HH12 ' HD2' ' A' ' 50' ' ' PRO . 7.8 mtm-85 -145.95 153.57 40.95 Favored 'General case' 0 N--CA 1.467 0.379 0 CA-C-N 115.685 -0.689 . . . . 1.0 110.468 179.157 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 53' ' ' ILE . . . . . 0.519 ' O ' ' N ' ' A' ' 55' ' ' ILE . 12.3 pt -65.65 127.99 27.72 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 CA-C-N 115.829 -0.623 . . . . 1.0 111.073 179.799 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 54' ' ' GLN . . . . . 0.468 ' O ' ' CZ ' ' A' ' 46' ' ' PHE . 4.9 pm0 -57.74 85.49 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 121.426 0.632 . . . . 1.0 109.714 -177.367 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 55' ' ' ILE . . . . . 0.519 ' N ' ' O ' ' A' ' 53' ' ' ILE . 0.5 OUTLIER -146.83 159.17 9.96 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.157 0 CA-C-N 115.066 -0.97 . . . . 1.0 110.043 178.269 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 56' ' ' GLY . . . . . 0.42 ' H ' HG13 ' A' ' 55' ' ' ILE . . . 114.23 0.61 23.75 Favored Glycine 0 C--N 1.332 0.36 0 N-CA-C 110.178 -1.169 . . . . 1.0 110.178 -178.183 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 57' ' ' ASP . . . . . 0.432 ' CG ' ' O ' ' A' ' 57' ' ' ASP . 13.2 p-10 -80.82 93.57 6.27 Favored 'General case' 0 N--CA 1.455 -0.197 0 C-N-CA 119.379 -0.929 . . . . 1.0 109.845 178.791 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 58' ' ' TRP . . . . . . . . . . . . . 10.8 m0 -88.7 169.21 11.86 Favored 'General case' 0 CA--C 1.547 0.856 0 CA-C-O 122.618 1.199 . . . . 1.0 111.63 -178.103 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 59' ' ' ARG . . . . . 0.425 ' CG ' ' H ' ' A' ' 60' ' ' TYR . 6.8 ptt85 -83.86 -60.91 1.96 Allowed 'General case' 0 C--N 1.31 -1.129 0 CA-C-N 112.119 -2.309 . . . . 1.0 113.5 -178.495 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 60' ' ' TYR . . . . . 0.425 ' H ' ' CG ' ' A' ' 59' ' ' ARG . 0.0 OUTLIER -89.19 -18.26 27.48 Favored 'General case' 0 C--O 1.248 0.998 0 N-CA-C 113.167 0.803 . . . . 1.0 113.167 -179.005 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 61' ' ' GLU . . . . . 0.519 ' O ' ' N ' ' A' ' 65' ' ' ASP . 25.0 tt0 -71.14 -12.95 61.77 Favored 'General case' 0 C--N 1.31 -1.149 0 O-C-N 121.973 -0.454 . . . . 1.0 110.662 -177.86 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 62' ' ' VAL . . . . . 0.613 HG23 ' H ' ' A' ' 63' ' ' ALA . 17.0 m -45.13 -56.26 0.96 Allowed 'Isoleucine or valine' 0 C--N 1.309 -1.188 0 C-N-CA 120.121 -0.632 . . . . 1.0 110.025 -175.124 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 63' ' ' ALA . . . . . 0.613 ' H ' HG23 ' A' ' 62' ' ' VAL . . . -65.91 -49.84 66.59 Favored 'General case' 0 N--CA 1.428 -1.53 0 CA-C-O 121.349 0.595 . . . . 1.0 109.435 179.728 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 1.8 t60 -54.04 -59.95 3.98 Favored 'General case' 0 CA--C 1.547 0.849 0 C-N-CA 119.474 -0.891 . . . . 1.0 109.934 -179.747 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 65' ' ' ASP . . . . . 0.556 ' C ' ' H ' ' A' ' 67' ' ' ARG . 2.6 t70 -66.94 -54.72 19.2 Favored 'General case' 0 C--O 1.244 0.808 0 CA-C-O 121.848 0.832 . . . . 1.0 110.729 177.851 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 66' ' ' GLY . . . . . 0.566 ' N ' ' O ' ' A' ' 62' ' ' VAL . . . -65.72 27.74 0.14 Allowed Glycine 0 CA--C 1.524 0.617 0 O-C-N 121.163 -0.961 . . . . 1.0 112.489 179.078 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 67' ' ' ARG . . . . . 0.718 ' O ' ' N ' ' A' ' 69' ' ' LEU . 1.1 mtt-85 -76.43 -1.11 25.44 Favored 'General case' 0 C--N 1.322 -0.619 0 N-CA-C 108.72 -0.844 . . . . 1.0 108.72 175.775 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 68' ' ' LEU . . . . . 0.48 ' C ' ' O ' ' A' ' 67' ' ' ARG . 0.8 OUTLIER -32.39 -26.01 0.0 OUTLIER 'General case' 0 N--CA 1.488 1.44 0 N-CA-C 107.732 -1.21 . . . . 1.0 107.732 -177.486 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 69' ' ' LEU . . . . . 0.718 ' N ' ' O ' ' A' ' 67' ' ' ARG . 20.0 tp -66.91 -67.67 0.43 Allowed 'General case' 0 CA--C 1.548 0.875 0 C-N-CA 119.342 -0.943 . . . . 1.0 108.853 177.029 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 70' ' ' ALA . . . . . 0.702 ' C ' ' H ' ' A' ' 72' ' ' HIS . . . -78.1 -73.45 0.31 Allowed 'General case' 0 N--CA 1.472 0.653 0 N-CA-C 107.577 -1.268 . . . . 1.0 107.577 179.084 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 71' ' ' ALA . . . . . 0.484 ' HB3' ' CB ' ' A' ' 67' ' ' ARG . . . -48.02 5.51 0.0 OUTLIER 'General case' 0 N--CA 1.469 0.522 0 C-N-CA 124.273 1.029 . . . . 1.0 112.261 177.81 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 72' ' ' HIS . . . . . 0.702 ' H ' ' C ' ' A' ' 70' ' ' ALA . 0.0 OUTLIER -21.87 -75.92 0.01 OUTLIER 'General case' 0 CA--C 1.516 -0.351 0 C-N-CA 123.332 0.653 . . . . 1.0 112.328 -177.956 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 73' ' ' MET . . . . . 0.636 ' H ' ' CG ' ' A' ' 72' ' ' HIS . 57.9 mtm -69.29 -45.31 69.94 Favored 'General case' 0 C--N 1.311 -1.097 0 C-N-CA 118.692 -1.203 . . . . 1.0 109.463 178.065 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 74' ' ' VAL . . . . . 0.729 ' O ' ' N ' ' A' ' 76' ' ' GLY . 85.3 t -41.1 -42.27 0.67 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.384 0 CA-C-O 118.604 -0.712 . . . . 1.0 110.167 -176.553 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 75' ' ' ASN . . . . . 0.513 ' OD1' HG21 ' A' ' 78' ' ' VAL . 0.8 OUTLIER -36.66 -15.58 0.0 OUTLIER 'General case' 0 N--CA 1.48 1.067 0 CA-C-O 121.497 0.665 . . . . 1.0 110.721 178.363 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 76' ' ' GLY . . . . . 0.729 ' N ' ' O ' ' A' ' 74' ' ' VAL . . . -43.92 -20.14 0.14 Allowed Glycine 0 CA--C 1.539 1.549 0 N-CA-C 108.734 -1.747 . . . . 1.0 108.734 176.971 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 77' ' ' ILE . . . . . 0.627 ' O ' ' N ' ' A' ' 80' ' ' ALA . 0.2 OUTLIER -73.45 -50.33 31.28 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.14 0 CA-C-O 122.274 1.035 . . . . 1.0 108.524 178.85 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 78' ' ' VAL . . . . . 0.513 HG21 ' OD1' ' A' ' 75' ' ' ASN . 93.5 t -35.54 -36.3 0.08 OUTLIER 'Isoleucine or valine' 0 CA--C 1.553 1.083 0 CA-C-N 112.092 -2.322 . . . . 1.0 107.956 -176.254 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 79' ' ' ILE . . . . . 0.563 HG13 ' O ' ' A' ' 76' ' ' GLY . 1.4 pp -95.37 -24.97 4.59 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.852 0 CA-C-N 116.195 -0.457 . . . . 1.0 111.355 177.614 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 80' ' ' ALA . . . . . 0.627 ' N ' ' O ' ' A' ' 77' ' ' ILE . . . -80.67 -14.96 57.69 Favored 'General case' 0 N--CA 1.475 0.779 0 O-C-N 122.261 -0.274 . . . . 1.0 111.564 179.278 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 33.1 tt0 -81.17 -67.88 0.74 Allowed 'General case' 0 N--CA 1.444 -0.74 0 N-CA-C 109.448 -0.575 . . . . 1.0 109.448 177.668 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 82' ' ' ASP . . . . . 0.815 ' O ' ' N ' ' A' ' 84' ' ' LEU . 89.1 m-20 -59.35 -60.52 3.73 Favored 'General case' 0 CA--C 1.504 -0.801 0 C-N-CA 119.075 -1.05 . . . . 1.0 109.039 -179.454 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 83' ' ' ALA . . . . . 0.527 ' O ' ' N ' ' A' ' 86' ' ' ALA . . . 22.83 -68.21 0.0 OUTLIER 'General case' 0 N--CA 1.484 1.235 0 O-C-N 124.852 1.345 . . . . 1.0 111.386 -179.957 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 84' ' ' LEU . . . . . 0.815 ' N ' ' O ' ' A' ' 82' ' ' ASP . 4.8 tt -29.31 -45.3 0.04 OUTLIER 'General case' 0 N--CA 1.478 0.95 0 C-N-CA 123.512 0.725 . . . . 1.0 112.666 -178.288 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 85' ' ' ILE . . . . . 0.616 ' O ' ' HB3' ' A' ' 88' ' ' ALA . 3.3 pt -91.12 -36.55 8.21 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.87 0 N-CA-C 109.384 -0.598 . . . . 1.0 109.384 178.081 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 86' ' ' ALA . . . . . 0.547 ' C ' ' H ' ' A' ' 88' ' ' ALA . . . -51.16 -55.78 16.13 Favored 'General case' 0 CA--C 1.534 0.34 0 C-N-CA 120.42 -0.512 . . . . 1.0 110.086 -178.749 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 27.3 mt-10 -61.55 5.66 0.07 Allowed 'General case' 0 C--N 1.326 -0.419 0 C-N-CA 120.656 -0.417 . . . . 1.0 110.664 -179.433 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 88' ' ' ALA . . . . . 0.616 ' HB3' ' O ' ' A' ' 85' ' ' ILE . . . -105.76 -23.98 12.6 Favored 'General case' 0 C--O 1.237 0.4 0 CA-C-N 116.402 -0.363 . . . . 1.0 110.506 179.55 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 89' ' ' VAL . . . . . 0.462 HG22 ' O ' ' A' ' 86' ' ' ALA . 9.3 m -88.63 -8.79 10.9 Favored 'Isoleucine or valine' 0 C--O 1.236 0.367 0 CA-C-N 115.98 -0.555 . . . . 1.0 109.716 179.307 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -40.92 -49.67 4.21 Favored Glycine 0 CA--C 1.535 1.301 0 CA-C-O 119.466 -0.63 . . . . 1.0 111.633 -177.999 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 85.7 Cg_exo -45.38 -27.83 3.48 Favored 'Trans proline' 0 N--CA 1.495 1.608 0 CA-C-N 120.072 1.936 . . . . 1.0 112.052 177.726 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 92' ' ' HIS . . . . . 0.51 ' ND1' ' HG2' ' A' ' 51' ' ' GLU . 25.9 t-80 -56.36 -33.91 66.13 Favored 'General case' 0 C--O 1.22 -0.476 0 N-CA-C 107.849 -1.167 . . . . 1.0 107.849 -177.607 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 93' ' ' LEU . . . . . 0.976 HD23 ' H ' ' A' ' 94' ' ' ALA . 0.5 OUTLIER -42.45 -51.85 4.85 Favored 'General case' 0 N--CA 1.473 0.697 0 C-N-CA 120.375 -0.53 . . . . 1.0 109.592 -179.833 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 94' ' ' ALA . . . . . 0.976 ' H ' HD23 ' A' ' 93' ' ' LEU . . . -56.1 -53.9 51.51 Favored 'General case' 0 N--CA 1.449 -0.513 0 N-CA-C 107.998 -1.112 . . . . 1.0 107.998 178.877 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 95' ' ' ARG . . . . . 0.596 ' C ' ' H ' ' A' ' 97' ' ' LEU . 0.2 OUTLIER -51.3 -58.57 5.83 Favored 'General case' 0 C--O 1.241 0.649 0 CA-C-O 123.358 1.551 . . . . 1.0 107.075 177.614 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 96' ' ' ALA . . . . . 0.85 ' O ' ' N ' ' A' ' 98' ' ' GLY . . . -49.24 -11.88 0.05 OUTLIER 'General case' 0 N--CA 1.427 -1.622 0 O-C-N 118.731 -2.481 . . . . 1.0 110.895 -179.842 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 97' ' ' LEU . . . . . 0.66 ' O ' ' N ' ' A' ' 100' ' ' ILE . 0.4 OUTLIER 4.79 -49.52 0.0 OUTLIER 'General case' 0 CA--C 1.511 -0.549 0 C-N-CA 124.9 1.28 . . . . 1.0 112.865 -170.101 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 98' ' ' GLY . . . . . 0.85 ' N ' ' O ' ' A' ' 96' ' ' ALA . . . -53.24 -22.41 14.43 Favored Glycine 0 N--CA 1.426 -2.008 0 N-CA-C 107.817 -2.113 . . . . 1.0 107.817 174.806 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 99' ' ' GLN . . . . . 0.652 ' O ' ' HG3' ' A' ' 103' ' ' ARG . 15.2 mm100 -71.54 -22.95 61.69 Favored 'General case' 0 CA--C 1.5 -0.975 0 C-N-CA 116.551 -2.06 . . . . 1.0 107.127 177.576 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 100' ' ' ILE . . . . . 0.66 ' N ' ' O ' ' A' ' 97' ' ' LEU . 2.8 tt -66.05 -34.78 72.54 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.135 0 O-C-N 124.797 1.311 . . . . 1.0 109.453 178.779 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 101' ' ' VAL . . . . . 0.557 ' CG1' ' N ' ' A' ' 102' ' ' CYS . 0.4 OUTLIER -57.96 -57.97 8.32 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 N-CA-C 106.852 -1.536 . . . . 1.0 106.852 -178.757 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 102' ' ' CYS . . . . . 0.681 ' O ' ' HB2' ' A' ' 106' ' ' ALA . 0.1 OUTLIER -48.99 -28.89 4.23 Favored 'General case' 0 N--CA 1.441 -0.883 0 CA-C-N 115.224 -0.898 . . . . 1.0 110.078 178.954 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 103' ' ' ARG . . . . . 0.652 ' HG3' ' O ' ' A' ' 99' ' ' GLN . 74.7 mtt-85 -72.58 -56.61 5.09 Favored 'General case' 0 N--CA 1.478 0.972 0 O-C-N 123.984 0.803 . . . . 1.0 110.085 179.063 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 104' ' ' TYR . . . . . 0.774 ' O ' ' HD1' ' A' ' 104' ' ' TYR . 0.5 OUTLIER -90.34 25.77 2.13 Favored 'General case' 0 CA--C 1.494 -1.187 0 C-N-CA 125.435 1.494 . . . . 1.0 108.44 177.291 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 105' ' ' GLY . . . . . 0.529 ' N ' ' O ' ' A' ' 101' ' ' VAL . . . -155.43 -91.02 0.08 OUTLIER Glycine 0 N--CA 1.443 -0.841 0 C-N-CA 118.793 -1.67 . . . . 1.0 109.86 176.932 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 106' ' ' ALA . . . . . 0.681 ' HB2' ' O ' ' A' ' 102' ' ' CYS . . . 58.18 114.36 0.01 OUTLIER 'General case' 0 CA--C 1.551 0.993 0 N-CA-C 108.92 -0.77 . . . . 1.0 108.92 -179.309 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 107' ' ' THR . . . . . 0.826 ' O ' ' HD2' ' A' ' 110' ' ' PRO . 5.2 m -134.7 -54.4 0.82 Allowed 'General case' 0 N--CA 1.481 1.115 0 N-CA-C 108.548 -0.908 . . . . 1.0 108.548 178.751 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 108' ' ' VAL . . . . . 0.525 ' O ' ' N ' ' A' ' 111' ' ' ASN . 16.7 m -70.85 -43.82 76.63 Favored 'Isoleucine or valine' 0 C--N 1.348 0.53 0 CA-C-O 121.993 0.901 . . . . 1.0 108.873 -179.574 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 109' ' ' ILE . . . . . 0.604 HG23 ' HD3' ' A' ' 110' ' ' PRO . 0.0 OUTLIER -39.06 -46.72 3.62 Favored Pre-proline 0 CA--C 1.553 1.065 0 CA-C-N 114.2 -1.364 . . . . 1.0 109.919 -178.179 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 110' ' ' PRO . . . . . 0.826 ' HD2' ' O ' ' A' ' 107' ' ' THR . 28.1 Cg_exo -64.43 -24.27 64.27 Favored 'Trans proline' 0 N--CA 1.504 2.108 0 C-N-CA 124.44 3.427 . . . . 1.0 111.871 177.675 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 111' ' ' ASN . . . . . 0.525 ' N ' ' O ' ' A' ' 108' ' ' VAL . 2.9 t-20 -62.3 -69.04 0.28 Allowed 'General case' 0 C--O 1.236 0.374 0 CA-C-N 115.996 -0.547 . . . . 1.0 109.74 -179.007 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 112' ' ' ILE . . . . . 0.505 ' O ' ' N ' ' A' ' 115' ' ' ALA . 0.0 OUTLIER -67.43 -36.55 76.78 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.538 0 CA-C-O 121.924 0.869 . . . . 1.0 110.13 178.777 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 113' ' ' ASN . . . . . 0.456 ' O ' ' HB3' ' A' ' 117' ' ' GLU . 10.3 t30 -48.27 -52.42 21.32 Favored 'General case' 0 C--N 1.309 -1.165 0 N-CA-C 107.266 -1.383 . . . . 1.0 107.266 -178.264 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -62.2 -24.72 67.38 Favored 'General case' 0 N--CA 1.451 -0.419 0 CA-C-N 116.378 -0.374 . . . . 1.0 110.432 177.307 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 115' ' ' ALA . . . . . 0.505 ' N ' ' O ' ' A' ' 112' ' ' ILE . . . -77.07 -59.1 2.92 Favored 'General case' 0 C--O 1.235 0.292 0 C-N-CA 119.957 -0.697 . . . . 1.0 110.799 178.419 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 116' ' ' ILE . . . . . 0.64 HG23 ' N ' ' A' ' 117' ' ' GLU . 11.5 tt -67.31 -50.54 61.79 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.571 0 CA-C-O 120.983 0.42 . . . . 1.0 110.906 -178.378 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 117' ' ' GLU . . . . . 0.64 ' N ' HG23 ' A' ' 116' ' ' ILE . 23.6 tt0 -42.63 -60.47 1.54 Allowed 'General case' 0 C--O 1.244 0.794 0 N-CA-C 108.074 -1.084 . . . . 1.0 108.074 -177.471 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 18.7 t -51.71 -23.48 3.38 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.086 0 CA-C-N 114.261 -1.336 . . . . 1.0 109.357 177.662 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 119' ' ' LEU . . . . . 0.623 ' N ' ' O ' ' A' ' 116' ' ' ILE . 2.5 tp -81.68 -62.67 1.58 Allowed 'General case' 0 C--N 1.344 0.328 0 C-N-CA 120.304 -0.558 . . . . 1.0 111.468 179.108 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -67.6 -86.77 0.08 OUTLIER Glycine 0 C--N 1.355 1.622 0 C-N-CA 117.421 -2.323 . . . . 1.0 110.417 179.756 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 38.3 m -162.61 -25.45 0.04 OUTLIER 'General case' 0 C--N 1.32 -0.682 0 N-CA-C 107.364 -1.347 . . . . 1.0 107.364 -179.962 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 122' ' ' GLY . . . . . 0.479 ' O ' ' N ' ' A' ' 124' ' ' ASP . . . 114.32 -35.79 4.28 Favored Glycine 0 C--N 1.347 1.152 0 C-N-CA 125.32 1.438 . . . . 1.0 113.539 178.907 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 123' ' ' THR . . . . . 0.458 HG23 ' O ' ' A' ' 123' ' ' THR . 1.8 t -33.21 92.12 0.01 OUTLIER 'General case' 0 N--CA 1.473 0.705 0 CA-C-N 120.124 1.962 . . . . 1.0 113.344 -179.124 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 124' ' ' ASP . . . . . 0.479 ' N ' ' O ' ' A' ' 122' ' ' GLY . 22.6 m-20 -142.65 143.22 32.27 Favored 'General case' 0 C--N 1.328 -0.344 0 N-CA-C 108.49 -0.93 . . . . 1.0 108.49 177.655 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 125' ' ' TYR . . . . . . . . . . . . . 11.2 t80 -148.64 143.19 26.37 Favored 'General case' 0 CA--C 1.536 0.412 0 N-CA-C 109.247 -0.649 . . . . 1.0 109.247 -179.591 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 126' ' ' ARG . . . . . 0.497 ' HB2' ' H63' ' A' ' 130' ' ' MTN . 4.0 mmp_? -151.76 155.15 37.67 Favored 'General case' 0 CA--C 1.535 0.372 0 CA-C-N 116.259 -0.428 . . . . 1.0 110.59 178.54 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 127' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--O 1.218 -0.576 0 CA-C-O 118.193 -0.908 . . . . 1.0 109.726 178.476 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 128' ' ' MTN . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 129' ' ' MTN . . . . . 0.678 ' H62' ' O ' ' A' ' 48' ' ' CYS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 130' ' ' MTN . . . . . 0.599 ' H92' ' HG2' ' A' ' 103' ' ' ARG . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 24.5 mmt . . . . . 0 N--CA 1.495 1.802 0 N-CA-C 109.081 -0.711 . . . . 1.0 109.081 . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 2' ' ' SER . . . . . 0.438 ' O ' ' OD1' ' A' ' 3' ' ' ASP . 58.3 p -108.84 11.23 26.29 Favored 'General case' 0 N--CA 1.469 0.495 0 C-N-CA 122.957 0.503 . . . . 1.0 110.247 179.489 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 3' ' ' ASP . . . . . 0.438 ' OD1' ' O ' ' A' ' 2' ' ' SER . 2.2 m-20 166.67 91.54 0.0 OUTLIER 'General case' 0 N--CA 1.468 0.429 0 CA-C-N 116.321 -0.4 . . . . 1.0 110.044 179.615 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 76.2 t80 -147.98 143.68 27.46 Favored 'General case' 0 C--N 1.332 -0.156 0 N-CA-C 109.993 -0.373 . . . . 1.0 109.993 179.364 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 5' ' ' ASP . . . . . 0.451 ' N ' ' OD1' ' A' ' 5' ' ' ASP . 0.3 OUTLIER -153.38 149.0 27.36 Favored 'General case' 0 CA--C 1.534 0.359 0 CA-C-N 116.657 -0.247 . . . . 1.0 110.361 -178.916 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 6' ' ' THR . . . . . 0.733 ' O ' ' N ' ' A' ' 10' ' ' SER . 62.6 p -70.39 -178.56 1.77 Allowed 'General case' 0 C--O 1.202 -1.439 0 C-N-CA 121.155 -0.218 . . . . 1.0 110.838 179.888 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 7' ' ' GLU . . . . . 0.483 ' O ' ' N ' ' A' ' 11' ' ' ARG . 0.0 OUTLIER -58.71 -56.14 25.99 Favored 'General case' 0 N--CA 1.48 1.025 0 CA-C-O 121.645 0.736 . . . . 1.0 110.785 -177.631 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 8' ' ' ARG . . . . . 0.806 ' O ' ' HB3' ' A' ' 12' ' ' ALA . 65.1 ttt180 -50.95 -56.49 12.15 Favored 'General case' 0 C--N 1.32 -0.716 0 N-CA-C 106.723 -1.584 . . . . 1.0 106.723 -178.562 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 9' ' ' VAL . . . . . 0.577 ' O ' ' CG2' ' A' ' 13' ' ' VAL . 48.7 t -65.91 -49.72 75.0 Favored 'Isoleucine or valine' 0 C--O 1.2 -1.514 0 CA-C-N 113.641 -1.618 . . . . 1.0 110.761 179.136 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 10' ' ' SER . . . . . 0.733 ' N ' ' O ' ' A' ' 6' ' ' THR . 38.9 t -67.68 -65.41 0.69 Allowed 'General case' 0 N--CA 1.478 0.97 0 O-C-N 121.585 -0.697 . . . . 1.0 112.436 -178.391 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 11' ' ' ARG . . . . . 0.52 ' O ' ' N ' ' A' ' 15' ' ' ALA . 21.6 ttt180 -65.38 -58.61 5.44 Favored 'General case' 0 N--CA 1.467 0.399 0 C-N-CA 120.749 -0.381 . . . . 1.0 111.491 -175.966 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 12' ' ' ALA . . . . . 0.806 ' HB3' ' O ' ' A' ' 8' ' ' ARG . . . -49.82 -49.2 49.8 Favored 'General case' 0 N--CA 1.473 0.703 0 N-CA-C 106.449 -1.686 . . . . 1.0 106.449 -176.937 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 13' ' ' VAL . . . . . 0.577 ' CG2' ' O ' ' A' ' 9' ' ' VAL . 93.9 t -60.71 -48.55 88.26 Favored 'Isoleucine or valine' 0 C--O 1.202 -1.412 0 C-N-CA 118.061 -1.456 . . . . 1.0 108.149 176.745 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 14' ' ' ALA . . . . . 0.667 ' O ' HG13 ' A' ' 18' ' ' VAL . . . -57.25 -61.96 2.1 Favored 'General case' 0 C--O 1.211 -0.934 0 C-N-CA 118.088 -1.445 . . . . 1.0 109.636 -179.849 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 15' ' ' ALA . . . . . 0.527 ' O ' ' N ' ' A' ' 19' ' ' GLY . . . -52.42 -54.64 29.43 Favored 'General case' 0 N--CA 1.473 0.721 0 CA-C-O 121.702 0.763 . . . . 1.0 109.857 -178.342 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 16' ' ' ALA . . . . . 0.567 ' C ' ' H ' ' A' ' 22' ' ' GLY . . . -61.88 -55.11 33.16 Favored 'General case' 0 C--N 1.309 -1.154 0 CA-C-N 114.57 -1.196 . . . . 1.0 109.051 -179.023 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 17' ' ' LEU . . . . . 0.567 ' N ' ' O ' ' A' ' 13' ' ' VAL . 6.7 tp -56.41 -53.22 59.94 Favored 'General case' 0 N--CA 1.478 0.96 0 CA-C-N 113.726 -1.579 . . . . 1.0 108.638 -177.504 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 18' ' ' VAL . . . . . 0.667 HG13 ' O ' ' A' ' 14' ' ' ALA . 3.5 m -68.02 -56.43 12.89 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.258 0 N-CA-C 108.63 -0.878 . . . . 1.0 108.63 179.262 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 19' ' ' GLY . . . . . 0.527 ' N ' ' O ' ' A' ' 15' ' ' ALA . . . -64.77 -171.69 2.81 Favored Glycine 0 CA--C 1.521 0.423 0 N-CA-C 110.28 -1.128 . . . . 1.0 110.28 179.571 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 20' ' ' PRO . . . . . 0.657 ' O ' ' N ' ' A' ' 24' ' ' ALA . 43.7 Cg_endo -80.63 -21.37 7.31 Favored 'Trans proline' 0 C--N 1.301 -1.942 0 C-N-CA 122.115 1.876 . . . . 1.0 113.097 -179.316 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -56.73 -58.13 16.03 Favored Glycine 0 CA--C 1.535 1.33 0 C-N-CA 119.488 -1.339 . . . . 1.0 110.355 -177.725 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 22' ' ' GLY . . . . . 0.567 ' H ' ' C ' ' A' ' 16' ' ' ALA . . . -62.68 -53.1 43.79 Favored Glycine 0 N--CA 1.471 0.976 0 N-CA-C 108.13 -1.988 . . . . 1.0 108.13 -179.845 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 23' ' ' VAL . . . . . 0.705 ' O ' HG12 ' A' ' 27' ' ' VAL . 0.5 OUTLIER -56.44 -38.38 55.76 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.737 0 N-CA-C 108.316 -0.994 . . . . 1.0 108.316 -179.411 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 24' ' ' ALA . . . . . 0.657 ' N ' ' O ' ' A' ' 20' ' ' PRO . . . -58.14 -59.99 4.44 Favored 'General case' 0 N--CA 1.468 0.436 0 C-N-CA 119.484 -0.886 . . . . 1.0 109.652 -179.301 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -62.74 -42.57 99.73 Favored 'General case' 0 CA--C 1.519 -0.217 0 C-N-CA 119.685 -0.806 . . . . 1.0 111.041 -178.642 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 69.9 t -61.93 -61.11 1.76 Allowed 'Isoleucine or valine' 0 N--CA 1.448 -0.536 0 C-N-CA 118.606 -1.238 . . . . 1.0 110.711 -178.33 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 27' ' ' VAL . . . . . 0.705 HG12 ' O ' ' A' ' 23' ' ' VAL . 9.8 p -60.21 -37.6 74.1 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.333 0 N-CA-C 112.749 0.648 . . . . 1.0 112.749 -176.706 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 28' ' ' LYS . . . . . 0.412 ' N ' HG13 ' A' ' 27' ' ' VAL . 59.8 tttm -69.0 -54.11 16.95 Favored 'General case' 0 C--N 1.315 -0.895 0 CA-C-O 121.815 0.816 . . . . 1.0 109.378 -178.916 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 95.0 t -64.17 -49.26 82.1 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.83 0 CA-C-N 114.216 -1.357 . . . . 1.0 110.29 -177.7 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 30' ' ' CYS . . . . . . . . . . . . . 44.5 t -67.03 -61.44 1.93 Allowed 'General case' 0 N--CA 1.444 -0.767 0 C-N-CA 119.07 -1.052 . . . . 1.0 110.416 -179.247 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 31' ' ' ALA . . . . . 0.655 ' HB3' ' O ' ' A' ' 27' ' ' VAL . . . -64.94 -53.79 40.81 Favored 'General case' 0 CA--C 1.514 -0.441 0 N-CA-C 112.726 0.639 . . . . 1.0 112.726 -175.427 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 32' ' ' GLY . . . . . 0.413 ' O ' ' CB ' ' A' ' 33' ' ' LEU . . . 89.05 72.02 1.27 Allowed Glycine 0 CA--C 1.522 0.506 0 N-CA-C 108.403 -1.879 . . . . 1.0 108.403 -177.446 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 33' ' ' LEU . . . . . 0.413 ' CB ' ' O ' ' A' ' 32' ' ' GLY . 6.1 tp 81.65 122.28 0.03 OUTLIER Pre-proline 0 CA--C 1.54 0.587 0 C-N-CA 122.858 0.463 . . . . 1.0 111.268 -179.547 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 39.8 Cg_endo -68.45 -18.36 43.69 Favored 'Trans proline' 0 N--CA 1.495 1.574 0 C-N-CA 121.433 1.422 . . . . 1.0 113.56 179.668 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -57.22 -61.03 7.97 Favored Glycine 0 C--N 1.338 0.677 0 C-N-CA 118.126 -1.987 . . . . 1.0 108.802 -179.022 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 36' ' ' VAL . . . . . 0.916 ' O ' HG22 ' A' ' 37' ' ' ILE . 9.0 p -69.25 -150.78 0.0 OUTLIER 'Isoleucine or valine' 0 C--O 1.215 -0.721 0 N-CA-C 106.057 -1.831 . . . . 1.0 106.057 177.869 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 37' ' ' ILE . . . . . 0.916 HG22 ' O ' ' A' ' 36' ' ' VAL . 6.8 tp 79.15 75.25 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.483 1.186 0 O-C-N 124.281 0.988 . . . . 1.0 112.597 179.444 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 10.3 m80 -136.23 130.46 33.14 Favored 'General case' 0 C--N 1.334 -0.08 0 O-C-N 120.858 -1.151 . . . . 1.0 108.653 177.619 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 39' ' ' THR . . . . . 0.501 ' OG1' ' NE ' ' A' ' 42' ' ' ARG . 20.0 p -110.19 144.54 30.28 Favored Pre-proline 0 N--CA 1.464 0.228 0 N-CA-C 109.65 -0.5 . . . . 1.0 109.65 -179.859 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 90.7 Cg_endo -73.27 -29.22 11.66 Favored 'Trans proline' 0 N--CA 1.493 1.497 0 C-N-CA 122.144 1.896 . . . . 1.0 113.425 -178.818 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -127.59 133.39 49.73 Favored 'General case' 0 N--CA 1.468 0.457 0 CA-C-N 116.767 -0.197 . . . . 1.0 110.786 179.123 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 42' ' ' ARG . . . . . 0.602 ' C ' ' H ' ' A' ' 44' ' ' GLY . 4.4 mtm180 -171.67 171.64 5.23 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-O 121.461 0.648 . . . . 1.0 109.529 176.391 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 43' ' ' ARG . . . . . 0.411 ' HG3' ' O ' ' A' ' 43' ' ' ARG . 0.0 OUTLIER -69.51 15.92 0.07 Allowed 'General case' 0 C--N 1.315 -0.898 0 CA-C-N 114.805 -1.089 . . . . 1.0 108.981 179.422 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 44' ' ' GLY . . . . . 0.602 ' H ' ' C ' ' A' ' 42' ' ' ARG . . . 93.9 -19.91 50.31 Favored Glycine 0 C--N 1.336 0.558 0 N-CA-C 110.035 -1.226 . . . . 1.0 110.035 179.232 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 45' ' ' PHE . . . . . 0.729 ' O ' ' HB2' ' A' ' 46' ' ' PHE . 1.1 p90 -167.23 169.08 12.88 Favored 'General case' 0 CA--C 1.538 0.485 0 N-CA-C 109.884 -0.414 . . . . 1.0 109.884 179.868 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 46' ' ' PHE . . . . . 0.729 ' HB2' ' O ' ' A' ' 45' ' ' PHE . 0.2 OUTLIER 148.12 71.24 0.0 OUTLIER 'General case' 0 N--CA 1.504 2.257 0 O-C-N 125.772 1.92 . . . . 1.0 110.176 178.555 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 47' ' ' ARG . . . . . 0.503 ' CB ' ' O ' ' A' ' 46' ' ' PHE . 4.2 mmt-85 142.94 142.87 0.0 OUTLIER 'General case' 0 N--CA 1.483 1.202 0 N-CA-C 108.831 -0.803 . . . . 1.0 108.831 179.082 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 1.8 t 70.75 68.6 0.19 Allowed 'General case' 0 N--CA 1.446 -0.661 0 N-CA-C 108.7 -0.852 . . . . 1.0 108.7 -179.594 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 49' ' ' ASN . . . . . 0.6 ' O ' ' N ' ' A' ' 51' ' ' GLU . 7.0 p30 -140.71 105.7 6.36 Favored Pre-proline 0 CA--C 1.54 0.579 0 N-CA-C 107.929 -1.137 . . . . 1.0 107.929 -179.89 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 50' ' ' PRO . . . . . 0.518 ' C ' ' H ' ' A' ' 52' ' ' ARG . 62.8 Cg_exo -49.72 68.64 0.02 OUTLIER 'Trans proline' 0 N--CA 1.505 2.174 0 C-N-CA 122.733 2.289 . . . . 1.0 114.533 -178.749 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 51' ' ' GLU . . . . . 0.6 ' N ' ' O ' ' A' ' 49' ' ' ASN . 42.6 mm-40 71.52 -23.13 0.19 Allowed 'General case' 0 N--CA 1.468 0.451 0 C-N-CA 122.636 0.375 . . . . 1.0 110.711 -179.695 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 52' ' ' ARG . . . . . 0.591 ' NH2' HH22 ' A' ' 126' ' ' ARG . 17.0 mmt180 -48.05 114.14 0.87 Allowed 'General case' 0 C--N 1.329 -0.319 0 N-CA-C 109.302 -0.629 . . . . 1.0 109.302 179.98 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 53' ' ' ILE . . . . . 0.466 ' O ' ' N ' ' A' ' 55' ' ' ILE . 21.5 tt -54.71 143.58 6.92 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-O 121.385 0.612 . . . . 1.0 110.482 -179.292 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 11.4 mm100 -64.65 77.64 0.04 OUTLIER 'General case' 0 C--N 1.318 -0.788 0 C-N-CA 119.123 -1.031 . . . . 1.0 109.683 -177.917 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 55' ' ' ILE . . . . . 0.466 ' N ' ' O ' ' A' ' 53' ' ' ILE . 3.2 tp -150.11 158.05 5.79 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.299 0 N-CA-C 110.406 -0.22 . . . . 1.0 110.406 178.179 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 113.44 -27.42 9.41 Favored Glycine 0 CA--C 1.519 0.296 0 N-CA-C 110.305 -1.118 . . . . 1.0 110.305 179.3 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 57' ' ' ASP . . . . . 0.453 ' OD1' ' N ' ' A' ' 57' ' ' ASP . 11.4 p-10 -57.43 101.95 0.08 Allowed 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 117.638 0.719 . . . . 1.0 110.254 179.529 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 58' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -86.25 176.06 8.14 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-O 122.526 1.155 . . . . 1.0 111.843 -179.169 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 59' ' ' ARG . . . . . 0.503 ' CG ' ' N ' ' A' ' 60' ' ' TYR . 22.2 ptt-85 -90.82 -56.38 3.2 Favored 'General case' 0 C--N 1.316 -0.884 0 CA-C-N 112.756 -2.02 . . . . 1.0 112.224 179.841 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 60' ' ' TYR . . . . . 0.503 ' N ' ' CG ' ' A' ' 59' ' ' ARG . 0.4 OUTLIER -91.22 -20.64 21.72 Favored 'General case' 0 C--O 1.247 0.967 0 CA-C-O 121.948 0.88 . . . . 1.0 113.046 -179.107 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 3.5 tt0 -79.21 -12.77 59.97 Favored 'General case' 0 N--CA 1.436 -1.157 0 N-CA-C 109.425 -0.583 . . . . 1.0 109.425 -179.893 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 62' ' ' VAL . . . . . 0.615 HG13 ' N ' ' A' ' 63' ' ' ALA . 6.1 p -46.84 -55.85 1.59 Allowed 'Isoleucine or valine' 0 C--O 1.212 -0.899 0 C-N-CA 119.656 -0.817 . . . . 1.0 109.811 -175.69 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 63' ' ' ALA . . . . . 0.615 ' N ' HG13 ' A' ' 62' ' ' VAL . . . -64.87 -54.63 27.96 Favored 'General case' 0 N--CA 1.435 -1.199 0 C-N-CA 120.177 -0.609 . . . . 1.0 109.509 -179.68 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 64' ' ' HIS . . . . . 0.424 ' O ' ' CG ' ' A' ' 67' ' ' ARG . 0.2 OUTLIER -48.45 -57.95 5.35 Favored 'General case' 0 CA--C 1.538 0.495 0 CA-C-N 115.484 -0.78 . . . . 1.0 110.153 -179.567 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 65' ' ' ASP . . . . . 0.659 ' C ' ' H ' ' A' ' 67' ' ' ARG . 0.8 OUTLIER -69.78 -46.49 65.65 Favored 'General case' 0 C--N 1.316 -0.858 0 CA-C-O 122.309 1.052 . . . . 1.0 110.222 179.19 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 66' ' ' GLY . . . . . 0.568 ' N ' ' O ' ' A' ' 62' ' ' VAL . . . -71.08 27.38 0.54 Allowed Glycine 0 N--CA 1.447 -0.621 0 N-CA-C 109.585 -1.406 . . . . 1.0 109.585 177.755 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 67' ' ' ARG . . . . . 0.697 ' O ' ' N ' ' A' ' 69' ' ' LEU . 14.5 mmt85 -74.9 1.26 13.16 Favored 'General case' 0 N--CA 1.441 -0.909 0 N-CA-C 107.87 -1.159 . . . . 1.0 107.87 176.23 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 68' ' ' LEU . . . . . 0.453 ' C ' ' O ' ' A' ' 67' ' ' ARG . 0.8 OUTLIER -33.05 -24.46 0.0 OUTLIER 'General case' 0 N--CA 1.475 0.79 0 O-C-N 123.745 0.653 . . . . 1.0 109.5 -175.99 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 69' ' ' LEU . . . . . 0.697 ' N ' ' O ' ' A' ' 67' ' ' ARG . 4.8 mp -67.31 -64.64 0.81 Allowed 'General case' 0 CA--C 1.54 0.571 0 C-N-CA 119.326 -0.95 . . . . 1.0 109.681 177.999 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 70' ' ' ALA . . . . . 0.664 ' C ' ' H ' ' A' ' 72' ' ' HIS . . . -80.53 -76.93 0.21 Allowed 'General case' 0 N--CA 1.473 0.685 0 N-CA-C 106.035 -1.839 . . . . 1.0 106.035 177.173 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 71' ' ' ALA . . . . . 0.473 ' HB3' ' CB ' ' A' ' 67' ' ' ARG . . . -42.6 0.59 0.0 OUTLIER 'General case' 0 N--CA 1.469 0.499 0 C-N-CA 124.631 1.173 . . . . 1.0 113.089 179.723 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 72' ' ' HIS . . . . . 0.664 ' H ' ' C ' ' A' ' 70' ' ' ALA . 1.2 p-80 -26.27 -58.71 0.08 Allowed 'General case' 0 C--N 1.342 0.251 0 C-N-CA 122.747 0.419 . . . . 1.0 111.541 -178.738 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 73' ' ' MET . . . . . 0.618 ' N ' ' CG ' ' A' ' 72' ' ' HIS . 49.5 mtt -75.37 -49.79 17.93 Favored 'General case' 0 C--N 1.321 -0.65 0 C-N-CA 120.545 -0.462 . . . . 1.0 109.878 177.408 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 74' ' ' VAL . . . . . 0.63 ' O ' ' N ' ' A' ' 76' ' ' GLY . 57.5 t -44.63 -42.07 2.19 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.167 0 CA-C-O 117.883 -1.056 . . . . 1.0 111.954 -175.409 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 75' ' ' ASN . . . . . 0.532 ' O ' HG23 ' A' ' 79' ' ' ILE . 40.7 t30 -40.13 -14.72 0.01 OUTLIER 'General case' 0 N--CA 1.478 0.938 0 CA-C-N 121.071 1.759 . . . . 1.0 112.195 176.796 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 76' ' ' GLY . . . . . 0.63 ' N ' ' O ' ' A' ' 74' ' ' VAL . . . -45.43 -24.04 0.95 Allowed Glycine 0 CA--C 1.539 1.566 0 N-CA-C 108.734 -1.746 . . . . 1.0 108.734 178.866 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 77' ' ' ILE . . . . . 0.535 ' O ' ' N ' ' A' ' 80' ' ' ALA . 2.2 pt -89.87 -61.62 1.86 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.719 0 CA-C-N 114.261 -0.97 . . . . 1.0 110.672 -178.837 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 78' ' ' VAL . . . . . 0.496 HG11 ' OD1' ' A' ' 65' ' ' ASP . 56.0 t -36.89 -29.91 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.448 -0.53 0 N-CA-C 109.267 -0.642 . . . . 1.0 109.267 -177.27 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 79' ' ' ILE . . . . . 0.82 ' O ' ' HB3' ' A' ' 83' ' ' ALA . 2.5 pt -64.75 -52.75 50.51 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.03 0 C-N-CA 119.151 -1.02 . . . . 1.0 109.626 178.786 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 80' ' ' ALA . . . . . 0.544 ' N ' ' CG1' ' A' ' 79' ' ' ILE . . . -55.86 -63.42 1.18 Allowed 'General case' 0 C--O 1.214 -0.768 0 C-N-CA 118.245 -1.382 . . . . 1.0 111.156 -178.489 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 47.5 mt-10 -50.1 -71.18 0.07 Allowed 'General case' 0 CA--C 1.531 0.216 0 C-N-CA 119.587 -0.845 . . . . 1.0 110.335 -179.151 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 21.2 t70 -62.88 -63.88 1.08 Allowed 'General case' 0 C--N 1.323 -0.582 0 C-N-CA 118.529 -1.268 . . . . 1.0 109.953 -177.997 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 83' ' ' ALA . . . . . 0.82 ' HB3' ' O ' ' A' ' 79' ' ' ILE . . . -53.04 -13.97 0.54 Allowed 'General case' 0 CA--C 1.536 0.409 0 C-N-CA 118.672 -1.211 . . . . 1.0 111.043 -177.801 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 84' ' ' LEU . . . . . 0.491 ' HB2' ' O ' ' A' ' 80' ' ' ALA . 1.0 OUTLIER -40.73 -16.54 0.01 OUTLIER 'General case' 0 C--N 1.37 1.495 0 CA-C-N 120.463 1.483 . . . . 1.0 112.047 -179.756 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 85' ' ' ILE . . . . . 0.58 ' N ' ' O ' ' A' ' 83' ' ' ALA . 19.8 pt -62.25 -41.65 92.29 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.245 0 N-CA-C 109.123 -0.695 . . . . 1.0 109.123 179.806 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 86' ' ' ALA . . . . . 0.438 ' CB ' ' CZ ' ' A' ' 52' ' ' ARG . . . -97.07 -2.7 42.74 Favored 'General case' 0 CA--C 1.539 0.523 0 C-N-CA 123.286 0.634 . . . . 1.0 112.506 179.896 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 34.1 tp10 -51.25 -20.89 1.79 Allowed 'General case' 0 C--N 1.32 -0.709 0 CA-C-N 115.307 -0.86 . . . . 1.0 109.842 -179.927 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -123.18 14.63 9.77 Favored 'General case' 0 N--CA 1.475 0.816 0 CA-C-O 121.459 0.647 . . . . 1.0 109.792 178.765 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 89' ' ' VAL . . . . . 0.595 ' O ' HG12 ' A' ' 89' ' ' VAL . 24.1 t -109.01 29.24 1.48 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.453 0 CA-C-N 114.579 -1.191 . . . . 1.0 109.655 177.861 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 90' ' ' GLY . . . . . 0.534 ' N ' ' CD ' ' A' ' 91' ' ' PRO . . . -68.78 -43.2 76.07 Favored Glycine 0 CA--C 1.525 0.694 0 N-CA-C 109.632 -1.387 . . . . 1.0 109.632 177.156 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 91' ' ' PRO . . . . . 0.534 ' CD ' ' N ' ' A' ' 90' ' ' GLY . 81.7 Cg_exo -45.71 -14.09 0.1 OUTLIER 'Trans proline' 0 N--CA 1.489 1.217 0 C-N-CA 121.686 1.591 . . . . 1.0 110.686 178.733 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 92' ' ' HIS . . . . . 0.671 ' CD2' HH21 ' A' ' 95' ' ' ARG . 40.9 t-80 -57.1 -17.38 10.32 Favored 'General case' 0 C--O 1.204 -1.32 0 N-CA-C 107.941 -1.133 . . . . 1.0 107.941 -179.886 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 93' ' ' LEU . . . . . 0.703 HD12 ' N ' ' A' ' 94' ' ' ALA . 2.9 pp -62.41 -55.7 25.33 Favored 'General case' 0 C--N 1.325 -0.468 0 N-CA-C 109.081 -0.711 . . . . 1.0 109.081 178.083 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 94' ' ' ALA . . . . . 0.703 ' N ' HD12 ' A' ' 93' ' ' LEU . . . -57.92 -52.52 65.14 Favored 'General case' 0 CA--C 1.513 -0.46 0 N-CA-C 108.64 -0.874 . . . . 1.0 108.64 179.476 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 95' ' ' ARG . . . . . 0.671 HH21 ' CD2' ' A' ' 92' ' ' HIS . 18.3 ttp180 -57.82 -58.37 8.65 Favored 'General case' 0 N--CA 1.446 -0.633 0 N-CA-C 106.692 -1.596 . . . . 1.0 106.692 178.482 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 96' ' ' ALA . . . . . 1.005 ' O ' ' N ' ' A' ' 98' ' ' GLY . . . -47.36 -10.95 0.02 OUTLIER 'General case' 0 C--N 1.299 -1.625 0 O-C-N 118.887 -2.383 . . . . 1.0 111.504 178.236 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 97' ' ' LEU . . . . . 0.734 HD12 ' N ' ' A' ' 98' ' ' GLY . 3.5 pp 9.49 -45.32 0.0 OUTLIER 'General case' 0 N--CA 1.475 0.796 0 C-N-CA 124.202 1.001 . . . . 1.0 112.177 -164.879 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 98' ' ' GLY . . . . . 1.005 ' N ' ' O ' ' A' ' 96' ' ' ALA . . . -53.33 -23.71 19.64 Favored Glycine 0 C--N 1.295 -1.736 0 N-CA-C 106.423 -2.671 . . . . 1.0 106.423 173.269 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 99' ' ' GLN . . . . . 0.536 ' HB2' ' HB3' ' A' ' 96' ' ' ALA . 1.1 tp-100 -58.27 -21.17 47.64 Favored 'General case' 0 C--N 1.367 1.346 0 N-CA-C 106.523 -1.658 . . . . 1.0 106.523 177.167 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 100' ' ' ILE . . . . . 0.661 ' N ' ' O ' ' A' ' 97' ' ' LEU . 84.3 mt -65.72 -42.49 92.64 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.925 0 CA-C-N 113.51 -1.677 . . . . 1.0 109.532 178.0 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 101' ' ' VAL . . . . . 0.601 HG13 ' N ' ' A' ' 102' ' ' CYS . 2.8 p -52.74 -62.84 0.55 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.383 0 C-N-CA 119.03 -1.068 . . . . 1.0 111.647 -177.055 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 102' ' ' CYS . . . . . 0.898 ' O ' ' HB2' ' A' ' 106' ' ' ALA . 0.8 OUTLIER -49.77 -22.5 1.44 Allowed 'General case' 0 C--N 1.316 -0.849 0 N-CA-C 112.421 0.526 . . . . 1.0 112.421 -177.572 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 60.1 ttt-85 -85.2 -46.89 10.64 Favored 'General case' 0 N--CA 1.482 1.146 0 CA-C-O 122.303 1.049 . . . . 1.0 112.344 179.584 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 104' ' ' TYR . . . . . 0.714 ' O ' ' CG ' ' A' ' 104' ' ' TYR . 0.0 OUTLIER -96.53 19.67 11.88 Favored 'General case' 0 C--N 1.308 -1.234 0 CA-C-N 113.341 -1.754 . . . . 1.0 109.539 178.591 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 105' ' ' GLY . . . . . 0.481 ' O ' ' HB3' ' A' ' 106' ' ' ALA . . . -153.06 -85.28 0.05 OUTLIER Glycine 0 C--N 1.342 0.888 1 N-CA-C 102.268 -4.333 . . . . 1.0 102.268 175.955 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 106' ' ' ALA . . . . . 0.898 ' HB2' ' O ' ' A' ' 102' ' ' CYS . . . 73.99 60.41 0.08 Allowed 'General case' 0 C--O 1.206 -1.232 0 N-CA-C 115.046 1.499 . . . . 1.0 115.046 176.568 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 75.6 m -82.53 -57.38 3.37 Favored 'General case' 0 CA--C 1.548 0.887 0 O-C-N 120.859 -1.151 . . . . 1.0 109.649 179.866 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 27.2 m -66.44 -7.17 5.1 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.056 0 CA-C-O 121.565 0.698 . . . . 1.0 111.525 -179.59 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 1.5 mp -83.16 -64.18 0.25 Allowed Pre-proline 0 CA--C 1.55 0.975 0 CA-C-N 114.607 -1.179 . . . . 1.0 111.401 -179.831 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 110' ' ' PRO . . . . . 0.709 ' CD ' ' O ' ' A' ' 106' ' ' ALA . 58.6 Cg_endo -66.35 -33.95 36.7 Favored 'Trans proline' 0 N--CA 1.504 2.115 0 C-N-CA 124.407 3.405 . . . . 1.0 113.131 179.753 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 111' ' ' ASN . . . . . 0.436 ' C ' ' N ' ' A' ' 113' ' ' ASN . 39.8 t30 -66.48 -67.73 0.43 Allowed 'General case' 0 C--O 1.237 0.417 0 C-N-CA 120.61 -0.436 . . . . 1.0 110.029 -178.012 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 7.4 mm -51.93 -22.2 2.69 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.639 0 CA-C-O 122.135 0.969 . . . . 1.0 108.511 178.651 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 113' ' ' ASN . . . . . 0.492 ' O ' HG22 ' A' ' 116' ' ' ILE . 0.9 OUTLIER -61.25 -53.3 58.62 Favored 'General case' 0 C--N 1.305 -1.34 0 CA-C-N 113.358 -1.746 . . . . 1.0 108.174 -178.188 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -55.52 -29.23 58.51 Favored 'General case' 0 C--N 1.313 -1.011 0 O-C-N 120.668 -1.27 . . . . 1.0 111.775 -179.617 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -83.29 -50.09 8.74 Favored 'General case' 0 C--O 1.212 -0.89 0 CA-C-O 121.777 0.798 . . . . 1.0 111.584 177.527 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 116' ' ' ILE . . . . . 0.556 ' CG2' ' N ' ' A' ' 117' ' ' GLU . 1.5 tp -46.21 -53.93 2.27 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.704 0 CA-C-N 114.194 -1.367 . . . . 1.0 107.676 -179.005 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 117' ' ' GLU . . . . . 0.556 ' N ' ' CG2' ' A' ' 116' ' ' ILE . 44.2 tt0 -40.05 -50.95 2.6 Favored 'General case' 0 N--CA 1.478 0.928 0 N-CA-C 105.034 -2.21 . . . . 1.0 105.034 -178.812 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 43.3 t -70.26 -53.16 24.39 Favored 'Isoleucine or valine' 0 CA--C 1.558 1.286 0 CA-C-N 113.3 -1.773 . . . . 1.0 111.08 178.192 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 119' ' ' LEU . . . . . 0.502 ' O ' HD13 ' A' ' 119' ' ' LEU . 0.1 OUTLIER -59.65 -24.87 64.22 Favored 'General case' 0 N--CA 1.482 1.138 0 N-CA-C 115.145 1.535 . . . . 1.0 115.145 -177.268 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -135.71 -48.43 0.08 OUTLIER Glycine 0 CA--C 1.542 1.759 0 CA-C-N 120.418 1.463 . . . . 1.0 113.035 177.234 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 1.2 m 160.56 -39.38 0.0 OUTLIER 'General case' 0 N--CA 1.468 0.472 0 N-CA-C 101.414 -3.55 . . . . 1.0 101.414 -177.268 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 122' ' ' GLY . . . . . 0.444 ' HA2' HG23 ' A' ' 116' ' ' ILE . . . 115.06 -32.89 5.57 Favored Glycine 0 CA--C 1.526 0.748 0 CA-C-N 111.114 -2.766 . . . . 1.0 116.869 175.638 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 123' ' ' THR . . . . . 0.44 ' C ' ' O ' ' A' ' 122' ' ' GLY . 43.8 m -40.63 98.35 0.01 OUTLIER 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 121.225 2.513 . . . . 1.0 112.967 -178.661 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 124' ' ' ASP . . . . . 0.441 ' N ' ' O ' ' A' ' 122' ' ' GLY . 31.8 m-20 -137.21 138.4 40.13 Favored 'General case' 0 N--CA 1.465 0.284 0 N-CA-C 107.207 -1.405 . . . . 1.0 107.207 177.112 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 125' ' ' TYR . . . . . 0.47 ' O ' ' CD1' ' A' ' 125' ' ' TYR . 0.1 OUTLIER -155.34 153.74 30.96 Favored 'General case' 0 CA--C 1.537 0.481 0 CA-C-O 121.18 0.514 . . . . 1.0 110.719 -179.581 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 126' ' ' ARG . . . . . 0.591 HH22 ' NH2' ' A' ' 52' ' ' ARG . 4.4 mtp85 -150.42 153.89 36.75 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.324 -0.853 . . . . 1.0 111.506 177.467 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 127' ' ' PHE . . . . . . . . . . . . . 47.3 p90 . . . . . 0 C--O 1.22 -0.451 0 CA-C-O 117.931 -1.033 . . . . 1.0 110.489 -179.474 . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 128' ' ' MTN . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 129' ' ' MTN . . . . . 0.466 ' H61' ' S1 ' ' A' ' 129' ' ' MTN . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 130' ' ' MTN . . . . . 0.674 ' H61' ' S1 ' ' A' ' 130' ' ' MTN . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 20.1 mmt . . . . . 0 N--CA 1.493 1.679 0 N-CA-C 108.779 -0.822 . . . . 1.0 108.779 . . . . . . . . . 0 0 . 1 . 021 nuclear build full ' A' A ' 2' ' ' SER . . . . . 0.431 ' O ' ' OD2' ' A' ' 3' ' ' ASP . 50.6 m -107.77 8.78 29.0 Favored 'General case' 0 N--CA 1.466 0.329 0 C-N-CA 122.322 0.249 . . . . 1.0 110.544 179.943 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 3' ' ' ASP . . . . . 0.431 ' OD2' ' O ' ' A' ' 2' ' ' SER . 0.4 OUTLIER 169.59 93.99 0.0 OUTLIER 'General case' 0 CA--C 1.534 0.338 0 N-CA-C 110.284 -0.265 . . . . 1.0 110.284 179.966 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 70.4 t80 -150.15 144.53 25.74 Favored 'General case' 0 N--CA 1.466 0.353 0 N-CA-C 110.228 -0.286 . . . . 1.0 110.228 179.587 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 47.9 m-20 -153.07 149.26 27.94 Favored 'General case' 0 N--CA 1.465 0.309 0 N-CA-C 110.233 -0.284 . . . . 1.0 110.233 179.888 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 6' ' ' THR . . . . . 0.669 HG22 ' H ' ' A' ' 7' ' ' GLU . 11.2 m -69.07 174.48 4.52 Favored 'General case' 0 C--O 1.205 -1.267 0 N-CA-C 109.793 -0.447 . . . . 1.0 109.793 179.774 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 7' ' ' GLU . . . . . 0.669 ' H ' HG22 ' A' ' 6' ' ' THR . 39.6 tt0 -61.55 -55.59 29.28 Favored 'General case' 0 C--N 1.317 -0.847 0 CA-C-O 121.475 0.655 . . . . 1.0 110.349 -177.822 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 8' ' ' ARG . . . . . 0.544 ' O ' ' CB ' ' A' ' 12' ' ' ALA . 7.4 ttp-105 -51.27 -57.81 7.86 Favored 'General case' 0 C--O 1.209 -1.072 0 N-CA-C 107.788 -1.19 . . . . 1.0 107.788 -178.188 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 9' ' ' VAL . . . . . 0.762 ' O ' HG13 ' A' ' 13' ' ' VAL . 0.0 OUTLIER -66.14 -47.0 86.19 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.071 0 CA-C-N 114.435 -1.257 . . . . 1.0 110.99 179.554 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 10' ' ' SER . . . . . 0.606 ' N ' ' O ' ' A' ' 6' ' ' THR . 35.4 t -62.93 -59.06 5.35 Favored 'General case' 0 N--CA 1.482 1.155 0 N-CA-C 108.582 -0.895 . . . . 1.0 108.582 179.636 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 11' ' ' ARG . . . . . 0.526 ' N ' ' O ' ' A' ' 7' ' ' GLU . 20.9 ttm180 -66.09 -55.06 18.4 Favored 'General case' 0 C--N 1.314 -0.944 0 O-C-N 121.732 -0.605 . . . . 1.0 110.815 -178.06 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 12' ' ' ALA . . . . . 0.544 ' CB ' ' O ' ' A' ' 8' ' ' ARG . . . -49.64 -53.31 24.93 Favored 'General case' 0 N--CA 1.485 1.276 0 C-N-CA 118.467 -1.293 . . . . 1.0 108.043 -176.566 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 13' ' ' VAL . . . . . 0.762 HG13 ' O ' ' A' ' 9' ' ' VAL . 4.5 m -60.58 -47.34 93.25 Favored 'Isoleucine or valine' 0 C--O 1.203 -1.377 0 C-N-CA 118.067 -1.453 . . . . 1.0 107.342 178.204 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 14' ' ' ALA . . . . . 0.779 ' O ' HG13 ' A' ' 18' ' ' VAL . . . -56.31 -62.11 1.94 Allowed 'General case' 0 C--O 1.206 -1.201 0 C-N-CA 117.062 -1.855 . . . . 1.0 109.706 179.645 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 15' ' ' ALA . . . . . 0.595 ' O ' ' N ' ' A' ' 19' ' ' GLY . . . -54.14 -56.26 19.91 Favored 'General case' 0 N--CA 1.472 0.659 0 CA-C-O 121.474 0.654 . . . . 1.0 110.097 -178.246 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 16' ' ' ALA . . . . . 0.668 ' HB1' ' CA ' ' A' ' 22' ' ' GLY . . . -62.28 -56.01 22.68 Favored 'General case' 0 CA--C 1.552 1.037 0 CA-C-N 115.25 -0.886 . . . . 1.0 109.281 -179.419 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 17' ' ' LEU . . . . . 0.661 ' O ' HD23 ' A' ' 17' ' ' LEU . 4.3 tt -57.17 -52.43 65.36 Favored 'General case' 0 N--CA 1.484 1.244 0 CA-C-N 114.675 -1.148 . . . . 1.0 108.275 -177.965 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 18' ' ' VAL . . . . . 0.779 HG13 ' O ' ' A' ' 14' ' ' ALA . 2.8 m -69.26 -57.87 7.29 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.349 0 C-N-CA 119.737 -0.785 . . . . 1.0 109.806 179.095 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 19' ' ' GLY . . . . . 0.595 ' N ' ' O ' ' A' ' 15' ' ' ALA . . . -59.86 -175.84 1.08 Allowed Glycine 0 N--CA 1.447 -0.585 0 N-CA-C 111.106 -0.798 . . . . 1.0 111.106 -179.261 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 20' ' ' PRO . . . . . 0.576 ' O ' ' N ' ' A' ' 24' ' ' ALA . 36.8 Cg_endo -83.47 -26.79 2.01 Favored 'Trans proline' 0 C--N 1.299 -2.044 0 C-N-CA 122.658 2.239 . . . . 1.0 112.988 -178.507 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 21' ' ' GLY . . . . . 0.46 ' O ' ' HB3' ' A' ' 24' ' ' ALA . . . -59.02 -58.65 13.41 Favored Glycine 0 N--CA 1.475 1.25 0 C-N-CA 120.066 -1.064 . . . . 1.0 111.536 -176.995 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 22' ' ' GLY . . . . . 0.668 ' CA ' ' HB1' ' A' ' 16' ' ' ALA . . . -55.96 -51.59 54.46 Favored Glycine 0 N--CA 1.474 1.23 0 N-CA-C 106.981 -2.448 . . . . 1.0 106.981 -178.158 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 47.9 t -59.56 -31.54 47.04 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.427 0 N-CA-C 108.735 -0.839 . . . . 1.0 108.735 178.792 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 24' ' ' ALA . . . . . 0.576 ' N ' ' O ' ' A' ' 20' ' ' PRO . . . -58.17 -63.09 1.38 Allowed 'General case' 0 C--N 1.348 0.502 0 C-N-CA 118.858 -1.137 . . . . 1.0 110.659 -178.742 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 25' ' ' LEU . . . . . 0.441 HD23 ' H ' ' A' ' 25' ' ' LEU . 0.1 OUTLIER -64.52 -43.37 94.28 Favored 'General case' 0 CA--C 1.517 -0.309 0 C-N-CA 119.858 -0.737 . . . . 1.0 111.814 -178.1 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 93.0 t -59.59 -59.63 3.64 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.544 0 C-N-CA 118.818 -1.153 . . . . 1.0 110.102 -177.927 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 27' ' ' VAL . . . . . 0.579 ' O ' ' HB3' ' A' ' 31' ' ' ALA . 0.6 OUTLIER -58.87 -34.76 53.33 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 O-C-N 122.235 -0.291 . . . . 1.0 111.1 -178.283 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 37.5 ttpt -67.16 -55.85 12.41 Favored 'General case' 0 C--N 1.325 -0.482 0 N-CA-C 109.391 -0.596 . . . . 1.0 109.391 -179.297 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 42.2 t -62.24 -47.82 91.32 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.605 0 CA-C-N 115.162 -0.926 . . . . 1.0 109.989 -179.07 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 30' ' ' CYS . . . . . . . . . . . . . 0.7 OUTLIER -67.47 -62.53 1.38 Allowed 'General case' 0 N--CA 1.446 -0.628 0 C-N-CA 119.052 -1.059 . . . . 1.0 110.841 -179.098 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 31' ' ' ALA . . . . . 0.579 ' HB3' ' O ' ' A' ' 27' ' ' VAL . . . -60.3 -51.61 68.82 Favored 'General case' 0 CA--C 1.506 -0.737 0 O-C-N 122.055 -0.403 . . . . 1.0 111.091 -176.697 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 32' ' ' GLY . . . . . 0.498 ' O ' ' HB2' ' A' ' 33' ' ' LEU . . . 84.66 75.04 1.23 Allowed Glycine 0 N--CA 1.442 -0.941 0 N-CA-C 109.828 -1.309 . . . . 1.0 109.828 -178.662 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 33' ' ' LEU . . . . . 0.498 ' HB2' ' O ' ' A' ' 32' ' ' GLY . 0.9 OUTLIER 87.21 100.39 0.03 OUTLIER Pre-proline 0 CA--C 1.549 0.917 0 C-N-CA 124.015 0.926 . . . . 1.0 110.654 -179.238 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 58.6 Cg_endo -71.4 -31.51 13.87 Favored 'Trans proline' 0 N--CA 1.502 1.997 0 C-N-CA 121.925 1.75 . . . . 1.0 114.807 -178.652 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -58.02 -58.96 11.85 Favored Glycine 0 N--CA 1.472 1.077 0 C-N-CA 118.466 -1.826 . . . . 1.0 108.957 -178.4 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 36' ' ' VAL . . . . . 0.587 HG22 ' N ' ' A' ' 37' ' ' ILE . 7.9 p -93.43 165.89 1.86 Allowed 'Isoleucine or valine' 0 CA--C 1.514 -0.415 0 N-CA-C 106.75 -1.574 . . . . 1.0 106.75 177.318 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 37' ' ' ILE . . . . . 0.587 ' N ' HG22 ' A' ' 36' ' ' VAL . 8.8 tp 115.81 121.57 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.476 0.842 0 O-C-N 124.523 1.139 . . . . 1.0 110.244 -179.841 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 0.9 OUTLIER -143.33 135.8 27.29 Favored 'General case' 0 CA--C 1.533 0.293 0 N-CA-C 109.146 -0.687 . . . . 1.0 109.146 179.461 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 10.4 m -111.47 111.2 55.11 Favored Pre-proline 0 N--CA 1.468 0.444 0 N-CA-C 109.55 -0.537 . . . . 1.0 109.55 179.266 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_exo -43.09 -85.83 0.01 OUTLIER 'Trans proline' 0 N--CA 1.491 1.366 0 C-N-CA 121.662 1.575 . . . . 1.0 112.834 -178.637 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -67.28 120.15 13.34 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 116.108 -0.496 . . . . 1.0 111.313 -177.784 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 3.6 ptm180 -174.04 175.39 2.77 Favored 'General case' 0 N--CA 1.448 -0.563 0 CA-C-N 116.101 -0.499 . . . . 1.0 110.01 178.46 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 5.3 tpt85 -57.53 -43.35 84.27 Favored 'General case' 0 C--N 1.32 -0.691 0 N-CA-C 107.452 -1.314 . . . . 1.0 107.452 179.919 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 44' ' ' GLY . . . . . 0.43 ' O ' ' CD1' ' A' ' 45' ' ' PHE . . . 121.5 -21.55 8.05 Favored Glycine 0 N--CA 1.465 0.613 0 N-CA-C 110.715 -0.954 . . . . 1.0 110.715 -179.127 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 45' ' ' PHE . . . . . 0.581 ' O ' ' HB2' ' A' ' 46' ' ' PHE . 42.6 m-85 -150.34 153.82 36.74 Favored 'General case' 0 C--O 1.216 -0.707 0 N-CA-C 109.006 -0.739 . . . . 1.0 109.006 177.795 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 46' ' ' PHE . . . . . 0.655 ' O ' ' HB2' ' A' ' 47' ' ' ARG . 8.6 m-85 128.59 96.33 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.582 0 O-C-N 124.939 1.399 . . . . 1.0 110.287 -179.933 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 47' ' ' ARG . . . . . 0.655 ' HB2' ' O ' ' A' ' 46' ' ' PHE . 0.7 OUTLIER 110.1 160.85 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.503 0 C-N-CA 125.464 1.506 . . . . 1.0 109.884 -179.809 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 48' ' ' CYS . . . . . 0.709 ' O ' ' H83' ' A' ' 129' ' ' MTN . 0.9 OUTLIER 67.8 70.64 0.34 Allowed 'General case' 0 C--O 1.224 -0.246 0 N-CA-C 108.811 -0.811 . . . . 1.0 108.811 -178.455 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 49' ' ' ASN . . . . . 0.654 HD22 ' HG2' ' A' ' 54' ' ' GLN . 16.8 m120 -136.13 129.37 17.93 Favored Pre-proline 0 CA--C 1.534 0.364 0 O-C-N 121.787 -0.571 . . . . 1.0 109.509 -178.979 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 50' ' ' PRO . . . . . 0.427 ' C ' ' N ' ' A' ' 52' ' ' ARG . 68.8 Cg_exo -46.75 74.57 0.01 OUTLIER 'Trans proline' 0 N--CA 1.498 1.78 0 C-N-CA 121.964 1.776 . . . . 1.0 113.476 179.927 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 51' ' ' GLU . . . . . 0.606 ' N ' ' O ' ' A' ' 49' ' ' ASN . 7.4 mm-40 48.84 14.09 0.07 Allowed 'General case' 0 C--N 1.331 -0.209 0 O-C-N 121.867 -0.521 . . . . 1.0 110.999 179.408 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 52' ' ' ARG . . . . . 0.427 ' N ' ' C ' ' A' ' 50' ' ' PRO . 1.4 ptp180 -116.45 162.23 17.88 Favored 'General case' 0 N--CA 1.472 0.65 0 CA-C-N 116.554 -0.294 . . . . 1.0 110.874 -179.573 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 19.4 tt -71.25 136.54 25.63 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.779 0 CA-C-O 123.508 1.623 . . . . 1.0 115.325 -177.146 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 54' ' ' GLN . . . . . 0.654 ' HG2' HD22 ' A' ' 49' ' ' ASN . 0.5 OUTLIER -74.93 87.6 2.31 Favored 'General case' 0 C--N 1.314 -0.973 0 CA-C-N 110.233 -3.167 . . . . 1.0 110.247 -178.985 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 55' ' ' ILE . . . . . 0.425 ' CG2' ' N ' ' A' ' 56' ' ' GLY . 5.9 mm -146.05 156.9 12.19 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.789 0 CA-C-N 115.703 -0.681 . . . . 1.0 109.883 177.495 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 56' ' ' GLY . . . . . 0.425 ' N ' ' CG2' ' A' ' 55' ' ' ILE . . . 110.52 -2.29 29.28 Favored Glycine 0 N--CA 1.475 1.243 0 N-CA-C 111.379 -0.688 . . . . 1.0 111.379 -179.897 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 13.9 p-10 -87.44 104.95 16.94 Favored 'General case' 0 N--CA 1.466 0.357 0 CA-C-O 121.396 0.617 . . . . 1.0 111.435 -179.815 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 58' ' ' TRP . . . . . . . . . . . . . 9.0 m0 -89.14 171.56 9.73 Favored 'General case' 0 CA--C 1.567 1.603 0 CA-C-O 122.941 1.353 . . . . 1.0 112.354 -178.634 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 59' ' ' ARG . . . . . 0.454 ' HE ' ' H ' ' A' ' 59' ' ' ARG . 0.0 OUTLIER -76.83 -61.71 1.88 Allowed 'General case' 0 N--CA 1.49 1.556 0 CA-C-N 111.12 -2.764 . . . . 1.0 113.902 -176.941 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 4.0 t80 -90.56 -9.03 48.64 Favored 'General case' 0 N--CA 1.484 1.23 0 CA-C-O 122.348 1.07 . . . . 1.0 112.753 -179.295 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 61' ' ' GLU . . . . . 0.477 ' O ' ' N ' ' A' ' 65' ' ' ASP . 2.7 tt0 -78.45 -14.48 59.35 Favored 'General case' 0 C--N 1.306 -1.3 0 CA-C-N 114.895 -1.048 . . . . 1.0 110.291 -179.637 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 62' ' ' VAL . . . . . 0.627 ' O ' ' N ' ' A' ' 66' ' ' GLY . 11.1 m -48.26 -55.79 2.63 Favored 'Isoleucine or valine' 0 C--O 1.204 -1.295 0 C-N-CA 119.566 -0.854 . . . . 1.0 109.241 -176.723 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 63' ' ' ALA . . . . . 0.587 ' H ' HG23 ' A' ' 62' ' ' VAL . . . -63.26 -54.65 34.01 Favored 'General case' 0 C--N 1.297 -1.677 0 O-C-N 121.588 -0.695 . . . . 1.0 109.359 179.438 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -50.56 -59.5 3.97 Favored 'General case' 0 CA--C 1.545 0.786 0 CA-C-N 115.342 -0.845 . . . . 1.0 110.234 -179.342 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 65' ' ' ASP . . . . . 0.591 ' C ' ' H ' ' A' ' 67' ' ' ARG . 26.8 t70 -72.42 -50.82 23.61 Favored 'General case' 0 C--N 1.312 -1.049 0 CA-C-O 121.91 0.862 . . . . 1.0 111.504 178.77 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 66' ' ' GLY . . . . . 0.627 ' N ' ' O ' ' A' ' 62' ' ' VAL . . . -69.96 29.5 0.41 Allowed Glycine 0 C--O 1.227 -0.329 0 O-C-N 120.986 -1.071 . . . . 1.0 111.046 177.661 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 67' ' ' ARG . . . . . 0.608 ' O ' ' N ' ' A' ' 69' ' ' LEU . 0.0 OUTLIER -77.96 8.41 4.73 Favored 'General case' 0 C--N 1.316 -0.856 0 N-CA-C 107.984 -1.117 . . . . 1.0 107.984 176.877 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 68' ' ' LEU . . . . . 0.646 HD23 ' N ' ' A' ' 68' ' ' LEU . 1.5 pt? -34.19 -27.96 0.01 OUTLIER 'General case' 0 N--CA 1.483 1.218 0 CA-C-O 121.757 0.789 . . . . 1.0 108.88 -178.158 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 69' ' ' LEU . . . . . 0.608 ' N ' ' O ' ' A' ' 67' ' ' ARG . 1.3 mt -64.57 -65.15 0.71 Allowed 'General case' 0 N--CA 1.473 0.715 0 C-N-CA 118.833 -1.147 . . . . 1.0 107.918 178.761 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 70' ' ' ALA . . . . . 0.653 ' C ' ' H ' ' A' ' 72' ' ' HIS . . . -78.22 -75.09 0.24 Allowed 'General case' 0 N--CA 1.469 0.494 0 N-CA-C 105.108 -2.182 . . . . 1.0 105.108 176.919 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 71' ' ' ALA . . . . . 0.46 ' O ' ' C ' ' A' ' 72' ' ' HIS . . . -44.87 4.1 0.0 OUTLIER 'General case' 0 CA--C 1.52 -0.209 0 C-N-CA 124.694 1.197 . . . . 1.0 113.425 178.57 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 72' ' ' HIS . . . . . 0.671 ' CG ' ' N ' ' A' ' 73' ' ' MET . 4.2 p-80 -28.22 -55.05 0.11 Allowed 'General case' 0 C--N 1.335 -0.065 0 CA-C-N 118.067 0.394 . . . . 1.0 111.967 -179.408 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 73' ' ' MET . . . . . 0.671 ' N ' ' CG ' ' A' ' 72' ' ' HIS . 3.8 ppp? -76.84 -53.5 7.82 Favored 'General case' 0 C--N 1.316 -0.858 0 N-CA-C 108.483 -0.932 . . . . 1.0 108.483 177.278 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 74' ' ' VAL . . . . . 0.725 ' O ' ' N ' ' A' ' 76' ' ' GLY . 65.8 t -44.51 -41.87 2.1 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.424 0 CA-C-O 117.748 -1.12 . . . . 1.0 110.775 -176.122 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 75' ' ' ASN . . . . . 0.533 ' C ' ' N ' ' A' ' 77' ' ' ILE . 1.8 t-20 -35.09 -14.58 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.7 0 CA-C-N 120.857 1.662 . . . . 1.0 112.836 178.403 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 76' ' ' GLY . . . . . 0.725 ' N ' ' O ' ' A' ' 74' ' ' VAL . . . -44.04 -19.21 0.11 Allowed Glycine 0 CA--C 1.543 1.82 0 N-CA-C 107.846 -2.102 . . . . 1.0 107.846 175.917 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 77' ' ' ILE . . . . . 0.533 ' N ' ' C ' ' A' ' 75' ' ' ASN . 0.8 OUTLIER -72.11 -54.98 14.85 Favored 'Isoleucine or valine' 0 C--O 1.207 -1.138 0 N-CA-C 107.683 -1.228 . . . . 1.0 107.683 178.267 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 78' ' ' VAL . . . . . 0.528 ' C ' ' O ' ' A' ' 77' ' ' ILE . 55.5 t -33.52 -37.51 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.314 -0.973 0 CA-C-N 113.252 -1.795 . . . . 1.0 106.849 -178.391 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 79' ' ' ILE . . . . . 0.546 ' O ' ' HB3' ' A' ' 83' ' ' ALA . 23.7 pt -97.77 -34.49 4.76 Favored 'Isoleucine or valine' 0 C--O 1.207 -1.146 0 CA-C-N 115.287 -0.869 . . . . 1.0 112.005 176.846 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 80' ' ' ALA . . . . . 0.501 ' N ' ' O ' ' A' ' 77' ' ' ILE . . . -84.78 -9.35 58.27 Favored 'General case' 0 N--CA 1.482 1.151 0 O-C-N 120.955 -1.091 . . . . 1.0 113.588 179.674 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 81' ' ' GLU . . . . . 0.495 ' N ' ' O ' ' A' ' 77' ' ' ILE . 82.3 tt0 -90.63 -75.77 0.45 Allowed 'General case' 0 N--CA 1.453 -0.314 0 N-CA-C 113.572 0.953 . . . . 1.0 113.572 -176.769 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 6.7 m-20 -91.04 -16.71 27.46 Favored 'General case' 0 C--O 1.22 -0.45 0 N-CA-C 113.463 0.912 . . . . 1.0 113.463 -179.141 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 83' ' ' ALA . . . . . 0.546 ' HB3' ' O ' ' A' ' 79' ' ' ILE . . . -46.7 -42.21 16.24 Favored 'General case' 0 C--O 1.22 -0.479 0 C-N-CA 119.369 -0.933 . . . . 1.0 111.348 -177.681 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 14.3 tp -37.46 -46.02 0.77 Allowed 'General case' 0 N--CA 1.47 0.55 0 CA-C-O 121.48 0.657 . . . . 1.0 110.613 -178.349 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -65.46 -37.1 79.24 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.855 0 CA-C-N 114.75 -1.114 . . . . 1.0 110.564 -179.127 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 86' ' ' ALA . . . . . 0.527 ' N ' ' O ' ' A' ' 83' ' ' ALA . . . -90.61 -26.03 19.86 Favored 'General case' 0 C--O 1.222 -0.372 0 CA-C-O 120.641 0.258 . . . . 1.0 111.668 -179.762 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 87' ' ' GLU . . . . . 0.534 ' N ' ' O ' ' A' ' 83' ' ' ALA . 30.6 tp10 -54.71 -24.94 24.33 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 121.423 0.63 . . . . 1.0 109.659 -179.068 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -72.25 -8.56 55.48 Favored 'General case' 0 C--N 1.324 -0.503 0 N-CA-C 107.823 -1.177 . . . . 1.0 107.823 178.89 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 89' ' ' VAL . . . . . 0.494 ' N ' ' O ' ' A' ' 86' ' ' ALA . 3.2 t -92.49 36.03 0.1 OUTLIER 'Isoleucine or valine' 0 C--N 1.315 -0.909 0 CA-C-N 112.759 -2.019 . . . . 1.0 107.414 177.478 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 90' ' ' GLY . . . . . 0.902 ' O ' ' N ' ' A' ' 92' ' ' HIS . . . -55.82 -25.27 44.09 Favored Glycine 0 C--N 1.366 2.237 0 CA-C-O 117.346 -1.808 . . . . 1.0 112.082 176.955 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 91' ' ' PRO . . . . . 0.729 ' HD2' ' N ' ' A' ' 90' ' ' GLY . 20.8 Cg_exo -32.99 1.28 0.0 OUTLIER 'Trans proline' 0 N--CA 1.496 1.641 0 C-N-CA 123.41 2.74 . . . . 1.0 113.526 173.295 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 92' ' ' HIS . . . . . 0.902 ' N ' ' O ' ' A' ' 90' ' ' GLY . 0.0 OUTLIER -49.82 -33.27 16.2 Favored 'General case' 0 N--CA 1.431 -1.412 0 N-CA-C 106.91 -1.515 . . . . 1.0 106.91 178.346 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 24.8 tp -59.8 -57.1 14.35 Favored 'General case' 0 N--CA 1.453 -0.284 0 N-CA-C 107.537 -1.283 . . . . 1.0 107.537 177.396 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -51.72 -53.9 34.2 Favored 'General case' 0 C--N 1.323 -0.561 0 N-CA-C 107.953 -1.128 . . . . 1.0 107.953 -178.955 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 6.2 mmp_? -64.81 -32.93 74.85 Favored 'General case' 0 N--CA 1.47 0.562 0 CA-C-O 121.894 0.854 . . . . 1.0 110.911 178.225 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 96' ' ' ALA . . . . . 0.811 ' O ' ' N ' ' A' ' 100' ' ' ILE . . . -48.16 -39.2 20.02 Favored 'General case' 0 N--CA 1.493 1.711 0 N-CA-C 105.489 -2.041 . . . . 1.0 105.489 -177.31 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 97' ' ' LEU . . . . . 0.536 HD13 ' C ' ' A' ' 97' ' ' LEU . 1.6 tm? -33.14 -24.34 0.0 OUTLIER 'General case' 0 CA--C 1.576 1.957 0 CA-C-N 112.693 -2.049 . . . . 1.0 107.219 -179.798 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 98' ' ' GLY . . . . . 0.722 ' N ' ' O ' ' A' ' 96' ' ' ALA . . . -90.04 -53.69 2.31 Favored Glycine 0 CA--C 1.557 2.665 0 CA-C-O 123.033 1.352 . . . . 1.0 111.796 171.226 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 99' ' ' GLN . . . . . 0.6 ' N ' ' O ' ' A' ' 96' ' ' ALA . 0.1 OUTLIER -77.97 8.02 5.27 Favored 'General case' 0 N--CA 1.443 -0.803 0 N-CA-C 107.458 -1.312 . . . . 1.0 107.458 177.691 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 100' ' ' ILE . . . . . 0.811 ' N ' ' O ' ' A' ' 96' ' ' ALA . 3.8 tp -61.73 -52.03 65.71 Favored 'Isoleucine or valine' 0 CA--C 1.48 -1.744 0 N-CA-C 107.076 -1.453 . . . . 1.0 107.076 179.416 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 101' ' ' VAL . . . . . 0.613 ' N ' HG23 ' A' ' 100' ' ' ILE . 62.7 t -52.93 -57.09 5.07 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 N-CA-C 106.464 -1.68 . . . . 1.0 106.464 177.654 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 102' ' ' CYS . . . . . 0.97 ' O ' ' HB2' ' A' ' 106' ' ' ALA . 0.0 OUTLIER -46.43 -19.8 0.09 Allowed 'General case' 0 CA--C 1.541 0.606 0 C-N-CA 120.038 -0.665 . . . . 1.0 109.423 -179.226 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 103' ' ' ARG . . . . . 0.574 HH21 ' CB ' ' A' ' 96' ' ' ALA . 11.4 mtm-85 -94.13 -48.28 6.28 Favored 'General case' 0 N--CA 1.474 0.763 0 N-CA-C 113.793 1.035 . . . . 1.0 113.793 178.228 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 104' ' ' TYR . . . . . 0.57 ' O ' ' CG ' ' A' ' 104' ' ' TYR . 60.8 t80 -103.92 21.44 16.33 Favored 'General case' 0 C--N 1.32 -0.706 0 C-N-CA 125.724 1.61 . . . . 1.0 110.895 -179.73 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 105' ' ' GLY . . . . . 0.596 ' N ' ' O ' ' A' ' 101' ' ' VAL . . . -165.08 -8.03 0.03 OUTLIER Glycine 0 N--CA 1.453 -0.169 0 C-N-CA 119.606 -1.283 . . . . 1.0 111.072 -179.8 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 106' ' ' ALA . . . . . 0.97 ' HB2' ' O ' ' A' ' 102' ' ' CYS . . . -28.72 117.65 0.11 Allowed 'General case' 0 CA--C 1.534 0.362 0 C-N-CA 122.117 0.167 . . . . 1.0 111.06 178.671 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 107' ' ' THR . . . . . 0.981 ' O ' ' HD2' ' A' ' 110' ' ' PRO . 6.6 m -135.7 -58.35 0.77 Allowed 'General case' 0 C--O 1.195 -1.777 0 N-CA-C 107.787 -1.19 . . . . 1.0 107.787 178.616 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 26.9 m -70.28 28.66 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.312 -1.061 0 O-C-N 120.735 -1.228 . . . . 1.0 108.847 -178.39 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 109' ' ' ILE . . . . . 0.681 HG21 ' HB1' ' A' ' 106' ' ' ALA . 0.0 OUTLIER -111.01 -45.18 0.08 OUTLIER Pre-proline 0 CA--C 1.55 0.969 0 O-C-N 121.834 -0.542 . . . . 1.0 110.277 178.86 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 110' ' ' PRO . . . . . 0.981 ' HD2' ' O ' ' A' ' 107' ' ' THR . 24.6 Cg_exo -66.72 -29.12 43.26 Favored 'Trans proline' 0 N--CA 1.496 1.675 0 C-N-CA 123.453 2.769 . . . . 1.0 111.262 -178.7 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 17.4 t-20 -68.35 -68.47 0.39 Allowed 'General case' 0 N--CA 1.455 -0.211 0 C-N-CA 120.405 -0.518 . . . . 1.0 109.847 -178.763 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 112' ' ' ILE . . . . . 0.41 HD13 HG21 ' A' ' 112' ' ' ILE . 21.3 pt -51.39 -28.57 8.15 Favored 'Isoleucine or valine' 0 C--O 1.217 -0.61 0 CA-C-O 122.623 1.202 . . . . 1.0 109.367 179.09 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 1.6 t30 -59.25 -51.89 68.01 Favored 'General case' 0 C--N 1.294 -1.814 0 CA-C-N 112.62 -2.082 . . . . 1.0 107.752 -177.855 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 114' ' ' ALA . . . . . 0.519 ' O ' HG23 ' A' ' 118' ' ' VAL . . . -59.59 -32.69 70.62 Favored 'General case' 0 N--CA 1.45 -0.464 0 N-CA-C 112.368 0.507 . . . . 1.0 112.368 -179.646 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -80.81 -53.47 6.46 Favored 'General case' 0 C--O 1.21 -0.977 0 CA-C-O 121.7 0.762 . . . . 1.0 110.398 178.141 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 116' ' ' ILE . . . . . 0.524 ' O ' ' N ' ' A' ' 120' ' ' GLY . 28.5 mt -50.32 -61.26 0.65 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.707 0 CA-C-N 114.143 -1.39 . . . . 1.0 108.6 -178.823 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 117' ' ' GLU . . . . . 0.422 ' C ' ' O ' ' A' ' 116' ' ' ILE . 49.2 mt-10 -42.16 -52.83 4.24 Favored 'General case' 0 C--N 1.307 -1.274 0 CA-C-N 112.239 -2.255 . . . . 1.0 106.791 -177.969 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 118' ' ' VAL . . . . . 0.519 HG23 ' O ' ' A' ' 114' ' ' ALA . 94.6 t -60.63 -53.05 54.3 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.492 0 N-CA-C 108.355 -0.98 . . . . 1.0 108.355 177.187 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 2.9 tp -51.29 -69.38 0.11 Allowed 'General case' 0 CA--C 1.536 0.414 0 N-CA-C 106.687 -1.597 . . . . 1.0 106.687 -178.775 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 120' ' ' GLY . . . . . 0.657 ' O ' ' OG1' ' A' ' 121' ' ' THR . . . -73.05 -84.59 0.25 Allowed Glycine 0 CA--C 1.537 1.419 0 C-N-CA 119.356 -1.402 . . . . 1.0 111.102 -179.555 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 121' ' ' THR . . . . . 0.657 ' OG1' ' O ' ' A' ' 120' ' ' GLY . 41.6 m 170.37 -39.72 0.0 OUTLIER 'General case' 0 N--CA 1.476 0.862 0 CA-C-N 113.649 -1.276 . . . . 1.0 112.67 179.156 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 122' ' ' GLY . . . . . 0.695 ' O ' ' N ' ' A' ' 124' ' ' ASP . . . 100.6 -18.78 54.64 Favored Glycine 0 N--CA 1.469 0.836 0 N-CA-C 106.815 -2.514 . . . . 1.0 106.815 -176.242 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 123' ' ' THR . . . . . 0.723 HG23 ' O ' ' A' ' 123' ' ' THR . 8.9 t -52.52 83.74 0.0 OUTLIER 'General case' 0 N--CA 1.477 0.875 0 N-CA-C 104.733 -2.321 . . . . 1.0 104.733 178.414 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 124' ' ' ASP . . . . . 0.695 ' N ' ' O ' ' A' ' 122' ' ' GLY . 4.9 m-20 -171.49 -175.43 1.61 Allowed 'General case' 0 CA--C 1.53 0.181 0 CA-C-N 113.976 -1.465 . . . . 1.0 111.434 179.523 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 125' ' ' TYR . . . . . . . . . . . . . 78.4 t80 -145.98 144.71 30.28 Favored 'General case' 0 CA--C 1.538 0.483 0 CA-C-N 114.749 -1.114 . . . . 1.0 109.011 175.813 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 36.4 mmt-85 -146.34 147.02 30.9 Favored 'General case' 0 N--CA 1.474 0.727 0 N-CA-C 109.794 -0.447 . . . . 1.0 109.794 179.848 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 127' ' ' PHE . . . . . 0.412 ' CD1' ' C ' ' A' ' 127' ' ' PHE . 0.1 OUTLIER . . . . . 0 C--O 1.221 -0.412 0 CA-C-O 117.937 -1.03 . . . . 1.0 110.558 179.328 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 128' ' ' MTN . . . . . 0.611 ' H82' ' NH2' ' A' ' 47' ' ' ARG . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 129' ' ' MTN . . . . . 0.709 ' H83' ' O ' ' A' ' 48' ' ' CYS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 130' ' ' MTN . . . . . 0.438 ' C7 ' ' NH1' ' A' ' 103' ' ' ARG . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 13.8 mmt . . . . . 0 N--CA 1.496 1.837 0 N-CA-C 109.691 -0.485 . . . . 1.0 109.691 . . . . . . . . . 0 0 . 1 . 022 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 98.1 p -106.35 9.44 31.86 Favored 'General case' 0 N--CA 1.469 0.482 0 CA-C-N 115.945 -0.57 . . . . 1.0 110.455 -179.946 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER 166.29 97.1 0.0 OUTLIER 'General case' 0 N--CA 1.466 0.362 0 CA-C-N 116.019 -0.537 . . . . 1.0 110.451 179.382 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 85.2 t80 -149.26 144.98 26.85 Favored 'General case' 0 N--CA 1.466 0.343 0 CA-C-N 116.053 -0.522 . . . . 1.0 110.104 179.441 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 5' ' ' ASP . . . . . 0.445 ' N ' ' OD1' ' A' ' 5' ' ' ASP . 5.1 p30 -153.54 148.65 26.8 Favored 'General case' 0 C--N 1.33 -0.274 0 N-CA-C 109.997 -0.372 . . . . 1.0 109.997 -179.761 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 6' ' ' THR . . . . . 0.577 ' O ' ' N ' ' A' ' 10' ' ' SER . 0.2 OUTLIER -70.87 177.15 3.79 Favored 'General case' 0 C--O 1.211 -0.95 0 C-N-CA 120.337 -0.545 . . . . 1.0 110.038 -179.979 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 7' ' ' GLU . . . . . 0.519 ' O ' ' N ' ' A' ' 11' ' ' ARG . 0.6 OUTLIER -59.62 -55.46 34.18 Favored 'General case' 0 C--N 1.317 -0.845 0 CA-C-O 121.566 0.698 . . . . 1.0 109.804 -178.436 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 8' ' ' ARG . . . . . 0.467 ' O ' ' HB3' ' A' ' 12' ' ' ALA . 0.2 OUTLIER -51.61 -57.11 10.06 Favored 'General case' 0 C--N 1.318 -0.761 0 N-CA-C 107.613 -1.255 . . . . 1.0 107.613 -178.182 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 9' ' ' VAL . . . . . 0.85 ' O ' HG13 ' A' ' 13' ' ' VAL . 0.0 OUTLIER -66.26 -47.9 82.87 Favored 'Isoleucine or valine' 0 CA--C 1.556 1.18 0 CA-C-N 114.036 -1.438 . . . . 1.0 110.127 -178.857 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 10' ' ' SER . . . . . 0.577 ' N ' ' O ' ' A' ' 6' ' ' THR . 32.6 t -62.45 -59.48 4.9 Favored 'General case' 0 N--CA 1.491 1.604 0 CA-C-O 121.022 0.439 . . . . 1.0 109.998 179.148 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 11' ' ' ARG . . . . . 0.553 ' O ' ' N ' ' A' ' 15' ' ' ALA . 20.2 tpp180 -66.08 -55.16 17.9 Favored 'General case' 0 CA--C 1.547 0.835 0 O-C-N 121.539 -0.726 . . . . 1.0 110.404 -177.397 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 12' ' ' ALA . . . . . 0.511 ' O ' ' HB3' ' A' ' 16' ' ' ALA . . . -50.97 -52.24 44.58 Favored 'General case' 0 N--CA 1.481 1.103 0 C-N-CA 118.228 -1.389 . . . . 1.0 107.307 -178.893 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 13' ' ' VAL . . . . . 0.85 HG13 ' O ' ' A' ' 9' ' ' VAL . 3.2 m -63.21 -48.91 85.36 Favored 'Isoleucine or valine' 0 C--O 1.199 -1.593 0 C-N-CA 117.796 -1.562 . . . . 1.0 108.791 177.576 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 14' ' ' ALA . . . . . 0.713 ' O ' HG13 ' A' ' 18' ' ' VAL . . . -57.12 -61.88 2.15 Favored 'General case' 0 C--O 1.211 -0.964 0 C-N-CA 117.621 -1.632 . . . . 1.0 109.638 179.039 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 15' ' ' ALA . . . . . 0.566 ' O ' ' N ' ' A' ' 19' ' ' GLY . . . -53.07 -55.78 21.21 Favored 'General case' 0 N--CA 1.475 0.82 0 CA-C-O 121.552 0.691 . . . . 1.0 110.263 -177.702 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 16' ' ' ALA . . . . . 0.541 ' CA ' ' H ' ' A' ' 22' ' ' GLY . . . -62.85 -54.55 37.11 Favored 'General case' 0 C--N 1.312 -1.055 0 CA-C-N 114.598 -1.183 . . . . 1.0 108.999 -179.346 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 17' ' ' LEU . . . . . 0.586 ' CB ' ' O ' ' A' ' 13' ' ' VAL . 24.2 tp -56.75 -53.96 51.75 Favored 'General case' 0 N--CA 1.477 0.922 0 CA-C-N 114.606 -1.179 . . . . 1.0 108.752 -177.284 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 18' ' ' VAL . . . . . 0.713 HG13 ' O ' ' A' ' 14' ' ' ALA . 2.5 m -68.58 -55.98 14.02 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.355 0 C-N-CA 119.511 -0.876 . . . . 1.0 109.139 179.637 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 19' ' ' GLY . . . . . 0.566 ' N ' ' O ' ' A' ' 15' ' ' ALA . . . -64.9 -165.28 1.07 Allowed Glycine 0 CA--C 1.525 0.693 0 CA-C-N 116.292 -0.413 . . . . 1.0 112.81 -178.596 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 20' ' ' PRO . . . . . 0.594 ' O ' ' N ' ' A' ' 24' ' ' ALA . 3.2 Cg_endo -81.17 -25.65 3.86 Favored 'Trans proline' 0 C--N 1.312 -1.374 0 C-N-CA 123.134 2.556 . . . . 1.0 112.486 -178.716 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -57.65 -58.75 12.93 Favored Glycine 0 CA--C 1.532 1.125 0 C-N-CA 119.522 -1.323 . . . . 1.0 110.924 -176.663 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 22' ' ' GLY . . . . . 0.678 ' O ' HG22 ' A' ' 26' ' ' VAL . . . -61.94 -54.36 35.78 Favored Glycine 0 N--CA 1.47 0.936 0 N-CA-C 108.152 -1.979 . . . . 1.0 108.152 -178.94 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 23' ' ' VAL . . . . . 0.566 ' O ' HG12 ' A' ' 27' ' ' VAL . 24.2 t -56.17 -38.66 55.1 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.636 0 N-CA-C 109.166 -0.679 . . . . 1.0 109.166 -179.794 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 24' ' ' ALA . . . . . 0.594 ' N ' ' O ' ' A' ' 20' ' ' PRO . . . -60.28 -61.06 2.88 Favored 'General case' 0 CA--C 1.536 0.414 0 C-N-CA 119.272 -0.971 . . . . 1.0 111.011 -179.488 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 16.3 mt -64.1 -46.88 82.27 Favored 'General case' 0 N--CA 1.468 0.447 0 N-CA-C 113.446 0.906 . . . . 1.0 113.446 -177.009 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 26' ' ' VAL . . . . . 0.678 HG22 ' O ' ' A' ' 22' ' ' GLY . 18.9 m -61.51 -58.26 8.38 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 C-N-CA 118.845 -1.142 . . . . 1.0 110.297 -177.688 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 27' ' ' VAL . . . . . 0.631 ' N ' HG23 ' A' ' 26' ' ' VAL . 1.1 p -63.07 -37.73 80.16 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 N-CA-C 112.518 0.562 . . . . 1.0 112.518 -177.377 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 7.9 tmtm? -67.52 -54.69 17.92 Favored 'General case' 0 C--N 1.319 -0.737 0 N-CA-C 108.556 -0.905 . . . . 1.0 108.556 -178.764 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 93.2 t -63.64 -48.48 86.52 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.972 0 CA-C-N 114.394 -1.275 . . . . 1.0 110.331 -178.294 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 30' ' ' CYS . . . . . . . . . . . . . 34.9 t -64.77 -60.8 2.68 Favored 'General case' 0 C--N 1.326 -0.445 0 C-N-CA 119.231 -0.988 . . . . 1.0 109.944 -179.106 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 31' ' ' ALA . . . . . 0.607 ' HB3' ' O ' ' A' ' 27' ' ' VAL . . . -64.11 -51.88 61.86 Favored 'General case' 0 C--N 1.325 -0.493 0 N-CA-C 111.992 0.367 . . . . 1.0 111.992 -176.074 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 88.48 74.09 1.28 Allowed Glycine 0 CA--C 1.527 0.805 0 N-CA-C 109.994 -1.242 . . . . 1.0 109.994 -179.196 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 38.6 mt 75.29 126.15 0.03 OUTLIER Pre-proline 0 N--CA 1.476 0.846 0 C-N-CA 122.815 0.446 . . . . 1.0 110.562 -179.422 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 56.6 Cg_endo -72.26 -13.01 28.13 Favored 'Trans proline' 0 N--CA 1.505 2.15 0 C-N-CA 122.227 1.952 . . . . 1.0 114.762 -179.316 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 35' ' ' GLY . . . . . 0.674 ' HA2' HD12 ' A' ' 112' ' ' ILE . . . -60.19 -59.57 10.13 Favored Glycine 0 N--CA 1.468 0.804 0 C-N-CA 118.156 -1.973 . . . . 1.0 109.584 -178.787 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 36' ' ' VAL . . . . . 0.425 HG12 ' H ' ' A' ' 37' ' ' ILE . 1.5 t -78.64 -145.56 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.323 -0.572 0 N-CA-C 107.089 -1.449 . . . . 1.0 107.089 178.095 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 37' ' ' ILE . . . . . 0.461 HG13 ' HB1' ' A' ' 31' ' ' ALA . 5.4 mm 76.71 78.36 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 N-CA-C 112.762 0.653 . . . . 1.0 112.762 177.756 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -135.99 126.99 27.77 Favored 'General case' 0 CA--C 1.538 0.484 0 N-CA-C 106.809 -1.552 . . . . 1.0 106.809 177.904 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 39' ' ' THR . . . . . 0.528 ' OG1' ' NH2' ' A' ' 47' ' ' ARG . 23.9 p -104.54 149.68 37.68 Favored Pre-proline 0 N--CA 1.47 0.57 0 N-CA-C 110.103 -0.332 . . . . 1.0 110.103 -178.972 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 89.6 Cg_endo -75.79 -34.31 3.28 Favored 'Trans proline' 0 C--N 1.311 -1.402 0 C-N-CA 121.675 1.583 . . . . 1.0 114.211 -178.685 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -128.82 134.64 48.41 Favored 'General case' 0 N--CA 1.477 0.88 0 CA-C-N 118.089 0.404 . . . . 1.0 111.548 179.035 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 42' ' ' ARG . . . . . 0.684 HH21 ' N ' ' A' ' 46' ' ' PHE . 16.6 ptm180 -169.37 167.89 9.83 Favored 'General case' 0 C--N 1.325 -0.491 0 C-N-CA 119.789 -0.765 . . . . 1.0 111.266 177.071 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -67.48 18.9 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.051 -0.522 . . . . 1.0 109.988 179.377 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 44' ' ' GLY . . . . . 0.635 ' H ' ' C ' ' A' ' 42' ' ' ARG . . . 79.45 -24.62 3.03 Favored Glycine 0 CA--C 1.522 0.502 0 N-CA-C 111.278 -0.729 . . . . 1.0 111.278 179.803 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 45' ' ' PHE . . . . . 0.541 ' C ' HH21 ' A' ' 42' ' ' ARG . 0.2 OUTLIER -150.54 149.14 29.54 Favored 'General case' 0 CA--C 1.542 0.65 0 N-CA-C 109.061 -0.718 . . . . 1.0 109.061 -178.886 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 46' ' ' PHE . . . . . 0.684 ' N ' HH21 ' A' ' 42' ' ' ARG . 1.9 m-30 144.53 73.45 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.826 0 O-C-N 124.408 1.067 . . . . 1.0 111.664 179.006 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 47' ' ' ARG . . . . . 1.028 ' O ' ' S1 ' ' A' ' 129' ' ' MTN . 2.2 ptt-85 135.2 151.09 0.0 OUTLIER 'General case' 0 N--CA 1.5 2.03 0 CA-C-O 116.905 -1.521 . . . . 1.0 108.643 -179.758 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 48' ' ' CYS . . . . . 0.691 ' O ' ' H61' ' A' ' 129' ' ' MTN . 6.2 p 51.1 62.31 2.78 Favored 'General case' 0 N--CA 1.482 1.161 0 CA-C-N 120.717 1.599 . . . . 1.0 111.982 -179.258 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -110.79 147.21 36.01 Favored Pre-proline 0 N--CA 1.473 0.702 0 N-CA-C 110.144 -0.317 . . . . 1.0 110.144 177.921 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 50' ' ' PRO . . . . . 0.408 ' HG2' ' HE ' ' A' ' 52' ' ' ARG . 72.4 Cg_endo -71.99 55.08 2.26 Favored 'Trans proline' 0 N--CA 1.494 1.516 0 C-N-CA 122.369 2.046 . . . . 1.0 111.762 179.959 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER 67.43 -3.42 1.07 Allowed 'General case' 0 N--CA 1.468 0.427 0 CA-C-N 115.071 -0.968 . . . . 1.0 111.474 179.189 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 52' ' ' ARG . . . . . 0.408 ' HE ' ' HG2' ' A' ' 50' ' ' PRO . 16.3 mtm-85 -85.92 154.03 21.78 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 121.377 0.608 . . . . 1.0 111.839 -179.557 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 53' ' ' ILE . . . . . 0.526 HG23 HG22 ' A' ' 55' ' ' ILE . 8.5 tp -68.22 137.0 25.39 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.306 0 CA-C-N 115.208 -0.905 . . . . 1.0 110.177 179.705 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -59.76 80.44 0.01 OUTLIER 'General case' 0 C--N 1.316 -0.858 0 CA-C-N 114.52 -1.218 . . . . 1.0 109.289 -177.548 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 55' ' ' ILE . . . . . 0.526 HG22 HG23 ' A' ' 53' ' ' ILE . 18.2 tt -149.17 157.91 6.58 Favored 'Isoleucine or valine' 0 C--N 1.348 0.538 0 N-CA-C 110.109 -0.33 . . . . 1.0 110.109 177.991 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 110.48 -6.38 29.99 Favored Glycine 0 N--CA 1.472 1.047 0 N-CA-C 110.698 -0.961 . . . . 1.0 110.698 -179.722 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 16.1 p-10 -76.46 98.31 4.56 Favored 'General case' 0 C--N 1.323 -0.58 0 N-CA-C 108.855 -0.794 . . . . 1.0 108.855 177.788 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 58' ' ' TRP . . . . . . . . . . . . . 24.1 m0 -87.84 174.54 8.3 Favored 'General case' 0 CA--C 1.533 0.324 0 CA-C-O 122.531 1.157 . . . . 1.0 112.513 -177.636 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 12.9 mtm180 -84.5 -62.03 1.65 Allowed 'General case' 0 C--N 1.317 -0.837 0 CA-C-N 112.523 -2.126 . . . . 1.0 112.628 -178.958 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 9.3 p90 -90.53 -15.25 31.04 Favored 'General case' 0 C--O 1.247 0.924 0 N-CA-C 113.615 0.969 . . . . 1.0 113.615 -178.861 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 4.8 tt0 -78.72 -14.44 59.28 Favored 'General case' 0 C--N 1.323 -0.554 0 O-C-N 121.569 -0.707 . . . . 1.0 110.53 -179.318 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 62' ' ' VAL . . . . . 0.566 ' O ' ' N ' ' A' ' 66' ' ' GLY . 27.8 m -46.26 -55.13 1.64 Allowed 'Isoleucine or valine' 0 C--O 1.209 -1.053 0 C-N-CA 119.931 -0.707 . . . . 1.0 110.099 -175.281 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 63' ' ' ALA . . . . . 0.554 ' N ' HG23 ' A' ' 62' ' ' VAL . . . -67.44 -52.17 42.78 Favored 'General case' 0 C--N 1.307 -1.273 0 CA-C-N 117.968 0.349 . . . . 1.0 110.25 -179.728 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 64' ' ' HIS . . . . . 0.498 ' O ' ' CG ' ' A' ' 67' ' ' ARG . 0.1 OUTLIER -50.3 -56.25 12.03 Favored 'General case' 0 CA--C 1.544 0.714 0 N-CA-C 108.595 -0.891 . . . . 1.0 108.595 -179.713 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 65' ' ' ASP . . . . . 0.697 ' C ' ' H ' ' A' ' 67' ' ' ARG . 21.0 t0 -69.8 -48.45 59.05 Favored 'General case' 0 C--N 1.318 -0.762 0 CA-C-O 121.813 0.816 . . . . 1.0 110.011 178.386 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 66' ' ' GLY . . . . . 0.566 ' N ' ' O ' ' A' ' 62' ' ' VAL . . . -68.74 27.2 0.29 Allowed Glycine 0 CA--C 1.516 0.153 0 N-CA-C 109.68 -1.368 . . . . 1.0 109.68 177.468 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 67' ' ' ARG . . . . . 0.748 ' HB3' ' HB3' ' A' ' 71' ' ' ALA . 29.0 mmt-85 -70.83 -0.74 9.71 Favored 'General case' 0 N--CA 1.438 -1.06 0 N-CA-C 106.486 -1.672 . . . . 1.0 106.486 174.771 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 68' ' ' LEU . . . . . 0.477 ' H ' ' C ' ' A' ' 66' ' ' GLY . 4.8 tt -32.95 -29.86 0.01 OUTLIER 'General case' 0 C--N 1.354 0.786 0 O-C-N 123.757 0.661 . . . . 1.0 109.327 -175.221 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 69' ' ' LEU . . . . . 0.617 ' N ' ' O ' ' A' ' 67' ' ' ARG . 4.3 tp -68.4 -66.94 0.51 Allowed 'General case' 0 CA--C 1.548 0.876 0 CA-C-N 114.554 -1.203 . . . . 1.0 111.224 179.748 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 70' ' ' ALA . . . . . 0.648 ' C ' ' H ' ' A' ' 72' ' ' HIS . . . -80.29 -78.56 0.17 Allowed 'General case' 0 N--CA 1.478 0.938 0 C-N-CA 118.145 -1.422 . . . . 1.0 108.862 179.814 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 71' ' ' ALA . . . . . 0.787 ' HB1' ' HB ' ' A' ' 74' ' ' VAL . . . -52.14 7.98 0.0 OUTLIER 'General case' 0 C--N 1.324 -0.522 0 C-N-CA 123.985 0.914 . . . . 1.0 112.468 -179.808 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 72' ' ' HIS . . . . . 0.648 ' H ' ' C ' ' A' ' 70' ' ' ALA . 6.2 p-80 -24.93 -51.91 0.03 OUTLIER 'General case' 0 N--CA 1.469 0.481 0 N-CA-C 113.034 0.753 . . . . 1.0 113.034 -178.907 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 73' ' ' MET . . . . . 0.615 ' N ' ' CG ' ' A' ' 72' ' ' HIS . 2.2 tpp -73.53 -49.32 27.09 Favored 'General case' 0 C--N 1.322 -0.606 0 C-N-CA 119.309 -0.956 . . . . 1.0 108.901 178.936 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 74' ' ' VAL . . . . . 0.787 ' HB ' ' HB1' ' A' ' 71' ' ' ALA . 61.8 t -43.46 -42.53 1.49 Allowed 'Isoleucine or valine' 0 CA--C 1.517 -0.3 0 CA-C-O 118.43 -0.795 . . . . 1.0 111.804 -175.706 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 75' ' ' ASN . . . . . 0.639 ' O ' HG12 ' A' ' 78' ' ' VAL . 0.4 OUTLIER -39.37 -13.86 0.01 OUTLIER 'General case' 0 N--CA 1.478 0.926 0 CA-C-N 120.01 1.277 . . . . 1.0 111.68 178.582 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 76' ' ' GLY . . . . . 0.667 ' N ' ' O ' ' A' ' 74' ' ' VAL . . . -43.31 -23.98 0.31 Allowed Glycine 0 CA--C 1.546 1.979 0 N-CA-C 108.068 -2.013 . . . . 1.0 108.068 178.412 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 77' ' ' ILE . . . . . 0.619 ' HA ' ' HB3' ' A' ' 80' ' ' ALA . 9.8 pt -69.75 -48.81 62.62 Favored 'Isoleucine or valine' 0 C--O 1.214 -0.799 0 N-CA-C 107.385 -1.339 . . . . 1.0 107.385 177.274 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 78' ' ' VAL . . . . . 0.639 HG12 ' O ' ' A' ' 75' ' ' ASN . 3.7 p -34.26 -36.68 0.06 OUTLIER 'Isoleucine or valine' 0 CA--C 1.542 0.643 0 N-CA-C 107.399 -1.334 . . . . 1.0 107.399 -177.076 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 79' ' ' ILE . . . . . 0.534 HG23 HG13 ' A' ' 78' ' ' VAL . 43.9 pt -97.65 -26.49 3.93 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.862 0 N-CA-C 111.924 0.342 . . . . 1.0 111.924 178.077 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 80' ' ' ALA . . . . . 0.619 ' HB3' ' HA ' ' A' ' 77' ' ' ILE . . . -86.6 -10.72 53.29 Favored 'General case' 0 N--CA 1.48 1.039 0 N-CA-C 113.475 0.917 . . . . 1.0 113.475 178.681 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 81' ' ' GLU . . . . . 0.489 ' N ' ' O ' ' A' ' 77' ' ' ILE . 2.6 mt-10 -78.56 -68.96 0.6 Allowed 'General case' 0 N--CA 1.436 -1.126 0 N-CA-C 107.405 -1.331 . . . . 1.0 107.405 178.041 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 82' ' ' ASP . . . . . 0.9 ' O ' ' N ' ' A' ' 84' ' ' LEU . 0.5 OUTLIER -59.58 -60.87 3.16 Favored 'General case' 0 N--CA 1.437 -1.101 0 N-CA-C 107.928 -1.138 . . . . 1.0 107.928 178.705 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 83' ' ' ALA . . . . . 0.638 ' HA ' ' HB3' ' A' ' 86' ' ' ALA . . . 31.8 -64.52 0.0 OUTLIER 'General case' 0 N--CA 1.478 0.946 0 O-C-N 124.501 1.126 . . . . 1.0 111.812 179.32 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 84' ' ' LEU . . . . . 0.9 ' N ' ' O ' ' A' ' 82' ' ' ASP . 19.9 mt -33.78 -37.48 0.04 OUTLIER 'General case' 0 N--CA 1.475 0.788 0 N-CA-C 112.8 0.667 . . . . 1.0 112.8 -177.68 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 85' ' ' ILE . . . . . 1.019 HD13 ' N ' ' A' ' 86' ' ' ALA . 0.0 OUTLIER -100.43 -34.44 4.09 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.473 0 N-CA-C 108.584 -0.895 . . . . 1.0 108.584 177.857 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 86' ' ' ALA . . . . . 1.019 ' N ' HD13 ' A' ' 85' ' ' ILE . . . -62.78 -61.25 2.54 Favored 'General case' 0 CA--C 1.539 0.55 0 CA-C-N 115.104 -0.953 . . . . 1.0 109.849 -179.413 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -64.66 16.35 0.02 OUTLIER 'General case' 0 CA--C 1.537 0.457 0 O-C-N 121.836 -0.54 . . . . 1.0 110.84 -179.206 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 88' ' ' ALA . . . . . 0.58 ' H ' ' C ' ' A' ' 86' ' ' ALA . . . -115.97 -14.94 11.23 Favored 'General case' 0 N--CA 1.466 0.353 0 N-CA-C 108.626 -0.879 . . . . 1.0 108.626 178.116 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 21.5 m -109.79 31.54 1.11 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.238 0 CA-C-N 115.11 -0.95 . . . . 1.0 109.775 177.734 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 90' ' ' GLY . . . . . 0.55 ' N ' ' CD ' ' A' ' 91' ' ' PRO . . . -69.29 -39.76 81.5 Favored Glycine 0 CA--C 1.529 0.907 0 N-CA-C 111.059 -0.817 . . . . 1.0 111.059 178.216 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 91' ' ' PRO . . . . . 0.55 ' CD ' ' N ' ' A' ' 90' ' ' GLY . 81.0 Cg_exo -48.24 -8.53 0.06 OUTLIER 'Trans proline' 0 N--CA 1.493 1.466 0 C-N-CA 121.836 1.691 . . . . 1.0 111.048 179.266 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 92' ' ' HIS . . . . . 0.549 ' H ' ' C ' ' A' ' 90' ' ' GLY . 28.9 t60 -58.05 -14.37 6.49 Favored 'General case' 0 C--O 1.214 -0.804 0 N-CA-C 108.245 -1.02 . . . . 1.0 108.245 179.893 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 93' ' ' LEU . . . . . 0.58 HD12 ' N ' ' A' ' 94' ' ' ALA . 1.2 pp -63.44 -55.97 19.92 Favored 'General case' 0 CA--C 1.531 0.24 0 N-CA-C 108.128 -1.064 . . . . 1.0 108.128 177.464 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 94' ' ' ALA . . . . . 0.58 ' N ' HD12 ' A' ' 93' ' ' LEU . . . -56.45 -50.57 71.32 Favored 'General case' 0 CA--C 1.515 -0.376 0 N-CA-C 108.804 -0.813 . . . . 1.0 108.804 178.861 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 95' ' ' ARG . . . . . 0.611 ' O ' ' N ' ' A' ' 97' ' ' LEU . 7.8 ttt180 -59.65 -59.61 5.17 Favored 'General case' 0 CA--C 1.507 -0.68 0 N-CA-C 106.994 -1.484 . . . . 1.0 106.994 178.472 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 96' ' ' ALA . . . . . 0.924 ' O ' ' N ' ' A' ' 98' ' ' GLY . . . -47.21 -14.2 0.03 OUTLIER 'General case' 0 N--CA 1.418 -2.035 0 O-C-N 119.026 -2.296 . . . . 1.0 111.23 -179.976 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 97' ' ' LEU . . . . . 0.693 ' O ' ' N ' ' A' ' 100' ' ' ILE . 16.4 tp 7.1 -51.94 0.0 OUTLIER 'General case' 0 N--CA 1.487 1.394 0 CA-C-O 118.133 -0.937 . . . . 1.0 110.407 -168.103 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 98' ' ' GLY . . . . . 0.924 ' N ' ' O ' ' A' ' 96' ' ' ALA . . . -50.74 -23.55 6.95 Favored Glycine 0 CA--C 1.548 2.122 0 CA-C-N 122.221 2.282 . . . . 1.0 107.618 173.753 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 99' ' ' GLN . . . . . 0.577 ' N ' ' O ' ' A' ' 96' ' ' ALA . 1.4 tp-100 -67.02 -20.48 65.87 Favored 'General case' 0 C--N 1.377 1.788 0 N-CA-C 106.665 -1.605 . . . . 1.0 106.665 176.805 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 100' ' ' ILE . . . . . 0.693 ' N ' ' O ' ' A' ' 97' ' ' LEU . 2.7 tp -63.57 -39.59 85.93 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.867 0 N-CA-C 107.245 -1.391 . . . . 1.0 107.245 177.664 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 101' ' ' VAL . . . . . 0.662 ' O ' ' N ' ' A' ' 105' ' ' GLY . 97.6 t -59.26 -61.71 1.33 Allowed 'Isoleucine or valine' 0 C--O 1.215 -0.731 0 N-CA-C 108.894 -0.78 . . . . 1.0 108.894 178.954 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 102' ' ' CYS . . . . . 0.818 ' O ' ' HB2' ' A' ' 106' ' ' ALA . 3.5 t -45.46 -26.99 0.64 Allowed 'General case' 0 C--N 1.315 -0.928 0 N-CA-C 112.368 0.507 . . . . 1.0 112.368 -179.089 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 53.8 ttt-85 -86.78 -47.39 9.12 Favored 'General case' 0 N--CA 1.494 1.752 0 CA-C-O 122.632 1.206 . . . . 1.0 112.891 179.639 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 104' ' ' TYR . . . . . 0.668 ' O ' ' CG ' ' A' ' 104' ' ' TYR . 0.0 OUTLIER -98.62 24.19 7.77 Favored 'General case' 0 C--N 1.299 -1.596 0 CA-C-N 112.203 -2.271 . . . . 1.0 107.88 178.09 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 105' ' ' GLY . . . . . 0.662 ' N ' ' O ' ' A' ' 101' ' ' VAL . . . -162.62 -94.82 0.1 Allowed Glycine 0 CA--C 1.533 1.206 0 N-CA-C 106.589 -2.604 . . . . 1.0 106.589 177.987 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 106' ' ' ALA . . . . . 0.818 ' HB2' ' O ' ' A' ' 102' ' ' CYS . . . 70.69 63.18 0.19 Allowed 'General case' 0 CA--C 1.543 0.679 0 N-CA-C 114.021 1.119 . . . . 1.0 114.021 -179.362 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 107' ' ' THR . . . . . 0.719 ' O ' ' HD2' ' A' ' 110' ' ' PRO . 97.9 m -79.96 -57.76 3.49 Favored 'General case' 0 C--O 1.212 -0.881 0 O-C-N 120.349 -1.469 . . . . 1.0 109.435 177.845 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 108' ' ' VAL . . . . . 0.659 ' O ' HG12 ' A' ' 108' ' ' VAL . 21.4 t -80.22 25.04 0.08 OUTLIER 'Isoleucine or valine' 0 CA--C 1.538 0.486 0 O-C-N 121.254 -0.903 . . . . 1.0 113.079 -175.997 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 109' ' ' ILE . . . . . 0.541 ' H ' ' HD3' ' A' ' 110' ' ' PRO . 0.5 OUTLIER -109.38 -38.25 0.13 Allowed Pre-proline 0 CA--C 1.561 1.381 0 CA-C-N 118.909 0.777 . . . . 1.0 110.71 176.683 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 110' ' ' PRO . . . . . 0.719 ' HD2' ' O ' ' A' ' 107' ' ' THR . 23.0 Cg_exo -67.88 -23.15 41.53 Favored 'Trans proline' 0 N--CA 1.507 2.296 0 C-N-CA 123.642 2.894 . . . . 1.0 110.794 178.291 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 21.3 t-20 -69.17 -67.84 0.45 Allowed 'General case' 0 C--O 1.237 0.423 0 N-CA-C 109.169 -0.678 . . . . 1.0 109.169 -179.624 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 112' ' ' ILE . . . . . 0.674 HD12 ' HA2' ' A' ' 35' ' ' GLY . 0.5 OUTLIER -49.03 -30.39 3.55 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.596 0 CA-C-O 121.911 0.863 . . . . 1.0 108.701 177.861 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 113' ' ' ASN . . . . . 0.468 ' HB3' ' O ' ' A' ' 110' ' ' PRO . 20.4 t30 -55.25 -55.56 30.0 Favored 'General case' 0 C--N 1.309 -1.153 0 CA-C-N 113.833 -1.53 . . . . 1.0 108.31 -178.111 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -56.75 -31.78 64.92 Favored 'General case' 0 CA--C 1.537 0.458 0 N-CA-C 113.116 0.784 . . . . 1.0 113.116 -179.469 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -81.04 -50.4 9.72 Favored 'General case' 0 N--CA 1.472 0.664 0 CA-C-O 121.988 0.899 . . . . 1.0 110.951 178.237 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 116' ' ' ILE . . . . . 0.541 HG22 ' N ' ' A' ' 117' ' ' GLU . 0.4 OUTLIER -49.07 -57.84 1.52 Allowed 'Isoleucine or valine' 0 C--N 1.314 -0.95 0 CA-C-N 113.969 -1.468 . . . . 1.0 107.562 -179.961 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 117' ' ' GLU . . . . . 0.541 ' N ' HG22 ' A' ' 116' ' ' ILE . 2.4 tt0 -37.89 -55.99 1.16 Allowed 'General case' 0 N--CA 1.475 0.808 0 CA-C-N 113.187 -1.824 . . . . 1.0 106.526 -178.711 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 84.6 t -58.58 -50.58 78.5 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.723 0 CA-C-N 113.314 -1.767 . . . . 1.0 108.386 178.818 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 119' ' ' LEU . . . . . 0.497 ' N ' ' O ' ' A' ' 116' ' ' ILE . 1.2 tp -57.38 -73.98 0.06 Allowed 'General case' 0 CA--C 1.547 0.861 0 C-N-CA 119.823 -0.751 . . . . 1.0 109.666 -178.239 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -77.62 -82.21 0.6 Allowed Glycine 0 CA--C 1.543 1.837 0 C-N-CA 118.55 -1.786 . . . . 1.0 113.209 -178.904 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 121' ' ' THR . . . . . 0.412 ' H ' ' H ' ' A' ' 122' ' ' GLY . 27.3 m -168.5 -22.92 0.02 OUTLIER 'General case' 0 C--N 1.303 -1.425 0 N-CA-C 105.2 -2.148 . . . . 1.0 105.2 -176.621 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 122' ' ' GLY . . . . . 0.412 ' H ' ' H ' ' A' ' 121' ' ' THR . . . 109.1 -33.61 6.04 Favored Glycine 0 N--CA 1.449 -0.472 0 CA-C-N 112.472 -2.149 . . . . 1.0 114.686 177.37 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 123' ' ' THR . . . . . 0.408 ' C ' ' O ' ' A' ' 122' ' ' GLY . 0.2 OUTLIER -41.75 106.89 0.07 Allowed 'General case' 0 CA--C 1.538 0.49 0 CA-C-N 120.351 2.075 . . . . 1.0 113.05 -177.515 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 28.8 m-20 -142.6 145.03 33.12 Favored 'General case' 0 N--CA 1.465 0.298 0 CA-C-N 114.276 -1.329 . . . . 1.0 108.768 178.082 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 125' ' ' TYR . . . . . 0.421 ' CD1' ' C ' ' A' ' 125' ' ' TYR . 0.0 OUTLIER -151.5 146.64 26.05 Favored 'General case' 0 CA--C 1.546 0.801 0 N-CA-C 109.061 -0.718 . . . . 1.0 109.061 179.191 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 126' ' ' ARG . . . . . 0.579 ' CB ' ' H62' ' A' ' 130' ' ' MTN . 11.9 mmp_? -146.92 151.68 37.43 Favored 'General case' 0 N--CA 1.472 0.645 0 CA-C-N 115.112 -0.949 . . . . 1.0 109.341 177.534 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 127' ' ' PHE . . . . . . . . . . . . . 7.9 p90 . . . . . 0 C--O 1.219 -0.539 0 CA-C-O 118.173 -0.918 . . . . 1.0 110.533 178.726 . . . . . . . . 0 0 . 1 . 022 nuclear build full ' A' A ' 128' ' ' MTN . . . . . 0.752 ' H61' ' S1 ' ' A' ' 128' ' ' MTN . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 129' ' ' MTN . . . . . 1.028 ' S1 ' ' O ' ' A' ' 47' ' ' ARG . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 130' ' ' MTN . . . . . 0.579 ' H62' ' CB ' ' A' ' 126' ' ' ARG . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.494 1.73 0 CA-C-O 121.226 0.536 . . . . 1.0 109.963 . . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 2' ' ' SER . . . . . 0.49 ' O ' ' CB ' ' A' ' 3' ' ' ASP . 6.7 m -83.92 9.14 12.93 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.448 -0.796 . . . . 1.0 110.892 179.825 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 3' ' ' ASP . . . . . 0.49 ' CB ' ' O ' ' A' ' 2' ' ' SER . 1.4 m-20 150.35 126.96 0.0 OUTLIER 'General case' 0 N--CA 1.478 0.956 0 O-C-N 124.088 0.867 . . . . 1.0 111.208 178.713 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 27.4 t80 -157.26 152.58 26.27 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.829 -0.623 . . . . 1.0 110.506 178.428 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 8.4 p30 -151.75 147.5 26.75 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.726 -0.67 . . . . 1.0 109.201 179.806 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 6' ' ' THR . . . . . 0.504 ' O ' ' N ' ' A' ' 10' ' ' SER . 0.2 OUTLIER -71.5 171.29 11.62 Favored 'General case' 0 C--O 1.211 -0.968 0 C-N-CA 120.917 -0.313 . . . . 1.0 110.179 -179.325 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 7' ' ' GLU . . . . . 0.529 ' O ' ' HG2' ' A' ' 11' ' ' ARG . 90.7 mt-10 -53.83 -69.58 0.12 Allowed 'General case' 0 C--N 1.31 -1.137 0 C-N-CA 120.645 -0.422 . . . . 1.0 110.2 -176.697 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 8' ' ' ARG . . . . . 0.493 ' O ' ' CB ' ' A' ' 12' ' ' ALA . 0.0 OUTLIER -42.22 -51.18 4.8 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-N 115.397 -0.819 . . . . 1.0 109.298 -176.299 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -66.83 -50.1 68.25 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.462 0 CA-C-N 115.151 -0.931 . . . . 1.0 111.055 177.657 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 10' ' ' SER . . . . . 0.504 ' N ' ' O ' ' A' ' 6' ' ' THR . 28.2 t -56.79 -40.24 75.54 Favored 'General case' 0 C--N 1.323 -0.564 0 N-CA-C 113.467 0.914 . . . . 1.0 113.467 -178.566 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 11' ' ' ARG . . . . . 0.677 ' O ' ' N ' ' A' ' 15' ' ' ALA . 2.3 ptp180 -85.76 -54.28 4.62 Favored 'General case' 0 C--O 1.213 -0.849 0 CA-C-O 121.743 0.783 . . . . 1.0 110.313 175.334 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 12' ' ' ALA . . . . . 0.678 ' O ' ' HB3' ' A' ' 16' ' ' ALA . . . -47.9 -52.83 17.85 Favored 'General case' 0 CA--C 1.496 -1.104 0 N-CA-C 106.896 -1.52 . . . . 1.0 106.896 -175.343 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 13' ' ' VAL . . . . . 0.626 ' O ' ' CB ' ' A' ' 17' ' ' LEU . 93.1 t -61.68 -54.86 29.09 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.466 0 C-N-CA 117.01 -1.876 . . . . 1.0 108.76 178.085 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 14' ' ' ALA . . . . . 0.828 ' O ' HG22 ' A' ' 18' ' ' VAL . . . -58.03 -64.64 0.84 Allowed 'General case' 0 C--O 1.207 -1.136 0 C-N-CA 117.81 -1.556 . . . . 1.0 110.755 -179.127 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 15' ' ' ALA . . . . . 0.677 ' N ' ' O ' ' A' ' 11' ' ' ARG . . . -52.78 -56.08 18.28 Favored 'General case' 0 N--CA 1.473 0.683 0 CA-C-O 121.053 0.454 . . . . 1.0 110.924 -179.23 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 16' ' ' ALA . . . . . 0.678 ' HB3' ' O ' ' A' ' 12' ' ' ALA . . . -63.96 -56.19 16.95 Favored 'General case' 0 C--N 1.312 -1.035 0 C-N-CA 119.172 -1.011 . . . . 1.0 109.199 -179.219 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 17' ' ' LEU . . . . . 0.626 ' CB ' ' O ' ' A' ' 13' ' ' VAL . 28.5 tp -55.85 -53.68 53.76 Favored 'General case' 0 N--CA 1.484 1.258 0 CA-C-N 114.95 -1.023 . . . . 1.0 108.705 -177.326 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 18' ' ' VAL . . . . . 0.828 HG22 ' O ' ' A' ' 14' ' ' ALA . 2.6 m -68.83 -58.2 6.49 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.365 0 N-CA-C 109.22 -0.659 . . . . 1.0 109.22 179.603 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 19' ' ' GLY . . . . . 0.575 ' N ' ' O ' ' A' ' 15' ' ' ALA . . . -58.83 -165.04 0.1 Allowed Glycine 0 N--CA 1.442 -0.915 0 N-CA-C 110.607 -0.997 . . . . 1.0 110.607 -178.844 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 20' ' ' PRO . . . . . 0.579 ' O ' ' N ' ' A' ' 24' ' ' ALA . 65.4 Cg_endo -82.86 -31.4 0.74 Allowed 'Trans proline' 0 C--N 1.296 -2.235 0 C-N-CA 122.632 2.222 . . . . 1.0 113.847 -177.788 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -61.56 -59.6 9.56 Favored Glycine 0 CA--C 1.539 1.573 0 C-N-CA 119.881 -1.152 . . . . 1.0 112.987 -176.683 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 22' ' ' GLY . . . . . 0.55 ' H ' ' CA ' ' A' ' 16' ' ' ALA . . . -56.36 -53.63 41.72 Favored Glycine 0 N--CA 1.47 0.939 0 N-CA-C 107.304 -2.318 . . . . 1.0 107.304 -176.564 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 23' ' ' VAL . . . . . 0.476 ' O ' HG12 ' A' ' 27' ' ' VAL . 1.1 p -62.64 -30.63 49.73 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.184 0 C-N-CA 119.211 -0.995 . . . . 1.0 109.394 179.116 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 24' ' ' ALA . . . . . 0.579 ' N ' ' O ' ' A' ' 20' ' ' PRO . . . -56.63 -63.75 1.1 Allowed 'General case' 0 C--N 1.357 0.906 0 C-N-CA 118.86 -1.136 . . . . 1.0 110.867 -178.376 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 10.4 mt -63.93 -42.84 97.25 Favored 'General case' 0 CA--C 1.517 -0.303 0 C-N-CA 120.404 -0.518 . . . . 1.0 111.54 -177.92 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 26' ' ' VAL . . . . . 0.4 HG23 ' O ' ' A' ' 22' ' ' GLY . 78.8 t -58.41 -59.98 2.88 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.519 0 C-N-CA 119.25 -0.98 . . . . 1.0 110.211 -178.13 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 27' ' ' VAL . . . . . 0.634 ' O ' ' HB3' ' A' ' 31' ' ' ALA . 1.9 p -63.42 -36.52 76.53 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 C-N-CA 120.643 -0.423 . . . . 1.0 111.627 -178.433 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 59.2 tttm -66.26 -57.2 8.05 Favored 'General case' 0 C--N 1.318 -0.774 0 C-N-CA 119.749 -0.78 . . . . 1.0 109.28 -178.742 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 96.2 t -64.51 -47.23 90.07 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.127 0 CA-C-N 114.716 -1.129 . . . . 1.0 110.046 -178.345 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 30' ' ' CYS . . . . . . . . . . . . . 54.1 t -66.81 -61.92 1.71 Allowed 'General case' 0 N--CA 1.448 -0.548 0 C-N-CA 119.475 -0.89 . . . . 1.0 110.613 -179.71 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 31' ' ' ALA . . . . . 0.634 ' HB3' ' O ' ' A' ' 27' ' ' VAL . . . -62.08 -46.02 90.93 Favored 'General case' 0 CA--C 1.506 -0.733 0 CA-C-O 121.061 0.458 . . . . 1.0 111.18 -176.45 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 32' ' ' GLY . . . . . 0.546 ' O ' ' HB2' ' A' ' 33' ' ' LEU . . . 77.77 69.13 1.43 Allowed Glycine 0 N--CA 1.444 -0.813 0 N-CA-C 110.122 -1.191 . . . . 1.0 110.122 -179.357 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 33' ' ' LEU . . . . . 0.546 ' HB2' ' O ' ' A' ' 32' ' ' GLY . 3.8 mp 84.61 86.99 0.05 OUTLIER Pre-proline 0 N--CA 1.477 0.907 0 O-C-N 124.769 0.923 . . . . 1.0 111.617 -179.21 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 29.4 Cg_endo -64.2 -15.88 51.94 Favored 'Trans proline' 0 N--CA 1.497 1.716 0 C-N-CA 121.525 1.484 . . . . 1.0 111.824 178.519 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -55.95 -59.63 10.3 Favored Glycine 0 CA--C 1.522 0.524 0 C-N-CA 119.02 -1.562 . . . . 1.0 109.435 -179.092 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 36' ' ' VAL . . . . . 0.588 ' O ' HG22 ' A' ' 37' ' ' ILE . 1.3 p -97.81 172.87 1.04 Allowed 'Isoleucine or valine' 0 CA--C 1.51 -0.587 0 N-CA-C 105.215 -2.143 . . . . 1.0 105.215 177.131 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 37' ' ' ILE . . . . . 0.588 HG22 ' O ' ' A' ' 36' ' ' VAL . 6.8 tp 113.07 120.02 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.477 0.907 0 O-C-N 124.689 1.243 . . . . 1.0 110.38 179.411 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 59.5 m80 -141.12 131.42 25.04 Favored 'General case' 0 C--N 1.328 -0.337 0 N-CA-C 108.484 -0.932 . . . . 1.0 108.484 179.395 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -94.64 132.75 27.99 Favored Pre-proline 0 CA--C 1.543 0.679 0 C-N-CA 121.047 -0.261 . . . . 1.0 110.775 -178.849 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 44.8 Cg_exo -54.36 -42.86 63.94 Favored 'Trans proline' 0 N--CA 1.495 1.567 0 C-N-CA 121.902 1.735 . . . . 1.0 113.726 179.363 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -126.38 132.79 51.47 Favored 'General case' 0 N--CA 1.468 0.44 0 CA-C-N 116.602 -0.272 . . . . 1.0 110.861 179.805 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 42' ' ' ARG . . . . . 0.663 ' C ' ' H ' ' A' ' 44' ' ' GLY . 17.6 ptm180 -166.32 163.73 17.56 Favored 'General case' 0 C--N 1.323 -0.548 0 C-N-CA 120.115 -0.634 . . . . 1.0 109.931 178.1 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 43' ' ' ARG . . . . . 0.529 ' C ' ' H ' ' A' ' 45' ' ' PHE . 0.1 OUTLIER -62.76 24.47 0.01 OUTLIER 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 115.872 -0.604 . . . . 1.0 110.348 -179.973 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 44' ' ' GLY . . . . . 0.663 ' H ' ' C ' ' A' ' 42' ' ' ARG . . . 70.32 -28.56 0.45 Allowed Glycine 0 C--N 1.339 0.723 0 N-CA-C 111.376 -0.69 . . . . 1.0 111.376 179.982 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 45' ' ' PHE . . . . . 0.552 ' CG ' ' N ' ' A' ' 46' ' ' PHE . 27.6 t80 -159.62 161.76 35.1 Favored 'General case' 0 C--N 1.32 -0.681 0 N-CA-C 109.084 -0.71 . . . . 1.0 109.084 179.199 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 46' ' ' PHE . . . . . 0.793 ' O ' ' HB2' ' A' ' 47' ' ' ARG . 2.3 m-30 132.65 91.43 0.0 OUTLIER 'General case' 0 N--CA 1.474 0.756 0 O-C-N 125.367 1.667 . . . . 1.0 107.109 -179.476 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 47' ' ' ARG . . . . . 0.793 ' HB2' ' O ' ' A' ' 46' ' ' PHE . 0.0 OUTLIER 125.96 139.71 0.0 OUTLIER 'General case' 0 N--CA 1.48 1.05 0 C-N-CA 124.52 1.128 . . . . 1.0 109.402 179.574 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 48' ' ' CYS . . . . . 0.621 ' O ' ' H83' ' A' ' 129' ' ' MTN . 0.0 OUTLIER 71.01 73.41 0.19 Allowed 'General case' 0 C--O 1.218 -0.584 0 N-CA-C 108.759 -0.83 . . . . 1.0 108.759 -178.759 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 49' ' ' ASN . . . . . 0.639 ' O ' ' N ' ' A' ' 51' ' ' GLU . 0.0 OUTLIER -132.51 130.13 21.68 Favored Pre-proline 0 CA--C 1.537 0.458 0 N-CA-C 108.629 -0.878 . . . . 1.0 108.629 -179.426 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_exo -53.22 58.04 0.02 OUTLIER 'Trans proline' 0 N--CA 1.507 2.274 0 C-N-CA 122.593 2.195 . . . . 1.0 113.696 178.656 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 51' ' ' GLU . . . . . 0.639 ' N ' ' O ' ' A' ' 49' ' ' ASN . 6.0 mp0 67.27 3.44 3.24 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.525 -0.307 . . . . 1.0 111.002 -179.974 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 28.8 mtt-85 -80.25 152.87 28.85 Favored 'General case' 0 CA--C 1.531 0.22 0 N-CA-C 109.751 -0.462 . . . . 1.0 109.751 179.776 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 53' ' ' ILE . . . . . 0.465 ' O ' ' N ' ' A' ' 55' ' ' ILE . 3.6 tp -69.8 136.37 26.3 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-O 120.736 0.303 . . . . 1.0 111.209 -179.469 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 54' ' ' GLN . . . . . 0.61 ' H ' ' CD ' ' A' ' 54' ' ' GLN . 1.8 mp0 -60.07 82.82 0.01 OUTLIER 'General case' 0 CA--C 1.54 0.568 0 C-N-CA 120.195 -0.602 . . . . 1.0 110.279 -176.643 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 55' ' ' ILE . . . . . 0.465 ' N ' ' O ' ' A' ' 53' ' ' ILE . 20.3 tt -149.5 159.98 5.34 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.372 0 CA-C-N 116.145 -0.479 . . . . 1.0 110.89 178.138 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 112.55 -2.42 26.3 Favored Glycine 0 N--CA 1.47 0.942 0 N-CA-C 111.184 -0.767 . . . . 1.0 111.184 -179.814 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 3.6 p-10 -80.07 98.09 7.11 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-O 121.45 0.643 . . . . 1.0 111.239 178.988 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 58' ' ' TRP . . . . . . . . . . . . . 7.1 m95 -85.96 171.72 11.23 Favored 'General case' 0 C--N 1.319 -0.755 0 CA-C-O 123.212 1.482 . . . . 1.0 111.541 -179.464 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -84.24 -60.92 1.94 Allowed 'General case' 0 C--N 1.305 -1.342 0 CA-C-N 111.146 -2.752 . . . . 1.0 112.786 -176.825 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -91.04 -15.28 29.83 Favored 'General case' 0 C--N 1.312 -1.064 0 CA-C-N 114.839 -1.073 . . . . 1.0 112.539 -179.055 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 61' ' ' GLU . . . . . 0.424 ' O ' ' N ' ' A' ' 65' ' ' ASP . 4.0 tt0 -80.93 -14.75 57.7 Favored 'General case' 0 C--N 1.312 -1.032 0 O-C-N 121.901 -0.499 . . . . 1.0 110.244 -179.473 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 62' ' ' VAL . . . . . 0.635 HG23 ' N ' ' A' ' 63' ' ' ALA . 29.0 m -47.16 -54.38 2.72 Favored 'Isoleucine or valine' 0 C--O 1.209 -1.057 0 C-N-CA 119.754 -0.778 . . . . 1.0 109.767 -176.851 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 63' ' ' ALA . . . . . 0.635 ' N ' HG23 ' A' ' 62' ' ' VAL . . . -66.62 -52.61 43.28 Favored 'General case' 0 C--N 1.306 -1.283 0 N-CA-C 109.559 -0.534 . . . . 1.0 109.559 -179.81 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 64' ' ' HIS . . . . . 0.443 ' O ' ' CG ' ' A' ' 67' ' ' ARG . 9.7 t60 -50.59 -58.8 4.98 Favored 'General case' 0 CA--C 1.542 0.66 0 CA-C-O 122.175 0.988 . . . . 1.0 109.933 -179.168 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 65' ' ' ASP . . . . . 0.606 ' C ' ' H ' ' A' ' 67' ' ' ARG . 58.9 t0 -67.83 -50.31 57.39 Favored 'General case' 0 C--N 1.31 -1.129 0 CA-C-O 122.492 1.139 . . . . 1.0 109.455 177.947 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 66' ' ' GLY . . . . . 0.658 ' O ' HD12 ' A' ' 68' ' ' LEU . . . -68.23 30.84 0.26 Allowed Glycine 0 C--O 1.224 -0.497 0 O-C-N 121.069 -1.02 . . . . 1.0 111.795 178.487 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 67' ' ' ARG . . . . . 0.709 ' CB ' ' HB3' ' A' ' 71' ' ' ALA . 4.7 mmm180 -74.22 5.47 4.43 Favored 'General case' 0 C--N 1.306 -1.323 0 N-CA-C 108.72 -0.845 . . . . 1.0 108.72 176.279 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 68' ' ' LEU . . . . . 0.658 HD12 ' O ' ' A' ' 66' ' ' GLY . 0.0 OUTLIER -34.22 -29.28 0.01 OUTLIER 'General case' 0 N--CA 1.481 1.09 0 N-CA-C 108.298 -1.001 . . . . 1.0 108.298 -176.671 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 69' ' ' LEU . . . . . 0.607 ' N ' ' O ' ' A' ' 67' ' ' ARG . 0.5 OUTLIER -68.36 -68.4 0.39 Allowed 'General case' 0 CA--C 1.546 0.817 0 C-N-CA 119.336 -0.946 . . . . 1.0 110.357 179.633 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 70' ' ' ALA . . . . . 0.69 ' C ' ' H ' ' A' ' 72' ' ' HIS . . . -78.29 -77.09 0.17 Allowed 'General case' 0 CA--C 1.51 -0.575 0 N-CA-C 108.344 -0.984 . . . . 1.0 108.344 179.925 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 71' ' ' ALA . . . . . 0.806 ' HB1' ' HB ' ' A' ' 74' ' ' VAL . . . -51.86 10.3 0.0 OUTLIER 'General case' 0 CA--C 1.537 0.458 0 C-N-CA 125.007 1.323 . . . . 1.0 111.953 178.188 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 72' ' ' HIS . . . . . 0.71 ' CG ' ' H ' ' A' ' 73' ' ' MET . 0.4 OUTLIER -21.37 -61.78 0.03 OUTLIER 'General case' 0 CA--C 1.519 -0.244 0 N-CA-C 113.9 1.074 . . . . 1.0 113.9 -178.957 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 73' ' ' MET . . . . . 0.71 ' H ' ' CG ' ' A' ' 72' ' ' HIS . 5.3 ptm -71.14 -45.6 63.23 Favored 'General case' 0 C--N 1.313 -0.978 0 N-CA-C 108.954 -0.758 . . . . 1.0 108.954 179.114 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 74' ' ' VAL . . . . . 0.806 ' HB ' ' HB1' ' A' ' 71' ' ' ALA . 79.7 t -40.88 -40.77 0.59 Allowed 'Isoleucine or valine' 0 CA--C 1.507 -0.697 0 CA-C-O 117.854 -1.07 . . . . 1.0 109.916 -175.937 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 75' ' ' ASN . . . . . 0.418 ' C ' ' N ' ' A' ' 77' ' ' ILE . 1.7 t-20 -33.59 -15.52 0.0 OUTLIER 'General case' 0 N--CA 1.482 1.136 0 CA-C-O 122.259 1.028 . . . . 1.0 110.891 178.305 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 76' ' ' GLY . . . . . 0.795 ' N ' ' O ' ' A' ' 74' ' ' VAL . . . -49.71 -22.04 3.87 Favored Glycine 0 N--CA 1.435 -1.414 0 N-CA-C 107.227 -2.349 . . . . 1.0 107.227 173.901 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 77' ' ' ILE . . . . . 0.418 ' N ' ' C ' ' A' ' 75' ' ' ASN . 85.2 mt -59.49 -52.84 56.24 Favored 'Isoleucine or valine' 0 C--N 1.351 0.658 0 CA-C-O 118.259 -0.876 . . . . 1.0 111.986 -179.927 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 33.0 t -51.04 -21.86 1.48 Allowed 'Isoleucine or valine' 0 C--N 1.351 0.659 0 CA-C-N 121.279 1.854 . . . . 1.0 112.477 -179.445 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 79' ' ' ILE . . . . . 0.72 ' O ' ' HB2' ' A' ' 83' ' ' ALA . 0.1 OUTLIER -94.88 -40.57 11.35 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.576 0 CA-C-N 116.102 -0.499 . . . . 1.0 109.888 179.713 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -77.32 -19.16 56.78 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.647 -0.706 . . . . 1.0 111.41 -179.232 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 22.5 tt0 -87.19 -67.6 0.81 Allowed 'General case' 0 N--CA 1.438 -1.047 0 N-CA-C 109.616 -0.513 . . . . 1.0 109.616 178.961 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 82' ' ' ASP . . . . . 0.817 ' O ' ' N ' ' A' ' 84' ' ' LEU . 15.6 m-20 -60.46 -61.18 2.78 Favored 'General case' 0 C--N 1.352 0.682 0 C-N-CA 118.91 -1.116 . . . . 1.0 109.267 -179.391 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 83' ' ' ALA . . . . . 0.72 ' HB2' ' O ' ' A' ' 79' ' ' ILE . . . 23.69 -67.29 0.0 OUTLIER 'General case' 0 N--CA 1.486 1.371 0 O-C-N 124.752 1.283 . . . . 1.0 112.063 179.868 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 84' ' ' LEU . . . . . 0.817 ' N ' ' O ' ' A' ' 82' ' ' ASP . 0.8 OUTLIER -33.21 -41.76 0.08 Allowed 'General case' 0 N--CA 1.476 0.843 0 C-N-CA 122.728 0.411 . . . . 1.0 111.934 -178.09 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 85' ' ' ILE . . . . . 0.523 ' O ' ' HB3' ' A' ' 88' ' ' ALA . 18.2 pt -95.2 -41.64 12.06 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.615 0 N-CA-C 109.146 -0.687 . . . . 1.0 109.146 178.675 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 86' ' ' ALA . . . . . 0.569 ' HB3' ' HA ' ' A' ' 83' ' ' ALA . . . -54.43 -57.87 9.64 Favored 'General case' 0 CA--C 1.54 0.585 0 CA-C-N 115.399 -0.818 . . . . 1.0 110.305 -179.448 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -71.16 10.58 0.55 Allowed 'General case' 0 CA--C 1.538 0.505 0 N-CA-C 111.838 0.31 . . . . 1.0 111.838 -179.023 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 88' ' ' ALA . . . . . 0.523 ' HB3' ' O ' ' A' ' 85' ' ' ILE . . . -99.28 -19.89 16.84 Favored 'General case' 0 N--CA 1.48 1.044 0 CA-C-O 122.738 1.256 . . . . 1.0 109.156 179.281 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 28.6 m -104.32 37.46 0.31 Allowed 'Isoleucine or valine' 0 C--N 1.313 -1.018 0 CA-C-N 111.832 -2.44 . . . . 1.0 110.004 178.259 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 90' ' ' GLY . . . . . 0.624 ' O ' ' N ' ' A' ' 92' ' ' HIS . . . -65.17 -41.02 97.16 Favored Glycine 0 CA--C 1.537 1.456 0 CA-C-O 118.853 -0.97 . . . . 1.0 111.671 177.144 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 91' ' ' PRO . . . . . 0.498 ' HD2' ' N ' ' A' ' 90' ' ' GLY . 88.3 Cg_exo -41.47 -11.71 0.03 OUTLIER 'Trans proline' 0 N--CA 1.5 1.879 0 C-N-CA 122.349 2.033 . . . . 1.0 112.008 178.923 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 92' ' ' HIS . . . . . 0.624 ' N ' ' O ' ' A' ' 90' ' ' GLY . 6.5 p-80 -55.08 -18.75 5.87 Favored 'General case' 0 C--O 1.194 -1.833 0 N-CA-C 108.615 -0.883 . . . . 1.0 108.615 -179.736 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 93' ' ' LEU . . . . . 0.568 HD12 ' N ' ' A' ' 94' ' ' ALA . 0.8 OUTLIER -62.53 -57.9 9.51 Favored 'General case' 0 C--N 1.317 -0.806 0 N-CA-C 108.763 -0.828 . . . . 1.0 108.763 179.225 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 94' ' ' ALA . . . . . 0.568 ' N ' HD12 ' A' ' 93' ' ' LEU . . . -58.27 -57.76 11.46 Favored 'General case' 0 N--CA 1.452 -0.369 0 CA-C-N 115.293 -0.867 . . . . 1.0 109.335 179.265 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 95' ' ' ARG . . . . . 0.588 ' O ' ' N ' ' A' ' 97' ' ' LEU . 37.4 mtp-105 -56.84 -59.67 4.69 Favored 'General case' 0 C--O 1.242 0.681 0 CA-C-O 123.098 1.428 . . . . 1.0 108.041 179.288 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 96' ' ' ALA . . . . . 0.84 ' O ' ' N ' ' A' ' 98' ' ' GLY . . . -47.32 -15.82 0.05 OUTLIER 'General case' 0 C--N 1.301 -1.502 0 O-C-N 118.572 -2.58 . . . . 1.0 111.042 -179.051 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 97' ' ' LEU . . . . . 0.641 ' O ' ' N ' ' A' ' 100' ' ' ILE 0.279 16.1 tp 6.17 -54.07 0.0 OUTLIER 'General case' 0 N--CA 1.477 0.906 0 CA-C-O 118.116 -0.945 . . . . 1.0 112.287 -168.266 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 98' ' ' GLY . . . . . 0.84 ' N ' ' O ' ' A' ' 96' ' ' ALA . . . -49.38 -24.44 5.24 Favored Glycine 0 C--N 1.295 -1.708 0 CA-C-N 122.303 2.32 . . . . 1.0 108.417 175.16 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 99' ' ' GLN . . . . . 0.509 ' N ' ' O ' ' A' ' 96' ' ' ALA . 40.9 mm-40 -71.39 -20.7 62.11 Favored 'General case' 0 C--N 1.371 1.538 0 C-N-CA 117.477 -1.689 . . . . 1.0 107.882 177.344 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 100' ' ' ILE . . . . . 0.641 ' N ' ' O ' ' A' ' 97' ' ' LEU . 0.3 OUTLIER -67.45 -40.66 84.96 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.499 0 N-CA-C 108.131 -1.063 . . . . 1.0 108.131 177.392 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 101' ' ' VAL . . . . . 0.678 ' O ' ' N ' ' A' ' 105' ' ' GLY . 0.4 OUTLIER -57.4 -58.35 6.41 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.605 0 N-CA-C 106.561 -1.644 . . . . 1.0 106.561 179.959 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 102' ' ' CYS . . . . . 0.969 ' O ' ' HB2' ' A' ' 106' ' ' ALA . 4.6 t -47.07 -21.87 0.28 Allowed 'General case' 0 C--O 1.209 -1.043 0 CA-C-N 115.666 -0.697 . . . . 1.0 110.649 -179.801 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 103' ' ' ARG . . . . . 0.402 ' N ' ' C ' ' A' ' 101' ' ' VAL . 2.1 tmm_? -88.57 -43.32 11.47 Favored 'General case' 0 N--CA 1.486 1.326 0 CA-C-O 122.689 1.233 . . . . 1.0 111.779 178.118 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 104' ' ' TYR . . . . . 0.779 ' O ' ' CG ' ' A' ' 104' ' ' TYR . 1.3 t80 -98.14 23.19 8.51 Favored 'General case' 0 C--N 1.31 -1.121 0 CA-C-N 112.373 -2.194 . . . . 1.0 108.572 177.238 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 105' ' ' GLY . . . . . 0.678 ' N ' ' O ' ' A' ' 101' ' ' VAL . . . -167.68 -92.19 0.08 OUTLIER Glycine 0 N--CA 1.446 -0.695 0 N-CA-C 107.104 -2.398 . . . . 1.0 107.104 177.756 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 106' ' ' ALA . . . . . 0.969 ' HB2' ' O ' ' A' ' 102' ' ' CYS . . . 67.36 63.18 0.44 Allowed 'General case' 0 N--CA 1.443 -0.793 0 N-CA-C 112.418 0.525 . . . . 1.0 112.418 179.83 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 107' ' ' THR . . . . . 0.475 ' O ' ' HD2' ' A' ' 110' ' ' PRO . 19.1 m -83.1 -65.05 1.06 Allowed 'General case' 0 CA--C 1.541 0.632 0 O-C-N 121.449 -0.782 . . . . 1.0 111.603 179.96 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 9.1 m -71.63 28.54 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.322 -0.616 0 O-C-N 121.078 -1.014 . . . . 1.0 111.644 -177.107 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 109' ' ' ILE . . . . . 0.756 ' H ' ' HD2' ' A' ' 110' ' ' PRO . 0.1 OUTLIER -112.48 -53.05 0.05 OUTLIER Pre-proline 0 CA--C 1.553 1.061 0 N-CA-C 108.167 -1.049 . . . . 1.0 108.167 176.117 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 110' ' ' PRO . . . . . 0.756 ' HD2' ' H ' ' A' ' 109' ' ' ILE . 19.1 Cg_endo -51.48 -29.78 32.8 Favored 'Trans proline' 0 N--CA 1.494 1.501 0 C-N-CA 122.563 2.176 . . . . 1.0 111.259 178.634 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 11.0 t-20 -63.01 -69.4 0.27 Allowed 'General case' 0 N--CA 1.466 0.356 0 C-N-CA 120.511 -0.476 . . . . 1.0 110.392 -179.339 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 112' ' ' ILE . . . . . 0.486 HG13 ' N ' ' A' ' 113' ' ' ASN . 26.6 pt -51.62 -31.13 12.27 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.457 0 CA-C-O 123.228 1.49 . . . . 1.0 109.717 179.502 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 113' ' ' ASN . . . . . 0.486 ' N ' HG13 ' A' ' 112' ' ' ILE . 0.0 OUTLIER -52.87 -52.58 56.85 Favored 'General case' 0 C--N 1.301 -1.511 0 CA-C-N 112.077 -2.329 . . . . 1.0 107.746 -177.858 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 114' ' ' ALA . . . . . 0.437 ' O ' HG23 ' A' ' 118' ' ' VAL . . . -60.09 -32.64 71.16 Favored 'General case' 0 N--CA 1.442 -0.848 0 N-CA-C 112.182 0.438 . . . . 1.0 112.182 179.625 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -81.27 -57.19 3.61 Favored 'General case' 0 C--O 1.215 -0.751 0 CA-C-O 121.499 0.666 . . . . 1.0 111.702 178.732 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 116' ' ' ILE . . . . . 0.529 ' O ' ' N ' ' A' ' 120' ' ' GLY . 3.4 mm -51.72 -57.86 2.94 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.715 0 CA-C-O 122.479 1.133 . . . . 1.0 108.043 -177.907 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 117' ' ' GLU . . . . . 0.537 ' O ' ' HA ' ' A' ' 121' ' ' THR . 6.5 mt-10 -40.15 -53.17 2.5 Favored 'General case' 0 C--N 1.315 -0.919 0 CA-C-N 112.285 -2.234 . . . . 1.0 105.927 -178.29 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 118' ' ' VAL . . . . . 0.437 HG23 ' O ' ' A' ' 114' ' ' ALA . 78.0 t -60.26 -52.04 65.91 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.608 0 C-N-CA 119.459 -0.896 . . . . 1.0 109.065 177.261 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 119' ' ' LEU . . . . . 0.488 ' N ' ' O ' ' A' ' 116' ' ' ILE . 0.9 OUTLIER -58.39 -70.31 0.15 Allowed 'General case' 0 N--CA 1.454 -0.253 0 C-N-CA 119.209 -0.997 . . . . 1.0 108.387 -177.656 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 120' ' ' GLY . . . . . 0.613 ' O ' ' OG1' ' A' ' 121' ' ' THR . . . -66.19 -84.99 0.08 OUTLIER Glycine 0 C--N 1.351 1.362 0 C-N-CA 118.127 -1.987 . . . . 1.0 109.159 178.41 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 121' ' ' THR . . . . . 0.613 ' OG1' ' O ' ' A' ' 120' ' ' GLY . 18.5 m 160.46 -34.55 0.0 OUTLIER 'General case' 0 N--CA 1.482 1.164 0 O-C-N 125.373 1.278 . . . . 1.0 112.858 179.421 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 122' ' ' GLY . . . . . 0.643 ' O ' ' N ' ' A' ' 124' ' ' ASP . . . 105.64 -14.19 46.31 Favored Glycine 0 N--CA 1.461 0.313 0 N-CA-C 107.285 -2.326 . . . . 1.0 107.285 -175.832 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 123' ' ' THR . . . . . 0.478 HG22 ' CD2' ' A' ' 72' ' ' HIS . 2.8 m -54.89 82.39 0.0 OUTLIER 'General case' 0 N--CA 1.465 0.311 0 N-CA-C 106.037 -1.838 . . . . 1.0 106.037 178.59 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 124' ' ' ASP . . . . . 0.643 ' N ' ' O ' ' A' ' 122' ' ' GLY . 18.2 t70 -164.29 170.34 16.33 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 114.057 -1.429 . . . . 1.0 112.117 -179.338 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 125' ' ' TYR . . . . . . . . . . . . . 33.5 t80 -151.32 149.01 28.85 Favored 'General case' 0 CA--C 1.535 0.391 0 CA-C-N 115.637 -0.71 . . . . 1.0 109.937 177.298 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 14.6 tpp180 -149.13 150.08 32.1 Favored 'General case' 0 CA--C 1.532 0.283 0 CA-C-N 115.792 -0.64 . . . . 1.0 110.169 177.785 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 127' ' ' PHE . . . . . 0.559 ' H ' HD12 ' A' ' 79' ' ' ILE . 20.4 t80 . . . . . 0 C--O 1.22 -0.469 0 CA-C-O 118.036 -0.983 . . . . 1.0 109.366 178.687 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 128' ' ' MTN . . . . . 0.661 ' H91' ' NH1' ' A' ' 47' ' ' ARG . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 129' ' ' MTN . . . . . 0.621 ' H83' ' O ' ' A' ' 48' ' ' CYS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 130' ' ' MTN . . . . . 0.601 ' H61' ' S1 ' ' A' ' 130' ' ' MTN . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 62.1 mtt . . . . . 0 N--CA 1.489 1.509 0 N-CA-C 108.961 -0.755 . . . . 1.0 108.961 . . . . . . . . . 0 0 . 1 . 024 nuclear build full ' A' A ' 2' ' ' SER . . . . . 0.458 ' O ' ' CB ' ' A' ' 3' ' ' ASP . 91.4 p -93.78 10.29 33.64 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.19 -0.459 . . . . 1.0 110.692 -179.793 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 3' ' ' ASP . . . . . 0.458 ' CB ' ' O ' ' A' ' 2' ' ' SER . 7.1 m-20 157.62 111.34 0.0 OUTLIER 'General case' 0 N--CA 1.471 0.618 0 O-C-N 123.82 0.7 . . . . 1.0 110.256 178.643 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 60.6 t80 -153.66 149.19 27.29 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-N 116.263 -0.426 . . . . 1.0 110.743 179.792 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 5' ' ' ASP . . . . . 0.528 ' N ' ' OD1' ' A' ' 5' ' ' ASP . 0.3 OUTLIER -155.31 150.77 27.22 Favored 'General case' 0 CA--C 1.533 0.312 0 CA-C-N 116.373 -0.376 . . . . 1.0 110.874 -179.057 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 6' ' ' THR . . . . . 0.564 HG22 ' H ' ' A' ' 7' ' ' GLU . 0.2 OUTLIER -61.38 -158.29 0.01 OUTLIER 'General case' 0 N--CA 1.464 0.264 0 C-N-CA 120.762 -0.375 . . . . 1.0 110.637 -179.532 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 7' ' ' GLU . . . . . 0.564 ' H ' HG22 ' A' ' 6' ' ' THR . 42.8 tt0 -74.34 -66.49 0.72 Allowed 'General case' 0 CA--C 1.502 -0.894 0 C-N-CA 120.699 -0.4 . . . . 1.0 110.047 -178.95 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 8' ' ' ARG . . . . . 0.534 ' O ' ' CB ' ' A' ' 12' ' ' ALA . 13.0 ttm105 -52.54 -44.98 66.16 Favored 'General case' 0 N--CA 1.437 -1.123 0 N-CA-C 112.432 0.53 . . . . 1.0 112.432 -177.057 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 9' ' ' VAL . . . . . 0.663 ' O ' HG22 ' A' ' 13' ' ' VAL . 97.7 t -64.78 -51.12 71.2 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.148 0 C-N-CA 117.986 -1.486 . . . . 1.0 109.212 179.284 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 34.3 t -63.49 -40.73 97.85 Favored 'General case' 0 N--CA 1.474 0.749 0 N-CA-C 114.355 1.243 . . . . 1.0 114.355 -179.066 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 11' ' ' ARG . . . . . 0.544 ' O ' ' N ' ' A' ' 15' ' ' ALA . 59.3 ttm-85 -80.16 -54.92 5.31 Favored 'General case' 0 CA--C 1.536 0.442 0 CA-C-O 122.714 1.245 . . . . 1.0 109.732 178.047 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 12' ' ' ALA . . . . . 0.716 ' O ' ' HB3' ' A' ' 16' ' ' ALA . . . -46.26 -48.59 17.96 Favored 'General case' 0 N--CA 1.483 1.213 0 CA-C-N 112.907 -1.951 . . . . 1.0 106.14 -176.218 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 13' ' ' VAL . . . . . 0.663 HG22 ' O ' ' A' ' 9' ' ' VAL . 34.0 m -60.63 -52.45 61.34 Favored 'Isoleucine or valine' 0 C--O 1.197 -1.663 0 C-N-CA 116.873 -1.931 . . . . 1.0 108.046 176.757 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 14' ' ' ALA . . . . . 0.715 ' O ' HG13 ' A' ' 18' ' ' VAL . . . -58.53 -64.59 0.87 Allowed 'General case' 0 N--CA 1.472 0.632 0 C-N-CA 118.428 -1.309 . . . . 1.0 111.736 179.911 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 15' ' ' ALA . . . . . 0.563 ' O ' ' N ' ' A' ' 19' ' ' GLY . . . -53.19 -55.99 19.91 Favored 'General case' 0 N--CA 1.475 0.802 0 CA-C-O 121.731 0.777 . . . . 1.0 110.161 -177.55 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 16' ' ' ALA . . . . . 0.716 ' HB3' ' O ' ' A' ' 12' ' ' ALA . . . -63.96 -53.84 43.92 Favored 'General case' 0 C--N 1.311 -1.098 0 CA-C-N 114.56 -1.2 . . . . 1.0 109.066 -178.985 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 17' ' ' LEU . . . . . 0.636 ' CB ' ' O ' ' A' ' 13' ' ' VAL . 33.0 tp -56.83 -53.73 54.48 Favored 'General case' 0 N--CA 1.484 1.232 0 C-N-CA 119.047 -1.061 . . . . 1.0 108.637 -177.505 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 18' ' ' VAL . . . . . 0.715 HG13 ' O ' ' A' ' 14' ' ' ALA . 1.7 m -69.94 -57.44 8.19 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.457 0 C-N-CA 119.778 -0.769 . . . . 1.0 110.032 179.515 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 19' ' ' GLY . . . . . 0.563 ' N ' ' O ' ' A' ' 15' ' ' ALA . . . -64.93 -172.76 3.36 Favored Glycine 0 CA--C 1.526 0.761 0 N-CA-C 110.816 -0.914 . . . . 1.0 110.816 -179.532 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 20' ' ' PRO . . . . . 0.587 ' O ' ' N ' ' A' ' 24' ' ' ALA . 6.0 Cg_exo -76.46 -22.95 11.9 Favored 'Trans proline' 0 N--CA 1.503 2.036 0 C-N-CA 123.481 2.787 . . . . 1.0 114.651 -178.442 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -59.82 -57.73 17.89 Favored Glycine 0 N--CA 1.475 1.264 0 C-N-CA 119.576 -1.297 . . . . 1.0 111.831 -176.505 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 22' ' ' GLY . . . . . 0.572 ' CA ' ' HB1' ' A' ' 16' ' ' ALA . . . -58.24 -55.51 30.28 Favored Glycine 0 N--CA 1.464 0.547 0 N-CA-C 108.07 -2.012 . . . . 1.0 108.07 -177.249 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 23' ' ' VAL . . . . . 0.532 ' CG2' ' O ' ' A' ' 19' ' ' GLY . 0.0 OUTLIER -61.5 -35.34 66.19 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.137 0 CA-C-N 114.918 -0.641 . . . . 1.0 109.771 -179.963 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 24' ' ' ALA . . . . . 0.587 ' N ' ' O ' ' A' ' 20' ' ' PRO . . . -54.6 -60.84 2.81 Favored 'General case' 0 CA--C 1.537 0.462 0 C-N-CA 118.223 -1.391 . . . . 1.0 108.893 -179.989 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 15.1 tp -63.01 -45.23 93.36 Favored 'General case' 0 C--N 1.341 0.229 0 CA-C-N 118.386 0.539 . . . . 1.0 112.192 -179.302 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 82.0 t -59.86 -60.02 3.13 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.227 0 C-N-CA 118.664 -1.215 . . . . 1.0 110.052 -177.138 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 27' ' ' VAL . . . . . 0.431 ' O ' ' HB3' ' A' ' 31' ' ' ALA . 2.6 t -59.19 -37.39 68.33 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.309 0 N-CA-C 112.024 0.379 . . . . 1.0 112.024 -178.341 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 25.2 tttm -65.25 -54.43 29.39 Favored 'General case' 0 C--N 1.319 -0.727 0 C-N-CA 119.936 -0.705 . . . . 1.0 109.275 -179.121 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 43.4 t -63.38 -47.1 93.42 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.993 0 CA-C-N 114.719 -1.128 . . . . 1.0 110.603 -178.332 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 30' ' ' CYS . . . . . 0.521 ' SG ' ' N ' ' A' ' 31' ' ' ALA . 0.0 OUTLIER -67.61 -61.09 2.06 Favored 'General case' 0 CA--C 1.533 0.3 0 C-N-CA 118.474 -1.29 . . . . 1.0 110.152 -179.714 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 31' ' ' ALA . . . . . 0.521 ' N ' ' SG ' ' A' ' 30' ' ' CYS . . . -64.3 -53.68 45.13 Favored 'General case' 0 CA--C 1.514 -0.429 0 N-CA-C 113.893 1.071 . . . . 1.0 113.893 -176.014 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 82.26 72.37 1.26 Allowed Glycine 0 CA--C 1.528 0.902 0 N-CA-C 109.018 -1.633 . . . . 1.0 109.018 -177.056 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 33' ' ' LEU . . . . . 0.445 ' O ' ' O ' ' A' ' 36' ' ' VAL . 2.9 mt 85.86 86.05 0.05 OUTLIER Pre-proline 0 N--CA 1.476 0.856 0 C-N-CA 123.409 0.683 . . . . 1.0 111.447 -179.788 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 52.7 Cg_exo -56.98 -26.76 69.93 Favored 'Trans proline' 0 N--CA 1.506 2.223 0 C-N-CA 123.366 2.71 . . . . 1.0 113.517 179.251 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -54.92 -57.0 20.15 Favored Glycine 0 CA--C 1.521 0.424 0 N-CA-C 108.224 -1.95 . . . . 1.0 108.224 -179.355 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 36' ' ' VAL . . . . . 0.537 ' O ' ' CB ' ' A' ' 37' ' ' ILE . 14.5 p -97.07 163.01 2.51 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 N-CA-C 107.521 -1.289 . . . . 1.0 107.521 177.755 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 37' ' ' ILE . . . . . 0.537 ' CB ' ' O ' ' A' ' 36' ' ' VAL . 3.7 mm 122.12 116.54 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.484 1.267 0 O-C-N 124.4 1.062 . . . . 1.0 109.499 -179.322 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -138.63 129.29 26.29 Favored 'General case' 0 C--N 1.329 -0.286 0 N-CA-C 107.55 -1.278 . . . . 1.0 107.55 178.704 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -95.95 154.07 39.06 Favored Pre-proline 0 N--CA 1.467 0.391 0 N-CA-C 109.87 -0.419 . . . . 1.0 109.87 -179.435 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 97.6 Cg_endo -77.52 -42.27 0.29 Allowed 'Trans proline' 0 C--N 1.311 -1.4 0 C-N-CA 122.25 1.966 . . . . 1.0 113.787 -179.101 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -125.2 131.58 53.15 Favored 'General case' 0 N--CA 1.466 0.351 0 CA-C-O 119.626 -0.226 . . . . 1.0 110.464 179.313 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 42' ' ' ARG . . . . . 0.629 ' C ' ' H ' ' A' ' 44' ' ' GLY . 0.4 OUTLIER -166.96 163.72 16.06 Favored 'General case' 0 C--N 1.326 -0.435 0 C-N-CA 119.756 -0.778 . . . . 1.0 110.433 178.037 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 43' ' ' ARG . . . . . 0.462 ' C ' ' H ' ' A' ' 45' ' ' PHE . 3.3 tpt85 -63.87 22.09 0.01 OUTLIER 'General case' 0 CA--C 1.538 0.505 0 CA-C-N 115.857 -0.61 . . . . 1.0 111.088 -179.204 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 44' ' ' GLY . . . . . 0.629 ' H ' ' C ' ' A' ' 42' ' ' ARG . . . 71.63 -27.92 0.61 Allowed Glycine 0 CA--C 1.527 0.819 0 N-CA-C 111.745 -0.542 . . . . 1.0 111.745 179.705 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 45' ' ' PHE . . . . . 0.485 ' O ' ' HB2' ' A' ' 46' ' ' PHE . 20.9 t80 -151.34 149.68 29.62 Favored 'General case' 0 C--O 1.218 -0.587 0 CA-C-N 117.166 0.483 . . . . 1.0 109.741 -179.258 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 46' ' ' PHE . . . . . 0.555 ' O ' ' CG ' ' A' ' 47' ' ' ARG . 1.8 m-85 141.14 83.66 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.836 0 C-N-CA 124.378 1.071 . . . . 1.0 109.736 179.154 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 47' ' ' ARG . . . . . 0.555 ' CG ' ' O ' ' A' ' 46' ' ' PHE . 3.9 mmp_? 137.63 134.44 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.51 0 C-N-CA 123.715 0.806 . . . . 1.0 109.186 179.489 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 48' ' ' CYS . . . . . 0.471 ' SG ' ' C ' ' A' ' 47' ' ' ARG . 2.0 m 77.22 69.45 0.05 Allowed 'General case' 0 C--O 1.218 -0.572 0 CA-C-N 118.409 0.549 . . . . 1.0 110.195 179.785 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -114.6 147.86 39.04 Favored Pre-proline 0 N--CA 1.464 0.265 0 O-C-N 120.748 -1.22 . . . . 1.0 108.864 179.543 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -73.02 59.26 3.58 Favored 'Trans proline' 0 C--N 1.308 -1.58 0 C-N-CA 121.836 1.691 . . . . 1.0 111.101 -179.975 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 22.7 mm-40 58.8 59.33 2.89 Favored 'General case' 0 N--CA 1.454 -0.259 0 CA-C-N 116.25 -0.432 . . . . 1.0 111.074 179.453 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 16.6 ptt180 -146.13 178.72 8.01 Favored 'General case' 0 N--CA 1.466 0.359 0 CA-C-N 116.24 -0.437 . . . . 1.0 110.377 179.724 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 53' ' ' ILE . . . . . 0.771 HD12 ' N ' ' A' ' 54' ' ' GLN . 0.1 OUTLIER -86.61 138.61 18.74 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.334 0 CA-C-O 121.655 0.741 . . . . 1.0 110.484 179.671 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 54' ' ' GLN . . . . . 0.771 ' N ' HD12 ' A' ' 53' ' ' ILE . 0.0 OUTLIER -62.34 82.84 0.02 OUTLIER 'General case' 0 C--N 1.319 -0.742 0 CA-C-N 114.701 -1.136 . . . . 1.0 109.033 -177.961 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 55' ' ' ILE . . . . . 0.438 ' N ' ' O ' ' A' ' 53' ' ' ILE . 21.2 tt -149.48 158.23 6.17 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.457 0 CA-C-N 115.858 -0.61 . . . . 1.0 110.611 178.156 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 109.31 -5.97 31.89 Favored Glycine 0 N--CA 1.473 1.129 0 N-CA-C 110.95 -0.86 . . . . 1.0 110.95 -179.969 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 13.1 p-10 -77.94 100.78 6.56 Favored 'General case' 0 C--N 1.323 -0.563 0 N-CA-C 109.026 -0.731 . . . . 1.0 109.026 178.751 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 58' ' ' TRP . . . . . 0.47 ' H ' ' CD ' ' A' ' 61' ' ' GLU . 0.3 OUTLIER -88.75 174.75 7.83 Favored 'General case' 0 CA--C 1.542 0.656 0 CA-C-O 123.18 1.466 . . . . 1.0 113.364 -177.625 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 9.0 mtm180 -80.5 -59.32 2.74 Favored 'General case' 0 C--N 1.315 -0.899 0 CA-C-N 111.416 -2.629 . . . . 1.0 113.418 -178.381 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 1.2 p90 -88.67 -10.03 49.97 Favored 'General case' 0 C--O 1.248 1.012 0 CA-C-N 114.81 -1.086 . . . . 1.0 113.573 -177.673 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 61' ' ' GLU . . . . . 0.513 ' O ' ' N ' ' A' ' 65' ' ' ASP . 13.5 pt-20 -71.8 -14.26 61.93 Favored 'General case' 0 C--N 1.313 -0.991 0 N-CA-C 113.198 0.814 . . . . 1.0 113.198 -177.767 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 62' ' ' VAL . . . . . 0.623 ' O ' ' N ' ' A' ' 66' ' ' GLY . 0.1 OUTLIER -48.72 -58.94 0.97 Allowed 'Isoleucine or valine' 0 C--O 1.204 -1.293 0 C-N-CA 119.195 -1.002 . . . . 1.0 108.5 -174.317 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -66.33 -56.67 10.02 Favored 'General case' 0 C--N 1.295 -1.799 0 O-C-N 121.797 -0.564 . . . . 1.0 110.867 -179.325 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 64' ' ' HIS . . . . . 0.56 ' O ' ' HB2' ' A' ' 67' ' ' ARG . 67.3 m-70 -53.39 -56.36 17.42 Favored 'General case' 0 N--CA 1.465 0.312 0 C-N-CA 119.148 -1.021 . . . . 1.0 109.59 -179.247 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 65' ' ' ASP . . . . . 0.609 ' C ' ' H ' ' A' ' 67' ' ' ARG . 10.0 t0 -77.63 -50.9 11.54 Favored 'General case' 0 C--N 1.312 -1.032 0 O-C-N 121.889 -0.507 . . . . 1.0 111.667 179.984 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 66' ' ' GLY . . . . . 0.623 ' N ' ' O ' ' A' ' 62' ' ' VAL . . . -71.83 26.84 0.63 Allowed Glycine 0 CA--C 1.524 0.655 0 O-C-N 120.608 -1.307 . . . . 1.0 110.412 178.042 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 67' ' ' ARG . . . . . 0.613 ' O ' ' N ' ' A' ' 69' ' ' LEU . 4.1 tpt85 -74.93 4.38 6.64 Favored 'General case' 0 N--CA 1.448 -0.566 0 N-CA-C 107.183 -1.414 . . . . 1.0 107.183 176.074 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 68' ' ' LEU . . . . . 0.493 ' H ' ' C ' ' A' ' 66' ' ' GLY . 12.9 mt -33.55 -28.13 0.01 OUTLIER 'General case' 0 N--CA 1.475 0.79 0 CA-C-N 114.687 -1.142 . . . . 1.0 108.871 -177.622 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 69' ' ' LEU . . . . . 0.613 ' N ' ' O ' ' A' ' 67' ' ' ARG . 3.0 tt -65.86 -66.03 0.6 Allowed 'General case' 0 CA--C 1.546 0.821 0 C-N-CA 119.293 -0.963 . . . . 1.0 110.085 -179.17 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 70' ' ' ALA . . . . . 0.64 ' C ' ' H ' ' A' ' 72' ' ' HIS . . . -79.1 -78.36 0.15 Allowed 'General case' 0 N--CA 1.475 0.819 0 C-N-CA 118.766 -1.174 . . . . 1.0 108.439 -179.842 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 71' ' ' ALA . . . . . 0.785 ' HB1' ' HB ' ' A' ' 74' ' ' VAL . . . -50.32 9.53 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.285 0 C-N-CA 125.651 1.581 . . . . 1.0 113.005 179.342 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 72' ' ' HIS . . . . . 0.64 ' H ' ' C ' ' A' ' 70' ' ' ALA . 0.4 OUTLIER -24.21 -58.75 0.05 Allowed 'General case' 0 C--N 1.33 -0.247 0 N-CA-C 113.765 1.024 . . . . 1.0 113.765 -177.197 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 73' ' ' MET . . . . . 0.563 ' H ' ' CG ' ' A' ' 72' ' ' HIS . 95.0 mtp -68.94 -45.99 69.34 Favored 'General case' 0 C--N 1.319 -0.746 0 C-N-CA 119.604 -0.838 . . . . 1.0 109.145 179.34 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 74' ' ' VAL . . . . . 0.785 ' HB ' ' HB1' ' A' ' 71' ' ' ALA . 39.2 t -45.26 -43.92 3.3 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.255 0 CA-C-O 117.658 -1.163 . . . . 1.0 111.685 -176.365 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 75' ' ' ASN . . . . . 0.702 HD21 HH22 ' A' ' 126' ' ' ARG . 0.7 OUTLIER -39.6 -11.14 0.01 OUTLIER 'General case' 0 C--N 1.362 1.134 0 CA-C-N 121.05 1.75 . . . . 1.0 111.419 178.994 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 76' ' ' GLY . . . . . 0.719 ' N ' ' O ' ' A' ' 74' ' ' VAL . . . -42.12 -27.3 0.41 Allowed Glycine 0 CA--C 1.536 1.384 0 N-CA-C 107.301 -2.32 . . . . 1.0 107.301 177.988 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 77' ' ' ILE . . . . . 0.668 ' HA ' ' HB3' ' A' ' 80' ' ' ALA . 7.1 pt -68.76 -49.45 64.09 Favored 'Isoleucine or valine' 0 C--O 1.212 -0.881 0 N-CA-C 108.663 -0.866 . . . . 1.0 108.663 176.653 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 78' ' ' VAL . . . . . 0.636 ' N ' ' O ' ' A' ' 75' ' ' ASN . 2.0 p -32.35 -39.09 0.04 OUTLIER 'Isoleucine or valine' 0 CA--C 1.545 0.769 0 N-CA-C 108.846 -0.798 . . . . 1.0 108.846 -176.369 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 79' ' ' ILE . . . . . 0.566 HG23 HG13 ' A' ' 78' ' ' VAL . 2.9 pp -97.71 -24.72 4.28 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.709 0 CA-C-O 121.153 0.501 . . . . 1.0 110.751 178.041 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 80' ' ' ALA . . . . . 0.668 ' HB3' ' HA ' ' A' ' 77' ' ' ILE . . . -86.98 -10.37 53.36 Favored 'General case' 0 CA--C 1.551 1.014 0 N-CA-C 113.381 0.882 . . . . 1.0 113.381 177.568 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 81' ' ' GLU . . . . . 0.596 ' N ' ' O ' ' A' ' 77' ' ' ILE . 81.9 tt0 -87.65 -71.22 0.58 Allowed 'General case' 0 N--CA 1.445 -0.699 0 CA-C-N 118.942 0.792 . . . . 1.0 109.426 -179.826 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 82' ' ' ASP . . . . . 0.648 ' O ' ' N ' ' A' ' 84' ' ' LEU . 0.7 OUTLIER -70.32 -11.63 61.04 Favored 'General case' 0 N--CA 1.444 -0.733 0 CA-C-N 119.109 0.868 . . . . 1.0 110.294 179.069 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 83' ' ' ALA . . . . . 0.805 ' O ' ' N ' ' A' ' 86' ' ' ALA . . . -18.79 -43.22 0.0 OUTLIER 'General case' 0 C--O 1.197 -1.668 0 O-C-N 124.072 0.858 . . . . 1.0 111.804 177.941 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 84' ' ' LEU . . . . . 0.648 ' N ' ' O ' ' A' ' 82' ' ' ASP . 19.1 mt -26.72 -30.55 0.0 OUTLIER 'General case' 0 N--CA 1.472 0.664 0 O-C-N 121.901 -0.5 . . . . 1.0 111.902 -175.801 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 85' ' ' ILE . . . . . 0.714 ' N ' ' O ' ' A' ' 83' ' ' ALA . 0.1 OUTLIER -98.57 -31.33 3.64 Favored 'Isoleucine or valine' 0 CA--C 1.551 1.009 0 N-CA-C 109.541 -0.54 . . . . 1.0 109.541 175.42 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 86' ' ' ALA . . . . . 0.805 ' N ' ' O ' ' A' ' 83' ' ' ALA . . . -91.89 -27.33 17.99 Favored 'General case' 0 N--CA 1.486 1.352 0 CA-C-O 121.897 0.856 . . . . 1.0 112.652 179.063 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 87' ' ' GLU . . . . . 0.604 ' N ' ' O ' ' A' ' 83' ' ' ALA . 3.3 pt-20 -47.33 -28.55 2.06 Favored 'General case' 0 C--N 1.313 -1.008 0 CA-C-N 114.089 -1.414 . . . . 1.0 109.963 -178.859 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -141.7 24.99 2.02 Favored 'General case' 0 N--CA 1.475 0.8 0 CA-C-O 121.585 0.707 . . . . 1.0 111.118 -178.99 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 89' ' ' VAL . . . . . 0.693 HG22 ' HB3' ' A' ' 92' ' ' HIS . 4.8 p -75.62 36.38 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.315 -0.921 0 CA-C-N 114.905 -1.043 . . . . 1.0 109.518 178.423 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 90' ' ' GLY . . . . . 0.529 ' O ' ' N ' ' A' ' 92' ' ' HIS . . . -66.77 -39.87 93.67 Favored Glycine 0 N--CA 1.439 -1.129 0 C-N-CA 119.055 -1.545 . . . . 1.0 111.138 178.693 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 91' ' ' PRO . . . . . 0.522 ' CD ' ' N ' ' A' ' 90' ' ' GLY . 95.8 Cg_exo -43.78 -20.1 0.23 Allowed 'Trans proline' 0 N--CA 1.49 1.293 0 CA-C-N 119.897 1.848 . . . . 1.0 110.003 179.777 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 92' ' ' HIS . . . . . 0.693 ' HB3' HG22 ' A' ' 89' ' ' VAL . 7.7 p-80 -60.65 -25.84 66.62 Favored 'General case' 0 C--O 1.218 -0.599 0 CA-C-N 114.724 -1.126 . . . . 1.0 109.396 179.649 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 93' ' ' LEU . . . . . 0.663 HD12 ' N ' ' A' ' 94' ' ' ALA . 2.2 pp -63.47 -58.7 6.2 Favored 'General case' 0 C--N 1.325 -0.494 0 N-CA-C 108.353 -0.98 . . . . 1.0 108.353 178.451 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 94' ' ' ALA . . . . . 0.663 ' N ' HD12 ' A' ' 93' ' ' LEU . . . -56.23 -55.93 27.2 Favored 'General case' 0 N--CA 1.452 -0.369 0 N-CA-C 109.26 -0.645 . . . . 1.0 109.26 179.096 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 95' ' ' ARG . . . . . 0.613 ' O ' ' N ' ' A' ' 97' ' ' LEU . 10.8 ttp180 -59.07 -61.04 2.94 Favored 'General case' 0 C--O 1.239 0.542 0 CA-C-O 122.333 1.064 . . . . 1.0 108.819 179.586 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 96' ' ' ALA . . . . . 0.871 ' O ' ' N ' ' A' ' 98' ' ' GLY . . . -47.68 -12.51 0.03 OUTLIER 'General case' 0 C--N 1.306 -1.319 0 O-C-N 118.56 -2.587 . . . . 1.0 112.072 -179.154 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 97' ' ' LEU . . . . . 0.829 HD12 ' N ' ' A' ' 98' ' ' GLY . 3.5 pp 5.34 -52.53 0.0 OUTLIER 'General case' 0 C--O 1.204 -1.328 0 CA-C-O 116.767 -1.587 . . . . 1.0 111.262 -166.595 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 98' ' ' GLY . . . . . 0.871 ' N ' ' O ' ' A' ' 96' ' ' ALA . . . -47.22 -24.14 2.13 Favored Glycine 0 C--N 1.303 -1.301 0 CA-C-N 123.381 2.809 . . . . 1.0 107.473 176.018 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 99' ' ' GLN . . . . . 0.524 ' HG2' ' HB1' ' A' ' 96' ' ' ALA . 57.5 mm-40 -64.44 -17.99 64.33 Favored 'General case' 0 C--N 1.361 1.098 0 C-N-CA 117.415 -1.714 . . . . 1.0 107.424 176.049 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 100' ' ' ILE . . . . . 0.799 ' N ' ' O ' ' A' ' 97' ' ' LEU . 12.1 tt -64.67 -44.75 96.63 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.629 0 N-CA-C 107.87 -1.159 . . . . 1.0 107.87 177.881 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 101' ' ' VAL . . . . . 0.801 ' O ' ' N ' ' A' ' 105' ' ' GLY . 68.9 t -60.14 -61.06 1.67 Allowed 'Isoleucine or valine' 0 C--O 1.209 -1.059 0 N-CA-C 107.585 -1.265 . . . . 1.0 107.585 179.499 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 102' ' ' CYS . . . . . 0.888 ' O ' ' HB2' ' A' ' 106' ' ' ALA . 0.5 OUTLIER -44.21 -19.02 0.02 OUTLIER 'General case' 0 C--N 1.319 -0.732 0 CA-C-O 121.399 0.619 . . . . 1.0 110.988 -179.458 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 103' ' ' ARG . . . . . 0.518 ' N ' ' O ' ' A' ' 101' ' ' VAL . 12.1 ttp-105 -95.44 -43.96 7.75 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-O 122.034 0.921 . . . . 1.0 111.889 177.383 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 104' ' ' TYR . . . . . 0.709 ' O ' ' CG ' ' A' ' 104' ' ' TYR . 0.1 OUTLIER -107.43 19.16 20.65 Favored 'General case' 0 CA--C 1.552 1.038 0 C-N-CA 126.628 1.971 . . . . 1.0 110.619 178.477 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 105' ' ' GLY . . . . . 0.801 ' N ' ' O ' ' A' ' 101' ' ' VAL . . . -162.64 -10.89 0.03 OUTLIER Glycine 0 C--N 1.332 0.324 0 C-N-CA 118.898 -1.62 . . . . 1.0 112.514 179.785 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 106' ' ' ALA . . . . . 0.888 ' HB2' ' O ' ' A' ' 102' ' ' CYS . . . -29.81 118.7 0.15 Allowed 'General case' 0 N--CA 1.463 0.219 0 CA-C-N 117.017 0.408 . . . . 1.0 110.081 179.391 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 107' ' ' THR . . . . . 0.798 ' O ' ' HD2' ' A' ' 110' ' ' PRO . 10.7 m -133.98 -62.48 0.76 Allowed 'General case' 0 C--O 1.192 -1.951 0 N-CA-C 105.542 -2.021 . . . . 1.0 105.542 178.042 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 26.1 m -61.89 28.57 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.309 -1.181 0 O-C-N 121.034 -1.041 . . . . 1.0 110.194 -179.878 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 109' ' ' ILE . . . . . 0.666 HG21 ' HB1' ' A' ' 106' ' ' ALA . 0.1 OUTLIER -111.81 -42.98 0.09 OUTLIER Pre-proline 0 C--N 1.372 1.545 0 CA-C-N 119.634 1.107 . . . . 1.0 111.381 177.575 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 110' ' ' PRO . . . . . 0.798 ' HD2' ' O ' ' A' ' 107' ' ' THR . 31.3 Cg_exo -65.1 -28.49 56.83 Favored 'Trans proline' 0 N--CA 1.499 1.799 0 C-N-CA 122.457 2.105 . . . . 1.0 111.869 -179.569 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 111' ' ' ASN . . . . . 0.437 ' C ' ' N ' ' A' ' 113' ' ' ASN . 0.1 OUTLIER -69.12 -69.08 0.36 Allowed 'General case' 0 CA--C 1.538 0.49 0 C-N-CA 119.687 -0.805 . . . . 1.0 109.851 -179.242 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 112' ' ' ILE . . . . . 0.5 ' O ' ' N ' ' A' ' 116' ' ' ILE . 13.1 pt -47.8 -28.29 1.57 Allowed 'Isoleucine or valine' 0 C--O 1.214 -0.785 0 CA-C-O 123.414 1.578 . . . . 1.0 108.531 179.593 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 113' ' ' ASN . . . . . 0.466 ' ND2' ' O ' ' A' ' 110' ' ' PRO . 0.0 OUTLIER -56.85 -52.74 63.91 Favored 'General case' 0 C--N 1.293 -1.864 0 CA-C-N 111.526 -2.579 . . . . 1.0 106.906 -178.935 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 114' ' ' ALA . . . . . 0.559 ' O ' HG23 ' A' ' 118' ' ' VAL . . . -62.37 -35.04 77.9 Favored 'General case' 0 C--N 1.322 -0.595 0 N-CA-C 112.842 0.682 . . . . 1.0 112.842 -179.914 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -82.8 -56.25 3.94 Favored 'General case' 0 C--O 1.21 -1.002 0 CA-C-N 119.486 1.039 . . . . 1.0 110.538 178.503 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 116' ' ' ILE . . . . . 0.541 ' O ' ' N ' ' A' ' 120' ' ' GLY . 50.8 mt -48.74 -60.88 0.61 Allowed 'Isoleucine or valine' 0 N--CA 1.478 0.954 0 CA-C-O 122.522 1.153 . . . . 1.0 108.107 -179.208 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 117' ' ' GLU . . . . . 0.445 ' HB2' ' O ' ' A' ' 113' ' ' ASN . 91.5 mt-10 -42.67 -53.56 4.42 Favored 'General case' 0 C--N 1.313 -0.988 0 CA-C-N 112.488 -2.142 . . . . 1.0 107.17 -178.761 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 118' ' ' VAL . . . . . 0.559 HG23 ' O ' ' A' ' 114' ' ' ALA . 69.1 t -60.72 -54.84 29.75 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.516 0 N-CA-C 109.143 -0.688 . . . . 1.0 109.143 177.281 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 3.3 tp -53.49 -71.66 0.07 Allowed 'General case' 0 N--CA 1.464 0.234 0 N-CA-C 108.038 -1.097 . . . . 1.0 108.038 -179.424 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 120' ' ' GLY . . . . . 0.541 ' N ' ' O ' ' A' ' 116' ' ' ILE . . . -66.62 -85.37 0.09 OUTLIER Glycine 0 CA--C 1.533 1.21 0 C-N-CA 118.567 -1.777 . . . . 1.0 110.063 179.369 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 121' ' ' THR . . . . . 0.419 HG23 ' H ' ' A' ' 123' ' ' THR . 1.6 t 168.67 -39.9 0.0 OUTLIER 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 112.633 -1.783 . . . . 1.0 112.756 -179.802 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 122' ' ' GLY . . . . . 0.619 ' O ' ' N ' ' A' ' 124' ' ' ASP . . . 100.99 -18.72 54.32 Favored Glycine 0 N--CA 1.469 0.856 0 N-CA-C 107.037 -2.425 . . . . 1.0 107.037 -176.884 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 123' ' ' THR . . . . . 0.419 ' H ' HG23 ' A' ' 121' ' ' THR . 25.5 m -51.63 86.71 0.0 OUTLIER 'General case' 0 N--CA 1.471 0.617 0 CA-C-N 111.884 -2.158 . . . . 1.0 105.463 178.261 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 124' ' ' ASP . . . . . 0.619 ' N ' ' O ' ' A' ' 122' ' ' GLY . 9.5 m-20 -160.3 165.1 31.95 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 114.372 -1.285 . . . . 1.0 112.062 -178.305 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 125' ' ' TYR . . . . . 0.576 ' O ' ' NH2' ' A' ' 126' ' ' ARG . 0.0 OUTLIER -151.13 146.98 26.51 Favored 'General case' 0 CA--C 1.541 0.61 0 N-CA-C 108.92 -0.771 . . . . 1.0 108.92 177.901 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 126' ' ' ARG . . . . . 0.702 HH22 HD21 ' A' ' 75' ' ' ASN . 0.1 OUTLIER -148.01 150.58 34.23 Favored 'General case' 0 CA--C 1.541 0.613 0 CA-C-N 115.762 -0.654 . . . . 1.0 109.718 177.453 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 127' ' ' PHE . . . . . . . . . . . . . 85.8 t80 . . . . . 0 N--CA 1.468 0.459 0 CA-C-O 118.011 -0.995 . . . . 1.0 110.726 178.918 . . . . . . . . 0 0 . 1 . 024 nuclear build full ' A' A ' 128' ' ' MTN . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 024 nuclear build full ' A' A ' 129' ' ' MTN . . . . . 0.467 ' H83' ' O ' ' A' ' 48' ' ' CYS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 130' ' ' MTN . . . . . 0.622 ' S1 ' ' H71' ' A' ' 130' ' ' MTN . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.492 ' SD ' ' CB ' ' A' ' 4' ' ' PHE . 19.6 mtp . . . . . 0 N--CA 1.492 1.63 0 N-CA-C 108.179 -1.045 . . . . 1.0 108.179 . . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 2' ' ' SER . . . . . 0.423 ' O ' ' CG ' ' A' ' 3' ' ' ASP . 88.6 p -107.7 7.87 28.68 Favored 'General case' 0 N--CA 1.468 0.452 0 CA-C-O 120.705 0.288 . . . . 1.0 110.412 -179.753 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 3' ' ' ASP . . . . . 0.423 ' CG ' ' O ' ' A' ' 2' ' ' SER . 12.1 m-20 168.35 94.25 0.0 OUTLIER 'General case' 0 N--CA 1.47 0.557 0 CA-C-N 115.469 -0.787 . . . . 1.0 110.468 179.014 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 4' ' ' PHE . . . . . 0.492 ' CB ' ' SD ' ' A' ' 1' ' ' MET . 37.9 t80 -149.8 145.56 26.68 Favored 'General case' 0 CA--C 1.517 -0.326 0 CA-C-N 116.212 -0.449 . . . . 1.0 110.516 179.501 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 61.5 m-20 -154.75 151.01 28.19 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 121.134 0.492 . . . . 1.0 110.007 179.763 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 6' ' ' THR . . . . . 0.644 ' O ' ' N ' ' A' ' 10' ' ' SER . 0.2 OUTLIER -67.17 173.23 3.95 Favored 'General case' 0 C--O 1.208 -1.123 0 CA-C-N 115.707 -0.679 . . . . 1.0 110.126 179.855 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 7' ' ' GLU . . . . . 0.595 ' O ' ' N ' ' A' ' 11' ' ' ARG . 1.5 tm-20 -58.07 -54.29 48.6 Favored 'General case' 0 C--N 1.309 -1.191 0 CA-C-O 121.877 0.846 . . . . 1.0 109.423 -179.303 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 8' ' ' ARG . . . . . 0.58 ' O ' ' HB3' ' A' ' 12' ' ' ALA . 27.9 ttp180 -53.82 -57.85 9.41 Favored 'General case' 0 C--N 1.311 -1.099 0 N-CA-C 107.967 -1.123 . . . . 1.0 107.967 -178.44 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 9' ' ' VAL . . . . . 0.853 ' O ' HG13 ' A' ' 13' ' ' VAL . 0.0 OUTLIER -63.61 -48.08 88.41 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.359 0 CA-C-N 114.772 -1.104 . . . . 1.0 109.807 179.27 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 10' ' ' SER . . . . . 0.644 ' N ' ' O ' ' A' ' 6' ' ' THR . 48.0 t -63.15 -60.74 3.01 Favored 'General case' 0 N--CA 1.481 1.107 0 C-N-CA 120.048 -0.661 . . . . 1.0 110.467 179.266 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 11' ' ' ARG . . . . . 0.595 ' N ' ' O ' ' A' ' 7' ' ' GLU . 11.2 ttt180 -62.77 -55.38 27.05 Favored 'General case' 0 C--N 1.316 -0.862 0 CA-C-O 121.707 0.765 . . . . 1.0 110.072 -177.005 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 12' ' ' ALA . . . . . 0.58 ' HB3' ' O ' ' A' ' 8' ' ' ARG . . . -52.37 -51.57 58.2 Favored 'General case' 0 C--N 1.316 -0.856 0 N-CA-C 107.015 -1.476 . . . . 1.0 107.015 -178.322 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 13' ' ' VAL . . . . . 0.853 HG13 ' O ' ' A' ' 9' ' ' VAL . 3.5 m -63.0 -45.84 97.86 Favored 'Isoleucine or valine' 0 C--O 1.2 -1.524 0 C-N-CA 117.387 -1.725 . . . . 1.0 108.888 177.839 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 14' ' ' ALA . . . . . 0.585 ' O ' HG13 ' A' ' 18' ' ' VAL . . . -59.79 -62.01 2.19 Favored 'General case' 0 N--CA 1.481 1.109 0 O-C-N 120.61 -1.306 . . . . 1.0 110.26 178.654 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 15' ' ' ALA . . . . . 0.542 ' N ' ' O ' ' A' ' 11' ' ' ARG . . . -52.15 -55.36 21.44 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-O 121.984 0.897 . . . . 1.0 109.415 -177.932 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 16' ' ' ALA . . . . . 0.51 ' C ' ' H ' ' A' ' 22' ' ' GLY . . . -62.29 -53.85 49.19 Favored 'General case' 0 C--N 1.31 -1.112 0 CA-C-N 114.233 -1.348 . . . . 1.0 108.811 -179.194 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 17' ' ' LEU . . . . . 0.607 ' CB ' ' O ' ' A' ' 13' ' ' VAL . 7.9 tt -57.1 -54.85 42.12 Favored 'General case' 0 N--CA 1.481 1.084 0 CA-C-N 114.738 -1.119 . . . . 1.0 109.462 -177.75 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 18' ' ' VAL . . . . . 0.585 HG13 ' O ' ' A' ' 14' ' ' ALA . 1.8 m -69.68 -57.25 8.84 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.63 0 C-N-CA 119.682 -0.807 . . . . 1.0 109.673 178.932 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 19' ' ' GLY . . . . . 0.543 ' O ' ' CG2' ' A' ' 23' ' ' VAL . . . -65.2 -166.99 1.57 Allowed Glycine 0 CA--C 1.537 1.432 0 N-CA-C 111.477 -0.649 . . . . 1.0 111.477 -179.875 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 20' ' ' PRO . . . . . 0.498 ' O ' ' HB2' ' A' ' 24' ' ' ALA . 83.5 Cg_endo -78.18 -24.87 7.7 Favored 'Trans proline' 0 N--CA 1.509 2.407 0 C-N-CA 123.628 2.885 . . . . 1.0 115.138 -177.825 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -57.32 -57.26 20.72 Favored Glycine 0 N--CA 1.478 1.448 0 C-N-CA 120.221 -0.99 . . . . 1.0 111.694 -176.765 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 22' ' ' GLY . . . . . 0.51 ' H ' ' C ' ' A' ' 16' ' ' ALA . . . -60.33 -56.21 25.77 Favored Glycine 0 N--CA 1.468 0.819 0 N-CA-C 109.274 -1.531 . . . . 1.0 109.274 -177.234 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 23' ' ' VAL . . . . . 0.543 ' CG2' ' O ' ' A' ' 19' ' ' GLY . 0.0 OUTLIER -61.89 -35.98 71.22 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.958 0 CA-C-N 114.867 -0.666 . . . . 1.0 110.106 -178.845 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 24' ' ' ALA . . . . . 0.498 ' HB2' ' O ' ' A' ' 20' ' ' PRO . . . -56.23 -59.97 4.17 Favored 'General case' 0 CA--C 1.538 0.51 0 C-N-CA 117.779 -1.568 . . . . 1.0 108.325 179.531 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 14.3 tp -66.66 -43.87 83.38 Favored 'General case' 0 C--N 1.348 0.505 0 N-CA-C 113.113 0.783 . . . . 1.0 113.113 -178.635 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 79.2 t -60.71 -58.7 6.24 Favored 'Isoleucine or valine' 0 C--N 1.34 0.188 0 C-N-CA 118.137 -1.425 . . . . 1.0 109.253 -177.243 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 27' ' ' VAL . . . . . 0.422 ' O ' ' HB3' ' A' ' 31' ' ' ALA . 60.7 t -61.14 -37.76 78.16 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.374 0 N-CA-C 112.96 0.726 . . . . 1.0 112.96 -177.914 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 28' ' ' LYS . . . . . 0.406 ' CG ' ' O ' ' A' ' 24' ' ' ALA . 30.0 mmtm -64.23 -52.68 57.59 Favored 'General case' 0 CA--C 1.509 -0.631 0 N-CA-C 108.372 -0.973 . . . . 1.0 108.372 -179.812 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 92.8 t -65.07 -47.91 86.0 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.874 0 CA-C-N 113.445 -1.707 . . . . 1.0 110.797 -177.361 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 30' ' ' CYS . . . . . . . . . . . . . 11.5 t -65.8 -61.11 2.25 Favored 'General case' 0 N--CA 1.445 -0.684 0 C-N-CA 118.685 -1.206 . . . . 1.0 109.86 -179.747 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 31' ' ' ALA . . . . . 0.438 ' HA ' HD13 ' A' ' 37' ' ' ILE . . . -66.62 -53.95 28.63 Favored 'General case' 0 CA--C 1.518 -0.261 0 N-CA-C 113.668 0.988 . . . . 1.0 113.668 -176.221 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 85.1 73.57 1.27 Allowed Glycine 0 CA--C 1.533 1.17 0 N-CA-C 109.913 -1.275 . . . . 1.0 109.913 -177.253 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 4.7 mt 76.78 106.26 0.03 OUTLIER Pre-proline 0 N--CA 1.475 0.8 0 C-N-CA 123.416 0.686 . . . . 1.0 111.524 -179.706 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 74.9 Cg_exo -51.42 -15.6 2.63 Favored 'Trans proline' 0 N--CA 1.506 2.243 0 C-N-CA 122.889 2.393 . . . . 1.0 114.967 179.365 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -56.7 -57.87 17.33 Favored Glycine 0 CA--C 1.526 0.746 0 N-CA-C 107.584 -2.207 . . . . 1.0 107.584 -179.791 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 36' ' ' VAL . . . . . 0.848 ' O ' HG22 ' A' ' 37' ' ' ILE . 5.6 p -79.01 -147.2 0.01 OUTLIER 'Isoleucine or valine' 0 C--O 1.22 -0.459 0 N-CA-C 108.247 -1.019 . . . . 1.0 108.247 178.572 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 37' ' ' ILE . . . . . 0.848 HG22 ' O ' ' A' ' 36' ' ' VAL . 9.1 tp 70.52 79.74 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.475 0.814 0 CA-C-O 122.157 0.98 . . . . 1.0 112.969 -179.217 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 60.3 m80 -137.79 132.08 32.15 Favored 'General case' 0 N--CA 1.453 -0.283 0 N-CA-C 108.183 -1.043 . . . . 1.0 108.183 177.267 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 10.0 m -128.99 115.71 18.94 Favored Pre-proline 0 C--N 1.326 -0.434 0 N-CA-C 108.38 -0.97 . . . . 1.0 108.38 -179.284 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_exo -42.94 -66.65 0.15 Allowed 'Trans proline' 0 C--N 1.317 -1.122 0 C-N-CA 121.017 1.145 . . . . 1.0 111.558 -178.503 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -75.6 115.33 15.17 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 115.262 -0.881 . . . . 1.0 112.848 -177.292 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 42' ' ' ARG . . . . . 0.628 ' C ' ' H ' ' A' ' 44' ' ' GLY . 32.9 ptt180 -166.12 162.4 17.7 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 114.817 -1.083 . . . . 1.0 109.987 179.225 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 43' ' ' ARG . . . . . 0.522 ' C ' ' H ' ' A' ' 45' ' ' PHE . 0.2 OUTLIER -65.99 18.63 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.318 -0.401 . . . . 1.0 110.235 -179.263 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 44' ' ' GLY . . . . . 0.628 ' H ' ' C ' ' A' ' 42' ' ' ARG . . . 70.57 -26.59 0.48 Allowed Glycine 0 N--CA 1.448 -0.531 0 N-CA-C 110.824 -0.91 . . . . 1.0 110.824 179.846 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 45' ' ' PHE . . . . . 0.59 ' CE2' ' H82' ' A' ' 129' ' ' MTN . 7.6 t80 -155.33 150.65 27.05 Favored 'General case' 0 CA--C 1.541 0.622 0 N-CA-C 108.892 -0.781 . . . . 1.0 108.892 -178.906 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 46' ' ' PHE . . . . . 0.497 ' CE1' ' NE2' ' A' ' 54' ' ' GLN . 15.3 t80 172.21 7.15 0.0 OUTLIER 'General case' 0 N--CA 1.483 1.208 0 O-C-N 124.014 0.821 . . . . 1.0 113.155 176.273 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 47' ' ' ARG . . . . . 0.403 ' HB3' ' O ' ' A' ' 46' ' ' PHE . 0.0 OUTLIER 172.2 -176.0 0.05 Allowed 'General case' 0 C--N 1.328 -0.334 0 N-CA-C 109.765 -0.457 . . . . 1.0 109.765 179.689 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 48' ' ' CYS . . . . . 0.411 ' O ' ' H83' ' A' ' 129' ' ' MTN . 0.0 OUTLIER 70.64 63.01 0.19 Allowed 'General case' 0 CA--C 1.546 0.819 0 N-CA-C 108.901 -0.777 . . . . 1.0 108.901 179.938 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 49' ' ' ASN . . . . . 0.553 ' O ' ' N ' ' A' ' 51' ' ' GLU . 0.1 OUTLIER -151.06 133.21 8.17 Favored Pre-proline 0 CA--C 1.546 0.818 0 N-CA-C 108.169 -1.048 . . . . 1.0 108.169 178.891 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 50' ' ' PRO . . . . . 0.551 ' HD2' HH21 ' A' ' 52' ' ' ARG . 16.3 Cg_endo -55.13 73.86 0.03 OUTLIER 'Trans proline' 0 N--CA 1.502 1.999 0 CA-C-N 120.995 1.391 . . . . 1.0 113.833 -179.816 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 51' ' ' GLU . . . . . 0.553 ' N ' ' O ' ' A' ' 49' ' ' ASN . 40.2 mm-40 62.01 69.8 0.61 Allowed 'General case' 0 N--CA 1.468 0.441 0 N-CA-C 113.428 0.899 . . . . 1.0 113.428 177.975 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 52' ' ' ARG . . . . . 0.551 HH21 ' HD2' ' A' ' 50' ' ' PRO . 0.0 OUTLIER -141.67 150.68 42.22 Favored 'General case' 0 N--CA 1.471 0.579 0 N-CA-C 108.772 -0.825 . . . . 1.0 108.772 178.155 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 53' ' ' ILE . . . . . 0.553 HD13 ' H ' ' A' ' 54' ' ' GLN . 0.4 OUTLIER -74.44 136.37 25.38 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.372 0 CA-C-O 121.623 0.725 . . . . 1.0 111.43 -178.679 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 54' ' ' GLN . . . . . 0.553 ' H ' HD13 ' A' ' 53' ' ' ILE . 1.9 pt20 -62.9 82.21 0.02 OUTLIER 'General case' 0 N--CA 1.469 0.492 0 CA-C-N 114.611 -1.177 . . . . 1.0 110.143 -177.172 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 16.0 tt -149.52 159.07 5.68 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.27 0 CA-C-N 115.97 -0.559 . . . . 1.0 110.141 178.113 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 112.26 -2.92 26.73 Favored Glycine 0 N--CA 1.472 1.043 0 N-CA-C 110.669 -0.973 . . . . 1.0 110.669 -179.713 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 57' ' ' ASP . . . . . 0.484 ' OD2' ' O ' ' A' ' 43' ' ' ARG . 25.3 t70 -82.91 98.71 9.34 Favored 'General case' 0 C--N 1.323 -0.554 0 N-CA-C 109.619 -0.511 . . . . 1.0 109.619 179.426 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 58' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -87.3 174.49 8.54 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-O 122.615 1.198 . . . . 1.0 112.764 -177.899 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 59' ' ' ARG . . . . . 0.447 ' HG3' ' N ' ' A' ' 60' ' ' TYR . 2.1 ptt180 -86.17 -56.96 3.21 Favored 'General case' 0 C--N 1.318 -0.783 0 CA-C-N 111.824 -2.444 . . . . 1.0 112.259 -179.538 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 60' ' ' TYR . . . . . 0.447 ' N ' ' HG3' ' A' ' 59' ' ' ARG . 41.4 t80 -92.42 -17.28 24.8 Favored 'General case' 0 C--O 1.249 1.052 0 N-CA-C 113.521 0.934 . . . . 1.0 113.521 -179.181 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 5.3 tt0 -79.51 -13.9 59.25 Favored 'General case' 0 C--N 1.313 -0.996 0 CA-C-N 115.973 -0.558 . . . . 1.0 110.482 -179.292 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 62' ' ' VAL . . . . . 0.645 ' O ' ' N ' ' A' ' 66' ' ' GLY . 27.4 m -47.39 -55.32 2.22 Favored 'Isoleucine or valine' 0 C--O 1.201 -1.498 0 C-N-CA 119.326 -0.95 . . . . 1.0 110.107 -176.608 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 63' ' ' ALA . . . . . 0.619 ' N ' HG23 ' A' ' 62' ' ' VAL . . . -68.77 -54.87 13.43 Favored 'General case' 0 C--N 1.306 -1.292 0 C-N-CA 119.338 -0.945 . . . . 1.0 109.416 -178.466 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 64' ' ' HIS . . . . . 0.474 ' O ' ' HB2' ' A' ' 67' ' ' ARG . 6.6 t-80 -44.98 -58.38 3.2 Favored 'General case' 0 N--CA 1.472 0.645 0 CA-C-O 121.519 0.676 . . . . 1.0 109.99 179.516 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 65' ' ' ASP . . . . . 0.529 ' C ' ' H ' ' A' ' 67' ' ' ARG . 0.5 OUTLIER -73.18 -47.02 47.23 Favored 'General case' 0 C--N 1.313 -1.006 0 CA-C-N 115.551 -0.75 . . . . 1.0 109.991 177.917 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 66' ' ' GLY . . . . . 0.645 ' N ' ' O ' ' A' ' 62' ' ' VAL . . . -75.4 25.46 1.34 Allowed Glycine 0 CA--C 1.53 0.977 0 O-C-N 120.526 -1.359 . . . . 1.0 110.354 177.5 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 67' ' ' ARG . . . . . 0.603 ' O ' ' N ' ' A' ' 69' ' ' LEU . 5.5 mmt180 -72.02 5.26 2.8 Favored 'General case' 0 CA--C 1.508 -0.655 0 N-CA-C 105.969 -1.863 . . . . 1.0 105.969 175.115 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 68' ' ' LEU . . . . . 0.553 ' H ' ' C ' ' A' ' 66' ' ' GLY . 0.7 OUTLIER -33.94 -28.1 0.01 OUTLIER 'General case' 0 C--N 1.354 0.787 0 O-C-N 124.181 0.926 . . . . 1.0 109.173 -176.709 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 69' ' ' LEU . . . . . 0.603 ' N ' ' O ' ' A' ' 67' ' ' ARG . 9.0 mp -62.47 -64.94 0.77 Allowed 'General case' 0 N--CA 1.471 0.624 0 C-N-CA 118.885 -1.126 . . . . 1.0 108.237 177.362 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 70' ' ' ALA . . . . . 0.586 ' O ' ' N ' ' A' ' 72' ' ' HIS . . . -76.71 -74.28 0.25 Allowed 'General case' 0 C--O 1.217 -0.634 0 N-CA-C 104.833 -2.284 . . . . 1.0 104.833 177.126 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 71' ' ' ALA . . . . . 0.463 ' O ' ' OD1' ' A' ' 75' ' ' ASN . . . -40.66 2.65 0.0 OUTLIER 'General case' 0 N--CA 1.473 0.707 0 N-CA-C 115.27 1.582 . . . . 1.0 115.27 179.832 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 72' ' ' HIS . . . . . 0.645 ' CG ' ' H ' ' A' ' 73' ' ' MET . 0.0 OUTLIER -30.45 -81.97 0.01 OUTLIER 'General case' 0 CA--C 1.532 0.284 0 CA-C-N 119.954 1.252 . . . . 1.0 114.114 -176.425 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 73' ' ' MET . . . . . 0.645 ' H ' ' CG ' ' A' ' 72' ' ' HIS . 72.1 mtm -63.9 -53.64 47.34 Favored 'General case' 0 N--CA 1.439 -0.979 0 C-N-CA 120.002 -0.679 . . . . 1.0 110.066 -179.443 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 74' ' ' VAL . . . . . 0.683 ' O ' ' N ' ' A' ' 76' ' ' GLY . 0.6 OUTLIER -46.25 -35.86 2.49 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.718 0 CA-C-O 117.533 -1.222 . . . . 1.0 111.644 -176.092 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 75' ' ' ASN . . . . . 0.569 ' C ' ' N ' ' A' ' 77' ' ' ILE . 16.1 m120 -39.95 -9.46 0.01 OUTLIER 'General case' 0 N--CA 1.497 1.9 0 CA-C-N 121.055 1.752 . . . . 1.0 112.363 177.759 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 76' ' ' GLY . . . . . 0.683 ' N ' ' O ' ' A' ' 74' ' ' VAL . . . -41.95 -21.67 0.08 OUTLIER Glycine 0 CA--C 1.542 1.732 0 N-CA-C 107.533 -2.227 . . . . 1.0 107.533 177.051 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 77' ' ' ILE . . . . . 0.756 ' HA ' ' HB3' ' A' ' 80' ' ' ALA . 13.4 pt -74.87 -53.2 17.08 Favored 'Isoleucine or valine' 0 C--O 1.213 -0.86 0 CA-C-N 114.968 -0.616 . . . . 1.0 109.536 177.565 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 78' ' ' VAL . . . . . 0.531 ' N ' ' O ' ' A' ' 75' ' ' ASN . 3.2 p -36.15 -30.14 0.04 OUTLIER 'Isoleucine or valine' 0 CA--C 1.554 1.12 0 N-CA-C 108.631 -0.877 . . . . 1.0 108.631 -174.332 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 79' ' ' ILE . . . . . 0.882 ' O ' ' HB2' ' A' ' 83' ' ' ALA . 0.0 OUTLIER -94.64 -28.16 4.2 Favored 'Isoleucine or valine' 0 CA--C 1.555 1.135 0 CA-C-O 121.186 0.517 . . . . 1.0 109.978 176.907 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 80' ' ' ALA . . . . . 0.756 ' HB3' ' HA ' ' A' ' 77' ' ' ILE . . . -87.48 -10.88 50.6 Favored 'General case' 0 CA--C 1.553 1.063 0 C-N-CA 124.153 0.981 . . . . 1.0 113.419 177.752 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 81' ' ' GLU . . . . . 0.542 ' N ' ' O ' ' A' ' 77' ' ' ILE . 2.3 mt-10 -83.2 -70.55 0.55 Allowed 'General case' 0 C--N 1.354 0.803 0 CA-C-N 119.309 0.959 . . . . 1.0 108.561 178.759 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 82' ' ' ASP . . . . . 0.491 ' O ' ' N ' ' A' ' 84' ' ' LEU . 8.8 p-10 -78.07 -12.29 59.98 Favored 'General case' 0 N--CA 1.445 -0.683 0 CA-C-N 118.315 0.507 . . . . 1.0 111.565 -179.637 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 83' ' ' ALA . . . . . 0.882 ' HB2' ' O ' ' A' ' 79' ' ' ILE . . . -22.48 -44.16 0.01 OUTLIER 'General case' 0 N--CA 1.475 0.818 0 N-CA-C 113.207 0.817 . . . . 1.0 113.207 177.683 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 84' ' ' LEU . . . . . 0.491 ' N ' ' O ' ' A' ' 82' ' ' ASP . 0.4 OUTLIER -36.9 -34.94 0.08 Allowed 'General case' 0 N--CA 1.469 0.518 0 N-CA-C 112.576 0.584 . . . . 1.0 112.576 -176.782 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 85' ' ' ILE . . . . . 0.444 ' O ' HG13 ' A' ' 89' ' ' VAL . 2.0 pt -99.95 -41.72 9.63 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.669 0 N-CA-C 108.391 -0.966 . . . . 1.0 108.391 177.444 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 86' ' ' ALA . . . . . 0.764 ' HB3' ' HA ' ' A' ' 83' ' ' ALA . . . -59.58 -56.87 16.45 Favored 'General case' 0 CA--C 1.537 0.479 0 CA-C-N 113.93 -1.487 . . . . 1.0 109.639 -179.01 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 87' ' ' GLU . . . . . 0.492 ' N ' ' O ' ' A' ' 83' ' ' ALA . 14.4 tt0 -70.92 -21.48 62.36 Favored 'General case' 0 CA--C 1.544 0.744 0 O-C-N 121.184 -0.947 . . . . 1.0 112.951 -177.439 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -74.43 -5.41 42.32 Favored 'General case' 0 N--CA 1.48 1.049 0 CA-C-O 122.931 1.348 . . . . 1.0 108.759 179.711 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 89' ' ' VAL . . . . . 0.728 HG22 ' O ' ' A' ' 86' ' ' ALA . 11.7 m -109.85 37.34 0.52 Allowed 'Isoleucine or valine' 0 C--N 1.312 -1.036 0 CA-C-N 112.351 -2.204 . . . . 1.0 109.896 178.017 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 90' ' ' GLY . . . . . 0.596 ' C ' ' H ' ' A' ' 92' ' ' HIS . . . -75.86 -36.35 42.26 Favored Glycine 0 C--N 1.349 1.254 0 N-CA-C 110.63 -0.988 . . . . 1.0 110.63 178.803 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 91' ' ' PRO . . . . . 0.581 ' CD ' ' N ' ' A' ' 90' ' ' GLY . 82.8 Cg_exo -48.26 -9.21 0.07 OUTLIER 'Trans proline' 0 N--CA 1.499 1.798 0 C-N-CA 122.191 1.928 . . . . 1.0 109.971 176.982 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 92' ' ' HIS . . . . . 0.596 ' H ' ' C ' ' A' ' 90' ' ' GLY . 1.8 p80 -55.99 -17.35 6.55 Favored 'General case' 0 N--CA 1.445 -0.717 0 N-CA-C 107.519 -1.289 . . . . 1.0 107.519 179.253 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 93' ' ' LEU . . . . . 0.579 HD12 ' N ' ' A' ' 94' ' ' ALA . 1.4 pp -63.32 -58.76 6.08 Favored 'General case' 0 N--CA 1.451 -0.405 0 N-CA-C 108.995 -0.743 . . . . 1.0 108.995 177.542 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 94' ' ' ALA . . . . . 0.579 ' N ' HD12 ' A' ' 93' ' ' LEU . . . -57.1 -50.91 71.33 Favored 'General case' 0 CA--C 1.515 -0.377 0 C-N-CA 120.318 -0.553 . . . . 1.0 110.095 -179.996 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 95' ' ' ARG . . . . . 0.652 ' O ' ' N ' ' A' ' 97' ' ' LEU . 83.7 mtt85 -59.36 -55.95 28.23 Favored 'General case' 0 C--N 1.322 -0.623 0 N-CA-C 107.516 -1.29 . . . . 1.0 107.516 178.781 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 96' ' ' ALA . . . . . 0.87 ' O ' ' N ' ' A' ' 98' ' ' GLY . . . -46.8 -13.42 0.03 OUTLIER 'General case' 0 N--CA 1.427 -1.575 0 O-C-N 119.118 -2.238 . . . . 1.0 110.15 179.846 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 97' ' ' LEU . . . . . 0.744 ' O ' ' N ' ' A' ' 100' ' ' ILE . 0.4 OUTLIER 7.38 -54.71 0.0 OUTLIER 'General case' 0 C--N 1.372 1.544 0 CA-C-O 117.547 -1.216 . . . . 1.0 109.993 -169.298 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 98' ' ' GLY . . . . . 0.87 ' N ' ' O ' ' A' ' 96' ' ' ALA . . . -49.01 -24.0 4.14 Favored Glycine 0 C--N 1.289 -2.079 0 CA-C-N 122.833 2.561 . . . . 1.0 108.849 174.767 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 99' ' ' GLN . . . . . 0.576 ' N ' ' O ' ' A' ' 96' ' ' ALA . 0.0 OUTLIER -66.36 -15.89 63.63 Favored 'General case' 0 C--N 1.364 1.223 0 N-CA-C 106.405 -1.702 . . . . 1.0 106.405 177.249 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 100' ' ' ILE . . . . . 0.744 ' N ' ' O ' ' A' ' 97' ' ' LEU . 0.4 OUTLIER -64.04 -45.58 96.24 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.52 0 N-CA-C 108.088 -1.079 . . . . 1.0 108.088 177.089 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 101' ' ' VAL . . . . . 0.651 ' O ' ' N ' ' A' ' 105' ' ' GLY . 71.9 t -53.74 -61.61 0.87 Allowed 'Isoleucine or valine' 0 CA--C 1.5 -0.963 0 N-CA-C 108.433 -0.951 . . . . 1.0 108.433 179.411 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 102' ' ' CYS . . . . . 0.902 ' O ' ' HB2' ' A' ' 106' ' ' ALA . 4.2 t -46.07 -21.75 0.17 Allowed 'General case' 0 N--CA 1.427 -1.625 0 CA-C-N 115.569 -0.741 . . . . 1.0 112.317 -178.031 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -88.69 -43.78 11.06 Favored 'General case' 0 N--CA 1.484 1.255 0 O-C-N 124.194 0.934 . . . . 1.0 112.02 176.554 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 104' ' ' TYR . . . . . 0.643 ' O ' ' CD1' ' A' ' 104' ' ' TYR . 0.1 OUTLIER -101.3 21.23 14.4 Favored 'General case' 0 N--CA 1.473 0.692 0 CA-C-N 113.956 -1.475 . . . . 1.0 109.736 178.367 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 105' ' ' GLY . . . . . 0.651 ' N ' ' O ' ' A' ' 101' ' ' VAL . . . -159.59 -94.34 0.1 Allowed Glycine 0 C--N 1.345 1.051 0 N-CA-C 105.232 -3.147 . . . . 1.0 105.232 176.771 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 106' ' ' ALA . . . . . 0.902 ' HB2' ' O ' ' A' ' 102' ' ' CYS . . . 72.0 60.34 0.14 Allowed 'General case' 0 N--CA 1.446 -0.625 0 CA-C-O 119.333 -0.365 . . . . 1.0 111.729 -179.345 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 107' ' ' THR . . . . . 0.446 ' C ' ' H ' ' A' ' 109' ' ' ILE . 44.6 p -81.91 -62.54 1.6 Allowed 'General case' 0 C--N 1.353 0.724 0 O-C-N 120.375 -1.453 . . . . 1.0 109.521 179.403 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 15.5 m -65.2 22.45 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.35 0.599 0 N-CA-C 113.025 0.75 . . . . 1.0 113.025 -176.799 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 109' ' ' ILE . . . . . 0.7 ' H ' ' HD2' ' A' ' 110' ' ' PRO . 0.1 OUTLIER -114.92 -56.96 0.04 OUTLIER Pre-proline 0 CA--C 1.561 1.4 0 CA-C-N 119.089 0.859 . . . . 1.0 108.946 173.954 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 110' ' ' PRO . . . . . 0.7 ' HD2' ' H ' ' A' ' 109' ' ' ILE . 19.4 Cg_endo -52.24 -38.54 72.23 Favored 'Trans proline' 0 N--CA 1.497 1.696 0 C-N-CA 123.243 2.628 . . . . 1.0 112.723 -179.838 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 12.4 m120 -67.01 -68.06 0.41 Allowed 'General case' 0 CA--C 1.51 -0.577 0 C-N-CA 119.268 -0.973 . . . . 1.0 108.76 -177.762 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 112' ' ' ILE . . . . . 0.579 ' O ' ' N ' ' A' ' 115' ' ' ALA . 18.6 pt -51.64 -40.8 26.77 Favored 'Isoleucine or valine' 0 C--O 1.215 -0.749 0 N-CA-C 106.718 -1.586 . . . . 1.0 106.718 178.207 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 113' ' ' ASN . . . . . 0.459 ' HB2' ' O ' ' A' ' 109' ' ' ILE . 26.5 t-20 -45.78 -51.83 12.1 Favored 'General case' 0 CA--C 1.503 -0.836 0 CA-C-N 114.047 -1.433 . . . . 1.0 108.041 -176.49 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -64.02 -27.36 69.07 Favored 'General case' 0 N--CA 1.435 -1.195 0 C-N-CA 119.494 -0.882 . . . . 1.0 109.957 177.763 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 115' ' ' ALA . . . . . 0.579 ' N ' ' O ' ' A' ' 112' ' ' ILE . . . -76.08 -60.56 2.28 Favored 'General case' 0 N--CA 1.444 -0.757 0 N-CA-C 107.546 -1.279 . . . . 1.0 107.546 177.852 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 116' ' ' ILE . . . . . 0.577 ' O ' ' C ' ' A' ' 117' ' ' GLU . 1.3 mp -47.69 -42.47 9.03 Favored 'Isoleucine or valine' 0 C--N 1.363 1.184 0 N-CA-C 108.198 -1.038 . . . . 1.0 108.198 178.768 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 117' ' ' GLU . . . . . 0.577 ' C ' ' O ' ' A' ' 116' ' ' ILE . 23.6 tt0 -38.92 -55.57 1.52 Allowed 'General case' 0 N--CA 1.472 0.671 0 N-CA-C 104.607 -2.368 . . . . 1.0 104.607 178.439 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 118' ' ' VAL . . . . . 0.434 ' N ' ' O ' ' A' ' 115' ' ' ALA . 40.5 t -70.13 -55.07 15.96 Favored 'Isoleucine or valine' 0 CA--C 1.559 1.306 0 CA-C-N 113.954 -1.476 . . . . 1.0 110.77 176.11 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -60.39 -19.62 56.56 Favored 'General case' 0 N--CA 1.49 1.565 0 N-CA-C 115.491 1.663 . . . . 1.0 115.491 -177.735 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 120' ' ' GLY . . . . . 0.512 ' O ' ' CB ' ' A' ' 121' ' ' THR . . . -121.09 -43.95 0.42 Allowed Glycine 0 C--N 1.354 1.554 0 N-CA-C 108.618 -1.793 . . . . 1.0 108.618 176.581 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 121' ' ' THR . . . . . 0.552 ' HB ' HG22 ' A' ' 123' ' ' THR . 45.8 m 127.54 -46.33 0.01 OUTLIER 'General case' 0 N--CA 1.48 1.057 0 C-N-CA 124.962 1.305 . . . . 1.0 108.5 -179.55 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 122' ' ' GLY . . . . . 0.666 ' O ' ' N ' ' A' ' 124' ' ' ASP . . . 104.33 -15.55 50.2 Favored Glycine 0 N--CA 1.472 1.093 0 N-CA-C 108.499 -1.84 . . . . 1.0 108.499 -178.448 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 123' ' ' THR . . . . . 0.651 HG23 ' O ' ' A' ' 123' ' ' THR . 9.5 t -55.43 82.84 0.0 OUTLIER 'General case' 0 C--N 1.322 -0.628 0 N-CA-C 105.436 -2.061 . . . . 1.0 105.436 178.576 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 124' ' ' ASP . . . . . 0.666 ' N ' ' O ' ' A' ' 122' ' ' GLY . 53.0 p30 -167.68 176.11 6.6 Favored 'General case' 0 C--N 1.342 0.281 0 CA-C-N 114.581 -1.19 . . . . 1.0 112.17 179.825 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 125' ' ' TYR . . . . . . . . . . . . . 2.3 t80 -138.83 138.85 37.89 Favored 'General case' 0 CA--C 1.535 0.395 0 N-CA-C 107.914 -1.143 . . . . 1.0 107.914 175.827 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 1.3 mmp_? -145.63 145.12 30.82 Favored 'General case' 0 N--CA 1.47 0.555 0 N-CA-C 109.187 -0.671 . . . . 1.0 109.187 179.399 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 127' ' ' PHE . . . . . . . . . . . . . 6.5 p90 . . . . . 0 N--CA 1.47 0.571 0 CA-C-O 117.958 -1.02 . . . . 1.0 110.734 -179.651 . . . . . . . . 0 0 . 1 . 025 nuclear build full ' A' A ' 128' ' ' MTN . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 025 nuclear build full ' A' A ' 129' ' ' MTN . . . . . 0.59 ' H82' ' CE2' ' A' ' 45' ' ' PHE . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 130' ' ' MTN . . . . . 0.503 ' H61' ' S1 ' ' A' ' 130' ' ' MTN . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 62.2 mtt . . . . . 0 N--CA 1.491 1.615 0 N-CA-C 109.025 -0.731 . . . . 1.0 109.025 . . . . . . . . . 0 0 . 1 . 026 nuclear build full ' A' A ' 2' ' ' SER . . . . . 0.413 ' O ' ' CB ' ' A' ' 3' ' ' ASP . 61.2 p -104.65 9.4 35.2 Favored 'General case' 0 N--CA 1.467 0.389 0 C-N-CA 122.578 0.351 . . . . 1.0 110.925 -179.548 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 3' ' ' ASP . . . . . 0.413 ' CB ' ' O ' ' A' ' 2' ' ' SER . 0.9 OUTLIER 166.15 99.2 0.0 OUTLIER 'General case' 0 N--CA 1.466 0.357 0 O-C-N 123.411 0.444 . . . . 1.0 110.842 179.25 . . . . . . . . 3 3 . 1 . 026 nuclear build full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 65.9 t80 -149.97 144.67 25.99 Favored 'General case' 0 C--O 1.233 0.185 0 N-CA-C 110.045 -0.354 . . . . 1.0 110.045 179.446 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 45.2 m-20 -151.8 147.89 27.2 Favored 'General case' 0 C--N 1.331 -0.226 0 N-CA-C 109.909 -0.404 . . . . 1.0 109.909 -179.976 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 6' ' ' THR . . . . . 0.68 HG22 ' H ' ' A' ' 7' ' ' GLU . 18.9 m -68.9 174.64 4.24 Favored 'General case' 0 C--O 1.214 -0.801 0 C-N-CA 120.188 -0.605 . . . . 1.0 109.868 -179.924 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 7' ' ' GLU . . . . . 0.68 ' H ' HG22 ' A' ' 6' ' ' THR . 80.1 tt0 -60.76 -53.91 51.57 Favored 'General case' 0 C--N 1.314 -0.935 0 CA-C-O 121.814 0.816 . . . . 1.0 109.862 -177.982 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 8' ' ' ARG . . . . . 0.499 ' O ' ' CB ' ' A' ' 12' ' ' ALA . 18.3 ttm105 -53.19 -57.63 9.83 Favored 'General case' 0 C--N 1.309 -1.17 0 C-N-CA 119.103 -1.039 . . . . 1.0 108.283 -178.456 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 9' ' ' VAL . . . . . 0.543 ' O ' HG23 ' A' ' 13' ' ' VAL . 0.0 OUTLIER -65.09 -47.44 87.78 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.807 0 CA-C-N 113.913 -1.494 . . . . 1.0 110.227 179.687 . . . . . . . . 3 3 . 1 . 026 nuclear build full ' A' A ' 10' ' ' SER . . . . . 0.617 ' N ' ' O ' ' A' ' 6' ' ' THR . 35.0 t -62.99 -59.78 4.35 Favored 'General case' 0 N--CA 1.477 0.877 0 C-N-CA 119.504 -0.879 . . . . 1.0 109.0 179.575 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 11' ' ' ARG . . . . . 0.56 ' O ' ' N ' ' A' ' 15' ' ' ALA . 2.6 tpt180 -64.62 -56.13 15.87 Favored 'General case' 0 N--CA 1.474 0.747 0 CA-C-O 120.796 0.331 . . . . 1.0 111.094 -177.667 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 12' ' ' ALA . . . . . 0.507 ' O ' ' HB3' ' A' ' 16' ' ' ALA . . . -51.57 -51.12 58.01 Favored 'General case' 0 N--CA 1.485 1.318 0 N-CA-C 106.714 -1.588 . . . . 1.0 106.714 -178.952 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 13' ' ' VAL . . . . . 0.595 ' O ' ' CB ' ' A' ' 17' ' ' LEU . 64.1 t -61.67 -50.06 81.79 Favored 'Isoleucine or valine' 0 C--O 1.202 -1.408 0 C-N-CA 118.448 -1.301 . . . . 1.0 108.542 178.044 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 14' ' ' ALA . . . . . 0.669 ' O ' HG13 ' A' ' 18' ' ' VAL . . . -58.72 -61.12 2.85 Favored 'General case' 0 C--O 1.214 -0.78 0 C-N-CA 118.273 -1.371 . . . . 1.0 109.51 179.511 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 15' ' ' ALA . . . . . 0.572 ' O ' ' N ' ' A' ' 19' ' ' GLY . . . -53.06 -57.02 11.82 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-O 121.727 0.775 . . . . 1.0 110.499 -178.461 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 16' ' ' ALA . . . . . 0.507 ' HB3' ' O ' ' A' ' 12' ' ' ALA . . . -62.14 -53.2 58.79 Favored 'General case' 0 C--N 1.31 -1.151 0 CA-C-N 114.666 -1.152 . . . . 1.0 108.658 -179.086 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 17' ' ' LEU . . . . . 0.595 ' CB ' ' O ' ' A' ' 13' ' ' VAL . 6.3 tp -57.19 -52.84 63.71 Favored 'General case' 0 N--CA 1.475 0.814 0 CA-C-N 114.335 -1.302 . . . . 1.0 108.832 -177.918 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 18' ' ' VAL . . . . . 0.669 HG13 ' O ' ' A' ' 14' ' ' ALA . 3.1 m -68.62 -56.12 13.46 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.521 0 C-N-CA 119.498 -0.881 . . . . 1.0 109.693 179.215 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 19' ' ' GLY . . . . . 0.572 ' N ' ' O ' ' A' ' 15' ' ' ALA . . . -63.73 -169.52 1.49 Allowed Glycine 0 CA--C 1.525 0.695 0 N-CA-C 112.118 -0.393 . . . . 1.0 112.118 -178.966 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 20' ' ' PRO . . . . . 0.603 ' O ' ' N ' ' A' ' 24' ' ' ALA . 1.0 OUTLIER -79.42 -23.88 6.94 Favored 'Trans proline' 0 C--N 1.311 -1.401 0 C-N-CA 122.925 2.417 . . . . 1.0 112.993 -179.1 . . . . . . . . 3 3 . 1 . 026 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -59.71 -58.6 13.41 Favored Glycine 0 N--CA 1.475 1.3 0 C-N-CA 119.789 -1.196 . . . . 1.0 111.877 -176.674 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 22' ' ' GLY . . . . . 0.455 ' CA ' ' HB1' ' A' ' 16' ' ' ALA . . . -59.74 -51.76 57.04 Favored Glycine 0 CA--C 1.501 -0.815 0 N-CA-C 106.86 -2.496 . . . . 1.0 106.86 -178.012 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 23' ' ' VAL . . . . . 0.599 ' O ' HG12 ' A' ' 27' ' ' VAL . 29.5 t -58.32 -35.78 55.25 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.032 0 CA-C-N 114.126 -1.037 . . . . 1.0 108.941 -179.758 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 24' ' ' ALA . . . . . 0.603 ' N ' ' O ' ' A' ' 20' ' ' PRO . . . -61.92 -60.48 3.57 Favored 'General case' 0 CA--C 1.536 0.429 0 C-N-CA 118.524 -1.27 . . . . 1.0 110.255 -179.921 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 25' ' ' LEU . . . . . 0.531 ' N ' HD12 ' A' ' 25' ' ' LEU . 9.9 mp -65.02 -44.96 87.43 Favored 'General case' 0 C--N 1.344 0.332 0 CA-C-N 119.257 0.935 . . . . 1.0 112.408 -177.69 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 89.6 t -62.17 -58.79 5.99 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.308 0 C-N-CA 118.826 -1.149 . . . . 1.0 110.268 -177.311 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 27' ' ' VAL . . . . . 0.599 HG12 ' O ' ' A' ' 23' ' ' VAL . 1.3 p -60.28 -35.31 61.42 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 O-C-N 121.802 -0.561 . . . . 1.0 112.269 -177.476 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 14.0 tmtt? -67.88 -54.58 17.78 Favored 'General case' 0 C--N 1.318 -0.788 0 CA-C-O 121.449 0.643 . . . . 1.0 110.077 -178.591 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 29' ' ' VAL . . . . . 0.407 HG12 ' O ' ' A' ' 25' ' ' LEU . 9.9 p -63.11 -45.21 99.22 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.834 0 C-N-CA 119.338 -0.945 . . . . 1.0 110.508 -178.333 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 30' ' ' CYS . . . . . . . . . . . . . 1.4 t -66.3 -60.94 2.3 Favored 'General case' 0 CA--C 1.532 0.256 0 C-N-CA 119.123 -1.031 . . . . 1.0 110.004 -179.607 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 31' ' ' ALA . . . . . 0.5 ' HB2' ' NH1' ' A' ' 47' ' ' ARG . . . -64.65 -52.81 55.4 Favored 'General case' 0 CA--C 1.511 -0.536 0 N-CA-C 112.923 0.712 . . . . 1.0 112.923 -176.44 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 85.02 74.38 1.25 Allowed Glycine 0 CA--C 1.526 0.764 0 N-CA-C 109.135 -1.586 . . . . 1.0 109.135 -177.256 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 23.1 mt 86.09 95.49 0.03 OUTLIER Pre-proline 0 N--CA 1.479 0.983 0 C-N-CA 123.676 0.79 . . . . 1.0 110.521 -179.17 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 47.5 Cg_endo -68.3 -27.76 34.11 Favored 'Trans proline' 0 N--CA 1.506 2.26 0 C-N-CA 122.221 1.947 . . . . 1.0 115.085 -177.843 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 35' ' ' GLY . . . . . 0.402 ' HA3' HD12 ' A' ' 112' ' ' ILE . . . -62.08 -58.72 11.46 Favored Glycine 0 CA--C 1.53 1.029 0 C-N-CA 118.233 -1.937 . . . . 1.0 109.383 -178.678 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 36' ' ' VAL . . . . . 0.519 ' O ' HG22 ' A' ' 37' ' ' ILE . 11.3 p -88.88 162.09 2.61 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.462 0 N-CA-C 106.231 -1.766 . . . . 1.0 106.231 177.215 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 37' ' ' ILE . . . . . 0.519 HG22 ' O ' ' A' ' 36' ' ' VAL . 0.0 OUTLIER 118.99 120.01 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.476 0.865 0 C-N-CA 124.322 1.049 . . . . 1.0 108.506 -179.238 . . . . . . . . 3 3 . 1 . 026 nuclear build full ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 46.8 m80 -142.11 133.85 27.01 Favored 'General case' 0 C--N 1.332 -0.154 0 N-CA-C 108.412 -0.958 . . . . 1.0 108.412 179.072 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -110.38 134.87 20.69 Favored Pre-proline 0 C--N 1.325 -0.464 0 N-CA-C 108.439 -0.949 . . . . 1.0 108.439 -179.716 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 37.1 Cg_endo -66.36 -85.55 0.01 OUTLIER 'Trans proline' 0 N--CA 1.49 1.31 0 CA-C-N 119.994 1.034 . . . . 1.0 111.469 -179.047 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -66.16 121.9 16.22 Favored 'General case' 0 C--N 1.317 -0.808 0 CA-C-N 114.991 -1.004 . . . . 1.0 110.298 -178.714 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 42' ' ' ARG . . . . . 0.648 ' C ' ' H ' ' A' ' 44' ' ' GLY . 34.2 ptt180 -169.15 166.04 10.9 Favored 'General case' 0 N--CA 1.434 -1.27 0 N-CA-C 109.133 -0.691 . . . . 1.0 109.133 179.062 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 43' ' ' ARG . . . . . 0.611 ' HG3' ' O ' ' A' ' 45' ' ' PHE . 0.0 OUTLIER -65.33 25.07 0.02 OUTLIER 'General case' 0 C--N 1.311 -1.078 0 CA-C-N 115.717 -0.674 . . . . 1.0 110.249 -179.067 . . . . . . . . 3 3 . 1 . 026 nuclear build full ' A' A ' 44' ' ' GLY . . . . . 0.648 ' H ' ' C ' ' A' ' 42' ' ' ARG . . . 76.63 -24.92 1.78 Allowed Glycine 0 C--N 1.345 1.072 0 N-CA-C 111.869 -0.492 . . . . 1.0 111.869 179.27 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 45' ' ' PHE . . . . . 0.804 ' O ' ' HB2' ' A' ' 46' ' ' PHE . 35.2 t80 -162.76 164.81 26.11 Favored 'General case' 0 C--O 1.198 -1.606 0 CA-C-O 119.003 -0.522 . . . . 1.0 110.155 -179.268 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 46' ' ' PHE . . . . . 0.804 ' HB2' ' O ' ' A' ' 45' ' ' PHE . 2.7 t80 131.18 93.07 0.0 OUTLIER 'General case' 0 N--CA 1.517 2.894 0 C-N-CA 124.396 1.078 . . . . 1.0 111.134 178.125 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 47' ' ' ARG . . . . . 0.531 ' CB ' ' O ' ' A' ' 46' ' ' PHE . 2.1 tmm_? 118.46 151.82 0.0 OUTLIER 'General case' 0 N--CA 1.482 1.13 0 C-N-CA 124.697 1.199 . . . . 1.0 108.842 -179.981 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER 70.3 70.98 0.21 Allowed 'General case' 0 CA--C 1.534 0.357 0 N-CA-C 108.316 -0.994 . . . . 1.0 108.316 -177.918 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -134.75 140.11 34.37 Favored Pre-proline 0 CA--C 1.541 0.597 0 N-CA-C 108.467 -0.938 . . . . 1.0 108.467 -179.018 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 50' ' ' PRO . . . . . 0.413 ' C ' ' H ' ' A' ' 52' ' ' ARG . 55.3 Cg_endo -66.9 69.22 0.53 Allowed 'Trans proline' 0 N--CA 1.5 1.887 0 C-N-CA 121.793 1.662 . . . . 1.0 112.74 -179.032 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 51' ' ' GLU . . . . . 0.452 ' N ' ' CD ' ' A' ' 51' ' ' GLU . 0.7 OUTLIER 63.64 -9.16 0.14 Allowed 'General case' 0 N--CA 1.468 0.439 0 N-CA-C 112.574 0.583 . . . . 1.0 112.574 179.868 . . . . . . . . 3 3 . 1 . 026 nuclear build full ' A' A ' 52' ' ' ARG . . . . . 0.413 ' H ' ' C ' ' A' ' 50' ' ' PRO . 0.0 OUTLIER -76.6 168.99 19.11 Favored 'General case' 0 N--CA 1.466 0.36 0 C-N-CA 119.781 -0.768 . . . . 1.0 110.5 179.747 . . . . . . . . 3 3 . 1 . 026 nuclear build full ' A' A ' 53' ' ' ILE . . . . . 0.457 ' O ' ' N ' ' A' ' 55' ' ' ILE . 8.2 pt -81.42 135.77 24.41 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.464 0 CA-C-O 122.018 0.913 . . . . 1.0 110.97 -179.974 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 6.3 pm0 -61.42 83.14 0.01 OUTLIER 'General case' 0 C--N 1.314 -0.967 0 CA-C-N 113.712 -1.585 . . . . 1.0 108.82 -178.303 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 55' ' ' ILE . . . . . 0.457 ' N ' ' O ' ' A' ' 53' ' ' ILE . 20.8 tt -150.47 158.74 5.1 Favored 'Isoleucine or valine' 0 C--N 1.354 0.776 0 CA-C-N 116.429 -0.35 . . . . 1.0 110.654 178.255 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 107.72 -5.94 35.21 Favored Glycine 0 N--CA 1.486 2.017 0 N-CA-C 111.491 -0.644 . . . . 1.0 111.491 179.319 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 57' ' ' ASP . . . . . 0.445 ' CG ' ' NH1' ' A' ' 43' ' ' ARG . 8.4 p-10 -78.56 103.54 8.57 Favored 'General case' 0 C--N 1.311 -1.102 0 CA-C-N 114.501 -0.85 . . . . 1.0 109.91 178.604 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 58' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -89.74 173.15 8.44 Favored 'General case' 0 CA--C 1.555 1.169 0 CA-C-O 123.375 1.559 . . . . 1.0 114.417 -176.976 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 59' ' ' ARG . . . . . 0.705 ' HE ' ' H ' ' A' ' 59' ' ' ARG . 0.0 OUTLIER -74.04 -61.04 1.99 Allowed 'General case' 0 N--CA 1.479 0.993 0 CA-C-N 111.414 -2.63 . . . . 1.0 111.694 -178.825 . . . . . . . . 3 3 . 1 . 026 nuclear build full ' A' A ' 60' ' ' TYR . . . . . 0.544 ' O ' ' CG ' ' A' ' 60' ' ' TYR . 65.9 t80 -92.17 -8.91 44.22 Favored 'General case' 0 C--O 1.244 0.813 0 C-N-CA 124.593 1.157 . . . . 1.0 113.241 -179.661 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -79.12 -17.32 55.3 Favored 'General case' 0 N--CA 1.432 -1.346 0 O-C-N 121.348 -0.845 . . . . 1.0 111.366 -178.347 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 62' ' ' VAL . . . . . 0.655 ' O ' ' N ' ' A' ' 66' ' ' GLY . 25.9 m -49.02 -54.49 5.28 Favored 'Isoleucine or valine' 0 C--O 1.199 -1.603 0 C-N-CA 119.802 -0.759 . . . . 1.0 110.512 -174.954 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 63' ' ' ALA . . . . . 0.493 ' N ' HG23 ' A' ' 62' ' ' VAL . . . -69.03 -49.7 55.3 Favored 'General case' 0 C--N 1.308 -1.225 0 O-C-N 121.498 -0.751 . . . . 1.0 109.539 -179.427 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 64' ' ' HIS . . . . . 0.4 ' O ' ' HB2' ' A' ' 67' ' ' ARG . 1.0 OUTLIER -50.18 -56.57 10.49 Favored 'General case' 0 CA--C 1.54 0.592 0 CA-C-N 115.226 -0.897 . . . . 1.0 108.613 -179.005 . . . . . . . . 3 3 . 1 . 026 nuclear build full ' A' A ' 65' ' ' ASP . . . . . 0.599 ' C ' ' H ' ' A' ' 67' ' ' ARG . 32.7 t0 -74.69 -46.46 37.64 Favored 'General case' 0 C--N 1.317 -0.832 0 CA-C-N 115.594 -0.73 . . . . 1.0 110.115 178.094 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 66' ' ' GLY . . . . . 0.655 ' N ' ' O ' ' A' ' 62' ' ' VAL . . . -72.92 25.19 0.8 Allowed Glycine 0 N--CA 1.444 -0.822 0 N-CA-C 109.663 -1.375 . . . . 1.0 109.663 177.556 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 67' ' ' ARG . . . . . 0.627 ' O ' ' N ' ' A' ' 69' ' ' LEU . 0.0 OUTLIER -72.49 6.2 2.52 Favored 'General case' 0 N--CA 1.452 -0.335 0 N-CA-C 105.477 -2.045 . . . . 1.0 105.477 174.761 . . . . . . . . 3 3 . 1 . 026 nuclear build full ' A' A ' 68' ' ' LEU . . . . . 0.549 ' H ' ' C ' ' A' ' 66' ' ' GLY . 0.0 OUTLIER -33.1 -28.45 0.01 OUTLIER 'General case' 0 N--CA 1.483 1.202 0 N-CA-C 108.565 -0.902 . . . . 1.0 108.565 -175.746 . . . . . . . . 3 3 . 1 . 026 nuclear build full ' A' A ' 69' ' ' LEU . . . . . 0.627 ' N ' ' O ' ' A' ' 67' ' ' ARG . 8.5 tt -62.77 -64.33 0.95 Allowed 'General case' 0 C--N 1.323 -0.581 0 C-N-CA 118.797 -1.161 . . . . 1.0 108.988 178.476 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 70' ' ' ALA . . . . . 0.575 ' O ' ' N ' ' A' ' 72' ' ' HIS . . . -78.76 -74.45 0.28 Allowed 'General case' 0 N--CA 1.475 0.802 0 N-CA-C 105.485 -2.042 . . . . 1.0 105.485 176.657 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 71' ' ' ALA . . . . . 0.457 ' O ' ' C ' ' A' ' 72' ' ' HIS . . . -44.14 2.99 0.0 OUTLIER 'General case' 0 C--N 1.332 -0.158 0 C-N-CA 125.255 1.422 . . . . 1.0 114.352 179.687 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 72' ' ' HIS . . . . . 0.626 ' CG ' ' N ' ' A' ' 73' ' ' MET . 0.0 OUTLIER -28.49 -64.8 0.09 Allowed 'General case' 0 N--CA 1.47 0.564 0 CA-C-N 118.834 0.743 . . . . 1.0 111.585 -178.335 . . . . . . . . 3 3 . 1 . 026 nuclear build full ' A' A ' 73' ' ' MET . . . . . 0.626 ' N ' ' CG ' ' A' ' 72' ' ' HIS . 2.9 ptp -69.65 -50.69 41.67 Favored 'General case' 0 C--N 1.32 -0.685 0 C-N-CA 119.279 -0.968 . . . . 1.0 108.881 179.042 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 74' ' ' VAL . . . . . 0.693 ' O ' ' N ' ' A' ' 76' ' ' GLY . 86.2 t -44.85 -41.84 2.3 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.329 0 CA-C-O 117.628 -1.177 . . . . 1.0 111.433 -176.385 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 75' ' ' ASN . . . . . 0.523 ' O ' ' N ' ' A' ' 78' ' ' VAL . 1.3 t-20 -37.03 -13.45 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.703 0 CA-C-N 121.307 1.867 . . . . 1.0 112.802 179.431 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 76' ' ' GLY . . . . . 0.693 ' N ' ' O ' ' A' ' 74' ' ' VAL . . . -44.56 -25.98 0.96 Allowed Glycine 0 CA--C 1.544 1.897 0 CA-C-N 113.294 -1.776 . . . . 1.0 108.711 177.898 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 77' ' ' ILE . . . . . 0.688 ' HA ' ' HB3' ' A' ' 80' ' ' ALA . 0.2 OUTLIER -69.03 -48.07 71.89 Favored 'Isoleucine or valine' 0 C--O 1.209 -1.052 0 N-CA-C 107.519 -1.289 . . . . 1.0 107.519 178.07 . . . . . . . . 3 3 . 1 . 026 nuclear build full ' A' A ' 78' ' ' VAL . . . . . 0.639 ' H ' HD13 ' A' ' 77' ' ' ILE . 77.3 t -32.89 -35.59 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.476 0.856 0 CA-C-N 114.658 -1.155 . . . . 1.0 108.036 -176.391 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 79' ' ' ILE . . . . . 0.721 ' O ' ' HB2' ' A' ' 83' ' ' ALA . 39.0 pt -98.61 -28.44 3.56 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.948 0 CA-C-O 121.261 0.553 . . . . 1.0 111.813 176.932 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 80' ' ' ALA . . . . . 0.688 ' HB3' ' HA ' ' A' ' 77' ' ' ILE . . . -86.77 -13.76 44.26 Favored 'General case' 0 N--CA 1.477 0.922 0 N-CA-C 114.06 1.133 . . . . 1.0 114.06 178.557 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 81' ' ' GLU . . . . . 0.629 ' CG ' ' H ' ' A' ' 82' ' ' ASP . 16.1 pt-20 -83.13 -69.26 0.64 Allowed 'General case' 0 C--N 1.345 0.373 0 CA-C-N 119.042 0.837 . . . . 1.0 108.797 -179.676 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 82' ' ' ASP . . . . . 0.629 ' H ' ' CG ' ' A' ' 81' ' ' GLU . 67.1 m-20 -75.64 -10.79 59.74 Favored 'General case' 0 N--CA 1.442 -0.844 0 CA-C-N 118.075 0.398 . . . . 1.0 110.833 179.453 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 83' ' ' ALA . . . . . 0.746 ' HA ' ' HB3' ' A' ' 86' ' ' ALA . . . -19.84 -44.37 0.0 OUTLIER 'General case' 0 N--CA 1.472 0.643 0 N-CA-C 112.577 0.584 . . . . 1.0 112.577 177.029 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 84' ' ' LEU . . . . . 0.579 ' N ' ' O ' ' A' ' 82' ' ' ASP . 5.9 tp -31.65 -33.53 0.01 OUTLIER 'General case' 0 N--CA 1.473 0.702 0 CA-C-N 118.319 0.509 . . . . 1.0 111.746 -177.961 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 85' ' ' ILE . . . . . 0.716 ' O ' HG23 ' A' ' 89' ' ' VAL . 47.8 pt -100.51 -37.19 5.46 Favored 'Isoleucine or valine' 0 C--O 1.208 -1.108 0 N-CA-C 109.096 -0.705 . . . . 1.0 109.096 176.133 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 86' ' ' ALA . . . . . 0.746 ' HB3' ' HA ' ' A' ' 83' ' ' ALA . . . -66.24 -59.41 3.76 Favored 'General case' 0 C--N 1.317 -0.805 0 C-N-CA 119.647 -0.821 . . . . 1.0 111.381 -179.908 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -69.43 -18.36 63.73 Favored 'General case' 0 N--CA 1.47 0.544 0 CA-C-N 120.344 1.429 . . . . 1.0 112.294 -179.627 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -88.64 -13.1 40.67 Favored 'General case' 0 N--CA 1.475 0.817 0 CA-C-O 122.645 1.212 . . . . 1.0 108.141 179.358 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 89' ' ' VAL . . . . . 0.765 ' O ' HG12 ' A' ' 89' ' ' VAL . 53.3 t -92.22 39.66 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.32 -0.7 0 CA-C-N 111.953 -2.385 . . . . 1.0 109.474 177.654 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 90' ' ' GLY . . . . . 0.776 ' O ' ' N ' ' A' ' 92' ' ' HIS . . . -64.22 -30.17 77.05 Favored Glycine 0 C--N 1.371 2.476 0 CA-C-O 117.902 -1.499 . . . . 1.0 109.969 176.893 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 91' ' ' PRO . . . . . 0.599 ' HD2' ' N ' ' A' ' 90' ' ' GLY . 72.6 Cg_exo -40.26 -5.78 0.01 OUTLIER 'Trans proline' 0 N--CA 1.488 1.205 0 CA-C-N 120.926 2.363 . . . . 1.0 111.111 174.556 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 92' ' ' HIS . . . . . 0.776 ' N ' ' O ' ' A' ' 90' ' ' GLY . 2.5 p-80 -48.82 -24.48 1.45 Allowed 'General case' 0 N--CA 1.435 -1.211 0 N-CA-C 106.593 -1.632 . . . . 1.0 106.593 179.731 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 93' ' ' LEU . . . . . 0.553 HD12 ' N ' ' A' ' 94' ' ' ALA . 1.2 pp -60.54 -53.48 56.95 Favored 'General case' 0 N--CA 1.445 -0.697 0 N-CA-C 106.493 -1.669 . . . . 1.0 106.493 176.088 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 94' ' ' ALA . . . . . 0.553 ' N ' HD12 ' A' ' 93' ' ' LEU . . . -51.09 -53.17 36.45 Favored 'General case' 0 C--O 1.212 -0.899 0 N-CA-C 107.409 -1.33 . . . . 1.0 107.409 179.465 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 95' ' ' ARG . . . . . 0.489 ' HE ' ' HD3' ' A' ' 20' ' ' PRO . 4.5 mmp_? -61.94 -28.43 69.53 Favored 'General case' 0 CA--C 1.549 0.924 0 CA-C-O 122.297 1.046 . . . . 1.0 110.09 178.27 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 96' ' ' ALA . . . . . 0.905 ' O ' ' N ' ' A' ' 100' ' ' ILE . . . -50.4 -36.68 33.86 Favored 'General case' 0 C--O 1.195 -1.783 0 N-CA-C 107.105 -1.442 . . . . 1.0 107.105 -176.364 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 97' ' ' LEU . . . . . 0.441 ' C ' ' O ' ' A' ' 96' ' ' ALA . 0.4 OUTLIER -35.0 -23.9 0.01 OUTLIER 'General case' 0 CA--C 1.587 2.403 0 CA-C-N 113.48 -1.691 . . . . 1.0 108.512 -177.214 . . . . . . . . 3 3 . 1 . 026 nuclear build full ' A' A ' 98' ' ' GLY . . . . . 0.657 ' N ' ' O ' ' A' ' 96' ' ' ALA . . . -88.8 -53.02 2.65 Favored Glycine 0 CA--C 1.55 2.221 0 CA-C-O 123.223 1.457 . . . . 1.0 110.644 171.577 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 99' ' ' GLN . . . . . 0.586 ' N ' ' O ' ' A' ' 96' ' ' ALA . 12.2 mp0 -76.99 7.05 5.28 Favored 'General case' 0 N--CA 1.435 -1.178 0 N-CA-C 106.373 -1.714 . . . . 1.0 106.373 176.787 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 100' ' ' ILE . . . . . 0.905 ' N ' ' O ' ' A' ' 96' ' ' ALA . 0.3 OUTLIER -60.23 -52.99 54.87 Favored 'Isoleucine or valine' 0 CA--C 1.487 -1.476 0 N-CA-C 104.806 -2.294 . . . . 1.0 104.806 178.185 . . . . . . . . 3 3 . 1 . 026 nuclear build full ' A' A ' 101' ' ' VAL . . . . . 0.556 ' O ' ' N ' ' A' ' 105' ' ' GLY . 21.5 t -49.3 -60.41 0.74 Allowed 'Isoleucine or valine' 0 C--O 1.222 -0.394 0 C-N-CA 117.752 -1.579 . . . . 1.0 107.837 178.581 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 102' ' ' CYS . . . . . 0.858 ' O ' ' HB2' ' A' ' 106' ' ' ALA . 0.5 OUTLIER -50.17 -30.46 11.4 Favored 'General case' 0 C--N 1.317 -0.825 0 CA-C-N 114.931 -1.031 . . . . 1.0 110.961 -178.265 . . . . . . . . 3 3 . 1 . 026 nuclear build full ' A' A ' 103' ' ' ARG . . . . . 0.426 ' N ' ' O ' ' A' ' 99' ' ' GLN . 0.0 OUTLIER -83.69 -53.84 5.35 Favored 'General case' 0 N--CA 1.486 1.335 0 N-CA-C 114.205 1.187 . . . . 1.0 114.205 -179.322 . . . . . . . . 3 3 . 1 . 026 nuclear build full ' A' A ' 104' ' ' TYR . . . . . 0.662 ' O ' ' CG ' ' A' ' 104' ' ' TYR . 0.0 OUTLIER -94.1 21.5 6.76 Favored 'General case' 0 C--N 1.311 -1.09 0 C-N-CA 126.469 1.908 . . . . 1.0 107.871 179.122 . . . . . . . . 3 3 . 1 . 026 nuclear build full ' A' A ' 105' ' ' GLY . . . . . 0.556 ' N ' ' O ' ' A' ' 101' ' ' VAL . . . -156.76 -91.14 0.08 OUTLIER Glycine 0 N--CA 1.445 -0.733 0 N-CA-C 106.822 -2.511 . . . . 1.0 106.822 177.2 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 106' ' ' ALA . . . . . 0.858 ' HB2' ' O ' ' A' ' 102' ' ' CYS . . . 72.81 46.76 0.24 Allowed 'General case' 0 N--CA 1.449 -0.498 0 N-CA-C 112.076 0.398 . . . . 1.0 112.076 -179.94 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 10.3 t -76.67 7.22 4.83 Favored 'General case' 0 CA--C 1.513 -0.479 0 O-C-N 119.986 -1.696 . . . . 1.0 107.045 176.402 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 18.7 m -86.78 -52.53 11.65 Favored 'Isoleucine or valine' 0 C--N 1.35 0.615 0 CA-C-O 117.945 -1.026 . . . . 1.0 110.298 177.51 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 109' ' ' ILE . . . . . 0.566 ' CG2' ' HB1' ' A' ' 106' ' ' ALA . 0.1 OUTLIER -47.91 -33.93 4.99 Favored Pre-proline 0 C--N 1.368 1.394 0 N-CA-C 116.8 2.148 . . . . 1.0 116.8 -177.587 . . . . . . . . 3 3 . 1 . 026 nuclear build full ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 50.4 Cg_exo -54.79 -47.42 26.81 Favored 'Trans proline' 0 C--N 1.308 -1.564 0 CA-C-N 122.558 1.949 . . . . 1.0 112.439 -176.942 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 111' ' ' ASN . . . . . 0.462 ' O ' ' HB3' ' A' ' 114' ' ' ALA . 24.7 t-20 -72.29 -67.35 0.55 Allowed 'General case' 0 N--CA 1.467 0.4 0 C-N-CA 119.995 -0.682 . . . . 1.0 111.491 -177.184 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 112' ' ' ILE . . . . . 0.688 ' O ' ' HB ' ' A' ' 116' ' ' ILE . 0.9 OUTLIER -46.42 -28.85 0.97 Allowed 'Isoleucine or valine' 0 C--O 1.192 -1.948 0 O-C-N 121.927 -0.483 . . . . 1.0 111.99 -178.3 . . . . . . . . 3 3 . 1 . 026 nuclear build full ' A' A ' 113' ' ' ASN . . . . . 0.448 ' OD1' ' O ' ' A' ' 109' ' ' ILE . 4.3 m120 -72.0 -40.2 68.7 Favored 'General case' 0 N--CA 1.483 1.217 0 CA-C-O 123.544 1.64 . . . . 1.0 108.231 179.859 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 114' ' ' ALA . . . . . 0.462 ' HB3' ' O ' ' A' ' 111' ' ' ASN . . . -54.59 -50.0 69.07 Favored 'General case' 0 C--N 1.295 -1.796 0 CA-C-N 111.015 -2.812 . . . . 1.0 107.376 178.727 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 115' ' ' ALA . . . . . 0.722 ' O ' ' N ' ' A' ' 119' ' ' LEU . . . -85.13 -49.09 8.53 Favored 'General case' 0 C--O 1.199 -1.579 0 N-CA-C 114.402 1.26 . . . . 1.0 114.402 177.652 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 116' ' ' ILE . . . . . 0.688 ' HB ' ' O ' ' A' ' 112' ' ' ILE . 0.6 OUTLIER -42.79 -49.15 1.15 Allowed 'Isoleucine or valine' 0 N--CA 1.513 2.714 0 N-CA-C 106.109 -1.811 . . . . 1.0 106.109 179.569 . . . . . . . . 3 3 . 1 . 026 nuclear build full ' A' A ' 117' ' ' GLU . . . . . 0.439 ' C ' ' O ' ' A' ' 116' ' ' ILE . 68.3 mt-10 -45.99 -59.87 2.59 Favored 'General case' 0 C--N 1.308 -1.2 0 N-CA-C 105.573 -2.01 . . . . 1.0 105.573 177.907 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 118' ' ' VAL . . . . . 0.544 ' N ' ' O ' ' A' ' 115' ' ' ALA . 6.9 t -77.52 -57.37 5.83 Favored 'Isoleucine or valine' 0 CA--C 1.557 1.23 0 N-CA-C 113.558 0.947 . . . . 1.0 113.558 178.505 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 119' ' ' LEU . . . . . 0.722 ' N ' ' O ' ' A' ' 115' ' ' ALA . 1.3 tp -61.55 -24.44 66.64 Favored 'General case' 0 C--N 1.351 0.652 0 N-CA-C 116.218 1.933 . . . . 1.0 116.218 -178.728 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 120' ' ' GLY . . . . . 0.502 ' C ' HG22 ' A' ' 121' ' ' THR . . . -126.48 -54.93 0.15 Allowed Glycine 0 C--N 1.354 1.549 0 CA-C-N 120.506 1.503 . . . . 1.0 110.869 176.976 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 121' ' ' THR . . . . . 0.672 HG23 ' N ' ' A' ' 122' ' ' GLY . 2.1 t 143.39 -56.18 0.0 OUTLIER 'General case' 0 N--CA 1.477 0.907 0 C-N-CA 124.089 0.956 . . . . 1.0 112.036 -177.915 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 122' ' ' GLY . . . . . 0.672 ' N ' HG23 ' A' ' 121' ' ' THR . . . 92.6 -23.27 28.97 Favored Glycine 0 CA--C 1.531 1.053 0 N-CA-C 107.725 -2.15 . . . . 1.0 107.725 -176.583 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 123' ' ' THR . . . . . 0.615 HG22 HG21 ' A' ' 121' ' ' THR . 5.8 t -46.94 91.94 0.01 OUTLIER 'General case' 0 N--CA 1.477 0.918 0 N-CA-C 105.64 -1.985 . . . . 1.0 105.64 179.239 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 124' ' ' ASP . . . . . 0.592 ' N ' ' O ' ' A' ' 122' ' ' GLY . 48.2 p30 -169.76 -174.82 1.94 Allowed 'General case' 0 CA--C 1.537 0.458 0 CA-C-N 114.904 -1.044 . . . . 1.0 112.38 178.739 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 125' ' ' TYR . . . . . . . . . . . . . 16.9 t80 -148.59 147.63 29.22 Favored 'General case' 0 CA--C 1.542 0.644 0 CA-C-N 114.385 -1.28 . . . . 1.0 109.059 175.686 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 13.8 mtp85 -146.94 150.41 35.14 Favored 'General case' 0 N--CA 1.476 0.85 0 N-CA-C 109.812 -0.44 . . . . 1.0 109.812 177.38 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 127' ' ' PHE . . . . . . . . . . . . . 26.7 p90 . . . . . 0 C--O 1.22 -0.449 0 CA-C-O 118.176 -0.916 . . . . 1.0 111.231 -179.353 . . . . . . . . 0 0 . 1 . 026 nuclear build full ' A' A ' 128' ' ' MTN . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 026 nuclear build full ' A' A ' 129' ' ' MTN . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 026 nuclear build full ' A' A ' 130' ' ' MTN . . . . . 0.518 ' S1 ' ' H71' ' A' ' 130' ' ' MTN . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.488 1.456 0 N-CA-C 108.667 -0.864 . . . . 1.0 108.667 . . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 93.4 p -88.4 0.58 56.07 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.576 -0.284 . . . . 1.0 111.316 -179.967 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 2.0 t70 164.65 118.65 0.01 OUTLIER 'General case' 0 N--CA 1.479 0.988 0 O-C-N 123.391 0.432 . . . . 1.0 111.277 178.916 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 58.2 t80 -151.74 148.39 27.83 Favored 'General case' 0 N--CA 1.465 0.322 0 CA-C-O 121.078 0.466 . . . . 1.0 110.191 177.997 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 30.9 m-20 -152.29 148.12 27.16 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.596 -0.729 . . . . 1.0 109.788 179.754 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 6' ' ' THR . . . . . 1.038 ' H ' HG23 ' A' ' 9' ' ' VAL . 0.2 OUTLIER -106.72 -168.7 1.45 Allowed 'General case' 0 C--O 1.205 -1.286 0 CA-C-O 121.602 0.715 . . . . 1.0 109.832 -179.967 . . . . . . . . 3 3 . 1 . 027 nuclear build full ' A' A ' 7' ' ' GLU . . . . . 0.502 ' O ' ' CB ' ' A' ' 11' ' ' ARG . 71.6 mm-40 -57.66 -46.59 84.03 Favored 'General case' 0 C--N 1.297 -1.68 0 N-CA-C 109.438 -0.578 . . . . 1.0 109.438 179.77 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 8' ' ' ARG . . . . . 0.695 ' O ' ' HB3' ' A' ' 12' ' ' ALA . 16.8 mtt85 -66.58 -61.64 1.88 Allowed 'General case' 0 C--N 1.316 -0.864 0 C-N-CA 117.373 -1.731 . . . . 1.0 109.595 179.609 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 9' ' ' VAL . . . . . 1.038 HG23 ' H ' ' A' ' 6' ' ' THR . 0.0 OUTLIER -61.73 -52.86 55.83 Favored 'Isoleucine or valine' 0 C--O 1.204 -1.311 0 CA-C-N 114.769 -1.105 . . . . 1.0 110.703 -179.679 . . . . . . . . 3 3 . 1 . 027 nuclear build full ' A' A ' 10' ' ' SER . . . . . 0.72 ' N ' ' O ' ' A' ' 6' ' ' THR . 4.9 t -65.3 -61.5 2.08 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 122.074 -0.391 . . . . 1.0 111.619 178.761 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 11' ' ' ARG . . . . . 0.648 ' O ' ' HB3' ' A' ' 15' ' ' ALA . 29.4 ttt180 -62.06 -43.96 97.71 Favored 'General case' 0 C--N 1.31 -1.123 0 O-C-N 121.462 -0.774 . . . . 1.0 109.561 -175.698 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 12' ' ' ALA . . . . . 0.735 ' O ' ' HB3' ' A' ' 16' ' ' ALA . . . -70.33 -56.58 6.36 Favored 'General case' 0 N--CA 1.477 0.919 0 C-N-CA 118.825 -1.15 . . . . 1.0 109.161 176.801 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 13' ' ' VAL . . . . . 0.673 ' O ' ' CB ' ' A' ' 17' ' ' LEU . 55.0 t -61.46 -53.46 48.27 Favored 'Isoleucine or valine' 0 C--O 1.192 -1.961 0 C-N-CA 117.498 -1.681 . . . . 1.0 107.461 -178.779 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 14' ' ' ALA . . . . . 0.935 ' O ' HG22 ' A' ' 18' ' ' VAL . . . -62.82 -65.28 0.71 Allowed 'General case' 0 C--N 1.308 -1.217 0 C-N-CA 116.075 -2.25 . . . . 1.0 111.892 -179.814 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 15' ' ' ALA . . . . . 0.648 ' HB3' ' O ' ' A' ' 11' ' ' ARG . . . -55.35 -55.49 30.92 Favored 'General case' 0 C--O 1.217 -0.64 0 C-N-CA 118.321 -1.352 . . . . 1.0 111.545 -176.7 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 16' ' ' ALA . . . . . 0.735 ' HB3' ' O ' ' A' ' 12' ' ' ALA . . . -65.6 -58.67 5.2 Favored 'General case' 0 C--N 1.301 -1.502 0 C-N-CA 118.35 -1.34 . . . . 1.0 110.804 -178.491 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 17' ' ' LEU . . . . . 0.673 ' CB ' ' O ' ' A' ' 13' ' ' VAL . 5.7 tp -53.62 -55.3 27.02 Favored 'General case' 0 N--CA 1.489 1.504 0 N-CA-C 108.536 -0.913 . . . . 1.0 108.536 -179.294 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 18' ' ' VAL . . . . . 0.935 HG22 ' O ' ' A' ' 14' ' ' ALA . 2.2 m -71.03 -60.42 2.45 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.43 0 C-N-CA 118.975 -1.09 . . . . 1.0 110.85 -179.509 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 19' ' ' GLY . . . . . 0.528 ' N ' ' O ' ' A' ' 15' ' ' ALA . . . -54.54 -163.26 0.01 OUTLIER Glycine 0 N--CA 1.438 -1.218 0 CA-C-O 121.567 0.537 . . . . 1.0 113.179 -176.969 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 20' ' ' PRO . . . . . 0.72 ' O ' ' N ' ' A' ' 24' ' ' ALA . 90.6 Cg_endo -80.48 -24.75 5.06 Favored 'Trans proline' 0 C--N 1.302 -1.884 0 C-N-CA 122.246 1.964 . . . . 1.0 111.712 -179.112 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -62.11 -60.84 7.35 Favored Glycine 0 N--CA 1.47 0.914 0 C-N-CA 118.685 -1.721 . . . . 1.0 111.059 -176.921 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 22' ' ' GLY . . . . . 0.61 ' N ' ' O ' ' A' ' 16' ' ' ALA . . . -60.71 -50.39 68.1 Favored Glycine 0 C--N 1.304 -1.207 0 N-CA-C 106.954 -2.459 . . . . 1.0 106.954 179.017 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 83.2 t -58.41 -34.05 49.52 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.582 0 C-N-CA 118.837 -1.145 . . . . 1.0 107.991 -179.72 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 24' ' ' ALA . . . . . 0.72 ' N ' ' O ' ' A' ' 20' ' ' PRO . . . -61.71 -61.23 2.66 Favored 'General case' 0 N--CA 1.468 0.468 0 C-N-CA 118.685 -1.206 . . . . 1.0 109.376 179.402 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 25' ' ' LEU . . . . . 0.425 ' O ' HG12 ' A' ' 29' ' ' VAL . 58.0 mt -60.42 -45.19 94.49 Favored 'General case' 0 CA--C 1.508 -0.673 0 C-N-CA 119.59 -0.844 . . . . 1.0 110.478 -176.512 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 55.4 t -59.83 -60.34 2.66 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.512 0 C-N-CA 119.325 -0.95 . . . . 1.0 109.692 -178.278 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 27' ' ' VAL . . . . . 0.802 ' O ' ' HB3' ' A' ' 31' ' ' ALA . 62.1 t -58.57 -40.16 78.02 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.363 0 C-N-CA 120.543 -0.463 . . . . 1.0 110.534 -177.828 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 10.9 tttm -66.56 -55.26 16.27 Favored 'General case' 0 C--N 1.314 -0.946 0 C-N-CA 119.855 -0.738 . . . . 1.0 109.82 -178.701 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 29' ' ' VAL . . . . . 0.483 HG13 ' N ' ' A' ' 30' ' ' CYS . 3.2 p -65.82 -50.8 68.13 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 CA-C-N 115.294 -0.866 . . . . 1.0 111.011 -177.32 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 30' ' ' CYS . . . . . 0.483 ' N ' HG13 ' A' ' 29' ' ' VAL . 42.0 t -67.59 -62.61 1.34 Allowed 'General case' 0 N--CA 1.44 -0.945 0 C-N-CA 119.837 -0.745 . . . . 1.0 110.597 -179.208 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 31' ' ' ALA . . . . . 0.802 ' HB3' ' O ' ' A' ' 27' ' ' VAL . . . -62.74 -53.33 55.96 Favored 'General case' 0 N--CA 1.434 -1.273 0 C-N-CA 120.578 -0.449 . . . . 1.0 111.378 -175.459 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 69.8 66.23 2.3 Favored Glycine 0 N--CA 1.441 -1.022 0 C-N-CA 119.225 -1.464 . . . . 1.0 109.828 -179.428 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 33' ' ' LEU . . . . . 0.509 ' O ' ' CD1' ' A' ' 37' ' ' ILE . 6.2 mt 87.55 96.15 0.03 OUTLIER Pre-proline 0 N--CA 1.481 1.108 0 O-C-N 126.232 1.784 . . . . 1.0 112.049 -179.535 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 54.4 Cg_exo -46.23 -8.21 0.04 OUTLIER 'Trans proline' 0 N--CA 1.497 1.681 0 C-N-CA 122.39 2.06 . . . . 1.0 114.184 -179.825 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 35' ' ' GLY . . . . . 0.467 ' N ' ' O ' ' A' ' 33' ' ' LEU . . . -61.25 -60.27 8.59 Favored Glycine 0 CA--C 1.538 1.472 0 C-N-CA 118.466 -1.826 . . . . 1.0 109.867 -178.668 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 36' ' ' VAL . . . . . 0.855 HG22 ' H ' ' A' ' 37' ' ' ILE . 7.1 p -88.55 -139.84 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.473 0.687 0 CA-C-N 117.87 0.835 . . . . 1.0 109.072 179.369 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 37' ' ' ILE . . . . . 0.855 ' H ' HG22 ' A' ' 36' ' ' VAL . 2.5 mp 68.27 79.65 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.47 0.554 0 N-CA-C 112.575 0.583 . . . . 1.0 112.575 179.655 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -138.86 132.47 30.54 Favored 'General case' 0 CA--C 1.532 0.266 0 N-CA-C 108.383 -0.969 . . . . 1.0 108.383 178.397 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -107.43 159.3 30.7 Favored Pre-proline 0 N--CA 1.472 0.671 0 CA-C-N 116.515 -0.312 . . . . 1.0 110.182 -178.353 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 59.6 Cg_endo -71.97 -23.44 21.89 Favored 'Trans proline' 0 C--N 1.306 -1.668 0 C-N-CA 121.736 1.624 . . . . 1.0 111.947 178.668 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -119.76 83.99 2.13 Favored 'General case' 0 C--N 1.343 0.3 0 C-N-CA 120.553 -0.459 . . . . 1.0 110.582 179.281 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 42' ' ' ARG . . . . . 0.673 ' C ' ' H ' ' A' ' 44' ' ' GLY . 0.0 OUTLIER -103.86 135.26 45.73 Favored 'General case' 0 C--N 1.318 -0.803 0 CA-C-N 116.003 -0.544 . . . . 1.0 110.171 -177.644 . . . . . . . . 3 3 . 1 . 027 nuclear build full ' A' A ' 43' ' ' ARG . . . . . 0.619 ' C ' ' H ' ' A' ' 45' ' ' PHE . 42.9 tpt85 -64.31 22.65 0.01 OUTLIER 'General case' 0 C--N 1.314 -0.943 0 C-N-CA 119.913 -0.715 . . . . 1.0 109.763 179.092 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 44' ' ' GLY . . . . . 0.673 ' H ' ' C ' ' A' ' 42' ' ' ARG . . . 70.45 -28.04 0.46 Allowed Glycine 0 C--N 1.345 1.053 0 N-CA-C 110.764 -0.934 . . . . 1.0 110.764 179.223 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 45' ' ' PHE . . . . . 0.621 ' O ' ' HB2' ' A' ' 46' ' ' PHE . 31.0 p90 -164.71 172.61 12.83 Favored 'General case' 0 N--CA 1.45 -0.47 0 N-CA-C 108.521 -0.918 . . . . 1.0 108.521 -179.807 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 46' ' ' PHE . . . . . 0.621 ' HB2' ' O ' ' A' ' 45' ' ' PHE . 1.7 t80 116.16 96.41 0.0 OUTLIER 'General case' 0 N--CA 1.484 1.236 0 O-C-N 125.701 1.875 . . . . 1.0 108.153 -178.499 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 47' ' ' ARG . . . . . 0.547 ' O ' ' CB ' ' A' ' 48' ' ' CYS . 3.9 mmp_? 115.16 133.41 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.611 0 O-C-N 125.06 1.475 . . . . 1.0 109.859 -179.551 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 48' ' ' CYS . . . . . 0.547 ' CB ' ' O ' ' A' ' 47' ' ' ARG . 43.7 t 121.95 -5.59 0.0 OUTLIER 'General case' 0 CA--C 1.51 -0.595 0 O-C-N 125.305 1.628 . . . . 1.0 111.059 177.406 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -120.59 149.89 51.16 Favored Pre-proline 0 CA--C 1.534 0.356 0 N-CA-C 109.84 -0.43 . . . . 1.0 109.84 179.867 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 50' ' ' PRO . . . . . 0.562 ' C ' ' H ' ' A' ' 52' ' ' ARG . 98.9 Cg_endo -76.46 87.16 1.47 Allowed 'Trans proline' 0 N--CA 1.493 1.47 0 C-N-CA 122.277 1.985 . . . . 1.0 114.041 -179.888 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 51' ' ' GLU . . . . . 0.433 ' CD ' ' O ' ' A' ' 50' ' ' PRO . 0.0 OUTLIER 66.44 -32.7 0.18 Allowed 'General case' 0 N--CA 1.472 0.649 0 N-CA-C 112.09 0.404 . . . . 1.0 112.09 176.269 . . . . . . . . 3 3 . 1 . 027 nuclear build full ' A' A ' 52' ' ' ARG . . . . . 0.856 HH11 ' HB1' ' A' ' 86' ' ' ALA . 5.4 mtm180 -45.39 140.08 3.29 Favored 'General case' 0 C--N 1.315 -0.903 0 CA-C-O 121.941 0.877 . . . . 1.0 112.198 -178.094 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 2.2 tp -82.22 166.07 2.4 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 114.35 -1.295 . . . . 1.0 108.7 177.999 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 16.7 mt-30 -135.73 134.6 39.23 Favored 'General case' 0 N--CA 1.453 -0.288 0 N-CA-C 108.423 -0.954 . . . . 1.0 108.423 179.795 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 2.3 pp -142.68 153.66 17.6 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.366 0 N-CA-C 109.881 -0.414 . . . . 1.0 109.881 178.288 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 105.1 2.36 41.89 Favored Glycine 0 CA--C 1.529 0.95 0 N-CA-C 110.077 -1.209 . . . . 1.0 110.077 -178.348 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 58.0 m-20 -86.78 103.99 15.73 Favored 'General case' 0 N--CA 1.471 0.605 0 CA-C-O 122.141 0.972 . . . . 1.0 112.722 -178.333 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 58' ' ' TRP . . . . . 0.54 ' HB2' ' HB2' ' A' ' 61' ' ' GLU . 13.3 m95 -78.78 178.41 7.93 Favored 'General case' 0 C--N 1.315 -0.922 0 CA-C-N 113.484 -1.689 . . . . 1.0 108.937 177.879 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 59' ' ' ARG . . . . . 0.506 ' HG2' ' H ' ' A' ' 60' ' ' TYR . 0.0 OUTLIER -101.23 -56.95 2.19 Favored 'General case' 0 CA--C 1.557 1.244 0 CA-C-N 119.494 1.043 . . . . 1.0 112.533 178.814 . . . . . . . . 3 3 . 1 . 027 nuclear build full ' A' A ' 60' ' ' TYR . . . . . 0.506 ' H ' ' HG2' ' A' ' 59' ' ' ARG . 63.2 t80 -80.5 -13.5 59.05 Favored 'General case' 0 N--CA 1.485 1.305 0 C-N-CA 125.341 1.456 . . . . 1.0 112.581 -178.209 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 61' ' ' GLU . . . . . 0.541 ' O ' ' N ' ' A' ' 65' ' ' ASP . 10.1 mt-10 -79.49 -14.59 58.79 Favored 'General case' 0 C--N 1.298 -1.641 0 CA-C-N 114.963 -1.017 . . . . 1.0 108.903 178.244 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 62' ' ' VAL . . . . . 0.502 HG13 ' O ' ' A' ' 59' ' ' ARG . 13.4 m -44.26 -44.39 2.22 Favored 'Isoleucine or valine' 0 CA--C 1.491 -1.317 0 N-CA-C 109.331 -0.618 . . . . 1.0 109.331 -176.41 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 63' ' ' ALA . . . . . 0.548 ' O ' ' HG2' ' A' ' 67' ' ' ARG . . . -69.2 -46.74 66.71 Favored 'General case' 0 N--CA 1.411 -2.423 0 N-CA-C 107.947 -1.131 . . . . 1.0 107.947 177.61 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 64' ' ' HIS . . . . . 0.496 ' N ' ' O ' ' A' ' 61' ' ' GLU . 1.3 t-80 -56.04 -60.42 3.51 Favored 'General case' 0 CA--C 1.546 0.805 0 CA-C-N 115.512 -0.767 . . . . 1.0 111.049 178.891 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 65' ' ' ASP . . . . . 0.69 ' C ' ' H ' ' A' ' 67' ' ' ARG . 10.4 t70 -66.15 -54.69 22.35 Favored 'General case' 0 C--O 1.248 0.974 0 O-C-N 121.489 -0.757 . . . . 1.0 109.639 178.062 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 66' ' ' GLY . . . . . 0.456 ' N ' ' O ' ' A' ' 62' ' ' VAL . . . -63.22 32.49 0.08 OUTLIER Glycine 0 N--CA 1.471 0.982 0 N-CA-C 110.603 -0.999 . . . . 1.0 110.603 177.526 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 67' ' ' ARG . . . . . 0.723 ' HB3' ' H ' ' A' ' 71' ' ' ALA . 0.2 OUTLIER -75.75 1.74 13.97 Favored 'General case' 0 N--CA 1.435 -1.197 0 CA-C-N 114.639 -0.781 . . . . 1.0 109.113 175.71 . . . . . . . . 3 3 . 1 . 027 nuclear build full ' A' A ' 68' ' ' LEU . . . . . 0.538 ' O ' ' HA ' ' A' ' 72' ' ' HIS . 10.2 mp -33.72 -29.67 0.01 OUTLIER 'General case' 0 N--CA 1.501 2.118 0 N-CA-C 106.848 -1.538 . . . . 1.0 106.848 -177.597 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 69' ' ' LEU . . . . . 0.63 ' N ' ' O ' ' A' ' 67' ' ' ARG . 5.2 tp -61.85 -65.61 0.66 Allowed 'General case' 0 CA--C 1.553 1.06 0 C-N-CA 117.825 -1.55 . . . . 1.0 107.441 175.439 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 70' ' ' ALA . . . . . 0.642 ' O ' ' CG ' ' A' ' 72' ' ' HIS . . . -75.32 -68.59 0.54 Allowed 'General case' 0 N--CA 1.477 0.9 0 N-CA-C 106.456 -1.683 . . . . 1.0 106.456 175.684 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 71' ' ' ALA . . . . . 0.723 ' H ' ' HB3' ' A' ' 67' ' ' ARG . . . -47.17 2.54 0.0 OUTLIER 'General case' 0 N--CA 1.477 0.922 0 C-N-CA 124.686 1.194 . . . . 1.0 113.48 178.876 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 72' ' ' HIS . . . . . 0.642 ' CG ' ' O ' ' A' ' 70' ' ' ALA . 0.2 OUTLIER -19.94 -82.63 0.0 OUTLIER 'General case' 0 C--N 1.324 -0.525 0 N-CA-C 113.589 0.959 . . . . 1.0 113.589 -174.259 . . . . . . . . 3 3 . 1 . 027 nuclear build full ' A' A ' 73' ' ' MET . . . . . 0.521 ' N ' ' SD ' ' A' ' 73' ' ' MET . 0.7 OUTLIER -74.29 -41.79 60.62 Favored 'General case' 0 C--N 1.3 -1.545 0 CA-C-N 118.928 0.786 . . . . 1.0 111.122 178.389 . . . . . . . . 3 3 . 1 . 027 nuclear build full ' A' A ' 74' ' ' VAL . . . . . 0.594 ' O ' ' N ' ' A' ' 76' ' ' GLY . 0.8 OUTLIER -44.74 -41.78 2.22 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.796 0 C-N-CA 119.694 -0.803 . . . . 1.0 110.441 -174.62 . . . . . . . . 3 3 . 1 . 027 nuclear build full ' A' A ' 75' ' ' ASN . . . . . 0.567 ' O ' ' N ' ' A' ' 77' ' ' ILE . 28.2 t30 -39.16 -17.9 0.01 OUTLIER 'General case' 0 N--CA 1.48 1.033 0 CA-C-O 122.401 1.096 . . . . 1.0 110.964 178.029 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 76' ' ' GLY . . . . . 0.728 ' O ' HD12 ' A' ' 79' ' ' ILE . . . -43.41 -16.14 0.03 OUTLIER Glycine 0 CA--C 1.564 3.095 0 N-CA-C 108.634 -1.786 . . . . 1.0 108.634 176.051 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 77' ' ' ILE . . . . . 0.784 ' O ' ' N ' ' A' ' 80' ' ' ALA . 2.6 pp -89.91 -46.0 15.08 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.227 0 N-CA-C 108.428 -0.953 . . . . 1.0 108.428 -179.354 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 78' ' ' VAL . . . . . 0.501 ' N ' HD12 ' A' ' 77' ' ' ILE . 1.0 OUTLIER -34.34 -27.94 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.571 1.766 0 N-CA-C 108.775 -0.824 . . . . 1.0 108.775 -174.816 . . . . . . . . 3 3 . 1 . 027 nuclear build full ' A' A ' 79' ' ' ILE . . . . . 0.934 HD13 ' N ' ' A' ' 80' ' ' ALA . 0.0 OUTLIER -92.0 -17.32 7.64 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.907 0 C-N-CA 124.86 1.264 . . . . 1.0 111.765 177.383 . . . . . . . . 3 3 . 1 . 027 nuclear build full ' A' A ' 80' ' ' ALA . . . . . 0.934 ' N ' HD13 ' A' ' 79' ' ' ILE . . . -65.86 -14.05 60.74 Favored 'General case' 0 C--N 1.321 -0.639 0 O-C-N 122.156 -0.34 . . . . 1.0 111.215 178.105 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 34.6 mt-10 -122.78 -47.89 2.05 Favored 'General case' 0 N--CA 1.47 0.534 0 CA-C-O 121.767 0.794 . . . . 1.0 109.435 175.759 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -59.94 -62.08 2.13 Favored 'General case' 0 CA--C 1.53 0.209 0 CA-C-N 115.22 -0.9 . . . . 1.0 109.314 -179.745 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 83' ' ' ALA . . . . . 0.648 ' HB3' ' O ' ' A' ' 79' ' ' ILE . . . -47.5 -45.23 26.21 Favored 'General case' 0 N--CA 1.467 0.42 0 CA-C-N 116.587 -0.279 . . . . 1.0 110.798 -179.248 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 84' ' ' LEU . . . . . 0.545 HD13 ' O ' ' A' ' 80' ' ' ALA . 1.5 tp -28.83 -44.85 0.03 OUTLIER 'General case' 0 N--CA 1.483 1.187 0 CA-C-N 116.36 -0.382 . . . . 1.0 111.636 -174.683 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 85' ' ' ILE . . . . . 0.438 HG13 ' H ' ' A' ' 86' ' ' ALA . 3.4 pt -91.57 -49.77 13.07 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.742 0 N-CA-C 109.102 -0.703 . . . . 1.0 109.102 177.138 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 86' ' ' ALA . . . . . 0.856 ' HB1' HH11 ' A' ' 52' ' ' ARG . . . -48.22 -36.0 12.97 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.608 -0.724 . . . . 1.0 110.261 -178.723 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 5.3 mm-40 -57.51 -23.56 50.93 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.864 -0.607 . . . . 1.0 110.051 179.213 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -73.26 -9.51 58.79 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 121.22 0.533 . . . . 1.0 109.733 179.505 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 89' ' ' VAL . . . . . 0.629 ' O ' HG12 ' A' ' 89' ' ' VAL . 40.5 t -105.46 36.91 0.37 Allowed 'Isoleucine or valine' 0 C--O 1.234 0.268 0 CA-C-N 115.433 -0.803 . . . . 1.0 109.413 179.198 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 90' ' ' GLY . . . . . 0.537 ' O ' ' N ' ' A' ' 92' ' ' HIS . . . -66.71 -43.11 92.65 Favored Glycine 0 CA--C 1.539 1.531 0 N-CA-C 111.205 -0.758 . . . . 1.0 111.205 178.859 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 91' ' ' PRO . . . . . 0.472 ' CD ' ' N ' ' A' ' 90' ' ' GLY . 87.3 Cg_exo -42.3 -15.33 0.05 OUTLIER 'Trans proline' 0 N--CA 1.497 1.71 0 C-N-CA 122.03 1.82 . . . . 1.0 112.386 179.982 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 92' ' ' HIS . . . . . 0.537 ' N ' ' O ' ' A' ' 90' ' ' GLY . 5.6 p-80 -60.52 -15.51 28.05 Favored 'General case' 0 C--N 1.322 -0.601 0 N-CA-C 108.662 -0.866 . . . . 1.0 108.662 179.52 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 93' ' ' LEU . . . . . 0.737 HD12 ' N ' ' A' ' 94' ' ' ALA . 2.3 pp -72.95 -58.48 3.29 Favored 'General case' 0 C--N 1.323 -0.557 0 N-CA-C 108.836 -0.801 . . . . 1.0 108.836 179.915 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 94' ' ' ALA . . . . . 0.737 ' N ' HD12 ' A' ' 93' ' ' LEU . . . -59.23 -55.8 30.25 Favored 'General case' 0 C--O 1.236 0.391 0 CA-C-O 120.907 0.384 . . . . 1.0 109.997 179.744 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 95' ' ' ARG . . . . . 0.73 ' O ' ' N ' ' A' ' 97' ' ' LEU . 11.1 ttm180 -52.85 -59.3 4.67 Favored 'General case' 0 C--O 1.24 0.558 0 N-CA-C 107.079 -1.452 . . . . 1.0 107.079 178.777 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 96' ' ' ALA . . . . . 0.875 ' O ' ' N ' ' A' ' 98' ' ' GLY . . . -46.4 -7.67 0.01 OUTLIER 'General case' 0 N--CA 1.427 -1.616 0 O-C-N 119.029 -2.295 . . . . 1.0 112.525 -177.33 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 97' ' ' LEU . . . . . 0.73 ' N ' ' O ' ' A' ' 95' ' ' ARG . 0.4 OUTLIER 2.85 -50.57 0.0 OUTLIER 'General case' 0 C--N 1.36 1.062 0 O-C-N 124.776 1.297 . . . . 1.0 110.522 -169.447 . . . . . . . . 3 3 . 1 . 027 nuclear build full ' A' A ' 98' ' ' GLY . . . . . 0.952 ' O ' HG12 ' A' ' 101' ' ' VAL . . . -52.65 -17.52 4.67 Favored Glycine 0 N--CA 1.422 -2.265 0 CA-C-N 122.088 2.222 . . . . 1.0 107.902 174.001 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 99' ' ' GLN . . . . . 0.697 ' N ' ' O ' ' A' ' 96' ' ' ALA . 68.8 tp60 -73.96 -25.31 59.88 Favored 'General case' 0 CA--C 1.512 -0.5 0 C-N-CA 117.746 -1.582 . . . . 1.0 107.066 178.69 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 100' ' ' ILE . . . . . 0.619 ' N ' ' O ' ' A' ' 97' ' ' LEU . 4.9 tt -62.55 -35.51 70.49 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.883 0 CA-C-N 114.522 -1.217 . . . . 1.0 110.207 178.617 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 101' ' ' VAL . . . . . 0.952 HG12 ' O ' ' A' ' 98' ' ' GLY . 8.7 p -61.83 -58.69 6.42 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.698 0 C-N-CA 118.514 -1.274 . . . . 1.0 108.976 -179.599 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 102' ' ' CYS . . . . . 0.994 ' O ' ' HB2' ' A' ' 106' ' ' ALA . 0.1 OUTLIER -42.23 -24.53 0.05 Allowed 'General case' 0 N--CA 1.437 -1.104 0 N-CA-C 112.109 0.411 . . . . 1.0 112.109 -177.451 . . . . . . . . 3 3 . 1 . 027 nuclear build full ' A' A ' 103' ' ' ARG . . . . . 0.428 ' N ' ' O ' ' A' ' 101' ' ' VAL . 9.4 ttp180 -88.81 -33.15 17.52 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-O 122.435 1.112 . . . . 1.0 111.207 178.39 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 104' ' ' TYR . . . . . 0.689 ' O ' ' CG ' ' A' ' 104' ' ' TYR . 0.3 OUTLIER -100.71 17.49 21.81 Favored 'General case' 0 C--N 1.312 -1.044 0 CA-C-N 113.365 -1.743 . . . . 1.0 109.822 177.352 . . . . . . . . 3 3 . 1 . 027 nuclear build full ' A' A ' 105' ' ' GLY . . . . . 0.528 ' N ' ' O ' ' A' ' 101' ' ' VAL . . . -165.29 -82.3 0.05 OUTLIER Glycine 0 N--CA 1.447 -0.599 0 N-CA-C 106.945 -2.462 . . . . 1.0 106.945 175.97 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 106' ' ' ALA . . . . . 0.994 ' HB2' ' O ' ' A' ' 102' ' ' CYS . . . 70.47 68.89 0.2 Allowed 'General case' 0 N--CA 1.437 -1.094 0 N-CA-C 112.256 0.465 . . . . 1.0 112.256 179.043 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 107' ' ' THR . . . . . 0.575 ' O ' ' HG2' ' A' ' 110' ' ' PRO . 25.2 m -76.27 -55.46 5.55 Favored 'General case' 0 C--O 1.213 -0.819 0 O-C-N 120.737 -1.227 . . . . 1.0 109.433 177.907 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 108' ' ' VAL . . . . . 0.604 ' O ' ' HB2' ' A' ' 111' ' ' ASN . 35.7 m -72.54 -48.39 47.2 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.205 0 CA-C-O 121.283 0.563 . . . . 1.0 111.692 -178.72 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 109' ' ' ILE . . . . . 0.57 ' N ' HG23 ' A' ' 108' ' ' VAL . 0.0 OUTLIER -41.31 -45.6 7.19 Favored Pre-proline 0 C--N 1.316 -0.854 0 CA-C-O 118.001 -0.999 . . . . 1.0 109.737 -178.027 . . . . . . . . 3 3 . 1 . 027 nuclear build full ' A' A ' 110' ' ' PRO . . . . . 0.575 ' HG2' ' O ' ' A' ' 107' ' ' THR . 72.6 Cg_endo -63.21 -18.06 63.08 Favored 'Trans proline' 0 C--O 1.2 -1.418 0 CA-C-N 122.388 1.889 . . . . 1.0 111.25 177.65 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 111' ' ' ASN . . . . . 0.604 ' HB2' ' O ' ' A' ' 108' ' ' VAL . 0.4 OUTLIER -62.2 -66.26 0.57 Allowed 'General case' 0 N--CA 1.478 0.974 0 N-CA-C 108.375 -0.972 . . . . 1.0 108.375 178.803 . . . . . . . . 3 3 . 1 . 027 nuclear build full ' A' A ' 112' ' ' ILE . . . . . 0.61 ' O ' ' HB ' ' A' ' 116' ' ' ILE . 1.5 pt -48.27 -22.78 0.66 Allowed 'Isoleucine or valine' 0 C--O 1.219 -0.51 0 N-CA-C 107.864 -1.161 . . . . 1.0 107.864 179.714 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 113' ' ' ASN . . . . . 0.726 ' O ' ' HB2' ' A' ' 117' ' ' GLU . 11.8 m-20 -84.61 -53.68 5.23 Favored 'General case' 0 N--CA 1.44 -0.935 0 CA-C-O 124.01 1.862 . . . . 1.0 110.063 177.474 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 114' ' ' ALA . . . . . 0.449 ' N ' ' O ' ' A' ' 110' ' ' PRO . . . -56.12 -55.78 28.92 Favored 'General case' 0 C--N 1.29 -1.979 0 CA-C-N 114.376 -1.284 . . . . 1.0 109.619 -178.952 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -80.38 -61.02 2.1 Favored 'General case' 0 C--O 1.244 0.81 0 N-CA-C 114.554 1.316 . . . . 1.0 114.554 179.706 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 116' ' ' ILE . . . . . 0.61 ' HB ' ' O ' ' A' ' 112' ' ' ILE . 36.4 mm -72.46 -40.03 63.18 Favored 'Isoleucine or valine' 0 C--O 1.211 -0.938 0 N-CA-C 114.35 1.241 . . . . 1.0 114.35 -175.234 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 117' ' ' GLU . . . . . 0.726 ' HB2' ' O ' ' A' ' 113' ' ' ASN . 1.2 tt0 -51.85 -62.78 1.41 Allowed 'General case' 0 CA--C 1.486 -1.484 0 CA-C-N 118.12 0.418 . . . . 1.0 110.611 -176.334 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 38.8 t -55.54 -14.23 1.31 Allowed 'Isoleucine or valine' 0 N--CA 1.424 -1.774 0 C-N-CA 117.836 -1.546 . . . . 1.0 109.253 -177.244 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 119' ' ' LEU . . . . . 0.416 ' N ' ' C ' ' A' ' 117' ' ' GLU . 1.1 tp -92.54 -56.66 2.94 Favored 'General case' 0 CA--C 1.552 1.044 0 N-CA-C 113.682 0.993 . . . . 1.0 113.682 176.857 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -68.75 -50.52 35.58 Favored Glycine 0 C--N 1.358 1.764 0 C-N-CA 120.062 -1.066 . . . . 1.0 114.47 -174.68 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 1.9 t 155.56 -40.0 0.01 OUTLIER 'General case' 0 N--CA 1.476 0.865 0 N-CA-C 106.396 -1.705 . . . . 1.0 106.396 -178.273 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 122' ' ' GLY . . . . . 0.51 ' O ' ' N ' ' A' ' 124' ' ' ASP . . . 113.62 -34.37 5.05 Favored Glycine 0 CA--C 1.532 1.108 0 C-N-CA 126.217 1.865 . . . . 1.0 112.862 179.684 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 123' ' ' THR . . . . . 0.446 ' C ' ' O ' ' A' ' 122' ' ' GLY . 33.4 m -32.84 90.91 0.0 OUTLIER 'General case' 0 N--CA 1.486 1.341 0 CA-C-N 120.219 2.009 . . . . 1.0 112.01 -178.698 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 124' ' ' ASP . . . . . 0.51 ' N ' ' O ' ' A' ' 122' ' ' GLY . 39.7 m-20 -145.52 146.16 31.33 Favored 'General case' 0 CA--C 1.537 0.457 0 N-CA-C 108.763 -0.828 . . . . 1.0 108.763 178.089 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 125' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -153.7 150.58 28.71 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-O 120.85 0.357 . . . . 1.0 110.195 -178.851 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 126' ' ' ARG . . . . . 0.589 ' HB3' ' H62' ' A' ' 130' ' ' MTN . 2.7 tpt180 -149.08 151.26 34.13 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.894 -0.594 . . . . 1.0 109.801 177.059 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 127' ' ' PHE . . . . . 0.669 ' OXT' ' H63' ' A' ' 130' ' ' MTN . 19.5 m-85 . . . . . 0 C--O 1.218 -0.583 0 CA-C-O 117.973 -1.013 . . . . 1.0 112.043 -178.864 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 128' ' ' MTN . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 027 nuclear build full ' A' A ' 129' ' ' MTN . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 027 nuclear build full ' A' A ' 130' ' ' MTN . . . . . 0.669 ' H63' ' OXT' ' A' ' 127' ' ' PHE . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.444 ' SD ' ' CD2' ' A' ' 4' ' ' PHE . 38.2 mtt . . . . . 0 N--CA 1.49 1.545 0 N-CA-C 108.503 -0.925 . . . . 1.0 108.503 . . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 2' ' ' SER . . . . . 0.46 ' O ' ' CB ' ' A' ' 3' ' ' ASP . 14.8 m -95.31 10.5 35.96 Favored 'General case' 0 N--CA 1.466 0.357 0 C-N-CA 122.628 0.371 . . . . 1.0 110.939 -179.503 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 3' ' ' ASP . . . . . 0.46 ' CB ' ' O ' ' A' ' 2' ' ' SER . 0.2 OUTLIER 157.4 109.21 0.0 OUTLIER 'General case' 0 N--CA 1.473 0.687 0 O-C-N 124.077 0.861 . . . . 1.0 109.999 178.87 . . . . . . . . 3 3 . 1 . 028 nuclear build full ' A' A ' 4' ' ' PHE . . . . . 0.444 ' CD2' ' SD ' ' A' ' 1' ' ' MET . 14.9 t80 -152.99 148.21 26.82 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.121 -0.49 . . . . 1.0 110.515 179.695 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 5' ' ' ASP . . . . . 0.4 ' OD1' ' O ' ' A' ' 4' ' ' PHE . 9.5 m-20 -154.23 150.16 27.76 Favored 'General case' 0 CA--C 1.536 0.407 0 N-CA-C 109.404 -0.591 . . . . 1.0 109.404 179.761 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 6' ' ' THR . . . . . 0.511 ' O ' ' N ' ' A' ' 10' ' ' SER . 0.2 OUTLIER -62.2 167.51 3.99 Favored 'General case' 0 C--O 1.218 -0.603 0 C-N-CA 120.126 -0.63 . . . . 1.0 110.216 -178.804 . . . . . . . . 3 3 . 1 . 028 nuclear build full ' A' A ' 7' ' ' GLU . . . . . 0.582 ' O ' ' N ' ' A' ' 11' ' ' ARG . 3.1 tt0 -59.69 -58.37 8.86 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-O 121.401 0.62 . . . . 1.0 110.45 -177.947 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 8' ' ' ARG . . . . . 0.485 ' O ' ' CB ' ' A' ' 12' ' ' ALA . 18.2 ttm180 -51.16 -54.85 21.51 Favored 'General case' 0 C--N 1.311 -1.083 0 N-CA-C 108.174 -1.047 . . . . 1.0 108.174 -177.159 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 9' ' ' VAL . . . . . 0.823 ' O ' HG13 ' A' ' 13' ' ' VAL . 6.8 p -62.09 -48.82 86.71 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.127 0 CA-C-N 114.067 -1.424 . . . . 1.0 109.819 178.901 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 10' ' ' SER . . . . . 0.511 ' N ' ' O ' ' A' ' 6' ' ' THR . 42.8 t -62.43 -59.58 4.77 Favored 'General case' 0 N--CA 1.481 1.105 0 C-N-CA 120.198 -0.601 . . . . 1.0 109.702 -179.995 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 11' ' ' ARG . . . . . 0.582 ' N ' ' O ' ' A' ' 7' ' ' GLU . 0.4 OUTLIER -62.59 -57.44 11.09 Favored 'General case' 0 C--N 1.317 -0.823 0 O-C-N 121.742 -0.599 . . . . 1.0 110.19 -178.324 . . . . . . . . 3 3 . 1 . 028 nuclear build full ' A' A ' 12' ' ' ALA . . . . . 0.531 ' O ' ' HB3' ' A' ' 16' ' ' ALA . . . -50.36 -51.58 44.58 Favored 'General case' 0 N--CA 1.476 0.861 0 N-CA-C 108.004 -1.11 . . . . 1.0 108.004 -178.091 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 13' ' ' VAL . . . . . 0.823 HG13 ' O ' ' A' ' 9' ' ' VAL . 4.5 m -60.78 -50.13 81.75 Favored 'Isoleucine or valine' 0 C--O 1.203 -1.344 0 C-N-CA 116.92 -1.912 . . . . 1.0 108.029 177.632 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 14' ' ' ALA . . . . . 0.502 ' O ' HG23 ' A' ' 18' ' ' VAL . . . -57.44 -62.68 1.6 Allowed 'General case' 0 N--CA 1.479 1.008 0 C-N-CA 118.633 -1.227 . . . . 1.0 110.929 179.013 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 15' ' ' ALA . . . . . 0.549 ' N ' ' O ' ' A' ' 11' ' ' ARG . . . -55.51 -55.8 27.65 Favored 'General case' 0 N--CA 1.47 0.557 0 CA-C-O 121.413 0.625 . . . . 1.0 110.208 -178.473 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 16' ' ' ALA . . . . . 0.531 ' HB3' ' O ' ' A' ' 12' ' ' ALA . . . -58.05 -53.94 52.58 Favored 'General case' 0 C--N 1.317 -0.811 0 N-CA-C 108.138 -1.06 . . . . 1.0 108.138 -179.313 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 17' ' ' LEU . . . . . 0.599 ' CB ' ' O ' ' A' ' 13' ' ' VAL . 39.4 tp -53.86 -48.96 69.48 Favored 'General case' 0 N--CA 1.482 1.135 0 CA-C-N 113.513 -1.676 . . . . 1.0 107.662 -178.059 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 18' ' ' VAL . . . . . 0.502 HG23 ' O ' ' A' ' 14' ' ' ALA . 54.1 t -67.3 -58.4 6.41 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.504 0 CA-C-O 121.076 0.465 . . . . 1.0 110.223 179.94 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 19' ' ' GLY . . . . . 0.528 ' N ' ' O ' ' A' ' 15' ' ' ALA . . . -71.03 -163.96 5.47 Favored Glycine 0 CA--C 1.526 0.765 0 CA-C-N 115.5 -0.773 . . . . 1.0 112.054 -178.64 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 20' ' ' PRO . . . . . 0.571 ' O ' ' N ' ' A' ' 24' ' ' ALA . 57.5 Cg_endo -79.59 -27.23 4.24 Favored 'Trans proline' 0 N--CA 1.492 1.39 0 C-N-CA 122.72 2.28 . . . . 1.0 115.443 -178.098 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -59.0 -58.45 14.52 Favored Glycine 0 N--CA 1.477 1.414 0 C-N-CA 119.097 -1.525 . . . . 1.0 110.965 -177.01 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 22' ' ' GLY . . . . . 0.499 ' N ' ' HB1' ' A' ' 16' ' ' ALA . . . -59.21 -54.91 33.94 Favored Glycine 0 N--CA 1.467 0.749 0 N-CA-C 107.843 -2.103 . . . . 1.0 107.843 -178.387 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 23' ' ' VAL . . . . . 0.557 ' O ' HG12 ' A' ' 27' ' ' VAL . 54.1 t -57.36 -36.96 54.61 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.907 0 CA-C-N 114.721 -0.74 . . . . 1.0 109.814 -179.472 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 24' ' ' ALA . . . . . 0.571 ' N ' ' O ' ' A' ' 20' ' ' PRO . . . -57.66 -60.58 3.46 Favored 'General case' 0 C--N 1.325 -0.483 0 C-N-CA 118.93 -1.108 . . . . 1.0 109.182 -179.851 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 9.3 tp -63.19 -44.05 96.48 Favored 'General case' 0 C--N 1.347 0.47 0 CA-C-N 119.325 0.966 . . . . 1.0 111.73 -178.907 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 72.6 t -61.05 -60.77 2.13 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.176 0 C-N-CA 118.364 -1.334 . . . . 1.0 110.504 -177.748 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 27' ' ' VAL . . . . . 0.603 ' O ' ' HB3' ' A' ' 31' ' ' ALA . 2.4 p -58.57 -37.41 64.78 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.417 0 N-CA-C 113.264 0.838 . . . . 1.0 113.264 -177.539 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 35.9 ttmt -67.67 -53.27 29.13 Favored 'General case' 0 C--N 1.315 -0.899 0 CA-C-O 122.102 0.953 . . . . 1.0 108.811 -178.719 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 80.2 t -63.82 -48.93 84.18 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.074 0 CA-C-N 113.743 -1.571 . . . . 1.0 110.891 -177.542 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 30' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -65.34 -60.88 2.51 Favored 'General case' 0 N--CA 1.449 -0.487 0 C-N-CA 118.868 -1.133 . . . . 1.0 109.496 -179.756 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 31' ' ' ALA . . . . . 0.603 ' HB3' ' O ' ' A' ' 27' ' ' VAL . . . -64.83 -54.44 30.99 Favored 'General case' 0 C--N 1.331 -0.225 0 N-CA-C 113.605 0.965 . . . . 1.0 113.605 -175.901 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 84.36 75.77 1.2 Allowed Glycine 0 CA--C 1.527 0.798 0 N-CA-C 109.421 -1.472 . . . . 1.0 109.421 -177.81 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 33' ' ' LEU . . . . . 0.52 ' O ' ' O ' ' A' ' 36' ' ' VAL . 12.3 mt 85.55 85.37 0.05 OUTLIER Pre-proline 0 N--CA 1.479 0.983 0 C-N-CA 123.711 0.804 . . . . 1.0 110.49 -178.9 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 53.0 Cg_exo -54.93 -30.89 71.13 Favored 'Trans proline' 0 N--CA 1.508 2.342 0 C-N-CA 123.253 2.635 . . . . 1.0 114.307 -179.832 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 35' ' ' GLY . . . . . 0.407 ' C ' HD11 ' A' ' 116' ' ' ILE . . . -58.81 -58.04 16.67 Favored Glycine 0 CA--C 1.525 0.678 0 C-N-CA 118.759 -1.686 . . . . 1.0 109.651 -178.369 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 36' ' ' VAL . . . . . 0.657 ' O ' HG22 ' A' ' 37' ' ' ILE . 7.1 p -97.82 165.27 2.17 Favored 'Isoleucine or valine' 0 C--O 1.219 -0.55 0 N-CA-C 106.71 -1.589 . . . . 1.0 106.71 178.266 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 37' ' ' ILE . . . . . 0.657 HG22 ' O ' ' A' ' 36' ' ' VAL . 8.1 tt 117.82 123.23 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.481 1.097 0 C-N-CA 123.927 0.891 . . . . 1.0 109.596 -179.19 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 21.9 m80 -140.64 131.41 25.81 Favored 'General case' 0 C--N 1.324 -0.513 0 N-CA-C 107.902 -1.147 . . . . 1.0 107.902 178.724 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -90.03 146.45 35.09 Favored Pre-proline 0 C--N 1.33 -0.247 0 N-CA-C 108.955 -0.757 . . . . 1.0 108.955 -179.747 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -72.92 -44.01 0.69 Allowed 'Trans proline' 0 C--N 1.307 -1.619 0 C-N-CA 121.641 1.56 . . . . 1.0 112.579 -179.24 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -126.17 130.06 50.25 Favored 'General case' 0 CA--C 1.518 -0.266 0 CA-C-N 116.254 -0.43 . . . . 1.0 110.118 -179.608 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 42' ' ' ARG . . . . . 0.609 ' C ' ' H ' ' A' ' 44' ' ' GLY . 0.0 OUTLIER -169.49 157.27 7.17 Favored 'General case' 0 C--N 1.313 -0.997 0 N-CA-C 106.016 -1.846 . . . . 1.0 106.016 177.976 . . . . . . . . 3 3 . 1 . 028 nuclear build full ' A' A ' 43' ' ' ARG . . . . . 0.436 ' O ' ' CG ' ' A' ' 43' ' ' ARG . 10.3 ttt85 -64.82 33.81 0.02 OUTLIER 'General case' 0 CA--C 1.529 0.137 0 CA-C-N 119.866 1.212 . . . . 1.0 112.115 -178.266 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 44' ' ' GLY . . . . . 0.609 ' H ' ' C ' ' A' ' 42' ' ' ARG . . . 91.42 -24.3 20.39 Favored Glycine 0 CA--C 1.522 0.484 0 N-CA-C 110.426 -1.069 . . . . 1.0 110.426 179.995 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 45' ' ' PHE . . . . . 0.526 ' CZ ' ' OD2' ' A' ' 57' ' ' ASP . 50.0 p90 -177.49 -178.93 0.79 Allowed 'General case' 0 CA--C 1.54 0.576 0 CA-C-O 120.85 0.357 . . . . 1.0 111.623 -179.941 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER 165.03 15.46 0.0 OUTLIER 'General case' 0 N--CA 1.487 1.389 0 CA-C-N 114.947 -1.024 . . . . 1.0 113.139 177.073 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 47' ' ' ARG . . . . . 0.639 ' O ' ' SG ' ' A' ' 48' ' ' CYS . 2.5 mtp-105 -176.38 -179.12 1.02 Allowed 'General case' 0 C--N 1.315 -0.905 0 N-CA-C 108.591 -0.892 . . . . 1.0 108.591 -179.072 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 48' ' ' CYS . . . . . 0.674 ' O ' ' SG ' ' A' ' 48' ' ' CYS . 1.5 p 61.43 63.49 1.19 Allowed 'General case' 0 C--N 1.341 0.206 0 CA-C-O 121.68 0.752 . . . . 1.0 110.084 -179.326 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -137.14 143.53 42.31 Favored Pre-proline 0 CA--C 1.535 0.39 0 N-CA-C 108.552 -0.907 . . . . 1.0 108.552 179.418 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 50' ' ' PRO . . . . . 0.494 ' HG2' HH11 ' A' ' 52' ' ' ARG . 94.7 Cg_endo -73.01 61.85 3.94 Favored 'Trans proline' 0 N--CA 1.497 1.719 0 C-N-CA 122.251 1.967 . . . . 1.0 112.431 -179.476 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 97.8 mt-10 59.34 6.13 0.71 Allowed 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.975 -0.557 . . . . 1.0 111.84 179.595 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 52' ' ' ARG . . . . . 0.494 HH11 ' HG2' ' A' ' 50' ' ' PRO . 75.0 mtt85 -82.91 139.12 33.58 Favored 'General case' 0 N--CA 1.465 0.291 0 N-CA-C 109.029 -0.73 . . . . 1.0 109.029 177.971 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 53' ' ' ILE . . . . . 0.465 HG23 HG22 ' A' ' 55' ' ' ILE . 13.0 tt -67.42 137.92 23.78 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.276 0 CA-C-O 122.647 1.213 . . . . 1.0 113.691 -177.314 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -64.13 78.59 0.04 OUTLIER 'General case' 0 CA--C 1.545 0.753 0 CA-C-N 112.38 -2.191 . . . . 1.0 108.984 -178.464 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 55' ' ' ILE . . . . . 0.465 HG22 HG23 ' A' ' 53' ' ' ILE . 18.0 tt -148.15 154.96 10.06 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.667 0 CA-C-N 115.997 -0.547 . . . . 1.0 109.99 178.251 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 109.59 -3.46 30.8 Favored Glycine 0 N--CA 1.471 0.998 0 N-CA-C 109.914 -1.274 . . . . 1.0 109.914 -179.594 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 57' ' ' ASP . . . . . 0.526 ' OD2' ' CZ ' ' A' ' 45' ' ' PHE . 37.6 m-20 -83.96 100.93 11.35 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 114.249 -0.975 . . . . 1.0 110.091 179.448 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 58' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -86.52 173.68 9.44 Favored 'General case' 0 N--CA 1.471 0.595 0 CA-C-O 123.65 1.69 . . . . 1.0 113.41 -178.287 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 59' ' ' ARG . . . . . 0.423 HH11 ' HD2' ' A' ' 59' ' ' ARG . 24.9 mtm180 -79.44 -56.23 4.47 Favored 'General case' 0 C--N 1.309 -1.175 0 CA-C-N 110.402 -3.09 . . . . 1.0 112.161 -179.428 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -91.1 -11.73 37.72 Favored 'General case' 0 C--O 1.249 1.046 0 CA-C-N 114.81 -1.086 . . . . 1.0 113.916 -178.372 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 61' ' ' GLU . . . . . 0.405 ' O ' ' N ' ' A' ' 65' ' ' ASP . 9.3 pt-20 -76.57 -13.95 60.04 Favored 'General case' 0 C--N 1.318 -0.784 0 N-CA-C 113.298 0.851 . . . . 1.0 113.298 -177.615 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 62' ' ' VAL . . . . . 0.623 ' O ' ' N ' ' A' ' 66' ' ' GLY . 0.2 OUTLIER -49.52 -58.7 1.25 Allowed 'Isoleucine or valine' 0 C--O 1.207 -1.165 0 C-N-CA 118.857 -1.137 . . . . 1.0 109.209 -175.829 . . . . . . . . 3 3 . 1 . 028 nuclear build full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -66.77 -61.5 1.93 Allowed 'General case' 0 C--N 1.302 -1.459 0 CA-C-O 120.874 0.369 . . . . 1.0 110.907 -179.01 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 2.3 t-80 -48.4 -56.72 7.43 Favored 'General case' 0 CA--C 1.535 0.389 0 C-N-CA 119.419 -0.912 . . . . 1.0 108.93 -178.916 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 65' ' ' ASP . . . . . 0.866 ' O ' HD22 ' A' ' 68' ' ' LEU . 19.2 t70 -70.08 -45.5 66.89 Favored 'General case' 0 C--O 1.207 -1.171 0 CA-C-N 115.072 -0.967 . . . . 1.0 111.197 179.761 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 66' ' ' GLY . . . . . 0.623 ' N ' ' O ' ' A' ' 62' ' ' VAL . . . -77.49 26.35 1.93 Allowed Glycine 0 N--CA 1.471 1.002 0 N-CA-C 111.018 -0.833 . . . . 1.0 111.018 179.715 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 67' ' ' ARG . . . . . 0.438 ' H ' ' C ' ' A' ' 65' ' ' ASP . 57.7 ttt180 -95.76 -9.95 30.4 Favored 'General case' 0 CA--C 1.536 0.406 0 N-CA-C 107.971 -1.122 . . . . 1.0 107.971 172.832 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 68' ' ' LEU . . . . . 0.866 HD22 ' O ' ' A' ' 65' ' ' ASP . 0.0 OUTLIER -69.87 -37.81 76.22 Favored 'General case' 0 C--O 1.197 -1.681 0 CA-C-N 114.303 -1.317 . . . . 1.0 112.974 -178.044 . . . . . . . . 3 3 . 1 . 028 nuclear build full ' A' A ' 69' ' ' LEU . . . . . 0.519 ' O ' ' ND1' ' A' ' 72' ' ' HIS . 7.8 tt -44.81 -58.31 3.19 Favored 'General case' 0 N--CA 1.475 0.794 0 C-N-CA 118.302 -1.359 . . . . 1.0 108.869 -176.121 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 70' ' ' ALA . . . . . 0.578 ' O ' ' CE1' ' A' ' 72' ' ' HIS . . . -51.61 -72.3 0.05 Allowed 'General case' 0 C--N 1.317 -0.837 0 N-CA-C 104.937 -2.246 . . . . 1.0 104.937 177.884 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 71' ' ' ALA . . . . . 0.729 ' O ' ' N ' ' A' ' 73' ' ' MET . . . -64.87 18.21 0.02 OUTLIER 'General case' 0 C--N 1.316 -0.877 0 C-N-CA 128.04 2.536 . . . . 1.0 114.251 178.385 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 72' ' ' HIS . . . . . 0.826 ' N ' ' O ' ' A' ' 68' ' ' LEU . 0.0 OUTLIER -24.78 -17.95 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.557 0 N-CA-C 115.589 1.7 . . . . 1.0 115.589 -174.461 . . . . . . . . 3 3 . 1 . 028 nuclear build full ' A' A ' 73' ' ' MET . . . . . 0.729 ' N ' ' O ' ' A' ' 71' ' ' ALA . 72.5 mtp -73.39 -25.09 60.42 Favored 'General case' 0 CA--C 1.545 0.768 0 CA-C-N 119.986 1.266 . . . . 1.0 108.551 176.965 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 74' ' ' VAL . . . . . 0.725 ' O ' ' N ' ' A' ' 76' ' ' GLY . 90.8 t -61.53 -52.66 58.46 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.672 0 CA-C-N 114.444 -1.253 . . . . 1.0 108.84 178.857 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 75' ' ' ASN . . . . . 0.439 ' O ' HG22 ' A' ' 79' ' ' ILE . 17.3 t30 -32.61 -13.75 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.667 0 N-CA-C 113.444 0.905 . . . . 1.0 113.444 -178.26 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 76' ' ' GLY . . . . . 0.725 ' N ' ' O ' ' A' ' 74' ' ' VAL . . . -50.88 -22.26 5.88 Favored Glycine 0 CA--C 1.539 1.539 0 N-CA-C 109.344 -1.502 . . . . 1.0 109.344 176.045 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 77' ' ' ILE . . . . . 0.566 HG13 ' H ' ' A' ' 78' ' ' VAL . 0.5 OUTLIER -78.0 -63.95 1.0 Allowed 'Isoleucine or valine' 0 C--O 1.218 -0.568 0 CA-C-O 121.947 0.88 . . . . 1.0 109.432 179.203 . . . . . . . . 3 3 . 1 . 028 nuclear build full ' A' A ' 78' ' ' VAL . . . . . 0.566 ' H ' HG13 ' A' ' 77' ' ' ILE . 74.8 t -34.87 -33.66 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.318 -0.766 0 CA-C-N 112.719 -2.037 . . . . 1.0 106.309 -177.105 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 79' ' ' ILE . . . . . 0.622 HD13 ' N ' ' A' ' 80' ' ' ALA . 0.0 OUTLIER -97.39 -34.42 4.82 Favored 'Isoleucine or valine' 0 CA--C 1.569 1.699 0 CA-C-N 115.585 -0.734 . . . . 1.0 111.905 175.134 . . . . . . . . 3 3 . 1 . 028 nuclear build full ' A' A ' 80' ' ' ALA . . . . . 0.622 ' N ' HD13 ' A' ' 79' ' ' ILE . . . -84.82 -10.35 57.26 Favored 'General case' 0 N--CA 1.492 1.642 0 N-CA-C 114.471 1.285 . . . . 1.0 114.471 179.452 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 81' ' ' GLU . . . . . 0.418 ' N ' ' O ' ' A' ' 77' ' ' ILE . 86.6 tt0 -89.4 -70.98 0.63 Allowed 'General case' 0 N--CA 1.438 -1.038 0 O-C-N 121.786 -0.571 . . . . 1.0 111.09 179.775 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 25.4 m-20 -91.02 -15.6 29.32 Favored 'General case' 0 CA--C 1.549 0.923 0 N-CA-C 115.864 1.801 . . . . 1.0 115.864 -178.796 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 83' ' ' ALA . . . . . 0.554 ' O ' ' N ' ' A' ' 85' ' ' ILE . . . -52.84 -42.48 65.21 Favored 'General case' 0 N--CA 1.475 0.779 0 C-N-CA 118.248 -1.381 . . . . 1.0 111.454 -177.863 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 11.2 mp -39.87 -20.83 0.01 OUTLIER 'General case' 0 N--CA 1.469 0.508 0 CA-C-N 118.447 0.567 . . . . 1.0 111.307 -179.049 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 85' ' ' ILE . . . . . 0.554 ' N ' ' O ' ' A' ' 83' ' ' ALA . 54.1 mt -93.43 -34.99 6.13 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.587 -0.279 . . . . 1.0 111.154 -179.866 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 86' ' ' ALA . . . . . 0.822 ' O ' HG22 ' A' ' 89' ' ' VAL . . . -92.91 -26.27 17.68 Favored 'General case' 0 C--O 1.222 -0.371 0 CA-C-O 120.597 0.237 . . . . 1.0 111.582 179.734 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -56.06 -7.12 0.3 Allowed 'General case' 0 C--N 1.328 -0.347 0 C-N-CA 119.73 -0.788 . . . . 1.0 110.418 -178.83 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 88' ' ' ALA . . . . . 0.45 ' H ' ' C ' ' A' ' 86' ' ' ALA . . . -84.17 -2.58 57.1 Favored 'General case' 0 N--CA 1.472 0.663 0 CA-C-O 122.407 1.099 . . . . 1.0 108.79 178.543 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 89' ' ' VAL . . . . . 0.822 HG22 ' O ' ' A' ' 86' ' ' ALA . 3.1 m -97.6 34.9 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.432 0 CA-C-N 113.042 -1.89 . . . . 1.0 110.59 179.098 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 90' ' ' GLY . . . . . 0.551 ' N ' ' CD ' ' A' ' 91' ' ' PRO . . . -78.13 -36.62 30.94 Favored Glycine 0 C--N 1.347 1.194 0 N-CA-C 111.6 -0.6 . . . . 1.0 111.6 178.932 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 91' ' ' PRO . . . . . 0.551 ' CD ' ' N ' ' A' ' 90' ' ' GLY . 93.4 Cg_exo -46.55 -15.11 0.16 Allowed 'Trans proline' 0 N--CA 1.496 1.665 0 C-N-CA 121.872 1.715 . . . . 1.0 109.07 177.913 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 92' ' ' HIS . . . . . 0.612 ' ND1' ' N ' ' A' ' 93' ' ' LEU . 0.0 OUTLIER -56.01 -15.76 3.98 Favored 'General case' 0 N--CA 1.442 -0.875 0 CA-C-N 113.922 -1.49 . . . . 1.0 107.754 179.148 . . . . . . . . 3 3 . 1 . 028 nuclear build full ' A' A ' 93' ' ' LEU . . . . . 0.725 HD12 ' N ' ' A' ' 94' ' ' ALA . 2.1 pp -64.04 -58.22 7.32 Favored 'General case' 0 C--O 1.232 0.14 0 N-CA-C 108.997 -0.742 . . . . 1.0 108.997 176.822 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 94' ' ' ALA . . . . . 0.725 ' N ' HD12 ' A' ' 93' ' ' LEU . . . -57.34 -52.62 64.61 Favored 'General case' 0 CA--C 1.517 -0.323 0 N-CA-C 108.851 -0.796 . . . . 1.0 108.851 179.719 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 95' ' ' ARG . . . . . 0.621 ' O ' ' N ' ' A' ' 97' ' ' LEU . 4.9 tmm_? -60.16 -60.91 3.06 Favored 'General case' 0 N--CA 1.446 -0.628 0 N-CA-C 108.506 -0.924 . . . . 1.0 108.506 -179.792 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 96' ' ' ALA . . . . . 0.986 ' O ' ' N ' ' A' ' 98' ' ' GLY . . . -47.66 -12.09 0.03 OUTLIER 'General case' 0 N--CA 1.432 -1.343 0 O-C-N 118.532 -2.605 . . . . 1.0 111.478 179.484 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 97' ' ' LEU . . . . . 0.706 ' O ' ' N ' ' A' ' 100' ' ' ILE . 7.7 tp 6.87 -48.9 0.0 OUTLIER 'General case' 0 C--N 1.378 1.809 0 CA-C-O 117.584 -1.198 . . . . 1.0 109.937 -166.771 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 98' ' ' GLY . . . . . 0.986 ' N ' ' O ' ' A' ' 96' ' ' ALA . . . -49.57 -24.12 5.32 Favored Glycine 0 CA--C 1.548 2.106 0 CA-C-N 122.507 2.412 . . . . 1.0 107.417 173.493 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 99' ' ' GLN . . . . . 0.563 ' O ' ' S1 ' ' A' ' 130' ' ' MTN . 12.3 mt-30 -64.36 -19.38 65.44 Favored 'General case' 0 C--N 1.379 1.878 0 C-N-CA 117.324 -1.75 . . . . 1.0 107.058 176.829 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 100' ' ' ILE . . . . . 0.706 ' N ' ' O ' ' A' ' 97' ' ' LEU . 1.5 tp -65.3 -39.22 84.66 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.817 0 N-CA-C 108.228 -1.027 . . . . 1.0 108.228 179.724 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 101' ' ' VAL . . . . . 0.723 ' O ' ' N ' ' A' ' 105' ' ' GLY . 97.7 t -59.19 -62.72 0.91 Allowed 'Isoleucine or valine' 0 C--O 1.217 -0.627 0 C-N-CA 119.537 -0.865 . . . . 1.0 110.59 -178.44 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 102' ' ' CYS . . . . . 0.879 ' O ' ' HB2' ' A' ' 106' ' ' ALA . 0.5 OUTLIER -48.26 -18.63 0.23 Allowed 'General case' 0 N--CA 1.477 0.883 0 C-N-CA 119.093 -1.043 . . . . 1.0 110.826 -178.31 . . . . . . . . 3 3 . 1 . 028 nuclear build full ' A' A ' 103' ' ' ARG . . . . . 0.497 HH11 ' CG ' ' A' ' 103' ' ' ARG . 0.0 OUTLIER -88.63 -49.3 6.96 Favored 'General case' 0 N--CA 1.479 1.014 0 CA-C-O 121.783 0.802 . . . . 1.0 112.071 177.638 . . . . . . . . 3 3 . 1 . 028 nuclear build full ' A' A ' 104' ' ' TYR . . . . . . . . . . . . . 22.8 t80 -105.84 21.53 17.12 Favored 'General case' 0 N--CA 1.472 0.644 0 C-N-CA 125.935 1.694 . . . . 1.0 111.413 178.43 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 105' ' ' GLY . . . . . 0.723 ' N ' ' O ' ' A' ' 101' ' ' VAL . . . -159.33 -8.32 0.05 OUTLIER Glycine 0 CA--C 1.527 0.835 0 C-N-CA 120.394 -0.907 . . . . 1.0 112.081 -179.791 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 106' ' ' ALA . . . . . 0.879 ' HB2' ' O ' ' A' ' 102' ' ' CYS . . . -29.03 114.16 0.09 Allowed 'General case' 0 N--CA 1.466 0.327 0 N-CA-C 112.209 0.448 . . . . 1.0 112.209 179.51 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 107' ' ' THR . . . . . 0.607 ' C ' ' H ' ' A' ' 109' ' ' ILE . 26.7 m -134.55 -62.64 0.73 Allowed 'General case' 0 C--O 1.224 -0.247 0 N-CA-C 105.609 -1.997 . . . . 1.0 105.609 176.782 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 108' ' ' VAL . . . . . 0.631 ' O ' HG22 ' A' ' 108' ' ' VAL . 12.7 p -64.44 23.25 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.437 -1.078 0 O-C-N 121.792 -0.568 . . . . 1.0 109.539 179.33 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 109' ' ' ILE . . . . . 0.628 ' H ' ' HD2' ' A' ' 110' ' ' PRO . 0.1 OUTLIER -115.81 -53.98 0.04 OUTLIER Pre-proline 0 CA--C 1.562 1.405 0 N-CA-C 107.708 -1.219 . . . . 1.0 107.708 174.658 . . . . . . . . 3 3 . 1 . 028 nuclear build full ' A' A ' 110' ' ' PRO . . . . . 0.628 ' HD2' ' H ' ' A' ' 109' ' ' ILE . 18.3 Cg_endo -52.85 -36.65 75.04 Favored 'Trans proline' 0 N--CA 1.51 2.446 0 CA-C-N 121.92 1.721 . . . . 1.0 112.199 175.869 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 111' ' ' ASN . . . . . 0.429 ' C ' ' N ' ' A' ' 113' ' ' ASN . 6.2 t30 -68.25 -68.42 0.39 Allowed 'General case' 0 C--N 1.328 -0.356 0 C-N-CA 119.448 -0.901 . . . . 1.0 110.106 -177.907 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 112' ' ' ILE . . . . . 0.448 ' O ' ' N ' ' A' ' 116' ' ' ILE . 3.9 pt -51.0 -25.99 4.01 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.263 0 CA-C-O 123.07 1.414 . . . . 1.0 108.098 179.262 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 113' ' ' ASN . . . . . 0.558 ' ND2' ' OE2' ' A' ' 117' ' ' GLU . 15.4 t-20 -59.21 -52.37 65.96 Favored 'General case' 0 C--N 1.306 -1.286 0 CA-C-N 111.987 -2.369 . . . . 1.0 107.982 -177.886 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 114' ' ' ALA . . . . . 0.54 ' O ' HG23 ' A' ' 118' ' ' VAL . . . -64.08 -31.17 72.26 Favored 'General case' 0 C--N 1.323 -0.562 0 N-CA-C 113.103 0.779 . . . . 1.0 113.103 179.675 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 115' ' ' ALA . . . . . 0.454 ' O ' ' N ' ' A' ' 119' ' ' LEU . . . -85.15 -58.42 2.69 Favored 'General case' 0 N--CA 1.476 0.848 0 CA-C-N 119.36 0.982 . . . . 1.0 111.655 178.494 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 116' ' ' ILE . . . . . 0.448 ' N ' ' O ' ' A' ' 112' ' ' ILE . 31.2 mt -51.11 -57.71 2.67 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.402 0 N-CA-C 107.217 -1.401 . . . . 1.0 107.217 -178.375 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 117' ' ' GLU . . . . . 0.558 ' OE2' ' ND2' ' A' ' 113' ' ' ASN . 56.0 mt-10 -51.68 -50.37 60.56 Favored 'General case' 0 C--N 1.307 -1.277 0 CA-C-N 112.771 -2.013 . . . . 1.0 107.056 -179.15 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 118' ' ' VAL . . . . . 0.54 HG23 ' O ' ' A' ' 114' ' ' ALA . 17.0 t -59.83 -28.86 41.79 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.8 0 C-N-CA 119.642 -0.823 . . . . 1.0 110.021 178.378 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 119' ' ' LEU . . . . . 0.454 ' N ' ' O ' ' A' ' 115' ' ' ALA . 3.9 tt -78.42 -61.58 1.96 Allowed 'General case' 0 C--N 1.354 0.8 0 CA-C-N 120.396 1.453 . . . . 1.0 107.466 177.962 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 120' ' ' GLY . . . . . 0.444 ' C ' ' OG1' ' A' ' 121' ' ' THR . . . -64.31 -82.25 0.1 Allowed Glycine 0 C--N 1.358 1.771 0 C-N-CA 119.036 -1.554 . . . . 1.0 109.299 178.291 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 121' ' ' THR . . . . . 0.491 ' OG1' HG22 ' A' ' 123' ' ' THR . 0.0 OUTLIER 167.76 -38.85 0.0 OUTLIER 'General case' 0 CA--C 1.542 0.659 0 CA-C-N 113.968 -1.116 . . . . 1.0 113.041 178.817 . . . . . . . . 3 3 . 1 . 028 nuclear build full ' A' A ' 122' ' ' GLY . . . . . 0.643 ' O ' ' N ' ' A' ' 124' ' ' ASP . . . 103.28 -15.91 53.74 Favored Glycine 0 N--CA 1.478 1.475 0 N-CA-C 107.243 -2.343 . . . . 1.0 107.243 -176.345 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 123' ' ' THR . . . . . 0.538 HG23 ' O ' ' A' ' 123' ' ' THR . 9.1 t -58.38 81.19 0.01 OUTLIER 'General case' 0 CA--C 1.545 0.787 0 CA-C-N 111.272 -2.464 . . . . 1.0 105.36 178.279 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 124' ' ' ASP . . . . . 0.643 ' N ' ' O ' ' A' ' 122' ' ' GLY . 35.8 m-20 -165.39 174.55 9.94 Favored 'General case' 0 N--CA 1.475 0.79 0 CA-C-N 112.818 -1.992 . . . . 1.0 112.457 179.989 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 125' ' ' TYR . . . . . . . . . . . . . 6.1 t80 -142.85 138.83 30.58 Favored 'General case' 0 CA--C 1.54 0.596 0 N-CA-C 107.655 -1.239 . . . . 1.0 107.655 175.588 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 9.6 tpt180 -149.88 153.12 36.19 Favored 'General case' 0 N--CA 1.467 0.39 0 N-CA-C 110.236 -0.283 . . . . 1.0 110.236 178.075 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 127' ' ' PHE . . . . . . . . . . . . . 22.4 p90 . . . . . 0 N--CA 1.469 0.486 0 CA-C-O 118.034 -0.984 . . . . 1.0 110.743 179.926 . . . . . . . . 0 0 . 1 . 028 nuclear build full ' A' A ' 128' ' ' MTN . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 028 nuclear build full ' A' A ' 129' ' ' MTN . . . . . 0.639 ' H62' ' SG ' ' A' ' 48' ' ' CYS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 130' ' ' MTN . . . . . 0.563 ' S1 ' ' O ' ' A' ' 99' ' ' GLN . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 4.6 tpp . . . . . 0 N--CA 1.489 1.498 0 N-CA-C 109.194 -0.669 . . . . 1.0 109.194 . . . . . . . . . 0 0 . 1 . 029 nuclear build full ' A' A ' 2' ' ' SER . . . . . 0.484 ' O ' ' CB ' ' A' ' 3' ' ' ASP . 87.7 p -89.61 12.42 16.82 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.877 -0.602 . . . . 1.0 110.499 -179.951 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 3' ' ' ASP . . . . . 0.484 ' CB ' ' O ' ' A' ' 2' ' ' SER . 4.7 t0 151.22 116.58 0.0 OUTLIER 'General case' 0 N--CA 1.473 0.699 0 O-C-N 124.075 0.86 . . . . 1.0 109.963 178.606 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 4' ' ' PHE . . . . . 0.434 ' O ' ' OD1' ' A' ' 5' ' ' ASP . 13.8 t80 -152.38 148.05 27.02 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.645 -0.707 . . . . 1.0 110.305 179.559 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 5' ' ' ASP . . . . . 0.434 ' OD1' ' O ' ' A' ' 4' ' ' PHE . 2.2 m-20 -154.78 151.52 28.78 Favored 'General case' 0 C--O 1.234 0.242 0 N-CA-C 109.703 -0.48 . . . . 1.0 109.703 179.634 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 6' ' ' THR . . . . . 0.416 ' C ' ' O ' ' A' ' 5' ' ' ASP . 3.0 m -38.76 143.07 0.16 Allowed 'General case' 0 N--CA 1.467 0.4 0 N-CA-C 109.53 -0.544 . . . . 1.0 109.53 179.994 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 35.9 tt0 -47.27 -52.4 16.27 Favored 'General case' 0 C--N 1.316 -0.86 0 CA-C-O 118.347 -0.835 . . . . 1.0 112.698 -174.934 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 8' ' ' ARG . . . . . 0.524 ' O ' ' HB3' ' A' ' 12' ' ' ALA . 24.3 ptt180 -63.48 -35.5 80.66 Favored 'General case' 0 N--CA 1.447 -0.59 0 CA-C-N 120.824 1.647 . . . . 1.0 109.816 179.022 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 9' ' ' VAL . . . . . 0.658 ' O ' HG23 ' A' ' 13' ' ' VAL . 93.6 t -62.34 -52.23 62.58 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.714 0 C-N-CA 118.665 -1.214 . . . . 1.0 108.009 178.481 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 80.0 p -67.61 -38.72 84.35 Favored 'General case' 0 CA--C 1.543 0.696 0 N-CA-C 113.353 0.872 . . . . 1.0 113.353 179.384 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 11' ' ' ARG . . . . . 0.596 ' O ' ' N ' ' A' ' 14' ' ' ALA . 5.0 tpp180 -75.77 -63.0 1.4 Allowed 'General case' 0 N--CA 1.472 0.649 0 CA-C-O 122.335 1.064 . . . . 1.0 109.098 178.039 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 12' ' ' ALA . . . . . 0.621 ' O ' ' HB3' ' A' ' 16' ' ' ALA . . . -46.67 -37.56 8.48 Favored 'General case' 0 N--CA 1.474 0.762 0 CA-C-N 112.724 -2.034 . . . . 1.0 105.955 -175.323 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 13' ' ' VAL . . . . . 0.658 HG23 ' O ' ' A' ' 9' ' ' VAL . 11.9 t -59.8 -50.84 78.53 Favored 'Isoleucine or valine' 0 C--O 1.206 -1.215 0 C-N-CA 118.574 -1.25 . . . . 1.0 107.869 175.68 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 14' ' ' ALA . . . . . 0.596 ' N ' ' O ' ' A' ' 11' ' ' ARG . . . -60.85 -63.59 1.24 Allowed 'General case' 0 C--O 1.219 -0.531 0 C-N-CA 118.717 -1.193 . . . . 1.0 111.235 179.178 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 15' ' ' ALA . . . . . 0.495 ' O ' ' N ' ' A' ' 19' ' ' GLY . . . -52.48 -54.93 25.96 Favored 'General case' 0 N--CA 1.479 1.003 0 CA-C-O 121.826 0.822 . . . . 1.0 110.143 -176.735 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 16' ' ' ALA . . . . . 0.621 ' HB3' ' O ' ' A' ' 12' ' ' ALA . . . -61.97 -53.36 56.77 Favored 'General case' 0 C--N 1.308 -1.201 0 CA-C-N 113.877 -1.511 . . . . 1.0 108.685 -179.239 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 17' ' ' LEU . . . . . 0.599 ' CB ' ' O ' ' A' ' 13' ' ' VAL . 3.1 tp -57.06 -51.75 68.02 Favored 'General case' 0 N--CA 1.479 1.016 0 C-N-CA 118.944 -1.102 . . . . 1.0 109.083 -177.336 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 18' ' ' VAL . . . . . 0.574 HG13 ' O ' ' A' ' 14' ' ' ALA . 3.2 m -68.78 -56.5 11.95 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.269 0 C-N-CA 119.04 -1.064 . . . . 1.0 108.864 179.397 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 19' ' ' GLY . . . . . 0.559 ' N ' HG23 ' A' ' 18' ' ' VAL . . . -60.73 -169.25 0.51 Allowed Glycine 0 CA--C 1.532 1.133 0 N-CA-C 111.786 -0.526 . . . . 1.0 111.786 179.881 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 20' ' ' PRO . . . . . 0.611 ' O ' ' N ' ' A' ' 24' ' ' ALA . 27.7 Cg_endo -81.57 -32.89 0.76 Allowed 'Trans proline' 0 N--CA 1.493 1.49 0 C-N-CA 123.323 2.682 . . . . 1.0 115.154 -178.656 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -57.64 -57.29 20.59 Favored Glycine 0 N--CA 1.479 1.539 0 C-N-CA 120.246 -0.978 . . . . 1.0 111.623 -176.565 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 22' ' ' GLY . . . . . 0.584 ' CA ' ' HB1' ' A' ' 16' ' ' ALA . . . -56.69 -50.47 63.11 Favored Glycine 0 N--CA 1.472 1.039 0 N-CA-C 107.075 -2.41 . . . . 1.0 107.075 -178.17 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 23' ' ' VAL . . . . . 0.526 ' O ' HG12 ' A' ' 27' ' ' VAL . 41.8 t -61.7 -34.95 64.56 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.051 0 CA-C-N 114.834 -0.683 . . . . 1.0 109.85 179.371 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 24' ' ' ALA . . . . . 0.611 ' N ' ' O ' ' A' ' 20' ' ' PRO . . . -57.07 -61.14 2.66 Favored 'General case' 0 N--CA 1.454 -0.231 0 C-N-CA 118.978 -1.089 . . . . 1.0 109.404 -179.145 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 8.4 tt -65.98 -42.48 89.8 Favored 'General case' 0 C--N 1.342 0.283 0 C-N-CA 119.657 -0.817 . . . . 1.0 111.922 -178.715 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 59.3 t -59.37 -58.69 5.88 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.182 0 C-N-CA 118.472 -1.291 . . . . 1.0 109.501 -178.017 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 27' ' ' VAL . . . . . 0.526 HG12 ' O ' ' A' ' 23' ' ' VAL . 1.8 p -63.4 -36.75 77.4 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.454 0 N-CA-C 112.953 0.723 . . . . 1.0 112.953 -177.706 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 24.7 tttm -64.68 -53.28 49.91 Favored 'General case' 0 C--N 1.324 -0.533 0 N-CA-C 108.293 -1.003 . . . . 1.0 108.293 -178.597 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 74.1 t -59.65 -44.83 94.33 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.829 0 CA-C-N 114.523 -1.217 . . . . 1.0 109.906 -178.81 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 30' ' ' CYS . . . . . 0.566 ' SG ' ' N ' ' A' ' 31' ' ' ALA . 0.5 OUTLIER -64.56 -57.25 9.67 Favored 'General case' 0 CA--C 1.539 0.543 0 C-N-CA 118.43 -1.308 . . . . 1.0 109.143 -179.804 . . . . . . . . 3 3 . 1 . 029 nuclear build full ' A' A ' 31' ' ' ALA . . . . . 0.566 ' N ' ' SG ' ' A' ' 30' ' ' CYS . . . -64.35 -56.09 16.74 Favored 'General case' 0 N--CA 1.468 0.436 0 N-CA-C 116.276 1.954 . . . . 1.0 116.276 -175.984 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 32' ' ' GLY . . . . . 0.472 ' O ' ' HB2' ' A' ' 33' ' ' LEU . . . 81.5 73.44 1.2 Allowed Glycine 0 CA--C 1.537 1.425 0 N-CA-C 108.694 -1.762 . . . . 1.0 108.694 -175.539 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 33' ' ' LEU . . . . . 0.472 ' HB2' ' O ' ' A' ' 32' ' ' GLY . 15.8 mt 81.34 110.04 0.03 OUTLIER Pre-proline 0 N--CA 1.486 1.345 0 C-N-CA 124.68 1.192 . . . . 1.0 111.745 -178.657 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 52.4 Cg_exo -54.62 -14.48 7.45 Favored 'Trans proline' 0 N--CA 1.507 2.308 0 C-N-CA 122.348 2.032 . . . . 1.0 113.325 178.355 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -56.46 -55.87 27.43 Favored Glycine 0 CA--C 1.534 1.236 0 C-N-CA 119.159 -1.496 . . . . 1.0 109.588 -178.458 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 36' ' ' VAL . . . . . 0.832 HG13 ' H ' ' A' ' 37' ' ' ILE . 6.1 p -69.78 -70.08 0.25 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.5 0 N-CA-C 112.958 0.725 . . . . 1.0 112.958 -177.53 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 37' ' ' ILE . . . . . 0.832 ' H ' HG13 ' A' ' 36' ' ' VAL . 53.1 mt 9.46 68.16 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.486 1.373 0 N-CA-C 114.035 1.124 . . . . 1.0 114.035 -178.061 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 38' ' ' HIS . . . . . 0.433 ' O ' ' CG ' ' A' ' 38' ' ' HIS . 0.0 OUTLIER -131.75 118.47 19.99 Favored 'General case' 0 N--CA 1.447 -0.587 0 CA-C-N 122.161 2.255 . . . . 1.0 106.477 177.484 . . . . . . . . 3 3 . 1 . 029 nuclear build full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 3.9 m -101.88 122.65 46.59 Favored Pre-proline 0 C--N 1.323 -0.56 0 C-N-CA 120.478 -0.489 . . . . 1.0 110.508 -178.684 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 58.3 Cg_exo -48.85 -37.43 36.15 Favored 'Trans proline' 0 N--CA 1.491 1.346 0 C-N-CA 121.133 1.222 . . . . 1.0 112.829 179.896 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -124.71 131.03 53.49 Favored 'General case' 0 N--CA 1.467 0.379 0 N-CA-C 109.831 -0.433 . . . . 1.0 109.831 178.479 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 42' ' ' ARG . . . . . 0.671 ' C ' ' H ' ' A' ' 44' ' ' GLY . 28.7 ptt-85 -168.27 165.57 12.93 Favored 'General case' 0 C--N 1.322 -0.614 0 C-N-CA 119.608 -0.837 . . . . 1.0 110.628 178.094 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 43' ' ' ARG . . . . . 0.41 ' O ' ' HG2' ' A' ' 43' ' ' ARG . 21.1 ttt180 -65.63 17.75 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.464 0 N-CA-C 108.795 -0.817 . . . . 1.0 108.795 179.206 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 44' ' ' GLY . . . . . 0.671 ' H ' ' C ' ' A' ' 42' ' ' ARG . . . 82.91 -24.59 5.14 Favored Glycine 0 N--CA 1.447 -0.627 0 N-CA-C 110.857 -0.897 . . . . 1.0 110.857 -179.947 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 45' ' ' PHE . . . . . 0.653 ' N ' ' CD1' ' A' ' 45' ' ' PHE . 0.0 OUTLIER -163.78 164.1 23.78 Favored 'General case' 0 CA--C 1.551 1.008 0 CA-C-N 116.98 0.39 . . . . 1.0 110.137 -178.633 . . . . . . . . 3 3 . 1 . 029 nuclear build full ' A' A ' 46' ' ' PHE . . . . . 0.576 ' N ' ' HE ' ' A' ' 47' ' ' ARG . 0.6 OUTLIER 144.01 4.31 0.0 OUTLIER 'General case' 0 N--CA 1.505 2.297 0 O-C-N 125.065 1.478 . . . . 1.0 111.92 177.531 . . . . . . . . 3 3 . 1 . 029 nuclear build full ' A' A ' 47' ' ' ARG . . . . . 0.576 ' HE ' ' N ' ' A' ' 46' ' ' PHE . 0.0 OUTLIER -117.27 -149.49 0.44 Allowed 'General case' 0 N--CA 1.472 0.65 0 CA-C-N 117.912 0.324 . . . . 1.0 110.182 -179.183 . . . . . . . . 3 3 . 1 . 029 nuclear build full ' A' A ' 48' ' ' CYS . . . . . 0.537 ' C ' ' O ' ' A' ' 47' ' ' ARG . 25.8 p -15.32 93.98 0.01 OUTLIER 'General case' 0 N--CA 1.484 1.239 0 O-C-N 124.346 1.029 . . . . 1.0 110.456 179.872 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 49' ' ' ASN . . . . . 0.507 ' ND2' ' O ' ' A' ' 52' ' ' ARG . 0.1 OUTLIER -123.31 140.73 34.43 Favored Pre-proline 0 CA--C 1.541 0.607 0 N-CA-C 108.746 -0.835 . . . . 1.0 108.746 -178.1 . . . . . . . . 3 3 . 1 . 029 nuclear build full ' A' A ' 50' ' ' PRO . . . . . 0.48 ' C ' ' H ' ' A' ' 52' ' ' ARG . 64.9 Cg_endo -73.44 59.91 4.03 Favored 'Trans proline' 0 N--CA 1.493 1.445 0 C-N-CA 121.613 1.542 . . . . 1.0 112.047 -179.861 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 20.8 mp0 68.04 -24.85 0.13 Allowed 'General case' 0 N--CA 1.469 0.478 0 CA-C-N 115.677 -0.692 . . . . 1.0 112.055 179.614 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 52' ' ' ARG . . . . . 0.507 ' O ' ' ND2' ' A' ' 49' ' ' ASN . 47.1 mmt-85 -59.24 174.95 0.35 Allowed 'General case' 0 CA--C 1.518 -0.252 0 C-N-CA 120.299 -0.561 . . . . 1.0 109.731 -179.928 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -99.15 145.31 10.54 Favored 'Isoleucine or valine' 0 C--O 1.232 0.133 0 CA-C-O 122.133 0.968 . . . . 1.0 111.141 -179.199 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 54' ' ' GLN . . . . . 0.613 ' H ' ' CD ' ' A' ' 54' ' ' GLN . 0.0 OUTLIER -63.91 79.27 0.03 OUTLIER 'General case' 0 C--N 1.316 -0.862 0 CA-C-N 113.345 -1.752 . . . . 1.0 110.363 -177.532 . . . . . . . . 3 3 . 1 . 029 nuclear build full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -148.91 156.51 7.76 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.412 0 N-CA-C 108.984 -0.747 . . . . 1.0 108.984 176.914 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 56' ' ' GLY . . . . . 0.567 ' O ' ' CD1' ' A' ' 58' ' ' TRP . . . 110.17 -4.99 30.17 Favored Glycine 0 N--CA 1.469 0.891 0 N-CA-C 109.767 -1.333 . . . . 1.0 109.767 -178.821 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 57' ' ' ASP . . . . . 0.533 ' OD1' ' N ' ' A' ' 57' ' ' ASP . 12.7 p-10 -80.02 98.54 7.25 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 114.914 -0.643 . . . . 1.0 109.469 178.885 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 58' ' ' TRP . . . . . 0.567 ' CD1' ' O ' ' A' ' 56' ' ' GLY . 18.4 m95 -84.84 176.79 8.28 Favored 'General case' 0 N--CA 1.464 0.239 0 CA-C-O 122.561 1.172 . . . . 1.0 113.084 -178.521 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 1.3 mpp_? -90.11 -60.06 2.03 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 112.26 -2.246 . . . . 1.0 111.494 179.781 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -90.68 -18.18 25.51 Favored 'General case' 0 N--CA 1.48 1.069 0 N-CA-C 113.925 1.083 . . . . 1.0 113.925 -179.462 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 3.4 tt0 -82.66 -13.91 55.6 Favored 'General case' 0 C--N 1.318 -0.784 0 O-C-N 121.397 -0.815 . . . . 1.0 110.719 -179.48 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 62' ' ' VAL . . . . . 0.655 ' O ' ' N ' ' A' ' 66' ' ' GLY . 28.2 m -51.51 -54.58 11.55 Favored 'Isoleucine or valine' 0 C--O 1.203 -1.377 0 C-N-CA 120.263 -0.575 . . . . 1.0 111.212 -176.77 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 63' ' ' ALA . . . . . 0.625 ' N ' HG23 ' A' ' 62' ' ' VAL . . . -71.25 -53.84 12.96 Favored 'General case' 0 C--N 1.315 -0.894 0 CA-C-N 119.59 1.086 . . . . 1.0 109.282 -177.747 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 64' ' ' HIS . . . . . 0.741 ' CD2' HH12 ' A' ' 67' ' ' ARG . 0.5 OUTLIER -45.2 -54.61 6.73 Favored 'General case' 0 CA--C 1.536 0.409 0 N-CA-C 107.969 -1.123 . . . . 1.0 107.969 179.157 . . . . . . . . 3 3 . 1 . 029 nuclear build full ' A' A ' 65' ' ' ASP . . . . . 0.562 ' C ' ' H ' ' A' ' 67' ' ' ARG . 11.1 t70 -73.83 -49.07 26.94 Favored 'General case' 0 C--N 1.314 -0.975 0 CA-C-N 114.428 -1.26 . . . . 1.0 111.16 179.343 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 66' ' ' GLY . . . . . 0.655 ' N ' ' O ' ' A' ' 62' ' ' VAL . . . -75.13 26.81 1.19 Allowed Glycine 0 C--N 1.317 -0.509 0 N-CA-C 109.88 -1.288 . . . . 1.0 109.88 177.41 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 67' ' ' ARG . . . . . 0.741 HH12 ' CD2' ' A' ' 64' ' ' HIS . 21.5 mtt85 -71.57 8.2 1.19 Allowed 'General case' 0 CA--C 1.504 -0.826 0 N-CA-C 105.22 -2.141 . . . . 1.0 105.22 173.629 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 68' ' ' LEU . . . . . 0.654 ' H ' ' C ' ' A' ' 66' ' ' GLY . 1.5 pp -32.27 -29.83 0.01 OUTLIER 'General case' 0 C--N 1.347 0.498 0 O-C-N 124.112 0.883 . . . . 1.0 108.982 -177.252 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 69' ' ' LEU . . . . . 0.631 ' N ' ' O ' ' A' ' 67' ' ' ARG . 2.1 tt -62.38 -64.36 0.95 Allowed 'General case' 0 C--N 1.321 -0.632 0 C-N-CA 119.095 -1.042 . . . . 1.0 108.423 177.14 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 70' ' ' ALA . . . . . 0.592 ' O ' ' N ' ' A' ' 72' ' ' HIS . . . -77.45 -73.17 0.32 Allowed 'General case' 0 N--CA 1.47 0.537 0 N-CA-C 104.319 -2.475 . . . . 1.0 104.319 176.161 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 71' ' ' ALA . . . . . 0.504 ' O ' ' C ' ' A' ' 72' ' ' HIS . . . -41.22 2.8 0.0 OUTLIER 'General case' 0 C--N 1.322 -0.619 0 N-CA-C 115.533 1.679 . . . . 1.0 115.533 179.77 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 72' ' ' HIS . . . . . 0.633 ' CD2' ' H ' ' A' ' 73' ' ' MET . 1.9 p-80 -29.06 -63.84 0.11 Allowed 'General case' 0 N--CA 1.47 0.528 0 CA-C-N 120.6 1.545 . . . . 1.0 112.458 -176.29 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 73' ' ' MET . . . . . 0.633 ' H ' ' CD2' ' A' ' 72' ' ' HIS . 0.0 OUTLIER -71.72 -48.69 45.43 Favored 'General case' 0 C--N 1.325 -0.473 0 C-N-CA 119.236 -0.986 . . . . 1.0 109.84 177.765 . . . . . . . . 3 3 . 1 . 029 nuclear build full ' A' A ' 74' ' ' VAL . . . . . 0.746 ' O ' ' N ' ' A' ' 76' ' ' GLY . 58.0 t -45.62 -43.32 3.93 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.387 0 CA-C-O 117.397 -1.287 . . . . 1.0 112.08 -175.843 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 75' ' ' ASN . . . . . 0.424 ' O ' ' N ' ' A' ' 78' ' ' VAL . 16.2 t30 -35.75 -12.17 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.613 0 CA-C-N 121.265 1.848 . . . . 1.0 112.467 178.549 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 76' ' ' GLY . . . . . 0.746 ' N ' ' O ' ' A' ' 74' ' ' VAL . . . -46.04 -25.02 1.58 Allowed Glycine 0 CA--C 1.54 1.654 0 N-CA-C 108.349 -1.9 . . . . 1.0 108.349 176.721 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 77' ' ' ILE . . . . . 0.56 ' O ' ' N ' ' A' ' 80' ' ' ALA . 5.5 pt -63.24 -54.76 28.98 Favored 'Isoleucine or valine' 0 C--O 1.219 -0.511 0 N-CA-C 107.873 -1.158 . . . . 1.0 107.873 178.421 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 78' ' ' VAL . . . . . 0.471 ' C ' ' O ' ' A' ' 77' ' ' ILE . 59.7 t -36.04 -33.07 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.316 -0.885 0 CA-C-N 112.186 -2.279 . . . . 1.0 106.962 -177.108 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 79' ' ' ILE . . . . . 0.716 ' O ' ' HB2' ' A' ' 83' ' ' ALA . 0.0 OUTLIER -98.39 -33.44 4.18 Favored 'Isoleucine or valine' 0 CA--C 1.556 1.178 0 CA-C-N 115.795 -0.639 . . . . 1.0 111.018 177.828 . . . . . . . . 3 3 . 1 . 029 nuclear build full ' A' A ' 80' ' ' ALA . . . . . 0.56 ' N ' ' O ' ' A' ' 77' ' ' ILE . . . -84.86 -13.37 51.16 Favored 'General case' 0 N--CA 1.48 1.048 0 N-CA-C 114.842 1.423 . . . . 1.0 114.842 -179.096 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 81' ' ' GLU . . . . . 0.452 ' N ' ' O ' ' A' ' 77' ' ' ILE . 41.8 mt-10 -88.48 -67.33 0.84 Allowed 'General case' 0 CA--C 1.506 -0.724 0 O-C-N 121.656 -0.652 . . . . 1.0 109.383 178.098 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 82' ' ' ASP . . . . . 0.541 ' O ' ' N ' ' A' ' 84' ' ' LEU . 24.3 t0 -73.25 -13.92 61.23 Favored 'General case' 0 N--CA 1.442 -0.858 0 CA-C-N 119.043 0.838 . . . . 1.0 111.908 179.792 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 83' ' ' ALA . . . . . 0.737 ' HA ' ' HB3' ' A' ' 86' ' ' ALA . . . -20.47 -47.2 0.01 OUTLIER 'General case' 0 N--CA 1.478 0.96 0 CA-C-N 118.39 0.541 . . . . 1.0 112.032 178.221 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 84' ' ' LEU . . . . . 0.541 ' N ' ' O ' ' A' ' 82' ' ' ASP . 3.7 mm? -34.29 -35.91 0.04 OUTLIER 'General case' 0 N--CA 1.478 0.949 0 N-CA-C 113.209 0.818 . . . . 1.0 113.209 -178.163 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 85' ' ' ILE . . . . . 0.417 HD12 ' HA ' ' A' ' 85' ' ' ILE . 11.2 tp -100.42 -36.86 5.28 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.66 0 N-CA-C 108.548 -0.908 . . . . 1.0 108.548 177.88 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 86' ' ' ALA . . . . . 0.737 ' HB3' ' HA ' ' A' ' 83' ' ' ALA . . . -61.21 -58.82 6.73 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 114.426 -1.261 . . . . 1.0 109.132 179.973 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 87' ' ' GLU . . . . . 0.408 ' N ' ' O ' ' A' ' 83' ' ' ALA . 2.5 tt0 -71.5 24.04 0.04 OUTLIER 'General case' 0 CA--C 1.542 0.642 0 O-C-N 121.321 -0.862 . . . . 1.0 112.364 -178.931 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 88' ' ' ALA . . . . . 0.43 ' H ' ' C ' ' A' ' 86' ' ' ALA . . . -126.64 -16.63 5.23 Favored 'General case' 0 N--CA 1.478 0.971 0 CA-C-O 122.213 1.006 . . . . 1.0 108.999 179.131 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 21.2 m -101.48 33.89 0.37 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.456 0 CA-C-N 113.406 -1.724 . . . . 1.0 109.09 178.328 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 90' ' ' GLY . . . . . 0.595 ' C ' ' H ' ' A' ' 92' ' ' HIS . . . -69.3 -35.45 76.69 Favored Glycine 0 C--N 1.345 1.044 0 N-CA-C 111.16 -0.776 . . . . 1.0 111.16 179.009 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 91' ' ' PRO . . . . . 0.583 ' CD ' ' N ' ' A' ' 90' ' ' GLY . 89.4 Cg_exo -48.35 -8.08 0.06 OUTLIER 'Trans proline' 0 N--CA 1.498 1.746 0 C-N-CA 122.002 1.801 . . . . 1.0 110.702 177.897 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 92' ' ' HIS . . . . . 0.601 ' ND1' ' N ' ' A' ' 93' ' ' LEU . 0.9 OUTLIER -57.54 -20.11 29.56 Favored 'General case' 0 N--CA 1.444 -0.746 0 N-CA-C 107.771 -1.196 . . . . 1.0 107.771 179.367 . . . . . . . . 3 3 . 1 . 029 nuclear build full ' A' A ' 93' ' ' LEU . . . . . 0.693 HD12 ' N ' ' A' ' 94' ' ' ALA . 2.2 pp -65.63 -58.09 6.56 Favored 'General case' 0 N--CA 1.451 -0.393 0 N-CA-C 108.507 -0.923 . . . . 1.0 108.507 178.507 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 94' ' ' ALA . . . . . 0.693 ' N ' HD12 ' A' ' 93' ' ' LEU . . . -55.11 -54.21 46.03 Favored 'General case' 0 N--CA 1.452 -0.336 0 N-CA-C 108.962 -0.755 . . . . 1.0 108.962 179.305 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 95' ' ' ARG . . . . . 0.579 ' O ' ' N ' ' A' ' 97' ' ' LEU . 29.2 mtm180 -58.69 -58.86 6.73 Favored 'General case' 0 C--O 1.242 0.689 0 CA-C-O 122.529 1.157 . . . . 1.0 108.254 179.461 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 96' ' ' ALA . . . . . 0.886 ' O ' ' N ' ' A' ' 98' ' ' GLY . . . -48.55 -14.1 0.06 Allowed 'General case' 0 N--CA 1.424 -1.754 0 O-C-N 118.961 -2.337 . . . . 1.0 111.297 -178.856 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 97' ' ' LEU . . . . . 0.735 ' O ' ' N ' ' A' ' 100' ' ' ILE . 1.9 tp 5.23 -52.34 0.0 OUTLIER 'General case' 0 C--N 1.367 1.358 0 CA-C-O 116.427 -1.749 . . . . 1.0 110.447 -167.765 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 98' ' ' GLY . . . . . 0.886 ' N ' ' O ' ' A' ' 96' ' ' ALA . . . -48.66 -23.65 3.49 Favored Glycine 0 CA--C 1.542 1.735 0 CA-C-N 123.916 3.053 . . . . 1.0 108.034 174.733 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 99' ' ' GLN . . . . . 0.687 HE21 ' HB3' ' A' ' 96' ' ' ALA . 8.0 tt0 -68.81 -19.22 64.27 Favored 'General case' 0 C--N 1.364 1.211 0 N-CA-C 107.285 -1.376 . . . . 1.0 107.285 177.536 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 100' ' ' ILE . . . . . 0.735 ' N ' ' O ' ' A' ' 97' ' ' LEU . 1.9 tp -65.54 -42.58 93.43 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 N-CA-C 107.103 -1.443 . . . . 1.0 107.103 177.128 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 101' ' ' VAL . . . . . 0.743 ' O ' ' N ' ' A' ' 105' ' ' GLY . 61.0 t -55.68 -60.03 2.1 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.43 0 N-CA-C 106.931 -1.507 . . . . 1.0 106.931 178.704 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 102' ' ' CYS . . . . . 0.859 ' O ' ' HB2' ' A' ' 106' ' ' ALA . 0.5 OUTLIER -46.35 -18.37 0.06 Allowed 'General case' 0 C--N 1.32 -0.708 0 CA-C-N 116.433 -0.349 . . . . 1.0 111.622 -179.666 . . . . . . . . 3 3 . 1 . 029 nuclear build full ' A' A ' 103' ' ' ARG . . . . . 0.416 ' N ' ' O ' ' A' ' 101' ' ' VAL . 1.1 ttp180 -92.77 -44.65 8.41 Favored 'General case' 0 N--CA 1.478 0.946 0 CA-C-O 121.948 0.88 . . . . 1.0 111.068 176.951 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 104' ' ' TYR . . . . . 0.583 ' O ' ' CG ' ' A' ' 104' ' ' TYR . 0.0 OUTLIER -106.57 21.85 16.79 Favored 'General case' 0 C--N 1.317 -0.808 0 C-N-CA 126.297 1.839 . . . . 1.0 111.215 179.416 . . . . . . . . 3 3 . 1 . 029 nuclear build full ' A' A ' 105' ' ' GLY . . . . . 0.769 ' O ' ' N ' ' A' ' 107' ' ' THR . . . -170.12 -7.33 0.03 OUTLIER Glycine 0 C--N 1.339 0.747 0 C-N-CA 118.495 -1.812 . . . . 1.0 113.481 178.619 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 106' ' ' ALA . . . . . 0.859 ' HB2' ' O ' ' A' ' 102' ' ' CYS . . . -31.64 69.49 0.0 OUTLIER 'General case' 0 N--CA 1.467 0.387 0 N-CA-C 113.752 1.019 . . . . 1.0 113.752 -177.738 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 107' ' ' THR . . . . . 0.769 ' N ' ' O ' ' A' ' 105' ' ' GLY . 4.8 t -91.84 4.22 53.38 Favored 'General case' 0 N--CA 1.436 -1.171 0 N-CA-C 105.668 -1.975 . . . . 1.0 105.668 176.151 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 108' ' ' VAL . . . . . 0.529 HG13 ' N ' ' A' ' 109' ' ' ILE . 11.2 p -87.77 -57.35 4.31 Favored 'Isoleucine or valine' 0 C--N 1.357 0.928 0 CA-C-N 115.851 -0.613 . . . . 1.0 110.624 178.333 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 109' ' ' ILE . . . . . 0.529 ' N ' HG13 ' A' ' 108' ' ' VAL . 0.1 OUTLIER -62.95 -37.98 38.5 Favored Pre-proline 0 C--N 1.359 0.987 0 N-CA-C 114.476 1.288 . . . . 1.0 114.476 -176.911 . . . . . . . . 3 3 . 1 . 029 nuclear build full ' A' A ' 110' ' ' PRO . . . . . 0.435 ' CD ' ' O ' ' A' ' 106' ' ' ALA . 62.5 Cg_exo -49.04 -44.9 31.2 Favored 'Trans proline' 0 N--CA 1.497 1.703 0 CA-C-N 121.158 1.449 . . . . 1.0 113.649 -176.418 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 9.0 t30 -68.03 -67.55 0.45 Allowed 'General case' 0 C--N 1.326 -0.422 0 C-N-CA 118.735 -1.186 . . . . 1.0 110.435 -177.815 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 6.3 pt -52.89 -23.2 4.99 Favored 'Isoleucine or valine' 0 C--O 1.214 -0.778 0 N-CA-C 108.78 -0.822 . . . . 1.0 108.78 179.391 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 113' ' ' ASN . . . . . 0.456 ' HB2' ' O ' ' A' ' 109' ' ' ILE . 20.2 t30 -59.43 -51.45 69.84 Favored 'General case' 0 C--N 1.314 -0.943 0 CA-C-N 113.731 -1.577 . . . . 1.0 108.334 -178.423 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -58.64 -28.9 66.11 Favored 'General case' 0 N--CA 1.443 -0.805 0 C-N-CA 120.345 -0.542 . . . . 1.0 111.202 179.874 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 115' ' ' ALA . . . . . 0.578 ' O ' ' N ' ' A' ' 119' ' ' LEU . . . -81.12 -50.29 9.8 Favored 'General case' 0 C--O 1.208 -1.123 0 C-N-CA 120.084 -0.646 . . . . 1.0 109.292 177.275 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 116' ' ' ILE . . . . . 0.413 ' C ' ' O ' ' A' ' 115' ' ' ALA . 35.8 mt -42.85 -48.39 1.19 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.408 0 N-CA-C 104.997 -2.223 . . . . 1.0 104.997 179.104 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 117' ' ' GLU . . . . . 0.493 ' O ' ' HA ' ' A' ' 121' ' ' THR . 55.7 tt0 -46.51 -58.32 3.89 Favored 'General case' 0 C--N 1.314 -0.951 0 CA-C-N 111.294 -2.685 . . . . 1.0 106.332 177.814 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 118' ' ' VAL . . . . . 0.574 ' N ' ' O ' ' A' ' 115' ' ' ALA . 15.8 t -64.44 -56.23 17.34 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.747 0 C-N-CA 120.085 -0.646 . . . . 1.0 110.486 177.398 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 119' ' ' LEU . . . . . 0.578 ' N ' ' O ' ' A' ' 115' ' ' ALA . 1.1 mm? -51.77 -20.63 2.26 Favored 'General case' 0 N--CA 1.451 -0.377 0 N-CA-C 113.984 1.105 . . . . 1.0 113.984 -178.532 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 120' ' ' GLY . . . . . 0.448 ' O ' ' CB ' ' A' ' 121' ' ' THR . . . -134.16 -68.64 0.07 OUTLIER Glycine 0 CA--C 1.554 2.486 0 N-CA-C 105.996 -2.842 . . . . 1.0 105.996 173.974 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 121' ' ' THR . . . . . 0.495 ' CG2' HG22 ' A' ' 123' ' ' THR . 2.3 m 152.7 -31.96 0.01 OUTLIER 'General case' 0 N--CA 1.481 1.101 0 CA-C-N 112.656 -1.772 . . . . 1.0 112.01 178.478 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 122' ' ' GLY . . . . . 0.67 ' O ' ' N ' ' A' ' 124' ' ' ASP . . . 104.02 -17.03 49.5 Favored Glycine 0 N--CA 1.471 1.016 0 N-CA-C 108.875 -1.69 . . . . 1.0 108.875 -177.973 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 123' ' ' THR . . . . . 0.495 HG22 ' CG2' ' A' ' 121' ' ' THR . 0.0 OUTLIER -55.4 84.98 0.0 OUTLIER 'General case' 0 CA--C 1.539 0.527 0 N-CA-C 105.566 -2.013 . . . . 1.0 105.566 178.548 . . . . . . . . 3 3 . 1 . 029 nuclear build full ' A' A ' 124' ' ' ASP . . . . . 0.67 ' N ' ' O ' ' A' ' 122' ' ' GLY . 63.7 m-20 -163.56 170.81 16.7 Favored 'General case' 0 N--CA 1.471 0.575 0 CA-C-N 113.428 -1.715 . . . . 1.0 112.342 -179.086 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 125' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -144.15 138.73 28.36 Favored 'General case' 0 CA--C 1.547 0.846 0 N-CA-C 107.377 -1.342 . . . . 1.0 107.377 176.449 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 25.6 mmm180 -149.31 153.85 38.12 Favored 'General case' 0 N--CA 1.476 0.851 0 N-CA-C 109.872 -0.418 . . . . 1.0 109.872 178.575 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 127' ' ' PHE . . . . . 0.478 ' OXT' ' CD1' ' A' ' 127' ' ' PHE . 0.1 OUTLIER . . . . . 0 N--CA 1.471 0.589 0 CA-C-O 118.076 -0.964 . . . . 1.0 110.269 178.862 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 128' ' ' MTN . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 029 nuclear build full ' A' A ' 129' ' ' MTN . . . . . 0.488 ' C2 ' ' SG ' ' A' ' 48' ' ' CYS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 130' ' ' MTN . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 030 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.495 1.8 0 N-CA-C 109.92 -0.4 . . . . 1.0 109.92 . . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 2' ' ' SER . . . . . 0.49 ' O ' ' CB ' ' A' ' 3' ' ' ASP . 9.0 t -86.49 13.78 7.82 Favored 'General case' 0 C--O 1.225 -0.23 0 CA-C-N 115.786 -0.643 . . . . 1.0 111.264 -179.918 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 3' ' ' ASP . . . . . 0.49 ' CB ' ' O ' ' A' ' 2' ' ' SER . 21.5 m-20 146.43 122.27 0.0 OUTLIER 'General case' 0 N--CA 1.478 0.955 0 O-C-N 124.577 1.173 . . . . 1.0 110.524 178.948 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 47.8 t80 -154.78 150.52 27.63 Favored 'General case' 0 N--CA 1.466 0.361 0 CA-C-N 116.062 -0.517 . . . . 1.0 110.573 179.028 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -152.39 147.97 26.92 Favored 'General case' 0 CA--C 1.543 0.694 0 CA-C-N 116.364 -0.38 . . . . 1.0 110.263 -178.529 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 6' ' ' THR . . . . . 0.479 HG22 ' H ' ' A' ' 7' ' ' GLU . 0.2 OUTLIER -61.49 -157.6 0.01 OUTLIER 'General case' 0 N--CA 1.472 0.671 0 C-N-CA 121.032 -0.267 . . . . 1.0 111.037 -179.187 . . . . . . . . 3 3 . 1 . 030 nuclear build full ' A' A ' 7' ' ' GLU . . . . . 0.479 ' H ' HG22 ' A' ' 6' ' ' THR . 3.2 pt-20 -75.76 -67.57 0.66 Allowed 'General case' 0 C--O 1.216 -0.698 0 CA-C-O 118.553 -0.737 . . . . 1.0 110.245 -179.367 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 8' ' ' ARG . . . . . 0.473 ' H ' ' CG ' ' A' ' 7' ' ' GLU . 7.0 tmm_? -47.08 -43.01 19.81 Favored 'General case' 0 CA--C 1.493 -1.214 0 CA-C-N 119.645 1.111 . . . . 1.0 111.781 -177.858 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 9' ' ' VAL . . . . . 0.438 ' O ' HG23 ' A' ' 13' ' ' VAL . 0.1 OUTLIER -68.96 -52.99 28.74 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.94 0 C-N-CA 118.933 -1.107 . . . . 1.0 108.779 179.063 . . . . . . . . 3 3 . 1 . 030 nuclear build full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 39.5 t -58.67 -42.75 89.18 Favored 'General case' 0 N--CA 1.455 -0.207 0 CA-C-O 118.868 -0.587 . . . . 1.0 111.968 179.528 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 11' ' ' ARG . . . . . 0.678 ' O ' ' N ' ' A' ' 14' ' ' ALA . 0.0 OUTLIER -74.17 -59.97 2.48 Favored 'General case' 0 CA--C 1.492 -1.256 0 N-CA-C 106.85 -1.537 . . . . 1.0 106.85 178.051 . . . . . . . . 3 3 . 1 . 030 nuclear build full ' A' A ' 12' ' ' ALA . . . . . 0.651 ' O ' ' HB3' ' A' ' 16' ' ' ALA . . . -38.91 -43.08 0.92 Allowed 'General case' 0 CA--C 1.487 -1.475 0 CA-C-N 119.108 0.867 . . . . 1.0 108.783 -175.879 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 13' ' ' VAL . . . . . 0.693 ' O ' ' HB3' ' A' ' 17' ' ' LEU . 71.5 t -60.12 -52.53 60.21 Favored 'Isoleucine or valine' 0 C--O 1.186 -2.252 0 C-N-CA 115.984 -2.286 . . . . 1.0 106.822 177.664 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 14' ' ' ALA . . . . . 0.796 ' O ' HG13 ' A' ' 18' ' ' VAL . . . -66.1 -64.89 0.76 Allowed 'General case' 0 C--O 1.209 -1.041 0 O-C-N 120.329 -1.482 . . . . 1.0 113.122 177.954 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 15' ' ' ALA . . . . . 0.525 ' O ' ' N ' ' A' ' 19' ' ' GLY . . . -57.19 -59.13 5.56 Favored 'General case' 0 N--CA 1.497 1.878 0 C-N-CA 119.739 -0.784 . . . . 1.0 112.86 -175.263 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 16' ' ' ALA . . . . . 0.668 ' HB1' ' CA ' ' A' ' 22' ' ' GLY . . . -61.62 -54.89 36.86 Favored 'General case' 0 CA--C 1.556 1.206 0 CA-C-O 122.533 1.158 . . . . 1.0 109.866 -177.678 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 17' ' ' LEU . . . . . 0.693 ' HB3' ' O ' ' A' ' 13' ' ' VAL . 21.1 tp -57.57 -51.17 70.56 Favored 'General case' 0 N--CA 1.481 1.102 0 CA-C-N 113.57 -1.65 . . . . 1.0 108.194 -177.452 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 18' ' ' VAL . . . . . 0.796 HG13 ' O ' ' A' ' 14' ' ' ALA . 3.0 m -70.34 -57.08 8.92 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.461 0 C-N-CA 118.927 -1.109 . . . . 1.0 110.168 179.636 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 19' ' ' GLY . . . . . 0.525 ' N ' ' O ' ' A' ' 15' ' ' ALA . . . -61.62 -177.43 2.53 Favored Glycine 0 N--CA 1.446 -0.697 0 N-CA-C 111.718 -0.553 . . . . 1.0 111.718 -178.045 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 20' ' ' PRO . . . . . 0.569 ' O ' ' N ' ' A' ' 24' ' ' ALA . 54.4 Cg_endo -82.81 -23.63 3.76 Favored 'Trans proline' 0 C--N 1.303 -1.85 0 C-N-CA 123.045 2.497 . . . . 1.0 112.065 -179.271 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -60.51 -59.22 10.66 Favored Glycine 0 CA--C 1.535 1.301 0 C-N-CA 120.046 -1.073 . . . . 1.0 111.321 -176.952 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 22' ' ' GLY . . . . . 0.668 ' CA ' ' HB1' ' A' ' 16' ' ' ALA . . . -56.14 -52.91 46.34 Favored Glycine 0 N--CA 1.469 0.893 0 N-CA-C 107.101 -2.399 . . . . 1.0 107.101 -178.411 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 23' ' ' VAL . . . . . 0.479 ' O ' HG12 ' A' ' 27' ' ' VAL . 36.7 t -59.28 -33.25 50.34 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.185 0 C-N-CA 119.774 -0.77 . . . . 1.0 109.143 179.836 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 24' ' ' ALA . . . . . 0.569 ' N ' ' O ' ' A' ' 20' ' ' PRO . . . -55.33 -62.29 1.77 Allowed 'General case' 0 N--CA 1.479 1.018 0 C-N-CA 119.239 -0.984 . . . . 1.0 110.568 -179.886 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 18.3 mt -63.66 -43.3 97.12 Favored 'General case' 0 C--N 1.345 0.392 0 C-N-CA 119.919 -0.712 . . . . 1.0 112.39 -177.854 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 95.2 t -60.22 -60.53 2.42 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.79 0 C-N-CA 118.591 -1.244 . . . . 1.0 111.279 -177.608 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 27' ' ' VAL . . . . . 0.513 ' O ' ' HB3' ' A' ' 31' ' ' ALA . 3.1 p -59.61 -34.26 54.48 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.2 0 N-CA-C 112.681 0.623 . . . . 1.0 112.681 -177.58 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 71.3 tttt -66.79 -54.71 19.9 Favored 'General case' 0 C--N 1.312 -1.034 0 CA-C-O 122.317 1.056 . . . . 1.0 108.79 -179.68 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 98.6 t -62.88 -47.67 91.72 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.145 0 CA-C-N 113.553 -1.658 . . . . 1.0 110.499 -177.092 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 30' ' ' CYS . . . . . 0.561 ' SG ' ' N ' ' A' ' 31' ' ' ALA . 0.0 OUTLIER -67.48 -61.17 2.03 Favored 'General case' 0 CA--C 1.533 0.326 0 C-N-CA 118.729 -1.188 . . . . 1.0 110.198 -179.692 . . . . . . . . 3 3 . 1 . 030 nuclear build full ' A' A ' 31' ' ' ALA . . . . . 0.561 ' N ' ' SG ' ' A' ' 30' ' ' CYS . . . -60.38 -53.85 52.71 Favored 'General case' 0 CA--C 1.509 -0.6 0 CA-C-N 118.25 0.477 . . . . 1.0 111.99 -177.001 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 32' ' ' GLY . . . . . 0.495 ' O ' ' CB ' ' A' ' 33' ' ' LEU . . . 87.33 74.36 1.28 Allowed Glycine 0 CA--C 1.521 0.416 0 N-CA-C 108.632 -1.787 . . . . 1.0 108.632 -178.529 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 33' ' ' LEU . . . . . 0.501 HD22 ' H ' ' A' ' 36' ' ' VAL . 1.1 tt 85.81 85.31 0.05 OUTLIER Pre-proline 0 CA--C 1.546 0.792 0 CA-C-O 120.692 0.282 . . . . 1.0 110.414 -179.343 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 51.7 Cg_exo -53.23 -30.4 51.11 Favored 'Trans proline' 0 N--CA 1.502 1.99 0 C-N-CA 123.005 2.47 . . . . 1.0 114.227 -179.679 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -57.23 -60.75 8.45 Favored Glycine 0 N--CA 1.469 0.856 0 C-N-CA 119.062 -1.542 . . . . 1.0 110.185 -178.653 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 36' ' ' VAL . . . . . 0.585 ' O ' HG22 ' A' ' 37' ' ' ILE . 2.7 p -88.77 160.49 2.82 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.479 0 N-CA-C 105.77 -1.937 . . . . 1.0 105.77 177.808 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 37' ' ' ILE . . . . . 0.663 HG23 ' O ' ' A' ' 37' ' ' ILE . 0.7 OUTLIER 125.61 113.56 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.479 0.996 0 O-C-N 124.682 1.239 . . . . 1.0 110.373 179.711 . . . . . . . . 3 3 . 1 . 030 nuclear build full ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 22.5 m80 -139.83 131.81 27.79 Favored 'General case' 0 N--CA 1.467 0.418 0 N-CA-C 108.557 -0.905 . . . . 1.0 108.557 179.263 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 9.2 p -99.37 149.4 35.8 Favored Pre-proline 0 N--CA 1.469 0.478 0 CA-C-N 116.969 -0.105 . . . . 1.0 110.743 -179.46 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 91.2 Cg_endo -75.29 -37.98 1.66 Allowed 'Trans proline' 0 N--CA 1.494 1.539 0 C-N-CA 122.317 2.012 . . . . 1.0 113.345 -179.123 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -128.2 134.38 49.02 Favored 'General case' 0 N--CA 1.472 0.665 0 N-CA-C 111.555 0.206 . . . . 1.0 111.555 179.611 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 42' ' ' ARG . . . . . 0.683 ' C ' ' H ' ' A' ' 44' ' ' GLY . 0.0 OUTLIER -169.86 165.95 9.61 Favored 'General case' 0 C--N 1.325 -0.487 0 C-N-CA 120.17 -0.612 . . . . 1.0 109.697 178.391 . . . . . . . . 3 3 . 1 . 030 nuclear build full ' A' A ' 43' ' ' ARG . . . . . 0.463 ' C ' ' H ' ' A' ' 45' ' ' PHE . 0.0 OUTLIER -61.89 24.92 0.01 OUTLIER 'General case' 0 CA--C 1.548 0.896 0 CA-C-N 115.494 -0.775 . . . . 1.0 110.553 179.82 . . . . . . . . 3 3 . 1 . 030 nuclear build full ' A' A ' 44' ' ' GLY . . . . . 0.683 ' H ' ' C ' ' A' ' 42' ' ' ARG . . . 76.42 -26.08 1.61 Allowed Glycine 0 C--N 1.345 1.073 0 N-CA-C 110.452 -1.059 . . . . 1.0 110.452 -179.948 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 45' ' ' PHE . . . . . 0.578 ' O ' ' HB2' ' A' ' 46' ' ' PHE . 6.6 p90 -169.37 172.12 7.37 Favored 'General case' 0 C--O 1.219 -0.518 0 N-CA-C 109.966 -0.383 . . . . 1.0 109.966 179.743 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 46' ' ' PHE . . . . . 0.578 ' HB2' ' O ' ' A' ' 45' ' ' PHE . 1.1 m-85 131.63 99.57 0.0 OUTLIER 'General case' 0 N--CA 1.501 2.083 0 O-C-N 125.763 1.914 . . . . 1.0 109.802 178.695 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 47' ' ' ARG . . . . . 0.644 ' HG2' ' H ' ' A' ' 48' ' ' CYS . 15.6 ttp85 93.88 175.27 0.01 OUTLIER 'General case' 0 N--CA 1.468 0.446 0 O-C-N 123.596 0.56 . . . . 1.0 110.254 179.09 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 48' ' ' CYS . . . . . 0.644 ' H ' ' HG2' ' A' ' 47' ' ' ARG . 2.5 t 67.53 62.68 0.43 Allowed 'General case' 0 N--CA 1.445 -0.707 0 N-CA-C 106.373 -1.714 . . . . 1.0 106.373 -178.351 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 49' ' ' ASN . . . . . 0.559 ' N ' ' OD1' ' A' ' 49' ' ' ASN . 1.1 p30 -156.21 155.74 29.41 Favored Pre-proline 0 N--CA 1.449 -0.508 0 N-CA-C 108.097 -1.075 . . . . 1.0 108.097 178.865 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 50' ' ' PRO . . . . . 0.428 ' O ' ' NH1' ' A' ' 52' ' ' ARG . 50.8 Cg_endo -67.59 76.5 0.54 Allowed 'Trans proline' 0 C--N 1.303 -1.828 0 C-N-CA 121.967 1.778 . . . . 1.0 112.272 177.238 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 9.0 pt-20 40.12 63.97 0.98 Allowed 'General case' 0 N--CA 1.477 0.921 0 N-CA-C 112.532 0.567 . . . . 1.0 112.532 -179.95 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 52' ' ' ARG . . . . . 0.68 HH22 ' CE1' ' A' ' 92' ' ' HIS . 77.6 mtt85 -147.28 136.02 22.05 Favored 'General case' 0 N--CA 1.472 0.627 0 CA-C-N 116.049 -0.523 . . . . 1.0 111.844 178.896 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -54.44 164.75 0.29 Allowed 'Isoleucine or valine' 0 N--CA 1.478 0.942 0 N-CA-C 107.212 -1.403 . . . . 1.0 107.212 177.455 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 39.9 mm-40 -121.0 115.04 22.4 Favored 'General case' 0 CA--C 1.548 0.891 0 CA-C-N 121.845 2.111 . . . . 1.0 109.245 179.949 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 55' ' ' ILE . . . . . 0.457 HD12 ' N ' ' A' ' 56' ' ' GLY . 0.7 OUTLIER -146.7 157.73 10.8 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.017 0 CA-C-N 118.476 0.58 . . . . 1.0 109.532 177.704 . . . . . . . . 3 3 . 1 . 030 nuclear build full ' A' A ' 56' ' ' GLY . . . . . 0.457 ' N ' HD12 ' A' ' 55' ' ' ILE . . . 110.84 -6.81 29.45 Favored Glycine 0 N--CA 1.481 1.68 0 CA-C-N 118.752 0.706 . . . . 1.0 112.3 -179.595 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -112.64 127.88 56.23 Favored 'General case' 0 C--N 1.32 -0.682 0 N-CA-C 108.677 -0.86 . . . . 1.0 108.677 178.126 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 58' ' ' TRP . . . . . 0.538 ' H ' ' HB2' ' A' ' 61' ' ' GLU . 5.0 m0 -139.18 158.48 44.1 Favored 'General case' 0 N--CA 1.455 -0.216 0 CA-C-O 122.808 1.29 . . . . 1.0 109.529 179.298 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 34.9 ptt-85 -41.03 -36.41 0.67 Allowed 'General case' 0 C--N 1.296 -1.728 0 CA-C-N 112.318 -2.219 . . . . 1.0 109.181 -178.616 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 42.8 t80 -90.94 -35.67 14.58 Favored 'General case' 0 N--CA 1.481 1.09 0 CA-C-O 121.687 0.756 . . . . 1.0 112.449 178.82 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 61' ' ' GLU . . . . . 0.538 ' HB2' ' H ' ' A' ' 58' ' ' TRP . 92.5 mt-10 -77.67 -13.92 59.77 Favored 'General case' 0 N--CA 1.443 -0.812 0 O-C-N 121.757 -0.589 . . . . 1.0 110.53 179.926 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 62' ' ' VAL . . . . . 0.628 HG13 ' N ' ' A' ' 63' ' ' ALA . 7.3 p -46.71 -56.2 1.42 Allowed 'Isoleucine or valine' 0 C--O 1.213 -0.858 0 C-N-CA 119.444 -0.902 . . . . 1.0 109.318 -175.664 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 63' ' ' ALA . . . . . 0.628 ' N ' HG13 ' A' ' 62' ' ' VAL . . . -64.77 -54.29 33.6 Favored 'General case' 0 C--N 1.302 -1.483 0 O-C-N 121.966 -0.459 . . . . 1.0 110.059 179.94 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 2.9 m-70 -53.16 -57.74 9.44 Favored 'General case' 0 CA--C 1.549 0.917 0 C-N-CA 119.591 -0.844 . . . . 1.0 109.813 -179.205 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 65' ' ' ASP . . . . . 0.623 ' C ' ' H ' ' A' ' 67' ' ' ARG . 33.8 t0 -72.72 -52.07 16.68 Favored 'General case' 0 C--O 1.245 0.854 0 CA-C-O 121.899 0.857 . . . . 1.0 111.48 179.111 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 66' ' ' GLY . . . . . 0.584 ' N ' ' O ' ' A' ' 62' ' ' VAL . . . -69.51 27.71 0.36 Allowed Glycine 0 C--O 1.226 -0.374 0 O-C-N 120.74 -1.225 . . . . 1.0 110.66 177.04 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 67' ' ' ARG . . . . . 0.709 ' O ' ' N ' ' A' ' 69' ' ' LEU . 8.0 mtm-85 -75.63 5.58 5.91 Favored 'General case' 0 CA--C 1.507 -0.673 0 N-CA-C 108.011 -1.107 . . . . 1.0 108.011 176.049 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 68' ' ' LEU . . . . . 0.46 ' C ' ' O ' ' A' ' 67' ' ' ARG . 2.7 mt -31.43 -25.5 0.0 OUTLIER 'General case' 0 N--CA 1.486 1.35 0 N-CA-C 108.311 -0.996 . . . . 1.0 108.311 -177.694 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 69' ' ' LEU . . . . . 0.709 ' N ' ' O ' ' A' ' 67' ' ' ARG . 48.1 tp -64.85 -65.35 0.69 Allowed 'General case' 0 N--CA 1.472 0.637 0 N-CA-C 108.662 -0.866 . . . . 1.0 108.662 177.655 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 70' ' ' ALA . . . . . 0.631 ' O ' ' N ' ' A' ' 72' ' ' HIS . . . -80.66 -73.96 0.34 Allowed 'General case' 0 N--CA 1.47 0.55 0 N-CA-C 104.438 -2.43 . . . . 1.0 104.438 176.906 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 71' ' ' ALA . . . . . 0.489 ' O ' ' C ' ' A' ' 72' ' ' HIS . . . -42.83 0.89 0.0 OUTLIER 'General case' 0 CA--C 1.513 -0.47 0 C-N-CA 124.864 1.265 . . . . 1.0 113.647 179.493 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 72' ' ' HIS . . . . . 0.671 ' CG ' ' N ' ' A' ' 73' ' ' MET . 0.0 OUTLIER -26.65 -63.5 0.08 Allowed 'General case' 0 C--N 1.346 0.434 0 CA-C-N 118.243 0.474 . . . . 1.0 110.421 -179.825 . . . . . . . . 3 3 . 1 . 030 nuclear build full ' A' A ' 73' ' ' MET . . . . . 0.671 ' N ' ' CG ' ' A' ' 72' ' ' HIS . 12.5 ttm -74.32 -50.86 17.06 Favored 'General case' 0 C--N 1.323 -0.563 0 C-N-CA 119.043 -1.063 . . . . 1.0 109.917 178.668 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 74' ' ' VAL . . . . . 0.564 ' O ' ' N ' ' A' ' 76' ' ' GLY . 41.2 t -46.09 -45.78 5.77 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.269 0 CA-C-O 117.604 -1.189 . . . . 1.0 112.589 -175.018 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 75' ' ' ASN . . . . . 0.674 ' O ' HG23 ' A' ' 79' ' ' ILE . 8.2 t-20 -42.54 -15.71 0.01 OUTLIER 'General case' 0 C--N 1.35 0.6 0 CA-C-N 121.227 1.83 . . . . 1.0 111.425 177.336 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 76' ' ' GLY . . . . . 0.564 ' N ' ' O ' ' A' ' 74' ' ' VAL . . . -46.18 -25.65 1.92 Allowed Glycine 0 CA--C 1.531 1.084 0 N-CA-C 108.984 -1.646 . . . . 1.0 108.984 -179.921 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 77' ' ' ILE . . . . . 0.526 ' O ' ' N ' ' A' ' 79' ' ' ILE . 0.9 OUTLIER -86.32 -61.96 1.65 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.699 0 CA-C-N 113.886 -1.157 . . . . 1.0 110.615 -178.099 . . . . . . . . 3 3 . 1 . 030 nuclear build full ' A' A ' 78' ' ' VAL . . . . . 0.427 ' C ' ' O ' ' A' ' 77' ' ' ILE . 12.2 t -37.86 -27.34 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.443 -0.789 0 N-CA-C 109.221 -0.659 . . . . 1.0 109.221 -178.308 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 79' ' ' ILE . . . . . 0.832 ' O ' ' HB3' ' A' ' 83' ' ' ALA . 0.9 OUTLIER -67.99 -51.87 44.93 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.788 0 C-N-CA 119.827 -0.749 . . . . 1.0 110.857 178.916 . . . . . . . . 3 3 . 1 . 030 nuclear build full ' A' A ' 80' ' ' ALA . . . . . 0.512 ' N ' ' CG1' ' A' ' 79' ' ' ILE . . . -61.48 -63.14 1.37 Allowed 'General case' 0 C--O 1.231 0.097 0 C-N-CA 119.131 -1.028 . . . . 1.0 110.89 -178.656 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 81' ' ' GLU . . . . . 0.434 ' HG2' ' H ' ' A' ' 81' ' ' GLU . 0.2 OUTLIER -49.28 -72.64 0.05 OUTLIER 'General case' 0 CA--C 1.536 0.437 0 C-N-CA 119.57 -0.852 . . . . 1.0 109.924 -179.495 . . . . . . . . 3 3 . 1 . 030 nuclear build full ' A' A ' 82' ' ' ASP . . . . . 0.471 ' O ' ' N ' ' A' ' 84' ' ' LEU . 33.4 m-20 -59.6 -63.31 1.35 Allowed 'General case' 0 C--N 1.331 -0.227 0 C-N-CA 118.233 -1.387 . . . . 1.0 109.897 -178.285 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 83' ' ' ALA . . . . . 0.832 ' HB3' ' O ' ' A' ' 79' ' ' ILE . . . -68.82 57.95 0.09 Allowed 'General case' 0 C--N 1.317 -0.814 0 C-N-CA 119.416 -0.914 . . . . 1.0 110.395 -179.61 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 84' ' ' LEU . . . . . 0.471 ' N ' ' O ' ' A' ' 82' ' ' ASP . 0.2 OUTLIER -79.68 7.09 9.11 Favored 'General case' 0 C--N 1.351 0.672 0 N-CA-C 108.62 -0.881 . . . . 1.0 108.62 179.033 . . . . . . . . 3 3 . 1 . 030 nuclear build full ' A' A ' 85' ' ' ILE . . . . . 0.782 ' O ' ' HB ' ' A' ' 89' ' ' VAL . 0.0 OUTLIER -92.06 -7.96 10.42 Favored 'Isoleucine or valine' 0 C--O 1.193 -1.88 0 CA-C-N 114.647 -1.161 . . . . 1.0 108.652 178.648 . . . . . . . . 3 3 . 1 . 030 nuclear build full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -96.76 -12.96 23.01 Favored 'General case' 0 CA--C 1.544 0.747 0 CA-C-O 120.696 0.284 . . . . 1.0 111.709 179.704 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -88.53 -37.13 15.97 Favored 'General case' 0 N--CA 1.481 1.076 0 N-CA-C 113.321 0.86 . . . . 1.0 113.321 -178.493 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -112.88 -8.41 13.71 Favored 'General case' 0 N--CA 1.482 1.129 0 CA-C-O 121.57 0.7 . . . . 1.0 110.971 -178.629 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 89' ' ' VAL . . . . . 0.782 ' HB ' ' O ' ' A' ' 85' ' ' ILE . 14.9 t -99.43 33.34 0.31 Allowed 'Isoleucine or valine' 0 CA--C 1.503 -0.861 0 CA-C-N 115.144 -0.935 . . . . 1.0 109.425 178.095 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 90' ' ' GLY . . . . . 0.644 ' N ' ' HD2' ' A' ' 91' ' ' PRO . . . -67.42 -42.35 89.56 Favored Glycine 0 CA--C 1.537 1.414 0 N-CA-C 110.091 -1.204 . . . . 1.0 110.091 176.531 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 91' ' ' PRO . . . . . 0.644 ' HD2' ' N ' ' A' ' 90' ' ' GLY . 5.8 Cg_exo -42.09 -13.93 0.04 OUTLIER 'Trans proline' 0 N--CA 1.496 1.655 0 C-N-CA 122.152 1.901 . . . . 1.0 111.034 177.753 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 92' ' ' HIS . . . . . 0.68 ' CE1' HH22 ' A' ' 52' ' ' ARG . 47.9 p-80 -57.16 -18.42 15.21 Favored 'General case' 0 C--O 1.202 -1.397 0 N-CA-C 107.94 -1.133 . . . . 1.0 107.94 179.928 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 93' ' ' LEU . . . . . 0.646 HD12 ' N ' ' A' ' 94' ' ' ALA . 1.3 pp -65.67 -57.69 7.48 Favored 'General case' 0 C--N 1.325 -0.495 0 N-CA-C 108.785 -0.82 . . . . 1.0 108.785 179.537 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 94' ' ' ALA . . . . . 0.646 ' N ' HD12 ' A' ' 93' ' ' LEU . . . -58.35 -53.95 52.53 Favored 'General case' 0 CA--C 1.515 -0.396 0 N-CA-C 108.78 -0.822 . . . . 1.0 108.78 179.031 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 95' ' ' ARG . . . . . 0.692 ' O ' ' N ' ' A' ' 97' ' ' LEU . 6.8 mtm-85 -58.09 -58.3 9.02 Favored 'General case' 0 N--CA 1.449 -0.486 0 N-CA-C 107.322 -1.362 . . . . 1.0 107.322 178.732 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 96' ' ' ALA . . . . . 0.942 ' O ' ' N ' ' A' ' 98' ' ' GLY . . . -46.14 -11.62 0.02 OUTLIER 'General case' 0 C--N 1.308 -1.224 0 O-C-N 118.49 -2.631 . . . . 1.0 110.807 -179.687 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 97' ' ' LEU . . . . . 0.718 ' O ' ' N ' ' A' ' 100' ' ' ILE . 4.3 tt 9.22 -54.09 0.0 OUTLIER 'General case' 0 N--CA 1.476 0.873 0 CA-C-O 117.474 -1.25 . . . . 1.0 109.817 -168.19 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 98' ' ' GLY . . . . . 0.942 ' N ' ' O ' ' A' ' 96' ' ' ALA . . . -47.63 -22.46 1.8 Allowed Glycine 0 CA--C 1.547 2.086 0 CA-C-N 122.328 2.331 . . . . 1.0 107.295 174.908 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 99' ' ' GLN . . . . . 0.533 ' N ' ' O ' ' A' ' 96' ' ' ALA . 4.3 tp-100 -65.34 -20.5 66.42 Favored 'General case' 0 C--N 1.378 1.813 0 C-N-CA 117.975 -1.49 . . . . 1.0 108.439 176.922 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 100' ' ' ILE . . . . . 0.718 ' N ' ' O ' ' A' ' 97' ' ' LEU . 18.7 mm -64.13 -47.05 91.81 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.753 0 CA-C-N 114.438 -1.255 . . . . 1.0 108.325 177.489 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 101' ' ' VAL . . . . . 0.709 ' O ' ' N ' ' A' ' 105' ' ' GLY . 57.4 t -60.44 -58.96 4.99 Favored 'Isoleucine or valine' 0 C--O 1.219 -0.526 0 N-CA-C 106.945 -1.502 . . . . 1.0 106.945 179.58 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 102' ' ' CYS . . . . . 0.966 ' O ' ' HB2' ' A' ' 106' ' ' ALA . 0.0 OUTLIER -45.22 -17.92 0.03 OUTLIER 'General case' 0 N--CA 1.444 -0.726 0 CA-C-O 121.423 0.63 . . . . 1.0 110.268 -179.889 . . . . . . . . 3 3 . 1 . 030 nuclear build full ' A' A ' 103' ' ' ARG . . . . . 0.62 ' NH2' ' CZ ' ' A' ' 104' ' ' TYR . 0.1 OUTLIER -95.48 -44.43 7.53 Favored 'General case' 0 N--CA 1.474 0.759 0 CA-C-O 122.47 1.129 . . . . 1.0 112.359 177.985 . . . . . . . . 3 3 . 1 . 030 nuclear build full ' A' A ' 104' ' ' TYR . . . . . 0.62 ' CZ ' ' NH2' ' A' ' 103' ' ' ARG . 12.1 m-85 -107.16 21.41 17.57 Favored 'General case' 0 C--N 1.318 -0.761 0 C-N-CA 127.251 2.22 . . . . 1.0 111.861 179.507 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 105' ' ' GLY . . . . . 0.709 ' N ' ' O ' ' A' ' 101' ' ' VAL . . . -170.83 -10.68 0.02 OUTLIER Glycine 0 C--N 1.341 0.806 0 C-N-CA 119.356 -1.402 . . . . 1.0 112.155 179.664 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 106' ' ' ALA . . . . . 0.966 ' HB2' ' O ' ' A' ' 102' ' ' CYS . . . -28.77 75.13 0.0 OUTLIER 'General case' 0 CA--C 1.512 -0.492 0 N-CA-C 113.805 1.039 . . . . 1.0 113.805 -179.472 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 107' ' ' THR . . . . . 0.693 ' N ' ' O ' ' A' ' 105' ' ' GLY . 15.2 t -91.22 5.95 47.08 Favored 'General case' 0 N--CA 1.434 -1.264 0 N-CA-C 106.045 -1.835 . . . . 1.0 106.045 178.177 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 108' ' ' VAL . . . . . 0.724 ' O ' HG22 ' A' ' 108' ' ' VAL . 11.8 p -95.84 17.01 2.02 Favored 'Isoleucine or valine' 0 C--N 1.352 0.687 0 CA-C-O 118.493 -0.765 . . . . 1.0 110.873 177.077 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 109' ' ' ILE . . . . . 0.676 ' N ' ' CD ' ' A' ' 110' ' ' PRO . 40.5 pt -105.77 -14.85 0.15 Allowed Pre-proline 0 N--CA 1.438 -1.073 0 CA-C-N 121.255 1.843 . . . . 1.0 110.457 177.915 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 110' ' ' PRO . . . . . 0.676 ' CD ' ' N ' ' A' ' 109' ' ' ILE . 55.7 Cg_endo -67.36 -48.21 1.8 Allowed 'Trans proline' 0 N--CA 1.493 1.465 0 CA-C-N 121.163 1.451 . . . . 1.0 113.094 -175.728 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 15.6 t-20 -67.47 -66.36 0.57 Allowed 'General case' 0 N--CA 1.453 -0.304 0 C-N-CA 119.756 -0.777 . . . . 1.0 109.874 -179.125 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 112' ' ' ILE . . . . . 0.515 ' O ' ' HB ' ' A' ' 116' ' ' ILE . 2.9 tt -43.56 -40.52 1.37 Allowed 'Isoleucine or valine' 0 CA--C 1.548 0.904 0 N-CA-C 113.093 0.775 . . . . 1.0 113.093 -178.247 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 5.8 m-80 -67.86 -41.12 83.39 Favored 'General case' 0 C--N 1.31 -1.134 0 CA-C-O 122.449 1.119 . . . . 1.0 109.295 178.061 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -59.62 -52.02 67.31 Favored 'General case' 0 C--N 1.296 -1.74 0 CA-C-N 113.386 -1.734 . . . . 1.0 108.95 179.912 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -78.81 -57.04 3.96 Favored 'General case' 0 CA--C 1.537 0.456 0 N-CA-C 114.047 1.128 . . . . 1.0 114.047 179.517 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 116' ' ' ILE . . . . . 0.586 ' O ' ' N ' ' A' ' 120' ' ' GLY . 4.5 mm -52.05 -51.16 31.76 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.209 0 CA-C-O 122.008 0.909 . . . . 1.0 112.445 -176.55 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 117' ' ' GLU . . . . . 0.489 ' C ' ' O ' ' A' ' 116' ' ' ILE . 65.4 mt-10 -45.07 -56.92 4.24 Favored 'General case' 0 C--N 1.313 -0.982 0 N-CA-C 105.516 -2.031 . . . . 1.0 105.516 -176.662 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 96.7 t -58.07 -53.92 39.24 Favored 'Isoleucine or valine' 0 CA--C 1.554 1.129 0 C-N-CA 119.919 -0.712 . . . . 1.0 109.444 177.49 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 4.6 tt -51.92 -68.91 0.13 Allowed 'General case' 0 N--CA 1.48 1.033 0 N-CA-C 106.82 -1.548 . . . . 1.0 106.82 -178.628 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 120' ' ' GLY . . . . . 0.586 ' N ' ' O ' ' A' ' 116' ' ' ILE . . . -73.33 -82.65 0.33 Allowed Glycine 0 CA--C 1.548 2.156 0 C-N-CA 120.897 -0.668 . . . . 1.0 112.34 -179.158 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 121' ' ' THR . . . . . 0.495 ' OG1' ' O ' ' A' ' 120' ' ' GLY . 4.2 m 155.6 -34.31 0.01 OUTLIER 'General case' 0 N--CA 1.482 1.155 0 CA-C-N 112.435 -1.883 . . . . 1.0 112.355 179.397 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 122' ' ' GLY . . . . . 0.684 ' O ' ' N ' ' A' ' 124' ' ' ASP . . . 103.96 -17.76 47.98 Favored Glycine 0 N--CA 1.461 0.313 0 N-CA-C 106.198 -2.761 . . . . 1.0 106.198 -176.589 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 123' ' ' THR . . . . . 0.706 HG23 ' O ' ' A' ' 123' ' ' THR . 9.6 t -55.98 81.31 0.0 OUTLIER 'General case' 0 N--CA 1.468 0.475 0 N-CA-C 105.519 -2.03 . . . . 1.0 105.519 178.758 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 124' ' ' ASP . . . . . 0.684 ' N ' ' O ' ' A' ' 122' ' ' GLY . 40.7 m-20 -166.81 178.85 5.64 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 112.871 -1.968 . . . . 1.0 111.66 179.041 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 125' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -147.34 143.76 28.26 Favored 'General case' 0 CA--C 1.545 0.78 0 N-CA-C 108.154 -1.054 . . . . 1.0 108.154 176.473 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 72.2 mtt-85 -150.92 155.8 39.88 Favored 'General case' 0 N--CA 1.47 0.569 0 CA-C-O 120.801 0.334 . . . . 1.0 111.011 176.535 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 127' ' ' PHE . . . . . 0.473 ' OXT' ' CG ' ' A' ' 127' ' ' PHE . 5.8 p90 . . . . . 0 C--O 1.218 -0.603 0 CA-C-O 118.188 -0.91 . . . . 1.0 110.159 179.276 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 128' ' ' MTN . . . . . 0.492 ' H91' ' HD3' ' A' ' 47' ' ' ARG . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 129' ' ' MTN . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 030 nuclear build full ' A' A ' 130' ' ' MTN . . . . . 0.414 ' C6 ' ' SG ' ' A' ' 102' ' ' CYS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 N--CA 1.488 1.468 0 N-CA-C 108.866 -0.79 . . . . 1.0 108.866 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 85.5 p -106.87 10.47 30.62 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.297 -0.41 . . . . 1.0 110.405 -179.575 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 1.7 t70 166.07 94.37 0.0 OUTLIER 'General case' 0 N--CA 1.465 0.322 0 CA-C-N 115.965 -0.561 . . . . 1.0 110.003 179.646 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 54.7 t80 -149.04 144.77 26.92 Favored 'General case' 0 C--N 1.33 -0.262 0 N-CA-C 110.293 -0.262 . . . . 1.0 110.293 179.369 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 5' ' ' ASP . . . . . 0.516 ' N ' ' OD1' ' A' ' 5' ' ' ASP . 0.6 OUTLIER -154.95 151.48 28.57 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.799 0.333 . . . . 1.0 110.554 -179.285 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 6' ' ' THR . . . . . 0.672 ' O ' ' N ' ' A' ' 10' ' ' SER . 0.2 OUTLIER -67.99 176.18 2.75 Favored 'General case' 0 C--O 1.206 -1.223 0 CA-C-N 116.352 -0.385 . . . . 1.0 110.526 -179.617 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . 0.527 ' O ' ' N ' ' A' ' 11' ' ' ARG . 82.2 tt0 -58.49 -58.76 7.12 Favored 'General case' 0 C--N 1.318 -0.769 0 CA-C-O 121.466 0.651 . . . . 1.0 110.254 -177.558 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 8' ' ' ARG . . . . . 0.825 ' O ' ' HB3' ' A' ' 12' ' ' ALA . 26.9 mtp180 -47.86 -55.06 10.64 Favored 'General case' 0 C--O 1.213 -0.82 0 N-CA-C 107.06 -1.459 . . . . 1.0 107.06 -178.874 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . 0.585 ' O ' ' CG2' ' A' ' 13' ' ' VAL . 63.1 t -64.89 -49.17 81.15 Favored 'Isoleucine or valine' 0 C--O 1.199 -1.589 0 CA-C-N 114.356 -1.293 . . . . 1.0 110.702 177.971 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 10' ' ' SER . . . . . 0.672 ' N ' ' O ' ' A' ' 6' ' ' THR . 75.2 m -67.82 -65.54 0.68 Allowed 'General case' 0 C--N 1.316 -0.882 0 C-N-CA 119.764 -0.774 . . . . 1.0 112.098 -178.302 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 11' ' ' ARG . . . . . 0.527 ' N ' ' O ' ' A' ' 7' ' ' GLU . 11.2 ttm180 -64.35 -58.48 6.38 Favored 'General case' 0 C--N 1.324 -0.519 0 C-N-CA 119.839 -0.744 . . . . 1.0 111.764 -176.066 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . 0.825 ' HB3' ' O ' ' A' ' 8' ' ' ARG . . . -47.9 -48.64 31.42 Favored 'General case' 0 CA--C 1.539 0.547 0 N-CA-C 106.71 -1.589 . . . . 1.0 106.71 -177.907 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . 0.659 ' O ' ' N ' ' A' ' 17' ' ' LEU . 97.6 t -62.07 -50.9 78.2 Favored 'Isoleucine or valine' 0 C--O 1.194 -1.846 0 C-N-CA 118.839 -1.145 . . . . 1.0 109.28 177.281 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . 0.578 ' O ' HG13 ' A' ' 18' ' ' VAL . . . -56.85 -62.21 1.9 Allowed 'General case' 0 C--O 1.207 -1.151 0 O-C-N 120.871 -1.143 . . . . 1.0 109.572 -179.938 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . 0.558 ' O ' ' N ' ' A' ' 19' ' ' GLY . . . -51.36 -54.3 27.78 Favored 'General case' 0 C--N 1.319 -0.754 0 CA-C-O 121.79 0.805 . . . . 1.0 109.248 -178.521 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . 0.466 ' CB ' ' O ' ' A' ' 12' ' ' ALA . . . -61.52 -54.63 40.73 Favored 'General case' 0 C--N 1.308 -1.218 0 CA-C-N 114.62 -1.173 . . . . 1.0 108.508 -179.207 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . 0.659 ' N ' ' O ' ' A' ' 13' ' ' VAL . 42.4 tp -55.46 -54.29 45.72 Favored 'General case' 0 N--CA 1.478 0.961 0 CA-C-N 113.574 -1.648 . . . . 1.0 109.053 -177.16 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . 0.582 HG23 ' N ' ' A' ' 19' ' ' GLY . 3.6 m -68.65 -57.0 10.24 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.235 0 N-CA-C 108.992 -0.744 . . . . 1.0 108.992 178.912 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . 0.582 ' N ' HG23 ' A' ' 18' ' ' VAL . . . -63.04 -170.72 1.37 Allowed Glycine 0 CA--C 1.525 0.66 0 N-CA-C 110.829 -0.908 . . . . 1.0 110.829 -179.992 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 20' ' ' PRO . . . . . 0.648 ' O ' ' N ' ' A' ' 24' ' ' ALA . 93.0 Cg_endo -79.25 -27.02 4.65 Favored 'Trans proline' 0 C--N 1.308 -1.591 0 C-N-CA 122.797 2.331 . . . . 1.0 114.129 -178.33 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -57.16 -56.21 26.23 Favored Glycine 0 N--CA 1.477 1.375 0 C-N-CA 119.822 -1.18 . . . . 1.0 111.064 -177.624 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . 0.465 ' H ' ' C ' ' A' ' 16' ' ' ALA . . . -60.38 -55.83 27.85 Favored Glycine 0 N--CA 1.468 0.803 0 N-CA-C 108.587 -1.805 . . . . 1.0 108.587 -178.39 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -59.77 -35.15 58.41 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.204 0 CA-C-N 114.561 -0.82 . . . . 1.0 109.417 -179.94 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . 0.648 ' N ' ' O ' ' A' ' 20' ' ' PRO . . . -57.89 -61.92 2.19 Favored 'General case' 0 N--CA 1.452 -0.36 0 C-N-CA 118.99 -1.084 . . . . 1.0 109.739 -178.704 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 16.2 tp -65.38 -42.11 93.04 Favored 'General case' 0 N--CA 1.451 -0.411 0 C-N-CA 119.853 -0.739 . . . . 1.0 111.904 -178.326 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 89.6 t -61.57 -60.39 2.78 Favored 'Isoleucine or valine' 0 CA--C 1.522 -0.104 0 C-N-CA 118.834 -1.147 . . . . 1.0 110.307 -177.931 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . 0.558 ' O ' ' HB3' ' A' ' 31' ' ' ALA . 93.4 t -62.57 -38.26 81.03 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 N-CA-C 112.814 0.672 . . . . 1.0 112.814 -178.316 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 3.3 ttmp? -64.34 -55.02 24.05 Favored 'General case' 0 C--N 1.314 -0.95 0 CA-C-O 121.929 0.871 . . . . 1.0 108.775 -178.213 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 55.6 t -64.58 -45.15 96.35 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.008 0 CA-C-N 113.632 -1.622 . . . . 1.0 109.801 -178.533 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 30' ' ' CYS . . . . . . . . . . . . . 43.1 t -65.85 -61.16 2.22 Favored 'General case' 0 N--CA 1.445 -0.715 0 C-N-CA 118.666 -1.213 . . . . 1.0 108.743 179.729 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . 0.558 ' HB3' ' O ' ' A' ' 27' ' ' VAL . . . -63.73 -57.09 11.06 Favored 'General case' 0 CA--C 1.512 -0.514 0 N-CA-C 113.486 0.921 . . . . 1.0 113.486 -176.358 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . 0.475 ' O ' ' CB ' ' A' ' 33' ' ' LEU . . . 89.92 74.02 1.28 Allowed Glycine 0 CA--C 1.526 0.737 0 N-CA-C 110.862 -0.895 . . . . 1.0 110.862 -178.92 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . 0.475 ' CB ' ' O ' ' A' ' 32' ' ' GLY . 4.7 tp 87.43 84.08 0.04 OUTLIER Pre-proline 0 CA--C 1.544 0.746 0 CA-C-O 120.999 0.428 . . . . 1.0 111.204 179.578 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 52.1 Cg_exo -55.48 -33.3 85.69 Favored 'Trans proline' 0 N--CA 1.503 2.037 0 C-N-CA 123.798 2.998 . . . . 1.0 115.298 -179.528 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -55.39 -58.65 12.88 Favored Glycine 0 N--CA 1.469 0.871 0 C-N-CA 118.462 -1.827 . . . . 1.0 108.616 -178.804 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . 0.639 ' O ' HG22 ' A' ' 37' ' ' ILE . 23.2 m -86.77 160.05 3.06 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.649 0 N-CA-C 107.081 -1.451 . . . . 1.0 107.081 177.616 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . 0.7 HG23 ' O ' ' A' ' 37' ' ' ILE . 14.3 tt 126.97 115.35 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.477 0.886 0 O-C-N 124.195 0.934 . . . . 1.0 110.503 -179.741 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -141.04 133.14 27.88 Favored 'General case' 0 C--N 1.325 -0.494 0 N-CA-C 108.154 -1.054 . . . . 1.0 108.154 177.518 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 38.8 p -115.03 143.55 30.38 Favored Pre-proline 0 C--N 1.33 -0.265 0 N-CA-C 108.771 -0.826 . . . . 1.0 108.771 179.501 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 40' ' ' PRO . . . . . 0.458 ' HG2' ' H ' ' A' ' 41' ' ' ALA . 57.1 Cg_endo -72.22 -82.73 0.01 OUTLIER 'Trans proline' 0 C--N 1.306 -1.699 0 C-N-CA 121.708 1.605 . . . . 1.0 112.551 -179.363 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . 0.458 ' H ' ' HG2' ' A' ' 40' ' ' PRO . . . -78.34 124.11 27.74 Favored 'General case' 0 C--N 1.311 -1.074 0 CA-C-N 114.436 -1.256 . . . . 1.0 111.686 -176.7 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . 0.699 ' C ' ' H ' ' A' ' 44' ' ' GLY . 13.6 ptt180 -170.9 169.71 6.66 Favored 'General case' 0 C--N 1.313 -0.981 0 CA-C-N 114.634 -1.167 . . . . 1.0 109.696 178.786 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 7.2 tpt180 -61.65 18.04 0.01 OUTLIER 'General case' 0 C--N 1.322 -0.608 0 C-N-CA 120.568 -0.453 . . . . 1.0 109.957 178.321 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . 0.699 ' H ' ' C ' ' A' ' 42' ' ' ARG . . . 82.98 -24.83 5.04 Favored Glycine 0 N--CA 1.446 -0.634 0 N-CA-C 110.506 -1.038 . . . . 1.0 110.506 -179.658 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . 0.759 ' O ' ' CG ' ' A' ' 46' ' ' PHE . 0.2 OUTLIER -164.5 172.82 12.81 Favored 'General case' 0 C--O 1.221 -0.403 0 C-N-CA 121.101 -0.24 . . . . 1.0 110.656 -179.553 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 46' ' ' PHE . . . . . 0.759 ' CG ' ' O ' ' A' ' 45' ' ' PHE . 22.0 m-30 127.1 90.41 0.0 OUTLIER 'General case' 0 N--CA 1.484 1.256 0 O-C-N 125.534 1.771 . . . . 1.0 111.688 179.391 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 47' ' ' ARG . . . . . 0.721 ' O ' ' SG ' ' A' ' 48' ' ' CYS . 2.2 ptm180 121.09 156.49 0.0 OUTLIER 'General case' 0 N--CA 1.477 0.895 0 O-C-N 125.449 1.718 . . . . 1.0 109.187 179.355 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 48' ' ' CYS . . . . . 0.721 ' SG ' ' O ' ' A' ' 47' ' ' ARG . 2.0 p 67.74 68.85 0.36 Allowed 'General case' 0 CA--C 1.532 0.284 0 CA-C-O 121.897 0.856 . . . . 1.0 109.523 -179.156 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -142.91 151.84 57.31 Favored Pre-proline 0 CA--C 1.534 0.361 0 N-CA-C 108.297 -1.001 . . . . 1.0 108.297 179.864 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 89.3 Cg_endo -77.31 69.9 6.98 Favored 'Trans proline' 0 C--N 1.308 -1.58 0 C-N-CA 122.015 1.81 . . . . 1.0 112.608 -179.728 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 5.4 tp10 64.68 26.93 13.19 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 120.697 0.284 . . . . 1.0 111.462 179.198 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -102.28 138.92 38.57 Favored 'General case' 0 N--CA 1.466 0.373 0 CA-C-N 116.474 -0.33 . . . . 1.0 110.262 179.066 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . 0.445 ' O ' ' N ' ' A' ' 55' ' ' ILE . 19.6 tt -66.61 139.64 20.8 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.251 0 CA-C-O 121.423 0.63 . . . . 1.0 110.718 179.553 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 4.2 pt20 -63.41 80.41 0.02 OUTLIER 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 114.781 -1.1 . . . . 1.0 109.586 -178.458 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . 0.445 ' N ' ' O ' ' A' ' 53' ' ' ILE . 1.8 tt -148.03 156.89 8.9 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.415 0 N-CA-C 109.902 -0.407 . . . . 1.0 109.902 178.242 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 113.57 -4.67 24.69 Favored Glycine 0 N--CA 1.467 0.705 0 N-CA-C 110.606 -0.998 . . . . 1.0 110.606 -179.765 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 14.8 p-10 -79.36 96.48 6.01 Favored 'General case' 0 C--N 1.325 -0.464 0 N-CA-C 109.318 -0.623 . . . . 1.0 109.318 177.625 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 58' ' ' TRP . . . . . 0.519 ' CE3' ' NH1' ' A' ' 59' ' ' ARG . 0.8 OUTLIER -86.54 176.36 7.86 Favored 'General case' 0 N--CA 1.467 0.421 0 CA-C-O 122.229 1.014 . . . . 1.0 112.647 -178.37 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 59' ' ' ARG . . . . . 0.519 ' NH1' ' CE3' ' A' ' 58' ' ' TRP . 0.0 OUTLIER -87.29 -56.28 3.43 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 113.326 -1.761 . . . . 1.0 112.388 -179.394 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 73.6 t80 -93.81 -16.86 23.7 Favored 'General case' 0 C--O 1.249 1.044 0 CA-C-O 121.813 0.816 . . . . 1.0 113.153 -179.112 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . 0.459 ' O ' ' N ' ' A' ' 65' ' ' ASP . 6.5 tt0 -78.79 -13.23 59.92 Favored 'General case' 0 N--CA 1.444 -0.766 0 O-C-N 121.418 -0.801 . . . . 1.0 111.516 -178.24 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 62' ' ' VAL . . . . . 0.596 ' O ' ' N ' ' A' ' 66' ' ' GLY . 0.0 OUTLIER -47.8 -55.63 2.38 Favored 'Isoleucine or valine' 0 C--O 1.208 -1.11 0 C-N-CA 119.244 -0.983 . . . . 1.0 109.589 -175.559 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -65.01 -52.42 56.19 Favored 'General case' 0 C--N 1.31 -1.136 0 C-N-CA 119.335 -0.946 . . . . 1.0 109.192 -179.984 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 64' ' ' HIS . . . . . 0.504 ' O ' ' HB2' ' A' ' 67' ' ' ARG . 6.0 t-80 -50.78 -57.78 7.54 Favored 'General case' 0 CA--C 1.536 0.43 0 C-N-CA 119.463 -0.895 . . . . 1.0 109.894 -179.534 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 65' ' ' ASP . . . . . 0.577 ' O ' ' ND2' ' A' ' 75' ' ' ASN . 3.3 t0 -70.1 -47.05 63.46 Favored 'General case' 0 C--N 1.314 -0.963 0 CA-C-O 122.065 0.935 . . . . 1.0 110.303 179.188 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . 0.596 ' N ' ' O ' ' A' ' 62' ' ' VAL . . . -70.13 28.25 0.43 Allowed Glycine 0 C--N 1.316 -0.572 0 O-C-N 121.47 -0.769 . . . . 1.0 111.642 179.725 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 67' ' ' ARG . . . . . 0.557 ' H ' ' C ' ' A' ' 65' ' ' ASP . 0.0 OUTLIER -81.25 -3.01 51.08 Favored 'General case' 0 C--N 1.319 -0.755 0 N-CA-C 107.964 -1.124 . . . . 1.0 107.964 176.559 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . 0.417 ' O ' ' HB3' ' A' ' 72' ' ' HIS . 8.7 tp -42.25 -31.67 0.42 Allowed 'General case' 0 C--O 1.216 -0.679 0 CA-C-N 115.567 -0.742 . . . . 1.0 109.495 -179.904 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 3.8 tt -67.83 -68.66 0.37 Allowed 'General case' 0 CA--C 1.54 0.581 0 C-N-CA 118.434 -1.306 . . . . 1.0 112.877 -177.347 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . 0.572 ' C ' ' H ' ' A' ' 72' ' ' HIS . . . -74.58 -84.36 0.05 OUTLIER 'General case' 0 N--CA 1.47 0.563 0 C-N-CA 116.757 -1.977 . . . . 1.0 109.03 -176.426 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 71' ' ' ALA . . . . . 0.884 ' O ' ' N ' ' A' ' 73' ' ' MET . . . -56.37 16.28 0.0 OUTLIER 'General case' 0 C--N 1.308 -1.233 0 C-N-CA 124.993 1.317 . . . . 1.0 113.588 -179.738 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 72' ' ' HIS . . . . . 0.572 ' H ' ' C ' ' A' ' 70' ' ' ALA . 0.0 OUTLIER -17.92 -29.32 0.0 OUTLIER 'General case' 0 N--CA 1.473 0.676 0 N-CA-C 112.758 0.651 . . . . 1.0 112.758 -175.048 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 73' ' ' MET . . . . . 0.884 ' N ' ' O ' ' A' ' 71' ' ' ALA . 19.0 mmt -64.81 -56.59 12.59 Favored 'General case' 0 N--CA 1.446 -0.646 0 C-N-CA 119.667 -0.813 . . . . 1.0 108.84 176.4 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . 0.665 ' O ' ' N ' ' A' ' 76' ' ' GLY . 34.8 m -43.96 -50.97 1.62 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.821 0 CA-C-O 117.814 -1.089 . . . . 1.0 111.565 -174.815 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 75' ' ' ASN . . . . . 0.577 ' ND2' ' O ' ' A' ' 65' ' ' ASP . 2.0 t-20 -36.42 -18.24 0.0 OUTLIER 'General case' 0 N--CA 1.47 0.533 0 CA-C-N 121.042 1.746 . . . . 1.0 112.299 -179.831 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 76' ' ' GLY . . . . . 0.665 ' N ' ' O ' ' A' ' 74' ' ' VAL . . . -47.72 -28.19 5.1 Favored Glycine 0 CA--C 1.537 1.437 0 N-CA-C 109.16 -1.576 . . . . 1.0 109.16 177.681 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 77' ' ' ILE . . . . . 0.612 ' HA ' ' HB3' ' A' ' 80' ' ' ALA . 6.9 pt -69.29 -51.77 39.7 Favored 'Isoleucine or valine' 0 C--O 1.21 -1.009 0 CA-C-O 122.114 0.959 . . . . 1.0 108.828 -179.967 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . 0.484 ' C ' ' O ' ' A' ' 77' ' ' ILE . 77.0 t -36.25 -33.12 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.313 -0.979 0 CA-C-N 113.003 -1.908 . . . . 1.0 107.292 -176.701 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . 0.624 ' O ' ' HB3' ' A' ' 83' ' ' ALA . 0.7 OUTLIER -96.77 -31.68 4.02 Favored 'Isoleucine or valine' 0 C--O 1.213 -0.842 0 CA-C-N 115.606 -0.724 . . . . 1.0 110.938 176.653 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 80' ' ' ALA . . . . . 0.612 ' HB3' ' HA ' ' A' ' 77' ' ' ILE . . . -82.45 -8.78 59.61 Favored 'General case' 0 N--CA 1.473 0.68 0 N-CA-C 112.521 0.563 . . . . 1.0 112.521 179.367 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 81' ' ' GLU . . . . . 0.806 ' O ' HD21 ' A' ' 84' ' ' LEU . 7.6 mm-40 -91.15 -72.69 0.57 Allowed 'General case' 0 N--CA 1.439 -0.982 0 O-C-N 122.036 -0.415 . . . . 1.0 112.018 -178.258 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 8.3 t70 -92.68 -14.4 28.12 Favored 'General case' 0 C--N 1.346 0.423 0 N-CA-C 115.024 1.49 . . . . 1.0 115.024 -178.89 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . 0.624 ' HB3' ' O ' ' A' ' 79' ' ' ILE . . . -54.26 -44.8 72.14 Favored 'General case' 0 CA--C 1.54 0.595 0 C-N-CA 118.464 -1.294 . . . . 1.0 112.894 -177.505 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . 1.019 ' H ' HD13 ' A' ' 84' ' ' LEU . 0.0 OUTLIER -42.75 -14.74 0.01 OUTLIER 'General case' 0 N--CA 1.474 0.752 0 CA-C-N 119.018 0.826 . . . . 1.0 111.079 -177.682 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 85' ' ' ILE . . . . . 0.583 ' N ' ' O ' ' A' ' 83' ' ' ALA . 3.5 mm -94.04 -29.81 4.27 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.25 0 C-N-CA 120.674 -0.41 . . . . 1.0 110.223 179.056 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 86' ' ' ALA . . . . . 0.672 ' C ' ' H ' ' A' ' 88' ' ' ALA . . . -93.02 -24.24 18.4 Favored 'General case' 0 CA--C 1.522 -0.125 0 CA-C-O 121.513 0.673 . . . . 1.0 109.732 179.26 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 20.3 tt0 -63.82 25.85 0.01 OUTLIER 'General case' 0 C--N 1.32 -0.714 0 CA-C-O 121.491 0.662 . . . . 1.0 110.474 -179.036 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 88' ' ' ALA . . . . . 0.672 ' H ' ' C ' ' A' ' 86' ' ' ALA . . . -123.31 -7.31 8.19 Favored 'General case' 0 N--CA 1.474 0.766 0 CA-C-O 122.207 1.004 . . . . 1.0 108.519 178.836 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 89' ' ' VAL . . . . . 0.498 HG23 ' O ' ' A' ' 86' ' ' ALA . 2.4 t -84.31 36.9 0.05 OUTLIER 'Isoleucine or valine' 0 C--O 1.216 -0.659 0 CA-C-N 112.77 -2.014 . . . . 1.0 109.172 178.383 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 90' ' ' GLY . . . . . 0.513 ' N ' ' CD ' ' A' ' 91' ' ' PRO . . . -74.26 -40.52 40.98 Favored Glycine 0 C--N 1.345 1.052 0 C-N-CA 120.504 -0.855 . . . . 1.0 111.382 179.57 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 91' ' ' PRO . . . . . 0.513 ' CD ' ' N ' ' A' ' 90' ' ' GLY . 98.3 Cg_exo -43.51 -21.64 0.31 Allowed 'Trans proline' 0 N--CA 1.497 1.698 0 CA-C-N 119.572 1.686 . . . . 1.0 109.788 -179.701 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 92' ' ' HIS . . . . . 0.799 ' O ' ' N ' ' A' ' 96' ' ' ALA . 0.3 OUTLIER -55.34 -18.4 6.49 Favored 'General case' 0 C--O 1.194 -1.832 0 N-CA-C 107.167 -1.42 . . . . 1.0 107.167 179.897 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 93' ' ' LEU . . . . . 0.656 HD12 ' N ' ' A' ' 94' ' ' ALA . 2.8 pp -51.01 -53.66 31.45 Favored 'General case' 0 CA--C 1.541 0.612 0 N-CA-C 108.669 -0.863 . . . . 1.0 108.669 178.556 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 94' ' ' ALA . . . . . 0.656 ' N ' HD12 ' A' ' 93' ' ' LEU . . . -52.23 -44.87 65.06 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-N 114.521 -1.218 . . . . 1.0 108.972 -179.279 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 95' ' ' ARG . . . . . 0.579 ' C ' ' H ' ' A' ' 97' ' ' LEU . 0.0 OUTLIER -78.18 -49.87 13.01 Favored 'General case' 0 CA--C 1.553 1.077 0 CA-C-O 125.921 2.772 . . . . 1.0 109.142 178.619 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 96' ' ' ALA . . . . . 0.799 ' N ' ' O ' ' A' ' 92' ' ' HIS . . . -68.49 28.0 0.03 OUTLIER 'General case' 0 C--N 1.259 -3.335 0 CA-C-N 112.901 -1.954 . . . . 1.0 107.264 173.028 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 97' ' ' LEU . . . . . 1.034 HD13 ' H ' ' A' ' 98' ' ' GLY . 0.0 OUTLIER -43.71 -46.34 7.45 Favored 'General case' 0 C--O 1.202 -1.444 0 N-CA-C 108.861 -0.792 . . . . 1.0 108.861 178.64 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 98' ' ' GLY . . . . . 1.034 ' H ' HD13 ' A' ' 97' ' ' LEU . . . -49.22 -28.2 8.32 Favored Glycine 0 CA--C 1.5 -0.891 0 N-CA-C 107.867 -2.093 . . . . 1.0 107.867 -179.862 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 99' ' ' GLN . . . . . 0.62 ' N ' ' O ' ' A' ' 96' ' ' ALA . 0.0 OUTLIER -59.41 -22.19 61.05 Favored 'General case' 0 C--O 1.216 -0.7 0 N-CA-C 106.693 -1.595 . . . . 1.0 106.693 176.811 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 100' ' ' ILE . . . . . 0.744 ' N ' ' O ' ' A' ' 97' ' ' LEU . 6.1 mm -67.68 -51.55 49.73 Favored 'Isoleucine or valine' 0 C--O 1.207 -1.155 0 CA-C-N 115.387 -0.824 . . . . 1.0 110.045 178.704 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 101' ' ' VAL . . . . . 0.698 ' O ' ' N ' ' A' ' 105' ' ' GLY . 0.4 OUTLIER -52.87 -61.06 0.89 Allowed 'Isoleucine or valine' 0 C--O 1.213 -0.835 0 C-N-CA 119.085 -1.046 . . . . 1.0 110.412 -178.296 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 102' ' ' CYS . . . . . 0.878 ' O ' ' HB2' ' A' ' 106' ' ' ALA . 1.4 p -56.06 -21.77 23.74 Favored 'General case' 0 C--N 1.316 -0.881 0 C-N-CA 118.942 -1.103 . . . . 1.0 110.062 -176.98 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -84.51 -53.89 5.12 Favored 'General case' 0 N--CA 1.481 1.082 0 O-C-N 124.339 1.025 . . . . 1.0 112.399 178.888 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 104' ' ' TYR . . . . . . . . . . . . . 17.9 t80 -96.37 21.18 9.41 Favored 'General case' 0 C--N 1.309 -1.19 0 C-N-CA 126.44 1.896 . . . . 1.0 108.753 178.636 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 105' ' ' GLY . . . . . 0.698 ' N ' ' O ' ' A' ' 101' ' ' VAL . . . -153.62 -96.49 0.13 Allowed Glycine 0 C--N 1.335 0.492 0 N-CA-C 107.893 -2.083 . . . . 1.0 107.893 178.926 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 106' ' ' ALA . . . . . 0.878 ' HB2' ' O ' ' A' ' 102' ' ' CYS . . . 67.2 109.37 0.04 OUTLIER 'General case' 0 CA--C 1.541 0.622 0 O-C-N 122.988 -0.125 . . . . 1.0 111.297 -178.976 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 107' ' ' THR . . . . . 0.65 ' C ' ' H ' ' A' ' 109' ' ' ILE . 0.3 OUTLIER -134.66 -63.69 0.7 Allowed 'General case' 0 C--N 1.353 0.731 0 N-CA-C 105.932 -1.877 . . . . 1.0 105.932 176.926 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 26.9 m -67.16 23.61 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.324 -0.519 0 O-C-N 121.657 -0.652 . . . . 1.0 109.453 179.686 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 109' ' ' ILE . . . . . 0.713 ' H ' ' HD2' ' A' ' 110' ' ' PRO . 0.1 OUTLIER -115.5 -57.09 0.04 OUTLIER Pre-proline 0 CA--C 1.552 1.032 0 N-CA-C 108.278 -1.008 . . . . 1.0 108.278 175.79 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 110' ' ' PRO . . . . . 0.713 ' HD2' ' H ' ' A' ' 109' ' ' ILE . 18.6 Cg_endo -53.82 -39.46 84.05 Favored 'Trans proline' 0 N--CA 1.506 2.237 0 C-N-CA 122.673 2.249 . . . . 1.0 112.046 177.584 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 111' ' ' ASN . . . . . 0.447 ' C ' ' N ' ' A' ' 113' ' ' ASN . 39.3 t30 -67.68 -67.62 0.45 Allowed 'General case' 0 C--O 1.238 0.45 0 C-N-CA 119.91 -0.716 . . . . 1.0 110.463 -178.342 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 112' ' ' ILE . . . . . 0.647 ' C ' HD12 ' A' ' 112' ' ' ILE . 1.4 pp -52.88 -21.45 3.11 Favored 'Isoleucine or valine' 0 C--O 1.212 -0.87 0 CA-C-O 121.998 0.904 . . . . 1.0 108.647 -179.924 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 113' ' ' ASN . . . . . 0.447 ' N ' ' C ' ' A' ' 111' ' ' ASN . 0.0 OUTLIER -60.58 -52.82 63.52 Favored 'General case' 0 C--N 1.311 -1.093 0 CA-C-N 112.698 -2.046 . . . . 1.0 108.813 -179.894 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -58.18 -28.83 65.13 Favored 'General case' 0 N--CA 1.455 -0.194 0 CA-C-N 119.01 0.823 . . . . 1.0 111.48 179.226 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 115' ' ' ALA . . . . . 0.555 ' O ' ' N ' ' A' ' 118' ' ' VAL . . . -81.1 -52.06 7.8 Favored 'General case' 0 C--O 1.219 -0.53 0 N-CA-C 109.108 -0.701 . . . . 1.0 109.108 177.552 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 116' ' ' ILE . . . . . 0.454 HD13 HD13 ' A' ' 112' ' ' ILE . 1.2 tp -42.13 -49.7 0.96 Allowed 'Isoleucine or valine' 0 N--CA 1.478 0.943 0 N-CA-C 105.611 -1.996 . . . . 1.0 105.611 179.766 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 117' ' ' GLU . . . . . 0.471 ' O ' ' HA ' ' A' ' 121' ' ' THR . 62.7 mt-10 -45.1 -57.53 3.82 Favored 'General case' 0 C--N 1.312 -1.036 0 CA-C-N 110.493 -3.049 . . . . 1.0 105.857 178.341 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 118' ' ' VAL . . . . . 0.555 ' N ' ' O ' ' A' ' 115' ' ' ALA . 54.9 t -68.15 -57.13 10.22 Favored 'Isoleucine or valine' 0 CA--C 1.551 1.004 0 C-N-CA 120.684 -0.406 . . . . 1.0 111.046 178.042 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 119' ' ' LEU . . . . . 0.506 ' N ' ' O ' ' A' ' 115' ' ' ALA . 59.2 tp -52.77 -19.85 2.77 Favored 'General case' 0 CA--C 1.538 0.492 0 N-CA-C 113.78 1.03 . . . . 1.0 113.78 -178.666 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 120' ' ' GLY . . . . . 0.607 ' O ' ' OG1' ' A' ' 121' ' ' THR . . . -127.3 -73.81 0.19 Allowed Glycine 0 CA--C 1.547 2.076 0 N-CA-C 106.535 -2.626 . . . . 1.0 106.535 172.719 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 121' ' ' THR . . . . . 0.607 ' OG1' ' O ' ' A' ' 120' ' ' GLY . 17.6 m 161.9 -44.62 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.772 0 CA-C-N 112.686 -1.757 . . . . 1.0 112.796 179.444 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 122' ' ' GLY . . . . . 0.68 ' O ' ' N ' ' A' ' 124' ' ' ASP . . . 104.76 -15.22 49.07 Favored Glycine 0 N--CA 1.471 0.985 0 N-CA-C 108.282 -1.927 . . . . 1.0 108.282 -175.98 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 123' ' ' THR . . . . . 0.689 HG23 ' O ' ' A' ' 123' ' ' THR . 8.4 t -56.95 81.11 0.01 OUTLIER 'General case' 0 N--CA 1.469 0.511 0 N-CA-C 104.615 -2.365 . . . . 1.0 104.615 178.438 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 124' ' ' ASP . . . . . 0.68 ' N ' ' O ' ' A' ' 122' ' ' GLY . 28.6 m-20 -166.93 178.37 5.83 Favored 'General case' 0 N--CA 1.465 0.307 0 CA-C-N 113.464 -1.698 . . . . 1.0 111.552 179.815 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 125' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -142.06 143.07 32.93 Favored 'General case' 0 CA--C 1.54 0.564 0 N-CA-C 108.086 -1.079 . . . . 1.0 108.086 175.766 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 3.0 tpm_? -147.43 146.02 29.42 Favored 'General case' 0 C--N 1.332 -0.185 0 N-CA-C 110.049 -0.352 . . . . 1.0 110.049 179.43 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 127' ' ' PHE . . . . . . . . . . . . . 1.5 t80 . . . . . 0 C--O 1.221 -0.411 0 CA-C-O 117.94 -1.028 . . . . 1.0 109.528 179.498 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 11.8 mtt . . . . . 0 N--CA 1.49 1.55 0 N-CA-C 108.918 -0.771 . . . . 1.0 108.918 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 93.1 p -90.12 3.64 52.76 Favored 'General case' 0 N--CA 1.464 0.238 0 CA-C-N 116.564 -0.289 . . . . 1.0 110.933 -179.555 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 2.1 t70 163.14 114.96 0.0 OUTLIER 'General case' 0 N--CA 1.465 0.296 0 O-C-N 123.675 0.609 . . . . 1.0 110.04 179.162 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 92.8 t80 -147.57 143.99 28.16 Favored 'General case' 0 CA--C 1.513 -0.446 0 N-CA-C 109.133 -0.691 . . . . 1.0 109.133 178.861 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 5' ' ' ASP . . . . . 0.44 ' HB2' ' N ' ' A' ' 10' ' ' SER . 1.0 OUTLIER -153.32 148.64 27.01 Favored 'General case' 0 C--N 1.326 -0.444 0 C-N-CA 120.557 -0.457 . . . . 1.0 110.512 -179.39 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 6' ' ' THR . . . . . 0.696 ' O ' ' N ' ' A' ' 10' ' ' SER . 0.2 OUTLIER -116.72 -152.7 0.51 Allowed 'General case' 0 C--O 1.209 -1.031 0 CA-C-O 121.425 0.631 . . . . 1.0 110.313 179.896 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . 0.579 ' OE1' ' N ' ' A' ' 8' ' ' ARG . 0.0 OUTLIER -59.34 -49.64 77.05 Favored 'General case' 0 C--N 1.309 -1.196 0 CA-C-O 121.872 0.844 . . . . 1.0 110.603 -177.895 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 8' ' ' ARG . . . . . 0.855 ' O ' ' HB3' ' A' ' 12' ' ' ALA . 5.0 ptt180 -67.35 -57.79 5.98 Favored 'General case' 0 C--N 1.302 -1.487 0 C-N-CA 118.725 -1.19 . . . . 1.0 108.759 178.43 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . 0.55 ' O ' HG12 ' A' ' 13' ' ' VAL . 6.7 t -66.08 -53.45 37.27 Favored 'Isoleucine or valine' 0 C--O 1.197 -1.665 0 C-N-CA 119.219 -0.992 . . . . 1.0 111.427 -178.322 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 10' ' ' SER . . . . . 0.696 ' N ' ' O ' ' A' ' 6' ' ' THR . 1.4 t -69.23 -62.46 1.37 Allowed 'General case' 0 C--N 1.309 -1.188 0 C-N-CA 119.363 -0.935 . . . . 1.0 111.974 -178.972 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 11' ' ' ARG . . . . . 0.597 ' O ' ' HB3' ' A' ' 15' ' ' ALA . 1.7 mmt180 -65.3 -45.55 83.96 Favored 'General case' 0 N--CA 1.474 0.74 0 N-CA-C 112.53 0.567 . . . . 1.0 112.53 -176.229 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . 0.855 ' HB3' ' O ' ' A' ' 8' ' ' ARG . . . -68.57 -55.59 11.12 Favored 'General case' 0 C--N 1.326 -0.45 0 C-N-CA 118.068 -1.453 . . . . 1.0 108.412 178.463 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . 0.642 ' O ' ' CB ' ' A' ' 17' ' ' LEU . 0.4 OUTLIER -62.44 -52.59 58.14 Favored 'Isoleucine or valine' 0 C--O 1.201 -1.471 0 C-N-CA 118.225 -1.39 . . . . 1.0 109.145 -179.264 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . 0.734 ' O ' HG22 ' A' ' 18' ' ' VAL . . . -61.05 -61.35 2.64 Favored 'General case' 0 C--N 1.314 -0.978 0 C-N-CA 117.177 -1.809 . . . . 1.0 110.429 179.929 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . 0.597 ' HB3' ' O ' ' A' ' 11' ' ' ARG . . . -54.17 -56.12 21.25 Favored 'General case' 0 N--CA 1.475 0.815 0 C-N-CA 119.268 -0.973 . . . . 1.0 110.141 -178.058 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . 0.623 ' HB3' ' O ' ' A' ' 12' ' ' ALA . . . -65.43 -55.71 16.49 Favored 'General case' 0 C--N 1.315 -0.909 0 C-N-CA 118.793 -1.163 . . . . 1.0 110.364 -179.271 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . 0.642 ' CB ' ' O ' ' A' ' 13' ' ' VAL . 10.8 tp -57.16 -56.14 25.58 Favored 'General case' 0 N--CA 1.485 1.293 0 C-N-CA 119.341 -0.944 . . . . 1.0 108.665 -178.184 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . 0.734 HG22 ' O ' ' A' ' 14' ' ' ALA . 1.3 m -71.68 -57.75 6.7 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.571 0 C-N-CA 119.519 -0.872 . . . . 1.0 110.557 -179.711 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . 0.53 ' N ' ' O ' ' A' ' 15' ' ' ALA . . . -62.9 -163.33 0.38 Allowed Glycine 0 CA--C 1.522 0.503 0 N-CA-C 111.748 -0.541 . . . . 1.0 111.748 -178.041 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 20' ' ' PRO . . . . . 0.601 ' O ' ' N ' ' A' ' 24' ' ' ALA . 69.3 Cg_endo -80.51 -21.91 7.09 Favored 'Trans proline' 0 C--N 1.304 -1.797 0 C-N-CA 122.419 2.079 . . . . 1.0 114.472 -178.044 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -60.66 -61.04 7.48 Favored Glycine 0 N--CA 1.476 1.326 0 C-N-CA 118.945 -1.598 . . . . 1.0 111.489 -177.165 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . 0.607 ' H ' ' CA ' ' A' ' 16' ' ' ALA . . . -59.63 -54.65 35.9 Favored Glycine 0 N--CA 1.466 0.66 0 N-CA-C 107.903 -2.079 . . . . 1.0 107.903 179.674 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . 0.605 ' O ' HG12 ' A' ' 27' ' ' VAL . 85.0 t -56.57 -34.15 41.27 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 C-N-CA 119.46 -0.896 . . . . 1.0 109.411 -179.273 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . 0.601 ' N ' ' O ' ' A' ' 20' ' ' PRO . . . -64.65 -61.35 2.25 Favored 'General case' 0 N--CA 1.47 0.533 0 C-N-CA 118.879 -1.129 . . . . 1.0 110.341 179.314 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 13.4 tp -61.05 -49.45 77.33 Favored 'General case' 0 CA--C 1.519 -0.219 0 C-N-CA 120.049 -0.66 . . . . 1.0 112.119 -177.015 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 70.0 t -59.18 -60.05 2.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 C-N-CA 119.095 -1.042 . . . . 1.0 110.476 -177.521 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . 0.72 ' O ' ' HB3' ' A' ' 31' ' ' ALA . 1.4 p -59.54 -38.46 75.48 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 C-N-CA 120.406 -0.517 . . . . 1.0 111.709 -177.163 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 88.5 tttt -69.28 -55.81 9.4 Favored 'General case' 0 C--N 1.317 -0.847 0 C-N-CA 120.161 -0.616 . . . . 1.0 110.113 -179.174 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 53.8 t -66.25 -52.09 51.55 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.619 0 CA-C-N 115.318 -0.855 . . . . 1.0 111.633 -176.499 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 30' ' ' CYS . . . . . . . . . . . . . 49.4 t -66.55 -60.79 2.4 Favored 'General case' 0 N--CA 1.445 -0.723 0 C-N-CA 118.761 -1.175 . . . . 1.0 110.589 -178.086 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . 0.72 ' HB3' ' O ' ' A' ' 27' ' ' VAL . . . -64.5 -49.97 69.24 Favored 'General case' 0 CA--C 1.513 -0.463 0 C-N-CA 120.691 -0.404 . . . . 1.0 111.78 -175.627 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . 0.512 ' O ' ' CB ' ' A' ' 33' ' ' LEU . . . 77.78 62.57 2.35 Favored Glycine 0 N--CA 1.447 -0.622 0 N-CA-C 107.923 -2.071 . . . . 1.0 107.923 -177.492 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . 0.512 ' CB ' ' O ' ' A' ' 32' ' ' GLY . 9.8 tp 90.32 94.43 0.03 OUTLIER Pre-proline 0 CA--C 1.541 0.625 0 CA-C-N 115.093 -0.553 . . . . 1.0 110.076 -179.064 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 59.4 Cg_endo -74.15 -11.27 23.13 Favored 'Trans proline' 0 N--CA 1.495 1.61 0 C-N-CA 122.012 1.808 . . . . 1.0 112.56 -179.212 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -58.04 -60.81 8.27 Favored Glycine 0 CA--C 1.534 1.235 0 C-N-CA 118.834 -1.65 . . . . 1.0 109.401 -178.847 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . 0.638 ' O ' HG22 ' A' ' 37' ' ' ILE . 1.6 m -90.19 176.4 0.66 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.47 0 N-CA-C 106.496 -1.668 . . . . 1.0 106.496 176.676 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . 0.638 HG22 ' O ' ' A' ' 36' ' ' VAL . 9.5 tt 107.72 115.49 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.481 1.089 0 O-C-N 124.787 1.304 . . . . 1.0 110.234 179.564 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 76.6 m80 -143.62 136.91 27.91 Favored 'General case' 0 C--O 1.231 0.093 0 CA-C-O 120.862 0.363 . . . . 1.0 110.024 179.995 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -106.93 118.62 53.67 Favored Pre-proline 0 CA--C 1.535 0.399 0 N-CA-C 109.17 -0.678 . . . . 1.0 109.17 179.167 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 65.8 Cg_exo -47.13 -24.22 3.37 Favored 'Trans proline' 0 N--CA 1.493 1.483 0 C-N-CA 121.629 1.553 . . . . 1.0 113.549 -179.403 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -127.94 135.95 50.66 Favored 'General case' 0 N--CA 1.467 0.377 0 CA-C-O 119.911 -0.09 . . . . 1.0 110.824 179.013 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . 0.718 ' C ' ' H ' ' A' ' 44' ' ' GLY . 14.0 ptm180 -167.16 166.42 14.97 Favored 'General case' 0 C--N 1.319 -0.726 0 C-N-CA 120.015 -0.674 . . . . 1.0 110.485 178.226 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 43' ' ' ARG . . . . . 0.649 ' C ' ' H ' ' A' ' 45' ' ' PHE . 25.6 tpt180 -62.13 22.54 0.01 OUTLIER 'General case' 0 CA--C 1.545 0.769 0 CA-C-O 121.63 0.728 . . . . 1.0 109.826 -179.92 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . 0.718 ' H ' ' C ' ' A' ' 42' ' ' ARG . . . 66.85 -30.28 0.18 Allowed Glycine 0 C--N 1.337 0.599 0 N-CA-C 110.663 -0.975 . . . . 1.0 110.663 179.125 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . 0.649 ' H ' ' C ' ' A' ' 43' ' ' ARG . 0.7 OUTLIER -166.43 173.12 10.22 Favored 'General case' 0 N--CA 1.446 -0.649 0 N-CA-C 108.939 -0.763 . . . . 1.0 108.939 -179.194 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 46' ' ' PHE . . . . . 0.547 ' CB ' ' O ' ' A' ' 45' ' ' PHE . 6.8 t80 110.4 106.67 0.0 OUTLIER 'General case' 0 N--CA 1.48 1.053 0 O-C-N 125.278 1.611 . . . . 1.0 109.495 179.555 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 47' ' ' ARG . . . . . 0.42 ' CB ' ' O ' ' A' ' 46' ' ' PHE . 2.5 ptm180 102.67 150.61 0.01 OUTLIER 'General case' 0 N--CA 1.48 1.03 0 O-C-N 125.012 1.445 . . . . 1.0 110.695 -179.452 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 37.5 t 60.84 67.49 0.81 Allowed 'General case' 0 CA--C 1.509 -0.619 0 N-CA-C 108.256 -1.016 . . . . 1.0 108.256 179.453 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 49' ' ' ASN . . . . . 0.526 ' O ' ' N ' ' A' ' 51' ' ' GLU . 0.5 OUTLIER -130.73 160.97 63.94 Favored Pre-proline 0 C--N 1.327 -0.395 0 CA-C-N 115.892 -0.595 . . . . 1.0 109.912 -178.842 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 50' ' ' PRO . . . . . 0.565 ' HG3' HH21 ' A' ' 52' ' ' ARG . 17.9 Cg_endo -62.12 52.59 0.11 Allowed 'Trans proline' 0 N--CA 1.494 1.557 0 C-N-CA 123.049 2.5 . . . . 1.0 112.061 179.394 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . 0.526 ' N ' ' O ' ' A' ' 49' ' ' ASN . 1.4 pm0 29.72 44.38 0.02 OUTLIER 'General case' 0 N--CA 1.471 0.599 0 CA-C-N 115.991 -0.549 . . . . 1.0 112.355 179.64 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . 0.569 ' HD2' ' HB1' ' A' ' 86' ' ' ALA . 75.5 mtm180 -122.85 141.56 51.74 Favored 'General case' 0 N--CA 1.476 0.846 0 N-CA-C 109.86 -0.422 . . . . 1.0 109.86 178.808 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 8.8 tp -37.66 135.68 0.24 Allowed 'Isoleucine or valine' 0 CA--C 1.53 0.179 0 CA-C-O 122.666 1.222 . . . . 1.0 112.745 -174.923 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -92.03 77.29 5.38 Favored 'General case' 0 C--N 1.339 0.121 0 CA-C-N 112.589 -2.096 . . . . 1.0 113.076 -177.899 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 3.8 tp -144.26 150.33 16.78 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.365 0 N-CA-C 108.471 -0.937 . . . . 1.0 108.471 176.82 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 104.27 2.29 44.6 Favored Glycine 0 CA--C 1.527 0.806 0 N-CA-C 109.495 -1.442 . . . . 1.0 109.495 -179.056 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . 0.443 ' CG ' ' CE2' ' A' ' 45' ' ' PHE . 22.6 m-20 -86.13 107.07 17.68 Favored 'General case' 0 CA--C 1.538 0.516 0 N-CA-C 113.032 0.753 . . . . 1.0 113.032 -178.69 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 58' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -80.56 178.74 8.13 Favored 'General case' 0 N--CA 1.469 0.515 0 CA-C-N 114.387 -1.279 . . . . 1.0 108.324 177.997 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 59' ' ' ARG . . . . . 0.826 ' HE ' ' H ' ' A' ' 59' ' ' ARG . 0.0 OUTLIER -101.23 -54.2 2.84 Favored 'General case' 0 CA--C 1.545 0.755 0 CA-C-N 119.246 0.93 . . . . 1.0 110.576 178.295 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -79.19 -13.26 59.81 Favored 'General case' 0 N--CA 1.482 1.151 0 CA-C-N 114.52 -1.218 . . . . 1.0 111.3 -178.914 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . 0.413 ' O ' ' N ' ' A' ' 65' ' ' ASP . 42.5 tt0 -69.25 -13.92 62.67 Favored 'General case' 0 C--N 1.303 -1.44 0 CA-C-N 115.124 -0.943 . . . . 1.0 108.459 179.11 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 62' ' ' VAL . . . . . 0.654 HG13 ' O ' ' A' ' 59' ' ' ARG . 11.6 m -44.59 -51.64 1.81 Allowed 'Isoleucine or valine' 0 C--N 1.317 -0.844 0 CA-C-N 115.787 -0.642 . . . . 1.0 110.516 -175.757 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 63' ' ' ALA . . . . . 0.626 ' O ' ' HG2' ' A' ' 67' ' ' ARG . . . -67.38 -47.28 70.81 Favored 'General case' 0 N--CA 1.423 -1.798 0 C-N-CA 119.608 -0.837 . . . . 1.0 109.028 179.871 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 64' ' ' HIS . . . . . 0.437 ' O ' ' CG ' ' A' ' 67' ' ' ARG . 0.2 OUTLIER -54.04 -59.59 4.45 Favored 'General case' 0 CA--C 1.542 0.649 0 CA-C-N 115.756 -0.657 . . . . 1.0 110.301 179.612 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 65' ' ' ASP . . . . . 0.64 ' C ' ' H ' ' A' ' 67' ' ' ARG . 1.1 t70 -65.99 -52.24 51.21 Favored 'General case' 0 C--O 1.242 0.666 0 CA-C-O 121.658 0.742 . . . . 1.0 109.21 177.864 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . 0.498 ' N ' ' O ' ' A' ' 62' ' ' VAL . . . -64.27 29.18 0.1 OUTLIER Glycine 0 CA--C 1.53 1.031 0 N-CA-C 110.979 -0.849 . . . . 1.0 110.979 178.002 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 67' ' ' ARG . . . . . 0.64 ' H ' ' C ' ' A' ' 65' ' ' ASP . 5.5 mmm180 -78.9 -4.18 48.43 Favored 'General case' 0 C--N 1.323 -0.566 0 N-CA-C 108.056 -1.09 . . . . 1.0 108.056 175.836 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . 0.456 ' C ' ' O ' ' A' ' 67' ' ' ARG . 0.6 OUTLIER -35.45 -29.16 0.01 OUTLIER 'General case' 0 N--CA 1.48 1.075 0 N-CA-C 108.033 -1.099 . . . . 1.0 108.033 -177.298 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . 0.576 ' N ' ' O ' ' A' ' 67' ' ' ARG . 8.4 tt -62.83 -64.86 0.79 Allowed 'General case' 0 C--N 1.313 -1.02 0 N-CA-C 106.914 -1.513 . . . . 1.0 106.914 177.224 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . 0.621 ' C ' ' H ' ' A' ' 72' ' ' HIS . . . -76.96 -71.43 0.4 Allowed 'General case' 0 N--CA 1.467 0.388 0 N-CA-C 106.642 -1.614 . . . . 1.0 106.642 177.187 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 71' ' ' ALA . . . . . 0.531 ' O ' ' C ' ' A' ' 72' ' ' HIS . . . -45.07 0.39 0.0 OUTLIER 'General case' 0 N--CA 1.475 0.775 0 C-N-CA 124.188 0.995 . . . . 1.0 113.404 178.384 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 72' ' ' HIS . . . . . 0.638 ' CG ' ' N ' ' A' ' 73' ' ' MET . 0.0 OUTLIER -22.09 -62.67 0.03 OUTLIER 'General case' 0 C--O 1.231 0.13 0 CA-C-N 117.951 0.342 . . . . 1.0 111.311 -176.142 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 73' ' ' MET . . . . . 0.638 ' N ' ' CG ' ' A' ' 72' ' ' HIS . 31.6 ttm -75.54 -50.07 16.75 Favored 'General case' 0 C--N 1.319 -0.752 0 C-N-CA 118.881 -1.127 . . . . 1.0 109.667 177.823 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . 0.643 ' O ' ' N ' ' A' ' 76' ' ' GLY . 97.2 t -43.75 -46.18 1.89 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.375 0 CA-C-O 118.472 -0.775 . . . . 1.0 110.378 -175.434 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 75' ' ' ASN . . . . . 0.499 ' O ' ' N ' ' A' ' 77' ' ' ILE . 0.5 OUTLIER -36.81 -19.37 0.01 OUTLIER 'General case' 0 N--CA 1.487 1.414 0 CA-C-N 119.779 1.172 . . . . 1.0 111.356 179.232 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 76' ' ' GLY . . . . . 0.643 ' N ' ' O ' ' A' ' 74' ' ' VAL . . . -44.03 -19.58 0.13 Allowed Glycine 0 CA--C 1.544 1.855 0 N-CA-C 108.967 -1.653 . . . . 1.0 108.967 177.237 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 77' ' ' ILE . . . . . 0.666 ' O ' ' N ' ' A' ' 80' ' ' ALA . 12.2 pt -90.13 -51.45 11.95 Favored 'Isoleucine or valine' 0 C--N 1.346 0.433 0 N-CA-C 108.621 -0.881 . . . . 1.0 108.621 179.371 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . 0.465 ' C ' ' O ' ' A' ' 77' ' ' ILE . 42.3 t -34.86 -36.86 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.446 -0.642 0 N-CA-C 109.003 -0.74 . . . . 1.0 109.003 -177.796 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . 0.414 ' N ' ' O ' ' A' ' 77' ' ' ILE . 33.0 pt -90.44 -21.06 6.75 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.575 0 CA-C-N 116.159 -0.473 . . . . 1.0 111.934 179.788 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 80' ' ' ALA . . . . . 0.666 ' N ' ' O ' ' A' ' 77' ' ' ILE . . . -82.99 -7.31 59.68 Favored 'General case' 0 CA--C 1.536 0.404 0 C-N-CA 123.771 0.828 . . . . 1.0 111.244 177.102 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 3.7 mm-40 -74.0 -68.72 0.49 Allowed 'General case' 0 N--CA 1.452 -0.356 0 N-CA-C 108.771 -0.826 . . . . 1.0 108.771 178.444 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 82' ' ' ASP . . . . . 0.594 ' O ' ' N ' ' A' ' 84' ' ' LEU . 18.8 p-10 -59.23 -59.19 5.85 Favored 'General case' 0 CA--C 1.512 -0.511 0 C-N-CA 119.489 -0.884 . . . . 1.0 108.941 179.578 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . 0.535 ' C ' ' O ' ' A' ' 82' ' ' ASP . . . 3.35 -70.47 0.0 OUTLIER 'General case' 0 N--CA 1.486 1.365 0 O-C-N 124.469 1.105 . . . . 1.0 111.069 -179.913 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . 0.594 ' N ' ' O ' ' A' ' 82' ' ' ASP . 58.8 mt -26.78 -44.68 0.02 OUTLIER 'General case' 0 N--CA 1.474 0.746 0 CA-C-N 115.435 -0.802 . . . . 1.0 111.044 -176.64 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 85' ' ' ILE . . . . . 0.45 ' H ' HG13 ' A' ' 85' ' ' ILE . 1.3 pp -97.65 -49.5 11.84 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.293 0 N-CA-C 108.299 -1.0 . . . . 1.0 108.299 177.636 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 86' ' ' ALA . . . . . 0.692 ' C ' ' H ' ' A' ' 88' ' ' ALA . . . -44.45 -41.94 6.66 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 114.453 -1.249 . . . . 1.0 110.333 179.938 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 10.6 pt-20 -60.54 24.84 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.361 -0.381 . . . . 1.0 111.061 179.922 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 88' ' ' ALA . . . . . 0.692 ' H ' ' C ' ' A' ' 86' ' ' ALA . . . -122.76 -9.15 8.39 Favored 'General case' 0 N--CA 1.456 -0.173 0 CA-C-N 116.229 -0.441 . . . . 1.0 109.854 179.592 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 89' ' ' VAL . . . . . 0.509 HG23 ' O ' ' A' ' 89' ' ' VAL . 4.0 m -107.66 34.69 0.59 Allowed 'Isoleucine or valine' 0 C--O 1.224 -0.267 0 N-CA-C 109.093 -0.706 . . . . 1.0 109.093 179.377 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 90' ' ' GLY . . . . . 0.558 ' O ' ' N ' ' A' ' 92' ' ' HIS . . . -67.49 -40.42 91.09 Favored Glycine 0 CA--C 1.532 1.118 0 CA-C-O 119.616 -0.547 . . . . 1.0 111.957 179.16 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 91' ' ' PRO . . . . . 0.508 ' CD ' ' N ' ' A' ' 90' ' ' GLY . 80.4 Cg_exo -44.06 -13.19 0.05 OUTLIER 'Trans proline' 0 N--CA 1.494 1.549 0 C-N-CA 122.066 1.844 . . . . 1.0 111.483 179.294 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 92' ' ' HIS . . . . . 0.558 ' N ' ' O ' ' A' ' 90' ' ' GLY . 2.8 p80 -58.15 -17.13 16.39 Favored 'General case' 0 N--CA 1.44 -0.928 0 CA-C-N 115.676 -0.693 . . . . 1.0 109.201 179.396 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 93' ' ' LEU . . . . . 0.676 HD12 ' N ' ' A' ' 94' ' ' ALA . 1.5 pp -69.71 -59.18 3.11 Favored 'General case' 0 C--O 1.234 0.276 0 N-CA-C 109.759 -0.46 . . . . 1.0 109.759 178.993 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 94' ' ' ALA . . . . . 0.676 ' N ' HD12 ' A' ' 93' ' ' LEU . . . -55.87 -51.42 67.6 Favored 'General case' 0 CA--C 1.512 -0.508 0 N-CA-C 108.854 -0.795 . . . . 1.0 108.854 179.509 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 95' ' ' ARG . . . . . 0.657 ' O ' ' N ' ' A' ' 97' ' ' LEU . 7.1 mmm-85 -54.09 -59.02 5.2 Favored 'General case' 0 C--O 1.246 0.882 0 CA-C-O 122.985 1.374 . . . . 1.0 107.642 178.572 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 96' ' ' ALA . . . . . 0.77 ' O ' ' N ' ' A' ' 98' ' ' GLY . . . -46.33 -12.14 0.02 OUTLIER 'General case' 0 C--N 1.304 -1.375 0 O-C-N 119.524 -1.985 . . . . 1.0 111.556 -177.262 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 97' ' ' LEU . . . . . 0.657 ' N ' ' O ' ' A' ' 95' ' ' ARG . 0.3 OUTLIER 1.17 -53.76 0.0 OUTLIER 'General case' 0 N--CA 1.482 1.147 0 C-N-CA 124.246 1.018 . . . . 1.0 112.011 -169.101 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 98' ' ' GLY . . . . . 0.77 ' N ' ' O ' ' A' ' 96' ' ' ALA . . . -50.71 -23.27 6.58 Favored Glycine 0 C--N 1.3 -1.427 0 CA-C-N 121.905 2.138 . . . . 1.0 108.918 175.642 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 99' ' ' GLN . . . . . 0.615 ' HB2' ' HB1' ' A' ' 96' ' ' ALA . 9.4 tt0 -69.25 -24.07 63.94 Favored 'General case' 0 C--N 1.353 0.742 0 N-CA-C 107.872 -1.158 . . . . 1.0 107.872 178.011 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 100' ' ' ILE . . . . . 0.588 ' N ' ' O ' ' A' ' 97' ' ' LEU . 0.9 OUTLIER -63.6 -38.61 82.7 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.676 0 CA-C-N 114.471 -1.241 . . . . 1.0 108.895 178.442 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 101' ' ' VAL . . . . . 0.542 ' O ' ' N ' ' A' ' 105' ' ' GLY . 86.9 t -61.72 -60.01 3.39 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.199 0 N-CA-C 109.156 -0.683 . . . . 1.0 109.156 179.987 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 102' ' ' CYS . . . . . 0.897 ' O ' ' HB2' ' A' ' 106' ' ' ALA . 0.0 OUTLIER -44.41 -20.53 0.03 OUTLIER 'General case' 0 C--O 1.22 -0.478 0 CA-C-O 119.641 -0.218 . . . . 1.0 111.2 -178.574 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 103' ' ' ARG . . . . . 0.441 ' N ' ' O ' ' A' ' 101' ' ' VAL . 17.1 ttm180 -88.82 -37.36 15.45 Favored 'General case' 0 N--CA 1.484 1.239 0 CA-C-O 122.766 1.27 . . . . 1.0 110.664 178.316 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 104' ' ' TYR . . . . . 0.588 ' O ' ' CG ' ' A' ' 104' ' ' TYR . 50.9 t80 -99.79 20.99 13.16 Favored 'General case' 0 C--N 1.31 -1.116 0 CA-C-N 112.117 -2.31 . . . . 1.0 110.342 177.184 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 105' ' ' GLY . . . . . 0.542 ' N ' ' O ' ' A' ' 101' ' ' VAL . . . -163.5 -88.81 0.07 OUTLIER Glycine 0 N--CA 1.445 -0.719 0 N-CA-C 108.023 -2.031 . . . . 1.0 108.023 178.073 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 106' ' ' ALA . . . . . 0.897 ' HB2' ' O ' ' A' ' 102' ' ' CYS . . . 66.46 66.62 0.46 Allowed 'General case' 0 N--CA 1.441 -0.892 0 CA-C-N 115.654 -0.273 . . . . 1.0 111.545 -179.857 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 14.0 m -77.47 -60.97 2.14 Favored 'General case' 0 N--CA 1.473 0.718 0 O-C-N 121.325 -0.859 . . . . 1.0 109.388 179.711 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 108' ' ' VAL . . . . . 0.491 HG23 ' N ' ' A' ' 109' ' ' ILE . 32.3 m -66.51 -43.92 90.56 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.171 0 CA-C-O 121.293 0.568 . . . . 1.0 109.511 -179.158 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 109' ' ' ILE . . . . . 0.491 ' N ' HG23 ' A' ' 108' ' ' VAL . 1.8 mm -36.5 -61.23 0.64 Allowed Pre-proline 0 CA--C 1.549 0.932 0 CA-C-O 118.171 -0.919 . . . . 1.0 111.095 -178.269 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 110' ' ' PRO . . . . . 0.584 ' CD ' ' O ' ' A' ' 106' ' ' ALA . 55.5 Cg_endo -63.85 -21.33 69.17 Favored 'Trans proline' 0 N--CA 1.505 2.149 0 C-N-CA 124.013 3.142 . . . . 1.0 113.11 179.875 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 14.7 t-20 -63.31 -69.9 0.24 Allowed 'General case' 0 N--CA 1.467 0.392 0 C-N-CA 120.387 -0.525 . . . . 1.0 111.175 -178.191 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 112' ' ' ILE . . . . . 0.821 HD13 ' N ' ' A' ' 113' ' ' ASN . 0.0 OUTLIER -73.07 -25.33 21.65 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.567 0 CA-C-O 121.969 0.89 . . . . 1.0 109.499 -179.643 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 113' ' ' ASN . . . . . 0.821 ' N ' HD13 ' A' ' 112' ' ' ILE . 0.4 OUTLIER -52.02 -59.2 4.63 Favored 'General case' 0 C--N 1.3 -1.552 0 CA-C-N 114.002 -1.453 . . . . 1.0 108.908 -177.45 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -66.26 -20.46 66.12 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 115.891 -0.595 . . . . 1.0 110.954 179.107 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -76.41 -60.81 2.18 Favored 'General case' 0 N--CA 1.443 -0.804 0 C-N-CA 120.282 -0.567 . . . . 1.0 111.171 178.001 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 116' ' ' ILE . . . . . 0.526 ' O ' ' N ' ' A' ' 119' ' ' LEU . 7.6 tt -72.39 -41.54 64.97 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.213 0 O-C-N 121.213 -0.93 . . . . 1.0 111.981 -178.236 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 117' ' ' GLU . . . . . 0.566 ' OE1' ' ND2' ' A' ' 113' ' ' ASN . 1.0 OUTLIER -48.81 -58.61 4.53 Favored 'General case' 0 CA--C 1.508 -0.671 0 N-CA-C 108.288 -1.005 . . . . 1.0 108.288 -178.476 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 86.9 t -54.71 -14.26 0.96 Allowed 'Isoleucine or valine' 0 N--CA 1.436 -1.131 0 C-N-CA 120.253 -0.579 . . . . 1.0 109.442 179.52 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 119' ' ' LEU . . . . . 0.526 ' N ' ' O ' ' A' ' 116' ' ' ILE . 0.2 OUTLIER -76.33 -60.18 2.45 Favored 'General case' 0 C--N 1.347 0.477 0 N-CA-C 107.77 -1.196 . . . . 1.0 107.77 175.796 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -68.25 -83.08 0.15 Allowed Glycine 0 C--N 1.364 2.114 0 C-N-CA 117.57 -2.253 . . . . 1.0 111.23 179.449 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 121' ' ' THR . . . . . 0.444 ' H ' ' H ' ' A' ' 122' ' ' GLY . 18.8 m -161.36 -17.97 0.05 OUTLIER 'General case' 0 C--N 1.326 -0.427 0 N-CA-C 108.564 -0.902 . . . . 1.0 108.564 -179.639 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 122' ' ' GLY . . . . . 0.444 ' H ' ' H ' ' A' ' 121' ' ' THR . . . 111.26 -35.91 4.49 Favored Glycine 0 CA--C 1.523 0.577 0 CA-C-N 113.959 -1.473 . . . . 1.0 112.1 179.569 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 123' ' ' THR . . . . . 0.416 ' C ' ' O ' ' A' ' 122' ' ' GLY . 0.1 OUTLIER -33.43 95.4 0.01 OUTLIER 'General case' 0 N--CA 1.471 0.614 0 CA-C-N 118.342 1.071 . . . . 1.0 112.489 -178.618 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 124' ' ' ASP . . . . . 0.414 ' N ' ' O ' ' A' ' 122' ' ' GLY . 55.6 m-20 -148.59 147.88 29.51 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 115.484 -0.78 . . . . 1.0 109.548 179.26 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 125' ' ' TYR . . . . . 0.418 ' CD1' ' C ' ' A' ' 125' ' ' TYR . 0.0 OUTLIER -151.85 150.25 29.89 Favored 'General case' 0 CA--C 1.532 0.279 0 CA-C-O 120.863 0.363 . . . . 1.0 110.124 179.946 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -149.67 150.55 32.32 Favored 'General case' 0 CA--C 1.537 0.45 0 CA-C-N 116.07 -0.513 . . . . 1.0 110.019 177.719 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 127' ' ' PHE . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 C--O 1.22 -0.467 0 CA-C-O 118.172 -0.918 . . . . 1.0 109.249 179.44 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 N--CA 1.493 1.715 0 N-CA-C 109.259 -0.645 . . . . 1.0 109.259 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 2' ' ' SER . . . . . 0.487 ' O ' ' CG ' ' A' ' 3' ' ' ASP . 55.1 p -83.28 5.63 22.48 Favored 'General case' 0 CA--C 1.531 0.246 0 CA-C-N 116.489 -0.323 . . . . 1.0 111.478 -179.062 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 3' ' ' ASP . . . . . 0.487 ' CG ' ' O ' ' A' ' 2' ' ' SER . 24.0 m-20 153.69 127.41 0.0 OUTLIER 'General case' 0 N--CA 1.477 0.876 0 O-C-N 123.904 0.753 . . . . 1.0 111.2 178.94 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 60.9 t80 -155.92 151.19 26.73 Favored 'General case' 0 N--CA 1.462 0.145 0 CA-C-N 116.089 -0.505 . . . . 1.0 110.953 179.235 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 4.2 p30 -153.7 148.63 26.63 Favored 'General case' 0 CA--C 1.536 0.419 0 CA-C-N 116.308 -0.406 . . . . 1.0 110.158 -179.692 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 6' ' ' THR . . . . . 0.816 ' O ' ' N ' ' A' ' 10' ' ' SER . 0.1 OUTLIER -80.76 170.4 16.35 Favored 'General case' 0 C--O 1.188 -2.165 0 C-N-CA 120.856 -0.338 . . . . 1.0 110.305 -179.39 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . 0.541 ' O ' ' N ' ' A' ' 11' ' ' ARG . 39.2 tt0 -56.87 -57.05 14.16 Favored 'General case' 0 C--N 1.313 -0.984 0 CA-C-O 121.775 0.797 . . . . 1.0 110.54 -177.974 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 8' ' ' ARG . . . . . 0.757 ' O ' ' HB3' ' A' ' 12' ' ' ALA . 0.0 OUTLIER -54.02 -55.51 26.66 Favored 'General case' 0 C--N 1.313 -1.01 0 N-CA-C 106.96 -1.496 . . . . 1.0 106.96 -178.079 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . 0.683 ' O ' ' HB ' ' A' ' 13' ' ' VAL . 0.2 OUTLIER -66.41 -51.89 52.97 Favored 'Isoleucine or valine' 0 C--O 1.189 -2.124 0 CA-C-N 114.35 -1.296 . . . . 1.0 109.659 179.651 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 10' ' ' SER . . . . . 0.816 ' N ' ' O ' ' A' ' 6' ' ' THR . 22.5 t -65.78 -64.89 0.76 Allowed 'General case' 0 N--CA 1.482 1.139 0 C-N-CA 120.256 -0.578 . . . . 1.0 111.649 -178.924 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 11' ' ' ARG . . . . . 0.541 ' N ' ' O ' ' A' ' 7' ' ' GLU . 0.3 OUTLIER -65.52 -57.82 7.3 Favored 'General case' 0 C--O 1.218 -0.589 0 N-CA-C 112.313 0.486 . . . . 1.0 112.313 -176.81 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . 0.757 ' HB3' ' O ' ' A' ' 8' ' ' ARG . . . -54.12 -49.69 68.59 Favored 'General case' 0 N--CA 1.476 0.856 0 C-N-CA 117.874 -1.53 . . . . 1.0 107.41 -176.497 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . 0.683 ' HB ' ' O ' ' A' ' 9' ' ' VAL . 91.2 t -62.34 -50.05 81.49 Favored 'Isoleucine or valine' 0 C--O 1.197 -1.679 0 N-CA-C 107.585 -1.265 . . . . 1.0 107.585 178.476 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . 0.776 ' O ' HG22 ' A' ' 18' ' ' VAL . . . -56.41 -60.24 3.8 Favored 'General case' 0 C--O 1.207 -1.143 0 C-N-CA 117.57 -1.652 . . . . 1.0 108.508 -178.806 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . 0.55 ' O ' ' N ' ' A' ' 19' ' ' GLY . . . -53.63 -53.65 48.91 Favored 'General case' 0 C--N 1.322 -0.618 0 O-C-N 123.718 0.636 . . . . 1.0 109.726 -178.855 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . 0.46 ' C ' ' H ' ' A' ' 22' ' ' GLY . . . -63.72 -57.98 8.31 Favored 'General case' 0 N--CA 1.474 0.745 0 CA-C-O 121.693 0.759 . . . . 1.0 109.707 -179.547 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . 0.61 ' N ' ' O ' ' A' ' 13' ' ' VAL . 7.5 tt -55.42 -54.46 43.47 Favored 'General case' 0 N--CA 1.477 0.903 0 CA-C-N 114.422 -1.263 . . . . 1.0 108.652 -178.578 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . 0.776 HG22 ' O ' ' A' ' 14' ' ' ALA . 2.3 m -69.16 -57.45 8.56 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.568 0 C-N-CA 119.335 -0.946 . . . . 1.0 109.166 179.857 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . 0.55 ' N ' ' O ' ' A' ' 15' ' ' ALA . . . -56.78 -162.95 0.03 OUTLIER Glycine 0 C--O 1.22 -0.77 0 N-CA-C 111.225 -0.75 . . . . 1.0 111.225 -178.317 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 20' ' ' PRO . . . . . 0.441 ' O ' ' N ' ' A' ' 24' ' ' ALA . 83.0 Cg_endo -82.76 -30.34 1.05 Allowed 'Trans proline' 0 C--N 1.303 -1.836 0 C-N-CA 122.508 2.139 . . . . 1.0 113.988 -178.619 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . 0.42 ' O ' ' HB3' ' A' ' 24' ' ' ALA . . . -62.87 -61.52 6.38 Favored Glycine 0 N--CA 1.48 1.57 0 C-N-CA 119.897 -1.144 . . . . 1.0 113.364 -176.508 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . 0.46 ' H ' ' C ' ' A' ' 16' ' ' ALA . . . -54.16 -52.81 41.27 Favored Glycine 0 N--CA 1.471 0.997 0 N-CA-C 106.6 -2.6 . . . . 1.0 106.6 -177.11 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . 0.547 ' O ' HG12 ' A' ' 27' ' ' VAL . 12.3 t -57.06 -29.17 30.92 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.853 0 C-N-CA 119.569 -0.852 . . . . 1.0 109.096 177.696 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . 0.441 ' N ' ' O ' ' A' ' 20' ' ' PRO . . . -61.89 -63.63 1.2 Allowed 'General case' 0 C--N 1.349 0.568 0 C-N-CA 118.106 -1.437 . . . . 1.0 111.138 179.922 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . 0.588 ' N ' HD12 ' A' ' 25' ' ' LEU . 9.6 mp -63.6 -47.72 80.28 Favored 'General case' 0 N--CA 1.472 0.649 0 CA-C-N 119.008 0.822 . . . . 1.0 112.651 -177.486 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 94.9 t -58.01 -58.84 4.67 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.575 0 C-N-CA 119.169 -1.013 . . . . 1.0 110.061 -177.416 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . 0.809 ' O ' ' HB3' ' A' ' 31' ' ' ALA . 0.5 OUTLIER -61.41 -36.33 72.35 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.601 0 CA-C-O 121.224 0.535 . . . . 1.0 110.322 -178.505 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . 0.405 ' CB ' ' O ' ' A' ' 24' ' ' ALA . 33.0 tttm -67.52 -58.52 4.57 Favored 'General case' 0 C--N 1.316 -0.891 0 C-N-CA 119.461 -0.896 . . . . 1.0 110.424 -178.918 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 95.8 t -65.32 -49.85 76.43 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.116 0 C-N-CA 119.821 -0.752 . . . . 1.0 111.221 -177.283 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 30' ' ' CYS . . . . . . . . . . . . . 4.9 t -65.65 -61.64 1.97 Allowed 'General case' 0 N--CA 1.44 -0.969 0 C-N-CA 119.197 -1.001 . . . . 1.0 109.826 -179.344 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . 0.809 ' HB3' ' O ' ' A' ' 27' ' ' VAL . . . -63.07 -49.47 74.4 Favored 'General case' 0 C--N 1.322 -0.621 0 C-N-CA 119.968 -0.693 . . . . 1.0 110.714 -177.244 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . 0.53 ' O ' ' HB2' ' A' ' 33' ' ' LEU . . . 58.44 60.02 9.71 Favored Glycine 0 C--O 1.222 -0.62 0 CA-C-O 118.165 -1.353 . . . . 1.0 111.003 179.644 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . 0.664 HD23 HG22 ' A' ' 112' ' ' ILE . 6.3 mp 100.21 140.62 0.02 OUTLIER Pre-proline 0 N--CA 1.484 1.26 0 C-N-CA 125.478 1.511 . . . . 1.0 111.65 179.761 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 31.3 Cg_exo -51.76 -57.76 1.98 Allowed 'Trans proline' 0 N--CA 1.501 1.936 0 C-N-CA 122.17 1.913 . . . . 1.0 113.763 -178.505 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . 0.464 ' O ' ' C ' ' A' ' 36' ' ' VAL . . . -65.85 -59.65 7.34 Favored Glycine 0 C--N 1.338 0.678 0 C-N-CA 117.944 -2.074 . . . . 1.0 109.223 -178.404 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . 0.976 ' O ' HG22 ' A' ' 37' ' ' ILE . 70.4 t -38.94 139.36 0.23 Allowed 'Isoleucine or valine' 0 C--O 1.215 -0.73 0 N-CA-C 107.398 -1.334 . . . . 1.0 107.398 178.658 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . 0.976 HG22 ' O ' ' A' ' 36' ' ' VAL . 2.3 tp 71.96 73.3 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.476 0.831 0 CA-C-O 122.266 1.031 . . . . 1.0 110.15 -177.201 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 7.2 p80 -139.42 136.04 34.25 Favored 'General case' 0 C--N 1.322 -0.592 0 O-C-N 120.514 -1.366 . . . . 1.0 109.489 179.988 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -113.77 140.0 24.16 Favored Pre-proline 0 CA--C 1.533 0.32 0 N-CA-C 109.251 -0.648 . . . . 1.0 109.251 179.528 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 59.8 Cg_endo -71.28 -7.36 21.17 Favored 'Trans proline' 0 C--N 1.311 -1.41 0 C-N-CA 122.058 1.838 . . . . 1.0 112.187 -179.38 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -112.78 91.91 3.82 Favored 'General case' 0 CA--C 1.507 -0.691 0 C-N-CA 120.591 -0.444 . . . . 1.0 111.13 -178.078 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . 0.656 ' C ' ' H ' ' A' ' 44' ' ' GLY . 0.6 OUTLIER -123.58 140.3 53.14 Favored 'General case' 0 CA--C 1.537 0.453 0 CA-C-O 121.744 0.783 . . . . 1.0 111.576 -178.361 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 43' ' ' ARG . . . . . 0.686 ' C ' ' H ' ' A' ' 45' ' ' PHE . 1.5 tpp180 -59.31 37.74 0.01 OUTLIER 'General case' 0 CA--C 1.562 1.415 0 CA-C-N 112.976 -1.92 . . . . 1.0 108.303 -179.714 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . 0.656 ' H ' ' C ' ' A' ' 42' ' ' ARG . . . 67.8 -30.13 0.23 Allowed Glycine 0 C--N 1.338 0.656 0 N-CA-C 109.605 -1.398 . . . . 1.0 109.605 -179.11 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . 0.686 ' H ' ' C ' ' A' ' 43' ' ' ARG . 0.2 OUTLIER -170.39 175.28 4.87 Favored 'General case' 0 N--CA 1.443 -0.821 0 CA-C-N 114.749 -0.725 . . . . 1.0 109.126 179.379 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 46' ' ' PHE . . . . . 0.549 ' HB2' ' O ' ' A' ' 45' ' ' PHE . 8.6 m-85 114.84 110.56 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.668 0 C-N-CA 126.868 2.067 . . . . 1.0 108.432 -179.272 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 47' ' ' ARG . . . . . 0.512 ' HB2' ' O ' ' A' ' 46' ' ' PHE . 3.6 mmp_? 100.11 153.36 0.01 OUTLIER 'General case' 0 N--CA 1.469 0.516 0 O-C-N 124.94 1.4 . . . . 1.0 111.266 179.62 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER 66.44 70.51 0.41 Allowed 'General case' 0 N--CA 1.449 -0.48 0 CA-C-N 114.778 -1.101 . . . . 1.0 109.315 179.825 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 49' ' ' ASN . . . . . 0.5 ' O ' ' N ' ' A' ' 51' ' ' GLU . 0.7 OUTLIER -136.45 160.73 65.66 Favored Pre-proline 0 N--CA 1.466 0.367 0 CA-C-N 116.455 -0.339 . . . . 1.0 110.473 -179.175 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 25.1 Cg_endo -60.54 58.74 0.09 OUTLIER 'Trans proline' 0 N--CA 1.499 1.798 0 C-N-CA 123.265 2.643 . . . . 1.0 111.886 179.054 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . 0.5 ' N ' ' O ' ' A' ' 49' ' ' ASN . 2.9 tt0 45.33 29.85 0.62 Allowed 'General case' 0 CA--C 1.536 0.407 0 CA-C-O 121.121 0.486 . . . . 1.0 110.442 179.13 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . 0.632 ' NH2' ' CE1' ' A' ' 92' ' ' HIS . 49.5 mtt180 -124.59 151.84 44.3 Favored 'General case' 0 N--CA 1.472 0.637 0 CA-C-O 121.541 0.686 . . . . 1.0 110.978 179.527 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 7.2 tp -55.87 139.99 14.46 Favored 'Isoleucine or valine' 0 CA--C 1.555 1.141 0 CA-C-O 123.935 1.826 . . . . 1.0 115.217 -177.407 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 54' ' ' GLN . . . . . 0.431 ' H ' ' CD ' ' A' ' 54' ' ' GLN . 0.2 OUTLIER -86.53 86.11 7.33 Favored 'General case' 0 C--N 1.316 -0.864 0 CA-C-N 110.229 -3.168 . . . . 1.0 112.258 179.833 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 19.6 tt -143.92 151.0 16.55 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.032 0 N-CA-C 109.522 -0.548 . . . . 1.0 109.522 177.578 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 102.13 1.3 51.37 Favored Glycine 0 C--N 1.343 0.964 0 N-CA-C 110.753 -0.939 . . . . 1.0 110.753 179.837 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 1.3 p30 -89.71 113.28 24.76 Favored 'General case' 0 CA--C 1.54 0.566 0 CA-C-O 122.294 1.045 . . . . 1.0 113.226 -177.881 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 58' ' ' TRP . . . . . . . . . . . . . 36.4 m0 -81.74 -177.27 6.49 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 113.952 -1.476 . . . . 1.0 108.287 177.696 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 59' ' ' ARG . . . . . 0.649 ' HD2' ' H ' ' A' ' 59' ' ' ARG . 0.0 OUTLIER -97.3 -53.58 3.43 Favored 'General case' 0 CA--C 1.556 1.196 0 CA-C-N 119.18 0.9 . . . . 1.0 110.642 179.717 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 60' ' ' TYR . . . . . 0.485 ' O ' ' CG ' ' A' ' 60' ' ' TYR . 77.0 t80 -77.47 -6.0 51.92 Favored 'General case' 0 N--CA 1.483 1.207 0 C-N-CA 125.778 1.631 . . . . 1.0 111.833 -179.367 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -70.1 -16.7 63.16 Favored 'General case' 0 C--N 1.307 -1.244 0 CA-C-O 121.575 0.703 . . . . 1.0 109.453 179.181 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 62' ' ' VAL . . . . . 0.489 ' O ' ' N ' ' A' ' 66' ' ' GLY . 6.1 m -45.81 -52.37 2.8 Favored 'Isoleucine or valine' 0 CA--C 1.5 -0.961 0 C-N-CA 120.067 -0.653 . . . . 1.0 110.512 -174.774 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 63' ' ' ALA . . . . . 0.435 ' O ' ' HG2' ' A' ' 67' ' ' ARG . . . -65.2 -47.75 75.82 Favored 'General case' 0 N--CA 1.424 -1.768 0 N-CA-C 109.447 -0.575 . . . . 1.0 109.447 179.414 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 64' ' ' HIS . . . . . 0.407 ' O ' ' CG ' ' A' ' 67' ' ' ARG . 0.1 OUTLIER -54.71 -59.46 4.68 Favored 'General case' 0 CA--C 1.549 0.907 0 CA-C-N 115.474 -0.785 . . . . 1.0 110.54 179.837 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 65' ' ' ASP . . . . . 0.642 ' C ' ' H ' ' A' ' 67' ' ' ARG . 13.4 m-20 -67.72 -50.0 59.7 Favored 'General case' 0 C--O 1.243 0.751 0 N-CA-C 108.322 -0.992 . . . . 1.0 108.322 178.36 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . 0.489 ' N ' ' O ' ' A' ' 62' ' ' VAL . . . -63.23 30.24 0.08 OUTLIER Glycine 0 C--N 1.336 0.533 0 O-C-N 121.873 -0.517 . . . . 1.0 112.097 179.013 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 67' ' ' ARG . . . . . 0.793 ' HB3' ' HB3' ' A' ' 71' ' ' ALA . 14.9 mmt180 -78.96 -3.0 42.76 Favored 'General case' 0 C--N 1.308 -1.219 0 N-CA-C 108.322 -0.992 . . . . 1.0 108.322 175.927 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . 0.6 HD23 ' N ' ' A' ' 68' ' ' LEU . 1.8 pt? -36.11 -29.95 0.02 OUTLIER 'General case' 0 N--CA 1.477 0.921 0 N-CA-C 108.57 -0.9 . . . . 1.0 108.57 -176.948 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . 0.558 ' N ' ' O ' ' A' ' 67' ' ' ARG . 0.5 OUTLIER -71.91 -69.52 0.39 Allowed 'General case' 0 CA--C 1.538 0.5 0 CA-C-N 115.15 -0.932 . . . . 1.0 111.206 -178.583 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . 0.6 ' C ' ' H ' ' A' ' 72' ' ' HIS . . . -76.53 -78.16 0.13 Allowed 'General case' 0 N--CA 1.463 0.221 0 C-N-CA 119.201 -1.0 . . . . 1.0 109.2 -179.458 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 71' ' ' ALA . . . . . 0.793 ' HB3' ' HB3' ' A' ' 67' ' ' ARG . . . -58.84 13.05 0.01 OUTLIER 'General case' 0 C--N 1.321 -0.643 0 C-N-CA 124.444 1.098 . . . . 1.0 113.159 -179.019 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 72' ' ' HIS . . . . . 0.68 ' CD2' ' OG1' ' A' ' 123' ' ' THR . 0.0 OUTLIER -18.1 -60.05 0.02 OUTLIER 'General case' 0 CA--C 1.534 0.353 0 N-CA-C 113.32 0.859 . . . . 1.0 113.32 -177.429 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 73' ' ' MET . . . . . 0.649 ' N ' ' CG ' ' A' ' 72' ' ' HIS . 0.0 OUTLIER -64.82 -53.96 38.59 Favored 'General case' 0 C--N 1.317 -0.81 0 C-N-CA 119.831 -0.748 . . . . 1.0 111.341 -177.842 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . 0.635 ' O ' ' N ' ' A' ' 76' ' ' GLY . 0.8 OUTLIER -44.31 -46.31 2.36 Favored 'Isoleucine or valine' 0 C--O 1.215 -0.75 0 CA-C-O 117.989 -1.005 . . . . 1.0 111.219 -174.566 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 75' ' ' ASN . . . . . 0.48 ' C ' ' N ' ' A' ' 77' ' ' ILE . 2.3 t30 -37.66 -21.47 0.01 OUTLIER 'General case' 0 N--CA 1.482 1.16 0 CA-C-O 122.972 1.368 . . . . 1.0 110.026 178.3 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 76' ' ' GLY . . . . . 0.635 ' N ' ' O ' ' A' ' 74' ' ' VAL . . . -49.49 -20.41 2.51 Favored Glycine 0 C--O 1.21 -1.361 0 N-CA-C 107.666 -2.174 . . . . 1.0 107.666 175.235 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 77' ' ' ILE . . . . . 0.538 ' N ' ' O ' ' A' ' 74' ' ' VAL . 7.9 pt -56.84 -46.93 83.65 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.454 0 CA-C-N 115.301 -0.45 . . . . 1.0 111.75 -177.556 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 57.9 t -44.14 -17.99 0.06 OUTLIER 'Isoleucine or valine' 0 CA--C 1.51 -0.562 0 CA-C-N 118.775 0.716 . . . . 1.0 112.39 179.805 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . 0.496 ' N ' ' O ' ' A' ' 77' ' ' ILE . 0.6 OUTLIER -91.33 -40.17 12.28 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.759 0 C-N-CA 119.593 -0.843 . . . . 1.0 112.506 179.555 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 80' ' ' ALA . . . . . 0.416 ' N ' ' CG1' ' A' ' 79' ' ' ILE . . . -82.01 -24.41 35.41 Favored 'General case' 0 C--N 1.328 -0.344 0 N-CA-C 114.279 1.215 . . . . 1.0 114.279 -178.241 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 81' ' ' GLU . . . . . 0.613 ' O ' HD12 ' A' ' 84' ' ' LEU . 0.0 OUTLIER -92.24 -74.45 0.51 Allowed 'General case' 0 N--CA 1.469 0.515 0 N-CA-C 113.998 1.11 . . . . 1.0 113.998 -177.591 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 82' ' ' ASP . . . . . 0.716 ' O ' HG22 ' A' ' 85' ' ' ILE . 9.3 m-20 -92.17 -22.2 19.97 Favored 'General case' 0 C--O 1.217 -0.627 0 N-CA-C 115.291 1.589 . . . . 1.0 115.291 -177.993 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . 0.582 ' O ' ' N ' ' A' ' 85' ' ' ILE . . . -58.68 -40.77 84.53 Favored 'General case' 0 N--CA 1.461 0.108 0 C-N-CA 118.405 -1.318 . . . . 1.0 112.101 -176.005 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . 0.715 ' C ' HD22 ' A' ' 84' ' ' LEU . 0.0 OUTLIER -41.45 -14.81 0.01 OUTLIER 'General case' 0 CA--C 1.536 0.406 0 N-CA-C 112.742 0.645 . . . . 1.0 112.742 -178.488 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 85' ' ' ILE . . . . . 0.716 HG22 ' O ' ' A' ' 82' ' ' ASP . 3.5 tt -90.07 -43.95 14.79 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.408 0 N-CA-C 112.029 0.381 . . . . 1.0 112.029 179.87 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 86' ' ' ALA . . . . . 0.483 ' N ' HG23 ' A' ' 85' ' ' ILE . . . -94.2 -23.48 17.88 Favored 'General case' 0 CA--C 1.527 0.082 0 CA-C-O 120.681 0.277 . . . . 1.0 111.337 -178.826 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 87' ' ' GLU . . . . . 0.581 ' OE1' ' N ' ' A' ' 88' ' ' ALA . 0.0 OUTLIER -83.72 -26.97 29.29 Favored 'General case' 0 C--N 1.332 -0.187 0 N-CA-C 109.277 -0.638 . . . . 1.0 109.277 179.813 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 88' ' ' ALA . . . . . 0.581 ' N ' ' OE1' ' A' ' 87' ' ' GLU . . . -62.95 13.44 0.02 OUTLIER 'General case' 0 N--CA 1.445 -0.717 0 CA-C-N 115.669 -0.696 . . . . 1.0 110.717 -179.689 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 89' ' ' VAL . . . . . 0.588 ' O ' ' N ' ' A' ' 92' ' ' HIS . 33.5 t -84.89 45.2 0.06 OUTLIER 'Isoleucine or valine' 0 C--O 1.218 -0.558 0 CA-C-N 118.385 0.539 . . . . 1.0 110.996 -179.942 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 90' ' ' GLY . . . . . 0.724 ' O ' ' N ' ' A' ' 92' ' ' HIS . . . -30.08 -42.22 0.05 OUTLIER Glycine 0 CA--C 1.539 1.553 0 CA-C-O 117.575 -1.68 . . . . 1.0 111.149 -174.782 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 91' ' ' PRO . . . . . 0.502 ' C ' ' N ' ' A' ' 93' ' ' LEU . 95.3 Cg_exo -43.11 -4.0 0.01 OUTLIER 'Trans proline' 0 N--CA 1.499 1.842 0 CA-C-N 121.807 2.804 . . . . 1.0 111.602 170.475 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 92' ' ' HIS . . . . . 0.724 ' N ' ' O ' ' A' ' 90' ' ' GLY . 0.4 OUTLIER -48.47 -15.83 0.09 Allowed 'General case' 0 C--N 1.343 0.308 0 N-CA-C 107.873 -1.158 . . . . 1.0 107.873 -177.308 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 93' ' ' LEU . . . . . 0.625 ' O ' ' N ' ' A' ' 96' ' ' ALA . 7.1 tp -58.49 -50.27 74.36 Favored 'General case' 0 N--CA 1.447 -0.592 0 N-CA-C 106.62 -1.622 . . . . 1.0 106.62 176.183 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 94' ' ' ALA . . . . . 0.447 ' N ' ' O ' ' A' ' 91' ' ' PRO . . . -46.91 -50.43 18.79 Favored 'General case' 0 CA--C 1.518 -0.267 0 N-CA-C 107.685 -1.228 . . . . 1.0 107.685 -178.089 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 95' ' ' ARG . . . . . 0.51 ' HE ' ' HA ' ' A' ' 92' ' ' HIS . 4.5 mtm-85 -61.33 -28.48 69.24 Favored 'General case' 0 N--CA 1.443 -0.78 0 N-CA-C 109.057 -0.72 . . . . 1.0 109.057 176.122 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 96' ' ' ALA . . . . . 0.675 ' O ' ' N ' ' A' ' 100' ' ' ILE . . . -54.34 -52.06 62.76 Favored 'General case' 0 N--CA 1.475 0.822 0 N-CA-C 107.104 -1.443 . . . . 1.0 107.104 -179.946 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 97' ' ' LEU . . . . . 0.555 ' O ' HG22 ' A' ' 100' ' ' ILE . 0.7 OUTLIER -36.57 -26.18 0.01 OUTLIER 'General case' 0 CA--C 1.577 1.992 0 CA-C-N 114.274 -1.33 . . . . 1.0 108.485 -178.04 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 98' ' ' GLY . . . . . 0.572 ' N ' ' O ' ' A' ' 96' ' ' ALA . . . -84.68 -51.09 3.96 Favored Glycine 0 CA--C 1.55 2.279 0 CA-C-O 123.814 1.786 . . . . 1.0 110.749 173.939 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 99' ' ' GLN . . . . . 0.558 ' N ' ' O ' ' A' ' 96' ' ' ALA . 30.2 mm100 -75.84 9.71 2.22 Favored 'General case' 0 N--CA 1.428 -1.543 0 CA-C-N 113.514 -1.343 . . . . 1.0 107.649 177.037 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 100' ' ' ILE . . . . . 0.788 HG23 ' N ' ' A' ' 101' ' ' VAL . 9.7 tt -61.62 -55.8 22.01 Favored 'Isoleucine or valine' 0 CA--C 1.482 -1.651 0 N-CA-C 109.307 -0.627 . . . . 1.0 109.307 179.063 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 101' ' ' VAL . . . . . 0.788 ' N ' HG23 ' A' ' 100' ' ' ILE . 5.8 p -56.68 -59.48 2.96 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.739 0 C-N-CA 117.485 -1.686 . . . . 1.0 107.739 179.789 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 102' ' ' CYS . . . . . 0.949 ' O ' ' HB2' ' A' ' 106' ' ' ALA . 0.5 OUTLIER -44.24 -18.13 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.438 0 C-N-CA 120.5 -0.48 . . . . 1.0 111.448 -177.001 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 103' ' ' ARG . . . . . 0.497 ' NH2' ' HB1' ' A' ' 96' ' ' ALA . 6.1 ttp180 -98.07 -37.42 9.75 Favored 'General case' 0 N--CA 1.474 0.739 0 CA-C-O 121.944 0.878 . . . . 1.0 112.859 178.127 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 104' ' ' TYR . . . . . 0.637 ' O ' ' CG ' ' A' ' 104' ' ' TYR . 51.5 t80 -101.84 21.69 14.17 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-N 113.785 -1.552 . . . . 1.0 110.552 179.206 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 105' ' ' GLY . . . . . 0.769 ' O ' ' N ' ' A' ' 107' ' ' THR . . . -171.36 -12.26 0.02 OUTLIER Glycine 0 C--O 1.22 -0.741 0 C-N-CA 119.145 -1.503 . . . . 1.0 112.286 179.516 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 106' ' ' ALA . . . . . 0.949 ' HB2' ' O ' ' A' ' 102' ' ' CYS . . . -16.53 67.38 0.0 OUTLIER 'General case' 0 N--CA 1.476 0.874 0 O-C-N 124.432 0.725 . . . . 1.0 111.989 -179.8 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 107' ' ' THR . . . . . 0.769 ' N ' ' O ' ' A' ' 105' ' ' GLY . 9.9 t -117.78 -7.01 11.03 Favored 'General case' 0 CA--C 1.516 -0.33 0 N-CA-C 109.448 -0.575 . . . . 1.0 109.448 -179.621 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 11.5 m -87.14 17.7 0.57 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.452 0 N-CA-C 109.546 -0.538 . . . . 1.0 109.546 179.76 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 109' ' ' ILE . . . . . 0.723 ' N ' ' HD2' ' A' ' 110' ' ' PRO . 48.5 pt -113.71 -19.02 0.11 Allowed Pre-proline 0 CA--C 1.576 1.953 0 N-CA-C 113.773 1.027 . . . . 1.0 113.773 177.58 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 110' ' ' PRO . . . . . 0.723 ' HD2' ' N ' ' A' ' 109' ' ' ILE . 14.2 Cg_endo -53.73 -38.64 85.03 Favored 'Trans proline' 0 N--CA 1.497 1.703 0 C-N-CA 123.736 2.957 . . . . 1.0 113.991 -172.684 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 23.7 t30 -63.24 -67.95 0.38 Allowed 'General case' 0 N--CA 1.441 -0.881 0 C-N-CA 118.526 -1.27 . . . . 1.0 109.278 -179.268 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 112' ' ' ILE . . . . . 0.664 HG22 HD23 ' A' ' 33' ' ' LEU . 0.1 OUTLIER -63.35 -29.54 47.5 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.387 0 CA-C-O 121.416 0.627 . . . . 1.0 110.016 -178.261 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 113' ' ' ASN . . . . . 0.54 HD22 ' N ' ' A' ' 114' ' ' ALA . 0.7 OUTLIER -58.76 -64.02 1.08 Allowed 'General case' 0 C--N 1.309 -1.169 0 C-N-CA 118.874 -1.13 . . . . 1.0 110.044 -175.882 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 114' ' ' ALA . . . . . 0.54 ' N ' HD22 ' A' ' 113' ' ' ASN . . . -62.65 -25.74 68.28 Favored 'General case' 0 C--N 1.319 -0.73 0 C-N-CA 119.936 -0.706 . . . . 1.0 111.986 -179.708 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -77.39 -59.33 2.82 Favored 'General case' 0 C--O 1.232 0.173 0 C-N-CA 119.463 -0.895 . . . . 1.0 110.459 179.176 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 116' ' ' ILE . . . . . 0.417 ' O ' ' N ' ' A' ' 119' ' ' LEU . 50.4 mt -63.58 -48.34 87.29 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.398 0 C-N-CA 119.954 -0.698 . . . . 1.0 109.604 -179.379 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 117' ' ' GLU . . . . . 0.503 ' OE2' ' OD1' ' A' ' 113' ' ' ASN . 93.4 mt-10 -46.94 -67.0 0.32 Allowed 'General case' 0 CA--C 1.503 -0.865 0 C-N-CA 119.835 -0.746 . . . . 1.0 109.195 -178.245 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 39.5 t -48.48 -22.53 0.68 Allowed 'Isoleucine or valine' 0 N--CA 1.44 -0.936 0 C-N-CA 120.114 -0.634 . . . . 1.0 109.971 179.744 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 119' ' ' LEU . . . . . 0.417 ' N ' ' O ' ' A' ' 116' ' ' ILE . 0.4 OUTLIER -78.45 -60.03 2.54 Favored 'General case' 0 C--N 1.346 0.431 0 N-CA-C 107.736 -1.209 . . . . 1.0 107.736 178.721 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 120' ' ' GLY . . . . . 0.561 ' C ' HG22 ' A' ' 121' ' ' THR . . . -62.28 -81.43 0.09 OUTLIER Glycine 0 C--N 1.354 1.537 0 C-N-CA 117.907 -2.092 . . . . 1.0 108.292 176.51 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 121' ' ' THR . . . . . 0.722 HG23 ' H ' ' A' ' 123' ' ' THR . 1.4 t 151.08 -16.12 0.0 OUTLIER 'General case' 0 N--CA 1.486 1.37 0 O-C-N 125.322 1.248 . . . . 1.0 113.505 178.28 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 122' ' ' GLY . . . . . 0.657 ' O ' ' N ' ' A' ' 124' ' ' ASP . . . 109.74 -13.18 32.44 Favored Glycine 0 N--CA 1.47 0.919 0 N-CA-C 108.521 -1.831 . . . . 1.0 108.521 -176.195 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 123' ' ' THR . . . . . 0.746 HG23 ' O ' ' A' ' 123' ' ' THR . 15.1 t -58.58 80.0 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.202 0 N-CA-C 106.755 -1.572 . . . . 1.0 106.755 178.735 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 124' ' ' ASP . . . . . 0.657 ' N ' ' O ' ' A' ' 122' ' ' GLY . 14.9 t70 -164.62 169.09 17.43 Favored 'General case' 0 N--CA 1.444 -0.76 0 CA-C-N 113.719 -1.582 . . . . 1.0 112.107 -179.631 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 125' ' ' TYR . . . . . 0.551 ' C ' ' CD1' ' A' ' 125' ' ' TYR . 0.0 OUTLIER -146.68 145.47 30.02 Favored 'General case' 0 CA--C 1.54 0.584 0 N-CA-C 108.889 -0.782 . . . . 1.0 108.889 177.393 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -148.84 149.06 30.65 Favored 'General case' 0 CA--C 1.536 0.418 0 N-CA-C 110.166 -0.309 . . . . 1.0 110.166 178.266 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 127' ' ' PHE . . . . . . . . . . . . . 27.2 p90 . . . . . 0 N--CA 1.471 0.595 0 CA-C-O 117.864 -1.065 . . . . 1.0 110.249 179.08 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 39.0 mtt . . . . . 0 N--CA 1.489 1.475 0 N-CA-C 108.704 -0.851 . . . . 1.0 108.704 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 78.3 p -109.16 -3.79 17.03 Favored 'General case' 0 N--CA 1.466 0.334 0 CA-C-N 116.336 -0.393 . . . . 1.0 110.575 178.912 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 3' ' ' ASP . . . . . 0.44 ' OD1' ' N ' ' A' ' 3' ' ' ASP . 7.8 p-10 -174.66 91.96 0.07 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.28 -0.418 . . . . 1.0 111.785 -179.72 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 52.2 t80 -150.2 144.31 25.56 Favored 'General case' 0 C--N 1.328 -0.335 0 N-CA-C 109.367 -0.605 . . . . 1.0 109.367 179.162 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 5' ' ' ASP . . . . . 0.834 ' OD1' ' N ' ' A' ' 10' ' ' SER . 31.8 t0 -150.66 146.82 26.73 Favored 'General case' 0 C--N 1.328 -0.337 0 N-CA-C 110.082 -0.34 . . . . 1.0 110.082 -179.29 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 6' ' ' THR . . . . . 0.663 ' N ' ' OD1' ' A' ' 5' ' ' ASP . 0.2 OUTLIER -100.79 -178.1 3.67 Favored 'General case' 0 C--O 1.199 -1.599 0 CA-C-O 121.103 0.478 . . . . 1.0 110.782 179.904 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . 0.553 ' O ' ' HB3' ' A' ' 11' ' ' ARG . 29.0 tt0 -55.04 -41.23 71.15 Favored 'General case' 0 C--N 1.303 -1.442 0 CA-C-N 116.477 -0.329 . . . . 1.0 111.488 179.181 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 8' ' ' ARG . . . . . 0.713 ' O ' ' HB3' ' A' ' 12' ' ' ALA . 31.3 mtp180 -69.02 -63.98 0.96 Allowed 'General case' 0 C--N 1.313 -0.996 0 CA-C-O 123.086 1.422 . . . . 1.0 110.249 178.886 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . 0.643 ' O ' ' HB ' ' A' ' 13' ' ' VAL . 12.2 t -57.63 -43.67 83.91 Favored 'Isoleucine or valine' 0 C--N 1.282 -2.358 0 CA-C-N 114.464 -1.244 . . . . 1.0 109.188 178.304 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 10' ' ' SER . . . . . 0.834 ' N ' ' OD1' ' A' ' 5' ' ' ASP . 14.9 t -68.6 -65.92 0.64 Allowed 'General case' 0 C--N 1.305 -1.337 0 O-C-N 121.256 -0.902 . . . . 1.0 111.282 -179.02 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 11' ' ' ARG . . . . . 0.553 ' HB3' ' O ' ' A' ' 7' ' ' GLU . 23.1 tpp180 -60.94 -42.41 98.13 Favored 'General case' 0 C--N 1.314 -0.973 0 CA-C-N 116.278 -0.419 . . . . 1.0 110.566 -177.562 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . 0.713 ' HB3' ' O ' ' A' ' 8' ' ' ARG . . . -69.56 -61.04 1.95 Allowed 'General case' 0 C--N 1.319 -0.752 0 C-N-CA 119.106 -1.038 . . . . 1.0 111.169 -179.602 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . 0.798 ' O ' ' CB ' ' A' ' 17' ' ' LEU . 0.3 OUTLIER -56.8 -45.9 83.21 Favored 'Isoleucine or valine' 0 C--O 1.187 -2.228 0 N-CA-C 106.602 -1.629 . . . . 1.0 106.602 179.921 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . 0.965 ' O ' HG22 ' A' ' 18' ' ' VAL . . . -66.47 -65.51 0.67 Allowed 'General case' 0 C--N 1.307 -1.263 0 C-N-CA 117.094 -1.842 . . . . 1.0 112.731 -178.745 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . 0.524 ' O ' ' N ' ' A' ' 19' ' ' GLY . . . -50.16 -53.45 27.6 Favored 'General case' 0 C--N 1.32 -0.708 0 N-CA-C 108.088 -1.079 . . . . 1.0 108.088 179.897 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . 0.607 ' HB3' ' O ' ' A' ' 12' ' ' ALA . . . -66.34 -59.95 3.23 Favored 'General case' 0 C--N 1.298 -1.667 0 C-N-CA 118.27 -1.372 . . . . 1.0 111.41 179.512 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . 0.798 ' CB ' ' O ' ' A' ' 13' ' ' VAL . 7.7 tt -55.01 -55.55 29.66 Favored 'General case' 0 N--CA 1.481 1.114 0 CA-C-N 114.777 -1.101 . . . . 1.0 108.625 -176.884 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . 0.965 HG22 ' O ' ' A' ' 14' ' ' ALA . 2.0 m -71.12 -59.36 3.52 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.658 0 CA-C-N 116.146 -0.479 . . . . 1.0 110.692 179.603 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . 0.592 ' N ' ' CG2' ' A' ' 18' ' ' VAL . . . -55.48 -171.69 0.1 OUTLIER Glycine 0 CA--C 1.486 -1.741 0 N-CA-C 109.593 -1.403 . . . . 1.0 109.593 -176.986 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 20' ' ' PRO . . . . . 0.613 ' O ' ' N ' ' A' ' 24' ' ' ALA . 81.1 Cg_endo -81.69 -26.88 2.89 Favored 'Trans proline' 0 C--N 1.286 -2.758 0 C-N-CA 122.025 1.817 . . . . 1.0 113.894 -177.555 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . 0.583 ' O ' ' HB3' ' A' ' 24' ' ' ALA . . . -59.81 -59.05 11.2 Favored Glycine 0 N--CA 1.473 1.159 0 O-C-N 124.156 0.91 . . . . 1.0 111.357 -178.903 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -55.79 -56.99 21.03 Favored Glycine 0 CA--C 1.5 -0.848 0 C-N-CA 117.083 -2.484 . . . . 1.0 107.577 -177.823 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . 0.543 ' O ' HG12 ' A' ' 27' ' ' VAL . 93.2 t -53.94 -29.59 18.57 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.145 0 CA-C-N 113.97 -1.115 . . . . 1.0 108.201 178.573 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . 0.613 ' N ' ' O ' ' A' ' 20' ' ' PRO . . . -63.63 -65.53 0.67 Allowed 'General case' 0 C--O 1.213 -0.825 0 C-N-CA 119.503 -0.879 . . . . 1.0 111.291 -178.939 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . 0.557 ' O ' HD12 ' A' ' 25' ' ' LEU . 0.4 OUTLIER -58.35 -48.68 79.81 Favored 'General case' 0 C--N 1.311 -1.092 0 C-N-CA 119.632 -0.827 . . . . 1.0 111.131 -179.139 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . 0.426 ' N ' ' HG ' ' A' ' 25' ' ' LEU . 81.5 t -58.26 -61.42 1.37 Allowed 'Isoleucine or valine' 0 CA--C 1.503 -0.849 0 C-N-CA 119.517 -0.873 . . . . 1.0 110.471 -174.404 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . 0.643 ' O ' ' HB3' ' A' ' 31' ' ' ALA . 2.0 p -56.35 -36.59 47.25 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.97 0 C-N-CA 120.081 -0.648 . . . . 1.0 109.632 -178.969 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 20.1 mtpp -68.13 -59.3 3.34 Favored 'General case' 0 C--N 1.318 -0.775 0 C-N-CA 119.452 -0.899 . . . . 1.0 111.932 -176.84 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 2.9 t -62.24 -50.22 80.85 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.379 0 CA-C-N 114.504 -1.225 . . . . 1.0 110.191 -177.688 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 30' ' ' CYS . . . . . . . . . . . . . 21.2 t -64.32 -62.36 1.65 Allowed 'General case' 0 N--CA 1.442 -0.857 0 C-N-CA 119.214 -0.994 . . . . 1.0 110.484 -177.598 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . 0.643 ' HB3' ' O ' ' A' ' 27' ' ' VAL . . . -56.46 -48.19 77.59 Favored 'General case' 0 CA--C 1.502 -0.878 0 CA-C-O 121.536 0.684 . . . . 1.0 110.076 -176.879 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . 0.64 ' O ' ' HB2' ' A' ' 33' ' ' LEU . . . 76.78 68.37 1.54 Allowed Glycine 0 CA--C 1.496 -1.114 0 N-CA-C 109.915 -1.274 . . . . 1.0 109.915 -179.657 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . 0.64 ' HB2' ' O ' ' A' ' 32' ' ' GLY . 5.2 mt 86.04 123.29 0.03 OUTLIER Pre-proline 0 CA--C 1.544 0.742 0 O-C-N 124.965 1.038 . . . . 1.0 110.402 -179.159 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 34' ' ' PRO . . . . . 0.541 ' HD2' HD23 ' A' ' 33' ' ' LEU . 49.2 Cg_endo -69.22 -17.94 39.78 Favored 'Trans proline' 0 N--CA 1.493 1.456 0 C-N-CA 122.131 1.887 . . . . 1.0 112.903 -178.324 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . 0.439 ' C ' HG21 ' A' ' 112' ' ' ILE . . . -62.95 -63.62 4.45 Favored Glycine 0 CA--C 1.527 0.806 0 C-N-CA 118.497 -1.811 . . . . 1.0 111.187 -178.093 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . 0.881 HG22 ' H ' ' A' ' 37' ' ' ILE . 5.1 p -77.5 -152.73 0.02 OUTLIER 'Isoleucine or valine' 0 CA--C 1.491 -1.304 0 N-CA-C 107.334 -1.358 . . . . 1.0 107.334 -179.641 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . 0.881 ' H ' HG22 ' A' ' 36' ' ' VAL . 0.3 OUTLIER 75.62 76.69 0.04 OUTLIER 'Isoleucine or valine' 0 C--O 1.218 -0.574 0 O-C-N 125.132 1.52 . . . . 1.0 111.534 178.069 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 38' ' ' HIS . . . . . 0.564 ' ND1' ' O ' ' A' ' 37' ' ' ILE . 1.8 m80 -137.64 133.93 34.9 Favored 'General case' 0 CA--C 1.487 -1.453 0 O-C-N 119.304 -2.122 . . . . 1.0 107.594 179.781 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 39' ' ' THR . . . . . 0.563 ' OG1' ' O ' ' A' ' 41' ' ' ALA . 0.5 OUTLIER -107.99 122.78 39.67 Favored Pre-proline 0 CA--C 1.54 0.568 0 O-C-N 123.74 0.65 . . . . 1.0 110.549 -178.963 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 32.6 Cg_exo -61.83 -23.57 76.22 Favored 'Trans proline' 0 N--CA 1.495 1.57 0 C-N-CA 122.483 2.122 . . . . 1.0 112.378 178.046 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . 0.563 ' O ' ' OG1' ' A' ' 39' ' ' THR . . . -128.14 132.62 48.92 Favored 'General case' 0 N--CA 1.475 0.783 0 C-N-CA 122.394 0.278 . . . . 1.0 110.421 178.301 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . 0.435 ' CD ' ' O ' ' A' ' 39' ' ' THR . 0.0 OUTLIER -177.56 -177.59 0.68 Allowed 'General case' 0 N--CA 1.465 0.278 0 CA-C-N 117.962 0.346 . . . . 1.0 110.893 179.721 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 77.1 ttt180 -57.16 -46.1 83.04 Favored 'General case' 0 CA--C 1.536 0.427 0 N-CA-C 107.911 -1.144 . . . . 1.0 107.911 177.873 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . 0.516 ' C ' ' CG ' ' A' ' 45' ' ' PHE . . . 118.09 -25.57 8.27 Favored Glycine 0 N--CA 1.474 1.184 0 CA-C-O 120.067 -0.296 . . . . 1.0 112.642 178.912 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . 0.71 ' O ' ' HB2' ' A' ' 46' ' ' PHE . 0.1 OUTLIER -159.19 166.42 31.47 Favored 'General case' 0 CA--C 1.486 -1.496 0 N-CA-C 106.966 -1.494 . . . . 1.0 106.966 -179.258 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 46' ' ' PHE . . . . . 0.71 ' HB2' ' O ' ' A' ' 45' ' ' PHE . 31.2 m-85 104.1 116.95 0.01 OUTLIER 'General case' 0 N--CA 1.487 1.379 0 O-C-N 126.134 2.147 . . . . 1.0 110.589 179.815 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 47' ' ' ARG . . . . . 0.564 ' CG ' ' O ' ' A' ' 46' ' ' PHE . 0.0 OUTLIER 87.29 161.36 0.08 Allowed 'General case' 0 C--N 1.348 0.531 0 O-C-N 124.487 1.117 . . . . 1.0 110.499 179.366 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 48' ' ' CYS . . . . . 0.449 ' N ' ' HD3' ' A' ' 47' ' ' ARG . 41.2 t 61.67 67.19 0.78 Allowed 'General case' 0 CA--C 1.506 -0.723 0 N-CA-C 109.629 -0.508 . . . . 1.0 109.629 178.379 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 49' ' ' ASN . . . . . 0.769 ' O ' ' N ' ' A' ' 51' ' ' GLU . 10.5 m-80 -150.76 157.66 35.79 Favored Pre-proline 0 C--N 1.319 -0.721 0 CA-C-O 118.333 -0.842 . . . . 1.0 109.323 179.053 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 50' ' ' PRO . . . . . 0.6 ' HB2' ' HE ' ' A' ' 52' ' ' ARG . 50.1 Cg_exo -45.52 54.5 0.01 OUTLIER 'Trans proline' 0 N--CA 1.506 2.259 0 C-N-CA 123.768 2.979 . . . . 1.0 112.724 178.173 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . 0.769 ' N ' ' O ' ' A' ' 49' ' ' ASN . 1.6 mt-10 47.48 54.67 9.33 Favored 'General case' 0 C--N 1.33 -0.263 0 C-N-CA 123.357 0.663 . . . . 1.0 111.616 179.332 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . 0.6 ' HE ' ' HB2' ' A' ' 50' ' ' PRO . 34.3 mtm105 -152.24 167.2 29.38 Favored 'General case' 0 N--CA 1.469 0.507 0 CA-C-N 116.429 -0.35 . . . . 1.0 110.732 -179.125 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . 0.505 ' C ' ' NE2' ' A' ' 54' ' ' GLN . 2.2 tp -83.5 169.45 1.55 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.342 0 N-CA-C 108.531 -0.915 . . . . 1.0 108.531 178.536 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 54' ' ' GLN . . . . . 0.505 ' NE2' ' C ' ' A' ' 53' ' ' ILE . 0.0 OUTLIER -135.35 132.18 37.31 Favored 'General case' 0 N--CA 1.466 0.333 0 N-CA-C 109.294 -0.632 . . . . 1.0 109.294 -179.395 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . 0.467 ' N ' HD13 ' A' ' 55' ' ' ILE . 0.2 OUTLIER -145.4 154.63 13.62 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 N-CA-C 110.243 -0.28 . . . . 1.0 110.243 179.695 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 100.63 4.62 54.61 Favored Glycine 0 C--N 1.335 0.501 0 N-CA-C 109.975 -1.25 . . . . 1.0 109.975 179.47 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 73.1 m-20 -95.1 116.77 29.15 Favored 'General case' 0 CA--C 1.541 0.627 0 CA-C-O 122.842 1.306 . . . . 1.0 113.095 -179.68 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 58' ' ' TRP . . . . . 0.466 ' H ' ' CD ' ' A' ' 61' ' ' GLU . 17.8 m0 -79.19 179.46 7.37 Favored 'General case' 0 N--CA 1.483 1.206 0 CA-C-N 112.731 -2.031 . . . . 1.0 110.185 178.191 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 59' ' ' ARG . . . . . 0.537 ' HG2' ' H ' ' A' ' 60' ' ' TYR . 0.0 OUTLIER -93.22 -55.9 3.15 Favored 'General case' 0 CA--C 1.544 0.715 0 CA-C-N 118.434 0.561 . . . . 1.0 111.111 178.65 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 60' ' ' TYR . . . . . 0.537 ' H ' ' HG2' ' A' ' 59' ' ' ARG . 34.4 p90 -69.99 0.67 5.58 Favored 'General case' 0 C--O 1.239 0.53 0 C-N-CA 124.171 0.988 . . . . 1.0 108.866 178.676 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . 0.548 ' O ' ' N ' ' A' ' 65' ' ' ASP . 1.3 tt0 -61.63 -17.92 57.29 Favored 'General case' 0 C--O 1.21 -1.0 0 CA-C-N 115.348 -0.842 . . . . 1.0 112.447 -178.76 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 62' ' ' VAL . . . . . 0.719 HG23 ' H ' ' A' ' 63' ' ' ALA . 17.4 m -46.61 -56.29 1.36 Allowed 'Isoleucine or valine' 0 C--N 1.304 -1.394 0 N-CA-C 109.299 -0.63 . . . . 1.0 109.299 -174.724 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 63' ' ' ALA . . . . . 0.719 ' H ' HG23 ' A' ' 62' ' ' VAL . . . -60.9 -51.22 70.22 Favored 'General case' 0 N--CA 1.423 -1.796 0 N-CA-C 108.493 -0.928 . . . . 1.0 108.493 178.786 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 64' ' ' HIS . . . . . 0.562 ' HA ' ' HE ' ' A' ' 67' ' ' ARG . 19.1 t-80 -57.61 -60.62 3.4 Favored 'General case' 0 CA--C 1.548 0.903 0 CA-C-O 121.809 0.814 . . . . 1.0 112.356 -179.643 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 65' ' ' ASP . . . . . 0.613 ' C ' ' H ' ' A' ' 67' ' ' ARG . 29.7 t70 -66.83 -53.47 32.33 Favored 'General case' 0 C--N 1.312 -1.051 0 O-C-N 121.264 -0.897 . . . . 1.0 110.246 -179.267 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . 0.447 ' N ' ' O ' ' A' ' 62' ' ' VAL . . . -60.96 30.4 0.05 OUTLIER Glycine 0 CA--C 1.527 0.841 0 CA-C-N 115.734 -0.666 . . . . 1.0 112.593 -179.212 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 67' ' ' ARG . . . . . 0.613 ' H ' ' C ' ' A' ' 65' ' ' ASP . 94.8 mtt-85 -82.83 -5.09 58.8 Favored 'General case' 0 C--N 1.321 -0.672 0 O-C-N 122.746 -0.267 . . . . 1.0 111.647 175.697 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . 0.711 ' O ' ' HA ' ' A' ' 72' ' ' HIS . 0.2 OUTLIER -38.11 -28.74 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.524 0 CA-C-O 123.33 1.538 . . . . 1.0 107.084 178.907 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . 0.656 HD12 ' N ' ' A' ' 70' ' ' ALA . 0.9 OUTLIER -65.89 -64.01 0.96 Allowed 'General case' 0 CA--C 1.552 1.024 0 N-CA-C 105.847 -1.909 . . . . 1.0 105.847 175.716 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . 0.738 ' C ' ' H ' ' A' ' 72' ' ' HIS . . . -77.57 -73.36 0.31 Allowed 'General case' 0 C--N 1.364 1.232 0 N-CA-C 107.458 -1.312 . . . . 1.0 107.458 178.712 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 71' ' ' ALA . . . . . 0.757 ' HB1' ' HB ' ' A' ' 74' ' ' VAL . . . -50.17 7.4 0.0 OUTLIER 'General case' 0 C--N 1.351 0.671 0 C-N-CA 124.746 1.218 . . . . 1.0 110.744 177.834 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 72' ' ' HIS . . . . . 0.738 ' H ' ' C ' ' A' ' 70' ' ' ALA . 0.0 OUTLIER -17.56 -65.11 0.02 OUTLIER 'General case' 0 CA--C 1.492 -1.271 0 C-N-CA 123.565 0.746 . . . . 1.0 111.208 -175.852 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 73' ' ' MET . . . . . 0.499 ' N ' ' ND1' ' A' ' 72' ' ' HIS . 0.0 OUTLIER -77.24 -48.57 17.18 Favored 'General case' 0 C--N 1.292 -1.914 0 C-N-CA 120.275 -0.57 . . . . 1.0 110.452 178.264 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . 0.757 ' HB ' ' HB1' ' A' ' 71' ' ' ALA . 69.3 t -42.08 -44.45 0.98 Allowed 'Isoleucine or valine' 0 C--O 1.221 -0.405 0 CA-C-O 117.64 -1.172 . . . . 1.0 109.388 -174.7 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 75' ' ' ASN . . . . . 0.406 ' C ' ' N ' ' A' ' 77' ' ' ILE . 27.7 t-20 -36.75 -19.26 0.01 OUTLIER 'General case' 0 CA--C 1.553 1.094 0 CA-C-O 123.327 1.537 . . . . 1.0 110.639 179.342 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 76' ' ' GLY . . . . . 0.692 ' O ' HG12 ' A' ' 79' ' ' ILE . . . -49.05 -20.97 2.22 Favored Glycine 0 CA--C 1.543 1.827 0 N-CA-C 108.657 -1.777 . . . . 1.0 108.657 174.864 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 77' ' ' ILE . . . . . 0.485 HG13 ' H ' ' A' ' 78' ' ' VAL . 4.7 pt -47.4 -50.31 7.99 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.64 0 O-C-N 120.972 -1.31 . . . . 1.0 113.059 -179.02 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . 0.485 ' H ' HG13 ' A' ' 77' ' ' ILE . 12.0 p -55.1 -22.1 10.0 Favored 'Isoleucine or valine' 0 CA--C 1.504 -0.791 0 CA-C-O 120.832 0.348 . . . . 1.0 111.11 -178.024 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . 0.803 ' O ' ' HB2' ' A' ' 83' ' ' ALA . 0.5 OUTLIER -83.44 -46.01 18.56 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.867 0 C-N-CA 119.871 -0.731 . . . . 1.0 110.873 179.885 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 80' ' ' ALA . . . . . 0.507 ' N ' ' CG1' ' A' ' 79' ' ' ILE . . . -76.99 -21.84 54.08 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 115.633 -0.712 . . . . 1.0 111.007 -178.74 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 81' ' ' GLU . . . . . 0.547 ' OE1' ' N ' ' A' ' 81' ' ' GLU . 0.7 OUTLIER -83.07 -69.24 0.64 Allowed 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.011 -0.54 . . . . 1.0 111.093 -179.569 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 82' ' ' ASP . . . . . 0.636 ' O ' ' N ' ' A' ' 84' ' ' LEU . 88.9 m-20 -60.54 -60.86 3.13 Favored 'General case' 0 CA--C 1.496 -1.104 0 CA-C-O 118.048 -0.977 . . . . 1.0 110.376 -177.622 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . 0.803 ' HB2' ' O ' ' A' ' 79' ' ' ILE . . . 0.94 -66.22 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.773 0 O-C-N 125.475 1.735 . . . . 1.0 110.312 -179.793 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . 0.636 ' N ' ' O ' ' A' ' 82' ' ' ASP . 4.4 mm? -25.15 -49.87 0.03 OUTLIER 'General case' 0 N--CA 1.473 0.687 0 CA-C-N 115.521 -0.763 . . . . 1.0 109.802 -176.713 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 85' ' ' ILE . . . . . 0.627 HG23 ' N ' ' A' ' 86' ' ' ALA . 13.7 tt -98.29 -51.0 10.76 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.699 0 N-CA-C 109.438 -0.579 . . . . 1.0 109.438 177.014 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 86' ' ' ALA . . . . . 0.952 ' O ' HG13 ' A' ' 89' ' ' VAL . . . -50.39 -46.95 56.47 Favored 'General case' 0 C--O 1.224 -0.267 0 CA-C-N 116.026 -0.533 . . . . 1.0 110.747 -179.184 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 87' ' ' GLU . . . . . 0.568 ' N ' ' O ' ' A' ' 83' ' ' ALA . 22.6 tp10 -47.7 -18.32 0.14 Allowed 'General case' 0 C--N 1.323 -0.577 0 CA-C-O 120.987 0.422 . . . . 1.0 110.328 179.601 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 88' ' ' ALA . . . . . 0.84 ' C ' ' H ' ' A' ' 90' ' ' GLY . . . -74.45 6.11 4.04 Favored 'General case' 0 CA--C 1.491 -1.309 0 CA-C-N 115.745 -0.661 . . . . 1.0 110.818 -179.718 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 89' ' ' VAL . . . . . 0.952 HG13 ' O ' ' A' ' 86' ' ' ALA . 19.3 m -48.63 15.88 0.0 OUTLIER 'Isoleucine or valine' 0 C--O 1.216 -0.685 0 O-C-N 124.529 1.143 . . . . 1.0 111.616 -179.746 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 90' ' ' GLY . . . . . 0.84 ' H ' ' C ' ' A' ' 88' ' ' ALA . . . -33.58 -50.65 0.57 Allowed Glycine 0 C--N 1.351 1.386 0 N-CA-C 108.05 -2.02 . . . . 1.0 108.05 -177.08 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 91' ' ' PRO . . . . . 0.466 ' O ' ' N ' ' A' ' 94' ' ' ALA . 73.0 Cg_exo -48.11 0.35 0.02 OUTLIER 'Trans proline' 0 N--CA 1.495 1.565 0 C-N-CA 122.463 2.109 . . . . 1.0 112.216 173.163 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 92' ' ' HIS . . . . . 0.715 ' N ' ' O ' ' A' ' 89' ' ' VAL . 0.0 OUTLIER -47.57 -37.05 11.55 Favored 'General case' 0 N--CA 1.445 -0.707 0 N-CA-C 107.794 -1.187 . . . . 1.0 107.794 -176.053 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 1.5 pp -61.78 -37.8 85.67 Favored 'General case' 0 N--CA 1.436 -1.145 0 CA-C-O 121.702 0.763 . . . . 1.0 111.107 178.59 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 94' ' ' ALA . . . . . 0.466 ' N ' ' O ' ' A' ' 91' ' ' PRO . . . -62.57 -62.4 1.77 Allowed 'General case' 0 C--N 1.33 -0.26 0 N-CA-C 107.795 -1.187 . . . . 1.0 107.795 179.279 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 63.4 mmt-85 -59.52 -28.84 67.43 Favored 'General case' 0 N--CA 1.438 -1.059 0 N-CA-C 109.237 -0.653 . . . . 1.0 109.237 179.71 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 96' ' ' ALA . . . . . 0.797 ' O ' ' N ' ' A' ' 100' ' ' ILE . . . -59.49 -53.87 53.09 Favored 'General case' 0 CA--C 1.496 -1.13 0 N-CA-C 107.114 -1.439 . . . . 1.0 107.114 179.915 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 97' ' ' LEU . . . . . 0.643 ' O ' HG22 ' A' ' 100' ' ' ILE . 0.9 OUTLIER -37.78 -32.17 0.05 Allowed 'General case' 0 CA--C 1.556 1.175 0 N-CA-C 108.217 -1.031 . . . . 1.0 108.217 -179.191 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 98' ' ' GLY . . . . . 0.485 ' N ' ' O ' ' A' ' 96' ' ' ALA . . . -82.17 -52.72 3.92 Favored Glycine 0 CA--C 1.564 3.152 0 CA-C-O 123.692 1.718 . . . . 1.0 112.131 173.875 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 99' ' ' GLN . . . . . 0.442 ' N ' ' O ' ' A' ' 96' ' ' ALA . 60.9 mm-40 -77.71 9.59 3.34 Favored 'General case' 0 N--CA 1.44 -0.932 0 N-CA-C 107.978 -1.119 . . . . 1.0 107.978 178.895 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 100' ' ' ILE . . . . . 0.797 ' N ' ' O ' ' A' ' 96' ' ' ALA . 18.9 tt -59.74 -55.1 26.13 Favored 'Isoleucine or valine' 0 CA--C 1.493 -1.215 0 N-CA-C 109.578 -0.527 . . . . 1.0 109.578 -178.51 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 101' ' ' VAL . . . . . 0.728 HG13 ' H ' ' A' ' 102' ' ' CYS . 4.2 p -58.58 -58.85 4.88 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.535 0 C-N-CA 118.862 -1.135 . . . . 1.0 108.26 178.636 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 102' ' ' CYS . . . . . 0.728 ' H ' HG13 ' A' ' 101' ' ' VAL . 13.1 t -45.61 -26.57 0.63 Allowed 'General case' 0 C--O 1.215 -0.75 0 C-N-CA 120.212 -0.595 . . . . 1.0 109.525 -177.835 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 103' ' ' ARG . . . . . 0.431 ' N ' ' C ' ' A' ' 101' ' ' VAL . 0.0 OUTLIER -88.63 -41.96 12.32 Favored 'General case' 0 CA--C 1.549 0.911 0 CA-C-O 122.347 1.07 . . . . 1.0 113.846 179.598 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 104' ' ' TYR . . . . . 0.748 ' CG ' ' O ' ' A' ' 104' ' ' TYR . 4.0 t80 -95.25 23.0 6.16 Favored 'General case' 0 C--N 1.303 -1.445 0 C-N-CA 127.05 2.14 . . . . 1.0 108.722 178.128 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 105' ' ' GLY . . . . . 0.522 ' N ' ' O ' ' A' ' 101' ' ' VAL . . . -163.15 -86.29 0.06 OUTLIER Glycine 0 N--CA 1.442 -0.93 0 N-CA-C 108.058 -2.017 . . . . 1.0 108.058 178.102 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 106' ' ' ALA . . . . . 0.695 ' HB2' ' O ' ' A' ' 102' ' ' CYS . . . 64.08 66.66 0.63 Allowed 'General case' 0 C--N 1.32 -0.681 0 N-CA-C 112.42 0.526 . . . . 1.0 112.42 179.854 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 107' ' ' THR . . . . . 0.505 ' C ' ' HD2' ' A' ' 110' ' ' PRO . 0.5 OUTLIER -109.61 -9.93 14.86 Favored 'General case' 0 CA--C 1.536 0.431 0 O-C-N 122.136 -0.352 . . . . 1.0 110.438 179.086 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 108' ' ' VAL . . . . . 0.613 ' C ' ' HD2' ' A' ' 110' ' ' PRO . 0.0 OUTLIER -82.6 -62.81 1.34 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.694 0 N-CA-C 113.595 0.961 . . . . 1.0 113.595 -176.359 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 109' ' ' ILE . . . . . 0.594 ' N ' ' CD ' ' A' ' 110' ' ' PRO . 0.6 OUTLIER -54.61 -35.99 38.56 Favored Pre-proline 0 C--N 1.321 -0.673 0 N-CA-C 112.161 0.43 . . . . 1.0 112.161 179.933 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 110' ' ' PRO . . . . . 0.613 ' HD2' ' C ' ' A' ' 108' ' ' VAL . 81.4 Cg_exo -45.81 -32.48 9.19 Favored 'Trans proline' 0 C--N 1.323 -0.779 0 C-N-CA 122.258 1.972 . . . . 1.0 112.565 -174.697 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 111' ' ' ASN . . . . . 0.687 ' CG ' ' H ' ' A' ' 112' ' ' ILE . 12.5 p-10 -61.66 -68.62 0.3 Allowed 'General case' 0 CA--C 1.545 0.753 0 C-N-CA 119.699 -0.801 . . . . 1.0 110.355 -179.674 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 112' ' ' ILE . . . . . 0.687 ' H ' ' CG ' ' A' ' 111' ' ' ASN . 2.9 mm -74.7 -24.8 18.54 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.746 0 CA-C-O 121.851 0.834 . . . . 1.0 110.026 -178.122 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 18.9 t30 -51.72 -58.89 5.11 Favored 'General case' 0 C--N 1.298 -1.651 0 CA-C-N 114.159 -1.382 . . . . 1.0 109.933 -178.416 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -66.09 -19.5 65.86 Favored 'General case' 0 N--CA 1.447 -0.584 0 CA-C-N 116.22 -0.445 . . . . 1.0 110.359 179.197 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -75.13 -61.03 2.03 Favored 'General case' 0 CA--C 1.544 0.72 0 C-N-CA 120.312 -0.555 . . . . 1.0 111.242 178.388 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 116' ' ' ILE . . . . . 0.477 ' O ' ' CB ' ' A' ' 119' ' ' LEU . 15.1 tt -67.57 -38.94 81.41 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.334 0 O-C-N 121.052 -1.03 . . . . 1.0 110.918 -178.851 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 117' ' ' GLU . . . . . 0.472 ' C ' ' N ' ' A' ' 119' ' ' LEU . 1.0 OUTLIER -46.67 -68.06 0.23 Allowed 'General case' 0 C--N 1.3 -1.583 0 CA-C-N 115.334 -0.848 . . . . 1.0 110.493 -178.249 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 118' ' ' VAL . . . . . 0.44 HG12 ' O ' ' A' ' 118' ' ' VAL . 89.8 t -47.31 -14.03 0.08 OUTLIER 'Isoleucine or valine' 0 CA--C 1.505 -0.757 0 CA-C-N 114.838 -1.073 . . . . 1.0 109.515 -178.396 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 119' ' ' LEU . . . . . 0.477 ' CB ' ' O ' ' A' ' 116' ' ' ILE . 3.2 tp -77.19 -61.6 1.93 Allowed 'General case' 0 N--CA 1.45 -0.447 0 C-N-CA 119.464 -0.894 . . . . 1.0 110.43 179.101 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -73.36 -81.13 0.41 Allowed Glycine 0 C--N 1.362 2.013 0 C-N-CA 117.891 -2.1 . . . . 1.0 111.339 -178.348 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 1.2 t -158.53 -18.63 0.07 Allowed 'General case' 0 C--N 1.322 -0.601 0 CA-C-O 121.237 0.542 . . . . 1.0 110.601 -179.033 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 122' ' ' GLY . . . . . 0.453 ' O ' ' C ' ' A' ' 123' ' ' THR . . . 107.7 -38.45 3.32 Favored Glycine 0 N--CA 1.472 1.076 0 C-N-CA 125.026 1.298 . . . . 1.0 112.758 178.889 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 123' ' ' THR . . . . . 0.453 ' C ' ' O ' ' A' ' 122' ' ' GLY . 8.5 m -30.62 102.73 0.02 OUTLIER 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 118.49 1.145 . . . . 1.0 112.427 -177.128 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 38.0 p-10 -143.72 139.72 29.62 Favored 'General case' 0 C--N 1.332 -0.158 0 N-CA-C 106.985 -1.487 . . . . 1.0 106.985 178.744 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 125' ' ' TYR . . . . . 0.535 ' OH ' ' CE1' ' A' ' 127' ' ' PHE . 0.0 OUTLIER -153.95 150.72 28.61 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 116.185 -0.461 . . . . 1.0 110.165 -177.848 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 126' ' ' ARG . . . . . 0.509 ' HG2' ' O ' ' A' ' 125' ' ' TYR . 2.0 mmp_? -152.07 156.97 40.97 Favored 'General case' 0 CA--C 1.538 0.483 0 O-C-N 124.497 1.123 . . . . 1.0 111.962 176.829 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 127' ' ' PHE . . . . . 0.535 ' CE1' ' OH ' ' A' ' 125' ' ' TYR . 1.1 p90 . . . . . 0 C--O 1.222 -0.377 0 CA-C-O 118.007 -0.997 . . . . 1.0 110.465 178.886 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . 0.457 ' SD ' ' N ' ' A' ' 1' ' ' MET . 0.0 OUTLIER . . . . . 0 N--CA 1.493 1.696 0 N-CA-C 109.236 -0.654 . . . . 1.0 109.236 . . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 2' ' ' SER . . . . . 0.517 ' O ' ' CB ' ' A' ' 3' ' ' ASP . 87.6 p -86.47 9.09 19.31 Favored 'General case' 0 N--CA 1.463 0.209 0 CA-C-N 116.554 -0.294 . . . . 1.0 111.204 -179.818 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 3' ' ' ASP . . . . . 0.517 ' CB ' ' O ' ' A' ' 2' ' ' SER . 3.5 t70 149.99 123.81 0.0 OUTLIER 'General case' 0 N--CA 1.479 0.995 0 O-C-N 124.16 0.912 . . . . 1.0 111.189 178.551 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . 0.412 ' O ' ' OD1' ' A' ' 5' ' ' ASP . 83.9 t80 -155.25 150.92 27.48 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.408 -0.814 . . . . 1.0 110.403 178.812 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 5' ' ' ASP . . . . . 0.412 ' OD1' ' O ' ' A' ' 4' ' ' PHE . 74.9 m-20 -150.8 148.12 28.12 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.065 -0.516 . . . . 1.0 109.703 179.513 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 6' ' ' THR . . . . . 0.71 ' O ' ' N ' ' A' ' 10' ' ' SER . 0.2 OUTLIER -70.19 167.85 16.98 Favored 'General case' 0 C--O 1.195 -1.802 0 CA-C-O 121.156 0.503 . . . . 1.0 110.274 -179.461 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . 0.593 ' O ' ' N ' ' A' ' 11' ' ' ARG . 5.4 pt-20 -57.62 -57.78 11.21 Favored 'General case' 0 C--N 1.299 -1.587 0 CA-C-O 121.271 0.558 . . . . 1.0 110.369 -179.26 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 8' ' ' ARG . . . . . 0.79 ' O ' ' HB3' ' A' ' 12' ' ' ALA . 7.9 ttm180 -52.64 -56.07 18.01 Favored 'General case' 0 C--N 1.316 -0.87 0 N-CA-C 107.805 -1.183 . . . . 1.0 107.805 -178.187 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . 0.543 ' O ' ' CG2' ' A' ' 13' ' ' VAL . 0.0 OUTLIER -64.46 -50.42 76.2 Favored 'Isoleucine or valine' 0 C--O 1.203 -1.355 0 C-N-CA 119.488 -0.885 . . . . 1.0 109.816 178.718 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 10' ' ' SER . . . . . 0.71 ' N ' ' O ' ' A' ' 6' ' ' THR . 20.9 t -65.41 -63.92 0.98 Allowed 'General case' 0 C--N 1.316 -0.884 0 C-N-CA 119.42 -0.912 . . . . 1.0 111.257 -178.565 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 11' ' ' ARG . . . . . 0.593 ' N ' ' O ' ' A' ' 7' ' ' GLU . 4.1 tpp180 -63.9 -59.03 5.02 Favored 'General case' 0 N--CA 1.471 0.624 0 CA-C-O 121.103 0.477 . . . . 1.0 111.888 -176.804 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . 0.79 ' HB3' ' O ' ' A' ' 8' ' ' ARG . . . -50.18 -49.38 52.58 Favored 'General case' 0 C--N 1.317 -0.82 0 N-CA-C 107.458 -1.312 . . . . 1.0 107.458 -177.232 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . 0.6 ' O ' ' N ' ' A' ' 17' ' ' LEU . 93.4 t -60.92 -49.47 84.52 Favored 'Isoleucine or valine' 0 C--O 1.198 -1.607 0 C-N-CA 118.733 -1.187 . . . . 1.0 107.946 177.347 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . 0.631 ' O ' HG13 ' A' ' 18' ' ' VAL . . . -57.53 -62.11 2.02 Favored 'General case' 0 C--O 1.212 -0.889 0 C-N-CA 118.519 -1.273 . . . . 1.0 109.913 -179.8 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . 0.57 ' O ' ' N ' ' A' ' 19' ' ' GLY . . . -51.28 -53.57 34.36 Favored 'General case' 0 N--CA 1.472 0.648 0 CA-C-O 121.706 0.765 . . . . 1.0 109.287 -178.245 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . 0.412 ' HB1' ' CA ' ' A' ' 22' ' ' GLY . . . -62.94 -55.08 29.01 Favored 'General case' 0 C--N 1.309 -1.186 0 CA-C-N 114.603 -1.18 . . . . 1.0 109.037 -178.988 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . 0.6 ' N ' ' O ' ' A' ' 13' ' ' VAL . 4.8 tt -55.91 -54.16 48.11 Favored 'General case' 0 N--CA 1.478 0.966 0 CA-C-N 113.921 -1.49 . . . . 1.0 109.063 -177.413 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . 0.631 HG13 ' O ' ' A' ' 14' ' ' ALA . 2.3 m -69.29 -57.4 8.62 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.359 0 N-CA-C 108.939 -0.763 . . . . 1.0 108.939 178.426 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . 0.57 ' N ' ' O ' ' A' ' 15' ' ' ALA . . . -58.03 -169.45 0.18 Allowed Glycine 0 C--O 1.216 -1.027 0 N-CA-C 110.67 -0.972 . . . . 1.0 110.67 179.722 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 20' ' ' PRO . . . . . 0.499 ' O ' ' N ' ' A' ' 24' ' ' ALA . 3.5 Cg_endo -79.62 -31.07 2.13 Favored 'Trans proline' 0 N--CA 1.499 1.798 0 C-N-CA 123.052 2.501 . . . . 1.0 115.154 -178.06 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -59.88 -57.43 19.39 Favored Glycine 0 N--CA 1.475 1.298 0 C-N-CA 120.699 -0.763 . . . . 1.0 112.665 -176.8 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . 0.412 ' CA ' ' HB1' ' A' ' 16' ' ' ALA . . . -55.99 -54.16 37.28 Favored Glycine 0 N--CA 1.469 0.844 0 N-CA-C 107.74 -2.144 . . . . 1.0 107.74 -175.534 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . 0.576 ' O ' HG12 ' A' ' 27' ' ' VAL . 0.0 OUTLIER -60.84 -32.23 51.61 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.391 0 CA-C-N 114.617 -0.792 . . . . 1.0 109.607 178.923 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . 0.499 ' N ' ' O ' ' A' ' 20' ' ' PRO . . . -56.01 -62.12 1.92 Allowed 'General case' 0 CA--C 1.532 0.28 0 C-N-CA 117.993 -1.483 . . . . 1.0 109.408 179.791 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -65.56 -45.16 84.39 Favored 'General case' 0 C--N 1.341 0.23 0 N-CA-C 112.82 0.674 . . . . 1.0 112.82 -178.464 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 98.5 t -60.22 -59.11 4.57 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.192 0 C-N-CA 118.849 -1.14 . . . . 1.0 110.21 -177.375 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . 0.576 HG12 ' O ' ' A' ' 23' ' ' VAL . 1.2 p -59.74 -35.16 58.33 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.286 0 CA-C-O 120.982 0.42 . . . . 1.0 111.95 -178.341 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 32.2 ttpt -66.54 -53.92 29.44 Favored 'General case' 0 C--N 1.315 -0.921 0 CA-C-O 121.906 0.86 . . . . 1.0 109.069 -178.376 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 91.1 t -64.37 -48.59 84.62 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.1 0 CA-C-N 113.668 -1.605 . . . . 1.0 111.557 -177.413 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 30' ' ' CYS . . . . . 0.572 ' SG ' ' N ' ' A' ' 31' ' ' ALA . 0.0 OUTLIER -63.82 -58.58 6.37 Favored 'General case' 0 N--CA 1.452 -0.336 0 C-N-CA 118.86 -1.136 . . . . 1.0 108.518 -179.299 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . 0.572 ' N ' ' SG ' ' A' ' 30' ' ' CYS . . . -61.7 -53.52 55.02 Favored 'General case' 0 C--N 1.326 -0.415 0 N-CA-C 112.422 0.527 . . . . 1.0 112.422 -177.515 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . 0.473 ' O ' ' CB ' ' A' ' 33' ' ' LEU . . . 86.86 74.42 1.27 Allowed Glycine 0 CA--C 1.522 0.481 0 N-CA-C 110.656 -0.978 . . . . 1.0 110.656 -178.87 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . 0.473 ' CB ' ' O ' ' A' ' 32' ' ' GLY . 1.0 OUTLIER 86.06 101.84 0.03 OUTLIER Pre-proline 0 CA--C 1.547 0.841 0 N-CA-C 109.813 -0.44 . . . . 1.0 109.813 -179.876 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 55.9 Cg_endo -71.48 -26.02 20.64 Favored 'Trans proline' 0 N--CA 1.501 1.96 0 C-N-CA 122.087 1.858 . . . . 1.0 114.055 -177.955 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -59.84 -59.45 10.47 Favored Glycine 0 CA--C 1.523 0.554 0 C-N-CA 118.081 -2.009 . . . . 1.0 108.884 -178.539 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . 0.64 ' O ' HG22 ' A' ' 37' ' ' ILE . 10.8 p -90.53 161.92 2.54 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.541 0 N-CA-C 107.277 -1.379 . . . . 1.0 107.277 177.565 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . 0.64 HG22 ' O ' ' A' ' 36' ' ' VAL . 14.8 tt 120.0 113.17 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.472 0.626 0 O-C-N 124.85 1.344 . . . . 1.0 110.061 179.615 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 22.7 m-70 -140.61 135.46 31.76 Favored 'General case' 0 C--N 1.322 -0.625 0 N-CA-C 108.874 -0.787 . . . . 1.0 108.874 178.87 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 42.5 p -112.54 139.8 23.1 Favored Pre-proline 0 C--N 1.331 -0.23 0 N-CA-C 109.146 -0.687 . . . . 1.0 109.146 179.716 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 40' ' ' PRO . . . . . 0.42 ' HG2' ' H ' ' A' ' 41' ' ' ALA . 57.6 Cg_endo -70.88 -87.15 0.0 OUTLIER 'Trans proline' 0 C--N 1.312 -1.367 0 C-N-CA 121.747 1.631 . . . . 1.0 112.015 -179.433 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . 0.42 ' H ' ' HG2' ' A' ' 40' ' ' PRO . . . -66.6 125.07 24.62 Favored 'General case' 0 C--N 1.315 -0.93 0 CA-C-N 114.786 -1.097 . . . . 1.0 110.623 -178.902 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . 0.657 ' C ' ' H ' ' A' ' 44' ' ' GLY . 4.2 ptt180 -170.7 168.42 7.44 Favored 'General case' 0 N--CA 1.445 -0.711 0 CA-C-N 115.556 -0.747 . . . . 1.0 109.779 179.893 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -63.31 24.86 0.01 OUTLIER 'General case' 0 C--N 1.317 -0.826 0 CA-C-N 115.88 -0.6 . . . . 1.0 110.369 179.83 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . 0.657 ' H ' ' C ' ' A' ' 42' ' ' ARG . . . 87.14 -26.2 7.1 Favored Glycine 0 C--N 1.333 0.402 0 N-CA-C 110.605 -0.998 . . . . 1.0 110.605 179.4 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . 0.646 ' CG ' ' O ' ' A' ' 44' ' ' GLY . 74.0 m-85 -167.37 175.15 7.45 Favored 'General case' 0 C--O 1.216 -0.675 0 O-C-N 124.759 0.917 . . . . 1.0 110.696 178.551 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 46' ' ' PHE . . . . . 0.577 ' HB2' ' O ' ' A' ' 45' ' ' PHE . 2.0 m-85 132.58 89.02 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.611 0 C-N-CA 125.625 1.57 . . . . 1.0 109.432 179.01 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 47' ' ' ARG . . . . . 0.508 ' CB ' ' O ' ' A' ' 46' ' ' PHE . 48.6 mmt-85 124.53 142.06 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.509 0 C-N-CA 124.33 1.052 . . . . 1.0 110.781 178.666 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 2.6 t 69.45 70.62 0.25 Allowed 'General case' 0 C--N 1.331 -0.226 0 N-CA-C 108.355 -0.98 . . . . 1.0 108.355 -178.916 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 49' ' ' ASN . . . . . 0.585 ' CG ' HE22 ' A' ' 54' ' ' GLN . 1.7 p30 -125.17 152.79 71.34 Favored Pre-proline 0 C--O 1.233 0.232 0 CA-C-N 116.448 -0.342 . . . . 1.0 110.551 -178.969 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 50' ' ' PRO . . . . . 0.527 ' HG2' HH11 ' A' ' 52' ' ' ARG . 78.7 Cg_endo -73.17 55.84 3.03 Favored 'Trans proline' 0 C--N 1.311 -1.427 0 C-N-CA 122.022 1.815 . . . . 1.0 110.812 178.889 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 46.8 mm-40 68.18 -2.5 1.5 Allowed 'General case' 0 CA--C 1.528 0.127 0 CA-C-N 116.149 -0.478 . . . . 1.0 111.08 -179.635 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . 0.527 HH11 ' HG2' ' A' ' 50' ' ' PRO . 80.0 mtt85 -77.85 159.71 28.78 Favored 'General case' 0 N--CA 1.466 0.329 0 CA-C-O 120.999 0.428 . . . . 1.0 110.581 179.095 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . 0.429 ' O ' ' N ' ' A' ' 55' ' ' ILE . 19.4 tt -78.13 138.71 19.77 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.187 0 CA-C-N 115.906 -0.588 . . . . 1.0 111.218 -179.324 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 54' ' ' GLN . . . . . 0.585 HE22 ' CG ' ' A' ' 49' ' ' ASN . 29.2 mm-40 -63.16 81.4 0.02 OUTLIER 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 115.273 -0.876 . . . . 1.0 110.468 -177.973 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . 0.429 ' N ' ' O ' ' A' ' 53' ' ' ILE . 15.4 tt -147.01 156.02 11.01 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.152 0 CA-C-N 115.264 -0.88 . . . . 1.0 109.613 177.63 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 109.97 -2.13 30.12 Favored Glycine 0 N--CA 1.466 0.634 0 N-CA-C 110.683 -0.967 . . . . 1.0 110.683 -179.748 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . 0.418 ' O ' ' CG ' ' A' ' 57' ' ' ASP . 18.9 p-10 -79.43 99.56 7.25 Favored 'General case' 0 C--N 1.325 -0.468 0 N-CA-C 109.33 -0.619 . . . . 1.0 109.33 178.891 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 58' ' ' TRP . . . . . . . . . . . . . 3.9 m0 -89.99 170.58 10.23 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 123.753 1.739 . . . . 1.0 113.337 -177.052 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 59' ' ' ARG . . . . . 0.444 ' HG3' ' N ' ' A' ' 60' ' ' TYR . 48.3 ptt85 -82.29 -57.89 3.18 Favored 'General case' 0 C--N 1.312 -1.062 0 CA-C-N 110.393 -3.094 . . . . 1.0 112.779 -178.865 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 60' ' ' TYR . . . . . 0.444 ' N ' ' HG3' ' A' ' 59' ' ' ARG . 79.9 t80 -92.67 -15.68 26.46 Favored 'General case' 0 N--CA 1.485 1.285 0 N-CA-C 113.406 0.891 . . . . 1.0 113.406 -179.979 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 6.3 tt0 -77.49 -14.03 59.78 Favored 'General case' 0 C--N 1.313 -1.005 0 CA-C-N 116.065 -0.516 . . . . 1.0 111.073 -178.852 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 62' ' ' VAL . . . . . 0.638 ' O ' ' N ' ' A' ' 66' ' ' GLY . 27.5 m -48.22 -54.65 3.86 Favored 'Isoleucine or valine' 0 C--O 1.198 -1.616 0 C-N-CA 119.485 -0.886 . . . . 1.0 109.84 -175.346 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 63' ' ' ALA . . . . . 0.583 ' N ' HG23 ' A' ' 62' ' ' VAL . . . -68.01 -50.65 54.23 Favored 'General case' 0 C--N 1.306 -1.297 0 O-C-N 121.32 -0.862 . . . . 1.0 109.022 -179.968 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -48.5 -58.59 4.44 Favored 'General case' 0 N--CA 1.465 0.307 0 C-N-CA 119.594 -0.842 . . . . 1.0 109.274 -179.893 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 65' ' ' ASP . . . . . 0.538 ' C ' ' H ' ' A' ' 67' ' ' ARG . 18.5 t0 -71.63 -49.97 35.14 Favored 'General case' 0 C--N 1.314 -0.968 0 CA-C-N 115.147 -0.933 . . . . 1.0 110.159 178.832 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . 0.638 ' N ' ' O ' ' A' ' 62' ' ' VAL . . . -71.69 25.83 0.62 Allowed Glycine 0 CA--C 1.52 0.393 0 N-CA-C 110.915 -0.874 . . . . 1.0 110.915 178.241 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 67' ' ' ARG . . . . . 0.628 ' O ' ' N ' ' A' ' 69' ' ' LEU . 0.2 OUTLIER -75.89 2.49 12.31 Favored 'General case' 0 C--N 1.323 -0.564 0 N-CA-C 105.706 -1.961 . . . . 1.0 105.706 175.607 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . 0.519 HD12 ' O ' ' A' ' 66' ' ' GLY . 0.0 OUTLIER -35.23 -27.32 0.01 OUTLIER 'General case' 0 N--CA 1.482 1.169 0 N-CA-C 107.991 -1.114 . . . . 1.0 107.991 -176.559 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . 0.639 HD13 ' C ' ' A' ' 69' ' ' LEU . 2.9 tm? -62.68 -64.49 0.9 Allowed 'General case' 0 C--N 1.323 -0.56 0 C-N-CA 117.679 -1.608 . . . . 1.0 107.732 177.772 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . 0.689 ' C ' ' H ' ' A' ' 72' ' ' HIS . . . -79.01 -74.52 0.28 Allowed 'General case' 0 N--CA 1.479 0.995 0 N-CA-C 107.385 -1.339 . . . . 1.0 107.385 178.509 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 71' ' ' ALA . . . . . 0.435 ' O ' ' C ' ' A' ' 72' ' ' HIS . . . -45.15 4.16 0.0 OUTLIER 'General case' 0 C--O 1.224 -0.239 0 C-N-CA 124.849 1.26 . . . . 1.0 112.479 178.754 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 72' ' ' HIS . . . . . 0.689 ' H ' ' C ' ' A' ' 70' ' ' ALA . 1.9 t60 -29.83 -73.85 0.03 OUTLIER 'General case' 0 C--N 1.333 -0.123 0 N-CA-C 112.261 0.467 . . . . 1.0 112.261 -179.373 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 73' ' ' MET . . . . . 0.598 ' N ' ' SD ' ' A' ' 73' ' ' MET . 0.0 OUTLIER -58.34 -54.51 46.24 Favored 'General case' 0 C--N 1.329 -0.32 0 N-CA-C 106.521 -1.659 . . . . 1.0 106.521 178.655 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . 0.765 ' O ' ' N ' ' A' ' 76' ' ' GLY . 61.4 t -42.38 -39.83 0.87 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-O 117.271 -1.347 . . . . 1.0 111.681 -176.13 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 75' ' ' ASN . . . . . 0.492 ' C ' ' N ' ' A' ' 77' ' ' ILE . 33.4 p-10 -35.15 -15.18 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.607 0 CA-C-N 120.824 1.647 . . . . 1.0 110.806 179.558 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 76' ' ' GLY . . . . . 0.765 ' N ' ' O ' ' A' ' 74' ' ' VAL . . . -49.6 -19.93 2.38 Favored Glycine 0 N--CA 1.436 -1.328 0 N-CA-C 107.244 -2.343 . . . . 1.0 107.244 173.394 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 77' ' ' ILE . . . . . 0.492 ' N ' ' C ' ' A' ' 75' ' ' ASN . 14.1 pt -56.49 -50.59 72.17 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.032 0 CA-C-O 117.747 -1.12 . . . . 1.0 110.384 -179.334 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 24.4 t -54.71 -20.69 5.82 Favored 'Isoleucine or valine' 0 C--N 1.352 0.699 0 CA-C-N 121.095 1.77 . . . . 1.0 113.427 179.701 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . 0.593 ' CG2' HH22 ' A' ' 126' ' ' ARG . 44.8 pt -91.68 -40.27 12.25 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.34 0 C-N-CA 118.888 -1.125 . . . . 1.0 109.677 178.012 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -79.56 -19.85 48.46 Favored 'General case' 0 CA--C 1.538 0.494 0 N-CA-C 113.604 0.964 . . . . 1.0 113.604 179.495 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 81' ' ' GLU . . . . . 0.538 ' CG ' ' H ' ' A' ' 82' ' ' ASP . 1.1 pp20? -94.15 -71.52 0.66 Allowed 'General case' 0 C--N 1.345 0.4 0 N-CA-C 114.47 1.285 . . . . 1.0 114.47 -177.474 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 82' ' ' ASP . . . . . 0.538 ' H ' ' CG ' ' A' ' 81' ' ' GLU . 27.4 t70 -88.93 -15.04 35.31 Favored 'General case' 0 CA--C 1.538 0.493 0 N-CA-C 114.447 1.277 . . . . 1.0 114.447 -178.237 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . 0.59 ' O ' ' N ' ' A' ' 87' ' ' GLU . . . -49.75 -46.21 50.27 Favored 'General case' 0 C--O 1.214 -0.813 0 C-N-CA 118.116 -1.434 . . . . 1.0 112.352 -177.816 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . 0.648 HD13 ' O ' ' A' ' 84' ' ' LEU . 2.7 tm? -39.77 -45.47 1.75 Allowed 'General case' 0 N--CA 1.471 0.586 0 CA-C-N 118.207 0.458 . . . . 1.0 111.602 -178.026 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 85' ' ' ILE . . . . . 0.422 HG22 ' O ' ' A' ' 82' ' ' ASP . 6.4 tt -66.36 -34.64 71.5 Favored 'Isoleucine or valine' 0 C--O 1.235 0.296 0 C-N-CA 119.698 -0.801 . . . . 1.0 111.022 -179.583 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 86' ' ' ALA . . . . . 0.867 ' O ' HG22 ' A' ' 89' ' ' VAL . . . -93.64 -23.88 18.1 Favored 'General case' 0 C--O 1.211 -0.967 0 N-CA-C 111.728 0.27 . . . . 1.0 111.728 179.904 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 87' ' ' GLU . . . . . 0.59 ' N ' ' O ' ' A' ' 83' ' ' ALA . 38.9 tp10 -54.51 -18.81 4.76 Favored 'General case' 0 C--N 1.324 -0.509 0 O-C-N 121.447 -0.783 . . . . 1.0 109.946 -178.818 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -75.49 -5.83 47.12 Favored 'General case' 0 N--CA 1.473 0.687 0 CA-C-O 122.762 1.268 . . . . 1.0 108.097 178.329 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 89' ' ' VAL . . . . . 0.867 HG22 ' O ' ' A' ' 86' ' ' ALA . 3.2 m -86.05 36.31 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.318 -0.785 0 CA-C-N 112.173 -2.285 . . . . 1.0 107.962 177.085 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 90' ' ' GLY . . . . . 0.882 ' O ' ' N ' ' A' ' 92' ' ' HIS . . . -56.26 -19.66 25.72 Favored Glycine 0 C--N 1.373 2.601 0 CA-C-O 117.049 -1.973 . . . . 1.0 113.465 178.362 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 91' ' ' PRO . . . . . 0.699 ' HD2' ' N ' ' A' ' 90' ' ' GLY . 3.0 Cg_exo -34.38 3.42 0.0 OUTLIER 'Trans proline' 0 N--CA 1.499 1.817 0 CA-C-N 121.618 2.709 . . . . 1.0 113.693 172.409 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 92' ' ' HIS . . . . . 0.882 ' N ' ' O ' ' A' ' 90' ' ' GLY . 1.4 t-160 -47.2 -35.15 7.12 Favored 'General case' 0 N--CA 1.443 -0.816 0 N-CA-C 106.04 -1.837 . . . . 1.0 106.04 179.484 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 93' ' ' LEU . . . . . 0.439 ' O ' ' HB3' ' A' ' 96' ' ' ALA . 5.6 tp -62.57 -45.86 91.0 Favored 'General case' 0 C--N 1.35 0.609 0 N-CA-C 108.652 -0.869 . . . . 1.0 108.652 176.058 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 94' ' ' ALA . . . . . 0.545 ' N ' ' O ' ' A' ' 91' ' ' PRO . . . -53.69 -58.17 8.18 Favored 'General case' 0 C--N 1.333 -0.15 0 N-CA-C 106.344 -1.724 . . . . 1.0 106.344 178.685 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -58.32 -29.73 66.14 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-N 114.65 -1.159 . . . . 1.0 109.314 177.981 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 96' ' ' ALA . . . . . 0.855 ' O ' ' N ' ' A' ' 100' ' ' ILE . . . -54.35 -51.21 65.47 Favored 'General case' 0 C--O 1.199 -1.57 0 N-CA-C 107.84 -1.17 . . . . 1.0 107.84 -176.145 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 97' ' ' LEU . . . . . 0.583 ' O ' HG22 ' A' ' 100' ' ' ILE . 2.7 tm? -34.02 -28.37 0.01 OUTLIER 'General case' 0 CA--C 1.567 1.622 0 CA-C-N 113.788 -1.551 . . . . 1.0 108.052 -178.03 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 98' ' ' GLY . . . . . 0.648 ' N ' ' O ' ' A' ' 96' ' ' ALA . . . -89.37 -53.32 2.49 Favored Glycine 0 CA--C 1.56 2.866 0 CA-C-O 123.279 1.488 . . . . 1.0 111.956 170.46 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 99' ' ' GLN . . . . . 0.541 ' N ' ' O ' ' A' ' 96' ' ' ALA . 5.4 mm100 -75.93 6.48 5.09 Favored 'General case' 0 N--CA 1.439 -0.986 0 N-CA-C 107.64 -1.244 . . . . 1.0 107.64 179.156 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 100' ' ' ILE . . . . . 0.855 ' N ' ' O ' ' A' ' 96' ' ' ALA . 19.2 tt -63.46 -50.6 77.86 Favored 'Isoleucine or valine' 0 CA--C 1.471 -2.069 0 N-CA-C 107.784 -1.191 . . . . 1.0 107.784 -179.956 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 101' ' ' VAL . . . . . 0.673 ' O ' ' N ' ' A' ' 105' ' ' GLY . 76.1 t -51.84 -60.16 1.14 Allowed 'Isoleucine or valine' 0 C--O 1.212 -0.893 0 C-N-CA 118.292 -1.363 . . . . 1.0 107.389 178.691 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 102' ' ' CYS . . . . . 0.808 ' O ' ' HB2' ' A' ' 106' ' ' ALA . 0.0 OUTLIER -53.63 -25.39 17.55 Favored 'General case' 0 C--N 1.306 -1.299 0 CA-C-N 115.428 -0.806 . . . . 1.0 111.434 -176.78 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 51.1 ttm-85 -84.36 -52.05 6.49 Favored 'General case' 0 N--CA 1.488 1.471 0 CA-C-O 122.415 1.102 . . . . 1.0 113.337 -179.407 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 104' ' ' TYR . . . . . 0.671 ' O ' ' CG ' ' A' ' 104' ' ' TYR . 0.0 OUTLIER -96.33 21.79 8.61 Favored 'General case' 0 C--N 1.302 -1.488 0 C-N-CA 127.378 2.271 . . . . 1.0 106.819 177.874 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 105' ' ' GLY . . . . . 0.673 ' N ' ' O ' ' A' ' 101' ' ' VAL . . . -159.08 -97.88 0.13 Allowed Glycine 0 CA--C 1.53 0.99 0 N-CA-C 109.442 -1.463 . . . . 1.0 109.442 179.028 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 106' ' ' ALA . . . . . 0.808 ' HB2' ' O ' ' A' ' 102' ' ' CYS . . . 60.64 114.38 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.253 0 N-CA-C 108.985 -0.746 . . . . 1.0 108.985 -176.254 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 107' ' ' THR . . . . . 0.852 ' O ' ' HD2' ' A' ' 110' ' ' PRO . 22.0 m -133.28 -61.61 0.82 Allowed 'General case' 0 C--O 1.194 -1.819 0 N-CA-C 106.789 -1.56 . . . . 1.0 106.789 177.78 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 32.7 m -71.5 30.66 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.318 -0.795 0 O-C-N 121.22 -0.925 . . . . 1.0 109.251 -178.239 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 109' ' ' ILE . . . . . 0.65 HD13 ' HB1' ' A' ' 106' ' ' ALA . 0.1 OUTLIER -111.8 -40.46 0.1 Allowed Pre-proline 0 CA--C 1.56 1.346 0 CA-C-N 118.573 0.624 . . . . 1.0 110.882 177.969 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 110' ' ' PRO . . . . . 0.852 ' HD2' ' O ' ' A' ' 107' ' ' THR . 31.2 Cg_exo -65.33 -23.83 58.49 Favored 'Trans proline' 0 N--CA 1.496 1.62 0 C-N-CA 122.609 2.206 . . . . 1.0 111.82 179.72 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 111' ' ' ASN . . . . . 0.549 ' CG ' ' N ' ' A' ' 112' ' ' ILE . 0.0 OUTLIER -66.43 -66.77 0.51 Allowed 'General case' 0 CA--C 1.535 0.384 0 C-N-CA 119.51 -0.876 . . . . 1.0 109.132 -179.353 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 112' ' ' ILE . . . . . 0.549 ' N ' ' CG ' ' A' ' 111' ' ' ASN . 0.0 OUTLIER -52.43 -32.47 16.49 Favored 'Isoleucine or valine' 0 C--O 1.213 -0.821 0 CA-C-O 122.253 1.025 . . . . 1.0 109.139 178.783 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 113' ' ' ASN . . . . . 0.483 ' HB2' ' HA ' ' A' ' 110' ' ' PRO . 8.4 m-20 -55.39 -55.29 33.28 Favored 'General case' 0 C--N 1.296 -1.722 0 CA-C-N 113.345 -1.752 . . . . 1.0 107.581 -179.105 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -60.51 -29.31 69.01 Favored 'General case' 0 N--CA 1.44 -0.958 0 C-N-CA 119.383 -0.927 . . . . 1.0 110.995 178.934 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -77.93 -59.56 2.73 Favored 'General case' 0 N--CA 1.451 -0.413 0 C-N-CA 119.558 -0.857 . . . . 1.0 110.031 178.949 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 116' ' ' ILE . . . . . 0.64 ' O ' ' N ' ' A' ' 120' ' ' GLY . 1.4 tp -50.8 -48.21 28.34 Favored 'Isoleucine or valine' 0 CA--C 1.498 -1.055 0 N-CA-C 108.859 -0.793 . . . . 1.0 108.859 -179.096 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 117' ' ' GLU . . . . . 0.53 ' N ' ' CG2' ' A' ' 116' ' ' ILE . 51.6 mt-10 -38.9 -58.53 1.08 Allowed 'General case' 0 C--N 1.317 -0.838 0 N-CA-C 104.707 -2.331 . . . . 1.0 104.707 179.424 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 99.4 t -58.62 -52.02 64.81 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.716 0 C-N-CA 119.608 -0.837 . . . . 1.0 109.076 176.951 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 119' ' ' LEU . . . . . 0.474 ' N ' ' O ' ' A' ' 116' ' ' ILE . 0.3 OUTLIER -56.34 -69.64 0.14 Allowed 'General case' 0 N--CA 1.47 0.561 0 C-N-CA 118.362 -1.335 . . . . 1.0 107.641 -178.594 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 120' ' ' GLY . . . . . 0.64 ' N ' ' O ' ' A' ' 116' ' ' ILE . . . -72.0 -85.11 0.2 Allowed Glycine 0 CA--C 1.55 2.223 0 C-N-CA 119.172 -1.489 . . . . 1.0 111.25 178.229 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 121' ' ' THR . . . . . 0.487 ' HA ' ' O ' ' A' ' 117' ' ' GLU . 1.5 t 160.96 -27.66 0.0 OUTLIER 'General case' 0 N--CA 1.486 1.375 0 CA-C-N 113.797 -1.202 . . . . 1.0 113.362 -178.715 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 122' ' ' GLY . . . . . 0.632 ' O ' ' N ' ' A' ' 124' ' ' ASP . . . 97.38 -21.74 44.54 Favored Glycine 0 N--CA 1.476 1.36 0 N-CA-C 107.884 -2.086 . . . . 1.0 107.884 -177.511 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 123' ' ' THR . . . . . 0.542 ' O ' ' NE2' ' A' ' 72' ' ' HIS . 7.6 m -47.7 89.41 0.0 OUTLIER 'General case' 0 N--CA 1.467 0.413 0 N-CA-C 105.21 -2.144 . . . . 1.0 105.21 177.603 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 124' ' ' ASP . . . . . 0.632 ' N ' ' O ' ' A' ' 122' ' ' GLY . 29.8 t70 -166.32 175.57 8.14 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 114.856 -1.065 . . . . 1.0 112.361 -179.505 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 125' ' ' TYR . . . . . 0.488 ' N ' ' CG ' ' A' ' 124' ' ' ASP . 56.2 t80 -146.71 145.32 29.95 Favored 'General case' 0 CA--C 1.533 0.298 0 CA-C-N 115.102 -0.954 . . . . 1.0 109.106 176.7 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 126' ' ' ARG . . . . . 0.593 HH22 ' CG2' ' A' ' 79' ' ' ILE . 0.8 OUTLIER -147.18 146.46 29.86 Favored 'General case' 0 C--N 1.327 -0.387 0 N-CA-C 108.701 -0.851 . . . . 1.0 108.701 178.91 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 127' ' ' PHE . . . . . . . . . . . . . 29.2 p90 . . . . . 0 N--CA 1.47 0.573 0 CA-C-O 117.899 -1.048 . . . . 1.0 110.297 179.737 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . 0.591 ' SD ' ' N ' ' A' ' 1' ' ' MET . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.619 0 N-CA-C 108.998 -0.742 . . . . 1.0 108.998 . . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 2' ' ' SER . . . . . 0.466 ' O ' ' CB ' ' A' ' 3' ' ' ASP . 78.2 p -81.07 5.92 15.15 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.854 -0.612 . . . . 1.0 110.771 -179.805 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 3' ' ' ASP . . . . . 0.478 ' N ' ' OD1' ' A' ' 3' ' ' ASP . 5.1 p30 154.17 127.72 0.0 OUTLIER 'General case' 0 N--CA 1.472 0.629 0 O-C-N 123.669 0.606 . . . . 1.0 110.556 178.965 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 71.9 t80 -154.1 149.7 27.41 Favored 'General case' 0 N--CA 1.466 0.338 0 CA-C-O 120.789 0.328 . . . . 1.0 110.762 179.33 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 68.4 m-20 -152.92 147.96 26.58 Favored 'General case' 0 CA--C 1.535 0.389 0 N-CA-C 109.555 -0.535 . . . . 1.0 109.555 179.747 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 6' ' ' THR . . . . . 0.809 ' O ' ' N ' ' A' ' 10' ' ' SER . 0.2 OUTLIER -93.64 -177.61 4.44 Favored 'General case' 0 C--O 1.187 -2.225 0 CA-C-N 116.68 -0.236 . . . . 1.0 110.972 -179.485 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . 0.532 ' O ' ' N ' ' A' ' 11' ' ' ARG . 66.5 tt0 -59.93 -55.44 34.1 Favored 'General case' 0 N--CA 1.476 0.849 0 CA-C-O 121.518 0.675 . . . . 1.0 110.933 -179.274 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 8' ' ' ARG . . . . . 0.531 ' O ' ' CB ' ' A' ' 12' ' ' ALA . 0.6 OUTLIER -53.58 -58.98 5.22 Favored 'General case' 0 C--N 1.304 -1.409 0 N-CA-C 107.749 -1.204 . . . . 1.0 107.749 179.865 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . 0.849 ' O ' HG13 ' A' ' 13' ' ' VAL . 0.0 OUTLIER -65.47 -49.32 78.96 Favored 'Isoleucine or valine' 0 CA--C 1.559 1.308 0 CA-C-N 114.575 -1.193 . . . . 1.0 110.978 179.816 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 10' ' ' SER . . . . . 0.809 ' N ' ' O ' ' A' ' 6' ' ' THR . 32.2 t -61.11 -57.94 10.42 Favored 'General case' 0 N--CA 1.492 1.668 0 CA-C-O 122.23 1.014 . . . . 1.0 108.315 179.057 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 11' ' ' ARG . . . . . 0.677 ' O ' ' HB3' ' A' ' 15' ' ' ALA . 7.6 tpt180 -61.97 -40.79 96.8 Favored 'General case' 0 C--N 1.315 -0.92 0 CA-C-N 115.412 -0.813 . . . . 1.0 109.167 -177.578 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . 0.756 ' O ' ' HB3' ' A' ' 16' ' ' ALA . . . -68.05 -55.44 12.55 Favored 'General case' 0 N--CA 1.475 0.825 0 C-N-CA 119.193 -1.003 . . . . 1.0 108.557 176.164 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . 0.849 HG13 ' O ' ' A' ' 9' ' ' VAL . 4.5 m -63.28 -53.03 51.09 Favored 'Isoleucine or valine' 0 C--O 1.205 -1.246 0 C-N-CA 118.241 -1.384 . . . . 1.0 108.894 -178.957 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . 0.838 ' O ' HG22 ' A' ' 18' ' ' VAL . . . -60.8 -64.35 0.98 Allowed 'General case' 0 C--N 1.305 -1.347 0 C-N-CA 117.953 -1.499 . . . . 1.0 110.464 179.668 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . 0.677 ' HB3' ' O ' ' A' ' 11' ' ' ARG . . . -56.52 -56.45 21.05 Favored 'General case' 0 N--CA 1.479 0.992 0 C-N-CA 119.522 -0.871 . . . . 1.0 111.375 -177.883 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . 0.756 ' HB3' ' O ' ' A' ' 12' ' ' ALA . . . -65.6 -56.42 12.31 Favored 'General case' 0 C--N 1.318 -0.791 0 C-N-CA 119.068 -1.053 . . . . 1.0 110.298 -178.596 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . 0.625 ' CB ' ' O ' ' A' ' 13' ' ' VAL . 5.2 tt -58.36 -54.94 41.39 Favored 'General case' 0 N--CA 1.485 1.293 0 C-N-CA 118.869 -1.132 . . . . 1.0 108.853 -178.289 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . 0.838 HG22 ' O ' ' A' ' 14' ' ' ALA . 1.3 m -71.88 -57.75 6.65 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.858 0 C-N-CA 119.112 -1.035 . . . . 1.0 110.851 -179.823 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . 0.515 ' N ' ' O ' ' A' ' 15' ' ' ALA . . . -57.33 -175.22 0.34 Allowed Glycine 0 N--CA 1.444 -0.808 0 C-N-CA 121.23 -0.509 . . . . 1.0 112.076 -177.036 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 20' ' ' PRO . . . . . 0.638 ' O ' ' N ' ' A' ' 24' ' ' ALA . 4.1 Cg_endo -81.06 -27.03 3.16 Favored 'Trans proline' 0 C--N 1.307 -1.647 0 C-N-CA 122.749 2.3 . . . . 1.0 113.172 -178.433 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -63.05 -61.26 6.57 Favored Glycine 0 N--CA 1.474 1.17 0 C-N-CA 119.279 -1.439 . . . . 1.0 112.432 -176.33 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . 0.529 ' H ' ' HA ' ' A' ' 16' ' ' ALA . . . -53.08 -51.87 43.55 Favored Glycine 0 N--CA 1.472 1.087 0 N-CA-C 106.14 -2.784 . . . . 1.0 106.14 -177.697 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . 0.414 ' O ' HG12 ' A' ' 27' ' ' VAL . 40.5 t -61.61 -31.5 50.91 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.089 0 C-N-CA 119.42 -0.912 . . . . 1.0 109.811 178.517 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . 0.638 ' N ' ' O ' ' A' ' 20' ' ' PRO . . . -57.68 -62.49 1.76 Allowed 'General case' 0 C--N 1.353 0.756 0 C-N-CA 118.551 -1.26 . . . . 1.0 109.703 -179.501 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . 0.498 ' C ' HD12 ' A' ' 25' ' ' LEU . 0.5 OUTLIER -61.42 -44.72 96.64 Favored 'General case' 0 N--CA 1.464 0.251 0 C-N-CA 119.902 -0.719 . . . . 1.0 111.93 -178.237 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . 0.479 ' N ' ' HG ' ' A' ' 25' ' ' LEU . 31.6 t -58.98 -58.35 7.27 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.819 0 C-N-CA 119.455 -0.898 . . . . 1.0 110.278 -177.843 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . 0.566 ' O ' ' HB3' ' A' ' 31' ' ' ALA . 1.4 p -63.01 -36.67 76.78 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.716 0 C-N-CA 120.393 -0.523 . . . . 1.0 110.971 -177.999 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 2.0 tppp? -65.47 -57.81 7.37 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-O 121.756 0.788 . . . . 1.0 109.199 -179.237 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 79.3 t -63.56 -47.78 89.9 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.023 0 CA-C-N 114.622 -1.172 . . . . 1.0 110.208 -177.351 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 30' ' ' CYS . . . . . . . . . . . . . 51.4 t -65.56 -61.02 2.34 Favored 'General case' 0 N--CA 1.446 -0.64 0 C-N-CA 119.355 -0.938 . . . . 1.0 110.358 -179.397 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . 0.566 ' HB3' ' O ' ' A' ' 27' ' ' VAL . . . -59.71 -47.8 84.21 Favored 'General case' 0 CA--C 1.515 -0.378 0 O-C-N 122.083 -0.385 . . . . 1.0 111.158 -176.954 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . 0.497 ' O ' ' HB2' ' A' ' 33' ' ' LEU . . . 72.89 64.62 2.51 Favored Glycine 0 N--CA 1.449 -0.492 0 N-CA-C 108.788 -1.725 . . . . 1.0 108.788 -178.144 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . 0.497 ' HB2' ' O ' ' A' ' 32' ' ' GLY . 27.2 mt 83.77 129.88 0.03 OUTLIER Pre-proline 0 CA--C 1.544 0.739 0 O-C-N 125.295 1.233 . . . . 1.0 111.12 -178.465 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 58.7 Cg_endo -72.13 -5.26 16.76 Favored 'Trans proline' 0 N--CA 1.495 1.594 0 C-N-CA 122.788 2.325 . . . . 1.0 112.599 179.028 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . 0.404 ' HA2' HD12 ' A' ' 112' ' ' ILE . . . -62.12 -62.16 5.94 Favored Glycine 0 C--N 1.336 0.568 0 C-N-CA 118.405 -1.855 . . . . 1.0 111.095 -178.565 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . 0.834 HG22 ' H ' ' A' ' 37' ' ' ILE . 8.7 p -87.26 -142.71 0.01 OUTLIER 'Isoleucine or valine' 0 C--O 1.216 -0.683 0 N-CA-C 107.552 -1.277 . . . . 1.0 107.552 178.793 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . 0.834 ' H ' HG22 ' A' ' 36' ' ' VAL . 0.3 OUTLIER 70.54 76.46 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.473 0.716 0 CA-C-O 122.344 1.069 . . . . 1.0 111.42 179.842 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 95.4 m-70 -139.75 133.2 30.12 Favored 'General case' 0 C--N 1.33 -0.269 0 O-C-N 120.989 -1.069 . . . . 1.0 109.18 179.311 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -108.57 124.79 33.39 Favored Pre-proline 0 CA--C 1.541 0.615 0 N-CA-C 109.67 -0.493 . . . . 1.0 109.67 179.789 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 52.0 Cg_exo -49.94 -23.08 8.39 Favored 'Trans proline' 0 N--CA 1.5 1.866 0 C-N-CA 121.796 1.664 . . . . 1.0 113.827 179.985 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -126.17 134.86 51.15 Favored 'General case' 0 N--CA 1.469 0.506 0 N-CA-C 111.311 0.115 . . . . 1.0 111.311 178.54 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . 0.682 ' C ' ' H ' ' A' ' 44' ' ' GLY . 19.3 ttp-105 -164.68 164.46 21.37 Favored 'General case' 0 C--N 1.328 -0.353 0 C-N-CA 120.197 -0.601 . . . . 1.0 109.787 177.172 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 43' ' ' ARG . . . . . 0.625 ' C ' ' H ' ' A' ' 45' ' ' PHE . 4.7 tpt180 -60.92 24.59 0.01 OUTLIER 'General case' 0 CA--C 1.545 0.75 0 CA-C-N 115.789 -0.642 . . . . 1.0 110.623 -178.864 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . 0.682 ' H ' ' C ' ' A' ' 42' ' ' ARG . . . 66.27 -32.12 0.16 Allowed Glycine 0 C--N 1.34 0.769 0 N-CA-C 110.65 -0.98 . . . . 1.0 110.65 179.456 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . 0.637 ' O ' ' HB2' ' A' ' 46' ' ' PHE . 11.8 t80 -169.34 170.81 8.24 Favored 'General case' 0 N--CA 1.446 -0.642 0 N-CA-C 108.378 -0.971 . . . . 1.0 108.378 179.141 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 46' ' ' PHE . . . . . 0.637 ' HB2' ' O ' ' A' ' 45' ' ' PHE . 1.0 OUTLIER 120.8 106.64 0.0 OUTLIER 'General case' 0 N--CA 1.497 1.921 0 C-N-CA 127.333 2.253 . . . . 1.0 106.34 -179.346 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 47' ' ' ARG . . . . . 0.531 ' HB2' ' O ' ' A' ' 46' ' ' PHE . 0.1 OUTLIER 103.24 149.84 0.01 OUTLIER 'General case' 0 N--CA 1.479 1.0 0 C-N-CA 124.827 1.251 . . . . 1.0 109.86 -178.602 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 48' ' ' CYS . . . . . 0.511 ' SG ' ' C ' ' A' ' 47' ' ' ARG . 0.0 OUTLIER 64.3 71.92 0.46 Allowed 'General case' 0 CA--C 1.534 0.361 0 CA-C-N 114.984 -1.007 . . . . 1.0 110.396 -178.892 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -140.85 163.53 42.13 Favored Pre-proline 0 C--N 1.33 -0.269 0 O-C-N 121.92 -0.487 . . . . 1.0 110.747 -179.22 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 38.4 Cg_endo -66.18 47.08 0.22 Allowed 'Trans proline' 0 N--CA 1.498 1.773 0 C-N-CA 123.107 2.538 . . . . 1.0 111.78 178.738 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . 0.531 ' OE1' ' NH2' ' A' ' 95' ' ' ARG . 7.6 mt-10 57.02 12.4 1.22 Allowed 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 115.37 -0.832 . . . . 1.0 111.393 179.593 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 24.9 ptt85 -85.87 147.31 26.33 Favored 'General case' 0 C--N 1.333 -0.119 0 N-CA-C 107.296 -1.372 . . . . 1.0 107.296 177.846 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 8.8 tp -49.46 138.4 4.89 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.496 0 CA-C-O 122.012 0.91 . . . . 1.0 113.033 -177.893 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 54' ' ' GLN . . . . . 0.587 ' H ' ' CD ' ' A' ' 54' ' ' GLN . 0.0 OUTLIER -76.17 79.51 2.98 Favored 'General case' 0 CA--C 1.534 0.351 0 CA-C-N 114.074 -1.421 . . . . 1.0 109.222 179.613 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 1.8 mt -147.38 157.12 9.88 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.75 0 CA-C-N 115.244 -0.889 . . . . 1.0 110.211 178.094 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 108.5 -0.24 32.67 Favored Glycine 0 C--N 1.338 0.691 0 N-CA-C 110.553 -1.019 . . . . 1.0 110.553 179.766 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . 0.424 ' O ' ' OD1' ' A' ' 57' ' ' ASP . 31.1 p-10 -80.27 101.74 9.08 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 121.584 0.707 . . . . 1.0 112.393 -178.816 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 58' ' ' TRP . . . . . . . . . . . . . 10.0 m0 -78.61 179.12 7.3 Favored 'General case' 0 C--N 1.323 -0.548 0 N-CA-C 108.028 -1.101 . . . . 1.0 108.028 178.34 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 59' ' ' ARG . . . . . 0.577 ' O ' ' CG2' ' A' ' 62' ' ' VAL . 1.0 OUTLIER -100.28 -49.12 4.36 Favored 'General case' 0 CA--C 1.546 0.81 0 CA-C-N 121.522 1.965 . . . . 1.0 111.613 178.535 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 60' ' ' TYR . . . . . 0.411 ' CD1' ' C ' ' A' ' 60' ' ' TYR . 3.7 p90 -85.98 -9.6 56.55 Favored 'General case' 0 N--CA 1.488 1.43 0 C-N-CA 124.997 1.319 . . . . 1.0 113.281 -177.98 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . 0.402 ' O ' ' N ' ' A' ' 65' ' ' ASP . 27.1 tt0 -75.32 -14.07 60.46 Favored 'General case' 0 C--N 1.308 -1.219 0 O-C-N 121.554 -0.716 . . . . 1.0 110.622 -178.952 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 62' ' ' VAL . . . . . 0.577 ' CG2' ' O ' ' A' ' 59' ' ' ARG . 0.0 OUTLIER -44.28 -50.34 1.92 Allowed 'Isoleucine or valine' 0 C--N 1.315 -0.901 0 N-CA-C 109.715 -0.476 . . . . 1.0 109.715 -175.69 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 63' ' ' ALA . . . . . 0.508 ' O ' ' HG2' ' A' ' 67' ' ' ARG . . . -67.6 -47.15 70.52 Favored 'General case' 0 N--CA 1.425 -1.683 0 N-CA-C 108.587 -0.894 . . . . 1.0 108.587 -179.878 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 64' ' ' HIS . . . . . 0.449 ' O ' ' CG ' ' A' ' 67' ' ' ARG . 0.5 OUTLIER -55.21 -59.22 5.07 Favored 'General case' 0 CA--C 1.547 0.841 0 CA-C-N 115.292 -0.867 . . . . 1.0 109.871 179.683 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 65' ' ' ASP . . . . . 0.639 ' C ' ' H ' ' A' ' 67' ' ' ARG . 29.6 t70 -67.08 -53.39 31.38 Favored 'General case' 0 C--O 1.243 0.739 0 CA-C-O 121.667 0.746 . . . . 1.0 109.27 178.438 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . 0.551 ' N ' ' O ' ' A' ' 62' ' ' VAL . . . -63.3 31.14 0.08 OUTLIER Glycine 0 CA--C 1.523 0.573 0 N-CA-C 111.477 -0.649 . . . . 1.0 111.477 178.263 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 67' ' ' ARG . . . . . 0.77 ' HB3' ' HB3' ' A' ' 71' ' ' ALA . 6.3 mmt180 -76.34 -2.59 32.47 Favored 'General case' 0 C--N 1.315 -0.901 0 N-CA-C 108.07 -1.085 . . . . 1.0 108.07 174.876 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . 0.483 ' C ' ' O ' ' A' ' 67' ' ' ARG . 5.8 tt -35.16 -30.35 0.01 OUTLIER 'General case' 0 N--CA 1.475 0.82 0 N-CA-C 108.63 -0.878 . . . . 1.0 108.63 -176.403 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . 0.57 ' N ' ' O ' ' A' ' 67' ' ' ARG . 9.9 mp -69.24 -68.57 0.39 Allowed 'General case' 0 CA--C 1.549 0.921 0 CA-C-N 115.09 -0.959 . . . . 1.0 111.063 179.686 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . 0.613 ' C ' ' H ' ' A' ' 72' ' ' HIS . . . -77.16 -76.85 0.16 Allowed 'General case' 0 N--CA 1.473 0.723 0 C-N-CA 119.016 -1.074 . . . . 1.0 109.457 -178.373 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 71' ' ' ALA . . . . . 0.77 ' HB3' ' HB3' ' A' ' 67' ' ' ARG . . . -57.31 10.48 0.01 OUTLIER 'General case' 0 C--N 1.324 -0.502 0 C-N-CA 124.652 1.181 . . . . 1.0 112.574 179.784 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 72' ' ' HIS . . . . . 0.878 ' CD2' ' H ' ' A' ' 73' ' ' MET . 1.3 p80 -19.84 -48.23 0.01 OUTLIER 'General case' 0 N--CA 1.465 0.323 0 N-CA-C 114.669 1.359 . . . . 1.0 114.669 -177.197 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 73' ' ' MET . . . . . 0.878 ' H ' ' CD2' ' A' ' 72' ' ' HIS . 15.4 ptp -74.87 -47.91 27.67 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 119.275 0.943 . . . . 1.0 109.353 179.058 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . 0.705 ' HB ' ' HB1' ' A' ' 71' ' ' ALA . 59.3 t -43.23 -48.46 1.41 Allowed 'Isoleucine or valine' 0 C--O 1.214 -0.79 0 CA-C-O 117.736 -1.126 . . . . 1.0 110.972 -175.389 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 75' ' ' ASN . . . . . 0.402 ' C ' ' O ' ' A' ' 74' ' ' VAL . 3.9 m120 -37.52 -19.66 0.01 OUTLIER 'General case' 0 N--CA 1.48 1.075 0 CA-C-O 122.714 1.245 . . . . 1.0 109.987 178.507 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 76' ' ' GLY . . . . . 0.661 ' N ' ' O ' ' A' ' 74' ' ' VAL . . . -50.99 -24.3 8.3 Favored Glycine 0 C--O 1.213 -1.177 0 N-CA-C 108.143 -1.983 . . . . 1.0 108.143 176.207 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 77' ' ' ILE . . . . . 0.444 ' N ' ' O ' ' A' ' 74' ' ' VAL . 9.5 pt -45.64 -43.78 4.1 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.323 0 O-C-N 122.289 -0.536 . . . . 1.0 110.9 179.523 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 57.5 t -55.65 -22.04 11.5 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.343 0 CA-C-N 118.649 0.659 . . . . 1.0 111.05 -179.67 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . 0.611 ' O ' ' HB2' ' A' ' 83' ' ' ALA . 0.3 OUTLIER -88.03 -42.49 15.0 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.715 0 C-N-CA 119.32 -0.952 . . . . 1.0 110.058 178.556 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -78.93 -23.03 44.95 Favored 'General case' 0 CA--C 1.537 0.444 0 N-CA-C 112.262 0.467 . . . . 1.0 112.262 -178.892 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 94.8 mt-10 -91.11 -68.25 0.8 Allowed 'General case' 0 CA--C 1.533 0.289 0 N-CA-C 112.475 0.546 . . . . 1.0 112.475 178.718 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 82' ' ' ASP . . . . . 0.46 ' O ' ' C ' ' A' ' 83' ' ' ALA . 1.2 m-20 -74.76 -21.49 59.31 Favored 'General case' 0 C--N 1.349 0.555 0 N-CA-C 114.991 1.478 . . . . 1.0 114.991 -176.35 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . 0.682 ' HA ' ' HB3' ' A' ' 86' ' ' ALA . . . -37.38 -50.08 1.03 Allowed 'General case' 0 N--CA 1.483 1.187 0 CA-C-N 120.253 1.388 . . . . 1.0 111.355 178.743 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . 0.49 ' C ' ' O ' ' A' ' 83' ' ' ALA . 0.1 OUTLIER -26.88 -41.74 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.609 0 CA-C-O 120.62 0.248 . . . . 1.0 110.645 -175.327 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 85' ' ' ILE . . . . . 0.505 ' N ' ' O ' ' A' ' 83' ' ' ALA . 2.9 pt -98.63 -46.65 12.39 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 N-CA-C 109.468 -0.568 . . . . 1.0 109.468 177.605 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 86' ' ' ALA . . . . . 0.682 ' HB3' ' HA ' ' A' ' 83' ' ' ALA . . . -49.54 -44.27 46.44 Favored 'General case' 0 N--CA 1.461 0.102 0 CA-C-N 115.931 -0.577 . . . . 1.0 110.14 -177.913 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 21.6 pt-20 -53.73 -21.9 8.1 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.929 0.395 . . . . 1.0 110.54 179.62 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -82.36 -13.84 56.23 Favored 'General case' 0 CA--C 1.517 -0.316 0 CA-C-O 121.289 0.566 . . . . 1.0 109.889 -179.476 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 89' ' ' VAL . . . . . 0.513 ' O ' HG12 ' A' ' 89' ' ' VAL . 18.5 t -93.06 34.74 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.553 0 CA-C-N 114.964 -1.016 . . . . 1.0 109.419 178.972 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 90' ' ' GLY . . . . . 0.534 ' O ' ' N ' ' A' ' 92' ' ' HIS . . . -74.66 -41.44 35.17 Favored Glycine 0 CA--C 1.539 1.555 0 N-CA-C 111.501 -0.64 . . . . 1.0 111.501 179.09 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 91' ' ' PRO . . . . . 0.48 ' CD ' ' N ' ' A' ' 90' ' ' GLY . 91.0 Cg_exo -41.35 -20.89 0.11 Allowed 'Trans proline' 0 N--CA 1.492 1.391 0 CA-C-N 119.354 1.577 . . . . 1.0 111.177 -179.795 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 92' ' ' HIS . . . . . 0.692 ' O ' ' N ' ' A' ' 96' ' ' ALA . 27.6 p-80 -53.73 -38.7 64.6 Favored 'General case' 0 C--O 1.196 -1.733 0 N-CA-C 106.489 -1.671 . . . . 1.0 106.489 -179.162 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 93' ' ' LEU . . . . . 0.777 HD12 ' N ' ' A' ' 94' ' ' ALA . 2.6 pp -46.17 -58.98 3.18 Favored 'General case' 0 C--N 1.319 -0.745 0 C-N-CA 120.183 -0.607 . . . . 1.0 110.428 -179.757 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 94' ' ' ALA . . . . . 0.777 ' N ' HD12 ' A' ' 93' ' ' LEU . . . -59.5 -56.79 17.59 Favored 'General case' 0 N--CA 1.465 0.275 0 CA-C-N 118.514 0.597 . . . . 1.0 109.692 -179.953 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 95' ' ' ARG . . . . . 0.668 ' O ' ' N ' ' A' ' 97' ' ' LEU . 5.8 mtp-105 -54.53 -58.61 6.82 Favored 'General case' 0 C--O 1.238 0.494 0 N-CA-C 107.789 -1.189 . . . . 1.0 107.789 178.347 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 96' ' ' ALA . . . . . 0.745 ' O ' ' N ' ' A' ' 98' ' ' GLY . . . -45.15 -12.99 0.02 OUTLIER 'General case' 0 C--N 1.294 -1.821 0 O-C-N 119.383 -2.073 . . . . 1.0 110.627 179.558 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 97' ' ' LEU . . . . . 0.668 ' N ' ' O ' ' A' ' 95' ' ' ARG . 0.8 OUTLIER 1.91 -54.71 0.0 OUTLIER 'General case' 0 N--CA 1.48 1.026 0 C-N-CA 124.407 1.083 . . . . 1.0 111.987 -169.958 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 98' ' ' GLY . . . . . 0.745 ' N ' ' O ' ' A' ' 96' ' ' ALA . . . -48.85 -23.05 3.25 Favored Glycine 0 CA--C 1.539 1.554 0 CA-C-N 122.233 2.288 . . . . 1.0 108.62 175.173 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 99' ' ' GLN . . . . . 0.627 ' N ' ' O ' ' A' ' 96' ' ' ALA . 1.2 mp0 -69.68 -24.14 63.55 Favored 'General case' 0 C--N 1.364 1.204 0 C-N-CA 118.338 -1.345 . . . . 1.0 107.776 178.47 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 100' ' ' ILE . . . . . 0.584 ' N ' ' O ' ' A' ' 97' ' ' LEU . 4.7 mm -65.23 -40.03 87.36 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.755 0 CA-C-N 115.026 -0.988 . . . . 1.0 108.762 177.945 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 101' ' ' VAL . . . . . 0.565 ' O ' ' N ' ' A' ' 105' ' ' GLY . 0.5 OUTLIER -58.52 -57.28 11.67 Favored 'Isoleucine or valine' 0 C--N 1.343 0.289 0 N-CA-C 107.407 -1.331 . . . . 1.0 107.407 179.669 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 102' ' ' CYS . . . . . 0.944 ' O ' ' HB2' ' A' ' 106' ' ' ALA . 0.7 OUTLIER -41.6 -17.61 0.01 OUTLIER 'General case' 0 CA--C 1.536 0.417 0 CA-C-O 120.763 0.316 . . . . 1.0 111.107 -179.537 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 103' ' ' ARG . . . . . 0.528 ' N ' ' O ' ' A' ' 101' ' ' VAL . 4.3 ttm180 -93.29 -35.01 13.3 Favored 'General case' 0 N--CA 1.478 0.954 0 CA-C-O 122.327 1.061 . . . . 1.0 111.523 177.71 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 104' ' ' TYR . . . . . 0.75 ' O ' ' CG ' ' A' ' 104' ' ' TYR . 1.2 t80 -106.44 19.08 21.04 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 112.722 -2.035 . . . . 1.0 109.746 177.817 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 105' ' ' GLY . . . . . 0.735 ' O ' ' N ' ' A' ' 107' ' ' THR . . . -165.76 -18.88 0.02 OUTLIER Glycine 0 C--O 1.223 -0.538 0 C-N-CA 117.461 -2.304 . . . . 1.0 113.035 179.263 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 106' ' ' ALA . . . . . 0.944 ' HB2' ' O ' ' A' ' 102' ' ' CYS . . . -11.39 65.0 0.0 OUTLIER 'General case' 0 N--CA 1.477 0.915 0 O-C-N 124.778 0.928 . . . . 1.0 111.93 -179.55 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 107' ' ' THR . . . . . 0.735 ' N ' ' O ' ' A' ' 105' ' ' GLY . 99.4 m -98.42 -4.41 34.7 Favored 'General case' 0 CA--C 1.511 -0.55 0 O-C-N 121.678 -0.639 . . . . 1.0 109.347 -178.999 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 108' ' ' VAL . . . . . 0.518 ' C ' ' HD2' ' A' ' 110' ' ' PRO . 41.2 t -81.86 -54.05 10.67 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.494 0 CA-C-N 116.288 -0.414 . . . . 1.0 110.105 178.466 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 109' ' ' ILE . . . . . 0.507 ' O ' ' CB ' ' A' ' 113' ' ' ASN . 0.2 OUTLIER -47.49 -38.86 17.82 Favored Pre-proline 0 N--CA 1.473 0.699 0 N-CA-C 114.822 1.415 . . . . 1.0 114.822 -179.095 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 110' ' ' PRO . . . . . 0.518 ' HD2' ' C ' ' A' ' 108' ' ' VAL . 83.7 Cg_exo -47.02 -41.49 26.19 Favored 'Trans proline' 0 C--N 1.31 -1.48 0 C-N-CA 121.929 1.753 . . . . 1.0 112.623 -174.818 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 1.2 t-20 -63.49 -69.39 0.27 Allowed 'General case' 0 CA--C 1.536 0.421 0 C-N-CA 118.877 -1.129 . . . . 1.0 110.29 179.88 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 112' ' ' ILE . . . . . 0.448 ' O ' ' N ' ' A' ' 116' ' ' ILE . 0.1 OUTLIER -61.84 -44.74 99.28 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.539 0 CA-C-O 121.325 0.583 . . . . 1.0 110.543 -178.1 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 113' ' ' ASN . . . . . 0.507 ' CB ' ' O ' ' A' ' 109' ' ' ILE . 20.9 t30 -45.79 -62.17 1.42 Allowed 'General case' 0 C--N 1.309 -1.168 0 CA-C-N 115.3 -0.864 . . . . 1.0 111.511 -174.733 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -61.67 -24.59 66.85 Favored 'General case' 0 N--CA 1.433 -1.294 0 C-N-CA 118.873 -1.131 . . . . 1.0 110.703 179.586 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -82.32 -61.43 1.9 Allowed 'General case' 0 C--O 1.239 0.504 0 N-CA-C 113.95 1.093 . . . . 1.0 113.95 178.323 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 116' ' ' ILE . . . . . 0.589 ' O ' ' N ' ' A' ' 119' ' ' LEU . 47.0 mt -69.82 -49.03 60.71 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.678 0 O-C-N 120.501 -1.374 . . . . 1.0 111.596 -177.985 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 117' ' ' GLU . . . . . 0.479 ' OE1' ' OD1' ' A' ' 113' ' ' ASN . 18.5 tt0 -46.2 -61.58 1.71 Allowed 'General case' 0 C--N 1.312 -1.05 0 N-CA-C 108.393 -0.966 . . . . 1.0 108.393 -177.106 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 97.5 t -54.28 -16.02 1.31 Allowed 'Isoleucine or valine' 0 N--CA 1.44 -0.96 0 O-C-N 124.408 1.068 . . . . 1.0 109.317 178.453 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 119' ' ' LEU . . . . . 0.589 ' N ' ' O ' ' A' ' 116' ' ' ILE . 0.2 OUTLIER -80.01 -61.31 2.03 Favored 'General case' 0 C--N 1.349 0.551 0 C-N-CA 119.793 -0.763 . . . . 1.0 110.453 178.342 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -66.62 -85.52 0.08 OUTLIER Glycine 0 C--N 1.361 1.96 0 C-N-CA 117.519 -2.277 . . . . 1.0 112.103 179.916 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -163.73 -27.18 0.04 OUTLIER 'General case' 0 N--CA 1.473 0.713 0 N-CA-C 107.422 -1.325 . . . . 1.0 107.422 -178.604 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 122' ' ' GLY . . . . . 0.554 ' O ' ' N ' ' A' ' 124' ' ' ASP . . . 116.76 -36.2 3.86 Favored Glycine 0 CA--C 1.531 1.033 0 CA-C-N 113.933 -1.485 . . . . 1.0 113.432 179.699 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 123' ' ' THR . . . . . 0.454 ' C ' ' O ' ' A' ' 122' ' ' GLY . 0.1 OUTLIER -32.78 89.64 0.0 OUTLIER 'General case' 0 N--CA 1.476 0.839 0 CA-C-N 120.578 2.189 . . . . 1.0 112.774 -178.652 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 124' ' ' ASP . . . . . 0.554 ' N ' ' O ' ' A' ' 122' ' ' GLY . 11.6 t0 -147.45 143.86 28.21 Favored 'General case' 0 CA--C 1.521 -0.162 0 N-CA-C 108.454 -0.943 . . . . 1.0 108.454 179.94 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 125' ' ' TYR . . . . . 0.471 ' O ' ' CD1' ' A' ' 125' ' ' TYR . 0.1 OUTLIER -150.79 148.43 28.5 Favored 'General case' 0 C--N 1.324 -0.526 0 N-CA-C 109.596 -0.52 . . . . 1.0 109.596 179.891 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 126' ' ' ARG . . . . . 0.435 ' NE ' ' HA ' ' A' ' 126' ' ' ARG . 10.8 mmp_? -145.74 148.4 32.95 Favored 'General case' 0 N--CA 1.471 0.623 0 N-CA-C 109.592 -0.521 . . . . 1.0 109.592 177.264 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 127' ' ' PHE . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 C--O 1.218 -0.575 0 CA-C-O 118.049 -0.977 . . . . 1.0 110.008 -179.9 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 60.1 mtt . . . . . 0 N--CA 1.491 1.584 0 N-CA-C 109.013 -0.736 . . . . 1.0 109.013 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 48.7 m -107.78 -0.97 21.33 Favored 'General case' 0 N--CA 1.466 0.351 0 CA-C-N 116.404 -0.362 . . . . 1.0 110.692 179.553 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 3' ' ' ASP . . . . . 0.526 ' N ' ' OD1' ' A' ' 3' ' ' ASP . 8.1 p-10 -178.83 92.66 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.478 -0.328 . . . . 1.0 110.854 -179.747 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 37.2 t80 -151.59 147.75 27.16 Favored 'General case' 0 CA--C 1.513 -0.444 0 CA-C-O 120.899 0.38 . . . . 1.0 110.112 179.358 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 5' ' ' ASP . . . . . 0.498 ' C ' ' OG ' ' A' ' 10' ' ' SER . 32.1 p30 -156.58 153.05 28.02 Favored 'General case' 0 N--CA 1.448 -0.538 0 CA-C-N 116.058 -0.519 . . . . 1.0 110.748 179.472 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 6' ' ' THR . . . . . 0.957 ' H ' HG23 ' A' ' 9' ' ' VAL . 0.2 OUTLIER -102.69 -170.2 1.77 Allowed 'General case' 0 C--O 1.199 -1.605 0 CA-C-O 121.661 0.743 . . . . 1.0 110.467 178.131 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . 0.464 ' O ' ' HB2' ' A' ' 11' ' ' ARG . 33.4 tt0 -56.25 -40.97 75.0 Favored 'General case' 0 C--N 1.304 -1.391 0 CA-C-O 121.653 0.74 . . . . 1.0 110.586 -179.555 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 8' ' ' ARG . . . . . 0.82 ' O ' ' HB3' ' A' ' 12' ' ' ALA . 0.9 OUTLIER -70.01 -62.78 1.25 Allowed 'General case' 0 C--N 1.31 -1.122 0 C-N-CA 118.654 -1.218 . . . . 1.0 111.252 179.548 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . 0.957 HG23 ' H ' ' A' ' 6' ' ' THR . 0.0 OUTLIER -62.7 -48.45 88.08 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.712 0 CA-C-N 114.113 -1.403 . . . . 1.0 108.229 179.144 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 10' ' ' SER . . . . . 0.669 ' N ' ' O ' ' A' ' 6' ' ' THR . 1.6 m -67.8 -68.35 0.39 Allowed 'General case' 0 C--O 1.189 -2.128 0 C-N-CA 118.3 -1.36 . . . . 1.0 112.915 179.857 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 11' ' ' ARG . . . . . 0.57 ' O ' ' N ' ' A' ' 15' ' ' ALA . 2.3 mmt85 -67.83 -49.93 59.46 Favored 'General case' 0 N--CA 1.48 1.072 0 N-CA-C 113.965 1.098 . . . . 1.0 113.965 -176.551 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . 0.82 ' HB3' ' O ' ' A' ' 8' ' ' ARG . . . -60.69 -58.74 7.16 Favored 'General case' 0 C--N 1.314 -0.956 0 C-N-CA 117.866 -1.534 . . . . 1.0 107.526 -178.873 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . 0.696 ' O ' ' N ' ' A' ' 17' ' ' LEU . 0.5 OUTLIER -60.0 -50.36 80.46 Favored 'Isoleucine or valine' 0 C--O 1.184 -2.393 0 N-CA-C 106.561 -1.644 . . . . 1.0 106.561 179.215 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . 0.844 ' O ' HG22 ' A' ' 18' ' ' VAL . . . -58.76 -64.05 1.07 Allowed 'General case' 0 C--O 1.199 -1.599 0 C-N-CA 116.493 -2.083 . . . . 1.0 111.497 -179.101 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . 0.575 ' O ' ' N ' ' A' ' 19' ' ' GLY . . . -52.21 -55.04 23.69 Favored 'General case' 0 C--N 1.314 -0.949 0 N-CA-C 108.46 -0.941 . . . . 1.0 108.46 -178.622 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . 0.559 ' HB3' ' O ' ' A' ' 12' ' ' ALA . . . -64.36 -57.86 8.13 Favored 'General case' 0 C--N 1.304 -1.395 0 C-N-CA 118.886 -1.126 . . . . 1.0 111.042 -179.95 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . 0.696 ' N ' ' O ' ' A' ' 13' ' ' VAL . 19.1 tp -55.78 -55.27 34.4 Favored 'General case' 0 N--CA 1.49 1.569 0 N-CA-C 107.909 -1.145 . . . . 1.0 107.909 -177.768 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . 0.844 HG22 ' O ' ' A' ' 14' ' ' ALA . 1.5 m -71.29 -59.13 3.75 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.411 0 CA-C-N 116.045 -0.525 . . . . 1.0 110.471 179.925 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . 0.575 ' N ' ' O ' ' A' ' 15' ' ' ALA . . . -56.67 -169.27 0.1 OUTLIER Glycine 0 N--CA 1.438 -1.187 0 N-CA-C 111.225 -0.75 . . . . 1.0 111.225 -177.655 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 20' ' ' PRO . . . . . 0.642 ' O ' ' N ' ' A' ' 24' ' ' ALA . 58.6 Cg_endo -85.32 -29.24 0.66 Allowed 'Trans proline' 0 C--N 1.29 -2.5 0 C-N-CA 122.456 2.104 . . . . 1.0 113.455 -177.564 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . 0.443 ' O ' ' HB3' ' A' ' 24' ' ' ALA . . . -60.42 -59.73 9.79 Favored Glycine 0 N--CA 1.471 0.993 0 C-N-CA 120.143 -1.027 . . . . 1.0 112.26 -177.747 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . 0.495 ' H ' ' HA ' ' A' ' 16' ' ' ALA . . . -56.51 -53.33 44.24 Favored Glycine 0 CA--C 1.497 -1.072 0 N-CA-C 106.53 -2.628 . . . . 1.0 106.53 -176.374 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . 0.526 ' O ' HG12 ' A' ' 27' ' ' VAL . 22.4 t -56.74 -31.22 34.62 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.242 0 N-CA-C 108.216 -1.031 . . . . 1.0 108.216 178.043 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . 0.642 ' N ' ' O ' ' A' ' 20' ' ' PRO . . . -59.18 -63.21 1.38 Allowed 'General case' 0 C--N 1.354 0.791 0 C-N-CA 118.712 -1.195 . . . . 1.0 110.331 -178.823 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . 0.44 ' H ' ' HG ' ' A' ' 25' ' ' LEU . 1.2 mt -62.27 -46.04 90.59 Favored 'General case' 0 C--N 1.325 -0.458 0 C-N-CA 120.335 -0.546 . . . . 1.0 111.333 -177.063 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 88.0 t -59.64 -58.94 4.87 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.669 0 C-N-CA 119.898 -0.721 . . . . 1.0 109.604 -177.78 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . 0.526 HG12 ' O ' ' A' ' 23' ' ' VAL . 1.5 p -60.62 -37.45 75.53 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.508 0 C-N-CA 120.076 -0.65 . . . . 1.0 110.245 -177.99 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 27.2 ttpp -65.29 -56.96 9.75 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 115.89 -0.595 . . . . 1.0 110.462 -179.018 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 84.1 t -63.27 -47.88 90.05 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.784 0 CA-C-N 114.936 -1.029 . . . . 1.0 109.692 -177.715 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 30' ' ' CYS . . . . . . . . . . . . . 36.8 t -65.01 -60.82 2.62 Favored 'General case' 0 N--CA 1.441 -0.884 0 C-N-CA 119.787 -0.765 . . . . 1.0 109.588 -178.82 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . 0.523 ' HB3' ' O ' ' A' ' 27' ' ' VAL . . . -57.8 -47.62 82.07 Favored 'General case' 0 CA--C 1.497 -1.091 0 CA-C-O 121.29 0.567 . . . . 1.0 109.769 -176.427 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . 0.468 ' O ' ' HB2' ' A' ' 33' ' ' LEU . . . 74.2 67.92 1.67 Allowed Glycine 0 N--CA 1.439 -1.131 0 N-CA-C 108.982 -1.647 . . . . 1.0 108.982 -178.525 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . 0.478 ' O ' ' O ' ' A' ' 36' ' ' VAL . 17.7 mt 97.41 78.52 0.02 OUTLIER Pre-proline 0 N--CA 1.47 0.54 0 C-N-CA 124.542 1.137 . . . . 1.0 110.645 -179.452 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 76.5 Cg_exo -45.93 -29.45 5.99 Favored 'Trans proline' 0 C--N 1.312 -1.386 0 C-N-CA 121.973 1.782 . . . . 1.0 112.672 179.793 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -60.38 -60.61 8.26 Favored Glycine 0 CA--C 1.536 1.37 0 C-N-CA 118.756 -1.687 . . . . 1.0 109.894 -178.375 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . 0.703 HG22 ' H ' ' A' ' 37' ' ' ILE . 8.5 p -98.81 177.87 0.66 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.68 0 N-CA-C 107.36 -1.348 . . . . 1.0 107.36 177.793 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . 0.703 ' H ' HG22 ' A' ' 36' ' ' VAL . 2.9 mm 101.15 120.34 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.479 1.01 0 O-C-N 124.818 1.323 . . . . 1.0 110.952 179.609 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 79.8 m80 -142.75 136.97 29.44 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 115.572 -0.74 . . . . 1.0 109.508 178.456 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 11.1 m -91.95 127.48 49.52 Favored Pre-proline 0 CA--C 1.537 0.474 0 N-CA-C 108.966 -0.753 . . . . 1.0 108.966 179.678 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 29.7 Cg_endo -62.94 -30.55 76.97 Favored 'Trans proline' 0 N--CA 1.498 1.745 0 C-N-CA 121.752 1.635 . . . . 1.0 113.368 -178.192 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -110.36 90.93 3.46 Favored 'General case' 0 CA--C 1.507 -0.696 0 CA-C-O 121.599 0.714 . . . . 1.0 112.664 -176.498 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 16.3 ptm180 -139.82 143.0 36.61 Favored 'General case' 0 C--N 1.318 -0.768 0 CA-C-N 114.552 -1.204 . . . . 1.0 108.479 178.927 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 76.5 ttt180 -50.91 -15.61 0.32 Allowed 'General case' 0 N--CA 1.451 -0.41 0 O-C-N 121.958 -0.464 . . . . 1.0 111.299 -176.003 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 119.11 -25.34 7.89 Favored Glycine 0 N--CA 1.468 0.792 0 N-CA-C 111.148 -0.781 . . . . 1.0 111.148 178.885 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . 0.565 ' O ' ' CD1' ' A' ' 46' ' ' PHE . 0.6 OUTLIER -156.84 161.53 39.72 Favored 'General case' 0 C--N 1.323 -0.557 0 N-CA-C 108.171 -1.048 . . . . 1.0 108.171 178.446 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 46' ' ' PHE . . . . . 0.834 ' O ' ' CD1' ' A' ' 46' ' ' PHE . 0.0 OUTLIER 115.66 120.46 0.0 OUTLIER 'General case' 0 N--CA 1.479 1.024 0 O-C-N 125.288 1.618 . . . . 1.0 112.433 179.342 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 47' ' ' ARG . . . . . 0.594 ' HB2' ' O ' ' A' ' 46' ' ' PHE . 5.9 mtm180 76.75 163.32 0.24 Allowed 'General case' 0 N--CA 1.479 1.023 0 O-C-N 119.266 -2.146 . . . . 1.0 110.727 -178.67 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 4.1 t 61.35 70.03 0.63 Allowed 'General case' 0 C--O 1.232 0.147 0 N-CA-C 108.786 -0.82 . . . . 1.0 108.786 -178.196 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 49' ' ' ASN . . . . . 0.605 ' O ' ' N ' ' A' ' 51' ' ' GLU . 0.0 OUTLIER -146.1 163.95 27.75 Favored Pre-proline 0 CA--C 1.538 0.511 0 N-CA-C 109.519 -0.549 . . . . 1.0 109.519 -178.726 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 50' ' ' PRO . . . . . 0.512 ' O ' ' NE ' ' A' ' 52' ' ' ARG . 11.2 Cg_endo -54.41 58.48 0.03 OUTLIER 'Trans proline' 0 N--CA 1.514 2.68 0 C-N-CA 123.32 2.68 . . . . 1.0 112.057 179.611 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . 0.605 ' N ' ' O ' ' A' ' 49' ' ' ASN . 40.5 mt-10 55.02 37.39 28.84 Favored 'General case' 0 N--CA 1.475 0.797 0 O-C-N 121.192 -0.943 . . . . 1.0 112.678 176.956 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . 0.551 ' O ' ' ND2' ' A' ' 49' ' ' ASN . 0.0 OUTLIER -151.69 179.9 8.0 Favored 'General case' 0 N--CA 1.476 0.829 0 CA-C-O 121.71 0.767 . . . . 1.0 110.439 179.069 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 4.6 tp -82.25 168.72 1.74 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 114.869 -1.059 . . . . 1.0 108.993 177.78 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 1.1 tp60 -132.44 131.98 42.29 Favored 'General case' 0 CA--C 1.533 0.318 0 N-CA-C 108.793 -0.817 . . . . 1.0 108.793 178.624 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 20.4 tt -144.91 155.08 14.13 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.661 0 N-CA-C 110.334 -0.247 . . . . 1.0 110.334 178.563 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 101.38 1.57 53.74 Favored Glycine 0 C--N 1.341 0.842 0 N-CA-C 110.157 -1.177 . . . . 1.0 110.157 -179.827 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 9.4 t70 -93.2 115.55 28.16 Favored 'General case' 0 CA--C 1.539 0.521 0 CA-C-O 122.229 1.014 . . . . 1.0 113.035 -178.214 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 58' ' ' TRP . . . . . 0.649 ' HB2' ' HB2' ' A' ' 61' ' ' GLU . 37.7 m0 -82.92 -178.4 7.1 Favored 'General case' 0 C--N 1.318 -0.799 0 CA-C-N 112.673 -2.058 . . . . 1.0 109.411 177.682 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 59' ' ' ARG . . . . . 0.445 ' HG3' ' H ' ' A' ' 60' ' ' TYR . 13.7 ptt-85 -94.61 -55.39 3.16 Favored 'General case' 0 CA--C 1.543 0.701 0 CA-C-O 121.24 0.543 . . . . 1.0 111.333 179.412 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 60' ' ' TYR . . . . . 0.573 ' O ' ' CG ' ' A' ' 60' ' ' TYR . 17.3 t80 -76.68 -4.03 41.04 Favored 'General case' 0 N--CA 1.476 0.836 0 C-N-CA 124.327 1.051 . . . . 1.0 111.255 179.231 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . 0.649 ' HB2' ' HB2' ' A' ' 58' ' ' TRP . 31.8 tt0 -77.36 -17.33 58.33 Favored 'General case' 0 C--N 1.309 -1.16 0 O-C-N 121.447 -0.783 . . . . 1.0 111.089 -179.994 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 62' ' ' VAL . . . . . 0.439 ' O ' ' N ' ' A' ' 66' ' ' GLY . 91.0 t -46.08 -49.33 5.2 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.03 0 N-CA-C 109.043 -0.725 . . . . 1.0 109.043 -175.639 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 63' ' ' ALA . . . . . 0.546 ' O ' ' HG3' ' A' ' 67' ' ' ARG . . . -64.91 -49.33 70.86 Favored 'General case' 0 N--CA 1.419 -1.993 0 N-CA-C 108.624 -0.88 . . . . 1.0 108.624 177.358 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 4.3 t-80 -56.0 -61.65 2.24 Favored 'General case' 0 CA--C 1.547 0.85 0 CA-C-N 115.977 -0.556 . . . . 1.0 111.904 179.52 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 65' ' ' ASP . . . . . 0.648 ' C ' ' H ' ' A' ' 67' ' ' ARG . 13.7 t70 -66.79 -54.34 23.67 Favored 'General case' 0 C--O 1.246 0.918 0 O-C-N 121.226 -0.921 . . . . 1.0 110.31 178.507 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . 0.439 ' N ' ' O ' ' A' ' 62' ' ' VAL . . . -62.91 32.9 0.07 OUTLIER Glycine 0 CA--C 1.523 0.587 0 N-CA-C 111.52 -0.632 . . . . 1.0 111.52 178.825 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 67' ' ' ARG . . . . . 0.75 ' HB3' ' H ' ' A' ' 71' ' ' ALA . 50.5 mtt180 -77.03 4.16 10.71 Favored 'General case' 0 C--N 1.313 -0.986 0 C-N-CA 123.739 0.816 . . . . 1.0 110.352 175.641 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . 0.582 ' O ' ' HA ' ' A' ' 72' ' ' HIS . 0.8 OUTLIER -33.95 -31.1 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.651 0 N-CA-C 107.335 -1.357 . . . . 1.0 107.335 -179.267 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . 0.611 ' N ' ' O ' ' A' ' 67' ' ' ARG . 0.3 OUTLIER -63.48 -65.14 0.73 Allowed 'General case' 0 C--N 1.312 -1.064 0 C-N-CA 118.037 -1.465 . . . . 1.0 107.213 175.838 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . 0.68 ' C ' ' H ' ' A' ' 72' ' ' HIS . . . -76.64 -73.67 0.27 Allowed 'General case' 0 N--CA 1.474 0.749 0 N-CA-C 107.537 -1.283 . . . . 1.0 107.537 178.627 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 71' ' ' ALA . . . . . 0.75 ' H ' ' HB3' ' A' ' 67' ' ' ARG . . . -49.7 4.63 0.01 OUTLIER 'General case' 0 N--CA 1.476 0.835 0 C-N-CA 125.907 1.683 . . . . 1.0 112.07 178.475 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 72' ' ' HIS . . . . . 0.997 ' CD2' ' H ' ' A' ' 73' ' ' MET . 1.4 p80 -17.74 -62.56 0.02 OUTLIER 'General case' 0 CA--C 1.519 -0.225 0 O-C-N 123.755 0.66 . . . . 1.0 112.519 -175.899 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 73' ' ' MET . . . . . 0.997 ' H ' ' CD2' ' A' ' 72' ' ' HIS . 16.6 ptm -80.89 -45.63 16.5 Favored 'General case' 0 C--N 1.298 -1.644 0 CA-C-N 117.968 0.349 . . . . 1.0 110.56 177.41 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . 0.672 ' O ' ' N ' ' A' ' 76' ' ' GLY . 97.3 t -40.7 -43.41 0.63 Allowed 'Isoleucine or valine' 0 C--N 1.35 0.592 0 CA-C-O 118.687 -0.673 . . . . 1.0 110.076 -174.164 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 19.4 t-20 -36.75 -19.64 0.01 OUTLIER 'General case' 0 N--CA 1.477 0.882 0 CA-C-O 122.491 1.139 . . . . 1.0 110.533 179.107 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 76' ' ' GLY . . . . . 0.672 ' N ' ' O ' ' A' ' 74' ' ' VAL . . . -50.38 -21.02 4.06 Favored Glycine 0 C--O 1.205 -1.709 0 N-CA-C 108.991 -1.644 . . . . 1.0 108.991 174.321 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 77' ' ' ILE . . . . . 0.437 ' N ' ' O ' ' A' ' 74' ' ' VAL . 6.1 pt -54.49 -46.82 71.39 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.555 0 O-C-N 121.637 -0.92 . . . . 1.0 112.446 -176.934 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . 0.405 ' N ' HG13 ' A' ' 77' ' ' ILE . 3.7 t -59.29 -19.24 15.73 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.716 0 O-C-N 121.925 -0.484 . . . . 1.0 111.93 -178.406 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . 0.935 ' O ' ' HB2' ' A' ' 83' ' ' ALA . 0.3 OUTLIER -81.39 -46.06 20.46 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.702 0 C-N-CA 119.941 -0.704 . . . . 1.0 111.493 -179.748 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 80' ' ' ALA . . . . . 0.466 ' N ' ' CG1' ' A' ' 79' ' ' ILE . . . -84.17 -18.66 35.94 Favored 'General case' 0 N--CA 1.467 0.384 0 N-CA-C 112.791 0.663 . . . . 1.0 112.791 179.41 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 64.5 mt-10 -84.7 -71.85 0.5 Allowed 'General case' 0 C--O 1.231 0.124 0 N-CA-C 112.964 0.727 . . . . 1.0 112.964 -178.813 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 82' ' ' ASP . . . . . 0.432 ' O ' ' C ' ' A' ' 83' ' ' ALA . 93.4 m-20 -71.05 -18.08 62.58 Favored 'General case' 0 CA--C 1.515 -0.403 0 N-CA-C 111.612 0.227 . . . . 1.0 111.612 -177.669 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . 0.935 ' HB2' ' O ' ' A' ' 79' ' ' ILE . . . -36.14 -50.81 0.73 Allowed 'General case' 0 N--CA 1.47 0.575 0 C-N-CA 120.612 -0.435 . . . . 1.0 110.907 177.898 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . 0.442 ' C ' ' O ' ' A' ' 83' ' ' ALA . 0.2 OUTLIER -28.79 -46.88 0.05 OUTLIER 'General case' 0 N--CA 1.48 1.054 0 CA-C-N 116.175 -0.466 . . . . 1.0 111.257 -173.825 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 73.8 mt -95.11 -54.67 6.89 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.704 0 N-CA-C 109.831 -0.433 . . . . 1.0 109.831 178.061 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -43.38 -39.98 3.45 Favored 'General case' 0 N--CA 1.465 0.298 0 CA-C-N 115.759 -0.655 . . . . 1.0 110.317 -178.83 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 79.7 tt0 -54.74 -29.74 54.41 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.785 -0.643 . . . . 1.0 110.65 -179.879 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -77.77 -12.46 59.98 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.632 -0.713 . . . . 1.0 109.377 -179.909 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 89' ' ' VAL . . . . . 0.458 ' C ' ' HD2' ' A' ' 91' ' ' PRO . 3.5 t -86.92 39.12 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.448 -0.553 0 N-CA-C 108.172 -1.047 . . . . 1.0 108.172 178.556 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 90' ' ' GLY . . . . . 0.859 ' O ' ' N ' ' A' ' 92' ' ' HIS . . . -55.69 -24.63 40.96 Favored Glycine 0 C--N 1.362 1.997 0 CA-C-O 117.294 -1.837 . . . . 1.0 111.156 176.934 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 91' ' ' PRO . . . . . 0.692 ' HD2' ' N ' ' A' ' 90' ' ' GLY . 26.0 Cg_exo -32.27 -3.74 0.0 OUTLIER 'Trans proline' 0 N--CA 1.507 2.299 0 C-N-CA 123.828 3.018 . . . . 1.0 113.495 173.365 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 92' ' ' HIS . . . . . 0.859 ' N ' ' O ' ' A' ' 90' ' ' GLY . 20.6 t60 -50.95 -30.83 15.98 Favored 'General case' 0 N--CA 1.443 -0.791 0 N-CA-C 107.098 -1.445 . . . . 1.0 107.098 177.34 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 93' ' ' LEU . . . . . 0.634 ' O ' ' N ' ' A' ' 96' ' ' ALA . 0.4 OUTLIER -59.42 -58.37 8.91 Favored 'General case' 0 C--O 1.214 -0.809 0 CA-C-N 119.064 0.847 . . . . 1.0 109.27 176.808 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 94' ' ' ALA . . . . . 0.503 ' H ' ' HG ' ' A' ' 93' ' ' LEU . . . -48.28 -53.3 17.7 Favored 'General case' 0 C--O 1.221 -0.406 0 N-CA-C 106.56 -1.644 . . . . 1.0 106.56 -178.712 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 95' ' ' ARG . . . . . 0.557 HH21 ' HB3' ' A' ' 91' ' ' PRO . 0.0 OUTLIER -59.5 -26.5 65.34 Favored 'General case' 0 C--N 1.305 -1.339 0 N-CA-C 108.699 -0.852 . . . . 1.0 108.699 176.328 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 96' ' ' ALA . . . . . 0.84 ' O ' ' N ' ' A' ' 100' ' ' ILE . . . -59.31 -52.55 65.16 Favored 'General case' 0 C--O 1.202 -1.43 0 N-CA-C 106.735 -1.58 . . . . 1.0 106.735 179.624 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 97' ' ' LEU . . . . . 0.532 ' O ' HG22 ' A' ' 100' ' ' ILE . 1.5 mt -38.3 -32.11 0.06 Allowed 'General case' 0 CA--C 1.576 1.976 0 N-CA-C 107.401 -1.333 . . . . 1.0 107.401 -179.439 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 98' ' ' GLY . . . . . 0.479 ' N ' ' O ' ' A' ' 96' ' ' ALA . . . -82.09 -52.14 4.17 Favored Glycine 0 CA--C 1.551 2.332 0 CA-C-O 123.422 1.568 . . . . 1.0 111.356 173.897 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 99' ' ' GLN . . . . . 0.435 ' N ' ' O ' ' A' ' 96' ' ' ALA . 76.1 mm-40 -78.39 9.63 3.76 Favored 'General case' 0 N--CA 1.434 -1.235 0 N-CA-C 108.185 -1.042 . . . . 1.0 108.185 178.794 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 100' ' ' ILE . . . . . 0.84 ' N ' ' O ' ' A' ' 96' ' ' ALA . 1.1 tt -59.49 -51.46 72.39 Favored 'Isoleucine or valine' 0 CA--C 1.477 -1.85 0 N-CA-C 108.015 -1.106 . . . . 1.0 108.015 179.917 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 101' ' ' VAL . . . . . 0.687 ' N ' HG23 ' A' ' 100' ' ' ILE . 70.6 t -57.2 -57.23 10.84 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.768 0 C-N-CA 116.666 -2.014 . . . . 1.0 106.627 178.307 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 102' ' ' CYS . . . . . 0.969 ' O ' ' HB2' ' A' ' 106' ' ' ALA . 1.9 t -45.13 -23.09 0.13 Allowed 'General case' 0 C--O 1.218 -0.584 0 C-N-CA 119.559 -0.857 . . . . 1.0 110.809 -177.573 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 103' ' ' ARG . . . . . 0.417 HH11 ' HG3' ' A' ' 103' ' ' ARG . 0.0 OUTLIER -91.29 -43.19 9.95 Favored 'General case' 0 CA--C 1.541 0.627 0 CA-C-O 122.095 0.95 . . . . 1.0 113.147 179.302 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 104' ' ' TYR . . . . . 0.746 ' O ' ' CG ' ' A' ' 104' ' ' TYR . 0.2 OUTLIER -102.88 21.55 15.41 Favored 'General case' 0 C--N 1.31 -1.146 0 CA-C-N 113.292 -1.776 . . . . 1.0 109.886 179.813 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 105' ' ' GLY . . . . . 0.766 ' O ' ' N ' ' A' ' 107' ' ' THR . . . -166.01 -14.52 0.02 OUTLIER Glycine 0 C--O 1.215 -1.093 0 C-N-CA 118.381 -1.866 . . . . 1.0 111.39 178.193 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 106' ' ' ALA . . . . . 0.969 ' HB2' ' O ' ' A' ' 102' ' ' CYS . . . -13.87 65.86 0.0 OUTLIER 'General case' 0 N--CA 1.478 0.933 0 O-C-N 124.742 0.907 . . . . 1.0 112.002 -179.876 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 107' ' ' THR . . . . . 0.766 ' N ' ' O ' ' A' ' 105' ' ' GLY . 99.5 m -101.25 -4.37 27.25 Favored 'General case' 0 N--CA 1.452 -0.348 0 CA-C-N 115.869 -0.605 . . . . 1.0 110.048 -179.419 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 108' ' ' VAL . . . . . 0.714 HG23 ' N ' ' A' ' 109' ' ' ILE . 33.3 m -85.19 -58.22 3.68 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.466 0 N-CA-C 111.647 0.24 . . . . 1.0 111.647 -178.579 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 109' ' ' ILE . . . . . 0.714 ' N ' HG23 ' A' ' 108' ' ' VAL . 0.3 OUTLIER -47.79 -43.37 52.08 Favored Pre-proline 0 C--N 1.353 0.754 0 N-CA-C 112.709 0.633 . . . . 1.0 112.709 179.244 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 110' ' ' PRO . . . . . 0.61 ' HD2' ' N ' ' A' ' 109' ' ' ILE . 7.9 Cg_endo -40.51 -38.32 2.43 Favored 'Trans proline' 0 N--CA 1.482 0.81 0 C-N-CA 121.154 1.236 . . . . 1.0 113.126 -175.4 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 16.8 t-20 -64.56 -68.26 0.37 Allowed 'General case' 0 C--N 1.315 -0.906 0 C-N-CA 118.601 -1.24 . . . . 1.0 110.726 -178.344 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 112' ' ' ILE . . . . . 0.42 ' H ' HG23 ' A' ' 112' ' ' ILE . 2.0 pt -67.59 -27.8 39.63 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.54 0 CA-C-O 121.841 0.829 . . . . 1.0 111.547 -178.004 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 113' ' ' ASN . . . . . 0.622 HD22 ' N ' ' A' ' 114' ' ' ALA . 0.3 OUTLIER -54.98 -61.51 2.26 Favored 'General case' 0 C--N 1.306 -1.304 0 CA-C-N 114.075 -1.42 . . . . 1.0 109.837 -175.281 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 114' ' ' ALA . . . . . 0.622 ' N ' HD22 ' A' ' 113' ' ' ASN . . . -61.81 -22.55 65.56 Favored 'General case' 0 C--N 1.306 -1.301 0 CA-C-N 116.063 -0.517 . . . . 1.0 110.709 -179.979 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -78.48 -60.74 2.25 Favored 'General case' 0 N--CA 1.448 -0.532 0 N-CA-C 112.715 0.635 . . . . 1.0 112.715 178.278 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 116' ' ' ILE . . . . . 0.476 ' O ' ' CB ' ' A' ' 119' ' ' LEU . 95.3 mt -69.4 -46.21 77.03 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.323 0 O-C-N 120.477 -1.39 . . . . 1.0 112.359 -177.094 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 117' ' ' GLU . . . . . 0.462 ' OE1' ' ND2' ' A' ' 113' ' ' ASN . 94.9 mt-10 -47.59 -64.37 0.8 Allowed 'General case' 0 C--N 1.316 -0.856 0 CA-C-N 115.538 -0.755 . . . . 1.0 110.109 -176.994 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 4.1 p -51.71 -15.14 0.48 Allowed 'Isoleucine or valine' 0 N--CA 1.437 -1.107 0 CA-C-N 115.4 -0.818 . . . . 1.0 109.251 -179.662 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 119' ' ' LEU . . . . . 0.476 ' CB ' ' O ' ' A' ' 116' ' ' ILE . 1.6 tt -77.13 -61.07 2.11 Favored 'General case' 0 C--N 1.348 0.508 0 C-N-CA 119.116 -1.033 . . . . 1.0 109.328 177.949 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -70.39 -81.21 0.26 Allowed Glycine 0 C--N 1.355 1.618 0 C-N-CA 117.259 -2.4 . . . . 1.0 111.076 179.55 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 121' ' ' THR . . . . . 0.4 ' H ' ' H ' ' A' ' 122' ' ' GLY . 45.2 m -160.41 -17.82 0.06 Allowed 'General case' 0 CA--C 1.54 0.592 0 CA-C-O 121.414 0.626 . . . . 1.0 109.97 -179.595 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 122' ' ' GLY . . . . . 0.441 ' O ' ' C ' ' A' ' 123' ' ' THR . . . 109.88 -36.8 4.09 Favored Glycine 0 N--CA 1.476 1.327 0 C-N-CA 125.215 1.388 . . . . 1.0 111.888 179.96 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 123' ' ' THR . . . . . 0.599 HG23 ' O ' ' A' ' 123' ' ' THR . 4.2 t -31.17 94.98 0.01 OUTLIER 'General case' 0 N--CA 1.473 0.676 0 CA-C-N 118.47 1.135 . . . . 1.0 112.675 -178.708 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 124' ' ' ASP . . . . . 0.407 ' N ' ' O ' ' A' ' 122' ' ' GLY . 73.1 m-20 -143.67 144.58 31.93 Favored 'General case' 0 C--N 1.33 -0.275 0 N-CA-C 108.56 -0.904 . . . . 1.0 108.56 178.571 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 125' ' ' TYR . . . . . 0.433 ' O ' ' NE ' ' A' ' 126' ' ' ARG . 0.0 OUTLIER -151.74 148.96 28.52 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.763 0.316 . . . . 1.0 110.305 -178.525 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 126' ' ' ARG . . . . . 0.433 ' NE ' ' O ' ' A' ' 125' ' ' TYR . 0.0 OUTLIER -149.85 151.78 34.05 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.167 -0.47 . . . . 1.0 110.006 177.928 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 127' ' ' PHE . . . . . 0.548 ' O ' ' CD2' ' A' ' 92' ' ' HIS . 0.1 OUTLIER . . . . . 0 C--O 1.22 -0.481 0 CA-C-O 117.873 -1.06 . . . . 1.0 110.398 -178.57 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 2.2 mpt? . . . . . 0 N--CA 1.491 1.612 0 N-CA-C 109.139 -0.689 . . . . 1.0 109.139 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 51.9 m -95.64 1.72 53.75 Favored 'General case' 0 N--CA 1.463 0.187 0 CA-C-N 116.449 -0.341 . . . . 1.0 110.913 -179.825 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER 169.56 106.68 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.361 -0.381 . . . . 1.0 110.274 -179.94 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 18.2 t80 -149.21 145.53 27.17 Favored 'General case' 0 C--N 1.33 -0.254 0 N-CA-C 109.723 -0.473 . . . . 1.0 109.723 178.896 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 14.4 m-20 -152.82 147.71 26.34 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.359 -0.382 . . . . 1.0 110.117 -179.025 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 6' ' ' THR . . . . . 1.008 ' H ' HG23 ' A' ' 9' ' ' VAL . 0.2 OUTLIER -103.88 -165.97 1.21 Allowed 'General case' 0 C--O 1.206 -1.191 0 CA-C-O 121.51 0.671 . . . . 1.0 109.386 178.931 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . 0.728 ' O ' ' HB2' ' A' ' 11' ' ' ARG . 27.5 tt0 -58.92 -45.31 90.67 Favored 'General case' 0 C--N 1.304 -1.371 0 CA-C-O 121.891 0.853 . . . . 1.0 110.548 -179.801 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 8' ' ' ARG . . . . . 0.693 ' O ' ' HB3' ' A' ' 12' ' ' ALA . 0.1 OUTLIER -67.9 -60.13 2.75 Favored 'General case' 0 C--N 1.306 -1.301 0 C-N-CA 118.953 -1.099 . . . . 1.0 109.482 179.065 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . 1.008 HG23 ' H ' ' A' ' 6' ' ' THR . 0.0 OUTLIER -66.32 -50.69 65.9 Favored 'Isoleucine or valine' 0 C--O 1.201 -1.449 0 CA-C-N 115.107 -0.951 . . . . 1.0 110.686 -178.777 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 10' ' ' SER . . . . . 0.657 ' N ' ' O ' ' A' ' 6' ' ' THR . 2.5 t -65.69 -62.23 1.63 Allowed 'General case' 0 N--CA 1.488 1.447 0 C-N-CA 120.025 -0.67 . . . . 1.0 111.176 179.185 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 11' ' ' ARG . . . . . 0.728 ' HB2' ' O ' ' A' ' 7' ' ' GLU . 4.6 mmt85 -64.87 -41.18 95.88 Favored 'General case' 0 CA--C 1.547 0.861 0 CA-C-O 119.302 -0.38 . . . . 1.0 111.792 -177.213 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . 0.693 ' HB3' ' O ' ' A' ' 8' ' ' ARG . . . -69.61 -54.17 15.28 Favored 'General case' 0 N--CA 1.483 1.19 0 C-N-CA 118.165 -1.414 . . . . 1.0 108.125 175.84 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . 0.643 ' O ' ' CB ' ' A' ' 17' ' ' LEU . 60.3 t -61.67 -55.02 27.07 Favored 'Isoleucine or valine' 0 C--O 1.198 -1.647 0 C-N-CA 117.423 -1.711 . . . . 1.0 108.438 -179.033 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . 0.793 ' O ' HG22 ' A' ' 18' ' ' VAL . . . -57.1 -62.27 1.87 Allowed 'General case' 0 C--O 1.211 -0.925 0 C-N-CA 118.542 -1.263 . . . . 1.0 109.95 179.653 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . 0.537 ' HB3' ' O ' ' A' ' 11' ' ' ARG . . . -55.34 -55.66 28.94 Favored 'General case' 0 N--CA 1.475 0.805 0 C-N-CA 118.807 -1.157 . . . . 1.0 110.517 -176.952 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . 0.612 ' HB3' ' O ' ' A' ' 12' ' ' ALA . . . -65.66 -55.98 14.58 Favored 'General case' 0 CA--C 1.547 0.847 0 C-N-CA 119.761 -0.776 . . . . 1.0 110.033 -178.889 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . 0.643 ' CB ' ' O ' ' A' ' 13' ' ' VAL . 7.3 tp -56.8 -57.58 11.83 Favored 'General case' 0 N--CA 1.483 1.186 0 CA-C-N 115.397 -0.819 . . . . 1.0 108.827 -178.965 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . 0.793 HG22 ' O ' ' A' ' 14' ' ' ALA . 1.3 m -71.82 -58.22 5.61 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.423 0 C-N-CA 119.282 -0.967 . . . . 1.0 110.772 -179.536 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . 0.489 ' N ' ' O ' ' A' ' 15' ' ' ALA . . . -56.34 -172.94 0.16 Allowed Glycine 0 CA--C 1.519 0.341 0 C-N-CA 120.924 -0.655 . . . . 1.0 112.109 -177.768 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 20' ' ' PRO . . . . . 0.605 ' O ' ' N ' ' A' ' 24' ' ' ALA . 1.7 Cg_endo -81.05 -21.96 6.36 Favored 'Trans proline' 0 C--N 1.308 -1.581 0 C-N-CA 123.122 2.548 . . . . 1.0 112.501 -178.841 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -63.35 -62.03 5.76 Favored Glycine 0 N--CA 1.478 1.437 0 C-N-CA 119.687 -1.245 . . . . 1.0 112.906 -176.492 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . 0.587 ' H ' ' HA ' ' A' ' 16' ' ' ALA . . . -55.44 -52.03 50.56 Favored Glycine 0 N--CA 1.472 1.048 0 N-CA-C 106.277 -2.729 . . . . 1.0 106.277 -179.255 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . 0.488 ' O ' HG12 ' A' ' 27' ' ' VAL . 26.7 t -58.23 -31.81 43.12 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.731 0 C-N-CA 119.455 -0.898 . . . . 1.0 108.966 178.326 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . 0.605 ' N ' ' O ' ' A' ' 20' ' ' PRO . . . -60.2 -61.97 2.21 Favored 'General case' 0 N--CA 1.481 1.09 0 C-N-CA 118.616 -1.233 . . . . 1.0 109.677 178.614 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . 0.724 HD12 ' O ' ' A' ' 25' ' ' LEU . 0.9 OUTLIER -60.33 -50.35 73.98 Favored 'General case' 0 N--CA 1.478 0.938 0 N-CA-C 112.633 0.605 . . . . 1.0 112.633 -178.482 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 86.0 t -57.89 -59.44 3.42 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.021 0 C-N-CA 118.986 -1.086 . . . . 1.0 110.612 -177.204 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . 0.598 ' O ' ' HB3' ' A' ' 31' ' ' ALA . 1.2 p -58.41 -36.54 59.18 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.687 0 C-N-CA 120.672 -0.411 . . . . 1.0 111.16 -178.089 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 20.9 tttt -65.84 -56.57 11.2 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-O 121.463 0.649 . . . . 1.0 109.884 -179.706 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 25.1 t -63.51 -49.27 83.3 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.54 0 CA-C-N 115.292 -0.867 . . . . 1.0 111.088 -177.776 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 30' ' ' CYS . . . . . . . . . . . . . 14.0 t -63.54 -61.61 2.21 Favored 'General case' 0 C--N 1.316 -0.849 0 C-N-CA 118.901 -1.12 . . . . 1.0 109.43 -179.396 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . 0.628 ' O ' HD12 ' A' ' 37' ' ' ILE . . . -58.44 -50.89 72.07 Favored 'General case' 0 C--N 1.319 -0.718 0 C-N-CA 120.553 -0.459 . . . . 1.0 110.847 -178.416 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . 0.527 ' O ' ' CB ' ' A' ' 33' ' ' LEU . . . 74.51 67.85 1.67 Allowed Glycine 0 CA--C 1.518 0.238 0 N-CA-C 108.158 -1.977 . . . . 1.0 108.158 -178.383 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . 0.601 HD23 ' CG2' ' A' ' 36' ' ' VAL . 13.5 tp 94.34 81.31 0.03 OUTLIER Pre-proline 0 CA--C 1.54 0.588 0 CA-C-N 114.457 -0.871 . . . . 1.0 109.663 -177.719 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 13.0 Cg_endo -54.53 -23.08 30.35 Favored 'Trans proline' 0 N--CA 1.502 2.027 0 C-N-CA 121.637 1.558 . . . . 1.0 113.952 -179.276 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . 0.949 ' O ' HD12 ' A' ' 112' ' ' ILE . . . -62.56 -61.61 6.37 Favored Glycine 0 CA--C 1.536 1.356 0 C-N-CA 117.873 -2.108 . . . . 1.0 109.863 -178.403 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . 0.641 ' O ' HG22 ' A' ' 37' ' ' ILE . 2.6 m -95.57 178.39 0.59 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.519 0 N-CA-C 107.965 -1.124 . . . . 1.0 107.965 176.579 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . 0.641 HG22 ' O ' ' A' ' 36' ' ' VAL . 0.1 OUTLIER 102.56 121.94 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.479 0.989 0 O-C-N 124.297 0.998 . . . . 1.0 112.036 179.601 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 81.3 m-70 -143.2 135.29 26.98 Favored 'General case' 0 N--CA 1.463 0.198 0 N-CA-C 109.073 -0.714 . . . . 1.0 109.073 178.445 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 39' ' ' THR . . . . . 0.403 ' O ' ' CG ' ' A' ' 42' ' ' ARG . 0.0 OUTLIER -90.62 115.83 65.05 Favored Pre-proline 0 CA--C 1.546 0.804 0 N-CA-C 109.329 -0.619 . . . . 1.0 109.329 179.774 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 50.2 Cg_exo -49.01 -32.63 23.97 Favored 'Trans proline' 0 N--CA 1.496 1.619 0 C-N-CA 121.678 1.585 . . . . 1.0 113.569 -179.053 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -111.34 93.67 4.59 Favored 'General case' 0 CA--C 1.513 -0.459 0 N-CA-C 114.051 1.13 . . . . 1.0 114.051 -175.12 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . 0.42 ' C ' ' N ' ' A' ' 44' ' ' GLY . 0.2 OUTLIER -141.6 143.06 33.49 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 114.589 -1.187 . . . . 1.0 108.271 178.806 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 43' ' ' ARG . . . . . 0.441 HH22 ' HB3' ' A' ' 59' ' ' ARG . 14.9 tpt85 -50.49 -13.35 0.12 Allowed 'General case' 0 C--N 1.322 -0.6 0 C-N-CA 120.447 -0.501 . . . . 1.0 110.806 -177.164 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . 0.42 ' N ' ' C ' ' A' ' 42' ' ' ARG . . . 121.08 -23.52 7.68 Favored Glycine 0 N--CA 1.472 1.095 0 N-CA-C 110.346 -1.102 . . . . 1.0 110.346 179.823 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . 0.541 ' O ' ' CB ' ' A' ' 46' ' ' PHE . 36.0 p90 -152.25 159.6 43.51 Favored 'General case' 0 C--N 1.327 -0.391 0 N-CA-C 108.601 -0.889 . . . . 1.0 108.601 177.618 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 46' ' ' PHE . . . . . 0.541 ' CB ' ' O ' ' A' ' 45' ' ' PHE . 4.7 t80 117.24 103.11 0.0 OUTLIER 'General case' 0 N--CA 1.487 1.41 0 O-C-N 124.61 1.194 . . . . 1.0 110.274 -179.954 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 47' ' ' ARG . . . . . 0.491 ' CB ' ' O ' ' A' ' 46' ' ' PHE . 6.5 ptp180 120.5 135.68 0.0 OUTLIER 'General case' 0 N--CA 1.488 1.453 0 C-N-CA 124.886 1.274 . . . . 1.0 110.557 179.609 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 2.6 t 67.61 73.68 0.32 Allowed 'General case' 0 C--O 1.218 -0.588 0 C-N-CA 119.718 -0.793 . . . . 1.0 110.229 177.939 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 49' ' ' ASN . . . . . 0.767 ' H ' HD22 ' A' ' 49' ' ' ASN . 0.0 OUTLIER -135.82 153.56 77.29 Favored Pre-proline 0 N--CA 1.47 0.542 0 CA-C-O 119.427 -0.321 . . . . 1.0 110.173 -178.634 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 50' ' ' PRO . . . . . 0.42 ' C ' ' H ' ' A' ' 52' ' ' ARG . 33.7 Cg_endo -60.31 47.84 0.07 OUTLIER 'Trans proline' 0 N--CA 1.509 2.431 0 C-N-CA 122.763 2.308 . . . . 1.0 113.278 179.503 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . 0.491 ' N ' ' O ' ' A' ' 49' ' ' ASN . 15.8 mp0 70.77 -18.5 0.25 Allowed 'General case' 0 N--CA 1.47 0.561 0 C-N-CA 123.571 0.748 . . . . 1.0 111.486 179.697 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . 0.42 ' H ' ' C ' ' A' ' 50' ' ' PRO . 1.6 mpp_? -56.92 138.78 53.44 Favored 'General case' 0 CA--C 1.531 0.242 0 N-CA-C 109.436 -0.579 . . . . 1.0 109.436 179.445 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . 0.647 HG23 HG22 ' A' ' 55' ' ' ILE . 2.6 tp -58.91 129.83 21.54 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-N 115.551 -0.75 . . . . 1.0 110.917 -179.188 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 54' ' ' GLN . . . . . 0.511 ' NE2' ' OD1' ' A' ' 49' ' ' ASN . 0.0 OUTLIER -59.34 79.26 0.01 OUTLIER 'General case' 0 CA--C 1.537 0.474 0 N-CA-C 108.28 -1.007 . . . . 1.0 108.28 -178.014 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . 0.647 HG22 HG23 ' A' ' 53' ' ' ILE . 13.9 tt -154.49 162.97 1.79 Allowed 'Isoleucine or valine' 0 CA--C 1.523 -0.066 0 CA-C-N 114.802 -1.09 . . . . 1.0 111.325 178.438 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 100.81 -28.07 17.67 Favored Glycine 0 N--CA 1.452 -0.25 0 N-CA-C 111.943 -0.463 . . . . 1.0 111.943 176.849 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 12.9 m-20 -67.81 135.53 52.74 Favored 'General case' 0 N--CA 1.446 -0.646 0 CA-C-O 122.807 1.289 . . . . 1.0 113.661 -177.42 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 58' ' ' TRP . . . . . . . . . . . . . 32.4 m0 -78.13 -179.06 5.93 Favored 'General case' 0 N--CA 1.44 -0.964 0 CA-C-N 112.484 -2.143 . . . . 1.0 107.235 177.293 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 59' ' ' ARG . . . . . 0.65 ' H ' ' CD ' ' A' ' 59' ' ' ARG . 0.0 OUTLIER -99.05 -56.12 2.51 Favored 'General case' 0 CA--C 1.557 1.232 0 CA-C-N 119.646 1.112 . . . . 1.0 111.896 -179.734 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 60' ' ' TYR . . . . . 0.401 ' H ' ' HD2' ' A' ' 59' ' ' ARG . 24.8 t80 -78.66 -7.24 57.47 Favored 'General case' 0 N--CA 1.481 1.119 0 C-N-CA 125.429 1.492 . . . . 1.0 111.688 -178.418 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 69.4 tt0 -71.36 -13.89 62.01 Favored 'General case' 0 C--N 1.296 -1.749 0 CA-C-N 114.944 -1.025 . . . . 1.0 109.358 179.814 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 62' ' ' VAL . . . . . 0.513 ' O ' ' N ' ' A' ' 66' ' ' GLY . 10.4 m -44.51 -51.83 1.73 Allowed 'Isoleucine or valine' 0 CA--C 1.496 -1.133 0 C-N-CA 120.449 -0.501 . . . . 1.0 110.36 -175.448 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 63' ' ' ALA . . . . . 0.669 ' O ' ' HG2' ' A' ' 67' ' ' ARG . . . -65.51 -48.15 73.51 Favored 'General case' 0 N--CA 1.421 -1.919 0 N-CA-C 109.223 -0.658 . . . . 1.0 109.223 179.517 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 64' ' ' HIS . . . . . 0.408 ' O ' ' CG ' ' A' ' 67' ' ' ARG . 1.2 m-70 -54.57 -58.47 7.35 Favored 'General case' 0 CA--C 1.548 0.89 0 O-C-N 123.913 0.758 . . . . 1.0 110.368 179.829 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 65' ' ' ASP . . . . . 0.65 ' C ' ' H ' ' A' ' 67' ' ' ARG . 23.8 t70 -67.45 -53.38 29.43 Favored 'General case' 0 C--O 1.24 0.604 0 CA-C-O 121.15 0.5 . . . . 1.0 109.751 178.264 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . 0.513 ' N ' ' O ' ' A' ' 62' ' ' VAL . . . -63.72 30.94 0.09 OUTLIER Glycine 0 CA--C 1.527 0.826 0 N-CA-C 110.866 -0.894 . . . . 1.0 110.866 177.65 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 67' ' ' ARG . . . . . 0.669 ' HG2' ' O ' ' A' ' 63' ' ' ALA . 24.1 mmm-85 -80.25 -3.73 50.39 Favored 'General case' 0 N--CA 1.448 -0.567 0 N-CA-C 107.704 -1.221 . . . . 1.0 107.704 175.855 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . 0.476 ' O ' ' HA ' ' A' ' 72' ' ' HIS . 4.9 tt -35.1 -29.86 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.792 0 N-CA-C 107.705 -1.22 . . . . 1.0 107.705 -178.741 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . 0.818 HD23 ' H ' ' A' ' 70' ' ' ALA . 1.2 pt? -62.92 -62.34 1.78 Allowed 'General case' 0 N--CA 1.48 1.048 0 C-N-CA 117.121 -1.832 . . . . 1.0 106.914 177.689 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . 0.818 ' H ' HD23 ' A' ' 69' ' ' LEU . . . -77.56 -72.55 0.35 Allowed 'General case' 0 C--O 1.214 -0.777 0 N-CA-C 106.663 -1.606 . . . . 1.0 106.663 178.057 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 71' ' ' ALA . . . . . 0.511 ' O ' ' C ' ' A' ' 72' ' ' HIS . . . -45.06 3.72 0.0 OUTLIER 'General case' 0 CA--C 1.516 -0.355 0 C-N-CA 124.402 1.081 . . . . 1.0 112.847 177.633 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 72' ' ' HIS . . . . . 0.687 ' H ' ' C ' ' A' ' 70' ' ' ALA . 0.0 OUTLIER -21.57 -68.29 0.03 OUTLIER 'General case' 0 CA--C 1.518 -0.275 0 C-N-CA 122.872 0.469 . . . . 1.0 111.437 -176.8 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 73' ' ' MET . . . . . 0.563 ' N ' ' ND1' ' A' ' 72' ' ' HIS . 32.6 mtt -73.51 -48.02 36.51 Favored 'General case' 0 C--N 1.31 -1.148 0 C-N-CA 119.069 -1.052 . . . . 1.0 109.151 177.355 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . 0.677 ' O ' ' N ' ' A' ' 76' ' ' GLY . 65.5 t -43.79 -49.21 1.78 Allowed 'Isoleucine or valine' 0 C--O 1.22 -0.497 0 CA-C-O 118.141 -0.933 . . . . 1.0 111.04 -176.146 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 75' ' ' ASN . . . . . 0.47 ' C ' ' N ' ' A' ' 77' ' ' ILE . 21.8 t30 -36.52 -20.34 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.746 0 CA-C-N 120.238 1.381 . . . . 1.0 110.312 177.755 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 76' ' ' GLY . . . . . 0.677 ' N ' ' O ' ' A' ' 74' ' ' VAL . . . -49.3 -20.87 2.51 Favored Glycine 0 C--O 1.216 -1.019 0 N-CA-C 107.948 -2.061 . . . . 1.0 107.948 174.885 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 77' ' ' ILE . . . . . 0.477 ' N ' ' O ' ' A' ' 74' ' ' VAL . 82.2 mt -53.27 -43.77 51.49 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.133 0 O-C-N 122.635 -0.333 . . . . 1.0 111.019 -178.044 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 42.5 t -50.44 -19.78 0.79 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.424 0 CA-C-N 118.667 0.667 . . . . 1.0 111.978 -179.445 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . 0.747 ' O ' ' HB2' ' A' ' 83' ' ' ALA . 0.3 OUTLIER -90.15 -38.67 11.27 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.077 0 C-N-CA 120.007 -0.677 . . . . 1.0 111.543 179.466 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -82.37 -27.36 32.17 Favored 'General case' 0 CA--C 1.541 0.633 0 N-CA-C 113.116 0.784 . . . . 1.0 113.116 -179.255 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 81' ' ' GLU . . . . . 0.644 ' CG ' ' N ' ' A' ' 82' ' ' ASP . 12.6 pt-20 -84.3 -67.63 0.78 Allowed 'General case' 0 CA--C 1.544 0.72 0 N-CA-C 110.152 -0.314 . . . . 1.0 110.152 178.171 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 82' ' ' ASP . . . . . 0.644 ' N ' ' CG ' ' A' ' 81' ' ' GLU . 67.1 m-20 -66.25 -20.05 66.0 Favored 'General case' 0 CA--C 1.495 -1.164 0 O-C-N 121.269 -0.894 . . . . 1.0 112.384 -177.664 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . 0.747 ' HB2' ' O ' ' A' ' 79' ' ' ILE . . . -18.65 -55.03 0.01 OUTLIER 'General case' 0 N--CA 1.468 0.465 0 CA-C-O 118.946 -0.549 . . . . 1.0 111.846 176.642 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . 0.449 ' N ' ' O ' ' A' ' 82' ' ' ASP . 3.8 mm? -28.0 -53.78 0.09 Allowed 'General case' 0 N--CA 1.484 1.227 0 CA-C-N 119.657 1.117 . . . . 1.0 113.43 -177.896 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 85' ' ' ILE . . . . . 0.599 ' O ' ' HB3' ' A' ' 88' ' ' ALA . 15.6 pt -91.05 -35.43 7.15 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 C-N-CA 120.587 -0.445 . . . . 1.0 109.811 -179.404 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 86' ' ' ALA . . . . . 0.797 ' O ' HG13 ' A' ' 89' ' ' VAL . . . -52.92 -54.92 27.79 Favored 'General case' 0 C--N 1.33 -0.244 0 C-N-CA 120.376 -0.529 . . . . 1.0 109.685 -179.514 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 87' ' ' GLU . . . . . 0.405 ' OE1' ' C ' ' A' ' 87' ' ' GLU . 9.0 tm-20 -57.4 -21.04 33.67 Favored 'General case' 0 C--N 1.33 -0.277 0 C-N-CA 120.062 -0.655 . . . . 1.0 109.508 179.304 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 88' ' ' ALA . . . . . 0.696 ' C ' ' H ' ' A' ' 90' ' ' GLY . . . -73.36 -13.51 61.11 Favored 'General case' 0 C--O 1.225 -0.192 0 C-N-CA 120.352 -0.539 . . . . 1.0 109.923 179.457 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 89' ' ' VAL . . . . . 0.797 HG13 ' O ' ' A' ' 86' ' ' ALA . 27.8 m -49.09 11.4 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.48 1.037 0 N-CA-C 113.27 0.841 . . . . 1.0 113.27 -178.979 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 90' ' ' GLY . . . . . 0.73 ' O ' ' N ' ' A' ' 92' ' ' HIS . . . -34.37 -42.12 0.27 Allowed Glycine 0 CA--C 1.543 1.83 0 CA-C-O 117.871 -1.516 . . . . 1.0 110.561 -177.26 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 91' ' ' PRO . . . . . 0.495 ' HD2' ' N ' ' A' ' 90' ' ' GLY . 1.1 Cg_endo -44.64 0.76 0.01 OUTLIER 'Trans proline' 0 N--CA 1.5 1.911 0 CA-C-N 121.292 2.546 . . . . 1.0 110.925 170.724 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 92' ' ' HIS . . . . . 0.73 ' N ' ' O ' ' A' ' 90' ' ' GLY . 16.4 t-80 -51.17 -41.7 60.33 Favored 'General case' 0 CA--C 1.51 -0.589 0 N-CA-C 109.21 -0.663 . . . . 1.0 109.21 -177.454 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 39.0 tp -63.03 -39.86 96.0 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 119.17 0.895 . . . . 1.0 110.349 177.718 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -61.8 -60.21 4.0 Favored 'General case' 0 CA--C 1.496 -1.116 0 N-CA-C 106.085 -1.82 . . . . 1.0 106.085 -179.398 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 95' ' ' ARG . . . . . 0.417 HH12 ' HD3' ' A' ' 20' ' ' PRO . 3.7 mmp_? -57.8 -29.92 65.27 Favored 'General case' 0 N--CA 1.432 -1.34 0 CA-C-N 115.29 -0.868 . . . . 1.0 108.738 177.825 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 96' ' ' ALA . . . . . 0.806 ' O ' ' N ' ' A' ' 100' ' ' ILE . . . -59.04 -53.81 54.21 Favored 'General case' 0 C--O 1.198 -1.617 0 C-N-CA 118.127 -1.429 . . . . 1.0 108.558 -176.73 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 97' ' ' LEU . . . . . 0.487 ' C ' ' O ' ' A' ' 96' ' ' ALA . 1.2 tt -34.46 -28.82 0.01 OUTLIER 'General case' 0 CA--C 1.565 1.521 0 O-C-N 124.341 1.026 . . . . 1.0 108.59 -177.929 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 98' ' ' GLY . . . . . 0.616 ' N ' ' O ' ' A' ' 96' ' ' ALA . . . -88.62 -53.08 2.67 Favored Glycine 0 CA--C 1.543 1.829 0 CA-C-O 123.589 1.66 . . . . 1.0 111.401 174.144 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 99' ' ' GLN . . . . . 0.487 ' N ' ' O ' ' A' ' 96' ' ' ALA . 6.1 tt0 -78.73 6.18 9.52 Favored 'General case' 0 N--CA 1.433 -1.309 0 CA-C-N 114.473 -0.864 . . . . 1.0 108.991 178.693 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 100' ' ' ILE . . . . . 0.806 ' N ' ' O ' ' A' ' 96' ' ' ALA . 0.2 OUTLIER -63.8 -47.09 92.46 Favored 'Isoleucine or valine' 0 CA--C 1.495 -1.159 0 N-CA-C 108.022 -1.103 . . . . 1.0 108.022 179.948 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 101' ' ' VAL . . . . . 0.628 HG23 ' H ' ' A' ' 102' ' ' CYS . 17.6 m -55.54 -60.01 2.08 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.477 0 C-N-CA 117.035 -1.866 . . . . 1.0 108.958 179.65 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 102' ' ' CYS . . . . . 0.628 ' H ' HG23 ' A' ' 101' ' ' VAL . 42.3 t -41.11 -19.71 0.01 OUTLIER 'General case' 0 C--N 1.311 -1.075 0 N-CA-C 113.217 0.821 . . . . 1.0 113.217 -176.231 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 103' ' ' ARG . . . . . 0.517 ' N ' ' O ' ' A' ' 101' ' ' VAL . 7.6 ttp180 -89.98 -35.27 15.64 Favored 'General case' 0 N--CA 1.497 1.922 0 N-CA-C 114.534 1.309 . . . . 1.0 114.534 178.956 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 104' ' ' TYR . . . . . 0.649 ' O ' ' CG ' ' A' ' 104' ' ' TYR . 0.0 OUTLIER -100.18 22.97 10.63 Favored 'General case' 0 C--N 1.303 -1.45 0 CA-C-N 113.188 -1.824 . . . . 1.0 110.076 -179.816 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 105' ' ' GLY . . . . . 0.535 ' O ' ' HB3' ' A' ' 106' ' ' ALA . . . -161.5 -88.15 0.07 OUTLIER Glycine 0 N--CA 1.451 -0.33 0 N-CA-C 107.413 -2.275 . . . . 1.0 107.413 179.64 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 106' ' ' ALA . . . . . 0.561 ' O ' ' CD ' ' A' ' 110' ' ' PRO . . . 69.53 58.17 0.32 Allowed 'General case' 0 CA--C 1.548 0.895 0 N-CA-C 112.704 0.631 . . . . 1.0 112.704 179.334 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 107' ' ' THR . . . . . 0.498 ' O ' ' HD2' ' A' ' 110' ' ' PRO . 20.0 m -76.41 -57.84 3.63 Favored 'General case' 0 N--CA 1.48 1.037 0 O-C-N 121.257 -0.902 . . . . 1.0 109.384 179.555 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 108' ' ' VAL . . . . . 0.525 HG23 ' N ' ' A' ' 109' ' ' ILE . 16.5 m -68.61 -45.45 81.53 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.747 0 N-CA-C 110.405 -0.22 . . . . 1.0 110.405 -179.371 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 109' ' ' ILE . . . . . 0.525 ' N ' HG23 ' A' ' 108' ' ' VAL . 0.8 OUTLIER -36.83 -54.01 1.79 Allowed Pre-proline 0 CA--C 1.568 1.659 0 CA-C-N 116.159 -0.473 . . . . 1.0 110.199 -178.694 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 110' ' ' PRO . . . . . 0.561 ' CD ' ' O ' ' A' ' 106' ' ' ALA . 31.4 Cg_exo -57.14 -24.52 59.1 Favored 'Trans proline' 0 N--CA 1.504 2.141 0 C-N-CA 123.296 2.664 . . . . 1.0 113.087 176.284 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 111' ' ' ASN . . . . . 0.567 ' CG ' ' N ' ' A' ' 112' ' ' ILE . 0.1 OUTLIER -63.04 -66.19 0.58 Allowed 'General case' 0 CA--C 1.54 0.587 0 C-N-CA 120.114 -0.634 . . . . 1.0 109.8 -178.531 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 112' ' ' ILE . . . . . 0.949 HD12 ' O ' ' A' ' 35' ' ' GLY . 1.9 tt -61.56 -27.84 42.86 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.493 0 CA-C-O 121.308 0.575 . . . . 1.0 110.804 178.707 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 113' ' ' ASN . . . . . 0.445 ' O ' ' HB2' ' A' ' 117' ' ' GLU . 1.6 m120 -57.54 -64.88 0.75 Allowed 'General case' 0 C--N 1.305 -1.341 0 CA-C-N 115.066 -0.97 . . . . 1.0 111.275 -175.203 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -67.63 -23.86 65.39 Favored 'General case' 0 C--N 1.318 -0.796 0 N-CA-C 112.124 0.416 . . . . 1.0 112.124 -178.926 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -78.97 -62.91 1.55 Allowed 'General case' 0 CA--C 1.536 0.422 0 N-CA-C 112.828 0.677 . . . . 1.0 112.828 178.988 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 116' ' ' ILE . . . . . 0.606 HD12 HG13 ' A' ' 112' ' ' ILE . 19.7 mt -69.68 -47.09 72.86 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.651 0 O-C-N 121.414 -0.804 . . . . 1.0 112.532 -178.329 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 117' ' ' GLU . . . . . 0.445 ' HB2' ' O ' ' A' ' 113' ' ' ASN . 73.9 mt-10 -46.84 -59.73 2.88 Favored 'General case' 0 CA--C 1.498 -1.04 0 N-CA-C 108.681 -0.859 . . . . 1.0 108.681 -177.001 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 88.9 t -55.59 -16.19 2.3 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.314 0 CA-C-N 115.407 -0.815 . . . . 1.0 109.191 179.052 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 119' ' ' LEU . . . . . 0.583 ' N ' ' O ' ' A' ' 116' ' ' ILE . 0.2 OUTLIER -79.87 -61.11 2.09 Favored 'General case' 0 C--N 1.351 0.633 0 C-N-CA 119.691 -0.803 . . . . 1.0 109.362 176.964 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 120' ' ' GLY . . . . . 0.547 ' O ' HG23 ' A' ' 121' ' ' THR . . . -67.15 -84.39 0.1 Allowed Glycine 0 C--N 1.361 1.97 0 C-N-CA 117.154 -2.451 . . . . 1.0 110.874 178.705 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 121' ' ' THR . . . . . 0.547 HG23 ' O ' ' A' ' 120' ' ' GLY . 9.3 p -159.27 -23.71 0.07 Allowed 'General case' 0 C--N 1.32 -0.688 0 N-CA-C 108.274 -1.01 . . . . 1.0 108.274 -179.564 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 122' ' ' GLY . . . . . 0.462 ' O ' ' C ' ' A' ' 123' ' ' THR . . . 112.54 -37.09 3.8 Favored Glycine 0 CA--C 1.525 0.681 0 CA-C-N 113.895 -1.502 . . . . 1.0 111.913 179.368 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 123' ' ' THR . . . . . 0.586 HG23 ' O ' ' A' ' 123' ' ' THR . 4.2 t -30.46 93.22 0.01 OUTLIER 'General case' 0 N--CA 1.472 0.675 0 CA-C-N 118.781 1.291 . . . . 1.0 112.33 -178.932 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 124' ' ' ASP . . . . . 0.46 ' N ' ' O ' ' A' ' 122' ' ' GLY . 40.9 m-20 -146.35 143.43 29.09 Favored 'General case' 0 C--N 1.332 -0.159 0 N-CA-C 108.946 -0.761 . . . . 1.0 108.946 179.238 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 125' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -148.01 147.16 29.32 Favored 'General case' 0 CA--C 1.535 0.385 0 N-CA-C 109.695 -0.483 . . . . 1.0 109.695 179.725 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 8.3 mmm180 -146.15 146.24 30.78 Favored 'General case' 0 CA--C 1.536 0.414 0 N-CA-C 109.018 -0.734 . . . . 1.0 109.018 178.622 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 127' ' ' PHE . . . . . 0.534 ' OXT' ' CD2' ' A' ' 127' ' ' PHE . 87.4 t80 . . . . . 0 N--CA 1.473 0.713 0 CA-C-O 118.069 -0.967 . . . . 1.0 110.865 179.557 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . 0.42 ' C ' ' H ' ' A' ' 3' ' ' ASP . 0.4 OUTLIER . . . . . 0 N--CA 1.489 1.495 0 N-CA-C 108.19 -1.041 . . . . 1.0 108.19 . . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 2' ' ' SER . . . . . 0.55 ' O ' ' CB ' ' A' ' 3' ' ' ASP . 75.0 m -75.61 13.48 0.79 Allowed 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 116.25 -0.432 . . . . 1.0 110.852 179.709 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 3' ' ' ASP . . . . . 0.55 ' CB ' ' O ' ' A' ' 2' ' ' SER . 21.4 t0 135.69 134.15 0.0 OUTLIER 'General case' 0 N--CA 1.478 0.954 0 O-C-N 124.68 1.238 . . . . 1.0 110.346 179.066 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . 0.521 ' N ' ' OD1' ' A' ' 3' ' ' ASP . 71.1 t80 -167.36 91.8 0.38 Allowed 'General case' 0 C--N 1.329 -0.3 0 N-CA-C 114.833 1.42 . . . . 1.0 114.833 175.164 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 65.6 m-20 -73.61 146.78 44.4 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 114.684 -1.144 . . . . 1.0 109.212 178.898 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 6' ' ' THR . . . . . 0.483 ' O ' ' N ' ' A' ' 10' ' ' SER . 58.6 m -56.59 160.48 3.23 Favored 'General case' 0 C--O 1.217 -0.649 0 C-N-CA 120.076 -0.649 . . . . 1.0 109.505 179.519 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . 0.559 ' O ' ' N ' ' A' ' 11' ' ' ARG . 30.6 tt0 -57.07 -60.43 3.6 Favored 'General case' 0 C--N 1.316 -0.855 0 CA-C-O 121.565 0.697 . . . . 1.0 109.372 -178.072 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 8' ' ' ARG . . . . . 0.538 ' CG ' ' N ' ' A' ' 9' ' ' VAL . 48.0 ptt85 -49.36 -52.31 29.08 Favored 'General case' 0 C--N 1.313 -0.987 0 N-CA-C 108.082 -1.081 . . . . 1.0 108.082 -177.472 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . 0.584 ' O ' HG23 ' A' ' 13' ' ' VAL . 57.0 t -62.74 -48.02 90.09 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.36 0 CA-C-N 114.837 -1.074 . . . . 1.0 109.262 179.814 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 10' ' ' SER . . . . . 0.483 ' N ' ' O ' ' A' ' 6' ' ' THR . 48.3 t -63.41 -62.31 1.76 Allowed 'General case' 0 N--CA 1.476 0.836 0 CA-C-N 115.835 -0.621 . . . . 1.0 109.979 -179.214 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 11' ' ' ARG . . . . . 0.559 ' N ' ' O ' ' A' ' 7' ' ' GLU . 0.0 OUTLIER -57.42 -57.56 12.13 Favored 'General case' 0 N--CA 1.47 0.55 0 N-CA-C 109.062 -0.718 . . . . 1.0 109.062 -178.671 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . 0.513 ' CB ' ' O ' ' A' ' 8' ' ' ARG . . . -47.99 -48.09 32.74 Favored 'General case' 0 N--CA 1.478 0.954 0 N-CA-C 106.193 -1.78 . . . . 1.0 106.193 -178.198 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . 0.584 HG23 ' O ' ' A' ' 9' ' ' VAL . 45.1 t -60.5 -47.89 90.78 Favored 'Isoleucine or valine' 0 C--O 1.203 -1.392 0 C-N-CA 119.078 -1.049 . . . . 1.0 108.886 176.817 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . 0.564 ' O ' HG13 ' A' ' 18' ' ' VAL . . . -60.96 -61.91 2.23 Favored 'General case' 0 C--O 1.212 -0.903 0 C-N-CA 119.017 -1.073 . . . . 1.0 110.018 179.145 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . 0.533 ' O ' ' N ' ' A' ' 19' ' ' GLY . . . -51.84 -55.06 22.27 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-O 121.932 0.872 . . . . 1.0 109.228 -177.902 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . 0.511 ' C ' ' H ' ' A' ' 22' ' ' GLY . . . -61.57 -54.4 43.51 Favored 'General case' 0 C--N 1.311 -1.07 0 CA-C-N 114.135 -1.393 . . . . 1.0 109.113 -179.43 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . 0.668 HD23 ' C ' ' A' ' 17' ' ' LEU . 6.8 tt -57.19 -54.16 49.91 Favored 'General case' 0 N--CA 1.484 1.257 0 CA-C-N 114.411 -1.268 . . . . 1.0 109.312 -177.711 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . 0.564 HG13 ' O ' ' A' ' 14' ' ' ALA . 2.6 m -68.45 -56.46 12.4 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.501 0 C-N-CA 119.384 -0.926 . . . . 1.0 109.324 178.893 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . 0.533 ' N ' ' O ' ' A' ' 15' ' ' ALA . . . -64.17 -170.7 2.06 Favored Glycine 0 CA--C 1.526 0.731 0 N-CA-C 111.352 -0.699 . . . . 1.0 111.352 -179.568 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 20' ' ' PRO . . . . . 0.522 ' O ' ' N ' ' A' ' 24' ' ' ALA . 1.8 Cg_endo -77.41 -25.12 8.58 Favored 'Trans proline' 0 N--CA 1.494 1.53 0 C-N-CA 123.011 2.474 . . . . 1.0 114.522 -178.561 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . 0.433 ' O ' ' HB3' ' A' ' 24' ' ' ALA . . . -59.33 -58.48 14.19 Favored Glycine 0 N--CA 1.476 1.322 0 C-N-CA 119.894 -1.146 . . . . 1.0 111.358 -177.22 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . 0.511 ' H ' ' C ' ' A' ' 16' ' ' ALA . . . -57.64 -54.16 39.42 Favored Glycine 0 N--CA 1.471 0.975 0 N-CA-C 106.813 -2.515 . . . . 1.0 106.813 -178.136 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . 0.586 ' O ' HG12 ' A' ' 27' ' ' VAL . 53.9 t -53.96 -33.03 23.28 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.059 0 CA-C-N 114.543 -0.828 . . . . 1.0 109.069 179.313 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . 0.522 ' N ' ' O ' ' A' ' 20' ' ' PRO . . . -60.73 -61.02 2.89 Favored 'General case' 0 CA--C 1.53 0.204 0 C-N-CA 118.554 -1.258 . . . . 1.0 109.486 179.559 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 3.7 tp -64.34 -47.43 79.4 Favored 'General case' 0 C--N 1.344 0.346 0 N-CA-C 113.497 0.925 . . . . 1.0 113.497 -177.985 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 98.6 t -60.23 -60.58 2.34 Favored 'Isoleucine or valine' 0 C--N 1.339 0.137 0 C-N-CA 118.366 -1.334 . . . . 1.0 110.231 -176.976 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . 0.586 HG12 ' O ' ' A' ' 23' ' ' VAL . 1.4 p -55.14 -35.23 34.75 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.244 0 CA-C-O 120.869 0.366 . . . . 1.0 111.798 -178.209 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 8.2 tttm -67.56 -54.02 23.41 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-O 121.51 0.671 . . . . 1.0 109.436 -179.016 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 44.2 t -61.75 -49.67 83.34 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.887 0 CA-C-N 114.68 -1.146 . . . . 1.0 111.246 -178.527 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 30' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -64.96 -61.18 2.32 Favored 'General case' 0 CA--C 1.534 0.346 0 C-N-CA 118.542 -1.263 . . . . 1.0 109.905 -179.218 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . 0.509 ' HB2' HH12 ' A' ' 47' ' ' ARG . . . -60.84 -51.65 68.42 Favored 'General case' 0 CA--C 1.515 -0.396 0 N-CA-C 112.535 0.569 . . . . 1.0 112.535 -176.702 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . 0.489 ' O ' ' CB ' ' A' ' 33' ' ' LEU . . . 81.57 77.19 1.04 Allowed Glycine 0 CA--C 1.523 0.534 0 N-CA-C 108.856 -1.698 . . . . 1.0 108.856 -178.069 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . 0.5 HD22 ' H ' ' A' ' 36' ' ' VAL . 1.3 tt 84.74 85.41 0.05 OUTLIER Pre-proline 0 CA--C 1.543 0.676 0 N-CA-C 109.523 -0.547 . . . . 1.0 109.523 -178.961 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 77.8 Cg_exo -52.35 -33.05 54.38 Favored 'Trans proline' 0 N--CA 1.51 2.496 0 C-N-CA 123.564 2.842 . . . . 1.0 114.556 -178.504 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -58.98 -58.79 12.69 Favored Glycine 0 CA--C 1.527 0.84 0 C-N-CA 118.974 -1.584 . . . . 1.0 109.843 -178.083 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . 0.614 ' O ' HG22 ' A' ' 37' ' ' ILE . 0.4 OUTLIER -94.38 160.62 2.69 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.453 0 N-CA-C 107.083 -1.451 . . . . 1.0 107.083 178.641 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . 0.686 HG23 ' O ' ' A' ' 37' ' ' ILE . 5.9 tp 124.63 111.27 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.484 1.272 0 O-C-N 124.141 0.901 . . . . 1.0 109.069 -178.944 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 57.0 m80 -138.39 130.72 28.82 Favored 'General case' 0 C--N 1.329 -0.304 0 N-CA-C 108.044 -1.095 . . . . 1.0 108.044 178.865 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 11.2 t -91.79 153.19 43.69 Favored Pre-proline 0 N--CA 1.467 0.418 0 CA-C-O 119.391 -0.338 . . . . 1.0 110.363 -179.023 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 6.1 Cg_endo -86.11 -38.74 0.09 OUTLIER 'Trans proline' 0 N--CA 1.483 0.881 0 C-N-CA 121.213 1.275 . . . . 1.0 112.828 -179.786 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -125.53 129.88 50.62 Favored 'General case' 0 N--CA 1.47 0.561 0 CA-C-N 116.203 -0.453 . . . . 1.0 109.918 179.361 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . 0.717 HH12 ' CD ' ' A' ' 47' ' ' ARG . 42.0 ttp180 -176.18 168.95 2.84 Favored 'General case' 0 C--N 1.323 -0.584 0 N-CA-C 107.12 -1.437 . . . . 1.0 107.12 177.294 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 43' ' ' ARG . . . . . 0.457 ' N ' ' HG2' ' A' ' 42' ' ' ARG . 0.0 OUTLIER -52.51 -37.34 57.27 Favored 'General case' 0 N--CA 1.449 -0.478 0 CA-C-N 120.114 1.325 . . . . 1.0 109.132 -179.642 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 125.16 -19.62 6.79 Favored Glycine 0 C--N 1.34 0.773 0 N-CA-C 111.079 -0.809 . . . . 1.0 111.079 -179.106 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . 0.499 ' O ' ' CB ' ' A' ' 46' ' ' PHE . 4.5 t80 -149.7 149.94 31.35 Favored 'General case' 0 CA--C 1.538 0.509 0 CA-C-N 117.815 0.808 . . . . 1.0 109.019 179.76 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 46' ' ' PHE . . . . . 0.499 ' CB ' ' O ' ' A' ' 45' ' ' PHE . 3.8 m-30 132.31 86.17 0.0 OUTLIER 'General case' 0 N--CA 1.484 1.239 0 N-CA-C 107.384 -1.339 . . . . 1.0 107.384 -179.559 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 47' ' ' ARG . . . . . 0.717 ' CD ' HH12 ' A' ' 42' ' ' ARG . 5.7 ptp180 132.87 141.91 0.0 OUTLIER 'General case' 0 N--CA 1.485 1.279 0 O-C-N 124.434 1.084 . . . . 1.0 110.932 178.188 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 3.3 m 71.03 71.5 0.18 Allowed 'General case' 0 N--CA 1.455 -0.179 0 N-CA-C 110.286 -0.264 . . . . 1.0 110.286 -179.992 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 49' ' ' ASN . . . . . 0.452 ' O ' ' N ' ' A' ' 51' ' ' GLU . 69.4 m-80 -132.44 140.32 37.52 Favored Pre-proline 0 C--N 1.33 -0.263 0 N-CA-C 108.007 -1.108 . . . . 1.0 108.007 179.226 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 44.1 Cg_endo -67.86 65.55 0.91 Allowed 'Trans proline' 0 C--N 1.312 -1.394 0 C-N-CA 121.54 1.493 . . . . 1.0 111.374 -179.339 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . 0.525 ' N ' ' OE1' ' A' ' 51' ' ' GLU . 0.0 OUTLIER 64.11 7.48 3.45 Favored 'General case' 0 N--CA 1.463 0.196 0 CA-C-N 114.92 -1.036 . . . . 1.0 111.061 -179.638 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . 0.551 HH11 ' HB1' ' A' ' 86' ' ' ALA . 33.1 mtt-85 -87.97 159.85 18.14 Favored 'General case' 0 C--N 1.331 -0.233 0 N-CA-C 109.572 -0.529 . . . . 1.0 109.572 179.278 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . 0.468 ' O ' ' N ' ' A' ' 55' ' ' ILE . 10.7 tt -79.85 135.54 25.29 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-O 121.87 0.843 . . . . 1.0 111.605 -179.245 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 54' ' ' GLN . . . . . 0.453 ' OE1' ' CE2' ' A' ' 46' ' ' PHE . 5.0 pt20 -61.04 83.24 0.01 OUTLIER 'General case' 0 C--N 1.32 -0.68 0 CA-C-N 114.267 -1.333 . . . . 1.0 109.013 -178.487 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . 0.468 ' N ' ' O ' ' A' ' 53' ' ' ILE . 13.1 tt -149.65 158.64 5.81 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.472 0 CA-C-N 115.717 -0.674 . . . . 1.0 110.547 178.164 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 107.13 -5.33 36.06 Favored Glycine 0 N--CA 1.473 1.15 0 N-CA-C 110.991 -0.844 . . . . 1.0 110.991 179.187 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . 0.41 ' HB3' ' CB ' ' A' ' 45' ' ' PHE . 3.7 p-10 -81.2 105.58 12.51 Favored 'General case' 0 C--N 1.316 -0.877 0 CA-C-N 114.912 -0.644 . . . . 1.0 110.256 179.769 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 58' ' ' TRP . . . . . . . . . . . . . 1.4 m95 -91.09 173.9 7.7 Favored 'General case' 0 CA--C 1.541 0.6 0 CA-C-O 124.289 1.995 . . . . 1.0 114.836 -177.011 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 31.2 mtm180 -78.54 -62.64 1.62 Allowed 'General case' 0 C--N 1.312 -1.053 0 CA-C-N 109.266 -3.606 . . . . 1.0 111.654 -179.096 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 60' ' ' TYR . . . . . 0.499 ' O ' ' CG ' ' A' ' 60' ' ' TYR . 47.1 t80 -91.95 -11.87 34.98 Favored 'General case' 0 C--O 1.249 1.078 0 N-CA-C 113.621 0.971 . . . . 1.0 113.621 179.612 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 6.7 tt0 -81.63 -15.78 53.55 Favored 'General case' 0 N--CA 1.443 -0.82 0 O-C-N 120.686 -1.259 . . . . 1.0 111.804 -178.689 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 62' ' ' VAL . . . . . 0.568 ' O ' ' N ' ' A' ' 66' ' ' GLY . 0.0 OUTLIER -46.57 -52.65 3.47 Favored 'Isoleucine or valine' 0 C--O 1.208 -1.095 0 C-N-CA 120.231 -0.588 . . . . 1.0 111.719 -174.524 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -69.1 -46.4 67.82 Favored 'General case' 0 C--N 1.311 -1.098 0 C-N-CA 119.376 -0.93 . . . . 1.0 109.616 -179.218 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 3.0 m-70 -50.57 -55.4 16.41 Favored 'General case' 0 N--CA 1.469 0.483 0 C-N-CA 119.08 -1.048 . . . . 1.0 108.823 179.222 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 65' ' ' ASP . . . . . 0.748 ' C ' ' H ' ' A' ' 67' ' ' ARG . 34.3 m-20 -73.58 -48.99 28.53 Favored 'General case' 0 C--O 1.244 0.765 0 CA-C-O 121.214 0.53 . . . . 1.0 109.886 178.714 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . 0.568 ' N ' ' O ' ' A' ' 62' ' ' VAL . . . -65.77 27.92 0.14 Allowed Glycine 0 N--CA 1.451 -0.351 0 N-CA-C 110.152 -1.179 . . . . 1.0 110.152 177.396 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 67' ' ' ARG . . . . . 0.748 ' H ' ' C ' ' A' ' 65' ' ' ASP . 0.0 OUTLIER -73.4 0.34 12.51 Favored 'General case' 0 N--CA 1.433 -1.321 0 N-CA-C 105.869 -1.901 . . . . 1.0 105.869 174.058 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . 0.44 ' H ' ' C ' ' A' ' 66' ' ' GLY . 1.0 OUTLIER -39.05 -39.3 0.54 Allowed 'General case' 0 C--N 1.346 0.434 0 CA-C-N 116.162 -0.472 . . . . 1.0 110.478 -177.978 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -64.5 -69.08 0.31 Allowed 'General case' 0 N--CA 1.48 1.044 0 C-N-CA 119.258 -0.977 . . . . 1.0 113.34 -175.662 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . 0.509 ' C ' ' H ' ' A' ' 72' ' ' HIS . . . -77.07 -79.07 0.11 Allowed 'General case' 0 CA--C 1.512 -0.483 0 C-N-CA 117.957 -1.497 . . . . 1.0 110.107 -176.037 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 71' ' ' ALA . . . . . 0.778 ' O ' ' N ' ' A' ' 73' ' ' MET . . . -65.24 14.95 0.03 OUTLIER 'General case' 0 C--N 1.312 -1.035 0 C-N-CA 124.784 1.234 . . . . 1.0 112.85 -178.365 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 72' ' ' HIS . . . . . 0.509 ' H ' ' C ' ' A' ' 70' ' ' ALA . 0.8 OUTLIER -18.55 -32.97 0.0 OUTLIER 'General case' 0 N--CA 1.467 0.404 0 O-C-N 124.315 1.01 . . . . 1.0 113.197 -175.036 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 73' ' ' MET . . . . . 0.778 ' N ' ' O ' ' A' ' 71' ' ' ALA . 8.6 ptp -61.15 -53.13 60.8 Favored 'General case' 0 C--N 1.319 -0.76 0 C-N-CA 118.755 -1.178 . . . . 1.0 108.465 176.49 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . 0.713 ' O ' ' N ' ' A' ' 76' ' ' GLY . 34.2 m -44.65 -51.64 1.84 Allowed 'Isoleucine or valine' 0 C--O 1.206 -1.219 0 CA-C-O 116.363 -1.78 . . . . 1.0 112.426 -175.112 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 75' ' ' ASN . . . . . 0.413 ' C ' ' O ' ' A' ' 74' ' ' VAL . 5.9 t30 -36.68 -17.21 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.49 0 CA-C-N 122.472 2.396 . . . . 1.0 111.604 -179.231 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 76' ' ' GLY . . . . . 0.713 ' N ' ' O ' ' A' ' 74' ' ' VAL . . . -54.39 -23.66 27.54 Favored Glycine 0 CA--C 1.532 1.115 0 N-CA-C 107.178 -2.369 . . . . 1.0 107.178 174.252 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 77' ' ' ILE . . . . . 0.568 ' N ' ' O ' ' A' ' 74' ' ' VAL . 18.2 pt -51.06 -48.98 29.55 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.033 0 CA-C-O 118.457 -0.782 . . . . 1.0 109.874 -179.793 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 19.3 t -55.97 -19.73 7.65 Favored 'Isoleucine or valine' 0 C--N 1.345 0.409 0 CA-C-N 120.94 1.7 . . . . 1.0 112.833 178.775 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . 0.588 ' O ' ' HB3' ' A' ' 83' ' ' ALA . 0.6 OUTLIER -90.6 -44.71 14.79 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.402 0 C-N-CA 119.683 -0.807 . . . . 1.0 109.855 179.077 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 80' ' ' ALA . . . . . 0.475 ' N ' HG13 ' A' ' 79' ' ' ILE . . . -80.04 -17.59 52.37 Favored 'General case' 0 C--N 1.323 -0.546 0 N-CA-C 113.267 0.84 . . . . 1.0 113.267 -179.587 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 81' ' ' GLU . . . . . 0.574 ' CG ' ' H ' ' A' ' 82' ' ' ASP . 10.2 pt-20 -94.18 -70.66 0.7 Allowed 'General case' 0 CA--C 1.537 0.463 0 C-N-CA 119.624 -0.83 . . . . 1.0 113.206 -177.987 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 82' ' ' ASP . . . . . 0.574 ' H ' ' CG ' ' A' ' 81' ' ' GLU . 13.4 t70 -90.62 -14.27 32.71 Favored 'General case' 0 CA--C 1.537 0.472 0 N-CA-C 114.821 1.415 . . . . 1.0 114.821 -178.49 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . 0.588 ' HB3' ' O ' ' A' ' 79' ' ' ILE . . . -52.16 -46.32 65.41 Favored 'General case' 0 C--O 1.22 -0.498 0 C-N-CA 117.644 -1.622 . . . . 1.0 111.203 -178.924 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . 0.491 ' O ' HD12 ' A' ' 84' ' ' LEU . 0.1 OUTLIER -39.34 -25.79 0.02 OUTLIER 'General case' 0 N--CA 1.469 0.499 0 O-C-N 121.427 -0.795 . . . . 1.0 111.533 -179.605 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 85' ' ' ILE . . . . . 0.499 ' N ' ' O ' ' A' ' 83' ' ' ALA . 3.2 tt -91.18 -34.41 6.34 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.327 0 C-N-CA 120.851 -0.339 . . . . 1.0 110.236 179.119 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 86' ' ' ALA . . . . . 0.551 ' HB1' HH11 ' A' ' 52' ' ' ARG . . . -95.52 -29.0 14.6 Favored 'General case' 0 C--O 1.207 -1.16 0 O-C-N 122.038 -0.414 . . . . 1.0 111.572 178.994 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 87' ' ' GLU . . . . . 0.422 ' OE1' ' N ' ' A' ' 88' ' ' ALA . 0.3 OUTLIER -61.59 -17.34 54.72 Favored 'General case' 0 C--N 1.321 -0.673 0 O-C-N 121.237 -0.914 . . . . 1.0 110.077 -179.262 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 88' ' ' ALA . . . . . 0.422 ' N ' ' OE1' ' A' ' 87' ' ' GLU . . . -73.89 -4.59 35.94 Favored 'General case' 0 N--CA 1.477 0.888 0 CA-C-O 123.549 1.643 . . . . 1.0 106.759 177.163 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 89' ' ' VAL . . . . . 0.566 ' O ' HG12 ' A' ' 89' ' ' VAL . 26.0 t -80.96 39.51 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.44 -0.964 0 CA-C-N 110.91 -2.859 . . . . 1.0 108.178 175.866 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 90' ' ' GLY . . . . . 0.844 ' O ' ' N ' ' A' ' 92' ' ' HIS . . . -56.91 -29.02 58.46 Favored Glycine 0 C--N 1.37 2.461 0 CA-C-O 117.423 -1.765 . . . . 1.0 111.844 177.337 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 91' ' ' PRO . . . . . 0.603 ' HD2' ' N ' ' A' ' 90' ' ' GLY . 52.2 Cg_exo -38.36 -2.19 0.0 OUTLIER 'Trans proline' 0 N--CA 1.498 1.75 0 CA-C-N 121.672 2.736 . . . . 1.0 111.728 173.945 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 92' ' ' HIS . . . . . 0.844 ' N ' ' O ' ' A' ' 90' ' ' GLY . 18.1 p-80 -50.19 -31.3 13.44 Favored 'General case' 0 N--CA 1.432 -1.365 0 N-CA-C 106.966 -1.494 . . . . 1.0 106.966 179.243 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 93' ' ' LEU . . . . . 0.432 ' O ' ' HB3' ' A' ' 96' ' ' ALA . 1.5 tt -61.02 -50.13 74.6 Favored 'General case' 0 C--O 1.222 -0.36 0 N-CA-C 106.995 -1.483 . . . . 1.0 106.995 176.367 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 94' ' ' ALA . . . . . 0.479 ' N ' ' O ' ' A' ' 91' ' ' PRO . . . -52.04 -54.91 24.41 Favored 'General case' 0 C--N 1.322 -0.628 0 N-CA-C 107.586 -1.264 . . . . 1.0 107.586 179.644 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -63.63 -29.72 70.93 Favored 'General case' 0 CA--C 1.543 0.685 0 CA-C-O 121.537 0.684 . . . . 1.0 109.574 178.405 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 96' ' ' ALA . . . . . 0.783 ' O ' ' N ' ' A' ' 100' ' ' ILE . . . -50.9 -42.94 59.65 Favored 'General case' 0 C--O 1.197 -1.691 0 N-CA-C 106.799 -1.556 . . . . 1.0 106.799 -177.754 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 97' ' ' LEU . . . . . 0.517 ' O ' ' CG2' ' A' ' 100' ' ' ILE . 0.3 OUTLIER -35.61 -23.05 0.01 OUTLIER 'General case' 0 CA--C 1.594 2.641 0 CA-C-N 114.18 -1.373 . . . . 1.0 108.005 -177.156 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 98' ' ' GLY . . . . . 0.674 ' N ' ' O ' ' A' ' 96' ' ' ALA . . . -86.06 -50.23 3.97 Favored Glycine 0 CA--C 1.562 3.011 0 CA-C-O 123.057 1.365 . . . . 1.0 111.286 169.713 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 99' ' ' GLN . . . . . 0.692 ' N ' ' O ' ' A' ' 96' ' ' ALA . 0.0 OUTLIER -76.59 7.16 4.82 Favored 'General case' 0 N--CA 1.441 -0.878 0 N-CA-C 106.391 -1.707 . . . . 1.0 106.391 177.142 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 100' ' ' ILE . . . . . 0.783 ' N ' ' O ' ' A' ' 96' ' ' ALA . 17.7 tt -58.12 -55.4 22.31 Favored 'Isoleucine or valine' 0 CA--C 1.481 -1.69 0 N-CA-C 106.232 -1.766 . . . . 1.0 106.232 177.438 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 101' ' ' VAL . . . . . 0.684 ' O ' ' N ' ' A' ' 105' ' ' GLY . 7.0 p -57.49 -60.04 2.58 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.579 0 C-N-CA 118.368 -1.333 . . . . 1.0 107.871 178.668 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 102' ' ' CYS . . . . . 0.885 ' O ' ' HB2' ' A' ' 106' ' ' ALA . 18.2 t -52.48 -26.26 12.45 Favored 'General case' 0 C--N 1.32 -0.707 0 N-CA-C 112.712 0.634 . . . . 1.0 112.712 -177.324 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 103' ' ' ARG . . . . . 0.536 ' N ' ' O ' ' A' ' 99' ' ' GLN . 45.6 ttt180 -86.23 -49.31 7.8 Favored 'General case' 0 N--CA 1.49 1.568 0 CA-C-O 122.763 1.268 . . . . 1.0 112.686 179.019 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 104' ' ' TYR . . . . . 0.686 ' O ' ' CG ' ' A' ' 104' ' ' TYR . 0.0 OUTLIER -97.04 24.13 6.59 Favored 'General case' 0 C--N 1.295 -1.8 0 CA-C-N 112.258 -2.246 . . . . 1.0 107.571 178.618 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 105' ' ' GLY . . . . . 0.684 ' N ' ' O ' ' A' ' 101' ' ' VAL . . . -164.92 -96.84 0.11 Allowed Glycine 0 CA--C 1.533 1.206 0 N-CA-C 108.166 -1.974 . . . . 1.0 108.166 179.081 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 106' ' ' ALA . . . . . 0.885 ' HB2' ' O ' ' A' ' 102' ' ' CYS . . . 68.4 55.68 0.5 Allowed 'General case' 0 CA--C 1.534 0.351 0 C-N-CA 122.989 0.515 . . . . 1.0 111.747 -178.886 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 107' ' ' THR . . . . . 0.548 HG22 ' O ' ' A' ' 107' ' ' THR . 91.8 m -80.32 6.1 12.96 Favored 'General case' 0 CA--C 1.514 -0.407 0 N-CA-C 107.222 -1.399 . . . . 1.0 107.222 177.033 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 108' ' ' VAL . . . . . 0.455 HG23 ' N ' ' A' ' 109' ' ' ILE . 18.0 m -84.4 -54.03 9.68 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.242 0 CA-C-N 115.575 -0.739 . . . . 1.0 110.472 178.721 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 109' ' ' ILE . . . . . 0.468 ' N ' ' HD2' ' A' ' 110' ' ' PRO . 85.4 mt -41.99 -51.89 9.69 Favored Pre-proline 0 C--N 1.347 0.46 0 N-CA-C 114.805 1.409 . . . . 1.0 114.805 -179.446 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 110' ' ' PRO . . . . . 0.468 ' HD2' ' N ' ' A' ' 109' ' ' ILE . 2.3 Cg_endo -40.68 -52.02 3.34 Favored 'Trans proline' 0 C--N 1.314 -1.286 0 CA-C-N 120.618 1.257 . . . . 1.0 113.293 -176.407 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 111' ' ' ASN . . . . . 0.434 ' ND2' ' H ' ' A' ' 112' ' ' ILE . 0.8 OUTLIER -69.51 -69.12 0.36 Allowed 'General case' 0 C--O 1.233 0.222 0 C-N-CA 118.229 -1.389 . . . . 1.0 110.444 -178.403 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 112' ' ' ILE . . . . . 0.625 HD13 ' N ' ' A' ' 113' ' ' ASN . 0.0 OUTLIER -46.97 -27.62 0.91 Allowed 'Isoleucine or valine' 0 C--O 1.216 -0.672 0 N-CA-C 109.174 -0.676 . . . . 1.0 109.174 -179.947 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 113' ' ' ASN . . . . . 0.625 ' N ' HD13 ' A' ' 112' ' ' ILE . 16.4 t-20 -58.19 -54.55 45.76 Favored 'General case' 0 C--N 1.308 -1.198 0 C-N-CA 118.131 -1.428 . . . . 1.0 108.096 -177.928 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 114' ' ' ALA . . . . . 0.477 ' O ' ' HG2' ' A' ' 117' ' ' GLU . . . -58.69 -33.9 70.67 Favored 'General case' 0 N--CA 1.447 -0.611 0 N-CA-C 113.116 0.784 . . . . 1.0 113.116 -178.633 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -82.99 -49.44 9.58 Favored 'General case' 0 C--O 1.215 -0.761 0 O-C-N 120.426 -1.421 . . . . 1.0 110.8 179.173 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 116' ' ' ILE . . . . . 0.53 HD12 HD11 ' A' ' 112' ' ' ILE . 0.6 OUTLIER -50.91 -54.92 8.51 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.184 0 N-CA-C 107.345 -1.354 . . . . 1.0 107.345 -179.415 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 117' ' ' GLU . . . . . 0.504 ' O ' ' HA ' ' A' ' 121' ' ' THR . 17.5 pt-20 -45.96 -58.11 3.83 Favored 'General case' 0 C--O 1.212 -0.898 0 CA-C-N 113.175 -1.83 . . . . 1.0 106.136 -179.052 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 118' ' ' VAL . . . . . 0.466 ' N ' ' CG ' ' A' ' 117' ' ' GLU . 57.7 t -58.36 -53.35 47.51 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.133 0 C-N-CA 119.89 -0.724 . . . . 1.0 110.207 179.068 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 13.2 tp -53.76 -73.04 0.05 OUTLIER 'General case' 0 CA--C 1.54 0.581 0 N-CA-C 108.129 -1.063 . . . . 1.0 108.129 -178.66 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 120' ' ' GLY . . . . . 0.512 ' O ' ' CB ' ' A' ' 121' ' ' THR . . . -67.82 -76.11 0.43 Allowed Glycine 0 CA--C 1.54 1.603 0 C-N-CA 118.948 -1.596 . . . . 1.0 111.026 179.165 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 121' ' ' THR . . . . . 0.512 ' CB ' ' O ' ' A' ' 120' ' ' GLY . 2.3 m 144.92 -27.4 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.434 0 CA-C-N 112.536 -1.832 . . . . 1.0 111.026 -178.381 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 122' ' ' GLY . . . . . 0.659 ' O ' ' N ' ' A' ' 124' ' ' ASP . . . 104.72 -17.94 44.87 Favored Glycine 0 C--O 1.223 -0.577 0 N-CA-C 107.944 -2.062 . . . . 1.0 107.944 -177.0 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 123' ' ' THR . . . . . 0.683 HG23 ' O ' ' A' ' 123' ' ' THR . 11.0 t -54.41 83.52 0.0 OUTLIER 'General case' 0 CA--C 1.532 0.275 0 N-CA-C 106.351 -1.722 . . . . 1.0 106.351 178.617 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 124' ' ' ASP . . . . . 0.659 ' N ' ' O ' ' A' ' 122' ' ' GLY . 48.5 p-10 -166.93 176.77 6.77 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 113.539 -1.664 . . . . 1.0 111.375 179.285 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 125' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -146.76 144.63 29.53 Favored 'General case' 0 CA--C 1.541 0.605 0 N-CA-C 108.364 -0.976 . . . . 1.0 108.364 176.904 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 38.0 ttm180 -149.84 151.74 34.0 Favored 'General case' 0 N--CA 1.471 0.588 0 CA-C-O 120.534 0.207 . . . . 1.0 110.935 178.844 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 127' ' ' PHE . . . . . . . . . . . . . 13.9 p90 . . . . . 0 C--O 1.219 -0.506 0 CA-C-O 117.958 -1.02 . . . . 1.0 110.646 -179.985 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . 0.513 ' SD ' ' N ' ' A' ' 1' ' ' MET . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.558 0 N-CA-C 108.862 -0.792 . . . . 1.0 108.862 . . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 2' ' ' SER . . . . . 0.508 ' O ' ' CG ' ' A' ' 3' ' ' ASP . 70.8 m -72.4 7.71 1.68 Allowed 'General case' 0 C--O 1.223 -0.31 0 CA-C-O 119.43 -0.319 . . . . 1.0 110.844 179.474 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 3' ' ' ASP . . . . . 0.508 ' CG ' ' O ' ' A' ' 2' ' ' SER . 62.1 m-20 144.16 137.39 0.0 OUTLIER 'General case' 0 N--CA 1.482 1.141 0 O-C-N 124.189 0.93 . . . . 1.0 110.097 179.239 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 91.4 t80 -154.92 150.46 27.44 Favored 'General case' 0 N--CA 1.465 0.296 0 CA-C-N 116.073 -0.512 . . . . 1.0 110.88 179.214 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -150.13 145.23 26.19 Favored 'General case' 0 CA--C 1.543 0.686 0 N-CA-C 109.553 -0.536 . . . . 1.0 109.553 179.465 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 6' ' ' THR . . . . . 0.843 ' O ' ' N ' ' A' ' 10' ' ' SER . 0.2 OUTLIER -87.14 176.71 7.46 Favored 'General case' 0 C--O 1.179 -2.627 0 CA-C-O 120.43 0.157 . . . . 1.0 111.236 -179.27 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . 0.588 ' O ' ' N ' ' A' ' 11' ' ' ARG . 10.9 mt-10 -60.65 -50.68 72.53 Favored 'General case' 0 C--N 1.312 -1.056 0 CA-C-O 121.194 0.521 . . . . 1.0 109.713 -179.405 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 8' ' ' ARG . . . . . 0.671 ' O ' ' HB3' ' A' ' 12' ' ' ALA . 18.6 mtp-105 -57.95 -58.93 6.23 Favored 'General case' 0 C--N 1.315 -0.916 0 C-N-CA 118.416 -1.313 . . . . 1.0 107.536 -179.011 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . 0.693 ' O ' ' HB ' ' A' ' 13' ' ' VAL . 0.0 OUTLIER -66.82 -50.83 61.82 Favored 'Isoleucine or valine' 0 C--O 1.183 -2.418 0 CA-C-N 114.267 -1.333 . . . . 1.0 109.287 179.686 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 10' ' ' SER . . . . . 0.843 ' N ' ' O ' ' A' ' 6' ' ' THR . 19.3 t -63.84 -61.16 2.47 Favored 'General case' 0 N--CA 1.492 1.669 0 C-N-CA 119.437 -0.905 . . . . 1.0 110.268 179.171 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 11' ' ' ARG . . . . . 0.588 ' N ' ' O ' ' A' ' 7' ' ' GLU . 5.3 tpt180 -67.39 -54.32 21.5 Favored 'General case' 0 C--O 1.214 -0.797 0 N-CA-C 112.546 0.573 . . . . 1.0 112.546 -176.674 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . 0.671 ' HB3' ' O ' ' A' ' 8' ' ' ARG . . . -56.06 -50.7 70.22 Favored 'General case' 0 N--CA 1.476 0.862 0 C-N-CA 117.023 -1.871 . . . . 1.0 106.565 -178.09 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . 0.693 ' HB ' ' O ' ' A' ' 9' ' ' VAL . 65.7 t -61.25 -48.49 88.7 Favored 'Isoleucine or valine' 0 C--O 1.18 -2.593 0 N-CA-C 107.033 -1.469 . . . . 1.0 107.033 178.659 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . 0.746 ' O ' HG13 ' A' ' 18' ' ' VAL . . . -59.32 -61.56 2.53 Favored 'General case' 0 C--O 1.201 -1.467 0 C-N-CA 118.132 -1.427 . . . . 1.0 109.696 179.253 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . 0.572 ' O ' ' N ' ' A' ' 19' ' ' GLY . . . -52.57 -53.38 47.29 Favored 'General case' 0 C--O 1.216 -0.685 0 N-CA-C 108.576 -0.898 . . . . 1.0 108.576 -178.456 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . 0.662 ' CA ' ' H ' ' A' ' 22' ' ' GLY . . . -65.42 -57.15 9.02 Favored 'General case' 0 CA--C 1.546 0.792 0 CA-C-O 121.663 0.744 . . . . 1.0 109.951 -179.747 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . 0.676 ' N ' ' O ' ' A' ' 13' ' ' VAL . 18.7 tp -55.74 -55.98 25.93 Favored 'General case' 0 N--CA 1.491 1.582 0 N-CA-C 107.953 -1.128 . . . . 1.0 107.953 -178.929 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . 0.746 HG13 ' O ' ' A' ' 14' ' ' ALA . 1.2 m -70.89 -59.02 3.87 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.397 0 C-N-CA 119.854 -0.738 . . . . 1.0 110.136 -179.896 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . 0.572 ' N ' ' O ' ' A' ' 15' ' ' ALA . . . -60.75 -161.93 0.13 Allowed Glycine 0 C--N 1.338 0.651 0 N-CA-C 111.819 -0.512 . . . . 1.0 111.819 -178.399 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 20' ' ' PRO . . . . . 0.654 ' O ' ' HB2' ' A' ' 24' ' ' ALA . 86.3 Cg_endo -81.23 -23.1 5.43 Favored 'Trans proline' 0 C--N 1.318 -1.04 0 C-N-CA 123.165 2.577 . . . . 1.0 113.682 -177.979 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -63.35 -62.29 5.52 Favored Glycine 0 N--CA 1.484 1.847 0 C-N-CA 120.178 -1.01 . . . . 1.0 112.996 -176.406 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . 0.662 ' H ' ' CA ' ' A' ' 16' ' ' ALA . . . -57.61 -57.61 18.87 Favored Glycine 0 C--N 1.312 -0.784 0 N-CA-C 107.349 -2.301 . . . . 1.0 107.349 -177.845 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . 0.488 HG22 ' O ' ' A' ' 19' ' ' GLY . 34.3 m -56.63 -32.28 36.94 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.744 0 C-N-CA 118.773 -1.171 . . . . 1.0 109.294 -179.977 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . 0.654 ' HB2' ' O ' ' A' ' 20' ' ' PRO . . . -60.5 -62.13 2.09 Favored 'General case' 0 N--CA 1.471 0.6 0 C-N-CA 118.142 -1.423 . . . . 1.0 110.117 179.745 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 18.4 mt -61.38 -47.8 84.17 Favored 'General case' 0 CA--C 1.514 -0.43 0 CA-C-N 118.616 0.644 . . . . 1.0 112.137 -177.28 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 90.5 t -58.55 -59.14 4.04 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.535 0 C-N-CA 119.29 -0.964 . . . . 1.0 109.61 -177.846 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . 0.725 ' O ' ' HB3' ' A' ' 31' ' ' ALA . 84.8 t -57.28 -38.65 63.12 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.462 0 CA-C-O 120.866 0.365 . . . . 1.0 110.482 -178.236 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 9.2 ttmt -66.37 -55.33 16.38 Favored 'General case' 0 C--N 1.316 -0.876 0 C-N-CA 119.686 -0.806 . . . . 1.0 109.956 -178.873 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 92.3 t -63.73 -51.39 70.53 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.777 0 CA-C-N 114.903 -1.044 . . . . 1.0 110.917 -176.541 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 30' ' ' CYS . . . . . . . . . . . . . 50.1 t -64.54 -61.55 2.14 Favored 'General case' 0 N--CA 1.443 -0.779 0 C-N-CA 119.407 -0.917 . . . . 1.0 109.889 -179.084 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . 0.725 ' HB3' ' O ' ' A' ' 27' ' ' VAL . . . -59.3 -53.54 57.12 Favored 'General case' 0 C--N 1.318 -0.773 0 CA-C-O 120.874 0.369 . . . . 1.0 111.354 -177.295 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . 0.519 ' O ' ' CB ' ' A' ' 33' ' ' LEU . . . 80.29 69.68 1.38 Allowed Glycine 0 CA--C 1.521 0.418 0 N-CA-C 109.898 -1.281 . . . . 1.0 109.898 -179.77 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . 0.659 ' CD2' ' H ' ' A' ' 35' ' ' GLY . 2.0 tt 88.96 101.6 0.03 OUTLIER Pre-proline 0 CA--C 1.545 0.781 0 CA-C-N 115.442 -0.379 . . . . 1.0 110.553 -179.821 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 51.7 Cg_exo -51.86 -21.97 12.94 Favored 'Trans proline' 0 N--CA 1.503 2.05 0 C-N-CA 122.328 2.018 . . . . 1.0 113.939 179.745 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . 0.659 ' H ' ' CD2' ' A' ' 33' ' ' LEU . . . -62.12 -62.3 5.8 Favored Glycine 0 C--N 1.34 0.796 0 C-N-CA 119.263 -1.446 . . . . 1.0 109.952 -178.389 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . 0.919 HG22 ' H ' ' A' ' 37' ' ' ILE . 8.4 p -73.37 -152.88 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.325 -0.488 0 N-CA-C 107.96 -1.126 . . . . 1.0 107.96 178.333 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . 0.919 ' H ' HG22 ' A' ' 36' ' ' VAL . 2.1 mm 70.96 79.33 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.475 0.804 0 CA-C-O 122.069 0.938 . . . . 1.0 112.79 179.598 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 88.0 m-70 -135.32 129.56 33.68 Favored 'General case' 0 C--N 1.318 -0.763 0 N-CA-C 106.826 -1.546 . . . . 1.0 106.826 176.971 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 25.1 m -120.44 132.2 24.21 Favored Pre-proline 0 N--CA 1.465 0.297 0 N-CA-C 110.073 -0.343 . . . . 1.0 110.073 -178.883 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 27.7 Cg_endo -62.98 -78.17 0.01 OUTLIER 'Trans proline' 0 N--CA 1.49 1.311 0 CA-C-N 119.654 0.912 . . . . 1.0 111.898 -179.457 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -67.72 125.65 26.9 Favored 'General case' 0 C--N 1.317 -0.844 0 CA-C-N 114.859 -1.064 . . . . 1.0 110.613 -178.805 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . 0.531 ' HG2' ' H ' ' A' ' 43' ' ' ARG . 31.0 ttp180 -173.28 174.52 3.33 Favored 'General case' 0 C--N 1.32 -0.674 0 CA-C-N 115.832 -0.622 . . . . 1.0 109.982 179.516 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 43' ' ' ARG . . . . . 0.56 ' NH1' ' OD2' ' A' ' 57' ' ' ASP . 1.1 tmt_? -58.08 -45.19 87.55 Favored 'General case' 0 CA--C 1.541 0.598 0 N-CA-C 107.1 -1.444 . . . . 1.0 107.1 179.528 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . 0.476 ' O ' ' CD1' ' A' ' 45' ' ' PHE . . . 123.58 -25.12 6.31 Favored Glycine 0 CA--C 1.533 1.173 0 CA-C-O 119.852 -0.416 . . . . 1.0 112.147 179.138 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . 0.64 ' O ' ' HB2' ' A' ' 46' ' ' PHE . 7.5 m-85 -156.52 162.92 39.91 Favored 'General case' 0 N--CA 1.474 0.749 0 N-CA-C 109.111 -0.7 . . . . 1.0 109.111 177.726 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 46' ' ' PHE . . . . . 0.65 ' O ' ' CG ' ' A' ' 47' ' ' ARG . 6.9 m-85 118.41 104.08 0.0 OUTLIER 'General case' 0 N--CA 1.499 2.001 0 O-C-N 125.375 1.672 . . . . 1.0 110.592 -179.743 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 47' ' ' ARG . . . . . 0.756 ' O ' ' SG ' ' A' ' 48' ' ' CYS . 0.0 OUTLIER 98.42 162.78 0.01 OUTLIER 'General case' 0 N--CA 1.472 0.64 0 O-C-N 125.08 1.488 . . . . 1.0 111.434 178.232 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 48' ' ' CYS . . . . . 0.756 ' SG ' ' O ' ' A' ' 47' ' ' ARG . 7.0 p 56.66 72.08 0.53 Allowed 'General case' 0 C--O 1.202 -1.416 0 O-C-N 125.081 1.488 . . . . 1.0 110.567 -177.591 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 49' ' ' ASN . . . . . 0.697 ' O ' ' N ' ' A' ' 51' ' ' GLU . 0.5 OUTLIER -144.66 155.45 56.53 Favored Pre-proline 0 N--CA 1.474 0.728 0 CA-C-O 118.753 -0.642 . . . . 1.0 110.438 179.752 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 50' ' ' PRO . . . . . 0.475 ' C ' ' H ' ' A' ' 52' ' ' ARG . 53.9 Cg_exo -51.8 57.75 0.02 OUTLIER 'Trans proline' 0 N--CA 1.509 2.419 0 C-N-CA 122.688 2.259 . . . . 1.0 112.138 177.775 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . 0.697 ' N ' ' O ' ' A' ' 49' ' ' ASN . 59.2 mm-40 47.93 13.56 0.04 OUTLIER 'General case' 0 C--N 1.321 -0.658 0 N-CA-C 110.029 -0.36 . . . . 1.0 110.029 -179.129 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . 0.639 HH11 ' CE1' ' A' ' 92' ' ' HIS . 23.5 mtm-85 -100.08 142.86 30.99 Favored 'General case' 0 N--CA 1.475 0.806 0 CA-C-O 121.204 0.526 . . . . 1.0 112.052 -179.857 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 9.6 tp -53.29 135.89 14.92 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.648 0 CA-C-O 124.426 2.06 . . . . 1.0 114.579 -178.661 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -88.62 88.02 7.47 Favored 'General case' 0 C--N 1.312 -1.022 0 CA-C-N 110.063 -3.244 . . . . 1.0 113.643 179.567 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 18.6 tt -144.47 153.34 15.06 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.67 0 CA-C-N 115.478 -0.783 . . . . 1.0 109.678 177.273 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 107.76 3.1 34.61 Favored Glycine 0 C--N 1.348 1.226 0 N-CA-C 110.878 -0.889 . . . . 1.0 110.878 -179.891 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . 0.56 ' OD2' ' NH1' ' A' ' 43' ' ' ARG . 5.6 p-10 -86.88 103.38 15.22 Favored 'General case' 0 CA--C 1.533 0.292 0 CA-C-O 122.185 0.993 . . . . 1.0 112.651 -178.834 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 58' ' ' TRP . . . . . . . . . . . . . 38.4 m0 -81.39 -177.97 6.73 Favored 'General case' 0 N--CA 1.47 0.563 0 CA-C-N 114.023 -1.444 . . . . 1.0 108.154 178.205 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 59' ' ' ARG . . . . . 0.659 ' HD2' ' H ' ' A' ' 59' ' ' ARG . 0.0 OUTLIER -101.85 -54.86 2.63 Favored 'General case' 0 CA--C 1.56 1.359 0 CA-C-N 121.91 2.141 . . . . 1.0 110.74 179.676 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 60' ' ' TYR . . . . . 0.517 ' H ' ' HD2' ' A' ' 59' ' ' ARG . 93.2 t80 -79.45 -14.34 58.98 Favored 'General case' 0 N--CA 1.485 1.305 0 C-N-CA 125.723 1.609 . . . . 1.0 112.225 -178.283 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 31.9 tt0 -70.77 -14.11 62.31 Favored 'General case' 0 C--N 1.304 -1.387 0 N-CA-C 108.635 -0.876 . . . . 1.0 108.635 -179.874 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 62' ' ' VAL . . . . . 0.518 HG13 ' O ' ' A' ' 59' ' ' ARG . 13.4 m -45.7 -53.07 2.29 Favored 'Isoleucine or valine' 0 CA--C 1.493 -1.244 0 CA-C-N 115.811 -0.632 . . . . 1.0 109.972 -174.495 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 63' ' ' ALA . . . . . 0.85 ' O ' ' HD2' ' A' ' 67' ' ' ARG . . . -65.2 -50.39 66.06 Favored 'General case' 0 N--CA 1.415 -2.189 0 N-CA-C 108.943 -0.762 . . . . 1.0 108.943 179.364 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -51.03 -59.39 4.21 Favored 'General case' 0 CA--C 1.548 0.904 0 C-N-CA 119.795 -0.762 . . . . 1.0 110.715 -179.996 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 65' ' ' ASP . . . . . 0.6 ' C ' ' H ' ' A' ' 67' ' ' ARG . 28.9 t70 -64.79 -50.34 67.16 Favored 'General case' 0 C--O 1.241 0.632 0 CA-C-O 121.694 0.759 . . . . 1.0 109.704 178.371 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . 0.416 ' N ' ' O ' ' A' ' 62' ' ' VAL . . . -61.34 29.53 0.05 OUTLIER Glycine 0 CA--C 1.535 1.325 0 O-C-N 121.801 -0.562 . . . . 1.0 112.016 178.106 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 67' ' ' ARG . . . . . 0.85 ' HD2' ' O ' ' A' ' 63' ' ' ALA . 0.0 OUTLIER -79.58 -2.84 44.29 Favored 'General case' 0 CA--C 1.5 -0.946 0 CA-C-O 118.632 -0.699 . . . . 1.0 109.371 175.206 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . 0.555 ' O ' ' CG ' ' A' ' 72' ' ' HIS . 11.1 mp -33.94 -28.06 0.01 OUTLIER 'General case' 0 N--CA 1.486 1.327 0 N-CA-C 107.023 -1.473 . . . . 1.0 107.023 -179.012 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . 0.674 ' N ' ' O ' ' A' ' 67' ' ' ARG . 3.4 tt -64.83 -64.23 0.92 Allowed 'General case' 0 CA--C 1.548 0.898 0 N-CA-C 106.572 -1.64 . . . . 1.0 106.572 175.573 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . 0.68 ' C ' ' H ' ' A' ' 72' ' ' HIS . . . -78.76 -73.53 0.32 Allowed 'General case' 0 N--CA 1.478 0.948 0 N-CA-C 107.828 -1.175 . . . . 1.0 107.828 177.865 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 71' ' ' ALA . . . . . 0.735 ' H ' ' HB3' ' A' ' 67' ' ' ARG . . . -46.23 2.34 0.0 OUTLIER 'General case' 0 N--CA 1.469 0.499 0 C-N-CA 124.435 1.094 . . . . 1.0 112.747 178.402 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 72' ' ' HIS . . . . . 0.68 ' H ' ' C ' ' A' ' 70' ' ' ALA . 0.2 OUTLIER -20.02 -70.53 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.227 0 C-N-CA 123.179 0.592 . . . . 1.0 111.139 -177.993 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 73' ' ' MET . . . . . . . . . . . . . 16.4 mtm -73.9 -47.63 36.55 Favored 'General case' 0 C--N 1.31 -1.131 0 C-N-CA 118.967 -1.093 . . . . 1.0 109.611 177.149 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . 0.577 ' O ' ' N ' ' A' ' 76' ' ' GLY . 24.4 t -46.68 -48.98 6.94 Favored 'Isoleucine or valine' 0 C--N 1.344 0.354 0 CA-C-O 118.456 -0.783 . . . . 1.0 110.958 -176.599 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 75' ' ' ASN . . . . . 0.888 ' O ' HG22 ' A' ' 78' ' ' VAL . 26.9 t-20 -39.18 -21.56 0.01 OUTLIER 'General case' 0 C--N 1.352 0.705 0 CA-C-O 122.895 1.331 . . . . 1.0 110.435 177.401 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 76' ' ' GLY . . . . . 0.577 ' N ' ' O ' ' A' ' 74' ' ' VAL . . . -42.31 -19.89 0.06 OUTLIER Glycine 0 CA--C 1.539 1.533 0 CA-C-N 113.55 -1.659 . . . . 1.0 109.248 178.864 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 77' ' ' ILE . . . . . 0.689 ' O ' ' N ' ' A' ' 80' ' ' ALA . 7.7 pt -71.24 -45.41 70.71 Favored 'Isoleucine or valine' 0 C--O 1.207 -1.174 0 CA-C-O 122.01 0.91 . . . . 1.0 109.458 -179.341 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . 0.888 HG22 ' O ' ' A' ' 75' ' ' ASN . 26.8 m -35.21 -32.43 0.04 OUTLIER 'Isoleucine or valine' 0 CA--C 1.556 1.178 0 CA-C-N 113.058 -1.883 . . . . 1.0 107.359 -176.483 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . 0.529 ' N ' ' O ' ' A' ' 77' ' ' ILE . 1.1 pp -92.94 -26.97 4.66 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 CA-C-O 121.511 0.672 . . . . 1.0 111.571 177.525 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 80' ' ' ALA . . . . . 0.689 ' N ' ' O ' ' A' ' 77' ' ' ILE . . . -87.24 -18.78 29.46 Favored 'General case' 0 CA--C 1.55 0.949 0 N-CA-C 113.35 0.87 . . . . 1.0 113.35 178.976 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 81' ' ' GLU . . . . . 0.424 ' N ' ' O ' ' A' ' 77' ' ' ILE . 9.3 mm-40 -82.46 -71.87 0.47 Allowed 'General case' 0 N--CA 1.45 -0.426 0 C-N-CA 122.667 0.387 . . . . 1.0 110.169 -179.908 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 82' ' ' ASP . . . . . 0.549 ' O ' ' N ' ' A' ' 84' ' ' LEU . 92.9 m-20 -66.42 -16.81 64.39 Favored 'General case' 0 N--CA 1.444 -0.761 0 CA-C-O 119.09 -0.481 . . . . 1.0 110.261 -179.382 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . 0.501 ' O ' ' N ' ' A' ' 86' ' ' ALA . . . -15.19 -50.09 0.0 OUTLIER 'General case' 0 C--N 1.355 0.811 0 N-CA-C 113.04 0.755 . . . . 1.0 113.04 178.05 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . 0.549 ' N ' ' O ' ' A' ' 82' ' ' ASP . 0.2 OUTLIER -27.58 -50.78 0.06 Allowed 'General case' 0 C--N 1.355 0.827 0 N-CA-C 113.046 0.758 . . . . 1.0 113.046 -177.057 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 19.9 pt -85.57 -37.78 12.32 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.664 0 N-CA-C 109.584 -0.524 . . . . 1.0 109.584 179.235 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 86' ' ' ALA . . . . . 0.682 ' O ' ' N ' ' A' ' 88' ' ' ALA . . . -47.46 -54.86 10.31 Favored 'General case' 0 CA--C 1.518 -0.287 0 C-N-CA 120.329 -0.548 . . . . 1.0 110.333 -179.341 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 87' ' ' GLU . . . . . 0.573 ' C ' ' H ' ' A' ' 89' ' ' VAL . 0.5 OUTLIER -38.21 -14.81 0.01 OUTLIER 'General case' 0 CA--C 1.539 0.525 0 CA-C-N 117.768 0.258 . . . . 1.0 111.214 -179.686 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 88' ' ' ALA . . . . . 0.682 ' N ' ' O ' ' A' ' 86' ' ' ALA . . . -54.8 -5.26 0.08 Allowed 'General case' 0 C--O 1.218 -0.577 0 N-CA-C 108.811 -0.811 . . . . 1.0 108.811 177.213 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 89' ' ' VAL . . . . . 0.573 ' H ' ' C ' ' A' ' 87' ' ' GLU . 4.4 m -33.13 -31.53 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.551 0.991 0 CA-C-O 121.099 0.476 . . . . 1.0 110.787 -177.591 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 90' ' ' GLY . . . . . 0.523 ' N ' ' O ' ' A' ' 88' ' ' ALA . . . -49.33 -75.2 0.21 Allowed Glycine 0 CA--C 1.549 2.2 0 C-N-CA 119.889 -1.148 . . . . 1.0 111.21 -178.734 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 91' ' ' PRO . . . . . 0.473 ' HD2' ' O ' ' A' ' 88' ' ' ALA . 9.9 Cg_endo -52.05 -28.88 34.14 Favored 'Trans proline' 0 N--CA 1.504 2.114 0 C-N-CA 122.955 2.437 . . . . 1.0 111.229 176.663 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 92' ' ' HIS . . . . . 0.639 ' CE1' HH11 ' A' ' 52' ' ' ARG . 26.9 m80 -54.14 -19.37 4.91 Favored 'General case' 0 CA--C 1.514 -0.424 0 N-CA-C 107.4 -1.333 . . . . 1.0 107.4 -176.473 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 93' ' ' LEU . . . . . 0.549 ' O ' ' N ' ' A' ' 96' ' ' ALA . 20.7 tp -57.03 -49.98 74.13 Favored 'General case' 0 N--CA 1.45 -0.425 0 N-CA-C 106.59 -1.633 . . . . 1.0 106.59 176.797 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -49.13 -51.9 29.36 Favored 'General case' 0 CA--C 1.517 -0.301 0 N-CA-C 106.662 -1.607 . . . . 1.0 106.662 -179.352 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 3.0 mmt180 -61.03 -32.13 71.75 Favored 'General case' 0 C--N 1.316 -0.849 0 N-CA-C 108.622 -0.881 . . . . 1.0 108.622 177.191 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 96' ' ' ALA . . . . . 0.777 ' O ' ' N ' ' A' ' 100' ' ' ILE . . . -55.82 -51.44 67.47 Favored 'General case' 0 C--O 1.199 -1.556 0 C-N-CA 118.817 -1.153 . . . . 1.0 107.918 -178.947 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 97' ' ' LEU . . . . . 0.466 ' C ' ' O ' ' A' ' 96' ' ' ALA . 0.2 OUTLIER -34.15 -26.15 0.01 OUTLIER 'General case' 0 CA--C 1.587 2.399 0 N-CA-C 107.58 -1.267 . . . . 1.0 107.58 -178.325 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 98' ' ' GLY . . . . . 0.659 ' N ' ' O ' ' A' ' 96' ' ' ALA . . . -86.48 -52.77 3.1 Favored Glycine 0 CA--C 1.546 1.981 0 CA-C-O 123.967 1.871 . . . . 1.0 110.617 173.963 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 99' ' ' GLN . . . . . 0.612 ' N ' ' O ' ' A' ' 96' ' ' ALA . 24.6 tt0 -76.97 7.56 4.74 Favored 'General case' 0 N--CA 1.418 -2.047 0 N-CA-C 107.837 -1.171 . . . . 1.0 107.837 177.177 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 100' ' ' ILE . . . . . 0.777 ' N ' ' O ' ' A' ' 96' ' ' ALA . 6.8 tp -62.48 -47.91 90.77 Favored 'Isoleucine or valine' 0 CA--C 1.481 -1.678 0 N-CA-C 108.66 -0.867 . . . . 1.0 108.66 179.82 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 101' ' ' VAL . . . . . 0.57 ' N ' ' CG2' ' A' ' 100' ' ' ILE . 46.3 t -53.57 -59.92 1.61 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.622 0 C-N-CA 117.352 -1.739 . . . . 1.0 108.341 179.095 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 102' ' ' CYS . . . . . 0.687 ' O ' ' HB2' ' A' ' 106' ' ' ALA . 0.0 OUTLIER -52.41 -31.7 35.52 Favored 'General case' 0 CA--C 1.545 0.767 0 C-N-CA 119.831 -0.748 . . . . 1.0 111.215 -176.743 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 103' ' ' ARG . . . . . 0.431 ' NH2' ' CB ' ' A' ' 96' ' ' ALA . 11.8 ttp180 -82.15 -47.89 11.98 Favored 'General case' 0 N--CA 1.494 1.759 0 CA-C-O 122.287 1.041 . . . . 1.0 113.014 178.666 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 104' ' ' TYR . . . . . 0.439 ' CD2' ' O ' ' A' ' 104' ' ' TYR . 50.6 t80 -92.08 22.73 4.17 Favored 'General case' 0 C--N 1.29 -1.98 0 CA-C-N 113.653 -1.612 . . . . 1.0 108.502 178.802 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 105' ' ' GLY . . . . . 0.527 ' N ' ' O ' ' A' ' 101' ' ' VAL . . . -159.81 -86.98 0.06 OUTLIER Glycine 0 CA--C 1.526 0.779 0 N-CA-C 110.337 -1.105 . . . . 1.0 110.337 178.618 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 106' ' ' ALA . . . . . 0.687 ' HB2' ' O ' ' A' ' 102' ' ' CYS . . . 57.13 106.65 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.17 0 N-CA-C 109.22 -0.659 . . . . 1.0 109.22 -177.117 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 107' ' ' THR . . . . . 0.633 ' O ' ' CD ' ' A' ' 110' ' ' PRO . 26.0 m -134.24 -60.59 0.8 Allowed 'General case' 0 C--O 1.205 -1.276 0 CA-C-O 118.606 -0.711 . . . . 1.0 110.076 179.086 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 108' ' ' VAL . . . . . 0.65 ' O ' HG22 ' A' ' 108' ' ' VAL . 12.3 p -82.83 34.97 0.04 OUTLIER 'Isoleucine or valine' 0 C--O 1.235 0.29 0 C-N-CA 123.659 0.784 . . . . 1.0 111.265 -175.812 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 109' ' ' ILE . . . . . 0.665 ' N ' ' CD ' ' A' ' 110' ' ' PRO . 31.5 pt -104.7 -22.87 0.19 Allowed Pre-proline 0 CA--C 1.568 1.641 0 CA-C-N 115.876 -0.602 . . . . 1.0 111.363 177.55 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 110' ' ' PRO . . . . . 0.665 ' CD ' ' N ' ' A' ' 109' ' ' ILE . 71.6 Cg_endo -73.14 -15.66 25.6 Favored 'Trans proline' 0 N--CA 1.483 0.883 0 C-N-CA 123.292 2.661 . . . . 1.0 113.674 -177.402 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 6.3 t30 -61.72 -69.2 0.26 Allowed 'General case' 0 C--O 1.237 0.401 0 C-N-CA 120.357 -0.537 . . . . 1.0 110.472 -177.941 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 112' ' ' ILE . . . . . 0.472 HG21 ' HA3' ' A' ' 35' ' ' GLY . 0.0 OUTLIER -65.53 -28.68 44.92 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.413 0 CA-C-O 122.015 0.912 . . . . 1.0 109.996 179.614 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 113' ' ' ASN . . . . . 0.487 ' O ' ' OE1' ' A' ' 117' ' ' GLU . 42.1 t30 -55.16 -63.86 1.02 Allowed 'General case' 0 C--N 1.306 -1.32 0 CA-C-N 115.062 -0.972 . . . . 1.0 110.519 -176.738 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -61.49 -23.06 65.63 Favored 'General case' 0 C--N 1.31 -1.132 0 C-N-CA 120.788 -0.365 . . . . 1.0 111.383 179.832 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 115' ' ' ALA . . . . . 0.475 ' O ' HG12 ' A' ' 118' ' ' VAL . . . -79.34 -60.01 2.54 Favored 'General case' 0 CA--C 1.536 0.433 0 N-CA-C 112.485 0.55 . . . . 1.0 112.485 178.733 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 116' ' ' ILE . . . . . 0.549 ' O ' ' N ' ' A' ' 119' ' ' LEU . 3.3 mm -70.3 -49.11 56.74 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.365 0 O-C-N 121.102 -0.999 . . . . 1.0 112.187 -177.982 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 117' ' ' GLU . . . . . 0.612 ' N ' ' OE1' ' A' ' 117' ' ' GLU . 10.3 mp0 -46.96 -61.55 1.82 Allowed 'General case' 0 C--N 1.317 -0.846 0 N-CA-C 108.728 -0.841 . . . . 1.0 108.728 -176.815 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 118' ' ' VAL . . . . . 0.475 HG12 ' O ' ' A' ' 115' ' ' ALA . 2.0 p -51.9 -16.35 0.64 Allowed 'Isoleucine or valine' 0 N--CA 1.443 -0.797 0 C-N-CA 119.896 -0.721 . . . . 1.0 109.078 179.157 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 119' ' ' LEU . . . . . 0.549 ' N ' ' O ' ' A' ' 116' ' ' ILE . 0.3 OUTLIER -78.39 -60.45 2.37 Favored 'General case' 0 C--N 1.356 0.87 0 N-CA-C 108.808 -0.812 . . . . 1.0 108.808 176.802 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -68.29 -83.07 0.15 Allowed Glycine 0 C--N 1.367 2.251 0 C-N-CA 116.759 -2.639 . . . . 1.0 110.747 178.671 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 121' ' ' THR . . . . . 0.441 ' OG1' ' NE2' ' A' ' 72' ' ' HIS . 13.3 m -159.75 -18.83 0.06 Allowed 'General case' 0 N--CA 1.475 0.801 0 CA-C-O 122.107 0.956 . . . . 1.0 109.307 -179.645 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 122' ' ' GLY . . . . . 0.45 ' O ' ' C ' ' A' ' 123' ' ' THR . . . 111.48 -36.73 4.04 Favored Glycine 0 CA--C 1.523 0.588 0 CA-C-N 113.365 -1.743 . . . . 1.0 112.098 179.733 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 123' ' ' THR . . . . . 0.45 ' C ' ' O ' ' A' ' 122' ' ' GLY . 91.1 m -31.4 95.15 0.01 OUTLIER 'General case' 0 N--CA 1.477 0.904 0 CA-C-N 118.913 1.356 . . . . 1.0 112.369 -178.267 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 124' ' ' ASP . . . . . 0.406 ' N ' ' O ' ' A' ' 122' ' ' GLY . 0.0 OUTLIER -146.02 144.6 30.19 Favored 'General case' 0 C--N 1.347 0.494 0 N-CA-C 108.259 -1.015 . . . . 1.0 108.259 178.596 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 125' ' ' TYR . . . . . 0.451 ' O ' ' NE ' ' A' ' 126' ' ' ARG . 1.1 p90 -149.57 148.79 29.76 Favored 'General case' 0 C--N 1.325 -0.498 0 N-CA-C 109.951 -0.389 . . . . 1.0 109.951 179.817 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 126' ' ' ARG . . . . . 0.574 ' HA ' ' HE ' ' A' ' 126' ' ' ARG . 0.0 OUTLIER -146.73 149.48 33.49 Favored 'General case' 0 N--CA 1.465 0.302 0 N-CA-C 109.2 -0.667 . . . . 1.0 109.2 177.081 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 127' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.222 -0.389 0 CA-C-O 117.998 -1.001 . . . . 1.0 111.057 -178.507 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.492 1.633 0 N-CA-C 109.219 -0.66 . . . . 1.0 109.219 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 2' ' ' SER . . . . . 0.462 ' O ' ' CG ' ' A' ' 3' ' ' ASP . 86.7 p -89.19 4.48 48.47 Favored 'General case' 0 N--CA 1.463 0.212 0 CA-C-N 115.97 -0.559 . . . . 1.0 111.338 -179.56 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 3' ' ' ASP . . . . . 0.462 ' CG ' ' O ' ' A' ' 2' ' ' SER . 11.4 m-20 160.39 118.46 0.0 OUTLIER 'General case' 0 N--CA 1.465 0.316 0 O-C-N 123.578 0.549 . . . . 1.0 110.833 179.44 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . 0.443 ' O ' ' OD1' ' A' ' 5' ' ' ASP . 72.9 t80 -149.79 145.57 26.69 Favored 'General case' 0 CA--C 1.518 -0.261 0 N-CA-C 109.073 -0.714 . . . . 1.0 109.073 178.027 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 5' ' ' ASP . . . . . 0.443 ' OD1' ' O ' ' A' ' 4' ' ' PHE . 72.0 m-20 -149.92 146.5 27.1 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.963 -0.562 . . . . 1.0 110.472 -179.054 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 6' ' ' THR . . . . . 0.696 ' O ' ' N ' ' A' ' 10' ' ' SER . 0.2 OUTLIER -114.31 -156.23 0.59 Allowed 'General case' 0 C--O 1.206 -1.219 0 CA-C-O 121.699 0.762 . . . . 1.0 110.245 179.291 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . 0.503 ' O ' ' CB ' ' A' ' 11' ' ' ARG . 10.5 tm-20 -57.04 -48.37 78.68 Favored 'General case' 0 C--N 1.306 -1.323 0 O-C-N 121.67 -0.643 . . . . 1.0 110.361 -178.443 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 8' ' ' ARG . . . . . 0.849 ' O ' ' HB3' ' A' ' 12' ' ' ALA . 39.1 ttm180 -67.28 -58.23 5.21 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-O 122.046 0.927 . . . . 1.0 109.781 178.506 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . 0.65 ' O ' ' HB ' ' A' ' 13' ' ' VAL . 0.2 OUTLIER -65.2 -51.16 68.76 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.847 0 CA-C-N 114.64 -1.163 . . . . 1.0 109.456 -178.243 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 10' ' ' SER . . . . . 0.697 ' O ' ' HB3' ' A' ' 14' ' ' ALA . 1.1 m -69.43 -64.07 0.95 Allowed 'General case' 0 C--N 1.302 -1.462 0 O-C-N 120.78 -1.2 . . . . 1.0 111.325 178.801 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 11' ' ' ARG . . . . . 0.741 ' O ' ' HB3' ' A' ' 15' ' ' ALA . 30.5 ttm-85 -63.97 -48.65 75.63 Favored 'General case' 0 N--CA 1.472 0.633 0 O-C-N 121.396 -0.815 . . . . 1.0 112.735 -176.206 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . 0.849 ' HB3' ' O ' ' A' ' 8' ' ' ARG . . . -70.03 -58.61 3.63 Favored 'General case' 0 N--CA 1.472 0.663 0 C-N-CA 118.96 -1.096 . . . . 1.0 109.284 178.286 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . 0.722 ' O ' ' HB3' ' A' ' 17' ' ' LEU . 1.0 OUTLIER -63.18 -54.08 37.78 Favored 'Isoleucine or valine' 0 C--O 1.195 -1.788 0 C-N-CA 117.773 -1.571 . . . . 1.0 108.921 -179.662 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . 0.946 ' O ' HG22 ' A' ' 18' ' ' VAL . . . -63.48 -62.87 1.39 Allowed 'General case' 0 N--CA 1.48 1.073 0 C-N-CA 117.123 -1.831 . . . . 1.0 111.353 179.888 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . 0.741 ' HB3' ' O ' ' A' ' 11' ' ' ARG . . . -54.93 -55.98 24.61 Favored 'General case' 0 N--CA 1.485 1.286 0 C-N-CA 118.877 -1.129 . . . . 1.0 111.311 -177.327 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . 0.761 ' HB3' ' O ' ' A' ' 12' ' ' ALA . . . -66.06 -57.16 8.34 Favored 'General case' 0 CA--C 1.548 0.874 0 C-N-CA 119.589 -0.844 . . . . 1.0 109.935 -178.425 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . 0.722 ' HB3' ' O ' ' A' ' 13' ' ' VAL . 7.0 tt -56.29 -54.07 49.77 Favored 'General case' 0 N--CA 1.483 1.206 0 CA-C-N 115.065 -0.97 . . . . 1.0 108.421 -178.224 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . 0.946 HG22 ' O ' ' A' ' 14' ' ' ALA . 1.8 m -71.14 -57.81 6.71 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.602 0 C-N-CA 119.307 -0.957 . . . . 1.0 110.169 179.868 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . 0.539 ' N ' ' O ' ' A' ' 15' ' ' ALA . . . -57.88 -171.54 0.25 Allowed Glycine 0 N--CA 1.448 -0.526 0 N-CA-C 111.17 -0.772 . . . . 1.0 111.17 -177.911 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 20' ' ' PRO . . . . . 0.585 ' O ' ' N ' ' A' ' 24' ' ' ALA . 89.8 Cg_endo -81.76 -24.51 4.12 Favored 'Trans proline' 0 C--N 1.298 -2.1 0 C-N-CA 122.691 2.261 . . . . 1.0 113.276 -178.583 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . 0.445 ' O ' ' HB3' ' A' ' 24' ' ' ALA . . . -63.96 -61.89 5.71 Favored Glycine 0 N--CA 1.484 1.856 0 C-N-CA 119.237 -1.458 . . . . 1.0 111.981 -176.992 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . 0.512 ' H ' ' HA ' ' A' ' 16' ' ' ALA . . . -53.01 -51.83 43.55 Favored Glycine 0 N--CA 1.47 0.927 0 N-CA-C 106.212 -2.755 . . . . 1.0 106.212 179.69 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 34.3 t -56.88 -30.74 34.12 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.733 0 N-CA-C 108.832 -0.803 . . . . 1.0 108.832 178.332 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . 0.585 ' N ' ' O ' ' A' ' 20' ' ' PRO . . . -58.22 -61.37 2.62 Favored 'General case' 0 C--N 1.352 0.706 0 C-N-CA 118.354 -1.339 . . . . 1.0 109.499 179.638 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . 0.516 ' N ' HD12 ' A' ' 25' ' ' LEU . 9.0 mp -57.59 -44.27 85.24 Favored 'General case' 0 C--O 1.223 -0.315 0 C-N-CA 119.629 -0.829 . . . . 1.0 110.341 -177.893 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 65.5 t -58.6 -60.33 2.46 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.861 0 C-N-CA 119.087 -1.045 . . . . 1.0 111.053 -178.61 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . 0.553 ' O ' ' HB3' ' A' ' 31' ' ' ALA . 18.1 t -58.51 -41.83 82.88 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.231 0 N-CA-C 112.843 0.683 . . . . 1.0 112.843 -177.64 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . 0.616 ' NZ ' HG23 ' A' ' 29' ' ' VAL . 3.9 pptp? -68.33 -54.41 17.56 Favored 'General case' 0 C--N 1.325 -0.459 0 C-N-CA 119.078 -1.049 . . . . 1.0 109.966 -178.027 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . 0.616 HG23 ' NZ ' ' A' ' 28' ' ' LYS . 1.3 t -60.58 -50.71 79.32 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.6 0 C-N-CA 119.748 -0.781 . . . . 1.0 110.576 179.862 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 30' ' ' CYS . . . . . . . . . . . . . 8.6 t -65.14 -63.1 1.19 Allowed 'General case' 0 N--CA 1.447 -0.6 0 C-N-CA 119.425 -0.91 . . . . 1.0 110.51 -179.184 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . 0.553 ' HB3' ' O ' ' A' ' 27' ' ' VAL . . . -56.19 -50.38 71.39 Favored 'General case' 0 CA--C 1.517 -0.323 0 C-N-CA 120.3 -0.56 . . . . 1.0 111.168 -177.53 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . 0.45 ' O ' ' HB2' ' A' ' 33' ' ' LEU . . . 74.3 70.44 1.25 Allowed Glycine 0 N--CA 1.45 -0.43 0 N-CA-C 108.621 -1.791 . . . . 1.0 108.621 -178.182 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . 0.45 ' HB2' ' O ' ' A' ' 32' ' ' GLY . 0.1 OUTLIER 84.75 93.8 0.04 OUTLIER Pre-proline 0 CA--C 1.55 0.968 0 O-C-N 124.477 0.751 . . . . 1.0 109.657 -178.286 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 74.7 Cg_exo -45.69 -13.55 0.08 OUTLIER 'Trans proline' 0 N--CA 1.491 1.378 0 C-N-CA 121.919 1.746 . . . . 1.0 113.634 -179.56 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . 0.433 ' N ' ' O ' ' A' ' 33' ' ' LEU . . . -62.81 -61.85 6.07 Favored Glycine 0 N--CA 1.471 0.989 0 C-N-CA 118.885 -1.626 . . . . 1.0 110.422 -178.263 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . 0.762 ' O ' HG22 ' A' ' 37' ' ' ILE . 34.3 m -76.94 -147.01 0.01 OUTLIER 'Isoleucine or valine' 0 C--O 1.213 -0.858 0 N-CA-C 107.58 -1.267 . . . . 1.0 107.58 178.431 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . 0.762 HG22 ' O ' ' A' ' 36' ' ' VAL . 0.3 OUTLIER 71.93 75.4 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.474 0.741 0 CA-C-O 122.993 1.378 . . . . 1.0 111.675 179.934 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 38' ' ' HIS . . . . . 0.433 ' CD2' ' O ' ' A' ' 37' ' ' ILE . 35.1 m170 -137.75 131.97 32.06 Favored 'General case' 0 C--N 1.327 -0.376 0 O-C-N 120.707 -1.246 . . . . 1.0 109.103 178.997 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 39' ' ' THR . . . . . 0.406 HG23 ' O ' ' A' ' 39' ' ' THR . 1.7 t -128.65 112.99 19.19 Favored Pre-proline 0 CA--C 1.542 0.642 0 N-CA-C 109.015 -0.735 . . . . 1.0 109.015 179.745 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 40' ' ' PRO . . . . . 0.547 ' O ' ' NE ' ' A' ' 42' ' ' ARG . 83.8 Cg_exo -42.63 -68.05 0.11 Allowed 'Trans proline' 0 N--CA 1.49 1.293 0 C-N-CA 121.542 1.495 . . . . 1.0 112.569 -178.673 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -74.7 128.02 34.54 Favored 'General case' 0 C--N 1.316 -0.889 0 CA-C-N 115.173 -0.921 . . . . 1.0 111.244 -177.694 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . 0.643 ' C ' ' H ' ' A' ' 44' ' ' GLY . 0.1 OUTLIER -173.78 175.44 2.89 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 114.859 -1.064 . . . . 1.0 110.726 179.631 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 43' ' ' ARG . . . . . 0.573 ' C ' ' H ' ' A' ' 45' ' ' PHE . 25.3 tpt180 -63.51 19.11 0.01 OUTLIER 'General case' 0 CA--C 1.549 0.905 0 CA-C-O 121.254 0.549 . . . . 1.0 109.927 178.532 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . 0.643 ' H ' ' C ' ' A' ' 42' ' ' ARG . . . 69.93 -27.94 0.41 Allowed Glycine 0 C--N 1.342 0.906 0 N-CA-C 110.66 -0.976 . . . . 1.0 110.66 -179.715 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . 0.668 ' O ' ' HB2' ' A' ' 46' ' ' PHE . 1.1 p90 -159.79 161.01 34.52 Favored 'General case' 0 C--N 1.326 -0.415 0 N-CA-C 109.022 -0.733 . . . . 1.0 109.022 179.77 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 46' ' ' PHE . . . . . 0.668 ' HB2' ' O ' ' A' ' 45' ' ' PHE . 0.7 OUTLIER 131.87 94.35 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.506 0 O-C-N 125.414 1.696 . . . . 1.0 109.604 179.153 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 47' ' ' ARG . . . . . 0.581 ' CB ' ' O ' ' A' ' 46' ' ' PHE . 0.0 OUTLIER 112.58 143.14 0.0 OUTLIER 'General case' 0 N--CA 1.48 1.072 0 O-C-N 124.415 1.072 . . . . 1.0 111.709 178.229 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 35.8 t 66.96 73.18 0.35 Allowed 'General case' 0 C--O 1.22 -0.463 0 O-C-N 124.317 1.011 . . . . 1.0 110.579 179.257 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 49' ' ' ASN . . . . . 0.528 ' C ' HD22 ' A' ' 49' ' ' ASN . 0.4 OUTLIER -136.44 153.89 76.54 Favored Pre-proline 0 CA--C 1.536 0.435 0 N-CA-C 109.863 -0.421 . . . . 1.0 109.863 -179.19 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 50' ' ' PRO . . . . . 0.534 ' C ' ' H ' ' A' ' 52' ' ' ARG . 27.9 Cg_endo -58.64 56.67 0.06 OUTLIER 'Trans proline' 0 N--CA 1.51 2.455 0 C-N-CA 123.219 2.612 . . . . 1.0 113.516 179.931 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . 0.558 ' OE1' ' ND1' ' A' ' 92' ' ' HIS . 49.1 mt-10 63.85 -34.44 0.14 Allowed 'General case' 0 N--CA 1.47 0.541 0 CA-C-N 116.129 -0.487 . . . . 1.0 111.984 179.855 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . 0.534 ' H ' ' C ' ' A' ' 50' ' ' PRO . 75.7 mtt85 -45.9 136.3 6.5 Favored 'General case' 0 C--N 1.325 -0.468 0 N-CA-C 109.588 -0.523 . . . . 1.0 109.588 179.696 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . 0.607 ' O ' ' N ' ' A' ' 55' ' ' ILE . 3.0 tp -49.73 125.56 3.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 N-CA-C 109.615 -0.513 . . . . 1.0 109.615 -178.713 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -57.17 80.37 0.01 OUTLIER 'General case' 0 C--N 1.322 -0.588 0 CA-C-O 121.931 0.872 . . . . 1.0 109.054 -177.393 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . 0.607 ' N ' ' O ' ' A' ' 53' ' ' ILE . 3.3 tt -155.12 165.01 1.26 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.249 0 CA-C-N 114.687 -1.142 . . . . 1.0 111.449 178.501 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 105.55 -28.83 12.77 Favored Glycine 0 C--O 1.226 -0.405 0 CA-C-N 115.916 -0.584 . . . . 1.0 112.134 176.737 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -52.56 117.61 3.01 Favored 'General case' 0 CA--C 1.537 0.478 0 CA-C-N 118.013 0.906 . . . . 1.0 112.627 -178.783 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 58' ' ' TRP . . . . . 0.447 ' HB2' ' HB3' ' A' ' 61' ' ' GLU . 36.1 m95 -79.83 168.26 19.51 Favored 'General case' 0 CA--C 1.556 1.182 0 CA-C-O 124.214 1.959 . . . . 1.0 111.045 178.649 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 59' ' ' ARG . . . . . 0.545 ' HD3' ' H ' ' A' ' 59' ' ' ARG . 0.0 OUTLIER -86.17 -64.14 1.2 Allowed 'General case' 0 N--CA 1.509 2.518 0 CA-C-N 110.745 -2.934 . . . . 1.0 112.902 -176.989 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 60' ' ' TYR . . . . . 0.415 ' O ' ' CG ' ' A' ' 60' ' ' TYR . 17.5 t80 -88.07 -16.44 33.56 Favored 'General case' 0 N--CA 1.483 1.205 0 N-CA-C 113.171 0.804 . . . . 1.0 113.171 179.728 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . 0.531 ' O ' ' N ' ' A' ' 65' ' ' ASP . 11.3 tt0 -79.42 -12.88 59.89 Favored 'General case' 0 C--N 1.313 -1.002 0 O-C-N 121.704 -0.622 . . . . 1.0 109.64 179.941 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 62' ' ' VAL . . . . . 0.557 ' O ' ' N ' ' A' ' 66' ' ' GLY . 12.2 m -45.42 -51.4 2.74 Favored 'Isoleucine or valine' 0 CA--C 1.5 -0.974 0 C-N-CA 120.04 -0.664 . . . . 1.0 110.354 -176.126 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 63' ' ' ALA . . . . . 0.487 ' N ' HG23 ' A' ' 62' ' ' VAL . . . -68.29 -48.35 65.19 Favored 'General case' 0 N--CA 1.426 -1.66 0 C-N-CA 119.752 -0.779 . . . . 1.0 109.325 179.763 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 1.8 t-80 -56.49 -59.65 4.68 Favored 'General case' 0 CA--C 1.545 0.755 0 CA-C-N 115.358 -0.837 . . . . 1.0 110.37 -179.645 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 65' ' ' ASP . . . . . 0.586 ' C ' ' H ' ' A' ' 67' ' ' ARG . 1.0 OUTLIER -69.42 -55.46 10.25 Favored 'General case' 0 CA--C 1.549 0.917 0 CA-C-O 121.976 0.893 . . . . 1.0 109.756 177.767 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . 0.557 ' N ' ' O ' ' A' ' 62' ' ' VAL . . . -67.34 33.3 0.2 Allowed Glycine 0 CA--C 1.529 0.939 0 O-C-N 120.726 -1.234 . . . . 1.0 111.227 178.957 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 67' ' ' ARG . . . . . 0.644 ' O ' ' N ' ' A' ' 69' ' ' LEU . 0.8 OUTLIER -77.98 5.93 8.82 Favored 'General case' 0 C--N 1.32 -0.678 0 N-CA-C 108.85 -0.796 . . . . 1.0 108.85 177.045 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . 0.506 ' O ' ' HA ' ' A' ' 72' ' ' HIS . 0.3 OUTLIER -32.86 -28.36 0.01 OUTLIER 'General case' 0 N--CA 1.487 1.396 0 N-CA-C 108.226 -1.027 . . . . 1.0 108.226 -177.879 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . 0.644 ' N ' ' O ' ' A' ' 67' ' ' ARG . 2.4 mp -64.4 -65.2 0.71 Allowed 'General case' 0 N--CA 1.469 0.488 0 C-N-CA 117.922 -1.511 . . . . 1.0 107.301 177.16 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . 0.662 ' C ' ' H ' ' A' ' 72' ' ' HIS . . . -76.09 -72.22 0.34 Allowed 'General case' 0 CA--C 1.51 -0.573 0 N-CA-C 106.157 -1.794 . . . . 1.0 106.157 178.249 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 71' ' ' ALA . . . . . 0.612 ' H ' ' HB3' ' A' ' 67' ' ' ARG . . . -43.87 3.22 0.0 OUTLIER 'General case' 0 N--CA 1.472 0.634 0 C-N-CA 125.135 1.374 . . . . 1.0 113.798 176.897 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 72' ' ' HIS . . . . . 1.038 ' CD2' ' H ' ' A' ' 73' ' ' MET . 0.4 OUTLIER -19.41 -65.92 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.314 0 N-CA-C 112.728 0.64 . . . . 1.0 112.728 -176.372 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 73' ' ' MET . . . . . 1.038 ' H ' ' CD2' ' A' ' 72' ' ' HIS . 28.1 mtt -76.64 -45.78 28.56 Favored 'General case' 0 N--CA 1.438 -1.059 0 CA-C-N 119.023 0.828 . . . . 1.0 109.22 177.557 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . 0.591 ' O ' ' N ' ' A' ' 76' ' ' GLY . 94.5 t -45.27 -50.37 2.9 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.306 0 CA-C-O 118.082 -0.961 . . . . 1.0 109.894 -177.099 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 75' ' ' ASN . . . . . 0.512 ' C ' ' N ' ' A' ' 77' ' ' ILE . 19.0 t-20 -39.44 -21.18 0.01 OUTLIER 'General case' 0 C--N 1.357 0.925 0 CA-C-N 120.312 1.415 . . . . 1.0 110.715 177.346 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 76' ' ' GLY . . . . . 0.591 ' N ' ' O ' ' A' ' 74' ' ' VAL . . . -43.48 -20.95 0.14 Allowed Glycine 0 CA--C 1.534 1.237 0 N-CA-C 108.675 -1.77 . . . . 1.0 108.675 178.934 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 77' ' ' ILE . . . . . 0.772 ' O ' ' N ' ' A' ' 80' ' ' ALA . 96.7 mt -82.43 -50.04 16.49 Favored 'Isoleucine or valine' 0 C--O 1.213 -0.855 0 N-CA-C 108.766 -0.827 . . . . 1.0 108.766 179.421 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . 0.467 ' C ' ' O ' ' A' ' 77' ' ' ILE . 43.8 t -35.4 -34.49 0.06 OUTLIER 'Isoleucine or valine' 0 CA--C 1.541 0.603 0 N-CA-C 108.481 -0.933 . . . . 1.0 108.481 -178.254 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . 0.744 ' O ' ' HB2' ' A' ' 83' ' ' ALA . 0.1 OUTLIER -88.16 -24.7 6.1 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.602 0 CA-C-O 121.007 0.432 . . . . 1.0 110.104 178.789 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 80' ' ' ALA . . . . . 0.772 ' N ' ' O ' ' A' ' 77' ' ' ILE . . . -89.78 -9.25 49.96 Favored 'General case' 0 CA--C 1.539 0.522 0 C-N-CA 123.843 0.857 . . . . 1.0 111.653 177.061 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 81' ' ' GLU . . . . . 0.62 ' O ' HD11 ' A' ' 84' ' ' LEU . 51.2 tp10 -77.86 -71.77 0.4 Allowed 'General case' 0 N--CA 1.444 -0.765 0 CA-C-O 118.477 -0.773 . . . . 1.0 111.516 -179.288 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 82' ' ' ASP . . . . . 0.589 ' O ' HG13 ' A' ' 85' ' ' ILE . 1.7 m-20 -81.67 -18.72 43.53 Favored 'General case' 0 C--O 1.21 -0.983 0 O-C-N 123.517 0.51 . . . . 1.0 112.226 -178.095 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . 0.744 ' HB2' ' O ' ' A' ' 79' ' ' ILE . . . -45.05 -52.41 9.0 Favored 'General case' 0 N--CA 1.469 0.491 0 N-CA-C 115.093 1.516 . . . . 1.0 115.093 -179.813 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . 0.985 ' H ' HD13 ' A' ' 84' ' ' LEU . 0.0 OUTLIER -31.78 -28.67 0.01 OUTLIER 'General case' 0 N--CA 1.48 1.048 0 CA-C-O 118.962 -0.542 . . . . 1.0 112.408 -174.304 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 85' ' ' ILE . . . . . 0.596 ' N ' ' O ' ' A' ' 83' ' ' ALA . 1.4 pp -100.02 -58.9 3.58 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.878 0 CA-C-N 118.631 0.65 . . . . 1.0 109.262 177.565 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 86' ' ' ALA . . . . . 0.538 ' H ' HG13 ' A' ' 85' ' ' ILE . . . -53.22 -37.53 62.11 Favored 'General case' 0 C--O 1.222 -0.347 0 CA-C-N 115.6 -0.727 . . . . 1.0 110.745 179.869 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 9.8 tt0 -47.5 -11.86 0.03 OUTLIER 'General case' 0 N--CA 1.465 0.295 0 CA-C-O 121.07 0.462 . . . . 1.0 110.046 179.649 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 88' ' ' ALA . . . . . 0.521 ' H ' ' C ' ' A' ' 86' ' ' ALA . . . -84.16 -2.33 56.65 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.754 -0.657 . . . . 1.0 110.103 179.657 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 89' ' ' VAL . . . . . 0.688 ' O ' HG12 ' A' ' 89' ' ' VAL . 54.2 t -93.25 33.03 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.62 0 CA-C-N 115.414 -0.812 . . . . 1.0 109.231 179.079 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 90' ' ' GLY . . . . . 0.633 ' N ' ' HD2' ' A' ' 91' ' ' PRO . . . -67.22 -44.81 85.27 Favored Glycine 0 CA--C 1.535 1.342 0 CA-C-O 119.163 -0.798 . . . . 1.0 112.005 178.134 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 91' ' ' PRO . . . . . 0.633 ' HD2' ' N ' ' A' ' 90' ' ' GLY . 7.7 Cg_exo -39.3 -18.55 0.04 OUTLIER 'Trans proline' 0 N--CA 1.493 1.445 0 C-N-CA 122.236 1.957 . . . . 1.0 111.336 179.263 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 92' ' ' HIS . . . . . 0.713 ' O ' ' N ' ' A' ' 96' ' ' ALA . 3.3 p80 -53.95 -44.83 71.04 Favored 'General case' 0 N--CA 1.441 -0.923 0 N-CA-C 106.357 -1.72 . . . . 1.0 106.357 -179.568 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 93' ' ' LEU . . . . . 0.747 HD12 ' N ' ' A' ' 94' ' ' ALA . 2.3 pp -41.51 -61.38 1.07 Allowed 'General case' 0 CA--C 1.566 1.572 0 C-N-CA 119.578 -0.849 . . . . 1.0 111.762 177.682 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 94' ' ' ALA . . . . . 0.747 ' N ' HD12 ' A' ' 93' ' ' LEU . . . -58.29 -58.76 7.07 Favored 'General case' 0 C--O 1.219 -0.547 0 CA-C-N 119.229 0.922 . . . . 1.0 108.763 179.67 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 95' ' ' ARG . . . . . 0.578 ' O ' ' N ' ' A' ' 97' ' ' LEU . 44.7 mtp85 -51.56 -61.38 2.28 Favored 'General case' 0 C--O 1.246 0.885 0 CA-C-O 123.359 1.552 . . . . 1.0 108.658 178.177 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 96' ' ' ALA . . . . . 0.845 ' O ' ' N ' ' A' ' 98' ' ' GLY . . . -47.82 -14.37 0.05 OUTLIER 'General case' 0 N--CA 1.43 -1.429 0 O-C-N 118.186 -2.821 . . . . 1.0 111.206 -178.446 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 97' ' ' LEU . . . . . 0.628 ' O ' ' N ' ' A' ' 100' ' ' ILE 0.258 6.1 tt 3.68 -51.28 0.0 OUTLIER 'General case' 0 C--N 1.368 1.393 0 C-N-CA 124.109 0.964 . . . . 1.0 112.736 -170.72 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 98' ' ' GLY . . . . . 0.845 ' N ' ' O ' ' A' ' 96' ' ' ALA . . . -49.56 -23.05 4.36 Favored Glycine 0 N--CA 1.434 -1.479 0 CA-C-N 122.187 2.267 . . . . 1.0 108.152 174.589 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 99' ' ' GLN . . . . . 0.522 ' N ' ' O ' ' A' ' 96' ' ' ALA . 25.2 mm100 -68.88 -19.81 64.24 Favored 'General case' 0 C--N 1.363 1.162 0 C-N-CA 117.308 -1.757 . . . . 1.0 108.58 177.765 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 100' ' ' ILE . . . . . 0.628 ' N ' ' O ' ' A' ' 97' ' ' LEU . 10.3 mt -65.41 -32.72 59.45 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.813 0 C-N-CA 119.749 -0.781 . . . . 1.0 110.214 177.179 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 101' ' ' VAL . . . . . 0.744 HG12 ' O ' ' A' ' 98' ' ' GLY . 3.8 p -60.13 -62.09 1.22 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.509 0 C-N-CA 119.355 -0.938 . . . . 1.0 110.622 -178.847 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 102' ' ' CYS . . . . . 0.867 ' O ' ' HB2' ' A' ' 106' ' ' ALA . 1.2 p -48.72 -19.29 0.34 Allowed 'General case' 0 C--O 1.217 -0.627 0 O-C-N 122.122 -0.361 . . . . 1.0 111.655 -178.364 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 103' ' ' ARG . . . . . 0.61 HH11 ' CG ' ' A' ' 103' ' ' ARG . 0.0 OUTLIER -85.9 -42.61 13.93 Favored 'General case' 0 N--CA 1.498 1.943 0 CA-C-O 124.419 2.057 . . . . 1.0 111.235 -179.98 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 104' ' ' TYR . . . . . 0.803 ' O ' ' CD1' ' A' ' 104' ' ' TYR . 0.0 OUTLIER -97.62 22.48 8.93 Favored 'General case' 0 C--N 1.267 -2.995 0 CA-C-N 110.561 -3.018 . . . . 1.0 107.332 176.949 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 105' ' ' GLY . . . . . 0.512 ' N ' ' O ' ' A' ' 101' ' ' VAL . . . -165.5 -88.3 0.07 OUTLIER Glycine 0 CA--C 1.529 0.913 0 O-C-N 119.634 -1.916 . . . . 1.0 109.081 179.13 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 106' ' ' ALA . . . . . 0.867 ' HB2' ' O ' ' A' ' 102' ' ' CYS . . . 65.52 58.58 0.82 Allowed 'General case' 0 CA--C 1.533 0.308 0 CA-C-O 120.885 0.374 . . . . 1.0 110.688 -178.713 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 13.1 t -89.49 -5.34 57.4 Favored 'General case' 0 CA--C 1.514 -0.412 0 N-CA-C 108.614 -0.884 . . . . 1.0 108.614 178.593 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 108' ' ' VAL . . . . . 0.618 HG23 ' N ' ' A' ' 109' ' ' ILE . 14.7 m -87.53 -53.54 9.76 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.626 0 C-N-CA 120.842 -0.343 . . . . 1.0 110.608 178.537 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 109' ' ' ILE . . . . . 0.618 ' N ' HG23 ' A' ' 108' ' ' VAL . 0.2 OUTLIER -50.34 -34.34 10.65 Favored Pre-proline 0 C--N 1.351 0.658 0 N-CA-C 115.086 1.513 . . . . 1.0 115.086 -178.921 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 110' ' ' PRO . . . . . 0.507 ' CD ' ' N ' ' A' ' 109' ' ' ILE . 76.8 Cg_exo -53.07 -37.89 79.78 Favored 'Trans proline' 0 C--N 1.307 -1.612 0 CA-C-N 120.458 1.199 . . . . 1.0 111.276 -175.212 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -64.76 -67.48 0.43 Allowed 'General case' 0 C--N 1.325 -0.471 0 C-N-CA 119.639 -0.824 . . . . 1.0 109.326 179.647 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 112' ' ' ILE . . . . . 0.485 ' CG1' ' N ' ' A' ' 113' ' ' ASN . 0.3 OUTLIER -60.28 -44.91 96.7 Favored 'Isoleucine or valine' 0 C--O 1.213 -0.817 0 C-N-CA 120.245 -0.582 . . . . 1.0 110.527 -178.819 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 113' ' ' ASN . . . . . 0.498 ' CB ' ' O ' ' A' ' 109' ' ' ILE . 18.0 t30 -44.14 -63.07 0.94 Allowed 'General case' 0 C--N 1.31 -1.118 0 CA-C-N 115.181 -0.918 . . . . 1.0 112.113 -174.659 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -57.18 -23.8 50.05 Favored 'General case' 0 C--N 1.312 -1.061 0 C-N-CA 119.743 -0.783 . . . . 1.0 111.555 -179.664 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -84.21 -58.46 2.75 Favored 'General case' 0 CA--C 1.555 1.162 0 CA-C-O 122.503 1.144 . . . . 1.0 113.846 178.191 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 116' ' ' ILE . . . . . 0.497 ' O ' ' N ' ' A' ' 119' ' ' LEU . 76.0 mt -65.88 -59.8 3.52 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.863 0 CA-C-N 113.814 -1.539 . . . . 1.0 110.825 -177.254 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 117' ' ' GLU . . . . . 0.448 ' HB3' ' O ' ' A' ' 113' ' ' ASN . 11.3 tt0 -45.1 -62.49 1.22 Allowed 'General case' 0 C--N 1.307 -1.257 0 CA-C-N 116.058 -0.519 . . . . 1.0 109.743 -178.285 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 48.7 t -53.49 -14.88 0.76 Allowed 'Isoleucine or valine' 0 N--CA 1.437 -1.119 0 C-N-CA 119.922 -0.711 . . . . 1.0 109.628 -179.782 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 119' ' ' LEU . . . . . 0.497 ' N ' ' O ' ' A' ' 116' ' ' ILE . 3.7 tp -79.79 -60.79 2.21 Favored 'General case' 0 C--N 1.348 0.527 0 C-N-CA 119.776 -0.77 . . . . 1.0 109.966 178.261 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -70.3 -85.1 0.16 Allowed Glycine 0 C--N 1.357 1.735 0 C-N-CA 118.626 -1.75 . . . . 1.0 111.285 179.925 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 121' ' ' THR . . . . . 0.428 ' H ' ' H ' ' A' ' 122' ' ' GLY . 7.7 m -164.57 -22.79 0.03 OUTLIER 'General case' 0 C--N 1.325 -0.478 0 N-CA-C 108.121 -1.066 . . . . 1.0 108.121 -179.035 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 122' ' ' GLY . . . . . 0.53 ' O ' ' N ' ' A' ' 124' ' ' ASP . . . 114.37 -36.42 3.98 Favored Glycine 0 CA--C 1.523 0.562 0 CA-C-O 118.125 -1.375 . . . . 1.0 113.028 179.308 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 123' ' ' THR . . . . . 0.461 ' C ' ' O ' ' A' ' 122' ' ' GLY . 0.0 OUTLIER -32.54 91.32 0.0 OUTLIER 'General case' 0 N--CA 1.47 0.573 0 CA-C-N 119.609 1.705 . . . . 1.0 112.065 -179.565 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 124' ' ' ASP . . . . . 0.53 ' N ' ' O ' ' A' ' 122' ' ' GLY . 11.6 p-10 -146.43 144.39 29.67 Favored 'General case' 0 N--CA 1.463 0.222 0 N-CA-C 108.986 -0.746 . . . . 1.0 108.986 179.051 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 125' ' ' TYR . . . . . 0.419 ' CD1' ' C ' ' A' ' 125' ' ' TYR . 0.2 OUTLIER -151.07 148.99 28.99 Favored 'General case' 0 CA--C 1.536 0.442 0 CA-C-O 121.367 0.603 . . . . 1.0 110.247 -179.962 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 74.8 mtt85 -149.57 150.88 32.92 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.59 -0.732 . . . . 1.0 110.245 178.077 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 127' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--O 1.22 -0.476 0 CA-C-O 118.042 -0.98 . . . . 1.0 109.291 178.83 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.7 mpt? . . . . . 0 N--CA 1.492 1.633 0 N-CA-C 109.061 -0.718 . . . . 1.0 109.061 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 33.4 m -107.69 7.68 28.6 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.322 -0.399 . . . . 1.0 110.402 179.872 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 3' ' ' ASP . . . . . 0.408 ' N ' ' OD1' ' A' ' 3' ' ' ASP . 1.2 p30 170.72 93.12 0.0 OUTLIER 'General case' 0 N--CA 1.463 0.213 0 CA-C-N 116.288 -0.415 . . . . 1.0 110.414 179.77 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 72.8 t80 -150.84 145.59 25.78 Favored 'General case' 0 N--CA 1.462 0.15 0 CA-C-O 120.684 0.278 . . . . 1.0 110.51 -179.998 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 5' ' ' ASP . . . . . 0.479 ' N ' ' OD1' ' A' ' 5' ' ' ASP . 3.4 p30 -155.53 151.68 27.94 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.434 -0.348 . . . . 1.0 110.444 179.901 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 6' ' ' THR . . . . . 0.552 ' O ' ' N ' ' A' ' 10' ' ' SER . 0.2 OUTLIER -64.7 169.16 5.26 Favored 'General case' 0 C--O 1.208 -1.119 0 N-CA-C 109.556 -0.535 . . . . 1.0 109.556 179.979 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . 0.497 ' O ' ' N ' ' A' ' 11' ' ' ARG . 0.0 OUTLIER -59.33 -58.05 10.33 Favored 'General case' 0 C--N 1.315 -0.93 0 CA-C-O 121.359 0.6 . . . . 1.0 110.213 -178.44 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 8' ' ' ARG . . . . . 0.509 ' O ' ' CB ' ' A' ' 12' ' ' ALA . 1.8 ptm180 -50.83 -56.31 12.8 Favored 'General case' 0 C--O 1.212 -0.899 0 N-CA-C 107.994 -1.113 . . . . 1.0 107.994 -177.825 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . 0.436 ' H ' ' HG3' ' A' ' 8' ' ' ARG . 0.0 OUTLIER -64.12 -47.46 90.06 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.966 0 CA-C-N 115.037 -0.983 . . . . 1.0 110.364 179.502 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 10' ' ' SER . . . . . 0.552 ' N ' ' O ' ' A' ' 6' ' ' THR . 47.9 t -63.81 -63.06 1.27 Allowed 'General case' 0 N--CA 1.48 1.037 0 O-C-N 123.454 0.471 . . . . 1.0 110.905 -178.968 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 11' ' ' ARG . . . . . 0.497 ' N ' ' O ' ' A' ' 7' ' ' GLU . 12.1 ttt180 -58.68 -54.82 42.8 Favored 'General case' 0 N--CA 1.469 0.489 0 N-CA-C 109.404 -0.591 . . . . 1.0 109.404 -177.069 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . 0.588 ' O ' ' HB3' ' A' ' 16' ' ' ALA . . . -46.48 -46.82 19.24 Favored 'General case' 0 N--CA 1.477 0.923 0 N-CA-C 105.762 -1.94 . . . . 1.0 105.762 -178.13 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . 0.604 ' O ' ' CB ' ' A' ' 17' ' ' LEU . 1.5 t -61.32 -52.02 66.21 Favored 'Isoleucine or valine' 0 C--O 1.206 -1.196 0 CA-C-N 114.495 -1.23 . . . . 1.0 108.147 176.004 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . 0.769 ' O ' HG13 ' A' ' 18' ' ' VAL . . . -57.21 -63.65 1.15 Allowed 'General case' 0 C--O 1.213 -0.86 0 C-N-CA 117.763 -1.575 . . . . 1.0 110.232 -179.876 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . 0.557 ' O ' ' N ' ' A' ' 19' ' ' GLY . . . -53.8 -56.26 19.07 Favored 'General case' 0 N--CA 1.473 0.71 0 CA-C-O 121.559 0.695 . . . . 1.0 110.916 -177.956 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . 0.588 ' HB3' ' O ' ' A' ' 12' ' ' ALA . . . -64.63 -55.57 19.4 Favored 'General case' 0 C--N 1.31 -1.112 0 CA-C-N 115.135 -0.938 . . . . 1.0 109.611 -178.419 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . 0.612 HD13 ' O ' ' A' ' 17' ' ' LEU . 0.3 OUTLIER -57.85 -52.14 66.73 Favored 'General case' 0 N--CA 1.474 0.766 0 CA-C-N 114.506 -1.224 . . . . 1.0 108.004 -177.516 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . 0.769 HG13 ' O ' ' A' ' 14' ' ' ALA . 2.3 m -68.37 -57.28 9.59 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.605 0 C-N-CA 118.86 -1.136 . . . . 1.0 109.706 178.685 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . 0.557 ' N ' ' O ' ' A' ' 15' ' ' ALA . . . -61.95 -171.84 1.21 Allowed Glycine 0 C--N 1.332 0.319 0 N-CA-C 110.941 -0.863 . . . . 1.0 110.941 -179.059 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 20' ' ' PRO . . . . . 0.603 ' O ' ' N ' ' A' ' 24' ' ' ALA . 2.1 Cg_endo -78.24 -26.3 6.38 Favored 'Trans proline' 0 C--N 1.309 -1.514 0 C-N-CA 122.636 2.224 . . . . 1.0 113.993 -178.752 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -59.62 -58.06 16.26 Favored Glycine 0 N--CA 1.48 1.591 0 C-N-CA 120.256 -0.973 . . . . 1.0 111.808 -177.031 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . 0.507 ' CA ' ' HB1' ' A' ' 16' ' ' ALA . . . -57.91 -52.12 54.13 Favored Glycine 0 N--CA 1.469 0.859 0 N-CA-C 107.112 -2.395 . . . . 1.0 107.112 -177.901 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . 0.612 ' O ' HG12 ' A' ' 27' ' ' VAL . 9.6 t -58.91 -32.66 47.79 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.078 0 CA-C-N 114.487 -0.856 . . . . 1.0 109.513 179.115 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . 0.603 ' N ' ' O ' ' A' ' 20' ' ' PRO . . . -58.51 -61.27 2.72 Favored 'General case' 0 CA--C 1.533 0.307 0 C-N-CA 118.503 -1.279 . . . . 1.0 109.579 -179.947 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . 0.554 ' C ' HD12 ' A' ' 25' ' ' LEU . 0.3 OUTLIER -65.04 -43.85 91.03 Favored 'General case' 0 CA--C 1.535 0.387 0 N-CA-C 112.763 0.653 . . . . 1.0 112.763 -177.939 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . 0.412 ' N ' ' HG ' ' A' ' 25' ' ' LEU . 53.4 t -61.46 -59.83 3.66 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.171 0 C-N-CA 118.77 -1.172 . . . . 1.0 110.011 -177.626 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . 0.612 HG12 ' O ' ' A' ' 23' ' ' VAL . 2.3 p -58.39 -35.6 54.79 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.217 0 N-CA-C 112.016 0.376 . . . . 1.0 112.016 -178.071 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 6.7 ttmm -67.29 -55.09 15.33 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-O 121.727 0.775 . . . . 1.0 109.477 -179.017 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 94.9 t -64.39 -48.22 86.18 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.673 0 CA-C-N 114.281 -1.327 . . . . 1.0 111.131 -177.689 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 30' ' ' CYS . . . . . . . . . . . . . 2.2 t -65.05 -61.23 2.28 Favored 'General case' 0 N--CA 1.447 -0.601 0 C-N-CA 118.807 -1.157 . . . . 1.0 109.189 -179.255 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . 0.564 ' HB3' ' O ' ' A' ' 27' ' ' VAL . . . -62.46 -51.87 65.77 Favored 'General case' 0 CA--C 1.51 -0.56 0 N-CA-C 112.29 0.478 . . . . 1.0 112.29 -177.06 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . 0.705 ' O ' HD11 ' A' ' 37' ' ' ILE . . . 81.46 71.62 1.28 Allowed Glycine 0 CA--C 1.523 0.581 0 N-CA-C 108.432 -1.867 . . . . 1.0 108.432 -177.967 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . 0.44 ' O ' ' O ' ' A' ' 36' ' ' VAL . 5.2 mt 89.06 73.42 0.05 OUTLIER Pre-proline 0 N--CA 1.476 0.835 0 C-N-CA 123.293 0.637 . . . . 1.0 109.809 -179.502 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 76.6 Cg_exo -50.74 -32.14 35.45 Favored 'Trans proline' 0 N--CA 1.507 2.31 0 C-N-CA 123.728 2.952 . . . . 1.0 114.954 -179.076 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -58.43 -57.44 19.86 Favored Glycine 0 CA--C 1.533 1.161 0 C-N-CA 118.492 -1.813 . . . . 1.0 108.9 -178.828 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . 0.536 ' O ' ' HB ' ' A' ' 37' ' ' ILE . 13.9 p -92.48 167.45 1.64 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.579 0 N-CA-C 106.917 -1.512 . . . . 1.0 106.917 177.447 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . 0.705 HD11 ' O ' ' A' ' 32' ' ' GLY . 91.4 mt 111.22 127.09 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.478 0.971 0 C-N-CA 123.827 0.851 . . . . 1.0 109.581 -179.529 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -141.59 132.38 25.78 Favored 'General case' 0 C--N 1.331 -0.236 0 N-CA-C 108.085 -1.08 . . . . 1.0 108.085 179.792 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 7.3 p -93.31 124.43 57.69 Favored Pre-proline 0 CA--C 1.534 0.35 0 N-CA-C 109.656 -0.498 . . . . 1.0 109.656 -179.792 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 52.5 Cg_exo -50.27 -37.62 50.06 Favored 'Trans proline' 0 N--CA 1.488 1.192 0 C-N-CA 121.399 1.399 . . . . 1.0 113.21 -179.702 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -121.47 101.43 7.61 Favored 'General case' 0 N--CA 1.47 0.535 0 N-CA-C 112.614 0.598 . . . . 1.0 112.614 -177.659 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . 0.746 ' C ' ' H ' ' A' ' 44' ' ' GLY . 14.4 ptm180 -135.84 152.86 51.49 Favored 'General case' 0 C--N 1.316 -0.868 0 CA-C-O 121.735 0.779 . . . . 1.0 112.834 179.773 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 43' ' ' ARG . . . . . 0.526 ' O ' ' CD1' ' A' ' 45' ' ' PHE . 61.0 ttt180 -61.18 28.97 0.01 OUTLIER 'General case' 0 CA--C 1.539 0.552 0 CA-C-N 113.531 -1.668 . . . . 1.0 109.225 -179.84 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . 0.746 ' H ' ' C ' ' A' ' 42' ' ' ARG . . . 75.65 -26.46 1.36 Allowed Glycine 0 N--CA 1.448 -0.527 0 N-CA-C 110.396 -1.081 . . . . 1.0 110.396 179.899 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . 0.699 ' N ' ' CD1' ' A' ' 45' ' ' PHE . 0.0 OUTLIER -172.79 172.61 4.07 Favored 'General case' 0 CA--C 1.536 0.423 0 CA-C-O 119.293 -0.384 . . . . 1.0 110.125 -177.867 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 46' ' ' PHE . . . . . 0.666 ' HB2' ' O ' ' A' ' 45' ' ' PHE . 0.4 OUTLIER 126.17 102.31 0.0 OUTLIER 'General case' 0 N--CA 1.505 2.296 0 O-C-N 125.675 1.859 . . . . 1.0 109.724 179.583 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 47' ' ' ARG . . . . . 0.567 ' NE ' ' O ' ' A' ' 46' ' ' PHE . 1.6 ptp180 108.1 162.37 0.0 OUTLIER 'General case' 0 N--CA 1.487 1.395 0 O-C-N 124.302 1.002 . . . . 1.0 110.669 178.942 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER 69.2 70.46 0.26 Allowed 'General case' 0 N--CA 1.453 -0.293 0 N-CA-C 108.343 -0.984 . . . . 1.0 108.343 -179.366 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 49' ' ' ASN . . . . . 0.581 ' O ' ' N ' ' A' ' 51' ' ' GLU . 2.7 p30 -147.13 138.87 13.54 Favored Pre-proline 0 CA--C 1.542 0.645 0 N-CA-C 108.252 -1.018 . . . . 1.0 108.252 179.82 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 50' ' ' PRO . . . . . 0.459 ' C ' ' H ' ' A' ' 52' ' ' ARG . 34.8 Cg_exo -54.61 72.05 0.03 OUTLIER 'Trans proline' 0 N--CA 1.502 1.987 0 C-N-CA 121.495 1.463 . . . . 1.0 112.299 179.456 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . 0.581 ' N ' ' O ' ' A' ' 49' ' ' ASN . 1.2 mp0 57.24 4.5 0.21 Allowed 'General case' 0 C--N 1.324 -0.514 0 O-C-N 121.736 -0.603 . . . . 1.0 111.091 179.304 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . 0.459 ' H ' ' C ' ' A' ' 50' ' ' PRO . 92.5 mtt180 -84.89 141.16 30.61 Favored 'General case' 0 CA--C 1.513 -0.452 0 N-CA-C 109.325 -0.62 . . . . 1.0 109.325 178.774 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 14.2 tt -66.48 146.91 12.9 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.704 0 CA-C-O 123.146 1.451 . . . . 1.0 113.355 -177.544 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -74.95 81.01 2.17 Favored 'General case' 0 C--N 1.311 -1.104 0 CA-C-N 111.309 -2.678 . . . . 1.0 111.071 -178.952 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 2.4 pp -148.49 156.89 8.13 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.888 0 N-CA-C 109.78 -0.452 . . . . 1.0 109.78 176.708 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 106.51 -3.84 37.11 Favored Glycine 0 N--CA 1.474 1.176 0 N-CA-C 110.266 -1.134 . . . . 1.0 110.266 179.575 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . 0.434 ' HB3' ' CD1' ' A' ' 45' ' ' PHE . 18.9 m-20 -80.94 103.98 11.14 Favored 'General case' 0 C--N 1.317 -0.831 0 CA-C-N 114.279 -0.96 . . . . 1.0 110.06 178.963 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 58' ' ' TRP . . . . . . . . . . . . . 5.9 m0 -90.09 172.24 8.97 Favored 'General case' 0 CA--C 1.542 0.659 0 CA-C-O 123.678 1.704 . . . . 1.0 114.288 -177.283 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 59' ' ' ARG . . . . . 0.478 ' CG ' ' N ' ' A' ' 60' ' ' TYR . 28.5 ptt-85 -78.6 -60.18 2.48 Favored 'General case' 0 CA--C 1.55 0.946 0 CA-C-N 110.451 -3.068 . . . . 1.0 113.865 -177.661 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 60' ' ' TYR . . . . . 0.478 ' N ' ' CG ' ' A' ' 59' ' ' ARG . 0.3 OUTLIER -92.21 -9.94 40.45 Favored 'General case' 0 N--CA 1.483 1.191 0 C-N-CA 124.122 0.969 . . . . 1.0 113.151 -179.728 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 22.3 tt0 -77.26 -14.73 59.7 Favored 'General case' 0 C--N 1.31 -1.133 0 CA-C-N 115.886 -0.597 . . . . 1.0 111.688 -178.3 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 62' ' ' VAL . . . . . 0.605 ' O ' ' N ' ' A' ' 66' ' ' GLY . 0.6 OUTLIER -48.05 -55.85 2.43 Favored 'Isoleucine or valine' 0 C--O 1.207 -1.14 0 C-N-CA 119.825 -0.75 . . . . 1.0 110.265 -175.156 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 63' ' ' ALA . . . . . 0.543 ' O ' ' HG3' ' A' ' 67' ' ' ARG . . . -65.98 -52.73 46.93 Favored 'General case' 0 C--N 1.307 -1.269 0 C-N-CA 119.722 -0.791 . . . . 1.0 109.75 -178.966 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 85.4 m-70 -48.9 -57.37 6.55 Favored 'General case' 0 N--CA 1.472 0.626 0 O-C-N 124.093 0.871 . . . . 1.0 109.964 -179.72 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 65' ' ' ASP . . . . . 0.615 ' C ' ' H ' ' A' ' 67' ' ' ARG . 5.8 t0 -72.45 -47.83 45.78 Favored 'General case' 0 C--N 1.313 -1.001 0 CA-C-O 121.582 0.706 . . . . 1.0 110.362 178.8 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . 0.605 ' N ' ' O ' ' A' ' 62' ' ' VAL . . . -70.71 26.47 0.5 Allowed Glycine 0 C--N 1.32 -0.322 0 O-C-N 120.868 -1.145 . . . . 1.0 110.636 177.985 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 67' ' ' ARG . . . . . 0.615 ' H ' ' C ' ' A' ' 65' ' ' ASP . 6.0 mtp85 -73.11 3.89 5.02 Favored 'General case' 0 N--CA 1.445 -0.688 0 N-CA-C 106.514 -1.661 . . . . 1.0 106.514 175.418 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . 0.484 ' H ' ' C ' ' A' ' 66' ' ' GLY . 0.0 OUTLIER -33.21 -29.65 0.01 OUTLIER 'General case' 0 N--CA 1.486 1.367 0 N-CA-C 108.489 -0.93 . . . . 1.0 108.489 -176.794 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . 0.606 ' N ' ' O ' ' A' ' 67' ' ' ARG . 22.2 mt -61.87 -63.39 1.27 Allowed 'General case' 0 C--N 1.315 -0.933 0 C-N-CA 118.542 -1.263 . . . . 1.0 107.814 178.289 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . 0.637 ' C ' ' H ' ' A' ' 72' ' ' HIS . . . -79.18 -75.28 0.25 Allowed 'General case' 0 N--CA 1.465 0.303 0 N-CA-C 106.271 -1.752 . . . . 1.0 106.271 176.635 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 71' ' ' ALA . . . . . 0.459 ' O ' ' C ' ' A' ' 72' ' ' HIS . . . -44.1 3.71 0.0 OUTLIER 'General case' 0 CA--C 1.519 -0.223 0 C-N-CA 124.826 1.25 . . . . 1.0 113.831 178.947 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 72' ' ' HIS . . . . . 0.637 ' H ' ' C ' ' A' ' 70' ' ' ALA . 0.2 OUTLIER -28.4 -67.85 0.07 Allowed 'General case' 0 N--CA 1.463 0.19 0 CA-C-N 118.36 0.527 . . . . 1.0 111.589 -178.658 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 73' ' ' MET . . . . . . . . . . . . . 13.8 ptp -69.57 -48.57 59.82 Favored 'General case' 0 C--N 1.325 -0.469 0 C-N-CA 118.983 -1.087 . . . . 1.0 108.968 178.525 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . 0.753 ' O ' ' N ' ' A' ' 76' ' ' GLY . 68.8 t -43.76 -40.54 1.48 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.265 0 CA-C-O 117.351 -1.309 . . . . 1.0 111.539 -176.35 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 75' ' ' ASN . . . . . 0.47 ' C ' ' N ' ' A' ' 77' ' ' ILE . 3.0 m120 -35.14 -12.62 0.0 OUTLIER 'General case' 0 N--CA 1.501 2.078 0 CA-C-N 121.244 1.838 . . . . 1.0 112.257 179.277 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 76' ' ' GLY . . . . . 0.753 ' N ' ' O ' ' A' ' 74' ' ' VAL . . . -45.72 -21.44 0.55 Allowed Glycine 0 CA--C 1.542 1.739 0 N-CA-C 107.844 -2.102 . . . . 1.0 107.844 175.173 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 77' ' ' ILE . . . . . 0.575 HG13 ' H ' ' A' ' 78' ' ' VAL . 1.2 pt -72.11 -55.9 11.86 Favored 'Isoleucine or valine' 0 C--O 1.216 -0.692 0 N-CA-C 107.696 -1.224 . . . . 1.0 107.696 178.021 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . 0.575 ' H ' HG13 ' A' ' 77' ' ' ILE . 95.8 t -33.79 -34.99 0.04 OUTLIER 'Isoleucine or valine' 0 CA--C 1.546 0.794 0 CA-C-N 113.2 -1.818 . . . . 1.0 106.849 -177.565 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . 0.633 ' O ' ' HB3' ' A' ' 83' ' ' ALA . 0.0 OUTLIER -98.31 -33.24 4.12 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.878 0 CA-C-N 115.605 -0.725 . . . . 1.0 112.416 176.556 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 80' ' ' ALA . . . . . 0.537 ' N ' ' O ' ' A' ' 77' ' ' ILE . . . -84.2 -10.71 57.5 Favored 'General case' 0 N--CA 1.478 0.974 0 O-C-N 121.257 -0.902 . . . . 1.0 113.184 179.662 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 81' ' ' GLU . . . . . 0.445 ' N ' ' O ' ' A' ' 77' ' ' ILE . 0.0 OUTLIER -89.27 -73.89 0.49 Allowed 'General case' 0 N--CA 1.451 -0.424 0 N-CA-C 112.115 0.413 . . . . 1.0 112.115 -177.629 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 24.3 m-20 -91.75 -16.8 26.35 Favored 'General case' 0 C--N 1.346 0.437 0 N-CA-C 114.532 1.308 . . . . 1.0 114.532 -179.096 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . 0.633 ' HB3' ' O ' ' A' ' 79' ' ' ILE . . . -49.67 -42.12 44.68 Favored 'General case' 0 C--O 1.211 -0.965 0 C-N-CA 118.304 -1.358 . . . . 1.0 110.792 -177.391 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . 0.564 HD13 ' O ' ' A' ' 84' ' ' LEU . 0.2 OUTLIER -40.33 -35.13 0.39 Allowed 'General case' 0 CA--C 1.543 0.7 0 CA-C-O 120.819 0.342 . . . . 1.0 111.131 -179.789 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 1.2 pp -74.4 -33.69 34.21 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.433 0 C-N-CA 119.999 -0.68 . . . . 1.0 110.125 178.477 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 86' ' ' ALA . . . . . 0.569 ' N ' ' O ' ' A' ' 83' ' ' ALA . . . -96.23 -26.36 15.46 Favored 'General case' 0 CA--C 1.54 0.573 0 CA-C-O 120.798 0.333 . . . . 1.0 111.698 179.175 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 87' ' ' GLU . . . . . 0.542 ' N ' ' O ' ' A' ' 83' ' ' ALA . 44.8 tt0 -57.9 -20.25 35.75 Favored 'General case' 0 C--N 1.329 -0.318 0 O-C-N 121.667 -0.646 . . . . 1.0 110.103 -178.833 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -71.98 -1.6 15.13 Favored 'General case' 0 N--CA 1.47 0.533 0 N-CA-C 107.494 -1.299 . . . . 1.0 107.494 178.095 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 89' ' ' VAL . . . . . 0.481 ' H ' ' C ' ' A' ' 87' ' ' GLU . 3.5 t -98.54 36.02 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.447 -0.616 0 CA-C-N 111.922 -2.399 . . . . 1.0 107.831 177.029 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 90' ' ' GLY . . . . . 0.844 ' O ' ' N ' ' A' ' 92' ' ' HIS . . . -55.95 -26.91 49.56 Favored Glycine 0 C--N 1.367 2.26 0 CA-C-O 117.609 -1.662 . . . . 1.0 111.519 176.672 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 91' ' ' PRO . . . . . 0.727 ' HD2' ' N ' ' A' ' 90' ' ' GLY . 11.5 Cg_exo -36.48 3.09 0.0 OUTLIER 'Trans proline' 0 N--CA 1.499 1.803 0 C-N-CA 123.084 2.523 . . . . 1.0 113.68 173.913 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 92' ' ' HIS . . . . . 0.844 ' N ' ' O ' ' A' ' 90' ' ' GLY . 0.0 OUTLIER -47.48 -27.91 1.95 Allowed 'General case' 0 N--CA 1.436 -1.141 0 N-CA-C 106.942 -1.503 . . . . 1.0 106.942 -179.887 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 93' ' ' LEU . . . . . 0.593 HD12 ' N ' ' A' ' 94' ' ' ALA . 2.0 pp -58.49 -52.46 65.55 Favored 'General case' 0 N--CA 1.448 -0.545 0 N-CA-C 106.931 -1.507 . . . . 1.0 106.931 176.417 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 94' ' ' ALA . . . . . 0.593 ' N ' HD12 ' A' ' 93' ' ' LEU . . . -49.8 -52.05 35.05 Favored 'General case' 0 C--O 1.221 -0.447 0 N-CA-C 107.457 -1.312 . . . . 1.0 107.457 -179.84 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 1.3 mpt_? -64.37 -31.44 72.64 Favored 'General case' 0 C--N 1.321 -0.666 0 N-CA-C 109.386 -0.598 . . . . 1.0 109.386 178.146 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 96' ' ' ALA . . . . . 0.842 ' O ' ' N ' ' A' ' 100' ' ' ILE . . . -50.87 -44.17 59.63 Favored 'General case' 0 C--O 1.197 -1.673 0 N-CA-C 106.368 -1.716 . . . . 1.0 106.368 -176.448 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 97' ' ' LEU . . . . . 0.506 ' O ' HG22 ' A' ' 100' ' ' ILE . 2.1 tt -35.05 -24.84 0.01 OUTLIER 'General case' 0 CA--C 1.588 2.423 0 CA-C-N 112.585 -2.098 . . . . 1.0 107.625 -178.937 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 98' ' ' GLY . . . . . 0.674 ' N ' ' O ' ' A' ' 96' ' ' ALA . . . -89.32 -51.84 2.85 Favored Glycine 0 CA--C 1.563 3.043 0 CA-C-O 123.312 1.507 . . . . 1.0 111.686 170.763 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 99' ' ' GLN . . . . . 0.562 ' N ' ' O ' ' A' ' 96' ' ' ALA . 6.3 mt-30 -76.72 8.43 3.66 Favored 'General case' 0 N--CA 1.437 -1.111 0 N-CA-C 106.607 -1.627 . . . . 1.0 106.607 177.676 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 100' ' ' ILE . . . . . 0.842 ' N ' ' O ' ' A' ' 96' ' ' ALA . 20.3 tt -59.36 -52.98 54.47 Favored 'Isoleucine or valine' 0 CA--C 1.474 -1.971 0 N-CA-C 106.276 -1.75 . . . . 1.0 106.276 178.296 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 101' ' ' VAL . . . . . 0.676 ' N ' HG23 ' A' ' 100' ' ' ILE . 0.2 OUTLIER -57.05 -61.03 1.4 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.658 0 C-N-CA 118.273 -1.371 . . . . 1.0 108.299 179.415 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 102' ' ' CYS . . . . . 0.879 ' O ' ' HB2' ' A' ' 106' ' ' ALA . 0.1 OUTLIER -50.63 -25.03 3.73 Favored 'General case' 0 C--N 1.317 -0.845 0 C-N-CA 120.588 -0.445 . . . . 1.0 111.179 -177.15 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 68.8 ttp85 -85.74 -49.0 8.29 Favored 'General case' 0 N--CA 1.482 1.158 0 O-C-N 124.731 1.269 . . . . 1.0 112.566 179.238 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 104' ' ' TYR . . . . . 0.735 ' O ' ' CG ' ' A' ' 104' ' ' TYR . 0.1 OUTLIER -96.38 23.63 6.55 Favored 'General case' 0 C--N 1.302 -1.457 0 C-N-CA 126.918 2.087 . . . . 1.0 108.788 179.401 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 105' ' ' GLY . . . . . 0.584 ' N ' ' O ' ' A' ' 101' ' ' VAL . . . -162.56 -93.4 0.09 OUTLIER Glycine 0 N--CA 1.45 -0.402 0 N-CA-C 106.608 -2.597 . . . . 1.0 106.608 178.313 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 106' ' ' ALA . . . . . 0.879 ' HB2' ' O ' ' A' ' 102' ' ' CYS . . . 69.06 64.14 0.29 Allowed 'General case' 0 C--O 1.219 -0.548 0 N-CA-C 113.146 0.795 . . . . 1.0 113.146 179.267 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 96.2 m -78.21 -58.73 3.1 Favored 'General case' 0 CA--C 1.547 0.829 0 O-C-N 121.152 -0.967 . . . . 1.0 109.353 179.529 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 108' ' ' VAL . . . . . 0.44 HG13 ' N ' ' A' ' 109' ' ' ILE . 3.8 p -58.64 -44.38 89.52 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-O 121.856 0.836 . . . . 1.0 109.662 -177.376 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 109' ' ' ILE . . . . . 0.449 ' HB ' ' HB1' ' A' ' 106' ' ' ALA . 3.3 mm -41.41 -61.41 1.4 Allowed Pre-proline 0 CA--C 1.569 1.689 0 CA-C-N 114.134 -1.394 . . . . 1.0 109.217 179.769 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 110' ' ' PRO . . . . . 0.638 ' CD ' ' O ' ' A' ' 106' ' ' ALA . 21.5 Cg_exo -47.64 -36.92 26.23 Favored 'Trans proline' 0 N--CA 1.502 1.998 0 C-N-CA 123.511 2.807 . . . . 1.0 113.401 174.802 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 111' ' ' ASN . . . . . 0.431 ' C ' ' N ' ' A' ' 113' ' ' ASN . 5.4 t30 -67.7 -67.78 0.43 Allowed 'General case' 0 C--O 1.236 0.381 0 O-C-N 121.082 -1.011 . . . . 1.0 109.946 -177.999 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 112' ' ' ILE . . . . . 0.452 ' H ' HG23 ' A' ' 112' ' ' ILE . 2.1 pt -49.02 -24.37 1.11 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-O 122.481 1.134 . . . . 1.0 109.154 -179.531 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 113' ' ' ASN . . . . . 0.466 ' HB3' ' O ' ' A' ' 110' ' ' PRO . 40.1 t30 -59.72 -53.71 54.77 Favored 'General case' 0 C--N 1.307 -1.264 0 CA-C-N 112.649 -2.069 . . . . 1.0 107.778 -177.695 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 114' ' ' ALA . . . . . 0.43 ' O ' HG22 ' A' ' 118' ' ' VAL . . . -56.92 -32.42 65.92 Favored 'General case' 0 N--CA 1.445 -0.687 0 CA-C-O 119.04 -0.505 . . . . 1.0 112.262 -179.652 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -78.83 -47.25 16.99 Favored 'General case' 0 C--O 1.211 -0.925 0 CA-C-O 122.314 1.054 . . . . 1.0 110.109 178.487 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 116' ' ' ILE . . . . . 0.468 ' O ' ' N ' ' A' ' 120' ' ' GLY . 32.2 mt -53.67 -53.09 28.27 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.101 0 CA-C-N 113.507 -1.679 . . . . 1.0 107.452 -179.148 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 117' ' ' GLU . . . . . 0.433 ' O ' ' HA ' ' A' ' 121' ' ' THR . 10.6 tt0 -44.36 -64.68 0.63 Allowed 'General case' 0 C--N 1.317 -0.816 0 CA-C-N 112.915 -1.948 . . . . 1.0 108.385 -179.249 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 118' ' ' VAL . . . . . 0.43 HG22 ' O ' ' A' ' 114' ' ' ALA . 29.2 m -59.6 -50.7 79.0 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.663 0 C-N-CA 119.652 -0.819 . . . . 1.0 109.723 179.885 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 119' ' ' LEU . . . . . 0.408 ' N ' HG23 ' A' ' 118' ' ' VAL . 0.4 OUTLIER -52.54 -71.29 0.07 Allowed 'General case' 0 CA--C 1.539 0.534 0 N-CA-C 106.845 -1.539 . . . . 1.0 106.845 -178.083 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 120' ' ' GLY . . . . . 0.701 ' O ' ' OG1' ' A' ' 121' ' ' THR . . . -69.28 -79.2 0.3 Allowed Glycine 0 CA--C 1.539 1.537 0 C-N-CA 119.133 -1.508 . . . . 1.0 111.023 179.964 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 121' ' ' THR . . . . . 0.701 ' OG1' ' O ' ' A' ' 120' ' ' GLY . 51.8 m 157.3 -32.01 0.0 OUTLIER 'General case' 0 N--CA 1.487 1.417 0 CA-C-N 112.422 -1.889 . . . . 1.0 111.818 179.859 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 122' ' ' GLY . . . . . 0.621 ' O ' ' N ' ' A' ' 124' ' ' ASP . . . 98.0 -21.81 44.12 Favored Glycine 0 N--CA 1.465 0.613 0 N-CA-C 108.027 -2.029 . . . . 1.0 108.027 -177.291 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 123' ' ' THR . . . . . 0.547 ' O ' ' CE1' ' A' ' 72' ' ' HIS . 58.3 m -46.22 90.61 0.0 OUTLIER 'General case' 0 N--CA 1.476 0.839 0 N-CA-C 105.928 -1.878 . . . . 1.0 105.928 177.832 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 124' ' ' ASP . . . . . 0.621 ' N ' ' O ' ' A' ' 122' ' ' GLY . 51.4 p-10 -162.86 171.1 17.19 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 115.596 -0.729 . . . . 1.0 112.177 -179.343 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 125' ' ' TYR . . . . . . . . . . . . . 86.0 t80 -142.55 141.91 32.11 Favored 'General case' 0 C--N 1.329 -0.315 0 N-CA-C 108.758 -0.831 . . . . 1.0 108.758 176.593 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 126' ' ' ARG . . . . . 0.442 HH22 ' HB ' ' A' ' 79' ' ' ILE . 14.3 mmm180 -147.75 147.87 30.35 Favored 'General case' 0 CA--C 1.533 0.306 0 N-CA-C 109.876 -0.416 . . . . 1.0 109.876 179.218 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 127' ' ' PHE . . . . . . . . . . . . . 23.2 t80 . . . . . 0 N--CA 1.471 0.607 0 CA-C-O 117.995 -1.003 . . . . 1.0 110.824 179.775 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 2.7 mmt . . . . . 0 N--CA 1.489 1.479 0 N-CA-C 108.838 -0.801 . . . . 1.0 108.838 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 2' ' ' SER . . . . . 0.503 ' O ' ' CB ' ' A' ' 3' ' ' ASP . 47.1 t -73.36 4.94 4.07 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.218 -0.446 . . . . 1.0 110.732 179.777 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 3' ' ' ASP . . . . . 0.503 ' CB ' ' O ' ' A' ' 2' ' ' SER . 12.0 p30 149.22 135.57 0.0 OUTLIER 'General case' 0 N--CA 1.478 0.928 0 O-C-N 123.725 0.64 . . . . 1.0 110.81 179.759 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 87.3 t80 -154.15 149.43 27.07 Favored 'General case' 0 CA--C 1.518 -0.268 0 CA-C-O 121.014 0.435 . . . . 1.0 110.365 178.982 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 5' ' ' ASP . . . . . 0.417 ' HB2' ' N ' ' A' ' 10' ' ' SER . 0.9 OUTLIER -150.78 147.33 27.16 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.133 -0.485 . . . . 1.0 110.055 179.935 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 6' ' ' THR . . . . . 0.731 ' O ' ' N ' ' A' ' 10' ' ' SER . 0.2 OUTLIER -112.21 -162.74 0.81 Allowed 'General case' 0 C--O 1.207 -1.172 0 CA-C-O 121.629 0.728 . . . . 1.0 110.749 -178.639 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . 0.548 ' O ' ' HB2' ' A' ' 11' ' ' ARG . 73.2 mm-40 -54.41 -43.45 71.52 Favored 'General case' 0 C--N 1.304 -1.399 0 CA-C-O 121.984 0.897 . . . . 1.0 108.733 -179.233 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 8' ' ' ARG . . . . . 0.902 ' O ' ' HB3' ' A' ' 12' ' ' ALA . 60.0 mtp180 -72.73 -60.68 2.12 Favored 'General case' 0 C--N 1.313 -0.987 0 C-N-CA 118.095 -1.442 . . . . 1.0 110.487 177.713 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . 1.005 ' O ' ' HB ' ' A' ' 13' ' ' VAL . 10.7 t -60.51 -51.11 76.91 Favored 'Isoleucine or valine' 0 C--O 1.196 -1.761 0 C-N-CA 117.921 -1.512 . . . . 1.0 110.639 179.963 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 10' ' ' SER . . . . . 0.731 ' N ' ' O ' ' A' ' 6' ' ' THR . 2.6 t -70.09 -66.25 0.62 Allowed 'General case' 0 C--N 1.303 -1.445 0 O-C-N 121.271 -0.893 . . . . 1.0 113.03 -178.775 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 11' ' ' ARG . . . . . 0.548 ' HB2' ' O ' ' A' ' 7' ' ' GLU . 1.7 mmt85 -62.11 -43.87 97.89 Favored 'General case' 0 C--N 1.318 -0.787 0 CA-C-O 120.455 0.169 . . . . 1.0 111.4 -176.496 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . 0.902 ' HB3' ' O ' ' A' ' 8' ' ' ARG . . . -70.74 -59.7 2.66 Favored 'General case' 0 C--N 1.32 -0.68 0 C-N-CA 118.4 -1.32 . . . . 1.0 110.241 -179.993 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . 1.005 ' HB ' ' O ' ' A' ' 9' ' ' VAL . 4.6 t -57.35 -51.3 71.28 Favored 'Isoleucine or valine' 0 C--O 1.199 -1.605 0 N-CA-C 107.029 -1.471 . . . . 1.0 107.029 179.503 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . 0.954 ' O ' HG22 ' A' ' 18' ' ' VAL . . . -62.06 -66.5 0.53 Allowed 'General case' 0 C--N 1.306 -1.284 0 C-N-CA 115.549 -2.461 . . . . 1.0 113.061 -178.765 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . 0.546 ' HB3' ' O ' ' A' ' 11' ' ' ARG . . . -51.18 -55.27 18.82 Favored 'General case' 0 C--N 1.319 -0.737 0 C-N-CA 119.706 -0.797 . . . . 1.0 109.257 -178.728 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . 0.659 ' HB3' ' O ' ' A' ' 12' ' ' ALA . . . -64.35 -59.17 4.69 Favored 'General case' 0 C--N 1.299 -1.605 0 C-N-CA 118.101 -1.44 . . . . 1.0 111.346 -179.924 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . 0.701 ' CB ' ' O ' ' A' ' 13' ' ' VAL . 6.8 tt -55.09 -55.23 33.36 Favored 'General case' 0 N--CA 1.477 0.876 0 N-CA-C 108.832 -0.803 . . . . 1.0 108.832 -177.051 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . 0.954 HG22 ' O ' ' A' ' 14' ' ' ALA . 2.3 m -71.26 -58.86 4.22 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 CA-C-N 115.895 -0.593 . . . . 1.0 110.212 -179.817 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . 0.558 ' N ' ' CG2' ' A' ' 18' ' ' VAL . . . -58.16 -166.44 0.12 Allowed Glycine 0 CA--C 1.491 -1.454 0 N-CA-C 110.815 -0.914 . . . . 1.0 110.815 -177.322 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 20' ' ' PRO . . . . . 0.607 ' O ' ' N ' ' A' ' 24' ' ' ALA . 1.0 OUTLIER -79.85 -26.18 4.72 Favored 'Trans proline' 0 C--N 1.292 -2.421 0 C-N-CA 122.032 1.822 . . . . 1.0 113.59 -177.657 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . 0.518 ' O ' ' HB3' ' A' ' 24' ' ' ALA . . . -62.68 -58.49 11.97 Favored Glycine 0 N--CA 1.473 1.156 0 C-N-CA 119.496 -1.335 . . . . 1.0 111.877 -178.217 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . 0.644 ' N ' ' O ' ' A' ' 16' ' ' ALA . . . -57.61 -54.15 39.53 Favored Glycine 0 C--N 1.307 -1.068 0 C-N-CA 116.447 -2.787 . . . . 1.0 107.073 -178.778 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . 0.516 ' O ' HG12 ' A' ' 27' ' ' VAL . 54.0 t -52.63 -31.26 15.8 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.042 0 N-CA-C 107.859 -1.163 . . . . 1.0 107.859 178.564 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . 0.607 ' N ' ' O ' ' A' ' 20' ' ' PRO . . . -63.72 -63.9 1.04 Allowed 'General case' 0 C--O 1.218 -0.593 0 C-N-CA 119.416 -0.914 . . . . 1.0 110.969 -179.467 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 61.6 mt -61.64 -46.47 89.63 Favored 'General case' 0 C--N 1.321 -0.64 0 C-N-CA 119.666 -0.814 . . . . 1.0 111.881 -176.571 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 92.1 t -60.35 -60.75 2.1 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.531 0 C-N-CA 119.708 -0.797 . . . . 1.0 110.041 -177.004 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . 0.551 ' O ' ' HB3' ' A' ' 31' ' ' ALA . 2.2 p -54.81 -36.68 38.05 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.736 0 C-N-CA 119.622 -0.831 . . . . 1.0 109.203 -177.819 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . 0.44 ' HB2' ' O ' ' A' ' 24' ' ' ALA . 3.7 tmmm? -66.2 -55.52 15.85 Favored 'General case' 0 C--N 1.315 -0.892 0 C-N-CA 119.254 -0.979 . . . . 1.0 110.713 -177.532 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 82.3 t -62.95 -49.9 81.76 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.973 0 CA-C-N 114.641 -1.163 . . . . 1.0 110.135 -177.517 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 30' ' ' CYS . . . . . . . . . . . . . 4.1 t -65.27 -62.11 1.73 Allowed 'General case' 0 N--CA 1.443 -0.822 0 C-N-CA 119.675 -0.81 . . . . 1.0 109.458 -178.544 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . 0.551 ' HB3' ' O ' ' A' ' 27' ' ' VAL . . . -51.71 -46.44 63.93 Favored 'General case' 0 CA--C 1.5 -0.97 0 CA-C-O 121.282 0.563 . . . . 1.0 110.568 -176.23 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . 0.462 ' O ' ' CB ' ' A' ' 33' ' ' LEU . . . 66.56 67.05 2.13 Favored Glycine 0 N--CA 1.443 -0.896 0 N-CA-C 109.627 -1.389 . . . . 1.0 109.627 -179.998 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . 0.462 ' CB ' ' O ' ' A' ' 32' ' ' GLY . 0.3 OUTLIER 82.88 104.26 0.03 OUTLIER Pre-proline 0 CA--C 1.542 0.644 0 CA-C-N 113.048 -1.576 . . . . 1.0 108.343 -178.622 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 52.2 Cg_exo -48.64 -20.34 2.64 Favored 'Trans proline' 0 N--CA 1.499 1.825 0 C-N-CA 122.504 2.136 . . . . 1.0 114.293 -178.259 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . 0.527 ' CA ' HD12 ' A' ' 112' ' ' ILE . . . -67.54 -62.72 4.16 Favored Glycine 0 N--CA 1.467 0.74 0 C-N-CA 118.357 -1.877 . . . . 1.0 112.27 -176.73 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . 0.75 ' O ' HG22 ' A' ' 37' ' ' ILE . 18.3 m -78.83 -153.88 0.03 OUTLIER 'Isoleucine or valine' 0 C--O 1.216 -0.696 0 N-CA-C 108.121 -1.066 . . . . 1.0 108.121 -179.119 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . 0.75 HG22 ' O ' ' A' ' 36' ' ' VAL . 0.3 OUTLIER 73.63 77.06 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.32 -0.688 0 O-C-N 124.2 0.938 . . . . 1.0 111.553 178.97 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 1.3 t60 -139.32 135.73 34.08 Favored 'General case' 0 CA--C 1.492 -1.278 0 O-C-N 120.906 -1.121 . . . . 1.0 109.329 179.4 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 3.3 m -115.32 132.19 23.2 Favored Pre-proline 0 N--CA 1.451 -0.409 0 C-N-CA 120.413 -0.515 . . . . 1.0 109.984 -178.913 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 23.6 Cg_endo -62.14 -15.21 42.56 Favored 'Trans proline' 0 N--CA 1.494 1.52 0 C-N-CA 122.039 1.826 . . . . 1.0 112.179 179.356 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -128.79 135.11 48.7 Favored 'General case' 0 N--CA 1.468 0.438 0 CA-C-N 116.729 -0.214 . . . . 1.0 110.504 178.399 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . 0.573 ' HG2' ' N ' ' A' ' 43' ' ' ARG . 39.1 ttp180 -173.16 174.25 3.45 Favored 'General case' 0 C--N 1.328 -0.339 0 C-N-CA 120.558 -0.457 . . . . 1.0 111.14 178.718 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 43' ' ' ARG . . . . . 0.573 ' N ' ' HG2' ' A' ' 42' ' ' ARG . 67.1 ttt-85 -57.61 -45.97 84.68 Favored 'General case' 0 CA--C 1.538 0.517 0 N-CA-C 107.697 -1.224 . . . . 1.0 107.697 178.53 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . 0.436 ' O ' ' CD1' ' A' ' 45' ' ' PHE . . . 121.58 -25.03 7.04 Favored Glycine 0 N--CA 1.481 1.675 0 CA-C-N 116.925 -0.125 . . . . 1.0 112.829 179.653 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . 0.815 ' O ' ' HB2' ' A' ' 46' ' ' PHE . 1.5 m-85 -158.58 167.52 29.38 Favored 'General case' 0 C--N 1.306 -1.314 0 N-CA-C 108.23 -1.026 . . . . 1.0 108.23 179.564 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 46' ' ' PHE . . . . . 0.815 ' HB2' ' O ' ' A' ' 45' ' ' PHE . 0.2 OUTLIER 107.45 116.7 0.01 OUTLIER 'General case' 0 N--CA 1.472 0.66 0 O-C-N 125.094 1.496 . . . . 1.0 111.367 179.408 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 47' ' ' ARG . . . . . 0.459 ' CB ' ' O ' ' A' ' 46' ' ' PHE . 9.5 ptt85 90.36 156.5 0.04 OUTLIER 'General case' 0 N--CA 1.479 1.01 0 O-C-N 123.64 0.587 . . . . 1.0 111.405 179.325 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 37.3 t 61.15 68.08 0.76 Allowed 'General case' 0 CA--C 1.509 -0.609 0 CA-C-N 116.151 -0.477 . . . . 1.0 109.851 179.145 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 49' ' ' ASN . . . . . 0.667 ' O ' ' N ' ' A' ' 51' ' ' GLU . 0.2 OUTLIER -149.56 159.14 36.97 Favored Pre-proline 0 C--N 1.315 -0.898 0 CA-C-N 115.869 -0.605 . . . . 1.0 109.381 179.203 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 4.1 Cg_endo -48.87 53.34 0.02 OUTLIER 'Trans proline' 0 N--CA 1.511 2.527 0 C-N-CA 123.981 3.121 . . . . 1.0 113.919 177.544 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . 0.667 ' N ' ' O ' ' A' ' 49' ' ' ASN . 2.7 mm-40 42.56 57.71 3.37 Favored 'General case' 0 CA--C 1.536 0.414 0 CA-C-O 121.246 0.546 . . . . 1.0 111.756 178.038 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . 0.854 HH21 HD12 ' A' ' 85' ' ' ILE . 2.5 ptm180 -156.36 168.83 26.12 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.308 -0.406 . . . . 1.0 111.501 179.225 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . 0.427 HG13 ' N ' ' A' ' 54' ' ' GLN . 7.4 tp -83.44 166.94 2.06 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 N-CA-C 108.612 -0.884 . . . . 1.0 108.612 176.65 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 54' ' ' GLN . . . . . 0.427 ' N ' HG13 ' A' ' 53' ' ' ILE . 35.8 mt-30 -134.72 134.31 40.88 Favored 'General case' 0 N--CA 1.467 0.415 0 O-C-N 121.775 -0.578 . . . . 1.0 109.551 179.419 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . 0.476 HG22 HD11 ' A' ' 85' ' ' ILE . 19.9 tt -144.36 154.06 15.12 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.637 0 N-CA-C 110.139 -0.319 . . . . 1.0 110.139 178.948 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 103.23 4.51 47.29 Favored Glycine 0 N--CA 1.469 0.866 0 N-CA-C 110.178 -1.169 . . . . 1.0 110.178 -179.059 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 29.3 t70 -95.49 114.16 25.89 Favored 'General case' 0 CA--C 1.54 0.589 0 N-CA-C 113.632 0.975 . . . . 1.0 113.632 -178.886 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 58' ' ' TRP . . . . . 0.539 ' HB2' ' HB2' ' A' ' 61' ' ' GLU . 35.4 m95 -83.07 -176.69 6.46 Favored 'General case' 0 C--O 1.236 0.375 0 CA-C-N 112.527 -2.124 . . . . 1.0 109.677 176.15 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 59' ' ' ARG . . . . . 0.584 ' HD2' ' H ' ' A' ' 59' ' ' ARG . 0.0 OUTLIER -94.45 -55.61 3.1 Favored 'General case' 0 CA--C 1.547 0.844 0 CA-C-O 121.545 0.688 . . . . 1.0 110.471 179.566 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 60' ' ' TYR . . . . . 0.544 ' O ' ' CG ' ' A' ' 60' ' ' TYR . 4.7 t80 -73.96 -5.69 42.78 Favored 'General case' 0 N--CA 1.469 0.481 0 C-N-CA 124.338 1.055 . . . . 1.0 110.146 178.317 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . 0.539 ' HB2' ' HB2' ' A' ' 58' ' ' TRP . 4.7 tt0 -68.57 -17.91 64.23 Favored 'General case' 0 C--N 1.312 -1.058 0 O-C-N 121.07 -1.019 . . . . 1.0 111.444 -179.56 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 62' ' ' VAL . . . . . 0.496 HG23 ' N ' ' A' ' 63' ' ' ALA . 16.1 m -42.01 -49.63 0.93 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.504 0 CA-C-O 121.118 0.485 . . . . 1.0 109.706 -174.42 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 63' ' ' ALA . . . . . 0.496 ' N ' HG23 ' A' ' 62' ' ' VAL . . . -64.23 -45.25 89.0 Favored 'General case' 0 N--CA 1.42 -1.958 0 N-CA-C 108.316 -0.994 . . . . 1.0 108.316 177.039 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 64' ' ' HIS . . . . . 0.529 ' N ' ' O ' ' A' ' 61' ' ' GLU . 0.1 OUTLIER -56.68 -61.3 2.52 Favored 'General case' 0 CA--C 1.537 0.455 0 C-N-CA 118.927 -1.109 . . . . 1.0 111.108 179.803 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 65' ' ' ASP . . . . . 0.715 ' C ' ' H ' ' A' ' 67' ' ' ARG . 4.6 m-20 -63.19 -48.44 78.32 Favored 'General case' 0 C--O 1.24 0.594 0 CA-C-O 121.526 0.679 . . . . 1.0 109.808 179.139 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -62.2 28.76 0.06 OUTLIER Glycine 0 C--N 1.317 -0.499 0 N-CA-C 110.87 -0.892 . . . . 1.0 110.87 -179.09 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 67' ' ' ARG . . . . . 0.715 ' H ' ' C ' ' A' ' 65' ' ' ASP . 0.0 OUTLIER -82.92 -13.82 55.33 Favored 'General case' 0 N--CA 1.436 -1.153 0 C-N-CA 122.766 0.426 . . . . 1.0 111.558 176.394 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . 0.672 ' O ' ' HA ' ' A' ' 72' ' ' HIS . 0.8 OUTLIER -40.24 -30.11 0.09 Allowed 'General case' 0 C--O 1.22 -0.451 0 N-CA-C 107.009 -1.478 . . . . 1.0 107.009 179.05 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . 0.488 ' N ' ' C ' ' A' ' 67' ' ' ARG . 3.4 tt -65.67 -66.12 0.59 Allowed 'General case' 0 C--N 1.311 -1.071 0 C-N-CA 117.39 -1.724 . . . . 1.0 108.267 177.877 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . 0.697 ' C ' ' H ' ' A' ' 72' ' ' HIS . . . -76.32 -74.45 0.23 Allowed 'General case' 0 N--CA 1.466 0.346 0 N-CA-C 108.895 -0.78 . . . . 1.0 108.895 -179.753 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 71' ' ' ALA . . . . . 0.695 ' HB1' ' HB ' ' A' ' 74' ' ' VAL . . . -58.0 13.51 0.01 OUTLIER 'General case' 0 C--N 1.321 -0.65 0 C-N-CA 124.25 1.02 . . . . 1.0 110.851 -178.163 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 72' ' ' HIS . . . . . 0.697 ' H ' ' C ' ' A' ' 70' ' ' ALA . 0.3 OUTLIER -12.07 -74.53 0.01 OUTLIER 'General case' 0 N--CA 1.478 0.959 0 C-N-CA 124.295 1.038 . . . . 1.0 113.113 -174.654 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 73' ' ' MET . . . . . . . . . . . . . 1.4 mpt? -62.63 -41.91 99.29 Favored 'General case' 0 C--N 1.285 -2.216 0 C-N-CA 119.164 -1.014 . . . . 1.0 111.565 -178.431 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . 0.695 ' HB ' ' HB1' ' A' ' 71' ' ' ALA . 41.4 t -44.27 -49.3 2.12 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.346 0 C-N-CA 119.864 -0.734 . . . . 1.0 110.103 -175.515 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 75' ' ' ASN . . . . . 0.498 ' O ' ' N ' ' A' ' 77' ' ' ILE . 14.0 t-20 -39.52 -21.57 0.01 OUTLIER 'General case' 0 N--CA 1.472 0.664 0 CA-C-O 122.787 1.279 . . . . 1.0 111.441 -179.815 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 76' ' ' GLY . . . . . 0.569 ' N ' ' O ' ' A' ' 74' ' ' VAL . . . -43.87 -19.5 0.11 Allowed Glycine 0 CA--C 1.539 1.585 0 CA-C-N 113.662 -1.608 . . . . 1.0 109.827 178.674 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 77' ' ' ILE . . . . . 0.655 ' O ' ' N ' ' A' ' 80' ' ' ALA . 10.3 pt -88.17 -47.0 15.72 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.45 0 N-CA-C 108.386 -0.968 . . . . 1.0 108.386 -178.674 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . 0.524 ' O ' ' HB3' ' A' ' 82' ' ' ASP . 21.6 t -37.74 -35.7 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.433 -1.3 0 N-CA-C 108.14 -1.059 . . . . 1.0 108.14 -177.165 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . 0.551 ' O ' ' HB3' ' A' ' 83' ' ' ALA . 0.3 OUTLIER -87.07 -24.48 6.39 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.34 0 CA-C-O 121.03 0.443 . . . . 1.0 111.083 179.577 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 80' ' ' ALA . . . . . 0.655 ' N ' ' O ' ' A' ' 77' ' ' ILE . . . -73.29 -10.48 59.8 Favored 'General case' 0 C--N 1.319 -0.737 0 O-C-N 122.21 -0.306 . . . . 1.0 111.809 179.119 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 71.8 mt-10 -120.99 -62.79 1.41 Allowed 'General case' 0 CA--C 1.531 0.247 0 CA-C-O 121.705 0.764 . . . . 1.0 111.133 176.953 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 82' ' ' ASP . . . . . 0.839 ' O ' HG13 ' A' ' 85' ' ' ILE . 0.0 OUTLIER -58.73 -62.83 1.58 Allowed 'General case' 0 C--O 1.202 -1.401 0 CA-C-N 114.939 -1.028 . . . . 1.0 109.561 -179.54 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . 0.551 ' HB3' ' O ' ' A' ' 79' ' ' ILE . . . -56.63 -38.08 71.63 Favored 'General case' 0 CA--C 1.506 -0.718 0 C-N-CA 119.803 -0.759 . . . . 1.0 110.14 -176.087 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . 0.713 HD13 ' O ' ' A' ' 84' ' ' LEU . 3.4 tm? -32.01 -35.32 0.02 OUTLIER 'General case' 0 CA--C 1.51 -0.564 0 CA-C-N 115.525 -0.762 . . . . 1.0 111.839 -174.647 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 85' ' ' ILE . . . . . 0.854 HD12 HH21 ' A' ' 52' ' ' ARG . 4.7 mt -43.96 -17.83 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.323 -0.544 0 C-N-CA 120.492 -0.483 . . . . 1.0 110.205 179.622 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 86' ' ' ALA . . . . . 0.674 ' O ' ' N ' ' A' ' 90' ' ' GLY . . . -60.61 -58.46 8.37 Favored 'General case' 0 C--O 1.221 -0.446 0 C-N-CA 119.898 -0.721 . . . . 1.0 109.768 179.852 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 87' ' ' GLU . . . . . 0.444 ' OE1' ' N ' ' A' ' 87' ' ' GLU . 0.2 OUTLIER -35.64 -24.15 0.01 OUTLIER 'General case' 0 N--CA 1.468 0.468 0 CA-C-O 121.023 0.44 . . . . 1.0 110.663 -177.981 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 88' ' ' ALA . . . . . 0.621 ' N ' ' O ' ' A' ' 86' ' ' ALA . . . -101.31 -43.46 5.95 Favored 'General case' 0 C--O 1.237 0.444 0 N-CA-C 109.099 -0.704 . . . . 1.0 109.099 177.324 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 89' ' ' VAL . . . . . 0.634 ' C ' ' HD2' ' A' ' 91' ' ' PRO . 3.0 t -100.19 38.26 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.34 0.186 0 N-CA-C 108.775 -0.824 . . . . 1.0 108.775 178.01 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 90' ' ' GLY . . . . . 0.889 ' O ' ' N ' ' A' ' 92' ' ' HIS . . . -62.08 -17.59 55.78 Favored Glycine 0 C--N 1.358 1.801 0 CA-C-O 117.553 -1.693 . . . . 1.0 111.92 177.83 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 91' ' ' PRO . . . . . 0.783 ' HD2' ' N ' ' A' ' 90' ' ' GLY . 75.3 Cg_exo -32.62 1.01 0.0 OUTLIER 'Trans proline' 0 N--CA 1.513 2.659 0 C-N-CA 124.382 3.388 . . . . 1.0 113.694 171.811 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 92' ' ' HIS . . . . . 0.889 ' N ' ' O ' ' A' ' 90' ' ' GLY . 42.1 t-80 -49.88 -30.11 9.43 Favored 'General case' 0 N--CA 1.427 -1.591 0 N-CA-C 108.357 -0.979 . . . . 1.0 108.357 176.479 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 93' ' ' LEU . . . . . 0.672 ' O ' ' N ' ' A' ' 96' ' ' ALA . 0.8 OUTLIER -61.17 -60.64 3.45 Favored 'General case' 0 C--O 1.222 -0.367 0 N-CA-C 107.358 -1.349 . . . . 1.0 107.358 177.684 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 94' ' ' ALA . . . . . 0.607 ' HB3' HH21 ' A' ' 95' ' ' ARG . . . -45.75 -51.18 13.01 Favored 'General case' 0 N--CA 1.437 -1.104 0 N-CA-C 108.064 -1.087 . . . . 1.0 108.064 -179.193 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 95' ' ' ARG . . . . . 0.607 HH21 ' HB3' ' A' ' 94' ' ' ALA . 0.0 OUTLIER -60.21 -25.27 65.48 Favored 'General case' 0 N--CA 1.434 -1.226 0 C-N-CA 120.013 -0.675 . . . . 1.0 109.334 176.494 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 96' ' ' ALA . . . . . 0.759 ' O ' ' N ' ' A' ' 100' ' ' ILE . . . -57.05 -52.1 66.61 Favored 'General case' 0 C--O 1.207 -1.135 0 N-CA-C 107.227 -1.397 . . . . 1.0 107.227 179.511 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 97' ' ' LEU . . . . . 0.705 ' O ' HG22 ' A' ' 100' ' ' ILE . 0.1 OUTLIER -35.55 -29.16 0.01 OUTLIER 'General case' 0 CA--C 1.567 1.63 0 N-CA-C 107.238 -1.393 . . . . 1.0 107.238 -179.716 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 98' ' ' GLY . . . . . 0.611 ' N ' ' O ' ' A' ' 96' ' ' ALA . . . -81.51 -52.9 4.01 Favored Glycine 0 CA--C 1.551 2.309 0 CA-C-O 123.083 1.379 . . . . 1.0 110.831 174.422 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 99' ' ' GLN . . . . . 0.612 ' N ' ' O ' ' A' ' 96' ' ' ALA . 27.0 mt-30 -79.19 7.66 7.24 Favored 'General case' 0 N--CA 1.438 -1.028 0 N-CA-C 108.548 -0.908 . . . . 1.0 108.548 178.366 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 100' ' ' ILE . . . . . 0.759 ' N ' ' O ' ' A' ' 96' ' ' ALA . 16.7 tt -60.39 -51.25 75.2 Favored 'Isoleucine or valine' 0 CA--C 1.493 -1.233 0 N-CA-C 108.71 -0.848 . . . . 1.0 108.71 179.826 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 101' ' ' VAL . . . . . 0.674 ' N ' HG23 ' A' ' 100' ' ' ILE . 24.1 t -55.05 -57.12 7.87 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.977 0 C-N-CA 117.083 -1.847 . . . . 1.0 107.058 178.058 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 102' ' ' CYS . . . . . 0.786 ' O ' ' HB2' ' A' ' 106' ' ' ALA . 4.9 t -44.47 -25.63 0.28 Allowed 'General case' 0 C--O 1.214 -0.791 0 C-N-CA 120.085 -0.646 . . . . 1.0 109.854 -178.944 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 103' ' ' ARG . . . . . 0.426 ' N ' ' C ' ' A' ' 101' ' ' VAL . 1.7 tpp85 -87.19 -45.06 11.0 Favored 'General case' 0 N--CA 1.476 0.862 0 N-CA-C 113.444 0.905 . . . . 1.0 113.444 179.459 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 104' ' ' TYR . . . . . 0.747 ' O ' ' CG ' ' A' ' 104' ' ' TYR . 3.0 t80 -99.19 19.63 14.98 Favored 'General case' 0 C--N 1.31 -1.121 0 C-N-CA 127.066 2.146 . . . . 1.0 110.137 -179.623 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 105' ' ' GLY . . . . . 0.869 ' O ' HG23 ' A' ' 107' ' ' THR . . . -164.27 -7.79 0.03 OUTLIER Glycine 0 N--CA 1.441 -0.975 0 C-N-CA 117.891 -2.1 . . . . 1.0 111.588 177.337 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 106' ' ' ALA . . . . . 0.786 ' HB2' ' O ' ' A' ' 102' ' ' CYS . . . -15.53 62.7 0.0 OUTLIER 'General case' 0 N--CA 1.471 0.6 0 O-C-N 125.147 1.145 . . . . 1.0 111.997 -179.034 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 107' ' ' THR . . . . . 0.869 HG23 ' O ' ' A' ' 105' ' ' GLY . 11.4 p -100.38 -2.81 32.47 Favored 'General case' 0 CA--C 1.534 0.339 0 CA-C-N 116.265 -0.425 . . . . 1.0 110.119 -179.425 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 108' ' ' VAL . . . . . 0.732 HG13 ' N ' ' A' ' 109' ' ' ILE . 8.1 p -84.72 -57.84 4.03 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.427 0 CA-C-N 116.389 -0.369 . . . . 1.0 111.057 -178.194 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 109' ' ' ILE . . . . . 0.732 ' N ' HG13 ' A' ' 108' ' ' VAL . 0.2 OUTLIER -47.22 -47.76 56.03 Favored Pre-proline 0 CA--C 1.503 -0.842 0 C-N-CA 122.756 0.422 . . . . 1.0 111.852 179.458 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 110' ' ' PRO . . . . . 0.618 ' HD2' ' N ' ' A' ' 109' ' ' ILE . 6.0 Cg_endo -40.65 -39.84 3.15 Favored 'Trans proline' 0 CA--C 1.507 -0.85 0 C-N-CA 121.025 1.15 . . . . 1.0 114.081 -172.414 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 19.6 m-20 -65.09 -68.0 0.39 Allowed 'General case' 0 C--N 1.305 -1.33 0 C-N-CA 119.047 -1.061 . . . . 1.0 110.475 -176.967 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 112' ' ' ILE . . . . . 0.527 HD12 ' CA ' ' A' ' 35' ' ' GLY . 0.0 OUTLIER -69.21 -25.48 29.65 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.788 0 CA-C-N 115.498 -0.773 . . . . 1.0 110.594 -178.012 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 113' ' ' ASN . . . . . 0.485 ' CB ' ' O ' ' A' ' 109' ' ' ILE . 7.0 t30 -54.65 -61.83 2.05 Favored 'General case' 0 CA--C 1.488 -1.438 0 CA-C-N 114.268 -1.333 . . . . 1.0 110.854 -174.882 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -65.12 -20.46 66.47 Favored 'General case' 0 N--CA 1.432 -1.35 0 O-C-N 124.233 0.958 . . . . 1.0 110.255 -179.723 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -75.33 -61.78 1.79 Allowed 'General case' 0 C--O 1.241 0.624 0 C-N-CA 120.255 -0.578 . . . . 1.0 112.078 178.86 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 116' ' ' ILE . . . . . 0.484 ' O ' ' CB ' ' A' ' 119' ' ' LEU . 26.5 pt -68.52 -40.92 82.72 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.498 0 O-C-N 121.079 -1.013 . . . . 1.0 111.589 -177.895 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 117' ' ' GLU . . . . . 0.471 ' C ' ' N ' ' A' ' 119' ' ' LEU . 2.6 tt0 -47.21 -66.2 0.44 Allowed 'General case' 0 C--N 1.317 -0.823 0 CA-C-N 115.42 -0.809 . . . . 1.0 110.432 -177.18 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 72.0 t -50.11 -14.58 0.26 Allowed 'Isoleucine or valine' 0 N--CA 1.437 -1.121 0 O-C-N 124.572 1.17 . . . . 1.0 109.332 -178.822 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 119' ' ' LEU . . . . . 0.484 ' CB ' ' O ' ' A' ' 116' ' ' ILE . 0.2 OUTLIER -79.04 -62.6 1.64 Allowed 'General case' 0 N--CA 1.451 -0.413 0 C-N-CA 119.316 -0.954 . . . . 1.0 109.514 176.345 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -70.18 -84.98 0.16 Allowed Glycine 0 N--CA 1.481 1.689 0 C-N-CA 117.53 -2.271 . . . . 1.0 112.052 -179.139 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 34.0 m -161.8 -19.73 0.05 OUTLIER 'General case' 0 CA--C 1.542 0.651 0 CA-C-O 120.769 0.319 . . . . 1.0 110.231 -179.139 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 122' ' ' GLY . . . . . 0.481 ' O ' ' N ' ' A' ' 124' ' ' ASP . . . 111.59 -36.13 4.35 Favored Glycine 0 N--CA 1.477 1.387 0 C-N-CA 125.202 1.382 . . . . 1.0 112.138 179.752 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 123' ' ' THR . . . . . 0.464 ' C ' ' O ' ' A' ' 122' ' ' GLY . 0.0 OUTLIER -32.09 93.21 0.01 OUTLIER 'General case' 0 N--CA 1.469 0.523 0 CA-C-N 118.867 1.333 . . . . 1.0 112.461 -177.888 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 124' ' ' ASP . . . . . 0.481 ' N ' ' O ' ' A' ' 122' ' ' GLY . 8.7 t70 -141.49 141.6 33.62 Favored 'General case' 0 C--N 1.328 -0.352 0 N-CA-C 107.425 -1.324 . . . . 1.0 107.425 177.452 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 125' ' ' TYR . . . . . . . . . . . . . 9.7 t80 -153.58 147.24 25.16 Favored 'General case' 0 C--N 1.324 -0.532 0 N-CA-C 109.692 -0.484 . . . . 1.0 109.692 -177.569 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 9.0 mmp_? -147.5 152.08 37.43 Favored 'General case' 0 CA--C 1.542 0.646 0 CA-C-N 115.532 -0.758 . . . . 1.0 110.777 177.281 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 127' ' ' PHE . . . . . . . . . . . . . 22.6 p90 . . . . . 0 N--CA 1.47 0.574 0 CA-C-O 118.275 -0.869 . . . . 1.0 110.253 179.608 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 64.6 mtt . . . . . 0 N--CA 1.491 1.577 0 N-CA-C 109.332 -0.618 . . . . 1.0 109.332 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 88.9 p -103.63 7.7 37.51 Favored 'General case' 0 N--CA 1.467 0.398 0 CA-C-N 116.097 -0.501 . . . . 1.0 110.751 -179.723 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 3' ' ' ASP . . . . . 0.459 ' N ' ' OD1' ' A' ' 3' ' ' ASP . 1.6 p30 167.42 99.87 0.0 OUTLIER 'General case' 0 N--CA 1.466 0.342 0 CA-C-N 116.109 -0.496 . . . . 1.0 110.42 179.096 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 16.6 t80 -150.21 145.82 26.47 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.219 -0.446 . . . . 1.0 110.059 179.329 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 5' ' ' ASP . . . . . 0.615 ' OD1' ' N ' ' A' ' 10' ' ' SER . 0.3 OUTLIER -157.21 153.42 27.58 Favored 'General case' 0 C--N 1.327 -0.377 0 N-CA-C 109.887 -0.412 . . . . 1.0 109.887 179.674 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 6' ' ' THR . . . . . 0.657 ' O ' ' N ' ' A' ' 10' ' ' SER . 0.2 OUTLIER -75.01 175.74 7.87 Favored 'General case' 0 C--O 1.212 -0.872 0 CA-C-N 116.112 -0.495 . . . . 1.0 111.802 -178.123 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . 0.504 ' O ' ' N ' ' A' ' 11' ' ' ARG . 0.5 OUTLIER -58.7 -56.21 25.19 Favored 'General case' 0 N--CA 1.478 0.974 0 CA-C-N 115.72 -0.673 . . . . 1.0 109.863 -178.781 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 8' ' ' ARG . . . . . 0.725 ' O ' ' HB3' ' A' ' 12' ' ' ALA . 0.0 OUTLIER -49.39 -54.77 15.67 Favored 'General case' 0 C--N 1.318 -0.794 0 N-CA-C 106.349 -1.723 . . . . 1.0 106.349 -178.034 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . 0.792 ' O ' ' HB ' ' A' ' 13' ' ' VAL . 1.3 t -63.74 -46.46 94.49 Favored 'Isoleucine or valine' 0 C--O 1.193 -1.914 0 CA-C-N 111.834 -2.439 . . . . 1.0 109.165 -179.705 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 10' ' ' SER . . . . . 0.657 ' N ' ' O ' ' A' ' 6' ' ' THR . 6.6 t -69.67 -63.32 1.1 Allowed 'General case' 0 N--CA 1.487 1.405 0 N-CA-C 112.648 0.61 . . . . 1.0 112.648 -178.279 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 11' ' ' ARG . . . . . 0.519 ' O ' ' N ' ' A' ' 15' ' ' ALA . 3.6 mmt85 -64.07 -55.39 22.42 Favored 'General case' 0 N--CA 1.478 0.963 0 CA-C-O 121.119 0.485 . . . . 1.0 110.866 -176.402 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . 0.725 ' HB3' ' O ' ' A' ' 8' ' ' ARG . . . -51.24 -50.73 58.61 Favored 'General case' 0 C--N 1.314 -0.953 0 N-CA-C 106.363 -1.717 . . . . 1.0 106.363 -178.756 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . 0.792 ' HB ' ' O ' ' A' ' 9' ' ' VAL . 8.1 t -60.62 -52.26 63.54 Favored 'Isoleucine or valine' 0 C--O 1.197 -1.662 0 C-N-CA 119.419 -0.912 . . . . 1.0 109.184 176.823 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . 0.651 ' O ' HG13 ' A' ' 18' ' ' VAL . . . -58.24 -62.13 2.06 Favored 'General case' 0 C--O 1.21 -1.019 0 C-N-CA 118.682 -1.207 . . . . 1.0 110.185 -179.352 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . 0.563 ' O ' ' N ' ' A' ' 19' ' ' GLY . . . -52.25 -55.64 19.98 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-O 121.918 0.866 . . . . 1.0 109.943 -178.245 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . 0.553 ' CA ' ' H ' ' A' ' 22' ' ' GLY . . . -61.27 -54.76 39.94 Favored 'General case' 0 C--N 1.311 -1.101 0 CA-C-N 114.413 -1.267 . . . . 1.0 109.097 -179.269 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . 0.578 ' CB ' ' O ' ' A' ' 13' ' ' VAL . 7.0 tt -57.79 -53.7 55.24 Favored 'General case' 0 N--CA 1.482 1.153 0 CA-C-N 114.001 -1.454 . . . . 1.0 109.294 -177.693 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . 0.651 HG13 ' O ' ' A' ' 14' ' ' ALA . 2.6 m -68.98 -56.67 11.17 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.501 0 C-N-CA 119.268 -0.973 . . . . 1.0 109.274 178.978 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . 0.563 ' N ' ' O ' ' A' ' 15' ' ' ALA . . . -66.74 -160.59 1.0 Allowed Glycine 0 CA--C 1.534 1.248 0 CA-C-N 116.771 -0.195 . . . . 1.0 113.162 -178.037 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 20' ' ' PRO . . . . . 0.588 ' O ' ' HB2' ' A' ' 24' ' ' ALA . 90.8 Cg_endo -79.87 -30.02 2.49 Favored 'Trans proline' 0 N--CA 1.502 2.026 0 C-N-CA 123.476 2.784 . . . . 1.0 115.117 -177.42 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -60.15 -58.21 15.21 Favored Glycine 0 N--CA 1.478 1.437 0 C-N-CA 119.864 -1.16 . . . . 1.0 112.458 -176.296 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . 0.553 ' H ' ' CA ' ' A' ' 16' ' ' ALA . . . -59.16 -56.26 26.21 Favored Glycine 0 C--N 1.312 -0.757 0 N-CA-C 108.403 -1.879 . . . . 1.0 108.403 -177.243 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . 0.462 HG22 ' O ' ' A' ' 19' ' ' GLY . 34.6 m -59.77 -34.39 55.46 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.84 0 C-N-CA 120.109 -0.636 . . . . 1.0 109.713 -179.489 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . 0.588 ' HB2' ' O ' ' A' ' 20' ' ' PRO . . . -57.38 -61.52 2.43 Favored 'General case' 0 CA--C 1.534 0.337 0 C-N-CA 118.078 -1.449 . . . . 1.0 109.011 179.884 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 5.2 mp -63.85 -44.18 93.91 Favored 'General case' 0 C--N 1.347 0.465 0 C-N-CA 120.24 -0.584 . . . . 1.0 112.19 -178.598 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 73.8 t -60.87 -59.59 3.99 Favored 'Isoleucine or valine' 0 CA--C 1.527 0.083 0 C-N-CA 118.776 -1.169 . . . . 1.0 109.793 -177.991 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . 0.651 ' O ' ' HB3' ' A' ' 31' ' ' ALA . 83.9 t -59.97 -39.16 79.43 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.212 0 N-CA-C 112.19 0.441 . . . . 1.0 112.19 -178.429 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 27.5 tttm -65.94 -54.42 26.59 Favored 'General case' 0 C--N 1.319 -0.739 0 N-CA-C 108.941 -0.763 . . . . 1.0 108.941 -179.223 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 59.5 t -63.98 -48.44 86.05 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.825 0 CA-C-N 114.599 -1.182 . . . . 1.0 110.587 -177.892 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 30' ' ' CYS . . . . . . . . . . . . . 20.0 t -65.16 -61.23 2.26 Favored 'General case' 0 N--CA 1.446 -0.664 0 C-N-CA 119.245 -0.982 . . . . 1.0 109.566 -179.51 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . 0.651 ' HB3' ' O ' ' A' ' 27' ' ' VAL . . . -65.18 -53.2 48.49 Favored 'General case' 0 N--CA 1.453 -0.309 0 N-CA-C 113.487 0.921 . . . . 1.0 113.487 -176.24 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 84.6 77.89 1.15 Allowed Glycine 0 CA--C 1.527 0.822 0 C-N-CA 120.338 -0.934 . . . . 1.0 111.474 -179.76 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . 0.445 ' O ' ' N ' ' A' ' 35' ' ' GLY . 10.0 mp 69.89 101.37 0.04 OUTLIER Pre-proline 0 CA--C 1.548 0.88 0 C-N-CA 123.207 0.603 . . . . 1.0 110.25 -179.131 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 1.1 Cg_endo -45.26 -10.13 0.04 OUTLIER 'Trans proline' 0 N--CA 1.501 1.944 0 C-N-CA 122.109 1.872 . . . . 1.0 114.818 -179.247 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . 0.445 ' N ' ' O ' ' A' ' 33' ' ' LEU . . . -60.82 -59.76 9.62 Favored Glycine 0 N--CA 1.468 0.823 0 C-N-CA 118.223 -1.941 . . . . 1.0 110.088 -178.037 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . 0.884 HG22 ' H ' ' A' ' 37' ' ' ILE . 9.4 p -83.87 -146.58 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.465 0.324 0 N-CA-C 109.303 -0.629 . . . . 1.0 109.303 -179.945 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . 0.884 ' H ' HG22 ' A' ' 36' ' ' VAL . 2.2 mp 73.71 76.8 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.474 0.727 0 CA-C-N 117.949 0.341 . . . . 1.0 111.578 -179.551 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 98.9 m-70 -134.94 127.2 30.15 Favored 'General case' 0 N--CA 1.451 -0.385 0 N-CA-C 106.902 -1.518 . . . . 1.0 106.902 177.777 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 27.7 p -109.1 146.55 34.09 Favored Pre-proline 0 C--N 1.328 -0.349 0 N-CA-C 109.631 -0.507 . . . . 1.0 109.631 -179.037 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 51.0 Cg_endo -66.0 -24.94 52.23 Favored 'Trans proline' 0 C--N 1.306 -1.659 0 C-N-CA 121.502 1.468 . . . . 1.0 112.819 -178.854 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -126.81 130.15 49.69 Favored 'General case' 0 CA--C 1.516 -0.349 0 N-CA-C 109.567 -0.531 . . . . 1.0 109.567 178.921 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . 0.67 ' C ' ' H ' ' A' ' 44' ' ' GLY . 4.0 tmm_? -159.27 156.05 28.04 Favored 'General case' 0 C--N 1.318 -0.781 0 C-N-CA 119.908 -0.717 . . . . 1.0 109.175 178.05 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 43' ' ' ARG . . . . . 0.409 ' C ' ' H ' ' A' ' 45' ' ' PHE . 0.2 OUTLIER -62.97 17.95 0.01 OUTLIER 'General case' 0 C--N 1.32 -0.7 0 CA-C-N 115.963 -0.562 . . . . 1.0 110.147 179.204 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . 0.67 ' H ' ' C ' ' A' ' 42' ' ' ARG . . . 76.59 -27.19 1.58 Allowed Glycine 0 C--N 1.337 0.617 0 N-CA-C 111.306 -0.718 . . . . 1.0 111.306 179.389 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . 0.564 ' N ' ' CD1' ' A' ' 45' ' ' PHE . 0.1 OUTLIER -155.59 156.58 35.33 Favored 'General case' 0 CA--C 1.548 0.868 0 N-CA-C 109.795 -0.446 . . . . 1.0 109.795 -179.684 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 46' ' ' PHE . . . . . 0.613 ' O ' ' HB2' ' A' ' 47' ' ' ARG . 0.5 OUTLIER 139.66 85.36 0.0 OUTLIER 'General case' 0 N--CA 1.5 2.068 0 C-N-CA 126.23 1.812 . . . . 1.0 109.05 179.251 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 47' ' ' ARG . . . . . 0.613 ' HB2' ' O ' ' A' ' 46' ' ' PHE . 2.5 mtm-85 131.89 138.24 0.0 OUTLIER 'General case' 0 N--CA 1.505 2.294 0 C-N-CA 125.189 1.396 . . . . 1.0 109.989 178.528 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 48' ' ' CYS . . . . . 0.546 ' SG ' ' C ' ' A' ' 47' ' ' ARG . 0.0 OUTLIER 75.5 70.66 0.08 Allowed 'General case' 0 C--O 1.219 -0.531 0 N-CA-C 108.988 -0.745 . . . . 1.0 108.988 179.662 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 49' ' ' ASN . . . . . 0.649 ' O ' ' N ' ' A' ' 51' ' ' GLU . 1.2 p-10 -143.32 116.09 5.95 Favored Pre-proline 0 C--N 1.327 -0.407 0 N-CA-C 107.988 -1.116 . . . . 1.0 107.988 -179.733 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 74.7 Cg_exo -47.42 63.52 0.01 OUTLIER 'Trans proline' 0 N--CA 1.509 2.399 0 C-N-CA 122.688 2.258 . . . . 1.0 114.788 -178.801 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . 0.649 ' N ' ' O ' ' A' ' 49' ' ' ASN . 17.1 mp0 62.02 28.49 17.26 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.463 -0.335 . . . . 1.0 111.064 -179.644 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -102.71 134.34 46.25 Favored 'General case' 0 CA--C 1.516 -0.329 0 N-CA-C 109.206 -0.664 . . . . 1.0 109.206 178.55 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . 0.419 ' O ' ' N ' ' A' ' 55' ' ' ILE . 13.0 tt -57.92 138.58 18.68 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.374 0 CA-C-O 122.273 1.035 . . . . 1.0 112.066 -178.056 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 54' ' ' GLN . . . . . 0.544 ' OE1' ' CE2' ' A' ' 46' ' ' PHE . 0.0 OUTLIER -65.98 80.62 0.08 Allowed 'General case' 0 C--N 1.318 -0.794 0 CA-C-N 113.75 -1.568 . . . . 1.0 108.067 -179.761 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . 0.427 ' CG2' ' N ' ' A' ' 56' ' ' GLY . 11.7 mt -149.12 158.06 6.54 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.657 0 CA-C-N 115.864 -0.607 . . . . 1.0 109.835 178.694 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . 0.427 ' N ' ' CG2' ' A' ' 55' ' ' ILE . . . 111.62 -2.14 27.65 Favored Glycine 0 N--CA 1.468 0.817 0 N-CA-C 110.205 -1.158 . . . . 1.0 110.205 -179.865 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . 0.464 ' OD1' ' CG ' ' A' ' 45' ' ' PHE . 36.3 m-20 -79.19 97.95 6.41 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 115.234 -0.483 . . . . 1.0 110.533 179.533 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 58' ' ' TRP . . . . . . . . . . . . . 6.5 m0 -87.99 172.27 9.69 Favored 'General case' 0 CA--C 1.539 0.525 0 CA-C-O 123.0 1.381 . . . . 1.0 112.58 -177.956 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 59' ' ' ARG . . . . . 0.677 ' H ' ' CD ' ' A' ' 59' ' ' ARG . 0.0 OUTLIER -82.49 -60.43 2.2 Favored 'General case' 0 C--N 1.311 -1.097 0 CA-C-N 111.622 -2.535 . . . . 1.0 112.839 -179.31 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 44.8 t80 -91.69 -14.04 30.71 Favored 'General case' 0 C--N 1.317 -0.824 0 N-CA-C 113.777 1.028 . . . . 1.0 113.777 -179.118 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 4.6 tt0 -80.18 -14.61 58.32 Favored 'General case' 0 C--O 1.214 -0.804 0 O-C-N 121.709 -0.619 . . . . 1.0 110.592 -179.493 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 62' ' ' VAL . . . . . 0.637 ' O ' ' N ' ' A' ' 66' ' ' GLY . 28.9 m -46.46 -54.25 2.24 Favored 'Isoleucine or valine' 0 C--O 1.212 -0.92 0 C-N-CA 119.268 -0.973 . . . . 1.0 110.46 -175.715 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 63' ' ' ALA . . . . . 0.567 ' N ' HG23 ' A' ' 62' ' ' VAL . . . -67.42 -48.39 67.44 Favored 'General case' 0 C--N 1.303 -1.428 0 O-C-N 121.402 -0.811 . . . . 1.0 108.962 179.824 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 11.0 t-80 -51.56 -58.09 7.28 Favored 'General case' 0 CA--C 1.541 0.627 0 C-N-CA 119.463 -0.895 . . . . 1.0 109.419 -179.649 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 65' ' ' ASP . . . . . 0.592 ' C ' ' H ' ' A' ' 67' ' ' ARG . 22.8 m-20 -75.38 -52.03 11.74 Favored 'General case' 0 C--O 1.245 0.826 0 CA-C-N 115.733 -0.667 . . . . 1.0 111.24 178.837 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . 0.637 ' N ' ' O ' ' A' ' 62' ' ' VAL . . . -71.76 25.97 0.63 Allowed Glycine 0 CA--C 1.522 0.483 0 O-C-N 120.345 -1.472 . . . . 1.0 110.337 177.423 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 67' ' ' ARG . . . . . 0.671 ' O ' ' N ' ' A' ' 69' ' ' LEU . 0.6 OUTLIER -71.71 7.2 1.58 Allowed 'General case' 0 CA--C 1.507 -0.687 0 N-CA-C 106.197 -1.779 . . . . 1.0 106.197 174.47 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . 0.588 ' H ' ' C ' ' A' ' 66' ' ' GLY . 3.1 mt -30.48 -30.11 0.01 OUTLIER 'General case' 0 N--CA 1.472 0.669 0 O-C-N 124.045 0.84 . . . . 1.0 108.767 -177.653 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . 0.671 ' N ' ' O ' ' A' ' 67' ' ' ARG . 10.9 mp -62.35 -66.15 0.58 Allowed 'General case' 0 N--CA 1.476 0.842 0 C-N-CA 119.296 -0.961 . . . . 1.0 109.016 178.401 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . 0.627 ' C ' ' H ' ' A' ' 72' ' ' HIS . . . -79.49 -75.63 0.24 Allowed 'General case' 0 N--CA 1.476 0.835 0 N-CA-C 107.36 -1.348 . . . . 1.0 107.36 178.051 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 71' ' ' ALA . . . . . 0.474 ' HB3' ' CB ' ' A' ' 67' ' ' ARG . . . -46.44 5.87 0.0 OUTLIER 'General case' 0 CA--C 1.536 0.409 0 C-N-CA 124.837 1.255 . . . . 1.0 113.539 177.671 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 72' ' ' HIS . . . . . 0.627 ' H ' ' C ' ' A' ' 70' ' ' ALA . 1.1 t-80 -28.69 -68.17 0.07 Allowed 'General case' 0 N--CA 1.467 0.414 0 C-N-CA 122.827 0.451 . . . . 1.0 111.788 -179.449 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 73' ' ' MET . . . . . 0.549 ' N ' ' SD ' ' A' ' 73' ' ' MET . 0.0 OUTLIER -66.83 -47.58 71.58 Favored 'General case' 0 C--N 1.329 -0.325 0 C-N-CA 118.263 -1.375 . . . . 1.0 109.133 178.966 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . 0.793 ' O ' ' N ' ' A' ' 76' ' ' GLY . 72.9 t -42.2 -41.17 0.91 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.26 0 CA-C-O 117.621 -1.18 . . . . 1.0 111.524 -176.089 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 75' ' ' ASN . . . . . 0.596 ' ND2' HG21 ' A' ' 78' ' ' VAL . 3.0 t-20 -33.63 -12.22 0.0 OUTLIER 'General case' 0 N--CA 1.498 1.947 0 CA-C-N 120.175 1.352 . . . . 1.0 112.315 179.25 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 76' ' ' GLY . . . . . 0.793 ' N ' ' O ' ' A' ' 74' ' ' VAL . . . -48.86 -22.67 3.04 Favored Glycine 0 CA--C 1.542 1.736 0 N-CA-C 108.455 -1.858 . . . . 1.0 108.455 174.629 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 77' ' ' ILE . . . . . 0.667 ' O ' ' N ' ' A' ' 80' ' ' ALA . 0.9 OUTLIER -75.54 -59.86 2.88 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.588 0 N-CA-C 108.068 -1.086 . . . . 1.0 108.068 178.36 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . 0.596 HG21 ' ND2' ' A' ' 75' ' ' ASN . 75.6 t -34.39 -31.18 0.02 OUTLIER 'Isoleucine or valine' 0 CA--C 1.547 0.828 0 CA-C-N 113.532 -1.667 . . . . 1.0 107.947 -176.207 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . 0.665 ' O ' ' HB2' ' A' ' 83' ' ' ALA . 40.3 pt -95.45 -29.9 4.03 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.843 0 CA-C-N 115.989 -0.55 . . . . 1.0 111.595 178.392 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 80' ' ' ALA . . . . . 0.667 ' N ' ' O ' ' A' ' 77' ' ' ILE . . . -86.14 -10.79 54.17 Favored 'General case' 0 CA--C 1.548 0.882 0 N-CA-C 113.284 0.846 . . . . 1.0 113.284 178.387 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 8.5 mt-10 -83.1 -68.56 0.7 Allowed 'General case' 0 C--N 1.355 0.805 0 CA-C-N 118.855 0.752 . . . . 1.0 109.067 178.254 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 82' ' ' ASP . . . . . 0.512 ' O ' ' C ' ' A' ' 83' ' ' ALA . 49.7 p-10 -74.95 -14.2 60.61 Favored 'General case' 0 N--CA 1.443 -0.796 0 CA-C-O 118.846 -0.597 . . . . 1.0 112.136 -179.48 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . 0.704 ' HA ' ' HB3' ' A' ' 86' ' ' ALA . . . -23.08 -47.35 0.01 OUTLIER 'General case' 0 N--CA 1.473 0.698 0 CA-C-N 118.436 0.562 . . . . 1.0 112.013 177.746 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . 0.48 ' N ' ' O ' ' A' ' 82' ' ' ASP . 2.9 tt -37.7 -36.2 0.17 Allowed 'General case' 0 N--CA 1.465 0.324 0 N-CA-C 112.85 0.685 . . . . 1.0 112.85 -177.617 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 85' ' ' ILE . . . . . 0.407 HG21 HD13 ' A' ' 85' ' ' ILE . 11.2 pt -98.68 -43.1 11.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 N-CA-C 108.436 -0.95 . . . . 1.0 108.436 177.526 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 86' ' ' ALA . . . . . 0.704 ' HB3' ' HA ' ' A' ' 83' ' ' ALA . . . -56.36 -57.45 12.2 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 114.142 -1.39 . . . . 1.0 109.503 179.45 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 87' ' ' GLU . . . . . 0.533 ' N ' ' O ' ' A' ' 83' ' ' ALA . 19.8 tt0 -79.3 26.41 0.28 Allowed 'General case' 0 CA--C 1.544 0.723 0 O-C-N 120.851 -1.156 . . . . 1.0 112.202 -178.149 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -116.49 -15.75 10.86 Favored 'General case' 0 N--CA 1.489 1.504 0 CA-C-O 123.415 1.579 . . . . 1.0 107.896 177.68 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 89' ' ' VAL . . . . . 0.415 HG22 ' O ' ' A' ' 86' ' ' ALA . 5.3 m -100.44 39.23 0.15 Allowed 'Isoleucine or valine' 0 C--O 1.205 -1.238 0 CA-C-N 110.83 -2.896 . . . . 1.0 109.987 178.573 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 90' ' ' GLY . . . . . 0.536 ' O ' ' N ' ' A' ' 92' ' ' HIS . . . -71.59 -39.15 61.13 Favored Glycine 0 C--N 1.351 1.381 0 N-CA-C 111.023 -0.831 . . . . 1.0 111.023 178.329 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 91' ' ' PRO . . . . . 0.528 ' CD ' ' N ' ' A' ' 90' ' ' GLY . 89.6 Cg_exo -46.45 -12.82 0.09 OUTLIER 'Trans proline' 0 N--CA 1.497 1.712 0 C-N-CA 121.572 1.515 . . . . 1.0 110.346 178.406 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 92' ' ' HIS . . . . . 0.536 ' N ' ' O ' ' A' ' 90' ' ' GLY . 3.5 p80 -57.54 -17.15 12.35 Favored 'General case' 0 C--O 1.208 -1.108 0 N-CA-C 107.56 -1.274 . . . . 1.0 107.56 179.675 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 93' ' ' LEU . . . . . 0.712 HD12 ' N ' ' A' ' 94' ' ' ALA . 2.1 pp -67.84 -59.37 3.35 Favored 'General case' 0 N--CA 1.455 -0.215 0 N-CA-C 108.817 -0.809 . . . . 1.0 108.817 178.884 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 94' ' ' ALA . . . . . 0.712 ' N ' HD12 ' A' ' 93' ' ' LEU . . . -56.45 -53.36 58.31 Favored 'General case' 0 N--CA 1.454 -0.265 0 N-CA-C 108.914 -0.773 . . . . 1.0 108.914 178.701 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 95' ' ' ARG . . . . . 0.643 ' O ' ' N ' ' A' ' 97' ' ' LEU . 42.8 mtm105 -57.54 -57.44 12.69 Favored 'General case' 0 C--O 1.241 0.653 0 N-CA-C 107.822 -1.177 . . . . 1.0 107.822 178.846 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 96' ' ' ALA . . . . . 0.885 ' O ' ' N ' ' A' ' 98' ' ' GLY . . . -47.47 -12.35 0.03 OUTLIER 'General case' 0 N--CA 1.436 -1.128 0 O-C-N 118.905 -2.372 . . . . 1.0 110.375 -179.195 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 97' ' ' LEU . . . . . 0.692 ' O ' ' N ' ' A' ' 100' ' ' ILE . 16.2 tp 5.96 -53.25 0.0 OUTLIER 'General case' 0 C--N 1.377 1.801 0 CA-C-O 117.481 -1.247 . . . . 1.0 110.275 -167.843 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 98' ' ' GLY . . . . . 0.885 ' N ' ' O ' ' A' ' 96' ' ' ALA . . . -49.06 -23.75 4.06 Favored Glycine 0 CA--C 1.543 1.784 0 CA-C-N 122.572 2.442 . . . . 1.0 107.902 175.331 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 99' ' ' GLN . . . . . 0.552 ' N ' ' O ' ' A' ' 96' ' ' ALA . 0.0 OUTLIER -63.88 -17.45 63.2 Favored 'General case' 0 C--N 1.36 1.026 0 N-CA-C 107.046 -1.465 . . . . 1.0 107.046 176.706 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 100' ' ' ILE . . . . . 0.692 ' N ' ' O ' ' A' ' 97' ' ' LEU . 1.9 tp -66.42 -43.33 91.18 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.518 0 N-CA-C 108.746 -0.835 . . . . 1.0 108.746 178.98 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 101' ' ' VAL . . . . . 0.672 ' O ' ' N ' ' A' ' 105' ' ' GLY . 0.5 OUTLIER -54.48 -58.28 4.25 Favored 'Isoleucine or valine' 0 C--O 1.219 -0.546 0 N-CA-C 106.844 -1.539 . . . . 1.0 106.844 178.69 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 102' ' ' CYS . . . . . 0.838 ' O ' ' HB2' ' A' ' 106' ' ' ALA . 17.1 t -44.74 -20.6 0.04 OUTLIER 'General case' 0 C--N 1.314 -0.974 0 CA-C-N 115.961 -0.563 . . . . 1.0 111.977 -179.932 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 103' ' ' ARG . . . . . 0.522 HH11 ' CG ' ' A' ' 103' ' ' ARG . 0.0 OUTLIER -92.76 -44.69 8.4 Favored 'General case' 0 N--CA 1.472 0.646 0 CA-C-O 122.328 1.061 . . . . 1.0 111.521 178.299 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 104' ' ' TYR . . . . . 0.581 ' CD2' ' O ' ' A' ' 104' ' ' TYR . 0.0 OUTLIER -105.72 22.39 15.64 Favored 'General case' 0 C--N 1.312 -1.027 0 CA-C-N 113.625 -1.625 . . . . 1.0 111.325 179.294 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 105' ' ' GLY . . . . . 0.776 ' O ' ' N ' ' A' ' 107' ' ' THR . . . -171.67 -9.29 0.02 OUTLIER Glycine 0 C--N 1.345 1.028 0 C-N-CA 118.437 -1.84 . . . . 1.0 113.125 178.987 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 106' ' ' ALA . . . . . 0.838 ' HB2' ' O ' ' A' ' 102' ' ' CYS . . . -27.71 68.68 0.0 OUTLIER 'General case' 0 N--CA 1.475 0.793 0 N-CA-C 113.521 0.934 . . . . 1.0 113.521 -178.707 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 107' ' ' THR . . . . . 0.776 ' N ' ' O ' ' A' ' 105' ' ' GLY . 8.8 t -91.9 2.66 56.39 Favored 'General case' 0 CA--C 1.51 -0.595 0 N-CA-C 106.902 -1.518 . . . . 1.0 106.902 177.601 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 60.2 t -85.37 -57.73 4.09 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.76 0 CA-C-N 115.475 -0.784 . . . . 1.0 110.514 178.547 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 109' ' ' ILE . . . . . 0.523 ' N ' ' HD2' ' A' ' 110' ' ' PRO . 0.1 OUTLIER -65.98 -39.8 32.76 Favored Pre-proline 0 CA--C 1.555 1.158 0 N-CA-C 114.552 1.316 . . . . 1.0 114.552 -177.971 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 110' ' ' PRO . . . . . 0.547 ' CD ' ' O ' ' A' ' 106' ' ' ALA . 6.8 Cg_endo -48.13 -47.7 18.71 Favored 'Trans proline' 0 N--CA 1.504 2.096 0 CA-C-N 122.397 1.892 . . . . 1.0 113.065 -178.283 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 23.4 t30 -64.79 -67.03 0.47 Allowed 'General case' 0 N--CA 1.464 0.248 0 C-N-CA 119.47 -0.892 . . . . 1.0 109.434 -178.267 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 112' ' ' ILE . . . . . 0.458 ' O ' ' N ' ' A' ' 115' ' ' ALA . 28.3 mm -49.25 -39.92 13.3 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.575 0 CA-C-O 122.813 1.292 . . . . 1.0 108.459 179.737 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 113' ' ' ASN . . . . . 0.483 ' CB ' ' O ' ' A' ' 109' ' ' ILE . 6.4 t-20 -47.14 -51.14 18.9 Favored 'General case' 0 C--N 1.31 -1.121 0 CA-C-N 112.273 -2.24 . . . . 1.0 108.03 -176.892 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -62.21 -29.81 70.64 Favored 'General case' 0 N--CA 1.441 -0.894 0 C-N-CA 119.611 -0.835 . . . . 1.0 110.343 178.772 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 115' ' ' ALA . . . . . 0.458 ' N ' ' O ' ' A' ' 112' ' ' ILE . . . -77.34 -60.44 2.36 Favored 'General case' 0 C--N 1.347 0.477 0 C-N-CA 119.659 -0.817 . . . . 1.0 110.031 179.077 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 116' ' ' ILE . . . . . 0.506 ' O ' ' N ' ' A' ' 120' ' ' GLY . 1.0 OUTLIER -49.95 -50.07 19.93 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.707 0 CA-C-O 122.013 0.911 . . . . 1.0 109.562 -179.41 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 117' ' ' GLU . . . . . 0.476 ' N ' HG22 ' A' ' 116' ' ' ILE . 17.8 mt-10 -42.53 -55.73 3.37 Favored 'General case' 0 C--N 1.316 -0.887 0 N-CA-C 106.106 -1.812 . . . . 1.0 106.106 -179.394 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 98.8 t -58.82 -53.11 51.95 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.677 0 C-N-CA 119.428 -0.909 . . . . 1.0 108.787 176.875 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -51.74 -72.62 0.05 OUTLIER 'General case' 0 CA--C 1.543 0.707 0 N-CA-C 108.083 -1.081 . . . . 1.0 108.083 -178.699 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 120' ' ' GLY . . . . . 0.506 ' N ' ' O ' ' A' ' 116' ' ' ILE . . . -64.9 -79.03 0.19 Allowed Glycine 0 CA--C 1.541 1.698 0 C-N-CA 119.055 -1.545 . . . . 1.0 110.3 179.308 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 121' ' ' THR . . . . . 0.494 ' OG1' ' O ' ' A' ' 120' ' ' GLY . 2.8 m 154.27 -31.57 0.01 OUTLIER 'General case' 0 N--CA 1.481 1.098 0 CA-C-N 112.371 -1.914 . . . . 1.0 111.463 179.974 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 122' ' ' GLY . . . . . 0.669 ' O ' ' N ' ' A' ' 124' ' ' ASP . . . 104.25 -17.5 47.54 Favored Glycine 0 N--CA 1.462 0.373 0 N-CA-C 107.319 -2.312 . . . . 1.0 107.319 -176.46 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 123' ' ' THR . . . . . 0.702 HG23 ' O ' ' A' ' 123' ' ' THR . 12.7 t -56.37 82.3 0.01 OUTLIER 'General case' 0 N--CA 1.469 0.509 0 N-CA-C 106.031 -1.84 . . . . 1.0 106.031 178.647 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 124' ' ' ASP . . . . . 0.669 ' N ' ' O ' ' A' ' 122' ' ' GLY . 34.6 m-20 -167.26 178.05 5.79 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 112.826 -1.988 . . . . 1.0 111.516 179.01 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 125' ' ' TYR . . . . . . . . . . . . . 21.3 t80 -141.96 140.22 32.67 Favored 'General case' 0 CA--C 1.536 0.417 0 N-CA-C 107.328 -1.36 . . . . 1.0 107.328 174.932 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 24.0 mmm-85 -146.18 148.1 32.18 Favored 'General case' 0 N--CA 1.471 0.598 0 N-CA-C 109.879 -0.415 . . . . 1.0 109.879 178.594 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 127' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 C--N 1.327 -0.409 0 CA-C-O 117.982 -1.009 . . . . 1.0 110.079 179.3 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.494 1.75 0 N-CA-C 108.103 -1.073 . . . . 1.0 108.103 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 2' ' ' SER . . . . . 0.46 ' O ' ' CB ' ' A' ' 3' ' ' ASP . 93.9 p -70.66 7.1 1.19 Allowed 'General case' 0 C--O 1.223 -0.316 0 CA-C-O 119.449 -0.31 . . . . 1.0 111.352 179.615 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 3' ' ' ASP . . . . . 0.46 ' CB ' ' O ' ' A' ' 2' ' ' SER . 12.7 p-10 142.55 142.19 0.0 OUTLIER 'General case' 0 N--CA 1.481 1.079 0 O-C-N 124.126 0.891 . . . . 1.0 110.349 179.07 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 42.1 t80 -155.59 151.33 27.41 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 121.134 0.492 . . . . 1.0 110.532 178.701 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 5' ' ' ASP . . . . . 0.482 ' C ' ' OG ' ' A' ' 10' ' ' SER . 51.3 m-20 -148.46 144.6 27.5 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.562 -0.745 . . . . 1.0 109.53 179.84 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 6' ' ' THR . . . . . 1.009 HG22 ' H ' ' A' ' 7' ' ' GLU . 5.6 m -109.46 -161.57 0.77 Allowed 'General case' 0 C--O 1.206 -1.188 0 CA-C-O 121.656 0.741 . . . . 1.0 110.48 -179.776 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . 1.009 ' H ' HG22 ' A' ' 6' ' ' THR . 28.5 tt0 -58.26 -44.37 88.31 Favored 'General case' 0 C--N 1.302 -1.497 0 CA-C-O 121.872 0.844 . . . . 1.0 109.447 -178.5 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 8' ' ' ARG . . . . . 0.836 ' O ' ' HB3' ' A' ' 12' ' ' ALA . 21.8 ttp-105 -69.87 -60.64 2.18 Favored 'General case' 0 C--N 1.307 -1.241 0 C-N-CA 117.916 -1.514 . . . . 1.0 110.089 178.242 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . 0.957 HG23 ' H ' ' A' ' 6' ' ' THR . 0.1 OUTLIER -61.38 -52.61 59.27 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.412 0 CA-C-N 115.11 -0.95 . . . . 1.0 110.129 -179.6 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 10' ' ' SER . . . . . 0.674 ' N ' ' O ' ' A' ' 6' ' ' THR . 1.2 m -68.21 -65.21 0.72 Allowed 'General case' 0 N--CA 1.487 1.409 0 C-N-CA 120.166 -0.614 . . . . 1.0 112.525 179.66 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 11' ' ' ARG . . . . . 0.643 ' O ' ' HB3' ' A' ' 15' ' ' ALA . 5.0 mtt-85 -61.9 -43.41 98.89 Favored 'General case' 0 C--N 1.317 -0.841 0 C-N-CA 120.419 -0.512 . . . . 1.0 111.382 -176.955 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . 0.836 ' HB3' ' O ' ' A' ' 8' ' ' ARG . . . -69.87 -57.58 4.88 Favored 'General case' 0 N--CA 1.468 0.443 0 C-N-CA 118.334 -1.346 . . . . 1.0 108.998 178.719 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . 0.673 ' O ' ' CB ' ' A' ' 17' ' ' LEU . 41.7 t -61.84 -55.44 24.24 Favored 'Isoleucine or valine' 0 C--O 1.198 -1.623 0 C-N-CA 117.51 -1.676 . . . . 1.0 107.879 -179.266 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . 0.892 ' O ' HG22 ' A' ' 18' ' ' VAL . . . -57.96 -64.92 0.74 Allowed 'General case' 0 C--N 1.313 -1.009 0 C-N-CA 116.53 -2.068 . . . . 1.0 111.457 -179.94 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . 0.643 ' HB3' ' O ' ' A' ' 11' ' ' ARG . . . -54.59 -54.71 37.74 Favored 'General case' 0 C--O 1.218 -0.601 0 C-N-CA 118.596 -1.242 . . . . 1.0 110.334 -177.187 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . 0.711 ' HB3' ' O ' ' A' ' 12' ' ' ALA . . . -65.69 -55.64 16.34 Favored 'General case' 0 C--N 1.309 -1.176 0 C-N-CA 118.676 -1.21 . . . . 1.0 110.569 -179.109 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . 0.673 ' CB ' ' O ' ' A' ' 13' ' ' VAL . 2.2 tp -56.51 -54.56 44.4 Favored 'General case' 0 N--CA 1.491 1.591 0 N-CA-C 108.087 -1.079 . . . . 1.0 108.087 -177.728 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . 0.892 HG22 ' O ' ' A' ' 14' ' ' ALA . 1.8 m -71.88 -58.59 4.77 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.405 0 C-N-CA 120.371 -0.531 . . . . 1.0 110.446 -179.953 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . 0.559 ' N ' ' O ' ' A' ' 15' ' ' ALA . . . -60.67 -168.39 0.43 Allowed Glycine 0 N--CA 1.439 -1.131 0 N-CA-C 111.969 -0.452 . . . . 1.0 111.969 -177.288 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 20' ' ' PRO . . . . . 0.677 ' O ' ' N ' ' A' ' 24' ' ' ALA . 4.2 Cg_endo -81.73 -25.96 3.34 Favored 'Trans proline' 0 C--N 1.294 -2.339 0 C-N-CA 121.847 1.698 . . . . 1.0 113.72 -178.041 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -63.51 -60.01 8.03 Favored Glycine 0 N--CA 1.473 1.134 0 C-N-CA 118.984 -1.579 . . . . 1.0 112.679 -176.004 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . 0.605 ' H ' ' HA ' ' A' ' 16' ' ' ALA . . . -57.31 -53.01 48.15 Favored Glycine 0 C--N 1.31 -0.874 0 N-CA-C 106.259 -2.736 . . . . 1.0 106.259 -178.848 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . 0.497 ' O ' HG12 ' A' ' 27' ' ' VAL . 21.3 t -56.37 -32.29 35.31 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.849 0 N-CA-C 108.177 -1.045 . . . . 1.0 108.177 178.428 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . 0.677 ' N ' ' O ' ' A' ' 20' ' ' PRO . . . -60.4 -62.88 1.54 Allowed 'General case' 0 C--N 1.352 0.716 0 C-N-CA 118.573 -1.251 . . . . 1.0 110.087 -179.47 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 86.5 mt -61.91 -46.32 89.89 Favored 'General case' 0 CA--C 1.516 -0.336 0 C-N-CA 120.202 -0.599 . . . . 1.0 111.612 -177.223 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 97.9 t -59.85 -59.85 3.39 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.582 0 C-N-CA 119.332 -0.947 . . . . 1.0 110.393 -177.617 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . 0.552 ' O ' ' HB3' ' A' ' 31' ' ' ALA . 1.4 p -58.65 -36.93 62.49 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.442 0 C-N-CA 120.571 -0.452 . . . . 1.0 110.345 -177.353 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 8.7 tttm -65.69 -56.19 13.41 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 115.646 -0.706 . . . . 1.0 109.869 -179.882 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 97.6 t -62.29 -48.73 86.99 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.699 0 CA-C-N 115.314 -0.857 . . . . 1.0 110.002 -177.699 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 30' ' ' CYS . . . . . . . . . . . . . 49.2 t -65.45 -62.1 1.72 Allowed 'General case' 0 N--CA 1.443 -0.796 0 C-N-CA 119.849 -0.74 . . . . 1.0 110.206 -178.815 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . 0.552 ' HB3' ' O ' ' A' ' 27' ' ' VAL . . . -57.15 -50.21 73.52 Favored 'General case' 0 CA--C 1.507 -0.697 0 CA-C-O 120.879 0.371 . . . . 1.0 110.26 -176.668 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . 0.417 ' O ' ' HB2' ' A' ' 33' ' ' LEU . . . 74.82 70.66 1.22 Allowed Glycine 0 N--CA 1.443 -0.859 0 N-CA-C 109.001 -1.64 . . . . 1.0 109.001 -178.106 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . 0.417 ' HB2' ' O ' ' A' ' 32' ' ' GLY . 5.2 mt 91.79 82.81 0.04 OUTLIER Pre-proline 0 C--N 1.332 -0.192 0 O-C-N 124.963 1.037 . . . . 1.0 109.453 -178.281 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 50.8 Cg_exo -50.39 -28.85 22.11 Favored 'Trans proline' 0 C--N 1.312 -1.37 0 C-N-CA 122.481 2.121 . . . . 1.0 113.555 -179.333 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -62.36 -61.02 7.01 Favored Glycine 0 N--CA 1.47 0.932 0 C-N-CA 118.353 -1.88 . . . . 1.0 109.909 -178.027 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . 0.643 ' O ' HG22 ' A' ' 37' ' ' ILE . 11.4 p -86.47 167.11 1.84 Allowed 'Isoleucine or valine' 0 CA--C 1.507 -0.698 0 N-CA-C 107.719 -1.215 . . . . 1.0 107.719 178.41 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . 0.656 HG23 ' O ' ' A' ' 37' ' ' ILE . 8.2 tt 115.91 107.37 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.484 1.257 0 O-C-N 125.403 1.689 . . . . 1.0 110.6 179.752 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 60.8 m80 -140.39 135.67 32.32 Favored 'General case' 0 C--N 1.328 -0.337 0 O-C-N 121.95 -0.469 . . . . 1.0 109.782 179.153 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 6.1 m -106.42 130.93 22.18 Favored Pre-proline 0 CA--C 1.534 0.342 0 N-CA-C 110.278 -0.268 . . . . 1.0 110.278 -179.582 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 37.0 Cg_endo -65.69 -24.07 55.56 Favored 'Trans proline' 0 N--CA 1.493 1.465 0 C-N-CA 121.141 1.227 . . . . 1.0 112.702 -179.684 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -128.47 135.99 50.22 Favored 'General case' 0 N--CA 1.466 0.361 0 N-CA-C 110.376 -0.231 . . . . 1.0 110.376 177.839 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . 0.693 ' C ' ' H ' ' A' ' 44' ' ' GLY . 11.8 ptm180 -171.23 172.09 5.42 Favored 'General case' 0 C--N 1.322 -0.608 0 C-N-CA 120.2 -0.6 . . . . 1.0 110.941 178.342 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 43' ' ' ARG . . . . . 0.518 ' C ' ' H ' ' A' ' 45' ' ' PHE . 37.2 tpt85 -63.33 24.13 0.01 OUTLIER 'General case' 0 CA--C 1.55 0.953 0 CA-C-O 121.518 0.675 . . . . 1.0 109.816 179.296 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . 0.693 ' H ' ' C ' ' A' ' 42' ' ' ARG . . . 76.98 -26.78 1.72 Allowed Glycine 0 C--N 1.338 0.686 0 N-CA-C 110.533 -1.027 . . . . 1.0 110.533 179.394 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . 0.572 ' O ' ' HB2' ' A' ' 46' ' ' PHE . 11.8 p90 -175.32 -174.15 0.71 Allowed 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 114.352 -0.924 . . . . 1.0 109.451 179.87 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 46' ' ' PHE . . . . . 0.572 ' HB2' ' O ' ' A' ' 45' ' ' PHE . 0.7 OUTLIER 110.81 107.38 0.0 OUTLIER 'General case' 0 N--CA 1.479 1.015 0 O-C-N 125.398 1.686 . . . . 1.0 109.851 -179.78 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 47' ' ' ARG . . . . . 0.515 ' CB ' ' O ' ' A' ' 46' ' ' PHE . 34.3 ttm-85 97.69 154.21 0.02 OUTLIER 'General case' 0 N--CA 1.472 0.655 0 O-C-N 123.966 0.791 . . . . 1.0 110.964 179.7 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 4.4 t 67.2 86.5 0.13 Allowed 'General case' 0 C--N 1.328 -0.335 0 N-CA-C 108.161 -1.051 . . . . 1.0 108.161 -177.685 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 49' ' ' ASN . . . . . 0.501 ' O ' ' N ' ' A' ' 51' ' ' GLU . 0.0 OUTLIER -153.0 160.71 30.6 Favored Pre-proline 0 N--CA 1.466 0.364 0 CA-C-N 115.675 -0.693 . . . . 1.0 111.33 -179.352 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 30.8 Cg_endo -63.13 60.94 0.17 Allowed 'Trans proline' 0 C--N 1.311 -1.409 0 C-N-CA 122.545 2.163 . . . . 1.0 111.403 177.976 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . 0.501 ' N ' ' O ' ' A' ' 49' ' ' ASN . 40.9 mt-10 41.91 37.72 0.87 Allowed 'General case' 0 C--O 1.233 0.227 0 CA-C-O 120.68 0.276 . . . . 1.0 111.501 178.31 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . 0.726 ' HE ' ' HB ' ' A' ' 89' ' ' VAL . 73.9 mtt85 -146.62 167.78 22.9 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 121.025 0.44 . . . . 1.0 111.702 -179.119 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 21.0 tt -76.22 164.13 3.67 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.324 0 N-CA-C 108.061 -1.088 . . . . 1.0 108.061 176.891 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 56.1 tt0 -132.82 131.2 40.78 Favored 'General case' 0 CA--C 1.535 0.399 0 N-CA-C 108.857 -0.794 . . . . 1.0 108.857 179.057 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 10.5 tt -143.48 153.82 16.37 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.728 0 N-CA-C 110.169 -0.308 . . . . 1.0 110.169 178.852 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 104.14 2.35 45.03 Favored Glycine 0 C--N 1.341 0.848 0 N-CA-C 109.851 -1.3 . . . . 1.0 109.851 -179.108 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 18.2 m-20 -90.57 109.8 20.95 Favored 'General case' 0 CA--C 1.542 0.642 0 CA-C-O 122.138 0.971 . . . . 1.0 113.09 -178.152 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 58' ' ' TRP . . . . . 0.56 ' CD1' ' OE1' ' A' ' 61' ' ' GLU . 9.2 m95 -82.8 -176.92 6.54 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 113.43 -1.714 . . . . 1.0 108.678 176.599 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 59' ' ' ARG . . . . . 0.431 ' HG2' ' H ' ' A' ' 59' ' ' ARG . 8.0 ptm180 -98.64 -54.28 3.07 Favored 'General case' 0 CA--C 1.552 1.042 0 CA-C-N 118.955 0.798 . . . . 1.0 111.188 178.21 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 60' ' ' TYR . . . . . 0.411 ' H ' ' CG ' ' A' ' 59' ' ' ARG . 0.2 OUTLIER -80.29 -11.24 59.74 Favored 'General case' 0 N--CA 1.479 1.007 0 C-N-CA 124.561 1.145 . . . . 1.0 112.397 -178.511 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . 0.56 ' OE1' ' CD1' ' A' ' 58' ' ' TRP . 86.6 mt-10 -80.08 -16.47 54.94 Favored 'General case' 0 CA--C 1.496 -1.127 0 O-C-N 121.58 -0.7 . . . . 1.0 110.413 179.302 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 62' ' ' VAL . . . . . 0.516 HG23 ' N ' ' A' ' 63' ' ' ALA . 28.7 m -44.24 -46.52 2.3 Favored 'Isoleucine or valine' 0 CA--C 1.499 -1.01 0 N-CA-C 109.215 -0.661 . . . . 1.0 109.215 -175.798 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 63' ' ' ALA . . . . . 0.516 ' N ' HG23 ' A' ' 62' ' ' VAL . . . -66.19 -46.29 77.84 Favored 'General case' 0 N--CA 1.415 -2.206 0 N-CA-C 108.109 -1.071 . . . . 1.0 108.109 177.147 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 64' ' ' HIS . . . . . 0.485 ' N ' ' O ' ' A' ' 61' ' ' GLU . 4.2 t-80 -57.96 -60.65 3.4 Favored 'General case' 0 CA--C 1.547 0.83 0 CA-C-N 115.572 -0.74 . . . . 1.0 111.269 179.322 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 65' ' ' ASP . . . . . 0.609 ' C ' ' H ' ' A' ' 67' ' ' ARG . 0.7 OUTLIER -69.96 -55.63 9.11 Favored 'General case' 0 CA--C 1.554 1.116 0 O-C-N 121.128 -0.983 . . . . 1.0 110.24 178.632 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . 0.478 ' N ' ' O ' ' A' ' 62' ' ' VAL . . . -64.84 32.59 0.1 Allowed Glycine 0 N--CA 1.471 1.008 0 O-C-N 121.475 -0.765 . . . . 1.0 111.421 178.461 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 67' ' ' ARG . . . . . 0.714 ' HB3' ' H ' ' A' ' 71' ' ' ALA . 0.0 OUTLIER -77.45 6.4 7.07 Favored 'General case' 0 C--N 1.316 -0.863 0 C-N-CA 123.605 0.762 . . . . 1.0 110.08 176.173 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . 0.613 ' O ' ' HA ' ' A' ' 72' ' ' HIS . 0.8 OUTLIER -33.15 -30.16 0.01 OUTLIER 'General case' 0 N--CA 1.486 1.366 0 N-CA-C 107.481 -1.303 . . . . 1.0 107.481 -179.072 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . 0.63 ' N ' ' O ' ' A' ' 67' ' ' ARG . 2.3 mt -63.25 -64.68 0.84 Allowed 'General case' 0 C--N 1.317 -0.847 0 C-N-CA 117.509 -1.676 . . . . 1.0 107.558 176.754 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . 0.677 ' C ' ' H ' ' A' ' 72' ' ' HIS . . . -77.17 -72.25 0.36 Allowed 'General case' 0 N--CA 1.478 0.932 0 N-CA-C 106.671 -1.603 . . . . 1.0 106.671 177.615 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 71' ' ' ALA . . . . . 0.714 ' H ' ' HB3' ' A' ' 67' ' ' ARG . . . -49.16 4.19 0.01 OUTLIER 'General case' 0 N--CA 1.467 0.418 0 C-N-CA 125.203 1.401 . . . . 1.0 112.31 178.536 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 72' ' ' HIS . . . . . 0.707 ' CG ' ' H ' ' A' ' 73' ' ' MET . 0.0 OUTLIER -18.11 -72.87 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.396 0 C-N-CA 123.155 0.582 . . . . 1.0 112.527 -176.592 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 73' ' ' MET . . . . . 0.707 ' H ' ' CG ' ' A' ' 72' ' ' HIS . 45.4 mtt -71.28 -43.04 67.93 Favored 'General case' 0 C--N 1.298 -1.658 0 C-N-CA 119.309 -0.957 . . . . 1.0 110.239 178.082 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . 0.618 ' O ' ' N ' ' A' ' 76' ' ' GLY . 42.3 t -43.08 -45.99 1.32 Allowed 'Isoleucine or valine' 0 N--CA 1.463 0.21 0 CA-C-O 118.822 -0.609 . . . . 1.0 110.248 -175.4 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 75' ' ' ASN . . . . . 0.508 ' O ' ' N ' ' A' ' 77' ' ' ILE . 5.2 t30 -38.45 -18.96 0.01 OUTLIER 'General case' 0 N--CA 1.473 0.693 0 CA-C-O 122.025 0.917 . . . . 1.0 111.815 179.192 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 76' ' ' GLY . . . . . 0.618 ' N ' ' O ' ' A' ' 74' ' ' VAL . . . -43.35 -19.05 0.07 OUTLIER Glycine 0 CA--C 1.54 1.641 0 N-CA-C 109.344 -1.503 . . . . 1.0 109.344 177.89 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 77' ' ' ILE . . . . . 0.767 ' O ' ' N ' ' A' ' 80' ' ' ALA . 9.7 pt -89.9 -49.7 13.61 Favored 'Isoleucine or valine' 0 C--O 1.211 -0.952 0 N-CA-C 107.982 -1.118 . . . . 1.0 107.982 179.963 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . 0.484 ' C ' ' O ' ' A' ' 77' ' ' ILE . 6.0 t -35.15 -35.04 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.447 -0.583 0 N-CA-C 108.532 -0.914 . . . . 1.0 108.532 -177.268 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . 0.616 ' O ' ' HB3' ' A' ' 83' ' ' ALA . 1.3 pp -91.56 -21.92 6.28 Favored 'Isoleucine or valine' 0 C--O 1.198 -1.638 0 CA-C-N 115.824 -0.626 . . . . 1.0 110.26 178.511 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 80' ' ' ALA . . . . . 0.767 ' N ' ' O ' ' A' ' 77' ' ' ILE . . . -92.65 -9.64 40.21 Favored 'General case' 0 CA--C 1.554 1.111 0 O-C-N 121.368 -0.832 . . . . 1.0 112.682 176.258 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 81' ' ' GLU . . . . . 0.531 ' N ' ' O ' ' A' ' 77' ' ' ILE . 4.9 mm-40 -79.15 -76.76 0.19 Allowed 'General case' 0 C--N 1.344 0.328 0 N-CA-C 112.583 0.586 . . . . 1.0 112.583 -176.121 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 82' ' ' ASP . . . . . 0.78 ' O ' HG12 ' A' ' 85' ' ' ILE . 5.9 m-20 -86.42 -17.34 34.58 Favored 'General case' 0 C--O 1.206 -1.205 0 CA-C-N 116.455 -0.339 . . . . 1.0 111.201 -179.795 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . 0.616 ' HB3' ' O ' ' A' ' 79' ' ' ILE . . . -58.47 -40.09 81.74 Favored 'General case' 0 C--N 1.316 -0.854 0 C-N-CA 118.188 -1.405 . . . . 1.0 111.944 -175.888 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . 0.727 HD13 ' O ' ' A' ' 84' ' ' LEU . 3.4 tm? -37.72 -37.07 0.21 Allowed 'General case' 0 N--CA 1.467 0.399 0 N-CA-C 112.719 0.637 . . . . 1.0 112.719 -175.65 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 85' ' ' ILE . . . . . 0.78 HG12 ' O ' ' A' ' 82' ' ' ASP . 22.4 pt -69.49 -26.49 31.28 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.568 0 C-N-CA 120.341 -0.544 . . . . 1.0 111.547 -179.804 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 86' ' ' ALA . . . . . 0.528 ' N ' ' O ' ' A' ' 83' ' ' ALA . . . -86.34 -15.16 41.4 Favored 'General case' 0 C--N 1.33 -0.249 0 N-CA-C 111.935 0.346 . . . . 1.0 111.935 -179.328 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 3.4 tt0 -53.04 -8.88 0.11 Allowed 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 120.868 0.366 . . . . 1.0 110.034 -179.467 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 88' ' ' ALA . . . . . 0.475 ' H ' ' C ' ' A' ' 86' ' ' ALA . . . -93.26 -8.1 43.16 Favored 'General case' 0 N--CA 1.47 0.573 0 CA-C-O 121.529 0.681 . . . . 1.0 109.421 -179.914 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 89' ' ' VAL . . . . . 0.726 ' HB ' ' HE ' ' A' ' 52' ' ' ARG . 4.5 t -92.61 36.22 0.1 OUTLIER 'Isoleucine or valine' 0 N--CA 1.438 -1.058 0 N-CA-C 108.103 -1.073 . . . . 1.0 108.103 178.602 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 90' ' ' GLY . . . . . 0.866 ' O ' ' N ' ' A' ' 92' ' ' HIS . . . -50.88 -28.15 15.79 Favored Glycine 0 C--N 1.355 1.585 0 CA-C-O 117.303 -1.832 . . . . 1.0 111.247 176.309 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 91' ' ' PRO . . . . . 0.667 ' HD2' ' N ' ' A' ' 90' ' ' GLY . 27.9 Cg_exo -32.73 -1.76 0.0 OUTLIER 'Trans proline' 0 N--CA 1.506 2.232 0 C-N-CA 123.388 2.725 . . . . 1.0 114.112 173.644 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 92' ' ' HIS . . . . . 0.866 ' N ' ' O ' ' A' ' 90' ' ' GLY . 1.5 t-80 -50.4 -29.73 10.81 Favored 'General case' 0 N--CA 1.443 -0.817 0 N-CA-C 107.094 -1.447 . . . . 1.0 107.094 178.897 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 93' ' ' LEU . . . . . 0.635 HD12 ' N ' ' A' ' 94' ' ' ALA . 2.0 pp -60.04 -52.29 66.01 Favored 'General case' 0 N--CA 1.448 -0.565 0 N-CA-C 108.404 -0.962 . . . . 1.0 108.404 177.185 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 94' ' ' ALA . . . . . 0.635 ' N ' HD12 ' A' ' 93' ' ' LEU . . . -50.61 -56.02 13.69 Favored 'General case' 0 CA--C 1.515 -0.394 0 N-CA-C 107.236 -1.394 . . . . 1.0 107.236 -179.433 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 95' ' ' ARG . . . . . 0.42 HH11 ' HG3' ' A' ' 20' ' ' PRO . 89.8 mtt-85 -59.41 -32.18 69.93 Favored 'General case' 0 C--N 1.313 -0.999 0 N-CA-C 108.325 -0.991 . . . . 1.0 108.325 177.538 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 96' ' ' ALA . . . . . 0.768 ' O ' ' N ' ' A' ' 100' ' ' ILE . . . -55.75 -49.77 72.21 Favored 'General case' 0 C--O 1.207 -1.156 0 N-CA-C 106.824 -1.547 . . . . 1.0 106.824 -178.741 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 97' ' ' LEU . . . . . 0.552 ' O ' HG22 ' A' ' 100' ' ' ILE . 0.6 OUTLIER -36.88 -26.58 0.01 OUTLIER 'General case' 0 CA--C 1.568 1.669 0 N-CA-C 107.216 -1.401 . . . . 1.0 107.216 -179.912 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 98' ' ' GLY . . . . . 0.606 ' N ' ' O ' ' A' ' 96' ' ' ALA . . . -84.95 -52.87 3.32 Favored Glycine 0 CA--C 1.55 2.261 0 CA-C-O 123.119 1.399 . . . . 1.0 111.19 173.816 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 99' ' ' GLN . . . . . 0.563 ' N ' ' O ' ' A' ' 96' ' ' ALA . 24.9 mt-30 -79.07 7.97 6.52 Favored 'General case' 0 N--CA 1.438 -1.073 0 CA-C-N 114.742 -0.729 . . . . 1.0 109.521 177.989 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 100' ' ' ILE . . . . . 0.768 ' N ' ' O ' ' A' ' 96' ' ' ALA . 14.7 tt -60.3 -49.77 82.9 Favored 'Isoleucine or valine' 0 CA--C 1.484 -1.561 0 N-CA-C 107.936 -1.135 . . . . 1.0 107.936 179.694 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 101' ' ' VAL . . . . . 0.705 ' N ' HG23 ' A' ' 100' ' ' ILE . 22.7 t -60.12 -56.7 15.78 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.636 0 C-N-CA 116.495 -2.082 . . . . 1.0 107.763 178.135 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 102' ' ' CYS . . . . . 0.531 ' O ' ' O ' ' A' ' 105' ' ' GLY . 0.5 OUTLIER -46.53 -38.17 8.98 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 114.971 -1.013 . . . . 1.0 110.663 -175.869 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 7.3 ttp180 -65.05 -54.62 27.32 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 125.595 1.809 . . . . 1.0 113.302 176.844 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 104' ' ' TYR . . . . . 0.656 ' O ' ' CG ' ' A' ' 104' ' ' TYR . 50.8 t80 -93.28 32.0 1.4 Allowed 'General case' 0 C--N 1.311 -1.096 0 C-N-CA 126.082 1.753 . . . . 1.0 107.441 178.969 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 105' ' ' GLY . . . . . 0.539 ' O ' ' CB ' ' A' ' 106' ' ' ALA . . . 172.56 -141.78 6.43 Favored Glycine 0 N--CA 1.431 -1.649 0 N-CA-C 107.199 -2.36 . . . . 1.0 107.199 178.665 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 106' ' ' ALA . . . . . 0.539 ' CB ' ' O ' ' A' ' 105' ' ' GLY . . . 109.67 107.63 0.0 OUTLIER 'General case' 0 C--N 1.315 -0.896 0 C-N-CA 126.736 2.014 . . . . 1.0 116.237 178.712 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 107' ' ' THR . . . . . 0.532 ' O ' ' HG2' ' A' ' 110' ' ' PRO . 27.7 m -72.44 -52.06 17.54 Favored 'General case' 0 N--CA 1.476 0.842 0 CA-C-N 115.614 -0.721 . . . . 1.0 110.12 175.252 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 108' ' ' VAL . . . . . 0.561 HG13 ' N ' ' A' ' 109' ' ' ILE . 8.7 p -61.46 -46.12 97.22 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.035 0 O-C-N 121.639 -0.663 . . . . 1.0 112.019 -178.452 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 109' ' ' ILE . . . . . 0.561 ' N ' HG13 ' A' ' 108' ' ' VAL . 2.6 mt -38.0 -59.6 1.15 Allowed Pre-proline 0 N--CA 1.484 1.253 0 CA-C-N 116.399 -0.364 . . . . 1.0 110.778 -178.401 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 110' ' ' PRO . . . . . 0.532 ' HG2' ' O ' ' A' ' 107' ' ' THR . 31.9 Cg_endo -56.18 -21.82 37.35 Favored 'Trans proline' 0 C--N 1.314 -1.25 0 C-N-CA 120.895 1.064 . . . . 1.0 112.177 -177.888 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 4.0 m-80 -64.37 -65.7 0.64 Allowed 'General case' 0 N--CA 1.469 0.522 0 C-N-CA 119.631 -0.827 . . . . 1.0 109.808 178.77 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 112' ' ' ILE . . . . . 0.662 ' O ' ' HB ' ' A' ' 116' ' ' ILE . 2.0 tt -45.72 -27.45 0.64 Allowed 'Isoleucine or valine' 0 C--O 1.22 -0.474 0 CA-C-O 122.383 1.087 . . . . 1.0 109.121 -179.166 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 113' ' ' ASN . . . . . 0.754 ' O ' ' HB3' ' A' ' 117' ' ' GLU . 25.4 t-20 -84.05 -53.03 5.83 Favored 'General case' 0 C--N 1.308 -1.199 0 CA-C-O 122.953 1.359 . . . . 1.0 110.018 178.949 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -56.07 -58.04 9.58 Favored 'General case' 0 C--N 1.295 -1.793 0 C-N-CA 119.257 -0.977 . . . . 1.0 110.261 -178.688 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -79.89 -59.59 2.67 Favored 'General case' 0 C--O 1.246 0.893 0 N-CA-C 114.465 1.283 . . . . 1.0 114.465 179.921 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 116' ' ' ILE . . . . . 0.662 ' HB ' ' O ' ' A' ' 112' ' ' ILE . 11.2 mt -68.23 -55.36 16.67 Favored 'Isoleucine or valine' 0 C--O 1.217 -0.638 0 C-N-CA 117.919 -1.512 . . . . 1.0 113.055 -175.183 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 117' ' ' GLU . . . . . 0.754 ' HB3' ' O ' ' A' ' 113' ' ' ASN . 0.0 OUTLIER -39.56 -65.6 0.37 Allowed 'General case' 0 C--O 1.251 1.166 0 C-N-CA 121.079 -0.248 . . . . 1.0 110.453 -174.271 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 2.5 t -45.36 -18.63 0.1 Allowed 'Isoleucine or valine' 0 N--CA 1.446 -0.643 0 C-N-CA 119.124 -1.031 . . . . 1.0 109.81 -178.963 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 119' ' ' LEU . . . . . 0.603 ' N ' ' O ' ' A' ' 116' ' ' ILE . 4.7 tt -88.57 -54.92 3.94 Favored 'General case' 0 CA--C 1.538 0.504 0 N-CA-C 112.566 0.58 . . . . 1.0 112.566 176.899 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 120' ' ' GLY . . . . . 0.575 ' C ' ' H ' ' A' ' 122' ' ' GLY . . . -93.3 44.87 2.44 Favored Glycine 0 C--N 1.367 2.251 0 C-N-CA 119.821 -1.18 . . . . 1.0 113.937 -175.968 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 121' ' ' THR . . . . . 0.427 ' HB ' ' O ' ' A' ' 120' ' ' GLY . 41.5 m 73.66 -27.85 0.19 Allowed 'General case' 0 N--CA 1.476 0.848 0 C-N-CA 123.432 0.693 . . . . 1.0 109.92 177.742 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 122' ' ' GLY . . . . . 0.575 ' H ' ' C ' ' A' ' 120' ' ' GLY . . . 106.81 -36.07 4.64 Favored Glycine 0 C--N 1.319 -0.405 0 C-N-CA 124.777 1.179 . . . . 1.0 110.634 179.811 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 123' ' ' THR . . . . . 0.434 ' C ' ' O ' ' A' ' 122' ' ' GLY . 81.4 m -31.42 98.96 0.01 OUTLIER 'General case' 0 N--CA 1.465 0.281 0 CA-C-N 117.643 0.722 . . . . 1.0 112.421 -178.07 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 12.1 p-10 -142.83 143.25 32.05 Favored 'General case' 0 N--CA 1.45 -0.439 0 N-CA-C 108.058 -1.09 . . . . 1.0 108.058 177.352 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 125' ' ' TYR . . . . . 0.517 ' OH ' ' CD1' ' A' ' 127' ' ' PHE . 0.0 OUTLIER -153.03 149.1 27.81 Favored 'General case' 0 CA--C 1.542 0.646 0 C-N-CA 122.95 0.5 . . . . 1.0 109.682 -178.498 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 126' ' ' ARG . . . . . 0.465 ' NE ' ' O ' ' A' ' 125' ' ' TYR . 9.6 mmp_? -149.58 152.85 36.17 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.857 -0.61 . . . . 1.0 109.92 177.24 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 127' ' ' PHE . . . . . 0.517 ' CD1' ' OH ' ' A' ' 125' ' ' TYR . 10.6 p90 . . . . . 0 C--O 1.221 -0.436 0 CA-C-O 118.041 -0.981 . . . . 1.0 110.152 179.262 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.586 0 N-CA-C 109.083 -0.71 . . . . 1.0 109.083 . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 2' ' ' SER . . . . . 0.414 ' O ' ' CG ' ' A' ' 3' ' ' ASP . 87.3 p -104.18 8.92 36.34 Favored 'General case' 0 N--CA 1.465 0.31 0 CA-C-N 115.672 -0.694 . . . . 1.0 110.187 -179.708 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 3' ' ' ASP . . . . . 0.414 ' CG ' ' O ' ' A' ' 2' ' ' SER . 1.6 m-20 166.44 98.32 0.0 OUTLIER 'General case' 0 CA--C 1.532 0.258 0 CA-C-N 116.163 -0.471 . . . . 1.0 109.963 178.974 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 3.4 t80 -149.68 145.84 26.93 Favored 'General case' 0 C--N 1.33 -0.251 0 N-CA-C 109.612 -0.514 . . . . 1.0 109.612 179.122 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 5' ' ' ASP . . . . . 0.631 ' O ' ' O ' ' A' ' 6' ' ' THR . 0.1 OUTLIER -155.06 154.31 32.25 Favored 'General case' 0 C--N 1.327 -0.413 0 N-CA-C 109.229 -0.656 . . . . 1.0 109.229 -179.95 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 6' ' ' THR . . . . . 0.726 HG22 ' H ' ' A' ' 7' ' ' GLU . 3.1 m -37.1 177.51 0.0 OUTLIER 'General case' 0 N--CA 1.469 0.501 0 CA-C-O 121.656 0.741 . . . . 1.0 111.646 -178.23 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . 0.726 ' H ' HG22 ' A' ' 6' ' ' THR . 50.9 mt-10 -66.29 -58.44 5.34 Favored 'General case' 0 C--N 1.319 -0.759 0 CA-C-N 116.231 -0.44 . . . . 1.0 110.758 -178.808 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 8' ' ' ARG . . . . . 0.409 ' HG3' ' N ' ' A' ' 9' ' ' VAL . 0.0 OUTLIER -68.55 -31.49 70.74 Favored 'General case' 0 N--CA 1.451 -0.41 0 CA-C-N 119.01 0.823 . . . . 1.0 111.029 179.477 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . 0.629 ' O ' HG23 ' A' ' 13' ' ' VAL . 60.0 t -66.69 -55.07 19.7 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.705 0 N-CA-C 108.228 -1.027 . . . . 1.0 108.228 179.651 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 22.9 t -68.49 -38.46 81.0 Favored 'General case' 0 C--N 1.321 -0.658 0 O-C-N 121.912 -0.493 . . . . 1.0 111.626 178.251 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 14.3 ttt-85 -74.12 -64.09 1.09 Allowed 'General case' 0 N--CA 1.453 -0.314 0 CA-C-O 118.488 -0.768 . . . . 1.0 111.361 -179.505 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . 0.547 ' O ' ' HB3' ' A' ' 16' ' ' ALA . . . -52.29 -30.77 29.72 Favored 'General case' 0 CA--C 1.501 -0.914 0 CA-C-N 120.319 1.418 . . . . 1.0 110.09 -179.48 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . 0.629 HG23 ' O ' ' A' ' 9' ' ' VAL . 3.6 t -56.27 -52.0 56.76 Favored 'Isoleucine or valine' 0 C--O 1.202 -1.43 0 N-CA-C 106.15 -1.796 . . . . 1.0 106.15 176.922 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . 0.615 ' O ' HG13 ' A' ' 18' ' ' VAL . . . -59.16 -63.54 1.26 Allowed 'General case' 0 CA--C 1.544 0.743 0 C-N-CA 117.395 -1.722 . . . . 1.0 110.983 177.72 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . 0.528 ' O ' ' N ' ' A' ' 19' ' ' GLY . . . -53.13 -54.73 31.38 Favored 'General case' 0 N--CA 1.484 1.225 0 CA-C-O 122.16 0.981 . . . . 1.0 110.844 -177.139 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . 0.579 ' HB1' ' CA ' ' A' ' 22' ' ' GLY . . . -63.07 -53.75 48.71 Favored 'General case' 0 C--N 1.303 -1.439 0 CA-C-N 113.915 -1.493 . . . . 1.0 108.984 -178.47 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . 0.607 ' CB ' ' O ' ' A' ' 13' ' ' VAL . 10.0 tp -57.47 -52.46 65.3 Favored 'General case' 0 N--CA 1.484 1.267 0 CA-C-N 114.48 -1.236 . . . . 1.0 108.576 -176.759 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . 0.615 HG13 ' O ' ' A' ' 14' ' ' ALA . 3.5 m -67.46 -56.56 12.9 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.245 0 C-N-CA 119.043 -1.063 . . . . 1.0 108.763 179.153 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . 0.528 ' N ' ' O ' ' A' ' 15' ' ' ALA . . . -61.61 -167.1 0.47 Allowed Glycine 0 CA--C 1.522 0.499 0 N-CA-C 111.58 -0.608 . . . . 1.0 111.58 -179.704 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 20' ' ' PRO . . . . . 0.627 ' O ' ' N ' ' A' ' 24' ' ' ALA . 56.1 Cg_endo -81.86 -32.71 0.75 Allowed 'Trans proline' 0 C--N 1.304 -1.773 0 C-N-CA 122.72 2.28 . . . . 1.0 114.467 -178.2 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -58.17 -57.41 19.98 Favored Glycine 0 N--CA 1.479 1.525 0 C-N-CA 120.481 -0.866 . . . . 1.0 112.318 -177.328 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . 0.579 ' CA ' ' HB1' ' A' ' 16' ' ' ALA . . . -58.65 -49.7 74.67 Favored Glycine 0 N--CA 1.472 1.034 0 N-CA-C 105.849 -2.9 . . . . 1.0 105.849 -176.123 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . 0.509 ' O ' HG12 ' A' ' 27' ' ' VAL . 2.5 t -58.7 -33.76 49.85 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.079 0 CA-C-N 114.035 -1.082 . . . . 1.0 108.355 178.334 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . 0.627 ' N ' ' O ' ' A' ' 20' ' ' PRO . . . -58.2 -61.9 2.22 Favored 'General case' 0 CA--C 1.536 0.413 0 C-N-CA 118.276 -1.37 . . . . 1.0 110.309 -179.511 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 56.5 mt -64.73 -42.67 95.04 Favored 'General case' 0 CA--C 1.52 -0.211 0 CA-C-N 118.982 0.81 . . . . 1.0 112.374 -177.49 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 75.1 t -60.68 -58.69 6.29 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.358 0 C-N-CA 119.096 -1.042 . . . . 1.0 109.327 -177.313 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . 0.509 HG12 ' O ' ' A' ' 23' ' ' VAL . 1.9 p -60.35 -34.66 58.44 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.518 0 N-CA-C 112.286 0.476 . . . . 1.0 112.286 -177.86 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 7.6 tppt? -65.55 -53.6 39.76 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-O 122.246 1.022 . . . . 1.0 109.094 -178.494 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 88.1 t -63.11 -46.58 95.68 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.125 0 CA-C-N 113.216 -1.811 . . . . 1.0 109.863 -177.231 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 30' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -65.35 -59.83 3.62 Favored 'General case' 0 N--CA 1.447 -0.602 0 C-N-CA 118.455 -1.298 . . . . 1.0 109.054 -179.419 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -60.27 -52.36 65.63 Favored 'General case' 0 CA--C 1.509 -0.619 0 N-CA-C 112.118 0.414 . . . . 1.0 112.118 -176.708 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . 0.471 ' O ' ' CB ' ' A' ' 33' ' ' LEU . . . 83.57 77.58 1.11 Allowed Glycine 0 CA--C 1.524 0.642 0 N-CA-C 109.918 -1.273 . . . . 1.0 109.918 -178.55 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . 0.471 ' CB ' ' O ' ' A' ' 32' ' ' GLY . 4.0 tp 85.02 107.84 0.03 OUTLIER Pre-proline 0 CA--C 1.548 0.884 0 O-C-N 123.885 0.403 . . . . 1.0 110.685 -179.927 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 37.6 Cg_endo -67.83 -27.51 37.32 Favored 'Trans proline' 0 N--CA 1.499 1.837 0 C-N-CA 121.632 1.555 . . . . 1.0 113.711 -179.001 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -60.83 -59.72 9.68 Favored Glycine 0 CA--C 1.525 0.694 0 C-N-CA 118.516 -1.802 . . . . 1.0 109.551 -177.564 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . 0.864 ' O ' HG23 ' A' ' 37' ' ' ILE . 1.7 p -84.01 142.71 13.04 Favored 'Isoleucine or valine' 0 C--O 1.211 -0.924 0 N-CA-C 106.822 -1.547 . . . . 1.0 106.822 178.011 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . 0.864 HG23 ' O ' ' A' ' 36' ' ' VAL . 0.6 OUTLIER 150.54 88.87 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.475 0.809 0 O-C-N 123.556 0.535 . . . . 1.0 109.75 179.694 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 26.2 m-70 -134.64 128.0 32.25 Favored 'General case' 0 C--O 1.233 0.195 0 N-CA-C 107.277 -1.379 . . . . 1.0 107.277 176.91 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 39' ' ' THR . . . . . 0.553 ' O ' ' NH2' ' A' ' 42' ' ' ARG . 1.0 OUTLIER -121.6 158.5 53.85 Favored Pre-proline 0 N--CA 1.468 0.463 0 N-CA-C 109.43 -0.581 . . . . 1.0 109.43 -179.189 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 40' ' ' PRO . . . . . 0.508 ' HG2' ' H ' ' A' ' 41' ' ' ALA . 97.4 Cg_endo -85.41 -78.76 0.0 OUTLIER 'Trans proline' 0 C--N 1.31 -1.456 0 C-N-CA 121.36 1.374 . . . . 1.0 113.306 179.99 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . 0.508 ' H ' ' HG2' ' A' ' 40' ' ' PRO . . . -76.11 123.3 25.59 Favored 'General case' 0 C--N 1.319 -0.737 0 CA-C-N 114.955 -1.021 . . . . 1.0 111.875 -176.802 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . 0.655 ' C ' ' H ' ' A' ' 44' ' ' GLY . 0.0 OUTLIER -171.14 171.06 5.89 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 114.493 -1.23 . . . . 1.0 109.502 179.071 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 8.6 tpt180 -63.53 18.07 0.01 OUTLIER 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.512 -0.767 . . . . 1.0 109.761 178.989 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . 0.655 ' H ' ' C ' ' A' ' 42' ' ' ARG . . . 81.38 -25.48 3.77 Favored Glycine 0 C--N 1.336 0.542 0 N-CA-C 110.731 -0.948 . . . . 1.0 110.731 179.343 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . 0.538 ' O ' ' CD1' ' A' ' 46' ' ' PHE . 84.9 t80 -161.72 163.23 29.81 Favored 'General case' 0 CA--C 1.535 0.388 0 N-CA-C 110.5 -0.185 . . . . 1.0 110.5 -179.328 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 46' ' ' PHE . . . . . 0.538 ' CD1' ' O ' ' A' ' 45' ' ' PHE . 3.9 m-30 136.61 86.49 0.0 OUTLIER 'General case' 0 N--CA 1.487 1.405 0 O-C-N 124.782 1.301 . . . . 1.0 110.308 179.369 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 47' ' ' ARG . . . . . 0.509 ' CB ' ' O ' ' A' ' 46' ' ' PHE . 5.2 mmp_? 132.57 140.77 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.512 0 C-N-CA 124.392 1.077 . . . . 1.0 109.642 178.568 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 1.9 t 72.74 72.02 0.14 Allowed 'General case' 0 N--CA 1.451 -0.386 0 C-N-CA 120.277 -0.569 . . . . 1.0 109.672 -179.631 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 49' ' ' ASN . . . . . 0.655 ' O ' ' N ' ' A' ' 51' ' ' GLU . 0.0 OUTLIER -136.37 121.9 13.38 Favored Pre-proline 0 C--O 1.221 -0.439 0 N-CA-C 107.923 -1.14 . . . . 1.0 107.923 -179.464 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 52.4 Cg_exo -52.21 63.96 0.02 OUTLIER 'Trans proline' 0 N--CA 1.503 2.03 0 C-N-CA 121.94 1.76 . . . . 1.0 113.311 178.786 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . 0.655 ' N ' ' O ' ' A' ' 49' ' ' ASN . 2.5 mp0 65.05 36.79 7.15 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 120.523 0.202 . . . . 1.0 110.81 -179.978 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . 0.489 HH21 ' HB3' ' A' ' 86' ' ' ALA . 4.7 mtp85 -111.21 138.58 47.48 Favored 'General case' 0 N--CA 1.466 0.367 0 CA-C-N 116.515 -0.311 . . . . 1.0 110.176 179.634 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . 0.578 HG23 HG23 ' A' ' 55' ' ' ILE . 4.7 tp -66.54 141.38 18.07 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-O 121.836 0.826 . . . . 1.0 110.611 179.97 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 54' ' ' GLN . . . . . 0.521 ' O ' ' CG ' ' A' ' 54' ' ' GLN . 0.0 OUTLIER -63.03 80.78 0.02 OUTLIER 'General case' 0 CA--C 1.55 0.977 0 CA-C-N 113.739 -1.573 . . . . 1.0 109.915 -176.433 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . 0.827 HD13 ' O ' ' A' ' 55' ' ' ILE . 0.0 OUTLIER -150.05 158.38 5.65 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.875 0 O-C-N 121.038 -1.039 . . . . 1.0 110.224 178.091 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 110.43 -7.26 30.29 Favored Glycine 0 N--CA 1.474 1.17 0 N-CA-C 111.05 -0.82 . . . . 1.0 111.05 -179.522 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . 0.452 ' O ' ' OD1' ' A' ' 57' ' ' ASP . 42.3 p-10 -77.22 97.88 4.95 Favored 'General case' 0 C--N 1.318 -0.769 0 N-CA-C 108.079 -1.082 . . . . 1.0 108.079 177.59 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 58' ' ' TRP . . . . . . . . . . . . . 0.6 OUTLIER -88.88 175.19 7.55 Favored 'General case' 0 CA--C 1.538 0.506 0 CA-C-O 122.757 1.265 . . . . 1.0 112.321 -177.753 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 59' ' ' ARG . . . . . 0.52 ' HD2' ' H ' ' A' ' 59' ' ' ARG . 0.6 OUTLIER -88.52 -57.69 2.83 Favored 'General case' 0 C--N 1.318 -0.79 0 CA-C-N 112.479 -2.146 . . . . 1.0 112.985 179.963 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 79.0 t80 -90.73 -17.73 26.2 Favored 'General case' 0 C--O 1.245 0.866 0 CA-C-N 115.115 -0.948 . . . . 1.0 113.012 -178.553 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . 0.485 ' O ' ' N ' ' A' ' 65' ' ' ASP . 17.6 tt0 -77.19 -12.9 60.0 Favored 'General case' 0 N--CA 1.435 -1.214 0 O-C-N 121.844 -0.535 . . . . 1.0 110.275 -178.605 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 62' ' ' VAL . . . . . 0.576 HG23 ' H ' ' A' ' 63' ' ' ALA . 16.1 m -45.45 -55.73 1.18 Allowed 'Isoleucine or valine' 0 C--O 1.21 -1.01 0 C-N-CA 119.602 -0.839 . . . . 1.0 109.126 -175.385 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 63' ' ' ALA . . . . . 0.576 ' H ' HG23 ' A' ' 62' ' ' VAL . . . -65.43 -48.86 71.29 Favored 'General case' 0 C--N 1.306 -1.315 0 N-CA-C 109.306 -0.627 . . . . 1.0 109.306 178.721 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER -53.15 -58.85 5.61 Favored 'General case' 0 CA--C 1.539 0.533 0 C-N-CA 119.28 -0.968 . . . . 1.0 109.429 -179.084 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 65' ' ' ASP . . . . . 0.54 ' C ' ' H ' ' A' ' 67' ' ' ARG . 19.0 m-20 -65.28 -45.67 83.52 Favored 'General case' 0 C--N 1.324 -0.524 0 N-CA-C 108.849 -0.797 . . . . 1.0 108.849 178.085 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . 0.521 ' N ' ' O ' ' A' ' 62' ' ' VAL . . . -67.49 24.44 0.22 Allowed Glycine 0 C--N 1.338 0.655 0 N-CA-C 111.629 -0.588 . . . . 1.0 111.629 -179.976 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 67' ' ' ARG . . . . . 0.54 ' H ' ' C ' ' A' ' 65' ' ' ASP . 0.0 OUTLIER -86.36 -9.89 55.47 Favored 'General case' 0 C--N 1.315 -0.893 0 N-CA-C 108.587 -0.894 . . . . 1.0 108.587 175.602 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . 0.513 ' O ' ' CA ' ' A' ' 72' ' ' HIS . 1.4 pt? -63.35 -34.92 78.77 Favored 'General case' 0 N--CA 1.472 0.632 0 N-CA-C 112.97 0.73 . . . . 1.0 112.97 -177.868 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -52.29 -65.51 0.55 Allowed 'General case' 0 C--N 1.317 -0.828 0 C-N-CA 117.433 -1.707 . . . . 1.0 109.25 -177.622 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -64.7 -75.76 0.08 Allowed 'General case' 0 C--N 1.312 -1.029 0 N-CA-C 106.511 -1.662 . . . . 1.0 106.511 -179.811 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 71' ' ' ALA . . . . . 0.745 ' O ' ' N ' ' A' ' 73' ' ' MET . . . -59.56 15.74 0.01 OUTLIER 'General case' 0 C--N 1.321 -0.636 0 C-N-CA 127.172 2.189 . . . . 1.0 116.084 179.94 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 72' ' ' HIS . . . . . 0.513 ' CA ' ' O ' ' A' ' 68' ' ' LEU . 0.0 OUTLIER -21.94 -28.48 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.588 0 CA-C-N 119.638 1.108 . . . . 1.0 113.756 -176.11 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 73' ' ' MET . . . . . 0.745 ' N ' ' O ' ' A' ' 71' ' ' ALA . 4.0 mmt -63.72 -56.65 14.03 Favored 'General case' 0 C--N 1.317 -0.816 0 C-N-CA 117.64 -1.624 . . . . 1.0 106.875 174.789 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . 0.783 ' O ' ' N ' ' A' ' 76' ' ' GLY . 27.9 t -36.92 -51.08 0.3 Allowed 'Isoleucine or valine' 0 N--CA 1.48 1.037 0 CA-C-O 118.483 -0.77 . . . . 1.0 111.155 -175.86 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 75' ' ' ASN . . . . . 0.524 ' O ' HG12 ' A' ' 78' ' ' VAL . 26.0 t30 -30.71 -16.64 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.492 0 CA-C-N 119.302 0.956 . . . . 1.0 113.382 -178.2 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 76' ' ' GLY . . . . . 0.783 ' N ' ' O ' ' A' ' 74' ' ' VAL . . . -48.2 -25.05 3.85 Favored Glycine 0 CA--C 1.543 1.822 0 N-CA-C 109.991 -1.243 . . . . 1.0 109.991 176.404 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 77' ' ' ILE . . . . . 0.578 HG13 ' H ' ' A' ' 78' ' ' VAL . 3.0 pt -73.29 -55.55 12.3 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.679 0 CA-C-O 122.366 1.079 . . . . 1.0 109.078 178.552 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . 0.578 ' H ' HG13 ' A' ' 77' ' ' ILE . 1.4 p -38.59 -34.85 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.311 -1.083 0 CA-C-N 112.395 -2.184 . . . . 1.0 105.405 -175.666 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . 0.728 ' O ' ' HB3' ' A' ' 83' ' ' ALA . 16.2 pt -100.06 -37.58 5.92 Favored 'Isoleucine or valine' 0 CA--C 1.554 1.126 0 N-CA-C 113.924 1.083 . . . . 1.0 113.924 176.712 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 80' ' ' ALA . . . . . 0.519 ' N ' ' O ' ' A' ' 76' ' ' GLY . . . -82.39 -12.78 57.7 Favored 'General case' 0 N--CA 1.478 0.969 0 N-CA-C 113.645 0.98 . . . . 1.0 113.645 -178.86 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 45.5 tt0 -92.17 -73.14 0.56 Allowed 'General case' 0 N--CA 1.439 -0.995 0 CA-C-O 118.918 -0.563 . . . . 1.0 112.507 -178.636 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 28.3 m-20 -93.82 -16.84 23.72 Favored 'General case' 0 C--N 1.352 0.69 0 N-CA-C 114.843 1.423 . . . . 1.0 114.843 -178.551 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . 0.728 ' HB3' ' O ' ' A' ' 79' ' ' ILE . . . -52.94 -41.46 64.51 Favored 'General case' 0 N--CA 1.468 0.44 0 C-N-CA 118.713 -1.195 . . . . 1.0 111.205 -177.588 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 49.5 mt -39.37 -15.71 0.01 OUTLIER 'General case' 0 CA--C 1.538 0.505 0 N-CA-C 111.869 0.322 . . . . 1.0 111.869 -179.577 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 85' ' ' ILE . . . . . 0.62 ' N ' ' O ' ' A' ' 83' ' ' ALA . 0.8 OUTLIER -96.68 -31.55 4.01 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.618 0 C-N-CA 120.973 -0.291 . . . . 1.0 111.246 178.285 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 86' ' ' ALA . . . . . 0.658 ' O ' HG22 ' A' ' 89' ' ' VAL . . . -94.64 -28.66 15.25 Favored 'General case' 0 N--CA 1.466 0.375 0 CA-C-O 120.811 0.339 . . . . 1.0 111.842 -179.408 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -54.54 -7.7 0.18 Allowed 'General case' 0 C--N 1.32 -0.703 0 C-N-CA 119.308 -0.957 . . . . 1.0 110.196 -178.781 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 88' ' ' ALA . . . . . 0.483 ' H ' ' C ' ' A' ' 86' ' ' ALA . . . -79.73 -0.85 35.93 Favored 'General case' 0 N--CA 1.472 0.655 0 CA-C-O 122.209 1.004 . . . . 1.0 109.245 179.324 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 89' ' ' VAL . . . . . 0.658 HG22 ' O ' ' A' ' 86' ' ' ALA . 3.2 m -102.01 34.53 0.36 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.54 0 CA-C-N 113.025 -1.898 . . . . 1.0 109.744 178.548 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 90' ' ' GLY . . . . . 0.612 ' C ' ' H ' ' A' ' 92' ' ' HIS . . . -67.06 -38.27 92.38 Favored Glycine 0 C--N 1.345 1.052 0 N-CA-C 111.146 -0.782 . . . . 1.0 111.146 178.575 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 91' ' ' PRO . . . . . 0.539 ' CD ' ' N ' ' A' ' 90' ' ' GLY . 80.6 Cg_exo -46.96 -8.0 0.04 OUTLIER 'Trans proline' 0 N--CA 1.488 1.199 0 C-N-CA 121.75 1.633 . . . . 1.0 110.712 177.995 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 92' ' ' HIS . . . . . 0.612 ' H ' ' C ' ' A' ' 90' ' ' GLY . 2.6 p80 -57.42 -21.05 33.95 Favored 'General case' 0 N--CA 1.439 -1.0 0 N-CA-C 108.051 -1.092 . . . . 1.0 108.051 179.949 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 93' ' ' LEU . . . . . 0.656 HD12 ' N ' ' A' ' 94' ' ' ALA . 2.3 pp -61.64 -58.52 7.76 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.764 -0.653 . . . . 1.0 109.345 178.307 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 94' ' ' ALA . . . . . 0.656 ' N ' HD12 ' A' ' 93' ' ' LEU . . . -56.01 -52.39 64.38 Favored 'General case' 0 CA--C 1.515 -0.374 0 N-CA-C 108.983 -0.747 . . . . 1.0 108.983 179.532 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 95' ' ' ARG . . . . . 0.627 ' O ' ' N ' ' A' ' 97' ' ' LEU . 33.5 ttp180 -58.95 -60.25 4.16 Favored 'General case' 0 N--CA 1.442 -0.86 0 N-CA-C 107.565 -1.272 . . . . 1.0 107.565 178.39 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 96' ' ' ALA . . . . . 0.978 ' O ' ' N ' ' A' ' 98' ' ' GLY . . . -47.18 -13.71 0.03 OUTLIER 'General case' 0 C--N 1.301 -1.533 0 O-C-N 119.104 -2.247 . . . . 1.0 111.153 -178.689 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 97' ' ' LEU . . . . . 0.688 ' O ' ' N ' ' A' ' 100' ' ' ILE . 1.3 tm? 6.91 -52.53 0.0 OUTLIER 'General case' 0 C--N 1.365 1.242 0 CA-C-O 118.13 -0.938 . . . . 1.0 108.881 -166.886 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 98' ' ' GLY . . . . . 0.978 ' N ' ' O ' ' A' ' 96' ' ' ALA . . . -49.93 -24.29 6.19 Favored Glycine 0 CA--C 1.545 1.934 0 N-CA-C 107.898 -2.081 . . . . 1.0 107.898 174.218 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 99' ' ' GLN . . . . . 0.645 ' N ' ' O ' ' A' ' 96' ' ' ALA . 19.0 mt-30 -67.68 -19.32 65.16 Favored 'General case' 0 C--N 1.364 1.222 0 C-N-CA 116.073 -2.251 . . . . 1.0 107.263 176.375 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 100' ' ' ILE . . . . . 0.688 ' N ' ' O ' ' A' ' 97' ' ' LEU . 3.4 mm -66.67 -43.6 90.16 Favored 'Isoleucine or valine' 0 C--O 1.212 -0.872 0 C-N-CA 119.171 -1.012 . . . . 1.0 109.519 177.594 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 101' ' ' VAL . . . . . 0.503 HG13 ' N ' ' A' ' 102' ' ' CYS . 4.6 p -60.27 -56.8 15.19 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.32 0 C-N-CA 116.684 -2.006 . . . . 1.0 107.483 -179.924 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 102' ' ' CYS . . . . . 0.953 ' O ' ' HB2' ' A' ' 106' ' ' ALA . 0.5 OUTLIER -51.09 -31.67 19.78 Favored 'General case' 0 C--O 1.214 -0.812 0 CA-C-O 121.223 0.535 . . . . 1.0 112.019 179.845 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 103' ' ' ARG . . . . . 0.484 HH22 ' HB3' ' A' ' 93' ' ' LEU . 3.2 ttp180 -85.34 -47.46 10.0 Favored 'General case' 0 N--CA 1.477 0.904 0 CA-C-N 115.254 -0.884 . . . . 1.0 111.745 179.545 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 104' ' ' TYR . . . . . 0.401 ' O ' ' CG ' ' A' ' 104' ' ' TYR . 8.7 t80 -49.73 -19.36 0.62 Allowed 'General case' 0 C--N 1.3 -1.571 0 CA-C-N 114.086 -1.416 . . . . 1.0 108.937 179.28 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 105' ' ' GLY . . . . . 0.475 ' O ' ' HB3' ' A' ' 106' ' ' ALA . . . -173.64 -46.52 0.05 OUTLIER Glycine 0 N--CA 1.448 -0.526 0 C-N-CA 117.967 -2.063 . . . . 1.0 110.828 179.379 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 106' ' ' ALA . . . . . 0.953 ' HB2' ' O ' ' A' ' 102' ' ' CYS . . . 69.7 82.63 0.16 Allowed 'General case' 0 N--CA 1.44 -0.963 0 N-CA-C 111.628 0.232 . . . . 1.0 111.628 -179.081 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 107' ' ' THR . . . . . 0.426 ' O ' ' CD ' ' A' ' 110' ' ' PRO . 9.4 t -92.26 3.49 55.27 Favored 'General case' 0 CA--C 1.514 -0.44 0 N-CA-C 107.304 -1.369 . . . . 1.0 107.304 177.164 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 108' ' ' VAL . . . . . 0.76 ' O ' HG12 ' A' ' 108' ' ' VAL . 62.2 t -90.65 20.11 0.64 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.526 0 CA-C-N 114.883 -1.053 . . . . 1.0 111.352 178.593 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 109' ' ' ILE . . . . . 0.688 ' N ' ' CD ' ' A' ' 110' ' ' PRO . 0.1 OUTLIER -106.07 -18.26 0.17 Allowed Pre-proline 0 CA--C 1.548 0.869 0 O-C-N 120.162 -1.586 . . . . 1.0 110.954 177.994 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 110' ' ' PRO . . . . . 0.688 ' CD ' ' N ' ' A' ' 109' ' ' ILE . 19.5 Cg_endo -59.5 -49.56 10.2 Favored 'Trans proline' 0 N--CA 1.482 0.851 0 CA-C-N 120.5 1.214 . . . . 1.0 113.095 -174.533 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 111' ' ' ASN . . . . . 0.451 HD22 ' C ' ' A' ' 111' ' ' ASN . 0.2 OUTLIER -68.66 -66.78 0.53 Allowed 'General case' 0 C--O 1.217 -0.617 0 C-N-CA 118.542 -1.263 . . . . 1.0 109.55 -178.526 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 112' ' ' ILE . . . . . 0.581 ' O ' ' HB ' ' A' ' 116' ' ' ILE . 0.9 OUTLIER -48.41 -38.64 9.08 Favored 'Isoleucine or valine' 0 C--O 1.213 -0.862 0 CA-C-O 121.127 0.489 . . . . 1.0 111.659 -177.854 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 113' ' ' ASN . . . . . 0.556 ' N ' HG23 ' A' ' 112' ' ' ILE . 1.6 t-20 -67.59 -40.61 84.8 Favored 'General case' 0 C--N 1.313 -1.019 0 N-CA-C 106.502 -1.666 . . . . 1.0 106.502 178.585 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 114' ' ' ALA . . . . . 0.407 ' N ' ' O ' ' A' ' 111' ' ' ASN . . . -61.16 -51.4 69.21 Favored 'General case' 0 C--N 1.306 -1.307 0 CA-C-N 112.956 -1.929 . . . . 1.0 108.249 179.198 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -80.09 -59.7 2.62 Favored 'General case' 0 CA--C 1.544 0.725 0 N-CA-C 114.782 1.401 . . . . 1.0 114.782 179.582 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 116' ' ' ILE . . . . . 0.581 ' HB ' ' O ' ' A' ' 112' ' ' ILE . 0.7 OUTLIER -47.34 -50.53 7.52 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.884 0 CA-C-N 119.483 1.038 . . . . 1.0 111.52 -178.202 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 117' ' ' GLU . . . . . 0.498 ' CG ' ' N ' ' A' ' 118' ' ' VAL . 13.3 pt-20 -43.3 -58.57 2.47 Favored 'General case' 0 C--N 1.322 -0.623 0 N-CA-C 105.701 -1.962 . . . . 1.0 105.701 -179.365 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 118' ' ' VAL . . . . . 0.498 ' N ' ' CG ' ' A' ' 117' ' ' GLU . 88.1 t -58.43 -53.37 47.5 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.069 0 C-N-CA 119.24 -0.984 . . . . 1.0 110.043 177.757 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -52.31 -71.75 0.06 Allowed 'General case' 0 CA--C 1.545 0.765 0 N-CA-C 107.805 -1.183 . . . . 1.0 107.805 -177.922 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 120' ' ' GLY . . . . . 0.531 ' N ' ' O ' ' A' ' 116' ' ' ILE . . . -70.18 -76.05 0.55 Allowed Glycine 0 CA--C 1.546 2.002 0 C-N-CA 119.737 -1.221 . . . . 1.0 111.267 -179.87 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 121' ' ' THR . . . . . 0.493 ' CB ' ' O ' ' A' ' 120' ' ' GLY . 1.9 m 148.33 -28.68 0.01 OUTLIER 'General case' 0 N--CA 1.487 1.404 0 CA-C-N 112.294 -1.953 . . . . 1.0 110.914 -178.414 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 122' ' ' GLY . . . . . 0.643 ' O ' ' N ' ' A' ' 124' ' ' ASP . . . 102.59 -17.25 53.67 Favored Glycine 0 C--O 1.224 -0.497 0 N-CA-C 107.629 -2.188 . . . . 1.0 107.629 -176.856 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 123' ' ' THR . . . . . 0.6 HG23 ' O ' ' A' ' 123' ' ' THR . 8.1 t -53.99 85.34 0.0 OUTLIER 'General case' 0 N--CA 1.466 0.34 0 N-CA-C 106.043 -1.836 . . . . 1.0 106.043 178.379 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 124' ' ' ASP . . . . . 0.643 ' N ' ' O ' ' A' ' 122' ' ' GLY . 45.3 m-20 -163.41 169.45 18.91 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 113.344 -1.753 . . . . 1.0 111.972 -179.537 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 125' ' ' TYR . . . . . . . . . . . . . 2.0 t80 -146.47 144.52 29.72 Favored 'General case' 0 CA--C 1.542 0.662 0 N-CA-C 108.461 -0.94 . . . . 1.0 108.461 176.258 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 126' ' ' ARG . . . . . 0.641 HH21 HG21 ' A' ' 79' ' ' ILE . 1.9 mtp85 -146.44 149.33 33.5 Favored 'General case' 0 N--CA 1.466 0.326 0 N-CA-C 109.446 -0.576 . . . . 1.0 109.446 177.611 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 127' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.219 -0.506 0 CA-C-O 117.869 -1.062 . . . . 1.0 109.112 179.252 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . 0.587 ' SD ' ' N ' ' A' ' 1' ' ' MET . 0.0 OUTLIER . . . . . 0 N--CA 1.493 1.682 0 N-CA-C 108.561 -0.903 . . . . 1.0 108.561 . . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 35.9 t -106.18 7.96 31.83 Favored 'General case' 0 N--CA 1.466 0.337 0 CA-C-N 116.317 -0.401 . . . . 1.0 110.361 -179.867 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 3.9 t0 167.5 96.86 0.0 OUTLIER 'General case' 0 N--CA 1.47 0.551 0 O-C-N 123.728 0.642 . . . . 1.0 110.242 179.244 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 82.7 t80 -150.34 146.29 26.65 Favored 'General case' 0 N--CA 1.463 0.191 0 CA-C-N 116.161 -0.472 . . . . 1.0 110.568 179.7 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 5' ' ' ASP . . . . . 0.51 ' N ' ' OD1' ' A' ' 5' ' ' ASP . 1.5 p30 -158.55 153.95 25.86 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 121.129 0.49 . . . . 1.0 110.407 179.984 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 6' ' ' THR . . . . . 0.614 ' O ' ' N ' ' A' ' 10' ' ' SER . 0.2 OUTLIER -69.72 170.55 10.7 Favored 'General case' 0 C--O 1.205 -1.251 0 CA-C-N 115.777 -0.647 . . . . 1.0 110.359 -179.453 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 1.6 tm-20 -55.31 -58.36 8.03 Favored 'General case' 0 C--N 1.31 -1.144 0 CA-C-N 115.367 -0.833 . . . . 1.0 109.72 -178.719 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 8' ' ' ARG . . . . . 0.583 HH11 HG13 ' A' ' 9' ' ' VAL . 5.5 tmm_? -51.52 -54.7 24.58 Favored 'General case' 0 C--N 1.311 -1.072 0 C-N-CA 119.17 -1.012 . . . . 1.0 108.599 -177.553 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . 0.583 HG13 HH11 ' A' ' 8' ' ' ARG . 0.0 OUTLIER -65.51 -48.76 81.69 Favored 'Isoleucine or valine' 0 CA--C 1.551 0.991 0 CA-C-N 115.673 -0.694 . . . . 1.0 110.718 178.896 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 10' ' ' SER . . . . . 0.614 ' N ' ' O ' ' A' ' 6' ' ' THR . 35.5 t -63.41 -41.11 98.71 Favored 'General case' 0 C--N 1.318 -0.778 0 N-CA-C 115.007 1.484 . . . . 1.0 115.007 -178.18 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 11' ' ' ARG . . . . . 0.597 ' O ' ' N ' ' A' ' 15' ' ' ALA . 56.9 ttm-85 -79.99 -55.11 5.19 Favored 'General case' 0 C--O 1.216 -0.704 0 CA-C-O 122.478 1.133 . . . . 1.0 108.988 176.808 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . 0.563 ' O ' ' HB3' ' A' ' 16' ' ' ALA . . . -45.85 -50.31 14.4 Favored 'General case' 0 N--CA 1.469 0.489 0 N-CA-C 106.361 -1.718 . . . . 1.0 106.361 -177.605 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . 0.602 ' O ' ' CB ' ' A' ' 17' ' ' LEU . 75.0 t -60.24 -49.8 82.75 Favored 'Isoleucine or valine' 0 C--O 1.202 -1.433 0 C-N-CA 118.265 -1.374 . . . . 1.0 107.686 177.568 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . 0.676 ' O ' HG13 ' A' ' 18' ' ' VAL . . . -59.01 -62.84 1.58 Allowed 'General case' 0 N--CA 1.48 1.072 0 C-N-CA 119.356 -0.938 . . . . 1.0 111.443 178.821 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . 0.597 ' N ' ' O ' ' A' ' 11' ' ' ARG . . . -53.43 -55.38 25.66 Favored 'General case' 0 N--CA 1.473 0.71 0 CA-C-O 121.586 0.707 . . . . 1.0 109.902 -177.77 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . 0.563 ' HB3' ' O ' ' A' ' 12' ' ' ALA . . . -63.91 -53.99 41.77 Favored 'General case' 0 C--N 1.314 -0.935 0 CA-C-N 114.39 -1.277 . . . . 1.0 108.879 -179.272 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . 0.602 ' CB ' ' O ' ' A' ' 13' ' ' VAL . 8.2 tt -56.57 -53.71 54.41 Favored 'General case' 0 N--CA 1.477 0.907 0 C-N-CA 118.698 -1.201 . . . . 1.0 109.026 -177.477 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . 0.676 HG13 ' O ' ' A' ' 14' ' ' ALA . 2.4 m -68.4 -55.78 14.94 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.798 0 C-N-CA 119.436 -0.906 . . . . 1.0 109.84 179.599 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . 0.505 ' N ' ' CG2' ' A' ' 18' ' ' VAL . . . -65.88 -174.46 5.28 Favored Glycine 0 CA--C 1.531 1.071 0 N-CA-C 111.825 -0.51 . . . . 1.0 111.825 -178.617 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 20' ' ' PRO . . . . . 0.597 ' O ' ' N ' ' A' ' 24' ' ' ALA . 1.3 Cg_endo -77.22 -23.15 10.55 Favored 'Trans proline' 0 N--CA 1.492 1.394 0 C-N-CA 123.065 2.51 . . . . 1.0 114.501 -179.123 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -59.73 -58.56 13.6 Favored Glycine 0 N--CA 1.474 1.185 0 C-N-CA 119.517 -1.325 . . . . 1.0 110.893 -177.205 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . 0.512 ' CA ' ' HB1' ' A' ' 16' ' ' ALA . . . -56.63 -53.37 44.23 Favored Glycine 0 C--N 1.314 -0.659 0 N-CA-C 107.231 -2.348 . . . . 1.0 107.231 -178.743 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . 0.586 ' O ' HG12 ' A' ' 27' ' ' VAL . 60.9 t -58.01 -31.74 42.01 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.883 0 CA-C-N 114.789 -0.705 . . . . 1.0 110.245 179.598 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . 0.597 ' N ' ' O ' ' A' ' 20' ' ' PRO . . . -61.54 -59.96 4.42 Favored 'General case' 0 CA--C 1.533 0.307 0 C-N-CA 118.884 -1.126 . . . . 1.0 108.61 179.888 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 19.1 tp -61.94 -47.6 84.16 Favored 'General case' 0 C--N 1.342 0.282 0 N-CA-C 112.852 0.686 . . . . 1.0 112.852 -179.099 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 89.9 t -60.03 -60.19 2.91 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.189 0 C-N-CA 119.055 -1.058 . . . . 1.0 110.105 -177.669 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . 0.661 ' O ' ' HB3' ' A' ' 31' ' ' ALA . 1.8 p -58.91 -35.33 55.92 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.352 0 N-CA-C 112.456 0.539 . . . . 1.0 112.456 -178.52 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 1.1 mmmm -66.08 -54.48 25.24 Favored 'General case' 0 CA--C 1.517 -0.298 0 C-N-CA 119.499 -0.881 . . . . 1.0 108.874 -178.745 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 4.0 t -65.89 -48.78 80.78 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.842 0 CA-C-N 114.016 -1.447 . . . . 1.0 111.017 -177.242 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 30' ' ' CYS . . . . . . . . . . . . . 4.8 t -64.45 -60.51 3.07 Favored 'General case' 0 N--CA 1.445 -0.721 0 C-N-CA 117.685 -1.606 . . . . 1.0 109.61 -179.837 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . 0.661 ' HB3' ' O ' ' A' ' 27' ' ' VAL . . . -68.2 -55.59 11.76 Favored 'General case' 0 C--N 1.331 -0.235 0 N-CA-C 114.846 1.425 . . . . 1.0 114.846 -175.163 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . 0.41 ' O ' ' CB ' ' A' ' 33' ' ' LEU . . . 85.69 72.9 1.28 Allowed Glycine 0 CA--C 1.534 1.223 0 C-N-CA 120.673 -0.775 . . . . 1.0 111.56 -178.76 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . 0.436 ' O ' ' N ' ' A' ' 35' ' ' GLY . 0.9 OUTLIER 73.0 99.36 0.04 OUTLIER Pre-proline 0 CA--C 1.554 1.101 0 C-N-CA 120.985 -0.286 . . . . 1.0 111.304 178.107 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_exo -43.45 -9.98 0.03 OUTLIER 'Trans proline' 0 N--CA 1.511 2.525 0 C-N-CA 123.92 3.08 . . . . 1.0 115.57 -179.218 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . 0.436 ' N ' ' O ' ' A' ' 33' ' ' LEU . . . -59.54 -59.04 11.3 Favored Glycine 0 CA--C 1.529 0.952 0 C-N-CA 118.562 -1.78 . . . . 1.0 109.189 -179.047 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . 0.446 HG22 ' H ' ' A' ' 36' ' ' VAL . 6.1 m -85.96 -148.1 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.332 -0.177 0 N-CA-C 109.199 -0.667 . . . . 1.0 109.199 179.422 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . 0.48 HD13 ' HB1' ' A' ' 31' ' ' ALA . 2.1 mp 74.71 80.03 0.04 OUTLIER 'Isoleucine or valine' 0 CA--C 1.514 -0.436 0 N-CA-C 112.819 0.674 . . . . 1.0 112.819 179.415 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 55.6 m80 -135.71 126.74 27.85 Favored 'General case' 0 C--N 1.329 -0.29 0 N-CA-C 106.514 -1.661 . . . . 1.0 106.514 176.979 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 39' ' ' THR . . . . . 0.576 ' OG1' ' NE ' ' A' ' 42' ' ' ARG . 0.0 OUTLIER -103.36 136.63 19.19 Favored Pre-proline 0 N--CA 1.469 0.492 0 N-CA-C 109.835 -0.431 . . . . 1.0 109.835 -178.968 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 32.3 Cg_exo -53.92 -32.53 68.11 Favored 'Trans proline' 0 N--CA 1.486 1.088 0 C-N-CA 121.076 1.184 . . . . 1.0 113.529 -179.68 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -128.21 132.06 48.82 Favored 'General case' 0 N--CA 1.463 0.192 0 O-C-N 122.191 -0.318 . . . . 1.0 111.226 -179.864 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . 0.708 ' C ' ' H ' ' A' ' 44' ' ' GLY . 12.1 mtm180 -160.39 158.57 29.78 Favored 'General case' 0 C--N 1.321 -0.665 0 N-CA-C 109.151 -0.685 . . . . 1.0 109.151 176.131 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 43' ' ' ARG . . . . . 0.416 ' C ' ' H ' ' A' ' 45' ' ' PHE . 41.9 ttt85 -60.28 23.46 0.01 OUTLIER 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 115.487 -0.779 . . . . 1.0 110.142 179.933 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . 0.708 ' H ' ' C ' ' A' ' 42' ' ' ARG . . . 80.68 -26.38 3.17 Favored Glycine 0 N--CA 1.445 -0.72 0 N-CA-C 110.126 -1.19 . . . . 1.0 110.126 -179.645 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . 0.588 ' CG ' ' C ' ' A' ' 44' ' ' GLY . 0.1 OUTLIER -179.33 -174.13 0.3 Allowed 'General case' 0 CA--C 1.537 0.464 0 C-N-CA 120.91 -0.316 . . . . 1.0 111.083 -178.801 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 46' ' ' PHE . . . . . 0.549 ' CB ' ' O ' ' A' ' 45' ' ' PHE . 15.2 t80 117.64 107.05 0.0 OUTLIER 'General case' 0 N--CA 1.488 1.428 0 O-C-N 125.044 1.465 . . . . 1.0 109.359 -179.454 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 47' ' ' ARG . . . . . 0.496 ' CB ' ' O ' ' A' ' 46' ' ' PHE . 3.9 tmm_? 100.09 167.3 0.01 OUTLIER 'General case' 0 N--CA 1.467 0.395 0 CA-C-N 115.141 -0.936 . . . . 1.0 108.632 -178.244 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 7.7 t 75.6 -18.03 0.48 Allowed 'General case' 0 N--CA 1.472 0.643 0 CA-C-O 120.646 0.26 . . . . 1.0 111.332 -179.158 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 49' ' ' ASN . . . . . 0.751 ' ND2' ' H ' ' A' ' 52' ' ' ARG . 0.2 OUTLIER -62.2 146.27 92.69 Favored Pre-proline 0 CA--C 1.547 0.838 0 CA-C-N 116.317 -0.402 . . . . 1.0 111.909 -179.17 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 50' ' ' PRO . . . . . 0.417 ' N ' ' ND2' ' A' ' 49' ' ' ASN . 25.2 Cg_exo -60.68 66.65 0.08 OUTLIER 'Trans proline' 0 N--CA 1.501 1.94 0 C-N-CA 121.918 1.746 . . . . 1.0 111.703 177.289 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . 0.522 ' N ' ' O ' ' A' ' 49' ' ' ASN . 23.1 mm-40 46.76 55.73 7.44 Favored 'General case' 0 CA--C 1.554 1.096 0 N-CA-C 113.074 0.768 . . . . 1.0 113.074 177.979 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . 0.751 ' H ' ' ND2' ' A' ' 49' ' ' ASN . 7.7 mtt-85 -143.57 155.72 44.38 Favored 'General case' 0 N--CA 1.498 1.928 0 CA-C-O 119.494 -0.289 . . . . 1.0 110.555 178.225 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 10.4 tp -75.75 127.94 37.24 Favored 'Isoleucine or valine' 0 CA--C 1.56 1.358 0 N-CA-C 116.258 1.947 . . . . 1.0 116.258 -174.361 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 47.3 tp60 -65.2 86.0 0.06 Allowed 'General case' 0 N--CA 1.476 0.848 0 CA-C-N 109.728 -3.396 . . . . 1.0 109.457 -177.716 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . 0.486 HD13 ' N ' ' A' ' 56' ' ' GLY . 0.0 OUTLIER -147.27 155.58 10.86 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.845 0 N-CA-C 109.692 -0.484 . . . . 1.0 109.692 178.151 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . 0.486 ' N ' HD13 ' A' ' 55' ' ' ILE . . . 107.51 -5.38 35.29 Favored Glycine 0 N--CA 1.48 1.621 0 N-CA-C 111.262 -0.735 . . . . 1.0 111.262 179.452 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -112.7 129.61 56.34 Favored 'General case' 0 C--N 1.317 -0.808 0 N-CA-C 108.206 -1.035 . . . . 1.0 108.206 178.071 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 58' ' ' TRP . . . . . 0.6 ' H ' ' HB2' ' A' ' 61' ' ' GLU . 11.5 m0 -134.25 152.36 51.78 Favored 'General case' 0 C--N 1.348 0.536 0 CA-C-O 122.333 1.063 . . . . 1.0 109.834 -179.829 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -37.73 -39.79 0.37 Allowed 'General case' 0 CA--C 1.558 1.252 0 CA-C-N 113.047 -1.888 . . . . 1.0 110.767 -177.015 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 7.3 t80 -86.29 -27.4 24.4 Favored 'General case' 0 N--CA 1.481 1.099 0 CA-C-O 121.953 0.882 . . . . 1.0 112.626 -179.434 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . 0.6 ' HB2' ' H ' ' A' ' 58' ' ' TRP . 39.9 mt-10 -78.64 -13.0 60.04 Favored 'General case' 0 CA--C 1.509 -0.613 0 CA-C-N 115.639 -0.709 . . . . 1.0 110.377 179.015 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 62' ' ' VAL . . . . . 0.654 ' O ' ' N ' ' A' ' 66' ' ' GLY . 49.5 t -50.01 -57.06 2.51 Favored 'Isoleucine or valine' 0 C--O 1.202 -1.401 0 C-N-CA 119.328 -0.949 . . . . 1.0 109.8 -176.806 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 63' ' ' ALA . . . . . 0.48 ' O ' ' HG3' ' A' ' 67' ' ' ARG . . . -65.27 -57.36 8.64 Favored 'General case' 0 C--N 1.307 -1.278 0 O-C-N 121.33 -0.856 . . . . 1.0 110.21 -178.669 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 40.3 t-80 -47.44 -56.92 6.01 Favored 'General case' 0 N--CA 1.472 0.67 0 O-C-N 124.171 0.919 . . . . 1.0 109.573 179.976 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 65' ' ' ASP . . . . . 0.585 ' C ' ' H ' ' A' ' 67' ' ' ARG . 30.0 t0 -74.56 -48.99 23.58 Favored 'General case' 0 C--N 1.316 -0.853 0 CA-C-N 115.476 -0.784 . . . . 1.0 111.167 179.511 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . 0.654 ' N ' ' O ' ' A' ' 62' ' ' VAL . . . -74.3 26.42 1.04 Allowed Glycine 0 CA--C 1.521 0.427 0 N-CA-C 109.905 -1.278 . . . . 1.0 109.905 177.35 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 67' ' ' ARG . . . . . 0.647 ' O ' ' N ' ' A' ' 69' ' ' LEU . 33.4 mtm180 -71.97 5.51 2.62 Favored 'General case' 0 CA--C 1.512 -0.516 0 N-CA-C 104.996 -2.224 . . . . 1.0 104.996 174.032 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . 0.578 ' H ' ' C ' ' A' ' 66' ' ' GLY . 7.9 tt -31.76 -29.13 0.01 OUTLIER 'General case' 0 N--CA 1.473 0.686 0 O-C-N 124.11 0.881 . . . . 1.0 108.948 -177.417 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . 0.647 ' N ' ' O ' ' A' ' 67' ' ' ARG . 1.3 mt -64.35 -65.66 0.65 Allowed 'General case' 0 C--N 1.322 -0.628 0 C-N-CA 119.341 -0.943 . . . . 1.0 108.825 178.895 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . 0.622 ' O ' ' N ' ' A' ' 72' ' ' HIS . . . -78.62 -76.68 0.19 Allowed 'General case' 0 N--CA 1.47 0.554 0 N-CA-C 106.376 -1.712 . . . . 1.0 106.376 177.793 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 71' ' ' ALA . . . . . 0.482 ' O ' ' C ' ' A' ' 72' ' ' HIS . . . -43.06 4.13 0.0 OUTLIER 'General case' 0 C--N 1.326 -0.437 0 N-CA-C 114.336 1.235 . . . . 1.0 114.336 177.906 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 72' ' ' HIS . . . . . 0.704 ' CD2' ' H ' ' A' ' 73' ' ' MET . 1.4 p80 -32.21 -53.8 0.3 Allowed 'General case' 0 N--CA 1.467 0.407 0 CA-C-N 120.126 1.33 . . . . 1.0 112.11 -177.851 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 73' ' ' MET . . . . . 0.704 ' H ' ' CD2' ' A' ' 72' ' ' HIS . 4.9 tpp -73.57 -56.85 4.5 Favored 'General case' 0 C--N 1.331 -0.219 0 N-CA-C 108.017 -1.105 . . . . 1.0 108.017 177.926 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . 0.74 ' O ' ' N ' ' A' ' 76' ' ' GLY . 62.1 t -45.47 -42.72 3.44 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.319 0 CA-C-O 116.964 -1.493 . . . . 1.0 111.316 -176.515 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 75' ' ' ASN . . . . . 0.485 ' C ' ' N ' ' A' ' 77' ' ' ILE . 1.2 m-20 -36.55 -13.84 0.0 OUTLIER 'General case' 0 N--CA 1.501 2.078 0 CA-C-N 121.77 2.077 . . . . 1.0 111.318 177.907 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 76' ' ' GLY . . . . . 0.74 ' N ' ' O ' ' A' ' 74' ' ' VAL . . . -49.12 -20.7 2.19 Favored Glycine 0 CA--C 1.535 1.321 0 N-CA-C 106.624 -2.591 . . . . 1.0 106.624 173.035 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 77' ' ' ILE . . . . . 0.512 ' O ' ' N ' ' A' ' 81' ' ' GLU . 25.4 pt -61.21 -48.81 87.29 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.925 0 CA-C-O 117.043 -1.456 . . . . 1.0 112.159 -179.114 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . 0.409 HG12 ' O ' ' A' ' 75' ' ' ASN . 9.9 p -57.5 -18.49 9.22 Favored 'Isoleucine or valine' 0 C--N 1.363 1.162 0 CA-C-N 122.925 2.602 . . . . 1.0 113.069 179.444 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . 0.673 ' O ' ' HB3' ' A' ' 83' ' ' ALA . 0.1 OUTLIER -89.67 -38.63 11.38 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 N-CA-C 107.042 -1.466 . . . . 1.0 107.042 177.904 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -80.9 -16.67 52.96 Favored 'General case' 0 CA--C 1.538 0.483 0 CA-C-N 114.822 -1.081 . . . . 1.0 113.496 178.589 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 81' ' ' GLU . . . . . 0.512 ' N ' ' O ' ' A' ' 77' ' ' ILE . 48.2 tt0 -93.68 -71.94 0.63 Allowed 'General case' 0 N--CA 1.448 -0.543 0 CA-C-N 118.882 0.764 . . . . 1.0 112.47 -178.385 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 25.2 m-20 -89.29 -15.82 32.61 Favored 'General case' 0 CA--C 1.549 0.907 0 N-CA-C 115.717 1.747 . . . . 1.0 115.717 -178.137 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . 0.673 ' HB3' ' O ' ' A' ' 79' ' ' ILE . . . -54.51 -44.94 73.17 Favored 'General case' 0 N--CA 1.475 0.802 0 C-N-CA 118.747 -1.181 . . . . 1.0 111.897 -177.821 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . 0.741 HD13 ' O ' ' A' ' 84' ' ' LEU . 3.4 tm? -40.0 -28.74 0.06 Allowed 'General case' 0 CA--C 1.54 0.588 0 CA-C-N 119.141 0.882 . . . . 1.0 111.119 179.686 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 85' ' ' ILE . . . . . 0.421 ' N ' ' O ' ' A' ' 83' ' ' ALA . 68.1 mt -83.75 -37.13 12.99 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.509 0 CA-C-N 116.543 -0.298 . . . . 1.0 110.884 178.419 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 86' ' ' ALA . . . . . 0.77 ' O ' HG22 ' A' ' 89' ' ' VAL . . . -93.41 -26.83 17.06 Favored 'General case' 0 N--CA 1.471 0.623 0 CA-C-O 120.863 0.363 . . . . 1.0 111.324 179.855 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 87' ' ' GLU . . . . . 0.474 ' C ' ' H ' ' A' ' 89' ' ' VAL . 40.6 tp10 -54.26 -11.31 0.48 Allowed 'General case' 0 C--N 1.324 -0.514 0 CA-C-O 121.134 0.492 . . . . 1.0 110.081 -179.456 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 88' ' ' ALA . . . . . 0.407 ' N ' ' C ' ' A' ' 86' ' ' ALA . . . -74.8 2.25 10.57 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-O 122.439 1.114 . . . . 1.0 108.342 178.382 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 89' ' ' VAL . . . . . 0.77 HG22 ' O ' ' A' ' 86' ' ' ALA . 2.1 m -114.5 36.21 0.84 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.516 0 CA-C-N 112.766 -2.015 . . . . 1.0 110.334 178.914 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 90' ' ' GLY . . . . . 0.593 ' N ' ' CD ' ' A' ' 91' ' ' PRO . . . -77.59 -37.66 30.15 Favored Glycine 0 CA--C 1.534 1.26 0 N-CA-C 110.548 -1.021 . . . . 1.0 110.548 179.032 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 91' ' ' PRO . . . . . 0.593 ' CD ' ' N ' ' A' ' 90' ' ' GLY . 77.1 Cg_exo -50.63 -7.87 0.13 Allowed 'Trans proline' 0 N--CA 1.499 1.823 0 C-N-CA 122.459 2.106 . . . . 1.0 110.552 178.513 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 92' ' ' HIS . . . . . 0.697 ' NE2' ' NH2' ' A' ' 52' ' ' ARG . 0.2 OUTLIER -56.38 -12.22 1.57 Allowed 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 114.211 -1.359 . . . . 1.0 107.847 178.805 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 93' ' ' LEU . . . . . 0.62 HD12 ' N ' ' A' ' 94' ' ' ALA . 1.7 pp -68.34 -59.57 3.09 Favored 'General case' 0 CA--C 1.528 0.107 0 CA-C-N 115.493 -0.776 . . . . 1.0 109.172 178.158 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 94' ' ' ALA . . . . . 0.62 ' N ' HD12 ' A' ' 93' ' ' LEU . . . -58.22 -50.06 74.89 Favored 'General case' 0 CA--C 1.52 -0.208 0 C-N-CA 120.017 -0.673 . . . . 1.0 109.363 179.761 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 95' ' ' ARG . . . . . 0.594 ' O ' ' N ' ' A' ' 97' ' ' LEU . 17.2 tpt180 -56.72 -57.62 11.64 Favored 'General case' 0 CA--C 1.534 0.335 0 CA-C-O 123.034 1.397 . . . . 1.0 107.609 179.314 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 96' ' ' ALA . . . . . 1.046 ' O ' ' N ' ' A' ' 98' ' ' GLY . . . -49.21 -9.62 0.03 OUTLIER 'General case' 0 C--N 1.304 -1.403 0 O-C-N 118.643 -2.536 . . . . 1.0 111.126 179.395 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 97' ' ' LEU . . . . . 0.973 HD13 ' N ' ' A' ' 98' ' ' GLY . 0.0 OUTLIER 8.23 -47.81 0.0 OUTLIER 'General case' 0 N--CA 1.498 1.969 0 CA-C-O 117.361 -1.304 . . . . 1.0 109.105 -166.703 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 98' ' ' GLY . . . . . 1.046 ' N ' ' O ' ' A' ' 96' ' ' ALA . . . -48.03 -24.13 3.08 Favored Glycine 0 CA--C 1.551 2.313 0 CA-C-N 122.975 2.625 . . . . 1.0 107.071 171.998 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 99' ' ' GLN . . . . . 0.485 ' N ' ' O ' ' A' ' 96' ' ' ALA . 5.7 mm100 -69.82 -24.32 63.45 Favored 'General case' 0 C--N 1.386 2.17 0 C-N-CA 117.863 -1.535 . . . . 1.0 107.759 175.701 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 100' ' ' ILE . . . . . 0.72 ' N ' ' O ' ' A' ' 97' ' ' LEU . 10.2 mt -65.48 -45.61 92.32 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.837 0 C-N-CA 119.829 -0.748 . . . . 1.0 109.107 177.209 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 101' ' ' VAL . . . . . 0.699 ' O ' ' N ' ' A' ' 105' ' ' GLY . 21.7 t -55.23 -60.73 1.41 Allowed 'Isoleucine or valine' 0 C--O 1.214 -0.806 0 N-CA-C 108.065 -1.087 . . . . 1.0 108.065 178.723 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 102' ' ' CYS . . . . . 0.687 ' O ' ' HB2' ' A' ' 106' ' ' ALA . 0.5 OUTLIER -49.91 -22.16 1.42 Allowed 'General case' 0 C--O 1.204 -1.325 0 N-CA-C 112.768 0.655 . . . . 1.0 112.768 -179.163 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 58.8 ttt-85 -89.09 -48.13 7.62 Favored 'General case' 0 N--CA 1.485 1.292 0 CA-C-O 123.229 1.49 . . . . 1.0 112.194 179.418 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 104' ' ' TYR . . . . . 0.664 ' O ' ' CG ' ' A' ' 104' ' ' TYR . 0.0 OUTLIER -98.52 25.31 6.49 Favored 'General case' 0 C--N 1.297 -1.684 0 CA-C-N 111.663 -2.517 . . . . 1.0 107.157 177.849 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 105' ' ' GLY . . . . . 0.699 ' N ' ' O ' ' A' ' 101' ' ' VAL . . . -167.59 -100.61 0.14 Allowed Glycine 0 N--CA 1.441 -0.972 0 N-CA-C 108.725 -1.75 . . . . 1.0 108.725 179.363 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 106' ' ' ALA . . . . . 0.687 ' HB2' ' O ' ' A' ' 102' ' ' CYS . . . 73.6 59.14 0.09 Allowed 'General case' 0 N--CA 1.442 -0.827 0 CA-C-O 119.262 -0.399 . . . . 1.0 111.22 -178.6 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -80.11 5.37 14.49 Favored 'General case' 0 CA--C 1.51 -0.594 0 O-C-N 119.764 -1.835 . . . . 1.0 106.319 176.341 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 17.4 m -83.77 -53.52 11.03 Favored 'Isoleucine or valine' 0 C--N 1.347 0.472 0 C-N-CA 120.338 -0.545 . . . . 1.0 110.591 178.138 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 109' ' ' ILE . . . . . 0.654 HG23 ' HB1' ' A' ' 106' ' ' ALA . 0.1 OUTLIER -49.02 -37.7 21.01 Favored Pre-proline 0 N--CA 1.472 0.666 0 N-CA-C 115.308 1.596 . . . . 1.0 115.308 -176.894 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_exo -51.52 -49.36 17.43 Favored 'Trans proline' 0 C--N 1.311 -1.433 0 CA-C-N 122.386 1.888 . . . . 1.0 113.126 -176.475 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 87.2 m-20 -70.7 -69.05 0.39 Allowed 'General case' 0 CA--C 1.53 0.199 0 C-N-CA 118.829 -1.148 . . . . 1.0 110.915 -178.833 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 112' ' ' ILE . . . . . 0.404 HG23 ' H ' ' A' ' 112' ' ' ILE . 6.4 pt -46.22 -28.37 0.86 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.467 0 CA-C-O 121.826 0.822 . . . . 1.0 109.736 -179.477 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 113' ' ' ASN . . . . . 0.484 ' CB ' ' O ' ' A' ' 109' ' ' ILE . 34.2 t30 -61.92 -55.15 32.57 Favored 'General case' 0 CA--C 1.506 -0.733 0 CA-C-N 114.301 -1.318 . . . . 1.0 107.811 -178.976 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -61.98 -36.5 81.64 Favored 'General case' 0 N--CA 1.439 -0.976 0 CA-C-N 118.86 0.755 . . . . 1.0 112.387 -179.036 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -75.48 -58.92 2.99 Favored 'General case' 0 C--N 1.349 0.557 0 CA-C-N 120.402 1.455 . . . . 1.0 110.114 179.572 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 116' ' ' ILE . . . . . 0.537 ' O ' ' N ' ' A' ' 120' ' ' GLY . 5.0 mm -49.37 -48.87 18.63 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.663 0 CA-C-O 121.619 0.723 . . . . 1.0 109.182 -178.173 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 117' ' ' GLU . . . . . 0.501 ' O ' ' HA ' ' A' ' 121' ' ' THR . 37.7 tt0 -39.96 -60.74 0.97 Allowed 'General case' 0 C--O 1.215 -0.735 0 N-CA-C 106.213 -1.773 . . . . 1.0 106.213 179.279 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 94.2 t -59.14 -53.96 40.85 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.873 0 CA-C-N 114.973 -1.012 . . . . 1.0 109.824 178.559 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -53.09 -71.44 0.07 Allowed 'General case' 0 CA--C 1.552 1.021 0 N-CA-C 108.087 -1.079 . . . . 1.0 108.087 -178.395 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 120' ' ' GLY . . . . . 0.537 ' N ' ' O ' ' A' ' 116' ' ' ILE . . . -66.68 -76.85 0.33 Allowed Glycine 0 CA--C 1.538 1.502 0 C-N-CA 119.54 -1.314 . . . . 1.0 110.635 179.713 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 121' ' ' THR . . . . . 0.522 ' CB ' ' O ' ' A' ' 120' ' ' GLY . 2.2 m 145.43 -29.16 0.01 OUTLIER 'General case' 0 N--CA 1.486 1.359 0 CA-C-N 111.516 -2.342 . . . . 1.0 111.015 -178.451 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 122' ' ' GLY . . . . . 0.625 ' O ' ' N ' ' A' ' 124' ' ' ASP . . . 106.6 -16.12 41.0 Favored Glycine 0 C--O 1.226 -0.372 0 N-CA-C 107.763 -2.135 . . . . 1.0 107.763 -176.541 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 123' ' ' THR . . . . . 0.584 HG23 ' O ' ' A' ' 123' ' ' THR . 12.6 t -59.65 82.23 0.01 OUTLIER 'General case' 0 CA--C 1.537 0.471 0 N-CA-C 107.02 -1.474 . . . . 1.0 107.02 178.94 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 124' ' ' ASP . . . . . 0.625 ' N ' ' O ' ' A' ' 122' ' ' GLY . 27.8 m-20 -163.5 172.27 14.69 Favored 'General case' 0 N--CA 1.453 -0.302 0 CA-C-N 112.074 -2.33 . . . . 1.0 110.745 178.859 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 125' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -143.9 142.04 30.58 Favored 'General case' 0 C--N 1.32 -0.691 0 N-CA-C 107.298 -1.371 . . . . 1.0 107.298 175.846 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 126' ' ' ARG . . . . . 0.408 ' HA ' ' NE ' ' A' ' 126' ' ' ARG . 1.3 tpm_? -149.67 152.0 34.63 Favored 'General case' 0 C--N 1.33 -0.244 0 N-CA-C 110.111 -0.329 . . . . 1.0 110.111 178.772 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 127' ' ' PHE . . . . . . . . . . . . . 2.4 p90 . . . . . 0 N--CA 1.471 0.585 0 CA-C-O 117.874 -1.06 . . . . 1.0 111.12 -179.86 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 4.7 mmt . . . . . 0 N--CA 1.491 1.613 0 N-CA-C 109.686 -0.487 . . . . 1.0 109.686 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 34.6 t -107.45 5.06 26.88 Favored 'General case' 0 N--CA 1.467 0.422 0 CA-C-N 116.11 -0.495 . . . . 1.0 110.273 179.33 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 1.3 p30 173.96 94.59 0.01 OUTLIER 'General case' 0 CA--C 1.53 0.182 0 CA-C-N 116.032 -0.531 . . . . 1.0 111.823 -179.893 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . 0.429 ' O ' ' OD1' ' A' ' 5' ' ' ASP . 1.4 t80 -151.27 146.75 26.26 Favored 'General case' 0 N--CA 1.464 0.255 0 CA-C-N 116.341 -0.39 . . . . 1.0 110.25 178.937 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 5' ' ' ASP . . . . . 0.429 ' OD1' ' O ' ' A' ' 4' ' ' PHE . 0.0 OUTLIER -155.95 151.95 27.61 Favored 'General case' 0 CA--C 1.538 0.51 0 N-CA-C 109.453 -0.573 . . . . 1.0 109.453 179.523 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 6' ' ' THR . . . . . 0.685 ' O ' ' N ' ' A' ' 10' ' ' SER . 0.3 OUTLIER -69.24 168.5 14.04 Favored 'General case' 0 C--O 1.204 -1.339 0 CA-C-N 116.206 -0.452 . . . . 1.0 110.143 -179.234 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . 0.562 ' O ' ' N ' ' A' ' 11' ' ' ARG . 0.9 OUTLIER -58.14 -60.11 4.26 Favored 'General case' 0 C--N 1.317 -0.82 0 CA-C-O 121.352 0.596 . . . . 1.0 109.567 -177.646 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 8' ' ' ARG . . . . . 0.749 ' O ' ' HB3' ' A' ' 12' ' ' ALA . 0.0 OUTLIER -49.23 -53.78 19.84 Favored 'General case' 0 CA--C 1.545 0.751 0 N-CA-C 107.637 -1.245 . . . . 1.0 107.637 -178.304 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . 0.598 ' O ' ' HB ' ' A' ' 13' ' ' VAL . 0.0 OUTLIER -66.97 -50.64 62.68 Favored 'Isoleucine or valine' 0 C--O 1.196 -1.734 0 CA-C-N 115.155 -0.93 . . . . 1.0 109.794 179.294 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 10' ' ' SER . . . . . 0.685 ' N ' ' O ' ' A' ' 6' ' ' THR . 25.6 t -62.83 -63.79 1.11 Allowed 'General case' 0 C--N 1.313 -0.985 0 C-N-CA 119.595 -0.842 . . . . 1.0 111.055 -179.582 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 11' ' ' ARG . . . . . 0.562 ' N ' ' O ' ' A' ' 7' ' ' GLU . 38.2 ttm-85 -65.9 -61.35 2.11 Favored 'General case' 0 N--CA 1.466 0.366 0 C-N-CA 120.463 -0.495 . . . . 1.0 111.88 -175.945 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . 0.749 ' HB3' ' O ' ' A' ' 8' ' ' ARG . . . -48.66 -47.49 40.54 Favored 'General case' 0 N--CA 1.474 0.739 0 N-CA-C 107.257 -1.386 . . . . 1.0 107.257 -177.868 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . 0.598 ' HB ' ' O ' ' A' ' 9' ' ' VAL . 84.2 t -62.24 -51.04 77.21 Favored 'Isoleucine or valine' 0 C--O 1.205 -1.241 0 C-N-CA 118.548 -1.261 . . . . 1.0 108.187 177.098 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . 0.754 ' O ' HG13 ' A' ' 18' ' ' VAL . . . -55.94 -61.29 2.47 Favored 'General case' 0 C--O 1.21 -1.023 0 C-N-CA 117.933 -1.507 . . . . 1.0 108.775 -179.712 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . 0.578 ' O ' ' N ' ' A' ' 19' ' ' GLY . . . -52.17 -54.56 29.2 Favored 'General case' 0 N--CA 1.47 0.564 0 CA-C-O 121.467 0.651 . . . . 1.0 109.855 -178.849 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . 0.432 ' CB ' ' O ' ' A' ' 12' ' ' ALA . . . -63.73 -57.23 10.61 Favored 'General case' 0 C--N 1.316 -0.877 0 CA-C-N 114.994 -1.003 . . . . 1.0 109.943 -179.011 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . 0.586 ' N ' ' O ' ' A' ' 13' ' ' VAL . 1.2 tt -57.0 -53.29 59.71 Favored 'General case' 0 C--N 1.315 -0.916 0 CA-C-N 114.51 -1.223 . . . . 1.0 108.017 -177.85 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . 0.754 HG13 ' O ' ' A' ' 14' ' ' ALA . 2.4 m -68.57 -58.44 5.86 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.526 0 C-N-CA 119.446 -0.902 . . . . 1.0 109.592 178.923 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . 0.598 ' O ' ' CG2' ' A' ' 23' ' ' VAL . . . -55.7 -169.31 0.07 OUTLIER Glycine 0 C--O 1.213 -1.179 0 N-CA-C 110.287 -1.125 . . . . 1.0 110.287 -179.515 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 20' ' ' PRO . . . . . 0.465 ' O ' ' N ' ' A' ' 24' ' ' ALA . 1.9 Cg_endo -78.96 -32.55 1.84 Allowed 'Trans proline' 0 C--N 1.305 -1.721 0 C-N-CA 123.114 2.543 . . . . 1.0 114.625 -178.524 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -60.19 -57.88 16.89 Favored Glycine 0 N--CA 1.478 1.48 0 C-N-CA 120.164 -1.017 . . . . 1.0 113.348 -176.192 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . 0.408 ' N ' ' O ' ' A' ' 16' ' ' ALA . . . -55.37 -51.76 52.24 Favored Glycine 0 N--CA 1.469 0.867 0 N-CA-C 107.401 -2.28 . . . . 1.0 107.401 -176.851 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . 0.598 ' CG2' ' O ' ' A' ' 19' ' ' GLY . 0.1 OUTLIER -60.81 -31.45 49.52 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.999 0 N-CA-C 108.692 -0.855 . . . . 1.0 108.692 178.277 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . 0.465 ' N ' ' O ' ' A' ' 20' ' ' PRO . . . -58.11 -62.07 2.09 Favored 'General case' 0 C--N 1.34 0.17 0 C-N-CA 117.766 -1.573 . . . . 1.0 109.487 -179.655 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . 0.473 HD23 ' N ' ' A' ' 25' ' ' LEU . 0.0 OUTLIER -62.95 -46.35 88.15 Favored 'General case' 0 CA--C 1.53 0.209 0 O-C-N 121.377 -0.827 . . . . 1.0 111.599 -178.168 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 79.5 t -57.49 -57.99 7.95 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 C-N-CA 119.562 -0.855 . . . . 1.0 109.338 -178.033 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . 0.663 ' O ' ' HB3' ' A' ' 31' ' ' ALA . 49.0 t -60.64 -37.27 75.09 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.65 0 CA-C-O 120.663 0.268 . . . . 1.0 110.743 -178.977 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . 0.434 ' CG ' ' O ' ' A' ' 24' ' ' ALA . 32.5 mmtt -65.91 -56.6 10.94 Favored 'General case' 0 CA--C 1.513 -0.453 0 C-N-CA 119.693 -0.803 . . . . 1.0 109.662 -178.573 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 94.7 t -63.37 -48.21 88.31 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.011 0 CA-C-N 114.365 -1.289 . . . . 1.0 109.942 -177.624 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 30' ' ' CYS . . . . . . . . . . . . . 20.2 t -66.33 -61.1 2.19 Favored 'General case' 0 N--CA 1.443 -0.814 0 C-N-CA 118.936 -1.106 . . . . 1.0 110.372 -179.417 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . 0.663 ' HB3' ' O ' ' A' ' 27' ' ' VAL . . . -63.1 -52.0 64.37 Favored 'General case' 0 CA--C 1.514 -0.434 0 N-CA-C 112.057 0.392 . . . . 1.0 112.057 -176.583 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . 0.437 ' O ' ' HB2' ' A' ' 33' ' ' LEU . . . 82.31 69.26 1.4 Allowed Glycine 0 CA--C 1.521 0.447 0 N-CA-C 109.696 -1.362 . . . . 1.0 109.696 -178.978 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . 0.491 ' O ' ' O ' ' A' ' 36' ' ' VAL . 3.9 mt 90.38 82.97 0.04 OUTLIER Pre-proline 0 N--CA 1.475 0.795 0 C-N-CA 123.565 0.746 . . . . 1.0 111.858 179.583 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 53.0 Cg_exo -54.89 -25.85 45.7 Favored 'Trans proline' 0 N--CA 1.499 1.796 0 C-N-CA 123.008 2.472 . . . . 1.0 112.73 178.562 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -57.15 -58.96 11.88 Favored Glycine 0 CA--C 1.531 1.06 0 N-CA-C 108.86 -1.696 . . . . 1.0 108.86 -179.349 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . 0.666 ' O ' HG22 ' A' ' 37' ' ' ILE . 14.1 p -98.09 169.44 1.51 Allowed 'Isoleucine or valine' 0 C--O 1.219 -0.516 0 N-CA-C 106.602 -1.629 . . . . 1.0 106.602 176.71 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . 0.666 HG22 ' O ' ' A' ' 36' ' ' VAL . 8.9 tt 117.14 116.52 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.486 1.337 0 O-C-N 124.532 1.145 . . . . 1.0 110.366 -179.725 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 38' ' ' HIS . . . . . 0.496 ' CD2' ' N ' ' A' ' 38' ' ' HIS . 0.4 OUTLIER -138.03 129.13 27.34 Favored 'General case' 0 N--CA 1.463 0.193 0 N-CA-C 108.215 -1.031 . . . . 1.0 108.215 178.983 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 12.8 m -99.53 133.22 22.05 Favored Pre-proline 0 C--N 1.328 -0.367 0 N-CA-C 109.049 -0.722 . . . . 1.0 109.049 179.251 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 42.1 Cg_endo -66.33 -96.3 0.0 OUTLIER 'Trans proline' 0 N--CA 1.492 1.423 0 C-N-CA 120.926 1.084 . . . . 1.0 111.827 -179.451 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -62.48 123.78 19.22 Favored 'General case' 0 C--N 1.319 -0.748 0 CA-C-N 115.895 -0.593 . . . . 1.0 110.092 -179.06 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . 0.598 ' C ' ' H ' ' A' ' 44' ' ' GLY . 2.8 mmm-85 -169.75 167.32 9.46 Favored 'General case' 0 C--N 1.32 -0.713 0 N-CA-C 108.798 -0.816 . . . . 1.0 108.798 179.332 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 43' ' ' ARG . . . . . 0.586 ' HG3' ' O ' ' A' ' 45' ' ' PHE . 0.3 OUTLIER -66.48 26.71 0.02 OUTLIER 'General case' 0 C--N 1.316 -0.857 0 CA-C-N 115.157 -0.929 . . . . 1.0 110.721 179.696 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . 0.598 ' H ' ' C ' ' A' ' 42' ' ' ARG . . . 80.68 -26.19 3.21 Favored Glycine 0 CA--C 1.528 0.883 0 N-CA-C 111.677 -0.569 . . . . 1.0 111.677 179.758 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . 0.741 ' CG ' ' N ' ' A' ' 46' ' ' PHE . 0.5 OUTLIER -174.88 175.36 2.38 Favored 'General case' 0 C--O 1.2 -1.531 0 C-N-CA 120.888 -0.325 . . . . 1.0 110.95 -179.157 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 46' ' ' PHE . . . . . 0.741 ' N ' ' CG ' ' A' ' 45' ' ' PHE . 13.8 t80 161.13 13.86 0.0 OUTLIER 'General case' 0 N--CA 1.478 0.964 0 CA-C-N 116.296 -0.411 . . . . 1.0 110.997 176.429 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 47' ' ' ARG . . . . . 0.62 HH22 ' HB2' ' A' ' 31' ' ' ALA . 3.9 mtp180 -175.64 169.24 3.08 Favored 'General case' 0 C--N 1.325 -0.462 0 C-N-CA 119.831 -0.748 . . . . 1.0 110.692 -178.61 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 48' ' ' CYS . . . . . 0.48 ' SG ' ' C ' ' A' ' 47' ' ' ARG . 1.2 m 72.62 69.32 0.13 Allowed 'General case' 0 N--CA 1.452 -0.373 0 N-CA-C 108.246 -1.02 . . . . 1.0 108.246 -178.437 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 49' ' ' ASN . . . . . 0.687 ' N ' ' OD1' ' A' ' 49' ' ' ASN . 0.0 OUTLIER -132.21 123.76 18.97 Favored Pre-proline 0 N--CA 1.468 0.472 0 CA-C-O 118.628 -0.701 . . . . 1.0 109.465 -179.215 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 50' ' ' PRO . . . . . 0.589 ' O ' ' CD ' ' A' ' 51' ' ' GLU . 75.0 Cg_exo -45.82 68.82 0.01 OUTLIER 'Trans proline' 0 N--CA 1.495 1.597 0 C-N-CA 121.928 1.752 . . . . 1.0 114.992 179.98 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . 0.668 ' N ' ' O ' ' A' ' 49' ' ' ASN . 10.3 pm0 62.98 23.39 13.99 Favored 'General case' 0 N--CA 1.472 0.653 0 C-N-CA 123.251 0.62 . . . . 1.0 112.365 -179.305 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 25.4 mtp85 -103.65 159.39 15.65 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 120.934 0.397 . . . . 1.0 111.71 -178.926 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . 0.479 ' O ' ' N ' ' A' ' 55' ' ' ILE . 6.8 tp -75.15 137.51 22.83 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.167 0 CA-C-O 120.95 0.405 . . . . 1.0 110.916 -179.657 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 54' ' ' GLN . . . . . 0.439 ' OE1' ' O ' ' A' ' 46' ' ' PHE . 28.0 mt-30 -60.85 81.78 0.01 OUTLIER 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.763 -0.653 . . . . 1.0 110.935 -176.507 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . 0.479 ' N ' ' O ' ' A' ' 53' ' ' ILE . 11.1 tt -148.58 158.8 6.98 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.358 0 CA-C-N 115.684 -0.689 . . . . 1.0 110.453 177.69 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 111.98 -2.3 27.13 Favored Glycine 0 N--CA 1.468 0.826 0 N-CA-C 111.277 -0.729 . . . . 1.0 111.277 -179.566 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . 0.503 ' OD2' ' NH1' ' A' ' 43' ' ' ARG . 1.6 p-10 -80.91 97.6 7.49 Favored 'General case' 0 CA--C 1.516 -0.338 0 C-N-CA 119.968 -0.693 . . . . 1.0 109.307 178.281 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 58' ' ' TRP . . . . . . . . . . . . . 6.2 m0 -88.62 173.09 8.82 Favored 'General case' 0 C--N 1.319 -0.741 0 CA-C-O 122.8 1.286 . . . . 1.0 112.526 -178.146 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 59' ' ' ARG . . . . . 0.401 ' H ' ' HD3' ' A' ' 59' ' ' ARG . 0.4 OUTLIER -85.26 -60.31 2.07 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 111.896 -2.411 . . . . 1.0 113.306 -178.433 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 75.2 t80 -90.83 -16.95 27.4 Favored 'General case' 0 N--CA 1.479 1.025 0 N-CA-C 113.74 1.015 . . . . 1.0 113.74 -178.883 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . 0.516 ' O ' ' N ' ' A' ' 65' ' ' ASP . 0.0 OUTLIER -77.91 -13.16 59.98 Favored 'General case' 0 C--N 1.318 -0.8 0 O-C-N 121.92 -0.487 . . . . 1.0 110.304 -179.149 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 62' ' ' VAL . . . . . 0.604 ' O ' ' N ' ' A' ' 66' ' ' GLY . 2.5 m -47.17 -55.45 1.96 Allowed 'Isoleucine or valine' 0 C--O 1.209 -1.074 0 C-N-CA 119.442 -0.903 . . . . 1.0 110.12 -176.431 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 63' ' ' ALA . . . . . 0.456 ' H ' HG23 ' A' ' 62' ' ' VAL . . . -67.2 -50.97 58.91 Favored 'General case' 0 C--N 1.307 -1.271 0 O-C-N 121.325 -0.859 . . . . 1.0 110.443 179.959 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 64' ' ' HIS . . . . . 0.513 ' O ' ' HB2' ' A' ' 67' ' ' ARG . 0.5 OUTLIER -56.3 -56.94 14.88 Favored 'General case' 0 CA--C 1.54 0.594 0 C-N-CA 119.192 -1.003 . . . . 1.0 109.359 -179.953 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 65' ' ' ASP . . . . . 0.601 ' C ' ' H ' ' A' ' 67' ' ' ARG . 25.7 t70 -72.34 -53.04 13.49 Favored 'General case' 0 C--N 1.316 -0.887 0 O-C-N 121.486 -0.759 . . . . 1.0 110.601 178.556 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . 0.604 ' N ' ' O ' ' A' ' 62' ' ' VAL . . . -65.25 30.35 0.12 Allowed Glycine 0 CA--C 1.526 0.753 0 O-C-N 121.151 -0.968 . . . . 1.0 111.457 179.051 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 67' ' ' ARG . . . . . 0.601 ' H ' ' C ' ' A' ' 65' ' ' ASP . 7.6 ttt85 -81.19 1.27 32.79 Favored 'General case' 0 C--N 1.32 -0.71 0 N-CA-C 107.34 -1.356 . . . . 1.0 107.34 175.662 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . 0.55 HD23 ' N ' ' A' ' 68' ' ' LEU . 2.1 pt? -39.52 -31.14 0.08 Allowed 'General case' 0 C--N 1.35 0.617 0 CA-C-O 121.275 0.56 . . . . 1.0 109.837 -178.459 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . 0.412 ' N ' ' O ' ' A' ' 67' ' ' ARG . 4.3 tt -67.91 -68.58 0.38 Allowed 'General case' 0 CA--C 1.545 0.753 0 C-N-CA 119.32 -0.952 . . . . 1.0 112.65 -175.782 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . 0.53 ' C ' ' H ' ' A' ' 72' ' ' HIS . . . -73.6 -78.42 0.09 Allowed 'General case' 0 N--CA 1.474 0.76 0 C-N-CA 118.653 -1.219 . . . . 1.0 109.878 -176.981 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 71' ' ' ALA . . . . . 0.809 ' O ' ' N ' ' A' ' 73' ' ' MET . . . -62.43 14.82 0.01 OUTLIER 'General case' 0 C--N 1.318 -0.779 0 C-N-CA 125.964 1.705 . . . . 1.0 112.55 179.221 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 72' ' ' HIS . . . . . 0.53 ' H ' ' C ' ' A' ' 70' ' ' ALA . 52.8 p-80 -19.02 -29.68 0.0 OUTLIER 'General case' 0 N--CA 1.468 0.452 0 N-CA-C 114.056 1.132 . . . . 1.0 114.056 -174.744 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 73' ' ' MET . . . . . 0.809 ' N ' ' O ' ' A' ' 71' ' ' ALA . 20.9 mtt -66.25 -54.91 19.38 Favored 'General case' 0 C--N 1.318 -0.789 0 C-N-CA 119.118 -1.033 . . . . 1.0 109.336 176.123 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . 0.634 ' O ' ' N ' ' A' ' 76' ' ' GLY . 34.6 m -43.57 -52.95 1.13 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.579 0 CA-C-O 117.298 -1.334 . . . . 1.0 111.614 -174.74 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 75' ' ' ASN . . . . . 0.575 ' N ' HG23 ' A' ' 74' ' ' VAL . 3.4 m120 -38.53 -19.79 0.01 OUTLIER 'General case' 0 N--CA 1.482 1.138 0 CA-C-N 120.603 1.547 . . . . 1.0 110.992 -179.666 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 76' ' ' GLY . . . . . 0.634 ' N ' ' O ' ' A' ' 74' ' ' VAL . . . -48.22 -24.45 3.51 Favored Glycine 0 CA--C 1.532 1.141 0 N-CA-C 107.214 -2.354 . . . . 1.0 107.214 176.664 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 77' ' ' ILE . . . . . 0.54 ' O ' ' N ' ' A' ' 81' ' ' GLU . 24.1 pt -59.02 -43.21 88.44 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.056 0 C-N-CA 119.722 -0.791 . . . . 1.0 110.941 -179.309 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . 0.419 ' CG2' ' OD1' ' A' ' 65' ' ' ASP . 60.6 t -56.64 -25.25 20.94 Favored 'Isoleucine or valine' 0 C--O 1.24 0.601 0 CA-C-N 121.708 2.049 . . . . 1.0 114.147 -178.887 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . 0.854 ' O ' ' HB2' ' A' ' 83' ' ' ALA . 0.8 OUTLIER -91.08 -37.09 8.78 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.452 0 N-CA-C 108.005 -1.109 . . . . 1.0 108.005 178.804 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 80' ' ' ALA . . . . . 0.418 ' N ' HG13 ' A' ' 79' ' ' ILE . . . -79.8 -17.54 53.13 Favored 'General case' 0 CA--C 1.545 0.772 0 CA-C-N 115.469 -0.787 . . . . 1.0 112.033 178.927 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 81' ' ' GLU . . . . . 0.54 ' N ' ' O ' ' A' ' 77' ' ' ILE . 62.5 mm-40 -91.91 -67.36 0.86 Allowed 'General case' 0 N--CA 1.447 -0.582 0 O-C-N 121.748 -0.595 . . . . 1.0 110.581 178.492 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 82' ' ' ASP . . . . . 0.519 ' O ' ' C ' ' A' ' 83' ' ' ALA . 1.5 m-20 -72.2 -18.06 61.88 Favored 'General case' 0 N--CA 1.45 -0.464 0 O-C-N 121.11 -0.994 . . . . 1.0 112.794 -178.272 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . 0.854 ' HB2' ' O ' ' A' ' 79' ' ' ILE . . . -21.08 -51.31 0.01 OUTLIER 'General case' 0 N--CA 1.479 0.998 0 CA-C-N 119.048 0.84 . . . . 1.0 112.464 178.656 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . 0.46 ' N ' ' O ' ' A' ' 82' ' ' ASP . 3.6 mm? -31.94 -39.64 0.03 OUTLIER 'General case' 0 N--CA 1.479 0.988 0 N-CA-C 111.805 0.298 . . . . 1.0 111.805 -176.627 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 85' ' ' ILE . . . . . 0.49 ' O ' ' HB3' ' A' ' 88' ' ' ALA . 67.9 mt -94.95 -40.36 11.09 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.452 0 CA-C-O 120.896 0.379 . . . . 1.0 110.764 178.407 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 86' ' ' ALA . . . . . 0.527 ' HB3' ' HA ' ' A' ' 83' ' ' ALA . . . -53.64 -59.33 4.74 Favored 'General case' 0 CA--C 1.533 0.309 0 CA-C-N 115.951 -0.568 . . . . 1.0 111.537 -178.159 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 15.1 pt-20 -62.32 -14.21 36.97 Favored 'General case' 0 CA--C 1.518 -0.276 0 C-N-CA 120.96 -0.296 . . . . 1.0 110.681 -178.996 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 88' ' ' ALA . . . . . 0.49 ' HB3' ' O ' ' A' ' 85' ' ' ILE . . . -77.18 -18.92 57.41 Favored 'General case' 0 C--N 1.325 -0.497 0 N-CA-C 108.586 -0.894 . . . . 1.0 108.586 179.109 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 89' ' ' VAL . . . . . 0.431 ' O ' ' OE2' ' A' ' 51' ' ' GLU . 35.6 m -113.97 35.19 0.91 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.22 0 CA-C-N 113.61 -1.632 . . . . 1.0 110.781 178.705 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 90' ' ' GLY . . . . . 0.633 ' C ' ' H ' ' A' ' 92' ' ' HIS . . . -69.61 -33.44 71.78 Favored Glycine 0 C--N 1.351 1.407 0 CA-C-O 119.205 -0.775 . . . . 1.0 111.99 178.243 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 91' ' ' PRO . . . . . 0.552 ' CD ' ' N ' ' A' ' 90' ' ' GLY . 78.6 Cg_exo -45.57 -4.0 0.02 OUTLIER 'Trans proline' 0 N--CA 1.501 1.941 0 C-N-CA 122.379 2.053 . . . . 1.0 112.659 177.703 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 92' ' ' HIS . . . . . 0.65 ' O ' ' HB3' ' A' ' 96' ' ' ALA . 0.0 OUTLIER -49.31 -15.52 0.14 Allowed 'General case' 0 N--CA 1.448 -0.531 0 O-C-N 123.794 0.684 . . . . 1.0 110.047 -178.718 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 93' ' ' LEU . . . . . 0.661 HD12 ' N ' ' A' ' 94' ' ' ALA . 1.7 pp -66.28 -58.06 6.17 Favored 'General case' 0 N--CA 1.445 -0.692 0 N-CA-C 108.892 -0.781 . . . . 1.0 108.892 177.095 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 94' ' ' ALA . . . . . 0.661 ' N ' HD12 ' A' ' 93' ' ' LEU . . . -59.77 -58.19 9.64 Favored 'General case' 0 N--CA 1.449 -0.489 0 N-CA-C 109.959 -0.386 . . . . 1.0 109.959 179.725 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 95' ' ' ARG . . . . . 0.613 ' O ' ' N ' ' A' ' 97' ' ' LEU . 0.0 OUTLIER -61.47 -63.53 1.24 Allowed 'General case' 0 N--CA 1.449 -0.492 0 CA-C-O 121.428 0.632 . . . . 1.0 109.572 -178.592 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 96' ' ' ALA . . . . . 0.957 ' O ' ' N ' ' A' ' 98' ' ' GLY . . . -49.44 -11.08 0.04 OUTLIER 'General case' 0 N--CA 1.438 -1.064 0 O-C-N 118.791 -2.443 . . . . 1.0 111.266 -178.911 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 97' ' ' LEU . . . . . 0.745 ' O ' ' N ' ' A' ' 100' ' ' ILE . 0.3 OUTLIER 5.89 -48.0 0.0 OUTLIER 'General case' 0 N--CA 1.487 1.419 0 C-N-CA 124.426 1.09 . . . . 1.0 110.38 -167.96 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 98' ' ' GLY . . . . . 0.957 ' N ' ' O ' ' A' ' 96' ' ' ALA . . . -51.35 -24.28 10.28 Favored Glycine 0 C--N 1.286 -2.214 0 N-CA-C 106.488 -2.645 . . . . 1.0 106.488 173.273 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 99' ' ' GLN . . . . . 0.625 ' N ' ' O ' ' A' ' 96' ' ' ALA . 35.1 mt-30 -65.57 -23.16 66.79 Favored 'General case' 0 C--N 1.377 1.766 0 N-CA-C 105.94 -1.874 . . . . 1.0 105.94 175.983 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 100' ' ' ILE . . . . . 0.745 ' N ' ' O ' ' A' ' 97' ' ' LEU . 1.4 tp -64.59 -37.06 79.11 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.21 0 C-N-CA 118.87 -1.132 . . . . 1.0 108.118 178.884 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 101' ' ' VAL . . . . . 0.711 ' O ' ' N ' ' A' ' 105' ' ' GLY . 88.1 t -57.62 -63.13 0.71 Allowed 'Isoleucine or valine' 0 C--O 1.216 -0.704 0 C-N-CA 119.923 -0.711 . . . . 1.0 109.687 178.713 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 102' ' ' CYS . . . . . 0.957 ' O ' ' HB2' ' A' ' 106' ' ' ALA . 0.9 OUTLIER -49.22 -17.34 0.23 Allowed 'General case' 0 CA--C 1.545 0.754 0 C-N-CA 118.36 -1.336 . . . . 1.0 111.579 -178.446 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 24.0 ttm180 -89.64 -46.71 8.44 Favored 'General case' 0 N--CA 1.479 0.998 0 CA-C-O 122.573 1.178 . . . . 1.0 111.851 178.275 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 104' ' ' TYR . . . . . 0.622 ' O ' ' CG ' ' A' ' 104' ' ' TYR . 0.0 OUTLIER -104.47 21.83 16.01 Favored 'General case' 0 CA--C 1.549 0.931 0 CA-C-N 112.684 -2.053 . . . . 1.0 110.208 178.262 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 105' ' ' GLY . . . . . 0.756 ' O ' ' N ' ' A' ' 107' ' ' THR . . . -168.26 -12.5 0.02 OUTLIER Glycine 0 C--N 1.345 1.03 0 C-N-CA 118.523 -1.798 . . . . 1.0 113.969 178.769 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 106' ' ' ALA . . . . . 0.957 ' HB2' ' O ' ' A' ' 102' ' ' CYS . . . -20.08 64.8 0.0 OUTLIER 'General case' 0 N--CA 1.479 0.98 0 N-CA-C 114.671 1.36 . . . . 1.0 114.671 -179.601 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 107' ' ' THR . . . . . 0.756 ' N ' ' O ' ' A' ' 105' ' ' GLY . 96.4 m -102.28 -4.96 24.84 Favored 'General case' 0 N--CA 1.447 -0.585 0 N-CA-C 107.532 -1.285 . . . . 1.0 107.532 177.008 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 16.9 m -95.59 11.69 4.36 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.511 0 CA-C-N 116.084 -0.507 . . . . 1.0 110.053 176.325 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 109' ' ' ILE . . . . . 0.646 ' N ' ' CD ' ' A' ' 110' ' ' PRO . 0.1 OUTLIER -112.81 -27.94 0.12 Allowed Pre-proline 0 CA--C 1.555 1.161 0 CA-C-N 119.187 0.903 . . . . 1.0 111.64 177.523 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 110' ' ' PRO . . . . . 0.646 ' CD ' ' N ' ' A' ' 109' ' ' ILE . 48.7 Cg_endo -65.86 -37.41 27.36 Favored 'Trans proline' 0 N--CA 1.496 1.643 0 C-N-CA 122.827 2.351 . . . . 1.0 113.579 -173.19 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 34.3 t30 -64.57 -67.95 0.39 Allowed 'General case' 0 CA--C 1.507 -0.686 0 C-N-CA 119.061 -1.056 . . . . 1.0 109.078 -178.186 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 112' ' ' ILE . . . . . 0.596 ' O ' HG22 ' A' ' 116' ' ' ILE . 6.3 pt -52.01 -42.54 34.64 Favored 'Isoleucine or valine' 0 C--O 1.209 -1.038 0 CA-C-O 122.065 0.936 . . . . 1.0 108.857 179.907 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 113' ' ' ASN . . . . . 0.544 ' N ' ' CG1' ' A' ' 112' ' ' ILE . 2.8 m120 -50.19 -53.57 26.98 Favored 'General case' 0 C--N 1.315 -0.922 0 CA-C-N 113.929 -1.487 . . . . 1.0 108.745 -176.738 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 114' ' ' ALA . . . . . 0.444 ' O ' ' CG2' ' A' ' 118' ' ' VAL . . . -62.97 -34.36 77.35 Favored 'General case' 0 C--N 1.311 -1.083 0 O-C-N 121.035 -1.04 . . . . 1.0 112.501 179.551 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -84.63 -60.02 2.19 Favored 'General case' 0 N--CA 1.471 0.605 0 CA-C-N 118.672 0.669 . . . . 1.0 112.684 179.095 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 116' ' ' ILE . . . . . 0.622 HG23 ' N ' ' A' ' 117' ' ' GLU . 9.9 tt -54.57 -61.87 0.89 Allowed 'Isoleucine or valine' 0 C--O 1.223 -0.313 0 CA-C-N 115.336 -0.847 . . . . 1.0 108.795 -176.998 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 117' ' ' GLU . . . . . 0.622 ' N ' HG23 ' A' ' 116' ' ' ILE . 98.2 mt-10 -45.46 -49.3 13.58 Favored 'General case' 0 C--N 1.314 -0.935 0 N-CA-C 106.501 -1.666 . . . . 1.0 106.501 -178.236 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 118' ' ' VAL . . . . . 0.444 ' CG2' ' O ' ' A' ' 114' ' ' ALA . 23.8 t -62.77 -30.18 48.8 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.689 0 CA-C-O 118.88 -0.581 . . . . 1.0 109.913 178.164 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 119' ' ' LEU . . . . . 0.573 ' N ' ' O ' ' A' ' 116' ' ' ILE . 14.3 tp -80.66 -63.01 1.5 Allowed 'General case' 0 C--N 1.351 0.653 0 CA-C-N 120.028 1.285 . . . . 1.0 108.032 178.548 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 120' ' ' GLY . . . . . 0.465 ' N ' ' O ' ' A' ' 116' ' ' ILE . . . -61.65 -86.81 0.04 OUTLIER Glycine 0 N--CA 1.434 -1.462 0 C-N-CA 117.991 -2.052 . . . . 1.0 108.415 177.839 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 121' ' ' THR . . . . . 0.433 HG22 ' C ' ' A' ' 120' ' ' GLY . 0.0 OUTLIER 171.96 -41.4 0.01 OUTLIER 'General case' 0 C--N 1.316 -0.849 0 CA-C-N 113.947 -1.127 . . . . 1.0 113.755 179.737 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 122' ' ' GLY . . . . . 0.651 ' O ' ' N ' ' A' ' 124' ' ' ASP . . . 102.17 -16.78 55.18 Favored Glycine 0 N--CA 1.472 1.069 0 N-CA-C 108.015 -2.034 . . . . 1.0 108.015 -176.959 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 123' ' ' THR . . . . . 0.663 HG23 ' O ' ' A' ' 123' ' ' THR . 1.7 t -52.62 86.84 0.0 OUTLIER 'General case' 0 CA--C 1.538 0.505 0 N-CA-C 105.479 -2.045 . . . . 1.0 105.479 179.063 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 124' ' ' ASP . . . . . 0.651 ' N ' ' O ' ' A' ' 122' ' ' GLY . 37.5 m-20 -164.48 171.65 14.35 Favored 'General case' 0 CA--C 1.522 -0.107 0 CA-C-N 114.107 -1.406 . . . . 1.0 112.018 -178.462 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 125' ' ' TYR . . . . . . . . . . . . . 26.1 t80 -148.38 145.42 28.06 Favored 'General case' 0 CA--C 1.536 0.415 0 CA-C-N 114.785 -1.098 . . . . 1.0 108.633 175.678 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 126' ' ' ARG . . . . . 0.42 HH21 ' CG2' ' A' ' 79' ' ' ILE . 2.6 mmp_? -145.5 149.4 34.56 Favored 'General case' 0 N--CA 1.474 0.765 0 N-CA-C 109.5 -0.556 . . . . 1.0 109.5 178.16 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 127' ' ' PHE . . . . . . . . . . . . . 40.4 p90 . . . . . 0 C--O 1.22 -0.454 0 CA-C-O 118.086 -0.959 . . . . 1.0 110.709 179.713 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . 0.467 ' C ' ' H ' ' A' ' 3' ' ' ASP . 57.9 mtt . . . . . 0 N--CA 1.493 1.68 0 N-CA-C 108.902 -0.777 . . . . 1.0 108.902 . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 2' ' ' SER . . . . . 0.531 ' O ' ' CG ' ' A' ' 3' ' ' ASP . 6.9 t -69.44 10.01 0.4 Allowed 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.309 -0.405 . . . . 1.0 111.013 178.915 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 3' ' ' ASP . . . . . 0.531 ' CG ' ' O ' ' A' ' 2' ' ' SER . 80.9 m-20 138.3 142.82 0.0 OUTLIER 'General case' 0 N--CA 1.486 1.326 0 O-C-N 124.564 1.165 . . . . 1.0 109.954 179.075 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 60.9 t80 -156.4 152.5 27.6 Favored 'General case' 0 N--CA 1.463 0.225 0 CA-C-N 115.932 -0.576 . . . . 1.0 110.642 179.341 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 69.9 m-20 -150.07 146.19 26.8 Favored 'General case' 0 CA--C 1.534 0.334 0 N-CA-C 109.09 -0.707 . . . . 1.0 109.09 179.435 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 6' ' ' THR . . . . . 0.802 ' O ' ' N ' ' A' ' 10' ' ' SER . 0.2 OUTLIER -87.74 177.67 6.95 Favored 'General case' 0 C--O 1.194 -1.859 0 CA-C-O 121.094 0.473 . . . . 1.0 111.314 -178.702 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . 0.413 ' O ' ' N ' ' A' ' 11' ' ' ARG . 7.7 tm-20 -56.54 -58.18 9.15 Favored 'General case' 0 C--N 1.312 -1.052 0 CA-C-O 121.687 0.755 . . . . 1.0 110.932 -177.894 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 8' ' ' ARG . . . . . 0.803 ' O ' ' HB3' ' A' ' 12' ' ' ALA . 48.6 ttp85 -55.01 -57.28 12.32 Favored 'General case' 0 C--N 1.318 -0.777 0 CA-C-N 114.089 -1.414 . . . . 1.0 107.8 -178.02 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . 0.65 ' O ' ' HB ' ' A' ' 13' ' ' VAL . 0.0 OUTLIER -66.31 -54.06 30.14 Favored 'Isoleucine or valine' 0 C--O 1.188 -2.164 0 CA-C-N 114.499 -1.228 . . . . 1.0 110.655 178.883 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 10' ' ' SER . . . . . 0.802 ' N ' ' O ' ' A' ' 6' ' ' THR . 11.0 t -67.03 -64.58 0.82 Allowed 'General case' 0 N--CA 1.486 1.369 0 CA-C-N 118.769 0.713 . . . . 1.0 112.406 -178.132 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 11' ' ' ARG . . . . . 0.511 ' O ' ' N ' ' A' ' 15' ' ' ALA . 6.7 tpt180 -63.57 -59.07 5.1 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-O 121.083 0.468 . . . . 1.0 111.371 -175.104 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . 0.803 ' HB3' ' O ' ' A' ' 8' ' ' ARG . . . -51.58 -46.76 63.61 Favored 'General case' 0 C--N 1.322 -0.619 0 N-CA-C 106.512 -1.662 . . . . 1.0 106.512 -176.022 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . 0.659 ' O ' ' N ' ' A' ' 17' ' ' LEU . 67.6 t -62.3 -50.99 77.72 Favored 'Isoleucine or valine' 0 C--O 1.2 -1.532 0 CA-C-N 114.664 -1.153 . . . . 1.0 107.931 177.499 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . 0.819 ' O ' HG22 ' A' ' 18' ' ' VAL . . . -57.17 -62.39 1.79 Allowed 'General case' 0 C--O 1.207 -1.138 0 C-N-CA 117.335 -1.746 . . . . 1.0 109.097 -178.723 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . 0.585 ' O ' ' N ' ' A' ' 19' ' ' GLY . . . -53.73 -53.91 45.57 Favored 'General case' 0 C--O 1.215 -0.753 0 O-C-N 123.843 0.714 . . . . 1.0 109.703 -178.684 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . 0.488 ' CB ' ' O ' ' A' ' 12' ' ' ALA . . . -63.8 -57.8 8.8 Favored 'General case' 0 N--CA 1.474 0.738 0 C-N-CA 120.022 -0.671 . . . . 1.0 110.215 -179.737 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . 0.659 ' N ' ' O ' ' A' ' 13' ' ' VAL . 6.1 tt -55.91 -54.53 43.61 Favored 'General case' 0 N--CA 1.48 1.072 0 CA-C-N 114.752 -1.113 . . . . 1.0 108.012 -178.013 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . 0.819 HG22 ' O ' ' A' ' 14' ' ' ALA . 2.2 m -69.39 -58.34 5.91 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 C-N-CA 119.374 -0.93 . . . . 1.0 109.104 179.913 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . 0.585 ' N ' ' O ' ' A' ' 15' ' ' ALA . . . -54.97 -167.11 0.03 OUTLIER Glycine 0 C--O 1.225 -0.44 0 N-CA-C 111.298 -0.721 . . . . 1.0 111.298 -178.276 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 20' ' ' PRO . . . . . 0.673 ' O ' ' N ' ' A' ' 24' ' ' ALA . 74.0 Cg_endo -83.6 -28.97 1.19 Allowed 'Trans proline' 0 C--N 1.296 -2.184 0 C-N-CA 122.73 2.287 . . . . 1.0 112.556 -178.582 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -62.11 -59.63 9.24 Favored Glycine 0 N--CA 1.475 1.24 0 C-N-CA 119.508 -1.33 . . . . 1.0 111.902 -176.671 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . 0.459 ' N ' ' O ' ' A' ' 16' ' ' ALA . . . -55.72 -51.17 56.83 Favored Glycine 0 N--CA 1.47 0.909 0 N-CA-C 106.503 -2.639 . . . . 1.0 106.503 -178.608 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . 0.462 ' O ' HG12 ' A' ' 27' ' ' VAL . 38.3 t -60.41 -32.58 51.47 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.607 0 C-N-CA 119.493 -0.883 . . . . 1.0 109.19 178.415 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . 0.673 ' N ' ' O ' ' A' ' 20' ' ' PRO . . . -59.37 -63.85 1.15 Allowed 'General case' 0 C--N 1.349 0.552 0 C-N-CA 118.761 -1.176 . . . . 1.0 110.425 -178.709 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 19.5 mt -62.18 -44.19 97.15 Favored 'General case' 0 CA--C 1.509 -0.63 0 C-N-CA 119.581 -0.848 . . . . 1.0 110.845 -177.878 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . 0.415 HG23 ' O ' ' A' ' 22' ' ' GLY . 71.1 t -57.88 -60.4 2.23 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.695 0 C-N-CA 119.004 -1.078 . . . . 1.0 110.012 -178.186 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . 0.522 ' O ' ' HB3' ' A' ' 31' ' ' ALA . 1.4 p -60.46 -36.07 67.18 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-O 120.81 0.338 . . . . 1.0 111.645 -178.31 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 21.6 ttpp -65.72 -56.27 12.93 Favored 'General case' 0 C--N 1.321 -0.673 0 N-CA-C 109.004 -0.739 . . . . 1.0 109.004 -179.645 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 94.6 t -61.06 -47.7 92.38 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.614 0 CA-C-N 115.001 -1.0 . . . . 1.0 109.743 -178.328 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 30' ' ' CYS . . . . . 0.659 ' SG ' ' N ' ' A' ' 31' ' ' ALA . 0.0 OUTLIER -66.1 -60.38 2.87 Favored 'General case' 0 C--N 1.326 -0.446 0 C-N-CA 118.79 -1.164 . . . . 1.0 110.132 -179.511 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . 0.659 ' N ' ' SG ' ' A' ' 30' ' ' CYS . . . -60.43 -50.98 71.42 Favored 'General case' 0 CA--C 1.507 -0.697 0 C-N-CA 120.986 -0.286 . . . . 1.0 111.093 -176.003 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . 0.53 ' O ' ' CB ' ' A' ' 33' ' ' LEU . . . 78.23 69.58 1.38 Allowed Glycine 0 N--CA 1.448 -0.541 0 N-CA-C 109.516 -1.434 . . . . 1.0 109.516 -178.616 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . 0.53 ' CB ' ' O ' ' A' ' 32' ' ' GLY . 1.2 tt 90.31 77.21 0.04 OUTLIER Pre-proline 0 CA--C 1.534 0.359 0 CA-C-N 115.176 -0.512 . . . . 1.0 110.388 -179.58 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 58.8 Cg_exo -50.47 -23.09 9.95 Favored 'Trans proline' 0 N--CA 1.492 1.415 0 C-N-CA 122.839 2.359 . . . . 1.0 112.491 179.578 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . 0.524 ' H ' HD23 ' A' ' 33' ' ' LEU . . . -58.03 -61.08 7.84 Favored Glycine 0 CA--C 1.538 1.53 0 C-N-CA 119.102 -1.523 . . . . 1.0 109.538 -178.616 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . 0.613 HG22 ' N ' ' A' ' 37' ' ' ILE . 13.5 p -94.93 171.73 1.1 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.651 0 N-CA-C 107.108 -1.441 . . . . 1.0 107.108 176.901 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . 0.613 ' N ' HG22 ' A' ' 36' ' ' VAL . 4.1 mm 112.79 113.54 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.484 1.249 0 O-C-N 124.614 1.196 . . . . 1.0 110.009 -179.73 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 16.9 m-70 -139.98 133.58 30.27 Favored 'General case' 0 C--N 1.332 -0.17 0 N-CA-C 108.651 -0.87 . . . . 1.0 108.651 179.2 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 11.4 m -107.84 109.79 62.27 Favored Pre-proline 0 N--CA 1.469 0.492 0 N-CA-C 109.975 -0.38 . . . . 1.0 109.975 179.99 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 40' ' ' PRO . . . . . 0.459 ' HB2' ' H ' ' A' ' 41' ' ' ALA . 79.0 Cg_exo -42.6 -90.9 0.0 OUTLIER 'Trans proline' 0 N--CA 1.493 1.444 0 C-N-CA 121.471 1.447 . . . . 1.0 112.252 -179.127 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . 0.459 ' H ' ' HB2' ' A' ' 40' ' ' PRO . . . -65.56 125.02 23.89 Favored 'General case' 0 C--N 1.324 -0.541 0 N-CA-C 109.447 -0.575 . . . . 1.0 109.447 -179.389 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 34.5 ptt180 -174.2 177.05 2.37 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.205 -0.452 . . . . 1.0 110.617 179.394 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 4.3 tpp180 -58.58 -45.55 88.83 Favored 'General case' 0 C--N 1.324 -0.53 0 N-CA-C 107.965 -1.124 . . . . 1.0 107.965 178.711 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 122.24 -25.11 6.77 Favored Glycine 0 N--CA 1.471 1.016 0 N-CA-C 111.134 -0.786 . . . . 1.0 111.134 -179.788 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . 0.543 ' O ' ' HB2' ' A' ' 46' ' ' PHE . 64.7 t80 -149.98 153.66 36.93 Favored 'General case' 0 N--CA 1.466 0.368 0 N-CA-C 107.726 -1.213 . . . . 1.0 107.726 176.812 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 46' ' ' PHE . . . . . 0.79 ' O ' ' HB2' ' A' ' 47' ' ' ARG . 2.1 m-85 128.59 95.99 0.0 OUTLIER 'General case' 0 N--CA 1.481 1.109 0 C-N-CA 126.054 1.742 . . . . 1.0 108.317 -178.735 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 47' ' ' ARG . . . . . 0.79 ' HB2' ' O ' ' A' ' 46' ' ' PHE . 0.1 OUTLIER 118.16 137.79 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.825 0 C-N-CA 124.766 1.227 . . . . 1.0 110.151 179.308 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 5.4 t 71.07 78.64 0.17 Allowed 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 116.074 -0.512 . . . . 1.0 110.413 179.287 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 49' ' ' ASN . . . . . 0.523 ' O ' ' N ' ' A' ' 51' ' ' GLU . 9.4 p30 -144.66 145.43 28.23 Favored Pre-proline 0 C--N 1.324 -0.515 0 CA-C-N 115.632 -0.713 . . . . 1.0 110.838 179.753 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 50' ' ' PRO . . . . . 0.514 ' HD2' HH12 ' A' ' 52' ' ' ARG . 20.5 Cg_endo -61.27 55.48 0.1 Allowed 'Trans proline' 0 N--CA 1.494 1.524 0 C-N-CA 121.979 1.786 . . . . 1.0 113.239 179.901 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . 0.523 ' N ' ' O ' ' A' ' 49' ' ' ASN . 2.3 mp0 65.9 68.34 0.46 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.679 -0.691 . . . . 1.0 111.497 177.967 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . 0.514 HH12 ' HD2' ' A' ' 50' ' ' PRO . 7.8 mtm-85 -145.95 153.57 40.95 Favored 'General case' 0 N--CA 1.467 0.379 0 CA-C-N 115.685 -0.689 . . . . 1.0 110.468 179.157 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . 0.519 ' O ' ' N ' ' A' ' 55' ' ' ILE . 12.3 pt -65.65 127.99 27.72 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 CA-C-N 115.829 -0.623 . . . . 1.0 111.073 179.799 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 54' ' ' GLN . . . . . 0.741 ' H ' HE21 ' A' ' 54' ' ' GLN . 0.0 OUTLIER -57.74 85.49 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 121.426 0.632 . . . . 1.0 109.714 -177.367 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . 0.519 ' N ' ' O ' ' A' ' 53' ' ' ILE . 0.5 OUTLIER -146.83 159.17 9.96 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.157 0 CA-C-N 115.066 -0.97 . . . . 1.0 110.043 178.269 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . 0.42 ' H ' HG13 ' A' ' 55' ' ' ILE . . . 114.23 0.61 23.75 Favored Glycine 0 C--N 1.332 0.36 0 N-CA-C 110.178 -1.169 . . . . 1.0 110.178 -178.183 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . 0.432 ' CG ' ' O ' ' A' ' 57' ' ' ASP . 13.2 p-10 -80.82 93.57 6.27 Favored 'General case' 0 N--CA 1.455 -0.197 0 C-N-CA 119.379 -0.929 . . . . 1.0 109.845 178.791 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 58' ' ' TRP . . . . . . . . . . . . . 10.8 m0 -88.7 169.21 11.86 Favored 'General case' 0 CA--C 1.547 0.856 0 CA-C-O 122.618 1.199 . . . . 1.0 111.63 -178.103 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 59' ' ' ARG . . . . . 0.425 ' CG ' ' H ' ' A' ' 60' ' ' TYR . 6.8 ptt85 -83.86 -60.91 1.96 Allowed 'General case' 0 C--N 1.31 -1.129 0 CA-C-N 112.119 -2.309 . . . . 1.0 113.5 -178.495 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 60' ' ' TYR . . . . . 0.425 ' H ' ' CG ' ' A' ' 59' ' ' ARG . 0.0 OUTLIER -89.19 -18.26 27.48 Favored 'General case' 0 C--O 1.248 0.998 0 N-CA-C 113.167 0.803 . . . . 1.0 113.167 -179.005 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . 0.519 ' O ' ' N ' ' A' ' 65' ' ' ASP . 25.0 tt0 -71.14 -12.95 61.77 Favored 'General case' 0 C--N 1.31 -1.149 0 O-C-N 121.973 -0.454 . . . . 1.0 110.662 -177.86 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 62' ' ' VAL . . . . . 0.613 HG23 ' H ' ' A' ' 63' ' ' ALA . 17.0 m -45.13 -56.26 0.96 Allowed 'Isoleucine or valine' 0 C--N 1.309 -1.188 0 C-N-CA 120.121 -0.632 . . . . 1.0 110.025 -175.124 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 63' ' ' ALA . . . . . 0.613 ' H ' HG23 ' A' ' 62' ' ' VAL . . . -65.91 -49.84 66.59 Favored 'General case' 0 N--CA 1.428 -1.53 0 CA-C-O 121.349 0.595 . . . . 1.0 109.435 179.728 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 1.8 t60 -54.04 -59.95 3.98 Favored 'General case' 0 CA--C 1.547 0.849 0 C-N-CA 119.474 -0.891 . . . . 1.0 109.934 -179.747 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 65' ' ' ASP . . . . . 0.556 ' C ' ' H ' ' A' ' 67' ' ' ARG . 2.6 t70 -66.94 -54.72 19.2 Favored 'General case' 0 C--O 1.244 0.808 0 CA-C-O 121.848 0.832 . . . . 1.0 110.729 177.851 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . 0.566 ' N ' ' O ' ' A' ' 62' ' ' VAL . . . -65.72 27.74 0.14 Allowed Glycine 0 CA--C 1.524 0.617 0 O-C-N 121.163 -0.961 . . . . 1.0 112.489 179.078 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 67' ' ' ARG . . . . . 0.718 ' O ' ' N ' ' A' ' 69' ' ' LEU . 1.1 mtt-85 -76.43 -1.11 25.44 Favored 'General case' 0 C--N 1.322 -0.619 0 N-CA-C 108.72 -0.844 . . . . 1.0 108.72 175.775 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . 0.48 ' C ' ' O ' ' A' ' 67' ' ' ARG . 0.8 OUTLIER -32.39 -26.01 0.0 OUTLIER 'General case' 0 N--CA 1.488 1.44 0 N-CA-C 107.732 -1.21 . . . . 1.0 107.732 -177.486 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . 0.718 ' N ' ' O ' ' A' ' 67' ' ' ARG . 20.0 tp -66.91 -67.67 0.43 Allowed 'General case' 0 CA--C 1.548 0.875 0 C-N-CA 119.342 -0.943 . . . . 1.0 108.853 177.029 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . 0.702 ' C ' ' H ' ' A' ' 72' ' ' HIS . . . -78.1 -73.45 0.31 Allowed 'General case' 0 N--CA 1.472 0.653 0 N-CA-C 107.577 -1.268 . . . . 1.0 107.577 179.084 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 71' ' ' ALA . . . . . 0.484 ' HB3' ' CB ' ' A' ' 67' ' ' ARG . . . -48.02 5.51 0.0 OUTLIER 'General case' 0 N--CA 1.469 0.522 0 C-N-CA 124.273 1.029 . . . . 1.0 112.261 177.81 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 72' ' ' HIS . . . . . 0.702 ' H ' ' C ' ' A' ' 70' ' ' ALA . 0.0 OUTLIER -21.87 -75.92 0.01 OUTLIER 'General case' 0 CA--C 1.516 -0.351 0 C-N-CA 123.332 0.653 . . . . 1.0 112.328 -177.956 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 73' ' ' MET . . . . . 0.636 ' H ' ' CG ' ' A' ' 72' ' ' HIS . 57.9 mtm -69.29 -45.31 69.94 Favored 'General case' 0 C--N 1.311 -1.097 0 C-N-CA 118.692 -1.203 . . . . 1.0 109.463 178.065 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . 0.729 ' O ' ' N ' ' A' ' 76' ' ' GLY . 85.3 t -41.1 -42.27 0.67 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.384 0 CA-C-O 118.604 -0.712 . . . . 1.0 110.167 -176.553 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 75' ' ' ASN . . . . . 0.661 ' ND2' HG21 ' A' ' 78' ' ' VAL . 1.0 OUTLIER -36.66 -15.58 0.0 OUTLIER 'General case' 0 N--CA 1.48 1.067 0 CA-C-O 121.497 0.665 . . . . 1.0 110.721 178.363 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 76' ' ' GLY . . . . . 0.729 ' N ' ' O ' ' A' ' 74' ' ' VAL . . . -43.92 -20.14 0.14 Allowed Glycine 0 CA--C 1.539 1.549 0 N-CA-C 108.734 -1.747 . . . . 1.0 108.734 176.971 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 77' ' ' ILE . . . . . 0.627 ' O ' ' N ' ' A' ' 80' ' ' ALA . 0.2 OUTLIER -73.45 -50.33 31.28 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.14 0 CA-C-O 122.274 1.035 . . . . 1.0 108.524 178.85 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . 0.661 HG21 ' ND2' ' A' ' 75' ' ' ASN . 93.5 t -35.54 -36.3 0.08 OUTLIER 'Isoleucine or valine' 0 CA--C 1.553 1.083 0 CA-C-N 112.092 -2.322 . . . . 1.0 107.956 -176.254 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . 0.563 HG13 ' O ' ' A' ' 76' ' ' GLY . 1.4 pp -95.37 -24.97 4.59 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.852 0 CA-C-N 116.195 -0.457 . . . . 1.0 111.355 177.614 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 80' ' ' ALA . . . . . 0.627 ' N ' ' O ' ' A' ' 77' ' ' ILE . . . -80.67 -14.96 57.69 Favored 'General case' 0 N--CA 1.475 0.779 0 O-C-N 122.261 -0.274 . . . . 1.0 111.564 179.278 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 33.1 tt0 -81.17 -67.88 0.74 Allowed 'General case' 0 N--CA 1.444 -0.74 0 N-CA-C 109.448 -0.575 . . . . 1.0 109.448 177.668 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 82' ' ' ASP . . . . . 0.815 ' O ' ' N ' ' A' ' 84' ' ' LEU . 89.1 m-20 -59.35 -60.52 3.73 Favored 'General case' 0 CA--C 1.504 -0.801 0 C-N-CA 119.075 -1.05 . . . . 1.0 109.039 -179.454 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . 0.527 ' O ' ' N ' ' A' ' 86' ' ' ALA . . . 22.83 -68.21 0.0 OUTLIER 'General case' 0 N--CA 1.484 1.235 0 O-C-N 124.852 1.345 . . . . 1.0 111.386 -179.957 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . 0.815 ' N ' ' O ' ' A' ' 82' ' ' ASP . 4.8 tt -29.31 -45.3 0.04 OUTLIER 'General case' 0 N--CA 1.478 0.95 0 C-N-CA 123.512 0.725 . . . . 1.0 112.666 -178.288 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 85' ' ' ILE . . . . . 0.616 ' O ' ' HB3' ' A' ' 88' ' ' ALA . 3.3 pt -91.12 -36.55 8.21 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.87 0 N-CA-C 109.384 -0.598 . . . . 1.0 109.384 178.081 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 86' ' ' ALA . . . . . 0.547 ' C ' ' H ' ' A' ' 88' ' ' ALA . . . -51.16 -55.78 16.13 Favored 'General case' 0 CA--C 1.534 0.34 0 C-N-CA 120.42 -0.512 . . . . 1.0 110.086 -178.749 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 27.3 mt-10 -61.55 5.66 0.07 Allowed 'General case' 0 C--N 1.326 -0.419 0 C-N-CA 120.656 -0.417 . . . . 1.0 110.664 -179.433 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 88' ' ' ALA . . . . . 0.616 ' HB3' ' O ' ' A' ' 85' ' ' ILE . . . -105.76 -23.98 12.6 Favored 'General case' 0 C--O 1.237 0.4 0 CA-C-N 116.402 -0.363 . . . . 1.0 110.506 179.55 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 89' ' ' VAL . . . . . 0.462 HG22 ' O ' ' A' ' 86' ' ' ALA . 9.3 m -88.63 -8.79 10.9 Favored 'Isoleucine or valine' 0 C--O 1.236 0.367 0 CA-C-N 115.98 -0.555 . . . . 1.0 109.716 179.307 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -40.92 -49.67 4.21 Favored Glycine 0 CA--C 1.535 1.301 0 CA-C-O 119.466 -0.63 . . . . 1.0 111.633 -177.999 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 85.7 Cg_exo -45.38 -27.83 3.48 Favored 'Trans proline' 0 N--CA 1.495 1.608 0 CA-C-N 120.072 1.936 . . . . 1.0 112.052 177.726 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 92' ' ' HIS . . . . . 0.51 ' ND1' ' HG2' ' A' ' 51' ' ' GLU . 25.9 t-80 -56.36 -33.91 66.13 Favored 'General case' 0 C--O 1.22 -0.476 0 N-CA-C 107.849 -1.167 . . . . 1.0 107.849 -177.607 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 93' ' ' LEU . . . . . 0.976 HD23 ' H ' ' A' ' 94' ' ' ALA . 0.5 OUTLIER -42.45 -51.85 4.85 Favored 'General case' 0 N--CA 1.473 0.697 0 C-N-CA 120.375 -0.53 . . . . 1.0 109.592 -179.833 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 94' ' ' ALA . . . . . 0.976 ' H ' HD23 ' A' ' 93' ' ' LEU . . . -56.1 -53.9 51.51 Favored 'General case' 0 N--CA 1.449 -0.513 0 N-CA-C 107.998 -1.112 . . . . 1.0 107.998 178.877 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 95' ' ' ARG . . . . . 0.596 ' C ' ' H ' ' A' ' 97' ' ' LEU . 0.2 OUTLIER -51.3 -58.57 5.83 Favored 'General case' 0 C--O 1.241 0.649 0 CA-C-O 123.358 1.551 . . . . 1.0 107.075 177.614 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 96' ' ' ALA . . . . . 0.85 ' O ' ' N ' ' A' ' 98' ' ' GLY . . . -49.24 -11.88 0.05 OUTLIER 'General case' 0 N--CA 1.427 -1.622 0 O-C-N 118.731 -2.481 . . . . 1.0 110.895 -179.842 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 97' ' ' LEU . . . . . 0.66 ' O ' ' N ' ' A' ' 100' ' ' ILE . 0.4 OUTLIER 4.79 -49.52 0.0 OUTLIER 'General case' 0 CA--C 1.511 -0.549 0 C-N-CA 124.9 1.28 . . . . 1.0 112.865 -170.101 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 98' ' ' GLY . . . . . 0.85 ' N ' ' O ' ' A' ' 96' ' ' ALA . . . -53.24 -22.41 14.43 Favored Glycine 0 N--CA 1.426 -2.008 0 N-CA-C 107.817 -2.113 . . . . 1.0 107.817 174.806 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 99' ' ' GLN . . . . . 0.652 ' O ' ' HG3' ' A' ' 103' ' ' ARG . 15.2 mm100 -71.54 -22.95 61.69 Favored 'General case' 0 CA--C 1.5 -0.975 0 C-N-CA 116.551 -2.06 . . . . 1.0 107.127 177.576 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 100' ' ' ILE . . . . . 0.66 ' N ' ' O ' ' A' ' 97' ' ' LEU . 2.8 tt -66.05 -34.78 72.54 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.135 0 O-C-N 124.797 1.311 . . . . 1.0 109.453 178.779 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 101' ' ' VAL . . . . . 0.557 ' CG1' ' N ' ' A' ' 102' ' ' CYS . 0.4 OUTLIER -57.96 -57.97 8.32 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 N-CA-C 106.852 -1.536 . . . . 1.0 106.852 -178.757 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 102' ' ' CYS . . . . . 0.681 ' O ' ' HB2' ' A' ' 106' ' ' ALA . 0.1 OUTLIER -48.99 -28.89 4.23 Favored 'General case' 0 N--CA 1.441 -0.883 0 CA-C-N 115.224 -0.898 . . . . 1.0 110.078 178.954 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 103' ' ' ARG . . . . . 0.652 ' HG3' ' O ' ' A' ' 99' ' ' GLN . 74.7 mtt-85 -72.58 -56.61 5.09 Favored 'General case' 0 N--CA 1.478 0.972 0 O-C-N 123.984 0.803 . . . . 1.0 110.085 179.063 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 104' ' ' TYR . . . . . 0.774 ' O ' ' HD1' ' A' ' 104' ' ' TYR . 0.5 OUTLIER -90.34 25.77 2.13 Favored 'General case' 0 CA--C 1.494 -1.187 0 C-N-CA 125.435 1.494 . . . . 1.0 108.44 177.291 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 105' ' ' GLY . . . . . 0.529 ' N ' ' O ' ' A' ' 101' ' ' VAL . . . -155.43 -91.02 0.08 OUTLIER Glycine 0 N--CA 1.443 -0.841 0 C-N-CA 118.793 -1.67 . . . . 1.0 109.86 176.932 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 106' ' ' ALA . . . . . 0.681 ' HB2' ' O ' ' A' ' 102' ' ' CYS . . . 58.18 114.36 0.01 OUTLIER 'General case' 0 CA--C 1.551 0.993 0 N-CA-C 108.92 -0.77 . . . . 1.0 108.92 -179.309 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 107' ' ' THR . . . . . 0.826 ' O ' ' HD2' ' A' ' 110' ' ' PRO . 5.2 m -134.7 -54.4 0.82 Allowed 'General case' 0 N--CA 1.481 1.115 0 N-CA-C 108.548 -0.908 . . . . 1.0 108.548 178.751 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 108' ' ' VAL . . . . . 0.525 ' O ' ' N ' ' A' ' 111' ' ' ASN . 16.7 m -70.85 -43.82 76.63 Favored 'Isoleucine or valine' 0 C--N 1.348 0.53 0 CA-C-O 121.993 0.901 . . . . 1.0 108.873 -179.574 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 109' ' ' ILE . . . . . 0.604 HG23 ' HD3' ' A' ' 110' ' ' PRO . 0.0 OUTLIER -39.06 -46.72 3.62 Favored Pre-proline 0 CA--C 1.553 1.065 0 CA-C-N 114.2 -1.364 . . . . 1.0 109.919 -178.179 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 110' ' ' PRO . . . . . 0.826 ' HD2' ' O ' ' A' ' 107' ' ' THR . 28.1 Cg_exo -64.43 -24.27 64.27 Favored 'Trans proline' 0 N--CA 1.504 2.108 0 C-N-CA 124.44 3.427 . . . . 1.0 111.871 177.675 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 111' ' ' ASN . . . . . 0.525 ' N ' ' O ' ' A' ' 108' ' ' VAL . 2.9 t-20 -62.3 -69.04 0.28 Allowed 'General case' 0 C--O 1.236 0.374 0 CA-C-N 115.996 -0.547 . . . . 1.0 109.74 -179.007 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 112' ' ' ILE . . . . . 0.505 ' O ' ' N ' ' A' ' 115' ' ' ALA . 0.0 OUTLIER -67.43 -36.55 76.78 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.538 0 CA-C-O 121.924 0.869 . . . . 1.0 110.13 178.777 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 113' ' ' ASN . . . . . 0.456 ' O ' ' HB3' ' A' ' 117' ' ' GLU . 10.3 t30 -48.27 -52.42 21.32 Favored 'General case' 0 C--N 1.309 -1.165 0 N-CA-C 107.266 -1.383 . . . . 1.0 107.266 -178.264 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -62.2 -24.72 67.38 Favored 'General case' 0 N--CA 1.451 -0.419 0 CA-C-N 116.378 -0.374 . . . . 1.0 110.432 177.307 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 115' ' ' ALA . . . . . 0.505 ' N ' ' O ' ' A' ' 112' ' ' ILE . . . -77.07 -59.1 2.92 Favored 'General case' 0 C--O 1.235 0.292 0 C-N-CA 119.957 -0.697 . . . . 1.0 110.799 178.419 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 116' ' ' ILE . . . . . 0.64 HG23 ' N ' ' A' ' 117' ' ' GLU . 11.5 tt -67.31 -50.54 61.79 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.571 0 CA-C-O 120.983 0.42 . . . . 1.0 110.906 -178.378 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 117' ' ' GLU . . . . . 0.64 ' N ' HG23 ' A' ' 116' ' ' ILE . 23.6 tt0 -42.63 -60.47 1.54 Allowed 'General case' 0 C--O 1.244 0.794 0 N-CA-C 108.074 -1.084 . . . . 1.0 108.074 -177.471 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 18.7 t -51.71 -23.48 3.38 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.086 0 CA-C-N 114.261 -1.336 . . . . 1.0 109.357 177.662 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 119' ' ' LEU . . . . . 0.623 ' N ' ' O ' ' A' ' 116' ' ' ILE . 2.5 tp -81.68 -62.67 1.58 Allowed 'General case' 0 C--N 1.344 0.328 0 C-N-CA 120.304 -0.558 . . . . 1.0 111.468 179.108 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -67.6 -86.77 0.08 OUTLIER Glycine 0 C--N 1.355 1.622 0 C-N-CA 117.421 -2.323 . . . . 1.0 110.417 179.756 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 38.3 m -162.61 -25.45 0.04 OUTLIER 'General case' 0 C--N 1.32 -0.682 0 N-CA-C 107.364 -1.347 . . . . 1.0 107.364 -179.962 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 122' ' ' GLY . . . . . 0.479 ' O ' ' N ' ' A' ' 124' ' ' ASP . . . 114.32 -35.79 4.28 Favored Glycine 0 C--N 1.347 1.152 0 C-N-CA 125.32 1.438 . . . . 1.0 113.539 178.907 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 123' ' ' THR . . . . . 0.458 HG23 ' O ' ' A' ' 123' ' ' THR . 1.8 t -33.21 92.12 0.01 OUTLIER 'General case' 0 N--CA 1.473 0.705 0 CA-C-N 120.124 1.962 . . . . 1.0 113.344 -179.124 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 124' ' ' ASP . . . . . 0.479 ' N ' ' O ' ' A' ' 122' ' ' GLY . 22.6 m-20 -142.65 143.22 32.27 Favored 'General case' 0 C--N 1.328 -0.344 0 N-CA-C 108.49 -0.93 . . . . 1.0 108.49 177.655 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 125' ' ' TYR . . . . . . . . . . . . . 11.2 t80 -148.64 143.19 26.37 Favored 'General case' 0 CA--C 1.536 0.412 0 N-CA-C 109.247 -0.649 . . . . 1.0 109.247 -179.591 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 4.0 mmp_? -151.76 155.15 37.67 Favored 'General case' 0 CA--C 1.535 0.372 0 CA-C-N 116.259 -0.428 . . . . 1.0 110.59 178.54 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 127' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--O 1.218 -0.576 0 CA-C-O 118.193 -0.908 . . . . 1.0 109.726 178.476 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 24.5 mmt . . . . . 0 N--CA 1.495 1.802 0 N-CA-C 109.081 -0.711 . . . . 1.0 109.081 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 2' ' ' SER . . . . . 0.438 ' O ' ' OD1' ' A' ' 3' ' ' ASP . 58.3 p -108.84 11.23 26.29 Favored 'General case' 0 N--CA 1.469 0.495 0 C-N-CA 122.957 0.503 . . . . 1.0 110.247 179.489 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 3' ' ' ASP . . . . . 0.438 ' OD1' ' O ' ' A' ' 2' ' ' SER . 2.2 m-20 166.67 91.54 0.0 OUTLIER 'General case' 0 N--CA 1.468 0.429 0 CA-C-N 116.321 -0.4 . . . . 1.0 110.044 179.615 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 76.2 t80 -147.98 143.68 27.46 Favored 'General case' 0 C--N 1.332 -0.156 0 N-CA-C 109.993 -0.373 . . . . 1.0 109.993 179.364 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 5' ' ' ASP . . . . . 0.451 ' N ' ' OD1' ' A' ' 5' ' ' ASP . 0.3 OUTLIER -153.38 149.0 27.36 Favored 'General case' 0 CA--C 1.534 0.359 0 CA-C-N 116.657 -0.247 . . . . 1.0 110.361 -178.916 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 6' ' ' THR . . . . . 0.733 ' O ' ' N ' ' A' ' 10' ' ' SER . 62.6 p -70.39 -178.56 1.77 Allowed 'General case' 0 C--O 1.202 -1.439 0 C-N-CA 121.155 -0.218 . . . . 1.0 110.838 179.888 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . 0.483 ' O ' ' N ' ' A' ' 11' ' ' ARG . 0.0 OUTLIER -58.71 -56.14 25.99 Favored 'General case' 0 N--CA 1.48 1.025 0 CA-C-O 121.645 0.736 . . . . 1.0 110.785 -177.631 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 8' ' ' ARG . . . . . 0.806 ' O ' ' HB3' ' A' ' 12' ' ' ALA . 65.1 ttt180 -50.95 -56.49 12.15 Favored 'General case' 0 C--N 1.32 -0.716 0 N-CA-C 106.723 -1.584 . . . . 1.0 106.723 -178.562 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . 0.577 ' O ' ' CG2' ' A' ' 13' ' ' VAL . 48.7 t -65.91 -49.72 75.0 Favored 'Isoleucine or valine' 0 C--O 1.2 -1.514 0 CA-C-N 113.641 -1.618 . . . . 1.0 110.761 179.136 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 10' ' ' SER . . . . . 0.733 ' N ' ' O ' ' A' ' 6' ' ' THR . 38.9 t -67.68 -65.41 0.69 Allowed 'General case' 0 N--CA 1.478 0.97 0 O-C-N 121.585 -0.697 . . . . 1.0 112.436 -178.391 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 11' ' ' ARG . . . . . 0.52 ' O ' ' N ' ' A' ' 15' ' ' ALA . 21.6 ttt180 -65.38 -58.61 5.44 Favored 'General case' 0 N--CA 1.467 0.399 0 C-N-CA 120.749 -0.381 . . . . 1.0 111.491 -175.966 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . 0.806 ' HB3' ' O ' ' A' ' 8' ' ' ARG . . . -49.82 -49.2 49.8 Favored 'General case' 0 N--CA 1.473 0.703 0 N-CA-C 106.449 -1.686 . . . . 1.0 106.449 -176.937 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . 0.577 ' CG2' ' O ' ' A' ' 9' ' ' VAL . 93.9 t -60.71 -48.55 88.26 Favored 'Isoleucine or valine' 0 C--O 1.202 -1.412 0 C-N-CA 118.061 -1.456 . . . . 1.0 108.149 176.745 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . 0.667 ' O ' HG13 ' A' ' 18' ' ' VAL . . . -57.25 -61.96 2.1 Favored 'General case' 0 C--O 1.211 -0.934 0 C-N-CA 118.088 -1.445 . . . . 1.0 109.636 -179.849 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . 0.527 ' O ' ' N ' ' A' ' 19' ' ' GLY . . . -52.42 -54.64 29.43 Favored 'General case' 0 N--CA 1.473 0.721 0 CA-C-O 121.702 0.763 . . . . 1.0 109.857 -178.342 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . 0.567 ' C ' ' H ' ' A' ' 22' ' ' GLY . . . -61.88 -55.11 33.16 Favored 'General case' 0 C--N 1.309 -1.154 0 CA-C-N 114.57 -1.196 . . . . 1.0 109.051 -179.023 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . 0.567 ' N ' ' O ' ' A' ' 13' ' ' VAL . 6.7 tp -56.41 -53.22 59.94 Favored 'General case' 0 N--CA 1.478 0.96 0 CA-C-N 113.726 -1.579 . . . . 1.0 108.638 -177.504 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . 0.667 HG13 ' O ' ' A' ' 14' ' ' ALA . 3.5 m -68.02 -56.43 12.89 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.258 0 N-CA-C 108.63 -0.878 . . . . 1.0 108.63 179.262 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . 0.527 ' N ' ' O ' ' A' ' 15' ' ' ALA . . . -64.77 -171.69 2.81 Favored Glycine 0 CA--C 1.521 0.423 0 N-CA-C 110.28 -1.128 . . . . 1.0 110.28 179.571 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 20' ' ' PRO . . . . . 0.657 ' O ' ' N ' ' A' ' 24' ' ' ALA . 43.7 Cg_endo -80.63 -21.37 7.31 Favored 'Trans proline' 0 C--N 1.301 -1.942 0 C-N-CA 122.115 1.876 . . . . 1.0 113.097 -179.316 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -56.73 -58.13 16.03 Favored Glycine 0 CA--C 1.535 1.33 0 C-N-CA 119.488 -1.339 . . . . 1.0 110.355 -177.725 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . 0.567 ' H ' ' C ' ' A' ' 16' ' ' ALA . . . -62.68 -53.1 43.79 Favored Glycine 0 N--CA 1.471 0.976 0 N-CA-C 108.13 -1.988 . . . . 1.0 108.13 -179.845 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . 0.705 ' O ' HG12 ' A' ' 27' ' ' VAL . 0.5 OUTLIER -56.44 -38.38 55.76 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.737 0 N-CA-C 108.316 -0.994 . . . . 1.0 108.316 -179.411 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . 0.657 ' N ' ' O ' ' A' ' 20' ' ' PRO . . . -58.14 -59.99 4.44 Favored 'General case' 0 N--CA 1.468 0.436 0 C-N-CA 119.484 -0.886 . . . . 1.0 109.652 -179.301 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -62.74 -42.57 99.73 Favored 'General case' 0 CA--C 1.519 -0.217 0 C-N-CA 119.685 -0.806 . . . . 1.0 111.041 -178.642 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 69.9 t -61.93 -61.11 1.76 Allowed 'Isoleucine or valine' 0 N--CA 1.448 -0.536 0 C-N-CA 118.606 -1.238 . . . . 1.0 110.711 -178.33 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . 0.705 HG12 ' O ' ' A' ' 23' ' ' VAL . 9.8 p -60.21 -37.6 74.1 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.333 0 N-CA-C 112.749 0.648 . . . . 1.0 112.749 -176.706 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . 0.412 ' N ' HG13 ' A' ' 27' ' ' VAL . 59.8 tttm -69.0 -54.11 16.95 Favored 'General case' 0 C--N 1.315 -0.895 0 CA-C-O 121.815 0.816 . . . . 1.0 109.378 -178.916 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 95.0 t -64.17 -49.26 82.1 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.83 0 CA-C-N 114.216 -1.357 . . . . 1.0 110.29 -177.7 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 30' ' ' CYS . . . . . . . . . . . . . 44.5 t -67.03 -61.44 1.93 Allowed 'General case' 0 N--CA 1.444 -0.767 0 C-N-CA 119.07 -1.052 . . . . 1.0 110.416 -179.247 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . 0.655 ' HB3' ' O ' ' A' ' 27' ' ' VAL . . . -64.94 -53.79 40.81 Favored 'General case' 0 CA--C 1.514 -0.441 0 N-CA-C 112.726 0.639 . . . . 1.0 112.726 -175.427 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . 0.413 ' O ' ' CB ' ' A' ' 33' ' ' LEU . . . 89.05 72.02 1.27 Allowed Glycine 0 CA--C 1.522 0.506 0 N-CA-C 108.403 -1.879 . . . . 1.0 108.403 -177.446 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . 0.413 ' CB ' ' O ' ' A' ' 32' ' ' GLY . 6.1 tp 81.65 122.28 0.03 OUTLIER Pre-proline 0 CA--C 1.54 0.587 0 C-N-CA 122.858 0.463 . . . . 1.0 111.268 -179.547 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 39.8 Cg_endo -68.45 -18.36 43.69 Favored 'Trans proline' 0 N--CA 1.495 1.574 0 C-N-CA 121.433 1.422 . . . . 1.0 113.56 179.668 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -57.22 -61.03 7.97 Favored Glycine 0 C--N 1.338 0.677 0 C-N-CA 118.126 -1.987 . . . . 1.0 108.802 -179.022 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . 0.916 ' O ' HG22 ' A' ' 37' ' ' ILE . 9.0 p -69.25 -150.78 0.0 OUTLIER 'Isoleucine or valine' 0 C--O 1.215 -0.721 0 N-CA-C 106.057 -1.831 . . . . 1.0 106.057 177.869 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . 0.916 HG22 ' O ' ' A' ' 36' ' ' VAL . 6.8 tp 79.15 75.25 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.483 1.186 0 O-C-N 124.281 0.988 . . . . 1.0 112.597 179.444 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 10.3 m80 -136.23 130.46 33.14 Favored 'General case' 0 C--N 1.334 -0.08 0 O-C-N 120.858 -1.151 . . . . 1.0 108.653 177.619 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 39' ' ' THR . . . . . 0.501 ' OG1' ' NE ' ' A' ' 42' ' ' ARG . 20.0 p -110.19 144.54 30.28 Favored Pre-proline 0 N--CA 1.464 0.228 0 N-CA-C 109.65 -0.5 . . . . 1.0 109.65 -179.859 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 90.7 Cg_endo -73.27 -29.22 11.66 Favored 'Trans proline' 0 N--CA 1.493 1.497 0 C-N-CA 122.144 1.896 . . . . 1.0 113.425 -178.818 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -127.59 133.39 49.73 Favored 'General case' 0 N--CA 1.468 0.457 0 CA-C-N 116.767 -0.197 . . . . 1.0 110.786 179.123 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . 0.602 ' C ' ' H ' ' A' ' 44' ' ' GLY . 4.4 mtm180 -171.67 171.64 5.23 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-O 121.461 0.648 . . . . 1.0 109.529 176.391 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 43' ' ' ARG . . . . . 0.411 ' HG3' ' O ' ' A' ' 43' ' ' ARG . 0.0 OUTLIER -69.51 15.92 0.07 Allowed 'General case' 0 C--N 1.315 -0.898 0 CA-C-N 114.805 -1.089 . . . . 1.0 108.981 179.422 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . 0.602 ' H ' ' C ' ' A' ' 42' ' ' ARG . . . 93.9 -19.91 50.31 Favored Glycine 0 C--N 1.336 0.558 0 N-CA-C 110.035 -1.226 . . . . 1.0 110.035 179.232 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . 0.729 ' O ' ' HB2' ' A' ' 46' ' ' PHE . 1.1 p90 -167.23 169.08 12.88 Favored 'General case' 0 CA--C 1.538 0.485 0 N-CA-C 109.884 -0.414 . . . . 1.0 109.884 179.868 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 46' ' ' PHE . . . . . 0.729 ' HB2' ' O ' ' A' ' 45' ' ' PHE . 0.2 OUTLIER 148.12 71.24 0.0 OUTLIER 'General case' 0 N--CA 1.504 2.257 0 O-C-N 125.772 1.92 . . . . 1.0 110.176 178.555 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 47' ' ' ARG . . . . . 0.503 ' CB ' ' O ' ' A' ' 46' ' ' PHE . 4.2 mmt-85 142.94 142.87 0.0 OUTLIER 'General case' 0 N--CA 1.483 1.202 0 N-CA-C 108.831 -0.803 . . . . 1.0 108.831 179.082 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 1.8 t 70.75 68.6 0.19 Allowed 'General case' 0 N--CA 1.446 -0.661 0 N-CA-C 108.7 -0.852 . . . . 1.0 108.7 -179.594 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 49' ' ' ASN . . . . . 0.605 ' ND2' ' O ' ' A' ' 49' ' ' ASN . 3.2 p-10 -140.71 105.7 6.36 Favored Pre-proline 0 CA--C 1.54 0.579 0 N-CA-C 107.929 -1.137 . . . . 1.0 107.929 -179.89 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 50' ' ' PRO . . . . . 0.518 ' C ' ' H ' ' A' ' 52' ' ' ARG . 62.8 Cg_exo -49.72 68.64 0.02 OUTLIER 'Trans proline' 0 N--CA 1.505 2.174 0 C-N-CA 122.733 2.289 . . . . 1.0 114.533 -178.749 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . 0.6 ' N ' ' O ' ' A' ' 49' ' ' ASN . 42.6 mm-40 71.52 -23.13 0.19 Allowed 'General case' 0 N--CA 1.468 0.451 0 C-N-CA 122.636 0.375 . . . . 1.0 110.711 -179.695 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . 0.591 ' NH2' HH22 ' A' ' 126' ' ' ARG . 17.0 mmt180 -48.05 114.14 0.87 Allowed 'General case' 0 C--N 1.329 -0.319 0 N-CA-C 109.302 -0.629 . . . . 1.0 109.302 179.98 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . 0.466 ' O ' ' N ' ' A' ' 55' ' ' ILE . 21.5 tt -54.71 143.58 6.92 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-O 121.385 0.612 . . . . 1.0 110.482 -179.292 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 11.4 mm100 -64.65 77.64 0.04 OUTLIER 'General case' 0 C--N 1.318 -0.788 0 C-N-CA 119.123 -1.031 . . . . 1.0 109.683 -177.917 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . 0.466 ' N ' ' O ' ' A' ' 53' ' ' ILE . 3.2 tp -150.11 158.05 5.79 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.299 0 N-CA-C 110.406 -0.22 . . . . 1.0 110.406 178.179 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 113.44 -27.42 9.41 Favored Glycine 0 CA--C 1.519 0.296 0 N-CA-C 110.305 -1.118 . . . . 1.0 110.305 179.3 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . 0.453 ' OD1' ' N ' ' A' ' 57' ' ' ASP . 11.4 p-10 -57.43 101.95 0.08 Allowed 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 117.638 0.719 . . . . 1.0 110.254 179.529 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 58' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -86.25 176.06 8.14 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-O 122.526 1.155 . . . . 1.0 111.843 -179.169 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 59' ' ' ARG . . . . . 0.503 ' CG ' ' N ' ' A' ' 60' ' ' TYR . 22.2 ptt-85 -90.82 -56.38 3.2 Favored 'General case' 0 C--N 1.316 -0.884 0 CA-C-N 112.756 -2.02 . . . . 1.0 112.224 179.841 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 60' ' ' TYR . . . . . 0.503 ' N ' ' CG ' ' A' ' 59' ' ' ARG . 0.4 OUTLIER -91.22 -20.64 21.72 Favored 'General case' 0 C--O 1.247 0.967 0 CA-C-O 121.948 0.88 . . . . 1.0 113.046 -179.107 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 3.5 tt0 -79.21 -12.77 59.97 Favored 'General case' 0 N--CA 1.436 -1.157 0 N-CA-C 109.425 -0.583 . . . . 1.0 109.425 -179.893 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 62' ' ' VAL . . . . . 0.615 HG13 ' N ' ' A' ' 63' ' ' ALA . 6.1 p -46.84 -55.85 1.59 Allowed 'Isoleucine or valine' 0 C--O 1.212 -0.899 0 C-N-CA 119.656 -0.817 . . . . 1.0 109.811 -175.69 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 63' ' ' ALA . . . . . 0.615 ' N ' HG13 ' A' ' 62' ' ' VAL . . . -64.87 -54.63 27.96 Favored 'General case' 0 N--CA 1.435 -1.199 0 C-N-CA 120.177 -0.609 . . . . 1.0 109.509 -179.68 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 64' ' ' HIS . . . . . 0.424 ' O ' ' CG ' ' A' ' 67' ' ' ARG . 0.2 OUTLIER -48.45 -57.95 5.35 Favored 'General case' 0 CA--C 1.538 0.495 0 CA-C-N 115.484 -0.78 . . . . 1.0 110.153 -179.567 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 65' ' ' ASP . . . . . 0.659 ' C ' ' H ' ' A' ' 67' ' ' ARG . 0.8 OUTLIER -69.78 -46.49 65.65 Favored 'General case' 0 C--N 1.316 -0.858 0 CA-C-O 122.309 1.052 . . . . 1.0 110.222 179.19 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . 0.568 ' N ' ' O ' ' A' ' 62' ' ' VAL . . . -71.08 27.38 0.54 Allowed Glycine 0 N--CA 1.447 -0.621 0 N-CA-C 109.585 -1.406 . . . . 1.0 109.585 177.755 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 67' ' ' ARG . . . . . 0.697 ' O ' ' N ' ' A' ' 69' ' ' LEU . 14.5 mmt85 -74.9 1.26 13.16 Favored 'General case' 0 N--CA 1.441 -0.909 0 N-CA-C 107.87 -1.159 . . . . 1.0 107.87 176.23 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . 0.453 ' C ' ' O ' ' A' ' 67' ' ' ARG . 0.8 OUTLIER -33.05 -24.46 0.0 OUTLIER 'General case' 0 N--CA 1.475 0.79 0 O-C-N 123.745 0.653 . . . . 1.0 109.5 -175.99 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . 0.697 ' N ' ' O ' ' A' ' 67' ' ' ARG . 4.8 mp -67.31 -64.64 0.81 Allowed 'General case' 0 CA--C 1.54 0.571 0 C-N-CA 119.326 -0.95 . . . . 1.0 109.681 177.999 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . 0.664 ' C ' ' H ' ' A' ' 72' ' ' HIS . . . -80.53 -76.93 0.21 Allowed 'General case' 0 N--CA 1.473 0.685 0 N-CA-C 106.035 -1.839 . . . . 1.0 106.035 177.173 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 71' ' ' ALA . . . . . 0.473 ' HB3' ' CB ' ' A' ' 67' ' ' ARG . . . -42.6 0.59 0.0 OUTLIER 'General case' 0 N--CA 1.469 0.499 0 C-N-CA 124.631 1.173 . . . . 1.0 113.089 179.723 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 72' ' ' HIS . . . . . 0.664 ' H ' ' C ' ' A' ' 70' ' ' ALA . 1.2 p-80 -26.27 -58.71 0.08 Allowed 'General case' 0 C--N 1.342 0.251 0 C-N-CA 122.747 0.419 . . . . 1.0 111.541 -178.738 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 73' ' ' MET . . . . . 0.618 ' N ' ' CG ' ' A' ' 72' ' ' HIS . 49.5 mtt -75.37 -49.79 17.93 Favored 'General case' 0 C--N 1.321 -0.65 0 C-N-CA 120.545 -0.462 . . . . 1.0 109.878 177.408 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . 0.63 ' O ' ' N ' ' A' ' 76' ' ' GLY . 57.5 t -44.63 -42.07 2.19 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.167 0 CA-C-O 117.883 -1.056 . . . . 1.0 111.954 -175.409 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 75' ' ' ASN . . . . . 0.532 ' O ' HG23 ' A' ' 79' ' ' ILE . 40.7 t30 -40.13 -14.72 0.01 OUTLIER 'General case' 0 N--CA 1.478 0.938 0 CA-C-N 121.071 1.759 . . . . 1.0 112.195 176.796 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 76' ' ' GLY . . . . . 0.63 ' N ' ' O ' ' A' ' 74' ' ' VAL . . . -45.43 -24.04 0.95 Allowed Glycine 0 CA--C 1.539 1.566 0 N-CA-C 108.734 -1.746 . . . . 1.0 108.734 178.866 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 77' ' ' ILE . . . . . 0.535 ' O ' ' N ' ' A' ' 80' ' ' ALA . 2.2 pt -89.87 -61.62 1.86 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.719 0 CA-C-N 114.261 -0.97 . . . . 1.0 110.672 -178.837 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . 0.496 HG11 ' OD1' ' A' ' 65' ' ' ASP . 56.0 t -36.89 -29.91 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.448 -0.53 0 N-CA-C 109.267 -0.642 . . . . 1.0 109.267 -177.27 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . 0.82 ' O ' ' HB3' ' A' ' 83' ' ' ALA . 2.5 pt -64.75 -52.75 50.51 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.03 0 C-N-CA 119.151 -1.02 . . . . 1.0 109.626 178.786 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 80' ' ' ALA . . . . . 0.544 ' N ' ' CG1' ' A' ' 79' ' ' ILE . . . -55.86 -63.42 1.18 Allowed 'General case' 0 C--O 1.214 -0.768 0 C-N-CA 118.245 -1.382 . . . . 1.0 111.156 -178.489 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 47.5 mt-10 -50.1 -71.18 0.07 Allowed 'General case' 0 CA--C 1.531 0.216 0 C-N-CA 119.587 -0.845 . . . . 1.0 110.335 -179.151 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 21.2 t70 -62.88 -63.88 1.08 Allowed 'General case' 0 C--N 1.323 -0.582 0 C-N-CA 118.529 -1.268 . . . . 1.0 109.953 -177.997 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . 0.82 ' HB3' ' O ' ' A' ' 79' ' ' ILE . . . -53.04 -13.97 0.54 Allowed 'General case' 0 CA--C 1.536 0.409 0 C-N-CA 118.672 -1.211 . . . . 1.0 111.043 -177.801 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . 0.491 ' HB2' ' O ' ' A' ' 80' ' ' ALA . 1.0 OUTLIER -40.73 -16.54 0.01 OUTLIER 'General case' 0 C--N 1.37 1.495 0 CA-C-N 120.463 1.483 . . . . 1.0 112.047 -179.756 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 85' ' ' ILE . . . . . 0.58 ' N ' ' O ' ' A' ' 83' ' ' ALA . 19.8 pt -62.25 -41.65 92.29 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.245 0 N-CA-C 109.123 -0.695 . . . . 1.0 109.123 179.806 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 86' ' ' ALA . . . . . 0.438 ' CB ' ' CZ ' ' A' ' 52' ' ' ARG . . . -97.07 -2.7 42.74 Favored 'General case' 0 CA--C 1.539 0.523 0 C-N-CA 123.286 0.634 . . . . 1.0 112.506 179.896 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 34.1 tp10 -51.25 -20.89 1.79 Allowed 'General case' 0 C--N 1.32 -0.709 0 CA-C-N 115.307 -0.86 . . . . 1.0 109.842 -179.927 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -123.18 14.63 9.77 Favored 'General case' 0 N--CA 1.475 0.816 0 CA-C-O 121.459 0.647 . . . . 1.0 109.792 178.765 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 89' ' ' VAL . . . . . 0.595 ' O ' HG12 ' A' ' 89' ' ' VAL . 24.1 t -109.01 29.24 1.48 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.453 0 CA-C-N 114.579 -1.191 . . . . 1.0 109.655 177.861 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 90' ' ' GLY . . . . . 0.534 ' N ' ' CD ' ' A' ' 91' ' ' PRO . . . -68.78 -43.2 76.07 Favored Glycine 0 CA--C 1.525 0.694 0 N-CA-C 109.632 -1.387 . . . . 1.0 109.632 177.156 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 91' ' ' PRO . . . . . 0.534 ' CD ' ' N ' ' A' ' 90' ' ' GLY . 81.7 Cg_exo -45.71 -14.09 0.1 OUTLIER 'Trans proline' 0 N--CA 1.489 1.217 0 C-N-CA 121.686 1.591 . . . . 1.0 110.686 178.733 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 92' ' ' HIS . . . . . 0.671 ' CD2' HH21 ' A' ' 95' ' ' ARG . 40.9 t-80 -57.1 -17.38 10.32 Favored 'General case' 0 C--O 1.204 -1.32 0 N-CA-C 107.941 -1.133 . . . . 1.0 107.941 -179.886 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 93' ' ' LEU . . . . . 0.703 HD12 ' N ' ' A' ' 94' ' ' ALA . 2.9 pp -62.41 -55.7 25.33 Favored 'General case' 0 C--N 1.325 -0.468 0 N-CA-C 109.081 -0.711 . . . . 1.0 109.081 178.083 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 94' ' ' ALA . . . . . 0.703 ' N ' HD12 ' A' ' 93' ' ' LEU . . . -57.92 -52.52 65.14 Favored 'General case' 0 CA--C 1.513 -0.46 0 N-CA-C 108.64 -0.874 . . . . 1.0 108.64 179.476 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 95' ' ' ARG . . . . . 0.671 HH21 ' CD2' ' A' ' 92' ' ' HIS . 18.3 ttp180 -57.82 -58.37 8.65 Favored 'General case' 0 N--CA 1.446 -0.633 0 N-CA-C 106.692 -1.596 . . . . 1.0 106.692 178.482 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 96' ' ' ALA . . . . . 1.005 ' O ' ' N ' ' A' ' 98' ' ' GLY . . . -47.36 -10.95 0.02 OUTLIER 'General case' 0 C--N 1.299 -1.625 0 O-C-N 118.887 -2.383 . . . . 1.0 111.504 178.236 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 97' ' ' LEU . . . . . 0.734 HD12 ' N ' ' A' ' 98' ' ' GLY . 3.5 pp 9.49 -45.32 0.0 OUTLIER 'General case' 0 N--CA 1.475 0.796 0 C-N-CA 124.202 1.001 . . . . 1.0 112.177 -164.879 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 98' ' ' GLY . . . . . 1.005 ' N ' ' O ' ' A' ' 96' ' ' ALA . . . -53.33 -23.71 19.64 Favored Glycine 0 C--N 1.295 -1.736 0 N-CA-C 106.423 -2.671 . . . . 1.0 106.423 173.269 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 99' ' ' GLN . . . . . 0.536 ' HB2' ' HB3' ' A' ' 96' ' ' ALA . 1.1 tp-100 -58.27 -21.17 47.64 Favored 'General case' 0 C--N 1.367 1.346 0 N-CA-C 106.523 -1.658 . . . . 1.0 106.523 177.167 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 100' ' ' ILE . . . . . 0.661 ' N ' ' O ' ' A' ' 97' ' ' LEU . 84.3 mt -65.72 -42.49 92.64 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.925 0 CA-C-N 113.51 -1.677 . . . . 1.0 109.532 178.0 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 101' ' ' VAL . . . . . 0.601 HG13 ' N ' ' A' ' 102' ' ' CYS . 2.8 p -52.74 -62.84 0.55 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.383 0 C-N-CA 119.03 -1.068 . . . . 1.0 111.647 -177.055 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 102' ' ' CYS . . . . . 0.898 ' O ' ' HB2' ' A' ' 106' ' ' ALA . 0.8 OUTLIER -49.77 -22.5 1.44 Allowed 'General case' 0 C--N 1.316 -0.849 0 N-CA-C 112.421 0.526 . . . . 1.0 112.421 -177.572 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 60.1 ttt-85 -85.2 -46.89 10.64 Favored 'General case' 0 N--CA 1.482 1.146 0 CA-C-O 122.303 1.049 . . . . 1.0 112.344 179.584 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 104' ' ' TYR . . . . . 0.714 ' O ' ' CG ' ' A' ' 104' ' ' TYR . 0.0 OUTLIER -96.53 19.67 11.88 Favored 'General case' 0 C--N 1.308 -1.234 0 CA-C-N 113.341 -1.754 . . . . 1.0 109.539 178.591 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 105' ' ' GLY . . . . . 0.481 ' O ' ' HB3' ' A' ' 106' ' ' ALA . . . -153.06 -85.28 0.05 OUTLIER Glycine 0 C--N 1.342 0.888 1 N-CA-C 102.268 -4.333 . . . . 1.0 102.268 175.955 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 106' ' ' ALA . . . . . 0.898 ' HB2' ' O ' ' A' ' 102' ' ' CYS . . . 73.99 60.41 0.08 Allowed 'General case' 0 C--O 1.206 -1.232 0 N-CA-C 115.046 1.499 . . . . 1.0 115.046 176.568 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 75.6 m -82.53 -57.38 3.37 Favored 'General case' 0 CA--C 1.548 0.887 0 O-C-N 120.859 -1.151 . . . . 1.0 109.649 179.866 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 27.2 m -66.44 -7.17 5.1 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.056 0 CA-C-O 121.565 0.698 . . . . 1.0 111.525 -179.59 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 1.5 mp -83.16 -64.18 0.25 Allowed Pre-proline 0 CA--C 1.55 0.975 0 CA-C-N 114.607 -1.179 . . . . 1.0 111.401 -179.831 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 110' ' ' PRO . . . . . 0.709 ' CD ' ' O ' ' A' ' 106' ' ' ALA . 58.6 Cg_endo -66.35 -33.95 36.7 Favored 'Trans proline' 0 N--CA 1.504 2.115 0 C-N-CA 124.407 3.405 . . . . 1.0 113.131 179.753 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 111' ' ' ASN . . . . . 0.436 ' C ' ' N ' ' A' ' 113' ' ' ASN . 39.8 t30 -66.48 -67.73 0.43 Allowed 'General case' 0 C--O 1.237 0.417 0 C-N-CA 120.61 -0.436 . . . . 1.0 110.029 -178.012 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 7.4 mm -51.93 -22.2 2.69 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.639 0 CA-C-O 122.135 0.969 . . . . 1.0 108.511 178.651 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 113' ' ' ASN . . . . . 0.492 ' O ' HG22 ' A' ' 116' ' ' ILE . 0.9 OUTLIER -61.25 -53.3 58.62 Favored 'General case' 0 C--N 1.305 -1.34 0 CA-C-N 113.358 -1.746 . . . . 1.0 108.174 -178.188 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -55.52 -29.23 58.51 Favored 'General case' 0 C--N 1.313 -1.011 0 O-C-N 120.668 -1.27 . . . . 1.0 111.775 -179.617 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -83.29 -50.09 8.74 Favored 'General case' 0 C--O 1.212 -0.89 0 CA-C-O 121.777 0.798 . . . . 1.0 111.584 177.527 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 116' ' ' ILE . . . . . 0.556 ' CG2' ' N ' ' A' ' 117' ' ' GLU . 1.5 tp -46.21 -53.93 2.27 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.704 0 CA-C-N 114.194 -1.367 . . . . 1.0 107.676 -179.005 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 117' ' ' GLU . . . . . 0.556 ' N ' ' CG2' ' A' ' 116' ' ' ILE . 44.2 tt0 -40.05 -50.95 2.6 Favored 'General case' 0 N--CA 1.478 0.928 0 N-CA-C 105.034 -2.21 . . . . 1.0 105.034 -178.812 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 43.3 t -70.26 -53.16 24.39 Favored 'Isoleucine or valine' 0 CA--C 1.558 1.286 0 CA-C-N 113.3 -1.773 . . . . 1.0 111.08 178.192 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 119' ' ' LEU . . . . . 0.502 ' O ' HD13 ' A' ' 119' ' ' LEU . 0.1 OUTLIER -59.65 -24.87 64.22 Favored 'General case' 0 N--CA 1.482 1.138 0 N-CA-C 115.145 1.535 . . . . 1.0 115.145 -177.268 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -135.71 -48.43 0.08 OUTLIER Glycine 0 CA--C 1.542 1.759 0 CA-C-N 120.418 1.463 . . . . 1.0 113.035 177.234 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 1.2 m 160.56 -39.38 0.0 OUTLIER 'General case' 0 N--CA 1.468 0.472 0 N-CA-C 101.414 -3.55 . . . . 1.0 101.414 -177.268 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 122' ' ' GLY . . . . . 0.444 ' HA2' HG23 ' A' ' 116' ' ' ILE . . . 115.06 -32.89 5.57 Favored Glycine 0 CA--C 1.526 0.748 0 CA-C-N 111.114 -2.766 . . . . 1.0 116.869 175.638 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 123' ' ' THR . . . . . 0.44 ' C ' ' O ' ' A' ' 122' ' ' GLY . 43.8 m -40.63 98.35 0.01 OUTLIER 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 121.225 2.513 . . . . 1.0 112.967 -178.661 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 124' ' ' ASP . . . . . 0.441 ' N ' ' O ' ' A' ' 122' ' ' GLY . 31.8 m-20 -137.21 138.4 40.13 Favored 'General case' 0 N--CA 1.465 0.284 0 N-CA-C 107.207 -1.405 . . . . 1.0 107.207 177.112 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 125' ' ' TYR . . . . . 0.47 ' O ' ' CD1' ' A' ' 125' ' ' TYR . 0.1 OUTLIER -155.34 153.74 30.96 Favored 'General case' 0 CA--C 1.537 0.481 0 CA-C-O 121.18 0.514 . . . . 1.0 110.719 -179.581 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 126' ' ' ARG . . . . . 0.591 HH22 ' NH2' ' A' ' 52' ' ' ARG . 4.4 mtp85 -150.42 153.89 36.75 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.324 -0.853 . . . . 1.0 111.506 177.467 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 127' ' ' PHE . . . . . . . . . . . . . 47.3 p90 . . . . . 0 C--O 1.22 -0.451 0 CA-C-O 117.931 -1.033 . . . . 1.0 110.489 -179.474 . . . . . . . . 0 0 . 1 . 021 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 20.1 mmt . . . . . 0 N--CA 1.493 1.679 0 N-CA-C 108.779 -0.822 . . . . 1.0 108.779 . . . . . . . . . 0 0 . 1 . 021 nuclear nobuild core ' A' A ' 2' ' ' SER . . . . . 0.431 ' O ' ' OD2' ' A' ' 3' ' ' ASP . 50.6 m -107.77 8.78 29.0 Favored 'General case' 0 N--CA 1.466 0.329 0 C-N-CA 122.322 0.249 . . . . 1.0 110.544 179.943 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 3' ' ' ASP . . . . . 0.431 ' OD2' ' O ' ' A' ' 2' ' ' SER . 0.4 OUTLIER 169.59 93.99 0.0 OUTLIER 'General case' 0 CA--C 1.534 0.338 0 N-CA-C 110.284 -0.265 . . . . 1.0 110.284 179.966 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 70.4 t80 -150.15 144.53 25.74 Favored 'General case' 0 N--CA 1.466 0.353 0 N-CA-C 110.228 -0.286 . . . . 1.0 110.228 179.587 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 47.9 m-20 -153.07 149.26 27.94 Favored 'General case' 0 N--CA 1.465 0.309 0 N-CA-C 110.233 -0.284 . . . . 1.0 110.233 179.888 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 6' ' ' THR . . . . . 0.669 HG22 ' H ' ' A' ' 7' ' ' GLU . 11.2 m -69.07 174.48 4.52 Favored 'General case' 0 C--O 1.205 -1.267 0 N-CA-C 109.793 -0.447 . . . . 1.0 109.793 179.774 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . 0.669 ' H ' HG22 ' A' ' 6' ' ' THR . 39.6 tt0 -61.55 -55.59 29.28 Favored 'General case' 0 C--N 1.317 -0.847 0 CA-C-O 121.475 0.655 . . . . 1.0 110.349 -177.822 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 8' ' ' ARG . . . . . 0.544 ' O ' ' CB ' ' A' ' 12' ' ' ALA . 7.4 ttp-105 -51.27 -57.81 7.86 Favored 'General case' 0 C--O 1.209 -1.072 0 N-CA-C 107.788 -1.19 . . . . 1.0 107.788 -178.188 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . 0.762 ' O ' HG13 ' A' ' 13' ' ' VAL . 0.0 OUTLIER -66.14 -47.0 86.19 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.071 0 CA-C-N 114.435 -1.257 . . . . 1.0 110.99 179.554 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 10' ' ' SER . . . . . 0.606 ' N ' ' O ' ' A' ' 6' ' ' THR . 35.4 t -62.93 -59.06 5.35 Favored 'General case' 0 N--CA 1.482 1.155 0 N-CA-C 108.582 -0.895 . . . . 1.0 108.582 179.636 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 11' ' ' ARG . . . . . 0.526 ' N ' ' O ' ' A' ' 7' ' ' GLU . 20.9 ttm180 -66.09 -55.06 18.4 Favored 'General case' 0 C--N 1.314 -0.944 0 O-C-N 121.732 -0.605 . . . . 1.0 110.815 -178.06 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . 0.544 ' CB ' ' O ' ' A' ' 8' ' ' ARG . . . -49.64 -53.31 24.93 Favored 'General case' 0 N--CA 1.485 1.276 0 C-N-CA 118.467 -1.293 . . . . 1.0 108.043 -176.566 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . 0.762 HG13 ' O ' ' A' ' 9' ' ' VAL . 4.5 m -60.58 -47.34 93.25 Favored 'Isoleucine or valine' 0 C--O 1.203 -1.377 0 C-N-CA 118.067 -1.453 . . . . 1.0 107.342 178.204 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . 0.779 ' O ' HG13 ' A' ' 18' ' ' VAL . . . -56.31 -62.11 1.94 Allowed 'General case' 0 C--O 1.206 -1.201 0 C-N-CA 117.062 -1.855 . . . . 1.0 109.706 179.645 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . 0.595 ' O ' ' N ' ' A' ' 19' ' ' GLY . . . -54.14 -56.26 19.91 Favored 'General case' 0 N--CA 1.472 0.659 0 CA-C-O 121.474 0.654 . . . . 1.0 110.097 -178.246 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . 0.668 ' HB1' ' CA ' ' A' ' 22' ' ' GLY . . . -62.28 -56.01 22.68 Favored 'General case' 0 CA--C 1.552 1.037 0 CA-C-N 115.25 -0.886 . . . . 1.0 109.281 -179.419 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . 0.661 ' O ' HD23 ' A' ' 17' ' ' LEU . 4.3 tt -57.17 -52.43 65.36 Favored 'General case' 0 N--CA 1.484 1.244 0 CA-C-N 114.675 -1.148 . . . . 1.0 108.275 -177.965 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . 0.779 HG13 ' O ' ' A' ' 14' ' ' ALA . 2.8 m -69.26 -57.87 7.29 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.349 0 C-N-CA 119.737 -0.785 . . . . 1.0 109.806 179.095 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . 0.595 ' N ' ' O ' ' A' ' 15' ' ' ALA . . . -59.86 -175.84 1.08 Allowed Glycine 0 N--CA 1.447 -0.585 0 N-CA-C 111.106 -0.798 . . . . 1.0 111.106 -179.261 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 20' ' ' PRO . . . . . 0.576 ' O ' ' N ' ' A' ' 24' ' ' ALA . 36.8 Cg_endo -83.47 -26.79 2.01 Favored 'Trans proline' 0 C--N 1.299 -2.044 0 C-N-CA 122.658 2.239 . . . . 1.0 112.988 -178.507 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . 0.46 ' O ' ' HB3' ' A' ' 24' ' ' ALA . . . -59.02 -58.65 13.41 Favored Glycine 0 N--CA 1.475 1.25 0 C-N-CA 120.066 -1.064 . . . . 1.0 111.536 -176.995 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . 0.668 ' CA ' ' HB1' ' A' ' 16' ' ' ALA . . . -55.96 -51.59 54.46 Favored Glycine 0 N--CA 1.474 1.23 0 N-CA-C 106.981 -2.448 . . . . 1.0 106.981 -178.158 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 47.9 t -59.56 -31.54 47.04 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.427 0 N-CA-C 108.735 -0.839 . . . . 1.0 108.735 178.792 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . 0.576 ' N ' ' O ' ' A' ' 20' ' ' PRO . . . -58.17 -63.09 1.38 Allowed 'General case' 0 C--N 1.348 0.502 0 C-N-CA 118.858 -1.137 . . . . 1.0 110.659 -178.742 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . 0.441 HD23 ' H ' ' A' ' 25' ' ' LEU . 0.1 OUTLIER -64.52 -43.37 94.28 Favored 'General case' 0 CA--C 1.517 -0.309 0 C-N-CA 119.858 -0.737 . . . . 1.0 111.814 -178.1 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 93.0 t -59.59 -59.63 3.64 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.544 0 C-N-CA 118.818 -1.153 . . . . 1.0 110.102 -177.927 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . 0.579 ' O ' ' HB3' ' A' ' 31' ' ' ALA . 0.6 OUTLIER -58.87 -34.76 53.33 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 O-C-N 122.235 -0.291 . . . . 1.0 111.1 -178.283 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 37.5 ttpt -67.16 -55.85 12.41 Favored 'General case' 0 C--N 1.325 -0.482 0 N-CA-C 109.391 -0.596 . . . . 1.0 109.391 -179.297 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 42.2 t -62.24 -47.82 91.32 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.605 0 CA-C-N 115.162 -0.926 . . . . 1.0 109.989 -179.07 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 30' ' ' CYS . . . . . . . . . . . . . 0.7 OUTLIER -67.47 -62.53 1.38 Allowed 'General case' 0 N--CA 1.446 -0.628 0 C-N-CA 119.052 -1.059 . . . . 1.0 110.841 -179.098 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . 0.579 ' HB3' ' O ' ' A' ' 27' ' ' VAL . . . -60.3 -51.61 68.82 Favored 'General case' 0 CA--C 1.506 -0.737 0 O-C-N 122.055 -0.403 . . . . 1.0 111.091 -176.697 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . 0.498 ' O ' ' HB2' ' A' ' 33' ' ' LEU . . . 84.66 75.04 1.23 Allowed Glycine 0 N--CA 1.442 -0.941 0 N-CA-C 109.828 -1.309 . . . . 1.0 109.828 -178.662 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . 0.498 ' HB2' ' O ' ' A' ' 32' ' ' GLY . 0.9 OUTLIER 87.21 100.39 0.03 OUTLIER Pre-proline 0 CA--C 1.549 0.917 0 C-N-CA 124.015 0.926 . . . . 1.0 110.654 -179.238 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 58.6 Cg_endo -71.4 -31.51 13.87 Favored 'Trans proline' 0 N--CA 1.502 1.997 0 C-N-CA 121.925 1.75 . . . . 1.0 114.807 -178.652 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -58.02 -58.96 11.85 Favored Glycine 0 N--CA 1.472 1.077 0 C-N-CA 118.466 -1.826 . . . . 1.0 108.957 -178.4 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . 0.587 HG22 ' N ' ' A' ' 37' ' ' ILE . 7.9 p -93.43 165.89 1.86 Allowed 'Isoleucine or valine' 0 CA--C 1.514 -0.415 0 N-CA-C 106.75 -1.574 . . . . 1.0 106.75 177.318 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . 0.587 ' N ' HG22 ' A' ' 36' ' ' VAL . 8.8 tp 115.81 121.57 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.476 0.842 0 O-C-N 124.523 1.139 . . . . 1.0 110.244 -179.841 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 0.9 OUTLIER -143.33 135.8 27.29 Favored 'General case' 0 CA--C 1.533 0.293 0 N-CA-C 109.146 -0.687 . . . . 1.0 109.146 179.461 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 10.4 m -111.47 111.2 55.11 Favored Pre-proline 0 N--CA 1.468 0.444 0 N-CA-C 109.55 -0.537 . . . . 1.0 109.55 179.266 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_exo -43.09 -85.83 0.01 OUTLIER 'Trans proline' 0 N--CA 1.491 1.366 0 C-N-CA 121.662 1.575 . . . . 1.0 112.834 -178.637 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -67.28 120.15 13.34 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 116.108 -0.496 . . . . 1.0 111.313 -177.784 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 3.6 ptm180 -174.04 175.39 2.77 Favored 'General case' 0 N--CA 1.448 -0.563 0 CA-C-N 116.101 -0.499 . . . . 1.0 110.01 178.46 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 5.3 tpt85 -57.53 -43.35 84.27 Favored 'General case' 0 C--N 1.32 -0.691 0 N-CA-C 107.452 -1.314 . . . . 1.0 107.452 179.919 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . 0.43 ' O ' ' CD1' ' A' ' 45' ' ' PHE . . . 121.5 -21.55 8.05 Favored Glycine 0 N--CA 1.465 0.613 0 N-CA-C 110.715 -0.954 . . . . 1.0 110.715 -179.127 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . 0.581 ' O ' ' HB2' ' A' ' 46' ' ' PHE . 42.6 m-85 -150.34 153.82 36.74 Favored 'General case' 0 C--O 1.216 -0.707 0 N-CA-C 109.006 -0.739 . . . . 1.0 109.006 177.795 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 46' ' ' PHE . . . . . 0.655 ' O ' ' HB2' ' A' ' 47' ' ' ARG . 8.6 m-85 128.59 96.33 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.582 0 O-C-N 124.939 1.399 . . . . 1.0 110.287 -179.933 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 47' ' ' ARG . . . . . 0.655 ' HB2' ' O ' ' A' ' 46' ' ' PHE . 0.7 OUTLIER 110.1 160.85 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.503 0 C-N-CA 125.464 1.506 . . . . 1.0 109.884 -179.809 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 0.9 OUTLIER 67.8 70.64 0.34 Allowed 'General case' 0 C--O 1.224 -0.246 0 N-CA-C 108.811 -0.811 . . . . 1.0 108.811 -178.455 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 49' ' ' ASN . . . . . 0.631 HD21 ' CG ' ' A' ' 54' ' ' GLN . 39.4 m-80 -136.13 129.37 17.93 Favored Pre-proline 0 CA--C 1.534 0.364 0 O-C-N 121.787 -0.571 . . . . 1.0 109.509 -178.979 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 50' ' ' PRO . . . . . 0.427 ' C ' ' N ' ' A' ' 52' ' ' ARG . 68.8 Cg_exo -46.75 74.57 0.01 OUTLIER 'Trans proline' 0 N--CA 1.498 1.78 0 C-N-CA 121.964 1.776 . . . . 1.0 113.476 179.927 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . 0.606 ' N ' ' O ' ' A' ' 49' ' ' ASN . 7.4 mm-40 48.84 14.09 0.07 Allowed 'General case' 0 C--N 1.331 -0.209 0 O-C-N 121.867 -0.521 . . . . 1.0 110.999 179.408 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . 0.427 ' N ' ' C ' ' A' ' 50' ' ' PRO . 1.4 ptp180 -116.45 162.23 17.88 Favored 'General case' 0 N--CA 1.472 0.65 0 CA-C-N 116.554 -0.294 . . . . 1.0 110.874 -179.573 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 19.4 tt -71.25 136.54 25.63 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.779 0 CA-C-O 123.508 1.623 . . . . 1.0 115.325 -177.146 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 54' ' ' GLN . . . . . 0.631 ' CG ' HD21 ' A' ' 49' ' ' ASN . 0.5 OUTLIER -74.93 87.6 2.31 Favored 'General case' 0 C--N 1.314 -0.973 0 CA-C-N 110.233 -3.167 . . . . 1.0 110.247 -178.985 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . 0.425 ' CG2' ' N ' ' A' ' 56' ' ' GLY . 5.9 mm -146.05 156.9 12.19 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.789 0 CA-C-N 115.703 -0.681 . . . . 1.0 109.883 177.495 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . 0.425 ' N ' ' CG2' ' A' ' 55' ' ' ILE . . . 110.52 -2.29 29.28 Favored Glycine 0 N--CA 1.475 1.243 0 N-CA-C 111.379 -0.688 . . . . 1.0 111.379 -179.897 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 13.9 p-10 -87.44 104.95 16.94 Favored 'General case' 0 N--CA 1.466 0.357 0 CA-C-O 121.396 0.617 . . . . 1.0 111.435 -179.815 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 58' ' ' TRP . . . . . . . . . . . . . 9.0 m0 -89.14 171.56 9.73 Favored 'General case' 0 CA--C 1.567 1.603 0 CA-C-O 122.941 1.353 . . . . 1.0 112.354 -178.634 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 59' ' ' ARG . . . . . 0.454 ' HE ' ' H ' ' A' ' 59' ' ' ARG . 0.0 OUTLIER -76.83 -61.71 1.88 Allowed 'General case' 0 N--CA 1.49 1.556 0 CA-C-N 111.12 -2.764 . . . . 1.0 113.902 -176.941 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 4.0 t80 -90.56 -9.03 48.64 Favored 'General case' 0 N--CA 1.484 1.23 0 CA-C-O 122.348 1.07 . . . . 1.0 112.753 -179.295 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . 0.477 ' O ' ' N ' ' A' ' 65' ' ' ASP . 2.7 tt0 -78.45 -14.48 59.35 Favored 'General case' 0 C--N 1.306 -1.3 0 CA-C-N 114.895 -1.048 . . . . 1.0 110.291 -179.637 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 62' ' ' VAL . . . . . 0.627 ' O ' ' N ' ' A' ' 66' ' ' GLY . 11.1 m -48.26 -55.79 2.63 Favored 'Isoleucine or valine' 0 C--O 1.204 -1.295 0 C-N-CA 119.566 -0.854 . . . . 1.0 109.241 -176.723 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 63' ' ' ALA . . . . . 0.587 ' H ' HG23 ' A' ' 62' ' ' VAL . . . -63.26 -54.65 34.01 Favored 'General case' 0 C--N 1.297 -1.677 0 O-C-N 121.588 -0.695 . . . . 1.0 109.359 179.438 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -50.56 -59.5 3.97 Favored 'General case' 0 CA--C 1.545 0.786 0 CA-C-N 115.342 -0.845 . . . . 1.0 110.234 -179.342 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 65' ' ' ASP . . . . . 0.591 ' C ' ' H ' ' A' ' 67' ' ' ARG . 26.8 t70 -72.42 -50.82 23.61 Favored 'General case' 0 C--N 1.312 -1.049 0 CA-C-O 121.91 0.862 . . . . 1.0 111.504 178.77 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . 0.627 ' N ' ' O ' ' A' ' 62' ' ' VAL . . . -69.96 29.5 0.41 Allowed Glycine 0 C--O 1.227 -0.329 0 O-C-N 120.986 -1.071 . . . . 1.0 111.046 177.661 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 67' ' ' ARG . . . . . 0.608 ' O ' ' N ' ' A' ' 69' ' ' LEU . 0.0 OUTLIER -77.96 8.41 4.73 Favored 'General case' 0 C--N 1.316 -0.856 0 N-CA-C 107.984 -1.117 . . . . 1.0 107.984 176.877 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . 0.646 HD23 ' N ' ' A' ' 68' ' ' LEU . 1.5 pt? -34.19 -27.96 0.01 OUTLIER 'General case' 0 N--CA 1.483 1.218 0 CA-C-O 121.757 0.789 . . . . 1.0 108.88 -178.158 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . 0.608 ' N ' ' O ' ' A' ' 67' ' ' ARG . 1.3 mt -64.57 -65.15 0.71 Allowed 'General case' 0 N--CA 1.473 0.715 0 C-N-CA 118.833 -1.147 . . . . 1.0 107.918 178.761 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . 0.653 ' C ' ' H ' ' A' ' 72' ' ' HIS . . . -78.22 -75.09 0.24 Allowed 'General case' 0 N--CA 1.469 0.494 0 N-CA-C 105.108 -2.182 . . . . 1.0 105.108 176.919 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 71' ' ' ALA . . . . . 0.46 ' O ' ' C ' ' A' ' 72' ' ' HIS . . . -44.87 4.1 0.0 OUTLIER 'General case' 0 CA--C 1.52 -0.209 0 C-N-CA 124.694 1.197 . . . . 1.0 113.425 178.57 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 72' ' ' HIS . . . . . 0.81 ' CD2' ' H ' ' A' ' 73' ' ' MET . 1.5 p80 -28.22 -55.05 0.11 Allowed 'General case' 0 C--N 1.335 -0.065 0 CA-C-N 118.067 0.394 . . . . 1.0 111.967 -179.408 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 73' ' ' MET . . . . . 0.81 ' H ' ' CD2' ' A' ' 72' ' ' HIS . 3.8 ppp? -76.84 -53.5 7.82 Favored 'General case' 0 C--N 1.316 -0.858 0 N-CA-C 108.483 -0.932 . . . . 1.0 108.483 177.278 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . 0.725 ' O ' ' N ' ' A' ' 76' ' ' GLY . 65.8 t -44.51 -41.87 2.1 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.424 0 CA-C-O 117.748 -1.12 . . . . 1.0 110.775 -176.122 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 75' ' ' ASN . . . . . 0.533 ' C ' ' N ' ' A' ' 77' ' ' ILE . 1.8 t-20 -35.09 -14.58 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.7 0 CA-C-N 120.857 1.662 . . . . 1.0 112.836 178.403 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 76' ' ' GLY . . . . . 0.725 ' N ' ' O ' ' A' ' 74' ' ' VAL . . . -44.04 -19.21 0.11 Allowed Glycine 0 CA--C 1.543 1.82 0 N-CA-C 107.846 -2.102 . . . . 1.0 107.846 175.917 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 77' ' ' ILE . . . . . 0.533 ' N ' ' C ' ' A' ' 75' ' ' ASN . 0.8 OUTLIER -72.11 -54.98 14.85 Favored 'Isoleucine or valine' 0 C--O 1.207 -1.138 0 N-CA-C 107.683 -1.228 . . . . 1.0 107.683 178.267 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . 0.528 ' C ' ' O ' ' A' ' 77' ' ' ILE . 55.5 t -33.52 -37.51 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.314 -0.973 0 CA-C-N 113.252 -1.795 . . . . 1.0 106.849 -178.391 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . 0.546 ' O ' ' HB3' ' A' ' 83' ' ' ALA . 23.7 pt -97.77 -34.49 4.76 Favored 'Isoleucine or valine' 0 C--O 1.207 -1.146 0 CA-C-N 115.287 -0.869 . . . . 1.0 112.005 176.846 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 80' ' ' ALA . . . . . 0.501 ' N ' ' O ' ' A' ' 77' ' ' ILE . . . -84.78 -9.35 58.27 Favored 'General case' 0 N--CA 1.482 1.151 0 O-C-N 120.955 -1.091 . . . . 1.0 113.588 179.674 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 81' ' ' GLU . . . . . 0.495 ' N ' ' O ' ' A' ' 77' ' ' ILE . 82.3 tt0 -90.63 -75.77 0.45 Allowed 'General case' 0 N--CA 1.453 -0.314 0 N-CA-C 113.572 0.953 . . . . 1.0 113.572 -176.769 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 6.7 m-20 -91.04 -16.71 27.46 Favored 'General case' 0 C--O 1.22 -0.45 0 N-CA-C 113.463 0.912 . . . . 1.0 113.463 -179.141 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . 0.546 ' HB3' ' O ' ' A' ' 79' ' ' ILE . . . -46.7 -42.21 16.24 Favored 'General case' 0 C--O 1.22 -0.479 0 C-N-CA 119.369 -0.933 . . . . 1.0 111.348 -177.681 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 14.3 tp -37.46 -46.02 0.77 Allowed 'General case' 0 N--CA 1.47 0.55 0 CA-C-O 121.48 0.657 . . . . 1.0 110.613 -178.349 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -65.46 -37.1 79.24 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.855 0 CA-C-N 114.75 -1.114 . . . . 1.0 110.564 -179.127 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 86' ' ' ALA . . . . . 0.527 ' N ' ' O ' ' A' ' 83' ' ' ALA . . . -90.61 -26.03 19.86 Favored 'General case' 0 C--O 1.222 -0.372 0 CA-C-O 120.641 0.258 . . . . 1.0 111.668 -179.762 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 87' ' ' GLU . . . . . 0.534 ' N ' ' O ' ' A' ' 83' ' ' ALA . 30.6 tp10 -54.71 -24.94 24.33 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 121.423 0.63 . . . . 1.0 109.659 -179.068 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -72.25 -8.56 55.48 Favored 'General case' 0 C--N 1.324 -0.503 0 N-CA-C 107.823 -1.177 . . . . 1.0 107.823 178.89 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 89' ' ' VAL . . . . . 0.494 ' N ' ' O ' ' A' ' 86' ' ' ALA . 3.2 t -92.49 36.03 0.1 OUTLIER 'Isoleucine or valine' 0 C--N 1.315 -0.909 0 CA-C-N 112.759 -2.019 . . . . 1.0 107.414 177.478 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 90' ' ' GLY . . . . . 0.902 ' O ' ' N ' ' A' ' 92' ' ' HIS . . . -55.82 -25.27 44.09 Favored Glycine 0 C--N 1.366 2.237 0 CA-C-O 117.346 -1.808 . . . . 1.0 112.082 176.955 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 91' ' ' PRO . . . . . 0.729 ' HD2' ' N ' ' A' ' 90' ' ' GLY . 20.8 Cg_exo -32.99 1.28 0.0 OUTLIER 'Trans proline' 0 N--CA 1.496 1.641 0 C-N-CA 123.41 2.74 . . . . 1.0 113.526 173.295 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 92' ' ' HIS . . . . . 0.902 ' N ' ' O ' ' A' ' 90' ' ' GLY . 0.0 OUTLIER -49.82 -33.27 16.2 Favored 'General case' 0 N--CA 1.431 -1.412 0 N-CA-C 106.91 -1.515 . . . . 1.0 106.91 178.346 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 24.8 tp -59.8 -57.1 14.35 Favored 'General case' 0 N--CA 1.453 -0.284 0 N-CA-C 107.537 -1.283 . . . . 1.0 107.537 177.396 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -51.72 -53.9 34.2 Favored 'General case' 0 C--N 1.323 -0.561 0 N-CA-C 107.953 -1.128 . . . . 1.0 107.953 -178.955 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 6.2 mmp_? -64.81 -32.93 74.85 Favored 'General case' 0 N--CA 1.47 0.562 0 CA-C-O 121.894 0.854 . . . . 1.0 110.911 178.225 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 96' ' ' ALA . . . . . 0.811 ' O ' ' N ' ' A' ' 100' ' ' ILE . . . -48.16 -39.2 20.02 Favored 'General case' 0 N--CA 1.493 1.711 0 N-CA-C 105.489 -2.041 . . . . 1.0 105.489 -177.31 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 97' ' ' LEU . . . . . 0.536 HD13 ' C ' ' A' ' 97' ' ' LEU . 1.6 tm? -33.14 -24.34 0.0 OUTLIER 'General case' 0 CA--C 1.576 1.957 0 CA-C-N 112.693 -2.049 . . . . 1.0 107.219 -179.798 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 98' ' ' GLY . . . . . 0.722 ' N ' ' O ' ' A' ' 96' ' ' ALA . . . -90.04 -53.69 2.31 Favored Glycine 0 CA--C 1.557 2.665 0 CA-C-O 123.033 1.352 . . . . 1.0 111.796 171.226 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 99' ' ' GLN . . . . . 0.6 ' N ' ' O ' ' A' ' 96' ' ' ALA . 0.1 OUTLIER -77.97 8.02 5.27 Favored 'General case' 0 N--CA 1.443 -0.803 0 N-CA-C 107.458 -1.312 . . . . 1.0 107.458 177.691 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 100' ' ' ILE . . . . . 0.811 ' N ' ' O ' ' A' ' 96' ' ' ALA . 3.8 tp -61.73 -52.03 65.71 Favored 'Isoleucine or valine' 0 CA--C 1.48 -1.744 0 N-CA-C 107.076 -1.453 . . . . 1.0 107.076 179.416 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 101' ' ' VAL . . . . . 0.613 ' N ' HG23 ' A' ' 100' ' ' ILE . 62.7 t -52.93 -57.09 5.07 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 N-CA-C 106.464 -1.68 . . . . 1.0 106.464 177.654 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 102' ' ' CYS . . . . . 0.97 ' O ' ' HB2' ' A' ' 106' ' ' ALA . 0.0 OUTLIER -46.43 -19.8 0.09 Allowed 'General case' 0 CA--C 1.541 0.606 0 C-N-CA 120.038 -0.665 . . . . 1.0 109.423 -179.226 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 103' ' ' ARG . . . . . 0.574 HH21 ' CB ' ' A' ' 96' ' ' ALA . 11.4 mtm-85 -94.13 -48.28 6.28 Favored 'General case' 0 N--CA 1.474 0.763 0 N-CA-C 113.793 1.035 . . . . 1.0 113.793 178.228 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 104' ' ' TYR . . . . . 0.57 ' O ' ' CG ' ' A' ' 104' ' ' TYR . 60.8 t80 -103.92 21.44 16.33 Favored 'General case' 0 C--N 1.32 -0.706 0 C-N-CA 125.724 1.61 . . . . 1.0 110.895 -179.73 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 105' ' ' GLY . . . . . 0.596 ' N ' ' O ' ' A' ' 101' ' ' VAL . . . -165.08 -8.03 0.03 OUTLIER Glycine 0 N--CA 1.453 -0.169 0 C-N-CA 119.606 -1.283 . . . . 1.0 111.072 -179.8 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 106' ' ' ALA . . . . . 0.97 ' HB2' ' O ' ' A' ' 102' ' ' CYS . . . -28.72 117.65 0.11 Allowed 'General case' 0 CA--C 1.534 0.362 0 C-N-CA 122.117 0.167 . . . . 1.0 111.06 178.671 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 107' ' ' THR . . . . . 0.981 ' O ' ' HD2' ' A' ' 110' ' ' PRO . 6.6 m -135.7 -58.35 0.77 Allowed 'General case' 0 C--O 1.195 -1.777 0 N-CA-C 107.787 -1.19 . . . . 1.0 107.787 178.616 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 26.9 m -70.28 28.66 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.312 -1.061 0 O-C-N 120.735 -1.228 . . . . 1.0 108.847 -178.39 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 109' ' ' ILE . . . . . 0.681 HG21 ' HB1' ' A' ' 106' ' ' ALA . 0.0 OUTLIER -111.01 -45.18 0.08 OUTLIER Pre-proline 0 CA--C 1.55 0.969 0 O-C-N 121.834 -0.542 . . . . 1.0 110.277 178.86 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 110' ' ' PRO . . . . . 0.981 ' HD2' ' O ' ' A' ' 107' ' ' THR . 24.6 Cg_exo -66.72 -29.12 43.26 Favored 'Trans proline' 0 N--CA 1.496 1.675 0 C-N-CA 123.453 2.769 . . . . 1.0 111.262 -178.7 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 4.9 t30 -68.35 -68.47 0.39 Allowed 'General case' 0 N--CA 1.455 -0.211 0 C-N-CA 120.405 -0.518 . . . . 1.0 109.847 -178.763 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 112' ' ' ILE . . . . . 0.41 HD13 HG21 ' A' ' 112' ' ' ILE . 21.3 pt -51.39 -28.57 8.15 Favored 'Isoleucine or valine' 0 C--O 1.217 -0.61 0 CA-C-O 122.623 1.202 . . . . 1.0 109.367 179.09 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 1.6 t30 -59.25 -51.89 68.01 Favored 'General case' 0 C--N 1.294 -1.814 0 CA-C-N 112.62 -2.082 . . . . 1.0 107.752 -177.855 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 114' ' ' ALA . . . . . 0.519 ' O ' HG23 ' A' ' 118' ' ' VAL . . . -59.59 -32.69 70.62 Favored 'General case' 0 N--CA 1.45 -0.464 0 N-CA-C 112.368 0.507 . . . . 1.0 112.368 -179.646 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -80.81 -53.47 6.46 Favored 'General case' 0 C--O 1.21 -0.977 0 CA-C-O 121.7 0.762 . . . . 1.0 110.398 178.141 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 116' ' ' ILE . . . . . 0.524 ' O ' ' N ' ' A' ' 120' ' ' GLY . 28.5 mt -50.32 -61.26 0.65 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.707 0 CA-C-N 114.143 -1.39 . . . . 1.0 108.6 -178.823 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 117' ' ' GLU . . . . . 0.422 ' C ' ' O ' ' A' ' 116' ' ' ILE . 49.2 mt-10 -42.16 -52.83 4.24 Favored 'General case' 0 C--N 1.307 -1.274 0 CA-C-N 112.239 -2.255 . . . . 1.0 106.791 -177.969 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 118' ' ' VAL . . . . . 0.519 HG23 ' O ' ' A' ' 114' ' ' ALA . 94.6 t -60.63 -53.05 54.3 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.492 0 N-CA-C 108.355 -0.98 . . . . 1.0 108.355 177.187 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 2.9 tp -51.29 -69.38 0.11 Allowed 'General case' 0 CA--C 1.536 0.414 0 N-CA-C 106.687 -1.597 . . . . 1.0 106.687 -178.775 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 120' ' ' GLY . . . . . 0.657 ' O ' ' OG1' ' A' ' 121' ' ' THR . . . -73.05 -84.59 0.25 Allowed Glycine 0 CA--C 1.537 1.419 0 C-N-CA 119.356 -1.402 . . . . 1.0 111.102 -179.555 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 121' ' ' THR . . . . . 0.657 ' OG1' ' O ' ' A' ' 120' ' ' GLY . 41.6 m 170.37 -39.72 0.0 OUTLIER 'General case' 0 N--CA 1.476 0.862 0 CA-C-N 113.649 -1.276 . . . . 1.0 112.67 179.156 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 122' ' ' GLY . . . . . 0.695 ' O ' ' N ' ' A' ' 124' ' ' ASP . . . 100.6 -18.78 54.64 Favored Glycine 0 N--CA 1.469 0.836 0 N-CA-C 106.815 -2.514 . . . . 1.0 106.815 -176.242 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 123' ' ' THR . . . . . 0.723 HG23 ' O ' ' A' ' 123' ' ' THR . 8.9 t -52.52 83.74 0.0 OUTLIER 'General case' 0 N--CA 1.477 0.875 0 N-CA-C 104.733 -2.321 . . . . 1.0 104.733 178.414 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 124' ' ' ASP . . . . . 0.695 ' N ' ' O ' ' A' ' 122' ' ' GLY . 4.9 m-20 -171.49 -175.43 1.61 Allowed 'General case' 0 CA--C 1.53 0.181 0 CA-C-N 113.976 -1.465 . . . . 1.0 111.434 179.523 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 125' ' ' TYR . . . . . . . . . . . . . 78.4 t80 -145.98 144.71 30.28 Favored 'General case' 0 CA--C 1.538 0.483 0 CA-C-N 114.749 -1.114 . . . . 1.0 109.011 175.813 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 36.4 mmt-85 -146.34 147.02 30.9 Favored 'General case' 0 N--CA 1.474 0.727 0 N-CA-C 109.794 -0.447 . . . . 1.0 109.794 179.848 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 127' ' ' PHE . . . . . 0.412 ' CD1' ' C ' ' A' ' 127' ' ' PHE . 0.1 OUTLIER . . . . . 0 C--O 1.221 -0.412 0 CA-C-O 117.937 -1.03 . . . . 1.0 110.558 179.328 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 13.8 mmt . . . . . 0 N--CA 1.496 1.837 0 N-CA-C 109.691 -0.485 . . . . 1.0 109.691 . . . . . . . . . 0 0 . 1 . 022 nuclear nobuild core ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 98.1 p -106.35 9.44 31.86 Favored 'General case' 0 N--CA 1.469 0.482 0 CA-C-N 115.945 -0.57 . . . . 1.0 110.455 -179.946 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER 166.29 97.1 0.0 OUTLIER 'General case' 0 N--CA 1.466 0.362 0 CA-C-N 116.019 -0.537 . . . . 1.0 110.451 179.382 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 85.2 t80 -149.26 144.98 26.85 Favored 'General case' 0 N--CA 1.466 0.343 0 CA-C-N 116.053 -0.522 . . . . 1.0 110.104 179.441 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 5' ' ' ASP . . . . . 0.445 ' N ' ' OD1' ' A' ' 5' ' ' ASP . 5.1 p30 -153.54 148.65 26.8 Favored 'General case' 0 C--N 1.33 -0.274 0 N-CA-C 109.997 -0.372 . . . . 1.0 109.997 -179.761 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 6' ' ' THR . . . . . 0.577 ' O ' ' N ' ' A' ' 10' ' ' SER . 0.2 OUTLIER -70.87 177.15 3.79 Favored 'General case' 0 C--O 1.211 -0.95 0 C-N-CA 120.337 -0.545 . . . . 1.0 110.038 -179.979 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . 0.519 ' O ' ' N ' ' A' ' 11' ' ' ARG . 0.6 OUTLIER -59.62 -55.46 34.18 Favored 'General case' 0 C--N 1.317 -0.845 0 CA-C-O 121.566 0.698 . . . . 1.0 109.804 -178.436 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 8' ' ' ARG . . . . . 0.467 ' O ' ' HB3' ' A' ' 12' ' ' ALA . 0.2 OUTLIER -51.61 -57.11 10.06 Favored 'General case' 0 C--N 1.318 -0.761 0 N-CA-C 107.613 -1.255 . . . . 1.0 107.613 -178.182 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . 0.85 ' O ' HG13 ' A' ' 13' ' ' VAL . 0.0 OUTLIER -66.26 -47.9 82.87 Favored 'Isoleucine or valine' 0 CA--C 1.556 1.18 0 CA-C-N 114.036 -1.438 . . . . 1.0 110.127 -178.857 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 10' ' ' SER . . . . . 0.577 ' N ' ' O ' ' A' ' 6' ' ' THR . 32.6 t -62.45 -59.48 4.9 Favored 'General case' 0 N--CA 1.491 1.604 0 CA-C-O 121.022 0.439 . . . . 1.0 109.998 179.148 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 11' ' ' ARG . . . . . 0.553 ' O ' ' N ' ' A' ' 15' ' ' ALA . 20.2 tpp180 -66.08 -55.16 17.9 Favored 'General case' 0 CA--C 1.547 0.835 0 O-C-N 121.539 -0.726 . . . . 1.0 110.404 -177.397 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . 0.511 ' O ' ' HB3' ' A' ' 16' ' ' ALA . . . -50.97 -52.24 44.58 Favored 'General case' 0 N--CA 1.481 1.103 0 C-N-CA 118.228 -1.389 . . . . 1.0 107.307 -178.893 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . 0.85 HG13 ' O ' ' A' ' 9' ' ' VAL . 3.2 m -63.21 -48.91 85.36 Favored 'Isoleucine or valine' 0 C--O 1.199 -1.593 0 C-N-CA 117.796 -1.562 . . . . 1.0 108.791 177.576 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . 0.713 ' O ' HG13 ' A' ' 18' ' ' VAL . . . -57.12 -61.88 2.15 Favored 'General case' 0 C--O 1.211 -0.964 0 C-N-CA 117.621 -1.632 . . . . 1.0 109.638 179.039 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . 0.566 ' O ' ' N ' ' A' ' 19' ' ' GLY . . . -53.07 -55.78 21.21 Favored 'General case' 0 N--CA 1.475 0.82 0 CA-C-O 121.552 0.691 . . . . 1.0 110.263 -177.702 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . 0.541 ' CA ' ' H ' ' A' ' 22' ' ' GLY . . . -62.85 -54.55 37.11 Favored 'General case' 0 C--N 1.312 -1.055 0 CA-C-N 114.598 -1.183 . . . . 1.0 108.999 -179.346 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . 0.586 ' CB ' ' O ' ' A' ' 13' ' ' VAL . 24.2 tp -56.75 -53.96 51.75 Favored 'General case' 0 N--CA 1.477 0.922 0 CA-C-N 114.606 -1.179 . . . . 1.0 108.752 -177.284 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . 0.713 HG13 ' O ' ' A' ' 14' ' ' ALA . 2.5 m -68.58 -55.98 14.02 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.355 0 C-N-CA 119.511 -0.876 . . . . 1.0 109.139 179.637 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . 0.566 ' N ' ' O ' ' A' ' 15' ' ' ALA . . . -64.9 -165.28 1.07 Allowed Glycine 0 CA--C 1.525 0.693 0 CA-C-N 116.292 -0.413 . . . . 1.0 112.81 -178.596 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 20' ' ' PRO . . . . . 0.594 ' O ' ' N ' ' A' ' 24' ' ' ALA . 3.2 Cg_endo -81.17 -25.65 3.86 Favored 'Trans proline' 0 C--N 1.312 -1.374 0 C-N-CA 123.134 2.556 . . . . 1.0 112.486 -178.716 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -57.65 -58.75 12.93 Favored Glycine 0 CA--C 1.532 1.125 0 C-N-CA 119.522 -1.323 . . . . 1.0 110.924 -176.663 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . 0.678 ' O ' HG22 ' A' ' 26' ' ' VAL . . . -61.94 -54.36 35.78 Favored Glycine 0 N--CA 1.47 0.936 0 N-CA-C 108.152 -1.979 . . . . 1.0 108.152 -178.94 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . 0.566 ' O ' HG12 ' A' ' 27' ' ' VAL . 24.2 t -56.17 -38.66 55.1 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.636 0 N-CA-C 109.166 -0.679 . . . . 1.0 109.166 -179.794 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . 0.594 ' N ' ' O ' ' A' ' 20' ' ' PRO . . . -60.28 -61.06 2.88 Favored 'General case' 0 CA--C 1.536 0.414 0 C-N-CA 119.272 -0.971 . . . . 1.0 111.011 -179.488 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 16.3 mt -64.1 -46.88 82.27 Favored 'General case' 0 N--CA 1.468 0.447 0 N-CA-C 113.446 0.906 . . . . 1.0 113.446 -177.009 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . 0.678 HG22 ' O ' ' A' ' 22' ' ' GLY . 18.9 m -61.51 -58.26 8.38 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 C-N-CA 118.845 -1.142 . . . . 1.0 110.297 -177.688 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . 0.631 ' N ' HG23 ' A' ' 26' ' ' VAL . 1.1 p -63.07 -37.73 80.16 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 N-CA-C 112.518 0.562 . . . . 1.0 112.518 -177.377 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 7.9 tmtm? -67.52 -54.69 17.92 Favored 'General case' 0 C--N 1.319 -0.737 0 N-CA-C 108.556 -0.905 . . . . 1.0 108.556 -178.764 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 93.2 t -63.64 -48.48 86.52 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.972 0 CA-C-N 114.394 -1.275 . . . . 1.0 110.331 -178.294 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 30' ' ' CYS . . . . . . . . . . . . . 34.9 t -64.77 -60.8 2.68 Favored 'General case' 0 C--N 1.326 -0.445 0 C-N-CA 119.231 -0.988 . . . . 1.0 109.944 -179.106 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . 0.607 ' HB3' ' O ' ' A' ' 27' ' ' VAL . . . -64.11 -51.88 61.86 Favored 'General case' 0 C--N 1.325 -0.493 0 N-CA-C 111.992 0.367 . . . . 1.0 111.992 -176.074 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 88.48 74.09 1.28 Allowed Glycine 0 CA--C 1.527 0.805 0 N-CA-C 109.994 -1.242 . . . . 1.0 109.994 -179.196 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 38.6 mt 75.29 126.15 0.03 OUTLIER Pre-proline 0 N--CA 1.476 0.846 0 C-N-CA 122.815 0.446 . . . . 1.0 110.562 -179.422 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 56.6 Cg_endo -72.26 -13.01 28.13 Favored 'Trans proline' 0 N--CA 1.505 2.15 0 C-N-CA 122.227 1.952 . . . . 1.0 114.762 -179.316 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . 0.674 ' HA2' HD12 ' A' ' 112' ' ' ILE . . . -60.19 -59.57 10.13 Favored Glycine 0 N--CA 1.468 0.804 0 C-N-CA 118.156 -1.973 . . . . 1.0 109.584 -178.787 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . 0.425 HG12 ' H ' ' A' ' 37' ' ' ILE . 1.5 t -78.64 -145.56 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.323 -0.572 0 N-CA-C 107.089 -1.449 . . . . 1.0 107.089 178.095 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . 0.461 HG13 ' HB1' ' A' ' 31' ' ' ALA . 5.4 mm 76.71 78.36 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 N-CA-C 112.762 0.653 . . . . 1.0 112.762 177.756 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -135.99 126.99 27.77 Favored 'General case' 0 CA--C 1.538 0.484 0 N-CA-C 106.809 -1.552 . . . . 1.0 106.809 177.904 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 39' ' ' THR . . . . . 0.528 ' OG1' ' NH2' ' A' ' 47' ' ' ARG . 23.9 p -104.54 149.68 37.68 Favored Pre-proline 0 N--CA 1.47 0.57 0 N-CA-C 110.103 -0.332 . . . . 1.0 110.103 -178.972 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 89.6 Cg_endo -75.79 -34.31 3.28 Favored 'Trans proline' 0 C--N 1.311 -1.402 0 C-N-CA 121.675 1.583 . . . . 1.0 114.211 -178.685 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -128.82 134.64 48.41 Favored 'General case' 0 N--CA 1.477 0.88 0 CA-C-N 118.089 0.404 . . . . 1.0 111.548 179.035 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . 0.684 HH21 ' N ' ' A' ' 46' ' ' PHE . 16.6 ptm180 -169.37 167.89 9.83 Favored 'General case' 0 C--N 1.325 -0.491 0 C-N-CA 119.789 -0.765 . . . . 1.0 111.266 177.071 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -67.48 18.9 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.051 -0.522 . . . . 1.0 109.988 179.377 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . 0.635 ' H ' ' C ' ' A' ' 42' ' ' ARG . . . 79.45 -24.62 3.03 Favored Glycine 0 CA--C 1.522 0.502 0 N-CA-C 111.278 -0.729 . . . . 1.0 111.278 179.803 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . 0.541 ' C ' HH21 ' A' ' 42' ' ' ARG . 0.2 OUTLIER -150.54 149.14 29.54 Favored 'General case' 0 CA--C 1.542 0.65 0 N-CA-C 109.061 -0.718 . . . . 1.0 109.061 -178.886 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 46' ' ' PHE . . . . . 0.684 ' N ' HH21 ' A' ' 42' ' ' ARG . 1.9 m-30 144.53 73.45 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.826 0 O-C-N 124.408 1.067 . . . . 1.0 111.664 179.006 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 47' ' ' ARG . . . . . 0.559 ' O ' ' SG ' ' A' ' 48' ' ' CYS . 2.2 ptt-85 135.2 151.09 0.0 OUTLIER 'General case' 0 N--CA 1.5 2.03 0 CA-C-O 116.905 -1.521 . . . . 1.0 108.643 -179.758 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 48' ' ' CYS . . . . . 0.559 ' SG ' ' O ' ' A' ' 47' ' ' ARG . 6.2 p 51.1 62.31 2.78 Favored 'General case' 0 N--CA 1.482 1.161 0 CA-C-N 120.717 1.599 . . . . 1.0 111.982 -179.258 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -110.79 147.21 36.01 Favored Pre-proline 0 N--CA 1.473 0.702 0 N-CA-C 110.144 -0.317 . . . . 1.0 110.144 177.921 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 50' ' ' PRO . . . . . 0.408 ' HG2' ' HE ' ' A' ' 52' ' ' ARG . 72.4 Cg_endo -71.99 55.08 2.26 Favored 'Trans proline' 0 N--CA 1.494 1.516 0 C-N-CA 122.369 2.046 . . . . 1.0 111.762 179.959 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER 67.43 -3.42 1.07 Allowed 'General case' 0 N--CA 1.468 0.427 0 CA-C-N 115.071 -0.968 . . . . 1.0 111.474 179.189 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . 0.408 ' HE ' ' HG2' ' A' ' 50' ' ' PRO . 16.3 mtm-85 -85.92 154.03 21.78 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 121.377 0.608 . . . . 1.0 111.839 -179.557 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . 0.526 HG23 HG22 ' A' ' 55' ' ' ILE . 8.5 tp -68.22 137.0 25.39 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.306 0 CA-C-N 115.208 -0.905 . . . . 1.0 110.177 179.705 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -59.76 80.44 0.01 OUTLIER 'General case' 0 C--N 1.316 -0.858 0 CA-C-N 114.52 -1.218 . . . . 1.0 109.289 -177.548 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . 0.526 HG22 HG23 ' A' ' 53' ' ' ILE . 18.2 tt -149.17 157.91 6.58 Favored 'Isoleucine or valine' 0 C--N 1.348 0.538 0 N-CA-C 110.109 -0.33 . . . . 1.0 110.109 177.991 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 110.48 -6.38 29.99 Favored Glycine 0 N--CA 1.472 1.047 0 N-CA-C 110.698 -0.961 . . . . 1.0 110.698 -179.722 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 16.1 p-10 -76.46 98.31 4.56 Favored 'General case' 0 C--N 1.323 -0.58 0 N-CA-C 108.855 -0.794 . . . . 1.0 108.855 177.788 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 58' ' ' TRP . . . . . . . . . . . . . 24.1 m0 -87.84 174.54 8.3 Favored 'General case' 0 CA--C 1.533 0.324 0 CA-C-O 122.531 1.157 . . . . 1.0 112.513 -177.636 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 12.9 mtm180 -84.5 -62.03 1.65 Allowed 'General case' 0 C--N 1.317 -0.837 0 CA-C-N 112.523 -2.126 . . . . 1.0 112.628 -178.958 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 9.3 p90 -90.53 -15.25 31.04 Favored 'General case' 0 C--O 1.247 0.924 0 N-CA-C 113.615 0.969 . . . . 1.0 113.615 -178.861 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 4.8 tt0 -78.72 -14.44 59.28 Favored 'General case' 0 C--N 1.323 -0.554 0 O-C-N 121.569 -0.707 . . . . 1.0 110.53 -179.318 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 62' ' ' VAL . . . . . 0.566 ' O ' ' N ' ' A' ' 66' ' ' GLY . 27.8 m -46.26 -55.13 1.64 Allowed 'Isoleucine or valine' 0 C--O 1.209 -1.053 0 C-N-CA 119.931 -0.707 . . . . 1.0 110.099 -175.281 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 63' ' ' ALA . . . . . 0.554 ' N ' HG23 ' A' ' 62' ' ' VAL . . . -67.44 -52.17 42.78 Favored 'General case' 0 C--N 1.307 -1.273 0 CA-C-N 117.968 0.349 . . . . 1.0 110.25 -179.728 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 64' ' ' HIS . . . . . 0.498 ' O ' ' CG ' ' A' ' 67' ' ' ARG . 0.1 OUTLIER -50.3 -56.25 12.03 Favored 'General case' 0 CA--C 1.544 0.714 0 N-CA-C 108.595 -0.891 . . . . 1.0 108.595 -179.713 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 65' ' ' ASP . . . . . 0.697 ' C ' ' H ' ' A' ' 67' ' ' ARG . 21.0 t0 -69.8 -48.45 59.05 Favored 'General case' 0 C--N 1.318 -0.762 0 CA-C-O 121.813 0.816 . . . . 1.0 110.011 178.386 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . 0.566 ' N ' ' O ' ' A' ' 62' ' ' VAL . . . -68.74 27.2 0.29 Allowed Glycine 0 CA--C 1.516 0.153 0 N-CA-C 109.68 -1.368 . . . . 1.0 109.68 177.468 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 67' ' ' ARG . . . . . 0.748 ' HB3' ' HB3' ' A' ' 71' ' ' ALA . 29.0 mmt-85 -70.83 -0.74 9.71 Favored 'General case' 0 N--CA 1.438 -1.06 0 N-CA-C 106.486 -1.672 . . . . 1.0 106.486 174.771 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . 0.477 ' H ' ' C ' ' A' ' 66' ' ' GLY . 4.8 tt -32.95 -29.86 0.01 OUTLIER 'General case' 0 C--N 1.354 0.786 0 O-C-N 123.757 0.661 . . . . 1.0 109.327 -175.221 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . 0.617 ' N ' ' O ' ' A' ' 67' ' ' ARG . 4.3 tp -68.4 -66.94 0.51 Allowed 'General case' 0 CA--C 1.548 0.876 0 CA-C-N 114.554 -1.203 . . . . 1.0 111.224 179.748 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . 0.648 ' C ' ' H ' ' A' ' 72' ' ' HIS . . . -80.29 -78.56 0.17 Allowed 'General case' 0 N--CA 1.478 0.938 0 C-N-CA 118.145 -1.422 . . . . 1.0 108.862 179.814 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 71' ' ' ALA . . . . . 0.787 ' HB1' ' HB ' ' A' ' 74' ' ' VAL . . . -52.14 7.98 0.0 OUTLIER 'General case' 0 C--N 1.324 -0.522 0 C-N-CA 123.985 0.914 . . . . 1.0 112.468 -179.808 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 72' ' ' HIS . . . . . 0.793 ' CD2' ' H ' ' A' ' 73' ' ' MET . 1.3 p80 -24.93 -51.91 0.03 OUTLIER 'General case' 0 N--CA 1.469 0.481 0 N-CA-C 113.034 0.753 . . . . 1.0 113.034 -178.907 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 73' ' ' MET . . . . . 0.793 ' H ' ' CD2' ' A' ' 72' ' ' HIS . 2.2 tpp -73.53 -49.32 27.09 Favored 'General case' 0 C--N 1.322 -0.606 0 C-N-CA 119.309 -0.956 . . . . 1.0 108.901 178.936 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . 0.787 ' HB ' ' HB1' ' A' ' 71' ' ' ALA . 61.8 t -43.46 -42.53 1.49 Allowed 'Isoleucine or valine' 0 CA--C 1.517 -0.3 0 CA-C-O 118.43 -0.795 . . . . 1.0 111.804 -175.706 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 75' ' ' ASN . . . . . 0.639 ' O ' HG12 ' A' ' 78' ' ' VAL . 0.7 OUTLIER -39.37 -13.86 0.01 OUTLIER 'General case' 0 N--CA 1.478 0.926 0 CA-C-N 120.01 1.277 . . . . 1.0 111.68 178.582 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 76' ' ' GLY . . . . . 0.667 ' N ' ' O ' ' A' ' 74' ' ' VAL . . . -43.31 -23.98 0.31 Allowed Glycine 0 CA--C 1.546 1.979 0 N-CA-C 108.068 -2.013 . . . . 1.0 108.068 178.412 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 77' ' ' ILE . . . . . 0.619 ' HA ' ' HB3' ' A' ' 80' ' ' ALA . 9.8 pt -69.75 -48.81 62.62 Favored 'Isoleucine or valine' 0 C--O 1.214 -0.799 0 N-CA-C 107.385 -1.339 . . . . 1.0 107.385 177.274 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . 0.639 HG12 ' O ' ' A' ' 75' ' ' ASN . 3.7 p -34.26 -36.68 0.06 OUTLIER 'Isoleucine or valine' 0 CA--C 1.542 0.643 0 N-CA-C 107.399 -1.334 . . . . 1.0 107.399 -177.076 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . 0.534 HG23 HG13 ' A' ' 78' ' ' VAL . 43.9 pt -97.65 -26.49 3.93 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.862 0 N-CA-C 111.924 0.342 . . . . 1.0 111.924 178.077 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 80' ' ' ALA . . . . . 0.619 ' HB3' ' HA ' ' A' ' 77' ' ' ILE . . . -86.6 -10.72 53.29 Favored 'General case' 0 N--CA 1.48 1.039 0 N-CA-C 113.475 0.917 . . . . 1.0 113.475 178.681 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 81' ' ' GLU . . . . . 0.489 ' N ' ' O ' ' A' ' 77' ' ' ILE . 2.6 mt-10 -78.56 -68.96 0.6 Allowed 'General case' 0 N--CA 1.436 -1.126 0 N-CA-C 107.405 -1.331 . . . . 1.0 107.405 178.041 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 82' ' ' ASP . . . . . 0.9 ' O ' ' N ' ' A' ' 84' ' ' LEU . 0.5 OUTLIER -59.58 -60.87 3.16 Favored 'General case' 0 N--CA 1.437 -1.101 0 N-CA-C 107.928 -1.138 . . . . 1.0 107.928 178.705 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . 0.638 ' HA ' ' HB3' ' A' ' 86' ' ' ALA . . . 31.8 -64.52 0.0 OUTLIER 'General case' 0 N--CA 1.478 0.946 0 O-C-N 124.501 1.126 . . . . 1.0 111.812 179.32 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . 0.9 ' N ' ' O ' ' A' ' 82' ' ' ASP . 19.9 mt -33.78 -37.48 0.04 OUTLIER 'General case' 0 N--CA 1.475 0.788 0 N-CA-C 112.8 0.667 . . . . 1.0 112.8 -177.68 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 85' ' ' ILE . . . . . 1.019 HD13 ' N ' ' A' ' 86' ' ' ALA . 0.0 OUTLIER -100.43 -34.44 4.09 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.473 0 N-CA-C 108.584 -0.895 . . . . 1.0 108.584 177.857 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 86' ' ' ALA . . . . . 1.019 ' N ' HD13 ' A' ' 85' ' ' ILE . . . -62.78 -61.25 2.54 Favored 'General case' 0 CA--C 1.539 0.55 0 CA-C-N 115.104 -0.953 . . . . 1.0 109.849 -179.413 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -64.66 16.35 0.02 OUTLIER 'General case' 0 CA--C 1.537 0.457 0 O-C-N 121.836 -0.54 . . . . 1.0 110.84 -179.206 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 88' ' ' ALA . . . . . 0.58 ' H ' ' C ' ' A' ' 86' ' ' ALA . . . -115.97 -14.94 11.23 Favored 'General case' 0 N--CA 1.466 0.353 0 N-CA-C 108.626 -0.879 . . . . 1.0 108.626 178.116 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 21.5 m -109.79 31.54 1.11 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.238 0 CA-C-N 115.11 -0.95 . . . . 1.0 109.775 177.734 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 90' ' ' GLY . . . . . 0.55 ' N ' ' CD ' ' A' ' 91' ' ' PRO . . . -69.29 -39.76 81.5 Favored Glycine 0 CA--C 1.529 0.907 0 N-CA-C 111.059 -0.817 . . . . 1.0 111.059 178.216 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 91' ' ' PRO . . . . . 0.55 ' CD ' ' N ' ' A' ' 90' ' ' GLY . 81.0 Cg_exo -48.24 -8.53 0.06 OUTLIER 'Trans proline' 0 N--CA 1.493 1.466 0 C-N-CA 121.836 1.691 . . . . 1.0 111.048 179.266 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 92' ' ' HIS . . . . . 0.549 ' H ' ' C ' ' A' ' 90' ' ' GLY . 28.9 t60 -58.05 -14.37 6.49 Favored 'General case' 0 C--O 1.214 -0.804 0 N-CA-C 108.245 -1.02 . . . . 1.0 108.245 179.893 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 93' ' ' LEU . . . . . 0.58 HD12 ' N ' ' A' ' 94' ' ' ALA . 1.2 pp -63.44 -55.97 19.92 Favored 'General case' 0 CA--C 1.531 0.24 0 N-CA-C 108.128 -1.064 . . . . 1.0 108.128 177.464 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 94' ' ' ALA . . . . . 0.58 ' N ' HD12 ' A' ' 93' ' ' LEU . . . -56.45 -50.57 71.32 Favored 'General case' 0 CA--C 1.515 -0.376 0 N-CA-C 108.804 -0.813 . . . . 1.0 108.804 178.861 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 95' ' ' ARG . . . . . 0.611 ' O ' ' N ' ' A' ' 97' ' ' LEU . 7.8 ttt180 -59.65 -59.61 5.17 Favored 'General case' 0 CA--C 1.507 -0.68 0 N-CA-C 106.994 -1.484 . . . . 1.0 106.994 178.472 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 96' ' ' ALA . . . . . 0.924 ' O ' ' N ' ' A' ' 98' ' ' GLY . . . -47.21 -14.2 0.03 OUTLIER 'General case' 0 N--CA 1.418 -2.035 0 O-C-N 119.026 -2.296 . . . . 1.0 111.23 -179.976 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 97' ' ' LEU . . . . . 0.693 ' O ' ' N ' ' A' ' 100' ' ' ILE . 16.4 tp 7.1 -51.94 0.0 OUTLIER 'General case' 0 N--CA 1.487 1.394 0 CA-C-O 118.133 -0.937 . . . . 1.0 110.407 -168.103 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 98' ' ' GLY . . . . . 0.924 ' N ' ' O ' ' A' ' 96' ' ' ALA . . . -50.74 -23.55 6.95 Favored Glycine 0 CA--C 1.548 2.122 0 CA-C-N 122.221 2.282 . . . . 1.0 107.618 173.753 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 99' ' ' GLN . . . . . 0.577 ' N ' ' O ' ' A' ' 96' ' ' ALA . 1.4 tp-100 -67.02 -20.48 65.87 Favored 'General case' 0 C--N 1.377 1.788 0 N-CA-C 106.665 -1.605 . . . . 1.0 106.665 176.805 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 100' ' ' ILE . . . . . 0.693 ' N ' ' O ' ' A' ' 97' ' ' LEU . 2.7 tp -63.57 -39.59 85.93 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.867 0 N-CA-C 107.245 -1.391 . . . . 1.0 107.245 177.664 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 101' ' ' VAL . . . . . 0.662 ' O ' ' N ' ' A' ' 105' ' ' GLY . 97.6 t -59.26 -61.71 1.33 Allowed 'Isoleucine or valine' 0 C--O 1.215 -0.731 0 N-CA-C 108.894 -0.78 . . . . 1.0 108.894 178.954 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 102' ' ' CYS . . . . . 0.818 ' O ' ' HB2' ' A' ' 106' ' ' ALA . 3.5 t -45.46 -26.99 0.64 Allowed 'General case' 0 C--N 1.315 -0.928 0 N-CA-C 112.368 0.507 . . . . 1.0 112.368 -179.089 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 53.8 ttt-85 -86.78 -47.39 9.12 Favored 'General case' 0 N--CA 1.494 1.752 0 CA-C-O 122.632 1.206 . . . . 1.0 112.891 179.639 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 104' ' ' TYR . . . . . 0.668 ' O ' ' CG ' ' A' ' 104' ' ' TYR . 0.0 OUTLIER -98.62 24.19 7.77 Favored 'General case' 0 C--N 1.299 -1.596 0 CA-C-N 112.203 -2.271 . . . . 1.0 107.88 178.09 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 105' ' ' GLY . . . . . 0.662 ' N ' ' O ' ' A' ' 101' ' ' VAL . . . -162.62 -94.82 0.1 Allowed Glycine 0 CA--C 1.533 1.206 0 N-CA-C 106.589 -2.604 . . . . 1.0 106.589 177.987 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 106' ' ' ALA . . . . . 0.818 ' HB2' ' O ' ' A' ' 102' ' ' CYS . . . 70.69 63.18 0.19 Allowed 'General case' 0 CA--C 1.543 0.679 0 N-CA-C 114.021 1.119 . . . . 1.0 114.021 -179.362 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 107' ' ' THR . . . . . 0.719 ' O ' ' HD2' ' A' ' 110' ' ' PRO . 97.9 m -79.96 -57.76 3.49 Favored 'General case' 0 C--O 1.212 -0.881 0 O-C-N 120.349 -1.469 . . . . 1.0 109.435 177.845 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 108' ' ' VAL . . . . . 0.659 ' O ' HG12 ' A' ' 108' ' ' VAL . 21.4 t -80.22 25.04 0.08 OUTLIER 'Isoleucine or valine' 0 CA--C 1.538 0.486 0 O-C-N 121.254 -0.903 . . . . 1.0 113.079 -175.997 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 109' ' ' ILE . . . . . 0.541 ' H ' ' HD3' ' A' ' 110' ' ' PRO . 0.5 OUTLIER -109.38 -38.25 0.13 Allowed Pre-proline 0 CA--C 1.561 1.381 0 CA-C-N 118.909 0.777 . . . . 1.0 110.71 176.683 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 110' ' ' PRO . . . . . 0.719 ' HD2' ' O ' ' A' ' 107' ' ' THR . 23.0 Cg_exo -67.88 -23.15 41.53 Favored 'Trans proline' 0 N--CA 1.507 2.296 0 C-N-CA 123.642 2.894 . . . . 1.0 110.794 178.291 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 21.3 t-20 -69.17 -67.84 0.45 Allowed 'General case' 0 C--O 1.237 0.423 0 N-CA-C 109.169 -0.678 . . . . 1.0 109.169 -179.624 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 112' ' ' ILE . . . . . 0.674 HD12 ' HA2' ' A' ' 35' ' ' GLY . 0.5 OUTLIER -49.03 -30.39 3.55 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.596 0 CA-C-O 121.911 0.863 . . . . 1.0 108.701 177.861 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 113' ' ' ASN . . . . . 0.468 ' HB3' ' O ' ' A' ' 110' ' ' PRO . 20.4 t30 -55.25 -55.56 30.0 Favored 'General case' 0 C--N 1.309 -1.153 0 CA-C-N 113.833 -1.53 . . . . 1.0 108.31 -178.111 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -56.75 -31.78 64.92 Favored 'General case' 0 CA--C 1.537 0.458 0 N-CA-C 113.116 0.784 . . . . 1.0 113.116 -179.469 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -81.04 -50.4 9.72 Favored 'General case' 0 N--CA 1.472 0.664 0 CA-C-O 121.988 0.899 . . . . 1.0 110.951 178.237 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 116' ' ' ILE . . . . . 0.541 HG22 ' N ' ' A' ' 117' ' ' GLU . 0.4 OUTLIER -49.07 -57.84 1.52 Allowed 'Isoleucine or valine' 0 C--N 1.314 -0.95 0 CA-C-N 113.969 -1.468 . . . . 1.0 107.562 -179.961 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 117' ' ' GLU . . . . . 0.541 ' N ' HG22 ' A' ' 116' ' ' ILE . 2.4 tt0 -37.89 -55.99 1.16 Allowed 'General case' 0 N--CA 1.475 0.808 0 CA-C-N 113.187 -1.824 . . . . 1.0 106.526 -178.711 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 84.6 t -58.58 -50.58 78.5 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.723 0 CA-C-N 113.314 -1.767 . . . . 1.0 108.386 178.818 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 119' ' ' LEU . . . . . 0.497 ' N ' ' O ' ' A' ' 116' ' ' ILE . 1.2 tp -57.38 -73.98 0.06 Allowed 'General case' 0 CA--C 1.547 0.861 0 C-N-CA 119.823 -0.751 . . . . 1.0 109.666 -178.239 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -77.62 -82.21 0.6 Allowed Glycine 0 CA--C 1.543 1.837 0 C-N-CA 118.55 -1.786 . . . . 1.0 113.209 -178.904 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 121' ' ' THR . . . . . 0.412 ' H ' ' H ' ' A' ' 122' ' ' GLY . 27.3 m -168.5 -22.92 0.02 OUTLIER 'General case' 0 C--N 1.303 -1.425 0 N-CA-C 105.2 -2.148 . . . . 1.0 105.2 -176.621 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 122' ' ' GLY . . . . . 0.412 ' H ' ' H ' ' A' ' 121' ' ' THR . . . 109.1 -33.61 6.04 Favored Glycine 0 N--CA 1.449 -0.472 0 CA-C-N 112.472 -2.149 . . . . 1.0 114.686 177.37 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 123' ' ' THR . . . . . 0.408 ' C ' ' O ' ' A' ' 122' ' ' GLY . 0.2 OUTLIER -41.75 106.89 0.07 Allowed 'General case' 0 CA--C 1.538 0.49 0 CA-C-N 120.351 2.075 . . . . 1.0 113.05 -177.515 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 28.8 m-20 -142.6 145.03 33.12 Favored 'General case' 0 N--CA 1.465 0.298 0 CA-C-N 114.276 -1.329 . . . . 1.0 108.768 178.082 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 125' ' ' TYR . . . . . 0.421 ' CD1' ' C ' ' A' ' 125' ' ' TYR . 0.0 OUTLIER -151.5 146.64 26.05 Favored 'General case' 0 CA--C 1.546 0.801 0 N-CA-C 109.061 -0.718 . . . . 1.0 109.061 179.191 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 11.9 mmp_? -146.92 151.68 37.43 Favored 'General case' 0 N--CA 1.472 0.645 0 CA-C-N 115.112 -0.949 . . . . 1.0 109.341 177.534 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 127' ' ' PHE . . . . . . . . . . . . . 7.9 p90 . . . . . 0 C--O 1.219 -0.539 0 CA-C-O 118.173 -0.918 . . . . 1.0 110.533 178.726 . . . . . . . . 0 0 . 1 . 023 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.494 1.73 0 CA-C-O 121.226 0.536 . . . . 1.0 109.963 . . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 2' ' ' SER . . . . . 0.49 ' O ' ' CB ' ' A' ' 3' ' ' ASP . 6.7 m -83.92 9.14 12.93 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.448 -0.796 . . . . 1.0 110.892 179.825 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 3' ' ' ASP . . . . . 0.49 ' CB ' ' O ' ' A' ' 2' ' ' SER . 1.4 m-20 150.35 126.96 0.0 OUTLIER 'General case' 0 N--CA 1.478 0.956 0 O-C-N 124.088 0.867 . . . . 1.0 111.208 178.713 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 27.4 t80 -157.26 152.58 26.27 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.829 -0.623 . . . . 1.0 110.506 178.428 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 8.4 p30 -151.75 147.5 26.75 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.726 -0.67 . . . . 1.0 109.201 179.806 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 6' ' ' THR . . . . . 0.504 ' O ' ' N ' ' A' ' 10' ' ' SER . 0.2 OUTLIER -71.5 171.29 11.62 Favored 'General case' 0 C--O 1.211 -0.968 0 C-N-CA 120.917 -0.313 . . . . 1.0 110.179 -179.325 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . 0.529 ' O ' ' HG2' ' A' ' 11' ' ' ARG . 90.7 mt-10 -53.83 -69.58 0.12 Allowed 'General case' 0 C--N 1.31 -1.137 0 C-N-CA 120.645 -0.422 . . . . 1.0 110.2 -176.697 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 8' ' ' ARG . . . . . 0.493 ' O ' ' CB ' ' A' ' 12' ' ' ALA . 0.0 OUTLIER -42.22 -51.18 4.8 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-N 115.397 -0.819 . . . . 1.0 109.298 -176.299 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -66.83 -50.1 68.25 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.462 0 CA-C-N 115.151 -0.931 . . . . 1.0 111.055 177.657 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 10' ' ' SER . . . . . 0.504 ' N ' ' O ' ' A' ' 6' ' ' THR . 28.2 t -56.79 -40.24 75.54 Favored 'General case' 0 C--N 1.323 -0.564 0 N-CA-C 113.467 0.914 . . . . 1.0 113.467 -178.566 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 11' ' ' ARG . . . . . 0.677 ' O ' ' N ' ' A' ' 15' ' ' ALA . 2.3 ptp180 -85.76 -54.28 4.62 Favored 'General case' 0 C--O 1.213 -0.849 0 CA-C-O 121.743 0.783 . . . . 1.0 110.313 175.334 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . 0.678 ' O ' ' HB3' ' A' ' 16' ' ' ALA . . . -47.9 -52.83 17.85 Favored 'General case' 0 CA--C 1.496 -1.104 0 N-CA-C 106.896 -1.52 . . . . 1.0 106.896 -175.343 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . 0.626 ' O ' ' CB ' ' A' ' 17' ' ' LEU . 93.1 t -61.68 -54.86 29.09 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.466 0 C-N-CA 117.01 -1.876 . . . . 1.0 108.76 178.085 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . 0.828 ' O ' HG22 ' A' ' 18' ' ' VAL . . . -58.03 -64.64 0.84 Allowed 'General case' 0 C--O 1.207 -1.136 0 C-N-CA 117.81 -1.556 . . . . 1.0 110.755 -179.127 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . 0.677 ' N ' ' O ' ' A' ' 11' ' ' ARG . . . -52.78 -56.08 18.28 Favored 'General case' 0 N--CA 1.473 0.683 0 CA-C-O 121.053 0.454 . . . . 1.0 110.924 -179.23 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . 0.678 ' HB3' ' O ' ' A' ' 12' ' ' ALA . . . -63.96 -56.19 16.95 Favored 'General case' 0 C--N 1.312 -1.035 0 C-N-CA 119.172 -1.011 . . . . 1.0 109.199 -179.219 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . 0.626 ' CB ' ' O ' ' A' ' 13' ' ' VAL . 28.5 tp -55.85 -53.68 53.76 Favored 'General case' 0 N--CA 1.484 1.258 0 CA-C-N 114.95 -1.023 . . . . 1.0 108.705 -177.326 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . 0.828 HG22 ' O ' ' A' ' 14' ' ' ALA . 2.6 m -68.83 -58.2 6.49 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.365 0 N-CA-C 109.22 -0.659 . . . . 1.0 109.22 179.603 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . 0.575 ' N ' ' O ' ' A' ' 15' ' ' ALA . . . -58.83 -165.04 0.1 Allowed Glycine 0 N--CA 1.442 -0.915 0 N-CA-C 110.607 -0.997 . . . . 1.0 110.607 -178.844 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 20' ' ' PRO . . . . . 0.579 ' O ' ' N ' ' A' ' 24' ' ' ALA . 65.4 Cg_endo -82.86 -31.4 0.74 Allowed 'Trans proline' 0 C--N 1.296 -2.235 0 C-N-CA 122.632 2.222 . . . . 1.0 113.847 -177.788 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -61.56 -59.6 9.56 Favored Glycine 0 CA--C 1.539 1.573 0 C-N-CA 119.881 -1.152 . . . . 1.0 112.987 -176.683 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . 0.55 ' H ' ' CA ' ' A' ' 16' ' ' ALA . . . -56.36 -53.63 41.72 Favored Glycine 0 N--CA 1.47 0.939 0 N-CA-C 107.304 -2.318 . . . . 1.0 107.304 -176.564 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . 0.476 ' O ' HG12 ' A' ' 27' ' ' VAL . 1.1 p -62.64 -30.63 49.73 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.184 0 C-N-CA 119.211 -0.995 . . . . 1.0 109.394 179.116 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . 0.579 ' N ' ' O ' ' A' ' 20' ' ' PRO . . . -56.63 -63.75 1.1 Allowed 'General case' 0 C--N 1.357 0.906 0 C-N-CA 118.86 -1.136 . . . . 1.0 110.867 -178.376 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 10.4 mt -63.93 -42.84 97.25 Favored 'General case' 0 CA--C 1.517 -0.303 0 C-N-CA 120.404 -0.518 . . . . 1.0 111.54 -177.92 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . 0.4 HG23 ' O ' ' A' ' 22' ' ' GLY . 78.8 t -58.41 -59.98 2.88 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.519 0 C-N-CA 119.25 -0.98 . . . . 1.0 110.211 -178.13 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . 0.634 ' O ' ' HB3' ' A' ' 31' ' ' ALA . 1.9 p -63.42 -36.52 76.53 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 C-N-CA 120.643 -0.423 . . . . 1.0 111.627 -178.433 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 59.2 tttm -66.26 -57.2 8.05 Favored 'General case' 0 C--N 1.318 -0.774 0 C-N-CA 119.749 -0.78 . . . . 1.0 109.28 -178.742 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 96.2 t -64.51 -47.23 90.07 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.127 0 CA-C-N 114.716 -1.129 . . . . 1.0 110.046 -178.345 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 30' ' ' CYS . . . . . . . . . . . . . 54.1 t -66.81 -61.92 1.71 Allowed 'General case' 0 N--CA 1.448 -0.548 0 C-N-CA 119.475 -0.89 . . . . 1.0 110.613 -179.71 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . 0.634 ' HB3' ' O ' ' A' ' 27' ' ' VAL . . . -62.08 -46.02 90.93 Favored 'General case' 0 CA--C 1.506 -0.733 0 CA-C-O 121.061 0.458 . . . . 1.0 111.18 -176.45 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . 0.546 ' O ' ' HB2' ' A' ' 33' ' ' LEU . . . 77.77 69.13 1.43 Allowed Glycine 0 N--CA 1.444 -0.813 0 N-CA-C 110.122 -1.191 . . . . 1.0 110.122 -179.357 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . 0.546 ' HB2' ' O ' ' A' ' 32' ' ' GLY . 3.8 mp 84.61 86.99 0.05 OUTLIER Pre-proline 0 N--CA 1.477 0.907 0 O-C-N 124.769 0.923 . . . . 1.0 111.617 -179.21 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 29.4 Cg_endo -64.2 -15.88 51.94 Favored 'Trans proline' 0 N--CA 1.497 1.716 0 C-N-CA 121.525 1.484 . . . . 1.0 111.824 178.519 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -55.95 -59.63 10.3 Favored Glycine 0 CA--C 1.522 0.524 0 C-N-CA 119.02 -1.562 . . . . 1.0 109.435 -179.092 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . 0.588 ' O ' HG22 ' A' ' 37' ' ' ILE . 1.3 p -97.81 172.87 1.04 Allowed 'Isoleucine or valine' 0 CA--C 1.51 -0.587 0 N-CA-C 105.215 -2.143 . . . . 1.0 105.215 177.131 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . 0.588 HG22 ' O ' ' A' ' 36' ' ' VAL . 6.8 tp 113.07 120.02 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.477 0.907 0 O-C-N 124.689 1.243 . . . . 1.0 110.38 179.411 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 59.5 m80 -141.12 131.42 25.04 Favored 'General case' 0 C--N 1.328 -0.337 0 N-CA-C 108.484 -0.932 . . . . 1.0 108.484 179.395 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -94.64 132.75 27.99 Favored Pre-proline 0 CA--C 1.543 0.679 0 C-N-CA 121.047 -0.261 . . . . 1.0 110.775 -178.849 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 44.8 Cg_exo -54.36 -42.86 63.94 Favored 'Trans proline' 0 N--CA 1.495 1.567 0 C-N-CA 121.902 1.735 . . . . 1.0 113.726 179.363 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -126.38 132.79 51.47 Favored 'General case' 0 N--CA 1.468 0.44 0 CA-C-N 116.602 -0.272 . . . . 1.0 110.861 179.805 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . 0.663 ' C ' ' H ' ' A' ' 44' ' ' GLY . 17.6 ptm180 -166.32 163.73 17.56 Favored 'General case' 0 C--N 1.323 -0.548 0 C-N-CA 120.115 -0.634 . . . . 1.0 109.931 178.1 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 43' ' ' ARG . . . . . 0.529 ' C ' ' H ' ' A' ' 45' ' ' PHE . 0.1 OUTLIER -62.76 24.47 0.01 OUTLIER 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 115.872 -0.604 . . . . 1.0 110.348 -179.973 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . 0.663 ' H ' ' C ' ' A' ' 42' ' ' ARG . . . 70.32 -28.56 0.45 Allowed Glycine 0 C--N 1.339 0.723 0 N-CA-C 111.376 -0.69 . . . . 1.0 111.376 179.982 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . 0.552 ' CG ' ' N ' ' A' ' 46' ' ' PHE . 27.6 t80 -159.62 161.76 35.1 Favored 'General case' 0 C--N 1.32 -0.681 0 N-CA-C 109.084 -0.71 . . . . 1.0 109.084 179.199 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 46' ' ' PHE . . . . . 0.793 ' O ' ' HB2' ' A' ' 47' ' ' ARG . 2.3 m-30 132.65 91.43 0.0 OUTLIER 'General case' 0 N--CA 1.474 0.756 0 O-C-N 125.367 1.667 . . . . 1.0 107.109 -179.476 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 47' ' ' ARG . . . . . 0.793 ' HB2' ' O ' ' A' ' 46' ' ' PHE . 0.0 OUTLIER 125.96 139.71 0.0 OUTLIER 'General case' 0 N--CA 1.48 1.05 0 C-N-CA 124.52 1.128 . . . . 1.0 109.402 179.574 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 48' ' ' CYS . . . . . 0.535 ' SG ' ' C ' ' A' ' 47' ' ' ARG . 0.0 OUTLIER 71.01 73.41 0.19 Allowed 'General case' 0 C--O 1.218 -0.584 0 N-CA-C 108.759 -0.83 . . . . 1.0 108.759 -178.759 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 49' ' ' ASN . . . . . 0.639 ' O ' ' N ' ' A' ' 51' ' ' GLU . 0.0 OUTLIER -132.51 130.13 21.68 Favored Pre-proline 0 CA--C 1.537 0.458 0 N-CA-C 108.629 -0.878 . . . . 1.0 108.629 -179.426 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_exo -53.22 58.04 0.02 OUTLIER 'Trans proline' 0 N--CA 1.507 2.274 0 C-N-CA 122.593 2.195 . . . . 1.0 113.696 178.656 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . 0.639 ' N ' ' O ' ' A' ' 49' ' ' ASN . 6.0 mp0 67.27 3.44 3.24 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.525 -0.307 . . . . 1.0 111.002 -179.974 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 28.8 mtt-85 -80.25 152.87 28.85 Favored 'General case' 0 CA--C 1.531 0.22 0 N-CA-C 109.751 -0.462 . . . . 1.0 109.751 179.776 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . 0.465 ' O ' ' N ' ' A' ' 55' ' ' ILE . 3.6 tp -69.8 136.37 26.3 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-O 120.736 0.303 . . . . 1.0 111.209 -179.469 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 54' ' ' GLN . . . . . 0.61 ' H ' ' CD ' ' A' ' 54' ' ' GLN . 0.0 OUTLIER -60.07 82.82 0.01 OUTLIER 'General case' 0 CA--C 1.54 0.568 0 C-N-CA 120.195 -0.602 . . . . 1.0 110.279 -176.643 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . 0.465 ' N ' ' O ' ' A' ' 53' ' ' ILE . 20.3 tt -149.5 159.98 5.34 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.372 0 CA-C-N 116.145 -0.479 . . . . 1.0 110.89 178.138 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 112.55 -2.42 26.3 Favored Glycine 0 N--CA 1.47 0.942 0 N-CA-C 111.184 -0.767 . . . . 1.0 111.184 -179.814 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 3.6 p-10 -80.07 98.09 7.11 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-O 121.45 0.643 . . . . 1.0 111.239 178.988 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 58' ' ' TRP . . . . . . . . . . . . . 7.1 m95 -85.96 171.72 11.23 Favored 'General case' 0 C--N 1.319 -0.755 0 CA-C-O 123.212 1.482 . . . . 1.0 111.541 -179.464 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -84.24 -60.92 1.94 Allowed 'General case' 0 C--N 1.305 -1.342 0 CA-C-N 111.146 -2.752 . . . . 1.0 112.786 -176.825 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -91.04 -15.28 29.83 Favored 'General case' 0 C--N 1.312 -1.064 0 CA-C-N 114.839 -1.073 . . . . 1.0 112.539 -179.055 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . 0.424 ' O ' ' N ' ' A' ' 65' ' ' ASP . 4.0 tt0 -80.93 -14.75 57.7 Favored 'General case' 0 C--N 1.312 -1.032 0 O-C-N 121.901 -0.499 . . . . 1.0 110.244 -179.473 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 62' ' ' VAL . . . . . 0.635 HG23 ' N ' ' A' ' 63' ' ' ALA . 29.0 m -47.16 -54.38 2.72 Favored 'Isoleucine or valine' 0 C--O 1.209 -1.057 0 C-N-CA 119.754 -0.778 . . . . 1.0 109.767 -176.851 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 63' ' ' ALA . . . . . 0.635 ' N ' HG23 ' A' ' 62' ' ' VAL . . . -66.62 -52.61 43.28 Favored 'General case' 0 C--N 1.306 -1.283 0 N-CA-C 109.559 -0.534 . . . . 1.0 109.559 -179.81 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 64' ' ' HIS . . . . . 0.443 ' O ' ' CG ' ' A' ' 67' ' ' ARG . 9.7 t60 -50.59 -58.8 4.98 Favored 'General case' 0 CA--C 1.542 0.66 0 CA-C-O 122.175 0.988 . . . . 1.0 109.933 -179.168 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 65' ' ' ASP . . . . . 0.606 ' C ' ' H ' ' A' ' 67' ' ' ARG . 58.9 t0 -67.83 -50.31 57.39 Favored 'General case' 0 C--N 1.31 -1.129 0 CA-C-O 122.492 1.139 . . . . 1.0 109.455 177.947 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . 0.658 ' O ' HD12 ' A' ' 68' ' ' LEU . . . -68.23 30.84 0.26 Allowed Glycine 0 C--O 1.224 -0.497 0 O-C-N 121.069 -1.02 . . . . 1.0 111.795 178.487 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 67' ' ' ARG . . . . . 0.709 ' CB ' ' HB3' ' A' ' 71' ' ' ALA . 4.7 mmm180 -74.22 5.47 4.43 Favored 'General case' 0 C--N 1.306 -1.323 0 N-CA-C 108.72 -0.845 . . . . 1.0 108.72 176.279 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . 0.658 HD12 ' O ' ' A' ' 66' ' ' GLY . 0.0 OUTLIER -34.22 -29.28 0.01 OUTLIER 'General case' 0 N--CA 1.481 1.09 0 N-CA-C 108.298 -1.001 . . . . 1.0 108.298 -176.671 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . 0.607 ' N ' ' O ' ' A' ' 67' ' ' ARG . 0.5 OUTLIER -68.36 -68.4 0.39 Allowed 'General case' 0 CA--C 1.546 0.817 0 C-N-CA 119.336 -0.946 . . . . 1.0 110.357 179.633 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . 0.69 ' C ' ' H ' ' A' ' 72' ' ' HIS . . . -78.29 -77.09 0.17 Allowed 'General case' 0 CA--C 1.51 -0.575 0 N-CA-C 108.344 -0.984 . . . . 1.0 108.344 179.925 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 71' ' ' ALA . . . . . 0.806 ' HB1' ' HB ' ' A' ' 74' ' ' VAL . . . -51.86 10.3 0.0 OUTLIER 'General case' 0 CA--C 1.537 0.458 0 C-N-CA 125.007 1.323 . . . . 1.0 111.953 178.188 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 72' ' ' HIS . . . . . 1.009 ' CD2' ' H ' ' A' ' 73' ' ' MET . 0.3 OUTLIER -21.37 -61.78 0.03 OUTLIER 'General case' 0 CA--C 1.519 -0.244 0 N-CA-C 113.9 1.074 . . . . 1.0 113.9 -178.957 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 73' ' ' MET . . . . . 1.009 ' H ' ' CD2' ' A' ' 72' ' ' HIS . 5.3 ptm -71.14 -45.6 63.23 Favored 'General case' 0 C--N 1.313 -0.978 0 N-CA-C 108.954 -0.758 . . . . 1.0 108.954 179.114 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . 0.806 ' HB ' ' HB1' ' A' ' 71' ' ' ALA . 79.7 t -40.88 -40.77 0.59 Allowed 'Isoleucine or valine' 0 CA--C 1.507 -0.697 0 CA-C-O 117.854 -1.07 . . . . 1.0 109.916 -175.937 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 75' ' ' ASN . . . . . 0.418 ' C ' ' N ' ' A' ' 77' ' ' ILE . 1.7 t-20 -33.59 -15.52 0.0 OUTLIER 'General case' 0 N--CA 1.482 1.136 0 CA-C-O 122.259 1.028 . . . . 1.0 110.891 178.305 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 76' ' ' GLY . . . . . 0.795 ' N ' ' O ' ' A' ' 74' ' ' VAL . . . -49.71 -22.04 3.87 Favored Glycine 0 N--CA 1.435 -1.414 0 N-CA-C 107.227 -2.349 . . . . 1.0 107.227 173.901 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 77' ' ' ILE . . . . . 0.418 ' N ' ' C ' ' A' ' 75' ' ' ASN . 85.2 mt -59.49 -52.84 56.24 Favored 'Isoleucine or valine' 0 C--N 1.351 0.658 0 CA-C-O 118.259 -0.876 . . . . 1.0 111.986 -179.927 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 33.0 t -51.04 -21.86 1.48 Allowed 'Isoleucine or valine' 0 C--N 1.351 0.659 0 CA-C-N 121.279 1.854 . . . . 1.0 112.477 -179.445 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . 0.72 ' O ' ' HB2' ' A' ' 83' ' ' ALA . 0.1 OUTLIER -94.88 -40.57 11.35 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.576 0 CA-C-N 116.102 -0.499 . . . . 1.0 109.888 179.713 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -77.32 -19.16 56.78 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.647 -0.706 . . . . 1.0 111.41 -179.232 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 22.5 tt0 -87.19 -67.6 0.81 Allowed 'General case' 0 N--CA 1.438 -1.047 0 N-CA-C 109.616 -0.513 . . . . 1.0 109.616 178.961 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 82' ' ' ASP . . . . . 0.817 ' O ' ' N ' ' A' ' 84' ' ' LEU . 15.6 m-20 -60.46 -61.18 2.78 Favored 'General case' 0 C--N 1.352 0.682 0 C-N-CA 118.91 -1.116 . . . . 1.0 109.267 -179.391 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . 0.72 ' HB2' ' O ' ' A' ' 79' ' ' ILE . . . 23.69 -67.29 0.0 OUTLIER 'General case' 0 N--CA 1.486 1.371 0 O-C-N 124.752 1.283 . . . . 1.0 112.063 179.868 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . 0.817 ' N ' ' O ' ' A' ' 82' ' ' ASP . 0.8 OUTLIER -33.21 -41.76 0.08 Allowed 'General case' 0 N--CA 1.476 0.843 0 C-N-CA 122.728 0.411 . . . . 1.0 111.934 -178.09 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 85' ' ' ILE . . . . . 0.523 ' O ' ' HB3' ' A' ' 88' ' ' ALA . 18.2 pt -95.2 -41.64 12.06 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.615 0 N-CA-C 109.146 -0.687 . . . . 1.0 109.146 178.675 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 86' ' ' ALA . . . . . 0.569 ' HB3' ' HA ' ' A' ' 83' ' ' ALA . . . -54.43 -57.87 9.64 Favored 'General case' 0 CA--C 1.54 0.585 0 CA-C-N 115.399 -0.818 . . . . 1.0 110.305 -179.448 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -71.16 10.58 0.55 Allowed 'General case' 0 CA--C 1.538 0.505 0 N-CA-C 111.838 0.31 . . . . 1.0 111.838 -179.023 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 88' ' ' ALA . . . . . 0.523 ' HB3' ' O ' ' A' ' 85' ' ' ILE . . . -99.28 -19.89 16.84 Favored 'General case' 0 N--CA 1.48 1.044 0 CA-C-O 122.738 1.256 . . . . 1.0 109.156 179.281 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 28.6 m -104.32 37.46 0.31 Allowed 'Isoleucine or valine' 0 C--N 1.313 -1.018 0 CA-C-N 111.832 -2.44 . . . . 1.0 110.004 178.259 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 90' ' ' GLY . . . . . 0.624 ' O ' ' N ' ' A' ' 92' ' ' HIS . . . -65.17 -41.02 97.16 Favored Glycine 0 CA--C 1.537 1.456 0 CA-C-O 118.853 -0.97 . . . . 1.0 111.671 177.144 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 91' ' ' PRO . . . . . 0.498 ' HD2' ' N ' ' A' ' 90' ' ' GLY . 88.3 Cg_exo -41.47 -11.71 0.03 OUTLIER 'Trans proline' 0 N--CA 1.5 1.879 0 C-N-CA 122.349 2.033 . . . . 1.0 112.008 178.923 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 92' ' ' HIS . . . . . 0.624 ' N ' ' O ' ' A' ' 90' ' ' GLY . 6.5 p-80 -55.08 -18.75 5.87 Favored 'General case' 0 C--O 1.194 -1.833 0 N-CA-C 108.615 -0.883 . . . . 1.0 108.615 -179.736 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 93' ' ' LEU . . . . . 0.568 HD12 ' N ' ' A' ' 94' ' ' ALA . 0.8 OUTLIER -62.53 -57.9 9.51 Favored 'General case' 0 C--N 1.317 -0.806 0 N-CA-C 108.763 -0.828 . . . . 1.0 108.763 179.225 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 94' ' ' ALA . . . . . 0.568 ' N ' HD12 ' A' ' 93' ' ' LEU . . . -58.27 -57.76 11.46 Favored 'General case' 0 N--CA 1.452 -0.369 0 CA-C-N 115.293 -0.867 . . . . 1.0 109.335 179.265 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 95' ' ' ARG . . . . . 0.588 ' O ' ' N ' ' A' ' 97' ' ' LEU . 37.4 mtp-105 -56.84 -59.67 4.69 Favored 'General case' 0 C--O 1.242 0.681 0 CA-C-O 123.098 1.428 . . . . 1.0 108.041 179.288 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 96' ' ' ALA . . . . . 0.84 ' O ' ' N ' ' A' ' 98' ' ' GLY . . . -47.32 -15.82 0.05 OUTLIER 'General case' 0 C--N 1.301 -1.502 0 O-C-N 118.572 -2.58 . . . . 1.0 111.042 -179.051 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 97' ' ' LEU . . . . . 0.641 ' O ' ' N ' ' A' ' 100' ' ' ILE 0.279 16.1 tp 6.17 -54.07 0.0 OUTLIER 'General case' 0 N--CA 1.477 0.906 0 CA-C-O 118.116 -0.945 . . . . 1.0 112.287 -168.266 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 98' ' ' GLY . . . . . 0.84 ' N ' ' O ' ' A' ' 96' ' ' ALA . . . -49.38 -24.44 5.24 Favored Glycine 0 C--N 1.295 -1.708 0 CA-C-N 122.303 2.32 . . . . 1.0 108.417 175.16 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 99' ' ' GLN . . . . . 0.509 ' N ' ' O ' ' A' ' 96' ' ' ALA . 40.9 mm-40 -71.39 -20.7 62.11 Favored 'General case' 0 C--N 1.371 1.538 0 C-N-CA 117.477 -1.689 . . . . 1.0 107.882 177.344 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 100' ' ' ILE . . . . . 0.641 ' N ' ' O ' ' A' ' 97' ' ' LEU . 0.3 OUTLIER -67.45 -40.66 84.96 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.499 0 N-CA-C 108.131 -1.063 . . . . 1.0 108.131 177.392 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 101' ' ' VAL . . . . . 0.678 ' O ' ' N ' ' A' ' 105' ' ' GLY . 0.4 OUTLIER -57.4 -58.35 6.41 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.605 0 N-CA-C 106.561 -1.644 . . . . 1.0 106.561 179.959 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 102' ' ' CYS . . . . . 0.969 ' O ' ' HB2' ' A' ' 106' ' ' ALA . 4.6 t -47.07 -21.87 0.28 Allowed 'General case' 0 C--O 1.209 -1.043 0 CA-C-N 115.666 -0.697 . . . . 1.0 110.649 -179.801 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 103' ' ' ARG . . . . . 0.402 ' N ' ' C ' ' A' ' 101' ' ' VAL . 2.1 tmm_? -88.57 -43.32 11.47 Favored 'General case' 0 N--CA 1.486 1.326 0 CA-C-O 122.689 1.233 . . . . 1.0 111.779 178.118 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 104' ' ' TYR . . . . . 0.779 ' O ' ' CG ' ' A' ' 104' ' ' TYR . 1.3 t80 -98.14 23.19 8.51 Favored 'General case' 0 C--N 1.31 -1.121 0 CA-C-N 112.373 -2.194 . . . . 1.0 108.572 177.238 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 105' ' ' GLY . . . . . 0.678 ' N ' ' O ' ' A' ' 101' ' ' VAL . . . -167.68 -92.19 0.08 OUTLIER Glycine 0 N--CA 1.446 -0.695 0 N-CA-C 107.104 -2.398 . . . . 1.0 107.104 177.756 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 106' ' ' ALA . . . . . 0.969 ' HB2' ' O ' ' A' ' 102' ' ' CYS . . . 67.36 63.18 0.44 Allowed 'General case' 0 N--CA 1.443 -0.793 0 N-CA-C 112.418 0.525 . . . . 1.0 112.418 179.83 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 107' ' ' THR . . . . . 0.475 ' O ' ' HD2' ' A' ' 110' ' ' PRO . 19.1 m -83.1 -65.05 1.06 Allowed 'General case' 0 CA--C 1.541 0.632 0 O-C-N 121.449 -0.782 . . . . 1.0 111.603 179.96 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 9.1 m -71.63 28.54 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.322 -0.616 0 O-C-N 121.078 -1.014 . . . . 1.0 111.644 -177.107 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 109' ' ' ILE . . . . . 0.756 ' H ' ' HD2' ' A' ' 110' ' ' PRO . 0.1 OUTLIER -112.48 -53.05 0.05 OUTLIER Pre-proline 0 CA--C 1.553 1.061 0 N-CA-C 108.167 -1.049 . . . . 1.0 108.167 176.117 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 110' ' ' PRO . . . . . 0.756 ' HD2' ' H ' ' A' ' 109' ' ' ILE . 19.1 Cg_endo -51.48 -29.78 32.8 Favored 'Trans proline' 0 N--CA 1.494 1.501 0 C-N-CA 122.563 2.176 . . . . 1.0 111.259 178.634 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 11.0 t-20 -63.01 -69.4 0.27 Allowed 'General case' 0 N--CA 1.466 0.356 0 C-N-CA 120.511 -0.476 . . . . 1.0 110.392 -179.339 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 112' ' ' ILE . . . . . 0.486 HG13 ' N ' ' A' ' 113' ' ' ASN . 26.6 pt -51.62 -31.13 12.27 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.457 0 CA-C-O 123.228 1.49 . . . . 1.0 109.717 179.502 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 113' ' ' ASN . . . . . 0.486 ' N ' HG13 ' A' ' 112' ' ' ILE . 0.0 OUTLIER -52.87 -52.58 56.85 Favored 'General case' 0 C--N 1.301 -1.511 0 CA-C-N 112.077 -2.329 . . . . 1.0 107.746 -177.858 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 114' ' ' ALA . . . . . 0.437 ' O ' HG23 ' A' ' 118' ' ' VAL . . . -60.09 -32.64 71.16 Favored 'General case' 0 N--CA 1.442 -0.848 0 N-CA-C 112.182 0.438 . . . . 1.0 112.182 179.625 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -81.27 -57.19 3.61 Favored 'General case' 0 C--O 1.215 -0.751 0 CA-C-O 121.499 0.666 . . . . 1.0 111.702 178.732 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 116' ' ' ILE . . . . . 0.529 ' O ' ' N ' ' A' ' 120' ' ' GLY . 3.4 mm -51.72 -57.86 2.94 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.715 0 CA-C-O 122.479 1.133 . . . . 1.0 108.043 -177.907 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 117' ' ' GLU . . . . . 0.537 ' O ' ' HA ' ' A' ' 121' ' ' THR . 6.5 mt-10 -40.15 -53.17 2.5 Favored 'General case' 0 C--N 1.315 -0.919 0 CA-C-N 112.285 -2.234 . . . . 1.0 105.927 -178.29 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 118' ' ' VAL . . . . . 0.437 HG23 ' O ' ' A' ' 114' ' ' ALA . 78.0 t -60.26 -52.04 65.91 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.608 0 C-N-CA 119.459 -0.896 . . . . 1.0 109.065 177.261 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 119' ' ' LEU . . . . . 0.488 ' N ' ' O ' ' A' ' 116' ' ' ILE . 0.9 OUTLIER -58.39 -70.31 0.15 Allowed 'General case' 0 N--CA 1.454 -0.253 0 C-N-CA 119.209 -0.997 . . . . 1.0 108.387 -177.656 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 120' ' ' GLY . . . . . 0.613 ' O ' ' OG1' ' A' ' 121' ' ' THR . . . -66.19 -84.99 0.08 OUTLIER Glycine 0 C--N 1.351 1.362 0 C-N-CA 118.127 -1.987 . . . . 1.0 109.159 178.41 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 121' ' ' THR . . . . . 0.613 ' OG1' ' O ' ' A' ' 120' ' ' GLY . 18.5 m 160.46 -34.55 0.0 OUTLIER 'General case' 0 N--CA 1.482 1.164 0 O-C-N 125.373 1.278 . . . . 1.0 112.858 179.421 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 122' ' ' GLY . . . . . 0.643 ' O ' ' N ' ' A' ' 124' ' ' ASP . . . 105.64 -14.19 46.31 Favored Glycine 0 N--CA 1.461 0.313 0 N-CA-C 107.285 -2.326 . . . . 1.0 107.285 -175.832 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 123' ' ' THR . . . . . 0.44 ' OG1' ' CG2' ' A' ' 121' ' ' THR . 2.8 m -54.89 82.39 0.0 OUTLIER 'General case' 0 N--CA 1.465 0.311 0 N-CA-C 106.037 -1.838 . . . . 1.0 106.037 178.59 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 124' ' ' ASP . . . . . 0.643 ' N ' ' O ' ' A' ' 122' ' ' GLY . 18.2 t70 -164.29 170.34 16.33 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 114.057 -1.429 . . . . 1.0 112.117 -179.338 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 125' ' ' TYR . . . . . . . . . . . . . 33.5 t80 -151.32 149.01 28.85 Favored 'General case' 0 CA--C 1.535 0.391 0 CA-C-N 115.637 -0.71 . . . . 1.0 109.937 177.298 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 14.6 tpp180 -149.13 150.08 32.1 Favored 'General case' 0 CA--C 1.532 0.283 0 CA-C-N 115.792 -0.64 . . . . 1.0 110.169 177.785 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 127' ' ' PHE . . . . . 0.559 ' H ' HD12 ' A' ' 79' ' ' ILE . 20.4 t80 . . . . . 0 C--O 1.22 -0.469 0 CA-C-O 118.036 -0.983 . . . . 1.0 109.366 178.687 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 62.1 mtt . . . . . 0 N--CA 1.489 1.509 0 N-CA-C 108.961 -0.755 . . . . 1.0 108.961 . . . . . . . . . 0 0 . 1 . 024 nuclear nobuild core ' A' A ' 2' ' ' SER . . . . . 0.458 ' O ' ' CB ' ' A' ' 3' ' ' ASP . 91.4 p -93.78 10.29 33.64 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.19 -0.459 . . . . 1.0 110.692 -179.793 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 3' ' ' ASP . . . . . 0.458 ' CB ' ' O ' ' A' ' 2' ' ' SER . 7.1 m-20 157.62 111.34 0.0 OUTLIER 'General case' 0 N--CA 1.471 0.618 0 O-C-N 123.82 0.7 . . . . 1.0 110.256 178.643 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 60.6 t80 -153.66 149.19 27.29 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-N 116.263 -0.426 . . . . 1.0 110.743 179.792 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 5' ' ' ASP . . . . . 0.528 ' N ' ' OD1' ' A' ' 5' ' ' ASP . 0.3 OUTLIER -155.31 150.77 27.22 Favored 'General case' 0 CA--C 1.533 0.312 0 CA-C-N 116.373 -0.376 . . . . 1.0 110.874 -179.057 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' A' A ' 6' ' ' THR . . . . . 0.564 HG22 ' H ' ' A' ' 7' ' ' GLU . 0.2 OUTLIER -61.38 -158.29 0.01 OUTLIER 'General case' 0 N--CA 1.464 0.264 0 C-N-CA 120.762 -0.375 . . . . 1.0 110.637 -179.532 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . 0.564 ' H ' HG22 ' A' ' 6' ' ' THR . 42.8 tt0 -74.34 -66.49 0.72 Allowed 'General case' 0 CA--C 1.502 -0.894 0 C-N-CA 120.699 -0.4 . . . . 1.0 110.047 -178.95 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 8' ' ' ARG . . . . . 0.534 ' O ' ' CB ' ' A' ' 12' ' ' ALA . 13.0 ttm105 -52.54 -44.98 66.16 Favored 'General case' 0 N--CA 1.437 -1.123 0 N-CA-C 112.432 0.53 . . . . 1.0 112.432 -177.057 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . 0.663 ' O ' HG22 ' A' ' 13' ' ' VAL . 97.7 t -64.78 -51.12 71.2 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.148 0 C-N-CA 117.986 -1.486 . . . . 1.0 109.212 179.284 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 34.3 t -63.49 -40.73 97.85 Favored 'General case' 0 N--CA 1.474 0.749 0 N-CA-C 114.355 1.243 . . . . 1.0 114.355 -179.066 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 11' ' ' ARG . . . . . 0.544 ' O ' ' N ' ' A' ' 15' ' ' ALA . 59.3 ttm-85 -80.16 -54.92 5.31 Favored 'General case' 0 CA--C 1.536 0.442 0 CA-C-O 122.714 1.245 . . . . 1.0 109.732 178.047 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . 0.716 ' O ' ' HB3' ' A' ' 16' ' ' ALA . . . -46.26 -48.59 17.96 Favored 'General case' 0 N--CA 1.483 1.213 0 CA-C-N 112.907 -1.951 . . . . 1.0 106.14 -176.218 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . 0.663 HG22 ' O ' ' A' ' 9' ' ' VAL . 34.0 m -60.63 -52.45 61.34 Favored 'Isoleucine or valine' 0 C--O 1.197 -1.663 0 C-N-CA 116.873 -1.931 . . . . 1.0 108.046 176.757 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . 0.715 ' O ' HG13 ' A' ' 18' ' ' VAL . . . -58.53 -64.59 0.87 Allowed 'General case' 0 N--CA 1.472 0.632 0 C-N-CA 118.428 -1.309 . . . . 1.0 111.736 179.911 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . 0.563 ' O ' ' N ' ' A' ' 19' ' ' GLY . . . -53.19 -55.99 19.91 Favored 'General case' 0 N--CA 1.475 0.802 0 CA-C-O 121.731 0.777 . . . . 1.0 110.161 -177.55 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . 0.716 ' HB3' ' O ' ' A' ' 12' ' ' ALA . . . -63.96 -53.84 43.92 Favored 'General case' 0 C--N 1.311 -1.098 0 CA-C-N 114.56 -1.2 . . . . 1.0 109.066 -178.985 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . 0.636 ' CB ' ' O ' ' A' ' 13' ' ' VAL . 33.0 tp -56.83 -53.73 54.48 Favored 'General case' 0 N--CA 1.484 1.232 0 C-N-CA 119.047 -1.061 . . . . 1.0 108.637 -177.505 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . 0.715 HG13 ' O ' ' A' ' 14' ' ' ALA . 1.7 m -69.94 -57.44 8.19 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.457 0 C-N-CA 119.778 -0.769 . . . . 1.0 110.032 179.515 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . 0.563 ' N ' ' O ' ' A' ' 15' ' ' ALA . . . -64.93 -172.76 3.36 Favored Glycine 0 CA--C 1.526 0.761 0 N-CA-C 110.816 -0.914 . . . . 1.0 110.816 -179.532 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 20' ' ' PRO . . . . . 0.587 ' O ' ' N ' ' A' ' 24' ' ' ALA . 6.0 Cg_exo -76.46 -22.95 11.9 Favored 'Trans proline' 0 N--CA 1.503 2.036 0 C-N-CA 123.481 2.787 . . . . 1.0 114.651 -178.442 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -59.82 -57.73 17.89 Favored Glycine 0 N--CA 1.475 1.264 0 C-N-CA 119.576 -1.297 . . . . 1.0 111.831 -176.505 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . 0.572 ' CA ' ' HB1' ' A' ' 16' ' ' ALA . . . -58.24 -55.51 30.28 Favored Glycine 0 N--CA 1.464 0.547 0 N-CA-C 108.07 -2.012 . . . . 1.0 108.07 -177.249 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . 0.532 ' CG2' ' O ' ' A' ' 19' ' ' GLY . 0.0 OUTLIER -61.5 -35.34 66.19 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.137 0 CA-C-N 114.918 -0.641 . . . . 1.0 109.771 -179.963 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . 0.587 ' N ' ' O ' ' A' ' 20' ' ' PRO . . . -54.6 -60.84 2.81 Favored 'General case' 0 CA--C 1.537 0.462 0 C-N-CA 118.223 -1.391 . . . . 1.0 108.893 -179.989 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 15.1 tp -63.01 -45.23 93.36 Favored 'General case' 0 C--N 1.341 0.229 0 CA-C-N 118.386 0.539 . . . . 1.0 112.192 -179.302 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 82.0 t -59.86 -60.02 3.13 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.227 0 C-N-CA 118.664 -1.215 . . . . 1.0 110.052 -177.138 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . 0.431 ' O ' ' HB3' ' A' ' 31' ' ' ALA . 2.6 t -59.19 -37.39 68.33 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.309 0 N-CA-C 112.024 0.379 . . . . 1.0 112.024 -178.341 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 25.2 tttm -65.25 -54.43 29.39 Favored 'General case' 0 C--N 1.319 -0.727 0 C-N-CA 119.936 -0.705 . . . . 1.0 109.275 -179.121 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 43.4 t -63.38 -47.1 93.42 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.993 0 CA-C-N 114.719 -1.128 . . . . 1.0 110.603 -178.332 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 30' ' ' CYS . . . . . 0.521 ' SG ' ' N ' ' A' ' 31' ' ' ALA . 0.0 OUTLIER -67.61 -61.09 2.06 Favored 'General case' 0 CA--C 1.533 0.3 0 C-N-CA 118.474 -1.29 . . . . 1.0 110.152 -179.714 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . 0.521 ' N ' ' SG ' ' A' ' 30' ' ' CYS . . . -64.3 -53.68 45.13 Favored 'General case' 0 CA--C 1.514 -0.429 0 N-CA-C 113.893 1.071 . . . . 1.0 113.893 -176.014 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 82.26 72.37 1.26 Allowed Glycine 0 CA--C 1.528 0.902 0 N-CA-C 109.018 -1.633 . . . . 1.0 109.018 -177.056 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . 0.445 ' O ' ' O ' ' A' ' 36' ' ' VAL . 2.9 mt 85.86 86.05 0.05 OUTLIER Pre-proline 0 N--CA 1.476 0.856 0 C-N-CA 123.409 0.683 . . . . 1.0 111.447 -179.788 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 52.7 Cg_exo -56.98 -26.76 69.93 Favored 'Trans proline' 0 N--CA 1.506 2.223 0 C-N-CA 123.366 2.71 . . . . 1.0 113.517 179.251 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -54.92 -57.0 20.15 Favored Glycine 0 CA--C 1.521 0.424 0 N-CA-C 108.224 -1.95 . . . . 1.0 108.224 -179.355 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . 0.537 ' O ' ' CB ' ' A' ' 37' ' ' ILE . 14.5 p -97.07 163.01 2.51 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 N-CA-C 107.521 -1.289 . . . . 1.0 107.521 177.755 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . 0.537 ' CB ' ' O ' ' A' ' 36' ' ' VAL . 3.7 mm 122.12 116.54 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.484 1.267 0 O-C-N 124.4 1.062 . . . . 1.0 109.499 -179.322 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 38' ' ' HIS . . . . . 0.405 ' CD2' ' N ' ' A' ' 38' ' ' HIS . 0.0 OUTLIER -138.63 129.29 26.29 Favored 'General case' 0 C--N 1.329 -0.286 0 N-CA-C 107.55 -1.278 . . . . 1.0 107.55 178.704 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -95.95 154.07 39.06 Favored Pre-proline 0 N--CA 1.467 0.391 0 N-CA-C 109.87 -0.419 . . . . 1.0 109.87 -179.435 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 97.6 Cg_endo -77.52 -42.27 0.29 Allowed 'Trans proline' 0 C--N 1.311 -1.4 0 C-N-CA 122.25 1.966 . . . . 1.0 113.787 -179.101 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -125.2 131.58 53.15 Favored 'General case' 0 N--CA 1.466 0.351 0 CA-C-O 119.626 -0.226 . . . . 1.0 110.464 179.313 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . 0.629 ' C ' ' H ' ' A' ' 44' ' ' GLY . 0.4 OUTLIER -166.96 163.72 16.06 Favored 'General case' 0 C--N 1.326 -0.435 0 C-N-CA 119.756 -0.778 . . . . 1.0 110.433 178.037 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' A' A ' 43' ' ' ARG . . . . . 0.462 ' C ' ' H ' ' A' ' 45' ' ' PHE . 3.3 tpt85 -63.87 22.09 0.01 OUTLIER 'General case' 0 CA--C 1.538 0.505 0 CA-C-N 115.857 -0.61 . . . . 1.0 111.088 -179.204 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . 0.629 ' H ' ' C ' ' A' ' 42' ' ' ARG . . . 71.63 -27.92 0.61 Allowed Glycine 0 CA--C 1.527 0.819 0 N-CA-C 111.745 -0.542 . . . . 1.0 111.745 179.705 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . 0.485 ' O ' ' HB2' ' A' ' 46' ' ' PHE . 20.9 t80 -151.34 149.68 29.62 Favored 'General case' 0 C--O 1.218 -0.587 0 CA-C-N 117.166 0.483 . . . . 1.0 109.741 -179.258 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 46' ' ' PHE . . . . . 0.555 ' O ' ' CG ' ' A' ' 47' ' ' ARG . 1.8 m-85 141.14 83.66 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.836 0 C-N-CA 124.378 1.071 . . . . 1.0 109.736 179.154 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 47' ' ' ARG . . . . . 0.555 ' CG ' ' O ' ' A' ' 46' ' ' PHE . 3.9 mmp_? 137.63 134.44 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.51 0 C-N-CA 123.715 0.806 . . . . 1.0 109.186 179.489 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 48' ' ' CYS . . . . . 0.471 ' SG ' ' C ' ' A' ' 47' ' ' ARG . 2.0 m 77.22 69.45 0.05 Allowed 'General case' 0 C--O 1.218 -0.572 0 CA-C-N 118.409 0.549 . . . . 1.0 110.195 179.785 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -114.6 147.86 39.04 Favored Pre-proline 0 N--CA 1.464 0.265 0 O-C-N 120.748 -1.22 . . . . 1.0 108.864 179.543 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -73.02 59.26 3.58 Favored 'Trans proline' 0 C--N 1.308 -1.58 0 C-N-CA 121.836 1.691 . . . . 1.0 111.101 -179.975 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 22.7 mm-40 58.8 59.33 2.89 Favored 'General case' 0 N--CA 1.454 -0.259 0 CA-C-N 116.25 -0.432 . . . . 1.0 111.074 179.453 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 16.6 ptt180 -146.13 178.72 8.01 Favored 'General case' 0 N--CA 1.466 0.359 0 CA-C-N 116.24 -0.437 . . . . 1.0 110.377 179.724 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . 0.771 HD12 ' N ' ' A' ' 54' ' ' GLN . 0.1 OUTLIER -86.61 138.61 18.74 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.334 0 CA-C-O 121.655 0.741 . . . . 1.0 110.484 179.671 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' A' A ' 54' ' ' GLN . . . . . 0.771 ' N ' HD12 ' A' ' 53' ' ' ILE . 0.0 OUTLIER -62.34 82.84 0.02 OUTLIER 'General case' 0 C--N 1.319 -0.742 0 CA-C-N 114.701 -1.136 . . . . 1.0 109.033 -177.961 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . 0.438 ' N ' ' O ' ' A' ' 53' ' ' ILE . 21.2 tt -149.48 158.23 6.17 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.457 0 CA-C-N 115.858 -0.61 . . . . 1.0 110.611 178.156 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 109.31 -5.97 31.89 Favored Glycine 0 N--CA 1.473 1.129 0 N-CA-C 110.95 -0.86 . . . . 1.0 110.95 -179.969 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 13.1 p-10 -77.94 100.78 6.56 Favored 'General case' 0 C--N 1.323 -0.563 0 N-CA-C 109.026 -0.731 . . . . 1.0 109.026 178.751 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 58' ' ' TRP . . . . . 0.47 ' H ' ' CD ' ' A' ' 61' ' ' GLU . 0.3 OUTLIER -88.75 174.75 7.83 Favored 'General case' 0 CA--C 1.542 0.656 0 CA-C-O 123.18 1.466 . . . . 1.0 113.364 -177.625 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 9.0 mtm180 -80.5 -59.32 2.74 Favored 'General case' 0 C--N 1.315 -0.899 0 CA-C-N 111.416 -2.629 . . . . 1.0 113.418 -178.381 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 1.2 p90 -88.67 -10.03 49.97 Favored 'General case' 0 C--O 1.248 1.012 0 CA-C-N 114.81 -1.086 . . . . 1.0 113.573 -177.673 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . 0.513 ' O ' ' N ' ' A' ' 65' ' ' ASP . 13.5 pt-20 -71.8 -14.26 61.93 Favored 'General case' 0 C--N 1.313 -0.991 0 N-CA-C 113.198 0.814 . . . . 1.0 113.198 -177.767 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 62' ' ' VAL . . . . . 0.623 ' O ' ' N ' ' A' ' 66' ' ' GLY . 0.1 OUTLIER -48.72 -58.94 0.97 Allowed 'Isoleucine or valine' 0 C--O 1.204 -1.293 0 C-N-CA 119.195 -1.002 . . . . 1.0 108.5 -174.317 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -66.33 -56.67 10.02 Favored 'General case' 0 C--N 1.295 -1.799 0 O-C-N 121.797 -0.564 . . . . 1.0 110.867 -179.325 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 64' ' ' HIS . . . . . 0.56 ' O ' ' HB2' ' A' ' 67' ' ' ARG . 67.3 m-70 -53.39 -56.36 17.42 Favored 'General case' 0 N--CA 1.465 0.312 0 C-N-CA 119.148 -1.021 . . . . 1.0 109.59 -179.247 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 65' ' ' ASP . . . . . 0.609 ' C ' ' H ' ' A' ' 67' ' ' ARG . 10.0 t0 -77.63 -50.9 11.54 Favored 'General case' 0 C--N 1.312 -1.032 0 O-C-N 121.889 -0.507 . . . . 1.0 111.667 179.984 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . 0.623 ' N ' ' O ' ' A' ' 62' ' ' VAL . . . -71.83 26.84 0.63 Allowed Glycine 0 CA--C 1.524 0.655 0 O-C-N 120.608 -1.307 . . . . 1.0 110.412 178.042 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 67' ' ' ARG . . . . . 0.613 ' O ' ' N ' ' A' ' 69' ' ' LEU . 4.1 tpt85 -74.93 4.38 6.64 Favored 'General case' 0 N--CA 1.448 -0.566 0 N-CA-C 107.183 -1.414 . . . . 1.0 107.183 176.074 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . 0.493 ' H ' ' C ' ' A' ' 66' ' ' GLY . 12.9 mt -33.55 -28.13 0.01 OUTLIER 'General case' 0 N--CA 1.475 0.79 0 CA-C-N 114.687 -1.142 . . . . 1.0 108.871 -177.622 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . 0.613 ' N ' ' O ' ' A' ' 67' ' ' ARG . 3.0 tt -65.86 -66.03 0.6 Allowed 'General case' 0 CA--C 1.546 0.821 0 C-N-CA 119.293 -0.963 . . . . 1.0 110.085 -179.17 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . 0.64 ' C ' ' H ' ' A' ' 72' ' ' HIS . . . -79.1 -78.36 0.15 Allowed 'General case' 0 N--CA 1.475 0.819 0 C-N-CA 118.766 -1.174 . . . . 1.0 108.439 -179.842 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 71' ' ' ALA . . . . . 0.785 ' HB1' ' HB ' ' A' ' 74' ' ' VAL . . . -50.32 9.53 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.285 0 C-N-CA 125.651 1.581 . . . . 1.0 113.005 179.342 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 72' ' ' HIS . . . . . 0.973 ' CD2' ' H ' ' A' ' 73' ' ' MET . 0.3 OUTLIER -24.21 -58.75 0.05 Allowed 'General case' 0 C--N 1.33 -0.247 0 N-CA-C 113.765 1.024 . . . . 1.0 113.765 -177.197 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' A' A ' 73' ' ' MET . . . . . 0.973 ' H ' ' CD2' ' A' ' 72' ' ' HIS . 95.0 mtp -68.94 -45.99 69.34 Favored 'General case' 0 C--N 1.319 -0.746 0 C-N-CA 119.604 -0.838 . . . . 1.0 109.145 179.34 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . 0.785 ' HB ' ' HB1' ' A' ' 71' ' ' ALA . 39.2 t -45.26 -43.92 3.3 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.255 0 CA-C-O 117.658 -1.163 . . . . 1.0 111.685 -176.365 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 75' ' ' ASN . . . . . 0.702 HD21 HH22 ' A' ' 126' ' ' ARG . 0.7 OUTLIER -39.6 -11.14 0.01 OUTLIER 'General case' 0 C--N 1.362 1.134 0 CA-C-N 121.05 1.75 . . . . 1.0 111.419 178.994 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' A' A ' 76' ' ' GLY . . . . . 0.719 ' N ' ' O ' ' A' ' 74' ' ' VAL . . . -42.12 -27.3 0.41 Allowed Glycine 0 CA--C 1.536 1.384 0 N-CA-C 107.301 -2.32 . . . . 1.0 107.301 177.988 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 77' ' ' ILE . . . . . 0.668 ' HA ' ' HB3' ' A' ' 80' ' ' ALA . 7.1 pt -68.76 -49.45 64.09 Favored 'Isoleucine or valine' 0 C--O 1.212 -0.881 0 N-CA-C 108.663 -0.866 . . . . 1.0 108.663 176.653 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . 0.636 ' N ' ' O ' ' A' ' 75' ' ' ASN . 2.0 p -32.35 -39.09 0.04 OUTLIER 'Isoleucine or valine' 0 CA--C 1.545 0.769 0 N-CA-C 108.846 -0.798 . . . . 1.0 108.846 -176.369 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . 0.566 HG23 HG13 ' A' ' 78' ' ' VAL . 2.9 pp -97.71 -24.72 4.28 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.709 0 CA-C-O 121.153 0.501 . . . . 1.0 110.751 178.041 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 80' ' ' ALA . . . . . 0.668 ' HB3' ' HA ' ' A' ' 77' ' ' ILE . . . -86.98 -10.37 53.36 Favored 'General case' 0 CA--C 1.551 1.014 0 N-CA-C 113.381 0.882 . . . . 1.0 113.381 177.568 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 81' ' ' GLU . . . . . 0.596 ' N ' ' O ' ' A' ' 77' ' ' ILE . 81.9 tt0 -87.65 -71.22 0.58 Allowed 'General case' 0 N--CA 1.445 -0.699 0 CA-C-N 118.942 0.792 . . . . 1.0 109.426 -179.826 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 82' ' ' ASP . . . . . 0.648 ' O ' ' N ' ' A' ' 84' ' ' LEU . 0.7 OUTLIER -70.32 -11.63 61.04 Favored 'General case' 0 N--CA 1.444 -0.733 0 CA-C-N 119.109 0.868 . . . . 1.0 110.294 179.069 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . 0.805 ' O ' ' N ' ' A' ' 86' ' ' ALA . . . -18.79 -43.22 0.0 OUTLIER 'General case' 0 C--O 1.197 -1.668 0 O-C-N 124.072 0.858 . . . . 1.0 111.804 177.941 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . 0.648 ' N ' ' O ' ' A' ' 82' ' ' ASP . 19.1 mt -26.72 -30.55 0.0 OUTLIER 'General case' 0 N--CA 1.472 0.664 0 O-C-N 121.901 -0.5 . . . . 1.0 111.902 -175.801 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 85' ' ' ILE . . . . . 0.714 ' N ' ' O ' ' A' ' 83' ' ' ALA . 0.1 OUTLIER -98.57 -31.33 3.64 Favored 'Isoleucine or valine' 0 CA--C 1.551 1.009 0 N-CA-C 109.541 -0.54 . . . . 1.0 109.541 175.42 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' A' A ' 86' ' ' ALA . . . . . 0.805 ' N ' ' O ' ' A' ' 83' ' ' ALA . . . -91.89 -27.33 17.99 Favored 'General case' 0 N--CA 1.486 1.352 0 CA-C-O 121.897 0.856 . . . . 1.0 112.652 179.063 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 87' ' ' GLU . . . . . 0.604 ' N ' ' O ' ' A' ' 83' ' ' ALA . 3.3 pt-20 -47.33 -28.55 2.06 Favored 'General case' 0 C--N 1.313 -1.008 0 CA-C-N 114.089 -1.414 . . . . 1.0 109.963 -178.859 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -141.7 24.99 2.02 Favored 'General case' 0 N--CA 1.475 0.8 0 CA-C-O 121.585 0.707 . . . . 1.0 111.118 -178.99 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 89' ' ' VAL . . . . . 0.693 HG22 ' HB3' ' A' ' 92' ' ' HIS . 4.8 p -75.62 36.38 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.315 -0.921 0 CA-C-N 114.905 -1.043 . . . . 1.0 109.518 178.423 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 90' ' ' GLY . . . . . 0.529 ' O ' ' N ' ' A' ' 92' ' ' HIS . . . -66.77 -39.87 93.67 Favored Glycine 0 N--CA 1.439 -1.129 0 C-N-CA 119.055 -1.545 . . . . 1.0 111.138 178.693 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 91' ' ' PRO . . . . . 0.522 ' CD ' ' N ' ' A' ' 90' ' ' GLY . 95.8 Cg_exo -43.78 -20.1 0.23 Allowed 'Trans proline' 0 N--CA 1.49 1.293 0 CA-C-N 119.897 1.848 . . . . 1.0 110.003 179.777 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 92' ' ' HIS . . . . . 0.693 ' HB3' HG22 ' A' ' 89' ' ' VAL . 7.7 p-80 -60.65 -25.84 66.62 Favored 'General case' 0 C--O 1.218 -0.599 0 CA-C-N 114.724 -1.126 . . . . 1.0 109.396 179.649 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 93' ' ' LEU . . . . . 0.663 HD12 ' N ' ' A' ' 94' ' ' ALA . 2.2 pp -63.47 -58.7 6.2 Favored 'General case' 0 C--N 1.325 -0.494 0 N-CA-C 108.353 -0.98 . . . . 1.0 108.353 178.451 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 94' ' ' ALA . . . . . 0.663 ' N ' HD12 ' A' ' 93' ' ' LEU . . . -56.23 -55.93 27.2 Favored 'General case' 0 N--CA 1.452 -0.369 0 N-CA-C 109.26 -0.645 . . . . 1.0 109.26 179.096 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 95' ' ' ARG . . . . . 0.613 ' O ' ' N ' ' A' ' 97' ' ' LEU . 10.8 ttp180 -59.07 -61.04 2.94 Favored 'General case' 0 C--O 1.239 0.542 0 CA-C-O 122.333 1.064 . . . . 1.0 108.819 179.586 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 96' ' ' ALA . . . . . 0.871 ' O ' ' N ' ' A' ' 98' ' ' GLY . . . -47.68 -12.51 0.03 OUTLIER 'General case' 0 C--N 1.306 -1.319 0 O-C-N 118.56 -2.587 . . . . 1.0 112.072 -179.154 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 97' ' ' LEU . . . . . 0.829 HD12 ' N ' ' A' ' 98' ' ' GLY . 3.5 pp 5.34 -52.53 0.0 OUTLIER 'General case' 0 C--O 1.204 -1.328 0 CA-C-O 116.767 -1.587 . . . . 1.0 111.262 -166.595 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 98' ' ' GLY . . . . . 0.871 ' N ' ' O ' ' A' ' 96' ' ' ALA . . . -47.22 -24.14 2.13 Favored Glycine 0 C--N 1.303 -1.301 0 CA-C-N 123.381 2.809 . . . . 1.0 107.473 176.018 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 99' ' ' GLN . . . . . 0.524 ' HG2' ' HB1' ' A' ' 96' ' ' ALA . 57.5 mm-40 -64.44 -17.99 64.33 Favored 'General case' 0 C--N 1.361 1.098 0 C-N-CA 117.415 -1.714 . . . . 1.0 107.424 176.049 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 100' ' ' ILE . . . . . 0.799 ' N ' ' O ' ' A' ' 97' ' ' LEU . 12.1 tt -64.67 -44.75 96.63 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.629 0 N-CA-C 107.87 -1.159 . . . . 1.0 107.87 177.881 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 101' ' ' VAL . . . . . 0.801 ' O ' ' N ' ' A' ' 105' ' ' GLY . 68.9 t -60.14 -61.06 1.67 Allowed 'Isoleucine or valine' 0 C--O 1.209 -1.059 0 N-CA-C 107.585 -1.265 . . . . 1.0 107.585 179.499 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 102' ' ' CYS . . . . . 0.888 ' O ' ' HB2' ' A' ' 106' ' ' ALA . 0.5 OUTLIER -44.21 -19.02 0.02 OUTLIER 'General case' 0 C--N 1.319 -0.732 0 CA-C-O 121.399 0.619 . . . . 1.0 110.988 -179.458 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' A' A ' 103' ' ' ARG . . . . . 0.518 ' N ' ' O ' ' A' ' 101' ' ' VAL . 12.1 ttp-105 -95.44 -43.96 7.75 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-O 122.034 0.921 . . . . 1.0 111.889 177.383 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 104' ' ' TYR . . . . . 0.709 ' O ' ' CG ' ' A' ' 104' ' ' TYR . 0.1 OUTLIER -107.43 19.16 20.65 Favored 'General case' 0 CA--C 1.552 1.038 0 C-N-CA 126.628 1.971 . . . . 1.0 110.619 178.477 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' A' A ' 105' ' ' GLY . . . . . 0.801 ' N ' ' O ' ' A' ' 101' ' ' VAL . . . -162.64 -10.89 0.03 OUTLIER Glycine 0 C--N 1.332 0.324 0 C-N-CA 118.898 -1.62 . . . . 1.0 112.514 179.785 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 106' ' ' ALA . . . . . 0.888 ' HB2' ' O ' ' A' ' 102' ' ' CYS . . . -29.81 118.7 0.15 Allowed 'General case' 0 N--CA 1.463 0.219 0 CA-C-N 117.017 0.408 . . . . 1.0 110.081 179.391 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 107' ' ' THR . . . . . 0.798 ' O ' ' HD2' ' A' ' 110' ' ' PRO . 10.7 m -133.98 -62.48 0.76 Allowed 'General case' 0 C--O 1.192 -1.951 0 N-CA-C 105.542 -2.021 . . . . 1.0 105.542 178.042 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 26.1 m -61.89 28.57 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.309 -1.181 0 O-C-N 121.034 -1.041 . . . . 1.0 110.194 -179.878 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 109' ' ' ILE . . . . . 0.666 HG21 ' HB1' ' A' ' 106' ' ' ALA . 0.1 OUTLIER -111.81 -42.98 0.09 OUTLIER Pre-proline 0 C--N 1.372 1.545 0 CA-C-N 119.634 1.107 . . . . 1.0 111.381 177.575 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' A' A ' 110' ' ' PRO . . . . . 0.798 ' HD2' ' O ' ' A' ' 107' ' ' THR . 31.3 Cg_exo -65.1 -28.49 56.83 Favored 'Trans proline' 0 N--CA 1.499 1.799 0 C-N-CA 122.457 2.105 . . . . 1.0 111.869 -179.569 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 111' ' ' ASN . . . . . 0.437 ' C ' ' N ' ' A' ' 113' ' ' ASN . 0.1 OUTLIER -69.12 -69.08 0.36 Allowed 'General case' 0 CA--C 1.538 0.49 0 C-N-CA 119.687 -0.805 . . . . 1.0 109.851 -179.242 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' A' A ' 112' ' ' ILE . . . . . 0.5 ' O ' ' N ' ' A' ' 116' ' ' ILE . 13.1 pt -47.8 -28.29 1.57 Allowed 'Isoleucine or valine' 0 C--O 1.214 -0.785 0 CA-C-O 123.414 1.578 . . . . 1.0 108.531 179.593 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 113' ' ' ASN . . . . . 0.558 ' ND2' ' OE2' ' A' ' 117' ' ' GLU . 0.1 OUTLIER -56.85 -52.74 63.91 Favored 'General case' 0 C--N 1.293 -1.864 0 CA-C-N 111.526 -2.579 . . . . 1.0 106.906 -178.935 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' A' A ' 114' ' ' ALA . . . . . 0.559 ' O ' HG23 ' A' ' 118' ' ' VAL . . . -62.37 -35.04 77.9 Favored 'General case' 0 C--N 1.322 -0.595 0 N-CA-C 112.842 0.682 . . . . 1.0 112.842 -179.914 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -82.8 -56.25 3.94 Favored 'General case' 0 C--O 1.21 -1.002 0 CA-C-N 119.486 1.039 . . . . 1.0 110.538 178.503 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 116' ' ' ILE . . . . . 0.541 ' O ' ' N ' ' A' ' 120' ' ' GLY . 50.8 mt -48.74 -60.88 0.61 Allowed 'Isoleucine or valine' 0 N--CA 1.478 0.954 0 CA-C-O 122.522 1.153 . . . . 1.0 108.107 -179.208 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 117' ' ' GLU . . . . . 0.558 ' OE2' ' ND2' ' A' ' 113' ' ' ASN . 91.5 mt-10 -42.67 -53.56 4.42 Favored 'General case' 0 C--N 1.313 -0.988 0 CA-C-N 112.488 -2.142 . . . . 1.0 107.17 -178.761 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 118' ' ' VAL . . . . . 0.559 HG23 ' O ' ' A' ' 114' ' ' ALA . 69.1 t -60.72 -54.84 29.75 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.516 0 N-CA-C 109.143 -0.688 . . . . 1.0 109.143 177.281 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 3.3 tp -53.49 -71.66 0.07 Allowed 'General case' 0 N--CA 1.464 0.234 0 N-CA-C 108.038 -1.097 . . . . 1.0 108.038 -179.424 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 120' ' ' GLY . . . . . 0.541 ' N ' ' O ' ' A' ' 116' ' ' ILE . . . -66.62 -85.37 0.09 OUTLIER Glycine 0 CA--C 1.533 1.21 0 C-N-CA 118.567 -1.777 . . . . 1.0 110.063 179.369 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 121' ' ' THR . . . . . 0.419 HG23 ' H ' ' A' ' 123' ' ' THR . 1.6 t 168.67 -39.9 0.0 OUTLIER 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 112.633 -1.783 . . . . 1.0 112.756 -179.802 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 122' ' ' GLY . . . . . 0.619 ' O ' ' N ' ' A' ' 124' ' ' ASP . . . 100.99 -18.72 54.32 Favored Glycine 0 N--CA 1.469 0.856 0 N-CA-C 107.037 -2.425 . . . . 1.0 107.037 -176.884 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 123' ' ' THR . . . . . 0.419 ' H ' HG23 ' A' ' 121' ' ' THR . 25.5 m -51.63 86.71 0.0 OUTLIER 'General case' 0 N--CA 1.471 0.617 0 CA-C-N 111.884 -2.158 . . . . 1.0 105.463 178.261 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 124' ' ' ASP . . . . . 0.619 ' N ' ' O ' ' A' ' 122' ' ' GLY . 9.5 m-20 -160.3 165.1 31.95 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 114.372 -1.285 . . . . 1.0 112.062 -178.305 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 125' ' ' TYR . . . . . 0.576 ' O ' ' NH2' ' A' ' 126' ' ' ARG . 0.0 OUTLIER -151.13 146.98 26.51 Favored 'General case' 0 CA--C 1.541 0.61 0 N-CA-C 108.92 -0.771 . . . . 1.0 108.92 177.901 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' A' A ' 126' ' ' ARG . . . . . 0.702 HH22 HD21 ' A' ' 75' ' ' ASN . 0.1 OUTLIER -148.01 150.58 34.23 Favored 'General case' 0 CA--C 1.541 0.613 0 CA-C-N 115.762 -0.654 . . . . 1.0 109.718 177.453 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' A' A ' 127' ' ' PHE . . . . . . . . . . . . . 85.8 t80 . . . . . 0 N--CA 1.468 0.459 0 CA-C-O 118.011 -0.995 . . . . 1.0 110.726 178.918 . . . . . . . . 0 0 . 1 . 025 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . 0.492 ' SD ' ' CB ' ' A' ' 4' ' ' PHE . 19.6 mtp . . . . . 0 N--CA 1.492 1.63 0 N-CA-C 108.179 -1.045 . . . . 1.0 108.179 . . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 2' ' ' SER . . . . . 0.423 ' O ' ' CG ' ' A' ' 3' ' ' ASP . 88.6 p -107.7 7.87 28.68 Favored 'General case' 0 N--CA 1.468 0.452 0 CA-C-O 120.705 0.288 . . . . 1.0 110.412 -179.753 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 3' ' ' ASP . . . . . 0.423 ' CG ' ' O ' ' A' ' 2' ' ' SER . 12.1 m-20 168.35 94.25 0.0 OUTLIER 'General case' 0 N--CA 1.47 0.557 0 CA-C-N 115.469 -0.787 . . . . 1.0 110.468 179.014 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . 0.492 ' CB ' ' SD ' ' A' ' 1' ' ' MET . 37.9 t80 -149.8 145.56 26.68 Favored 'General case' 0 CA--C 1.517 -0.326 0 CA-C-N 116.212 -0.449 . . . . 1.0 110.516 179.501 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 61.5 m-20 -154.75 151.01 28.19 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 121.134 0.492 . . . . 1.0 110.007 179.763 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 6' ' ' THR . . . . . 0.644 ' O ' ' N ' ' A' ' 10' ' ' SER . 0.2 OUTLIER -67.17 173.23 3.95 Favored 'General case' 0 C--O 1.208 -1.123 0 CA-C-N 115.707 -0.679 . . . . 1.0 110.126 179.855 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . 0.595 ' O ' ' N ' ' A' ' 11' ' ' ARG . 1.5 tm-20 -58.07 -54.29 48.6 Favored 'General case' 0 C--N 1.309 -1.191 0 CA-C-O 121.877 0.846 . . . . 1.0 109.423 -179.303 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 8' ' ' ARG . . . . . 0.58 ' O ' ' HB3' ' A' ' 12' ' ' ALA . 27.9 ttp180 -53.82 -57.85 9.41 Favored 'General case' 0 C--N 1.311 -1.099 0 N-CA-C 107.967 -1.123 . . . . 1.0 107.967 -178.44 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . 0.853 ' O ' HG13 ' A' ' 13' ' ' VAL . 0.0 OUTLIER -63.61 -48.08 88.41 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.359 0 CA-C-N 114.772 -1.104 . . . . 1.0 109.807 179.27 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild core ' A' A ' 10' ' ' SER . . . . . 0.644 ' N ' ' O ' ' A' ' 6' ' ' THR . 48.0 t -63.15 -60.74 3.01 Favored 'General case' 0 N--CA 1.481 1.107 0 C-N-CA 120.048 -0.661 . . . . 1.0 110.467 179.266 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 11' ' ' ARG . . . . . 0.595 ' N ' ' O ' ' A' ' 7' ' ' GLU . 11.2 ttt180 -62.77 -55.38 27.05 Favored 'General case' 0 C--N 1.316 -0.862 0 CA-C-O 121.707 0.765 . . . . 1.0 110.072 -177.005 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . 0.58 ' HB3' ' O ' ' A' ' 8' ' ' ARG . . . -52.37 -51.57 58.2 Favored 'General case' 0 C--N 1.316 -0.856 0 N-CA-C 107.015 -1.476 . . . . 1.0 107.015 -178.322 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . 0.853 HG13 ' O ' ' A' ' 9' ' ' VAL . 3.5 m -63.0 -45.84 97.86 Favored 'Isoleucine or valine' 0 C--O 1.2 -1.524 0 C-N-CA 117.387 -1.725 . . . . 1.0 108.888 177.839 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . 0.585 ' O ' HG13 ' A' ' 18' ' ' VAL . . . -59.79 -62.01 2.19 Favored 'General case' 0 N--CA 1.481 1.109 0 O-C-N 120.61 -1.306 . . . . 1.0 110.26 178.654 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . 0.542 ' N ' ' O ' ' A' ' 11' ' ' ARG . . . -52.15 -55.36 21.44 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-O 121.984 0.897 . . . . 1.0 109.415 -177.932 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . 0.51 ' C ' ' H ' ' A' ' 22' ' ' GLY . . . -62.29 -53.85 49.19 Favored 'General case' 0 C--N 1.31 -1.112 0 CA-C-N 114.233 -1.348 . . . . 1.0 108.811 -179.194 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . 0.607 ' CB ' ' O ' ' A' ' 13' ' ' VAL . 7.9 tt -57.1 -54.85 42.12 Favored 'General case' 0 N--CA 1.481 1.084 0 CA-C-N 114.738 -1.119 . . . . 1.0 109.462 -177.75 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . 0.585 HG13 ' O ' ' A' ' 14' ' ' ALA . 1.8 m -69.68 -57.25 8.84 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.63 0 C-N-CA 119.682 -0.807 . . . . 1.0 109.673 178.932 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . 0.543 ' O ' ' CG2' ' A' ' 23' ' ' VAL . . . -65.2 -166.99 1.57 Allowed Glycine 0 CA--C 1.537 1.432 0 N-CA-C 111.477 -0.649 . . . . 1.0 111.477 -179.875 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 20' ' ' PRO . . . . . 0.498 ' O ' ' HB2' ' A' ' 24' ' ' ALA . 83.5 Cg_endo -78.18 -24.87 7.7 Favored 'Trans proline' 0 N--CA 1.509 2.407 0 C-N-CA 123.628 2.885 . . . . 1.0 115.138 -177.825 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -57.32 -57.26 20.72 Favored Glycine 0 N--CA 1.478 1.448 0 C-N-CA 120.221 -0.99 . . . . 1.0 111.694 -176.765 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . 0.51 ' H ' ' C ' ' A' ' 16' ' ' ALA . . . -60.33 -56.21 25.77 Favored Glycine 0 N--CA 1.468 0.819 0 N-CA-C 109.274 -1.531 . . . . 1.0 109.274 -177.234 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . 0.543 ' CG2' ' O ' ' A' ' 19' ' ' GLY . 0.0 OUTLIER -61.89 -35.98 71.22 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.958 0 CA-C-N 114.867 -0.666 . . . . 1.0 110.106 -178.845 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . 0.498 ' HB2' ' O ' ' A' ' 20' ' ' PRO . . . -56.23 -59.97 4.17 Favored 'General case' 0 CA--C 1.538 0.51 0 C-N-CA 117.779 -1.568 . . . . 1.0 108.325 179.531 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 14.3 tp -66.66 -43.87 83.38 Favored 'General case' 0 C--N 1.348 0.505 0 N-CA-C 113.113 0.783 . . . . 1.0 113.113 -178.635 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 79.2 t -60.71 -58.7 6.24 Favored 'Isoleucine or valine' 0 C--N 1.34 0.188 0 C-N-CA 118.137 -1.425 . . . . 1.0 109.253 -177.243 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . 0.422 ' O ' ' HB3' ' A' ' 31' ' ' ALA . 60.7 t -61.14 -37.76 78.16 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.374 0 N-CA-C 112.96 0.726 . . . . 1.0 112.96 -177.914 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . 0.406 ' CG ' ' O ' ' A' ' 24' ' ' ALA . 30.0 mmtm -64.23 -52.68 57.59 Favored 'General case' 0 CA--C 1.509 -0.631 0 N-CA-C 108.372 -0.973 . . . . 1.0 108.372 -179.812 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 92.8 t -65.07 -47.91 86.0 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.874 0 CA-C-N 113.445 -1.707 . . . . 1.0 110.797 -177.361 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 30' ' ' CYS . . . . . . . . . . . . . 11.5 t -65.8 -61.11 2.25 Favored 'General case' 0 N--CA 1.445 -0.684 0 C-N-CA 118.685 -1.206 . . . . 1.0 109.86 -179.747 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . 0.438 ' HA ' HD13 ' A' ' 37' ' ' ILE . . . -66.62 -53.95 28.63 Favored 'General case' 0 CA--C 1.518 -0.261 0 N-CA-C 113.668 0.988 . . . . 1.0 113.668 -176.221 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 85.1 73.57 1.27 Allowed Glycine 0 CA--C 1.533 1.17 0 N-CA-C 109.913 -1.275 . . . . 1.0 109.913 -177.253 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 4.7 mt 76.78 106.26 0.03 OUTLIER Pre-proline 0 N--CA 1.475 0.8 0 C-N-CA 123.416 0.686 . . . . 1.0 111.524 -179.706 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 74.9 Cg_exo -51.42 -15.6 2.63 Favored 'Trans proline' 0 N--CA 1.506 2.243 0 C-N-CA 122.889 2.393 . . . . 1.0 114.967 179.365 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -56.7 -57.87 17.33 Favored Glycine 0 CA--C 1.526 0.746 0 N-CA-C 107.584 -2.207 . . . . 1.0 107.584 -179.791 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . 0.848 ' O ' HG22 ' A' ' 37' ' ' ILE . 5.6 p -79.01 -147.2 0.01 OUTLIER 'Isoleucine or valine' 0 C--O 1.22 -0.459 0 N-CA-C 108.247 -1.019 . . . . 1.0 108.247 178.572 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . 0.848 HG22 ' O ' ' A' ' 36' ' ' VAL . 9.1 tp 70.52 79.74 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.475 0.814 0 CA-C-O 122.157 0.98 . . . . 1.0 112.969 -179.217 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 60.3 m80 -137.79 132.08 32.15 Favored 'General case' 0 N--CA 1.453 -0.283 0 N-CA-C 108.183 -1.043 . . . . 1.0 108.183 177.267 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 10.0 m -128.99 115.71 18.94 Favored Pre-proline 0 C--N 1.326 -0.434 0 N-CA-C 108.38 -0.97 . . . . 1.0 108.38 -179.284 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_exo -42.94 -66.65 0.15 Allowed 'Trans proline' 0 C--N 1.317 -1.122 0 C-N-CA 121.017 1.145 . . . . 1.0 111.558 -178.503 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -75.6 115.33 15.17 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 115.262 -0.881 . . . . 1.0 112.848 -177.292 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . 0.628 ' C ' ' H ' ' A' ' 44' ' ' GLY . 32.9 ptt180 -166.12 162.4 17.7 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 114.817 -1.083 . . . . 1.0 109.987 179.225 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 43' ' ' ARG . . . . . 0.522 ' C ' ' H ' ' A' ' 45' ' ' PHE . 0.2 OUTLIER -65.99 18.63 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.318 -0.401 . . . . 1.0 110.235 -179.263 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . 0.628 ' H ' ' C ' ' A' ' 42' ' ' ARG . . . 70.57 -26.59 0.48 Allowed Glycine 0 N--CA 1.448 -0.531 0 N-CA-C 110.824 -0.91 . . . . 1.0 110.824 179.846 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . 0.522 ' H ' ' C ' ' A' ' 43' ' ' ARG . 7.6 t80 -155.33 150.65 27.05 Favored 'General case' 0 CA--C 1.541 0.622 0 N-CA-C 108.892 -0.781 . . . . 1.0 108.892 -178.906 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 46' ' ' PHE . . . . . 0.497 ' CE1' ' NE2' ' A' ' 54' ' ' GLN . 15.3 t80 172.21 7.15 0.0 OUTLIER 'General case' 0 N--CA 1.483 1.208 0 O-C-N 124.014 0.821 . . . . 1.0 113.155 176.273 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 47' ' ' ARG . . . . . 0.403 ' HB3' ' O ' ' A' ' 46' ' ' PHE . 0.0 OUTLIER 172.2 -176.0 0.05 Allowed 'General case' 0 C--N 1.328 -0.334 0 N-CA-C 109.765 -0.457 . . . . 1.0 109.765 179.689 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild core ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER 70.64 63.01 0.19 Allowed 'General case' 0 CA--C 1.546 0.819 0 N-CA-C 108.901 -0.777 . . . . 1.0 108.901 179.938 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 49' ' ' ASN . . . . . 0.593 ' ND2' ' NH2' ' A' ' 52' ' ' ARG . 1.6 t30 -151.06 133.21 8.17 Favored Pre-proline 0 CA--C 1.546 0.818 0 N-CA-C 108.169 -1.048 . . . . 1.0 108.169 178.891 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 50' ' ' PRO . . . . . 0.551 ' HD2' HH21 ' A' ' 52' ' ' ARG . 16.3 Cg_endo -55.13 73.86 0.03 OUTLIER 'Trans proline' 0 N--CA 1.502 1.999 0 CA-C-N 120.995 1.391 . . . . 1.0 113.833 -179.816 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . 0.553 ' N ' ' O ' ' A' ' 49' ' ' ASN . 40.2 mm-40 62.01 69.8 0.61 Allowed 'General case' 0 N--CA 1.468 0.441 0 N-CA-C 113.428 0.899 . . . . 1.0 113.428 177.975 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . 0.593 ' NH2' ' ND2' ' A' ' 49' ' ' ASN . 0.0 OUTLIER -141.67 150.68 42.22 Favored 'General case' 0 N--CA 1.471 0.579 0 N-CA-C 108.772 -0.825 . . . . 1.0 108.772 178.155 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . 0.553 HD13 ' H ' ' A' ' 54' ' ' GLN . 0.4 OUTLIER -74.44 136.37 25.38 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.372 0 CA-C-O 121.623 0.725 . . . . 1.0 111.43 -178.679 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild core ' A' A ' 54' ' ' GLN . . . . . 0.553 ' H ' HD13 ' A' ' 53' ' ' ILE . 1.9 pt20 -62.9 82.21 0.02 OUTLIER 'General case' 0 N--CA 1.469 0.492 0 CA-C-N 114.611 -1.177 . . . . 1.0 110.143 -177.172 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 16.0 tt -149.52 159.07 5.68 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.27 0 CA-C-N 115.97 -0.559 . . . . 1.0 110.141 178.113 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 112.26 -2.92 26.73 Favored Glycine 0 N--CA 1.472 1.043 0 N-CA-C 110.669 -0.973 . . . . 1.0 110.669 -179.713 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . 0.484 ' OD2' ' O ' ' A' ' 43' ' ' ARG . 25.3 t70 -82.91 98.71 9.34 Favored 'General case' 0 C--N 1.323 -0.554 0 N-CA-C 109.619 -0.511 . . . . 1.0 109.619 179.426 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 58' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -87.3 174.49 8.54 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-O 122.615 1.198 . . . . 1.0 112.764 -177.899 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 59' ' ' ARG . . . . . 0.447 ' HG3' ' N ' ' A' ' 60' ' ' TYR . 2.1 ptt180 -86.17 -56.96 3.21 Favored 'General case' 0 C--N 1.318 -0.783 0 CA-C-N 111.824 -2.444 . . . . 1.0 112.259 -179.538 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 60' ' ' TYR . . . . . 0.447 ' N ' ' HG3' ' A' ' 59' ' ' ARG . 41.4 t80 -92.42 -17.28 24.8 Favored 'General case' 0 C--O 1.249 1.052 0 N-CA-C 113.521 0.934 . . . . 1.0 113.521 -179.181 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 5.3 tt0 -79.51 -13.9 59.25 Favored 'General case' 0 C--N 1.313 -0.996 0 CA-C-N 115.973 -0.558 . . . . 1.0 110.482 -179.292 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 62' ' ' VAL . . . . . 0.645 ' O ' ' N ' ' A' ' 66' ' ' GLY . 27.4 m -47.39 -55.32 2.22 Favored 'Isoleucine or valine' 0 C--O 1.201 -1.498 0 C-N-CA 119.326 -0.95 . . . . 1.0 110.107 -176.608 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 63' ' ' ALA . . . . . 0.619 ' N ' HG23 ' A' ' 62' ' ' VAL . . . -68.77 -54.87 13.43 Favored 'General case' 0 C--N 1.306 -1.292 0 C-N-CA 119.338 -0.945 . . . . 1.0 109.416 -178.466 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 64' ' ' HIS . . . . . 0.474 ' O ' ' HB2' ' A' ' 67' ' ' ARG . 6.6 t-80 -44.98 -58.38 3.2 Favored 'General case' 0 N--CA 1.472 0.645 0 CA-C-O 121.519 0.676 . . . . 1.0 109.99 179.516 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 65' ' ' ASP . . . . . 0.529 ' C ' ' H ' ' A' ' 67' ' ' ARG . 0.5 OUTLIER -73.18 -47.02 47.23 Favored 'General case' 0 C--N 1.313 -1.006 0 CA-C-N 115.551 -0.75 . . . . 1.0 109.991 177.917 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . 0.645 ' N ' ' O ' ' A' ' 62' ' ' VAL . . . -75.4 25.46 1.34 Allowed Glycine 0 CA--C 1.53 0.977 0 O-C-N 120.526 -1.359 . . . . 1.0 110.354 177.5 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 67' ' ' ARG . . . . . 0.603 ' O ' ' N ' ' A' ' 69' ' ' LEU . 5.5 mmt180 -72.02 5.26 2.8 Favored 'General case' 0 CA--C 1.508 -0.655 0 N-CA-C 105.969 -1.863 . . . . 1.0 105.969 175.115 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . 0.553 ' H ' ' C ' ' A' ' 66' ' ' GLY . 0.7 OUTLIER -33.94 -28.1 0.01 OUTLIER 'General case' 0 C--N 1.354 0.787 0 O-C-N 124.181 0.926 . . . . 1.0 109.173 -176.709 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . 0.603 ' N ' ' O ' ' A' ' 67' ' ' ARG . 9.0 mp -62.47 -64.94 0.77 Allowed 'General case' 0 N--CA 1.471 0.624 0 C-N-CA 118.885 -1.126 . . . . 1.0 108.237 177.362 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . 0.691 ' O ' ' CD2' ' A' ' 72' ' ' HIS . . . -76.71 -74.28 0.25 Allowed 'General case' 0 C--O 1.217 -0.634 0 N-CA-C 104.833 -2.284 . . . . 1.0 104.833 177.126 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 71' ' ' ALA . . . . . 0.463 ' O ' ' OD1' ' A' ' 75' ' ' ASN . . . -40.66 2.65 0.0 OUTLIER 'General case' 0 N--CA 1.473 0.707 0 N-CA-C 115.27 1.582 . . . . 1.0 115.27 179.832 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 72' ' ' HIS . . . . . 0.862 ' CD2' ' H ' ' A' ' 73' ' ' MET . 0.3 OUTLIER -30.45 -81.97 0.01 OUTLIER 'General case' 0 CA--C 1.532 0.284 0 CA-C-N 119.954 1.252 . . . . 1.0 114.114 -176.425 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild core ' A' A ' 73' ' ' MET . . . . . 0.862 ' H ' ' CD2' ' A' ' 72' ' ' HIS . 72.1 mtm -63.9 -53.64 47.34 Favored 'General case' 0 N--CA 1.439 -0.979 0 C-N-CA 120.002 -0.679 . . . . 1.0 110.066 -179.443 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . 0.683 ' O ' ' N ' ' A' ' 76' ' ' GLY . 0.6 OUTLIER -46.25 -35.86 2.49 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.718 0 CA-C-O 117.533 -1.222 . . . . 1.0 111.644 -176.092 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild core ' A' A ' 75' ' ' ASN . . . . . 0.569 ' C ' ' N ' ' A' ' 77' ' ' ILE . 16.1 m120 -39.95 -9.46 0.01 OUTLIER 'General case' 0 N--CA 1.497 1.9 0 CA-C-N 121.055 1.752 . . . . 1.0 112.363 177.759 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 76' ' ' GLY . . . . . 0.683 ' N ' ' O ' ' A' ' 74' ' ' VAL . . . -41.95 -21.67 0.08 OUTLIER Glycine 0 CA--C 1.542 1.732 0 N-CA-C 107.533 -2.227 . . . . 1.0 107.533 177.051 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 77' ' ' ILE . . . . . 0.756 ' HA ' ' HB3' ' A' ' 80' ' ' ALA . 13.4 pt -74.87 -53.2 17.08 Favored 'Isoleucine or valine' 0 C--O 1.213 -0.86 0 CA-C-N 114.968 -0.616 . . . . 1.0 109.536 177.565 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . 0.531 ' N ' ' O ' ' A' ' 75' ' ' ASN . 3.2 p -36.15 -30.14 0.04 OUTLIER 'Isoleucine or valine' 0 CA--C 1.554 1.12 0 N-CA-C 108.631 -0.877 . . . . 1.0 108.631 -174.332 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . 0.882 ' O ' ' HB2' ' A' ' 83' ' ' ALA . 0.0 OUTLIER -94.64 -28.16 4.2 Favored 'Isoleucine or valine' 0 CA--C 1.555 1.135 0 CA-C-O 121.186 0.517 . . . . 1.0 109.978 176.907 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild core ' A' A ' 80' ' ' ALA . . . . . 0.756 ' HB3' ' HA ' ' A' ' 77' ' ' ILE . . . -87.48 -10.88 50.6 Favored 'General case' 0 CA--C 1.553 1.063 0 C-N-CA 124.153 0.981 . . . . 1.0 113.419 177.752 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 81' ' ' GLU . . . . . 0.542 ' N ' ' O ' ' A' ' 77' ' ' ILE . 2.3 mt-10 -83.2 -70.55 0.55 Allowed 'General case' 0 C--N 1.354 0.803 0 CA-C-N 119.309 0.959 . . . . 1.0 108.561 178.759 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 82' ' ' ASP . . . . . 0.491 ' O ' ' N ' ' A' ' 84' ' ' LEU . 8.8 p-10 -78.07 -12.29 59.98 Favored 'General case' 0 N--CA 1.445 -0.683 0 CA-C-N 118.315 0.507 . . . . 1.0 111.565 -179.637 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . 0.882 ' HB2' ' O ' ' A' ' 79' ' ' ILE . . . -22.48 -44.16 0.01 OUTLIER 'General case' 0 N--CA 1.475 0.818 0 N-CA-C 113.207 0.817 . . . . 1.0 113.207 177.683 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . 0.491 ' N ' ' O ' ' A' ' 82' ' ' ASP . 0.4 OUTLIER -36.9 -34.94 0.08 Allowed 'General case' 0 N--CA 1.469 0.518 0 N-CA-C 112.576 0.584 . . . . 1.0 112.576 -176.782 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild core ' A' A ' 85' ' ' ILE . . . . . 0.444 ' O ' HG13 ' A' ' 89' ' ' VAL . 2.0 pt -99.95 -41.72 9.63 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.669 0 N-CA-C 108.391 -0.966 . . . . 1.0 108.391 177.444 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 86' ' ' ALA . . . . . 0.764 ' HB3' ' HA ' ' A' ' 83' ' ' ALA . . . -59.58 -56.87 16.45 Favored 'General case' 0 CA--C 1.537 0.479 0 CA-C-N 113.93 -1.487 . . . . 1.0 109.639 -179.01 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 87' ' ' GLU . . . . . 0.492 ' N ' ' O ' ' A' ' 83' ' ' ALA . 14.4 tt0 -70.92 -21.48 62.36 Favored 'General case' 0 CA--C 1.544 0.744 0 O-C-N 121.184 -0.947 . . . . 1.0 112.951 -177.439 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -74.43 -5.41 42.32 Favored 'General case' 0 N--CA 1.48 1.049 0 CA-C-O 122.931 1.348 . . . . 1.0 108.759 179.711 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 89' ' ' VAL . . . . . 0.728 HG22 ' O ' ' A' ' 86' ' ' ALA . 11.7 m -109.85 37.34 0.52 Allowed 'Isoleucine or valine' 0 C--N 1.312 -1.036 0 CA-C-N 112.351 -2.204 . . . . 1.0 109.896 178.017 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 90' ' ' GLY . . . . . 0.596 ' C ' ' H ' ' A' ' 92' ' ' HIS . . . -75.86 -36.35 42.26 Favored Glycine 0 C--N 1.349 1.254 0 N-CA-C 110.63 -0.988 . . . . 1.0 110.63 178.803 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 91' ' ' PRO . . . . . 0.581 ' CD ' ' N ' ' A' ' 90' ' ' GLY . 82.8 Cg_exo -48.26 -9.21 0.07 OUTLIER 'Trans proline' 0 N--CA 1.499 1.798 0 C-N-CA 122.191 1.928 . . . . 1.0 109.971 176.982 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 92' ' ' HIS . . . . . 0.596 ' H ' ' C ' ' A' ' 90' ' ' GLY . 1.8 p80 -55.99 -17.35 6.55 Favored 'General case' 0 N--CA 1.445 -0.717 0 N-CA-C 107.519 -1.289 . . . . 1.0 107.519 179.253 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 93' ' ' LEU . . . . . 0.579 HD12 ' N ' ' A' ' 94' ' ' ALA . 1.4 pp -63.32 -58.76 6.08 Favored 'General case' 0 N--CA 1.451 -0.405 0 N-CA-C 108.995 -0.743 . . . . 1.0 108.995 177.542 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 94' ' ' ALA . . . . . 0.579 ' N ' HD12 ' A' ' 93' ' ' LEU . . . -57.1 -50.91 71.33 Favored 'General case' 0 CA--C 1.515 -0.377 0 C-N-CA 120.318 -0.553 . . . . 1.0 110.095 -179.996 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 95' ' ' ARG . . . . . 0.652 ' O ' ' N ' ' A' ' 97' ' ' LEU . 83.7 mtt85 -59.36 -55.95 28.23 Favored 'General case' 0 C--N 1.322 -0.623 0 N-CA-C 107.516 -1.29 . . . . 1.0 107.516 178.781 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 96' ' ' ALA . . . . . 0.87 ' O ' ' N ' ' A' ' 98' ' ' GLY . . . -46.8 -13.42 0.03 OUTLIER 'General case' 0 N--CA 1.427 -1.575 0 O-C-N 119.118 -2.238 . . . . 1.0 110.15 179.846 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 97' ' ' LEU . . . . . 0.744 ' O ' ' N ' ' A' ' 100' ' ' ILE . 0.4 OUTLIER 7.38 -54.71 0.0 OUTLIER 'General case' 0 C--N 1.372 1.544 0 CA-C-O 117.547 -1.216 . . . . 1.0 109.993 -169.298 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild core ' A' A ' 98' ' ' GLY . . . . . 0.87 ' N ' ' O ' ' A' ' 96' ' ' ALA . . . -49.01 -24.0 4.14 Favored Glycine 0 C--N 1.289 -2.079 0 CA-C-N 122.833 2.561 . . . . 1.0 108.849 174.767 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 99' ' ' GLN . . . . . 0.576 ' N ' ' O ' ' A' ' 96' ' ' ALA . 1.9 tp60 -66.36 -15.89 63.63 Favored 'General case' 0 C--N 1.364 1.223 0 N-CA-C 106.405 -1.702 . . . . 1.0 106.405 177.249 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 100' ' ' ILE . . . . . 0.744 ' N ' ' O ' ' A' ' 97' ' ' LEU . 0.4 OUTLIER -64.04 -45.58 96.24 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.52 0 N-CA-C 108.088 -1.079 . . . . 1.0 108.088 177.089 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild core ' A' A ' 101' ' ' VAL . . . . . 0.651 ' O ' ' N ' ' A' ' 105' ' ' GLY . 71.9 t -53.74 -61.61 0.87 Allowed 'Isoleucine or valine' 0 CA--C 1.5 -0.963 0 N-CA-C 108.433 -0.951 . . . . 1.0 108.433 179.411 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 102' ' ' CYS . . . . . 0.902 ' O ' ' HB2' ' A' ' 106' ' ' ALA . 4.2 t -46.07 -21.75 0.17 Allowed 'General case' 0 N--CA 1.427 -1.625 0 CA-C-N 115.569 -0.741 . . . . 1.0 112.317 -178.031 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -88.69 -43.78 11.06 Favored 'General case' 0 N--CA 1.484 1.255 0 O-C-N 124.194 0.934 . . . . 1.0 112.02 176.554 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 104' ' ' TYR . . . . . 0.643 ' O ' ' CD1' ' A' ' 104' ' ' TYR . 0.1 OUTLIER -101.3 21.23 14.4 Favored 'General case' 0 N--CA 1.473 0.692 0 CA-C-N 113.956 -1.475 . . . . 1.0 109.736 178.367 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild core ' A' A ' 105' ' ' GLY . . . . . 0.651 ' N ' ' O ' ' A' ' 101' ' ' VAL . . . -159.59 -94.34 0.1 Allowed Glycine 0 C--N 1.345 1.051 0 N-CA-C 105.232 -3.147 . . . . 1.0 105.232 176.771 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 106' ' ' ALA . . . . . 0.902 ' HB2' ' O ' ' A' ' 102' ' ' CYS . . . 72.0 60.34 0.14 Allowed 'General case' 0 N--CA 1.446 -0.625 0 CA-C-O 119.333 -0.365 . . . . 1.0 111.729 -179.345 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 107' ' ' THR . . . . . 0.446 ' C ' ' H ' ' A' ' 109' ' ' ILE . 44.6 p -81.91 -62.54 1.6 Allowed 'General case' 0 C--N 1.353 0.724 0 O-C-N 120.375 -1.453 . . . . 1.0 109.521 179.403 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 15.5 m -65.2 22.45 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.35 0.599 0 N-CA-C 113.025 0.75 . . . . 1.0 113.025 -176.799 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 109' ' ' ILE . . . . . 0.7 ' H ' ' HD2' ' A' ' 110' ' ' PRO . 0.1 OUTLIER -114.92 -56.96 0.04 OUTLIER Pre-proline 0 CA--C 1.561 1.4 0 CA-C-N 119.089 0.859 . . . . 1.0 108.946 173.954 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild core ' A' A ' 110' ' ' PRO . . . . . 0.7 ' HD2' ' H ' ' A' ' 109' ' ' ILE . 19.4 Cg_endo -52.24 -38.54 72.23 Favored 'Trans proline' 0 N--CA 1.497 1.696 0 C-N-CA 123.243 2.628 . . . . 1.0 112.723 -179.838 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 12.4 m120 -67.01 -68.06 0.41 Allowed 'General case' 0 CA--C 1.51 -0.577 0 C-N-CA 119.268 -0.973 . . . . 1.0 108.76 -177.762 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 112' ' ' ILE . . . . . 0.579 ' O ' ' N ' ' A' ' 115' ' ' ALA . 18.6 pt -51.64 -40.8 26.77 Favored 'Isoleucine or valine' 0 C--O 1.215 -0.749 0 N-CA-C 106.718 -1.586 . . . . 1.0 106.718 178.207 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 113' ' ' ASN . . . . . 0.459 ' HB2' ' O ' ' A' ' 109' ' ' ILE . 26.5 t-20 -45.78 -51.83 12.1 Favored 'General case' 0 CA--C 1.503 -0.836 0 CA-C-N 114.047 -1.433 . . . . 1.0 108.041 -176.49 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -64.02 -27.36 69.07 Favored 'General case' 0 N--CA 1.435 -1.195 0 C-N-CA 119.494 -0.882 . . . . 1.0 109.957 177.763 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 115' ' ' ALA . . . . . 0.579 ' N ' ' O ' ' A' ' 112' ' ' ILE . . . -76.08 -60.56 2.28 Favored 'General case' 0 N--CA 1.444 -0.757 0 N-CA-C 107.546 -1.279 . . . . 1.0 107.546 177.852 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 116' ' ' ILE . . . . . 0.577 ' O ' ' C ' ' A' ' 117' ' ' GLU . 1.3 mp -47.69 -42.47 9.03 Favored 'Isoleucine or valine' 0 C--N 1.363 1.184 0 N-CA-C 108.198 -1.038 . . . . 1.0 108.198 178.768 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 117' ' ' GLU . . . . . 0.577 ' C ' ' O ' ' A' ' 116' ' ' ILE . 23.6 tt0 -38.92 -55.57 1.52 Allowed 'General case' 0 N--CA 1.472 0.671 0 N-CA-C 104.607 -2.368 . . . . 1.0 104.607 178.439 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 118' ' ' VAL . . . . . 0.434 ' N ' ' O ' ' A' ' 115' ' ' ALA . 40.5 t -70.13 -55.07 15.96 Favored 'Isoleucine or valine' 0 CA--C 1.559 1.306 0 CA-C-N 113.954 -1.476 . . . . 1.0 110.77 176.11 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -60.39 -19.62 56.56 Favored 'General case' 0 N--CA 1.49 1.565 0 N-CA-C 115.491 1.663 . . . . 1.0 115.491 -177.735 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 120' ' ' GLY . . . . . 0.512 ' O ' ' CB ' ' A' ' 121' ' ' THR . . . -121.09 -43.95 0.42 Allowed Glycine 0 C--N 1.354 1.554 0 N-CA-C 108.618 -1.793 . . . . 1.0 108.618 176.581 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 121' ' ' THR . . . . . 0.552 ' HB ' HG22 ' A' ' 123' ' ' THR . 45.8 m 127.54 -46.33 0.01 OUTLIER 'General case' 0 N--CA 1.48 1.057 0 C-N-CA 124.962 1.305 . . . . 1.0 108.5 -179.55 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 122' ' ' GLY . . . . . 0.666 ' O ' ' N ' ' A' ' 124' ' ' ASP . . . 104.33 -15.55 50.2 Favored Glycine 0 N--CA 1.472 1.093 0 N-CA-C 108.499 -1.84 . . . . 1.0 108.499 -178.448 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 123' ' ' THR . . . . . 0.651 HG23 ' O ' ' A' ' 123' ' ' THR . 9.5 t -55.43 82.84 0.0 OUTLIER 'General case' 0 C--N 1.322 -0.628 0 N-CA-C 105.436 -2.061 . . . . 1.0 105.436 178.576 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 124' ' ' ASP . . . . . 0.666 ' N ' ' O ' ' A' ' 122' ' ' GLY . 53.0 p30 -167.68 176.11 6.6 Favored 'General case' 0 C--N 1.342 0.281 0 CA-C-N 114.581 -1.19 . . . . 1.0 112.17 179.825 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 125' ' ' TYR . . . . . . . . . . . . . 2.3 t80 -138.83 138.85 37.89 Favored 'General case' 0 CA--C 1.535 0.395 0 N-CA-C 107.914 -1.143 . . . . 1.0 107.914 175.827 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 1.3 mmp_? -145.63 145.12 30.82 Favored 'General case' 0 N--CA 1.47 0.555 0 N-CA-C 109.187 -0.671 . . . . 1.0 109.187 179.399 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 127' ' ' PHE . . . . . . . . . . . . . 6.5 p90 . . . . . 0 N--CA 1.47 0.571 0 CA-C-O 117.958 -1.02 . . . . 1.0 110.734 -179.651 . . . . . . . . 0 0 . 1 . 026 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 62.2 mtt . . . . . 0 N--CA 1.491 1.615 0 N-CA-C 109.025 -0.731 . . . . 1.0 109.025 . . . . . . . . . 0 0 . 1 . 026 nuclear nobuild core ' A' A ' 2' ' ' SER . . . . . 0.413 ' O ' ' CB ' ' A' ' 3' ' ' ASP . 61.2 p -104.65 9.4 35.2 Favored 'General case' 0 N--CA 1.467 0.389 0 C-N-CA 122.578 0.351 . . . . 1.0 110.925 -179.548 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 3' ' ' ASP . . . . . 0.413 ' CB ' ' O ' ' A' ' 2' ' ' SER . 0.9 OUTLIER 166.15 99.2 0.0 OUTLIER 'General case' 0 N--CA 1.466 0.357 0 O-C-N 123.411 0.444 . . . . 1.0 110.842 179.25 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 65.9 t80 -149.97 144.67 25.99 Favored 'General case' 0 C--O 1.233 0.185 0 N-CA-C 110.045 -0.354 . . . . 1.0 110.045 179.446 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 45.2 m-20 -151.8 147.89 27.2 Favored 'General case' 0 C--N 1.331 -0.226 0 N-CA-C 109.909 -0.404 . . . . 1.0 109.909 -179.976 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 6' ' ' THR . . . . . 0.68 HG22 ' H ' ' A' ' 7' ' ' GLU . 18.9 m -68.9 174.64 4.24 Favored 'General case' 0 C--O 1.214 -0.801 0 C-N-CA 120.188 -0.605 . . . . 1.0 109.868 -179.924 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . 0.68 ' H ' HG22 ' A' ' 6' ' ' THR . 80.1 tt0 -60.76 -53.91 51.57 Favored 'General case' 0 C--N 1.314 -0.935 0 CA-C-O 121.814 0.816 . . . . 1.0 109.862 -177.982 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 8' ' ' ARG . . . . . 0.499 ' O ' ' CB ' ' A' ' 12' ' ' ALA . 18.3 ttm105 -53.19 -57.63 9.83 Favored 'General case' 0 C--N 1.309 -1.17 0 C-N-CA 119.103 -1.039 . . . . 1.0 108.283 -178.456 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . 0.543 ' O ' HG23 ' A' ' 13' ' ' VAL . 0.0 OUTLIER -65.09 -47.44 87.78 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.807 0 CA-C-N 113.913 -1.494 . . . . 1.0 110.227 179.687 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild core ' A' A ' 10' ' ' SER . . . . . 0.617 ' N ' ' O ' ' A' ' 6' ' ' THR . 35.0 t -62.99 -59.78 4.35 Favored 'General case' 0 N--CA 1.477 0.877 0 C-N-CA 119.504 -0.879 . . . . 1.0 109.0 179.575 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 11' ' ' ARG . . . . . 0.56 ' O ' ' N ' ' A' ' 15' ' ' ALA . 2.6 tpt180 -64.62 -56.13 15.87 Favored 'General case' 0 N--CA 1.474 0.747 0 CA-C-O 120.796 0.331 . . . . 1.0 111.094 -177.667 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . 0.507 ' O ' ' HB3' ' A' ' 16' ' ' ALA . . . -51.57 -51.12 58.01 Favored 'General case' 0 N--CA 1.485 1.318 0 N-CA-C 106.714 -1.588 . . . . 1.0 106.714 -178.952 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . 0.595 ' O ' ' CB ' ' A' ' 17' ' ' LEU . 64.1 t -61.67 -50.06 81.79 Favored 'Isoleucine or valine' 0 C--O 1.202 -1.408 0 C-N-CA 118.448 -1.301 . . . . 1.0 108.542 178.044 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . 0.669 ' O ' HG13 ' A' ' 18' ' ' VAL . . . -58.72 -61.12 2.85 Favored 'General case' 0 C--O 1.214 -0.78 0 C-N-CA 118.273 -1.371 . . . . 1.0 109.51 179.511 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . 0.572 ' O ' ' N ' ' A' ' 19' ' ' GLY . . . -53.06 -57.02 11.82 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-O 121.727 0.775 . . . . 1.0 110.499 -178.461 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . 0.507 ' HB3' ' O ' ' A' ' 12' ' ' ALA . . . -62.14 -53.2 58.79 Favored 'General case' 0 C--N 1.31 -1.151 0 CA-C-N 114.666 -1.152 . . . . 1.0 108.658 -179.086 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . 0.595 ' CB ' ' O ' ' A' ' 13' ' ' VAL . 6.3 tp -57.19 -52.84 63.71 Favored 'General case' 0 N--CA 1.475 0.814 0 CA-C-N 114.335 -1.302 . . . . 1.0 108.832 -177.918 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . 0.669 HG13 ' O ' ' A' ' 14' ' ' ALA . 3.1 m -68.62 -56.12 13.46 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.521 0 C-N-CA 119.498 -0.881 . . . . 1.0 109.693 179.215 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . 0.572 ' N ' ' O ' ' A' ' 15' ' ' ALA . . . -63.73 -169.52 1.49 Allowed Glycine 0 CA--C 1.525 0.695 0 N-CA-C 112.118 -0.393 . . . . 1.0 112.118 -178.966 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 20' ' ' PRO . . . . . 0.603 ' O ' ' N ' ' A' ' 24' ' ' ALA . 1.0 OUTLIER -79.42 -23.88 6.94 Favored 'Trans proline' 0 C--N 1.311 -1.401 0 C-N-CA 122.925 2.417 . . . . 1.0 112.993 -179.1 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -59.71 -58.6 13.41 Favored Glycine 0 N--CA 1.475 1.3 0 C-N-CA 119.789 -1.196 . . . . 1.0 111.877 -176.674 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . 0.455 ' CA ' ' HB1' ' A' ' 16' ' ' ALA . . . -59.74 -51.76 57.04 Favored Glycine 0 CA--C 1.501 -0.815 0 N-CA-C 106.86 -2.496 . . . . 1.0 106.86 -178.012 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . 0.599 ' O ' HG12 ' A' ' 27' ' ' VAL . 29.5 t -58.32 -35.78 55.25 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.032 0 CA-C-N 114.126 -1.037 . . . . 1.0 108.941 -179.758 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . 0.603 ' N ' ' O ' ' A' ' 20' ' ' PRO . . . -61.92 -60.48 3.57 Favored 'General case' 0 CA--C 1.536 0.429 0 C-N-CA 118.524 -1.27 . . . . 1.0 110.255 -179.921 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . 0.531 ' N ' HD12 ' A' ' 25' ' ' LEU . 9.9 mp -65.02 -44.96 87.43 Favored 'General case' 0 C--N 1.344 0.332 0 CA-C-N 119.257 0.935 . . . . 1.0 112.408 -177.69 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 89.6 t -62.17 -58.79 5.99 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.308 0 C-N-CA 118.826 -1.149 . . . . 1.0 110.268 -177.311 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . 0.599 HG12 ' O ' ' A' ' 23' ' ' VAL . 1.3 p -60.28 -35.31 61.42 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 O-C-N 121.802 -0.561 . . . . 1.0 112.269 -177.476 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 14.0 tmtt? -67.88 -54.58 17.78 Favored 'General case' 0 C--N 1.318 -0.788 0 CA-C-O 121.449 0.643 . . . . 1.0 110.077 -178.591 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . 0.407 HG12 ' O ' ' A' ' 25' ' ' LEU . 9.9 p -63.11 -45.21 99.22 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.834 0 C-N-CA 119.338 -0.945 . . . . 1.0 110.508 -178.333 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 30' ' ' CYS . . . . . . . . . . . . . 1.4 t -66.3 -60.94 2.3 Favored 'General case' 0 CA--C 1.532 0.256 0 C-N-CA 119.123 -1.031 . . . . 1.0 110.004 -179.607 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . 0.5 ' HB2' ' NH1' ' A' ' 47' ' ' ARG . . . -64.65 -52.81 55.4 Favored 'General case' 0 CA--C 1.511 -0.536 0 N-CA-C 112.923 0.712 . . . . 1.0 112.923 -176.44 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 85.02 74.38 1.25 Allowed Glycine 0 CA--C 1.526 0.764 0 N-CA-C 109.135 -1.586 . . . . 1.0 109.135 -177.256 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 23.1 mt 86.09 95.49 0.03 OUTLIER Pre-proline 0 N--CA 1.479 0.983 0 C-N-CA 123.676 0.79 . . . . 1.0 110.521 -179.17 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 47.5 Cg_endo -68.3 -27.76 34.11 Favored 'Trans proline' 0 N--CA 1.506 2.26 0 C-N-CA 122.221 1.947 . . . . 1.0 115.085 -177.843 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . 0.402 ' HA3' HD12 ' A' ' 112' ' ' ILE . . . -62.08 -58.72 11.46 Favored Glycine 0 CA--C 1.53 1.029 0 C-N-CA 118.233 -1.937 . . . . 1.0 109.383 -178.678 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . 0.519 ' O ' HG22 ' A' ' 37' ' ' ILE . 11.3 p -88.88 162.09 2.61 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.462 0 N-CA-C 106.231 -1.766 . . . . 1.0 106.231 177.215 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . 0.519 HG22 ' O ' ' A' ' 36' ' ' VAL . 0.0 OUTLIER 118.99 120.01 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.476 0.865 0 C-N-CA 124.322 1.049 . . . . 1.0 108.506 -179.238 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild core ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 46.8 m80 -142.11 133.85 27.01 Favored 'General case' 0 C--N 1.332 -0.154 0 N-CA-C 108.412 -0.958 . . . . 1.0 108.412 179.072 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -110.38 134.87 20.69 Favored Pre-proline 0 C--N 1.325 -0.464 0 N-CA-C 108.439 -0.949 . . . . 1.0 108.439 -179.716 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 37.1 Cg_endo -66.36 -85.55 0.01 OUTLIER 'Trans proline' 0 N--CA 1.49 1.31 0 CA-C-N 119.994 1.034 . . . . 1.0 111.469 -179.047 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -66.16 121.9 16.22 Favored 'General case' 0 C--N 1.317 -0.808 0 CA-C-N 114.991 -1.004 . . . . 1.0 110.298 -178.714 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . 0.648 ' C ' ' H ' ' A' ' 44' ' ' GLY . 34.2 ptt180 -169.15 166.04 10.9 Favored 'General case' 0 N--CA 1.434 -1.27 0 N-CA-C 109.133 -0.691 . . . . 1.0 109.133 179.062 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 43' ' ' ARG . . . . . 0.611 ' HG3' ' O ' ' A' ' 45' ' ' PHE . 0.0 OUTLIER -65.33 25.07 0.02 OUTLIER 'General case' 0 C--N 1.311 -1.078 0 CA-C-N 115.717 -0.674 . . . . 1.0 110.249 -179.067 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . 0.648 ' H ' ' C ' ' A' ' 42' ' ' ARG . . . 76.63 -24.92 1.78 Allowed Glycine 0 C--N 1.345 1.072 0 N-CA-C 111.869 -0.492 . . . . 1.0 111.869 179.27 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . 0.804 ' O ' ' HB2' ' A' ' 46' ' ' PHE . 35.2 t80 -162.76 164.81 26.11 Favored 'General case' 0 C--O 1.198 -1.606 0 CA-C-O 119.003 -0.522 . . . . 1.0 110.155 -179.268 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 46' ' ' PHE . . . . . 0.804 ' HB2' ' O ' ' A' ' 45' ' ' PHE . 2.7 t80 131.18 93.07 0.0 OUTLIER 'General case' 0 N--CA 1.517 2.894 0 C-N-CA 124.396 1.078 . . . . 1.0 111.134 178.125 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 47' ' ' ARG . . . . . 0.531 ' CB ' ' O ' ' A' ' 46' ' ' PHE . 2.1 tmm_? 118.46 151.82 0.0 OUTLIER 'General case' 0 N--CA 1.482 1.13 0 C-N-CA 124.697 1.199 . . . . 1.0 108.842 -179.981 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER 70.3 70.98 0.21 Allowed 'General case' 0 CA--C 1.534 0.357 0 N-CA-C 108.316 -0.994 . . . . 1.0 108.316 -177.918 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -134.75 140.11 34.37 Favored Pre-proline 0 CA--C 1.541 0.597 0 N-CA-C 108.467 -0.938 . . . . 1.0 108.467 -179.018 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 50' ' ' PRO . . . . . 0.413 ' C ' ' H ' ' A' ' 52' ' ' ARG . 55.3 Cg_endo -66.9 69.22 0.53 Allowed 'Trans proline' 0 N--CA 1.5 1.887 0 C-N-CA 121.793 1.662 . . . . 1.0 112.74 -179.032 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . 0.452 ' N ' ' CD ' ' A' ' 51' ' ' GLU . 0.7 OUTLIER 63.64 -9.16 0.14 Allowed 'General case' 0 N--CA 1.468 0.439 0 N-CA-C 112.574 0.583 . . . . 1.0 112.574 179.868 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . 0.413 ' H ' ' C ' ' A' ' 50' ' ' PRO . 0.0 OUTLIER -76.6 168.99 19.11 Favored 'General case' 0 N--CA 1.466 0.36 0 C-N-CA 119.781 -0.768 . . . . 1.0 110.5 179.747 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . 0.457 ' O ' ' N ' ' A' ' 55' ' ' ILE . 8.2 pt -81.42 135.77 24.41 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.464 0 CA-C-O 122.018 0.913 . . . . 1.0 110.97 -179.974 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 6.3 pm0 -61.42 83.14 0.01 OUTLIER 'General case' 0 C--N 1.314 -0.967 0 CA-C-N 113.712 -1.585 . . . . 1.0 108.82 -178.303 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . 0.457 ' N ' ' O ' ' A' ' 53' ' ' ILE . 20.8 tt -150.47 158.74 5.1 Favored 'Isoleucine or valine' 0 C--N 1.354 0.776 0 CA-C-N 116.429 -0.35 . . . . 1.0 110.654 178.255 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 107.72 -5.94 35.21 Favored Glycine 0 N--CA 1.486 2.017 0 N-CA-C 111.491 -0.644 . . . . 1.0 111.491 179.319 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . 0.445 ' CG ' ' NH1' ' A' ' 43' ' ' ARG . 8.4 p-10 -78.56 103.54 8.57 Favored 'General case' 0 C--N 1.311 -1.102 0 CA-C-N 114.501 -0.85 . . . . 1.0 109.91 178.604 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 58' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -89.74 173.15 8.44 Favored 'General case' 0 CA--C 1.555 1.169 0 CA-C-O 123.375 1.559 . . . . 1.0 114.417 -176.976 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 59' ' ' ARG . . . . . 0.705 ' HE ' ' H ' ' A' ' 59' ' ' ARG . 0.0 OUTLIER -74.04 -61.04 1.99 Allowed 'General case' 0 N--CA 1.479 0.993 0 CA-C-N 111.414 -2.63 . . . . 1.0 111.694 -178.825 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild core ' A' A ' 60' ' ' TYR . . . . . 0.544 ' O ' ' CG ' ' A' ' 60' ' ' TYR . 65.9 t80 -92.17 -8.91 44.22 Favored 'General case' 0 C--O 1.244 0.813 0 C-N-CA 124.593 1.157 . . . . 1.0 113.241 -179.661 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -79.12 -17.32 55.3 Favored 'General case' 0 N--CA 1.432 -1.346 0 O-C-N 121.348 -0.845 . . . . 1.0 111.366 -178.347 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 62' ' ' VAL . . . . . 0.655 ' O ' ' N ' ' A' ' 66' ' ' GLY . 25.9 m -49.02 -54.49 5.28 Favored 'Isoleucine or valine' 0 C--O 1.199 -1.603 0 C-N-CA 119.802 -0.759 . . . . 1.0 110.512 -174.954 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 63' ' ' ALA . . . . . 0.493 ' N ' HG23 ' A' ' 62' ' ' VAL . . . -69.03 -49.7 55.3 Favored 'General case' 0 C--N 1.308 -1.225 0 O-C-N 121.498 -0.751 . . . . 1.0 109.539 -179.427 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 64' ' ' HIS . . . . . 0.4 ' O ' ' HB2' ' A' ' 67' ' ' ARG . 1.0 OUTLIER -50.18 -56.57 10.49 Favored 'General case' 0 CA--C 1.54 0.592 0 CA-C-N 115.226 -0.897 . . . . 1.0 108.613 -179.005 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild core ' A' A ' 65' ' ' ASP . . . . . 0.599 ' C ' ' H ' ' A' ' 67' ' ' ARG . 32.7 t0 -74.69 -46.46 37.64 Favored 'General case' 0 C--N 1.317 -0.832 0 CA-C-N 115.594 -0.73 . . . . 1.0 110.115 178.094 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . 0.655 ' N ' ' O ' ' A' ' 62' ' ' VAL . . . -72.92 25.19 0.8 Allowed Glycine 0 N--CA 1.444 -0.822 0 N-CA-C 109.663 -1.375 . . . . 1.0 109.663 177.556 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 67' ' ' ARG . . . . . 0.627 ' O ' ' N ' ' A' ' 69' ' ' LEU . 0.0 OUTLIER -72.49 6.2 2.52 Favored 'General case' 0 N--CA 1.452 -0.335 0 N-CA-C 105.477 -2.045 . . . . 1.0 105.477 174.761 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . 0.549 ' H ' ' C ' ' A' ' 66' ' ' GLY . 0.0 OUTLIER -33.1 -28.45 0.01 OUTLIER 'General case' 0 N--CA 1.483 1.202 0 N-CA-C 108.565 -0.902 . . . . 1.0 108.565 -175.746 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . 0.627 ' N ' ' O ' ' A' ' 67' ' ' ARG . 8.5 tt -62.77 -64.33 0.95 Allowed 'General case' 0 C--N 1.323 -0.581 0 C-N-CA 118.797 -1.161 . . . . 1.0 108.988 178.476 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . 0.575 ' O ' ' N ' ' A' ' 72' ' ' HIS . . . -78.76 -74.45 0.28 Allowed 'General case' 0 N--CA 1.475 0.802 0 N-CA-C 105.485 -2.042 . . . . 1.0 105.485 176.657 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 71' ' ' ALA . . . . . 0.457 ' O ' ' C ' ' A' ' 72' ' ' HIS . . . -44.14 2.99 0.0 OUTLIER 'General case' 0 C--N 1.332 -0.158 0 C-N-CA 125.255 1.422 . . . . 1.0 114.352 179.687 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 72' ' ' HIS . . . . . 0.626 ' CG ' ' N ' ' A' ' 73' ' ' MET . 0.0 OUTLIER -28.49 -64.8 0.09 Allowed 'General case' 0 N--CA 1.47 0.564 0 CA-C-N 118.834 0.743 . . . . 1.0 111.585 -178.335 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild core ' A' A ' 73' ' ' MET . . . . . 0.626 ' N ' ' CG ' ' A' ' 72' ' ' HIS . 2.9 ptp -69.65 -50.69 41.67 Favored 'General case' 0 C--N 1.32 -0.685 0 C-N-CA 119.279 -0.968 . . . . 1.0 108.881 179.042 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . 0.693 ' O ' ' N ' ' A' ' 76' ' ' GLY . 86.2 t -44.85 -41.84 2.3 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.329 0 CA-C-O 117.628 -1.177 . . . . 1.0 111.433 -176.385 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 75' ' ' ASN . . . . . 0.523 ' O ' ' N ' ' A' ' 78' ' ' VAL . 4.1 t30 -37.03 -13.45 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.703 0 CA-C-N 121.307 1.867 . . . . 1.0 112.802 179.431 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 76' ' ' GLY . . . . . 0.693 ' N ' ' O ' ' A' ' 74' ' ' VAL . . . -44.56 -25.98 0.96 Allowed Glycine 0 CA--C 1.544 1.897 0 CA-C-N 113.294 -1.776 . . . . 1.0 108.711 177.898 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 77' ' ' ILE . . . . . 0.688 ' HA ' ' HB3' ' A' ' 80' ' ' ALA . 0.2 OUTLIER -69.03 -48.07 71.89 Favored 'Isoleucine or valine' 0 C--O 1.209 -1.052 0 N-CA-C 107.519 -1.289 . . . . 1.0 107.519 178.07 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . 0.639 ' H ' HD13 ' A' ' 77' ' ' ILE . 77.3 t -32.89 -35.59 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.476 0.856 0 CA-C-N 114.658 -1.155 . . . . 1.0 108.036 -176.391 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . 0.721 ' O ' ' HB2' ' A' ' 83' ' ' ALA . 39.0 pt -98.61 -28.44 3.56 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.948 0 CA-C-O 121.261 0.553 . . . . 1.0 111.813 176.932 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 80' ' ' ALA . . . . . 0.688 ' HB3' ' HA ' ' A' ' 77' ' ' ILE . . . -86.77 -13.76 44.26 Favored 'General case' 0 N--CA 1.477 0.922 0 N-CA-C 114.06 1.133 . . . . 1.0 114.06 178.557 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 81' ' ' GLU . . . . . 0.629 ' CG ' ' H ' ' A' ' 82' ' ' ASP . 16.1 pt-20 -83.13 -69.26 0.64 Allowed 'General case' 0 C--N 1.345 0.373 0 CA-C-N 119.042 0.837 . . . . 1.0 108.797 -179.676 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 82' ' ' ASP . . . . . 0.629 ' H ' ' CG ' ' A' ' 81' ' ' GLU . 67.1 m-20 -75.64 -10.79 59.74 Favored 'General case' 0 N--CA 1.442 -0.844 0 CA-C-N 118.075 0.398 . . . . 1.0 110.833 179.453 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . 0.746 ' HA ' ' HB3' ' A' ' 86' ' ' ALA . . . -19.84 -44.37 0.0 OUTLIER 'General case' 0 N--CA 1.472 0.643 0 N-CA-C 112.577 0.584 . . . . 1.0 112.577 177.029 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . 0.579 ' N ' ' O ' ' A' ' 82' ' ' ASP . 5.9 tp -31.65 -33.53 0.01 OUTLIER 'General case' 0 N--CA 1.473 0.702 0 CA-C-N 118.319 0.509 . . . . 1.0 111.746 -177.961 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 85' ' ' ILE . . . . . 0.716 ' O ' HG23 ' A' ' 89' ' ' VAL . 47.8 pt -100.51 -37.19 5.46 Favored 'Isoleucine or valine' 0 C--O 1.208 -1.108 0 N-CA-C 109.096 -0.705 . . . . 1.0 109.096 176.133 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 86' ' ' ALA . . . . . 0.746 ' HB3' ' HA ' ' A' ' 83' ' ' ALA . . . -66.24 -59.41 3.76 Favored 'General case' 0 C--N 1.317 -0.805 0 C-N-CA 119.647 -0.821 . . . . 1.0 111.381 -179.908 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -69.43 -18.36 63.73 Favored 'General case' 0 N--CA 1.47 0.544 0 CA-C-N 120.344 1.429 . . . . 1.0 112.294 -179.627 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -88.64 -13.1 40.67 Favored 'General case' 0 N--CA 1.475 0.817 0 CA-C-O 122.645 1.212 . . . . 1.0 108.141 179.358 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 89' ' ' VAL . . . . . 0.765 ' O ' HG12 ' A' ' 89' ' ' VAL . 53.3 t -92.22 39.66 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.32 -0.7 0 CA-C-N 111.953 -2.385 . . . . 1.0 109.474 177.654 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 90' ' ' GLY . . . . . 0.776 ' O ' ' N ' ' A' ' 92' ' ' HIS . . . -64.22 -30.17 77.05 Favored Glycine 0 C--N 1.371 2.476 0 CA-C-O 117.902 -1.499 . . . . 1.0 109.969 176.893 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 91' ' ' PRO . . . . . 0.599 ' HD2' ' N ' ' A' ' 90' ' ' GLY . 72.6 Cg_exo -40.26 -5.78 0.01 OUTLIER 'Trans proline' 0 N--CA 1.488 1.205 0 CA-C-N 120.926 2.363 . . . . 1.0 111.111 174.556 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 92' ' ' HIS . . . . . 0.776 ' N ' ' O ' ' A' ' 90' ' ' GLY . 2.5 p-80 -48.82 -24.48 1.45 Allowed 'General case' 0 N--CA 1.435 -1.211 0 N-CA-C 106.593 -1.632 . . . . 1.0 106.593 179.731 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 93' ' ' LEU . . . . . 0.553 HD12 ' N ' ' A' ' 94' ' ' ALA . 1.2 pp -60.54 -53.48 56.95 Favored 'General case' 0 N--CA 1.445 -0.697 0 N-CA-C 106.493 -1.669 . . . . 1.0 106.493 176.088 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 94' ' ' ALA . . . . . 0.553 ' N ' HD12 ' A' ' 93' ' ' LEU . . . -51.09 -53.17 36.45 Favored 'General case' 0 C--O 1.212 -0.899 0 N-CA-C 107.409 -1.33 . . . . 1.0 107.409 179.465 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 95' ' ' ARG . . . . . 0.489 ' HE ' ' HD3' ' A' ' 20' ' ' PRO . 4.5 mmp_? -61.94 -28.43 69.53 Favored 'General case' 0 CA--C 1.549 0.924 0 CA-C-O 122.297 1.046 . . . . 1.0 110.09 178.27 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 96' ' ' ALA . . . . . 0.905 ' O ' ' N ' ' A' ' 100' ' ' ILE . . . -50.4 -36.68 33.86 Favored 'General case' 0 C--O 1.195 -1.783 0 N-CA-C 107.105 -1.442 . . . . 1.0 107.105 -176.364 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 97' ' ' LEU . . . . . 0.441 ' C ' ' O ' ' A' ' 96' ' ' ALA . 0.4 OUTLIER -35.0 -23.9 0.01 OUTLIER 'General case' 0 CA--C 1.587 2.403 0 CA-C-N 113.48 -1.691 . . . . 1.0 108.512 -177.214 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild core ' A' A ' 98' ' ' GLY . . . . . 0.657 ' N ' ' O ' ' A' ' 96' ' ' ALA . . . -88.8 -53.02 2.65 Favored Glycine 0 CA--C 1.55 2.221 0 CA-C-O 123.223 1.457 . . . . 1.0 110.644 171.577 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 99' ' ' GLN . . . . . 0.586 ' N ' ' O ' ' A' ' 96' ' ' ALA . 12.2 mp0 -76.99 7.05 5.28 Favored 'General case' 0 N--CA 1.435 -1.178 0 N-CA-C 106.373 -1.714 . . . . 1.0 106.373 176.787 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 100' ' ' ILE . . . . . 0.905 ' N ' ' O ' ' A' ' 96' ' ' ALA . 0.3 OUTLIER -60.23 -52.99 54.87 Favored 'Isoleucine or valine' 0 CA--C 1.487 -1.476 0 N-CA-C 104.806 -2.294 . . . . 1.0 104.806 178.185 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild core ' A' A ' 101' ' ' VAL . . . . . 0.556 ' O ' ' N ' ' A' ' 105' ' ' GLY . 21.5 t -49.3 -60.41 0.74 Allowed 'Isoleucine or valine' 0 C--O 1.222 -0.394 0 C-N-CA 117.752 -1.579 . . . . 1.0 107.837 178.581 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 102' ' ' CYS . . . . . 0.858 ' O ' ' HB2' ' A' ' 106' ' ' ALA . 0.5 OUTLIER -50.17 -30.46 11.4 Favored 'General case' 0 C--N 1.317 -0.825 0 CA-C-N 114.931 -1.031 . . . . 1.0 110.961 -178.265 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild core ' A' A ' 103' ' ' ARG . . . . . 0.426 ' N ' ' O ' ' A' ' 99' ' ' GLN . 0.0 OUTLIER -83.69 -53.84 5.35 Favored 'General case' 0 N--CA 1.486 1.335 0 N-CA-C 114.205 1.187 . . . . 1.0 114.205 -179.322 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild core ' A' A ' 104' ' ' TYR . . . . . 0.662 ' O ' ' CG ' ' A' ' 104' ' ' TYR . 0.0 OUTLIER -94.1 21.5 6.76 Favored 'General case' 0 C--N 1.311 -1.09 0 C-N-CA 126.469 1.908 . . . . 1.0 107.871 179.122 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild core ' A' A ' 105' ' ' GLY . . . . . 0.556 ' N ' ' O ' ' A' ' 101' ' ' VAL . . . -156.76 -91.14 0.08 OUTLIER Glycine 0 N--CA 1.445 -0.733 0 N-CA-C 106.822 -2.511 . . . . 1.0 106.822 177.2 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 106' ' ' ALA . . . . . 0.858 ' HB2' ' O ' ' A' ' 102' ' ' CYS . . . 72.81 46.76 0.24 Allowed 'General case' 0 N--CA 1.449 -0.498 0 N-CA-C 112.076 0.398 . . . . 1.0 112.076 -179.94 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 10.3 t -76.67 7.22 4.83 Favored 'General case' 0 CA--C 1.513 -0.479 0 O-C-N 119.986 -1.696 . . . . 1.0 107.045 176.402 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 18.7 m -86.78 -52.53 11.65 Favored 'Isoleucine or valine' 0 C--N 1.35 0.615 0 CA-C-O 117.945 -1.026 . . . . 1.0 110.298 177.51 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 109' ' ' ILE . . . . . 0.566 ' CG2' ' HB1' ' A' ' 106' ' ' ALA . 0.1 OUTLIER -47.91 -33.93 4.99 Favored Pre-proline 0 C--N 1.368 1.394 0 N-CA-C 116.8 2.148 . . . . 1.0 116.8 -177.587 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild core ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 50.4 Cg_exo -54.79 -47.42 26.81 Favored 'Trans proline' 0 C--N 1.308 -1.564 0 CA-C-N 122.558 1.949 . . . . 1.0 112.439 -176.942 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 111' ' ' ASN . . . . . 0.462 ' O ' ' HB3' ' A' ' 114' ' ' ALA . 24.7 t-20 -72.29 -67.35 0.55 Allowed 'General case' 0 N--CA 1.467 0.4 0 C-N-CA 119.995 -0.682 . . . . 1.0 111.491 -177.184 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 112' ' ' ILE . . . . . 0.688 ' O ' ' HB ' ' A' ' 116' ' ' ILE . 0.9 OUTLIER -46.42 -28.85 0.97 Allowed 'Isoleucine or valine' 0 C--O 1.192 -1.948 0 O-C-N 121.927 -0.483 . . . . 1.0 111.99 -178.3 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild core ' A' A ' 113' ' ' ASN . . . . . 0.448 ' OD1' ' O ' ' A' ' 109' ' ' ILE . 4.3 m120 -72.0 -40.2 68.7 Favored 'General case' 0 N--CA 1.483 1.217 0 CA-C-O 123.544 1.64 . . . . 1.0 108.231 179.859 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 114' ' ' ALA . . . . . 0.462 ' HB3' ' O ' ' A' ' 111' ' ' ASN . . . -54.59 -50.0 69.07 Favored 'General case' 0 C--N 1.295 -1.796 0 CA-C-N 111.015 -2.812 . . . . 1.0 107.376 178.727 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 115' ' ' ALA . . . . . 0.722 ' O ' ' N ' ' A' ' 119' ' ' LEU . . . -85.13 -49.09 8.53 Favored 'General case' 0 C--O 1.199 -1.579 0 N-CA-C 114.402 1.26 . . . . 1.0 114.402 177.652 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 116' ' ' ILE . . . . . 0.688 ' HB ' ' O ' ' A' ' 112' ' ' ILE . 0.6 OUTLIER -42.79 -49.15 1.15 Allowed 'Isoleucine or valine' 0 N--CA 1.513 2.714 0 N-CA-C 106.109 -1.811 . . . . 1.0 106.109 179.569 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild core ' A' A ' 117' ' ' GLU . . . . . 0.439 ' C ' ' O ' ' A' ' 116' ' ' ILE . 68.3 mt-10 -45.99 -59.87 2.59 Favored 'General case' 0 C--N 1.308 -1.2 0 N-CA-C 105.573 -2.01 . . . . 1.0 105.573 177.907 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 118' ' ' VAL . . . . . 0.544 ' N ' ' O ' ' A' ' 115' ' ' ALA . 6.9 t -77.52 -57.37 5.83 Favored 'Isoleucine or valine' 0 CA--C 1.557 1.23 0 N-CA-C 113.558 0.947 . . . . 1.0 113.558 178.505 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 119' ' ' LEU . . . . . 0.722 ' N ' ' O ' ' A' ' 115' ' ' ALA . 1.3 tp -61.55 -24.44 66.64 Favored 'General case' 0 C--N 1.351 0.652 0 N-CA-C 116.218 1.933 . . . . 1.0 116.218 -178.728 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 120' ' ' GLY . . . . . 0.502 ' C ' HG22 ' A' ' 121' ' ' THR . . . -126.48 -54.93 0.15 Allowed Glycine 0 C--N 1.354 1.549 0 CA-C-N 120.506 1.503 . . . . 1.0 110.869 176.976 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 121' ' ' THR . . . . . 0.672 HG23 ' N ' ' A' ' 122' ' ' GLY . 2.1 t 143.39 -56.18 0.0 OUTLIER 'General case' 0 N--CA 1.477 0.907 0 C-N-CA 124.089 0.956 . . . . 1.0 112.036 -177.915 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 122' ' ' GLY . . . . . 0.672 ' N ' HG23 ' A' ' 121' ' ' THR . . . 92.6 -23.27 28.97 Favored Glycine 0 CA--C 1.531 1.053 0 N-CA-C 107.725 -2.15 . . . . 1.0 107.725 -176.583 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 123' ' ' THR . . . . . 0.615 HG22 HG21 ' A' ' 121' ' ' THR . 5.8 t -46.94 91.94 0.01 OUTLIER 'General case' 0 N--CA 1.477 0.918 0 N-CA-C 105.64 -1.985 . . . . 1.0 105.64 179.239 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 124' ' ' ASP . . . . . 0.592 ' N ' ' O ' ' A' ' 122' ' ' GLY . 48.2 p30 -169.76 -174.82 1.94 Allowed 'General case' 0 CA--C 1.537 0.458 0 CA-C-N 114.904 -1.044 . . . . 1.0 112.38 178.739 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 125' ' ' TYR . . . . . . . . . . . . . 16.9 t80 -148.59 147.63 29.22 Favored 'General case' 0 CA--C 1.542 0.644 0 CA-C-N 114.385 -1.28 . . . . 1.0 109.059 175.686 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 13.8 mtp85 -146.94 150.41 35.14 Favored 'General case' 0 N--CA 1.476 0.85 0 N-CA-C 109.812 -0.44 . . . . 1.0 109.812 177.38 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 127' ' ' PHE . . . . . . . . . . . . . 26.7 p90 . . . . . 0 C--O 1.22 -0.449 0 CA-C-O 118.176 -0.916 . . . . 1.0 111.231 -179.353 . . . . . . . . 0 0 . 1 . 027 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.488 1.456 0 N-CA-C 108.667 -0.864 . . . . 1.0 108.667 . . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 93.4 p -88.4 0.58 56.07 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.576 -0.284 . . . . 1.0 111.316 -179.967 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 2.0 t70 164.65 118.65 0.01 OUTLIER 'General case' 0 N--CA 1.479 0.988 0 O-C-N 123.391 0.432 . . . . 1.0 111.277 178.916 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 58.2 t80 -151.74 148.39 27.83 Favored 'General case' 0 N--CA 1.465 0.322 0 CA-C-O 121.078 0.466 . . . . 1.0 110.191 177.997 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 30.9 m-20 -152.29 148.12 27.16 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.596 -0.729 . . . . 1.0 109.788 179.754 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 6' ' ' THR . . . . . 1.038 ' H ' HG23 ' A' ' 9' ' ' VAL . 0.2 OUTLIER -106.72 -168.7 1.45 Allowed 'General case' 0 C--O 1.205 -1.286 0 CA-C-O 121.602 0.715 . . . . 1.0 109.832 -179.967 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . 0.502 ' O ' ' CB ' ' A' ' 11' ' ' ARG . 71.6 mm-40 -57.66 -46.59 84.03 Favored 'General case' 0 C--N 1.297 -1.68 0 N-CA-C 109.438 -0.578 . . . . 1.0 109.438 179.77 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 8' ' ' ARG . . . . . 0.695 ' O ' ' HB3' ' A' ' 12' ' ' ALA . 16.8 mtt85 -66.58 -61.64 1.88 Allowed 'General case' 0 C--N 1.316 -0.864 0 C-N-CA 117.373 -1.731 . . . . 1.0 109.595 179.609 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . 1.038 HG23 ' H ' ' A' ' 6' ' ' THR . 0.0 OUTLIER -61.73 -52.86 55.83 Favored 'Isoleucine or valine' 0 C--O 1.204 -1.311 0 CA-C-N 114.769 -1.105 . . . . 1.0 110.703 -179.679 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild core ' A' A ' 10' ' ' SER . . . . . 0.72 ' N ' ' O ' ' A' ' 6' ' ' THR . 4.9 t -65.3 -61.5 2.08 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 122.074 -0.391 . . . . 1.0 111.619 178.761 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 11' ' ' ARG . . . . . 0.648 ' O ' ' HB3' ' A' ' 15' ' ' ALA . 29.4 ttt180 -62.06 -43.96 97.71 Favored 'General case' 0 C--N 1.31 -1.123 0 O-C-N 121.462 -0.774 . . . . 1.0 109.561 -175.698 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . 0.735 ' O ' ' HB3' ' A' ' 16' ' ' ALA . . . -70.33 -56.58 6.36 Favored 'General case' 0 N--CA 1.477 0.919 0 C-N-CA 118.825 -1.15 . . . . 1.0 109.161 176.801 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . 0.673 ' O ' ' CB ' ' A' ' 17' ' ' LEU . 55.0 t -61.46 -53.46 48.27 Favored 'Isoleucine or valine' 0 C--O 1.192 -1.961 0 C-N-CA 117.498 -1.681 . . . . 1.0 107.461 -178.779 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . 0.935 ' O ' HG22 ' A' ' 18' ' ' VAL . . . -62.82 -65.28 0.71 Allowed 'General case' 0 C--N 1.308 -1.217 0 C-N-CA 116.075 -2.25 . . . . 1.0 111.892 -179.814 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . 0.648 ' HB3' ' O ' ' A' ' 11' ' ' ARG . . . -55.35 -55.49 30.92 Favored 'General case' 0 C--O 1.217 -0.64 0 C-N-CA 118.321 -1.352 . . . . 1.0 111.545 -176.7 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . 0.735 ' HB3' ' O ' ' A' ' 12' ' ' ALA . . . -65.6 -58.67 5.2 Favored 'General case' 0 C--N 1.301 -1.502 0 C-N-CA 118.35 -1.34 . . . . 1.0 110.804 -178.491 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . 0.673 ' CB ' ' O ' ' A' ' 13' ' ' VAL . 5.7 tp -53.62 -55.3 27.02 Favored 'General case' 0 N--CA 1.489 1.504 0 N-CA-C 108.536 -0.913 . . . . 1.0 108.536 -179.294 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . 0.935 HG22 ' O ' ' A' ' 14' ' ' ALA . 2.2 m -71.03 -60.42 2.45 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.43 0 C-N-CA 118.975 -1.09 . . . . 1.0 110.85 -179.509 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . 0.528 ' N ' ' O ' ' A' ' 15' ' ' ALA . . . -54.54 -163.26 0.01 OUTLIER Glycine 0 N--CA 1.438 -1.218 0 CA-C-O 121.567 0.537 . . . . 1.0 113.179 -176.969 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 20' ' ' PRO . . . . . 0.72 ' O ' ' N ' ' A' ' 24' ' ' ALA . 90.6 Cg_endo -80.48 -24.75 5.06 Favored 'Trans proline' 0 C--N 1.302 -1.884 0 C-N-CA 122.246 1.964 . . . . 1.0 111.712 -179.112 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -62.11 -60.84 7.35 Favored Glycine 0 N--CA 1.47 0.914 0 C-N-CA 118.685 -1.721 . . . . 1.0 111.059 -176.921 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . 0.61 ' N ' ' O ' ' A' ' 16' ' ' ALA . . . -60.71 -50.39 68.1 Favored Glycine 0 C--N 1.304 -1.207 0 N-CA-C 106.954 -2.459 . . . . 1.0 106.954 179.017 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 83.2 t -58.41 -34.05 49.52 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.582 0 C-N-CA 118.837 -1.145 . . . . 1.0 107.991 -179.72 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . 0.72 ' N ' ' O ' ' A' ' 20' ' ' PRO . . . -61.71 -61.23 2.66 Favored 'General case' 0 N--CA 1.468 0.468 0 C-N-CA 118.685 -1.206 . . . . 1.0 109.376 179.402 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . 0.425 ' O ' HG12 ' A' ' 29' ' ' VAL . 58.0 mt -60.42 -45.19 94.49 Favored 'General case' 0 CA--C 1.508 -0.673 0 C-N-CA 119.59 -0.844 . . . . 1.0 110.478 -176.512 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 55.4 t -59.83 -60.34 2.66 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.512 0 C-N-CA 119.325 -0.95 . . . . 1.0 109.692 -178.278 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . 0.802 ' O ' ' HB3' ' A' ' 31' ' ' ALA . 62.1 t -58.57 -40.16 78.02 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.363 0 C-N-CA 120.543 -0.463 . . . . 1.0 110.534 -177.828 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 10.9 tttm -66.56 -55.26 16.27 Favored 'General case' 0 C--N 1.314 -0.946 0 C-N-CA 119.855 -0.738 . . . . 1.0 109.82 -178.701 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . 0.483 HG13 ' N ' ' A' ' 30' ' ' CYS . 3.2 p -65.82 -50.8 68.13 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 CA-C-N 115.294 -0.866 . . . . 1.0 111.011 -177.32 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 30' ' ' CYS . . . . . 0.483 ' N ' HG13 ' A' ' 29' ' ' VAL . 42.0 t -67.59 -62.61 1.34 Allowed 'General case' 0 N--CA 1.44 -0.945 0 C-N-CA 119.837 -0.745 . . . . 1.0 110.597 -179.208 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . 0.802 ' HB3' ' O ' ' A' ' 27' ' ' VAL . . . -62.74 -53.33 55.96 Favored 'General case' 0 N--CA 1.434 -1.273 0 C-N-CA 120.578 -0.449 . . . . 1.0 111.378 -175.459 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 69.8 66.23 2.3 Favored Glycine 0 N--CA 1.441 -1.022 0 C-N-CA 119.225 -1.464 . . . . 1.0 109.828 -179.428 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . 0.509 ' O ' ' CD1' ' A' ' 37' ' ' ILE . 6.2 mt 87.55 96.15 0.03 OUTLIER Pre-proline 0 N--CA 1.481 1.108 0 O-C-N 126.232 1.784 . . . . 1.0 112.049 -179.535 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 54.4 Cg_exo -46.23 -8.21 0.04 OUTLIER 'Trans proline' 0 N--CA 1.497 1.681 0 C-N-CA 122.39 2.06 . . . . 1.0 114.184 -179.825 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . 0.467 ' N ' ' O ' ' A' ' 33' ' ' LEU . . . -61.25 -60.27 8.59 Favored Glycine 0 CA--C 1.538 1.472 0 C-N-CA 118.466 -1.826 . . . . 1.0 109.867 -178.668 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . 0.855 HG22 ' H ' ' A' ' 37' ' ' ILE . 7.1 p -88.55 -139.84 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.473 0.687 0 CA-C-N 117.87 0.835 . . . . 1.0 109.072 179.369 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . 0.855 ' H ' HG22 ' A' ' 36' ' ' VAL . 2.5 mp 68.27 79.65 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.47 0.554 0 N-CA-C 112.575 0.583 . . . . 1.0 112.575 179.655 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 38' ' ' HIS . . . . . 0.515 ' CD2' ' N ' ' A' ' 38' ' ' HIS . 0.0 OUTLIER -138.86 132.47 30.54 Favored 'General case' 0 CA--C 1.532 0.266 0 N-CA-C 108.383 -0.969 . . . . 1.0 108.383 178.397 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -107.43 159.3 30.7 Favored Pre-proline 0 N--CA 1.472 0.671 0 CA-C-N 116.515 -0.312 . . . . 1.0 110.182 -178.353 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 59.6 Cg_endo -71.97 -23.44 21.89 Favored 'Trans proline' 0 C--N 1.306 -1.668 0 C-N-CA 121.736 1.624 . . . . 1.0 111.947 178.668 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -119.76 83.99 2.13 Favored 'General case' 0 C--N 1.343 0.3 0 C-N-CA 120.553 -0.459 . . . . 1.0 110.582 179.281 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . 0.673 ' C ' ' H ' ' A' ' 44' ' ' GLY . 0.0 OUTLIER -103.86 135.26 45.73 Favored 'General case' 0 C--N 1.318 -0.803 0 CA-C-N 116.003 -0.544 . . . . 1.0 110.171 -177.644 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild core ' A' A ' 43' ' ' ARG . . . . . 0.619 ' C ' ' H ' ' A' ' 45' ' ' PHE . 42.9 tpt85 -64.31 22.65 0.01 OUTLIER 'General case' 0 C--N 1.314 -0.943 0 C-N-CA 119.913 -0.715 . . . . 1.0 109.763 179.092 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . 0.673 ' H ' ' C ' ' A' ' 42' ' ' ARG . . . 70.45 -28.04 0.46 Allowed Glycine 0 C--N 1.345 1.053 0 N-CA-C 110.764 -0.934 . . . . 1.0 110.764 179.223 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . 0.621 ' O ' ' HB2' ' A' ' 46' ' ' PHE . 31.0 p90 -164.71 172.61 12.83 Favored 'General case' 0 N--CA 1.45 -0.47 0 N-CA-C 108.521 -0.918 . . . . 1.0 108.521 -179.807 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 46' ' ' PHE . . . . . 0.621 ' HB2' ' O ' ' A' ' 45' ' ' PHE . 1.7 t80 116.16 96.41 0.0 OUTLIER 'General case' 0 N--CA 1.484 1.236 0 O-C-N 125.701 1.875 . . . . 1.0 108.153 -178.499 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 47' ' ' ARG . . . . . 0.547 ' O ' ' CB ' ' A' ' 48' ' ' CYS . 3.9 mmp_? 115.16 133.41 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.611 0 O-C-N 125.06 1.475 . . . . 1.0 109.859 -179.551 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 48' ' ' CYS . . . . . 0.547 ' CB ' ' O ' ' A' ' 47' ' ' ARG . 43.7 t 121.95 -5.59 0.0 OUTLIER 'General case' 0 CA--C 1.51 -0.595 0 O-C-N 125.305 1.628 . . . . 1.0 111.059 177.406 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -120.59 149.89 51.16 Favored Pre-proline 0 CA--C 1.534 0.356 0 N-CA-C 109.84 -0.43 . . . . 1.0 109.84 179.867 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 50' ' ' PRO . . . . . 0.562 ' C ' ' H ' ' A' ' 52' ' ' ARG . 98.9 Cg_endo -76.46 87.16 1.47 Allowed 'Trans proline' 0 N--CA 1.493 1.47 0 C-N-CA 122.277 1.985 . . . . 1.0 114.041 -179.888 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . 0.433 ' CD ' ' O ' ' A' ' 50' ' ' PRO . 0.0 OUTLIER 66.44 -32.7 0.18 Allowed 'General case' 0 N--CA 1.472 0.649 0 N-CA-C 112.09 0.404 . . . . 1.0 112.09 176.269 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . 0.856 HH11 ' HB1' ' A' ' 86' ' ' ALA . 5.4 mtm180 -45.39 140.08 3.29 Favored 'General case' 0 C--N 1.315 -0.903 0 CA-C-O 121.941 0.877 . . . . 1.0 112.198 -178.094 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 2.2 tp -82.22 166.07 2.4 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 114.35 -1.295 . . . . 1.0 108.7 177.999 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 16.7 mt-30 -135.73 134.6 39.23 Favored 'General case' 0 N--CA 1.453 -0.288 0 N-CA-C 108.423 -0.954 . . . . 1.0 108.423 179.795 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 2.3 pp -142.68 153.66 17.6 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.366 0 N-CA-C 109.881 -0.414 . . . . 1.0 109.881 178.288 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 105.1 2.36 41.89 Favored Glycine 0 CA--C 1.529 0.95 0 N-CA-C 110.077 -1.209 . . . . 1.0 110.077 -178.348 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 58.0 m-20 -86.78 103.99 15.73 Favored 'General case' 0 N--CA 1.471 0.605 0 CA-C-O 122.141 0.972 . . . . 1.0 112.722 -178.333 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 58' ' ' TRP . . . . . 0.54 ' HB2' ' HB2' ' A' ' 61' ' ' GLU . 13.3 m95 -78.78 178.41 7.93 Favored 'General case' 0 C--N 1.315 -0.922 0 CA-C-N 113.484 -1.689 . . . . 1.0 108.937 177.879 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 59' ' ' ARG . . . . . 0.506 ' HG2' ' H ' ' A' ' 60' ' ' TYR . 0.0 OUTLIER -101.23 -56.95 2.19 Favored 'General case' 0 CA--C 1.557 1.244 0 CA-C-N 119.494 1.043 . . . . 1.0 112.533 178.814 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild core ' A' A ' 60' ' ' TYR . . . . . 0.506 ' H ' ' HG2' ' A' ' 59' ' ' ARG . 63.2 t80 -80.5 -13.5 59.05 Favored 'General case' 0 N--CA 1.485 1.305 0 C-N-CA 125.341 1.456 . . . . 1.0 112.581 -178.209 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . 0.541 ' O ' ' N ' ' A' ' 65' ' ' ASP . 10.1 mt-10 -79.49 -14.59 58.79 Favored 'General case' 0 C--N 1.298 -1.641 0 CA-C-N 114.963 -1.017 . . . . 1.0 108.903 178.244 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 62' ' ' VAL . . . . . 0.502 HG13 ' O ' ' A' ' 59' ' ' ARG . 13.4 m -44.26 -44.39 2.22 Favored 'Isoleucine or valine' 0 CA--C 1.491 -1.317 0 N-CA-C 109.331 -0.618 . . . . 1.0 109.331 -176.41 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 63' ' ' ALA . . . . . 0.548 ' O ' ' HG2' ' A' ' 67' ' ' ARG . . . -69.2 -46.74 66.71 Favored 'General case' 0 N--CA 1.411 -2.423 0 N-CA-C 107.947 -1.131 . . . . 1.0 107.947 177.61 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 64' ' ' HIS . . . . . 0.496 ' N ' ' O ' ' A' ' 61' ' ' GLU . 1.3 t-80 -56.04 -60.42 3.51 Favored 'General case' 0 CA--C 1.546 0.805 0 CA-C-N 115.512 -0.767 . . . . 1.0 111.049 178.891 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 65' ' ' ASP . . . . . 0.69 ' C ' ' H ' ' A' ' 67' ' ' ARG . 10.4 t70 -66.15 -54.69 22.35 Favored 'General case' 0 C--O 1.248 0.974 0 O-C-N 121.489 -0.757 . . . . 1.0 109.639 178.062 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . 0.456 ' N ' ' O ' ' A' ' 62' ' ' VAL . . . -63.22 32.49 0.08 OUTLIER Glycine 0 N--CA 1.471 0.982 0 N-CA-C 110.603 -0.999 . . . . 1.0 110.603 177.526 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 67' ' ' ARG . . . . . 0.723 ' HB3' ' H ' ' A' ' 71' ' ' ALA . 0.2 OUTLIER -75.75 1.74 13.97 Favored 'General case' 0 N--CA 1.435 -1.197 0 CA-C-N 114.639 -0.781 . . . . 1.0 109.113 175.71 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . 0.538 ' O ' ' HA ' ' A' ' 72' ' ' HIS . 10.2 mp -33.72 -29.67 0.01 OUTLIER 'General case' 0 N--CA 1.501 2.118 0 N-CA-C 106.848 -1.538 . . . . 1.0 106.848 -177.597 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . 0.63 ' N ' ' O ' ' A' ' 67' ' ' ARG . 5.2 tp -61.85 -65.61 0.66 Allowed 'General case' 0 CA--C 1.553 1.06 0 C-N-CA 117.825 -1.55 . . . . 1.0 107.441 175.439 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . 0.642 ' O ' ' CG ' ' A' ' 72' ' ' HIS . . . -75.32 -68.59 0.54 Allowed 'General case' 0 N--CA 1.477 0.9 0 N-CA-C 106.456 -1.683 . . . . 1.0 106.456 175.684 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 71' ' ' ALA . . . . . 0.723 ' H ' ' HB3' ' A' ' 67' ' ' ARG . . . -47.17 2.54 0.0 OUTLIER 'General case' 0 N--CA 1.477 0.922 0 C-N-CA 124.686 1.194 . . . . 1.0 113.48 178.876 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 72' ' ' HIS . . . . . 0.642 ' CG ' ' O ' ' A' ' 70' ' ' ALA . 0.3 OUTLIER -19.94 -82.63 0.0 OUTLIER 'General case' 0 C--N 1.324 -0.525 0 N-CA-C 113.589 0.959 . . . . 1.0 113.589 -174.259 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild core ' A' A ' 73' ' ' MET . . . . . 0.641 ' H ' ' CD2' ' A' ' 72' ' ' HIS . 0.7 OUTLIER -74.29 -41.79 60.62 Favored 'General case' 0 C--N 1.3 -1.545 0 CA-C-N 118.928 0.786 . . . . 1.0 111.122 178.389 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . 0.594 ' O ' ' N ' ' A' ' 76' ' ' GLY . 0.8 OUTLIER -44.74 -41.78 2.22 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.796 0 C-N-CA 119.694 -0.803 . . . . 1.0 110.441 -174.62 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild core ' A' A ' 75' ' ' ASN . . . . . 0.567 ' O ' ' N ' ' A' ' 77' ' ' ILE . 28.2 t30 -39.16 -17.9 0.01 OUTLIER 'General case' 0 N--CA 1.48 1.033 0 CA-C-O 122.401 1.096 . . . . 1.0 110.964 178.029 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 76' ' ' GLY . . . . . 0.728 ' O ' HD12 ' A' ' 79' ' ' ILE . . . -43.41 -16.14 0.03 OUTLIER Glycine 0 CA--C 1.564 3.095 0 N-CA-C 108.634 -1.786 . . . . 1.0 108.634 176.051 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 77' ' ' ILE . . . . . 0.784 ' O ' ' N ' ' A' ' 80' ' ' ALA . 2.6 pp -89.91 -46.0 15.08 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.227 0 N-CA-C 108.428 -0.953 . . . . 1.0 108.428 -179.354 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . 0.501 ' N ' HD12 ' A' ' 77' ' ' ILE . 1.0 OUTLIER -34.34 -27.94 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.571 1.766 0 N-CA-C 108.775 -0.824 . . . . 1.0 108.775 -174.816 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . 0.934 HD13 ' N ' ' A' ' 80' ' ' ALA . 0.0 OUTLIER -92.0 -17.32 7.64 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.907 0 C-N-CA 124.86 1.264 . . . . 1.0 111.765 177.383 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild core ' A' A ' 80' ' ' ALA . . . . . 0.934 ' N ' HD13 ' A' ' 79' ' ' ILE . . . -65.86 -14.05 60.74 Favored 'General case' 0 C--N 1.321 -0.639 0 O-C-N 122.156 -0.34 . . . . 1.0 111.215 178.105 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 34.6 mt-10 -122.78 -47.89 2.05 Favored 'General case' 0 N--CA 1.47 0.534 0 CA-C-O 121.767 0.794 . . . . 1.0 109.435 175.759 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -59.94 -62.08 2.13 Favored 'General case' 0 CA--C 1.53 0.209 0 CA-C-N 115.22 -0.9 . . . . 1.0 109.314 -179.745 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . 0.648 ' HB3' ' O ' ' A' ' 79' ' ' ILE . . . -47.5 -45.23 26.21 Favored 'General case' 0 N--CA 1.467 0.42 0 CA-C-N 116.587 -0.279 . . . . 1.0 110.798 -179.248 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . 0.545 HD13 ' O ' ' A' ' 80' ' ' ALA . 1.5 tp -28.83 -44.85 0.03 OUTLIER 'General case' 0 N--CA 1.483 1.187 0 CA-C-N 116.36 -0.382 . . . . 1.0 111.636 -174.683 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 85' ' ' ILE . . . . . 0.438 HG13 ' H ' ' A' ' 86' ' ' ALA . 3.4 pt -91.57 -49.77 13.07 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.742 0 N-CA-C 109.102 -0.703 . . . . 1.0 109.102 177.138 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 86' ' ' ALA . . . . . 0.856 ' HB1' HH11 ' A' ' 52' ' ' ARG . . . -48.22 -36.0 12.97 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.608 -0.724 . . . . 1.0 110.261 -178.723 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 5.3 mm-40 -57.51 -23.56 50.93 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.864 -0.607 . . . . 1.0 110.051 179.213 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -73.26 -9.51 58.79 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 121.22 0.533 . . . . 1.0 109.733 179.505 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 89' ' ' VAL . . . . . 0.629 ' O ' HG12 ' A' ' 89' ' ' VAL . 40.5 t -105.46 36.91 0.37 Allowed 'Isoleucine or valine' 0 C--O 1.234 0.268 0 CA-C-N 115.433 -0.803 . . . . 1.0 109.413 179.198 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 90' ' ' GLY . . . . . 0.537 ' O ' ' N ' ' A' ' 92' ' ' HIS . . . -66.71 -43.11 92.65 Favored Glycine 0 CA--C 1.539 1.531 0 N-CA-C 111.205 -0.758 . . . . 1.0 111.205 178.859 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 91' ' ' PRO . . . . . 0.472 ' CD ' ' N ' ' A' ' 90' ' ' GLY . 87.3 Cg_exo -42.3 -15.33 0.05 OUTLIER 'Trans proline' 0 N--CA 1.497 1.71 0 C-N-CA 122.03 1.82 . . . . 1.0 112.386 179.982 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 92' ' ' HIS . . . . . 0.537 ' N ' ' O ' ' A' ' 90' ' ' GLY . 5.6 p-80 -60.52 -15.51 28.05 Favored 'General case' 0 C--N 1.322 -0.601 0 N-CA-C 108.662 -0.866 . . . . 1.0 108.662 179.52 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 93' ' ' LEU . . . . . 0.737 HD12 ' N ' ' A' ' 94' ' ' ALA . 2.3 pp -72.95 -58.48 3.29 Favored 'General case' 0 C--N 1.323 -0.557 0 N-CA-C 108.836 -0.801 . . . . 1.0 108.836 179.915 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 94' ' ' ALA . . . . . 0.737 ' N ' HD12 ' A' ' 93' ' ' LEU . . . -59.23 -55.8 30.25 Favored 'General case' 0 C--O 1.236 0.391 0 CA-C-O 120.907 0.384 . . . . 1.0 109.997 179.744 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 95' ' ' ARG . . . . . 0.73 ' O ' ' N ' ' A' ' 97' ' ' LEU . 11.1 ttm180 -52.85 -59.3 4.67 Favored 'General case' 0 C--O 1.24 0.558 0 N-CA-C 107.079 -1.452 . . . . 1.0 107.079 178.777 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 96' ' ' ALA . . . . . 0.875 ' O ' ' N ' ' A' ' 98' ' ' GLY . . . -46.4 -7.67 0.01 OUTLIER 'General case' 0 N--CA 1.427 -1.616 0 O-C-N 119.029 -2.295 . . . . 1.0 112.525 -177.33 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 97' ' ' LEU . . . . . 0.73 ' N ' ' O ' ' A' ' 95' ' ' ARG . 0.4 OUTLIER 2.85 -50.57 0.0 OUTLIER 'General case' 0 C--N 1.36 1.062 0 O-C-N 124.776 1.297 . . . . 1.0 110.522 -169.447 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild core ' A' A ' 98' ' ' GLY . . . . . 0.952 ' O ' HG12 ' A' ' 101' ' ' VAL . . . -52.65 -17.52 4.67 Favored Glycine 0 N--CA 1.422 -2.265 0 CA-C-N 122.088 2.222 . . . . 1.0 107.902 174.001 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 99' ' ' GLN . . . . . 0.697 ' N ' ' O ' ' A' ' 96' ' ' ALA . 68.8 tp60 -73.96 -25.31 59.88 Favored 'General case' 0 CA--C 1.512 -0.5 0 C-N-CA 117.746 -1.582 . . . . 1.0 107.066 178.69 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 100' ' ' ILE . . . . . 0.619 ' N ' ' O ' ' A' ' 97' ' ' LEU . 4.9 tt -62.55 -35.51 70.49 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.883 0 CA-C-N 114.522 -1.217 . . . . 1.0 110.207 178.617 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 101' ' ' VAL . . . . . 0.952 HG12 ' O ' ' A' ' 98' ' ' GLY . 8.7 p -61.83 -58.69 6.42 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.698 0 C-N-CA 118.514 -1.274 . . . . 1.0 108.976 -179.599 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 102' ' ' CYS . . . . . 0.994 ' O ' ' HB2' ' A' ' 106' ' ' ALA . 0.1 OUTLIER -42.23 -24.53 0.05 Allowed 'General case' 0 N--CA 1.437 -1.104 0 N-CA-C 112.109 0.411 . . . . 1.0 112.109 -177.451 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild core ' A' A ' 103' ' ' ARG . . . . . 0.428 ' N ' ' O ' ' A' ' 101' ' ' VAL . 9.4 ttp180 -88.81 -33.15 17.52 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-O 122.435 1.112 . . . . 1.0 111.207 178.39 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 104' ' ' TYR . . . . . 0.689 ' O ' ' CG ' ' A' ' 104' ' ' TYR . 0.3 OUTLIER -100.71 17.49 21.81 Favored 'General case' 0 C--N 1.312 -1.044 0 CA-C-N 113.365 -1.743 . . . . 1.0 109.822 177.352 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild core ' A' A ' 105' ' ' GLY . . . . . 0.528 ' N ' ' O ' ' A' ' 101' ' ' VAL . . . -165.29 -82.3 0.05 OUTLIER Glycine 0 N--CA 1.447 -0.599 0 N-CA-C 106.945 -2.462 . . . . 1.0 106.945 175.97 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 106' ' ' ALA . . . . . 0.994 ' HB2' ' O ' ' A' ' 102' ' ' CYS . . . 70.47 68.89 0.2 Allowed 'General case' 0 N--CA 1.437 -1.094 0 N-CA-C 112.256 0.465 . . . . 1.0 112.256 179.043 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 107' ' ' THR . . . . . 0.575 ' O ' ' HG2' ' A' ' 110' ' ' PRO . 25.2 m -76.27 -55.46 5.55 Favored 'General case' 0 C--O 1.213 -0.819 0 O-C-N 120.737 -1.227 . . . . 1.0 109.433 177.907 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 108' ' ' VAL . . . . . 0.604 ' O ' ' HB2' ' A' ' 111' ' ' ASN . 35.7 m -72.54 -48.39 47.2 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.205 0 CA-C-O 121.283 0.563 . . . . 1.0 111.692 -178.72 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 109' ' ' ILE . . . . . 0.57 ' N ' HG23 ' A' ' 108' ' ' VAL . 0.0 OUTLIER -41.31 -45.6 7.19 Favored Pre-proline 0 C--N 1.316 -0.854 0 CA-C-O 118.001 -0.999 . . . . 1.0 109.737 -178.027 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild core ' A' A ' 110' ' ' PRO . . . . . 0.575 ' HG2' ' O ' ' A' ' 107' ' ' THR . 72.6 Cg_endo -63.21 -18.06 63.08 Favored 'Trans proline' 0 C--O 1.2 -1.418 0 CA-C-N 122.388 1.889 . . . . 1.0 111.25 177.65 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 111' ' ' ASN . . . . . 0.604 ' HB2' ' O ' ' A' ' 108' ' ' VAL . 0.4 OUTLIER -62.2 -66.26 0.57 Allowed 'General case' 0 N--CA 1.478 0.974 0 N-CA-C 108.375 -0.972 . . . . 1.0 108.375 178.803 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild core ' A' A ' 112' ' ' ILE . . . . . 0.61 ' O ' ' HB ' ' A' ' 116' ' ' ILE . 1.5 pt -48.27 -22.78 0.66 Allowed 'Isoleucine or valine' 0 C--O 1.219 -0.51 0 N-CA-C 107.864 -1.161 . . . . 1.0 107.864 179.714 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 113' ' ' ASN . . . . . 0.726 ' O ' ' HB2' ' A' ' 117' ' ' GLU . 11.8 m-20 -84.61 -53.68 5.23 Favored 'General case' 0 N--CA 1.44 -0.935 0 CA-C-O 124.01 1.862 . . . . 1.0 110.063 177.474 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 114' ' ' ALA . . . . . 0.449 ' N ' ' O ' ' A' ' 110' ' ' PRO . . . -56.12 -55.78 28.92 Favored 'General case' 0 C--N 1.29 -1.979 0 CA-C-N 114.376 -1.284 . . . . 1.0 109.619 -178.952 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -80.38 -61.02 2.1 Favored 'General case' 0 C--O 1.244 0.81 0 N-CA-C 114.554 1.316 . . . . 1.0 114.554 179.706 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 116' ' ' ILE . . . . . 0.61 ' HB ' ' O ' ' A' ' 112' ' ' ILE . 36.4 mm -72.46 -40.03 63.18 Favored 'Isoleucine or valine' 0 C--O 1.211 -0.938 0 N-CA-C 114.35 1.241 . . . . 1.0 114.35 -175.234 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 117' ' ' GLU . . . . . 0.726 ' HB2' ' O ' ' A' ' 113' ' ' ASN . 1.2 tt0 -51.85 -62.78 1.41 Allowed 'General case' 0 CA--C 1.486 -1.484 0 CA-C-N 118.12 0.418 . . . . 1.0 110.611 -176.334 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 38.8 t -55.54 -14.23 1.31 Allowed 'Isoleucine or valine' 0 N--CA 1.424 -1.774 0 C-N-CA 117.836 -1.546 . . . . 1.0 109.253 -177.244 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 119' ' ' LEU . . . . . 0.416 ' N ' ' C ' ' A' ' 117' ' ' GLU . 1.1 tp -92.54 -56.66 2.94 Favored 'General case' 0 CA--C 1.552 1.044 0 N-CA-C 113.682 0.993 . . . . 1.0 113.682 176.857 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -68.75 -50.52 35.58 Favored Glycine 0 C--N 1.358 1.764 0 C-N-CA 120.062 -1.066 . . . . 1.0 114.47 -174.68 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 1.9 t 155.56 -40.0 0.01 OUTLIER 'General case' 0 N--CA 1.476 0.865 0 N-CA-C 106.396 -1.705 . . . . 1.0 106.396 -178.273 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 122' ' ' GLY . . . . . 0.51 ' O ' ' N ' ' A' ' 124' ' ' ASP . . . 113.62 -34.37 5.05 Favored Glycine 0 CA--C 1.532 1.108 0 C-N-CA 126.217 1.865 . . . . 1.0 112.862 179.684 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 123' ' ' THR . . . . . 0.446 ' C ' ' O ' ' A' ' 122' ' ' GLY . 33.4 m -32.84 90.91 0.0 OUTLIER 'General case' 0 N--CA 1.486 1.341 0 CA-C-N 120.219 2.009 . . . . 1.0 112.01 -178.698 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 124' ' ' ASP . . . . . 0.51 ' N ' ' O ' ' A' ' 122' ' ' GLY . 39.7 m-20 -145.52 146.16 31.33 Favored 'General case' 0 CA--C 1.537 0.457 0 N-CA-C 108.763 -0.828 . . . . 1.0 108.763 178.089 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 125' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -153.7 150.58 28.71 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-O 120.85 0.357 . . . . 1.0 110.195 -178.851 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 2.7 tpt180 -149.08 151.26 34.13 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.894 -0.594 . . . . 1.0 109.801 177.059 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 127' ' ' PHE . . . . . . . . . . . . . 19.5 m-85 . . . . . 0 C--O 1.218 -0.583 0 CA-C-O 117.973 -1.013 . . . . 1.0 112.043 -178.864 . . . . . . . . 0 0 . 1 . 028 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . 0.444 ' SD ' ' CD2' ' A' ' 4' ' ' PHE . 38.2 mtt . . . . . 0 N--CA 1.49 1.545 0 N-CA-C 108.503 -0.925 . . . . 1.0 108.503 . . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 2' ' ' SER . . . . . 0.46 ' O ' ' CB ' ' A' ' 3' ' ' ASP . 14.8 m -95.31 10.5 35.96 Favored 'General case' 0 N--CA 1.466 0.357 0 C-N-CA 122.628 0.371 . . . . 1.0 110.939 -179.503 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 3' ' ' ASP . . . . . 0.46 ' CB ' ' O ' ' A' ' 2' ' ' SER . 0.2 OUTLIER 157.4 109.21 0.0 OUTLIER 'General case' 0 N--CA 1.473 0.687 0 O-C-N 124.077 0.861 . . . . 1.0 109.999 178.87 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . 0.444 ' CD2' ' SD ' ' A' ' 1' ' ' MET . 14.9 t80 -152.99 148.21 26.82 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.121 -0.49 . . . . 1.0 110.515 179.695 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 5' ' ' ASP . . . . . 0.4 ' OD1' ' O ' ' A' ' 4' ' ' PHE . 9.5 m-20 -154.23 150.16 27.76 Favored 'General case' 0 CA--C 1.536 0.407 0 N-CA-C 109.404 -0.591 . . . . 1.0 109.404 179.761 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 6' ' ' THR . . . . . 0.511 ' O ' ' N ' ' A' ' 10' ' ' SER . 0.2 OUTLIER -62.2 167.51 3.99 Favored 'General case' 0 C--O 1.218 -0.603 0 C-N-CA 120.126 -0.63 . . . . 1.0 110.216 -178.804 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . 0.582 ' O ' ' N ' ' A' ' 11' ' ' ARG . 3.1 tt0 -59.69 -58.37 8.86 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-O 121.401 0.62 . . . . 1.0 110.45 -177.947 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 8' ' ' ARG . . . . . 0.485 ' O ' ' CB ' ' A' ' 12' ' ' ALA . 18.2 ttm180 -51.16 -54.85 21.51 Favored 'General case' 0 C--N 1.311 -1.083 0 N-CA-C 108.174 -1.047 . . . . 1.0 108.174 -177.159 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . 0.823 ' O ' HG13 ' A' ' 13' ' ' VAL . 6.8 p -62.09 -48.82 86.71 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.127 0 CA-C-N 114.067 -1.424 . . . . 1.0 109.819 178.901 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 10' ' ' SER . . . . . 0.511 ' N ' ' O ' ' A' ' 6' ' ' THR . 42.8 t -62.43 -59.58 4.77 Favored 'General case' 0 N--CA 1.481 1.105 0 C-N-CA 120.198 -0.601 . . . . 1.0 109.702 -179.995 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 11' ' ' ARG . . . . . 0.582 ' N ' ' O ' ' A' ' 7' ' ' GLU . 0.4 OUTLIER -62.59 -57.44 11.09 Favored 'General case' 0 C--N 1.317 -0.823 0 O-C-N 121.742 -0.599 . . . . 1.0 110.19 -178.324 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . 0.531 ' O ' ' HB3' ' A' ' 16' ' ' ALA . . . -50.36 -51.58 44.58 Favored 'General case' 0 N--CA 1.476 0.861 0 N-CA-C 108.004 -1.11 . . . . 1.0 108.004 -178.091 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . 0.823 HG13 ' O ' ' A' ' 9' ' ' VAL . 4.5 m -60.78 -50.13 81.75 Favored 'Isoleucine or valine' 0 C--O 1.203 -1.344 0 C-N-CA 116.92 -1.912 . . . . 1.0 108.029 177.632 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . 0.502 ' O ' HG23 ' A' ' 18' ' ' VAL . . . -57.44 -62.68 1.6 Allowed 'General case' 0 N--CA 1.479 1.008 0 C-N-CA 118.633 -1.227 . . . . 1.0 110.929 179.013 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . 0.549 ' N ' ' O ' ' A' ' 11' ' ' ARG . . . -55.51 -55.8 27.65 Favored 'General case' 0 N--CA 1.47 0.557 0 CA-C-O 121.413 0.625 . . . . 1.0 110.208 -178.473 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . 0.531 ' HB3' ' O ' ' A' ' 12' ' ' ALA . . . -58.05 -53.94 52.58 Favored 'General case' 0 C--N 1.317 -0.811 0 N-CA-C 108.138 -1.06 . . . . 1.0 108.138 -179.313 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . 0.599 ' CB ' ' O ' ' A' ' 13' ' ' VAL . 39.4 tp -53.86 -48.96 69.48 Favored 'General case' 0 N--CA 1.482 1.135 0 CA-C-N 113.513 -1.676 . . . . 1.0 107.662 -178.059 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . 0.502 HG23 ' O ' ' A' ' 14' ' ' ALA . 54.1 t -67.3 -58.4 6.41 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.504 0 CA-C-O 121.076 0.465 . . . . 1.0 110.223 179.94 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . 0.528 ' N ' ' O ' ' A' ' 15' ' ' ALA . . . -71.03 -163.96 5.47 Favored Glycine 0 CA--C 1.526 0.765 0 CA-C-N 115.5 -0.773 . . . . 1.0 112.054 -178.64 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 20' ' ' PRO . . . . . 0.571 ' O ' ' N ' ' A' ' 24' ' ' ALA . 57.5 Cg_endo -79.59 -27.23 4.24 Favored 'Trans proline' 0 N--CA 1.492 1.39 0 C-N-CA 122.72 2.28 . . . . 1.0 115.443 -178.098 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -59.0 -58.45 14.52 Favored Glycine 0 N--CA 1.477 1.414 0 C-N-CA 119.097 -1.525 . . . . 1.0 110.965 -177.01 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . 0.499 ' N ' ' HB1' ' A' ' 16' ' ' ALA . . . -59.21 -54.91 33.94 Favored Glycine 0 N--CA 1.467 0.749 0 N-CA-C 107.843 -2.103 . . . . 1.0 107.843 -178.387 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . 0.557 ' O ' HG12 ' A' ' 27' ' ' VAL . 54.1 t -57.36 -36.96 54.61 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.907 0 CA-C-N 114.721 -0.74 . . . . 1.0 109.814 -179.472 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . 0.571 ' N ' ' O ' ' A' ' 20' ' ' PRO . . . -57.66 -60.58 3.46 Favored 'General case' 0 C--N 1.325 -0.483 0 C-N-CA 118.93 -1.108 . . . . 1.0 109.182 -179.851 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 9.3 tp -63.19 -44.05 96.48 Favored 'General case' 0 C--N 1.347 0.47 0 CA-C-N 119.325 0.966 . . . . 1.0 111.73 -178.907 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 72.6 t -61.05 -60.77 2.13 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.176 0 C-N-CA 118.364 -1.334 . . . . 1.0 110.504 -177.748 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . 0.603 ' O ' ' HB3' ' A' ' 31' ' ' ALA . 2.4 p -58.57 -37.41 64.78 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.417 0 N-CA-C 113.264 0.838 . . . . 1.0 113.264 -177.539 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 35.9 ttmt -67.67 -53.27 29.13 Favored 'General case' 0 C--N 1.315 -0.899 0 CA-C-O 122.102 0.953 . . . . 1.0 108.811 -178.719 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 80.2 t -63.82 -48.93 84.18 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.074 0 CA-C-N 113.743 -1.571 . . . . 1.0 110.891 -177.542 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 30' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -65.34 -60.88 2.51 Favored 'General case' 0 N--CA 1.449 -0.487 0 C-N-CA 118.868 -1.133 . . . . 1.0 109.496 -179.756 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . 0.603 ' HB3' ' O ' ' A' ' 27' ' ' VAL . . . -64.83 -54.44 30.99 Favored 'General case' 0 C--N 1.331 -0.225 0 N-CA-C 113.605 0.965 . . . . 1.0 113.605 -175.901 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 84.36 75.77 1.2 Allowed Glycine 0 CA--C 1.527 0.798 0 N-CA-C 109.421 -1.472 . . . . 1.0 109.421 -177.81 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . 0.52 ' O ' ' O ' ' A' ' 36' ' ' VAL . 12.3 mt 85.55 85.37 0.05 OUTLIER Pre-proline 0 N--CA 1.479 0.983 0 C-N-CA 123.711 0.804 . . . . 1.0 110.49 -178.9 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 53.0 Cg_exo -54.93 -30.89 71.13 Favored 'Trans proline' 0 N--CA 1.508 2.342 0 C-N-CA 123.253 2.635 . . . . 1.0 114.307 -179.832 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . 0.407 ' C ' HD11 ' A' ' 116' ' ' ILE . . . -58.81 -58.04 16.67 Favored Glycine 0 CA--C 1.525 0.678 0 C-N-CA 118.759 -1.686 . . . . 1.0 109.651 -178.369 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . 0.657 ' O ' HG22 ' A' ' 37' ' ' ILE . 7.1 p -97.82 165.27 2.17 Favored 'Isoleucine or valine' 0 C--O 1.219 -0.55 0 N-CA-C 106.71 -1.589 . . . . 1.0 106.71 178.266 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . 0.657 HG22 ' O ' ' A' ' 36' ' ' VAL . 8.1 tt 117.82 123.23 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.481 1.097 0 C-N-CA 123.927 0.891 . . . . 1.0 109.596 -179.19 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 21.9 m80 -140.64 131.41 25.81 Favored 'General case' 0 C--N 1.324 -0.513 0 N-CA-C 107.902 -1.147 . . . . 1.0 107.902 178.724 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -90.03 146.45 35.09 Favored Pre-proline 0 C--N 1.33 -0.247 0 N-CA-C 108.955 -0.757 . . . . 1.0 108.955 -179.747 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -72.92 -44.01 0.69 Allowed 'Trans proline' 0 C--N 1.307 -1.619 0 C-N-CA 121.641 1.56 . . . . 1.0 112.579 -179.24 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -126.17 130.06 50.25 Favored 'General case' 0 CA--C 1.518 -0.266 0 CA-C-N 116.254 -0.43 . . . . 1.0 110.118 -179.608 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . 0.609 ' C ' ' H ' ' A' ' 44' ' ' GLY . 0.0 OUTLIER -169.49 157.27 7.17 Favored 'General case' 0 C--N 1.313 -0.997 0 N-CA-C 106.016 -1.846 . . . . 1.0 106.016 177.976 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild core ' A' A ' 43' ' ' ARG . . . . . 0.436 ' O ' ' CG ' ' A' ' 43' ' ' ARG . 10.3 ttt85 -64.82 33.81 0.02 OUTLIER 'General case' 0 CA--C 1.529 0.137 0 CA-C-N 119.866 1.212 . . . . 1.0 112.115 -178.266 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . 0.609 ' H ' ' C ' ' A' ' 42' ' ' ARG . . . 91.42 -24.3 20.39 Favored Glycine 0 CA--C 1.522 0.484 0 N-CA-C 110.426 -1.069 . . . . 1.0 110.426 179.995 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . 0.526 ' CZ ' ' OD2' ' A' ' 57' ' ' ASP . 50.0 p90 -177.49 -178.93 0.79 Allowed 'General case' 0 CA--C 1.54 0.576 0 CA-C-O 120.85 0.357 . . . . 1.0 111.623 -179.941 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER 165.03 15.46 0.0 OUTLIER 'General case' 0 N--CA 1.487 1.389 0 CA-C-N 114.947 -1.024 . . . . 1.0 113.139 177.073 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 47' ' ' ARG . . . . . 0.639 ' O ' ' SG ' ' A' ' 48' ' ' CYS . 2.5 mtp-105 -176.38 -179.12 1.02 Allowed 'General case' 0 C--N 1.315 -0.905 0 N-CA-C 108.591 -0.892 . . . . 1.0 108.591 -179.072 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 48' ' ' CYS . . . . . 0.674 ' O ' ' SG ' ' A' ' 48' ' ' CYS . 1.5 p 61.43 63.49 1.19 Allowed 'General case' 0 C--N 1.341 0.206 0 CA-C-O 121.68 0.752 . . . . 1.0 110.084 -179.326 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 49' ' ' ASN . . . . . 0.449 ' OD1' ' NE2' ' A' ' 54' ' ' GLN . 0.2 OUTLIER -137.14 143.53 42.31 Favored Pre-proline 0 CA--C 1.535 0.39 0 N-CA-C 108.552 -0.907 . . . . 1.0 108.552 179.418 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild core ' A' A ' 50' ' ' PRO . . . . . 0.494 ' HG2' HH11 ' A' ' 52' ' ' ARG . 94.7 Cg_endo -73.01 61.85 3.94 Favored 'Trans proline' 0 N--CA 1.497 1.719 0 C-N-CA 122.251 1.967 . . . . 1.0 112.431 -179.476 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 97.8 mt-10 59.34 6.13 0.71 Allowed 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.975 -0.557 . . . . 1.0 111.84 179.595 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . 0.494 HH11 ' HG2' ' A' ' 50' ' ' PRO . 75.0 mtt85 -82.91 139.12 33.58 Favored 'General case' 0 N--CA 1.465 0.291 0 N-CA-C 109.029 -0.73 . . . . 1.0 109.029 177.971 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . 0.465 HG23 HG22 ' A' ' 55' ' ' ILE . 13.0 tt -67.42 137.92 23.78 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.276 0 CA-C-O 122.647 1.213 . . . . 1.0 113.691 -177.314 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 54' ' ' GLN . . . . . 0.449 ' NE2' ' OD1' ' A' ' 49' ' ' ASN . 1.8 mp0 -64.13 78.59 0.04 OUTLIER 'General case' 0 CA--C 1.545 0.753 0 CA-C-N 112.38 -2.191 . . . . 1.0 108.984 -178.464 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . 0.465 HG22 HG23 ' A' ' 53' ' ' ILE . 18.0 tt -148.15 154.96 10.06 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.667 0 CA-C-N 115.997 -0.547 . . . . 1.0 109.99 178.251 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 109.59 -3.46 30.8 Favored Glycine 0 N--CA 1.471 0.998 0 N-CA-C 109.914 -1.274 . . . . 1.0 109.914 -179.594 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . 0.526 ' OD2' ' CZ ' ' A' ' 45' ' ' PHE . 37.6 m-20 -83.96 100.93 11.35 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 114.249 -0.975 . . . . 1.0 110.091 179.448 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 58' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -86.52 173.68 9.44 Favored 'General case' 0 N--CA 1.471 0.595 0 CA-C-O 123.65 1.69 . . . . 1.0 113.41 -178.287 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 59' ' ' ARG . . . . . 0.423 HH11 ' HD2' ' A' ' 59' ' ' ARG . 24.9 mtm180 -79.44 -56.23 4.47 Favored 'General case' 0 C--N 1.309 -1.175 0 CA-C-N 110.402 -3.09 . . . . 1.0 112.161 -179.428 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -91.1 -11.73 37.72 Favored 'General case' 0 C--O 1.249 1.046 0 CA-C-N 114.81 -1.086 . . . . 1.0 113.916 -178.372 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . 0.405 ' O ' ' N ' ' A' ' 65' ' ' ASP . 9.3 pt-20 -76.57 -13.95 60.04 Favored 'General case' 0 C--N 1.318 -0.784 0 N-CA-C 113.298 0.851 . . . . 1.0 113.298 -177.615 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 62' ' ' VAL . . . . . 0.623 ' O ' ' N ' ' A' ' 66' ' ' GLY . 0.2 OUTLIER -49.52 -58.7 1.25 Allowed 'Isoleucine or valine' 0 C--O 1.207 -1.165 0 C-N-CA 118.857 -1.137 . . . . 1.0 109.209 -175.829 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -66.77 -61.5 1.93 Allowed 'General case' 0 C--N 1.302 -1.459 0 CA-C-O 120.874 0.369 . . . . 1.0 110.907 -179.01 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 2.3 t-80 -48.4 -56.72 7.43 Favored 'General case' 0 CA--C 1.535 0.389 0 C-N-CA 119.419 -0.912 . . . . 1.0 108.93 -178.916 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 65' ' ' ASP . . . . . 0.866 ' O ' HD22 ' A' ' 68' ' ' LEU . 19.2 t70 -70.08 -45.5 66.89 Favored 'General case' 0 C--O 1.207 -1.171 0 CA-C-N 115.072 -0.967 . . . . 1.0 111.197 179.761 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . 0.623 ' N ' ' O ' ' A' ' 62' ' ' VAL . . . -77.49 26.35 1.93 Allowed Glycine 0 N--CA 1.471 1.002 0 N-CA-C 111.018 -0.833 . . . . 1.0 111.018 179.715 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 67' ' ' ARG . . . . . 0.438 ' H ' ' C ' ' A' ' 65' ' ' ASP . 57.7 ttt180 -95.76 -9.95 30.4 Favored 'General case' 0 CA--C 1.536 0.406 0 N-CA-C 107.971 -1.122 . . . . 1.0 107.971 172.832 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . 0.866 HD22 ' O ' ' A' ' 65' ' ' ASP . 0.0 OUTLIER -69.87 -37.81 76.22 Favored 'General case' 0 C--O 1.197 -1.681 0 CA-C-N 114.303 -1.317 . . . . 1.0 112.974 -178.044 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . 0.519 ' O ' ' ND1' ' A' ' 72' ' ' HIS . 7.8 tt -44.81 -58.31 3.19 Favored 'General case' 0 N--CA 1.475 0.794 0 C-N-CA 118.302 -1.359 . . . . 1.0 108.869 -176.121 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . 0.578 ' O ' ' CE1' ' A' ' 72' ' ' HIS . . . -51.61 -72.3 0.05 Allowed 'General case' 0 C--N 1.317 -0.837 0 N-CA-C 104.937 -2.246 . . . . 1.0 104.937 177.884 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 71' ' ' ALA . . . . . 0.729 ' O ' ' N ' ' A' ' 73' ' ' MET . . . -64.87 18.21 0.02 OUTLIER 'General case' 0 C--N 1.316 -0.877 0 C-N-CA 128.04 2.536 . . . . 1.0 114.251 178.385 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 72' ' ' HIS . . . . . 0.826 ' N ' ' O ' ' A' ' 68' ' ' LEU . 0.0 OUTLIER -24.78 -17.95 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.557 0 N-CA-C 115.589 1.7 . . . . 1.0 115.589 -174.461 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild core ' A' A ' 73' ' ' MET . . . . . 0.729 ' N ' ' O ' ' A' ' 71' ' ' ALA . 72.5 mtp -73.39 -25.09 60.42 Favored 'General case' 0 CA--C 1.545 0.768 0 CA-C-N 119.986 1.266 . . . . 1.0 108.551 176.965 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . 0.725 ' O ' ' N ' ' A' ' 76' ' ' GLY . 90.8 t -61.53 -52.66 58.46 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.672 0 CA-C-N 114.444 -1.253 . . . . 1.0 108.84 178.857 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 75' ' ' ASN . . . . . 0.439 ' O ' HG22 ' A' ' 79' ' ' ILE . 27.5 t-20 -32.61 -13.75 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.667 0 N-CA-C 113.444 0.905 . . . . 1.0 113.444 -178.26 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 76' ' ' GLY . . . . . 0.725 ' N ' ' O ' ' A' ' 74' ' ' VAL . . . -50.88 -22.26 5.88 Favored Glycine 0 CA--C 1.539 1.539 0 N-CA-C 109.344 -1.502 . . . . 1.0 109.344 176.045 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 77' ' ' ILE . . . . . 0.566 HG13 ' H ' ' A' ' 78' ' ' VAL . 0.5 OUTLIER -78.0 -63.95 1.0 Allowed 'Isoleucine or valine' 0 C--O 1.218 -0.568 0 CA-C-O 121.947 0.88 . . . . 1.0 109.432 179.203 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . 0.566 ' H ' HG13 ' A' ' 77' ' ' ILE . 74.8 t -34.87 -33.66 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.318 -0.766 0 CA-C-N 112.719 -2.037 . . . . 1.0 106.309 -177.105 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . 0.622 HD13 ' N ' ' A' ' 80' ' ' ALA . 0.0 OUTLIER -97.39 -34.42 4.82 Favored 'Isoleucine or valine' 0 CA--C 1.569 1.699 0 CA-C-N 115.585 -0.734 . . . . 1.0 111.905 175.134 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild core ' A' A ' 80' ' ' ALA . . . . . 0.622 ' N ' HD13 ' A' ' 79' ' ' ILE . . . -84.82 -10.35 57.26 Favored 'General case' 0 N--CA 1.492 1.642 0 N-CA-C 114.471 1.285 . . . . 1.0 114.471 179.452 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 81' ' ' GLU . . . . . 0.418 ' N ' ' O ' ' A' ' 77' ' ' ILE . 86.6 tt0 -89.4 -70.98 0.63 Allowed 'General case' 0 N--CA 1.438 -1.038 0 O-C-N 121.786 -0.571 . . . . 1.0 111.09 179.775 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 25.4 m-20 -91.02 -15.6 29.32 Favored 'General case' 0 CA--C 1.549 0.923 0 N-CA-C 115.864 1.801 . . . . 1.0 115.864 -178.796 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . 0.554 ' O ' ' N ' ' A' ' 85' ' ' ILE . . . -52.84 -42.48 65.21 Favored 'General case' 0 N--CA 1.475 0.779 0 C-N-CA 118.248 -1.381 . . . . 1.0 111.454 -177.863 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 11.2 mp -39.87 -20.83 0.01 OUTLIER 'General case' 0 N--CA 1.469 0.508 0 CA-C-N 118.447 0.567 . . . . 1.0 111.307 -179.049 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 85' ' ' ILE . . . . . 0.554 ' N ' ' O ' ' A' ' 83' ' ' ALA . 54.1 mt -93.43 -34.99 6.13 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.587 -0.279 . . . . 1.0 111.154 -179.866 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 86' ' ' ALA . . . . . 0.822 ' O ' HG22 ' A' ' 89' ' ' VAL . . . -92.91 -26.27 17.68 Favored 'General case' 0 C--O 1.222 -0.371 0 CA-C-O 120.597 0.237 . . . . 1.0 111.582 179.734 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -56.06 -7.12 0.3 Allowed 'General case' 0 C--N 1.328 -0.347 0 C-N-CA 119.73 -0.788 . . . . 1.0 110.418 -178.83 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 88' ' ' ALA . . . . . 0.45 ' H ' ' C ' ' A' ' 86' ' ' ALA . . . -84.17 -2.58 57.1 Favored 'General case' 0 N--CA 1.472 0.663 0 CA-C-O 122.407 1.099 . . . . 1.0 108.79 178.543 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 89' ' ' VAL . . . . . 0.822 HG22 ' O ' ' A' ' 86' ' ' ALA . 3.1 m -97.6 34.9 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.432 0 CA-C-N 113.042 -1.89 . . . . 1.0 110.59 179.098 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 90' ' ' GLY . . . . . 0.551 ' N ' ' CD ' ' A' ' 91' ' ' PRO . . . -78.13 -36.62 30.94 Favored Glycine 0 C--N 1.347 1.194 0 N-CA-C 111.6 -0.6 . . . . 1.0 111.6 178.932 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 91' ' ' PRO . . . . . 0.551 ' CD ' ' N ' ' A' ' 90' ' ' GLY . 93.4 Cg_exo -46.55 -15.11 0.16 Allowed 'Trans proline' 0 N--CA 1.496 1.665 0 C-N-CA 121.872 1.715 . . . . 1.0 109.07 177.913 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 92' ' ' HIS . . . . . 0.612 ' ND1' ' N ' ' A' ' 93' ' ' LEU . 0.0 OUTLIER -56.01 -15.76 3.98 Favored 'General case' 0 N--CA 1.442 -0.875 0 CA-C-N 113.922 -1.49 . . . . 1.0 107.754 179.148 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild core ' A' A ' 93' ' ' LEU . . . . . 0.725 HD12 ' N ' ' A' ' 94' ' ' ALA . 2.1 pp -64.04 -58.22 7.32 Favored 'General case' 0 C--O 1.232 0.14 0 N-CA-C 108.997 -0.742 . . . . 1.0 108.997 176.822 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 94' ' ' ALA . . . . . 0.725 ' N ' HD12 ' A' ' 93' ' ' LEU . . . -57.34 -52.62 64.61 Favored 'General case' 0 CA--C 1.517 -0.323 0 N-CA-C 108.851 -0.796 . . . . 1.0 108.851 179.719 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 95' ' ' ARG . . . . . 0.621 ' O ' ' N ' ' A' ' 97' ' ' LEU . 4.9 tmm_? -60.16 -60.91 3.06 Favored 'General case' 0 N--CA 1.446 -0.628 0 N-CA-C 108.506 -0.924 . . . . 1.0 108.506 -179.792 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 96' ' ' ALA . . . . . 0.986 ' O ' ' N ' ' A' ' 98' ' ' GLY . . . -47.66 -12.09 0.03 OUTLIER 'General case' 0 N--CA 1.432 -1.343 0 O-C-N 118.532 -2.605 . . . . 1.0 111.478 179.484 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 97' ' ' LEU . . . . . 0.706 ' O ' ' N ' ' A' ' 100' ' ' ILE . 7.7 tp 6.87 -48.9 0.0 OUTLIER 'General case' 0 C--N 1.378 1.809 0 CA-C-O 117.584 -1.198 . . . . 1.0 109.937 -166.771 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 98' ' ' GLY . . . . . 0.986 ' N ' ' O ' ' A' ' 96' ' ' ALA . . . -49.57 -24.12 5.32 Favored Glycine 0 CA--C 1.548 2.106 0 CA-C-N 122.507 2.412 . . . . 1.0 107.417 173.493 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 99' ' ' GLN . . . . . 0.543 ' N ' ' O ' ' A' ' 96' ' ' ALA . 12.3 mt-30 -64.36 -19.38 65.44 Favored 'General case' 0 C--N 1.379 1.878 0 C-N-CA 117.324 -1.75 . . . . 1.0 107.058 176.829 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 100' ' ' ILE . . . . . 0.706 ' N ' ' O ' ' A' ' 97' ' ' LEU . 1.5 tp -65.3 -39.22 84.66 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.817 0 N-CA-C 108.228 -1.027 . . . . 1.0 108.228 179.724 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 101' ' ' VAL . . . . . 0.723 ' O ' ' N ' ' A' ' 105' ' ' GLY . 97.7 t -59.19 -62.72 0.91 Allowed 'Isoleucine or valine' 0 C--O 1.217 -0.627 0 C-N-CA 119.537 -0.865 . . . . 1.0 110.59 -178.44 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 102' ' ' CYS . . . . . 0.879 ' O ' ' HB2' ' A' ' 106' ' ' ALA . 0.5 OUTLIER -48.26 -18.63 0.23 Allowed 'General case' 0 N--CA 1.477 0.883 0 C-N-CA 119.093 -1.043 . . . . 1.0 110.826 -178.31 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild core ' A' A ' 103' ' ' ARG . . . . . 0.497 HH11 ' CG ' ' A' ' 103' ' ' ARG . 0.0 OUTLIER -88.63 -49.3 6.96 Favored 'General case' 0 N--CA 1.479 1.014 0 CA-C-O 121.783 0.802 . . . . 1.0 112.071 177.638 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild core ' A' A ' 104' ' ' TYR . . . . . . . . . . . . . 22.8 t80 -105.84 21.53 17.12 Favored 'General case' 0 N--CA 1.472 0.644 0 C-N-CA 125.935 1.694 . . . . 1.0 111.413 178.43 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 105' ' ' GLY . . . . . 0.723 ' N ' ' O ' ' A' ' 101' ' ' VAL . . . -159.33 -8.32 0.05 OUTLIER Glycine 0 CA--C 1.527 0.835 0 C-N-CA 120.394 -0.907 . . . . 1.0 112.081 -179.791 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 106' ' ' ALA . . . . . 0.879 ' HB2' ' O ' ' A' ' 102' ' ' CYS . . . -29.03 114.16 0.09 Allowed 'General case' 0 N--CA 1.466 0.327 0 N-CA-C 112.209 0.448 . . . . 1.0 112.209 179.51 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 107' ' ' THR . . . . . 0.607 ' C ' ' H ' ' A' ' 109' ' ' ILE . 26.7 m -134.55 -62.64 0.73 Allowed 'General case' 0 C--O 1.224 -0.247 0 N-CA-C 105.609 -1.997 . . . . 1.0 105.609 176.782 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 108' ' ' VAL . . . . . 0.631 ' O ' HG22 ' A' ' 108' ' ' VAL . 12.7 p -64.44 23.25 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.437 -1.078 0 O-C-N 121.792 -0.568 . . . . 1.0 109.539 179.33 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 109' ' ' ILE . . . . . 0.628 ' H ' ' HD2' ' A' ' 110' ' ' PRO . 0.1 OUTLIER -115.81 -53.98 0.04 OUTLIER Pre-proline 0 CA--C 1.562 1.405 0 N-CA-C 107.708 -1.219 . . . . 1.0 107.708 174.658 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild core ' A' A ' 110' ' ' PRO . . . . . 0.628 ' HD2' ' H ' ' A' ' 109' ' ' ILE . 18.3 Cg_endo -52.85 -36.65 75.04 Favored 'Trans proline' 0 N--CA 1.51 2.446 0 CA-C-N 121.92 1.721 . . . . 1.0 112.199 175.869 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 111' ' ' ASN . . . . . 0.429 ' C ' ' N ' ' A' ' 113' ' ' ASN . 6.2 t30 -68.25 -68.42 0.39 Allowed 'General case' 0 C--N 1.328 -0.356 0 C-N-CA 119.448 -0.901 . . . . 1.0 110.106 -177.907 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 112' ' ' ILE . . . . . 0.448 ' O ' ' N ' ' A' ' 116' ' ' ILE . 3.9 pt -51.0 -25.99 4.01 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.263 0 CA-C-O 123.07 1.414 . . . . 1.0 108.098 179.262 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 113' ' ' ASN . . . . . 0.558 ' ND2' ' OE2' ' A' ' 117' ' ' GLU . 15.4 t-20 -59.21 -52.37 65.96 Favored 'General case' 0 C--N 1.306 -1.286 0 CA-C-N 111.987 -2.369 . . . . 1.0 107.982 -177.886 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 114' ' ' ALA . . . . . 0.54 ' O ' HG23 ' A' ' 118' ' ' VAL . . . -64.08 -31.17 72.26 Favored 'General case' 0 C--N 1.323 -0.562 0 N-CA-C 113.103 0.779 . . . . 1.0 113.103 179.675 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 115' ' ' ALA . . . . . 0.454 ' O ' ' N ' ' A' ' 119' ' ' LEU . . . -85.15 -58.42 2.69 Favored 'General case' 0 N--CA 1.476 0.848 0 CA-C-N 119.36 0.982 . . . . 1.0 111.655 178.494 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 116' ' ' ILE . . . . . 0.448 ' N ' ' O ' ' A' ' 112' ' ' ILE . 31.2 mt -51.11 -57.71 2.67 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.402 0 N-CA-C 107.217 -1.401 . . . . 1.0 107.217 -178.375 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 117' ' ' GLU . . . . . 0.558 ' OE2' ' ND2' ' A' ' 113' ' ' ASN . 56.0 mt-10 -51.68 -50.37 60.56 Favored 'General case' 0 C--N 1.307 -1.277 0 CA-C-N 112.771 -2.013 . . . . 1.0 107.056 -179.15 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 118' ' ' VAL . . . . . 0.54 HG23 ' O ' ' A' ' 114' ' ' ALA . 17.0 t -59.83 -28.86 41.79 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.8 0 C-N-CA 119.642 -0.823 . . . . 1.0 110.021 178.378 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 119' ' ' LEU . . . . . 0.454 ' N ' ' O ' ' A' ' 115' ' ' ALA . 3.9 tt -78.42 -61.58 1.96 Allowed 'General case' 0 C--N 1.354 0.8 0 CA-C-N 120.396 1.453 . . . . 1.0 107.466 177.962 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 120' ' ' GLY . . . . . 0.444 ' C ' ' OG1' ' A' ' 121' ' ' THR . . . -64.31 -82.25 0.1 Allowed Glycine 0 C--N 1.358 1.771 0 C-N-CA 119.036 -1.554 . . . . 1.0 109.299 178.291 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 121' ' ' THR . . . . . 0.491 ' OG1' HG22 ' A' ' 123' ' ' THR . 0.0 OUTLIER 167.76 -38.85 0.0 OUTLIER 'General case' 0 CA--C 1.542 0.659 0 CA-C-N 113.968 -1.116 . . . . 1.0 113.041 178.817 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild core ' A' A ' 122' ' ' GLY . . . . . 0.643 ' O ' ' N ' ' A' ' 124' ' ' ASP . . . 103.28 -15.91 53.74 Favored Glycine 0 N--CA 1.478 1.475 0 N-CA-C 107.243 -2.343 . . . . 1.0 107.243 -176.345 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 123' ' ' THR . . . . . 0.538 HG23 ' O ' ' A' ' 123' ' ' THR . 9.1 t -58.38 81.19 0.01 OUTLIER 'General case' 0 CA--C 1.545 0.787 0 CA-C-N 111.272 -2.464 . . . . 1.0 105.36 178.279 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 124' ' ' ASP . . . . . 0.643 ' N ' ' O ' ' A' ' 122' ' ' GLY . 35.8 m-20 -165.39 174.55 9.94 Favored 'General case' 0 N--CA 1.475 0.79 0 CA-C-N 112.818 -1.992 . . . . 1.0 112.457 179.989 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 125' ' ' TYR . . . . . . . . . . . . . 6.1 t80 -142.85 138.83 30.58 Favored 'General case' 0 CA--C 1.54 0.596 0 N-CA-C 107.655 -1.239 . . . . 1.0 107.655 175.588 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 9.6 tpt180 -149.88 153.12 36.19 Favored 'General case' 0 N--CA 1.467 0.39 0 N-CA-C 110.236 -0.283 . . . . 1.0 110.236 178.075 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 127' ' ' PHE . . . . . . . . . . . . . 22.4 p90 . . . . . 0 N--CA 1.469 0.486 0 CA-C-O 118.034 -0.984 . . . . 1.0 110.743 179.926 . . . . . . . . 0 0 . 1 . 029 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 4.6 tpp . . . . . 0 N--CA 1.489 1.498 0 N-CA-C 109.194 -0.669 . . . . 1.0 109.194 . . . . . . . . . 0 0 . 1 . 029 nuclear nobuild core ' A' A ' 2' ' ' SER . . . . . 0.484 ' O ' ' CB ' ' A' ' 3' ' ' ASP . 87.7 p -89.61 12.42 16.82 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.877 -0.602 . . . . 1.0 110.499 -179.951 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 3' ' ' ASP . . . . . 0.484 ' CB ' ' O ' ' A' ' 2' ' ' SER . 4.7 t0 151.22 116.58 0.0 OUTLIER 'General case' 0 N--CA 1.473 0.699 0 O-C-N 124.075 0.86 . . . . 1.0 109.963 178.606 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . 0.434 ' O ' ' OD1' ' A' ' 5' ' ' ASP . 13.8 t80 -152.38 148.05 27.02 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.645 -0.707 . . . . 1.0 110.305 179.559 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 5' ' ' ASP . . . . . 0.434 ' OD1' ' O ' ' A' ' 4' ' ' PHE . 2.2 m-20 -154.78 151.52 28.78 Favored 'General case' 0 C--O 1.234 0.242 0 N-CA-C 109.703 -0.48 . . . . 1.0 109.703 179.634 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 6' ' ' THR . . . . . 0.416 ' C ' ' O ' ' A' ' 5' ' ' ASP . 3.0 m -38.76 143.07 0.16 Allowed 'General case' 0 N--CA 1.467 0.4 0 N-CA-C 109.53 -0.544 . . . . 1.0 109.53 179.994 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 35.9 tt0 -47.27 -52.4 16.27 Favored 'General case' 0 C--N 1.316 -0.86 0 CA-C-O 118.347 -0.835 . . . . 1.0 112.698 -174.934 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 8' ' ' ARG . . . . . 0.524 ' O ' ' HB3' ' A' ' 12' ' ' ALA . 24.3 ptt180 -63.48 -35.5 80.66 Favored 'General case' 0 N--CA 1.447 -0.59 0 CA-C-N 120.824 1.647 . . . . 1.0 109.816 179.022 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . 0.658 ' O ' HG23 ' A' ' 13' ' ' VAL . 93.6 t -62.34 -52.23 62.58 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.714 0 C-N-CA 118.665 -1.214 . . . . 1.0 108.009 178.481 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 80.0 p -67.61 -38.72 84.35 Favored 'General case' 0 CA--C 1.543 0.696 0 N-CA-C 113.353 0.872 . . . . 1.0 113.353 179.384 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 11' ' ' ARG . . . . . 0.596 ' O ' ' N ' ' A' ' 14' ' ' ALA . 5.0 tpp180 -75.77 -63.0 1.4 Allowed 'General case' 0 N--CA 1.472 0.649 0 CA-C-O 122.335 1.064 . . . . 1.0 109.098 178.039 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . 0.621 ' O ' ' HB3' ' A' ' 16' ' ' ALA . . . -46.67 -37.56 8.48 Favored 'General case' 0 N--CA 1.474 0.762 0 CA-C-N 112.724 -2.034 . . . . 1.0 105.955 -175.323 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . 0.658 HG23 ' O ' ' A' ' 9' ' ' VAL . 11.9 t -59.8 -50.84 78.53 Favored 'Isoleucine or valine' 0 C--O 1.206 -1.215 0 C-N-CA 118.574 -1.25 . . . . 1.0 107.869 175.68 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . 0.596 ' N ' ' O ' ' A' ' 11' ' ' ARG . . . -60.85 -63.59 1.24 Allowed 'General case' 0 C--O 1.219 -0.531 0 C-N-CA 118.717 -1.193 . . . . 1.0 111.235 179.178 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . 0.495 ' O ' ' N ' ' A' ' 19' ' ' GLY . . . -52.48 -54.93 25.96 Favored 'General case' 0 N--CA 1.479 1.003 0 CA-C-O 121.826 0.822 . . . . 1.0 110.143 -176.735 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . 0.621 ' HB3' ' O ' ' A' ' 12' ' ' ALA . . . -61.97 -53.36 56.77 Favored 'General case' 0 C--N 1.308 -1.201 0 CA-C-N 113.877 -1.511 . . . . 1.0 108.685 -179.239 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . 0.599 ' CB ' ' O ' ' A' ' 13' ' ' VAL . 3.1 tp -57.06 -51.75 68.02 Favored 'General case' 0 N--CA 1.479 1.016 0 C-N-CA 118.944 -1.102 . . . . 1.0 109.083 -177.336 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . 0.574 HG13 ' O ' ' A' ' 14' ' ' ALA . 3.2 m -68.78 -56.5 11.95 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.269 0 C-N-CA 119.04 -1.064 . . . . 1.0 108.864 179.397 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . 0.559 ' N ' HG23 ' A' ' 18' ' ' VAL . . . -60.73 -169.25 0.51 Allowed Glycine 0 CA--C 1.532 1.133 0 N-CA-C 111.786 -0.526 . . . . 1.0 111.786 179.881 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 20' ' ' PRO . . . . . 0.611 ' O ' ' N ' ' A' ' 24' ' ' ALA . 27.7 Cg_endo -81.57 -32.89 0.76 Allowed 'Trans proline' 0 N--CA 1.493 1.49 0 C-N-CA 123.323 2.682 . . . . 1.0 115.154 -178.656 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -57.64 -57.29 20.59 Favored Glycine 0 N--CA 1.479 1.539 0 C-N-CA 120.246 -0.978 . . . . 1.0 111.623 -176.565 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . 0.584 ' CA ' ' HB1' ' A' ' 16' ' ' ALA . . . -56.69 -50.47 63.11 Favored Glycine 0 N--CA 1.472 1.039 0 N-CA-C 107.075 -2.41 . . . . 1.0 107.075 -178.17 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . 0.526 ' O ' HG12 ' A' ' 27' ' ' VAL . 41.8 t -61.7 -34.95 64.56 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.051 0 CA-C-N 114.834 -0.683 . . . . 1.0 109.85 179.371 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . 0.611 ' N ' ' O ' ' A' ' 20' ' ' PRO . . . -57.07 -61.14 2.66 Favored 'General case' 0 N--CA 1.454 -0.231 0 C-N-CA 118.978 -1.089 . . . . 1.0 109.404 -179.145 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 8.4 tt -65.98 -42.48 89.8 Favored 'General case' 0 C--N 1.342 0.283 0 C-N-CA 119.657 -0.817 . . . . 1.0 111.922 -178.715 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 59.3 t -59.37 -58.69 5.88 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.182 0 C-N-CA 118.472 -1.291 . . . . 1.0 109.501 -178.017 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . 0.526 HG12 ' O ' ' A' ' 23' ' ' VAL . 1.8 p -63.4 -36.75 77.4 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.454 0 N-CA-C 112.953 0.723 . . . . 1.0 112.953 -177.706 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 24.7 tttm -64.68 -53.28 49.91 Favored 'General case' 0 C--N 1.324 -0.533 0 N-CA-C 108.293 -1.003 . . . . 1.0 108.293 -178.597 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 74.1 t -59.65 -44.83 94.33 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.829 0 CA-C-N 114.523 -1.217 . . . . 1.0 109.906 -178.81 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 30' ' ' CYS . . . . . 0.566 ' SG ' ' N ' ' A' ' 31' ' ' ALA . 0.5 OUTLIER -64.56 -57.25 9.67 Favored 'General case' 0 CA--C 1.539 0.543 0 C-N-CA 118.43 -1.308 . . . . 1.0 109.143 -179.804 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . 0.566 ' N ' ' SG ' ' A' ' 30' ' ' CYS . . . -64.35 -56.09 16.74 Favored 'General case' 0 N--CA 1.468 0.436 0 N-CA-C 116.276 1.954 . . . . 1.0 116.276 -175.984 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . 0.472 ' O ' ' HB2' ' A' ' 33' ' ' LEU . . . 81.5 73.44 1.2 Allowed Glycine 0 CA--C 1.537 1.425 0 N-CA-C 108.694 -1.762 . . . . 1.0 108.694 -175.539 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . 0.472 ' HB2' ' O ' ' A' ' 32' ' ' GLY . 15.8 mt 81.34 110.04 0.03 OUTLIER Pre-proline 0 N--CA 1.486 1.345 0 C-N-CA 124.68 1.192 . . . . 1.0 111.745 -178.657 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 52.4 Cg_exo -54.62 -14.48 7.45 Favored 'Trans proline' 0 N--CA 1.507 2.308 0 C-N-CA 122.348 2.032 . . . . 1.0 113.325 178.355 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -56.46 -55.87 27.43 Favored Glycine 0 CA--C 1.534 1.236 0 C-N-CA 119.159 -1.496 . . . . 1.0 109.588 -178.458 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . 0.832 HG13 ' H ' ' A' ' 37' ' ' ILE . 6.1 p -69.78 -70.08 0.25 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.5 0 N-CA-C 112.958 0.725 . . . . 1.0 112.958 -177.53 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . 0.832 ' H ' HG13 ' A' ' 36' ' ' VAL . 53.1 mt 9.46 68.16 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.486 1.373 0 N-CA-C 114.035 1.124 . . . . 1.0 114.035 -178.061 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 38' ' ' HIS . . . . . 0.61 ' H ' ' CD2' ' A' ' 38' ' ' HIS . 0.3 OUTLIER -131.75 118.47 19.99 Favored 'General case' 0 N--CA 1.447 -0.587 0 CA-C-N 122.161 2.255 . . . . 1.0 106.477 177.484 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 3.9 m -101.88 122.65 46.59 Favored Pre-proline 0 C--N 1.323 -0.56 0 C-N-CA 120.478 -0.489 . . . . 1.0 110.508 -178.684 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 58.3 Cg_exo -48.85 -37.43 36.15 Favored 'Trans proline' 0 N--CA 1.491 1.346 0 C-N-CA 121.133 1.222 . . . . 1.0 112.829 179.896 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -124.71 131.03 53.49 Favored 'General case' 0 N--CA 1.467 0.379 0 N-CA-C 109.831 -0.433 . . . . 1.0 109.831 178.479 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . 0.671 ' C ' ' H ' ' A' ' 44' ' ' GLY . 28.7 ptt-85 -168.27 165.57 12.93 Favored 'General case' 0 C--N 1.322 -0.614 0 C-N-CA 119.608 -0.837 . . . . 1.0 110.628 178.094 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 43' ' ' ARG . . . . . 0.41 ' O ' ' HG2' ' A' ' 43' ' ' ARG . 21.1 ttt180 -65.63 17.75 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.464 0 N-CA-C 108.795 -0.817 . . . . 1.0 108.795 179.206 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . 0.671 ' H ' ' C ' ' A' ' 42' ' ' ARG . . . 82.91 -24.59 5.14 Favored Glycine 0 N--CA 1.447 -0.627 0 N-CA-C 110.857 -0.897 . . . . 1.0 110.857 -179.947 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . 0.653 ' N ' ' CD1' ' A' ' 45' ' ' PHE . 0.0 OUTLIER -163.78 164.1 23.78 Favored 'General case' 0 CA--C 1.551 1.008 0 CA-C-N 116.98 0.39 . . . . 1.0 110.137 -178.633 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild core ' A' A ' 46' ' ' PHE . . . . . 0.576 ' N ' ' HE ' ' A' ' 47' ' ' ARG . 0.6 OUTLIER 144.01 4.31 0.0 OUTLIER 'General case' 0 N--CA 1.505 2.297 0 O-C-N 125.065 1.478 . . . . 1.0 111.92 177.531 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild core ' A' A ' 47' ' ' ARG . . . . . 0.576 ' HE ' ' N ' ' A' ' 46' ' ' PHE . 0.0 OUTLIER -117.27 -149.49 0.44 Allowed 'General case' 0 N--CA 1.472 0.65 0 CA-C-N 117.912 0.324 . . . . 1.0 110.182 -179.183 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild core ' A' A ' 48' ' ' CYS . . . . . 0.537 ' C ' ' O ' ' A' ' 47' ' ' ARG . 25.8 p -15.32 93.98 0.01 OUTLIER 'General case' 0 N--CA 1.484 1.239 0 O-C-N 124.346 1.029 . . . . 1.0 110.456 179.872 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 49' ' ' ASN . . . . . 0.507 ' ND2' ' O ' ' A' ' 52' ' ' ARG . 0.1 OUTLIER -123.31 140.73 34.43 Favored Pre-proline 0 CA--C 1.541 0.607 0 N-CA-C 108.746 -0.835 . . . . 1.0 108.746 -178.1 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild core ' A' A ' 50' ' ' PRO . . . . . 0.48 ' C ' ' H ' ' A' ' 52' ' ' ARG . 64.9 Cg_endo -73.44 59.91 4.03 Favored 'Trans proline' 0 N--CA 1.493 1.445 0 C-N-CA 121.613 1.542 . . . . 1.0 112.047 -179.861 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 20.8 mp0 68.04 -24.85 0.13 Allowed 'General case' 0 N--CA 1.469 0.478 0 CA-C-N 115.677 -0.692 . . . . 1.0 112.055 179.614 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . 0.507 ' O ' ' ND2' ' A' ' 49' ' ' ASN . 47.1 mmt-85 -59.24 174.95 0.35 Allowed 'General case' 0 CA--C 1.518 -0.252 0 C-N-CA 120.299 -0.561 . . . . 1.0 109.731 -179.928 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -99.15 145.31 10.54 Favored 'Isoleucine or valine' 0 C--O 1.232 0.133 0 CA-C-O 122.133 0.968 . . . . 1.0 111.141 -179.199 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 54' ' ' GLN . . . . . 0.613 ' H ' ' CD ' ' A' ' 54' ' ' GLN . 0.0 OUTLIER -63.91 79.27 0.03 OUTLIER 'General case' 0 C--N 1.316 -0.862 0 CA-C-N 113.345 -1.752 . . . . 1.0 110.363 -177.532 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -148.91 156.51 7.76 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.412 0 N-CA-C 108.984 -0.747 . . . . 1.0 108.984 176.914 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . 0.567 ' O ' ' CD1' ' A' ' 58' ' ' TRP . . . 110.17 -4.99 30.17 Favored Glycine 0 N--CA 1.469 0.891 0 N-CA-C 109.767 -1.333 . . . . 1.0 109.767 -178.821 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . 0.533 ' OD1' ' N ' ' A' ' 57' ' ' ASP . 12.7 p-10 -80.02 98.54 7.25 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 114.914 -0.643 . . . . 1.0 109.469 178.885 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 58' ' ' TRP . . . . . 0.567 ' CD1' ' O ' ' A' ' 56' ' ' GLY . 18.4 m95 -84.84 176.79 8.28 Favored 'General case' 0 N--CA 1.464 0.239 0 CA-C-O 122.561 1.172 . . . . 1.0 113.084 -178.521 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 1.3 mpp_? -90.11 -60.06 2.03 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 112.26 -2.246 . . . . 1.0 111.494 179.781 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -90.68 -18.18 25.51 Favored 'General case' 0 N--CA 1.48 1.069 0 N-CA-C 113.925 1.083 . . . . 1.0 113.925 -179.462 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 3.4 tt0 -82.66 -13.91 55.6 Favored 'General case' 0 C--N 1.318 -0.784 0 O-C-N 121.397 -0.815 . . . . 1.0 110.719 -179.48 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 62' ' ' VAL . . . . . 0.655 ' O ' ' N ' ' A' ' 66' ' ' GLY . 28.2 m -51.51 -54.58 11.55 Favored 'Isoleucine or valine' 0 C--O 1.203 -1.377 0 C-N-CA 120.263 -0.575 . . . . 1.0 111.212 -176.77 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 63' ' ' ALA . . . . . 0.625 ' N ' HG23 ' A' ' 62' ' ' VAL . . . -71.25 -53.84 12.96 Favored 'General case' 0 C--N 1.315 -0.894 0 CA-C-N 119.59 1.086 . . . . 1.0 109.282 -177.747 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 64' ' ' HIS . . . . . 0.741 ' CD2' HH12 ' A' ' 67' ' ' ARG . 0.5 OUTLIER -45.2 -54.61 6.73 Favored 'General case' 0 CA--C 1.536 0.409 0 N-CA-C 107.969 -1.123 . . . . 1.0 107.969 179.157 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild core ' A' A ' 65' ' ' ASP . . . . . 0.562 ' C ' ' H ' ' A' ' 67' ' ' ARG . 11.1 t70 -73.83 -49.07 26.94 Favored 'General case' 0 C--N 1.314 -0.975 0 CA-C-N 114.428 -1.26 . . . . 1.0 111.16 179.343 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . 0.655 ' N ' ' O ' ' A' ' 62' ' ' VAL . . . -75.13 26.81 1.19 Allowed Glycine 0 C--N 1.317 -0.509 0 N-CA-C 109.88 -1.288 . . . . 1.0 109.88 177.41 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 67' ' ' ARG . . . . . 0.741 HH12 ' CD2' ' A' ' 64' ' ' HIS . 21.5 mtt85 -71.57 8.2 1.19 Allowed 'General case' 0 CA--C 1.504 -0.826 0 N-CA-C 105.22 -2.141 . . . . 1.0 105.22 173.629 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . 0.654 ' H ' ' C ' ' A' ' 66' ' ' GLY . 1.5 pp -32.27 -29.83 0.01 OUTLIER 'General case' 0 C--N 1.347 0.498 0 O-C-N 124.112 0.883 . . . . 1.0 108.982 -177.252 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . 0.631 ' N ' ' O ' ' A' ' 67' ' ' ARG . 2.1 tt -62.38 -64.36 0.95 Allowed 'General case' 0 C--N 1.321 -0.632 0 C-N-CA 119.095 -1.042 . . . . 1.0 108.423 177.14 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . 0.592 ' O ' ' N ' ' A' ' 72' ' ' HIS . . . -77.45 -73.17 0.32 Allowed 'General case' 0 N--CA 1.47 0.537 0 N-CA-C 104.319 -2.475 . . . . 1.0 104.319 176.161 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 71' ' ' ALA . . . . . 0.504 ' O ' ' C ' ' A' ' 72' ' ' HIS . . . -41.22 2.8 0.0 OUTLIER 'General case' 0 C--N 1.322 -0.619 0 N-CA-C 115.533 1.679 . . . . 1.0 115.533 179.77 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 72' ' ' HIS . . . . . 0.633 ' CD2' ' H ' ' A' ' 73' ' ' MET . 1.9 p-80 -29.06 -63.84 0.11 Allowed 'General case' 0 N--CA 1.47 0.528 0 CA-C-N 120.6 1.545 . . . . 1.0 112.458 -176.29 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 73' ' ' MET . . . . . 0.633 ' H ' ' CD2' ' A' ' 72' ' ' HIS . 0.0 OUTLIER -71.72 -48.69 45.43 Favored 'General case' 0 C--N 1.325 -0.473 0 C-N-CA 119.236 -0.986 . . . . 1.0 109.84 177.765 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . 0.746 ' O ' ' N ' ' A' ' 76' ' ' GLY . 58.0 t -45.62 -43.32 3.93 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.387 0 CA-C-O 117.397 -1.287 . . . . 1.0 112.08 -175.843 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 75' ' ' ASN . . . . . 0.424 ' O ' ' N ' ' A' ' 78' ' ' VAL . 16.2 t30 -35.75 -12.17 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.613 0 CA-C-N 121.265 1.848 . . . . 1.0 112.467 178.549 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 76' ' ' GLY . . . . . 0.746 ' N ' ' O ' ' A' ' 74' ' ' VAL . . . -46.04 -25.02 1.58 Allowed Glycine 0 CA--C 1.54 1.654 0 N-CA-C 108.349 -1.9 . . . . 1.0 108.349 176.721 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 77' ' ' ILE . . . . . 0.56 ' O ' ' N ' ' A' ' 80' ' ' ALA . 5.5 pt -63.24 -54.76 28.98 Favored 'Isoleucine or valine' 0 C--O 1.219 -0.511 0 N-CA-C 107.873 -1.158 . . . . 1.0 107.873 178.421 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . 0.471 ' C ' ' O ' ' A' ' 77' ' ' ILE . 59.7 t -36.04 -33.07 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.316 -0.885 0 CA-C-N 112.186 -2.279 . . . . 1.0 106.962 -177.108 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . 0.716 ' O ' ' HB2' ' A' ' 83' ' ' ALA . 0.0 OUTLIER -98.39 -33.44 4.18 Favored 'Isoleucine or valine' 0 CA--C 1.556 1.178 0 CA-C-N 115.795 -0.639 . . . . 1.0 111.018 177.828 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild core ' A' A ' 80' ' ' ALA . . . . . 0.56 ' N ' ' O ' ' A' ' 77' ' ' ILE . . . -84.86 -13.37 51.16 Favored 'General case' 0 N--CA 1.48 1.048 0 N-CA-C 114.842 1.423 . . . . 1.0 114.842 -179.096 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 81' ' ' GLU . . . . . 0.452 ' N ' ' O ' ' A' ' 77' ' ' ILE . 41.8 mt-10 -88.48 -67.33 0.84 Allowed 'General case' 0 CA--C 1.506 -0.724 0 O-C-N 121.656 -0.652 . . . . 1.0 109.383 178.098 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 82' ' ' ASP . . . . . 0.541 ' O ' ' N ' ' A' ' 84' ' ' LEU . 24.3 t0 -73.25 -13.92 61.23 Favored 'General case' 0 N--CA 1.442 -0.858 0 CA-C-N 119.043 0.838 . . . . 1.0 111.908 179.792 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . 0.737 ' HA ' ' HB3' ' A' ' 86' ' ' ALA . . . -20.47 -47.2 0.01 OUTLIER 'General case' 0 N--CA 1.478 0.96 0 CA-C-N 118.39 0.541 . . . . 1.0 112.032 178.221 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . 0.541 ' N ' ' O ' ' A' ' 82' ' ' ASP . 3.7 mm? -34.29 -35.91 0.04 OUTLIER 'General case' 0 N--CA 1.478 0.949 0 N-CA-C 113.209 0.818 . . . . 1.0 113.209 -178.163 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 85' ' ' ILE . . . . . 0.417 HD12 ' HA ' ' A' ' 85' ' ' ILE . 11.2 tp -100.42 -36.86 5.28 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.66 0 N-CA-C 108.548 -0.908 . . . . 1.0 108.548 177.88 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 86' ' ' ALA . . . . . 0.737 ' HB3' ' HA ' ' A' ' 83' ' ' ALA . . . -61.21 -58.82 6.73 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 114.426 -1.261 . . . . 1.0 109.132 179.973 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 87' ' ' GLU . . . . . 0.408 ' N ' ' O ' ' A' ' 83' ' ' ALA . 2.5 tt0 -71.5 24.04 0.04 OUTLIER 'General case' 0 CA--C 1.542 0.642 0 O-C-N 121.321 -0.862 . . . . 1.0 112.364 -178.931 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 88' ' ' ALA . . . . . 0.43 ' H ' ' C ' ' A' ' 86' ' ' ALA . . . -126.64 -16.63 5.23 Favored 'General case' 0 N--CA 1.478 0.971 0 CA-C-O 122.213 1.006 . . . . 1.0 108.999 179.131 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 21.2 m -101.48 33.89 0.37 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.456 0 CA-C-N 113.406 -1.724 . . . . 1.0 109.09 178.328 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 90' ' ' GLY . . . . . 0.595 ' C ' ' H ' ' A' ' 92' ' ' HIS . . . -69.3 -35.45 76.69 Favored Glycine 0 C--N 1.345 1.044 0 N-CA-C 111.16 -0.776 . . . . 1.0 111.16 179.009 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 91' ' ' PRO . . . . . 0.583 ' CD ' ' N ' ' A' ' 90' ' ' GLY . 89.4 Cg_exo -48.35 -8.08 0.06 OUTLIER 'Trans proline' 0 N--CA 1.498 1.746 0 C-N-CA 122.002 1.801 . . . . 1.0 110.702 177.897 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 92' ' ' HIS . . . . . 0.601 ' ND1' ' N ' ' A' ' 93' ' ' LEU . 0.9 OUTLIER -57.54 -20.11 29.56 Favored 'General case' 0 N--CA 1.444 -0.746 0 N-CA-C 107.771 -1.196 . . . . 1.0 107.771 179.367 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild core ' A' A ' 93' ' ' LEU . . . . . 0.693 HD12 ' N ' ' A' ' 94' ' ' ALA . 2.2 pp -65.63 -58.09 6.56 Favored 'General case' 0 N--CA 1.451 -0.393 0 N-CA-C 108.507 -0.923 . . . . 1.0 108.507 178.507 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 94' ' ' ALA . . . . . 0.693 ' N ' HD12 ' A' ' 93' ' ' LEU . . . -55.11 -54.21 46.03 Favored 'General case' 0 N--CA 1.452 -0.336 0 N-CA-C 108.962 -0.755 . . . . 1.0 108.962 179.305 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 95' ' ' ARG . . . . . 0.579 ' O ' ' N ' ' A' ' 97' ' ' LEU . 29.2 mtm180 -58.69 -58.86 6.73 Favored 'General case' 0 C--O 1.242 0.689 0 CA-C-O 122.529 1.157 . . . . 1.0 108.254 179.461 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 96' ' ' ALA . . . . . 0.886 ' O ' ' N ' ' A' ' 98' ' ' GLY . . . -48.55 -14.1 0.06 Allowed 'General case' 0 N--CA 1.424 -1.754 0 O-C-N 118.961 -2.337 . . . . 1.0 111.297 -178.856 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 97' ' ' LEU . . . . . 0.735 ' O ' ' N ' ' A' ' 100' ' ' ILE . 1.9 tp 5.23 -52.34 0.0 OUTLIER 'General case' 0 C--N 1.367 1.358 0 CA-C-O 116.427 -1.749 . . . . 1.0 110.447 -167.765 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 98' ' ' GLY . . . . . 0.886 ' N ' ' O ' ' A' ' 96' ' ' ALA . . . -48.66 -23.65 3.49 Favored Glycine 0 CA--C 1.542 1.735 0 CA-C-N 123.916 3.053 . . . . 1.0 108.034 174.733 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 99' ' ' GLN . . . . . 0.572 ' N ' ' O ' ' A' ' 96' ' ' ALA . 59.0 tt0 -68.81 -19.22 64.27 Favored 'General case' 0 C--N 1.364 1.211 0 N-CA-C 107.285 -1.376 . . . . 1.0 107.285 177.536 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 100' ' ' ILE . . . . . 0.735 ' N ' ' O ' ' A' ' 97' ' ' LEU . 1.9 tp -65.54 -42.58 93.43 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 N-CA-C 107.103 -1.443 . . . . 1.0 107.103 177.128 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 101' ' ' VAL . . . . . 0.743 ' O ' ' N ' ' A' ' 105' ' ' GLY . 61.0 t -55.68 -60.03 2.1 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.43 0 N-CA-C 106.931 -1.507 . . . . 1.0 106.931 178.704 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 102' ' ' CYS . . . . . 0.859 ' O ' ' HB2' ' A' ' 106' ' ' ALA . 0.5 OUTLIER -46.35 -18.37 0.06 Allowed 'General case' 0 C--N 1.32 -0.708 0 CA-C-N 116.433 -0.349 . . . . 1.0 111.622 -179.666 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild core ' A' A ' 103' ' ' ARG . . . . . 0.416 ' N ' ' O ' ' A' ' 101' ' ' VAL . 1.1 ttp180 -92.77 -44.65 8.41 Favored 'General case' 0 N--CA 1.478 0.946 0 CA-C-O 121.948 0.88 . . . . 1.0 111.068 176.951 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 104' ' ' TYR . . . . . 0.583 ' O ' ' CG ' ' A' ' 104' ' ' TYR . 0.0 OUTLIER -106.57 21.85 16.79 Favored 'General case' 0 C--N 1.317 -0.808 0 C-N-CA 126.297 1.839 . . . . 1.0 111.215 179.416 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild core ' A' A ' 105' ' ' GLY . . . . . 0.769 ' O ' ' N ' ' A' ' 107' ' ' THR . . . -170.12 -7.33 0.03 OUTLIER Glycine 0 C--N 1.339 0.747 0 C-N-CA 118.495 -1.812 . . . . 1.0 113.481 178.619 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 106' ' ' ALA . . . . . 0.859 ' HB2' ' O ' ' A' ' 102' ' ' CYS . . . -31.64 69.49 0.0 OUTLIER 'General case' 0 N--CA 1.467 0.387 0 N-CA-C 113.752 1.019 . . . . 1.0 113.752 -177.738 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 107' ' ' THR . . . . . 0.769 ' N ' ' O ' ' A' ' 105' ' ' GLY . 4.8 t -91.84 4.22 53.38 Favored 'General case' 0 N--CA 1.436 -1.171 0 N-CA-C 105.668 -1.975 . . . . 1.0 105.668 176.151 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 108' ' ' VAL . . . . . 0.529 HG13 ' N ' ' A' ' 109' ' ' ILE . 11.2 p -87.77 -57.35 4.31 Favored 'Isoleucine or valine' 0 C--N 1.357 0.928 0 CA-C-N 115.851 -0.613 . . . . 1.0 110.624 178.333 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 109' ' ' ILE . . . . . 0.529 ' N ' HG13 ' A' ' 108' ' ' VAL . 0.1 OUTLIER -62.95 -37.98 38.5 Favored Pre-proline 0 C--N 1.359 0.987 0 N-CA-C 114.476 1.288 . . . . 1.0 114.476 -176.911 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild core ' A' A ' 110' ' ' PRO . . . . . 0.435 ' CD ' ' O ' ' A' ' 106' ' ' ALA . 62.5 Cg_exo -49.04 -44.9 31.2 Favored 'Trans proline' 0 N--CA 1.497 1.703 0 CA-C-N 121.158 1.449 . . . . 1.0 113.649 -176.418 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 9.0 t30 -68.03 -67.55 0.45 Allowed 'General case' 0 C--N 1.326 -0.422 0 C-N-CA 118.735 -1.186 . . . . 1.0 110.435 -177.815 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 6.3 pt -52.89 -23.2 4.99 Favored 'Isoleucine or valine' 0 C--O 1.214 -0.778 0 N-CA-C 108.78 -0.822 . . . . 1.0 108.78 179.391 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 113' ' ' ASN . . . . . 0.456 ' HB2' ' O ' ' A' ' 109' ' ' ILE . 20.2 t30 -59.43 -51.45 69.84 Favored 'General case' 0 C--N 1.314 -0.943 0 CA-C-N 113.731 -1.577 . . . . 1.0 108.334 -178.423 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -58.64 -28.9 66.11 Favored 'General case' 0 N--CA 1.443 -0.805 0 C-N-CA 120.345 -0.542 . . . . 1.0 111.202 179.874 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 115' ' ' ALA . . . . . 0.578 ' O ' ' N ' ' A' ' 119' ' ' LEU . . . -81.12 -50.29 9.8 Favored 'General case' 0 C--O 1.208 -1.123 0 C-N-CA 120.084 -0.646 . . . . 1.0 109.292 177.275 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 116' ' ' ILE . . . . . 0.413 ' C ' ' O ' ' A' ' 115' ' ' ALA . 35.8 mt -42.85 -48.39 1.19 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.408 0 N-CA-C 104.997 -2.223 . . . . 1.0 104.997 179.104 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 117' ' ' GLU . . . . . 0.493 ' O ' ' HA ' ' A' ' 121' ' ' THR . 55.7 tt0 -46.51 -58.32 3.89 Favored 'General case' 0 C--N 1.314 -0.951 0 CA-C-N 111.294 -2.685 . . . . 1.0 106.332 177.814 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 118' ' ' VAL . . . . . 0.574 ' N ' ' O ' ' A' ' 115' ' ' ALA . 15.8 t -64.44 -56.23 17.34 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.747 0 C-N-CA 120.085 -0.646 . . . . 1.0 110.486 177.398 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 119' ' ' LEU . . . . . 0.578 ' N ' ' O ' ' A' ' 115' ' ' ALA . 1.1 mm? -51.77 -20.63 2.26 Favored 'General case' 0 N--CA 1.451 -0.377 0 N-CA-C 113.984 1.105 . . . . 1.0 113.984 -178.532 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 120' ' ' GLY . . . . . 0.448 ' O ' ' CB ' ' A' ' 121' ' ' THR . . . -134.16 -68.64 0.07 OUTLIER Glycine 0 CA--C 1.554 2.486 0 N-CA-C 105.996 -2.842 . . . . 1.0 105.996 173.974 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 121' ' ' THR . . . . . 0.495 ' CG2' HG22 ' A' ' 123' ' ' THR . 2.3 m 152.7 -31.96 0.01 OUTLIER 'General case' 0 N--CA 1.481 1.101 0 CA-C-N 112.656 -1.772 . . . . 1.0 112.01 178.478 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 122' ' ' GLY . . . . . 0.67 ' O ' ' N ' ' A' ' 124' ' ' ASP . . . 104.02 -17.03 49.5 Favored Glycine 0 N--CA 1.471 1.016 0 N-CA-C 108.875 -1.69 . . . . 1.0 108.875 -177.973 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 123' ' ' THR . . . . . 0.495 HG22 ' CG2' ' A' ' 121' ' ' THR . 0.0 OUTLIER -55.4 84.98 0.0 OUTLIER 'General case' 0 CA--C 1.539 0.527 0 N-CA-C 105.566 -2.013 . . . . 1.0 105.566 178.548 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild core ' A' A ' 124' ' ' ASP . . . . . 0.67 ' N ' ' O ' ' A' ' 122' ' ' GLY . 63.7 m-20 -163.56 170.81 16.7 Favored 'General case' 0 N--CA 1.471 0.575 0 CA-C-N 113.428 -1.715 . . . . 1.0 112.342 -179.086 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 125' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -144.15 138.73 28.36 Favored 'General case' 0 CA--C 1.547 0.846 0 N-CA-C 107.377 -1.342 . . . . 1.0 107.377 176.449 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 25.6 mmm180 -149.31 153.85 38.12 Favored 'General case' 0 N--CA 1.476 0.851 0 N-CA-C 109.872 -0.418 . . . . 1.0 109.872 178.575 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 127' ' ' PHE . . . . . 0.478 ' OXT' ' CD1' ' A' ' 127' ' ' PHE . 0.1 OUTLIER . . . . . 0 N--CA 1.471 0.589 0 CA-C-O 118.076 -0.964 . . . . 1.0 110.269 178.862 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.495 1.8 0 N-CA-C 109.92 -0.4 . . . . 1.0 109.92 . . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 2' ' ' SER . . . . . 0.49 ' O ' ' CB ' ' A' ' 3' ' ' ASP . 9.0 t -86.49 13.78 7.82 Favored 'General case' 0 C--O 1.225 -0.23 0 CA-C-N 115.786 -0.643 . . . . 1.0 111.264 -179.918 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 3' ' ' ASP . . . . . 0.49 ' CB ' ' O ' ' A' ' 2' ' ' SER . 21.5 m-20 146.43 122.27 0.0 OUTLIER 'General case' 0 N--CA 1.478 0.955 0 O-C-N 124.577 1.173 . . . . 1.0 110.524 178.948 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 47.8 t80 -154.78 150.52 27.63 Favored 'General case' 0 N--CA 1.466 0.361 0 CA-C-N 116.062 -0.517 . . . . 1.0 110.573 179.028 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -152.39 147.97 26.92 Favored 'General case' 0 CA--C 1.543 0.694 0 CA-C-N 116.364 -0.38 . . . . 1.0 110.263 -178.529 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 6' ' ' THR . . . . . 0.479 HG22 ' H ' ' A' ' 7' ' ' GLU . 0.2 OUTLIER -61.49 -157.6 0.01 OUTLIER 'General case' 0 N--CA 1.472 0.671 0 C-N-CA 121.032 -0.267 . . . . 1.0 111.037 -179.187 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . 0.479 ' H ' HG22 ' A' ' 6' ' ' THR . 3.2 pt-20 -75.76 -67.57 0.66 Allowed 'General case' 0 C--O 1.216 -0.698 0 CA-C-O 118.553 -0.737 . . . . 1.0 110.245 -179.367 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 8' ' ' ARG . . . . . 0.473 ' H ' ' CG ' ' A' ' 7' ' ' GLU . 7.0 tmm_? -47.08 -43.01 19.81 Favored 'General case' 0 CA--C 1.493 -1.214 0 CA-C-N 119.645 1.111 . . . . 1.0 111.781 -177.858 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . 0.438 ' O ' HG23 ' A' ' 13' ' ' VAL . 0.1 OUTLIER -68.96 -52.99 28.74 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.94 0 C-N-CA 118.933 -1.107 . . . . 1.0 108.779 179.063 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 39.5 t -58.67 -42.75 89.18 Favored 'General case' 0 N--CA 1.455 -0.207 0 CA-C-O 118.868 -0.587 . . . . 1.0 111.968 179.528 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 11' ' ' ARG . . . . . 0.678 ' O ' ' N ' ' A' ' 14' ' ' ALA . 0.0 OUTLIER -74.17 -59.97 2.48 Favored 'General case' 0 CA--C 1.492 -1.256 0 N-CA-C 106.85 -1.537 . . . . 1.0 106.85 178.051 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . 0.651 ' O ' ' HB3' ' A' ' 16' ' ' ALA . . . -38.91 -43.08 0.92 Allowed 'General case' 0 CA--C 1.487 -1.475 0 CA-C-N 119.108 0.867 . . . . 1.0 108.783 -175.879 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . 0.693 ' O ' ' HB3' ' A' ' 17' ' ' LEU . 71.5 t -60.12 -52.53 60.21 Favored 'Isoleucine or valine' 0 C--O 1.186 -2.252 0 C-N-CA 115.984 -2.286 . . . . 1.0 106.822 177.664 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . 0.796 ' O ' HG13 ' A' ' 18' ' ' VAL . . . -66.1 -64.89 0.76 Allowed 'General case' 0 C--O 1.209 -1.041 0 O-C-N 120.329 -1.482 . . . . 1.0 113.122 177.954 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . 0.525 ' O ' ' N ' ' A' ' 19' ' ' GLY . . . -57.19 -59.13 5.56 Favored 'General case' 0 N--CA 1.497 1.878 0 C-N-CA 119.739 -0.784 . . . . 1.0 112.86 -175.263 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . 0.668 ' HB1' ' CA ' ' A' ' 22' ' ' GLY . . . -61.62 -54.89 36.86 Favored 'General case' 0 CA--C 1.556 1.206 0 CA-C-O 122.533 1.158 . . . . 1.0 109.866 -177.678 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . 0.693 ' HB3' ' O ' ' A' ' 13' ' ' VAL . 21.1 tp -57.57 -51.17 70.56 Favored 'General case' 0 N--CA 1.481 1.102 0 CA-C-N 113.57 -1.65 . . . . 1.0 108.194 -177.452 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . 0.796 HG13 ' O ' ' A' ' 14' ' ' ALA . 3.0 m -70.34 -57.08 8.92 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.461 0 C-N-CA 118.927 -1.109 . . . . 1.0 110.168 179.636 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . 0.525 ' N ' ' O ' ' A' ' 15' ' ' ALA . . . -61.62 -177.43 2.53 Favored Glycine 0 N--CA 1.446 -0.697 0 N-CA-C 111.718 -0.553 . . . . 1.0 111.718 -178.045 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 20' ' ' PRO . . . . . 0.569 ' O ' ' N ' ' A' ' 24' ' ' ALA . 54.4 Cg_endo -82.81 -23.63 3.76 Favored 'Trans proline' 0 C--N 1.303 -1.85 0 C-N-CA 123.045 2.497 . . . . 1.0 112.065 -179.271 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -60.51 -59.22 10.66 Favored Glycine 0 CA--C 1.535 1.301 0 C-N-CA 120.046 -1.073 . . . . 1.0 111.321 -176.952 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . 0.668 ' CA ' ' HB1' ' A' ' 16' ' ' ALA . . . -56.14 -52.91 46.34 Favored Glycine 0 N--CA 1.469 0.893 0 N-CA-C 107.101 -2.399 . . . . 1.0 107.101 -178.411 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . 0.479 ' O ' HG12 ' A' ' 27' ' ' VAL . 36.7 t -59.28 -33.25 50.34 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.185 0 C-N-CA 119.774 -0.77 . . . . 1.0 109.143 179.836 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . 0.569 ' N ' ' O ' ' A' ' 20' ' ' PRO . . . -55.33 -62.29 1.77 Allowed 'General case' 0 N--CA 1.479 1.018 0 C-N-CA 119.239 -0.984 . . . . 1.0 110.568 -179.886 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 18.3 mt -63.66 -43.3 97.12 Favored 'General case' 0 C--N 1.345 0.392 0 C-N-CA 119.919 -0.712 . . . . 1.0 112.39 -177.854 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 95.2 t -60.22 -60.53 2.42 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.79 0 C-N-CA 118.591 -1.244 . . . . 1.0 111.279 -177.608 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . 0.513 ' O ' ' HB3' ' A' ' 31' ' ' ALA . 3.1 p -59.61 -34.26 54.48 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.2 0 N-CA-C 112.681 0.623 . . . . 1.0 112.681 -177.58 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 71.3 tttt -66.79 -54.71 19.9 Favored 'General case' 0 C--N 1.312 -1.034 0 CA-C-O 122.317 1.056 . . . . 1.0 108.79 -179.68 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 98.6 t -62.88 -47.67 91.72 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.145 0 CA-C-N 113.553 -1.658 . . . . 1.0 110.499 -177.092 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 30' ' ' CYS . . . . . 0.561 ' SG ' ' N ' ' A' ' 31' ' ' ALA . 0.0 OUTLIER -67.48 -61.17 2.03 Favored 'General case' 0 CA--C 1.533 0.326 0 C-N-CA 118.729 -1.188 . . . . 1.0 110.198 -179.692 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . 0.561 ' N ' ' SG ' ' A' ' 30' ' ' CYS . . . -60.38 -53.85 52.71 Favored 'General case' 0 CA--C 1.509 -0.6 0 CA-C-N 118.25 0.477 . . . . 1.0 111.99 -177.001 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . 0.495 ' O ' ' CB ' ' A' ' 33' ' ' LEU . . . 87.33 74.36 1.28 Allowed Glycine 0 CA--C 1.521 0.416 0 N-CA-C 108.632 -1.787 . . . . 1.0 108.632 -178.529 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . 0.501 HD22 ' H ' ' A' ' 36' ' ' VAL . 1.1 tt 85.81 85.31 0.05 OUTLIER Pre-proline 0 CA--C 1.546 0.792 0 CA-C-O 120.692 0.282 . . . . 1.0 110.414 -179.343 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 51.7 Cg_exo -53.23 -30.4 51.11 Favored 'Trans proline' 0 N--CA 1.502 1.99 0 C-N-CA 123.005 2.47 . . . . 1.0 114.227 -179.679 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -57.23 -60.75 8.45 Favored Glycine 0 N--CA 1.469 0.856 0 C-N-CA 119.062 -1.542 . . . . 1.0 110.185 -178.653 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . 0.585 ' O ' HG22 ' A' ' 37' ' ' ILE . 2.7 p -88.77 160.49 2.82 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.479 0 N-CA-C 105.77 -1.937 . . . . 1.0 105.77 177.808 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . 0.663 HG23 ' O ' ' A' ' 37' ' ' ILE . 0.7 OUTLIER 125.61 113.56 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.479 0.996 0 O-C-N 124.682 1.239 . . . . 1.0 110.373 179.711 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild core ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 22.5 m80 -139.83 131.81 27.79 Favored 'General case' 0 N--CA 1.467 0.418 0 N-CA-C 108.557 -0.905 . . . . 1.0 108.557 179.263 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 9.2 p -99.37 149.4 35.8 Favored Pre-proline 0 N--CA 1.469 0.478 0 CA-C-N 116.969 -0.105 . . . . 1.0 110.743 -179.46 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 91.2 Cg_endo -75.29 -37.98 1.66 Allowed 'Trans proline' 0 N--CA 1.494 1.539 0 C-N-CA 122.317 2.012 . . . . 1.0 113.345 -179.123 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -128.2 134.38 49.02 Favored 'General case' 0 N--CA 1.472 0.665 0 N-CA-C 111.555 0.206 . . . . 1.0 111.555 179.611 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . 0.683 ' C ' ' H ' ' A' ' 44' ' ' GLY . 0.0 OUTLIER -169.86 165.95 9.61 Favored 'General case' 0 C--N 1.325 -0.487 0 C-N-CA 120.17 -0.612 . . . . 1.0 109.697 178.391 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild core ' A' A ' 43' ' ' ARG . . . . . 0.463 ' C ' ' H ' ' A' ' 45' ' ' PHE . 0.0 OUTLIER -61.89 24.92 0.01 OUTLIER 'General case' 0 CA--C 1.548 0.896 0 CA-C-N 115.494 -0.775 . . . . 1.0 110.553 179.82 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . 0.683 ' H ' ' C ' ' A' ' 42' ' ' ARG . . . 76.42 -26.08 1.61 Allowed Glycine 0 C--N 1.345 1.073 0 N-CA-C 110.452 -1.059 . . . . 1.0 110.452 -179.948 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . 0.578 ' O ' ' HB2' ' A' ' 46' ' ' PHE . 6.6 p90 -169.37 172.12 7.37 Favored 'General case' 0 C--O 1.219 -0.518 0 N-CA-C 109.966 -0.383 . . . . 1.0 109.966 179.743 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 46' ' ' PHE . . . . . 0.578 ' HB2' ' O ' ' A' ' 45' ' ' PHE . 1.1 m-85 131.63 99.57 0.0 OUTLIER 'General case' 0 N--CA 1.501 2.083 0 O-C-N 125.763 1.914 . . . . 1.0 109.802 178.695 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 47' ' ' ARG . . . . . 0.644 ' HG2' ' H ' ' A' ' 48' ' ' CYS . 15.6 ttp85 93.88 175.27 0.01 OUTLIER 'General case' 0 N--CA 1.468 0.446 0 O-C-N 123.596 0.56 . . . . 1.0 110.254 179.09 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 48' ' ' CYS . . . . . 0.644 ' H ' ' HG2' ' A' ' 47' ' ' ARG . 2.5 t 67.53 62.68 0.43 Allowed 'General case' 0 N--CA 1.445 -0.707 0 N-CA-C 106.373 -1.714 . . . . 1.0 106.373 -178.351 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 49' ' ' ASN . . . . . 0.559 ' N ' ' OD1' ' A' ' 49' ' ' ASN . 1.1 p30 -156.21 155.74 29.41 Favored Pre-proline 0 N--CA 1.449 -0.508 0 N-CA-C 108.097 -1.075 . . . . 1.0 108.097 178.865 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 50' ' ' PRO . . . . . 0.428 ' O ' ' NH1' ' A' ' 52' ' ' ARG . 50.8 Cg_endo -67.59 76.5 0.54 Allowed 'Trans proline' 0 C--N 1.303 -1.828 0 C-N-CA 121.967 1.778 . . . . 1.0 112.272 177.238 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 9.0 pt-20 40.12 63.97 0.98 Allowed 'General case' 0 N--CA 1.477 0.921 0 N-CA-C 112.532 0.567 . . . . 1.0 112.532 -179.95 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . 0.68 HH22 ' CE1' ' A' ' 92' ' ' HIS . 77.6 mtt85 -147.28 136.02 22.05 Favored 'General case' 0 N--CA 1.472 0.627 0 CA-C-N 116.049 -0.523 . . . . 1.0 111.844 178.896 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -54.44 164.75 0.29 Allowed 'Isoleucine or valine' 0 N--CA 1.478 0.942 0 N-CA-C 107.212 -1.403 . . . . 1.0 107.212 177.455 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 39.9 mm-40 -121.0 115.04 22.4 Favored 'General case' 0 CA--C 1.548 0.891 0 CA-C-N 121.845 2.111 . . . . 1.0 109.245 179.949 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . 0.457 HD12 ' N ' ' A' ' 56' ' ' GLY . 0.7 OUTLIER -146.7 157.73 10.8 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.017 0 CA-C-N 118.476 0.58 . . . . 1.0 109.532 177.704 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . 0.457 ' N ' HD12 ' A' ' 55' ' ' ILE . . . 110.84 -6.81 29.45 Favored Glycine 0 N--CA 1.481 1.68 0 CA-C-N 118.752 0.706 . . . . 1.0 112.3 -179.595 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -112.64 127.88 56.23 Favored 'General case' 0 C--N 1.32 -0.682 0 N-CA-C 108.677 -0.86 . . . . 1.0 108.677 178.126 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 58' ' ' TRP . . . . . 0.538 ' H ' ' HB2' ' A' ' 61' ' ' GLU . 5.0 m0 -139.18 158.48 44.1 Favored 'General case' 0 N--CA 1.455 -0.216 0 CA-C-O 122.808 1.29 . . . . 1.0 109.529 179.298 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 34.9 ptt-85 -41.03 -36.41 0.67 Allowed 'General case' 0 C--N 1.296 -1.728 0 CA-C-N 112.318 -2.219 . . . . 1.0 109.181 -178.616 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 42.8 t80 -90.94 -35.67 14.58 Favored 'General case' 0 N--CA 1.481 1.09 0 CA-C-O 121.687 0.756 . . . . 1.0 112.449 178.82 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . 0.538 ' HB2' ' H ' ' A' ' 58' ' ' TRP . 92.5 mt-10 -77.67 -13.92 59.77 Favored 'General case' 0 N--CA 1.443 -0.812 0 O-C-N 121.757 -0.589 . . . . 1.0 110.53 179.926 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 62' ' ' VAL . . . . . 0.628 HG13 ' N ' ' A' ' 63' ' ' ALA . 7.3 p -46.71 -56.2 1.42 Allowed 'Isoleucine or valine' 0 C--O 1.213 -0.858 0 C-N-CA 119.444 -0.902 . . . . 1.0 109.318 -175.664 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 63' ' ' ALA . . . . . 0.628 ' N ' HG13 ' A' ' 62' ' ' VAL . . . -64.77 -54.29 33.6 Favored 'General case' 0 C--N 1.302 -1.483 0 O-C-N 121.966 -0.459 . . . . 1.0 110.059 179.94 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 2.9 m-70 -53.16 -57.74 9.44 Favored 'General case' 0 CA--C 1.549 0.917 0 C-N-CA 119.591 -0.844 . . . . 1.0 109.813 -179.205 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 65' ' ' ASP . . . . . 0.623 ' C ' ' H ' ' A' ' 67' ' ' ARG . 33.8 t0 -72.72 -52.07 16.68 Favored 'General case' 0 C--O 1.245 0.854 0 CA-C-O 121.899 0.857 . . . . 1.0 111.48 179.111 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . 0.584 ' N ' ' O ' ' A' ' 62' ' ' VAL . . . -69.51 27.71 0.36 Allowed Glycine 0 C--O 1.226 -0.374 0 O-C-N 120.74 -1.225 . . . . 1.0 110.66 177.04 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 67' ' ' ARG . . . . . 0.709 ' O ' ' N ' ' A' ' 69' ' ' LEU . 8.0 mtm-85 -75.63 5.58 5.91 Favored 'General case' 0 CA--C 1.507 -0.673 0 N-CA-C 108.011 -1.107 . . . . 1.0 108.011 176.049 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . 0.46 ' C ' ' O ' ' A' ' 67' ' ' ARG . 2.7 mt -31.43 -25.5 0.0 OUTLIER 'General case' 0 N--CA 1.486 1.35 0 N-CA-C 108.311 -0.996 . . . . 1.0 108.311 -177.694 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . 0.709 ' N ' ' O ' ' A' ' 67' ' ' ARG . 48.1 tp -64.85 -65.35 0.69 Allowed 'General case' 0 N--CA 1.472 0.637 0 N-CA-C 108.662 -0.866 . . . . 1.0 108.662 177.655 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . 0.631 ' O ' ' N ' ' A' ' 72' ' ' HIS . . . -80.66 -73.96 0.34 Allowed 'General case' 0 N--CA 1.47 0.55 0 N-CA-C 104.438 -2.43 . . . . 1.0 104.438 176.906 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 71' ' ' ALA . . . . . 0.489 ' O ' ' C ' ' A' ' 72' ' ' HIS . . . -42.83 0.89 0.0 OUTLIER 'General case' 0 CA--C 1.513 -0.47 0 C-N-CA 124.864 1.265 . . . . 1.0 113.647 179.493 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 72' ' ' HIS . . . . . 0.671 ' CG ' ' N ' ' A' ' 73' ' ' MET . 0.0 OUTLIER -26.65 -63.5 0.08 Allowed 'General case' 0 C--N 1.346 0.434 0 CA-C-N 118.243 0.474 . . . . 1.0 110.421 -179.825 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild core ' A' A ' 73' ' ' MET . . . . . 0.671 ' N ' ' CG ' ' A' ' 72' ' ' HIS . 12.5 ttm -74.32 -50.86 17.06 Favored 'General case' 0 C--N 1.323 -0.563 0 C-N-CA 119.043 -1.063 . . . . 1.0 109.917 178.668 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . 0.564 ' O ' ' N ' ' A' ' 76' ' ' GLY . 41.2 t -46.09 -45.78 5.77 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.269 0 CA-C-O 117.604 -1.189 . . . . 1.0 112.589 -175.018 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 75' ' ' ASN . . . . . 0.674 ' O ' HG23 ' A' ' 79' ' ' ILE . 8.2 t-20 -42.54 -15.71 0.01 OUTLIER 'General case' 0 C--N 1.35 0.6 0 CA-C-N 121.227 1.83 . . . . 1.0 111.425 177.336 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 76' ' ' GLY . . . . . 0.564 ' N ' ' O ' ' A' ' 74' ' ' VAL . . . -46.18 -25.65 1.92 Allowed Glycine 0 CA--C 1.531 1.084 0 N-CA-C 108.984 -1.646 . . . . 1.0 108.984 -179.921 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 77' ' ' ILE . . . . . 0.526 ' O ' ' N ' ' A' ' 79' ' ' ILE . 0.9 OUTLIER -86.32 -61.96 1.65 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.699 0 CA-C-N 113.886 -1.157 . . . . 1.0 110.615 -178.099 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . 0.427 ' C ' ' O ' ' A' ' 77' ' ' ILE . 12.2 t -37.86 -27.34 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.443 -0.789 0 N-CA-C 109.221 -0.659 . . . . 1.0 109.221 -178.308 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . 0.832 ' O ' ' HB3' ' A' ' 83' ' ' ALA . 0.9 OUTLIER -67.99 -51.87 44.93 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.788 0 C-N-CA 119.827 -0.749 . . . . 1.0 110.857 178.916 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild core ' A' A ' 80' ' ' ALA . . . . . 0.512 ' N ' ' CG1' ' A' ' 79' ' ' ILE . . . -61.48 -63.14 1.37 Allowed 'General case' 0 C--O 1.231 0.097 0 C-N-CA 119.131 -1.028 . . . . 1.0 110.89 -178.656 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 81' ' ' GLU . . . . . 0.434 ' HG2' ' H ' ' A' ' 81' ' ' GLU . 0.2 OUTLIER -49.28 -72.64 0.05 OUTLIER 'General case' 0 CA--C 1.536 0.437 0 C-N-CA 119.57 -0.852 . . . . 1.0 109.924 -179.495 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild core ' A' A ' 82' ' ' ASP . . . . . 0.471 ' O ' ' N ' ' A' ' 84' ' ' LEU . 33.4 m-20 -59.6 -63.31 1.35 Allowed 'General case' 0 C--N 1.331 -0.227 0 C-N-CA 118.233 -1.387 . . . . 1.0 109.897 -178.285 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . 0.832 ' HB3' ' O ' ' A' ' 79' ' ' ILE . . . -68.82 57.95 0.09 Allowed 'General case' 0 C--N 1.317 -0.814 0 C-N-CA 119.416 -0.914 . . . . 1.0 110.395 -179.61 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . 0.471 ' N ' ' O ' ' A' ' 82' ' ' ASP . 0.2 OUTLIER -79.68 7.09 9.11 Favored 'General case' 0 C--N 1.351 0.672 0 N-CA-C 108.62 -0.881 . . . . 1.0 108.62 179.033 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild core ' A' A ' 85' ' ' ILE . . . . . 0.782 ' O ' ' HB ' ' A' ' 89' ' ' VAL . 0.0 OUTLIER -92.06 -7.96 10.42 Favored 'Isoleucine or valine' 0 C--O 1.193 -1.88 0 CA-C-N 114.647 -1.161 . . . . 1.0 108.652 178.648 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -96.76 -12.96 23.01 Favored 'General case' 0 CA--C 1.544 0.747 0 CA-C-O 120.696 0.284 . . . . 1.0 111.709 179.704 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -88.53 -37.13 15.97 Favored 'General case' 0 N--CA 1.481 1.076 0 N-CA-C 113.321 0.86 . . . . 1.0 113.321 -178.493 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -112.88 -8.41 13.71 Favored 'General case' 0 N--CA 1.482 1.129 0 CA-C-O 121.57 0.7 . . . . 1.0 110.971 -178.629 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 89' ' ' VAL . . . . . 0.782 ' HB ' ' O ' ' A' ' 85' ' ' ILE . 14.9 t -99.43 33.34 0.31 Allowed 'Isoleucine or valine' 0 CA--C 1.503 -0.861 0 CA-C-N 115.144 -0.935 . . . . 1.0 109.425 178.095 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 90' ' ' GLY . . . . . 0.644 ' N ' ' HD2' ' A' ' 91' ' ' PRO . . . -67.42 -42.35 89.56 Favored Glycine 0 CA--C 1.537 1.414 0 N-CA-C 110.091 -1.204 . . . . 1.0 110.091 176.531 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 91' ' ' PRO . . . . . 0.644 ' HD2' ' N ' ' A' ' 90' ' ' GLY . 5.8 Cg_exo -42.09 -13.93 0.04 OUTLIER 'Trans proline' 0 N--CA 1.496 1.655 0 C-N-CA 122.152 1.901 . . . . 1.0 111.034 177.753 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 92' ' ' HIS . . . . . 0.68 ' CE1' HH22 ' A' ' 52' ' ' ARG . 47.9 p-80 -57.16 -18.42 15.21 Favored 'General case' 0 C--O 1.202 -1.397 0 N-CA-C 107.94 -1.133 . . . . 1.0 107.94 179.928 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 93' ' ' LEU . . . . . 0.646 HD12 ' N ' ' A' ' 94' ' ' ALA . 1.3 pp -65.67 -57.69 7.48 Favored 'General case' 0 C--N 1.325 -0.495 0 N-CA-C 108.785 -0.82 . . . . 1.0 108.785 179.537 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 94' ' ' ALA . . . . . 0.646 ' N ' HD12 ' A' ' 93' ' ' LEU . . . -58.35 -53.95 52.53 Favored 'General case' 0 CA--C 1.515 -0.396 0 N-CA-C 108.78 -0.822 . . . . 1.0 108.78 179.031 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 95' ' ' ARG . . . . . 0.692 ' O ' ' N ' ' A' ' 97' ' ' LEU . 6.8 mtm-85 -58.09 -58.3 9.02 Favored 'General case' 0 N--CA 1.449 -0.486 0 N-CA-C 107.322 -1.362 . . . . 1.0 107.322 178.732 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 96' ' ' ALA . . . . . 0.942 ' O ' ' N ' ' A' ' 98' ' ' GLY . . . -46.14 -11.62 0.02 OUTLIER 'General case' 0 C--N 1.308 -1.224 0 O-C-N 118.49 -2.631 . . . . 1.0 110.807 -179.687 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 97' ' ' LEU . . . . . 0.718 ' O ' ' N ' ' A' ' 100' ' ' ILE . 4.3 tt 9.22 -54.09 0.0 OUTLIER 'General case' 0 N--CA 1.476 0.873 0 CA-C-O 117.474 -1.25 . . . . 1.0 109.817 -168.19 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 98' ' ' GLY . . . . . 0.942 ' N ' ' O ' ' A' ' 96' ' ' ALA . . . -47.63 -22.46 1.8 Allowed Glycine 0 CA--C 1.547 2.086 0 CA-C-N 122.328 2.331 . . . . 1.0 107.295 174.908 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 99' ' ' GLN . . . . . 0.533 ' N ' ' O ' ' A' ' 96' ' ' ALA . 4.3 tp-100 -65.34 -20.5 66.42 Favored 'General case' 0 C--N 1.378 1.813 0 C-N-CA 117.975 -1.49 . . . . 1.0 108.439 176.922 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 100' ' ' ILE . . . . . 0.718 ' N ' ' O ' ' A' ' 97' ' ' LEU . 18.7 mm -64.13 -47.05 91.81 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.753 0 CA-C-N 114.438 -1.255 . . . . 1.0 108.325 177.489 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 101' ' ' VAL . . . . . 0.709 ' O ' ' N ' ' A' ' 105' ' ' GLY . 57.4 t -60.44 -58.96 4.99 Favored 'Isoleucine or valine' 0 C--O 1.219 -0.526 0 N-CA-C 106.945 -1.502 . . . . 1.0 106.945 179.58 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 102' ' ' CYS . . . . . 0.966 ' O ' ' HB2' ' A' ' 106' ' ' ALA . 0.0 OUTLIER -45.22 -17.92 0.03 OUTLIER 'General case' 0 N--CA 1.444 -0.726 0 CA-C-O 121.423 0.63 . . . . 1.0 110.268 -179.889 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild core ' A' A ' 103' ' ' ARG . . . . . 0.62 ' NH2' ' CZ ' ' A' ' 104' ' ' TYR . 0.1 OUTLIER -95.48 -44.43 7.53 Favored 'General case' 0 N--CA 1.474 0.759 0 CA-C-O 122.47 1.129 . . . . 1.0 112.359 177.985 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild core ' A' A ' 104' ' ' TYR . . . . . 0.62 ' CZ ' ' NH2' ' A' ' 103' ' ' ARG . 12.1 m-85 -107.16 21.41 17.57 Favored 'General case' 0 C--N 1.318 -0.761 0 C-N-CA 127.251 2.22 . . . . 1.0 111.861 179.507 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 105' ' ' GLY . . . . . 0.709 ' N ' ' O ' ' A' ' 101' ' ' VAL . . . -170.83 -10.68 0.02 OUTLIER Glycine 0 C--N 1.341 0.806 0 C-N-CA 119.356 -1.402 . . . . 1.0 112.155 179.664 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 106' ' ' ALA . . . . . 0.966 ' HB2' ' O ' ' A' ' 102' ' ' CYS . . . -28.77 75.13 0.0 OUTLIER 'General case' 0 CA--C 1.512 -0.492 0 N-CA-C 113.805 1.039 . . . . 1.0 113.805 -179.472 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 107' ' ' THR . . . . . 0.693 ' N ' ' O ' ' A' ' 105' ' ' GLY . 15.2 t -91.22 5.95 47.08 Favored 'General case' 0 N--CA 1.434 -1.264 0 N-CA-C 106.045 -1.835 . . . . 1.0 106.045 178.177 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 108' ' ' VAL . . . . . 0.724 ' O ' HG22 ' A' ' 108' ' ' VAL . 11.8 p -95.84 17.01 2.02 Favored 'Isoleucine or valine' 0 C--N 1.352 0.687 0 CA-C-O 118.493 -0.765 . . . . 1.0 110.873 177.077 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 109' ' ' ILE . . . . . 0.676 ' N ' ' CD ' ' A' ' 110' ' ' PRO . 40.5 pt -105.77 -14.85 0.15 Allowed Pre-proline 0 N--CA 1.438 -1.073 0 CA-C-N 121.255 1.843 . . . . 1.0 110.457 177.915 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 110' ' ' PRO . . . . . 0.676 ' CD ' ' N ' ' A' ' 109' ' ' ILE . 55.7 Cg_endo -67.36 -48.21 1.8 Allowed 'Trans proline' 0 N--CA 1.493 1.465 0 CA-C-N 121.163 1.451 . . . . 1.0 113.094 -175.728 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 15.6 t-20 -67.47 -66.36 0.57 Allowed 'General case' 0 N--CA 1.453 -0.304 0 C-N-CA 119.756 -0.777 . . . . 1.0 109.874 -179.125 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 112' ' ' ILE . . . . . 0.515 ' O ' ' HB ' ' A' ' 116' ' ' ILE . 2.9 tt -43.56 -40.52 1.37 Allowed 'Isoleucine or valine' 0 CA--C 1.548 0.904 0 N-CA-C 113.093 0.775 . . . . 1.0 113.093 -178.247 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 5.8 m-80 -67.86 -41.12 83.39 Favored 'General case' 0 C--N 1.31 -1.134 0 CA-C-O 122.449 1.119 . . . . 1.0 109.295 178.061 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -59.62 -52.02 67.31 Favored 'General case' 0 C--N 1.296 -1.74 0 CA-C-N 113.386 -1.734 . . . . 1.0 108.95 179.912 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -78.81 -57.04 3.96 Favored 'General case' 0 CA--C 1.537 0.456 0 N-CA-C 114.047 1.128 . . . . 1.0 114.047 179.517 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 116' ' ' ILE . . . . . 0.586 ' O ' ' N ' ' A' ' 120' ' ' GLY . 4.5 mm -52.05 -51.16 31.76 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.209 0 CA-C-O 122.008 0.909 . . . . 1.0 112.445 -176.55 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 117' ' ' GLU . . . . . 0.489 ' C ' ' O ' ' A' ' 116' ' ' ILE . 65.4 mt-10 -45.07 -56.92 4.24 Favored 'General case' 0 C--N 1.313 -0.982 0 N-CA-C 105.516 -2.031 . . . . 1.0 105.516 -176.662 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 96.7 t -58.07 -53.92 39.24 Favored 'Isoleucine or valine' 0 CA--C 1.554 1.129 0 C-N-CA 119.919 -0.712 . . . . 1.0 109.444 177.49 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 4.6 tt -51.92 -68.91 0.13 Allowed 'General case' 0 N--CA 1.48 1.033 0 N-CA-C 106.82 -1.548 . . . . 1.0 106.82 -178.628 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 120' ' ' GLY . . . . . 0.586 ' N ' ' O ' ' A' ' 116' ' ' ILE . . . -73.33 -82.65 0.33 Allowed Glycine 0 CA--C 1.548 2.156 0 C-N-CA 120.897 -0.668 . . . . 1.0 112.34 -179.158 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 121' ' ' THR . . . . . 0.495 ' OG1' ' O ' ' A' ' 120' ' ' GLY . 4.2 m 155.6 -34.31 0.01 OUTLIER 'General case' 0 N--CA 1.482 1.155 0 CA-C-N 112.435 -1.883 . . . . 1.0 112.355 179.397 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 122' ' ' GLY . . . . . 0.684 ' O ' ' N ' ' A' ' 124' ' ' ASP . . . 103.96 -17.76 47.98 Favored Glycine 0 N--CA 1.461 0.313 0 N-CA-C 106.198 -2.761 . . . . 1.0 106.198 -176.589 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 123' ' ' THR . . . . . 0.706 HG23 ' O ' ' A' ' 123' ' ' THR . 9.6 t -55.98 81.31 0.0 OUTLIER 'General case' 0 N--CA 1.468 0.475 0 N-CA-C 105.519 -2.03 . . . . 1.0 105.519 178.758 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 124' ' ' ASP . . . . . 0.684 ' N ' ' O ' ' A' ' 122' ' ' GLY . 40.7 m-20 -166.81 178.85 5.64 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 112.871 -1.968 . . . . 1.0 111.66 179.041 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 125' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -147.34 143.76 28.26 Favored 'General case' 0 CA--C 1.545 0.78 0 N-CA-C 108.154 -1.054 . . . . 1.0 108.154 176.473 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 72.2 mtt-85 -150.92 155.8 39.88 Favored 'General case' 0 N--CA 1.47 0.569 0 CA-C-O 120.801 0.334 . . . . 1.0 111.011 176.535 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 127' ' ' PHE . . . . . 0.473 ' OXT' ' CG ' ' A' ' 127' ' ' PHE . 5.8 p90 . . . . . 0 C--O 1.218 -0.603 0 CA-C-O 118.188 -0.91 . . . . 1.0 110.159 179.276 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 N--CA 1.488 1.468 0 N-CA-C 108.866 -0.79 . . . . 1.0 108.866 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 85.5 p -106.87 10.47 30.62 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.297 -0.41 . . . . 1.0 110.405 -179.575 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 1.7 t70 166.07 94.37 0.0 OUTLIER 'General case' 0 N--CA 1.465 0.322 0 CA-C-N 115.965 -0.561 . . . . 1.0 110.003 179.646 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 54.7 t80 -149.04 144.77 26.92 Favored 'General case' 0 C--N 1.33 -0.262 0 N-CA-C 110.293 -0.262 . . . . 1.0 110.293 179.369 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' ASP . . . . . 0.516 ' N ' ' OD1' ' A' ' 5' ' ' ASP . 0.6 OUTLIER -154.95 151.48 28.57 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.799 0.333 . . . . 1.0 110.554 -179.285 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' THR . . . . . 0.672 ' O ' ' N ' ' A' ' 10' ' ' SER . 0.2 OUTLIER -67.99 176.18 2.75 Favored 'General case' 0 C--O 1.206 -1.223 0 CA-C-N 116.352 -0.385 . . . . 1.0 110.526 -179.617 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . 0.527 ' O ' ' N ' ' A' ' 11' ' ' ARG . 82.2 tt0 -58.49 -58.76 7.12 Favored 'General case' 0 C--N 1.318 -0.769 0 CA-C-O 121.466 0.651 . . . . 1.0 110.254 -177.558 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' ARG . . . . . 0.825 ' O ' ' HB3' ' A' ' 12' ' ' ALA . 26.9 mtp180 -47.86 -55.06 10.64 Favored 'General case' 0 C--O 1.213 -0.82 0 N-CA-C 107.06 -1.459 . . . . 1.0 107.06 -178.874 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . 0.585 ' O ' ' CG2' ' A' ' 13' ' ' VAL . 63.1 t -64.89 -49.17 81.15 Favored 'Isoleucine or valine' 0 C--O 1.199 -1.589 0 CA-C-N 114.356 -1.293 . . . . 1.0 110.702 177.971 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . 0.672 ' N ' ' O ' ' A' ' 6' ' ' THR . 75.2 m -67.82 -65.54 0.68 Allowed 'General case' 0 C--N 1.316 -0.882 0 C-N-CA 119.764 -0.774 . . . . 1.0 112.098 -178.302 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' ARG . . . . . 0.527 ' N ' ' O ' ' A' ' 7' ' ' GLU . 11.2 ttm180 -64.35 -58.48 6.38 Favored 'General case' 0 C--N 1.324 -0.519 0 C-N-CA 119.839 -0.744 . . . . 1.0 111.764 -176.066 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . 0.825 ' HB3' ' O ' ' A' ' 8' ' ' ARG . . . -47.9 -48.64 31.42 Favored 'General case' 0 CA--C 1.539 0.547 0 N-CA-C 106.71 -1.589 . . . . 1.0 106.71 -177.907 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . 0.659 ' O ' ' N ' ' A' ' 17' ' ' LEU . 97.6 t -62.07 -50.9 78.2 Favored 'Isoleucine or valine' 0 C--O 1.194 -1.846 0 C-N-CA 118.839 -1.145 . . . . 1.0 109.28 177.281 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . 0.578 ' O ' HG13 ' A' ' 18' ' ' VAL . . . -56.85 -62.21 1.9 Allowed 'General case' 0 C--O 1.207 -1.151 0 O-C-N 120.871 -1.143 . . . . 1.0 109.572 -179.938 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . 0.558 ' O ' ' N ' ' A' ' 19' ' ' GLY . . . -51.36 -54.3 27.78 Favored 'General case' 0 C--N 1.319 -0.754 0 CA-C-O 121.79 0.805 . . . . 1.0 109.248 -178.521 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . 0.466 ' CB ' ' O ' ' A' ' 12' ' ' ALA . . . -61.52 -54.63 40.73 Favored 'General case' 0 C--N 1.308 -1.218 0 CA-C-N 114.62 -1.173 . . . . 1.0 108.508 -179.207 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . 0.659 ' N ' ' O ' ' A' ' 13' ' ' VAL . 42.4 tp -55.46 -54.29 45.72 Favored 'General case' 0 N--CA 1.478 0.961 0 CA-C-N 113.574 -1.648 . . . . 1.0 109.053 -177.16 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . 0.582 HG23 ' N ' ' A' ' 19' ' ' GLY . 3.6 m -68.65 -57.0 10.24 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.235 0 N-CA-C 108.992 -0.744 . . . . 1.0 108.992 178.912 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . 0.582 ' N ' HG23 ' A' ' 18' ' ' VAL . . . -63.04 -170.72 1.37 Allowed Glycine 0 CA--C 1.525 0.66 0 N-CA-C 110.829 -0.908 . . . . 1.0 110.829 -179.992 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' PRO . . . . . 0.648 ' O ' ' N ' ' A' ' 24' ' ' ALA . 93.0 Cg_endo -79.25 -27.02 4.65 Favored 'Trans proline' 0 C--N 1.308 -1.591 0 C-N-CA 122.797 2.331 . . . . 1.0 114.129 -178.33 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -57.16 -56.21 26.23 Favored Glycine 0 N--CA 1.477 1.375 0 C-N-CA 119.822 -1.18 . . . . 1.0 111.064 -177.624 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . 0.465 ' H ' ' C ' ' A' ' 16' ' ' ALA . . . -60.38 -55.83 27.85 Favored Glycine 0 N--CA 1.468 0.803 0 N-CA-C 108.587 -1.805 . . . . 1.0 108.587 -178.39 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -59.77 -35.15 58.41 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.204 0 CA-C-N 114.561 -0.82 . . . . 1.0 109.417 -179.94 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . 0.648 ' N ' ' O ' ' A' ' 20' ' ' PRO . . . -57.89 -61.92 2.19 Favored 'General case' 0 N--CA 1.452 -0.36 0 C-N-CA 118.99 -1.084 . . . . 1.0 109.739 -178.704 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 16.2 tp -65.38 -42.11 93.04 Favored 'General case' 0 N--CA 1.451 -0.411 0 C-N-CA 119.853 -0.739 . . . . 1.0 111.904 -178.326 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 89.6 t -61.57 -60.39 2.78 Favored 'Isoleucine or valine' 0 CA--C 1.522 -0.104 0 C-N-CA 118.834 -1.147 . . . . 1.0 110.307 -177.931 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . 0.558 ' O ' ' HB3' ' A' ' 31' ' ' ALA . 93.4 t -62.57 -38.26 81.03 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 N-CA-C 112.814 0.672 . . . . 1.0 112.814 -178.316 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 3.3 ttmp? -64.34 -55.02 24.05 Favored 'General case' 0 C--N 1.314 -0.95 0 CA-C-O 121.929 0.871 . . . . 1.0 108.775 -178.213 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 55.6 t -64.58 -45.15 96.35 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.008 0 CA-C-N 113.632 -1.622 . . . . 1.0 109.801 -178.533 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' CYS . . . . . . . . . . . . . 43.1 t -65.85 -61.16 2.22 Favored 'General case' 0 N--CA 1.445 -0.715 0 C-N-CA 118.666 -1.213 . . . . 1.0 108.743 179.729 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . 0.558 ' HB3' ' O ' ' A' ' 27' ' ' VAL . . . -63.73 -57.09 11.06 Favored 'General case' 0 CA--C 1.512 -0.514 0 N-CA-C 113.486 0.921 . . . . 1.0 113.486 -176.358 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . 0.475 ' O ' ' CB ' ' A' ' 33' ' ' LEU . . . 89.92 74.02 1.28 Allowed Glycine 0 CA--C 1.526 0.737 0 N-CA-C 110.862 -0.895 . . . . 1.0 110.862 -178.92 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . 0.475 ' CB ' ' O ' ' A' ' 32' ' ' GLY . 4.7 tp 87.43 84.08 0.04 OUTLIER Pre-proline 0 CA--C 1.544 0.746 0 CA-C-O 120.999 0.428 . . . . 1.0 111.204 179.578 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 52.1 Cg_exo -55.48 -33.3 85.69 Favored 'Trans proline' 0 N--CA 1.503 2.037 0 C-N-CA 123.798 2.998 . . . . 1.0 115.298 -179.528 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -55.39 -58.65 12.88 Favored Glycine 0 N--CA 1.469 0.871 0 C-N-CA 118.462 -1.827 . . . . 1.0 108.616 -178.804 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . 0.639 ' O ' HG22 ' A' ' 37' ' ' ILE . 23.2 m -86.77 160.05 3.06 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.649 0 N-CA-C 107.081 -1.451 . . . . 1.0 107.081 177.616 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . 0.7 HG23 ' O ' ' A' ' 37' ' ' ILE . 14.3 tt 126.97 115.35 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.477 0.886 0 O-C-N 124.195 0.934 . . . . 1.0 110.503 -179.741 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -141.04 133.14 27.88 Favored 'General case' 0 C--N 1.325 -0.494 0 N-CA-C 108.154 -1.054 . . . . 1.0 108.154 177.518 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 38.8 p -115.03 143.55 30.38 Favored Pre-proline 0 C--N 1.33 -0.265 0 N-CA-C 108.771 -0.826 . . . . 1.0 108.771 179.501 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 40' ' ' PRO . . . . . 0.458 ' HG2' ' H ' ' A' ' 41' ' ' ALA . 57.1 Cg_endo -72.22 -82.73 0.01 OUTLIER 'Trans proline' 0 C--N 1.306 -1.699 0 C-N-CA 121.708 1.605 . . . . 1.0 112.551 -179.363 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . 0.458 ' H ' ' HG2' ' A' ' 40' ' ' PRO . . . -78.34 124.11 27.74 Favored 'General case' 0 C--N 1.311 -1.074 0 CA-C-N 114.436 -1.256 . . . . 1.0 111.686 -176.7 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . 0.699 ' C ' ' H ' ' A' ' 44' ' ' GLY . 13.6 ptt180 -170.9 169.71 6.66 Favored 'General case' 0 C--N 1.313 -0.981 0 CA-C-N 114.634 -1.167 . . . . 1.0 109.696 178.786 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 7.2 tpt180 -61.65 18.04 0.01 OUTLIER 'General case' 0 C--N 1.322 -0.608 0 C-N-CA 120.568 -0.453 . . . . 1.0 109.957 178.321 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . 0.699 ' H ' ' C ' ' A' ' 42' ' ' ARG . . . 82.98 -24.83 5.04 Favored Glycine 0 N--CA 1.446 -0.634 0 N-CA-C 110.506 -1.038 . . . . 1.0 110.506 -179.658 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . 0.759 ' O ' ' CG ' ' A' ' 46' ' ' PHE . 0.2 OUTLIER -164.5 172.82 12.81 Favored 'General case' 0 C--O 1.221 -0.403 0 C-N-CA 121.101 -0.24 . . . . 1.0 110.656 -179.553 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 46' ' ' PHE . . . . . 0.759 ' CG ' ' O ' ' A' ' 45' ' ' PHE . 22.0 m-30 127.1 90.41 0.0 OUTLIER 'General case' 0 N--CA 1.484 1.256 0 O-C-N 125.534 1.771 . . . . 1.0 111.688 179.391 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 47' ' ' ARG . . . . . 0.721 ' O ' ' SG ' ' A' ' 48' ' ' CYS . 2.2 ptm180 121.09 156.49 0.0 OUTLIER 'General case' 0 N--CA 1.477 0.895 0 O-C-N 125.449 1.718 . . . . 1.0 109.187 179.355 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 48' ' ' CYS . . . . . 0.781 ' SG ' ' H62' ' A' ' 129' ' ' MTN . 2.0 p 67.74 68.85 0.36 Allowed 'General case' 0 CA--C 1.532 0.284 0 CA-C-O 121.897 0.856 . . . . 1.0 109.523 -179.156 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -142.91 151.84 57.31 Favored Pre-proline 0 CA--C 1.534 0.361 0 N-CA-C 108.297 -1.001 . . . . 1.0 108.297 179.864 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 89.3 Cg_endo -77.31 69.9 6.98 Favored 'Trans proline' 0 C--N 1.308 -1.58 0 C-N-CA 122.015 1.81 . . . . 1.0 112.608 -179.728 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 5.4 tp10 64.68 26.93 13.19 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 120.697 0.284 . . . . 1.0 111.462 179.198 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -102.28 138.92 38.57 Favored 'General case' 0 N--CA 1.466 0.373 0 CA-C-N 116.474 -0.33 . . . . 1.0 110.262 179.066 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . 0.445 ' O ' ' N ' ' A' ' 55' ' ' ILE . 19.6 tt -66.61 139.64 20.8 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.251 0 CA-C-O 121.423 0.63 . . . . 1.0 110.718 179.553 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 4.2 pt20 -63.41 80.41 0.02 OUTLIER 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 114.781 -1.1 . . . . 1.0 109.586 -178.458 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . 0.445 ' N ' ' O ' ' A' ' 53' ' ' ILE . 1.8 tt -148.03 156.89 8.9 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.415 0 N-CA-C 109.902 -0.407 . . . . 1.0 109.902 178.242 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 113.57 -4.67 24.69 Favored Glycine 0 N--CA 1.467 0.705 0 N-CA-C 110.606 -0.998 . . . . 1.0 110.606 -179.765 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 14.8 p-10 -79.36 96.48 6.01 Favored 'General case' 0 C--N 1.325 -0.464 0 N-CA-C 109.318 -0.623 . . . . 1.0 109.318 177.625 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 58' ' ' TRP . . . . . 0.519 ' CE3' ' NH1' ' A' ' 59' ' ' ARG . 0.8 OUTLIER -86.54 176.36 7.86 Favored 'General case' 0 N--CA 1.467 0.421 0 CA-C-O 122.229 1.014 . . . . 1.0 112.647 -178.37 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 59' ' ' ARG . . . . . 0.519 ' NH1' ' CE3' ' A' ' 58' ' ' TRP . 0.0 OUTLIER -87.29 -56.28 3.43 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 113.326 -1.761 . . . . 1.0 112.388 -179.394 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 73.6 t80 -93.81 -16.86 23.7 Favored 'General case' 0 C--O 1.249 1.044 0 CA-C-O 121.813 0.816 . . . . 1.0 113.153 -179.112 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . 0.459 ' O ' ' N ' ' A' ' 65' ' ' ASP . 6.5 tt0 -78.79 -13.23 59.92 Favored 'General case' 0 N--CA 1.444 -0.766 0 O-C-N 121.418 -0.801 . . . . 1.0 111.516 -178.24 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . 0.596 ' O ' ' N ' ' A' ' 66' ' ' GLY . 0.0 OUTLIER -47.8 -55.63 2.38 Favored 'Isoleucine or valine' 0 C--O 1.208 -1.11 0 C-N-CA 119.244 -0.983 . . . . 1.0 109.589 -175.559 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -65.01 -52.42 56.19 Favored 'General case' 0 C--N 1.31 -1.136 0 C-N-CA 119.335 -0.946 . . . . 1.0 109.192 -179.984 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 64' ' ' HIS . . . . . 0.504 ' O ' ' HB2' ' A' ' 67' ' ' ARG . 6.0 t-80 -50.78 -57.78 7.54 Favored 'General case' 0 CA--C 1.536 0.43 0 C-N-CA 119.463 -0.895 . . . . 1.0 109.894 -179.534 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . 0.577 ' O ' ' ND2' ' A' ' 75' ' ' ASN . 3.3 t0 -70.1 -47.05 63.46 Favored 'General case' 0 C--N 1.314 -0.963 0 CA-C-O 122.065 0.935 . . . . 1.0 110.303 179.188 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . 0.596 ' N ' ' O ' ' A' ' 62' ' ' VAL . . . -70.13 28.25 0.43 Allowed Glycine 0 C--N 1.316 -0.572 0 O-C-N 121.47 -0.769 . . . . 1.0 111.642 179.725 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 67' ' ' ARG . . . . . 0.557 ' H ' ' C ' ' A' ' 65' ' ' ASP . 0.0 OUTLIER -81.25 -3.01 51.08 Favored 'General case' 0 C--N 1.319 -0.755 0 N-CA-C 107.964 -1.124 . . . . 1.0 107.964 176.559 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . 0.417 ' O ' ' HB3' ' A' ' 72' ' ' HIS . 8.7 tp -42.25 -31.67 0.42 Allowed 'General case' 0 C--O 1.216 -0.679 0 CA-C-N 115.567 -0.742 . . . . 1.0 109.495 -179.904 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 3.8 tt -67.83 -68.66 0.37 Allowed 'General case' 0 CA--C 1.54 0.581 0 C-N-CA 118.434 -1.306 . . . . 1.0 112.877 -177.347 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . 0.572 ' C ' ' H ' ' A' ' 72' ' ' HIS . . . -74.58 -84.36 0.05 OUTLIER 'General case' 0 N--CA 1.47 0.563 0 C-N-CA 116.757 -1.977 . . . . 1.0 109.03 -176.426 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . 0.884 ' O ' ' N ' ' A' ' 73' ' ' MET . . . -56.37 16.28 0.0 OUTLIER 'General case' 0 C--N 1.308 -1.233 0 C-N-CA 124.993 1.317 . . . . 1.0 113.588 -179.738 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 72' ' ' HIS . . . . . 0.572 ' H ' ' C ' ' A' ' 70' ' ' ALA . 0.0 OUTLIER -17.92 -29.32 0.0 OUTLIER 'General case' 0 N--CA 1.473 0.676 0 N-CA-C 112.758 0.651 . . . . 1.0 112.758 -175.048 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 73' ' ' MET . . . . . 0.884 ' N ' ' O ' ' A' ' 71' ' ' ALA . 19.0 mmt -64.81 -56.59 12.59 Favored 'General case' 0 N--CA 1.446 -0.646 0 C-N-CA 119.667 -0.813 . . . . 1.0 108.84 176.4 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . 0.665 ' O ' ' N ' ' A' ' 76' ' ' GLY . 34.8 m -43.96 -50.97 1.62 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.821 0 CA-C-O 117.814 -1.089 . . . . 1.0 111.565 -174.815 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 75' ' ' ASN . . . . . 0.577 ' ND2' ' O ' ' A' ' 65' ' ' ASP . 2.0 t-20 -36.42 -18.24 0.0 OUTLIER 'General case' 0 N--CA 1.47 0.533 0 CA-C-N 121.042 1.746 . . . . 1.0 112.299 -179.831 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . 0.665 ' N ' ' O ' ' A' ' 74' ' ' VAL . . . -47.72 -28.19 5.1 Favored Glycine 0 CA--C 1.537 1.437 0 N-CA-C 109.16 -1.576 . . . . 1.0 109.16 177.681 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . 0.612 ' HA ' ' HB3' ' A' ' 80' ' ' ALA . 6.9 pt -69.29 -51.77 39.7 Favored 'Isoleucine or valine' 0 C--O 1.21 -1.009 0 CA-C-O 122.114 0.959 . . . . 1.0 108.828 -179.967 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . 0.484 ' C ' ' O ' ' A' ' 77' ' ' ILE . 77.0 t -36.25 -33.12 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.313 -0.979 0 CA-C-N 113.003 -1.908 . . . . 1.0 107.292 -176.701 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . 0.624 ' O ' ' HB3' ' A' ' 83' ' ' ALA . 0.7 OUTLIER -96.77 -31.68 4.02 Favored 'Isoleucine or valine' 0 C--O 1.213 -0.842 0 CA-C-N 115.606 -0.724 . . . . 1.0 110.938 176.653 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 80' ' ' ALA . . . . . 0.612 ' HB3' ' HA ' ' A' ' 77' ' ' ILE . . . -82.45 -8.78 59.61 Favored 'General case' 0 N--CA 1.473 0.68 0 N-CA-C 112.521 0.563 . . . . 1.0 112.521 179.367 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . 0.806 ' O ' HD21 ' A' ' 84' ' ' LEU . 7.6 mm-40 -91.15 -72.69 0.57 Allowed 'General case' 0 N--CA 1.439 -0.982 0 O-C-N 122.036 -0.415 . . . . 1.0 112.018 -178.258 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 8.3 t70 -92.68 -14.4 28.12 Favored 'General case' 0 C--N 1.346 0.423 0 N-CA-C 115.024 1.49 . . . . 1.0 115.024 -178.89 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . 0.624 ' HB3' ' O ' ' A' ' 79' ' ' ILE . . . -54.26 -44.8 72.14 Favored 'General case' 0 CA--C 1.54 0.595 0 C-N-CA 118.464 -1.294 . . . . 1.0 112.894 -177.505 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . 1.019 ' H ' HD13 ' A' ' 84' ' ' LEU . 0.0 OUTLIER -42.75 -14.74 0.01 OUTLIER 'General case' 0 N--CA 1.474 0.752 0 CA-C-N 119.018 0.826 . . . . 1.0 111.079 -177.682 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 85' ' ' ILE . . . . . 0.583 ' N ' ' O ' ' A' ' 83' ' ' ALA . 3.5 mm -94.04 -29.81 4.27 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.25 0 C-N-CA 120.674 -0.41 . . . . 1.0 110.223 179.056 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . 0.672 ' C ' ' H ' ' A' ' 88' ' ' ALA . . . -93.02 -24.24 18.4 Favored 'General case' 0 CA--C 1.522 -0.125 0 CA-C-O 121.513 0.673 . . . . 1.0 109.732 179.26 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 20.3 tt0 -63.82 25.85 0.01 OUTLIER 'General case' 0 C--N 1.32 -0.714 0 CA-C-O 121.491 0.662 . . . . 1.0 110.474 -179.036 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . 0.672 ' H ' ' C ' ' A' ' 86' ' ' ALA . . . -123.31 -7.31 8.19 Favored 'General case' 0 N--CA 1.474 0.766 0 CA-C-O 122.207 1.004 . . . . 1.0 108.519 178.836 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 89' ' ' VAL . . . . . 0.498 HG23 ' O ' ' A' ' 86' ' ' ALA . 2.4 t -84.31 36.9 0.05 OUTLIER 'Isoleucine or valine' 0 C--O 1.216 -0.659 0 CA-C-N 112.77 -2.014 . . . . 1.0 109.172 178.383 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 90' ' ' GLY . . . . . 0.513 ' N ' ' CD ' ' A' ' 91' ' ' PRO . . . -74.26 -40.52 40.98 Favored Glycine 0 C--N 1.345 1.052 0 C-N-CA 120.504 -0.855 . . . . 1.0 111.382 179.57 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 91' ' ' PRO . . . . . 0.513 ' CD ' ' N ' ' A' ' 90' ' ' GLY . 98.3 Cg_exo -43.51 -21.64 0.31 Allowed 'Trans proline' 0 N--CA 1.497 1.698 0 CA-C-N 119.572 1.686 . . . . 1.0 109.788 -179.701 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 92' ' ' HIS . . . . . 0.799 ' O ' ' N ' ' A' ' 96' ' ' ALA . 0.3 OUTLIER -55.34 -18.4 6.49 Favored 'General case' 0 C--O 1.194 -1.832 0 N-CA-C 107.167 -1.42 . . . . 1.0 107.167 179.897 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . 0.656 HD12 ' N ' ' A' ' 94' ' ' ALA . 2.8 pp -51.01 -53.66 31.45 Favored 'General case' 0 CA--C 1.541 0.612 0 N-CA-C 108.669 -0.863 . . . . 1.0 108.669 178.556 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 94' ' ' ALA . . . . . 0.656 ' N ' HD12 ' A' ' 93' ' ' LEU . . . -52.23 -44.87 65.06 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-N 114.521 -1.218 . . . . 1.0 108.972 -179.279 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 95' ' ' ARG . . . . . 0.579 ' C ' ' H ' ' A' ' 97' ' ' LEU . 0.0 OUTLIER -78.18 -49.87 13.01 Favored 'General case' 0 CA--C 1.553 1.077 0 CA-C-O 125.921 2.772 . . . . 1.0 109.142 178.619 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 96' ' ' ALA . . . . . 0.799 ' N ' ' O ' ' A' ' 92' ' ' HIS . . . -68.49 28.0 0.03 OUTLIER 'General case' 0 C--N 1.259 -3.335 0 CA-C-N 112.901 -1.954 . . . . 1.0 107.264 173.028 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . 1.034 HD13 ' H ' ' A' ' 98' ' ' GLY . 0.0 OUTLIER -43.71 -46.34 7.45 Favored 'General case' 0 C--O 1.202 -1.444 0 N-CA-C 108.861 -0.792 . . . . 1.0 108.861 178.64 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 98' ' ' GLY . . . . . 1.034 ' H ' HD13 ' A' ' 97' ' ' LEU . . . -49.22 -28.2 8.32 Favored Glycine 0 CA--C 1.5 -0.891 0 N-CA-C 107.867 -2.093 . . . . 1.0 107.867 -179.862 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 99' ' ' GLN . . . . . 0.661 ' O ' ' S1 ' ' A' ' 130' ' ' MTN . 0.0 OUTLIER -59.41 -22.19 61.05 Favored 'General case' 0 C--O 1.216 -0.7 0 N-CA-C 106.693 -1.595 . . . . 1.0 106.693 176.811 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 100' ' ' ILE . . . . . 0.744 ' N ' ' O ' ' A' ' 97' ' ' LEU . 6.1 mm -67.68 -51.55 49.73 Favored 'Isoleucine or valine' 0 C--O 1.207 -1.155 0 CA-C-N 115.387 -0.824 . . . . 1.0 110.045 178.704 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 101' ' ' VAL . . . . . 0.698 ' O ' ' N ' ' A' ' 105' ' ' GLY . 0.4 OUTLIER -52.87 -61.06 0.89 Allowed 'Isoleucine or valine' 0 C--O 1.213 -0.835 0 C-N-CA 119.085 -1.046 . . . . 1.0 110.412 -178.296 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 102' ' ' CYS . . . . . 0.878 ' O ' ' HB2' ' A' ' 106' ' ' ALA . 1.4 p -56.06 -21.77 23.74 Favored 'General case' 0 C--N 1.316 -0.881 0 C-N-CA 118.942 -1.103 . . . . 1.0 110.062 -176.98 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -84.51 -53.89 5.12 Favored 'General case' 0 N--CA 1.481 1.082 0 O-C-N 124.339 1.025 . . . . 1.0 112.399 178.888 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 104' ' ' TYR . . . . . . . . . . . . . 17.9 t80 -96.37 21.18 9.41 Favored 'General case' 0 C--N 1.309 -1.19 0 C-N-CA 126.44 1.896 . . . . 1.0 108.753 178.636 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 105' ' ' GLY . . . . . 0.698 ' N ' ' O ' ' A' ' 101' ' ' VAL . . . -153.62 -96.49 0.13 Allowed Glycine 0 C--N 1.335 0.492 0 N-CA-C 107.893 -2.083 . . . . 1.0 107.893 178.926 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 106' ' ' ALA . . . . . 0.878 ' HB2' ' O ' ' A' ' 102' ' ' CYS . . . 67.2 109.37 0.04 OUTLIER 'General case' 0 CA--C 1.541 0.622 0 O-C-N 122.988 -0.125 . . . . 1.0 111.297 -178.976 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 107' ' ' THR . . . . . 0.65 ' C ' ' H ' ' A' ' 109' ' ' ILE . 0.3 OUTLIER -134.66 -63.69 0.7 Allowed 'General case' 0 C--N 1.353 0.731 0 N-CA-C 105.932 -1.877 . . . . 1.0 105.932 176.926 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 26.9 m -67.16 23.61 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.324 -0.519 0 O-C-N 121.657 -0.652 . . . . 1.0 109.453 179.686 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 109' ' ' ILE . . . . . 0.713 ' H ' ' HD2' ' A' ' 110' ' ' PRO . 0.1 OUTLIER -115.5 -57.09 0.04 OUTLIER Pre-proline 0 CA--C 1.552 1.032 0 N-CA-C 108.278 -1.008 . . . . 1.0 108.278 175.79 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 110' ' ' PRO . . . . . 0.713 ' HD2' ' H ' ' A' ' 109' ' ' ILE . 18.6 Cg_endo -53.82 -39.46 84.05 Favored 'Trans proline' 0 N--CA 1.506 2.237 0 C-N-CA 122.673 2.249 . . . . 1.0 112.046 177.584 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 111' ' ' ASN . . . . . 0.447 ' C ' ' N ' ' A' ' 113' ' ' ASN . 39.3 t30 -67.68 -67.62 0.45 Allowed 'General case' 0 C--O 1.238 0.45 0 C-N-CA 119.91 -0.716 . . . . 1.0 110.463 -178.342 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 112' ' ' ILE . . . . . 0.647 ' C ' HD12 ' A' ' 112' ' ' ILE . 1.4 pp -52.88 -21.45 3.11 Favored 'Isoleucine or valine' 0 C--O 1.212 -0.87 0 CA-C-O 121.998 0.904 . . . . 1.0 108.647 -179.924 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 113' ' ' ASN . . . . . 0.447 ' N ' ' C ' ' A' ' 111' ' ' ASN . 0.0 OUTLIER -60.58 -52.82 63.52 Favored 'General case' 0 C--N 1.311 -1.093 0 CA-C-N 112.698 -2.046 . . . . 1.0 108.813 -179.894 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -58.18 -28.83 65.13 Favored 'General case' 0 N--CA 1.455 -0.194 0 CA-C-N 119.01 0.823 . . . . 1.0 111.48 179.226 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 115' ' ' ALA . . . . . 0.555 ' O ' ' N ' ' A' ' 118' ' ' VAL . . . -81.1 -52.06 7.8 Favored 'General case' 0 C--O 1.219 -0.53 0 N-CA-C 109.108 -0.701 . . . . 1.0 109.108 177.552 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 116' ' ' ILE . . . . . 0.454 HD13 HD13 ' A' ' 112' ' ' ILE . 1.2 tp -42.13 -49.7 0.96 Allowed 'Isoleucine or valine' 0 N--CA 1.478 0.943 0 N-CA-C 105.611 -1.996 . . . . 1.0 105.611 179.766 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 117' ' ' GLU . . . . . 0.471 ' O ' ' HA ' ' A' ' 121' ' ' THR . 62.7 mt-10 -45.1 -57.53 3.82 Favored 'General case' 0 C--N 1.312 -1.036 0 CA-C-N 110.493 -3.049 . . . . 1.0 105.857 178.341 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 118' ' ' VAL . . . . . 0.555 ' N ' ' O ' ' A' ' 115' ' ' ALA . 54.9 t -68.15 -57.13 10.22 Favored 'Isoleucine or valine' 0 CA--C 1.551 1.004 0 C-N-CA 120.684 -0.406 . . . . 1.0 111.046 178.042 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 119' ' ' LEU . . . . . 0.506 ' N ' ' O ' ' A' ' 115' ' ' ALA . 59.2 tp -52.77 -19.85 2.77 Favored 'General case' 0 CA--C 1.538 0.492 0 N-CA-C 113.78 1.03 . . . . 1.0 113.78 -178.666 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 120' ' ' GLY . . . . . 0.607 ' O ' ' OG1' ' A' ' 121' ' ' THR . . . -127.3 -73.81 0.19 Allowed Glycine 0 CA--C 1.547 2.076 0 N-CA-C 106.535 -2.626 . . . . 1.0 106.535 172.719 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 121' ' ' THR . . . . . 0.607 ' OG1' ' O ' ' A' ' 120' ' ' GLY . 17.6 m 161.9 -44.62 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.772 0 CA-C-N 112.686 -1.757 . . . . 1.0 112.796 179.444 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 122' ' ' GLY . . . . . 0.68 ' O ' ' N ' ' A' ' 124' ' ' ASP . . . 104.76 -15.22 49.07 Favored Glycine 0 N--CA 1.471 0.985 0 N-CA-C 108.282 -1.927 . . . . 1.0 108.282 -175.98 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 123' ' ' THR . . . . . 0.689 HG23 ' O ' ' A' ' 123' ' ' THR . 8.4 t -56.95 81.11 0.01 OUTLIER 'General case' 0 N--CA 1.469 0.511 0 N-CA-C 104.615 -2.365 . . . . 1.0 104.615 178.438 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 124' ' ' ASP . . . . . 0.68 ' N ' ' O ' ' A' ' 122' ' ' GLY . 28.6 m-20 -166.93 178.37 5.83 Favored 'General case' 0 N--CA 1.465 0.307 0 CA-C-N 113.464 -1.698 . . . . 1.0 111.552 179.815 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 125' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -142.06 143.07 32.93 Favored 'General case' 0 CA--C 1.54 0.564 0 N-CA-C 108.086 -1.079 . . . . 1.0 108.086 175.766 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 3.0 tpm_? -147.43 146.02 29.42 Favored 'General case' 0 C--N 1.332 -0.185 0 N-CA-C 110.049 -0.352 . . . . 1.0 110.049 179.43 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 127' ' ' PHE . . . . . . . . . . . . . 1.5 t80 . . . . . 0 C--O 1.221 -0.411 0 CA-C-O 117.94 -1.028 . . . . 1.0 109.528 179.498 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 128' ' ' MTN . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 129' ' ' MTN . . . . . 0.781 ' H62' ' SG ' ' A' ' 48' ' ' CYS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 130' ' ' MTN . . . . . 0.661 ' S1 ' ' O ' ' A' ' 99' ' ' GLN . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 11.8 mtt . . . . . 0 N--CA 1.49 1.55 0 N-CA-C 108.918 -0.771 . . . . 1.0 108.918 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 93.1 p -90.12 3.64 52.76 Favored 'General case' 0 N--CA 1.464 0.238 0 CA-C-N 116.564 -0.289 . . . . 1.0 110.933 -179.555 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 2.1 t70 163.14 114.96 0.0 OUTLIER 'General case' 0 N--CA 1.465 0.296 0 O-C-N 123.675 0.609 . . . . 1.0 110.04 179.162 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 92.8 t80 -147.57 143.99 28.16 Favored 'General case' 0 CA--C 1.513 -0.446 0 N-CA-C 109.133 -0.691 . . . . 1.0 109.133 178.861 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 5' ' ' ASP . . . . . 0.44 ' HB2' ' N ' ' A' ' 10' ' ' SER . 1.0 OUTLIER -153.32 148.64 27.01 Favored 'General case' 0 C--N 1.326 -0.444 0 C-N-CA 120.557 -0.457 . . . . 1.0 110.512 -179.39 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 6' ' ' THR . . . . . 0.696 ' O ' ' N ' ' A' ' 10' ' ' SER . 0.2 OUTLIER -116.72 -152.7 0.51 Allowed 'General case' 0 C--O 1.209 -1.031 0 CA-C-O 121.425 0.631 . . . . 1.0 110.313 179.896 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . 0.579 ' OE1' ' N ' ' A' ' 8' ' ' ARG . 0.0 OUTLIER -59.34 -49.64 77.05 Favored 'General case' 0 C--N 1.309 -1.196 0 CA-C-O 121.872 0.844 . . . . 1.0 110.603 -177.895 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 8' ' ' ARG . . . . . 0.855 ' O ' ' HB3' ' A' ' 12' ' ' ALA . 5.0 ptt180 -67.35 -57.79 5.98 Favored 'General case' 0 C--N 1.302 -1.487 0 C-N-CA 118.725 -1.19 . . . . 1.0 108.759 178.43 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . 0.55 ' O ' HG12 ' A' ' 13' ' ' VAL . 6.7 t -66.08 -53.45 37.27 Favored 'Isoleucine or valine' 0 C--O 1.197 -1.665 0 C-N-CA 119.219 -0.992 . . . . 1.0 111.427 -178.322 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . 0.696 ' N ' ' O ' ' A' ' 6' ' ' THR . 1.4 t -69.23 -62.46 1.37 Allowed 'General case' 0 C--N 1.309 -1.188 0 C-N-CA 119.363 -0.935 . . . . 1.0 111.974 -178.972 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 11' ' ' ARG . . . . . 0.597 ' O ' ' HB3' ' A' ' 15' ' ' ALA . 1.7 mmt180 -65.3 -45.55 83.96 Favored 'General case' 0 N--CA 1.474 0.74 0 N-CA-C 112.53 0.567 . . . . 1.0 112.53 -176.229 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . 0.855 ' HB3' ' O ' ' A' ' 8' ' ' ARG . . . -68.57 -55.59 11.12 Favored 'General case' 0 C--N 1.326 -0.45 0 C-N-CA 118.068 -1.453 . . . . 1.0 108.412 178.463 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . 0.642 ' O ' ' CB ' ' A' ' 17' ' ' LEU . 0.4 OUTLIER -62.44 -52.59 58.14 Favored 'Isoleucine or valine' 0 C--O 1.201 -1.471 0 C-N-CA 118.225 -1.39 . . . . 1.0 109.145 -179.264 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . 0.734 ' O ' HG22 ' A' ' 18' ' ' VAL . . . -61.05 -61.35 2.64 Favored 'General case' 0 C--N 1.314 -0.978 0 C-N-CA 117.177 -1.809 . . . . 1.0 110.429 179.929 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . 0.597 ' HB3' ' O ' ' A' ' 11' ' ' ARG . . . -54.17 -56.12 21.25 Favored 'General case' 0 N--CA 1.475 0.815 0 C-N-CA 119.268 -0.973 . . . . 1.0 110.141 -178.058 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . 0.623 ' HB3' ' O ' ' A' ' 12' ' ' ALA . . . -65.43 -55.71 16.49 Favored 'General case' 0 C--N 1.315 -0.909 0 C-N-CA 118.793 -1.163 . . . . 1.0 110.364 -179.271 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . 0.642 ' CB ' ' O ' ' A' ' 13' ' ' VAL . 10.8 tp -57.16 -56.14 25.58 Favored 'General case' 0 N--CA 1.485 1.293 0 C-N-CA 119.341 -0.944 . . . . 1.0 108.665 -178.184 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . 0.734 HG22 ' O ' ' A' ' 14' ' ' ALA . 1.3 m -71.68 -57.75 6.7 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.571 0 C-N-CA 119.519 -0.872 . . . . 1.0 110.557 -179.711 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . 0.53 ' N ' ' O ' ' A' ' 15' ' ' ALA . . . -62.9 -163.33 0.38 Allowed Glycine 0 CA--C 1.522 0.503 0 N-CA-C 111.748 -0.541 . . . . 1.0 111.748 -178.041 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' PRO . . . . . 0.601 ' O ' ' N ' ' A' ' 24' ' ' ALA . 69.3 Cg_endo -80.51 -21.91 7.09 Favored 'Trans proline' 0 C--N 1.304 -1.797 0 C-N-CA 122.419 2.079 . . . . 1.0 114.472 -178.044 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -60.66 -61.04 7.48 Favored Glycine 0 N--CA 1.476 1.326 0 C-N-CA 118.945 -1.598 . . . . 1.0 111.489 -177.165 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . 0.607 ' H ' ' CA ' ' A' ' 16' ' ' ALA . . . -59.63 -54.65 35.9 Favored Glycine 0 N--CA 1.466 0.66 0 N-CA-C 107.903 -2.079 . . . . 1.0 107.903 179.674 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . 0.605 ' O ' HG12 ' A' ' 27' ' ' VAL . 85.0 t -56.57 -34.15 41.27 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 C-N-CA 119.46 -0.896 . . . . 1.0 109.411 -179.273 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . 0.601 ' N ' ' O ' ' A' ' 20' ' ' PRO . . . -64.65 -61.35 2.25 Favored 'General case' 0 N--CA 1.47 0.533 0 C-N-CA 118.879 -1.129 . . . . 1.0 110.341 179.314 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 13.4 tp -61.05 -49.45 77.33 Favored 'General case' 0 CA--C 1.519 -0.219 0 C-N-CA 120.049 -0.66 . . . . 1.0 112.119 -177.015 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 70.0 t -59.18 -60.05 2.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 C-N-CA 119.095 -1.042 . . . . 1.0 110.476 -177.521 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . 0.72 ' O ' ' HB3' ' A' ' 31' ' ' ALA . 1.4 p -59.54 -38.46 75.48 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 C-N-CA 120.406 -0.517 . . . . 1.0 111.709 -177.163 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 88.5 tttt -69.28 -55.81 9.4 Favored 'General case' 0 C--N 1.317 -0.847 0 C-N-CA 120.161 -0.616 . . . . 1.0 110.113 -179.174 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 53.8 t -66.25 -52.09 51.55 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.619 0 CA-C-N 115.318 -0.855 . . . . 1.0 111.633 -176.499 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 30' ' ' CYS . . . . . . . . . . . . . 49.4 t -66.55 -60.79 2.4 Favored 'General case' 0 N--CA 1.445 -0.723 0 C-N-CA 118.761 -1.175 . . . . 1.0 110.589 -178.086 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . 0.72 ' HB3' ' O ' ' A' ' 27' ' ' VAL . . . -64.5 -49.97 69.24 Favored 'General case' 0 CA--C 1.513 -0.463 0 C-N-CA 120.691 -0.404 . . . . 1.0 111.78 -175.627 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . 0.512 ' O ' ' CB ' ' A' ' 33' ' ' LEU . . . 77.78 62.57 2.35 Favored Glycine 0 N--CA 1.447 -0.622 0 N-CA-C 107.923 -2.071 . . . . 1.0 107.923 -177.492 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . 0.512 ' CB ' ' O ' ' A' ' 32' ' ' GLY . 9.8 tp 90.32 94.43 0.03 OUTLIER Pre-proline 0 CA--C 1.541 0.625 0 CA-C-N 115.093 -0.553 . . . . 1.0 110.076 -179.064 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 59.4 Cg_endo -74.15 -11.27 23.13 Favored 'Trans proline' 0 N--CA 1.495 1.61 0 C-N-CA 122.012 1.808 . . . . 1.0 112.56 -179.212 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -58.04 -60.81 8.27 Favored Glycine 0 CA--C 1.534 1.235 0 C-N-CA 118.834 -1.65 . . . . 1.0 109.401 -178.847 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . 0.638 ' O ' HG22 ' A' ' 37' ' ' ILE . 1.6 m -90.19 176.4 0.66 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.47 0 N-CA-C 106.496 -1.668 . . . . 1.0 106.496 176.676 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . 0.638 HG22 ' O ' ' A' ' 36' ' ' VAL . 9.5 tt 107.72 115.49 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.481 1.089 0 O-C-N 124.787 1.304 . . . . 1.0 110.234 179.564 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 76.6 m80 -143.62 136.91 27.91 Favored 'General case' 0 C--O 1.231 0.093 0 CA-C-O 120.862 0.363 . . . . 1.0 110.024 179.995 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -106.93 118.62 53.67 Favored Pre-proline 0 CA--C 1.535 0.399 0 N-CA-C 109.17 -0.678 . . . . 1.0 109.17 179.167 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 65.8 Cg_exo -47.13 -24.22 3.37 Favored 'Trans proline' 0 N--CA 1.493 1.483 0 C-N-CA 121.629 1.553 . . . . 1.0 113.549 -179.403 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -127.94 135.95 50.66 Favored 'General case' 0 N--CA 1.467 0.377 0 CA-C-O 119.911 -0.09 . . . . 1.0 110.824 179.013 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . 0.718 ' C ' ' H ' ' A' ' 44' ' ' GLY . 14.0 ptm180 -167.16 166.42 14.97 Favored 'General case' 0 C--N 1.319 -0.726 0 C-N-CA 120.015 -0.674 . . . . 1.0 110.485 178.226 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 43' ' ' ARG . . . . . 0.649 ' C ' ' H ' ' A' ' 45' ' ' PHE . 25.6 tpt180 -62.13 22.54 0.01 OUTLIER 'General case' 0 CA--C 1.545 0.769 0 CA-C-O 121.63 0.728 . . . . 1.0 109.826 -179.92 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . 0.718 ' H ' ' C ' ' A' ' 42' ' ' ARG . . . 66.85 -30.28 0.18 Allowed Glycine 0 C--N 1.337 0.599 0 N-CA-C 110.663 -0.975 . . . . 1.0 110.663 179.125 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . 0.649 ' H ' ' C ' ' A' ' 43' ' ' ARG . 0.7 OUTLIER -166.43 173.12 10.22 Favored 'General case' 0 N--CA 1.446 -0.649 0 N-CA-C 108.939 -0.763 . . . . 1.0 108.939 -179.194 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 46' ' ' PHE . . . . . 0.547 ' CB ' ' O ' ' A' ' 45' ' ' PHE . 6.8 t80 110.4 106.67 0.0 OUTLIER 'General case' 0 N--CA 1.48 1.053 0 O-C-N 125.278 1.611 . . . . 1.0 109.495 179.555 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 47' ' ' ARG . . . . . 1.085 ' HE ' ' H91' ' A' ' 128' ' ' MTN . 2.5 ptm180 102.67 150.61 0.01 OUTLIER 'General case' 0 N--CA 1.48 1.03 0 O-C-N 125.012 1.445 . . . . 1.0 110.695 -179.452 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 48' ' ' CYS . . . . . 0.807 ' O ' ' H62' ' A' ' 129' ' ' MTN . 37.5 t 60.84 67.49 0.81 Allowed 'General case' 0 CA--C 1.509 -0.619 0 N-CA-C 108.256 -1.016 . . . . 1.0 108.256 179.453 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 49' ' ' ASN . . . . . 0.526 ' O ' ' N ' ' A' ' 51' ' ' GLU . 0.5 OUTLIER -130.73 160.97 63.94 Favored Pre-proline 0 C--N 1.327 -0.395 0 CA-C-N 115.892 -0.595 . . . . 1.0 109.912 -178.842 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . 0.565 ' HG3' HH21 ' A' ' 52' ' ' ARG . 17.9 Cg_endo -62.12 52.59 0.11 Allowed 'Trans proline' 0 N--CA 1.494 1.557 0 C-N-CA 123.049 2.5 . . . . 1.0 112.061 179.394 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . 0.526 ' N ' ' O ' ' A' ' 49' ' ' ASN . 1.4 pm0 29.72 44.38 0.02 OUTLIER 'General case' 0 N--CA 1.471 0.599 0 CA-C-N 115.991 -0.549 . . . . 1.0 112.355 179.64 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . 0.569 ' HD2' ' HB1' ' A' ' 86' ' ' ALA . 75.5 mtm180 -122.85 141.56 51.74 Favored 'General case' 0 N--CA 1.476 0.846 0 N-CA-C 109.86 -0.422 . . . . 1.0 109.86 178.808 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 8.8 tp -37.66 135.68 0.24 Allowed 'Isoleucine or valine' 0 CA--C 1.53 0.179 0 CA-C-O 122.666 1.222 . . . . 1.0 112.745 -174.923 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -92.03 77.29 5.38 Favored 'General case' 0 C--N 1.339 0.121 0 CA-C-N 112.589 -2.096 . . . . 1.0 113.076 -177.899 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 3.8 tp -144.26 150.33 16.78 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.365 0 N-CA-C 108.471 -0.937 . . . . 1.0 108.471 176.82 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 104.27 2.29 44.6 Favored Glycine 0 CA--C 1.527 0.806 0 N-CA-C 109.495 -1.442 . . . . 1.0 109.495 -179.056 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . 0.443 ' CG ' ' CE2' ' A' ' 45' ' ' PHE . 22.6 m-20 -86.13 107.07 17.68 Favored 'General case' 0 CA--C 1.538 0.516 0 N-CA-C 113.032 0.753 . . . . 1.0 113.032 -178.69 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 58' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -80.56 178.74 8.13 Favored 'General case' 0 N--CA 1.469 0.515 0 CA-C-N 114.387 -1.279 . . . . 1.0 108.324 177.997 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 59' ' ' ARG . . . . . 0.826 ' HE ' ' H ' ' A' ' 59' ' ' ARG . 0.0 OUTLIER -101.23 -54.2 2.84 Favored 'General case' 0 CA--C 1.545 0.755 0 CA-C-N 119.246 0.93 . . . . 1.0 110.576 178.295 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -79.19 -13.26 59.81 Favored 'General case' 0 N--CA 1.482 1.151 0 CA-C-N 114.52 -1.218 . . . . 1.0 111.3 -178.914 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . 0.413 ' O ' ' N ' ' A' ' 65' ' ' ASP . 42.5 tt0 -69.25 -13.92 62.67 Favored 'General case' 0 C--N 1.303 -1.44 0 CA-C-N 115.124 -0.943 . . . . 1.0 108.459 179.11 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . 0.654 HG13 ' O ' ' A' ' 59' ' ' ARG . 11.6 m -44.59 -51.64 1.81 Allowed 'Isoleucine or valine' 0 C--N 1.317 -0.844 0 CA-C-N 115.787 -0.642 . . . . 1.0 110.516 -175.757 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 63' ' ' ALA . . . . . 0.626 ' O ' ' HG2' ' A' ' 67' ' ' ARG . . . -67.38 -47.28 70.81 Favored 'General case' 0 N--CA 1.423 -1.798 0 C-N-CA 119.608 -0.837 . . . . 1.0 109.028 179.871 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 64' ' ' HIS . . . . . 0.437 ' O ' ' CG ' ' A' ' 67' ' ' ARG . 0.2 OUTLIER -54.04 -59.59 4.45 Favored 'General case' 0 CA--C 1.542 0.649 0 CA-C-N 115.756 -0.657 . . . . 1.0 110.301 179.612 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . 0.64 ' C ' ' H ' ' A' ' 67' ' ' ARG . 1.1 t70 -65.99 -52.24 51.21 Favored 'General case' 0 C--O 1.242 0.666 0 CA-C-O 121.658 0.742 . . . . 1.0 109.21 177.864 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . 0.498 ' N ' ' O ' ' A' ' 62' ' ' VAL . . . -64.27 29.18 0.1 OUTLIER Glycine 0 CA--C 1.53 1.031 0 N-CA-C 110.979 -0.849 . . . . 1.0 110.979 178.002 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 67' ' ' ARG . . . . . 0.64 ' H ' ' C ' ' A' ' 65' ' ' ASP . 5.5 mmm180 -78.9 -4.18 48.43 Favored 'General case' 0 C--N 1.323 -0.566 0 N-CA-C 108.056 -1.09 . . . . 1.0 108.056 175.836 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . 0.456 ' C ' ' O ' ' A' ' 67' ' ' ARG . 0.6 OUTLIER -35.45 -29.16 0.01 OUTLIER 'General case' 0 N--CA 1.48 1.075 0 N-CA-C 108.033 -1.099 . . . . 1.0 108.033 -177.298 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . 0.576 ' N ' ' O ' ' A' ' 67' ' ' ARG . 8.4 tt -62.83 -64.86 0.79 Allowed 'General case' 0 C--N 1.313 -1.02 0 N-CA-C 106.914 -1.513 . . . . 1.0 106.914 177.224 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . 0.621 ' C ' ' H ' ' A' ' 72' ' ' HIS . . . -76.96 -71.43 0.4 Allowed 'General case' 0 N--CA 1.467 0.388 0 N-CA-C 106.642 -1.614 . . . . 1.0 106.642 177.187 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . 0.531 ' O ' ' C ' ' A' ' 72' ' ' HIS . . . -45.07 0.39 0.0 OUTLIER 'General case' 0 N--CA 1.475 0.775 0 C-N-CA 124.188 0.995 . . . . 1.0 113.404 178.384 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 72' ' ' HIS . . . . . 0.638 ' CG ' ' N ' ' A' ' 73' ' ' MET . 0.0 OUTLIER -22.09 -62.67 0.03 OUTLIER 'General case' 0 C--O 1.231 0.13 0 CA-C-N 117.951 0.342 . . . . 1.0 111.311 -176.142 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 73' ' ' MET . . . . . 0.638 ' N ' ' CG ' ' A' ' 72' ' ' HIS . 31.6 ttm -75.54 -50.07 16.75 Favored 'General case' 0 C--N 1.319 -0.752 0 C-N-CA 118.881 -1.127 . . . . 1.0 109.667 177.823 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . 0.643 ' O ' ' N ' ' A' ' 76' ' ' GLY . 97.2 t -43.75 -46.18 1.89 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.375 0 CA-C-O 118.472 -0.775 . . . . 1.0 110.378 -175.434 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 75' ' ' ASN . . . . . 0.499 ' O ' ' N ' ' A' ' 77' ' ' ILE . 0.5 OUTLIER -36.81 -19.37 0.01 OUTLIER 'General case' 0 N--CA 1.487 1.414 0 CA-C-N 119.779 1.172 . . . . 1.0 111.356 179.232 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . 0.643 ' N ' ' O ' ' A' ' 74' ' ' VAL . . . -44.03 -19.58 0.13 Allowed Glycine 0 CA--C 1.544 1.855 0 N-CA-C 108.967 -1.653 . . . . 1.0 108.967 177.237 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . 0.666 ' O ' ' N ' ' A' ' 80' ' ' ALA . 12.2 pt -90.13 -51.45 11.95 Favored 'Isoleucine or valine' 0 C--N 1.346 0.433 0 N-CA-C 108.621 -0.881 . . . . 1.0 108.621 179.371 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . 0.465 ' C ' ' O ' ' A' ' 77' ' ' ILE . 42.3 t -34.86 -36.86 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.446 -0.642 0 N-CA-C 109.003 -0.74 . . . . 1.0 109.003 -177.796 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . 0.414 ' N ' ' O ' ' A' ' 77' ' ' ILE . 33.0 pt -90.44 -21.06 6.75 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.575 0 CA-C-N 116.159 -0.473 . . . . 1.0 111.934 179.788 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 80' ' ' ALA . . . . . 0.666 ' N ' ' O ' ' A' ' 77' ' ' ILE . . . -82.99 -7.31 59.68 Favored 'General case' 0 CA--C 1.536 0.404 0 C-N-CA 123.771 0.828 . . . . 1.0 111.244 177.102 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 3.7 mm-40 -74.0 -68.72 0.49 Allowed 'General case' 0 N--CA 1.452 -0.356 0 N-CA-C 108.771 -0.826 . . . . 1.0 108.771 178.444 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 82' ' ' ASP . . . . . 0.594 ' O ' ' N ' ' A' ' 84' ' ' LEU . 18.8 p-10 -59.23 -59.19 5.85 Favored 'General case' 0 CA--C 1.512 -0.511 0 C-N-CA 119.489 -0.884 . . . . 1.0 108.941 179.578 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . 0.535 ' C ' ' O ' ' A' ' 82' ' ' ASP . . . 3.35 -70.47 0.0 OUTLIER 'General case' 0 N--CA 1.486 1.365 0 O-C-N 124.469 1.105 . . . . 1.0 111.069 -179.913 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . 0.594 ' N ' ' O ' ' A' ' 82' ' ' ASP . 58.8 mt -26.78 -44.68 0.02 OUTLIER 'General case' 0 N--CA 1.474 0.746 0 CA-C-N 115.435 -0.802 . . . . 1.0 111.044 -176.64 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 85' ' ' ILE . . . . . 0.45 ' H ' HG13 ' A' ' 85' ' ' ILE . 1.3 pp -97.65 -49.5 11.84 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.293 0 N-CA-C 108.299 -1.0 . . . . 1.0 108.299 177.636 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . 0.692 ' C ' ' H ' ' A' ' 88' ' ' ALA . . . -44.45 -41.94 6.66 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 114.453 -1.249 . . . . 1.0 110.333 179.938 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 10.6 pt-20 -60.54 24.84 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.361 -0.381 . . . . 1.0 111.061 179.922 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . 0.692 ' H ' ' C ' ' A' ' 86' ' ' ALA . . . -122.76 -9.15 8.39 Favored 'General case' 0 N--CA 1.456 -0.173 0 CA-C-N 116.229 -0.441 . . . . 1.0 109.854 179.592 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 89' ' ' VAL . . . . . 0.509 HG23 ' O ' ' A' ' 89' ' ' VAL . 4.0 m -107.66 34.69 0.59 Allowed 'Isoleucine or valine' 0 C--O 1.224 -0.267 0 N-CA-C 109.093 -0.706 . . . . 1.0 109.093 179.377 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 90' ' ' GLY . . . . . 0.558 ' O ' ' N ' ' A' ' 92' ' ' HIS . . . -67.49 -40.42 91.09 Favored Glycine 0 CA--C 1.532 1.118 0 CA-C-O 119.616 -0.547 . . . . 1.0 111.957 179.16 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 91' ' ' PRO . . . . . 0.508 ' CD ' ' N ' ' A' ' 90' ' ' GLY . 80.4 Cg_exo -44.06 -13.19 0.05 OUTLIER 'Trans proline' 0 N--CA 1.494 1.549 0 C-N-CA 122.066 1.844 . . . . 1.0 111.483 179.294 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 92' ' ' HIS . . . . . 0.558 ' N ' ' O ' ' A' ' 90' ' ' GLY . 2.8 p80 -58.15 -17.13 16.39 Favored 'General case' 0 N--CA 1.44 -0.928 0 CA-C-N 115.676 -0.693 . . . . 1.0 109.201 179.396 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . 0.676 HD12 ' N ' ' A' ' 94' ' ' ALA . 1.5 pp -69.71 -59.18 3.11 Favored 'General case' 0 C--O 1.234 0.276 0 N-CA-C 109.759 -0.46 . . . . 1.0 109.759 178.993 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 94' ' ' ALA . . . . . 0.676 ' N ' HD12 ' A' ' 93' ' ' LEU . . . -55.87 -51.42 67.6 Favored 'General case' 0 CA--C 1.512 -0.508 0 N-CA-C 108.854 -0.795 . . . . 1.0 108.854 179.509 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 95' ' ' ARG . . . . . 0.657 ' O ' ' N ' ' A' ' 97' ' ' LEU . 7.1 mmm-85 -54.09 -59.02 5.2 Favored 'General case' 0 C--O 1.246 0.882 0 CA-C-O 122.985 1.374 . . . . 1.0 107.642 178.572 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 96' ' ' ALA . . . . . 0.77 ' O ' ' N ' ' A' ' 98' ' ' GLY . . . -46.33 -12.14 0.02 OUTLIER 'General case' 0 C--N 1.304 -1.375 0 O-C-N 119.524 -1.985 . . . . 1.0 111.556 -177.262 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . 0.657 ' N ' ' O ' ' A' ' 95' ' ' ARG . 0.3 OUTLIER 1.17 -53.76 0.0 OUTLIER 'General case' 0 N--CA 1.482 1.147 0 C-N-CA 124.246 1.018 . . . . 1.0 112.011 -169.101 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 98' ' ' GLY . . . . . 0.77 ' N ' ' O ' ' A' ' 96' ' ' ALA . . . -50.71 -23.27 6.58 Favored Glycine 0 C--N 1.3 -1.427 0 CA-C-N 121.905 2.138 . . . . 1.0 108.918 175.642 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 99' ' ' GLN . . . . . 0.615 ' HB2' ' HB1' ' A' ' 96' ' ' ALA . 9.4 tt0 -69.25 -24.07 63.94 Favored 'General case' 0 C--N 1.353 0.742 0 N-CA-C 107.872 -1.158 . . . . 1.0 107.872 178.011 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 100' ' ' ILE . . . . . 0.588 ' N ' ' O ' ' A' ' 97' ' ' LEU . 0.9 OUTLIER -63.6 -38.61 82.7 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.676 0 CA-C-N 114.471 -1.241 . . . . 1.0 108.895 178.442 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 101' ' ' VAL . . . . . 0.542 ' O ' ' N ' ' A' ' 105' ' ' GLY . 86.9 t -61.72 -60.01 3.39 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.199 0 N-CA-C 109.156 -0.683 . . . . 1.0 109.156 179.987 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 102' ' ' CYS . . . . . 0.897 ' O ' ' HB2' ' A' ' 106' ' ' ALA . 0.0 OUTLIER -44.41 -20.53 0.03 OUTLIER 'General case' 0 C--O 1.22 -0.478 0 CA-C-O 119.641 -0.218 . . . . 1.0 111.2 -178.574 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 103' ' ' ARG . . . . . 0.441 ' N ' ' O ' ' A' ' 101' ' ' VAL . 17.1 ttm180 -88.82 -37.36 15.45 Favored 'General case' 0 N--CA 1.484 1.239 0 CA-C-O 122.766 1.27 . . . . 1.0 110.664 178.316 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 104' ' ' TYR . . . . . 0.588 ' O ' ' CG ' ' A' ' 104' ' ' TYR . 50.9 t80 -99.79 20.99 13.16 Favored 'General case' 0 C--N 1.31 -1.116 0 CA-C-N 112.117 -2.31 . . . . 1.0 110.342 177.184 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 105' ' ' GLY . . . . . 0.542 ' N ' ' O ' ' A' ' 101' ' ' VAL . . . -163.5 -88.81 0.07 OUTLIER Glycine 0 N--CA 1.445 -0.719 0 N-CA-C 108.023 -2.031 . . . . 1.0 108.023 178.073 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 106' ' ' ALA . . . . . 0.897 ' HB2' ' O ' ' A' ' 102' ' ' CYS . . . 66.46 66.62 0.46 Allowed 'General case' 0 N--CA 1.441 -0.892 0 CA-C-N 115.654 -0.273 . . . . 1.0 111.545 -179.857 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 14.0 m -77.47 -60.97 2.14 Favored 'General case' 0 N--CA 1.473 0.718 0 O-C-N 121.325 -0.859 . . . . 1.0 109.388 179.711 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . 0.491 HG23 ' N ' ' A' ' 109' ' ' ILE . 32.3 m -66.51 -43.92 90.56 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.171 0 CA-C-O 121.293 0.568 . . . . 1.0 109.511 -179.158 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 109' ' ' ILE . . . . . 0.491 ' N ' HG23 ' A' ' 108' ' ' VAL . 1.8 mm -36.5 -61.23 0.64 Allowed Pre-proline 0 CA--C 1.549 0.932 0 CA-C-O 118.171 -0.919 . . . . 1.0 111.095 -178.269 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 110' ' ' PRO . . . . . 0.584 ' CD ' ' O ' ' A' ' 106' ' ' ALA . 55.5 Cg_endo -63.85 -21.33 69.17 Favored 'Trans proline' 0 N--CA 1.505 2.149 0 C-N-CA 124.013 3.142 . . . . 1.0 113.11 179.875 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 14.7 t-20 -63.31 -69.9 0.24 Allowed 'General case' 0 N--CA 1.467 0.392 0 C-N-CA 120.387 -0.525 . . . . 1.0 111.175 -178.191 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 112' ' ' ILE . . . . . 0.821 HD13 ' N ' ' A' ' 113' ' ' ASN . 0.0 OUTLIER -73.07 -25.33 21.65 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.567 0 CA-C-O 121.969 0.89 . . . . 1.0 109.499 -179.643 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 113' ' ' ASN . . . . . 0.821 ' N ' HD13 ' A' ' 112' ' ' ILE . 0.4 OUTLIER -52.02 -59.2 4.63 Favored 'General case' 0 C--N 1.3 -1.552 0 CA-C-N 114.002 -1.453 . . . . 1.0 108.908 -177.45 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -66.26 -20.46 66.12 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 115.891 -0.595 . . . . 1.0 110.954 179.107 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -76.41 -60.81 2.18 Favored 'General case' 0 N--CA 1.443 -0.804 0 C-N-CA 120.282 -0.567 . . . . 1.0 111.171 178.001 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 116' ' ' ILE . . . . . 0.526 ' O ' ' N ' ' A' ' 119' ' ' LEU . 7.6 tt -72.39 -41.54 64.97 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.213 0 O-C-N 121.213 -0.93 . . . . 1.0 111.981 -178.236 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 117' ' ' GLU . . . . . 0.566 ' OE1' ' ND2' ' A' ' 113' ' ' ASN . 1.0 OUTLIER -48.81 -58.61 4.53 Favored 'General case' 0 CA--C 1.508 -0.671 0 N-CA-C 108.288 -1.005 . . . . 1.0 108.288 -178.476 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 86.9 t -54.71 -14.26 0.96 Allowed 'Isoleucine or valine' 0 N--CA 1.436 -1.131 0 C-N-CA 120.253 -0.579 . . . . 1.0 109.442 179.52 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 119' ' ' LEU . . . . . 0.526 ' N ' ' O ' ' A' ' 116' ' ' ILE . 0.2 OUTLIER -76.33 -60.18 2.45 Favored 'General case' 0 C--N 1.347 0.477 0 N-CA-C 107.77 -1.196 . . . . 1.0 107.77 175.796 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -68.25 -83.08 0.15 Allowed Glycine 0 C--N 1.364 2.114 0 C-N-CA 117.57 -2.253 . . . . 1.0 111.23 179.449 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 121' ' ' THR . . . . . 0.444 ' H ' ' H ' ' A' ' 122' ' ' GLY . 18.8 m -161.36 -17.97 0.05 OUTLIER 'General case' 0 C--N 1.326 -0.427 0 N-CA-C 108.564 -0.902 . . . . 1.0 108.564 -179.639 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 122' ' ' GLY . . . . . 0.444 ' H ' ' H ' ' A' ' 121' ' ' THR . . . 111.26 -35.91 4.49 Favored Glycine 0 CA--C 1.523 0.577 0 CA-C-N 113.959 -1.473 . . . . 1.0 112.1 179.569 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 123' ' ' THR . . . . . 0.416 ' C ' ' O ' ' A' ' 122' ' ' GLY . 0.1 OUTLIER -33.43 95.4 0.01 OUTLIER 'General case' 0 N--CA 1.471 0.614 0 CA-C-N 118.342 1.071 . . . . 1.0 112.489 -178.618 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 124' ' ' ASP . . . . . 0.414 ' N ' ' O ' ' A' ' 122' ' ' GLY . 55.6 m-20 -148.59 147.88 29.51 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 115.484 -0.78 . . . . 1.0 109.548 179.26 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 125' ' ' TYR . . . . . 0.418 ' CD1' ' C ' ' A' ' 125' ' ' TYR . 0.0 OUTLIER -151.85 150.25 29.89 Favored 'General case' 0 CA--C 1.532 0.279 0 CA-C-O 120.863 0.363 . . . . 1.0 110.124 179.946 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 126' ' ' ARG . . . . . 0.43 ' HB3' ' H62' ' A' ' 130' ' ' MTN . 0.0 OUTLIER -149.67 150.55 32.32 Favored 'General case' 0 CA--C 1.537 0.45 0 CA-C-N 116.07 -0.513 . . . . 1.0 110.019 177.719 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 127' ' ' PHE . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 C--O 1.22 -0.467 0 CA-C-O 118.172 -0.918 . . . . 1.0 109.249 179.44 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 128' ' ' MTN . . . . . 1.085 ' H91' ' HE ' ' A' ' 47' ' ' ARG . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 129' ' ' MTN . . . . . 0.807 ' H62' ' O ' ' A' ' 48' ' ' CYS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 130' ' ' MTN . . . . . 0.43 ' H62' ' HB3' ' A' ' 126' ' ' ARG . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 N--CA 1.493 1.715 0 N-CA-C 109.259 -0.645 . . . . 1.0 109.259 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . 0.487 ' O ' ' CG ' ' A' ' 3' ' ' ASP . 55.1 p -83.28 5.63 22.48 Favored 'General case' 0 CA--C 1.531 0.246 0 CA-C-N 116.489 -0.323 . . . . 1.0 111.478 -179.062 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . 0.487 ' CG ' ' O ' ' A' ' 2' ' ' SER . 24.0 m-20 153.69 127.41 0.0 OUTLIER 'General case' 0 N--CA 1.477 0.876 0 O-C-N 123.904 0.753 . . . . 1.0 111.2 178.94 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 60.9 t80 -155.92 151.19 26.73 Favored 'General case' 0 N--CA 1.462 0.145 0 CA-C-N 116.089 -0.505 . . . . 1.0 110.953 179.235 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 4.2 p30 -153.7 148.63 26.63 Favored 'General case' 0 CA--C 1.536 0.419 0 CA-C-N 116.308 -0.406 . . . . 1.0 110.158 -179.692 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 6' ' ' THR . . . . . 0.816 ' O ' ' N ' ' A' ' 10' ' ' SER . 0.1 OUTLIER -80.76 170.4 16.35 Favored 'General case' 0 C--O 1.188 -2.165 0 C-N-CA 120.856 -0.338 . . . . 1.0 110.305 -179.39 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . 0.541 ' O ' ' N ' ' A' ' 11' ' ' ARG . 39.2 tt0 -56.87 -57.05 14.16 Favored 'General case' 0 C--N 1.313 -0.984 0 CA-C-O 121.775 0.797 . . . . 1.0 110.54 -177.974 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 8' ' ' ARG . . . . . 0.757 ' O ' ' HB3' ' A' ' 12' ' ' ALA . 0.0 OUTLIER -54.02 -55.51 26.66 Favored 'General case' 0 C--N 1.313 -1.01 0 N-CA-C 106.96 -1.496 . . . . 1.0 106.96 -178.079 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . 0.683 ' O ' ' HB ' ' A' ' 13' ' ' VAL . 0.2 OUTLIER -66.41 -51.89 52.97 Favored 'Isoleucine or valine' 0 C--O 1.189 -2.124 0 CA-C-N 114.35 -1.296 . . . . 1.0 109.659 179.651 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . 0.816 ' N ' ' O ' ' A' ' 6' ' ' THR . 22.5 t -65.78 -64.89 0.76 Allowed 'General case' 0 N--CA 1.482 1.139 0 C-N-CA 120.256 -0.578 . . . . 1.0 111.649 -178.924 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 11' ' ' ARG . . . . . 0.541 ' N ' ' O ' ' A' ' 7' ' ' GLU . 0.3 OUTLIER -65.52 -57.82 7.3 Favored 'General case' 0 C--O 1.218 -0.589 0 N-CA-C 112.313 0.486 . . . . 1.0 112.313 -176.81 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . 0.757 ' HB3' ' O ' ' A' ' 8' ' ' ARG . . . -54.12 -49.69 68.59 Favored 'General case' 0 N--CA 1.476 0.856 0 C-N-CA 117.874 -1.53 . . . . 1.0 107.41 -176.497 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . 0.683 ' HB ' ' O ' ' A' ' 9' ' ' VAL . 91.2 t -62.34 -50.05 81.49 Favored 'Isoleucine or valine' 0 C--O 1.197 -1.679 0 N-CA-C 107.585 -1.265 . . . . 1.0 107.585 178.476 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . 0.776 ' O ' HG22 ' A' ' 18' ' ' VAL . . . -56.41 -60.24 3.8 Favored 'General case' 0 C--O 1.207 -1.143 0 C-N-CA 117.57 -1.652 . . . . 1.0 108.508 -178.806 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . 0.55 ' O ' ' N ' ' A' ' 19' ' ' GLY . . . -53.63 -53.65 48.91 Favored 'General case' 0 C--N 1.322 -0.618 0 O-C-N 123.718 0.636 . . . . 1.0 109.726 -178.855 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . 0.46 ' C ' ' H ' ' A' ' 22' ' ' GLY . . . -63.72 -57.98 8.31 Favored 'General case' 0 N--CA 1.474 0.745 0 CA-C-O 121.693 0.759 . . . . 1.0 109.707 -179.547 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . 0.61 ' N ' ' O ' ' A' ' 13' ' ' VAL . 7.5 tt -55.42 -54.46 43.47 Favored 'General case' 0 N--CA 1.477 0.903 0 CA-C-N 114.422 -1.263 . . . . 1.0 108.652 -178.578 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . 0.776 HG22 ' O ' ' A' ' 14' ' ' ALA . 2.3 m -69.16 -57.45 8.56 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.568 0 C-N-CA 119.335 -0.946 . . . . 1.0 109.166 179.857 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . 0.55 ' N ' ' O ' ' A' ' 15' ' ' ALA . . . -56.78 -162.95 0.03 OUTLIER Glycine 0 C--O 1.22 -0.77 0 N-CA-C 111.225 -0.75 . . . . 1.0 111.225 -178.317 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' PRO . . . . . 0.441 ' O ' ' N ' ' A' ' 24' ' ' ALA . 83.0 Cg_endo -82.76 -30.34 1.05 Allowed 'Trans proline' 0 C--N 1.303 -1.836 0 C-N-CA 122.508 2.139 . . . . 1.0 113.988 -178.619 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . 0.42 ' O ' ' HB3' ' A' ' 24' ' ' ALA . . . -62.87 -61.52 6.38 Favored Glycine 0 N--CA 1.48 1.57 0 C-N-CA 119.897 -1.144 . . . . 1.0 113.364 -176.508 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . 0.46 ' H ' ' C ' ' A' ' 16' ' ' ALA . . . -54.16 -52.81 41.27 Favored Glycine 0 N--CA 1.471 0.997 0 N-CA-C 106.6 -2.6 . . . . 1.0 106.6 -177.11 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . 0.547 ' O ' HG12 ' A' ' 27' ' ' VAL . 12.3 t -57.06 -29.17 30.92 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.853 0 C-N-CA 119.569 -0.852 . . . . 1.0 109.096 177.696 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . 0.441 ' N ' ' O ' ' A' ' 20' ' ' PRO . . . -61.89 -63.63 1.2 Allowed 'General case' 0 C--N 1.349 0.568 0 C-N-CA 118.106 -1.437 . . . . 1.0 111.138 179.922 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . 0.588 ' N ' HD12 ' A' ' 25' ' ' LEU . 9.6 mp -63.6 -47.72 80.28 Favored 'General case' 0 N--CA 1.472 0.649 0 CA-C-N 119.008 0.822 . . . . 1.0 112.651 -177.486 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 94.9 t -58.01 -58.84 4.67 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.575 0 C-N-CA 119.169 -1.013 . . . . 1.0 110.061 -177.416 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . 0.809 ' O ' ' HB3' ' A' ' 31' ' ' ALA . 0.5 OUTLIER -61.41 -36.33 72.35 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.601 0 CA-C-O 121.224 0.535 . . . . 1.0 110.322 -178.505 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . 0.405 ' CB ' ' O ' ' A' ' 24' ' ' ALA . 33.0 tttm -67.52 -58.52 4.57 Favored 'General case' 0 C--N 1.316 -0.891 0 C-N-CA 119.461 -0.896 . . . . 1.0 110.424 -178.918 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 95.8 t -65.32 -49.85 76.43 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.116 0 C-N-CA 119.821 -0.752 . . . . 1.0 111.221 -177.283 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 30' ' ' CYS . . . . . . . . . . . . . 4.9 t -65.65 -61.64 1.97 Allowed 'General case' 0 N--CA 1.44 -0.969 0 C-N-CA 119.197 -1.001 . . . . 1.0 109.826 -179.344 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . 0.809 ' HB3' ' O ' ' A' ' 27' ' ' VAL . . . -63.07 -49.47 74.4 Favored 'General case' 0 C--N 1.322 -0.621 0 C-N-CA 119.968 -0.693 . . . . 1.0 110.714 -177.244 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . 0.53 ' O ' ' HB2' ' A' ' 33' ' ' LEU . . . 58.44 60.02 9.71 Favored Glycine 0 C--O 1.222 -0.62 0 CA-C-O 118.165 -1.353 . . . . 1.0 111.003 179.644 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . 0.664 HD23 HG22 ' A' ' 112' ' ' ILE . 6.3 mp 100.21 140.62 0.02 OUTLIER Pre-proline 0 N--CA 1.484 1.26 0 C-N-CA 125.478 1.511 . . . . 1.0 111.65 179.761 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 31.3 Cg_exo -51.76 -57.76 1.98 Allowed 'Trans proline' 0 N--CA 1.501 1.936 0 C-N-CA 122.17 1.913 . . . . 1.0 113.763 -178.505 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . 0.464 ' O ' ' C ' ' A' ' 36' ' ' VAL . . . -65.85 -59.65 7.34 Favored Glycine 0 C--N 1.338 0.678 0 C-N-CA 117.944 -2.074 . . . . 1.0 109.223 -178.404 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . 0.976 ' O ' HG22 ' A' ' 37' ' ' ILE . 70.4 t -38.94 139.36 0.23 Allowed 'Isoleucine or valine' 0 C--O 1.215 -0.73 0 N-CA-C 107.398 -1.334 . . . . 1.0 107.398 178.658 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . 0.976 HG22 ' O ' ' A' ' 36' ' ' VAL . 2.3 tp 71.96 73.3 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.476 0.831 0 CA-C-O 122.266 1.031 . . . . 1.0 110.15 -177.201 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 7.2 p80 -139.42 136.04 34.25 Favored 'General case' 0 C--N 1.322 -0.592 0 O-C-N 120.514 -1.366 . . . . 1.0 109.489 179.988 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -113.77 140.0 24.16 Favored Pre-proline 0 CA--C 1.533 0.32 0 N-CA-C 109.251 -0.648 . . . . 1.0 109.251 179.528 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 59.8 Cg_endo -71.28 -7.36 21.17 Favored 'Trans proline' 0 C--N 1.311 -1.41 0 C-N-CA 122.058 1.838 . . . . 1.0 112.187 -179.38 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -112.78 91.91 3.82 Favored 'General case' 0 CA--C 1.507 -0.691 0 C-N-CA 120.591 -0.444 . . . . 1.0 111.13 -178.078 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . 0.656 ' C ' ' H ' ' A' ' 44' ' ' GLY . 0.6 OUTLIER -123.58 140.3 53.14 Favored 'General case' 0 CA--C 1.537 0.453 0 CA-C-O 121.744 0.783 . . . . 1.0 111.576 -178.361 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 43' ' ' ARG . . . . . 0.686 ' C ' ' H ' ' A' ' 45' ' ' PHE . 1.5 tpp180 -59.31 37.74 0.01 OUTLIER 'General case' 0 CA--C 1.562 1.415 0 CA-C-N 112.976 -1.92 . . . . 1.0 108.303 -179.714 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . 0.656 ' H ' ' C ' ' A' ' 42' ' ' ARG . . . 67.8 -30.13 0.23 Allowed Glycine 0 C--N 1.338 0.656 0 N-CA-C 109.605 -1.398 . . . . 1.0 109.605 -179.11 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . 0.686 ' H ' ' C ' ' A' ' 43' ' ' ARG . 0.2 OUTLIER -170.39 175.28 4.87 Favored 'General case' 0 N--CA 1.443 -0.821 0 CA-C-N 114.749 -0.725 . . . . 1.0 109.126 179.379 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 46' ' ' PHE . . . . . 0.549 ' HB2' ' O ' ' A' ' 45' ' ' PHE . 8.6 m-85 114.84 110.56 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.668 0 C-N-CA 126.868 2.067 . . . . 1.0 108.432 -179.272 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 47' ' ' ARG . . . . . 0.512 ' HB2' ' O ' ' A' ' 46' ' ' PHE . 3.6 mmp_? 100.11 153.36 0.01 OUTLIER 'General case' 0 N--CA 1.469 0.516 0 O-C-N 124.94 1.4 . . . . 1.0 111.266 179.62 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 48' ' ' CYS . . . . . 0.616 ' O ' ' H62' ' A' ' 129' ' ' MTN . 0.5 OUTLIER 66.44 70.51 0.41 Allowed 'General case' 0 N--CA 1.449 -0.48 0 CA-C-N 114.778 -1.101 . . . . 1.0 109.315 179.825 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 49' ' ' ASN . . . . . 0.5 ' O ' ' N ' ' A' ' 51' ' ' GLU . 0.7 OUTLIER -136.45 160.73 65.66 Favored Pre-proline 0 N--CA 1.466 0.367 0 CA-C-N 116.455 -0.339 . . . . 1.0 110.473 -179.175 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 25.1 Cg_endo -60.54 58.74 0.09 OUTLIER 'Trans proline' 0 N--CA 1.499 1.798 0 C-N-CA 123.265 2.643 . . . . 1.0 111.886 179.054 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . 0.5 ' N ' ' O ' ' A' ' 49' ' ' ASN . 2.9 tt0 45.33 29.85 0.62 Allowed 'General case' 0 CA--C 1.536 0.407 0 CA-C-O 121.121 0.486 . . . . 1.0 110.442 179.13 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . 0.632 ' NH2' ' CE1' ' A' ' 92' ' ' HIS . 49.5 mtt180 -124.59 151.84 44.3 Favored 'General case' 0 N--CA 1.472 0.637 0 CA-C-O 121.541 0.686 . . . . 1.0 110.978 179.527 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 7.2 tp -55.87 139.99 14.46 Favored 'Isoleucine or valine' 0 CA--C 1.555 1.141 0 CA-C-O 123.935 1.826 . . . . 1.0 115.217 -177.407 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 54' ' ' GLN . . . . . 0.431 ' H ' ' CD ' ' A' ' 54' ' ' GLN . 0.2 OUTLIER -86.53 86.11 7.33 Favored 'General case' 0 C--N 1.316 -0.864 0 CA-C-N 110.229 -3.168 . . . . 1.0 112.258 179.833 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 19.6 tt -143.92 151.0 16.55 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.032 0 N-CA-C 109.522 -0.548 . . . . 1.0 109.522 177.578 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 102.13 1.3 51.37 Favored Glycine 0 C--N 1.343 0.964 0 N-CA-C 110.753 -0.939 . . . . 1.0 110.753 179.837 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 1.3 p30 -89.71 113.28 24.76 Favored 'General case' 0 CA--C 1.54 0.566 0 CA-C-O 122.294 1.045 . . . . 1.0 113.226 -177.881 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 58' ' ' TRP . . . . . . . . . . . . . 36.4 m0 -81.74 -177.27 6.49 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 113.952 -1.476 . . . . 1.0 108.287 177.696 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 59' ' ' ARG . . . . . 0.649 ' HD2' ' H ' ' A' ' 59' ' ' ARG . 0.0 OUTLIER -97.3 -53.58 3.43 Favored 'General case' 0 CA--C 1.556 1.196 0 CA-C-N 119.18 0.9 . . . . 1.0 110.642 179.717 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 60' ' ' TYR . . . . . 0.485 ' O ' ' CG ' ' A' ' 60' ' ' TYR . 77.0 t80 -77.47 -6.0 51.92 Favored 'General case' 0 N--CA 1.483 1.207 0 C-N-CA 125.778 1.631 . . . . 1.0 111.833 -179.367 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -70.1 -16.7 63.16 Favored 'General case' 0 C--N 1.307 -1.244 0 CA-C-O 121.575 0.703 . . . . 1.0 109.453 179.181 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . 0.489 ' O ' ' N ' ' A' ' 66' ' ' GLY . 6.1 m -45.81 -52.37 2.8 Favored 'Isoleucine or valine' 0 CA--C 1.5 -0.961 0 C-N-CA 120.067 -0.653 . . . . 1.0 110.512 -174.774 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 63' ' ' ALA . . . . . 0.435 ' O ' ' HG2' ' A' ' 67' ' ' ARG . . . -65.2 -47.75 75.82 Favored 'General case' 0 N--CA 1.424 -1.768 0 N-CA-C 109.447 -0.575 . . . . 1.0 109.447 179.414 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 64' ' ' HIS . . . . . 0.407 ' O ' ' CG ' ' A' ' 67' ' ' ARG . 0.1 OUTLIER -54.71 -59.46 4.68 Favored 'General case' 0 CA--C 1.549 0.907 0 CA-C-N 115.474 -0.785 . . . . 1.0 110.54 179.837 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . 0.642 ' C ' ' H ' ' A' ' 67' ' ' ARG . 13.4 m-20 -67.72 -50.0 59.7 Favored 'General case' 0 C--O 1.243 0.751 0 N-CA-C 108.322 -0.992 . . . . 1.0 108.322 178.36 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . 0.489 ' N ' ' O ' ' A' ' 62' ' ' VAL . . . -63.23 30.24 0.08 OUTLIER Glycine 0 C--N 1.336 0.533 0 O-C-N 121.873 -0.517 . . . . 1.0 112.097 179.013 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 67' ' ' ARG . . . . . 0.793 ' HB3' ' HB3' ' A' ' 71' ' ' ALA . 14.9 mmt180 -78.96 -3.0 42.76 Favored 'General case' 0 C--N 1.308 -1.219 0 N-CA-C 108.322 -0.992 . . . . 1.0 108.322 175.927 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . 0.6 HD23 ' N ' ' A' ' 68' ' ' LEU . 1.8 pt? -36.11 -29.95 0.02 OUTLIER 'General case' 0 N--CA 1.477 0.921 0 N-CA-C 108.57 -0.9 . . . . 1.0 108.57 -176.948 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . 0.558 ' N ' ' O ' ' A' ' 67' ' ' ARG . 0.5 OUTLIER -71.91 -69.52 0.39 Allowed 'General case' 0 CA--C 1.538 0.5 0 CA-C-N 115.15 -0.932 . . . . 1.0 111.206 -178.583 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . 0.6 ' C ' ' H ' ' A' ' 72' ' ' HIS . . . -76.53 -78.16 0.13 Allowed 'General case' 0 N--CA 1.463 0.221 0 C-N-CA 119.201 -1.0 . . . . 1.0 109.2 -179.458 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . 0.793 ' HB3' ' HB3' ' A' ' 67' ' ' ARG . . . -58.84 13.05 0.01 OUTLIER 'General case' 0 C--N 1.321 -0.643 0 C-N-CA 124.444 1.098 . . . . 1.0 113.159 -179.019 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 72' ' ' HIS . . . . . 0.68 ' CD2' ' OG1' ' A' ' 123' ' ' THR . 0.0 OUTLIER -18.1 -60.05 0.02 OUTLIER 'General case' 0 CA--C 1.534 0.353 0 N-CA-C 113.32 0.859 . . . . 1.0 113.32 -177.429 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 73' ' ' MET . . . . . 0.649 ' N ' ' CG ' ' A' ' 72' ' ' HIS . 0.0 OUTLIER -64.82 -53.96 38.59 Favored 'General case' 0 C--N 1.317 -0.81 0 C-N-CA 119.831 -0.748 . . . . 1.0 111.341 -177.842 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . 0.635 ' O ' ' N ' ' A' ' 76' ' ' GLY . 0.8 OUTLIER -44.31 -46.31 2.36 Favored 'Isoleucine or valine' 0 C--O 1.215 -0.75 0 CA-C-O 117.989 -1.005 . . . . 1.0 111.219 -174.566 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 75' ' ' ASN . . . . . 0.48 ' C ' ' N ' ' A' ' 77' ' ' ILE . 2.3 t30 -37.66 -21.47 0.01 OUTLIER 'General case' 0 N--CA 1.482 1.16 0 CA-C-O 122.972 1.368 . . . . 1.0 110.026 178.3 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . 0.635 ' N ' ' O ' ' A' ' 74' ' ' VAL . . . -49.49 -20.41 2.51 Favored Glycine 0 C--O 1.21 -1.361 0 N-CA-C 107.666 -2.174 . . . . 1.0 107.666 175.235 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . 0.538 ' N ' ' O ' ' A' ' 74' ' ' VAL . 7.9 pt -56.84 -46.93 83.65 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.454 0 CA-C-N 115.301 -0.45 . . . . 1.0 111.75 -177.556 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 57.9 t -44.14 -17.99 0.06 OUTLIER 'Isoleucine or valine' 0 CA--C 1.51 -0.562 0 CA-C-N 118.775 0.716 . . . . 1.0 112.39 179.805 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . 0.496 ' N ' ' O ' ' A' ' 77' ' ' ILE . 0.6 OUTLIER -91.33 -40.17 12.28 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.759 0 C-N-CA 119.593 -0.843 . . . . 1.0 112.506 179.555 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 80' ' ' ALA . . . . . 0.416 ' N ' ' CG1' ' A' ' 79' ' ' ILE . . . -82.01 -24.41 35.41 Favored 'General case' 0 C--N 1.328 -0.344 0 N-CA-C 114.279 1.215 . . . . 1.0 114.279 -178.241 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . 0.613 ' O ' HD12 ' A' ' 84' ' ' LEU . 0.0 OUTLIER -92.24 -74.45 0.51 Allowed 'General case' 0 N--CA 1.469 0.515 0 N-CA-C 113.998 1.11 . . . . 1.0 113.998 -177.591 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 82' ' ' ASP . . . . . 0.716 ' O ' HG22 ' A' ' 85' ' ' ILE . 9.3 m-20 -92.17 -22.2 19.97 Favored 'General case' 0 C--O 1.217 -0.627 0 N-CA-C 115.291 1.589 . . . . 1.0 115.291 -177.993 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . 0.582 ' O ' ' N ' ' A' ' 85' ' ' ILE . . . -58.68 -40.77 84.53 Favored 'General case' 0 N--CA 1.461 0.108 0 C-N-CA 118.405 -1.318 . . . . 1.0 112.101 -176.005 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . 0.715 ' C ' HD22 ' A' ' 84' ' ' LEU . 0.0 OUTLIER -41.45 -14.81 0.01 OUTLIER 'General case' 0 CA--C 1.536 0.406 0 N-CA-C 112.742 0.645 . . . . 1.0 112.742 -178.488 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 85' ' ' ILE . . . . . 0.716 HG22 ' O ' ' A' ' 82' ' ' ASP . 3.5 tt -90.07 -43.95 14.79 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.408 0 N-CA-C 112.029 0.381 . . . . 1.0 112.029 179.87 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . 0.483 ' N ' HG23 ' A' ' 85' ' ' ILE . . . -94.2 -23.48 17.88 Favored 'General case' 0 CA--C 1.527 0.082 0 CA-C-O 120.681 0.277 . . . . 1.0 111.337 -178.826 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . 0.581 ' OE1' ' N ' ' A' ' 88' ' ' ALA . 0.0 OUTLIER -83.72 -26.97 29.29 Favored 'General case' 0 C--N 1.332 -0.187 0 N-CA-C 109.277 -0.638 . . . . 1.0 109.277 179.813 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . 0.581 ' N ' ' OE1' ' A' ' 87' ' ' GLU . . . -62.95 13.44 0.02 OUTLIER 'General case' 0 N--CA 1.445 -0.717 0 CA-C-N 115.669 -0.696 . . . . 1.0 110.717 -179.689 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 89' ' ' VAL . . . . . 0.588 ' O ' ' N ' ' A' ' 92' ' ' HIS . 33.5 t -84.89 45.2 0.06 OUTLIER 'Isoleucine or valine' 0 C--O 1.218 -0.558 0 CA-C-N 118.385 0.539 . . . . 1.0 110.996 -179.942 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 90' ' ' GLY . . . . . 0.724 ' O ' ' N ' ' A' ' 92' ' ' HIS . . . -30.08 -42.22 0.05 OUTLIER Glycine 0 CA--C 1.539 1.553 0 CA-C-O 117.575 -1.68 . . . . 1.0 111.149 -174.782 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 91' ' ' PRO . . . . . 0.502 ' C ' ' N ' ' A' ' 93' ' ' LEU . 95.3 Cg_exo -43.11 -4.0 0.01 OUTLIER 'Trans proline' 0 N--CA 1.499 1.842 0 CA-C-N 121.807 2.804 . . . . 1.0 111.602 170.475 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 92' ' ' HIS . . . . . 0.724 ' N ' ' O ' ' A' ' 90' ' ' GLY . 0.4 OUTLIER -48.47 -15.83 0.09 Allowed 'General case' 0 C--N 1.343 0.308 0 N-CA-C 107.873 -1.158 . . . . 1.0 107.873 -177.308 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . 0.625 ' O ' ' N ' ' A' ' 96' ' ' ALA . 7.1 tp -58.49 -50.27 74.36 Favored 'General case' 0 N--CA 1.447 -0.592 0 N-CA-C 106.62 -1.622 . . . . 1.0 106.62 176.183 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 94' ' ' ALA . . . . . 0.447 ' N ' ' O ' ' A' ' 91' ' ' PRO . . . -46.91 -50.43 18.79 Favored 'General case' 0 CA--C 1.518 -0.267 0 N-CA-C 107.685 -1.228 . . . . 1.0 107.685 -178.089 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 95' ' ' ARG . . . . . 0.51 ' HE ' ' HA ' ' A' ' 92' ' ' HIS . 4.5 mtm-85 -61.33 -28.48 69.24 Favored 'General case' 0 N--CA 1.443 -0.78 0 N-CA-C 109.057 -0.72 . . . . 1.0 109.057 176.122 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 96' ' ' ALA . . . . . 0.675 ' O ' ' N ' ' A' ' 100' ' ' ILE . . . -54.34 -52.06 62.76 Favored 'General case' 0 N--CA 1.475 0.822 0 N-CA-C 107.104 -1.443 . . . . 1.0 107.104 -179.946 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . 0.555 ' O ' HG22 ' A' ' 100' ' ' ILE . 0.7 OUTLIER -36.57 -26.18 0.01 OUTLIER 'General case' 0 CA--C 1.577 1.992 0 CA-C-N 114.274 -1.33 . . . . 1.0 108.485 -178.04 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 98' ' ' GLY . . . . . 0.572 ' N ' ' O ' ' A' ' 96' ' ' ALA . . . -84.68 -51.09 3.96 Favored Glycine 0 CA--C 1.55 2.279 0 CA-C-O 123.814 1.786 . . . . 1.0 110.749 173.939 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 99' ' ' GLN . . . . . 0.558 ' N ' ' O ' ' A' ' 96' ' ' ALA . 30.2 mm100 -75.84 9.71 2.22 Favored 'General case' 0 N--CA 1.428 -1.543 0 CA-C-N 113.514 -1.343 . . . . 1.0 107.649 177.037 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 100' ' ' ILE . . . . . 0.788 HG23 ' N ' ' A' ' 101' ' ' VAL . 9.7 tt -61.62 -55.8 22.01 Favored 'Isoleucine or valine' 0 CA--C 1.482 -1.651 0 N-CA-C 109.307 -0.627 . . . . 1.0 109.307 179.063 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 101' ' ' VAL . . . . . 0.788 ' N ' HG23 ' A' ' 100' ' ' ILE . 5.8 p -56.68 -59.48 2.96 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.739 0 C-N-CA 117.485 -1.686 . . . . 1.0 107.739 179.789 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 102' ' ' CYS . . . . . 0.949 ' O ' ' HB2' ' A' ' 106' ' ' ALA . 0.5 OUTLIER -44.24 -18.13 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.438 0 C-N-CA 120.5 -0.48 . . . . 1.0 111.448 -177.001 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 103' ' ' ARG . . . . . 0.497 ' NH2' ' HB1' ' A' ' 96' ' ' ALA . 6.1 ttp180 -98.07 -37.42 9.75 Favored 'General case' 0 N--CA 1.474 0.739 0 CA-C-O 121.944 0.878 . . . . 1.0 112.859 178.127 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 104' ' ' TYR . . . . . 0.637 ' O ' ' CG ' ' A' ' 104' ' ' TYR . 51.5 t80 -101.84 21.69 14.17 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-N 113.785 -1.552 . . . . 1.0 110.552 179.206 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 105' ' ' GLY . . . . . 0.769 ' O ' ' N ' ' A' ' 107' ' ' THR . . . -171.36 -12.26 0.02 OUTLIER Glycine 0 C--O 1.22 -0.741 0 C-N-CA 119.145 -1.503 . . . . 1.0 112.286 179.516 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 106' ' ' ALA . . . . . 0.949 ' HB2' ' O ' ' A' ' 102' ' ' CYS . . . -16.53 67.38 0.0 OUTLIER 'General case' 0 N--CA 1.476 0.874 0 O-C-N 124.432 0.725 . . . . 1.0 111.989 -179.8 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 107' ' ' THR . . . . . 0.769 ' N ' ' O ' ' A' ' 105' ' ' GLY . 9.9 t -117.78 -7.01 11.03 Favored 'General case' 0 CA--C 1.516 -0.33 0 N-CA-C 109.448 -0.575 . . . . 1.0 109.448 -179.621 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 11.5 m -87.14 17.7 0.57 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.452 0 N-CA-C 109.546 -0.538 . . . . 1.0 109.546 179.76 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 109' ' ' ILE . . . . . 0.723 ' N ' ' HD2' ' A' ' 110' ' ' PRO . 48.5 pt -113.71 -19.02 0.11 Allowed Pre-proline 0 CA--C 1.576 1.953 0 N-CA-C 113.773 1.027 . . . . 1.0 113.773 177.58 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 110' ' ' PRO . . . . . 0.723 ' HD2' ' N ' ' A' ' 109' ' ' ILE . 14.2 Cg_endo -53.73 -38.64 85.03 Favored 'Trans proline' 0 N--CA 1.497 1.703 0 C-N-CA 123.736 2.957 . . . . 1.0 113.991 -172.684 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 23.7 t30 -63.24 -67.95 0.38 Allowed 'General case' 0 N--CA 1.441 -0.881 0 C-N-CA 118.526 -1.27 . . . . 1.0 109.278 -179.268 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 112' ' ' ILE . . . . . 0.664 HG22 HD23 ' A' ' 33' ' ' LEU . 0.1 OUTLIER -63.35 -29.54 47.5 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.387 0 CA-C-O 121.416 0.627 . . . . 1.0 110.016 -178.261 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 113' ' ' ASN . . . . . 0.54 HD22 ' N ' ' A' ' 114' ' ' ALA . 0.7 OUTLIER -58.76 -64.02 1.08 Allowed 'General case' 0 C--N 1.309 -1.169 0 C-N-CA 118.874 -1.13 . . . . 1.0 110.044 -175.882 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 114' ' ' ALA . . . . . 0.54 ' N ' HD22 ' A' ' 113' ' ' ASN . . . -62.65 -25.74 68.28 Favored 'General case' 0 C--N 1.319 -0.73 0 C-N-CA 119.936 -0.706 . . . . 1.0 111.986 -179.708 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -77.39 -59.33 2.82 Favored 'General case' 0 C--O 1.232 0.173 0 C-N-CA 119.463 -0.895 . . . . 1.0 110.459 179.176 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 116' ' ' ILE . . . . . 0.417 ' O ' ' N ' ' A' ' 119' ' ' LEU . 50.4 mt -63.58 -48.34 87.29 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.398 0 C-N-CA 119.954 -0.698 . . . . 1.0 109.604 -179.379 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 117' ' ' GLU . . . . . 0.503 ' OE2' ' OD1' ' A' ' 113' ' ' ASN . 93.4 mt-10 -46.94 -67.0 0.32 Allowed 'General case' 0 CA--C 1.503 -0.865 0 C-N-CA 119.835 -0.746 . . . . 1.0 109.195 -178.245 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 39.5 t -48.48 -22.53 0.68 Allowed 'Isoleucine or valine' 0 N--CA 1.44 -0.936 0 C-N-CA 120.114 -0.634 . . . . 1.0 109.971 179.744 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 119' ' ' LEU . . . . . 0.417 ' N ' ' O ' ' A' ' 116' ' ' ILE . 0.4 OUTLIER -78.45 -60.03 2.54 Favored 'General case' 0 C--N 1.346 0.431 0 N-CA-C 107.736 -1.209 . . . . 1.0 107.736 178.721 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 120' ' ' GLY . . . . . 0.561 ' C ' HG22 ' A' ' 121' ' ' THR . . . -62.28 -81.43 0.09 OUTLIER Glycine 0 C--N 1.354 1.537 0 C-N-CA 117.907 -2.092 . . . . 1.0 108.292 176.51 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 121' ' ' THR . . . . . 0.722 HG23 ' H ' ' A' ' 123' ' ' THR . 1.4 t 151.08 -16.12 0.0 OUTLIER 'General case' 0 N--CA 1.486 1.37 0 O-C-N 125.322 1.248 . . . . 1.0 113.505 178.28 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 122' ' ' GLY . . . . . 0.657 ' O ' ' N ' ' A' ' 124' ' ' ASP . . . 109.74 -13.18 32.44 Favored Glycine 0 N--CA 1.47 0.919 0 N-CA-C 108.521 -1.831 . . . . 1.0 108.521 -176.195 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 123' ' ' THR . . . . . 0.746 HG23 ' O ' ' A' ' 123' ' ' THR . 15.1 t -58.58 80.0 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.202 0 N-CA-C 106.755 -1.572 . . . . 1.0 106.755 178.735 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 124' ' ' ASP . . . . . 0.657 ' N ' ' O ' ' A' ' 122' ' ' GLY . 14.9 t70 -164.62 169.09 17.43 Favored 'General case' 0 N--CA 1.444 -0.76 0 CA-C-N 113.719 -1.582 . . . . 1.0 112.107 -179.631 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 125' ' ' TYR . . . . . 0.551 ' C ' ' CD1' ' A' ' 125' ' ' TYR . 0.0 OUTLIER -146.68 145.47 30.02 Favored 'General case' 0 CA--C 1.54 0.584 0 N-CA-C 108.889 -0.782 . . . . 1.0 108.889 177.393 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -148.84 149.06 30.65 Favored 'General case' 0 CA--C 1.536 0.418 0 N-CA-C 110.166 -0.309 . . . . 1.0 110.166 178.266 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 127' ' ' PHE . . . . . . . . . . . . . 27.2 p90 . . . . . 0 N--CA 1.471 0.595 0 CA-C-O 117.864 -1.065 . . . . 1.0 110.249 179.08 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 128' ' ' MTN . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 129' ' ' MTN . . . . . 0.616 ' H62' ' O ' ' A' ' 48' ' ' CYS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 130' ' ' MTN . . . . . 0.597 ' S1 ' ' H71' ' A' ' 130' ' ' MTN . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 39.0 mtt . . . . . 0 N--CA 1.489 1.475 0 N-CA-C 108.704 -0.851 . . . . 1.0 108.704 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 78.3 p -109.16 -3.79 17.03 Favored 'General case' 0 N--CA 1.466 0.334 0 CA-C-N 116.336 -0.393 . . . . 1.0 110.575 178.912 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . 0.44 ' OD1' ' N ' ' A' ' 3' ' ' ASP . 7.8 p-10 -174.66 91.96 0.07 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.28 -0.418 . . . . 1.0 111.785 -179.72 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 52.2 t80 -150.2 144.31 25.56 Favored 'General case' 0 C--N 1.328 -0.335 0 N-CA-C 109.367 -0.605 . . . . 1.0 109.367 179.162 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 5' ' ' ASP . . . . . 0.834 ' OD1' ' N ' ' A' ' 10' ' ' SER . 31.8 t0 -150.66 146.82 26.73 Favored 'General case' 0 C--N 1.328 -0.337 0 N-CA-C 110.082 -0.34 . . . . 1.0 110.082 -179.29 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 6' ' ' THR . . . . . 0.663 ' N ' ' OD1' ' A' ' 5' ' ' ASP . 0.2 OUTLIER -100.79 -178.1 3.67 Favored 'General case' 0 C--O 1.199 -1.599 0 CA-C-O 121.103 0.478 . . . . 1.0 110.782 179.904 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . 0.553 ' O ' ' HB3' ' A' ' 11' ' ' ARG . 29.0 tt0 -55.04 -41.23 71.15 Favored 'General case' 0 C--N 1.303 -1.442 0 CA-C-N 116.477 -0.329 . . . . 1.0 111.488 179.181 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 8' ' ' ARG . . . . . 0.713 ' O ' ' HB3' ' A' ' 12' ' ' ALA . 31.3 mtp180 -69.02 -63.98 0.96 Allowed 'General case' 0 C--N 1.313 -0.996 0 CA-C-O 123.086 1.422 . . . . 1.0 110.249 178.886 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . 0.643 ' O ' ' HB ' ' A' ' 13' ' ' VAL . 12.2 t -57.63 -43.67 83.91 Favored 'Isoleucine or valine' 0 C--N 1.282 -2.358 0 CA-C-N 114.464 -1.244 . . . . 1.0 109.188 178.304 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . 0.834 ' N ' ' OD1' ' A' ' 5' ' ' ASP . 14.9 t -68.6 -65.92 0.64 Allowed 'General case' 0 C--N 1.305 -1.337 0 O-C-N 121.256 -0.902 . . . . 1.0 111.282 -179.02 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 11' ' ' ARG . . . . . 0.553 ' HB3' ' O ' ' A' ' 7' ' ' GLU . 23.1 tpp180 -60.94 -42.41 98.13 Favored 'General case' 0 C--N 1.314 -0.973 0 CA-C-N 116.278 -0.419 . . . . 1.0 110.566 -177.562 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . 0.713 ' HB3' ' O ' ' A' ' 8' ' ' ARG . . . -69.56 -61.04 1.95 Allowed 'General case' 0 C--N 1.319 -0.752 0 C-N-CA 119.106 -1.038 . . . . 1.0 111.169 -179.602 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . 0.798 ' O ' ' CB ' ' A' ' 17' ' ' LEU . 0.3 OUTLIER -56.8 -45.9 83.21 Favored 'Isoleucine or valine' 0 C--O 1.187 -2.228 0 N-CA-C 106.602 -1.629 . . . . 1.0 106.602 179.921 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . 0.965 ' O ' HG22 ' A' ' 18' ' ' VAL . . . -66.47 -65.51 0.67 Allowed 'General case' 0 C--N 1.307 -1.263 0 C-N-CA 117.094 -1.842 . . . . 1.0 112.731 -178.745 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . 0.524 ' O ' ' N ' ' A' ' 19' ' ' GLY . . . -50.16 -53.45 27.6 Favored 'General case' 0 C--N 1.32 -0.708 0 N-CA-C 108.088 -1.079 . . . . 1.0 108.088 179.897 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . 0.607 ' HB3' ' O ' ' A' ' 12' ' ' ALA . . . -66.34 -59.95 3.23 Favored 'General case' 0 C--N 1.298 -1.667 0 C-N-CA 118.27 -1.372 . . . . 1.0 111.41 179.512 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . 0.798 ' CB ' ' O ' ' A' ' 13' ' ' VAL . 7.7 tt -55.01 -55.55 29.66 Favored 'General case' 0 N--CA 1.481 1.114 0 CA-C-N 114.777 -1.101 . . . . 1.0 108.625 -176.884 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . 0.965 HG22 ' O ' ' A' ' 14' ' ' ALA . 2.0 m -71.12 -59.36 3.52 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.658 0 CA-C-N 116.146 -0.479 . . . . 1.0 110.692 179.603 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . 0.592 ' N ' ' CG2' ' A' ' 18' ' ' VAL . . . -55.48 -171.69 0.1 OUTLIER Glycine 0 CA--C 1.486 -1.741 0 N-CA-C 109.593 -1.403 . . . . 1.0 109.593 -176.986 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' PRO . . . . . 0.613 ' O ' ' N ' ' A' ' 24' ' ' ALA . 81.1 Cg_endo -81.69 -26.88 2.89 Favored 'Trans proline' 0 C--N 1.286 -2.758 0 C-N-CA 122.025 1.817 . . . . 1.0 113.894 -177.555 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . 0.583 ' O ' ' HB3' ' A' ' 24' ' ' ALA . . . -59.81 -59.05 11.2 Favored Glycine 0 N--CA 1.473 1.159 0 O-C-N 124.156 0.91 . . . . 1.0 111.357 -178.903 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -55.79 -56.99 21.03 Favored Glycine 0 CA--C 1.5 -0.848 0 C-N-CA 117.083 -2.484 . . . . 1.0 107.577 -177.823 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . 0.543 ' O ' HG12 ' A' ' 27' ' ' VAL . 93.2 t -53.94 -29.59 18.57 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.145 0 CA-C-N 113.97 -1.115 . . . . 1.0 108.201 178.573 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . 0.613 ' N ' ' O ' ' A' ' 20' ' ' PRO . . . -63.63 -65.53 0.67 Allowed 'General case' 0 C--O 1.213 -0.825 0 C-N-CA 119.503 -0.879 . . . . 1.0 111.291 -178.939 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . 0.557 ' O ' HD12 ' A' ' 25' ' ' LEU . 0.4 OUTLIER -58.35 -48.68 79.81 Favored 'General case' 0 C--N 1.311 -1.092 0 C-N-CA 119.632 -0.827 . . . . 1.0 111.131 -179.139 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . 0.426 ' N ' ' HG ' ' A' ' 25' ' ' LEU . 81.5 t -58.26 -61.42 1.37 Allowed 'Isoleucine or valine' 0 CA--C 1.503 -0.849 0 C-N-CA 119.517 -0.873 . . . . 1.0 110.471 -174.404 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . 0.643 ' O ' ' HB3' ' A' ' 31' ' ' ALA . 2.0 p -56.35 -36.59 47.25 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.97 0 C-N-CA 120.081 -0.648 . . . . 1.0 109.632 -178.969 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 20.1 mtpp -68.13 -59.3 3.34 Favored 'General case' 0 C--N 1.318 -0.775 0 C-N-CA 119.452 -0.899 . . . . 1.0 111.932 -176.84 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 2.9 t -62.24 -50.22 80.85 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.379 0 CA-C-N 114.504 -1.225 . . . . 1.0 110.191 -177.688 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 30' ' ' CYS . . . . . . . . . . . . . 21.2 t -64.32 -62.36 1.65 Allowed 'General case' 0 N--CA 1.442 -0.857 0 C-N-CA 119.214 -0.994 . . . . 1.0 110.484 -177.598 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . 0.643 ' HB3' ' O ' ' A' ' 27' ' ' VAL . . . -56.46 -48.19 77.59 Favored 'General case' 0 CA--C 1.502 -0.878 0 CA-C-O 121.536 0.684 . . . . 1.0 110.076 -176.879 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . 0.64 ' O ' ' HB2' ' A' ' 33' ' ' LEU . . . 76.78 68.37 1.54 Allowed Glycine 0 CA--C 1.496 -1.114 0 N-CA-C 109.915 -1.274 . . . . 1.0 109.915 -179.657 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . 0.64 ' HB2' ' O ' ' A' ' 32' ' ' GLY . 5.2 mt 86.04 123.29 0.03 OUTLIER Pre-proline 0 CA--C 1.544 0.742 0 O-C-N 124.965 1.038 . . . . 1.0 110.402 -179.159 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 34' ' ' PRO . . . . . 0.541 ' HD2' HD23 ' A' ' 33' ' ' LEU . 49.2 Cg_endo -69.22 -17.94 39.78 Favored 'Trans proline' 0 N--CA 1.493 1.456 0 C-N-CA 122.131 1.887 . . . . 1.0 112.903 -178.324 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . 0.439 ' C ' HG21 ' A' ' 112' ' ' ILE . . . -62.95 -63.62 4.45 Favored Glycine 0 CA--C 1.527 0.806 0 C-N-CA 118.497 -1.811 . . . . 1.0 111.187 -178.093 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . 0.881 HG22 ' H ' ' A' ' 37' ' ' ILE . 5.1 p -77.5 -152.73 0.02 OUTLIER 'Isoleucine or valine' 0 CA--C 1.491 -1.304 0 N-CA-C 107.334 -1.358 . . . . 1.0 107.334 -179.641 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . 0.881 ' H ' HG22 ' A' ' 36' ' ' VAL . 0.3 OUTLIER 75.62 76.69 0.04 OUTLIER 'Isoleucine or valine' 0 C--O 1.218 -0.574 0 O-C-N 125.132 1.52 . . . . 1.0 111.534 178.069 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 38' ' ' HIS . . . . . 0.564 ' ND1' ' O ' ' A' ' 37' ' ' ILE . 1.8 m80 -137.64 133.93 34.9 Favored 'General case' 0 CA--C 1.487 -1.453 0 O-C-N 119.304 -2.122 . . . . 1.0 107.594 179.781 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . 0.563 ' OG1' ' O ' ' A' ' 41' ' ' ALA . 0.5 OUTLIER -107.99 122.78 39.67 Favored Pre-proline 0 CA--C 1.54 0.568 0 O-C-N 123.74 0.65 . . . . 1.0 110.549 -178.963 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 32.6 Cg_exo -61.83 -23.57 76.22 Favored 'Trans proline' 0 N--CA 1.495 1.57 0 C-N-CA 122.483 2.122 . . . . 1.0 112.378 178.046 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . 0.563 ' O ' ' OG1' ' A' ' 39' ' ' THR . . . -128.14 132.62 48.92 Favored 'General case' 0 N--CA 1.475 0.783 0 C-N-CA 122.394 0.278 . . . . 1.0 110.421 178.301 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . 0.435 ' CD ' ' O ' ' A' ' 39' ' ' THR . 0.0 OUTLIER -177.56 -177.59 0.68 Allowed 'General case' 0 N--CA 1.465 0.278 0 CA-C-N 117.962 0.346 . . . . 1.0 110.893 179.721 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 77.1 ttt180 -57.16 -46.1 83.04 Favored 'General case' 0 CA--C 1.536 0.427 0 N-CA-C 107.911 -1.144 . . . . 1.0 107.911 177.873 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . 0.516 ' C ' ' CG ' ' A' ' 45' ' ' PHE . . . 118.09 -25.57 8.27 Favored Glycine 0 N--CA 1.474 1.184 0 CA-C-O 120.067 -0.296 . . . . 1.0 112.642 178.912 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . 0.71 ' O ' ' HB2' ' A' ' 46' ' ' PHE . 0.1 OUTLIER -159.19 166.42 31.47 Favored 'General case' 0 CA--C 1.486 -1.496 0 N-CA-C 106.966 -1.494 . . . . 1.0 106.966 -179.258 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 46' ' ' PHE . . . . . 0.71 ' HB2' ' O ' ' A' ' 45' ' ' PHE . 31.2 m-85 104.1 116.95 0.01 OUTLIER 'General case' 0 N--CA 1.487 1.379 0 O-C-N 126.134 2.147 . . . . 1.0 110.589 179.815 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 47' ' ' ARG . . . . . 0.635 ' HE ' ' C9 ' ' A' ' 128' ' ' MTN . 0.0 OUTLIER 87.29 161.36 0.08 Allowed 'General case' 0 C--N 1.348 0.531 0 O-C-N 124.487 1.117 . . . . 1.0 110.499 179.366 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 48' ' ' CYS . . . . . 0.449 ' N ' ' HD3' ' A' ' 47' ' ' ARG . 41.2 t 61.67 67.19 0.78 Allowed 'General case' 0 CA--C 1.506 -0.723 0 N-CA-C 109.629 -0.508 . . . . 1.0 109.629 178.379 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 49' ' ' ASN . . . . . 0.769 ' O ' ' N ' ' A' ' 51' ' ' GLU . 10.5 m-80 -150.76 157.66 35.79 Favored Pre-proline 0 C--N 1.319 -0.721 0 CA-C-O 118.333 -0.842 . . . . 1.0 109.323 179.053 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . 0.6 ' HB2' ' HE ' ' A' ' 52' ' ' ARG . 50.1 Cg_exo -45.52 54.5 0.01 OUTLIER 'Trans proline' 0 N--CA 1.506 2.259 0 C-N-CA 123.768 2.979 . . . . 1.0 112.724 178.173 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . 0.769 ' N ' ' O ' ' A' ' 49' ' ' ASN . 1.6 mt-10 47.48 54.67 9.33 Favored 'General case' 0 C--N 1.33 -0.263 0 C-N-CA 123.357 0.663 . . . . 1.0 111.616 179.332 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . 0.6 ' HE ' ' HB2' ' A' ' 50' ' ' PRO . 34.3 mtm105 -152.24 167.2 29.38 Favored 'General case' 0 N--CA 1.469 0.507 0 CA-C-N 116.429 -0.35 . . . . 1.0 110.732 -179.125 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . 0.505 ' C ' ' NE2' ' A' ' 54' ' ' GLN . 2.2 tp -83.5 169.45 1.55 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.342 0 N-CA-C 108.531 -0.915 . . . . 1.0 108.531 178.536 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 54' ' ' GLN . . . . . 0.505 ' NE2' ' C ' ' A' ' 53' ' ' ILE . 0.0 OUTLIER -135.35 132.18 37.31 Favored 'General case' 0 N--CA 1.466 0.333 0 N-CA-C 109.294 -0.632 . . . . 1.0 109.294 -179.395 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . 0.467 ' N ' HD13 ' A' ' 55' ' ' ILE . 0.2 OUTLIER -145.4 154.63 13.62 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 N-CA-C 110.243 -0.28 . . . . 1.0 110.243 179.695 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 100.63 4.62 54.61 Favored Glycine 0 C--N 1.335 0.501 0 N-CA-C 109.975 -1.25 . . . . 1.0 109.975 179.47 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 73.1 m-20 -95.1 116.77 29.15 Favored 'General case' 0 CA--C 1.541 0.627 0 CA-C-O 122.842 1.306 . . . . 1.0 113.095 -179.68 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 58' ' ' TRP . . . . . 0.466 ' H ' ' CD ' ' A' ' 61' ' ' GLU . 17.8 m0 -79.19 179.46 7.37 Favored 'General case' 0 N--CA 1.483 1.206 0 CA-C-N 112.731 -2.031 . . . . 1.0 110.185 178.191 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 59' ' ' ARG . . . . . 0.537 ' HG2' ' H ' ' A' ' 60' ' ' TYR . 0.0 OUTLIER -93.22 -55.9 3.15 Favored 'General case' 0 CA--C 1.544 0.715 0 CA-C-N 118.434 0.561 . . . . 1.0 111.111 178.65 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 60' ' ' TYR . . . . . 0.537 ' H ' ' HG2' ' A' ' 59' ' ' ARG . 34.4 p90 -69.99 0.67 5.58 Favored 'General case' 0 C--O 1.239 0.53 0 C-N-CA 124.171 0.988 . . . . 1.0 108.866 178.676 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . 0.548 ' O ' ' N ' ' A' ' 65' ' ' ASP . 1.3 tt0 -61.63 -17.92 57.29 Favored 'General case' 0 C--O 1.21 -1.0 0 CA-C-N 115.348 -0.842 . . . . 1.0 112.447 -178.76 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . 0.719 HG23 ' H ' ' A' ' 63' ' ' ALA . 17.4 m -46.61 -56.29 1.36 Allowed 'Isoleucine or valine' 0 C--N 1.304 -1.394 0 N-CA-C 109.299 -0.63 . . . . 1.0 109.299 -174.724 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 63' ' ' ALA . . . . . 0.719 ' H ' HG23 ' A' ' 62' ' ' VAL . . . -60.9 -51.22 70.22 Favored 'General case' 0 N--CA 1.423 -1.796 0 N-CA-C 108.493 -0.928 . . . . 1.0 108.493 178.786 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 64' ' ' HIS . . . . . 0.562 ' HA ' ' HE ' ' A' ' 67' ' ' ARG . 19.1 t-80 -57.61 -60.62 3.4 Favored 'General case' 0 CA--C 1.548 0.903 0 CA-C-O 121.809 0.814 . . . . 1.0 112.356 -179.643 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . 0.613 ' C ' ' H ' ' A' ' 67' ' ' ARG . 29.7 t70 -66.83 -53.47 32.33 Favored 'General case' 0 C--N 1.312 -1.051 0 O-C-N 121.264 -0.897 . . . . 1.0 110.246 -179.267 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . 0.447 ' N ' ' O ' ' A' ' 62' ' ' VAL . . . -60.96 30.4 0.05 OUTLIER Glycine 0 CA--C 1.527 0.841 0 CA-C-N 115.734 -0.666 . . . . 1.0 112.593 -179.212 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 67' ' ' ARG . . . . . 0.613 ' H ' ' C ' ' A' ' 65' ' ' ASP . 94.8 mtt-85 -82.83 -5.09 58.8 Favored 'General case' 0 C--N 1.321 -0.672 0 O-C-N 122.746 -0.267 . . . . 1.0 111.647 175.697 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . 0.711 ' O ' ' HA ' ' A' ' 72' ' ' HIS . 0.2 OUTLIER -38.11 -28.74 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.524 0 CA-C-O 123.33 1.538 . . . . 1.0 107.084 178.907 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . 0.656 HD12 ' N ' ' A' ' 70' ' ' ALA . 0.9 OUTLIER -65.89 -64.01 0.96 Allowed 'General case' 0 CA--C 1.552 1.024 0 N-CA-C 105.847 -1.909 . . . . 1.0 105.847 175.716 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . 0.738 ' C ' ' H ' ' A' ' 72' ' ' HIS . . . -77.57 -73.36 0.31 Allowed 'General case' 0 C--N 1.364 1.232 0 N-CA-C 107.458 -1.312 . . . . 1.0 107.458 178.712 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . 0.757 ' HB1' ' HB ' ' A' ' 74' ' ' VAL . . . -50.17 7.4 0.0 OUTLIER 'General case' 0 C--N 1.351 0.671 0 C-N-CA 124.746 1.218 . . . . 1.0 110.744 177.834 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 72' ' ' HIS . . . . . 0.738 ' H ' ' C ' ' A' ' 70' ' ' ALA . 0.0 OUTLIER -17.56 -65.11 0.02 OUTLIER 'General case' 0 CA--C 1.492 -1.271 0 C-N-CA 123.565 0.746 . . . . 1.0 111.208 -175.852 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 73' ' ' MET . . . . . 0.499 ' N ' ' ND1' ' A' ' 72' ' ' HIS . 0.0 OUTLIER -77.24 -48.57 17.18 Favored 'General case' 0 C--N 1.292 -1.914 0 C-N-CA 120.275 -0.57 . . . . 1.0 110.452 178.264 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . 0.757 ' HB ' ' HB1' ' A' ' 71' ' ' ALA . 69.3 t -42.08 -44.45 0.98 Allowed 'Isoleucine or valine' 0 C--O 1.221 -0.405 0 CA-C-O 117.64 -1.172 . . . . 1.0 109.388 -174.7 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 75' ' ' ASN . . . . . 0.406 ' C ' ' N ' ' A' ' 77' ' ' ILE . 27.7 t-20 -36.75 -19.26 0.01 OUTLIER 'General case' 0 CA--C 1.553 1.094 0 CA-C-O 123.327 1.537 . . . . 1.0 110.639 179.342 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . 0.692 ' O ' HG12 ' A' ' 79' ' ' ILE . . . -49.05 -20.97 2.22 Favored Glycine 0 CA--C 1.543 1.827 0 N-CA-C 108.657 -1.777 . . . . 1.0 108.657 174.864 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . 0.485 HG13 ' H ' ' A' ' 78' ' ' VAL . 4.7 pt -47.4 -50.31 7.99 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.64 0 O-C-N 120.972 -1.31 . . . . 1.0 113.059 -179.02 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . 0.485 ' H ' HG13 ' A' ' 77' ' ' ILE . 12.0 p -55.1 -22.1 10.0 Favored 'Isoleucine or valine' 0 CA--C 1.504 -0.791 0 CA-C-O 120.832 0.348 . . . . 1.0 111.11 -178.024 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . 0.803 ' O ' ' HB2' ' A' ' 83' ' ' ALA . 0.5 OUTLIER -83.44 -46.01 18.56 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.867 0 C-N-CA 119.871 -0.731 . . . . 1.0 110.873 179.885 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 80' ' ' ALA . . . . . 0.507 ' N ' ' CG1' ' A' ' 79' ' ' ILE . . . -76.99 -21.84 54.08 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 115.633 -0.712 . . . . 1.0 111.007 -178.74 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . 0.547 ' OE1' ' N ' ' A' ' 81' ' ' GLU . 0.7 OUTLIER -83.07 -69.24 0.64 Allowed 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.011 -0.54 . . . . 1.0 111.093 -179.569 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 82' ' ' ASP . . . . . 0.636 ' O ' ' N ' ' A' ' 84' ' ' LEU . 88.9 m-20 -60.54 -60.86 3.13 Favored 'General case' 0 CA--C 1.496 -1.104 0 CA-C-O 118.048 -0.977 . . . . 1.0 110.376 -177.622 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . 0.803 ' HB2' ' O ' ' A' ' 79' ' ' ILE . . . 0.94 -66.22 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.773 0 O-C-N 125.475 1.735 . . . . 1.0 110.312 -179.793 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . 0.636 ' N ' ' O ' ' A' ' 82' ' ' ASP . 4.4 mm? -25.15 -49.87 0.03 OUTLIER 'General case' 0 N--CA 1.473 0.687 0 CA-C-N 115.521 -0.763 . . . . 1.0 109.802 -176.713 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 85' ' ' ILE . . . . . 0.627 HG23 ' N ' ' A' ' 86' ' ' ALA . 13.7 tt -98.29 -51.0 10.76 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.699 0 N-CA-C 109.438 -0.579 . . . . 1.0 109.438 177.014 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . 0.952 ' O ' HG13 ' A' ' 89' ' ' VAL . . . -50.39 -46.95 56.47 Favored 'General case' 0 C--O 1.224 -0.267 0 CA-C-N 116.026 -0.533 . . . . 1.0 110.747 -179.184 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . 0.568 ' N ' ' O ' ' A' ' 83' ' ' ALA . 22.6 tp10 -47.7 -18.32 0.14 Allowed 'General case' 0 C--N 1.323 -0.577 0 CA-C-O 120.987 0.422 . . . . 1.0 110.328 179.601 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . 0.84 ' C ' ' H ' ' A' ' 90' ' ' GLY . . . -74.45 6.11 4.04 Favored 'General case' 0 CA--C 1.491 -1.309 0 CA-C-N 115.745 -0.661 . . . . 1.0 110.818 -179.718 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 89' ' ' VAL . . . . . 0.952 HG13 ' O ' ' A' ' 86' ' ' ALA . 19.3 m -48.63 15.88 0.0 OUTLIER 'Isoleucine or valine' 0 C--O 1.216 -0.685 0 O-C-N 124.529 1.143 . . . . 1.0 111.616 -179.746 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 90' ' ' GLY . . . . . 0.84 ' H ' ' C ' ' A' ' 88' ' ' ALA . . . -33.58 -50.65 0.57 Allowed Glycine 0 C--N 1.351 1.386 0 N-CA-C 108.05 -2.02 . . . . 1.0 108.05 -177.08 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 91' ' ' PRO . . . . . 0.466 ' O ' ' N ' ' A' ' 94' ' ' ALA . 73.0 Cg_exo -48.11 0.35 0.02 OUTLIER 'Trans proline' 0 N--CA 1.495 1.565 0 C-N-CA 122.463 2.109 . . . . 1.0 112.216 173.163 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 92' ' ' HIS . . . . . 0.715 ' N ' ' O ' ' A' ' 89' ' ' VAL . 0.0 OUTLIER -47.57 -37.05 11.55 Favored 'General case' 0 N--CA 1.445 -0.707 0 N-CA-C 107.794 -1.187 . . . . 1.0 107.794 -176.053 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 1.5 pp -61.78 -37.8 85.67 Favored 'General case' 0 N--CA 1.436 -1.145 0 CA-C-O 121.702 0.763 . . . . 1.0 111.107 178.59 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 94' ' ' ALA . . . . . 0.466 ' N ' ' O ' ' A' ' 91' ' ' PRO . . . -62.57 -62.4 1.77 Allowed 'General case' 0 C--N 1.33 -0.26 0 N-CA-C 107.795 -1.187 . . . . 1.0 107.795 179.279 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 63.4 mmt-85 -59.52 -28.84 67.43 Favored 'General case' 0 N--CA 1.438 -1.059 0 N-CA-C 109.237 -0.653 . . . . 1.0 109.237 179.71 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 96' ' ' ALA . . . . . 0.797 ' O ' ' N ' ' A' ' 100' ' ' ILE . . . -59.49 -53.87 53.09 Favored 'General case' 0 CA--C 1.496 -1.13 0 N-CA-C 107.114 -1.439 . . . . 1.0 107.114 179.915 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . 0.643 ' O ' HG22 ' A' ' 100' ' ' ILE . 0.9 OUTLIER -37.78 -32.17 0.05 Allowed 'General case' 0 CA--C 1.556 1.175 0 N-CA-C 108.217 -1.031 . . . . 1.0 108.217 -179.191 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 98' ' ' GLY . . . . . 0.485 ' N ' ' O ' ' A' ' 96' ' ' ALA . . . -82.17 -52.72 3.92 Favored Glycine 0 CA--C 1.564 3.152 0 CA-C-O 123.692 1.718 . . . . 1.0 112.131 173.875 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 99' ' ' GLN . . . . . 0.442 ' N ' ' O ' ' A' ' 96' ' ' ALA . 60.9 mm-40 -77.71 9.59 3.34 Favored 'General case' 0 N--CA 1.44 -0.932 0 N-CA-C 107.978 -1.119 . . . . 1.0 107.978 178.895 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 100' ' ' ILE . . . . . 0.797 ' N ' ' O ' ' A' ' 96' ' ' ALA . 18.9 tt -59.74 -55.1 26.13 Favored 'Isoleucine or valine' 0 CA--C 1.493 -1.215 0 N-CA-C 109.578 -0.527 . . . . 1.0 109.578 -178.51 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 101' ' ' VAL . . . . . 0.728 HG13 ' H ' ' A' ' 102' ' ' CYS . 4.2 p -58.58 -58.85 4.88 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.535 0 C-N-CA 118.862 -1.135 . . . . 1.0 108.26 178.636 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 102' ' ' CYS . . . . . 0.728 ' H ' HG13 ' A' ' 101' ' ' VAL . 13.1 t -45.61 -26.57 0.63 Allowed 'General case' 0 C--O 1.215 -0.75 0 C-N-CA 120.212 -0.595 . . . . 1.0 109.525 -177.835 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 103' ' ' ARG . . . . . 0.431 ' N ' ' C ' ' A' ' 101' ' ' VAL . 0.0 OUTLIER -88.63 -41.96 12.32 Favored 'General case' 0 CA--C 1.549 0.911 0 CA-C-O 122.347 1.07 . . . . 1.0 113.846 179.598 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 104' ' ' TYR . . . . . 0.748 ' CG ' ' O ' ' A' ' 104' ' ' TYR . 4.0 t80 -95.25 23.0 6.16 Favored 'General case' 0 C--N 1.303 -1.445 0 C-N-CA 127.05 2.14 . . . . 1.0 108.722 178.128 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 105' ' ' GLY . . . . . 0.522 ' N ' ' O ' ' A' ' 101' ' ' VAL . . . -163.15 -86.29 0.06 OUTLIER Glycine 0 N--CA 1.442 -0.93 0 N-CA-C 108.058 -2.017 . . . . 1.0 108.058 178.102 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 106' ' ' ALA . . . . . 0.695 ' HB2' ' O ' ' A' ' 102' ' ' CYS . . . 64.08 66.66 0.63 Allowed 'General case' 0 C--N 1.32 -0.681 0 N-CA-C 112.42 0.526 . . . . 1.0 112.42 179.854 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 107' ' ' THR . . . . . 0.505 ' C ' ' HD2' ' A' ' 110' ' ' PRO . 0.5 OUTLIER -109.61 -9.93 14.86 Favored 'General case' 0 CA--C 1.536 0.431 0 O-C-N 122.136 -0.352 . . . . 1.0 110.438 179.086 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . 0.613 ' C ' ' HD2' ' A' ' 110' ' ' PRO . 0.0 OUTLIER -82.6 -62.81 1.34 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.694 0 N-CA-C 113.595 0.961 . . . . 1.0 113.595 -176.359 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 109' ' ' ILE . . . . . 0.594 ' N ' ' CD ' ' A' ' 110' ' ' PRO . 0.6 OUTLIER -54.61 -35.99 38.56 Favored Pre-proline 0 C--N 1.321 -0.673 0 N-CA-C 112.161 0.43 . . . . 1.0 112.161 179.933 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 110' ' ' PRO . . . . . 0.613 ' HD2' ' C ' ' A' ' 108' ' ' VAL . 81.4 Cg_exo -45.81 -32.48 9.19 Favored 'Trans proline' 0 C--N 1.323 -0.779 0 C-N-CA 122.258 1.972 . . . . 1.0 112.565 -174.697 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 111' ' ' ASN . . . . . 0.687 ' CG ' ' H ' ' A' ' 112' ' ' ILE . 12.5 p-10 -61.66 -68.62 0.3 Allowed 'General case' 0 CA--C 1.545 0.753 0 C-N-CA 119.699 -0.801 . . . . 1.0 110.355 -179.674 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 112' ' ' ILE . . . . . 0.687 ' H ' ' CG ' ' A' ' 111' ' ' ASN . 2.9 mm -74.7 -24.8 18.54 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.746 0 CA-C-O 121.851 0.834 . . . . 1.0 110.026 -178.122 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 18.9 t30 -51.72 -58.89 5.11 Favored 'General case' 0 C--N 1.298 -1.651 0 CA-C-N 114.159 -1.382 . . . . 1.0 109.933 -178.416 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -66.09 -19.5 65.86 Favored 'General case' 0 N--CA 1.447 -0.584 0 CA-C-N 116.22 -0.445 . . . . 1.0 110.359 179.197 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -75.13 -61.03 2.03 Favored 'General case' 0 CA--C 1.544 0.72 0 C-N-CA 120.312 -0.555 . . . . 1.0 111.242 178.388 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 116' ' ' ILE . . . . . 0.477 ' O ' ' CB ' ' A' ' 119' ' ' LEU . 15.1 tt -67.57 -38.94 81.41 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.334 0 O-C-N 121.052 -1.03 . . . . 1.0 110.918 -178.851 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 117' ' ' GLU . . . . . 0.472 ' C ' ' N ' ' A' ' 119' ' ' LEU . 1.0 OUTLIER -46.67 -68.06 0.23 Allowed 'General case' 0 C--N 1.3 -1.583 0 CA-C-N 115.334 -0.848 . . . . 1.0 110.493 -178.249 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 118' ' ' VAL . . . . . 0.44 HG12 ' O ' ' A' ' 118' ' ' VAL . 89.8 t -47.31 -14.03 0.08 OUTLIER 'Isoleucine or valine' 0 CA--C 1.505 -0.757 0 CA-C-N 114.838 -1.073 . . . . 1.0 109.515 -178.396 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 119' ' ' LEU . . . . . 0.477 ' CB ' ' O ' ' A' ' 116' ' ' ILE . 3.2 tp -77.19 -61.6 1.93 Allowed 'General case' 0 N--CA 1.45 -0.447 0 C-N-CA 119.464 -0.894 . . . . 1.0 110.43 179.101 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -73.36 -81.13 0.41 Allowed Glycine 0 C--N 1.362 2.013 0 C-N-CA 117.891 -2.1 . . . . 1.0 111.339 -178.348 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 1.2 t -158.53 -18.63 0.07 Allowed 'General case' 0 C--N 1.322 -0.601 0 CA-C-O 121.237 0.542 . . . . 1.0 110.601 -179.033 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 122' ' ' GLY . . . . . 0.453 ' O ' ' C ' ' A' ' 123' ' ' THR . . . 107.7 -38.45 3.32 Favored Glycine 0 N--CA 1.472 1.076 0 C-N-CA 125.026 1.298 . . . . 1.0 112.758 178.889 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 123' ' ' THR . . . . . 0.453 ' C ' ' O ' ' A' ' 122' ' ' GLY . 8.5 m -30.62 102.73 0.02 OUTLIER 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 118.49 1.145 . . . . 1.0 112.427 -177.128 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 38.0 p-10 -143.72 139.72 29.62 Favored 'General case' 0 C--N 1.332 -0.158 0 N-CA-C 106.985 -1.487 . . . . 1.0 106.985 178.744 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 125' ' ' TYR . . . . . 0.535 ' OH ' ' CE1' ' A' ' 127' ' ' PHE . 0.0 OUTLIER -153.95 150.72 28.61 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 116.185 -0.461 . . . . 1.0 110.165 -177.848 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 126' ' ' ARG . . . . . 0.509 ' HG2' ' O ' ' A' ' 125' ' ' TYR . 2.0 mmp_? -152.07 156.97 40.97 Favored 'General case' 0 CA--C 1.538 0.483 0 O-C-N 124.497 1.123 . . . . 1.0 111.962 176.829 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 127' ' ' PHE . . . . . 0.535 ' CE1' ' OH ' ' A' ' 125' ' ' TYR . 1.1 p90 . . . . . 0 C--O 1.222 -0.377 0 CA-C-O 118.007 -0.997 . . . . 1.0 110.465 178.886 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 128' ' ' MTN . . . . . 0.635 ' C9 ' ' HE ' ' A' ' 47' ' ' ARG . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 129' ' ' MTN . . . . . 0.545 ' C8 ' HD21 ' A' ' 49' ' ' ASN . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 130' ' ' MTN . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.457 ' SD ' ' N ' ' A' ' 1' ' ' MET . 0.0 OUTLIER . . . . . 0 N--CA 1.493 1.696 0 N-CA-C 109.236 -0.654 . . . . 1.0 109.236 . . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . 0.517 ' O ' ' CB ' ' A' ' 3' ' ' ASP . 87.6 p -86.47 9.09 19.31 Favored 'General case' 0 N--CA 1.463 0.209 0 CA-C-N 116.554 -0.294 . . . . 1.0 111.204 -179.818 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . 0.517 ' CB ' ' O ' ' A' ' 2' ' ' SER . 3.5 t70 149.99 123.81 0.0 OUTLIER 'General case' 0 N--CA 1.479 0.995 0 O-C-N 124.16 0.912 . . . . 1.0 111.189 178.551 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . 0.412 ' O ' ' OD1' ' A' ' 5' ' ' ASP . 83.9 t80 -155.25 150.92 27.48 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.408 -0.814 . . . . 1.0 110.403 178.812 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 5' ' ' ASP . . . . . 0.412 ' OD1' ' O ' ' A' ' 4' ' ' PHE . 74.9 m-20 -150.8 148.12 28.12 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.065 -0.516 . . . . 1.0 109.703 179.513 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 6' ' ' THR . . . . . 0.71 ' O ' ' N ' ' A' ' 10' ' ' SER . 0.2 OUTLIER -70.19 167.85 16.98 Favored 'General case' 0 C--O 1.195 -1.802 0 CA-C-O 121.156 0.503 . . . . 1.0 110.274 -179.461 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . 0.593 ' O ' ' N ' ' A' ' 11' ' ' ARG . 5.4 pt-20 -57.62 -57.78 11.21 Favored 'General case' 0 C--N 1.299 -1.587 0 CA-C-O 121.271 0.558 . . . . 1.0 110.369 -179.26 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 8' ' ' ARG . . . . . 0.79 ' O ' ' HB3' ' A' ' 12' ' ' ALA . 7.9 ttm180 -52.64 -56.07 18.01 Favored 'General case' 0 C--N 1.316 -0.87 0 N-CA-C 107.805 -1.183 . . . . 1.0 107.805 -178.187 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . 0.543 ' O ' ' CG2' ' A' ' 13' ' ' VAL . 0.0 OUTLIER -64.46 -50.42 76.2 Favored 'Isoleucine or valine' 0 C--O 1.203 -1.355 0 C-N-CA 119.488 -0.885 . . . . 1.0 109.816 178.718 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . 0.71 ' N ' ' O ' ' A' ' 6' ' ' THR . 20.9 t -65.41 -63.92 0.98 Allowed 'General case' 0 C--N 1.316 -0.884 0 C-N-CA 119.42 -0.912 . . . . 1.0 111.257 -178.565 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 11' ' ' ARG . . . . . 0.593 ' N ' ' O ' ' A' ' 7' ' ' GLU . 4.1 tpp180 -63.9 -59.03 5.02 Favored 'General case' 0 N--CA 1.471 0.624 0 CA-C-O 121.103 0.477 . . . . 1.0 111.888 -176.804 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . 0.79 ' HB3' ' O ' ' A' ' 8' ' ' ARG . . . -50.18 -49.38 52.58 Favored 'General case' 0 C--N 1.317 -0.82 0 N-CA-C 107.458 -1.312 . . . . 1.0 107.458 -177.232 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . 0.6 ' O ' ' N ' ' A' ' 17' ' ' LEU . 93.4 t -60.92 -49.47 84.52 Favored 'Isoleucine or valine' 0 C--O 1.198 -1.607 0 C-N-CA 118.733 -1.187 . . . . 1.0 107.946 177.347 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . 0.631 ' O ' HG13 ' A' ' 18' ' ' VAL . . . -57.53 -62.11 2.02 Favored 'General case' 0 C--O 1.212 -0.889 0 C-N-CA 118.519 -1.273 . . . . 1.0 109.913 -179.8 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . 0.57 ' O ' ' N ' ' A' ' 19' ' ' GLY . . . -51.28 -53.57 34.36 Favored 'General case' 0 N--CA 1.472 0.648 0 CA-C-O 121.706 0.765 . . . . 1.0 109.287 -178.245 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . 0.412 ' HB1' ' CA ' ' A' ' 22' ' ' GLY . . . -62.94 -55.08 29.01 Favored 'General case' 0 C--N 1.309 -1.186 0 CA-C-N 114.603 -1.18 . . . . 1.0 109.037 -178.988 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . 0.6 ' N ' ' O ' ' A' ' 13' ' ' VAL . 4.8 tt -55.91 -54.16 48.11 Favored 'General case' 0 N--CA 1.478 0.966 0 CA-C-N 113.921 -1.49 . . . . 1.0 109.063 -177.413 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . 0.631 HG13 ' O ' ' A' ' 14' ' ' ALA . 2.3 m -69.29 -57.4 8.62 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.359 0 N-CA-C 108.939 -0.763 . . . . 1.0 108.939 178.426 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . 0.57 ' N ' ' O ' ' A' ' 15' ' ' ALA . . . -58.03 -169.45 0.18 Allowed Glycine 0 C--O 1.216 -1.027 0 N-CA-C 110.67 -0.972 . . . . 1.0 110.67 179.722 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' PRO . . . . . 0.499 ' O ' ' N ' ' A' ' 24' ' ' ALA . 3.5 Cg_endo -79.62 -31.07 2.13 Favored 'Trans proline' 0 N--CA 1.499 1.798 0 C-N-CA 123.052 2.501 . . . . 1.0 115.154 -178.06 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -59.88 -57.43 19.39 Favored Glycine 0 N--CA 1.475 1.298 0 C-N-CA 120.699 -0.763 . . . . 1.0 112.665 -176.8 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . 0.412 ' CA ' ' HB1' ' A' ' 16' ' ' ALA . . . -55.99 -54.16 37.28 Favored Glycine 0 N--CA 1.469 0.844 0 N-CA-C 107.74 -2.144 . . . . 1.0 107.74 -175.534 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . 0.576 ' O ' HG12 ' A' ' 27' ' ' VAL . 0.0 OUTLIER -60.84 -32.23 51.61 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.391 0 CA-C-N 114.617 -0.792 . . . . 1.0 109.607 178.923 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . 0.499 ' N ' ' O ' ' A' ' 20' ' ' PRO . . . -56.01 -62.12 1.92 Allowed 'General case' 0 CA--C 1.532 0.28 0 C-N-CA 117.993 -1.483 . . . . 1.0 109.408 179.791 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -65.56 -45.16 84.39 Favored 'General case' 0 C--N 1.341 0.23 0 N-CA-C 112.82 0.674 . . . . 1.0 112.82 -178.464 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 98.5 t -60.22 -59.11 4.57 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.192 0 C-N-CA 118.849 -1.14 . . . . 1.0 110.21 -177.375 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . 0.576 HG12 ' O ' ' A' ' 23' ' ' VAL . 1.2 p -59.74 -35.16 58.33 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.286 0 CA-C-O 120.982 0.42 . . . . 1.0 111.95 -178.341 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 32.2 ttpt -66.54 -53.92 29.44 Favored 'General case' 0 C--N 1.315 -0.921 0 CA-C-O 121.906 0.86 . . . . 1.0 109.069 -178.376 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 91.1 t -64.37 -48.59 84.62 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.1 0 CA-C-N 113.668 -1.605 . . . . 1.0 111.557 -177.413 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 30' ' ' CYS . . . . . 0.572 ' SG ' ' N ' ' A' ' 31' ' ' ALA . 0.0 OUTLIER -63.82 -58.58 6.37 Favored 'General case' 0 N--CA 1.452 -0.336 0 C-N-CA 118.86 -1.136 . . . . 1.0 108.518 -179.299 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . 0.572 ' N ' ' SG ' ' A' ' 30' ' ' CYS . . . -61.7 -53.52 55.02 Favored 'General case' 0 C--N 1.326 -0.415 0 N-CA-C 112.422 0.527 . . . . 1.0 112.422 -177.515 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . 0.473 ' O ' ' CB ' ' A' ' 33' ' ' LEU . . . 86.86 74.42 1.27 Allowed Glycine 0 CA--C 1.522 0.481 0 N-CA-C 110.656 -0.978 . . . . 1.0 110.656 -178.87 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . 0.473 ' CB ' ' O ' ' A' ' 32' ' ' GLY . 1.0 OUTLIER 86.06 101.84 0.03 OUTLIER Pre-proline 0 CA--C 1.547 0.841 0 N-CA-C 109.813 -0.44 . . . . 1.0 109.813 -179.876 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 55.9 Cg_endo -71.48 -26.02 20.64 Favored 'Trans proline' 0 N--CA 1.501 1.96 0 C-N-CA 122.087 1.858 . . . . 1.0 114.055 -177.955 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -59.84 -59.45 10.47 Favored Glycine 0 CA--C 1.523 0.554 0 C-N-CA 118.081 -2.009 . . . . 1.0 108.884 -178.539 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . 0.64 ' O ' HG22 ' A' ' 37' ' ' ILE . 10.8 p -90.53 161.92 2.54 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.541 0 N-CA-C 107.277 -1.379 . . . . 1.0 107.277 177.565 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . 0.64 HG22 ' O ' ' A' ' 36' ' ' VAL . 14.8 tt 120.0 113.17 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.472 0.626 0 O-C-N 124.85 1.344 . . . . 1.0 110.061 179.615 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 22.7 m-70 -140.61 135.46 31.76 Favored 'General case' 0 C--N 1.322 -0.625 0 N-CA-C 108.874 -0.787 . . . . 1.0 108.874 178.87 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 42.5 p -112.54 139.8 23.1 Favored Pre-proline 0 C--N 1.331 -0.23 0 N-CA-C 109.146 -0.687 . . . . 1.0 109.146 179.716 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 40' ' ' PRO . . . . . 0.42 ' HG2' ' H ' ' A' ' 41' ' ' ALA . 57.6 Cg_endo -70.88 -87.15 0.0 OUTLIER 'Trans proline' 0 C--N 1.312 -1.367 0 C-N-CA 121.747 1.631 . . . . 1.0 112.015 -179.433 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . 0.42 ' H ' ' HG2' ' A' ' 40' ' ' PRO . . . -66.6 125.07 24.62 Favored 'General case' 0 C--N 1.315 -0.93 0 CA-C-N 114.786 -1.097 . . . . 1.0 110.623 -178.902 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . 0.657 ' C ' ' H ' ' A' ' 44' ' ' GLY . 4.2 ptt180 -170.7 168.42 7.44 Favored 'General case' 0 N--CA 1.445 -0.711 0 CA-C-N 115.556 -0.747 . . . . 1.0 109.779 179.893 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -63.31 24.86 0.01 OUTLIER 'General case' 0 C--N 1.317 -0.826 0 CA-C-N 115.88 -0.6 . . . . 1.0 110.369 179.83 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . 0.657 ' H ' ' C ' ' A' ' 42' ' ' ARG . . . 87.14 -26.2 7.1 Favored Glycine 0 C--N 1.333 0.402 0 N-CA-C 110.605 -0.998 . . . . 1.0 110.605 179.4 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . 0.646 ' CG ' ' O ' ' A' ' 44' ' ' GLY . 74.0 m-85 -167.37 175.15 7.45 Favored 'General case' 0 C--O 1.216 -0.675 0 O-C-N 124.759 0.917 . . . . 1.0 110.696 178.551 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 46' ' ' PHE . . . . . 0.577 ' HB2' ' O ' ' A' ' 45' ' ' PHE . 2.0 m-85 132.58 89.02 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.611 0 C-N-CA 125.625 1.57 . . . . 1.0 109.432 179.01 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 47' ' ' ARG . . . . . 0.508 ' CB ' ' O ' ' A' ' 46' ' ' PHE . 48.6 mmt-85 124.53 142.06 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.509 0 C-N-CA 124.33 1.052 . . . . 1.0 110.781 178.666 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 48' ' ' CYS . . . . . 0.44 ' O ' ' H62' ' A' ' 129' ' ' MTN . 2.6 t 69.45 70.62 0.25 Allowed 'General case' 0 C--N 1.331 -0.226 0 N-CA-C 108.355 -0.98 . . . . 1.0 108.355 -178.916 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 49' ' ' ASN . . . . . 0.585 ' CG ' HE22 ' A' ' 54' ' ' GLN . 1.7 p30 -125.17 152.79 71.34 Favored Pre-proline 0 C--O 1.233 0.232 0 CA-C-N 116.448 -0.342 . . . . 1.0 110.551 -178.969 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . 0.527 ' HG2' HH11 ' A' ' 52' ' ' ARG . 78.7 Cg_endo -73.17 55.84 3.03 Favored 'Trans proline' 0 C--N 1.311 -1.427 0 C-N-CA 122.022 1.815 . . . . 1.0 110.812 178.889 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 46.8 mm-40 68.18 -2.5 1.5 Allowed 'General case' 0 CA--C 1.528 0.127 0 CA-C-N 116.149 -0.478 . . . . 1.0 111.08 -179.635 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . 0.527 HH11 ' HG2' ' A' ' 50' ' ' PRO . 80.0 mtt85 -77.85 159.71 28.78 Favored 'General case' 0 N--CA 1.466 0.329 0 CA-C-O 120.999 0.428 . . . . 1.0 110.581 179.095 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . 0.429 ' O ' ' N ' ' A' ' 55' ' ' ILE . 19.4 tt -78.13 138.71 19.77 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.187 0 CA-C-N 115.906 -0.588 . . . . 1.0 111.218 -179.324 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 54' ' ' GLN . . . . . 0.585 HE22 ' CG ' ' A' ' 49' ' ' ASN . 29.2 mm-40 -63.16 81.4 0.02 OUTLIER 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 115.273 -0.876 . . . . 1.0 110.468 -177.973 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . 0.429 ' N ' ' O ' ' A' ' 53' ' ' ILE . 15.4 tt -147.01 156.02 11.01 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.152 0 CA-C-N 115.264 -0.88 . . . . 1.0 109.613 177.63 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 109.97 -2.13 30.12 Favored Glycine 0 N--CA 1.466 0.634 0 N-CA-C 110.683 -0.967 . . . . 1.0 110.683 -179.748 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . 0.418 ' O ' ' CG ' ' A' ' 57' ' ' ASP . 18.9 p-10 -79.43 99.56 7.25 Favored 'General case' 0 C--N 1.325 -0.468 0 N-CA-C 109.33 -0.619 . . . . 1.0 109.33 178.891 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 58' ' ' TRP . . . . . . . . . . . . . 3.9 m0 -89.99 170.58 10.23 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 123.753 1.739 . . . . 1.0 113.337 -177.052 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 59' ' ' ARG . . . . . 0.444 ' HG3' ' N ' ' A' ' 60' ' ' TYR . 48.3 ptt85 -82.29 -57.89 3.18 Favored 'General case' 0 C--N 1.312 -1.062 0 CA-C-N 110.393 -3.094 . . . . 1.0 112.779 -178.865 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 60' ' ' TYR . . . . . 0.444 ' N ' ' HG3' ' A' ' 59' ' ' ARG . 79.9 t80 -92.67 -15.68 26.46 Favored 'General case' 0 N--CA 1.485 1.285 0 N-CA-C 113.406 0.891 . . . . 1.0 113.406 -179.979 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 6.3 tt0 -77.49 -14.03 59.78 Favored 'General case' 0 C--N 1.313 -1.005 0 CA-C-N 116.065 -0.516 . . . . 1.0 111.073 -178.852 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . 0.638 ' O ' ' N ' ' A' ' 66' ' ' GLY . 27.5 m -48.22 -54.65 3.86 Favored 'Isoleucine or valine' 0 C--O 1.198 -1.616 0 C-N-CA 119.485 -0.886 . . . . 1.0 109.84 -175.346 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 63' ' ' ALA . . . . . 0.583 ' N ' HG23 ' A' ' 62' ' ' VAL . . . -68.01 -50.65 54.23 Favored 'General case' 0 C--N 1.306 -1.297 0 O-C-N 121.32 -0.862 . . . . 1.0 109.022 -179.968 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -48.5 -58.59 4.44 Favored 'General case' 0 N--CA 1.465 0.307 0 C-N-CA 119.594 -0.842 . . . . 1.0 109.274 -179.893 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . 0.538 ' C ' ' H ' ' A' ' 67' ' ' ARG . 18.5 t0 -71.63 -49.97 35.14 Favored 'General case' 0 C--N 1.314 -0.968 0 CA-C-N 115.147 -0.933 . . . . 1.0 110.159 178.832 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . 0.638 ' N ' ' O ' ' A' ' 62' ' ' VAL . . . -71.69 25.83 0.62 Allowed Glycine 0 CA--C 1.52 0.393 0 N-CA-C 110.915 -0.874 . . . . 1.0 110.915 178.241 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 67' ' ' ARG . . . . . 0.628 ' O ' ' N ' ' A' ' 69' ' ' LEU . 0.2 OUTLIER -75.89 2.49 12.31 Favored 'General case' 0 C--N 1.323 -0.564 0 N-CA-C 105.706 -1.961 . . . . 1.0 105.706 175.607 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . 0.519 HD12 ' O ' ' A' ' 66' ' ' GLY . 0.0 OUTLIER -35.23 -27.32 0.01 OUTLIER 'General case' 0 N--CA 1.482 1.169 0 N-CA-C 107.991 -1.114 . . . . 1.0 107.991 -176.559 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . 0.639 HD13 ' C ' ' A' ' 69' ' ' LEU . 2.9 tm? -62.68 -64.49 0.9 Allowed 'General case' 0 C--N 1.323 -0.56 0 C-N-CA 117.679 -1.608 . . . . 1.0 107.732 177.772 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . 0.689 ' C ' ' H ' ' A' ' 72' ' ' HIS . . . -79.01 -74.52 0.28 Allowed 'General case' 0 N--CA 1.479 0.995 0 N-CA-C 107.385 -1.339 . . . . 1.0 107.385 178.509 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . 0.435 ' O ' ' C ' ' A' ' 72' ' ' HIS . . . -45.15 4.16 0.0 OUTLIER 'General case' 0 C--O 1.224 -0.239 0 C-N-CA 124.849 1.26 . . . . 1.0 112.479 178.754 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 72' ' ' HIS . . . . . 0.689 ' H ' ' C ' ' A' ' 70' ' ' ALA . 1.9 t60 -29.83 -73.85 0.03 OUTLIER 'General case' 0 C--N 1.333 -0.123 0 N-CA-C 112.261 0.467 . . . . 1.0 112.261 -179.373 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 73' ' ' MET . . . . . 0.598 ' N ' ' SD ' ' A' ' 73' ' ' MET . 0.0 OUTLIER -58.34 -54.51 46.24 Favored 'General case' 0 C--N 1.329 -0.32 0 N-CA-C 106.521 -1.659 . . . . 1.0 106.521 178.655 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . 0.765 ' O ' ' N ' ' A' ' 76' ' ' GLY . 61.4 t -42.38 -39.83 0.87 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-O 117.271 -1.347 . . . . 1.0 111.681 -176.13 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 75' ' ' ASN . . . . . 0.492 ' C ' ' N ' ' A' ' 77' ' ' ILE . 33.4 p-10 -35.15 -15.18 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.607 0 CA-C-N 120.824 1.647 . . . . 1.0 110.806 179.558 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . 0.765 ' N ' ' O ' ' A' ' 74' ' ' VAL . . . -49.6 -19.93 2.38 Favored Glycine 0 N--CA 1.436 -1.328 0 N-CA-C 107.244 -2.343 . . . . 1.0 107.244 173.394 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . 0.492 ' N ' ' C ' ' A' ' 75' ' ' ASN . 14.1 pt -56.49 -50.59 72.17 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.032 0 CA-C-O 117.747 -1.12 . . . . 1.0 110.384 -179.334 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 24.4 t -54.71 -20.69 5.82 Favored 'Isoleucine or valine' 0 C--N 1.352 0.699 0 CA-C-N 121.095 1.77 . . . . 1.0 113.427 179.701 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . 0.593 ' CG2' HH22 ' A' ' 126' ' ' ARG . 44.8 pt -91.68 -40.27 12.25 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.34 0 C-N-CA 118.888 -1.125 . . . . 1.0 109.677 178.012 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -79.56 -19.85 48.46 Favored 'General case' 0 CA--C 1.538 0.494 0 N-CA-C 113.604 0.964 . . . . 1.0 113.604 179.495 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . 0.538 ' CG ' ' H ' ' A' ' 82' ' ' ASP . 1.1 pp20? -94.15 -71.52 0.66 Allowed 'General case' 0 C--N 1.345 0.4 0 N-CA-C 114.47 1.285 . . . . 1.0 114.47 -177.474 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 82' ' ' ASP . . . . . 0.538 ' H ' ' CG ' ' A' ' 81' ' ' GLU . 27.4 t70 -88.93 -15.04 35.31 Favored 'General case' 0 CA--C 1.538 0.493 0 N-CA-C 114.447 1.277 . . . . 1.0 114.447 -178.237 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . 0.59 ' O ' ' N ' ' A' ' 87' ' ' GLU . . . -49.75 -46.21 50.27 Favored 'General case' 0 C--O 1.214 -0.813 0 C-N-CA 118.116 -1.434 . . . . 1.0 112.352 -177.816 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . 0.648 HD13 ' O ' ' A' ' 84' ' ' LEU . 2.7 tm? -39.77 -45.47 1.75 Allowed 'General case' 0 N--CA 1.471 0.586 0 CA-C-N 118.207 0.458 . . . . 1.0 111.602 -178.026 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 85' ' ' ILE . . . . . 0.422 HG22 ' O ' ' A' ' 82' ' ' ASP . 6.4 tt -66.36 -34.64 71.5 Favored 'Isoleucine or valine' 0 C--O 1.235 0.296 0 C-N-CA 119.698 -0.801 . . . . 1.0 111.022 -179.583 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . 0.867 ' O ' HG22 ' A' ' 89' ' ' VAL . . . -93.64 -23.88 18.1 Favored 'General case' 0 C--O 1.211 -0.967 0 N-CA-C 111.728 0.27 . . . . 1.0 111.728 179.904 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . 0.59 ' N ' ' O ' ' A' ' 83' ' ' ALA . 38.9 tp10 -54.51 -18.81 4.76 Favored 'General case' 0 C--N 1.324 -0.509 0 O-C-N 121.447 -0.783 . . . . 1.0 109.946 -178.818 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -75.49 -5.83 47.12 Favored 'General case' 0 N--CA 1.473 0.687 0 CA-C-O 122.762 1.268 . . . . 1.0 108.097 178.329 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 89' ' ' VAL . . . . . 0.867 HG22 ' O ' ' A' ' 86' ' ' ALA . 3.2 m -86.05 36.31 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.318 -0.785 0 CA-C-N 112.173 -2.285 . . . . 1.0 107.962 177.085 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 90' ' ' GLY . . . . . 0.882 ' O ' ' N ' ' A' ' 92' ' ' HIS . . . -56.26 -19.66 25.72 Favored Glycine 0 C--N 1.373 2.601 0 CA-C-O 117.049 -1.973 . . . . 1.0 113.465 178.362 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 91' ' ' PRO . . . . . 0.699 ' HD2' ' N ' ' A' ' 90' ' ' GLY . 3.0 Cg_exo -34.38 3.42 0.0 OUTLIER 'Trans proline' 0 N--CA 1.499 1.817 0 CA-C-N 121.618 2.709 . . . . 1.0 113.693 172.409 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 92' ' ' HIS . . . . . 0.882 ' N ' ' O ' ' A' ' 90' ' ' GLY . 1.4 t-160 -47.2 -35.15 7.12 Favored 'General case' 0 N--CA 1.443 -0.816 0 N-CA-C 106.04 -1.837 . . . . 1.0 106.04 179.484 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . 0.439 ' O ' ' HB3' ' A' ' 96' ' ' ALA . 5.6 tp -62.57 -45.86 91.0 Favored 'General case' 0 C--N 1.35 0.609 0 N-CA-C 108.652 -0.869 . . . . 1.0 108.652 176.058 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 94' ' ' ALA . . . . . 0.545 ' N ' ' O ' ' A' ' 91' ' ' PRO . . . -53.69 -58.17 8.18 Favored 'General case' 0 C--N 1.333 -0.15 0 N-CA-C 106.344 -1.724 . . . . 1.0 106.344 178.685 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -58.32 -29.73 66.14 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-N 114.65 -1.159 . . . . 1.0 109.314 177.981 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 96' ' ' ALA . . . . . 0.855 ' O ' ' N ' ' A' ' 100' ' ' ILE . . . -54.35 -51.21 65.47 Favored 'General case' 0 C--O 1.199 -1.57 0 N-CA-C 107.84 -1.17 . . . . 1.0 107.84 -176.145 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . 0.583 ' O ' HG22 ' A' ' 100' ' ' ILE . 2.7 tm? -34.02 -28.37 0.01 OUTLIER 'General case' 0 CA--C 1.567 1.622 0 CA-C-N 113.788 -1.551 . . . . 1.0 108.052 -178.03 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 98' ' ' GLY . . . . . 0.648 ' N ' ' O ' ' A' ' 96' ' ' ALA . . . -89.37 -53.32 2.49 Favored Glycine 0 CA--C 1.56 2.866 0 CA-C-O 123.279 1.488 . . . . 1.0 111.956 170.46 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 99' ' ' GLN . . . . . 0.541 ' N ' ' O ' ' A' ' 96' ' ' ALA . 5.4 mm100 -75.93 6.48 5.09 Favored 'General case' 0 N--CA 1.439 -0.986 0 N-CA-C 107.64 -1.244 . . . . 1.0 107.64 179.156 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 100' ' ' ILE . . . . . 0.855 ' N ' ' O ' ' A' ' 96' ' ' ALA . 19.2 tt -63.46 -50.6 77.86 Favored 'Isoleucine or valine' 0 CA--C 1.471 -2.069 0 N-CA-C 107.784 -1.191 . . . . 1.0 107.784 -179.956 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 101' ' ' VAL . . . . . 0.673 ' O ' ' N ' ' A' ' 105' ' ' GLY . 76.1 t -51.84 -60.16 1.14 Allowed 'Isoleucine or valine' 0 C--O 1.212 -0.893 0 C-N-CA 118.292 -1.363 . . . . 1.0 107.389 178.691 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 102' ' ' CYS . . . . . 0.808 ' O ' ' HB2' ' A' ' 106' ' ' ALA . 0.0 OUTLIER -53.63 -25.39 17.55 Favored 'General case' 0 C--N 1.306 -1.299 0 CA-C-N 115.428 -0.806 . . . . 1.0 111.434 -176.78 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 103' ' ' ARG . . . . . 0.424 ' HG3' ' H81' ' A' ' 130' ' ' MTN . 51.1 ttm-85 -84.36 -52.05 6.49 Favored 'General case' 0 N--CA 1.488 1.471 0 CA-C-O 122.415 1.102 . . . . 1.0 113.337 -179.407 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 104' ' ' TYR . . . . . 0.671 ' O ' ' CG ' ' A' ' 104' ' ' TYR . 0.0 OUTLIER -96.33 21.79 8.61 Favored 'General case' 0 C--N 1.302 -1.488 0 C-N-CA 127.378 2.271 . . . . 1.0 106.819 177.874 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 105' ' ' GLY . . . . . 0.673 ' N ' ' O ' ' A' ' 101' ' ' VAL . . . -159.08 -97.88 0.13 Allowed Glycine 0 CA--C 1.53 0.99 0 N-CA-C 109.442 -1.463 . . . . 1.0 109.442 179.028 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 106' ' ' ALA . . . . . 0.808 ' HB2' ' O ' ' A' ' 102' ' ' CYS . . . 60.64 114.38 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.253 0 N-CA-C 108.985 -0.746 . . . . 1.0 108.985 -176.254 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 107' ' ' THR . . . . . 0.852 ' O ' ' HD2' ' A' ' 110' ' ' PRO . 22.0 m -133.28 -61.61 0.82 Allowed 'General case' 0 C--O 1.194 -1.819 0 N-CA-C 106.789 -1.56 . . . . 1.0 106.789 177.78 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 32.7 m -71.5 30.66 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.318 -0.795 0 O-C-N 121.22 -0.925 . . . . 1.0 109.251 -178.239 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 109' ' ' ILE . . . . . 0.65 HD13 ' HB1' ' A' ' 106' ' ' ALA . 0.1 OUTLIER -111.8 -40.46 0.1 Allowed Pre-proline 0 CA--C 1.56 1.346 0 CA-C-N 118.573 0.624 . . . . 1.0 110.882 177.969 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 110' ' ' PRO . . . . . 0.852 ' HD2' ' O ' ' A' ' 107' ' ' THR . 31.2 Cg_exo -65.33 -23.83 58.49 Favored 'Trans proline' 0 N--CA 1.496 1.62 0 C-N-CA 122.609 2.206 . . . . 1.0 111.82 179.72 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 111' ' ' ASN . . . . . 0.549 ' CG ' ' N ' ' A' ' 112' ' ' ILE . 0.0 OUTLIER -66.43 -66.77 0.51 Allowed 'General case' 0 CA--C 1.535 0.384 0 C-N-CA 119.51 -0.876 . . . . 1.0 109.132 -179.353 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 112' ' ' ILE . . . . . 0.549 ' N ' ' CG ' ' A' ' 111' ' ' ASN . 0.0 OUTLIER -52.43 -32.47 16.49 Favored 'Isoleucine or valine' 0 C--O 1.213 -0.821 0 CA-C-O 122.253 1.025 . . . . 1.0 109.139 178.783 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 113' ' ' ASN . . . . . 0.483 ' HB2' ' HA ' ' A' ' 110' ' ' PRO . 8.4 m-20 -55.39 -55.29 33.28 Favored 'General case' 0 C--N 1.296 -1.722 0 CA-C-N 113.345 -1.752 . . . . 1.0 107.581 -179.105 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -60.51 -29.31 69.01 Favored 'General case' 0 N--CA 1.44 -0.958 0 C-N-CA 119.383 -0.927 . . . . 1.0 110.995 178.934 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -77.93 -59.56 2.73 Favored 'General case' 0 N--CA 1.451 -0.413 0 C-N-CA 119.558 -0.857 . . . . 1.0 110.031 178.949 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 116' ' ' ILE . . . . . 0.64 ' O ' ' N ' ' A' ' 120' ' ' GLY . 1.4 tp -50.8 -48.21 28.34 Favored 'Isoleucine or valine' 0 CA--C 1.498 -1.055 0 N-CA-C 108.859 -0.793 . . . . 1.0 108.859 -179.096 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 117' ' ' GLU . . . . . 0.53 ' N ' ' CG2' ' A' ' 116' ' ' ILE . 51.6 mt-10 -38.9 -58.53 1.08 Allowed 'General case' 0 C--N 1.317 -0.838 0 N-CA-C 104.707 -2.331 . . . . 1.0 104.707 179.424 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 99.4 t -58.62 -52.02 64.81 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.716 0 C-N-CA 119.608 -0.837 . . . . 1.0 109.076 176.951 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 119' ' ' LEU . . . . . 0.474 ' N ' ' O ' ' A' ' 116' ' ' ILE . 0.3 OUTLIER -56.34 -69.64 0.14 Allowed 'General case' 0 N--CA 1.47 0.561 0 C-N-CA 118.362 -1.335 . . . . 1.0 107.641 -178.594 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 120' ' ' GLY . . . . . 0.64 ' N ' ' O ' ' A' ' 116' ' ' ILE . . . -72.0 -85.11 0.2 Allowed Glycine 0 CA--C 1.55 2.223 0 C-N-CA 119.172 -1.489 . . . . 1.0 111.25 178.229 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 121' ' ' THR . . . . . 0.487 ' HA ' ' O ' ' A' ' 117' ' ' GLU . 1.5 t 160.96 -27.66 0.0 OUTLIER 'General case' 0 N--CA 1.486 1.375 0 CA-C-N 113.797 -1.202 . . . . 1.0 113.362 -178.715 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 122' ' ' GLY . . . . . 0.632 ' O ' ' N ' ' A' ' 124' ' ' ASP . . . 97.38 -21.74 44.54 Favored Glycine 0 N--CA 1.476 1.36 0 N-CA-C 107.884 -2.086 . . . . 1.0 107.884 -177.511 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 123' ' ' THR . . . . . 0.542 ' O ' ' NE2' ' A' ' 72' ' ' HIS . 7.6 m -47.7 89.41 0.0 OUTLIER 'General case' 0 N--CA 1.467 0.413 0 N-CA-C 105.21 -2.144 . . . . 1.0 105.21 177.603 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 124' ' ' ASP . . . . . 0.632 ' N ' ' O ' ' A' ' 122' ' ' GLY . 29.8 t70 -166.32 175.57 8.14 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 114.856 -1.065 . . . . 1.0 112.361 -179.505 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 125' ' ' TYR . . . . . 0.488 ' N ' ' CG ' ' A' ' 124' ' ' ASP . 56.2 t80 -146.71 145.32 29.95 Favored 'General case' 0 CA--C 1.533 0.298 0 CA-C-N 115.102 -0.954 . . . . 1.0 109.106 176.7 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 126' ' ' ARG . . . . . 0.593 HH22 ' CG2' ' A' ' 79' ' ' ILE . 0.8 OUTLIER -147.18 146.46 29.86 Favored 'General case' 0 C--N 1.327 -0.387 0 N-CA-C 108.701 -0.851 . . . . 1.0 108.701 178.91 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 127' ' ' PHE . . . . . . . . . . . . . 29.2 p90 . . . . . 0 N--CA 1.47 0.573 0 CA-C-O 117.899 -1.048 . . . . 1.0 110.297 179.737 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 128' ' ' MTN . . . . . 0.468 ' H92' ' NH2' ' A' ' 47' ' ' ARG . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 129' ' ' MTN . . . . . 0.44 ' H62' ' O ' ' A' ' 48' ' ' CYS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 130' ' ' MTN . . . . . 0.424 ' H81' ' HG3' ' A' ' 103' ' ' ARG . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.591 ' SD ' ' N ' ' A' ' 1' ' ' MET . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.619 0 N-CA-C 108.998 -0.742 . . . . 1.0 108.998 . . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . 0.466 ' O ' ' CB ' ' A' ' 3' ' ' ASP . 78.2 p -81.07 5.92 15.15 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.854 -0.612 . . . . 1.0 110.771 -179.805 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . 0.478 ' N ' ' OD1' ' A' ' 3' ' ' ASP . 5.1 p30 154.17 127.72 0.0 OUTLIER 'General case' 0 N--CA 1.472 0.629 0 O-C-N 123.669 0.606 . . . . 1.0 110.556 178.965 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 71.9 t80 -154.1 149.7 27.41 Favored 'General case' 0 N--CA 1.466 0.338 0 CA-C-O 120.789 0.328 . . . . 1.0 110.762 179.33 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 68.4 m-20 -152.92 147.96 26.58 Favored 'General case' 0 CA--C 1.535 0.389 0 N-CA-C 109.555 -0.535 . . . . 1.0 109.555 179.747 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 6' ' ' THR . . . . . 0.809 ' O ' ' N ' ' A' ' 10' ' ' SER . 0.2 OUTLIER -93.64 -177.61 4.44 Favored 'General case' 0 C--O 1.187 -2.225 0 CA-C-N 116.68 -0.236 . . . . 1.0 110.972 -179.485 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . 0.532 ' O ' ' N ' ' A' ' 11' ' ' ARG . 66.5 tt0 -59.93 -55.44 34.1 Favored 'General case' 0 N--CA 1.476 0.849 0 CA-C-O 121.518 0.675 . . . . 1.0 110.933 -179.274 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 8' ' ' ARG . . . . . 0.531 ' O ' ' CB ' ' A' ' 12' ' ' ALA . 0.6 OUTLIER -53.58 -58.98 5.22 Favored 'General case' 0 C--N 1.304 -1.409 0 N-CA-C 107.749 -1.204 . . . . 1.0 107.749 179.865 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . 0.849 ' O ' HG13 ' A' ' 13' ' ' VAL . 0.0 OUTLIER -65.47 -49.32 78.96 Favored 'Isoleucine or valine' 0 CA--C 1.559 1.308 0 CA-C-N 114.575 -1.193 . . . . 1.0 110.978 179.816 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . 0.809 ' N ' ' O ' ' A' ' 6' ' ' THR . 32.2 t -61.11 -57.94 10.42 Favored 'General case' 0 N--CA 1.492 1.668 0 CA-C-O 122.23 1.014 . . . . 1.0 108.315 179.057 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 11' ' ' ARG . . . . . 0.677 ' O ' ' HB3' ' A' ' 15' ' ' ALA . 7.6 tpt180 -61.97 -40.79 96.8 Favored 'General case' 0 C--N 1.315 -0.92 0 CA-C-N 115.412 -0.813 . . . . 1.0 109.167 -177.578 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . 0.756 ' O ' ' HB3' ' A' ' 16' ' ' ALA . . . -68.05 -55.44 12.55 Favored 'General case' 0 N--CA 1.475 0.825 0 C-N-CA 119.193 -1.003 . . . . 1.0 108.557 176.164 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . 0.849 HG13 ' O ' ' A' ' 9' ' ' VAL . 4.5 m -63.28 -53.03 51.09 Favored 'Isoleucine or valine' 0 C--O 1.205 -1.246 0 C-N-CA 118.241 -1.384 . . . . 1.0 108.894 -178.957 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . 0.838 ' O ' HG22 ' A' ' 18' ' ' VAL . . . -60.8 -64.35 0.98 Allowed 'General case' 0 C--N 1.305 -1.347 0 C-N-CA 117.953 -1.499 . . . . 1.0 110.464 179.668 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . 0.677 ' HB3' ' O ' ' A' ' 11' ' ' ARG . . . -56.52 -56.45 21.05 Favored 'General case' 0 N--CA 1.479 0.992 0 C-N-CA 119.522 -0.871 . . . . 1.0 111.375 -177.883 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . 0.756 ' HB3' ' O ' ' A' ' 12' ' ' ALA . . . -65.6 -56.42 12.31 Favored 'General case' 0 C--N 1.318 -0.791 0 C-N-CA 119.068 -1.053 . . . . 1.0 110.298 -178.596 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . 0.625 ' CB ' ' O ' ' A' ' 13' ' ' VAL . 5.2 tt -58.36 -54.94 41.39 Favored 'General case' 0 N--CA 1.485 1.293 0 C-N-CA 118.869 -1.132 . . . . 1.0 108.853 -178.289 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . 0.838 HG22 ' O ' ' A' ' 14' ' ' ALA . 1.3 m -71.88 -57.75 6.65 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.858 0 C-N-CA 119.112 -1.035 . . . . 1.0 110.851 -179.823 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . 0.515 ' N ' ' O ' ' A' ' 15' ' ' ALA . . . -57.33 -175.22 0.34 Allowed Glycine 0 N--CA 1.444 -0.808 0 C-N-CA 121.23 -0.509 . . . . 1.0 112.076 -177.036 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 20' ' ' PRO . . . . . 0.638 ' O ' ' N ' ' A' ' 24' ' ' ALA . 4.1 Cg_endo -81.06 -27.03 3.16 Favored 'Trans proline' 0 C--N 1.307 -1.647 0 C-N-CA 122.749 2.3 . . . . 1.0 113.172 -178.433 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -63.05 -61.26 6.57 Favored Glycine 0 N--CA 1.474 1.17 0 C-N-CA 119.279 -1.439 . . . . 1.0 112.432 -176.33 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . 0.529 ' H ' ' HA ' ' A' ' 16' ' ' ALA . . . -53.08 -51.87 43.55 Favored Glycine 0 N--CA 1.472 1.087 0 N-CA-C 106.14 -2.784 . . . . 1.0 106.14 -177.697 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . 0.414 ' O ' HG12 ' A' ' 27' ' ' VAL . 40.5 t -61.61 -31.5 50.91 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.089 0 C-N-CA 119.42 -0.912 . . . . 1.0 109.811 178.517 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . 0.638 ' N ' ' O ' ' A' ' 20' ' ' PRO . . . -57.68 -62.49 1.76 Allowed 'General case' 0 C--N 1.353 0.756 0 C-N-CA 118.551 -1.26 . . . . 1.0 109.703 -179.501 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . 0.498 ' C ' HD12 ' A' ' 25' ' ' LEU . 0.5 OUTLIER -61.42 -44.72 96.64 Favored 'General case' 0 N--CA 1.464 0.251 0 C-N-CA 119.902 -0.719 . . . . 1.0 111.93 -178.237 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . 0.479 ' N ' ' HG ' ' A' ' 25' ' ' LEU . 31.6 t -58.98 -58.35 7.27 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.819 0 C-N-CA 119.455 -0.898 . . . . 1.0 110.278 -177.843 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . 0.566 ' O ' ' HB3' ' A' ' 31' ' ' ALA . 1.4 p -63.01 -36.67 76.78 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.716 0 C-N-CA 120.393 -0.523 . . . . 1.0 110.971 -177.999 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 2.0 tppp? -65.47 -57.81 7.37 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-O 121.756 0.788 . . . . 1.0 109.199 -179.237 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 79.3 t -63.56 -47.78 89.9 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.023 0 CA-C-N 114.622 -1.172 . . . . 1.0 110.208 -177.351 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 30' ' ' CYS . . . . . . . . . . . . . 51.4 t -65.56 -61.02 2.34 Favored 'General case' 0 N--CA 1.446 -0.64 0 C-N-CA 119.355 -0.938 . . . . 1.0 110.358 -179.397 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . 0.566 ' HB3' ' O ' ' A' ' 27' ' ' VAL . . . -59.71 -47.8 84.21 Favored 'General case' 0 CA--C 1.515 -0.378 0 O-C-N 122.083 -0.385 . . . . 1.0 111.158 -176.954 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . 0.497 ' O ' ' HB2' ' A' ' 33' ' ' LEU . . . 72.89 64.62 2.51 Favored Glycine 0 N--CA 1.449 -0.492 0 N-CA-C 108.788 -1.725 . . . . 1.0 108.788 -178.144 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . 0.497 ' HB2' ' O ' ' A' ' 32' ' ' GLY . 27.2 mt 83.77 129.88 0.03 OUTLIER Pre-proline 0 CA--C 1.544 0.739 0 O-C-N 125.295 1.233 . . . . 1.0 111.12 -178.465 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 58.7 Cg_endo -72.13 -5.26 16.76 Favored 'Trans proline' 0 N--CA 1.495 1.594 0 C-N-CA 122.788 2.325 . . . . 1.0 112.599 179.028 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . 0.404 ' HA2' HD12 ' A' ' 112' ' ' ILE . . . -62.12 -62.16 5.94 Favored Glycine 0 C--N 1.336 0.568 0 C-N-CA 118.405 -1.855 . . . . 1.0 111.095 -178.565 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . 0.834 HG22 ' H ' ' A' ' 37' ' ' ILE . 8.7 p -87.26 -142.71 0.01 OUTLIER 'Isoleucine or valine' 0 C--O 1.216 -0.683 0 N-CA-C 107.552 -1.277 . . . . 1.0 107.552 178.793 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . 0.834 ' H ' HG22 ' A' ' 36' ' ' VAL . 0.3 OUTLIER 70.54 76.46 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.473 0.716 0 CA-C-O 122.344 1.069 . . . . 1.0 111.42 179.842 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 95.4 m-70 -139.75 133.2 30.12 Favored 'General case' 0 C--N 1.33 -0.269 0 O-C-N 120.989 -1.069 . . . . 1.0 109.18 179.311 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -108.57 124.79 33.39 Favored Pre-proline 0 CA--C 1.541 0.615 0 N-CA-C 109.67 -0.493 . . . . 1.0 109.67 179.789 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 52.0 Cg_exo -49.94 -23.08 8.39 Favored 'Trans proline' 0 N--CA 1.5 1.866 0 C-N-CA 121.796 1.664 . . . . 1.0 113.827 179.985 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -126.17 134.86 51.15 Favored 'General case' 0 N--CA 1.469 0.506 0 N-CA-C 111.311 0.115 . . . . 1.0 111.311 178.54 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . 0.682 ' C ' ' H ' ' A' ' 44' ' ' GLY . 19.3 ttp-105 -164.68 164.46 21.37 Favored 'General case' 0 C--N 1.328 -0.353 0 C-N-CA 120.197 -0.601 . . . . 1.0 109.787 177.172 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 43' ' ' ARG . . . . . 0.625 ' C ' ' H ' ' A' ' 45' ' ' PHE . 4.7 tpt180 -60.92 24.59 0.01 OUTLIER 'General case' 0 CA--C 1.545 0.75 0 CA-C-N 115.789 -0.642 . . . . 1.0 110.623 -178.864 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . 0.682 ' H ' ' C ' ' A' ' 42' ' ' ARG . . . 66.27 -32.12 0.16 Allowed Glycine 0 C--N 1.34 0.769 0 N-CA-C 110.65 -0.98 . . . . 1.0 110.65 179.456 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . 0.637 ' O ' ' HB2' ' A' ' 46' ' ' PHE . 11.8 t80 -169.34 170.81 8.24 Favored 'General case' 0 N--CA 1.446 -0.642 0 N-CA-C 108.378 -0.971 . . . . 1.0 108.378 179.141 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 46' ' ' PHE . . . . . 0.637 ' HB2' ' O ' ' A' ' 45' ' ' PHE . 1.0 OUTLIER 120.8 106.64 0.0 OUTLIER 'General case' 0 N--CA 1.497 1.921 0 C-N-CA 127.333 2.253 . . . . 1.0 106.34 -179.346 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 47' ' ' ARG . . . . . 0.531 ' HB2' ' O ' ' A' ' 46' ' ' PHE . 0.1 OUTLIER 103.24 149.84 0.01 OUTLIER 'General case' 0 N--CA 1.479 1.0 0 C-N-CA 124.827 1.251 . . . . 1.0 109.86 -178.602 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 48' ' ' CYS . . . . . 0.511 ' SG ' ' C ' ' A' ' 47' ' ' ARG . 0.0 OUTLIER 64.3 71.92 0.46 Allowed 'General case' 0 CA--C 1.534 0.361 0 CA-C-N 114.984 -1.007 . . . . 1.0 110.396 -178.892 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -140.85 163.53 42.13 Favored Pre-proline 0 C--N 1.33 -0.269 0 O-C-N 121.92 -0.487 . . . . 1.0 110.747 -179.22 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 38.4 Cg_endo -66.18 47.08 0.22 Allowed 'Trans proline' 0 N--CA 1.498 1.773 0 C-N-CA 123.107 2.538 . . . . 1.0 111.78 178.738 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . 0.531 ' OE1' ' NH2' ' A' ' 95' ' ' ARG . 7.6 mt-10 57.02 12.4 1.22 Allowed 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 115.37 -0.832 . . . . 1.0 111.393 179.593 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 24.9 ptt85 -85.87 147.31 26.33 Favored 'General case' 0 C--N 1.333 -0.119 0 N-CA-C 107.296 -1.372 . . . . 1.0 107.296 177.846 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 8.8 tp -49.46 138.4 4.89 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.496 0 CA-C-O 122.012 0.91 . . . . 1.0 113.033 -177.893 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 54' ' ' GLN . . . . . 0.587 ' H ' ' CD ' ' A' ' 54' ' ' GLN . 0.0 OUTLIER -76.17 79.51 2.98 Favored 'General case' 0 CA--C 1.534 0.351 0 CA-C-N 114.074 -1.421 . . . . 1.0 109.222 179.613 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 1.8 mt -147.38 157.12 9.88 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.75 0 CA-C-N 115.244 -0.889 . . . . 1.0 110.211 178.094 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 108.5 -0.24 32.67 Favored Glycine 0 C--N 1.338 0.691 0 N-CA-C 110.553 -1.019 . . . . 1.0 110.553 179.766 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . 0.424 ' O ' ' OD1' ' A' ' 57' ' ' ASP . 31.1 p-10 -80.27 101.74 9.08 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 121.584 0.707 . . . . 1.0 112.393 -178.816 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 58' ' ' TRP . . . . . . . . . . . . . 10.0 m0 -78.61 179.12 7.3 Favored 'General case' 0 C--N 1.323 -0.548 0 N-CA-C 108.028 -1.101 . . . . 1.0 108.028 178.34 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 59' ' ' ARG . . . . . 0.577 ' O ' ' CG2' ' A' ' 62' ' ' VAL . 1.0 OUTLIER -100.28 -49.12 4.36 Favored 'General case' 0 CA--C 1.546 0.81 0 CA-C-N 121.522 1.965 . . . . 1.0 111.613 178.535 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 60' ' ' TYR . . . . . 0.411 ' CD1' ' C ' ' A' ' 60' ' ' TYR . 3.7 p90 -85.98 -9.6 56.55 Favored 'General case' 0 N--CA 1.488 1.43 0 C-N-CA 124.997 1.319 . . . . 1.0 113.281 -177.98 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . 0.402 ' O ' ' N ' ' A' ' 65' ' ' ASP . 27.1 tt0 -75.32 -14.07 60.46 Favored 'General case' 0 C--N 1.308 -1.219 0 O-C-N 121.554 -0.716 . . . . 1.0 110.622 -178.952 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . 0.577 ' CG2' ' O ' ' A' ' 59' ' ' ARG . 0.0 OUTLIER -44.28 -50.34 1.92 Allowed 'Isoleucine or valine' 0 C--N 1.315 -0.901 0 N-CA-C 109.715 -0.476 . . . . 1.0 109.715 -175.69 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 63' ' ' ALA . . . . . 0.508 ' O ' ' HG2' ' A' ' 67' ' ' ARG . . . -67.6 -47.15 70.52 Favored 'General case' 0 N--CA 1.425 -1.683 0 N-CA-C 108.587 -0.894 . . . . 1.0 108.587 -179.878 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 64' ' ' HIS . . . . . 0.449 ' O ' ' CG ' ' A' ' 67' ' ' ARG . 0.5 OUTLIER -55.21 -59.22 5.07 Favored 'General case' 0 CA--C 1.547 0.841 0 CA-C-N 115.292 -0.867 . . . . 1.0 109.871 179.683 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . 0.639 ' C ' ' H ' ' A' ' 67' ' ' ARG . 29.6 t70 -67.08 -53.39 31.38 Favored 'General case' 0 C--O 1.243 0.739 0 CA-C-O 121.667 0.746 . . . . 1.0 109.27 178.438 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . 0.551 ' N ' ' O ' ' A' ' 62' ' ' VAL . . . -63.3 31.14 0.08 OUTLIER Glycine 0 CA--C 1.523 0.573 0 N-CA-C 111.477 -0.649 . . . . 1.0 111.477 178.263 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 67' ' ' ARG . . . . . 0.77 ' HB3' ' HB3' ' A' ' 71' ' ' ALA . 6.3 mmt180 -76.34 -2.59 32.47 Favored 'General case' 0 C--N 1.315 -0.901 0 N-CA-C 108.07 -1.085 . . . . 1.0 108.07 174.876 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . 0.483 ' C ' ' O ' ' A' ' 67' ' ' ARG . 5.8 tt -35.16 -30.35 0.01 OUTLIER 'General case' 0 N--CA 1.475 0.82 0 N-CA-C 108.63 -0.878 . . . . 1.0 108.63 -176.403 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . 0.57 ' N ' ' O ' ' A' ' 67' ' ' ARG . 9.9 mp -69.24 -68.57 0.39 Allowed 'General case' 0 CA--C 1.549 0.921 0 CA-C-N 115.09 -0.959 . . . . 1.0 111.063 179.686 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . 0.613 ' C ' ' H ' ' A' ' 72' ' ' HIS . . . -77.16 -76.85 0.16 Allowed 'General case' 0 N--CA 1.473 0.723 0 C-N-CA 119.016 -1.074 . . . . 1.0 109.457 -178.373 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . 0.77 ' HB3' ' HB3' ' A' ' 67' ' ' ARG . . . -57.31 10.48 0.01 OUTLIER 'General case' 0 C--N 1.324 -0.502 0 C-N-CA 124.652 1.181 . . . . 1.0 112.574 179.784 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 72' ' ' HIS . . . . . 0.878 ' CD2' ' H ' ' A' ' 73' ' ' MET . 1.3 p80 -19.84 -48.23 0.01 OUTLIER 'General case' 0 N--CA 1.465 0.323 0 N-CA-C 114.669 1.359 . . . . 1.0 114.669 -177.197 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 73' ' ' MET . . . . . 0.878 ' H ' ' CD2' ' A' ' 72' ' ' HIS . 15.4 ptp -74.87 -47.91 27.67 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 119.275 0.943 . . . . 1.0 109.353 179.058 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . 0.705 ' HB ' ' HB1' ' A' ' 71' ' ' ALA . 59.3 t -43.23 -48.46 1.41 Allowed 'Isoleucine or valine' 0 C--O 1.214 -0.79 0 CA-C-O 117.736 -1.126 . . . . 1.0 110.972 -175.389 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 75' ' ' ASN . . . . . 0.402 ' C ' ' O ' ' A' ' 74' ' ' VAL . 3.9 m120 -37.52 -19.66 0.01 OUTLIER 'General case' 0 N--CA 1.48 1.075 0 CA-C-O 122.714 1.245 . . . . 1.0 109.987 178.507 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . 0.661 ' N ' ' O ' ' A' ' 74' ' ' VAL . . . -50.99 -24.3 8.3 Favored Glycine 0 C--O 1.213 -1.177 0 N-CA-C 108.143 -1.983 . . . . 1.0 108.143 176.207 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . 0.444 ' N ' ' O ' ' A' ' 74' ' ' VAL . 9.5 pt -45.64 -43.78 4.1 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.323 0 O-C-N 122.289 -0.536 . . . . 1.0 110.9 179.523 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 57.5 t -55.65 -22.04 11.5 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.343 0 CA-C-N 118.649 0.659 . . . . 1.0 111.05 -179.67 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . 0.611 ' O ' ' HB2' ' A' ' 83' ' ' ALA . 0.3 OUTLIER -88.03 -42.49 15.0 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.715 0 C-N-CA 119.32 -0.952 . . . . 1.0 110.058 178.556 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -78.93 -23.03 44.95 Favored 'General case' 0 CA--C 1.537 0.444 0 N-CA-C 112.262 0.467 . . . . 1.0 112.262 -178.892 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 94.8 mt-10 -91.11 -68.25 0.8 Allowed 'General case' 0 CA--C 1.533 0.289 0 N-CA-C 112.475 0.546 . . . . 1.0 112.475 178.718 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 82' ' ' ASP . . . . . 0.46 ' O ' ' C ' ' A' ' 83' ' ' ALA . 1.2 m-20 -74.76 -21.49 59.31 Favored 'General case' 0 C--N 1.349 0.555 0 N-CA-C 114.991 1.478 . . . . 1.0 114.991 -176.35 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . 0.682 ' HA ' ' HB3' ' A' ' 86' ' ' ALA . . . -37.38 -50.08 1.03 Allowed 'General case' 0 N--CA 1.483 1.187 0 CA-C-N 120.253 1.388 . . . . 1.0 111.355 178.743 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . 0.49 ' C ' ' O ' ' A' ' 83' ' ' ALA . 0.1 OUTLIER -26.88 -41.74 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.609 0 CA-C-O 120.62 0.248 . . . . 1.0 110.645 -175.327 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 85' ' ' ILE . . . . . 0.505 ' N ' ' O ' ' A' ' 83' ' ' ALA . 2.9 pt -98.63 -46.65 12.39 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 N-CA-C 109.468 -0.568 . . . . 1.0 109.468 177.605 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . 0.682 ' HB3' ' HA ' ' A' ' 83' ' ' ALA . . . -49.54 -44.27 46.44 Favored 'General case' 0 N--CA 1.461 0.102 0 CA-C-N 115.931 -0.577 . . . . 1.0 110.14 -177.913 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 21.6 pt-20 -53.73 -21.9 8.1 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.929 0.395 . . . . 1.0 110.54 179.62 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -82.36 -13.84 56.23 Favored 'General case' 0 CA--C 1.517 -0.316 0 CA-C-O 121.289 0.566 . . . . 1.0 109.889 -179.476 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 89' ' ' VAL . . . . . 0.513 ' O ' HG12 ' A' ' 89' ' ' VAL . 18.5 t -93.06 34.74 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.553 0 CA-C-N 114.964 -1.016 . . . . 1.0 109.419 178.972 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 90' ' ' GLY . . . . . 0.534 ' O ' ' N ' ' A' ' 92' ' ' HIS . . . -74.66 -41.44 35.17 Favored Glycine 0 CA--C 1.539 1.555 0 N-CA-C 111.501 -0.64 . . . . 1.0 111.501 179.09 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 91' ' ' PRO . . . . . 0.48 ' CD ' ' N ' ' A' ' 90' ' ' GLY . 91.0 Cg_exo -41.35 -20.89 0.11 Allowed 'Trans proline' 0 N--CA 1.492 1.391 0 CA-C-N 119.354 1.577 . . . . 1.0 111.177 -179.795 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 92' ' ' HIS . . . . . 0.692 ' O ' ' N ' ' A' ' 96' ' ' ALA . 27.6 p-80 -53.73 -38.7 64.6 Favored 'General case' 0 C--O 1.196 -1.733 0 N-CA-C 106.489 -1.671 . . . . 1.0 106.489 -179.162 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . 0.777 HD12 ' N ' ' A' ' 94' ' ' ALA . 2.6 pp -46.17 -58.98 3.18 Favored 'General case' 0 C--N 1.319 -0.745 0 C-N-CA 120.183 -0.607 . . . . 1.0 110.428 -179.757 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 94' ' ' ALA . . . . . 0.777 ' N ' HD12 ' A' ' 93' ' ' LEU . . . -59.5 -56.79 17.59 Favored 'General case' 0 N--CA 1.465 0.275 0 CA-C-N 118.514 0.597 . . . . 1.0 109.692 -179.953 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 95' ' ' ARG . . . . . 0.668 ' O ' ' N ' ' A' ' 97' ' ' LEU . 5.8 mtp-105 -54.53 -58.61 6.82 Favored 'General case' 0 C--O 1.238 0.494 0 N-CA-C 107.789 -1.189 . . . . 1.0 107.789 178.347 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 96' ' ' ALA . . . . . 0.745 ' O ' ' N ' ' A' ' 98' ' ' GLY . . . -45.15 -12.99 0.02 OUTLIER 'General case' 0 C--N 1.294 -1.821 0 O-C-N 119.383 -2.073 . . . . 1.0 110.627 179.558 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . 0.668 ' N ' ' O ' ' A' ' 95' ' ' ARG . 0.8 OUTLIER 1.91 -54.71 0.0 OUTLIER 'General case' 0 N--CA 1.48 1.026 0 C-N-CA 124.407 1.083 . . . . 1.0 111.987 -169.958 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 98' ' ' GLY . . . . . 0.745 ' N ' ' O ' ' A' ' 96' ' ' ALA . . . -48.85 -23.05 3.25 Favored Glycine 0 CA--C 1.539 1.554 0 CA-C-N 122.233 2.288 . . . . 1.0 108.62 175.173 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 99' ' ' GLN . . . . . 0.627 ' N ' ' O ' ' A' ' 96' ' ' ALA . 1.2 mp0 -69.68 -24.14 63.55 Favored 'General case' 0 C--N 1.364 1.204 0 C-N-CA 118.338 -1.345 . . . . 1.0 107.776 178.47 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 100' ' ' ILE . . . . . 0.584 ' N ' ' O ' ' A' ' 97' ' ' LEU . 4.7 mm -65.23 -40.03 87.36 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.755 0 CA-C-N 115.026 -0.988 . . . . 1.0 108.762 177.945 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 101' ' ' VAL . . . . . 0.565 ' O ' ' N ' ' A' ' 105' ' ' GLY . 0.5 OUTLIER -58.52 -57.28 11.67 Favored 'Isoleucine or valine' 0 C--N 1.343 0.289 0 N-CA-C 107.407 -1.331 . . . . 1.0 107.407 179.669 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 102' ' ' CYS . . . . . 0.944 ' O ' ' HB2' ' A' ' 106' ' ' ALA . 0.7 OUTLIER -41.6 -17.61 0.01 OUTLIER 'General case' 0 CA--C 1.536 0.417 0 CA-C-O 120.763 0.316 . . . . 1.0 111.107 -179.537 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 103' ' ' ARG . . . . . 0.528 ' N ' ' O ' ' A' ' 101' ' ' VAL . 4.3 ttm180 -93.29 -35.01 13.3 Favored 'General case' 0 N--CA 1.478 0.954 0 CA-C-O 122.327 1.061 . . . . 1.0 111.523 177.71 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 104' ' ' TYR . . . . . 0.75 ' O ' ' CG ' ' A' ' 104' ' ' TYR . 1.2 t80 -106.44 19.08 21.04 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 112.722 -2.035 . . . . 1.0 109.746 177.817 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 105' ' ' GLY . . . . . 0.735 ' O ' ' N ' ' A' ' 107' ' ' THR . . . -165.76 -18.88 0.02 OUTLIER Glycine 0 C--O 1.223 -0.538 0 C-N-CA 117.461 -2.304 . . . . 1.0 113.035 179.263 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 106' ' ' ALA . . . . . 0.944 ' HB2' ' O ' ' A' ' 102' ' ' CYS . . . -11.39 65.0 0.0 OUTLIER 'General case' 0 N--CA 1.477 0.915 0 O-C-N 124.778 0.928 . . . . 1.0 111.93 -179.55 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 107' ' ' THR . . . . . 0.735 ' N ' ' O ' ' A' ' 105' ' ' GLY . 99.4 m -98.42 -4.41 34.7 Favored 'General case' 0 CA--C 1.511 -0.55 0 O-C-N 121.678 -0.639 . . . . 1.0 109.347 -178.999 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . 0.518 ' C ' ' HD2' ' A' ' 110' ' ' PRO . 41.2 t -81.86 -54.05 10.67 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.494 0 CA-C-N 116.288 -0.414 . . . . 1.0 110.105 178.466 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 109' ' ' ILE . . . . . 0.507 ' O ' ' CB ' ' A' ' 113' ' ' ASN . 0.2 OUTLIER -47.49 -38.86 17.82 Favored Pre-proline 0 N--CA 1.473 0.699 0 N-CA-C 114.822 1.415 . . . . 1.0 114.822 -179.095 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 110' ' ' PRO . . . . . 0.518 ' HD2' ' C ' ' A' ' 108' ' ' VAL . 83.7 Cg_exo -47.02 -41.49 26.19 Favored 'Trans proline' 0 C--N 1.31 -1.48 0 C-N-CA 121.929 1.753 . . . . 1.0 112.623 -174.818 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 1.2 t-20 -63.49 -69.39 0.27 Allowed 'General case' 0 CA--C 1.536 0.421 0 C-N-CA 118.877 -1.129 . . . . 1.0 110.29 179.88 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 112' ' ' ILE . . . . . 0.448 ' O ' ' N ' ' A' ' 116' ' ' ILE . 0.1 OUTLIER -61.84 -44.74 99.28 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.539 0 CA-C-O 121.325 0.583 . . . . 1.0 110.543 -178.1 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 113' ' ' ASN . . . . . 0.507 ' CB ' ' O ' ' A' ' 109' ' ' ILE . 20.9 t30 -45.79 -62.17 1.42 Allowed 'General case' 0 C--N 1.309 -1.168 0 CA-C-N 115.3 -0.864 . . . . 1.0 111.511 -174.733 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -61.67 -24.59 66.85 Favored 'General case' 0 N--CA 1.433 -1.294 0 C-N-CA 118.873 -1.131 . . . . 1.0 110.703 179.586 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -82.32 -61.43 1.9 Allowed 'General case' 0 C--O 1.239 0.504 0 N-CA-C 113.95 1.093 . . . . 1.0 113.95 178.323 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 116' ' ' ILE . . . . . 0.589 ' O ' ' N ' ' A' ' 119' ' ' LEU . 47.0 mt -69.82 -49.03 60.71 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.678 0 O-C-N 120.501 -1.374 . . . . 1.0 111.596 -177.985 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 117' ' ' GLU . . . . . 0.479 ' OE1' ' OD1' ' A' ' 113' ' ' ASN . 18.5 tt0 -46.2 -61.58 1.71 Allowed 'General case' 0 C--N 1.312 -1.05 0 N-CA-C 108.393 -0.966 . . . . 1.0 108.393 -177.106 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 97.5 t -54.28 -16.02 1.31 Allowed 'Isoleucine or valine' 0 N--CA 1.44 -0.96 0 O-C-N 124.408 1.068 . . . . 1.0 109.317 178.453 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 119' ' ' LEU . . . . . 0.589 ' N ' ' O ' ' A' ' 116' ' ' ILE . 0.2 OUTLIER -80.01 -61.31 2.03 Favored 'General case' 0 C--N 1.349 0.551 0 C-N-CA 119.793 -0.763 . . . . 1.0 110.453 178.342 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -66.62 -85.52 0.08 OUTLIER Glycine 0 C--N 1.361 1.96 0 C-N-CA 117.519 -2.277 . . . . 1.0 112.103 179.916 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -163.73 -27.18 0.04 OUTLIER 'General case' 0 N--CA 1.473 0.713 0 N-CA-C 107.422 -1.325 . . . . 1.0 107.422 -178.604 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 122' ' ' GLY . . . . . 0.554 ' O ' ' N ' ' A' ' 124' ' ' ASP . . . 116.76 -36.2 3.86 Favored Glycine 0 CA--C 1.531 1.033 0 CA-C-N 113.933 -1.485 . . . . 1.0 113.432 179.699 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 123' ' ' THR . . . . . 0.454 ' C ' ' O ' ' A' ' 122' ' ' GLY . 0.1 OUTLIER -32.78 89.64 0.0 OUTLIER 'General case' 0 N--CA 1.476 0.839 0 CA-C-N 120.578 2.189 . . . . 1.0 112.774 -178.652 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 124' ' ' ASP . . . . . 0.554 ' N ' ' O ' ' A' ' 122' ' ' GLY . 11.6 t0 -147.45 143.86 28.21 Favored 'General case' 0 CA--C 1.521 -0.162 0 N-CA-C 108.454 -0.943 . . . . 1.0 108.454 179.94 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 125' ' ' TYR . . . . . 0.471 ' O ' ' CD1' ' A' ' 125' ' ' TYR . 0.1 OUTLIER -150.79 148.43 28.5 Favored 'General case' 0 C--N 1.324 -0.526 0 N-CA-C 109.596 -0.52 . . . . 1.0 109.596 179.891 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 126' ' ' ARG . . . . . 0.545 ' CB ' ' H62' ' A' ' 130' ' ' MTN . 10.8 mmp_? -145.74 148.4 32.95 Favored 'General case' 0 N--CA 1.471 0.623 0 N-CA-C 109.592 -0.521 . . . . 1.0 109.592 177.264 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 127' ' ' PHE . . . . . 0.466 ' OXT' ' H63' ' A' ' 130' ' ' MTN . 0.9 OUTLIER . . . . . 0 C--O 1.218 -0.575 0 CA-C-O 118.049 -0.977 . . . . 1.0 110.008 -179.9 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 128' ' ' MTN . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 129' ' ' MTN . . . . . 0.529 ' S1 ' ' O ' ' A' ' 47' ' ' ARG . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 130' ' ' MTN . . . . . 0.545 ' H62' ' CB ' ' A' ' 126' ' ' ARG . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 60.1 mtt . . . . . 0 N--CA 1.491 1.584 0 N-CA-C 109.013 -0.736 . . . . 1.0 109.013 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 48.7 m -107.78 -0.97 21.33 Favored 'General case' 0 N--CA 1.466 0.351 0 CA-C-N 116.404 -0.362 . . . . 1.0 110.692 179.553 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . 0.526 ' N ' ' OD1' ' A' ' 3' ' ' ASP . 8.1 p-10 -178.83 92.66 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.478 -0.328 . . . . 1.0 110.854 -179.747 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 37.2 t80 -151.59 147.75 27.16 Favored 'General case' 0 CA--C 1.513 -0.444 0 CA-C-O 120.899 0.38 . . . . 1.0 110.112 179.358 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 5' ' ' ASP . . . . . 0.498 ' C ' ' OG ' ' A' ' 10' ' ' SER . 32.1 p30 -156.58 153.05 28.02 Favored 'General case' 0 N--CA 1.448 -0.538 0 CA-C-N 116.058 -0.519 . . . . 1.0 110.748 179.472 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 6' ' ' THR . . . . . 0.957 ' H ' HG23 ' A' ' 9' ' ' VAL . 0.2 OUTLIER -102.69 -170.2 1.77 Allowed 'General case' 0 C--O 1.199 -1.605 0 CA-C-O 121.661 0.743 . . . . 1.0 110.467 178.131 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . 0.464 ' O ' ' HB2' ' A' ' 11' ' ' ARG . 33.4 tt0 -56.25 -40.97 75.0 Favored 'General case' 0 C--N 1.304 -1.391 0 CA-C-O 121.653 0.74 . . . . 1.0 110.586 -179.555 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 8' ' ' ARG . . . . . 0.82 ' O ' ' HB3' ' A' ' 12' ' ' ALA . 0.9 OUTLIER -70.01 -62.78 1.25 Allowed 'General case' 0 C--N 1.31 -1.122 0 C-N-CA 118.654 -1.218 . . . . 1.0 111.252 179.548 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . 0.957 HG23 ' H ' ' A' ' 6' ' ' THR . 0.0 OUTLIER -62.7 -48.45 88.08 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.712 0 CA-C-N 114.113 -1.403 . . . . 1.0 108.229 179.144 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . 0.669 ' N ' ' O ' ' A' ' 6' ' ' THR . 1.6 m -67.8 -68.35 0.39 Allowed 'General case' 0 C--O 1.189 -2.128 0 C-N-CA 118.3 -1.36 . . . . 1.0 112.915 179.857 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 11' ' ' ARG . . . . . 0.57 ' O ' ' N ' ' A' ' 15' ' ' ALA . 2.3 mmt85 -67.83 -49.93 59.46 Favored 'General case' 0 N--CA 1.48 1.072 0 N-CA-C 113.965 1.098 . . . . 1.0 113.965 -176.551 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . 0.82 ' HB3' ' O ' ' A' ' 8' ' ' ARG . . . -60.69 -58.74 7.16 Favored 'General case' 0 C--N 1.314 -0.956 0 C-N-CA 117.866 -1.534 . . . . 1.0 107.526 -178.873 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . 0.696 ' O ' ' N ' ' A' ' 17' ' ' LEU . 0.5 OUTLIER -60.0 -50.36 80.46 Favored 'Isoleucine or valine' 0 C--O 1.184 -2.393 0 N-CA-C 106.561 -1.644 . . . . 1.0 106.561 179.215 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . 0.844 ' O ' HG22 ' A' ' 18' ' ' VAL . . . -58.76 -64.05 1.07 Allowed 'General case' 0 C--O 1.199 -1.599 0 C-N-CA 116.493 -2.083 . . . . 1.0 111.497 -179.101 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . 0.575 ' O ' ' N ' ' A' ' 19' ' ' GLY . . . -52.21 -55.04 23.69 Favored 'General case' 0 C--N 1.314 -0.949 0 N-CA-C 108.46 -0.941 . . . . 1.0 108.46 -178.622 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . 0.559 ' HB3' ' O ' ' A' ' 12' ' ' ALA . . . -64.36 -57.86 8.13 Favored 'General case' 0 C--N 1.304 -1.395 0 C-N-CA 118.886 -1.126 . . . . 1.0 111.042 -179.95 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . 0.696 ' N ' ' O ' ' A' ' 13' ' ' VAL . 19.1 tp -55.78 -55.27 34.4 Favored 'General case' 0 N--CA 1.49 1.569 0 N-CA-C 107.909 -1.145 . . . . 1.0 107.909 -177.768 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . 0.844 HG22 ' O ' ' A' ' 14' ' ' ALA . 1.5 m -71.29 -59.13 3.75 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.411 0 CA-C-N 116.045 -0.525 . . . . 1.0 110.471 179.925 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . 0.575 ' N ' ' O ' ' A' ' 15' ' ' ALA . . . -56.67 -169.27 0.1 OUTLIER Glycine 0 N--CA 1.438 -1.187 0 N-CA-C 111.225 -0.75 . . . . 1.0 111.225 -177.655 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 20' ' ' PRO . . . . . 0.642 ' O ' ' N ' ' A' ' 24' ' ' ALA . 58.6 Cg_endo -85.32 -29.24 0.66 Allowed 'Trans proline' 0 C--N 1.29 -2.5 0 C-N-CA 122.456 2.104 . . . . 1.0 113.455 -177.564 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . 0.443 ' O ' ' HB3' ' A' ' 24' ' ' ALA . . . -60.42 -59.73 9.79 Favored Glycine 0 N--CA 1.471 0.993 0 C-N-CA 120.143 -1.027 . . . . 1.0 112.26 -177.747 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . 0.495 ' H ' ' HA ' ' A' ' 16' ' ' ALA . . . -56.51 -53.33 44.24 Favored Glycine 0 CA--C 1.497 -1.072 0 N-CA-C 106.53 -2.628 . . . . 1.0 106.53 -176.374 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . 0.526 ' O ' HG12 ' A' ' 27' ' ' VAL . 22.4 t -56.74 -31.22 34.62 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.242 0 N-CA-C 108.216 -1.031 . . . . 1.0 108.216 178.043 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . 0.642 ' N ' ' O ' ' A' ' 20' ' ' PRO . . . -59.18 -63.21 1.38 Allowed 'General case' 0 C--N 1.354 0.791 0 C-N-CA 118.712 -1.195 . . . . 1.0 110.331 -178.823 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . 0.44 ' H ' ' HG ' ' A' ' 25' ' ' LEU . 1.2 mt -62.27 -46.04 90.59 Favored 'General case' 0 C--N 1.325 -0.458 0 C-N-CA 120.335 -0.546 . . . . 1.0 111.333 -177.063 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 88.0 t -59.64 -58.94 4.87 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.669 0 C-N-CA 119.898 -0.721 . . . . 1.0 109.604 -177.78 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . 0.526 HG12 ' O ' ' A' ' 23' ' ' VAL . 1.5 p -60.62 -37.45 75.53 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.508 0 C-N-CA 120.076 -0.65 . . . . 1.0 110.245 -177.99 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 27.2 ttpp -65.29 -56.96 9.75 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 115.89 -0.595 . . . . 1.0 110.462 -179.018 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 84.1 t -63.27 -47.88 90.05 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.784 0 CA-C-N 114.936 -1.029 . . . . 1.0 109.692 -177.715 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 30' ' ' CYS . . . . . . . . . . . . . 36.8 t -65.01 -60.82 2.62 Favored 'General case' 0 N--CA 1.441 -0.884 0 C-N-CA 119.787 -0.765 . . . . 1.0 109.588 -178.82 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . 0.523 ' HB3' ' O ' ' A' ' 27' ' ' VAL . . . -57.8 -47.62 82.07 Favored 'General case' 0 CA--C 1.497 -1.091 0 CA-C-O 121.29 0.567 . . . . 1.0 109.769 -176.427 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . 0.468 ' O ' ' HB2' ' A' ' 33' ' ' LEU . . . 74.2 67.92 1.67 Allowed Glycine 0 N--CA 1.439 -1.131 0 N-CA-C 108.982 -1.647 . . . . 1.0 108.982 -178.525 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . 0.478 ' O ' ' O ' ' A' ' 36' ' ' VAL . 17.7 mt 97.41 78.52 0.02 OUTLIER Pre-proline 0 N--CA 1.47 0.54 0 C-N-CA 124.542 1.137 . . . . 1.0 110.645 -179.452 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 76.5 Cg_exo -45.93 -29.45 5.99 Favored 'Trans proline' 0 C--N 1.312 -1.386 0 C-N-CA 121.973 1.782 . . . . 1.0 112.672 179.793 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -60.38 -60.61 8.26 Favored Glycine 0 CA--C 1.536 1.37 0 C-N-CA 118.756 -1.687 . . . . 1.0 109.894 -178.375 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . 0.703 HG22 ' H ' ' A' ' 37' ' ' ILE . 8.5 p -98.81 177.87 0.66 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.68 0 N-CA-C 107.36 -1.348 . . . . 1.0 107.36 177.793 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . 0.703 ' H ' HG22 ' A' ' 36' ' ' VAL . 2.9 mm 101.15 120.34 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.479 1.01 0 O-C-N 124.818 1.323 . . . . 1.0 110.952 179.609 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 79.8 m80 -142.75 136.97 29.44 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 115.572 -0.74 . . . . 1.0 109.508 178.456 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 11.1 m -91.95 127.48 49.52 Favored Pre-proline 0 CA--C 1.537 0.474 0 N-CA-C 108.966 -0.753 . . . . 1.0 108.966 179.678 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 29.7 Cg_endo -62.94 -30.55 76.97 Favored 'Trans proline' 0 N--CA 1.498 1.745 0 C-N-CA 121.752 1.635 . . . . 1.0 113.368 -178.192 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -110.36 90.93 3.46 Favored 'General case' 0 CA--C 1.507 -0.696 0 CA-C-O 121.599 0.714 . . . . 1.0 112.664 -176.498 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 16.3 ptm180 -139.82 143.0 36.61 Favored 'General case' 0 C--N 1.318 -0.768 0 CA-C-N 114.552 -1.204 . . . . 1.0 108.479 178.927 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 76.5 ttt180 -50.91 -15.61 0.32 Allowed 'General case' 0 N--CA 1.451 -0.41 0 O-C-N 121.958 -0.464 . . . . 1.0 111.299 -176.003 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 119.11 -25.34 7.89 Favored Glycine 0 N--CA 1.468 0.792 0 N-CA-C 111.148 -0.781 . . . . 1.0 111.148 178.885 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . 0.565 ' O ' ' CD1' ' A' ' 46' ' ' PHE . 0.6 OUTLIER -156.84 161.53 39.72 Favored 'General case' 0 C--N 1.323 -0.557 0 N-CA-C 108.171 -1.048 . . . . 1.0 108.171 178.446 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 46' ' ' PHE . . . . . 0.834 ' O ' ' CD1' ' A' ' 46' ' ' PHE . 0.0 OUTLIER 115.66 120.46 0.0 OUTLIER 'General case' 0 N--CA 1.479 1.024 0 O-C-N 125.288 1.618 . . . . 1.0 112.433 179.342 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 47' ' ' ARG . . . . . 0.594 ' HB2' ' O ' ' A' ' 46' ' ' PHE . 5.9 mtm180 76.75 163.32 0.24 Allowed 'General case' 0 N--CA 1.479 1.023 0 O-C-N 119.266 -2.146 . . . . 1.0 110.727 -178.67 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 48' ' ' CYS . . . . . 0.441 ' C ' ' S1 ' ' A' ' 129' ' ' MTN . 4.1 t 61.35 70.03 0.63 Allowed 'General case' 0 C--O 1.232 0.147 0 N-CA-C 108.786 -0.82 . . . . 1.0 108.786 -178.196 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 49' ' ' ASN . . . . . 0.605 ' O ' ' N ' ' A' ' 51' ' ' GLU . 0.0 OUTLIER -146.1 163.95 27.75 Favored Pre-proline 0 CA--C 1.538 0.511 0 N-CA-C 109.519 -0.549 . . . . 1.0 109.519 -178.726 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . 0.512 ' O ' ' NE ' ' A' ' 52' ' ' ARG . 11.2 Cg_endo -54.41 58.48 0.03 OUTLIER 'Trans proline' 0 N--CA 1.514 2.68 0 C-N-CA 123.32 2.68 . . . . 1.0 112.057 179.611 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . 0.605 ' N ' ' O ' ' A' ' 49' ' ' ASN . 40.5 mt-10 55.02 37.39 28.84 Favored 'General case' 0 N--CA 1.475 0.797 0 O-C-N 121.192 -0.943 . . . . 1.0 112.678 176.956 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . 0.551 ' O ' ' ND2' ' A' ' 49' ' ' ASN . 0.0 OUTLIER -151.69 179.9 8.0 Favored 'General case' 0 N--CA 1.476 0.829 0 CA-C-O 121.71 0.767 . . . . 1.0 110.439 179.069 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 4.6 tp -82.25 168.72 1.74 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 114.869 -1.059 . . . . 1.0 108.993 177.78 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 1.1 tp60 -132.44 131.98 42.29 Favored 'General case' 0 CA--C 1.533 0.318 0 N-CA-C 108.793 -0.817 . . . . 1.0 108.793 178.624 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 20.4 tt -144.91 155.08 14.13 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.661 0 N-CA-C 110.334 -0.247 . . . . 1.0 110.334 178.563 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 101.38 1.57 53.74 Favored Glycine 0 C--N 1.341 0.842 0 N-CA-C 110.157 -1.177 . . . . 1.0 110.157 -179.827 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 9.4 t70 -93.2 115.55 28.16 Favored 'General case' 0 CA--C 1.539 0.521 0 CA-C-O 122.229 1.014 . . . . 1.0 113.035 -178.214 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 58' ' ' TRP . . . . . 0.649 ' HB2' ' HB2' ' A' ' 61' ' ' GLU . 37.7 m0 -82.92 -178.4 7.1 Favored 'General case' 0 C--N 1.318 -0.799 0 CA-C-N 112.673 -2.058 . . . . 1.0 109.411 177.682 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 59' ' ' ARG . . . . . 0.445 ' HG3' ' H ' ' A' ' 60' ' ' TYR . 13.7 ptt-85 -94.61 -55.39 3.16 Favored 'General case' 0 CA--C 1.543 0.701 0 CA-C-O 121.24 0.543 . . . . 1.0 111.333 179.412 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 60' ' ' TYR . . . . . 0.573 ' O ' ' CG ' ' A' ' 60' ' ' TYR . 17.3 t80 -76.68 -4.03 41.04 Favored 'General case' 0 N--CA 1.476 0.836 0 C-N-CA 124.327 1.051 . . . . 1.0 111.255 179.231 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . 0.649 ' HB2' ' HB2' ' A' ' 58' ' ' TRP . 31.8 tt0 -77.36 -17.33 58.33 Favored 'General case' 0 C--N 1.309 -1.16 0 O-C-N 121.447 -0.783 . . . . 1.0 111.089 -179.994 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . 0.439 ' O ' ' N ' ' A' ' 66' ' ' GLY . 91.0 t -46.08 -49.33 5.2 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.03 0 N-CA-C 109.043 -0.725 . . . . 1.0 109.043 -175.639 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 63' ' ' ALA . . . . . 0.546 ' O ' ' HG3' ' A' ' 67' ' ' ARG . . . -64.91 -49.33 70.86 Favored 'General case' 0 N--CA 1.419 -1.993 0 N-CA-C 108.624 -0.88 . . . . 1.0 108.624 177.358 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 4.3 t-80 -56.0 -61.65 2.24 Favored 'General case' 0 CA--C 1.547 0.85 0 CA-C-N 115.977 -0.556 . . . . 1.0 111.904 179.52 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . 0.648 ' C ' ' H ' ' A' ' 67' ' ' ARG . 13.7 t70 -66.79 -54.34 23.67 Favored 'General case' 0 C--O 1.246 0.918 0 O-C-N 121.226 -0.921 . . . . 1.0 110.31 178.507 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . 0.439 ' N ' ' O ' ' A' ' 62' ' ' VAL . . . -62.91 32.9 0.07 OUTLIER Glycine 0 CA--C 1.523 0.587 0 N-CA-C 111.52 -0.632 . . . . 1.0 111.52 178.825 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 67' ' ' ARG . . . . . 0.75 ' HB3' ' H ' ' A' ' 71' ' ' ALA . 50.5 mtt180 -77.03 4.16 10.71 Favored 'General case' 0 C--N 1.313 -0.986 0 C-N-CA 123.739 0.816 . . . . 1.0 110.352 175.641 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . 0.582 ' O ' ' HA ' ' A' ' 72' ' ' HIS . 0.8 OUTLIER -33.95 -31.1 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.651 0 N-CA-C 107.335 -1.357 . . . . 1.0 107.335 -179.267 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . 0.611 ' N ' ' O ' ' A' ' 67' ' ' ARG . 0.3 OUTLIER -63.48 -65.14 0.73 Allowed 'General case' 0 C--N 1.312 -1.064 0 C-N-CA 118.037 -1.465 . . . . 1.0 107.213 175.838 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . 0.68 ' C ' ' H ' ' A' ' 72' ' ' HIS . . . -76.64 -73.67 0.27 Allowed 'General case' 0 N--CA 1.474 0.749 0 N-CA-C 107.537 -1.283 . . . . 1.0 107.537 178.627 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . 0.75 ' H ' ' HB3' ' A' ' 67' ' ' ARG . . . -49.7 4.63 0.01 OUTLIER 'General case' 0 N--CA 1.476 0.835 0 C-N-CA 125.907 1.683 . . . . 1.0 112.07 178.475 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 72' ' ' HIS . . . . . 0.997 ' CD2' ' H ' ' A' ' 73' ' ' MET . 1.4 p80 -17.74 -62.56 0.02 OUTLIER 'General case' 0 CA--C 1.519 -0.225 0 O-C-N 123.755 0.66 . . . . 1.0 112.519 -175.899 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 73' ' ' MET . . . . . 0.997 ' H ' ' CD2' ' A' ' 72' ' ' HIS . 16.6 ptm -80.89 -45.63 16.5 Favored 'General case' 0 C--N 1.298 -1.644 0 CA-C-N 117.968 0.349 . . . . 1.0 110.56 177.41 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . 0.672 ' O ' ' N ' ' A' ' 76' ' ' GLY . 97.3 t -40.7 -43.41 0.63 Allowed 'Isoleucine or valine' 0 C--N 1.35 0.592 0 CA-C-O 118.687 -0.673 . . . . 1.0 110.076 -174.164 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 19.4 t-20 -36.75 -19.64 0.01 OUTLIER 'General case' 0 N--CA 1.477 0.882 0 CA-C-O 122.491 1.139 . . . . 1.0 110.533 179.107 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . 0.672 ' N ' ' O ' ' A' ' 74' ' ' VAL . . . -50.38 -21.02 4.06 Favored Glycine 0 C--O 1.205 -1.709 0 N-CA-C 108.991 -1.644 . . . . 1.0 108.991 174.321 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . 0.437 ' N ' ' O ' ' A' ' 74' ' ' VAL . 6.1 pt -54.49 -46.82 71.39 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.555 0 O-C-N 121.637 -0.92 . . . . 1.0 112.446 -176.934 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . 0.405 ' N ' HG13 ' A' ' 77' ' ' ILE . 3.7 t -59.29 -19.24 15.73 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.716 0 O-C-N 121.925 -0.484 . . . . 1.0 111.93 -178.406 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . 0.935 ' O ' ' HB2' ' A' ' 83' ' ' ALA . 0.3 OUTLIER -81.39 -46.06 20.46 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.702 0 C-N-CA 119.941 -0.704 . . . . 1.0 111.493 -179.748 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 80' ' ' ALA . . . . . 0.466 ' N ' ' CG1' ' A' ' 79' ' ' ILE . . . -84.17 -18.66 35.94 Favored 'General case' 0 N--CA 1.467 0.384 0 N-CA-C 112.791 0.663 . . . . 1.0 112.791 179.41 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 64.5 mt-10 -84.7 -71.85 0.5 Allowed 'General case' 0 C--O 1.231 0.124 0 N-CA-C 112.964 0.727 . . . . 1.0 112.964 -178.813 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 82' ' ' ASP . . . . . 0.432 ' O ' ' C ' ' A' ' 83' ' ' ALA . 93.4 m-20 -71.05 -18.08 62.58 Favored 'General case' 0 CA--C 1.515 -0.403 0 N-CA-C 111.612 0.227 . . . . 1.0 111.612 -177.669 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . 0.935 ' HB2' ' O ' ' A' ' 79' ' ' ILE . . . -36.14 -50.81 0.73 Allowed 'General case' 0 N--CA 1.47 0.575 0 C-N-CA 120.612 -0.435 . . . . 1.0 110.907 177.898 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . 0.442 ' C ' ' O ' ' A' ' 83' ' ' ALA . 0.2 OUTLIER -28.79 -46.88 0.05 OUTLIER 'General case' 0 N--CA 1.48 1.054 0 CA-C-N 116.175 -0.466 . . . . 1.0 111.257 -173.825 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 73.8 mt -95.11 -54.67 6.89 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.704 0 N-CA-C 109.831 -0.433 . . . . 1.0 109.831 178.061 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -43.38 -39.98 3.45 Favored 'General case' 0 N--CA 1.465 0.298 0 CA-C-N 115.759 -0.655 . . . . 1.0 110.317 -178.83 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 79.7 tt0 -54.74 -29.74 54.41 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.785 -0.643 . . . . 1.0 110.65 -179.879 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -77.77 -12.46 59.98 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.632 -0.713 . . . . 1.0 109.377 -179.909 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 89' ' ' VAL . . . . . 0.458 ' C ' ' HD2' ' A' ' 91' ' ' PRO . 3.5 t -86.92 39.12 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.448 -0.553 0 N-CA-C 108.172 -1.047 . . . . 1.0 108.172 178.556 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 90' ' ' GLY . . . . . 0.859 ' O ' ' N ' ' A' ' 92' ' ' HIS . . . -55.69 -24.63 40.96 Favored Glycine 0 C--N 1.362 1.997 0 CA-C-O 117.294 -1.837 . . . . 1.0 111.156 176.934 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 91' ' ' PRO . . . . . 0.692 ' HD2' ' N ' ' A' ' 90' ' ' GLY . 26.0 Cg_exo -32.27 -3.74 0.0 OUTLIER 'Trans proline' 0 N--CA 1.507 2.299 0 C-N-CA 123.828 3.018 . . . . 1.0 113.495 173.365 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 92' ' ' HIS . . . . . 0.859 ' N ' ' O ' ' A' ' 90' ' ' GLY . 20.6 t60 -50.95 -30.83 15.98 Favored 'General case' 0 N--CA 1.443 -0.791 0 N-CA-C 107.098 -1.445 . . . . 1.0 107.098 177.34 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . 0.634 ' O ' ' N ' ' A' ' 96' ' ' ALA . 0.4 OUTLIER -59.42 -58.37 8.91 Favored 'General case' 0 C--O 1.214 -0.809 0 CA-C-N 119.064 0.847 . . . . 1.0 109.27 176.808 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 94' ' ' ALA . . . . . 0.503 ' H ' ' HG ' ' A' ' 93' ' ' LEU . . . -48.28 -53.3 17.7 Favored 'General case' 0 C--O 1.221 -0.406 0 N-CA-C 106.56 -1.644 . . . . 1.0 106.56 -178.712 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 95' ' ' ARG . . . . . 0.557 HH21 ' HB3' ' A' ' 91' ' ' PRO . 0.0 OUTLIER -59.5 -26.5 65.34 Favored 'General case' 0 C--N 1.305 -1.339 0 N-CA-C 108.699 -0.852 . . . . 1.0 108.699 176.328 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 96' ' ' ALA . . . . . 0.84 ' O ' ' N ' ' A' ' 100' ' ' ILE . . . -59.31 -52.55 65.16 Favored 'General case' 0 C--O 1.202 -1.43 0 N-CA-C 106.735 -1.58 . . . . 1.0 106.735 179.624 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . 0.532 ' O ' HG22 ' A' ' 100' ' ' ILE . 1.5 mt -38.3 -32.11 0.06 Allowed 'General case' 0 CA--C 1.576 1.976 0 N-CA-C 107.401 -1.333 . . . . 1.0 107.401 -179.439 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 98' ' ' GLY . . . . . 0.479 ' N ' ' O ' ' A' ' 96' ' ' ALA . . . -82.09 -52.14 4.17 Favored Glycine 0 CA--C 1.551 2.332 0 CA-C-O 123.422 1.568 . . . . 1.0 111.356 173.897 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 99' ' ' GLN . . . . . 0.435 ' N ' ' O ' ' A' ' 96' ' ' ALA . 76.1 mm-40 -78.39 9.63 3.76 Favored 'General case' 0 N--CA 1.434 -1.235 0 N-CA-C 108.185 -1.042 . . . . 1.0 108.185 178.794 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 100' ' ' ILE . . . . . 0.84 ' N ' ' O ' ' A' ' 96' ' ' ALA . 1.1 tt -59.49 -51.46 72.39 Favored 'Isoleucine or valine' 0 CA--C 1.477 -1.85 0 N-CA-C 108.015 -1.106 . . . . 1.0 108.015 179.917 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 101' ' ' VAL . . . . . 0.687 ' N ' HG23 ' A' ' 100' ' ' ILE . 70.6 t -57.2 -57.23 10.84 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.768 0 C-N-CA 116.666 -2.014 . . . . 1.0 106.627 178.307 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 102' ' ' CYS . . . . . 0.969 ' O ' ' HB2' ' A' ' 106' ' ' ALA . 1.9 t -45.13 -23.09 0.13 Allowed 'General case' 0 C--O 1.218 -0.584 0 C-N-CA 119.559 -0.857 . . . . 1.0 110.809 -177.573 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 103' ' ' ARG . . . . . 0.417 HH11 ' HG3' ' A' ' 103' ' ' ARG . 0.0 OUTLIER -91.29 -43.19 9.95 Favored 'General case' 0 CA--C 1.541 0.627 0 CA-C-O 122.095 0.95 . . . . 1.0 113.147 179.302 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 104' ' ' TYR . . . . . 0.746 ' O ' ' CG ' ' A' ' 104' ' ' TYR . 0.2 OUTLIER -102.88 21.55 15.41 Favored 'General case' 0 C--N 1.31 -1.146 0 CA-C-N 113.292 -1.776 . . . . 1.0 109.886 179.813 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 105' ' ' GLY . . . . . 0.766 ' O ' ' N ' ' A' ' 107' ' ' THR . . . -166.01 -14.52 0.02 OUTLIER Glycine 0 C--O 1.215 -1.093 0 C-N-CA 118.381 -1.866 . . . . 1.0 111.39 178.193 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 106' ' ' ALA . . . . . 0.969 ' HB2' ' O ' ' A' ' 102' ' ' CYS . . . -13.87 65.86 0.0 OUTLIER 'General case' 0 N--CA 1.478 0.933 0 O-C-N 124.742 0.907 . . . . 1.0 112.002 -179.876 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 107' ' ' THR . . . . . 0.766 ' N ' ' O ' ' A' ' 105' ' ' GLY . 99.5 m -101.25 -4.37 27.25 Favored 'General case' 0 N--CA 1.452 -0.348 0 CA-C-N 115.869 -0.605 . . . . 1.0 110.048 -179.419 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . 0.714 HG23 ' N ' ' A' ' 109' ' ' ILE . 33.3 m -85.19 -58.22 3.68 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.466 0 N-CA-C 111.647 0.24 . . . . 1.0 111.647 -178.579 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 109' ' ' ILE . . . . . 0.714 ' N ' HG23 ' A' ' 108' ' ' VAL . 0.3 OUTLIER -47.79 -43.37 52.08 Favored Pre-proline 0 C--N 1.353 0.754 0 N-CA-C 112.709 0.633 . . . . 1.0 112.709 179.244 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 110' ' ' PRO . . . . . 0.61 ' HD2' ' N ' ' A' ' 109' ' ' ILE . 7.9 Cg_endo -40.51 -38.32 2.43 Favored 'Trans proline' 0 N--CA 1.482 0.81 0 C-N-CA 121.154 1.236 . . . . 1.0 113.126 -175.4 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 16.8 t-20 -64.56 -68.26 0.37 Allowed 'General case' 0 C--N 1.315 -0.906 0 C-N-CA 118.601 -1.24 . . . . 1.0 110.726 -178.344 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 112' ' ' ILE . . . . . 0.42 ' H ' HG23 ' A' ' 112' ' ' ILE . 2.0 pt -67.59 -27.8 39.63 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.54 0 CA-C-O 121.841 0.829 . . . . 1.0 111.547 -178.004 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 113' ' ' ASN . . . . . 0.622 HD22 ' N ' ' A' ' 114' ' ' ALA . 0.3 OUTLIER -54.98 -61.51 2.26 Favored 'General case' 0 C--N 1.306 -1.304 0 CA-C-N 114.075 -1.42 . . . . 1.0 109.837 -175.281 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 114' ' ' ALA . . . . . 0.622 ' N ' HD22 ' A' ' 113' ' ' ASN . . . -61.81 -22.55 65.56 Favored 'General case' 0 C--N 1.306 -1.301 0 CA-C-N 116.063 -0.517 . . . . 1.0 110.709 -179.979 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -78.48 -60.74 2.25 Favored 'General case' 0 N--CA 1.448 -0.532 0 N-CA-C 112.715 0.635 . . . . 1.0 112.715 178.278 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 116' ' ' ILE . . . . . 0.476 ' O ' ' CB ' ' A' ' 119' ' ' LEU . 95.3 mt -69.4 -46.21 77.03 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.323 0 O-C-N 120.477 -1.39 . . . . 1.0 112.359 -177.094 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 117' ' ' GLU . . . . . 0.462 ' OE1' ' ND2' ' A' ' 113' ' ' ASN . 94.9 mt-10 -47.59 -64.37 0.8 Allowed 'General case' 0 C--N 1.316 -0.856 0 CA-C-N 115.538 -0.755 . . . . 1.0 110.109 -176.994 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 4.1 p -51.71 -15.14 0.48 Allowed 'Isoleucine or valine' 0 N--CA 1.437 -1.107 0 CA-C-N 115.4 -0.818 . . . . 1.0 109.251 -179.662 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 119' ' ' LEU . . . . . 0.476 ' CB ' ' O ' ' A' ' 116' ' ' ILE . 1.6 tt -77.13 -61.07 2.11 Favored 'General case' 0 C--N 1.348 0.508 0 C-N-CA 119.116 -1.033 . . . . 1.0 109.328 177.949 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -70.39 -81.21 0.26 Allowed Glycine 0 C--N 1.355 1.618 0 C-N-CA 117.259 -2.4 . . . . 1.0 111.076 179.55 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 121' ' ' THR . . . . . 0.4 ' H ' ' H ' ' A' ' 122' ' ' GLY . 45.2 m -160.41 -17.82 0.06 Allowed 'General case' 0 CA--C 1.54 0.592 0 CA-C-O 121.414 0.626 . . . . 1.0 109.97 -179.595 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 122' ' ' GLY . . . . . 0.441 ' O ' ' C ' ' A' ' 123' ' ' THR . . . 109.88 -36.8 4.09 Favored Glycine 0 N--CA 1.476 1.327 0 C-N-CA 125.215 1.388 . . . . 1.0 111.888 179.96 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 123' ' ' THR . . . . . 0.599 HG23 ' O ' ' A' ' 123' ' ' THR . 4.2 t -31.17 94.98 0.01 OUTLIER 'General case' 0 N--CA 1.473 0.676 0 CA-C-N 118.47 1.135 . . . . 1.0 112.675 -178.708 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 124' ' ' ASP . . . . . 0.407 ' N ' ' O ' ' A' ' 122' ' ' GLY . 73.1 m-20 -143.67 144.58 31.93 Favored 'General case' 0 C--N 1.33 -0.275 0 N-CA-C 108.56 -0.904 . . . . 1.0 108.56 178.571 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 125' ' ' TYR . . . . . 0.433 ' O ' ' NE ' ' A' ' 126' ' ' ARG . 0.0 OUTLIER -151.74 148.96 28.52 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.763 0.316 . . . . 1.0 110.305 -178.525 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 126' ' ' ARG . . . . . 0.548 ' HB3' ' H62' ' A' ' 130' ' ' MTN . 0.0 OUTLIER -149.85 151.78 34.05 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.167 -0.47 . . . . 1.0 110.006 177.928 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 127' ' ' PHE . . . . . 0.548 ' O ' ' CD2' ' A' ' 92' ' ' HIS . 0.1 OUTLIER . . . . . 0 C--O 1.22 -0.481 0 CA-C-O 117.873 -1.06 . . . . 1.0 110.398 -178.57 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 128' ' ' MTN . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 129' ' ' MTN . . . . . 0.441 ' S1 ' ' C ' ' A' ' 48' ' ' CYS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 130' ' ' MTN . . . . . 0.548 ' H62' ' HB3' ' A' ' 126' ' ' ARG . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 2.2 mpt? . . . . . 0 N--CA 1.491 1.612 0 N-CA-C 109.139 -0.689 . . . . 1.0 109.139 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 51.9 m -95.64 1.72 53.75 Favored 'General case' 0 N--CA 1.463 0.187 0 CA-C-N 116.449 -0.341 . . . . 1.0 110.913 -179.825 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER 169.56 106.68 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.361 -0.381 . . . . 1.0 110.274 -179.94 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 18.2 t80 -149.21 145.53 27.17 Favored 'General case' 0 C--N 1.33 -0.254 0 N-CA-C 109.723 -0.473 . . . . 1.0 109.723 178.896 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 14.4 m-20 -152.82 147.71 26.34 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.359 -0.382 . . . . 1.0 110.117 -179.025 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 6' ' ' THR . . . . . 1.008 ' H ' HG23 ' A' ' 9' ' ' VAL . 0.2 OUTLIER -103.88 -165.97 1.21 Allowed 'General case' 0 C--O 1.206 -1.191 0 CA-C-O 121.51 0.671 . . . . 1.0 109.386 178.931 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . 0.728 ' O ' ' HB2' ' A' ' 11' ' ' ARG . 27.5 tt0 -58.92 -45.31 90.67 Favored 'General case' 0 C--N 1.304 -1.371 0 CA-C-O 121.891 0.853 . . . . 1.0 110.548 -179.801 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 8' ' ' ARG . . . . . 0.693 ' O ' ' HB3' ' A' ' 12' ' ' ALA . 0.1 OUTLIER -67.9 -60.13 2.75 Favored 'General case' 0 C--N 1.306 -1.301 0 C-N-CA 118.953 -1.099 . . . . 1.0 109.482 179.065 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . 1.008 HG23 ' H ' ' A' ' 6' ' ' THR . 0.0 OUTLIER -66.32 -50.69 65.9 Favored 'Isoleucine or valine' 0 C--O 1.201 -1.449 0 CA-C-N 115.107 -0.951 . . . . 1.0 110.686 -178.777 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . 0.657 ' N ' ' O ' ' A' ' 6' ' ' THR . 2.5 t -65.69 -62.23 1.63 Allowed 'General case' 0 N--CA 1.488 1.447 0 C-N-CA 120.025 -0.67 . . . . 1.0 111.176 179.185 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 11' ' ' ARG . . . . . 0.728 ' HB2' ' O ' ' A' ' 7' ' ' GLU . 4.6 mmt85 -64.87 -41.18 95.88 Favored 'General case' 0 CA--C 1.547 0.861 0 CA-C-O 119.302 -0.38 . . . . 1.0 111.792 -177.213 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . 0.693 ' HB3' ' O ' ' A' ' 8' ' ' ARG . . . -69.61 -54.17 15.28 Favored 'General case' 0 N--CA 1.483 1.19 0 C-N-CA 118.165 -1.414 . . . . 1.0 108.125 175.84 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . 0.643 ' O ' ' CB ' ' A' ' 17' ' ' LEU . 60.3 t -61.67 -55.02 27.07 Favored 'Isoleucine or valine' 0 C--O 1.198 -1.647 0 C-N-CA 117.423 -1.711 . . . . 1.0 108.438 -179.033 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . 0.793 ' O ' HG22 ' A' ' 18' ' ' VAL . . . -57.1 -62.27 1.87 Allowed 'General case' 0 C--O 1.211 -0.925 0 C-N-CA 118.542 -1.263 . . . . 1.0 109.95 179.653 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . 0.537 ' HB3' ' O ' ' A' ' 11' ' ' ARG . . . -55.34 -55.66 28.94 Favored 'General case' 0 N--CA 1.475 0.805 0 C-N-CA 118.807 -1.157 . . . . 1.0 110.517 -176.952 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . 0.612 ' HB3' ' O ' ' A' ' 12' ' ' ALA . . . -65.66 -55.98 14.58 Favored 'General case' 0 CA--C 1.547 0.847 0 C-N-CA 119.761 -0.776 . . . . 1.0 110.033 -178.889 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . 0.643 ' CB ' ' O ' ' A' ' 13' ' ' VAL . 7.3 tp -56.8 -57.58 11.83 Favored 'General case' 0 N--CA 1.483 1.186 0 CA-C-N 115.397 -0.819 . . . . 1.0 108.827 -178.965 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . 0.793 HG22 ' O ' ' A' ' 14' ' ' ALA . 1.3 m -71.82 -58.22 5.61 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.423 0 C-N-CA 119.282 -0.967 . . . . 1.0 110.772 -179.536 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . 0.489 ' N ' ' O ' ' A' ' 15' ' ' ALA . . . -56.34 -172.94 0.16 Allowed Glycine 0 CA--C 1.519 0.341 0 C-N-CA 120.924 -0.655 . . . . 1.0 112.109 -177.768 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 20' ' ' PRO . . . . . 0.605 ' O ' ' N ' ' A' ' 24' ' ' ALA . 1.7 Cg_endo -81.05 -21.96 6.36 Favored 'Trans proline' 0 C--N 1.308 -1.581 0 C-N-CA 123.122 2.548 . . . . 1.0 112.501 -178.841 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -63.35 -62.03 5.76 Favored Glycine 0 N--CA 1.478 1.437 0 C-N-CA 119.687 -1.245 . . . . 1.0 112.906 -176.492 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . 0.587 ' H ' ' HA ' ' A' ' 16' ' ' ALA . . . -55.44 -52.03 50.56 Favored Glycine 0 N--CA 1.472 1.048 0 N-CA-C 106.277 -2.729 . . . . 1.0 106.277 -179.255 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . 0.488 ' O ' HG12 ' A' ' 27' ' ' VAL . 26.7 t -58.23 -31.81 43.12 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.731 0 C-N-CA 119.455 -0.898 . . . . 1.0 108.966 178.326 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . 0.605 ' N ' ' O ' ' A' ' 20' ' ' PRO . . . -60.2 -61.97 2.21 Favored 'General case' 0 N--CA 1.481 1.09 0 C-N-CA 118.616 -1.233 . . . . 1.0 109.677 178.614 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . 0.724 HD12 ' O ' ' A' ' 25' ' ' LEU . 0.9 OUTLIER -60.33 -50.35 73.98 Favored 'General case' 0 N--CA 1.478 0.938 0 N-CA-C 112.633 0.605 . . . . 1.0 112.633 -178.482 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 86.0 t -57.89 -59.44 3.42 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.021 0 C-N-CA 118.986 -1.086 . . . . 1.0 110.612 -177.204 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . 0.598 ' O ' ' HB3' ' A' ' 31' ' ' ALA . 1.2 p -58.41 -36.54 59.18 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.687 0 C-N-CA 120.672 -0.411 . . . . 1.0 111.16 -178.089 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 20.9 tttt -65.84 -56.57 11.2 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-O 121.463 0.649 . . . . 1.0 109.884 -179.706 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 25.1 t -63.51 -49.27 83.3 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.54 0 CA-C-N 115.292 -0.867 . . . . 1.0 111.088 -177.776 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 30' ' ' CYS . . . . . . . . . . . . . 14.0 t -63.54 -61.61 2.21 Favored 'General case' 0 C--N 1.316 -0.849 0 C-N-CA 118.901 -1.12 . . . . 1.0 109.43 -179.396 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . 0.628 ' O ' HD12 ' A' ' 37' ' ' ILE . . . -58.44 -50.89 72.07 Favored 'General case' 0 C--N 1.319 -0.718 0 C-N-CA 120.553 -0.459 . . . . 1.0 110.847 -178.416 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . 0.527 ' O ' ' CB ' ' A' ' 33' ' ' LEU . . . 74.51 67.85 1.67 Allowed Glycine 0 CA--C 1.518 0.238 0 N-CA-C 108.158 -1.977 . . . . 1.0 108.158 -178.383 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . 0.601 HD23 ' CG2' ' A' ' 36' ' ' VAL . 13.5 tp 94.34 81.31 0.03 OUTLIER Pre-proline 0 CA--C 1.54 0.588 0 CA-C-N 114.457 -0.871 . . . . 1.0 109.663 -177.719 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 13.0 Cg_endo -54.53 -23.08 30.35 Favored 'Trans proline' 0 N--CA 1.502 2.027 0 C-N-CA 121.637 1.558 . . . . 1.0 113.952 -179.276 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . 0.949 ' O ' HD12 ' A' ' 112' ' ' ILE . . . -62.56 -61.61 6.37 Favored Glycine 0 CA--C 1.536 1.356 0 C-N-CA 117.873 -2.108 . . . . 1.0 109.863 -178.403 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . 0.641 ' O ' HG22 ' A' ' 37' ' ' ILE . 2.6 m -95.57 178.39 0.59 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.519 0 N-CA-C 107.965 -1.124 . . . . 1.0 107.965 176.579 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . 0.641 HG22 ' O ' ' A' ' 36' ' ' VAL . 0.1 OUTLIER 102.56 121.94 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.479 0.989 0 O-C-N 124.297 0.998 . . . . 1.0 112.036 179.601 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 81.3 m-70 -143.2 135.29 26.98 Favored 'General case' 0 N--CA 1.463 0.198 0 N-CA-C 109.073 -0.714 . . . . 1.0 109.073 178.445 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . 0.403 ' O ' ' CG ' ' A' ' 42' ' ' ARG . 0.0 OUTLIER -90.62 115.83 65.05 Favored Pre-proline 0 CA--C 1.546 0.804 0 N-CA-C 109.329 -0.619 . . . . 1.0 109.329 179.774 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 50.2 Cg_exo -49.01 -32.63 23.97 Favored 'Trans proline' 0 N--CA 1.496 1.619 0 C-N-CA 121.678 1.585 . . . . 1.0 113.569 -179.053 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -111.34 93.67 4.59 Favored 'General case' 0 CA--C 1.513 -0.459 0 N-CA-C 114.051 1.13 . . . . 1.0 114.051 -175.12 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . 0.42 ' C ' ' N ' ' A' ' 44' ' ' GLY . 0.2 OUTLIER -141.6 143.06 33.49 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 114.589 -1.187 . . . . 1.0 108.271 178.806 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 43' ' ' ARG . . . . . 0.441 HH22 ' HB3' ' A' ' 59' ' ' ARG . 14.9 tpt85 -50.49 -13.35 0.12 Allowed 'General case' 0 C--N 1.322 -0.6 0 C-N-CA 120.447 -0.501 . . . . 1.0 110.806 -177.164 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . 0.42 ' N ' ' C ' ' A' ' 42' ' ' ARG . . . 121.08 -23.52 7.68 Favored Glycine 0 N--CA 1.472 1.095 0 N-CA-C 110.346 -1.102 . . . . 1.0 110.346 179.823 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . 0.541 ' O ' ' CB ' ' A' ' 46' ' ' PHE . 36.0 p90 -152.25 159.6 43.51 Favored 'General case' 0 C--N 1.327 -0.391 0 N-CA-C 108.601 -0.889 . . . . 1.0 108.601 177.618 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 46' ' ' PHE . . . . . 0.541 ' CB ' ' O ' ' A' ' 45' ' ' PHE . 4.7 t80 117.24 103.11 0.0 OUTLIER 'General case' 0 N--CA 1.487 1.41 0 O-C-N 124.61 1.194 . . . . 1.0 110.274 -179.954 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 47' ' ' ARG . . . . . 0.541 HH12 ' H91' ' A' ' 128' ' ' MTN . 6.5 ptp180 120.5 135.68 0.0 OUTLIER 'General case' 0 N--CA 1.488 1.453 0 C-N-CA 124.886 1.274 . . . . 1.0 110.557 179.609 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 48' ' ' CYS . . . . . 0.821 ' O ' ' H62' ' A' ' 129' ' ' MTN . 2.6 t 67.61 73.68 0.32 Allowed 'General case' 0 C--O 1.218 -0.588 0 C-N-CA 119.718 -0.793 . . . . 1.0 110.229 177.939 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 49' ' ' ASN . . . . . 0.767 ' H ' HD22 ' A' ' 49' ' ' ASN . 0.0 OUTLIER -135.82 153.56 77.29 Favored Pre-proline 0 N--CA 1.47 0.542 0 CA-C-O 119.427 -0.321 . . . . 1.0 110.173 -178.634 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . 0.42 ' C ' ' H ' ' A' ' 52' ' ' ARG . 33.7 Cg_endo -60.31 47.84 0.07 OUTLIER 'Trans proline' 0 N--CA 1.509 2.431 0 C-N-CA 122.763 2.308 . . . . 1.0 113.278 179.503 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . 0.491 ' N ' ' O ' ' A' ' 49' ' ' ASN . 15.8 mp0 70.77 -18.5 0.25 Allowed 'General case' 0 N--CA 1.47 0.561 0 C-N-CA 123.571 0.748 . . . . 1.0 111.486 179.697 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . 0.42 ' H ' ' C ' ' A' ' 50' ' ' PRO . 1.6 mpp_? -56.92 138.78 53.44 Favored 'General case' 0 CA--C 1.531 0.242 0 N-CA-C 109.436 -0.579 . . . . 1.0 109.436 179.445 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . 0.647 HG23 HG22 ' A' ' 55' ' ' ILE . 2.6 tp -58.91 129.83 21.54 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-N 115.551 -0.75 . . . . 1.0 110.917 -179.188 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 54' ' ' GLN . . . . . 0.511 ' NE2' ' OD1' ' A' ' 49' ' ' ASN . 0.0 OUTLIER -59.34 79.26 0.01 OUTLIER 'General case' 0 CA--C 1.537 0.474 0 N-CA-C 108.28 -1.007 . . . . 1.0 108.28 -178.014 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . 0.647 HG22 HG23 ' A' ' 53' ' ' ILE . 13.9 tt -154.49 162.97 1.79 Allowed 'Isoleucine or valine' 0 CA--C 1.523 -0.066 0 CA-C-N 114.802 -1.09 . . . . 1.0 111.325 178.438 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 100.81 -28.07 17.67 Favored Glycine 0 N--CA 1.452 -0.25 0 N-CA-C 111.943 -0.463 . . . . 1.0 111.943 176.849 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 12.9 m-20 -67.81 135.53 52.74 Favored 'General case' 0 N--CA 1.446 -0.646 0 CA-C-O 122.807 1.289 . . . . 1.0 113.661 -177.42 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 58' ' ' TRP . . . . . . . . . . . . . 32.4 m0 -78.13 -179.06 5.93 Favored 'General case' 0 N--CA 1.44 -0.964 0 CA-C-N 112.484 -2.143 . . . . 1.0 107.235 177.293 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 59' ' ' ARG . . . . . 0.65 ' H ' ' CD ' ' A' ' 59' ' ' ARG . 0.0 OUTLIER -99.05 -56.12 2.51 Favored 'General case' 0 CA--C 1.557 1.232 0 CA-C-N 119.646 1.112 . . . . 1.0 111.896 -179.734 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 60' ' ' TYR . . . . . 0.401 ' H ' ' HD2' ' A' ' 59' ' ' ARG . 24.8 t80 -78.66 -7.24 57.47 Favored 'General case' 0 N--CA 1.481 1.119 0 C-N-CA 125.429 1.492 . . . . 1.0 111.688 -178.418 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 69.4 tt0 -71.36 -13.89 62.01 Favored 'General case' 0 C--N 1.296 -1.749 0 CA-C-N 114.944 -1.025 . . . . 1.0 109.358 179.814 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . 0.513 ' O ' ' N ' ' A' ' 66' ' ' GLY . 10.4 m -44.51 -51.83 1.73 Allowed 'Isoleucine or valine' 0 CA--C 1.496 -1.133 0 C-N-CA 120.449 -0.501 . . . . 1.0 110.36 -175.448 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 63' ' ' ALA . . . . . 0.669 ' O ' ' HG2' ' A' ' 67' ' ' ARG . . . -65.51 -48.15 73.51 Favored 'General case' 0 N--CA 1.421 -1.919 0 N-CA-C 109.223 -0.658 . . . . 1.0 109.223 179.517 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 64' ' ' HIS . . . . . 0.408 ' O ' ' CG ' ' A' ' 67' ' ' ARG . 1.2 m-70 -54.57 -58.47 7.35 Favored 'General case' 0 CA--C 1.548 0.89 0 O-C-N 123.913 0.758 . . . . 1.0 110.368 179.829 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . 0.65 ' C ' ' H ' ' A' ' 67' ' ' ARG . 23.8 t70 -67.45 -53.38 29.43 Favored 'General case' 0 C--O 1.24 0.604 0 CA-C-O 121.15 0.5 . . . . 1.0 109.751 178.264 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . 0.513 ' N ' ' O ' ' A' ' 62' ' ' VAL . . . -63.72 30.94 0.09 OUTLIER Glycine 0 CA--C 1.527 0.826 0 N-CA-C 110.866 -0.894 . . . . 1.0 110.866 177.65 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 67' ' ' ARG . . . . . 0.669 ' HG2' ' O ' ' A' ' 63' ' ' ALA . 24.1 mmm-85 -80.25 -3.73 50.39 Favored 'General case' 0 N--CA 1.448 -0.567 0 N-CA-C 107.704 -1.221 . . . . 1.0 107.704 175.855 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . 0.476 ' O ' ' HA ' ' A' ' 72' ' ' HIS . 4.9 tt -35.1 -29.86 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.792 0 N-CA-C 107.705 -1.22 . . . . 1.0 107.705 -178.741 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . 0.818 HD23 ' H ' ' A' ' 70' ' ' ALA . 1.2 pt? -62.92 -62.34 1.78 Allowed 'General case' 0 N--CA 1.48 1.048 0 C-N-CA 117.121 -1.832 . . . . 1.0 106.914 177.689 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . 0.818 ' H ' HD23 ' A' ' 69' ' ' LEU . . . -77.56 -72.55 0.35 Allowed 'General case' 0 C--O 1.214 -0.777 0 N-CA-C 106.663 -1.606 . . . . 1.0 106.663 178.057 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . 0.511 ' O ' ' C ' ' A' ' 72' ' ' HIS . . . -45.06 3.72 0.0 OUTLIER 'General case' 0 CA--C 1.516 -0.355 0 C-N-CA 124.402 1.081 . . . . 1.0 112.847 177.633 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 72' ' ' HIS . . . . . 0.687 ' H ' ' C ' ' A' ' 70' ' ' ALA . 0.0 OUTLIER -21.57 -68.29 0.03 OUTLIER 'General case' 0 CA--C 1.518 -0.275 0 C-N-CA 122.872 0.469 . . . . 1.0 111.437 -176.8 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 73' ' ' MET . . . . . 0.563 ' N ' ' ND1' ' A' ' 72' ' ' HIS . 32.6 mtt -73.51 -48.02 36.51 Favored 'General case' 0 C--N 1.31 -1.148 0 C-N-CA 119.069 -1.052 . . . . 1.0 109.151 177.355 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . 0.677 ' O ' ' N ' ' A' ' 76' ' ' GLY . 65.5 t -43.79 -49.21 1.78 Allowed 'Isoleucine or valine' 0 C--O 1.22 -0.497 0 CA-C-O 118.141 -0.933 . . . . 1.0 111.04 -176.146 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 75' ' ' ASN . . . . . 0.47 ' C ' ' N ' ' A' ' 77' ' ' ILE . 21.8 t30 -36.52 -20.34 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.746 0 CA-C-N 120.238 1.381 . . . . 1.0 110.312 177.755 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . 0.677 ' N ' ' O ' ' A' ' 74' ' ' VAL . . . -49.3 -20.87 2.51 Favored Glycine 0 C--O 1.216 -1.019 0 N-CA-C 107.948 -2.061 . . . . 1.0 107.948 174.885 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . 0.477 ' N ' ' O ' ' A' ' 74' ' ' VAL . 82.2 mt -53.27 -43.77 51.49 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.133 0 O-C-N 122.635 -0.333 . . . . 1.0 111.019 -178.044 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 42.5 t -50.44 -19.78 0.79 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.424 0 CA-C-N 118.667 0.667 . . . . 1.0 111.978 -179.445 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . 0.747 ' O ' ' HB2' ' A' ' 83' ' ' ALA . 0.3 OUTLIER -90.15 -38.67 11.27 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.077 0 C-N-CA 120.007 -0.677 . . . . 1.0 111.543 179.466 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -82.37 -27.36 32.17 Favored 'General case' 0 CA--C 1.541 0.633 0 N-CA-C 113.116 0.784 . . . . 1.0 113.116 -179.255 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . 0.644 ' CG ' ' N ' ' A' ' 82' ' ' ASP . 12.6 pt-20 -84.3 -67.63 0.78 Allowed 'General case' 0 CA--C 1.544 0.72 0 N-CA-C 110.152 -0.314 . . . . 1.0 110.152 178.171 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 82' ' ' ASP . . . . . 0.644 ' N ' ' CG ' ' A' ' 81' ' ' GLU . 67.1 m-20 -66.25 -20.05 66.0 Favored 'General case' 0 CA--C 1.495 -1.164 0 O-C-N 121.269 -0.894 . . . . 1.0 112.384 -177.664 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . 0.747 ' HB2' ' O ' ' A' ' 79' ' ' ILE . . . -18.65 -55.03 0.01 OUTLIER 'General case' 0 N--CA 1.468 0.465 0 CA-C-O 118.946 -0.549 . . . . 1.0 111.846 176.642 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . 0.449 ' N ' ' O ' ' A' ' 82' ' ' ASP . 3.8 mm? -28.0 -53.78 0.09 Allowed 'General case' 0 N--CA 1.484 1.227 0 CA-C-N 119.657 1.117 . . . . 1.0 113.43 -177.896 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 85' ' ' ILE . . . . . 0.599 ' O ' ' HB3' ' A' ' 88' ' ' ALA . 15.6 pt -91.05 -35.43 7.15 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 C-N-CA 120.587 -0.445 . . . . 1.0 109.811 -179.404 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . 0.797 ' O ' HG13 ' A' ' 89' ' ' VAL . . . -52.92 -54.92 27.79 Favored 'General case' 0 C--N 1.33 -0.244 0 C-N-CA 120.376 -0.529 . . . . 1.0 109.685 -179.514 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . 0.405 ' OE1' ' C ' ' A' ' 87' ' ' GLU . 9.0 tm-20 -57.4 -21.04 33.67 Favored 'General case' 0 C--N 1.33 -0.277 0 C-N-CA 120.062 -0.655 . . . . 1.0 109.508 179.304 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . 0.696 ' C ' ' H ' ' A' ' 90' ' ' GLY . . . -73.36 -13.51 61.11 Favored 'General case' 0 C--O 1.225 -0.192 0 C-N-CA 120.352 -0.539 . . . . 1.0 109.923 179.457 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 89' ' ' VAL . . . . . 0.797 HG13 ' O ' ' A' ' 86' ' ' ALA . 27.8 m -49.09 11.4 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.48 1.037 0 N-CA-C 113.27 0.841 . . . . 1.0 113.27 -178.979 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 90' ' ' GLY . . . . . 0.73 ' O ' ' N ' ' A' ' 92' ' ' HIS . . . -34.37 -42.12 0.27 Allowed Glycine 0 CA--C 1.543 1.83 0 CA-C-O 117.871 -1.516 . . . . 1.0 110.561 -177.26 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 91' ' ' PRO . . . . . 0.495 ' HD2' ' N ' ' A' ' 90' ' ' GLY . 1.1 Cg_endo -44.64 0.76 0.01 OUTLIER 'Trans proline' 0 N--CA 1.5 1.911 0 CA-C-N 121.292 2.546 . . . . 1.0 110.925 170.724 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 92' ' ' HIS . . . . . 0.73 ' N ' ' O ' ' A' ' 90' ' ' GLY . 16.4 t-80 -51.17 -41.7 60.33 Favored 'General case' 0 CA--C 1.51 -0.589 0 N-CA-C 109.21 -0.663 . . . . 1.0 109.21 -177.454 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 39.0 tp -63.03 -39.86 96.0 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 119.17 0.895 . . . . 1.0 110.349 177.718 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -61.8 -60.21 4.0 Favored 'General case' 0 CA--C 1.496 -1.116 0 N-CA-C 106.085 -1.82 . . . . 1.0 106.085 -179.398 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 95' ' ' ARG . . . . . 0.417 HH12 ' HD3' ' A' ' 20' ' ' PRO . 3.7 mmp_? -57.8 -29.92 65.27 Favored 'General case' 0 N--CA 1.432 -1.34 0 CA-C-N 115.29 -0.868 . . . . 1.0 108.738 177.825 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 96' ' ' ALA . . . . . 0.806 ' O ' ' N ' ' A' ' 100' ' ' ILE . . . -59.04 -53.81 54.21 Favored 'General case' 0 C--O 1.198 -1.617 0 C-N-CA 118.127 -1.429 . . . . 1.0 108.558 -176.73 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . 0.487 ' C ' ' O ' ' A' ' 96' ' ' ALA . 1.2 tt -34.46 -28.82 0.01 OUTLIER 'General case' 0 CA--C 1.565 1.521 0 O-C-N 124.341 1.026 . . . . 1.0 108.59 -177.929 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 98' ' ' GLY . . . . . 0.616 ' N ' ' O ' ' A' ' 96' ' ' ALA . . . -88.62 -53.08 2.67 Favored Glycine 0 CA--C 1.543 1.829 0 CA-C-O 123.589 1.66 . . . . 1.0 111.401 174.144 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 99' ' ' GLN . . . . . 0.487 ' N ' ' O ' ' A' ' 96' ' ' ALA . 6.1 tt0 -78.73 6.18 9.52 Favored 'General case' 0 N--CA 1.433 -1.309 0 CA-C-N 114.473 -0.864 . . . . 1.0 108.991 178.693 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 100' ' ' ILE . . . . . 0.806 ' N ' ' O ' ' A' ' 96' ' ' ALA . 0.2 OUTLIER -63.8 -47.09 92.46 Favored 'Isoleucine or valine' 0 CA--C 1.495 -1.159 0 N-CA-C 108.022 -1.103 . . . . 1.0 108.022 179.948 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 101' ' ' VAL . . . . . 0.628 HG23 ' H ' ' A' ' 102' ' ' CYS . 17.6 m -55.54 -60.01 2.08 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.477 0 C-N-CA 117.035 -1.866 . . . . 1.0 108.958 179.65 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 102' ' ' CYS . . . . . 0.628 ' H ' HG23 ' A' ' 101' ' ' VAL . 42.3 t -41.11 -19.71 0.01 OUTLIER 'General case' 0 C--N 1.311 -1.075 0 N-CA-C 113.217 0.821 . . . . 1.0 113.217 -176.231 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 103' ' ' ARG . . . . . 0.517 ' N ' ' O ' ' A' ' 101' ' ' VAL . 7.6 ttp180 -89.98 -35.27 15.64 Favored 'General case' 0 N--CA 1.497 1.922 0 N-CA-C 114.534 1.309 . . . . 1.0 114.534 178.956 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 104' ' ' TYR . . . . . 0.649 ' O ' ' CG ' ' A' ' 104' ' ' TYR . 0.0 OUTLIER -100.18 22.97 10.63 Favored 'General case' 0 C--N 1.303 -1.45 0 CA-C-N 113.188 -1.824 . . . . 1.0 110.076 -179.816 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 105' ' ' GLY . . . . . 0.535 ' O ' ' HB3' ' A' ' 106' ' ' ALA . . . -161.5 -88.15 0.07 OUTLIER Glycine 0 N--CA 1.451 -0.33 0 N-CA-C 107.413 -2.275 . . . . 1.0 107.413 179.64 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 106' ' ' ALA . . . . . 0.561 ' O ' ' CD ' ' A' ' 110' ' ' PRO . . . 69.53 58.17 0.32 Allowed 'General case' 0 CA--C 1.548 0.895 0 N-CA-C 112.704 0.631 . . . . 1.0 112.704 179.334 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 107' ' ' THR . . . . . 0.498 ' O ' ' HD2' ' A' ' 110' ' ' PRO . 20.0 m -76.41 -57.84 3.63 Favored 'General case' 0 N--CA 1.48 1.037 0 O-C-N 121.257 -0.902 . . . . 1.0 109.384 179.555 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . 0.525 HG23 ' N ' ' A' ' 109' ' ' ILE . 16.5 m -68.61 -45.45 81.53 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.747 0 N-CA-C 110.405 -0.22 . . . . 1.0 110.405 -179.371 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 109' ' ' ILE . . . . . 0.525 ' N ' HG23 ' A' ' 108' ' ' VAL . 0.8 OUTLIER -36.83 -54.01 1.79 Allowed Pre-proline 0 CA--C 1.568 1.659 0 CA-C-N 116.159 -0.473 . . . . 1.0 110.199 -178.694 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 110' ' ' PRO . . . . . 0.561 ' CD ' ' O ' ' A' ' 106' ' ' ALA . 31.4 Cg_exo -57.14 -24.52 59.1 Favored 'Trans proline' 0 N--CA 1.504 2.141 0 C-N-CA 123.296 2.664 . . . . 1.0 113.087 176.284 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 111' ' ' ASN . . . . . 0.567 ' CG ' ' N ' ' A' ' 112' ' ' ILE . 0.1 OUTLIER -63.04 -66.19 0.58 Allowed 'General case' 0 CA--C 1.54 0.587 0 C-N-CA 120.114 -0.634 . . . . 1.0 109.8 -178.531 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 112' ' ' ILE . . . . . 0.949 HD12 ' O ' ' A' ' 35' ' ' GLY . 1.9 tt -61.56 -27.84 42.86 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.493 0 CA-C-O 121.308 0.575 . . . . 1.0 110.804 178.707 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 113' ' ' ASN . . . . . 0.445 ' O ' ' HB2' ' A' ' 117' ' ' GLU . 1.6 m120 -57.54 -64.88 0.75 Allowed 'General case' 0 C--N 1.305 -1.341 0 CA-C-N 115.066 -0.97 . . . . 1.0 111.275 -175.203 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -67.63 -23.86 65.39 Favored 'General case' 0 C--N 1.318 -0.796 0 N-CA-C 112.124 0.416 . . . . 1.0 112.124 -178.926 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -78.97 -62.91 1.55 Allowed 'General case' 0 CA--C 1.536 0.422 0 N-CA-C 112.828 0.677 . . . . 1.0 112.828 178.988 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 116' ' ' ILE . . . . . 0.606 HD12 HG13 ' A' ' 112' ' ' ILE . 19.7 mt -69.68 -47.09 72.86 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.651 0 O-C-N 121.414 -0.804 . . . . 1.0 112.532 -178.329 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 117' ' ' GLU . . . . . 0.445 ' HB2' ' O ' ' A' ' 113' ' ' ASN . 73.9 mt-10 -46.84 -59.73 2.88 Favored 'General case' 0 CA--C 1.498 -1.04 0 N-CA-C 108.681 -0.859 . . . . 1.0 108.681 -177.001 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 88.9 t -55.59 -16.19 2.3 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.314 0 CA-C-N 115.407 -0.815 . . . . 1.0 109.191 179.052 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 119' ' ' LEU . . . . . 0.583 ' N ' ' O ' ' A' ' 116' ' ' ILE . 0.2 OUTLIER -79.87 -61.11 2.09 Favored 'General case' 0 C--N 1.351 0.633 0 C-N-CA 119.691 -0.803 . . . . 1.0 109.362 176.964 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 120' ' ' GLY . . . . . 0.547 ' O ' HG23 ' A' ' 121' ' ' THR . . . -67.15 -84.39 0.1 Allowed Glycine 0 C--N 1.361 1.97 0 C-N-CA 117.154 -2.451 . . . . 1.0 110.874 178.705 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 121' ' ' THR . . . . . 0.547 HG23 ' O ' ' A' ' 120' ' ' GLY . 9.3 p -159.27 -23.71 0.07 Allowed 'General case' 0 C--N 1.32 -0.688 0 N-CA-C 108.274 -1.01 . . . . 1.0 108.274 -179.564 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 122' ' ' GLY . . . . . 0.462 ' O ' ' C ' ' A' ' 123' ' ' THR . . . 112.54 -37.09 3.8 Favored Glycine 0 CA--C 1.525 0.681 0 CA-C-N 113.895 -1.502 . . . . 1.0 111.913 179.368 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 123' ' ' THR . . . . . 0.586 HG23 ' O ' ' A' ' 123' ' ' THR . 4.2 t -30.46 93.22 0.01 OUTLIER 'General case' 0 N--CA 1.472 0.675 0 CA-C-N 118.781 1.291 . . . . 1.0 112.33 -178.932 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 124' ' ' ASP . . . . . 0.46 ' N ' ' O ' ' A' ' 122' ' ' GLY . 40.9 m-20 -146.35 143.43 29.09 Favored 'General case' 0 C--N 1.332 -0.159 0 N-CA-C 108.946 -0.761 . . . . 1.0 108.946 179.238 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 125' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -148.01 147.16 29.32 Favored 'General case' 0 CA--C 1.535 0.385 0 N-CA-C 109.695 -0.483 . . . . 1.0 109.695 179.725 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 126' ' ' ARG . . . . . 0.64 ' HB2' ' H63' ' A' ' 130' ' ' MTN . 8.3 mmm180 -146.15 146.24 30.78 Favored 'General case' 0 CA--C 1.536 0.414 0 N-CA-C 109.018 -0.734 . . . . 1.0 109.018 178.622 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 127' ' ' PHE . . . . . 0.534 ' OXT' ' CD2' ' A' ' 127' ' ' PHE . 87.4 t80 . . . . . 0 N--CA 1.473 0.713 0 CA-C-O 118.069 -0.967 . . . . 1.0 110.865 179.557 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 128' ' ' MTN . . . . . 0.541 ' H91' HH12 ' A' ' 47' ' ' ARG . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 129' ' ' MTN . . . . . 0.821 ' H62' ' O ' ' A' ' 48' ' ' CYS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 130' ' ' MTN . . . . . 0.64 ' H63' ' HB2' ' A' ' 126' ' ' ARG . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.42 ' C ' ' H ' ' A' ' 3' ' ' ASP . 0.4 OUTLIER . . . . . 0 N--CA 1.489 1.495 0 N-CA-C 108.19 -1.041 . . . . 1.0 108.19 . . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . 0.55 ' O ' ' CB ' ' A' ' 3' ' ' ASP . 75.0 m -75.61 13.48 0.79 Allowed 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 116.25 -0.432 . . . . 1.0 110.852 179.709 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . 0.55 ' CB ' ' O ' ' A' ' 2' ' ' SER . 21.4 t0 135.69 134.15 0.0 OUTLIER 'General case' 0 N--CA 1.478 0.954 0 O-C-N 124.68 1.238 . . . . 1.0 110.346 179.066 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . 0.521 ' N ' ' OD1' ' A' ' 3' ' ' ASP . 71.1 t80 -167.36 91.8 0.38 Allowed 'General case' 0 C--N 1.329 -0.3 0 N-CA-C 114.833 1.42 . . . . 1.0 114.833 175.164 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 65.6 m-20 -73.61 146.78 44.4 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 114.684 -1.144 . . . . 1.0 109.212 178.898 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 6' ' ' THR . . . . . 0.483 ' O ' ' N ' ' A' ' 10' ' ' SER . 58.6 m -56.59 160.48 3.23 Favored 'General case' 0 C--O 1.217 -0.649 0 C-N-CA 120.076 -0.649 . . . . 1.0 109.505 179.519 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . 0.559 ' O ' ' N ' ' A' ' 11' ' ' ARG . 30.6 tt0 -57.07 -60.43 3.6 Favored 'General case' 0 C--N 1.316 -0.855 0 CA-C-O 121.565 0.697 . . . . 1.0 109.372 -178.072 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 8' ' ' ARG . . . . . 0.538 ' CG ' ' N ' ' A' ' 9' ' ' VAL . 48.0 ptt85 -49.36 -52.31 29.08 Favored 'General case' 0 C--N 1.313 -0.987 0 N-CA-C 108.082 -1.081 . . . . 1.0 108.082 -177.472 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . 0.584 ' O ' HG23 ' A' ' 13' ' ' VAL . 57.0 t -62.74 -48.02 90.09 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.36 0 CA-C-N 114.837 -1.074 . . . . 1.0 109.262 179.814 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . 0.483 ' N ' ' O ' ' A' ' 6' ' ' THR . 48.3 t -63.41 -62.31 1.76 Allowed 'General case' 0 N--CA 1.476 0.836 0 CA-C-N 115.835 -0.621 . . . . 1.0 109.979 -179.214 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 11' ' ' ARG . . . . . 0.559 ' N ' ' O ' ' A' ' 7' ' ' GLU . 0.0 OUTLIER -57.42 -57.56 12.13 Favored 'General case' 0 N--CA 1.47 0.55 0 N-CA-C 109.062 -0.718 . . . . 1.0 109.062 -178.671 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . 0.513 ' CB ' ' O ' ' A' ' 8' ' ' ARG . . . -47.99 -48.09 32.74 Favored 'General case' 0 N--CA 1.478 0.954 0 N-CA-C 106.193 -1.78 . . . . 1.0 106.193 -178.198 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . 0.584 HG23 ' O ' ' A' ' 9' ' ' VAL . 45.1 t -60.5 -47.89 90.78 Favored 'Isoleucine or valine' 0 C--O 1.203 -1.392 0 C-N-CA 119.078 -1.049 . . . . 1.0 108.886 176.817 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . 0.564 ' O ' HG13 ' A' ' 18' ' ' VAL . . . -60.96 -61.91 2.23 Favored 'General case' 0 C--O 1.212 -0.903 0 C-N-CA 119.017 -1.073 . . . . 1.0 110.018 179.145 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . 0.533 ' O ' ' N ' ' A' ' 19' ' ' GLY . . . -51.84 -55.06 22.27 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-O 121.932 0.872 . . . . 1.0 109.228 -177.902 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . 0.511 ' C ' ' H ' ' A' ' 22' ' ' GLY . . . -61.57 -54.4 43.51 Favored 'General case' 0 C--N 1.311 -1.07 0 CA-C-N 114.135 -1.393 . . . . 1.0 109.113 -179.43 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . 0.668 HD23 ' C ' ' A' ' 17' ' ' LEU . 6.8 tt -57.19 -54.16 49.91 Favored 'General case' 0 N--CA 1.484 1.257 0 CA-C-N 114.411 -1.268 . . . . 1.0 109.312 -177.711 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . 0.564 HG13 ' O ' ' A' ' 14' ' ' ALA . 2.6 m -68.45 -56.46 12.4 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.501 0 C-N-CA 119.384 -0.926 . . . . 1.0 109.324 178.893 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . 0.533 ' N ' ' O ' ' A' ' 15' ' ' ALA . . . -64.17 -170.7 2.06 Favored Glycine 0 CA--C 1.526 0.731 0 N-CA-C 111.352 -0.699 . . . . 1.0 111.352 -179.568 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 20' ' ' PRO . . . . . 0.522 ' O ' ' N ' ' A' ' 24' ' ' ALA . 1.8 Cg_endo -77.41 -25.12 8.58 Favored 'Trans proline' 0 N--CA 1.494 1.53 0 C-N-CA 123.011 2.474 . . . . 1.0 114.522 -178.561 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . 0.433 ' O ' ' HB3' ' A' ' 24' ' ' ALA . . . -59.33 -58.48 14.19 Favored Glycine 0 N--CA 1.476 1.322 0 C-N-CA 119.894 -1.146 . . . . 1.0 111.358 -177.22 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . 0.511 ' H ' ' C ' ' A' ' 16' ' ' ALA . . . -57.64 -54.16 39.42 Favored Glycine 0 N--CA 1.471 0.975 0 N-CA-C 106.813 -2.515 . . . . 1.0 106.813 -178.136 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . 0.586 ' O ' HG12 ' A' ' 27' ' ' VAL . 53.9 t -53.96 -33.03 23.28 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.059 0 CA-C-N 114.543 -0.828 . . . . 1.0 109.069 179.313 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . 0.522 ' N ' ' O ' ' A' ' 20' ' ' PRO . . . -60.73 -61.02 2.89 Favored 'General case' 0 CA--C 1.53 0.204 0 C-N-CA 118.554 -1.258 . . . . 1.0 109.486 179.559 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 3.7 tp -64.34 -47.43 79.4 Favored 'General case' 0 C--N 1.344 0.346 0 N-CA-C 113.497 0.925 . . . . 1.0 113.497 -177.985 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 98.6 t -60.23 -60.58 2.34 Favored 'Isoleucine or valine' 0 C--N 1.339 0.137 0 C-N-CA 118.366 -1.334 . . . . 1.0 110.231 -176.976 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . 0.586 HG12 ' O ' ' A' ' 23' ' ' VAL . 1.4 p -55.14 -35.23 34.75 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.244 0 CA-C-O 120.869 0.366 . . . . 1.0 111.798 -178.209 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 8.2 tttm -67.56 -54.02 23.41 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-O 121.51 0.671 . . . . 1.0 109.436 -179.016 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 44.2 t -61.75 -49.67 83.34 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.887 0 CA-C-N 114.68 -1.146 . . . . 1.0 111.246 -178.527 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 30' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -64.96 -61.18 2.32 Favored 'General case' 0 CA--C 1.534 0.346 0 C-N-CA 118.542 -1.263 . . . . 1.0 109.905 -179.218 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . 0.509 ' HB2' HH12 ' A' ' 47' ' ' ARG . . . -60.84 -51.65 68.42 Favored 'General case' 0 CA--C 1.515 -0.396 0 N-CA-C 112.535 0.569 . . . . 1.0 112.535 -176.702 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . 0.489 ' O ' ' CB ' ' A' ' 33' ' ' LEU . . . 81.57 77.19 1.04 Allowed Glycine 0 CA--C 1.523 0.534 0 N-CA-C 108.856 -1.698 . . . . 1.0 108.856 -178.069 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . 0.5 HD22 ' H ' ' A' ' 36' ' ' VAL . 1.3 tt 84.74 85.41 0.05 OUTLIER Pre-proline 0 CA--C 1.543 0.676 0 N-CA-C 109.523 -0.547 . . . . 1.0 109.523 -178.961 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 77.8 Cg_exo -52.35 -33.05 54.38 Favored 'Trans proline' 0 N--CA 1.51 2.496 0 C-N-CA 123.564 2.842 . . . . 1.0 114.556 -178.504 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -58.98 -58.79 12.69 Favored Glycine 0 CA--C 1.527 0.84 0 C-N-CA 118.974 -1.584 . . . . 1.0 109.843 -178.083 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . 0.614 ' O ' HG22 ' A' ' 37' ' ' ILE . 0.4 OUTLIER -94.38 160.62 2.69 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.453 0 N-CA-C 107.083 -1.451 . . . . 1.0 107.083 178.641 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . 0.686 HG23 ' O ' ' A' ' 37' ' ' ILE . 5.9 tp 124.63 111.27 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.484 1.272 0 O-C-N 124.141 0.901 . . . . 1.0 109.069 -178.944 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 57.0 m80 -138.39 130.72 28.82 Favored 'General case' 0 C--N 1.329 -0.304 0 N-CA-C 108.044 -1.095 . . . . 1.0 108.044 178.865 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 11.2 t -91.79 153.19 43.69 Favored Pre-proline 0 N--CA 1.467 0.418 0 CA-C-O 119.391 -0.338 . . . . 1.0 110.363 -179.023 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 6.1 Cg_endo -86.11 -38.74 0.09 OUTLIER 'Trans proline' 0 N--CA 1.483 0.881 0 C-N-CA 121.213 1.275 . . . . 1.0 112.828 -179.786 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -125.53 129.88 50.62 Favored 'General case' 0 N--CA 1.47 0.561 0 CA-C-N 116.203 -0.453 . . . . 1.0 109.918 179.361 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . 0.717 HH12 ' CD ' ' A' ' 47' ' ' ARG . 42.0 ttp180 -176.18 168.95 2.84 Favored 'General case' 0 C--N 1.323 -0.584 0 N-CA-C 107.12 -1.437 . . . . 1.0 107.12 177.294 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 43' ' ' ARG . . . . . 0.457 ' N ' ' HG2' ' A' ' 42' ' ' ARG . 0.0 OUTLIER -52.51 -37.34 57.27 Favored 'General case' 0 N--CA 1.449 -0.478 0 CA-C-N 120.114 1.325 . . . . 1.0 109.132 -179.642 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 125.16 -19.62 6.79 Favored Glycine 0 C--N 1.34 0.773 0 N-CA-C 111.079 -0.809 . . . . 1.0 111.079 -179.106 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . 0.499 ' O ' ' CB ' ' A' ' 46' ' ' PHE . 4.5 t80 -149.7 149.94 31.35 Favored 'General case' 0 CA--C 1.538 0.509 0 CA-C-N 117.815 0.808 . . . . 1.0 109.019 179.76 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 46' ' ' PHE . . . . . 0.499 ' CB ' ' O ' ' A' ' 45' ' ' PHE . 3.8 m-30 132.31 86.17 0.0 OUTLIER 'General case' 0 N--CA 1.484 1.239 0 N-CA-C 107.384 -1.339 . . . . 1.0 107.384 -179.559 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 47' ' ' ARG . . . . . 0.717 ' CD ' HH12 ' A' ' 42' ' ' ARG . 5.7 ptp180 132.87 141.91 0.0 OUTLIER 'General case' 0 N--CA 1.485 1.279 0 O-C-N 124.434 1.084 . . . . 1.0 110.932 178.188 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 3.3 m 71.03 71.5 0.18 Allowed 'General case' 0 N--CA 1.455 -0.179 0 N-CA-C 110.286 -0.264 . . . . 1.0 110.286 -179.992 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 49' ' ' ASN . . . . . 0.452 ' O ' ' N ' ' A' ' 51' ' ' GLU . 69.4 m-80 -132.44 140.32 37.52 Favored Pre-proline 0 C--N 1.33 -0.263 0 N-CA-C 108.007 -1.108 . . . . 1.0 108.007 179.226 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 44.1 Cg_endo -67.86 65.55 0.91 Allowed 'Trans proline' 0 C--N 1.312 -1.394 0 C-N-CA 121.54 1.493 . . . . 1.0 111.374 -179.339 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . 0.525 ' N ' ' OE1' ' A' ' 51' ' ' GLU . 0.0 OUTLIER 64.11 7.48 3.45 Favored 'General case' 0 N--CA 1.463 0.196 0 CA-C-N 114.92 -1.036 . . . . 1.0 111.061 -179.638 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . 0.551 HH11 ' HB1' ' A' ' 86' ' ' ALA . 33.1 mtt-85 -87.97 159.85 18.14 Favored 'General case' 0 C--N 1.331 -0.233 0 N-CA-C 109.572 -0.529 . . . . 1.0 109.572 179.278 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . 0.468 ' O ' ' N ' ' A' ' 55' ' ' ILE . 10.7 tt -79.85 135.54 25.29 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-O 121.87 0.843 . . . . 1.0 111.605 -179.245 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 54' ' ' GLN . . . . . 0.453 ' OE1' ' CE2' ' A' ' 46' ' ' PHE . 5.0 pt20 -61.04 83.24 0.01 OUTLIER 'General case' 0 C--N 1.32 -0.68 0 CA-C-N 114.267 -1.333 . . . . 1.0 109.013 -178.487 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . 0.468 ' N ' ' O ' ' A' ' 53' ' ' ILE . 13.1 tt -149.65 158.64 5.81 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.472 0 CA-C-N 115.717 -0.674 . . . . 1.0 110.547 178.164 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 107.13 -5.33 36.06 Favored Glycine 0 N--CA 1.473 1.15 0 N-CA-C 110.991 -0.844 . . . . 1.0 110.991 179.187 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . 0.41 ' HB3' ' CB ' ' A' ' 45' ' ' PHE . 3.7 p-10 -81.2 105.58 12.51 Favored 'General case' 0 C--N 1.316 -0.877 0 CA-C-N 114.912 -0.644 . . . . 1.0 110.256 179.769 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 58' ' ' TRP . . . . . . . . . . . . . 1.4 m95 -91.09 173.9 7.7 Favored 'General case' 0 CA--C 1.541 0.6 0 CA-C-O 124.289 1.995 . . . . 1.0 114.836 -177.011 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 31.2 mtm180 -78.54 -62.64 1.62 Allowed 'General case' 0 C--N 1.312 -1.053 0 CA-C-N 109.266 -3.606 . . . . 1.0 111.654 -179.096 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 60' ' ' TYR . . . . . 0.499 ' O ' ' CG ' ' A' ' 60' ' ' TYR . 47.1 t80 -91.95 -11.87 34.98 Favored 'General case' 0 C--O 1.249 1.078 0 N-CA-C 113.621 0.971 . . . . 1.0 113.621 179.612 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 6.7 tt0 -81.63 -15.78 53.55 Favored 'General case' 0 N--CA 1.443 -0.82 0 O-C-N 120.686 -1.259 . . . . 1.0 111.804 -178.689 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . 0.568 ' O ' ' N ' ' A' ' 66' ' ' GLY . 0.0 OUTLIER -46.57 -52.65 3.47 Favored 'Isoleucine or valine' 0 C--O 1.208 -1.095 0 C-N-CA 120.231 -0.588 . . . . 1.0 111.719 -174.524 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -69.1 -46.4 67.82 Favored 'General case' 0 C--N 1.311 -1.098 0 C-N-CA 119.376 -0.93 . . . . 1.0 109.616 -179.218 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 3.0 m-70 -50.57 -55.4 16.41 Favored 'General case' 0 N--CA 1.469 0.483 0 C-N-CA 119.08 -1.048 . . . . 1.0 108.823 179.222 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . 0.748 ' C ' ' H ' ' A' ' 67' ' ' ARG . 34.3 m-20 -73.58 -48.99 28.53 Favored 'General case' 0 C--O 1.244 0.765 0 CA-C-O 121.214 0.53 . . . . 1.0 109.886 178.714 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . 0.568 ' N ' ' O ' ' A' ' 62' ' ' VAL . . . -65.77 27.92 0.14 Allowed Glycine 0 N--CA 1.451 -0.351 0 N-CA-C 110.152 -1.179 . . . . 1.0 110.152 177.396 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 67' ' ' ARG . . . . . 0.748 ' H ' ' C ' ' A' ' 65' ' ' ASP . 0.0 OUTLIER -73.4 0.34 12.51 Favored 'General case' 0 N--CA 1.433 -1.321 0 N-CA-C 105.869 -1.901 . . . . 1.0 105.869 174.058 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . 0.44 ' H ' ' C ' ' A' ' 66' ' ' GLY . 1.0 OUTLIER -39.05 -39.3 0.54 Allowed 'General case' 0 C--N 1.346 0.434 0 CA-C-N 116.162 -0.472 . . . . 1.0 110.478 -177.978 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -64.5 -69.08 0.31 Allowed 'General case' 0 N--CA 1.48 1.044 0 C-N-CA 119.258 -0.977 . . . . 1.0 113.34 -175.662 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . 0.509 ' C ' ' H ' ' A' ' 72' ' ' HIS . . . -77.07 -79.07 0.11 Allowed 'General case' 0 CA--C 1.512 -0.483 0 C-N-CA 117.957 -1.497 . . . . 1.0 110.107 -176.037 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . 0.778 ' O ' ' N ' ' A' ' 73' ' ' MET . . . -65.24 14.95 0.03 OUTLIER 'General case' 0 C--N 1.312 -1.035 0 C-N-CA 124.784 1.234 . . . . 1.0 112.85 -178.365 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 72' ' ' HIS . . . . . 0.509 ' H ' ' C ' ' A' ' 70' ' ' ALA . 0.8 OUTLIER -18.55 -32.97 0.0 OUTLIER 'General case' 0 N--CA 1.467 0.404 0 O-C-N 124.315 1.01 . . . . 1.0 113.197 -175.036 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 73' ' ' MET . . . . . 0.778 ' N ' ' O ' ' A' ' 71' ' ' ALA . 8.6 ptp -61.15 -53.13 60.8 Favored 'General case' 0 C--N 1.319 -0.76 0 C-N-CA 118.755 -1.178 . . . . 1.0 108.465 176.49 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . 0.713 ' O ' ' N ' ' A' ' 76' ' ' GLY . 34.2 m -44.65 -51.64 1.84 Allowed 'Isoleucine or valine' 0 C--O 1.206 -1.219 0 CA-C-O 116.363 -1.78 . . . . 1.0 112.426 -175.112 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 75' ' ' ASN . . . . . 0.413 ' C ' ' O ' ' A' ' 74' ' ' VAL . 5.9 t30 -36.68 -17.21 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.49 0 CA-C-N 122.472 2.396 . . . . 1.0 111.604 -179.231 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . 0.713 ' N ' ' O ' ' A' ' 74' ' ' VAL . . . -54.39 -23.66 27.54 Favored Glycine 0 CA--C 1.532 1.115 0 N-CA-C 107.178 -2.369 . . . . 1.0 107.178 174.252 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . 0.568 ' N ' ' O ' ' A' ' 74' ' ' VAL . 18.2 pt -51.06 -48.98 29.55 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.033 0 CA-C-O 118.457 -0.782 . . . . 1.0 109.874 -179.793 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 19.3 t -55.97 -19.73 7.65 Favored 'Isoleucine or valine' 0 C--N 1.345 0.409 0 CA-C-N 120.94 1.7 . . . . 1.0 112.833 178.775 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . 0.588 ' O ' ' HB3' ' A' ' 83' ' ' ALA . 0.6 OUTLIER -90.6 -44.71 14.79 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.402 0 C-N-CA 119.683 -0.807 . . . . 1.0 109.855 179.077 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 80' ' ' ALA . . . . . 0.475 ' N ' HG13 ' A' ' 79' ' ' ILE . . . -80.04 -17.59 52.37 Favored 'General case' 0 C--N 1.323 -0.546 0 N-CA-C 113.267 0.84 . . . . 1.0 113.267 -179.587 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . 0.574 ' CG ' ' H ' ' A' ' 82' ' ' ASP . 10.2 pt-20 -94.18 -70.66 0.7 Allowed 'General case' 0 CA--C 1.537 0.463 0 C-N-CA 119.624 -0.83 . . . . 1.0 113.206 -177.987 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 82' ' ' ASP . . . . . 0.574 ' H ' ' CG ' ' A' ' 81' ' ' GLU . 13.4 t70 -90.62 -14.27 32.71 Favored 'General case' 0 CA--C 1.537 0.472 0 N-CA-C 114.821 1.415 . . . . 1.0 114.821 -178.49 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . 0.588 ' HB3' ' O ' ' A' ' 79' ' ' ILE . . . -52.16 -46.32 65.41 Favored 'General case' 0 C--O 1.22 -0.498 0 C-N-CA 117.644 -1.622 . . . . 1.0 111.203 -178.924 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . 0.491 ' O ' HD12 ' A' ' 84' ' ' LEU . 0.1 OUTLIER -39.34 -25.79 0.02 OUTLIER 'General case' 0 N--CA 1.469 0.499 0 O-C-N 121.427 -0.795 . . . . 1.0 111.533 -179.605 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 85' ' ' ILE . . . . . 0.499 ' N ' ' O ' ' A' ' 83' ' ' ALA . 3.2 tt -91.18 -34.41 6.34 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.327 0 C-N-CA 120.851 -0.339 . . . . 1.0 110.236 179.119 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . 0.551 ' HB1' HH11 ' A' ' 52' ' ' ARG . . . -95.52 -29.0 14.6 Favored 'General case' 0 C--O 1.207 -1.16 0 O-C-N 122.038 -0.414 . . . . 1.0 111.572 178.994 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . 0.422 ' OE1' ' N ' ' A' ' 88' ' ' ALA . 0.3 OUTLIER -61.59 -17.34 54.72 Favored 'General case' 0 C--N 1.321 -0.673 0 O-C-N 121.237 -0.914 . . . . 1.0 110.077 -179.262 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . 0.422 ' N ' ' OE1' ' A' ' 87' ' ' GLU . . . -73.89 -4.59 35.94 Favored 'General case' 0 N--CA 1.477 0.888 0 CA-C-O 123.549 1.643 . . . . 1.0 106.759 177.163 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 89' ' ' VAL . . . . . 0.566 ' O ' HG12 ' A' ' 89' ' ' VAL . 26.0 t -80.96 39.51 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.44 -0.964 0 CA-C-N 110.91 -2.859 . . . . 1.0 108.178 175.866 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 90' ' ' GLY . . . . . 0.844 ' O ' ' N ' ' A' ' 92' ' ' HIS . . . -56.91 -29.02 58.46 Favored Glycine 0 C--N 1.37 2.461 0 CA-C-O 117.423 -1.765 . . . . 1.0 111.844 177.337 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 91' ' ' PRO . . . . . 0.603 ' HD2' ' N ' ' A' ' 90' ' ' GLY . 52.2 Cg_exo -38.36 -2.19 0.0 OUTLIER 'Trans proline' 0 N--CA 1.498 1.75 0 CA-C-N 121.672 2.736 . . . . 1.0 111.728 173.945 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 92' ' ' HIS . . . . . 0.844 ' N ' ' O ' ' A' ' 90' ' ' GLY . 18.1 p-80 -50.19 -31.3 13.44 Favored 'General case' 0 N--CA 1.432 -1.365 0 N-CA-C 106.966 -1.494 . . . . 1.0 106.966 179.243 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . 0.432 ' O ' ' HB3' ' A' ' 96' ' ' ALA . 1.5 tt -61.02 -50.13 74.6 Favored 'General case' 0 C--O 1.222 -0.36 0 N-CA-C 106.995 -1.483 . . . . 1.0 106.995 176.367 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 94' ' ' ALA . . . . . 0.479 ' N ' ' O ' ' A' ' 91' ' ' PRO . . . -52.04 -54.91 24.41 Favored 'General case' 0 C--N 1.322 -0.628 0 N-CA-C 107.586 -1.264 . . . . 1.0 107.586 179.644 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -63.63 -29.72 70.93 Favored 'General case' 0 CA--C 1.543 0.685 0 CA-C-O 121.537 0.684 . . . . 1.0 109.574 178.405 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 96' ' ' ALA . . . . . 0.783 ' O ' ' N ' ' A' ' 100' ' ' ILE . . . -50.9 -42.94 59.65 Favored 'General case' 0 C--O 1.197 -1.691 0 N-CA-C 106.799 -1.556 . . . . 1.0 106.799 -177.754 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . 0.517 ' O ' ' CG2' ' A' ' 100' ' ' ILE . 0.3 OUTLIER -35.61 -23.05 0.01 OUTLIER 'General case' 0 CA--C 1.594 2.641 0 CA-C-N 114.18 -1.373 . . . . 1.0 108.005 -177.156 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 98' ' ' GLY . . . . . 0.674 ' N ' ' O ' ' A' ' 96' ' ' ALA . . . -86.06 -50.23 3.97 Favored Glycine 0 CA--C 1.562 3.011 0 CA-C-O 123.057 1.365 . . . . 1.0 111.286 169.713 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 99' ' ' GLN . . . . . 0.692 ' N ' ' O ' ' A' ' 96' ' ' ALA . 0.0 OUTLIER -76.59 7.16 4.82 Favored 'General case' 0 N--CA 1.441 -0.878 0 N-CA-C 106.391 -1.707 . . . . 1.0 106.391 177.142 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 100' ' ' ILE . . . . . 0.783 ' N ' ' O ' ' A' ' 96' ' ' ALA . 17.7 tt -58.12 -55.4 22.31 Favored 'Isoleucine or valine' 0 CA--C 1.481 -1.69 0 N-CA-C 106.232 -1.766 . . . . 1.0 106.232 177.438 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 101' ' ' VAL . . . . . 0.684 ' O ' ' N ' ' A' ' 105' ' ' GLY . 7.0 p -57.49 -60.04 2.58 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.579 0 C-N-CA 118.368 -1.333 . . . . 1.0 107.871 178.668 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 102' ' ' CYS . . . . . 0.885 ' O ' ' HB2' ' A' ' 106' ' ' ALA . 18.2 t -52.48 -26.26 12.45 Favored 'General case' 0 C--N 1.32 -0.707 0 N-CA-C 112.712 0.634 . . . . 1.0 112.712 -177.324 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 103' ' ' ARG . . . . . 0.536 ' N ' ' O ' ' A' ' 99' ' ' GLN . 45.6 ttt180 -86.23 -49.31 7.8 Favored 'General case' 0 N--CA 1.49 1.568 0 CA-C-O 122.763 1.268 . . . . 1.0 112.686 179.019 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 104' ' ' TYR . . . . . 0.686 ' O ' ' CG ' ' A' ' 104' ' ' TYR . 0.0 OUTLIER -97.04 24.13 6.59 Favored 'General case' 0 C--N 1.295 -1.8 0 CA-C-N 112.258 -2.246 . . . . 1.0 107.571 178.618 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 105' ' ' GLY . . . . . 0.684 ' N ' ' O ' ' A' ' 101' ' ' VAL . . . -164.92 -96.84 0.11 Allowed Glycine 0 CA--C 1.533 1.206 0 N-CA-C 108.166 -1.974 . . . . 1.0 108.166 179.081 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 106' ' ' ALA . . . . . 0.885 ' HB2' ' O ' ' A' ' 102' ' ' CYS . . . 68.4 55.68 0.5 Allowed 'General case' 0 CA--C 1.534 0.351 0 C-N-CA 122.989 0.515 . . . . 1.0 111.747 -178.886 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 107' ' ' THR . . . . . 0.548 HG22 ' O ' ' A' ' 107' ' ' THR . 91.8 m -80.32 6.1 12.96 Favored 'General case' 0 CA--C 1.514 -0.407 0 N-CA-C 107.222 -1.399 . . . . 1.0 107.222 177.033 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . 0.455 HG23 ' N ' ' A' ' 109' ' ' ILE . 18.0 m -84.4 -54.03 9.68 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.242 0 CA-C-N 115.575 -0.739 . . . . 1.0 110.472 178.721 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 109' ' ' ILE . . . . . 0.468 ' N ' ' HD2' ' A' ' 110' ' ' PRO . 85.4 mt -41.99 -51.89 9.69 Favored Pre-proline 0 C--N 1.347 0.46 0 N-CA-C 114.805 1.409 . . . . 1.0 114.805 -179.446 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 110' ' ' PRO . . . . . 0.468 ' HD2' ' N ' ' A' ' 109' ' ' ILE . 2.3 Cg_endo -40.68 -52.02 3.34 Favored 'Trans proline' 0 C--N 1.314 -1.286 0 CA-C-N 120.618 1.257 . . . . 1.0 113.293 -176.407 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 111' ' ' ASN . . . . . 0.434 ' ND2' ' H ' ' A' ' 112' ' ' ILE . 0.8 OUTLIER -69.51 -69.12 0.36 Allowed 'General case' 0 C--O 1.233 0.222 0 C-N-CA 118.229 -1.389 . . . . 1.0 110.444 -178.403 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 112' ' ' ILE . . . . . 0.625 HD13 ' N ' ' A' ' 113' ' ' ASN . 0.0 OUTLIER -46.97 -27.62 0.91 Allowed 'Isoleucine or valine' 0 C--O 1.216 -0.672 0 N-CA-C 109.174 -0.676 . . . . 1.0 109.174 -179.947 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 113' ' ' ASN . . . . . 0.625 ' N ' HD13 ' A' ' 112' ' ' ILE . 16.4 t-20 -58.19 -54.55 45.76 Favored 'General case' 0 C--N 1.308 -1.198 0 C-N-CA 118.131 -1.428 . . . . 1.0 108.096 -177.928 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 114' ' ' ALA . . . . . 0.477 ' O ' ' HG2' ' A' ' 117' ' ' GLU . . . -58.69 -33.9 70.67 Favored 'General case' 0 N--CA 1.447 -0.611 0 N-CA-C 113.116 0.784 . . . . 1.0 113.116 -178.633 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -82.99 -49.44 9.58 Favored 'General case' 0 C--O 1.215 -0.761 0 O-C-N 120.426 -1.421 . . . . 1.0 110.8 179.173 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 116' ' ' ILE . . . . . 0.53 HD12 HD11 ' A' ' 112' ' ' ILE . 0.6 OUTLIER -50.91 -54.92 8.51 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.184 0 N-CA-C 107.345 -1.354 . . . . 1.0 107.345 -179.415 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 117' ' ' GLU . . . . . 0.504 ' O ' ' HA ' ' A' ' 121' ' ' THR . 17.5 pt-20 -45.96 -58.11 3.83 Favored 'General case' 0 C--O 1.212 -0.898 0 CA-C-N 113.175 -1.83 . . . . 1.0 106.136 -179.052 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 118' ' ' VAL . . . . . 0.466 ' N ' ' CG ' ' A' ' 117' ' ' GLU . 57.7 t -58.36 -53.35 47.51 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.133 0 C-N-CA 119.89 -0.724 . . . . 1.0 110.207 179.068 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 13.2 tp -53.76 -73.04 0.05 OUTLIER 'General case' 0 CA--C 1.54 0.581 0 N-CA-C 108.129 -1.063 . . . . 1.0 108.129 -178.66 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 120' ' ' GLY . . . . . 0.512 ' O ' ' CB ' ' A' ' 121' ' ' THR . . . -67.82 -76.11 0.43 Allowed Glycine 0 CA--C 1.54 1.603 0 C-N-CA 118.948 -1.596 . . . . 1.0 111.026 179.165 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 121' ' ' THR . . . . . 0.512 ' CB ' ' O ' ' A' ' 120' ' ' GLY . 2.3 m 144.92 -27.4 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.434 0 CA-C-N 112.536 -1.832 . . . . 1.0 111.026 -178.381 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 122' ' ' GLY . . . . . 0.659 ' O ' ' N ' ' A' ' 124' ' ' ASP . . . 104.72 -17.94 44.87 Favored Glycine 0 C--O 1.223 -0.577 0 N-CA-C 107.944 -2.062 . . . . 1.0 107.944 -177.0 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 123' ' ' THR . . . . . 0.683 HG23 ' O ' ' A' ' 123' ' ' THR . 11.0 t -54.41 83.52 0.0 OUTLIER 'General case' 0 CA--C 1.532 0.275 0 N-CA-C 106.351 -1.722 . . . . 1.0 106.351 178.617 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 124' ' ' ASP . . . . . 0.659 ' N ' ' O ' ' A' ' 122' ' ' GLY . 48.5 p-10 -166.93 176.77 6.77 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 113.539 -1.664 . . . . 1.0 111.375 179.285 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 125' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -146.76 144.63 29.53 Favored 'General case' 0 CA--C 1.541 0.605 0 N-CA-C 108.364 -0.976 . . . . 1.0 108.364 176.904 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 38.0 ttm180 -149.84 151.74 34.0 Favored 'General case' 0 N--CA 1.471 0.588 0 CA-C-O 120.534 0.207 . . . . 1.0 110.935 178.844 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 127' ' ' PHE . . . . . . . . . . . . . 13.9 p90 . . . . . 0 C--O 1.219 -0.506 0 CA-C-O 117.958 -1.02 . . . . 1.0 110.646 -179.985 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 128' ' ' MTN . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 129' ' ' MTN . . . . . 0.489 ' H82' ' CZ ' ' A' ' 45' ' ' PHE . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 130' ' ' MTN . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.513 ' SD ' ' N ' ' A' ' 1' ' ' MET . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.558 0 N-CA-C 108.862 -0.792 . . . . 1.0 108.862 . . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . 0.508 ' O ' ' CG ' ' A' ' 3' ' ' ASP . 70.8 m -72.4 7.71 1.68 Allowed 'General case' 0 C--O 1.223 -0.31 0 CA-C-O 119.43 -0.319 . . . . 1.0 110.844 179.474 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . 0.508 ' CG ' ' O ' ' A' ' 2' ' ' SER . 62.1 m-20 144.16 137.39 0.0 OUTLIER 'General case' 0 N--CA 1.482 1.141 0 O-C-N 124.189 0.93 . . . . 1.0 110.097 179.239 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 91.4 t80 -154.92 150.46 27.44 Favored 'General case' 0 N--CA 1.465 0.296 0 CA-C-N 116.073 -0.512 . . . . 1.0 110.88 179.214 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -150.13 145.23 26.19 Favored 'General case' 0 CA--C 1.543 0.686 0 N-CA-C 109.553 -0.536 . . . . 1.0 109.553 179.465 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 6' ' ' THR . . . . . 0.843 ' O ' ' N ' ' A' ' 10' ' ' SER . 0.2 OUTLIER -87.14 176.71 7.46 Favored 'General case' 0 C--O 1.179 -2.627 0 CA-C-O 120.43 0.157 . . . . 1.0 111.236 -179.27 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . 0.588 ' O ' ' N ' ' A' ' 11' ' ' ARG . 10.9 mt-10 -60.65 -50.68 72.53 Favored 'General case' 0 C--N 1.312 -1.056 0 CA-C-O 121.194 0.521 . . . . 1.0 109.713 -179.405 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 8' ' ' ARG . . . . . 0.671 ' O ' ' HB3' ' A' ' 12' ' ' ALA . 18.6 mtp-105 -57.95 -58.93 6.23 Favored 'General case' 0 C--N 1.315 -0.916 0 C-N-CA 118.416 -1.313 . . . . 1.0 107.536 -179.011 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . 0.693 ' O ' ' HB ' ' A' ' 13' ' ' VAL . 0.0 OUTLIER -66.82 -50.83 61.82 Favored 'Isoleucine or valine' 0 C--O 1.183 -2.418 0 CA-C-N 114.267 -1.333 . . . . 1.0 109.287 179.686 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . 0.843 ' N ' ' O ' ' A' ' 6' ' ' THR . 19.3 t -63.84 -61.16 2.47 Favored 'General case' 0 N--CA 1.492 1.669 0 C-N-CA 119.437 -0.905 . . . . 1.0 110.268 179.171 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 11' ' ' ARG . . . . . 0.588 ' N ' ' O ' ' A' ' 7' ' ' GLU . 5.3 tpt180 -67.39 -54.32 21.5 Favored 'General case' 0 C--O 1.214 -0.797 0 N-CA-C 112.546 0.573 . . . . 1.0 112.546 -176.674 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . 0.671 ' HB3' ' O ' ' A' ' 8' ' ' ARG . . . -56.06 -50.7 70.22 Favored 'General case' 0 N--CA 1.476 0.862 0 C-N-CA 117.023 -1.871 . . . . 1.0 106.565 -178.09 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . 0.693 ' HB ' ' O ' ' A' ' 9' ' ' VAL . 65.7 t -61.25 -48.49 88.7 Favored 'Isoleucine or valine' 0 C--O 1.18 -2.593 0 N-CA-C 107.033 -1.469 . . . . 1.0 107.033 178.659 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . 0.746 ' O ' HG13 ' A' ' 18' ' ' VAL . . . -59.32 -61.56 2.53 Favored 'General case' 0 C--O 1.201 -1.467 0 C-N-CA 118.132 -1.427 . . . . 1.0 109.696 179.253 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . 0.572 ' O ' ' N ' ' A' ' 19' ' ' GLY . . . -52.57 -53.38 47.29 Favored 'General case' 0 C--O 1.216 -0.685 0 N-CA-C 108.576 -0.898 . . . . 1.0 108.576 -178.456 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . 0.662 ' CA ' ' H ' ' A' ' 22' ' ' GLY . . . -65.42 -57.15 9.02 Favored 'General case' 0 CA--C 1.546 0.792 0 CA-C-O 121.663 0.744 . . . . 1.0 109.951 -179.747 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . 0.676 ' N ' ' O ' ' A' ' 13' ' ' VAL . 18.7 tp -55.74 -55.98 25.93 Favored 'General case' 0 N--CA 1.491 1.582 0 N-CA-C 107.953 -1.128 . . . . 1.0 107.953 -178.929 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . 0.746 HG13 ' O ' ' A' ' 14' ' ' ALA . 1.2 m -70.89 -59.02 3.87 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.397 0 C-N-CA 119.854 -0.738 . . . . 1.0 110.136 -179.896 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . 0.572 ' N ' ' O ' ' A' ' 15' ' ' ALA . . . -60.75 -161.93 0.13 Allowed Glycine 0 C--N 1.338 0.651 0 N-CA-C 111.819 -0.512 . . . . 1.0 111.819 -178.399 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 20' ' ' PRO . . . . . 0.654 ' O ' ' HB2' ' A' ' 24' ' ' ALA . 86.3 Cg_endo -81.23 -23.1 5.43 Favored 'Trans proline' 0 C--N 1.318 -1.04 0 C-N-CA 123.165 2.577 . . . . 1.0 113.682 -177.979 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -63.35 -62.29 5.52 Favored Glycine 0 N--CA 1.484 1.847 0 C-N-CA 120.178 -1.01 . . . . 1.0 112.996 -176.406 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . 0.662 ' H ' ' CA ' ' A' ' 16' ' ' ALA . . . -57.61 -57.61 18.87 Favored Glycine 0 C--N 1.312 -0.784 0 N-CA-C 107.349 -2.301 . . . . 1.0 107.349 -177.845 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . 0.488 HG22 ' O ' ' A' ' 19' ' ' GLY . 34.3 m -56.63 -32.28 36.94 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.744 0 C-N-CA 118.773 -1.171 . . . . 1.0 109.294 -179.977 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . 0.654 ' HB2' ' O ' ' A' ' 20' ' ' PRO . . . -60.5 -62.13 2.09 Favored 'General case' 0 N--CA 1.471 0.6 0 C-N-CA 118.142 -1.423 . . . . 1.0 110.117 179.745 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 18.4 mt -61.38 -47.8 84.17 Favored 'General case' 0 CA--C 1.514 -0.43 0 CA-C-N 118.616 0.644 . . . . 1.0 112.137 -177.28 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 90.5 t -58.55 -59.14 4.04 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.535 0 C-N-CA 119.29 -0.964 . . . . 1.0 109.61 -177.846 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . 0.725 ' O ' ' HB3' ' A' ' 31' ' ' ALA . 84.8 t -57.28 -38.65 63.12 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.462 0 CA-C-O 120.866 0.365 . . . . 1.0 110.482 -178.236 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 9.2 ttmt -66.37 -55.33 16.38 Favored 'General case' 0 C--N 1.316 -0.876 0 C-N-CA 119.686 -0.806 . . . . 1.0 109.956 -178.873 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 92.3 t -63.73 -51.39 70.53 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.777 0 CA-C-N 114.903 -1.044 . . . . 1.0 110.917 -176.541 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 30' ' ' CYS . . . . . . . . . . . . . 50.1 t -64.54 -61.55 2.14 Favored 'General case' 0 N--CA 1.443 -0.779 0 C-N-CA 119.407 -0.917 . . . . 1.0 109.889 -179.084 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . 0.725 ' HB3' ' O ' ' A' ' 27' ' ' VAL . . . -59.3 -53.54 57.12 Favored 'General case' 0 C--N 1.318 -0.773 0 CA-C-O 120.874 0.369 . . . . 1.0 111.354 -177.295 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . 0.519 ' O ' ' CB ' ' A' ' 33' ' ' LEU . . . 80.29 69.68 1.38 Allowed Glycine 0 CA--C 1.521 0.418 0 N-CA-C 109.898 -1.281 . . . . 1.0 109.898 -179.77 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . 0.659 ' CD2' ' H ' ' A' ' 35' ' ' GLY . 2.0 tt 88.96 101.6 0.03 OUTLIER Pre-proline 0 CA--C 1.545 0.781 0 CA-C-N 115.442 -0.379 . . . . 1.0 110.553 -179.821 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 51.7 Cg_exo -51.86 -21.97 12.94 Favored 'Trans proline' 0 N--CA 1.503 2.05 0 C-N-CA 122.328 2.018 . . . . 1.0 113.939 179.745 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . 0.659 ' H ' ' CD2' ' A' ' 33' ' ' LEU . . . -62.12 -62.3 5.8 Favored Glycine 0 C--N 1.34 0.796 0 C-N-CA 119.263 -1.446 . . . . 1.0 109.952 -178.389 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . 0.919 HG22 ' H ' ' A' ' 37' ' ' ILE . 8.4 p -73.37 -152.88 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.325 -0.488 0 N-CA-C 107.96 -1.126 . . . . 1.0 107.96 178.333 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . 0.919 ' H ' HG22 ' A' ' 36' ' ' VAL . 2.1 mm 70.96 79.33 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.475 0.804 0 CA-C-O 122.069 0.938 . . . . 1.0 112.79 179.598 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 88.0 m-70 -135.32 129.56 33.68 Favored 'General case' 0 C--N 1.318 -0.763 0 N-CA-C 106.826 -1.546 . . . . 1.0 106.826 176.971 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 25.1 m -120.44 132.2 24.21 Favored Pre-proline 0 N--CA 1.465 0.297 0 N-CA-C 110.073 -0.343 . . . . 1.0 110.073 -178.883 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 27.7 Cg_endo -62.98 -78.17 0.01 OUTLIER 'Trans proline' 0 N--CA 1.49 1.311 0 CA-C-N 119.654 0.912 . . . . 1.0 111.898 -179.457 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -67.72 125.65 26.9 Favored 'General case' 0 C--N 1.317 -0.844 0 CA-C-N 114.859 -1.064 . . . . 1.0 110.613 -178.805 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . 0.531 ' HG2' ' H ' ' A' ' 43' ' ' ARG . 31.0 ttp180 -173.28 174.52 3.33 Favored 'General case' 0 C--N 1.32 -0.674 0 CA-C-N 115.832 -0.622 . . . . 1.0 109.982 179.516 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 43' ' ' ARG . . . . . 0.56 ' NH1' ' OD2' ' A' ' 57' ' ' ASP . 1.1 tmt_? -58.08 -45.19 87.55 Favored 'General case' 0 CA--C 1.541 0.598 0 N-CA-C 107.1 -1.444 . . . . 1.0 107.1 179.528 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . 0.476 ' O ' ' CD1' ' A' ' 45' ' ' PHE . . . 123.58 -25.12 6.31 Favored Glycine 0 CA--C 1.533 1.173 0 CA-C-O 119.852 -0.416 . . . . 1.0 112.147 179.138 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . 0.64 ' O ' ' HB2' ' A' ' 46' ' ' PHE . 7.5 m-85 -156.52 162.92 39.91 Favored 'General case' 0 N--CA 1.474 0.749 0 N-CA-C 109.111 -0.7 . . . . 1.0 109.111 177.726 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 46' ' ' PHE . . . . . 0.65 ' O ' ' CG ' ' A' ' 47' ' ' ARG . 6.9 m-85 118.41 104.08 0.0 OUTLIER 'General case' 0 N--CA 1.499 2.001 0 O-C-N 125.375 1.672 . . . . 1.0 110.592 -179.743 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 47' ' ' ARG . . . . . 0.756 ' O ' ' SG ' ' A' ' 48' ' ' CYS . 0.0 OUTLIER 98.42 162.78 0.01 OUTLIER 'General case' 0 N--CA 1.472 0.64 0 O-C-N 125.08 1.488 . . . . 1.0 111.434 178.232 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 48' ' ' CYS . . . . . 0.762 ' O ' ' H61' ' A' ' 129' ' ' MTN . 7.0 p 56.66 72.08 0.53 Allowed 'General case' 0 C--O 1.202 -1.416 0 O-C-N 125.081 1.488 . . . . 1.0 110.567 -177.591 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 49' ' ' ASN . . . . . 0.697 ' O ' ' N ' ' A' ' 51' ' ' GLU . 0.5 OUTLIER -144.66 155.45 56.53 Favored Pre-proline 0 N--CA 1.474 0.728 0 CA-C-O 118.753 -0.642 . . . . 1.0 110.438 179.752 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . 0.475 ' C ' ' H ' ' A' ' 52' ' ' ARG . 53.9 Cg_exo -51.8 57.75 0.02 OUTLIER 'Trans proline' 0 N--CA 1.509 2.419 0 C-N-CA 122.688 2.259 . . . . 1.0 112.138 177.775 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . 0.697 ' N ' ' O ' ' A' ' 49' ' ' ASN . 59.2 mm-40 47.93 13.56 0.04 OUTLIER 'General case' 0 C--N 1.321 -0.658 0 N-CA-C 110.029 -0.36 . . . . 1.0 110.029 -179.129 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . 0.639 HH11 ' CE1' ' A' ' 92' ' ' HIS . 23.5 mtm-85 -100.08 142.86 30.99 Favored 'General case' 0 N--CA 1.475 0.806 0 CA-C-O 121.204 0.526 . . . . 1.0 112.052 -179.857 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 9.6 tp -53.29 135.89 14.92 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.648 0 CA-C-O 124.426 2.06 . . . . 1.0 114.579 -178.661 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -88.62 88.02 7.47 Favored 'General case' 0 C--N 1.312 -1.022 0 CA-C-N 110.063 -3.244 . . . . 1.0 113.643 179.567 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 18.6 tt -144.47 153.34 15.06 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.67 0 CA-C-N 115.478 -0.783 . . . . 1.0 109.678 177.273 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 107.76 3.1 34.61 Favored Glycine 0 C--N 1.348 1.226 0 N-CA-C 110.878 -0.889 . . . . 1.0 110.878 -179.891 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . 0.56 ' OD2' ' NH1' ' A' ' 43' ' ' ARG . 5.6 p-10 -86.88 103.38 15.22 Favored 'General case' 0 CA--C 1.533 0.292 0 CA-C-O 122.185 0.993 . . . . 1.0 112.651 -178.834 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 58' ' ' TRP . . . . . . . . . . . . . 38.4 m0 -81.39 -177.97 6.73 Favored 'General case' 0 N--CA 1.47 0.563 0 CA-C-N 114.023 -1.444 . . . . 1.0 108.154 178.205 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 59' ' ' ARG . . . . . 0.659 ' HD2' ' H ' ' A' ' 59' ' ' ARG . 0.0 OUTLIER -101.85 -54.86 2.63 Favored 'General case' 0 CA--C 1.56 1.359 0 CA-C-N 121.91 2.141 . . . . 1.0 110.74 179.676 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 60' ' ' TYR . . . . . 0.517 ' H ' ' HD2' ' A' ' 59' ' ' ARG . 93.2 t80 -79.45 -14.34 58.98 Favored 'General case' 0 N--CA 1.485 1.305 0 C-N-CA 125.723 1.609 . . . . 1.0 112.225 -178.283 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 31.9 tt0 -70.77 -14.11 62.31 Favored 'General case' 0 C--N 1.304 -1.387 0 N-CA-C 108.635 -0.876 . . . . 1.0 108.635 -179.874 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . 0.518 HG13 ' O ' ' A' ' 59' ' ' ARG . 13.4 m -45.7 -53.07 2.29 Favored 'Isoleucine or valine' 0 CA--C 1.493 -1.244 0 CA-C-N 115.811 -0.632 . . . . 1.0 109.972 -174.495 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 63' ' ' ALA . . . . . 0.85 ' O ' ' HD2' ' A' ' 67' ' ' ARG . . . -65.2 -50.39 66.06 Favored 'General case' 0 N--CA 1.415 -2.189 0 N-CA-C 108.943 -0.762 . . . . 1.0 108.943 179.364 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -51.03 -59.39 4.21 Favored 'General case' 0 CA--C 1.548 0.904 0 C-N-CA 119.795 -0.762 . . . . 1.0 110.715 -179.996 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . 0.6 ' C ' ' H ' ' A' ' 67' ' ' ARG . 28.9 t70 -64.79 -50.34 67.16 Favored 'General case' 0 C--O 1.241 0.632 0 CA-C-O 121.694 0.759 . . . . 1.0 109.704 178.371 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . 0.416 ' N ' ' O ' ' A' ' 62' ' ' VAL . . . -61.34 29.53 0.05 OUTLIER Glycine 0 CA--C 1.535 1.325 0 O-C-N 121.801 -0.562 . . . . 1.0 112.016 178.106 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 67' ' ' ARG . . . . . 0.85 ' HD2' ' O ' ' A' ' 63' ' ' ALA . 0.0 OUTLIER -79.58 -2.84 44.29 Favored 'General case' 0 CA--C 1.5 -0.946 0 CA-C-O 118.632 -0.699 . . . . 1.0 109.371 175.206 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . 0.555 ' O ' ' CG ' ' A' ' 72' ' ' HIS . 11.1 mp -33.94 -28.06 0.01 OUTLIER 'General case' 0 N--CA 1.486 1.327 0 N-CA-C 107.023 -1.473 . . . . 1.0 107.023 -179.012 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . 0.674 ' N ' ' O ' ' A' ' 67' ' ' ARG . 3.4 tt -64.83 -64.23 0.92 Allowed 'General case' 0 CA--C 1.548 0.898 0 N-CA-C 106.572 -1.64 . . . . 1.0 106.572 175.573 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . 0.68 ' C ' ' H ' ' A' ' 72' ' ' HIS . . . -78.76 -73.53 0.32 Allowed 'General case' 0 N--CA 1.478 0.948 0 N-CA-C 107.828 -1.175 . . . . 1.0 107.828 177.865 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . 0.735 ' H ' ' HB3' ' A' ' 67' ' ' ARG . . . -46.23 2.34 0.0 OUTLIER 'General case' 0 N--CA 1.469 0.499 0 C-N-CA 124.435 1.094 . . . . 1.0 112.747 178.402 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 72' ' ' HIS . . . . . 0.68 ' H ' ' C ' ' A' ' 70' ' ' ALA . 0.2 OUTLIER -20.02 -70.53 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.227 0 C-N-CA 123.179 0.592 . . . . 1.0 111.139 -177.993 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 73' ' ' MET . . . . . . . . . . . . . 16.4 mtm -73.9 -47.63 36.55 Favored 'General case' 0 C--N 1.31 -1.131 0 C-N-CA 118.967 -1.093 . . . . 1.0 109.611 177.149 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . 0.577 ' O ' ' N ' ' A' ' 76' ' ' GLY . 24.4 t -46.68 -48.98 6.94 Favored 'Isoleucine or valine' 0 C--N 1.344 0.354 0 CA-C-O 118.456 -0.783 . . . . 1.0 110.958 -176.599 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 75' ' ' ASN . . . . . 0.888 ' O ' HG22 ' A' ' 78' ' ' VAL . 26.9 t-20 -39.18 -21.56 0.01 OUTLIER 'General case' 0 C--N 1.352 0.705 0 CA-C-O 122.895 1.331 . . . . 1.0 110.435 177.401 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . 0.577 ' N ' ' O ' ' A' ' 74' ' ' VAL . . . -42.31 -19.89 0.06 OUTLIER Glycine 0 CA--C 1.539 1.533 0 CA-C-N 113.55 -1.659 . . . . 1.0 109.248 178.864 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . 0.689 ' O ' ' N ' ' A' ' 80' ' ' ALA . 7.7 pt -71.24 -45.41 70.71 Favored 'Isoleucine or valine' 0 C--O 1.207 -1.174 0 CA-C-O 122.01 0.91 . . . . 1.0 109.458 -179.341 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . 0.888 HG22 ' O ' ' A' ' 75' ' ' ASN . 26.8 m -35.21 -32.43 0.04 OUTLIER 'Isoleucine or valine' 0 CA--C 1.556 1.178 0 CA-C-N 113.058 -1.883 . . . . 1.0 107.359 -176.483 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . 0.529 ' N ' ' O ' ' A' ' 77' ' ' ILE . 1.1 pp -92.94 -26.97 4.66 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 CA-C-O 121.511 0.672 . . . . 1.0 111.571 177.525 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 80' ' ' ALA . . . . . 0.689 ' N ' ' O ' ' A' ' 77' ' ' ILE . . . -87.24 -18.78 29.46 Favored 'General case' 0 CA--C 1.55 0.949 0 N-CA-C 113.35 0.87 . . . . 1.0 113.35 178.976 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . 0.424 ' N ' ' O ' ' A' ' 77' ' ' ILE . 9.3 mm-40 -82.46 -71.87 0.47 Allowed 'General case' 0 N--CA 1.45 -0.426 0 C-N-CA 122.667 0.387 . . . . 1.0 110.169 -179.908 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 82' ' ' ASP . . . . . 0.549 ' O ' ' N ' ' A' ' 84' ' ' LEU . 92.9 m-20 -66.42 -16.81 64.39 Favored 'General case' 0 N--CA 1.444 -0.761 0 CA-C-O 119.09 -0.481 . . . . 1.0 110.261 -179.382 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . 0.501 ' O ' ' N ' ' A' ' 86' ' ' ALA . . . -15.19 -50.09 0.0 OUTLIER 'General case' 0 C--N 1.355 0.811 0 N-CA-C 113.04 0.755 . . . . 1.0 113.04 178.05 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . 0.549 ' N ' ' O ' ' A' ' 82' ' ' ASP . 0.2 OUTLIER -27.58 -50.78 0.06 Allowed 'General case' 0 C--N 1.355 0.827 0 N-CA-C 113.046 0.758 . . . . 1.0 113.046 -177.057 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 19.9 pt -85.57 -37.78 12.32 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.664 0 N-CA-C 109.584 -0.524 . . . . 1.0 109.584 179.235 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . 0.682 ' O ' ' N ' ' A' ' 88' ' ' ALA . . . -47.46 -54.86 10.31 Favored 'General case' 0 CA--C 1.518 -0.287 0 C-N-CA 120.329 -0.548 . . . . 1.0 110.333 -179.341 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . 0.573 ' C ' ' H ' ' A' ' 89' ' ' VAL . 0.5 OUTLIER -38.21 -14.81 0.01 OUTLIER 'General case' 0 CA--C 1.539 0.525 0 CA-C-N 117.768 0.258 . . . . 1.0 111.214 -179.686 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . 0.682 ' N ' ' O ' ' A' ' 86' ' ' ALA . . . -54.8 -5.26 0.08 Allowed 'General case' 0 C--O 1.218 -0.577 0 N-CA-C 108.811 -0.811 . . . . 1.0 108.811 177.213 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 89' ' ' VAL . . . . . 0.573 ' H ' ' C ' ' A' ' 87' ' ' GLU . 4.4 m -33.13 -31.53 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.551 0.991 0 CA-C-O 121.099 0.476 . . . . 1.0 110.787 -177.591 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 90' ' ' GLY . . . . . 0.523 ' N ' ' O ' ' A' ' 88' ' ' ALA . . . -49.33 -75.2 0.21 Allowed Glycine 0 CA--C 1.549 2.2 0 C-N-CA 119.889 -1.148 . . . . 1.0 111.21 -178.734 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 91' ' ' PRO . . . . . 0.473 ' HD2' ' O ' ' A' ' 88' ' ' ALA . 9.9 Cg_endo -52.05 -28.88 34.14 Favored 'Trans proline' 0 N--CA 1.504 2.114 0 C-N-CA 122.955 2.437 . . . . 1.0 111.229 176.663 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 92' ' ' HIS . . . . . 0.639 ' CE1' HH11 ' A' ' 52' ' ' ARG . 26.9 m80 -54.14 -19.37 4.91 Favored 'General case' 0 CA--C 1.514 -0.424 0 N-CA-C 107.4 -1.333 . . . . 1.0 107.4 -176.473 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . 0.549 ' O ' ' N ' ' A' ' 96' ' ' ALA . 20.7 tp -57.03 -49.98 74.13 Favored 'General case' 0 N--CA 1.45 -0.425 0 N-CA-C 106.59 -1.633 . . . . 1.0 106.59 176.797 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -49.13 -51.9 29.36 Favored 'General case' 0 CA--C 1.517 -0.301 0 N-CA-C 106.662 -1.607 . . . . 1.0 106.662 -179.352 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 3.0 mmt180 -61.03 -32.13 71.75 Favored 'General case' 0 C--N 1.316 -0.849 0 N-CA-C 108.622 -0.881 . . . . 1.0 108.622 177.191 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 96' ' ' ALA . . . . . 0.777 ' O ' ' N ' ' A' ' 100' ' ' ILE . . . -55.82 -51.44 67.47 Favored 'General case' 0 C--O 1.199 -1.556 0 C-N-CA 118.817 -1.153 . . . . 1.0 107.918 -178.947 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . 0.466 ' C ' ' O ' ' A' ' 96' ' ' ALA . 0.2 OUTLIER -34.15 -26.15 0.01 OUTLIER 'General case' 0 CA--C 1.587 2.399 0 N-CA-C 107.58 -1.267 . . . . 1.0 107.58 -178.325 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 98' ' ' GLY . . . . . 0.659 ' N ' ' O ' ' A' ' 96' ' ' ALA . . . -86.48 -52.77 3.1 Favored Glycine 0 CA--C 1.546 1.981 0 CA-C-O 123.967 1.871 . . . . 1.0 110.617 173.963 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 99' ' ' GLN . . . . . 0.612 ' N ' ' O ' ' A' ' 96' ' ' ALA . 24.6 tt0 -76.97 7.56 4.74 Favored 'General case' 0 N--CA 1.418 -2.047 0 N-CA-C 107.837 -1.171 . . . . 1.0 107.837 177.177 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 100' ' ' ILE . . . . . 0.777 ' N ' ' O ' ' A' ' 96' ' ' ALA . 6.8 tp -62.48 -47.91 90.77 Favored 'Isoleucine or valine' 0 CA--C 1.481 -1.678 0 N-CA-C 108.66 -0.867 . . . . 1.0 108.66 179.82 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 101' ' ' VAL . . . . . 0.57 ' N ' ' CG2' ' A' ' 100' ' ' ILE . 46.3 t -53.57 -59.92 1.61 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.622 0 C-N-CA 117.352 -1.739 . . . . 1.0 108.341 179.095 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 102' ' ' CYS . . . . . 0.689 ' SG ' ' H71' ' A' ' 130' ' ' MTN . 0.0 OUTLIER -52.41 -31.7 35.52 Favored 'General case' 0 CA--C 1.545 0.767 0 C-N-CA 119.831 -0.748 . . . . 1.0 111.215 -176.743 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 103' ' ' ARG . . . . . 0.571 ' HA ' ' H73' ' A' ' 130' ' ' MTN . 11.8 ttp180 -82.15 -47.89 11.98 Favored 'General case' 0 N--CA 1.494 1.759 0 CA-C-O 122.287 1.041 . . . . 1.0 113.014 178.666 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 104' ' ' TYR . . . . . 0.439 ' CD2' ' O ' ' A' ' 104' ' ' TYR . 50.6 t80 -92.08 22.73 4.17 Favored 'General case' 0 C--N 1.29 -1.98 0 CA-C-N 113.653 -1.612 . . . . 1.0 108.502 178.802 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 105' ' ' GLY . . . . . 0.527 ' N ' ' O ' ' A' ' 101' ' ' VAL . . . -159.81 -86.98 0.06 OUTLIER Glycine 0 CA--C 1.526 0.779 0 N-CA-C 110.337 -1.105 . . . . 1.0 110.337 178.618 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 106' ' ' ALA . . . . . 0.687 ' HB2' ' O ' ' A' ' 102' ' ' CYS . . . 57.13 106.65 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.17 0 N-CA-C 109.22 -0.659 . . . . 1.0 109.22 -177.117 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 107' ' ' THR . . . . . 0.633 ' O ' ' CD ' ' A' ' 110' ' ' PRO . 26.0 m -134.24 -60.59 0.8 Allowed 'General case' 0 C--O 1.205 -1.276 0 CA-C-O 118.606 -0.711 . . . . 1.0 110.076 179.086 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . 0.65 ' O ' HG22 ' A' ' 108' ' ' VAL . 12.3 p -82.83 34.97 0.04 OUTLIER 'Isoleucine or valine' 0 C--O 1.235 0.29 0 C-N-CA 123.659 0.784 . . . . 1.0 111.265 -175.812 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 109' ' ' ILE . . . . . 0.665 ' N ' ' CD ' ' A' ' 110' ' ' PRO . 31.5 pt -104.7 -22.87 0.19 Allowed Pre-proline 0 CA--C 1.568 1.641 0 CA-C-N 115.876 -0.602 . . . . 1.0 111.363 177.55 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 110' ' ' PRO . . . . . 0.665 ' CD ' ' N ' ' A' ' 109' ' ' ILE . 71.6 Cg_endo -73.14 -15.66 25.6 Favored 'Trans proline' 0 N--CA 1.483 0.883 0 C-N-CA 123.292 2.661 . . . . 1.0 113.674 -177.402 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 6.3 t30 -61.72 -69.2 0.26 Allowed 'General case' 0 C--O 1.237 0.401 0 C-N-CA 120.357 -0.537 . . . . 1.0 110.472 -177.941 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 112' ' ' ILE . . . . . 0.472 HG21 ' HA3' ' A' ' 35' ' ' GLY . 0.0 OUTLIER -65.53 -28.68 44.92 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.413 0 CA-C-O 122.015 0.912 . . . . 1.0 109.996 179.614 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 113' ' ' ASN . . . . . 0.487 ' O ' ' OE1' ' A' ' 117' ' ' GLU . 42.1 t30 -55.16 -63.86 1.02 Allowed 'General case' 0 C--N 1.306 -1.32 0 CA-C-N 115.062 -0.972 . . . . 1.0 110.519 -176.738 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -61.49 -23.06 65.63 Favored 'General case' 0 C--N 1.31 -1.132 0 C-N-CA 120.788 -0.365 . . . . 1.0 111.383 179.832 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 115' ' ' ALA . . . . . 0.475 ' O ' HG12 ' A' ' 118' ' ' VAL . . . -79.34 -60.01 2.54 Favored 'General case' 0 CA--C 1.536 0.433 0 N-CA-C 112.485 0.55 . . . . 1.0 112.485 178.733 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 116' ' ' ILE . . . . . 0.549 ' O ' ' N ' ' A' ' 119' ' ' LEU . 3.3 mm -70.3 -49.11 56.74 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.365 0 O-C-N 121.102 -0.999 . . . . 1.0 112.187 -177.982 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 117' ' ' GLU . . . . . 0.612 ' N ' ' OE1' ' A' ' 117' ' ' GLU . 10.3 mp0 -46.96 -61.55 1.82 Allowed 'General case' 0 C--N 1.317 -0.846 0 N-CA-C 108.728 -0.841 . . . . 1.0 108.728 -176.815 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 118' ' ' VAL . . . . . 0.475 HG12 ' O ' ' A' ' 115' ' ' ALA . 2.0 p -51.9 -16.35 0.64 Allowed 'Isoleucine or valine' 0 N--CA 1.443 -0.797 0 C-N-CA 119.896 -0.721 . . . . 1.0 109.078 179.157 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 119' ' ' LEU . . . . . 0.549 ' N ' ' O ' ' A' ' 116' ' ' ILE . 0.3 OUTLIER -78.39 -60.45 2.37 Favored 'General case' 0 C--N 1.356 0.87 0 N-CA-C 108.808 -0.812 . . . . 1.0 108.808 176.802 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -68.29 -83.07 0.15 Allowed Glycine 0 C--N 1.367 2.251 0 C-N-CA 116.759 -2.639 . . . . 1.0 110.747 178.671 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 121' ' ' THR . . . . . 0.441 ' OG1' ' NE2' ' A' ' 72' ' ' HIS . 13.3 m -159.75 -18.83 0.06 Allowed 'General case' 0 N--CA 1.475 0.801 0 CA-C-O 122.107 0.956 . . . . 1.0 109.307 -179.645 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 122' ' ' GLY . . . . . 0.45 ' O ' ' C ' ' A' ' 123' ' ' THR . . . 111.48 -36.73 4.04 Favored Glycine 0 CA--C 1.523 0.588 0 CA-C-N 113.365 -1.743 . . . . 1.0 112.098 179.733 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 123' ' ' THR . . . . . 0.45 ' C ' ' O ' ' A' ' 122' ' ' GLY . 91.1 m -31.4 95.15 0.01 OUTLIER 'General case' 0 N--CA 1.477 0.904 0 CA-C-N 118.913 1.356 . . . . 1.0 112.369 -178.267 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 124' ' ' ASP . . . . . 0.406 ' N ' ' O ' ' A' ' 122' ' ' GLY . 0.0 OUTLIER -146.02 144.6 30.19 Favored 'General case' 0 C--N 1.347 0.494 0 N-CA-C 108.259 -1.015 . . . . 1.0 108.259 178.596 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 125' ' ' TYR . . . . . 0.451 ' O ' ' NE ' ' A' ' 126' ' ' ARG . 1.1 p90 -149.57 148.79 29.76 Favored 'General case' 0 C--N 1.325 -0.498 0 N-CA-C 109.951 -0.389 . . . . 1.0 109.951 179.817 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 126' ' ' ARG . . . . . 0.574 ' HA ' ' HE ' ' A' ' 126' ' ' ARG . 0.0 OUTLIER -146.73 149.48 33.49 Favored 'General case' 0 N--CA 1.465 0.302 0 N-CA-C 109.2 -0.667 . . . . 1.0 109.2 177.081 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 127' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.222 -0.389 0 CA-C-O 117.998 -1.001 . . . . 1.0 111.057 -178.507 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 128' ' ' MTN . . . . . 0.49 ' H92' ' HE ' ' A' ' 47' ' ' ARG . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 129' ' ' MTN . . . . . 0.776 ' S1 ' ' H71' ' A' ' 129' ' ' MTN . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 130' ' ' MTN . . . . . 0.689 ' H71' ' SG ' ' A' ' 102' ' ' CYS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.492 1.633 0 N-CA-C 109.219 -0.66 . . . . 1.0 109.219 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . 0.462 ' O ' ' CG ' ' A' ' 3' ' ' ASP . 86.7 p -89.19 4.48 48.47 Favored 'General case' 0 N--CA 1.463 0.212 0 CA-C-N 115.97 -0.559 . . . . 1.0 111.338 -179.56 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . 0.462 ' CG ' ' O ' ' A' ' 2' ' ' SER . 11.4 m-20 160.39 118.46 0.0 OUTLIER 'General case' 0 N--CA 1.465 0.316 0 O-C-N 123.578 0.549 . . . . 1.0 110.833 179.44 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . 0.443 ' O ' ' OD1' ' A' ' 5' ' ' ASP . 72.9 t80 -149.79 145.57 26.69 Favored 'General case' 0 CA--C 1.518 -0.261 0 N-CA-C 109.073 -0.714 . . . . 1.0 109.073 178.027 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 5' ' ' ASP . . . . . 0.443 ' OD1' ' O ' ' A' ' 4' ' ' PHE . 72.0 m-20 -149.92 146.5 27.1 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.963 -0.562 . . . . 1.0 110.472 -179.054 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 6' ' ' THR . . . . . 0.696 ' O ' ' N ' ' A' ' 10' ' ' SER . 0.2 OUTLIER -114.31 -156.23 0.59 Allowed 'General case' 0 C--O 1.206 -1.219 0 CA-C-O 121.699 0.762 . . . . 1.0 110.245 179.291 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . 0.503 ' O ' ' CB ' ' A' ' 11' ' ' ARG . 10.5 tm-20 -57.04 -48.37 78.68 Favored 'General case' 0 C--N 1.306 -1.323 0 O-C-N 121.67 -0.643 . . . . 1.0 110.361 -178.443 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 8' ' ' ARG . . . . . 0.849 ' O ' ' HB3' ' A' ' 12' ' ' ALA . 39.1 ttm180 -67.28 -58.23 5.21 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-O 122.046 0.927 . . . . 1.0 109.781 178.506 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . 0.65 ' O ' ' HB ' ' A' ' 13' ' ' VAL . 0.2 OUTLIER -65.2 -51.16 68.76 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.847 0 CA-C-N 114.64 -1.163 . . . . 1.0 109.456 -178.243 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . 0.697 ' O ' ' HB3' ' A' ' 14' ' ' ALA . 1.1 m -69.43 -64.07 0.95 Allowed 'General case' 0 C--N 1.302 -1.462 0 O-C-N 120.78 -1.2 . . . . 1.0 111.325 178.801 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 11' ' ' ARG . . . . . 0.741 ' O ' ' HB3' ' A' ' 15' ' ' ALA . 30.5 ttm-85 -63.97 -48.65 75.63 Favored 'General case' 0 N--CA 1.472 0.633 0 O-C-N 121.396 -0.815 . . . . 1.0 112.735 -176.206 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . 0.849 ' HB3' ' O ' ' A' ' 8' ' ' ARG . . . -70.03 -58.61 3.63 Favored 'General case' 0 N--CA 1.472 0.663 0 C-N-CA 118.96 -1.096 . . . . 1.0 109.284 178.286 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . 0.722 ' O ' ' HB3' ' A' ' 17' ' ' LEU . 1.0 OUTLIER -63.18 -54.08 37.78 Favored 'Isoleucine or valine' 0 C--O 1.195 -1.788 0 C-N-CA 117.773 -1.571 . . . . 1.0 108.921 -179.662 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . 0.946 ' O ' HG22 ' A' ' 18' ' ' VAL . . . -63.48 -62.87 1.39 Allowed 'General case' 0 N--CA 1.48 1.073 0 C-N-CA 117.123 -1.831 . . . . 1.0 111.353 179.888 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . 0.741 ' HB3' ' O ' ' A' ' 11' ' ' ARG . . . -54.93 -55.98 24.61 Favored 'General case' 0 N--CA 1.485 1.286 0 C-N-CA 118.877 -1.129 . . . . 1.0 111.311 -177.327 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . 0.761 ' HB3' ' O ' ' A' ' 12' ' ' ALA . . . -66.06 -57.16 8.34 Favored 'General case' 0 CA--C 1.548 0.874 0 C-N-CA 119.589 -0.844 . . . . 1.0 109.935 -178.425 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . 0.722 ' HB3' ' O ' ' A' ' 13' ' ' VAL . 7.0 tt -56.29 -54.07 49.77 Favored 'General case' 0 N--CA 1.483 1.206 0 CA-C-N 115.065 -0.97 . . . . 1.0 108.421 -178.224 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . 0.946 HG22 ' O ' ' A' ' 14' ' ' ALA . 1.8 m -71.14 -57.81 6.71 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.602 0 C-N-CA 119.307 -0.957 . . . . 1.0 110.169 179.868 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . 0.539 ' N ' ' O ' ' A' ' 15' ' ' ALA . . . -57.88 -171.54 0.25 Allowed Glycine 0 N--CA 1.448 -0.526 0 N-CA-C 111.17 -0.772 . . . . 1.0 111.17 -177.911 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 20' ' ' PRO . . . . . 0.585 ' O ' ' N ' ' A' ' 24' ' ' ALA . 89.8 Cg_endo -81.76 -24.51 4.12 Favored 'Trans proline' 0 C--N 1.298 -2.1 0 C-N-CA 122.691 2.261 . . . . 1.0 113.276 -178.583 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . 0.445 ' O ' ' HB3' ' A' ' 24' ' ' ALA . . . -63.96 -61.89 5.71 Favored Glycine 0 N--CA 1.484 1.856 0 C-N-CA 119.237 -1.458 . . . . 1.0 111.981 -176.992 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . 0.512 ' H ' ' HA ' ' A' ' 16' ' ' ALA . . . -53.01 -51.83 43.55 Favored Glycine 0 N--CA 1.47 0.927 0 N-CA-C 106.212 -2.755 . . . . 1.0 106.212 179.69 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 34.3 t -56.88 -30.74 34.12 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.733 0 N-CA-C 108.832 -0.803 . . . . 1.0 108.832 178.332 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . 0.585 ' N ' ' O ' ' A' ' 20' ' ' PRO . . . -58.22 -61.37 2.62 Favored 'General case' 0 C--N 1.352 0.706 0 C-N-CA 118.354 -1.339 . . . . 1.0 109.499 179.638 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . 0.516 ' N ' HD12 ' A' ' 25' ' ' LEU . 9.0 mp -57.59 -44.27 85.24 Favored 'General case' 0 C--O 1.223 -0.315 0 C-N-CA 119.629 -0.829 . . . . 1.0 110.341 -177.893 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 65.5 t -58.6 -60.33 2.46 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.861 0 C-N-CA 119.087 -1.045 . . . . 1.0 111.053 -178.61 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . 0.553 ' O ' ' HB3' ' A' ' 31' ' ' ALA . 18.1 t -58.51 -41.83 82.88 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.231 0 N-CA-C 112.843 0.683 . . . . 1.0 112.843 -177.64 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . 0.616 ' NZ ' HG23 ' A' ' 29' ' ' VAL . 3.9 pptp? -68.33 -54.41 17.56 Favored 'General case' 0 C--N 1.325 -0.459 0 C-N-CA 119.078 -1.049 . . . . 1.0 109.966 -178.027 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . 0.616 HG23 ' NZ ' ' A' ' 28' ' ' LYS . 1.3 t -60.58 -50.71 79.32 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.6 0 C-N-CA 119.748 -0.781 . . . . 1.0 110.576 179.862 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 30' ' ' CYS . . . . . . . . . . . . . 8.6 t -65.14 -63.1 1.19 Allowed 'General case' 0 N--CA 1.447 -0.6 0 C-N-CA 119.425 -0.91 . . . . 1.0 110.51 -179.184 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . 0.553 ' HB3' ' O ' ' A' ' 27' ' ' VAL . . . -56.19 -50.38 71.39 Favored 'General case' 0 CA--C 1.517 -0.323 0 C-N-CA 120.3 -0.56 . . . . 1.0 111.168 -177.53 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . 0.45 ' O ' ' HB2' ' A' ' 33' ' ' LEU . . . 74.3 70.44 1.25 Allowed Glycine 0 N--CA 1.45 -0.43 0 N-CA-C 108.621 -1.791 . . . . 1.0 108.621 -178.182 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . 0.45 ' HB2' ' O ' ' A' ' 32' ' ' GLY . 0.1 OUTLIER 84.75 93.8 0.04 OUTLIER Pre-proline 0 CA--C 1.55 0.968 0 O-C-N 124.477 0.751 . . . . 1.0 109.657 -178.286 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 74.7 Cg_exo -45.69 -13.55 0.08 OUTLIER 'Trans proline' 0 N--CA 1.491 1.378 0 C-N-CA 121.919 1.746 . . . . 1.0 113.634 -179.56 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . 0.433 ' N ' ' O ' ' A' ' 33' ' ' LEU . . . -62.81 -61.85 6.07 Favored Glycine 0 N--CA 1.471 0.989 0 C-N-CA 118.885 -1.626 . . . . 1.0 110.422 -178.263 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . 0.762 ' O ' HG22 ' A' ' 37' ' ' ILE . 34.3 m -76.94 -147.01 0.01 OUTLIER 'Isoleucine or valine' 0 C--O 1.213 -0.858 0 N-CA-C 107.58 -1.267 . . . . 1.0 107.58 178.431 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . 0.762 HG22 ' O ' ' A' ' 36' ' ' VAL . 0.3 OUTLIER 71.93 75.4 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.474 0.741 0 CA-C-O 122.993 1.378 . . . . 1.0 111.675 179.934 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 38' ' ' HIS . . . . . 0.433 ' CD2' ' O ' ' A' ' 37' ' ' ILE . 35.1 m170 -137.75 131.97 32.06 Favored 'General case' 0 C--N 1.327 -0.376 0 O-C-N 120.707 -1.246 . . . . 1.0 109.103 178.997 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . 0.406 HG23 ' O ' ' A' ' 39' ' ' THR . 1.7 t -128.65 112.99 19.19 Favored Pre-proline 0 CA--C 1.542 0.642 0 N-CA-C 109.015 -0.735 . . . . 1.0 109.015 179.745 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 40' ' ' PRO . . . . . 0.547 ' O ' ' NE ' ' A' ' 42' ' ' ARG . 83.8 Cg_exo -42.63 -68.05 0.11 Allowed 'Trans proline' 0 N--CA 1.49 1.293 0 C-N-CA 121.542 1.495 . . . . 1.0 112.569 -178.673 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -74.7 128.02 34.54 Favored 'General case' 0 C--N 1.316 -0.889 0 CA-C-N 115.173 -0.921 . . . . 1.0 111.244 -177.694 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . 0.643 ' C ' ' H ' ' A' ' 44' ' ' GLY . 0.1 OUTLIER -173.78 175.44 2.89 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 114.859 -1.064 . . . . 1.0 110.726 179.631 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 43' ' ' ARG . . . . . 0.573 ' C ' ' H ' ' A' ' 45' ' ' PHE . 25.3 tpt180 -63.51 19.11 0.01 OUTLIER 'General case' 0 CA--C 1.549 0.905 0 CA-C-O 121.254 0.549 . . . . 1.0 109.927 178.532 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . 0.643 ' H ' ' C ' ' A' ' 42' ' ' ARG . . . 69.93 -27.94 0.41 Allowed Glycine 0 C--N 1.342 0.906 0 N-CA-C 110.66 -0.976 . . . . 1.0 110.66 -179.715 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . 0.668 ' O ' ' HB2' ' A' ' 46' ' ' PHE . 1.1 p90 -159.79 161.01 34.52 Favored 'General case' 0 C--N 1.326 -0.415 0 N-CA-C 109.022 -0.733 . . . . 1.0 109.022 179.77 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 46' ' ' PHE . . . . . 0.668 ' HB2' ' O ' ' A' ' 45' ' ' PHE . 0.7 OUTLIER 131.87 94.35 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.506 0 O-C-N 125.414 1.696 . . . . 1.0 109.604 179.153 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 47' ' ' ARG . . . . . 0.581 ' CB ' ' O ' ' A' ' 46' ' ' PHE . 0.0 OUTLIER 112.58 143.14 0.0 OUTLIER 'General case' 0 N--CA 1.48 1.072 0 O-C-N 124.415 1.072 . . . . 1.0 111.709 178.229 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 48' ' ' CYS . . . . . 0.485 ' O ' ' H62' ' A' ' 129' ' ' MTN . 35.8 t 66.96 73.18 0.35 Allowed 'General case' 0 C--O 1.22 -0.463 0 O-C-N 124.317 1.011 . . . . 1.0 110.579 179.257 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 49' ' ' ASN . . . . . 0.528 ' C ' HD22 ' A' ' 49' ' ' ASN . 0.4 OUTLIER -136.44 153.89 76.54 Favored Pre-proline 0 CA--C 1.536 0.435 0 N-CA-C 109.863 -0.421 . . . . 1.0 109.863 -179.19 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . 0.534 ' C ' ' H ' ' A' ' 52' ' ' ARG . 27.9 Cg_endo -58.64 56.67 0.06 OUTLIER 'Trans proline' 0 N--CA 1.51 2.455 0 C-N-CA 123.219 2.612 . . . . 1.0 113.516 179.931 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . 0.558 ' OE1' ' ND1' ' A' ' 92' ' ' HIS . 49.1 mt-10 63.85 -34.44 0.14 Allowed 'General case' 0 N--CA 1.47 0.541 0 CA-C-N 116.129 -0.487 . . . . 1.0 111.984 179.855 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . 0.534 ' H ' ' C ' ' A' ' 50' ' ' PRO . 75.7 mtt85 -45.9 136.3 6.5 Favored 'General case' 0 C--N 1.325 -0.468 0 N-CA-C 109.588 -0.523 . . . . 1.0 109.588 179.696 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . 0.607 ' O ' ' N ' ' A' ' 55' ' ' ILE . 3.0 tp -49.73 125.56 3.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 N-CA-C 109.615 -0.513 . . . . 1.0 109.615 -178.713 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -57.17 80.37 0.01 OUTLIER 'General case' 0 C--N 1.322 -0.588 0 CA-C-O 121.931 0.872 . . . . 1.0 109.054 -177.393 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . 0.607 ' N ' ' O ' ' A' ' 53' ' ' ILE . 3.3 tt -155.12 165.01 1.26 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.249 0 CA-C-N 114.687 -1.142 . . . . 1.0 111.449 178.501 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 105.55 -28.83 12.77 Favored Glycine 0 C--O 1.226 -0.405 0 CA-C-N 115.916 -0.584 . . . . 1.0 112.134 176.737 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -52.56 117.61 3.01 Favored 'General case' 0 CA--C 1.537 0.478 0 CA-C-N 118.013 0.906 . . . . 1.0 112.627 -178.783 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 58' ' ' TRP . . . . . 0.447 ' HB2' ' HB3' ' A' ' 61' ' ' GLU . 36.1 m95 -79.83 168.26 19.51 Favored 'General case' 0 CA--C 1.556 1.182 0 CA-C-O 124.214 1.959 . . . . 1.0 111.045 178.649 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 59' ' ' ARG . . . . . 0.545 ' HD3' ' H ' ' A' ' 59' ' ' ARG . 0.0 OUTLIER -86.17 -64.14 1.2 Allowed 'General case' 0 N--CA 1.509 2.518 0 CA-C-N 110.745 -2.934 . . . . 1.0 112.902 -176.989 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 60' ' ' TYR . . . . . 0.415 ' O ' ' CG ' ' A' ' 60' ' ' TYR . 17.5 t80 -88.07 -16.44 33.56 Favored 'General case' 0 N--CA 1.483 1.205 0 N-CA-C 113.171 0.804 . . . . 1.0 113.171 179.728 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . 0.531 ' O ' ' N ' ' A' ' 65' ' ' ASP . 11.3 tt0 -79.42 -12.88 59.89 Favored 'General case' 0 C--N 1.313 -1.002 0 O-C-N 121.704 -0.622 . . . . 1.0 109.64 179.941 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . 0.557 ' O ' ' N ' ' A' ' 66' ' ' GLY . 12.2 m -45.42 -51.4 2.74 Favored 'Isoleucine or valine' 0 CA--C 1.5 -0.974 0 C-N-CA 120.04 -0.664 . . . . 1.0 110.354 -176.126 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 63' ' ' ALA . . . . . 0.487 ' N ' HG23 ' A' ' 62' ' ' VAL . . . -68.29 -48.35 65.19 Favored 'General case' 0 N--CA 1.426 -1.66 0 C-N-CA 119.752 -0.779 . . . . 1.0 109.325 179.763 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 1.8 t-80 -56.49 -59.65 4.68 Favored 'General case' 0 CA--C 1.545 0.755 0 CA-C-N 115.358 -0.837 . . . . 1.0 110.37 -179.645 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . 0.586 ' C ' ' H ' ' A' ' 67' ' ' ARG . 1.0 OUTLIER -69.42 -55.46 10.25 Favored 'General case' 0 CA--C 1.549 0.917 0 CA-C-O 121.976 0.893 . . . . 1.0 109.756 177.767 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . 0.557 ' N ' ' O ' ' A' ' 62' ' ' VAL . . . -67.34 33.3 0.2 Allowed Glycine 0 CA--C 1.529 0.939 0 O-C-N 120.726 -1.234 . . . . 1.0 111.227 178.957 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 67' ' ' ARG . . . . . 0.644 ' O ' ' N ' ' A' ' 69' ' ' LEU . 0.8 OUTLIER -77.98 5.93 8.82 Favored 'General case' 0 C--N 1.32 -0.678 0 N-CA-C 108.85 -0.796 . . . . 1.0 108.85 177.045 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . 0.506 ' O ' ' HA ' ' A' ' 72' ' ' HIS . 0.3 OUTLIER -32.86 -28.36 0.01 OUTLIER 'General case' 0 N--CA 1.487 1.396 0 N-CA-C 108.226 -1.027 . . . . 1.0 108.226 -177.879 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . 0.644 ' N ' ' O ' ' A' ' 67' ' ' ARG . 2.4 mp -64.4 -65.2 0.71 Allowed 'General case' 0 N--CA 1.469 0.488 0 C-N-CA 117.922 -1.511 . . . . 1.0 107.301 177.16 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . 0.662 ' C ' ' H ' ' A' ' 72' ' ' HIS . . . -76.09 -72.22 0.34 Allowed 'General case' 0 CA--C 1.51 -0.573 0 N-CA-C 106.157 -1.794 . . . . 1.0 106.157 178.249 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . 0.612 ' H ' ' HB3' ' A' ' 67' ' ' ARG . . . -43.87 3.22 0.0 OUTLIER 'General case' 0 N--CA 1.472 0.634 0 C-N-CA 125.135 1.374 . . . . 1.0 113.798 176.897 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 72' ' ' HIS . . . . . 1.038 ' CD2' ' H ' ' A' ' 73' ' ' MET . 0.4 OUTLIER -19.41 -65.92 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.314 0 N-CA-C 112.728 0.64 . . . . 1.0 112.728 -176.372 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 73' ' ' MET . . . . . 1.038 ' H ' ' CD2' ' A' ' 72' ' ' HIS . 28.1 mtt -76.64 -45.78 28.56 Favored 'General case' 0 N--CA 1.438 -1.059 0 CA-C-N 119.023 0.828 . . . . 1.0 109.22 177.557 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . 0.591 ' O ' ' N ' ' A' ' 76' ' ' GLY . 94.5 t -45.27 -50.37 2.9 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.306 0 CA-C-O 118.082 -0.961 . . . . 1.0 109.894 -177.099 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 75' ' ' ASN . . . . . 0.512 ' C ' ' N ' ' A' ' 77' ' ' ILE . 19.0 t-20 -39.44 -21.18 0.01 OUTLIER 'General case' 0 C--N 1.357 0.925 0 CA-C-N 120.312 1.415 . . . . 1.0 110.715 177.346 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . 0.591 ' N ' ' O ' ' A' ' 74' ' ' VAL . . . -43.48 -20.95 0.14 Allowed Glycine 0 CA--C 1.534 1.237 0 N-CA-C 108.675 -1.77 . . . . 1.0 108.675 178.934 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . 0.772 ' O ' ' N ' ' A' ' 80' ' ' ALA . 96.7 mt -82.43 -50.04 16.49 Favored 'Isoleucine or valine' 0 C--O 1.213 -0.855 0 N-CA-C 108.766 -0.827 . . . . 1.0 108.766 179.421 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . 0.467 ' C ' ' O ' ' A' ' 77' ' ' ILE . 43.8 t -35.4 -34.49 0.06 OUTLIER 'Isoleucine or valine' 0 CA--C 1.541 0.603 0 N-CA-C 108.481 -0.933 . . . . 1.0 108.481 -178.254 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . 0.744 ' O ' ' HB2' ' A' ' 83' ' ' ALA . 0.1 OUTLIER -88.16 -24.7 6.1 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.602 0 CA-C-O 121.007 0.432 . . . . 1.0 110.104 178.789 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 80' ' ' ALA . . . . . 0.772 ' N ' ' O ' ' A' ' 77' ' ' ILE . . . -89.78 -9.25 49.96 Favored 'General case' 0 CA--C 1.539 0.522 0 C-N-CA 123.843 0.857 . . . . 1.0 111.653 177.061 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . 0.62 ' O ' HD11 ' A' ' 84' ' ' LEU . 51.2 tp10 -77.86 -71.77 0.4 Allowed 'General case' 0 N--CA 1.444 -0.765 0 CA-C-O 118.477 -0.773 . . . . 1.0 111.516 -179.288 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 82' ' ' ASP . . . . . 0.589 ' O ' HG13 ' A' ' 85' ' ' ILE . 1.7 m-20 -81.67 -18.72 43.53 Favored 'General case' 0 C--O 1.21 -0.983 0 O-C-N 123.517 0.51 . . . . 1.0 112.226 -178.095 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . 0.744 ' HB2' ' O ' ' A' ' 79' ' ' ILE . . . -45.05 -52.41 9.0 Favored 'General case' 0 N--CA 1.469 0.491 0 N-CA-C 115.093 1.516 . . . . 1.0 115.093 -179.813 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . 0.985 ' H ' HD13 ' A' ' 84' ' ' LEU . 0.0 OUTLIER -31.78 -28.67 0.01 OUTLIER 'General case' 0 N--CA 1.48 1.048 0 CA-C-O 118.962 -0.542 . . . . 1.0 112.408 -174.304 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 85' ' ' ILE . . . . . 0.596 ' N ' ' O ' ' A' ' 83' ' ' ALA . 1.4 pp -100.02 -58.9 3.58 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.878 0 CA-C-N 118.631 0.65 . . . . 1.0 109.262 177.565 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . 0.538 ' H ' HG13 ' A' ' 85' ' ' ILE . . . -53.22 -37.53 62.11 Favored 'General case' 0 C--O 1.222 -0.347 0 CA-C-N 115.6 -0.727 . . . . 1.0 110.745 179.869 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 9.8 tt0 -47.5 -11.86 0.03 OUTLIER 'General case' 0 N--CA 1.465 0.295 0 CA-C-O 121.07 0.462 . . . . 1.0 110.046 179.649 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . 0.521 ' H ' ' C ' ' A' ' 86' ' ' ALA . . . -84.16 -2.33 56.65 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.754 -0.657 . . . . 1.0 110.103 179.657 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 89' ' ' VAL . . . . . 0.688 ' O ' HG12 ' A' ' 89' ' ' VAL . 54.2 t -93.25 33.03 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.62 0 CA-C-N 115.414 -0.812 . . . . 1.0 109.231 179.079 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 90' ' ' GLY . . . . . 0.633 ' N ' ' HD2' ' A' ' 91' ' ' PRO . . . -67.22 -44.81 85.27 Favored Glycine 0 CA--C 1.535 1.342 0 CA-C-O 119.163 -0.798 . . . . 1.0 112.005 178.134 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 91' ' ' PRO . . . . . 0.633 ' HD2' ' N ' ' A' ' 90' ' ' GLY . 7.7 Cg_exo -39.3 -18.55 0.04 OUTLIER 'Trans proline' 0 N--CA 1.493 1.445 0 C-N-CA 122.236 1.957 . . . . 1.0 111.336 179.263 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 92' ' ' HIS . . . . . 0.713 ' O ' ' N ' ' A' ' 96' ' ' ALA . 3.3 p80 -53.95 -44.83 71.04 Favored 'General case' 0 N--CA 1.441 -0.923 0 N-CA-C 106.357 -1.72 . . . . 1.0 106.357 -179.568 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . 0.747 HD12 ' N ' ' A' ' 94' ' ' ALA . 2.3 pp -41.51 -61.38 1.07 Allowed 'General case' 0 CA--C 1.566 1.572 0 C-N-CA 119.578 -0.849 . . . . 1.0 111.762 177.682 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 94' ' ' ALA . . . . . 0.747 ' N ' HD12 ' A' ' 93' ' ' LEU . . . -58.29 -58.76 7.07 Favored 'General case' 0 C--O 1.219 -0.547 0 CA-C-N 119.229 0.922 . . . . 1.0 108.763 179.67 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 95' ' ' ARG . . . . . 0.578 ' O ' ' N ' ' A' ' 97' ' ' LEU . 44.7 mtp85 -51.56 -61.38 2.28 Favored 'General case' 0 C--O 1.246 0.885 0 CA-C-O 123.359 1.552 . . . . 1.0 108.658 178.177 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 96' ' ' ALA . . . . . 0.845 ' O ' ' N ' ' A' ' 98' ' ' GLY . . . -47.82 -14.37 0.05 OUTLIER 'General case' 0 N--CA 1.43 -1.429 0 O-C-N 118.186 -2.821 . . . . 1.0 111.206 -178.446 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . 0.628 ' O ' ' N ' ' A' ' 100' ' ' ILE 0.258 6.1 tt 3.68 -51.28 0.0 OUTLIER 'General case' 0 C--N 1.368 1.393 0 C-N-CA 124.109 0.964 . . . . 1.0 112.736 -170.72 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 98' ' ' GLY . . . . . 0.845 ' N ' ' O ' ' A' ' 96' ' ' ALA . . . -49.56 -23.05 4.36 Favored Glycine 0 N--CA 1.434 -1.479 0 CA-C-N 122.187 2.267 . . . . 1.0 108.152 174.589 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 99' ' ' GLN . . . . . 0.6 ' NE2' ' S1 ' ' A' ' 130' ' ' MTN . 25.2 mm100 -68.88 -19.81 64.24 Favored 'General case' 0 C--N 1.363 1.162 0 C-N-CA 117.308 -1.757 . . . . 1.0 108.58 177.765 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 100' ' ' ILE . . . . . 0.628 ' N ' ' O ' ' A' ' 97' ' ' LEU . 10.3 mt -65.41 -32.72 59.45 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.813 0 C-N-CA 119.749 -0.781 . . . . 1.0 110.214 177.179 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 101' ' ' VAL . . . . . 0.744 HG12 ' O ' ' A' ' 98' ' ' GLY . 3.8 p -60.13 -62.09 1.22 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.509 0 C-N-CA 119.355 -0.938 . . . . 1.0 110.622 -178.847 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 102' ' ' CYS . . . . . 0.867 ' O ' ' HB2' ' A' ' 106' ' ' ALA . 1.2 p -48.72 -19.29 0.34 Allowed 'General case' 0 C--O 1.217 -0.627 0 O-C-N 122.122 -0.361 . . . . 1.0 111.655 -178.364 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 103' ' ' ARG . . . . . 0.61 HH11 ' CG ' ' A' ' 103' ' ' ARG . 0.0 OUTLIER -85.9 -42.61 13.93 Favored 'General case' 0 N--CA 1.498 1.943 0 CA-C-O 124.419 2.057 . . . . 1.0 111.235 -179.98 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 104' ' ' TYR . . . . . 0.803 ' O ' ' CD1' ' A' ' 104' ' ' TYR . 0.0 OUTLIER -97.62 22.48 8.93 Favored 'General case' 0 C--N 1.267 -2.995 0 CA-C-N 110.561 -3.018 . . . . 1.0 107.332 176.949 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 105' ' ' GLY . . . . . 0.512 ' N ' ' O ' ' A' ' 101' ' ' VAL . . . -165.5 -88.3 0.07 OUTLIER Glycine 0 CA--C 1.529 0.913 0 O-C-N 119.634 -1.916 . . . . 1.0 109.081 179.13 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 106' ' ' ALA . . . . . 0.867 ' HB2' ' O ' ' A' ' 102' ' ' CYS . . . 65.52 58.58 0.82 Allowed 'General case' 0 CA--C 1.533 0.308 0 CA-C-O 120.885 0.374 . . . . 1.0 110.688 -178.713 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 13.1 t -89.49 -5.34 57.4 Favored 'General case' 0 CA--C 1.514 -0.412 0 N-CA-C 108.614 -0.884 . . . . 1.0 108.614 178.593 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . 0.618 HG23 ' N ' ' A' ' 109' ' ' ILE . 14.7 m -87.53 -53.54 9.76 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.626 0 C-N-CA 120.842 -0.343 . . . . 1.0 110.608 178.537 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 109' ' ' ILE . . . . . 0.618 ' N ' HG23 ' A' ' 108' ' ' VAL . 0.2 OUTLIER -50.34 -34.34 10.65 Favored Pre-proline 0 C--N 1.351 0.658 0 N-CA-C 115.086 1.513 . . . . 1.0 115.086 -178.921 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 110' ' ' PRO . . . . . 0.507 ' CD ' ' N ' ' A' ' 109' ' ' ILE . 76.8 Cg_exo -53.07 -37.89 79.78 Favored 'Trans proline' 0 C--N 1.307 -1.612 0 CA-C-N 120.458 1.199 . . . . 1.0 111.276 -175.212 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -64.76 -67.48 0.43 Allowed 'General case' 0 C--N 1.325 -0.471 0 C-N-CA 119.639 -0.824 . . . . 1.0 109.326 179.647 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 112' ' ' ILE . . . . . 0.485 ' CG1' ' N ' ' A' ' 113' ' ' ASN . 0.3 OUTLIER -60.28 -44.91 96.7 Favored 'Isoleucine or valine' 0 C--O 1.213 -0.817 0 C-N-CA 120.245 -0.582 . . . . 1.0 110.527 -178.819 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 113' ' ' ASN . . . . . 0.498 ' CB ' ' O ' ' A' ' 109' ' ' ILE . 18.0 t30 -44.14 -63.07 0.94 Allowed 'General case' 0 C--N 1.31 -1.118 0 CA-C-N 115.181 -0.918 . . . . 1.0 112.113 -174.659 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -57.18 -23.8 50.05 Favored 'General case' 0 C--N 1.312 -1.061 0 C-N-CA 119.743 -0.783 . . . . 1.0 111.555 -179.664 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -84.21 -58.46 2.75 Favored 'General case' 0 CA--C 1.555 1.162 0 CA-C-O 122.503 1.144 . . . . 1.0 113.846 178.191 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 116' ' ' ILE . . . . . 0.497 ' O ' ' N ' ' A' ' 119' ' ' LEU . 76.0 mt -65.88 -59.8 3.52 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.863 0 CA-C-N 113.814 -1.539 . . . . 1.0 110.825 -177.254 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 117' ' ' GLU . . . . . 0.448 ' HB3' ' O ' ' A' ' 113' ' ' ASN . 11.3 tt0 -45.1 -62.49 1.22 Allowed 'General case' 0 C--N 1.307 -1.257 0 CA-C-N 116.058 -0.519 . . . . 1.0 109.743 -178.285 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 48.7 t -53.49 -14.88 0.76 Allowed 'Isoleucine or valine' 0 N--CA 1.437 -1.119 0 C-N-CA 119.922 -0.711 . . . . 1.0 109.628 -179.782 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 119' ' ' LEU . . . . . 0.497 ' N ' ' O ' ' A' ' 116' ' ' ILE . 3.7 tp -79.79 -60.79 2.21 Favored 'General case' 0 C--N 1.348 0.527 0 C-N-CA 119.776 -0.77 . . . . 1.0 109.966 178.261 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -70.3 -85.1 0.16 Allowed Glycine 0 C--N 1.357 1.735 0 C-N-CA 118.626 -1.75 . . . . 1.0 111.285 179.925 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 121' ' ' THR . . . . . 0.428 ' H ' ' H ' ' A' ' 122' ' ' GLY . 7.7 m -164.57 -22.79 0.03 OUTLIER 'General case' 0 C--N 1.325 -0.478 0 N-CA-C 108.121 -1.066 . . . . 1.0 108.121 -179.035 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 122' ' ' GLY . . . . . 0.53 ' O ' ' N ' ' A' ' 124' ' ' ASP . . . 114.37 -36.42 3.98 Favored Glycine 0 CA--C 1.523 0.562 0 CA-C-O 118.125 -1.375 . . . . 1.0 113.028 179.308 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 123' ' ' THR . . . . . 0.461 ' C ' ' O ' ' A' ' 122' ' ' GLY . 0.0 OUTLIER -32.54 91.32 0.0 OUTLIER 'General case' 0 N--CA 1.47 0.573 0 CA-C-N 119.609 1.705 . . . . 1.0 112.065 -179.565 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 124' ' ' ASP . . . . . 0.53 ' N ' ' O ' ' A' ' 122' ' ' GLY . 11.6 p-10 -146.43 144.39 29.67 Favored 'General case' 0 N--CA 1.463 0.222 0 N-CA-C 108.986 -0.746 . . . . 1.0 108.986 179.051 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 125' ' ' TYR . . . . . 0.419 ' CD1' ' C ' ' A' ' 125' ' ' TYR . 0.2 OUTLIER -151.07 148.99 28.99 Favored 'General case' 0 CA--C 1.536 0.442 0 CA-C-O 121.367 0.603 . . . . 1.0 110.247 -179.962 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 74.8 mtt85 -149.57 150.88 32.92 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.59 -0.732 . . . . 1.0 110.245 178.077 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 127' ' ' PHE . . . . . 0.457 ' C ' ' H63' ' A' ' 130' ' ' MTN . 0.3 OUTLIER . . . . . 0 C--O 1.22 -0.476 0 CA-C-O 118.042 -0.98 . . . . 1.0 109.291 178.83 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 128' ' ' MTN . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 129' ' ' MTN . . . . . 0.485 ' H62' ' O ' ' A' ' 48' ' ' CYS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 130' ' ' MTN . . . . . 0.6 ' S1 ' ' NE2' ' A' ' 99' ' ' GLN . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.7 mpt? . . . . . 0 N--CA 1.492 1.633 0 N-CA-C 109.061 -0.718 . . . . 1.0 109.061 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 33.4 m -107.69 7.68 28.6 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.322 -0.399 . . . . 1.0 110.402 179.872 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . 0.408 ' N ' ' OD1' ' A' ' 3' ' ' ASP . 1.2 p30 170.72 93.12 0.0 OUTLIER 'General case' 0 N--CA 1.463 0.213 0 CA-C-N 116.288 -0.415 . . . . 1.0 110.414 179.77 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 72.8 t80 -150.84 145.59 25.78 Favored 'General case' 0 N--CA 1.462 0.15 0 CA-C-O 120.684 0.278 . . . . 1.0 110.51 -179.998 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 5' ' ' ASP . . . . . 0.479 ' N ' ' OD1' ' A' ' 5' ' ' ASP . 3.4 p30 -155.53 151.68 27.94 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.434 -0.348 . . . . 1.0 110.444 179.901 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 6' ' ' THR . . . . . 0.552 ' O ' ' N ' ' A' ' 10' ' ' SER . 0.2 OUTLIER -64.7 169.16 5.26 Favored 'General case' 0 C--O 1.208 -1.119 0 N-CA-C 109.556 -0.535 . . . . 1.0 109.556 179.979 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . 0.497 ' O ' ' N ' ' A' ' 11' ' ' ARG . 0.0 OUTLIER -59.33 -58.05 10.33 Favored 'General case' 0 C--N 1.315 -0.93 0 CA-C-O 121.359 0.6 . . . . 1.0 110.213 -178.44 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 8' ' ' ARG . . . . . 0.509 ' O ' ' CB ' ' A' ' 12' ' ' ALA . 1.8 ptm180 -50.83 -56.31 12.8 Favored 'General case' 0 C--O 1.212 -0.899 0 N-CA-C 107.994 -1.113 . . . . 1.0 107.994 -177.825 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . 0.436 ' H ' ' HG3' ' A' ' 8' ' ' ARG . 0.0 OUTLIER -64.12 -47.46 90.06 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.966 0 CA-C-N 115.037 -0.983 . . . . 1.0 110.364 179.502 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . 0.552 ' N ' ' O ' ' A' ' 6' ' ' THR . 47.9 t -63.81 -63.06 1.27 Allowed 'General case' 0 N--CA 1.48 1.037 0 O-C-N 123.454 0.471 . . . . 1.0 110.905 -178.968 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 11' ' ' ARG . . . . . 0.497 ' N ' ' O ' ' A' ' 7' ' ' GLU . 12.1 ttt180 -58.68 -54.82 42.8 Favored 'General case' 0 N--CA 1.469 0.489 0 N-CA-C 109.404 -0.591 . . . . 1.0 109.404 -177.069 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . 0.588 ' O ' ' HB3' ' A' ' 16' ' ' ALA . . . -46.48 -46.82 19.24 Favored 'General case' 0 N--CA 1.477 0.923 0 N-CA-C 105.762 -1.94 . . . . 1.0 105.762 -178.13 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . 0.604 ' O ' ' CB ' ' A' ' 17' ' ' LEU . 1.5 t -61.32 -52.02 66.21 Favored 'Isoleucine or valine' 0 C--O 1.206 -1.196 0 CA-C-N 114.495 -1.23 . . . . 1.0 108.147 176.004 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . 0.769 ' O ' HG13 ' A' ' 18' ' ' VAL . . . -57.21 -63.65 1.15 Allowed 'General case' 0 C--O 1.213 -0.86 0 C-N-CA 117.763 -1.575 . . . . 1.0 110.232 -179.876 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . 0.557 ' O ' ' N ' ' A' ' 19' ' ' GLY . . . -53.8 -56.26 19.07 Favored 'General case' 0 N--CA 1.473 0.71 0 CA-C-O 121.559 0.695 . . . . 1.0 110.916 -177.956 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . 0.588 ' HB3' ' O ' ' A' ' 12' ' ' ALA . . . -64.63 -55.57 19.4 Favored 'General case' 0 C--N 1.31 -1.112 0 CA-C-N 115.135 -0.938 . . . . 1.0 109.611 -178.419 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . 0.612 HD13 ' O ' ' A' ' 17' ' ' LEU . 0.3 OUTLIER -57.85 -52.14 66.73 Favored 'General case' 0 N--CA 1.474 0.766 0 CA-C-N 114.506 -1.224 . . . . 1.0 108.004 -177.516 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . 0.769 HG13 ' O ' ' A' ' 14' ' ' ALA . 2.3 m -68.37 -57.28 9.59 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.605 0 C-N-CA 118.86 -1.136 . . . . 1.0 109.706 178.685 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . 0.557 ' N ' ' O ' ' A' ' 15' ' ' ALA . . . -61.95 -171.84 1.21 Allowed Glycine 0 C--N 1.332 0.319 0 N-CA-C 110.941 -0.863 . . . . 1.0 110.941 -179.059 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 20' ' ' PRO . . . . . 0.603 ' O ' ' N ' ' A' ' 24' ' ' ALA . 2.1 Cg_endo -78.24 -26.3 6.38 Favored 'Trans proline' 0 C--N 1.309 -1.514 0 C-N-CA 122.636 2.224 . . . . 1.0 113.993 -178.752 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -59.62 -58.06 16.26 Favored Glycine 0 N--CA 1.48 1.591 0 C-N-CA 120.256 -0.973 . . . . 1.0 111.808 -177.031 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . 0.507 ' CA ' ' HB1' ' A' ' 16' ' ' ALA . . . -57.91 -52.12 54.13 Favored Glycine 0 N--CA 1.469 0.859 0 N-CA-C 107.112 -2.395 . . . . 1.0 107.112 -177.901 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . 0.612 ' O ' HG12 ' A' ' 27' ' ' VAL . 9.6 t -58.91 -32.66 47.79 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.078 0 CA-C-N 114.487 -0.856 . . . . 1.0 109.513 179.115 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . 0.603 ' N ' ' O ' ' A' ' 20' ' ' PRO . . . -58.51 -61.27 2.72 Favored 'General case' 0 CA--C 1.533 0.307 0 C-N-CA 118.503 -1.279 . . . . 1.0 109.579 -179.947 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . 0.554 ' C ' HD12 ' A' ' 25' ' ' LEU . 0.3 OUTLIER -65.04 -43.85 91.03 Favored 'General case' 0 CA--C 1.535 0.387 0 N-CA-C 112.763 0.653 . . . . 1.0 112.763 -177.939 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . 0.412 ' N ' ' HG ' ' A' ' 25' ' ' LEU . 53.4 t -61.46 -59.83 3.66 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.171 0 C-N-CA 118.77 -1.172 . . . . 1.0 110.011 -177.626 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . 0.612 HG12 ' O ' ' A' ' 23' ' ' VAL . 2.3 p -58.39 -35.6 54.79 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.217 0 N-CA-C 112.016 0.376 . . . . 1.0 112.016 -178.071 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 6.7 ttmm -67.29 -55.09 15.33 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-O 121.727 0.775 . . . . 1.0 109.477 -179.017 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 94.9 t -64.39 -48.22 86.18 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.673 0 CA-C-N 114.281 -1.327 . . . . 1.0 111.131 -177.689 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 30' ' ' CYS . . . . . . . . . . . . . 2.2 t -65.05 -61.23 2.28 Favored 'General case' 0 N--CA 1.447 -0.601 0 C-N-CA 118.807 -1.157 . . . . 1.0 109.189 -179.255 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . 0.564 ' HB3' ' O ' ' A' ' 27' ' ' VAL . . . -62.46 -51.87 65.77 Favored 'General case' 0 CA--C 1.51 -0.56 0 N-CA-C 112.29 0.478 . . . . 1.0 112.29 -177.06 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . 0.705 ' O ' HD11 ' A' ' 37' ' ' ILE . . . 81.46 71.62 1.28 Allowed Glycine 0 CA--C 1.523 0.581 0 N-CA-C 108.432 -1.867 . . . . 1.0 108.432 -177.967 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . 0.44 ' O ' ' O ' ' A' ' 36' ' ' VAL . 5.2 mt 89.06 73.42 0.05 OUTLIER Pre-proline 0 N--CA 1.476 0.835 0 C-N-CA 123.293 0.637 . . . . 1.0 109.809 -179.502 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 76.6 Cg_exo -50.74 -32.14 35.45 Favored 'Trans proline' 0 N--CA 1.507 2.31 0 C-N-CA 123.728 2.952 . . . . 1.0 114.954 -179.076 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -58.43 -57.44 19.86 Favored Glycine 0 CA--C 1.533 1.161 0 C-N-CA 118.492 -1.813 . . . . 1.0 108.9 -178.828 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . 0.536 ' O ' ' HB ' ' A' ' 37' ' ' ILE . 13.9 p -92.48 167.45 1.64 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.579 0 N-CA-C 106.917 -1.512 . . . . 1.0 106.917 177.447 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . 0.705 HD11 ' O ' ' A' ' 32' ' ' GLY . 91.4 mt 111.22 127.09 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.478 0.971 0 C-N-CA 123.827 0.851 . . . . 1.0 109.581 -179.529 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -141.59 132.38 25.78 Favored 'General case' 0 C--N 1.331 -0.236 0 N-CA-C 108.085 -1.08 . . . . 1.0 108.085 179.792 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 7.3 p -93.31 124.43 57.69 Favored Pre-proline 0 CA--C 1.534 0.35 0 N-CA-C 109.656 -0.498 . . . . 1.0 109.656 -179.792 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 52.5 Cg_exo -50.27 -37.62 50.06 Favored 'Trans proline' 0 N--CA 1.488 1.192 0 C-N-CA 121.399 1.399 . . . . 1.0 113.21 -179.702 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -121.47 101.43 7.61 Favored 'General case' 0 N--CA 1.47 0.535 0 N-CA-C 112.614 0.598 . . . . 1.0 112.614 -177.659 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . 0.746 ' C ' ' H ' ' A' ' 44' ' ' GLY . 14.4 ptm180 -135.84 152.86 51.49 Favored 'General case' 0 C--N 1.316 -0.868 0 CA-C-O 121.735 0.779 . . . . 1.0 112.834 179.773 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 43' ' ' ARG . . . . . 0.526 ' O ' ' CD1' ' A' ' 45' ' ' PHE . 61.0 ttt180 -61.18 28.97 0.01 OUTLIER 'General case' 0 CA--C 1.539 0.552 0 CA-C-N 113.531 -1.668 . . . . 1.0 109.225 -179.84 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . 0.746 ' H ' ' C ' ' A' ' 42' ' ' ARG . . . 75.65 -26.46 1.36 Allowed Glycine 0 N--CA 1.448 -0.527 0 N-CA-C 110.396 -1.081 . . . . 1.0 110.396 179.899 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . 0.699 ' N ' ' CD1' ' A' ' 45' ' ' PHE . 0.0 OUTLIER -172.79 172.61 4.07 Favored 'General case' 0 CA--C 1.536 0.423 0 CA-C-O 119.293 -0.384 . . . . 1.0 110.125 -177.867 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 46' ' ' PHE . . . . . 0.666 ' HB2' ' O ' ' A' ' 45' ' ' PHE . 0.4 OUTLIER 126.17 102.31 0.0 OUTLIER 'General case' 0 N--CA 1.505 2.296 0 O-C-N 125.675 1.859 . . . . 1.0 109.724 179.583 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 47' ' ' ARG . . . . . 0.643 ' NH1' ' H73' ' A' ' 128' ' ' MTN . 1.6 ptp180 108.1 162.37 0.0 OUTLIER 'General case' 0 N--CA 1.487 1.395 0 O-C-N 124.302 1.002 . . . . 1.0 110.669 178.942 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 48' ' ' CYS . . . . . 0.409 ' O ' ' H83' ' A' ' 129' ' ' MTN . 0.1 OUTLIER 69.2 70.46 0.26 Allowed 'General case' 0 N--CA 1.453 -0.293 0 N-CA-C 108.343 -0.984 . . . . 1.0 108.343 -179.366 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 49' ' ' ASN . . . . . 0.581 ' O ' ' N ' ' A' ' 51' ' ' GLU . 2.7 p30 -147.13 138.87 13.54 Favored Pre-proline 0 CA--C 1.542 0.645 0 N-CA-C 108.252 -1.018 . . . . 1.0 108.252 179.82 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . 0.459 ' C ' ' H ' ' A' ' 52' ' ' ARG . 34.8 Cg_exo -54.61 72.05 0.03 OUTLIER 'Trans proline' 0 N--CA 1.502 1.987 0 C-N-CA 121.495 1.463 . . . . 1.0 112.299 179.456 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . 0.581 ' N ' ' O ' ' A' ' 49' ' ' ASN . 1.2 mp0 57.24 4.5 0.21 Allowed 'General case' 0 C--N 1.324 -0.514 0 O-C-N 121.736 -0.603 . . . . 1.0 111.091 179.304 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . 0.459 ' H ' ' C ' ' A' ' 50' ' ' PRO . 92.5 mtt180 -84.89 141.16 30.61 Favored 'General case' 0 CA--C 1.513 -0.452 0 N-CA-C 109.325 -0.62 . . . . 1.0 109.325 178.774 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 14.2 tt -66.48 146.91 12.9 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.704 0 CA-C-O 123.146 1.451 . . . . 1.0 113.355 -177.544 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -74.95 81.01 2.17 Favored 'General case' 0 C--N 1.311 -1.104 0 CA-C-N 111.309 -2.678 . . . . 1.0 111.071 -178.952 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 2.4 pp -148.49 156.89 8.13 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.888 0 N-CA-C 109.78 -0.452 . . . . 1.0 109.78 176.708 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 106.51 -3.84 37.11 Favored Glycine 0 N--CA 1.474 1.176 0 N-CA-C 110.266 -1.134 . . . . 1.0 110.266 179.575 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . 0.434 ' HB3' ' CD1' ' A' ' 45' ' ' PHE . 18.9 m-20 -80.94 103.98 11.14 Favored 'General case' 0 C--N 1.317 -0.831 0 CA-C-N 114.279 -0.96 . . . . 1.0 110.06 178.963 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 58' ' ' TRP . . . . . . . . . . . . . 5.9 m0 -90.09 172.24 8.97 Favored 'General case' 0 CA--C 1.542 0.659 0 CA-C-O 123.678 1.704 . . . . 1.0 114.288 -177.283 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 59' ' ' ARG . . . . . 0.478 ' CG ' ' N ' ' A' ' 60' ' ' TYR . 28.5 ptt-85 -78.6 -60.18 2.48 Favored 'General case' 0 CA--C 1.55 0.946 0 CA-C-N 110.451 -3.068 . . . . 1.0 113.865 -177.661 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 60' ' ' TYR . . . . . 0.478 ' N ' ' CG ' ' A' ' 59' ' ' ARG . 0.3 OUTLIER -92.21 -9.94 40.45 Favored 'General case' 0 N--CA 1.483 1.191 0 C-N-CA 124.122 0.969 . . . . 1.0 113.151 -179.728 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 22.3 tt0 -77.26 -14.73 59.7 Favored 'General case' 0 C--N 1.31 -1.133 0 CA-C-N 115.886 -0.597 . . . . 1.0 111.688 -178.3 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . 0.605 ' O ' ' N ' ' A' ' 66' ' ' GLY . 0.6 OUTLIER -48.05 -55.85 2.43 Favored 'Isoleucine or valine' 0 C--O 1.207 -1.14 0 C-N-CA 119.825 -0.75 . . . . 1.0 110.265 -175.156 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 63' ' ' ALA . . . . . 0.543 ' O ' ' HG3' ' A' ' 67' ' ' ARG . . . -65.98 -52.73 46.93 Favored 'General case' 0 C--N 1.307 -1.269 0 C-N-CA 119.722 -0.791 . . . . 1.0 109.75 -178.966 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 85.4 m-70 -48.9 -57.37 6.55 Favored 'General case' 0 N--CA 1.472 0.626 0 O-C-N 124.093 0.871 . . . . 1.0 109.964 -179.72 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . 0.615 ' C ' ' H ' ' A' ' 67' ' ' ARG . 5.8 t0 -72.45 -47.83 45.78 Favored 'General case' 0 C--N 1.313 -1.001 0 CA-C-O 121.582 0.706 . . . . 1.0 110.362 178.8 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . 0.605 ' N ' ' O ' ' A' ' 62' ' ' VAL . . . -70.71 26.47 0.5 Allowed Glycine 0 C--N 1.32 -0.322 0 O-C-N 120.868 -1.145 . . . . 1.0 110.636 177.985 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 67' ' ' ARG . . . . . 0.615 ' H ' ' C ' ' A' ' 65' ' ' ASP . 6.0 mtp85 -73.11 3.89 5.02 Favored 'General case' 0 N--CA 1.445 -0.688 0 N-CA-C 106.514 -1.661 . . . . 1.0 106.514 175.418 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . 0.484 ' H ' ' C ' ' A' ' 66' ' ' GLY . 0.0 OUTLIER -33.21 -29.65 0.01 OUTLIER 'General case' 0 N--CA 1.486 1.367 0 N-CA-C 108.489 -0.93 . . . . 1.0 108.489 -176.794 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . 0.606 ' N ' ' O ' ' A' ' 67' ' ' ARG . 22.2 mt -61.87 -63.39 1.27 Allowed 'General case' 0 C--N 1.315 -0.933 0 C-N-CA 118.542 -1.263 . . . . 1.0 107.814 178.289 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . 0.637 ' C ' ' H ' ' A' ' 72' ' ' HIS . . . -79.18 -75.28 0.25 Allowed 'General case' 0 N--CA 1.465 0.303 0 N-CA-C 106.271 -1.752 . . . . 1.0 106.271 176.635 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . 0.459 ' O ' ' C ' ' A' ' 72' ' ' HIS . . . -44.1 3.71 0.0 OUTLIER 'General case' 0 CA--C 1.519 -0.223 0 C-N-CA 124.826 1.25 . . . . 1.0 113.831 178.947 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 72' ' ' HIS . . . . . 0.637 ' H ' ' C ' ' A' ' 70' ' ' ALA . 0.2 OUTLIER -28.4 -67.85 0.07 Allowed 'General case' 0 N--CA 1.463 0.19 0 CA-C-N 118.36 0.527 . . . . 1.0 111.589 -178.658 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 73' ' ' MET . . . . . . . . . . . . . 13.8 ptp -69.57 -48.57 59.82 Favored 'General case' 0 C--N 1.325 -0.469 0 C-N-CA 118.983 -1.087 . . . . 1.0 108.968 178.525 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . 0.753 ' O ' ' N ' ' A' ' 76' ' ' GLY . 68.8 t -43.76 -40.54 1.48 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.265 0 CA-C-O 117.351 -1.309 . . . . 1.0 111.539 -176.35 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 75' ' ' ASN . . . . . 0.47 ' C ' ' N ' ' A' ' 77' ' ' ILE . 3.0 m120 -35.14 -12.62 0.0 OUTLIER 'General case' 0 N--CA 1.501 2.078 0 CA-C-N 121.244 1.838 . . . . 1.0 112.257 179.277 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . 0.753 ' N ' ' O ' ' A' ' 74' ' ' VAL . . . -45.72 -21.44 0.55 Allowed Glycine 0 CA--C 1.542 1.739 0 N-CA-C 107.844 -2.102 . . . . 1.0 107.844 175.173 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . 0.575 HG13 ' H ' ' A' ' 78' ' ' VAL . 1.2 pt -72.11 -55.9 11.86 Favored 'Isoleucine or valine' 0 C--O 1.216 -0.692 0 N-CA-C 107.696 -1.224 . . . . 1.0 107.696 178.021 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . 0.575 ' H ' HG13 ' A' ' 77' ' ' ILE . 95.8 t -33.79 -34.99 0.04 OUTLIER 'Isoleucine or valine' 0 CA--C 1.546 0.794 0 CA-C-N 113.2 -1.818 . . . . 1.0 106.849 -177.565 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . 0.633 ' O ' ' HB3' ' A' ' 83' ' ' ALA . 0.0 OUTLIER -98.31 -33.24 4.12 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.878 0 CA-C-N 115.605 -0.725 . . . . 1.0 112.416 176.556 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 80' ' ' ALA . . . . . 0.537 ' N ' ' O ' ' A' ' 77' ' ' ILE . . . -84.2 -10.71 57.5 Favored 'General case' 0 N--CA 1.478 0.974 0 O-C-N 121.257 -0.902 . . . . 1.0 113.184 179.662 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . 0.445 ' N ' ' O ' ' A' ' 77' ' ' ILE . 0.0 OUTLIER -89.27 -73.89 0.49 Allowed 'General case' 0 N--CA 1.451 -0.424 0 N-CA-C 112.115 0.413 . . . . 1.0 112.115 -177.629 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 24.3 m-20 -91.75 -16.8 26.35 Favored 'General case' 0 C--N 1.346 0.437 0 N-CA-C 114.532 1.308 . . . . 1.0 114.532 -179.096 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . 0.633 ' HB3' ' O ' ' A' ' 79' ' ' ILE . . . -49.67 -42.12 44.68 Favored 'General case' 0 C--O 1.211 -0.965 0 C-N-CA 118.304 -1.358 . . . . 1.0 110.792 -177.391 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . 0.564 HD13 ' O ' ' A' ' 84' ' ' LEU . 0.2 OUTLIER -40.33 -35.13 0.39 Allowed 'General case' 0 CA--C 1.543 0.7 0 CA-C-O 120.819 0.342 . . . . 1.0 111.131 -179.789 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 1.2 pp -74.4 -33.69 34.21 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.433 0 C-N-CA 119.999 -0.68 . . . . 1.0 110.125 178.477 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . 0.569 ' N ' ' O ' ' A' ' 83' ' ' ALA . . . -96.23 -26.36 15.46 Favored 'General case' 0 CA--C 1.54 0.573 0 CA-C-O 120.798 0.333 . . . . 1.0 111.698 179.175 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . 0.542 ' N ' ' O ' ' A' ' 83' ' ' ALA . 44.8 tt0 -57.9 -20.25 35.75 Favored 'General case' 0 C--N 1.329 -0.318 0 O-C-N 121.667 -0.646 . . . . 1.0 110.103 -178.833 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -71.98 -1.6 15.13 Favored 'General case' 0 N--CA 1.47 0.533 0 N-CA-C 107.494 -1.299 . . . . 1.0 107.494 178.095 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 89' ' ' VAL . . . . . 0.481 ' H ' ' C ' ' A' ' 87' ' ' GLU . 3.5 t -98.54 36.02 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.447 -0.616 0 CA-C-N 111.922 -2.399 . . . . 1.0 107.831 177.029 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 90' ' ' GLY . . . . . 0.844 ' O ' ' N ' ' A' ' 92' ' ' HIS . . . -55.95 -26.91 49.56 Favored Glycine 0 C--N 1.367 2.26 0 CA-C-O 117.609 -1.662 . . . . 1.0 111.519 176.672 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 91' ' ' PRO . . . . . 0.727 ' HD2' ' N ' ' A' ' 90' ' ' GLY . 11.5 Cg_exo -36.48 3.09 0.0 OUTLIER 'Trans proline' 0 N--CA 1.499 1.803 0 C-N-CA 123.084 2.523 . . . . 1.0 113.68 173.913 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 92' ' ' HIS . . . . . 0.844 ' N ' ' O ' ' A' ' 90' ' ' GLY . 0.0 OUTLIER -47.48 -27.91 1.95 Allowed 'General case' 0 N--CA 1.436 -1.141 0 N-CA-C 106.942 -1.503 . . . . 1.0 106.942 -179.887 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . 0.593 HD12 ' N ' ' A' ' 94' ' ' ALA . 2.0 pp -58.49 -52.46 65.55 Favored 'General case' 0 N--CA 1.448 -0.545 0 N-CA-C 106.931 -1.507 . . . . 1.0 106.931 176.417 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 94' ' ' ALA . . . . . 0.593 ' N ' HD12 ' A' ' 93' ' ' LEU . . . -49.8 -52.05 35.05 Favored 'General case' 0 C--O 1.221 -0.447 0 N-CA-C 107.457 -1.312 . . . . 1.0 107.457 -179.84 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 1.3 mpt_? -64.37 -31.44 72.64 Favored 'General case' 0 C--N 1.321 -0.666 0 N-CA-C 109.386 -0.598 . . . . 1.0 109.386 178.146 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 96' ' ' ALA . . . . . 0.842 ' O ' ' N ' ' A' ' 100' ' ' ILE . . . -50.87 -44.17 59.63 Favored 'General case' 0 C--O 1.197 -1.673 0 N-CA-C 106.368 -1.716 . . . . 1.0 106.368 -176.448 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . 0.506 ' O ' HG22 ' A' ' 100' ' ' ILE . 2.1 tt -35.05 -24.84 0.01 OUTLIER 'General case' 0 CA--C 1.588 2.423 0 CA-C-N 112.585 -2.098 . . . . 1.0 107.625 -178.937 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 98' ' ' GLY . . . . . 0.674 ' N ' ' O ' ' A' ' 96' ' ' ALA . . . -89.32 -51.84 2.85 Favored Glycine 0 CA--C 1.563 3.043 0 CA-C-O 123.312 1.507 . . . . 1.0 111.686 170.763 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 99' ' ' GLN . . . . . 0.562 ' N ' ' O ' ' A' ' 96' ' ' ALA . 6.3 mt-30 -76.72 8.43 3.66 Favored 'General case' 0 N--CA 1.437 -1.111 0 N-CA-C 106.607 -1.627 . . . . 1.0 106.607 177.676 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 100' ' ' ILE . . . . . 0.842 ' N ' ' O ' ' A' ' 96' ' ' ALA . 20.3 tt -59.36 -52.98 54.47 Favored 'Isoleucine or valine' 0 CA--C 1.474 -1.971 0 N-CA-C 106.276 -1.75 . . . . 1.0 106.276 178.296 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 101' ' ' VAL . . . . . 0.676 ' N ' HG23 ' A' ' 100' ' ' ILE . 0.2 OUTLIER -57.05 -61.03 1.4 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.658 0 C-N-CA 118.273 -1.371 . . . . 1.0 108.299 179.415 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 102' ' ' CYS . . . . . 0.879 ' O ' ' HB2' ' A' ' 106' ' ' ALA . 0.1 OUTLIER -50.63 -25.03 3.73 Favored 'General case' 0 C--N 1.317 -0.845 0 C-N-CA 120.588 -0.445 . . . . 1.0 111.179 -177.15 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 68.8 ttp85 -85.74 -49.0 8.29 Favored 'General case' 0 N--CA 1.482 1.158 0 O-C-N 124.731 1.269 . . . . 1.0 112.566 179.238 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 104' ' ' TYR . . . . . 0.735 ' O ' ' CG ' ' A' ' 104' ' ' TYR . 0.1 OUTLIER -96.38 23.63 6.55 Favored 'General case' 0 C--N 1.302 -1.457 0 C-N-CA 126.918 2.087 . . . . 1.0 108.788 179.401 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 105' ' ' GLY . . . . . 0.584 ' N ' ' O ' ' A' ' 101' ' ' VAL . . . -162.56 -93.4 0.09 OUTLIER Glycine 0 N--CA 1.45 -0.402 0 N-CA-C 106.608 -2.597 . . . . 1.0 106.608 178.313 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 106' ' ' ALA . . . . . 0.879 ' HB2' ' O ' ' A' ' 102' ' ' CYS . . . 69.06 64.14 0.29 Allowed 'General case' 0 C--O 1.219 -0.548 0 N-CA-C 113.146 0.795 . . . . 1.0 113.146 179.267 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 96.2 m -78.21 -58.73 3.1 Favored 'General case' 0 CA--C 1.547 0.829 0 O-C-N 121.152 -0.967 . . . . 1.0 109.353 179.529 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . 0.44 HG13 ' N ' ' A' ' 109' ' ' ILE . 3.8 p -58.64 -44.38 89.52 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-O 121.856 0.836 . . . . 1.0 109.662 -177.376 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 109' ' ' ILE . . . . . 0.449 ' HB ' ' HB1' ' A' ' 106' ' ' ALA . 3.3 mm -41.41 -61.41 1.4 Allowed Pre-proline 0 CA--C 1.569 1.689 0 CA-C-N 114.134 -1.394 . . . . 1.0 109.217 179.769 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 110' ' ' PRO . . . . . 0.638 ' CD ' ' O ' ' A' ' 106' ' ' ALA . 21.5 Cg_exo -47.64 -36.92 26.23 Favored 'Trans proline' 0 N--CA 1.502 1.998 0 C-N-CA 123.511 2.807 . . . . 1.0 113.401 174.802 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 111' ' ' ASN . . . . . 0.431 ' C ' ' N ' ' A' ' 113' ' ' ASN . 5.4 t30 -67.7 -67.78 0.43 Allowed 'General case' 0 C--O 1.236 0.381 0 O-C-N 121.082 -1.011 . . . . 1.0 109.946 -177.999 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 112' ' ' ILE . . . . . 0.452 ' H ' HG23 ' A' ' 112' ' ' ILE . 2.1 pt -49.02 -24.37 1.11 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-O 122.481 1.134 . . . . 1.0 109.154 -179.531 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 113' ' ' ASN . . . . . 0.466 ' HB3' ' O ' ' A' ' 110' ' ' PRO . 40.1 t30 -59.72 -53.71 54.77 Favored 'General case' 0 C--N 1.307 -1.264 0 CA-C-N 112.649 -2.069 . . . . 1.0 107.778 -177.695 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 114' ' ' ALA . . . . . 0.43 ' O ' HG22 ' A' ' 118' ' ' VAL . . . -56.92 -32.42 65.92 Favored 'General case' 0 N--CA 1.445 -0.687 0 CA-C-O 119.04 -0.505 . . . . 1.0 112.262 -179.652 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -78.83 -47.25 16.99 Favored 'General case' 0 C--O 1.211 -0.925 0 CA-C-O 122.314 1.054 . . . . 1.0 110.109 178.487 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 116' ' ' ILE . . . . . 0.468 ' O ' ' N ' ' A' ' 120' ' ' GLY . 32.2 mt -53.67 -53.09 28.27 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.101 0 CA-C-N 113.507 -1.679 . . . . 1.0 107.452 -179.148 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 117' ' ' GLU . . . . . 0.433 ' O ' ' HA ' ' A' ' 121' ' ' THR . 10.6 tt0 -44.36 -64.68 0.63 Allowed 'General case' 0 C--N 1.317 -0.816 0 CA-C-N 112.915 -1.948 . . . . 1.0 108.385 -179.249 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 118' ' ' VAL . . . . . 0.43 HG22 ' O ' ' A' ' 114' ' ' ALA . 29.2 m -59.6 -50.7 79.0 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.663 0 C-N-CA 119.652 -0.819 . . . . 1.0 109.723 179.885 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 119' ' ' LEU . . . . . 0.408 ' N ' HG23 ' A' ' 118' ' ' VAL . 0.4 OUTLIER -52.54 -71.29 0.07 Allowed 'General case' 0 CA--C 1.539 0.534 0 N-CA-C 106.845 -1.539 . . . . 1.0 106.845 -178.083 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 120' ' ' GLY . . . . . 0.701 ' O ' ' OG1' ' A' ' 121' ' ' THR . . . -69.28 -79.2 0.3 Allowed Glycine 0 CA--C 1.539 1.537 0 C-N-CA 119.133 -1.508 . . . . 1.0 111.023 179.964 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 121' ' ' THR . . . . . 0.701 ' OG1' ' O ' ' A' ' 120' ' ' GLY . 51.8 m 157.3 -32.01 0.0 OUTLIER 'General case' 0 N--CA 1.487 1.417 0 CA-C-N 112.422 -1.889 . . . . 1.0 111.818 179.859 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 122' ' ' GLY . . . . . 0.621 ' O ' ' N ' ' A' ' 124' ' ' ASP . . . 98.0 -21.81 44.12 Favored Glycine 0 N--CA 1.465 0.613 0 N-CA-C 108.027 -2.029 . . . . 1.0 108.027 -177.291 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 123' ' ' THR . . . . . 0.547 ' O ' ' CE1' ' A' ' 72' ' ' HIS . 58.3 m -46.22 90.61 0.0 OUTLIER 'General case' 0 N--CA 1.476 0.839 0 N-CA-C 105.928 -1.878 . . . . 1.0 105.928 177.832 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 124' ' ' ASP . . . . . 0.621 ' N ' ' O ' ' A' ' 122' ' ' GLY . 51.4 p-10 -162.86 171.1 17.19 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 115.596 -0.729 . . . . 1.0 112.177 -179.343 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 125' ' ' TYR . . . . . . . . . . . . . 86.0 t80 -142.55 141.91 32.11 Favored 'General case' 0 C--N 1.329 -0.315 0 N-CA-C 108.758 -0.831 . . . . 1.0 108.758 176.593 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 126' ' ' ARG . . . . . 0.442 HH22 ' HB ' ' A' ' 79' ' ' ILE . 14.3 mmm180 -147.75 147.87 30.35 Favored 'General case' 0 CA--C 1.533 0.306 0 N-CA-C 109.876 -0.416 . . . . 1.0 109.876 179.218 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 127' ' ' PHE . . . . . . . . . . . . . 23.2 t80 . . . . . 0 N--CA 1.471 0.607 0 CA-C-O 117.995 -1.003 . . . . 1.0 110.824 179.775 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 128' ' ' MTN . . . . . 0.647 ' S1 ' ' H71' ' A' ' 128' ' ' MTN . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 129' ' ' MTN . . . . . 0.59 ' H61' ' S1 ' ' A' ' 129' ' ' MTN . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 130' ' ' MTN . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 2.7 mmt . . . . . 0 N--CA 1.489 1.479 0 N-CA-C 108.838 -0.801 . . . . 1.0 108.838 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . 0.503 ' O ' ' CB ' ' A' ' 3' ' ' ASP . 47.1 t -73.36 4.94 4.07 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.218 -0.446 . . . . 1.0 110.732 179.777 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . 0.503 ' CB ' ' O ' ' A' ' 2' ' ' SER . 12.0 p30 149.22 135.57 0.0 OUTLIER 'General case' 0 N--CA 1.478 0.928 0 O-C-N 123.725 0.64 . . . . 1.0 110.81 179.759 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 87.3 t80 -154.15 149.43 27.07 Favored 'General case' 0 CA--C 1.518 -0.268 0 CA-C-O 121.014 0.435 . . . . 1.0 110.365 178.982 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 5' ' ' ASP . . . . . 0.417 ' HB2' ' N ' ' A' ' 10' ' ' SER . 0.9 OUTLIER -150.78 147.33 27.16 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.133 -0.485 . . . . 1.0 110.055 179.935 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 6' ' ' THR . . . . . 0.731 ' O ' ' N ' ' A' ' 10' ' ' SER . 0.2 OUTLIER -112.21 -162.74 0.81 Allowed 'General case' 0 C--O 1.207 -1.172 0 CA-C-O 121.629 0.728 . . . . 1.0 110.749 -178.639 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . 0.548 ' O ' ' HB2' ' A' ' 11' ' ' ARG . 73.2 mm-40 -54.41 -43.45 71.52 Favored 'General case' 0 C--N 1.304 -1.399 0 CA-C-O 121.984 0.897 . . . . 1.0 108.733 -179.233 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 8' ' ' ARG . . . . . 0.902 ' O ' ' HB3' ' A' ' 12' ' ' ALA . 60.0 mtp180 -72.73 -60.68 2.12 Favored 'General case' 0 C--N 1.313 -0.987 0 C-N-CA 118.095 -1.442 . . . . 1.0 110.487 177.713 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . 1.005 ' O ' ' HB ' ' A' ' 13' ' ' VAL . 10.7 t -60.51 -51.11 76.91 Favored 'Isoleucine or valine' 0 C--O 1.196 -1.761 0 C-N-CA 117.921 -1.512 . . . . 1.0 110.639 179.963 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . 0.731 ' N ' ' O ' ' A' ' 6' ' ' THR . 2.6 t -70.09 -66.25 0.62 Allowed 'General case' 0 C--N 1.303 -1.445 0 O-C-N 121.271 -0.893 . . . . 1.0 113.03 -178.775 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 11' ' ' ARG . . . . . 0.548 ' HB2' ' O ' ' A' ' 7' ' ' GLU . 1.7 mmt85 -62.11 -43.87 97.89 Favored 'General case' 0 C--N 1.318 -0.787 0 CA-C-O 120.455 0.169 . . . . 1.0 111.4 -176.496 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . 0.902 ' HB3' ' O ' ' A' ' 8' ' ' ARG . . . -70.74 -59.7 2.66 Favored 'General case' 0 C--N 1.32 -0.68 0 C-N-CA 118.4 -1.32 . . . . 1.0 110.241 -179.993 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . 1.005 ' HB ' ' O ' ' A' ' 9' ' ' VAL . 4.6 t -57.35 -51.3 71.28 Favored 'Isoleucine or valine' 0 C--O 1.199 -1.605 0 N-CA-C 107.029 -1.471 . . . . 1.0 107.029 179.503 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . 0.954 ' O ' HG22 ' A' ' 18' ' ' VAL . . . -62.06 -66.5 0.53 Allowed 'General case' 0 C--N 1.306 -1.284 0 C-N-CA 115.549 -2.461 . . . . 1.0 113.061 -178.765 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . 0.546 ' HB3' ' O ' ' A' ' 11' ' ' ARG . . . -51.18 -55.27 18.82 Favored 'General case' 0 C--N 1.319 -0.737 0 C-N-CA 119.706 -0.797 . . . . 1.0 109.257 -178.728 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . 0.659 ' HB3' ' O ' ' A' ' 12' ' ' ALA . . . -64.35 -59.17 4.69 Favored 'General case' 0 C--N 1.299 -1.605 0 C-N-CA 118.101 -1.44 . . . . 1.0 111.346 -179.924 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . 0.701 ' CB ' ' O ' ' A' ' 13' ' ' VAL . 6.8 tt -55.09 -55.23 33.36 Favored 'General case' 0 N--CA 1.477 0.876 0 N-CA-C 108.832 -0.803 . . . . 1.0 108.832 -177.051 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . 0.954 HG22 ' O ' ' A' ' 14' ' ' ALA . 2.3 m -71.26 -58.86 4.22 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 CA-C-N 115.895 -0.593 . . . . 1.0 110.212 -179.817 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . 0.558 ' N ' ' CG2' ' A' ' 18' ' ' VAL . . . -58.16 -166.44 0.12 Allowed Glycine 0 CA--C 1.491 -1.454 0 N-CA-C 110.815 -0.914 . . . . 1.0 110.815 -177.322 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 20' ' ' PRO . . . . . 0.607 ' O ' ' N ' ' A' ' 24' ' ' ALA . 1.0 OUTLIER -79.85 -26.18 4.72 Favored 'Trans proline' 0 C--N 1.292 -2.421 0 C-N-CA 122.032 1.822 . . . . 1.0 113.59 -177.657 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . 0.518 ' O ' ' HB3' ' A' ' 24' ' ' ALA . . . -62.68 -58.49 11.97 Favored Glycine 0 N--CA 1.473 1.156 0 C-N-CA 119.496 -1.335 . . . . 1.0 111.877 -178.217 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . 0.644 ' N ' ' O ' ' A' ' 16' ' ' ALA . . . -57.61 -54.15 39.53 Favored Glycine 0 C--N 1.307 -1.068 0 C-N-CA 116.447 -2.787 . . . . 1.0 107.073 -178.778 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . 0.516 ' O ' HG12 ' A' ' 27' ' ' VAL . 54.0 t -52.63 -31.26 15.8 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.042 0 N-CA-C 107.859 -1.163 . . . . 1.0 107.859 178.564 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . 0.607 ' N ' ' O ' ' A' ' 20' ' ' PRO . . . -63.72 -63.9 1.04 Allowed 'General case' 0 C--O 1.218 -0.593 0 C-N-CA 119.416 -0.914 . . . . 1.0 110.969 -179.467 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 61.6 mt -61.64 -46.47 89.63 Favored 'General case' 0 C--N 1.321 -0.64 0 C-N-CA 119.666 -0.814 . . . . 1.0 111.881 -176.571 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 92.1 t -60.35 -60.75 2.1 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.531 0 C-N-CA 119.708 -0.797 . . . . 1.0 110.041 -177.004 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . 0.551 ' O ' ' HB3' ' A' ' 31' ' ' ALA . 2.2 p -54.81 -36.68 38.05 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.736 0 C-N-CA 119.622 -0.831 . . . . 1.0 109.203 -177.819 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . 0.44 ' HB2' ' O ' ' A' ' 24' ' ' ALA . 3.7 tmmm? -66.2 -55.52 15.85 Favored 'General case' 0 C--N 1.315 -0.892 0 C-N-CA 119.254 -0.979 . . . . 1.0 110.713 -177.532 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 82.3 t -62.95 -49.9 81.76 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.973 0 CA-C-N 114.641 -1.163 . . . . 1.0 110.135 -177.517 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 30' ' ' CYS . . . . . . . . . . . . . 4.1 t -65.27 -62.11 1.73 Allowed 'General case' 0 N--CA 1.443 -0.822 0 C-N-CA 119.675 -0.81 . . . . 1.0 109.458 -178.544 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . 0.551 ' HB3' ' O ' ' A' ' 27' ' ' VAL . . . -51.71 -46.44 63.93 Favored 'General case' 0 CA--C 1.5 -0.97 0 CA-C-O 121.282 0.563 . . . . 1.0 110.568 -176.23 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . 0.462 ' O ' ' CB ' ' A' ' 33' ' ' LEU . . . 66.56 67.05 2.13 Favored Glycine 0 N--CA 1.443 -0.896 0 N-CA-C 109.627 -1.389 . . . . 1.0 109.627 -179.998 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . 0.462 ' CB ' ' O ' ' A' ' 32' ' ' GLY . 0.3 OUTLIER 82.88 104.26 0.03 OUTLIER Pre-proline 0 CA--C 1.542 0.644 0 CA-C-N 113.048 -1.576 . . . . 1.0 108.343 -178.622 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 52.2 Cg_exo -48.64 -20.34 2.64 Favored 'Trans proline' 0 N--CA 1.499 1.825 0 C-N-CA 122.504 2.136 . . . . 1.0 114.293 -178.259 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . 0.527 ' CA ' HD12 ' A' ' 112' ' ' ILE . . . -67.54 -62.72 4.16 Favored Glycine 0 N--CA 1.467 0.74 0 C-N-CA 118.357 -1.877 . . . . 1.0 112.27 -176.73 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . 0.75 ' O ' HG22 ' A' ' 37' ' ' ILE . 18.3 m -78.83 -153.88 0.03 OUTLIER 'Isoleucine or valine' 0 C--O 1.216 -0.696 0 N-CA-C 108.121 -1.066 . . . . 1.0 108.121 -179.119 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . 0.75 HG22 ' O ' ' A' ' 36' ' ' VAL . 0.3 OUTLIER 73.63 77.06 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.32 -0.688 0 O-C-N 124.2 0.938 . . . . 1.0 111.553 178.97 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 1.3 t60 -139.32 135.73 34.08 Favored 'General case' 0 CA--C 1.492 -1.278 0 O-C-N 120.906 -1.121 . . . . 1.0 109.329 179.4 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 3.3 m -115.32 132.19 23.2 Favored Pre-proline 0 N--CA 1.451 -0.409 0 C-N-CA 120.413 -0.515 . . . . 1.0 109.984 -178.913 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 23.6 Cg_endo -62.14 -15.21 42.56 Favored 'Trans proline' 0 N--CA 1.494 1.52 0 C-N-CA 122.039 1.826 . . . . 1.0 112.179 179.356 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -128.79 135.11 48.7 Favored 'General case' 0 N--CA 1.468 0.438 0 CA-C-N 116.729 -0.214 . . . . 1.0 110.504 178.399 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . 0.573 ' HG2' ' N ' ' A' ' 43' ' ' ARG . 39.1 ttp180 -173.16 174.25 3.45 Favored 'General case' 0 C--N 1.328 -0.339 0 C-N-CA 120.558 -0.457 . . . . 1.0 111.14 178.718 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 43' ' ' ARG . . . . . 0.573 ' N ' ' HG2' ' A' ' 42' ' ' ARG . 67.1 ttt-85 -57.61 -45.97 84.68 Favored 'General case' 0 CA--C 1.538 0.517 0 N-CA-C 107.697 -1.224 . . . . 1.0 107.697 178.53 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . 0.436 ' O ' ' CD1' ' A' ' 45' ' ' PHE . . . 121.58 -25.03 7.04 Favored Glycine 0 N--CA 1.481 1.675 0 CA-C-N 116.925 -0.125 . . . . 1.0 112.829 179.653 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . 0.815 ' O ' ' HB2' ' A' ' 46' ' ' PHE . 1.5 m-85 -158.58 167.52 29.38 Favored 'General case' 0 C--N 1.306 -1.314 0 N-CA-C 108.23 -1.026 . . . . 1.0 108.23 179.564 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 46' ' ' PHE . . . . . 0.815 ' HB2' ' O ' ' A' ' 45' ' ' PHE . 0.2 OUTLIER 107.45 116.7 0.01 OUTLIER 'General case' 0 N--CA 1.472 0.66 0 O-C-N 125.094 1.496 . . . . 1.0 111.367 179.408 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 47' ' ' ARG . . . . . 0.459 ' CB ' ' O ' ' A' ' 46' ' ' PHE . 9.5 ptt85 90.36 156.5 0.04 OUTLIER 'General case' 0 N--CA 1.479 1.01 0 O-C-N 123.64 0.587 . . . . 1.0 111.405 179.325 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 37.3 t 61.15 68.08 0.76 Allowed 'General case' 0 CA--C 1.509 -0.609 0 CA-C-N 116.151 -0.477 . . . . 1.0 109.851 179.145 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 49' ' ' ASN . . . . . 0.667 ' O ' ' N ' ' A' ' 51' ' ' GLU . 0.2 OUTLIER -149.56 159.14 36.97 Favored Pre-proline 0 C--N 1.315 -0.898 0 CA-C-N 115.869 -0.605 . . . . 1.0 109.381 179.203 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 4.1 Cg_endo -48.87 53.34 0.02 OUTLIER 'Trans proline' 0 N--CA 1.511 2.527 0 C-N-CA 123.981 3.121 . . . . 1.0 113.919 177.544 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . 0.667 ' N ' ' O ' ' A' ' 49' ' ' ASN . 2.7 mm-40 42.56 57.71 3.37 Favored 'General case' 0 CA--C 1.536 0.414 0 CA-C-O 121.246 0.546 . . . . 1.0 111.756 178.038 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . 0.854 HH21 HD12 ' A' ' 85' ' ' ILE . 2.5 ptm180 -156.36 168.83 26.12 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.308 -0.406 . . . . 1.0 111.501 179.225 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . 0.427 HG13 ' N ' ' A' ' 54' ' ' GLN . 7.4 tp -83.44 166.94 2.06 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 N-CA-C 108.612 -0.884 . . . . 1.0 108.612 176.65 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 54' ' ' GLN . . . . . 0.427 ' N ' HG13 ' A' ' 53' ' ' ILE . 35.8 mt-30 -134.72 134.31 40.88 Favored 'General case' 0 N--CA 1.467 0.415 0 O-C-N 121.775 -0.578 . . . . 1.0 109.551 179.419 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . 0.476 HG22 HD11 ' A' ' 85' ' ' ILE . 19.9 tt -144.36 154.06 15.12 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.637 0 N-CA-C 110.139 -0.319 . . . . 1.0 110.139 178.948 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 103.23 4.51 47.29 Favored Glycine 0 N--CA 1.469 0.866 0 N-CA-C 110.178 -1.169 . . . . 1.0 110.178 -179.059 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 29.3 t70 -95.49 114.16 25.89 Favored 'General case' 0 CA--C 1.54 0.589 0 N-CA-C 113.632 0.975 . . . . 1.0 113.632 -178.886 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 58' ' ' TRP . . . . . 0.539 ' HB2' ' HB2' ' A' ' 61' ' ' GLU . 35.4 m95 -83.07 -176.69 6.46 Favored 'General case' 0 C--O 1.236 0.375 0 CA-C-N 112.527 -2.124 . . . . 1.0 109.677 176.15 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 59' ' ' ARG . . . . . 0.584 ' HD2' ' H ' ' A' ' 59' ' ' ARG . 0.0 OUTLIER -94.45 -55.61 3.1 Favored 'General case' 0 CA--C 1.547 0.844 0 CA-C-O 121.545 0.688 . . . . 1.0 110.471 179.566 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 60' ' ' TYR . . . . . 0.544 ' O ' ' CG ' ' A' ' 60' ' ' TYR . 4.7 t80 -73.96 -5.69 42.78 Favored 'General case' 0 N--CA 1.469 0.481 0 C-N-CA 124.338 1.055 . . . . 1.0 110.146 178.317 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . 0.539 ' HB2' ' HB2' ' A' ' 58' ' ' TRP . 4.7 tt0 -68.57 -17.91 64.23 Favored 'General case' 0 C--N 1.312 -1.058 0 O-C-N 121.07 -1.019 . . . . 1.0 111.444 -179.56 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . 0.496 HG23 ' N ' ' A' ' 63' ' ' ALA . 16.1 m -42.01 -49.63 0.93 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.504 0 CA-C-O 121.118 0.485 . . . . 1.0 109.706 -174.42 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 63' ' ' ALA . . . . . 0.496 ' N ' HG23 ' A' ' 62' ' ' VAL . . . -64.23 -45.25 89.0 Favored 'General case' 0 N--CA 1.42 -1.958 0 N-CA-C 108.316 -0.994 . . . . 1.0 108.316 177.039 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 64' ' ' HIS . . . . . 0.529 ' N ' ' O ' ' A' ' 61' ' ' GLU . 0.1 OUTLIER -56.68 -61.3 2.52 Favored 'General case' 0 CA--C 1.537 0.455 0 C-N-CA 118.927 -1.109 . . . . 1.0 111.108 179.803 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . 0.715 ' C ' ' H ' ' A' ' 67' ' ' ARG . 4.6 m-20 -63.19 -48.44 78.32 Favored 'General case' 0 C--O 1.24 0.594 0 CA-C-O 121.526 0.679 . . . . 1.0 109.808 179.139 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -62.2 28.76 0.06 OUTLIER Glycine 0 C--N 1.317 -0.499 0 N-CA-C 110.87 -0.892 . . . . 1.0 110.87 -179.09 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 67' ' ' ARG . . . . . 0.715 ' H ' ' C ' ' A' ' 65' ' ' ASP . 0.0 OUTLIER -82.92 -13.82 55.33 Favored 'General case' 0 N--CA 1.436 -1.153 0 C-N-CA 122.766 0.426 . . . . 1.0 111.558 176.394 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . 0.672 ' O ' ' HA ' ' A' ' 72' ' ' HIS . 0.8 OUTLIER -40.24 -30.11 0.09 Allowed 'General case' 0 C--O 1.22 -0.451 0 N-CA-C 107.009 -1.478 . . . . 1.0 107.009 179.05 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . 0.488 ' N ' ' C ' ' A' ' 67' ' ' ARG . 3.4 tt -65.67 -66.12 0.59 Allowed 'General case' 0 C--N 1.311 -1.071 0 C-N-CA 117.39 -1.724 . . . . 1.0 108.267 177.877 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . 0.697 ' C ' ' H ' ' A' ' 72' ' ' HIS . . . -76.32 -74.45 0.23 Allowed 'General case' 0 N--CA 1.466 0.346 0 N-CA-C 108.895 -0.78 . . . . 1.0 108.895 -179.753 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . 0.695 ' HB1' ' HB ' ' A' ' 74' ' ' VAL . . . -58.0 13.51 0.01 OUTLIER 'General case' 0 C--N 1.321 -0.65 0 C-N-CA 124.25 1.02 . . . . 1.0 110.851 -178.163 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 72' ' ' HIS . . . . . 0.697 ' H ' ' C ' ' A' ' 70' ' ' ALA . 0.3 OUTLIER -12.07 -74.53 0.01 OUTLIER 'General case' 0 N--CA 1.478 0.959 0 C-N-CA 124.295 1.038 . . . . 1.0 113.113 -174.654 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 73' ' ' MET . . . . . . . . . . . . . 1.4 mpt? -62.63 -41.91 99.29 Favored 'General case' 0 C--N 1.285 -2.216 0 C-N-CA 119.164 -1.014 . . . . 1.0 111.565 -178.431 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . 0.695 ' HB ' ' HB1' ' A' ' 71' ' ' ALA . 41.4 t -44.27 -49.3 2.12 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.346 0 C-N-CA 119.864 -0.734 . . . . 1.0 110.103 -175.515 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 75' ' ' ASN . . . . . 0.498 ' O ' ' N ' ' A' ' 77' ' ' ILE . 14.0 t-20 -39.52 -21.57 0.01 OUTLIER 'General case' 0 N--CA 1.472 0.664 0 CA-C-O 122.787 1.279 . . . . 1.0 111.441 -179.815 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . 0.569 ' N ' ' O ' ' A' ' 74' ' ' VAL . . . -43.87 -19.5 0.11 Allowed Glycine 0 CA--C 1.539 1.585 0 CA-C-N 113.662 -1.608 . . . . 1.0 109.827 178.674 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . 0.655 ' O ' ' N ' ' A' ' 80' ' ' ALA . 10.3 pt -88.17 -47.0 15.72 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.45 0 N-CA-C 108.386 -0.968 . . . . 1.0 108.386 -178.674 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . 0.524 ' O ' ' HB3' ' A' ' 82' ' ' ASP . 21.6 t -37.74 -35.7 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.433 -1.3 0 N-CA-C 108.14 -1.059 . . . . 1.0 108.14 -177.165 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . 0.551 ' O ' ' HB3' ' A' ' 83' ' ' ALA . 0.3 OUTLIER -87.07 -24.48 6.39 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.34 0 CA-C-O 121.03 0.443 . . . . 1.0 111.083 179.577 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 80' ' ' ALA . . . . . 0.655 ' N ' ' O ' ' A' ' 77' ' ' ILE . . . -73.29 -10.48 59.8 Favored 'General case' 0 C--N 1.319 -0.737 0 O-C-N 122.21 -0.306 . . . . 1.0 111.809 179.119 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 71.8 mt-10 -120.99 -62.79 1.41 Allowed 'General case' 0 CA--C 1.531 0.247 0 CA-C-O 121.705 0.764 . . . . 1.0 111.133 176.953 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 82' ' ' ASP . . . . . 0.839 ' O ' HG13 ' A' ' 85' ' ' ILE . 0.0 OUTLIER -58.73 -62.83 1.58 Allowed 'General case' 0 C--O 1.202 -1.401 0 CA-C-N 114.939 -1.028 . . . . 1.0 109.561 -179.54 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . 0.551 ' HB3' ' O ' ' A' ' 79' ' ' ILE . . . -56.63 -38.08 71.63 Favored 'General case' 0 CA--C 1.506 -0.718 0 C-N-CA 119.803 -0.759 . . . . 1.0 110.14 -176.087 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . 0.713 HD13 ' O ' ' A' ' 84' ' ' LEU . 3.4 tm? -32.01 -35.32 0.02 OUTLIER 'General case' 0 CA--C 1.51 -0.564 0 CA-C-N 115.525 -0.762 . . . . 1.0 111.839 -174.647 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 85' ' ' ILE . . . . . 0.854 HD12 HH21 ' A' ' 52' ' ' ARG . 4.7 mt -43.96 -17.83 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.323 -0.544 0 C-N-CA 120.492 -0.483 . . . . 1.0 110.205 179.622 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . 0.674 ' O ' ' N ' ' A' ' 90' ' ' GLY . . . -60.61 -58.46 8.37 Favored 'General case' 0 C--O 1.221 -0.446 0 C-N-CA 119.898 -0.721 . . . . 1.0 109.768 179.852 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . 0.444 ' OE1' ' N ' ' A' ' 87' ' ' GLU . 0.2 OUTLIER -35.64 -24.15 0.01 OUTLIER 'General case' 0 N--CA 1.468 0.468 0 CA-C-O 121.023 0.44 . . . . 1.0 110.663 -177.981 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . 0.621 ' N ' ' O ' ' A' ' 86' ' ' ALA . . . -101.31 -43.46 5.95 Favored 'General case' 0 C--O 1.237 0.444 0 N-CA-C 109.099 -0.704 . . . . 1.0 109.099 177.324 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 89' ' ' VAL . . . . . 0.634 ' C ' ' HD2' ' A' ' 91' ' ' PRO . 3.0 t -100.19 38.26 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.34 0.186 0 N-CA-C 108.775 -0.824 . . . . 1.0 108.775 178.01 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 90' ' ' GLY . . . . . 0.889 ' O ' ' N ' ' A' ' 92' ' ' HIS . . . -62.08 -17.59 55.78 Favored Glycine 0 C--N 1.358 1.801 0 CA-C-O 117.553 -1.693 . . . . 1.0 111.92 177.83 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 91' ' ' PRO . . . . . 0.783 ' HD2' ' N ' ' A' ' 90' ' ' GLY . 75.3 Cg_exo -32.62 1.01 0.0 OUTLIER 'Trans proline' 0 N--CA 1.513 2.659 0 C-N-CA 124.382 3.388 . . . . 1.0 113.694 171.811 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 92' ' ' HIS . . . . . 0.889 ' N ' ' O ' ' A' ' 90' ' ' GLY . 42.1 t-80 -49.88 -30.11 9.43 Favored 'General case' 0 N--CA 1.427 -1.591 0 N-CA-C 108.357 -0.979 . . . . 1.0 108.357 176.479 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . 0.672 ' O ' ' N ' ' A' ' 96' ' ' ALA . 0.8 OUTLIER -61.17 -60.64 3.45 Favored 'General case' 0 C--O 1.222 -0.367 0 N-CA-C 107.358 -1.349 . . . . 1.0 107.358 177.684 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 94' ' ' ALA . . . . . 0.607 ' HB3' HH21 ' A' ' 95' ' ' ARG . . . -45.75 -51.18 13.01 Favored 'General case' 0 N--CA 1.437 -1.104 0 N-CA-C 108.064 -1.087 . . . . 1.0 108.064 -179.193 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 95' ' ' ARG . . . . . 0.607 HH21 ' HB3' ' A' ' 94' ' ' ALA . 0.0 OUTLIER -60.21 -25.27 65.48 Favored 'General case' 0 N--CA 1.434 -1.226 0 C-N-CA 120.013 -0.675 . . . . 1.0 109.334 176.494 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 96' ' ' ALA . . . . . 0.759 ' O ' ' N ' ' A' ' 100' ' ' ILE . . . -57.05 -52.1 66.61 Favored 'General case' 0 C--O 1.207 -1.135 0 N-CA-C 107.227 -1.397 . . . . 1.0 107.227 179.511 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . 0.705 ' O ' HG22 ' A' ' 100' ' ' ILE . 0.1 OUTLIER -35.55 -29.16 0.01 OUTLIER 'General case' 0 CA--C 1.567 1.63 0 N-CA-C 107.238 -1.393 . . . . 1.0 107.238 -179.716 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 98' ' ' GLY . . . . . 0.611 ' N ' ' O ' ' A' ' 96' ' ' ALA . . . -81.51 -52.9 4.01 Favored Glycine 0 CA--C 1.551 2.309 0 CA-C-O 123.083 1.379 . . . . 1.0 110.831 174.422 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 99' ' ' GLN . . . . . 0.612 ' N ' ' O ' ' A' ' 96' ' ' ALA . 27.0 mt-30 -79.19 7.66 7.24 Favored 'General case' 0 N--CA 1.438 -1.028 0 N-CA-C 108.548 -0.908 . . . . 1.0 108.548 178.366 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 100' ' ' ILE . . . . . 0.759 ' N ' ' O ' ' A' ' 96' ' ' ALA . 16.7 tt -60.39 -51.25 75.2 Favored 'Isoleucine or valine' 0 CA--C 1.493 -1.233 0 N-CA-C 108.71 -0.848 . . . . 1.0 108.71 179.826 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 101' ' ' VAL . . . . . 0.674 ' N ' HG23 ' A' ' 100' ' ' ILE . 24.1 t -55.05 -57.12 7.87 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.977 0 C-N-CA 117.083 -1.847 . . . . 1.0 107.058 178.058 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 102' ' ' CYS . . . . . 0.786 ' O ' ' HB2' ' A' ' 106' ' ' ALA . 4.9 t -44.47 -25.63 0.28 Allowed 'General case' 0 C--O 1.214 -0.791 0 C-N-CA 120.085 -0.646 . . . . 1.0 109.854 -178.944 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 103' ' ' ARG . . . . . 0.426 ' N ' ' C ' ' A' ' 101' ' ' VAL . 1.7 tpp85 -87.19 -45.06 11.0 Favored 'General case' 0 N--CA 1.476 0.862 0 N-CA-C 113.444 0.905 . . . . 1.0 113.444 179.459 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 104' ' ' TYR . . . . . 0.747 ' O ' ' CG ' ' A' ' 104' ' ' TYR . 3.0 t80 -99.19 19.63 14.98 Favored 'General case' 0 C--N 1.31 -1.121 0 C-N-CA 127.066 2.146 . . . . 1.0 110.137 -179.623 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 105' ' ' GLY . . . . . 0.869 ' O ' HG23 ' A' ' 107' ' ' THR . . . -164.27 -7.79 0.03 OUTLIER Glycine 0 N--CA 1.441 -0.975 0 C-N-CA 117.891 -2.1 . . . . 1.0 111.588 177.337 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 106' ' ' ALA . . . . . 0.786 ' HB2' ' O ' ' A' ' 102' ' ' CYS . . . -15.53 62.7 0.0 OUTLIER 'General case' 0 N--CA 1.471 0.6 0 O-C-N 125.147 1.145 . . . . 1.0 111.997 -179.034 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 107' ' ' THR . . . . . 0.869 HG23 ' O ' ' A' ' 105' ' ' GLY . 11.4 p -100.38 -2.81 32.47 Favored 'General case' 0 CA--C 1.534 0.339 0 CA-C-N 116.265 -0.425 . . . . 1.0 110.119 -179.425 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . 0.732 HG13 ' N ' ' A' ' 109' ' ' ILE . 8.1 p -84.72 -57.84 4.03 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.427 0 CA-C-N 116.389 -0.369 . . . . 1.0 111.057 -178.194 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 109' ' ' ILE . . . . . 0.732 ' N ' HG13 ' A' ' 108' ' ' VAL . 0.2 OUTLIER -47.22 -47.76 56.03 Favored Pre-proline 0 CA--C 1.503 -0.842 0 C-N-CA 122.756 0.422 . . . . 1.0 111.852 179.458 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 110' ' ' PRO . . . . . 0.618 ' HD2' ' N ' ' A' ' 109' ' ' ILE . 6.0 Cg_endo -40.65 -39.84 3.15 Favored 'Trans proline' 0 CA--C 1.507 -0.85 0 C-N-CA 121.025 1.15 . . . . 1.0 114.081 -172.414 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 19.6 m-20 -65.09 -68.0 0.39 Allowed 'General case' 0 C--N 1.305 -1.33 0 C-N-CA 119.047 -1.061 . . . . 1.0 110.475 -176.967 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 112' ' ' ILE . . . . . 0.527 HD12 ' CA ' ' A' ' 35' ' ' GLY . 0.0 OUTLIER -69.21 -25.48 29.65 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.788 0 CA-C-N 115.498 -0.773 . . . . 1.0 110.594 -178.012 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 113' ' ' ASN . . . . . 0.485 ' CB ' ' O ' ' A' ' 109' ' ' ILE . 7.0 t30 -54.65 -61.83 2.05 Favored 'General case' 0 CA--C 1.488 -1.438 0 CA-C-N 114.268 -1.333 . . . . 1.0 110.854 -174.882 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -65.12 -20.46 66.47 Favored 'General case' 0 N--CA 1.432 -1.35 0 O-C-N 124.233 0.958 . . . . 1.0 110.255 -179.723 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -75.33 -61.78 1.79 Allowed 'General case' 0 C--O 1.241 0.624 0 C-N-CA 120.255 -0.578 . . . . 1.0 112.078 178.86 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 116' ' ' ILE . . . . . 0.484 ' O ' ' CB ' ' A' ' 119' ' ' LEU . 26.5 pt -68.52 -40.92 82.72 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.498 0 O-C-N 121.079 -1.013 . . . . 1.0 111.589 -177.895 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 117' ' ' GLU . . . . . 0.471 ' C ' ' N ' ' A' ' 119' ' ' LEU . 2.6 tt0 -47.21 -66.2 0.44 Allowed 'General case' 0 C--N 1.317 -0.823 0 CA-C-N 115.42 -0.809 . . . . 1.0 110.432 -177.18 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 72.0 t -50.11 -14.58 0.26 Allowed 'Isoleucine or valine' 0 N--CA 1.437 -1.121 0 O-C-N 124.572 1.17 . . . . 1.0 109.332 -178.822 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 119' ' ' LEU . . . . . 0.484 ' CB ' ' O ' ' A' ' 116' ' ' ILE . 0.2 OUTLIER -79.04 -62.6 1.64 Allowed 'General case' 0 N--CA 1.451 -0.413 0 C-N-CA 119.316 -0.954 . . . . 1.0 109.514 176.345 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -70.18 -84.98 0.16 Allowed Glycine 0 N--CA 1.481 1.689 0 C-N-CA 117.53 -2.271 . . . . 1.0 112.052 -179.139 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 34.0 m -161.8 -19.73 0.05 OUTLIER 'General case' 0 CA--C 1.542 0.651 0 CA-C-O 120.769 0.319 . . . . 1.0 110.231 -179.139 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 122' ' ' GLY . . . . . 0.481 ' O ' ' N ' ' A' ' 124' ' ' ASP . . . 111.59 -36.13 4.35 Favored Glycine 0 N--CA 1.477 1.387 0 C-N-CA 125.202 1.382 . . . . 1.0 112.138 179.752 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 123' ' ' THR . . . . . 0.464 ' C ' ' O ' ' A' ' 122' ' ' GLY . 0.0 OUTLIER -32.09 93.21 0.01 OUTLIER 'General case' 0 N--CA 1.469 0.523 0 CA-C-N 118.867 1.333 . . . . 1.0 112.461 -177.888 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 124' ' ' ASP . . . . . 0.481 ' N ' ' O ' ' A' ' 122' ' ' GLY . 8.7 t70 -141.49 141.6 33.62 Favored 'General case' 0 C--N 1.328 -0.352 0 N-CA-C 107.425 -1.324 . . . . 1.0 107.425 177.452 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 125' ' ' TYR . . . . . . . . . . . . . 9.7 t80 -153.58 147.24 25.16 Favored 'General case' 0 C--N 1.324 -0.532 0 N-CA-C 109.692 -0.484 . . . . 1.0 109.692 -177.569 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 126' ' ' ARG . . . . . 0.4 ' CB ' ' H62' ' A' ' 130' ' ' MTN . 9.0 mmp_? -147.5 152.08 37.43 Favored 'General case' 0 CA--C 1.542 0.646 0 CA-C-N 115.532 -0.758 . . . . 1.0 110.777 177.281 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 127' ' ' PHE . . . . . . . . . . . . . 22.6 p90 . . . . . 0 N--CA 1.47 0.574 0 CA-C-O 118.275 -0.869 . . . . 1.0 110.253 179.608 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 128' ' ' MTN . . . . . 0.411 ' H91' ' HD3' ' A' ' 47' ' ' ARG . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 129' ' ' MTN . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 130' ' ' MTN . . . . . 0.628 ' S1 ' ' O ' ' A' ' 102' ' ' CYS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 64.6 mtt . . . . . 0 N--CA 1.491 1.577 0 N-CA-C 109.332 -0.618 . . . . 1.0 109.332 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 88.9 p -103.63 7.7 37.51 Favored 'General case' 0 N--CA 1.467 0.398 0 CA-C-N 116.097 -0.501 . . . . 1.0 110.751 -179.723 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . 0.459 ' N ' ' OD1' ' A' ' 3' ' ' ASP . 1.6 p30 167.42 99.87 0.0 OUTLIER 'General case' 0 N--CA 1.466 0.342 0 CA-C-N 116.109 -0.496 . . . . 1.0 110.42 179.096 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 16.6 t80 -150.21 145.82 26.47 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.219 -0.446 . . . . 1.0 110.059 179.329 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 5' ' ' ASP . . . . . 0.615 ' OD1' ' N ' ' A' ' 10' ' ' SER . 0.3 OUTLIER -157.21 153.42 27.58 Favored 'General case' 0 C--N 1.327 -0.377 0 N-CA-C 109.887 -0.412 . . . . 1.0 109.887 179.674 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 6' ' ' THR . . . . . 0.657 ' O ' ' N ' ' A' ' 10' ' ' SER . 0.2 OUTLIER -75.01 175.74 7.87 Favored 'General case' 0 C--O 1.212 -0.872 0 CA-C-N 116.112 -0.495 . . . . 1.0 111.802 -178.123 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . 0.504 ' O ' ' N ' ' A' ' 11' ' ' ARG . 0.5 OUTLIER -58.7 -56.21 25.19 Favored 'General case' 0 N--CA 1.478 0.974 0 CA-C-N 115.72 -0.673 . . . . 1.0 109.863 -178.781 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 8' ' ' ARG . . . . . 0.725 ' O ' ' HB3' ' A' ' 12' ' ' ALA . 0.0 OUTLIER -49.39 -54.77 15.67 Favored 'General case' 0 C--N 1.318 -0.794 0 N-CA-C 106.349 -1.723 . . . . 1.0 106.349 -178.034 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . 0.792 ' O ' ' HB ' ' A' ' 13' ' ' VAL . 1.3 t -63.74 -46.46 94.49 Favored 'Isoleucine or valine' 0 C--O 1.193 -1.914 0 CA-C-N 111.834 -2.439 . . . . 1.0 109.165 -179.705 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . 0.657 ' N ' ' O ' ' A' ' 6' ' ' THR . 6.6 t -69.67 -63.32 1.1 Allowed 'General case' 0 N--CA 1.487 1.405 0 N-CA-C 112.648 0.61 . . . . 1.0 112.648 -178.279 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 11' ' ' ARG . . . . . 0.519 ' O ' ' N ' ' A' ' 15' ' ' ALA . 3.6 mmt85 -64.07 -55.39 22.42 Favored 'General case' 0 N--CA 1.478 0.963 0 CA-C-O 121.119 0.485 . . . . 1.0 110.866 -176.402 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . 0.725 ' HB3' ' O ' ' A' ' 8' ' ' ARG . . . -51.24 -50.73 58.61 Favored 'General case' 0 C--N 1.314 -0.953 0 N-CA-C 106.363 -1.717 . . . . 1.0 106.363 -178.756 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . 0.792 ' HB ' ' O ' ' A' ' 9' ' ' VAL . 8.1 t -60.62 -52.26 63.54 Favored 'Isoleucine or valine' 0 C--O 1.197 -1.662 0 C-N-CA 119.419 -0.912 . . . . 1.0 109.184 176.823 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . 0.651 ' O ' HG13 ' A' ' 18' ' ' VAL . . . -58.24 -62.13 2.06 Favored 'General case' 0 C--O 1.21 -1.019 0 C-N-CA 118.682 -1.207 . . . . 1.0 110.185 -179.352 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . 0.563 ' O ' ' N ' ' A' ' 19' ' ' GLY . . . -52.25 -55.64 19.98 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-O 121.918 0.866 . . . . 1.0 109.943 -178.245 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . 0.553 ' CA ' ' H ' ' A' ' 22' ' ' GLY . . . -61.27 -54.76 39.94 Favored 'General case' 0 C--N 1.311 -1.101 0 CA-C-N 114.413 -1.267 . . . . 1.0 109.097 -179.269 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . 0.578 ' CB ' ' O ' ' A' ' 13' ' ' VAL . 7.0 tt -57.79 -53.7 55.24 Favored 'General case' 0 N--CA 1.482 1.153 0 CA-C-N 114.001 -1.454 . . . . 1.0 109.294 -177.693 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . 0.651 HG13 ' O ' ' A' ' 14' ' ' ALA . 2.6 m -68.98 -56.67 11.17 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.501 0 C-N-CA 119.268 -0.973 . . . . 1.0 109.274 178.978 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . 0.563 ' N ' ' O ' ' A' ' 15' ' ' ALA . . . -66.74 -160.59 1.0 Allowed Glycine 0 CA--C 1.534 1.248 0 CA-C-N 116.771 -0.195 . . . . 1.0 113.162 -178.037 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 20' ' ' PRO . . . . . 0.588 ' O ' ' HB2' ' A' ' 24' ' ' ALA . 90.8 Cg_endo -79.87 -30.02 2.49 Favored 'Trans proline' 0 N--CA 1.502 2.026 0 C-N-CA 123.476 2.784 . . . . 1.0 115.117 -177.42 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -60.15 -58.21 15.21 Favored Glycine 0 N--CA 1.478 1.437 0 C-N-CA 119.864 -1.16 . . . . 1.0 112.458 -176.296 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . 0.553 ' H ' ' CA ' ' A' ' 16' ' ' ALA . . . -59.16 -56.26 26.21 Favored Glycine 0 C--N 1.312 -0.757 0 N-CA-C 108.403 -1.879 . . . . 1.0 108.403 -177.243 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . 0.462 HG22 ' O ' ' A' ' 19' ' ' GLY . 34.6 m -59.77 -34.39 55.46 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.84 0 C-N-CA 120.109 -0.636 . . . . 1.0 109.713 -179.489 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . 0.588 ' HB2' ' O ' ' A' ' 20' ' ' PRO . . . -57.38 -61.52 2.43 Favored 'General case' 0 CA--C 1.534 0.337 0 C-N-CA 118.078 -1.449 . . . . 1.0 109.011 179.884 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 5.2 mp -63.85 -44.18 93.91 Favored 'General case' 0 C--N 1.347 0.465 0 C-N-CA 120.24 -0.584 . . . . 1.0 112.19 -178.598 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 73.8 t -60.87 -59.59 3.99 Favored 'Isoleucine or valine' 0 CA--C 1.527 0.083 0 C-N-CA 118.776 -1.169 . . . . 1.0 109.793 -177.991 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . 0.651 ' O ' ' HB3' ' A' ' 31' ' ' ALA . 83.9 t -59.97 -39.16 79.43 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.212 0 N-CA-C 112.19 0.441 . . . . 1.0 112.19 -178.429 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 27.5 tttm -65.94 -54.42 26.59 Favored 'General case' 0 C--N 1.319 -0.739 0 N-CA-C 108.941 -0.763 . . . . 1.0 108.941 -179.223 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 59.5 t -63.98 -48.44 86.05 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.825 0 CA-C-N 114.599 -1.182 . . . . 1.0 110.587 -177.892 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 30' ' ' CYS . . . . . . . . . . . . . 20.0 t -65.16 -61.23 2.26 Favored 'General case' 0 N--CA 1.446 -0.664 0 C-N-CA 119.245 -0.982 . . . . 1.0 109.566 -179.51 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . 0.651 ' HB3' ' O ' ' A' ' 27' ' ' VAL . . . -65.18 -53.2 48.49 Favored 'General case' 0 N--CA 1.453 -0.309 0 N-CA-C 113.487 0.921 . . . . 1.0 113.487 -176.24 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 84.6 77.89 1.15 Allowed Glycine 0 CA--C 1.527 0.822 0 C-N-CA 120.338 -0.934 . . . . 1.0 111.474 -179.76 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . 0.445 ' O ' ' N ' ' A' ' 35' ' ' GLY . 10.0 mp 69.89 101.37 0.04 OUTLIER Pre-proline 0 CA--C 1.548 0.88 0 C-N-CA 123.207 0.603 . . . . 1.0 110.25 -179.131 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 1.1 Cg_endo -45.26 -10.13 0.04 OUTLIER 'Trans proline' 0 N--CA 1.501 1.944 0 C-N-CA 122.109 1.872 . . . . 1.0 114.818 -179.247 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . 0.445 ' N ' ' O ' ' A' ' 33' ' ' LEU . . . -60.82 -59.76 9.62 Favored Glycine 0 N--CA 1.468 0.823 0 C-N-CA 118.223 -1.941 . . . . 1.0 110.088 -178.037 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . 0.884 HG22 ' H ' ' A' ' 37' ' ' ILE . 9.4 p -83.87 -146.58 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.465 0.324 0 N-CA-C 109.303 -0.629 . . . . 1.0 109.303 -179.945 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . 0.884 ' H ' HG22 ' A' ' 36' ' ' VAL . 2.2 mp 73.71 76.8 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.474 0.727 0 CA-C-N 117.949 0.341 . . . . 1.0 111.578 -179.551 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 98.9 m-70 -134.94 127.2 30.15 Favored 'General case' 0 N--CA 1.451 -0.385 0 N-CA-C 106.902 -1.518 . . . . 1.0 106.902 177.777 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 27.7 p -109.1 146.55 34.09 Favored Pre-proline 0 C--N 1.328 -0.349 0 N-CA-C 109.631 -0.507 . . . . 1.0 109.631 -179.037 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 51.0 Cg_endo -66.0 -24.94 52.23 Favored 'Trans proline' 0 C--N 1.306 -1.659 0 C-N-CA 121.502 1.468 . . . . 1.0 112.819 -178.854 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -126.81 130.15 49.69 Favored 'General case' 0 CA--C 1.516 -0.349 0 N-CA-C 109.567 -0.531 . . . . 1.0 109.567 178.921 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . 0.67 ' C ' ' H ' ' A' ' 44' ' ' GLY . 4.0 tmm_? -159.27 156.05 28.04 Favored 'General case' 0 C--N 1.318 -0.781 0 C-N-CA 119.908 -0.717 . . . . 1.0 109.175 178.05 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 43' ' ' ARG . . . . . 0.409 ' C ' ' H ' ' A' ' 45' ' ' PHE . 0.2 OUTLIER -62.97 17.95 0.01 OUTLIER 'General case' 0 C--N 1.32 -0.7 0 CA-C-N 115.963 -0.562 . . . . 1.0 110.147 179.204 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . 0.67 ' H ' ' C ' ' A' ' 42' ' ' ARG . . . 76.59 -27.19 1.58 Allowed Glycine 0 C--N 1.337 0.617 0 N-CA-C 111.306 -0.718 . . . . 1.0 111.306 179.389 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . 0.564 ' N ' ' CD1' ' A' ' 45' ' ' PHE . 0.1 OUTLIER -155.59 156.58 35.33 Favored 'General case' 0 CA--C 1.548 0.868 0 N-CA-C 109.795 -0.446 . . . . 1.0 109.795 -179.684 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 46' ' ' PHE . . . . . 0.613 ' O ' ' HB2' ' A' ' 47' ' ' ARG . 0.5 OUTLIER 139.66 85.36 0.0 OUTLIER 'General case' 0 N--CA 1.5 2.068 0 C-N-CA 126.23 1.812 . . . . 1.0 109.05 179.251 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 47' ' ' ARG . . . . . 0.917 HH12 ' H91' ' A' ' 128' ' ' MTN . 2.5 mtm-85 131.89 138.24 0.0 OUTLIER 'General case' 0 N--CA 1.505 2.294 0 C-N-CA 125.189 1.396 . . . . 1.0 109.989 178.528 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 48' ' ' CYS . . . . . 0.853 ' O ' ' H83' ' A' ' 129' ' ' MTN . 0.0 OUTLIER 75.5 70.66 0.08 Allowed 'General case' 0 C--O 1.219 -0.531 0 N-CA-C 108.988 -0.745 . . . . 1.0 108.988 179.662 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 49' ' ' ASN . . . . . 0.649 ' O ' ' N ' ' A' ' 51' ' ' GLU . 1.2 p-10 -143.32 116.09 5.95 Favored Pre-proline 0 C--N 1.327 -0.407 0 N-CA-C 107.988 -1.116 . . . . 1.0 107.988 -179.733 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 74.7 Cg_exo -47.42 63.52 0.01 OUTLIER 'Trans proline' 0 N--CA 1.509 2.399 0 C-N-CA 122.688 2.258 . . . . 1.0 114.788 -178.801 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . 0.649 ' N ' ' O ' ' A' ' 49' ' ' ASN . 17.1 mp0 62.02 28.49 17.26 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.463 -0.335 . . . . 1.0 111.064 -179.644 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -102.71 134.34 46.25 Favored 'General case' 0 CA--C 1.516 -0.329 0 N-CA-C 109.206 -0.664 . . . . 1.0 109.206 178.55 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . 0.419 ' O ' ' N ' ' A' ' 55' ' ' ILE . 13.0 tt -57.92 138.58 18.68 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.374 0 CA-C-O 122.273 1.035 . . . . 1.0 112.066 -178.056 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 54' ' ' GLN . . . . . 0.544 ' OE1' ' CE2' ' A' ' 46' ' ' PHE . 0.0 OUTLIER -65.98 80.62 0.08 Allowed 'General case' 0 C--N 1.318 -0.794 0 CA-C-N 113.75 -1.568 . . . . 1.0 108.067 -179.761 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . 0.427 ' CG2' ' N ' ' A' ' 56' ' ' GLY . 11.7 mt -149.12 158.06 6.54 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.657 0 CA-C-N 115.864 -0.607 . . . . 1.0 109.835 178.694 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . 0.427 ' N ' ' CG2' ' A' ' 55' ' ' ILE . . . 111.62 -2.14 27.65 Favored Glycine 0 N--CA 1.468 0.817 0 N-CA-C 110.205 -1.158 . . . . 1.0 110.205 -179.865 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . 0.464 ' OD1' ' CG ' ' A' ' 45' ' ' PHE . 36.3 m-20 -79.19 97.95 6.41 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 115.234 -0.483 . . . . 1.0 110.533 179.533 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 58' ' ' TRP . . . . . . . . . . . . . 6.5 m0 -87.99 172.27 9.69 Favored 'General case' 0 CA--C 1.539 0.525 0 CA-C-O 123.0 1.381 . . . . 1.0 112.58 -177.956 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 59' ' ' ARG . . . . . 0.677 ' H ' ' CD ' ' A' ' 59' ' ' ARG . 0.0 OUTLIER -82.49 -60.43 2.2 Favored 'General case' 0 C--N 1.311 -1.097 0 CA-C-N 111.622 -2.535 . . . . 1.0 112.839 -179.31 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 44.8 t80 -91.69 -14.04 30.71 Favored 'General case' 0 C--N 1.317 -0.824 0 N-CA-C 113.777 1.028 . . . . 1.0 113.777 -179.118 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 4.6 tt0 -80.18 -14.61 58.32 Favored 'General case' 0 C--O 1.214 -0.804 0 O-C-N 121.709 -0.619 . . . . 1.0 110.592 -179.493 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . 0.637 ' O ' ' N ' ' A' ' 66' ' ' GLY . 28.9 m -46.46 -54.25 2.24 Favored 'Isoleucine or valine' 0 C--O 1.212 -0.92 0 C-N-CA 119.268 -0.973 . . . . 1.0 110.46 -175.715 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 63' ' ' ALA . . . . . 0.567 ' N ' HG23 ' A' ' 62' ' ' VAL . . . -67.42 -48.39 67.44 Favored 'General case' 0 C--N 1.303 -1.428 0 O-C-N 121.402 -0.811 . . . . 1.0 108.962 179.824 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 11.0 t-80 -51.56 -58.09 7.28 Favored 'General case' 0 CA--C 1.541 0.627 0 C-N-CA 119.463 -0.895 . . . . 1.0 109.419 -179.649 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . 0.592 ' C ' ' H ' ' A' ' 67' ' ' ARG . 22.8 m-20 -75.38 -52.03 11.74 Favored 'General case' 0 C--O 1.245 0.826 0 CA-C-N 115.733 -0.667 . . . . 1.0 111.24 178.837 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . 0.637 ' N ' ' O ' ' A' ' 62' ' ' VAL . . . -71.76 25.97 0.63 Allowed Glycine 0 CA--C 1.522 0.483 0 O-C-N 120.345 -1.472 . . . . 1.0 110.337 177.423 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 67' ' ' ARG . . . . . 0.671 ' O ' ' N ' ' A' ' 69' ' ' LEU . 0.6 OUTLIER -71.71 7.2 1.58 Allowed 'General case' 0 CA--C 1.507 -0.687 0 N-CA-C 106.197 -1.779 . . . . 1.0 106.197 174.47 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . 0.588 ' H ' ' C ' ' A' ' 66' ' ' GLY . 3.1 mt -30.48 -30.11 0.01 OUTLIER 'General case' 0 N--CA 1.472 0.669 0 O-C-N 124.045 0.84 . . . . 1.0 108.767 -177.653 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . 0.671 ' N ' ' O ' ' A' ' 67' ' ' ARG . 10.9 mp -62.35 -66.15 0.58 Allowed 'General case' 0 N--CA 1.476 0.842 0 C-N-CA 119.296 -0.961 . . . . 1.0 109.016 178.401 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . 0.627 ' C ' ' H ' ' A' ' 72' ' ' HIS . . . -79.49 -75.63 0.24 Allowed 'General case' 0 N--CA 1.476 0.835 0 N-CA-C 107.36 -1.348 . . . . 1.0 107.36 178.051 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . 0.474 ' HB3' ' CB ' ' A' ' 67' ' ' ARG . . . -46.44 5.87 0.0 OUTLIER 'General case' 0 CA--C 1.536 0.409 0 C-N-CA 124.837 1.255 . . . . 1.0 113.539 177.671 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 72' ' ' HIS . . . . . 0.627 ' H ' ' C ' ' A' ' 70' ' ' ALA . 1.1 t-80 -28.69 -68.17 0.07 Allowed 'General case' 0 N--CA 1.467 0.414 0 C-N-CA 122.827 0.451 . . . . 1.0 111.788 -179.449 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 73' ' ' MET . . . . . 0.549 ' N ' ' SD ' ' A' ' 73' ' ' MET . 0.0 OUTLIER -66.83 -47.58 71.58 Favored 'General case' 0 C--N 1.329 -0.325 0 C-N-CA 118.263 -1.375 . . . . 1.0 109.133 178.966 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . 0.793 ' O ' ' N ' ' A' ' 76' ' ' GLY . 72.9 t -42.2 -41.17 0.91 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.26 0 CA-C-O 117.621 -1.18 . . . . 1.0 111.524 -176.089 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 75' ' ' ASN . . . . . 0.596 ' ND2' HG21 ' A' ' 78' ' ' VAL . 3.0 t-20 -33.63 -12.22 0.0 OUTLIER 'General case' 0 N--CA 1.498 1.947 0 CA-C-N 120.175 1.352 . . . . 1.0 112.315 179.25 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . 0.793 ' N ' ' O ' ' A' ' 74' ' ' VAL . . . -48.86 -22.67 3.04 Favored Glycine 0 CA--C 1.542 1.736 0 N-CA-C 108.455 -1.858 . . . . 1.0 108.455 174.629 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . 0.667 ' O ' ' N ' ' A' ' 80' ' ' ALA . 0.9 OUTLIER -75.54 -59.86 2.88 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.588 0 N-CA-C 108.068 -1.086 . . . . 1.0 108.068 178.36 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . 0.596 HG21 ' ND2' ' A' ' 75' ' ' ASN . 75.6 t -34.39 -31.18 0.02 OUTLIER 'Isoleucine or valine' 0 CA--C 1.547 0.828 0 CA-C-N 113.532 -1.667 . . . . 1.0 107.947 -176.207 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . 0.665 ' O ' ' HB2' ' A' ' 83' ' ' ALA . 40.3 pt -95.45 -29.9 4.03 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.843 0 CA-C-N 115.989 -0.55 . . . . 1.0 111.595 178.392 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 80' ' ' ALA . . . . . 0.667 ' N ' ' O ' ' A' ' 77' ' ' ILE . . . -86.14 -10.79 54.17 Favored 'General case' 0 CA--C 1.548 0.882 0 N-CA-C 113.284 0.846 . . . . 1.0 113.284 178.387 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 8.5 mt-10 -83.1 -68.56 0.7 Allowed 'General case' 0 C--N 1.355 0.805 0 CA-C-N 118.855 0.752 . . . . 1.0 109.067 178.254 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 82' ' ' ASP . . . . . 0.512 ' O ' ' C ' ' A' ' 83' ' ' ALA . 49.7 p-10 -74.95 -14.2 60.61 Favored 'General case' 0 N--CA 1.443 -0.796 0 CA-C-O 118.846 -0.597 . . . . 1.0 112.136 -179.48 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . 0.704 ' HA ' ' HB3' ' A' ' 86' ' ' ALA . . . -23.08 -47.35 0.01 OUTLIER 'General case' 0 N--CA 1.473 0.698 0 CA-C-N 118.436 0.562 . . . . 1.0 112.013 177.746 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . 0.48 ' N ' ' O ' ' A' ' 82' ' ' ASP . 2.9 tt -37.7 -36.2 0.17 Allowed 'General case' 0 N--CA 1.465 0.324 0 N-CA-C 112.85 0.685 . . . . 1.0 112.85 -177.617 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 85' ' ' ILE . . . . . 0.407 HG21 HD13 ' A' ' 85' ' ' ILE . 11.2 pt -98.68 -43.1 11.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 N-CA-C 108.436 -0.95 . . . . 1.0 108.436 177.526 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . 0.704 ' HB3' ' HA ' ' A' ' 83' ' ' ALA . . . -56.36 -57.45 12.2 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 114.142 -1.39 . . . . 1.0 109.503 179.45 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . 0.533 ' N ' ' O ' ' A' ' 83' ' ' ALA . 19.8 tt0 -79.3 26.41 0.28 Allowed 'General case' 0 CA--C 1.544 0.723 0 O-C-N 120.851 -1.156 . . . . 1.0 112.202 -178.149 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -116.49 -15.75 10.86 Favored 'General case' 0 N--CA 1.489 1.504 0 CA-C-O 123.415 1.579 . . . . 1.0 107.896 177.68 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 89' ' ' VAL . . . . . 0.415 HG22 ' O ' ' A' ' 86' ' ' ALA . 5.3 m -100.44 39.23 0.15 Allowed 'Isoleucine or valine' 0 C--O 1.205 -1.238 0 CA-C-N 110.83 -2.896 . . . . 1.0 109.987 178.573 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 90' ' ' GLY . . . . . 0.536 ' O ' ' N ' ' A' ' 92' ' ' HIS . . . -71.59 -39.15 61.13 Favored Glycine 0 C--N 1.351 1.381 0 N-CA-C 111.023 -0.831 . . . . 1.0 111.023 178.329 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 91' ' ' PRO . . . . . 0.528 ' CD ' ' N ' ' A' ' 90' ' ' GLY . 89.6 Cg_exo -46.45 -12.82 0.09 OUTLIER 'Trans proline' 0 N--CA 1.497 1.712 0 C-N-CA 121.572 1.515 . . . . 1.0 110.346 178.406 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 92' ' ' HIS . . . . . 0.536 ' N ' ' O ' ' A' ' 90' ' ' GLY . 3.5 p80 -57.54 -17.15 12.35 Favored 'General case' 0 C--O 1.208 -1.108 0 N-CA-C 107.56 -1.274 . . . . 1.0 107.56 179.675 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . 0.712 HD12 ' N ' ' A' ' 94' ' ' ALA . 2.1 pp -67.84 -59.37 3.35 Favored 'General case' 0 N--CA 1.455 -0.215 0 N-CA-C 108.817 -0.809 . . . . 1.0 108.817 178.884 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 94' ' ' ALA . . . . . 0.712 ' N ' HD12 ' A' ' 93' ' ' LEU . . . -56.45 -53.36 58.31 Favored 'General case' 0 N--CA 1.454 -0.265 0 N-CA-C 108.914 -0.773 . . . . 1.0 108.914 178.701 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 95' ' ' ARG . . . . . 0.643 ' O ' ' N ' ' A' ' 97' ' ' LEU . 42.8 mtm105 -57.54 -57.44 12.69 Favored 'General case' 0 C--O 1.241 0.653 0 N-CA-C 107.822 -1.177 . . . . 1.0 107.822 178.846 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 96' ' ' ALA . . . . . 0.885 ' O ' ' N ' ' A' ' 98' ' ' GLY . . . -47.47 -12.35 0.03 OUTLIER 'General case' 0 N--CA 1.436 -1.128 0 O-C-N 118.905 -2.372 . . . . 1.0 110.375 -179.195 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . 0.692 ' O ' ' N ' ' A' ' 100' ' ' ILE . 16.2 tp 5.96 -53.25 0.0 OUTLIER 'General case' 0 C--N 1.377 1.801 0 CA-C-O 117.481 -1.247 . . . . 1.0 110.275 -167.843 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 98' ' ' GLY . . . . . 0.885 ' N ' ' O ' ' A' ' 96' ' ' ALA . . . -49.06 -23.75 4.06 Favored Glycine 0 CA--C 1.543 1.784 0 CA-C-N 122.572 2.442 . . . . 1.0 107.902 175.331 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 99' ' ' GLN . . . . . 0.552 ' N ' ' O ' ' A' ' 96' ' ' ALA . 0.0 OUTLIER -63.88 -17.45 63.2 Favored 'General case' 0 C--N 1.36 1.026 0 N-CA-C 107.046 -1.465 . . . . 1.0 107.046 176.706 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 100' ' ' ILE . . . . . 0.692 ' N ' ' O ' ' A' ' 97' ' ' LEU . 1.9 tp -66.42 -43.33 91.18 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.518 0 N-CA-C 108.746 -0.835 . . . . 1.0 108.746 178.98 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 101' ' ' VAL . . . . . 0.672 ' O ' ' N ' ' A' ' 105' ' ' GLY . 0.5 OUTLIER -54.48 -58.28 4.25 Favored 'Isoleucine or valine' 0 C--O 1.219 -0.546 0 N-CA-C 106.844 -1.539 . . . . 1.0 106.844 178.69 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 102' ' ' CYS . . . . . 0.838 ' O ' ' HB2' ' A' ' 106' ' ' ALA . 17.1 t -44.74 -20.6 0.04 OUTLIER 'General case' 0 C--N 1.314 -0.974 0 CA-C-N 115.961 -0.563 . . . . 1.0 111.977 -179.932 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 103' ' ' ARG . . . . . 0.522 HH11 ' CG ' ' A' ' 103' ' ' ARG . 0.0 OUTLIER -92.76 -44.69 8.4 Favored 'General case' 0 N--CA 1.472 0.646 0 CA-C-O 122.328 1.061 . . . . 1.0 111.521 178.299 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 104' ' ' TYR . . . . . 0.581 ' CD2' ' O ' ' A' ' 104' ' ' TYR . 0.0 OUTLIER -105.72 22.39 15.64 Favored 'General case' 0 C--N 1.312 -1.027 0 CA-C-N 113.625 -1.625 . . . . 1.0 111.325 179.294 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 105' ' ' GLY . . . . . 0.776 ' O ' ' N ' ' A' ' 107' ' ' THR . . . -171.67 -9.29 0.02 OUTLIER Glycine 0 C--N 1.345 1.028 0 C-N-CA 118.437 -1.84 . . . . 1.0 113.125 178.987 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 106' ' ' ALA . . . . . 0.838 ' HB2' ' O ' ' A' ' 102' ' ' CYS . . . -27.71 68.68 0.0 OUTLIER 'General case' 0 N--CA 1.475 0.793 0 N-CA-C 113.521 0.934 . . . . 1.0 113.521 -178.707 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 107' ' ' THR . . . . . 0.776 ' N ' ' O ' ' A' ' 105' ' ' GLY . 8.8 t -91.9 2.66 56.39 Favored 'General case' 0 CA--C 1.51 -0.595 0 N-CA-C 106.902 -1.518 . . . . 1.0 106.902 177.601 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 60.2 t -85.37 -57.73 4.09 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.76 0 CA-C-N 115.475 -0.784 . . . . 1.0 110.514 178.547 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 109' ' ' ILE . . . . . 0.523 ' N ' ' HD2' ' A' ' 110' ' ' PRO . 0.1 OUTLIER -65.98 -39.8 32.76 Favored Pre-proline 0 CA--C 1.555 1.158 0 N-CA-C 114.552 1.316 . . . . 1.0 114.552 -177.971 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 110' ' ' PRO . . . . . 0.547 ' CD ' ' O ' ' A' ' 106' ' ' ALA . 6.8 Cg_endo -48.13 -47.7 18.71 Favored 'Trans proline' 0 N--CA 1.504 2.096 0 CA-C-N 122.397 1.892 . . . . 1.0 113.065 -178.283 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 23.4 t30 -64.79 -67.03 0.47 Allowed 'General case' 0 N--CA 1.464 0.248 0 C-N-CA 119.47 -0.892 . . . . 1.0 109.434 -178.267 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 112' ' ' ILE . . . . . 0.458 ' O ' ' N ' ' A' ' 115' ' ' ALA . 28.3 mm -49.25 -39.92 13.3 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.575 0 CA-C-O 122.813 1.292 . . . . 1.0 108.459 179.737 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 113' ' ' ASN . . . . . 0.483 ' CB ' ' O ' ' A' ' 109' ' ' ILE . 6.4 t-20 -47.14 -51.14 18.9 Favored 'General case' 0 C--N 1.31 -1.121 0 CA-C-N 112.273 -2.24 . . . . 1.0 108.03 -176.892 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -62.21 -29.81 70.64 Favored 'General case' 0 N--CA 1.441 -0.894 0 C-N-CA 119.611 -0.835 . . . . 1.0 110.343 178.772 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 115' ' ' ALA . . . . . 0.458 ' N ' ' O ' ' A' ' 112' ' ' ILE . . . -77.34 -60.44 2.36 Favored 'General case' 0 C--N 1.347 0.477 0 C-N-CA 119.659 -0.817 . . . . 1.0 110.031 179.077 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 116' ' ' ILE . . . . . 0.506 ' O ' ' N ' ' A' ' 120' ' ' GLY . 1.0 OUTLIER -49.95 -50.07 19.93 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.707 0 CA-C-O 122.013 0.911 . . . . 1.0 109.562 -179.41 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 117' ' ' GLU . . . . . 0.476 ' N ' HG22 ' A' ' 116' ' ' ILE . 17.8 mt-10 -42.53 -55.73 3.37 Favored 'General case' 0 C--N 1.316 -0.887 0 N-CA-C 106.106 -1.812 . . . . 1.0 106.106 -179.394 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 98.8 t -58.82 -53.11 51.95 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.677 0 C-N-CA 119.428 -0.909 . . . . 1.0 108.787 176.875 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -51.74 -72.62 0.05 OUTLIER 'General case' 0 CA--C 1.543 0.707 0 N-CA-C 108.083 -1.081 . . . . 1.0 108.083 -178.699 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 120' ' ' GLY . . . . . 0.506 ' N ' ' O ' ' A' ' 116' ' ' ILE . . . -64.9 -79.03 0.19 Allowed Glycine 0 CA--C 1.541 1.698 0 C-N-CA 119.055 -1.545 . . . . 1.0 110.3 179.308 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 121' ' ' THR . . . . . 0.494 ' OG1' ' O ' ' A' ' 120' ' ' GLY . 2.8 m 154.27 -31.57 0.01 OUTLIER 'General case' 0 N--CA 1.481 1.098 0 CA-C-N 112.371 -1.914 . . . . 1.0 111.463 179.974 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 122' ' ' GLY . . . . . 0.669 ' O ' ' N ' ' A' ' 124' ' ' ASP . . . 104.25 -17.5 47.54 Favored Glycine 0 N--CA 1.462 0.373 0 N-CA-C 107.319 -2.312 . . . . 1.0 107.319 -176.46 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 123' ' ' THR . . . . . 0.702 HG23 ' O ' ' A' ' 123' ' ' THR . 12.7 t -56.37 82.3 0.01 OUTLIER 'General case' 0 N--CA 1.469 0.509 0 N-CA-C 106.031 -1.84 . . . . 1.0 106.031 178.647 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 124' ' ' ASP . . . . . 0.669 ' N ' ' O ' ' A' ' 122' ' ' GLY . 34.6 m-20 -167.26 178.05 5.79 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 112.826 -1.988 . . . . 1.0 111.516 179.01 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 125' ' ' TYR . . . . . . . . . . . . . 21.3 t80 -141.96 140.22 32.67 Favored 'General case' 0 CA--C 1.536 0.417 0 N-CA-C 107.328 -1.36 . . . . 1.0 107.328 174.932 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 24.0 mmm-85 -146.18 148.1 32.18 Favored 'General case' 0 N--CA 1.471 0.598 0 N-CA-C 109.879 -0.415 . . . . 1.0 109.879 178.594 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 127' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 C--N 1.327 -0.409 0 CA-C-O 117.982 -1.009 . . . . 1.0 110.079 179.3 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 128' ' ' MTN . . . . . 0.917 ' H91' HH12 ' A' ' 47' ' ' ARG . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 129' ' ' MTN . . . . . 0.853 ' H83' ' O ' ' A' ' 48' ' ' CYS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 130' ' ' MTN . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.494 1.75 0 N-CA-C 108.103 -1.073 . . . . 1.0 108.103 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . 0.46 ' O ' ' CB ' ' A' ' 3' ' ' ASP . 93.9 p -70.66 7.1 1.19 Allowed 'General case' 0 C--O 1.223 -0.316 0 CA-C-O 119.449 -0.31 . . . . 1.0 111.352 179.615 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . 0.46 ' CB ' ' O ' ' A' ' 2' ' ' SER . 12.7 p-10 142.55 142.19 0.0 OUTLIER 'General case' 0 N--CA 1.481 1.079 0 O-C-N 124.126 0.891 . . . . 1.0 110.349 179.07 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 42.1 t80 -155.59 151.33 27.41 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 121.134 0.492 . . . . 1.0 110.532 178.701 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 5' ' ' ASP . . . . . 0.482 ' C ' ' OG ' ' A' ' 10' ' ' SER . 51.3 m-20 -148.46 144.6 27.5 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.562 -0.745 . . . . 1.0 109.53 179.84 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 6' ' ' THR . . . . . 1.009 HG22 ' H ' ' A' ' 7' ' ' GLU . 5.6 m -109.46 -161.57 0.77 Allowed 'General case' 0 C--O 1.206 -1.188 0 CA-C-O 121.656 0.741 . . . . 1.0 110.48 -179.776 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . 1.009 ' H ' HG22 ' A' ' 6' ' ' THR . 28.5 tt0 -58.26 -44.37 88.31 Favored 'General case' 0 C--N 1.302 -1.497 0 CA-C-O 121.872 0.844 . . . . 1.0 109.447 -178.5 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 8' ' ' ARG . . . . . 0.836 ' O ' ' HB3' ' A' ' 12' ' ' ALA . 21.8 ttp-105 -69.87 -60.64 2.18 Favored 'General case' 0 C--N 1.307 -1.241 0 C-N-CA 117.916 -1.514 . . . . 1.0 110.089 178.242 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . 0.957 HG23 ' H ' ' A' ' 6' ' ' THR . 0.1 OUTLIER -61.38 -52.61 59.27 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.412 0 CA-C-N 115.11 -0.95 . . . . 1.0 110.129 -179.6 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . 0.674 ' N ' ' O ' ' A' ' 6' ' ' THR . 1.2 m -68.21 -65.21 0.72 Allowed 'General case' 0 N--CA 1.487 1.409 0 C-N-CA 120.166 -0.614 . . . . 1.0 112.525 179.66 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 11' ' ' ARG . . . . . 0.643 ' O ' ' HB3' ' A' ' 15' ' ' ALA . 5.0 mtt-85 -61.9 -43.41 98.89 Favored 'General case' 0 C--N 1.317 -0.841 0 C-N-CA 120.419 -0.512 . . . . 1.0 111.382 -176.955 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . 0.836 ' HB3' ' O ' ' A' ' 8' ' ' ARG . . . -69.87 -57.58 4.88 Favored 'General case' 0 N--CA 1.468 0.443 0 C-N-CA 118.334 -1.346 . . . . 1.0 108.998 178.719 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . 0.673 ' O ' ' CB ' ' A' ' 17' ' ' LEU . 41.7 t -61.84 -55.44 24.24 Favored 'Isoleucine or valine' 0 C--O 1.198 -1.623 0 C-N-CA 117.51 -1.676 . . . . 1.0 107.879 -179.266 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . 0.892 ' O ' HG22 ' A' ' 18' ' ' VAL . . . -57.96 -64.92 0.74 Allowed 'General case' 0 C--N 1.313 -1.009 0 C-N-CA 116.53 -2.068 . . . . 1.0 111.457 -179.94 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . 0.643 ' HB3' ' O ' ' A' ' 11' ' ' ARG . . . -54.59 -54.71 37.74 Favored 'General case' 0 C--O 1.218 -0.601 0 C-N-CA 118.596 -1.242 . . . . 1.0 110.334 -177.187 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . 0.711 ' HB3' ' O ' ' A' ' 12' ' ' ALA . . . -65.69 -55.64 16.34 Favored 'General case' 0 C--N 1.309 -1.176 0 C-N-CA 118.676 -1.21 . . . . 1.0 110.569 -179.109 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . 0.673 ' CB ' ' O ' ' A' ' 13' ' ' VAL . 2.2 tp -56.51 -54.56 44.4 Favored 'General case' 0 N--CA 1.491 1.591 0 N-CA-C 108.087 -1.079 . . . . 1.0 108.087 -177.728 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . 0.892 HG22 ' O ' ' A' ' 14' ' ' ALA . 1.8 m -71.88 -58.59 4.77 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.405 0 C-N-CA 120.371 -0.531 . . . . 1.0 110.446 -179.953 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . 0.559 ' N ' ' O ' ' A' ' 15' ' ' ALA . . . -60.67 -168.39 0.43 Allowed Glycine 0 N--CA 1.439 -1.131 0 N-CA-C 111.969 -0.452 . . . . 1.0 111.969 -177.288 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 20' ' ' PRO . . . . . 0.677 ' O ' ' N ' ' A' ' 24' ' ' ALA . 4.2 Cg_endo -81.73 -25.96 3.34 Favored 'Trans proline' 0 C--N 1.294 -2.339 0 C-N-CA 121.847 1.698 . . . . 1.0 113.72 -178.041 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -63.51 -60.01 8.03 Favored Glycine 0 N--CA 1.473 1.134 0 C-N-CA 118.984 -1.579 . . . . 1.0 112.679 -176.004 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . 0.605 ' H ' ' HA ' ' A' ' 16' ' ' ALA . . . -57.31 -53.01 48.15 Favored Glycine 0 C--N 1.31 -0.874 0 N-CA-C 106.259 -2.736 . . . . 1.0 106.259 -178.848 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . 0.497 ' O ' HG12 ' A' ' 27' ' ' VAL . 21.3 t -56.37 -32.29 35.31 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.849 0 N-CA-C 108.177 -1.045 . . . . 1.0 108.177 178.428 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . 0.677 ' N ' ' O ' ' A' ' 20' ' ' PRO . . . -60.4 -62.88 1.54 Allowed 'General case' 0 C--N 1.352 0.716 0 C-N-CA 118.573 -1.251 . . . . 1.0 110.087 -179.47 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 86.5 mt -61.91 -46.32 89.89 Favored 'General case' 0 CA--C 1.516 -0.336 0 C-N-CA 120.202 -0.599 . . . . 1.0 111.612 -177.223 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 97.9 t -59.85 -59.85 3.39 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.582 0 C-N-CA 119.332 -0.947 . . . . 1.0 110.393 -177.617 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . 0.552 ' O ' ' HB3' ' A' ' 31' ' ' ALA . 1.4 p -58.65 -36.93 62.49 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.442 0 C-N-CA 120.571 -0.452 . . . . 1.0 110.345 -177.353 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 8.7 tttm -65.69 -56.19 13.41 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 115.646 -0.706 . . . . 1.0 109.869 -179.882 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 97.6 t -62.29 -48.73 86.99 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.699 0 CA-C-N 115.314 -0.857 . . . . 1.0 110.002 -177.699 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 30' ' ' CYS . . . . . . . . . . . . . 49.2 t -65.45 -62.1 1.72 Allowed 'General case' 0 N--CA 1.443 -0.796 0 C-N-CA 119.849 -0.74 . . . . 1.0 110.206 -178.815 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . 0.552 ' HB3' ' O ' ' A' ' 27' ' ' VAL . . . -57.15 -50.21 73.52 Favored 'General case' 0 CA--C 1.507 -0.697 0 CA-C-O 120.879 0.371 . . . . 1.0 110.26 -176.668 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . 0.417 ' O ' ' HB2' ' A' ' 33' ' ' LEU . . . 74.82 70.66 1.22 Allowed Glycine 0 N--CA 1.443 -0.859 0 N-CA-C 109.001 -1.64 . . . . 1.0 109.001 -178.106 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . 0.417 ' HB2' ' O ' ' A' ' 32' ' ' GLY . 5.2 mt 91.79 82.81 0.04 OUTLIER Pre-proline 0 C--N 1.332 -0.192 0 O-C-N 124.963 1.037 . . . . 1.0 109.453 -178.281 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 50.8 Cg_exo -50.39 -28.85 22.11 Favored 'Trans proline' 0 C--N 1.312 -1.37 0 C-N-CA 122.481 2.121 . . . . 1.0 113.555 -179.333 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -62.36 -61.02 7.01 Favored Glycine 0 N--CA 1.47 0.932 0 C-N-CA 118.353 -1.88 . . . . 1.0 109.909 -178.027 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . 0.643 ' O ' HG22 ' A' ' 37' ' ' ILE . 11.4 p -86.47 167.11 1.84 Allowed 'Isoleucine or valine' 0 CA--C 1.507 -0.698 0 N-CA-C 107.719 -1.215 . . . . 1.0 107.719 178.41 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . 0.656 HG23 ' O ' ' A' ' 37' ' ' ILE . 8.2 tt 115.91 107.37 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.484 1.257 0 O-C-N 125.403 1.689 . . . . 1.0 110.6 179.752 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 60.8 m80 -140.39 135.67 32.32 Favored 'General case' 0 C--N 1.328 -0.337 0 O-C-N 121.95 -0.469 . . . . 1.0 109.782 179.153 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 6.1 m -106.42 130.93 22.18 Favored Pre-proline 0 CA--C 1.534 0.342 0 N-CA-C 110.278 -0.268 . . . . 1.0 110.278 -179.582 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 37.0 Cg_endo -65.69 -24.07 55.56 Favored 'Trans proline' 0 N--CA 1.493 1.465 0 C-N-CA 121.141 1.227 . . . . 1.0 112.702 -179.684 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -128.47 135.99 50.22 Favored 'General case' 0 N--CA 1.466 0.361 0 N-CA-C 110.376 -0.231 . . . . 1.0 110.376 177.839 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . 0.693 ' C ' ' H ' ' A' ' 44' ' ' GLY . 11.8 ptm180 -171.23 172.09 5.42 Favored 'General case' 0 C--N 1.322 -0.608 0 C-N-CA 120.2 -0.6 . . . . 1.0 110.941 178.342 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 43' ' ' ARG . . . . . 0.518 ' C ' ' H ' ' A' ' 45' ' ' PHE . 37.2 tpt85 -63.33 24.13 0.01 OUTLIER 'General case' 0 CA--C 1.55 0.953 0 CA-C-O 121.518 0.675 . . . . 1.0 109.816 179.296 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . 0.693 ' H ' ' C ' ' A' ' 42' ' ' ARG . . . 76.98 -26.78 1.72 Allowed Glycine 0 C--N 1.338 0.686 0 N-CA-C 110.533 -1.027 . . . . 1.0 110.533 179.394 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . 0.572 ' O ' ' HB2' ' A' ' 46' ' ' PHE . 11.8 p90 -175.32 -174.15 0.71 Allowed 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 114.352 -0.924 . . . . 1.0 109.451 179.87 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 46' ' ' PHE . . . . . 0.572 ' HB2' ' O ' ' A' ' 45' ' ' PHE . 0.7 OUTLIER 110.81 107.38 0.0 OUTLIER 'General case' 0 N--CA 1.479 1.015 0 O-C-N 125.398 1.686 . . . . 1.0 109.851 -179.78 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 47' ' ' ARG . . . . . 0.72 ' NE ' ' H73' ' A' ' 128' ' ' MTN . 34.3 ttm-85 97.69 154.21 0.02 OUTLIER 'General case' 0 N--CA 1.472 0.655 0 O-C-N 123.966 0.791 . . . . 1.0 110.964 179.7 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 4.4 t 67.2 86.5 0.13 Allowed 'General case' 0 C--N 1.328 -0.335 0 N-CA-C 108.161 -1.051 . . . . 1.0 108.161 -177.685 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 49' ' ' ASN . . . . . 0.501 ' O ' ' N ' ' A' ' 51' ' ' GLU . 0.0 OUTLIER -153.0 160.71 30.6 Favored Pre-proline 0 N--CA 1.466 0.364 0 CA-C-N 115.675 -0.693 . . . . 1.0 111.33 -179.352 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 30.8 Cg_endo -63.13 60.94 0.17 Allowed 'Trans proline' 0 C--N 1.311 -1.409 0 C-N-CA 122.545 2.163 . . . . 1.0 111.403 177.976 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . 0.501 ' N ' ' O ' ' A' ' 49' ' ' ASN . 40.9 mt-10 41.91 37.72 0.87 Allowed 'General case' 0 C--O 1.233 0.227 0 CA-C-O 120.68 0.276 . . . . 1.0 111.501 178.31 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . 0.726 ' HE ' ' HB ' ' A' ' 89' ' ' VAL . 73.9 mtt85 -146.62 167.78 22.9 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 121.025 0.44 . . . . 1.0 111.702 -179.119 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 21.0 tt -76.22 164.13 3.67 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.324 0 N-CA-C 108.061 -1.088 . . . . 1.0 108.061 176.891 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 56.1 tt0 -132.82 131.2 40.78 Favored 'General case' 0 CA--C 1.535 0.399 0 N-CA-C 108.857 -0.794 . . . . 1.0 108.857 179.057 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 10.5 tt -143.48 153.82 16.37 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.728 0 N-CA-C 110.169 -0.308 . . . . 1.0 110.169 178.852 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 104.14 2.35 45.03 Favored Glycine 0 C--N 1.341 0.848 0 N-CA-C 109.851 -1.3 . . . . 1.0 109.851 -179.108 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 18.2 m-20 -90.57 109.8 20.95 Favored 'General case' 0 CA--C 1.542 0.642 0 CA-C-O 122.138 0.971 . . . . 1.0 113.09 -178.152 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 58' ' ' TRP . . . . . 0.56 ' CD1' ' OE1' ' A' ' 61' ' ' GLU . 9.2 m95 -82.8 -176.92 6.54 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 113.43 -1.714 . . . . 1.0 108.678 176.599 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 59' ' ' ARG . . . . . 0.431 ' HG2' ' H ' ' A' ' 59' ' ' ARG . 8.0 ptm180 -98.64 -54.28 3.07 Favored 'General case' 0 CA--C 1.552 1.042 0 CA-C-N 118.955 0.798 . . . . 1.0 111.188 178.21 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 60' ' ' TYR . . . . . 0.411 ' H ' ' CG ' ' A' ' 59' ' ' ARG . 0.2 OUTLIER -80.29 -11.24 59.74 Favored 'General case' 0 N--CA 1.479 1.007 0 C-N-CA 124.561 1.145 . . . . 1.0 112.397 -178.511 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . 0.56 ' OE1' ' CD1' ' A' ' 58' ' ' TRP . 86.6 mt-10 -80.08 -16.47 54.94 Favored 'General case' 0 CA--C 1.496 -1.127 0 O-C-N 121.58 -0.7 . . . . 1.0 110.413 179.302 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . 0.516 HG23 ' N ' ' A' ' 63' ' ' ALA . 28.7 m -44.24 -46.52 2.3 Favored 'Isoleucine or valine' 0 CA--C 1.499 -1.01 0 N-CA-C 109.215 -0.661 . . . . 1.0 109.215 -175.798 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 63' ' ' ALA . . . . . 0.516 ' N ' HG23 ' A' ' 62' ' ' VAL . . . -66.19 -46.29 77.84 Favored 'General case' 0 N--CA 1.415 -2.206 0 N-CA-C 108.109 -1.071 . . . . 1.0 108.109 177.147 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 64' ' ' HIS . . . . . 0.485 ' N ' ' O ' ' A' ' 61' ' ' GLU . 4.2 t-80 -57.96 -60.65 3.4 Favored 'General case' 0 CA--C 1.547 0.83 0 CA-C-N 115.572 -0.74 . . . . 1.0 111.269 179.322 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . 0.609 ' C ' ' H ' ' A' ' 67' ' ' ARG . 0.7 OUTLIER -69.96 -55.63 9.11 Favored 'General case' 0 CA--C 1.554 1.116 0 O-C-N 121.128 -0.983 . . . . 1.0 110.24 178.632 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . 0.478 ' N ' ' O ' ' A' ' 62' ' ' VAL . . . -64.84 32.59 0.1 Allowed Glycine 0 N--CA 1.471 1.008 0 O-C-N 121.475 -0.765 . . . . 1.0 111.421 178.461 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 67' ' ' ARG . . . . . 0.714 ' HB3' ' H ' ' A' ' 71' ' ' ALA . 0.0 OUTLIER -77.45 6.4 7.07 Favored 'General case' 0 C--N 1.316 -0.863 0 C-N-CA 123.605 0.762 . . . . 1.0 110.08 176.173 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . 0.613 ' O ' ' HA ' ' A' ' 72' ' ' HIS . 0.8 OUTLIER -33.15 -30.16 0.01 OUTLIER 'General case' 0 N--CA 1.486 1.366 0 N-CA-C 107.481 -1.303 . . . . 1.0 107.481 -179.072 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . 0.63 ' N ' ' O ' ' A' ' 67' ' ' ARG . 2.3 mt -63.25 -64.68 0.84 Allowed 'General case' 0 C--N 1.317 -0.847 0 C-N-CA 117.509 -1.676 . . . . 1.0 107.558 176.754 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . 0.677 ' C ' ' H ' ' A' ' 72' ' ' HIS . . . -77.17 -72.25 0.36 Allowed 'General case' 0 N--CA 1.478 0.932 0 N-CA-C 106.671 -1.603 . . . . 1.0 106.671 177.615 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . 0.714 ' H ' ' HB3' ' A' ' 67' ' ' ARG . . . -49.16 4.19 0.01 OUTLIER 'General case' 0 N--CA 1.467 0.418 0 C-N-CA 125.203 1.401 . . . . 1.0 112.31 178.536 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 72' ' ' HIS . . . . . 0.707 ' CG ' ' H ' ' A' ' 73' ' ' MET . 0.0 OUTLIER -18.11 -72.87 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.396 0 C-N-CA 123.155 0.582 . . . . 1.0 112.527 -176.592 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 73' ' ' MET . . . . . 0.707 ' H ' ' CG ' ' A' ' 72' ' ' HIS . 45.4 mtt -71.28 -43.04 67.93 Favored 'General case' 0 C--N 1.298 -1.658 0 C-N-CA 119.309 -0.957 . . . . 1.0 110.239 178.082 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . 0.618 ' O ' ' N ' ' A' ' 76' ' ' GLY . 42.3 t -43.08 -45.99 1.32 Allowed 'Isoleucine or valine' 0 N--CA 1.463 0.21 0 CA-C-O 118.822 -0.609 . . . . 1.0 110.248 -175.4 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 75' ' ' ASN . . . . . 0.508 ' O ' ' N ' ' A' ' 77' ' ' ILE . 5.2 t30 -38.45 -18.96 0.01 OUTLIER 'General case' 0 N--CA 1.473 0.693 0 CA-C-O 122.025 0.917 . . . . 1.0 111.815 179.192 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . 0.618 ' N ' ' O ' ' A' ' 74' ' ' VAL . . . -43.35 -19.05 0.07 OUTLIER Glycine 0 CA--C 1.54 1.641 0 N-CA-C 109.344 -1.503 . . . . 1.0 109.344 177.89 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . 0.767 ' O ' ' N ' ' A' ' 80' ' ' ALA . 9.7 pt -89.9 -49.7 13.61 Favored 'Isoleucine or valine' 0 C--O 1.211 -0.952 0 N-CA-C 107.982 -1.118 . . . . 1.0 107.982 179.963 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . 0.484 ' C ' ' O ' ' A' ' 77' ' ' ILE . 6.0 t -35.15 -35.04 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.447 -0.583 0 N-CA-C 108.532 -0.914 . . . . 1.0 108.532 -177.268 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . 0.616 ' O ' ' HB3' ' A' ' 83' ' ' ALA . 1.3 pp -91.56 -21.92 6.28 Favored 'Isoleucine or valine' 0 C--O 1.198 -1.638 0 CA-C-N 115.824 -0.626 . . . . 1.0 110.26 178.511 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 80' ' ' ALA . . . . . 0.767 ' N ' ' O ' ' A' ' 77' ' ' ILE . . . -92.65 -9.64 40.21 Favored 'General case' 0 CA--C 1.554 1.111 0 O-C-N 121.368 -0.832 . . . . 1.0 112.682 176.258 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . 0.531 ' N ' ' O ' ' A' ' 77' ' ' ILE . 4.9 mm-40 -79.15 -76.76 0.19 Allowed 'General case' 0 C--N 1.344 0.328 0 N-CA-C 112.583 0.586 . . . . 1.0 112.583 -176.121 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 82' ' ' ASP . . . . . 0.78 ' O ' HG12 ' A' ' 85' ' ' ILE . 5.9 m-20 -86.42 -17.34 34.58 Favored 'General case' 0 C--O 1.206 -1.205 0 CA-C-N 116.455 -0.339 . . . . 1.0 111.201 -179.795 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . 0.616 ' HB3' ' O ' ' A' ' 79' ' ' ILE . . . -58.47 -40.09 81.74 Favored 'General case' 0 C--N 1.316 -0.854 0 C-N-CA 118.188 -1.405 . . . . 1.0 111.944 -175.888 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . 0.727 HD13 ' O ' ' A' ' 84' ' ' LEU . 3.4 tm? -37.72 -37.07 0.21 Allowed 'General case' 0 N--CA 1.467 0.399 0 N-CA-C 112.719 0.637 . . . . 1.0 112.719 -175.65 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 85' ' ' ILE . . . . . 0.78 HG12 ' O ' ' A' ' 82' ' ' ASP . 22.4 pt -69.49 -26.49 31.28 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.568 0 C-N-CA 120.341 -0.544 . . . . 1.0 111.547 -179.804 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . 0.528 ' N ' ' O ' ' A' ' 83' ' ' ALA . . . -86.34 -15.16 41.4 Favored 'General case' 0 C--N 1.33 -0.249 0 N-CA-C 111.935 0.346 . . . . 1.0 111.935 -179.328 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 3.4 tt0 -53.04 -8.88 0.11 Allowed 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 120.868 0.366 . . . . 1.0 110.034 -179.467 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . 0.475 ' H ' ' C ' ' A' ' 86' ' ' ALA . . . -93.26 -8.1 43.16 Favored 'General case' 0 N--CA 1.47 0.573 0 CA-C-O 121.529 0.681 . . . . 1.0 109.421 -179.914 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 89' ' ' VAL . . . . . 0.726 ' HB ' ' HE ' ' A' ' 52' ' ' ARG . 4.5 t -92.61 36.22 0.1 OUTLIER 'Isoleucine or valine' 0 N--CA 1.438 -1.058 0 N-CA-C 108.103 -1.073 . . . . 1.0 108.103 178.602 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 90' ' ' GLY . . . . . 0.866 ' O ' ' N ' ' A' ' 92' ' ' HIS . . . -50.88 -28.15 15.79 Favored Glycine 0 C--N 1.355 1.585 0 CA-C-O 117.303 -1.832 . . . . 1.0 111.247 176.309 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 91' ' ' PRO . . . . . 0.667 ' HD2' ' N ' ' A' ' 90' ' ' GLY . 27.9 Cg_exo -32.73 -1.76 0.0 OUTLIER 'Trans proline' 0 N--CA 1.506 2.232 0 C-N-CA 123.388 2.725 . . . . 1.0 114.112 173.644 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 92' ' ' HIS . . . . . 0.866 ' N ' ' O ' ' A' ' 90' ' ' GLY . 1.5 t-80 -50.4 -29.73 10.81 Favored 'General case' 0 N--CA 1.443 -0.817 0 N-CA-C 107.094 -1.447 . . . . 1.0 107.094 178.897 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . 0.635 HD12 ' N ' ' A' ' 94' ' ' ALA . 2.0 pp -60.04 -52.29 66.01 Favored 'General case' 0 N--CA 1.448 -0.565 0 N-CA-C 108.404 -0.962 . . . . 1.0 108.404 177.185 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 94' ' ' ALA . . . . . 0.635 ' N ' HD12 ' A' ' 93' ' ' LEU . . . -50.61 -56.02 13.69 Favored 'General case' 0 CA--C 1.515 -0.394 0 N-CA-C 107.236 -1.394 . . . . 1.0 107.236 -179.433 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 95' ' ' ARG . . . . . 0.42 HH11 ' HG3' ' A' ' 20' ' ' PRO . 89.8 mtt-85 -59.41 -32.18 69.93 Favored 'General case' 0 C--N 1.313 -0.999 0 N-CA-C 108.325 -0.991 . . . . 1.0 108.325 177.538 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 96' ' ' ALA . . . . . 0.768 ' O ' ' N ' ' A' ' 100' ' ' ILE . . . -55.75 -49.77 72.21 Favored 'General case' 0 C--O 1.207 -1.156 0 N-CA-C 106.824 -1.547 . . . . 1.0 106.824 -178.741 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . 0.552 ' O ' HG22 ' A' ' 100' ' ' ILE . 0.6 OUTLIER -36.88 -26.58 0.01 OUTLIER 'General case' 0 CA--C 1.568 1.669 0 N-CA-C 107.216 -1.401 . . . . 1.0 107.216 -179.912 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 98' ' ' GLY . . . . . 0.606 ' N ' ' O ' ' A' ' 96' ' ' ALA . . . -84.95 -52.87 3.32 Favored Glycine 0 CA--C 1.55 2.261 0 CA-C-O 123.119 1.399 . . . . 1.0 111.19 173.816 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 99' ' ' GLN . . . . . 0.563 ' N ' ' O ' ' A' ' 96' ' ' ALA . 24.9 mt-30 -79.07 7.97 6.52 Favored 'General case' 0 N--CA 1.438 -1.073 0 CA-C-N 114.742 -0.729 . . . . 1.0 109.521 177.989 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 100' ' ' ILE . . . . . 0.768 ' N ' ' O ' ' A' ' 96' ' ' ALA . 14.7 tt -60.3 -49.77 82.9 Favored 'Isoleucine or valine' 0 CA--C 1.484 -1.561 0 N-CA-C 107.936 -1.135 . . . . 1.0 107.936 179.694 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 101' ' ' VAL . . . . . 0.705 ' N ' HG23 ' A' ' 100' ' ' ILE . 22.7 t -60.12 -56.7 15.78 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.636 0 C-N-CA 116.495 -2.082 . . . . 1.0 107.763 178.135 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 102' ' ' CYS . . . . . 0.531 ' O ' ' O ' ' A' ' 105' ' ' GLY . 0.5 OUTLIER -46.53 -38.17 8.98 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 114.971 -1.013 . . . . 1.0 110.663 -175.869 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 7.3 ttp180 -65.05 -54.62 27.32 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 125.595 1.809 . . . . 1.0 113.302 176.844 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 104' ' ' TYR . . . . . 0.656 ' O ' ' CG ' ' A' ' 104' ' ' TYR . 50.8 t80 -93.28 32.0 1.4 Allowed 'General case' 0 C--N 1.311 -1.096 0 C-N-CA 126.082 1.753 . . . . 1.0 107.441 178.969 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 105' ' ' GLY . . . . . 0.539 ' O ' ' CB ' ' A' ' 106' ' ' ALA . . . 172.56 -141.78 6.43 Favored Glycine 0 N--CA 1.431 -1.649 0 N-CA-C 107.199 -2.36 . . . . 1.0 107.199 178.665 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 106' ' ' ALA . . . . . 0.539 ' CB ' ' O ' ' A' ' 105' ' ' GLY . . . 109.67 107.63 0.0 OUTLIER 'General case' 0 C--N 1.315 -0.896 0 C-N-CA 126.736 2.014 . . . . 1.0 116.237 178.712 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 107' ' ' THR . . . . . 0.532 ' O ' ' HG2' ' A' ' 110' ' ' PRO . 27.7 m -72.44 -52.06 17.54 Favored 'General case' 0 N--CA 1.476 0.842 0 CA-C-N 115.614 -0.721 . . . . 1.0 110.12 175.252 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . 0.561 HG13 ' N ' ' A' ' 109' ' ' ILE . 8.7 p -61.46 -46.12 97.22 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.035 0 O-C-N 121.639 -0.663 . . . . 1.0 112.019 -178.452 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 109' ' ' ILE . . . . . 0.561 ' N ' HG13 ' A' ' 108' ' ' VAL . 2.6 mt -38.0 -59.6 1.15 Allowed Pre-proline 0 N--CA 1.484 1.253 0 CA-C-N 116.399 -0.364 . . . . 1.0 110.778 -178.401 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 110' ' ' PRO . . . . . 0.532 ' HG2' ' O ' ' A' ' 107' ' ' THR . 31.9 Cg_endo -56.18 -21.82 37.35 Favored 'Trans proline' 0 C--N 1.314 -1.25 0 C-N-CA 120.895 1.064 . . . . 1.0 112.177 -177.888 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 4.0 m-80 -64.37 -65.7 0.64 Allowed 'General case' 0 N--CA 1.469 0.522 0 C-N-CA 119.631 -0.827 . . . . 1.0 109.808 178.77 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 112' ' ' ILE . . . . . 0.662 ' O ' ' HB ' ' A' ' 116' ' ' ILE . 2.0 tt -45.72 -27.45 0.64 Allowed 'Isoleucine or valine' 0 C--O 1.22 -0.474 0 CA-C-O 122.383 1.087 . . . . 1.0 109.121 -179.166 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 113' ' ' ASN . . . . . 0.754 ' O ' ' HB3' ' A' ' 117' ' ' GLU . 25.4 t-20 -84.05 -53.03 5.83 Favored 'General case' 0 C--N 1.308 -1.199 0 CA-C-O 122.953 1.359 . . . . 1.0 110.018 178.949 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -56.07 -58.04 9.58 Favored 'General case' 0 C--N 1.295 -1.793 0 C-N-CA 119.257 -0.977 . . . . 1.0 110.261 -178.688 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -79.89 -59.59 2.67 Favored 'General case' 0 C--O 1.246 0.893 0 N-CA-C 114.465 1.283 . . . . 1.0 114.465 179.921 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 116' ' ' ILE . . . . . 0.662 ' HB ' ' O ' ' A' ' 112' ' ' ILE . 11.2 mt -68.23 -55.36 16.67 Favored 'Isoleucine or valine' 0 C--O 1.217 -0.638 0 C-N-CA 117.919 -1.512 . . . . 1.0 113.055 -175.183 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 117' ' ' GLU . . . . . 0.754 ' HB3' ' O ' ' A' ' 113' ' ' ASN . 0.0 OUTLIER -39.56 -65.6 0.37 Allowed 'General case' 0 C--O 1.251 1.166 0 C-N-CA 121.079 -0.248 . . . . 1.0 110.453 -174.271 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 2.5 t -45.36 -18.63 0.1 Allowed 'Isoleucine or valine' 0 N--CA 1.446 -0.643 0 C-N-CA 119.124 -1.031 . . . . 1.0 109.81 -178.963 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 119' ' ' LEU . . . . . 0.603 ' N ' ' O ' ' A' ' 116' ' ' ILE . 4.7 tt -88.57 -54.92 3.94 Favored 'General case' 0 CA--C 1.538 0.504 0 N-CA-C 112.566 0.58 . . . . 1.0 112.566 176.899 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 120' ' ' GLY . . . . . 0.575 ' C ' ' H ' ' A' ' 122' ' ' GLY . . . -93.3 44.87 2.44 Favored Glycine 0 C--N 1.367 2.251 0 C-N-CA 119.821 -1.18 . . . . 1.0 113.937 -175.968 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 121' ' ' THR . . . . . 0.427 ' HB ' ' O ' ' A' ' 120' ' ' GLY . 41.5 m 73.66 -27.85 0.19 Allowed 'General case' 0 N--CA 1.476 0.848 0 C-N-CA 123.432 0.693 . . . . 1.0 109.92 177.742 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 122' ' ' GLY . . . . . 0.575 ' H ' ' C ' ' A' ' 120' ' ' GLY . . . 106.81 -36.07 4.64 Favored Glycine 0 C--N 1.319 -0.405 0 C-N-CA 124.777 1.179 . . . . 1.0 110.634 179.811 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 123' ' ' THR . . . . . 0.434 ' C ' ' O ' ' A' ' 122' ' ' GLY . 81.4 m -31.42 98.96 0.01 OUTLIER 'General case' 0 N--CA 1.465 0.281 0 CA-C-N 117.643 0.722 . . . . 1.0 112.421 -178.07 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 12.1 p-10 -142.83 143.25 32.05 Favored 'General case' 0 N--CA 1.45 -0.439 0 N-CA-C 108.058 -1.09 . . . . 1.0 108.058 177.352 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 125' ' ' TYR . . . . . 0.517 ' OH ' ' CD1' ' A' ' 127' ' ' PHE . 0.0 OUTLIER -153.03 149.1 27.81 Favored 'General case' 0 CA--C 1.542 0.646 0 C-N-CA 122.95 0.5 . . . . 1.0 109.682 -178.498 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 126' ' ' ARG . . . . . 0.465 ' NE ' ' O ' ' A' ' 125' ' ' TYR . 9.6 mmp_? -149.58 152.85 36.17 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.857 -0.61 . . . . 1.0 109.92 177.24 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 127' ' ' PHE . . . . . 0.517 ' CD1' ' OH ' ' A' ' 125' ' ' TYR . 10.6 p90 . . . . . 0 C--O 1.221 -0.436 0 CA-C-O 118.041 -0.981 . . . . 1.0 110.152 179.262 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 128' ' ' MTN . . . . . 0.72 ' H73' ' NE ' ' A' ' 47' ' ' ARG . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 129' ' ' MTN . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 130' ' ' MTN . . . . . 0.46 ' H62' ' CB ' ' A' ' 126' ' ' ARG . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.586 0 N-CA-C 109.083 -0.71 . . . . 1.0 109.083 . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . 0.414 ' O ' ' CG ' ' A' ' 3' ' ' ASP . 87.3 p -104.18 8.92 36.34 Favored 'General case' 0 N--CA 1.465 0.31 0 CA-C-N 115.672 -0.694 . . . . 1.0 110.187 -179.708 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . 0.414 ' CG ' ' O ' ' A' ' 2' ' ' SER . 1.6 m-20 166.44 98.32 0.0 OUTLIER 'General case' 0 CA--C 1.532 0.258 0 CA-C-N 116.163 -0.471 . . . . 1.0 109.963 178.974 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 3.4 t80 -149.68 145.84 26.93 Favored 'General case' 0 C--N 1.33 -0.251 0 N-CA-C 109.612 -0.514 . . . . 1.0 109.612 179.122 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 5' ' ' ASP . . . . . 0.631 ' O ' ' O ' ' A' ' 6' ' ' THR . 0.1 OUTLIER -155.06 154.31 32.25 Favored 'General case' 0 C--N 1.327 -0.413 0 N-CA-C 109.229 -0.656 . . . . 1.0 109.229 -179.95 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 6' ' ' THR . . . . . 0.726 HG22 ' H ' ' A' ' 7' ' ' GLU . 3.1 m -37.1 177.51 0.0 OUTLIER 'General case' 0 N--CA 1.469 0.501 0 CA-C-O 121.656 0.741 . . . . 1.0 111.646 -178.23 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . 0.726 ' H ' HG22 ' A' ' 6' ' ' THR . 50.9 mt-10 -66.29 -58.44 5.34 Favored 'General case' 0 C--N 1.319 -0.759 0 CA-C-N 116.231 -0.44 . . . . 1.0 110.758 -178.808 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 8' ' ' ARG . . . . . 0.409 ' HG3' ' N ' ' A' ' 9' ' ' VAL . 0.0 OUTLIER -68.55 -31.49 70.74 Favored 'General case' 0 N--CA 1.451 -0.41 0 CA-C-N 119.01 0.823 . . . . 1.0 111.029 179.477 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . 0.629 ' O ' HG23 ' A' ' 13' ' ' VAL . 60.0 t -66.69 -55.07 19.7 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.705 0 N-CA-C 108.228 -1.027 . . . . 1.0 108.228 179.651 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 22.9 t -68.49 -38.46 81.0 Favored 'General case' 0 C--N 1.321 -0.658 0 O-C-N 121.912 -0.493 . . . . 1.0 111.626 178.251 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 14.3 ttt-85 -74.12 -64.09 1.09 Allowed 'General case' 0 N--CA 1.453 -0.314 0 CA-C-O 118.488 -0.768 . . . . 1.0 111.361 -179.505 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . 0.547 ' O ' ' HB3' ' A' ' 16' ' ' ALA . . . -52.29 -30.77 29.72 Favored 'General case' 0 CA--C 1.501 -0.914 0 CA-C-N 120.319 1.418 . . . . 1.0 110.09 -179.48 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . 0.629 HG23 ' O ' ' A' ' 9' ' ' VAL . 3.6 t -56.27 -52.0 56.76 Favored 'Isoleucine or valine' 0 C--O 1.202 -1.43 0 N-CA-C 106.15 -1.796 . . . . 1.0 106.15 176.922 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . 0.615 ' O ' HG13 ' A' ' 18' ' ' VAL . . . -59.16 -63.54 1.26 Allowed 'General case' 0 CA--C 1.544 0.743 0 C-N-CA 117.395 -1.722 . . . . 1.0 110.983 177.72 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . 0.528 ' O ' ' N ' ' A' ' 19' ' ' GLY . . . -53.13 -54.73 31.38 Favored 'General case' 0 N--CA 1.484 1.225 0 CA-C-O 122.16 0.981 . . . . 1.0 110.844 -177.139 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . 0.579 ' HB1' ' CA ' ' A' ' 22' ' ' GLY . . . -63.07 -53.75 48.71 Favored 'General case' 0 C--N 1.303 -1.439 0 CA-C-N 113.915 -1.493 . . . . 1.0 108.984 -178.47 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . 0.607 ' CB ' ' O ' ' A' ' 13' ' ' VAL . 10.0 tp -57.47 -52.46 65.3 Favored 'General case' 0 N--CA 1.484 1.267 0 CA-C-N 114.48 -1.236 . . . . 1.0 108.576 -176.759 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . 0.615 HG13 ' O ' ' A' ' 14' ' ' ALA . 3.5 m -67.46 -56.56 12.9 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.245 0 C-N-CA 119.043 -1.063 . . . . 1.0 108.763 179.153 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . 0.528 ' N ' ' O ' ' A' ' 15' ' ' ALA . . . -61.61 -167.1 0.47 Allowed Glycine 0 CA--C 1.522 0.499 0 N-CA-C 111.58 -0.608 . . . . 1.0 111.58 -179.704 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 20' ' ' PRO . . . . . 0.627 ' O ' ' N ' ' A' ' 24' ' ' ALA . 56.1 Cg_endo -81.86 -32.71 0.75 Allowed 'Trans proline' 0 C--N 1.304 -1.773 0 C-N-CA 122.72 2.28 . . . . 1.0 114.467 -178.2 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -58.17 -57.41 19.98 Favored Glycine 0 N--CA 1.479 1.525 0 C-N-CA 120.481 -0.866 . . . . 1.0 112.318 -177.328 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . 0.579 ' CA ' ' HB1' ' A' ' 16' ' ' ALA . . . -58.65 -49.7 74.67 Favored Glycine 0 N--CA 1.472 1.034 0 N-CA-C 105.849 -2.9 . . . . 1.0 105.849 -176.123 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . 0.509 ' O ' HG12 ' A' ' 27' ' ' VAL . 2.5 t -58.7 -33.76 49.85 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.079 0 CA-C-N 114.035 -1.082 . . . . 1.0 108.355 178.334 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . 0.627 ' N ' ' O ' ' A' ' 20' ' ' PRO . . . -58.2 -61.9 2.22 Favored 'General case' 0 CA--C 1.536 0.413 0 C-N-CA 118.276 -1.37 . . . . 1.0 110.309 -179.511 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 56.5 mt -64.73 -42.67 95.04 Favored 'General case' 0 CA--C 1.52 -0.211 0 CA-C-N 118.982 0.81 . . . . 1.0 112.374 -177.49 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 75.1 t -60.68 -58.69 6.29 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.358 0 C-N-CA 119.096 -1.042 . . . . 1.0 109.327 -177.313 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . 0.509 HG12 ' O ' ' A' ' 23' ' ' VAL . 1.9 p -60.35 -34.66 58.44 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.518 0 N-CA-C 112.286 0.476 . . . . 1.0 112.286 -177.86 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 7.6 tppt? -65.55 -53.6 39.76 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-O 122.246 1.022 . . . . 1.0 109.094 -178.494 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 88.1 t -63.11 -46.58 95.68 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.125 0 CA-C-N 113.216 -1.811 . . . . 1.0 109.863 -177.231 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 30' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -65.35 -59.83 3.62 Favored 'General case' 0 N--CA 1.447 -0.602 0 C-N-CA 118.455 -1.298 . . . . 1.0 109.054 -179.419 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -60.27 -52.36 65.63 Favored 'General case' 0 CA--C 1.509 -0.619 0 N-CA-C 112.118 0.414 . . . . 1.0 112.118 -176.708 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . 0.471 ' O ' ' CB ' ' A' ' 33' ' ' LEU . . . 83.57 77.58 1.11 Allowed Glycine 0 CA--C 1.524 0.642 0 N-CA-C 109.918 -1.273 . . . . 1.0 109.918 -178.55 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . 0.471 ' CB ' ' O ' ' A' ' 32' ' ' GLY . 4.0 tp 85.02 107.84 0.03 OUTLIER Pre-proline 0 CA--C 1.548 0.884 0 O-C-N 123.885 0.403 . . . . 1.0 110.685 -179.927 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 37.6 Cg_endo -67.83 -27.51 37.32 Favored 'Trans proline' 0 N--CA 1.499 1.837 0 C-N-CA 121.632 1.555 . . . . 1.0 113.711 -179.001 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -60.83 -59.72 9.68 Favored Glycine 0 CA--C 1.525 0.694 0 C-N-CA 118.516 -1.802 . . . . 1.0 109.551 -177.564 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . 0.864 ' O ' HG23 ' A' ' 37' ' ' ILE . 1.7 p -84.01 142.71 13.04 Favored 'Isoleucine or valine' 0 C--O 1.211 -0.924 0 N-CA-C 106.822 -1.547 . . . . 1.0 106.822 178.011 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . 0.864 HG23 ' O ' ' A' ' 36' ' ' VAL . 0.6 OUTLIER 150.54 88.87 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.475 0.809 0 O-C-N 123.556 0.535 . . . . 1.0 109.75 179.694 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 26.2 m-70 -134.64 128.0 32.25 Favored 'General case' 0 C--O 1.233 0.195 0 N-CA-C 107.277 -1.379 . . . . 1.0 107.277 176.91 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . 0.553 ' O ' ' NH2' ' A' ' 42' ' ' ARG . 1.0 OUTLIER -121.6 158.5 53.85 Favored Pre-proline 0 N--CA 1.468 0.463 0 N-CA-C 109.43 -0.581 . . . . 1.0 109.43 -179.189 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 40' ' ' PRO . . . . . 0.508 ' HG2' ' H ' ' A' ' 41' ' ' ALA . 97.4 Cg_endo -85.41 -78.76 0.0 OUTLIER 'Trans proline' 0 C--N 1.31 -1.456 0 C-N-CA 121.36 1.374 . . . . 1.0 113.306 179.99 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . 0.508 ' H ' ' HG2' ' A' ' 40' ' ' PRO . . . -76.11 123.3 25.59 Favored 'General case' 0 C--N 1.319 -0.737 0 CA-C-N 114.955 -1.021 . . . . 1.0 111.875 -176.802 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . 0.655 ' C ' ' H ' ' A' ' 44' ' ' GLY . 0.0 OUTLIER -171.14 171.06 5.89 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 114.493 -1.23 . . . . 1.0 109.502 179.071 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 8.6 tpt180 -63.53 18.07 0.01 OUTLIER 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.512 -0.767 . . . . 1.0 109.761 178.989 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . 0.655 ' H ' ' C ' ' A' ' 42' ' ' ARG . . . 81.38 -25.48 3.77 Favored Glycine 0 C--N 1.336 0.542 0 N-CA-C 110.731 -0.948 . . . . 1.0 110.731 179.343 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . 0.538 ' O ' ' CD1' ' A' ' 46' ' ' PHE . 84.9 t80 -161.72 163.23 29.81 Favored 'General case' 0 CA--C 1.535 0.388 0 N-CA-C 110.5 -0.185 . . . . 1.0 110.5 -179.328 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 46' ' ' PHE . . . . . 0.538 ' CD1' ' O ' ' A' ' 45' ' ' PHE . 3.9 m-30 136.61 86.49 0.0 OUTLIER 'General case' 0 N--CA 1.487 1.405 0 O-C-N 124.782 1.301 . . . . 1.0 110.308 179.369 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 47' ' ' ARG . . . . . 0.509 ' CB ' ' O ' ' A' ' 46' ' ' PHE . 5.2 mmp_? 132.57 140.77 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.512 0 C-N-CA 124.392 1.077 . . . . 1.0 109.642 178.568 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 48' ' ' CYS . . . . . 0.786 ' O ' ' H62' ' A' ' 129' ' ' MTN . 1.9 t 72.74 72.02 0.14 Allowed 'General case' 0 N--CA 1.451 -0.386 0 C-N-CA 120.277 -0.569 . . . . 1.0 109.672 -179.631 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 49' ' ' ASN . . . . . 0.655 ' O ' ' N ' ' A' ' 51' ' ' GLU . 0.0 OUTLIER -136.37 121.9 13.38 Favored Pre-proline 0 C--O 1.221 -0.439 0 N-CA-C 107.923 -1.14 . . . . 1.0 107.923 -179.464 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 52.4 Cg_exo -52.21 63.96 0.02 OUTLIER 'Trans proline' 0 N--CA 1.503 2.03 0 C-N-CA 121.94 1.76 . . . . 1.0 113.311 178.786 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . 0.655 ' N ' ' O ' ' A' ' 49' ' ' ASN . 2.5 mp0 65.05 36.79 7.15 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 120.523 0.202 . . . . 1.0 110.81 -179.978 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . 0.489 HH21 ' HB3' ' A' ' 86' ' ' ALA . 4.7 mtp85 -111.21 138.58 47.48 Favored 'General case' 0 N--CA 1.466 0.367 0 CA-C-N 116.515 -0.311 . . . . 1.0 110.176 179.634 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . 0.578 HG23 HG23 ' A' ' 55' ' ' ILE . 4.7 tp -66.54 141.38 18.07 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-O 121.836 0.826 . . . . 1.0 110.611 179.97 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 54' ' ' GLN . . . . . 0.521 ' O ' ' CG ' ' A' ' 54' ' ' GLN . 0.0 OUTLIER -63.03 80.78 0.02 OUTLIER 'General case' 0 CA--C 1.55 0.977 0 CA-C-N 113.739 -1.573 . . . . 1.0 109.915 -176.433 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . 0.827 HD13 ' O ' ' A' ' 55' ' ' ILE . 0.0 OUTLIER -150.05 158.38 5.65 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.875 0 O-C-N 121.038 -1.039 . . . . 1.0 110.224 178.091 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 110.43 -7.26 30.29 Favored Glycine 0 N--CA 1.474 1.17 0 N-CA-C 111.05 -0.82 . . . . 1.0 111.05 -179.522 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . 0.452 ' O ' ' OD1' ' A' ' 57' ' ' ASP . 42.3 p-10 -77.22 97.88 4.95 Favored 'General case' 0 C--N 1.318 -0.769 0 N-CA-C 108.079 -1.082 . . . . 1.0 108.079 177.59 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 58' ' ' TRP . . . . . . . . . . . . . 0.6 OUTLIER -88.88 175.19 7.55 Favored 'General case' 0 CA--C 1.538 0.506 0 CA-C-O 122.757 1.265 . . . . 1.0 112.321 -177.753 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 59' ' ' ARG . . . . . 0.52 ' HD2' ' H ' ' A' ' 59' ' ' ARG . 0.6 OUTLIER -88.52 -57.69 2.83 Favored 'General case' 0 C--N 1.318 -0.79 0 CA-C-N 112.479 -2.146 . . . . 1.0 112.985 179.963 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 79.0 t80 -90.73 -17.73 26.2 Favored 'General case' 0 C--O 1.245 0.866 0 CA-C-N 115.115 -0.948 . . . . 1.0 113.012 -178.553 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . 0.485 ' O ' ' N ' ' A' ' 65' ' ' ASP . 17.6 tt0 -77.19 -12.9 60.0 Favored 'General case' 0 N--CA 1.435 -1.214 0 O-C-N 121.844 -0.535 . . . . 1.0 110.275 -178.605 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . 0.576 HG23 ' H ' ' A' ' 63' ' ' ALA . 16.1 m -45.45 -55.73 1.18 Allowed 'Isoleucine or valine' 0 C--O 1.21 -1.01 0 C-N-CA 119.602 -0.839 . . . . 1.0 109.126 -175.385 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 63' ' ' ALA . . . . . 0.576 ' H ' HG23 ' A' ' 62' ' ' VAL . . . -65.43 -48.86 71.29 Favored 'General case' 0 C--N 1.306 -1.315 0 N-CA-C 109.306 -0.627 . . . . 1.0 109.306 178.721 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER -53.15 -58.85 5.61 Favored 'General case' 0 CA--C 1.539 0.533 0 C-N-CA 119.28 -0.968 . . . . 1.0 109.429 -179.084 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . 0.54 ' C ' ' H ' ' A' ' 67' ' ' ARG . 19.0 m-20 -65.28 -45.67 83.52 Favored 'General case' 0 C--N 1.324 -0.524 0 N-CA-C 108.849 -0.797 . . . . 1.0 108.849 178.085 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . 0.521 ' N ' ' O ' ' A' ' 62' ' ' VAL . . . -67.49 24.44 0.22 Allowed Glycine 0 C--N 1.338 0.655 0 N-CA-C 111.629 -0.588 . . . . 1.0 111.629 -179.976 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 67' ' ' ARG . . . . . 0.54 ' H ' ' C ' ' A' ' 65' ' ' ASP . 0.0 OUTLIER -86.36 -9.89 55.47 Favored 'General case' 0 C--N 1.315 -0.893 0 N-CA-C 108.587 -0.894 . . . . 1.0 108.587 175.602 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . 0.513 ' O ' ' CA ' ' A' ' 72' ' ' HIS . 1.4 pt? -63.35 -34.92 78.77 Favored 'General case' 0 N--CA 1.472 0.632 0 N-CA-C 112.97 0.73 . . . . 1.0 112.97 -177.868 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -52.29 -65.51 0.55 Allowed 'General case' 0 C--N 1.317 -0.828 0 C-N-CA 117.433 -1.707 . . . . 1.0 109.25 -177.622 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -64.7 -75.76 0.08 Allowed 'General case' 0 C--N 1.312 -1.029 0 N-CA-C 106.511 -1.662 . . . . 1.0 106.511 -179.811 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . 0.745 ' O ' ' N ' ' A' ' 73' ' ' MET . . . -59.56 15.74 0.01 OUTLIER 'General case' 0 C--N 1.321 -0.636 0 C-N-CA 127.172 2.189 . . . . 1.0 116.084 179.94 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 72' ' ' HIS . . . . . 0.513 ' CA ' ' O ' ' A' ' 68' ' ' LEU . 0.0 OUTLIER -21.94 -28.48 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.588 0 CA-C-N 119.638 1.108 . . . . 1.0 113.756 -176.11 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 73' ' ' MET . . . . . 0.745 ' N ' ' O ' ' A' ' 71' ' ' ALA . 4.0 mmt -63.72 -56.65 14.03 Favored 'General case' 0 C--N 1.317 -0.816 0 C-N-CA 117.64 -1.624 . . . . 1.0 106.875 174.789 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . 0.783 ' O ' ' N ' ' A' ' 76' ' ' GLY . 27.9 t -36.92 -51.08 0.3 Allowed 'Isoleucine or valine' 0 N--CA 1.48 1.037 0 CA-C-O 118.483 -0.77 . . . . 1.0 111.155 -175.86 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 75' ' ' ASN . . . . . 0.524 ' O ' HG12 ' A' ' 78' ' ' VAL . 26.0 t30 -30.71 -16.64 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.492 0 CA-C-N 119.302 0.956 . . . . 1.0 113.382 -178.2 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . 0.783 ' N ' ' O ' ' A' ' 74' ' ' VAL . . . -48.2 -25.05 3.85 Favored Glycine 0 CA--C 1.543 1.822 0 N-CA-C 109.991 -1.243 . . . . 1.0 109.991 176.404 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . 0.578 HG13 ' H ' ' A' ' 78' ' ' VAL . 3.0 pt -73.29 -55.55 12.3 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.679 0 CA-C-O 122.366 1.079 . . . . 1.0 109.078 178.552 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . 0.578 ' H ' HG13 ' A' ' 77' ' ' ILE . 1.4 p -38.59 -34.85 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.311 -1.083 0 CA-C-N 112.395 -2.184 . . . . 1.0 105.405 -175.666 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . 0.728 ' O ' ' HB3' ' A' ' 83' ' ' ALA . 16.2 pt -100.06 -37.58 5.92 Favored 'Isoleucine or valine' 0 CA--C 1.554 1.126 0 N-CA-C 113.924 1.083 . . . . 1.0 113.924 176.712 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 80' ' ' ALA . . . . . 0.519 ' N ' ' O ' ' A' ' 76' ' ' GLY . . . -82.39 -12.78 57.7 Favored 'General case' 0 N--CA 1.478 0.969 0 N-CA-C 113.645 0.98 . . . . 1.0 113.645 -178.86 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 45.5 tt0 -92.17 -73.14 0.56 Allowed 'General case' 0 N--CA 1.439 -0.995 0 CA-C-O 118.918 -0.563 . . . . 1.0 112.507 -178.636 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 28.3 m-20 -93.82 -16.84 23.72 Favored 'General case' 0 C--N 1.352 0.69 0 N-CA-C 114.843 1.423 . . . . 1.0 114.843 -178.551 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . 0.728 ' HB3' ' O ' ' A' ' 79' ' ' ILE . . . -52.94 -41.46 64.51 Favored 'General case' 0 N--CA 1.468 0.44 0 C-N-CA 118.713 -1.195 . . . . 1.0 111.205 -177.588 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 49.5 mt -39.37 -15.71 0.01 OUTLIER 'General case' 0 CA--C 1.538 0.505 0 N-CA-C 111.869 0.322 . . . . 1.0 111.869 -179.577 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 85' ' ' ILE . . . . . 0.62 ' N ' ' O ' ' A' ' 83' ' ' ALA . 0.8 OUTLIER -96.68 -31.55 4.01 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.618 0 C-N-CA 120.973 -0.291 . . . . 1.0 111.246 178.285 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . 0.658 ' O ' HG22 ' A' ' 89' ' ' VAL . . . -94.64 -28.66 15.25 Favored 'General case' 0 N--CA 1.466 0.375 0 CA-C-O 120.811 0.339 . . . . 1.0 111.842 -179.408 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -54.54 -7.7 0.18 Allowed 'General case' 0 C--N 1.32 -0.703 0 C-N-CA 119.308 -0.957 . . . . 1.0 110.196 -178.781 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . 0.483 ' H ' ' C ' ' A' ' 86' ' ' ALA . . . -79.73 -0.85 35.93 Favored 'General case' 0 N--CA 1.472 0.655 0 CA-C-O 122.209 1.004 . . . . 1.0 109.245 179.324 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 89' ' ' VAL . . . . . 0.658 HG22 ' O ' ' A' ' 86' ' ' ALA . 3.2 m -102.01 34.53 0.36 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.54 0 CA-C-N 113.025 -1.898 . . . . 1.0 109.744 178.548 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 90' ' ' GLY . . . . . 0.612 ' C ' ' H ' ' A' ' 92' ' ' HIS . . . -67.06 -38.27 92.38 Favored Glycine 0 C--N 1.345 1.052 0 N-CA-C 111.146 -0.782 . . . . 1.0 111.146 178.575 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 91' ' ' PRO . . . . . 0.539 ' CD ' ' N ' ' A' ' 90' ' ' GLY . 80.6 Cg_exo -46.96 -8.0 0.04 OUTLIER 'Trans proline' 0 N--CA 1.488 1.199 0 C-N-CA 121.75 1.633 . . . . 1.0 110.712 177.995 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 92' ' ' HIS . . . . . 0.612 ' H ' ' C ' ' A' ' 90' ' ' GLY . 2.6 p80 -57.42 -21.05 33.95 Favored 'General case' 0 N--CA 1.439 -1.0 0 N-CA-C 108.051 -1.092 . . . . 1.0 108.051 179.949 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . 0.656 HD12 ' N ' ' A' ' 94' ' ' ALA . 2.3 pp -61.64 -58.52 7.76 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.764 -0.653 . . . . 1.0 109.345 178.307 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 94' ' ' ALA . . . . . 0.656 ' N ' HD12 ' A' ' 93' ' ' LEU . . . -56.01 -52.39 64.38 Favored 'General case' 0 CA--C 1.515 -0.374 0 N-CA-C 108.983 -0.747 . . . . 1.0 108.983 179.532 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 95' ' ' ARG . . . . . 0.627 ' O ' ' N ' ' A' ' 97' ' ' LEU . 33.5 ttp180 -58.95 -60.25 4.16 Favored 'General case' 0 N--CA 1.442 -0.86 0 N-CA-C 107.565 -1.272 . . . . 1.0 107.565 178.39 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 96' ' ' ALA . . . . . 0.978 ' O ' ' N ' ' A' ' 98' ' ' GLY . . . -47.18 -13.71 0.03 OUTLIER 'General case' 0 C--N 1.301 -1.533 0 O-C-N 119.104 -2.247 . . . . 1.0 111.153 -178.689 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . 0.688 ' O ' ' N ' ' A' ' 100' ' ' ILE . 1.3 tm? 6.91 -52.53 0.0 OUTLIER 'General case' 0 C--N 1.365 1.242 0 CA-C-O 118.13 -0.938 . . . . 1.0 108.881 -166.886 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 98' ' ' GLY . . . . . 0.978 ' N ' ' O ' ' A' ' 96' ' ' ALA . . . -49.93 -24.29 6.19 Favored Glycine 0 CA--C 1.545 1.934 0 N-CA-C 107.898 -2.081 . . . . 1.0 107.898 174.218 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 99' ' ' GLN . . . . . 0.645 ' N ' ' O ' ' A' ' 96' ' ' ALA . 19.0 mt-30 -67.68 -19.32 65.16 Favored 'General case' 0 C--N 1.364 1.222 0 C-N-CA 116.073 -2.251 . . . . 1.0 107.263 176.375 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 100' ' ' ILE . . . . . 0.688 ' N ' ' O ' ' A' ' 97' ' ' LEU . 3.4 mm -66.67 -43.6 90.16 Favored 'Isoleucine or valine' 0 C--O 1.212 -0.872 0 C-N-CA 119.171 -1.012 . . . . 1.0 109.519 177.594 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 101' ' ' VAL . . . . . 0.503 HG13 ' N ' ' A' ' 102' ' ' CYS . 4.6 p -60.27 -56.8 15.19 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.32 0 C-N-CA 116.684 -2.006 . . . . 1.0 107.483 -179.924 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 102' ' ' CYS . . . . . 0.953 ' O ' ' HB2' ' A' ' 106' ' ' ALA . 0.5 OUTLIER -51.09 -31.67 19.78 Favored 'General case' 0 C--O 1.214 -0.812 0 CA-C-O 121.223 0.535 . . . . 1.0 112.019 179.845 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 103' ' ' ARG . . . . . 0.484 HH22 ' HB3' ' A' ' 93' ' ' LEU . 3.2 ttp180 -85.34 -47.46 10.0 Favored 'General case' 0 N--CA 1.477 0.904 0 CA-C-N 115.254 -0.884 . . . . 1.0 111.745 179.545 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 104' ' ' TYR . . . . . 0.401 ' O ' ' CG ' ' A' ' 104' ' ' TYR . 8.7 t80 -49.73 -19.36 0.62 Allowed 'General case' 0 C--N 1.3 -1.571 0 CA-C-N 114.086 -1.416 . . . . 1.0 108.937 179.28 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 105' ' ' GLY . . . . . 0.475 ' O ' ' HB3' ' A' ' 106' ' ' ALA . . . -173.64 -46.52 0.05 OUTLIER Glycine 0 N--CA 1.448 -0.526 0 C-N-CA 117.967 -2.063 . . . . 1.0 110.828 179.379 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 106' ' ' ALA . . . . . 0.953 ' HB2' ' O ' ' A' ' 102' ' ' CYS . . . 69.7 82.63 0.16 Allowed 'General case' 0 N--CA 1.44 -0.963 0 N-CA-C 111.628 0.232 . . . . 1.0 111.628 -179.081 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 107' ' ' THR . . . . . 0.426 ' O ' ' CD ' ' A' ' 110' ' ' PRO . 9.4 t -92.26 3.49 55.27 Favored 'General case' 0 CA--C 1.514 -0.44 0 N-CA-C 107.304 -1.369 . . . . 1.0 107.304 177.164 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . 0.76 ' O ' HG12 ' A' ' 108' ' ' VAL . 62.2 t -90.65 20.11 0.64 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.526 0 CA-C-N 114.883 -1.053 . . . . 1.0 111.352 178.593 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 109' ' ' ILE . . . . . 0.688 ' N ' ' CD ' ' A' ' 110' ' ' PRO . 0.1 OUTLIER -106.07 -18.26 0.17 Allowed Pre-proline 0 CA--C 1.548 0.869 0 O-C-N 120.162 -1.586 . . . . 1.0 110.954 177.994 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 110' ' ' PRO . . . . . 0.688 ' CD ' ' N ' ' A' ' 109' ' ' ILE . 19.5 Cg_endo -59.5 -49.56 10.2 Favored 'Trans proline' 0 N--CA 1.482 0.851 0 CA-C-N 120.5 1.214 . . . . 1.0 113.095 -174.533 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 111' ' ' ASN . . . . . 0.451 HD22 ' C ' ' A' ' 111' ' ' ASN . 0.2 OUTLIER -68.66 -66.78 0.53 Allowed 'General case' 0 C--O 1.217 -0.617 0 C-N-CA 118.542 -1.263 . . . . 1.0 109.55 -178.526 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 112' ' ' ILE . . . . . 0.581 ' O ' ' HB ' ' A' ' 116' ' ' ILE . 0.9 OUTLIER -48.41 -38.64 9.08 Favored 'Isoleucine or valine' 0 C--O 1.213 -0.862 0 CA-C-O 121.127 0.489 . . . . 1.0 111.659 -177.854 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 113' ' ' ASN . . . . . 0.556 ' N ' HG23 ' A' ' 112' ' ' ILE . 1.6 t-20 -67.59 -40.61 84.8 Favored 'General case' 0 C--N 1.313 -1.019 0 N-CA-C 106.502 -1.666 . . . . 1.0 106.502 178.585 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 114' ' ' ALA . . . . . 0.407 ' N ' ' O ' ' A' ' 111' ' ' ASN . . . -61.16 -51.4 69.21 Favored 'General case' 0 C--N 1.306 -1.307 0 CA-C-N 112.956 -1.929 . . . . 1.0 108.249 179.198 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -80.09 -59.7 2.62 Favored 'General case' 0 CA--C 1.544 0.725 0 N-CA-C 114.782 1.401 . . . . 1.0 114.782 179.582 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 116' ' ' ILE . . . . . 0.581 ' HB ' ' O ' ' A' ' 112' ' ' ILE . 0.7 OUTLIER -47.34 -50.53 7.52 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.884 0 CA-C-N 119.483 1.038 . . . . 1.0 111.52 -178.202 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 117' ' ' GLU . . . . . 0.498 ' CG ' ' N ' ' A' ' 118' ' ' VAL . 13.3 pt-20 -43.3 -58.57 2.47 Favored 'General case' 0 C--N 1.322 -0.623 0 N-CA-C 105.701 -1.962 . . . . 1.0 105.701 -179.365 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 118' ' ' VAL . . . . . 0.498 ' N ' ' CG ' ' A' ' 117' ' ' GLU . 88.1 t -58.43 -53.37 47.5 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.069 0 C-N-CA 119.24 -0.984 . . . . 1.0 110.043 177.757 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -52.31 -71.75 0.06 Allowed 'General case' 0 CA--C 1.545 0.765 0 N-CA-C 107.805 -1.183 . . . . 1.0 107.805 -177.922 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 120' ' ' GLY . . . . . 0.531 ' N ' ' O ' ' A' ' 116' ' ' ILE . . . -70.18 -76.05 0.55 Allowed Glycine 0 CA--C 1.546 2.002 0 C-N-CA 119.737 -1.221 . . . . 1.0 111.267 -179.87 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 121' ' ' THR . . . . . 0.493 ' CB ' ' O ' ' A' ' 120' ' ' GLY . 1.9 m 148.33 -28.68 0.01 OUTLIER 'General case' 0 N--CA 1.487 1.404 0 CA-C-N 112.294 -1.953 . . . . 1.0 110.914 -178.414 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 122' ' ' GLY . . . . . 0.643 ' O ' ' N ' ' A' ' 124' ' ' ASP . . . 102.59 -17.25 53.67 Favored Glycine 0 C--O 1.224 -0.497 0 N-CA-C 107.629 -2.188 . . . . 1.0 107.629 -176.856 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 123' ' ' THR . . . . . 0.6 HG23 ' O ' ' A' ' 123' ' ' THR . 8.1 t -53.99 85.34 0.0 OUTLIER 'General case' 0 N--CA 1.466 0.34 0 N-CA-C 106.043 -1.836 . . . . 1.0 106.043 178.379 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 124' ' ' ASP . . . . . 0.643 ' N ' ' O ' ' A' ' 122' ' ' GLY . 45.3 m-20 -163.41 169.45 18.91 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 113.344 -1.753 . . . . 1.0 111.972 -179.537 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 125' ' ' TYR . . . . . . . . . . . . . 2.0 t80 -146.47 144.52 29.72 Favored 'General case' 0 CA--C 1.542 0.662 0 N-CA-C 108.461 -0.94 . . . . 1.0 108.461 176.258 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 126' ' ' ARG . . . . . 0.641 HH21 HG21 ' A' ' 79' ' ' ILE . 1.9 mtp85 -146.44 149.33 33.5 Favored 'General case' 0 N--CA 1.466 0.326 0 N-CA-C 109.446 -0.576 . . . . 1.0 109.446 177.611 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 127' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.219 -0.506 0 CA-C-O 117.869 -1.062 . . . . 1.0 109.112 179.252 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 128' ' ' MTN . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 129' ' ' MTN . . . . . 0.786 ' H62' ' O ' ' A' ' 48' ' ' CYS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 130' ' ' MTN . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.587 ' SD ' ' N ' ' A' ' 1' ' ' MET . 0.0 OUTLIER . . . . . 0 N--CA 1.493 1.682 0 N-CA-C 108.561 -0.903 . . . . 1.0 108.561 . . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 35.9 t -106.18 7.96 31.83 Favored 'General case' 0 N--CA 1.466 0.337 0 CA-C-N 116.317 -0.401 . . . . 1.0 110.361 -179.867 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 3.9 t0 167.5 96.86 0.0 OUTLIER 'General case' 0 N--CA 1.47 0.551 0 O-C-N 123.728 0.642 . . . . 1.0 110.242 179.244 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 82.7 t80 -150.34 146.29 26.65 Favored 'General case' 0 N--CA 1.463 0.191 0 CA-C-N 116.161 -0.472 . . . . 1.0 110.568 179.7 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 5' ' ' ASP . . . . . 0.51 ' N ' ' OD1' ' A' ' 5' ' ' ASP . 1.5 p30 -158.55 153.95 25.86 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 121.129 0.49 . . . . 1.0 110.407 179.984 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 6' ' ' THR . . . . . 0.614 ' O ' ' N ' ' A' ' 10' ' ' SER . 0.2 OUTLIER -69.72 170.55 10.7 Favored 'General case' 0 C--O 1.205 -1.251 0 CA-C-N 115.777 -0.647 . . . . 1.0 110.359 -179.453 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 1.6 tm-20 -55.31 -58.36 8.03 Favored 'General case' 0 C--N 1.31 -1.144 0 CA-C-N 115.367 -0.833 . . . . 1.0 109.72 -178.719 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 8' ' ' ARG . . . . . 0.583 HH11 HG13 ' A' ' 9' ' ' VAL . 5.5 tmm_? -51.52 -54.7 24.58 Favored 'General case' 0 C--N 1.311 -1.072 0 C-N-CA 119.17 -1.012 . . . . 1.0 108.599 -177.553 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . 0.583 HG13 HH11 ' A' ' 8' ' ' ARG . 0.0 OUTLIER -65.51 -48.76 81.69 Favored 'Isoleucine or valine' 0 CA--C 1.551 0.991 0 CA-C-N 115.673 -0.694 . . . . 1.0 110.718 178.896 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . 0.614 ' N ' ' O ' ' A' ' 6' ' ' THR . 35.5 t -63.41 -41.11 98.71 Favored 'General case' 0 C--N 1.318 -0.778 0 N-CA-C 115.007 1.484 . . . . 1.0 115.007 -178.18 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 11' ' ' ARG . . . . . 0.597 ' O ' ' N ' ' A' ' 15' ' ' ALA . 56.9 ttm-85 -79.99 -55.11 5.19 Favored 'General case' 0 C--O 1.216 -0.704 0 CA-C-O 122.478 1.133 . . . . 1.0 108.988 176.808 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . 0.563 ' O ' ' HB3' ' A' ' 16' ' ' ALA . . . -45.85 -50.31 14.4 Favored 'General case' 0 N--CA 1.469 0.489 0 N-CA-C 106.361 -1.718 . . . . 1.0 106.361 -177.605 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . 0.602 ' O ' ' CB ' ' A' ' 17' ' ' LEU . 75.0 t -60.24 -49.8 82.75 Favored 'Isoleucine or valine' 0 C--O 1.202 -1.433 0 C-N-CA 118.265 -1.374 . . . . 1.0 107.686 177.568 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . 0.676 ' O ' HG13 ' A' ' 18' ' ' VAL . . . -59.01 -62.84 1.58 Allowed 'General case' 0 N--CA 1.48 1.072 0 C-N-CA 119.356 -0.938 . . . . 1.0 111.443 178.821 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . 0.597 ' N ' ' O ' ' A' ' 11' ' ' ARG . . . -53.43 -55.38 25.66 Favored 'General case' 0 N--CA 1.473 0.71 0 CA-C-O 121.586 0.707 . . . . 1.0 109.902 -177.77 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . 0.563 ' HB3' ' O ' ' A' ' 12' ' ' ALA . . . -63.91 -53.99 41.77 Favored 'General case' 0 C--N 1.314 -0.935 0 CA-C-N 114.39 -1.277 . . . . 1.0 108.879 -179.272 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . 0.602 ' CB ' ' O ' ' A' ' 13' ' ' VAL . 8.2 tt -56.57 -53.71 54.41 Favored 'General case' 0 N--CA 1.477 0.907 0 C-N-CA 118.698 -1.201 . . . . 1.0 109.026 -177.477 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . 0.676 HG13 ' O ' ' A' ' 14' ' ' ALA . 2.4 m -68.4 -55.78 14.94 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.798 0 C-N-CA 119.436 -0.906 . . . . 1.0 109.84 179.599 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . 0.505 ' N ' ' CG2' ' A' ' 18' ' ' VAL . . . -65.88 -174.46 5.28 Favored Glycine 0 CA--C 1.531 1.071 0 N-CA-C 111.825 -0.51 . . . . 1.0 111.825 -178.617 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 20' ' ' PRO . . . . . 0.597 ' O ' ' N ' ' A' ' 24' ' ' ALA . 1.3 Cg_endo -77.22 -23.15 10.55 Favored 'Trans proline' 0 N--CA 1.492 1.394 0 C-N-CA 123.065 2.51 . . . . 1.0 114.501 -179.123 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -59.73 -58.56 13.6 Favored Glycine 0 N--CA 1.474 1.185 0 C-N-CA 119.517 -1.325 . . . . 1.0 110.893 -177.205 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . 0.512 ' CA ' ' HB1' ' A' ' 16' ' ' ALA . . . -56.63 -53.37 44.23 Favored Glycine 0 C--N 1.314 -0.659 0 N-CA-C 107.231 -2.348 . . . . 1.0 107.231 -178.743 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . 0.586 ' O ' HG12 ' A' ' 27' ' ' VAL . 60.9 t -58.01 -31.74 42.01 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.883 0 CA-C-N 114.789 -0.705 . . . . 1.0 110.245 179.598 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . 0.597 ' N ' ' O ' ' A' ' 20' ' ' PRO . . . -61.54 -59.96 4.42 Favored 'General case' 0 CA--C 1.533 0.307 0 C-N-CA 118.884 -1.126 . . . . 1.0 108.61 179.888 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 19.1 tp -61.94 -47.6 84.16 Favored 'General case' 0 C--N 1.342 0.282 0 N-CA-C 112.852 0.686 . . . . 1.0 112.852 -179.099 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 89.9 t -60.03 -60.19 2.91 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.189 0 C-N-CA 119.055 -1.058 . . . . 1.0 110.105 -177.669 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . 0.661 ' O ' ' HB3' ' A' ' 31' ' ' ALA . 1.8 p -58.91 -35.33 55.92 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.352 0 N-CA-C 112.456 0.539 . . . . 1.0 112.456 -178.52 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 1.1 mmmm -66.08 -54.48 25.24 Favored 'General case' 0 CA--C 1.517 -0.298 0 C-N-CA 119.499 -0.881 . . . . 1.0 108.874 -178.745 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 4.0 t -65.89 -48.78 80.78 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.842 0 CA-C-N 114.016 -1.447 . . . . 1.0 111.017 -177.242 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 30' ' ' CYS . . . . . . . . . . . . . 4.8 t -64.45 -60.51 3.07 Favored 'General case' 0 N--CA 1.445 -0.721 0 C-N-CA 117.685 -1.606 . . . . 1.0 109.61 -179.837 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . 0.661 ' HB3' ' O ' ' A' ' 27' ' ' VAL . . . -68.2 -55.59 11.76 Favored 'General case' 0 C--N 1.331 -0.235 0 N-CA-C 114.846 1.425 . . . . 1.0 114.846 -175.163 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . 0.41 ' O ' ' CB ' ' A' ' 33' ' ' LEU . . . 85.69 72.9 1.28 Allowed Glycine 0 CA--C 1.534 1.223 0 C-N-CA 120.673 -0.775 . . . . 1.0 111.56 -178.76 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . 0.436 ' O ' ' N ' ' A' ' 35' ' ' GLY . 0.9 OUTLIER 73.0 99.36 0.04 OUTLIER Pre-proline 0 CA--C 1.554 1.101 0 C-N-CA 120.985 -0.286 . . . . 1.0 111.304 178.107 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_exo -43.45 -9.98 0.03 OUTLIER 'Trans proline' 0 N--CA 1.511 2.525 0 C-N-CA 123.92 3.08 . . . . 1.0 115.57 -179.218 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . 0.436 ' N ' ' O ' ' A' ' 33' ' ' LEU . . . -59.54 -59.04 11.3 Favored Glycine 0 CA--C 1.529 0.952 0 C-N-CA 118.562 -1.78 . . . . 1.0 109.189 -179.047 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . 0.446 HG22 ' H ' ' A' ' 36' ' ' VAL . 6.1 m -85.96 -148.1 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.332 -0.177 0 N-CA-C 109.199 -0.667 . . . . 1.0 109.199 179.422 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . 0.48 HD13 ' HB1' ' A' ' 31' ' ' ALA . 2.1 mp 74.71 80.03 0.04 OUTLIER 'Isoleucine or valine' 0 CA--C 1.514 -0.436 0 N-CA-C 112.819 0.674 . . . . 1.0 112.819 179.415 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 55.6 m80 -135.71 126.74 27.85 Favored 'General case' 0 C--N 1.329 -0.29 0 N-CA-C 106.514 -1.661 . . . . 1.0 106.514 176.979 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . 0.576 ' OG1' ' NE ' ' A' ' 42' ' ' ARG . 0.0 OUTLIER -103.36 136.63 19.19 Favored Pre-proline 0 N--CA 1.469 0.492 0 N-CA-C 109.835 -0.431 . . . . 1.0 109.835 -178.968 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 32.3 Cg_exo -53.92 -32.53 68.11 Favored 'Trans proline' 0 N--CA 1.486 1.088 0 C-N-CA 121.076 1.184 . . . . 1.0 113.529 -179.68 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -128.21 132.06 48.82 Favored 'General case' 0 N--CA 1.463 0.192 0 O-C-N 122.191 -0.318 . . . . 1.0 111.226 -179.864 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . 0.708 ' C ' ' H ' ' A' ' 44' ' ' GLY . 12.1 mtm180 -160.39 158.57 29.78 Favored 'General case' 0 C--N 1.321 -0.665 0 N-CA-C 109.151 -0.685 . . . . 1.0 109.151 176.131 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 43' ' ' ARG . . . . . 0.416 ' C ' ' H ' ' A' ' 45' ' ' PHE . 41.9 ttt85 -60.28 23.46 0.01 OUTLIER 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 115.487 -0.779 . . . . 1.0 110.142 179.933 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . 0.708 ' H ' ' C ' ' A' ' 42' ' ' ARG . . . 80.68 -26.38 3.17 Favored Glycine 0 N--CA 1.445 -0.72 0 N-CA-C 110.126 -1.19 . . . . 1.0 110.126 -179.645 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . 0.588 ' CG ' ' C ' ' A' ' 44' ' ' GLY . 0.1 OUTLIER -179.33 -174.13 0.3 Allowed 'General case' 0 CA--C 1.537 0.464 0 C-N-CA 120.91 -0.316 . . . . 1.0 111.083 -178.801 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 46' ' ' PHE . . . . . 0.549 ' CB ' ' O ' ' A' ' 45' ' ' PHE . 15.2 t80 117.64 107.05 0.0 OUTLIER 'General case' 0 N--CA 1.488 1.428 0 O-C-N 125.044 1.465 . . . . 1.0 109.359 -179.454 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 47' ' ' ARG . . . . . 0.496 ' CB ' ' O ' ' A' ' 46' ' ' PHE . 3.9 tmm_? 100.09 167.3 0.01 OUTLIER 'General case' 0 N--CA 1.467 0.395 0 CA-C-N 115.141 -0.936 . . . . 1.0 108.632 -178.244 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 7.7 t 75.6 -18.03 0.48 Allowed 'General case' 0 N--CA 1.472 0.643 0 CA-C-O 120.646 0.26 . . . . 1.0 111.332 -179.158 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 49' ' ' ASN . . . . . 0.751 ' ND2' ' H ' ' A' ' 52' ' ' ARG . 0.2 OUTLIER -62.2 146.27 92.69 Favored Pre-proline 0 CA--C 1.547 0.838 0 CA-C-N 116.317 -0.402 . . . . 1.0 111.909 -179.17 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . 0.417 ' N ' ' ND2' ' A' ' 49' ' ' ASN . 25.2 Cg_exo -60.68 66.65 0.08 OUTLIER 'Trans proline' 0 N--CA 1.501 1.94 0 C-N-CA 121.918 1.746 . . . . 1.0 111.703 177.289 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . 0.522 ' N ' ' O ' ' A' ' 49' ' ' ASN . 23.1 mm-40 46.76 55.73 7.44 Favored 'General case' 0 CA--C 1.554 1.096 0 N-CA-C 113.074 0.768 . . . . 1.0 113.074 177.979 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . 0.751 ' H ' ' ND2' ' A' ' 49' ' ' ASN . 7.7 mtt-85 -143.57 155.72 44.38 Favored 'General case' 0 N--CA 1.498 1.928 0 CA-C-O 119.494 -0.289 . . . . 1.0 110.555 178.225 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 10.4 tp -75.75 127.94 37.24 Favored 'Isoleucine or valine' 0 CA--C 1.56 1.358 0 N-CA-C 116.258 1.947 . . . . 1.0 116.258 -174.361 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 47.3 tp60 -65.2 86.0 0.06 Allowed 'General case' 0 N--CA 1.476 0.848 0 CA-C-N 109.728 -3.396 . . . . 1.0 109.457 -177.716 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . 0.486 HD13 ' N ' ' A' ' 56' ' ' GLY . 0.0 OUTLIER -147.27 155.58 10.86 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.845 0 N-CA-C 109.692 -0.484 . . . . 1.0 109.692 178.151 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . 0.486 ' N ' HD13 ' A' ' 55' ' ' ILE . . . 107.51 -5.38 35.29 Favored Glycine 0 N--CA 1.48 1.621 0 N-CA-C 111.262 -0.735 . . . . 1.0 111.262 179.452 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -112.7 129.61 56.34 Favored 'General case' 0 C--N 1.317 -0.808 0 N-CA-C 108.206 -1.035 . . . . 1.0 108.206 178.071 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 58' ' ' TRP . . . . . 0.6 ' H ' ' HB2' ' A' ' 61' ' ' GLU . 11.5 m0 -134.25 152.36 51.78 Favored 'General case' 0 C--N 1.348 0.536 0 CA-C-O 122.333 1.063 . . . . 1.0 109.834 -179.829 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -37.73 -39.79 0.37 Allowed 'General case' 0 CA--C 1.558 1.252 0 CA-C-N 113.047 -1.888 . . . . 1.0 110.767 -177.015 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 7.3 t80 -86.29 -27.4 24.4 Favored 'General case' 0 N--CA 1.481 1.099 0 CA-C-O 121.953 0.882 . . . . 1.0 112.626 -179.434 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . 0.6 ' HB2' ' H ' ' A' ' 58' ' ' TRP . 39.9 mt-10 -78.64 -13.0 60.04 Favored 'General case' 0 CA--C 1.509 -0.613 0 CA-C-N 115.639 -0.709 . . . . 1.0 110.377 179.015 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . 0.654 ' O ' ' N ' ' A' ' 66' ' ' GLY . 49.5 t -50.01 -57.06 2.51 Favored 'Isoleucine or valine' 0 C--O 1.202 -1.401 0 C-N-CA 119.328 -0.949 . . . . 1.0 109.8 -176.806 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 63' ' ' ALA . . . . . 0.48 ' O ' ' HG3' ' A' ' 67' ' ' ARG . . . -65.27 -57.36 8.64 Favored 'General case' 0 C--N 1.307 -1.278 0 O-C-N 121.33 -0.856 . . . . 1.0 110.21 -178.669 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 40.3 t-80 -47.44 -56.92 6.01 Favored 'General case' 0 N--CA 1.472 0.67 0 O-C-N 124.171 0.919 . . . . 1.0 109.573 179.976 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . 0.585 ' C ' ' H ' ' A' ' 67' ' ' ARG . 30.0 t0 -74.56 -48.99 23.58 Favored 'General case' 0 C--N 1.316 -0.853 0 CA-C-N 115.476 -0.784 . . . . 1.0 111.167 179.511 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . 0.654 ' N ' ' O ' ' A' ' 62' ' ' VAL . . . -74.3 26.42 1.04 Allowed Glycine 0 CA--C 1.521 0.427 0 N-CA-C 109.905 -1.278 . . . . 1.0 109.905 177.35 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 67' ' ' ARG . . . . . 0.647 ' O ' ' N ' ' A' ' 69' ' ' LEU . 33.4 mtm180 -71.97 5.51 2.62 Favored 'General case' 0 CA--C 1.512 -0.516 0 N-CA-C 104.996 -2.224 . . . . 1.0 104.996 174.032 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . 0.578 ' H ' ' C ' ' A' ' 66' ' ' GLY . 7.9 tt -31.76 -29.13 0.01 OUTLIER 'General case' 0 N--CA 1.473 0.686 0 O-C-N 124.11 0.881 . . . . 1.0 108.948 -177.417 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . 0.647 ' N ' ' O ' ' A' ' 67' ' ' ARG . 1.3 mt -64.35 -65.66 0.65 Allowed 'General case' 0 C--N 1.322 -0.628 0 C-N-CA 119.341 -0.943 . . . . 1.0 108.825 178.895 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . 0.622 ' O ' ' N ' ' A' ' 72' ' ' HIS . . . -78.62 -76.68 0.19 Allowed 'General case' 0 N--CA 1.47 0.554 0 N-CA-C 106.376 -1.712 . . . . 1.0 106.376 177.793 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . 0.482 ' O ' ' C ' ' A' ' 72' ' ' HIS . . . -43.06 4.13 0.0 OUTLIER 'General case' 0 C--N 1.326 -0.437 0 N-CA-C 114.336 1.235 . . . . 1.0 114.336 177.906 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 72' ' ' HIS . . . . . 0.704 ' CD2' ' H ' ' A' ' 73' ' ' MET . 1.4 p80 -32.21 -53.8 0.3 Allowed 'General case' 0 N--CA 1.467 0.407 0 CA-C-N 120.126 1.33 . . . . 1.0 112.11 -177.851 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 73' ' ' MET . . . . . 0.704 ' H ' ' CD2' ' A' ' 72' ' ' HIS . 4.9 tpp -73.57 -56.85 4.5 Favored 'General case' 0 C--N 1.331 -0.219 0 N-CA-C 108.017 -1.105 . . . . 1.0 108.017 177.926 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . 0.74 ' O ' ' N ' ' A' ' 76' ' ' GLY . 62.1 t -45.47 -42.72 3.44 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.319 0 CA-C-O 116.964 -1.493 . . . . 1.0 111.316 -176.515 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 75' ' ' ASN . . . . . 0.485 ' C ' ' N ' ' A' ' 77' ' ' ILE . 1.2 m-20 -36.55 -13.84 0.0 OUTLIER 'General case' 0 N--CA 1.501 2.078 0 CA-C-N 121.77 2.077 . . . . 1.0 111.318 177.907 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . 0.74 ' N ' ' O ' ' A' ' 74' ' ' VAL . . . -49.12 -20.7 2.19 Favored Glycine 0 CA--C 1.535 1.321 0 N-CA-C 106.624 -2.591 . . . . 1.0 106.624 173.035 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . 0.512 ' O ' ' N ' ' A' ' 81' ' ' GLU . 25.4 pt -61.21 -48.81 87.29 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.925 0 CA-C-O 117.043 -1.456 . . . . 1.0 112.159 -179.114 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . 0.409 HG12 ' O ' ' A' ' 75' ' ' ASN . 9.9 p -57.5 -18.49 9.22 Favored 'Isoleucine or valine' 0 C--N 1.363 1.162 0 CA-C-N 122.925 2.602 . . . . 1.0 113.069 179.444 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . 0.673 ' O ' ' HB3' ' A' ' 83' ' ' ALA . 0.1 OUTLIER -89.67 -38.63 11.38 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 N-CA-C 107.042 -1.466 . . . . 1.0 107.042 177.904 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -80.9 -16.67 52.96 Favored 'General case' 0 CA--C 1.538 0.483 0 CA-C-N 114.822 -1.081 . . . . 1.0 113.496 178.589 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . 0.512 ' N ' ' O ' ' A' ' 77' ' ' ILE . 48.2 tt0 -93.68 -71.94 0.63 Allowed 'General case' 0 N--CA 1.448 -0.543 0 CA-C-N 118.882 0.764 . . . . 1.0 112.47 -178.385 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 25.2 m-20 -89.29 -15.82 32.61 Favored 'General case' 0 CA--C 1.549 0.907 0 N-CA-C 115.717 1.747 . . . . 1.0 115.717 -178.137 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . 0.673 ' HB3' ' O ' ' A' ' 79' ' ' ILE . . . -54.51 -44.94 73.17 Favored 'General case' 0 N--CA 1.475 0.802 0 C-N-CA 118.747 -1.181 . . . . 1.0 111.897 -177.821 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . 0.741 HD13 ' O ' ' A' ' 84' ' ' LEU . 3.4 tm? -40.0 -28.74 0.06 Allowed 'General case' 0 CA--C 1.54 0.588 0 CA-C-N 119.141 0.882 . . . . 1.0 111.119 179.686 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 85' ' ' ILE . . . . . 0.421 ' N ' ' O ' ' A' ' 83' ' ' ALA . 68.1 mt -83.75 -37.13 12.99 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.509 0 CA-C-N 116.543 -0.298 . . . . 1.0 110.884 178.419 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . 0.77 ' O ' HG22 ' A' ' 89' ' ' VAL . . . -93.41 -26.83 17.06 Favored 'General case' 0 N--CA 1.471 0.623 0 CA-C-O 120.863 0.363 . . . . 1.0 111.324 179.855 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . 0.474 ' C ' ' H ' ' A' ' 89' ' ' VAL . 40.6 tp10 -54.26 -11.31 0.48 Allowed 'General case' 0 C--N 1.324 -0.514 0 CA-C-O 121.134 0.492 . . . . 1.0 110.081 -179.456 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . 0.407 ' N ' ' C ' ' A' ' 86' ' ' ALA . . . -74.8 2.25 10.57 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-O 122.439 1.114 . . . . 1.0 108.342 178.382 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 89' ' ' VAL . . . . . 0.77 HG22 ' O ' ' A' ' 86' ' ' ALA . 2.1 m -114.5 36.21 0.84 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.516 0 CA-C-N 112.766 -2.015 . . . . 1.0 110.334 178.914 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 90' ' ' GLY . . . . . 0.593 ' N ' ' CD ' ' A' ' 91' ' ' PRO . . . -77.59 -37.66 30.15 Favored Glycine 0 CA--C 1.534 1.26 0 N-CA-C 110.548 -1.021 . . . . 1.0 110.548 179.032 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 91' ' ' PRO . . . . . 0.593 ' CD ' ' N ' ' A' ' 90' ' ' GLY . 77.1 Cg_exo -50.63 -7.87 0.13 Allowed 'Trans proline' 0 N--CA 1.499 1.823 0 C-N-CA 122.459 2.106 . . . . 1.0 110.552 178.513 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 92' ' ' HIS . . . . . 0.697 ' NE2' ' NH2' ' A' ' 52' ' ' ARG . 0.2 OUTLIER -56.38 -12.22 1.57 Allowed 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 114.211 -1.359 . . . . 1.0 107.847 178.805 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . 0.62 HD12 ' N ' ' A' ' 94' ' ' ALA . 1.7 pp -68.34 -59.57 3.09 Favored 'General case' 0 CA--C 1.528 0.107 0 CA-C-N 115.493 -0.776 . . . . 1.0 109.172 178.158 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 94' ' ' ALA . . . . . 0.62 ' N ' HD12 ' A' ' 93' ' ' LEU . . . -58.22 -50.06 74.89 Favored 'General case' 0 CA--C 1.52 -0.208 0 C-N-CA 120.017 -0.673 . . . . 1.0 109.363 179.761 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 95' ' ' ARG . . . . . 0.594 ' O ' ' N ' ' A' ' 97' ' ' LEU . 17.2 tpt180 -56.72 -57.62 11.64 Favored 'General case' 0 CA--C 1.534 0.335 0 CA-C-O 123.034 1.397 . . . . 1.0 107.609 179.314 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 96' ' ' ALA . . . . . 1.046 ' O ' ' N ' ' A' ' 98' ' ' GLY . . . -49.21 -9.62 0.03 OUTLIER 'General case' 0 C--N 1.304 -1.403 0 O-C-N 118.643 -2.536 . . . . 1.0 111.126 179.395 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . 0.973 HD13 ' N ' ' A' ' 98' ' ' GLY . 0.0 OUTLIER 8.23 -47.81 0.0 OUTLIER 'General case' 0 N--CA 1.498 1.969 0 CA-C-O 117.361 -1.304 . . . . 1.0 109.105 -166.703 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 98' ' ' GLY . . . . . 1.046 ' N ' ' O ' ' A' ' 96' ' ' ALA . . . -48.03 -24.13 3.08 Favored Glycine 0 CA--C 1.551 2.313 0 CA-C-N 122.975 2.625 . . . . 1.0 107.071 171.998 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 99' ' ' GLN . . . . . 0.485 ' N ' ' O ' ' A' ' 96' ' ' ALA . 5.7 mm100 -69.82 -24.32 63.45 Favored 'General case' 0 C--N 1.386 2.17 0 C-N-CA 117.863 -1.535 . . . . 1.0 107.759 175.701 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 100' ' ' ILE . . . . . 0.72 ' N ' ' O ' ' A' ' 97' ' ' LEU . 10.2 mt -65.48 -45.61 92.32 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.837 0 C-N-CA 119.829 -0.748 . . . . 1.0 109.107 177.209 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 101' ' ' VAL . . . . . 0.699 ' O ' ' N ' ' A' ' 105' ' ' GLY . 21.7 t -55.23 -60.73 1.41 Allowed 'Isoleucine or valine' 0 C--O 1.214 -0.806 0 N-CA-C 108.065 -1.087 . . . . 1.0 108.065 178.723 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 102' ' ' CYS . . . . . 0.687 ' O ' ' HB2' ' A' ' 106' ' ' ALA . 0.5 OUTLIER -49.91 -22.16 1.42 Allowed 'General case' 0 C--O 1.204 -1.325 0 N-CA-C 112.768 0.655 . . . . 1.0 112.768 -179.163 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 58.8 ttt-85 -89.09 -48.13 7.62 Favored 'General case' 0 N--CA 1.485 1.292 0 CA-C-O 123.229 1.49 . . . . 1.0 112.194 179.418 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 104' ' ' TYR . . . . . 0.664 ' O ' ' CG ' ' A' ' 104' ' ' TYR . 0.0 OUTLIER -98.52 25.31 6.49 Favored 'General case' 0 C--N 1.297 -1.684 0 CA-C-N 111.663 -2.517 . . . . 1.0 107.157 177.849 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 105' ' ' GLY . . . . . 0.699 ' N ' ' O ' ' A' ' 101' ' ' VAL . . . -167.59 -100.61 0.14 Allowed Glycine 0 N--CA 1.441 -0.972 0 N-CA-C 108.725 -1.75 . . . . 1.0 108.725 179.363 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 106' ' ' ALA . . . . . 0.687 ' HB2' ' O ' ' A' ' 102' ' ' CYS . . . 73.6 59.14 0.09 Allowed 'General case' 0 N--CA 1.442 -0.827 0 CA-C-O 119.262 -0.399 . . . . 1.0 111.22 -178.6 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -80.11 5.37 14.49 Favored 'General case' 0 CA--C 1.51 -0.594 0 O-C-N 119.764 -1.835 . . . . 1.0 106.319 176.341 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 17.4 m -83.77 -53.52 11.03 Favored 'Isoleucine or valine' 0 C--N 1.347 0.472 0 C-N-CA 120.338 -0.545 . . . . 1.0 110.591 178.138 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 109' ' ' ILE . . . . . 0.654 HG23 ' HB1' ' A' ' 106' ' ' ALA . 0.1 OUTLIER -49.02 -37.7 21.01 Favored Pre-proline 0 N--CA 1.472 0.666 0 N-CA-C 115.308 1.596 . . . . 1.0 115.308 -176.894 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_exo -51.52 -49.36 17.43 Favored 'Trans proline' 0 C--N 1.311 -1.433 0 CA-C-N 122.386 1.888 . . . . 1.0 113.126 -176.475 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 87.2 m-20 -70.7 -69.05 0.39 Allowed 'General case' 0 CA--C 1.53 0.199 0 C-N-CA 118.829 -1.148 . . . . 1.0 110.915 -178.833 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 112' ' ' ILE . . . . . 0.404 HG23 ' H ' ' A' ' 112' ' ' ILE . 6.4 pt -46.22 -28.37 0.86 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.467 0 CA-C-O 121.826 0.822 . . . . 1.0 109.736 -179.477 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 113' ' ' ASN . . . . . 0.484 ' CB ' ' O ' ' A' ' 109' ' ' ILE . 34.2 t30 -61.92 -55.15 32.57 Favored 'General case' 0 CA--C 1.506 -0.733 0 CA-C-N 114.301 -1.318 . . . . 1.0 107.811 -178.976 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -61.98 -36.5 81.64 Favored 'General case' 0 N--CA 1.439 -0.976 0 CA-C-N 118.86 0.755 . . . . 1.0 112.387 -179.036 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -75.48 -58.92 2.99 Favored 'General case' 0 C--N 1.349 0.557 0 CA-C-N 120.402 1.455 . . . . 1.0 110.114 179.572 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 116' ' ' ILE . . . . . 0.537 ' O ' ' N ' ' A' ' 120' ' ' GLY . 5.0 mm -49.37 -48.87 18.63 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.663 0 CA-C-O 121.619 0.723 . . . . 1.0 109.182 -178.173 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 117' ' ' GLU . . . . . 0.501 ' O ' ' HA ' ' A' ' 121' ' ' THR . 37.7 tt0 -39.96 -60.74 0.97 Allowed 'General case' 0 C--O 1.215 -0.735 0 N-CA-C 106.213 -1.773 . . . . 1.0 106.213 179.279 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 94.2 t -59.14 -53.96 40.85 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.873 0 CA-C-N 114.973 -1.012 . . . . 1.0 109.824 178.559 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -53.09 -71.44 0.07 Allowed 'General case' 0 CA--C 1.552 1.021 0 N-CA-C 108.087 -1.079 . . . . 1.0 108.087 -178.395 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 120' ' ' GLY . . . . . 0.537 ' N ' ' O ' ' A' ' 116' ' ' ILE . . . -66.68 -76.85 0.33 Allowed Glycine 0 CA--C 1.538 1.502 0 C-N-CA 119.54 -1.314 . . . . 1.0 110.635 179.713 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 121' ' ' THR . . . . . 0.522 ' CB ' ' O ' ' A' ' 120' ' ' GLY . 2.2 m 145.43 -29.16 0.01 OUTLIER 'General case' 0 N--CA 1.486 1.359 0 CA-C-N 111.516 -2.342 . . . . 1.0 111.015 -178.451 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 122' ' ' GLY . . . . . 0.625 ' O ' ' N ' ' A' ' 124' ' ' ASP . . . 106.6 -16.12 41.0 Favored Glycine 0 C--O 1.226 -0.372 0 N-CA-C 107.763 -2.135 . . . . 1.0 107.763 -176.541 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 123' ' ' THR . . . . . 0.584 HG23 ' O ' ' A' ' 123' ' ' THR . 12.6 t -59.65 82.23 0.01 OUTLIER 'General case' 0 CA--C 1.537 0.471 0 N-CA-C 107.02 -1.474 . . . . 1.0 107.02 178.94 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 124' ' ' ASP . . . . . 0.625 ' N ' ' O ' ' A' ' 122' ' ' GLY . 27.8 m-20 -163.5 172.27 14.69 Favored 'General case' 0 N--CA 1.453 -0.302 0 CA-C-N 112.074 -2.33 . . . . 1.0 110.745 178.859 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 125' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -143.9 142.04 30.58 Favored 'General case' 0 C--N 1.32 -0.691 0 N-CA-C 107.298 -1.371 . . . . 1.0 107.298 175.846 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 126' ' ' ARG . . . . . 0.408 ' HA ' ' NE ' ' A' ' 126' ' ' ARG . 1.3 tpm_? -149.67 152.0 34.63 Favored 'General case' 0 C--N 1.33 -0.244 0 N-CA-C 110.111 -0.329 . . . . 1.0 110.111 178.772 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 127' ' ' PHE . . . . . . . . . . . . . 2.4 p90 . . . . . 0 N--CA 1.471 0.585 0 CA-C-O 117.874 -1.06 . . . . 1.0 111.12 -179.86 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 128' ' ' MTN . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 129' ' ' MTN . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 130' ' ' MTN . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 4.7 mmt . . . . . 0 N--CA 1.491 1.613 0 N-CA-C 109.686 -0.487 . . . . 1.0 109.686 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 34.6 t -107.45 5.06 26.88 Favored 'General case' 0 N--CA 1.467 0.422 0 CA-C-N 116.11 -0.495 . . . . 1.0 110.273 179.33 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 1.3 p30 173.96 94.59 0.01 OUTLIER 'General case' 0 CA--C 1.53 0.182 0 CA-C-N 116.032 -0.531 . . . . 1.0 111.823 -179.893 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . 0.429 ' O ' ' OD1' ' A' ' 5' ' ' ASP . 1.4 t80 -151.27 146.75 26.26 Favored 'General case' 0 N--CA 1.464 0.255 0 CA-C-N 116.341 -0.39 . . . . 1.0 110.25 178.937 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 5' ' ' ASP . . . . . 0.429 ' OD1' ' O ' ' A' ' 4' ' ' PHE . 0.0 OUTLIER -155.95 151.95 27.61 Favored 'General case' 0 CA--C 1.538 0.51 0 N-CA-C 109.453 -0.573 . . . . 1.0 109.453 179.523 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 6' ' ' THR . . . . . 0.685 ' O ' ' N ' ' A' ' 10' ' ' SER . 0.3 OUTLIER -69.24 168.5 14.04 Favored 'General case' 0 C--O 1.204 -1.339 0 CA-C-N 116.206 -0.452 . . . . 1.0 110.143 -179.234 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . 0.562 ' O ' ' N ' ' A' ' 11' ' ' ARG . 0.9 OUTLIER -58.14 -60.11 4.26 Favored 'General case' 0 C--N 1.317 -0.82 0 CA-C-O 121.352 0.596 . . . . 1.0 109.567 -177.646 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 8' ' ' ARG . . . . . 0.749 ' O ' ' HB3' ' A' ' 12' ' ' ALA . 0.0 OUTLIER -49.23 -53.78 19.84 Favored 'General case' 0 CA--C 1.545 0.751 0 N-CA-C 107.637 -1.245 . . . . 1.0 107.637 -178.304 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . 0.598 ' O ' ' HB ' ' A' ' 13' ' ' VAL . 0.0 OUTLIER -66.97 -50.64 62.68 Favored 'Isoleucine or valine' 0 C--O 1.196 -1.734 0 CA-C-N 115.155 -0.93 . . . . 1.0 109.794 179.294 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . 0.685 ' N ' ' O ' ' A' ' 6' ' ' THR . 25.6 t -62.83 -63.79 1.11 Allowed 'General case' 0 C--N 1.313 -0.985 0 C-N-CA 119.595 -0.842 . . . . 1.0 111.055 -179.582 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 11' ' ' ARG . . . . . 0.562 ' N ' ' O ' ' A' ' 7' ' ' GLU . 38.2 ttm-85 -65.9 -61.35 2.11 Favored 'General case' 0 N--CA 1.466 0.366 0 C-N-CA 120.463 -0.495 . . . . 1.0 111.88 -175.945 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . 0.749 ' HB3' ' O ' ' A' ' 8' ' ' ARG . . . -48.66 -47.49 40.54 Favored 'General case' 0 N--CA 1.474 0.739 0 N-CA-C 107.257 -1.386 . . . . 1.0 107.257 -177.868 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . 0.598 ' HB ' ' O ' ' A' ' 9' ' ' VAL . 84.2 t -62.24 -51.04 77.21 Favored 'Isoleucine or valine' 0 C--O 1.205 -1.241 0 C-N-CA 118.548 -1.261 . . . . 1.0 108.187 177.098 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . 0.754 ' O ' HG13 ' A' ' 18' ' ' VAL . . . -55.94 -61.29 2.47 Favored 'General case' 0 C--O 1.21 -1.023 0 C-N-CA 117.933 -1.507 . . . . 1.0 108.775 -179.712 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . 0.578 ' O ' ' N ' ' A' ' 19' ' ' GLY . . . -52.17 -54.56 29.2 Favored 'General case' 0 N--CA 1.47 0.564 0 CA-C-O 121.467 0.651 . . . . 1.0 109.855 -178.849 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . 0.432 ' CB ' ' O ' ' A' ' 12' ' ' ALA . . . -63.73 -57.23 10.61 Favored 'General case' 0 C--N 1.316 -0.877 0 CA-C-N 114.994 -1.003 . . . . 1.0 109.943 -179.011 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . 0.586 ' N ' ' O ' ' A' ' 13' ' ' VAL . 1.2 tt -57.0 -53.29 59.71 Favored 'General case' 0 C--N 1.315 -0.916 0 CA-C-N 114.51 -1.223 . . . . 1.0 108.017 -177.85 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . 0.754 HG13 ' O ' ' A' ' 14' ' ' ALA . 2.4 m -68.57 -58.44 5.86 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.526 0 C-N-CA 119.446 -0.902 . . . . 1.0 109.592 178.923 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . 0.598 ' O ' ' CG2' ' A' ' 23' ' ' VAL . . . -55.7 -169.31 0.07 OUTLIER Glycine 0 C--O 1.213 -1.179 0 N-CA-C 110.287 -1.125 . . . . 1.0 110.287 -179.515 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 20' ' ' PRO . . . . . 0.465 ' O ' ' N ' ' A' ' 24' ' ' ALA . 1.9 Cg_endo -78.96 -32.55 1.84 Allowed 'Trans proline' 0 C--N 1.305 -1.721 0 C-N-CA 123.114 2.543 . . . . 1.0 114.625 -178.524 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -60.19 -57.88 16.89 Favored Glycine 0 N--CA 1.478 1.48 0 C-N-CA 120.164 -1.017 . . . . 1.0 113.348 -176.192 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . 0.408 ' N ' ' O ' ' A' ' 16' ' ' ALA . . . -55.37 -51.76 52.24 Favored Glycine 0 N--CA 1.469 0.867 0 N-CA-C 107.401 -2.28 . . . . 1.0 107.401 -176.851 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . 0.598 ' CG2' ' O ' ' A' ' 19' ' ' GLY . 0.1 OUTLIER -60.81 -31.45 49.52 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.999 0 N-CA-C 108.692 -0.855 . . . . 1.0 108.692 178.277 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . 0.465 ' N ' ' O ' ' A' ' 20' ' ' PRO . . . -58.11 -62.07 2.09 Favored 'General case' 0 C--N 1.34 0.17 0 C-N-CA 117.766 -1.573 . . . . 1.0 109.487 -179.655 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . 0.473 HD23 ' N ' ' A' ' 25' ' ' LEU . 0.0 OUTLIER -62.95 -46.35 88.15 Favored 'General case' 0 CA--C 1.53 0.209 0 O-C-N 121.377 -0.827 . . . . 1.0 111.599 -178.168 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 79.5 t -57.49 -57.99 7.95 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 C-N-CA 119.562 -0.855 . . . . 1.0 109.338 -178.033 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . 0.663 ' O ' ' HB3' ' A' ' 31' ' ' ALA . 49.0 t -60.64 -37.27 75.09 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.65 0 CA-C-O 120.663 0.268 . . . . 1.0 110.743 -178.977 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . 0.434 ' CG ' ' O ' ' A' ' 24' ' ' ALA . 32.5 mmtt -65.91 -56.6 10.94 Favored 'General case' 0 CA--C 1.513 -0.453 0 C-N-CA 119.693 -0.803 . . . . 1.0 109.662 -178.573 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 94.7 t -63.37 -48.21 88.31 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.011 0 CA-C-N 114.365 -1.289 . . . . 1.0 109.942 -177.624 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 30' ' ' CYS . . . . . . . . . . . . . 20.2 t -66.33 -61.1 2.19 Favored 'General case' 0 N--CA 1.443 -0.814 0 C-N-CA 118.936 -1.106 . . . . 1.0 110.372 -179.417 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . 0.663 ' HB3' ' O ' ' A' ' 27' ' ' VAL . . . -63.1 -52.0 64.37 Favored 'General case' 0 CA--C 1.514 -0.434 0 N-CA-C 112.057 0.392 . . . . 1.0 112.057 -176.583 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . 0.437 ' O ' ' HB2' ' A' ' 33' ' ' LEU . . . 82.31 69.26 1.4 Allowed Glycine 0 CA--C 1.521 0.447 0 N-CA-C 109.696 -1.362 . . . . 1.0 109.696 -178.978 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . 0.491 ' O ' ' O ' ' A' ' 36' ' ' VAL . 3.9 mt 90.38 82.97 0.04 OUTLIER Pre-proline 0 N--CA 1.475 0.795 0 C-N-CA 123.565 0.746 . . . . 1.0 111.858 179.583 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 53.0 Cg_exo -54.89 -25.85 45.7 Favored 'Trans proline' 0 N--CA 1.499 1.796 0 C-N-CA 123.008 2.472 . . . . 1.0 112.73 178.562 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -57.15 -58.96 11.88 Favored Glycine 0 CA--C 1.531 1.06 0 N-CA-C 108.86 -1.696 . . . . 1.0 108.86 -179.349 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . 0.666 ' O ' HG22 ' A' ' 37' ' ' ILE . 14.1 p -98.09 169.44 1.51 Allowed 'Isoleucine or valine' 0 C--O 1.219 -0.516 0 N-CA-C 106.602 -1.629 . . . . 1.0 106.602 176.71 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . 0.666 HG22 ' O ' ' A' ' 36' ' ' VAL . 8.9 tt 117.14 116.52 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.486 1.337 0 O-C-N 124.532 1.145 . . . . 1.0 110.366 -179.725 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 38' ' ' HIS . . . . . 0.496 ' CD2' ' N ' ' A' ' 38' ' ' HIS . 0.4 OUTLIER -138.03 129.13 27.34 Favored 'General case' 0 N--CA 1.463 0.193 0 N-CA-C 108.215 -1.031 . . . . 1.0 108.215 178.983 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 12.8 m -99.53 133.22 22.05 Favored Pre-proline 0 C--N 1.328 -0.367 0 N-CA-C 109.049 -0.722 . . . . 1.0 109.049 179.251 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 42.1 Cg_endo -66.33 -96.3 0.0 OUTLIER 'Trans proline' 0 N--CA 1.492 1.423 0 C-N-CA 120.926 1.084 . . . . 1.0 111.827 -179.451 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -62.48 123.78 19.22 Favored 'General case' 0 C--N 1.319 -0.748 0 CA-C-N 115.895 -0.593 . . . . 1.0 110.092 -179.06 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . 0.598 ' C ' ' H ' ' A' ' 44' ' ' GLY . 2.8 mmm-85 -169.75 167.32 9.46 Favored 'General case' 0 C--N 1.32 -0.713 0 N-CA-C 108.798 -0.816 . . . . 1.0 108.798 179.332 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 43' ' ' ARG . . . . . 0.586 ' HG3' ' O ' ' A' ' 45' ' ' PHE . 0.3 OUTLIER -66.48 26.71 0.02 OUTLIER 'General case' 0 C--N 1.316 -0.857 0 CA-C-N 115.157 -0.929 . . . . 1.0 110.721 179.696 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . 0.598 ' H ' ' C ' ' A' ' 42' ' ' ARG . . . 80.68 -26.19 3.21 Favored Glycine 0 CA--C 1.528 0.883 0 N-CA-C 111.677 -0.569 . . . . 1.0 111.677 179.758 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . 0.741 ' CG ' ' N ' ' A' ' 46' ' ' PHE . 0.5 OUTLIER -174.88 175.36 2.38 Favored 'General case' 0 C--O 1.2 -1.531 0 C-N-CA 120.888 -0.325 . . . . 1.0 110.95 -179.157 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 46' ' ' PHE . . . . . 0.741 ' N ' ' CG ' ' A' ' 45' ' ' PHE . 13.8 t80 161.13 13.86 0.0 OUTLIER 'General case' 0 N--CA 1.478 0.964 0 CA-C-N 116.296 -0.411 . . . . 1.0 110.997 176.429 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 47' ' ' ARG . . . . . 0.62 HH22 ' HB2' ' A' ' 31' ' ' ALA . 3.9 mtp180 -175.64 169.24 3.08 Favored 'General case' 0 C--N 1.325 -0.462 0 C-N-CA 119.831 -0.748 . . . . 1.0 110.692 -178.61 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 48' ' ' CYS . . . . . 0.868 ' O ' ' H83' ' A' ' 129' ' ' MTN . 1.2 m 72.62 69.32 0.13 Allowed 'General case' 0 N--CA 1.452 -0.373 0 N-CA-C 108.246 -1.02 . . . . 1.0 108.246 -178.437 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 49' ' ' ASN . . . . . 0.687 ' N ' ' OD1' ' A' ' 49' ' ' ASN . 0.0 OUTLIER -132.21 123.76 18.97 Favored Pre-proline 0 N--CA 1.468 0.472 0 CA-C-O 118.628 -0.701 . . . . 1.0 109.465 -179.215 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . 0.589 ' O ' ' CD ' ' A' ' 51' ' ' GLU . 75.0 Cg_exo -45.82 68.82 0.01 OUTLIER 'Trans proline' 0 N--CA 1.495 1.597 0 C-N-CA 121.928 1.752 . . . . 1.0 114.992 179.98 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . 0.668 ' N ' ' O ' ' A' ' 49' ' ' ASN . 10.3 pm0 62.98 23.39 13.99 Favored 'General case' 0 N--CA 1.472 0.653 0 C-N-CA 123.251 0.62 . . . . 1.0 112.365 -179.305 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 25.4 mtp85 -103.65 159.39 15.65 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 120.934 0.397 . . . . 1.0 111.71 -178.926 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . 0.479 ' O ' ' N ' ' A' ' 55' ' ' ILE . 6.8 tp -75.15 137.51 22.83 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.167 0 CA-C-O 120.95 0.405 . . . . 1.0 110.916 -179.657 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 54' ' ' GLN . . . . . 0.439 ' OE1' ' O ' ' A' ' 46' ' ' PHE . 28.0 mt-30 -60.85 81.78 0.01 OUTLIER 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.763 -0.653 . . . . 1.0 110.935 -176.507 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . 0.479 ' N ' ' O ' ' A' ' 53' ' ' ILE . 11.1 tt -148.58 158.8 6.98 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.358 0 CA-C-N 115.684 -0.689 . . . . 1.0 110.453 177.69 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 111.98 -2.3 27.13 Favored Glycine 0 N--CA 1.468 0.826 0 N-CA-C 111.277 -0.729 . . . . 1.0 111.277 -179.566 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . 0.503 ' OD2' ' NH1' ' A' ' 43' ' ' ARG . 1.6 p-10 -80.91 97.6 7.49 Favored 'General case' 0 CA--C 1.516 -0.338 0 C-N-CA 119.968 -0.693 . . . . 1.0 109.307 178.281 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 58' ' ' TRP . . . . . . . . . . . . . 6.2 m0 -88.62 173.09 8.82 Favored 'General case' 0 C--N 1.319 -0.741 0 CA-C-O 122.8 1.286 . . . . 1.0 112.526 -178.146 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 59' ' ' ARG . . . . . 0.401 ' H ' ' HD3' ' A' ' 59' ' ' ARG . 0.4 OUTLIER -85.26 -60.31 2.07 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 111.896 -2.411 . . . . 1.0 113.306 -178.433 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 75.2 t80 -90.83 -16.95 27.4 Favored 'General case' 0 N--CA 1.479 1.025 0 N-CA-C 113.74 1.015 . . . . 1.0 113.74 -178.883 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . 0.516 ' O ' ' N ' ' A' ' 65' ' ' ASP . 0.0 OUTLIER -77.91 -13.16 59.98 Favored 'General case' 0 C--N 1.318 -0.8 0 O-C-N 121.92 -0.487 . . . . 1.0 110.304 -179.149 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . 0.604 ' O ' ' N ' ' A' ' 66' ' ' GLY . 2.5 m -47.17 -55.45 1.96 Allowed 'Isoleucine or valine' 0 C--O 1.209 -1.074 0 C-N-CA 119.442 -0.903 . . . . 1.0 110.12 -176.431 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 63' ' ' ALA . . . . . 0.456 ' H ' HG23 ' A' ' 62' ' ' VAL . . . -67.2 -50.97 58.91 Favored 'General case' 0 C--N 1.307 -1.271 0 O-C-N 121.325 -0.859 . . . . 1.0 110.443 179.959 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 64' ' ' HIS . . . . . 0.513 ' O ' ' HB2' ' A' ' 67' ' ' ARG . 0.5 OUTLIER -56.3 -56.94 14.88 Favored 'General case' 0 CA--C 1.54 0.594 0 C-N-CA 119.192 -1.003 . . . . 1.0 109.359 -179.953 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . 0.601 ' C ' ' H ' ' A' ' 67' ' ' ARG . 25.7 t70 -72.34 -53.04 13.49 Favored 'General case' 0 C--N 1.316 -0.887 0 O-C-N 121.486 -0.759 . . . . 1.0 110.601 178.556 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . 0.604 ' N ' ' O ' ' A' ' 62' ' ' VAL . . . -65.25 30.35 0.12 Allowed Glycine 0 CA--C 1.526 0.753 0 O-C-N 121.151 -0.968 . . . . 1.0 111.457 179.051 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 67' ' ' ARG . . . . . 0.601 ' H ' ' C ' ' A' ' 65' ' ' ASP . 7.6 ttt85 -81.19 1.27 32.79 Favored 'General case' 0 C--N 1.32 -0.71 0 N-CA-C 107.34 -1.356 . . . . 1.0 107.34 175.662 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . 0.55 HD23 ' N ' ' A' ' 68' ' ' LEU . 2.1 pt? -39.52 -31.14 0.08 Allowed 'General case' 0 C--N 1.35 0.617 0 CA-C-O 121.275 0.56 . . . . 1.0 109.837 -178.459 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . 0.412 ' N ' ' O ' ' A' ' 67' ' ' ARG . 4.3 tt -67.91 -68.58 0.38 Allowed 'General case' 0 CA--C 1.545 0.753 0 C-N-CA 119.32 -0.952 . . . . 1.0 112.65 -175.782 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . 0.53 ' C ' ' H ' ' A' ' 72' ' ' HIS . . . -73.6 -78.42 0.09 Allowed 'General case' 0 N--CA 1.474 0.76 0 C-N-CA 118.653 -1.219 . . . . 1.0 109.878 -176.981 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . 0.809 ' O ' ' N ' ' A' ' 73' ' ' MET . . . -62.43 14.82 0.01 OUTLIER 'General case' 0 C--N 1.318 -0.779 0 C-N-CA 125.964 1.705 . . . . 1.0 112.55 179.221 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 72' ' ' HIS . . . . . 0.53 ' H ' ' C ' ' A' ' 70' ' ' ALA . 52.8 p-80 -19.02 -29.68 0.0 OUTLIER 'General case' 0 N--CA 1.468 0.452 0 N-CA-C 114.056 1.132 . . . . 1.0 114.056 -174.744 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 73' ' ' MET . . . . . 0.809 ' N ' ' O ' ' A' ' 71' ' ' ALA . 20.9 mtt -66.25 -54.91 19.38 Favored 'General case' 0 C--N 1.318 -0.789 0 C-N-CA 119.118 -1.033 . . . . 1.0 109.336 176.123 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . 0.634 ' O ' ' N ' ' A' ' 76' ' ' GLY . 34.6 m -43.57 -52.95 1.13 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.579 0 CA-C-O 117.298 -1.334 . . . . 1.0 111.614 -174.74 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 75' ' ' ASN . . . . . 0.575 ' N ' HG23 ' A' ' 74' ' ' VAL . 3.4 m120 -38.53 -19.79 0.01 OUTLIER 'General case' 0 N--CA 1.482 1.138 0 CA-C-N 120.603 1.547 . . . . 1.0 110.992 -179.666 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . 0.634 ' N ' ' O ' ' A' ' 74' ' ' VAL . . . -48.22 -24.45 3.51 Favored Glycine 0 CA--C 1.532 1.141 0 N-CA-C 107.214 -2.354 . . . . 1.0 107.214 176.664 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . 0.54 ' O ' ' N ' ' A' ' 81' ' ' GLU . 24.1 pt -59.02 -43.21 88.44 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.056 0 C-N-CA 119.722 -0.791 . . . . 1.0 110.941 -179.309 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . 0.419 ' CG2' ' OD1' ' A' ' 65' ' ' ASP . 60.6 t -56.64 -25.25 20.94 Favored 'Isoleucine or valine' 0 C--O 1.24 0.601 0 CA-C-N 121.708 2.049 . . . . 1.0 114.147 -178.887 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . 0.854 ' O ' ' HB2' ' A' ' 83' ' ' ALA . 0.8 OUTLIER -91.08 -37.09 8.78 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.452 0 N-CA-C 108.005 -1.109 . . . . 1.0 108.005 178.804 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 80' ' ' ALA . . . . . 0.418 ' N ' HG13 ' A' ' 79' ' ' ILE . . . -79.8 -17.54 53.13 Favored 'General case' 0 CA--C 1.545 0.772 0 CA-C-N 115.469 -0.787 . . . . 1.0 112.033 178.927 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . 0.54 ' N ' ' O ' ' A' ' 77' ' ' ILE . 62.5 mm-40 -91.91 -67.36 0.86 Allowed 'General case' 0 N--CA 1.447 -0.582 0 O-C-N 121.748 -0.595 . . . . 1.0 110.581 178.492 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 82' ' ' ASP . . . . . 0.519 ' O ' ' C ' ' A' ' 83' ' ' ALA . 1.5 m-20 -72.2 -18.06 61.88 Favored 'General case' 0 N--CA 1.45 -0.464 0 O-C-N 121.11 -0.994 . . . . 1.0 112.794 -178.272 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . 0.854 ' HB2' ' O ' ' A' ' 79' ' ' ILE . . . -21.08 -51.31 0.01 OUTLIER 'General case' 0 N--CA 1.479 0.998 0 CA-C-N 119.048 0.84 . . . . 1.0 112.464 178.656 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . 0.46 ' N ' ' O ' ' A' ' 82' ' ' ASP . 3.6 mm? -31.94 -39.64 0.03 OUTLIER 'General case' 0 N--CA 1.479 0.988 0 N-CA-C 111.805 0.298 . . . . 1.0 111.805 -176.627 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 85' ' ' ILE . . . . . 0.49 ' O ' ' HB3' ' A' ' 88' ' ' ALA . 67.9 mt -94.95 -40.36 11.09 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.452 0 CA-C-O 120.896 0.379 . . . . 1.0 110.764 178.407 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . 0.527 ' HB3' ' HA ' ' A' ' 83' ' ' ALA . . . -53.64 -59.33 4.74 Favored 'General case' 0 CA--C 1.533 0.309 0 CA-C-N 115.951 -0.568 . . . . 1.0 111.537 -178.159 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 15.1 pt-20 -62.32 -14.21 36.97 Favored 'General case' 0 CA--C 1.518 -0.276 0 C-N-CA 120.96 -0.296 . . . . 1.0 110.681 -178.996 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . 0.49 ' HB3' ' O ' ' A' ' 85' ' ' ILE . . . -77.18 -18.92 57.41 Favored 'General case' 0 C--N 1.325 -0.497 0 N-CA-C 108.586 -0.894 . . . . 1.0 108.586 179.109 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 89' ' ' VAL . . . . . 0.431 ' O ' ' OE2' ' A' ' 51' ' ' GLU . 35.6 m -113.97 35.19 0.91 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.22 0 CA-C-N 113.61 -1.632 . . . . 1.0 110.781 178.705 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 90' ' ' GLY . . . . . 0.633 ' C ' ' H ' ' A' ' 92' ' ' HIS . . . -69.61 -33.44 71.78 Favored Glycine 0 C--N 1.351 1.407 0 CA-C-O 119.205 -0.775 . . . . 1.0 111.99 178.243 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 91' ' ' PRO . . . . . 0.552 ' CD ' ' N ' ' A' ' 90' ' ' GLY . 78.6 Cg_exo -45.57 -4.0 0.02 OUTLIER 'Trans proline' 0 N--CA 1.501 1.941 0 C-N-CA 122.379 2.053 . . . . 1.0 112.659 177.703 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 92' ' ' HIS . . . . . 0.65 ' O ' ' HB3' ' A' ' 96' ' ' ALA . 0.0 OUTLIER -49.31 -15.52 0.14 Allowed 'General case' 0 N--CA 1.448 -0.531 0 O-C-N 123.794 0.684 . . . . 1.0 110.047 -178.718 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . 0.661 HD12 ' N ' ' A' ' 94' ' ' ALA . 1.7 pp -66.28 -58.06 6.17 Favored 'General case' 0 N--CA 1.445 -0.692 0 N-CA-C 108.892 -0.781 . . . . 1.0 108.892 177.095 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 94' ' ' ALA . . . . . 0.661 ' N ' HD12 ' A' ' 93' ' ' LEU . . . -59.77 -58.19 9.64 Favored 'General case' 0 N--CA 1.449 -0.489 0 N-CA-C 109.959 -0.386 . . . . 1.0 109.959 179.725 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 95' ' ' ARG . . . . . 0.613 ' O ' ' N ' ' A' ' 97' ' ' LEU . 0.0 OUTLIER -61.47 -63.53 1.24 Allowed 'General case' 0 N--CA 1.449 -0.492 0 CA-C-O 121.428 0.632 . . . . 1.0 109.572 -178.592 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 96' ' ' ALA . . . . . 0.957 ' O ' ' N ' ' A' ' 98' ' ' GLY . . . -49.44 -11.08 0.04 OUTLIER 'General case' 0 N--CA 1.438 -1.064 0 O-C-N 118.791 -2.443 . . . . 1.0 111.266 -178.911 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . 0.745 ' O ' ' N ' ' A' ' 100' ' ' ILE . 0.3 OUTLIER 5.89 -48.0 0.0 OUTLIER 'General case' 0 N--CA 1.487 1.419 0 C-N-CA 124.426 1.09 . . . . 1.0 110.38 -167.96 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 98' ' ' GLY . . . . . 0.957 ' N ' ' O ' ' A' ' 96' ' ' ALA . . . -51.35 -24.28 10.28 Favored Glycine 0 C--N 1.286 -2.214 0 N-CA-C 106.488 -2.645 . . . . 1.0 106.488 173.273 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 99' ' ' GLN . . . . . 0.689 ' O ' ' S1 ' ' A' ' 130' ' ' MTN . 35.1 mt-30 -65.57 -23.16 66.79 Favored 'General case' 0 C--N 1.377 1.766 0 N-CA-C 105.94 -1.874 . . . . 1.0 105.94 175.983 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 100' ' ' ILE . . . . . 0.745 ' N ' ' O ' ' A' ' 97' ' ' LEU . 1.4 tp -64.59 -37.06 79.11 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.21 0 C-N-CA 118.87 -1.132 . . . . 1.0 108.118 178.884 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 101' ' ' VAL . . . . . 0.711 ' O ' ' N ' ' A' ' 105' ' ' GLY . 88.1 t -57.62 -63.13 0.71 Allowed 'Isoleucine or valine' 0 C--O 1.216 -0.704 0 C-N-CA 119.923 -0.711 . . . . 1.0 109.687 178.713 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 102' ' ' CYS . . . . . 0.957 ' O ' ' HB2' ' A' ' 106' ' ' ALA . 0.9 OUTLIER -49.22 -17.34 0.23 Allowed 'General case' 0 CA--C 1.545 0.754 0 C-N-CA 118.36 -1.336 . . . . 1.0 111.579 -178.446 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 24.0 ttm180 -89.64 -46.71 8.44 Favored 'General case' 0 N--CA 1.479 0.998 0 CA-C-O 122.573 1.178 . . . . 1.0 111.851 178.275 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 104' ' ' TYR . . . . . 0.622 ' O ' ' CG ' ' A' ' 104' ' ' TYR . 0.0 OUTLIER -104.47 21.83 16.01 Favored 'General case' 0 CA--C 1.549 0.931 0 CA-C-N 112.684 -2.053 . . . . 1.0 110.208 178.262 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 105' ' ' GLY . . . . . 0.756 ' O ' ' N ' ' A' ' 107' ' ' THR . . . -168.26 -12.5 0.02 OUTLIER Glycine 0 C--N 1.345 1.03 0 C-N-CA 118.523 -1.798 . . . . 1.0 113.969 178.769 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 106' ' ' ALA . . . . . 0.957 ' HB2' ' O ' ' A' ' 102' ' ' CYS . . . -20.08 64.8 0.0 OUTLIER 'General case' 0 N--CA 1.479 0.98 0 N-CA-C 114.671 1.36 . . . . 1.0 114.671 -179.601 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 107' ' ' THR . . . . . 0.756 ' N ' ' O ' ' A' ' 105' ' ' GLY . 96.4 m -102.28 -4.96 24.84 Favored 'General case' 0 N--CA 1.447 -0.585 0 N-CA-C 107.532 -1.285 . . . . 1.0 107.532 177.008 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 16.9 m -95.59 11.69 4.36 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.511 0 CA-C-N 116.084 -0.507 . . . . 1.0 110.053 176.325 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 109' ' ' ILE . . . . . 0.646 ' N ' ' CD ' ' A' ' 110' ' ' PRO . 0.1 OUTLIER -112.81 -27.94 0.12 Allowed Pre-proline 0 CA--C 1.555 1.161 0 CA-C-N 119.187 0.903 . . . . 1.0 111.64 177.523 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 110' ' ' PRO . . . . . 0.646 ' CD ' ' N ' ' A' ' 109' ' ' ILE . 48.7 Cg_endo -65.86 -37.41 27.36 Favored 'Trans proline' 0 N--CA 1.496 1.643 0 C-N-CA 122.827 2.351 . . . . 1.0 113.579 -173.19 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 34.3 t30 -64.57 -67.95 0.39 Allowed 'General case' 0 CA--C 1.507 -0.686 0 C-N-CA 119.061 -1.056 . . . . 1.0 109.078 -178.186 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 112' ' ' ILE . . . . . 0.596 ' O ' HG22 ' A' ' 116' ' ' ILE . 6.3 pt -52.01 -42.54 34.64 Favored 'Isoleucine or valine' 0 C--O 1.209 -1.038 0 CA-C-O 122.065 0.936 . . . . 1.0 108.857 179.907 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 113' ' ' ASN . . . . . 0.544 ' N ' ' CG1' ' A' ' 112' ' ' ILE . 2.8 m120 -50.19 -53.57 26.98 Favored 'General case' 0 C--N 1.315 -0.922 0 CA-C-N 113.929 -1.487 . . . . 1.0 108.745 -176.738 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 114' ' ' ALA . . . . . 0.444 ' O ' ' CG2' ' A' ' 118' ' ' VAL . . . -62.97 -34.36 77.35 Favored 'General case' 0 C--N 1.311 -1.083 0 O-C-N 121.035 -1.04 . . . . 1.0 112.501 179.551 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -84.63 -60.02 2.19 Favored 'General case' 0 N--CA 1.471 0.605 0 CA-C-N 118.672 0.669 . . . . 1.0 112.684 179.095 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 116' ' ' ILE . . . . . 0.622 HG23 ' N ' ' A' ' 117' ' ' GLU . 9.9 tt -54.57 -61.87 0.89 Allowed 'Isoleucine or valine' 0 C--O 1.223 -0.313 0 CA-C-N 115.336 -0.847 . . . . 1.0 108.795 -176.998 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 117' ' ' GLU . . . . . 0.622 ' N ' HG23 ' A' ' 116' ' ' ILE . 98.2 mt-10 -45.46 -49.3 13.58 Favored 'General case' 0 C--N 1.314 -0.935 0 N-CA-C 106.501 -1.666 . . . . 1.0 106.501 -178.236 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 118' ' ' VAL . . . . . 0.444 ' CG2' ' O ' ' A' ' 114' ' ' ALA . 23.8 t -62.77 -30.18 48.8 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.689 0 CA-C-O 118.88 -0.581 . . . . 1.0 109.913 178.164 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 119' ' ' LEU . . . . . 0.573 ' N ' ' O ' ' A' ' 116' ' ' ILE . 14.3 tp -80.66 -63.01 1.5 Allowed 'General case' 0 C--N 1.351 0.653 0 CA-C-N 120.028 1.285 . . . . 1.0 108.032 178.548 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 120' ' ' GLY . . . . . 0.465 ' N ' ' O ' ' A' ' 116' ' ' ILE . . . -61.65 -86.81 0.04 OUTLIER Glycine 0 N--CA 1.434 -1.462 0 C-N-CA 117.991 -2.052 . . . . 1.0 108.415 177.839 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 121' ' ' THR . . . . . 0.433 HG22 ' C ' ' A' ' 120' ' ' GLY . 0.0 OUTLIER 171.96 -41.4 0.01 OUTLIER 'General case' 0 C--N 1.316 -0.849 0 CA-C-N 113.947 -1.127 . . . . 1.0 113.755 179.737 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 122' ' ' GLY . . . . . 0.651 ' O ' ' N ' ' A' ' 124' ' ' ASP . . . 102.17 -16.78 55.18 Favored Glycine 0 N--CA 1.472 1.069 0 N-CA-C 108.015 -2.034 . . . . 1.0 108.015 -176.959 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 123' ' ' THR . . . . . 0.663 HG23 ' O ' ' A' ' 123' ' ' THR . 1.7 t -52.62 86.84 0.0 OUTLIER 'General case' 0 CA--C 1.538 0.505 0 N-CA-C 105.479 -2.045 . . . . 1.0 105.479 179.063 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 124' ' ' ASP . . . . . 0.651 ' N ' ' O ' ' A' ' 122' ' ' GLY . 37.5 m-20 -164.48 171.65 14.35 Favored 'General case' 0 CA--C 1.522 -0.107 0 CA-C-N 114.107 -1.406 . . . . 1.0 112.018 -178.462 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 125' ' ' TYR . . . . . . . . . . . . . 26.1 t80 -148.38 145.42 28.06 Favored 'General case' 0 CA--C 1.536 0.415 0 CA-C-N 114.785 -1.098 . . . . 1.0 108.633 175.678 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 126' ' ' ARG . . . . . 0.42 HH21 ' CG2' ' A' ' 79' ' ' ILE . 2.6 mmp_? -145.5 149.4 34.56 Favored 'General case' 0 N--CA 1.474 0.765 0 N-CA-C 109.5 -0.556 . . . . 1.0 109.5 178.16 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 127' ' ' PHE . . . . . . . . . . . . . 40.4 p90 . . . . . 0 C--O 1.22 -0.454 0 CA-C-O 118.086 -0.959 . . . . 1.0 110.709 179.713 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 128' ' ' MTN . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 129' ' ' MTN . . . . . 0.868 ' H83' ' O ' ' A' ' 48' ' ' CYS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 130' ' ' MTN . . . . . 0.689 ' S1 ' ' O ' ' A' ' 99' ' ' GLN . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.467 ' C ' ' H ' ' A' ' 3' ' ' ASP . 57.9 mtt . . . . . 0 N--CA 1.493 1.68 0 N-CA-C 108.902 -0.777 . . . . 1.0 108.902 . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . 0.531 ' O ' ' CG ' ' A' ' 3' ' ' ASP . 6.9 t -69.44 10.01 0.4 Allowed 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.309 -0.405 . . . . 1.0 111.013 178.915 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . 0.531 ' CG ' ' O ' ' A' ' 2' ' ' SER . 80.9 m-20 138.3 142.82 0.0 OUTLIER 'General case' 0 N--CA 1.486 1.326 0 O-C-N 124.564 1.165 . . . . 1.0 109.954 179.075 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 60.9 t80 -156.4 152.5 27.6 Favored 'General case' 0 N--CA 1.463 0.225 0 CA-C-N 115.932 -0.576 . . . . 1.0 110.642 179.341 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 69.9 m-20 -150.07 146.19 26.8 Favored 'General case' 0 CA--C 1.534 0.334 0 N-CA-C 109.09 -0.707 . . . . 1.0 109.09 179.435 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 6' ' ' THR . . . . . 0.802 ' O ' ' N ' ' A' ' 10' ' ' SER . 0.2 OUTLIER -87.74 177.67 6.95 Favored 'General case' 0 C--O 1.194 -1.859 0 CA-C-O 121.094 0.473 . . . . 1.0 111.314 -178.702 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . 0.413 ' O ' ' N ' ' A' ' 11' ' ' ARG . 7.7 tm-20 -56.54 -58.18 9.15 Favored 'General case' 0 C--N 1.312 -1.052 0 CA-C-O 121.687 0.755 . . . . 1.0 110.932 -177.894 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 8' ' ' ARG . . . . . 0.803 ' O ' ' HB3' ' A' ' 12' ' ' ALA . 48.6 ttp85 -55.01 -57.28 12.32 Favored 'General case' 0 C--N 1.318 -0.777 0 CA-C-N 114.089 -1.414 . . . . 1.0 107.8 -178.02 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . 0.65 ' O ' ' HB ' ' A' ' 13' ' ' VAL . 0.0 OUTLIER -66.31 -54.06 30.14 Favored 'Isoleucine or valine' 0 C--O 1.188 -2.164 0 CA-C-N 114.499 -1.228 . . . . 1.0 110.655 178.883 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . 0.802 ' N ' ' O ' ' A' ' 6' ' ' THR . 11.0 t -67.03 -64.58 0.82 Allowed 'General case' 0 N--CA 1.486 1.369 0 CA-C-N 118.769 0.713 . . . . 1.0 112.406 -178.132 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 11' ' ' ARG . . . . . 0.511 ' O ' ' N ' ' A' ' 15' ' ' ALA . 6.7 tpt180 -63.57 -59.07 5.1 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-O 121.083 0.468 . . . . 1.0 111.371 -175.104 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . 0.803 ' HB3' ' O ' ' A' ' 8' ' ' ARG . . . -51.58 -46.76 63.61 Favored 'General case' 0 C--N 1.322 -0.619 0 N-CA-C 106.512 -1.662 . . . . 1.0 106.512 -176.022 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . 0.659 ' O ' ' N ' ' A' ' 17' ' ' LEU . 67.6 t -62.3 -50.99 77.72 Favored 'Isoleucine or valine' 0 C--O 1.2 -1.532 0 CA-C-N 114.664 -1.153 . . . . 1.0 107.931 177.499 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . 0.819 ' O ' HG22 ' A' ' 18' ' ' VAL . . . -57.17 -62.39 1.79 Allowed 'General case' 0 C--O 1.207 -1.138 0 C-N-CA 117.335 -1.746 . . . . 1.0 109.097 -178.723 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . 0.585 ' O ' ' N ' ' A' ' 19' ' ' GLY . . . -53.73 -53.91 45.57 Favored 'General case' 0 C--O 1.215 -0.753 0 O-C-N 123.843 0.714 . . . . 1.0 109.703 -178.684 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . 0.488 ' CB ' ' O ' ' A' ' 12' ' ' ALA . . . -63.8 -57.8 8.8 Favored 'General case' 0 N--CA 1.474 0.738 0 C-N-CA 120.022 -0.671 . . . . 1.0 110.215 -179.737 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . 0.659 ' N ' ' O ' ' A' ' 13' ' ' VAL . 6.1 tt -55.91 -54.53 43.61 Favored 'General case' 0 N--CA 1.48 1.072 0 CA-C-N 114.752 -1.113 . . . . 1.0 108.012 -178.013 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . 0.819 HG22 ' O ' ' A' ' 14' ' ' ALA . 2.2 m -69.39 -58.34 5.91 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 C-N-CA 119.374 -0.93 . . . . 1.0 109.104 179.913 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . 0.585 ' N ' ' O ' ' A' ' 15' ' ' ALA . . . -54.97 -167.11 0.03 OUTLIER Glycine 0 C--O 1.225 -0.44 0 N-CA-C 111.298 -0.721 . . . . 1.0 111.298 -178.276 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 20' ' ' PRO . . . . . 0.673 ' O ' ' N ' ' A' ' 24' ' ' ALA . 74.0 Cg_endo -83.6 -28.97 1.19 Allowed 'Trans proline' 0 C--N 1.296 -2.184 0 C-N-CA 122.73 2.287 . . . . 1.0 112.556 -178.582 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -62.11 -59.63 9.24 Favored Glycine 0 N--CA 1.475 1.24 0 C-N-CA 119.508 -1.33 . . . . 1.0 111.902 -176.671 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . 0.459 ' N ' ' O ' ' A' ' 16' ' ' ALA . . . -55.72 -51.17 56.83 Favored Glycine 0 N--CA 1.47 0.909 0 N-CA-C 106.503 -2.639 . . . . 1.0 106.503 -178.608 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . 0.462 ' O ' HG12 ' A' ' 27' ' ' VAL . 38.3 t -60.41 -32.58 51.47 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.607 0 C-N-CA 119.493 -0.883 . . . . 1.0 109.19 178.415 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . 0.673 ' N ' ' O ' ' A' ' 20' ' ' PRO . . . -59.37 -63.85 1.15 Allowed 'General case' 0 C--N 1.349 0.552 0 C-N-CA 118.761 -1.176 . . . . 1.0 110.425 -178.709 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 19.5 mt -62.18 -44.19 97.15 Favored 'General case' 0 CA--C 1.509 -0.63 0 C-N-CA 119.581 -0.848 . . . . 1.0 110.845 -177.878 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . 0.415 HG23 ' O ' ' A' ' 22' ' ' GLY . 71.1 t -57.88 -60.4 2.23 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.695 0 C-N-CA 119.004 -1.078 . . . . 1.0 110.012 -178.186 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . 0.522 ' O ' ' HB3' ' A' ' 31' ' ' ALA . 1.4 p -60.46 -36.07 67.18 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-O 120.81 0.338 . . . . 1.0 111.645 -178.31 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 21.6 ttpp -65.72 -56.27 12.93 Favored 'General case' 0 C--N 1.321 -0.673 0 N-CA-C 109.004 -0.739 . . . . 1.0 109.004 -179.645 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 94.6 t -61.06 -47.7 92.38 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.614 0 CA-C-N 115.001 -1.0 . . . . 1.0 109.743 -178.328 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 30' ' ' CYS . . . . . 0.659 ' SG ' ' N ' ' A' ' 31' ' ' ALA . 0.0 OUTLIER -66.1 -60.38 2.87 Favored 'General case' 0 C--N 1.326 -0.446 0 C-N-CA 118.79 -1.164 . . . . 1.0 110.132 -179.511 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . 0.659 ' N ' ' SG ' ' A' ' 30' ' ' CYS . . . -60.43 -50.98 71.42 Favored 'General case' 0 CA--C 1.507 -0.697 0 C-N-CA 120.986 -0.286 . . . . 1.0 111.093 -176.003 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . 0.53 ' O ' ' CB ' ' A' ' 33' ' ' LEU . . . 78.23 69.58 1.38 Allowed Glycine 0 N--CA 1.448 -0.541 0 N-CA-C 109.516 -1.434 . . . . 1.0 109.516 -178.616 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . 0.53 ' CB ' ' O ' ' A' ' 32' ' ' GLY . 1.2 tt 90.31 77.21 0.04 OUTLIER Pre-proline 0 CA--C 1.534 0.359 0 CA-C-N 115.176 -0.512 . . . . 1.0 110.388 -179.58 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 58.8 Cg_exo -50.47 -23.09 9.95 Favored 'Trans proline' 0 N--CA 1.492 1.415 0 C-N-CA 122.839 2.359 . . . . 1.0 112.491 179.578 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . 0.524 ' H ' HD23 ' A' ' 33' ' ' LEU . . . -58.03 -61.08 7.84 Favored Glycine 0 CA--C 1.538 1.53 0 C-N-CA 119.102 -1.523 . . . . 1.0 109.538 -178.616 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . 0.613 HG22 ' N ' ' A' ' 37' ' ' ILE . 13.5 p -94.93 171.73 1.1 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.651 0 N-CA-C 107.108 -1.441 . . . . 1.0 107.108 176.901 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . 0.613 ' N ' HG22 ' A' ' 36' ' ' VAL . 4.1 mm 112.79 113.54 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.484 1.249 0 O-C-N 124.614 1.196 . . . . 1.0 110.009 -179.73 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 16.9 m-70 -139.98 133.58 30.27 Favored 'General case' 0 C--N 1.332 -0.17 0 N-CA-C 108.651 -0.87 . . . . 1.0 108.651 179.2 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 11.4 m -107.84 109.79 62.27 Favored Pre-proline 0 N--CA 1.469 0.492 0 N-CA-C 109.975 -0.38 . . . . 1.0 109.975 179.99 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 40' ' ' PRO . . . . . 0.459 ' HB2' ' H ' ' A' ' 41' ' ' ALA . 79.0 Cg_exo -42.6 -90.9 0.0 OUTLIER 'Trans proline' 0 N--CA 1.493 1.444 0 C-N-CA 121.471 1.447 . . . . 1.0 112.252 -179.127 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . 0.459 ' H ' ' HB2' ' A' ' 40' ' ' PRO . . . -65.56 125.02 23.89 Favored 'General case' 0 C--N 1.324 -0.541 0 N-CA-C 109.447 -0.575 . . . . 1.0 109.447 -179.389 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 34.5 ptt180 -174.2 177.05 2.37 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.205 -0.452 . . . . 1.0 110.617 179.394 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 4.3 tpp180 -58.58 -45.55 88.83 Favored 'General case' 0 C--N 1.324 -0.53 0 N-CA-C 107.965 -1.124 . . . . 1.0 107.965 178.711 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 122.24 -25.11 6.77 Favored Glycine 0 N--CA 1.471 1.016 0 N-CA-C 111.134 -0.786 . . . . 1.0 111.134 -179.788 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . 0.543 ' O ' ' HB2' ' A' ' 46' ' ' PHE . 64.7 t80 -149.98 153.66 36.93 Favored 'General case' 0 N--CA 1.466 0.368 0 N-CA-C 107.726 -1.213 . . . . 1.0 107.726 176.812 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 46' ' ' PHE . . . . . 0.79 ' O ' ' HB2' ' A' ' 47' ' ' ARG . 2.1 m-85 128.59 95.99 0.0 OUTLIER 'General case' 0 N--CA 1.481 1.109 0 C-N-CA 126.054 1.742 . . . . 1.0 108.317 -178.735 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 47' ' ' ARG . . . . . 0.79 ' HB2' ' O ' ' A' ' 46' ' ' PHE . 0.1 OUTLIER 118.16 137.79 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.825 0 C-N-CA 124.766 1.227 . . . . 1.0 110.151 179.308 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 48' ' ' CYS . . . . . 0.678 ' O ' ' H62' ' A' ' 129' ' ' MTN . 5.4 t 71.07 78.64 0.17 Allowed 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 116.074 -0.512 . . . . 1.0 110.413 179.287 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 49' ' ' ASN . . . . . 0.523 ' O ' ' N ' ' A' ' 51' ' ' GLU . 9.4 p30 -144.66 145.43 28.23 Favored Pre-proline 0 C--N 1.324 -0.515 0 CA-C-N 115.632 -0.713 . . . . 1.0 110.838 179.753 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . 0.514 ' HD2' HH12 ' A' ' 52' ' ' ARG . 20.5 Cg_endo -61.27 55.48 0.1 Allowed 'Trans proline' 0 N--CA 1.494 1.524 0 C-N-CA 121.979 1.786 . . . . 1.0 113.239 179.901 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . 0.523 ' N ' ' O ' ' A' ' 49' ' ' ASN . 2.3 mp0 65.9 68.34 0.46 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.679 -0.691 . . . . 1.0 111.497 177.967 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . 0.514 HH12 ' HD2' ' A' ' 50' ' ' PRO . 7.8 mtm-85 -145.95 153.57 40.95 Favored 'General case' 0 N--CA 1.467 0.379 0 CA-C-N 115.685 -0.689 . . . . 1.0 110.468 179.157 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . 0.519 ' O ' ' N ' ' A' ' 55' ' ' ILE . 12.3 pt -65.65 127.99 27.72 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 CA-C-N 115.829 -0.623 . . . . 1.0 111.073 179.799 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 54' ' ' GLN . . . . . 0.741 ' H ' HE21 ' A' ' 54' ' ' GLN . 0.0 OUTLIER -57.74 85.49 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 121.426 0.632 . . . . 1.0 109.714 -177.367 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . 0.519 ' N ' ' O ' ' A' ' 53' ' ' ILE . 0.5 OUTLIER -146.83 159.17 9.96 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.157 0 CA-C-N 115.066 -0.97 . . . . 1.0 110.043 178.269 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . 0.42 ' H ' HG13 ' A' ' 55' ' ' ILE . . . 114.23 0.61 23.75 Favored Glycine 0 C--N 1.332 0.36 0 N-CA-C 110.178 -1.169 . . . . 1.0 110.178 -178.183 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . 0.432 ' CG ' ' O ' ' A' ' 57' ' ' ASP . 13.2 p-10 -80.82 93.57 6.27 Favored 'General case' 0 N--CA 1.455 -0.197 0 C-N-CA 119.379 -0.929 . . . . 1.0 109.845 178.791 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 58' ' ' TRP . . . . . . . . . . . . . 10.8 m0 -88.7 169.21 11.86 Favored 'General case' 0 CA--C 1.547 0.856 0 CA-C-O 122.618 1.199 . . . . 1.0 111.63 -178.103 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 59' ' ' ARG . . . . . 0.425 ' CG ' ' H ' ' A' ' 60' ' ' TYR . 6.8 ptt85 -83.86 -60.91 1.96 Allowed 'General case' 0 C--N 1.31 -1.129 0 CA-C-N 112.119 -2.309 . . . . 1.0 113.5 -178.495 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 60' ' ' TYR . . . . . 0.425 ' H ' ' CG ' ' A' ' 59' ' ' ARG . 0.0 OUTLIER -89.19 -18.26 27.48 Favored 'General case' 0 C--O 1.248 0.998 0 N-CA-C 113.167 0.803 . . . . 1.0 113.167 -179.005 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . 0.519 ' O ' ' N ' ' A' ' 65' ' ' ASP . 25.0 tt0 -71.14 -12.95 61.77 Favored 'General case' 0 C--N 1.31 -1.149 0 O-C-N 121.973 -0.454 . . . . 1.0 110.662 -177.86 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . 0.613 HG23 ' H ' ' A' ' 63' ' ' ALA . 17.0 m -45.13 -56.26 0.96 Allowed 'Isoleucine or valine' 0 C--N 1.309 -1.188 0 C-N-CA 120.121 -0.632 . . . . 1.0 110.025 -175.124 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 63' ' ' ALA . . . . . 0.613 ' H ' HG23 ' A' ' 62' ' ' VAL . . . -65.91 -49.84 66.59 Favored 'General case' 0 N--CA 1.428 -1.53 0 CA-C-O 121.349 0.595 . . . . 1.0 109.435 179.728 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 1.8 t60 -54.04 -59.95 3.98 Favored 'General case' 0 CA--C 1.547 0.849 0 C-N-CA 119.474 -0.891 . . . . 1.0 109.934 -179.747 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . 0.556 ' C ' ' H ' ' A' ' 67' ' ' ARG . 2.6 t70 -66.94 -54.72 19.2 Favored 'General case' 0 C--O 1.244 0.808 0 CA-C-O 121.848 0.832 . . . . 1.0 110.729 177.851 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . 0.566 ' N ' ' O ' ' A' ' 62' ' ' VAL . . . -65.72 27.74 0.14 Allowed Glycine 0 CA--C 1.524 0.617 0 O-C-N 121.163 -0.961 . . . . 1.0 112.489 179.078 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 67' ' ' ARG . . . . . 0.718 ' O ' ' N ' ' A' ' 69' ' ' LEU . 1.1 mtt-85 -76.43 -1.11 25.44 Favored 'General case' 0 C--N 1.322 -0.619 0 N-CA-C 108.72 -0.844 . . . . 1.0 108.72 175.775 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . 0.48 ' C ' ' O ' ' A' ' 67' ' ' ARG . 0.8 OUTLIER -32.39 -26.01 0.0 OUTLIER 'General case' 0 N--CA 1.488 1.44 0 N-CA-C 107.732 -1.21 . . . . 1.0 107.732 -177.486 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . 0.718 ' N ' ' O ' ' A' ' 67' ' ' ARG . 20.0 tp -66.91 -67.67 0.43 Allowed 'General case' 0 CA--C 1.548 0.875 0 C-N-CA 119.342 -0.943 . . . . 1.0 108.853 177.029 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . 0.702 ' C ' ' H ' ' A' ' 72' ' ' HIS . . . -78.1 -73.45 0.31 Allowed 'General case' 0 N--CA 1.472 0.653 0 N-CA-C 107.577 -1.268 . . . . 1.0 107.577 179.084 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . 0.484 ' HB3' ' CB ' ' A' ' 67' ' ' ARG . . . -48.02 5.51 0.0 OUTLIER 'General case' 0 N--CA 1.469 0.522 0 C-N-CA 124.273 1.029 . . . . 1.0 112.261 177.81 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 72' ' ' HIS . . . . . 0.702 ' H ' ' C ' ' A' ' 70' ' ' ALA . 0.0 OUTLIER -21.87 -75.92 0.01 OUTLIER 'General case' 0 CA--C 1.516 -0.351 0 C-N-CA 123.332 0.653 . . . . 1.0 112.328 -177.956 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 73' ' ' MET . . . . . 0.636 ' H ' ' CG ' ' A' ' 72' ' ' HIS . 57.9 mtm -69.29 -45.31 69.94 Favored 'General case' 0 C--N 1.311 -1.097 0 C-N-CA 118.692 -1.203 . . . . 1.0 109.463 178.065 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . 0.729 ' O ' ' N ' ' A' ' 76' ' ' GLY . 85.3 t -41.1 -42.27 0.67 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.384 0 CA-C-O 118.604 -0.712 . . . . 1.0 110.167 -176.553 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 75' ' ' ASN . . . . . 0.661 ' ND2' HG21 ' A' ' 78' ' ' VAL . 1.0 OUTLIER -36.66 -15.58 0.0 OUTLIER 'General case' 0 N--CA 1.48 1.067 0 CA-C-O 121.497 0.665 . . . . 1.0 110.721 178.363 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . 0.729 ' N ' ' O ' ' A' ' 74' ' ' VAL . . . -43.92 -20.14 0.14 Allowed Glycine 0 CA--C 1.539 1.549 0 N-CA-C 108.734 -1.747 . . . . 1.0 108.734 176.971 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . 0.627 ' O ' ' N ' ' A' ' 80' ' ' ALA . 0.2 OUTLIER -73.45 -50.33 31.28 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.14 0 CA-C-O 122.274 1.035 . . . . 1.0 108.524 178.85 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . 0.661 HG21 ' ND2' ' A' ' 75' ' ' ASN . 93.5 t -35.54 -36.3 0.08 OUTLIER 'Isoleucine or valine' 0 CA--C 1.553 1.083 0 CA-C-N 112.092 -2.322 . . . . 1.0 107.956 -176.254 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . 0.563 HG13 ' O ' ' A' ' 76' ' ' GLY . 1.4 pp -95.37 -24.97 4.59 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.852 0 CA-C-N 116.195 -0.457 . . . . 1.0 111.355 177.614 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 80' ' ' ALA . . . . . 0.627 ' N ' ' O ' ' A' ' 77' ' ' ILE . . . -80.67 -14.96 57.69 Favored 'General case' 0 N--CA 1.475 0.779 0 O-C-N 122.261 -0.274 . . . . 1.0 111.564 179.278 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 33.1 tt0 -81.17 -67.88 0.74 Allowed 'General case' 0 N--CA 1.444 -0.74 0 N-CA-C 109.448 -0.575 . . . . 1.0 109.448 177.668 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 82' ' ' ASP . . . . . 0.815 ' O ' ' N ' ' A' ' 84' ' ' LEU . 89.1 m-20 -59.35 -60.52 3.73 Favored 'General case' 0 CA--C 1.504 -0.801 0 C-N-CA 119.075 -1.05 . . . . 1.0 109.039 -179.454 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . 0.527 ' O ' ' N ' ' A' ' 86' ' ' ALA . . . 22.83 -68.21 0.0 OUTLIER 'General case' 0 N--CA 1.484 1.235 0 O-C-N 124.852 1.345 . . . . 1.0 111.386 -179.957 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . 0.815 ' N ' ' O ' ' A' ' 82' ' ' ASP . 4.8 tt -29.31 -45.3 0.04 OUTLIER 'General case' 0 N--CA 1.478 0.95 0 C-N-CA 123.512 0.725 . . . . 1.0 112.666 -178.288 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 85' ' ' ILE . . . . . 0.616 ' O ' ' HB3' ' A' ' 88' ' ' ALA . 3.3 pt -91.12 -36.55 8.21 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.87 0 N-CA-C 109.384 -0.598 . . . . 1.0 109.384 178.081 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . 0.547 ' C ' ' H ' ' A' ' 88' ' ' ALA . . . -51.16 -55.78 16.13 Favored 'General case' 0 CA--C 1.534 0.34 0 C-N-CA 120.42 -0.512 . . . . 1.0 110.086 -178.749 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 27.3 mt-10 -61.55 5.66 0.07 Allowed 'General case' 0 C--N 1.326 -0.419 0 C-N-CA 120.656 -0.417 . . . . 1.0 110.664 -179.433 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . 0.616 ' HB3' ' O ' ' A' ' 85' ' ' ILE . . . -105.76 -23.98 12.6 Favored 'General case' 0 C--O 1.237 0.4 0 CA-C-N 116.402 -0.363 . . . . 1.0 110.506 179.55 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 89' ' ' VAL . . . . . 0.462 HG22 ' O ' ' A' ' 86' ' ' ALA . 9.3 m -88.63 -8.79 10.9 Favored 'Isoleucine or valine' 0 C--O 1.236 0.367 0 CA-C-N 115.98 -0.555 . . . . 1.0 109.716 179.307 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -40.92 -49.67 4.21 Favored Glycine 0 CA--C 1.535 1.301 0 CA-C-O 119.466 -0.63 . . . . 1.0 111.633 -177.999 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 85.7 Cg_exo -45.38 -27.83 3.48 Favored 'Trans proline' 0 N--CA 1.495 1.608 0 CA-C-N 120.072 1.936 . . . . 1.0 112.052 177.726 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 92' ' ' HIS . . . . . 0.51 ' ND1' ' HG2' ' A' ' 51' ' ' GLU . 25.9 t-80 -56.36 -33.91 66.13 Favored 'General case' 0 C--O 1.22 -0.476 0 N-CA-C 107.849 -1.167 . . . . 1.0 107.849 -177.607 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . 0.976 HD23 ' H ' ' A' ' 94' ' ' ALA . 0.5 OUTLIER -42.45 -51.85 4.85 Favored 'General case' 0 N--CA 1.473 0.697 0 C-N-CA 120.375 -0.53 . . . . 1.0 109.592 -179.833 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 94' ' ' ALA . . . . . 0.976 ' H ' HD23 ' A' ' 93' ' ' LEU . . . -56.1 -53.9 51.51 Favored 'General case' 0 N--CA 1.449 -0.513 0 N-CA-C 107.998 -1.112 . . . . 1.0 107.998 178.877 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 95' ' ' ARG . . . . . 0.596 ' C ' ' H ' ' A' ' 97' ' ' LEU . 0.2 OUTLIER -51.3 -58.57 5.83 Favored 'General case' 0 C--O 1.241 0.649 0 CA-C-O 123.358 1.551 . . . . 1.0 107.075 177.614 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 96' ' ' ALA . . . . . 0.85 ' O ' ' N ' ' A' ' 98' ' ' GLY . . . -49.24 -11.88 0.05 OUTLIER 'General case' 0 N--CA 1.427 -1.622 0 O-C-N 118.731 -2.481 . . . . 1.0 110.895 -179.842 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . 0.66 ' O ' ' N ' ' A' ' 100' ' ' ILE . 0.4 OUTLIER 4.79 -49.52 0.0 OUTLIER 'General case' 0 CA--C 1.511 -0.549 0 C-N-CA 124.9 1.28 . . . . 1.0 112.865 -170.101 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 98' ' ' GLY . . . . . 0.85 ' N ' ' O ' ' A' ' 96' ' ' ALA . . . -53.24 -22.41 14.43 Favored Glycine 0 N--CA 1.426 -2.008 0 N-CA-C 107.817 -2.113 . . . . 1.0 107.817 174.806 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 99' ' ' GLN . . . . . 0.652 ' O ' ' HG3' ' A' ' 103' ' ' ARG . 15.2 mm100 -71.54 -22.95 61.69 Favored 'General case' 0 CA--C 1.5 -0.975 0 C-N-CA 116.551 -2.06 . . . . 1.0 107.127 177.576 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 100' ' ' ILE . . . . . 0.66 ' N ' ' O ' ' A' ' 97' ' ' LEU . 2.8 tt -66.05 -34.78 72.54 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.135 0 O-C-N 124.797 1.311 . . . . 1.0 109.453 178.779 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 101' ' ' VAL . . . . . 0.557 ' CG1' ' N ' ' A' ' 102' ' ' CYS . 0.4 OUTLIER -57.96 -57.97 8.32 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 N-CA-C 106.852 -1.536 . . . . 1.0 106.852 -178.757 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 102' ' ' CYS . . . . . 0.681 ' O ' ' HB2' ' A' ' 106' ' ' ALA . 0.1 OUTLIER -48.99 -28.89 4.23 Favored 'General case' 0 N--CA 1.441 -0.883 0 CA-C-N 115.224 -0.898 . . . . 1.0 110.078 178.954 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 103' ' ' ARG . . . . . 0.652 ' HG3' ' O ' ' A' ' 99' ' ' GLN . 74.7 mtt-85 -72.58 -56.61 5.09 Favored 'General case' 0 N--CA 1.478 0.972 0 O-C-N 123.984 0.803 . . . . 1.0 110.085 179.063 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 104' ' ' TYR . . . . . 0.774 ' O ' ' HD1' ' A' ' 104' ' ' TYR . 0.5 OUTLIER -90.34 25.77 2.13 Favored 'General case' 0 CA--C 1.494 -1.187 0 C-N-CA 125.435 1.494 . . . . 1.0 108.44 177.291 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 105' ' ' GLY . . . . . 0.529 ' N ' ' O ' ' A' ' 101' ' ' VAL . . . -155.43 -91.02 0.08 OUTLIER Glycine 0 N--CA 1.443 -0.841 0 C-N-CA 118.793 -1.67 . . . . 1.0 109.86 176.932 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 106' ' ' ALA . . . . . 0.681 ' HB2' ' O ' ' A' ' 102' ' ' CYS . . . 58.18 114.36 0.01 OUTLIER 'General case' 0 CA--C 1.551 0.993 0 N-CA-C 108.92 -0.77 . . . . 1.0 108.92 -179.309 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 107' ' ' THR . . . . . 0.826 ' O ' ' HD2' ' A' ' 110' ' ' PRO . 5.2 m -134.7 -54.4 0.82 Allowed 'General case' 0 N--CA 1.481 1.115 0 N-CA-C 108.548 -0.908 . . . . 1.0 108.548 178.751 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . 0.525 ' O ' ' N ' ' A' ' 111' ' ' ASN . 16.7 m -70.85 -43.82 76.63 Favored 'Isoleucine or valine' 0 C--N 1.348 0.53 0 CA-C-O 121.993 0.901 . . . . 1.0 108.873 -179.574 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 109' ' ' ILE . . . . . 0.604 HG23 ' HD3' ' A' ' 110' ' ' PRO . 0.0 OUTLIER -39.06 -46.72 3.62 Favored Pre-proline 0 CA--C 1.553 1.065 0 CA-C-N 114.2 -1.364 . . . . 1.0 109.919 -178.179 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 110' ' ' PRO . . . . . 0.826 ' HD2' ' O ' ' A' ' 107' ' ' THR . 28.1 Cg_exo -64.43 -24.27 64.27 Favored 'Trans proline' 0 N--CA 1.504 2.108 0 C-N-CA 124.44 3.427 . . . . 1.0 111.871 177.675 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 111' ' ' ASN . . . . . 0.525 ' N ' ' O ' ' A' ' 108' ' ' VAL . 2.9 t-20 -62.3 -69.04 0.28 Allowed 'General case' 0 C--O 1.236 0.374 0 CA-C-N 115.996 -0.547 . . . . 1.0 109.74 -179.007 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 112' ' ' ILE . . . . . 0.505 ' O ' ' N ' ' A' ' 115' ' ' ALA . 0.0 OUTLIER -67.43 -36.55 76.78 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.538 0 CA-C-O 121.924 0.869 . . . . 1.0 110.13 178.777 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 113' ' ' ASN . . . . . 0.456 ' O ' ' HB3' ' A' ' 117' ' ' GLU . 10.3 t30 -48.27 -52.42 21.32 Favored 'General case' 0 C--N 1.309 -1.165 0 N-CA-C 107.266 -1.383 . . . . 1.0 107.266 -178.264 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -62.2 -24.72 67.38 Favored 'General case' 0 N--CA 1.451 -0.419 0 CA-C-N 116.378 -0.374 . . . . 1.0 110.432 177.307 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 115' ' ' ALA . . . . . 0.505 ' N ' ' O ' ' A' ' 112' ' ' ILE . . . -77.07 -59.1 2.92 Favored 'General case' 0 C--O 1.235 0.292 0 C-N-CA 119.957 -0.697 . . . . 1.0 110.799 178.419 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 116' ' ' ILE . . . . . 0.64 HG23 ' N ' ' A' ' 117' ' ' GLU . 11.5 tt -67.31 -50.54 61.79 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.571 0 CA-C-O 120.983 0.42 . . . . 1.0 110.906 -178.378 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 117' ' ' GLU . . . . . 0.64 ' N ' HG23 ' A' ' 116' ' ' ILE . 23.6 tt0 -42.63 -60.47 1.54 Allowed 'General case' 0 C--O 1.244 0.794 0 N-CA-C 108.074 -1.084 . . . . 1.0 108.074 -177.471 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 18.7 t -51.71 -23.48 3.38 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.086 0 CA-C-N 114.261 -1.336 . . . . 1.0 109.357 177.662 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 119' ' ' LEU . . . . . 0.623 ' N ' ' O ' ' A' ' 116' ' ' ILE . 2.5 tp -81.68 -62.67 1.58 Allowed 'General case' 0 C--N 1.344 0.328 0 C-N-CA 120.304 -0.558 . . . . 1.0 111.468 179.108 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -67.6 -86.77 0.08 OUTLIER Glycine 0 C--N 1.355 1.622 0 C-N-CA 117.421 -2.323 . . . . 1.0 110.417 179.756 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 38.3 m -162.61 -25.45 0.04 OUTLIER 'General case' 0 C--N 1.32 -0.682 0 N-CA-C 107.364 -1.347 . . . . 1.0 107.364 -179.962 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 122' ' ' GLY . . . . . 0.479 ' O ' ' N ' ' A' ' 124' ' ' ASP . . . 114.32 -35.79 4.28 Favored Glycine 0 C--N 1.347 1.152 0 C-N-CA 125.32 1.438 . . . . 1.0 113.539 178.907 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 123' ' ' THR . . . . . 0.458 HG23 ' O ' ' A' ' 123' ' ' THR . 1.8 t -33.21 92.12 0.01 OUTLIER 'General case' 0 N--CA 1.473 0.705 0 CA-C-N 120.124 1.962 . . . . 1.0 113.344 -179.124 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 124' ' ' ASP . . . . . 0.479 ' N ' ' O ' ' A' ' 122' ' ' GLY . 22.6 m-20 -142.65 143.22 32.27 Favored 'General case' 0 C--N 1.328 -0.344 0 N-CA-C 108.49 -0.93 . . . . 1.0 108.49 177.655 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 125' ' ' TYR . . . . . . . . . . . . . 11.2 t80 -148.64 143.19 26.37 Favored 'General case' 0 CA--C 1.536 0.412 0 N-CA-C 109.247 -0.649 . . . . 1.0 109.247 -179.591 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 126' ' ' ARG . . . . . 0.497 ' HB2' ' H63' ' A' ' 130' ' ' MTN . 4.0 mmp_? -151.76 155.15 37.67 Favored 'General case' 0 CA--C 1.535 0.372 0 CA-C-N 116.259 -0.428 . . . . 1.0 110.59 178.54 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 127' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--O 1.218 -0.576 0 CA-C-O 118.193 -0.908 . . . . 1.0 109.726 178.476 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 128' ' ' MTN . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 129' ' ' MTN . . . . . 0.678 ' H62' ' O ' ' A' ' 48' ' ' CYS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 130' ' ' MTN . . . . . 0.599 ' H92' ' HG2' ' A' ' 103' ' ' ARG . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 24.5 mmt . . . . . 0 N--CA 1.495 1.802 0 N-CA-C 109.081 -0.711 . . . . 1.0 109.081 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . 0.438 ' O ' ' OD1' ' A' ' 3' ' ' ASP . 58.3 p -108.84 11.23 26.29 Favored 'General case' 0 N--CA 1.469 0.495 0 C-N-CA 122.957 0.503 . . . . 1.0 110.247 179.489 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . 0.438 ' OD1' ' O ' ' A' ' 2' ' ' SER . 2.2 m-20 166.67 91.54 0.0 OUTLIER 'General case' 0 N--CA 1.468 0.429 0 CA-C-N 116.321 -0.4 . . . . 1.0 110.044 179.615 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 76.2 t80 -147.98 143.68 27.46 Favored 'General case' 0 C--N 1.332 -0.156 0 N-CA-C 109.993 -0.373 . . . . 1.0 109.993 179.364 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 5' ' ' ASP . . . . . 0.451 ' N ' ' OD1' ' A' ' 5' ' ' ASP . 0.3 OUTLIER -153.38 149.0 27.36 Favored 'General case' 0 CA--C 1.534 0.359 0 CA-C-N 116.657 -0.247 . . . . 1.0 110.361 -178.916 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 6' ' ' THR . . . . . 0.733 ' O ' ' N ' ' A' ' 10' ' ' SER . 62.6 p -70.39 -178.56 1.77 Allowed 'General case' 0 C--O 1.202 -1.439 0 C-N-CA 121.155 -0.218 . . . . 1.0 110.838 179.888 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . 0.483 ' O ' ' N ' ' A' ' 11' ' ' ARG . 0.0 OUTLIER -58.71 -56.14 25.99 Favored 'General case' 0 N--CA 1.48 1.025 0 CA-C-O 121.645 0.736 . . . . 1.0 110.785 -177.631 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 8' ' ' ARG . . . . . 0.806 ' O ' ' HB3' ' A' ' 12' ' ' ALA . 65.1 ttt180 -50.95 -56.49 12.15 Favored 'General case' 0 C--N 1.32 -0.716 0 N-CA-C 106.723 -1.584 . . . . 1.0 106.723 -178.562 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . 0.577 ' O ' ' CG2' ' A' ' 13' ' ' VAL . 48.7 t -65.91 -49.72 75.0 Favored 'Isoleucine or valine' 0 C--O 1.2 -1.514 0 CA-C-N 113.641 -1.618 . . . . 1.0 110.761 179.136 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . 0.733 ' N ' ' O ' ' A' ' 6' ' ' THR . 38.9 t -67.68 -65.41 0.69 Allowed 'General case' 0 N--CA 1.478 0.97 0 O-C-N 121.585 -0.697 . . . . 1.0 112.436 -178.391 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 11' ' ' ARG . . . . . 0.52 ' O ' ' N ' ' A' ' 15' ' ' ALA . 21.6 ttt180 -65.38 -58.61 5.44 Favored 'General case' 0 N--CA 1.467 0.399 0 C-N-CA 120.749 -0.381 . . . . 1.0 111.491 -175.966 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . 0.806 ' HB3' ' O ' ' A' ' 8' ' ' ARG . . . -49.82 -49.2 49.8 Favored 'General case' 0 N--CA 1.473 0.703 0 N-CA-C 106.449 -1.686 . . . . 1.0 106.449 -176.937 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . 0.577 ' CG2' ' O ' ' A' ' 9' ' ' VAL . 93.9 t -60.71 -48.55 88.26 Favored 'Isoleucine or valine' 0 C--O 1.202 -1.412 0 C-N-CA 118.061 -1.456 . . . . 1.0 108.149 176.745 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . 0.667 ' O ' HG13 ' A' ' 18' ' ' VAL . . . -57.25 -61.96 2.1 Favored 'General case' 0 C--O 1.211 -0.934 0 C-N-CA 118.088 -1.445 . . . . 1.0 109.636 -179.849 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . 0.527 ' O ' ' N ' ' A' ' 19' ' ' GLY . . . -52.42 -54.64 29.43 Favored 'General case' 0 N--CA 1.473 0.721 0 CA-C-O 121.702 0.763 . . . . 1.0 109.857 -178.342 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . 0.567 ' C ' ' H ' ' A' ' 22' ' ' GLY . . . -61.88 -55.11 33.16 Favored 'General case' 0 C--N 1.309 -1.154 0 CA-C-N 114.57 -1.196 . . . . 1.0 109.051 -179.023 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . 0.567 ' N ' ' O ' ' A' ' 13' ' ' VAL . 6.7 tp -56.41 -53.22 59.94 Favored 'General case' 0 N--CA 1.478 0.96 0 CA-C-N 113.726 -1.579 . . . . 1.0 108.638 -177.504 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . 0.667 HG13 ' O ' ' A' ' 14' ' ' ALA . 3.5 m -68.02 -56.43 12.89 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.258 0 N-CA-C 108.63 -0.878 . . . . 1.0 108.63 179.262 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . 0.527 ' N ' ' O ' ' A' ' 15' ' ' ALA . . . -64.77 -171.69 2.81 Favored Glycine 0 CA--C 1.521 0.423 0 N-CA-C 110.28 -1.128 . . . . 1.0 110.28 179.571 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 20' ' ' PRO . . . . . 0.657 ' O ' ' N ' ' A' ' 24' ' ' ALA . 43.7 Cg_endo -80.63 -21.37 7.31 Favored 'Trans proline' 0 C--N 1.301 -1.942 0 C-N-CA 122.115 1.876 . . . . 1.0 113.097 -179.316 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -56.73 -58.13 16.03 Favored Glycine 0 CA--C 1.535 1.33 0 C-N-CA 119.488 -1.339 . . . . 1.0 110.355 -177.725 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . 0.567 ' H ' ' C ' ' A' ' 16' ' ' ALA . . . -62.68 -53.1 43.79 Favored Glycine 0 N--CA 1.471 0.976 0 N-CA-C 108.13 -1.988 . . . . 1.0 108.13 -179.845 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . 0.705 ' O ' HG12 ' A' ' 27' ' ' VAL . 0.5 OUTLIER -56.44 -38.38 55.76 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.737 0 N-CA-C 108.316 -0.994 . . . . 1.0 108.316 -179.411 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . 0.657 ' N ' ' O ' ' A' ' 20' ' ' PRO . . . -58.14 -59.99 4.44 Favored 'General case' 0 N--CA 1.468 0.436 0 C-N-CA 119.484 -0.886 . . . . 1.0 109.652 -179.301 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -62.74 -42.57 99.73 Favored 'General case' 0 CA--C 1.519 -0.217 0 C-N-CA 119.685 -0.806 . . . . 1.0 111.041 -178.642 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 69.9 t -61.93 -61.11 1.76 Allowed 'Isoleucine or valine' 0 N--CA 1.448 -0.536 0 C-N-CA 118.606 -1.238 . . . . 1.0 110.711 -178.33 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . 0.705 HG12 ' O ' ' A' ' 23' ' ' VAL . 9.8 p -60.21 -37.6 74.1 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.333 0 N-CA-C 112.749 0.648 . . . . 1.0 112.749 -176.706 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . 0.412 ' N ' HG13 ' A' ' 27' ' ' VAL . 59.8 tttm -69.0 -54.11 16.95 Favored 'General case' 0 C--N 1.315 -0.895 0 CA-C-O 121.815 0.816 . . . . 1.0 109.378 -178.916 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 95.0 t -64.17 -49.26 82.1 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.83 0 CA-C-N 114.216 -1.357 . . . . 1.0 110.29 -177.7 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 30' ' ' CYS . . . . . . . . . . . . . 44.5 t -67.03 -61.44 1.93 Allowed 'General case' 0 N--CA 1.444 -0.767 0 C-N-CA 119.07 -1.052 . . . . 1.0 110.416 -179.247 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . 0.655 ' HB3' ' O ' ' A' ' 27' ' ' VAL . . . -64.94 -53.79 40.81 Favored 'General case' 0 CA--C 1.514 -0.441 0 N-CA-C 112.726 0.639 . . . . 1.0 112.726 -175.427 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . 0.413 ' O ' ' CB ' ' A' ' 33' ' ' LEU . . . 89.05 72.02 1.27 Allowed Glycine 0 CA--C 1.522 0.506 0 N-CA-C 108.403 -1.879 . . . . 1.0 108.403 -177.446 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . 0.413 ' CB ' ' O ' ' A' ' 32' ' ' GLY . 6.1 tp 81.65 122.28 0.03 OUTLIER Pre-proline 0 CA--C 1.54 0.587 0 C-N-CA 122.858 0.463 . . . . 1.0 111.268 -179.547 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 39.8 Cg_endo -68.45 -18.36 43.69 Favored 'Trans proline' 0 N--CA 1.495 1.574 0 C-N-CA 121.433 1.422 . . . . 1.0 113.56 179.668 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -57.22 -61.03 7.97 Favored Glycine 0 C--N 1.338 0.677 0 C-N-CA 118.126 -1.987 . . . . 1.0 108.802 -179.022 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . 0.916 ' O ' HG22 ' A' ' 37' ' ' ILE . 9.0 p -69.25 -150.78 0.0 OUTLIER 'Isoleucine or valine' 0 C--O 1.215 -0.721 0 N-CA-C 106.057 -1.831 . . . . 1.0 106.057 177.869 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . 0.916 HG22 ' O ' ' A' ' 36' ' ' VAL . 6.8 tp 79.15 75.25 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.483 1.186 0 O-C-N 124.281 0.988 . . . . 1.0 112.597 179.444 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 10.3 m80 -136.23 130.46 33.14 Favored 'General case' 0 C--N 1.334 -0.08 0 O-C-N 120.858 -1.151 . . . . 1.0 108.653 177.619 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . 0.501 ' OG1' ' NE ' ' A' ' 42' ' ' ARG . 20.0 p -110.19 144.54 30.28 Favored Pre-proline 0 N--CA 1.464 0.228 0 N-CA-C 109.65 -0.5 . . . . 1.0 109.65 -179.859 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 90.7 Cg_endo -73.27 -29.22 11.66 Favored 'Trans proline' 0 N--CA 1.493 1.497 0 C-N-CA 122.144 1.896 . . . . 1.0 113.425 -178.818 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -127.59 133.39 49.73 Favored 'General case' 0 N--CA 1.468 0.457 0 CA-C-N 116.767 -0.197 . . . . 1.0 110.786 179.123 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . 0.602 ' C ' ' H ' ' A' ' 44' ' ' GLY . 4.4 mtm180 -171.67 171.64 5.23 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-O 121.461 0.648 . . . . 1.0 109.529 176.391 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 43' ' ' ARG . . . . . 0.411 ' HG3' ' O ' ' A' ' 43' ' ' ARG . 0.0 OUTLIER -69.51 15.92 0.07 Allowed 'General case' 0 C--N 1.315 -0.898 0 CA-C-N 114.805 -1.089 . . . . 1.0 108.981 179.422 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . 0.602 ' H ' ' C ' ' A' ' 42' ' ' ARG . . . 93.9 -19.91 50.31 Favored Glycine 0 C--N 1.336 0.558 0 N-CA-C 110.035 -1.226 . . . . 1.0 110.035 179.232 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . 0.729 ' O ' ' HB2' ' A' ' 46' ' ' PHE . 1.1 p90 -167.23 169.08 12.88 Favored 'General case' 0 CA--C 1.538 0.485 0 N-CA-C 109.884 -0.414 . . . . 1.0 109.884 179.868 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 46' ' ' PHE . . . . . 0.729 ' HB2' ' O ' ' A' ' 45' ' ' PHE . 0.2 OUTLIER 148.12 71.24 0.0 OUTLIER 'General case' 0 N--CA 1.504 2.257 0 O-C-N 125.772 1.92 . . . . 1.0 110.176 178.555 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 47' ' ' ARG . . . . . 0.503 ' CB ' ' O ' ' A' ' 46' ' ' PHE . 4.2 mmt-85 142.94 142.87 0.0 OUTLIER 'General case' 0 N--CA 1.483 1.202 0 N-CA-C 108.831 -0.803 . . . . 1.0 108.831 179.082 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 1.8 t 70.75 68.6 0.19 Allowed 'General case' 0 N--CA 1.446 -0.661 0 N-CA-C 108.7 -0.852 . . . . 1.0 108.7 -179.594 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 49' ' ' ASN . . . . . 0.605 ' ND2' ' O ' ' A' ' 49' ' ' ASN . 3.2 p-10 -140.71 105.7 6.36 Favored Pre-proline 0 CA--C 1.54 0.579 0 N-CA-C 107.929 -1.137 . . . . 1.0 107.929 -179.89 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . 0.518 ' C ' ' H ' ' A' ' 52' ' ' ARG . 62.8 Cg_exo -49.72 68.64 0.02 OUTLIER 'Trans proline' 0 N--CA 1.505 2.174 0 C-N-CA 122.733 2.289 . . . . 1.0 114.533 -178.749 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . 0.6 ' N ' ' O ' ' A' ' 49' ' ' ASN . 42.6 mm-40 71.52 -23.13 0.19 Allowed 'General case' 0 N--CA 1.468 0.451 0 C-N-CA 122.636 0.375 . . . . 1.0 110.711 -179.695 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . 0.591 ' NH2' HH22 ' A' ' 126' ' ' ARG . 17.0 mmt180 -48.05 114.14 0.87 Allowed 'General case' 0 C--N 1.329 -0.319 0 N-CA-C 109.302 -0.629 . . . . 1.0 109.302 179.98 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . 0.466 ' O ' ' N ' ' A' ' 55' ' ' ILE . 21.5 tt -54.71 143.58 6.92 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-O 121.385 0.612 . . . . 1.0 110.482 -179.292 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 11.4 mm100 -64.65 77.64 0.04 OUTLIER 'General case' 0 C--N 1.318 -0.788 0 C-N-CA 119.123 -1.031 . . . . 1.0 109.683 -177.917 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . 0.466 ' N ' ' O ' ' A' ' 53' ' ' ILE . 3.2 tp -150.11 158.05 5.79 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.299 0 N-CA-C 110.406 -0.22 . . . . 1.0 110.406 178.179 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 113.44 -27.42 9.41 Favored Glycine 0 CA--C 1.519 0.296 0 N-CA-C 110.305 -1.118 . . . . 1.0 110.305 179.3 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . 0.453 ' OD1' ' N ' ' A' ' 57' ' ' ASP . 11.4 p-10 -57.43 101.95 0.08 Allowed 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 117.638 0.719 . . . . 1.0 110.254 179.529 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 58' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -86.25 176.06 8.14 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-O 122.526 1.155 . . . . 1.0 111.843 -179.169 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 59' ' ' ARG . . . . . 0.503 ' CG ' ' N ' ' A' ' 60' ' ' TYR . 22.2 ptt-85 -90.82 -56.38 3.2 Favored 'General case' 0 C--N 1.316 -0.884 0 CA-C-N 112.756 -2.02 . . . . 1.0 112.224 179.841 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 60' ' ' TYR . . . . . 0.503 ' N ' ' CG ' ' A' ' 59' ' ' ARG . 0.4 OUTLIER -91.22 -20.64 21.72 Favored 'General case' 0 C--O 1.247 0.967 0 CA-C-O 121.948 0.88 . . . . 1.0 113.046 -179.107 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 3.5 tt0 -79.21 -12.77 59.97 Favored 'General case' 0 N--CA 1.436 -1.157 0 N-CA-C 109.425 -0.583 . . . . 1.0 109.425 -179.893 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . 0.615 HG13 ' N ' ' A' ' 63' ' ' ALA . 6.1 p -46.84 -55.85 1.59 Allowed 'Isoleucine or valine' 0 C--O 1.212 -0.899 0 C-N-CA 119.656 -0.817 . . . . 1.0 109.811 -175.69 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 63' ' ' ALA . . . . . 0.615 ' N ' HG13 ' A' ' 62' ' ' VAL . . . -64.87 -54.63 27.96 Favored 'General case' 0 N--CA 1.435 -1.199 0 C-N-CA 120.177 -0.609 . . . . 1.0 109.509 -179.68 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 64' ' ' HIS . . . . . 0.424 ' O ' ' CG ' ' A' ' 67' ' ' ARG . 0.2 OUTLIER -48.45 -57.95 5.35 Favored 'General case' 0 CA--C 1.538 0.495 0 CA-C-N 115.484 -0.78 . . . . 1.0 110.153 -179.567 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . 0.659 ' C ' ' H ' ' A' ' 67' ' ' ARG . 0.8 OUTLIER -69.78 -46.49 65.65 Favored 'General case' 0 C--N 1.316 -0.858 0 CA-C-O 122.309 1.052 . . . . 1.0 110.222 179.19 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . 0.568 ' N ' ' O ' ' A' ' 62' ' ' VAL . . . -71.08 27.38 0.54 Allowed Glycine 0 N--CA 1.447 -0.621 0 N-CA-C 109.585 -1.406 . . . . 1.0 109.585 177.755 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 67' ' ' ARG . . . . . 0.697 ' O ' ' N ' ' A' ' 69' ' ' LEU . 14.5 mmt85 -74.9 1.26 13.16 Favored 'General case' 0 N--CA 1.441 -0.909 0 N-CA-C 107.87 -1.159 . . . . 1.0 107.87 176.23 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . 0.453 ' C ' ' O ' ' A' ' 67' ' ' ARG . 0.8 OUTLIER -33.05 -24.46 0.0 OUTLIER 'General case' 0 N--CA 1.475 0.79 0 O-C-N 123.745 0.653 . . . . 1.0 109.5 -175.99 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . 0.697 ' N ' ' O ' ' A' ' 67' ' ' ARG . 4.8 mp -67.31 -64.64 0.81 Allowed 'General case' 0 CA--C 1.54 0.571 0 C-N-CA 119.326 -0.95 . . . . 1.0 109.681 177.999 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . 0.664 ' C ' ' H ' ' A' ' 72' ' ' HIS . . . -80.53 -76.93 0.21 Allowed 'General case' 0 N--CA 1.473 0.685 0 N-CA-C 106.035 -1.839 . . . . 1.0 106.035 177.173 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . 0.473 ' HB3' ' CB ' ' A' ' 67' ' ' ARG . . . -42.6 0.59 0.0 OUTLIER 'General case' 0 N--CA 1.469 0.499 0 C-N-CA 124.631 1.173 . . . . 1.0 113.089 179.723 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 72' ' ' HIS . . . . . 0.664 ' H ' ' C ' ' A' ' 70' ' ' ALA . 1.2 p-80 -26.27 -58.71 0.08 Allowed 'General case' 0 C--N 1.342 0.251 0 C-N-CA 122.747 0.419 . . . . 1.0 111.541 -178.738 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 73' ' ' MET . . . . . 0.618 ' N ' ' CG ' ' A' ' 72' ' ' HIS . 49.5 mtt -75.37 -49.79 17.93 Favored 'General case' 0 C--N 1.321 -0.65 0 C-N-CA 120.545 -0.462 . . . . 1.0 109.878 177.408 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . 0.63 ' O ' ' N ' ' A' ' 76' ' ' GLY . 57.5 t -44.63 -42.07 2.19 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.167 0 CA-C-O 117.883 -1.056 . . . . 1.0 111.954 -175.409 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 75' ' ' ASN . . . . . 0.532 ' O ' HG23 ' A' ' 79' ' ' ILE . 40.7 t30 -40.13 -14.72 0.01 OUTLIER 'General case' 0 N--CA 1.478 0.938 0 CA-C-N 121.071 1.759 . . . . 1.0 112.195 176.796 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . 0.63 ' N ' ' O ' ' A' ' 74' ' ' VAL . . . -45.43 -24.04 0.95 Allowed Glycine 0 CA--C 1.539 1.566 0 N-CA-C 108.734 -1.746 . . . . 1.0 108.734 178.866 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . 0.535 ' O ' ' N ' ' A' ' 80' ' ' ALA . 2.2 pt -89.87 -61.62 1.86 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.719 0 CA-C-N 114.261 -0.97 . . . . 1.0 110.672 -178.837 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . 0.496 HG11 ' OD1' ' A' ' 65' ' ' ASP . 56.0 t -36.89 -29.91 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.448 -0.53 0 N-CA-C 109.267 -0.642 . . . . 1.0 109.267 -177.27 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . 0.82 ' O ' ' HB3' ' A' ' 83' ' ' ALA . 2.5 pt -64.75 -52.75 50.51 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.03 0 C-N-CA 119.151 -1.02 . . . . 1.0 109.626 178.786 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 80' ' ' ALA . . . . . 0.544 ' N ' ' CG1' ' A' ' 79' ' ' ILE . . . -55.86 -63.42 1.18 Allowed 'General case' 0 C--O 1.214 -0.768 0 C-N-CA 118.245 -1.382 . . . . 1.0 111.156 -178.489 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 47.5 mt-10 -50.1 -71.18 0.07 Allowed 'General case' 0 CA--C 1.531 0.216 0 C-N-CA 119.587 -0.845 . . . . 1.0 110.335 -179.151 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 21.2 t70 -62.88 -63.88 1.08 Allowed 'General case' 0 C--N 1.323 -0.582 0 C-N-CA 118.529 -1.268 . . . . 1.0 109.953 -177.997 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . 0.82 ' HB3' ' O ' ' A' ' 79' ' ' ILE . . . -53.04 -13.97 0.54 Allowed 'General case' 0 CA--C 1.536 0.409 0 C-N-CA 118.672 -1.211 . . . . 1.0 111.043 -177.801 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . 0.491 ' HB2' ' O ' ' A' ' 80' ' ' ALA . 1.0 OUTLIER -40.73 -16.54 0.01 OUTLIER 'General case' 0 C--N 1.37 1.495 0 CA-C-N 120.463 1.483 . . . . 1.0 112.047 -179.756 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 85' ' ' ILE . . . . . 0.58 ' N ' ' O ' ' A' ' 83' ' ' ALA . 19.8 pt -62.25 -41.65 92.29 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.245 0 N-CA-C 109.123 -0.695 . . . . 1.0 109.123 179.806 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . 0.438 ' CB ' ' CZ ' ' A' ' 52' ' ' ARG . . . -97.07 -2.7 42.74 Favored 'General case' 0 CA--C 1.539 0.523 0 C-N-CA 123.286 0.634 . . . . 1.0 112.506 179.896 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 34.1 tp10 -51.25 -20.89 1.79 Allowed 'General case' 0 C--N 1.32 -0.709 0 CA-C-N 115.307 -0.86 . . . . 1.0 109.842 -179.927 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -123.18 14.63 9.77 Favored 'General case' 0 N--CA 1.475 0.816 0 CA-C-O 121.459 0.647 . . . . 1.0 109.792 178.765 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 89' ' ' VAL . . . . . 0.595 ' O ' HG12 ' A' ' 89' ' ' VAL . 24.1 t -109.01 29.24 1.48 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.453 0 CA-C-N 114.579 -1.191 . . . . 1.0 109.655 177.861 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 90' ' ' GLY . . . . . 0.534 ' N ' ' CD ' ' A' ' 91' ' ' PRO . . . -68.78 -43.2 76.07 Favored Glycine 0 CA--C 1.525 0.694 0 N-CA-C 109.632 -1.387 . . . . 1.0 109.632 177.156 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 91' ' ' PRO . . . . . 0.534 ' CD ' ' N ' ' A' ' 90' ' ' GLY . 81.7 Cg_exo -45.71 -14.09 0.1 OUTLIER 'Trans proline' 0 N--CA 1.489 1.217 0 C-N-CA 121.686 1.591 . . . . 1.0 110.686 178.733 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 92' ' ' HIS . . . . . 0.671 ' CD2' HH21 ' A' ' 95' ' ' ARG . 40.9 t-80 -57.1 -17.38 10.32 Favored 'General case' 0 C--O 1.204 -1.32 0 N-CA-C 107.941 -1.133 . . . . 1.0 107.941 -179.886 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . 0.703 HD12 ' N ' ' A' ' 94' ' ' ALA . 2.9 pp -62.41 -55.7 25.33 Favored 'General case' 0 C--N 1.325 -0.468 0 N-CA-C 109.081 -0.711 . . . . 1.0 109.081 178.083 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 94' ' ' ALA . . . . . 0.703 ' N ' HD12 ' A' ' 93' ' ' LEU . . . -57.92 -52.52 65.14 Favored 'General case' 0 CA--C 1.513 -0.46 0 N-CA-C 108.64 -0.874 . . . . 1.0 108.64 179.476 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 95' ' ' ARG . . . . . 0.671 HH21 ' CD2' ' A' ' 92' ' ' HIS . 18.3 ttp180 -57.82 -58.37 8.65 Favored 'General case' 0 N--CA 1.446 -0.633 0 N-CA-C 106.692 -1.596 . . . . 1.0 106.692 178.482 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 96' ' ' ALA . . . . . 1.005 ' O ' ' N ' ' A' ' 98' ' ' GLY . . . -47.36 -10.95 0.02 OUTLIER 'General case' 0 C--N 1.299 -1.625 0 O-C-N 118.887 -2.383 . . . . 1.0 111.504 178.236 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . 0.734 HD12 ' N ' ' A' ' 98' ' ' GLY . 3.5 pp 9.49 -45.32 0.0 OUTLIER 'General case' 0 N--CA 1.475 0.796 0 C-N-CA 124.202 1.001 . . . . 1.0 112.177 -164.879 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 98' ' ' GLY . . . . . 1.005 ' N ' ' O ' ' A' ' 96' ' ' ALA . . . -53.33 -23.71 19.64 Favored Glycine 0 C--N 1.295 -1.736 0 N-CA-C 106.423 -2.671 . . . . 1.0 106.423 173.269 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 99' ' ' GLN . . . . . 0.536 ' HB2' ' HB3' ' A' ' 96' ' ' ALA . 1.1 tp-100 -58.27 -21.17 47.64 Favored 'General case' 0 C--N 1.367 1.346 0 N-CA-C 106.523 -1.658 . . . . 1.0 106.523 177.167 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 100' ' ' ILE . . . . . 0.661 ' N ' ' O ' ' A' ' 97' ' ' LEU . 84.3 mt -65.72 -42.49 92.64 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.925 0 CA-C-N 113.51 -1.677 . . . . 1.0 109.532 178.0 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 101' ' ' VAL . . . . . 0.601 HG13 ' N ' ' A' ' 102' ' ' CYS . 2.8 p -52.74 -62.84 0.55 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.383 0 C-N-CA 119.03 -1.068 . . . . 1.0 111.647 -177.055 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 102' ' ' CYS . . . . . 0.898 ' O ' ' HB2' ' A' ' 106' ' ' ALA . 0.8 OUTLIER -49.77 -22.5 1.44 Allowed 'General case' 0 C--N 1.316 -0.849 0 N-CA-C 112.421 0.526 . . . . 1.0 112.421 -177.572 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 60.1 ttt-85 -85.2 -46.89 10.64 Favored 'General case' 0 N--CA 1.482 1.146 0 CA-C-O 122.303 1.049 . . . . 1.0 112.344 179.584 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 104' ' ' TYR . . . . . 0.714 ' O ' ' CG ' ' A' ' 104' ' ' TYR . 0.0 OUTLIER -96.53 19.67 11.88 Favored 'General case' 0 C--N 1.308 -1.234 0 CA-C-N 113.341 -1.754 . . . . 1.0 109.539 178.591 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 105' ' ' GLY . . . . . 0.481 ' O ' ' HB3' ' A' ' 106' ' ' ALA . . . -153.06 -85.28 0.05 OUTLIER Glycine 0 C--N 1.342 0.888 1 N-CA-C 102.268 -4.333 . . . . 1.0 102.268 175.955 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 106' ' ' ALA . . . . . 0.898 ' HB2' ' O ' ' A' ' 102' ' ' CYS . . . 73.99 60.41 0.08 Allowed 'General case' 0 C--O 1.206 -1.232 0 N-CA-C 115.046 1.499 . . . . 1.0 115.046 176.568 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 75.6 m -82.53 -57.38 3.37 Favored 'General case' 0 CA--C 1.548 0.887 0 O-C-N 120.859 -1.151 . . . . 1.0 109.649 179.866 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 27.2 m -66.44 -7.17 5.1 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.056 0 CA-C-O 121.565 0.698 . . . . 1.0 111.525 -179.59 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 1.5 mp -83.16 -64.18 0.25 Allowed Pre-proline 0 CA--C 1.55 0.975 0 CA-C-N 114.607 -1.179 . . . . 1.0 111.401 -179.831 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 110' ' ' PRO . . . . . 0.709 ' CD ' ' O ' ' A' ' 106' ' ' ALA . 58.6 Cg_endo -66.35 -33.95 36.7 Favored 'Trans proline' 0 N--CA 1.504 2.115 0 C-N-CA 124.407 3.405 . . . . 1.0 113.131 179.753 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 111' ' ' ASN . . . . . 0.436 ' C ' ' N ' ' A' ' 113' ' ' ASN . 39.8 t30 -66.48 -67.73 0.43 Allowed 'General case' 0 C--O 1.237 0.417 0 C-N-CA 120.61 -0.436 . . . . 1.0 110.029 -178.012 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 7.4 mm -51.93 -22.2 2.69 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.639 0 CA-C-O 122.135 0.969 . . . . 1.0 108.511 178.651 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 113' ' ' ASN . . . . . 0.492 ' O ' HG22 ' A' ' 116' ' ' ILE . 0.9 OUTLIER -61.25 -53.3 58.62 Favored 'General case' 0 C--N 1.305 -1.34 0 CA-C-N 113.358 -1.746 . . . . 1.0 108.174 -178.188 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -55.52 -29.23 58.51 Favored 'General case' 0 C--N 1.313 -1.011 0 O-C-N 120.668 -1.27 . . . . 1.0 111.775 -179.617 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -83.29 -50.09 8.74 Favored 'General case' 0 C--O 1.212 -0.89 0 CA-C-O 121.777 0.798 . . . . 1.0 111.584 177.527 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 116' ' ' ILE . . . . . 0.556 ' CG2' ' N ' ' A' ' 117' ' ' GLU . 1.5 tp -46.21 -53.93 2.27 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.704 0 CA-C-N 114.194 -1.367 . . . . 1.0 107.676 -179.005 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 117' ' ' GLU . . . . . 0.556 ' N ' ' CG2' ' A' ' 116' ' ' ILE . 44.2 tt0 -40.05 -50.95 2.6 Favored 'General case' 0 N--CA 1.478 0.928 0 N-CA-C 105.034 -2.21 . . . . 1.0 105.034 -178.812 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 43.3 t -70.26 -53.16 24.39 Favored 'Isoleucine or valine' 0 CA--C 1.558 1.286 0 CA-C-N 113.3 -1.773 . . . . 1.0 111.08 178.192 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 119' ' ' LEU . . . . . 0.502 ' O ' HD13 ' A' ' 119' ' ' LEU . 0.1 OUTLIER -59.65 -24.87 64.22 Favored 'General case' 0 N--CA 1.482 1.138 0 N-CA-C 115.145 1.535 . . . . 1.0 115.145 -177.268 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -135.71 -48.43 0.08 OUTLIER Glycine 0 CA--C 1.542 1.759 0 CA-C-N 120.418 1.463 . . . . 1.0 113.035 177.234 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 1.2 m 160.56 -39.38 0.0 OUTLIER 'General case' 0 N--CA 1.468 0.472 0 N-CA-C 101.414 -3.55 . . . . 1.0 101.414 -177.268 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 122' ' ' GLY . . . . . 0.444 ' HA2' HG23 ' A' ' 116' ' ' ILE . . . 115.06 -32.89 5.57 Favored Glycine 0 CA--C 1.526 0.748 0 CA-C-N 111.114 -2.766 . . . . 1.0 116.869 175.638 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 123' ' ' THR . . . . . 0.44 ' C ' ' O ' ' A' ' 122' ' ' GLY . 43.8 m -40.63 98.35 0.01 OUTLIER 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 121.225 2.513 . . . . 1.0 112.967 -178.661 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 124' ' ' ASP . . . . . 0.441 ' N ' ' O ' ' A' ' 122' ' ' GLY . 31.8 m-20 -137.21 138.4 40.13 Favored 'General case' 0 N--CA 1.465 0.284 0 N-CA-C 107.207 -1.405 . . . . 1.0 107.207 177.112 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 125' ' ' TYR . . . . . 0.47 ' O ' ' CD1' ' A' ' 125' ' ' TYR . 0.1 OUTLIER -155.34 153.74 30.96 Favored 'General case' 0 CA--C 1.537 0.481 0 CA-C-O 121.18 0.514 . . . . 1.0 110.719 -179.581 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 126' ' ' ARG . . . . . 0.591 HH22 ' NH2' ' A' ' 52' ' ' ARG . 4.4 mtp85 -150.42 153.89 36.75 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.324 -0.853 . . . . 1.0 111.506 177.467 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 127' ' ' PHE . . . . . . . . . . . . . 47.3 p90 . . . . . 0 C--O 1.22 -0.451 0 CA-C-O 117.931 -1.033 . . . . 1.0 110.489 -179.474 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 128' ' ' MTN . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 129' ' ' MTN . . . . . 0.466 ' H61' ' S1 ' ' A' ' 129' ' ' MTN . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 130' ' ' MTN . . . . . 0.674 ' H61' ' S1 ' ' A' ' 130' ' ' MTN . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 20.1 mmt . . . . . 0 N--CA 1.493 1.679 0 N-CA-C 108.779 -0.822 . . . . 1.0 108.779 . . . . . . . . . 0 0 . 1 . 021 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . 0.431 ' O ' ' OD2' ' A' ' 3' ' ' ASP . 50.6 m -107.77 8.78 29.0 Favored 'General case' 0 N--CA 1.466 0.329 0 C-N-CA 122.322 0.249 . . . . 1.0 110.544 179.943 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . 0.431 ' OD2' ' O ' ' A' ' 2' ' ' SER . 0.4 OUTLIER 169.59 93.99 0.0 OUTLIER 'General case' 0 CA--C 1.534 0.338 0 N-CA-C 110.284 -0.265 . . . . 1.0 110.284 179.966 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 70.4 t80 -150.15 144.53 25.74 Favored 'General case' 0 N--CA 1.466 0.353 0 N-CA-C 110.228 -0.286 . . . . 1.0 110.228 179.587 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 47.9 m-20 -153.07 149.26 27.94 Favored 'General case' 0 N--CA 1.465 0.309 0 N-CA-C 110.233 -0.284 . . . . 1.0 110.233 179.888 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 6' ' ' THR . . . . . 0.669 HG22 ' H ' ' A' ' 7' ' ' GLU . 11.2 m -69.07 174.48 4.52 Favored 'General case' 0 C--O 1.205 -1.267 0 N-CA-C 109.793 -0.447 . . . . 1.0 109.793 179.774 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . 0.669 ' H ' HG22 ' A' ' 6' ' ' THR . 39.6 tt0 -61.55 -55.59 29.28 Favored 'General case' 0 C--N 1.317 -0.847 0 CA-C-O 121.475 0.655 . . . . 1.0 110.349 -177.822 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 8' ' ' ARG . . . . . 0.544 ' O ' ' CB ' ' A' ' 12' ' ' ALA . 7.4 ttp-105 -51.27 -57.81 7.86 Favored 'General case' 0 C--O 1.209 -1.072 0 N-CA-C 107.788 -1.19 . . . . 1.0 107.788 -178.188 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . 0.762 ' O ' HG13 ' A' ' 13' ' ' VAL . 0.0 OUTLIER -66.14 -47.0 86.19 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.071 0 CA-C-N 114.435 -1.257 . . . . 1.0 110.99 179.554 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . 0.606 ' N ' ' O ' ' A' ' 6' ' ' THR . 35.4 t -62.93 -59.06 5.35 Favored 'General case' 0 N--CA 1.482 1.155 0 N-CA-C 108.582 -0.895 . . . . 1.0 108.582 179.636 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 11' ' ' ARG . . . . . 0.526 ' N ' ' O ' ' A' ' 7' ' ' GLU . 20.9 ttm180 -66.09 -55.06 18.4 Favored 'General case' 0 C--N 1.314 -0.944 0 O-C-N 121.732 -0.605 . . . . 1.0 110.815 -178.06 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . 0.544 ' CB ' ' O ' ' A' ' 8' ' ' ARG . . . -49.64 -53.31 24.93 Favored 'General case' 0 N--CA 1.485 1.276 0 C-N-CA 118.467 -1.293 . . . . 1.0 108.043 -176.566 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . 0.762 HG13 ' O ' ' A' ' 9' ' ' VAL . 4.5 m -60.58 -47.34 93.25 Favored 'Isoleucine or valine' 0 C--O 1.203 -1.377 0 C-N-CA 118.067 -1.453 . . . . 1.0 107.342 178.204 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . 0.779 ' O ' HG13 ' A' ' 18' ' ' VAL . . . -56.31 -62.11 1.94 Allowed 'General case' 0 C--O 1.206 -1.201 0 C-N-CA 117.062 -1.855 . . . . 1.0 109.706 179.645 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . 0.595 ' O ' ' N ' ' A' ' 19' ' ' GLY . . . -54.14 -56.26 19.91 Favored 'General case' 0 N--CA 1.472 0.659 0 CA-C-O 121.474 0.654 . . . . 1.0 110.097 -178.246 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . 0.668 ' HB1' ' CA ' ' A' ' 22' ' ' GLY . . . -62.28 -56.01 22.68 Favored 'General case' 0 CA--C 1.552 1.037 0 CA-C-N 115.25 -0.886 . . . . 1.0 109.281 -179.419 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . 0.661 ' O ' HD23 ' A' ' 17' ' ' LEU . 4.3 tt -57.17 -52.43 65.36 Favored 'General case' 0 N--CA 1.484 1.244 0 CA-C-N 114.675 -1.148 . . . . 1.0 108.275 -177.965 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . 0.779 HG13 ' O ' ' A' ' 14' ' ' ALA . 2.8 m -69.26 -57.87 7.29 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.349 0 C-N-CA 119.737 -0.785 . . . . 1.0 109.806 179.095 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . 0.595 ' N ' ' O ' ' A' ' 15' ' ' ALA . . . -59.86 -175.84 1.08 Allowed Glycine 0 N--CA 1.447 -0.585 0 N-CA-C 111.106 -0.798 . . . . 1.0 111.106 -179.261 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 20' ' ' PRO . . . . . 0.576 ' O ' ' N ' ' A' ' 24' ' ' ALA . 36.8 Cg_endo -83.47 -26.79 2.01 Favored 'Trans proline' 0 C--N 1.299 -2.044 0 C-N-CA 122.658 2.239 . . . . 1.0 112.988 -178.507 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . 0.46 ' O ' ' HB3' ' A' ' 24' ' ' ALA . . . -59.02 -58.65 13.41 Favored Glycine 0 N--CA 1.475 1.25 0 C-N-CA 120.066 -1.064 . . . . 1.0 111.536 -176.995 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . 0.668 ' CA ' ' HB1' ' A' ' 16' ' ' ALA . . . -55.96 -51.59 54.46 Favored Glycine 0 N--CA 1.474 1.23 0 N-CA-C 106.981 -2.448 . . . . 1.0 106.981 -178.158 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 47.9 t -59.56 -31.54 47.04 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.427 0 N-CA-C 108.735 -0.839 . . . . 1.0 108.735 178.792 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . 0.576 ' N ' ' O ' ' A' ' 20' ' ' PRO . . . -58.17 -63.09 1.38 Allowed 'General case' 0 C--N 1.348 0.502 0 C-N-CA 118.858 -1.137 . . . . 1.0 110.659 -178.742 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . 0.441 HD23 ' H ' ' A' ' 25' ' ' LEU . 0.1 OUTLIER -64.52 -43.37 94.28 Favored 'General case' 0 CA--C 1.517 -0.309 0 C-N-CA 119.858 -0.737 . . . . 1.0 111.814 -178.1 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 93.0 t -59.59 -59.63 3.64 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.544 0 C-N-CA 118.818 -1.153 . . . . 1.0 110.102 -177.927 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . 0.579 ' O ' ' HB3' ' A' ' 31' ' ' ALA . 0.6 OUTLIER -58.87 -34.76 53.33 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 O-C-N 122.235 -0.291 . . . . 1.0 111.1 -178.283 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 37.5 ttpt -67.16 -55.85 12.41 Favored 'General case' 0 C--N 1.325 -0.482 0 N-CA-C 109.391 -0.596 . . . . 1.0 109.391 -179.297 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 42.2 t -62.24 -47.82 91.32 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.605 0 CA-C-N 115.162 -0.926 . . . . 1.0 109.989 -179.07 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 30' ' ' CYS . . . . . . . . . . . . . 0.7 OUTLIER -67.47 -62.53 1.38 Allowed 'General case' 0 N--CA 1.446 -0.628 0 C-N-CA 119.052 -1.059 . . . . 1.0 110.841 -179.098 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . 0.579 ' HB3' ' O ' ' A' ' 27' ' ' VAL . . . -60.3 -51.61 68.82 Favored 'General case' 0 CA--C 1.506 -0.737 0 O-C-N 122.055 -0.403 . . . . 1.0 111.091 -176.697 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . 0.498 ' O ' ' HB2' ' A' ' 33' ' ' LEU . . . 84.66 75.04 1.23 Allowed Glycine 0 N--CA 1.442 -0.941 0 N-CA-C 109.828 -1.309 . . . . 1.0 109.828 -178.662 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . 0.498 ' HB2' ' O ' ' A' ' 32' ' ' GLY . 0.9 OUTLIER 87.21 100.39 0.03 OUTLIER Pre-proline 0 CA--C 1.549 0.917 0 C-N-CA 124.015 0.926 . . . . 1.0 110.654 -179.238 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 58.6 Cg_endo -71.4 -31.51 13.87 Favored 'Trans proline' 0 N--CA 1.502 1.997 0 C-N-CA 121.925 1.75 . . . . 1.0 114.807 -178.652 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -58.02 -58.96 11.85 Favored Glycine 0 N--CA 1.472 1.077 0 C-N-CA 118.466 -1.826 . . . . 1.0 108.957 -178.4 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . 0.587 HG22 ' N ' ' A' ' 37' ' ' ILE . 7.9 p -93.43 165.89 1.86 Allowed 'Isoleucine or valine' 0 CA--C 1.514 -0.415 0 N-CA-C 106.75 -1.574 . . . . 1.0 106.75 177.318 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . 0.587 ' N ' HG22 ' A' ' 36' ' ' VAL . 8.8 tp 115.81 121.57 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.476 0.842 0 O-C-N 124.523 1.139 . . . . 1.0 110.244 -179.841 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 0.9 OUTLIER -143.33 135.8 27.29 Favored 'General case' 0 CA--C 1.533 0.293 0 N-CA-C 109.146 -0.687 . . . . 1.0 109.146 179.461 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 10.4 m -111.47 111.2 55.11 Favored Pre-proline 0 N--CA 1.468 0.444 0 N-CA-C 109.55 -0.537 . . . . 1.0 109.55 179.266 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_exo -43.09 -85.83 0.01 OUTLIER 'Trans proline' 0 N--CA 1.491 1.366 0 C-N-CA 121.662 1.575 . . . . 1.0 112.834 -178.637 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -67.28 120.15 13.34 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 116.108 -0.496 . . . . 1.0 111.313 -177.784 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 3.6 ptm180 -174.04 175.39 2.77 Favored 'General case' 0 N--CA 1.448 -0.563 0 CA-C-N 116.101 -0.499 . . . . 1.0 110.01 178.46 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 5.3 tpt85 -57.53 -43.35 84.27 Favored 'General case' 0 C--N 1.32 -0.691 0 N-CA-C 107.452 -1.314 . . . . 1.0 107.452 179.919 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . 0.43 ' O ' ' CD1' ' A' ' 45' ' ' PHE . . . 121.5 -21.55 8.05 Favored Glycine 0 N--CA 1.465 0.613 0 N-CA-C 110.715 -0.954 . . . . 1.0 110.715 -179.127 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . 0.581 ' O ' ' HB2' ' A' ' 46' ' ' PHE . 42.6 m-85 -150.34 153.82 36.74 Favored 'General case' 0 C--O 1.216 -0.707 0 N-CA-C 109.006 -0.739 . . . . 1.0 109.006 177.795 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 46' ' ' PHE . . . . . 0.655 ' O ' ' HB2' ' A' ' 47' ' ' ARG . 8.6 m-85 128.59 96.33 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.582 0 O-C-N 124.939 1.399 . . . . 1.0 110.287 -179.933 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 47' ' ' ARG . . . . . 0.655 ' HB2' ' O ' ' A' ' 46' ' ' PHE . 0.7 OUTLIER 110.1 160.85 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.503 0 C-N-CA 125.464 1.506 . . . . 1.0 109.884 -179.809 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 48' ' ' CYS . . . . . 0.709 ' O ' ' H83' ' A' ' 129' ' ' MTN . 0.9 OUTLIER 67.8 70.64 0.34 Allowed 'General case' 0 C--O 1.224 -0.246 0 N-CA-C 108.811 -0.811 . . . . 1.0 108.811 -178.455 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 49' ' ' ASN . . . . . 0.631 HD21 ' CG ' ' A' ' 54' ' ' GLN . 39.4 m-80 -136.13 129.37 17.93 Favored Pre-proline 0 CA--C 1.534 0.364 0 O-C-N 121.787 -0.571 . . . . 1.0 109.509 -178.979 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . 0.427 ' C ' ' N ' ' A' ' 52' ' ' ARG . 68.8 Cg_exo -46.75 74.57 0.01 OUTLIER 'Trans proline' 0 N--CA 1.498 1.78 0 C-N-CA 121.964 1.776 . . . . 1.0 113.476 179.927 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . 0.606 ' N ' ' O ' ' A' ' 49' ' ' ASN . 7.4 mm-40 48.84 14.09 0.07 Allowed 'General case' 0 C--N 1.331 -0.209 0 O-C-N 121.867 -0.521 . . . . 1.0 110.999 179.408 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . 0.427 ' N ' ' C ' ' A' ' 50' ' ' PRO . 1.4 ptp180 -116.45 162.23 17.88 Favored 'General case' 0 N--CA 1.472 0.65 0 CA-C-N 116.554 -0.294 . . . . 1.0 110.874 -179.573 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 19.4 tt -71.25 136.54 25.63 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.779 0 CA-C-O 123.508 1.623 . . . . 1.0 115.325 -177.146 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 54' ' ' GLN . . . . . 0.631 ' CG ' HD21 ' A' ' 49' ' ' ASN . 0.5 OUTLIER -74.93 87.6 2.31 Favored 'General case' 0 C--N 1.314 -0.973 0 CA-C-N 110.233 -3.167 . . . . 1.0 110.247 -178.985 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . 0.425 ' CG2' ' N ' ' A' ' 56' ' ' GLY . 5.9 mm -146.05 156.9 12.19 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.789 0 CA-C-N 115.703 -0.681 . . . . 1.0 109.883 177.495 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . 0.425 ' N ' ' CG2' ' A' ' 55' ' ' ILE . . . 110.52 -2.29 29.28 Favored Glycine 0 N--CA 1.475 1.243 0 N-CA-C 111.379 -0.688 . . . . 1.0 111.379 -179.897 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 13.9 p-10 -87.44 104.95 16.94 Favored 'General case' 0 N--CA 1.466 0.357 0 CA-C-O 121.396 0.617 . . . . 1.0 111.435 -179.815 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 58' ' ' TRP . . . . . . . . . . . . . 9.0 m0 -89.14 171.56 9.73 Favored 'General case' 0 CA--C 1.567 1.603 0 CA-C-O 122.941 1.353 . . . . 1.0 112.354 -178.634 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 59' ' ' ARG . . . . . 0.454 ' HE ' ' H ' ' A' ' 59' ' ' ARG . 0.0 OUTLIER -76.83 -61.71 1.88 Allowed 'General case' 0 N--CA 1.49 1.556 0 CA-C-N 111.12 -2.764 . . . . 1.0 113.902 -176.941 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 4.0 t80 -90.56 -9.03 48.64 Favored 'General case' 0 N--CA 1.484 1.23 0 CA-C-O 122.348 1.07 . . . . 1.0 112.753 -179.295 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . 0.477 ' O ' ' N ' ' A' ' 65' ' ' ASP . 2.7 tt0 -78.45 -14.48 59.35 Favored 'General case' 0 C--N 1.306 -1.3 0 CA-C-N 114.895 -1.048 . . . . 1.0 110.291 -179.637 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . 0.627 ' O ' ' N ' ' A' ' 66' ' ' GLY . 11.1 m -48.26 -55.79 2.63 Favored 'Isoleucine or valine' 0 C--O 1.204 -1.295 0 C-N-CA 119.566 -0.854 . . . . 1.0 109.241 -176.723 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 63' ' ' ALA . . . . . 0.587 ' H ' HG23 ' A' ' 62' ' ' VAL . . . -63.26 -54.65 34.01 Favored 'General case' 0 C--N 1.297 -1.677 0 O-C-N 121.588 -0.695 . . . . 1.0 109.359 179.438 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -50.56 -59.5 3.97 Favored 'General case' 0 CA--C 1.545 0.786 0 CA-C-N 115.342 -0.845 . . . . 1.0 110.234 -179.342 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . 0.591 ' C ' ' H ' ' A' ' 67' ' ' ARG . 26.8 t70 -72.42 -50.82 23.61 Favored 'General case' 0 C--N 1.312 -1.049 0 CA-C-O 121.91 0.862 . . . . 1.0 111.504 178.77 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . 0.627 ' N ' ' O ' ' A' ' 62' ' ' VAL . . . -69.96 29.5 0.41 Allowed Glycine 0 C--O 1.227 -0.329 0 O-C-N 120.986 -1.071 . . . . 1.0 111.046 177.661 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 67' ' ' ARG . . . . . 0.608 ' O ' ' N ' ' A' ' 69' ' ' LEU . 0.0 OUTLIER -77.96 8.41 4.73 Favored 'General case' 0 C--N 1.316 -0.856 0 N-CA-C 107.984 -1.117 . . . . 1.0 107.984 176.877 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . 0.646 HD23 ' N ' ' A' ' 68' ' ' LEU . 1.5 pt? -34.19 -27.96 0.01 OUTLIER 'General case' 0 N--CA 1.483 1.218 0 CA-C-O 121.757 0.789 . . . . 1.0 108.88 -178.158 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . 0.608 ' N ' ' O ' ' A' ' 67' ' ' ARG . 1.3 mt -64.57 -65.15 0.71 Allowed 'General case' 0 N--CA 1.473 0.715 0 C-N-CA 118.833 -1.147 . . . . 1.0 107.918 178.761 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . 0.653 ' C ' ' H ' ' A' ' 72' ' ' HIS . . . -78.22 -75.09 0.24 Allowed 'General case' 0 N--CA 1.469 0.494 0 N-CA-C 105.108 -2.182 . . . . 1.0 105.108 176.919 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . 0.46 ' O ' ' C ' ' A' ' 72' ' ' HIS . . . -44.87 4.1 0.0 OUTLIER 'General case' 0 CA--C 1.52 -0.209 0 C-N-CA 124.694 1.197 . . . . 1.0 113.425 178.57 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 72' ' ' HIS . . . . . 0.81 ' CD2' ' H ' ' A' ' 73' ' ' MET . 1.5 p80 -28.22 -55.05 0.11 Allowed 'General case' 0 C--N 1.335 -0.065 0 CA-C-N 118.067 0.394 . . . . 1.0 111.967 -179.408 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 73' ' ' MET . . . . . 0.81 ' H ' ' CD2' ' A' ' 72' ' ' HIS . 3.8 ppp? -76.84 -53.5 7.82 Favored 'General case' 0 C--N 1.316 -0.858 0 N-CA-C 108.483 -0.932 . . . . 1.0 108.483 177.278 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . 0.725 ' O ' ' N ' ' A' ' 76' ' ' GLY . 65.8 t -44.51 -41.87 2.1 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.424 0 CA-C-O 117.748 -1.12 . . . . 1.0 110.775 -176.122 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 75' ' ' ASN . . . . . 0.533 ' C ' ' N ' ' A' ' 77' ' ' ILE . 1.8 t-20 -35.09 -14.58 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.7 0 CA-C-N 120.857 1.662 . . . . 1.0 112.836 178.403 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . 0.725 ' N ' ' O ' ' A' ' 74' ' ' VAL . . . -44.04 -19.21 0.11 Allowed Glycine 0 CA--C 1.543 1.82 0 N-CA-C 107.846 -2.102 . . . . 1.0 107.846 175.917 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . 0.533 ' N ' ' C ' ' A' ' 75' ' ' ASN . 0.8 OUTLIER -72.11 -54.98 14.85 Favored 'Isoleucine or valine' 0 C--O 1.207 -1.138 0 N-CA-C 107.683 -1.228 . . . . 1.0 107.683 178.267 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . 0.528 ' C ' ' O ' ' A' ' 77' ' ' ILE . 55.5 t -33.52 -37.51 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.314 -0.973 0 CA-C-N 113.252 -1.795 . . . . 1.0 106.849 -178.391 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . 0.546 ' O ' ' HB3' ' A' ' 83' ' ' ALA . 23.7 pt -97.77 -34.49 4.76 Favored 'Isoleucine or valine' 0 C--O 1.207 -1.146 0 CA-C-N 115.287 -0.869 . . . . 1.0 112.005 176.846 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 80' ' ' ALA . . . . . 0.501 ' N ' ' O ' ' A' ' 77' ' ' ILE . . . -84.78 -9.35 58.27 Favored 'General case' 0 N--CA 1.482 1.151 0 O-C-N 120.955 -1.091 . . . . 1.0 113.588 179.674 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . 0.495 ' N ' ' O ' ' A' ' 77' ' ' ILE . 82.3 tt0 -90.63 -75.77 0.45 Allowed 'General case' 0 N--CA 1.453 -0.314 0 N-CA-C 113.572 0.953 . . . . 1.0 113.572 -176.769 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 6.7 m-20 -91.04 -16.71 27.46 Favored 'General case' 0 C--O 1.22 -0.45 0 N-CA-C 113.463 0.912 . . . . 1.0 113.463 -179.141 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . 0.546 ' HB3' ' O ' ' A' ' 79' ' ' ILE . . . -46.7 -42.21 16.24 Favored 'General case' 0 C--O 1.22 -0.479 0 C-N-CA 119.369 -0.933 . . . . 1.0 111.348 -177.681 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 14.3 tp -37.46 -46.02 0.77 Allowed 'General case' 0 N--CA 1.47 0.55 0 CA-C-O 121.48 0.657 . . . . 1.0 110.613 -178.349 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -65.46 -37.1 79.24 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.855 0 CA-C-N 114.75 -1.114 . . . . 1.0 110.564 -179.127 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . 0.527 ' N ' ' O ' ' A' ' 83' ' ' ALA . . . -90.61 -26.03 19.86 Favored 'General case' 0 C--O 1.222 -0.372 0 CA-C-O 120.641 0.258 . . . . 1.0 111.668 -179.762 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . 0.534 ' N ' ' O ' ' A' ' 83' ' ' ALA . 30.6 tp10 -54.71 -24.94 24.33 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 121.423 0.63 . . . . 1.0 109.659 -179.068 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -72.25 -8.56 55.48 Favored 'General case' 0 C--N 1.324 -0.503 0 N-CA-C 107.823 -1.177 . . . . 1.0 107.823 178.89 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 89' ' ' VAL . . . . . 0.494 ' N ' ' O ' ' A' ' 86' ' ' ALA . 3.2 t -92.49 36.03 0.1 OUTLIER 'Isoleucine or valine' 0 C--N 1.315 -0.909 0 CA-C-N 112.759 -2.019 . . . . 1.0 107.414 177.478 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 90' ' ' GLY . . . . . 0.902 ' O ' ' N ' ' A' ' 92' ' ' HIS . . . -55.82 -25.27 44.09 Favored Glycine 0 C--N 1.366 2.237 0 CA-C-O 117.346 -1.808 . . . . 1.0 112.082 176.955 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 91' ' ' PRO . . . . . 0.729 ' HD2' ' N ' ' A' ' 90' ' ' GLY . 20.8 Cg_exo -32.99 1.28 0.0 OUTLIER 'Trans proline' 0 N--CA 1.496 1.641 0 C-N-CA 123.41 2.74 . . . . 1.0 113.526 173.295 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 92' ' ' HIS . . . . . 0.902 ' N ' ' O ' ' A' ' 90' ' ' GLY . 0.0 OUTLIER -49.82 -33.27 16.2 Favored 'General case' 0 N--CA 1.431 -1.412 0 N-CA-C 106.91 -1.515 . . . . 1.0 106.91 178.346 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 24.8 tp -59.8 -57.1 14.35 Favored 'General case' 0 N--CA 1.453 -0.284 0 N-CA-C 107.537 -1.283 . . . . 1.0 107.537 177.396 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -51.72 -53.9 34.2 Favored 'General case' 0 C--N 1.323 -0.561 0 N-CA-C 107.953 -1.128 . . . . 1.0 107.953 -178.955 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 6.2 mmp_? -64.81 -32.93 74.85 Favored 'General case' 0 N--CA 1.47 0.562 0 CA-C-O 121.894 0.854 . . . . 1.0 110.911 178.225 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 96' ' ' ALA . . . . . 0.811 ' O ' ' N ' ' A' ' 100' ' ' ILE . . . -48.16 -39.2 20.02 Favored 'General case' 0 N--CA 1.493 1.711 0 N-CA-C 105.489 -2.041 . . . . 1.0 105.489 -177.31 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . 0.536 HD13 ' C ' ' A' ' 97' ' ' LEU . 1.6 tm? -33.14 -24.34 0.0 OUTLIER 'General case' 0 CA--C 1.576 1.957 0 CA-C-N 112.693 -2.049 . . . . 1.0 107.219 -179.798 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 98' ' ' GLY . . . . . 0.722 ' N ' ' O ' ' A' ' 96' ' ' ALA . . . -90.04 -53.69 2.31 Favored Glycine 0 CA--C 1.557 2.665 0 CA-C-O 123.033 1.352 . . . . 1.0 111.796 171.226 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 99' ' ' GLN . . . . . 0.6 ' N ' ' O ' ' A' ' 96' ' ' ALA . 0.1 OUTLIER -77.97 8.02 5.27 Favored 'General case' 0 N--CA 1.443 -0.803 0 N-CA-C 107.458 -1.312 . . . . 1.0 107.458 177.691 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 100' ' ' ILE . . . . . 0.811 ' N ' ' O ' ' A' ' 96' ' ' ALA . 3.8 tp -61.73 -52.03 65.71 Favored 'Isoleucine or valine' 0 CA--C 1.48 -1.744 0 N-CA-C 107.076 -1.453 . . . . 1.0 107.076 179.416 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 101' ' ' VAL . . . . . 0.613 ' N ' HG23 ' A' ' 100' ' ' ILE . 62.7 t -52.93 -57.09 5.07 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 N-CA-C 106.464 -1.68 . . . . 1.0 106.464 177.654 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 102' ' ' CYS . . . . . 0.97 ' O ' ' HB2' ' A' ' 106' ' ' ALA . 0.0 OUTLIER -46.43 -19.8 0.09 Allowed 'General case' 0 CA--C 1.541 0.606 0 C-N-CA 120.038 -0.665 . . . . 1.0 109.423 -179.226 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 103' ' ' ARG . . . . . 0.574 HH21 ' CB ' ' A' ' 96' ' ' ALA . 11.4 mtm-85 -94.13 -48.28 6.28 Favored 'General case' 0 N--CA 1.474 0.763 0 N-CA-C 113.793 1.035 . . . . 1.0 113.793 178.228 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 104' ' ' TYR . . . . . 0.57 ' O ' ' CG ' ' A' ' 104' ' ' TYR . 60.8 t80 -103.92 21.44 16.33 Favored 'General case' 0 C--N 1.32 -0.706 0 C-N-CA 125.724 1.61 . . . . 1.0 110.895 -179.73 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 105' ' ' GLY . . . . . 0.596 ' N ' ' O ' ' A' ' 101' ' ' VAL . . . -165.08 -8.03 0.03 OUTLIER Glycine 0 N--CA 1.453 -0.169 0 C-N-CA 119.606 -1.283 . . . . 1.0 111.072 -179.8 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 106' ' ' ALA . . . . . 0.97 ' HB2' ' O ' ' A' ' 102' ' ' CYS . . . -28.72 117.65 0.11 Allowed 'General case' 0 CA--C 1.534 0.362 0 C-N-CA 122.117 0.167 . . . . 1.0 111.06 178.671 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 107' ' ' THR . . . . . 0.981 ' O ' ' HD2' ' A' ' 110' ' ' PRO . 6.6 m -135.7 -58.35 0.77 Allowed 'General case' 0 C--O 1.195 -1.777 0 N-CA-C 107.787 -1.19 . . . . 1.0 107.787 178.616 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 26.9 m -70.28 28.66 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.312 -1.061 0 O-C-N 120.735 -1.228 . . . . 1.0 108.847 -178.39 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 109' ' ' ILE . . . . . 0.681 HG21 ' HB1' ' A' ' 106' ' ' ALA . 0.0 OUTLIER -111.01 -45.18 0.08 OUTLIER Pre-proline 0 CA--C 1.55 0.969 0 O-C-N 121.834 -0.542 . . . . 1.0 110.277 178.86 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 110' ' ' PRO . . . . . 0.981 ' HD2' ' O ' ' A' ' 107' ' ' THR . 24.6 Cg_exo -66.72 -29.12 43.26 Favored 'Trans proline' 0 N--CA 1.496 1.675 0 C-N-CA 123.453 2.769 . . . . 1.0 111.262 -178.7 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 4.9 t30 -68.35 -68.47 0.39 Allowed 'General case' 0 N--CA 1.455 -0.211 0 C-N-CA 120.405 -0.518 . . . . 1.0 109.847 -178.763 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 112' ' ' ILE . . . . . 0.41 HD13 HG21 ' A' ' 112' ' ' ILE . 21.3 pt -51.39 -28.57 8.15 Favored 'Isoleucine or valine' 0 C--O 1.217 -0.61 0 CA-C-O 122.623 1.202 . . . . 1.0 109.367 179.09 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 1.6 t30 -59.25 -51.89 68.01 Favored 'General case' 0 C--N 1.294 -1.814 0 CA-C-N 112.62 -2.082 . . . . 1.0 107.752 -177.855 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 114' ' ' ALA . . . . . 0.519 ' O ' HG23 ' A' ' 118' ' ' VAL . . . -59.59 -32.69 70.62 Favored 'General case' 0 N--CA 1.45 -0.464 0 N-CA-C 112.368 0.507 . . . . 1.0 112.368 -179.646 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -80.81 -53.47 6.46 Favored 'General case' 0 C--O 1.21 -0.977 0 CA-C-O 121.7 0.762 . . . . 1.0 110.398 178.141 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 116' ' ' ILE . . . . . 0.524 ' O ' ' N ' ' A' ' 120' ' ' GLY . 28.5 mt -50.32 -61.26 0.65 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.707 0 CA-C-N 114.143 -1.39 . . . . 1.0 108.6 -178.823 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 117' ' ' GLU . . . . . 0.422 ' C ' ' O ' ' A' ' 116' ' ' ILE . 49.2 mt-10 -42.16 -52.83 4.24 Favored 'General case' 0 C--N 1.307 -1.274 0 CA-C-N 112.239 -2.255 . . . . 1.0 106.791 -177.969 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 118' ' ' VAL . . . . . 0.519 HG23 ' O ' ' A' ' 114' ' ' ALA . 94.6 t -60.63 -53.05 54.3 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.492 0 N-CA-C 108.355 -0.98 . . . . 1.0 108.355 177.187 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 2.9 tp -51.29 -69.38 0.11 Allowed 'General case' 0 CA--C 1.536 0.414 0 N-CA-C 106.687 -1.597 . . . . 1.0 106.687 -178.775 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 120' ' ' GLY . . . . . 0.657 ' O ' ' OG1' ' A' ' 121' ' ' THR . . . -73.05 -84.59 0.25 Allowed Glycine 0 CA--C 1.537 1.419 0 C-N-CA 119.356 -1.402 . . . . 1.0 111.102 -179.555 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 121' ' ' THR . . . . . 0.657 ' OG1' ' O ' ' A' ' 120' ' ' GLY . 41.6 m 170.37 -39.72 0.0 OUTLIER 'General case' 0 N--CA 1.476 0.862 0 CA-C-N 113.649 -1.276 . . . . 1.0 112.67 179.156 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 122' ' ' GLY . . . . . 0.695 ' O ' ' N ' ' A' ' 124' ' ' ASP . . . 100.6 -18.78 54.64 Favored Glycine 0 N--CA 1.469 0.836 0 N-CA-C 106.815 -2.514 . . . . 1.0 106.815 -176.242 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 123' ' ' THR . . . . . 0.723 HG23 ' O ' ' A' ' 123' ' ' THR . 8.9 t -52.52 83.74 0.0 OUTLIER 'General case' 0 N--CA 1.477 0.875 0 N-CA-C 104.733 -2.321 . . . . 1.0 104.733 178.414 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 124' ' ' ASP . . . . . 0.695 ' N ' ' O ' ' A' ' 122' ' ' GLY . 4.9 m-20 -171.49 -175.43 1.61 Allowed 'General case' 0 CA--C 1.53 0.181 0 CA-C-N 113.976 -1.465 . . . . 1.0 111.434 179.523 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 125' ' ' TYR . . . . . . . . . . . . . 78.4 t80 -145.98 144.71 30.28 Favored 'General case' 0 CA--C 1.538 0.483 0 CA-C-N 114.749 -1.114 . . . . 1.0 109.011 175.813 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 36.4 mmt-85 -146.34 147.02 30.9 Favored 'General case' 0 N--CA 1.474 0.727 0 N-CA-C 109.794 -0.447 . . . . 1.0 109.794 179.848 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 127' ' ' PHE . . . . . 0.412 ' CD1' ' C ' ' A' ' 127' ' ' PHE . 0.1 OUTLIER . . . . . 0 C--O 1.221 -0.412 0 CA-C-O 117.937 -1.03 . . . . 1.0 110.558 179.328 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 128' ' ' MTN . . . . . 0.611 ' H82' ' NH2' ' A' ' 47' ' ' ARG . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 129' ' ' MTN . . . . . 0.709 ' H83' ' O ' ' A' ' 48' ' ' CYS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 130' ' ' MTN . . . . . 0.438 ' C7 ' ' NH1' ' A' ' 103' ' ' ARG . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 13.8 mmt . . . . . 0 N--CA 1.496 1.837 0 N-CA-C 109.691 -0.485 . . . . 1.0 109.691 . . . . . . . . . 0 0 . 1 . 022 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 98.1 p -106.35 9.44 31.86 Favored 'General case' 0 N--CA 1.469 0.482 0 CA-C-N 115.945 -0.57 . . . . 1.0 110.455 -179.946 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER 166.29 97.1 0.0 OUTLIER 'General case' 0 N--CA 1.466 0.362 0 CA-C-N 116.019 -0.537 . . . . 1.0 110.451 179.382 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 85.2 t80 -149.26 144.98 26.85 Favored 'General case' 0 N--CA 1.466 0.343 0 CA-C-N 116.053 -0.522 . . . . 1.0 110.104 179.441 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 5' ' ' ASP . . . . . 0.445 ' N ' ' OD1' ' A' ' 5' ' ' ASP . 5.1 p30 -153.54 148.65 26.8 Favored 'General case' 0 C--N 1.33 -0.274 0 N-CA-C 109.997 -0.372 . . . . 1.0 109.997 -179.761 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 6' ' ' THR . . . . . 0.577 ' O ' ' N ' ' A' ' 10' ' ' SER . 0.2 OUTLIER -70.87 177.15 3.79 Favored 'General case' 0 C--O 1.211 -0.95 0 C-N-CA 120.337 -0.545 . . . . 1.0 110.038 -179.979 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . 0.519 ' O ' ' N ' ' A' ' 11' ' ' ARG . 0.6 OUTLIER -59.62 -55.46 34.18 Favored 'General case' 0 C--N 1.317 -0.845 0 CA-C-O 121.566 0.698 . . . . 1.0 109.804 -178.436 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 8' ' ' ARG . . . . . 0.467 ' O ' ' HB3' ' A' ' 12' ' ' ALA . 0.2 OUTLIER -51.61 -57.11 10.06 Favored 'General case' 0 C--N 1.318 -0.761 0 N-CA-C 107.613 -1.255 . . . . 1.0 107.613 -178.182 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . 0.85 ' O ' HG13 ' A' ' 13' ' ' VAL . 0.0 OUTLIER -66.26 -47.9 82.87 Favored 'Isoleucine or valine' 0 CA--C 1.556 1.18 0 CA-C-N 114.036 -1.438 . . . . 1.0 110.127 -178.857 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . 0.577 ' N ' ' O ' ' A' ' 6' ' ' THR . 32.6 t -62.45 -59.48 4.9 Favored 'General case' 0 N--CA 1.491 1.604 0 CA-C-O 121.022 0.439 . . . . 1.0 109.998 179.148 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 11' ' ' ARG . . . . . 0.553 ' O ' ' N ' ' A' ' 15' ' ' ALA . 20.2 tpp180 -66.08 -55.16 17.9 Favored 'General case' 0 CA--C 1.547 0.835 0 O-C-N 121.539 -0.726 . . . . 1.0 110.404 -177.397 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . 0.511 ' O ' ' HB3' ' A' ' 16' ' ' ALA . . . -50.97 -52.24 44.58 Favored 'General case' 0 N--CA 1.481 1.103 0 C-N-CA 118.228 -1.389 . . . . 1.0 107.307 -178.893 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . 0.85 HG13 ' O ' ' A' ' 9' ' ' VAL . 3.2 m -63.21 -48.91 85.36 Favored 'Isoleucine or valine' 0 C--O 1.199 -1.593 0 C-N-CA 117.796 -1.562 . . . . 1.0 108.791 177.576 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . 0.713 ' O ' HG13 ' A' ' 18' ' ' VAL . . . -57.12 -61.88 2.15 Favored 'General case' 0 C--O 1.211 -0.964 0 C-N-CA 117.621 -1.632 . . . . 1.0 109.638 179.039 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . 0.566 ' O ' ' N ' ' A' ' 19' ' ' GLY . . . -53.07 -55.78 21.21 Favored 'General case' 0 N--CA 1.475 0.82 0 CA-C-O 121.552 0.691 . . . . 1.0 110.263 -177.702 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . 0.541 ' CA ' ' H ' ' A' ' 22' ' ' GLY . . . -62.85 -54.55 37.11 Favored 'General case' 0 C--N 1.312 -1.055 0 CA-C-N 114.598 -1.183 . . . . 1.0 108.999 -179.346 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . 0.586 ' CB ' ' O ' ' A' ' 13' ' ' VAL . 24.2 tp -56.75 -53.96 51.75 Favored 'General case' 0 N--CA 1.477 0.922 0 CA-C-N 114.606 -1.179 . . . . 1.0 108.752 -177.284 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . 0.713 HG13 ' O ' ' A' ' 14' ' ' ALA . 2.5 m -68.58 -55.98 14.02 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.355 0 C-N-CA 119.511 -0.876 . . . . 1.0 109.139 179.637 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . 0.566 ' N ' ' O ' ' A' ' 15' ' ' ALA . . . -64.9 -165.28 1.07 Allowed Glycine 0 CA--C 1.525 0.693 0 CA-C-N 116.292 -0.413 . . . . 1.0 112.81 -178.596 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 20' ' ' PRO . . . . . 0.594 ' O ' ' N ' ' A' ' 24' ' ' ALA . 3.2 Cg_endo -81.17 -25.65 3.86 Favored 'Trans proline' 0 C--N 1.312 -1.374 0 C-N-CA 123.134 2.556 . . . . 1.0 112.486 -178.716 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -57.65 -58.75 12.93 Favored Glycine 0 CA--C 1.532 1.125 0 C-N-CA 119.522 -1.323 . . . . 1.0 110.924 -176.663 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . 0.678 ' O ' HG22 ' A' ' 26' ' ' VAL . . . -61.94 -54.36 35.78 Favored Glycine 0 N--CA 1.47 0.936 0 N-CA-C 108.152 -1.979 . . . . 1.0 108.152 -178.94 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . 0.566 ' O ' HG12 ' A' ' 27' ' ' VAL . 24.2 t -56.17 -38.66 55.1 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.636 0 N-CA-C 109.166 -0.679 . . . . 1.0 109.166 -179.794 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . 0.594 ' N ' ' O ' ' A' ' 20' ' ' PRO . . . -60.28 -61.06 2.88 Favored 'General case' 0 CA--C 1.536 0.414 0 C-N-CA 119.272 -0.971 . . . . 1.0 111.011 -179.488 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 16.3 mt -64.1 -46.88 82.27 Favored 'General case' 0 N--CA 1.468 0.447 0 N-CA-C 113.446 0.906 . . . . 1.0 113.446 -177.009 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . 0.678 HG22 ' O ' ' A' ' 22' ' ' GLY . 18.9 m -61.51 -58.26 8.38 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 C-N-CA 118.845 -1.142 . . . . 1.0 110.297 -177.688 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . 0.631 ' N ' HG23 ' A' ' 26' ' ' VAL . 1.1 p -63.07 -37.73 80.16 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 N-CA-C 112.518 0.562 . . . . 1.0 112.518 -177.377 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 7.9 tmtm? -67.52 -54.69 17.92 Favored 'General case' 0 C--N 1.319 -0.737 0 N-CA-C 108.556 -0.905 . . . . 1.0 108.556 -178.764 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 93.2 t -63.64 -48.48 86.52 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.972 0 CA-C-N 114.394 -1.275 . . . . 1.0 110.331 -178.294 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 30' ' ' CYS . . . . . . . . . . . . . 34.9 t -64.77 -60.8 2.68 Favored 'General case' 0 C--N 1.326 -0.445 0 C-N-CA 119.231 -0.988 . . . . 1.0 109.944 -179.106 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . 0.607 ' HB3' ' O ' ' A' ' 27' ' ' VAL . . . -64.11 -51.88 61.86 Favored 'General case' 0 C--N 1.325 -0.493 0 N-CA-C 111.992 0.367 . . . . 1.0 111.992 -176.074 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 88.48 74.09 1.28 Allowed Glycine 0 CA--C 1.527 0.805 0 N-CA-C 109.994 -1.242 . . . . 1.0 109.994 -179.196 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 38.6 mt 75.29 126.15 0.03 OUTLIER Pre-proline 0 N--CA 1.476 0.846 0 C-N-CA 122.815 0.446 . . . . 1.0 110.562 -179.422 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 56.6 Cg_endo -72.26 -13.01 28.13 Favored 'Trans proline' 0 N--CA 1.505 2.15 0 C-N-CA 122.227 1.952 . . . . 1.0 114.762 -179.316 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . 0.674 ' HA2' HD12 ' A' ' 112' ' ' ILE . . . -60.19 -59.57 10.13 Favored Glycine 0 N--CA 1.468 0.804 0 C-N-CA 118.156 -1.973 . . . . 1.0 109.584 -178.787 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . 0.425 HG12 ' H ' ' A' ' 37' ' ' ILE . 1.5 t -78.64 -145.56 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.323 -0.572 0 N-CA-C 107.089 -1.449 . . . . 1.0 107.089 178.095 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . 0.461 HG13 ' HB1' ' A' ' 31' ' ' ALA . 5.4 mm 76.71 78.36 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 N-CA-C 112.762 0.653 . . . . 1.0 112.762 177.756 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -135.99 126.99 27.77 Favored 'General case' 0 CA--C 1.538 0.484 0 N-CA-C 106.809 -1.552 . . . . 1.0 106.809 177.904 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . 0.528 ' OG1' ' NH2' ' A' ' 47' ' ' ARG . 23.9 p -104.54 149.68 37.68 Favored Pre-proline 0 N--CA 1.47 0.57 0 N-CA-C 110.103 -0.332 . . . . 1.0 110.103 -178.972 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 89.6 Cg_endo -75.79 -34.31 3.28 Favored 'Trans proline' 0 C--N 1.311 -1.402 0 C-N-CA 121.675 1.583 . . . . 1.0 114.211 -178.685 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -128.82 134.64 48.41 Favored 'General case' 0 N--CA 1.477 0.88 0 CA-C-N 118.089 0.404 . . . . 1.0 111.548 179.035 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . 0.684 HH21 ' N ' ' A' ' 46' ' ' PHE . 16.6 ptm180 -169.37 167.89 9.83 Favored 'General case' 0 C--N 1.325 -0.491 0 C-N-CA 119.789 -0.765 . . . . 1.0 111.266 177.071 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -67.48 18.9 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.051 -0.522 . . . . 1.0 109.988 179.377 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . 0.635 ' H ' ' C ' ' A' ' 42' ' ' ARG . . . 79.45 -24.62 3.03 Favored Glycine 0 CA--C 1.522 0.502 0 N-CA-C 111.278 -0.729 . . . . 1.0 111.278 179.803 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . 0.541 ' C ' HH21 ' A' ' 42' ' ' ARG . 0.2 OUTLIER -150.54 149.14 29.54 Favored 'General case' 0 CA--C 1.542 0.65 0 N-CA-C 109.061 -0.718 . . . . 1.0 109.061 -178.886 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 46' ' ' PHE . . . . . 0.684 ' N ' HH21 ' A' ' 42' ' ' ARG . 1.9 m-30 144.53 73.45 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.826 0 O-C-N 124.408 1.067 . . . . 1.0 111.664 179.006 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 47' ' ' ARG . . . . . 1.028 ' O ' ' S1 ' ' A' ' 129' ' ' MTN . 2.2 ptt-85 135.2 151.09 0.0 OUTLIER 'General case' 0 N--CA 1.5 2.03 0 CA-C-O 116.905 -1.521 . . . . 1.0 108.643 -179.758 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 48' ' ' CYS . . . . . 0.691 ' O ' ' H61' ' A' ' 129' ' ' MTN . 6.2 p 51.1 62.31 2.78 Favored 'General case' 0 N--CA 1.482 1.161 0 CA-C-N 120.717 1.599 . . . . 1.0 111.982 -179.258 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -110.79 147.21 36.01 Favored Pre-proline 0 N--CA 1.473 0.702 0 N-CA-C 110.144 -0.317 . . . . 1.0 110.144 177.921 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . 0.408 ' HG2' ' HE ' ' A' ' 52' ' ' ARG . 72.4 Cg_endo -71.99 55.08 2.26 Favored 'Trans proline' 0 N--CA 1.494 1.516 0 C-N-CA 122.369 2.046 . . . . 1.0 111.762 179.959 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER 67.43 -3.42 1.07 Allowed 'General case' 0 N--CA 1.468 0.427 0 CA-C-N 115.071 -0.968 . . . . 1.0 111.474 179.189 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . 0.408 ' HE ' ' HG2' ' A' ' 50' ' ' PRO . 16.3 mtm-85 -85.92 154.03 21.78 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 121.377 0.608 . . . . 1.0 111.839 -179.557 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . 0.526 HG23 HG22 ' A' ' 55' ' ' ILE . 8.5 tp -68.22 137.0 25.39 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.306 0 CA-C-N 115.208 -0.905 . . . . 1.0 110.177 179.705 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -59.76 80.44 0.01 OUTLIER 'General case' 0 C--N 1.316 -0.858 0 CA-C-N 114.52 -1.218 . . . . 1.0 109.289 -177.548 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . 0.526 HG22 HG23 ' A' ' 53' ' ' ILE . 18.2 tt -149.17 157.91 6.58 Favored 'Isoleucine or valine' 0 C--N 1.348 0.538 0 N-CA-C 110.109 -0.33 . . . . 1.0 110.109 177.991 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 110.48 -6.38 29.99 Favored Glycine 0 N--CA 1.472 1.047 0 N-CA-C 110.698 -0.961 . . . . 1.0 110.698 -179.722 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 16.1 p-10 -76.46 98.31 4.56 Favored 'General case' 0 C--N 1.323 -0.58 0 N-CA-C 108.855 -0.794 . . . . 1.0 108.855 177.788 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 58' ' ' TRP . . . . . . . . . . . . . 24.1 m0 -87.84 174.54 8.3 Favored 'General case' 0 CA--C 1.533 0.324 0 CA-C-O 122.531 1.157 . . . . 1.0 112.513 -177.636 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 12.9 mtm180 -84.5 -62.03 1.65 Allowed 'General case' 0 C--N 1.317 -0.837 0 CA-C-N 112.523 -2.126 . . . . 1.0 112.628 -178.958 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 9.3 p90 -90.53 -15.25 31.04 Favored 'General case' 0 C--O 1.247 0.924 0 N-CA-C 113.615 0.969 . . . . 1.0 113.615 -178.861 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 4.8 tt0 -78.72 -14.44 59.28 Favored 'General case' 0 C--N 1.323 -0.554 0 O-C-N 121.569 -0.707 . . . . 1.0 110.53 -179.318 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . 0.566 ' O ' ' N ' ' A' ' 66' ' ' GLY . 27.8 m -46.26 -55.13 1.64 Allowed 'Isoleucine or valine' 0 C--O 1.209 -1.053 0 C-N-CA 119.931 -0.707 . . . . 1.0 110.099 -175.281 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 63' ' ' ALA . . . . . 0.554 ' N ' HG23 ' A' ' 62' ' ' VAL . . . -67.44 -52.17 42.78 Favored 'General case' 0 C--N 1.307 -1.273 0 CA-C-N 117.968 0.349 . . . . 1.0 110.25 -179.728 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 64' ' ' HIS . . . . . 0.498 ' O ' ' CG ' ' A' ' 67' ' ' ARG . 0.1 OUTLIER -50.3 -56.25 12.03 Favored 'General case' 0 CA--C 1.544 0.714 0 N-CA-C 108.595 -0.891 . . . . 1.0 108.595 -179.713 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . 0.697 ' C ' ' H ' ' A' ' 67' ' ' ARG . 21.0 t0 -69.8 -48.45 59.05 Favored 'General case' 0 C--N 1.318 -0.762 0 CA-C-O 121.813 0.816 . . . . 1.0 110.011 178.386 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . 0.566 ' N ' ' O ' ' A' ' 62' ' ' VAL . . . -68.74 27.2 0.29 Allowed Glycine 0 CA--C 1.516 0.153 0 N-CA-C 109.68 -1.368 . . . . 1.0 109.68 177.468 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 67' ' ' ARG . . . . . 0.748 ' HB3' ' HB3' ' A' ' 71' ' ' ALA . 29.0 mmt-85 -70.83 -0.74 9.71 Favored 'General case' 0 N--CA 1.438 -1.06 0 N-CA-C 106.486 -1.672 . . . . 1.0 106.486 174.771 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . 0.477 ' H ' ' C ' ' A' ' 66' ' ' GLY . 4.8 tt -32.95 -29.86 0.01 OUTLIER 'General case' 0 C--N 1.354 0.786 0 O-C-N 123.757 0.661 . . . . 1.0 109.327 -175.221 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . 0.617 ' N ' ' O ' ' A' ' 67' ' ' ARG . 4.3 tp -68.4 -66.94 0.51 Allowed 'General case' 0 CA--C 1.548 0.876 0 CA-C-N 114.554 -1.203 . . . . 1.0 111.224 179.748 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . 0.648 ' C ' ' H ' ' A' ' 72' ' ' HIS . . . -80.29 -78.56 0.17 Allowed 'General case' 0 N--CA 1.478 0.938 0 C-N-CA 118.145 -1.422 . . . . 1.0 108.862 179.814 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . 0.787 ' HB1' ' HB ' ' A' ' 74' ' ' VAL . . . -52.14 7.98 0.0 OUTLIER 'General case' 0 C--N 1.324 -0.522 0 C-N-CA 123.985 0.914 . . . . 1.0 112.468 -179.808 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 72' ' ' HIS . . . . . 0.793 ' CD2' ' H ' ' A' ' 73' ' ' MET . 1.3 p80 -24.93 -51.91 0.03 OUTLIER 'General case' 0 N--CA 1.469 0.481 0 N-CA-C 113.034 0.753 . . . . 1.0 113.034 -178.907 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 73' ' ' MET . . . . . 0.793 ' H ' ' CD2' ' A' ' 72' ' ' HIS . 2.2 tpp -73.53 -49.32 27.09 Favored 'General case' 0 C--N 1.322 -0.606 0 C-N-CA 119.309 -0.956 . . . . 1.0 108.901 178.936 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . 0.787 ' HB ' ' HB1' ' A' ' 71' ' ' ALA . 61.8 t -43.46 -42.53 1.49 Allowed 'Isoleucine or valine' 0 CA--C 1.517 -0.3 0 CA-C-O 118.43 -0.795 . . . . 1.0 111.804 -175.706 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 75' ' ' ASN . . . . . 0.639 ' O ' HG12 ' A' ' 78' ' ' VAL . 0.7 OUTLIER -39.37 -13.86 0.01 OUTLIER 'General case' 0 N--CA 1.478 0.926 0 CA-C-N 120.01 1.277 . . . . 1.0 111.68 178.582 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . 0.667 ' N ' ' O ' ' A' ' 74' ' ' VAL . . . -43.31 -23.98 0.31 Allowed Glycine 0 CA--C 1.546 1.979 0 N-CA-C 108.068 -2.013 . . . . 1.0 108.068 178.412 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . 0.619 ' HA ' ' HB3' ' A' ' 80' ' ' ALA . 9.8 pt -69.75 -48.81 62.62 Favored 'Isoleucine or valine' 0 C--O 1.214 -0.799 0 N-CA-C 107.385 -1.339 . . . . 1.0 107.385 177.274 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . 0.639 HG12 ' O ' ' A' ' 75' ' ' ASN . 3.7 p -34.26 -36.68 0.06 OUTLIER 'Isoleucine or valine' 0 CA--C 1.542 0.643 0 N-CA-C 107.399 -1.334 . . . . 1.0 107.399 -177.076 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . 0.534 HG23 HG13 ' A' ' 78' ' ' VAL . 43.9 pt -97.65 -26.49 3.93 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.862 0 N-CA-C 111.924 0.342 . . . . 1.0 111.924 178.077 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 80' ' ' ALA . . . . . 0.619 ' HB3' ' HA ' ' A' ' 77' ' ' ILE . . . -86.6 -10.72 53.29 Favored 'General case' 0 N--CA 1.48 1.039 0 N-CA-C 113.475 0.917 . . . . 1.0 113.475 178.681 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . 0.489 ' N ' ' O ' ' A' ' 77' ' ' ILE . 2.6 mt-10 -78.56 -68.96 0.6 Allowed 'General case' 0 N--CA 1.436 -1.126 0 N-CA-C 107.405 -1.331 . . . . 1.0 107.405 178.041 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 82' ' ' ASP . . . . . 0.9 ' O ' ' N ' ' A' ' 84' ' ' LEU . 0.5 OUTLIER -59.58 -60.87 3.16 Favored 'General case' 0 N--CA 1.437 -1.101 0 N-CA-C 107.928 -1.138 . . . . 1.0 107.928 178.705 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . 0.638 ' HA ' ' HB3' ' A' ' 86' ' ' ALA . . . 31.8 -64.52 0.0 OUTLIER 'General case' 0 N--CA 1.478 0.946 0 O-C-N 124.501 1.126 . . . . 1.0 111.812 179.32 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . 0.9 ' N ' ' O ' ' A' ' 82' ' ' ASP . 19.9 mt -33.78 -37.48 0.04 OUTLIER 'General case' 0 N--CA 1.475 0.788 0 N-CA-C 112.8 0.667 . . . . 1.0 112.8 -177.68 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 85' ' ' ILE . . . . . 1.019 HD13 ' N ' ' A' ' 86' ' ' ALA . 0.0 OUTLIER -100.43 -34.44 4.09 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.473 0 N-CA-C 108.584 -0.895 . . . . 1.0 108.584 177.857 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . 1.019 ' N ' HD13 ' A' ' 85' ' ' ILE . . . -62.78 -61.25 2.54 Favored 'General case' 0 CA--C 1.539 0.55 0 CA-C-N 115.104 -0.953 . . . . 1.0 109.849 -179.413 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -64.66 16.35 0.02 OUTLIER 'General case' 0 CA--C 1.537 0.457 0 O-C-N 121.836 -0.54 . . . . 1.0 110.84 -179.206 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . 0.58 ' H ' ' C ' ' A' ' 86' ' ' ALA . . . -115.97 -14.94 11.23 Favored 'General case' 0 N--CA 1.466 0.353 0 N-CA-C 108.626 -0.879 . . . . 1.0 108.626 178.116 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 21.5 m -109.79 31.54 1.11 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.238 0 CA-C-N 115.11 -0.95 . . . . 1.0 109.775 177.734 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 90' ' ' GLY . . . . . 0.55 ' N ' ' CD ' ' A' ' 91' ' ' PRO . . . -69.29 -39.76 81.5 Favored Glycine 0 CA--C 1.529 0.907 0 N-CA-C 111.059 -0.817 . . . . 1.0 111.059 178.216 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 91' ' ' PRO . . . . . 0.55 ' CD ' ' N ' ' A' ' 90' ' ' GLY . 81.0 Cg_exo -48.24 -8.53 0.06 OUTLIER 'Trans proline' 0 N--CA 1.493 1.466 0 C-N-CA 121.836 1.691 . . . . 1.0 111.048 179.266 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 92' ' ' HIS . . . . . 0.549 ' H ' ' C ' ' A' ' 90' ' ' GLY . 28.9 t60 -58.05 -14.37 6.49 Favored 'General case' 0 C--O 1.214 -0.804 0 N-CA-C 108.245 -1.02 . . . . 1.0 108.245 179.893 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . 0.58 HD12 ' N ' ' A' ' 94' ' ' ALA . 1.2 pp -63.44 -55.97 19.92 Favored 'General case' 0 CA--C 1.531 0.24 0 N-CA-C 108.128 -1.064 . . . . 1.0 108.128 177.464 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 94' ' ' ALA . . . . . 0.58 ' N ' HD12 ' A' ' 93' ' ' LEU . . . -56.45 -50.57 71.32 Favored 'General case' 0 CA--C 1.515 -0.376 0 N-CA-C 108.804 -0.813 . . . . 1.0 108.804 178.861 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 95' ' ' ARG . . . . . 0.611 ' O ' ' N ' ' A' ' 97' ' ' LEU . 7.8 ttt180 -59.65 -59.61 5.17 Favored 'General case' 0 CA--C 1.507 -0.68 0 N-CA-C 106.994 -1.484 . . . . 1.0 106.994 178.472 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 96' ' ' ALA . . . . . 0.924 ' O ' ' N ' ' A' ' 98' ' ' GLY . . . -47.21 -14.2 0.03 OUTLIER 'General case' 0 N--CA 1.418 -2.035 0 O-C-N 119.026 -2.296 . . . . 1.0 111.23 -179.976 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . 0.693 ' O ' ' N ' ' A' ' 100' ' ' ILE . 16.4 tp 7.1 -51.94 0.0 OUTLIER 'General case' 0 N--CA 1.487 1.394 0 CA-C-O 118.133 -0.937 . . . . 1.0 110.407 -168.103 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 98' ' ' GLY . . . . . 0.924 ' N ' ' O ' ' A' ' 96' ' ' ALA . . . -50.74 -23.55 6.95 Favored Glycine 0 CA--C 1.548 2.122 0 CA-C-N 122.221 2.282 . . . . 1.0 107.618 173.753 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 99' ' ' GLN . . . . . 0.577 ' N ' ' O ' ' A' ' 96' ' ' ALA . 1.4 tp-100 -67.02 -20.48 65.87 Favored 'General case' 0 C--N 1.377 1.788 0 N-CA-C 106.665 -1.605 . . . . 1.0 106.665 176.805 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 100' ' ' ILE . . . . . 0.693 ' N ' ' O ' ' A' ' 97' ' ' LEU . 2.7 tp -63.57 -39.59 85.93 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.867 0 N-CA-C 107.245 -1.391 . . . . 1.0 107.245 177.664 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 101' ' ' VAL . . . . . 0.662 ' O ' ' N ' ' A' ' 105' ' ' GLY . 97.6 t -59.26 -61.71 1.33 Allowed 'Isoleucine or valine' 0 C--O 1.215 -0.731 0 N-CA-C 108.894 -0.78 . . . . 1.0 108.894 178.954 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 102' ' ' CYS . . . . . 0.818 ' O ' ' HB2' ' A' ' 106' ' ' ALA . 3.5 t -45.46 -26.99 0.64 Allowed 'General case' 0 C--N 1.315 -0.928 0 N-CA-C 112.368 0.507 . . . . 1.0 112.368 -179.089 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 53.8 ttt-85 -86.78 -47.39 9.12 Favored 'General case' 0 N--CA 1.494 1.752 0 CA-C-O 122.632 1.206 . . . . 1.0 112.891 179.639 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 104' ' ' TYR . . . . . 0.668 ' O ' ' CG ' ' A' ' 104' ' ' TYR . 0.0 OUTLIER -98.62 24.19 7.77 Favored 'General case' 0 C--N 1.299 -1.596 0 CA-C-N 112.203 -2.271 . . . . 1.0 107.88 178.09 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 105' ' ' GLY . . . . . 0.662 ' N ' ' O ' ' A' ' 101' ' ' VAL . . . -162.62 -94.82 0.1 Allowed Glycine 0 CA--C 1.533 1.206 0 N-CA-C 106.589 -2.604 . . . . 1.0 106.589 177.987 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 106' ' ' ALA . . . . . 0.818 ' HB2' ' O ' ' A' ' 102' ' ' CYS . . . 70.69 63.18 0.19 Allowed 'General case' 0 CA--C 1.543 0.679 0 N-CA-C 114.021 1.119 . . . . 1.0 114.021 -179.362 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 107' ' ' THR . . . . . 0.719 ' O ' ' HD2' ' A' ' 110' ' ' PRO . 97.9 m -79.96 -57.76 3.49 Favored 'General case' 0 C--O 1.212 -0.881 0 O-C-N 120.349 -1.469 . . . . 1.0 109.435 177.845 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . 0.659 ' O ' HG12 ' A' ' 108' ' ' VAL . 21.4 t -80.22 25.04 0.08 OUTLIER 'Isoleucine or valine' 0 CA--C 1.538 0.486 0 O-C-N 121.254 -0.903 . . . . 1.0 113.079 -175.997 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 109' ' ' ILE . . . . . 0.541 ' H ' ' HD3' ' A' ' 110' ' ' PRO . 0.5 OUTLIER -109.38 -38.25 0.13 Allowed Pre-proline 0 CA--C 1.561 1.381 0 CA-C-N 118.909 0.777 . . . . 1.0 110.71 176.683 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 110' ' ' PRO . . . . . 0.719 ' HD2' ' O ' ' A' ' 107' ' ' THR . 23.0 Cg_exo -67.88 -23.15 41.53 Favored 'Trans proline' 0 N--CA 1.507 2.296 0 C-N-CA 123.642 2.894 . . . . 1.0 110.794 178.291 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 21.3 t-20 -69.17 -67.84 0.45 Allowed 'General case' 0 C--O 1.237 0.423 0 N-CA-C 109.169 -0.678 . . . . 1.0 109.169 -179.624 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 112' ' ' ILE . . . . . 0.674 HD12 ' HA2' ' A' ' 35' ' ' GLY . 0.5 OUTLIER -49.03 -30.39 3.55 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.596 0 CA-C-O 121.911 0.863 . . . . 1.0 108.701 177.861 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 113' ' ' ASN . . . . . 0.468 ' HB3' ' O ' ' A' ' 110' ' ' PRO . 20.4 t30 -55.25 -55.56 30.0 Favored 'General case' 0 C--N 1.309 -1.153 0 CA-C-N 113.833 -1.53 . . . . 1.0 108.31 -178.111 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -56.75 -31.78 64.92 Favored 'General case' 0 CA--C 1.537 0.458 0 N-CA-C 113.116 0.784 . . . . 1.0 113.116 -179.469 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -81.04 -50.4 9.72 Favored 'General case' 0 N--CA 1.472 0.664 0 CA-C-O 121.988 0.899 . . . . 1.0 110.951 178.237 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 116' ' ' ILE . . . . . 0.541 HG22 ' N ' ' A' ' 117' ' ' GLU . 0.4 OUTLIER -49.07 -57.84 1.52 Allowed 'Isoleucine or valine' 0 C--N 1.314 -0.95 0 CA-C-N 113.969 -1.468 . . . . 1.0 107.562 -179.961 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 117' ' ' GLU . . . . . 0.541 ' N ' HG22 ' A' ' 116' ' ' ILE . 2.4 tt0 -37.89 -55.99 1.16 Allowed 'General case' 0 N--CA 1.475 0.808 0 CA-C-N 113.187 -1.824 . . . . 1.0 106.526 -178.711 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 84.6 t -58.58 -50.58 78.5 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.723 0 CA-C-N 113.314 -1.767 . . . . 1.0 108.386 178.818 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 119' ' ' LEU . . . . . 0.497 ' N ' ' O ' ' A' ' 116' ' ' ILE . 1.2 tp -57.38 -73.98 0.06 Allowed 'General case' 0 CA--C 1.547 0.861 0 C-N-CA 119.823 -0.751 . . . . 1.0 109.666 -178.239 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -77.62 -82.21 0.6 Allowed Glycine 0 CA--C 1.543 1.837 0 C-N-CA 118.55 -1.786 . . . . 1.0 113.209 -178.904 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 121' ' ' THR . . . . . 0.412 ' H ' ' H ' ' A' ' 122' ' ' GLY . 27.3 m -168.5 -22.92 0.02 OUTLIER 'General case' 0 C--N 1.303 -1.425 0 N-CA-C 105.2 -2.148 . . . . 1.0 105.2 -176.621 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 122' ' ' GLY . . . . . 0.412 ' H ' ' H ' ' A' ' 121' ' ' THR . . . 109.1 -33.61 6.04 Favored Glycine 0 N--CA 1.449 -0.472 0 CA-C-N 112.472 -2.149 . . . . 1.0 114.686 177.37 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 123' ' ' THR . . . . . 0.408 ' C ' ' O ' ' A' ' 122' ' ' GLY . 0.2 OUTLIER -41.75 106.89 0.07 Allowed 'General case' 0 CA--C 1.538 0.49 0 CA-C-N 120.351 2.075 . . . . 1.0 113.05 -177.515 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 28.8 m-20 -142.6 145.03 33.12 Favored 'General case' 0 N--CA 1.465 0.298 0 CA-C-N 114.276 -1.329 . . . . 1.0 108.768 178.082 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 125' ' ' TYR . . . . . 0.421 ' CD1' ' C ' ' A' ' 125' ' ' TYR . 0.0 OUTLIER -151.5 146.64 26.05 Favored 'General case' 0 CA--C 1.546 0.801 0 N-CA-C 109.061 -0.718 . . . . 1.0 109.061 179.191 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 126' ' ' ARG . . . . . 0.579 ' CB ' ' H62' ' A' ' 130' ' ' MTN . 11.9 mmp_? -146.92 151.68 37.43 Favored 'General case' 0 N--CA 1.472 0.645 0 CA-C-N 115.112 -0.949 . . . . 1.0 109.341 177.534 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 127' ' ' PHE . . . . . . . . . . . . . 7.9 p90 . . . . . 0 C--O 1.219 -0.539 0 CA-C-O 118.173 -0.918 . . . . 1.0 110.533 178.726 . . . . . . . . 0 0 . 1 . 022 nuclear nobuild full ' A' A ' 128' ' ' MTN . . . . . 0.752 ' H61' ' S1 ' ' A' ' 128' ' ' MTN . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 129' ' ' MTN . . . . . 1.028 ' S1 ' ' O ' ' A' ' 47' ' ' ARG . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 130' ' ' MTN . . . . . 0.579 ' H62' ' CB ' ' A' ' 126' ' ' ARG . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.494 1.73 0 CA-C-O 121.226 0.536 . . . . 1.0 109.963 . . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . 0.49 ' O ' ' CB ' ' A' ' 3' ' ' ASP . 6.7 m -83.92 9.14 12.93 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.448 -0.796 . . . . 1.0 110.892 179.825 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . 0.49 ' CB ' ' O ' ' A' ' 2' ' ' SER . 1.4 m-20 150.35 126.96 0.0 OUTLIER 'General case' 0 N--CA 1.478 0.956 0 O-C-N 124.088 0.867 . . . . 1.0 111.208 178.713 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 27.4 t80 -157.26 152.58 26.27 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.829 -0.623 . . . . 1.0 110.506 178.428 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 8.4 p30 -151.75 147.5 26.75 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.726 -0.67 . . . . 1.0 109.201 179.806 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 6' ' ' THR . . . . . 0.504 ' O ' ' N ' ' A' ' 10' ' ' SER . 0.2 OUTLIER -71.5 171.29 11.62 Favored 'General case' 0 C--O 1.211 -0.968 0 C-N-CA 120.917 -0.313 . . . . 1.0 110.179 -179.325 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . 0.529 ' O ' ' HG2' ' A' ' 11' ' ' ARG . 90.7 mt-10 -53.83 -69.58 0.12 Allowed 'General case' 0 C--N 1.31 -1.137 0 C-N-CA 120.645 -0.422 . . . . 1.0 110.2 -176.697 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 8' ' ' ARG . . . . . 0.493 ' O ' ' CB ' ' A' ' 12' ' ' ALA . 0.0 OUTLIER -42.22 -51.18 4.8 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-N 115.397 -0.819 . . . . 1.0 109.298 -176.299 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -66.83 -50.1 68.25 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.462 0 CA-C-N 115.151 -0.931 . . . . 1.0 111.055 177.657 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . 0.504 ' N ' ' O ' ' A' ' 6' ' ' THR . 28.2 t -56.79 -40.24 75.54 Favored 'General case' 0 C--N 1.323 -0.564 0 N-CA-C 113.467 0.914 . . . . 1.0 113.467 -178.566 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 11' ' ' ARG . . . . . 0.677 ' O ' ' N ' ' A' ' 15' ' ' ALA . 2.3 ptp180 -85.76 -54.28 4.62 Favored 'General case' 0 C--O 1.213 -0.849 0 CA-C-O 121.743 0.783 . . . . 1.0 110.313 175.334 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . 0.678 ' O ' ' HB3' ' A' ' 16' ' ' ALA . . . -47.9 -52.83 17.85 Favored 'General case' 0 CA--C 1.496 -1.104 0 N-CA-C 106.896 -1.52 . . . . 1.0 106.896 -175.343 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . 0.626 ' O ' ' CB ' ' A' ' 17' ' ' LEU . 93.1 t -61.68 -54.86 29.09 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.466 0 C-N-CA 117.01 -1.876 . . . . 1.0 108.76 178.085 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . 0.828 ' O ' HG22 ' A' ' 18' ' ' VAL . . . -58.03 -64.64 0.84 Allowed 'General case' 0 C--O 1.207 -1.136 0 C-N-CA 117.81 -1.556 . . . . 1.0 110.755 -179.127 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . 0.677 ' N ' ' O ' ' A' ' 11' ' ' ARG . . . -52.78 -56.08 18.28 Favored 'General case' 0 N--CA 1.473 0.683 0 CA-C-O 121.053 0.454 . . . . 1.0 110.924 -179.23 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . 0.678 ' HB3' ' O ' ' A' ' 12' ' ' ALA . . . -63.96 -56.19 16.95 Favored 'General case' 0 C--N 1.312 -1.035 0 C-N-CA 119.172 -1.011 . . . . 1.0 109.199 -179.219 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . 0.626 ' CB ' ' O ' ' A' ' 13' ' ' VAL . 28.5 tp -55.85 -53.68 53.76 Favored 'General case' 0 N--CA 1.484 1.258 0 CA-C-N 114.95 -1.023 . . . . 1.0 108.705 -177.326 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . 0.828 HG22 ' O ' ' A' ' 14' ' ' ALA . 2.6 m -68.83 -58.2 6.49 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.365 0 N-CA-C 109.22 -0.659 . . . . 1.0 109.22 179.603 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . 0.575 ' N ' ' O ' ' A' ' 15' ' ' ALA . . . -58.83 -165.04 0.1 Allowed Glycine 0 N--CA 1.442 -0.915 0 N-CA-C 110.607 -0.997 . . . . 1.0 110.607 -178.844 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 20' ' ' PRO . . . . . 0.579 ' O ' ' N ' ' A' ' 24' ' ' ALA . 65.4 Cg_endo -82.86 -31.4 0.74 Allowed 'Trans proline' 0 C--N 1.296 -2.235 0 C-N-CA 122.632 2.222 . . . . 1.0 113.847 -177.788 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -61.56 -59.6 9.56 Favored Glycine 0 CA--C 1.539 1.573 0 C-N-CA 119.881 -1.152 . . . . 1.0 112.987 -176.683 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . 0.55 ' H ' ' CA ' ' A' ' 16' ' ' ALA . . . -56.36 -53.63 41.72 Favored Glycine 0 N--CA 1.47 0.939 0 N-CA-C 107.304 -2.318 . . . . 1.0 107.304 -176.564 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . 0.476 ' O ' HG12 ' A' ' 27' ' ' VAL . 1.1 p -62.64 -30.63 49.73 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.184 0 C-N-CA 119.211 -0.995 . . . . 1.0 109.394 179.116 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . 0.579 ' N ' ' O ' ' A' ' 20' ' ' PRO . . . -56.63 -63.75 1.1 Allowed 'General case' 0 C--N 1.357 0.906 0 C-N-CA 118.86 -1.136 . . . . 1.0 110.867 -178.376 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 10.4 mt -63.93 -42.84 97.25 Favored 'General case' 0 CA--C 1.517 -0.303 0 C-N-CA 120.404 -0.518 . . . . 1.0 111.54 -177.92 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . 0.4 HG23 ' O ' ' A' ' 22' ' ' GLY . 78.8 t -58.41 -59.98 2.88 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.519 0 C-N-CA 119.25 -0.98 . . . . 1.0 110.211 -178.13 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . 0.634 ' O ' ' HB3' ' A' ' 31' ' ' ALA . 1.9 p -63.42 -36.52 76.53 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 C-N-CA 120.643 -0.423 . . . . 1.0 111.627 -178.433 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 59.2 tttm -66.26 -57.2 8.05 Favored 'General case' 0 C--N 1.318 -0.774 0 C-N-CA 119.749 -0.78 . . . . 1.0 109.28 -178.742 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 96.2 t -64.51 -47.23 90.07 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.127 0 CA-C-N 114.716 -1.129 . . . . 1.0 110.046 -178.345 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 30' ' ' CYS . . . . . . . . . . . . . 54.1 t -66.81 -61.92 1.71 Allowed 'General case' 0 N--CA 1.448 -0.548 0 C-N-CA 119.475 -0.89 . . . . 1.0 110.613 -179.71 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . 0.634 ' HB3' ' O ' ' A' ' 27' ' ' VAL . . . -62.08 -46.02 90.93 Favored 'General case' 0 CA--C 1.506 -0.733 0 CA-C-O 121.061 0.458 . . . . 1.0 111.18 -176.45 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . 0.546 ' O ' ' HB2' ' A' ' 33' ' ' LEU . . . 77.77 69.13 1.43 Allowed Glycine 0 N--CA 1.444 -0.813 0 N-CA-C 110.122 -1.191 . . . . 1.0 110.122 -179.357 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . 0.546 ' HB2' ' O ' ' A' ' 32' ' ' GLY . 3.8 mp 84.61 86.99 0.05 OUTLIER Pre-proline 0 N--CA 1.477 0.907 0 O-C-N 124.769 0.923 . . . . 1.0 111.617 -179.21 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 29.4 Cg_endo -64.2 -15.88 51.94 Favored 'Trans proline' 0 N--CA 1.497 1.716 0 C-N-CA 121.525 1.484 . . . . 1.0 111.824 178.519 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -55.95 -59.63 10.3 Favored Glycine 0 CA--C 1.522 0.524 0 C-N-CA 119.02 -1.562 . . . . 1.0 109.435 -179.092 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . 0.588 ' O ' HG22 ' A' ' 37' ' ' ILE . 1.3 p -97.81 172.87 1.04 Allowed 'Isoleucine or valine' 0 CA--C 1.51 -0.587 0 N-CA-C 105.215 -2.143 . . . . 1.0 105.215 177.131 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . 0.588 HG22 ' O ' ' A' ' 36' ' ' VAL . 6.8 tp 113.07 120.02 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.477 0.907 0 O-C-N 124.689 1.243 . . . . 1.0 110.38 179.411 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 59.5 m80 -141.12 131.42 25.04 Favored 'General case' 0 C--N 1.328 -0.337 0 N-CA-C 108.484 -0.932 . . . . 1.0 108.484 179.395 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -94.64 132.75 27.99 Favored Pre-proline 0 CA--C 1.543 0.679 0 C-N-CA 121.047 -0.261 . . . . 1.0 110.775 -178.849 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 44.8 Cg_exo -54.36 -42.86 63.94 Favored 'Trans proline' 0 N--CA 1.495 1.567 0 C-N-CA 121.902 1.735 . . . . 1.0 113.726 179.363 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -126.38 132.79 51.47 Favored 'General case' 0 N--CA 1.468 0.44 0 CA-C-N 116.602 -0.272 . . . . 1.0 110.861 179.805 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . 0.663 ' C ' ' H ' ' A' ' 44' ' ' GLY . 17.6 ptm180 -166.32 163.73 17.56 Favored 'General case' 0 C--N 1.323 -0.548 0 C-N-CA 120.115 -0.634 . . . . 1.0 109.931 178.1 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 43' ' ' ARG . . . . . 0.529 ' C ' ' H ' ' A' ' 45' ' ' PHE . 0.1 OUTLIER -62.76 24.47 0.01 OUTLIER 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 115.872 -0.604 . . . . 1.0 110.348 -179.973 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . 0.663 ' H ' ' C ' ' A' ' 42' ' ' ARG . . . 70.32 -28.56 0.45 Allowed Glycine 0 C--N 1.339 0.723 0 N-CA-C 111.376 -0.69 . . . . 1.0 111.376 179.982 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . 0.552 ' CG ' ' N ' ' A' ' 46' ' ' PHE . 27.6 t80 -159.62 161.76 35.1 Favored 'General case' 0 C--N 1.32 -0.681 0 N-CA-C 109.084 -0.71 . . . . 1.0 109.084 179.199 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 46' ' ' PHE . . . . . 0.793 ' O ' ' HB2' ' A' ' 47' ' ' ARG . 2.3 m-30 132.65 91.43 0.0 OUTLIER 'General case' 0 N--CA 1.474 0.756 0 O-C-N 125.367 1.667 . . . . 1.0 107.109 -179.476 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 47' ' ' ARG . . . . . 0.793 ' HB2' ' O ' ' A' ' 46' ' ' PHE . 0.0 OUTLIER 125.96 139.71 0.0 OUTLIER 'General case' 0 N--CA 1.48 1.05 0 C-N-CA 124.52 1.128 . . . . 1.0 109.402 179.574 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 48' ' ' CYS . . . . . 0.621 ' O ' ' H83' ' A' ' 129' ' ' MTN . 0.0 OUTLIER 71.01 73.41 0.19 Allowed 'General case' 0 C--O 1.218 -0.584 0 N-CA-C 108.759 -0.83 . . . . 1.0 108.759 -178.759 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 49' ' ' ASN . . . . . 0.639 ' O ' ' N ' ' A' ' 51' ' ' GLU . 0.0 OUTLIER -132.51 130.13 21.68 Favored Pre-proline 0 CA--C 1.537 0.458 0 N-CA-C 108.629 -0.878 . . . . 1.0 108.629 -179.426 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_exo -53.22 58.04 0.02 OUTLIER 'Trans proline' 0 N--CA 1.507 2.274 0 C-N-CA 122.593 2.195 . . . . 1.0 113.696 178.656 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . 0.639 ' N ' ' O ' ' A' ' 49' ' ' ASN . 6.0 mp0 67.27 3.44 3.24 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.525 -0.307 . . . . 1.0 111.002 -179.974 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 28.8 mtt-85 -80.25 152.87 28.85 Favored 'General case' 0 CA--C 1.531 0.22 0 N-CA-C 109.751 -0.462 . . . . 1.0 109.751 179.776 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . 0.465 ' O ' ' N ' ' A' ' 55' ' ' ILE . 3.6 tp -69.8 136.37 26.3 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-O 120.736 0.303 . . . . 1.0 111.209 -179.469 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 54' ' ' GLN . . . . . 0.61 ' H ' ' CD ' ' A' ' 54' ' ' GLN . 0.0 OUTLIER -60.07 82.82 0.01 OUTLIER 'General case' 0 CA--C 1.54 0.568 0 C-N-CA 120.195 -0.602 . . . . 1.0 110.279 -176.643 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . 0.465 ' N ' ' O ' ' A' ' 53' ' ' ILE . 20.3 tt -149.5 159.98 5.34 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.372 0 CA-C-N 116.145 -0.479 . . . . 1.0 110.89 178.138 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 112.55 -2.42 26.3 Favored Glycine 0 N--CA 1.47 0.942 0 N-CA-C 111.184 -0.767 . . . . 1.0 111.184 -179.814 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 3.6 p-10 -80.07 98.09 7.11 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-O 121.45 0.643 . . . . 1.0 111.239 178.988 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 58' ' ' TRP . . . . . . . . . . . . . 7.1 m95 -85.96 171.72 11.23 Favored 'General case' 0 C--N 1.319 -0.755 0 CA-C-O 123.212 1.482 . . . . 1.0 111.541 -179.464 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -84.24 -60.92 1.94 Allowed 'General case' 0 C--N 1.305 -1.342 0 CA-C-N 111.146 -2.752 . . . . 1.0 112.786 -176.825 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -91.04 -15.28 29.83 Favored 'General case' 0 C--N 1.312 -1.064 0 CA-C-N 114.839 -1.073 . . . . 1.0 112.539 -179.055 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . 0.424 ' O ' ' N ' ' A' ' 65' ' ' ASP . 4.0 tt0 -80.93 -14.75 57.7 Favored 'General case' 0 C--N 1.312 -1.032 0 O-C-N 121.901 -0.499 . . . . 1.0 110.244 -179.473 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . 0.635 HG23 ' N ' ' A' ' 63' ' ' ALA . 29.0 m -47.16 -54.38 2.72 Favored 'Isoleucine or valine' 0 C--O 1.209 -1.057 0 C-N-CA 119.754 -0.778 . . . . 1.0 109.767 -176.851 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 63' ' ' ALA . . . . . 0.635 ' N ' HG23 ' A' ' 62' ' ' VAL . . . -66.62 -52.61 43.28 Favored 'General case' 0 C--N 1.306 -1.283 0 N-CA-C 109.559 -0.534 . . . . 1.0 109.559 -179.81 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 64' ' ' HIS . . . . . 0.443 ' O ' ' CG ' ' A' ' 67' ' ' ARG . 9.7 t60 -50.59 -58.8 4.98 Favored 'General case' 0 CA--C 1.542 0.66 0 CA-C-O 122.175 0.988 . . . . 1.0 109.933 -179.168 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . 0.606 ' C ' ' H ' ' A' ' 67' ' ' ARG . 58.9 t0 -67.83 -50.31 57.39 Favored 'General case' 0 C--N 1.31 -1.129 0 CA-C-O 122.492 1.139 . . . . 1.0 109.455 177.947 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . 0.658 ' O ' HD12 ' A' ' 68' ' ' LEU . . . -68.23 30.84 0.26 Allowed Glycine 0 C--O 1.224 -0.497 0 O-C-N 121.069 -1.02 . . . . 1.0 111.795 178.487 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 67' ' ' ARG . . . . . 0.709 ' CB ' ' HB3' ' A' ' 71' ' ' ALA . 4.7 mmm180 -74.22 5.47 4.43 Favored 'General case' 0 C--N 1.306 -1.323 0 N-CA-C 108.72 -0.845 . . . . 1.0 108.72 176.279 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . 0.658 HD12 ' O ' ' A' ' 66' ' ' GLY . 0.0 OUTLIER -34.22 -29.28 0.01 OUTLIER 'General case' 0 N--CA 1.481 1.09 0 N-CA-C 108.298 -1.001 . . . . 1.0 108.298 -176.671 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . 0.607 ' N ' ' O ' ' A' ' 67' ' ' ARG . 0.5 OUTLIER -68.36 -68.4 0.39 Allowed 'General case' 0 CA--C 1.546 0.817 0 C-N-CA 119.336 -0.946 . . . . 1.0 110.357 179.633 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . 0.69 ' C ' ' H ' ' A' ' 72' ' ' HIS . . . -78.29 -77.09 0.17 Allowed 'General case' 0 CA--C 1.51 -0.575 0 N-CA-C 108.344 -0.984 . . . . 1.0 108.344 179.925 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . 0.806 ' HB1' ' HB ' ' A' ' 74' ' ' VAL . . . -51.86 10.3 0.0 OUTLIER 'General case' 0 CA--C 1.537 0.458 0 C-N-CA 125.007 1.323 . . . . 1.0 111.953 178.188 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 72' ' ' HIS . . . . . 1.009 ' CD2' ' H ' ' A' ' 73' ' ' MET . 0.3 OUTLIER -21.37 -61.78 0.03 OUTLIER 'General case' 0 CA--C 1.519 -0.244 0 N-CA-C 113.9 1.074 . . . . 1.0 113.9 -178.957 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 73' ' ' MET . . . . . 1.009 ' H ' ' CD2' ' A' ' 72' ' ' HIS . 5.3 ptm -71.14 -45.6 63.23 Favored 'General case' 0 C--N 1.313 -0.978 0 N-CA-C 108.954 -0.758 . . . . 1.0 108.954 179.114 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . 0.806 ' HB ' ' HB1' ' A' ' 71' ' ' ALA . 79.7 t -40.88 -40.77 0.59 Allowed 'Isoleucine or valine' 0 CA--C 1.507 -0.697 0 CA-C-O 117.854 -1.07 . . . . 1.0 109.916 -175.937 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 75' ' ' ASN . . . . . 0.418 ' C ' ' N ' ' A' ' 77' ' ' ILE . 1.7 t-20 -33.59 -15.52 0.0 OUTLIER 'General case' 0 N--CA 1.482 1.136 0 CA-C-O 122.259 1.028 . . . . 1.0 110.891 178.305 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . 0.795 ' N ' ' O ' ' A' ' 74' ' ' VAL . . . -49.71 -22.04 3.87 Favored Glycine 0 N--CA 1.435 -1.414 0 N-CA-C 107.227 -2.349 . . . . 1.0 107.227 173.901 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . 0.418 ' N ' ' C ' ' A' ' 75' ' ' ASN . 85.2 mt -59.49 -52.84 56.24 Favored 'Isoleucine or valine' 0 C--N 1.351 0.658 0 CA-C-O 118.259 -0.876 . . . . 1.0 111.986 -179.927 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 33.0 t -51.04 -21.86 1.48 Allowed 'Isoleucine or valine' 0 C--N 1.351 0.659 0 CA-C-N 121.279 1.854 . . . . 1.0 112.477 -179.445 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . 0.72 ' O ' ' HB2' ' A' ' 83' ' ' ALA . 0.1 OUTLIER -94.88 -40.57 11.35 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.576 0 CA-C-N 116.102 -0.499 . . . . 1.0 109.888 179.713 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -77.32 -19.16 56.78 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.647 -0.706 . . . . 1.0 111.41 -179.232 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 22.5 tt0 -87.19 -67.6 0.81 Allowed 'General case' 0 N--CA 1.438 -1.047 0 N-CA-C 109.616 -0.513 . . . . 1.0 109.616 178.961 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 82' ' ' ASP . . . . . 0.817 ' O ' ' N ' ' A' ' 84' ' ' LEU . 15.6 m-20 -60.46 -61.18 2.78 Favored 'General case' 0 C--N 1.352 0.682 0 C-N-CA 118.91 -1.116 . . . . 1.0 109.267 -179.391 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . 0.72 ' HB2' ' O ' ' A' ' 79' ' ' ILE . . . 23.69 -67.29 0.0 OUTLIER 'General case' 0 N--CA 1.486 1.371 0 O-C-N 124.752 1.283 . . . . 1.0 112.063 179.868 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . 0.817 ' N ' ' O ' ' A' ' 82' ' ' ASP . 0.8 OUTLIER -33.21 -41.76 0.08 Allowed 'General case' 0 N--CA 1.476 0.843 0 C-N-CA 122.728 0.411 . . . . 1.0 111.934 -178.09 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 85' ' ' ILE . . . . . 0.523 ' O ' ' HB3' ' A' ' 88' ' ' ALA . 18.2 pt -95.2 -41.64 12.06 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.615 0 N-CA-C 109.146 -0.687 . . . . 1.0 109.146 178.675 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . 0.569 ' HB3' ' HA ' ' A' ' 83' ' ' ALA . . . -54.43 -57.87 9.64 Favored 'General case' 0 CA--C 1.54 0.585 0 CA-C-N 115.399 -0.818 . . . . 1.0 110.305 -179.448 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -71.16 10.58 0.55 Allowed 'General case' 0 CA--C 1.538 0.505 0 N-CA-C 111.838 0.31 . . . . 1.0 111.838 -179.023 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . 0.523 ' HB3' ' O ' ' A' ' 85' ' ' ILE . . . -99.28 -19.89 16.84 Favored 'General case' 0 N--CA 1.48 1.044 0 CA-C-O 122.738 1.256 . . . . 1.0 109.156 179.281 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 28.6 m -104.32 37.46 0.31 Allowed 'Isoleucine or valine' 0 C--N 1.313 -1.018 0 CA-C-N 111.832 -2.44 . . . . 1.0 110.004 178.259 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 90' ' ' GLY . . . . . 0.624 ' O ' ' N ' ' A' ' 92' ' ' HIS . . . -65.17 -41.02 97.16 Favored Glycine 0 CA--C 1.537 1.456 0 CA-C-O 118.853 -0.97 . . . . 1.0 111.671 177.144 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 91' ' ' PRO . . . . . 0.498 ' HD2' ' N ' ' A' ' 90' ' ' GLY . 88.3 Cg_exo -41.47 -11.71 0.03 OUTLIER 'Trans proline' 0 N--CA 1.5 1.879 0 C-N-CA 122.349 2.033 . . . . 1.0 112.008 178.923 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 92' ' ' HIS . . . . . 0.624 ' N ' ' O ' ' A' ' 90' ' ' GLY . 6.5 p-80 -55.08 -18.75 5.87 Favored 'General case' 0 C--O 1.194 -1.833 0 N-CA-C 108.615 -0.883 . . . . 1.0 108.615 -179.736 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . 0.568 HD12 ' N ' ' A' ' 94' ' ' ALA . 0.8 OUTLIER -62.53 -57.9 9.51 Favored 'General case' 0 C--N 1.317 -0.806 0 N-CA-C 108.763 -0.828 . . . . 1.0 108.763 179.225 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 94' ' ' ALA . . . . . 0.568 ' N ' HD12 ' A' ' 93' ' ' LEU . . . -58.27 -57.76 11.46 Favored 'General case' 0 N--CA 1.452 -0.369 0 CA-C-N 115.293 -0.867 . . . . 1.0 109.335 179.265 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 95' ' ' ARG . . . . . 0.588 ' O ' ' N ' ' A' ' 97' ' ' LEU . 37.4 mtp-105 -56.84 -59.67 4.69 Favored 'General case' 0 C--O 1.242 0.681 0 CA-C-O 123.098 1.428 . . . . 1.0 108.041 179.288 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 96' ' ' ALA . . . . . 0.84 ' O ' ' N ' ' A' ' 98' ' ' GLY . . . -47.32 -15.82 0.05 OUTLIER 'General case' 0 C--N 1.301 -1.502 0 O-C-N 118.572 -2.58 . . . . 1.0 111.042 -179.051 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . 0.641 ' O ' ' N ' ' A' ' 100' ' ' ILE 0.279 16.1 tp 6.17 -54.07 0.0 OUTLIER 'General case' 0 N--CA 1.477 0.906 0 CA-C-O 118.116 -0.945 . . . . 1.0 112.287 -168.266 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 98' ' ' GLY . . . . . 0.84 ' N ' ' O ' ' A' ' 96' ' ' ALA . . . -49.38 -24.44 5.24 Favored Glycine 0 C--N 1.295 -1.708 0 CA-C-N 122.303 2.32 . . . . 1.0 108.417 175.16 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 99' ' ' GLN . . . . . 0.509 ' N ' ' O ' ' A' ' 96' ' ' ALA . 40.9 mm-40 -71.39 -20.7 62.11 Favored 'General case' 0 C--N 1.371 1.538 0 C-N-CA 117.477 -1.689 . . . . 1.0 107.882 177.344 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 100' ' ' ILE . . . . . 0.641 ' N ' ' O ' ' A' ' 97' ' ' LEU . 0.3 OUTLIER -67.45 -40.66 84.96 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.499 0 N-CA-C 108.131 -1.063 . . . . 1.0 108.131 177.392 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 101' ' ' VAL . . . . . 0.678 ' O ' ' N ' ' A' ' 105' ' ' GLY . 0.4 OUTLIER -57.4 -58.35 6.41 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.605 0 N-CA-C 106.561 -1.644 . . . . 1.0 106.561 179.959 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 102' ' ' CYS . . . . . 0.969 ' O ' ' HB2' ' A' ' 106' ' ' ALA . 4.6 t -47.07 -21.87 0.28 Allowed 'General case' 0 C--O 1.209 -1.043 0 CA-C-N 115.666 -0.697 . . . . 1.0 110.649 -179.801 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 103' ' ' ARG . . . . . 0.402 ' N ' ' C ' ' A' ' 101' ' ' VAL . 2.1 tmm_? -88.57 -43.32 11.47 Favored 'General case' 0 N--CA 1.486 1.326 0 CA-C-O 122.689 1.233 . . . . 1.0 111.779 178.118 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 104' ' ' TYR . . . . . 0.779 ' O ' ' CG ' ' A' ' 104' ' ' TYR . 1.3 t80 -98.14 23.19 8.51 Favored 'General case' 0 C--N 1.31 -1.121 0 CA-C-N 112.373 -2.194 . . . . 1.0 108.572 177.238 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 105' ' ' GLY . . . . . 0.678 ' N ' ' O ' ' A' ' 101' ' ' VAL . . . -167.68 -92.19 0.08 OUTLIER Glycine 0 N--CA 1.446 -0.695 0 N-CA-C 107.104 -2.398 . . . . 1.0 107.104 177.756 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 106' ' ' ALA . . . . . 0.969 ' HB2' ' O ' ' A' ' 102' ' ' CYS . . . 67.36 63.18 0.44 Allowed 'General case' 0 N--CA 1.443 -0.793 0 N-CA-C 112.418 0.525 . . . . 1.0 112.418 179.83 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 107' ' ' THR . . . . . 0.475 ' O ' ' HD2' ' A' ' 110' ' ' PRO . 19.1 m -83.1 -65.05 1.06 Allowed 'General case' 0 CA--C 1.541 0.632 0 O-C-N 121.449 -0.782 . . . . 1.0 111.603 179.96 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 9.1 m -71.63 28.54 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.322 -0.616 0 O-C-N 121.078 -1.014 . . . . 1.0 111.644 -177.107 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 109' ' ' ILE . . . . . 0.756 ' H ' ' HD2' ' A' ' 110' ' ' PRO . 0.1 OUTLIER -112.48 -53.05 0.05 OUTLIER Pre-proline 0 CA--C 1.553 1.061 0 N-CA-C 108.167 -1.049 . . . . 1.0 108.167 176.117 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 110' ' ' PRO . . . . . 0.756 ' HD2' ' H ' ' A' ' 109' ' ' ILE . 19.1 Cg_endo -51.48 -29.78 32.8 Favored 'Trans proline' 0 N--CA 1.494 1.501 0 C-N-CA 122.563 2.176 . . . . 1.0 111.259 178.634 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 11.0 t-20 -63.01 -69.4 0.27 Allowed 'General case' 0 N--CA 1.466 0.356 0 C-N-CA 120.511 -0.476 . . . . 1.0 110.392 -179.339 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 112' ' ' ILE . . . . . 0.486 HG13 ' N ' ' A' ' 113' ' ' ASN . 26.6 pt -51.62 -31.13 12.27 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.457 0 CA-C-O 123.228 1.49 . . . . 1.0 109.717 179.502 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 113' ' ' ASN . . . . . 0.486 ' N ' HG13 ' A' ' 112' ' ' ILE . 0.0 OUTLIER -52.87 -52.58 56.85 Favored 'General case' 0 C--N 1.301 -1.511 0 CA-C-N 112.077 -2.329 . . . . 1.0 107.746 -177.858 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 114' ' ' ALA . . . . . 0.437 ' O ' HG23 ' A' ' 118' ' ' VAL . . . -60.09 -32.64 71.16 Favored 'General case' 0 N--CA 1.442 -0.848 0 N-CA-C 112.182 0.438 . . . . 1.0 112.182 179.625 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -81.27 -57.19 3.61 Favored 'General case' 0 C--O 1.215 -0.751 0 CA-C-O 121.499 0.666 . . . . 1.0 111.702 178.732 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 116' ' ' ILE . . . . . 0.529 ' O ' ' N ' ' A' ' 120' ' ' GLY . 3.4 mm -51.72 -57.86 2.94 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.715 0 CA-C-O 122.479 1.133 . . . . 1.0 108.043 -177.907 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 117' ' ' GLU . . . . . 0.537 ' O ' ' HA ' ' A' ' 121' ' ' THR . 6.5 mt-10 -40.15 -53.17 2.5 Favored 'General case' 0 C--N 1.315 -0.919 0 CA-C-N 112.285 -2.234 . . . . 1.0 105.927 -178.29 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 118' ' ' VAL . . . . . 0.437 HG23 ' O ' ' A' ' 114' ' ' ALA . 78.0 t -60.26 -52.04 65.91 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.608 0 C-N-CA 119.459 -0.896 . . . . 1.0 109.065 177.261 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 119' ' ' LEU . . . . . 0.488 ' N ' ' O ' ' A' ' 116' ' ' ILE . 0.9 OUTLIER -58.39 -70.31 0.15 Allowed 'General case' 0 N--CA 1.454 -0.253 0 C-N-CA 119.209 -0.997 . . . . 1.0 108.387 -177.656 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 120' ' ' GLY . . . . . 0.613 ' O ' ' OG1' ' A' ' 121' ' ' THR . . . -66.19 -84.99 0.08 OUTLIER Glycine 0 C--N 1.351 1.362 0 C-N-CA 118.127 -1.987 . . . . 1.0 109.159 178.41 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 121' ' ' THR . . . . . 0.613 ' OG1' ' O ' ' A' ' 120' ' ' GLY . 18.5 m 160.46 -34.55 0.0 OUTLIER 'General case' 0 N--CA 1.482 1.164 0 O-C-N 125.373 1.278 . . . . 1.0 112.858 179.421 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 122' ' ' GLY . . . . . 0.643 ' O ' ' N ' ' A' ' 124' ' ' ASP . . . 105.64 -14.19 46.31 Favored Glycine 0 N--CA 1.461 0.313 0 N-CA-C 107.285 -2.326 . . . . 1.0 107.285 -175.832 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 123' ' ' THR . . . . . 0.44 ' OG1' ' CG2' ' A' ' 121' ' ' THR . 2.8 m -54.89 82.39 0.0 OUTLIER 'General case' 0 N--CA 1.465 0.311 0 N-CA-C 106.037 -1.838 . . . . 1.0 106.037 178.59 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 124' ' ' ASP . . . . . 0.643 ' N ' ' O ' ' A' ' 122' ' ' GLY . 18.2 t70 -164.29 170.34 16.33 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 114.057 -1.429 . . . . 1.0 112.117 -179.338 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 125' ' ' TYR . . . . . . . . . . . . . 33.5 t80 -151.32 149.01 28.85 Favored 'General case' 0 CA--C 1.535 0.391 0 CA-C-N 115.637 -0.71 . . . . 1.0 109.937 177.298 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 14.6 tpp180 -149.13 150.08 32.1 Favored 'General case' 0 CA--C 1.532 0.283 0 CA-C-N 115.792 -0.64 . . . . 1.0 110.169 177.785 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 127' ' ' PHE . . . . . 0.559 ' H ' HD12 ' A' ' 79' ' ' ILE . 20.4 t80 . . . . . 0 C--O 1.22 -0.469 0 CA-C-O 118.036 -0.983 . . . . 1.0 109.366 178.687 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 128' ' ' MTN . . . . . 0.661 ' H91' ' NH1' ' A' ' 47' ' ' ARG . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 129' ' ' MTN . . . . . 0.621 ' H83' ' O ' ' A' ' 48' ' ' CYS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 130' ' ' MTN . . . . . 0.601 ' H61' ' S1 ' ' A' ' 130' ' ' MTN . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 62.1 mtt . . . . . 0 N--CA 1.489 1.509 0 N-CA-C 108.961 -0.755 . . . . 1.0 108.961 . . . . . . . . . 0 0 . 1 . 024 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . 0.458 ' O ' ' CB ' ' A' ' 3' ' ' ASP . 91.4 p -93.78 10.29 33.64 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.19 -0.459 . . . . 1.0 110.692 -179.793 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . 0.458 ' CB ' ' O ' ' A' ' 2' ' ' SER . 7.1 m-20 157.62 111.34 0.0 OUTLIER 'General case' 0 N--CA 1.471 0.618 0 O-C-N 123.82 0.7 . . . . 1.0 110.256 178.643 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 60.6 t80 -153.66 149.19 27.29 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-N 116.263 -0.426 . . . . 1.0 110.743 179.792 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 5' ' ' ASP . . . . . 0.528 ' N ' ' OD1' ' A' ' 5' ' ' ASP . 0.3 OUTLIER -155.31 150.77 27.22 Favored 'General case' 0 CA--C 1.533 0.312 0 CA-C-N 116.373 -0.376 . . . . 1.0 110.874 -179.057 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 6' ' ' THR . . . . . 0.564 HG22 ' H ' ' A' ' 7' ' ' GLU . 0.2 OUTLIER -61.38 -158.29 0.01 OUTLIER 'General case' 0 N--CA 1.464 0.264 0 C-N-CA 120.762 -0.375 . . . . 1.0 110.637 -179.532 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . 0.564 ' H ' HG22 ' A' ' 6' ' ' THR . 42.8 tt0 -74.34 -66.49 0.72 Allowed 'General case' 0 CA--C 1.502 -0.894 0 C-N-CA 120.699 -0.4 . . . . 1.0 110.047 -178.95 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 8' ' ' ARG . . . . . 0.534 ' O ' ' CB ' ' A' ' 12' ' ' ALA . 13.0 ttm105 -52.54 -44.98 66.16 Favored 'General case' 0 N--CA 1.437 -1.123 0 N-CA-C 112.432 0.53 . . . . 1.0 112.432 -177.057 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . 0.663 ' O ' HG22 ' A' ' 13' ' ' VAL . 97.7 t -64.78 -51.12 71.2 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.148 0 C-N-CA 117.986 -1.486 . . . . 1.0 109.212 179.284 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 34.3 t -63.49 -40.73 97.85 Favored 'General case' 0 N--CA 1.474 0.749 0 N-CA-C 114.355 1.243 . . . . 1.0 114.355 -179.066 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 11' ' ' ARG . . . . . 0.544 ' O ' ' N ' ' A' ' 15' ' ' ALA . 59.3 ttm-85 -80.16 -54.92 5.31 Favored 'General case' 0 CA--C 1.536 0.442 0 CA-C-O 122.714 1.245 . . . . 1.0 109.732 178.047 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . 0.716 ' O ' ' HB3' ' A' ' 16' ' ' ALA . . . -46.26 -48.59 17.96 Favored 'General case' 0 N--CA 1.483 1.213 0 CA-C-N 112.907 -1.951 . . . . 1.0 106.14 -176.218 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . 0.663 HG22 ' O ' ' A' ' 9' ' ' VAL . 34.0 m -60.63 -52.45 61.34 Favored 'Isoleucine or valine' 0 C--O 1.197 -1.663 0 C-N-CA 116.873 -1.931 . . . . 1.0 108.046 176.757 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . 0.715 ' O ' HG13 ' A' ' 18' ' ' VAL . . . -58.53 -64.59 0.87 Allowed 'General case' 0 N--CA 1.472 0.632 0 C-N-CA 118.428 -1.309 . . . . 1.0 111.736 179.911 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . 0.563 ' O ' ' N ' ' A' ' 19' ' ' GLY . . . -53.19 -55.99 19.91 Favored 'General case' 0 N--CA 1.475 0.802 0 CA-C-O 121.731 0.777 . . . . 1.0 110.161 -177.55 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . 0.716 ' HB3' ' O ' ' A' ' 12' ' ' ALA . . . -63.96 -53.84 43.92 Favored 'General case' 0 C--N 1.311 -1.098 0 CA-C-N 114.56 -1.2 . . . . 1.0 109.066 -178.985 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . 0.636 ' CB ' ' O ' ' A' ' 13' ' ' VAL . 33.0 tp -56.83 -53.73 54.48 Favored 'General case' 0 N--CA 1.484 1.232 0 C-N-CA 119.047 -1.061 . . . . 1.0 108.637 -177.505 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . 0.715 HG13 ' O ' ' A' ' 14' ' ' ALA . 1.7 m -69.94 -57.44 8.19 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.457 0 C-N-CA 119.778 -0.769 . . . . 1.0 110.032 179.515 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . 0.563 ' N ' ' O ' ' A' ' 15' ' ' ALA . . . -64.93 -172.76 3.36 Favored Glycine 0 CA--C 1.526 0.761 0 N-CA-C 110.816 -0.914 . . . . 1.0 110.816 -179.532 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 20' ' ' PRO . . . . . 0.587 ' O ' ' N ' ' A' ' 24' ' ' ALA . 6.0 Cg_exo -76.46 -22.95 11.9 Favored 'Trans proline' 0 N--CA 1.503 2.036 0 C-N-CA 123.481 2.787 . . . . 1.0 114.651 -178.442 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -59.82 -57.73 17.89 Favored Glycine 0 N--CA 1.475 1.264 0 C-N-CA 119.576 -1.297 . . . . 1.0 111.831 -176.505 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . 0.572 ' CA ' ' HB1' ' A' ' 16' ' ' ALA . . . -58.24 -55.51 30.28 Favored Glycine 0 N--CA 1.464 0.547 0 N-CA-C 108.07 -2.012 . . . . 1.0 108.07 -177.249 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . 0.532 ' CG2' ' O ' ' A' ' 19' ' ' GLY . 0.0 OUTLIER -61.5 -35.34 66.19 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.137 0 CA-C-N 114.918 -0.641 . . . . 1.0 109.771 -179.963 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . 0.587 ' N ' ' O ' ' A' ' 20' ' ' PRO . . . -54.6 -60.84 2.81 Favored 'General case' 0 CA--C 1.537 0.462 0 C-N-CA 118.223 -1.391 . . . . 1.0 108.893 -179.989 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 15.1 tp -63.01 -45.23 93.36 Favored 'General case' 0 C--N 1.341 0.229 0 CA-C-N 118.386 0.539 . . . . 1.0 112.192 -179.302 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 82.0 t -59.86 -60.02 3.13 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.227 0 C-N-CA 118.664 -1.215 . . . . 1.0 110.052 -177.138 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . 0.431 ' O ' ' HB3' ' A' ' 31' ' ' ALA . 2.6 t -59.19 -37.39 68.33 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.309 0 N-CA-C 112.024 0.379 . . . . 1.0 112.024 -178.341 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 25.2 tttm -65.25 -54.43 29.39 Favored 'General case' 0 C--N 1.319 -0.727 0 C-N-CA 119.936 -0.705 . . . . 1.0 109.275 -179.121 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 43.4 t -63.38 -47.1 93.42 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.993 0 CA-C-N 114.719 -1.128 . . . . 1.0 110.603 -178.332 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 30' ' ' CYS . . . . . 0.521 ' SG ' ' N ' ' A' ' 31' ' ' ALA . 0.0 OUTLIER -67.61 -61.09 2.06 Favored 'General case' 0 CA--C 1.533 0.3 0 C-N-CA 118.474 -1.29 . . . . 1.0 110.152 -179.714 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . 0.521 ' N ' ' SG ' ' A' ' 30' ' ' CYS . . . -64.3 -53.68 45.13 Favored 'General case' 0 CA--C 1.514 -0.429 0 N-CA-C 113.893 1.071 . . . . 1.0 113.893 -176.014 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 82.26 72.37 1.26 Allowed Glycine 0 CA--C 1.528 0.902 0 N-CA-C 109.018 -1.633 . . . . 1.0 109.018 -177.056 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . 0.445 ' O ' ' O ' ' A' ' 36' ' ' VAL . 2.9 mt 85.86 86.05 0.05 OUTLIER Pre-proline 0 N--CA 1.476 0.856 0 C-N-CA 123.409 0.683 . . . . 1.0 111.447 -179.788 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 52.7 Cg_exo -56.98 -26.76 69.93 Favored 'Trans proline' 0 N--CA 1.506 2.223 0 C-N-CA 123.366 2.71 . . . . 1.0 113.517 179.251 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -54.92 -57.0 20.15 Favored Glycine 0 CA--C 1.521 0.424 0 N-CA-C 108.224 -1.95 . . . . 1.0 108.224 -179.355 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . 0.537 ' O ' ' CB ' ' A' ' 37' ' ' ILE . 14.5 p -97.07 163.01 2.51 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 N-CA-C 107.521 -1.289 . . . . 1.0 107.521 177.755 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . 0.537 ' CB ' ' O ' ' A' ' 36' ' ' VAL . 3.7 mm 122.12 116.54 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.484 1.267 0 O-C-N 124.4 1.062 . . . . 1.0 109.499 -179.322 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 38' ' ' HIS . . . . . 0.405 ' CD2' ' N ' ' A' ' 38' ' ' HIS . 0.0 OUTLIER -138.63 129.29 26.29 Favored 'General case' 0 C--N 1.329 -0.286 0 N-CA-C 107.55 -1.278 . . . . 1.0 107.55 178.704 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -95.95 154.07 39.06 Favored Pre-proline 0 N--CA 1.467 0.391 0 N-CA-C 109.87 -0.419 . . . . 1.0 109.87 -179.435 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 97.6 Cg_endo -77.52 -42.27 0.29 Allowed 'Trans proline' 0 C--N 1.311 -1.4 0 C-N-CA 122.25 1.966 . . . . 1.0 113.787 -179.101 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -125.2 131.58 53.15 Favored 'General case' 0 N--CA 1.466 0.351 0 CA-C-O 119.626 -0.226 . . . . 1.0 110.464 179.313 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . 0.629 ' C ' ' H ' ' A' ' 44' ' ' GLY . 0.4 OUTLIER -166.96 163.72 16.06 Favored 'General case' 0 C--N 1.326 -0.435 0 C-N-CA 119.756 -0.778 . . . . 1.0 110.433 178.037 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 43' ' ' ARG . . . . . 0.462 ' C ' ' H ' ' A' ' 45' ' ' PHE . 3.3 tpt85 -63.87 22.09 0.01 OUTLIER 'General case' 0 CA--C 1.538 0.505 0 CA-C-N 115.857 -0.61 . . . . 1.0 111.088 -179.204 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . 0.629 ' H ' ' C ' ' A' ' 42' ' ' ARG . . . 71.63 -27.92 0.61 Allowed Glycine 0 CA--C 1.527 0.819 0 N-CA-C 111.745 -0.542 . . . . 1.0 111.745 179.705 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . 0.485 ' O ' ' HB2' ' A' ' 46' ' ' PHE . 20.9 t80 -151.34 149.68 29.62 Favored 'General case' 0 C--O 1.218 -0.587 0 CA-C-N 117.166 0.483 . . . . 1.0 109.741 -179.258 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 46' ' ' PHE . . . . . 0.555 ' O ' ' CG ' ' A' ' 47' ' ' ARG . 1.8 m-85 141.14 83.66 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.836 0 C-N-CA 124.378 1.071 . . . . 1.0 109.736 179.154 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 47' ' ' ARG . . . . . 0.555 ' CG ' ' O ' ' A' ' 46' ' ' PHE . 3.9 mmp_? 137.63 134.44 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.51 0 C-N-CA 123.715 0.806 . . . . 1.0 109.186 179.489 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 48' ' ' CYS . . . . . 0.471 ' SG ' ' C ' ' A' ' 47' ' ' ARG . 2.0 m 77.22 69.45 0.05 Allowed 'General case' 0 C--O 1.218 -0.572 0 CA-C-N 118.409 0.549 . . . . 1.0 110.195 179.785 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -114.6 147.86 39.04 Favored Pre-proline 0 N--CA 1.464 0.265 0 O-C-N 120.748 -1.22 . . . . 1.0 108.864 179.543 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -73.02 59.26 3.58 Favored 'Trans proline' 0 C--N 1.308 -1.58 0 C-N-CA 121.836 1.691 . . . . 1.0 111.101 -179.975 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 22.7 mm-40 58.8 59.33 2.89 Favored 'General case' 0 N--CA 1.454 -0.259 0 CA-C-N 116.25 -0.432 . . . . 1.0 111.074 179.453 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 16.6 ptt180 -146.13 178.72 8.01 Favored 'General case' 0 N--CA 1.466 0.359 0 CA-C-N 116.24 -0.437 . . . . 1.0 110.377 179.724 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . 0.771 HD12 ' N ' ' A' ' 54' ' ' GLN . 0.1 OUTLIER -86.61 138.61 18.74 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.334 0 CA-C-O 121.655 0.741 . . . . 1.0 110.484 179.671 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 54' ' ' GLN . . . . . 0.771 ' N ' HD12 ' A' ' 53' ' ' ILE . 0.0 OUTLIER -62.34 82.84 0.02 OUTLIER 'General case' 0 C--N 1.319 -0.742 0 CA-C-N 114.701 -1.136 . . . . 1.0 109.033 -177.961 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . 0.438 ' N ' ' O ' ' A' ' 53' ' ' ILE . 21.2 tt -149.48 158.23 6.17 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.457 0 CA-C-N 115.858 -0.61 . . . . 1.0 110.611 178.156 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 109.31 -5.97 31.89 Favored Glycine 0 N--CA 1.473 1.129 0 N-CA-C 110.95 -0.86 . . . . 1.0 110.95 -179.969 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 13.1 p-10 -77.94 100.78 6.56 Favored 'General case' 0 C--N 1.323 -0.563 0 N-CA-C 109.026 -0.731 . . . . 1.0 109.026 178.751 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 58' ' ' TRP . . . . . 0.47 ' H ' ' CD ' ' A' ' 61' ' ' GLU . 0.3 OUTLIER -88.75 174.75 7.83 Favored 'General case' 0 CA--C 1.542 0.656 0 CA-C-O 123.18 1.466 . . . . 1.0 113.364 -177.625 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 9.0 mtm180 -80.5 -59.32 2.74 Favored 'General case' 0 C--N 1.315 -0.899 0 CA-C-N 111.416 -2.629 . . . . 1.0 113.418 -178.381 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 1.2 p90 -88.67 -10.03 49.97 Favored 'General case' 0 C--O 1.248 1.012 0 CA-C-N 114.81 -1.086 . . . . 1.0 113.573 -177.673 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . 0.513 ' O ' ' N ' ' A' ' 65' ' ' ASP . 13.5 pt-20 -71.8 -14.26 61.93 Favored 'General case' 0 C--N 1.313 -0.991 0 N-CA-C 113.198 0.814 . . . . 1.0 113.198 -177.767 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . 0.623 ' O ' ' N ' ' A' ' 66' ' ' GLY . 0.1 OUTLIER -48.72 -58.94 0.97 Allowed 'Isoleucine or valine' 0 C--O 1.204 -1.293 0 C-N-CA 119.195 -1.002 . . . . 1.0 108.5 -174.317 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -66.33 -56.67 10.02 Favored 'General case' 0 C--N 1.295 -1.799 0 O-C-N 121.797 -0.564 . . . . 1.0 110.867 -179.325 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 64' ' ' HIS . . . . . 0.56 ' O ' ' HB2' ' A' ' 67' ' ' ARG . 67.3 m-70 -53.39 -56.36 17.42 Favored 'General case' 0 N--CA 1.465 0.312 0 C-N-CA 119.148 -1.021 . . . . 1.0 109.59 -179.247 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . 0.609 ' C ' ' H ' ' A' ' 67' ' ' ARG . 10.0 t0 -77.63 -50.9 11.54 Favored 'General case' 0 C--N 1.312 -1.032 0 O-C-N 121.889 -0.507 . . . . 1.0 111.667 179.984 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . 0.623 ' N ' ' O ' ' A' ' 62' ' ' VAL . . . -71.83 26.84 0.63 Allowed Glycine 0 CA--C 1.524 0.655 0 O-C-N 120.608 -1.307 . . . . 1.0 110.412 178.042 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 67' ' ' ARG . . . . . 0.613 ' O ' ' N ' ' A' ' 69' ' ' LEU . 4.1 tpt85 -74.93 4.38 6.64 Favored 'General case' 0 N--CA 1.448 -0.566 0 N-CA-C 107.183 -1.414 . . . . 1.0 107.183 176.074 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . 0.493 ' H ' ' C ' ' A' ' 66' ' ' GLY . 12.9 mt -33.55 -28.13 0.01 OUTLIER 'General case' 0 N--CA 1.475 0.79 0 CA-C-N 114.687 -1.142 . . . . 1.0 108.871 -177.622 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . 0.613 ' N ' ' O ' ' A' ' 67' ' ' ARG . 3.0 tt -65.86 -66.03 0.6 Allowed 'General case' 0 CA--C 1.546 0.821 0 C-N-CA 119.293 -0.963 . . . . 1.0 110.085 -179.17 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . 0.64 ' C ' ' H ' ' A' ' 72' ' ' HIS . . . -79.1 -78.36 0.15 Allowed 'General case' 0 N--CA 1.475 0.819 0 C-N-CA 118.766 -1.174 . . . . 1.0 108.439 -179.842 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . 0.785 ' HB1' ' HB ' ' A' ' 74' ' ' VAL . . . -50.32 9.53 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.285 0 C-N-CA 125.651 1.581 . . . . 1.0 113.005 179.342 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 72' ' ' HIS . . . . . 0.973 ' CD2' ' H ' ' A' ' 73' ' ' MET . 0.3 OUTLIER -24.21 -58.75 0.05 Allowed 'General case' 0 C--N 1.33 -0.247 0 N-CA-C 113.765 1.024 . . . . 1.0 113.765 -177.197 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 73' ' ' MET . . . . . 0.973 ' H ' ' CD2' ' A' ' 72' ' ' HIS . 95.0 mtp -68.94 -45.99 69.34 Favored 'General case' 0 C--N 1.319 -0.746 0 C-N-CA 119.604 -0.838 . . . . 1.0 109.145 179.34 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . 0.785 ' HB ' ' HB1' ' A' ' 71' ' ' ALA . 39.2 t -45.26 -43.92 3.3 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.255 0 CA-C-O 117.658 -1.163 . . . . 1.0 111.685 -176.365 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 75' ' ' ASN . . . . . 0.702 HD21 HH22 ' A' ' 126' ' ' ARG . 0.7 OUTLIER -39.6 -11.14 0.01 OUTLIER 'General case' 0 C--N 1.362 1.134 0 CA-C-N 121.05 1.75 . . . . 1.0 111.419 178.994 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . 0.719 ' N ' ' O ' ' A' ' 74' ' ' VAL . . . -42.12 -27.3 0.41 Allowed Glycine 0 CA--C 1.536 1.384 0 N-CA-C 107.301 -2.32 . . . . 1.0 107.301 177.988 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . 0.668 ' HA ' ' HB3' ' A' ' 80' ' ' ALA . 7.1 pt -68.76 -49.45 64.09 Favored 'Isoleucine or valine' 0 C--O 1.212 -0.881 0 N-CA-C 108.663 -0.866 . . . . 1.0 108.663 176.653 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . 0.636 ' N ' ' O ' ' A' ' 75' ' ' ASN . 2.0 p -32.35 -39.09 0.04 OUTLIER 'Isoleucine or valine' 0 CA--C 1.545 0.769 0 N-CA-C 108.846 -0.798 . . . . 1.0 108.846 -176.369 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . 0.566 HG23 HG13 ' A' ' 78' ' ' VAL . 2.9 pp -97.71 -24.72 4.28 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.709 0 CA-C-O 121.153 0.501 . . . . 1.0 110.751 178.041 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 80' ' ' ALA . . . . . 0.668 ' HB3' ' HA ' ' A' ' 77' ' ' ILE . . . -86.98 -10.37 53.36 Favored 'General case' 0 CA--C 1.551 1.014 0 N-CA-C 113.381 0.882 . . . . 1.0 113.381 177.568 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . 0.596 ' N ' ' O ' ' A' ' 77' ' ' ILE . 81.9 tt0 -87.65 -71.22 0.58 Allowed 'General case' 0 N--CA 1.445 -0.699 0 CA-C-N 118.942 0.792 . . . . 1.0 109.426 -179.826 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 82' ' ' ASP . . . . . 0.648 ' O ' ' N ' ' A' ' 84' ' ' LEU . 0.7 OUTLIER -70.32 -11.63 61.04 Favored 'General case' 0 N--CA 1.444 -0.733 0 CA-C-N 119.109 0.868 . . . . 1.0 110.294 179.069 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . 0.805 ' O ' ' N ' ' A' ' 86' ' ' ALA . . . -18.79 -43.22 0.0 OUTLIER 'General case' 0 C--O 1.197 -1.668 0 O-C-N 124.072 0.858 . . . . 1.0 111.804 177.941 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . 0.648 ' N ' ' O ' ' A' ' 82' ' ' ASP . 19.1 mt -26.72 -30.55 0.0 OUTLIER 'General case' 0 N--CA 1.472 0.664 0 O-C-N 121.901 -0.5 . . . . 1.0 111.902 -175.801 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 85' ' ' ILE . . . . . 0.714 ' N ' ' O ' ' A' ' 83' ' ' ALA . 0.1 OUTLIER -98.57 -31.33 3.64 Favored 'Isoleucine or valine' 0 CA--C 1.551 1.009 0 N-CA-C 109.541 -0.54 . . . . 1.0 109.541 175.42 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . 0.805 ' N ' ' O ' ' A' ' 83' ' ' ALA . . . -91.89 -27.33 17.99 Favored 'General case' 0 N--CA 1.486 1.352 0 CA-C-O 121.897 0.856 . . . . 1.0 112.652 179.063 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . 0.604 ' N ' ' O ' ' A' ' 83' ' ' ALA . 3.3 pt-20 -47.33 -28.55 2.06 Favored 'General case' 0 C--N 1.313 -1.008 0 CA-C-N 114.089 -1.414 . . . . 1.0 109.963 -178.859 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -141.7 24.99 2.02 Favored 'General case' 0 N--CA 1.475 0.8 0 CA-C-O 121.585 0.707 . . . . 1.0 111.118 -178.99 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 89' ' ' VAL . . . . . 0.693 HG22 ' HB3' ' A' ' 92' ' ' HIS . 4.8 p -75.62 36.38 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.315 -0.921 0 CA-C-N 114.905 -1.043 . . . . 1.0 109.518 178.423 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 90' ' ' GLY . . . . . 0.529 ' O ' ' N ' ' A' ' 92' ' ' HIS . . . -66.77 -39.87 93.67 Favored Glycine 0 N--CA 1.439 -1.129 0 C-N-CA 119.055 -1.545 . . . . 1.0 111.138 178.693 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 91' ' ' PRO . . . . . 0.522 ' CD ' ' N ' ' A' ' 90' ' ' GLY . 95.8 Cg_exo -43.78 -20.1 0.23 Allowed 'Trans proline' 0 N--CA 1.49 1.293 0 CA-C-N 119.897 1.848 . . . . 1.0 110.003 179.777 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 92' ' ' HIS . . . . . 0.693 ' HB3' HG22 ' A' ' 89' ' ' VAL . 7.7 p-80 -60.65 -25.84 66.62 Favored 'General case' 0 C--O 1.218 -0.599 0 CA-C-N 114.724 -1.126 . . . . 1.0 109.396 179.649 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . 0.663 HD12 ' N ' ' A' ' 94' ' ' ALA . 2.2 pp -63.47 -58.7 6.2 Favored 'General case' 0 C--N 1.325 -0.494 0 N-CA-C 108.353 -0.98 . . . . 1.0 108.353 178.451 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 94' ' ' ALA . . . . . 0.663 ' N ' HD12 ' A' ' 93' ' ' LEU . . . -56.23 -55.93 27.2 Favored 'General case' 0 N--CA 1.452 -0.369 0 N-CA-C 109.26 -0.645 . . . . 1.0 109.26 179.096 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 95' ' ' ARG . . . . . 0.613 ' O ' ' N ' ' A' ' 97' ' ' LEU . 10.8 ttp180 -59.07 -61.04 2.94 Favored 'General case' 0 C--O 1.239 0.542 0 CA-C-O 122.333 1.064 . . . . 1.0 108.819 179.586 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 96' ' ' ALA . . . . . 0.871 ' O ' ' N ' ' A' ' 98' ' ' GLY . . . -47.68 -12.51 0.03 OUTLIER 'General case' 0 C--N 1.306 -1.319 0 O-C-N 118.56 -2.587 . . . . 1.0 112.072 -179.154 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . 0.829 HD12 ' N ' ' A' ' 98' ' ' GLY . 3.5 pp 5.34 -52.53 0.0 OUTLIER 'General case' 0 C--O 1.204 -1.328 0 CA-C-O 116.767 -1.587 . . . . 1.0 111.262 -166.595 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 98' ' ' GLY . . . . . 0.871 ' N ' ' O ' ' A' ' 96' ' ' ALA . . . -47.22 -24.14 2.13 Favored Glycine 0 C--N 1.303 -1.301 0 CA-C-N 123.381 2.809 . . . . 1.0 107.473 176.018 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 99' ' ' GLN . . . . . 0.524 ' HG2' ' HB1' ' A' ' 96' ' ' ALA . 57.5 mm-40 -64.44 -17.99 64.33 Favored 'General case' 0 C--N 1.361 1.098 0 C-N-CA 117.415 -1.714 . . . . 1.0 107.424 176.049 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 100' ' ' ILE . . . . . 0.799 ' N ' ' O ' ' A' ' 97' ' ' LEU . 12.1 tt -64.67 -44.75 96.63 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.629 0 N-CA-C 107.87 -1.159 . . . . 1.0 107.87 177.881 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 101' ' ' VAL . . . . . 0.801 ' O ' ' N ' ' A' ' 105' ' ' GLY . 68.9 t -60.14 -61.06 1.67 Allowed 'Isoleucine or valine' 0 C--O 1.209 -1.059 0 N-CA-C 107.585 -1.265 . . . . 1.0 107.585 179.499 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 102' ' ' CYS . . . . . 0.888 ' O ' ' HB2' ' A' ' 106' ' ' ALA . 0.5 OUTLIER -44.21 -19.02 0.02 OUTLIER 'General case' 0 C--N 1.319 -0.732 0 CA-C-O 121.399 0.619 . . . . 1.0 110.988 -179.458 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 103' ' ' ARG . . . . . 0.518 ' N ' ' O ' ' A' ' 101' ' ' VAL . 12.1 ttp-105 -95.44 -43.96 7.75 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-O 122.034 0.921 . . . . 1.0 111.889 177.383 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 104' ' ' TYR . . . . . 0.709 ' O ' ' CG ' ' A' ' 104' ' ' TYR . 0.1 OUTLIER -107.43 19.16 20.65 Favored 'General case' 0 CA--C 1.552 1.038 0 C-N-CA 126.628 1.971 . . . . 1.0 110.619 178.477 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 105' ' ' GLY . . . . . 0.801 ' N ' ' O ' ' A' ' 101' ' ' VAL . . . -162.64 -10.89 0.03 OUTLIER Glycine 0 C--N 1.332 0.324 0 C-N-CA 118.898 -1.62 . . . . 1.0 112.514 179.785 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 106' ' ' ALA . . . . . 0.888 ' HB2' ' O ' ' A' ' 102' ' ' CYS . . . -29.81 118.7 0.15 Allowed 'General case' 0 N--CA 1.463 0.219 0 CA-C-N 117.017 0.408 . . . . 1.0 110.081 179.391 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 107' ' ' THR . . . . . 0.798 ' O ' ' HD2' ' A' ' 110' ' ' PRO . 10.7 m -133.98 -62.48 0.76 Allowed 'General case' 0 C--O 1.192 -1.951 0 N-CA-C 105.542 -2.021 . . . . 1.0 105.542 178.042 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 26.1 m -61.89 28.57 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.309 -1.181 0 O-C-N 121.034 -1.041 . . . . 1.0 110.194 -179.878 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 109' ' ' ILE . . . . . 0.666 HG21 ' HB1' ' A' ' 106' ' ' ALA . 0.1 OUTLIER -111.81 -42.98 0.09 OUTLIER Pre-proline 0 C--N 1.372 1.545 0 CA-C-N 119.634 1.107 . . . . 1.0 111.381 177.575 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 110' ' ' PRO . . . . . 0.798 ' HD2' ' O ' ' A' ' 107' ' ' THR . 31.3 Cg_exo -65.1 -28.49 56.83 Favored 'Trans proline' 0 N--CA 1.499 1.799 0 C-N-CA 122.457 2.105 . . . . 1.0 111.869 -179.569 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 111' ' ' ASN . . . . . 0.437 ' C ' ' N ' ' A' ' 113' ' ' ASN . 0.1 OUTLIER -69.12 -69.08 0.36 Allowed 'General case' 0 CA--C 1.538 0.49 0 C-N-CA 119.687 -0.805 . . . . 1.0 109.851 -179.242 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 112' ' ' ILE . . . . . 0.5 ' O ' ' N ' ' A' ' 116' ' ' ILE . 13.1 pt -47.8 -28.29 1.57 Allowed 'Isoleucine or valine' 0 C--O 1.214 -0.785 0 CA-C-O 123.414 1.578 . . . . 1.0 108.531 179.593 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 113' ' ' ASN . . . . . 0.558 ' ND2' ' OE2' ' A' ' 117' ' ' GLU . 0.1 OUTLIER -56.85 -52.74 63.91 Favored 'General case' 0 C--N 1.293 -1.864 0 CA-C-N 111.526 -2.579 . . . . 1.0 106.906 -178.935 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 114' ' ' ALA . . . . . 0.559 ' O ' HG23 ' A' ' 118' ' ' VAL . . . -62.37 -35.04 77.9 Favored 'General case' 0 C--N 1.322 -0.595 0 N-CA-C 112.842 0.682 . . . . 1.0 112.842 -179.914 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -82.8 -56.25 3.94 Favored 'General case' 0 C--O 1.21 -1.002 0 CA-C-N 119.486 1.039 . . . . 1.0 110.538 178.503 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 116' ' ' ILE . . . . . 0.541 ' O ' ' N ' ' A' ' 120' ' ' GLY . 50.8 mt -48.74 -60.88 0.61 Allowed 'Isoleucine or valine' 0 N--CA 1.478 0.954 0 CA-C-O 122.522 1.153 . . . . 1.0 108.107 -179.208 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 117' ' ' GLU . . . . . 0.558 ' OE2' ' ND2' ' A' ' 113' ' ' ASN . 91.5 mt-10 -42.67 -53.56 4.42 Favored 'General case' 0 C--N 1.313 -0.988 0 CA-C-N 112.488 -2.142 . . . . 1.0 107.17 -178.761 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 118' ' ' VAL . . . . . 0.559 HG23 ' O ' ' A' ' 114' ' ' ALA . 69.1 t -60.72 -54.84 29.75 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.516 0 N-CA-C 109.143 -0.688 . . . . 1.0 109.143 177.281 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 3.3 tp -53.49 -71.66 0.07 Allowed 'General case' 0 N--CA 1.464 0.234 0 N-CA-C 108.038 -1.097 . . . . 1.0 108.038 -179.424 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 120' ' ' GLY . . . . . 0.541 ' N ' ' O ' ' A' ' 116' ' ' ILE . . . -66.62 -85.37 0.09 OUTLIER Glycine 0 CA--C 1.533 1.21 0 C-N-CA 118.567 -1.777 . . . . 1.0 110.063 179.369 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 121' ' ' THR . . . . . 0.419 HG23 ' H ' ' A' ' 123' ' ' THR . 1.6 t 168.67 -39.9 0.0 OUTLIER 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 112.633 -1.783 . . . . 1.0 112.756 -179.802 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 122' ' ' GLY . . . . . 0.619 ' O ' ' N ' ' A' ' 124' ' ' ASP . . . 100.99 -18.72 54.32 Favored Glycine 0 N--CA 1.469 0.856 0 N-CA-C 107.037 -2.425 . . . . 1.0 107.037 -176.884 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 123' ' ' THR . . . . . 0.419 ' H ' HG23 ' A' ' 121' ' ' THR . 25.5 m -51.63 86.71 0.0 OUTLIER 'General case' 0 N--CA 1.471 0.617 0 CA-C-N 111.884 -2.158 . . . . 1.0 105.463 178.261 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 124' ' ' ASP . . . . . 0.619 ' N ' ' O ' ' A' ' 122' ' ' GLY . 9.5 m-20 -160.3 165.1 31.95 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 114.372 -1.285 . . . . 1.0 112.062 -178.305 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 125' ' ' TYR . . . . . 0.576 ' O ' ' NH2' ' A' ' 126' ' ' ARG . 0.0 OUTLIER -151.13 146.98 26.51 Favored 'General case' 0 CA--C 1.541 0.61 0 N-CA-C 108.92 -0.771 . . . . 1.0 108.92 177.901 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 126' ' ' ARG . . . . . 0.702 HH22 HD21 ' A' ' 75' ' ' ASN . 0.1 OUTLIER -148.01 150.58 34.23 Favored 'General case' 0 CA--C 1.541 0.613 0 CA-C-N 115.762 -0.654 . . . . 1.0 109.718 177.453 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 127' ' ' PHE . . . . . . . . . . . . . 85.8 t80 . . . . . 0 N--CA 1.468 0.459 0 CA-C-O 118.011 -0.995 . . . . 1.0 110.726 178.918 . . . . . . . . 0 0 . 1 . 024 nuclear nobuild full ' A' A ' 128' ' ' MTN . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 024 nuclear nobuild full ' A' A ' 129' ' ' MTN . . . . . 0.467 ' H83' ' O ' ' A' ' 48' ' ' CYS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 130' ' ' MTN . . . . . 0.622 ' S1 ' ' H71' ' A' ' 130' ' ' MTN . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.492 ' SD ' ' CB ' ' A' ' 4' ' ' PHE . 19.6 mtp . . . . . 0 N--CA 1.492 1.63 0 N-CA-C 108.179 -1.045 . . . . 1.0 108.179 . . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . 0.423 ' O ' ' CG ' ' A' ' 3' ' ' ASP . 88.6 p -107.7 7.87 28.68 Favored 'General case' 0 N--CA 1.468 0.452 0 CA-C-O 120.705 0.288 . . . . 1.0 110.412 -179.753 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . 0.423 ' CG ' ' O ' ' A' ' 2' ' ' SER . 12.1 m-20 168.35 94.25 0.0 OUTLIER 'General case' 0 N--CA 1.47 0.557 0 CA-C-N 115.469 -0.787 . . . . 1.0 110.468 179.014 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . 0.492 ' CB ' ' SD ' ' A' ' 1' ' ' MET . 37.9 t80 -149.8 145.56 26.68 Favored 'General case' 0 CA--C 1.517 -0.326 0 CA-C-N 116.212 -0.449 . . . . 1.0 110.516 179.501 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 61.5 m-20 -154.75 151.01 28.19 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 121.134 0.492 . . . . 1.0 110.007 179.763 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 6' ' ' THR . . . . . 0.644 ' O ' ' N ' ' A' ' 10' ' ' SER . 0.2 OUTLIER -67.17 173.23 3.95 Favored 'General case' 0 C--O 1.208 -1.123 0 CA-C-N 115.707 -0.679 . . . . 1.0 110.126 179.855 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . 0.595 ' O ' ' N ' ' A' ' 11' ' ' ARG . 1.5 tm-20 -58.07 -54.29 48.6 Favored 'General case' 0 C--N 1.309 -1.191 0 CA-C-O 121.877 0.846 . . . . 1.0 109.423 -179.303 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 8' ' ' ARG . . . . . 0.58 ' O ' ' HB3' ' A' ' 12' ' ' ALA . 27.9 ttp180 -53.82 -57.85 9.41 Favored 'General case' 0 C--N 1.311 -1.099 0 N-CA-C 107.967 -1.123 . . . . 1.0 107.967 -178.44 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . 0.853 ' O ' HG13 ' A' ' 13' ' ' VAL . 0.0 OUTLIER -63.61 -48.08 88.41 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.359 0 CA-C-N 114.772 -1.104 . . . . 1.0 109.807 179.27 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . 0.644 ' N ' ' O ' ' A' ' 6' ' ' THR . 48.0 t -63.15 -60.74 3.01 Favored 'General case' 0 N--CA 1.481 1.107 0 C-N-CA 120.048 -0.661 . . . . 1.0 110.467 179.266 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 11' ' ' ARG . . . . . 0.595 ' N ' ' O ' ' A' ' 7' ' ' GLU . 11.2 ttt180 -62.77 -55.38 27.05 Favored 'General case' 0 C--N 1.316 -0.862 0 CA-C-O 121.707 0.765 . . . . 1.0 110.072 -177.005 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . 0.58 ' HB3' ' O ' ' A' ' 8' ' ' ARG . . . -52.37 -51.57 58.2 Favored 'General case' 0 C--N 1.316 -0.856 0 N-CA-C 107.015 -1.476 . . . . 1.0 107.015 -178.322 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . 0.853 HG13 ' O ' ' A' ' 9' ' ' VAL . 3.5 m -63.0 -45.84 97.86 Favored 'Isoleucine or valine' 0 C--O 1.2 -1.524 0 C-N-CA 117.387 -1.725 . . . . 1.0 108.888 177.839 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . 0.585 ' O ' HG13 ' A' ' 18' ' ' VAL . . . -59.79 -62.01 2.19 Favored 'General case' 0 N--CA 1.481 1.109 0 O-C-N 120.61 -1.306 . . . . 1.0 110.26 178.654 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . 0.542 ' N ' ' O ' ' A' ' 11' ' ' ARG . . . -52.15 -55.36 21.44 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-O 121.984 0.897 . . . . 1.0 109.415 -177.932 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . 0.51 ' C ' ' H ' ' A' ' 22' ' ' GLY . . . -62.29 -53.85 49.19 Favored 'General case' 0 C--N 1.31 -1.112 0 CA-C-N 114.233 -1.348 . . . . 1.0 108.811 -179.194 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . 0.607 ' CB ' ' O ' ' A' ' 13' ' ' VAL . 7.9 tt -57.1 -54.85 42.12 Favored 'General case' 0 N--CA 1.481 1.084 0 CA-C-N 114.738 -1.119 . . . . 1.0 109.462 -177.75 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . 0.585 HG13 ' O ' ' A' ' 14' ' ' ALA . 1.8 m -69.68 -57.25 8.84 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.63 0 C-N-CA 119.682 -0.807 . . . . 1.0 109.673 178.932 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . 0.543 ' O ' ' CG2' ' A' ' 23' ' ' VAL . . . -65.2 -166.99 1.57 Allowed Glycine 0 CA--C 1.537 1.432 0 N-CA-C 111.477 -0.649 . . . . 1.0 111.477 -179.875 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 20' ' ' PRO . . . . . 0.498 ' O ' ' HB2' ' A' ' 24' ' ' ALA . 83.5 Cg_endo -78.18 -24.87 7.7 Favored 'Trans proline' 0 N--CA 1.509 2.407 0 C-N-CA 123.628 2.885 . . . . 1.0 115.138 -177.825 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -57.32 -57.26 20.72 Favored Glycine 0 N--CA 1.478 1.448 0 C-N-CA 120.221 -0.99 . . . . 1.0 111.694 -176.765 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . 0.51 ' H ' ' C ' ' A' ' 16' ' ' ALA . . . -60.33 -56.21 25.77 Favored Glycine 0 N--CA 1.468 0.819 0 N-CA-C 109.274 -1.531 . . . . 1.0 109.274 -177.234 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . 0.543 ' CG2' ' O ' ' A' ' 19' ' ' GLY . 0.0 OUTLIER -61.89 -35.98 71.22 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.958 0 CA-C-N 114.867 -0.666 . . . . 1.0 110.106 -178.845 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . 0.498 ' HB2' ' O ' ' A' ' 20' ' ' PRO . . . -56.23 -59.97 4.17 Favored 'General case' 0 CA--C 1.538 0.51 0 C-N-CA 117.779 -1.568 . . . . 1.0 108.325 179.531 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 14.3 tp -66.66 -43.87 83.38 Favored 'General case' 0 C--N 1.348 0.505 0 N-CA-C 113.113 0.783 . . . . 1.0 113.113 -178.635 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 79.2 t -60.71 -58.7 6.24 Favored 'Isoleucine or valine' 0 C--N 1.34 0.188 0 C-N-CA 118.137 -1.425 . . . . 1.0 109.253 -177.243 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . 0.422 ' O ' ' HB3' ' A' ' 31' ' ' ALA . 60.7 t -61.14 -37.76 78.16 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.374 0 N-CA-C 112.96 0.726 . . . . 1.0 112.96 -177.914 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . 0.406 ' CG ' ' O ' ' A' ' 24' ' ' ALA . 30.0 mmtm -64.23 -52.68 57.59 Favored 'General case' 0 CA--C 1.509 -0.631 0 N-CA-C 108.372 -0.973 . . . . 1.0 108.372 -179.812 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 92.8 t -65.07 -47.91 86.0 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.874 0 CA-C-N 113.445 -1.707 . . . . 1.0 110.797 -177.361 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 30' ' ' CYS . . . . . . . . . . . . . 11.5 t -65.8 -61.11 2.25 Favored 'General case' 0 N--CA 1.445 -0.684 0 C-N-CA 118.685 -1.206 . . . . 1.0 109.86 -179.747 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . 0.438 ' HA ' HD13 ' A' ' 37' ' ' ILE . . . -66.62 -53.95 28.63 Favored 'General case' 0 CA--C 1.518 -0.261 0 N-CA-C 113.668 0.988 . . . . 1.0 113.668 -176.221 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 85.1 73.57 1.27 Allowed Glycine 0 CA--C 1.533 1.17 0 N-CA-C 109.913 -1.275 . . . . 1.0 109.913 -177.253 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 4.7 mt 76.78 106.26 0.03 OUTLIER Pre-proline 0 N--CA 1.475 0.8 0 C-N-CA 123.416 0.686 . . . . 1.0 111.524 -179.706 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 74.9 Cg_exo -51.42 -15.6 2.63 Favored 'Trans proline' 0 N--CA 1.506 2.243 0 C-N-CA 122.889 2.393 . . . . 1.0 114.967 179.365 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -56.7 -57.87 17.33 Favored Glycine 0 CA--C 1.526 0.746 0 N-CA-C 107.584 -2.207 . . . . 1.0 107.584 -179.791 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . 0.848 ' O ' HG22 ' A' ' 37' ' ' ILE . 5.6 p -79.01 -147.2 0.01 OUTLIER 'Isoleucine or valine' 0 C--O 1.22 -0.459 0 N-CA-C 108.247 -1.019 . . . . 1.0 108.247 178.572 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . 0.848 HG22 ' O ' ' A' ' 36' ' ' VAL . 9.1 tp 70.52 79.74 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.475 0.814 0 CA-C-O 122.157 0.98 . . . . 1.0 112.969 -179.217 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 60.3 m80 -137.79 132.08 32.15 Favored 'General case' 0 N--CA 1.453 -0.283 0 N-CA-C 108.183 -1.043 . . . . 1.0 108.183 177.267 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 10.0 m -128.99 115.71 18.94 Favored Pre-proline 0 C--N 1.326 -0.434 0 N-CA-C 108.38 -0.97 . . . . 1.0 108.38 -179.284 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_exo -42.94 -66.65 0.15 Allowed 'Trans proline' 0 C--N 1.317 -1.122 0 C-N-CA 121.017 1.145 . . . . 1.0 111.558 -178.503 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -75.6 115.33 15.17 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 115.262 -0.881 . . . . 1.0 112.848 -177.292 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . 0.628 ' C ' ' H ' ' A' ' 44' ' ' GLY . 32.9 ptt180 -166.12 162.4 17.7 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 114.817 -1.083 . . . . 1.0 109.987 179.225 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 43' ' ' ARG . . . . . 0.522 ' C ' ' H ' ' A' ' 45' ' ' PHE . 0.2 OUTLIER -65.99 18.63 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.318 -0.401 . . . . 1.0 110.235 -179.263 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . 0.628 ' H ' ' C ' ' A' ' 42' ' ' ARG . . . 70.57 -26.59 0.48 Allowed Glycine 0 N--CA 1.448 -0.531 0 N-CA-C 110.824 -0.91 . . . . 1.0 110.824 179.846 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . 0.59 ' CE2' ' H82' ' A' ' 129' ' ' MTN . 7.6 t80 -155.33 150.65 27.05 Favored 'General case' 0 CA--C 1.541 0.622 0 N-CA-C 108.892 -0.781 . . . . 1.0 108.892 -178.906 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 46' ' ' PHE . . . . . 0.497 ' CE1' ' NE2' ' A' ' 54' ' ' GLN . 15.3 t80 172.21 7.15 0.0 OUTLIER 'General case' 0 N--CA 1.483 1.208 0 O-C-N 124.014 0.821 . . . . 1.0 113.155 176.273 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 47' ' ' ARG . . . . . 0.403 ' HB3' ' O ' ' A' ' 46' ' ' PHE . 0.0 OUTLIER 172.2 -176.0 0.05 Allowed 'General case' 0 C--N 1.328 -0.334 0 N-CA-C 109.765 -0.457 . . . . 1.0 109.765 179.689 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 48' ' ' CYS . . . . . 0.411 ' O ' ' H83' ' A' ' 129' ' ' MTN . 0.0 OUTLIER 70.64 63.01 0.19 Allowed 'General case' 0 CA--C 1.546 0.819 0 N-CA-C 108.901 -0.777 . . . . 1.0 108.901 179.938 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 49' ' ' ASN . . . . . 0.593 ' ND2' ' NH2' ' A' ' 52' ' ' ARG . 1.6 t30 -151.06 133.21 8.17 Favored Pre-proline 0 CA--C 1.546 0.818 0 N-CA-C 108.169 -1.048 . . . . 1.0 108.169 178.891 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . 0.551 ' HD2' HH21 ' A' ' 52' ' ' ARG . 16.3 Cg_endo -55.13 73.86 0.03 OUTLIER 'Trans proline' 0 N--CA 1.502 1.999 0 CA-C-N 120.995 1.391 . . . . 1.0 113.833 -179.816 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . 0.553 ' N ' ' O ' ' A' ' 49' ' ' ASN . 40.2 mm-40 62.01 69.8 0.61 Allowed 'General case' 0 N--CA 1.468 0.441 0 N-CA-C 113.428 0.899 . . . . 1.0 113.428 177.975 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . 0.593 ' NH2' ' ND2' ' A' ' 49' ' ' ASN . 0.0 OUTLIER -141.67 150.68 42.22 Favored 'General case' 0 N--CA 1.471 0.579 0 N-CA-C 108.772 -0.825 . . . . 1.0 108.772 178.155 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . 0.553 HD13 ' H ' ' A' ' 54' ' ' GLN . 0.4 OUTLIER -74.44 136.37 25.38 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.372 0 CA-C-O 121.623 0.725 . . . . 1.0 111.43 -178.679 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 54' ' ' GLN . . . . . 0.553 ' H ' HD13 ' A' ' 53' ' ' ILE . 1.9 pt20 -62.9 82.21 0.02 OUTLIER 'General case' 0 N--CA 1.469 0.492 0 CA-C-N 114.611 -1.177 . . . . 1.0 110.143 -177.172 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 16.0 tt -149.52 159.07 5.68 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.27 0 CA-C-N 115.97 -0.559 . . . . 1.0 110.141 178.113 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 112.26 -2.92 26.73 Favored Glycine 0 N--CA 1.472 1.043 0 N-CA-C 110.669 -0.973 . . . . 1.0 110.669 -179.713 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . 0.484 ' OD2' ' O ' ' A' ' 43' ' ' ARG . 25.3 t70 -82.91 98.71 9.34 Favored 'General case' 0 C--N 1.323 -0.554 0 N-CA-C 109.619 -0.511 . . . . 1.0 109.619 179.426 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 58' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -87.3 174.49 8.54 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-O 122.615 1.198 . . . . 1.0 112.764 -177.899 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 59' ' ' ARG . . . . . 0.447 ' HG3' ' N ' ' A' ' 60' ' ' TYR . 2.1 ptt180 -86.17 -56.96 3.21 Favored 'General case' 0 C--N 1.318 -0.783 0 CA-C-N 111.824 -2.444 . . . . 1.0 112.259 -179.538 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 60' ' ' TYR . . . . . 0.447 ' N ' ' HG3' ' A' ' 59' ' ' ARG . 41.4 t80 -92.42 -17.28 24.8 Favored 'General case' 0 C--O 1.249 1.052 0 N-CA-C 113.521 0.934 . . . . 1.0 113.521 -179.181 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 5.3 tt0 -79.51 -13.9 59.25 Favored 'General case' 0 C--N 1.313 -0.996 0 CA-C-N 115.973 -0.558 . . . . 1.0 110.482 -179.292 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . 0.645 ' O ' ' N ' ' A' ' 66' ' ' GLY . 27.4 m -47.39 -55.32 2.22 Favored 'Isoleucine or valine' 0 C--O 1.201 -1.498 0 C-N-CA 119.326 -0.95 . . . . 1.0 110.107 -176.608 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 63' ' ' ALA . . . . . 0.619 ' N ' HG23 ' A' ' 62' ' ' VAL . . . -68.77 -54.87 13.43 Favored 'General case' 0 C--N 1.306 -1.292 0 C-N-CA 119.338 -0.945 . . . . 1.0 109.416 -178.466 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 64' ' ' HIS . . . . . 0.474 ' O ' ' HB2' ' A' ' 67' ' ' ARG . 6.6 t-80 -44.98 -58.38 3.2 Favored 'General case' 0 N--CA 1.472 0.645 0 CA-C-O 121.519 0.676 . . . . 1.0 109.99 179.516 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . 0.529 ' C ' ' H ' ' A' ' 67' ' ' ARG . 0.5 OUTLIER -73.18 -47.02 47.23 Favored 'General case' 0 C--N 1.313 -1.006 0 CA-C-N 115.551 -0.75 . . . . 1.0 109.991 177.917 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . 0.645 ' N ' ' O ' ' A' ' 62' ' ' VAL . . . -75.4 25.46 1.34 Allowed Glycine 0 CA--C 1.53 0.977 0 O-C-N 120.526 -1.359 . . . . 1.0 110.354 177.5 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 67' ' ' ARG . . . . . 0.603 ' O ' ' N ' ' A' ' 69' ' ' LEU . 5.5 mmt180 -72.02 5.26 2.8 Favored 'General case' 0 CA--C 1.508 -0.655 0 N-CA-C 105.969 -1.863 . . . . 1.0 105.969 175.115 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . 0.553 ' H ' ' C ' ' A' ' 66' ' ' GLY . 0.7 OUTLIER -33.94 -28.1 0.01 OUTLIER 'General case' 0 C--N 1.354 0.787 0 O-C-N 124.181 0.926 . . . . 1.0 109.173 -176.709 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . 0.603 ' N ' ' O ' ' A' ' 67' ' ' ARG . 9.0 mp -62.47 -64.94 0.77 Allowed 'General case' 0 N--CA 1.471 0.624 0 C-N-CA 118.885 -1.126 . . . . 1.0 108.237 177.362 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . 0.691 ' O ' ' CD2' ' A' ' 72' ' ' HIS . . . -76.71 -74.28 0.25 Allowed 'General case' 0 C--O 1.217 -0.634 0 N-CA-C 104.833 -2.284 . . . . 1.0 104.833 177.126 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . 0.463 ' O ' ' OD1' ' A' ' 75' ' ' ASN . . . -40.66 2.65 0.0 OUTLIER 'General case' 0 N--CA 1.473 0.707 0 N-CA-C 115.27 1.582 . . . . 1.0 115.27 179.832 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 72' ' ' HIS . . . . . 0.862 ' CD2' ' H ' ' A' ' 73' ' ' MET . 0.3 OUTLIER -30.45 -81.97 0.01 OUTLIER 'General case' 0 CA--C 1.532 0.284 0 CA-C-N 119.954 1.252 . . . . 1.0 114.114 -176.425 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 73' ' ' MET . . . . . 0.862 ' H ' ' CD2' ' A' ' 72' ' ' HIS . 72.1 mtm -63.9 -53.64 47.34 Favored 'General case' 0 N--CA 1.439 -0.979 0 C-N-CA 120.002 -0.679 . . . . 1.0 110.066 -179.443 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . 0.683 ' O ' ' N ' ' A' ' 76' ' ' GLY . 0.6 OUTLIER -46.25 -35.86 2.49 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.718 0 CA-C-O 117.533 -1.222 . . . . 1.0 111.644 -176.092 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 75' ' ' ASN . . . . . 0.569 ' C ' ' N ' ' A' ' 77' ' ' ILE . 16.1 m120 -39.95 -9.46 0.01 OUTLIER 'General case' 0 N--CA 1.497 1.9 0 CA-C-N 121.055 1.752 . . . . 1.0 112.363 177.759 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . 0.683 ' N ' ' O ' ' A' ' 74' ' ' VAL . . . -41.95 -21.67 0.08 OUTLIER Glycine 0 CA--C 1.542 1.732 0 N-CA-C 107.533 -2.227 . . . . 1.0 107.533 177.051 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . 0.756 ' HA ' ' HB3' ' A' ' 80' ' ' ALA . 13.4 pt -74.87 -53.2 17.08 Favored 'Isoleucine or valine' 0 C--O 1.213 -0.86 0 CA-C-N 114.968 -0.616 . . . . 1.0 109.536 177.565 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . 0.531 ' N ' ' O ' ' A' ' 75' ' ' ASN . 3.2 p -36.15 -30.14 0.04 OUTLIER 'Isoleucine or valine' 0 CA--C 1.554 1.12 0 N-CA-C 108.631 -0.877 . . . . 1.0 108.631 -174.332 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . 0.882 ' O ' ' HB2' ' A' ' 83' ' ' ALA . 0.0 OUTLIER -94.64 -28.16 4.2 Favored 'Isoleucine or valine' 0 CA--C 1.555 1.135 0 CA-C-O 121.186 0.517 . . . . 1.0 109.978 176.907 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 80' ' ' ALA . . . . . 0.756 ' HB3' ' HA ' ' A' ' 77' ' ' ILE . . . -87.48 -10.88 50.6 Favored 'General case' 0 CA--C 1.553 1.063 0 C-N-CA 124.153 0.981 . . . . 1.0 113.419 177.752 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . 0.542 ' N ' ' O ' ' A' ' 77' ' ' ILE . 2.3 mt-10 -83.2 -70.55 0.55 Allowed 'General case' 0 C--N 1.354 0.803 0 CA-C-N 119.309 0.959 . . . . 1.0 108.561 178.759 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 82' ' ' ASP . . . . . 0.491 ' O ' ' N ' ' A' ' 84' ' ' LEU . 8.8 p-10 -78.07 -12.29 59.98 Favored 'General case' 0 N--CA 1.445 -0.683 0 CA-C-N 118.315 0.507 . . . . 1.0 111.565 -179.637 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . 0.882 ' HB2' ' O ' ' A' ' 79' ' ' ILE . . . -22.48 -44.16 0.01 OUTLIER 'General case' 0 N--CA 1.475 0.818 0 N-CA-C 113.207 0.817 . . . . 1.0 113.207 177.683 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . 0.491 ' N ' ' O ' ' A' ' 82' ' ' ASP . 0.4 OUTLIER -36.9 -34.94 0.08 Allowed 'General case' 0 N--CA 1.469 0.518 0 N-CA-C 112.576 0.584 . . . . 1.0 112.576 -176.782 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 85' ' ' ILE . . . . . 0.444 ' O ' HG13 ' A' ' 89' ' ' VAL . 2.0 pt -99.95 -41.72 9.63 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.669 0 N-CA-C 108.391 -0.966 . . . . 1.0 108.391 177.444 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . 0.764 ' HB3' ' HA ' ' A' ' 83' ' ' ALA . . . -59.58 -56.87 16.45 Favored 'General case' 0 CA--C 1.537 0.479 0 CA-C-N 113.93 -1.487 . . . . 1.0 109.639 -179.01 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . 0.492 ' N ' ' O ' ' A' ' 83' ' ' ALA . 14.4 tt0 -70.92 -21.48 62.36 Favored 'General case' 0 CA--C 1.544 0.744 0 O-C-N 121.184 -0.947 . . . . 1.0 112.951 -177.439 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -74.43 -5.41 42.32 Favored 'General case' 0 N--CA 1.48 1.049 0 CA-C-O 122.931 1.348 . . . . 1.0 108.759 179.711 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 89' ' ' VAL . . . . . 0.728 HG22 ' O ' ' A' ' 86' ' ' ALA . 11.7 m -109.85 37.34 0.52 Allowed 'Isoleucine or valine' 0 C--N 1.312 -1.036 0 CA-C-N 112.351 -2.204 . . . . 1.0 109.896 178.017 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 90' ' ' GLY . . . . . 0.596 ' C ' ' H ' ' A' ' 92' ' ' HIS . . . -75.86 -36.35 42.26 Favored Glycine 0 C--N 1.349 1.254 0 N-CA-C 110.63 -0.988 . . . . 1.0 110.63 178.803 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 91' ' ' PRO . . . . . 0.581 ' CD ' ' N ' ' A' ' 90' ' ' GLY . 82.8 Cg_exo -48.26 -9.21 0.07 OUTLIER 'Trans proline' 0 N--CA 1.499 1.798 0 C-N-CA 122.191 1.928 . . . . 1.0 109.971 176.982 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 92' ' ' HIS . . . . . 0.596 ' H ' ' C ' ' A' ' 90' ' ' GLY . 1.8 p80 -55.99 -17.35 6.55 Favored 'General case' 0 N--CA 1.445 -0.717 0 N-CA-C 107.519 -1.289 . . . . 1.0 107.519 179.253 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . 0.579 HD12 ' N ' ' A' ' 94' ' ' ALA . 1.4 pp -63.32 -58.76 6.08 Favored 'General case' 0 N--CA 1.451 -0.405 0 N-CA-C 108.995 -0.743 . . . . 1.0 108.995 177.542 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 94' ' ' ALA . . . . . 0.579 ' N ' HD12 ' A' ' 93' ' ' LEU . . . -57.1 -50.91 71.33 Favored 'General case' 0 CA--C 1.515 -0.377 0 C-N-CA 120.318 -0.553 . . . . 1.0 110.095 -179.996 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 95' ' ' ARG . . . . . 0.652 ' O ' ' N ' ' A' ' 97' ' ' LEU . 83.7 mtt85 -59.36 -55.95 28.23 Favored 'General case' 0 C--N 1.322 -0.623 0 N-CA-C 107.516 -1.29 . . . . 1.0 107.516 178.781 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 96' ' ' ALA . . . . . 0.87 ' O ' ' N ' ' A' ' 98' ' ' GLY . . . -46.8 -13.42 0.03 OUTLIER 'General case' 0 N--CA 1.427 -1.575 0 O-C-N 119.118 -2.238 . . . . 1.0 110.15 179.846 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . 0.744 ' O ' ' N ' ' A' ' 100' ' ' ILE . 0.4 OUTLIER 7.38 -54.71 0.0 OUTLIER 'General case' 0 C--N 1.372 1.544 0 CA-C-O 117.547 -1.216 . . . . 1.0 109.993 -169.298 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 98' ' ' GLY . . . . . 0.87 ' N ' ' O ' ' A' ' 96' ' ' ALA . . . -49.01 -24.0 4.14 Favored Glycine 0 C--N 1.289 -2.079 0 CA-C-N 122.833 2.561 . . . . 1.0 108.849 174.767 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 99' ' ' GLN . . . . . 0.576 ' N ' ' O ' ' A' ' 96' ' ' ALA . 1.9 tp60 -66.36 -15.89 63.63 Favored 'General case' 0 C--N 1.364 1.223 0 N-CA-C 106.405 -1.702 . . . . 1.0 106.405 177.249 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 100' ' ' ILE . . . . . 0.744 ' N ' ' O ' ' A' ' 97' ' ' LEU . 0.4 OUTLIER -64.04 -45.58 96.24 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.52 0 N-CA-C 108.088 -1.079 . . . . 1.0 108.088 177.089 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 101' ' ' VAL . . . . . 0.651 ' O ' ' N ' ' A' ' 105' ' ' GLY . 71.9 t -53.74 -61.61 0.87 Allowed 'Isoleucine or valine' 0 CA--C 1.5 -0.963 0 N-CA-C 108.433 -0.951 . . . . 1.0 108.433 179.411 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 102' ' ' CYS . . . . . 0.902 ' O ' ' HB2' ' A' ' 106' ' ' ALA . 4.2 t -46.07 -21.75 0.17 Allowed 'General case' 0 N--CA 1.427 -1.625 0 CA-C-N 115.569 -0.741 . . . . 1.0 112.317 -178.031 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -88.69 -43.78 11.06 Favored 'General case' 0 N--CA 1.484 1.255 0 O-C-N 124.194 0.934 . . . . 1.0 112.02 176.554 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 104' ' ' TYR . . . . . 0.643 ' O ' ' CD1' ' A' ' 104' ' ' TYR . 0.1 OUTLIER -101.3 21.23 14.4 Favored 'General case' 0 N--CA 1.473 0.692 0 CA-C-N 113.956 -1.475 . . . . 1.0 109.736 178.367 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 105' ' ' GLY . . . . . 0.651 ' N ' ' O ' ' A' ' 101' ' ' VAL . . . -159.59 -94.34 0.1 Allowed Glycine 0 C--N 1.345 1.051 0 N-CA-C 105.232 -3.147 . . . . 1.0 105.232 176.771 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 106' ' ' ALA . . . . . 0.902 ' HB2' ' O ' ' A' ' 102' ' ' CYS . . . 72.0 60.34 0.14 Allowed 'General case' 0 N--CA 1.446 -0.625 0 CA-C-O 119.333 -0.365 . . . . 1.0 111.729 -179.345 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 107' ' ' THR . . . . . 0.446 ' C ' ' H ' ' A' ' 109' ' ' ILE . 44.6 p -81.91 -62.54 1.6 Allowed 'General case' 0 C--N 1.353 0.724 0 O-C-N 120.375 -1.453 . . . . 1.0 109.521 179.403 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 15.5 m -65.2 22.45 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.35 0.599 0 N-CA-C 113.025 0.75 . . . . 1.0 113.025 -176.799 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 109' ' ' ILE . . . . . 0.7 ' H ' ' HD2' ' A' ' 110' ' ' PRO . 0.1 OUTLIER -114.92 -56.96 0.04 OUTLIER Pre-proline 0 CA--C 1.561 1.4 0 CA-C-N 119.089 0.859 . . . . 1.0 108.946 173.954 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 110' ' ' PRO . . . . . 0.7 ' HD2' ' H ' ' A' ' 109' ' ' ILE . 19.4 Cg_endo -52.24 -38.54 72.23 Favored 'Trans proline' 0 N--CA 1.497 1.696 0 C-N-CA 123.243 2.628 . . . . 1.0 112.723 -179.838 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 12.4 m120 -67.01 -68.06 0.41 Allowed 'General case' 0 CA--C 1.51 -0.577 0 C-N-CA 119.268 -0.973 . . . . 1.0 108.76 -177.762 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 112' ' ' ILE . . . . . 0.579 ' O ' ' N ' ' A' ' 115' ' ' ALA . 18.6 pt -51.64 -40.8 26.77 Favored 'Isoleucine or valine' 0 C--O 1.215 -0.749 0 N-CA-C 106.718 -1.586 . . . . 1.0 106.718 178.207 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 113' ' ' ASN . . . . . 0.459 ' HB2' ' O ' ' A' ' 109' ' ' ILE . 26.5 t-20 -45.78 -51.83 12.1 Favored 'General case' 0 CA--C 1.503 -0.836 0 CA-C-N 114.047 -1.433 . . . . 1.0 108.041 -176.49 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -64.02 -27.36 69.07 Favored 'General case' 0 N--CA 1.435 -1.195 0 C-N-CA 119.494 -0.882 . . . . 1.0 109.957 177.763 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 115' ' ' ALA . . . . . 0.579 ' N ' ' O ' ' A' ' 112' ' ' ILE . . . -76.08 -60.56 2.28 Favored 'General case' 0 N--CA 1.444 -0.757 0 N-CA-C 107.546 -1.279 . . . . 1.0 107.546 177.852 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 116' ' ' ILE . . . . . 0.577 ' O ' ' C ' ' A' ' 117' ' ' GLU . 1.3 mp -47.69 -42.47 9.03 Favored 'Isoleucine or valine' 0 C--N 1.363 1.184 0 N-CA-C 108.198 -1.038 . . . . 1.0 108.198 178.768 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 117' ' ' GLU . . . . . 0.577 ' C ' ' O ' ' A' ' 116' ' ' ILE . 23.6 tt0 -38.92 -55.57 1.52 Allowed 'General case' 0 N--CA 1.472 0.671 0 N-CA-C 104.607 -2.368 . . . . 1.0 104.607 178.439 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 118' ' ' VAL . . . . . 0.434 ' N ' ' O ' ' A' ' 115' ' ' ALA . 40.5 t -70.13 -55.07 15.96 Favored 'Isoleucine or valine' 0 CA--C 1.559 1.306 0 CA-C-N 113.954 -1.476 . . . . 1.0 110.77 176.11 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -60.39 -19.62 56.56 Favored 'General case' 0 N--CA 1.49 1.565 0 N-CA-C 115.491 1.663 . . . . 1.0 115.491 -177.735 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 120' ' ' GLY . . . . . 0.512 ' O ' ' CB ' ' A' ' 121' ' ' THR . . . -121.09 -43.95 0.42 Allowed Glycine 0 C--N 1.354 1.554 0 N-CA-C 108.618 -1.793 . . . . 1.0 108.618 176.581 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 121' ' ' THR . . . . . 0.552 ' HB ' HG22 ' A' ' 123' ' ' THR . 45.8 m 127.54 -46.33 0.01 OUTLIER 'General case' 0 N--CA 1.48 1.057 0 C-N-CA 124.962 1.305 . . . . 1.0 108.5 -179.55 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 122' ' ' GLY . . . . . 0.666 ' O ' ' N ' ' A' ' 124' ' ' ASP . . . 104.33 -15.55 50.2 Favored Glycine 0 N--CA 1.472 1.093 0 N-CA-C 108.499 -1.84 . . . . 1.0 108.499 -178.448 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 123' ' ' THR . . . . . 0.651 HG23 ' O ' ' A' ' 123' ' ' THR . 9.5 t -55.43 82.84 0.0 OUTLIER 'General case' 0 C--N 1.322 -0.628 0 N-CA-C 105.436 -2.061 . . . . 1.0 105.436 178.576 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 124' ' ' ASP . . . . . 0.666 ' N ' ' O ' ' A' ' 122' ' ' GLY . 53.0 p30 -167.68 176.11 6.6 Favored 'General case' 0 C--N 1.342 0.281 0 CA-C-N 114.581 -1.19 . . . . 1.0 112.17 179.825 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 125' ' ' TYR . . . . . . . . . . . . . 2.3 t80 -138.83 138.85 37.89 Favored 'General case' 0 CA--C 1.535 0.395 0 N-CA-C 107.914 -1.143 . . . . 1.0 107.914 175.827 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 1.3 mmp_? -145.63 145.12 30.82 Favored 'General case' 0 N--CA 1.47 0.555 0 N-CA-C 109.187 -0.671 . . . . 1.0 109.187 179.399 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 127' ' ' PHE . . . . . . . . . . . . . 6.5 p90 . . . . . 0 N--CA 1.47 0.571 0 CA-C-O 117.958 -1.02 . . . . 1.0 110.734 -179.651 . . . . . . . . 0 0 . 1 . 025 nuclear nobuild full ' A' A ' 128' ' ' MTN . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 025 nuclear nobuild full ' A' A ' 129' ' ' MTN . . . . . 0.59 ' H82' ' CE2' ' A' ' 45' ' ' PHE . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 130' ' ' MTN . . . . . 0.503 ' H61' ' S1 ' ' A' ' 130' ' ' MTN . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 62.2 mtt . . . . . 0 N--CA 1.491 1.615 0 N-CA-C 109.025 -0.731 . . . . 1.0 109.025 . . . . . . . . . 0 0 . 1 . 026 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . 0.413 ' O ' ' CB ' ' A' ' 3' ' ' ASP . 61.2 p -104.65 9.4 35.2 Favored 'General case' 0 N--CA 1.467 0.389 0 C-N-CA 122.578 0.351 . . . . 1.0 110.925 -179.548 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . 0.413 ' CB ' ' O ' ' A' ' 2' ' ' SER . 0.9 OUTLIER 166.15 99.2 0.0 OUTLIER 'General case' 0 N--CA 1.466 0.357 0 O-C-N 123.411 0.444 . . . . 1.0 110.842 179.25 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 65.9 t80 -149.97 144.67 25.99 Favored 'General case' 0 C--O 1.233 0.185 0 N-CA-C 110.045 -0.354 . . . . 1.0 110.045 179.446 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 45.2 m-20 -151.8 147.89 27.2 Favored 'General case' 0 C--N 1.331 -0.226 0 N-CA-C 109.909 -0.404 . . . . 1.0 109.909 -179.976 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 6' ' ' THR . . . . . 0.68 HG22 ' H ' ' A' ' 7' ' ' GLU . 18.9 m -68.9 174.64 4.24 Favored 'General case' 0 C--O 1.214 -0.801 0 C-N-CA 120.188 -0.605 . . . . 1.0 109.868 -179.924 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . 0.68 ' H ' HG22 ' A' ' 6' ' ' THR . 80.1 tt0 -60.76 -53.91 51.57 Favored 'General case' 0 C--N 1.314 -0.935 0 CA-C-O 121.814 0.816 . . . . 1.0 109.862 -177.982 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 8' ' ' ARG . . . . . 0.499 ' O ' ' CB ' ' A' ' 12' ' ' ALA . 18.3 ttm105 -53.19 -57.63 9.83 Favored 'General case' 0 C--N 1.309 -1.17 0 C-N-CA 119.103 -1.039 . . . . 1.0 108.283 -178.456 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . 0.543 ' O ' HG23 ' A' ' 13' ' ' VAL . 0.0 OUTLIER -65.09 -47.44 87.78 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.807 0 CA-C-N 113.913 -1.494 . . . . 1.0 110.227 179.687 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . 0.617 ' N ' ' O ' ' A' ' 6' ' ' THR . 35.0 t -62.99 -59.78 4.35 Favored 'General case' 0 N--CA 1.477 0.877 0 C-N-CA 119.504 -0.879 . . . . 1.0 109.0 179.575 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 11' ' ' ARG . . . . . 0.56 ' O ' ' N ' ' A' ' 15' ' ' ALA . 2.6 tpt180 -64.62 -56.13 15.87 Favored 'General case' 0 N--CA 1.474 0.747 0 CA-C-O 120.796 0.331 . . . . 1.0 111.094 -177.667 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . 0.507 ' O ' ' HB3' ' A' ' 16' ' ' ALA . . . -51.57 -51.12 58.01 Favored 'General case' 0 N--CA 1.485 1.318 0 N-CA-C 106.714 -1.588 . . . . 1.0 106.714 -178.952 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . 0.595 ' O ' ' CB ' ' A' ' 17' ' ' LEU . 64.1 t -61.67 -50.06 81.79 Favored 'Isoleucine or valine' 0 C--O 1.202 -1.408 0 C-N-CA 118.448 -1.301 . . . . 1.0 108.542 178.044 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . 0.669 ' O ' HG13 ' A' ' 18' ' ' VAL . . . -58.72 -61.12 2.85 Favored 'General case' 0 C--O 1.214 -0.78 0 C-N-CA 118.273 -1.371 . . . . 1.0 109.51 179.511 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . 0.572 ' O ' ' N ' ' A' ' 19' ' ' GLY . . . -53.06 -57.02 11.82 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-O 121.727 0.775 . . . . 1.0 110.499 -178.461 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . 0.507 ' HB3' ' O ' ' A' ' 12' ' ' ALA . . . -62.14 -53.2 58.79 Favored 'General case' 0 C--N 1.31 -1.151 0 CA-C-N 114.666 -1.152 . . . . 1.0 108.658 -179.086 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . 0.595 ' CB ' ' O ' ' A' ' 13' ' ' VAL . 6.3 tp -57.19 -52.84 63.71 Favored 'General case' 0 N--CA 1.475 0.814 0 CA-C-N 114.335 -1.302 . . . . 1.0 108.832 -177.918 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . 0.669 HG13 ' O ' ' A' ' 14' ' ' ALA . 3.1 m -68.62 -56.12 13.46 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.521 0 C-N-CA 119.498 -0.881 . . . . 1.0 109.693 179.215 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . 0.572 ' N ' ' O ' ' A' ' 15' ' ' ALA . . . -63.73 -169.52 1.49 Allowed Glycine 0 CA--C 1.525 0.695 0 N-CA-C 112.118 -0.393 . . . . 1.0 112.118 -178.966 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 20' ' ' PRO . . . . . 0.603 ' O ' ' N ' ' A' ' 24' ' ' ALA . 1.0 OUTLIER -79.42 -23.88 6.94 Favored 'Trans proline' 0 C--N 1.311 -1.401 0 C-N-CA 122.925 2.417 . . . . 1.0 112.993 -179.1 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -59.71 -58.6 13.41 Favored Glycine 0 N--CA 1.475 1.3 0 C-N-CA 119.789 -1.196 . . . . 1.0 111.877 -176.674 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . 0.455 ' CA ' ' HB1' ' A' ' 16' ' ' ALA . . . -59.74 -51.76 57.04 Favored Glycine 0 CA--C 1.501 -0.815 0 N-CA-C 106.86 -2.496 . . . . 1.0 106.86 -178.012 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . 0.599 ' O ' HG12 ' A' ' 27' ' ' VAL . 29.5 t -58.32 -35.78 55.25 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.032 0 CA-C-N 114.126 -1.037 . . . . 1.0 108.941 -179.758 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . 0.603 ' N ' ' O ' ' A' ' 20' ' ' PRO . . . -61.92 -60.48 3.57 Favored 'General case' 0 CA--C 1.536 0.429 0 C-N-CA 118.524 -1.27 . . . . 1.0 110.255 -179.921 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . 0.531 ' N ' HD12 ' A' ' 25' ' ' LEU . 9.9 mp -65.02 -44.96 87.43 Favored 'General case' 0 C--N 1.344 0.332 0 CA-C-N 119.257 0.935 . . . . 1.0 112.408 -177.69 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 89.6 t -62.17 -58.79 5.99 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.308 0 C-N-CA 118.826 -1.149 . . . . 1.0 110.268 -177.311 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . 0.599 HG12 ' O ' ' A' ' 23' ' ' VAL . 1.3 p -60.28 -35.31 61.42 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 O-C-N 121.802 -0.561 . . . . 1.0 112.269 -177.476 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 14.0 tmtt? -67.88 -54.58 17.78 Favored 'General case' 0 C--N 1.318 -0.788 0 CA-C-O 121.449 0.643 . . . . 1.0 110.077 -178.591 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . 0.407 HG12 ' O ' ' A' ' 25' ' ' LEU . 9.9 p -63.11 -45.21 99.22 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.834 0 C-N-CA 119.338 -0.945 . . . . 1.0 110.508 -178.333 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 30' ' ' CYS . . . . . . . . . . . . . 1.4 t -66.3 -60.94 2.3 Favored 'General case' 0 CA--C 1.532 0.256 0 C-N-CA 119.123 -1.031 . . . . 1.0 110.004 -179.607 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . 0.5 ' HB2' ' NH1' ' A' ' 47' ' ' ARG . . . -64.65 -52.81 55.4 Favored 'General case' 0 CA--C 1.511 -0.536 0 N-CA-C 112.923 0.712 . . . . 1.0 112.923 -176.44 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 85.02 74.38 1.25 Allowed Glycine 0 CA--C 1.526 0.764 0 N-CA-C 109.135 -1.586 . . . . 1.0 109.135 -177.256 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 23.1 mt 86.09 95.49 0.03 OUTLIER Pre-proline 0 N--CA 1.479 0.983 0 C-N-CA 123.676 0.79 . . . . 1.0 110.521 -179.17 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 47.5 Cg_endo -68.3 -27.76 34.11 Favored 'Trans proline' 0 N--CA 1.506 2.26 0 C-N-CA 122.221 1.947 . . . . 1.0 115.085 -177.843 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . 0.402 ' HA3' HD12 ' A' ' 112' ' ' ILE . . . -62.08 -58.72 11.46 Favored Glycine 0 CA--C 1.53 1.029 0 C-N-CA 118.233 -1.937 . . . . 1.0 109.383 -178.678 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . 0.519 ' O ' HG22 ' A' ' 37' ' ' ILE . 11.3 p -88.88 162.09 2.61 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.462 0 N-CA-C 106.231 -1.766 . . . . 1.0 106.231 177.215 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . 0.519 HG22 ' O ' ' A' ' 36' ' ' VAL . 0.0 OUTLIER 118.99 120.01 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.476 0.865 0 C-N-CA 124.322 1.049 . . . . 1.0 108.506 -179.238 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild full ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 46.8 m80 -142.11 133.85 27.01 Favored 'General case' 0 C--N 1.332 -0.154 0 N-CA-C 108.412 -0.958 . . . . 1.0 108.412 179.072 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -110.38 134.87 20.69 Favored Pre-proline 0 C--N 1.325 -0.464 0 N-CA-C 108.439 -0.949 . . . . 1.0 108.439 -179.716 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 37.1 Cg_endo -66.36 -85.55 0.01 OUTLIER 'Trans proline' 0 N--CA 1.49 1.31 0 CA-C-N 119.994 1.034 . . . . 1.0 111.469 -179.047 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -66.16 121.9 16.22 Favored 'General case' 0 C--N 1.317 -0.808 0 CA-C-N 114.991 -1.004 . . . . 1.0 110.298 -178.714 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . 0.648 ' C ' ' H ' ' A' ' 44' ' ' GLY . 34.2 ptt180 -169.15 166.04 10.9 Favored 'General case' 0 N--CA 1.434 -1.27 0 N-CA-C 109.133 -0.691 . . . . 1.0 109.133 179.062 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 43' ' ' ARG . . . . . 0.611 ' HG3' ' O ' ' A' ' 45' ' ' PHE . 0.0 OUTLIER -65.33 25.07 0.02 OUTLIER 'General case' 0 C--N 1.311 -1.078 0 CA-C-N 115.717 -0.674 . . . . 1.0 110.249 -179.067 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . 0.648 ' H ' ' C ' ' A' ' 42' ' ' ARG . . . 76.63 -24.92 1.78 Allowed Glycine 0 C--N 1.345 1.072 0 N-CA-C 111.869 -0.492 . . . . 1.0 111.869 179.27 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . 0.804 ' O ' ' HB2' ' A' ' 46' ' ' PHE . 35.2 t80 -162.76 164.81 26.11 Favored 'General case' 0 C--O 1.198 -1.606 0 CA-C-O 119.003 -0.522 . . . . 1.0 110.155 -179.268 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 46' ' ' PHE . . . . . 0.804 ' HB2' ' O ' ' A' ' 45' ' ' PHE . 2.7 t80 131.18 93.07 0.0 OUTLIER 'General case' 0 N--CA 1.517 2.894 0 C-N-CA 124.396 1.078 . . . . 1.0 111.134 178.125 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 47' ' ' ARG . . . . . 0.531 ' CB ' ' O ' ' A' ' 46' ' ' PHE . 2.1 tmm_? 118.46 151.82 0.0 OUTLIER 'General case' 0 N--CA 1.482 1.13 0 C-N-CA 124.697 1.199 . . . . 1.0 108.842 -179.981 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER 70.3 70.98 0.21 Allowed 'General case' 0 CA--C 1.534 0.357 0 N-CA-C 108.316 -0.994 . . . . 1.0 108.316 -177.918 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -134.75 140.11 34.37 Favored Pre-proline 0 CA--C 1.541 0.597 0 N-CA-C 108.467 -0.938 . . . . 1.0 108.467 -179.018 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . 0.413 ' C ' ' H ' ' A' ' 52' ' ' ARG . 55.3 Cg_endo -66.9 69.22 0.53 Allowed 'Trans proline' 0 N--CA 1.5 1.887 0 C-N-CA 121.793 1.662 . . . . 1.0 112.74 -179.032 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . 0.452 ' N ' ' CD ' ' A' ' 51' ' ' GLU . 0.7 OUTLIER 63.64 -9.16 0.14 Allowed 'General case' 0 N--CA 1.468 0.439 0 N-CA-C 112.574 0.583 . . . . 1.0 112.574 179.868 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . 0.413 ' H ' ' C ' ' A' ' 50' ' ' PRO . 0.0 OUTLIER -76.6 168.99 19.11 Favored 'General case' 0 N--CA 1.466 0.36 0 C-N-CA 119.781 -0.768 . . . . 1.0 110.5 179.747 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . 0.457 ' O ' ' N ' ' A' ' 55' ' ' ILE . 8.2 pt -81.42 135.77 24.41 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.464 0 CA-C-O 122.018 0.913 . . . . 1.0 110.97 -179.974 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 6.3 pm0 -61.42 83.14 0.01 OUTLIER 'General case' 0 C--N 1.314 -0.967 0 CA-C-N 113.712 -1.585 . . . . 1.0 108.82 -178.303 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . 0.457 ' N ' ' O ' ' A' ' 53' ' ' ILE . 20.8 tt -150.47 158.74 5.1 Favored 'Isoleucine or valine' 0 C--N 1.354 0.776 0 CA-C-N 116.429 -0.35 . . . . 1.0 110.654 178.255 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 107.72 -5.94 35.21 Favored Glycine 0 N--CA 1.486 2.017 0 N-CA-C 111.491 -0.644 . . . . 1.0 111.491 179.319 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . 0.445 ' CG ' ' NH1' ' A' ' 43' ' ' ARG . 8.4 p-10 -78.56 103.54 8.57 Favored 'General case' 0 C--N 1.311 -1.102 0 CA-C-N 114.501 -0.85 . . . . 1.0 109.91 178.604 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 58' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -89.74 173.15 8.44 Favored 'General case' 0 CA--C 1.555 1.169 0 CA-C-O 123.375 1.559 . . . . 1.0 114.417 -176.976 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 59' ' ' ARG . . . . . 0.705 ' HE ' ' H ' ' A' ' 59' ' ' ARG . 0.0 OUTLIER -74.04 -61.04 1.99 Allowed 'General case' 0 N--CA 1.479 0.993 0 CA-C-N 111.414 -2.63 . . . . 1.0 111.694 -178.825 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild full ' A' A ' 60' ' ' TYR . . . . . 0.544 ' O ' ' CG ' ' A' ' 60' ' ' TYR . 65.9 t80 -92.17 -8.91 44.22 Favored 'General case' 0 C--O 1.244 0.813 0 C-N-CA 124.593 1.157 . . . . 1.0 113.241 -179.661 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -79.12 -17.32 55.3 Favored 'General case' 0 N--CA 1.432 -1.346 0 O-C-N 121.348 -0.845 . . . . 1.0 111.366 -178.347 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . 0.655 ' O ' ' N ' ' A' ' 66' ' ' GLY . 25.9 m -49.02 -54.49 5.28 Favored 'Isoleucine or valine' 0 C--O 1.199 -1.603 0 C-N-CA 119.802 -0.759 . . . . 1.0 110.512 -174.954 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 63' ' ' ALA . . . . . 0.493 ' N ' HG23 ' A' ' 62' ' ' VAL . . . -69.03 -49.7 55.3 Favored 'General case' 0 C--N 1.308 -1.225 0 O-C-N 121.498 -0.751 . . . . 1.0 109.539 -179.427 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 64' ' ' HIS . . . . . 0.4 ' O ' ' HB2' ' A' ' 67' ' ' ARG . 1.0 OUTLIER -50.18 -56.57 10.49 Favored 'General case' 0 CA--C 1.54 0.592 0 CA-C-N 115.226 -0.897 . . . . 1.0 108.613 -179.005 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . 0.599 ' C ' ' H ' ' A' ' 67' ' ' ARG . 32.7 t0 -74.69 -46.46 37.64 Favored 'General case' 0 C--N 1.317 -0.832 0 CA-C-N 115.594 -0.73 . . . . 1.0 110.115 178.094 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . 0.655 ' N ' ' O ' ' A' ' 62' ' ' VAL . . . -72.92 25.19 0.8 Allowed Glycine 0 N--CA 1.444 -0.822 0 N-CA-C 109.663 -1.375 . . . . 1.0 109.663 177.556 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 67' ' ' ARG . . . . . 0.627 ' O ' ' N ' ' A' ' 69' ' ' LEU . 0.0 OUTLIER -72.49 6.2 2.52 Favored 'General case' 0 N--CA 1.452 -0.335 0 N-CA-C 105.477 -2.045 . . . . 1.0 105.477 174.761 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . 0.549 ' H ' ' C ' ' A' ' 66' ' ' GLY . 0.0 OUTLIER -33.1 -28.45 0.01 OUTLIER 'General case' 0 N--CA 1.483 1.202 0 N-CA-C 108.565 -0.902 . . . . 1.0 108.565 -175.746 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . 0.627 ' N ' ' O ' ' A' ' 67' ' ' ARG . 8.5 tt -62.77 -64.33 0.95 Allowed 'General case' 0 C--N 1.323 -0.581 0 C-N-CA 118.797 -1.161 . . . . 1.0 108.988 178.476 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . 0.575 ' O ' ' N ' ' A' ' 72' ' ' HIS . . . -78.76 -74.45 0.28 Allowed 'General case' 0 N--CA 1.475 0.802 0 N-CA-C 105.485 -2.042 . . . . 1.0 105.485 176.657 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . 0.457 ' O ' ' C ' ' A' ' 72' ' ' HIS . . . -44.14 2.99 0.0 OUTLIER 'General case' 0 C--N 1.332 -0.158 0 C-N-CA 125.255 1.422 . . . . 1.0 114.352 179.687 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 72' ' ' HIS . . . . . 0.626 ' CG ' ' N ' ' A' ' 73' ' ' MET . 0.0 OUTLIER -28.49 -64.8 0.09 Allowed 'General case' 0 N--CA 1.47 0.564 0 CA-C-N 118.834 0.743 . . . . 1.0 111.585 -178.335 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild full ' A' A ' 73' ' ' MET . . . . . 0.626 ' N ' ' CG ' ' A' ' 72' ' ' HIS . 2.9 ptp -69.65 -50.69 41.67 Favored 'General case' 0 C--N 1.32 -0.685 0 C-N-CA 119.279 -0.968 . . . . 1.0 108.881 179.042 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . 0.693 ' O ' ' N ' ' A' ' 76' ' ' GLY . 86.2 t -44.85 -41.84 2.3 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.329 0 CA-C-O 117.628 -1.177 . . . . 1.0 111.433 -176.385 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 75' ' ' ASN . . . . . 0.523 ' O ' ' N ' ' A' ' 78' ' ' VAL . 4.1 t30 -37.03 -13.45 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.703 0 CA-C-N 121.307 1.867 . . . . 1.0 112.802 179.431 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . 0.693 ' N ' ' O ' ' A' ' 74' ' ' VAL . . . -44.56 -25.98 0.96 Allowed Glycine 0 CA--C 1.544 1.897 0 CA-C-N 113.294 -1.776 . . . . 1.0 108.711 177.898 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . 0.688 ' HA ' ' HB3' ' A' ' 80' ' ' ALA . 0.2 OUTLIER -69.03 -48.07 71.89 Favored 'Isoleucine or valine' 0 C--O 1.209 -1.052 0 N-CA-C 107.519 -1.289 . . . . 1.0 107.519 178.07 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . 0.639 ' H ' HD13 ' A' ' 77' ' ' ILE . 77.3 t -32.89 -35.59 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.476 0.856 0 CA-C-N 114.658 -1.155 . . . . 1.0 108.036 -176.391 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . 0.721 ' O ' ' HB2' ' A' ' 83' ' ' ALA . 39.0 pt -98.61 -28.44 3.56 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.948 0 CA-C-O 121.261 0.553 . . . . 1.0 111.813 176.932 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 80' ' ' ALA . . . . . 0.688 ' HB3' ' HA ' ' A' ' 77' ' ' ILE . . . -86.77 -13.76 44.26 Favored 'General case' 0 N--CA 1.477 0.922 0 N-CA-C 114.06 1.133 . . . . 1.0 114.06 178.557 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . 0.629 ' CG ' ' H ' ' A' ' 82' ' ' ASP . 16.1 pt-20 -83.13 -69.26 0.64 Allowed 'General case' 0 C--N 1.345 0.373 0 CA-C-N 119.042 0.837 . . . . 1.0 108.797 -179.676 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 82' ' ' ASP . . . . . 0.629 ' H ' ' CG ' ' A' ' 81' ' ' GLU . 67.1 m-20 -75.64 -10.79 59.74 Favored 'General case' 0 N--CA 1.442 -0.844 0 CA-C-N 118.075 0.398 . . . . 1.0 110.833 179.453 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . 0.746 ' HA ' ' HB3' ' A' ' 86' ' ' ALA . . . -19.84 -44.37 0.0 OUTLIER 'General case' 0 N--CA 1.472 0.643 0 N-CA-C 112.577 0.584 . . . . 1.0 112.577 177.029 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . 0.579 ' N ' ' O ' ' A' ' 82' ' ' ASP . 5.9 tp -31.65 -33.53 0.01 OUTLIER 'General case' 0 N--CA 1.473 0.702 0 CA-C-N 118.319 0.509 . . . . 1.0 111.746 -177.961 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 85' ' ' ILE . . . . . 0.716 ' O ' HG23 ' A' ' 89' ' ' VAL . 47.8 pt -100.51 -37.19 5.46 Favored 'Isoleucine or valine' 0 C--O 1.208 -1.108 0 N-CA-C 109.096 -0.705 . . . . 1.0 109.096 176.133 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . 0.746 ' HB3' ' HA ' ' A' ' 83' ' ' ALA . . . -66.24 -59.41 3.76 Favored 'General case' 0 C--N 1.317 -0.805 0 C-N-CA 119.647 -0.821 . . . . 1.0 111.381 -179.908 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -69.43 -18.36 63.73 Favored 'General case' 0 N--CA 1.47 0.544 0 CA-C-N 120.344 1.429 . . . . 1.0 112.294 -179.627 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -88.64 -13.1 40.67 Favored 'General case' 0 N--CA 1.475 0.817 0 CA-C-O 122.645 1.212 . . . . 1.0 108.141 179.358 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 89' ' ' VAL . . . . . 0.765 ' O ' HG12 ' A' ' 89' ' ' VAL . 53.3 t -92.22 39.66 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.32 -0.7 0 CA-C-N 111.953 -2.385 . . . . 1.0 109.474 177.654 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 90' ' ' GLY . . . . . 0.776 ' O ' ' N ' ' A' ' 92' ' ' HIS . . . -64.22 -30.17 77.05 Favored Glycine 0 C--N 1.371 2.476 0 CA-C-O 117.902 -1.499 . . . . 1.0 109.969 176.893 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 91' ' ' PRO . . . . . 0.599 ' HD2' ' N ' ' A' ' 90' ' ' GLY . 72.6 Cg_exo -40.26 -5.78 0.01 OUTLIER 'Trans proline' 0 N--CA 1.488 1.205 0 CA-C-N 120.926 2.363 . . . . 1.0 111.111 174.556 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 92' ' ' HIS . . . . . 0.776 ' N ' ' O ' ' A' ' 90' ' ' GLY . 2.5 p-80 -48.82 -24.48 1.45 Allowed 'General case' 0 N--CA 1.435 -1.211 0 N-CA-C 106.593 -1.632 . . . . 1.0 106.593 179.731 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . 0.553 HD12 ' N ' ' A' ' 94' ' ' ALA . 1.2 pp -60.54 -53.48 56.95 Favored 'General case' 0 N--CA 1.445 -0.697 0 N-CA-C 106.493 -1.669 . . . . 1.0 106.493 176.088 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 94' ' ' ALA . . . . . 0.553 ' N ' HD12 ' A' ' 93' ' ' LEU . . . -51.09 -53.17 36.45 Favored 'General case' 0 C--O 1.212 -0.899 0 N-CA-C 107.409 -1.33 . . . . 1.0 107.409 179.465 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 95' ' ' ARG . . . . . 0.489 ' HE ' ' HD3' ' A' ' 20' ' ' PRO . 4.5 mmp_? -61.94 -28.43 69.53 Favored 'General case' 0 CA--C 1.549 0.924 0 CA-C-O 122.297 1.046 . . . . 1.0 110.09 178.27 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 96' ' ' ALA . . . . . 0.905 ' O ' ' N ' ' A' ' 100' ' ' ILE . . . -50.4 -36.68 33.86 Favored 'General case' 0 C--O 1.195 -1.783 0 N-CA-C 107.105 -1.442 . . . . 1.0 107.105 -176.364 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . 0.441 ' C ' ' O ' ' A' ' 96' ' ' ALA . 0.4 OUTLIER -35.0 -23.9 0.01 OUTLIER 'General case' 0 CA--C 1.587 2.403 0 CA-C-N 113.48 -1.691 . . . . 1.0 108.512 -177.214 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild full ' A' A ' 98' ' ' GLY . . . . . 0.657 ' N ' ' O ' ' A' ' 96' ' ' ALA . . . -88.8 -53.02 2.65 Favored Glycine 0 CA--C 1.55 2.221 0 CA-C-O 123.223 1.457 . . . . 1.0 110.644 171.577 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 99' ' ' GLN . . . . . 0.586 ' N ' ' O ' ' A' ' 96' ' ' ALA . 12.2 mp0 -76.99 7.05 5.28 Favored 'General case' 0 N--CA 1.435 -1.178 0 N-CA-C 106.373 -1.714 . . . . 1.0 106.373 176.787 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 100' ' ' ILE . . . . . 0.905 ' N ' ' O ' ' A' ' 96' ' ' ALA . 0.3 OUTLIER -60.23 -52.99 54.87 Favored 'Isoleucine or valine' 0 CA--C 1.487 -1.476 0 N-CA-C 104.806 -2.294 . . . . 1.0 104.806 178.185 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild full ' A' A ' 101' ' ' VAL . . . . . 0.556 ' O ' ' N ' ' A' ' 105' ' ' GLY . 21.5 t -49.3 -60.41 0.74 Allowed 'Isoleucine or valine' 0 C--O 1.222 -0.394 0 C-N-CA 117.752 -1.579 . . . . 1.0 107.837 178.581 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 102' ' ' CYS . . . . . 0.858 ' O ' ' HB2' ' A' ' 106' ' ' ALA . 0.5 OUTLIER -50.17 -30.46 11.4 Favored 'General case' 0 C--N 1.317 -0.825 0 CA-C-N 114.931 -1.031 . . . . 1.0 110.961 -178.265 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild full ' A' A ' 103' ' ' ARG . . . . . 0.426 ' N ' ' O ' ' A' ' 99' ' ' GLN . 0.0 OUTLIER -83.69 -53.84 5.35 Favored 'General case' 0 N--CA 1.486 1.335 0 N-CA-C 114.205 1.187 . . . . 1.0 114.205 -179.322 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild full ' A' A ' 104' ' ' TYR . . . . . 0.662 ' O ' ' CG ' ' A' ' 104' ' ' TYR . 0.0 OUTLIER -94.1 21.5 6.76 Favored 'General case' 0 C--N 1.311 -1.09 0 C-N-CA 126.469 1.908 . . . . 1.0 107.871 179.122 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild full ' A' A ' 105' ' ' GLY . . . . . 0.556 ' N ' ' O ' ' A' ' 101' ' ' VAL . . . -156.76 -91.14 0.08 OUTLIER Glycine 0 N--CA 1.445 -0.733 0 N-CA-C 106.822 -2.511 . . . . 1.0 106.822 177.2 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 106' ' ' ALA . . . . . 0.858 ' HB2' ' O ' ' A' ' 102' ' ' CYS . . . 72.81 46.76 0.24 Allowed 'General case' 0 N--CA 1.449 -0.498 0 N-CA-C 112.076 0.398 . . . . 1.0 112.076 -179.94 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 10.3 t -76.67 7.22 4.83 Favored 'General case' 0 CA--C 1.513 -0.479 0 O-C-N 119.986 -1.696 . . . . 1.0 107.045 176.402 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 18.7 m -86.78 -52.53 11.65 Favored 'Isoleucine or valine' 0 C--N 1.35 0.615 0 CA-C-O 117.945 -1.026 . . . . 1.0 110.298 177.51 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 109' ' ' ILE . . . . . 0.566 ' CG2' ' HB1' ' A' ' 106' ' ' ALA . 0.1 OUTLIER -47.91 -33.93 4.99 Favored Pre-proline 0 C--N 1.368 1.394 0 N-CA-C 116.8 2.148 . . . . 1.0 116.8 -177.587 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild full ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 50.4 Cg_exo -54.79 -47.42 26.81 Favored 'Trans proline' 0 C--N 1.308 -1.564 0 CA-C-N 122.558 1.949 . . . . 1.0 112.439 -176.942 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 111' ' ' ASN . . . . . 0.462 ' O ' ' HB3' ' A' ' 114' ' ' ALA . 24.7 t-20 -72.29 -67.35 0.55 Allowed 'General case' 0 N--CA 1.467 0.4 0 C-N-CA 119.995 -0.682 . . . . 1.0 111.491 -177.184 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 112' ' ' ILE . . . . . 0.688 ' O ' ' HB ' ' A' ' 116' ' ' ILE . 0.9 OUTLIER -46.42 -28.85 0.97 Allowed 'Isoleucine or valine' 0 C--O 1.192 -1.948 0 O-C-N 121.927 -0.483 . . . . 1.0 111.99 -178.3 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild full ' A' A ' 113' ' ' ASN . . . . . 0.448 ' OD1' ' O ' ' A' ' 109' ' ' ILE . 4.3 m120 -72.0 -40.2 68.7 Favored 'General case' 0 N--CA 1.483 1.217 0 CA-C-O 123.544 1.64 . . . . 1.0 108.231 179.859 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 114' ' ' ALA . . . . . 0.462 ' HB3' ' O ' ' A' ' 111' ' ' ASN . . . -54.59 -50.0 69.07 Favored 'General case' 0 C--N 1.295 -1.796 0 CA-C-N 111.015 -2.812 . . . . 1.0 107.376 178.727 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 115' ' ' ALA . . . . . 0.722 ' O ' ' N ' ' A' ' 119' ' ' LEU . . . -85.13 -49.09 8.53 Favored 'General case' 0 C--O 1.199 -1.579 0 N-CA-C 114.402 1.26 . . . . 1.0 114.402 177.652 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 116' ' ' ILE . . . . . 0.688 ' HB ' ' O ' ' A' ' 112' ' ' ILE . 0.6 OUTLIER -42.79 -49.15 1.15 Allowed 'Isoleucine or valine' 0 N--CA 1.513 2.714 0 N-CA-C 106.109 -1.811 . . . . 1.0 106.109 179.569 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild full ' A' A ' 117' ' ' GLU . . . . . 0.439 ' C ' ' O ' ' A' ' 116' ' ' ILE . 68.3 mt-10 -45.99 -59.87 2.59 Favored 'General case' 0 C--N 1.308 -1.2 0 N-CA-C 105.573 -2.01 . . . . 1.0 105.573 177.907 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 118' ' ' VAL . . . . . 0.544 ' N ' ' O ' ' A' ' 115' ' ' ALA . 6.9 t -77.52 -57.37 5.83 Favored 'Isoleucine or valine' 0 CA--C 1.557 1.23 0 N-CA-C 113.558 0.947 . . . . 1.0 113.558 178.505 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 119' ' ' LEU . . . . . 0.722 ' N ' ' O ' ' A' ' 115' ' ' ALA . 1.3 tp -61.55 -24.44 66.64 Favored 'General case' 0 C--N 1.351 0.652 0 N-CA-C 116.218 1.933 . . . . 1.0 116.218 -178.728 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 120' ' ' GLY . . . . . 0.502 ' C ' HG22 ' A' ' 121' ' ' THR . . . -126.48 -54.93 0.15 Allowed Glycine 0 C--N 1.354 1.549 0 CA-C-N 120.506 1.503 . . . . 1.0 110.869 176.976 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 121' ' ' THR . . . . . 0.672 HG23 ' N ' ' A' ' 122' ' ' GLY . 2.1 t 143.39 -56.18 0.0 OUTLIER 'General case' 0 N--CA 1.477 0.907 0 C-N-CA 124.089 0.956 . . . . 1.0 112.036 -177.915 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 122' ' ' GLY . . . . . 0.672 ' N ' HG23 ' A' ' 121' ' ' THR . . . 92.6 -23.27 28.97 Favored Glycine 0 CA--C 1.531 1.053 0 N-CA-C 107.725 -2.15 . . . . 1.0 107.725 -176.583 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 123' ' ' THR . . . . . 0.615 HG22 HG21 ' A' ' 121' ' ' THR . 5.8 t -46.94 91.94 0.01 OUTLIER 'General case' 0 N--CA 1.477 0.918 0 N-CA-C 105.64 -1.985 . . . . 1.0 105.64 179.239 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 124' ' ' ASP . . . . . 0.592 ' N ' ' O ' ' A' ' 122' ' ' GLY . 48.2 p30 -169.76 -174.82 1.94 Allowed 'General case' 0 CA--C 1.537 0.458 0 CA-C-N 114.904 -1.044 . . . . 1.0 112.38 178.739 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 125' ' ' TYR . . . . . . . . . . . . . 16.9 t80 -148.59 147.63 29.22 Favored 'General case' 0 CA--C 1.542 0.644 0 CA-C-N 114.385 -1.28 . . . . 1.0 109.059 175.686 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 13.8 mtp85 -146.94 150.41 35.14 Favored 'General case' 0 N--CA 1.476 0.85 0 N-CA-C 109.812 -0.44 . . . . 1.0 109.812 177.38 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 127' ' ' PHE . . . . . . . . . . . . . 26.7 p90 . . . . . 0 C--O 1.22 -0.449 0 CA-C-O 118.176 -0.916 . . . . 1.0 111.231 -179.353 . . . . . . . . 0 0 . 1 . 026 nuclear nobuild full ' A' A ' 128' ' ' MTN . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 026 nuclear nobuild full ' A' A ' 129' ' ' MTN . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 026 nuclear nobuild full ' A' A ' 130' ' ' MTN . . . . . 0.518 ' S1 ' ' H71' ' A' ' 130' ' ' MTN . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.488 1.456 0 N-CA-C 108.667 -0.864 . . . . 1.0 108.667 . . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 93.4 p -88.4 0.58 56.07 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.576 -0.284 . . . . 1.0 111.316 -179.967 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 2.0 t70 164.65 118.65 0.01 OUTLIER 'General case' 0 N--CA 1.479 0.988 0 O-C-N 123.391 0.432 . . . . 1.0 111.277 178.916 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 58.2 t80 -151.74 148.39 27.83 Favored 'General case' 0 N--CA 1.465 0.322 0 CA-C-O 121.078 0.466 . . . . 1.0 110.191 177.997 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 30.9 m-20 -152.29 148.12 27.16 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.596 -0.729 . . . . 1.0 109.788 179.754 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 6' ' ' THR . . . . . 1.038 ' H ' HG23 ' A' ' 9' ' ' VAL . 0.2 OUTLIER -106.72 -168.7 1.45 Allowed 'General case' 0 C--O 1.205 -1.286 0 CA-C-O 121.602 0.715 . . . . 1.0 109.832 -179.967 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . 0.502 ' O ' ' CB ' ' A' ' 11' ' ' ARG . 71.6 mm-40 -57.66 -46.59 84.03 Favored 'General case' 0 C--N 1.297 -1.68 0 N-CA-C 109.438 -0.578 . . . . 1.0 109.438 179.77 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 8' ' ' ARG . . . . . 0.695 ' O ' ' HB3' ' A' ' 12' ' ' ALA . 16.8 mtt85 -66.58 -61.64 1.88 Allowed 'General case' 0 C--N 1.316 -0.864 0 C-N-CA 117.373 -1.731 . . . . 1.0 109.595 179.609 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . 1.038 HG23 ' H ' ' A' ' 6' ' ' THR . 0.0 OUTLIER -61.73 -52.86 55.83 Favored 'Isoleucine or valine' 0 C--O 1.204 -1.311 0 CA-C-N 114.769 -1.105 . . . . 1.0 110.703 -179.679 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . 0.72 ' N ' ' O ' ' A' ' 6' ' ' THR . 4.9 t -65.3 -61.5 2.08 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 122.074 -0.391 . . . . 1.0 111.619 178.761 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 11' ' ' ARG . . . . . 0.648 ' O ' ' HB3' ' A' ' 15' ' ' ALA . 29.4 ttt180 -62.06 -43.96 97.71 Favored 'General case' 0 C--N 1.31 -1.123 0 O-C-N 121.462 -0.774 . . . . 1.0 109.561 -175.698 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . 0.735 ' O ' ' HB3' ' A' ' 16' ' ' ALA . . . -70.33 -56.58 6.36 Favored 'General case' 0 N--CA 1.477 0.919 0 C-N-CA 118.825 -1.15 . . . . 1.0 109.161 176.801 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . 0.673 ' O ' ' CB ' ' A' ' 17' ' ' LEU . 55.0 t -61.46 -53.46 48.27 Favored 'Isoleucine or valine' 0 C--O 1.192 -1.961 0 C-N-CA 117.498 -1.681 . . . . 1.0 107.461 -178.779 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . 0.935 ' O ' HG22 ' A' ' 18' ' ' VAL . . . -62.82 -65.28 0.71 Allowed 'General case' 0 C--N 1.308 -1.217 0 C-N-CA 116.075 -2.25 . . . . 1.0 111.892 -179.814 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . 0.648 ' HB3' ' O ' ' A' ' 11' ' ' ARG . . . -55.35 -55.49 30.92 Favored 'General case' 0 C--O 1.217 -0.64 0 C-N-CA 118.321 -1.352 . . . . 1.0 111.545 -176.7 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . 0.735 ' HB3' ' O ' ' A' ' 12' ' ' ALA . . . -65.6 -58.67 5.2 Favored 'General case' 0 C--N 1.301 -1.502 0 C-N-CA 118.35 -1.34 . . . . 1.0 110.804 -178.491 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . 0.673 ' CB ' ' O ' ' A' ' 13' ' ' VAL . 5.7 tp -53.62 -55.3 27.02 Favored 'General case' 0 N--CA 1.489 1.504 0 N-CA-C 108.536 -0.913 . . . . 1.0 108.536 -179.294 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . 0.935 HG22 ' O ' ' A' ' 14' ' ' ALA . 2.2 m -71.03 -60.42 2.45 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.43 0 C-N-CA 118.975 -1.09 . . . . 1.0 110.85 -179.509 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . 0.528 ' N ' ' O ' ' A' ' 15' ' ' ALA . . . -54.54 -163.26 0.01 OUTLIER Glycine 0 N--CA 1.438 -1.218 0 CA-C-O 121.567 0.537 . . . . 1.0 113.179 -176.969 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 20' ' ' PRO . . . . . 0.72 ' O ' ' N ' ' A' ' 24' ' ' ALA . 90.6 Cg_endo -80.48 -24.75 5.06 Favored 'Trans proline' 0 C--N 1.302 -1.884 0 C-N-CA 122.246 1.964 . . . . 1.0 111.712 -179.112 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -62.11 -60.84 7.35 Favored Glycine 0 N--CA 1.47 0.914 0 C-N-CA 118.685 -1.721 . . . . 1.0 111.059 -176.921 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . 0.61 ' N ' ' O ' ' A' ' 16' ' ' ALA . . . -60.71 -50.39 68.1 Favored Glycine 0 C--N 1.304 -1.207 0 N-CA-C 106.954 -2.459 . . . . 1.0 106.954 179.017 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 83.2 t -58.41 -34.05 49.52 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.582 0 C-N-CA 118.837 -1.145 . . . . 1.0 107.991 -179.72 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . 0.72 ' N ' ' O ' ' A' ' 20' ' ' PRO . . . -61.71 -61.23 2.66 Favored 'General case' 0 N--CA 1.468 0.468 0 C-N-CA 118.685 -1.206 . . . . 1.0 109.376 179.402 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . 0.425 ' O ' HG12 ' A' ' 29' ' ' VAL . 58.0 mt -60.42 -45.19 94.49 Favored 'General case' 0 CA--C 1.508 -0.673 0 C-N-CA 119.59 -0.844 . . . . 1.0 110.478 -176.512 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 55.4 t -59.83 -60.34 2.66 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.512 0 C-N-CA 119.325 -0.95 . . . . 1.0 109.692 -178.278 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . 0.802 ' O ' ' HB3' ' A' ' 31' ' ' ALA . 62.1 t -58.57 -40.16 78.02 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.363 0 C-N-CA 120.543 -0.463 . . . . 1.0 110.534 -177.828 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 10.9 tttm -66.56 -55.26 16.27 Favored 'General case' 0 C--N 1.314 -0.946 0 C-N-CA 119.855 -0.738 . . . . 1.0 109.82 -178.701 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . 0.483 HG13 ' N ' ' A' ' 30' ' ' CYS . 3.2 p -65.82 -50.8 68.13 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 CA-C-N 115.294 -0.866 . . . . 1.0 111.011 -177.32 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 30' ' ' CYS . . . . . 0.483 ' N ' HG13 ' A' ' 29' ' ' VAL . 42.0 t -67.59 -62.61 1.34 Allowed 'General case' 0 N--CA 1.44 -0.945 0 C-N-CA 119.837 -0.745 . . . . 1.0 110.597 -179.208 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . 0.802 ' HB3' ' O ' ' A' ' 27' ' ' VAL . . . -62.74 -53.33 55.96 Favored 'General case' 0 N--CA 1.434 -1.273 0 C-N-CA 120.578 -0.449 . . . . 1.0 111.378 -175.459 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 69.8 66.23 2.3 Favored Glycine 0 N--CA 1.441 -1.022 0 C-N-CA 119.225 -1.464 . . . . 1.0 109.828 -179.428 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . 0.509 ' O ' ' CD1' ' A' ' 37' ' ' ILE . 6.2 mt 87.55 96.15 0.03 OUTLIER Pre-proline 0 N--CA 1.481 1.108 0 O-C-N 126.232 1.784 . . . . 1.0 112.049 -179.535 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 54.4 Cg_exo -46.23 -8.21 0.04 OUTLIER 'Trans proline' 0 N--CA 1.497 1.681 0 C-N-CA 122.39 2.06 . . . . 1.0 114.184 -179.825 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . 0.467 ' N ' ' O ' ' A' ' 33' ' ' LEU . . . -61.25 -60.27 8.59 Favored Glycine 0 CA--C 1.538 1.472 0 C-N-CA 118.466 -1.826 . . . . 1.0 109.867 -178.668 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . 0.855 HG22 ' H ' ' A' ' 37' ' ' ILE . 7.1 p -88.55 -139.84 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.473 0.687 0 CA-C-N 117.87 0.835 . . . . 1.0 109.072 179.369 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . 0.855 ' H ' HG22 ' A' ' 36' ' ' VAL . 2.5 mp 68.27 79.65 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.47 0.554 0 N-CA-C 112.575 0.583 . . . . 1.0 112.575 179.655 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 38' ' ' HIS . . . . . 0.515 ' CD2' ' N ' ' A' ' 38' ' ' HIS . 0.0 OUTLIER -138.86 132.47 30.54 Favored 'General case' 0 CA--C 1.532 0.266 0 N-CA-C 108.383 -0.969 . . . . 1.0 108.383 178.397 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -107.43 159.3 30.7 Favored Pre-proline 0 N--CA 1.472 0.671 0 CA-C-N 116.515 -0.312 . . . . 1.0 110.182 -178.353 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 59.6 Cg_endo -71.97 -23.44 21.89 Favored 'Trans proline' 0 C--N 1.306 -1.668 0 C-N-CA 121.736 1.624 . . . . 1.0 111.947 178.668 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -119.76 83.99 2.13 Favored 'General case' 0 C--N 1.343 0.3 0 C-N-CA 120.553 -0.459 . . . . 1.0 110.582 179.281 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . 0.673 ' C ' ' H ' ' A' ' 44' ' ' GLY . 0.0 OUTLIER -103.86 135.26 45.73 Favored 'General case' 0 C--N 1.318 -0.803 0 CA-C-N 116.003 -0.544 . . . . 1.0 110.171 -177.644 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild full ' A' A ' 43' ' ' ARG . . . . . 0.619 ' C ' ' H ' ' A' ' 45' ' ' PHE . 42.9 tpt85 -64.31 22.65 0.01 OUTLIER 'General case' 0 C--N 1.314 -0.943 0 C-N-CA 119.913 -0.715 . . . . 1.0 109.763 179.092 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . 0.673 ' H ' ' C ' ' A' ' 42' ' ' ARG . . . 70.45 -28.04 0.46 Allowed Glycine 0 C--N 1.345 1.053 0 N-CA-C 110.764 -0.934 . . . . 1.0 110.764 179.223 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . 0.621 ' O ' ' HB2' ' A' ' 46' ' ' PHE . 31.0 p90 -164.71 172.61 12.83 Favored 'General case' 0 N--CA 1.45 -0.47 0 N-CA-C 108.521 -0.918 . . . . 1.0 108.521 -179.807 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 46' ' ' PHE . . . . . 0.621 ' HB2' ' O ' ' A' ' 45' ' ' PHE . 1.7 t80 116.16 96.41 0.0 OUTLIER 'General case' 0 N--CA 1.484 1.236 0 O-C-N 125.701 1.875 . . . . 1.0 108.153 -178.499 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 47' ' ' ARG . . . . . 0.547 ' O ' ' CB ' ' A' ' 48' ' ' CYS . 3.9 mmp_? 115.16 133.41 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.611 0 O-C-N 125.06 1.475 . . . . 1.0 109.859 -179.551 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 48' ' ' CYS . . . . . 0.547 ' CB ' ' O ' ' A' ' 47' ' ' ARG . 43.7 t 121.95 -5.59 0.0 OUTLIER 'General case' 0 CA--C 1.51 -0.595 0 O-C-N 125.305 1.628 . . . . 1.0 111.059 177.406 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -120.59 149.89 51.16 Favored Pre-proline 0 CA--C 1.534 0.356 0 N-CA-C 109.84 -0.43 . . . . 1.0 109.84 179.867 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . 0.562 ' C ' ' H ' ' A' ' 52' ' ' ARG . 98.9 Cg_endo -76.46 87.16 1.47 Allowed 'Trans proline' 0 N--CA 1.493 1.47 0 C-N-CA 122.277 1.985 . . . . 1.0 114.041 -179.888 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . 0.433 ' CD ' ' O ' ' A' ' 50' ' ' PRO . 0.0 OUTLIER 66.44 -32.7 0.18 Allowed 'General case' 0 N--CA 1.472 0.649 0 N-CA-C 112.09 0.404 . . . . 1.0 112.09 176.269 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . 0.856 HH11 ' HB1' ' A' ' 86' ' ' ALA . 5.4 mtm180 -45.39 140.08 3.29 Favored 'General case' 0 C--N 1.315 -0.903 0 CA-C-O 121.941 0.877 . . . . 1.0 112.198 -178.094 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 2.2 tp -82.22 166.07 2.4 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 114.35 -1.295 . . . . 1.0 108.7 177.999 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 16.7 mt-30 -135.73 134.6 39.23 Favored 'General case' 0 N--CA 1.453 -0.288 0 N-CA-C 108.423 -0.954 . . . . 1.0 108.423 179.795 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 2.3 pp -142.68 153.66 17.6 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.366 0 N-CA-C 109.881 -0.414 . . . . 1.0 109.881 178.288 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 105.1 2.36 41.89 Favored Glycine 0 CA--C 1.529 0.95 0 N-CA-C 110.077 -1.209 . . . . 1.0 110.077 -178.348 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 58.0 m-20 -86.78 103.99 15.73 Favored 'General case' 0 N--CA 1.471 0.605 0 CA-C-O 122.141 0.972 . . . . 1.0 112.722 -178.333 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 58' ' ' TRP . . . . . 0.54 ' HB2' ' HB2' ' A' ' 61' ' ' GLU . 13.3 m95 -78.78 178.41 7.93 Favored 'General case' 0 C--N 1.315 -0.922 0 CA-C-N 113.484 -1.689 . . . . 1.0 108.937 177.879 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 59' ' ' ARG . . . . . 0.506 ' HG2' ' H ' ' A' ' 60' ' ' TYR . 0.0 OUTLIER -101.23 -56.95 2.19 Favored 'General case' 0 CA--C 1.557 1.244 0 CA-C-N 119.494 1.043 . . . . 1.0 112.533 178.814 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild full ' A' A ' 60' ' ' TYR . . . . . 0.506 ' H ' ' HG2' ' A' ' 59' ' ' ARG . 63.2 t80 -80.5 -13.5 59.05 Favored 'General case' 0 N--CA 1.485 1.305 0 C-N-CA 125.341 1.456 . . . . 1.0 112.581 -178.209 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . 0.541 ' O ' ' N ' ' A' ' 65' ' ' ASP . 10.1 mt-10 -79.49 -14.59 58.79 Favored 'General case' 0 C--N 1.298 -1.641 0 CA-C-N 114.963 -1.017 . . . . 1.0 108.903 178.244 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . 0.502 HG13 ' O ' ' A' ' 59' ' ' ARG . 13.4 m -44.26 -44.39 2.22 Favored 'Isoleucine or valine' 0 CA--C 1.491 -1.317 0 N-CA-C 109.331 -0.618 . . . . 1.0 109.331 -176.41 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 63' ' ' ALA . . . . . 0.548 ' O ' ' HG2' ' A' ' 67' ' ' ARG . . . -69.2 -46.74 66.71 Favored 'General case' 0 N--CA 1.411 -2.423 0 N-CA-C 107.947 -1.131 . . . . 1.0 107.947 177.61 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 64' ' ' HIS . . . . . 0.496 ' N ' ' O ' ' A' ' 61' ' ' GLU . 1.3 t-80 -56.04 -60.42 3.51 Favored 'General case' 0 CA--C 1.546 0.805 0 CA-C-N 115.512 -0.767 . . . . 1.0 111.049 178.891 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . 0.69 ' C ' ' H ' ' A' ' 67' ' ' ARG . 10.4 t70 -66.15 -54.69 22.35 Favored 'General case' 0 C--O 1.248 0.974 0 O-C-N 121.489 -0.757 . . . . 1.0 109.639 178.062 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . 0.456 ' N ' ' O ' ' A' ' 62' ' ' VAL . . . -63.22 32.49 0.08 OUTLIER Glycine 0 N--CA 1.471 0.982 0 N-CA-C 110.603 -0.999 . . . . 1.0 110.603 177.526 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 67' ' ' ARG . . . . . 0.723 ' HB3' ' H ' ' A' ' 71' ' ' ALA . 0.2 OUTLIER -75.75 1.74 13.97 Favored 'General case' 0 N--CA 1.435 -1.197 0 CA-C-N 114.639 -0.781 . . . . 1.0 109.113 175.71 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . 0.538 ' O ' ' HA ' ' A' ' 72' ' ' HIS . 10.2 mp -33.72 -29.67 0.01 OUTLIER 'General case' 0 N--CA 1.501 2.118 0 N-CA-C 106.848 -1.538 . . . . 1.0 106.848 -177.597 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . 0.63 ' N ' ' O ' ' A' ' 67' ' ' ARG . 5.2 tp -61.85 -65.61 0.66 Allowed 'General case' 0 CA--C 1.553 1.06 0 C-N-CA 117.825 -1.55 . . . . 1.0 107.441 175.439 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . 0.642 ' O ' ' CG ' ' A' ' 72' ' ' HIS . . . -75.32 -68.59 0.54 Allowed 'General case' 0 N--CA 1.477 0.9 0 N-CA-C 106.456 -1.683 . . . . 1.0 106.456 175.684 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . 0.723 ' H ' ' HB3' ' A' ' 67' ' ' ARG . . . -47.17 2.54 0.0 OUTLIER 'General case' 0 N--CA 1.477 0.922 0 C-N-CA 124.686 1.194 . . . . 1.0 113.48 178.876 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 72' ' ' HIS . . . . . 0.642 ' CG ' ' O ' ' A' ' 70' ' ' ALA . 0.3 OUTLIER -19.94 -82.63 0.0 OUTLIER 'General case' 0 C--N 1.324 -0.525 0 N-CA-C 113.589 0.959 . . . . 1.0 113.589 -174.259 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild full ' A' A ' 73' ' ' MET . . . . . 0.641 ' H ' ' CD2' ' A' ' 72' ' ' HIS . 0.7 OUTLIER -74.29 -41.79 60.62 Favored 'General case' 0 C--N 1.3 -1.545 0 CA-C-N 118.928 0.786 . . . . 1.0 111.122 178.389 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . 0.594 ' O ' ' N ' ' A' ' 76' ' ' GLY . 0.8 OUTLIER -44.74 -41.78 2.22 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.796 0 C-N-CA 119.694 -0.803 . . . . 1.0 110.441 -174.62 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild full ' A' A ' 75' ' ' ASN . . . . . 0.567 ' O ' ' N ' ' A' ' 77' ' ' ILE . 28.2 t30 -39.16 -17.9 0.01 OUTLIER 'General case' 0 N--CA 1.48 1.033 0 CA-C-O 122.401 1.096 . . . . 1.0 110.964 178.029 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . 0.728 ' O ' HD12 ' A' ' 79' ' ' ILE . . . -43.41 -16.14 0.03 OUTLIER Glycine 0 CA--C 1.564 3.095 0 N-CA-C 108.634 -1.786 . . . . 1.0 108.634 176.051 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . 0.784 ' O ' ' N ' ' A' ' 80' ' ' ALA . 2.6 pp -89.91 -46.0 15.08 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.227 0 N-CA-C 108.428 -0.953 . . . . 1.0 108.428 -179.354 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . 0.501 ' N ' HD12 ' A' ' 77' ' ' ILE . 1.0 OUTLIER -34.34 -27.94 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.571 1.766 0 N-CA-C 108.775 -0.824 . . . . 1.0 108.775 -174.816 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . 0.934 HD13 ' N ' ' A' ' 80' ' ' ALA . 0.0 OUTLIER -92.0 -17.32 7.64 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.907 0 C-N-CA 124.86 1.264 . . . . 1.0 111.765 177.383 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild full ' A' A ' 80' ' ' ALA . . . . . 0.934 ' N ' HD13 ' A' ' 79' ' ' ILE . . . -65.86 -14.05 60.74 Favored 'General case' 0 C--N 1.321 -0.639 0 O-C-N 122.156 -0.34 . . . . 1.0 111.215 178.105 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 34.6 mt-10 -122.78 -47.89 2.05 Favored 'General case' 0 N--CA 1.47 0.534 0 CA-C-O 121.767 0.794 . . . . 1.0 109.435 175.759 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -59.94 -62.08 2.13 Favored 'General case' 0 CA--C 1.53 0.209 0 CA-C-N 115.22 -0.9 . . . . 1.0 109.314 -179.745 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . 0.648 ' HB3' ' O ' ' A' ' 79' ' ' ILE . . . -47.5 -45.23 26.21 Favored 'General case' 0 N--CA 1.467 0.42 0 CA-C-N 116.587 -0.279 . . . . 1.0 110.798 -179.248 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . 0.545 HD13 ' O ' ' A' ' 80' ' ' ALA . 1.5 tp -28.83 -44.85 0.03 OUTLIER 'General case' 0 N--CA 1.483 1.187 0 CA-C-N 116.36 -0.382 . . . . 1.0 111.636 -174.683 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 85' ' ' ILE . . . . . 0.438 HG13 ' H ' ' A' ' 86' ' ' ALA . 3.4 pt -91.57 -49.77 13.07 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.742 0 N-CA-C 109.102 -0.703 . . . . 1.0 109.102 177.138 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . 0.856 ' HB1' HH11 ' A' ' 52' ' ' ARG . . . -48.22 -36.0 12.97 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.608 -0.724 . . . . 1.0 110.261 -178.723 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 5.3 mm-40 -57.51 -23.56 50.93 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.864 -0.607 . . . . 1.0 110.051 179.213 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -73.26 -9.51 58.79 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 121.22 0.533 . . . . 1.0 109.733 179.505 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 89' ' ' VAL . . . . . 0.629 ' O ' HG12 ' A' ' 89' ' ' VAL . 40.5 t -105.46 36.91 0.37 Allowed 'Isoleucine or valine' 0 C--O 1.234 0.268 0 CA-C-N 115.433 -0.803 . . . . 1.0 109.413 179.198 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 90' ' ' GLY . . . . . 0.537 ' O ' ' N ' ' A' ' 92' ' ' HIS . . . -66.71 -43.11 92.65 Favored Glycine 0 CA--C 1.539 1.531 0 N-CA-C 111.205 -0.758 . . . . 1.0 111.205 178.859 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 91' ' ' PRO . . . . . 0.472 ' CD ' ' N ' ' A' ' 90' ' ' GLY . 87.3 Cg_exo -42.3 -15.33 0.05 OUTLIER 'Trans proline' 0 N--CA 1.497 1.71 0 C-N-CA 122.03 1.82 . . . . 1.0 112.386 179.982 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 92' ' ' HIS . . . . . 0.537 ' N ' ' O ' ' A' ' 90' ' ' GLY . 5.6 p-80 -60.52 -15.51 28.05 Favored 'General case' 0 C--N 1.322 -0.601 0 N-CA-C 108.662 -0.866 . . . . 1.0 108.662 179.52 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . 0.737 HD12 ' N ' ' A' ' 94' ' ' ALA . 2.3 pp -72.95 -58.48 3.29 Favored 'General case' 0 C--N 1.323 -0.557 0 N-CA-C 108.836 -0.801 . . . . 1.0 108.836 179.915 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 94' ' ' ALA . . . . . 0.737 ' N ' HD12 ' A' ' 93' ' ' LEU . . . -59.23 -55.8 30.25 Favored 'General case' 0 C--O 1.236 0.391 0 CA-C-O 120.907 0.384 . . . . 1.0 109.997 179.744 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 95' ' ' ARG . . . . . 0.73 ' O ' ' N ' ' A' ' 97' ' ' LEU . 11.1 ttm180 -52.85 -59.3 4.67 Favored 'General case' 0 C--O 1.24 0.558 0 N-CA-C 107.079 -1.452 . . . . 1.0 107.079 178.777 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 96' ' ' ALA . . . . . 0.875 ' O ' ' N ' ' A' ' 98' ' ' GLY . . . -46.4 -7.67 0.01 OUTLIER 'General case' 0 N--CA 1.427 -1.616 0 O-C-N 119.029 -2.295 . . . . 1.0 112.525 -177.33 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . 0.73 ' N ' ' O ' ' A' ' 95' ' ' ARG . 0.4 OUTLIER 2.85 -50.57 0.0 OUTLIER 'General case' 0 C--N 1.36 1.062 0 O-C-N 124.776 1.297 . . . . 1.0 110.522 -169.447 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild full ' A' A ' 98' ' ' GLY . . . . . 0.952 ' O ' HG12 ' A' ' 101' ' ' VAL . . . -52.65 -17.52 4.67 Favored Glycine 0 N--CA 1.422 -2.265 0 CA-C-N 122.088 2.222 . . . . 1.0 107.902 174.001 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 99' ' ' GLN . . . . . 0.697 ' N ' ' O ' ' A' ' 96' ' ' ALA . 68.8 tp60 -73.96 -25.31 59.88 Favored 'General case' 0 CA--C 1.512 -0.5 0 C-N-CA 117.746 -1.582 . . . . 1.0 107.066 178.69 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 100' ' ' ILE . . . . . 0.619 ' N ' ' O ' ' A' ' 97' ' ' LEU . 4.9 tt -62.55 -35.51 70.49 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.883 0 CA-C-N 114.522 -1.217 . . . . 1.0 110.207 178.617 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 101' ' ' VAL . . . . . 0.952 HG12 ' O ' ' A' ' 98' ' ' GLY . 8.7 p -61.83 -58.69 6.42 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.698 0 C-N-CA 118.514 -1.274 . . . . 1.0 108.976 -179.599 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 102' ' ' CYS . . . . . 0.994 ' O ' ' HB2' ' A' ' 106' ' ' ALA . 0.1 OUTLIER -42.23 -24.53 0.05 Allowed 'General case' 0 N--CA 1.437 -1.104 0 N-CA-C 112.109 0.411 . . . . 1.0 112.109 -177.451 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild full ' A' A ' 103' ' ' ARG . . . . . 0.428 ' N ' ' O ' ' A' ' 101' ' ' VAL . 9.4 ttp180 -88.81 -33.15 17.52 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-O 122.435 1.112 . . . . 1.0 111.207 178.39 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 104' ' ' TYR . . . . . 0.689 ' O ' ' CG ' ' A' ' 104' ' ' TYR . 0.3 OUTLIER -100.71 17.49 21.81 Favored 'General case' 0 C--N 1.312 -1.044 0 CA-C-N 113.365 -1.743 . . . . 1.0 109.822 177.352 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild full ' A' A ' 105' ' ' GLY . . . . . 0.528 ' N ' ' O ' ' A' ' 101' ' ' VAL . . . -165.29 -82.3 0.05 OUTLIER Glycine 0 N--CA 1.447 -0.599 0 N-CA-C 106.945 -2.462 . . . . 1.0 106.945 175.97 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 106' ' ' ALA . . . . . 0.994 ' HB2' ' O ' ' A' ' 102' ' ' CYS . . . 70.47 68.89 0.2 Allowed 'General case' 0 N--CA 1.437 -1.094 0 N-CA-C 112.256 0.465 . . . . 1.0 112.256 179.043 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 107' ' ' THR . . . . . 0.575 ' O ' ' HG2' ' A' ' 110' ' ' PRO . 25.2 m -76.27 -55.46 5.55 Favored 'General case' 0 C--O 1.213 -0.819 0 O-C-N 120.737 -1.227 . . . . 1.0 109.433 177.907 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . 0.604 ' O ' ' HB2' ' A' ' 111' ' ' ASN . 35.7 m -72.54 -48.39 47.2 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.205 0 CA-C-O 121.283 0.563 . . . . 1.0 111.692 -178.72 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 109' ' ' ILE . . . . . 0.57 ' N ' HG23 ' A' ' 108' ' ' VAL . 0.0 OUTLIER -41.31 -45.6 7.19 Favored Pre-proline 0 C--N 1.316 -0.854 0 CA-C-O 118.001 -0.999 . . . . 1.0 109.737 -178.027 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild full ' A' A ' 110' ' ' PRO . . . . . 0.575 ' HG2' ' O ' ' A' ' 107' ' ' THR . 72.6 Cg_endo -63.21 -18.06 63.08 Favored 'Trans proline' 0 C--O 1.2 -1.418 0 CA-C-N 122.388 1.889 . . . . 1.0 111.25 177.65 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 111' ' ' ASN . . . . . 0.604 ' HB2' ' O ' ' A' ' 108' ' ' VAL . 0.4 OUTLIER -62.2 -66.26 0.57 Allowed 'General case' 0 N--CA 1.478 0.974 0 N-CA-C 108.375 -0.972 . . . . 1.0 108.375 178.803 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild full ' A' A ' 112' ' ' ILE . . . . . 0.61 ' O ' ' HB ' ' A' ' 116' ' ' ILE . 1.5 pt -48.27 -22.78 0.66 Allowed 'Isoleucine or valine' 0 C--O 1.219 -0.51 0 N-CA-C 107.864 -1.161 . . . . 1.0 107.864 179.714 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 113' ' ' ASN . . . . . 0.726 ' O ' ' HB2' ' A' ' 117' ' ' GLU . 11.8 m-20 -84.61 -53.68 5.23 Favored 'General case' 0 N--CA 1.44 -0.935 0 CA-C-O 124.01 1.862 . . . . 1.0 110.063 177.474 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 114' ' ' ALA . . . . . 0.449 ' N ' ' O ' ' A' ' 110' ' ' PRO . . . -56.12 -55.78 28.92 Favored 'General case' 0 C--N 1.29 -1.979 0 CA-C-N 114.376 -1.284 . . . . 1.0 109.619 -178.952 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -80.38 -61.02 2.1 Favored 'General case' 0 C--O 1.244 0.81 0 N-CA-C 114.554 1.316 . . . . 1.0 114.554 179.706 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 116' ' ' ILE . . . . . 0.61 ' HB ' ' O ' ' A' ' 112' ' ' ILE . 36.4 mm -72.46 -40.03 63.18 Favored 'Isoleucine or valine' 0 C--O 1.211 -0.938 0 N-CA-C 114.35 1.241 . . . . 1.0 114.35 -175.234 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 117' ' ' GLU . . . . . 0.726 ' HB2' ' O ' ' A' ' 113' ' ' ASN . 1.2 tt0 -51.85 -62.78 1.41 Allowed 'General case' 0 CA--C 1.486 -1.484 0 CA-C-N 118.12 0.418 . . . . 1.0 110.611 -176.334 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 38.8 t -55.54 -14.23 1.31 Allowed 'Isoleucine or valine' 0 N--CA 1.424 -1.774 0 C-N-CA 117.836 -1.546 . . . . 1.0 109.253 -177.244 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 119' ' ' LEU . . . . . 0.416 ' N ' ' C ' ' A' ' 117' ' ' GLU . 1.1 tp -92.54 -56.66 2.94 Favored 'General case' 0 CA--C 1.552 1.044 0 N-CA-C 113.682 0.993 . . . . 1.0 113.682 176.857 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -68.75 -50.52 35.58 Favored Glycine 0 C--N 1.358 1.764 0 C-N-CA 120.062 -1.066 . . . . 1.0 114.47 -174.68 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 1.9 t 155.56 -40.0 0.01 OUTLIER 'General case' 0 N--CA 1.476 0.865 0 N-CA-C 106.396 -1.705 . . . . 1.0 106.396 -178.273 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 122' ' ' GLY . . . . . 0.51 ' O ' ' N ' ' A' ' 124' ' ' ASP . . . 113.62 -34.37 5.05 Favored Glycine 0 CA--C 1.532 1.108 0 C-N-CA 126.217 1.865 . . . . 1.0 112.862 179.684 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 123' ' ' THR . . . . . 0.446 ' C ' ' O ' ' A' ' 122' ' ' GLY . 33.4 m -32.84 90.91 0.0 OUTLIER 'General case' 0 N--CA 1.486 1.341 0 CA-C-N 120.219 2.009 . . . . 1.0 112.01 -178.698 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 124' ' ' ASP . . . . . 0.51 ' N ' ' O ' ' A' ' 122' ' ' GLY . 39.7 m-20 -145.52 146.16 31.33 Favored 'General case' 0 CA--C 1.537 0.457 0 N-CA-C 108.763 -0.828 . . . . 1.0 108.763 178.089 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 125' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -153.7 150.58 28.71 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-O 120.85 0.357 . . . . 1.0 110.195 -178.851 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 126' ' ' ARG . . . . . 0.589 ' HB3' ' H62' ' A' ' 130' ' ' MTN . 2.7 tpt180 -149.08 151.26 34.13 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.894 -0.594 . . . . 1.0 109.801 177.059 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 127' ' ' PHE . . . . . 0.669 ' OXT' ' H63' ' A' ' 130' ' ' MTN . 19.5 m-85 . . . . . 0 C--O 1.218 -0.583 0 CA-C-O 117.973 -1.013 . . . . 1.0 112.043 -178.864 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 128' ' ' MTN . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 027 nuclear nobuild full ' A' A ' 129' ' ' MTN . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 027 nuclear nobuild full ' A' A ' 130' ' ' MTN . . . . . 0.669 ' H63' ' OXT' ' A' ' 127' ' ' PHE . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.444 ' SD ' ' CD2' ' A' ' 4' ' ' PHE . 38.2 mtt . . . . . 0 N--CA 1.49 1.545 0 N-CA-C 108.503 -0.925 . . . . 1.0 108.503 . . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . 0.46 ' O ' ' CB ' ' A' ' 3' ' ' ASP . 14.8 m -95.31 10.5 35.96 Favored 'General case' 0 N--CA 1.466 0.357 0 C-N-CA 122.628 0.371 . . . . 1.0 110.939 -179.503 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . 0.46 ' CB ' ' O ' ' A' ' 2' ' ' SER . 0.2 OUTLIER 157.4 109.21 0.0 OUTLIER 'General case' 0 N--CA 1.473 0.687 0 O-C-N 124.077 0.861 . . . . 1.0 109.999 178.87 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . 0.444 ' CD2' ' SD ' ' A' ' 1' ' ' MET . 14.9 t80 -152.99 148.21 26.82 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.121 -0.49 . . . . 1.0 110.515 179.695 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 5' ' ' ASP . . . . . 0.4 ' OD1' ' O ' ' A' ' 4' ' ' PHE . 9.5 m-20 -154.23 150.16 27.76 Favored 'General case' 0 CA--C 1.536 0.407 0 N-CA-C 109.404 -0.591 . . . . 1.0 109.404 179.761 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 6' ' ' THR . . . . . 0.511 ' O ' ' N ' ' A' ' 10' ' ' SER . 0.2 OUTLIER -62.2 167.51 3.99 Favored 'General case' 0 C--O 1.218 -0.603 0 C-N-CA 120.126 -0.63 . . . . 1.0 110.216 -178.804 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . 0.582 ' O ' ' N ' ' A' ' 11' ' ' ARG . 3.1 tt0 -59.69 -58.37 8.86 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-O 121.401 0.62 . . . . 1.0 110.45 -177.947 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 8' ' ' ARG . . . . . 0.485 ' O ' ' CB ' ' A' ' 12' ' ' ALA . 18.2 ttm180 -51.16 -54.85 21.51 Favored 'General case' 0 C--N 1.311 -1.083 0 N-CA-C 108.174 -1.047 . . . . 1.0 108.174 -177.159 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . 0.823 ' O ' HG13 ' A' ' 13' ' ' VAL . 6.8 p -62.09 -48.82 86.71 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.127 0 CA-C-N 114.067 -1.424 . . . . 1.0 109.819 178.901 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . 0.511 ' N ' ' O ' ' A' ' 6' ' ' THR . 42.8 t -62.43 -59.58 4.77 Favored 'General case' 0 N--CA 1.481 1.105 0 C-N-CA 120.198 -0.601 . . . . 1.0 109.702 -179.995 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 11' ' ' ARG . . . . . 0.582 ' N ' ' O ' ' A' ' 7' ' ' GLU . 0.4 OUTLIER -62.59 -57.44 11.09 Favored 'General case' 0 C--N 1.317 -0.823 0 O-C-N 121.742 -0.599 . . . . 1.0 110.19 -178.324 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . 0.531 ' O ' ' HB3' ' A' ' 16' ' ' ALA . . . -50.36 -51.58 44.58 Favored 'General case' 0 N--CA 1.476 0.861 0 N-CA-C 108.004 -1.11 . . . . 1.0 108.004 -178.091 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . 0.823 HG13 ' O ' ' A' ' 9' ' ' VAL . 4.5 m -60.78 -50.13 81.75 Favored 'Isoleucine or valine' 0 C--O 1.203 -1.344 0 C-N-CA 116.92 -1.912 . . . . 1.0 108.029 177.632 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . 0.502 ' O ' HG23 ' A' ' 18' ' ' VAL . . . -57.44 -62.68 1.6 Allowed 'General case' 0 N--CA 1.479 1.008 0 C-N-CA 118.633 -1.227 . . . . 1.0 110.929 179.013 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . 0.549 ' N ' ' O ' ' A' ' 11' ' ' ARG . . . -55.51 -55.8 27.65 Favored 'General case' 0 N--CA 1.47 0.557 0 CA-C-O 121.413 0.625 . . . . 1.0 110.208 -178.473 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . 0.531 ' HB3' ' O ' ' A' ' 12' ' ' ALA . . . -58.05 -53.94 52.58 Favored 'General case' 0 C--N 1.317 -0.811 0 N-CA-C 108.138 -1.06 . . . . 1.0 108.138 -179.313 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . 0.599 ' CB ' ' O ' ' A' ' 13' ' ' VAL . 39.4 tp -53.86 -48.96 69.48 Favored 'General case' 0 N--CA 1.482 1.135 0 CA-C-N 113.513 -1.676 . . . . 1.0 107.662 -178.059 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . 0.502 HG23 ' O ' ' A' ' 14' ' ' ALA . 54.1 t -67.3 -58.4 6.41 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.504 0 CA-C-O 121.076 0.465 . . . . 1.0 110.223 179.94 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . 0.528 ' N ' ' O ' ' A' ' 15' ' ' ALA . . . -71.03 -163.96 5.47 Favored Glycine 0 CA--C 1.526 0.765 0 CA-C-N 115.5 -0.773 . . . . 1.0 112.054 -178.64 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 20' ' ' PRO . . . . . 0.571 ' O ' ' N ' ' A' ' 24' ' ' ALA . 57.5 Cg_endo -79.59 -27.23 4.24 Favored 'Trans proline' 0 N--CA 1.492 1.39 0 C-N-CA 122.72 2.28 . . . . 1.0 115.443 -178.098 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -59.0 -58.45 14.52 Favored Glycine 0 N--CA 1.477 1.414 0 C-N-CA 119.097 -1.525 . . . . 1.0 110.965 -177.01 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . 0.499 ' N ' ' HB1' ' A' ' 16' ' ' ALA . . . -59.21 -54.91 33.94 Favored Glycine 0 N--CA 1.467 0.749 0 N-CA-C 107.843 -2.103 . . . . 1.0 107.843 -178.387 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . 0.557 ' O ' HG12 ' A' ' 27' ' ' VAL . 54.1 t -57.36 -36.96 54.61 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.907 0 CA-C-N 114.721 -0.74 . . . . 1.0 109.814 -179.472 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . 0.571 ' N ' ' O ' ' A' ' 20' ' ' PRO . . . -57.66 -60.58 3.46 Favored 'General case' 0 C--N 1.325 -0.483 0 C-N-CA 118.93 -1.108 . . . . 1.0 109.182 -179.851 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 9.3 tp -63.19 -44.05 96.48 Favored 'General case' 0 C--N 1.347 0.47 0 CA-C-N 119.325 0.966 . . . . 1.0 111.73 -178.907 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 72.6 t -61.05 -60.77 2.13 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.176 0 C-N-CA 118.364 -1.334 . . . . 1.0 110.504 -177.748 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . 0.603 ' O ' ' HB3' ' A' ' 31' ' ' ALA . 2.4 p -58.57 -37.41 64.78 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.417 0 N-CA-C 113.264 0.838 . . . . 1.0 113.264 -177.539 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 35.9 ttmt -67.67 -53.27 29.13 Favored 'General case' 0 C--N 1.315 -0.899 0 CA-C-O 122.102 0.953 . . . . 1.0 108.811 -178.719 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 80.2 t -63.82 -48.93 84.18 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.074 0 CA-C-N 113.743 -1.571 . . . . 1.0 110.891 -177.542 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 30' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -65.34 -60.88 2.51 Favored 'General case' 0 N--CA 1.449 -0.487 0 C-N-CA 118.868 -1.133 . . . . 1.0 109.496 -179.756 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . 0.603 ' HB3' ' O ' ' A' ' 27' ' ' VAL . . . -64.83 -54.44 30.99 Favored 'General case' 0 C--N 1.331 -0.225 0 N-CA-C 113.605 0.965 . . . . 1.0 113.605 -175.901 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 84.36 75.77 1.2 Allowed Glycine 0 CA--C 1.527 0.798 0 N-CA-C 109.421 -1.472 . . . . 1.0 109.421 -177.81 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . 0.52 ' O ' ' O ' ' A' ' 36' ' ' VAL . 12.3 mt 85.55 85.37 0.05 OUTLIER Pre-proline 0 N--CA 1.479 0.983 0 C-N-CA 123.711 0.804 . . . . 1.0 110.49 -178.9 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 53.0 Cg_exo -54.93 -30.89 71.13 Favored 'Trans proline' 0 N--CA 1.508 2.342 0 C-N-CA 123.253 2.635 . . . . 1.0 114.307 -179.832 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . 0.407 ' C ' HD11 ' A' ' 116' ' ' ILE . . . -58.81 -58.04 16.67 Favored Glycine 0 CA--C 1.525 0.678 0 C-N-CA 118.759 -1.686 . . . . 1.0 109.651 -178.369 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . 0.657 ' O ' HG22 ' A' ' 37' ' ' ILE . 7.1 p -97.82 165.27 2.17 Favored 'Isoleucine or valine' 0 C--O 1.219 -0.55 0 N-CA-C 106.71 -1.589 . . . . 1.0 106.71 178.266 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . 0.657 HG22 ' O ' ' A' ' 36' ' ' VAL . 8.1 tt 117.82 123.23 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.481 1.097 0 C-N-CA 123.927 0.891 . . . . 1.0 109.596 -179.19 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 21.9 m80 -140.64 131.41 25.81 Favored 'General case' 0 C--N 1.324 -0.513 0 N-CA-C 107.902 -1.147 . . . . 1.0 107.902 178.724 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -90.03 146.45 35.09 Favored Pre-proline 0 C--N 1.33 -0.247 0 N-CA-C 108.955 -0.757 . . . . 1.0 108.955 -179.747 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -72.92 -44.01 0.69 Allowed 'Trans proline' 0 C--N 1.307 -1.619 0 C-N-CA 121.641 1.56 . . . . 1.0 112.579 -179.24 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -126.17 130.06 50.25 Favored 'General case' 0 CA--C 1.518 -0.266 0 CA-C-N 116.254 -0.43 . . . . 1.0 110.118 -179.608 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . 0.609 ' C ' ' H ' ' A' ' 44' ' ' GLY . 0.0 OUTLIER -169.49 157.27 7.17 Favored 'General case' 0 C--N 1.313 -0.997 0 N-CA-C 106.016 -1.846 . . . . 1.0 106.016 177.976 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild full ' A' A ' 43' ' ' ARG . . . . . 0.436 ' O ' ' CG ' ' A' ' 43' ' ' ARG . 10.3 ttt85 -64.82 33.81 0.02 OUTLIER 'General case' 0 CA--C 1.529 0.137 0 CA-C-N 119.866 1.212 . . . . 1.0 112.115 -178.266 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . 0.609 ' H ' ' C ' ' A' ' 42' ' ' ARG . . . 91.42 -24.3 20.39 Favored Glycine 0 CA--C 1.522 0.484 0 N-CA-C 110.426 -1.069 . . . . 1.0 110.426 179.995 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . 0.526 ' CZ ' ' OD2' ' A' ' 57' ' ' ASP . 50.0 p90 -177.49 -178.93 0.79 Allowed 'General case' 0 CA--C 1.54 0.576 0 CA-C-O 120.85 0.357 . . . . 1.0 111.623 -179.941 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER 165.03 15.46 0.0 OUTLIER 'General case' 0 N--CA 1.487 1.389 0 CA-C-N 114.947 -1.024 . . . . 1.0 113.139 177.073 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 47' ' ' ARG . . . . . 0.639 ' O ' ' SG ' ' A' ' 48' ' ' CYS . 2.5 mtp-105 -176.38 -179.12 1.02 Allowed 'General case' 0 C--N 1.315 -0.905 0 N-CA-C 108.591 -0.892 . . . . 1.0 108.591 -179.072 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 48' ' ' CYS . . . . . 0.674 ' O ' ' SG ' ' A' ' 48' ' ' CYS . 1.5 p 61.43 63.49 1.19 Allowed 'General case' 0 C--N 1.341 0.206 0 CA-C-O 121.68 0.752 . . . . 1.0 110.084 -179.326 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 49' ' ' ASN . . . . . 0.449 ' OD1' ' NE2' ' A' ' 54' ' ' GLN . 0.2 OUTLIER -137.14 143.53 42.31 Favored Pre-proline 0 CA--C 1.535 0.39 0 N-CA-C 108.552 -0.907 . . . . 1.0 108.552 179.418 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . 0.494 ' HG2' HH11 ' A' ' 52' ' ' ARG . 94.7 Cg_endo -73.01 61.85 3.94 Favored 'Trans proline' 0 N--CA 1.497 1.719 0 C-N-CA 122.251 1.967 . . . . 1.0 112.431 -179.476 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 97.8 mt-10 59.34 6.13 0.71 Allowed 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.975 -0.557 . . . . 1.0 111.84 179.595 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . 0.494 HH11 ' HG2' ' A' ' 50' ' ' PRO . 75.0 mtt85 -82.91 139.12 33.58 Favored 'General case' 0 N--CA 1.465 0.291 0 N-CA-C 109.029 -0.73 . . . . 1.0 109.029 177.971 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . 0.465 HG23 HG22 ' A' ' 55' ' ' ILE . 13.0 tt -67.42 137.92 23.78 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.276 0 CA-C-O 122.647 1.213 . . . . 1.0 113.691 -177.314 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 54' ' ' GLN . . . . . 0.449 ' NE2' ' OD1' ' A' ' 49' ' ' ASN . 1.8 mp0 -64.13 78.59 0.04 OUTLIER 'General case' 0 CA--C 1.545 0.753 0 CA-C-N 112.38 -2.191 . . . . 1.0 108.984 -178.464 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . 0.465 HG22 HG23 ' A' ' 53' ' ' ILE . 18.0 tt -148.15 154.96 10.06 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.667 0 CA-C-N 115.997 -0.547 . . . . 1.0 109.99 178.251 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 109.59 -3.46 30.8 Favored Glycine 0 N--CA 1.471 0.998 0 N-CA-C 109.914 -1.274 . . . . 1.0 109.914 -179.594 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . 0.526 ' OD2' ' CZ ' ' A' ' 45' ' ' PHE . 37.6 m-20 -83.96 100.93 11.35 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 114.249 -0.975 . . . . 1.0 110.091 179.448 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 58' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -86.52 173.68 9.44 Favored 'General case' 0 N--CA 1.471 0.595 0 CA-C-O 123.65 1.69 . . . . 1.0 113.41 -178.287 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 59' ' ' ARG . . . . . 0.423 HH11 ' HD2' ' A' ' 59' ' ' ARG . 24.9 mtm180 -79.44 -56.23 4.47 Favored 'General case' 0 C--N 1.309 -1.175 0 CA-C-N 110.402 -3.09 . . . . 1.0 112.161 -179.428 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -91.1 -11.73 37.72 Favored 'General case' 0 C--O 1.249 1.046 0 CA-C-N 114.81 -1.086 . . . . 1.0 113.916 -178.372 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . 0.405 ' O ' ' N ' ' A' ' 65' ' ' ASP . 9.3 pt-20 -76.57 -13.95 60.04 Favored 'General case' 0 C--N 1.318 -0.784 0 N-CA-C 113.298 0.851 . . . . 1.0 113.298 -177.615 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . 0.623 ' O ' ' N ' ' A' ' 66' ' ' GLY . 0.2 OUTLIER -49.52 -58.7 1.25 Allowed 'Isoleucine or valine' 0 C--O 1.207 -1.165 0 C-N-CA 118.857 -1.137 . . . . 1.0 109.209 -175.829 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -66.77 -61.5 1.93 Allowed 'General case' 0 C--N 1.302 -1.459 0 CA-C-O 120.874 0.369 . . . . 1.0 110.907 -179.01 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 2.3 t-80 -48.4 -56.72 7.43 Favored 'General case' 0 CA--C 1.535 0.389 0 C-N-CA 119.419 -0.912 . . . . 1.0 108.93 -178.916 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . 0.866 ' O ' HD22 ' A' ' 68' ' ' LEU . 19.2 t70 -70.08 -45.5 66.89 Favored 'General case' 0 C--O 1.207 -1.171 0 CA-C-N 115.072 -0.967 . . . . 1.0 111.197 179.761 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . 0.623 ' N ' ' O ' ' A' ' 62' ' ' VAL . . . -77.49 26.35 1.93 Allowed Glycine 0 N--CA 1.471 1.002 0 N-CA-C 111.018 -0.833 . . . . 1.0 111.018 179.715 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 67' ' ' ARG . . . . . 0.438 ' H ' ' C ' ' A' ' 65' ' ' ASP . 57.7 ttt180 -95.76 -9.95 30.4 Favored 'General case' 0 CA--C 1.536 0.406 0 N-CA-C 107.971 -1.122 . . . . 1.0 107.971 172.832 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . 0.866 HD22 ' O ' ' A' ' 65' ' ' ASP . 0.0 OUTLIER -69.87 -37.81 76.22 Favored 'General case' 0 C--O 1.197 -1.681 0 CA-C-N 114.303 -1.317 . . . . 1.0 112.974 -178.044 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . 0.519 ' O ' ' ND1' ' A' ' 72' ' ' HIS . 7.8 tt -44.81 -58.31 3.19 Favored 'General case' 0 N--CA 1.475 0.794 0 C-N-CA 118.302 -1.359 . . . . 1.0 108.869 -176.121 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . 0.578 ' O ' ' CE1' ' A' ' 72' ' ' HIS . . . -51.61 -72.3 0.05 Allowed 'General case' 0 C--N 1.317 -0.837 0 N-CA-C 104.937 -2.246 . . . . 1.0 104.937 177.884 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . 0.729 ' O ' ' N ' ' A' ' 73' ' ' MET . . . -64.87 18.21 0.02 OUTLIER 'General case' 0 C--N 1.316 -0.877 0 C-N-CA 128.04 2.536 . . . . 1.0 114.251 178.385 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 72' ' ' HIS . . . . . 0.826 ' N ' ' O ' ' A' ' 68' ' ' LEU . 0.0 OUTLIER -24.78 -17.95 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.557 0 N-CA-C 115.589 1.7 . . . . 1.0 115.589 -174.461 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild full ' A' A ' 73' ' ' MET . . . . . 0.729 ' N ' ' O ' ' A' ' 71' ' ' ALA . 72.5 mtp -73.39 -25.09 60.42 Favored 'General case' 0 CA--C 1.545 0.768 0 CA-C-N 119.986 1.266 . . . . 1.0 108.551 176.965 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . 0.725 ' O ' ' N ' ' A' ' 76' ' ' GLY . 90.8 t -61.53 -52.66 58.46 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.672 0 CA-C-N 114.444 -1.253 . . . . 1.0 108.84 178.857 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 75' ' ' ASN . . . . . 0.439 ' O ' HG22 ' A' ' 79' ' ' ILE . 27.5 t-20 -32.61 -13.75 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.667 0 N-CA-C 113.444 0.905 . . . . 1.0 113.444 -178.26 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . 0.725 ' N ' ' O ' ' A' ' 74' ' ' VAL . . . -50.88 -22.26 5.88 Favored Glycine 0 CA--C 1.539 1.539 0 N-CA-C 109.344 -1.502 . . . . 1.0 109.344 176.045 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . 0.566 HG13 ' H ' ' A' ' 78' ' ' VAL . 0.5 OUTLIER -78.0 -63.95 1.0 Allowed 'Isoleucine or valine' 0 C--O 1.218 -0.568 0 CA-C-O 121.947 0.88 . . . . 1.0 109.432 179.203 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . 0.566 ' H ' HG13 ' A' ' 77' ' ' ILE . 74.8 t -34.87 -33.66 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.318 -0.766 0 CA-C-N 112.719 -2.037 . . . . 1.0 106.309 -177.105 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . 0.622 HD13 ' N ' ' A' ' 80' ' ' ALA . 0.0 OUTLIER -97.39 -34.42 4.82 Favored 'Isoleucine or valine' 0 CA--C 1.569 1.699 0 CA-C-N 115.585 -0.734 . . . . 1.0 111.905 175.134 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild full ' A' A ' 80' ' ' ALA . . . . . 0.622 ' N ' HD13 ' A' ' 79' ' ' ILE . . . -84.82 -10.35 57.26 Favored 'General case' 0 N--CA 1.492 1.642 0 N-CA-C 114.471 1.285 . . . . 1.0 114.471 179.452 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . 0.418 ' N ' ' O ' ' A' ' 77' ' ' ILE . 86.6 tt0 -89.4 -70.98 0.63 Allowed 'General case' 0 N--CA 1.438 -1.038 0 O-C-N 121.786 -0.571 . . . . 1.0 111.09 179.775 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 25.4 m-20 -91.02 -15.6 29.32 Favored 'General case' 0 CA--C 1.549 0.923 0 N-CA-C 115.864 1.801 . . . . 1.0 115.864 -178.796 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . 0.554 ' O ' ' N ' ' A' ' 85' ' ' ILE . . . -52.84 -42.48 65.21 Favored 'General case' 0 N--CA 1.475 0.779 0 C-N-CA 118.248 -1.381 . . . . 1.0 111.454 -177.863 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 11.2 mp -39.87 -20.83 0.01 OUTLIER 'General case' 0 N--CA 1.469 0.508 0 CA-C-N 118.447 0.567 . . . . 1.0 111.307 -179.049 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 85' ' ' ILE . . . . . 0.554 ' N ' ' O ' ' A' ' 83' ' ' ALA . 54.1 mt -93.43 -34.99 6.13 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.587 -0.279 . . . . 1.0 111.154 -179.866 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . 0.822 ' O ' HG22 ' A' ' 89' ' ' VAL . . . -92.91 -26.27 17.68 Favored 'General case' 0 C--O 1.222 -0.371 0 CA-C-O 120.597 0.237 . . . . 1.0 111.582 179.734 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -56.06 -7.12 0.3 Allowed 'General case' 0 C--N 1.328 -0.347 0 C-N-CA 119.73 -0.788 . . . . 1.0 110.418 -178.83 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . 0.45 ' H ' ' C ' ' A' ' 86' ' ' ALA . . . -84.17 -2.58 57.1 Favored 'General case' 0 N--CA 1.472 0.663 0 CA-C-O 122.407 1.099 . . . . 1.0 108.79 178.543 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 89' ' ' VAL . . . . . 0.822 HG22 ' O ' ' A' ' 86' ' ' ALA . 3.1 m -97.6 34.9 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.432 0 CA-C-N 113.042 -1.89 . . . . 1.0 110.59 179.098 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 90' ' ' GLY . . . . . 0.551 ' N ' ' CD ' ' A' ' 91' ' ' PRO . . . -78.13 -36.62 30.94 Favored Glycine 0 C--N 1.347 1.194 0 N-CA-C 111.6 -0.6 . . . . 1.0 111.6 178.932 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 91' ' ' PRO . . . . . 0.551 ' CD ' ' N ' ' A' ' 90' ' ' GLY . 93.4 Cg_exo -46.55 -15.11 0.16 Allowed 'Trans proline' 0 N--CA 1.496 1.665 0 C-N-CA 121.872 1.715 . . . . 1.0 109.07 177.913 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 92' ' ' HIS . . . . . 0.612 ' ND1' ' N ' ' A' ' 93' ' ' LEU . 0.0 OUTLIER -56.01 -15.76 3.98 Favored 'General case' 0 N--CA 1.442 -0.875 0 CA-C-N 113.922 -1.49 . . . . 1.0 107.754 179.148 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . 0.725 HD12 ' N ' ' A' ' 94' ' ' ALA . 2.1 pp -64.04 -58.22 7.32 Favored 'General case' 0 C--O 1.232 0.14 0 N-CA-C 108.997 -0.742 . . . . 1.0 108.997 176.822 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 94' ' ' ALA . . . . . 0.725 ' N ' HD12 ' A' ' 93' ' ' LEU . . . -57.34 -52.62 64.61 Favored 'General case' 0 CA--C 1.517 -0.323 0 N-CA-C 108.851 -0.796 . . . . 1.0 108.851 179.719 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 95' ' ' ARG . . . . . 0.621 ' O ' ' N ' ' A' ' 97' ' ' LEU . 4.9 tmm_? -60.16 -60.91 3.06 Favored 'General case' 0 N--CA 1.446 -0.628 0 N-CA-C 108.506 -0.924 . . . . 1.0 108.506 -179.792 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 96' ' ' ALA . . . . . 0.986 ' O ' ' N ' ' A' ' 98' ' ' GLY . . . -47.66 -12.09 0.03 OUTLIER 'General case' 0 N--CA 1.432 -1.343 0 O-C-N 118.532 -2.605 . . . . 1.0 111.478 179.484 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . 0.706 ' O ' ' N ' ' A' ' 100' ' ' ILE . 7.7 tp 6.87 -48.9 0.0 OUTLIER 'General case' 0 C--N 1.378 1.809 0 CA-C-O 117.584 -1.198 . . . . 1.0 109.937 -166.771 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 98' ' ' GLY . . . . . 0.986 ' N ' ' O ' ' A' ' 96' ' ' ALA . . . -49.57 -24.12 5.32 Favored Glycine 0 CA--C 1.548 2.106 0 CA-C-N 122.507 2.412 . . . . 1.0 107.417 173.493 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 99' ' ' GLN . . . . . 0.563 ' O ' ' S1 ' ' A' ' 130' ' ' MTN . 12.3 mt-30 -64.36 -19.38 65.44 Favored 'General case' 0 C--N 1.379 1.878 0 C-N-CA 117.324 -1.75 . . . . 1.0 107.058 176.829 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 100' ' ' ILE . . . . . 0.706 ' N ' ' O ' ' A' ' 97' ' ' LEU . 1.5 tp -65.3 -39.22 84.66 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.817 0 N-CA-C 108.228 -1.027 . . . . 1.0 108.228 179.724 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 101' ' ' VAL . . . . . 0.723 ' O ' ' N ' ' A' ' 105' ' ' GLY . 97.7 t -59.19 -62.72 0.91 Allowed 'Isoleucine or valine' 0 C--O 1.217 -0.627 0 C-N-CA 119.537 -0.865 . . . . 1.0 110.59 -178.44 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 102' ' ' CYS . . . . . 0.879 ' O ' ' HB2' ' A' ' 106' ' ' ALA . 0.5 OUTLIER -48.26 -18.63 0.23 Allowed 'General case' 0 N--CA 1.477 0.883 0 C-N-CA 119.093 -1.043 . . . . 1.0 110.826 -178.31 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild full ' A' A ' 103' ' ' ARG . . . . . 0.497 HH11 ' CG ' ' A' ' 103' ' ' ARG . 0.0 OUTLIER -88.63 -49.3 6.96 Favored 'General case' 0 N--CA 1.479 1.014 0 CA-C-O 121.783 0.802 . . . . 1.0 112.071 177.638 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild full ' A' A ' 104' ' ' TYR . . . . . . . . . . . . . 22.8 t80 -105.84 21.53 17.12 Favored 'General case' 0 N--CA 1.472 0.644 0 C-N-CA 125.935 1.694 . . . . 1.0 111.413 178.43 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 105' ' ' GLY . . . . . 0.723 ' N ' ' O ' ' A' ' 101' ' ' VAL . . . -159.33 -8.32 0.05 OUTLIER Glycine 0 CA--C 1.527 0.835 0 C-N-CA 120.394 -0.907 . . . . 1.0 112.081 -179.791 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 106' ' ' ALA . . . . . 0.879 ' HB2' ' O ' ' A' ' 102' ' ' CYS . . . -29.03 114.16 0.09 Allowed 'General case' 0 N--CA 1.466 0.327 0 N-CA-C 112.209 0.448 . . . . 1.0 112.209 179.51 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 107' ' ' THR . . . . . 0.607 ' C ' ' H ' ' A' ' 109' ' ' ILE . 26.7 m -134.55 -62.64 0.73 Allowed 'General case' 0 C--O 1.224 -0.247 0 N-CA-C 105.609 -1.997 . . . . 1.0 105.609 176.782 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . 0.631 ' O ' HG22 ' A' ' 108' ' ' VAL . 12.7 p -64.44 23.25 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.437 -1.078 0 O-C-N 121.792 -0.568 . . . . 1.0 109.539 179.33 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 109' ' ' ILE . . . . . 0.628 ' H ' ' HD2' ' A' ' 110' ' ' PRO . 0.1 OUTLIER -115.81 -53.98 0.04 OUTLIER Pre-proline 0 CA--C 1.562 1.405 0 N-CA-C 107.708 -1.219 . . . . 1.0 107.708 174.658 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild full ' A' A ' 110' ' ' PRO . . . . . 0.628 ' HD2' ' H ' ' A' ' 109' ' ' ILE . 18.3 Cg_endo -52.85 -36.65 75.04 Favored 'Trans proline' 0 N--CA 1.51 2.446 0 CA-C-N 121.92 1.721 . . . . 1.0 112.199 175.869 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 111' ' ' ASN . . . . . 0.429 ' C ' ' N ' ' A' ' 113' ' ' ASN . 6.2 t30 -68.25 -68.42 0.39 Allowed 'General case' 0 C--N 1.328 -0.356 0 C-N-CA 119.448 -0.901 . . . . 1.0 110.106 -177.907 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 112' ' ' ILE . . . . . 0.448 ' O ' ' N ' ' A' ' 116' ' ' ILE . 3.9 pt -51.0 -25.99 4.01 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.263 0 CA-C-O 123.07 1.414 . . . . 1.0 108.098 179.262 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 113' ' ' ASN . . . . . 0.558 ' ND2' ' OE2' ' A' ' 117' ' ' GLU . 15.4 t-20 -59.21 -52.37 65.96 Favored 'General case' 0 C--N 1.306 -1.286 0 CA-C-N 111.987 -2.369 . . . . 1.0 107.982 -177.886 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 114' ' ' ALA . . . . . 0.54 ' O ' HG23 ' A' ' 118' ' ' VAL . . . -64.08 -31.17 72.26 Favored 'General case' 0 C--N 1.323 -0.562 0 N-CA-C 113.103 0.779 . . . . 1.0 113.103 179.675 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 115' ' ' ALA . . . . . 0.454 ' O ' ' N ' ' A' ' 119' ' ' LEU . . . -85.15 -58.42 2.69 Favored 'General case' 0 N--CA 1.476 0.848 0 CA-C-N 119.36 0.982 . . . . 1.0 111.655 178.494 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 116' ' ' ILE . . . . . 0.448 ' N ' ' O ' ' A' ' 112' ' ' ILE . 31.2 mt -51.11 -57.71 2.67 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.402 0 N-CA-C 107.217 -1.401 . . . . 1.0 107.217 -178.375 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 117' ' ' GLU . . . . . 0.558 ' OE2' ' ND2' ' A' ' 113' ' ' ASN . 56.0 mt-10 -51.68 -50.37 60.56 Favored 'General case' 0 C--N 1.307 -1.277 0 CA-C-N 112.771 -2.013 . . . . 1.0 107.056 -179.15 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 118' ' ' VAL . . . . . 0.54 HG23 ' O ' ' A' ' 114' ' ' ALA . 17.0 t -59.83 -28.86 41.79 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.8 0 C-N-CA 119.642 -0.823 . . . . 1.0 110.021 178.378 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 119' ' ' LEU . . . . . 0.454 ' N ' ' O ' ' A' ' 115' ' ' ALA . 3.9 tt -78.42 -61.58 1.96 Allowed 'General case' 0 C--N 1.354 0.8 0 CA-C-N 120.396 1.453 . . . . 1.0 107.466 177.962 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 120' ' ' GLY . . . . . 0.444 ' C ' ' OG1' ' A' ' 121' ' ' THR . . . -64.31 -82.25 0.1 Allowed Glycine 0 C--N 1.358 1.771 0 C-N-CA 119.036 -1.554 . . . . 1.0 109.299 178.291 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 121' ' ' THR . . . . . 0.491 ' OG1' HG22 ' A' ' 123' ' ' THR . 0.0 OUTLIER 167.76 -38.85 0.0 OUTLIER 'General case' 0 CA--C 1.542 0.659 0 CA-C-N 113.968 -1.116 . . . . 1.0 113.041 178.817 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild full ' A' A ' 122' ' ' GLY . . . . . 0.643 ' O ' ' N ' ' A' ' 124' ' ' ASP . . . 103.28 -15.91 53.74 Favored Glycine 0 N--CA 1.478 1.475 0 N-CA-C 107.243 -2.343 . . . . 1.0 107.243 -176.345 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 123' ' ' THR . . . . . 0.538 HG23 ' O ' ' A' ' 123' ' ' THR . 9.1 t -58.38 81.19 0.01 OUTLIER 'General case' 0 CA--C 1.545 0.787 0 CA-C-N 111.272 -2.464 . . . . 1.0 105.36 178.279 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 124' ' ' ASP . . . . . 0.643 ' N ' ' O ' ' A' ' 122' ' ' GLY . 35.8 m-20 -165.39 174.55 9.94 Favored 'General case' 0 N--CA 1.475 0.79 0 CA-C-N 112.818 -1.992 . . . . 1.0 112.457 179.989 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 125' ' ' TYR . . . . . . . . . . . . . 6.1 t80 -142.85 138.83 30.58 Favored 'General case' 0 CA--C 1.54 0.596 0 N-CA-C 107.655 -1.239 . . . . 1.0 107.655 175.588 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 9.6 tpt180 -149.88 153.12 36.19 Favored 'General case' 0 N--CA 1.467 0.39 0 N-CA-C 110.236 -0.283 . . . . 1.0 110.236 178.075 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 127' ' ' PHE . . . . . . . . . . . . . 22.4 p90 . . . . . 0 N--CA 1.469 0.486 0 CA-C-O 118.034 -0.984 . . . . 1.0 110.743 179.926 . . . . . . . . 0 0 . 1 . 028 nuclear nobuild full ' A' A ' 128' ' ' MTN . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 028 nuclear nobuild full ' A' A ' 129' ' ' MTN . . . . . 0.639 ' H62' ' SG ' ' A' ' 48' ' ' CYS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 130' ' ' MTN . . . . . 0.563 ' S1 ' ' O ' ' A' ' 99' ' ' GLN . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 4.6 tpp . . . . . 0 N--CA 1.489 1.498 0 N-CA-C 109.194 -0.669 . . . . 1.0 109.194 . . . . . . . . . 0 0 . 1 . 029 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . 0.484 ' O ' ' CB ' ' A' ' 3' ' ' ASP . 87.7 p -89.61 12.42 16.82 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.877 -0.602 . . . . 1.0 110.499 -179.951 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . 0.484 ' CB ' ' O ' ' A' ' 2' ' ' SER . 4.7 t0 151.22 116.58 0.0 OUTLIER 'General case' 0 N--CA 1.473 0.699 0 O-C-N 124.075 0.86 . . . . 1.0 109.963 178.606 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . 0.434 ' O ' ' OD1' ' A' ' 5' ' ' ASP . 13.8 t80 -152.38 148.05 27.02 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.645 -0.707 . . . . 1.0 110.305 179.559 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 5' ' ' ASP . . . . . 0.434 ' OD1' ' O ' ' A' ' 4' ' ' PHE . 2.2 m-20 -154.78 151.52 28.78 Favored 'General case' 0 C--O 1.234 0.242 0 N-CA-C 109.703 -0.48 . . . . 1.0 109.703 179.634 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 6' ' ' THR . . . . . 0.416 ' C ' ' O ' ' A' ' 5' ' ' ASP . 3.0 m -38.76 143.07 0.16 Allowed 'General case' 0 N--CA 1.467 0.4 0 N-CA-C 109.53 -0.544 . . . . 1.0 109.53 179.994 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 35.9 tt0 -47.27 -52.4 16.27 Favored 'General case' 0 C--N 1.316 -0.86 0 CA-C-O 118.347 -0.835 . . . . 1.0 112.698 -174.934 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 8' ' ' ARG . . . . . 0.524 ' O ' ' HB3' ' A' ' 12' ' ' ALA . 24.3 ptt180 -63.48 -35.5 80.66 Favored 'General case' 0 N--CA 1.447 -0.59 0 CA-C-N 120.824 1.647 . . . . 1.0 109.816 179.022 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . 0.658 ' O ' HG23 ' A' ' 13' ' ' VAL . 93.6 t -62.34 -52.23 62.58 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.714 0 C-N-CA 118.665 -1.214 . . . . 1.0 108.009 178.481 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 80.0 p -67.61 -38.72 84.35 Favored 'General case' 0 CA--C 1.543 0.696 0 N-CA-C 113.353 0.872 . . . . 1.0 113.353 179.384 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 11' ' ' ARG . . . . . 0.596 ' O ' ' N ' ' A' ' 14' ' ' ALA . 5.0 tpp180 -75.77 -63.0 1.4 Allowed 'General case' 0 N--CA 1.472 0.649 0 CA-C-O 122.335 1.064 . . . . 1.0 109.098 178.039 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . 0.621 ' O ' ' HB3' ' A' ' 16' ' ' ALA . . . -46.67 -37.56 8.48 Favored 'General case' 0 N--CA 1.474 0.762 0 CA-C-N 112.724 -2.034 . . . . 1.0 105.955 -175.323 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . 0.658 HG23 ' O ' ' A' ' 9' ' ' VAL . 11.9 t -59.8 -50.84 78.53 Favored 'Isoleucine or valine' 0 C--O 1.206 -1.215 0 C-N-CA 118.574 -1.25 . . . . 1.0 107.869 175.68 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . 0.596 ' N ' ' O ' ' A' ' 11' ' ' ARG . . . -60.85 -63.59 1.24 Allowed 'General case' 0 C--O 1.219 -0.531 0 C-N-CA 118.717 -1.193 . . . . 1.0 111.235 179.178 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . 0.495 ' O ' ' N ' ' A' ' 19' ' ' GLY . . . -52.48 -54.93 25.96 Favored 'General case' 0 N--CA 1.479 1.003 0 CA-C-O 121.826 0.822 . . . . 1.0 110.143 -176.735 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . 0.621 ' HB3' ' O ' ' A' ' 12' ' ' ALA . . . -61.97 -53.36 56.77 Favored 'General case' 0 C--N 1.308 -1.201 0 CA-C-N 113.877 -1.511 . . . . 1.0 108.685 -179.239 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . 0.599 ' CB ' ' O ' ' A' ' 13' ' ' VAL . 3.1 tp -57.06 -51.75 68.02 Favored 'General case' 0 N--CA 1.479 1.016 0 C-N-CA 118.944 -1.102 . . . . 1.0 109.083 -177.336 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . 0.574 HG13 ' O ' ' A' ' 14' ' ' ALA . 3.2 m -68.78 -56.5 11.95 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.269 0 C-N-CA 119.04 -1.064 . . . . 1.0 108.864 179.397 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . 0.559 ' N ' HG23 ' A' ' 18' ' ' VAL . . . -60.73 -169.25 0.51 Allowed Glycine 0 CA--C 1.532 1.133 0 N-CA-C 111.786 -0.526 . . . . 1.0 111.786 179.881 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 20' ' ' PRO . . . . . 0.611 ' O ' ' N ' ' A' ' 24' ' ' ALA . 27.7 Cg_endo -81.57 -32.89 0.76 Allowed 'Trans proline' 0 N--CA 1.493 1.49 0 C-N-CA 123.323 2.682 . . . . 1.0 115.154 -178.656 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -57.64 -57.29 20.59 Favored Glycine 0 N--CA 1.479 1.539 0 C-N-CA 120.246 -0.978 . . . . 1.0 111.623 -176.565 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . 0.584 ' CA ' ' HB1' ' A' ' 16' ' ' ALA . . . -56.69 -50.47 63.11 Favored Glycine 0 N--CA 1.472 1.039 0 N-CA-C 107.075 -2.41 . . . . 1.0 107.075 -178.17 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . 0.526 ' O ' HG12 ' A' ' 27' ' ' VAL . 41.8 t -61.7 -34.95 64.56 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.051 0 CA-C-N 114.834 -0.683 . . . . 1.0 109.85 179.371 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . 0.611 ' N ' ' O ' ' A' ' 20' ' ' PRO . . . -57.07 -61.14 2.66 Favored 'General case' 0 N--CA 1.454 -0.231 0 C-N-CA 118.978 -1.089 . . . . 1.0 109.404 -179.145 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 8.4 tt -65.98 -42.48 89.8 Favored 'General case' 0 C--N 1.342 0.283 0 C-N-CA 119.657 -0.817 . . . . 1.0 111.922 -178.715 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 59.3 t -59.37 -58.69 5.88 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.182 0 C-N-CA 118.472 -1.291 . . . . 1.0 109.501 -178.017 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . 0.526 HG12 ' O ' ' A' ' 23' ' ' VAL . 1.8 p -63.4 -36.75 77.4 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.454 0 N-CA-C 112.953 0.723 . . . . 1.0 112.953 -177.706 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 24.7 tttm -64.68 -53.28 49.91 Favored 'General case' 0 C--N 1.324 -0.533 0 N-CA-C 108.293 -1.003 . . . . 1.0 108.293 -178.597 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 74.1 t -59.65 -44.83 94.33 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.829 0 CA-C-N 114.523 -1.217 . . . . 1.0 109.906 -178.81 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 30' ' ' CYS . . . . . 0.566 ' SG ' ' N ' ' A' ' 31' ' ' ALA . 0.5 OUTLIER -64.56 -57.25 9.67 Favored 'General case' 0 CA--C 1.539 0.543 0 C-N-CA 118.43 -1.308 . . . . 1.0 109.143 -179.804 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . 0.566 ' N ' ' SG ' ' A' ' 30' ' ' CYS . . . -64.35 -56.09 16.74 Favored 'General case' 0 N--CA 1.468 0.436 0 N-CA-C 116.276 1.954 . . . . 1.0 116.276 -175.984 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . 0.472 ' O ' ' HB2' ' A' ' 33' ' ' LEU . . . 81.5 73.44 1.2 Allowed Glycine 0 CA--C 1.537 1.425 0 N-CA-C 108.694 -1.762 . . . . 1.0 108.694 -175.539 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . 0.472 ' HB2' ' O ' ' A' ' 32' ' ' GLY . 15.8 mt 81.34 110.04 0.03 OUTLIER Pre-proline 0 N--CA 1.486 1.345 0 C-N-CA 124.68 1.192 . . . . 1.0 111.745 -178.657 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 52.4 Cg_exo -54.62 -14.48 7.45 Favored 'Trans proline' 0 N--CA 1.507 2.308 0 C-N-CA 122.348 2.032 . . . . 1.0 113.325 178.355 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -56.46 -55.87 27.43 Favored Glycine 0 CA--C 1.534 1.236 0 C-N-CA 119.159 -1.496 . . . . 1.0 109.588 -178.458 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . 0.832 HG13 ' H ' ' A' ' 37' ' ' ILE . 6.1 p -69.78 -70.08 0.25 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.5 0 N-CA-C 112.958 0.725 . . . . 1.0 112.958 -177.53 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . 0.832 ' H ' HG13 ' A' ' 36' ' ' VAL . 53.1 mt 9.46 68.16 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.486 1.373 0 N-CA-C 114.035 1.124 . . . . 1.0 114.035 -178.061 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 38' ' ' HIS . . . . . 0.61 ' H ' ' CD2' ' A' ' 38' ' ' HIS . 0.3 OUTLIER -131.75 118.47 19.99 Favored 'General case' 0 N--CA 1.447 -0.587 0 CA-C-N 122.161 2.255 . . . . 1.0 106.477 177.484 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 3.9 m -101.88 122.65 46.59 Favored Pre-proline 0 C--N 1.323 -0.56 0 C-N-CA 120.478 -0.489 . . . . 1.0 110.508 -178.684 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 58.3 Cg_exo -48.85 -37.43 36.15 Favored 'Trans proline' 0 N--CA 1.491 1.346 0 C-N-CA 121.133 1.222 . . . . 1.0 112.829 179.896 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -124.71 131.03 53.49 Favored 'General case' 0 N--CA 1.467 0.379 0 N-CA-C 109.831 -0.433 . . . . 1.0 109.831 178.479 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . 0.671 ' C ' ' H ' ' A' ' 44' ' ' GLY . 28.7 ptt-85 -168.27 165.57 12.93 Favored 'General case' 0 C--N 1.322 -0.614 0 C-N-CA 119.608 -0.837 . . . . 1.0 110.628 178.094 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 43' ' ' ARG . . . . . 0.41 ' O ' ' HG2' ' A' ' 43' ' ' ARG . 21.1 ttt180 -65.63 17.75 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.464 0 N-CA-C 108.795 -0.817 . . . . 1.0 108.795 179.206 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . 0.671 ' H ' ' C ' ' A' ' 42' ' ' ARG . . . 82.91 -24.59 5.14 Favored Glycine 0 N--CA 1.447 -0.627 0 N-CA-C 110.857 -0.897 . . . . 1.0 110.857 -179.947 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . 0.653 ' N ' ' CD1' ' A' ' 45' ' ' PHE . 0.0 OUTLIER -163.78 164.1 23.78 Favored 'General case' 0 CA--C 1.551 1.008 0 CA-C-N 116.98 0.39 . . . . 1.0 110.137 -178.633 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild full ' A' A ' 46' ' ' PHE . . . . . 0.576 ' N ' ' HE ' ' A' ' 47' ' ' ARG . 0.6 OUTLIER 144.01 4.31 0.0 OUTLIER 'General case' 0 N--CA 1.505 2.297 0 O-C-N 125.065 1.478 . . . . 1.0 111.92 177.531 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild full ' A' A ' 47' ' ' ARG . . . . . 0.576 ' HE ' ' N ' ' A' ' 46' ' ' PHE . 0.0 OUTLIER -117.27 -149.49 0.44 Allowed 'General case' 0 N--CA 1.472 0.65 0 CA-C-N 117.912 0.324 . . . . 1.0 110.182 -179.183 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild full ' A' A ' 48' ' ' CYS . . . . . 0.537 ' C ' ' O ' ' A' ' 47' ' ' ARG . 25.8 p -15.32 93.98 0.01 OUTLIER 'General case' 0 N--CA 1.484 1.239 0 O-C-N 124.346 1.029 . . . . 1.0 110.456 179.872 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 49' ' ' ASN . . . . . 0.507 ' ND2' ' O ' ' A' ' 52' ' ' ARG . 0.1 OUTLIER -123.31 140.73 34.43 Favored Pre-proline 0 CA--C 1.541 0.607 0 N-CA-C 108.746 -0.835 . . . . 1.0 108.746 -178.1 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . 0.48 ' C ' ' H ' ' A' ' 52' ' ' ARG . 64.9 Cg_endo -73.44 59.91 4.03 Favored 'Trans proline' 0 N--CA 1.493 1.445 0 C-N-CA 121.613 1.542 . . . . 1.0 112.047 -179.861 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 20.8 mp0 68.04 -24.85 0.13 Allowed 'General case' 0 N--CA 1.469 0.478 0 CA-C-N 115.677 -0.692 . . . . 1.0 112.055 179.614 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . 0.507 ' O ' ' ND2' ' A' ' 49' ' ' ASN . 47.1 mmt-85 -59.24 174.95 0.35 Allowed 'General case' 0 CA--C 1.518 -0.252 0 C-N-CA 120.299 -0.561 . . . . 1.0 109.731 -179.928 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -99.15 145.31 10.54 Favored 'Isoleucine or valine' 0 C--O 1.232 0.133 0 CA-C-O 122.133 0.968 . . . . 1.0 111.141 -179.199 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 54' ' ' GLN . . . . . 0.613 ' H ' ' CD ' ' A' ' 54' ' ' GLN . 0.0 OUTLIER -63.91 79.27 0.03 OUTLIER 'General case' 0 C--N 1.316 -0.862 0 CA-C-N 113.345 -1.752 . . . . 1.0 110.363 -177.532 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -148.91 156.51 7.76 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.412 0 N-CA-C 108.984 -0.747 . . . . 1.0 108.984 176.914 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . 0.567 ' O ' ' CD1' ' A' ' 58' ' ' TRP . . . 110.17 -4.99 30.17 Favored Glycine 0 N--CA 1.469 0.891 0 N-CA-C 109.767 -1.333 . . . . 1.0 109.767 -178.821 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . 0.533 ' OD1' ' N ' ' A' ' 57' ' ' ASP . 12.7 p-10 -80.02 98.54 7.25 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 114.914 -0.643 . . . . 1.0 109.469 178.885 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 58' ' ' TRP . . . . . 0.567 ' CD1' ' O ' ' A' ' 56' ' ' GLY . 18.4 m95 -84.84 176.79 8.28 Favored 'General case' 0 N--CA 1.464 0.239 0 CA-C-O 122.561 1.172 . . . . 1.0 113.084 -178.521 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 1.3 mpp_? -90.11 -60.06 2.03 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 112.26 -2.246 . . . . 1.0 111.494 179.781 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -90.68 -18.18 25.51 Favored 'General case' 0 N--CA 1.48 1.069 0 N-CA-C 113.925 1.083 . . . . 1.0 113.925 -179.462 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 3.4 tt0 -82.66 -13.91 55.6 Favored 'General case' 0 C--N 1.318 -0.784 0 O-C-N 121.397 -0.815 . . . . 1.0 110.719 -179.48 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . 0.655 ' O ' ' N ' ' A' ' 66' ' ' GLY . 28.2 m -51.51 -54.58 11.55 Favored 'Isoleucine or valine' 0 C--O 1.203 -1.377 0 C-N-CA 120.263 -0.575 . . . . 1.0 111.212 -176.77 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 63' ' ' ALA . . . . . 0.625 ' N ' HG23 ' A' ' 62' ' ' VAL . . . -71.25 -53.84 12.96 Favored 'General case' 0 C--N 1.315 -0.894 0 CA-C-N 119.59 1.086 . . . . 1.0 109.282 -177.747 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 64' ' ' HIS . . . . . 0.741 ' CD2' HH12 ' A' ' 67' ' ' ARG . 0.5 OUTLIER -45.2 -54.61 6.73 Favored 'General case' 0 CA--C 1.536 0.409 0 N-CA-C 107.969 -1.123 . . . . 1.0 107.969 179.157 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . 0.562 ' C ' ' H ' ' A' ' 67' ' ' ARG . 11.1 t70 -73.83 -49.07 26.94 Favored 'General case' 0 C--N 1.314 -0.975 0 CA-C-N 114.428 -1.26 . . . . 1.0 111.16 179.343 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . 0.655 ' N ' ' O ' ' A' ' 62' ' ' VAL . . . -75.13 26.81 1.19 Allowed Glycine 0 C--N 1.317 -0.509 0 N-CA-C 109.88 -1.288 . . . . 1.0 109.88 177.41 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 67' ' ' ARG . . . . . 0.741 HH12 ' CD2' ' A' ' 64' ' ' HIS . 21.5 mtt85 -71.57 8.2 1.19 Allowed 'General case' 0 CA--C 1.504 -0.826 0 N-CA-C 105.22 -2.141 . . . . 1.0 105.22 173.629 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . 0.654 ' H ' ' C ' ' A' ' 66' ' ' GLY . 1.5 pp -32.27 -29.83 0.01 OUTLIER 'General case' 0 C--N 1.347 0.498 0 O-C-N 124.112 0.883 . . . . 1.0 108.982 -177.252 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . 0.631 ' N ' ' O ' ' A' ' 67' ' ' ARG . 2.1 tt -62.38 -64.36 0.95 Allowed 'General case' 0 C--N 1.321 -0.632 0 C-N-CA 119.095 -1.042 . . . . 1.0 108.423 177.14 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . 0.592 ' O ' ' N ' ' A' ' 72' ' ' HIS . . . -77.45 -73.17 0.32 Allowed 'General case' 0 N--CA 1.47 0.537 0 N-CA-C 104.319 -2.475 . . . . 1.0 104.319 176.161 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . 0.504 ' O ' ' C ' ' A' ' 72' ' ' HIS . . . -41.22 2.8 0.0 OUTLIER 'General case' 0 C--N 1.322 -0.619 0 N-CA-C 115.533 1.679 . . . . 1.0 115.533 179.77 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 72' ' ' HIS . . . . . 0.633 ' CD2' ' H ' ' A' ' 73' ' ' MET . 1.9 p-80 -29.06 -63.84 0.11 Allowed 'General case' 0 N--CA 1.47 0.528 0 CA-C-N 120.6 1.545 . . . . 1.0 112.458 -176.29 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 73' ' ' MET . . . . . 0.633 ' H ' ' CD2' ' A' ' 72' ' ' HIS . 0.0 OUTLIER -71.72 -48.69 45.43 Favored 'General case' 0 C--N 1.325 -0.473 0 C-N-CA 119.236 -0.986 . . . . 1.0 109.84 177.765 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . 0.746 ' O ' ' N ' ' A' ' 76' ' ' GLY . 58.0 t -45.62 -43.32 3.93 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.387 0 CA-C-O 117.397 -1.287 . . . . 1.0 112.08 -175.843 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 75' ' ' ASN . . . . . 0.424 ' O ' ' N ' ' A' ' 78' ' ' VAL . 16.2 t30 -35.75 -12.17 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.613 0 CA-C-N 121.265 1.848 . . . . 1.0 112.467 178.549 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . 0.746 ' N ' ' O ' ' A' ' 74' ' ' VAL . . . -46.04 -25.02 1.58 Allowed Glycine 0 CA--C 1.54 1.654 0 N-CA-C 108.349 -1.9 . . . . 1.0 108.349 176.721 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . 0.56 ' O ' ' N ' ' A' ' 80' ' ' ALA . 5.5 pt -63.24 -54.76 28.98 Favored 'Isoleucine or valine' 0 C--O 1.219 -0.511 0 N-CA-C 107.873 -1.158 . . . . 1.0 107.873 178.421 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . 0.471 ' C ' ' O ' ' A' ' 77' ' ' ILE . 59.7 t -36.04 -33.07 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.316 -0.885 0 CA-C-N 112.186 -2.279 . . . . 1.0 106.962 -177.108 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . 0.716 ' O ' ' HB2' ' A' ' 83' ' ' ALA . 0.0 OUTLIER -98.39 -33.44 4.18 Favored 'Isoleucine or valine' 0 CA--C 1.556 1.178 0 CA-C-N 115.795 -0.639 . . . . 1.0 111.018 177.828 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild full ' A' A ' 80' ' ' ALA . . . . . 0.56 ' N ' ' O ' ' A' ' 77' ' ' ILE . . . -84.86 -13.37 51.16 Favored 'General case' 0 N--CA 1.48 1.048 0 N-CA-C 114.842 1.423 . . . . 1.0 114.842 -179.096 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . 0.452 ' N ' ' O ' ' A' ' 77' ' ' ILE . 41.8 mt-10 -88.48 -67.33 0.84 Allowed 'General case' 0 CA--C 1.506 -0.724 0 O-C-N 121.656 -0.652 . . . . 1.0 109.383 178.098 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 82' ' ' ASP . . . . . 0.541 ' O ' ' N ' ' A' ' 84' ' ' LEU . 24.3 t0 -73.25 -13.92 61.23 Favored 'General case' 0 N--CA 1.442 -0.858 0 CA-C-N 119.043 0.838 . . . . 1.0 111.908 179.792 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . 0.737 ' HA ' ' HB3' ' A' ' 86' ' ' ALA . . . -20.47 -47.2 0.01 OUTLIER 'General case' 0 N--CA 1.478 0.96 0 CA-C-N 118.39 0.541 . . . . 1.0 112.032 178.221 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . 0.541 ' N ' ' O ' ' A' ' 82' ' ' ASP . 3.7 mm? -34.29 -35.91 0.04 OUTLIER 'General case' 0 N--CA 1.478 0.949 0 N-CA-C 113.209 0.818 . . . . 1.0 113.209 -178.163 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 85' ' ' ILE . . . . . 0.417 HD12 ' HA ' ' A' ' 85' ' ' ILE . 11.2 tp -100.42 -36.86 5.28 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.66 0 N-CA-C 108.548 -0.908 . . . . 1.0 108.548 177.88 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . 0.737 ' HB3' ' HA ' ' A' ' 83' ' ' ALA . . . -61.21 -58.82 6.73 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 114.426 -1.261 . . . . 1.0 109.132 179.973 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . 0.408 ' N ' ' O ' ' A' ' 83' ' ' ALA . 2.5 tt0 -71.5 24.04 0.04 OUTLIER 'General case' 0 CA--C 1.542 0.642 0 O-C-N 121.321 -0.862 . . . . 1.0 112.364 -178.931 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . 0.43 ' H ' ' C ' ' A' ' 86' ' ' ALA . . . -126.64 -16.63 5.23 Favored 'General case' 0 N--CA 1.478 0.971 0 CA-C-O 122.213 1.006 . . . . 1.0 108.999 179.131 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 21.2 m -101.48 33.89 0.37 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.456 0 CA-C-N 113.406 -1.724 . . . . 1.0 109.09 178.328 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 90' ' ' GLY . . . . . 0.595 ' C ' ' H ' ' A' ' 92' ' ' HIS . . . -69.3 -35.45 76.69 Favored Glycine 0 C--N 1.345 1.044 0 N-CA-C 111.16 -0.776 . . . . 1.0 111.16 179.009 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 91' ' ' PRO . . . . . 0.583 ' CD ' ' N ' ' A' ' 90' ' ' GLY . 89.4 Cg_exo -48.35 -8.08 0.06 OUTLIER 'Trans proline' 0 N--CA 1.498 1.746 0 C-N-CA 122.002 1.801 . . . . 1.0 110.702 177.897 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 92' ' ' HIS . . . . . 0.601 ' ND1' ' N ' ' A' ' 93' ' ' LEU . 0.9 OUTLIER -57.54 -20.11 29.56 Favored 'General case' 0 N--CA 1.444 -0.746 0 N-CA-C 107.771 -1.196 . . . . 1.0 107.771 179.367 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . 0.693 HD12 ' N ' ' A' ' 94' ' ' ALA . 2.2 pp -65.63 -58.09 6.56 Favored 'General case' 0 N--CA 1.451 -0.393 0 N-CA-C 108.507 -0.923 . . . . 1.0 108.507 178.507 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 94' ' ' ALA . . . . . 0.693 ' N ' HD12 ' A' ' 93' ' ' LEU . . . -55.11 -54.21 46.03 Favored 'General case' 0 N--CA 1.452 -0.336 0 N-CA-C 108.962 -0.755 . . . . 1.0 108.962 179.305 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 95' ' ' ARG . . . . . 0.579 ' O ' ' N ' ' A' ' 97' ' ' LEU . 29.2 mtm180 -58.69 -58.86 6.73 Favored 'General case' 0 C--O 1.242 0.689 0 CA-C-O 122.529 1.157 . . . . 1.0 108.254 179.461 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 96' ' ' ALA . . . . . 0.886 ' O ' ' N ' ' A' ' 98' ' ' GLY . . . -48.55 -14.1 0.06 Allowed 'General case' 0 N--CA 1.424 -1.754 0 O-C-N 118.961 -2.337 . . . . 1.0 111.297 -178.856 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . 0.735 ' O ' ' N ' ' A' ' 100' ' ' ILE . 1.9 tp 5.23 -52.34 0.0 OUTLIER 'General case' 0 C--N 1.367 1.358 0 CA-C-O 116.427 -1.749 . . . . 1.0 110.447 -167.765 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 98' ' ' GLY . . . . . 0.886 ' N ' ' O ' ' A' ' 96' ' ' ALA . . . -48.66 -23.65 3.49 Favored Glycine 0 CA--C 1.542 1.735 0 CA-C-N 123.916 3.053 . . . . 1.0 108.034 174.733 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 99' ' ' GLN . . . . . 0.572 ' N ' ' O ' ' A' ' 96' ' ' ALA . 59.0 tt0 -68.81 -19.22 64.27 Favored 'General case' 0 C--N 1.364 1.211 0 N-CA-C 107.285 -1.376 . . . . 1.0 107.285 177.536 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 100' ' ' ILE . . . . . 0.735 ' N ' ' O ' ' A' ' 97' ' ' LEU . 1.9 tp -65.54 -42.58 93.43 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 N-CA-C 107.103 -1.443 . . . . 1.0 107.103 177.128 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 101' ' ' VAL . . . . . 0.743 ' O ' ' N ' ' A' ' 105' ' ' GLY . 61.0 t -55.68 -60.03 2.1 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.43 0 N-CA-C 106.931 -1.507 . . . . 1.0 106.931 178.704 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 102' ' ' CYS . . . . . 0.859 ' O ' ' HB2' ' A' ' 106' ' ' ALA . 0.5 OUTLIER -46.35 -18.37 0.06 Allowed 'General case' 0 C--N 1.32 -0.708 0 CA-C-N 116.433 -0.349 . . . . 1.0 111.622 -179.666 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild full ' A' A ' 103' ' ' ARG . . . . . 0.416 ' N ' ' O ' ' A' ' 101' ' ' VAL . 1.1 ttp180 -92.77 -44.65 8.41 Favored 'General case' 0 N--CA 1.478 0.946 0 CA-C-O 121.948 0.88 . . . . 1.0 111.068 176.951 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 104' ' ' TYR . . . . . 0.583 ' O ' ' CG ' ' A' ' 104' ' ' TYR . 0.0 OUTLIER -106.57 21.85 16.79 Favored 'General case' 0 C--N 1.317 -0.808 0 C-N-CA 126.297 1.839 . . . . 1.0 111.215 179.416 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild full ' A' A ' 105' ' ' GLY . . . . . 0.769 ' O ' ' N ' ' A' ' 107' ' ' THR . . . -170.12 -7.33 0.03 OUTLIER Glycine 0 C--N 1.339 0.747 0 C-N-CA 118.495 -1.812 . . . . 1.0 113.481 178.619 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 106' ' ' ALA . . . . . 0.859 ' HB2' ' O ' ' A' ' 102' ' ' CYS . . . -31.64 69.49 0.0 OUTLIER 'General case' 0 N--CA 1.467 0.387 0 N-CA-C 113.752 1.019 . . . . 1.0 113.752 -177.738 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 107' ' ' THR . . . . . 0.769 ' N ' ' O ' ' A' ' 105' ' ' GLY . 4.8 t -91.84 4.22 53.38 Favored 'General case' 0 N--CA 1.436 -1.171 0 N-CA-C 105.668 -1.975 . . . . 1.0 105.668 176.151 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . 0.529 HG13 ' N ' ' A' ' 109' ' ' ILE . 11.2 p -87.77 -57.35 4.31 Favored 'Isoleucine or valine' 0 C--N 1.357 0.928 0 CA-C-N 115.851 -0.613 . . . . 1.0 110.624 178.333 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 109' ' ' ILE . . . . . 0.529 ' N ' HG13 ' A' ' 108' ' ' VAL . 0.1 OUTLIER -62.95 -37.98 38.5 Favored Pre-proline 0 C--N 1.359 0.987 0 N-CA-C 114.476 1.288 . . . . 1.0 114.476 -176.911 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild full ' A' A ' 110' ' ' PRO . . . . . 0.435 ' CD ' ' O ' ' A' ' 106' ' ' ALA . 62.5 Cg_exo -49.04 -44.9 31.2 Favored 'Trans proline' 0 N--CA 1.497 1.703 0 CA-C-N 121.158 1.449 . . . . 1.0 113.649 -176.418 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 9.0 t30 -68.03 -67.55 0.45 Allowed 'General case' 0 C--N 1.326 -0.422 0 C-N-CA 118.735 -1.186 . . . . 1.0 110.435 -177.815 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 6.3 pt -52.89 -23.2 4.99 Favored 'Isoleucine or valine' 0 C--O 1.214 -0.778 0 N-CA-C 108.78 -0.822 . . . . 1.0 108.78 179.391 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 113' ' ' ASN . . . . . 0.456 ' HB2' ' O ' ' A' ' 109' ' ' ILE . 20.2 t30 -59.43 -51.45 69.84 Favored 'General case' 0 C--N 1.314 -0.943 0 CA-C-N 113.731 -1.577 . . . . 1.0 108.334 -178.423 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -58.64 -28.9 66.11 Favored 'General case' 0 N--CA 1.443 -0.805 0 C-N-CA 120.345 -0.542 . . . . 1.0 111.202 179.874 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 115' ' ' ALA . . . . . 0.578 ' O ' ' N ' ' A' ' 119' ' ' LEU . . . -81.12 -50.29 9.8 Favored 'General case' 0 C--O 1.208 -1.123 0 C-N-CA 120.084 -0.646 . . . . 1.0 109.292 177.275 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 116' ' ' ILE . . . . . 0.413 ' C ' ' O ' ' A' ' 115' ' ' ALA . 35.8 mt -42.85 -48.39 1.19 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.408 0 N-CA-C 104.997 -2.223 . . . . 1.0 104.997 179.104 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 117' ' ' GLU . . . . . 0.493 ' O ' ' HA ' ' A' ' 121' ' ' THR . 55.7 tt0 -46.51 -58.32 3.89 Favored 'General case' 0 C--N 1.314 -0.951 0 CA-C-N 111.294 -2.685 . . . . 1.0 106.332 177.814 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 118' ' ' VAL . . . . . 0.574 ' N ' ' O ' ' A' ' 115' ' ' ALA . 15.8 t -64.44 -56.23 17.34 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.747 0 C-N-CA 120.085 -0.646 . . . . 1.0 110.486 177.398 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 119' ' ' LEU . . . . . 0.578 ' N ' ' O ' ' A' ' 115' ' ' ALA . 1.1 mm? -51.77 -20.63 2.26 Favored 'General case' 0 N--CA 1.451 -0.377 0 N-CA-C 113.984 1.105 . . . . 1.0 113.984 -178.532 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 120' ' ' GLY . . . . . 0.448 ' O ' ' CB ' ' A' ' 121' ' ' THR . . . -134.16 -68.64 0.07 OUTLIER Glycine 0 CA--C 1.554 2.486 0 N-CA-C 105.996 -2.842 . . . . 1.0 105.996 173.974 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 121' ' ' THR . . . . . 0.495 ' CG2' HG22 ' A' ' 123' ' ' THR . 2.3 m 152.7 -31.96 0.01 OUTLIER 'General case' 0 N--CA 1.481 1.101 0 CA-C-N 112.656 -1.772 . . . . 1.0 112.01 178.478 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 122' ' ' GLY . . . . . 0.67 ' O ' ' N ' ' A' ' 124' ' ' ASP . . . 104.02 -17.03 49.5 Favored Glycine 0 N--CA 1.471 1.016 0 N-CA-C 108.875 -1.69 . . . . 1.0 108.875 -177.973 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 123' ' ' THR . . . . . 0.495 HG22 ' CG2' ' A' ' 121' ' ' THR . 0.0 OUTLIER -55.4 84.98 0.0 OUTLIER 'General case' 0 CA--C 1.539 0.527 0 N-CA-C 105.566 -2.013 . . . . 1.0 105.566 178.548 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild full ' A' A ' 124' ' ' ASP . . . . . 0.67 ' N ' ' O ' ' A' ' 122' ' ' GLY . 63.7 m-20 -163.56 170.81 16.7 Favored 'General case' 0 N--CA 1.471 0.575 0 CA-C-N 113.428 -1.715 . . . . 1.0 112.342 -179.086 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 125' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -144.15 138.73 28.36 Favored 'General case' 0 CA--C 1.547 0.846 0 N-CA-C 107.377 -1.342 . . . . 1.0 107.377 176.449 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 25.6 mmm180 -149.31 153.85 38.12 Favored 'General case' 0 N--CA 1.476 0.851 0 N-CA-C 109.872 -0.418 . . . . 1.0 109.872 178.575 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 127' ' ' PHE . . . . . 0.478 ' OXT' ' CD1' ' A' ' 127' ' ' PHE . 0.1 OUTLIER . . . . . 0 N--CA 1.471 0.589 0 CA-C-O 118.076 -0.964 . . . . 1.0 110.269 178.862 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 128' ' ' MTN . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 029 nuclear nobuild full ' A' A ' 129' ' ' MTN . . . . . 0.488 ' C2 ' ' SG ' ' A' ' 48' ' ' CYS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 130' ' ' MTN . . . . . 0.539 ' H61' HE21 ' A' ' 99' ' ' GLN . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.495 1.8 0 N-CA-C 109.92 -0.4 . . . . 1.0 109.92 . . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . 0.49 ' O ' ' CB ' ' A' ' 3' ' ' ASP . 9.0 t -86.49 13.78 7.82 Favored 'General case' 0 C--O 1.225 -0.23 0 CA-C-N 115.786 -0.643 . . . . 1.0 111.264 -179.918 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . 0.49 ' CB ' ' O ' ' A' ' 2' ' ' SER . 21.5 m-20 146.43 122.27 0.0 OUTLIER 'General case' 0 N--CA 1.478 0.955 0 O-C-N 124.577 1.173 . . . . 1.0 110.524 178.948 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 47.8 t80 -154.78 150.52 27.63 Favored 'General case' 0 N--CA 1.466 0.361 0 CA-C-N 116.062 -0.517 . . . . 1.0 110.573 179.028 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -152.39 147.97 26.92 Favored 'General case' 0 CA--C 1.543 0.694 0 CA-C-N 116.364 -0.38 . . . . 1.0 110.263 -178.529 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 6' ' ' THR . . . . . 0.479 HG22 ' H ' ' A' ' 7' ' ' GLU . 0.2 OUTLIER -61.49 -157.6 0.01 OUTLIER 'General case' 0 N--CA 1.472 0.671 0 C-N-CA 121.032 -0.267 . . . . 1.0 111.037 -179.187 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . 0.479 ' H ' HG22 ' A' ' 6' ' ' THR . 3.2 pt-20 -75.76 -67.57 0.66 Allowed 'General case' 0 C--O 1.216 -0.698 0 CA-C-O 118.553 -0.737 . . . . 1.0 110.245 -179.367 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 8' ' ' ARG . . . . . 0.473 ' H ' ' CG ' ' A' ' 7' ' ' GLU . 7.0 tmm_? -47.08 -43.01 19.81 Favored 'General case' 0 CA--C 1.493 -1.214 0 CA-C-N 119.645 1.111 . . . . 1.0 111.781 -177.858 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . 0.438 ' O ' HG23 ' A' ' 13' ' ' VAL . 0.1 OUTLIER -68.96 -52.99 28.74 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.94 0 C-N-CA 118.933 -1.107 . . . . 1.0 108.779 179.063 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 39.5 t -58.67 -42.75 89.18 Favored 'General case' 0 N--CA 1.455 -0.207 0 CA-C-O 118.868 -0.587 . . . . 1.0 111.968 179.528 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 11' ' ' ARG . . . . . 0.678 ' O ' ' N ' ' A' ' 14' ' ' ALA . 0.0 OUTLIER -74.17 -59.97 2.48 Favored 'General case' 0 CA--C 1.492 -1.256 0 N-CA-C 106.85 -1.537 . . . . 1.0 106.85 178.051 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . 0.651 ' O ' ' HB3' ' A' ' 16' ' ' ALA . . . -38.91 -43.08 0.92 Allowed 'General case' 0 CA--C 1.487 -1.475 0 CA-C-N 119.108 0.867 . . . . 1.0 108.783 -175.879 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . 0.693 ' O ' ' HB3' ' A' ' 17' ' ' LEU . 71.5 t -60.12 -52.53 60.21 Favored 'Isoleucine or valine' 0 C--O 1.186 -2.252 0 C-N-CA 115.984 -2.286 . . . . 1.0 106.822 177.664 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . 0.796 ' O ' HG13 ' A' ' 18' ' ' VAL . . . -66.1 -64.89 0.76 Allowed 'General case' 0 C--O 1.209 -1.041 0 O-C-N 120.329 -1.482 . . . . 1.0 113.122 177.954 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . 0.525 ' O ' ' N ' ' A' ' 19' ' ' GLY . . . -57.19 -59.13 5.56 Favored 'General case' 0 N--CA 1.497 1.878 0 C-N-CA 119.739 -0.784 . . . . 1.0 112.86 -175.263 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . 0.668 ' HB1' ' CA ' ' A' ' 22' ' ' GLY . . . -61.62 -54.89 36.86 Favored 'General case' 0 CA--C 1.556 1.206 0 CA-C-O 122.533 1.158 . . . . 1.0 109.866 -177.678 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . 0.693 ' HB3' ' O ' ' A' ' 13' ' ' VAL . 21.1 tp -57.57 -51.17 70.56 Favored 'General case' 0 N--CA 1.481 1.102 0 CA-C-N 113.57 -1.65 . . . . 1.0 108.194 -177.452 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . 0.796 HG13 ' O ' ' A' ' 14' ' ' ALA . 3.0 m -70.34 -57.08 8.92 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.461 0 C-N-CA 118.927 -1.109 . . . . 1.0 110.168 179.636 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . 0.525 ' N ' ' O ' ' A' ' 15' ' ' ALA . . . -61.62 -177.43 2.53 Favored Glycine 0 N--CA 1.446 -0.697 0 N-CA-C 111.718 -0.553 . . . . 1.0 111.718 -178.045 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 20' ' ' PRO . . . . . 0.569 ' O ' ' N ' ' A' ' 24' ' ' ALA . 54.4 Cg_endo -82.81 -23.63 3.76 Favored 'Trans proline' 0 C--N 1.303 -1.85 0 C-N-CA 123.045 2.497 . . . . 1.0 112.065 -179.271 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -60.51 -59.22 10.66 Favored Glycine 0 CA--C 1.535 1.301 0 C-N-CA 120.046 -1.073 . . . . 1.0 111.321 -176.952 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . 0.668 ' CA ' ' HB1' ' A' ' 16' ' ' ALA . . . -56.14 -52.91 46.34 Favored Glycine 0 N--CA 1.469 0.893 0 N-CA-C 107.101 -2.399 . . . . 1.0 107.101 -178.411 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . 0.479 ' O ' HG12 ' A' ' 27' ' ' VAL . 36.7 t -59.28 -33.25 50.34 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.185 0 C-N-CA 119.774 -0.77 . . . . 1.0 109.143 179.836 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . 0.569 ' N ' ' O ' ' A' ' 20' ' ' PRO . . . -55.33 -62.29 1.77 Allowed 'General case' 0 N--CA 1.479 1.018 0 C-N-CA 119.239 -0.984 . . . . 1.0 110.568 -179.886 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 18.3 mt -63.66 -43.3 97.12 Favored 'General case' 0 C--N 1.345 0.392 0 C-N-CA 119.919 -0.712 . . . . 1.0 112.39 -177.854 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 95.2 t -60.22 -60.53 2.42 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.79 0 C-N-CA 118.591 -1.244 . . . . 1.0 111.279 -177.608 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . 0.513 ' O ' ' HB3' ' A' ' 31' ' ' ALA . 3.1 p -59.61 -34.26 54.48 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.2 0 N-CA-C 112.681 0.623 . . . . 1.0 112.681 -177.58 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 71.3 tttt -66.79 -54.71 19.9 Favored 'General case' 0 C--N 1.312 -1.034 0 CA-C-O 122.317 1.056 . . . . 1.0 108.79 -179.68 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 98.6 t -62.88 -47.67 91.72 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.145 0 CA-C-N 113.553 -1.658 . . . . 1.0 110.499 -177.092 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 30' ' ' CYS . . . . . 0.561 ' SG ' ' N ' ' A' ' 31' ' ' ALA . 0.0 OUTLIER -67.48 -61.17 2.03 Favored 'General case' 0 CA--C 1.533 0.326 0 C-N-CA 118.729 -1.188 . . . . 1.0 110.198 -179.692 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . 0.561 ' N ' ' SG ' ' A' ' 30' ' ' CYS . . . -60.38 -53.85 52.71 Favored 'General case' 0 CA--C 1.509 -0.6 0 CA-C-N 118.25 0.477 . . . . 1.0 111.99 -177.001 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . 0.495 ' O ' ' CB ' ' A' ' 33' ' ' LEU . . . 87.33 74.36 1.28 Allowed Glycine 0 CA--C 1.521 0.416 0 N-CA-C 108.632 -1.787 . . . . 1.0 108.632 -178.529 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . 0.501 HD22 ' H ' ' A' ' 36' ' ' VAL . 1.1 tt 85.81 85.31 0.05 OUTLIER Pre-proline 0 CA--C 1.546 0.792 0 CA-C-O 120.692 0.282 . . . . 1.0 110.414 -179.343 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 51.7 Cg_exo -53.23 -30.4 51.11 Favored 'Trans proline' 0 N--CA 1.502 1.99 0 C-N-CA 123.005 2.47 . . . . 1.0 114.227 -179.679 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -57.23 -60.75 8.45 Favored Glycine 0 N--CA 1.469 0.856 0 C-N-CA 119.062 -1.542 . . . . 1.0 110.185 -178.653 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . 0.585 ' O ' HG22 ' A' ' 37' ' ' ILE . 2.7 p -88.77 160.49 2.82 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.479 0 N-CA-C 105.77 -1.937 . . . . 1.0 105.77 177.808 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . 0.663 HG23 ' O ' ' A' ' 37' ' ' ILE . 0.7 OUTLIER 125.61 113.56 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.479 0.996 0 O-C-N 124.682 1.239 . . . . 1.0 110.373 179.711 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild full ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 22.5 m80 -139.83 131.81 27.79 Favored 'General case' 0 N--CA 1.467 0.418 0 N-CA-C 108.557 -0.905 . . . . 1.0 108.557 179.263 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 9.2 p -99.37 149.4 35.8 Favored Pre-proline 0 N--CA 1.469 0.478 0 CA-C-N 116.969 -0.105 . . . . 1.0 110.743 -179.46 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 91.2 Cg_endo -75.29 -37.98 1.66 Allowed 'Trans proline' 0 N--CA 1.494 1.539 0 C-N-CA 122.317 2.012 . . . . 1.0 113.345 -179.123 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -128.2 134.38 49.02 Favored 'General case' 0 N--CA 1.472 0.665 0 N-CA-C 111.555 0.206 . . . . 1.0 111.555 179.611 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . 0.683 ' C ' ' H ' ' A' ' 44' ' ' GLY . 0.0 OUTLIER -169.86 165.95 9.61 Favored 'General case' 0 C--N 1.325 -0.487 0 C-N-CA 120.17 -0.612 . . . . 1.0 109.697 178.391 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild full ' A' A ' 43' ' ' ARG . . . . . 0.463 ' C ' ' H ' ' A' ' 45' ' ' PHE . 0.0 OUTLIER -61.89 24.92 0.01 OUTLIER 'General case' 0 CA--C 1.548 0.896 0 CA-C-N 115.494 -0.775 . . . . 1.0 110.553 179.82 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . 0.683 ' H ' ' C ' ' A' ' 42' ' ' ARG . . . 76.42 -26.08 1.61 Allowed Glycine 0 C--N 1.345 1.073 0 N-CA-C 110.452 -1.059 . . . . 1.0 110.452 -179.948 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . 0.578 ' O ' ' HB2' ' A' ' 46' ' ' PHE . 6.6 p90 -169.37 172.12 7.37 Favored 'General case' 0 C--O 1.219 -0.518 0 N-CA-C 109.966 -0.383 . . . . 1.0 109.966 179.743 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 46' ' ' PHE . . . . . 0.578 ' HB2' ' O ' ' A' ' 45' ' ' PHE . 1.1 m-85 131.63 99.57 0.0 OUTLIER 'General case' 0 N--CA 1.501 2.083 0 O-C-N 125.763 1.914 . . . . 1.0 109.802 178.695 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 47' ' ' ARG . . . . . 0.644 ' HG2' ' H ' ' A' ' 48' ' ' CYS . 15.6 ttp85 93.88 175.27 0.01 OUTLIER 'General case' 0 N--CA 1.468 0.446 0 O-C-N 123.596 0.56 . . . . 1.0 110.254 179.09 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 48' ' ' CYS . . . . . 0.644 ' H ' ' HG2' ' A' ' 47' ' ' ARG . 2.5 t 67.53 62.68 0.43 Allowed 'General case' 0 N--CA 1.445 -0.707 0 N-CA-C 106.373 -1.714 . . . . 1.0 106.373 -178.351 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 49' ' ' ASN . . . . . 0.559 ' N ' ' OD1' ' A' ' 49' ' ' ASN . 1.1 p30 -156.21 155.74 29.41 Favored Pre-proline 0 N--CA 1.449 -0.508 0 N-CA-C 108.097 -1.075 . . . . 1.0 108.097 178.865 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . 0.428 ' O ' ' NH1' ' A' ' 52' ' ' ARG . 50.8 Cg_endo -67.59 76.5 0.54 Allowed 'Trans proline' 0 C--N 1.303 -1.828 0 C-N-CA 121.967 1.778 . . . . 1.0 112.272 177.238 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 9.0 pt-20 40.12 63.97 0.98 Allowed 'General case' 0 N--CA 1.477 0.921 0 N-CA-C 112.532 0.567 . . . . 1.0 112.532 -179.95 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . 0.68 HH22 ' CE1' ' A' ' 92' ' ' HIS . 77.6 mtt85 -147.28 136.02 22.05 Favored 'General case' 0 N--CA 1.472 0.627 0 CA-C-N 116.049 -0.523 . . . . 1.0 111.844 178.896 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -54.44 164.75 0.29 Allowed 'Isoleucine or valine' 0 N--CA 1.478 0.942 0 N-CA-C 107.212 -1.403 . . . . 1.0 107.212 177.455 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 39.9 mm-40 -121.0 115.04 22.4 Favored 'General case' 0 CA--C 1.548 0.891 0 CA-C-N 121.845 2.111 . . . . 1.0 109.245 179.949 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . 0.457 HD12 ' N ' ' A' ' 56' ' ' GLY . 0.7 OUTLIER -146.7 157.73 10.8 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.017 0 CA-C-N 118.476 0.58 . . . . 1.0 109.532 177.704 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . 0.457 ' N ' HD12 ' A' ' 55' ' ' ILE . . . 110.84 -6.81 29.45 Favored Glycine 0 N--CA 1.481 1.68 0 CA-C-N 118.752 0.706 . . . . 1.0 112.3 -179.595 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -112.64 127.88 56.23 Favored 'General case' 0 C--N 1.32 -0.682 0 N-CA-C 108.677 -0.86 . . . . 1.0 108.677 178.126 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 58' ' ' TRP . . . . . 0.538 ' H ' ' HB2' ' A' ' 61' ' ' GLU . 5.0 m0 -139.18 158.48 44.1 Favored 'General case' 0 N--CA 1.455 -0.216 0 CA-C-O 122.808 1.29 . . . . 1.0 109.529 179.298 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 34.9 ptt-85 -41.03 -36.41 0.67 Allowed 'General case' 0 C--N 1.296 -1.728 0 CA-C-N 112.318 -2.219 . . . . 1.0 109.181 -178.616 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 42.8 t80 -90.94 -35.67 14.58 Favored 'General case' 0 N--CA 1.481 1.09 0 CA-C-O 121.687 0.756 . . . . 1.0 112.449 178.82 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . 0.538 ' HB2' ' H ' ' A' ' 58' ' ' TRP . 92.5 mt-10 -77.67 -13.92 59.77 Favored 'General case' 0 N--CA 1.443 -0.812 0 O-C-N 121.757 -0.589 . . . . 1.0 110.53 179.926 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . 0.628 HG13 ' N ' ' A' ' 63' ' ' ALA . 7.3 p -46.71 -56.2 1.42 Allowed 'Isoleucine or valine' 0 C--O 1.213 -0.858 0 C-N-CA 119.444 -0.902 . . . . 1.0 109.318 -175.664 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 63' ' ' ALA . . . . . 0.628 ' N ' HG13 ' A' ' 62' ' ' VAL . . . -64.77 -54.29 33.6 Favored 'General case' 0 C--N 1.302 -1.483 0 O-C-N 121.966 -0.459 . . . . 1.0 110.059 179.94 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 2.9 m-70 -53.16 -57.74 9.44 Favored 'General case' 0 CA--C 1.549 0.917 0 C-N-CA 119.591 -0.844 . . . . 1.0 109.813 -179.205 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . 0.623 ' C ' ' H ' ' A' ' 67' ' ' ARG . 33.8 t0 -72.72 -52.07 16.68 Favored 'General case' 0 C--O 1.245 0.854 0 CA-C-O 121.899 0.857 . . . . 1.0 111.48 179.111 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . 0.584 ' N ' ' O ' ' A' ' 62' ' ' VAL . . . -69.51 27.71 0.36 Allowed Glycine 0 C--O 1.226 -0.374 0 O-C-N 120.74 -1.225 . . . . 1.0 110.66 177.04 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 67' ' ' ARG . . . . . 0.709 ' O ' ' N ' ' A' ' 69' ' ' LEU . 8.0 mtm-85 -75.63 5.58 5.91 Favored 'General case' 0 CA--C 1.507 -0.673 0 N-CA-C 108.011 -1.107 . . . . 1.0 108.011 176.049 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . 0.46 ' C ' ' O ' ' A' ' 67' ' ' ARG . 2.7 mt -31.43 -25.5 0.0 OUTLIER 'General case' 0 N--CA 1.486 1.35 0 N-CA-C 108.311 -0.996 . . . . 1.0 108.311 -177.694 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . 0.709 ' N ' ' O ' ' A' ' 67' ' ' ARG . 48.1 tp -64.85 -65.35 0.69 Allowed 'General case' 0 N--CA 1.472 0.637 0 N-CA-C 108.662 -0.866 . . . . 1.0 108.662 177.655 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . 0.631 ' O ' ' N ' ' A' ' 72' ' ' HIS . . . -80.66 -73.96 0.34 Allowed 'General case' 0 N--CA 1.47 0.55 0 N-CA-C 104.438 -2.43 . . . . 1.0 104.438 176.906 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . 0.489 ' O ' ' C ' ' A' ' 72' ' ' HIS . . . -42.83 0.89 0.0 OUTLIER 'General case' 0 CA--C 1.513 -0.47 0 C-N-CA 124.864 1.265 . . . . 1.0 113.647 179.493 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 72' ' ' HIS . . . . . 0.671 ' CG ' ' N ' ' A' ' 73' ' ' MET . 0.0 OUTLIER -26.65 -63.5 0.08 Allowed 'General case' 0 C--N 1.346 0.434 0 CA-C-N 118.243 0.474 . . . . 1.0 110.421 -179.825 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild full ' A' A ' 73' ' ' MET . . . . . 0.671 ' N ' ' CG ' ' A' ' 72' ' ' HIS . 12.5 ttm -74.32 -50.86 17.06 Favored 'General case' 0 C--N 1.323 -0.563 0 C-N-CA 119.043 -1.063 . . . . 1.0 109.917 178.668 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . 0.564 ' O ' ' N ' ' A' ' 76' ' ' GLY . 41.2 t -46.09 -45.78 5.77 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.269 0 CA-C-O 117.604 -1.189 . . . . 1.0 112.589 -175.018 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 75' ' ' ASN . . . . . 0.674 ' O ' HG23 ' A' ' 79' ' ' ILE . 8.2 t-20 -42.54 -15.71 0.01 OUTLIER 'General case' 0 C--N 1.35 0.6 0 CA-C-N 121.227 1.83 . . . . 1.0 111.425 177.336 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . 0.564 ' N ' ' O ' ' A' ' 74' ' ' VAL . . . -46.18 -25.65 1.92 Allowed Glycine 0 CA--C 1.531 1.084 0 N-CA-C 108.984 -1.646 . . . . 1.0 108.984 -179.921 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . 0.526 ' O ' ' N ' ' A' ' 79' ' ' ILE . 0.9 OUTLIER -86.32 -61.96 1.65 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.699 0 CA-C-N 113.886 -1.157 . . . . 1.0 110.615 -178.099 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . 0.427 ' C ' ' O ' ' A' ' 77' ' ' ILE . 12.2 t -37.86 -27.34 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.443 -0.789 0 N-CA-C 109.221 -0.659 . . . . 1.0 109.221 -178.308 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . 0.832 ' O ' ' HB3' ' A' ' 83' ' ' ALA . 0.9 OUTLIER -67.99 -51.87 44.93 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.788 0 C-N-CA 119.827 -0.749 . . . . 1.0 110.857 178.916 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild full ' A' A ' 80' ' ' ALA . . . . . 0.512 ' N ' ' CG1' ' A' ' 79' ' ' ILE . . . -61.48 -63.14 1.37 Allowed 'General case' 0 C--O 1.231 0.097 0 C-N-CA 119.131 -1.028 . . . . 1.0 110.89 -178.656 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . 0.434 ' HG2' ' H ' ' A' ' 81' ' ' GLU . 0.2 OUTLIER -49.28 -72.64 0.05 OUTLIER 'General case' 0 CA--C 1.536 0.437 0 C-N-CA 119.57 -0.852 . . . . 1.0 109.924 -179.495 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild full ' A' A ' 82' ' ' ASP . . . . . 0.471 ' O ' ' N ' ' A' ' 84' ' ' LEU . 33.4 m-20 -59.6 -63.31 1.35 Allowed 'General case' 0 C--N 1.331 -0.227 0 C-N-CA 118.233 -1.387 . . . . 1.0 109.897 -178.285 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . 0.832 ' HB3' ' O ' ' A' ' 79' ' ' ILE . . . -68.82 57.95 0.09 Allowed 'General case' 0 C--N 1.317 -0.814 0 C-N-CA 119.416 -0.914 . . . . 1.0 110.395 -179.61 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . 0.471 ' N ' ' O ' ' A' ' 82' ' ' ASP . 0.2 OUTLIER -79.68 7.09 9.11 Favored 'General case' 0 C--N 1.351 0.672 0 N-CA-C 108.62 -0.881 . . . . 1.0 108.62 179.033 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild full ' A' A ' 85' ' ' ILE . . . . . 0.782 ' O ' ' HB ' ' A' ' 89' ' ' VAL . 0.0 OUTLIER -92.06 -7.96 10.42 Favored 'Isoleucine or valine' 0 C--O 1.193 -1.88 0 CA-C-N 114.647 -1.161 . . . . 1.0 108.652 178.648 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -96.76 -12.96 23.01 Favored 'General case' 0 CA--C 1.544 0.747 0 CA-C-O 120.696 0.284 . . . . 1.0 111.709 179.704 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -88.53 -37.13 15.97 Favored 'General case' 0 N--CA 1.481 1.076 0 N-CA-C 113.321 0.86 . . . . 1.0 113.321 -178.493 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -112.88 -8.41 13.71 Favored 'General case' 0 N--CA 1.482 1.129 0 CA-C-O 121.57 0.7 . . . . 1.0 110.971 -178.629 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 89' ' ' VAL . . . . . 0.782 ' HB ' ' O ' ' A' ' 85' ' ' ILE . 14.9 t -99.43 33.34 0.31 Allowed 'Isoleucine or valine' 0 CA--C 1.503 -0.861 0 CA-C-N 115.144 -0.935 . . . . 1.0 109.425 178.095 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 90' ' ' GLY . . . . . 0.644 ' N ' ' HD2' ' A' ' 91' ' ' PRO . . . -67.42 -42.35 89.56 Favored Glycine 0 CA--C 1.537 1.414 0 N-CA-C 110.091 -1.204 . . . . 1.0 110.091 176.531 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 91' ' ' PRO . . . . . 0.644 ' HD2' ' N ' ' A' ' 90' ' ' GLY . 5.8 Cg_exo -42.09 -13.93 0.04 OUTLIER 'Trans proline' 0 N--CA 1.496 1.655 0 C-N-CA 122.152 1.901 . . . . 1.0 111.034 177.753 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 92' ' ' HIS . . . . . 0.68 ' CE1' HH22 ' A' ' 52' ' ' ARG . 47.9 p-80 -57.16 -18.42 15.21 Favored 'General case' 0 C--O 1.202 -1.397 0 N-CA-C 107.94 -1.133 . . . . 1.0 107.94 179.928 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . 0.646 HD12 ' N ' ' A' ' 94' ' ' ALA . 1.3 pp -65.67 -57.69 7.48 Favored 'General case' 0 C--N 1.325 -0.495 0 N-CA-C 108.785 -0.82 . . . . 1.0 108.785 179.537 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 94' ' ' ALA . . . . . 0.646 ' N ' HD12 ' A' ' 93' ' ' LEU . . . -58.35 -53.95 52.53 Favored 'General case' 0 CA--C 1.515 -0.396 0 N-CA-C 108.78 -0.822 . . . . 1.0 108.78 179.031 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 95' ' ' ARG . . . . . 0.692 ' O ' ' N ' ' A' ' 97' ' ' LEU . 6.8 mtm-85 -58.09 -58.3 9.02 Favored 'General case' 0 N--CA 1.449 -0.486 0 N-CA-C 107.322 -1.362 . . . . 1.0 107.322 178.732 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 96' ' ' ALA . . . . . 0.942 ' O ' ' N ' ' A' ' 98' ' ' GLY . . . -46.14 -11.62 0.02 OUTLIER 'General case' 0 C--N 1.308 -1.224 0 O-C-N 118.49 -2.631 . . . . 1.0 110.807 -179.687 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . 0.718 ' O ' ' N ' ' A' ' 100' ' ' ILE . 4.3 tt 9.22 -54.09 0.0 OUTLIER 'General case' 0 N--CA 1.476 0.873 0 CA-C-O 117.474 -1.25 . . . . 1.0 109.817 -168.19 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 98' ' ' GLY . . . . . 0.942 ' N ' ' O ' ' A' ' 96' ' ' ALA . . . -47.63 -22.46 1.8 Allowed Glycine 0 CA--C 1.547 2.086 0 CA-C-N 122.328 2.331 . . . . 1.0 107.295 174.908 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 99' ' ' GLN . . . . . 0.533 ' N ' ' O ' ' A' ' 96' ' ' ALA . 4.3 tp-100 -65.34 -20.5 66.42 Favored 'General case' 0 C--N 1.378 1.813 0 C-N-CA 117.975 -1.49 . . . . 1.0 108.439 176.922 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 100' ' ' ILE . . . . . 0.718 ' N ' ' O ' ' A' ' 97' ' ' LEU . 18.7 mm -64.13 -47.05 91.81 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.753 0 CA-C-N 114.438 -1.255 . . . . 1.0 108.325 177.489 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 101' ' ' VAL . . . . . 0.709 ' O ' ' N ' ' A' ' 105' ' ' GLY . 57.4 t -60.44 -58.96 4.99 Favored 'Isoleucine or valine' 0 C--O 1.219 -0.526 0 N-CA-C 106.945 -1.502 . . . . 1.0 106.945 179.58 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 102' ' ' CYS . . . . . 0.966 ' O ' ' HB2' ' A' ' 106' ' ' ALA . 0.0 OUTLIER -45.22 -17.92 0.03 OUTLIER 'General case' 0 N--CA 1.444 -0.726 0 CA-C-O 121.423 0.63 . . . . 1.0 110.268 -179.889 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild full ' A' A ' 103' ' ' ARG . . . . . 0.62 ' NH2' ' CZ ' ' A' ' 104' ' ' TYR . 0.1 OUTLIER -95.48 -44.43 7.53 Favored 'General case' 0 N--CA 1.474 0.759 0 CA-C-O 122.47 1.129 . . . . 1.0 112.359 177.985 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild full ' A' A ' 104' ' ' TYR . . . . . 0.62 ' CZ ' ' NH2' ' A' ' 103' ' ' ARG . 12.1 m-85 -107.16 21.41 17.57 Favored 'General case' 0 C--N 1.318 -0.761 0 C-N-CA 127.251 2.22 . . . . 1.0 111.861 179.507 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 105' ' ' GLY . . . . . 0.709 ' N ' ' O ' ' A' ' 101' ' ' VAL . . . -170.83 -10.68 0.02 OUTLIER Glycine 0 C--N 1.341 0.806 0 C-N-CA 119.356 -1.402 . . . . 1.0 112.155 179.664 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 106' ' ' ALA . . . . . 0.966 ' HB2' ' O ' ' A' ' 102' ' ' CYS . . . -28.77 75.13 0.0 OUTLIER 'General case' 0 CA--C 1.512 -0.492 0 N-CA-C 113.805 1.039 . . . . 1.0 113.805 -179.472 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 107' ' ' THR . . . . . 0.693 ' N ' ' O ' ' A' ' 105' ' ' GLY . 15.2 t -91.22 5.95 47.08 Favored 'General case' 0 N--CA 1.434 -1.264 0 N-CA-C 106.045 -1.835 . . . . 1.0 106.045 178.177 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . 0.724 ' O ' HG22 ' A' ' 108' ' ' VAL . 11.8 p -95.84 17.01 2.02 Favored 'Isoleucine or valine' 0 C--N 1.352 0.687 0 CA-C-O 118.493 -0.765 . . . . 1.0 110.873 177.077 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 109' ' ' ILE . . . . . 0.676 ' N ' ' CD ' ' A' ' 110' ' ' PRO . 40.5 pt -105.77 -14.85 0.15 Allowed Pre-proline 0 N--CA 1.438 -1.073 0 CA-C-N 121.255 1.843 . . . . 1.0 110.457 177.915 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 110' ' ' PRO . . . . . 0.676 ' CD ' ' N ' ' A' ' 109' ' ' ILE . 55.7 Cg_endo -67.36 -48.21 1.8 Allowed 'Trans proline' 0 N--CA 1.493 1.465 0 CA-C-N 121.163 1.451 . . . . 1.0 113.094 -175.728 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 15.6 t-20 -67.47 -66.36 0.57 Allowed 'General case' 0 N--CA 1.453 -0.304 0 C-N-CA 119.756 -0.777 . . . . 1.0 109.874 -179.125 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 112' ' ' ILE . . . . . 0.515 ' O ' ' HB ' ' A' ' 116' ' ' ILE . 2.9 tt -43.56 -40.52 1.37 Allowed 'Isoleucine or valine' 0 CA--C 1.548 0.904 0 N-CA-C 113.093 0.775 . . . . 1.0 113.093 -178.247 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 5.8 m-80 -67.86 -41.12 83.39 Favored 'General case' 0 C--N 1.31 -1.134 0 CA-C-O 122.449 1.119 . . . . 1.0 109.295 178.061 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -59.62 -52.02 67.31 Favored 'General case' 0 C--N 1.296 -1.74 0 CA-C-N 113.386 -1.734 . . . . 1.0 108.95 179.912 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -78.81 -57.04 3.96 Favored 'General case' 0 CA--C 1.537 0.456 0 N-CA-C 114.047 1.128 . . . . 1.0 114.047 179.517 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 116' ' ' ILE . . . . . 0.586 ' O ' ' N ' ' A' ' 120' ' ' GLY . 4.5 mm -52.05 -51.16 31.76 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.209 0 CA-C-O 122.008 0.909 . . . . 1.0 112.445 -176.55 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 117' ' ' GLU . . . . . 0.489 ' C ' ' O ' ' A' ' 116' ' ' ILE . 65.4 mt-10 -45.07 -56.92 4.24 Favored 'General case' 0 C--N 1.313 -0.982 0 N-CA-C 105.516 -2.031 . . . . 1.0 105.516 -176.662 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 96.7 t -58.07 -53.92 39.24 Favored 'Isoleucine or valine' 0 CA--C 1.554 1.129 0 C-N-CA 119.919 -0.712 . . . . 1.0 109.444 177.49 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 4.6 tt -51.92 -68.91 0.13 Allowed 'General case' 0 N--CA 1.48 1.033 0 N-CA-C 106.82 -1.548 . . . . 1.0 106.82 -178.628 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 120' ' ' GLY . . . . . 0.586 ' N ' ' O ' ' A' ' 116' ' ' ILE . . . -73.33 -82.65 0.33 Allowed Glycine 0 CA--C 1.548 2.156 0 C-N-CA 120.897 -0.668 . . . . 1.0 112.34 -179.158 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 121' ' ' THR . . . . . 0.495 ' OG1' ' O ' ' A' ' 120' ' ' GLY . 4.2 m 155.6 -34.31 0.01 OUTLIER 'General case' 0 N--CA 1.482 1.155 0 CA-C-N 112.435 -1.883 . . . . 1.0 112.355 179.397 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 122' ' ' GLY . . . . . 0.684 ' O ' ' N ' ' A' ' 124' ' ' ASP . . . 103.96 -17.76 47.98 Favored Glycine 0 N--CA 1.461 0.313 0 N-CA-C 106.198 -2.761 . . . . 1.0 106.198 -176.589 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 123' ' ' THR . . . . . 0.706 HG23 ' O ' ' A' ' 123' ' ' THR . 9.6 t -55.98 81.31 0.0 OUTLIER 'General case' 0 N--CA 1.468 0.475 0 N-CA-C 105.519 -2.03 . . . . 1.0 105.519 178.758 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 124' ' ' ASP . . . . . 0.684 ' N ' ' O ' ' A' ' 122' ' ' GLY . 40.7 m-20 -166.81 178.85 5.64 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 112.871 -1.968 . . . . 1.0 111.66 179.041 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 125' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -147.34 143.76 28.26 Favored 'General case' 0 CA--C 1.545 0.78 0 N-CA-C 108.154 -1.054 . . . . 1.0 108.154 176.473 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 72.2 mtt-85 -150.92 155.8 39.88 Favored 'General case' 0 N--CA 1.47 0.569 0 CA-C-O 120.801 0.334 . . . . 1.0 111.011 176.535 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 127' ' ' PHE . . . . . 0.473 ' OXT' ' CG ' ' A' ' 127' ' ' PHE . 5.8 p90 . . . . . 0 C--O 1.218 -0.603 0 CA-C-O 118.188 -0.91 . . . . 1.0 110.159 179.276 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 128' ' ' MTN . . . . . 0.492 ' H91' ' HD3' ' A' ' 47' ' ' ARG . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 129' ' ' MTN . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 030 nuclear nobuild full ' A' A ' 130' ' ' MTN . . . . . 0.414 ' C6 ' ' SG ' ' A' ' 102' ' ' CYS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 stop_ save_